{"meta":{"query_hash":"606793aed8c0","filters":{"venue":"Clinical Cancer Research"},"cohort_total":2205,"direct_labels_cover":5,"predictions_cover":2205,"exported":2205,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/606793aed8c0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Cancer+Research"},"results":[{"id":"W1277142619","doi":"","title":"Targeting Y-box binding protein-1 (YB-1) in Her-2 over-expressing breast cancer cells induces apoptosis via the signal transducer and activator or transcription-3 (STAT3) pathway and suppresses tumor growth.","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"STAT3; Cancer research; Apoptosis; Carcinogenesis; STAT protein; Breast cancer; Biology; Cancer; Medicine; Chemistry; Molecular biology; Internal medicine","score_opus":0.08824881387887633,"score_gpt":0.38541249517700965,"score_spread":0.2971636812981333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1277142619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950486,0.0026113694,0.00011016256,0.0012225545,0.00011107049,0.0006522847,0.00019375992,0.0000104195815,0.000039781447],"genre_scores_gemma":[0.99161094,0.006603694,0.00012221037,0.00013273259,0.00050350605,0.0006798055,0.000013401758,0.00004150171,0.00029220938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973259,0.0005099983,0.00050438166,0.0007201638,0.00039474067,0.0005448335],"domain_scores_gemma":[0.99902374,0.0001990107,0.00010782451,0.00025749646,0.00021951295,0.00019240056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010923067,0.00021402349,0.0002848438,0.00008750273,0.0005389419,0.00010393928,0.0002964677,0.00019973775,0.00023843755],"category_scores_gemma":[0.00008952374,0.00014838082,0.00008020662,0.00032238755,0.0007644152,0.000041695836,0.00010126632,0.0006690377,0.0000013803896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075540825,0.00013171755,0.006990446,0.00009412891,0.000047822017,0.000005997986,0.00029551418,0.00001538206,0.98368806,0.000006326835,0.00054218934,0.0074269962],"study_design_scores_gemma":[0.001345372,0.00023319581,0.010863617,0.00019627954,0.000015615511,0.000011828433,0.00047864707,0.00008084429,0.9829293,0.00003302991,0.003507974,0.0003042957],"about_ca_topic_score_codex":0.0013347238,"about_ca_topic_score_gemma":0.0002166299,"teacher_disagreement_score":0.0071227006,"about_ca_system_score_codex":0.000059116413,"about_ca_system_score_gemma":0.00057057024,"threshold_uncertainty_score":0.6050794},"labels":[],"label_agreement":null},{"id":"W1483638371","doi":"","title":"Detection of JAK2 V617F mutation in patients with myeloproliferative disorders using real-time PCR","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Biology; Essential thrombocythemia; Point mutation; ABL; Polycythemia vera; Mutation; Chronic myelogenous leukemia; Allele; Leukemia; Cancer research; Molecular biology; Genetics; Immunology; Gene; Tyrosine kinase","score_opus":0.07058238119344454,"score_gpt":0.4381847314717254,"score_spread":0.3676023502782808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1483638371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970545,0.00008614037,0.00004560729,0.00035625682,0.000055053893,0.0012902308,0.000019676809,0.000015572443,0.001076915],"genre_scores_gemma":[0.9987864,0.00020239523,0.00040890393,0.000026565736,0.00014269933,0.00020655141,0.000046210134,0.00002679812,0.00015350664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974338,0.00040553167,0.00061864196,0.00043225085,0.0007571606,0.00035260574],"domain_scores_gemma":[0.9982682,0.00059088133,0.00014016971,0.00022259235,0.0006649356,0.00011326315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086505123,0.00014797851,0.00045550606,0.00024689254,0.00010479874,0.000016673139,0.000061174615,0.00013399842,0.00014525291],"category_scores_gemma":[0.00027220507,0.00010860781,0.000078551864,0.0006475666,0.00030886455,0.000101532045,0.000036738933,0.0004101248,0.000017271095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002713815,0.001489057,0.97949475,0.00005591117,0.00007235291,0.000011513339,0.00010940754,0.00022133678,0.000579722,0.000047128477,0.00006620846,0.0151387965],"study_design_scores_gemma":[0.00616804,0.0026382932,0.9843725,0.00023507774,0.00004245112,7.691435e-7,0.0000491356,0.0009889522,0.00506763,0.00024474275,0.00008715435,0.00010525246],"about_ca_topic_score_codex":0.004364567,"about_ca_topic_score_gemma":0.0030863679,"teacher_disagreement_score":0.015033544,"about_ca_system_score_codex":0.00038336223,"about_ca_system_score_gemma":0.0003807393,"threshold_uncertainty_score":0.65979487},"labels":[],"label_agreement":null},{"id":"W1486569912","doi":"","title":"17-allylamino-17-demethoxygeldanamycin disrupts SYT-SSX-β-catenin interaction in synovial sarcoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Pathogenesis; Catenin; Synovial sarcoma; Cancer research; Wnt signaling pathway; Transcription factor; Biology; Cell culture; Endogeny; Chromosomal translocation; Cell biology; Chemistry; Medicine; Signal transduction; Immunology; Sarcoma; Endocrinology; Pathology; Genetics; Gene","score_opus":0.1473770414746732,"score_gpt":0.5176270601803885,"score_spread":0.3702500187057153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486569912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98518777,0.0011643136,0.00037106476,0.002097407,0.00030280527,0.0008863952,0.000036107755,0.000016635151,0.009937479],"genre_scores_gemma":[0.9801386,0.00067405804,0.00037696012,0.00018191281,0.0019002414,0.00043755287,0.000110860004,0.000060783397,0.016119055],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940679,0.0017085759,0.0009936234,0.0011034843,0.00092466833,0.0012017526],"domain_scores_gemma":[0.99779856,0.0005306089,0.00008682321,0.000790515,0.0004867951,0.00030668196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057141953,0.0002510042,0.00041831215,0.00033038371,0.00018857465,0.000101339945,0.00077386573,0.0005775017,0.00071956735],"category_scores_gemma":[0.001923499,0.00023689226,0.00022388977,0.0006949012,0.00056260836,0.00001892928,0.00075307034,0.001752539,0.00018481053],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031134987,0.0014053943,0.17790878,0.00013742199,0.00010563135,0.000236335,0.00004967072,0.0003255489,0.6567862,0.00025055918,0.10771929,0.051961675],"study_design_scores_gemma":[0.005781475,0.0032047888,0.30185667,0.00031699226,0.000021520202,0.00003790371,0.00025001474,0.0011300171,0.33962995,0.0011213862,0.34556133,0.0010879653],"about_ca_topic_score_codex":0.0066689663,"about_ca_topic_score_gemma":0.01411083,"teacher_disagreement_score":0.31715626,"about_ca_system_score_codex":0.00029425565,"about_ca_system_score_gemma":0.00082460075,"threshold_uncertainty_score":0.9999457},"labels":[],"label_agreement":null},{"id":"W1497876949","doi":"","title":"Hsp90 and histone deactylase inhibitor have synergistic activity against synovial sarcoma.","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Beetle Biology and Toxicology Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Synovial sarcoma; Cancer research; Histone deacetylase; Histone deacetylase inhibitor; Cancer; Sarcoma; Soft tissue sarcoma; Malignancy; Medicine; Biology; Pathology; Internal medicine; Histone","score_opus":0.10337064429237634,"score_gpt":0.4744434188321503,"score_spread":0.37107277453977394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1497876949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913345,0.004227505,0.000037261107,0.001335835,0.00041556885,0.00022366479,0.00004518267,0.000014694754,0.002365771],"genre_scores_gemma":[0.9938954,0.0012815683,0.00004969627,0.00029185292,0.0018061738,0.00010150506,0.0000323405,0.000019347313,0.0025220788],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99781185,0.00054957735,0.00031175496,0.0006443344,0.00018174552,0.00050076185],"domain_scores_gemma":[0.99889624,0.00037690948,0.00007430812,0.0003195666,0.00018949721,0.00014345167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012612876,0.0001614937,0.00028994784,0.000057667847,0.00033508544,0.000018145602,0.00018890525,0.0004803697,0.0000163567],"category_scores_gemma":[0.0008245041,0.00014203874,0.00009840511,0.00008752673,0.0019561478,0.000004392425,0.00041202747,0.0006291784,0.000014788596],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002603973,0.0010595279,0.15554209,0.00007125724,0.00026064963,0.00011399926,0.000017792801,0.000010040195,0.73505414,0.00037807648,0.06968691,0.035201516],"study_design_scores_gemma":[0.0048017725,0.0029454438,0.5242979,0.00006811587,0.00007931683,0.000015395202,0.000074768664,0.000085748536,0.21298476,0.001033781,0.2527954,0.0008175928],"about_ca_topic_score_codex":0.0003448861,"about_ca_topic_score_gemma":0.0022316445,"teacher_disagreement_score":0.5220694,"about_ca_system_score_codex":0.000053677624,"about_ca_system_score_gemma":0.00023541656,"threshold_uncertainty_score":0.72075087},"labels":[],"label_agreement":null},{"id":"W1503342114","doi":"","title":"Shc proteins predict outcome in treatment-naïve breast cancer patients: Do they also predict chemotherapy benefit?","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Chemotherapy; Breast cancer; Cancer; Proportional hazards model; Multivariate analysis; Population; Confidence interval","score_opus":0.09110228045427787,"score_gpt":0.4546474611291503,"score_spread":0.3635451806748724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503342114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810366,0.0029525862,0.000010771737,0.0056060525,0.00060354464,0.004516902,0.0010061418,0.00015578503,0.004111623],"genre_scores_gemma":[0.987503,0.0045324736,0.00009341699,0.00048381794,0.0018332469,0.0024626146,0.0001396319,0.00016826861,0.0027835208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935917,0.00042467934,0.0015900427,0.0012986145,0.0017256727,0.0013692628],"domain_scores_gemma":[0.9968822,0.00041997916,0.00023718296,0.0010904616,0.0008206941,0.0005494937],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016911752,0.00047031525,0.0010823661,0.00044254676,0.0001762491,0.00008058548,0.00045005127,0.0006078834,0.0012861486],"category_scores_gemma":[0.0003251342,0.00036941667,0.00046131827,0.00094223995,0.0005399912,0.0001522023,0.00016775572,0.0016714988,0.00009864108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035306981,0.00317191,0.9162136,0.00012251691,0.0002519867,0.00010208032,0.00015061448,0.00015515058,0.000630784,0.00010717704,0.0034117524,0.07215175],"study_design_scores_gemma":[0.02009551,0.0028056635,0.9551784,0.0008339211,0.00011261626,0.0000128410775,0.00004750451,0.00027807275,0.0011344033,0.00053679495,0.01856776,0.0003965072],"about_ca_topic_score_codex":0.023535298,"about_ca_topic_score_gemma":0.008382121,"teacher_disagreement_score":0.071755245,"about_ca_system_score_codex":0.0026915153,"about_ca_system_score_gemma":0.0014753565,"threshold_uncertainty_score":0.9998758},"labels":[],"label_agreement":null},{"id":"W1511682218","doi":"10.1158/1078-0432.ccr-09-1363","title":"Preclinical Drug Development Must Consider the Impact on Metastasis","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"Metastasis; Angiogenesis; Medicine; Drug development; Drug; Oncology; Cancer research; Internal medicine; Pharmacology; Cancer","score_opus":0.28783176779316944,"score_gpt":0.5706689580236055,"score_spread":0.2828371902304361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1511682218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98575467,0.004760812,0.000038808706,0.0057566245,0.00025606542,0.00041128066,0.000026398317,0.000012939332,0.0029823796],"genre_scores_gemma":[0.9918545,0.002083544,0.00016860118,0.0024689313,0.0012014803,0.0000977994,0.00002145015,0.000021700862,0.0020819793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997028,0.0007039876,0.0005639031,0.0006195413,0.0005189409,0.00056564267],"domain_scores_gemma":[0.99813235,0.00053421553,0.00008484046,0.0006844426,0.00031420076,0.00024996474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042853407,0.0001857338,0.00027186258,0.000043691787,0.00029564105,0.000059320977,0.00052124215,0.00019349443,0.0004987662],"category_scores_gemma":[0.00072333164,0.00010474117,0.00036708525,0.00019891388,0.00042653686,0.0000034113946,0.00017589933,0.00055809383,0.000119072196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021609291,0.00085191935,0.024121614,0.000012799331,0.00053351675,0.000021639486,0.00012067547,0.00029389627,0.0040949965,0.00018343913,0.6153442,0.35226032],"study_design_scores_gemma":[0.0015316989,0.0017999395,0.30531928,0.00006919911,0.000037295897,0.0000057858465,0.00013677764,0.000051852505,0.04427513,0.0004309959,0.6459084,0.0004336126],"about_ca_topic_score_codex":0.00008108953,"about_ca_topic_score_gemma":0.000090403206,"teacher_disagreement_score":0.35182673,"about_ca_system_score_codex":0.00007113534,"about_ca_system_score_gemma":0.0009438096,"threshold_uncertainty_score":0.546114},"labels":[],"label_agreement":null},{"id":"W1517612673","doi":"10.1158/1078-0432.407.11.1","title":"Anti-Vascular Endothelial Growth Factor Receptor-2 Antibody Accelerates Renal Disease in the NZB/W F1 Murine Systemic Lupus Erythematosus Model","year":2005,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lupus nephritis; Vascular endothelial growth factor; Angiogenesis; Systemic lupus erythematosus; Immunology; Cancer; Antibody; Vascular endothelial growth factor A; Internal medicine; Disease; Pharmacology; VEGF receptors","score_opus":0.11204262173738834,"score_gpt":0.43335119729407373,"score_spread":0.3213085755566854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517612673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82749534,0.037116278,0.00023381601,0.12782656,0.0017727019,0.0025789756,0.0025435104,0.00004966575,0.0003831374],"genre_scores_gemma":[0.7384597,0.10691652,0.0001460818,0.09627634,0.044701904,0.0016485654,0.0028314374,0.0004035415,0.008615882],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99290866,0.0015722712,0.001168582,0.0015941001,0.0014562316,0.0013001439],"domain_scores_gemma":[0.99688244,0.0004730315,0.00027136077,0.0015075558,0.0005960611,0.0002695783],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002400844,0.0005974513,0.0009158751,0.00021274485,0.00025991854,0.00019319844,0.0018349508,0.001355156,0.00032564683],"category_scores_gemma":[0.0006718204,0.00038382577,0.0009034524,0.00037761588,0.0006694481,0.000014937199,0.0005521371,0.002877065,0.000083630104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072319753,0.0003229216,0.048190083,0.00074959954,0.00043084272,0.00024395228,0.00007614712,0.00042459482,0.015526743,0.00002489065,0.9319826,0.0013044595],"study_design_scores_gemma":[0.0026166246,0.00039737896,0.0023626438,0.00080073264,0.00012881309,0.000044277782,0.00004624694,0.0008008781,0.0030779347,0.00010530601,0.9885065,0.0011126776],"about_ca_topic_score_codex":0.00030651412,"about_ca_topic_score_gemma":0.00006847503,"teacher_disagreement_score":0.08903563,"about_ca_system_score_codex":0.00017441247,"about_ca_system_score_gemma":0.0014242283,"threshold_uncertainty_score":0.9999413},"labels":[],"label_agreement":null},{"id":"W1525177141","doi":"","title":"Characterization and functional implications of the interaction between the coxsackievirus and adenovirus receptor (CAR) and beta-catenin","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cell adhesion molecule; Biology; Cell adhesion; Immunoglobulin superfamily; Cancer cell; Cytoplasm; Cell biology; Neural cell adhesion molecule; Cancer; Cell; Cancer research; Genetics","score_opus":0.17589666114763355,"score_gpt":0.47508622111880017,"score_spread":0.2991895599711666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525177141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406755,0.0010352915,0.00017031534,0.0040977523,0.00008830731,0.00038326916,0.00007955444,0.0000034765053,0.00007449257],"genre_scores_gemma":[0.99602115,0.0028709767,0.000013496902,0.00019469409,0.0004967917,0.000049549,0.000053661784,0.0000148611425,0.00028483802],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99843764,0.00040848687,0.00032829694,0.00032821452,0.00026525758,0.00023209347],"domain_scores_gemma":[0.9987838,0.00041942042,0.00009331446,0.0003019304,0.0002922335,0.00010930085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028750147,0.00008425641,0.00012993316,0.00004932674,0.00027284527,0.000037174003,0.00017100055,0.00014197596,0.000043971053],"category_scores_gemma":[0.00028359029,0.000054234853,0.000044563087,0.00020701827,0.00086454296,0.000009147306,0.00027880413,0.0004235362,0.000002898237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086600863,0.000026998925,0.21876475,0.000013597026,0.000060971484,8.822252e-8,0.000030349853,6.307584e-7,0.69749933,0.000042811174,0.0003625012,0.08233195],"study_design_scores_gemma":[0.00044887792,0.00056436134,0.7557133,0.000015532532,0.0000144337055,0.00000275978,0.00005878291,0.000006950084,0.22789945,0.000068901834,0.015138352,0.00006831163],"about_ca_topic_score_codex":0.000080941725,"about_ca_topic_score_gemma":0.0002851249,"teacher_disagreement_score":0.53694856,"about_ca_system_score_codex":0.000022969843,"about_ca_system_score_gemma":0.00013954027,"threshold_uncertainty_score":0.31854445},"labels":[],"label_agreement":null},{"id":"W1541275643","doi":"10.1158/1557-3265.pms14-a12","title":"Abstract A12: Identification of pathways associated with abiraterone resistance in metastatic castration resistant prostate cancer: Preliminary results from the SU2C/AACR West Coast Prostate Cancer Dream Team","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Enzalutamide; Prostate cancer; Medicine; Biopsy; Oncology; PTEN; Cancer; Metastasis; Liquid biopsy; Prostate biopsy; Abiraterone; Circulating tumor cell; Cancer research; Internal medicine; Pathology; Androgen receptor; Biology; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.2170817800880807,"score_gpt":0.4558618881354091,"score_spread":0.2387801080473284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1541275643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96868026,0.0120096635,0.0000019091956,0.009654469,0.00028570075,0.0039971825,0.0048071383,0.00006278528,0.0005008983],"genre_scores_gemma":[0.9829466,0.009940042,0.0000854401,0.00009254168,0.00028505016,0.002169727,0.0009287164,0.00009364178,0.003458266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913058,0.0013339384,0.0022951206,0.0012798966,0.0026147594,0.0011704544],"domain_scores_gemma":[0.99241,0.0022586528,0.00092132937,0.0010996106,0.0027409275,0.0005694958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009133241,0.0004262393,0.0010036756,0.0002738288,0.00031435292,0.00016336593,0.0005645579,0.00024855172,0.000083835555],"category_scores_gemma":[0.002684961,0.00027517552,0.00014909709,0.0017592547,0.0014648768,0.00040315773,0.0001892385,0.001791398,0.000022201246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3550245,0.0061805435,0.48770767,0.001340537,0.002130283,0.0013573685,0.02582132,0.0012622238,0.039937124,0.000099724384,0.05271281,0.026425911],"study_design_scores_gemma":[0.020911742,0.0031580655,0.9544659,0.0041396697,0.00026414063,0.0000026677894,0.0041031917,0.0002759137,0.010037574,0.00058522035,0.0016380564,0.000417807],"about_ca_topic_score_codex":0.03022969,"about_ca_topic_score_gemma":0.10626475,"teacher_disagreement_score":0.46675828,"about_ca_system_score_codex":0.0018077275,"about_ca_system_score_gemma":0.006536921,"threshold_uncertainty_score":0.99997},"labels":[],"label_agreement":null},{"id":"W1595350374","doi":"","title":"Functional oxyhemoglobin and scattering indices for in-vivo characterization of breast cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Mammography; Cancer; Ductal carcinoma; Pathology; In vivo; Population; Angiogenesis; Cancer research; Internal medicine; Biology","score_opus":0.11298014684224644,"score_gpt":0.49799057718901163,"score_spread":0.3850104303467652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595350374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917795,0.00018573762,0.00026031505,0.006810042,0.000082269675,0.00038648723,0.00009524357,0.000025608027,0.00037476327],"genre_scores_gemma":[0.9972391,0.00059510936,0.0004658646,0.00016699983,0.00051148207,0.00021569997,0.000016819617,0.000014783852,0.0007741106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998801,0.0000541765,0.00036840903,0.00025760572,0.0002667891,0.0002519979],"domain_scores_gemma":[0.9992704,0.00023771616,0.000054364624,0.00011516298,0.00024594727,0.00007640628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094057625,0.00006784005,0.00025059842,0.00014768072,0.00004641343,0.000019508856,0.00005350614,0.000088814195,0.00023827737],"category_scores_gemma":[0.0000862796,0.000057679645,0.000047354573,0.0002288777,0.00035142165,0.00007198507,0.000045343422,0.00030449123,9.623634e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007165636,0.0001993891,0.5906411,0.00022509221,0.000014410248,0.0000022874758,0.000012782894,6.4371994e-7,0.3980594,0.0003718033,0.0015734006,0.008183136],"study_design_scores_gemma":[0.001009405,0.0001949099,0.95012987,0.00032639547,0.000014619059,0.0000046355103,0.00000933154,0.0003318979,0.045967866,0.0004633586,0.0014846408,0.00006308209],"about_ca_topic_score_codex":0.00094326405,"about_ca_topic_score_gemma":0.0001000062,"teacher_disagreement_score":0.3594888,"about_ca_system_score_codex":0.00008920818,"about_ca_system_score_gemma":0.0001826706,"threshold_uncertainty_score":0.260897},"labels":[],"label_agreement":null},{"id":"W1623327531","doi":"","title":"Expression of β-catenin, CDX1 and CDX2 in esophageal adenocarcinoma: association with survival after esophageal resection","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Immunohistochemistry; Wnt signaling pathway; Catenin; CDX2; Adenocarcinoma; Biology; Messenger RNA; Beta-catenin; Cancer research; Barrett's esophagus; Pathogenesis; Pathology; Esophageal disease; Survival analysis; Esophagus; Medicine; Internal medicine; Gene expression; Signal transduction; Cancer; Gene; Homeobox; Cell biology","score_opus":0.03712039638996548,"score_gpt":0.3833804896636444,"score_spread":0.3462600932736789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1623327531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947135,0.004220928,0.00006261967,0.00027407325,0.00019573036,0.00031787367,0.000020052312,0.0000068878153,0.00018837168],"genre_scores_gemma":[0.99702954,0.0004504034,0.0001072987,0.000012326786,0.00077027024,0.0001098922,0.000054516913,0.000025554957,0.0014401893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975538,0.0005426792,0.0004761108,0.00051807176,0.00055654236,0.00035276962],"domain_scores_gemma":[0.99900657,0.0001530934,0.00015059959,0.00025432813,0.00035519365,0.00008022879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019660532,0.00012134424,0.00023534331,0.00012931904,0.00006370885,0.000023886307,0.00011698075,0.000397952,0.00003869118],"category_scores_gemma":[0.00020415994,0.000108491244,0.00006072247,0.00033317588,0.00020174989,0.000013001742,0.00013153817,0.00044157926,0.0000028985583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031672993,0.00012303343,0.93110067,0.000046138503,0.000024567564,0.0000091244565,0.000025645193,0.00034812052,0.06250242,0.000014962698,0.0011034008,0.0015346198],"study_design_scores_gemma":[0.0017223594,0.00059240387,0.8702879,0.00006273112,0.000011993711,0.000001948849,0.000019820785,0.00007657781,0.12655951,0.00010860188,0.00044934978,0.00010680631],"about_ca_topic_score_codex":0.0009681814,"about_ca_topic_score_gemma":0.003105835,"teacher_disagreement_score":0.06405708,"about_ca_system_score_codex":0.00016413078,"about_ca_system_score_gemma":0.00022429177,"threshold_uncertainty_score":0.44241443},"labels":[],"label_agreement":null},{"id":"W1697331515","doi":"10.1158/1078-0432.ccr-15-0915","title":"Potential Proinvasive or Metastatic Effects of Preclinical Antiangiogenic Therapy Are Prevented by Concurrent Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bevacizumab; Chemotherapy; Metastasis; Paclitaxel; Oncology; Cancer; Adjuvant; Primary tumor; Combination therapy; Metastatic breast cancer; Breast cancer; Internal medicine; Cancer research; Pharmacology","score_opus":0.21296796785778155,"score_gpt":0.5138183914466772,"score_spread":0.30085042358889563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1697331515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95240754,0.044031214,0.00068997993,0.0007322704,0.0006955946,0.0012682691,0.00010773575,0.000013765509,0.000053641324],"genre_scores_gemma":[0.96998566,0.026155667,0.00017244302,0.00044634746,0.0008147151,0.0003417512,0.00006904297,0.0000573892,0.0019569965],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996407,0.0010040528,0.00072632794,0.0006927349,0.0006613124,0.00050861994],"domain_scores_gemma":[0.997727,0.00033401602,0.00027565303,0.00053516723,0.00075838505,0.00036978562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020225812,0.00021654052,0.0005283369,0.00005578722,0.000068296446,0.000024604306,0.000512012,0.0002482933,0.0001979116],"category_scores_gemma":[0.0010827215,0.00015662836,0.00042569128,0.00028757154,0.00061000156,0.0000071480613,0.00018761975,0.0003102617,0.000015279878],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011549707,0.003997803,0.053503845,0.00051607896,0.0024429325,0.000059004728,0.0001745798,0.000029995466,0.20457456,0.000022648544,0.56543434,0.15769453],"study_design_scores_gemma":[0.018411186,0.012085399,0.01664579,0.0004113243,0.00015061598,0.000015465122,0.00023658959,0.00014574203,0.74441946,0.00019172435,0.20655821,0.00072848273],"about_ca_topic_score_codex":0.00007429044,"about_ca_topic_score_gemma":0.00004504141,"teacher_disagreement_score":0.53984493,"about_ca_system_score_codex":0.00004337754,"about_ca_system_score_gemma":0.001043613,"threshold_uncertainty_score":0.6387119},"labels":[],"label_agreement":null},{"id":"W1772419959","doi":"10.1158/1078-0432.ccr-15-0373","title":"Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Biology; Exome; Copy number analysis; Exome sequencing; Epigenomics; Gene expression profiling; Transcriptome; Carcinogenesis; Cancer research; Genetics; Gene; Genome; Copy-number variation; DNA methylation; Gene expression; Phenotype","score_opus":0.3227779994311764,"score_gpt":0.5517655373498642,"score_spread":0.2289875379186878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1772419959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995222,0.0010510341,0.0000625244,0.0011703552,0.00011895225,0.0010886358,0.000041242885,0.000037949943,0.0012073428],"genre_scores_gemma":[0.9975082,0.00015878871,0.0015360966,0.00007095732,0.0001821755,0.000107503525,0.0000086039845,0.000058023623,0.00036960744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953912,0.0005198195,0.001028088,0.0005870445,0.0015674654,0.0009064222],"domain_scores_gemma":[0.9934331,0.0019719808,0.00022128053,0.00075682276,0.0026213778,0.0009954139],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016259945,0.00021401954,0.0008294565,0.00040053818,0.000032298303,0.000016477064,0.0005478857,0.000011526001,0.00016095064],"category_scores_gemma":[0.028411813,0.00016197258,0.00036172592,0.0011429895,0.0013491461,0.00008374936,0.0005045192,0.0014008752,0.000023757226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077397884,0.0029566549,0.93364936,0.00070340384,0.00018967409,0.00743736,0.000022406877,0.00026938206,0.040396888,0.00025877266,0.0024465036,0.003929807],"study_design_scores_gemma":[0.02553437,0.06473021,0.73139054,0.0021827281,0.0002816397,0.0058544474,0.00030709303,0.0048692063,0.15879832,0.0017641447,0.003588601,0.0006987097],"about_ca_topic_score_codex":0.0013096454,"about_ca_topic_score_gemma":0.00007579685,"teacher_disagreement_score":0.20225883,"about_ca_system_score_codex":0.000159834,"about_ca_system_score_gemma":0.002892039,"threshold_uncertainty_score":0.97977227},"labels":[],"label_agreement":null},{"id":"W1773612973","doi":"","title":"Molecular detection of lymph node micrometastases in colorectal cancer patients","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lymph; Lymph node; Micrometastasis; Colorectal cancer; RNA; Medicine; Reverse transcriptase; Molecular biology; Housekeeping gene; Complementary DNA; Pathology; Cancer; Cancer research; Biology; Metastasis; Gene expression; Gene; Internal medicine; Genetics","score_opus":0.08325653762700597,"score_gpt":0.4583809284153194,"score_spread":0.37512439078831344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1773612973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953346,0.002290744,0.000013422351,0.0002729008,0.00051004573,0.0007268022,0.00009681522,0.000020035233,0.0007346364],"genre_scores_gemma":[0.9985346,0.00050530396,0.00012267767,0.00010611759,0.00022840005,0.00035002097,0.000019016354,0.000039854294,0.000094007526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669725,0.00040139942,0.00083958486,0.0005332926,0.00096469204,0.0005637883],"domain_scores_gemma":[0.99814254,0.00052783673,0.00013112498,0.00026676295,0.0007688691,0.00016288443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011718294,0.00016304704,0.00052333897,0.00034483653,0.000050844083,0.000013509758,0.0002035379,0.00023330025,0.00039608957],"category_scores_gemma":[0.0008216237,0.00014737502,0.00017714067,0.001043207,0.0005594322,0.000041235533,0.0001487702,0.00064901274,0.000018173721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00159319,0.0007286513,0.750847,0.00013422495,0.00004217463,0.000020194888,0.00002116971,0.0001381433,0.23002537,0.00000620584,0.00040232702,0.016041366],"study_design_scores_gemma":[0.0025032253,0.00055958447,0.6576054,0.00015075637,0.000026497526,0.0000011630852,0.000015519525,0.0000902665,0.33819866,0.00009568954,0.00065258815,0.00010060896],"about_ca_topic_score_codex":0.009735542,"about_ca_topic_score_gemma":0.0022202989,"teacher_disagreement_score":0.1081733,"about_ca_system_score_codex":0.0006863801,"about_ca_system_score_gemma":0.0007388961,"threshold_uncertainty_score":0.9968587},"labels":[],"label_agreement":null},{"id":"W1823273489","doi":"10.1158/1078-0432.712.11.2","title":"Targeting Cyclooxygenase-2 Reduces Overt Toxicity toward Low-Dose Vinblastine and Extends Survival of Juvenile Mice with Friend Disease","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Vinblastine; Juvenile; Toxicity; Cyclooxygenase; Disease; Medicine; Pharmacology; Cancer research; Internal medicine; Oncology; Biology; Chemotherapy; Enzyme; Genetics; Biochemistry","score_opus":0.08365343658399149,"score_gpt":0.4381873482233783,"score_spread":0.3545339116393868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1823273489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412173,0.00250258,0.00001662761,0.0020512624,0.00023867727,0.0005398374,0.000052576386,0.00003628669,0.00044040362],"genre_scores_gemma":[0.9961291,0.0009750287,0.00028361968,0.00015369809,0.0018722523,0.00007832593,0.000017617971,0.000041251675,0.0004491081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966067,0.00044693143,0.00070640806,0.00058656756,0.0010290861,0.00062429236],"domain_scores_gemma":[0.9969346,0.001193164,0.00014944536,0.00033956402,0.00047628503,0.00090692204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034866969,0.0002016463,0.00065452507,0.00013220761,0.0001402923,0.000023497565,0.00017503047,0.00013950147,0.00034748483],"category_scores_gemma":[0.0024579833,0.00014667642,0.00011394922,0.00036407146,0.0007894806,0.00012705673,0.00017512911,0.0008508055,0.000017232209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056457136,0.00421148,0.64709467,0.004977756,0.00064036,0.0012822193,0.0020392134,0.00026932752,0.13501017,0.0003187318,0.028823027,0.1188759],"study_design_scores_gemma":[0.016686287,0.005052285,0.83964133,0.0027866818,0.0003352273,0.000022324683,0.000848546,0.006674429,0.0902618,0.00010387811,0.03663629,0.00095094094],"about_ca_topic_score_codex":0.00014987412,"about_ca_topic_score_gemma":0.000084837084,"teacher_disagreement_score":0.19254664,"about_ca_system_score_codex":0.00010420567,"about_ca_system_score_gemma":0.00089203025,"threshold_uncertainty_score":0.5981291},"labels":[],"label_agreement":null},{"id":"W1840612622","doi":"10.1158/1078-0432.ccr-15-0632","title":"Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Cancer Research UK; National Cancer Institute; National Center for Research Resources; Medical Research Council; Canadian Institutes of Health Research; Francis Crick Institute","keywords":"Ovarian cancer; Genome-wide association study; Cancer; Genome; Oncology; Biology; Medicine; Bioinformatics; Genetics; Internal medicine; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.15702767333752085,"score_gpt":0.43662526127310963,"score_spread":0.27959758793558875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1840612622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934793,0.001754203,0.00049908744,0.006241113,0.0004365255,0.00040570798,0.0010320864,0.000031567564,0.0002517744],"genre_scores_gemma":[0.989278,0.00075159804,0.000052747168,0.0013080477,0.0007933597,0.0003558466,0.000548184,0.000050908027,0.0068612886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953655,0.0009163984,0.0007427278,0.0009175377,0.0012378574,0.0008199518],"domain_scores_gemma":[0.99578434,0.0012187113,0.00035444298,0.0007173429,0.0015443608,0.00038077153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059621446,0.0002769404,0.00063035137,0.000119174205,0.00039660375,0.00023089343,0.0007462215,0.0005418803,0.00039655392],"category_scores_gemma":[0.0053054076,0.00019309674,0.00034525403,0.0011032011,0.00039086986,0.000016392622,0.00027184127,0.0009389951,0.00003059831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034528552,0.00016502387,0.9717548,0.000005870758,0.0041557,0.000006363077,0.00036667043,0.0008051441,0.017530056,0.000008042066,0.0046286755,0.00022840285],"study_design_scores_gemma":[0.002876147,0.00021921648,0.96956927,0.000058795653,0.00081194536,1.9876423e-7,0.00042188537,0.00021647221,0.0044626626,0.00010339855,0.020856978,0.00040304768],"about_ca_topic_score_codex":0.018927734,"about_ca_topic_score_gemma":0.0396758,"teacher_disagreement_score":0.020748062,"about_ca_system_score_codex":0.00056930765,"about_ca_system_score_gemma":0.001806072,"threshold_uncertainty_score":0.98760533},"labels":[],"label_agreement":null},{"id":"W1845272216","doi":"10.1158/1078-0432.ccr-14-3122","title":"<i>CCR</i> 20th Anniversary Commentary: Triple-Negative Breast Cancer in 2015—Still in the Ballpark","year":2015,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Sunnybrook Health Science Centre; Jewish General Hospital; Women's College Hospital","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Medicine; Cancer; Metastatic breast cancer; Oncology; Triple negative; Internal medicine","score_opus":0.12707794617638332,"score_gpt":0.4753581876632572,"score_spread":0.34828024148687386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1845272216","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013495041,0.012873638,0.0000012176629,0.96541375,0.0010783266,0.0015586069,0.004104747,0.000013240436,0.0014614455],"genre_scores_gemma":[0.113159664,0.036241833,0.000050594972,0.82312655,0.019315297,0.003224124,0.0016171178,0.0002146537,0.0030501839],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992792,0.0026373889,0.0008174083,0.0013478628,0.0011831826,0.0012221753],"domain_scores_gemma":[0.9970997,0.00091120275,0.00022016265,0.0010398262,0.00056840404,0.00016068746],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0032081269,0.0005239298,0.00085670373,0.00023196274,0.00013693685,0.000065145396,0.0014202361,0.0010701057,0.00025621802],"category_scores_gemma":[0.00033893503,0.00038752414,0.0002737902,0.00071476615,0.0012493023,0.000014961877,0.0007957356,0.004297411,0.000040490944],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012410677,0.00025162776,0.054137215,0.000063329964,0.00027950288,0.00030045208,0.00030533524,0.000013953252,0.0000115305575,0.000001094961,0.939872,0.0035228678],"study_design_scores_gemma":[0.0045536933,0.00033048788,0.07110368,0.00032079133,0.00006915528,0.000014669552,0.00049396226,0.000008056403,0.00003768331,0.00018132683,0.92240655,0.00047994117],"about_ca_topic_score_codex":0.02571091,"about_ca_topic_score_gemma":0.021916032,"teacher_disagreement_score":0.14228721,"about_ca_system_score_codex":0.0008166643,"about_ca_system_score_gemma":0.0014298906,"threshold_uncertainty_score":0.99985766},"labels":[],"label_agreement":null},{"id":"W1861748936","doi":"10.1158/1078-0432.ccr-15-0468","title":"Preclinical Efficacy and Safety Assessment of an Antibody–Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Takeda Pharmaceuticals International","keywords":"Breast cancer; Medicine; Antibody-drug conjugate; Cancer; Cancer research; Tissue microarray; Antibody; Immunohistochemistry; Cytotoxic T cell; Pharmacology; Pathology; Internal medicine; Monoclonal antibody; Immunology; In vitro; Biology","score_opus":0.3735274212817079,"score_gpt":0.6302471702096378,"score_spread":0.2567197489279299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1861748936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97296834,0.0018310108,0.00013022813,0.015148431,0.000386974,0.007891404,0.00035993662,0.00004570695,0.0012379676],"genre_scores_gemma":[0.99286634,0.00081253564,0.002131797,0.0003159737,0.0020222615,0.0011128958,0.000080751975,0.000085668726,0.0005717897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915965,0.0024366386,0.0016485275,0.0010509581,0.0021761907,0.0010911683],"domain_scores_gemma":[0.98886627,0.0057860245,0.0002523708,0.001134667,0.0026503915,0.001310293],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03278156,0.00026127236,0.0009780125,0.00015480703,0.0003222555,0.000090184185,0.00074301625,0.00027306555,0.0002444171],"category_scores_gemma":[0.006322674,0.00017344914,0.00023175217,0.000577134,0.0022000808,0.00013740337,0.000636213,0.002164004,0.00001136303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022906154,0.002251264,0.79078877,0.0015859389,0.00041778796,0.000091080154,0.0008002835,0.00004924801,0.006313026,0.00059024215,0.019826217,0.15437998],"study_design_scores_gemma":[0.03143685,0.011788653,0.84001094,0.0012014337,0.0002516979,0.00011104532,0.0014299812,0.016932268,0.0043891002,0.0009104755,0.090924054,0.0006135251],"about_ca_topic_score_codex":0.0009771547,"about_ca_topic_score_gemma":0.00015606078,"teacher_disagreement_score":0.15376645,"about_ca_system_score_codex":0.0003840755,"about_ca_system_score_gemma":0.0056003206,"threshold_uncertainty_score":0.99595493},"labels":[],"label_agreement":null},{"id":"W1866474482","doi":"10.1158/1557-3265.pms14-b45","title":"Abstract B45: A search for ideal siRNA targets involved in pathway cross-talks for combinational silencing in human cancer cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gene silencing; Survivin; RNA interference; Biology; PI3K/AKT/mTOR pathway; Cancer cell; Small interfering RNA; Cell biology; Protein kinase B; Signal transduction; Cell growth; MAPK/ERK pathway; Cancer research; Cancer; RNA; Genetics; Gene","score_opus":0.4204801651937695,"score_gpt":0.5800645947930788,"score_spread":0.1595844295993093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1866474482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913253,0.0021587643,0.00012396039,0.0020159825,0.00083528174,0.002912071,0.00024962847,0.000026571775,0.00035243074],"genre_scores_gemma":[0.9941792,0.00039483217,0.00026514058,0.0004917624,0.0012756726,0.0024083708,0.000074434276,0.00006871273,0.00084187207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995923,0.00017892478,0.001051894,0.0007603488,0.0010731694,0.0010126913],"domain_scores_gemma":[0.995847,0.0014280634,0.0001169973,0.0003488169,0.0017501378,0.0005089914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009178532,0.00020403184,0.00067778275,0.00038542322,0.0001653764,0.000079283775,0.0003269633,0.0003307899,0.0003993638],"category_scores_gemma":[0.0007394209,0.00018977739,0.00022904786,0.000500144,0.00032596057,0.0001497147,0.00011246353,0.0012314849,0.000009347646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026385436,0.00764193,0.40300348,0.0038512864,0.00050378597,0.00034002276,0.006645357,0.0032400654,0.30582273,0.015561652,0.036678147,0.19032611],"study_design_scores_gemma":[0.11853209,0.010243448,0.48861173,0.0029686948,0.000048197766,0.0000032872988,0.0029768122,0.012804488,0.2669246,0.047076512,0.048299827,0.0015103047],"about_ca_topic_score_codex":0.008289924,"about_ca_topic_score_gemma":0.011525269,"teacher_disagreement_score":0.1888158,"about_ca_system_score_codex":0.0012971377,"about_ca_system_score_gemma":0.0034344618,"threshold_uncertainty_score":0.99831396},"labels":[],"label_agreement":null},{"id":"W1875927722","doi":"10.1158/1078-0432.ccr-15-1848","title":"Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American College of Radiology Imaging Network","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Genotyping; Oncology; Single-nucleotide polymorphism; Lymphoma; Genotype; SNP; Randomized controlled trial; Biology; Gene","score_opus":0.22202483359602618,"score_gpt":0.49515386741850004,"score_spread":0.2731290338224739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875927722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96624476,0.0037909104,0.0000024983742,0.027659763,0.000318089,0.0011470322,0.0000743875,0.00004015707,0.00072241377],"genre_scores_gemma":[0.9938456,0.0012777736,0.00034783717,0.0013864577,0.00063328486,0.00071836496,0.000014844656,0.000041988427,0.001733853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995293,0.0012080794,0.0006967913,0.0008251966,0.0012329166,0.0007440141],"domain_scores_gemma":[0.9955109,0.0019305968,0.000056680834,0.00069873524,0.0004054049,0.001397732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077193696,0.0002125653,0.00068665895,0.00033724678,0.00008947983,0.00007541241,0.0002229211,0.00026542935,0.00032150396],"category_scores_gemma":[0.005095774,0.00016384169,0.00014294739,0.00070223596,0.00036509408,0.000083702354,0.0003289828,0.0003390817,0.00052545534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066094935,0.00525642,0.57351446,0.00006390418,0.00020820803,0.0014474264,0.00077172247,0.000002644191,0.00057311496,0.00017191753,0.09818973,0.2537055],"study_design_scores_gemma":[0.041213144,0.0063363924,0.69641334,0.00058750296,0.000060988325,0.000037035938,0.00027220958,0.0000813965,0.0030705654,0.00015031216,0.2515069,0.000270239],"about_ca_topic_score_codex":0.0015567996,"about_ca_topic_score_gemma":0.00023820497,"teacher_disagreement_score":0.25343525,"about_ca_system_score_codex":0.0010727581,"about_ca_system_score_gemma":0.0016533977,"threshold_uncertainty_score":0.67538404},"labels":[],"label_agreement":null},{"id":"W1907272683","doi":"10.1158/1078-0432.ccr-15-0866","title":"siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Clusterin; LNCaP; Enzalutamide; Prostate cancer; Cancer research; Androgen receptor; Gene silencing; Medicine; In vivo; Apoptosis; Chemistry; Cancer; Biology; Internal medicine","score_opus":0.16821349135734492,"score_gpt":0.4806860595481425,"score_spread":0.31247256819079755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907272683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985526,0.004737441,0.0000031067088,0.007491416,0.00028873762,0.0016684572,0.000050815168,0.00005682773,0.00017716365],"genre_scores_gemma":[0.9958903,0.0011740484,0.0008584767,0.00034202606,0.00032354833,0.0008533577,0.000015620293,0.00005218079,0.00049044704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559176,0.0009491099,0.0008135302,0.0008064332,0.0009778052,0.0008613597],"domain_scores_gemma":[0.9973395,0.0005668378,0.00016081026,0.00042355864,0.0006427427,0.00086657173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004028709,0.00022311858,0.00061453384,0.00016977456,0.00013972324,0.00007028725,0.00023160453,0.00018331407,0.00021720806],"category_scores_gemma":[0.0014468407,0.00016206822,0.000057413115,0.0004734619,0.0010177471,0.00017255188,0.0004896502,0.000825281,0.000025071053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04038186,0.00055573194,0.9141587,0.0004334769,0.000074784235,0.00043903885,0.0018131371,0.0000503289,0.017246021,0.0000141280425,0.0035445609,0.021288246],"study_design_scores_gemma":[0.09977211,0.053124778,0.7052145,0.0130021125,0.00052116154,0.00023982079,0.011949349,0.016533704,0.048895136,0.0023852107,0.045670796,0.0026913004],"about_ca_topic_score_codex":0.0008801351,"about_ca_topic_score_gemma":0.0013863076,"teacher_disagreement_score":0.20894417,"about_ca_system_score_codex":0.0003450088,"about_ca_system_score_gemma":0.0011771527,"threshold_uncertainty_score":0.660895},"labels":[],"label_agreement":null},{"id":"W1907991309","doi":"10.1158/1078-0432.ccr-15-0215","title":"Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Adjuvant; Sorafenib; Internal medicine; Renal function; Oncology; Urology; Hepatocellular carcinoma","score_opus":0.1551892286076148,"score_gpt":0.42482418811199524,"score_spread":0.26963495950438043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907991309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140555,0.0033557243,0.0000020727664,0.00018794036,0.00045305924,0.0015623485,0.0004803368,0.000018236975,0.0025347238],"genre_scores_gemma":[0.99794656,0.00041528553,0.000104683924,0.00011583672,0.00038877985,0.00014864984,0.0003531836,0.000047545956,0.00047948526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943026,0.0017271797,0.0010225589,0.000862212,0.0015236349,0.00056186423],"domain_scores_gemma":[0.9945727,0.0031079038,0.00022370424,0.00064275286,0.0007600784,0.0006928859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003259675,0.00027060907,0.0010538377,0.00031509897,0.00005610761,0.00002500126,0.00015269556,0.00025013922,0.000030316573],"category_scores_gemma":[0.002496862,0.0002081395,0.00019894078,0.0004366757,0.00033249546,0.00009340957,0.00018801902,0.001052301,0.000045646208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040750287,0.002362115,0.92293435,0.00030401698,0.0002403363,0.00023108239,0.00041438593,0.000017454346,0.002163413,0.0000116404735,0.011394571,0.019176349],"study_design_scores_gemma":[0.023579542,0.00819529,0.93270487,0.0003865589,0.0002872603,5.986064e-7,0.000118565804,0.000055956833,0.031314187,0.00011389937,0.003060457,0.00018282169],"about_ca_topic_score_codex":0.00724269,"about_ca_topic_score_gemma":0.0003511726,"teacher_disagreement_score":0.029150775,"about_ca_system_score_codex":0.00044048144,"about_ca_system_score_gemma":0.0007517341,"threshold_uncertainty_score":0.9993682},"labels":[],"label_agreement":null},{"id":"W1913097128","doi":"10.1158/1078-0432.1336.11.3","title":"Dual Inhibition of <i>RET</i> and <i>FGFR4</i> Restrains Medullary Thyroid Cancer Cell Growth","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Immunovaccine (Canada); University of Toronto","funders":"","keywords":"Medullary thyroid cancer; Medicine; Cancer; Medullary cavity; Thyroid cancer; Cancer research; Internal medicine; Endocrinology; Oncology","score_opus":0.08149313244203124,"score_gpt":0.4432948344094236,"score_spread":0.36180170196739236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1913097128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617446,0.008039624,0.000016040582,0.0024267097,0.00011475462,0.00041777384,0.00019485329,0.000019070925,0.0025966957],"genre_scores_gemma":[0.977742,0.019110573,0.00022582785,0.00036173922,0.0013176209,0.00012454386,0.000046022236,0.00006238022,0.0010092908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964799,0.0005931316,0.0006223984,0.00074788346,0.0008408602,0.000715781],"domain_scores_gemma":[0.9981057,0.00027276733,0.000111457855,0.00048060995,0.0006451466,0.0003843311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022545112,0.00019178468,0.00031197298,0.000088733184,0.00014642482,0.000040052986,0.00029523225,0.00036533142,0.00016785391],"category_scores_gemma":[0.00054482283,0.00017702914,0.0001377682,0.00024734304,0.0011244059,0.000021969665,0.00058717455,0.00077014795,0.00001949382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073975313,0.0002857464,0.020297375,0.00021026374,0.00005566687,0.00000991918,0.000080252736,0.000013175448,0.93073976,0.00011683569,0.041453436,0.0059978412],"study_design_scores_gemma":[0.0023607898,0.0016739678,0.021777468,0.00013509151,0.000018402421,0.0000075399835,0.00012320076,0.000057522368,0.932707,0.00020679495,0.04059482,0.0003373805],"about_ca_topic_score_codex":0.0009097658,"about_ca_topic_score_gemma":0.0017123629,"teacher_disagreement_score":0.011070948,"about_ca_system_score_codex":0.00008352344,"about_ca_system_score_gemma":0.0007433678,"threshold_uncertainty_score":0.7219039},"labels":[],"label_agreement":null},{"id":"W1923726874","doi":"10.1158/1078-0432.ccr-15-0744","title":"Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute","keywords":"Cyclin D1; Adenocarcinoma; Cancer research; Metastasis; Prostate; Medicine; Pathology; Carcinoma; Small-cell carcinoma; Cancer; Oncology; Biology; Cell cycle; Internal medicine","score_opus":0.35106830331324973,"score_gpt":0.49947318720320816,"score_spread":0.14840488388995843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1923726874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708099,0.012721964,0.000024301216,0.006820987,0.0008595489,0.003064231,0.00028347835,0.0001264254,0.0052891993],"genre_scores_gemma":[0.9770139,0.0009468584,0.000910695,0.00046343205,0.0017884985,0.0009938574,0.00037719464,0.00013715342,0.01736844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99234605,0.0010997793,0.0012694931,0.0014251531,0.0021701658,0.0016893798],"domain_scores_gemma":[0.9922286,0.0022930012,0.0001999966,0.0012339312,0.0020225088,0.0020219362],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003937747,0.00044448194,0.0010482392,0.000307399,0.0003395778,0.00020172307,0.0006534601,0.00036797006,0.0004936347],"category_scores_gemma":[0.0040812837,0.0003374814,0.00026663768,0.0012575904,0.0015976523,0.00014779955,0.00059403694,0.002342383,0.0006667762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048850626,0.0013752608,0.94470674,0.0005533362,0.00016848091,0.0018545793,0.0015565908,0.000004683831,0.00049187196,0.00003625348,0.032483425,0.011883707],"study_design_scores_gemma":[0.043753993,0.010407316,0.8723328,0.0013671283,0.0006161089,0.000058226753,0.005265773,0.001933457,0.015866844,0.006533296,0.04047418,0.0013908431],"about_ca_topic_score_codex":0.0060417852,"about_ca_topic_score_gemma":0.0004581709,"teacher_disagreement_score":0.07237391,"about_ca_system_score_codex":0.00096911076,"about_ca_system_score_gemma":0.005317388,"threshold_uncertainty_score":0.99995923},"labels":[],"label_agreement":null},{"id":"W1933707168","doi":"10.1158/1078-0432.1302.11.3","title":"Potentiation of a Dendritic Cell Vaccine for Murine Renal Cell Carcinoma by CpG Oligonucleotides","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immune system; Dendritic cell; CpG Oligodeoxynucleotide; Immunology; Cancer research; Immunotherapy; Antigen; CpG site; Biology; T cell; Tumor antigen","score_opus":0.0673276606742644,"score_gpt":0.4107871269102125,"score_spread":0.34345946623594814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933707168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604198,0.036459055,0.0002225194,0.0013834431,0.0003595605,0.000562991,0.00013499372,0.00002366475,0.0004339722],"genre_scores_gemma":[0.97968066,0.0021811912,0.00013754173,0.00018263818,0.00016426697,0.0001929954,0.00008609162,0.000033735254,0.017340863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972294,0.00081607315,0.000822859,0.0003965621,0.00010730771,0.0006277851],"domain_scores_gemma":[0.9972692,0.0016714348,0.00017066699,0.00041521058,0.0004305836,0.000042871285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021203,0.00015874032,0.00043038666,0.00016865699,0.00024516965,0.000017211401,0.0004361068,0.00030924773,0.0021237019],"category_scores_gemma":[0.00033065252,0.00014051054,0.00024734112,0.0002240053,0.0003121871,0.000107976,0.000117624564,0.0006434873,0.00017150067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005150388,0.00081764796,0.0036904155,0.00011852385,0.00008584966,0.0000012768069,0.00010992691,0.000008302372,0.88941824,0.000055281926,0.07214951,0.02839464],"study_design_scores_gemma":[0.0053064893,0.0013385485,0.012844698,0.000038033653,0.000032950742,0.0000035094401,0.00008441092,0.00001996456,0.7885926,0.00006552829,0.19152805,0.00014524245],"about_ca_topic_score_codex":0.00037058955,"about_ca_topic_score_gemma":0.000048193244,"teacher_disagreement_score":0.119378544,"about_ca_system_score_codex":0.00007821178,"about_ca_system_score_gemma":0.0002703767,"threshold_uncertainty_score":0.9987885},"labels":[],"label_agreement":null},{"id":"W1945293306","doi":"10.1158/1078-0432.ccr-15-1181","title":"CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Prostate; Stromal cell; Cancer research; PCA3; Cancer; Stroma; Tissue microarray; Medicine; Biology; Pathology; Internal medicine; Immunohistochemistry","score_opus":0.30692829316027903,"score_gpt":0.5311385521616998,"score_spread":0.22421025900142078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1945293306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919295,0.0064854273,0.000020316593,0.0006506671,0.0002300261,0.00040124712,0.000043240787,0.000009669893,0.00022994961],"genre_scores_gemma":[0.9953892,0.0013939579,0.00007300466,0.00030867805,0.0009201113,0.00026975307,0.000033539833,0.000028348177,0.0015833646],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755865,0.00044888965,0.0003924651,0.0005945962,0.00052668696,0.00047869055],"domain_scores_gemma":[0.9987358,0.00007557435,0.00006260952,0.00036997828,0.000380152,0.00037591497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397039,0.00012887067,0.00019225886,0.000072946896,0.000060984865,0.000043461714,0.0003418203,0.00020967273,0.00022898738],"category_scores_gemma":[0.0004182631,0.00010550175,0.000058884736,0.00020471273,0.00014601812,0.000011451341,0.0002919428,0.00055276527,0.000021665554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091008795,0.00034053758,0.9145054,0.000037083886,0.00003230387,0.000041710195,0.00049329037,0.00016584709,0.03265952,0.000005896205,0.043919206,0.006889093],"study_design_scores_gemma":[0.010663707,0.0055434285,0.30479732,0.0007143833,0.00004021326,0.000013372931,0.0018311021,0.00079183443,0.3816147,0.0011319013,0.29145133,0.0014066553],"about_ca_topic_score_codex":0.0009499329,"about_ca_topic_score_gemma":0.00029811586,"teacher_disagreement_score":0.6097081,"about_ca_system_score_codex":0.000059869646,"about_ca_system_score_gemma":0.0008344595,"threshold_uncertainty_score":0.43022364},"labels":[],"label_agreement":null},{"id":"W1953830900","doi":"10.1158/1078-0432.ccr-15-1186","title":"Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Cancer Institute; National Cancer Research Institute","keywords":"Embryonal carcinoma; Medicine; Oncology; Germ cell tumors; Cancer; Carcinoma; Stage (stratigraphy); Adjuvant therapy; Immunohistochemistry; Internal medicine; Chemotherapy; Pathology; Biology; Cellular differentiation","score_opus":0.2965083251211305,"score_gpt":0.5206071515538885,"score_spread":0.22409882643275797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953830900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935335,0.0046720756,0.0002722774,0.00008975747,0.00007052279,0.0011991045,0.00005151557,0.000017181319,0.00009408296],"genre_scores_gemma":[0.9971171,0.000035087432,0.0020953894,0.00002496695,0.00015973733,0.000102998725,0.000029888348,0.000028418199,0.00040642885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980072,0.00012770819,0.00049334747,0.0003746832,0.00064588926,0.00035119953],"domain_scores_gemma":[0.99787205,0.0005496909,0.00017992438,0.00023414352,0.00048501388,0.0006791803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094763836,0.0001189946,0.00035611648,0.00010765289,0.000079534126,0.0000220197,0.000071701535,0.00010775119,0.000032044987],"category_scores_gemma":[0.0020043093,0.00009152395,0.000103865095,0.00017310545,0.00021265518,0.00006009946,0.00011647325,0.00025750912,0.0000031328823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016088029,0.0004721124,0.9902175,0.00043253074,0.00002706526,0.0001029012,0.00009436872,0.000017061582,0.0008502936,0.000026599337,0.00045934407,0.0056914226],"study_design_scores_gemma":[0.00989172,0.002562475,0.97481316,0.0008841231,0.00020510632,0.000031100495,0.00035419784,0.006488841,0.0039509684,0.0003410434,0.0003101096,0.00016716994],"about_ca_topic_score_codex":0.0006752892,"about_ca_topic_score_gemma":0.000013733904,"teacher_disagreement_score":0.015404353,"about_ca_system_score_codex":0.00012136515,"about_ca_system_score_gemma":0.0027983508,"threshold_uncertainty_score":0.4964154},"labels":[],"label_agreement":null},{"id":"W1964066975","doi":"10.1158/1078-0432.ovca13-b14","title":"Abstract B14: Rapid RNA-based histotyping of ovarian carcinomas","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Serous fluid; Taxane; Serous carcinoma; Medicine; Oncology; Clear cell; Ovarian cancer; Internal medicine; Clear cell carcinoma; Ovarian carcinoma; Cancer; Pathology; Carcinoma; Breast cancer","score_opus":0.14243068921775606,"score_gpt":0.4747205185469886,"score_spread":0.33228982932923257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964066975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862419,0.0018778875,0.0022359653,0.0023873763,0.0000946422,0.0007000337,0.000029665049,0.000021494052,0.006411054],"genre_scores_gemma":[0.996421,0.00047531287,0.0016808305,0.00039214737,0.00023827552,0.00039146683,0.000061455416,0.000021306852,0.00031823566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984124,0.00019419084,0.0004384989,0.00043270766,0.00018975248,0.00033246857],"domain_scores_gemma":[0.9985993,0.00009913085,0.00010008086,0.000642459,0.00041004363,0.00014898763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011292807,0.000104059465,0.00019166488,0.00006172686,0.00009875747,0.000014482519,0.00041003505,0.00029618703,0.0006658634],"category_scores_gemma":[0.00024987326,0.00009322859,0.00016478737,0.0001537768,0.00050970964,0.0000025117547,0.00014290937,0.00037661116,0.00003734227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010912745,0.00019846298,0.0096828975,0.000047243884,0.000046827,0.000001892665,0.000005910665,0.000009986286,0.9229171,0.00047436793,0.023296682,0.04320947],"study_design_scores_gemma":[0.0011059921,0.0008794992,0.19648865,0.00006349996,0.000017286586,0.0000016405329,0.00003028859,0.0001620144,0.5775903,0.00096741354,0.22236082,0.00033260908],"about_ca_topic_score_codex":0.00071039353,"about_ca_topic_score_gemma":0.00005795694,"teacher_disagreement_score":0.34532684,"about_ca_system_score_codex":0.000024866367,"about_ca_system_score_gemma":0.00033240914,"threshold_uncertainty_score":0.72907376},"labels":[],"label_agreement":null},{"id":"W1964627756","doi":"10.1158/1078-0432.ccr-07-1409","title":"A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Ovarian cancer; Medicine; Confidence interval; Oncology; Chemotherapy; Internal medicine; Receiver operating characteristic; Hazard ratio; Cancer","score_opus":0.33078992845422023,"score_gpt":0.5583967393988145,"score_spread":0.22760681094459428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964627756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634815,0.0087153455,0.00031915904,0.023996178,0.00031590264,0.0029219743,0.000068876965,0.00006829414,0.00011281126],"genre_scores_gemma":[0.9824302,0.0052750176,0.00207116,0.0030909597,0.0014763053,0.0027428283,0.000009539,0.00006744872,0.0028365215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967143,0.0002399382,0.0007374959,0.00074816955,0.00068239606,0.00087771914],"domain_scores_gemma":[0.9911189,0.0069290707,0.00008974472,0.0003409491,0.00069130544,0.0008300388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008613002,0.00019480272,0.00053957105,0.0004704594,0.00024456,0.00006485741,0.00019565324,0.0002679569,0.000468485],"category_scores_gemma":[0.005549161,0.0001656254,0.00018977969,0.0013035334,0.00033995003,0.000070371854,0.000097293574,0.00048435075,0.000019761865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0148446895,0.0004360856,0.60392904,0.000102029415,0.000102590915,0.000018469362,0.0004254051,0.0000016422182,0.0005226246,0.00006578482,0.018396683,0.36115497],"study_design_scores_gemma":[0.005046017,0.0013133147,0.8066058,0.00024749027,0.000043143697,0.0000047769927,0.00010807465,0.00017648502,0.0036768026,0.00011450883,0.18248366,0.00017988372],"about_ca_topic_score_codex":0.0016633671,"about_ca_topic_score_gemma":0.00057352945,"teacher_disagreement_score":0.3609751,"about_ca_system_score_codex":0.0002565551,"about_ca_system_score_gemma":0.0007164061,"threshold_uncertainty_score":0.6754008},"labels":[],"label_agreement":null},{"id":"W1964963957","doi":"10.1158/1078-0432.ccr-08-1789","title":"Fascin Regulates Prostate Cancer Cell Invasion and Is Associated with Metastasis and Biochemical Failure in Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"DU145; Fascin; Prostate cancer; Cancer research; Prostate; Cancer; Metastasis; Medicine; Gene silencing; Internal medicine; Oncology; Biology; LNCaP; Immunohistochemistry","score_opus":0.05931760027762852,"score_gpt":0.41020200695574116,"score_spread":0.35088440667811266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964963957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833594,0.011355932,0.0000025374052,0.004477597,0.00005809826,0.00048999226,0.00014841596,0.000008140321,0.00009991418],"genre_scores_gemma":[0.9644345,0.033238586,0.000063678315,0.00046401995,0.00011016213,0.00016061716,0.000060437775,0.000025225976,0.0014427882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979251,0.00019610897,0.00037336515,0.00072892016,0.00029928942,0.00047721612],"domain_scores_gemma":[0.9990107,0.00008249258,0.00010216995,0.00026842646,0.00031733298,0.00021891882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009431457,0.00018491874,0.00029418455,0.00006976303,0.0001285532,0.000079169826,0.00014660324,0.00020985199,0.0001245781],"category_scores_gemma":[0.00017797803,0.00014733647,0.000059013975,0.00028642305,0.00021801471,0.00001822367,0.00016848186,0.00053705275,0.0000012951858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012351632,0.00039256696,0.0323853,0.00006994792,0.00014851787,0.000023067381,0.0003448468,0.000015588563,0.92631507,0.000025132293,0.018104797,0.020939974],"study_design_scores_gemma":[0.004292856,0.0021866336,0.023019124,0.00054950116,0.00008355576,0.000008199474,0.00053193665,0.00069075596,0.93006194,0.00050693675,0.037456308,0.0006122713],"about_ca_topic_score_codex":0.0014373456,"about_ca_topic_score_gemma":0.0053214002,"teacher_disagreement_score":0.021882655,"about_ca_system_score_codex":0.000091946575,"about_ca_system_score_gemma":0.00031136133,"threshold_uncertainty_score":0.60082066},"labels":[],"label_agreement":null},{"id":"W1965130823","doi":"10.1158/1078-0432.ccr-14-2668","title":"Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Foundation for the National Institutes of Health","keywords":"Metastasis; Rigidity (electromagnetism); Medicine; Radiology; Cancer; Internal medicine; Engineering; Structural engineering","score_opus":0.21530946700163828,"score_gpt":0.4998153551193157,"score_spread":0.2845058881176774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965130823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965163,0.0002951166,0.00043184115,0.001292879,0.000025359928,0.0009103096,0.00008113155,0.000024664654,0.0004224092],"genre_scores_gemma":[0.99830765,0.000018215736,0.00077389437,0.00021123346,0.00005914945,0.0001654683,0.00020127754,0.00001834612,0.0002447722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997082,0.00044365265,0.00036950025,0.0005208479,0.0012384524,0.00034554154],"domain_scores_gemma":[0.99828714,0.0003366212,0.000090329886,0.00040392464,0.00034665444,0.0005353324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015382178,0.0001596028,0.0005361341,0.00042887055,0.000059923997,0.00003713033,0.00007552539,0.000043004467,0.00019168625],"category_scores_gemma":[0.00033977575,0.00009627695,0.00008192894,0.0009903228,0.00027888233,0.00009380639,0.000037939575,0.00040988394,0.0000068137706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005273538,0.0012228749,0.98319745,0.00005946257,0.0010606942,0.00016241503,0.00007082117,0.001023863,1.151634e-7,0.000002725742,0.0011178252,0.0068082386],"study_design_scores_gemma":[0.014365387,0.004256615,0.9723352,0.00008194481,0.0015789968,4.147435e-7,0.00018843828,0.0028048242,0.000009635518,0.00001259877,0.004268509,0.00009743082],"about_ca_topic_score_codex":0.0007119828,"about_ca_topic_score_gemma":0.0002445447,"teacher_disagreement_score":0.010862221,"about_ca_system_score_codex":0.00028836765,"about_ca_system_score_gemma":0.00050980336,"threshold_uncertainty_score":0.392606},"labels":[],"label_agreement":null},{"id":"W1965232242","doi":"10.1158/1078-0432.ovca13-a53","title":"Abstract A53: Biomarkers of chemotherapy resistance in serous epithelial ovarian cancer identified by integrative genomic and transcriptomic analysis","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; Queen's University","funders":"","keywords":"Ovarian cancer; Chemotherapy; Gene expression profiling; Oncology; Microarray; Serous fluid; Microarray analysis techniques; Biology; Cancer research; Internal medicine; Cancer; Medicine; Gene expression; Bioinformatics; Gene; Genetics","score_opus":0.08205332957718654,"score_gpt":0.4533780097143822,"score_spread":0.37132468013719566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965232242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97764236,0.009351745,0.000015588677,0.010605082,0.0001500568,0.0012018672,0.0002610552,0.000014446989,0.00075782905],"genre_scores_gemma":[0.9799351,0.017788084,0.00022854404,0.00031038182,0.00014382403,0.00069079275,0.000026534854,0.000034987006,0.0008417157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691576,0.00029010052,0.00096414227,0.00077364134,0.0005379864,0.00051839533],"domain_scores_gemma":[0.99804735,0.000644975,0.00017809591,0.00047530234,0.00034171427,0.00031255954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015509931,0.00023029518,0.0009567231,0.0004094695,0.00007525747,0.000059149905,0.00021801799,0.00022073096,0.002407438],"category_scores_gemma":[0.00012018479,0.00017795502,0.00029072788,0.0011706783,0.0006312148,0.0001054573,0.000038711823,0.0006443244,0.000018096353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042327014,0.0013536351,0.87601125,0.00031056872,0.005492902,0.000042273157,0.0013885667,0.000006306545,0.034241732,0.000107700325,0.019584812,0.057227574],"study_design_scores_gemma":[0.0057251686,0.00022304054,0.98603547,0.00031347421,0.0003176367,4.1570112e-7,0.0002678217,0.000078868,0.004229504,0.00033958623,0.0023075687,0.00016143182],"about_ca_topic_score_codex":0.031859957,"about_ca_topic_score_gemma":0.022205219,"teacher_disagreement_score":0.11002426,"about_ca_system_score_codex":0.0005442539,"about_ca_system_score_gemma":0.0005698965,"threshold_uncertainty_score":0.9985045},"labels":[],"label_agreement":null},{"id":"W1966248219","doi":"10.1158/1078-0432.ccr-08-0469","title":"Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Vorinostat; Sorafenib; Histone deacetylase inhibitor; Cancer research; Histone deacetylase; Caspase 8; Chemistry; Programmed cell death; Apoptosis; Caspase 3; Biology; Histone; Biochemistry; Hepatocellular carcinoma","score_opus":0.1058552604124676,"score_gpt":0.4521050103355005,"score_spread":0.3462497499230329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966248219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978777,0.0006769076,0.00009629353,0.00047651675,0.00015254044,0.00036085086,0.000049764032,0.000013510339,0.0002958848],"genre_scores_gemma":[0.99408346,0.0028364863,0.00032334766,0.000104154286,0.00067664444,0.00007289755,0.0000515504,0.00003761926,0.0018138572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705684,0.0005683271,0.00041890045,0.000769427,0.0006215754,0.0005649574],"domain_scores_gemma":[0.9982802,0.00035432697,0.000059312028,0.00044063243,0.00041614295,0.00044934257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011564328,0.00016089635,0.00025504813,0.00010129101,0.00040210225,0.00003658993,0.00020285754,0.0002489285,0.000080760474],"category_scores_gemma":[0.0011263415,0.00014326154,0.00006557146,0.00018928773,0.001325423,0.0000120759705,0.0005099542,0.00071742304,0.000028942868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010908463,0.00015328085,0.0072896685,0.000056568522,0.00002679051,0.000062716514,0.000049088252,0.0000068208756,0.97343934,0.000014517896,0.012218287,0.0055920803],"study_design_scores_gemma":[0.0016777022,0.0008475663,0.040760726,0.00006289602,0.0000070516558,0.00003632818,0.000028755005,0.00027639733,0.92079246,0.00005814342,0.035175934,0.00027605693],"about_ca_topic_score_codex":0.00030793026,"about_ca_topic_score_gemma":0.000055219483,"teacher_disagreement_score":0.05264689,"about_ca_system_score_codex":0.000045957408,"about_ca_system_score_gemma":0.00040721134,"threshold_uncertainty_score":0.5842036},"labels":[],"label_agreement":null},{"id":"W1967264420","doi":"10.1158/1078-0432.ovca13-a17","title":"Abstract A17: FBxW7 duality in ovarian cancer: Novel insight into ovarian cancer pathogenesis","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Biology; Cancer research; Tissue microarray; Cell growth; Cell culture; Cancer; microRNA; Microarray analysis techniques; Transfection; Molecular biology; Immunohistochemistry; Immunology; Gene expression; Gene; Genetics","score_opus":0.16832284317935503,"score_gpt":0.46398677295393015,"score_spread":0.2956639297745751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967264420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829274,0.006437844,0.00007824727,0.004893272,0.0006975211,0.0011686549,0.00024974666,0.000023641665,0.0035237172],"genre_scores_gemma":[0.9855559,0.0074957614,0.0004019988,0.0011279222,0.0019242724,0.0022906638,0.00007216229,0.000067860594,0.0010634477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956327,0.00058236497,0.0009542371,0.0011646921,0.00065930723,0.0010067107],"domain_scores_gemma":[0.997538,0.0002422547,0.00016969281,0.0008856056,0.00065094064,0.00051353185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031768873,0.00030905457,0.00049221586,0.00014809177,0.000242227,0.00012448737,0.0007777924,0.00066989596,0.0027619104],"category_scores_gemma":[0.0007868578,0.00027995062,0.00022271964,0.0005533642,0.00049787574,0.000024004497,0.0005569347,0.0010697811,0.0001295777],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005799743,0.00084444135,0.1271895,0.0002557912,0.00016980122,0.0000237247,0.000366415,0.00006924396,0.72295445,0.00024077919,0.006701786,0.14060408],"study_design_scores_gemma":[0.0031298154,0.00045573837,0.6764877,0.00024823553,0.000021461383,0.0000027256444,0.00012881133,0.000112348855,0.14167322,0.00071990467,0.17631473,0.0007053232],"about_ca_topic_score_codex":0.05240135,"about_ca_topic_score_gemma":0.017319605,"teacher_disagreement_score":0.58128124,"about_ca_system_score_codex":0.00021056019,"about_ca_system_score_gemma":0.0016278249,"threshold_uncertainty_score":0.99996525},"labels":[],"label_agreement":null},{"id":"W1967639975","doi":"10.1158/1078-0432.ccr-14-2422","title":"First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Mucositis; Medicine; Pharmacodynamics; Pharmacokinetics; Nausea; Cancer; Adverse effect; Cmax; Internal medicine; Pharmacology; Biopsy; Gastroenterology; In vivo; Oncology; Toxicity","score_opus":0.19641384518763919,"score_gpt":0.5264327362187183,"score_spread":0.3300188910310792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967639975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958328,0.001999102,0.000003823807,0.0004221707,0.00067283004,0.00067138963,0.00001880214,0.0000063537864,0.00037274716],"genre_scores_gemma":[0.99780583,0.00032310325,0.000010664286,0.000118628115,0.0009876282,0.00015372103,0.0000037022796,0.000030401805,0.0005663265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712217,0.00075087784,0.0005499172,0.0005504885,0.0006276869,0.00039885714],"domain_scores_gemma":[0.99868953,0.00016425621,0.00010940897,0.00048723395,0.00033505168,0.00021452107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027918324,0.0001462408,0.00025932354,0.00007179093,0.000107589905,0.000021462354,0.0004766103,0.00014458543,0.000055704935],"category_scores_gemma":[0.00045989867,0.00011230115,0.00007510023,0.00029559436,0.0005595204,0.0000054613774,0.00064445706,0.00062981766,0.000004192165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021976116,0.0024885184,0.62675685,0.00018696774,0.0002975416,0.00003786447,0.0009490045,0.002169721,0.32011253,0.000027605665,0.036730163,0.008045635],"study_design_scores_gemma":[0.06493773,0.02130168,0.39413476,0.0007453516,0.00035007653,0.000031334395,0.0035240748,0.005753828,0.2830091,0.00090930186,0.22326364,0.0020391254],"about_ca_topic_score_codex":0.000650378,"about_ca_topic_score_gemma":0.0012938618,"teacher_disagreement_score":0.23262209,"about_ca_system_score_codex":0.00008239946,"about_ca_system_score_gemma":0.00035862578,"threshold_uncertainty_score":0.4579508},"labels":[],"label_agreement":null},{"id":"W1968120911","doi":"10.1158/1078-0432.ccr-14-1122-t","title":"A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; Institute of Cancer Research","funders":"Hong Kong Cancer Fund; Cancer Research UK; Wellcome Trust","keywords":"ELISPOT; Vaccination; Modified vaccinia Ankara; Virology; Antigen; Immunogenicity; Immunology; Vaccinia; Virus; Epitope; Biology; CD8; Medicine; Recombinant DNA; Gene","score_opus":0.10733756620650188,"score_gpt":0.469174388612978,"score_spread":0.36183682240647613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968120911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903137,0.0013486146,0.000044792636,0.0027134272,0.00091177947,0.002885751,0.00012250512,0.000059648104,0.0015997437],"genre_scores_gemma":[0.99392354,0.0027511255,0.00007470804,0.0010273408,0.00075173314,0.0008148576,0.00010535494,0.00008688448,0.00046446407],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936785,0.0010458753,0.0013376976,0.0011833813,0.0013658656,0.0013886796],"domain_scores_gemma":[0.996632,0.0009550846,0.00035653423,0.0006715633,0.00074929115,0.00063555245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038376192,0.0004047006,0.001352809,0.00044032824,0.00030098468,0.00008179458,0.00039686167,0.0004471331,0.0007840358],"category_scores_gemma":[0.0019375981,0.00031271996,0.00027035602,0.0013305242,0.00020577502,0.00018846916,0.00017249097,0.0019650462,0.000037731137],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34669363,0.005332945,0.5821909,0.00015916834,0.00049378024,0.00011841931,0.0008117169,0.00009251229,0.00043869956,0.0000986281,0.018365,0.045204613],"study_design_scores_gemma":[0.66644216,0.03293157,0.2837306,0.002010511,0.0002927797,0.000002009632,0.00040589983,0.0037814488,0.0012488943,0.000925496,0.0071376334,0.001090983],"about_ca_topic_score_codex":0.0074603856,"about_ca_topic_score_gemma":0.0036838742,"teacher_disagreement_score":0.31974855,"about_ca_system_score_codex":0.00095165457,"about_ca_system_score_gemma":0.0014718839,"threshold_uncertainty_score":0.99993247},"labels":[],"label_agreement":null},{"id":"W1968380007","doi":"10.1158/1078-0432.ccr-07-1347","title":"Rhabdoid Tumor Growth is Inhibited by Flavopiridol","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; Albert Einstein College of Medicine, Yeshiva University; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Cyclin D1; Cyclin-dependent kinase; Cancer research; Cyclin; In vivo; Cell cycle; Biology; Cell cycle checkpoint; Apoptosis; Cyclin A; In vitro; Cyclin B; Cell growth; Biochemistry","score_opus":0.17263395246410268,"score_gpt":0.48910284289031764,"score_spread":0.31646889042621495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968380007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914672,0.004218971,0.00014032572,0.0015325791,0.00022616211,0.00021790492,0.00008063789,0.000024157893,0.002092103],"genre_scores_gemma":[0.9838053,0.006336479,0.00014543274,0.0025112967,0.0011654668,0.000096775904,0.000058748803,0.000041086198,0.005839419],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975617,0.00026967318,0.00046101003,0.00065273314,0.0005298676,0.000524997],"domain_scores_gemma":[0.99858445,0.000097487864,0.00006622798,0.0004916536,0.0004962323,0.00026394546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001051537,0.00014867604,0.00023492293,0.000048492027,0.00025063174,0.000022912382,0.00038295233,0.00021182328,0.00033466096],"category_scores_gemma":[0.0005743277,0.00013400202,0.00017716213,0.0002653618,0.0005635203,0.0000041952667,0.00023896879,0.00056276284,0.00009661239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029704836,0.00017522284,0.016274529,0.000040247876,0.00005714103,0.000015111699,0.000053678,0.0000069528005,0.124280445,0.0000095215055,0.8548842,0.0039059136],"study_design_scores_gemma":[0.0028365536,0.0010282857,0.0041498933,0.00010005757,0.000016007809,0.000038516144,0.000073169795,0.0005794155,0.55410916,0.0002822791,0.43622237,0.000564266],"about_ca_topic_score_codex":0.000365425,"about_ca_topic_score_gemma":0.000031820582,"teacher_disagreement_score":0.42982873,"about_ca_system_score_codex":0.000048341706,"about_ca_system_score_gemma":0.0005567208,"threshold_uncertainty_score":0.5464444},"labels":[],"label_agreement":null},{"id":"W1969269674","doi":"10.1158/1078-0432.ccr-06-2971","title":"Hypoxia and Metastasis","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hypoxia (environmental); Metastasis; Medicine; Pathology; Internal medicine; Cancer; Chemistry; Oxygen","score_opus":0.4369067716985438,"score_gpt":0.5979723879879756,"score_spread":0.16106561628943178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969269674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014709294,0.995379,0.00002143474,0.00005380713,0.0019150898,0.00073861616,0.000185733,0.000012441349,0.0015468354],"genre_scores_gemma":[0.000009264879,0.98370826,0.00018115848,0.00015233099,0.010423363,0.00026724095,0.00013248308,0.00009438197,0.0050314977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99555016,0.00091319135,0.0009735264,0.0011746018,0.00056452816,0.0008239715],"domain_scores_gemma":[0.9976301,0.00044191553,0.00019574545,0.0009073537,0.00032593418,0.000498943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005359464,0.00038038645,0.0015273619,0.00022066107,0.0001643819,0.00007533589,0.000609437,0.00096062286,0.00016919857],"category_scores_gemma":[0.0009761106,0.00030652215,0.00070015714,0.00044801255,0.00078978704,0.0000035034573,0.0007138431,0.0014158535,0.000072936426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055807082,0.000054154792,0.000008752052,0.0019195987,0.00027556316,0.00000402761,0.0000033896872,4.4615632e-8,0.000016323282,0.00004158944,0.04200814,0.9556126],"study_design_scores_gemma":[0.00037899872,0.00019996022,0.000033317006,0.0008462437,0.00030873294,0.000018071652,0.0000088579945,2.117102e-7,0.00002243618,0.000034065273,0.99782026,0.0003288306],"about_ca_topic_score_codex":0.00013830692,"about_ca_topic_score_gemma":0.00021488394,"teacher_disagreement_score":0.95581216,"about_ca_system_score_codex":0.000049114493,"about_ca_system_score_gemma":0.0013711498,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W1969453628","doi":"10.1158/1078-0432.14aacriaslc-b19","title":"Abstract B19: Three-dimensional nuclear telomere organization and clinical significance in non-small cell lung cancer patients.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telomere; Cancer; Lung cancer; Oncology; Internal medicine; Interphase; Medicine; Biology; Pathology; Genetics; DNA","score_opus":0.0728585708960535,"score_gpt":0.4216324070994034,"score_spread":0.3487738362033499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969453628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524367,0.00083028217,0.00001542637,0.0014025175,0.0006224014,0.0010807029,0.0000299419,0.00005714984,0.0007179037],"genre_scores_gemma":[0.9949117,0.002254265,0.00028206632,0.0010352251,0.0010090056,0.00005447685,0.000032688098,0.00009393939,0.0003266595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952505,0.0004229399,0.0013818373,0.0011305871,0.0009864694,0.00082761503],"domain_scores_gemma":[0.9953658,0.0020132344,0.00023078785,0.00058472727,0.0010805584,0.0007248891],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035023196,0.00028448523,0.0008100914,0.00024441586,0.00023476288,0.000066649685,0.00035600446,0.00048543068,0.0011302215],"category_scores_gemma":[0.002486039,0.00024692834,0.0001391509,0.0009557451,0.00077114074,0.00014315313,0.00027643025,0.002092938,0.000121069155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061483536,0.0010000226,0.9559461,0.00034230237,0.00003636713,0.000028846616,0.00011350638,0.000016490374,0.00049764296,0.000037679347,0.005552715,0.035813518],"study_design_scores_gemma":[0.004239498,0.00059168163,0.9884289,0.00039243125,0.000049247043,0.0000015233065,0.000045799046,0.0024113788,0.00024234751,0.00004989163,0.003260913,0.00028642325],"about_ca_topic_score_codex":0.0018121847,"about_ca_topic_score_gemma":0.0014985036,"teacher_disagreement_score":0.03552709,"about_ca_system_score_codex":0.00024772008,"about_ca_system_score_gemma":0.0008720044,"threshold_uncertainty_score":0.9999983},"labels":[],"label_agreement":null},{"id":"W1971460933","doi":"10.1158/1078-0432.mechres-a65","title":"Abstract A65: Combinational siRNA silencing of MCL-1 and P-gp enhances the apoptotic response in Human Breast Cancer Cells","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gene silencing; Survivin; Small interfering RNA; Cancer research; Apoptosis; Cancer cell; Biology; Cell; Cancer; Chemistry; Cell culture; Transfection; Biochemistry","score_opus":0.11691506412690343,"score_gpt":0.4817236771012256,"score_spread":0.36480861297432216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971460933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964513,0.0022431083,0.0000025749555,0.0006776288,0.00017866422,0.00016430227,0.00005156733,0.0000020183215,0.0002288269],"genre_scores_gemma":[0.99717444,0.001962079,0.000006267164,0.0001315485,0.00035705723,0.00006109901,0.00000634389,0.0000105020945,0.00029066353],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983011,0.00040574596,0.0003844249,0.0002598002,0.0002924246,0.0003565348],"domain_scores_gemma":[0.99892193,0.00040979695,0.00008599634,0.0002419067,0.00023758238,0.00010281599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032347678,0.00009274778,0.00016548828,0.0000612718,0.00010487859,0.000019659778,0.00027563737,0.00013825737,0.00020835534],"category_scores_gemma":[0.00020387127,0.00006834453,0.00006582314,0.00012775746,0.00049041107,0.000011873998,0.00017469737,0.00037309216,0.0000068866566],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007612411,0.00017096885,0.03550124,0.00003351571,0.00003199072,8.4724377e-7,0.00012259436,0.000024098521,0.9585585,0.000034363256,0.0013396621,0.0034209571],"study_design_scores_gemma":[0.00040984282,0.00023757643,0.6272043,0.000082070976,0.000005221015,0.0000014616726,0.0001963261,0.000013051712,0.37117073,0.00006182334,0.00053171476,0.000085875225],"about_ca_topic_score_codex":0.000690262,"about_ca_topic_score_gemma":0.00026430847,"teacher_disagreement_score":0.59170306,"about_ca_system_score_codex":0.000034270404,"about_ca_system_score_gemma":0.0002338366,"threshold_uncertainty_score":0.27870092},"labels":[],"label_agreement":null},{"id":"W1972275697","doi":"10.1158/1078-0432.ovca13-a18","title":"Abstract A18: Defining ovarian mucinous tumors: Cancer genes and heterogeneity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"KRAS; CDKN2A; PTEN; Cancer research; Neuroblastoma RAS viral oncogene homolog; Ovarian cancer; Biology; Mucinous carcinoma; Genetic heterogeneity; Cancer; Mutation; Pathology; Gene; Adenocarcinoma; Medicine; Genetics; Phenotype; PI3K/AKT/mTOR pathway","score_opus":0.24405499687169965,"score_gpt":0.5141800381400699,"score_spread":0.2701250412683702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972275697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96594244,0.01928276,0.000003017126,0.011148196,0.00032852084,0.00098941,0.000050973664,0.000055477667,0.0021991942],"genre_scores_gemma":[0.98192745,0.013948492,0.0003834754,0.0010240455,0.00094888033,0.0013463304,0.000013323808,0.000051153806,0.00035682734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967933,0.00019856133,0.0006801695,0.0008438269,0.0006929857,0.0007911355],"domain_scores_gemma":[0.9972441,0.00082668423,0.00010864201,0.0005859739,0.0004923451,0.0007422323],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013731574,0.00023158538,0.00062057166,0.00013829822,0.00025715513,0.00013910174,0.00017770902,0.00021339093,0.0034729403],"category_scores_gemma":[0.00030022193,0.00017820491,0.00017650519,0.00031348818,0.0004593751,0.0001412733,0.00019773435,0.00084521895,0.0003508507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020339587,0.00045564483,0.7251924,0.00016330688,0.0002635835,0.00011348002,0.00007376722,0.0000052116807,0.00035688412,0.00016005176,0.0077913003,0.26522094],"study_design_scores_gemma":[0.002685733,0.00055696483,0.9818806,0.00045274378,0.0000739717,0.000016528642,0.00007650349,0.00008130326,0.0016003891,0.0002667907,0.012117538,0.00019091503],"about_ca_topic_score_codex":0.018112777,"about_ca_topic_score_gemma":0.001455727,"teacher_disagreement_score":0.26503003,"about_ca_system_score_codex":0.0003138549,"about_ca_system_score_gemma":0.000835971,"threshold_uncertainty_score":0.997438},"labels":[],"label_agreement":null},{"id":"W1973137136","doi":"10.1158/1078-0432.ccr-07-1188","title":"New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers: Cooperative Group Strategies for Assessing Optimal Approaches in Early-Stage Disease","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Irinotecan; FOLFOX; Colorectal cancer; Bevacizumab; Internal medicine; Oncology; Clinical trial; Cetuximab; Oxaliplatin; Adjuvant therapy; Stage (stratigraphy); Randomized controlled trial; Cancer; Surgery; Chemotherapy","score_opus":0.704436166274384,"score_gpt":0.5804388981919771,"score_spread":0.12399726808240685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973137136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08832547,0.9033571,0.0005203721,0.00038301077,0.00017775682,0.005587696,0.00021706232,0.000050140632,0.0013813752],"genre_scores_gemma":[0.043295316,0.9448124,0.00503016,0.000054577577,0.0011913636,0.0030010967,0.0001135438,0.00017108029,0.002330449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942636,0.00074693677,0.0013139102,0.0017607716,0.0007385048,0.001176317],"domain_scores_gemma":[0.9946727,0.0034055058,0.00030583327,0.0004098031,0.00017326589,0.0010328819],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032134724,0.00073030364,0.0028637343,0.000523468,0.00056402455,0.00094679487,0.00022945102,0.0004908158,0.00003764949],"category_scores_gemma":[0.0008463897,0.00055738003,0.00036002623,0.0009330207,0.0007389824,0.0004412427,0.00046074978,0.0017604366,0.0000019626557],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017678655,0.00024138148,0.011161345,0.010022844,0.00055476686,0.00022782145,0.0013666914,0.000025574771,3.3507678e-7,0.00040577486,0.00014497623,0.9740806],"study_design_scores_gemma":[0.015121912,0.01187582,0.11256392,0.07223855,0.0038633451,0.00003775053,0.021251226,0.0016170113,0.0000061035794,0.00017686207,0.7578555,0.003392031],"about_ca_topic_score_codex":0.005392468,"about_ca_topic_score_gemma":0.0034643519,"teacher_disagreement_score":0.9706886,"about_ca_system_score_codex":0.0015022323,"about_ca_system_score_gemma":0.0043126354,"threshold_uncertainty_score":0.9996878},"labels":[],"label_agreement":null},{"id":"W1973250008","doi":"10.1158/1078-0432.ccr-07-1270","title":"Magnetic Resonance Imaging of the Breast Improves Detection of Invasive Cancer, Preinvasive Cancer, and Premalignant Lesions during Surveillance of Women at High Risk for Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mammography; Breast cancer; Magnetic resonance imaging; Radiology; Cancer; Ductal carcinoma; Ultrasound; Population; Prospective cohort study; Pathology; Internal medicine","score_opus":0.05557337028759279,"score_gpt":0.4089099272557698,"score_spread":0.353336556968177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973250008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551227,0.035968635,0.000013154177,0.0024228962,0.00062995707,0.002343504,0.0034554328,0.000020808473,0.000022926464],"genre_scores_gemma":[0.89984006,0.09726612,0.00006538656,0.00007127779,0.0005984605,0.0017201249,0.0000028425784,0.00007189014,0.0003638578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476796,0.00045284,0.0015161952,0.0009574501,0.001146555,0.0011589662],"domain_scores_gemma":[0.9916497,0.0038191585,0.00095981907,0.00090062345,0.0022289422,0.00044178969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041217078,0.0003204413,0.0011286138,0.00025442106,0.000333987,0.000014718968,0.00050999766,0.0002389638,0.00024934328],"category_scores_gemma":[0.0010947447,0.00024448094,0.00028737626,0.0010521302,0.0019068784,0.00012506302,0.0005661404,0.0008198738,5.6901433e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005850701,0.00020953934,0.7555416,0.0020156272,0.00014752202,0.000004656837,0.0006370766,0.000061815794,0.093994364,0.000012734537,0.00027574706,0.14124858],"study_design_scores_gemma":[0.0037869709,0.00044230165,0.81864476,0.0024276855,0.00012325373,0.000021143884,0.00037567006,0.000069224945,0.1734896,0.00013542696,0.00029212816,0.00019184971],"about_ca_topic_score_codex":0.06124215,"about_ca_topic_score_gemma":0.060294252,"teacher_disagreement_score":0.14105673,"about_ca_system_score_codex":0.0020443215,"about_ca_system_score_gemma":0.002062612,"threshold_uncertainty_score":0.9969643},"labels":[],"label_agreement":null},{"id":"W1974267960","doi":"10.1158/1078-0432.ccr-10-3077","title":"A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; Association pour la Recherche sur le Cancer; Pfizer","keywords":"LNCaP; Prostate cancer; Cancer research; Protein kinase B; Geldanamycin; RANKL; Hsp90 inhibitor; Apoptosis; Metastasis; Medicine; Cancer; Endocrinology; Chemistry; Internal medicine; Hsp90; Receptor; Activator (genetics)","score_opus":0.255009640448238,"score_gpt":0.4650011787727075,"score_spread":0.20999153832446954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974267960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433684,0.0024709075,0.00017646584,0.0004688376,0.00020780349,0.0012148533,0.00041311578,0.000022649692,0.0006885473],"genre_scores_gemma":[0.9938222,0.0016031397,0.0009142255,0.00015127992,0.00076123007,0.00084765814,0.000013044192,0.00010277806,0.0017844097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952253,0.00055929215,0.0007956711,0.0012696903,0.00083298486,0.0013170642],"domain_scores_gemma":[0.9974783,0.00011013995,0.00010735505,0.00073511,0.00082930335,0.00073980645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030482858,0.00032816193,0.0004546155,0.0001782277,0.00036008115,0.00010537646,0.00050792005,0.00044071864,0.00026645354],"category_scores_gemma":[0.0006495464,0.0002948143,0.00013856156,0.00043795313,0.0008895357,0.000023974027,0.0011022042,0.0009467916,0.000032055654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019601914,0.00019577875,0.04102392,0.0001931476,0.00013090462,0.000032417458,0.00025520835,0.000009224504,0.93481344,0.000014621723,0.00041230762,0.02095881],"study_design_scores_gemma":[0.0023987347,0.0017832112,0.06251288,0.0002694887,0.000022717955,0.000019510382,0.00023762352,0.00008086481,0.925112,0.000043885502,0.0070299297,0.0004891698],"about_ca_topic_score_codex":0.002656057,"about_ca_topic_score_gemma":0.0037365376,"teacher_disagreement_score":0.021488959,"about_ca_system_score_codex":0.00013388472,"about_ca_system_score_gemma":0.0015810176,"threshold_uncertainty_score":0.9999504},"labels":[],"label_agreement":null},{"id":"W1974879801","doi":"10.1158/1078-0432.ccr-13-2574","title":"Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Osteosarcoma; Metastasis; Medicine; Disease; Cancer; Drug development; Mechanism (biology); Clinical trial; Oncology; Bioinformatics; Drug; Internal medicine; Cancer research; Pharmacology; Biology","score_opus":0.3342715610672236,"score_gpt":0.5364661219312107,"score_spread":0.20219456086398707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974879801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98247206,0.006682338,0.00002026325,0.008247603,0.00019990203,0.0012061751,0.000004022716,0.000039541934,0.0011280712],"genre_scores_gemma":[0.9936259,0.0009158002,0.0032861494,0.00049436523,0.00016923116,0.0011296618,0.000022819853,0.00003137019,0.00032471225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621135,0.00080060185,0.0006256646,0.00058275624,0.0011101597,0.0006694396],"domain_scores_gemma":[0.9974422,0.0014620112,0.00007803033,0.0004066452,0.00019817901,0.00041295367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004619027,0.00017310437,0.00056577777,0.00020332694,0.000106520005,0.000037527552,0.00019808121,0.00008384591,0.0003656807],"category_scores_gemma":[0.00086940726,0.00011714534,0.00013397855,0.0003696286,0.00021082525,0.0000569566,0.00021840209,0.0007189483,0.00021057657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036692165,0.0014268176,0.6282514,0.00012888372,0.00006116587,0.00027115483,0.00039739293,5.005894e-7,0.000014492905,0.00007803143,0.0031662812,0.36583698],"study_design_scores_gemma":[0.0059746816,0.0006626486,0.9018132,0.0010666486,0.00004038528,0.00001211997,0.0002689743,0.00019323023,0.0033969611,0.0004983735,0.085884206,0.00018855806],"about_ca_topic_score_codex":0.00024765413,"about_ca_topic_score_gemma":0.00030787796,"teacher_disagreement_score":0.36564842,"about_ca_system_score_codex":0.00031464337,"about_ca_system_score_gemma":0.00061083,"threshold_uncertainty_score":0.47770485},"labels":[],"label_agreement":null},{"id":"W1975100932","doi":"10.1158/1078-0432.ccr-08-0736","title":"Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; TRIUMF; BC Cancer Agency","funders":"","keywords":"Doxorubicin; Irinotecan; Hypoxia (environmental); Chemistry; Pathology; Perfusion; Tumor hypoxia; Distribution (mathematics); Cancer research; Vascular endothelial growth factor; Medicine; Colorectal cancer; Internal medicine; Cancer; Chemotherapy","score_opus":0.10986905531051253,"score_gpt":0.4099216826880941,"score_spread":0.30005262737758154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975100932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299747,0.0052582417,0.0012201468,0.00017438745,0.00007586526,0.00019883557,0.00004262908,0.000002190013,0.000030247487],"genre_scores_gemma":[0.99180543,0.0077781547,0.00004148281,0.000048489565,0.00019053182,0.000037221504,0.000028934464,0.000008335264,0.00006142474],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881256,0.00012633324,0.00033567764,0.00027525553,0.00027187046,0.00017828602],"domain_scores_gemma":[0.99917203,0.00010947592,0.00011337553,0.00022506715,0.0003185676,0.00006147468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010499393,0.00008130455,0.00017366567,0.000023516488,0.00013851338,0.0000063172943,0.000103674785,0.00009864821,0.000012526203],"category_scores_gemma":[0.00018880704,0.000056729274,0.000089300636,0.00013447348,0.00071283936,0.000006595135,0.00012265112,0.00012495043,4.5842927e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093347736,0.00017832361,0.13438788,0.0001269416,0.00015268261,8.168809e-7,0.000062673505,0.00008683121,0.8440943,0.000286926,0.0012016918,0.01848746],"study_design_scores_gemma":[0.0011035593,0.0011210376,0.69576424,0.000062698455,0.00003881866,0.000006817513,0.000103757025,0.0002252339,0.29023683,0.00009556699,0.011113606,0.00012782989],"about_ca_topic_score_codex":0.0003424657,"about_ca_topic_score_gemma":0.0000731035,"teacher_disagreement_score":0.5613764,"about_ca_system_score_codex":0.000016326823,"about_ca_system_score_gemma":0.00014375821,"threshold_uncertainty_score":0.26264864},"labels":[],"label_agreement":null},{"id":"W1975369490","doi":"10.1158/1078-0432.tcmusa10-a44","title":"Abstract A44: Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda®","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; Capecitabine; Pharmacology; Breast cancer; Chemistry; Cancer research; Thymidine phosphorylase; Growth inhibition; Cancer; Epidermal growth factor receptor; Cell growth; Medicine; Internal medicine; Colorectal cancer; Biochemistry","score_opus":0.17920524362037962,"score_gpt":0.5115915909656693,"score_spread":0.3323863473452897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975369490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694705,0.0005623463,0.0000026777839,0.0009643616,0.00015872568,0.000581233,0.00037525746,0.0000054910597,0.00040283636],"genre_scores_gemma":[0.99850965,0.0009506006,0.000019314717,0.000023355879,0.00021151162,0.0001260995,0.000031717063,0.000015836044,0.00011192052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983831,0.00016058933,0.00064631726,0.00026228832,0.00032812238,0.00021960457],"domain_scores_gemma":[0.99714375,0.0017102618,0.00030902206,0.00020321975,0.00052761566,0.00010613888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009920526,0.000114484945,0.00049761997,0.00018716833,0.00006404163,0.0000064206297,0.000080572994,0.00012334592,0.0006588032],"category_scores_gemma":[0.00008660161,0.000075014264,0.00008109559,0.00041350166,0.0011246417,0.000080390295,0.00005199457,0.0010330543,0.0000016209858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026970177,0.000706302,0.6362889,0.00022348751,0.00034343216,0.000007540229,0.00070407346,0.000013014753,0.3441392,0.00017713192,0.00017169597,0.014528235],"study_design_scores_gemma":[0.0027013181,0.00048186563,0.87502784,0.00031766557,0.00025585384,0.0000026179616,0.00026247388,0.000035364614,0.120500505,0.00022947263,0.00012035237,0.000064683605],"about_ca_topic_score_codex":0.014447162,"about_ca_topic_score_gemma":0.004906887,"teacher_disagreement_score":0.23873894,"about_ca_system_score_codex":0.000078898775,"about_ca_system_score_gemma":0.00037627912,"threshold_uncertainty_score":0.99211574},"labels":[],"label_agreement":null},{"id":"W1976464671","doi":"10.1158/1078-0432.ccr-05-2354","title":"Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Alberta Cancer Foundation; University of Calgary; Western University","funders":"","keywords":"Osteopontin; Medicine; Internal medicine; Breast cancer; Oncology; Metastatic breast cancer; Multivariate analysis; Malignancy; Metastasis; Univariate analysis; Cancer; Proportional hazards model; Survival analysis; Prospective cohort study; Clinical significance","score_opus":0.2536032763087579,"score_gpt":0.5181946307969726,"score_spread":0.2645913544882147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976464671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573023,0.0024488978,0.0000065005393,0.0065958085,0.00044330754,0.0015346066,0.00015641842,0.00004036707,0.0030438793],"genre_scores_gemma":[0.9922032,0.00040789729,0.00022140038,0.00021830572,0.0014822166,0.00076179457,0.000010815008,0.00004104378,0.00465337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616253,0.0005520296,0.0008828663,0.0006096448,0.0009918885,0.0008010543],"domain_scores_gemma":[0.99789107,0.0010733686,0.00009073398,0.0003284285,0.00039609152,0.00022029091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025685374,0.00019752518,0.0007059827,0.00019041642,0.0001464904,0.00005026476,0.00018113904,0.00014949181,0.0007711743],"category_scores_gemma":[0.0007621499,0.00015577575,0.00016792142,0.0005485255,0.000637034,0.00010074789,0.00025770548,0.0011548633,0.00015123011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042465986,0.0013137505,0.9362127,0.0004478158,0.00018730748,0.0007057574,0.00017069434,0.000119320575,0.0010318629,0.00031764535,0.02094899,0.03429756],"study_design_scores_gemma":[0.006748764,0.00056866894,0.98450524,0.0006931829,0.00009433139,0.00003847948,0.00032507945,0.0005455066,0.0007864487,0.0010560586,0.0044109807,0.00022725304],"about_ca_topic_score_codex":0.022623276,"about_ca_topic_score_gemma":0.010989754,"teacher_disagreement_score":0.048292547,"about_ca_system_score_codex":0.00029240502,"about_ca_system_score_gemma":0.0007655285,"threshold_uncertainty_score":0.98388517},"labels":[],"label_agreement":null},{"id":"W1976763248","doi":"10.1158/1078-0432.ccr-07-4781","title":"Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin <i>In vivo</i>","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Osteosarcoma; Oncostatin M; Medicine; Cancer research; Sarcoma; In vivo; Pathology; Bone cancer; Staurosporine; Internal medicine; Cytokine; Biology; Interleukin 6; Kinase; Protein kinase A","score_opus":0.1521995533053343,"score_gpt":0.4927389888784584,"score_spread":0.3405394355731241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976763248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895976,0.0008647506,0.0000025377274,0.007920026,0.00022450041,0.00072355074,0.00003826281,0.00001289788,0.0006158699],"genre_scores_gemma":[0.9974804,0.0009905491,0.000057294452,0.00043798014,0.00038109047,0.000069269154,0.0000030739502,0.000018014274,0.0005623558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977699,0.00050213566,0.0005408591,0.00033422263,0.000511025,0.00034189335],"domain_scores_gemma":[0.99608594,0.003056701,0.000064002605,0.00032637076,0.00025337754,0.00021361788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00273802,0.00011412069,0.00048638196,0.00017262285,0.00014471386,0.000015816935,0.00010993771,0.0000762977,0.00017364924],"category_scores_gemma":[0.0017953058,0.000070873786,0.00010701341,0.00051253516,0.0005238077,0.000046823243,0.00014425363,0.00087000284,0.000025201272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010457964,0.00071630947,0.30281082,0.000488407,0.000121703735,0.0017939757,0.0018470074,0.000029281451,0.5822845,0.00009668286,0.06819209,0.03116127],"study_design_scores_gemma":[0.005767219,0.007448077,0.09946908,0.0011458481,0.000045508117,0.00036236734,0.00045001897,0.00010968077,0.8343082,0.000029003937,0.050655622,0.00020934679],"about_ca_topic_score_codex":0.0014503811,"about_ca_topic_score_gemma":0.00059948326,"teacher_disagreement_score":0.25202373,"about_ca_system_score_codex":0.000058692567,"about_ca_system_score_gemma":0.00027920844,"threshold_uncertainty_score":0.3779778},"labels":[],"label_agreement":null},{"id":"W1977732806","doi":"10.1158/1078-0432.ccr-06-1508","title":"Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Imatinib; PDGFRA; GiST; Cancer research; Imatinib mesylate; Tyrosine-kinase inhibitor; Stromal tumor; Stromal cell; Sarcoma; Tyrosine kinase; Pathology; Medicine; Proto-Oncogene Proteins c-kit; Biology; Cancer; Internal medicine; Receptor; Stem cell factor","score_opus":0.22951050713044943,"score_gpt":0.5427864574524165,"score_spread":0.3132759503219671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977732806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564207,0.00049328856,0.00026740757,0.0013148196,0.00003378632,0.0011927374,0.000037786514,0.000050547984,0.00096758845],"genre_scores_gemma":[0.98511654,0.00009815696,0.013894881,0.00023355399,0.00013760186,0.00015539558,0.000016590657,0.000040836072,0.00030643103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455595,0.0008208506,0.0009966356,0.00085927016,0.0011495905,0.0016176926],"domain_scores_gemma":[0.99497926,0.0026823261,0.0001224352,0.0005187462,0.00061794365,0.0010793102],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00782367,0.00027981238,0.0007007157,0.00042306323,0.00015698811,0.00006639794,0.00025069388,0.000087476146,0.00037439502],"category_scores_gemma":[0.009219813,0.00020171789,0.00015815064,0.0007688826,0.0010260874,0.00009417035,0.00039913395,0.0017753377,0.00007076574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016158897,0.0012664911,0.89180005,0.00023728934,0.000042891006,0.065929696,0.00006953241,0.0000067750884,0.013871342,0.00015878705,0.0003211121,0.01013717],"study_design_scores_gemma":[0.0072466373,0.012631653,0.96089095,0.001326204,0.000032115742,0.0067109345,0.00078443665,0.00037934544,0.009056492,0.0005183124,0.00016780682,0.0002551103],"about_ca_topic_score_codex":0.0005875658,"about_ca_topic_score_gemma":0.0005468566,"teacher_disagreement_score":0.06909093,"about_ca_system_score_codex":0.00035002673,"about_ca_system_score_gemma":0.0009957195,"threshold_uncertainty_score":0.99912596},"labels":[],"label_agreement":null},{"id":"W1978066528","doi":"10.1158/1078-0432.ccr-14-2298","title":"Chemotherapy Rescues Hypoxic Tumor Cells and Induces Their Reoxygenation and Repopulation—An Effect That Is Inhibited by the Hypoxia-Activated Prodrug TH-302","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chemotherapy; Hypoxia (environmental); Prodrug; Doxorubicin; Repopulation; Cancer research; Biology; Medicine; Pharmacology; Internal medicine; Chemistry; Stem cell; Oxygen; Cell biology; Haematopoiesis","score_opus":0.13531656723271088,"score_gpt":0.4325922844217213,"score_spread":0.29727571718901047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978066528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98411506,0.012540486,0.000007260253,0.0017743222,0.0004763772,0.0008138819,0.000070482005,0.000021390955,0.00018070832],"genre_scores_gemma":[0.9890668,0.0073097553,0.000036988487,0.0009271529,0.0013944334,0.00016435237,0.00007856043,0.000044394106,0.0009775634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969623,0.0010118539,0.00038672175,0.0007597659,0.00047130013,0.0004080288],"domain_scores_gemma":[0.9984023,0.00021240664,0.0001522654,0.0005788306,0.00034471528,0.00030947558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038524056,0.00021630115,0.00031373213,0.000067845205,0.00024067659,0.00014326796,0.00026764165,0.00024553592,0.000016928463],"category_scores_gemma":[0.00063780247,0.00014103868,0.00007457392,0.00025836087,0.0005411561,0.000029871562,0.00019046174,0.000500422,0.0000027028493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011525679,0.00010811808,0.0028336896,0.00003233097,0.000097712706,8.937684e-7,0.0005006676,0.0000021873261,0.8737213,0.0000066964735,0.058542226,0.06300163],"study_design_scores_gemma":[0.0018598121,0.00077364757,0.009691787,0.000026304566,0.000022469801,0.000008394854,0.0002947859,0.00006805658,0.7415589,0.000257938,0.24521835,0.00021953166],"about_ca_topic_score_codex":0.00052385975,"about_ca_topic_score_gemma":0.00014273226,"teacher_disagreement_score":0.18667611,"about_ca_system_score_codex":0.00003710194,"about_ca_system_score_gemma":0.0002532692,"threshold_uncertainty_score":0.57513905},"labels":[],"label_agreement":null},{"id":"W1979364783","doi":"10.1158/1078-0432.ccr-14-3026","title":"Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Howard Hughes Medical Institute","keywords":"Osteosarcoma; PI3K/AKT/mTOR pathway; Druggability; Cancer research; Biology; Computational biology; Medicine; Bioinformatics; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.27754495892627834,"score_gpt":0.5097353448381213,"score_spread":0.232190385911843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979364783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883367,0.009481152,0.00010212291,0.0008237715,0.0002679003,0.00075596233,0.000017518752,0.00001644656,0.00019846315],"genre_scores_gemma":[0.9980587,0.00029078903,0.00008641477,0.00032122855,0.00039506378,0.00036604947,0.000021101452,0.00002851676,0.00043213682],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954777,0.0020519628,0.00075444655,0.0006614671,0.00059634005,0.00045810794],"domain_scores_gemma":[0.9979476,0.00063716737,0.0001216789,0.0005153247,0.0005084518,0.00026979373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008382556,0.00016316804,0.0004039912,0.00009817261,0.00010838248,0.00010750631,0.00020984405,0.0002850178,0.000040565705],"category_scores_gemma":[0.003526281,0.00014539204,0.00009664057,0.00025976967,0.0006781057,0.000014226994,0.0003203429,0.0005947069,0.000021524622],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008726484,0.0012361639,0.49720976,0.01176185,0.00088871113,0.00027964305,0.0016941614,0.00022252221,0.45489353,0.000584079,0.0112641435,0.011238966],"study_design_scores_gemma":[0.043374762,0.01916255,0.22136809,0.023239547,0.00048170536,0.00037077133,0.012341537,0.004375005,0.63130736,0.027485315,0.012106665,0.0043866774],"about_ca_topic_score_codex":0.00076924,"about_ca_topic_score_gemma":0.0010316597,"teacher_disagreement_score":0.27584165,"about_ca_system_score_codex":0.00010098498,"about_ca_system_score_gemma":0.000589414,"threshold_uncertainty_score":0.5928915},"labels":[],"label_agreement":null},{"id":"W1980136907","doi":"10.1158/1078-0432.ovca13-a81","title":"Abstract A81: Estrogen-responsiveness of the TFIID subunit TAF4B and its potential function in ovarian cancer, epigenetic regulation and meiotic DNA repair","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Biology; Estrogen; Epigenetics; Estrogen receptor; Endocrinology; Internal medicine; Cancer; Genetics; Medicine; Breast cancer; Gene","score_opus":0.14493503281830106,"score_gpt":0.45039400798789575,"score_spread":0.3054589751695947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980136907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897112,0.005584637,0.00000661646,0.003335482,0.0002923371,0.0009899937,0.000007644316,0.000010328933,0.00006175939],"genre_scores_gemma":[0.9979744,0.0011936988,0.000013970279,0.00006537127,0.0002684455,0.000111779205,0.0000035709843,0.00001042541,0.00035833343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976764,0.00076952897,0.0004904067,0.0005005103,0.00029573575,0.00026747413],"domain_scores_gemma":[0.99832857,0.0004552689,0.00010022976,0.00040845314,0.00057649816,0.00013100526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028059247,0.000097766206,0.00029923746,0.00009298266,0.00011868115,0.000009920297,0.00009311268,0.0002243046,0.00039713277],"category_scores_gemma":[0.0017693994,0.00006692162,0.00007608991,0.00030751125,0.00068286376,0.000081123195,0.000120582765,0.0006093126,0.000006392666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010290586,0.00025388805,0.8589184,0.00027906746,0.00011219272,0.000005873195,0.00009422601,0.000030966956,0.10633179,0.000110753084,0.00020793505,0.023364278],"study_design_scores_gemma":[0.0010502017,0.00034129227,0.9898969,0.00012476444,0.0000378062,0.000004003016,0.00005308675,0.0003058161,0.0069469227,0.0009636585,0.00021709484,0.000058470636],"about_ca_topic_score_codex":0.001672764,"about_ca_topic_score_gemma":0.00026105082,"teacher_disagreement_score":0.13097844,"about_ca_system_score_codex":0.00007737111,"about_ca_system_score_gemma":0.0004228534,"threshold_uncertainty_score":0.43483254},"labels":[],"label_agreement":null},{"id":"W1980243061","doi":"10.1158/1078-0432.ccr-10-3298","title":"Recombinant Human Erythropoietin in Combination with Chemotherapy Increases Breast Cancer Metastasis in Preclinical Mouse Models","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Janssen Canada; Canadian Institutes of Health Research","keywords":"Metastasis; Breast cancer; Erythropoietin; Recombinant DNA; Chemotherapy; Medicine; Cancer; Cancer research; Human breast; Oncology; Internal medicine; Biology; Gene; Biochemistry","score_opus":0.31986365134490014,"score_gpt":0.506537906879538,"score_spread":0.1866742555346379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980243061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811805,0.00081474247,0.000009135766,0.007969899,0.00010139148,0.0012907841,0.00003791178,0.000051820032,0.001606253],"genre_scores_gemma":[0.98757404,0.009088325,0.000739722,0.00042821592,0.00015979829,0.00072601467,0.000029941224,0.00007455923,0.0011793665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954273,0.00090274925,0.0011220978,0.0009122142,0.0008459724,0.00078963983],"domain_scores_gemma":[0.9977905,0.00057220994,0.00015801961,0.0006381076,0.00043774766,0.00040340557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036373797,0.00028610628,0.00091657304,0.00036810763,0.00012498094,0.000027729579,0.00028546638,0.00030120905,0.002175],"category_scores_gemma":[0.00017595803,0.00020822507,0.00017747731,0.0008431012,0.00094195124,0.00017734714,0.00012929065,0.0015036006,0.000027310969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008457187,0.015581273,0.9275576,0.00022933845,0.00023478725,0.00031906148,0.000813142,0.000024134122,0.00013245393,0.0009892174,0.0028867768,0.04277504],"study_design_scores_gemma":[0.03959584,0.006425633,0.94033176,0.0023473029,0.00014188513,0.000055611275,0.0011098512,0.0008486294,0.0027274159,0.0048990655,0.00087579817,0.00064120046],"about_ca_topic_score_codex":0.038173147,"about_ca_topic_score_gemma":0.011221537,"teacher_disagreement_score":0.042133838,"about_ca_system_score_codex":0.00064396055,"about_ca_system_score_gemma":0.00077330985,"threshold_uncertainty_score":0.99873716},"labels":[],"label_agreement":null},{"id":"W1980754306","doi":"10.1158/1078-0432.ccr-11-0127","title":"Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; Hospital for Sick Children; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research; Hungarian Scientific Research Fund; Brain Tumour Charity","keywords":"Senescence; Cancer research; MAPK/ERK pathway; Biology; Pilocytic astrocytoma; Genetics; Medicine; Signal transduction; Astrocytoma; Glioma","score_opus":0.4508395135005584,"score_gpt":0.5157327345350291,"score_spread":0.0648932210344707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980754306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960556,0.00016066676,0.000055976267,0.001409797,0.00022794321,0.0010282679,0.0000069425514,0.00003334746,0.0010214433],"genre_scores_gemma":[0.9974623,0.00023524175,0.00082141976,0.00030999634,0.00037345162,0.0005946793,0.000009016819,0.000032772696,0.00016112342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971606,0.00028957814,0.0006520247,0.0005950363,0.00070171227,0.0006010128],"domain_scores_gemma":[0.9981272,0.00046382635,0.00007829767,0.0004850754,0.00030980314,0.0005357484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012941861,0.00016114731,0.0004169078,0.0004225602,0.00012044055,0.000025392084,0.00018792886,0.00015980197,0.00039211303],"category_scores_gemma":[0.0008247906,0.00013802612,0.00010510463,0.0009970753,0.00011710007,0.00008412411,0.000100189594,0.00061041716,0.00033926376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010951684,0.0018993943,0.85673594,0.00008519618,0.00010728279,0.0006913601,0.0012025342,0.00002729983,0.0635135,0.00018567317,0.0011022439,0.073354386],"study_design_scores_gemma":[0.0025704245,0.0016243922,0.8978918,0.0004130219,0.00003031064,0.000009987921,0.0001926598,0.00014473843,0.096079886,0.00016382503,0.00072289805,0.00015602027],"about_ca_topic_score_codex":0.0013291135,"about_ca_topic_score_gemma":0.0013076088,"teacher_disagreement_score":0.07319837,"about_ca_system_score_codex":0.0006625348,"about_ca_system_score_gemma":0.00088684785,"threshold_uncertainty_score":0.5628542},"labels":[],"label_agreement":null},{"id":"W1981631249","doi":"10.1158/1078-0432.ccr-05-0429","title":"Intermittent Exposure of Primitive Quiescent Chronic Myeloid Leukemia Cells to Granulocyte-Colony Stimulating Factor <i>In vitro</i> Promotes their Elimination by Imatinib Mesylate","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Imatinib mesylate; Medicine; Myeloid leukemia; Granulocyte colony-stimulating factor; Imatinib; Mesylate; Pharmacology; CD34; Leukemia; Haematopoiesis; Immunology; Chemotherapy; Internal medicine; Stem cell; Chemistry; Biology","score_opus":0.073390416314338,"score_gpt":0.4188013356411297,"score_spread":0.3454109193267917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981631249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308705,0.001455816,0.00005556443,0.0012812121,0.00022985958,0.0030868805,0.0002473258,0.000053027183,0.00050328975],"genre_scores_gemma":[0.996983,0.00039736443,0.00039184224,0.00012851278,0.00039775582,0.00048228403,0.00013541654,0.00007208599,0.0010117695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948091,0.0005987374,0.0015374707,0.0009178137,0.0011576435,0.0009792183],"domain_scores_gemma":[0.99660903,0.0015211127,0.000299649,0.00064795336,0.0005996088,0.00032264416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018722926,0.00035591,0.000981886,0.00029621084,0.000112224734,0.000037766265,0.00035751614,0.000307625,0.00023849314],"category_scores_gemma":[0.0007087557,0.00028911734,0.00026933107,0.0006798652,0.00037749799,0.000117840835,0.00030009114,0.0012348535,0.000054582037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033742106,0.0013050747,0.04262607,0.0007822068,0.00017826264,0.00007197278,0.0009589562,0.0002723563,0.7682173,0.000017551603,0.003366378,0.17882964],"study_design_scores_gemma":[0.009290663,0.0032970845,0.20459878,0.0012574795,0.000056019144,0.000004367841,0.0001790652,0.002881616,0.77645785,0.00005478176,0.0016044806,0.0003178299],"about_ca_topic_score_codex":0.0025642174,"about_ca_topic_score_gemma":0.0005036325,"teacher_disagreement_score":0.1785118,"about_ca_system_score_codex":0.007817077,"about_ca_system_score_gemma":0.0023024548,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W1982792443","doi":"10.1158/1078-0432.ccr-03-0541","title":"Carbonic Anhydrase IX as a Marker for Poor Prognosis in Soft Tissue Sarcoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Sarcoma; Pathology; Soft tissue sarcoma; Soft tissue; Metastasis; Stroma; Immunohistochemistry; Medicine; Internal medicine; Cancer","score_opus":0.10740427588394963,"score_gpt":0.48592295641640376,"score_spread":0.37851868053245413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982792443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907505,0.0016373675,0.00035785418,0.004948364,0.00022093054,0.00075204717,0.000023246035,0.000013291509,0.0012964341],"genre_scores_gemma":[0.9951458,0.0007101578,0.00025152773,0.00089174253,0.00063071353,0.00043990416,0.00007661758,0.000024964453,0.0018285946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984162,0.00015778381,0.0003062102,0.00047703687,0.00023357652,0.0004091846],"domain_scores_gemma":[0.99928737,0.00008928636,0.00003840813,0.00021133934,0.00021556197,0.00015803914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014635385,0.000095928255,0.00015293786,0.000059068057,0.00009202491,0.000029128534,0.00016030793,0.00025038698,0.00025998623],"category_scores_gemma":[0.00091508747,0.000092530034,0.000104159466,0.00017313947,0.00021039574,0.00000502633,0.000104139355,0.00032591206,0.00006924647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008181234,0.0027468626,0.07981274,0.0003133939,0.00018133674,0.000087203756,0.00018462022,0.00030173015,0.64022607,0.0007245807,0.15380669,0.11343354],"study_design_scores_gemma":[0.009953471,0.006417088,0.022744842,0.00024510678,0.000023371935,0.000015814127,0.00019269096,0.00017917463,0.4825796,0.0038515534,0.47326368,0.00053364184],"about_ca_topic_score_codex":0.0005700959,"about_ca_topic_score_gemma":0.0019003856,"teacher_disagreement_score":0.31945696,"about_ca_system_score_codex":0.00006571057,"about_ca_system_score_gemma":0.0004971124,"threshold_uncertainty_score":0.37732652},"labels":[],"label_agreement":null},{"id":"W1983400019","doi":"10.1158/1078-0432.ccr-12-1518","title":"Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Association pour la Recherche sur le Cancer; Institute of Cancer Research; AstraZeneca","keywords":"Gefitinib; Medicine; Internal medicine; Oncology; Population; Randomization; Placebo; Epidermal growth factor receptor; Cancer; Randomized controlled trial; Pathology","score_opus":0.24955806398645167,"score_gpt":0.5430750267725832,"score_spread":0.2935169627861316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983400019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868709,0.0016889558,0.0000010032171,0.0072544594,0.0011237111,0.0020083322,0.00004658964,0.000028112294,0.000977971],"genre_scores_gemma":[0.9939376,0.0013198977,0.00006682591,0.0021194068,0.0011560816,0.00081321795,0.000015589729,0.00003389209,0.000537503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965207,0.00047771903,0.000770408,0.0005421646,0.00084782526,0.0008411842],"domain_scores_gemma":[0.997544,0.0010755156,0.00009513082,0.0002606617,0.00042093315,0.0006037732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001965597,0.00021907344,0.00086427684,0.00022012214,0.00019239323,0.00003347924,0.00011297245,0.0001837372,0.00018337244],"category_scores_gemma":[0.0032214902,0.00016301674,0.000092058384,0.0004817643,0.00017889775,0.00017596567,0.000143371,0.000964468,0.000028344464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028798956,0.000961702,0.89744705,0.000053147753,0.000045144097,0.0000069247003,0.0011852061,0.0000036856297,0.00043879234,0.0000067106766,0.007564426,0.06348825],"study_design_scores_gemma":[0.042029925,0.0034339442,0.94657207,0.00089437584,0.000018571442,2.9773835e-7,0.00014694789,0.00002249733,0.0010413296,0.000007191243,0.005654109,0.00017871572],"about_ca_topic_score_codex":0.0010685989,"about_ca_topic_score_gemma":0.0010747843,"teacher_disagreement_score":0.063309535,"about_ca_system_score_codex":0.0005361345,"about_ca_system_score_gemma":0.00039274344,"threshold_uncertainty_score":0.664763},"labels":[],"label_agreement":null},{"id":"W1984081057","doi":"10.1158/1078-0432.ccr-04-2472","title":"Reduction of Intracellular pH as a Strategy to Enhance the pH-Dependent Cytotoxic Effects of Melphalan for Human Breast Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Intracellular; Extracellular; Melphalan; Pharmacology; Chemotherapy; Toxicity; Intracellular pH; Cancer cell; Cell culture; Cancer research; Cytotoxicity; Cancer; Chemistry; Biology; Medicine; Biochemistry; In vitro; Internal medicine","score_opus":0.06719563692912052,"score_gpt":0.5019993930199956,"score_spread":0.4348037560908751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984081057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994634,0.0022102587,0.00020244968,0.0012736896,0.00013290528,0.0012687369,0.00012951621,0.0000051527436,0.00014334566],"genre_scores_gemma":[0.9936888,0.0021721981,0.000050676226,0.00006366112,0.0014567495,0.00062045734,0.000017465645,0.000032929984,0.0018970479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730664,0.00044941637,0.0005568897,0.0005567682,0.000597944,0.0005323178],"domain_scores_gemma":[0.99813914,0.00028334293,0.00013387103,0.0005931624,0.00063269987,0.00021777225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019614499,0.00014846287,0.00030878535,0.000073710005,0.00015836178,0.000023757915,0.00058091077,0.00021300338,0.00020947274],"category_scores_gemma":[0.00027803128,0.000111508816,0.00019631894,0.00024065662,0.0004659884,0.000007902429,0.00024260768,0.0004159621,0.000015650327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007079395,0.00031233724,0.0001903786,0.00019215429,0.00010971063,0.000002139088,0.000049711205,0.00021859905,0.9419945,0.000048435668,0.0024614225,0.05371266],"study_design_scores_gemma":[0.0006020541,0.0014714365,0.00049638323,0.00010787858,0.00002203149,0.000001710409,0.000108215805,0.000044618464,0.99315435,0.000088521214,0.0037832945,0.00011948914],"about_ca_topic_score_codex":0.0011141077,"about_ca_topic_score_gemma":0.00046985009,"teacher_disagreement_score":0.05359317,"about_ca_system_score_codex":0.00006635366,"about_ca_system_score_gemma":0.00054486166,"threshold_uncertainty_score":0.45471975},"labels":[],"label_agreement":null},{"id":"W1984391626","doi":"10.1158/1078-0432.tcmusa10-a11","title":"Abstract A11: Regulation of CD133 by the tubulin deacetylase HDAC6 can alter cancer cell state","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; HDAC6; Cell biology; Progenitor cell; Cancer research; Acetylation; Stem cell; Histone deacetylase; Molecular biology; Histone; Genetics","score_opus":0.06519240995401616,"score_gpt":0.4615438784333071,"score_spread":0.3963514684792909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984391626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924676,0.002267646,0.000016147585,0.0024393736,0.00055984984,0.00058531045,0.00037737784,0.000010755329,0.0012759494],"genre_scores_gemma":[0.9885293,0.0026592442,0.00005285493,0.00020548978,0.0011105835,0.00024345536,0.000102303646,0.000058430207,0.007038287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963063,0.00050976884,0.0007480942,0.00071383803,0.0009767091,0.00074527384],"domain_scores_gemma":[0.9971651,0.0003976504,0.0001836233,0.0010504501,0.00085202575,0.0003511571],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038436218,0.00020088101,0.00028994403,0.00006029141,0.00024662903,0.000052163647,0.00078737526,0.00036355798,0.001133074],"category_scores_gemma":[0.0007469091,0.00015234454,0.000203666,0.00028023933,0.0012446791,0.000010518246,0.00034998762,0.0015551948,0.000047135174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003950315,0.00020144157,0.0015304217,0.00005441326,0.000040883264,0.0000023874907,0.00007987415,0.00004468556,0.8331781,0.0000065038544,0.15185937,0.012606879],"study_design_scores_gemma":[0.0009088726,0.00027213854,0.0077025495,0.000027775215,0.00000890237,0.000001278182,0.00003800223,0.00008943134,0.86505646,0.000058639554,0.12565456,0.00018139201],"about_ca_topic_score_codex":0.009375963,"about_ca_topic_score_gemma":0.020236038,"teacher_disagreement_score":0.03187834,"about_ca_system_score_codex":0.00010445457,"about_ca_system_score_gemma":0.0011996081,"threshold_uncertainty_score":0.99978},"labels":[],"label_agreement":null},{"id":"W1984727975","doi":"10.1158/1078-0432.ovca13-b70","title":"Abstract B70: Akt-activated endothelium constitute a niche for residual disease and resistance to bevacizumab in ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bevacizumab; Ovarian cancer; Angiogenesis; Cancer research; Medicine; Matrigel; Protein kinase B; Cancer; Cancer cell; Immunology; Vascular endothelial growth factor; Biology; Internal medicine; Chemotherapy; Signal transduction; Cell biology","score_opus":0.09998340124556057,"score_gpt":0.45204887550893214,"score_spread":0.35206547426337154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984727975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743451,0.009996839,0.00006302015,0.00853248,0.0028093415,0.002337589,0.00063564925,0.000017419827,0.0012625711],"genre_scores_gemma":[0.96883714,0.007404268,0.0005254087,0.0012972547,0.0118733095,0.0035491074,0.00006244081,0.00006153722,0.006389541],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972907,0.00021166306,0.000551242,0.0008805379,0.00033707308,0.00072883395],"domain_scores_gemma":[0.9980174,0.00028854804,0.000081488084,0.0005418998,0.0004593069,0.00061140745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001301459,0.00020181543,0.0003610452,0.00011226654,0.0001559506,0.00008894091,0.0003427948,0.0002249812,0.00024211756],"category_scores_gemma":[0.001596501,0.00018722707,0.000107935855,0.00023006096,0.0004594149,0.000014942045,0.00021959095,0.0004006181,0.000015208465],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009665292,0.0003342911,0.02219316,0.00034451747,0.00019625637,0.000002901616,0.00014349165,0.000038876642,0.43922564,0.0007481976,0.5038256,0.023281768],"study_design_scores_gemma":[0.003611117,0.00018593586,0.14518362,0.00017366438,0.000024652587,6.184195e-7,0.000079171536,0.0000069614566,0.014666079,0.0007415742,0.83497393,0.0003526573],"about_ca_topic_score_codex":0.0027767122,"about_ca_topic_score_gemma":0.009679823,"teacher_disagreement_score":0.42455956,"about_ca_system_score_codex":0.00008801602,"about_ca_system_score_gemma":0.0013123767,"threshold_uncertainty_score":0.76348984},"labels":[],"label_agreement":null},{"id":"W1984747105","doi":"10.1158/1078-0432.ovca13-a45","title":"Abstract A45: Beclin1-independent autophagy promotes the survival of metastatic ovarian cancer cells","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Autophagy; Cell biology; Downregulation and upregulation; ATG5; BAG3; Biology; Autophagosome; Small interfering RNA; Cancer research; Chemistry; Cell culture; Transfection; Apoptosis; Biochemistry","score_opus":0.2438841706056255,"score_gpt":0.5240248442800706,"score_spread":0.28014067367444506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984747105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843534,0.0041834856,0.000017573597,0.006962624,0.00075574865,0.0017865903,0.00007211933,0.00004201628,0.0018263994],"genre_scores_gemma":[0.9923805,0.0025601631,0.00009525141,0.00058544945,0.0008099455,0.0006171136,0.000009052043,0.000048452257,0.0028940572],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957233,0.0006174199,0.000984229,0.0005324755,0.0014496747,0.00069291616],"domain_scores_gemma":[0.9955762,0.002048182,0.00021321967,0.0008617625,0.00084169634,0.00045894575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038474018,0.00020686776,0.0006689008,0.00011227877,0.00017957581,0.00005657757,0.000547143,0.00016808648,0.015940033],"category_scores_gemma":[0.00051951036,0.00012512917,0.00034857,0.0004431156,0.000811643,0.00011570778,0.00016843624,0.0013264458,0.00039543945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065478696,0.011123371,0.12803465,0.0031229674,0.0075673806,0.00076951744,0.0027489436,0.00016324059,0.1474251,0.003928007,0.08288764,0.6056813],"study_design_scores_gemma":[0.0047626356,0.00089731044,0.91487426,0.00038279683,0.00024283308,0.00000423405,0.00047502274,0.0006157153,0.065693915,0.0039765215,0.007794454,0.00028032408],"about_ca_topic_score_codex":0.0062534227,"about_ca_topic_score_gemma":0.0003005363,"teacher_disagreement_score":0.7868396,"about_ca_system_score_codex":0.00012416265,"about_ca_system_score_gemma":0.0014929681,"threshold_uncertainty_score":0.98495954},"labels":[],"label_agreement":null},{"id":"W1984754167","doi":"10.1158/1078-0432.ccr-06-2482","title":"Primary Tumor Levels of Human Tissue Kallikreins Affect Surgical Success and Survival in Ovarian Cancer Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ascites; Univariate analysis; Oncology; Internal medicine; Hazard ratio; Multivariate analysis; Plasminogen activator; Ovarian cancer; Kallikrein; Plasminogen activator inhibitor-1; Cancer; Gastroenterology; Gynecology; Confidence interval; Biology","score_opus":0.18198371862328605,"score_gpt":0.5220958549526304,"score_spread":0.3401121363293444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984754167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373466,0.002229338,0.000006992009,0.00064111623,0.0003383808,0.00072843133,0.000058832775,0.000020103891,0.0022421198],"genre_scores_gemma":[0.99753904,0.00048408547,0.00003527566,0.00012433456,0.0007243838,0.000041037318,0.000028728462,0.00003650167,0.0009865945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630195,0.0003968867,0.0010119074,0.0005669226,0.0010339491,0.0006883926],"domain_scores_gemma":[0.99687153,0.0017237593,0.00014574201,0.00032570618,0.00050473993,0.00042852736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005250743,0.00018024923,0.0007678896,0.0002727541,0.00012737191,0.000024169223,0.00021019662,0.0002069986,0.0007918569],"category_scores_gemma":[0.00054337113,0.00015536201,0.00011657558,0.0006386932,0.0006691723,0.00010708129,0.00020160852,0.00074630696,0.0000068205686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010238341,0.000582942,0.97124016,0.00026808807,0.00004600872,0.0001322466,0.00016150645,0.0000013169799,0.000660027,0.00036238832,0.0002895151,0.02523194],"study_design_scores_gemma":[0.0054387646,0.0009016247,0.9878019,0.00039141043,0.00002672598,0.0000029323976,0.00003175291,0.0000141891505,0.003020492,0.0001630713,0.0020514594,0.00015567128],"about_ca_topic_score_codex":0.006647356,"about_ca_topic_score_gemma":0.0057057426,"teacher_disagreement_score":0.025076268,"about_ca_system_score_codex":0.00022621476,"about_ca_system_score_gemma":0.0005356169,"threshold_uncertainty_score":0.99996746},"labels":[],"label_agreement":null},{"id":"W1985360090","doi":"10.1158/1078-0432.ccr-08-1726","title":"<i>In vivo</i> Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Prostate cancer; In vivo; Androgen receptor; Gene knockdown; Prostate; Castration; Androgen; Internal medicine; Endocrinology; Medicine; Cancer research; Oncology; Biology; Cancer; Hormone; Cell culture","score_opus":0.10638888335839422,"score_gpt":0.432199639747603,"score_spread":0.32581075638920876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985360090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889094,0.001598162,1.379374e-7,0.006023128,0.00008723957,0.0012582355,0.0001453829,0.0000060791576,0.0019722013],"genre_scores_gemma":[0.98777145,0.009595863,0.000050845396,0.00005298134,0.000096258256,0.00012022339,0.000017799934,0.00001827427,0.0022763077],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647135,0.0006214059,0.0010411957,0.00046773453,0.00095959497,0.00043873972],"domain_scores_gemma":[0.9979991,0.0006744283,0.0001881038,0.00037287144,0.0005867714,0.00017875024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002806758,0.00013956628,0.0004945096,0.00029140656,0.00011151138,0.000010829463,0.00014059982,0.00015354149,0.000118530974],"category_scores_gemma":[0.001029135,0.00008246472,0.000096179145,0.001236677,0.0012331511,0.00016192757,0.00016764688,0.00081034115,0.0000031174052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03678985,0.0015209247,0.79459465,0.001047079,0.000061098835,0.00041650294,0.0022242253,0.000009467202,0.12748258,0.00014503388,0.03390376,0.0018048099],"study_design_scores_gemma":[0.022128515,0.0028116107,0.4384248,0.0046482137,0.000024457553,0.000033736782,0.0008161749,0.000075177,0.5261223,0.0006767458,0.0040085986,0.00022973218],"about_ca_topic_score_codex":0.0026222817,"about_ca_topic_score_gemma":0.00087022374,"teacher_disagreement_score":0.39863965,"about_ca_system_score_codex":0.00021345654,"about_ca_system_score_gemma":0.0012199424,"threshold_uncertainty_score":0.45435965},"labels":[],"label_agreement":null},{"id":"W1985878765","doi":"10.1158/1078-0432.ccr-07-1066","title":"Combining the Antigen Processing Components TAP and Tapasin Elicits Enhanced Tumor-Free Survival","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"University of Toronto; Yale University","keywords":"MHC class I; CD8; Antigen processing; Antigen; Biology; Immunology; CTL*; Antigen presentation; Priming (agriculture); Transporter associated with antigen processing; Major histocompatibility complex; MHC class II; Dendritic cell; T cell; Cancer research; Immune system","score_opus":0.21577369691725387,"score_gpt":0.45141489050465233,"score_spread":0.23564119358739846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985878765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610473,0.03529292,0.000035229845,0.0010788993,0.00074302877,0.00046345528,0.000015415437,0.000053538643,0.0012702028],"genre_scores_gemma":[0.9891436,0.007597539,0.000022628008,0.00034452116,0.00012223188,0.00012538928,0.000013383571,0.000032376807,0.0025982906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955344,0.0023967973,0.0006229984,0.00047631466,0.00020373121,0.00076573796],"domain_scores_gemma":[0.9965303,0.0023563495,0.00014192198,0.0006128423,0.00031007951,0.000048502494],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0034989752,0.00019402524,0.00046417536,0.000110752815,0.0015782749,0.000049494465,0.0008575409,0.00022433863,0.00031442492],"category_scores_gemma":[0.0011890674,0.0001348209,0.00011186259,0.0003599799,0.0028404973,0.00012635786,0.00047034712,0.0015211699,0.00015638222],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007069677,0.000736297,0.0819019,0.00006145545,0.00044615127,0.00006321345,0.00249864,0.000002371416,0.77350086,0.00037430174,0.0059694177,0.1273757],"study_design_scores_gemma":[0.007664218,0.0009810649,0.66037816,0.0003111963,0.000027483748,0.00015832626,0.0009293441,0.000026276426,0.14500262,0.00045554905,0.18357378,0.0004919827],"about_ca_topic_score_codex":0.0005917435,"about_ca_topic_score_gemma":0.00004448125,"teacher_disagreement_score":0.62849826,"about_ca_system_score_codex":0.000044770106,"about_ca_system_score_gemma":0.0004032168,"threshold_uncertainty_score":0.9998732},"labels":[],"label_agreement":null},{"id":"W1985964388","doi":"10.1158/1078-0432.ccr-14-0307","title":"Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; SKiN Health; University of British Columbia; Quest University Canada; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Antigen; Vorinostat; Ectopic expression; Cancer research; Romidepsin; Lymphoma; Cutaneous T-cell lymphoma; Biology; Cancer; Downregulation and upregulation; Immunology; Medicine; Mycosis fungoides; Cell culture; Histone deacetylase; Gene; Histone; Genetics","score_opus":0.11120879619057882,"score_gpt":0.49429017240956596,"score_spread":0.38308137621898714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985964388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99213386,0.001284389,0.00001389787,0.00072603696,0.00022213307,0.0011031657,0.00003819562,0.000027279864,0.004451045],"genre_scores_gemma":[0.9939502,0.003154322,0.00013569,0.0002026738,0.0002936839,0.0002033984,0.000020815723,0.000054284723,0.0019849488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99474084,0.0009688921,0.0009763528,0.000766554,0.001640925,0.00090643525],"domain_scores_gemma":[0.99553,0.0019112434,0.0001422318,0.0007161324,0.001255772,0.0004446371],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016808263,0.00021205646,0.0007777079,0.0004272711,0.00012449204,0.000026086782,0.0004242983,0.00029266428,0.0009214464],"category_scores_gemma":[0.003675896,0.00017888704,0.00018229563,0.0009246575,0.00071624183,0.000056203302,0.0003198901,0.0007452005,0.00007933084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015355425,0.0019233396,0.90111613,0.00034695107,0.000020612184,0.00008663937,0.0001812656,0.000020890648,0.007473474,0.000015927199,0.0023384592,0.084940754],"study_design_scores_gemma":[0.019150639,0.0048046918,0.8849717,0.0016003827,0.00003948821,0.000034832403,0.00020065259,0.0025904935,0.07056815,0.000562132,0.015001746,0.00047509657],"about_ca_topic_score_codex":0.004149763,"about_ca_topic_score_gemma":0.0016282095,"teacher_disagreement_score":0.08446565,"about_ca_system_score_codex":0.00047110676,"about_ca_system_score_gemma":0.0012848086,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W1986849223","doi":"10.1158/1078-0432.tcmusa10-b44","title":"Abstract B44: Probing the effects of linker flexibility in second mitochondria-derived activator of caspases mimetic dimers and assessing their ability to induce apoptosis in a MDA-MB-231 cell line","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"XIAP; Caspase; Apoptosis; Inhibitor of apoptosis; Programmed cell death; Activator (genetics); Proteases; Intrinsic apoptosis; Amino acid; Cancer cell; Cell biology; Chemistry; Biochemistry; Biology; Molecular biology; Enzyme; Receptor; Cancer; Genetics","score_opus":0.08770937849672854,"score_gpt":0.4322579390847287,"score_spread":0.34454856058800015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986849223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768704,0.00028586853,0.000018743622,0.0003278177,0.00057332724,0.00096089,0.000020092884,0.00000348948,0.00012274904],"genre_scores_gemma":[0.999057,0.000108593595,0.00028947243,0.000109818735,0.0002209715,0.00014252507,0.0000075219327,0.000016497745,0.000047595284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734914,0.0008266869,0.0006683376,0.0006168843,0.00019501006,0.00034393804],"domain_scores_gemma":[0.99701935,0.0018580907,0.0001473353,0.0005969897,0.00023037342,0.00014788659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026569373,0.00015039614,0.00039438973,0.000109553985,0.000058728147,0.000021226373,0.00027182724,0.0003985448,0.00009571416],"category_scores_gemma":[0.0043094116,0.00010883162,0.000104668354,0.00033250207,0.00058479444,0.000011159465,0.00025361593,0.001128962,0.0000013585222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006923579,0.00032651192,0.029420983,0.00030695595,0.000013377152,0.0000013663322,0.00023156422,0.000013920533,0.9645029,0.000002179211,0.000090463094,0.004397447],"study_design_scores_gemma":[0.0009752731,0.000562551,0.119983055,0.000083666535,0.000006144382,7.1001097e-7,0.00017290056,0.00001781368,0.8775438,0.00005386348,0.0004961555,0.00010406877],"about_ca_topic_score_codex":0.00056267343,"about_ca_topic_score_gemma":0.0023040883,"teacher_disagreement_score":0.09056207,"about_ca_system_score_codex":0.00002407499,"about_ca_system_score_gemma":0.00040857898,"threshold_uncertainty_score":0.515908},"labels":[],"label_agreement":null},{"id":"W1987085807","doi":"10.1158/1078-0432.ccr-14-3141","title":"Clinically Relevant Molecular Subtypes in Leiomyosarcoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital","funders":"National Cancer Institute","keywords":"Leiomyosarcoma; Immunohistochemistry; Cancer; Tissue microarray; Biology; Pathology; Medicine; Oncology; Cancer research; Internal medicine","score_opus":0.3321692068341043,"score_gpt":0.5689218262367595,"score_spread":0.23675261940265518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987085807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781761,0.0013793845,0.000012647536,0.011048922,0.0002726295,0.0005128252,0.000006352398,0.000036740625,0.008554354],"genre_scores_gemma":[0.9949811,0.00073283626,0.00095295155,0.00066819385,0.0003443363,0.000114762035,0.000012364625,0.00003344607,0.0021599901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673945,0.0004936658,0.00082546804,0.0005335665,0.0008425393,0.00056530075],"domain_scores_gemma":[0.9976686,0.00056810514,0.000058650767,0.0005858618,0.00045578886,0.0006629645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041623143,0.00013089662,0.00050146243,0.0001753835,0.000034352222,0.000026507669,0.00021952506,0.00019372517,0.00019850915],"category_scores_gemma":[0.0024457977,0.00009965097,0.00015685307,0.0005260926,0.00033967875,0.000052889915,0.00024899488,0.0009990196,0.00041910642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002803191,0.0011844517,0.94776607,0.000040983425,0.00009646037,0.0024702237,0.000067418114,0.0000028550573,0.00021511459,0.00045941048,0.006256092,0.038637742],"study_design_scores_gemma":[0.01770402,0.007223346,0.8079783,0.00042147434,0.00007110013,0.00005557335,0.00015431596,0.00036148852,0.0007932049,0.0046450924,0.16027999,0.0003120908],"about_ca_topic_score_codex":0.0007176151,"about_ca_topic_score_gemma":0.00017179668,"teacher_disagreement_score":0.1540239,"about_ca_system_score_codex":0.00021643123,"about_ca_system_score_gemma":0.0010366291,"threshold_uncertainty_score":0.5386905},"labels":[],"label_agreement":null},{"id":"W1988632741","doi":"10.1158/1078-0432.ccr-13-2261","title":"“Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University","funders":"National Institute on Drug Abuse; National Institute on Alcohol Abuse and Alcoholism","keywords":"Medicine; Smoking cessation; Harm; Psychological intervention; Disease; Lung cancer; Tobacco smoke; Cancer; Stroke (engine); Harm reduction; Psychiatry; Environmental health; Family medicine; Public health; Psychology; Pathology; Social psychology; Internal medicine","score_opus":0.5939706063707296,"score_gpt":0.6846968558702444,"score_spread":0.0907262494995148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988632741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011869891,0.98655695,0.00018892487,0.0032491712,0.0029182213,0.002399752,0.00015552461,0.000051805477,0.003292642],"genre_scores_gemma":[0.017635718,0.9751881,0.000064000924,0.0005874347,0.002406129,0.0012954065,0.000061601044,0.000108395296,0.0026532626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9874822,0.0049989442,0.004092645,0.0010782597,0.0010234067,0.0013245654],"domain_scores_gemma":[0.9924716,0.003350003,0.0015725876,0.0013515078,0.000696085,0.00055824174],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.026257016,0.00035272716,0.0020981594,0.0005708535,0.0006760877,0.00007317269,0.0014118954,0.00074162305,0.0012193968],"category_scores_gemma":[0.0011240782,0.0002576155,0.0011070713,0.0015352803,0.00035705083,0.00011887455,0.0004673515,0.0037816844,0.00023591667],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004059536,0.00017009345,0.0020264536,0.002222945,0.00007558191,0.0000017754797,0.00023255448,0.0000015015248,1.8472374e-8,0.003647926,0.008208986,0.98337156],"study_design_scores_gemma":[0.00030742626,0.0007329508,0.0063559487,0.01886208,0.00014898652,0.0000028538598,0.00066412735,0.0000041586877,4.8432362e-8,0.0002487136,0.9724497,0.00022299786],"about_ca_topic_score_codex":0.011979138,"about_ca_topic_score_gemma":0.002548438,"teacher_disagreement_score":0.9831486,"about_ca_system_score_codex":0.0013549436,"about_ca_system_score_gemma":0.0017373594,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W1988878042","doi":"10.1158/1078-0432.ccr-14-1814","title":"A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":326,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trametinib; Internal medicine; Adverse effect; Stomatitis; MEK inhibitor; Rash; KRAS; Gastroenterology; Cancer; Oncology; Colorectal cancer; Kinase; MAPK/ERK pathway","score_opus":0.04835023933742931,"score_gpt":0.42858025652265425,"score_spread":0.3802300171852249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988878042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972096,0.000072258736,0.000057269608,0.0004099542,0.00017862333,0.0019967663,0.000024223948,0.0000113127035,0.000039969087],"genre_scores_gemma":[0.99900836,0.000016449814,0.00006844161,0.00009865087,0.00019255982,0.00044398106,0.000051002822,0.00005040059,0.000070165646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948492,0.001953189,0.00082325656,0.0007443203,0.0010751733,0.000554828],"domain_scores_gemma":[0.99749035,0.00039763405,0.00032407357,0.0006993739,0.0009802897,0.00010827015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029489791,0.0002483622,0.00047148488,0.00013293537,0.00014541126,0.000049386294,0.0005898659,0.00021518482,0.000020559502],"category_scores_gemma":[0.0012191378,0.00014814222,0.00007173022,0.0013896995,0.0006265257,0.000025392832,0.00021965227,0.0009693837,0.0000018170917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018940479,0.010671862,0.89804393,0.000076639895,0.00015249969,0.000004846996,0.00077635987,0.0016059639,0.0219706,0.000018863033,0.0010253221,0.046712615],"study_design_scores_gemma":[0.045702983,0.026920708,0.885449,0.00034633334,0.000047911464,7.6500515e-7,0.00063877145,0.00084102905,0.038566846,0.00005145777,0.0010066357,0.00042756394],"about_ca_topic_score_codex":0.000441523,"about_ca_topic_score_gemma":0.0058985143,"teacher_disagreement_score":0.04628505,"about_ca_system_score_codex":0.00016175423,"about_ca_system_score_gemma":0.0005871722,"threshold_uncertainty_score":0.6041064},"labels":[],"label_agreement":null},{"id":"W1988979114","doi":"10.1158/1078-0432.14aacriaslc-a16","title":"Abstract A16: Induction of activating transcription factor 3 is associated with cisplatin responsiveness in NSCLC: A potential predictive biomarker of response.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cisplatin; Cancer research; Transcriptome; Lung cancer; Biomarker; Medicine; Cell culture; In vivo; Ex vivo; Oncology; Predictive marker; Biology; Cancer; Internal medicine; Immunology; Chemotherapy; Gene expression; Gene; Genetics","score_opus":0.09948040028837343,"score_gpt":0.4366555907300218,"score_spread":0.33717519044164834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988979114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944934,0.00020228424,0.004012432,0.00031476415,0.000120739605,0.0005921075,0.00013467863,0.000007419549,0.00012213198],"genre_scores_gemma":[0.99932045,0.0001819901,0.000064231805,0.000031104657,0.00009840554,0.00009397632,0.000041949606,0.00004189123,0.00012598925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951993,0.0020425678,0.00072586176,0.0006163089,0.0009499818,0.00046595986],"domain_scores_gemma":[0.99758583,0.00048315365,0.0002808388,0.0004423998,0.0010726409,0.00013516044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005463308,0.00016573665,0.00038281435,0.000355781,0.000078061974,0.000017281262,0.0003064328,0.00054185203,0.00010717218],"category_scores_gemma":[0.00419156,0.00015321924,0.0001532578,0.0007545984,0.00047408495,0.000016645232,0.00011807622,0.00081770757,0.0000013226969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03241934,0.00025496594,0.0012670727,0.00005365492,0.00014128811,0.0000056466984,0.00013956203,0.00033015356,0.9480012,0.0000056219064,0.00012516117,0.017256305],"study_design_scores_gemma":[0.0032486296,0.0024232874,0.32871562,0.00043832505,0.000013972841,0.0000020436353,0.0001759266,0.00081732194,0.6635034,0.00006394927,0.0004356863,0.00016186465],"about_ca_topic_score_codex":0.00037128868,"about_ca_topic_score_gemma":0.00022348229,"teacher_disagreement_score":0.32744855,"about_ca_system_score_codex":0.00015193637,"about_ca_system_score_gemma":0.0009460125,"threshold_uncertainty_score":0.6248099},"labels":[],"label_agreement":null},{"id":"W1989683475","doi":"10.1158/1078-0432.ccr-04-1399","title":"Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Biology; In vivo; NAD+ kinase; Apoptosis; Phosphocholine; Cancer research; Mammary tumor; Bioenergetics; Programmed cell death; Biochemistry; Phospholipid; Mitochondrion; Cancer; Enzyme","score_opus":0.08103890061726868,"score_gpt":0.44479656908818904,"score_spread":0.3637576684709204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989683475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9463018,0.041130908,0.000007334212,0.009273055,0.0005528753,0.0011710537,0.00006558266,0.00013034709,0.0013670531],"genre_scores_gemma":[0.98328996,0.005820884,0.0003036527,0.0020421657,0.0030633847,0.000586248,0.0000263634,0.00012109246,0.0047462713],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99298817,0.0008454953,0.0011342595,0.0011768047,0.002482275,0.0013730257],"domain_scores_gemma":[0.99429643,0.0027992537,0.00021659315,0.00092849747,0.0009137391,0.000845506],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004778852,0.00041581606,0.0013300742,0.00034186666,0.00037701643,0.00011662723,0.0005392839,0.0004391551,0.0022125023],"category_scores_gemma":[0.00658573,0.00028809052,0.00029278581,0.0014658833,0.000925327,0.00014124037,0.00016128998,0.0028954712,0.00012954698],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009912292,0.0039233295,0.04910732,0.00025254258,0.000967512,0.00036482146,0.00031768152,0.00001409024,0.34274688,0.00012760113,0.45245528,0.13981065],"study_design_scores_gemma":[0.020001495,0.008260278,0.2543561,0.0042696353,0.0012937696,0.000029266655,0.0005877047,0.0020789057,0.5141596,0.000113211194,0.19346128,0.0013887262],"about_ca_topic_score_codex":0.00064508826,"about_ca_topic_score_gemma":0.00066093943,"teacher_disagreement_score":0.25899398,"about_ca_system_score_codex":0.00039675264,"about_ca_system_score_gemma":0.0009900619,"threshold_uncertainty_score":0.99995714},"labels":[],"label_agreement":null},{"id":"W1989991921","doi":"10.1158/1078-0432.ccr-14-2565","title":"Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or <i>BRCA</i> -Mutant Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cyclophosphamide; Veliparib; Ovarian cancer; Fallopian tube cancer; Fallopian tube; PARP inhibitor; Oncology; Internal medicine; Cancer; Chemotherapy; Gastroenterology; Surgery; Biology","score_opus":0.2632031430878121,"score_gpt":0.5062227187434356,"score_spread":0.2430195756556235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989991921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690149,0.0062050675,0.000056690726,0.014396387,0.002752024,0.006009782,0.00029411132,0.00009731107,0.0011737554],"genre_scores_gemma":[0.94538105,0.039275438,0.0019425926,0.003183923,0.0027536543,0.0040787077,0.00007101195,0.00016965655,0.0031439562],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99062836,0.0023159685,0.0025258446,0.001240253,0.0020707613,0.001218787],"domain_scores_gemma":[0.99369276,0.00278849,0.000444074,0.00094907335,0.001008826,0.0011167765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010760974,0.0004794291,0.002989412,0.0004140736,0.00015674089,0.00008252803,0.0005113417,0.0006267343,0.0010910043],"category_scores_gemma":[0.0030934657,0.00033849277,0.00030883474,0.0016247657,0.0022731046,0.00024141371,0.00030436562,0.0020932574,0.000013242306],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97063565,0.00079206994,0.007225938,0.00035072002,0.00045796757,0.0003915129,0.0006270572,0.00007613694,0.00058561243,0.00031000606,0.00806284,0.010484506],"study_design_scores_gemma":[0.9495453,0.0038002443,0.005454884,0.0010606844,0.00019559308,0.00004476376,0.000277008,0.00029499672,0.0012839062,0.0007751046,0.03680575,0.00046171813],"about_ca_topic_score_codex":0.054555047,"about_ca_topic_score_gemma":0.013342288,"teacher_disagreement_score":0.04121276,"about_ca_system_score_codex":0.0022384787,"about_ca_system_score_gemma":0.0136085935,"threshold_uncertainty_score":0.9999067},"labels":[],"label_agreement":null},{"id":"W1990275745","doi":"10.1158/1078-0432.ccr-09-0931","title":"Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Genentech; National Institutes of Health","keywords":"Trastuzumab; Medicine; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.31175981025520483,"score_gpt":0.6359241077453549,"score_spread":0.3241642974901501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990275745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823413,0.0028646113,0.000003948356,0.0058280067,0.00014267195,0.0014478762,0.00041141236,0.000043254553,0.0069169216],"genre_scores_gemma":[0.9941761,0.003237955,0.000043256456,0.0003930943,0.0009556734,0.00016891652,0.0000203941,0.00004353187,0.0009611028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99432635,0.0008423201,0.0009536457,0.00093322893,0.001819646,0.0011248132],"domain_scores_gemma":[0.99555063,0.0012397878,0.00016771478,0.0006943851,0.0013684006,0.0009790648],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002813603,0.00033419157,0.0012525573,0.0003774434,0.00029457128,0.00006039546,0.00039382937,0.00029931925,0.0015795244],"category_scores_gemma":[0.00028915753,0.00025548326,0.00037803335,0.0011020447,0.0016682255,0.000112507405,0.00014809352,0.0024422726,0.00004554257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024975238,0.005587191,0.6289237,0.00046534507,0.0015742388,0.0004466595,0.003061949,0.00018424087,0.016748106,0.0007585673,0.080173895,0.23710085],"study_design_scores_gemma":[0.0037582647,0.010017383,0.97946674,0.0011853576,0.00005483135,0.000025798998,0.0001932323,0.00011163477,0.0035885584,0.00036864678,0.0009883964,0.00024118485],"about_ca_topic_score_codex":0.007891753,"about_ca_topic_score_gemma":0.0005591569,"teacher_disagreement_score":0.350543,"about_ca_system_score_codex":0.0012926867,"about_ca_system_score_gemma":0.0020552077,"threshold_uncertainty_score":0.99998975},"labels":[],"label_agreement":null},{"id":"W1991216698","doi":"10.1158/1078-0432.ccr-07-0689","title":"BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Coalition for Research in Women's Health","funders":"","keywords":"Medicine; Breast cancer; Magnetic resonance imaging; Mammography; Cancer; Oncology; Internal medicine; Mutation; Gynecology; Radiology; Genetics; Biology","score_opus":0.13282258588526952,"score_gpt":0.4620309556758927,"score_spread":0.3292083697906232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991216698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800049,0.013075179,0.00022162945,0.0050152624,0.00027190632,0.00071286,0.00023893837,0.000009083946,0.00045025162],"genre_scores_gemma":[0.99492097,0.0026709754,0.00025406003,0.000921162,0.00081625814,0.00017739441,0.000064819695,0.000031845997,0.00014251232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966361,0.0009890674,0.00066624035,0.0006211933,0.00042685508,0.00066057337],"domain_scores_gemma":[0.99832076,0.0006407839,0.00010195091,0.00030520593,0.00037239573,0.00025890768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010532874,0.00016397546,0.0002672435,0.00031929955,0.0002953182,0.00013880136,0.00032696122,0.00018858045,0.0000453732],"category_scores_gemma":[0.0015029398,0.00013561461,0.000058638077,0.000739734,0.0007222092,0.000015579117,0.00013877006,0.0006231019,0.0000011756823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007878013,0.000048919246,0.686838,0.000053313703,0.00004270603,0.00021154515,0.0007349371,0.00004327773,0.0025018982,0.00019505384,0.005323478,0.3032191],"study_design_scores_gemma":[0.0019968848,0.00014257756,0.97371453,0.00013634478,0.00002910821,0.000081487655,0.0008273443,0.00051493,0.0006534038,0.00018604638,0.021499414,0.00021790186],"about_ca_topic_score_codex":0.16325536,"about_ca_topic_score_gemma":0.34887102,"teacher_disagreement_score":0.3030012,"about_ca_system_score_codex":0.0002015174,"about_ca_system_score_gemma":0.0007977327,"threshold_uncertainty_score":0.84231657},"labels":[],"label_agreement":null},{"id":"W1991981771","doi":"10.1158/1078-0432.12aacriaslc-b14","title":"Abstract B14: FISH-based differentiation of adenoma carcinoma (AC) from squamous cell carcinoma (SqCC): Optimizing probe selection using in silico modeling","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"In silico; Biology; Robustness (evolution); Computational biology; Computer science; Genetics; Gene","score_opus":0.12905630144277805,"score_gpt":0.3902430615559068,"score_spread":0.2611867601131288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991981771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656445,0.0010001082,0.0016429116,0.00006248475,0.00019531077,0.00031566079,0.00006836293,0.000006954349,0.00014377112],"genre_scores_gemma":[0.9979366,0.000040179555,0.0010367559,0.000037640682,0.00067432737,0.000059364185,0.00013635887,0.00003168521,0.000047059424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977793,0.0003109021,0.00067885563,0.00040284544,0.00030124577,0.0005268341],"domain_scores_gemma":[0.99898875,0.000135205,0.00015721988,0.0002949026,0.00027883428,0.00014510877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009723845,0.00015744478,0.000261727,0.00012905446,0.0001352685,0.000035344827,0.00022325666,0.0002942891,0.00013827108],"category_scores_gemma":[0.00014184731,0.00015973517,0.00013732615,0.00019826622,0.00009541587,0.000022114611,0.00013319527,0.00042131354,0.00000300123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035265193,0.00046011276,0.7306246,0.0001199365,0.000015791944,0.0000012585225,0.0002492729,0.020422736,0.24732861,0.000011427992,0.000059067603,0.00035453422],"study_design_scores_gemma":[0.0024764973,0.00041069183,0.5544234,0.000055656143,0.000044341738,0.0000015510885,0.0006679041,0.1162347,0.3251426,0.00006803198,0.0001108979,0.0003637377],"about_ca_topic_score_codex":0.0053341216,"about_ca_topic_score_gemma":0.00065111654,"teacher_disagreement_score":0.17620121,"about_ca_system_score_codex":0.00015458635,"about_ca_system_score_gemma":0.00045405223,"threshold_uncertainty_score":0.80636317},"labels":[],"label_agreement":null},{"id":"W1993224446","doi":"10.1158/1078-0432.ovca13-a47","title":"Abstract A47: The LKB1-AMPK pathway mediates the metabolic stress response of dormant ovarian cancer spheroids","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"AMPK; Spheroid; Cancer research; Cell biology; Cytostasis; Ovarian cancer; Protein kinase A; Autophagy; Biology; Cell culture; Medicine; Cancer; Kinase; Internal medicine; Apoptosis","score_opus":0.09032175024011889,"score_gpt":0.43401724280893944,"score_spread":0.34369549256882054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993224446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93985164,0.05156866,0.000011034683,0.00520395,0.0017344551,0.00083979015,0.00023028936,0.000011654362,0.0005485319],"genre_scores_gemma":[0.9473837,0.043941505,0.00003322423,0.0006347149,0.0049264887,0.00081020547,0.000022002296,0.000046480454,0.0022016813],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99587023,0.0012217335,0.00077032956,0.00058825425,0.0007961327,0.0007533343],"domain_scores_gemma":[0.99659914,0.0009526252,0.00022253595,0.0012119085,0.0007490975,0.00026467344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0054027014,0.00023473303,0.00042823446,0.00005572017,0.00030004958,0.00009342538,0.0012171272,0.00030687157,0.0012682729],"category_scores_gemma":[0.0013972332,0.00012938818,0.00031582118,0.00037738367,0.0013035549,0.000015257426,0.00046911684,0.0009132903,0.00005889262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004234962,0.00053029065,0.015860228,0.000113909504,0.00076776696,0.000004425973,0.0007890925,0.0001932258,0.573253,0.00047444607,0.11445353,0.28932515],"study_design_scores_gemma":[0.0011135812,0.00019426715,0.31130272,0.000049314025,0.000042820142,0.0000018329472,0.00048491269,0.00003150308,0.109381236,0.00020957683,0.5769757,0.0002125365],"about_ca_topic_score_codex":0.006801641,"about_ca_topic_score_gemma":0.0024999676,"teacher_disagreement_score":0.46387175,"about_ca_system_score_codex":0.000028588058,"about_ca_system_score_gemma":0.0013420671,"threshold_uncertainty_score":0.9998121},"labels":[],"label_agreement":null},{"id":"W1994269886","doi":"10.1158/1078-0432.ccr-09-1779","title":"Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Osteosarcoma; Sarcoma; Medicine; Cancer research; Tumor necrosis factor alpha; In vivo; Pathology; Apoptosis; Immunology; Biology","score_opus":0.2590216982651042,"score_gpt":0.4641788879618897,"score_spread":0.20515718969678554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994269886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425465,0.004795818,0.000011185635,0.0003262007,0.00011899577,0.0004533834,0.00002071875,0.0000053240433,0.000013742533],"genre_scores_gemma":[0.9851311,0.014026768,0.00032718288,0.00006694282,0.00026400562,0.00004725899,0.0000136843655,0.000021883008,0.00010121077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973423,0.0007430358,0.00054305803,0.00062940834,0.0004066123,0.00033560858],"domain_scores_gemma":[0.9980648,0.0010232213,0.00014808736,0.00034229606,0.00021287524,0.00020872934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030799103,0.00015174433,0.00033824725,0.00009068737,0.000080372934,0.00005382058,0.00020354732,0.00028626985,0.000037466398],"category_scores_gemma":[0.0022011856,0.00012521265,0.00009699237,0.00016603089,0.00062433165,0.000028114664,0.00036089096,0.0005639232,7.3066064e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016342503,0.0002493365,0.49541223,0.000052442938,0.000029275796,0.0000066876087,0.000029812853,4.4441705e-7,0.45600864,0.00006310573,0.000059471095,0.046454307],"study_design_scores_gemma":[0.001962446,0.0017122204,0.82783717,0.00017452033,0.000013774255,0.000012690345,0.00003808101,0.00008173957,0.16607505,0.00029472308,0.0016067527,0.00019083763],"about_ca_topic_score_codex":0.00080690894,"about_ca_topic_score_gemma":0.00167695,"teacher_disagreement_score":0.33242494,"about_ca_system_score_codex":0.000008647599,"about_ca_system_score_gemma":0.00020206509,"threshold_uncertainty_score":0.51060236},"labels":[],"label_agreement":null},{"id":"W1994354277","doi":"10.1158/1078-0432.ccr-05-1226","title":"The Use of Genetic Markers to Determine Risk for Prostate Cancer at Prostate Biopsy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Prostate cancer; Genotype; Medicine; Odds ratio; Confidence interval; Prostate biopsy; Prostate-specific antigen; Prostate; Rectal examination; Internal medicine; Oncology; Cancer; Biopsy; Gynecology; Gastroenterology; Biology; Gene; Genetics","score_opus":0.2778636771371092,"score_gpt":0.5130617719701321,"score_spread":0.23519809483302295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994354277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97135603,0.007153358,0.000014037008,0.015511266,0.00029483798,0.0047392324,0.00086122326,0.000024753195,0.00004523401],"genre_scores_gemma":[0.86641157,0.102125004,0.0042732633,0.0011815127,0.0010273004,0.011231381,0.000032227577,0.000119615936,0.01359815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651265,0.00027852712,0.0009394914,0.0006768455,0.00069673423,0.0008957344],"domain_scores_gemma":[0.994824,0.0027192195,0.00021479235,0.00074080157,0.00094027724,0.00056092115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001814537,0.00021297546,0.0005088164,0.00011197772,0.00037263113,0.00006186653,0.00023164216,0.000110411485,0.00018233099],"category_scores_gemma":[0.00135743,0.00013239202,0.00026103912,0.00044241815,0.00059189927,0.0000729449,0.00025299127,0.0004202715,0.000041781193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073671066,0.00024730313,0.4631056,0.00011797882,0.0001919458,0.0000145615895,0.00017867154,0.0001885252,0.00024185616,0.0000047258814,0.037302393,0.49103934],"study_design_scores_gemma":[0.003927718,0.002568687,0.4055997,0.00034951192,0.00015446729,0.000004350828,0.000038146787,0.0009852856,0.004011277,0.00004616259,0.58215374,0.00016093561],"about_ca_topic_score_codex":0.0016972072,"about_ca_topic_score_gemma":0.003141017,"teacher_disagreement_score":0.54485136,"about_ca_system_score_codex":0.0007916288,"about_ca_system_score_gemma":0.00077177695,"threshold_uncertainty_score":0.53987896},"labels":[],"label_agreement":null},{"id":"W1995761153","doi":"10.1158/1078-0432.ccr-05-1668","title":"Time to Detectable Metastatic Disease in Patients with Rising Prostate-Specific Antigen Values following Surgery or Radiation Therapy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Doubling time; Nomogram; Prostate cancer; Prostate-specific antigen; Univariate analysis; Proportional hazards model; Radiation therapy; Urology; Metastasis; Biochemical recurrence; Stage (stratigraphy); Survival analysis; Progression-free survival; Prostate; Magnetic resonance imaging; Oncology; Internal medicine; Surgery; Cancer; Radiology; Prostatectomy; Multivariate analysis; Overall survival","score_opus":0.1597383171101356,"score_gpt":0.46066021138463337,"score_spread":0.3009218942744978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995761153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004066,0.004941732,0.000004012409,0.0026151643,0.00009294023,0.002186658,0.00004121498,0.000033185675,0.000044416447],"genre_scores_gemma":[0.9919226,0.0058088577,0.0003041756,0.00047130822,0.00022175322,0.0006690913,0.00006363616,0.00005261836,0.00048597137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968811,0.0003882825,0.00059969607,0.0005956695,0.0008889847,0.00064624014],"domain_scores_gemma":[0.997204,0.0015319095,0.00007734409,0.00039157743,0.00025272596,0.00054246257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001987715,0.00017967811,0.00054954947,0.00029637737,0.00014120781,0.000072064155,0.0001012345,0.000039549956,0.000659546],"category_scores_gemma":[0.0005929407,0.000117360076,0.00014615145,0.00084563944,0.00011186364,0.00021273423,0.000047697555,0.00032469453,0.00020680655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010515969,0.0010893708,0.7604523,0.000036647787,0.00012893855,0.00013937589,0.0001607864,0.00014841228,0.000016814516,4.0747852e-7,0.0036021941,0.2237088],"study_design_scores_gemma":[0.0058528255,0.0017162429,0.970692,0.00064022373,0.000032618536,1.9601858e-7,0.000023972283,0.00013087715,0.00046144164,0.000018575029,0.020254346,0.00017668944],"about_ca_topic_score_codex":0.00015625998,"about_ca_topic_score_gemma":0.00006634757,"teacher_disagreement_score":0.22353211,"about_ca_system_score_codex":0.00065533037,"about_ca_system_score_gemma":0.0010654543,"threshold_uncertainty_score":0.72215664},"labels":[],"label_agreement":null},{"id":"W1998478034","doi":"10.1158/1078-0432.ccr-07-4475","title":"Intravesical Chemotherapy of High-Grade Bladder Cancer with HTI-286, A Synthetic Analogue of the Marine Sponge Product Hemiasterlin","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microbial Natural Products and Biosynthesis","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; Hôtel-Dieu de Québec; Vancouver General Hospital","funders":"","keywords":"In vivo; Medicine; Bladder cancer; Bioluminescence imaging; Urinary bladder; In vitro; Cytotoxicity; Cancer; Urology; Chemotherapy; Cancer research; Pathology; Luciferase; Cell culture; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.12123919443375632,"score_gpt":0.4175410524560927,"score_spread":0.2963018580223364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998478034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699619,0.0009393401,0.000001581049,0.027703231,0.00017103564,0.0009681202,0.000049928465,0.000014369332,0.00019053978],"genre_scores_gemma":[0.99188477,0.0038612948,0.00029683328,0.0004994876,0.00093336636,0.000018870902,0.0000054990755,0.000039084494,0.0024607694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99681896,0.00037218488,0.00075107114,0.0006433572,0.00092063635,0.0004937691],"domain_scores_gemma":[0.99744105,0.00048829726,0.00020997153,0.00091410236,0.00075552607,0.00019105765],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015014602,0.0002026346,0.0007923047,0.000119418706,0.00011139891,0.000007392582,0.0004411542,0.00017435612,0.0015926663],"category_scores_gemma":[0.00080772495,0.00010332855,0.00020594987,0.0009387098,0.0022406713,0.00004323664,0.00020220652,0.0011919568,0.000007227297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023903817,0.005156535,0.20995067,0.0019583271,0.0019517265,0.00018318444,0.0009785456,0.00002688178,0.45910984,0.00032688092,0.046547234,0.24990635],"study_design_scores_gemma":[0.0028906215,0.0011864457,0.37019858,0.0006463429,0.00014454291,0.00007792404,0.00004598897,0.000030016392,0.6141304,0.00008336649,0.010349817,0.00021599967],"about_ca_topic_score_codex":0.003296234,"about_ca_topic_score_gemma":0.0006540177,"teacher_disagreement_score":0.24969035,"about_ca_system_score_codex":0.00010415597,"about_ca_system_score_gemma":0.00096699834,"threshold_uncertainty_score":0.99932003},"labels":[],"label_agreement":null},{"id":"W1998770217","doi":"10.1158/1078-0432.ccr-05-2282","title":"Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl+ Leukemia Cells Sensitive and Resistant to Imatinib Mesylate","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Imatinib mesylate; Cancer research; Imatinib; K562 cells; MAPK/ERK pathway; Kinase; Chemistry; Biology; Leukemia; Myeloid leukemia; Immunology; Cell biology","score_opus":0.0918782453012303,"score_gpt":0.44457176942121357,"score_spread":0.3526935241199833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998770217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941394,0.0005287603,0.000008699697,0.0021826648,0.00017014824,0.0020847542,0.00013887741,0.000049602775,0.0006971111],"genre_scores_gemma":[0.9952566,0.00015648545,0.00043760453,0.000087685745,0.00062650075,0.0003541531,0.000051560142,0.00006034367,0.0029690776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99592596,0.0006841348,0.0009873434,0.0009544171,0.00066830614,0.00077983894],"domain_scores_gemma":[0.99655616,0.0018175308,0.00013565212,0.0004947789,0.00037789662,0.00061798515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015999197,0.0002983406,0.0007405379,0.00043551566,0.00019547425,0.000076340984,0.00011231797,0.00022711535,0.00009288159],"category_scores_gemma":[0.0014992177,0.00026325794,0.00009176321,0.00084828655,0.0005525641,0.00012538524,0.0003040304,0.0013780863,0.00005345034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070190798,0.0006147755,0.043998316,0.0005213622,0.0003058044,0.002120593,0.0007075186,0.000043248783,0.88907534,0.00011547037,0.009192169,0.046286352],"study_design_scores_gemma":[0.014401448,0.0022619308,0.2887534,0.003641208,0.00020482493,0.000015769328,0.00059426564,0.00042610514,0.6704957,0.0004556537,0.018053947,0.00069578446],"about_ca_topic_score_codex":0.023137975,"about_ca_topic_score_gemma":0.0038834244,"teacher_disagreement_score":0.24475507,"about_ca_system_score_codex":0.0031821239,"about_ca_system_score_gemma":0.0013892896,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W1999197387","doi":"10.1158/1078-0432.tcme10-a39","title":"Abstract A39: A newly defined role of clusterin in the formation of exosomes derived from prostate cancer cells","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clusterin; Microvesicles; Exosome; LNCaP; Cell biology; Prostate cancer; Cancer cell; Cancer research; Heat shock protein; Biology; Chemistry; Cancer; Apoptosis; microRNA; Biochemistry","score_opus":0.14035107051236625,"score_gpt":0.49153556192562226,"score_spread":0.35118449141325603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999197387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475616,0.0007582885,0.0000054030247,0.0024162605,0.00025720242,0.0009635997,0.00018999785,0.000010315954,0.0006427905],"genre_scores_gemma":[0.9978395,0.0009816218,0.00030441183,0.00021298327,0.00024164749,0.00032493877,0.0000248892,0.000019670704,0.00005034169],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974675,0.0003475853,0.0009088866,0.00030016186,0.0006111976,0.00036466948],"domain_scores_gemma":[0.9970042,0.0016565528,0.00021865174,0.00060144404,0.0003786923,0.00014045963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002082926,0.00011470848,0.00044944245,0.00014916921,0.00003857746,0.000013145007,0.00036442556,0.00019657846,0.00079290743],"category_scores_gemma":[0.0009853784,0.00008081024,0.00013089602,0.00032566974,0.00061507325,0.000086806554,0.00019980283,0.0010768407,0.000021197493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005066266,0.0007602394,0.15944211,0.00051193987,0.000049468603,0.000047753223,0.0034323256,0.00007499005,0.77535415,0.000025307623,0.0011770278,0.05405842],"study_design_scores_gemma":[0.0037352813,0.0003989923,0.9250376,0.00030603286,0.000041008243,0.0000035840374,0.0011190198,0.0010144731,0.06577186,0.0009442344,0.001521896,0.00010598531],"about_ca_topic_score_codex":0.004990469,"about_ca_topic_score_gemma":0.0065094763,"teacher_disagreement_score":0.76559556,"about_ca_system_score_codex":0.000059815942,"about_ca_system_score_gemma":0.0005789417,"threshold_uncertainty_score":0.86817807},"labels":[],"label_agreement":null},{"id":"W2000425014","doi":"10.1158/1078-0432.ccr-14-1552","title":"A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Veliparib; Medicine; Internal medicine; Gastroenterology; PARP inhibitor; Neutropenia; Ascites; Oncology; Cancer; Ovarian cancer; Leukopenia; Chemotherapy","score_opus":0.07481250261711388,"score_gpt":0.4690696051276442,"score_spread":0.3942571025105303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000425014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971828,0.00022818227,0.000021071055,0.00053036393,0.00006987463,0.001890661,0.000017704248,0.000015444073,0.00004389797],"genre_scores_gemma":[0.99871606,0.00033836308,0.00008023476,0.00011845089,0.0000667021,0.00058944797,0.000038453552,0.000030268793,0.00002202009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969952,0.000616768,0.0006723457,0.00047636783,0.0009072124,0.0003320796],"domain_scores_gemma":[0.9981309,0.00049757585,0.0002032736,0.00029924128,0.0007249495,0.00014403765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015405323,0.00015902493,0.0005396668,0.000389581,0.00008383949,0.00002150321,0.000099540426,0.000111901994,0.00004364743],"category_scores_gemma":[0.00018273415,0.00012461598,0.00002968258,0.0007726353,0.00034266512,0.00021004307,0.000027950078,0.0006195029,0.0000022602394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031426862,0.008820508,0.8866495,0.000071197486,0.00005268098,0.000008158544,0.0014298257,0.000095477626,0.00089958304,0.000007394538,0.000058978025,0.07047984],"study_design_scores_gemma":[0.09720323,0.022045514,0.87700856,0.0003601955,0.000012651813,0.0000016530818,0.0006393817,0.00094412186,0.0014811524,0.0000305303,0.00014640148,0.00012661265],"about_ca_topic_score_codex":0.0006901478,"about_ca_topic_score_gemma":0.00068944716,"teacher_disagreement_score":0.070353225,"about_ca_system_score_codex":0.00028691077,"about_ca_system_score_gemma":0.00035366116,"threshold_uncertainty_score":0.50816923},"labels":[],"label_agreement":null},{"id":"W2001203107","doi":"10.1158/1078-0432.ccr-05-0953","title":"Establishment of a Serum Tumor Marker for Preclinical Trials of Mouse Prostate Cancer Models","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Prostate cancer; Prostate; Cancer; Genetically modified mouse; Immunohistochemistry; PCA3; Intraepithelial neoplasia; Prostate-specific antigen; Biology; Tumor progression; Polyclonal antibodies; Medicine; Antibody; Cancer research; Pathology; Internal medicine; Transgene; Endocrinology; Immunology","score_opus":0.49579910674830113,"score_gpt":0.6044482097660626,"score_spread":0.10864910301776148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001203107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96239,0.012207826,0.00004306683,0.015138236,0.00030704963,0.0064395457,0.0023439806,0.000039393693,0.0010908851],"genre_scores_gemma":[0.9458952,0.022721507,0.0018508508,0.0003259566,0.0012118145,0.0032596332,0.00005413573,0.000092787945,0.024588123],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9925046,0.0011543329,0.0028908136,0.00082185026,0.0016050572,0.0010233363],"domain_scores_gemma":[0.99060947,0.0051339995,0.0005471933,0.00078585604,0.0023198903,0.00060358766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.018936276,0.00025915157,0.001915896,0.00033690693,0.0001125112,0.0000315089,0.0004199012,0.0002596574,0.0013358704],"category_scores_gemma":[0.004620672,0.00017975403,0.0007915733,0.0006355731,0.0010784375,0.00022264909,0.0002793876,0.00096531067,0.000010964134],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10640382,0.007813611,0.2277163,0.0051248753,0.0030178244,0.000043287422,0.0010334756,0.00099949,0.009340505,0.00079573866,0.07938043,0.55833066],"study_design_scores_gemma":[0.13439739,0.02470852,0.0902662,0.006866227,0.0020016602,0.000015270403,0.001476376,0.03256645,0.43320316,0.0067393063,0.26609054,0.0016688786],"about_ca_topic_score_codex":0.0005406565,"about_ca_topic_score_gemma":0.00022795181,"teacher_disagreement_score":0.5566618,"about_ca_system_score_codex":0.000423806,"about_ca_system_score_gemma":0.0035110873,"threshold_uncertainty_score":0.99957705},"labels":[],"label_agreement":null},{"id":"W2002260284","doi":"10.1158/1078-0432.mechres-b24","title":"Abstract B24: De novo and acquired resistance to first-line standard therapy in colorectal cancer: from cell lines to metastatic tumors","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Jewish General Hospital","funders":"","keywords":"Oxaliplatin; FOLFOX; Medicine; Folinic acid; Colorectal cancer; Regimen; Bevacizumab; Cancer; Oncology; Biopsy; Internal medicine; Cancer research; Clinical trial; Acquired resistance; Chemotherapy","score_opus":0.19251247305929647,"score_gpt":0.5070040595493386,"score_spread":0.3144915864900421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002260284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96518546,0.021326806,0.000008173992,0.010736324,0.0002713054,0.0014428204,0.00036847134,0.000030682688,0.0006299681],"genre_scores_gemma":[0.9820591,0.0136698745,0.0007147364,0.00094045955,0.00080671126,0.0011511951,0.000010672131,0.00004537148,0.0006018637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681586,0.00019602267,0.00067701185,0.00061148213,0.00072128116,0.0009783502],"domain_scores_gemma":[0.99693304,0.0015180416,0.00007567991,0.00027924488,0.0003622662,0.0008317148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001886353,0.0002563286,0.0008422796,0.0001979497,0.00019299095,0.000046193552,0.00018832344,0.00010276343,0.0005580005],"category_scores_gemma":[0.0007773434,0.00019590792,0.00011097971,0.000698361,0.00025853133,0.000095961586,0.00018759305,0.00045365127,0.000027920856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031137574,0.00095458335,0.8939885,0.0001776939,0.00026924955,0.00017295504,0.003307696,0.00003405204,0.0039205262,0.000011015399,0.0076970425,0.05832913],"study_design_scores_gemma":[0.0051977388,0.0022503808,0.9511136,0.0005027272,0.000048420625,0.0000016134613,0.00040344655,0.000009511786,0.0115331225,0.00012202323,0.028571691,0.0002457606],"about_ca_topic_score_codex":0.006034188,"about_ca_topic_score_gemma":0.03992984,"teacher_disagreement_score":0.05808337,"about_ca_system_score_codex":0.00084102695,"about_ca_system_score_gemma":0.0006794929,"threshold_uncertainty_score":0.97758895},"labels":[],"label_agreement":null},{"id":"W2003512271","doi":"10.1158/1078-0432.ccr-05-0403","title":"Evaluation of Radiation-Induced Oral Mucositis by Optical Coherence Tomography","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Optical coherence tomography; Mucositis; Tongue; Medicine; Oral mucosa; Nuclear medicine; Pathology; Radiation therapy; Radiology","score_opus":0.2098655478044746,"score_gpt":0.49624647890632084,"score_spread":0.28638093110184626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003512271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770667,0.003565293,0.0006002029,0.001003621,0.00019173863,0.0010712352,0.000078631296,0.00016945953,0.01625312],"genre_scores_gemma":[0.9974702,0.0005159529,0.0009253421,0.000038667164,0.00023325149,0.00074356515,0.000018989225,0.000029435736,0.000024589079],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9961863,0.00046118334,0.0007064912,0.00037593205,0.0017760753,0.0004940134],"domain_scores_gemma":[0.99714285,0.00094542885,0.000048916416,0.0005033798,0.001051799,0.0003076149],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060820677,0.00014220343,0.00029079537,0.00020823278,0.00009319989,0.000046324447,0.0004509026,0.00022821696,0.0011272741],"category_scores_gemma":[0.000680126,0.00014504173,0.00015642347,0.0014158089,0.0004173716,0.00018738984,0.00005787652,0.00080974627,0.00012280465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026027948,0.00027750438,0.0076181428,0.000037155027,0.00012837398,3.8096675e-7,0.000052768562,0.0017517075,0.006807881,0.0009443351,0.015598081,0.96675766],"study_design_scores_gemma":[0.008372617,0.0016977986,0.279124,0.00032674472,0.00071144925,0.0000041996336,0.0002749811,0.4301235,0.2021981,0.010019145,0.06534517,0.0018023003],"about_ca_topic_score_codex":0.00010130524,"about_ca_topic_score_gemma":0.00017204262,"teacher_disagreement_score":0.96495533,"about_ca_system_score_codex":0.00019107896,"about_ca_system_score_gemma":0.00025464094,"threshold_uncertainty_score":0.99978584},"labels":[],"label_agreement":null},{"id":"W2003852222","doi":"10.1158/1078-0432.ccr-05-2242","title":"Expression and Nuclear Localization of ErbB3 in Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of British Columbia; Centre Hospitalier de l’Université de Montréal","funders":"Institut Du Cancer de Montréal","keywords":"DU145; LNCaP; Prostate cancer; Prostate; Cancer; Tissue microarray; Pathology; Biology; Cancer research; PCA3; Immunohistochemistry; Medicine; Internal medicine","score_opus":0.22629727301224037,"score_gpt":0.5769018912532754,"score_spread":0.35060461824103506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003852222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617303,0.005502269,0.000016599686,0.0034330846,0.00014991926,0.0011168314,0.000032800417,0.000029878482,0.0035455588],"genre_scores_gemma":[0.9884919,0.009010677,0.000149757,0.00016734585,0.00041352253,0.00021207695,0.000009926914,0.00005047041,0.001494317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963874,0.00051531283,0.0007884847,0.0005502142,0.0011645711,0.000593993],"domain_scores_gemma":[0.99816895,0.00049053296,0.00008974137,0.00040373873,0.0006007697,0.0002462966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031783646,0.00012475155,0.00045897928,0.0003096953,0.000089490786,0.000029207671,0.00018160086,0.00018921813,0.00091807655],"category_scores_gemma":[0.00068327424,0.000104113315,0.00006745477,0.0008893008,0.00087208033,0.00009070755,0.0002440933,0.0010607616,0.000020588515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002379992,0.0005237274,0.90577245,0.0009529085,0.000019522968,0.000084423664,0.0003273757,0.0001560695,0.011464205,0.00031936818,0.03216454,0.04583543],"study_design_scores_gemma":[0.012177426,0.002261298,0.67830485,0.0057214815,0.000042897555,0.000013028069,0.0007108574,0.008308733,0.019322775,0.0027758186,0.26986203,0.00049881334],"about_ca_topic_score_codex":0.0094314385,"about_ca_topic_score_gemma":0.0013697366,"teacher_disagreement_score":0.23769748,"about_ca_system_score_codex":0.00031078546,"about_ca_system_score_gemma":0.0007985032,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2005021386","doi":"10.1158/1078-0432.ccr-09-0227","title":"<i>SMAD4</i> Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Rolfe Pancreatic Cancer Foundation; Lustgarten Foundation","keywords":"CDKN2A; Pancreatic cancer; Pancreas; Adenocarcinoma; Hazard ratio; Germline mutation; Gene; Internal medicine; Lymph node; Oncology; Biology; Cancer; Medicine; Cancer research; Mutation; Gastroenterology; Confidence interval; Genetics","score_opus":0.2538550752722822,"score_gpt":0.5412453488539867,"score_spread":0.2873902735817045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005021386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97168624,0.0018101952,0.000011720033,0.021268211,0.00006496404,0.001571129,0.00005148668,0.00006136479,0.003474681],"genre_scores_gemma":[0.9902923,0.0025001683,0.00033661598,0.0013134626,0.0003852166,0.0011355571,0.00005136137,0.000034088334,0.00395121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99540913,0.0008726069,0.0007732142,0.0006615206,0.0012374525,0.0010460456],"domain_scores_gemma":[0.9957889,0.0021743712,0.00014965492,0.00034787238,0.0010005138,0.0005387235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036108613,0.00019975349,0.0010131885,0.00033614508,0.00021376504,0.000039966497,0.00026978605,0.00033606074,0.00075362093],"category_scores_gemma":[0.003518658,0.000147444,0.00012708262,0.0016521685,0.0007637296,0.000091569076,0.000065249325,0.0017490597,0.0000684647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013537413,0.0013935759,0.9833155,0.00005332965,0.0002216096,0.00044420443,0.00014447047,0.000010697677,0.0003388931,0.00003965133,0.00498127,0.007703017],"study_design_scores_gemma":[0.0050721434,0.0022828833,0.9888211,0.0010027948,0.00019019771,0.000011468385,0.00021498953,0.0006965265,0.0004840822,0.00035980603,0.0006924218,0.00017161289],"about_ca_topic_score_codex":0.0012543043,"about_ca_topic_score_gemma":0.0030290796,"teacher_disagreement_score":0.019954748,"about_ca_system_score_codex":0.00072951184,"about_ca_system_score_gemma":0.0024613356,"threshold_uncertainty_score":0.82516205},"labels":[],"label_agreement":null},{"id":"W2005619963","doi":"10.1158/1078-0432.ccr-09-1676","title":"Pharmacologically Increased Tumor Hypoxia Can Be Measured by 18F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Positron emission tomography; Hypoxia (environmental); Tumor hypoxia; Cancer research; Medicine; Chemistry; Pharmacology; Internal medicine; Nuclear medicine; Oxygen","score_opus":0.05617671836184463,"score_gpt":0.4117741612188815,"score_spread":0.35559744285703687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005619963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816458,0.011135833,0.000024891191,0.004854867,0.000528109,0.0012752512,0.00026512725,0.00005062152,0.00021950396],"genre_scores_gemma":[0.98627025,0.0027733303,0.0003611696,0.007495957,0.0017595658,0.00038381835,0.000058995363,0.00004918449,0.0008477193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99346834,0.002080591,0.00086525275,0.0014617976,0.0009607958,0.0011632312],"domain_scores_gemma":[0.99682415,0.0004613364,0.0001822055,0.0006925467,0.000541152,0.0012986291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052136052,0.00042637473,0.00069191115,0.00023195056,0.00039082777,0.00012966628,0.00073026324,0.00026673792,0.00009944832],"category_scores_gemma":[0.002435292,0.00037163967,0.00028942438,0.0006747141,0.0005393987,0.000017660746,0.00030820555,0.00087507773,0.000008426768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012493326,0.00039277007,0.0015886388,0.000022625447,0.00006790565,0.00002328786,0.000039163646,0.000002740462,0.9042468,0.0000034782306,0.07134878,0.009770489],"study_design_scores_gemma":[0.002721954,0.0028783744,0.04391852,0.000068601265,0.000053360796,0.000020960262,0.000052456355,0.000010164716,0.7410775,0.00009380685,0.20863907,0.0004652684],"about_ca_topic_score_codex":0.00046725952,"about_ca_topic_score_gemma":0.00020965566,"teacher_disagreement_score":0.16316934,"about_ca_system_score_codex":0.00011095593,"about_ca_system_score_gemma":0.0010121856,"threshold_uncertainty_score":0.9998736},"labels":[],"label_agreement":null},{"id":"W2006003235","doi":"10.1158/1078-0432.ccr-14-3322","title":"The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia; Jewish General Hospital; Université Laval; Quest University Canada; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Mycosis fungoides; Cutaneous T-cell lymphoma; Lymphoma; Gene expression profiling; Medicine; Disease; Erythroderma; Oncology; Dermatology; Cancer research; Gene expression; Gene; Pathology; Biology; Genetics","score_opus":0.386392033437786,"score_gpt":0.5035192713262989,"score_spread":0.11712723788851293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006003235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886472,0.0040597753,0.00005536272,0.0038486721,0.00012706974,0.002362914,0.00009213122,0.000012958189,0.0007938896],"genre_scores_gemma":[0.97611177,0.015143347,0.0018399055,0.00022230207,0.00013285571,0.0008562023,0.000010183329,0.000043105872,0.0056403466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960186,0.00050719094,0.00071275124,0.0004968861,0.0017308143,0.0005337949],"domain_scores_gemma":[0.99531114,0.002009675,0.000083206054,0.00046047266,0.0015888229,0.0005466695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024449672,0.00014532458,0.00046218434,0.00015214567,0.00014022476,0.000047476984,0.00026746033,0.00011553375,0.000073032505],"category_scores_gemma":[0.0014404933,0.00010195945,0.00016019677,0.0005246635,0.0011982006,0.00005316714,0.00024734694,0.00031955706,0.00001384743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05465318,0.005812337,0.43655527,0.00400819,0.0015210307,0.00082392106,0.0026088262,0.00010990088,0.019993057,0.0058810124,0.022374444,0.44565883],"study_design_scores_gemma":[0.0854551,0.03900972,0.07446485,0.0040843054,0.0010542605,0.000716658,0.020905724,0.014234268,0.10443324,0.003684321,0.65009356,0.0018640221],"about_ca_topic_score_codex":0.0005568261,"about_ca_topic_score_gemma":0.00011094268,"teacher_disagreement_score":0.6277191,"about_ca_system_score_codex":0.0002459708,"about_ca_system_score_gemma":0.0008827057,"threshold_uncertainty_score":0.441482},"labels":[],"label_agreement":null},{"id":"W2006064982","doi":"10.1158/1078-0432.ccr-08-0360","title":"Osteopontin Levels in an Asbestos-Exposed Population","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workers Compensation Board of British Columbia","funders":"","keywords":"Osteopontin; Asbestosis; Asbestos; Mesothelioma; Medicine; Pathology; Gastroenterology; Population; Internal medicine; Pneumoconiosis; Lung","score_opus":0.3921080786062758,"score_gpt":0.5875942122883664,"score_spread":0.1954861336820906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006064982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579996,0.00024091097,0.0000015501073,0.0023785802,0.000068700756,0.00032173714,0.000015040237,0.00002071367,0.0011528031],"genre_scores_gemma":[0.99764854,0.000075791926,0.00012586844,0.00080683036,0.00039610107,0.000024507253,0.00008417526,0.000009093203,0.00082911976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828094,0.00021776582,0.00036625421,0.0003047596,0.00056249124,0.00026777276],"domain_scores_gemma":[0.99925864,0.00016253607,0.00002941141,0.00022866548,0.000055635584,0.000265095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095162936,0.00007062979,0.00019396865,0.000105257524,0.000058006397,0.000015851845,0.00009139773,0.00009504541,0.00079474],"category_scores_gemma":[0.00029472008,0.00005968141,0.00006529693,0.00023683484,0.00009834535,0.00011965017,0.000027285616,0.00039511808,0.00009463762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000822554,0.0006853693,0.9252756,0.000011746731,0.000004065669,0.000028698632,0.000021518501,0.000014157465,0.0008830572,0.000097296346,0.0004833928,0.07167251],"study_design_scores_gemma":[0.0010503137,0.0011273645,0.9956503,0.00007095144,0.0000081373655,0.0000011207003,0.000029495559,0.00015360536,0.00013619187,0.00093380816,0.00077278365,0.0000659532],"about_ca_topic_score_codex":0.0002786355,"about_ca_topic_score_gemma":0.00024342272,"teacher_disagreement_score":0.071606554,"about_ca_system_score_codex":0.00016239716,"about_ca_system_score_gemma":0.000108713255,"threshold_uncertainty_score":0.8701846},"labels":[],"label_agreement":null},{"id":"W2007431287","doi":"10.1158/1078-0432.ccr-05-2719","title":"Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Hazard ratio; Nottingham Prognostic Index; Breast cancer; Oncology; Medicine; Internal medicine; Tissue microarray; Immunohistochemistry; Estrogen receptor; Confidence interval; Cytokeratin; Univariate analysis; Multivariate analysis; Proportional hazards model; Progesterone receptor; Cancer; Pathology","score_opus":0.056888050917112104,"score_gpt":0.4291412701146157,"score_spread":0.37225321919750365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007431287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885238,0.0034221988,0.0000054461243,0.005846433,0.00028705294,0.00082423486,0.00023561998,0.000009019505,0.00084624026],"genre_scores_gemma":[0.99643284,0.0009423513,0.000018147777,0.00030704375,0.0006530062,0.00073710585,0.000012308042,0.0000375128,0.0008597114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968228,0.0004784602,0.0006593593,0.0006841591,0.00071593566,0.000639327],"domain_scores_gemma":[0.99835604,0.00031962135,0.00017150784,0.0005653865,0.0004977335,0.00008970385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011939124,0.00021022352,0.00034191168,0.000088180925,0.000137983,0.000027678758,0.00054704177,0.0002652954,0.00017101808],"category_scores_gemma":[0.0004086888,0.0001489027,0.00019445854,0.00060345855,0.0007559156,0.000006984824,0.00062573835,0.00060038874,0.000009517249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005450153,0.0004634893,0.9833764,0.00007142751,0.00010724376,0.000006119158,0.000038734262,0.000033435066,0.0009494246,0.000017193657,0.0071812444,0.0072102756],"study_design_scores_gemma":[0.0015969401,0.0000866598,0.99280846,0.00024138427,0.000031770414,0.000006443873,0.000056391473,0.000037726397,0.0016192767,0.00020088592,0.0031563528,0.00015771012],"about_ca_topic_score_codex":0.007148501,"about_ca_topic_score_gemma":0.0071964064,"teacher_disagreement_score":0.009432061,"about_ca_system_score_codex":0.00013411684,"about_ca_system_score_gemma":0.0008102562,"threshold_uncertainty_score":0.99946296},"labels":[],"label_agreement":null},{"id":"W2008392950","doi":"10.1158/1078-0432.ccr-04-0223","title":"Sp1-Mediated Transcriptional Control of Fibroblast Growth Factor Receptor 4 in Sarcomas of Skeletal Muscle Lineage","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Fibroblast growth factor receptor 4; Molecular biology; Biology; Cell culture; Transcription factor; Transfection; Fibroblast growth factor; Alveolar rhabdomyosarcoma; Gene; Cancer research; Receptor; Fibroblast growth factor receptor; Rhabdomyosarcoma; Genetics; Medicine; Pathology","score_opus":0.07681980686756272,"score_gpt":0.41707684945645424,"score_spread":0.3402570425888915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008392950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648786,0.0009789881,0.0003308525,0.00061012275,0.000111812726,0.0005734917,0.0007333824,0.000008354334,0.00016511472],"genre_scores_gemma":[0.9983871,0.0006459951,0.00025127016,0.000044731558,0.00031312552,0.000071922645,0.0001211575,0.000041316507,0.00012338471],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962,0.0006237935,0.0009893317,0.00059596647,0.0009259183,0.00066497695],"domain_scores_gemma":[0.9980059,0.00041007614,0.00013587104,0.00043244488,0.000744733,0.00027096333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016951758,0.0001873224,0.0004748721,0.00024197497,0.000048431688,0.000013572562,0.000601893,0.0003998623,0.00043842784],"category_scores_gemma":[0.001953532,0.00017438996,0.00028589324,0.0005615795,0.0010974414,0.000013873422,0.00016871913,0.0008564852,0.00003224531],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092259835,0.0005926197,0.028029917,0.00020701872,0.000075852455,0.0000048686397,0.0000586213,0.00007035187,0.9686304,0.0002702894,0.00028287273,0.00085462624],"study_design_scores_gemma":[0.010158725,0.0036728135,0.5066232,0.00035682696,0.000008047741,0.0000016169076,0.000090081514,0.00006706949,0.47218117,0.00019261388,0.0063125947,0.0003352586],"about_ca_topic_score_codex":0.0006545997,"about_ca_topic_score_gemma":0.00040985385,"teacher_disagreement_score":0.4964492,"about_ca_system_score_codex":0.00009368524,"about_ca_system_score_gemma":0.0010127877,"threshold_uncertainty_score":0.71114165},"labels":[],"label_agreement":null},{"id":"W2008401471","doi":"10.1158/1078-0432.ccr-13-2175","title":"Inactivation of the <i>CDKN2A</i> Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Health Research Board; King Fahad Medical City; University Health Network; Leukemia and Lymphoma Society of Canada","keywords":"CDKN2A; Follicular lymphoma; DNA methylation; Lymphoma; Methylation; CDKN2B; Biopsy; p14arf; Cancer research; CpG site; Oncology; Medicine; Mantle cell lymphoma; Pathology; Biology; Internal medicine; Cancer; Tumor suppressor gene; Carcinogenesis; Gene; Genetics; Gene expression","score_opus":0.15638008130249578,"score_gpt":0.47314775636562323,"score_spread":0.3167676750631274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008401471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913303,0.00051199936,0.000007669271,0.006845726,0.00009570819,0.0010259653,0.00006366505,0.000014885506,0.00010405669],"genre_scores_gemma":[0.99657387,0.00095699984,0.000059443428,0.0015219683,0.000104246385,0.00048687906,0.0000486509,0.000027605736,0.00022036984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956672,0.0015000396,0.0010758687,0.0005211482,0.0008836649,0.000352077],"domain_scores_gemma":[0.9938162,0.0048366715,0.00034225764,0.0004566539,0.00034824671,0.00019998504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040942547,0.00016983646,0.00073862623,0.00008795045,0.00014848595,0.000023576997,0.00015700547,0.00024392584,0.000088315384],"category_scores_gemma":[0.0034670783,0.00009541345,0.00016766513,0.0005588476,0.00044839177,0.00008197209,0.00018329996,0.00032967163,0.0000061175647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017245987,0.0015481948,0.97179264,0.00004665241,0.00015134223,0.000011846097,0.00004988107,0.000002796481,0.00042006574,0.000017792396,0.005063555,0.019170618],"study_design_scores_gemma":[0.009923156,0.0015725303,0.95492357,0.00030886967,0.0001410979,0.0000037676643,0.000021277478,0.0004921019,0.028072273,0.0000641622,0.0043677166,0.00010946306],"about_ca_topic_score_codex":0.0017619808,"about_ca_topic_score_gemma":0.0018245287,"teacher_disagreement_score":0.027652208,"about_ca_system_score_codex":0.00066370366,"about_ca_system_score_gemma":0.00022559703,"threshold_uncertainty_score":0.4150667},"labels":[],"label_agreement":null},{"id":"W2008413774","doi":"10.1158/1078-0432.mechres-ia11","title":"Abstract IA11: Using Molecular Profiling Strategies in Clinical Trials to Understand Resistance Mechanisms in the Era of Personalized Cancer Medicine","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Vemurafenib; Medicine; Acquired resistance; Druggability; Drug resistance; Clinical trial; Melanoma; Oncology; Precision medicine; Cancer; Cancer research; Ipilimumab; Internal medicine; Bioinformatics; Biology; Metastatic melanoma; Pathology; Immunotherapy; Gene; Genetics","score_opus":0.5070920791879917,"score_gpt":0.5937702580808246,"score_spread":0.08667817889283291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008413774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854543,0.00931169,0.0013107605,0.0016638659,0.00039004232,0.00091345824,0.000036099656,0.0000036192685,0.000916157],"genre_scores_gemma":[0.9956156,0.0021094999,0.00085033936,0.0004358315,0.0007848992,0.00010756563,0.000012845406,0.000023377646,0.000060034712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99356055,0.0030719575,0.0015848362,0.0004952157,0.00065803283,0.00062943465],"domain_scores_gemma":[0.99760026,0.0012418964,0.00024782433,0.00047767235,0.00022205598,0.00021029012],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034392457,0.00016786948,0.0006963759,0.00010053841,0.0000658019,0.00002456471,0.0004772038,0.00032635746,0.00012021012],"category_scores_gemma":[0.004317019,0.00011484188,0.0001907126,0.00042785463,0.0004911829,0.000013289258,0.00013147597,0.0009126522,0.0000022218774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051591354,0.00066244305,0.030166587,0.00035700612,0.00017535238,0.00005415645,0.0015055091,0.00020816152,0.9342448,0.019509548,0.0020794976,0.0058777765],"study_design_scores_gemma":[0.041740697,0.0073713395,0.30476975,0.0067857276,0.0004368842,0.00001976088,0.08620575,0.0004895865,0.46837294,0.041176535,0.039592464,0.003038554],"about_ca_topic_score_codex":0.00083063706,"about_ca_topic_score_gemma":0.0018834552,"teacher_disagreement_score":0.4658719,"about_ca_system_score_codex":0.000076123055,"about_ca_system_score_gemma":0.00092488417,"threshold_uncertainty_score":0.9942962},"labels":[],"label_agreement":null},{"id":"W2008436378","doi":"10.1158/1078-0432.12aacriaslc-b9","title":"Abstract B9: Cost effectiveness of gene expression profiling for tumor site origin","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Medicaid; Referral; Chemotherapy; Internal medicine; Malignancy; Observational study; Oncology; Cancer; Quality-adjusted life year; Cost effectiveness; Surgery; Emergency medicine; Health care; Family medicine","score_opus":0.3974266369920159,"score_gpt":0.5976157337536503,"score_spread":0.20018909676163438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008436378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234957,0.0037649726,0.00006821863,0.00021929055,0.00044470097,0.0025663918,0.00012976663,0.000018739149,0.00043836085],"genre_scores_gemma":[0.995,0.00061843626,0.0009045811,0.000055047454,0.0010472435,0.0022002475,0.00005241548,0.00003302522,0.000088982386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785525,0.00023648218,0.000476311,0.0003523779,0.000528065,0.00055152475],"domain_scores_gemma":[0.995213,0.003466824,0.000102391474,0.00036935753,0.0004698471,0.00037859575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045366115,0.00012362075,0.00050450815,0.00009254096,0.000092793525,0.000012219775,0.00009928867,0.000104667255,0.0002790426],"category_scores_gemma":[0.0008228898,0.00008979074,0.00022841136,0.00020746038,0.0001942264,0.00008295728,0.000062004285,0.00040123265,0.000042216343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00486725,0.0017286489,0.9159253,0.0013087166,0.00011410948,0.000015129378,0.0000528851,0.00000861591,0.059828643,0.00010484137,0.0019135345,0.014132309],"study_design_scores_gemma":[0.004037898,0.000654642,0.5302686,0.0009195698,0.000059080077,0.000002889741,0.000028359676,0.000017015267,0.4551599,0.000039427065,0.00872626,0.00008637137],"about_ca_topic_score_codex":0.0003332772,"about_ca_topic_score_gemma":0.00001859431,"teacher_disagreement_score":0.39533126,"about_ca_system_score_codex":0.00033193766,"about_ca_system_score_gemma":0.00045128673,"threshold_uncertainty_score":0.366156},"labels":[],"label_agreement":null},{"id":"W2008550171","doi":"10.1158/1078-0432.ccr-14-2199","title":"Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":285,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Montreal Neurological Institute and Hospital; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Fibroblast growth factor receptor; Biology; Glioma; IDH1; Cancer research; Fibroblast growth factor; Molecular biology; Mutant; Receptor; Gene; Genetics","score_opus":0.25454384176051664,"score_gpt":0.5072576175131832,"score_spread":0.25271377575266657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008550171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590975,0.00053821027,0.0000134867805,0.0027480382,0.00014358241,0.00042690118,0.000011140884,0.000012783375,0.0001960813],"genre_scores_gemma":[0.99834657,0.0011119432,0.000032968226,0.000094606694,0.00019471819,0.000086957436,0.000029610108,0.000012228759,0.00009042233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844253,0.00021868861,0.00043861437,0.0002616463,0.0004123001,0.00022621128],"domain_scores_gemma":[0.9984571,0.0002591833,0.00006322608,0.00020737875,0.0007516624,0.00026148203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014680373,0.000071804665,0.00026554472,0.0002701115,0.00005476067,0.000014026498,0.00003814459,0.00012015619,0.00009752507],"category_scores_gemma":[0.0013343063,0.00005802413,0.000040076207,0.0008593345,0.0002004114,0.00007129933,0.000087579836,0.00028592447,0.00002174321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011231522,0.0011758426,0.84820014,0.00007446861,0.000048132864,0.00012845342,0.00025942613,0.0000027933431,0.09152758,0.00014175304,0.0009895964,0.056328643],"study_design_scores_gemma":[0.0041742604,0.0013307701,0.95657206,0.00024630013,0.00002846293,0.000013270367,0.00012767622,0.00014648182,0.030563656,0.00021735244,0.006509335,0.000070352035],"about_ca_topic_score_codex":0.0005825809,"about_ca_topic_score_gemma":0.000477806,"teacher_disagreement_score":0.10837193,"about_ca_system_score_codex":0.00008364936,"about_ca_system_score_gemma":0.00030212273,"threshold_uncertainty_score":0.23661554},"labels":[],"label_agreement":null},{"id":"W2008650353","doi":"10.1158/1078-0432.mechres-b32","title":"Abstract B32: Impact of Lipid-Substitution on Assembly and Delivery of siRNA by Cationic Polymers","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Transfection; Small interfering RNA; Polymer; Chemistry; In vitro; Biochemistry; Cationic polymerization; In vivo; Combinatorial chemistry; Biology; Gene; Organic chemistry; Biotechnology","score_opus":0.1328208918245548,"score_gpt":0.4889012117126326,"score_spread":0.3560803198880778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008650353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460226,0.0040661916,0.000009299924,0.00006781079,0.00012334972,0.00011001049,0.00006282097,0.0000019679655,0.00095631316],"genre_scores_gemma":[0.99431956,0.005081649,0.0000081502885,0.00003912326,0.00029689964,0.000012478359,0.00003714475,0.000008631446,0.00019633948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988352,0.00012336245,0.00033082624,0.00021100506,0.0002264935,0.00027312737],"domain_scores_gemma":[0.99913347,0.00012982998,0.00010523094,0.0002474981,0.00023895623,0.0001450067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095400837,0.00008381095,0.00016732057,0.00005446794,0.000043822725,0.000008205761,0.0001570787,0.00017138821,0.00011776467],"category_scores_gemma":[0.00023183484,0.00006913573,0.00012601122,0.000095795476,0.00031978235,0.000010248906,0.000073804404,0.0002098772,0.000009553423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007404924,0.00030468975,0.097711995,0.000036861125,0.00012627509,3.098357e-7,0.000027954991,0.000016415319,0.87278414,0.00003398805,0.009496035,0.01872087],"study_design_scores_gemma":[0.000689933,0.001907161,0.43797848,0.000080700076,0.000015896712,0.000001308095,0.00004944581,0.000020761116,0.55618596,0.000016520778,0.0029088126,0.00014503852],"about_ca_topic_score_codex":0.0008079804,"about_ca_topic_score_gemma":0.000035051242,"teacher_disagreement_score":0.34026647,"about_ca_system_score_codex":0.000033826924,"about_ca_system_score_gemma":0.0003024717,"threshold_uncertainty_score":0.28192732},"labels":[],"label_agreement":null},{"id":"W2009623159","doi":"10.1158/1078-0432.ccr-08-1916","title":"Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Temozolomide; Dacarbazine; Melanoma; Methyltransferase; Medicine; Cancer research; DNA methylation; Methylation; Oncology; Gene expression; Biology; Gene; Glioma; Genetics","score_opus":0.14309020578417922,"score_gpt":0.5072967140975089,"score_spread":0.3642065083133297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009623159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973686,0.002224493,0.0000025015365,0.02254304,0.000048808743,0.0010269092,0.000007776535,0.00002598916,0.00043449126],"genre_scores_gemma":[0.9972035,0.0004774142,0.0005948001,0.0013263295,0.00011462244,0.0001727943,0.0000033351432,0.000014764581,0.000092419075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978242,0.00044990028,0.00040926665,0.00047463956,0.00039547903,0.00044649304],"domain_scores_gemma":[0.99830514,0.00075910595,0.000025706018,0.00033909184,0.00012691856,0.0004440338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030819247,0.000103755396,0.0003360824,0.000270921,0.00005181907,0.000026622842,0.000102586804,0.00012004581,0.00003473593],"category_scores_gemma":[0.0017366396,0.00008378561,0.00006263182,0.00039814753,0.00010653807,0.000025203444,0.00009088632,0.00046432109,0.000052750267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010899224,0.0007945277,0.82691413,0.000033316574,0.000053023487,0.0019890855,0.00013780547,0.000018431647,0.111970484,0.00017720374,0.002204124,0.04480864],"study_design_scores_gemma":[0.0034763908,0.0028248336,0.9753288,0.00018188173,0.000018008941,0.000014044495,0.000043462947,0.000120439894,0.014957209,0.0002469283,0.0027062038,0.00008181227],"about_ca_topic_score_codex":0.00013125647,"about_ca_topic_score_gemma":0.00004732367,"teacher_disagreement_score":0.14841464,"about_ca_system_score_codex":0.00022914077,"about_ca_system_score_gemma":0.00034939198,"threshold_uncertainty_score":0.34166783},"labels":[],"label_agreement":null},{"id":"W2010399667","doi":"10.1158/1078-0432.ccr-07-4879","title":"The Type 1 Insulin-Like Growth Factor Receptor Pathway","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Cancer Research UK; Wellcome Trust","keywords":"Insulin-like growth factor 1 receptor; Insulin receptor; Insulin-like growth factor; Receptor tyrosine kinase; Medicine; Targeted therapy; Tyrosine kinase; Insulin-Like Growth Factor Receptor; Receptor; Signal transduction; Cancer; Pharmacology; Cancer research; Insulin; Biology; Insulin resistance; Growth factor; Internal medicine; Cell biology","score_opus":0.38927773568903495,"score_gpt":0.5307568062604718,"score_spread":0.14147907057143688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010399667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005290661,0.98830974,0.0000011785422,0.0008055926,0.0041417177,0.0027184798,0.000213382,0.00014872498,0.0031321074],"genre_scores_gemma":[0.00015275464,0.9840028,0.00004934909,0.00037277795,0.004371014,0.00056626886,0.00022186105,0.0002698736,0.0099933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890295,0.0024071094,0.002813513,0.0015470766,0.0024068018,0.0017959677],"domain_scores_gemma":[0.9881519,0.0059419945,0.00055473775,0.001920044,0.002152027,0.0012792987],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0032467134,0.0008547772,0.0035121734,0.0004681713,0.0009981458,0.00015084453,0.0015413202,0.0017248768,0.00078571244],"category_scores_gemma":[0.00812972,0.0004900416,0.001792612,0.002628106,0.0018480826,0.00013252434,0.00072697795,0.007988887,0.0039607054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000386158,0.00027919596,0.00043467566,0.0029905424,0.00052164355,0.000103158374,0.000051889037,6.028018e-9,0.000001146614,0.000114512324,0.17883965,0.81627744],"study_design_scores_gemma":[0.0009229864,0.0013480281,0.0005441274,0.0044345222,0.00018801159,0.000048513644,0.000024789475,0.0000010906454,0.0000050443186,0.000050574938,0.99193275,0.0004995403],"about_ca_topic_score_codex":0.00024859555,"about_ca_topic_score_gemma":0.000027664677,"teacher_disagreement_score":0.8157779,"about_ca_system_score_codex":0.00083192374,"about_ca_system_score_gemma":0.008481524,"threshold_uncertainty_score":0.99975514},"labels":[],"label_agreement":null},{"id":"W2011143480","doi":"10.1158/1078-0432.ccr-09-1438","title":"Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Gary Bennett Family Fund; National Cancer Institute; Entertainment Industry Foundation","keywords":"Microsatellite instability; Colorectal cancer; KRAS; MLH1; Oncology; Medicine; CDKN2A; Hazard ratio; Internal medicine; Cancer; Lymph node; Cancer research; Pathology; Biology; DNA mismatch repair; Genetics; Microsatellite; Allele","score_opus":0.11687287108650775,"score_gpt":0.4473887609781676,"score_spread":0.33051588989165986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011143480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925923,0.0027104744,0.000011336537,0.0026034452,0.00023247775,0.00089764805,0.00018850125,0.00003160269,0.00073224265],"genre_scores_gemma":[0.9934061,0.004564545,0.000050409766,0.0011399109,0.00024639288,0.00021873586,0.000016676957,0.000038356793,0.00031886046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961037,0.0004114085,0.0007504037,0.00080052007,0.0013080266,0.00062595576],"domain_scores_gemma":[0.9969373,0.0006593855,0.00018534364,0.0004077473,0.0013354318,0.00047478708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030880577,0.00023870631,0.00086736993,0.0001845678,0.00013918981,0.00005564126,0.00019584416,0.0003177735,0.00047781385],"category_scores_gemma":[0.00067168695,0.00018357407,0.00012758697,0.00094310555,0.0004628,0.00010895009,0.00011449245,0.0006162014,0.000013357927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010747602,0.00096107414,0.91770923,0.00022698968,0.0005151196,0.000023645067,0.0008616568,0.000012881726,0.025962148,0.00003130733,0.002317968,0.04063036],"study_design_scores_gemma":[0.0051484797,0.0020662623,0.9725421,0.0006138545,0.000189618,0.0000038557964,0.00017921648,0.00013108144,0.016201189,0.000078662924,0.0025912356,0.00025445825],"about_ca_topic_score_codex":0.0045681363,"about_ca_topic_score_gemma":0.0023076616,"teacher_disagreement_score":0.05483284,"about_ca_system_score_codex":0.0015763708,"about_ca_system_score_gemma":0.0020702616,"threshold_uncertainty_score":0.7485933},"labels":[],"label_agreement":null},{"id":"W2011240752","doi":"10.1158/1078-0432.ccr-06-0383","title":"Sequential Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Response to Chemotherapy in Metastatic Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Progressive disease; Metastatic breast cancer; Standardized uptake value; Positron emission tomography; Fluorodeoxyglucose; Cancer; Nuclear medicine; Radiology; Internal medicine; Oncology","score_opus":0.23175786885143168,"score_gpt":0.581430282048542,"score_spread":0.3496724131971103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011240752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654319,0.0005439955,0.0026529557,0.029370574,0.00014352796,0.0016777411,0.000075052034,0.00007384491,0.000030359295],"genre_scores_gemma":[0.97276735,0.0003193085,0.023489477,0.00050003565,0.0011458753,0.0011913218,0.0000116406945,0.00005695006,0.0005180262],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971496,0.00033507554,0.0006718372,0.0005655823,0.0006485998,0.000629332],"domain_scores_gemma":[0.9979301,0.0007320494,0.00007258586,0.00043214872,0.00042260974,0.0004104678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039634,0.0001551135,0.0004214723,0.0003594084,0.00015645554,0.00004480883,0.00023722905,0.0001084696,0.00015107599],"category_scores_gemma":[0.00033877708,0.000131705,0.00018685134,0.0009920516,0.00022093597,0.00006277806,0.00009500905,0.00069587945,0.000003678591],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01741009,0.0015884489,0.17162584,0.0002975649,0.00009280511,0.0000710527,0.000113252456,0.000074363845,0.7220168,0.000088674155,0.0246188,0.062002316],"study_design_scores_gemma":[0.0154775195,0.0017901903,0.6449888,0.004786146,0.00027305583,0.00009298636,0.0001938543,0.013723316,0.23978694,0.003312742,0.07461942,0.00095502945],"about_ca_topic_score_codex":0.0038366506,"about_ca_topic_score_gemma":0.0000522336,"teacher_disagreement_score":0.48222986,"about_ca_system_score_codex":0.00043414652,"about_ca_system_score_gemma":0.0006338905,"threshold_uncertainty_score":0.5799894},"labels":[],"label_agreement":null},{"id":"W2011661083","doi":"10.1158/1078-0432.ovca13-ia8","title":"Abstract IA8: Discovering drivers in rare ovarian cancer subtypes","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous carcinoma; Ovarian cancer; Clear cell carcinoma; Context (archaeology); Clear cell; Cancer; Cancer research; Biology; Ovarian carcinoma; ARID1A; Mutation; Carcinoma; Medicine; Oncology; Bioinformatics; Internal medicine; Gene; Genetics","score_opus":0.20641064351636376,"score_gpt":0.514709670638262,"score_spread":0.3082990271218983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011661083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703818,0.002319853,0.0000022197928,0.01994247,0.0005075237,0.0011058816,0.00003538212,0.000034546334,0.0056703044],"genre_scores_gemma":[0.9889631,0.007370008,0.00010689195,0.0005505747,0.0007945483,0.001154003,0.000012902362,0.000039830542,0.0010081436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971737,0.00014466912,0.00059288717,0.0006668867,0.0006904371,0.0007313695],"domain_scores_gemma":[0.99804854,0.0006467848,0.00007447847,0.0005096236,0.0002816182,0.00043895197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000987214,0.00018182366,0.0005061187,0.0001945687,0.00010907076,0.00009143435,0.00021998014,0.0001959653,0.009467244],"category_scores_gemma":[0.0002955584,0.00014211376,0.00017933095,0.0005247158,0.0002992686,0.00021498345,0.00014312164,0.001048311,0.00046987392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002640198,0.00052820775,0.8910533,0.00012501067,0.0001483603,0.00017403826,0.00017476799,0.00003602675,0.00018707814,0.0002347931,0.0134130465,0.09366135],"study_design_scores_gemma":[0.0032754466,0.00024194979,0.97551125,0.00060860807,0.000029851984,0.0000017025357,0.00021191208,0.00007260616,0.0004715347,0.00026091022,0.01916638,0.0001478588],"about_ca_topic_score_codex":0.03891009,"about_ca_topic_score_gemma":0.0052971817,"teacher_disagreement_score":0.093513496,"about_ca_system_score_codex":0.0010197468,"about_ca_system_score_gemma":0.0009590146,"threshold_uncertainty_score":0.9914382},"labels":[],"label_agreement":null},{"id":"W2012668244","doi":"10.1158/1078-0432.ccr-06-0573","title":"HATH1 Expression in Mucinous Cancers of the Colorectum and Related Lesions","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Mucin 2; Mucin; Hyperplastic Polyp; Biology; Immunohistochemistry; Pathology; Cytoplasm; Carcinogenesis; Large intestine; Signet ring cell; Transcription factor; Cancer; Cancer research; Adenocarcinoma; Colorectal cancer; Gene expression; Immunology; Cell biology; Medicine; Gene","score_opus":0.07720023920719324,"score_gpt":0.4521628556623393,"score_spread":0.37496261645514606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012668244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389434,0.0018048403,0.000005154518,0.0008995379,0.00011148215,0.0004095792,0.0000130963535,0.00000334562,0.0028586322],"genre_scores_gemma":[0.9956774,0.0010225814,0.000043770153,0.000036117854,0.000094799994,0.00007914694,0.000008504086,0.000011600532,0.0030260815],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981018,0.0005409046,0.00036945197,0.00032685776,0.00036427611,0.00029676428],"domain_scores_gemma":[0.99918365,0.0001386277,0.00005848316,0.00033959135,0.00020290006,0.00007677009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001482714,0.00007101024,0.0001411905,0.00007172993,0.00012136014,0.000013589988,0.0002525127,0.00020422634,0.000109216395],"category_scores_gemma":[0.0006576372,0.00004923444,0.000067201334,0.00036055292,0.00057130103,0.0000031968054,0.0003140192,0.0004812068,0.0000036808526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094363425,0.0002851288,0.2908754,0.000071137256,0.000023942961,0.000011780328,0.000080910686,0.0005786944,0.6712133,0.00038076972,0.018513774,0.017021518],"study_design_scores_gemma":[0.0023503006,0.0005315917,0.6624244,0.00017393068,0.0000045631446,0.000004465136,0.00012197622,0.00047424264,0.2922933,0.001030107,0.040424723,0.00016641343],"about_ca_topic_score_codex":0.0023125233,"about_ca_topic_score_gemma":0.0033587196,"teacher_disagreement_score":0.37892,"about_ca_system_score_codex":0.0000515309,"about_ca_system_score_gemma":0.0004923401,"threshold_uncertainty_score":0.3495859},"labels":[],"label_agreement":null},{"id":"W2012704875","doi":"10.1158/1078-0432.ccr-07-0926","title":"Immune Expression and Inhibition of Heat Shock Protein 90 in Uveal Melanoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Melanoma; Hsp90 inhibitor; Immunohistochemistry; Heat shock protein; Cancer research; Apoptosis; Cell culture; Cell cycle; Cell growth; Western blot; Cell; Biology; Pathology; Chemistry; Molecular biology; Hsp90; Medicine; Immunology","score_opus":0.11332003699064894,"score_gpt":0.4509431362315512,"score_spread":0.3376230992409023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012704875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954086,0.002577109,0.0000401912,0.00050868234,0.000029728011,0.00082205696,0.000015484577,0.0000044105946,0.0005937548],"genre_scores_gemma":[0.996325,0.00217751,0.00020408139,0.000022472284,0.00021907527,0.0003152592,0.00002217585,0.000022421767,0.0006920092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705726,0.00083758065,0.00057264353,0.00050840166,0.00055119896,0.0004729169],"domain_scores_gemma":[0.99895126,0.00010887357,0.00003470138,0.00043620766,0.0002812621,0.00018769685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024404232,0.000110471716,0.00027200006,0.00014302162,0.00011952031,0.000010379025,0.00020677104,0.0003167434,0.000094711024],"category_scores_gemma":[0.0009863717,0.00009791246,0.000074419826,0.0002811422,0.00070284575,0.000008339449,0.00052381,0.00067453744,0.000009175036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082582276,0.00017858921,0.029992653,0.00007391177,0.000008939625,0.00002865265,0.000042557018,0.0000064548008,0.9659092,0.000011838876,0.0005447262,0.0023766465],"study_design_scores_gemma":[0.0014802386,0.0011352679,0.038411558,0.0001737825,9.4986643e-7,0.0000063004622,0.00004170218,0.000042457308,0.956101,0.000084595085,0.002410907,0.00011124775],"about_ca_topic_score_codex":0.0008245543,"about_ca_topic_score_gemma":0.00021022843,"teacher_disagreement_score":0.009808216,"about_ca_system_score_codex":0.000048747002,"about_ca_system_score_gemma":0.0004982471,"threshold_uncertainty_score":0.39927542},"labels":[],"label_agreement":null},{"id":"W2013520562","doi":"10.1158/1078-0432.ccr-14-0521","title":"Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Clinical trial; Medicine; Regimen; Drug development; Clinical study design; Clinical endpoint; Pharmacodynamics; Combination therapy; Phases of clinical research; Pharmacology; Intensive care medicine; Medical physics; Oncology; Drug; Pharmacokinetics; Internal medicine","score_opus":0.9658311449296211,"score_gpt":0.7722733089490966,"score_spread":0.19355783598052445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013520562","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017757124,0.36636722,0.57119834,0.0044666813,0.01482,0.04017327,0.0023145028,0.00008287941,0.00039950112],"genre_scores_gemma":[0.00026944184,0.7912688,0.20366259,0.00010231116,0.002079498,0.0017750557,0.000019138373,0.00017446114,0.00064868253],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8086574,0.16880392,0.017784853,0.0010605329,0.0029785214,0.0007147825],"domain_scores_gemma":[0.25739965,0.7278359,0.009622315,0.0026878696,0.0021305515,0.00032371806],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.28279766,0.0005278689,0.008029955,0.00025347574,0.00031888994,0.000050061484,0.003501273,0.0011736482,0.0003286808],"category_scores_gemma":[0.7000216,0.00029795125,0.0031610942,0.0016860509,0.004260525,0.000080351405,0.001302834,0.004211872,0.000011238687],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080314865,0.0035070714,0.000023478473,0.010815332,0.0013507163,6.6302925e-7,0.000083926665,0.00001994757,0.000004244558,0.061173912,0.055103187,0.85988605],"study_design_scores_gemma":[0.044966202,0.0030514197,0.00001459865,0.024532942,0.0035481704,0.0000012373044,0.000039879258,0.000856867,0.00012386857,0.8146475,0.107710645,0.0005066787],"about_ca_topic_score_codex":0.000031114832,"about_ca_topic_score_gemma":0.00000862899,"teacher_disagreement_score":0.85937935,"about_ca_system_score_codex":0.00024281046,"about_ca_system_score_gemma":0.0050460673,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W2013537032","doi":"10.1158/1078-0432.ccr-05-0209","title":"Pseudolaric Acid B, a Novel Microtubule-Destabilizing Agent That Circumvents Multidrug Resistance Phenotype and Exhibits Antitumor Activity <i>In vivo</i>","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biological Activity of Diterpenoids and Biflavonoids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"In vivo; Biology; Microtubule polymerization; Multiple drug resistance; Apoptosis; Cell cycle checkpoint; Cell culture; P-glycoprotein; Microtubule; Mechanism of action; Cell cycle; Tubulin; Cytotoxicity; Cell biology; Pharmacology; Drug resistance; Biochemistry; In vitro; Microbiology","score_opus":0.14493469520637312,"score_gpt":0.4273523832548519,"score_spread":0.2824176880484788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013537032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934145,0.003220011,0.00017712395,0.0019184167,0.00014333657,0.0004953579,0.000079105506,0.000016218533,0.00053588],"genre_scores_gemma":[0.9941064,0.0029344528,0.0010369828,0.00046855907,0.00055926107,0.0000796047,0.000009411636,0.000028111772,0.00077719893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970254,0.00042554835,0.00039360634,0.0010384269,0.00038659188,0.0007304664],"domain_scores_gemma":[0.9988007,0.00021414134,0.00011211155,0.00046139458,0.00014187269,0.00026977452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023634434,0.00023592517,0.00039013612,0.00007893348,0.00020729449,0.000083810104,0.00040637556,0.00038273996,0.00007152611],"category_scores_gemma":[0.0004913713,0.00020122292,0.00014494525,0.00023953174,0.00059805874,0.000027051521,0.0005248727,0.0008550015,0.000015482534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076073984,0.0007870807,0.036353406,0.00006954629,0.000028234821,0.000007013305,0.000030555395,0.0000030786643,0.94050735,0.000018618726,0.0010811164,0.020353284],"study_design_scores_gemma":[0.003288535,0.000707483,0.16959777,0.00021424823,0.000016021893,0.0000053480203,0.000065291155,0.00014381247,0.73787814,0.00011202472,0.08736898,0.0006023501],"about_ca_topic_score_codex":0.00019798297,"about_ca_topic_score_gemma":0.0024206713,"teacher_disagreement_score":0.20262921,"about_ca_system_score_codex":0.000094732,"about_ca_system_score_gemma":0.0001755741,"threshold_uncertainty_score":0.82056326},"labels":[],"label_agreement":null},{"id":"W2013612743","doi":"10.1158/1078-0432.ccr-08-1899","title":"Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Prostate cancer; Stroma; Cancer; Gene expression; Biology; Prostate; Cancer research; Pathology; Gene; Medicine; Genetics; Immunohistochemistry","score_opus":0.21587473288739326,"score_gpt":0.5894723836277024,"score_spread":0.37359765074030915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013612743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877783,0.0051913937,0.0000058329088,0.003793406,0.00009152054,0.00091919303,0.00023400167,0.000021592823,0.001964774],"genre_scores_gemma":[0.9890796,0.008889062,0.00017328335,0.0001378091,0.00022000384,0.00020983444,0.00006510167,0.00001284643,0.0012124804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960785,0.00046810726,0.0007567474,0.0006891679,0.0012511666,0.0007563138],"domain_scores_gemma":[0.9978155,0.00036017413,0.00012718858,0.0005462838,0.00075399,0.0003968729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002013566,0.0001687981,0.00085697515,0.000579087,0.000078676814,0.00002180975,0.00024931884,0.00017354294,0.00048396972],"category_scores_gemma":[0.000378173,0.00012306224,0.00030715668,0.003933854,0.00044585872,0.00011043633,0.000121474106,0.0007635018,0.000008301377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007601845,0.0009838708,0.94005,0.000050706913,0.0006303525,0.00020307991,0.00020159796,0.000109245884,0.0117255,0.000037706228,0.0018080284,0.036598064],"study_design_scores_gemma":[0.003922007,0.001334597,0.9792458,0.00030215888,0.00027871956,0.0000010904877,0.00017267998,0.00033673138,0.0132462,0.00034042448,0.00070089474,0.000118709846],"about_ca_topic_score_codex":0.0027927465,"about_ca_topic_score_gemma":0.0009932952,"teacher_disagreement_score":0.039195787,"about_ca_system_score_codex":0.0010299495,"about_ca_system_score_gemma":0.001322146,"threshold_uncertainty_score":0.5299129},"labels":[],"label_agreement":null},{"id":"W2015965838","doi":"10.1158/1078-0432.ovca13-a84","title":"Abstract A84: Metronomic cyclophosphamide, when combined with vaccination, increases the immunogenicity of the vaccine and modulates the tumor microenvironment to provide better anti-tumor activity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Sunnybrook Health Science Centre; Health Sciences Centre; Immunovaccine (Canada)","funders":"","keywords":"ELISPOT; Cytotoxic T cell; Immune system; Immunology; CD8; Tumor microenvironment; Immunogenicity; Tumor antigen; Antigen; CTL*; Granzyme B; Cancer vaccine; Medicine; Cancer research; Biology; Immunotherapy; In vitro","score_opus":0.03089693718776623,"score_gpt":0.33223389149760474,"score_spread":0.30133695430983853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015965838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97777843,0.007339056,0.0000062152244,0.012662393,0.00016276824,0.001983681,0.000032378473,0.000013880912,0.000021202917],"genre_scores_gemma":[0.99719316,0.00068971544,0.000017033668,0.000987884,0.000039951366,0.00043248865,0.000004155373,0.000028385184,0.0006072368],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99669635,0.0015905291,0.000596989,0.0004243348,0.00015703253,0.0005347688],"domain_scores_gemma":[0.99563533,0.0028921557,0.00027221098,0.00096270273,0.00019923029,0.000038367816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024813174,0.00022975919,0.00045175067,0.00006906691,0.00071175146,0.000068999056,0.0009550509,0.00010429322,0.0012463322],"category_scores_gemma":[0.0005275478,0.000102282735,0.00015095444,0.00023259854,0.00078039727,0.00015821069,0.00054981693,0.0010160062,0.00009422056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010621238,0.0010003306,0.31347406,0.0000657548,0.0012091014,0.0000022931822,0.00049878925,0.000041827487,0.624679,0.000038763774,0.00923971,0.039129097],"study_design_scores_gemma":[0.0017673995,0.00053615187,0.8443562,0.00005006245,0.00003554033,0.000008842592,0.00014537798,0.0000053942035,0.14617893,0.00012495577,0.0066708974,0.00012026126],"about_ca_topic_score_codex":0.007830346,"about_ca_topic_score_gemma":0.00031718766,"teacher_disagreement_score":0.5308821,"about_ca_system_score_codex":0.000112207475,"about_ca_system_score_gemma":0.00023363107,"threshold_uncertainty_score":0.9996667},"labels":[],"label_agreement":null},{"id":"W2016493248","doi":"10.1158/1078-0432.ccr-06-0547","title":"DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Alvin J. Siteman Cancer Center","keywords":"DNA repair; Biology; MSH2; Microsatellite instability; XRCC1; DNA mismatch repair; MLH1; Cancer research; Gene; Colorectal cancer; Gene expression profiling; Genome instability; DNA damage; Gene expression; Molecular biology; DNA; Cancer; Genetics; Microsatellite","score_opus":0.08811990991537905,"score_gpt":0.45051447353895846,"score_spread":0.3623945636235794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016493248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850178,0.0134687545,0.000013810345,0.00020001794,0.00013712127,0.00037064057,0.000040765826,0.000010767093,0.000740357],"genre_scores_gemma":[0.9936242,0.005065706,0.00031718265,0.000033743767,0.0004667582,0.00014388644,0.000041792904,0.000017584834,0.0002891202],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979544,0.0004245293,0.0004575844,0.0005761679,0.00021721853,0.0003700879],"domain_scores_gemma":[0.99926144,0.00014750501,0.00005369779,0.00021972539,0.00022301261,0.00009464526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026940897,0.00010359108,0.00017813507,0.00005424334,0.00008901193,0.000029243172,0.00012013041,0.00024243386,0.000030145351],"category_scores_gemma":[0.0003760651,0.000095931326,0.000078847545,0.00020515334,0.00037009886,0.000004159903,0.00018012011,0.00035519895,0.0000025770603],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001973152,0.000084834894,0.51012677,0.000026425294,0.000008503468,0.0000024924968,0.000011655259,0.000027397162,0.4785685,0.000040866693,0.00005350684,0.010851711],"study_design_scores_gemma":[0.0005669733,0.00022109562,0.4069127,0.000019382393,0.0000028834986,2.444384e-7,0.000019402214,0.00012051168,0.57363886,0.000486275,0.017891787,0.00011985648],"about_ca_topic_score_codex":0.0015851953,"about_ca_topic_score_gemma":0.0056832405,"teacher_disagreement_score":0.10321407,"about_ca_system_score_codex":0.00005714431,"about_ca_system_score_gemma":0.00035107526,"threshold_uncertainty_score":0.39119658},"labels":[],"label_agreement":null},{"id":"W2017858235","doi":"10.1158/1078-0432.ovca13-a27","title":"Abstract A27: The ovarian tumor tissue analysis (OTTA) consortium","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Calgary","funders":"","keywords":"Serous fluid; Tissue microarray; Ovarian cancer; Serous carcinoma; Immunohistochemistry; Pathology; Biology; Clear cell; Cancer; Oncology; Molecular pathology; Cancer research; Internal medicine; Medicine; Gene; Genetics","score_opus":0.22185382597507952,"score_gpt":0.5372881851395189,"score_spread":0.3154343591644394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017858235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86795187,0.0030521401,0.000026203783,0.10069292,0.00055416184,0.002320754,0.000059749,0.00007642905,0.025265785],"genre_scores_gemma":[0.99145865,0.001060472,0.0001511503,0.0020676532,0.0010706465,0.0011232934,0.000020398304,0.000030669245,0.0030170674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996556,0.0003470695,0.0007529721,0.0006693261,0.00097506883,0.00069959485],"domain_scores_gemma":[0.99560755,0.0019688217,0.00012372763,0.0010923964,0.0006649636,0.00054255675],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025636759,0.00018167464,0.0006415717,0.00020580455,0.00027196313,0.00015055279,0.00034625753,0.00013702744,0.023027914],"category_scores_gemma":[0.00070538855,0.00010686926,0.000385555,0.0013048655,0.0006688558,0.00008964826,0.00014452887,0.0010707573,0.001979261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033978402,0.0012786102,0.71780574,0.000085974076,0.003351275,0.00026527813,0.00012049265,0.000021277845,0.00018777895,0.00084948394,0.1714436,0.104250714],"study_design_scores_gemma":[0.0015036827,0.00036373254,0.9006543,0.000057610752,0.00057955587,0.0000044713447,0.000111802765,0.000101850055,0.00047666306,0.00032005087,0.09571297,0.000113300775],"about_ca_topic_score_codex":0.0083988225,"about_ca_topic_score_gemma":0.00088625844,"teacher_disagreement_score":0.18284857,"about_ca_system_score_codex":0.00025012955,"about_ca_system_score_gemma":0.00072875695,"threshold_uncertainty_score":0.99879783},"labels":[],"label_agreement":null},{"id":"W2018650005","doi":"10.1158/1078-0432.ccr-09-1192","title":"Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic Analysis","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Tamoxifen; Medicine; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Cancer; Metastasis","score_opus":0.1474246640642809,"score_gpt":0.5366681232496262,"score_spread":0.3892434591853453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018650005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855586,0.002023397,0.00023956825,0.008292738,0.00016252976,0.0026443903,0.0008551182,0.000034529905,0.0001891269],"genre_scores_gemma":[0.9940011,0.0023925363,0.00085242157,0.00022805513,0.0003093489,0.0010659964,0.00004030255,0.000082808045,0.0010274346],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9921339,0.0015416155,0.0015162545,0.0012305577,0.0022646862,0.0013129528],"domain_scores_gemma":[0.9954248,0.0013838287,0.00032710852,0.0009338626,0.0010438059,0.0008866093],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008562845,0.00037014973,0.001557197,0.0010621056,0.00030858422,0.00008678342,0.00063625,0.00032149564,0.0029425917],"category_scores_gemma":[0.0012834545,0.0002855204,0.00040447494,0.0033420117,0.0023590568,0.00018094858,0.0005117346,0.0037597944,0.00000812281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06217347,0.004054722,0.19669971,0.0015025905,0.0068371873,0.00047587708,0.0017636917,0.0002255492,0.28077838,0.00008419331,0.0071122223,0.4382924],"study_design_scores_gemma":[0.08402399,0.014099888,0.7711992,0.0023370958,0.004612201,0.00009970438,0.0023864328,0.0824796,0.02615709,0.0014601654,0.009181516,0.0019631162],"about_ca_topic_score_codex":0.021494878,"about_ca_topic_score_gemma":0.0060317926,"teacher_disagreement_score":0.5744995,"about_ca_system_score_codex":0.00049833144,"about_ca_system_score_gemma":0.0028736207,"threshold_uncertainty_score":0.9999597},"labels":[],"label_agreement":null},{"id":"W2019307617","doi":"10.1158/1078-0432.ccr-05-2050","title":"The Bisphosphonate Olpadronate Inhibits Skeletal Prostate Cancer Progression in a Green Fluorescent Protein Nude Mouse Model","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Prostate cancer; Bisphosphonate; Green fluorescent protein; Osteoprotegerin; Bone resorption; Medicine; Bone metastasis; Etidronic acid; Cancer research; Cancer; Pathology; Metastasis; Internal medicine; Endocrinology; Chemistry; Osteoporosis; Biochemistry","score_opus":0.11088911916593962,"score_gpt":0.5037433444387305,"score_spread":0.39285422527279085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019307617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715137,0.0060890615,0.000002201636,0.017410614,0.000120022705,0.004351628,0.00007028194,0.00006253678,0.00037996526],"genre_scores_gemma":[0.968613,0.003799179,0.00019842751,0.00028609013,0.0001534362,0.0042049703,0.00003103582,0.0000681891,0.022645619],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99510336,0.00042826723,0.0010183029,0.00074309984,0.0013509704,0.0013560278],"domain_scores_gemma":[0.9980874,0.00024176722,0.00015282122,0.0005437308,0.00047329624,0.0005009741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026842572,0.00025126428,0.00047744697,0.00014631034,0.00039650826,0.00005597014,0.000248347,0.00025239066,0.000050277376],"category_scores_gemma":[0.00023358228,0.0001528774,0.00015172808,0.00065437035,0.0006236924,0.000101274585,0.0002352562,0.0017203372,0.00006950813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012701589,0.003267999,0.45513624,0.00076345244,0.000119424665,0.00031556154,0.00025741875,0.00023709373,0.0031766472,0.000444998,0.0068941545,0.5166854],"study_design_scores_gemma":[0.0575698,0.00589928,0.692543,0.00672426,0.0001678013,0.000022247385,0.00017054344,0.067859374,0.082952626,0.010408557,0.07414796,0.0015345003],"about_ca_topic_score_codex":0.030469766,"about_ca_topic_score_gemma":0.023451306,"teacher_disagreement_score":0.5151509,"about_ca_system_score_codex":0.0007069627,"about_ca_system_score_gemma":0.002106829,"threshold_uncertainty_score":0.99436814},"labels":[],"label_agreement":null},{"id":"W2019458473","doi":"10.1158/1078-0432.ccr-10-1533","title":"Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":435,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Medicine; Estrogen receptor; Internal medicine; Oncology; Cancer; Basal (medicine); Population; Estrogen; Breast disease; Gynecology","score_opus":0.0692084032633277,"score_gpt":0.45154551464388737,"score_spread":0.3823371113805597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019458473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176514,0.001924098,7.096491e-7,0.0045734975,0.0005758349,0.000776974,0.00020600866,0.00001039757,0.00016735682],"genre_scores_gemma":[0.99517757,0.0020183302,0.0000059152535,0.00023466042,0.0017749524,0.00059065275,0.000019299325,0.000034558627,0.00014404078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683464,0.0007458346,0.0004317393,0.00081845565,0.00054484117,0.0006244863],"domain_scores_gemma":[0.99829894,0.00033729945,0.00008193286,0.0007209514,0.00038680088,0.00017406204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002592045,0.00023689297,0.00039266958,0.00008298755,0.0002533175,0.00007108449,0.00056712935,0.0001608199,0.00011852047],"category_scores_gemma":[0.00020705695,0.000163025,0.000093690076,0.00036862088,0.00081648165,0.000009763729,0.0005456788,0.0011166824,0.000012897175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001053825,0.0007201382,0.96955335,0.000025470408,0.00014448659,0.00006145488,0.0001830615,8.3192987e-7,0.0006178263,0.00001905237,0.00081821554,0.026802283],"study_design_scores_gemma":[0.0023575497,0.0002540698,0.99563277,0.000026417425,0.000040322782,0.00007891283,0.0002976091,0.0000014935343,0.00009885001,0.000024578932,0.0010062434,0.0001811968],"about_ca_topic_score_codex":0.0041370853,"about_ca_topic_score_gemma":0.0658988,"teacher_disagreement_score":0.06176171,"about_ca_system_score_codex":0.000055596316,"about_ca_system_score_gemma":0.00045807828,"threshold_uncertainty_score":0.9511461},"labels":[],"label_agreement":null},{"id":"W2019624319","doi":"10.1158/1078-0432.ccr-14-0305","title":"miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Prostate cancer; Bone metastasis; Metastasis; Epithelial–mesenchymal transition; Cancer research; Prostate; Cancer; Medicine; Carcinogenesis; Pathology; microRNA; Cancer cell; Cancer stem cell; Oncology; Mesenchymal stem cell; Biology; Internal medicine","score_opus":0.07423219067759994,"score_gpt":0.45062671169907,"score_spread":0.37639452102147003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019624319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452835,0.0026434874,0.00010806502,0.0016304912,0.00009307947,0.0006884308,0.00023359578,0.00001022663,0.00006429379],"genre_scores_gemma":[0.99730855,0.0009409716,0.00030763602,0.00013759988,0.0005462859,0.00026833173,0.00007495989,0.000036665217,0.0003789971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99735,0.0006080623,0.0005760337,0.0006323032,0.00041375018,0.00041987578],"domain_scores_gemma":[0.9984334,0.00009460565,0.00011385652,0.00045147008,0.00060259644,0.0003040364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002282452,0.00015872066,0.0003388267,0.000104331586,0.00015996625,0.000030651325,0.00021310533,0.00015560417,0.00012668366],"category_scores_gemma":[0.0004379808,0.00014336122,0.0001266948,0.00025450406,0.00048158446,0.000007751088,0.00015608067,0.00020546773,0.0000071635723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043747647,0.00016941532,0.006679045,0.00021060322,0.00009653053,0.000002128512,0.0001191178,0.00003930591,0.97583663,0.00007121995,0.002034587,0.01430395],"study_design_scores_gemma":[0.0016188674,0.0013587152,0.08798921,0.00017103019,0.00008068559,0.0000032826124,0.000060741695,0.00009182897,0.8814474,0.0005956168,0.026249958,0.00033270151],"about_ca_topic_score_codex":0.0005454799,"about_ca_topic_score_gemma":0.00043128058,"teacher_disagreement_score":0.09438926,"about_ca_system_score_codex":0.00003304299,"about_ca_system_score_gemma":0.0002865826,"threshold_uncertainty_score":0.5846101},"labels":[],"label_agreement":null},{"id":"W2020369202","doi":"10.1158/1078-0432.ccr-13-2270","title":"Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Cancer Research UK","keywords":"Lung cancer; Monocarboxylate transporter; Medicine; Transporter; Cancer; Cancer research; Biology; Internal medicine; Biochemistry; Gene","score_opus":0.07982957861680824,"score_gpt":0.4191240128012518,"score_spread":0.33929443418444355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020369202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863375,0.009734116,0.0000142574545,0.0008753411,0.0015125071,0.000739267,0.000045726236,0.000004623015,0.00073665637],"genre_scores_gemma":[0.983969,0.011073889,0.000028214125,0.0002141601,0.0019058599,0.00044441436,0.0000040359046,0.000029235129,0.0023312399],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99785006,0.00038676598,0.00045124444,0.0005098894,0.00029084404,0.00051121664],"domain_scores_gemma":[0.99877936,0.000086365275,0.00010855522,0.0005936726,0.00027327248,0.00015877126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010549509,0.000148432,0.0003106921,0.000055665343,0.000066226654,0.000020147829,0.00048087502,0.00029202295,0.00024079625],"category_scores_gemma":[0.000104871906,0.00010871409,0.00023576307,0.00029777904,0.00038280542,0.000008102037,0.00019272191,0.0007011827,0.000005955817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051058293,0.00039274563,0.19925201,0.00019355096,0.00007822985,0.0000010556283,0.00016921062,0.00009936153,0.7238121,0.00001001235,0.017087724,0.058393415],"study_design_scores_gemma":[0.0024106295,0.00019612271,0.5068938,0.00012492282,0.000038869934,4.259631e-7,0.00005292028,0.00021458491,0.39382812,0.00010712664,0.09583756,0.00029487236],"about_ca_topic_score_codex":0.0060021826,"about_ca_topic_score_gemma":0.0059931544,"teacher_disagreement_score":0.32998398,"about_ca_system_score_codex":0.000047254816,"about_ca_system_score_gemma":0.000703253,"threshold_uncertainty_score":0.9073545},"labels":[],"label_agreement":null},{"id":"W2020774281","doi":"10.1158/1078-0432.ccr-12-2557","title":"Sequence Dependence of MEK Inhibitor AZD6244 Combined with Gemcitabine for the Treatment of Biliary Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"","keywords":"Gemcitabine; MEK inhibitor; Cancer; Medicine; Cancer research; Internal medicine; Chemotherapy; Oncology; MAPK/ERK pathway; Kinase; Biology","score_opus":0.3591914135442596,"score_gpt":0.5259425249704123,"score_spread":0.16675111142615268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020774281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549859,0.03568112,0.000036682417,0.0066463943,0.00043414292,0.0018303538,0.00013700739,0.00001575186,0.00023261394],"genre_scores_gemma":[0.9827286,0.013812392,0.0002327952,0.00012800403,0.0009300432,0.0012692879,0.0000072717157,0.00002827278,0.0008633312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976534,0.00014436654,0.0005768461,0.00033551536,0.0007251089,0.00056471577],"domain_scores_gemma":[0.99575627,0.0024239002,0.00015370954,0.0005526271,0.0008878536,0.00022562096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013265011,0.00016971426,0.0006523845,0.00008421027,0.00013796786,0.000007328677,0.00021127032,0.00009749391,0.00016736613],"category_scores_gemma":[0.00031807696,0.00008883766,0.00022686114,0.000441665,0.0011382105,0.00008139763,0.000073242234,0.00028435828,0.0000032844227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009002109,0.0013377845,0.9342244,0.00043560384,0.0008045574,0.000007100083,0.0013604546,0.000007986996,0.0025073087,0.00018654359,0.0042377748,0.045888364],"study_design_scores_gemma":[0.013523993,0.021160537,0.89082277,0.00076999055,0.00087133935,0.000010247906,0.0014695142,0.00018302568,0.040068932,0.00014430285,0.030675894,0.00029944093],"about_ca_topic_score_codex":0.0025011455,"about_ca_topic_score_gemma":0.0014470656,"teacher_disagreement_score":0.04558892,"about_ca_system_score_codex":0.0002508602,"about_ca_system_score_gemma":0.0007649887,"threshold_uncertainty_score":0.41937843},"labels":[],"label_agreement":null},{"id":"W2021044447","doi":"10.1158/1078-0432.ccr-13-2659","title":"Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; DiagnoCure (Canada); BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Lymph node; Hazard ratio; Internal medicine; Colorectal cancer; Lymph; Retrospective cohort study; Confidence interval; Proportional hazards model; Clinical endpoint; Cancer; Oncology; Gastroenterology; Pathology; Clinical trial","score_opus":0.24945192933218374,"score_gpt":0.5462985880595691,"score_spread":0.29684665872738536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021044447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346626,0.0008266201,0.000036120575,0.0005466843,0.0004272917,0.00301309,0.00084614387,0.000039551316,0.0007982682],"genre_scores_gemma":[0.99575067,0.00016994069,0.001208965,0.0001810415,0.0004157126,0.0020057547,0.000036413967,0.000051920208,0.00017961212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99468243,0.0010073311,0.0011820004,0.0011819936,0.0012410976,0.0007051393],"domain_scores_gemma":[0.9895271,0.0070826137,0.00034304912,0.00076722424,0.0018537914,0.00042620132],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0036858472,0.00027022214,0.0011007499,0.00015922383,0.00015511873,0.00003482908,0.000335728,0.00017576908,0.00014518245],"category_scores_gemma":[0.019972479,0.00021045998,0.0003028645,0.00076848327,0.00048588112,0.000068988935,0.00029972976,0.00063428323,0.000018847752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02738672,0.002891123,0.8774935,0.00013002029,0.0006430316,0.00015845915,0.00042471566,0.000022534277,0.0020720281,0.000013510048,0.00040834266,0.08835604],"study_design_scores_gemma":[0.033329196,0.013295289,0.92982626,0.0014915479,0.0006991669,0.0000034845827,0.00036982892,0.004132104,0.014583719,0.00048173597,0.0014290186,0.0003586398],"about_ca_topic_score_codex":0.016919103,"about_ca_topic_score_gemma":0.0010861567,"teacher_disagreement_score":0.0879974,"about_ca_system_score_codex":0.00074478576,"about_ca_system_score_gemma":0.0008788563,"threshold_uncertainty_score":0.9896273},"labels":[],"label_agreement":null},{"id":"W2021333908","doi":"10.1158/1078-0432.ccr-14-1334","title":"A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Monoclonal antibody; Medicine; Antibody; Cancer; Monoclonal; Cancer research; Immunology; Oncology; Internal medicine","score_opus":0.06097244176865894,"score_gpt":0.458161321343711,"score_spread":0.39718887957505206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021333908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983633,0.00031156852,0.00013257851,0.000059976595,0.000101313875,0.000929982,0.00001742764,0.000007666901,0.000076160184],"genre_scores_gemma":[0.9990244,0.00013805229,0.00027238787,0.00006725913,0.0001882305,0.00019159063,0.00004408353,0.000048275433,0.000025708543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965015,0.00068035786,0.0007984285,0.00078728964,0.0006258104,0.00060657994],"domain_scores_gemma":[0.9984797,0.0003263692,0.00019476507,0.00045817986,0.00038997395,0.00015097161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027244072,0.00020125562,0.0004664932,0.00017398653,0.00008555183,0.00001559315,0.00043046565,0.00016896498,0.000040237588],"category_scores_gemma":[0.000559816,0.00017732175,0.00007832999,0.00048434554,0.00023110473,0.000010278941,0.00014550162,0.00059525674,0.0000027139556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007039111,0.003397738,0.88707805,0.000053996544,0.00008215621,0.0000078986295,0.00037195583,0.0097518675,0.08240543,0.0000049809887,0.00007171555,0.009735088],"study_design_scores_gemma":[0.21692015,0.10502357,0.45016184,0.0016896785,0.000076310884,0.0000010237177,0.0028548283,0.011281849,0.19613157,0.00022664196,0.013200963,0.0024315587],"about_ca_topic_score_codex":0.0011186922,"about_ca_topic_score_gemma":0.0023658685,"teacher_disagreement_score":0.4369162,"about_ca_system_score_codex":0.00013252326,"about_ca_system_score_gemma":0.00040503268,"threshold_uncertainty_score":0.72309715},"labels":[],"label_agreement":null},{"id":"W2021424812","doi":"10.1158/1078-0432.ccr-08-2859","title":"Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Tolerability; Medicine; Pharmacology; Toxicity; Pharmacodynamics; Volume of distribution; Peripheral blood mononuclear cell; Methyltransferase; Internal medicine; Adverse effect; Biology; In vitro; Methylation","score_opus":0.062393287014908816,"score_gpt":0.4842561042323729,"score_spread":0.4218628172174641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021424812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987571,0.00019208332,0.0000139773665,0.000041063537,0.000040648312,0.0008395149,0.000027114094,0.000004259647,0.00008423757],"genre_scores_gemma":[0.9994501,0.0002496921,0.00006307479,0.000023581399,0.00009040105,0.000023718087,0.000060125483,0.00002098197,0.000018362154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970677,0.0008433013,0.000769977,0.0004917596,0.00052337104,0.0003038998],"domain_scores_gemma":[0.9985682,0.00009222326,0.00015256507,0.00048573376,0.0005291988,0.00017210827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016949584,0.0001458327,0.00039888694,0.00015796206,0.00007081774,0.000010870067,0.00022971063,0.00013354741,0.000017807795],"category_scores_gemma":[0.0003746133,0.0001220846,0.00006840059,0.00030634672,0.00020028888,0.000011608435,0.00007067696,0.0002976735,7.508631e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029391285,0.008692084,0.10476884,0.000019460134,0.000038485465,0.000008629222,0.0003361886,0.00011682654,0.8459149,0.000005509208,0.000011708993,0.037148226],"study_design_scores_gemma":[0.010801565,0.05543892,0.31831253,0.000078440826,0.000018389239,6.263387e-8,0.00021847663,0.000020297024,0.6147936,0.00010615052,0.000058015852,0.00015357033],"about_ca_topic_score_codex":0.00021145442,"about_ca_topic_score_gemma":0.00051637064,"teacher_disagreement_score":0.23112132,"about_ca_system_score_codex":0.00002197052,"about_ca_system_score_gemma":0.00014728586,"threshold_uncertainty_score":0.49784654},"labels":[],"label_agreement":null},{"id":"W2022033134","doi":"10.1158/1078-0432.tcmusa10-a1","title":"Abstract A1: Clinical and biological significance of GSK-3β inactivation in breast cancer: An immunohistochemical study","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Breast cancer; GSK-3; Protein kinase B; Immunohistochemistry; Medicine; Cancer; GSK3B; PI3K/AKT/mTOR pathway; Cancer research; Internal medicine; Oncology; Glycogen synthase; Biology; Phosphorylation; Signal transduction; Glycogen; Biochemistry","score_opus":0.18055240348889637,"score_gpt":0.5343270259261224,"score_spread":0.353774622437226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022033134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712646,0.0007128179,0.0000086916225,0.00052121753,0.00059056503,0.0007752622,0.0001019062,0.000015501832,0.00014759472],"genre_scores_gemma":[0.99637,0.0016238973,0.00014301125,0.00012069841,0.0012836325,0.00035036812,0.000029443265,0.000037132882,0.000041776115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956438,0.00080274773,0.0012873628,0.0011696658,0.000526121,0.00057031686],"domain_scores_gemma":[0.99738544,0.0006339273,0.00025987386,0.000822217,0.0005795332,0.0003190059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061980104,0.00023826427,0.00058309885,0.00011353743,0.000106457985,0.000036540067,0.0007079899,0.00072464533,0.00025244182],"category_scores_gemma":[0.0013198816,0.00020925711,0.00014354243,0.00035722053,0.0018539062,0.00002068526,0.00035971074,0.0020844243,0.0000046556033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015943634,0.0010656053,0.56271136,0.000021389076,0.00004809253,0.000005954256,0.000035669742,0.000005945824,0.41537178,0.000018450017,0.00045146584,0.01866993],"study_design_scores_gemma":[0.002287281,0.0014956123,0.97128475,0.000054431683,0.00001298954,0.0000043809605,0.00019186847,0.000044909735,0.022270722,0.00015904207,0.0019088708,0.0002851587],"about_ca_topic_score_codex":0.0020001614,"about_ca_topic_score_gemma":0.0011526623,"teacher_disagreement_score":0.4085734,"about_ca_system_score_codex":0.00007331963,"about_ca_system_score_gemma":0.0008539626,"threshold_uncertainty_score":0.90559024},"labels":[],"label_agreement":null},{"id":"W2022709664","doi":"10.1158/1078-0432.tcme10-b28","title":"Abstract B28: Epigenetic contribution of Wnt antagonists SFRP1 and DKK1 as prognostic markers in colorectal cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"","keywords":"Colorectal cancer; DKK1; Methylation; Wnt signaling pathway; Microsatellite instability; Epigenetics; DNA methylation; Oncology; Population; Biology; Cancer; Internal medicine; Cancer research; Medicine; Genetics; Microsatellite; Gene; Allele; Gene expression","score_opus":0.05485635883217484,"score_gpt":0.470407721302421,"score_spread":0.41555136247024616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022709664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378175,0.0045590918,0.0000111086765,0.00041665303,0.0003193722,0.00055565557,0.000033188284,0.0000040929954,0.00031909774],"genre_scores_gemma":[0.9901536,0.009174658,0.00007204388,0.000026933209,0.0003012089,0.00014966249,0.00004219525,0.000018611196,0.00006108185],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99807113,0.00023487186,0.00051951077,0.00046587308,0.00031711615,0.00039146675],"domain_scores_gemma":[0.9987438,0.0003328739,0.0001186205,0.00020305638,0.0004196173,0.000182035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024332413,0.00012096206,0.00023621606,0.00008011231,0.00007572439,0.000027882155,0.0001821984,0.00034563252,0.00012893204],"category_scores_gemma":[0.001870287,0.000113354225,0.000071745606,0.00018227269,0.0005551759,0.000004480243,0.00014349286,0.0005789539,0.0000051587904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047344432,0.00010882574,0.37997445,0.000029971974,0.000026982285,0.0000039163506,0.000014913816,0.0000116351775,0.6026719,0.000042554977,0.00006103614,0.016580338],"study_design_scores_gemma":[0.0008663455,0.000474028,0.6643444,0.000035041325,0.0000085083175,6.453939e-7,0.000015610041,0.000053252515,0.33164394,0.00039712084,0.0020568387,0.0001042934],"about_ca_topic_score_codex":0.0011716575,"about_ca_topic_score_gemma":0.0048039155,"teacher_disagreement_score":0.28436995,"about_ca_system_score_codex":0.000028347258,"about_ca_system_score_gemma":0.0005251646,"threshold_uncertainty_score":0.4622451},"labels":[],"label_agreement":null},{"id":"W2024654743","doi":"10.1158/1078-0432.ovca13-a25","title":"Abstract A25: PPP2R1A mutations affect PP2A complex formation, and novel protein interactions in gynecological carcinoma cell lines","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Protein phosphatase 2; Cell culture; Somatic cell; Protein subunit; Genetics; Gene","score_opus":0.322294496576503,"score_gpt":0.5076780278910918,"score_spread":0.18538353131458885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024654743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780537,0.00033627122,0.00031890548,0.005682576,0.00016633372,0.002563622,0.000035897527,0.000049839084,0.003041216],"genre_scores_gemma":[0.996706,0.0001284789,0.00067805056,0.00027031347,0.00028760105,0.0012737743,0.000067747635,0.000030156445,0.00055787765],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99745184,0.00024538205,0.0007988442,0.0004806153,0.00049312616,0.00053021964],"domain_scores_gemma":[0.9972158,0.0012962316,0.000118841155,0.0003598081,0.0006418855,0.00036740655],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012404073,0.00016798842,0.00040533088,0.00030914895,0.0001764078,0.00007928162,0.00016125964,0.00019821594,0.0018492781],"category_scores_gemma":[0.0017686094,0.00014282411,0.00012760378,0.00057887234,0.00045945746,0.0002377163,0.000158529,0.0016842108,0.00025998778],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015320769,0.00590515,0.2468642,0.00172108,0.00019188957,0.00023448188,0.0012572573,0.00032418495,0.62069523,0.0007439182,0.042173143,0.078357376],"study_design_scores_gemma":[0.0037926135,0.0006197491,0.98033106,0.00023116487,0.000023464907,0.00002495458,0.0002830569,0.0037029397,0.0045315023,0.0003541806,0.005923393,0.00018191159],"about_ca_topic_score_codex":0.0024346903,"about_ca_topic_score_gemma":0.0019991824,"teacher_disagreement_score":0.73346686,"about_ca_system_score_codex":0.00036330122,"about_ca_system_score_gemma":0.0004916094,"threshold_uncertainty_score":0.9990632},"labels":[],"label_agreement":null},{"id":"W2025795030","doi":"10.1158/1078-0432.ccr-14-2603","title":"Development and Clinical Validation of an <i>In Situ</i> Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Computer Research Institute of Montréal; Centre Hospitalier de l’Université de Montréal; Queen's University","funders":"National Cancer Institute; National Comprehensive Cancer Network","keywords":"Medicine; Prostate cancer; Biomarker; Biopsy; Internal medicine; Risk assessment; Oncology; Cancer; Prostatectomy; Prostate; Predictive value; Predictive value of tests; Pathology","score_opus":0.32463453878355264,"score_gpt":0.5519130186668744,"score_spread":0.22727847988332173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025795030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479157,0.000946692,0.000062087805,0.0016628316,0.00016444518,0.002199906,0.000086172186,0.000012021116,0.00007430158],"genre_scores_gemma":[0.98929036,0.0017950226,0.0066943625,0.000101584235,0.00012000265,0.0018051813,0.00012299683,0.000024378915,0.000046094643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996514,0.0007565386,0.0012193155,0.00062399573,0.0005133152,0.0003728063],"domain_scores_gemma":[0.9970732,0.0013369583,0.00022826715,0.00031695317,0.00067617587,0.00036846029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011121946,0.00013855346,0.0005010033,0.00018450183,0.00004767633,0.000030889285,0.00009880343,0.00015734929,0.000017162423],"category_scores_gemma":[0.0015112549,0.000112733425,0.00007181037,0.00037877788,0.0002863276,0.0001351674,0.000039798368,0.00049186713,0.0000029816742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034242643,0.0015436078,0.7896136,0.00013208642,0.000049662052,0.000012154595,0.00027110972,0.000085265994,0.00024834476,0.00001331603,0.00026339994,0.2043432],"study_design_scores_gemma":[0.016854534,0.0016964946,0.9463487,0.00056256907,0.00006649828,6.784129e-7,0.00041150878,0.0042781075,0.025734993,0.00024357194,0.0036187856,0.0001835412],"about_ca_topic_score_codex":0.0013544605,"about_ca_topic_score_gemma":0.00425721,"teacher_disagreement_score":0.20415966,"about_ca_system_score_codex":0.00050649216,"about_ca_system_score_gemma":0.0025774546,"threshold_uncertainty_score":0.45971358},"labels":[],"label_agreement":null},{"id":"W2026022612","doi":"10.1158/1078-0432.ccr-07-1530","title":"Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and Efficacy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada","keywords":"Endostatin; Medicine; Chemistry; Cancer research; Immunology; Angiogenesis","score_opus":0.13695482618782623,"score_gpt":0.48156824361031697,"score_spread":0.34461341742249074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026022612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160653,0.0044429204,0.00065760646,0.0017211504,0.00024288114,0.0005895491,0.00007649732,0.000019037014,0.00064381293],"genre_scores_gemma":[0.9866264,0.007191266,0.002336879,0.0012956097,0.001376983,0.00015587325,0.00008775734,0.000057275807,0.00087194674],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967101,0.0004979536,0.0006119929,0.00092616846,0.00051263213,0.00074110844],"domain_scores_gemma":[0.9979512,0.0005066526,0.000098335884,0.0005155226,0.0003391771,0.0005891232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018784283,0.00022075773,0.00036658015,0.00010313846,0.000393744,0.000055741653,0.00039937638,0.0002493718,0.000099525394],"category_scores_gemma":[0.0011344694,0.00019569504,0.00017050005,0.00031073784,0.00062536675,0.0000071261125,0.00043532994,0.00044160814,0.00005652997],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018510269,0.00029706853,0.06720272,0.000073967974,0.00016373329,0.000067279114,0.0003863416,0.000025047286,0.8609303,0.00021900881,0.0183854,0.050398074],"study_design_scores_gemma":[0.0068996265,0.0060528596,0.21187511,0.00022547916,0.000041387928,0.000039013965,0.00089513196,0.00009686414,0.14143282,0.00035524284,0.63084203,0.001244461],"about_ca_topic_score_codex":0.00027349457,"about_ca_topic_score_gemma":0.00017409406,"teacher_disagreement_score":0.7194975,"about_ca_system_score_codex":0.00003409889,"about_ca_system_score_gemma":0.0008417624,"threshold_uncertainty_score":0.7980212},"labels":[],"label_agreement":null},{"id":"W2026076019","doi":"10.1158/1078-0432.ccr-07-5237","title":"Loss of Heterozygosity at the <i>BRCA2</i> Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline <i>BRCA2</i> Mutation","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Loss of heterozygosity; Germline mutation; Prostate cancer; Germline; Mutation; Cancer research; Biology; BRCA2 Protein; Cancer; Multiplex ligation-dependent probe amplification; Genetics; Gene; Exon; Allele","score_opus":0.06446206469220922,"score_gpt":0.39969916950797746,"score_spread":0.33523710481576824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026076019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935856,0.0020515076,0.0003985692,0.0018216503,0.00008305454,0.0013497648,0.0005911601,0.000013953658,0.00010472944],"genre_scores_gemma":[0.9948294,0.002305046,0.00022600112,0.0003339836,0.00017042621,0.0008435639,0.00051794905,0.00004481166,0.0007288274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99658436,0.0006095119,0.0008063604,0.00080954906,0.0007578407,0.000432366],"domain_scores_gemma":[0.9977234,0.00031377134,0.00032834828,0.0008114966,0.00069236814,0.00013063873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011731079,0.00020628469,0.00031601606,0.000069859,0.00028355536,0.000026705608,0.00047560275,0.00021865837,0.00006618065],"category_scores_gemma":[0.00021698127,0.00016063346,0.000089717585,0.000513102,0.0011075367,0.000014787165,0.00023622322,0.0005408185,0.00001117698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058842315,0.0005513487,0.4728182,0.000098976285,0.00037851647,0.000031322215,0.0023789217,0.00332403,0.47732878,0.0000042498386,0.023127131,0.014074293],"study_design_scores_gemma":[0.0048779338,0.00088481006,0.1084709,0.00011123885,0.000040665447,0.000016460843,0.0003127927,0.0010171378,0.8759986,0.0001778384,0.007693146,0.0003984518],"about_ca_topic_score_codex":0.0098653985,"about_ca_topic_score_gemma":0.02055977,"teacher_disagreement_score":0.39866984,"about_ca_system_score_codex":0.00069793884,"about_ca_system_score_gemma":0.0010818179,"threshold_uncertainty_score":0.9973125},"labels":[],"label_agreement":null},{"id":"W2026504560","doi":"10.1158/1078-0432.ccr-14-2552","title":"<i>CCR</i> 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping","year":2015,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Subtyping; Breast cancer; Cancer; Medicine; Clinical trial; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.15112496895435373,"score_gpt":0.4621677745794742,"score_spread":0.3110428056251205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026504560","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048167754,0.022488646,0.000038221522,0.92435366,0.0011965935,0.001097589,0.0015778445,0.000023306235,0.0010563973],"genre_scores_gemma":[0.120548,0.014297672,0.0007746396,0.83528775,0.020738218,0.0022926275,0.0026629986,0.00043964956,0.002958426],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521303,0.000918007,0.000825228,0.0009782192,0.0011887873,0.00087673485],"domain_scores_gemma":[0.99709636,0.00027021888,0.00030980172,0.0010287694,0.0011300365,0.0001648149],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020436305,0.00042644926,0.000675848,0.000103640225,0.00031108226,0.00003638693,0.0011715429,0.00075601746,0.00014519553],"category_scores_gemma":[0.00011029515,0.0003126809,0.00030429542,0.00032906255,0.00126113,0.0000063937705,0.0012832948,0.002112747,0.000021098049],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046716767,0.00010912853,0.008911343,0.0001414258,0.0011894483,0.000044508408,0.00016197524,0.000008697911,0.00051316625,0.0000014188194,0.97778004,0.010671683],"study_design_scores_gemma":[0.0012312493,0.00012440683,0.0070901704,0.00028826948,0.0001333545,0.000007447872,0.00018296906,0.0000022087493,0.0026339728,0.00004263808,0.987888,0.00037533697],"about_ca_topic_score_codex":0.0016684376,"about_ca_topic_score_gemma":0.00081378146,"teacher_disagreement_score":0.08906588,"about_ca_system_score_codex":0.00041191184,"about_ca_system_score_gemma":0.0024203705,"threshold_uncertainty_score":0.9999325},"labels":[],"label_agreement":null},{"id":"W2026813872","doi":"10.1158/1078-0432.ccr-13-2567","title":"Steroidogenic Germline Polymorphism Predictors of Prostate Cancer Progression in the Estradiol Pathway","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Prostate cancer; Single-nucleotide polymorphism; Oncology; Cancer; Internal medicine; SNP; Medicine; Disease; Prostate; Biology; Bioinformatics; Genotype; Genetics; Gene","score_opus":0.0762159687480923,"score_gpt":0.4414984084698597,"score_spread":0.36528243972176744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026813872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912058,0.005650887,0.000021924467,0.0019172477,0.00030344274,0.0006080666,0.00009161355,0.000006714764,0.00019426607],"genre_scores_gemma":[0.9941527,0.0040072687,0.00003103886,0.00027864135,0.00082587596,0.00033220858,0.00004159621,0.000026377269,0.0003042898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695855,0.0009571685,0.00060323096,0.00046440194,0.00052966404,0.00048696913],"domain_scores_gemma":[0.9988677,0.00021112646,0.00008937956,0.00053265295,0.00016185593,0.00013728424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030759545,0.00015135306,0.0002635911,0.000071714334,0.000090972004,0.000022194514,0.0005260861,0.00021568697,0.000068588146],"category_scores_gemma":[0.00020723493,0.000098520955,0.00016288513,0.0002774848,0.0005021011,0.0000055744486,0.00009816434,0.00055982487,0.0000053152326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025665925,0.0009465947,0.523535,0.00021035584,0.00015219997,0.00002370101,0.00079383247,0.00016657986,0.29524434,0.000319545,0.0049906163,0.17105061],"study_design_scores_gemma":[0.009363943,0.009840679,0.48080406,0.00086618,0.00009775565,0.000030033936,0.00038239057,0.00066445814,0.29902542,0.0007252854,0.19720063,0.0009991925],"about_ca_topic_score_codex":0.00045861024,"about_ca_topic_score_gemma":0.00051264174,"teacher_disagreement_score":0.19221002,"about_ca_system_score_codex":0.000020034868,"about_ca_system_score_gemma":0.00037526296,"threshold_uncertainty_score":0.4017568},"labels":[],"label_agreement":null},{"id":"W2027287873","doi":"10.1158/1078-0432.ccr-14-2206","title":"NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lung cancer; Gene signature; Cancer research; Cisplatin; Oncology; Medicine; Gene expression profiling; Vinorelbine; ERCC1; Gene; Chemotherapy; Tissue microarray; Cancer; Gene expression; Biology; Internal medicine; Genetics; DNA repair","score_opus":0.11004222712469494,"score_gpt":0.4269269755545507,"score_spread":0.3168847484298558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027287873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947132,0.0029477589,0.000050792478,0.0005664493,0.00010563431,0.00031998113,0.000020330988,0.000005091813,0.0012707638],"genre_scores_gemma":[0.9976532,0.0006165388,0.000109804176,0.00028450554,0.0005496108,0.00007498054,0.000048738788,0.000026195044,0.00063645106],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828947,0.00018329787,0.00033988702,0.0005459559,0.00025085066,0.00039055894],"domain_scores_gemma":[0.9989446,0.00011661778,0.000066494875,0.0003376461,0.0002830558,0.00025160803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001169134,0.00013132975,0.00022173356,0.000061026512,0.00005133818,0.000029122823,0.0002351604,0.00023723471,0.000025372712],"category_scores_gemma":[0.00037350992,0.00012340292,0.00005814007,0.0001294789,0.00025372932,0.000006524941,0.00019995774,0.0004000071,0.000005882186],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016166631,0.00042292962,0.50568205,0.000093019175,0.000018850345,0.000007883451,0.00039228736,0.000046330133,0.46326843,0.000053567965,0.008565711,0.019832244],"study_design_scores_gemma":[0.0043172142,0.00071368995,0.16671413,0.000023800867,0.00000432998,0.0000011537869,0.00033495337,0.00019721777,0.8098959,0.00077000924,0.01674688,0.00028071812],"about_ca_topic_score_codex":0.00036540919,"about_ca_topic_score_gemma":0.00024772278,"teacher_disagreement_score":0.34662747,"about_ca_system_score_codex":0.00007991721,"about_ca_system_score_gemma":0.00031559754,"threshold_uncertainty_score":0.5032225},"labels":[],"label_agreement":null},{"id":"W2030244887","doi":"10.1158/1078-0432.12aacriaslc-b34","title":"Abstract B34: Overcoming resistance to EGFR-Tyrosine Kinase Inhibitor therapy in non-small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Lung cancer; Cancer research; Targeted therapy; Medicine; Epidermal growth factor receptor; Receptor tyrosine kinase; Cancer; Small hairpin RNA; Tyrosine kinase; EGFR inhibitors; Bioinformatics; Biology; Gene; Oncology; Internal medicine; Receptor; Genetics","score_opus":0.1316648686409949,"score_gpt":0.519220940674001,"score_spread":0.3875560720330061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030244887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664665,0.019019833,0.000014650752,0.0057391273,0.0008130867,0.0017964195,0.00007072882,0.000034507528,0.006045144],"genre_scores_gemma":[0.98277426,0.005272925,0.00056143774,0.0013856925,0.0020902941,0.0011729603,0.000017427963,0.00006832302,0.0066567073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967198,0.00016713966,0.0007292232,0.0005963852,0.0007054077,0.0010820532],"domain_scores_gemma":[0.99745595,0.00069205114,0.00009809694,0.0005731595,0.00039180872,0.00078891113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001964869,0.00023541717,0.0005245284,0.00027070366,0.00018344715,0.000053045827,0.00022825916,0.00020995803,0.0008848081],"category_scores_gemma":[0.00027432723,0.00019098191,0.00016543096,0.0008306282,0.00015669179,0.00018165295,0.00011402525,0.0010392253,0.000090528236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024281438,0.001873334,0.9069664,0.00039708527,0.00013738587,0.00008845417,0.0016371978,0.000025736514,0.007950308,0.000055045697,0.044828035,0.03361287],"study_design_scores_gemma":[0.0067209215,0.00036568625,0.9024226,0.0011014981,0.00006224624,7.982559e-7,0.00024037843,0.000025771247,0.009792182,0.000028528684,0.078961626,0.00027775628],"about_ca_topic_score_codex":0.0037485228,"about_ca_topic_score_gemma":0.0030697177,"teacher_disagreement_score":0.034133594,"about_ca_system_score_codex":0.0013020637,"about_ca_system_score_gemma":0.0010960927,"threshold_uncertainty_score":0.9688028},"labels":[],"label_agreement":null},{"id":"W2030882637","doi":"10.1158/1078-0432.ccr-06-0261","title":"Biological Markers for Non–Small Cell Lung Cancer Patient Selection for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epidermal growth factor receptor; Cancer research; Tyrosine kinase; Lung cancer; Tyrosine-kinase inhibitor; Epidermal growth factor; Cancer; Receptor tyrosine kinase; Receptor; Medicine; Biology; Oncology; Internal medicine","score_opus":0.25774027928360477,"score_gpt":0.5452083421699896,"score_spread":0.2874680628863848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030882637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004517688,0.9729114,0.00022374073,0.0007939396,0.0017015184,0.01623344,0.0033602407,0.000079188845,0.00017884746],"genre_scores_gemma":[0.00039553505,0.9640143,0.0014434241,0.00027727624,0.004193386,0.02494371,0.0015243769,0.0001815097,0.0030264612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99461734,0.00059715955,0.0016528929,0.00140908,0.00056021713,0.0011633355],"domain_scores_gemma":[0.99379826,0.0032280488,0.0005116069,0.00042224422,0.0015182949,0.0005215661],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001221491,0.00063417363,0.0022845934,0.00033810118,0.0004325247,0.00008323548,0.0002850851,0.0009769764,0.0005123345],"category_scores_gemma":[0.00067302363,0.00042003422,0.0014970183,0.00070618995,0.00030935486,0.00007237446,0.00009731282,0.0012458498,0.000017103726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018656023,0.0011543832,0.0034873153,0.01156914,0.0008189878,0.000005621742,0.000040516446,0.0000010088521,0.000025184749,0.0000137128745,0.12615979,0.85485876],"study_design_scores_gemma":[0.004959114,0.0039973496,0.00040953822,0.0049595856,0.00090537284,0.0000024078965,0.000017376491,0.000064670785,0.00019065777,0.000019900475,0.98402077,0.00045323797],"about_ca_topic_score_codex":0.0012321428,"about_ca_topic_score_gemma":0.00018549654,"teacher_disagreement_score":0.857861,"about_ca_system_score_codex":0.0020060795,"about_ca_system_score_gemma":0.004393639,"threshold_uncertainty_score":0.9998251},"labels":[],"label_agreement":null},{"id":"W2031321898","doi":"10.1158/1078-0432.ccr-08-0566","title":"Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Prostate cancer; Cancer research; Small interfering RNA; LNCaP; Prostate; Cyclin D1; Phospholipase A2; Biology; Cancer cell; Cancer; Internal medicine; Endocrinology; Cell culture; Medicine; Cell cycle; Transfection; Biochemistry","score_opus":0.19966497363755867,"score_gpt":0.514358958069352,"score_spread":0.3146939844317933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031321898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845631,0.0073917313,0.00009254241,0.0038415897,0.0012295055,0.0024078893,0.00009457652,0.000079013385,0.0003000261],"genre_scores_gemma":[0.980725,0.00666392,0.00019549513,0.0013867904,0.0034123573,0.0022351027,0.000026979475,0.00008241087,0.005271944],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964432,0.0003405568,0.0006387591,0.0006289919,0.00090879726,0.0010396593],"domain_scores_gemma":[0.9973177,0.00067834154,0.00010140625,0.00049938605,0.0007662721,0.00063689944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025717563,0.00021592807,0.000617205,0.00014978118,0.0004216595,0.000023808734,0.0002338906,0.00026621445,0.00094321696],"category_scores_gemma":[0.0006518095,0.00016672748,0.0003471052,0.00041562555,0.00074504426,0.000080480146,0.00009745755,0.001091894,0.00013479943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037284296,0.0023942438,0.48994243,0.0021673748,0.0011808472,0.0021391755,0.0022513017,0.00015035195,0.019075053,0.00036729296,0.22347179,0.21957584],"study_design_scores_gemma":[0.029722935,0.00805451,0.23943321,0.0007398849,0.00033768595,0.00014390601,0.00018657689,0.005830607,0.049002375,0.0015278164,0.6639842,0.001036323],"about_ca_topic_score_codex":0.0006045301,"about_ca_topic_score_gemma":0.000069816895,"teacher_disagreement_score":0.44051236,"about_ca_system_score_codex":0.00021987592,"about_ca_system_score_gemma":0.002133424,"threshold_uncertainty_score":0.9999701},"labels":[],"label_agreement":null},{"id":"W2032531505","doi":"10.1158/1078-0432.ccr-07-4049","title":"Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Sodium-iodide symporter; Green fluorescent protein; Genetic enhancement; Cancer research; Multiplicity of infection; Transgene; Adenoviridae; In vivo; Viral vector; Molecular biology; Biology; Gene expression; Viral replication; Symporter; Chemistry; Virology; Virus; Gene","score_opus":0.15515661389208305,"score_gpt":0.46912257429037035,"score_spread":0.3139659603982873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032531505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923221,0.0033633176,0.001044096,0.0010098477,0.00016196672,0.0013800098,0.00062887685,0.000022336888,0.00006744403],"genre_scores_gemma":[0.9889856,0.0057713804,0.00044842137,0.00018865039,0.0012275515,0.0012629235,0.0017384376,0.00005976876,0.00031724758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967378,0.0006097716,0.0007335967,0.00096989237,0.0004850147,0.0004639667],"domain_scores_gemma":[0.99623847,0.00071890757,0.000247629,0.0013845232,0.0011937647,0.00021672118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017186078,0.00018199123,0.0003137779,0.00014155112,0.00033911376,0.000020904687,0.0005346629,0.000353253,0.00020717747],"category_scores_gemma":[0.001082896,0.0001690727,0.00023728638,0.00035225714,0.0005241119,0.000015776977,0.00010718106,0.00032347708,0.00002397292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038457634,0.0002294071,0.048727084,0.0000072808816,0.00012906962,2.5823215e-7,0.00010189408,0.000040492996,0.9302037,0.0000075486782,0.0059447675,0.010762779],"study_design_scores_gemma":[0.0022451885,0.001675238,0.18979305,0.00001179275,0.000007852668,9.797516e-7,0.000016190454,0.00009623214,0.80010223,0.00035240894,0.005534948,0.00016386407],"about_ca_topic_score_codex":0.00023502787,"about_ca_topic_score_gemma":0.00006083478,"teacher_disagreement_score":0.14106597,"about_ca_system_score_codex":0.00010201542,"about_ca_system_score_gemma":0.00095512293,"threshold_uncertainty_score":0.68945843},"labels":[],"label_agreement":null},{"id":"W2032550022","doi":"10.1158/1078-0432.ccr-07-1712","title":"Prognostic Significance of Macrophage Infiltration in Leiomyosarcomas","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute","keywords":"CD163; CD68; Tissue microarray; Pathology; Immunohistochemistry; Leiomyosarcoma; Immunostaining; Biology; Macrophage; Gene expression profiling; Medicine; Gene expression; Gene; In vitro","score_opus":0.35453724001654385,"score_gpt":0.537569916466439,"score_spread":0.18303267644989518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032550022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457365,0.0007940443,0.000029621096,0.0014093191,0.00004005081,0.0011164497,0.000011328485,0.000017887176,0.0020076681],"genre_scores_gemma":[0.99701566,0.0007095413,0.00094386656,0.00003756404,0.00015018166,0.00027724748,0.000011416757,0.000017138684,0.00083737564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709123,0.00044628762,0.00061649457,0.00036709988,0.00093272026,0.00054613716],"domain_scores_gemma":[0.9975296,0.0012123162,0.00006566777,0.00033573955,0.00051264756,0.00034401237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017826699,0.000103232036,0.00038055328,0.00024699385,0.00007316715,0.0000073506594,0.00015769035,0.00006425069,0.00030744966],"category_scores_gemma":[0.0032254315,0.00008250078,0.00010916029,0.0008061118,0.0008727252,0.000058217523,0.000078921774,0.0009190199,0.00007672924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012484884,0.0011041929,0.9840097,0.00018453418,0.000024459281,0.0016274865,0.00005399173,0.000004683599,0.0053783283,0.000105034145,0.0008041452,0.0054550003],"study_design_scores_gemma":[0.0025084428,0.0030272265,0.9854321,0.00033041628,0.0000090824415,0.00011404442,0.000043261116,0.00013216551,0.007514909,0.0002179424,0.00060756993,0.0000628537],"about_ca_topic_score_codex":0.0010080427,"about_ca_topic_score_gemma":0.00018999423,"teacher_disagreement_score":0.0053921468,"about_ca_system_score_codex":0.00017490485,"about_ca_system_score_gemma":0.0011854687,"threshold_uncertainty_score":0.3992735},"labels":[],"label_agreement":null},{"id":"W2034735917","doi":"10.1158/1078-0432.ovca13-ia18","title":"Abstract IA18: Evolutionary dynamics of high-grade serous ovarian cancer genomes across anatomic space and time","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Ovarian cancer; Serous fluid; Fallopian tube; Copy-number variation; Somatic evolution in cancer; Carcinogenesis; Amplicon; Copy number analysis; Exome; Germline mutation; Deep sequencing; Exome sequencing; Genetics; Cancer; Mutation; Gene; Genome","score_opus":0.04732317796940549,"score_gpt":0.42187591453508333,"score_spread":0.37455273656567784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034735917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850328,0.010276483,0.000025706922,0.0029787058,0.00026171328,0.00043315644,0.00063822087,0.000008566314,0.00034467876],"genre_scores_gemma":[0.9774213,0.020194236,0.00030583557,0.00017924333,0.00064564095,0.0001477358,0.000115398056,0.000039309372,0.00095131557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979514,0.00011721485,0.00047954643,0.0005802915,0.00030403404,0.00056750164],"domain_scores_gemma":[0.99834245,0.00029859936,0.00013275421,0.00049440115,0.00045678898,0.0002750143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007835356,0.00016880302,0.00032587018,0.000053646618,0.00015446458,0.00005875558,0.0003527297,0.00031301496,0.000415863],"category_scores_gemma":[0.00027851458,0.00016303183,0.00011323529,0.00017877508,0.00070873153,0.000009988405,0.0004747981,0.0004201483,0.00004246109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018009772,0.0013238898,0.44698164,0.0006294968,0.001168788,0.0000446906,0.00034534596,0.0017774486,0.16824816,0.0045164106,0.1392212,0.23394194],"study_design_scores_gemma":[0.0030518537,0.00081966346,0.9513266,0.000115243776,0.000042326472,0.000009785364,0.0002688364,0.002872604,0.009674187,0.0052413386,0.02594279,0.00063478237],"about_ca_topic_score_codex":0.009436796,"about_ca_topic_score_gemma":0.0020387997,"teacher_disagreement_score":0.50434494,"about_ca_system_score_codex":0.00015229669,"about_ca_system_score_gemma":0.00062357855,"threshold_uncertainty_score":0.9971594},"labels":[],"label_agreement":null},{"id":"W2037393257","doi":"10.1158/1078-0432.mechres-b45","title":"Abstract B45: Met-Dependent Positive and Negative Signaling Cascades in Gastric Cancer Cells","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Signal transduction; Phosphorylation; Autocrine signalling; Cell signaling; Cancer research; Receptor tyrosine kinase; Hepatocyte growth factor; Biology; Cell biology; Cancer; C-Met; Cancer cell; Receptor; Genetics","score_opus":0.22980232317326355,"score_gpt":0.5310729923425993,"score_spread":0.30127066916933576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037393257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852681,0.01136868,0.000028057948,0.0012221085,0.00045400963,0.0007641266,0.00006708445,0.000019361214,0.0008084649],"genre_scores_gemma":[0.98816776,0.008950518,0.00026130545,0.0005546611,0.001310735,0.00022584475,0.00000330168,0.000039291666,0.00048658703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99705917,0.00031216818,0.0005526309,0.00047289504,0.00073871587,0.0008643944],"domain_scores_gemma":[0.997446,0.0013638241,0.00009996311,0.00023319974,0.00028891774,0.00056809135],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034173105,0.00018116752,0.0005283657,0.00025556612,0.00011891398,0.000041071697,0.00013073784,0.00020803661,0.0016938549],"category_scores_gemma":[0.00022298661,0.00014741188,0.00011469076,0.0005144853,0.00028053793,0.00016824398,0.000115819974,0.0014453122,0.000032073724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075821658,0.0018081942,0.23195362,0.00042304606,0.0006763628,0.00031301173,0.004966475,0.000069231515,0.25944856,0.00088001357,0.002122894,0.48975644],"study_design_scores_gemma":[0.009940271,0.0020853651,0.69768786,0.0014126005,0.00013959382,0.00002775736,0.002919448,0.00012380112,0.27948043,0.0014867116,0.004110014,0.0005861294],"about_ca_topic_score_codex":0.008814372,"about_ca_topic_score_gemma":0.0010364489,"teacher_disagreement_score":0.4891703,"about_ca_system_score_codex":0.00047244687,"about_ca_system_score_gemma":0.00051739905,"threshold_uncertainty_score":0.9992187},"labels":[],"label_agreement":null},{"id":"W2037994659","doi":"10.1158/1078-0432.ovca13-b24","title":"Abstract B24: Using a unique genetically modified ovarian cancer cell line model to identify the targets for siRNA directed therapies","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Biology; Transcriptome; Ovarian cancer; Somatic cell; Missense mutation; Genetics; Gene; Cancer research; Cell culture; Synthetic lethality; Mutation; Cancer; DNA repair; Gene expression","score_opus":0.21377302288895195,"score_gpt":0.5268820149276521,"score_spread":0.31310899203870013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037994659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87735295,0.002447797,0.11035944,0.0063192286,0.000097414486,0.0027067936,0.00016093488,0.0000462325,0.00050923054],"genre_scores_gemma":[0.97942185,0.0026638785,0.011693535,0.0015599817,0.00046441617,0.00336691,0.000056543297,0.00005023177,0.00072267477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790794,0.00021965518,0.00047233404,0.0006403587,0.00021531306,0.00054440077],"domain_scores_gemma":[0.99806577,0.00015519437,0.00008842481,0.0006973764,0.00077085244,0.00022236275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012344483,0.00017744151,0.00022256597,0.00003657717,0.00029979952,0.000077766505,0.0006647855,0.00036377652,0.00014074246],"category_scores_gemma":[0.00021714573,0.00012770927,0.00018031136,0.00016954992,0.00031031916,0.000005519643,0.00030461221,0.00038321485,0.0000083812765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016419748,0.00015235589,0.00020729125,0.000022706135,0.00007847584,5.33502e-7,0.000032765995,0.0014945493,0.9781765,0.0003419925,0.009363086,0.009965598],"study_design_scores_gemma":[0.0022998003,0.0012267571,0.018017532,0.0001119099,0.00010035956,0.0000032462815,0.00012051985,0.1253315,0.7680423,0.016777724,0.066848576,0.0011197218],"about_ca_topic_score_codex":0.0018777829,"about_ca_topic_score_gemma":0.0005008241,"teacher_disagreement_score":0.2101341,"about_ca_system_score_codex":0.000051034716,"about_ca_system_score_gemma":0.00041067472,"threshold_uncertainty_score":0.5207833},"labels":[],"label_agreement":null},{"id":"W2040800786","doi":"10.1158/1078-0432.ccr-07-4066","title":"Higher Levels of the Anti-inflammatory Protein CC10 Are Associated with Improvement in Bronchial Dysplasia and Sputum Cytometric Assessment in Individuals at High Risk for Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Sputum; Medicine; Lung cancer; Dysplasia; Lung; Cancer; Immunology; Pathology; Internal medicine; Tuberculosis","score_opus":0.10749661215189232,"score_gpt":0.4445755469010139,"score_spread":0.3370789347491216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040800786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948861,0.00080939056,0.000006931592,0.0011917831,0.00015376043,0.0027164249,0.00018515959,0.000008090239,0.00004235216],"genre_scores_gemma":[0.9973546,0.00058799644,0.00011052233,0.000052001622,0.00028232048,0.0007490686,0.0000074535365,0.000035533045,0.00082047394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659574,0.0004017931,0.0008413613,0.0005057154,0.0010886381,0.0005667576],"domain_scores_gemma":[0.99779814,0.0010016969,0.00038222419,0.00028698277,0.00036657613,0.00016437161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036651848,0.00017885554,0.0007099835,0.00033331447,0.00016193585,0.000014685264,0.00019411689,0.00023737368,0.00027412342],"category_scores_gemma":[0.00082079833,0.00011648456,0.000107044725,0.0011964691,0.00040152555,0.00005594464,0.0002460042,0.0012247051,3.63262e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034796514,0.000347758,0.9921661,0.0002305657,0.0001541119,0.0000138796,0.00010423709,0.000039438713,0.0031579845,0.000012096264,0.00045267362,0.0029731607],"study_design_scores_gemma":[0.008882542,0.000581781,0.98007303,0.0011026688,0.000051629366,9.247502e-7,0.000040734452,0.00033615337,0.008522559,0.000026889655,0.00024569244,0.00013538104],"about_ca_topic_score_codex":0.0018566067,"about_ca_topic_score_gemma":0.0021605897,"teacher_disagreement_score":0.012093085,"about_ca_system_score_codex":0.0011664282,"about_ca_system_score_gemma":0.0012614109,"threshold_uncertainty_score":0.53208023},"labels":[],"label_agreement":null},{"id":"W2041226144","doi":"10.1158/1078-0432.ccr-10-1058","title":"DNA Ploidy Cytometry Testing for Cervical Cancer Screening in China – Letter","year":2010,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"False positive paradox; Medicine; Cancer; Table (database); False positive rate; Value (mathematics); Predictive value; Oncology; Statistics; Internal medicine; Mathematics; Computer science; Data mining","score_opus":0.39731410712005494,"score_gpt":0.5679452778277423,"score_spread":0.17063117070768735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041226144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022841297,0.0031625365,0.00013118185,0.957692,0.0019076959,0.0046077017,0.0006111594,0.00017358157,0.008872817],"genre_scores_gemma":[0.042726852,0.0016138859,0.0026542714,0.8093089,0.11831871,0.007931296,0.0006903868,0.0007989444,0.015956784],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870333,0.0009881059,0.0020974851,0.002507427,0.003908755,0.0034648906],"domain_scores_gemma":[0.9851484,0.009616745,0.0002796216,0.0016352934,0.0023632261,0.0009567222],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008548054,0.0007608134,0.0023350294,0.0016144627,0.00044324578,0.00027470672,0.001539769,0.005289769,0.011968939],"category_scores_gemma":[0.009314734,0.0006511534,0.000888155,0.0029683723,0.0015014955,0.00016772565,0.0010523127,0.045172855,0.0001449593],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018633447,0.00024334695,0.0887645,0.002424199,0.00020811854,0.0006704153,0.000044361543,0.0000025486936,0.0002487109,0.000005179262,0.74941987,0.15610538],"study_design_scores_gemma":[0.0051381257,0.0010198859,0.22531518,0.0008645376,0.00012151863,0.00001562875,0.000014586266,0.0005478322,0.00017880663,0.00030159033,0.7658591,0.00062316086],"about_ca_topic_score_codex":0.00788323,"about_ca_topic_score_gemma":0.0030713915,"teacher_disagreement_score":0.15548222,"about_ca_system_score_codex":0.00083831884,"about_ca_system_score_gemma":0.0035432272,"threshold_uncertainty_score":0.999594},"labels":[],"label_agreement":null},{"id":"W2041997366","doi":"10.1158/1078-0432.ccr-07-4427","title":"Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Pyrogenesis (Canada)","funders":"National Cancer Institute","keywords":"Ex vivo; In vivo; Histone deacetylase; Pharmacology; Pharmacodynamics; In vitro; Acetylation; Histone deacetylase inhibitor; Chemistry; Pharmacokinetics; Molecular biology; Cancer research; Biochemistry; Medicine; Histone; Biology","score_opus":0.4481591514104984,"score_gpt":0.5729885176329691,"score_spread":0.1248293662224707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041997366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956963,0.0013435833,0.0009094873,0.00015310418,0.0003350706,0.0011596137,0.000092715825,0.0000049259816,0.0003052095],"genre_scores_gemma":[0.99838775,0.00015368416,0.0003722868,0.00006758702,0.00057483977,0.00014725189,0.000020054416,0.000037249843,0.00023931339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99273425,0.0028840392,0.0008597915,0.00065764744,0.0024183942,0.00044589269],"domain_scores_gemma":[0.99582624,0.00091189204,0.00017857317,0.0008984334,0.0019523439,0.00023250695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0098152915,0.00014989346,0.00038299616,0.00010776483,0.0002499948,0.000010866555,0.0007694389,0.00031431558,0.000088233086],"category_scores_gemma":[0.0047061928,0.00012106786,0.00029463958,0.0004587733,0.0011335087,0.000008752067,0.0006996473,0.00074448343,0.0000066829534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002963007,0.00051068916,0.0014949508,0.000044921104,0.0001343116,0.0000014864207,0.00013418021,0.0034442733,0.9900547,0.000012874429,0.0014444673,0.0024268378],"study_design_scores_gemma":[0.0031057023,0.00062574283,0.005374257,0.00021198008,0.00009859027,0.0000022406641,0.00002306683,0.03310559,0.9561352,0.00029084322,0.00084084156,0.0001859475],"about_ca_topic_score_codex":0.0018405904,"about_ca_topic_score_gemma":0.00047812663,"teacher_disagreement_score":0.03391951,"about_ca_system_score_codex":0.00019037742,"about_ca_system_score_gemma":0.0022009225,"threshold_uncertainty_score":0.5634092},"labels":[],"label_agreement":null},{"id":"W2043131346","doi":"10.1158/1078-0432.ccr-09-0552","title":"Tissue Targeting in Cancer: eIF4E's Tale","year":2009,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cancer; Medicine; Biology; Cancer research; Internal medicine","score_opus":0.17645282955450728,"score_gpt":0.5362094550445523,"score_spread":0.35975662549004506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043131346","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09842427,0.12752669,0.00008495676,0.75738144,0.0059714927,0.0026174777,0.0008064636,0.00010716709,0.0070800288],"genre_scores_gemma":[0.08221554,0.064363785,0.00078048045,0.6711502,0.12263441,0.0026654634,0.002248885,0.00066465494,0.05327659],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929493,0.0012475457,0.0011896259,0.0018000846,0.0011941366,0.0016192779],"domain_scores_gemma":[0.997329,0.00043563903,0.00027716914,0.0011258584,0.0005984041,0.00023395434],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0036051357,0.00048248508,0.0008328024,0.0002548467,0.0001680642,0.000107836946,0.0015083975,0.002601519,0.00095052604],"category_scores_gemma":[0.0012293861,0.0004836993,0.00030821058,0.0005519444,0.00069203775,0.000007658123,0.00054664677,0.0064226845,0.00011434222],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017619545,0.00007789864,0.0027596266,0.00015543871,0.00008161345,0.0002564211,0.000017843091,0.00006914602,0.009116034,0.000001550277,0.9589101,0.028378153],"study_design_scores_gemma":[0.00082260557,0.0006948752,0.0004915954,0.00036077717,0.000021201131,0.0000033712245,0.000010777177,0.000015739422,0.014782839,0.00014440657,0.9820946,0.0005571968],"about_ca_topic_score_codex":0.0021806452,"about_ca_topic_score_gemma":0.0007411319,"teacher_disagreement_score":0.11666292,"about_ca_system_score_codex":0.0004347754,"about_ca_system_score_gemma":0.0020644807,"threshold_uncertainty_score":0.99996275},"labels":[],"label_agreement":null},{"id":"W2044240004","doi":"10.1158/1078-0432.ccr-11-2863","title":"Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"XRCC1; Cohort; Cancer; Medicine; Internal medicine; Immunohistochemistry; Oncology; Chemotherapy; Adjuvant; Biology; Gene; Genotype; Genetics","score_opus":0.09206586708181473,"score_gpt":0.46933410214475746,"score_spread":0.3772682350629427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044240004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982936,0.016154405,0.000024324512,0.00010201988,0.00008006784,0.00033456757,0.000049010174,0.000003820745,0.00031573712],"genre_scores_gemma":[0.9941637,0.004900142,0.00018864026,0.000030189625,0.00026401874,0.00025896358,0.0000069130215,0.000014330197,0.00017312766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985659,0.00029066118,0.00025712655,0.00030186202,0.00021209147,0.0003723208],"domain_scores_gemma":[0.9992135,0.00019406708,0.00004928913,0.0002046598,0.00012348818,0.00021495167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012001591,0.00008027884,0.00016684971,0.00006798327,0.00004281,0.000007986266,0.00011982989,0.0001642733,0.00004304805],"category_scores_gemma":[0.0008100554,0.00006838003,0.000032337914,0.00015732521,0.0003083049,0.0000071359273,0.00034932382,0.00029151552,0.0000012220283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029275243,0.00017831419,0.751719,0.000040223375,0.000029999337,9.999125e-7,0.00012216347,0.0000048906086,0.23056473,0.00004817007,0.00039658224,0.016602192],"study_design_scores_gemma":[0.0013061207,0.0010952229,0.8733714,0.00021541568,0.000027665303,0.000004849593,0.0005181395,0.0002640737,0.11636938,0.0004998324,0.0061483197,0.00017957245],"about_ca_topic_score_codex":0.0001784009,"about_ca_topic_score_gemma":0.00009959689,"teacher_disagreement_score":0.121652424,"about_ca_system_score_codex":0.000018499912,"about_ca_system_score_gemma":0.00016431347,"threshold_uncertainty_score":0.2788457},"labels":[],"label_agreement":null},{"id":"W2045088884","doi":"10.1158/1078-0432.ccr-14-1961","title":"Improvements in Radiographic Progression-Free Survival Stratified by <i>ERG</i> Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Abiraterone acetate; Prostate cancer; Medicine; Abiraterone; Oncology; Cancer; Internal medicine; Castration; Urology; Androgen deprivation therapy; Hormone","score_opus":0.15304353272124482,"score_gpt":0.47019087363733947,"score_spread":0.31714734091609464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045088884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868815,0.0056169643,0.0000013644485,0.0016960672,0.00019255346,0.004545482,0.0007173044,0.000047308906,0.00030147127],"genre_scores_gemma":[0.98807526,0.0062797735,0.00020129282,0.00010314579,0.00010155556,0.0030291043,0.0006136469,0.00009666785,0.0014995625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99184096,0.0011771059,0.0013467756,0.0011893311,0.0026464625,0.0017993931],"domain_scores_gemma":[0.9961549,0.00038172078,0.0002392343,0.00077685126,0.0012996128,0.0011476647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035111564,0.00044646702,0.0010037184,0.0006591676,0.00014647035,0.00014507561,0.00041316717,0.00018894626,0.00011119716],"category_scores_gemma":[0.0004253775,0.00030461673,0.00011245842,0.0025236057,0.00087394856,0.00034525807,0.00020227971,0.0014306346,0.000012824652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026299037,0.0030072245,0.9464226,0.00025753767,0.0003428644,0.00046204627,0.0004966975,0.000033551834,0.00492665,0.0000071484737,0.0032471118,0.014497525],"study_design_scores_gemma":[0.111473285,0.0150087485,0.8536598,0.0014823177,0.00019000519,0.0000031058498,0.0010333307,0.00037692537,0.013198081,0.0002985846,0.0024427574,0.00083303824],"about_ca_topic_score_codex":0.0144333765,"about_ca_topic_score_gemma":0.01695212,"teacher_disagreement_score":0.09276279,"about_ca_system_score_codex":0.0012345094,"about_ca_system_score_gemma":0.003441041,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W2047393760","doi":"10.1158/1078-0432.ccr-10-1962","title":"Evaluating Patient-Centered Outcomes in the Randomized Controlled Trial and Beyond: Informing the Future with Lessons from the Past","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"American Society of Clinical Oncology","keywords":"Randomized controlled trial; Medicine; Population; Perspective (graphical); Alternative medicine; Clinical trial; Outcome (game theory); Intensive care medicine; Internal medicine; Pathology; Computer science; Artificial intelligence","score_opus":0.32007105933268865,"score_gpt":0.5863388468956071,"score_spread":0.26626778756291847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047393760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020384112,0.9382634,2.5310297e-7,0.018580439,0.00088883785,0.021027459,0.00008551715,0.00001084514,0.0007591496],"genre_scores_gemma":[0.0030509739,0.9796271,0.000022218164,0.00076317706,0.0022720338,0.013990194,0.000037470614,0.000035744215,0.0002010921],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99078447,0.0049458113,0.0016958545,0.0005641835,0.0014817284,0.0005279391],"domain_scores_gemma":[0.95566636,0.042474315,0.0006143636,0.000807166,0.0003297213,0.000108091284],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012997369,0.00043490872,0.005110197,0.0000909874,0.00062424387,0.00017513754,0.0005442701,0.00032746387,0.000083822255],"category_scores_gemma":[0.0049027554,0.00011739762,0.0010942523,0.00040052857,0.0012366291,0.000043983007,0.00032521103,0.0037532193,0.0000048069487],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36314917,0.00015029138,0.0004552243,0.00016649031,0.0011905052,0.000013602872,0.0008014618,3.8627856e-8,7.842021e-9,0.000028275674,0.0003932558,0.6336517],"study_design_scores_gemma":[0.64270127,0.0013271997,0.000377599,0.0019526969,0.0026038152,0.0000055671026,0.001508196,0.000009378319,1.1151992e-8,0.000057857094,0.34932706,0.00012936945],"about_ca_topic_score_codex":0.0007408393,"about_ca_topic_score_gemma":0.004237229,"teacher_disagreement_score":0.63352233,"about_ca_system_score_codex":0.00014765513,"about_ca_system_score_gemma":0.0012920982,"threshold_uncertainty_score":0.99854517},"labels":[],"label_agreement":null},{"id":"W2047895823","doi":"10.1158/1078-0432.tcme10-a8","title":"Abstract A8: GPNMB is an independent prognostic indicator of recurrence and a therapeutic target in triple negative breast cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Armand Frappier Museum; Institut National de la Recherche Scientifique; McGill University","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Cancer; Cancer research; Tissue microarray; CA15-3; CA 15-3; Antibody-drug conjugate; Oncology; Metastasis; Internal medicine; Biomarker; Clinical significance; Antibody; Immunology; Biology; Monoclonal antibody","score_opus":0.10659314455077115,"score_gpt":0.4912167240344509,"score_spread":0.38462357948367976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047895823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955655,0.0022749507,0.0000021169596,0.00065210665,0.00014730154,0.0007348357,0.0004994732,0.00000447465,0.00011924049],"genre_scores_gemma":[0.995484,0.0034972057,0.00006053076,0.00010637481,0.0002576192,0.0004572832,0.000026081738,0.00002291521,0.00008801514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975313,0.00026725183,0.00042851706,0.00068356184,0.0005485413,0.00054085633],"domain_scores_gemma":[0.9986222,0.00018258869,0.0001133702,0.00042206887,0.000292491,0.00036728667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015095096,0.00015563337,0.00027952256,0.00013639643,0.00008652271,0.000040792074,0.00038539062,0.00025966714,0.0005941764],"category_scores_gemma":[0.0003389651,0.00012960035,0.00007636579,0.00028685373,0.0007360443,0.000013697938,0.00021631851,0.0010082717,0.000007807414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017021572,0.00077423983,0.8846419,0.000073471245,0.000130519,0.000014147412,0.00020737686,0.0000015596885,0.03248015,0.000018226534,0.0005103597,0.079445876],"study_design_scores_gemma":[0.0023844517,0.00077925494,0.96939284,0.000070040966,0.000010268508,0.0000046560576,0.00009267933,0.000041540028,0.025315424,0.0005788739,0.0011703986,0.00015954507],"about_ca_topic_score_codex":0.006032384,"about_ca_topic_score_gemma":0.013531629,"teacher_disagreement_score":0.08475096,"about_ca_system_score_codex":0.000049691964,"about_ca_system_score_gemma":0.0012096171,"threshold_uncertainty_score":0.91192},"labels":[],"label_agreement":null},{"id":"W2048460059","doi":"10.1158/1078-0432.ccr-07-4530","title":"Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Matrigel; In vivo; Integrin; Cancer research; Medicine; Pharmacology; Chemistry; Biology; Internal medicine; Receptor","score_opus":0.3295201294263861,"score_gpt":0.496083023901811,"score_spread":0.16656289447542494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048460059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467206,0.0014001223,0.000062501895,0.002183897,0.00012259386,0.001403382,0.00007608537,0.000010334832,0.000069014575],"genre_scores_gemma":[0.9959108,0.002314647,0.0007514393,0.00021560935,0.00014117036,0.00011173179,0.000007429781,0.00004300151,0.0005041712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993199,0.0022223257,0.0017785121,0.0006593806,0.0015134042,0.00062737765],"domain_scores_gemma":[0.99160963,0.0056507383,0.00035806763,0.000618976,0.0014483734,0.00031419372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069756475,0.00020039079,0.0009942048,0.00036573655,0.000088495945,0.0000051511147,0.00058201444,0.0002778337,0.00025390086],"category_scores_gemma":[0.0049071996,0.0001528614,0.00050114683,0.0016739978,0.0022583944,0.000109033965,0.0006894336,0.0010012797,0.000004294157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024474038,0.0016425544,0.54119676,0.00041931533,0.00021152494,0.00006792136,0.00036521282,0.00013488148,0.4296577,0.000043330318,0.0010381214,0.0007486054],"study_design_scores_gemma":[0.0071998583,0.0014380225,0.9188847,0.00027517017,0.00007889186,0.000031813048,0.00007153522,0.013277134,0.058336295,0.00011889746,0.00015115886,0.00013654455],"about_ca_topic_score_codex":0.0018106565,"about_ca_topic_score_gemma":0.00022498787,"teacher_disagreement_score":0.3776879,"about_ca_system_score_codex":0.00014940169,"about_ca_system_score_gemma":0.0019793566,"threshold_uncertainty_score":0.83211476},"labels":[],"label_agreement":null},{"id":"W2049601932","doi":"10.1158/1078-0432.ccr-13-0545","title":"Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":451,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CTLA-4; Medicine; Pharmacology; Immunology; Cancer research; Immune system; T cell","score_opus":0.09677112979043904,"score_gpt":0.45525412799294873,"score_spread":0.3584829982025097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049601932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272245,0.005136814,0.00011315106,0.0012979265,0.00012761571,0.00025225015,0.000008578231,0.0000050232534,0.00033621528],"genre_scores_gemma":[0.9934437,0.005224481,0.00007939442,0.00011592814,0.0006915411,0.000042334934,0.0000063551997,0.000013730779,0.00038250664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983853,0.0003572637,0.00030262046,0.00035994235,0.00026823665,0.00032663404],"domain_scores_gemma":[0.9989353,0.00029348294,0.00009817139,0.00028677366,0.00029189084,0.00009437206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016007279,0.000099051045,0.00021619568,0.00003093306,0.00017499135,0.00004073217,0.00028652165,0.00012764933,0.00022249216],"category_scores_gemma":[0.0004286814,0.000065730055,0.00007485243,0.00013666056,0.0005916551,0.000009718762,0.00031204708,0.0003589211,0.00001606976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060827744,0.000078552424,0.041305132,0.000049690232,0.000059403937,0.0000023292014,0.000025071373,0.000023630659,0.9345482,0.000026364769,0.020737542,0.0030832486],"study_design_scores_gemma":[0.00070280256,0.00042372182,0.11136118,0.00006632739,0.00002068497,0.0000044588924,0.00017973414,0.00033306243,0.87117785,0.00018140471,0.015325795,0.00022297514],"about_ca_topic_score_codex":0.0006194016,"about_ca_topic_score_gemma":0.000008199743,"teacher_disagreement_score":0.07005605,"about_ca_system_score_codex":0.0000057461925,"about_ca_system_score_gemma":0.00014678974,"threshold_uncertainty_score":0.2680394},"labels":[],"label_agreement":null},{"id":"W2049810240","doi":"10.1158/1078-0432.ccr-04-0438","title":"Effects of the Steroidal Aromatase Inhibitor Exemestane and the Nonsteroidal Aromatase Inhibitor Letrozole on Bone and Lipid Metabolism in Ovariectomized Rats","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Endocrinology; Internal medicine; Ovariectomized rat; Bone remodeling; Osteocalcin; Medicine; Aromatase inhibitor; Letrozole; Osteoporosis; Bone resorption; Bone mineral; Bone density; Osteopenia; Pyridinoline; Estrogen; Aromatase; Chemistry; Breast cancer; Cancer; Alkaline phosphatase","score_opus":0.01997192011029481,"score_gpt":0.3525607030916615,"score_spread":0.3325887829813667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049810240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854754,0.011646281,0.0000054100005,0.001273316,0.00036081747,0.0011430182,0.000046699286,0.0000064080705,0.000042636337],"genre_scores_gemma":[0.9961771,0.0027506289,0.00004580504,0.00024815626,0.00049944804,0.0001591965,0.000027147877,0.000026335363,0.00006622355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99682885,0.0012533189,0.000548085,0.0005243632,0.0004208579,0.00042451962],"domain_scores_gemma":[0.99839383,0.0007070736,0.00013142581,0.0005043692,0.00008124637,0.00018205757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023977044,0.00020706981,0.00048011675,0.000083013765,0.00016893791,0.0000515628,0.00024985234,0.0003174491,0.0000029093746],"category_scores_gemma":[0.0010969781,0.00011573143,0.00015260713,0.00026662793,0.0015391674,0.000009739724,0.0004980721,0.0009202671,0.000004788942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018444361,0.00081024313,0.0020239085,0.0002793433,0.00021536826,0.00009347852,0.00021850155,0.000037793514,0.97025436,0.0005224305,0.0017297013,0.0053704847],"study_design_scores_gemma":[0.041019358,0.0015257288,0.021697951,0.00052017724,0.00009944226,0.00003686334,0.000093003895,0.000048775913,0.9308458,0.00044963884,0.0033570435,0.0003062208],"about_ca_topic_score_codex":0.00018318156,"about_ca_topic_score_gemma":0.0000792751,"teacher_disagreement_score":0.03940859,"about_ca_system_score_codex":0.00002456478,"about_ca_system_score_gemma":0.00024899174,"threshold_uncertainty_score":0.5671126},"labels":[],"label_agreement":null},{"id":"W2050433141","doi":"10.1158/1078-0432.ccr-04-1751","title":"Preclinical Evaluation of the Pharmacodynamic Properties of 2,5-Diaziridinyl-3-Hydroxymethyl-6-Methyl-1,4-Benzoquinone","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"In vivo; Comet assay; DNA damage; Pharmacology; Cytotoxicity; Cisplatin; Mitomycin C; DNA; Topoisomerase; In vitro; Chemistry; Biochemistry; Biology; Chemotherapy","score_opus":0.7834550027564526,"score_gpt":0.6806333684334336,"score_spread":0.10282163432301905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050433141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828763,0.0077962955,0.0000068651543,0.0038954138,0.0015336786,0.0011305393,0.000080299666,0.000020369418,0.0026602133],"genre_scores_gemma":[0.994806,0.00276096,0.000058536967,0.00045811935,0.00086295337,0.0001675188,0.0000035392222,0.000027679007,0.00085471437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9894088,0.006724387,0.0013206713,0.00052179553,0.0014468012,0.0005775297],"domain_scores_gemma":[0.995568,0.0015856058,0.00042693786,0.0005180265,0.0016697138,0.00023173286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.020435091,0.0001986598,0.00053670513,0.000137689,0.0002787966,0.000014237192,0.0010110514,0.00041506,0.002376436],"category_scores_gemma":[0.0020821954,0.00013440696,0.00040127404,0.00064329966,0.0024150724,0.00014147552,0.0005051706,0.0022018827,0.000055853016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024002923,0.0036872611,0.11519733,0.00030713566,0.00081027276,0.0000021598858,0.0005299769,0.0024052423,0.48153523,0.00042286149,0.011317762,0.38138446],"study_design_scores_gemma":[0.008088458,0.0006089941,0.08488297,0.00036173634,0.0007122849,0.000004004666,0.00020176463,0.08802873,0.73818254,0.00073936407,0.07778257,0.00040656436],"about_ca_topic_score_codex":0.00012260034,"about_ca_topic_score_gemma":0.00014018438,"teacher_disagreement_score":0.3809779,"about_ca_system_score_codex":0.00019517766,"about_ca_system_score_gemma":0.0010328448,"threshold_uncertainty_score":0.9985355},"labels":[],"label_agreement":null},{"id":"W2050883767","doi":"10.1158/1078-0432.ccr-07-4992","title":"Shedding of Distinct Cryptic Collagen Epitope (HU177) in Sera of Melanoma Patients","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epitope; Melanoma; Angiogenesis; In vivo; Medicine; Extracellular matrix; Pathology; Clinical significance; Immunology; Antibody; Biology; Internal medicine; Cancer research","score_opus":0.13522927311187388,"score_gpt":0.4640377832935589,"score_spread":0.328808510181685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050883767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963746,0.002299037,0.000014082363,0.00007778724,0.00014258808,0.00022113128,0.000041462947,0.000001969571,0.00082735496],"genre_scores_gemma":[0.9960072,0.0031349794,0.00011434217,0.000041261905,0.0002323672,0.000047885034,0.00002357321,0.000017949242,0.00038045182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981182,0.0002742599,0.0006040271,0.00034511677,0.0003563142,0.0003020383],"domain_scores_gemma":[0.9988523,0.00016241004,0.00011909645,0.00034367843,0.00042487515,0.00009762508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010020863,0.000093834155,0.0003009565,0.00007102993,0.00005736001,0.0000035894163,0.00030581251,0.00017540784,0.00017047592],"category_scores_gemma":[0.0005984693,0.000082793675,0.00014903561,0.00027938982,0.00045675563,0.000003421941,0.00022895896,0.00012777033,0.000006375574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046069254,0.00027163827,0.97270393,0.00006078871,0.00004322513,0.000005058022,0.000048078793,0.000023766514,0.016929645,0.000019088162,0.0030638943,0.0063701877],"study_design_scores_gemma":[0.0014940624,0.0010403442,0.9308254,0.000088318,0.000008832249,7.7913523e-7,0.000043480333,0.000042863277,0.0553966,0.000045047636,0.010868796,0.00014546727],"about_ca_topic_score_codex":0.0003728704,"about_ca_topic_score_gemma":0.00018476191,"teacher_disagreement_score":0.04187853,"about_ca_system_score_codex":0.00003801444,"about_ca_system_score_gemma":0.000374753,"threshold_uncertainty_score":0.3376228},"labels":[],"label_agreement":null},{"id":"W2051474057","doi":"10.1158/1078-0432.tcmusa10-a53","title":"Abstract A53: Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: Potential regulation through targeting rho proteins","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"RHOA; Lovastatin; Gefitinib; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; EGFR inhibitors; Epidermal growth factor receptor; Chemistry; Farnesyl pyrophosphate; Actin cytoskeleton; Geranylgeranyl pyrophosphate; Erlotinib; Farnesyltransferase inhibitor; Cell biology; Pharmacology; Signal transduction; Biology; Farnesyltransferase; Cell; Cytoskeleton; Biochemistry; Receptor; Prenylation; Cholesterol","score_opus":0.04603905007341682,"score_gpt":0.38712713739721655,"score_spread":0.34108808732379975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051474057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953599,0.0004870509,0.0005271264,0.00034294848,0.0020254094,0.0006472226,0.000017080396,0.00001024135,0.00058304984],"genre_scores_gemma":[0.9899415,0.00035241197,0.0006635502,0.00008327059,0.008300462,0.00010719778,0.00013353268,0.0000342507,0.00038385365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785155,0.00024022521,0.0005261615,0.00060236856,0.00036946716,0.00041020467],"domain_scores_gemma":[0.99907446,0.00009933221,0.00015539803,0.00028701324,0.00026102178,0.0001227645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014359776,0.00014956854,0.00020516296,0.000071918905,0.00022901827,0.00009982602,0.00015281072,0.0003480032,0.00006746505],"category_scores_gemma":[0.00052414084,0.00014891865,0.00007123869,0.00023402926,0.00025608702,0.000027747556,0.0001418107,0.000747504,0.0000069863004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036278376,0.00027328913,0.0037643893,0.00007853759,0.0000047084336,2.2217786e-7,0.0001289865,0.00008121532,0.98197144,0.000025606883,0.0043300577,0.00897878],"study_design_scores_gemma":[0.0037892705,0.00027296867,0.07705134,0.000028102884,0.00001008727,9.136864e-7,0.00017347524,0.00029059386,0.8585816,0.00022961885,0.05929832,0.00027370238],"about_ca_topic_score_codex":0.0017286139,"about_ca_topic_score_gemma":0.0009488661,"teacher_disagreement_score":0.123389825,"about_ca_system_score_codex":0.000032907097,"about_ca_system_score_gemma":0.00036228145,"threshold_uncertainty_score":0.6072726},"labels":[],"label_agreement":null},{"id":"W2051976171","doi":"10.1158/1078-0432.ccr-10-2210","title":"Rapid Diagnosis of Medulloblastoma Molecular Subgroups","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; Cancer Research UK; Children's Cancer and Leukaemia Group","keywords":"PTCH1; Medulloblastoma; Sonic hedgehog; Wnt signaling pathway; Biology; Pathology; Cancer research; DNA methylation; Oncology; Internal medicine; Genetics; Medicine; Gene; Gene expression","score_opus":0.31504301951135183,"score_gpt":0.49966772303043416,"score_spread":0.18462470351908233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051976171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98574173,0.0052908,0.0000040792365,0.0015752481,0.00017247505,0.000559488,0.000016940372,0.000024921063,0.0066143298],"genre_scores_gemma":[0.9929807,0.0054911925,0.00040645004,0.0002498024,0.00013908921,0.00061573536,0.0000053640733,0.000029072313,0.00008254763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747294,0.0003195951,0.0005787157,0.0004182394,0.00076162233,0.00044886116],"domain_scores_gemma":[0.99765015,0.0007479695,0.00008197981,0.0005931746,0.0005178984,0.0004088488],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015729546,0.00012503647,0.0004876551,0.00018819286,0.000053794516,0.0000075607018,0.00020770417,0.00015919034,0.0038980483],"category_scores_gemma":[0.0008673844,0.000094618386,0.0002990485,0.00050634413,0.0005412251,0.000037091493,0.00014736217,0.00046012035,0.0001555963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008773846,0.0030894342,0.88707995,0.000109714914,0.00034853685,0.00056265143,0.00017119586,2.5071978e-7,0.0008532333,0.0011359451,0.008480313,0.09729141],"study_design_scores_gemma":[0.004250255,0.004124412,0.7722281,0.00037102198,0.00018051127,0.000011918991,0.0001302104,0.000017343627,0.20195736,0.00086985616,0.015704205,0.00015480682],"about_ca_topic_score_codex":0.0009305869,"about_ca_topic_score_gemma":0.00007960106,"teacher_disagreement_score":0.20110412,"about_ca_system_score_codex":0.00008394276,"about_ca_system_score_gemma":0.0002609899,"threshold_uncertainty_score":0.9970125},"labels":[],"label_agreement":null},{"id":"W2052404621","doi":"10.1158/1078-0432.tcmusa10-pr5","title":"Abstract PR5: Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes integrating tumor and microenvironment","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Univariate; Oncology; Medicine; Lymphoma; Stromal cell; Survival analysis; Internal medicine; Cancer research; Biology; Machine learning; Computer science; Multivariate statistics","score_opus":0.09799676627710484,"score_gpt":0.4264810766183701,"score_spread":0.32848431034126524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052404621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997772,0.0002520831,0.000002395682,0.0007600001,0.00011874754,0.00052818534,0.000074042044,0.000004888749,0.0004876818],"genre_scores_gemma":[0.999111,0.00038806352,0.00012044666,0.00007367135,0.0001113271,0.0001387919,0.000009594003,0.000013144436,0.000033935878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821204,0.0002405233,0.0005070979,0.00028616143,0.00051989144,0.00023430811],"domain_scores_gemma":[0.9974332,0.0018903248,0.00012251678,0.00036224542,0.000076990626,0.00011471409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002251567,0.00010089377,0.00030125908,0.000083597464,0.000059528174,0.000009209659,0.00010278907,0.00007608821,0.00019337755],"category_scores_gemma":[0.00043812935,0.000057216934,0.000084753236,0.00011225869,0.00028468572,0.000024649315,0.00008376399,0.0003380155,0.0000033246713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081645016,0.010289982,0.857956,0.00011615711,0.000013324191,0.000022454955,0.0000929314,0.0000023841865,0.11813712,0.000047056565,0.00018341556,0.012322754],"study_design_scores_gemma":[0.014123804,0.00057879585,0.80740845,0.00034259626,0.000015918175,7.928055e-7,0.00016313962,0.0006576354,0.17605095,0.000021714608,0.0005970304,0.000039148123],"about_ca_topic_score_codex":0.0005871242,"about_ca_topic_score_gemma":0.0003206761,"teacher_disagreement_score":0.057913832,"about_ca_system_score_codex":0.00009064288,"about_ca_system_score_gemma":0.00020302064,"threshold_uncertainty_score":0.23332389},"labels":[],"label_agreement":null},{"id":"W2053290453","doi":"10.1158/1078-0432.ccr-07-0835","title":"Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":65,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society; U.S. Department of Defense","keywords":"Vorinostat; Imatinib mesylate; Sorafenib; Cancer research; Chronic myelogenous leukemia; Histone deacetylase inhibitor; Imatinib; Histone deacetylase; Pharmacology; Biology; Chemistry; Leukemia; Myeloid leukemia; Immunology; Histone; Biochemistry","score_opus":0.18198482242363437,"score_gpt":0.5002775618152996,"score_spread":0.31829273939166525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053290453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944753,0.002812532,0.00008764485,0.0006021439,0.0002493759,0.00092620176,0.000030583462,0.000039400005,0.0007768321],"genre_scores_gemma":[0.9946236,0.0023601018,0.00026761956,0.00008181352,0.0010911175,0.000072409006,0.000053858785,0.000041653882,0.0014078481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966742,0.00028329605,0.0008715698,0.0007423403,0.0006021784,0.00082644605],"domain_scores_gemma":[0.99553627,0.0030931046,0.00011197131,0.00047120333,0.0002429776,0.0005444772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028727897,0.00022003449,0.00057325774,0.00040322577,0.00018663528,0.000046032477,0.00013618996,0.00027322577,0.00025112322],"category_scores_gemma":[0.0006266765,0.00019720076,0.00008086809,0.000554371,0.00073711644,0.00013521232,0.00024329821,0.0014424946,0.0000710997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014939759,0.00028232342,0.68047285,0.0005409157,0.00031649522,0.00036538945,0.0008139541,0.00006733191,0.014939165,0.00023939513,0.0018791677,0.29858902],"study_design_scores_gemma":[0.007752796,0.0011842217,0.97143596,0.00058654044,0.00014243141,0.00001909972,0.00021013147,0.0009783524,0.0063263937,0.0006280632,0.010473642,0.00026236614],"about_ca_topic_score_codex":0.005002278,"about_ca_topic_score_gemma":0.0073330407,"teacher_disagreement_score":0.29832664,"about_ca_system_score_codex":0.005755413,"about_ca_system_score_gemma":0.0023307467,"threshold_uncertainty_score":0.9980613},"labels":[],"label_agreement":null},{"id":"W2053442386","doi":"10.1158/1078-0432.ccr-07-1305","title":"High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council; University of Toronto","keywords":"CDKN2A; Comparative genomic hybridization; PDGFRA; Cancer research; Biology; Neurofibromatosis; Copy number analysis; Malignant peripheral nerve sheath tumor; Copy-number variation; Pathology; Tissue microarray; Microarray; Cancer; Gene; Medicine; Genetics; Gene expression","score_opus":0.24256511450375715,"score_gpt":0.45770958413560064,"score_spread":0.2151444696318435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053442386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974167,0.00047238867,0.0004641627,0.0002776957,0.00023065957,0.0009035664,0.000092154165,0.0000419737,0.00010070678],"genre_scores_gemma":[0.9922383,0.000092491005,0.0068491288,0.000111683694,0.0003937,0.000056198187,0.00010443754,0.000042621807,0.000111448615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99628127,0.0007352691,0.0010771004,0.00059682224,0.0007598396,0.0005496982],"domain_scores_gemma":[0.99784875,0.00038327574,0.00023975702,0.00040631354,0.0008343521,0.00028756235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012154925,0.0002026952,0.000789727,0.00014659483,0.00031677802,0.000023309069,0.00016734924,0.0001364324,0.00041835703],"category_scores_gemma":[0.0002829692,0.00017388319,0.00023333271,0.00057262176,0.00079412287,0.00010033016,0.000084652485,0.0006229635,0.000024869354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034340236,0.0006233198,0.43105218,0.00024876618,0.00008631191,0.00038128946,0.0001824351,0.0023118078,0.55904776,0.00011595572,0.002412301,0.00010383022],"study_design_scores_gemma":[0.004821118,0.001514793,0.22143404,0.0006494638,0.00007903403,0.00018061718,0.00020139401,0.030539617,0.73985785,0.00003704711,0.0003556684,0.00032932832],"about_ca_topic_score_codex":0.0010107538,"about_ca_topic_score_gemma":0.000016520822,"teacher_disagreement_score":0.20961812,"about_ca_system_score_codex":0.00032890774,"about_ca_system_score_gemma":0.0016210085,"threshold_uncertainty_score":0.7090751},"labels":[],"label_agreement":null},{"id":"W2053903430","doi":"10.1158/1078-0432.ccr-14-1370","title":"Molecular Pathways: GLI1-Induced Drug Glucuronidation in Resistant Cancer Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Glucuronidation; Cancer; Drug; Drug resistance; Biology; Cancer research; Computational biology; Medicine; Pharmacology; Genetics; In vitro","score_opus":0.3357610343445079,"score_gpt":0.5071455677267337,"score_spread":0.1713845333822258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053903430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867851,0.0029542076,0.000029483903,0.0051419684,0.0008349397,0.0008969474,0.000036211997,0.000058258225,0.0032628442],"genre_scores_gemma":[0.9956193,0.0014057775,0.00017598494,0.00045333375,0.0004965495,0.00030857613,0.0000289178,0.000056290308,0.001455246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99567693,0.00048211063,0.0008475012,0.0007167344,0.0014881681,0.0007885719],"domain_scores_gemma":[0.99766594,0.00022062055,0.00009874304,0.00061058585,0.00071143196,0.0006926683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004850301,0.00019978781,0.0005686937,0.00026152376,0.000079944635,0.0000385484,0.00031691857,0.00025473395,0.00026816345],"category_scores_gemma":[0.00035020555,0.0001648585,0.00017381384,0.000901685,0.00022694707,0.00009831327,0.0000824991,0.0013438214,0.0001066794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017425781,0.0029574877,0.042121757,0.0010527036,0.00030776652,0.0039362414,0.0032726533,0.0003685126,0.8388296,0.004446264,0.024267621,0.06101364],"study_design_scores_gemma":[0.022080256,0.0024036944,0.05057079,0.0028817744,0.00021365694,0.0000052625137,0.0035229744,0.0012498018,0.7979854,0.006632958,0.11128734,0.0011661035],"about_ca_topic_score_codex":0.0024347217,"about_ca_topic_score_gemma":0.0038894447,"teacher_disagreement_score":0.08701972,"about_ca_system_score_codex":0.00061511033,"about_ca_system_score_gemma":0.0024610772,"threshold_uncertainty_score":0.67227346},"labels":[],"label_agreement":null},{"id":"W2054855574","doi":"10.1158/1078-0432.ccr-06-2987","title":"Cytochrome P450 17A1 and Catechol <i>O</i>-Methyltransferase Polymorphisms and Age at Lynch Syndrome Colon Cancer Onset in Newfoundland","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Lynch syndrome; Colorectal cancer; Catechol-O-methyl transferase; Methyltransferase; Genetics; Cancer; Cytochrome P450; Medicine; Oncology; Internal medicine; Biology; Allele; Gene; DNA mismatch repair; Metabolism","score_opus":0.15631922591016315,"score_gpt":0.5010666176078626,"score_spread":0.3447473916976995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054855574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849312,0.009278758,0.000012146731,0.0031403522,0.00032608525,0.0015256985,0.00009797095,0.00004503455,0.0006427712],"genre_scores_gemma":[0.9875246,0.0085569145,0.0001813497,0.001037294,0.00028589778,0.00032317892,0.00001870029,0.00007034595,0.0020016734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953164,0.0003877176,0.0009880478,0.0010705735,0.0010521197,0.0011851332],"domain_scores_gemma":[0.9961842,0.0020354611,0.00008217495,0.00054080546,0.0002364724,0.000920908],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005100414,0.00031700937,0.0008911449,0.00044156756,0.0002193791,0.0000611961,0.00024863242,0.00052888814,0.00092125847],"category_scores_gemma":[0.0007401054,0.00027961654,0.00010601005,0.0009038396,0.0016028797,0.00008117826,0.0003260019,0.0017936096,0.0000272907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00506922,0.0002934459,0.9265033,0.00029325936,0.00011134993,0.002454868,0.00048141883,0.000003884439,0.046924554,0.000014329286,0.001787819,0.01606257],"study_design_scores_gemma":[0.005116756,0.0019099251,0.98125607,0.00040069598,0.000060600698,0.00030695772,0.000054673794,0.000027487487,0.0025616244,0.00017028795,0.007824888,0.00031006036],"about_ca_topic_score_codex":0.017856114,"about_ca_topic_score_gemma":0.07069718,"teacher_disagreement_score":0.05475276,"about_ca_system_score_codex":0.0013279158,"about_ca_system_score_gemma":0.00074399926,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W2054913636","doi":"10.1158/1078-0432.ccr-14-0341","title":"Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with <i>RAS–RAF</i> Mutations","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"KRAS; Medicine; MEK inhibitor; Colorectal cancer; Neuroblastoma RAS viral oncogene homolog; Melanoma; Cancer; Oncology; Internal medicine; Pharmacodynamics; Lung cancer; Adverse effect; Progressive disease; Cancer research; MAPK/ERK pathway; Pharmacokinetics; Kinase; Disease; Biology","score_opus":0.04652522395130103,"score_gpt":0.44238819226232884,"score_spread":0.3958629683110278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054913636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844176,0.00017903435,0.000028431747,0.00010749294,0.000109609195,0.0010150797,0.000052217103,0.000006428971,0.000059937465],"genre_scores_gemma":[0.9991706,0.00013034994,0.000052533287,0.00007102023,0.00010394671,0.0003122791,0.000040660852,0.000025969852,0.000092662776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781317,0.00058393,0.0003632452,0.0004888155,0.00042788585,0.0003229719],"domain_scores_gemma":[0.99876106,0.000121665566,0.00011665437,0.00033922723,0.00053454796,0.0001268515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006231678,0.00014289687,0.0002524717,0.00006045171,0.00012577287,0.000014804115,0.00021672965,0.0000904453,0.00001672107],"category_scores_gemma":[0.00021602793,0.00008801669,0.000029612163,0.0004795151,0.00030457834,0.000009795397,0.00015573628,0.0003802305,6.49386e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006039283,0.003996776,0.8031542,0.000071518,0.00011624811,0.0000038297017,0.00041438814,0.00037705075,0.12973946,0.000005904662,0.00045655473,0.055624805],"study_design_scores_gemma":[0.06600013,0.02764849,0.8186474,0.0003380747,0.00013008833,0.0000021603032,0.0007927629,0.0013512551,0.079675935,0.000030961226,0.0047881133,0.00059466425],"about_ca_topic_score_codex":0.000566184,"about_ca_topic_score_gemma":0.008907567,"teacher_disagreement_score":0.059960842,"about_ca_system_score_codex":0.000033188335,"about_ca_system_score_gemma":0.00036469518,"threshold_uncertainty_score":0.49706313},"labels":[],"label_agreement":null},{"id":"W2055340037","doi":"10.1158/1078-0432.ccr-14-1770","title":"Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Cyclophosphamide; Oncolytic virus; Medicine; Peripheral blood mononuclear cell; Neutralizing antibody; Titer; Antibody; Immunology; Immune system; Virology; Pharmacology; Chemotherapy; Internal medicine; Biology; In vitro","score_opus":0.1336147238726371,"score_gpt":0.5301574505187308,"score_spread":0.3965427266460937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055340037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576914,0.00067784626,0.00047851843,0.00042134695,0.00032257827,0.0019421425,0.000066048095,0.000015354317,0.00030703572],"genre_scores_gemma":[0.994832,0.0007194874,0.0009373482,0.0003910816,0.0016095288,0.00071110536,0.000057448964,0.0000809405,0.0006610894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955979,0.0009351613,0.0009772055,0.00087790686,0.0007494829,0.000862359],"domain_scores_gemma":[0.9966616,0.00052558887,0.00015156821,0.0011657975,0.000894526,0.0006009103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007768845,0.00020996532,0.00058034936,0.00016708193,0.00020985605,0.000049844035,0.0009246298,0.0002916622,0.00009839305],"category_scores_gemma":[0.0030247467,0.0002019809,0.00032213135,0.00034644376,0.0004206964,0.000011145496,0.00036496398,0.0004898656,0.000035970592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35443997,0.0014123695,0.00005800612,0.000054752374,0.00012524622,0.000004172751,0.000046204896,0.00075412256,0.53711027,0.000037347745,0.0011012803,0.10485627],"study_design_scores_gemma":[0.06387059,0.107946806,0.00007307414,0.00007916148,0.000022512884,0.0000015286553,0.00007394705,0.0020876797,0.8094817,0.00038987168,0.015623502,0.00034962973],"about_ca_topic_score_codex":0.00032856685,"about_ca_topic_score_gemma":0.00025687786,"teacher_disagreement_score":0.2905694,"about_ca_system_score_codex":0.00009786481,"about_ca_system_score_gemma":0.001275851,"threshold_uncertainty_score":0.8236542},"labels":[],"label_agreement":null},{"id":"W2055695109","doi":"10.1158/1078-0432.ccr-05-2130","title":"Irinotecan Inactivation Is Modulated by Epigenetic Silencing of<i>UGT1A1</i>in Colon Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Irinotecan; Epigenetics; Colorectal cancer; Gene silencing; Cancer; Medicine; Cancer research; Biology; Oncology; Internal medicine; Genetics","score_opus":0.10314148759952835,"score_gpt":0.48589279502434357,"score_spread":0.3827513074248152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055695109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993185,0.0047962815,0.00030651156,0.00062681484,0.0002196346,0.00038912368,0.00008858427,0.0000064198002,0.00038166952],"genre_scores_gemma":[0.99299824,0.0047957753,0.000060480477,0.00028162956,0.0003589148,0.00018507888,0.000043330685,0.000031796808,0.0012447648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979031,0.00021639506,0.0005389612,0.00051649765,0.00037250598,0.0004525186],"domain_scores_gemma":[0.9990466,0.000076873854,0.00012406266,0.0003584889,0.00030315996,0.00009079623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010214314,0.00013292955,0.00025669913,0.000088870154,0.00007012409,0.000017666207,0.00026170092,0.0002791348,0.00017788478],"category_scores_gemma":[0.0000635495,0.00013384418,0.00010133874,0.00036871785,0.0001968644,0.0000045263128,0.0001222469,0.00033769052,0.0000034181085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003331799,0.00019932099,0.007761642,0.000030581854,0.00003183666,0.0000012852499,0.000027278149,0.0002980517,0.9612089,0.00004871163,0.0036512597,0.026407944],"study_design_scores_gemma":[0.0011378897,0.00059342827,0.010608182,0.00006968147,0.000010394192,3.7412593e-7,0.00003776631,0.00042923258,0.95650333,0.00065825507,0.029780328,0.00017113131],"about_ca_topic_score_codex":0.010803631,"about_ca_topic_score_gemma":0.0027269053,"teacher_disagreement_score":0.026236814,"about_ca_system_score_codex":0.00014344032,"about_ca_system_score_gemma":0.00042921657,"threshold_uncertainty_score":0.9957835},"labels":[],"label_agreement":null},{"id":"W2057062854","doi":"10.1158/1078-0432.ovca13-b61","title":"Abstract B61: Proteomic profiling of ovarian cancer and mesothelial cells reveals novel mediators implicated in the metastatic progression of ovarian cancer to the peritoneum","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Ovarian cancer; Stromal cell; Proteome; Mesothelium; Mesothelial Cell; Cancer research; Biology; Cancer cell; Secretion; Cancer; Tumor microenvironment; Extracellular matrix; Cell culture; Proteomics; Transcriptome; Pathology; Medicine; Cell biology; Gene expression; Gene; Bioinformatics; Endocrinology; Biochemistry; Tumor cells; Genetics","score_opus":0.1030228359194799,"score_gpt":0.4835832791397178,"score_spread":0.3805604432202379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057062854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872794,0.0034294564,0.000012183548,0.0051753866,0.00011992139,0.0035323962,0.00038060997,0.000003900383,0.000066752706],"genre_scores_gemma":[0.9912907,0.0033539103,0.00036433397,0.00016126198,0.00031741775,0.004384593,0.00002136525,0.000031407406,0.00007503569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969254,0.00043698464,0.0007122067,0.00058462075,0.00072039245,0.0006203562],"domain_scores_gemma":[0.99823844,0.0002717979,0.00020010919,0.0006059942,0.00045664684,0.0002270031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026870011,0.00019023818,0.00038370403,0.000103294515,0.00013675432,0.000056065735,0.00066796446,0.00015087613,0.00013802513],"category_scores_gemma":[0.0004309065,0.00010753782,0.000115557574,0.0004724267,0.0005216816,0.000014404966,0.00031836538,0.0005579423,0.0000060401694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012867235,0.0005011343,0.050707225,0.00027260027,0.000269647,0.0000045589636,0.00035059184,0.000051305695,0.9135063,0.000038745024,0.0031082705,0.02990286],"study_design_scores_gemma":[0.0041414783,0.0013450935,0.30112594,0.00045529575,0.00006678524,0.0000029487264,0.00039108924,0.00012517085,0.68821836,0.00026978008,0.0035498487,0.00030821608],"about_ca_topic_score_codex":0.02234093,"about_ca_topic_score_gemma":0.003055955,"teacher_disagreement_score":0.2504187,"about_ca_system_score_codex":0.0000770308,"about_ca_system_score_gemma":0.00096348254,"threshold_uncertainty_score":0.98416936},"labels":[],"label_agreement":null},{"id":"W2057187391","doi":"10.1158/1078-0432.ccr-10-0505","title":"Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Tremelimumab; Medicine; Exemestane; Internal medicine; Breast cancer; Oncology; Adverse effect; Cancer; FOXP3; Immune system; Pharmacology; Immunology; Immunotherapy; Ipilimumab; Aromatase","score_opus":0.054415058311515815,"score_gpt":0.40782249443378715,"score_spread":0.3534074361222713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057187391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979362,0.00008572922,6.265546e-7,0.00037020093,0.00010324953,0.0013694874,0.000063115294,0.0000100447405,0.00006136548],"genre_scores_gemma":[0.99912167,0.0004471158,0.000055985085,0.000049951705,0.000021630536,0.00018841837,0.000039455543,0.00002517829,0.00005059933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802774,0.00016351436,0.00047377855,0.0004169849,0.00062444044,0.00029354362],"domain_scores_gemma":[0.9987441,0.00029164215,0.00017074838,0.00026758207,0.00040996133,0.00011597423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053009705,0.00014787563,0.00038627305,0.00026032396,0.000050169547,0.000011596703,0.000059914422,0.00016660834,0.00009271831],"category_scores_gemma":[0.00007011871,0.00009714919,0.000033828845,0.0005954188,0.00023655404,0.00010823469,0.000022068234,0.00050884206,6.371296e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042748142,0.0025951657,0.75504726,0.000028218841,0.0000400465,0.000005134703,0.00023156322,0.00010738557,0.016335472,0.0000029271243,0.000022506967,0.1828362],"study_design_scores_gemma":[0.031237416,0.0072308127,0.95196015,0.00089770614,0.0000128534075,3.1548592e-7,0.00006108012,0.0003776691,0.008008643,0.000007814637,0.00009637908,0.00010919355],"about_ca_topic_score_codex":0.0018622049,"about_ca_topic_score_gemma":0.0036474494,"teacher_disagreement_score":0.19691288,"about_ca_system_score_codex":0.00048949244,"about_ca_system_score_gemma":0.00035996814,"threshold_uncertainty_score":0.3961629},"labels":[],"label_agreement":null},{"id":"W2057985610","doi":"10.1158/1078-0432.ccr-10-2224","title":"The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non–Small Cell Lung Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Histology; Primary tumor; Lung cancer; Pathology; Cancer; Epidermal growth factor receptor; Oncology; Stage (stratigraphy); Cancer research; Internal medicine; Metastasis; Biology","score_opus":0.06839996388077083,"score_gpt":0.4448765100299225,"score_spread":0.3764765461491517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057985610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921916,0.0012443683,0.000015336082,0.00091409497,0.0004801776,0.0025231715,0.0012578962,0.000013378978,0.0013599693],"genre_scores_gemma":[0.99471295,0.0031321547,0.0001860634,0.0005020334,0.00035029155,0.00069728214,0.000015257271,0.000031271782,0.00037268994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958238,0.00052655686,0.0011881948,0.0007329353,0.0010182677,0.0007102272],"domain_scores_gemma":[0.9938049,0.0029032675,0.00030803512,0.0011837173,0.00095194456,0.000848187],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005746442,0.00021115465,0.0007069783,0.00019385494,0.00015869703,0.000020933681,0.00064707693,0.00015804516,0.0005820271],"category_scores_gemma":[0.002617608,0.00015158397,0.00028798621,0.0007938338,0.0011518573,0.000117504744,0.0003765158,0.0024028064,0.000006112254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012304078,0.0004958214,0.9650639,0.0010177948,0.00006633766,0.000014708405,0.0008854443,0.00001582723,0.0026325595,0.0000055123874,0.002619132,0.014878862],"study_design_scores_gemma":[0.0030820488,0.00085281214,0.98588884,0.00033616184,0.000088671026,1.7490302e-7,0.00012447702,0.0011947288,0.0036180182,0.000057528887,0.004608835,0.00014768325],"about_ca_topic_score_codex":0.017949734,"about_ca_topic_score_gemma":0.0056940597,"teacher_disagreement_score":0.020824937,"about_ca_system_score_codex":0.00040569296,"about_ca_system_score_gemma":0.005056588,"threshold_uncertainty_score":0.9998987},"labels":[],"label_agreement":null},{"id":"W2058363411","doi":"10.1158/1078-0432.ccr-07-4381","title":"Decreased Expression of Gastrokine 1 and the Trefoil Factor Interacting Protein TFIZ1/GKN2 in Gastric Cancer: Influence of Tumor Histology and Relationship to Prognosis","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Cancer; Biology; Immunohistochemistry; Tissue microarray; Adenocarcinoma; Pathology; Histology; Internal medicine; Cancer research; Medicine; Immunology; Genetics","score_opus":0.16990376046308517,"score_gpt":0.45906010153855686,"score_spread":0.2891563410754717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058363411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921906,0.0010156493,0.000007021763,0.0054656016,0.00004057813,0.0012253738,0.000022946235,0.000010922684,0.000021303982],"genre_scores_gemma":[0.9979705,0.00067384465,0.0003983444,0.0001549068,0.000060473507,0.0006677148,0.0000017574067,0.000016016875,0.000056437362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691266,0.0009255112,0.0009452658,0.000422169,0.00037483982,0.0004195538],"domain_scores_gemma":[0.996319,0.0024058272,0.00025106815,0.00026339898,0.00053644856,0.0002242675],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0015618274,0.00014271039,0.0006927942,0.00032908827,0.00011988723,0.000004356829,0.00015638227,0.00010974644,0.000028615274],"category_scores_gemma":[0.010015297,0.00009521173,0.000058033882,0.0005784248,0.0016438332,0.000079081175,0.00027544916,0.001140646,0.0000013745444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006232295,0.00016795177,0.9779236,0.00013675174,0.000048618767,0.000027003343,0.00094632385,0.000012039867,0.012716864,0.000005278653,0.00010247616,0.001680839],"study_design_scores_gemma":[0.0047936607,0.0010460487,0.9893648,0.0010675377,0.000028038736,0.000030485813,0.00016987586,0.00004235827,0.0033017837,0.000013722915,0.00008958511,0.00005209932],"about_ca_topic_score_codex":0.0018517735,"about_ca_topic_score_gemma":0.00053870224,"teacher_disagreement_score":0.011441246,"about_ca_system_score_codex":0.00013692417,"about_ca_system_score_gemma":0.00031732398,"threshold_uncertainty_score":0.99832374},"labels":[],"label_agreement":null},{"id":"W2059939561","doi":"10.1158/1078-0432.ccr-08-0021","title":"Reply to Letter to the Editor: a Response to the Letter of M. Tisdale","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Colocalization; Proteolysis; Glycosylation; Monoclonal antibody; Peptide; Antibody; Oligosaccharide; Biochemistry; Glycoprotein; Biology; Chemistry; Cell biology; Immunology; Enzyme","score_opus":0.10577662078188033,"score_gpt":0.4502158833830138,"score_spread":0.3444392626011335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059939561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.745476,0.0014439699,0.00017989492,0.24506244,0.006511563,0.00090340327,0.0000832789,0.000008024185,0.0003314359],"genre_scores_gemma":[0.54198825,0.0015746196,0.00038892005,0.25565878,0.16939612,0.0010216506,0.000011064081,0.00007823681,0.029882351],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968577,0.0009138362,0.00044150665,0.0005814316,0.0006632572,0.0005422683],"domain_scores_gemma":[0.99751914,0.00040817834,0.00004803172,0.0013020239,0.00041619872,0.00030644794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004498601,0.00013121196,0.00023974337,0.00007253538,0.00023566432,0.000026042908,0.0009038543,0.00014424189,0.00010809715],"category_scores_gemma":[0.0025873035,0.00008004237,0.00018144202,0.00042109413,0.00032635505,0.0000033859362,0.00063514616,0.0005173241,0.00023714696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002755309,0.00004265481,0.000369925,0.0000048884476,0.000028968087,0.0000024930978,0.0002897747,0.000043923454,0.07008563,0.000002600585,0.9215792,0.004794657],"study_design_scores_gemma":[0.00037086403,0.00057784223,0.0102516785,0.000016725915,0.000007037272,0.000003494726,0.000028532515,0.0000012332223,0.020002551,0.000004864753,0.96862274,0.00011245858],"about_ca_topic_score_codex":0.00055889145,"about_ca_topic_score_gemma":0.00054119853,"teacher_disagreement_score":0.20348772,"about_ca_system_score_codex":0.000033661105,"about_ca_system_score_gemma":0.00046024434,"threshold_uncertainty_score":0.32640332},"labels":[],"label_agreement":null},{"id":"W2060045463","doi":"10.1158/1078-0432.ovca13-a9","title":"Abstract A9: A whole-locus sequencing approach to identify polymorphisms associated with juvenile-onset granulosa cell tumor susceptibility in SWR mice","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Biology; Locus (genetics); Congenic; Carcinogenesis; Allele; Genetics; Epigenetics; Gene; Quantitative trait locus; Cancer research","score_opus":0.16583900280883065,"score_gpt":0.4523502060969039,"score_spread":0.2865112032880732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060045463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871722,0.0007101961,0.000009637983,0.0058212196,0.00016912518,0.0027682518,0.0001129633,0.000061656516,0.0031747739],"genre_scores_gemma":[0.995652,0.00010481074,0.00035590905,0.00093854027,0.00029460355,0.0016488782,0.00008153954,0.000069517366,0.00085416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944406,0.0005959952,0.0011203189,0.0013029723,0.0013371892,0.0012029103],"domain_scores_gemma":[0.99581325,0.0014473192,0.00019788237,0.00091161777,0.0007070249,0.0009229143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042040157,0.0003325704,0.00095365784,0.00032513,0.00017530721,0.00015706732,0.00039137303,0.00025895648,0.0009467088],"category_scores_gemma":[0.001123711,0.00025414588,0.0002329646,0.0012927921,0.00045090483,0.00019232073,0.00018668454,0.0017194183,0.00051236595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010998577,0.004211149,0.9626586,0.00022012951,0.00024188892,0.00039362468,0.0006037921,0.000063604835,0.0041518514,0.000010965721,0.020820973,0.005523576],"study_design_scores_gemma":[0.0056991386,0.0012097885,0.98872906,0.0007314559,0.00009536963,0.000011158197,0.00051297585,0.00011209338,0.0019171026,0.00015101225,0.0005268854,0.00030395566],"about_ca_topic_score_codex":0.026946573,"about_ca_topic_score_gemma":0.006971957,"teacher_disagreement_score":0.026070476,"about_ca_system_score_codex":0.0021872725,"about_ca_system_score_gemma":0.002003934,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2060277785","doi":"10.1158/1078-0432.ovca13-a20","title":"Abstract A20: Integrating high-throughput technologies for the identification and validation of ovarian cancer biomarkers","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Ovarian cancer; Cancer; Medicine; Biomarker discovery; Malignancy; Identification (biology); Biomarker; Proteomics; Bioinformatics; Computational biology; Oncology; Biology; Internal medicine; Gene","score_opus":0.1586183839477584,"score_gpt":0.5001702391840552,"score_spread":0.34155185523629683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060277785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782509,0.009739083,0.000692928,0.009834011,0.00013549972,0.0010816258,0.00011195709,0.000017337321,0.00013661411],"genre_scores_gemma":[0.98524237,0.01299182,0.00022465203,0.00004677152,0.00016639478,0.0011591782,0.00003167344,0.000008253349,0.00012888496],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985915,0.00013046479,0.0003829943,0.00037246305,0.00022283886,0.0002997777],"domain_scores_gemma":[0.99812305,0.00075694715,0.00010464261,0.00029473065,0.00065705896,0.00006358612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001852308,0.00008652226,0.00014461491,0.00003887349,0.00023519201,0.000058890022,0.000293435,0.00017665625,0.00006683869],"category_scores_gemma":[0.005229502,0.000050564613,0.00007834989,0.00016470192,0.0010877625,0.00000954384,0.00027807773,0.00022613435,0.0000041290677],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064009003,0.00013357522,0.033838544,0.00016970946,0.0003805384,3.4468476e-7,0.000028623721,0.000008134717,0.43292663,0.00090421725,0.027343214,0.50362635],"study_design_scores_gemma":[0.0015340165,0.0008742254,0.5418066,0.00012182225,0.00004570534,4.0848573e-7,0.0023598934,0.0002802649,0.4237465,0.012007188,0.016943885,0.000279514],"about_ca_topic_score_codex":0.0014802288,"about_ca_topic_score_gemma":0.00018769199,"teacher_disagreement_score":0.50796807,"about_ca_system_score_codex":0.000019549818,"about_ca_system_score_gemma":0.00015778115,"threshold_uncertainty_score":0.626058},"labels":[],"label_agreement":null},{"id":"W2063243732","doi":"10.1158/1078-0432.ccr-08-3076","title":"Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Mesenchymal stem cell; Neural stem cell; Stem cell; Glioma; Cancer research; Brainstem; Pathology; Biology; Medicine; Immunology; Cell biology; Neuroscience","score_opus":0.3441829397796936,"score_gpt":0.5337337856382064,"score_spread":0.18955084585851278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063243732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911779,0.0021878697,0.00001993363,0.0013905641,0.00050514407,0.0020264986,0.000018760911,0.00012904115,0.002544246],"genre_scores_gemma":[0.9892782,0.00025345755,0.00016470424,0.00034160088,0.0018849355,0.00004704926,0.000008775825,0.00010373687,0.007917565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9890386,0.0022970496,0.001827048,0.0016655553,0.0029657432,0.0022060093],"domain_scores_gemma":[0.9942677,0.001605683,0.00026920234,0.0011034308,0.0010416113,0.0017123442],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00999923,0.0005006814,0.0013150234,0.00062061433,0.0012408982,0.00034292275,0.0007589811,0.0005762924,0.00064517104],"category_scores_gemma":[0.00017448112,0.00043049487,0.0003529705,0.0013631645,0.0011304221,0.0002852919,0.00068772247,0.003364149,0.00011260777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007024512,0.0005238818,0.020201432,0.00057116314,0.000101276055,0.0013932496,0.00027992672,0.00006364773,0.9453389,0.00033113788,0.008228254,0.022264697],"study_design_scores_gemma":[0.025564887,0.020028902,0.036502812,0.0034660718,0.00042831164,0.0003874238,0.0049828785,0.026298588,0.8365367,0.0006266095,0.041847672,0.0033291322],"about_ca_topic_score_codex":0.0006172149,"about_ca_topic_score_gemma":0.000062425686,"teacher_disagreement_score":0.10880218,"about_ca_system_score_codex":0.000586721,"about_ca_system_score_gemma":0.00067083235,"threshold_uncertainty_score":0.9998147},"labels":[],"label_agreement":null},{"id":"W2065037500","doi":"10.1158/1078-0432.ccr-07-1955","title":"Bcl-B Expression in Human Epithelial and Nonepithelial Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cancer; Malignancy; Pathology; Lymphoma; Immunohistochemistry; Prostate cancer; Immunostaining; Carcinogenesis; Cancer research; Biology; Prostate; Germinal center; Breast cancer; Medicine; B cell; Internal medicine; Antibody; Immunology","score_opus":0.3592095641428239,"score_gpt":0.501245399538448,"score_spread":0.14203583539562414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065037500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734485,0.00022393795,0.000008019757,0.0004533004,0.00027238272,0.00024135623,0.000013289771,0.000032191652,0.0014106836],"genre_scores_gemma":[0.995361,0.0022581064,0.00007008885,0.00024813722,0.0005448383,0.000039862367,5.1160816e-7,0.000026511536,0.0014509779],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969172,0.00080920284,0.00046464286,0.00061291474,0.0006596083,0.00053641567],"domain_scores_gemma":[0.9984513,0.0009627792,0.000054625143,0.0002522014,0.00007147598,0.0002076454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018279168,0.000113726426,0.00026947644,0.00015825071,0.0005235317,0.000050109375,0.00034021752,0.0001450952,0.00063685974],"category_scores_gemma":[0.0012239058,0.00009286797,0.000070159775,0.00035564968,0.0010749036,0.00014024894,0.00032213904,0.0009004377,0.00009316297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002009922,0.00014947727,0.020982146,0.00001661701,0.0000011245988,0.000113207265,0.000412768,0.000006197716,0.97118646,0.00035728345,0.0017017047,0.004872033],"study_design_scores_gemma":[0.002847204,0.0006684602,0.054085366,0.0003041489,0.0000029100418,0.000024630604,0.0001481061,0.00023037293,0.8877414,0.0022965856,0.051265866,0.00038496792],"about_ca_topic_score_codex":0.00028255125,"about_ca_topic_score_gemma":0.00005854468,"teacher_disagreement_score":0.083445065,"about_ca_system_score_codex":0.00005043815,"about_ca_system_score_gemma":0.0001258005,"threshold_uncertainty_score":0.69731677},"labels":[],"label_agreement":null},{"id":"W2065915192","doi":"10.1158/1078-0432.ccr-14-0344","title":"Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Parks and Wilderness Society","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Imiquimod; Agonist; Medicine; TLR7; CD8; Genital warts; Immunology; Toll-like receptor; Virology; Antigen; Cancer research; Receptor; Immune system; Internal medicine; Innate immune system","score_opus":0.3316480913202369,"score_gpt":0.5352566410897088,"score_spread":0.2036085497694719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065915192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959264,0.0022868793,0.00074006466,0.017848257,0.00055605895,0.002608718,0.000092256385,0.000060945644,0.016542813],"genre_scores_gemma":[0.9924766,0.0014461334,0.00020762043,0.0026130814,0.0017083479,0.00045989038,0.00004101897,0.00005346629,0.0009938795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99307215,0.0016598265,0.0010562459,0.0009886724,0.0019315709,0.0012915363],"domain_scores_gemma":[0.9927237,0.004984187,0.0000822335,0.00090110174,0.0007832672,0.0005255046],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008756967,0.00027550053,0.0007845299,0.00025466288,0.00039507673,0.00024933356,0.00076172646,0.00023059626,0.0037760327],"category_scores_gemma":[0.0020755946,0.00019468833,0.0003254726,0.0011649331,0.0006122761,0.0002293469,0.00017683479,0.002595201,0.0011533197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025640132,0.004894842,0.3839148,0.0009675948,0.00020176843,0.00031623562,0.0072136302,0.0005374789,0.023118677,0.0016100276,0.15770131,0.3938835],"study_design_scores_gemma":[0.009152178,0.0034936229,0.36713684,0.0001225834,0.000022829296,0.000013120827,0.0013917984,0.0013567873,0.0014145382,0.00079126493,0.61465824,0.0004461879],"about_ca_topic_score_codex":0.0010098822,"about_ca_topic_score_gemma":0.0005799326,"teacher_disagreement_score":0.45695692,"about_ca_system_score_codex":0.00046307675,"about_ca_system_score_gemma":0.00060353393,"threshold_uncertainty_score":0.99970585},"labels":[],"label_agreement":null},{"id":"W2067155227","doi":"10.1158/1078-0432.ccr-07-4698","title":"Adjuvant Radioimmunotherapy Trial with Iodine-131–Labeled Anti–Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab′)2 after Resection of Liver Metastases from Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Carcinoembryonic antigen; Radioimmunotherapy; Medicine; Adjuvant; Colorectal cancer; Monoclonal antibody; Oncology; Surgical resection; Cancer; Antibody; Cancer research; Internal medicine; Pathology; Immunology","score_opus":0.2296091478252546,"score_gpt":0.5207940832102064,"score_spread":0.29118493538495177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067155227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98188746,0.014647679,0.000044542885,0.001013995,0.0002123022,0.0014841085,0.0004806839,0.000046135217,0.00018310157],"genre_scores_gemma":[0.9625494,0.033819262,0.00035386143,0.00016614668,0.0016812921,0.0007489074,0.000148259,0.000052319017,0.0004805762],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99596304,0.00047910647,0.00093428325,0.00082156924,0.0011435726,0.00065841177],"domain_scores_gemma":[0.99699914,0.001083703,0.00019443413,0.00058520376,0.0007067421,0.00043078404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001183367,0.00027789056,0.0009757853,0.00013738453,0.00027180373,0.000024352124,0.00030804184,0.00027633834,0.003071003],"category_scores_gemma":[0.00024940888,0.00021030476,0.00031767157,0.0008560636,0.0016017298,0.00012374595,0.000091425674,0.0014228276,0.00003060291],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27852848,0.0023852321,0.33762324,0.00019363452,0.0013364323,0.0003948988,0.00019914734,0.000032508848,0.37062323,0.000021306309,0.004424348,0.004237548],"study_design_scores_gemma":[0.05586929,0.0034457648,0.66896874,0.00034613945,0.00028815278,0.000051374464,0.000046940066,0.0006587477,0.25932533,0.000026706615,0.01061201,0.00036083526],"about_ca_topic_score_codex":0.0026114727,"about_ca_topic_score_gemma":0.00013148572,"teacher_disagreement_score":0.3313455,"about_ca_system_score_codex":0.00020902327,"about_ca_system_score_gemma":0.0014718932,"threshold_uncertainty_score":0.99784034},"labels":[],"label_agreement":null},{"id":"W2067252902","doi":"10.1158/1078-0432.ccr-04-2488","title":"Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Cancer Institute, University of Pittsburgh","keywords":"Hyperforin; Docetaxel; Pharmacology; Hepatocyte; Metabolism; Metabolite; Chemistry; CYP3A4; Cytochrome P450; Hypericum perforatum; CYP3A; Pharmacokinetics; Hydroxylation; Biochemistry; Enzyme; Medicine; In vitro; Internal medicine; Chemotherapy","score_opus":0.1275411279311244,"score_gpt":0.5018379043689848,"score_spread":0.3742967764378604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067252902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985085,0.0043700323,1.5261975e-8,0.0077370745,0.0004700136,0.0006560627,0.00008936977,0.000037836842,0.0015545704],"genre_scores_gemma":[0.99586064,0.0010989516,0.000004098254,0.00065030996,0.0010793209,0.0001326226,0.000008395062,0.0000020711598,0.0011636124],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963198,0.0015576126,0.0004548813,0.00044481913,0.00073466887,0.00048824964],"domain_scores_gemma":[0.9967182,0.0026637723,0.00012055687,0.00013391502,0.00021676414,0.0001467714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030099256,0.00018021865,0.00044182834,0.00001497862,0.00068379816,0.000034462166,0.00082004507,0.00016538356,0.0004903774],"category_scores_gemma":[0.0004538109,0.000050835282,0.00027187626,0.00045837509,0.0011793444,0.0000632748,0.00040964226,0.0012653536,0.00004426487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016312446,0.0006428394,0.16124769,0.000048767215,0.0003097488,0.0000065422887,0.000054575077,0.000018955834,0.2511415,0.0009783041,0.3927547,0.19116513],"study_design_scores_gemma":[0.0010554023,0.0012426376,0.113189735,0.000058004312,0.000060071914,0.0000013575699,0.000021485708,0.000014757825,0.09283216,0.00013178973,0.7911897,0.0002029412],"about_ca_topic_score_codex":0.0005146949,"about_ca_topic_score_gemma":0.0008776962,"teacher_disagreement_score":0.39843494,"about_ca_system_score_codex":0.0000780037,"about_ca_system_score_gemma":0.000028419898,"threshold_uncertainty_score":0.5497402},"labels":[],"label_agreement":null},{"id":"W2067322982","doi":"10.1158/1078-0432.ccr-10-2577","title":"The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Janssen Canada; Canadian Institutes of Health Research","keywords":"Erythropoietin; Erythropoietin receptor; Erythropoiesis; Medicine; Cancer; Cancer research; Chemotherapy; Anemia; Apoptosis; Cancer cell; Pharmacology; Internal medicine; Biology","score_opus":0.3779031268016942,"score_gpt":0.5947016967869888,"score_spread":0.21679856998529462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067322982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018246894,0.99281996,1.570041e-7,0.00037428903,0.00020330829,0.0021397502,0.000021270214,0.000022828617,0.0025937334],"genre_scores_gemma":[0.0020045456,0.9960004,0.00027851597,0.000020927519,0.0003870258,0.0004991589,0.000021336587,0.00008414897,0.00070393604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944729,0.0013305298,0.0018095078,0.0008053057,0.00081039075,0.00077135576],"domain_scores_gemma":[0.9951359,0.0029430855,0.0004737298,0.0007969162,0.00031277954,0.0003375655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004561087,0.00038523338,0.0021222224,0.00022942734,0.00028648225,0.000039085924,0.00036847612,0.00043481268,0.000325077],"category_scores_gemma":[0.0015952939,0.00021230367,0.000491903,0.00065071037,0.002094052,0.00003726062,0.00058242114,0.0021996186,0.000050570008],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019335718,0.00046808945,0.010896839,0.006754952,0.00014859259,0.00007483283,0.00008905541,3.71445e-8,5.495013e-7,0.00013880548,0.0009796845,0.9802552],"study_design_scores_gemma":[0.0011922277,0.0011057018,0.0012449294,0.039466918,0.0002958617,0.000033366057,0.00031060353,0.000017174696,0.000009294111,0.0002556151,0.9558682,0.00020014355],"about_ca_topic_score_codex":0.00046746238,"about_ca_topic_score_gemma":0.00011241875,"teacher_disagreement_score":0.98005503,"about_ca_system_score_codex":0.00028032082,"about_ca_system_score_gemma":0.0012674255,"threshold_uncertainty_score":0.9556371},"labels":[],"label_agreement":null},{"id":"W2067841857","doi":"10.1158/1078-0432.ccr-10-3314","title":"IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Medicine; Ovarian cancer; Cancer research; Cancer; Serous fluid; Angiogenesis; Internal medicine; Pathology","score_opus":0.34325376796023427,"score_gpt":0.49524241971514615,"score_spread":0.15198865175491189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067841857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96906286,0.0066504986,0.0000070586757,0.021780847,0.0003013708,0.0012994795,0.00005940906,0.00002318812,0.00081527355],"genre_scores_gemma":[0.9917691,0.002984637,0.00022691675,0.0026207422,0.00065568683,0.0009236659,0.0000026907212,0.000058696212,0.00075788697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960397,0.0012799905,0.0006200588,0.0006987535,0.00063876185,0.0007227676],"domain_scores_gemma":[0.99655384,0.0019518938,0.00007405194,0.00060645415,0.0003187819,0.0004949521],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052619693,0.00020749996,0.0004657629,0.0002674182,0.00023954712,0.000053497086,0.0002550503,0.00018489257,0.0014583452],"category_scores_gemma":[0.00036066616,0.00014002078,0.00015292865,0.000943752,0.00035021757,0.000047595193,0.00019520361,0.0007486724,0.00009380618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054673795,0.0027837337,0.76151425,0.0002664205,0.00058459095,0.00092695886,0.0095591815,0.00003728296,0.0066683968,0.0003544179,0.009825973,0.15280503],"study_design_scores_gemma":[0.0056093787,0.0030532393,0.9203479,0.00054132135,0.00016763755,0.000007947129,0.0012955184,0.000043339158,0.015744641,0.00022332181,0.052679684,0.00028602302],"about_ca_topic_score_codex":0.006355895,"about_ca_topic_score_gemma":0.0021158012,"teacher_disagreement_score":0.15883373,"about_ca_system_score_codex":0.00034094366,"about_ca_system_score_gemma":0.00096607517,"threshold_uncertainty_score":0.99945444},"labels":[],"label_agreement":null},{"id":"W2069326446","doi":"10.1158/1078-0432.ccr-14-0158","title":"Tumor Stromal Phenotypes Define VEGF Sensitivity—Letter","year":2014,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Stromal cell; Stroma; Pathology; Angiogenesis; Phenotype; Parenchyma; Colorectal cancer; Cancer; Desmoplasia; Biology; Cancer research; Medicine; Immunohistochemistry; Internal medicine","score_opus":0.28807936222836933,"score_gpt":0.506240839727046,"score_spread":0.2181614774986767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069326446","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015422118,0.0025774424,0.00008599983,0.97056544,0.002175553,0.0011602703,0.00025697023,0.00012276176,0.0076334756],"genre_scores_gemma":[0.01784849,0.0011167838,0.00045980726,0.895618,0.06753412,0.00025636394,0.00032754143,0.0002463763,0.01659252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.991668,0.0017284988,0.0011305162,0.0015234954,0.0023109245,0.0016385745],"domain_scores_gemma":[0.9938724,0.0029020412,0.00025475613,0.0015253787,0.00093082024,0.00051457784],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0053507504,0.00052390696,0.0018152962,0.000388141,0.00020084753,0.00011428899,0.00037550324,0.0010638069,0.0032885552],"category_scores_gemma":[0.0012412318,0.00043025767,0.00082413584,0.0005200993,0.0011184185,0.00005807786,0.00039692305,0.010934366,0.0014004232],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006255274,0.00013524044,0.0013540892,0.00090044254,0.00031326036,0.0036126752,0.000016234726,9.165153e-7,0.00020442615,0.000018561828,0.97429717,0.018521463],"study_design_scores_gemma":[0.0020219279,0.00084377633,0.0015787784,0.0006469752,0.00033661068,0.00010041895,0.000006599387,0.000020414349,0.00035315158,0.00012003341,0.9935558,0.00041554953],"about_ca_topic_score_codex":0.0016640653,"about_ca_topic_score_gemma":0.00029590362,"teacher_disagreement_score":0.07494741,"about_ca_system_score_codex":0.00043848596,"about_ca_system_score_gemma":0.0015675179,"threshold_uncertainty_score":0.9998149},"labels":[],"label_agreement":null},{"id":"W2070462086","doi":"10.1158/1078-0432.ovca13-ia26","title":"Abstract IA26: Protective immune networks in ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Immune system; CD8; Antigen; Cancer; Immunology; Cytotoxic T cell; Biology; Cancer research; Medicine; Internal medicine; Genetics","score_opus":0.18369874708787964,"score_gpt":0.513201799612445,"score_spread":0.3295030525245654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070462086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528132,0.016417168,0.00005611588,0.019606503,0.0009974552,0.004222511,0.000015395477,0.00006287155,0.005808746],"genre_scores_gemma":[0.98696333,0.006751771,0.000053578973,0.00081209344,0.0011191794,0.0024797998,0.000007167203,0.000046322875,0.001766758],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966421,0.00033729651,0.00090251496,0.000600419,0.00065392704,0.00086370116],"domain_scores_gemma":[0.9979143,0.00062247616,0.000116817624,0.0005580229,0.00050499704,0.00028340062],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034736842,0.000187553,0.00054496387,0.00021538511,0.00013545572,0.000069055335,0.00030452615,0.0003663044,0.009046887],"category_scores_gemma":[0.0003980158,0.0001476498,0.00024259496,0.00096950616,0.0006150452,0.00015529727,0.00012374492,0.002263337,0.00015722583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009797149,0.0010612588,0.19073686,0.00024463193,0.00053951924,0.00011737234,0.00035337923,0.00009263175,0.016511325,0.00006140426,0.022315223,0.75816923],"study_design_scores_gemma":[0.0048380853,0.00048117136,0.9807178,0.0006496257,0.000013776081,0.000003613956,0.00016433733,0.00045961057,0.0011039767,0.00028982523,0.011084713,0.00019347393],"about_ca_topic_score_codex":0.052332357,"about_ca_topic_score_gemma":0.0026120779,"teacher_disagreement_score":0.78998095,"about_ca_system_score_codex":0.000621951,"about_ca_system_score_gemma":0.0009798554,"threshold_uncertainty_score":0.99185896},"labels":[],"label_agreement":null},{"id":"W2070522618","doi":"10.1158/1078-0432.ccr-12-1397","title":"Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Cancer Research UK; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Lactate dehydrogenase; Internal medicine; Breast cancer; Proportional hazards model; Zoledronic acid; Cancer; Chemotherapy; Oncology; Relative risk; Gastroenterology; Retrospective cohort study; Urology; Surgery; Confidence interval; Biology","score_opus":0.08758147656428107,"score_gpt":0.4566996469113921,"score_spread":0.36911817034711103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070522618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884525,0.0008024806,0.0000017746332,0.00070653897,0.0001454588,0.0028290895,0.0070118383,0.000024112258,0.00002623103],"genre_scores_gemma":[0.99692154,0.00041080546,0.000089556714,0.00025432612,0.000060590704,0.001246642,0.00084028626,0.000054591743,0.00012168661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546516,0.0004952205,0.00089743605,0.00079003396,0.0010602279,0.0012919473],"domain_scores_gemma":[0.9967113,0.0008877761,0.00019842475,0.00044417926,0.00094067416,0.00081763574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014057348,0.000286721,0.0011520543,0.0005213893,0.000116520656,0.00002348509,0.00013008494,0.00019708382,0.0004620623],"category_scores_gemma":[0.00047319906,0.0002096533,0.0002104578,0.002618339,0.00021708687,0.0001912645,0.00008973955,0.0007404902,0.000025387419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012330548,0.0048313104,0.9728973,0.00007152411,0.0011092448,0.000024064368,0.00016374096,0.0000033796039,9.0826103e-7,0.0000020037016,0.00021802074,0.00834795],"study_design_scores_gemma":[0.019215262,0.0012345635,0.97797966,0.00021922668,0.00072075357,1.8511665e-7,0.000036306825,0.00014107251,0.000093915965,0.000027194883,0.00014153506,0.00019034655],"about_ca_topic_score_codex":0.060815632,"about_ca_topic_score_gemma":0.039019298,"teacher_disagreement_score":0.021796336,"about_ca_system_score_codex":0.0010962045,"about_ca_system_score_gemma":0.0006151752,"threshold_uncertainty_score":0.9785161},"labels":[],"label_agreement":null},{"id":"W2072638902","doi":"10.1158/1078-0432.ccr-10-3309","title":"Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Sunitinib; Nuclear medicine; Positron emission tomography; Cancer; Clinical endpoint; Biomarker; Stage (stratigraphy); Internal medicine; Oncology; Clinical trial","score_opus":0.5055549876519253,"score_gpt":0.5522083451222032,"score_spread":0.04665335747027788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072638902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878932,0.0010499407,0.0000050852223,0.0014880059,0.00020747764,0.0013439853,0.00006653373,0.000023203396,0.007922535],"genre_scores_gemma":[0.99317616,0.00058766536,0.00066830934,0.0003706093,0.00012589867,0.00046787327,0.000009467938,0.000064630774,0.0045293616],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99364746,0.002332555,0.0011662989,0.00075529615,0.0012497542,0.0008486521],"domain_scores_gemma":[0.99605876,0.0015938206,0.00014991702,0.00080948416,0.0006331108,0.0007549031],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006914149,0.00024133478,0.0008054965,0.0006621156,0.0000686873,0.00001827882,0.00036983806,0.00004672865,0.0069896406],"category_scores_gemma":[0.001668401,0.00019519511,0.00029674722,0.001212086,0.0005969725,0.00007395042,0.00030160486,0.00096321537,0.000379713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44795662,0.008444152,0.19456966,0.0014289053,0.0013899823,0.048217785,0.0033578202,0.000032133637,0.22852328,0.00016911786,0.027254,0.03865655],"study_design_scores_gemma":[0.018206453,0.015179549,0.64443827,0.0015366371,0.00045981724,0.00033227078,0.001217698,0.00023055992,0.2950809,0.0005144882,0.022150675,0.0006527055],"about_ca_topic_score_codex":0.016974613,"about_ca_topic_score_gemma":0.0015666112,"teacher_disagreement_score":0.4498686,"about_ca_system_score_codex":0.0005749398,"about_ca_system_score_gemma":0.002453441,"threshold_uncertainty_score":0.9939181},"labels":[],"label_agreement":null},{"id":"W2072990829","doi":"10.1158/1078-0432.ccr-08-0121","title":"Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Genentech","keywords":"Trastuzumab; Gene knockdown; Cancer research; Apoptosis; Molecular biology; Cell culture; Small interfering RNA; Biology; Cancer cell; Cancer; Medicine; Internal medicine; Breast cancer; Transfection; Biochemistry","score_opus":0.2929450628927039,"score_gpt":0.5554410195244822,"score_spread":0.2624959566317783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072990829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749329,0.0097265355,0.0000072406365,0.00869845,0.0005058381,0.0011896646,0.00025757172,0.000048622052,0.0046331547],"genre_scores_gemma":[0.95641595,0.037571914,0.0003901434,0.00023515538,0.00102038,0.0005920862,0.000009764009,0.00008108894,0.0036835356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99237645,0.0010629476,0.0014391537,0.0009938744,0.002852866,0.0012746885],"domain_scores_gemma":[0.9948262,0.0020234943,0.00017586396,0.0010063375,0.0012317214,0.0007363722],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048229643,0.00026092614,0.0010413639,0.00053215626,0.00018116483,0.000017890141,0.0007103624,0.00041464638,0.0035502391],"category_scores_gemma":[0.0009952554,0.00021647195,0.00025260705,0.0017830061,0.0020382972,0.00013811022,0.00034040379,0.002635074,0.00010304794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008890569,0.0017413006,0.69475484,0.0014711322,0.00008602676,0.00080307963,0.0013640735,0.000028532191,0.098206826,0.00006564604,0.17968722,0.012900735],"study_design_scores_gemma":[0.007318908,0.0007173664,0.82385445,0.00389945,0.000029416742,0.000029028683,0.00037152873,0.000087496024,0.12787353,0.00037510452,0.035011366,0.00043234252],"about_ca_topic_score_codex":0.00298042,"about_ca_topic_score_gemma":0.0019225237,"teacher_disagreement_score":0.14467585,"about_ca_system_score_codex":0.00093968504,"about_ca_system_score_gemma":0.0043413746,"threshold_uncertainty_score":0.9996659},"labels":[],"label_agreement":null},{"id":"W2073042319","doi":"10.1158/1078-0432.ccr-08-2790","title":"Therapeutic Efficacy of Seliciclib in Combination with Ionizing Radiation for Human Nasopharyngeal Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Nasopharyngeal carcinoma; Cancer research; Apoptosis; Cell cycle; Cell cycle checkpoint; Cyclin-dependent kinase; Radiation therapy; Biology; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.21045845608325892,"score_gpt":0.5280816959434151,"score_spread":0.3176232398601562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073042319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208903,0.0022919197,0.00036668568,0.0035992449,0.000062408435,0.0013613548,0.0000059357185,0.000027439162,0.0001960015],"genre_scores_gemma":[0.998515,0.00012519506,0.00039219527,0.00032882713,0.00031607106,0.00013599561,0.000024819894,0.000025975522,0.00013590367],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980082,0.00020625645,0.00053383806,0.000358148,0.0005141895,0.00037938697],"domain_scores_gemma":[0.9981607,0.0008242,0.00012525964,0.00029581302,0.00047579332,0.000118211894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015617076,0.00011465066,0.0004149213,0.00023681692,0.000097668824,0.000012243975,0.00014466642,0.00011242839,0.000040839102],"category_scores_gemma":[0.00021645236,0.0000937943,0.000088881694,0.0005583314,0.00025064417,0.00010581637,0.000016928567,0.0005126846,0.0000021288088],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01098661,0.0014402163,0.2499705,0.00018121298,0.00008191381,0.000013308012,0.00066565804,0.00009110597,0.012927293,0.0034687899,0.000079397105,0.720094],"study_design_scores_gemma":[0.016416278,0.0046791327,0.9674552,0.0002476948,0.000031229236,0.0000034922032,0.00010538186,0.00035188292,0.006308078,0.003206744,0.0010855836,0.00010930978],"about_ca_topic_score_codex":0.00015459555,"about_ca_topic_score_gemma":0.00006871824,"teacher_disagreement_score":0.7199847,"about_ca_system_score_codex":0.0002965847,"about_ca_system_score_gemma":0.00036932793,"threshold_uncertainty_score":0.38248205},"labels":[],"label_agreement":null},{"id":"W2076669505","doi":"10.1158/1078-0432.ccr-13-3368","title":"Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Biology; Ovarian cancer; Breast cancer; Cancer research; Population; Somatic hypermutation; Immune system; Metastasis; Cancer; B cell; Immunology; Antibody; Medicine; Genetics","score_opus":0.1014426997593371,"score_gpt":0.4251543637597016,"score_spread":0.3237116640003645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076669505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936756,0.0035082223,0.000015649814,0.0011954348,0.00023021168,0.0008599831,0.000029281236,0.000020140202,0.00046551452],"genre_scores_gemma":[0.99727476,0.001309367,0.00016980067,0.00038554872,0.00045443815,0.000080737016,0.000011790652,0.00004244906,0.0002711073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973473,0.00036504303,0.00045654186,0.0005679248,0.0007039335,0.00055925146],"domain_scores_gemma":[0.9983792,0.0005384642,0.00009329985,0.0003499782,0.00038846684,0.000250594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001741481,0.00017155988,0.00040665633,0.00019718394,0.00012702664,0.000056229957,0.0001591627,0.00020900698,0.00044172182],"category_scores_gemma":[0.00013265104,0.00012314739,0.00006735468,0.0006130528,0.0005971542,0.00008147965,0.000081498125,0.0009912625,0.000006554528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01113744,0.0006007565,0.9231073,0.00012457713,0.00005943602,0.000012005375,0.00008168023,0.000010561305,0.0005711046,0.000017470375,0.00097226445,0.06330536],"study_design_scores_gemma":[0.009673577,0.00117901,0.97950053,0.00058482646,0.000029367484,0.0000029511828,0.000032185344,0.00025373182,0.000121544246,0.000036334608,0.008412852,0.00017310961],"about_ca_topic_score_codex":0.0021460352,"about_ca_topic_score_gemma":0.0007130309,"teacher_disagreement_score":0.06313225,"about_ca_system_score_codex":0.00025502246,"about_ca_system_score_gemma":0.0005331902,"threshold_uncertainty_score":0.50218046},"labels":[],"label_agreement":null},{"id":"W2076899053","doi":"10.1158/1078-0432.ccr-14-2655","title":"Thomas C. Hall, MD, FACP: In Memoriam","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Graduation (instrument); Gratitude; Medical school; Medicine; Gerontology; Family medicine; Medical education; Psychology","score_opus":0.24147763738237202,"score_gpt":0.5572348235703496,"score_spread":0.31575718618797755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076899053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86091566,0.0019251346,0.00056880596,0.021524662,0.0022131086,0.0020428346,0.000017460705,0.00017169613,0.11062065],"genre_scores_gemma":[0.979009,0.0029321923,0.00084831927,0.0013541587,0.004864727,0.00034186852,0.000016380178,0.00008560268,0.010547804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99378026,0.0012714918,0.0008613046,0.0008435012,0.0019918184,0.0012516059],"domain_scores_gemma":[0.99282503,0.0046673003,0.000062916835,0.0010074312,0.0006518303,0.000785484],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.010258376,0.00019004218,0.0006897213,0.0004063837,0.00012418984,0.000058655798,0.0006091085,0.00040515847,0.0011770837],"category_scores_gemma":[0.010617492,0.00015007542,0.00018437118,0.0011213863,0.00093957916,0.00010403416,0.0005345389,0.002458768,0.0010374278],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00423857,0.0011465078,0.22616953,0.00041834416,0.00014978783,0.0005587565,0.00026790937,0.000020176043,0.0014139257,0.0031486887,0.61599034,0.14647748],"study_design_scores_gemma":[0.017556857,0.002624259,0.14045426,0.0006506617,0.000041660736,0.0000465233,0.00021027401,0.008906579,0.0015535698,0.0038842924,0.82364726,0.00042377034],"about_ca_topic_score_codex":0.0015291957,"about_ca_topic_score_gemma":0.00056494394,"teacher_disagreement_score":0.20765695,"about_ca_system_score_codex":0.0011578068,"about_ca_system_score_gemma":0.002469646,"threshold_uncertainty_score":0.9998426},"labels":[],"label_agreement":null},{"id":"W2077665371","doi":"10.1158/1078-0432.ccr-07-4628","title":"Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Oncolytic virus; Anaplastic thyroid cancer; Paclitaxel; Medicine; Cancer; Thyroid cancer; Virology; Oncology; Cancer research; Thyroid; Virus; Internal medicine","score_opus":0.1743229465674083,"score_gpt":0.5028413829996716,"score_spread":0.3285184364322633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077665371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98377836,0.014454466,0.000078342986,0.0005471074,0.00013369018,0.0005741103,0.00020647031,0.000008273948,0.00021919918],"genre_scores_gemma":[0.9698841,0.026879117,0.0001178266,0.00020477982,0.0006811891,0.0005696086,0.000022999962,0.000046275858,0.0015941131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973231,0.00042587475,0.0004930269,0.00062706496,0.0005033471,0.00062756764],"domain_scores_gemma":[0.9978466,0.00067801826,0.00008928971,0.0004872802,0.00060502667,0.00029380058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018128931,0.00015976538,0.00036803732,0.00010844686,0.0002159852,0.000016436652,0.00039001674,0.00025375263,0.00010409353],"category_scores_gemma":[0.0010760673,0.00014041594,0.00016472948,0.0002713886,0.001203081,0.000005734382,0.00023952076,0.0003087078,0.000006164156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044056386,0.0009961261,0.012638134,0.00040746722,0.00070914574,0.000029794639,0.00019958883,0.00023353987,0.741223,0.00012634728,0.03674815,0.16263233],"study_design_scores_gemma":[0.012209358,0.052022673,0.019412812,0.00025984342,0.00007471789,0.00002010281,0.0002294394,0.0012009011,0.6736071,0.0009060734,0.23913442,0.0009225416],"about_ca_topic_score_codex":0.00073494605,"about_ca_topic_score_gemma":0.0045251288,"teacher_disagreement_score":0.20238627,"about_ca_system_score_codex":0.00005807283,"about_ca_system_score_gemma":0.00119894,"threshold_uncertainty_score":0.5725996},"labels":[],"label_agreement":null},{"id":"W2078786745","doi":"10.1158/1078-0432.ccr-05-2762","title":"Influence of Formulation Vehicle on Metronomic Taxane Chemotherapy: Albumin-Bound versus Cremophor EL–Based Paclitaxel","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Taxane; Paclitaxel; Pharmacology; Medicine; Chemotherapy; Cancer; Internal medicine; Breast cancer","score_opus":0.10160094611451055,"score_gpt":0.47012205534468504,"score_spread":0.3685211092301745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078786745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971552,0.0012485638,0.00006148218,0.00041755423,0.00013417084,0.00026561125,0.00004191444,0.000007338976,0.00066815503],"genre_scores_gemma":[0.9979756,0.00038699407,0.00010822856,0.0002288973,0.0007403293,0.00007146004,0.000044616176,0.00003085963,0.00041303912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981158,0.00018767976,0.00047453065,0.0004708022,0.00037456024,0.00037665162],"domain_scores_gemma":[0.9986352,0.0002993227,0.00014392033,0.00049437536,0.0003307949,0.000096396856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011887033,0.00013656984,0.00023474643,0.000077026605,0.00010552114,0.000020949914,0.00029289417,0.00022756074,0.00009548631],"category_scores_gemma":[0.00024042113,0.00012393418,0.0002024599,0.00021568015,0.0003099358,0.000006249815,0.00007002548,0.00020642806,0.000022022117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015704438,0.0010877444,0.14174482,0.00013010667,0.00027377586,0.0000044953513,0.000020730075,0.019639665,0.76967704,0.0009977014,0.01596943,0.03475002],"study_design_scores_gemma":[0.0059418892,0.002922136,0.33929345,0.00007116415,0.000029198463,2.4832138e-7,0.000029948382,0.00092910585,0.6016308,0.00023845282,0.048573475,0.00034009916],"about_ca_topic_score_codex":0.00080471684,"about_ca_topic_score_gemma":0.0002549655,"teacher_disagreement_score":0.19754863,"about_ca_system_score_codex":0.00010154557,"about_ca_system_score_gemma":0.0003798216,"threshold_uncertainty_score":0.5053889},"labels":[],"label_agreement":null},{"id":"W2080518844","doi":"10.1158/1078-0432.ccr-07-0701","title":"Human Breast Cancer Cells Selected for Resistance to Trastuzumab <i>In vivo</i> Overexpress Epidermal Growth Factor Receptor and ErbB Ligands and Remain Dependent on the ErbB Receptor Network","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":506,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Trastuzumab; Gefitinib; Lapatinib; Erlotinib; Cancer research; Epidermal growth factor receptor; ErbB; In vivo; Epidermal growth factor; Growth factor receptor; Biology; Cancer; Receptor; Medicine; Breast cancer; Internal medicine","score_opus":0.12656251714838357,"score_gpt":0.4760326595411657,"score_spread":0.3494701423927821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080518844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713251,0.0019974788,0.00005551491,0.019900883,0.0005317498,0.0044667497,0.00086637953,0.00006621258,0.00078994414],"genre_scores_gemma":[0.9820852,0.003660092,0.00054696447,0.0023889693,0.003466727,0.00085544324,0.000014426884,0.00016835667,0.0068137897],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99208087,0.00086882565,0.0013438124,0.0015782112,0.0018990709,0.0022292114],"domain_scores_gemma":[0.99040633,0.0061042528,0.0001742863,0.0008250521,0.0012340111,0.0012560908],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011247864,0.000445604,0.0010040691,0.0003155386,0.0006452368,0.00016639997,0.00062037155,0.0004904439,0.0012262616],"category_scores_gemma":[0.002103018,0.00033623033,0.00015968514,0.0015642138,0.00083417393,0.000116960975,0.0003695892,0.0026200241,0.000022782106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030185862,0.0009955278,0.1269149,0.0015117486,0.00037201354,0.000102886326,0.0014134422,0.000030396624,0.18427606,0.0011632575,0.6370759,0.015958032],"study_design_scores_gemma":[0.018007083,0.006794556,0.4895768,0.008240636,0.00013171237,0.000028601087,0.0011611824,0.00015818593,0.28390256,0.0010134834,0.18908677,0.0018984588],"about_ca_topic_score_codex":0.0014511957,"about_ca_topic_score_gemma":0.009862454,"teacher_disagreement_score":0.4479891,"about_ca_system_score_codex":0.0012895941,"about_ca_system_score_gemma":0.0011548597,"threshold_uncertainty_score":0.999909},"labels":[],"label_agreement":null},{"id":"W2080520842","doi":"10.1158/1078-0432.ccr-14-0508","title":"Polymorphisms of Asparaginase Pathway and Asparaginase-Related Complications in Children with Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Asparaginase; Haplotype; Medicine; Genotype; Allele; Allergy; Immunology; Internal medicine; Pancreatitis; Gastroenterology; Leukemia; Oncology; Biology; Genetics; Lymphoblastic Leukemia; Gene","score_opus":0.05446510475932061,"score_gpt":0.4039746942426897,"score_spread":0.34950958948336913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080520842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924881,0.00058718846,0.0003513922,0.0025303902,0.000049703922,0.001224761,0.00005967414,0.000052293257,0.0026565394],"genre_scores_gemma":[0.99733675,0.00058942306,0.00055284327,0.00023847328,0.00013925422,0.00028055493,0.00005695562,0.00006847303,0.00073727313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951637,0.0007163376,0.0009897926,0.0009165437,0.0012834321,0.00093018945],"domain_scores_gemma":[0.9953488,0.00211541,0.00017550997,0.0010056507,0.0006319547,0.00072268286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029743516,0.00027213024,0.0008530071,0.00056463364,0.00014946301,0.00003769445,0.00046020243,0.0003192763,0.00017283019],"category_scores_gemma":[0.0012224319,0.00021053635,0.000105841056,0.0014476106,0.0023505678,0.00011648182,0.00034785338,0.0013873846,0.00009192243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030106455,0.0008323842,0.95729375,0.00015237834,0.0007593352,0.00017699775,0.0002052127,0.00014680406,0.0032337504,0.0036057166,0.0023289842,0.028254017],"study_design_scores_gemma":[0.013927371,0.0024550052,0.96882635,0.0005671097,0.00013556136,0.00039420766,0.000044346976,0.010055322,0.0018294998,0.0007954893,0.00068693963,0.0002827902],"about_ca_topic_score_codex":0.002102725,"about_ca_topic_score_gemma":0.00017421502,"teacher_disagreement_score":0.027971227,"about_ca_system_score_codex":0.0010701306,"about_ca_system_score_gemma":0.003888667,"threshold_uncertainty_score":0.86607647},"labels":[],"label_agreement":null},{"id":"W2080887232","doi":"10.1158/1078-0432.ccr-06-2972","title":"Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Radiation therapy; Prostate cancer; Androgen deprivation therapy; Medicine; Androgen; Internal medicine; Oncology; Cancer; Univariate analysis; Multivariate analysis; Hormone","score_opus":0.08647663225538417,"score_gpt":0.483430483112642,"score_spread":0.3969538508572578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080887232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983607,0.0010711737,0.00014873878,0.00037195004,0.000035298526,0.014588868,0.0000088843635,0.000010541888,0.00015754576],"genre_scores_gemma":[0.97573256,0.009878597,0.00022817563,0.00015974883,0.0003834071,0.013169575,0.00005056554,0.00003436671,0.00036299793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981801,0.00032421915,0.00040532084,0.00051564886,0.0002647821,0.00030993734],"domain_scores_gemma":[0.9993315,0.00011540127,0.00011538362,0.00020102256,0.00010382553,0.00013290114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020310807,0.00013800478,0.00021723204,0.00011391752,0.000109015,0.000026953718,0.00008331816,0.0002945317,0.000024488334],"category_scores_gemma":[0.000048066002,0.00009517846,0.000028740134,0.00017012675,0.00017238838,0.000012095284,0.000043897347,0.00026531992,3.7347294e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007406688,0.00018848472,0.42268384,0.000031207102,0.00003101397,0.000006770685,0.00008916801,0.000026556274,0.22188619,0.000020214822,0.00021144321,0.34741843],"study_design_scores_gemma":[0.014403038,0.0073130787,0.8130464,0.00012185463,0.0000077724,0.0000052332152,0.00007743982,0.00064835965,0.101325065,0.00011946449,0.062655635,0.00027669044],"about_ca_topic_score_codex":0.0003063497,"about_ca_topic_score_gemma":0.00043739413,"teacher_disagreement_score":0.39036253,"about_ca_system_score_codex":0.000094225936,"about_ca_system_score_gemma":0.00011650551,"threshold_uncertainty_score":0.3881265},"labels":[],"label_agreement":null},{"id":"W2080924817","doi":"10.1158/1078-0432.ccr-07-0484","title":"Sorafenib Inhibits the Imatinib-Resistant <i>KIT</i> <i>T670I</i> Gatekeeper Mutation in Gastrointestinal Stromal Tumor","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Sorafenib; Nilotinib; Imatinib; Dasatinib; Cancer research; Imatinib mesylate; Tyrosine kinase; Proto-Oncogene Proteins c-kit; Tyrosine-kinase inhibitor; Sunitinib; PDGFRA; Medicine; Stromal cell; Pharmacology; Biology; GiST; Internal medicine; Cancer; Stem cell factor; Stem cell; Progenitor cell; Hepatocellular carcinoma","score_opus":0.1724011015825633,"score_gpt":0.5144914392089194,"score_spread":0.3420903376263561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080924817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871248,0.0004322454,0.00017032903,0.006820145,0.00008043845,0.001570616,0.000031297055,0.00006379552,0.0037063202],"genre_scores_gemma":[0.99558866,0.000043580272,0.0022736175,0.0005756941,0.0005790233,0.00022809002,0.000028496574,0.000056678993,0.0006261666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934902,0.00073802954,0.001267163,0.00077970664,0.0019848046,0.0017400663],"domain_scores_gemma":[0.9943208,0.003103387,0.00016336465,0.0006527811,0.0009177908,0.00084189605],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0103827575,0.00028792064,0.00055147527,0.0003329933,0.00029556258,0.000100214034,0.00040213155,0.00006569439,0.00038257006],"category_scores_gemma":[0.0046824543,0.00019069671,0.00025540488,0.0011562456,0.0011249153,0.00012619927,0.00026739654,0.0025567177,0.0002809147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024074493,0.0036891026,0.89293265,0.00042438315,0.0001109975,0.01967602,0.00024417866,0.000049498638,0.027596122,0.0012118113,0.0070859254,0.022904815],"study_design_scores_gemma":[0.013505047,0.012502085,0.94543296,0.0029540623,0.00007164251,0.0029336459,0.0015849366,0.0006421705,0.015338312,0.0014446179,0.0031831341,0.0004074111],"about_ca_topic_score_codex":0.00123372,"about_ca_topic_score_gemma":0.0015553326,"teacher_disagreement_score":0.05250028,"about_ca_system_score_codex":0.00056764105,"about_ca_system_score_gemma":0.0012492174,"threshold_uncertainty_score":0.9997444},"labels":[],"label_agreement":null},{"id":"W2080947811","doi":"10.1158/1078-0432.ccr-13-3045","title":"A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma <i>In Situ</i> of the Breast","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"Transdermal; Tamoxifen; Medicine; Ductal carcinoma; Internal medicine; Breast cancer; Urology; Sex hormone-binding globulin; Selective estrogen receptor modulator; Gastroenterology; Endocrinology; Hormone; Cancer; Pharmacology","score_opus":0.07090408952545521,"score_gpt":0.42780496010190416,"score_spread":0.3569008705764489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080947811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963686,0.00038238402,0.0000066829807,0.001106258,0.00020328272,0.0011607284,0.00007805798,0.0000036533622,0.0006903676],"genre_scores_gemma":[0.99865854,0.00023765005,0.000027499447,0.000044539218,0.00032761446,0.00061344454,0.000011044807,0.00002349648,0.0000561599],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99575776,0.001788511,0.0008240593,0.00054227846,0.00052348786,0.0005639082],"domain_scores_gemma":[0.9982548,0.0007143492,0.00017121574,0.0005339448,0.00019526195,0.00013048157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035559586,0.00020192601,0.00092344003,0.00008109101,0.00007607224,0.00000821651,0.0004630351,0.00020622951,0.0000348828],"category_scores_gemma":[0.0005541759,0.0001274861,0.00023862888,0.00038133544,0.0016333639,0.000008131675,0.00030716497,0.0004597152,6.9819475e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9817519,0.0018182962,0.00844805,0.000043405882,0.00022659516,0.000008062669,0.00039107556,0.000051020583,0.0032776552,0.000044126857,0.00013261285,0.0038071508],"study_design_scores_gemma":[0.9617196,0.0043348023,0.025571324,0.00008287676,0.00005715015,0.000006744665,0.00011887983,0.00007194571,0.007257399,0.00009344375,0.00051226513,0.00017362444],"about_ca_topic_score_codex":0.0010039314,"about_ca_topic_score_gemma":0.001811252,"teacher_disagreement_score":0.020032404,"about_ca_system_score_codex":0.000086975604,"about_ca_system_score_gemma":0.0005162448,"threshold_uncertainty_score":0.60181975},"labels":[],"label_agreement":null},{"id":"W2081370824","doi":"10.1158/1078-0432.ovca13-a13","title":"Abstract A13: Molecular profiling of low grade serous ovarian tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Serous carcinoma; Loss of heterozygosity; Pathology; Cystadenocarcinoma; Medicine; Ovarian tumor; Oncology; Clear cell; Ovary; Ovarian cancer; Cancer research; Biology; Internal medicine; Carcinoma; Cancer; Gene; Genetics","score_opus":0.1915692505941295,"score_gpt":0.5080251463816321,"score_spread":0.3164558957875026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081370824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832726,0.0013791629,0.000017021177,0.00983319,0.00023924733,0.0014805952,0.000023025532,0.00003560989,0.0037195405],"genre_scores_gemma":[0.99636364,0.00069150655,0.0010359013,0.0005358085,0.00044669452,0.0006093848,0.000016738488,0.000043981014,0.00025632227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969464,0.00018717263,0.00079996226,0.0005614372,0.000901932,0.0006031122],"domain_scores_gemma":[0.99731034,0.00059458875,0.00013021531,0.0006688621,0.00082221767,0.0004737776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014220102,0.00016734953,0.0005767114,0.00014480988,0.00007760185,0.000039734303,0.00022647763,0.00017965354,0.0019820514],"category_scores_gemma":[0.000653869,0.00013007427,0.00025502263,0.00044900828,0.0003838003,0.00008341009,0.00011559299,0.0008685766,0.00027199363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010970087,0.006380023,0.7867855,0.0020787935,0.0012297608,0.0011793666,0.00023784433,0.0000912667,0.027912747,0.0031906045,0.024718368,0.14509876],"study_design_scores_gemma":[0.0047909208,0.0013181681,0.91664106,0.0010713778,0.00008313976,0.000012040306,0.00016311216,0.00017138135,0.07251815,0.0015561782,0.0014489515,0.00022553973],"about_ca_topic_score_codex":0.002736654,"about_ca_topic_score_gemma":0.000040948296,"teacher_disagreement_score":0.14487322,"about_ca_system_score_codex":0.00021390826,"about_ca_system_score_gemma":0.0008573651,"threshold_uncertainty_score":0.9989303},"labels":[],"label_agreement":null},{"id":"W2081436300","doi":"10.1158/1078-0432.ovca13-ia20","title":"Abstract IA20: Analyzing the cellular basis for heterogeneity in serous ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Serous fluid; Ovarian cancer; Cancer research; Population; Flow cytometry; Malignancy; Ovarian carcinoma; Medicine; Cancer stem cell; Cancer; Targeted therapy; Oncology; Biology; Pathology; Immunology; Internal medicine","score_opus":0.13728115749161565,"score_gpt":0.4445392617858377,"score_spread":0.30725810429422207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081436300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320537,0.0029355905,0.00021300644,0.0022685183,0.00025357513,0.000732687,0.000064251944,0.0000040745513,0.00032291384],"genre_scores_gemma":[0.9964948,0.0012102728,0.00016015454,0.00039771068,0.0009915876,0.0005360978,0.000033959812,0.00002895539,0.0001464439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981331,0.00017298474,0.00045206718,0.0005118035,0.00018974693,0.00054026715],"domain_scores_gemma":[0.9983362,0.0005193554,0.00006841522,0.00059704506,0.00031207738,0.00016690195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020062136,0.00012557748,0.00020455978,0.000055044373,0.00016649127,0.00009756088,0.00047474878,0.00020861242,0.00013792189],"category_scores_gemma":[0.0009931035,0.00009810237,0.00018852546,0.00018225911,0.00023277792,0.000004762708,0.00025290152,0.00039216073,0.000028964863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073603285,0.00046632922,0.680165,0.00015153186,0.0001965063,0.000017135331,0.0001275597,0.00051468983,0.1986058,0.00023406318,0.04098468,0.077800706],"study_design_scores_gemma":[0.00225957,0.0007343806,0.82516354,0.000054888016,0.000030156323,0.0000016993853,0.00022625894,0.0008123554,0.088875294,0.0010673228,0.08031971,0.00045484322],"about_ca_topic_score_codex":0.0029417516,"about_ca_topic_score_gemma":0.0031569903,"teacher_disagreement_score":0.14499855,"about_ca_system_score_codex":0.00007473381,"about_ca_system_score_gemma":0.0003842125,"threshold_uncertainty_score":0.4447068},"labels":[],"label_agreement":null},{"id":"W2082671989","doi":"10.1158/1078-0432.ccr-14-1324","title":"Molecular Characterization of Choroid Plexus Tumors Reveals Novel Clinically Relevant Subgroups","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Biology; DNA methylation; Gene; Copy-number variation; Cancer research; Somatic cell; Allele; Pathology; Methylation; Molecular biology; Genetics; Gene expression; Medicine; Genome; Endocrinology; Central nervous system","score_opus":0.13738952923192047,"score_gpt":0.4785498330281012,"score_spread":0.3411603037961808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082671989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937368,0.00019992754,0.00022134131,0.0038220785,0.00020419568,0.0008143085,0.000042660944,0.00003212482,0.0009265642],"genre_scores_gemma":[0.99692214,0.00091800134,0.0004355856,0.0007287693,0.0004756305,0.00020140955,0.000076610726,0.000044663466,0.00019719951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959823,0.0004904088,0.001402474,0.00061422406,0.0010009743,0.00050964043],"domain_scores_gemma":[0.9962608,0.00140056,0.00027716704,0.0007792404,0.0008363392,0.00044587374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048913164,0.00016726162,0.0007773737,0.00017336772,0.00007845484,0.00002467152,0.0002451835,0.0002255049,0.00024074117],"category_scores_gemma":[0.004122774,0.0001309722,0.00029856895,0.0005027193,0.00042507355,0.00005530255,0.00015812331,0.00068521686,0.00008619703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00136459,0.0028873712,0.50013727,0.00024683343,0.00020692968,0.00008609961,0.00005585704,0.000005082092,0.45766336,0.0024078772,0.00066521886,0.034273483],"study_design_scores_gemma":[0.0050882995,0.0030254212,0.95741796,0.0006359513,0.00010095439,0.000010649858,0.000015910658,0.00043793945,0.026610037,0.00041772748,0.006072148,0.00016700133],"about_ca_topic_score_codex":0.00016182257,"about_ca_topic_score_gemma":0.000014049243,"teacher_disagreement_score":0.45728067,"about_ca_system_score_codex":0.000111288966,"about_ca_system_score_gemma":0.00031275934,"threshold_uncertainty_score":0.5340891},"labels":[],"label_agreement":null},{"id":"W2082979527","doi":"10.1158/1078-0432.ccr-05-0415","title":"Identification of Mammaglobin as a Novel Serum Marker for Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Alvin J. Siteman Cancer Center","keywords":"Mammaglobin; Breast cancer; Medicine; Immunostaining; Cancer; Biomarker; Oncology; Internal medicine; Pathology; Immunology; Immunohistochemistry; Biology","score_opus":0.22976940447946537,"score_gpt":0.5628755103185055,"score_spread":0.3331061058390401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082979527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532714,0.0029761952,0.00041356732,0.037129257,0.0006898639,0.0018525601,0.0017750274,0.000035320805,0.0018568462],"genre_scores_gemma":[0.97649544,0.0039969357,0.00050169876,0.00073351216,0.001848862,0.00061439275,0.000012951705,0.000043227323,0.015752994],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99724203,0.00010407484,0.0008909325,0.0005155017,0.0007405738,0.00050687476],"domain_scores_gemma":[0.99735343,0.00046285058,0.00017236144,0.0005181857,0.0011765547,0.00031660957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003506682,0.00012760112,0.00046052813,0.00015122791,0.00009158123,0.000026135134,0.00022183482,0.000157771,0.0031894236],"category_scores_gemma":[0.00046438474,0.000108110704,0.00029271274,0.00048073888,0.00036399756,0.00009262498,0.000098309814,0.00047345262,0.000071388924],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057968143,0.0011343568,0.04179112,0.0007484685,0.00033324937,0.0000030984427,0.00010984396,0.000032880638,0.05723027,0.0005462666,0.038789548,0.8534841],"study_design_scores_gemma":[0.009053565,0.0005990225,0.48963138,0.0005218306,0.00030870136,0.000024410772,0.00019986353,0.00080904574,0.047421116,0.0002625999,0.45087206,0.0002964141],"about_ca_topic_score_codex":0.0010969024,"about_ca_topic_score_gemma":0.0007683007,"teacher_disagreement_score":0.8531877,"about_ca_system_score_codex":0.0003136292,"about_ca_system_score_gemma":0.0012329993,"threshold_uncertainty_score":0.9977218},"labels":[],"label_agreement":null},{"id":"W2086983721","doi":"10.1158/1078-0432.ccr-14-0831","title":"The Evolving Role of Molecular Markers in the Diagnosis and Management of Diffuse Glioma","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"IDH1; Glioma; IDH2; Epigenomics; Biology; Pathology; Bioinformatics; Medicine; Mutation; Cancer research; Genetics; DNA methylation; Gene","score_opus":0.1970773954162701,"score_gpt":0.5315476576836274,"score_spread":0.3344702622673573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086983721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017946444,0.97825634,2.2456501e-7,0.0006685599,0.000056818593,0.0022121912,0.00001634187,0.000003288196,0.00083976425],"genre_scores_gemma":[0.028177679,0.96937996,0.000029310893,0.00002601183,0.00006345108,0.002266043,0.0000068779086,0.000029361156,0.000021325504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995798,0.0014282641,0.001065866,0.00042074273,0.00090629817,0.00038081428],"domain_scores_gemma":[0.99234736,0.0061956253,0.0002625005,0.00090168446,0.00017289922,0.00011994872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004672284,0.00020363428,0.0013282603,0.00019979762,0.000080725484,0.000031906704,0.0004825989,0.00018610366,0.000039161496],"category_scores_gemma":[0.0007094524,0.00009619977,0.00047297607,0.00071307854,0.00060093123,0.000014927893,0.00034095737,0.00066920905,0.0000059292533],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073709714,0.00069245626,0.0051431865,0.010685587,0.0006296338,0.00017293345,0.000026609607,1.0362532e-7,7.1939706e-7,0.0005024795,0.0013216224,0.980751],"study_design_scores_gemma":[0.0020921435,0.00077628216,0.017820548,0.033598717,0.0013755347,0.000010690328,0.00025624663,0.000013392775,0.00002158431,0.0002582169,0.9436355,0.00014111139],"about_ca_topic_score_codex":0.00036619033,"about_ca_topic_score_gemma":0.00007828254,"teacher_disagreement_score":0.98060983,"about_ca_system_score_codex":0.00010653142,"about_ca_system_score_gemma":0.0001622562,"threshold_uncertainty_score":0.39229128},"labels":[],"label_agreement":null},{"id":"W2087146189","doi":"10.1158/1078-0432.ccr-1131-03","title":"<b> <i>In Vitro</i> </b> and <b> <i>in Vivo</i> </b> Characterization of Doxorubicin and Vincristine Coencapsulated within Liposomes through Use of Transition Metal Ion Complexation and pH Gradient Loading","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Stemcell Technologies; BC Cancer Agency","funders":"","keywords":"In vivo; Vincristine; In vitro; Liposome; Doxorubicin; Chemistry; Characterization (materials science); Biophysics; Materials science; Nanotechnology; Biochemistry; Medicine; Biology; Chemotherapy; Internal medicine; Cyclophosphamide","score_opus":0.11274904799988941,"score_gpt":0.3893579564175797,"score_spread":0.27660890841769026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087146189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979544,0.0002884024,0.00017344303,0.00080613577,0.00012298625,0.0005177189,0.000120345954,0.000013143244,0.0000034254513],"genre_scores_gemma":[0.99844736,0.00078925246,0.00054167124,0.00011428378,0.000044067077,0.00002644769,0.000015382298,0.000015257563,0.0000062752224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997352,0.00054456346,0.0009209553,0.00045372316,0.00043057182,0.00029820728],"domain_scores_gemma":[0.99879175,0.000506782,0.00022130481,0.00017115814,0.00021081633,0.0000981902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023242827,0.00012899678,0.00045040972,0.00018765191,0.00006754987,0.000045153483,0.00008427069,0.00010593617,0.000024618645],"category_scores_gemma":[0.0003088633,0.00011992925,0.000029271736,0.0005152253,0.0007039209,0.0006827342,0.00007778439,0.00024639882,0.0000011080682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015281367,0.00023573414,0.0019421452,0.00015507113,0.0000048733436,0.000009838992,0.0010353602,0.00028473118,0.99436814,0.00023319779,0.0000043563473,0.00019840377],"study_design_scores_gemma":[0.0025188387,0.0003139756,0.012244041,0.00028123474,0.000018419969,0.00000476868,0.00009236217,0.0019388432,0.9818983,0.00055956206,0.000018569797,0.00011106008],"about_ca_topic_score_codex":0.003021985,"about_ca_topic_score_gemma":0.0003934365,"teacher_disagreement_score":0.012469827,"about_ca_system_score_codex":0.0000952044,"about_ca_system_score_gemma":0.000111644855,"threshold_uncertainty_score":0.48905727},"labels":[],"label_agreement":null},{"id":"W2088060877","doi":"10.1158/1078-0432.tcme10-a27","title":"Abstract A27: Chronic exposure of malignant hematological cell lines to bortezomib induces de novo hot spot mutations in the PSMB5 gene","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Bortezomib; Cell culture; Medicine; Cancer research; Proteasome inhibitor; Multiple myeloma; Internal medicine; Biology; Genetics","score_opus":0.14305838479231506,"score_gpt":0.460805364926912,"score_spread":0.3177469801345969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088060877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637794,0.0010503795,0.000015838561,0.0012550803,0.00013189921,0.00047642252,0.000059101763,0.0000052065234,0.0006281212],"genre_scores_gemma":[0.99763656,0.0005562226,0.00041366907,0.00029325974,0.00070361997,0.00025294317,0.000029575129,0.000014806986,0.000099344106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803764,0.00030944915,0.0004904085,0.00039821357,0.00031389814,0.00045038885],"domain_scores_gemma":[0.9987166,0.00035383386,0.00007802976,0.0004708075,0.00022245571,0.00015825608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031283463,0.00011587256,0.00021570675,0.00006467517,0.000089989066,0.000028050728,0.00061514473,0.00034142382,0.00016677988],"category_scores_gemma":[0.00091736094,0.00007936549,0.00011343696,0.00024986494,0.00033713234,0.0000037022758,0.00017306182,0.00085547706,0.00001920448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022232959,0.00028608428,0.012775199,0.00005779513,0.000012450831,0.000029660478,0.00012445959,0.000023380628,0.98184884,0.000054544864,0.0009275796,0.0036376717],"study_design_scores_gemma":[0.0006425706,0.0007626059,0.09005674,0.00003230751,0.000005897878,0.000014163928,0.00014642609,0.000008224473,0.8992642,0.00015085127,0.00879091,0.00012508764],"about_ca_topic_score_codex":0.00021407811,"about_ca_topic_score_gemma":0.0013632447,"teacher_disagreement_score":0.08258463,"about_ca_system_score_codex":0.000018335886,"about_ca_system_score_gemma":0.00079515984,"threshold_uncertainty_score":0.37166697},"labels":[],"label_agreement":null},{"id":"W2088325873","doi":"10.1158/1078-0432.ccr-06-2882","title":"Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"PVT1; Cancer research; Ovarian cancer; Biology; Oncogene; Breast cancer; Small interfering RNA; Apoptosis; Cell culture; Gene duplication; Cancer; Long non-coding RNA; Molecular biology; RNA; Gene; Transfection; Cell cycle; Genetics","score_opus":0.06536243382452886,"score_gpt":0.43905936512894844,"score_spread":0.3736969313044196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088325873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939909,0.0014808057,0.00079960626,0.002984268,0.0001206262,0.00021888631,0.00025534775,0.0000015944585,0.00014798163],"genre_scores_gemma":[0.99769217,0.0013888888,0.000098418044,0.00029569006,0.00027682664,0.000044932214,0.00001570409,0.0000064860465,0.00018088364],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99895906,0.00015652103,0.00036277558,0.00020432546,0.000116081384,0.00020123886],"domain_scores_gemma":[0.99896365,0.00017542239,0.000080784506,0.00026652336,0.00045063498,0.00006296425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018074758,0.000055008233,0.000148615,0.000034925928,0.000072991446,0.000006848871,0.00019229489,0.00010564502,0.00003459698],"category_scores_gemma":[0.00017582446,0.00003890331,0.00004715798,0.00015398483,0.00032488178,0.0000018434183,0.00015882569,0.00012514892,0.0000016925381],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020368665,0.00020769614,0.18932551,0.000093024704,0.00018181372,7.9156484e-7,0.00021328802,0.0000795936,0.74875087,0.0057548047,0.0065400107,0.046815727],"study_design_scores_gemma":[0.00068995316,0.00044338586,0.88513756,0.000035988993,0.000019695059,0.0000021160797,0.00037100576,0.000012263833,0.08428357,0.0011593457,0.027752142,0.000092997354],"about_ca_topic_score_codex":0.0008620813,"about_ca_topic_score_gemma":0.0005960851,"teacher_disagreement_score":0.69581205,"about_ca_system_score_codex":0.000013220368,"about_ca_system_score_gemma":0.000174512,"threshold_uncertainty_score":0.15864308},"labels":[],"label_agreement":null},{"id":"W2088337613","doi":"10.1158/1078-0432.ccr-14-0857","title":"Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Pharmacogenetics; Toxicity; Medicine; Colorectal cancer; Oncology; Internal medicine; Clinical trial; Cancer; Genotype; Pharmacology; Biology; Genetics; Gene","score_opus":0.08266971454554922,"score_gpt":0.42585393903017715,"score_spread":0.34318422448462793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088337613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706024,0.0021915163,0.0000131236175,0.0001705472,0.00004490113,0.0003592955,0.000121659534,0.0000020928821,0.00003663704],"genre_scores_gemma":[0.99448115,0.005235291,0.00001835074,0.000024424648,0.00006264416,0.000054441083,0.000062733016,0.000011285033,0.000049676444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824315,0.00048462208,0.000377905,0.00030283802,0.00039500085,0.0001964684],"domain_scores_gemma":[0.99909186,0.00014285608,0.00014061571,0.00012389517,0.00036284656,0.0001379123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013115895,0.000096089425,0.0003495317,0.00014830631,0.00002449691,0.000009685329,0.000072299496,0.000133512,0.00001589352],"category_scores_gemma":[0.00016516048,0.00007291878,0.00004814911,0.0005449689,0.00017980221,0.0000064490473,0.000035478384,0.00015770609,1.1091609e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02090547,0.00027300758,0.96184486,0.000017260105,0.0004978312,0.0000014219735,0.00009343446,0.000111413545,0.009273205,0.0000027977446,0.000088011686,0.006891295],"study_design_scores_gemma":[0.03383939,0.0061018807,0.895593,0.000045157656,0.00050460314,3.1338007e-7,0.00005807848,0.0005132509,0.06291015,0.0000062057893,0.00024009995,0.00018788417],"about_ca_topic_score_codex":0.003309456,"about_ca_topic_score_gemma":0.004901655,"teacher_disagreement_score":0.06625186,"about_ca_system_score_codex":0.000058487134,"about_ca_system_score_gemma":0.00025934892,"threshold_uncertainty_score":0.50029296},"labels":[],"label_agreement":null},{"id":"W2089037180","doi":"10.1158/1078-0432.tcme10-b12","title":"Abstract B12: A novel gene signature associated with response to adoptively transferred T cells in a mouse model of breast cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"CD8; Adoptive cell transfer; Cancer research; Gene signature; Immunology; Breast cancer; Gene expression profiling; Cytotoxic T cell; Immunotherapy; Mammary tumor; Biology; Medicine; Cancer; T cell; Gene expression; Immune system; Internal medicine; Gene; In vitro","score_opus":0.09901090885076576,"score_gpt":0.44354881704082544,"score_spread":0.3445379081900597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089037180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934265,0.00017624117,0.000072701245,0.00093798776,0.000059989525,0.00075398927,0.004496218,0.0000081636435,0.00006821942],"genre_scores_gemma":[0.99749315,0.0004756936,0.00028323487,0.00013166296,0.00013075453,0.000413595,0.00005211682,0.000050655388,0.0009691385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971547,0.00022915,0.00045078134,0.0007124778,0.0007194491,0.00073340745],"domain_scores_gemma":[0.9980288,0.0002463958,0.000071950846,0.00049195363,0.00070693274,0.00045392915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021069897,0.00020617076,0.00036448936,0.00018284841,0.000075115735,0.00003072394,0.00047668893,0.00040542672,0.00011981773],"category_scores_gemma":[0.00045018407,0.00016849766,0.00013699933,0.00047581212,0.00039296946,0.000010454656,0.0001439365,0.001184283,0.0000049277714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023671435,0.0009923804,0.0060839094,0.000021180924,0.00017061442,0.000014344012,0.00008782843,0.0015380948,0.9648669,0.0000029038256,0.0005860673,0.0019643717],"study_design_scores_gemma":[0.008127274,0.0016593123,0.14165743,0.00016175986,0.000021474334,0.0000023079738,0.000051857085,0.00063357526,0.8465952,0.000020688594,0.00068336766,0.0003857002],"about_ca_topic_score_codex":0.0030532063,"about_ca_topic_score_gemma":0.03174405,"teacher_disagreement_score":0.13557352,"about_ca_system_score_codex":0.0001465237,"about_ca_system_score_gemma":0.0022321523,"threshold_uncertainty_score":0.9859241},"labels":[],"label_agreement":null},{"id":"W2090950165","doi":"10.1158/1078-0432.ccr-04-0076","title":"BNIP3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non–Small Cell Lung Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hypoxia (environmental); Biology; Phenotype; Cancer research; Hypoxia-inducible factors; Lung cancer; Gene expression; Hypoxia-Inducible Factor 1; In vivo; Transcription factor; Gene; Pathology; Medicine; Chemistry; Biochemistry; Genetics; Oxygen","score_opus":0.04907334760446654,"score_gpt":0.3875400082209513,"score_spread":0.3384666606164848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090950165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871712,0.009426282,0.000114198265,0.00093904574,0.0001619291,0.0019185113,0.000039587332,0.000018861221,0.00021039447],"genre_scores_gemma":[0.98853576,0.005309752,0.001438031,0.00026220546,0.0011306237,0.0017370798,0.000026585174,0.00007655027,0.0014834137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967946,0.00026234536,0.0004924479,0.0011151787,0.00056582614,0.00076961145],"domain_scores_gemma":[0.998537,0.00005072421,0.00014982809,0.00047408557,0.0004064485,0.0003818957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009285957,0.00030297492,0.00044633215,0.00013413458,0.00018173624,0.00007208481,0.00035490707,0.00045111618,0.00006934672],"category_scores_gemma":[0.00008555328,0.00021341415,0.00008443491,0.0004314889,0.00047091313,0.000018654715,0.0003186537,0.0008121048,0.0000029709372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034189525,0.0004160651,0.02538024,0.0002638714,0.000048368405,0.000016128695,0.00025938812,0.0001693258,0.9610014,0.0000024811668,0.002151465,0.0068722935],"study_design_scores_gemma":[0.00875516,0.0013314058,0.028780071,0.0015019233,0.00004210628,0.0000053149192,0.00014800004,0.000068144,0.9430512,0.000039718198,0.015795706,0.0004812146],"about_ca_topic_score_codex":0.0014593678,"about_ca_topic_score_gemma":0.0017878246,"teacher_disagreement_score":0.017950185,"about_ca_system_score_codex":0.000086130734,"about_ca_system_score_gemma":0.0010685105,"threshold_uncertainty_score":0.87027764},"labels":[],"label_agreement":null},{"id":"W2090985692","doi":"10.1158/1078-0432.ccr-07-5103","title":"RHAMM, p21 Combined Phenotype Identifies Microsatellite Instability-High Colorectal Cancers with a Highly Adverse Prognosis","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Microsatellite instability; Immunohistochemistry; Hazard ratio; Internal medicine; Colorectal cancer; Medicine; Tissue microarray; Epidermal growth factor receptor; Pathology; Oncology; Cancer research; Receptor; Gastroenterology; Cancer; Biology; Confidence interval; Microsatellite; Gene","score_opus":0.1424664337766563,"score_gpt":0.43913084560189386,"score_spread":0.29666441182523756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090985692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078953,0.0013791808,0.0000032848407,0.0021501079,0.00062271865,0.0025427905,0.00009170644,0.00018816472,0.0022325132],"genre_scores_gemma":[0.9923341,0.0027476598,0.00030561752,0.00028103506,0.00046650512,0.001287503,0.000093535775,0.000090545545,0.0023934846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99392396,0.00068497146,0.001021562,0.0013529146,0.0017830032,0.0012335856],"domain_scores_gemma":[0.99533904,0.00138879,0.00018244433,0.00077088043,0.0014109993,0.0009078214],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013863979,0.00041827196,0.0011435976,0.00026304723,0.0005305323,0.000047983984,0.00041488738,0.00033921492,0.0011873128],"category_scores_gemma":[0.00078534835,0.00031492003,0.00035494156,0.0018187222,0.0030470286,0.00022280945,0.00032078635,0.0016040187,0.00025887947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04147442,0.0018603789,0.93984586,0.00027504266,0.00081847777,0.0018025388,0.0006571898,0.000016975864,0.0013947152,0.000084024396,0.002532142,0.009238225],"study_design_scores_gemma":[0.013788565,0.010433547,0.94761086,0.00066184485,0.00022070752,0.00008871932,0.0002241957,0.000045555513,0.011568668,0.00015667081,0.014668752,0.00053191173],"about_ca_topic_score_codex":0.0070676217,"about_ca_topic_score_gemma":0.0035078428,"teacher_disagreement_score":0.027685855,"about_ca_system_score_codex":0.0018635003,"about_ca_system_score_gemma":0.0033188653,"threshold_uncertainty_score":0.99993026},"labels":[],"label_agreement":null},{"id":"W2092191811","doi":"10.1158/1078-0432.ccr-05-1980","title":"Genomic Alterations in Human Malignant Glioma Cells Associate with the Cell Resistance to the Combination Treatment with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Chemotherapy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; University of Pennsylvania","keywords":"Glioma; Biology; Cancer research; Comparative genomic hybridization; Fluorescence in situ hybridization; Chemotherapy; Apoptosis; Karyotype; Gene; Genetics; Chromosome","score_opus":0.034452235452986466,"score_gpt":0.3539885969643744,"score_spread":0.3195363615113879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092191811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540925,0.00034325995,0.00006930065,0.003181639,0.000035767946,0.00072160416,0.000023124589,0.000004902301,0.0002111621],"genre_scores_gemma":[0.995453,0.0002641516,0.000058607413,0.00010047387,0.00011509637,0.0001446481,0.000032440992,0.000021567437,0.0038100036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986204,0.00022949827,0.000274408,0.00039620025,0.00021420723,0.00026531742],"domain_scores_gemma":[0.99934775,0.00009001041,0.00009737344,0.00028512525,0.00012436406,0.000055383658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007600032,0.00012141487,0.00014592976,0.000046548845,0.00036956274,0.00009887076,0.0001339036,0.0000892041,0.000007712371],"category_scores_gemma":[0.0000075271196,0.00006280412,0.000038809172,0.00023134117,0.00012769371,0.0000049600335,0.000041465388,0.00016264227,0.0000016143446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049711147,0.00022190124,0.0044150045,0.000009464793,0.000039817405,0.0000031011446,0.00029979597,0.0004513943,0.99197054,0.00008243751,0.00086234306,0.0011470628],"study_design_scores_gemma":[0.0029803196,0.0016316359,0.066656835,0.000051534076,0.000019125493,0.0000011220451,0.00013261475,0.00012877835,0.921721,0.00011370865,0.0063958564,0.0001674986],"about_ca_topic_score_codex":0.0008749902,"about_ca_topic_score_gemma":0.0068987017,"teacher_disagreement_score":0.070249595,"about_ca_system_score_codex":0.000101153004,"about_ca_system_score_gemma":0.00011304409,"threshold_uncertainty_score":0.38496375},"labels":[],"label_agreement":null},{"id":"W2092860006","doi":"10.1158/1078-0432.ccr-14-1549","title":"Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate–Treated Castration-Resistant Prostate Cancer Patients","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Abiraterone acetate; Prostate cancer; Medicine; Prostate; Prostate-specific antigen; Urology; Castration; Oncology; Antigen; Internal medicine; Abiraterone; Cancer; Immunology; Hormone; Androgen receptor; Androgen deprivation therapy","score_opus":0.2623718972814189,"score_gpt":0.4778958899465421,"score_spread":0.21552399266512318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092860006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896762,0.0040796627,0.000002876523,0.0024238417,0.00033571987,0.0025923941,0.0002897181,0.00004714158,0.00055245135],"genre_scores_gemma":[0.9860883,0.009875101,0.000063538675,0.000044556695,0.00040443172,0.0003960792,0.00048399172,0.00006751254,0.0025765318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948478,0.0007120283,0.0010390274,0.00088346325,0.0015156348,0.0010020963],"domain_scores_gemma":[0.9966158,0.00046521027,0.00016127595,0.0004029903,0.0015449955,0.0008096874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023564666,0.00030414062,0.0007205274,0.0003510924,0.00015668228,0.00014314627,0.00015823083,0.00028538177,0.00012107797],"category_scores_gemma":[0.0003555367,0.00023873246,0.00007945928,0.00083759526,0.0007133047,0.0002545108,0.00019780558,0.0011726135,0.000051054303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007942492,0.000616429,0.97342527,0.00012664226,0.000111790054,0.0001170581,0.00077164685,0.00005080899,0.0014902363,0.000016631677,0.0023001377,0.013030842],"study_design_scores_gemma":[0.014866114,0.0033419663,0.972669,0.00036319744,0.000037285434,9.3568116e-7,0.00020395801,0.00020209303,0.0011583884,0.0002068122,0.0066959253,0.00025433503],"about_ca_topic_score_codex":0.0032226103,"about_ca_topic_score_gemma":0.0012116906,"teacher_disagreement_score":0.012776506,"about_ca_system_score_codex":0.00094673893,"about_ca_system_score_gemma":0.0010427411,"threshold_uncertainty_score":0.9735227},"labels":[],"label_agreement":null},{"id":"W2092865563","doi":"10.1158/1078-0432.ccr-11-1759","title":"Validation of Genetic Sequence Variants as Prognostic Factors in Early-Stage Head and Neck Squamous Cell Cancer Survival","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"ERCC1; Oncology; XRCC1; Internal medicine; Biology; Cancer; Head and neck cancer; Proportional hazards model; ERCC2; Medicine; XRCC3; DNA repair; Cancer research; Genotype; Single-nucleotide polymorphism; Genetics; Nucleotide excision repair; Gene","score_opus":0.4444109265001216,"score_gpt":0.5233155150313068,"score_spread":0.0789045885311852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092865563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413186,0.001931951,0.000003853741,0.00024903315,0.00029157355,0.0007975866,0.000046453515,0.000018764298,0.0025289261],"genre_scores_gemma":[0.99477375,0.0039374093,0.00012006436,0.000059382593,0.00014769653,0.00016027984,0.0000038286616,0.000029179497,0.0007684154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971067,0.00041113267,0.0007040541,0.0005443294,0.0006721477,0.00056167145],"domain_scores_gemma":[0.99797434,0.00088729104,0.00010981109,0.0003258489,0.0003947312,0.0003079519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013579635,0.00016482522,0.0006138531,0.00016867355,0.00008439421,0.000013890332,0.00017006454,0.00017501913,0.0005195303],"category_scores_gemma":[0.0012189196,0.00013411406,0.00007454644,0.000511625,0.0005494243,0.000081639664,0.0001603864,0.0007277494,0.000017135382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007187559,0.00034153785,0.9929483,0.00035260126,0.00002637316,0.000068456495,0.0017644024,0.0000028427212,0.0011032163,0.000025046034,0.000080113794,0.0025683718],"study_design_scores_gemma":[0.0022472532,0.0019304358,0.9882754,0.00032850442,0.000033837343,0.0000011051147,0.00026440236,0.000043880525,0.006350682,0.00011527715,0.00027883938,0.00013035248],"about_ca_topic_score_codex":0.0334788,"about_ca_topic_score_gemma":0.0027339307,"teacher_disagreement_score":0.030744871,"about_ca_system_score_codex":0.00015084537,"about_ca_system_score_gemma":0.00094470364,"threshold_uncertainty_score":0.9729574},"labels":[],"label_agreement":null},{"id":"W2093783077","doi":"10.1158/1078-0432.ccr-06-2309","title":"Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1075,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medicine; Bevacizumab; Irinotecan; Glioma; Surgery; Internal medicine; Chemotherapy; Gastroenterology; Cancer; Colorectal cancer","score_opus":0.2874148997796409,"score_gpt":0.5805459813262088,"score_spread":0.2931310815465679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093783077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335897,0.0025784625,0.0000019859247,0.002116848,0.000264248,0.001086727,0.000018716411,0.000009085159,0.00056497334],"genre_scores_gemma":[0.99769175,0.0016635215,0.00007147694,0.000039573588,0.00033951108,0.00011452743,0.0000066649504,0.000013894045,0.000059087564],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99746543,0.00018880732,0.0008193247,0.00040588825,0.0006524184,0.00046813677],"domain_scores_gemma":[0.9980808,0.0009261773,0.00008328607,0.0003395473,0.00022713412,0.0003430408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044257,0.000108229666,0.0004911741,0.0003507585,0.000069022695,0.000009201764,0.00009951938,0.00014188998,0.00016313391],"category_scores_gemma":[0.0009357502,0.00008036046,0.00011947663,0.0005703453,0.0003560467,0.000029108018,0.00016152665,0.0004963905,0.0000073143487],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15647005,0.028178047,0.024712544,0.00013730295,0.00011287969,0.0011894167,0.00023452296,2.6800507e-7,0.0027144437,0.00040311395,0.0015916498,0.78425574],"study_design_scores_gemma":[0.6986326,0.11713113,0.1119668,0.0012279272,0.00014202048,0.000042645104,0.00031494466,0.00009493876,0.047711678,0.00065741374,0.021786116,0.0002917542],"about_ca_topic_score_codex":0.00066541956,"about_ca_topic_score_gemma":0.00071659195,"teacher_disagreement_score":0.783964,"about_ca_system_score_codex":0.00016991672,"about_ca_system_score_gemma":0.0003055321,"threshold_uncertainty_score":0.32770047},"labels":[],"label_agreement":null},{"id":"W2093916414","doi":"10.1158/1078-0432.ccr-05-1664","title":"The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":496,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Doxorubicin; Distribution (mathematics); Hypoxia (environmental); Pathology; Cancer research; Medicine; Biology; Chemistry; Chemotherapy; Internal medicine; Oxygen","score_opus":0.09744040762682671,"score_gpt":0.4903308333198168,"score_spread":0.3928904256929901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093916414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97215945,0.0003928359,0.0000112340485,0.026016323,0.000107940345,0.0008310883,0.000010201008,0.0000073046413,0.00046365],"genre_scores_gemma":[0.9979335,0.0007477116,0.000014057324,0.00038199688,0.00039517248,0.00010079373,0.00000606416,0.000011438072,0.00040925673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976487,0.0004803626,0.00063883065,0.00026064084,0.0006342876,0.0003371913],"domain_scores_gemma":[0.99834603,0.0008672589,0.00007710093,0.0003938766,0.0002194752,0.000096246666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004556104,0.0000764946,0.00026998683,0.00007024501,0.000102483595,0.000015538242,0.00019894615,0.00011002886,0.000028217904],"category_scores_gemma":[0.0016578953,0.000047936617,0.00010727222,0.00096184143,0.00030177998,0.00006204199,0.00007497643,0.0009459929,0.000009718266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025130834,0.0010834393,0.69607615,0.00015155633,0.00010424368,0.000014187893,0.0023407259,0.0015448207,0.15047601,0.0017518355,0.0050032577,0.13894066],"study_design_scores_gemma":[0.001813205,0.00011809389,0.8171142,0.00049521355,0.000012913037,0.000001808042,0.00018646239,0.00038562654,0.17617388,0.000432999,0.00320633,0.000059265363],"about_ca_topic_score_codex":0.00053772365,"about_ca_topic_score_gemma":0.0019005791,"teacher_disagreement_score":0.1388814,"about_ca_system_score_codex":0.00033997258,"about_ca_system_score_gemma":0.0004708976,"threshold_uncertainty_score":0.4109921},"labels":[],"label_agreement":null},{"id":"W2094557342","doi":"10.1158/1078-0432.ccr-14-0959","title":"Molecular Pathways: Leveraging the BCL-2 Interactome to Kill Cancer Cells—Mitochondrial Outer Membrane Permeabilization and Beyond","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Autophagy; Bcl-2 family; Endoplasmic reticulum; Apoptosis; Interactome; Cancer; Mitochondrion; Programmed cell death; Biology; Cancer research; Unfolded protein response; Cancer cell; Cell biology; Genetics; Gene","score_opus":0.22788029592145786,"score_gpt":0.4959826187632003,"score_spread":0.26810232284174246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094557342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032642593,0.9916963,0.0003242848,0.00047518712,0.002064045,0.0018245992,0.00011877554,0.000013336336,0.000219204],"genre_scores_gemma":[0.0012827247,0.99335456,0.00011463998,0.00033323842,0.0026031916,0.0006607752,0.00020828939,0.000096223106,0.0013463603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591357,0.0010395935,0.0008018313,0.0010635874,0.0006528557,0.00052855845],"domain_scores_gemma":[0.99789876,0.00019188144,0.00019585718,0.0007777664,0.00057847606,0.00035723508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020150864,0.00036426357,0.0008518592,0.00014105326,0.00018592531,0.00015709132,0.000563315,0.0006424163,0.00009715255],"category_scores_gemma":[0.00033180614,0.00023701774,0.00035445526,0.00033903486,0.00024062114,0.00000845543,0.00075036386,0.0008403064,0.000027747097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012539758,0.00007108333,0.0000053595604,0.0015215449,0.00018354518,0.000014456408,0.00014472079,0.00009406207,0.012292663,0.000058146525,0.0064537358,0.97903526],"study_design_scores_gemma":[0.00040467683,0.00027184168,0.0000039305246,0.0010326898,0.0001474937,0.000006890058,0.00004152201,0.0000749155,0.0011612274,0.00007531322,0.99646163,0.00031786447],"about_ca_topic_score_codex":0.0001267909,"about_ca_topic_score_gemma":0.00012440862,"teacher_disagreement_score":0.9900079,"about_ca_system_score_codex":0.00014827869,"about_ca_system_score_gemma":0.0009546441,"threshold_uncertainty_score":0.9665303},"labels":[],"label_agreement":null},{"id":"W2095911832","doi":"10.1158/1078-0432.ccr-09-1611","title":"Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Research in Immunology and Cancer; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Celldex Therapeutics","keywords":"Breast cancer; Medicine; Cancer; Triple-negative breast cancer; Oncology; CA15-3; Tissue microarray; Internal medicine; Metastasis; Antibody-drug conjugate; Cancer research; Targeted therapy; Population; Clinical significance; Antibody; Immunology; Monoclonal antibody","score_opus":0.10772947021456651,"score_gpt":0.47237341969999735,"score_spread":0.36464394948543083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095911832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636054,0.0021181828,0.00008821254,0.0004388324,0.00013205982,0.00055213686,0.000289398,0.000005471332,0.000015161534],"genre_scores_gemma":[0.99825925,0.00037506706,0.0004974006,0.00018447227,0.00022538978,0.00037224774,0.000021011037,0.000026590807,0.00003855603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772793,0.00026247755,0.0004897105,0.0006370698,0.0004741502,0.00040866595],"domain_scores_gemma":[0.99873185,0.00017304906,0.0001284451,0.00046331275,0.000229169,0.00027419146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017376766,0.00014348149,0.00025486236,0.000111288304,0.00006410123,0.00003135168,0.0004494877,0.00022477728,0.0003415052],"category_scores_gemma":[0.000430065,0.0001263037,0.00005902603,0.000228103,0.00071494345,0.000010073434,0.00023468444,0.00075241603,0.0000049542577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066829514,0.0008155489,0.7177712,0.00013548564,0.00006555083,0.0000044838553,0.0001243964,0.000008395026,0.2590586,0.000031415027,0.00013594032,0.021180738],"study_design_scores_gemma":[0.0018464171,0.0006071197,0.9294434,0.00017248472,0.000026029042,0.000007685277,0.00009218944,0.0002805467,0.06497048,0.00037642376,0.0018978277,0.00027935722],"about_ca_topic_score_codex":0.0005551496,"about_ca_topic_score_gemma":0.00077635655,"teacher_disagreement_score":0.21167228,"about_ca_system_score_codex":0.00002005733,"about_ca_system_score_gemma":0.0010230066,"threshold_uncertainty_score":0.51505154},"labels":[],"label_agreement":null},{"id":"W2096139566","doi":"10.1158/1078-0432.ccr-08-2383","title":"DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Japan Society for the Promotion of Science; National Cancer Institute; National Institutes of Health; Gary Bennett Family Fund; Entertainment Industry Foundation","keywords":"DNA methylation; MLH1; Microsatellite instability; Biology; CpG site; Cancer research; Methylation; DNMT3B; Colorectal cancer; CDKN2A; Methyltransferase; Genetics; Molecular biology; Oncology; Cancer; Medicine; DNA mismatch repair; Microsatellite; Gene expression; Gene; Allele","score_opus":0.08936718973930444,"score_gpt":0.4964698144373147,"score_spread":0.4071026246980103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096139566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883529,0.007590698,0.00046248804,0.001967308,0.00032138207,0.000488555,0.00006965724,0.000008175502,0.00073882774],"genre_scores_gemma":[0.99413234,0.0034919714,0.0002451887,0.00037675223,0.0009170951,0.00019097308,0.000039729377,0.000019585066,0.0005863646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745965,0.000491698,0.00047595854,0.0006164204,0.00041294584,0.0005433349],"domain_scores_gemma":[0.9987917,0.00017854791,0.00006543258,0.00030481283,0.00036567953,0.00029383012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002147737,0.0001446865,0.0002776181,0.00010709673,0.00010474057,0.00004116888,0.00031066692,0.00031984143,0.00020398683],"category_scores_gemma":[0.0009573394,0.00012524649,0.00009698575,0.00035966004,0.000103016864,0.000005392248,0.00015997168,0.0004481707,0.000026256426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010026388,0.00016899208,0.04475872,0.000008986462,0.000021938486,0.0000065820864,0.0000572088,0.00020551194,0.9149479,0.000040417206,0.0069420068,0.031839076],"study_design_scores_gemma":[0.0014808949,0.0010705636,0.15783116,0.00006442315,0.0000077109,1.6332609e-7,0.000018185112,0.00008288815,0.7393535,0.00077977695,0.09907934,0.000231432],"about_ca_topic_score_codex":0.00029361687,"about_ca_topic_score_gemma":0.0017797622,"teacher_disagreement_score":0.17559445,"about_ca_system_score_codex":0.00007603777,"about_ca_system_score_gemma":0.0003378473,"threshold_uncertainty_score":0.51074034},"labels":[],"label_agreement":null},{"id":"W2096382704","doi":"10.1158/1078-0432.ccr-05-2106","title":"Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Internal medicine; Debulking; Kallikrein; Cancer; Oncology; Biomarker; Ovarian carcinoma; Ovarian tumor; Gastroenterology; Population; Ovary; Pathology; Biology; Enzyme","score_opus":0.17788709505015693,"score_gpt":0.5011132889933266,"score_spread":0.3232261939431697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096382704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97373545,0.00470769,0.000012330006,0.010543777,0.00017887379,0.0021006938,0.000030093326,0.00006567047,0.008625414],"genre_scores_gemma":[0.95678693,0.00022233516,0.00015847983,0.00059143273,0.0013675097,0.0010141048,0.000026905518,0.000060518545,0.039771773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958274,0.00041014433,0.0010113532,0.00078456005,0.0010039336,0.00096265884],"domain_scores_gemma":[0.998181,0.0003799275,0.00011955022,0.0005456601,0.00045709294,0.00031676167],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029790534,0.00022193027,0.0005913444,0.00028670437,0.00023347596,0.00007891797,0.0002691375,0.00030667242,0.004364234],"category_scores_gemma":[0.00048645696,0.0001949503,0.00020431656,0.0010159283,0.00046536681,0.00012478387,0.00014326964,0.0011039064,0.00013129579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051545294,0.0007262896,0.9570305,0.00024187725,0.000058535064,0.00012218379,0.00011280218,0.000014045072,0.0024642355,0.0012434055,0.0283875,0.0090832],"study_design_scores_gemma":[0.0036796895,0.00042132227,0.9525179,0.0010030031,0.000037491194,0.0000032901419,0.000046264802,0.00046388953,0.001999676,0.003308516,0.036268543,0.00025039414],"about_ca_topic_score_codex":0.03151099,"about_ca_topic_score_gemma":0.007925792,"teacher_disagreement_score":0.03114636,"about_ca_system_score_codex":0.000341589,"about_ca_system_score_gemma":0.0011965755,"threshold_uncertainty_score":0.9965459},"labels":[],"label_agreement":null},{"id":"W2096465543","doi":"10.1158/1078-0432.ccr-14-1213","title":"Intratumoral Heterogeneity: From Diversity Comes Resistance","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Epigenetics; Cancer; Biology; Cancer research; Disease; Cancer cell; Chemotherapy; Immunology; Medicine; Genetics; Pathology; Gene","score_opus":0.44339554056848224,"score_gpt":0.5623207732485241,"score_spread":0.1189252326800419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096465543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018702844,0.99372435,0.000008322512,0.000110092915,0.0010645366,0.0005991831,0.0017367917,0.000012418839,0.0008739996],"genre_scores_gemma":[0.00027509464,0.993617,0.00011292573,0.00016343263,0.0032710237,0.00014150476,0.00083458755,0.0000686773,0.0015157681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99586314,0.0009112543,0.0007823304,0.0011727303,0.0006420931,0.0006284316],"domain_scores_gemma":[0.9969734,0.00052929745,0.00024395205,0.001200247,0.00054154464,0.000511573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023669086,0.00035489598,0.0013770938,0.00008799571,0.00027642914,0.00010270865,0.0012459235,0.00078148884,0.000081678234],"category_scores_gemma":[0.0010580795,0.00031963168,0.0006136954,0.00028378042,0.00062384247,0.0000034638956,0.00320602,0.0011687633,0.00012247777],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028538628,0.00017289908,0.0015750387,0.001402558,0.0005143029,0.00006310996,0.000015166772,0.0000010850051,0.0000035028413,0.000060429644,0.3166527,0.6792538],"study_design_scores_gemma":[0.0004362555,0.00019404378,0.0000646376,0.0010080582,0.00017983122,0.0000011734869,0.00000924067,6.670034e-7,0.000015507667,0.00029012572,0.9974487,0.00035175608],"about_ca_topic_score_codex":0.00050127186,"about_ca_topic_score_gemma":0.003247866,"teacher_disagreement_score":0.680796,"about_ca_system_score_codex":0.000256969,"about_ca_system_score_gemma":0.002419752,"threshold_uncertainty_score":0.99992555},"labels":[],"label_agreement":null},{"id":"W2096574915","doi":"10.1158/1078-0432.ccr-05-2038","title":"A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Tolerability; Medicine; Desensitization (medicine); Adverse effect; Oncolytic virus; Regimen; Internal medicine; Dosing; Cohort; Cancer; Gastroenterology; Surgery","score_opus":0.2512174761703061,"score_gpt":0.5851435929750995,"score_spread":0.33392611680479345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096574915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978953,0.00031500714,0.0004291775,0.00004687064,0.00012807516,0.0009771897,0.000061546794,0.000008639701,0.00013818435],"genre_scores_gemma":[0.99817497,0.0002568176,0.00028018822,0.000034177116,0.0009892177,0.000042329008,0.00010049883,0.000041969248,0.00007984445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99413466,0.0025186732,0.0013919523,0.00066911266,0.0008420234,0.0004435951],"domain_scores_gemma":[0.9972082,0.000313953,0.00029817814,0.0008001957,0.0011674027,0.00021206836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006236507,0.00015857024,0.0004666559,0.00014898815,0.00012562292,0.000029872708,0.0004157615,0.00026619175,0.000060370785],"category_scores_gemma":[0.0006444399,0.0001550179,0.00013962507,0.00052251347,0.0006718283,0.0000120420955,0.00016429715,0.00051509234,0.0000038617436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03798358,0.025182173,0.021593273,0.000082085106,0.00024290105,0.000050403178,0.000107405656,0.0011612407,0.8280704,0.000035619552,0.0005036748,0.08498727],"study_design_scores_gemma":[0.0295068,0.24591035,0.012415828,0.00013087568,0.00016091656,0.000017897542,0.0010551087,0.015145855,0.6931106,0.00027835573,0.0016203137,0.0006471153],"about_ca_topic_score_codex":0.0018923975,"about_ca_topic_score_gemma":0.012487826,"teacher_disagreement_score":0.22072817,"about_ca_system_score_codex":0.000065294,"about_ca_system_score_gemma":0.0016593985,"threshold_uncertainty_score":0.69685},"labels":[],"label_agreement":null},{"id":"W2096651314","doi":"10.1158/1078-0432.ccr-12-3166","title":"A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Cancer Institute; Merck Sharp and Dohme","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Adverse effect; Tolerability; Pharmacology; Toxicity; Refractory (planetary science); Internal medicine; Oncology","score_opus":0.05185369558170813,"score_gpt":0.4665576708053146,"score_spread":0.41470397522360647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096651314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971483,0.0010410682,0.0000037438235,0.00006582874,0.0001770677,0.0014655711,0.00003569197,0.000005832259,0.00005694302],"genre_scores_gemma":[0.99809414,0.0010955144,0.000029039928,0.00007933116,0.00021885475,0.00037361542,0.00001795202,0.000038551338,0.000053025553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971512,0.00041731773,0.00073534023,0.00064890564,0.0005099941,0.00053725054],"domain_scores_gemma":[0.998643,0.00023142698,0.00016368243,0.00036262436,0.0003911073,0.00020818021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010508522,0.00018492596,0.0003668996,0.00021200204,0.000049384784,0.00002059752,0.00035970862,0.00011860135,0.0001204922],"category_scores_gemma":[0.00029733364,0.00015975235,0.000045371133,0.00034964565,0.0002919373,0.000015722933,0.00025910555,0.00063821796,0.0000061777987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031891407,0.0053473273,0.96852666,0.00012275993,0.0000655964,0.000016325004,0.00020147307,0.00029645726,0.006425143,1.9444344e-7,0.00066490925,0.0151440175],"study_design_scores_gemma":[0.06507847,0.014019258,0.9101007,0.00020893717,0.00006454038,7.763837e-7,0.00043191997,0.0028885163,0.0050943666,0.000013510166,0.0015408308,0.00055819517],"about_ca_topic_score_codex":0.001167532,"about_ca_topic_score_gemma":0.0008520654,"teacher_disagreement_score":0.061889324,"about_ca_system_score_codex":0.00009641075,"about_ca_system_score_gemma":0.00020797765,"threshold_uncertainty_score":0.6514512},"labels":[],"label_agreement":null},{"id":"W2096674277","doi":"10.1158/1078-0432.ccr-07-1632","title":"Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Psychosocial; Psychological intervention; Population; Randomized controlled trial; Cervical cancer; Cellular immunity; Quality of life (healthcare); Survivorship curve; Internal medicine; Cancer; Oncology; Psychoneuroimmunology; Immune system; Clinical trial; ELISPOT; Immunology; T cell; Psychiatry","score_opus":0.33210520181570763,"score_gpt":0.55984974275025,"score_spread":0.22774454093454238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096674277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819076,0.01092323,0.000010235746,0.003967793,0.000931644,0.0011225693,0.00017679558,0.000052748477,0.0009074005],"genre_scores_gemma":[0.9565113,0.040246215,0.00006984028,0.0005415877,0.0007020142,0.00036717067,0.00002380187,0.000045853318,0.0014922068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926523,0.002587337,0.0020289198,0.0006993176,0.0013587881,0.0006733145],"domain_scores_gemma":[0.99338377,0.003813679,0.00024837433,0.00083487865,0.0009890918,0.0007302242],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009165443,0.0002626643,0.0026123677,0.00021479667,0.00021547537,0.000023754972,0.00040427072,0.0004858875,0.0013204825],"category_scores_gemma":[0.0027620501,0.00019233415,0.00097328995,0.00056988036,0.004802291,0.00008641934,0.0004092354,0.0022477934,0.00001628919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036051366,0.00085295667,0.90470695,0.00018241182,0.00023913957,0.00008154684,0.00053335505,3.704166e-7,0.000026847845,0.000107490334,0.0021359252,0.055081654],"study_design_scores_gemma":[0.10285171,0.00085582613,0.8868827,0.00035290784,0.00038134743,0.000018144417,0.0005293542,0.000071345115,0.00018902752,0.00018246142,0.0074211676,0.00026395303],"about_ca_topic_score_codex":0.026416093,"about_ca_topic_score_gemma":0.008255036,"teacher_disagreement_score":0.06680035,"about_ca_system_score_codex":0.0001126147,"about_ca_system_score_gemma":0.0015303139,"threshold_uncertainty_score":0.9995924},"labels":[],"label_agreement":null},{"id":"W2096688512","doi":"10.1158/1078-0432.ccr-06-1317","title":"Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":311,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University; Vancouver General Hospital; University of British Columbia","funders":"National Institute of Dental and Craniofacial Research","keywords":"Pathology; Dysplasia; Biopsy; Subclinical infection; Loss of heterozygosity; Cancer; Histology; Carcinoma; Medicine; Epithelial dysplasia; Field cancerization; Biology; Basal cell; Internal medicine; Genetics; Allele","score_opus":0.16247608680602926,"score_gpt":0.5561283828978899,"score_spread":0.39365229609186064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096688512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984806,0.0002260204,0.00007468706,0.00011754648,0.0004501615,0.00037195417,0.0000639404,0.000007886628,0.0002071668],"genre_scores_gemma":[0.9992443,0.0001284564,0.000056233737,0.00004122528,0.00008910354,0.00014724137,0.000017914135,0.000008446522,0.000267109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786556,0.0006239121,0.0006898962,0.00024116527,0.00033560084,0.00024386885],"domain_scores_gemma":[0.99869204,0.0005381757,0.00014673779,0.00017371793,0.00039959728,0.00004975651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009629843,0.00006692946,0.0002262976,0.00014013467,0.000087998655,0.0000060077073,0.00011007749,0.00012582888,0.00027741652],"category_scores_gemma":[0.00035174206,0.000060886476,0.00005539335,0.00045217638,0.00016802229,0.00007580601,0.000052124884,0.00037462532,0.000018916986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046612456,0.0008068747,0.98712784,0.00010455915,0.00000791877,0.000009948668,0.000044886598,0.00003922998,0.0007826391,0.00025993356,0.00052311615,0.009826934],"study_design_scores_gemma":[0.0012268126,0.0005618348,0.97262317,0.000108591375,0.000008534977,3.7401864e-7,0.000020862348,0.0004205124,0.02441859,0.00033500118,0.00022473659,0.00005099198],"about_ca_topic_score_codex":0.020022225,"about_ca_topic_score_gemma":0.03734868,"teacher_disagreement_score":0.02363595,"about_ca_system_score_codex":0.00013411845,"about_ca_system_score_gemma":0.00019499418,"threshold_uncertainty_score":0.98650354},"labels":[],"label_agreement":null},{"id":"W2096806100","doi":"10.1158/1078-0432.ccr-08-0706","title":"High-Throughput Screening Identifies Cardiac Glycosides as Potent Inhibitors of Human Tissue Kallikrein Expression: Implications for Cancer Therapies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Proteases; Cancer; Biology; Kallikrein; Cancer research; Oncogene; Angiogenesis; Computational biology; Cell cycle; Genetics; Biochemistry; Enzyme","score_opus":0.28760387254845543,"score_gpt":0.5326923560664861,"score_spread":0.2450884835180307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096806100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661029,0.021728149,0.00025127994,0.009569596,0.0005826393,0.0013527387,0.00013663124,0.000075665375,0.0002003975],"genre_scores_gemma":[0.98313475,0.007912632,0.00095149287,0.00020536044,0.0022454238,0.0008839717,0.0000779976,0.00005926034,0.004529092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682266,0.00024659323,0.0010125566,0.0006308086,0.0007310715,0.0005563372],"domain_scores_gemma":[0.9964825,0.0011747129,0.00023083366,0.0006376891,0.0011763597,0.00029791088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013634913,0.00020810042,0.0007465608,0.00018369593,0.0007288477,0.00003631731,0.00027941586,0.00023219621,0.0003794974],"category_scores_gemma":[0.00061592995,0.00017489138,0.00037737814,0.00043716037,0.000993513,0.00016748733,0.00017362488,0.00043753308,0.000012863678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016654381,0.00078012235,0.60022616,0.0005761272,0.0008012464,0.000020554357,0.0029074072,0.0001101484,0.15513656,0.0040357066,0.11566777,0.11807277],"study_design_scores_gemma":[0.0027692462,0.0011813596,0.6909698,0.0010065594,0.00014196604,0.0000065788986,0.0006268075,0.000019366329,0.25180548,0.004407979,0.046721637,0.0003431957],"about_ca_topic_score_codex":0.0062380047,"about_ca_topic_score_gemma":0.0003152984,"teacher_disagreement_score":0.117729574,"about_ca_system_score_codex":0.00011458231,"about_ca_system_score_gemma":0.0005892351,"threshold_uncertainty_score":0.94300383},"labels":[],"label_agreement":null},{"id":"W2096822640","doi":"10.1158/1078-0432.ccr-07-4946","title":"Translocations Involving the Immunoglobulin Heavy Chain Gene Locus Predict Better Survival in Gastric Diffuse Large B-Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL; Wellcome Trust","keywords":"BCL6; Chromosomal translocation; Fluorescence in situ hybridization; Lymphoma; Biology; MALT lymphoma; Germinal center; Immunoglobulin heavy chain; Immunophenotyping; Pathology; Mucosa-associated lymphoid tissue; Diffuse large B-cell lymphoma; Gene rearrangement; BCL10; Cancer research; B cell; Immunology; Antibody; Medicine; Genetics; Antigen; Gene; Chromosome","score_opus":0.14671510116045278,"score_gpt":0.42349920412208497,"score_spread":0.2767841029616322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096822640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97492546,0.010485202,0.000034509503,0.0124359075,0.0002695599,0.0010404249,0.000073862204,0.000039639628,0.00069543364],"genre_scores_gemma":[0.9816597,0.014949402,0.00012426495,0.0008942088,0.00074913655,0.0006624588,0.0000468383,0.000038840182,0.00087514485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959253,0.0007739148,0.0008176792,0.0005919217,0.0009940026,0.00089718914],"domain_scores_gemma":[0.9970708,0.0014829158,0.0000731522,0.00079927215,0.00024603453,0.00032784537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027041999,0.0002120998,0.00051575806,0.00020204968,0.00060339365,0.000029760447,0.0003681826,0.00020143506,0.00020548051],"category_scores_gemma":[0.00041558009,0.00014014106,0.00025839076,0.0010049135,0.0005255779,0.00006353677,0.00020596635,0.0006153166,0.00010386152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011282387,0.02074332,0.93920803,0.00006984818,0.00016725935,0.00062033156,0.00095634966,0.000008872142,0.00027631357,0.00010042338,0.009015708,0.02770528],"study_design_scores_gemma":[0.03516481,0.0011912932,0.9443355,0.0002091047,0.000073908166,0.000043685573,0.00023948384,0.0006344071,0.0019810349,0.00007420558,0.015851887,0.00020068184],"about_ca_topic_score_codex":0.0023859846,"about_ca_topic_score_gemma":0.00089198066,"teacher_disagreement_score":0.034036573,"about_ca_system_score_codex":0.00062219275,"about_ca_system_score_gemma":0.0012259604,"threshold_uncertainty_score":0.5714786},"labels":[],"label_agreement":null},{"id":"W2096844711","doi":"10.1158/1078-0432.ccr-06-0957","title":"CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Fibroblast growth factor receptor 3; Receptor tyrosine kinase; In vivo; Cancer research; Medicine; Fibroblast growth factor; Fibroblast growth factor receptor; Multiple myeloma; Receptor; Tyrosine-kinase inhibitor; Pathology; Biology; Internal medicine; Cancer","score_opus":0.18414792516677891,"score_gpt":0.4696726158016773,"score_spread":0.2855246906348984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096844711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936784,0.0005634943,0.000095210184,0.00236451,0.0000819236,0.0017231577,0.00010808638,0.00005937891,0.0013258238],"genre_scores_gemma":[0.9911733,0.00048642032,0.0038862613,0.00021709099,0.000355223,0.00045897783,0.00008108,0.00007463603,0.003267005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941879,0.0006489735,0.0012230858,0.001099535,0.0013349885,0.0015055375],"domain_scores_gemma":[0.9969315,0.0013593915,0.000110594694,0.00053775654,0.00048125224,0.00057951926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014174988,0.0003315342,0.00081758975,0.00064685644,0.00017334112,0.000087832435,0.00041589938,0.00041138864,0.0004914864],"category_scores_gemma":[0.0023275034,0.00028105068,0.00020596194,0.0012453562,0.00041067816,0.00018576627,0.00031752372,0.0019473712,0.00022069826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036764601,0.0016040514,0.944821,0.0002621733,0.00006941662,0.00036946457,0.00040946377,0.00014143549,0.012641645,0.000025014204,0.003624071,0.032355778],"study_design_scores_gemma":[0.017732637,0.00050962,0.94216466,0.0010489767,0.000009842842,0.000006621431,0.000080683654,0.026526796,0.009615167,0.00022881424,0.0017199937,0.00035617233],"about_ca_topic_score_codex":0.008240698,"about_ca_topic_score_gemma":0.011437025,"teacher_disagreement_score":0.031999607,"about_ca_system_score_codex":0.00078819005,"about_ca_system_score_gemma":0.0016454832,"threshold_uncertainty_score":0.9999642},"labels":[],"label_agreement":null},{"id":"W2096850750","doi":"10.1158/1078-0432.ccr-04-0634","title":"Phase II Study of Feasibility of Dose-Dense FEC Followed by Alternating Weekly Taxanes in High-Risk, Four or More Node-Positive Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Pfizer","keywords":"Medicine; Epirubicin; Regimen; Breast cancer; Surgery; Docetaxel; Internal medicine; Chemotherapy; Cyclophosphamide; Gastroenterology; Cancer","score_opus":0.13489051055253148,"score_gpt":0.5051278133788082,"score_spread":0.3702373028262767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096850750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994662,0.0011920824,0.000009414559,0.0014271229,0.00017161324,0.0010446026,0.001458632,0.000009221308,0.000025323317],"genre_scores_gemma":[0.99766177,0.0013037598,0.000083913066,0.000059933664,0.00027201834,0.00039213974,0.000034266635,0.000039097275,0.0001530971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963109,0.0006626091,0.0009075864,0.0009011613,0.0006787372,0.00053899875],"domain_scores_gemma":[0.9978061,0.00032140632,0.0003709256,0.00063149864,0.00070675457,0.00016334059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015333125,0.0002620812,0.0006945391,0.000095431045,0.00019636354,0.000013078411,0.00044250785,0.00019325252,0.000056887628],"category_scores_gemma":[0.0006806711,0.00020748311,0.00017083852,0.0004522578,0.0006339355,0.000012083043,0.00056202646,0.0005249128,0.0000013895994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018014157,0.014528592,0.92631996,0.00011309896,0.00083024846,0.00006708155,0.0011392024,0.00036604673,0.019284759,0.0000032496496,0.0011556317,0.018177966],"study_design_scores_gemma":[0.054908384,0.012926722,0.89266133,0.0003984915,0.00020740437,0.000009343941,0.0028795262,0.00002460298,0.035370585,0.00007862245,0.00009071958,0.00044426165],"about_ca_topic_score_codex":0.0634766,"about_ca_topic_score_gemma":0.025914665,"teacher_disagreement_score":0.037561934,"about_ca_system_score_codex":0.00028901518,"about_ca_system_score_gemma":0.00069335155,"threshold_uncertainty_score":0.99185985},"labels":[],"label_agreement":null},{"id":"W2096932937","doi":"10.1158/1078-0432.ccr-05-0371","title":"PEX-Producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Glioma; Angiogenesis; Neural stem cell; Stem cell; Cancer research; Pathology; Cell culture; Transfection; Brain tumor; Biology; In vivo; U87; Medicine; Cell biology","score_opus":0.3616759159353036,"score_gpt":0.47574334626769726,"score_spread":0.11406743033239364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096932937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976973,0.000050062994,0.000029114059,0.00097505504,0.00027201767,0.00061009737,0.0000388057,0.00010301214,0.00022451169],"genre_scores_gemma":[0.9961297,0.00013368728,0.000055183493,0.0014327762,0.00054071465,0.00013407037,4.0344568e-7,0.000084299296,0.001489198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9935895,0.0013740389,0.0009870089,0.0016031588,0.0012881733,0.0011581166],"domain_scores_gemma":[0.99721664,0.0014049319,0.00013389633,0.00063880504,0.00018058765,0.00042511203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002457063,0.00026324915,0.0004645943,0.0004190774,0.00039142798,0.00016763188,0.0009297975,0.000116067866,0.00011434876],"category_scores_gemma":[0.00096156896,0.00024390085,0.00017396772,0.0010454576,0.0004047933,0.00030487584,0.0006533366,0.0016126701,0.00021579591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002117156,0.00044976748,0.00052319677,0.00004315761,0.0000017687181,0.00028876826,0.00010211543,0.0023178365,0.99347407,0.00093700504,0.0006289075,0.0010217086],"study_design_scores_gemma":[0.0009822024,0.0003665754,0.00019466999,0.00003721637,0.0000039598785,0.000014073163,0.0000163853,0.038927697,0.95893216,0.00015318644,0.0001413994,0.000230484],"about_ca_topic_score_codex":0.00012257618,"about_ca_topic_score_gemma":0.0002246149,"teacher_disagreement_score":0.036609862,"about_ca_system_score_codex":0.00017467189,"about_ca_system_score_gemma":0.0002504345,"threshold_uncertainty_score":0.9945988},"labels":[],"label_agreement":null},{"id":"W2097079447","doi":"10.1158/1078-0432.ccr-12-3696","title":"USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; University of Seoul; Seoul National University; University of Minnesota","keywords":"Gefitinib; Cancer research; Gene knockdown; Erlotinib; Lung cancer; ERBB3; Gene silencing; T790M; Downregulation and upregulation; Epidermal growth factor receptor; Tyrosine kinase; Biology; Cancer; Cell culture; Signal transduction; Medicine; Oncology; Gene; Cell biology; Biochemistry; Genetics","score_opus":0.1609707046166292,"score_gpt":0.4892345612672475,"score_spread":0.3282638566506183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097079447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97987735,0.009922488,0.0005405388,0.004606235,0.00031108587,0.0016877269,0.000352913,0.000012872938,0.0026887942],"genre_scores_gemma":[0.97675276,0.0024384107,0.004069883,0.0018312187,0.0016042505,0.004145797,0.000049697417,0.000062204366,0.009045785],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975927,0.0001806667,0.0005059938,0.00068303675,0.0003139641,0.00072367414],"domain_scores_gemma":[0.9985386,0.00030448224,0.00008326959,0.0004344327,0.00043747923,0.00020170571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019155656,0.00015154804,0.00027161374,0.00006920395,0.00013835031,0.00006231158,0.0004201139,0.00029975566,0.0007924075],"category_scores_gemma":[0.00086063636,0.0001421515,0.00015667539,0.00021944717,0.00022870406,0.000010156738,0.00023388793,0.00050281547,0.000019958967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022104827,0.0006259415,0.17355204,0.0009092338,0.00022167986,0.0000057796833,0.00041964554,0.000037854807,0.4073639,0.0011464217,0.39564806,0.017858969],"study_design_scores_gemma":[0.005022695,0.00053886446,0.03335622,0.0004397285,0.000015005928,8.912463e-7,0.00011924585,0.0011732369,0.15586635,0.0024229987,0.8004227,0.00062204147],"about_ca_topic_score_codex":0.0009187959,"about_ca_topic_score_gemma":0.0013749383,"teacher_disagreement_score":0.40477464,"about_ca_system_score_codex":0.00008156081,"about_ca_system_score_gemma":0.00053655,"threshold_uncertainty_score":0.8676306},"labels":[],"label_agreement":null},{"id":"W2097112996","doi":"10.1158/1078-0432.ccr-11-0563","title":"Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Follicular phase; Thyroid carcinoma; Medicine; Iodine; Refractory (planetary science); Selumetinib; Internal medicine; Oncology; Thyroid; Cancer; Biology; Chemistry","score_opus":0.21567589773801968,"score_gpt":0.5295338984641391,"score_spread":0.31385800072611947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097112996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98256874,0.013423462,7.819369e-7,0.00043792932,0.00015845863,0.003149309,0.000043352513,0.000025218078,0.00019273395],"genre_scores_gemma":[0.9918894,0.006009537,0.00011376143,0.00018708392,0.00058024685,0.0008082508,0.000019165347,0.00006886392,0.00032370244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954801,0.0007078815,0.0010988861,0.00074890774,0.0010487849,0.0009154157],"domain_scores_gemma":[0.997311,0.00074678723,0.00023952789,0.0006841108,0.000289695,0.0007288565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029766967,0.0003225976,0.0010628402,0.00029366554,0.00018715835,0.000020874848,0.00023071248,0.00014330338,0.00041448575],"category_scores_gemma":[0.00024368528,0.00021416186,0.000104999206,0.00063588,0.0003646091,0.00014457828,0.0002924874,0.0009359417,0.000014138988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017069096,0.029495731,0.92187756,0.0001495444,0.0005909509,0.00020241945,0.0016367534,0.0000016376148,0.0025612363,0.0000030264869,0.0015066249,0.02490543],"study_design_scores_gemma":[0.14827298,0.069398925,0.75845194,0.00047217484,0.00074366305,0.000027975771,0.0021926926,0.00006064859,0.0044839634,0.0000037826558,0.015452834,0.0004384233],"about_ca_topic_score_codex":0.001203027,"about_ca_topic_score_gemma":0.00040587445,"teacher_disagreement_score":0.16342561,"about_ca_system_score_codex":0.00038477944,"about_ca_system_score_gemma":0.0006439899,"threshold_uncertainty_score":0.8733267},"labels":[],"label_agreement":null},{"id":"W2097150676","doi":"10.1158/1078-0432.ccr-09-3013","title":"<i>Fibroblast Growth Factor Receptor 3</i> Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"KWF Kankerbestrijding","keywords":"Concomitant; Urine; Bladder cancer; Medicine; Cystoscopy; Fibroblast growth factor receptor 3; Urology; Internal medicine; Gastroenterology; Proportional hazards model; Prospective cohort study; Cancer; Urinary system; Pathology; Fibroblast growth factor; Receptor","score_opus":0.059444911751871866,"score_gpt":0.426285465540906,"score_spread":0.36684055378903413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097150676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938721,0.00006864421,0.0000866531,0.0014613573,0.00033207887,0.0020827248,0.0018370752,0.000032729757,0.0002266252],"genre_scores_gemma":[0.99652046,0.0002984673,0.00036271915,0.00032894095,0.00069391093,0.00085288327,0.00031610916,0.00007449727,0.0005520048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629235,0.00020383621,0.00077354687,0.00086595514,0.0012058776,0.00065841596],"domain_scores_gemma":[0.99491686,0.00143599,0.00028621207,0.0006347043,0.0022817191,0.00044450688],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068025995,0.00030121795,0.00091849215,0.0003637432,0.00016211328,0.000032388718,0.00027029414,0.00025300324,0.0011051462],"category_scores_gemma":[0.0009464728,0.0002152321,0.00039632004,0.0013175049,0.00051685167,0.00010839989,0.00006396212,0.000898409,0.000024137496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007899396,0.002188832,0.96679896,0.00048772254,0.0028008472,0.000008190775,0.00026912577,0.000046513323,0.0054064835,0.000027530705,0.0042835907,0.009782829],"study_design_scores_gemma":[0.009336935,0.003789706,0.9655832,0.00025095974,0.00033490692,2.2816657e-7,0.00003999037,0.0000707308,0.019521048,0.000052761774,0.00077245425,0.00024704594],"about_ca_topic_score_codex":0.0019446046,"about_ca_topic_score_gemma":0.0059959237,"teacher_disagreement_score":0.014114565,"about_ca_system_score_codex":0.00019920606,"about_ca_system_score_gemma":0.001053655,"threshold_uncertainty_score":0.99980795},"labels":[],"label_agreement":null},{"id":"W2097392662","doi":"10.1158/1078-0432.ccr-08-1970","title":"Quantitative Ultrasound Characterization of Responses to Radiotherapy in Cancer Mouse Models","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Radiation therapy; Ultrasound; Medicine; Nuclear medicine; Head and neck cancer; Cancer; In vivo; Radiology; Pathology; Internal medicine; Biology","score_opus":0.22808522426751734,"score_gpt":0.5001903900467286,"score_spread":0.2721051657792113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097392662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944923,0.00069387397,0.0028112626,0.0010476465,0.00006541054,0.00043012708,0.000116349795,0.000052015403,0.00029103874],"genre_scores_gemma":[0.989726,0.008605564,0.0006365762,0.0002130628,0.00012824716,0.00022983017,0.000010191331,0.000025183974,0.0004253218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859685,0.00017195709,0.0004315124,0.00023324031,0.00027143184,0.00029501587],"domain_scores_gemma":[0.9986003,0.00081992697,0.000028106437,0.0002583119,0.00017409728,0.000119232864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085820886,0.000095533454,0.00025603204,0.00020883828,0.000045807228,0.00002553007,0.00023706582,0.0001017828,0.00013410776],"category_scores_gemma":[0.00016878704,0.00009122957,0.00005208737,0.00069496955,0.000098230725,0.00012908944,0.000009280931,0.00035880302,0.000010785137],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000496865,0.00019136614,0.0048256456,0.0000263108,0.00003278624,0.0000010482962,0.0011768716,0.011095294,0.9620961,0.002042573,0.00045350663,0.017561663],"study_design_scores_gemma":[0.0039531826,0.0022953113,0.75892085,0.00058137794,0.00003176907,0.0000029286596,0.0005932457,0.05953316,0.13385011,0.007342983,0.031653486,0.0012415693],"about_ca_topic_score_codex":0.00023470951,"about_ca_topic_score_gemma":0.00026720064,"teacher_disagreement_score":0.82824594,"about_ca_system_score_codex":0.00015032676,"about_ca_system_score_gemma":0.00012789652,"threshold_uncertainty_score":0.3720234},"labels":[],"label_agreement":null},{"id":"W2097478662","doi":"10.1158/1078-0432.ccr-08-3012","title":"<i>MSH6</i> Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":388,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Royal College of Physicians and Surgeons of Canada; Wellcome Trust","keywords":"Temozolomide; MSH6; Cancer research; Biology; Medicine; Glioma; DNA mismatch repair; DNA repair; Genetics; Gene","score_opus":0.16339379708801627,"score_gpt":0.4951790380765004,"score_spread":0.3317852409884841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097478662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703938,0.009568538,9.313028e-7,0.017932694,0.00008999333,0.00081085885,0.000015229437,0.00004512851,0.0011428744],"genre_scores_gemma":[0.9826726,0.015283375,0.0002606402,0.0006146406,0.00027876775,0.0002521902,0.000008060477,0.000023964089,0.0006058129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971336,0.0003386892,0.00068019953,0.000627605,0.0006041857,0.0006157192],"domain_scores_gemma":[0.9977204,0.0011239354,0.000083092375,0.00044443278,0.0002205476,0.00040759632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015652102,0.00017811013,0.00051294966,0.00031384642,0.00018547365,0.000050173705,0.00014467993,0.00017551867,0.00010624067],"category_scores_gemma":[0.00084701926,0.00014188934,0.000116390984,0.00073859666,0.00038500887,0.00009967898,0.00005713909,0.0008071149,0.00004227573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007320992,0.0027044849,0.88252014,0.00011988758,0.00016720162,0.0020802899,0.00059502386,0.000020764,0.011078859,0.0004826445,0.00744488,0.08546486],"study_design_scores_gemma":[0.00818307,0.00077091734,0.97725457,0.0003230366,0.000021666196,0.000014010544,0.00008017289,0.000052407457,0.0063043865,0.0014926282,0.005352042,0.0001510899],"about_ca_topic_score_codex":0.00023920824,"about_ca_topic_score_gemma":0.0014033822,"teacher_disagreement_score":0.09473445,"about_ca_system_score_codex":0.00022642582,"about_ca_system_score_gemma":0.00028518584,"threshold_uncertainty_score":0.5786079},"labels":[],"label_agreement":null},{"id":"W2097556456","doi":"10.1158/1078-0432.ccr-07-0013","title":"A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Genotype; Genotyping; Bladder cancer; Biology; Single-nucleotide polymorphism; Cancer research; Molecular biology; Cancer; Internal medicine; Gene; Pathology; Medicine; Genetics","score_opus":0.14525737766863403,"score_gpt":0.48464544222902695,"score_spread":0.33938806456039294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097556456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98913515,0.0034279309,0.0000050947765,0.0054461234,0.00016681087,0.0013479952,0.000078251025,0.000027397875,0.000365249],"genre_scores_gemma":[0.99680203,0.0011043901,0.000102156664,0.0008886423,0.00027253732,0.00032839112,0.00002774629,0.00006898615,0.0004051224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951511,0.0005627392,0.0012760712,0.00082795694,0.0010457144,0.0011364189],"domain_scores_gemma":[0.9968007,0.0019840333,0.00013288292,0.00035090707,0.00032559247,0.0004058768],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005086794,0.0002590008,0.00082927034,0.0010110566,0.000082157,0.00004571999,0.00021998631,0.0004289029,0.00025700027],"category_scores_gemma":[0.0028785618,0.00023262153,0.000094796655,0.0019593246,0.0006851594,0.00013274727,0.00015844367,0.0028372032,0.000023419158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025933776,0.00042626756,0.9867188,0.00007158012,0.00006735879,0.0017962742,0.0010917205,0.000027464115,0.0008213782,0.00003775103,0.00035332525,0.005994754],"study_design_scores_gemma":[0.008249347,0.0008581976,0.98713934,0.0009260354,0.000034952176,0.000021008733,0.0007507909,0.00006808951,0.0012359144,0.00018600149,0.00026687732,0.00026341484],"about_ca_topic_score_codex":0.052523416,"about_ca_topic_score_gemma":0.26095238,"teacher_disagreement_score":0.20842896,"about_ca_system_score_codex":0.0014727094,"about_ca_system_score_gemma":0.0027298424,"threshold_uncertainty_score":0.9994633},"labels":[],"label_agreement":null},{"id":"W2097755642","doi":"10.1158/1078-0432.ccr-03-0087","title":"Epithelial-Cadherin and β-Catenin Expression Changes in Pancreatic Intraepithelial Neoplasia","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Pancreatic Intraepithelial Neoplasia; Catenin; Cadherin; Pathology; Wnt signaling pathway; Carcinogenesis; Adenocarcinoma; Adherens junction; Cancer research; GSK-3; Biology; Medicine; Pancreatic cancer; Kinase; Cell; Pancreatic ductal adenocarcinoma; Cancer; Internal medicine; Signal transduction; Cell biology","score_opus":0.09106746560202092,"score_gpt":0.43162321251512603,"score_spread":0.3405557469131051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097755642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948945,0.0025454555,0.000070855574,0.0015745495,0.00027306963,0.00030870517,0.000014592538,0.000013700981,0.00030455858],"genre_scores_gemma":[0.98762727,0.009418254,0.0006530816,0.00025163463,0.0008437552,0.00026101872,0.000022259364,0.00003400603,0.0008886975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978396,0.0002725123,0.00039186675,0.0006199791,0.00034672997,0.0005292528],"domain_scores_gemma":[0.9992438,0.000103521634,0.00006371015,0.00026402625,0.0001379323,0.00018703501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018166221,0.0001674437,0.00027008067,0.00011073645,0.00011320603,0.000042955355,0.0002951198,0.00029884168,0.00012630082],"category_scores_gemma":[0.00036316214,0.00014326315,0.000055622626,0.00025904973,0.00041402032,0.000006493756,0.0002917386,0.00048456652,0.00002940023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085820776,0.00014814887,0.0651231,0.00006765578,0.000043216834,0.00002643729,0.00033069713,0.00005747315,0.906213,0.000050062325,0.0016058579,0.025476182],"study_design_scores_gemma":[0.004080833,0.00081126235,0.0814452,0.00038611668,0.0000109469875,0.000008850726,0.00027638595,0.000012301572,0.87433994,0.0015221325,0.03667191,0.00043409906],"about_ca_topic_score_codex":0.00033173859,"about_ca_topic_score_gemma":0.0008996532,"teacher_disagreement_score":0.035066053,"about_ca_system_score_codex":0.00006681101,"about_ca_system_score_gemma":0.00040113405,"threshold_uncertainty_score":0.58421016},"labels":[],"label_agreement":null},{"id":"W2098342989","doi":"10.1158/1078-0432.ccr-07-0525","title":"Gene Expression Profiling from Formalin-Fixed Paraffin-Embedded Tumors of Pediatric Glioblastoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Biotechnology Research Institute; McGill University Health Centre; National Institute for Nanotechnology; Montreal Children's Hospital","funders":"Fonds de Recherche du Québec - Santé; Hungarian Scientific Research Fund","keywords":"Housekeeping gene; Gene expression profiling; RNA; Biology; Microarray analysis techniques; Microarray; Gene expression; Computational biology; Gene; Genetics","score_opus":0.08852408516250958,"score_gpt":0.4784650267202843,"score_spread":0.3899409415577747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098342989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858868,0.001310129,0.011729021,0.00009861156,0.000082439525,0.00045051464,0.0000556513,0.000023816563,0.00036300652],"genre_scores_gemma":[0.9842792,0.0010395162,0.013213089,0.000112678346,0.00094920263,0.00014222709,0.000122068726,0.000026510028,0.00011551084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779475,0.0002181914,0.0006733485,0.0005506886,0.00030493204,0.0004580818],"domain_scores_gemma":[0.9985002,0.0001727057,0.0001735228,0.00061977515,0.0003450923,0.00018866811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022620088,0.00013339515,0.00023981153,0.00009243808,0.00011505596,0.000010664472,0.00046542555,0.00038176656,0.00005846599],"category_scores_gemma":[0.00035360674,0.000116836534,0.0001656433,0.00029512637,0.00027832467,0.0000034689858,0.00037534174,0.00042609684,0.000012460407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005995823,0.00016605722,0.023302408,0.000015968764,0.000024228219,0.000005783116,0.000009216073,0.000006941092,0.9708367,0.00020575228,0.0019576363,0.0028697154],"study_design_scores_gemma":[0.00048161476,0.00051971676,0.0045581395,0.000015004888,0.000012026688,0.0000012569768,0.000028168844,0.000023106602,0.9914935,0.0005435595,0.0021906912,0.00013320945],"about_ca_topic_score_codex":0.00008619667,"about_ca_topic_score_gemma":0.000056346624,"teacher_disagreement_score":0.020656794,"about_ca_system_score_codex":0.000018150238,"about_ca_system_score_gemma":0.00022443914,"threshold_uncertainty_score":0.4764456},"labels":[],"label_agreement":null},{"id":"W2098653766","doi":"10.1158/1078-0432.ccr-07-1400","title":"Enhanced <i>In vitro</i> and <i>In vivo</i> Cytotoxicity of Combined Reovirus and Radiotherapy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Cytotoxicity; In vivo; In vitro; Radiation therapy; Cell culture; Cancer research; Combination therapy; Apoptosis; Biology; Pharmacology; Medicine; Biochemistry; Internal medicine","score_opus":0.1609870948368256,"score_gpt":0.48924520010780387,"score_spread":0.32825810527097826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098653766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929049,0.003028711,0.000027543618,0.0029192693,0.0000431281,0.00059066183,0.000022620457,0.000009435379,0.0004537118],"genre_scores_gemma":[0.9507092,0.047581166,0.00040221927,0.0007670076,0.00011197007,0.00008977827,0.0000025798774,0.000016602991,0.00031943654],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996735,0.0009446338,0.0007571448,0.00048182896,0.00040184308,0.00067955285],"domain_scores_gemma":[0.99848956,0.0006631921,0.00006170976,0.00027423276,0.00013943484,0.00037190155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003354528,0.00011934233,0.0008357209,0.00024314188,0.00005596278,0.0000055513883,0.00013017734,0.00017432625,0.000112312606],"category_scores_gemma":[0.001580278,0.00010222176,0.000073199364,0.00038090246,0.0016143993,0.00006249538,0.0001269535,0.0010548284,0.0000020898456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019456347,0.00043686948,0.40559822,0.00015531346,0.000031387943,0.00023248114,0.00010351131,0.0000018290443,0.5649744,0.00001646851,0.0019672324,0.007025929],"study_design_scores_gemma":[0.021568602,0.0056738895,0.8427405,0.00046755795,0.000006961255,0.000089874404,0.000090446665,0.00079742365,0.12583384,0.00030161184,0.0022257175,0.00020362431],"about_ca_topic_score_codex":0.0013153313,"about_ca_topic_score_gemma":0.00046885255,"teacher_disagreement_score":0.4391406,"about_ca_system_score_codex":0.00010336689,"about_ca_system_score_gemma":0.00024955298,"threshold_uncertainty_score":0.5948321},"labels":[],"label_agreement":null},{"id":"W2098739456","doi":"10.1158/1078-0432.ccr-08-1291","title":"Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Loss of heterozygosity; Uniparental disomy; Serous fluid; Biology; Ovarian cancer; Genome instability; Genetics; Gene duplication; Cancer research; Allele; Cancer; Chromosome; Gene; DNA damage; DNA; Karyotype","score_opus":0.21731051445294747,"score_gpt":0.46542768542570057,"score_spread":0.2481171709727531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098739456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331385,0.0021102116,0.0000020125476,0.0029154632,0.000115146286,0.0006203181,0.000061001225,0.000014715923,0.0008472804],"genre_scores_gemma":[0.9941372,0.005030723,0.000043903976,0.00017346471,0.00014571825,0.00011545994,0.00003143321,0.000023620276,0.0002984436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973369,0.0003842425,0.0006592059,0.0005289092,0.00058943836,0.00050126406],"domain_scores_gemma":[0.99807787,0.0008440379,0.000097231896,0.00038712847,0.00023909667,0.0003546088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012501079,0.0001477524,0.00064767955,0.00017823577,0.00011955616,0.000010976171,0.00014186883,0.00017829312,0.00026005082],"category_scores_gemma":[0.0005079419,0.00012544406,0.00013880494,0.00051894126,0.0008097266,0.000060337927,0.00018648728,0.00067794515,0.00001286399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058166013,0.0013083917,0.9954553,0.00006859717,0.00014654375,0.00046800563,0.00034317534,0.0000024546998,0.00005770745,0.00003791635,0.00033627314,0.0011939502],"study_design_scores_gemma":[0.0059874216,0.0008835883,0.9911651,0.00017255738,0.000038248476,0.000014116166,0.000052196916,0.000020472839,0.00021564492,0.00009540375,0.0012524828,0.00010279347],"about_ca_topic_score_codex":0.005266155,"about_ca_topic_score_gemma":0.0022317052,"teacher_disagreement_score":0.005405762,"about_ca_system_score_codex":0.0005035269,"about_ca_system_score_gemma":0.0006143722,"threshold_uncertainty_score":0.79608864},"labels":[],"label_agreement":null},{"id":"W2098749503","doi":"10.1158/1078-0432.ccr-15-0156","title":"An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"In vivo; Cancer research; Antigen; Monoclonal antibody; Antibody; Biology; Immunohistochemistry; Cytotoxic T cell; In vitro; Immunology","score_opus":0.32669273389124903,"score_gpt":0.5304941585481654,"score_spread":0.20380142465691636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098749503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881286,0.0045930627,0.000052784155,0.0028004453,0.00037774036,0.0025215324,0.00022224871,0.0001815951,0.0011219626],"genre_scores_gemma":[0.99166197,0.0043639247,0.0011095835,0.0009071955,0.00081349746,0.0003692859,0.000084451385,0.00015863022,0.000531495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9888879,0.002468127,0.0021828006,0.0013946109,0.003091441,0.001975093],"domain_scores_gemma":[0.9910163,0.0021961762,0.00036370195,0.0014455132,0.0033644028,0.0016138649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014377146,0.00045310953,0.0018424728,0.0008388289,0.00020025081,0.000121149315,0.0011542286,0.00022037697,0.0003189991],"category_scores_gemma":[0.0074481512,0.00039397008,0.00029788792,0.0022197203,0.0024389357,0.000356562,0.00052687596,0.0019608918,0.00011425136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010033057,0.0019932976,0.9125383,0.0018501143,0.00023669358,0.002769221,0.0019365102,0.0010112356,0.039456375,0.000048451908,0.016798807,0.0113279335],"study_design_scores_gemma":[0.051673573,0.008813522,0.6685107,0.015741147,0.0002048174,0.00017370384,0.007162976,0.106992565,0.074826606,0.0010957287,0.06207912,0.0027255695],"about_ca_topic_score_codex":0.012733836,"about_ca_topic_score_gemma":0.003652931,"teacher_disagreement_score":0.24402763,"about_ca_system_score_codex":0.0013782553,"about_ca_system_score_gemma":0.008338029,"threshold_uncertainty_score":0.9998512},"labels":[],"label_agreement":null},{"id":"W2098844349","doi":"10.1158/1078-0432.ccr-05-2352","title":"ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Aromatase; Coactivator; Estrogen receptor; Letrozole; Chromatin immunoprecipitation; Cancer research; Androstenedione; Biology; Aromatase inhibitor; Endocrinology; Promoter; Internal medicine; Molecular biology; Transcription factor; Cancer; Gene expression; Gene; Breast cancer; Medicine; Androgen; Biochemistry; Hormone","score_opus":0.055577664717632314,"score_gpt":0.4305431315087353,"score_spread":0.374965466791103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098844349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98504126,0.012480378,0.000023329987,0.001279826,0.00017421729,0.00031112996,0.000022541686,0.000013403841,0.0006539393],"genre_scores_gemma":[0.99527436,0.00083780504,0.00026579344,0.00026992965,0.0009851615,0.000052404175,0.00003388529,0.00002685407,0.0022538195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981973,0.0003535366,0.00030425264,0.00048660394,0.00026686394,0.00039143584],"domain_scores_gemma":[0.9991776,0.00015920159,0.000038165454,0.00029312228,0.0001281279,0.00020381167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014234686,0.00011301485,0.00015793486,0.00005428269,0.00016023118,0.000042871798,0.00017320269,0.00023910616,0.000030486117],"category_scores_gemma":[0.00019918731,0.00009503387,0.000073498115,0.00022029527,0.00025416,0.000002323268,0.00014883661,0.00039824186,0.00005035522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000988351,0.00014227953,0.011049083,0.00004362153,0.00006457422,0.000013849672,0.000025461244,0.00003792584,0.89427316,0.0002153103,0.08411315,0.00903323],"study_design_scores_gemma":[0.0013484274,0.0010605664,0.006603444,0.0001558025,0.00002152975,0.0000031078396,0.000068685855,0.00001575621,0.62575114,0.00069131143,0.3639051,0.00037515853],"about_ca_topic_score_codex":0.000085312466,"about_ca_topic_score_gemma":0.00007485048,"teacher_disagreement_score":0.27979195,"about_ca_system_score_codex":0.000024483517,"about_ca_system_score_gemma":0.00013070306,"threshold_uncertainty_score":0.38753688},"labels":[],"label_agreement":null},{"id":"W2099146388","doi":"10.1158/1078-0432.ccr-05-0130","title":"Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval","year":2005,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Melanoma; Renal cell carcinoma; Cancer; Oncology; Internal medicine; Clinical trial; Phases of clinical research; Kidney cancer; Carcinoma; Colorectal cancer; Cancer research","score_opus":0.8410193157045681,"score_gpt":0.7118782048524943,"score_spread":0.1291411108520738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099146388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031521913,0.95259994,0.00005019148,0.00020810412,0.0023184284,0.01047565,0.0023259728,0.0001169326,0.00038285943],"genre_scores_gemma":[0.0005897598,0.965005,0.025188034,0.00008925484,0.0028861158,0.0038135403,0.000008528984,0.00032375767,0.0020960213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94359124,0.03713157,0.010111462,0.0034252158,0.0036284898,0.0021120037],"domain_scores_gemma":[0.7221945,0.27195185,0.0018374231,0.0019429628,0.0013755243,0.0006977531],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.06671719,0.0011970489,0.009881116,0.0009994814,0.00019488209,0.00013830236,0.002041299,0.0023670194,0.00062408845],"category_scores_gemma":[0.21912839,0.00074214017,0.0011885689,0.0024259586,0.003739964,0.00018622878,0.0014921944,0.009357884,0.00008790637],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019055579,0.0028616278,0.029884499,0.009103399,0.0010373474,0.00034165505,0.00019067539,0.0000020850907,4.2135728e-8,0.00045109904,0.0032391716,0.9338328],"study_design_scores_gemma":[0.042586062,0.02370514,0.23234825,0.21396646,0.0041639637,0.000010784312,0.0004350815,0.00003067258,0.0000096474,0.03838918,0.43885913,0.005495618],"about_ca_topic_score_codex":0.00021919682,"about_ca_topic_score_gemma":0.001260428,"teacher_disagreement_score":0.9283372,"about_ca_system_score_codex":0.0020573386,"about_ca_system_score_gemma":0.007178491,"threshold_uncertainty_score":0.99950296},"labels":[],"label_agreement":null},{"id":"W2099233066","doi":"10.1158/1078-0432.ccr-04-0681","title":"Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial Component","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas College","funders":"","keywords":"Oligodendroglioma; Histopathology; Positron emission tomography; Nuclear medicine; Medicine; Pathology; Magnetic resonance imaging; Population; Single-photon emission computed tomography; Glioma; Radiology; Cancer research; Astrocytoma","score_opus":0.08857859999147794,"score_gpt":0.4497766269489197,"score_spread":0.36119802695744174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099233066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957746,0.001787907,0.00034046554,0.0013721352,0.000018436123,0.00055944815,0.0000058757146,0.000011089008,0.00012999172],"genre_scores_gemma":[0.99742246,0.00026673454,0.0020441795,0.000115812814,0.000031611118,0.000080994956,0.000016018888,0.000020308946,0.0000018922558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816096,0.0001795326,0.00033942366,0.0004076116,0.00060864154,0.00030385668],"domain_scores_gemma":[0.99905205,0.00011845435,0.000059312177,0.00028649048,0.0002372475,0.00024644498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059934636,0.00011877635,0.0003328234,0.00016560477,0.00003677365,0.000017173545,0.000079511185,0.00008278119,0.000023959936],"category_scores_gemma":[0.00006764378,0.00007950727,0.000040305225,0.0003528436,0.00055539806,0.00003822948,0.00006322754,0.0003776211,0.0000025845782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002758334,0.002033578,0.9489138,0.000046046145,0.000081261926,0.008456939,0.000107308246,0.0041012843,0.024464702,0.00071190816,0.000008959675,0.008315848],"study_design_scores_gemma":[0.01674925,0.007066552,0.90851384,0.0004749746,0.00012813005,0.00032560944,0.0001696732,0.0017463852,0.06368831,0.000886421,0.00005158073,0.00019925786],"about_ca_topic_score_codex":0.00085475843,"about_ca_topic_score_gemma":0.0001807784,"teacher_disagreement_score":0.040399976,"about_ca_system_score_codex":0.00012063805,"about_ca_system_score_gemma":0.00022693729,"threshold_uncertainty_score":0.32422125},"labels":[],"label_agreement":null},{"id":"W2099243020","doi":"10.1158/1078-0432.ccr-10-2981","title":"<i>In vivo</i> Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Drug Research and Development","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Chemistry; Bladder cancer; Docetaxel; In vitro; Pharmacology; Cancer research; Cancer; Medicine; Biochemistry; Internal medicine; Biology","score_opus":0.4088717360453616,"score_gpt":0.5471438405819348,"score_spread":0.13827210453657318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099243020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913787,0.0021058053,0.000014701099,0.00074747397,0.000359539,0.0032771584,0.00020788121,0.000008892521,0.0018998317],"genre_scores_gemma":[0.9924017,0.003612228,0.00030862444,0.0001490524,0.00041054824,0.0024822548,0.000008080549,0.000039484832,0.00058802223],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964189,0.00039922347,0.000994889,0.0005775629,0.001048416,0.00056100806],"domain_scores_gemma":[0.9965321,0.00075405394,0.00021114138,0.000489268,0.0017387001,0.00027478076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018872013,0.00021402708,0.0008522454,0.00020093806,0.000055130666,0.0000059670087,0.0001587879,0.0002158283,0.0020220147],"category_scores_gemma":[0.00052612636,0.00016021982,0.00033737253,0.00043854475,0.0005403457,0.0000934645,0.000044954486,0.00022460739,0.000011471922],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03536116,0.025501795,0.34637752,0.0018426877,0.0051254393,0.00017525068,0.01562754,0.00014484327,0.20871778,0.00063622906,0.011783452,0.34870633],"study_design_scores_gemma":[0.02549501,0.010933265,0.21862623,0.0005571044,0.001388268,0.000003486824,0.00046522447,0.000846448,0.7379889,0.0017156737,0.0017257739,0.00025462828],"about_ca_topic_score_codex":0.005062894,"about_ca_topic_score_gemma":0.0016707688,"teacher_disagreement_score":0.5292711,"about_ca_system_score_codex":0.00053552975,"about_ca_system_score_gemma":0.002667912,"threshold_uncertainty_score":0.9988903},"labels":[],"label_agreement":null},{"id":"W2099335989","doi":"10.1158/1078-0432.ccr-04-0220","title":"Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":2657,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; University of North Carolina at Chapel Hill; Michael Smith Health Research BC","keywords":"Cytokeratin; Tissue microarray; Immunohistochemistry; Basal (medicine); Breast cancer; Pathology; Breast carcinoma; Estrogen receptor; Biology; Estrogen; Oncology; Internal medicine; Medicine; Cancer; Endocrinology","score_opus":0.11674354598862836,"score_gpt":0.44685973792177414,"score_spread":0.3301161919331458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099335989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944146,0.00040416353,0.000008970306,0.0041101696,0.00027582786,0.00047639705,0.000054957392,0.000007434554,0.0002474339],"genre_scores_gemma":[0.9983732,0.0006847586,0.00005032107,0.000275362,0.00031704234,0.000022098824,0.000015910455,0.00002088498,0.00024040022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974731,0.0003567355,0.00092779996,0.00036698385,0.0005959029,0.00027945015],"domain_scores_gemma":[0.99760383,0.0005648023,0.00020763947,0.00062317273,0.0007715005,0.00022906213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019036348,0.00011057474,0.00051270606,0.0000776619,0.00008217088,0.000007424384,0.00025318834,0.0002585954,0.00014351567],"category_scores_gemma":[0.00077278196,0.00007389297,0.00025323132,0.0004462755,0.0016822447,0.000046900066,0.00031032367,0.00092413503,0.000007437261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015858184,0.0006138724,0.87088484,0.0001927567,0.00007250088,0.000011144423,0.000093522256,1.9921042e-7,0.11824452,0.0002911126,0.00023513108,0.0077745966],"study_design_scores_gemma":[0.0025079793,0.0005042164,0.98817015,0.0003301115,0.000066655615,0.00003681835,0.00005521015,0.000009558313,0.007855684,0.00017470978,0.00022183274,0.00006705587],"about_ca_topic_score_codex":0.00062244484,"about_ca_topic_score_gemma":0.00004927153,"teacher_disagreement_score":0.11728534,"about_ca_system_score_codex":0.000102186386,"about_ca_system_score_gemma":0.0016025997,"threshold_uncertainty_score":0.6198301},"labels":[],"label_agreement":null},{"id":"W2099370186","doi":"10.1158/1078-0432.ccr-11-0642","title":"β1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"Metastasis; Cancer; Breast cancer; Cancer research; Medicine; Melanoma; Dormancy; Cancer cell; Integrin; Primary tumor; Immunology; Oncology; Internal medicine; Biology; Receptor","score_opus":0.537161964723045,"score_gpt":0.6091279636354181,"score_spread":0.0719659989123731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099370186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015684727,0.989349,0.000013347966,0.0016997649,0.0011894187,0.0032774056,0.00010533767,0.0000342717,0.004174571],"genre_scores_gemma":[0.0002821777,0.99158037,0.00006249129,0.000606643,0.0018582892,0.0029526572,0.00009410102,0.00014608621,0.002417158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98685455,0.0055723297,0.0018868739,0.0015518445,0.0024708887,0.0016634925],"domain_scores_gemma":[0.9905819,0.0055425353,0.0003022214,0.0019714388,0.00084048737,0.00076138374],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.010859724,0.0005909755,0.002558678,0.00054494006,0.00021842596,0.00012932581,0.0023476738,0.0009994849,0.005302651],"category_scores_gemma":[0.0047117234,0.0003430962,0.0012311126,0.0023850633,0.0014128227,0.00007066388,0.0007832193,0.0107393125,0.001153823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000306669,0.0005783102,0.00032435913,0.006323334,0.00020310204,0.00044753565,0.00011342488,5.328489e-7,0.0000025392014,0.000047769965,0.020671321,0.9709811],"study_design_scores_gemma":[0.00085328164,0.0005043275,0.00032539642,0.012264687,0.00021300404,0.00003500044,0.00008549693,0.00004301291,0.000004027102,0.00009550323,0.98524,0.0003362541],"about_ca_topic_score_codex":0.0016480586,"about_ca_topic_score_gemma":0.00043803226,"teacher_disagreement_score":0.97064483,"about_ca_system_score_codex":0.00081043545,"about_ca_system_score_gemma":0.0072204475,"threshold_uncertainty_score":0.9999021},"labels":[],"label_agreement":null},{"id":"W2099678391","doi":"10.1158/1078-0432.ccr-06-1250","title":"Pharmacokinetics, Metabolism, and Oral Bioavailability of the DNA Methyltransferase Inhibitor 5-Fluoro-2′-Deoxycytidine in Mice","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of Pittsburgh","keywords":"Bioavailability; Pharmacokinetics; Pharmacology; Chemistry; In vivo; Catabolism; Cytidine; Metabolism; Metabolite; Oral administration; Deoxycytidine; Methyltransferase; Biochemistry; Enzyme; DNA; Biology; Medicine; Chemotherapy; Internal medicine; Methylation","score_opus":0.08026696402152493,"score_gpt":0.44568044347323726,"score_spread":0.3654134794517123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099678391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873558,0.01087773,0.000045850553,0.00080055674,0.00022909937,0.0003816126,0.000047729267,0.00000330578,0.0002582982],"genre_scores_gemma":[0.99518555,0.0037997677,0.00021371375,0.000057155677,0.00045931555,0.000036553472,0.0000148308245,0.000017075961,0.00021604904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748135,0.0008557987,0.0005874007,0.0004455668,0.00032853932,0.0003013477],"domain_scores_gemma":[0.99900025,0.00021402846,0.00006677538,0.00034118255,0.00029130263,0.00008646756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031066178,0.00011759896,0.00024091102,0.00005929281,0.00006460359,0.000017343747,0.00025240157,0.00018336698,0.000040337614],"category_scores_gemma":[0.00052570563,0.000087607084,0.000109928405,0.0003318441,0.0006793818,0.000004309861,0.00020300121,0.00037097116,0.0000015420547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002557281,0.00019739235,0.09888681,0.000027154932,0.00002305068,7.372304e-7,0.00001398623,0.000038717928,0.89302653,0.000064874905,0.00052220124,0.006942828],"study_design_scores_gemma":[0.0010709264,0.00012216823,0.16779615,0.000013276512,0.00001937575,1.8657352e-7,0.000012183203,0.000052236515,0.8113611,0.00055686873,0.018903142,0.00009237893],"about_ca_topic_score_codex":0.0012710507,"about_ca_topic_score_gemma":0.001530561,"teacher_disagreement_score":0.08166541,"about_ca_system_score_codex":0.000019996342,"about_ca_system_score_gemma":0.000194183,"threshold_uncertainty_score":0.35725132},"labels":[],"label_agreement":null},{"id":"W2099772080","doi":"10.1158/1078-0432.ccr-14-0706","title":"Identification of Differentially Expressed Long Noncoding RNAs in Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Long non-coding RNA; Epigenetics; Gene knockdown; Transcriptome; Phenotype; Cancer; Bladder cancer; Cancer research; Downregulation and upregulation; Disease; Gene expression profiling; Regulation of gene expression; Gene expression; Microarray; Computational biology; Gene; Genetics; Medicine; Pathology","score_opus":0.0977685692194695,"score_gpt":0.4781465611297945,"score_spread":0.38037799191032495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099772080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97315025,0.0018387922,0.022554442,0.00067713176,0.00051267794,0.00062948774,0.000036702837,0.000012045872,0.000588477],"genre_scores_gemma":[0.9941981,0.0034514624,0.000053524098,0.000081618986,0.00064392266,0.000331391,0.000031236657,0.000048693182,0.001160075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959804,0.0009579417,0.0008529761,0.00076535,0.00082575437,0.0006176182],"domain_scores_gemma":[0.9980389,0.00020862397,0.0001697291,0.0007627922,0.0006236858,0.00019629758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037597863,0.00015898008,0.00032947058,0.00022618497,0.00009218729,0.00005124414,0.00066352834,0.00037506977,0.0002652166],"category_scores_gemma":[0.0013961691,0.00015779921,0.00016839238,0.0004723661,0.00037304917,0.000008949639,0.00043777682,0.00075845834,0.000017663117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048234593,0.00019506394,0.0039166766,0.00008795727,0.00008534201,0.0000036902343,0.000040468134,0.00071214803,0.9506817,0.0001329818,0.0013178512,0.0423438],"study_design_scores_gemma":[0.001934206,0.0003847358,0.019760676,0.00015622967,0.000018350445,6.6583164e-7,0.000040300863,0.0030231394,0.966318,0.0003237826,0.0078015397,0.00023838389],"about_ca_topic_score_codex":0.00063156546,"about_ca_topic_score_gemma":0.0017031755,"teacher_disagreement_score":0.042105414,"about_ca_system_score_codex":0.00010283643,"about_ca_system_score_gemma":0.00054973894,"threshold_uncertainty_score":0.6434865},"labels":[],"label_agreement":null},{"id":"W2099814169","doi":"10.1158/1078-0432.ccr-08-0408","title":"Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Jewish General Hospital; Vancouver General Hospital; McGill University; University of British Columbia","funders":"","keywords":"Breast cancer; In vivo; Cancer research; Cancer; Insulin-like growth factor-binding protein; Biology; Tissue microarray; Growth factor; Internal medicine; Endocrinology; Insulin-like growth factor; Medicine; Receptor","score_opus":0.2161812379310138,"score_gpt":0.4342498657276004,"score_spread":0.2180686277965866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099814169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877677,0.0014507427,0.00005280899,0.0070188856,0.00036081686,0.0018180514,0.000662025,0.0001803145,0.00068866275],"genre_scores_gemma":[0.9891057,0.0023789639,0.00016801019,0.0020043496,0.00079857104,0.0005999904,0.000053968502,0.0001569076,0.004733522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99344885,0.00043618047,0.0011006383,0.0011814265,0.002270369,0.0015625522],"domain_scores_gemma":[0.99532133,0.0006403075,0.0002892888,0.0007097546,0.0020622413,0.0009770704],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016228801,0.00049254496,0.0011096923,0.00046124862,0.0006440073,0.00006686616,0.00054368697,0.00060080766,0.001721944],"category_scores_gemma":[0.00078579836,0.00035354623,0.00035354376,0.0021157372,0.001248766,0.00032240912,0.00021546661,0.0029543424,0.00017806859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004205234,0.002198726,0.96000737,0.00018942781,0.0012363038,0.00020663512,0.0009481645,0.000001114247,0.017728632,0.00007393099,0.009845963,0.0033584961],"study_design_scores_gemma":[0.009353608,0.0020383245,0.9734716,0.00081608206,0.00012477428,0.000067151246,0.00014931256,0.0001654023,0.0063982145,0.000087736094,0.006668121,0.0006596929],"about_ca_topic_score_codex":0.0016537057,"about_ca_topic_score_gemma":0.000102524544,"teacher_disagreement_score":0.013464208,"about_ca_system_score_codex":0.00079035305,"about_ca_system_score_gemma":0.0029353423,"threshold_uncertainty_score":0.99989164},"labels":[],"label_agreement":null},{"id":"W2099842815","doi":"10.1158/1078-0432.ccr-13-2147","title":"Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Victoria; Simon Fraser University; University of British Columbia","funders":"","keywords":"Ovarian cancer; ELISPOT; CD8; Epitope; Biology; Ovarian tumor; Cancer; Cancer research; Nonsynonymous substitution; Primary tumor; T cell; Immune system; Mutation; Cytotoxic T cell; Immunology; Medicine; Antibody; Metastasis; Genetics; Gene; Genome","score_opus":0.08844247405143725,"score_gpt":0.46397425790737373,"score_spread":0.3755317838559365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099842815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781946,0.0065521346,0.0000025381953,0.011810639,0.0009970003,0.001770142,0.0002152141,0.000024747458,0.00043296337],"genre_scores_gemma":[0.9931325,0.0025800315,0.00011118021,0.0011408598,0.0006399397,0.00068167754,0.000012501213,0.000038995473,0.0016623582],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965998,0.00049437943,0.00076548324,0.00056704984,0.0010200309,0.0005532346],"domain_scores_gemma":[0.99790925,0.00040892686,0.00017555921,0.00073893723,0.00045726515,0.00031005437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014520707,0.00016634949,0.0004950122,0.00007432548,0.00015740094,0.00003936528,0.00048174817,0.00012943933,0.0029146334],"category_scores_gemma":[0.00023172706,0.0001038346,0.00021965265,0.0006871451,0.00047765768,0.000065227876,0.00030677638,0.0008028128,0.000054465967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065099164,0.00050240895,0.24195355,0.00028575372,0.00020630339,0.000008249806,0.00020237459,0.0000018599328,0.5222403,0.0000016576274,0.07940044,0.14868723],"study_design_scores_gemma":[0.002860317,0.0004685894,0.887836,0.0010344533,0.000015681435,0.0000013287058,0.00004861103,0.000019746532,0.06682391,0.000029835524,0.04069714,0.00016442941],"about_ca_topic_score_codex":0.0072728484,"about_ca_topic_score_gemma":0.00040116571,"teacher_disagreement_score":0.6458824,"about_ca_system_score_codex":0.00045524962,"about_ca_system_score_gemma":0.00074751495,"threshold_uncertainty_score":0.9993378},"labels":[],"label_agreement":null},{"id":"W2099886521","doi":"10.1158/1078-0432.ccr-05-2508","title":"Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Medulloblastoma; Neural stem cell; Brain tumor; In vivo; Cancer research; Glioma; In vitro; Suicide gene; Stem cell; Biology; Genetic enhancement; Medicine; Pharmacology; Pathology; Gene; Cell biology; Biochemistry; Genetics","score_opus":0.1957928397752684,"score_gpt":0.5101373092039596,"score_spread":0.3143444694286912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099886521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923357,0.0034169427,0.00002434647,0.0013819725,0.00027705156,0.0013794416,0.000013203563,0.000057950616,0.0011133928],"genre_scores_gemma":[0.9914352,0.00007128825,0.00040480148,0.0004566489,0.0014559482,0.00020770475,0.0000053006515,0.00007180214,0.0058913045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944718,0.0008692558,0.0007988685,0.0009519417,0.001777385,0.0011307551],"domain_scores_gemma":[0.9974844,0.00062312535,0.00008156889,0.00052081054,0.0004126992,0.0008774331],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030083992,0.00026470041,0.0006432398,0.00030233923,0.00043124217,0.00011694398,0.0003602836,0.00019703357,0.0012851793],"category_scores_gemma":[0.00009807932,0.00020211359,0.00015621298,0.00055611174,0.0006282754,0.00010400762,0.00050177245,0.0014061203,0.00023629166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025694817,0.0007191171,0.038372867,0.00016293547,0.00006172203,0.000987546,0.0002126016,0.00002340758,0.92237914,0.00009309486,0.01085271,0.023565354],"study_design_scores_gemma":[0.009187012,0.009390734,0.10416004,0.0008409097,0.00006628836,0.00020070853,0.0009428296,0.004560043,0.8520099,0.00021754262,0.017587734,0.00083625305],"about_ca_topic_score_codex":0.0009494875,"about_ca_topic_score_gemma":0.000119828714,"teacher_disagreement_score":0.070369266,"about_ca_system_score_codex":0.00039652694,"about_ca_system_score_gemma":0.00026667913,"threshold_uncertainty_score":0.99962777},"labels":[],"label_agreement":null},{"id":"W2100100178","doi":"10.1158/1078-0432.ccr-05-2152","title":"Phase 1 and Pharmacokinetic Study of Intravenous Irinotecan in Refractory Solid Tumor Patients with Hepatic Dysfunction","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"National Center for Research Resources","keywords":"Medicine; Irinotecan; Bilirubin; Gastroenterology; Internal medicine; Pharmacokinetics; Neutropenia; Liver function; Nausea; Vomiting; Adverse effect; Jaundice; Liver function tests; Alanine transaminase; Toxicity; Cancer; Colorectal cancer","score_opus":0.06193093059145054,"score_gpt":0.4521873401978237,"score_spread":0.39025640960637314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100100178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986613,0.0004316033,0.000052779735,0.000031515137,0.00010871188,0.000615617,0.000021149202,0.0000034619084,0.00007390385],"genre_scores_gemma":[0.9992903,0.00026201023,0.000019169318,0.000053835047,0.00017831719,0.00010225425,0.000022578875,0.000021057323,0.000050469705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985076,0.00018791285,0.0003769393,0.00036882216,0.00029925175,0.0002594562],"domain_scores_gemma":[0.9993484,0.00004069152,0.00008988968,0.00022960913,0.00021466847,0.00007672886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005986003,0.00010182971,0.00020403702,0.000083755316,0.000047337195,0.000012514687,0.00011739632,0.00006455242,0.00002635189],"category_scores_gemma":[0.00003263149,0.000085695516,0.000026877839,0.00016434284,0.00016003633,0.0000035769622,0.000085488944,0.0002732604,7.8835654e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019127453,0.053554054,0.2316399,0.00033706028,0.00035591942,0.000062267354,0.0005903718,0.0006356679,0.41773024,0.00007103261,0.0003440904,0.27555194],"study_design_scores_gemma":[0.113915965,0.15529391,0.52704304,0.00034550027,0.00020937978,0.00000549898,0.0010735965,0.00044699694,0.18688275,0.00088839885,0.012876583,0.0010183535],"about_ca_topic_score_codex":0.0013407047,"about_ca_topic_score_gemma":0.0021464382,"teacher_disagreement_score":0.29540315,"about_ca_system_score_codex":0.000053525717,"about_ca_system_score_gemma":0.00020532325,"threshold_uncertainty_score":0.34945616},"labels":[],"label_agreement":null},{"id":"W2100157279","doi":"10.1158/1078-0432.ccr-13-2076","title":"Telomere Content and Risk of Second Malignant Neoplasm in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Cancer; Thyroid cancer; Medicine; Breast cancer; Telomere; Oncology; Internal medicine; Sarcoma; Pathology; Biology; Genetics","score_opus":0.1332779358747268,"score_gpt":0.42846442833934845,"score_spread":0.29518649246462164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100157279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97993016,0.013695927,8.060446e-7,0.0018830644,0.00052784226,0.003225961,0.0005286833,0.000023220266,0.00018432777],"genre_scores_gemma":[0.9767644,0.021093234,0.000030566545,0.00017876738,0.00044168945,0.0007990193,0.00001478747,0.00005602215,0.0006215367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932109,0.0014237144,0.0020935563,0.0010667915,0.001398738,0.000806297],"domain_scores_gemma":[0.99330664,0.00329697,0.0006455804,0.001227002,0.0010665861,0.00045724717],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004863259,0.0003413403,0.0014942726,0.00023263364,0.00016786909,0.0000411507,0.00055376533,0.00026143834,0.0017736364],"category_scores_gemma":[0.0023364488,0.00022025195,0.00023770185,0.0009662347,0.0010705858,0.00014073226,0.0003884411,0.0017789325,0.000012448821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043917057,0.0015678179,0.9498085,0.00011127585,0.0006213279,0.00009105736,0.0039479807,0.000004699409,0.0005479409,0.0000055243327,0.0010969348,0.04175778],"study_design_scores_gemma":[0.004426182,0.000767685,0.9854314,0.0007071212,0.00016340593,0.000011962993,0.0061740973,0.00003314709,0.0011271812,0.00009857386,0.0008334919,0.00022575194],"about_ca_topic_score_codex":0.5171557,"about_ca_topic_score_gemma":0.3311682,"teacher_disagreement_score":0.18598747,"about_ca_system_score_codex":0.00015105595,"about_ca_system_score_gemma":0.0016320257,"threshold_uncertainty_score":0.9991389},"labels":[],"label_agreement":null},{"id":"W2100204192","doi":"10.1158/1078-0432.ccr-07-1392","title":"Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Daiichi Sankyo Europe; National Cancer Institute; National Institutes of Health","keywords":"Cytotoxicity; Apoptosis; In vivo; Cancer research; Flow cytometry; Monoclonal antibody; Cell culture; Biodistribution; Programmed cell death; Tumor necrosis factor alpha; Cancer; Colorectal cancer; Cancer cell; In vitro; Antibody; Molecular biology; Medicine; Pathology; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.16091068210962134,"score_gpt":0.48472095671322557,"score_spread":0.32381027460360423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100204192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794674,0.000694694,0.000061517894,0.0004506608,0.000079775404,0.0006422262,0.000025570636,0.00000711525,0.0000917073],"genre_scores_gemma":[0.98716813,0.009629944,0.00020384819,0.000020611431,0.00024139619,0.00016505441,0.0001682955,0.00002796457,0.0023747631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982183,0.00023033938,0.000383492,0.00045776676,0.0003864368,0.0003236935],"domain_scores_gemma":[0.9991023,0.00005905339,0.00011861406,0.00029683506,0.0003139067,0.000109302055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041934912,0.00014583256,0.00034405515,0.00010102789,0.00014543357,0.0000103869725,0.00013027008,0.00019806948,0.00011184335],"category_scores_gemma":[0.000027359018,0.000084268824,0.000062562154,0.0003187524,0.00034739365,0.0000069703265,0.000034589513,0.00013911477,0.0000017101288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004903491,0.002598204,0.49593675,0.00008833713,0.00017131976,0.00007579461,0.00027149907,0.00020151412,0.48470575,0.00012558693,0.00060807844,0.010313683],"study_design_scores_gemma":[0.017654316,0.032437928,0.5079584,0.00031234106,0.0000610226,0.000025216537,0.00017196064,0.00019595164,0.40590897,0.00003379418,0.034734115,0.0005059529],"about_ca_topic_score_codex":0.0026759119,"about_ca_topic_score_gemma":0.0065289694,"teacher_disagreement_score":0.07879676,"about_ca_system_score_codex":0.00009259794,"about_ca_system_score_gemma":0.0004579802,"threshold_uncertainty_score":0.40451962},"labels":[],"label_agreement":null},{"id":"W2100232885","doi":"10.1158/1078-0432.ccr-03-0287","title":"Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen)","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"DU145; Biology; RNA; Antisense therapy; Messenger RNA; Cancer cell; Small interfering RNA; Protein biosynthesis; Antisense RNA; RNA interference; Sense (electronics); Cancer research; Molecular biology; Cell biology; Cancer; Chemistry; Biochemistry; Gene; Genetics; LNCaP","score_opus":0.042924687359141005,"score_gpt":0.4116320285965079,"score_spread":0.36870734123736687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100232885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963611,0.0016135847,0.000129972,0.0006141472,0.0003955047,0.0007967198,0.000035416586,0.000004027111,0.000049528324],"genre_scores_gemma":[0.99080074,0.008052087,0.00019130718,0.000051868927,0.00020491345,0.000101851576,0.000021281954,0.000021663753,0.0005542991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978491,0.0003936997,0.0005881387,0.00039587406,0.00046172435,0.00031145304],"domain_scores_gemma":[0.99875724,0.00026593756,0.00021178025,0.00041377594,0.0002688574,0.0000824345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012649122,0.00012652094,0.00026909495,0.00008733879,0.000080008846,0.000014851169,0.00020470009,0.00020842909,0.00003469706],"category_scores_gemma":[0.00022062504,0.00007665717,0.00012108192,0.0002564312,0.00040013329,0.000009355361,0.0001573134,0.00026311516,0.0000023864293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006030767,0.00017420972,0.0011276858,0.00024494377,0.000025211586,0.000003817081,0.00020171166,0.001262165,0.9779369,0.000053565524,0.00016697234,0.018199725],"study_design_scores_gemma":[0.0016843958,0.0004100739,0.03217196,0.00033626394,0.000016158247,4.0831338e-7,0.000083060564,0.000105360006,0.9638033,0.0005065498,0.0007806963,0.000101761085],"about_ca_topic_score_codex":0.0006246245,"about_ca_topic_score_gemma":0.0005187526,"teacher_disagreement_score":0.031044275,"about_ca_system_score_codex":0.000039474173,"about_ca_system_score_gemma":0.00030356203,"threshold_uncertainty_score":0.31259885},"labels":[],"label_agreement":null},{"id":"W2100378516","doi":"10.1158/1078-0432.ccr-10-0662","title":"Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"National Cancer Institute","keywords":"Granulocyte macrophage colony-stimulating factor; Medicine; Osteosarcoma; Internal medicine; Granulocyte; Oncology; Immunology; Respiratory disease; Granulocyte colony-stimulating factor; Chemotherapy; Pathology; Cytokine; Lung","score_opus":0.10764705623666995,"score_gpt":0.4748981249410533,"score_spread":0.3672510687043834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100378516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98981154,0.0012156115,0.000047176516,0.0037659856,0.0010967944,0.0030995428,0.00078246027,0.000034343768,0.00014654663],"genre_scores_gemma":[0.9971086,0.00018077662,0.00045719862,0.00013950514,0.0011394013,0.00067353674,0.00019448315,0.000044492324,0.00006203094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961598,0.0008735262,0.0009133276,0.00083697936,0.0007033117,0.0005130454],"domain_scores_gemma":[0.97558254,0.021875482,0.00029188328,0.0013577424,0.00046468282,0.00042766848],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030354592,0.00021813826,0.00071920647,0.00009794997,0.00033083247,0.000026404154,0.0004997789,0.0002990764,0.00014700922],"category_scores_gemma":[0.02334224,0.00016056572,0.00022925924,0.00026239915,0.0012304911,0.000057709254,0.0006419013,0.0015187556,0.0000062619856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011861038,0.00073579565,0.92019445,0.00030709748,0.00013665142,0.0011447561,0.00010280331,0.000006339686,0.0027543306,0.000056431938,0.00079506746,0.06190524],"study_design_scores_gemma":[0.0047413176,0.0016001574,0.9902754,0.0002788703,0.00010800957,0.000062496554,0.000018063189,0.00088009087,0.00013472483,0.0006886931,0.0010708916,0.0001413137],"about_ca_topic_score_codex":0.000585421,"about_ca_topic_score_gemma":0.00070365035,"teacher_disagreement_score":0.07008092,"about_ca_system_score_codex":0.000125606,"about_ca_system_score_gemma":0.00053334265,"threshold_uncertainty_score":0.98488456},"labels":[],"label_agreement":null},{"id":"W2100491190","doi":"10.1158/1078-0432.ccr-09-0628","title":"Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Ejection fraction; Medicine; Trastuzumab; Cardiology; Internal medicine; Aerobic exercise; VO2 max; Diastole; Breast cancer; Heart rate; Blood pressure; Cancer; Heart failure","score_opus":0.3383140390610262,"score_gpt":0.5224949249815398,"score_spread":0.18418088592051363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100491190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012315,0.0037802877,0.00025740106,0.0034780696,0.00021353585,0.00078120676,0.0000037248656,0.0000875182,0.0012751292],"genre_scores_gemma":[0.99356514,0.003278368,0.00055776635,0.0009772655,0.0011638333,0.000058101225,0.000018544572,0.000030360881,0.00035063396],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968019,0.0002721632,0.00066803803,0.0005952345,0.0009847129,0.00067792524],"domain_scores_gemma":[0.99830097,0.00031122917,0.00008562307,0.00044331842,0.0004192535,0.00043958516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034570952,0.00017484947,0.0006309145,0.00021997729,0.00022413404,0.000056426103,0.0002125677,0.00032793576,0.00016462001],"category_scores_gemma":[0.0006155742,0.00015380015,0.000336568,0.0007149654,0.00019985824,0.00013295199,0.0000367089,0.0015185596,0.000043616896],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006875922,0.00032234925,0.00051732175,0.000058055004,0.000069684036,0.00019017381,0.0008969484,0.000093960414,0.08833688,0.00007490944,0.001071616,0.9076805],"study_design_scores_gemma":[0.026824394,0.008576278,0.12396338,0.009184329,0.0007427647,0.00039018824,0.005180936,0.006349533,0.7658244,0.010404653,0.0406517,0.0019074813],"about_ca_topic_score_codex":0.000059241265,"about_ca_topic_score_gemma":0.000008884715,"teacher_disagreement_score":0.90577304,"about_ca_system_score_codex":0.00031269458,"about_ca_system_score_gemma":0.0007598636,"threshold_uncertainty_score":0.65974706},"labels":[],"label_agreement":null},{"id":"W2101076259","doi":"10.1158/1078-0432.ccr-04-2587","title":"A Predictive Model of Rectal Tumor Response to Preoperative Radiotherapy Using Classification and Regression Tree Methods","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Brachytherapy; Radiation therapy; Overfitting; Colorectal cancer; VEGF receptors; Cart; Oncology; Internal medicine; Pathology; Cancer; Machine learning","score_opus":0.47001025376073763,"score_gpt":0.634020811843012,"score_spread":0.16401055808227433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101076259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98907334,0.0015632556,0.0034313253,0.0037481776,0.00007389681,0.0014267263,0.000037282705,0.000030147665,0.0006158337],"genre_scores_gemma":[0.9300511,0.0006407175,0.06759091,0.000233833,0.00027103417,0.00030137147,0.000002593919,0.0000352558,0.00087318284],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954917,0.0021552027,0.00063743035,0.0006606317,0.0006833897,0.00037163444],"domain_scores_gemma":[0.9960171,0.0023520899,0.000117650045,0.00041166536,0.0006372166,0.00046428683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049691545,0.00016961127,0.0006065914,0.00025312245,0.00012290095,0.000019466566,0.00013661818,0.00015603754,0.0001242531],"category_scores_gemma":[0.0026253848,0.0001235765,0.00012900923,0.0006368716,0.00049414777,0.00012007072,0.00013484339,0.0006265722,0.0000035297244],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19509745,0.0012349461,0.06533994,0.000102302896,0.0003702,0.000029054081,0.002924494,0.0011592904,0.33279175,0.000059081227,0.0009364992,0.39995497],"study_design_scores_gemma":[0.008503087,0.009322148,0.32870713,0.0009673245,0.0001364932,0.000027394079,0.00040648857,0.6002333,0.04844027,0.00020229962,0.0027587549,0.00029529814],"about_ca_topic_score_codex":0.0000986651,"about_ca_topic_score_gemma":0.000048908707,"teacher_disagreement_score":0.599074,"about_ca_system_score_codex":0.00091827865,"about_ca_system_score_gemma":0.0009961895,"threshold_uncertainty_score":0.50393033},"labels":[],"label_agreement":null},{"id":"W2101657563","doi":"10.1158/1078-0432.ccr-05-1029","title":"The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":600,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Missense mutation; Breast cancer; Exon; Mutation; Germline mutation; Biology; Gene; Cancer research; Genetics; Cancer; Internal medicine; Oncology; Medicine","score_opus":0.10311501091779605,"score_gpt":0.49384996581352814,"score_spread":0.39073495489573207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101657563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911194,0.0016442981,0.00005093105,0.00441048,0.00040341273,0.0013629632,0.00015646958,0.000027676637,0.00082435855],"genre_scores_gemma":[0.9967853,0.0013768093,0.00027355904,0.0001620946,0.0005508043,0.00035288313,0.00004509494,0.00005666044,0.00039681554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949108,0.0009050523,0.0015745116,0.00057202694,0.0013577876,0.00067984255],"domain_scores_gemma":[0.9954066,0.0021518776,0.00026944018,0.0007853864,0.0011169049,0.00026975007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034910797,0.00017941084,0.0006270216,0.00017111227,0.00019061692,0.000029379473,0.0003550028,0.000262453,0.00016358333],"category_scores_gemma":[0.0010196106,0.00011746426,0.00022618378,0.0011027411,0.0014557926,0.000063838525,0.00014485489,0.0015938872,0.00003247483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019230435,0.0013764708,0.95422554,0.00010474545,0.00016620161,0.000043054697,0.000050848594,0.0005174259,0.00017271611,0.00028419023,0.003600017,0.037535734],"study_design_scores_gemma":[0.0066850185,0.0007832308,0.98805386,0.00052094465,0.00009952076,0.0000062110144,0.00004785775,0.00072459294,0.00031805845,0.00053009373,0.002101189,0.00012942211],"about_ca_topic_score_codex":0.004971013,"about_ca_topic_score_gemma":0.0046297493,"teacher_disagreement_score":0.037406314,"about_ca_system_score_codex":0.00041690312,"about_ca_system_score_gemma":0.002449079,"threshold_uncertainty_score":0.75147176},"labels":[],"label_agreement":null},{"id":"W2101886132","doi":"10.1158/1078-0432.ccr-06-1590","title":"Unexpected Immunohistochemical Localization of Deoxycytidine Kinase","year":2006,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunohistochemistry; Deoxycytidine; Deoxycytidine kinase; Cancer research; Kinase; Medicine; Pathology; Biology; Cancer; Cell biology; Internal medicine; Gemcitabine","score_opus":0.22737901066006602,"score_gpt":0.5476180348224294,"score_spread":0.3202390241623634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101886132","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18349469,0.014777063,0.0008940403,0.7625835,0.0011663524,0.004736624,0.00035799647,0.00020039061,0.031789348],"genre_scores_gemma":[0.18888046,0.015559061,0.003230111,0.46516573,0.057420455,0.0037779398,0.0116228135,0.0010448423,0.2532986],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99284256,0.0012794848,0.0016933691,0.0008891916,0.0022433607,0.00105202],"domain_scores_gemma":[0.99269617,0.003276184,0.0003018218,0.00116315,0.0022957772,0.00026691836],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003117425,0.0003214244,0.0018901271,0.00055643043,0.00014754743,0.000020154206,0.00053935294,0.002426922,0.0025396743],"category_scores_gemma":[0.0030010273,0.00026863615,0.00046216062,0.0010690731,0.0026261343,0.00003729546,0.00031108505,0.0077427733,0.0001891818],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007883141,0.00042282566,0.04368357,0.0009728971,0.00029565042,0.0007150389,0.000021183068,0.0000014580564,0.0007896354,0.000016760438,0.95081466,0.0014779869],"study_design_scores_gemma":[0.004367144,0.0018603938,0.010616463,0.0013497055,0.00047013338,0.000025310555,0.00002176247,0.00082339713,0.001241906,0.0006518436,0.9782144,0.00035755648],"about_ca_topic_score_codex":0.0021045883,"about_ca_topic_score_gemma":0.00003962917,"teacher_disagreement_score":0.2974178,"about_ca_system_score_codex":0.00082996907,"about_ca_system_score_gemma":0.0036371767,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W2102094932","doi":"10.1158/1078-0432.ccr-04-2379","title":"Increased Cyclooxygenase-2 Expression in Duodenal Compared with Colonic Tissues in Familial Adenomatous Polyposis and Relationship to the −765G → <i>C COX-2</i> Polymorphism","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Familial adenomatous polyposis; Gastroenterology; Internal medicine; Medicine; Colorectal cancer; Duodenum; Cyclooxygenase; Adenomatous polyposis coli; Intestinal polyp; Adenocarcinoma; COX-2 inhibitor; Duodenal cancer; Immunohistochemistry; Pathology; Cancer; Biology; Enzyme","score_opus":0.09705796834636993,"score_gpt":0.4373965849768265,"score_spread":0.34033861663045656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102094932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873254,0.0031044874,0.000004466661,0.007859236,0.00009449369,0.0013242031,0.000014606025,0.00002672115,0.00024643668],"genre_scores_gemma":[0.997255,0.00034510135,0.00018835743,0.0008408501,0.0007241689,0.00037792395,0.000010222978,0.000030986812,0.00022737257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966176,0.0009703448,0.0006089584,0.00047340852,0.00074955117,0.00058011094],"domain_scores_gemma":[0.99684894,0.0020960344,0.000067359884,0.00041656612,0.00012774993,0.00044334383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032365085,0.00016807012,0.00047986425,0.00029171232,0.00017608024,0.00003520774,0.00021041819,0.00019968639,0.00009020315],"category_scores_gemma":[0.0010321866,0.000109451925,0.000049733128,0.0006894656,0.000364004,0.000086101274,0.00013796592,0.001237486,0.00007630856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006161584,0.00029856243,0.98135847,0.0000706936,0.00001728493,0.0002156427,0.0009295672,0.00006957711,0.0021093094,0.000036382644,0.0050504818,0.0036824713],"study_design_scores_gemma":[0.005968453,0.000733548,0.98313665,0.00067058956,0.00001878966,0.000020624087,0.00020418457,0.00062652025,0.0021780136,0.000021331924,0.006268296,0.00015296858],"about_ca_topic_score_codex":0.0024223186,"about_ca_topic_score_gemma":0.010426647,"teacher_disagreement_score":0.009929666,"about_ca_system_score_codex":0.00026865397,"about_ca_system_score_gemma":0.00058930507,"threshold_uncertainty_score":0.58183134},"labels":[],"label_agreement":null},{"id":"W2102161352","doi":"10.1158/1078-0432.ccr-04-2064","title":"Placental Cadherin and the Basal Epithelial Phenotype of <i>BRCA1</i>-Related Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); McGill University; Jewish General Hospital; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Breast cancer; Oncology; Internal medicine; Cancer; Medicine; Univariate analysis; Lymph node; Cytokeratin; Basal (medicine); Pathology; Progesterone receptor; Estrogen receptor; Biology; Cancer research; Immunohistochemistry; Multivariate analysis","score_opus":0.05690589327891108,"score_gpt":0.441891027783803,"score_spread":0.3849851345048919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102161352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793118,0.00785212,0.000019200215,0.010325299,0.0004373615,0.0004022585,0.00026984466,0.000008085029,0.0013739886],"genre_scores_gemma":[0.9901961,0.0062445663,0.00013109126,0.0005230079,0.0012853849,0.00015750654,0.000014913798,0.000030640425,0.0014167675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781907,0.000500252,0.00049384154,0.0004477836,0.000378767,0.0003603186],"domain_scores_gemma":[0.9987797,0.00024009375,0.000105288535,0.00041380632,0.00033513823,0.00012597104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020468272,0.00012779099,0.00024151281,0.000039425136,0.00014701852,0.000023726443,0.00037226497,0.00022253336,0.0005768833],"category_scores_gemma":[0.00023483032,0.00009171114,0.00011817268,0.00022458714,0.0017718546,0.0000063745847,0.00032409377,0.0005133945,0.00001946587],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020347528,0.00085208326,0.08263864,0.00019197687,0.001548089,0.000008191313,0.0014708693,0.0026869664,0.17310628,0.0024914616,0.09970372,0.6149542],"study_design_scores_gemma":[0.041515514,0.0014400352,0.24867067,0.0003251339,0.0002933122,0.00006204302,0.0012130723,0.005011186,0.19689676,0.0020688323,0.50111365,0.0013897604],"about_ca_topic_score_codex":0.00088788883,"about_ca_topic_score_gemma":0.0011985531,"teacher_disagreement_score":0.61356443,"about_ca_system_score_codex":0.00011044586,"about_ca_system_score_gemma":0.00081666803,"threshold_uncertainty_score":0.6528472},"labels":[],"label_agreement":null},{"id":"W2102275596","doi":"10.1158/1078-0432.ccr-07-4418","title":"<i>In vivo</i>Optical Coherence Tomography Imaging of Preinvasive Bronchial Lesions","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Autofluorescence; Carcinoma in situ; Dysplasia; Medicine; Pathology; Optical coherence tomography; Histopathology; Metaplasia; Hyperplasia; Squamous metaplasia; Bronchoscopy; Endomicroscopy; In vivo; Carcinoma; Radiology; Epithelium; Biology","score_opus":0.12514116094198532,"score_gpt":0.42949127071195925,"score_spread":0.3043501097699739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102275596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751056,0.001376319,0.00070201873,0.0006809314,0.00028474486,0.0008623083,0.00007063031,0.00015459978,0.02076285],"genre_scores_gemma":[0.99654865,0.0012151774,0.0013374506,0.000062043706,0.00021978907,0.0004769433,0.0000020387963,0.000035531844,0.00010240189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717104,0.00018572711,0.0008083407,0.0004477554,0.0006834073,0.0007037247],"domain_scores_gemma":[0.9969564,0.001772824,0.000040532705,0.0005716592,0.00032299553,0.0003355991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009940373,0.00017010893,0.0003980211,0.0003649744,0.00012628164,0.000018252866,0.0006009948,0.00015872365,0.00065884297],"category_scores_gemma":[0.0003922926,0.00016947374,0.00022180422,0.0018519972,0.0016631932,0.00018285864,0.00014115068,0.001260159,0.000057144163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040413384,0.0018261216,0.8297719,0.0005015769,0.00023316768,0.00025147447,0.00083293195,0.0039758454,0.04552288,0.018316533,0.07024548,0.02811795],"study_design_scores_gemma":[0.006556875,0.0011381252,0.7939395,0.0010436596,0.00010859577,0.00006177496,0.00064630393,0.0194587,0.121703446,0.01936174,0.033811476,0.0021698424],"about_ca_topic_score_codex":0.00021966943,"about_ca_topic_score_gemma":0.0002010785,"teacher_disagreement_score":0.07618057,"about_ca_system_score_codex":0.00007116451,"about_ca_system_score_gemma":0.00024373528,"threshold_uncertainty_score":0.72138685},"labels":[],"label_agreement":null},{"id":"W2102533320","doi":"10.1158/1078-0432.ccr-07-4457","title":"Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Lung cancer; Immunohistochemistry; Biology; Biomarker; Peroxiredoxin; Survival analysis; Cancer research; Phenotype; Cancer; Gene; Oncology; Internal medicine; Medicine; Immunology; Genetics; Enzyme","score_opus":0.11592304915459783,"score_gpt":0.49125056369645953,"score_spread":0.3753275145418617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102533320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789686,0.019898543,0.000011466802,0.00055614917,0.000051105402,0.0003731106,0.000019686717,0.0000026842658,0.0001186209],"genre_scores_gemma":[0.98688173,0.012257012,0.000021554428,0.000054110125,0.00011417085,0.00016391317,0.000022369632,0.000008637193,0.00047650776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987719,0.00028940768,0.00026106843,0.00035258976,0.00012225384,0.00020276892],"domain_scores_gemma":[0.9993806,0.00014673654,0.00006201188,0.00014037725,0.0002006437,0.000069641246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006476084,0.00007778888,0.00015843441,0.00005237921,0.000081880105,0.0000047704107,0.00009941901,0.00019244595,0.000041561907],"category_scores_gemma":[0.0003431938,0.000065760534,0.000028164539,0.00013258719,0.00046019425,0.0000046601085,0.00010122097,0.00020925401,9.789261e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043245425,0.000057971578,0.7704787,0.000055181838,0.000040668405,0.000001057838,0.000114552124,0.000010643936,0.22240609,0.000179964,0.00018584233,0.0060368637],"study_design_scores_gemma":[0.0007248586,0.00033169345,0.91866684,0.000040633615,0.0000070502015,0.000004466702,0.00003116234,0.00040266063,0.078427404,0.00036500636,0.000914784,0.000083446605],"about_ca_topic_score_codex":0.00015334168,"about_ca_topic_score_gemma":0.00012059409,"teacher_disagreement_score":0.14818813,"about_ca_system_score_codex":0.000014699112,"about_ca_system_score_gemma":0.0002075342,"threshold_uncertainty_score":0.26816368},"labels":[],"label_agreement":null},{"id":"W2102550616","doi":"10.1158/1078-0432.ccr-08-3357","title":"Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","keywords":"Biology; Prostate cancer; DNA repair; Genetics; Missense mutation; DNA damage; Cancer research; Population; Radiosensitivity; Amplicon; Gene; Mutation; Cancer; Radiation therapy; Internal medicine; DNA; Medicine; Polymerase chain reaction","score_opus":0.1335603701311492,"score_gpt":0.4723985845695263,"score_spread":0.33883821443837714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102550616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845721,0.0072633084,0.0000051767292,0.005999743,0.0001874958,0.001523547,0.0002093407,0.000039707156,0.00019956833],"genre_scores_gemma":[0.95033705,0.047046747,0.00030991933,0.0014974566,0.0003413897,0.00020141288,0.000075140204,0.000023252886,0.00016761188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969257,0.0004495545,0.0006327572,0.00083776546,0.00058887876,0.00056535285],"domain_scores_gemma":[0.9981264,0.00076262647,0.0000866408,0.0004311744,0.00026872553,0.0003244656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011511694,0.00020009147,0.0006111368,0.00012718147,0.00010472494,0.00006685902,0.00009212524,0.00013654136,0.00004759839],"category_scores_gemma":[0.0002680875,0.00015100298,0.0001382065,0.00034981896,0.00037053978,0.00022229044,0.000059459177,0.0006242541,0.000008849956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003842523,0.0014036112,0.71843475,0.000040898823,0.000161099,0.0012309762,0.0006030112,0.000005551176,0.0009612154,0.00008729036,0.0011774868,0.27205157],"study_design_scores_gemma":[0.007601366,0.0030494954,0.9806961,0.0005824802,0.00003796376,0.0000079096835,0.00006324227,0.00031772134,0.001987577,0.0007422049,0.0047299727,0.00018398932],"about_ca_topic_score_codex":0.0015645374,"about_ca_topic_score_gemma":0.00016757911,"teacher_disagreement_score":0.27186757,"about_ca_system_score_codex":0.0004918193,"about_ca_system_score_gemma":0.00048335525,"threshold_uncertainty_score":0.6157723},"labels":[],"label_agreement":null},{"id":"W2102596641","doi":"10.1158/1078-0432.ccr-07-1658","title":"Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Progesterone receptor; Internal medicine; Medicine; Cytokeratin; Anthracycline; Tissue microarray; Basal (medicine); Biomarker; Estrogen receptor; Cancer; Proportional hazards model; Pathology; Surrogate endpoint; Immunohistochemistry; Biology","score_opus":0.1088655616907161,"score_gpt":0.41913822685961005,"score_spread":0.31027266516889396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102596641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750759,0.0099446885,0.000032629785,0.010700698,0.0009005551,0.0011076974,0.0016864701,0.000047640224,0.0005037364],"genre_scores_gemma":[0.9847789,0.009349249,0.00022700074,0.00068807387,0.000996194,0.0011982884,0.0001643243,0.00008495912,0.0025130277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582964,0.0007063914,0.0005883815,0.0011811645,0.00071065594,0.0009837694],"domain_scores_gemma":[0.99747044,0.0006377487,0.00012837516,0.00062311906,0.0007447423,0.000395597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008299579,0.0003750064,0.000537647,0.00009248918,0.00069998147,0.00005261937,0.0005288535,0.0003397425,0.00032808303],"category_scores_gemma":[0.0009431625,0.00028877525,0.00028325975,0.0005522183,0.0022249743,0.000015071053,0.00045807453,0.0005503301,0.000071139984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064167106,0.0011683807,0.63628,0.00008557917,0.0020092668,0.00006655515,0.0005182787,0.000020538266,0.007977032,0.000019466832,0.3314729,0.013965316],"study_design_scores_gemma":[0.007818987,0.0012804306,0.93993074,0.00019259233,0.00017929409,0.000035232737,0.00044440638,0.000081956176,0.009824059,0.00018697458,0.039179403,0.0008459341],"about_ca_topic_score_codex":0.008758447,"about_ca_topic_score_gemma":0.0018523127,"teacher_disagreement_score":0.30365077,"about_ca_system_score_codex":0.00025149647,"about_ca_system_score_gemma":0.0015589629,"threshold_uncertainty_score":0.9999564},"labels":[],"label_agreement":null},{"id":"W2102819165","doi":"10.1158/1078-0432.58.11.1","title":"Vaccination of Dendritic Cells Loaded with Interleukin-12-Secreting Cancer Cells Augments <i>In vivo</i> Antitumor Immunity: Characteristics of Syngeneic and Allogeneic Antigen-Presenting Cell Cancer Hybrid Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Japan Society for the Promotion of Science","keywords":"Cancer immunotherapy; Immunotherapy; Cancer; Cancer cell; Immunology; Immune system; Dendritic cell; Cancer research; Cancer vaccine; Interleukin 12; Medicine; Antigen; Antigen-presenting cell; T cell; Cytotoxic T cell; Biology; In vitro; Internal medicine","score_opus":0.056096816531421366,"score_gpt":0.3836351251316134,"score_spread":0.32753830860019206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102819165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97544974,0.022432957,0.000029104096,0.00013733824,0.0007692037,0.00075032696,0.00028244616,0.00001953779,0.00012933511],"genre_scores_gemma":[0.95752317,0.040261906,0.000092467,0.00010034375,0.000109888126,0.00012539148,0.000020835889,0.00006152586,0.00170446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950494,0.0015316879,0.0015474957,0.00065385643,0.00026667365,0.00095088815],"domain_scores_gemma":[0.9967243,0.0014389207,0.0006607744,0.0005739865,0.0005301331,0.00007185958],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025573843,0.00034486246,0.001023513,0.00043617413,0.00025312102,0.000041903982,0.0006783723,0.00030055825,0.0014000986],"category_scores_gemma":[0.00011139235,0.0003092023,0.0001668747,0.00042464206,0.00077584054,0.00020459955,0.00037221343,0.0012448202,0.000021790338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023574487,0.0005546446,0.045824986,0.0004046629,0.0002621649,0.000015259608,0.0005043355,0.00005243717,0.9325031,0.0000038503904,0.00033291493,0.017184205],"study_design_scores_gemma":[0.003277857,0.00047138843,0.0320359,0.0007132917,0.000063656276,0.000006138835,0.0002839753,0.000048019832,0.95776546,0.0000051899683,0.0050262325,0.00030290126],"about_ca_topic_score_codex":0.003419854,"about_ca_topic_score_gemma":0.0006801952,"teacher_disagreement_score":0.025262358,"about_ca_system_score_codex":0.00020375349,"about_ca_system_score_gemma":0.0006694953,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W2102881335","doi":"10.1158/1078-0432.ccr-07-0867","title":"Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Cancer research; Biology; Internal medicine; Medicine","score_opus":0.18087703472038388,"score_gpt":0.4915214089841079,"score_spread":0.31064437426372404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102881335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945727,0.0023788991,0.00010476737,0.00050237915,0.00009668399,0.0014110524,0.00007264751,0.00006158533,0.0007992859],"genre_scores_gemma":[0.99372476,0.002189532,0.00079986657,0.00021686331,0.0008583291,0.0004120858,0.00026077923,0.00011562319,0.00142217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99313277,0.0019110085,0.0011118888,0.0013632898,0.0012292424,0.0012518282],"domain_scores_gemma":[0.9962399,0.00073351705,0.00029868394,0.0012913904,0.0009387321,0.0004977976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027580992,0.00033192284,0.0004966418,0.00025549094,0.0011888633,0.000106870895,0.0008562819,0.0002952085,0.0002481207],"category_scores_gemma":[0.0028378791,0.0003103158,0.00025062988,0.00086378644,0.0013169412,0.000018911165,0.0007146656,0.001229908,0.0001086234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003297653,0.00048172637,0.0071377093,0.00005272281,0.00009713497,0.00013442608,0.00035042153,0.00008646054,0.9653338,0.00000989497,0.0045018718,0.018516146],"study_design_scores_gemma":[0.004557314,0.007002725,0.017703794,0.00018561057,0.0000178049,0.000032054424,0.00021117146,0.00017841868,0.965153,0.00010356452,0.004318677,0.00053588115],"about_ca_topic_score_codex":0.00029435562,"about_ca_topic_score_gemma":0.00012948639,"teacher_disagreement_score":0.017980264,"about_ca_system_score_codex":0.00012701248,"about_ca_system_score_gemma":0.0010608677,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W2102925061","doi":"10.1158/1078-0432.ccr-10-3405","title":"The Role of <i>KRAS</i> rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; Cancer Research UK; Peter MacCallum Cancer Centre; Wellcome Trust; Friedrich-Schiller-Universität Jena; Moffitt Cancer Center; University of South Florida; Deutsches Krebsforschungszentrum; Helsingin ja Uudenmaan Sairaanhoitopiiri; University College London; Helsingin Yliopisto","keywords":"KRAS; Ovarian cancer; Epithelial ovarian cancer; Medicine; Cancer; Oncology; Internal medicine; Pathology; Gynecology; Cancer research; Biology; Colorectal cancer","score_opus":0.5335970556706076,"score_gpt":0.5682043515900453,"score_spread":0.034607295919437786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102925061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931926,0.016190378,0.000036847603,0.028961454,0.0011864124,0.0058688647,0.0006724126,0.0000655132,0.015092113],"genre_scores_gemma":[0.9748582,0.018622575,0.0013510707,0.00043388116,0.0011365415,0.0033458197,0.00000998907,0.000043649314,0.00019824336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641365,0.0004770512,0.0014144945,0.0006525352,0.0003741494,0.00066810206],"domain_scores_gemma":[0.986845,0.010641215,0.0002704729,0.0008003343,0.0010951837,0.00034780073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005163414,0.00016344605,0.00062947633,0.00010507088,0.00026692761,0.000024787185,0.0004317353,0.00022970355,0.00013278985],"category_scores_gemma":[0.0054896306,0.00011090415,0.00030576534,0.0006732004,0.000838039,0.000059759426,0.0001804945,0.0008333286,0.000016860062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009641406,0.0008261034,0.7336421,0.000043017644,0.00015806819,0.0000043276655,0.00012137724,8.5739197e-7,0.0001604729,0.0024880837,0.0022548742,0.25933656],"study_design_scores_gemma":[0.0042377524,0.0015319588,0.9474366,0.00036804072,0.00012178193,0.000002481754,0.00018989092,0.000046280104,0.0021462059,0.009664137,0.034135114,0.00011977086],"about_ca_topic_score_codex":0.005743074,"about_ca_topic_score_gemma":0.0047822306,"teacher_disagreement_score":0.2592168,"about_ca_system_score_codex":0.0002556987,"about_ca_system_score_gemma":0.0027287358,"threshold_uncertainty_score":0.86818486},"labels":[],"label_agreement":null},{"id":"W2102984838","doi":"10.1158/1078-0432.ccr-07-4077","title":"Dietary Intake of Lactose as a Strong Predictor for Secretor Status of Nipple Aspirate Fluid in Healthy Premenopausal Nonlactating Women","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; NIH Clinical Center; National Center for Research Resources; National Institute of Environmental Health Sciences; University of Minnesota","keywords":"Menarche; Medicine; Odds ratio; Lactose; Confidence interval; Logistic regression; Physiology; Obstetrics; Breast cancer; Endocrinology; Breast feeding; Hormone; Anthropometry; Internal medicine; Pregnancy; Childbirth; Gynecology; Cancer; Food science; Biology; Pediatrics","score_opus":0.32998196154980924,"score_gpt":0.517350976716185,"score_spread":0.18736901516637577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102984838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606776,0.0012235973,0.00001331889,0.00051658065,0.00012010645,0.0012644165,0.0002345018,0.000015036086,0.00054470665],"genre_scores_gemma":[0.9973406,0.00086621847,0.0004868393,0.00015301081,0.00035228554,0.00041795612,0.00003793625,0.000037747595,0.00030739623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962374,0.00036197258,0.0011701973,0.00044835446,0.0007913795,0.0009907235],"domain_scores_gemma":[0.9969291,0.0011988122,0.00019453483,0.00042478865,0.00063755846,0.00061518775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026728585,0.0001440673,0.0007361076,0.00022957864,0.00009171749,0.0000051258157,0.00018733031,0.00017610374,0.00048967864],"category_scores_gemma":[0.0016826219,0.00012268765,0.00011981377,0.0005399352,0.0005302697,0.000081313134,0.00014774267,0.0007997728,0.0000055942937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034877826,0.0017753782,0.9024731,0.0017604663,0.0001775196,0.00007315512,0.002939516,0.000021434817,0.01704285,0.00008818143,0.0016880687,0.037082516],"study_design_scores_gemma":[0.009473906,0.019052751,0.96316665,0.00048535914,0.000028629958,0.000012453302,0.0017134806,0.0011096427,0.0016197753,0.00013601787,0.003046342,0.00015499479],"about_ca_topic_score_codex":0.002515074,"about_ca_topic_score_gemma":0.00028195663,"teacher_disagreement_score":0.06069356,"about_ca_system_score_codex":0.00040221625,"about_ca_system_score_gemma":0.0033781773,"threshold_uncertainty_score":0.59927416},"labels":[],"label_agreement":null},{"id":"W2103114638","doi":"10.1158/1078-0432.ccr-14-2993","title":"PTEN Loss Is Associated with Worse Outcome in <i>HER2</i> -Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"National Cancer Institute","keywords":"PTEN; Trastuzumab; Breast cancer; Medicine; Immunohistochemistry; Population; Cancer; Oncology; Internal medicine; Cancer research; Pathology; Biology; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.332316024989978,"score_gpt":0.5229535913488315,"score_spread":0.19063756635885348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103114638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711282,0.0005581154,0.0000070670467,0.020282602,0.00032653194,0.0024920085,0.001904467,0.00013833336,0.003162632],"genre_scores_gemma":[0.97307533,0.00054695393,0.00004629922,0.0041491613,0.00045457477,0.0011108838,0.00011557372,0.00022963223,0.02027159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9858378,0.0016943198,0.0018426913,0.0018730888,0.0061774924,0.0025746133],"domain_scores_gemma":[0.9891338,0.0018683564,0.00047652324,0.0013532414,0.005344125,0.0018240048],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008716968,0.0006241375,0.0018433501,0.00053148554,0.00028157947,0.0001770633,0.0010541948,0.000781829,0.0014485957],"category_scores_gemma":[0.0049120137,0.0004693261,0.00024449357,0.0037557506,0.0018208711,0.00029795972,0.00038628728,0.0046481704,0.00016963715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014517877,0.002092455,0.91926944,0.00015140123,0.0005340161,0.00048653706,0.0009074916,0.000013205912,0.000018808496,0.000009536848,0.058483835,0.0035153679],"study_design_scores_gemma":[0.023989143,0.0020813418,0.96030915,0.0030683721,0.00013843014,0.000007138829,0.0004122418,0.0001577294,0.00022263477,0.00008929592,0.00882819,0.000696322],"about_ca_topic_score_codex":0.009231568,"about_ca_topic_score_gemma":0.029131778,"teacher_disagreement_score":0.049655642,"about_ca_system_score_codex":0.006327055,"about_ca_system_score_gemma":0.0069742636,"threshold_uncertainty_score":0.9997758},"labels":[],"label_agreement":null},{"id":"W2103156714","doi":"10.1158/1078-0432.ccr-10-1233","title":"REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada); St. Thomas Hospital","funders":"National Cancer Institute; National Center for Research Resources; Cancer Research UK","keywords":"Docetaxel; Medicine; Neutropenia; Oncolytic virus; Cancer; Chemotherapy; Phases of clinical research; Internal medicine; Oncology; Progressive disease; Toxicity; Pharmacology; Gastroenterology","score_opus":0.07597896873666508,"score_gpt":0.5028271086333926,"score_spread":0.42684813989672754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103156714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977057,0.00072490127,0.0000011193509,0.00013210085,0.000091956514,0.0011329892,0.000054641838,0.0000052167643,0.00015137698],"genre_scores_gemma":[0.998125,0.00094190077,0.00004124496,0.000055644843,0.00017830002,0.00033644546,0.000016229458,0.000038375198,0.00026682173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712265,0.0004914122,0.0004934588,0.0006937352,0.0006615303,0.0005372318],"domain_scores_gemma":[0.9981905,0.0001444195,0.000100847974,0.00069238414,0.00063583185,0.00023601975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001991351,0.00015978854,0.00034597327,0.00014751538,0.00009277151,0.000023266404,0.00041382722,0.00018706509,0.00025118014],"category_scores_gemma":[0.00047219754,0.00012878436,0.00004225078,0.0004074725,0.0005870152,0.000008404433,0.00025630998,0.00095517974,0.0000043309924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076760806,0.007595367,0.4585005,0.000070167705,0.00020887506,0.00001889861,0.0003561652,0.000043988395,0.107920565,0.0000042754364,0.00047274158,0.34804764],"study_design_scores_gemma":[0.09115936,0.20228691,0.57627267,0.00018731746,0.00005817203,0.0000019218626,0.00079579593,0.00009464117,0.11507173,0.00011175365,0.012972761,0.0009869974],"about_ca_topic_score_codex":0.00071967783,"about_ca_topic_score_gemma":0.01471788,"teacher_disagreement_score":0.34706065,"about_ca_system_score_codex":0.000032981727,"about_ca_system_score_gemma":0.00056921877,"threshold_uncertainty_score":0.8212922},"labels":[],"label_agreement":null},{"id":"W2103323117","doi":"10.1158/1078-0432.ccr-08-3275","title":"Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Chemotherapy; Melanoma; Oncology; Metastasis; Cancer; Internal medicine; Cancer research","score_opus":0.11522847609623008,"score_gpt":0.4832665285959733,"score_spread":0.3680380524997432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103323117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691108,0.02897807,0.00002243203,0.0003918095,0.00026366243,0.0009981308,0.00001798712,0.000018775374,0.00019837068],"genre_scores_gemma":[0.9960745,0.0028903347,0.00008373556,0.00005281437,0.00002164177,0.00010010553,0.000024966685,0.000020373642,0.0007315546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960074,0.0021235966,0.0007784214,0.00044731758,0.00010001441,0.0005432969],"domain_scores_gemma":[0.9979607,0.001141494,0.00021769882,0.00045746504,0.00020056136,0.000022078151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021638856,0.00020298493,0.00070050947,0.00041868104,0.00022550352,0.000014495503,0.00029613962,0.00024378265,0.00028927348],"category_scores_gemma":[0.00013543213,0.00017303755,0.0002503185,0.0004915098,0.0005077699,0.00009966061,0.00003605639,0.00043936368,0.000030870982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056691,0.0020782934,0.002102461,0.000009317423,0.00031109276,0.000002810407,0.00063218194,0.00005642339,0.7799762,0.00030862854,0.000045909295,0.20880759],"study_design_scores_gemma":[0.01580224,0.009917985,0.1848847,0.00014271936,0.000049986236,0.0000062657923,0.0005435572,0.000027616748,0.77745426,0.00036645698,0.0105381925,0.00026602138],"about_ca_topic_score_codex":0.001200015,"about_ca_topic_score_gemma":0.000047621925,"teacher_disagreement_score":0.20854157,"about_ca_system_score_codex":0.00068634783,"about_ca_system_score_gemma":0.00020647635,"threshold_uncertainty_score":0.70562667},"labels":[],"label_agreement":null},{"id":"W2103346522","doi":"10.1158/1078-0432.ccr-10-3024","title":"Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomarkers in Disease Mechanisms","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Lung cancer; Medicine; Biomarker; Cancer; Receiver operating characteristic; Internal medicine; Stage (stratigraphy); Oncology; Carcinoma; Lung; Area under the curve; Gastroenterology; Pathology; Biology","score_opus":0.4052341066776421,"score_gpt":0.49071715523306314,"score_spread":0.08548304855542105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103346522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98076665,0.007444105,0.00023418164,0.0004339631,0.0016557985,0.0005891228,0.00026515295,0.000044761113,0.008566279],"genre_scores_gemma":[0.9966809,0.00026972842,0.00022915934,0.0002266339,0.000052318956,0.00009528194,0.000015402089,0.00002819117,0.002402368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972586,0.00062135,0.00068560155,0.0005724441,0.00016501639,0.000696987],"domain_scores_gemma":[0.9980276,0.0005837977,0.00013142746,0.0007260718,0.0004217985,0.00010930991],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026956012,0.00015541413,0.0003945702,0.0001869542,0.00014261021,0.000007855406,0.00075720384,0.00047126456,0.015689204],"category_scores_gemma":[0.00045054176,0.00013352686,0.00025778334,0.00041511876,0.0014996806,0.000059689482,0.00045687685,0.000736981,0.00041937546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060753454,0.0024910532,0.47366896,0.00028339642,0.0012511347,0.000033928696,0.0012530196,3.479991e-8,0.29574567,0.004286286,0.18493892,0.029972237],"study_design_scores_gemma":[0.0047657555,0.00062086526,0.77567774,0.00014274141,0.00011861832,0.000014278681,0.0003269658,0.00004090437,0.19382834,0.0014870428,0.022618836,0.00035789167],"about_ca_topic_score_codex":0.0010237134,"about_ca_topic_score_gemma":0.000039726427,"teacher_disagreement_score":0.30200878,"about_ca_system_score_codex":0.000071038085,"about_ca_system_score_gemma":0.00044072565,"threshold_uncertainty_score":0.9852106},"labels":[],"label_agreement":null},{"id":"W2103727417","doi":"10.1158/1078-0432.ccr-03-0569","title":"Changes in Gene Expression Induced by Phosphorothioate Oligodeoxynucleotides (Including G3139) in PC3 Prostate Carcinoma Cells Are Recapitulated at Least in Part by Treatment with Interferon-β and -γ","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Prostate; Gene expression; Carcinoma; Gene; Interferon; Biology; Cancer research; Medicine; Cancer; Internal medicine; Immunology; Genetics","score_opus":0.11748575378069331,"score_gpt":0.3874279057922098,"score_spread":0.2699421520115165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103727417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901124,0.007258305,5.7646537e-7,0.0015369119,0.00012504999,0.0008882966,0.000029529214,0.000016946991,0.000031958254],"genre_scores_gemma":[0.9900182,0.008729069,0.000009050845,0.00005793603,0.00001966101,0.00037011818,0.000077951874,0.00002802273,0.00069001626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970431,0.0009736561,0.0006102265,0.00059745664,0.00010105584,0.0006745257],"domain_scores_gemma":[0.99913216,0.0003254136,0.00014214842,0.00027090337,0.00007424315,0.000055141718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014427956,0.00022041006,0.0004917097,0.00025914048,0.00014025123,0.000027261136,0.0001705021,0.00036388641,0.00008348646],"category_scores_gemma":[0.00008463654,0.00017108036,0.00003389209,0.0003495081,0.0003226525,0.00012745943,0.00021374231,0.0007875854,0.000044305634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007241677,0.00061744597,0.073231876,0.000033534612,0.00002797839,0.000045145007,0.0018594725,0.000015648522,0.9100069,0.0000015377175,0.00041764393,0.006501151],"study_design_scores_gemma":[0.011315088,0.0017641139,0.025273867,0.0006601594,0.0000053322556,0.0000045722713,0.0005073402,0.000008302324,0.95811045,0.000016309354,0.0021387024,0.00019578151],"about_ca_topic_score_codex":0.004553719,"about_ca_topic_score_gemma":0.009585469,"teacher_disagreement_score":0.048103545,"about_ca_system_score_codex":0.0008223992,"about_ca_system_score_gemma":0.00017763945,"threshold_uncertainty_score":0.6976455},"labels":[],"label_agreement":null},{"id":"W2103808961","doi":"10.1158/1078-0432.ccr-06-2379","title":"Characterization and Magnetic Resonance Imaging of a Rat Model of Human B-Cell Central Nervous System Lymphoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Magnetic resonance imaging; Central nervous system; Lymphoma; Pathology; Characterization (materials science); Primary central nervous system lymphoma; Nuclear magnetic resonance; Medicine; Neuroscience; Biology; Radiology; Materials science; Nanotechnology; Physics","score_opus":0.10302826105775215,"score_gpt":0.4329346755516833,"score_spread":0.32990641449393115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103808961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326366,0.00529796,0.000072724884,0.00021193654,0.00009177996,0.00048576648,0.000026620593,0.000014354003,0.0005351689],"genre_scores_gemma":[0.9980221,0.0010792222,0.00011866586,0.000046451936,0.00015180798,0.000036962723,0.000016962367,0.00002087278,0.00050696055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801487,0.000107325504,0.0006833199,0.00031669415,0.00048881414,0.00038899196],"domain_scores_gemma":[0.99873114,0.0002861869,0.00012283205,0.0003049719,0.00033075488,0.00022412969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001282087,0.00010186971,0.0004115706,0.00012629127,0.00006925201,0.000011269237,0.00009105541,0.00007883067,0.00002609664],"category_scores_gemma":[0.0000844912,0.00008517255,0.000095282965,0.00022897268,0.00034350195,0.000041541254,0.000087649045,0.00012138705,0.0000022249633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083328097,0.000980144,0.53627414,0.00060067343,0.000013247381,0.0000740664,0.0002038058,0.0000031493475,0.066824906,0.00040165626,0.00017407554,0.39361688],"study_design_scores_gemma":[0.004244364,0.0006333038,0.9568587,0.0006022269,0.00005651684,0.000008052119,0.00014047453,0.0045014727,0.03248816,0.000016458649,0.00037350217,0.00007677716],"about_ca_topic_score_codex":0.00046636106,"about_ca_topic_score_gemma":0.000056236444,"teacher_disagreement_score":0.42058456,"about_ca_system_score_codex":0.00022561394,"about_ca_system_score_gemma":0.0002775979,"threshold_uncertainty_score":0.3473236},"labels":[],"label_agreement":null},{"id":"W2103812354","doi":"10.1158/1078-0432.ccr-11-2080","title":"Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Serous carcinoma; Serous Cystadenoma; Pathology; Biology; Carcinogenesis; Cystadenocarcinoma; Ovary; Ovarian cancer; Cancer research; Medicine; Cancer; Genetics","score_opus":0.5835839815901704,"score_gpt":0.5824806149641291,"score_spread":0.00110336662604138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103812354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.911807,0.00073351845,0.0004540047,0.034981016,0.0009045406,0.006109096,0.0002629911,0.000114216644,0.044633638],"genre_scores_gemma":[0.9896819,0.0004074462,0.0035868927,0.00055790815,0.00058768847,0.0033077113,0.000028047432,0.000037660546,0.0018047217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754477,0.00028665672,0.00071661815,0.00060971663,0.00034423615,0.000497981],"domain_scores_gemma":[0.9973249,0.00094054826,0.00008309434,0.00060466566,0.0006959911,0.00035083533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021654193,0.00013504397,0.00040312984,0.00013140346,0.00018416399,0.00003357416,0.00013620657,0.00018004024,0.0021441325],"category_scores_gemma":[0.00086170906,0.00011445178,0.00015510658,0.00054930407,0.00024921892,0.00008871789,0.000051655617,0.0005789871,0.00017066262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022955611,0.003941971,0.8710011,0.00017108713,0.0002558956,0.00227951,0.0013802145,0.000002264853,0.000019682524,0.011565245,0.07236801,0.034719445],"study_design_scores_gemma":[0.023071574,0.003930762,0.8647472,0.0009943441,0.00033200558,0.00083214743,0.0020785583,0.0006852065,0.0016343618,0.0126864165,0.08837361,0.0006338102],"about_ca_topic_score_codex":0.0045616757,"about_ca_topic_score_gemma":0.004747355,"teacher_disagreement_score":0.07787494,"about_ca_system_score_codex":0.0004205325,"about_ca_system_score_gemma":0.0010567536,"threshold_uncertainty_score":0.99876803},"labels":[],"label_agreement":null},{"id":"W2103830942","doi":"10.1158/1078-0432.ccr-04-2534","title":"Genetic Polymorphisms of Selected DNA Repair Genes, Estrogen and Progesterone Receptor Status, and Breast Cancer Risk","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Breast cancer; ERCC1; Odds ratio; Genotype; Oncology; Internal medicine; DNA repair; Biology; Cancer; Estrogen receptor; Medicine; Genetics; Gene; Nucleotide excision repair","score_opus":0.03953477060863891,"score_gpt":0.3877575085352418,"score_spread":0.3482227379266029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103830942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97259796,0.025898108,0.000016268788,0.00047395437,0.00008872737,0.0005021615,0.00036834853,0.000030014973,0.000024454817],"genre_scores_gemma":[0.95387787,0.04126693,0.003228893,0.000090019064,0.0007284212,0.0002001448,0.000030117888,0.000053919353,0.00052366615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707884,0.00055764714,0.0005467751,0.00079203676,0.00039624414,0.00062847027],"domain_scores_gemma":[0.9983673,0.00009413365,0.00015532026,0.000506926,0.00047405864,0.0004022379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011245912,0.00019091817,0.00032604806,0.00007441344,0.00011882396,0.00002623144,0.00020914523,0.00030093553,0.00016950021],"category_scores_gemma":[0.00025307678,0.00017460827,0.000090475834,0.00025975148,0.00058433233,0.000008534496,0.00037983563,0.0003850929,0.000006072042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007517295,0.00017615272,0.5212938,0.00006195481,0.00021895372,0.000002341481,0.000040045143,0.000008748258,0.34911263,0.000018402085,0.0022105586,0.1261047],"study_design_scores_gemma":[0.002887959,0.0018757735,0.6194025,0.00011292559,0.00011313477,0.000035454723,0.00006421082,0.0004016458,0.32070792,0.000069608825,0.053822115,0.0005067282],"about_ca_topic_score_codex":0.0010777403,"about_ca_topic_score_gemma":0.00081407087,"teacher_disagreement_score":0.12559797,"about_ca_system_score_codex":0.00005976875,"about_ca_system_score_gemma":0.00062136195,"threshold_uncertainty_score":0.7120319},"labels":[],"label_agreement":null},{"id":"W2103937028","doi":"10.1158/1078-0432.ccr-05-0157","title":"Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"HER2/neu; Trastuzumab; Cancer research; Cell sorting; In vivo; Neuroblastoma; Cell culture; Cytokine-induced killer cell; Cytotoxicity; Biology; Antibody; In vitro; Cell growth; Cytokine; Immunology; Cancer; Medicine; Internal medicine; Antigen; Flow cytometry; Breast cancer; CD3","score_opus":0.198309089651138,"score_gpt":0.48059172732610295,"score_spread":0.282282637674965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103937028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008113,0.00066481804,0.0000041856556,0.0039026963,0.00039437145,0.0011341656,0.00031481698,0.00007164879,0.003432179],"genre_scores_gemma":[0.9856012,0.001028617,0.00024420576,0.0008446811,0.0009798333,0.00020784984,0.000021636297,0.00009670679,0.010975312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99401915,0.0007684246,0.001057199,0.0009618718,0.0019417868,0.0012515537],"domain_scores_gemma":[0.995162,0.0016852352,0.00017324436,0.00095829373,0.0009566537,0.0010645805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018627553,0.00032241485,0.0009001883,0.00035606694,0.00016511012,0.000046994373,0.00053105835,0.00022719048,0.00088048365],"category_scores_gemma":[0.001041325,0.00025680117,0.00033647736,0.0009225438,0.0005178649,0.00011206004,0.00030709498,0.0015845984,0.00022124368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001900351,0.0023289118,0.0027656304,0.00029301792,0.00014566966,0.00034643148,0.0000962691,0.000007824032,0.8617393,0.0000017900538,0.10416428,0.026210567],"study_design_scores_gemma":[0.00630593,0.0025160322,0.013256067,0.00032421618,0.000043943764,0.000005395898,0.00009442476,0.00013277677,0.9447329,0.000017775534,0.032349143,0.00022136682],"about_ca_topic_score_codex":0.0010216826,"about_ca_topic_score_gemma":0.00018257965,"teacher_disagreement_score":0.08299367,"about_ca_system_score_codex":0.0002917696,"about_ca_system_score_gemma":0.0014286995,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W2103977830","doi":"10.1158/1078-0432.ccr-07-0828","title":"Nuclear Factor-Y and Epstein Barr Virus in Nasopharyngeal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"BZLF1; Chromatin immunoprecipitation; Lytic cycle; Biology; Transactivation; Transcription factor; Cancer research; Molecular biology; Nasopharyngeal carcinoma; Virus latency; Promoter; Gene expression; Viral replication; Virology; Virus; Genetics; Gene; Herpesviridae; Medicine; Internal medicine; Radiation therapy","score_opus":0.220601259047563,"score_gpt":0.49657411486172154,"score_spread":0.27597285581415854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103977830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97984654,0.010689697,4.180112e-7,0.0050693247,0.0002580758,0.00047172967,0.000049663537,0.000043037682,0.0035715206],"genre_scores_gemma":[0.95307666,0.04304033,0.000020866351,0.001585142,0.00044009398,0.00010158569,0.0000050103445,0.000046528905,0.0016838092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971003,0.00029892527,0.0005366867,0.00058542186,0.0007557946,0.00072289293],"domain_scores_gemma":[0.9985845,0.0003488776,0.00006558771,0.0003033235,0.00021697122,0.0004807076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009469855,0.00016487906,0.00056064676,0.00018684445,0.00021562622,0.000023761198,0.00017798877,0.00030536932,0.0023480372],"category_scores_gemma":[0.0005749484,0.00014365124,0.00012964531,0.00057110534,0.00072336517,0.000110891866,0.00014705426,0.0015009956,0.00008296291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029642608,0.00049446407,0.88238174,0.0001381216,0.00013720396,0.0004575422,0.0010558729,0.000008308882,0.0020138747,0.00011459984,0.051128224,0.059105802],"study_design_scores_gemma":[0.010018473,0.0011116168,0.91737384,0.00028034643,0.000027438902,0.000010847774,0.00038801535,0.00028635477,0.00033042606,0.0002323855,0.069645055,0.00029519649],"about_ca_topic_score_codex":0.010088323,"about_ca_topic_score_gemma":0.0032762755,"teacher_disagreement_score":0.058810607,"about_ca_system_score_codex":0.0004433388,"about_ca_system_score_gemma":0.00094066904,"threshold_uncertainty_score":0.99856395},"labels":[],"label_agreement":null},{"id":"W2104165403","doi":"10.1158/1078-0432.ccr-06-0235","title":"Expression of Late Cell Cycle Genes and an Increased Proliferative Capacity Characterize Very Early Relapse of Childhood Acute Lymphoblastic Leukemia","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Deutsche Kinderkrebsstiftung","keywords":"Immunophenotyping; Cell cycle; Oncology; Minimal residual disease; Gene expression profiling; Disease; Gene; Medicine; Mitosis; Internal medicine; Cancer research; Biology; Leukemia; Immunology; Gene expression; Cancer; Flow cytometry; Genetics","score_opus":0.052740009395507666,"score_gpt":0.3818445829184736,"score_spread":0.32910457352296596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104165403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997249,0.00042964137,0.00004169077,0.00013593402,0.00009146225,0.0010856034,0.00025040153,0.000038414568,0.0006778333],"genre_scores_gemma":[0.99696475,0.0009440514,0.00067201146,0.00006543058,0.00054757163,0.00014318549,0.00005997621,0.00006497358,0.00053805026],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99465054,0.0010475351,0.0011987602,0.0008086853,0.0015237245,0.0007707312],"domain_scores_gemma":[0.9954967,0.001739488,0.0003166864,0.000784262,0.0010577794,0.00060509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024611533,0.0002790743,0.0009814986,0.0003245564,0.00016937665,0.00003793048,0.00038379707,0.00042855326,0.00014533779],"category_scores_gemma":[0.0008449213,0.00022148667,0.0001779157,0.0005988007,0.0016175774,0.00028274412,0.0004058694,0.0010315126,0.000017723387],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009080103,0.0019208579,0.15253891,0.00071342,0.00018777017,0.00016460248,0.00065004226,0.00003267004,0.8303596,0.000074767995,0.0008834182,0.0033938359],"study_design_scores_gemma":[0.009611658,0.0028671771,0.6616261,0.0005879059,0.00012894317,0.000019393565,0.000061691426,0.001895954,0.3225543,0.0003350597,0.00009245359,0.00021939265],"about_ca_topic_score_codex":0.0051161055,"about_ca_topic_score_gemma":0.000062554966,"teacher_disagreement_score":0.5090872,"about_ca_system_score_codex":0.0006825081,"about_ca_system_score_gemma":0.0033423998,"threshold_uncertainty_score":0.9031964},"labels":[],"label_agreement":null},{"id":"W2104192439","doi":"10.1158/1078-0432.ccr-06-0089","title":"Strategies to Enhance Epidermal Growth Factor Inhibition: Targeting the Mevalonate Pathway","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Lovastatin; Gefitinib; Mevalonate pathway; Epidermal growth factor receptor; Pharmacology; Erlotinib; HMG-CoA reductase; Tyrosine-kinase inhibitor; Cancer research; EGFR inhibitors; CYP3A4; Signal transduction; Reductase; Biology; Chemistry; Cancer; Medicine; Endocrinology; Biochemistry; Internal medicine; Receptor; Cholesterol; Enzyme; Cytochrome P450","score_opus":0.16510943824146354,"score_gpt":0.5140349773078748,"score_spread":0.3489255390664113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104192439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027777546,0.9886073,0.00014139213,0.0005775803,0.006808779,0.0013031481,0.00046042958,0.000023303723,0.0018003316],"genre_scores_gemma":[0.00027380898,0.941081,0.000077523764,0.0003097203,0.053344086,0.0009452077,0.0003058041,0.00009603395,0.0035668311],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99380827,0.0018069563,0.0013358166,0.0012650383,0.00077746477,0.0010064564],"domain_scores_gemma":[0.9972842,0.00052866933,0.00030063643,0.0008575371,0.00070289744,0.00032606092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035515195,0.00047820192,0.0012905584,0.000121584606,0.0003749524,0.00020963098,0.0008934451,0.00071538513,0.00017512812],"category_scores_gemma":[0.0011177092,0.00032210333,0.0008528399,0.000537633,0.0005792166,0.000012055084,0.0007048356,0.0016652372,0.00013459566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007753708,0.0000832439,0.000011048465,0.00240808,0.00015286276,0.0000018768293,0.000027540327,0.0000039578536,0.00038766567,0.00028239077,0.36995664,0.6266071],"study_design_scores_gemma":[0.00016827439,0.00018275714,0.000030100227,0.0010596773,0.000064436936,0.0000043898526,0.000040994386,5.135499e-7,0.00045652787,0.00011832606,0.9974783,0.00039568913],"about_ca_topic_score_codex":0.00052617054,"about_ca_topic_score_gemma":0.0005263891,"teacher_disagreement_score":0.62752163,"about_ca_system_score_codex":0.0001038334,"about_ca_system_score_gemma":0.0029138387,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W2104296738","doi":"10.1158/1078-0432.ccr-04-1114","title":"Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Tamoxifen; Breast cancer; Oncology; Medicine; Estrogen receptor; Internal medicine; Proportional hazards model; Population; Adjuvant therapy; Progesterone receptor; Univariate analysis; Cancer; Estrogen; Hormonal therapy; Antiestrogen; Multivariate analysis","score_opus":0.06753129881208497,"score_gpt":0.43911928178271187,"score_spread":0.3715879829706269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104296738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081403,0.0043850713,0.000020762678,0.0031215535,0.0001628815,0.0010483399,0.00022861351,0.00000996175,0.0002087603],"genre_scores_gemma":[0.99387455,0.003654396,0.0002841623,0.00017009367,0.000565803,0.0005230526,0.000012902417,0.00003885847,0.0008761697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748486,0.00038970943,0.0005248465,0.0005962829,0.0004567997,0.0005475072],"domain_scores_gemma":[0.9987722,0.000057583005,0.00008641115,0.00048232317,0.00033016558,0.00027131452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015899955,0.00016141479,0.00030451236,0.00009668283,0.00006600678,0.000016986816,0.00046264246,0.00036819294,0.00011209811],"category_scores_gemma":[0.00023870842,0.00013481732,0.00013963992,0.0005046088,0.00033553794,0.000006339336,0.00016654887,0.00060010894,0.000023223427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044158543,0.0005408356,0.025422623,0.0000863938,0.00013770287,0.000014369992,0.00009585807,0.00031308417,0.946466,0.000112239155,0.0034977077,0.018897321],"study_design_scores_gemma":[0.0038151913,0.0014314762,0.05000395,0.00066154817,0.000005985946,0.000002090074,0.000032708766,0.0000034403527,0.93398553,0.00026973343,0.009510939,0.00027741614],"about_ca_topic_score_codex":0.00042103455,"about_ca_topic_score_gemma":0.00025496073,"teacher_disagreement_score":0.024581328,"about_ca_system_score_codex":0.00011683711,"about_ca_system_score_gemma":0.001040653,"threshold_uncertainty_score":0.5497691},"labels":[],"label_agreement":null},{"id":"W2104514175","doi":"10.1158/1078-0432.ccr-06-0571","title":"Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Survivin; Nasopharyngeal carcinoma; Immunohistochemistry; Epstein–Barr virus; In situ hybridization; Medicine; Oncology; Cancer; Cancer research; Biopsy; Internal medicine; Pathology; Radiation therapy; Virus; Biology; Immunology; Gene expression; Gene","score_opus":0.16903640305834577,"score_gpt":0.48823226402700565,"score_spread":0.3191958609686599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104514175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96632063,0.020948742,0.0000017393569,0.0091367485,0.00037843542,0.0011596178,0.000068072004,0.000018555029,0.001967487],"genre_scores_gemma":[0.9897003,0.00640456,0.000029083016,0.0002896685,0.0006439348,0.0005158439,0.000002540482,0.000029557412,0.0023844962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965179,0.0006104055,0.00081185804,0.0005606956,0.000864797,0.000634355],"domain_scores_gemma":[0.9971576,0.0017255227,0.00011391934,0.00043534336,0.00039359415,0.00017407617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002653824,0.00017240689,0.00072620995,0.000117509706,0.00015532902,0.000017913653,0.00026345157,0.00016430854,0.00019902723],"category_scores_gemma":[0.0010541317,0.000114068476,0.00012896558,0.00086514786,0.0013263414,0.000052886015,0.00024012364,0.0010760908,0.000008903008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000625307,0.00036496486,0.96893346,0.00036399876,0.00004866986,0.000018063469,0.0001313516,0.000009388189,0.0035553507,0.00013599322,0.012306258,0.013507207],"study_design_scores_gemma":[0.0022595192,0.00044312593,0.9809199,0.0008263095,0.00003795519,0.0000020537927,0.00009096615,0.00007842148,0.003852967,0.00034123927,0.011018341,0.00012919339],"about_ca_topic_score_codex":0.027381836,"about_ca_topic_score_gemma":0.042947732,"teacher_disagreement_score":0.023379711,"about_ca_system_score_codex":0.00020762041,"about_ca_system_score_gemma":0.0012853241,"threshold_uncertainty_score":0.9790949},"labels":[],"label_agreement":null},{"id":"W2104564014","doi":"10.1158/1078-0432.ccr-05-2423","title":"A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacokinetics; Medicine; Toxicity; Partial thromboplastin time; Pharmacology; Heparanase; Pharmacodynamics; Internal medicine; Gastroenterology; Coagulation; Cancer; Metastasis","score_opus":0.07814163126720325,"score_gpt":0.4798012006300278,"score_spread":0.40165956936282454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104564014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975672,0.00046378252,0.000003413859,0.00015506452,0.000057092475,0.0016128378,0.00004975964,0.0000034345662,0.00008746402],"genre_scores_gemma":[0.9991654,0.00018165319,0.000023814055,0.000047506455,0.00015354008,0.00029376667,0.000016430005,0.0000145207105,0.00010335487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970591,0.0008123501,0.0005229215,0.0005936413,0.00050766853,0.0005042905],"domain_scores_gemma":[0.99894404,0.0001304694,0.00009740907,0.00038611668,0.000315963,0.00012598479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013460583,0.00014950086,0.00031491334,0.00008398822,0.00013556902,0.000019510995,0.00040469444,0.00014098654,0.00003897271],"category_scores_gemma":[0.00032342022,0.00008696245,0.00006061567,0.00044704182,0.0007942734,0.000006486577,0.00044445955,0.00057408074,0.0000015593353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007994961,0.0077188998,0.93695617,0.00002453044,0.000042817206,0.000019518104,0.000030154368,0.00006486512,0.03227241,0.0000054132993,0.0005151263,0.014355141],"study_design_scores_gemma":[0.028914504,0.023148078,0.909238,0.000066798166,0.000012694114,0.0000011711255,0.00021883346,0.0000750111,0.03625523,0.00006327485,0.0017469202,0.0002595214],"about_ca_topic_score_codex":0.00040108166,"about_ca_topic_score_gemma":0.0010611219,"teacher_disagreement_score":0.027718196,"about_ca_system_score_codex":0.000038280552,"about_ca_system_score_gemma":0.00026352925,"threshold_uncertainty_score":0.35462257},"labels":[],"label_agreement":null},{"id":"W2104707958","doi":"10.1158/1078-0432.ccr-1123-03","title":"PC Cell-Derived Growth Factor Expression in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Prostate cancer; Intraepithelial neoplasia; Prostate; Medicine; High-grade prostatic intraepithelial neoplasia; Adenocarcinoma; Perineural invasion; Cancer; Cancer research; Oncology; Pathology; Internal medicine","score_opus":0.15024029292201196,"score_gpt":0.46486680585303125,"score_spread":0.3146265129310193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104707958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894604,0.0011181486,0.000035009627,0.0067394665,0.00011932117,0.0022686026,0.00003071958,0.000045501445,0.0001828328],"genre_scores_gemma":[0.995168,0.0023141569,0.00089344924,0.0002716071,0.00035065497,0.00046309672,0.000013525188,0.00006411797,0.00046143754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994983,0.0006920595,0.0008785437,0.000897722,0.0014394353,0.0011092075],"domain_scores_gemma":[0.99728584,0.00090364175,0.00009162749,0.00046067414,0.00047131983,0.00078691373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017056338,0.00024789202,0.0006406523,0.00031704645,0.00018057048,0.00009692156,0.0002991846,0.00030629456,0.00041610101],"category_scores_gemma":[0.0019000913,0.00018295101,0.00010183823,0.0007133039,0.0009605279,0.00019704555,0.00038788022,0.0022471012,0.000122009726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005411444,0.0013630355,0.7312126,0.0014373673,0.000050484054,0.00069897226,0.003163806,0.0000130740955,0.24211238,0.000077295204,0.00082082354,0.01363869],"study_design_scores_gemma":[0.009472195,0.0021675613,0.9570691,0.0009471761,0.000013964001,0.000014992303,0.00025871373,0.000110932626,0.028207827,0.0014085274,0.000107791326,0.00022122744],"about_ca_topic_score_codex":0.001148747,"about_ca_topic_score_gemma":0.00019114076,"teacher_disagreement_score":0.22585647,"about_ca_system_score_codex":0.0005386936,"about_ca_system_score_gemma":0.0013659762,"threshold_uncertainty_score":0.97626615},"labels":[],"label_agreement":null},{"id":"W2104721463","doi":"10.1158/1078-0432.ccr-07-0382","title":"Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Sorafenib; Medicine; Erlotinib; Pharmacokinetics; Adverse effect; Rash; Pharmacology; Internal medicine; Oncology; Hepatocellular carcinoma; Epidermal growth factor receptor; Cancer","score_opus":0.11430761267286169,"score_gpt":0.5290445278227675,"score_spread":0.41473691514990574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104721463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661815,0.00045848553,0.0000040527825,0.00035185803,0.00013085628,0.0016828907,0.00002011762,0.000010990632,0.0007225989],"genre_scores_gemma":[0.99922585,0.00030206193,0.000078997924,0.000043601856,0.00008331714,0.00009356599,0.00002232018,0.000014540372,0.0001357114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980108,0.00011642825,0.000605637,0.00031504763,0.00060733856,0.0003447567],"domain_scores_gemma":[0.9984878,0.0005569779,0.000112807866,0.00016425036,0.00052264996,0.0001555145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016718155,0.00010499453,0.00052035897,0.00017944757,0.00006750106,0.0000066557495,0.00005879108,0.00007192699,0.000050911378],"category_scores_gemma":[0.00068822276,0.00007386591,0.000049597944,0.00045597518,0.00041006258,0.00005738835,0.00006118488,0.00039077198,0.0000014633814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39134985,0.0070213485,0.41421348,0.00006754646,0.00010402673,0.000029416255,0.00027919118,9.529037e-7,0.00006703882,0.000045541037,0.0001504484,0.18667117],"study_design_scores_gemma":[0.26272333,0.030924508,0.70492446,0.00016456164,0.000026057325,2.502473e-7,0.00014182685,0.000014094027,0.00059820287,0.00007602714,0.00033110467,0.00007559051],"about_ca_topic_score_codex":0.00019816138,"about_ca_topic_score_gemma":0.00047823545,"teacher_disagreement_score":0.290711,"about_ca_system_score_codex":0.00015610206,"about_ca_system_score_gemma":0.00023993215,"threshold_uncertainty_score":0.30121642},"labels":[],"label_agreement":null},{"id":"W2105260398","doi":"10.1158/1078-0432.ccr-09-2166","title":"Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":396,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"microRNA; Head and neck squamous-cell carcinoma; Cancer research; Downregulation and upregulation; Cell cycle; Clonogenic assay; Gene knockdown; Biology; Cell growth; Flow cytometry; Cell; Cell culture; Cancer; Head and neck cancer; Molecular biology; Gene","score_opus":0.11343328049493545,"score_gpt":0.4556207139829654,"score_spread":0.34218743348802994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105260398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955551,0.0026943993,0.000059152895,0.00036892152,0.00028244502,0.0007453975,0.00006929877,0.0000087323815,0.00021653774],"genre_scores_gemma":[0.9963206,0.0001645471,0.0017200987,0.00014775294,0.0009566038,0.00015364618,0.00008577651,0.000030478166,0.00042047625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850917,0.00013262112,0.00029365832,0.0005231559,0.00016707263,0.00037431475],"domain_scores_gemma":[0.99861544,0.0002166605,0.000059146263,0.0003843179,0.00050633075,0.00021812985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000631208,0.00011090337,0.0001640061,0.000040689145,0.00015435388,0.000038502098,0.00019891352,0.0002541873,0.000027942546],"category_scores_gemma":[0.0003753328,0.000105544204,0.00010247678,0.00007862372,0.00037474645,0.0000034558457,0.00020363503,0.00041054413,0.000008009154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046681456,0.00008858624,0.03823442,0.00014000715,0.000012724712,0.0000017227499,0.000011445765,0.000004528774,0.9553799,0.000037710233,0.00333321,0.0022888987],"study_design_scores_gemma":[0.003117206,0.0007732635,0.110968895,0.000017826085,0.000021384874,0.0000052265777,0.000050437666,0.00026704487,0.70693254,0.00028323045,0.17729822,0.00026474876],"about_ca_topic_score_codex":0.00006768195,"about_ca_topic_score_gemma":0.00013059715,"teacher_disagreement_score":0.2484474,"about_ca_system_score_codex":0.000015340358,"about_ca_system_score_gemma":0.00030610836,"threshold_uncertainty_score":0.43039677},"labels":[],"label_agreement":null},{"id":"W2105298716","doi":"10.1158/1078-0432.ccr-04-0499","title":"A Clinicobiological Model Predicting Survival in Medulloblastoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; National Cancer Institute; Cancer Care Ontario; Eli Lilly and Company","keywords":"Medulloblastoma; Biology; Genetics","score_opus":0.4143517323627871,"score_gpt":0.5749078252633686,"score_spread":0.16055609290058148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105298716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889299,0.0006680957,0.000024705143,0.0074788234,0.0002272985,0.0006325827,0.000016362515,0.000052581392,0.0019696387],"genre_scores_gemma":[0.99693245,0.0012565916,0.0005458027,0.0003650264,0.0004262424,0.00033005944,0.000009392274,0.00002262652,0.00011179371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968861,0.00031932053,0.0007910627,0.0006365364,0.00067953137,0.00068746303],"domain_scores_gemma":[0.99763405,0.0012426559,0.00005949933,0.00039747957,0.0002503105,0.00041598242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038751632,0.0001447204,0.0005579623,0.00017457442,0.000094616684,0.00002298189,0.00019023371,0.0002914532,0.00017015867],"category_scores_gemma":[0.0023524908,0.00010337623,0.0002191304,0.0005315388,0.00042295206,0.000047687157,0.00019632616,0.0012641002,0.00012886914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011974899,0.0026320477,0.98093873,0.000035347573,0.00007336255,0.00047053365,0.000112246846,0.0013235328,0.00028273003,0.00085173803,0.00042797267,0.011654249],"study_design_scores_gemma":[0.018132987,0.0033610503,0.96299565,0.00069242343,0.000056175897,0.00002217111,0.0002428389,0.006186548,0.00095580757,0.0060453597,0.0010708503,0.00023813947],"about_ca_topic_score_codex":0.0007122819,"about_ca_topic_score_gemma":0.0011223305,"teacher_disagreement_score":0.0179431,"about_ca_system_score_codex":0.00038614756,"about_ca_system_score_gemma":0.0008448084,"threshold_uncertainty_score":0.54919565},"labels":[],"label_agreement":null},{"id":"W2105398998","doi":"10.1158/1078-0432.ccr-08-2635","title":"Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"Trastuzumab; Medicine; Apoptosis; Breast cancer; Positron emission tomography; Cancer; Cancer research; Immunohistochemistry; Annexin; Annexin A5; Pathology; Oncology; Internal medicine; Nuclear medicine; Biology","score_opus":0.3413549984427097,"score_gpt":0.6007117179825404,"score_spread":0.2593567195398307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105398998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9236141,0.0044072703,0.000046812605,0.06720478,0.00038546987,0.002483754,0.00022602628,0.00008125432,0.0015505478],"genre_scores_gemma":[0.9833018,0.012147627,0.00032806338,0.002146623,0.00082456286,0.00046718374,0.0000075022263,0.00008990608,0.0006867383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9890011,0.0029042386,0.0020464407,0.0014706122,0.0028546632,0.0017229758],"domain_scores_gemma":[0.9919628,0.0034655936,0.00017357546,0.001521692,0.0015841142,0.001292248],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.021277482,0.00036042376,0.0013210634,0.0010532904,0.00013246156,0.00006923268,0.0010517575,0.00041275544,0.0013651827],"category_scores_gemma":[0.0032923182,0.00030618327,0.0004059543,0.002927356,0.001160728,0.00024083056,0.00034084712,0.0026763834,0.000050913688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061837893,0.0017647763,0.5312965,0.00015242212,0.00018331585,0.0002679947,0.0004245188,0.00033754288,0.010291386,0.000040048944,0.02706086,0.36634275],"study_design_scores_gemma":[0.007468374,0.0028927228,0.97278166,0.0018228587,0.000024122492,0.000025099805,0.0001720023,0.0043489574,0.0016693225,0.00068508525,0.007772821,0.00033695216],"about_ca_topic_score_codex":0.00415523,"about_ca_topic_score_gemma":0.0003495113,"teacher_disagreement_score":0.4414852,"about_ca_system_score_codex":0.0009938179,"about_ca_system_score_gemma":0.005083622,"threshold_uncertainty_score":0.999939},"labels":[],"label_agreement":null},{"id":"W2105400786","doi":"10.1158/1078-0432.ccr-09-1357","title":"The Cross-Validated Adaptive Signature Design","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Classifier (UML); Adaptive design; Computer science; Signature (topology); Clinical trial; Cross-validation; Data mining; Medicine; Artificial intelligence; Machine learning; Mathematics; Pathology","score_opus":0.9293997658481492,"score_gpt":0.77552257358576,"score_spread":0.15387719226238916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105400786","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38028067,0.0026718264,0.4625733,0.04129512,0.051223923,0.019362375,0.0011145843,0.0018153464,0.039662864],"genre_scores_gemma":[0.25392428,0.00079102925,0.72931737,0.0005998096,0.0064004716,0.0009641284,0.0000016570799,0.00017518441,0.007826094],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9882316,0.0063880635,0.0017566622,0.0008620814,0.0016593521,0.0011022595],"domain_scores_gemma":[0.5650147,0.43114576,0.0002741835,0.0013920406,0.0016513902,0.0005219341],"candidate_categories":["metaresearch","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.070676595,0.00023528421,0.00068888447,0.000065324166,0.0008528597,0.0003443585,0.0016745002,0.00082053465,0.0018446846],"category_scores_gemma":[0.4899555,0.00014022052,0.00030286174,0.00073622324,0.0038324539,0.000084271865,0.0005422208,0.0070127617,0.0003190964],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058995816,0.00081657385,0.0026361644,0.0000736559,0.00041200398,0.000092086426,0.000111913374,0.000010144469,0.0034893956,0.5459272,0.22861005,0.21192119],"study_design_scores_gemma":[0.0011893504,0.00047575377,0.0022402797,0.000046040168,0.00003173449,0.0000017106903,0.000031681484,0.0005393244,0.003449813,0.97423905,0.01755017,0.00020509673],"about_ca_topic_score_codex":0.000046331974,"about_ca_topic_score_gemma":0.000097323624,"teacher_disagreement_score":0.4283118,"about_ca_system_score_codex":0.00007064987,"about_ca_system_score_gemma":0.0007371856,"threshold_uncertainty_score":0.9990678},"labels":[],"label_agreement":null},{"id":"W2105448858","doi":"10.1158/1078-0432.ccr-08-1898","title":"Expression of Hepatocyte Growth Factor and Its Receptor Met in Wilms' Tumors and Nephrogenic Rests Reflects Their Roles in Kidney Development","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Hepatocyte growth factor; Biology; Carcinogenesis; Stromal cell; Cancer research; Wilms' tumor; Epithelial–mesenchymal transition; Mesenchymal stem cell; Kidney development; Stroma; Pathology; Cell biology; Cancer; Receptor; Immunohistochemistry; Embryonic stem cell; Immunology; Medicine; Gene; Genetics; Metastasis","score_opus":0.08173116888536038,"score_gpt":0.4257291680823693,"score_spread":0.34399799919700896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105448858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906554,0.008465401,9.562128e-7,0.00045126706,0.00004007619,0.00026445647,0.00001274621,0.000003533871,0.00010615077],"genre_scores_gemma":[0.9824222,0.017057667,0.00009712183,0.00018775558,0.00007219955,0.00003728927,0.000013415086,0.000011139945,0.00010126425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819416,0.0003392235,0.00045842212,0.0004480312,0.00022311047,0.00033706767],"domain_scores_gemma":[0.9993554,0.000077768134,0.000072013,0.00015137528,0.00011711083,0.00022635136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090336637,0.00012683072,0.0002643116,0.00011944227,0.000049139384,0.000012643014,0.00017195422,0.00025741203,0.000011841832],"category_scores_gemma":[0.00040264128,0.00009362847,0.00003830097,0.00024572638,0.00016596614,0.000008125022,0.00015238838,0.00044577784,0.000001231234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013532782,0.000110901834,0.05821382,0.00008317674,0.000024048115,0.0000084919475,0.0003012773,0.0000044126427,0.9225671,0.000018571009,0.00057750306,0.016737362],"study_design_scores_gemma":[0.0013609101,0.000632213,0.08053697,0.00058565923,0.000002015563,0.0000020327639,0.00006615209,0.000015063826,0.91377026,0.00014769068,0.0027331237,0.00014789116],"about_ca_topic_score_codex":0.00006176738,"about_ca_topic_score_gemma":0.00017559895,"teacher_disagreement_score":0.02232315,"about_ca_system_score_codex":0.000049210226,"about_ca_system_score_gemma":0.0005343487,"threshold_uncertainty_score":0.3818058},"labels":[],"label_agreement":null},{"id":"W2105454171","doi":"10.1158/1078-0432.ccr-06-1716","title":"Tubedown Expression Correlates with the Differentiation Status and Aggressiveness of Neuroblastic Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Cancer Institute","keywords":"Neuroblastoma; Retinoic acid; Immunohistochemistry; Ganglioneuroma; Biology; Histopathology; Cellular differentiation; Western blot; Pathology; Blot; Cancer research; Internal medicine; Medicine; Cell culture; Immunology; Gene; Genetics","score_opus":0.08959263899150108,"score_gpt":0.46947758189421995,"score_spread":0.3798849429027189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105454171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977484,0.0006418616,0.000061219514,0.00065804686,0.00006103995,0.00059285754,0.000009322499,0.000016177046,0.00021108166],"genre_scores_gemma":[0.99863356,0.00075732754,0.000029919369,0.00004717272,0.00009993393,0.000045461347,0.0000069088837,0.00002290751,0.000356823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975098,0.00034211253,0.00034162233,0.0003452646,0.00090904214,0.00055216864],"domain_scores_gemma":[0.9961158,0.0026663877,0.000105206665,0.00031458674,0.000408409,0.00038959057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011063112,0.0001148508,0.00028260675,0.00014442981,0.00016845048,0.000024062207,0.000118101045,0.0000708832,0.00010926185],"category_scores_gemma":[0.000771819,0.000058555965,0.000055032397,0.00038664864,0.00086612813,0.00005877979,0.00015516212,0.00077632035,0.000009144993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011453299,0.00076912256,0.91970813,0.00025777952,0.00012751346,0.00035923987,0.00018000638,0.000010032708,0.026575204,0.0000731094,0.00073948526,0.039747052],"study_design_scores_gemma":[0.002992884,0.0026158434,0.9628448,0.00059282826,0.000037102433,0.000015888667,0.00012659474,0.000113604045,0.030249232,0.00007347566,0.00027546886,0.00006229916],"about_ca_topic_score_codex":0.000098453085,"about_ca_topic_score_gemma":0.00009035171,"teacher_disagreement_score":0.04313662,"about_ca_system_score_codex":0.000048913123,"about_ca_system_score_gemma":0.00027249288,"threshold_uncertainty_score":0.33727688},"labels":[],"label_agreement":null},{"id":"W2105537697","doi":"10.1158/1078-0432.ccr-11-2711","title":"Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prostate cancer; Radiation therapy; Hypoxia (environmental); Medicine; Tumor hypoxia; Internal medicine; Prostate; Oncology; Cancer; Hormonal therapy; Urology; Oxygen","score_opus":0.08039201231230002,"score_gpt":0.4619518288379821,"score_spread":0.38155981652568205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105537697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92543787,0.06390831,0.0007141144,0.0020838028,0.005360268,0.0019830267,0.00029704004,0.000053676336,0.00016188111],"genre_scores_gemma":[0.92123973,0.028685285,0.0048793084,0.003108601,0.034078747,0.0035248015,0.00020783603,0.00022805358,0.004047651],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950168,0.0005425648,0.0011086974,0.0010231904,0.00071913254,0.0015895856],"domain_scores_gemma":[0.99709517,0.00050085754,0.00020717268,0.0008143022,0.0005081228,0.00087438815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0050679343,0.00034602903,0.0007187577,0.00009590591,0.00026795513,0.00007754004,0.00068826595,0.0005442137,0.00017835532],"category_scores_gemma":[0.0019645095,0.00030277393,0.0007597991,0.00035236447,0.0006332837,0.000023084849,0.00028371307,0.00083216577,0.000016998121],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072470503,0.0009191778,0.061376892,0.00023308718,0.0009831508,0.0000038592466,0.00023835656,0.000027292414,0.3583455,0.00008985486,0.49589577,0.07463999],"study_design_scores_gemma":[0.0057685752,0.0007212423,0.0048750886,0.00009728522,0.000091001115,0.0000044138833,0.000079520454,0.00007763793,0.022217654,0.00008927469,0.96553785,0.00044046456],"about_ca_topic_score_codex":0.00017098349,"about_ca_topic_score_gemma":0.000105756146,"teacher_disagreement_score":0.46964207,"about_ca_system_score_codex":0.0001126896,"about_ca_system_score_gemma":0.0012129825,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W2105763895","doi":"10.1158/1078-0432.ccr-10-3097","title":"Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Receptor; Multiple myeloma; Growth factor; Growth inhibition; Insulin-like growth factor; In vivo; Bone marrow; Cell culture; Apoptosis; Biology; Fibroblast growth factor receptor 3; Pharmacology; Internal medicine; Fibroblast growth factor; Immunology; Medicine; Biochemistry","score_opus":0.1895705407986632,"score_gpt":0.4392424509220034,"score_spread":0.24967191012334022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105763895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966932,0.00022204281,0.00015711134,0.0010969206,0.000292758,0.0010399683,0.00021104337,0.000022103517,0.00026487157],"genre_scores_gemma":[0.99764997,0.001166961,0.00040945664,0.0001193842,0.00020389711,0.00009639735,0.00002945153,0.000034362223,0.00029014295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703264,0.00052917644,0.00044048188,0.00050245074,0.0009861805,0.0005090903],"domain_scores_gemma":[0.9978742,0.00036049203,0.00013442503,0.0005174191,0.00069826026,0.00041520086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010608663,0.0001665995,0.0004291502,0.00010557551,0.00015071292,0.00002233928,0.00024889794,0.00021447013,0.00048721983],"category_scores_gemma":[0.0016888714,0.00010908789,0.00015295816,0.0005372824,0.0007587257,0.00013910785,0.00036388132,0.00094419514,0.000027045295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031672788,0.0015240314,0.57125807,0.00023827174,0.00024508688,0.000027331163,0.0002995691,5.107501e-8,0.37544465,0.00008846195,0.00020199982,0.047505222],"study_design_scores_gemma":[0.0025468506,0.0006884976,0.7843035,0.00014353565,0.000017327578,0.0000027718554,0.000015311472,0.00009548059,0.21070284,0.00003442311,0.0013634904,0.00008596506],"about_ca_topic_score_codex":0.0006890312,"about_ca_topic_score_gemma":0.000023921251,"teacher_disagreement_score":0.21304546,"about_ca_system_score_codex":0.00011633429,"about_ca_system_score_gemma":0.00050249277,"threshold_uncertainty_score":0.5334715},"labels":[],"label_agreement":null},{"id":"W2105870502","doi":"10.1158/1078-0432.ccr-12-3572","title":"Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"microRNA; Metastasis; Oncology; Downregulation and upregulation; Internal medicine; Medicine; Human papillomavirus; Biomarker; Real-time polymerase chain reaction; Cancer research; Biology; Cancer; Gene; Genetics","score_opus":0.08864923568849564,"score_gpt":0.43346468408869726,"score_spread":0.3448154484002016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105870502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962401,0.0013963082,0.000016021218,0.00080404285,0.00017248077,0.0007302672,0.000016498654,0.000011041373,0.00061327626],"genre_scores_gemma":[0.99777114,0.00025420936,0.000076850556,0.00014451807,0.00040686957,0.00028274758,0.00010138395,0.000029004486,0.0009332556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750173,0.00062017323,0.00046002737,0.0005112001,0.00037806443,0.0005287991],"domain_scores_gemma":[0.99871993,0.00013285223,0.000071518596,0.00036777355,0.000485202,0.0002227072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012131657,0.00011673226,0.00019709767,0.0000841974,0.0000753486,0.000053437747,0.00033653397,0.0002738166,0.0006836277],"category_scores_gemma":[0.0015053884,0.00011064286,0.00011371965,0.0002805879,0.00025774504,0.000007637638,0.000257093,0.00039544934,0.00015846627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002823366,0.0005768429,0.7532925,0.00005355845,0.00007611435,0.00003057489,0.00002300209,0.000042926822,0.1898927,0.0000206535,0.029890971,0.025817847],"study_design_scores_gemma":[0.0011414592,0.00030826151,0.9891971,0.000028445262,0.000008601692,0.0000010826366,0.000016684899,0.00026264339,0.00584556,0.00020021186,0.0028475747,0.00014242576],"about_ca_topic_score_codex":0.00095478876,"about_ca_topic_score_gemma":0.00064157235,"teacher_disagreement_score":0.23590457,"about_ca_system_score_codex":0.00009491478,"about_ca_system_score_gemma":0.000536733,"threshold_uncertainty_score":0.74852437},"labels":[],"label_agreement":null},{"id":"W2106062955","doi":"10.1158/1078-0432.ccr-04-0651","title":"Characterization of Mutator Phenotype in Familial Colorectal Cancer Patients Not Fulfilling Amsterdam Criteria","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Microsatellite instability; DNA mismatch repair; Colorectal cancer; Medicine; Epigenetics; Phenotype; Familial adenomatous polyposis; Cancer; Lynch syndrome; Proband; Adenomatous polyposis coli; DNA methylation; Cancer research; Oncology; Genetics; Internal medicine; Biology; Mutation; Gene; Microsatellite; Allele; Gene expression","score_opus":0.13921050433544424,"score_gpt":0.48021050464886533,"score_spread":0.3410000003134211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106062955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957532,0.00016896916,0.000018845523,0.00080481026,0.0016995776,0.0011416165,0.00016395621,0.000026475775,0.00022252128],"genre_scores_gemma":[0.9975016,0.0007711024,0.00017682614,0.0003531049,0.0006908318,0.0003099239,0.000061804596,0.00005245277,0.00008232364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963348,0.00029131188,0.0010464734,0.0006227006,0.0010848629,0.0006198675],"domain_scores_gemma":[0.9979176,0.00032730398,0.00017588472,0.00030042735,0.0010009098,0.0002778566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012293903,0.00019810413,0.0006394272,0.0002725076,0.00007345776,0.000023825702,0.00026241667,0.00030191592,0.0007723651],"category_scores_gemma":[0.0010810972,0.00018094385,0.00014143696,0.0008035596,0.00053491426,0.00010167462,0.00018569805,0.00090173597,0.00003189182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062851855,0.0010902579,0.5782584,0.00030884595,0.00007078269,0.000025687963,0.00072318094,0.000058530775,0.38845277,0.000017166325,0.00007834659,0.02463084],"study_design_scores_gemma":[0.005339198,0.0017505576,0.8767394,0.00048655205,0.00002749364,8.3335533e-7,0.00004199881,0.00010084768,0.114812076,0.00009200311,0.00044052582,0.00016852366],"about_ca_topic_score_codex":0.0016407497,"about_ca_topic_score_gemma":0.0008970375,"teacher_disagreement_score":0.298481,"about_ca_system_score_codex":0.0008427597,"about_ca_system_score_gemma":0.0014325846,"threshold_uncertainty_score":0.8456856},"labels":[],"label_agreement":null},{"id":"W2106314624","doi":"10.1158/1078-0432.ccr-04-0165","title":"Patterns of Chromosomal Alterations in Breast Ductal Carcinoma <b> <i>In situ</i> </b>","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Ductal carcinoma; Breast cancer; Cancer; Biology; Mammary gland; Chromosome instability; Pathology; In situ; Comparative genomic hybridization; Histology; Carcinoma in situ; Oncology; Internal medicine; Medicine; Chromosome; Gene; Genetics","score_opus":0.06031662902823734,"score_gpt":0.39507401928895247,"score_spread":0.33475739026071516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106314624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977005,0.00030835648,0.00002962973,0.0009161013,0.00011272113,0.00018166412,0.00012038551,0.000002583062,0.0006280521],"genre_scores_gemma":[0.9989026,0.00029921325,0.000064814856,0.00007287983,0.00035134115,0.00007455032,0.000061992054,0.000012944301,0.0001596473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847066,0.000188188,0.0004936896,0.00032288212,0.00019620528,0.00032839735],"domain_scores_gemma":[0.9994017,0.000042845535,0.00004961895,0.00028183783,0.00014253163,0.00008145841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007097114,0.00008788848,0.00017983331,0.000092193506,0.000047718502,0.000016519758,0.00022750997,0.00013947181,0.00007464731],"category_scores_gemma":[0.00006801871,0.00008629689,0.00008085747,0.00018534325,0.0001247711,0.0000071229238,0.00016079702,0.00029435442,0.000008139616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021899918,0.0004437613,0.9108192,0.0000452644,0.000015484542,0.000031889595,0.00021960025,0.00073180505,0.0859564,0.00093074446,0.00010585154,0.00048099709],"study_design_scores_gemma":[0.0023948355,0.0003966819,0.9297511,0.00007657988,0.000004383445,0.000029904986,0.0004309849,0.000014925867,0.06576478,0.00044014756,0.0005341971,0.00016148017],"about_ca_topic_score_codex":0.0026634275,"about_ca_topic_score_gemma":0.0070000156,"teacher_disagreement_score":0.020191623,"about_ca_system_score_codex":0.00006902606,"about_ca_system_score_gemma":0.0005258018,"threshold_uncertainty_score":0.40263233},"labels":[],"label_agreement":null},{"id":"W2106381426","doi":"10.1158/1078-0432.ccr-05-2290","title":"Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":461,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"LNCaP; Medicine; Prostate cancer; Prostate-specific antigen; Gallic acid; Nitric oxide; Lipid peroxidation; Apoptosis; Internal medicine; Prostate; Gastroenterology; Cancer; Urology; Antioxidant; Endocrinology; Oxidative stress; Biology; Biochemistry","score_opus":0.24204669345587299,"score_gpt":0.5389426306171787,"score_spread":0.29689593716130575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106381426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859735,0.0034140241,0.000117634765,0.0025716552,0.0007037454,0.006565414,0.0005126565,0.00006271665,0.00007865627],"genre_scores_gemma":[0.9944714,0.000991322,0.00042402465,0.00008100399,0.00069633865,0.0026741563,0.000107423286,0.00009587055,0.00045848152],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99542177,0.0004486974,0.0014075872,0.00081594277,0.0008133426,0.0010926411],"domain_scores_gemma":[0.99437803,0.003546835,0.0003980038,0.00043273682,0.0010141734,0.00023020056],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.004895208,0.00025149347,0.00083553785,0.00048618042,0.0014944399,0.000112872454,0.00026462853,0.00014737969,0.000030039178],"category_scores_gemma":[0.00026744502,0.00019480752,0.0002459077,0.0011496786,0.0001797573,0.0002925841,0.000059851314,0.0004650303,0.000001512163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16094135,0.017177708,0.1183263,0.0020107292,0.000641579,0.00006591475,0.0050095743,0.0015889275,0.0056249974,0.0001304573,0.07159032,0.61689216],"study_design_scores_gemma":[0.20744562,0.14829978,0.3211232,0.006685676,0.0011189369,0.0000081819035,0.009344407,0.019646635,0.02487133,0.0036991201,0.25406814,0.003688957],"about_ca_topic_score_codex":0.0084606,"about_ca_topic_score_gemma":0.0061686803,"teacher_disagreement_score":0.61320317,"about_ca_system_score_codex":0.00040394854,"about_ca_system_score_gemma":0.0008299981,"threshold_uncertainty_score":0.99980545},"labels":[],"label_agreement":null},{"id":"W2106728539","doi":"10.1158/1078-0432.ccr-11-3216","title":"The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":434,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Value (mathematics); Cancer; Medicine; Pathology; Oncology; Internal medicine; Statistics","score_opus":0.3397851811151872,"score_gpt":0.5872416934896351,"score_spread":0.24745651237444788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106728539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002280381,0.9926517,2.0035203e-7,0.0025212762,0.0008224528,0.0032229517,0.0001578754,0.000009479122,0.00038602078],"genre_scores_gemma":[0.0006705052,0.9961792,0.000026389267,0.00050006143,0.0009267976,0.0013612409,0.000013642163,0.000061326784,0.00026079637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99128604,0.0032093644,0.0027312038,0.00054305245,0.0014045134,0.00082585047],"domain_scores_gemma":[0.98486125,0.012107906,0.0006677411,0.001222291,0.0009370768,0.0002037064],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011462279,0.0003660083,0.0025677106,0.00014679533,0.00018008203,0.000039212515,0.0010128438,0.00041698356,0.0002463584],"category_scores_gemma":[0.0108326115,0.00017186206,0.0014038534,0.0024170075,0.0020968223,0.00006200011,0.0003273293,0.0026918154,0.0000050004364],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034232886,0.00020994706,0.002513969,0.23208696,0.0002540766,0.000011642341,0.000055320805,3.1281413e-8,0.0000031859993,0.00019640347,0.0021263724,0.76219976],"study_design_scores_gemma":[0.00048413104,0.00021766094,0.0010493958,0.43128875,0.00054130174,0.00003103842,0.000017763823,0.0000020013028,0.000010189381,0.000031367454,0.56620675,0.000119648495],"about_ca_topic_score_codex":0.0006985194,"about_ca_topic_score_gemma":0.00017467192,"teacher_disagreement_score":0.76208013,"about_ca_system_score_codex":0.0006225743,"about_ca_system_score_gemma":0.006947468,"threshold_uncertainty_score":0.999609},"labels":[],"label_agreement":null},{"id":"W2106733257","doi":"10.1158/1078-0432.ccr-05-2433","title":"Antisense Suppression of Pygopus2 Results in Growth Arrest of Epithelial Ovarian Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ovarian cancer; Wnt signaling pathway; Cancer research; Biology; Cancer; Cell growth; Cell culture; Pathology; Signal transduction; Medicine; Cell biology","score_opus":0.08580160190825953,"score_gpt":0.44292132029260506,"score_spread":0.35711971838434553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106733257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521285,0.0017588768,0.000019874285,0.00073086115,0.0005629578,0.00024704187,0.00019415724,0.0000052050314,0.0012681441],"genre_scores_gemma":[0.99469966,0.002999099,0.00022915068,0.000036668473,0.0008216509,0.000063883104,0.00007596629,0.000024545709,0.0010493554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721485,0.00039017992,0.0009463021,0.0005193801,0.00050863385,0.00042062884],"domain_scores_gemma":[0.998613,0.00018891548,0.00020637861,0.00036012835,0.0005458699,0.00008573432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022440052,0.00013675036,0.0003440582,0.00012443849,0.00005171322,0.00001112961,0.00038375257,0.00029427072,0.0000961868],"category_scores_gemma":[0.00053748116,0.000119266326,0.00012394675,0.00039687473,0.00054669374,0.0000059615836,0.00022075215,0.00036379954,0.0000037590867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040927413,0.00034948817,0.15211084,0.00012369145,0.00005430938,0.000014122725,0.000066435,0.00013400112,0.8110164,0.00013824593,0.026350057,0.0055497033],"study_design_scores_gemma":[0.0032625564,0.0003229312,0.13431898,0.00032029074,0.000011302881,6.5984386e-7,0.000034357734,0.00004035129,0.8472068,0.00050756976,0.013774936,0.00019932522],"about_ca_topic_score_codex":0.00392224,"about_ca_topic_score_gemma":0.0013714709,"teacher_disagreement_score":0.036190394,"about_ca_system_score_codex":0.00004533466,"about_ca_system_score_gemma":0.0007267056,"threshold_uncertainty_score":0.59292793},"labels":[],"label_agreement":null},{"id":"W2106960759","doi":"10.1158/1078-0432.ccr-14-0289","title":"Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; University of Pittsburgh; Abbott Laboratories","keywords":"Biomarker; Pancreatic cancer; Medicine; Stage (stratigraphy); Cancer; CA19-9; Internal medicine; Biomarker discovery; Oncology; Population; Immunoassay; Pathology; Gastroenterology; Immunology; Biology; Proteomics; Antibody","score_opus":0.38768451371904855,"score_gpt":0.5759903231922189,"score_spread":0.18830580947317033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106960759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204785,0.00059943274,0.00012489682,0.0020822699,0.00015688798,0.0009783639,0.000012320105,0.000018843286,0.0039791195],"genre_scores_gemma":[0.9968118,0.0013006869,0.0005111783,0.000116525676,0.00030156563,0.00039371825,0.000008582147,0.000025671205,0.000530293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954071,0.0014310759,0.00087525655,0.00047424922,0.0011020509,0.00071027275],"domain_scores_gemma":[0.994885,0.0036744685,0.00015916779,0.00047625188,0.0004981876,0.00030688095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009763186,0.00013629663,0.00083551335,0.00037262304,0.00011683265,0.000018698516,0.0002499576,0.00020077519,0.0011453364],"category_scores_gemma":[0.002797397,0.000111589885,0.00013167216,0.0007093881,0.00066246395,0.00006512931,0.0001710974,0.0009195908,0.00003882093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001045278,0.00022063596,0.9587958,0.00025808776,0.00016637551,0.000011307889,0.00023182866,0.0000050327776,0.0018677898,0.00007339731,0.00063663034,0.036687832],"study_design_scores_gemma":[0.0039466727,0.0012536795,0.98383725,0.0007024119,0.00009284408,0.0000024683864,0.00030892473,0.0018865687,0.0059285364,0.0004015632,0.0015233939,0.00011568491],"about_ca_topic_score_codex":0.013679982,"about_ca_topic_score_gemma":0.0013550069,"teacher_disagreement_score":0.036572147,"about_ca_system_score_codex":0.0004039285,"about_ca_system_score_gemma":0.0008524796,"threshold_uncertainty_score":0.9997678},"labels":[],"label_agreement":null},{"id":"W2107089530","doi":"10.1158/1078-0432.ccr-09-1525","title":"Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":664,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overweight; Sarcopenia; Hazard ratio; Pancreatic cancer; Internal medicine; Body mass index; Confidence interval; Underweight; Weight loss; Cancer; Gastroenterology; Sarcopenic obesity; Obesity; Cachexia","score_opus":0.43357358609268365,"score_gpt":0.6035947952703241,"score_spread":0.17002120917764046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107089530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98831725,0.0013005245,9.71788e-7,0.0080786515,0.0001804707,0.0016576595,0.000046945363,0.00003525717,0.00038225861],"genre_scores_gemma":[0.9886457,0.0036361532,0.00027695723,0.0061243954,0.00044220008,0.00035210067,0.000017941758,0.000027095468,0.0004774989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597543,0.00072300225,0.0009668643,0.0006631901,0.0008291943,0.0008423391],"domain_scores_gemma":[0.9977267,0.0005632573,0.00008309627,0.0004911965,0.0003335612,0.0008021905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014677085,0.00016682128,0.00058998726,0.00038073462,0.00009594913,0.000027568884,0.00021705827,0.00021198714,0.0043947417],"category_scores_gemma":[0.00085803546,0.00012771506,0.00006960631,0.0009159259,0.00018493154,0.00023368972,0.000055894125,0.001526414,0.000066734756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003409307,0.0019422835,0.9207131,0.0002648902,0.000008079166,0.00033943704,0.001296869,0.0000025590116,0.00020030867,0.000027778056,0.0018004284,0.06999494],"study_design_scores_gemma":[0.004716495,0.0040266365,0.9773545,0.0017776455,0.000011974259,0.0000037899601,0.00043892558,0.0007690219,0.00018452342,0.00028886079,0.010256256,0.00017132658],"about_ca_topic_score_codex":0.0024917,"about_ca_topic_score_gemma":0.00907589,"teacher_disagreement_score":0.069823615,"about_ca_system_score_codex":0.0006820126,"about_ca_system_score_gemma":0.0015621089,"threshold_uncertainty_score":0.9965154},"labels":[],"label_agreement":null},{"id":"W2107151233","doi":"10.1158/1078-0432.ccr-06-1692","title":"Down-Regulation of CD9 Expression during Prostate Carcinoma Progression Is Associated with <i>CD9</i> mRNA Modifications","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; McGill University; McMaster University Medical Centre","funders":"","keywords":"Prostate cancer; Prostate; Carcinogenesis; Tetraspanin; Adenocarcinoma; Lymph node; Immunohistochemistry; Cancer research; Cancer; Intraepithelial neoplasia; Biology; Malignancy; Pathology; PCA3; Tumor progression; Medicine; Cell","score_opus":0.15378807464769353,"score_gpt":0.49925383344740915,"score_spread":0.34546575879971564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107151233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939947,0.0005238743,0.000104855506,0.0015255946,0.000060134826,0.00177523,0.000030820087,0.00006001349,0.0019247795],"genre_scores_gemma":[0.9946848,0.00029288567,0.0004995125,0.000061882,0.00020036403,0.00018197145,0.000059311744,0.00006153994,0.0039576953],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99418545,0.00051086355,0.0010408899,0.00075236626,0.0026253355,0.00088511244],"domain_scores_gemma":[0.9950801,0.0010559375,0.00028479847,0.0008520675,0.0021263682,0.00060071837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048730103,0.00019661494,0.0005109246,0.00034251183,0.00032799062,0.00003740692,0.00031207933,0.0003127573,0.0005237787],"category_scores_gemma":[0.0015767814,0.00014366314,0.00016155002,0.0014427385,0.00080470106,0.00012875856,0.00027844287,0.0013852837,0.000042017185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006832876,0.0012626303,0.4070602,0.0003748093,0.00007747566,0.00011413124,0.0005113592,0.000025814214,0.558297,0.000022578462,0.002983769,0.0224374],"study_design_scores_gemma":[0.0031965293,0.0008583031,0.630713,0.0008526629,0.000027265849,0.0000061266046,0.00012605729,0.00041930593,0.36293587,0.000051618077,0.0006826108,0.00013066578],"about_ca_topic_score_codex":0.00017435088,"about_ca_topic_score_gemma":0.00008054535,"teacher_disagreement_score":0.22365278,"about_ca_system_score_codex":0.0004153903,"about_ca_system_score_gemma":0.00071064156,"threshold_uncertainty_score":0.6018445},"labels":[],"label_agreement":null},{"id":"W2107296734","doi":"10.1158/1078-0432.ccr-08-3007","title":"Concurrent and Sequential Administration of Chemotherapy and the Mammalian Target of Rapamycin Inhibitor Temsirolimus in Human Cancer Cells and Xenografts","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Temsirolimus; LNCaP; Cell cycle; Cancer research; Chemotherapy; Medicine; Cancer cell; Pharmacology; Cancer; Biology; PI3K/AKT/mTOR pathway; Oncology; Internal medicine; Apoptosis; Discovery and development of mTOR inhibitors","score_opus":0.08325751658416727,"score_gpt":0.47348989003807546,"score_spread":0.39023237345390815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107296734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899066,0.0083755655,0.00001505868,0.0010336335,0.0001433807,0.00040131065,0.000054898494,0.0000022424183,0.00006732566],"genre_scores_gemma":[0.99324673,0.0059719747,0.00004168195,0.00015350284,0.0004452545,0.00004542424,0.000009401188,0.000011473906,0.00007457102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982883,0.00035220347,0.00050078,0.00036704712,0.00025433002,0.00023735069],"domain_scores_gemma":[0.9992761,0.00011729184,0.00014267383,0.00020494261,0.00016053663,0.00009847025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016965537,0.00011515129,0.00029824988,0.000054276785,0.00006064352,0.000021912889,0.00014270571,0.00017719169,0.00003105679],"category_scores_gemma":[0.000083869374,0.00008866429,0.00005315129,0.000119800265,0.0011695741,0.000005859692,0.00007540128,0.00029297647,9.9878264e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021510702,0.00018141644,0.030556364,0.00013987733,0.00006294915,0.000003357019,0.00027304338,0.000015051407,0.94028,0.00012853315,0.0013115769,0.024896743],"study_design_scores_gemma":[0.0068779113,0.0020377608,0.040083468,0.00015463519,0.000019923214,0.000002611753,0.00008959339,0.000092706876,0.9443368,0.00038283586,0.0057428987,0.0001789139],"about_ca_topic_score_codex":0.0003132036,"about_ca_topic_score_gemma":0.00035944514,"teacher_disagreement_score":0.024717828,"about_ca_system_score_codex":0.00002103793,"about_ca_system_score_gemma":0.00024633328,"threshold_uncertainty_score":0.43093443},"labels":[],"label_agreement":null},{"id":"W2107365189","doi":"10.1158/1078-0432.ccr-04-0097","title":"A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Carboplatin; Medicine; Topotecan; Fludarabine; Internal medicine; Leukemia; Regimen; Gastroenterology; Acute leukemia; Platelet transfusion; Oncology; Surgery; Chemotherapy; Cyclophosphamide; Platelet; Cisplatin","score_opus":0.06352704510688084,"score_gpt":0.4685404394304402,"score_spread":0.4050133943235594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107365189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963953,0.00028289188,0.0000059582862,0.00048344582,0.00006901172,0.0025330533,0.000102518454,0.000025704594,0.000102096485],"genre_scores_gemma":[0.9969056,0.0020357813,0.0002486255,0.00007696896,0.00013118809,0.00018998384,0.00002435394,0.00006016534,0.00032728064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955295,0.0006434287,0.0009002753,0.0008698427,0.0013569767,0.0007000309],"domain_scores_gemma":[0.997106,0.0009024089,0.00018266274,0.00061319803,0.0006345112,0.0005611912],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025860365,0.00024778428,0.0008569896,0.0004920809,0.00014603042,0.000030315869,0.00025644622,0.0002239706,0.000111590816],"category_scores_gemma":[0.0010466954,0.00017150404,0.00004490285,0.0010800527,0.00090945914,0.00015957504,0.0003503277,0.002757825,0.000005173043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06689877,0.0073285378,0.8250526,0.00025731654,0.00064328674,0.00074676925,0.001338814,0.000044523582,0.000665296,0.00001662084,0.0004092663,0.096598156],"study_design_scores_gemma":[0.17290235,0.04398792,0.78037953,0.00037780177,0.00025272166,0.000010196547,0.00076271675,0.00044690416,0.000288868,0.00008893098,0.00023752336,0.0002645498],"about_ca_topic_score_codex":0.012105111,"about_ca_topic_score_gemma":0.0032631094,"teacher_disagreement_score":0.106003575,"about_ca_system_score_codex":0.0012661283,"about_ca_system_score_gemma":0.0024262182,"threshold_uncertainty_score":0.99954283},"labels":[],"label_agreement":null},{"id":"W2107505408","doi":"10.1158/1078-0432.ccr-10-0054","title":"Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Gastroenterology; Neutropenia; Asymptomatic; Toxicity; Internal medicine; Cancer; Mesothelioma; Oncology; Pathology","score_opus":0.09101283434535412,"score_gpt":0.5106174238592381,"score_spread":0.419604589513884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107505408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983784,0.0003466403,0.0000053801077,0.0000438339,0.00010612654,0.0010203187,0.000019660327,0.000005132524,0.00007453559],"genre_scores_gemma":[0.9988877,0.00053424796,0.00016716927,0.00003822114,0.00014698035,0.000095870346,0.000021262547,0.000033276363,0.000075243086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976855,0.00047551538,0.0003910523,0.0005430876,0.0005075696,0.0003972549],"domain_scores_gemma":[0.99868816,0.00012592063,0.00010193988,0.00043654037,0.0004849517,0.00016245965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015592203,0.00013818736,0.0002698702,0.000121820136,0.000083635285,0.00001991657,0.00023836401,0.000121124154,0.00006892143],"category_scores_gemma":[0.00026597278,0.0001159794,0.000029539793,0.00043547753,0.00040591168,0.000012558768,0.000108716355,0.0008156576,0.0000010545637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044842333,0.0011568222,0.79550403,0.00002106911,0.0000961586,0.0000049278447,0.00025592998,0.000329898,0.11012267,0.0000067053406,0.000022960927,0.047636513],"study_design_scores_gemma":[0.044272922,0.06902026,0.844764,0.00006168097,0.000013026585,2.2074241e-7,0.0005001208,0.0005736896,0.039554283,0.000026762269,0.00082430127,0.00038873727],"about_ca_topic_score_codex":0.0008176481,"about_ca_topic_score_gemma":0.01668595,"teacher_disagreement_score":0.07056839,"about_ca_system_score_codex":0.000079192505,"about_ca_system_score_gemma":0.00054279424,"threshold_uncertainty_score":0.93111515},"labels":[],"label_agreement":null},{"id":"W2107529812","doi":"10.1158/1078-0432.ccr-13-1100","title":"Importance of 5α-Reductase Gene Polymorphisms on Circulating and Intraprostatic Androgens in Prostate Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research","keywords":"Dihydrotestosterone; Androsterone; Prostate cancer; Endocrinology; Internal medicine; Testosterone (patch); Androgen; Biology; Linkage disequilibrium; Prostate; Cancer; Allele; Hormone; Medicine; Genetics; Gene; Steroid; Haplotype","score_opus":0.18140556058099866,"score_gpt":0.5032266453304121,"score_spread":0.3218210847494134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107529812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98152786,0.00856367,5.8111345e-7,0.007227862,0.00011634691,0.0021131816,0.00008789334,0.000019910824,0.00034271195],"genre_scores_gemma":[0.9872395,0.01001216,0.00016369176,0.00031673032,0.00021328212,0.0010512584,0.000028766965,0.00004558581,0.0009290723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963639,0.00030959237,0.0008762934,0.0007107023,0.0008824462,0.0008570975],"domain_scores_gemma":[0.997729,0.00064131897,0.00014045805,0.00046932188,0.00052544504,0.00049447943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017376982,0.00020691127,0.00063544343,0.0003523977,0.00011602296,0.000041011637,0.00015906346,0.00012233133,0.0006835793],"category_scores_gemma":[0.0005595718,0.00015539395,0.000102097685,0.000855066,0.0009814947,0.00012900395,0.00014230204,0.0010291025,0.000027545875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001341401,0.00049434055,0.90797585,0.00030743438,0.00013204174,0.00024376865,0.00047464407,0.000014188185,0.02273081,0.000050784645,0.0013406251,0.064894095],"study_design_scores_gemma":[0.007839046,0.0019953712,0.9567661,0.0010877642,0.000049497463,0.00002569603,0.00038498762,0.0008899771,0.029211812,0.0011609434,0.00030200317,0.00028678938],"about_ca_topic_score_codex":0.0033888454,"about_ca_topic_score_gemma":0.00028341662,"teacher_disagreement_score":0.06460731,"about_ca_system_score_codex":0.00033514682,"about_ca_system_score_gemma":0.0010229815,"threshold_uncertainty_score":0.7484714},"labels":[],"label_agreement":null},{"id":"W2107566256","doi":"10.1158/1078-0432.ccr-05-1258","title":"Effect of the Selective Estrogen Receptor Modulator Arzoxifene on Repopulation of Hormone-Responsive Breast Cancer Xenografts between Courses of Chemotherapy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Chemotherapy; Breast cancer; Medicine; Paclitaxel; Clonogenic assay; Internal medicine; Estrogen receptor; Cancer research; Cancer; Estrogen; Adjuvant; Oncology; Endocrinology; Biology; Cell","score_opus":0.035433248075361926,"score_gpt":0.44801880723813103,"score_spread":0.4125855591627691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107566256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947814,0.0032982647,0.000004524327,0.00080033,0.00012990672,0.00072425214,0.00018495643,0.000005471351,0.00007089165],"genre_scores_gemma":[0.9970972,0.0018577236,0.00003910198,0.00003244965,0.00068670843,0.00007519163,0.000021190985,0.00003283161,0.00015762949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693733,0.0011704409,0.0006209628,0.00040753378,0.0005474421,0.00031626513],"domain_scores_gemma":[0.9979087,0.0005043772,0.00037537626,0.000519498,0.0005763772,0.000115661576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019297074,0.00017256584,0.00046239063,0.00008153566,0.00008050387,0.000005379044,0.00035283537,0.0003851513,0.000023481587],"category_scores_gemma":[0.00049657206,0.00011439947,0.0003210372,0.00041870328,0.0005928186,0.0000063030716,0.00011368752,0.00049508375,0.000002509747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009335173,0.0002679209,0.20655692,0.000071305796,0.0006367428,4.9006167e-7,0.00006611631,0.0005917013,0.7321704,0.000029031675,0.0037432737,0.046530917],"study_design_scores_gemma":[0.0015940159,0.0029696587,0.11676038,0.000108134176,0.000056393503,0.0000013872381,0.000009729242,0.000053577514,0.877503,0.0000098774035,0.00083149347,0.000102393904],"about_ca_topic_score_codex":0.00031626644,"about_ca_topic_score_gemma":0.000016916989,"teacher_disagreement_score":0.14533256,"about_ca_system_score_codex":0.00007136714,"about_ca_system_score_gemma":0.0003898741,"threshold_uncertainty_score":0.4665075},"labels":[],"label_agreement":null},{"id":"W2107838011","doi":"10.1158/1078-0432.ccr-14-2810","title":"Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Translational Impacts; Canadian Institutes of Health Research","keywords":"Bevacizumab; Medicine; Ovarian cancer; Camptothecin; Cancer; Combination therapy; Oncology; Cancer research; Internal medicine; Pharmacology; Chemotherapy; Biology","score_opus":0.08414878315593641,"score_gpt":0.4837361792371491,"score_spread":0.39958739608121274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107838011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564934,0.0024477057,0.00009667306,0.0005579538,0.0003025399,0.00045689679,0.00008734389,0.000008008305,0.00039353667],"genre_scores_gemma":[0.9943915,0.0026771596,0.00028745318,0.000120712175,0.0011137868,0.00021817443,0.00002298457,0.000037092632,0.0011311121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973248,0.00047564832,0.00057107024,0.0005765768,0.00048698945,0.0005648836],"domain_scores_gemma":[0.9985649,0.00018040618,0.00012419984,0.00045319155,0.00042638584,0.0002509169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017627733,0.00018133277,0.00047033725,0.00009413367,0.00007802361,0.000022556373,0.00031629662,0.00015274504,0.00042185152],"category_scores_gemma":[0.000314866,0.00012759787,0.00016420636,0.00037886683,0.0004963533,0.000014249408,0.00007565349,0.00042354708,0.0000067315727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03400677,0.00069818366,0.46328375,0.0001704441,0.00042095006,0.000005003375,0.0004351924,0.0041066706,0.3364434,0.00018908606,0.003886762,0.1563538],"study_design_scores_gemma":[0.0317776,0.0049710562,0.6367581,0.0005104155,0.000121969024,0.000015856009,0.00018377806,0.0025915175,0.12983677,0.0005389912,0.19165093,0.001043041],"about_ca_topic_score_codex":0.0024236906,"about_ca_topic_score_gemma":0.0111701535,"teacher_disagreement_score":0.20660663,"about_ca_system_score_codex":0.00005241132,"about_ca_system_score_gemma":0.0015978952,"threshold_uncertainty_score":0.62332076},"labels":[],"label_agreement":null},{"id":"W2108067150","doi":"10.1158/1078-0432.ccr-09-1877","title":"Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas M.D. Anderson Cancer Center","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Lynch syndrome; Medicine; Colorectal cancer; Microsatellite instability; Hazard ratio; Internal medicine; Cohort; Oncology; Cancer; Proportional hazards model; Confidence interval; Cancer registry; DNA mismatch repair; Allele; Genetics; Gene; Biology; Microsatellite","score_opus":0.10328428493311516,"score_gpt":0.425660060234612,"score_spread":0.32237577530149686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108067150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97171664,0.0093835015,0.0000011195438,0.0150203295,0.0010679702,0.001227603,0.0007586058,0.000017704844,0.0008064993],"genre_scores_gemma":[0.9691684,0.029243456,0.000032250602,0.00049641746,0.00039924696,0.00008765555,0.000010459034,0.00003420806,0.000527866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630105,0.0006896799,0.0006200245,0.0008606047,0.00090011256,0.0006285185],"domain_scores_gemma":[0.9947615,0.0036865228,0.0002488623,0.0005924674,0.00043870386,0.00027188964],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031985724,0.0002445584,0.00071862934,0.00009358197,0.0002956638,0.000048198624,0.0005237275,0.00044285512,0.0005619828],"category_scores_gemma":[0.0011447847,0.00015913711,0.00012428928,0.0005889387,0.004114496,0.00007420013,0.0005006588,0.002777165,0.0000023572043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016059073,0.00012772958,0.94734246,0.000106793734,0.00027576624,0.00006547898,0.0016978465,0.000021032578,0.0026958487,0.00003565004,0.0107871,0.020785207],"study_design_scores_gemma":[0.012303873,0.00030163123,0.975507,0.00069297454,0.00013873637,0.000010851808,0.0011451788,0.0004424283,0.0005552345,0.00016965106,0.008545204,0.00018720274],"about_ca_topic_score_codex":0.11966774,"about_ca_topic_score_gemma":0.1447541,"teacher_disagreement_score":0.028164558,"about_ca_system_score_codex":0.0003932181,"about_ca_system_score_gemma":0.0014852153,"threshold_uncertainty_score":0.99952346},"labels":[],"label_agreement":null},{"id":"W2108097215","doi":"10.1158/1078-0432.ccr-15-0831","title":"New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunotherapy; Sarcoma; Cancer immunotherapy; Medicine; Cancer; Computational biology; Biology; Genetics; Pathology","score_opus":0.6559328705354502,"score_gpt":0.5692865870122779,"score_spread":0.08664628352317238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108097215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054042907,0.9904565,0.000009303408,0.0010098788,0.00012880044,0.002243498,0.000012836953,0.000021163813,0.00071372953],"genre_scores_gemma":[0.0013311652,0.99611706,0.0008963035,0.00012878128,0.0005214932,0.00062938296,0.000041689804,0.000095508956,0.00023863374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996165,0.0007557558,0.00095641095,0.0008598856,0.00064815354,0.0006147977],"domain_scores_gemma":[0.997582,0.00090084295,0.00011816521,0.00069698325,0.00011851059,0.0005834652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003062812,0.00035326034,0.0021817954,0.0004422303,0.000052160518,0.00015524024,0.00032790026,0.00047212502,0.00008418498],"category_scores_gemma":[0.00017300934,0.00025742696,0.00034167475,0.00069264567,0.00018162937,0.000042501862,0.00028501046,0.0015356533,0.00010988627],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016344753,0.0002790318,0.005020944,0.002140267,0.0002771893,0.00030328432,0.00008456006,9.297782e-7,8.197551e-7,0.0005626936,0.00073518313,0.99043167],"study_design_scores_gemma":[0.0020370737,0.00074685295,0.005680492,0.00919824,0.00022850331,0.000027923126,0.00007899634,0.0000028693562,0.0000010925633,0.0012100397,0.9805108,0.00027717307],"about_ca_topic_score_codex":0.0011381303,"about_ca_topic_score_gemma":0.00023757474,"teacher_disagreement_score":0.9901545,"about_ca_system_score_codex":0.0006258824,"about_ca_system_score_gemma":0.0047930633,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W2108685474","doi":"10.1158/1078-0432.ccr-1127-3","title":"Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, Los Angeles; Trent University","keywords":"Corticotropic cell; Methylation; CpG site; Adenoma; Hyperplasia; DNA methylation; Cushing's disease; Biology; Pathology; Endocrinology; Internal medicine; Immunohistochemistry; Pituitary gland; Medicine; Disease; Gene; Gene expression; Hormone; Genetics","score_opus":0.08051291271177252,"score_gpt":0.4388766333275909,"score_spread":0.3583637206158184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108685474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935619,0.0023681826,0.000082374245,0.0026749612,0.000099279205,0.00068963814,0.00009546675,0.000023839111,0.00040433707],"genre_scores_gemma":[0.99847883,0.00024529872,0.00022408128,0.0005256507,0.00008062763,0.00015140996,0.00022141013,0.00002454433,0.000048158086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978667,0.000225215,0.00036833278,0.00050469954,0.00061063276,0.00042441272],"domain_scores_gemma":[0.99874043,0.0002590747,0.00004816486,0.00037421385,0.00020307086,0.00037506133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041427722,0.00014076446,0.00035432345,0.00013809002,0.000088668334,0.000023153367,0.00012371496,0.0001218369,0.00016459994],"category_scores_gemma":[0.0004883372,0.00010012673,0.0000795822,0.00026727043,0.00029861354,0.00010289876,0.00008103799,0.00051802763,0.00004449556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002695829,0.0013939824,0.9871393,0.000023489823,0.000073828916,0.0014229047,0.00015754823,0.000095868396,0.00001974194,0.00019278433,0.00007709297,0.0067076716],"study_design_scores_gemma":[0.010975819,0.00079840777,0.97832125,0.00013701634,0.00005927709,7.818357e-7,0.000054020107,0.000023001941,0.00007565494,0.009138702,0.0003002845,0.00011575577],"about_ca_topic_score_codex":0.0028722188,"about_ca_topic_score_gemma":0.0021752834,"teacher_disagreement_score":0.008945919,"about_ca_system_score_codex":0.00020433388,"about_ca_system_score_gemma":0.00064743374,"threshold_uncertainty_score":0.4341955},"labels":[],"label_agreement":null},{"id":"W2108729187","doi":"10.1158/1078-0432.ccr-03-0774","title":"Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Oesterreichische Nationalbank; Kamillo Eisner Stiftung; Universität Wien; Austrian Science Fund","keywords":"Apoptosis; Terminal deoxynucleotidyl transferase; Saline; TUNEL assay; Sarcoma; Immunohistochemistry; Cyclophosphamide; Cancer research; Medicine; Oligonucleotide; Biology; Pathology; Chemotherapy; Internal medicine; Biochemistry","score_opus":0.2572669998544351,"score_gpt":0.5329620560572201,"score_spread":0.27569505620278506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108729187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567194,0.003386864,0.03367986,0.003984923,0.00045099098,0.0010107829,0.00008740444,0.000019485416,0.0006602588],"genre_scores_gemma":[0.99310255,0.00046859906,0.0015579818,0.0006533393,0.0010879394,0.00016528786,0.000072265735,0.000030245174,0.0028618074],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986417,0.00005718419,0.00027496603,0.00042741036,0.0002375531,0.00036115822],"domain_scores_gemma":[0.99919546,0.00004550897,0.000042671803,0.00034008306,0.0002563076,0.00011994591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010995399,0.000094267896,0.00014322103,0.00003977945,0.00021835843,0.000029392508,0.00022876094,0.0002311055,0.00010763646],"category_scores_gemma":[0.000076387616,0.000079043704,0.00016860987,0.00010024355,0.00017877456,0.0000024590643,0.000105620384,0.00020432645,0.000011989694],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003425485,0.00040640717,0.0011484103,0.000046449022,0.00009588547,8.895567e-7,0.00004489818,0.000095398,0.9663791,0.0072200513,0.0030308764,0.021189103],"study_design_scores_gemma":[0.0055528875,0.0030499587,0.007883134,0.000047611473,0.000023244529,0.0000032060248,0.000057411053,0.000140373,0.33928666,0.04447518,0.5991472,0.00033312954],"about_ca_topic_score_codex":0.00011782319,"about_ca_topic_score_gemma":0.000100623045,"teacher_disagreement_score":0.6270924,"about_ca_system_score_codex":0.000034692308,"about_ca_system_score_gemma":0.00022775725,"threshold_uncertainty_score":0.32233086},"labels":[],"label_agreement":null},{"id":"W2109098197","doi":"10.1158/1078-0432.ccr-09-1602","title":"Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institutes of Health; University of Michigan","keywords":"Breast cancer; Gene expression profiling; Cancer; Gene signature; Metastasis; Lung cancer; Microarray analysis techniques; Survival analysis; DNA microarray; Biology; Computational biology; Oncology; Bioinformatics; Gene expression; Gene; Medicine; Internal medicine; Genetics","score_opus":0.4161668514677751,"score_gpt":0.5156638214219026,"score_spread":0.09949696995412749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109098197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937421,0.0015709278,0.00039623043,0.002091192,0.00023662343,0.0003923153,0.00061508385,0.000025800813,0.00092972576],"genre_scores_gemma":[0.99331224,0.0029118613,0.00028086422,0.00027148495,0.0007425966,0.00011515802,0.00030598737,0.000027441512,0.0020323605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970825,0.0005353442,0.0006182867,0.0007093198,0.0006463008,0.00040825887],"domain_scores_gemma":[0.9980803,0.000063996755,0.00019591348,0.00063494174,0.0007790553,0.00024577134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007750965,0.00019269019,0.00034613066,0.00007625678,0.00019973164,0.000043219796,0.0006081739,0.00041534653,0.00037012403],"category_scores_gemma":[0.000117148,0.00016074287,0.00012842445,0.00027497506,0.0003139372,0.00002372989,0.00022743072,0.00052173686,0.0000041581857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013271061,0.00019710102,0.0027655652,0.000019351268,0.000039654904,0.000001458195,0.00006673409,0.0002146785,0.95299965,0.00010320203,0.034049638,0.008215874],"study_design_scores_gemma":[0.0026553944,0.00064462743,0.16875444,0.00024798568,0.000023448805,0.0000014822626,0.00032499657,0.0003038388,0.7986949,0.0017553045,0.02614134,0.0004522484],"about_ca_topic_score_codex":0.0002911624,"about_ca_topic_score_gemma":0.00028054972,"teacher_disagreement_score":0.16598888,"about_ca_system_score_codex":0.000049187107,"about_ca_system_score_gemma":0.00059232704,"threshold_uncertainty_score":0.65549046},"labels":[],"label_agreement":null},{"id":"W2109140694","doi":"10.1158/1078-0432.621.11.2","title":"Classic and Molecular Cytogenetic Analyses Reveal Chromosomal Gains and Losses Correlated with Survival in Head and Neck Cancer Patients","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Head and neck cancer; Head and neck; Cancer; Biology; Cytogenetics; Oncology; Genetics; Pathology; Medicine; Chromosome; Surgery; Gene","score_opus":0.2669193044050199,"score_gpt":0.5405949756844544,"score_spread":0.2736756712794345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109140694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97551006,0.019923763,0.0000014504252,0.0034591886,0.00006823274,0.0005146751,0.00002815843,0.000016395432,0.00047805798],"genre_scores_gemma":[0.9810492,0.017763766,0.000110982925,0.00045936494,0.00021478429,0.00011010194,0.000006813197,0.00002984876,0.00025516498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745333,0.0002959857,0.00048468012,0.00064094766,0.000570506,0.00055455114],"domain_scores_gemma":[0.99857366,0.0004453041,0.0000615122,0.00021056799,0.00030729544,0.00040166226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063546357,0.0001962836,0.00069410604,0.00015962485,0.00014046027,0.000035407927,0.000073090756,0.00015783701,0.000057686793],"category_scores_gemma":[0.00033846564,0.0001446853,0.000039401973,0.000496304,0.0009478155,0.00007243478,0.00017200438,0.0007574442,0.0000030297037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014198093,0.00025898713,0.9708113,0.0001540004,0.0001348781,0.00007810473,0.00020931981,0.000009898128,0.000588251,0.000006895512,0.0004906799,0.02583789],"study_design_scores_gemma":[0.0067077135,0.0022800425,0.987037,0.00078303367,0.00008197918,0.0000063290427,0.00009369848,0.00029092428,0.00049222494,0.000015041489,0.0020367634,0.00017525049],"about_ca_topic_score_codex":0.0016814405,"about_ca_topic_score_gemma":0.009320404,"teacher_disagreement_score":0.02566264,"about_ca_system_score_codex":0.00013032115,"about_ca_system_score_gemma":0.000446624,"threshold_uncertainty_score":0.5900095},"labels":[],"label_agreement":null},{"id":"W2109142777","doi":"10.1158/1078-0432.ccr-05-1798","title":"Evaluation of Adverse Events Experienced by Older Patients Participating in Studies of Molecularly Targeted Agents Alone or in Combination","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Tolerability; Adverse effect; Medicine; Internal medicine; Toxicity; Clinical trial; Oncology; Database","score_opus":0.34036259393371626,"score_gpt":0.621832050974023,"score_spread":0.2814694570403068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109142777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974011,0.00087837345,0.000008668448,0.0001876609,0.000096878444,0.0012755855,0.000021751413,0.000004203153,0.00012575963],"genre_scores_gemma":[0.9981939,0.0001355112,0.000112066686,0.000030547853,0.000016582397,0.0013133925,0.00006514421,0.000011057202,0.000121770536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964489,0.0007230566,0.0009047092,0.00026347025,0.0014152821,0.0002446294],"domain_scores_gemma":[0.99768597,0.0003396526,0.0001868006,0.0001706616,0.0015615444,0.000055363238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029838963,0.000082390165,0.0003618813,0.00019170542,0.000034654033,0.0000014193698,0.00006974609,0.00007150659,0.00016934298],"category_scores_gemma":[0.0024750065,0.00006450201,0.000052094125,0.0006797822,0.00016483136,0.00009533529,0.000045826437,0.00017791719,0.0000018641124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005234124,0.003179293,0.9829623,0.00009808761,0.0001086449,0.000004829018,0.0019454483,0.00019225216,0.0006253165,0.000008861353,0.0005377135,0.009813835],"study_design_scores_gemma":[0.014855194,0.0008232179,0.97648484,0.0004837974,0.000108223445,6.233642e-8,0.0011713577,0.0018110629,0.0039299815,0.000247392,0.000024735062,0.00006013814],"about_ca_topic_score_codex":0.0023178759,"about_ca_topic_score_gemma":0.0010047534,"teacher_disagreement_score":0.014331781,"about_ca_system_score_codex":0.00056640885,"about_ca_system_score_gemma":0.0005139453,"threshold_uncertainty_score":0.35039505},"labels":[],"label_agreement":null},{"id":"W2109227311","doi":"10.1158/1078-0432.ccr-11-0237","title":"Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Sunitinib; Pharmacokinetics; Neutropenia; Mucositis; Internal medicine; Population; Pharmacodynamics; Gastroenterology; Cancer; Toxicity; Oncology; Pharmacology","score_opus":0.20572552419620968,"score_gpt":0.5238092103061034,"score_spread":0.3180836861098937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109227311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963141,0.00011837647,9.739282e-7,0.000034350443,0.00005831302,0.0029883494,0.000011746306,0.000014680919,0.00045911135],"genre_scores_gemma":[0.9990037,0.0003241387,0.00001959978,0.00007437623,0.00029840137,0.00022387992,0.000011418755,0.000026433889,0.000018043242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969966,0.0009106273,0.0006662431,0.0004578003,0.00064193376,0.0003268387],"domain_scores_gemma":[0.998514,0.00044249702,0.00015223863,0.00029906302,0.00036341517,0.00022880879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021770915,0.00013290982,0.0005967746,0.00032230341,0.00005643754,0.0000066103344,0.00013651444,0.000107679974,0.00015950619],"category_scores_gemma":[0.00028139944,0.00010527258,0.00004605263,0.00058442174,0.00024579975,0.00008269265,0.00009317935,0.0010468292,0.0000025141655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060759806,0.041732743,0.9057289,0.0000501673,0.00012793476,0.00006463437,0.0038708483,2.2751018e-7,0.00029679664,8.9376687e-7,0.00005009795,0.04200082],"study_design_scores_gemma":[0.044911776,0.05236104,0.899867,0.000049944985,0.00012612795,0.0000018952,0.002032924,0.0000038270127,0.0005191329,0.000008221522,0.000023481009,0.0000946514],"about_ca_topic_score_codex":0.00073274504,"about_ca_topic_score_gemma":0.00042856135,"teacher_disagreement_score":0.041906167,"about_ca_system_score_codex":0.00011647279,"about_ca_system_score_gemma":0.00030922436,"threshold_uncertainty_score":0.454801},"labels":[],"label_agreement":null},{"id":"W2109743880","doi":"10.1158/1078-0432.14aacriaslc-ia10","title":"Abstract IA10: Molecular testing to personalized EGFR and ALK inhibitor therapies in lung cancer.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Anaplastic lymphoma kinase; Lung cancer; Cancer research; Adenocarcinoma; Crizotinib; Targeted therapy; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Cancer; Medicine; Fusion gene; Tyrosine kinase; Fluorescence in situ hybridization; Biology; Pathology; Internal medicine; Gene; Genetics; Chromosome","score_opus":0.1627069123620948,"score_gpt":0.5623998535843598,"score_spread":0.39969294122226506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109743880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97706044,0.006633724,0.000025839468,0.011271182,0.00016652088,0.0008248182,0.000017582712,0.00003108275,0.003968783],"genre_scores_gemma":[0.99501187,0.0007785879,0.0010008245,0.0013067515,0.0005730517,0.0005315931,0.000005838158,0.00003357381,0.0007578953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794346,0.00018648832,0.00040254334,0.00048490686,0.00050497364,0.00047765137],"domain_scores_gemma":[0.9979775,0.0010296819,0.000048653426,0.00024831758,0.00033093977,0.00036490857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015328057,0.00013455162,0.000365265,0.0001595137,0.00013726224,0.000051449322,0.000104092986,0.00010862846,0.00027838035],"category_scores_gemma":[0.0013016458,0.00010604056,0.000068101945,0.00048635033,0.0002473874,0.000059982805,0.000081441365,0.0005620575,0.000014522562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084480434,0.00039765952,0.70512414,0.00038977113,0.00028204685,0.00011167385,0.0016744783,0.000039164228,0.0101126265,0.0005891956,0.004410719,0.27602372],"study_design_scores_gemma":[0.008387451,0.0010015164,0.9420485,0.001571989,0.00013094749,0.0000058092232,0.0005824768,0.00093452015,0.0012626731,0.00063241384,0.043136224,0.0003054658],"about_ca_topic_score_codex":0.0035598462,"about_ca_topic_score_gemma":0.000536131,"teacher_disagreement_score":0.27571827,"about_ca_system_score_codex":0.000338694,"about_ca_system_score_gemma":0.0006074837,"threshold_uncertainty_score":0.53814465},"labels":[],"label_agreement":null},{"id":"W2109841006","doi":"10.1158/1078-0432.ccr-07-4926","title":"Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of Chicago","keywords":"Azoxymethane; Aberrant crypt foci; Epidermal growth factor receptor; Gefitinib; Cancer research; Colorectal cancer; Cyclin D1; EGFR inhibitors; Cancer; Protein kinase B; Carcinogenesis; Growth factor receptor; Biology; Pathology; Medicine; Internal medicine; Signal transduction; Cell cycle; Cell biology","score_opus":0.3039764773076946,"score_gpt":0.5049068096902137,"score_spread":0.20093033238251912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109841006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800386,0.00905964,0.00010437262,0.00836078,0.00038919234,0.0017371539,0.00004434316,0.000024888634,0.00024103445],"genre_scores_gemma":[0.9797787,0.015084263,0.0011152148,0.0010464883,0.0005329238,0.0012601939,0.000016160784,0.00004064294,0.0011254136],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995746,0.0005519259,0.0008881569,0.0006959471,0.0012546291,0.0008633339],"domain_scores_gemma":[0.9968337,0.0018144621,0.0001327521,0.0003427627,0.00042844965,0.00044791892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029641709,0.000249617,0.00077157386,0.00017470645,0.00032126735,0.00003748221,0.00026440856,0.00023607578,0.00042553354],"category_scores_gemma":[0.0010944648,0.000154558,0.00013292913,0.0004989393,0.0007079011,0.000101583544,0.00016380733,0.0014450022,0.000027306593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027985942,0.002374667,0.329732,0.0017448728,0.0006801002,0.0009873972,0.010933149,0.00018289783,0.048959367,0.00029599387,0.08362881,0.4924948],"study_design_scores_gemma":[0.07755096,0.007480144,0.39103714,0.005883841,0.0006049835,0.00027270956,0.0016291068,0.014322756,0.14244168,0.0007165164,0.35540646,0.0026537143],"about_ca_topic_score_codex":0.00067295245,"about_ca_topic_score_gemma":0.00093089044,"teacher_disagreement_score":0.48984107,"about_ca_system_score_codex":0.0003953522,"about_ca_system_score_gemma":0.0021267075,"threshold_uncertainty_score":0.6302692},"labels":[],"label_agreement":null},{"id":"W2109881048","doi":"10.1158/1078-0432.ccr-07-0245","title":"Adeno-Associated Virus–Mediated Antiangiogenic Gene Therapy with Thrombospondin-1 Type 1 Repeats and Endostatin","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Endostatin; Adeno-associated virus; Angiogenesis; Angiogenesis inhibitor; Genetic enhancement; Thrombospondin 1; Angiostatin; Cancer research; Medicine; Vascular endothelial growth factor; Neovascularization; Pancreatic cancer; Cancer; Pathology; Immunology; Biology; Vector (molecular biology); Recombinant DNA; Internal medicine; Gene; VEGF receptors","score_opus":0.14684926569595355,"score_gpt":0.4769950841792521,"score_spread":0.3301458184832986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109881048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807523,0.017899701,0.000068216345,0.00025804827,0.00017422871,0.00032927436,0.00006977789,0.000019409885,0.00042905193],"genre_scores_gemma":[0.96786195,0.02958945,0.00020011143,0.00053213356,0.00057154795,0.00003162156,0.00013897617,0.00005425677,0.0010199405],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99752957,0.00029409156,0.00041179085,0.0006608237,0.00044953148,0.0006541696],"domain_scores_gemma":[0.99837536,0.00029585738,0.000111354064,0.00042146168,0.0005258182,0.00027016306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028653461,0.00018191883,0.00028165424,0.00008626707,0.00019087488,0.000038393326,0.0002590884,0.00032063134,0.00020513087],"category_scores_gemma":[0.00043336386,0.00014044394,0.00011264441,0.0005000145,0.0005185686,0.000005962028,0.00014586511,0.0003208221,0.000022944181],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039560907,0.000347149,0.24438646,0.00001382015,0.0005873151,0.0000578516,0.0000847536,0.0000037047464,0.7184836,0.000028939381,0.011575186,0.020475075],"study_design_scores_gemma":[0.004357652,0.0046230783,0.51406235,0.00006769027,0.000044039767,0.0000147763185,0.00013552443,0.000018794111,0.3660452,0.00005629085,0.11001725,0.00055733754],"about_ca_topic_score_codex":0.00029774662,"about_ca_topic_score_gemma":0.0008655175,"teacher_disagreement_score":0.35243845,"about_ca_system_score_codex":0.00004646875,"about_ca_system_score_gemma":0.0003940329,"threshold_uncertainty_score":0.57271373},"labels":[],"label_agreement":null},{"id":"W2109890006","doi":"10.1158/1078-0432.ccr-06-1234","title":"A Mass Balance and Disposition Study of the DNA Methyltransferase Inhibitor Zebularine (NSC 309132) and Three of Its Metabolites in Mice","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; University of Pittsburgh","keywords":"Uridine; Uracil; Metabolite; Urine; Chemistry; Cytidine; In vivo; Chromatography; Endocrinology; Internal medicine; Biochemistry; DNA; Biology; Medicine; RNA; Enzyme","score_opus":0.05843800623851291,"score_gpt":0.41694205755718,"score_spread":0.3585040513186671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109890006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873367,0.011820208,0.000060190923,0.0001909905,0.000047859277,0.00044796112,0.00002649316,0.0000011708347,0.000068419184],"genre_scores_gemma":[0.997088,0.0025983574,0.000072251656,0.000009532732,0.00012369681,0.000036330188,0.000006573465,0.000009002956,0.0000562582],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985113,0.0003972563,0.00040743043,0.0002883166,0.00024120342,0.00015448853],"domain_scores_gemma":[0.9993337,0.00015882215,0.00006536594,0.00020319731,0.00019669277,0.000042255164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014375502,0.00007586906,0.00019895483,0.000045772387,0.000043069944,0.000010804673,0.00012135423,0.00010371535,0.000004683087],"category_scores_gemma":[0.00023373106,0.00005624915,0.00004032267,0.00019957357,0.00020711959,0.0000042204942,0.00011313848,0.00018753202,1.2316421e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016905855,0.00019658085,0.36801124,0.00003654614,0.000018902616,4.912704e-7,0.000024241537,0.000017305789,0.630249,0.000055375443,0.000006240529,0.0012150132],"study_design_scores_gemma":[0.0011062039,0.0004449723,0.5130978,0.000024641831,0.000020168065,1.2456192e-7,0.000036049365,0.00011293611,0.48432606,0.00060436956,0.00017414232,0.000052491396],"about_ca_topic_score_codex":0.00061046705,"about_ca_topic_score_gemma":0.002194595,"teacher_disagreement_score":0.14592296,"about_ca_system_score_codex":0.0000068196246,"about_ca_system_score_gemma":0.000060817827,"threshold_uncertainty_score":0.22937739},"labels":[],"label_agreement":null},{"id":"W2109957199","doi":"10.1158/1078-0432.ccr-13-0526","title":"Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Metastasis; Cancer research; Hypoxia (environmental); Tumor hypoxia; Cervix; Cancer cell; Medicine; Mediator; Cancer; Biology; Signal transduction; Pathology; Internal medicine; Cell biology; Radiation therapy; Chemistry","score_opus":0.12678368595981854,"score_gpt":0.4416587083226234,"score_spread":0.31487502236280485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109957199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966696,0.0002774379,0.000014033617,0.0017896577,0.00007591305,0.0009036135,0.000042065545,0.0000020165508,0.00022566623],"genre_scores_gemma":[0.9990816,0.00013563877,0.00008932106,0.00003403176,0.00008113023,0.00019068026,0.0000042207243,0.000011282864,0.0003720927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975036,0.0011497567,0.00045955018,0.00024908845,0.00045362714,0.00018441102],"domain_scores_gemma":[0.9982439,0.00020965758,0.00025476477,0.00063705246,0.00060445507,0.000050162504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011993765,0.0000851787,0.00018793835,0.000025433343,0.000075905795,0.000009687302,0.0004027576,0.00013943725,0.00010092034],"category_scores_gemma":[0.0035459495,0.000047224625,0.00020511907,0.00029509948,0.00076358987,0.000010125969,0.0002767209,0.00025269514,0.000001407522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010576384,0.00033078698,0.0077446257,0.000113463844,0.00007555146,9.573833e-8,0.000076961005,0.000020424937,0.9848534,0.00015070828,0.00091054325,0.00466579],"study_design_scores_gemma":[0.00053525117,0.0003730511,0.054943323,0.00011490842,0.000017486045,3.4765606e-7,0.00016930373,0.000016403452,0.94177085,0.0012516752,0.00075591385,0.00005146277],"about_ca_topic_score_codex":0.00060240726,"about_ca_topic_score_gemma":0.00002963003,"teacher_disagreement_score":0.047198698,"about_ca_system_score_codex":0.000018517276,"about_ca_system_score_gemma":0.0004683885,"threshold_uncertainty_score":0.4245089},"labels":[],"label_agreement":null},{"id":"W2110155621","doi":"10.1158/1078-0432.ccr-05-0158","title":"Evaluating the Expression and Prognostic Value of TRAIL-R1 and TRAIL-R2 in Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Tissue microarray; Cytokeratin; Medicine; Cancer; Oncology; Stage (stratigraphy); Lymph node; Internal medicine; Immunohistochemistry; Receptor; Pathology; Receptor expression; Cancer research; Biology","score_opus":0.1752315273467045,"score_gpt":0.5236478960077964,"score_spread":0.3484163686610919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110155621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918297,0.0056111724,0.000030342906,0.0020527113,0.000053924046,0.00033769308,0.000017630131,0.0000022320874,0.00006460752],"genre_scores_gemma":[0.99344903,0.005422039,0.00027140058,0.0000784608,0.00041939592,0.0000928135,0.000005482731,0.000011544642,0.00024985525],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985309,0.00035771492,0.00030687536,0.00032305188,0.00026392477,0.0002175171],"domain_scores_gemma":[0.9993773,0.00018846593,0.00005934947,0.0001743792,0.00012387488,0.000076613884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022401072,0.00007633063,0.00013900164,0.00003449584,0.000088382316,0.000017921828,0.00011098532,0.00014506612,0.000056327255],"category_scores_gemma":[0.00020411513,0.000049951203,0.00003752493,0.00010211922,0.00027980062,0.000005204989,0.00013654382,0.000242603,4.997378e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041100295,0.000093941555,0.032996476,0.00006169277,0.00001680161,7.431405e-7,0.00017813838,0.00038772626,0.5949493,0.00009519508,0.00026180956,0.37054718],"study_design_scores_gemma":[0.0033999532,0.0011579031,0.9085227,0.000479118,0.000039576076,0.000015857187,0.00034055478,0.014456063,0.06505855,0.00081390224,0.0054368135,0.00027896822],"about_ca_topic_score_codex":0.00021524727,"about_ca_topic_score_gemma":0.000288265,"teacher_disagreement_score":0.87552625,"about_ca_system_score_codex":0.00001524378,"about_ca_system_score_gemma":0.00015941837,"threshold_uncertainty_score":0.20369509},"labels":[],"label_agreement":null},{"id":"W2110410873","doi":"10.1158/1078-0432.ccr-08-0524","title":"A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Carcinoembryonic antigen; Antibody; Medicine; Cancer; Antigen; Oncolytic adenovirus; Toxicity; Internal medicine; Virology; Immunology","score_opus":0.15553678229178985,"score_gpt":0.5162728224528756,"score_spread":0.3607360401610858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110410873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975677,0.0009813115,0.000002164163,0.00004578202,0.00009043658,0.0011305483,0.000017855205,0.000006499357,0.0001576918],"genre_scores_gemma":[0.9974642,0.0017808239,0.000030294736,0.00005528691,0.00016092231,0.00022843853,0.000013728744,0.00004383371,0.00022249599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968884,0.0005949348,0.00052360847,0.00061347836,0.00079910917,0.00058048987],"domain_scores_gemma":[0.99819237,0.00012683232,0.00009607284,0.0006300102,0.0007597405,0.00019497021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013045053,0.00015143622,0.00035981336,0.00015962996,0.00012218863,0.000010008934,0.00042146796,0.00014289732,0.00010328269],"category_scores_gemma":[0.00036762716,0.00012802625,0.00005141295,0.0007079034,0.00040811417,0.0000074467284,0.00022477594,0.0006646029,0.000009190877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095855616,0.012940469,0.72536176,0.000056073546,0.00025667227,0.00006489219,0.00062152237,0.0007539783,0.021395009,0.000001105396,0.00035351823,0.14233936],"study_design_scores_gemma":[0.0805308,0.32743374,0.5195727,0.00026795588,0.00004176007,0.000002765945,0.000688444,0.00014647968,0.066547185,0.000025871785,0.003921972,0.0008203326],"about_ca_topic_score_codex":0.000987922,"about_ca_topic_score_gemma":0.005346033,"teacher_disagreement_score":0.31449327,"about_ca_system_score_codex":0.0001342026,"about_ca_system_score_gemma":0.0012206953,"threshold_uncertainty_score":0.5220759},"labels":[],"label_agreement":null},{"id":"W2110496394","doi":"10.1158/1078-0432.ccr-08-1593","title":"Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Prostate cancer; Rectal examination; Nomogram; Medicine; Single-nucleotide polymorphism; Prostate biopsy; Oncology; Odds ratio; Prostate; Genotype; Confidence interval; Internal medicine; Cancer; Prostate-specific antigen; SNP; Genotyping; Biology; Genetics; Gene","score_opus":0.24755085391538156,"score_gpt":0.5216926095025093,"score_spread":0.2741417555871277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110496394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824334,0.006260808,0.00016155202,0.0029077216,0.00019955807,0.0019717435,0.00010885857,0.0000104374285,0.00013597996],"genre_scores_gemma":[0.9940297,0.004686985,0.0002328888,0.00012065182,0.00025529205,0.00053462654,0.0000028566133,0.000012787595,0.00012421176],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806565,0.00017004885,0.0006748309,0.00032227422,0.0004669112,0.00030029134],"domain_scores_gemma":[0.99734914,0.0010217081,0.00021814214,0.00039400734,0.0008921851,0.00012479117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017316672,0.00009668467,0.00037847838,0.000060086877,0.00011392801,0.000011608414,0.0001363737,0.00008967209,0.0000677101],"category_scores_gemma":[0.0005971597,0.00006097871,0.00015911684,0.00037510804,0.00036656944,0.000041226525,0.000042933996,0.00033776803,0.0000014696822],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022995293,0.00044738216,0.42090333,0.0001852869,0.00014434832,0.0000039602796,0.00016725821,0.000016159574,0.0035219432,0.00004873148,0.00036347058,0.5718986],"study_design_scores_gemma":[0.0022191706,0.0028939156,0.95960474,0.00026543933,0.00010448487,7.4301926e-7,0.000050860395,0.0009538952,0.031928223,0.0012573128,0.0006672163,0.000053985357],"about_ca_topic_score_codex":0.0020519295,"about_ca_topic_score_gemma":0.0004124185,"teacher_disagreement_score":0.57184464,"about_ca_system_score_codex":0.00008637408,"about_ca_system_score_gemma":0.0006877198,"threshold_uncertainty_score":0.31019172},"labels":[],"label_agreement":null},{"id":"W2110531477","doi":"10.1158/1557-3265.pms14-b06","title":"Abstract B06: Chemotherapeutic agents attenuate subsequent CXCL12-induced migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Waterloo","funders":"","keywords":"Cancer research; Propidium iodide; Colorectal cancer; Population; Cancer cell; Oxaliplatin; Irinotecan; Medicine; Cancer; Biology; Immunology; Internal medicine; Apoptosis; Programmed cell death; Biochemistry","score_opus":0.3588524277753227,"score_gpt":0.5301632315803533,"score_spread":0.17131080380503055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110531477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545085,0.00028458136,0.000042131993,0.002875624,0.00007067273,0.0009089422,0.00015474917,0.000023845445,0.00018859097],"genre_scores_gemma":[0.9972404,0.0005548004,0.00024124866,0.0007133985,0.0003438745,0.00017696408,0.000043163862,0.00003868724,0.00064744015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701995,0.0004086465,0.0007836988,0.0005417188,0.00074713264,0.00049886236],"domain_scores_gemma":[0.99642146,0.0012929474,0.0002973738,0.00023496729,0.0012345861,0.00051864446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037703398,0.00018784341,0.00057178567,0.00017645732,0.00015754132,0.00005190714,0.000115357885,0.0002120214,0.00021352178],"category_scores_gemma":[0.0008018993,0.00016474075,0.00018322555,0.0005047689,0.0002954544,0.00011652474,0.000055938053,0.00064663286,0.000014677843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021850402,0.00047611215,0.0133754,0.00037261142,0.0002580837,0.0000081919925,0.0006302627,0.000012834465,0.9597216,0.0000039178735,0.013227253,0.00972868],"study_design_scores_gemma":[0.006304976,0.00095839147,0.010610063,0.0013056117,0.00016694672,0.0000024552237,0.0009429575,0.004909103,0.9724788,0.00009747523,0.0019608452,0.00026237304],"about_ca_topic_score_codex":0.006072521,"about_ca_topic_score_gemma":0.0013407236,"teacher_disagreement_score":0.0127571905,"about_ca_system_score_codex":0.0004180639,"about_ca_system_score_gemma":0.000755373,"threshold_uncertainty_score":0.9179876},"labels":[],"label_agreement":null},{"id":"W2110949408","doi":"10.1158/1078-0432.ccr-13-3389","title":"Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells <i>In Vitro</i> and <i>In Vivo</i> and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"American Association for Cancer Research","keywords":"Temozolomide; In vivo; Glioblastoma; Blockade; In vitro; mTORC1; Medicine; Cancer research; Pharmacology; Chemistry; Internal medicine; Biology; PI3K/AKT/mTOR pathway; Apoptosis; Receptor","score_opus":0.03427321049620357,"score_gpt":0.37481956940058114,"score_spread":0.34054635890437757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110949408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972991,0.0006831843,0.000033035256,0.0008383892,0.0001302061,0.0005119371,0.0000679058,0.000015716105,0.00042054182],"genre_scores_gemma":[0.9968579,0.0002264671,0.00037723602,0.0013165599,0.00070922193,0.00020513425,0.0000075934404,0.00005596309,0.00024393291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959999,0.0010548478,0.00063845597,0.0010193647,0.00048931263,0.0007981659],"domain_scores_gemma":[0.99772114,0.0011049542,0.00010635685,0.00043118987,0.00018204834,0.0004543279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038956865,0.00026791124,0.0004920895,0.00019336665,0.00012038546,0.000083017854,0.00025780138,0.00023538493,0.000022590542],"category_scores_gemma":[0.0014422893,0.0002433091,0.000056643654,0.0004778943,0.0005251338,0.0000140928905,0.00048957433,0.00072347,0.0000041676053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004159594,0.00014162523,0.05866343,0.00011504322,0.000036756464,0.0000828059,0.000084497755,0.00014399736,0.93151706,0.000013567639,0.0015039183,0.0035376982],"study_design_scores_gemma":[0.0047670375,0.0025814539,0.006720425,0.00036408874,0.00001644136,0.000025893429,0.00016333636,0.00028427056,0.95690477,0.000057061254,0.02753046,0.0005847339],"about_ca_topic_score_codex":0.00092440477,"about_ca_topic_score_gemma":0.005659139,"teacher_disagreement_score":0.051943008,"about_ca_system_score_codex":0.00006292893,"about_ca_system_score_gemma":0.0003767818,"threshold_uncertainty_score":0.9921857},"labels":[],"label_agreement":null},{"id":"W2111144249","doi":"10.1158/1078-0432.ccr-06-1119","title":"The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor–Negative Model of Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Selective estrogen receptor modulator; Estrogen receptor; Estrogen; Pharmacology; In vivo; Mammary tumor; Cancer; Antiestrogen; Medicine; Internal medicine; Cancer research; Breast cancer; Biology; Biotechnology","score_opus":0.04765602354531068,"score_gpt":0.402088793871903,"score_spread":0.3544327703265923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111144249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948003,0.0036968184,0.0000056860895,0.00049133494,0.000029759585,0.00086790154,0.00006318061,0.0000019714957,0.000043020107],"genre_scores_gemma":[0.99331,0.006052818,0.00008169342,0.000010136802,0.00005780425,0.00026038007,0.000012584276,0.000015111171,0.00019949747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997602,0.0010759014,0.00047923214,0.00032552483,0.00028131393,0.00023605824],"domain_scores_gemma":[0.99891925,0.00026796045,0.00020954343,0.00030728767,0.00025034387,0.000045587964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011391602,0.00013400927,0.00026207077,0.00005459551,0.000097429256,0.000014544887,0.00024936863,0.00019694272,0.0000031727773],"category_scores_gemma":[0.00010614911,0.00006835245,0.00008792906,0.0003475833,0.00060867524,0.000015056365,0.00009795211,0.00023745242,1.04148526e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00863781,0.0026861874,0.35133582,0.00012151758,0.0004066467,0.0000027615106,0.00095826434,0.0027491387,0.58543193,0.0019882582,0.0004039062,0.045277778],"study_design_scores_gemma":[0.0076844385,0.0067472523,0.3646203,0.00043273496,0.00010008857,0.000009846256,0.0009783974,0.010499904,0.6048821,0.0035913745,0.00011891459,0.00033462263],"about_ca_topic_score_codex":0.0014418615,"about_ca_topic_score_gemma":0.0011596482,"teacher_disagreement_score":0.044943154,"about_ca_system_score_codex":0.000073822266,"about_ca_system_score_gemma":0.0004553069,"threshold_uncertainty_score":0.2787332},"labels":[],"label_agreement":null},{"id":"W2111159494","doi":"10.1158/1078-0432.ccr-06-0324","title":"Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Lung cancer; Immunohistochemistry; Pleural effusion; Antigen; Pathology; Medicine; Cancer; Antibody; Stage (stratigraphy); Effusion; Cancer research; Biology; Immunology; Internal medicine","score_opus":0.11075730612434151,"score_gpt":0.5258183928856719,"score_spread":0.41506108676133036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111159494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997475,0.0010512851,0.000019179462,0.00047367878,0.00011283676,0.00046496288,0.0001204478,0.000010998174,0.00027159887],"genre_scores_gemma":[0.9955797,0.0012247161,0.00002253635,0.0001728682,0.0003179615,0.00013268892,0.00007634017,0.000028800541,0.0024443953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681854,0.0006744514,0.00095060706,0.00064804003,0.0005116396,0.00039674176],"domain_scores_gemma":[0.9983915,0.00019252159,0.00026777276,0.0004947858,0.00051438605,0.0001390484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029861236,0.00013877156,0.00035905623,0.00008563037,0.000095401934,0.00003668445,0.00038238903,0.00037583744,0.00017001978],"category_scores_gemma":[0.0009798158,0.000109501656,0.00014604072,0.0002953461,0.00028076777,0.00001623451,0.0001594452,0.0004898179,0.0000070329083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005989806,0.0008279611,0.9189469,0.000035465604,0.000083184874,0.000008597164,0.000025072379,0.000049724375,0.07329896,0.00007010651,0.003522543,0.002532512],"study_design_scores_gemma":[0.0021022442,0.00074074644,0.8824205,0.00023182499,0.000019089503,4.663115e-7,0.00004268851,0.00071624387,0.11124889,0.00015565817,0.002113882,0.0002077749],"about_ca_topic_score_codex":0.0023766034,"about_ca_topic_score_gemma":0.00210099,"teacher_disagreement_score":0.037949927,"about_ca_system_score_codex":0.000053480606,"about_ca_system_score_gemma":0.0006224025,"threshold_uncertainty_score":0.44653478},"labels":[],"label_agreement":null},{"id":"W2111331823","doi":"10.1158/1078-0432.ccr-07-4969","title":"Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Urology; Endoglin; Biochemical recurrence; Plasminogen activator; Stage (stratigraphy); Internal medicine; Plasminogen activator inhibitor-1; Adjuvant therapy; Oncology; Cancer","score_opus":0.1822599578442139,"score_gpt":0.4472976957362071,"score_spread":0.2650377378919932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111331823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056214,0.0042703627,0.000036434467,0.0017941394,0.00014697974,0.0022952894,0.00068217504,0.000030905707,0.00018156836],"genre_scores_gemma":[0.99139357,0.005571587,0.00053028413,0.00019314612,0.00016803341,0.0018293111,0.000069552574,0.00003465865,0.00020987864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674743,0.00043437566,0.00092884054,0.0006035269,0.00084042345,0.0004454026],"domain_scores_gemma":[0.99724394,0.000733481,0.00016292588,0.00057953724,0.0008105672,0.0004695637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095284084,0.00018644269,0.0006093707,0.00012544474,0.00009595547,0.0000072079984,0.0001328941,0.00015706873,0.00036414035],"category_scores_gemma":[0.00087387906,0.00013660364,0.00030536565,0.00054077635,0.0019588885,0.00010760688,0.00008754891,0.00054870435,0.000005649354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027046235,0.004664039,0.95990425,0.0008927094,0.0007779788,0.00031369601,0.00045382895,0.000009520755,0.0016812745,0.000030454423,0.0021703963,0.002055594],"study_design_scores_gemma":[0.01615986,0.0076927845,0.9300957,0.0012419216,0.0004467786,0.0000058851056,0.00007510178,0.0006374799,0.041970763,0.00012844332,0.0013877781,0.00015751692],"about_ca_topic_score_codex":0.0005283715,"about_ca_topic_score_gemma":0.000018712222,"teacher_disagreement_score":0.04028949,"about_ca_system_score_codex":0.00019374366,"about_ca_system_score_gemma":0.0023758889,"threshold_uncertainty_score":0.72176063},"labels":[],"label_agreement":null},{"id":"W2111382211","doi":"10.1158/1078-0432.ccr-05-2703","title":"Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Prostate cancer; Internal medicine; Oncology; XRCC3; Medicine; Single-nucleotide polymorphism; Biology; Cancer research; Cancer; Urology; Genotype; Genetics; Gene","score_opus":0.06221923651045298,"score_gpt":0.4224770252036543,"score_spread":0.36025778869320135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111382211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923274,0.0027556273,0.0000056738027,0.0017069228,0.00008642425,0.0026658778,0.00036440042,0.000030226038,0.00005747712],"genre_scores_gemma":[0.98873985,0.0077280253,0.00047427797,0.00033005164,0.0002829935,0.001089197,0.000097986966,0.00004691222,0.0012106826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968361,0.00030845465,0.00101197,0.00057815295,0.00068172434,0.00058356556],"domain_scores_gemma":[0.99757737,0.0007097407,0.00036198052,0.00029326242,0.00083451037,0.00022316296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021701013,0.00020855138,0.000904424,0.00014055314,0.000079572725,0.000024901485,0.00008297053,0.00020331117,0.000045287445],"category_scores_gemma":[0.0001298954,0.00013589056,0.00014258306,0.0003747562,0.00037403012,0.00012638078,0.000036716225,0.0004416748,7.222175e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015350321,0.0013265056,0.9661514,0.000084402054,0.0005577508,0.00001251152,0.00007718074,0.000021986521,0.000110043504,0.000012972449,0.0011797511,0.015115171],"study_design_scores_gemma":[0.026421962,0.0060809683,0.95922446,0.00026793216,0.000191181,6.329974e-7,0.000010231633,0.00020311806,0.0039976714,0.000018947723,0.0034321463,0.00015074002],"about_ca_topic_score_codex":0.003326924,"about_ca_topic_score_gemma":0.002238066,"teacher_disagreement_score":0.014964431,"about_ca_system_score_codex":0.00053150783,"about_ca_system_score_gemma":0.0006227472,"threshold_uncertainty_score":0.55414563},"labels":[],"label_agreement":null},{"id":"W2111419022","doi":"10.1158/1078-0432.ccr-08-1770","title":"Polymorphisms in the <i>FAS</i> and <i>FASL</i> Genes and Survival of Early Stage Non–small Cell Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Fas ligand; Stage (stratigraphy); Biology; Cancer; Gene; Lung cancer; Oncology; Cancer research; Internal medicine; Medicine; Apoptosis; Genetics; Programmed cell death","score_opus":0.09465072844011445,"score_gpt":0.4296336444515013,"score_spread":0.33498291601138686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111419022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821336,0.015931096,0.000027510914,0.000771087,0.00009659091,0.00030081623,0.00006507682,0.000003761014,0.0006704586],"genre_scores_gemma":[0.9866456,0.011611134,0.000051884443,0.00046304113,0.00036604382,0.00004501406,0.000008261218,0.000015168838,0.0007938779],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997946,0.00047798496,0.00038407883,0.00046674433,0.0003117311,0.00041341083],"domain_scores_gemma":[0.99907196,0.00021631694,0.00007426812,0.00035587235,0.00014377745,0.0001378312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024945866,0.0001360356,0.00025924962,0.00005486712,0.000099490804,0.000041006886,0.00032348474,0.00020262662,0.000018714432],"category_scores_gemma":[0.00009691547,0.00010088324,0.00007033803,0.0001982316,0.0003624287,0.0000046228924,0.00012737454,0.00045598223,0.0000010069751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041317925,0.00017044801,0.27402323,0.000069216374,0.00002585692,0.000017460688,0.00035127197,0.000022371929,0.7093981,0.000041409916,0.00044311205,0.015024311],"study_design_scores_gemma":[0.0059719407,0.004558882,0.46586195,0.000305695,0.00008382215,0.0000071602817,0.00076473784,0.00039676353,0.48569095,0.0002986571,0.035209984,0.00084945996],"about_ca_topic_score_codex":0.0015836398,"about_ca_topic_score_gemma":0.00085494976,"teacher_disagreement_score":0.22370717,"about_ca_system_score_codex":0.000011521645,"about_ca_system_score_gemma":0.00030155183,"threshold_uncertainty_score":0.41138992},"labels":[],"label_agreement":null},{"id":"W2111422801","doi":"10.1158/1078-0432.ccr-13-3191","title":"Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Nantes; Ligue Contre le Cancer","keywords":"Osteosarcoma; Cancer research; SMAD; Metastasis; Medicine; Bone metastasis; Transforming growth factor; Primary tumor; Tumor progression; Cell cycle; Cell growth; Pathology; Cancer; Internal medicine; Biology","score_opus":0.070120306180943,"score_gpt":0.43119096240794674,"score_spread":0.36107065622700374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111422801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967039,0.0024087487,0.000032617,0.00007572016,0.000040900224,0.00020706096,0.000035855635,0.0000054723146,0.00048968184],"genre_scores_gemma":[0.9981187,0.0001554653,0.001138876,0.00012565509,0.00015010481,0.00010065501,0.00006233205,0.000018869789,0.0001293506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786514,0.000483055,0.00049599895,0.00045361495,0.00038004047,0.00032213025],"domain_scores_gemma":[0.99885553,0.0004162935,0.00008756662,0.00030300388,0.00016538671,0.00017223487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016289629,0.00011099605,0.00025173076,0.00008381069,0.00006802558,0.000016342407,0.0002822146,0.00011464645,0.00012628046],"category_scores_gemma":[0.0015239482,0.00009678155,0.000059902664,0.0001346607,0.0002967188,0.0000040202635,0.0005176477,0.00027092593,0.0000022734398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018592625,0.00081507355,0.3668447,0.00089992536,0.00017429043,0.000012800944,0.00019042156,0.000018619481,0.5564638,0.00004470089,0.014592005,0.058084436],"study_design_scores_gemma":[0.0019241745,0.00043499208,0.2093708,0.0004955758,0.000016811431,0.0000022209067,0.00005523196,0.00006226421,0.75878793,0.00011675444,0.028464928,0.00026828353],"about_ca_topic_score_codex":0.000061118706,"about_ca_topic_score_gemma":0.000047736274,"teacher_disagreement_score":0.20232421,"about_ca_system_score_codex":0.000027367865,"about_ca_system_score_gemma":0.00046753755,"threshold_uncertainty_score":0.3946637},"labels":[],"label_agreement":null},{"id":"W2111488265","doi":"10.1158/1078-0432.ccr-14-2497","title":"Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; Cancer Research UK; Francis Crick Institute","keywords":"Germline; Ovarian cancer; Germline mutation; Cancer; Epithelial ovarian cancer; Gynecology; Medicine; Oncology; Mutation; Internal medicine; Cancer research; Biology; Genetics; Gene","score_opus":0.08217853277080826,"score_gpt":0.4480162240044228,"score_spread":0.36583769123361454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111488265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396455,0.0005831913,0.0011258769,0.0023828226,0.00041350618,0.00092364737,0.00019762275,0.00001487245,0.00039388225],"genre_scores_gemma":[0.9898329,0.0020815893,0.0010807522,0.0006561333,0.001785286,0.0024972134,0.000064332984,0.00006684485,0.0019349743],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722874,0.00047402704,0.00048462726,0.00079021085,0.0003795936,0.0006428133],"domain_scores_gemma":[0.99807405,0.00070957775,0.00010298252,0.00042799755,0.00046378816,0.00022162868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033355432,0.00018247993,0.0003358944,0.00010052876,0.00014715776,0.0000613563,0.00029079523,0.0002627991,0.00011423676],"category_scores_gemma":[0.001207594,0.00014305321,0.000057472265,0.00035769146,0.0004959491,0.000011562536,0.00014982243,0.00039238806,0.0000053418344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038491145,0.0016577536,0.45742092,0.0009077625,0.00089165353,0.00007149768,0.0023199366,0.0031787965,0.041372504,0.0010054689,0.027293034,0.42538953],"study_design_scores_gemma":[0.043337677,0.010411543,0.26146898,0.00038654465,0.00009138709,0.000017474676,0.0021393502,0.002204299,0.03200483,0.0025740527,0.64372927,0.0016345737],"about_ca_topic_score_codex":0.0005211048,"about_ca_topic_score_gemma":0.009149073,"teacher_disagreement_score":0.61643624,"about_ca_system_score_codex":0.00022119484,"about_ca_system_score_gemma":0.0011982968,"threshold_uncertainty_score":0.58335406},"labels":[],"label_agreement":null},{"id":"W2111568097","doi":"10.1158/1078-0432.ccr-12-0286","title":"A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Health Science Centre; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Subtyping; Oncology; Breast cancer; Immunohistochemistry; Tamoxifen; Medicine; Internal medicine; Estrogen receptor; Progesterone receptor; Confidence interval; Population; Tissue microarray; Bioinformatics; Cancer; Biology","score_opus":0.18582417323574202,"score_gpt":0.4539281997971556,"score_spread":0.2681040265614136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111568097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98446035,0.013209844,0.00007732694,0.0006439874,0.00030612486,0.0004818804,0.0007147899,0.000007526378,0.000098155455],"genre_scores_gemma":[0.99347454,0.0035617326,0.0006201102,0.00006828925,0.0014258475,0.00054169854,0.00014765492,0.000021829339,0.00013829314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862605,0.00010143092,0.00032315793,0.00036702704,0.00021661693,0.00036570564],"domain_scores_gemma":[0.9989656,0.00023559254,0.00008000235,0.00025451765,0.00030858748,0.00015568819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007454083,0.00011007184,0.00024600571,0.00003895937,0.00009486716,0.000010029254,0.00012120384,0.0001838261,0.000032487555],"category_scores_gemma":[0.00033085016,0.00009155691,0.00009184045,0.00009685091,0.00034376254,0.0000071871605,0.00021887835,0.00015288603,0.0000032582213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015649267,0.00032377616,0.9105576,0.000049104958,0.00030338863,2.2695654e-7,0.00009632715,7.325976e-7,0.020420702,0.00005507937,0.0035625761,0.06306551],"study_design_scores_gemma":[0.0015510392,0.00058185146,0.922777,0.000033547676,0.000079026526,8.144341e-7,0.000065272776,0.000007085554,0.045396533,0.00027105084,0.029143387,0.000093414215],"about_ca_topic_score_codex":0.0004769965,"about_ca_topic_score_gemma":0.00023723778,"teacher_disagreement_score":0.06297209,"about_ca_system_score_codex":0.00003925293,"about_ca_system_score_gemma":0.00011675945,"threshold_uncertainty_score":0.37335825},"labels":[],"label_agreement":null},{"id":"W2111923037","doi":"10.1158/1078-0432.ccr-06-0330","title":"Nuclear Localization of Nuclear Factor-κB p65 in Primary Prostate Tumors Is Highly Predictive of Pelvic Lymph Node Metastases","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostatectomy; Prostate cancer; Odds ratio; Lymph node; Medicine; Logistic regression; Univariate analysis; Receiver operating characteristic; Oncology; Univariate; Prostate; Urology; Internal medicine; Multivariate analysis; Pathology; Multivariate statistics; Cancer; Mathematics; Statistics","score_opus":0.057873054949210224,"score_gpt":0.3872536656666992,"score_spread":0.329380610717489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111923037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746937,0.00070773915,0.00007748607,0.0001546949,0.00006852708,0.00037651803,0.00037919523,0.0000121035755,0.00075439806],"genre_scores_gemma":[0.9986966,0.000473779,0.00019840192,0.00017651576,0.00015005116,0.00002178172,0.00009995496,0.000051868978,0.00013099839],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718195,0.000496601,0.00081297616,0.00054017117,0.00058085204,0.00038741948],"domain_scores_gemma":[0.99855936,0.00014255664,0.00021974886,0.0004531746,0.0005269045,0.0000982872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011793352,0.00015000704,0.00039025632,0.00013609228,0.00005802449,0.000015597001,0.00034852515,0.0002141707,0.00014680091],"category_scores_gemma":[0.00032879526,0.00014160163,0.00014699253,0.00037786496,0.0006651745,0.00001030574,0.00028205433,0.0002829239,0.000013463719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040489426,0.0014231123,0.30270463,0.00071851234,0.00019131739,0.000029914734,0.00044887405,0.0032901953,0.67366636,0.0002484364,0.009090521,0.0041391556],"study_design_scores_gemma":[0.006438768,0.003087583,0.32273093,0.0007367612,0.00007137297,0.000005024449,0.00044645555,0.003155445,0.6395548,0.0007657128,0.022310376,0.0006967744],"about_ca_topic_score_codex":0.0010802856,"about_ca_topic_score_gemma":0.000048546473,"teacher_disagreement_score":0.034111574,"about_ca_system_score_codex":0.000096054944,"about_ca_system_score_gemma":0.00049240974,"threshold_uncertainty_score":0.57743466},"labels":[],"label_agreement":null},{"id":"W2112162466","doi":"10.1158/1078-0432.ccr-04-2047","title":"Antisense Inhibition of Methylenetetrahydrofolate Reductase Reduces Cancer Cell Survival <i>In vitro</i> and Tumor Growth <i>In vivo</i>","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"In vivo; Cisplatin; Methylenetetrahydrofolate reductase; Cytotoxic T cell; Growth inhibition; Cancer research; Cell growth; Biology; Pharmacology; Colorectal cancer; Cancer; Medicine; In vitro; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.11079809504736059,"score_gpt":0.4649986918685726,"score_spread":0.354200596821212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112162466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98224866,0.009717674,5.769443e-7,0.0039033873,0.00016349625,0.00076075713,0.00012649084,0.000018251463,0.0030606957],"genre_scores_gemma":[0.969133,0.028671287,0.00022999881,0.00023054738,0.0005498228,0.00012297892,0.000011813923,0.000046318626,0.0010042413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950352,0.00092453096,0.001123275,0.00081702473,0.0011536209,0.0009463944],"domain_scores_gemma":[0.99752396,0.0010499826,0.00012183645,0.00037116584,0.0004890085,0.0004440265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055457903,0.0002227685,0.00083243,0.00046686374,0.00007727835,0.00003154961,0.00018840485,0.00023597344,0.00042926855],"category_scores_gemma":[0.00063955114,0.00019469815,0.00014851983,0.0011928217,0.0007997901,0.00024797049,0.00021435546,0.0015267425,0.00001613249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040523824,0.0010729433,0.022889161,0.0004282651,0.00004175794,0.0003146823,0.00022947983,0.000008862628,0.9524446,0.000022767792,0.0026761445,0.015818957],"study_design_scores_gemma":[0.0052724523,0.00066051475,0.013866143,0.00047167766,0.000029295188,0.000010477717,0.00026805786,0.0005673701,0.9761101,0.0000848047,0.0024426023,0.00021648279],"about_ca_topic_score_codex":0.009801814,"about_ca_topic_score_gemma":0.0024630036,"teacher_disagreement_score":0.023665527,"about_ca_system_score_codex":0.0003500546,"about_ca_system_score_gemma":0.00088334887,"threshold_uncertainty_score":0.996792},"labels":[],"label_agreement":null},{"id":"W2112377066","doi":"10.1158/1078-0432.ccr-12-2812","title":"Molecular Markers in Key Steroidogenic Pathways, Circulating Steroid Levels, and Prostate Cancer Progression","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"CYP17A1; Prostate cancer; Single-nucleotide polymorphism; Oncology; Internal medicine; Dihydrotestosterone; SNP; Proportional hazards model; Cancer; Androgen deprivation therapy; Medicine; Biology; Androgen; Endocrinology; Hormone; Genetics; Gene; Genotype","score_opus":0.11095048884618637,"score_gpt":0.4624147126594092,"score_spread":0.35146422381322284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112377066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95931447,0.03925424,0.000008004858,0.00026755963,0.00023248729,0.00064143987,0.0000204242,0.00001143183,0.00024997385],"genre_scores_gemma":[0.99510604,0.0038562738,0.00011544847,0.00012839322,0.00032316035,0.000270875,0.000021106182,0.000044342232,0.00013435168],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99704266,0.0007844996,0.0004356338,0.00052984915,0.00038296875,0.0008243834],"domain_scores_gemma":[0.9990133,0.00009584454,0.000088107096,0.00032795183,0.0001248036,0.00034997883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026352685,0.00017971451,0.00024172643,0.00008530098,0.00011866194,0.000041756637,0.0001953017,0.0003655913,0.000026041558],"category_scores_gemma":[0.00027285152,0.00015045283,0.0000934538,0.00024207609,0.0003040683,0.000014631445,0.00036917522,0.00076565193,0.000008499956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006177553,0.00018848602,0.43937683,0.00010776019,0.00010169522,0.000033500524,0.00020410995,0.000033104665,0.45478076,0.000021407852,0.00041606234,0.104118526],"study_design_scores_gemma":[0.008518915,0.002737341,0.6412749,0.0012084732,0.00008706666,0.000056765108,0.0005940143,0.0008162617,0.326578,0.00018439293,0.0166131,0.0013307529],"about_ca_topic_score_codex":0.00010352866,"about_ca_topic_score_gemma":0.000044657285,"teacher_disagreement_score":0.20189808,"about_ca_system_score_codex":0.00006633283,"about_ca_system_score_gemma":0.0002538332,"threshold_uncertainty_score":0.61352885},"labels":[],"label_agreement":null},{"id":"W2112505356","doi":"10.1158/1078-0432.ccr-07-4393","title":"Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dasatinib; T cell; Cytotoxic T cell; Cytokine; Degranulation; Cancer research; CD8; Biology; LYN; Tyrosine kinase; CD28; Immunology; Cell biology; Signal transduction; Antigen; Immune system; Receptor; In vitro; Biochemistry","score_opus":0.23667664232533722,"score_gpt":0.48237610064549724,"score_spread":0.24569945832016002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112505356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837143,0.0039124247,0.00004086284,0.00066652027,0.00030180428,0.0011348239,0.000118049385,0.000044662876,0.00540944],"genre_scores_gemma":[0.98116446,0.009832094,0.00014876356,0.00008379374,0.0005817051,0.0002296983,0.00019471554,0.00003890715,0.007725874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969773,0.0003962924,0.0006720281,0.00052567426,0.0009499908,0.00047865935],"domain_scores_gemma":[0.9974366,0.0010735486,0.0001143893,0.00058501016,0.00047915746,0.00031133665],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013234923,0.00014547701,0.00046134822,0.00014069438,0.00020987283,0.000009392151,0.000111641566,0.00021126424,0.00194819],"category_scores_gemma":[0.0004031811,0.00012123303,0.0001885453,0.0005853868,0.0008483984,0.00006995521,0.00009464826,0.00093121757,0.0008186478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018661215,0.0025725267,0.32836798,0.00029011656,0.0001608693,0.00015950396,0.00019834374,0.0000022773252,0.08750619,0.000019502242,0.5645601,0.014296425],"study_design_scores_gemma":[0.024044197,0.005364644,0.37269372,0.0006223048,0.00006256541,0.000056476874,0.00016474015,0.000080842976,0.10300401,0.000053160275,0.4934885,0.00036487292],"about_ca_topic_score_codex":0.0004050564,"about_ca_topic_score_gemma":0.000026789181,"teacher_disagreement_score":0.07107165,"about_ca_system_score_codex":0.00074321614,"about_ca_system_score_gemma":0.0012957773,"threshold_uncertainty_score":0.99995935},"labels":[],"label_agreement":null},{"id":"W2112598101","doi":"10.1158/1078-0432.ccr-13-3063","title":"Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"World Health Organization","keywords":"Lung cancer; Liquid biopsy; Mutation; Cancer; DNA sequencing; Medicine; Somatic cell; Germline mutation; Cell-free fetal DNA; Deep sequencing; Oncology; Genome; DNA; Internal medicine; Pathology; Biology; Genetics; Gene","score_opus":0.08841003771622559,"score_gpt":0.42858706443737776,"score_spread":0.3401770267211522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112598101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918953,0.00522206,0.00055424235,0.00021836748,0.00022247552,0.00071839406,0.0010826464,0.0000034177906,0.000083057195],"genre_scores_gemma":[0.9977869,0.0007623637,0.00034738117,0.00007211,0.00038150736,0.00044553855,0.0001497864,0.000032190906,0.000022228041],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972213,0.00041655745,0.00093845965,0.00061745057,0.0004508939,0.00035536566],"domain_scores_gemma":[0.9965406,0.0017462765,0.00036641146,0.0006411381,0.00057434844,0.00013123502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009420318,0.00016205104,0.0004971951,0.000101091806,0.00007637247,0.000019092451,0.00048145768,0.00022588648,0.00018771894],"category_scores_gemma":[0.002658969,0.000168687,0.00014956298,0.00037126834,0.00038856085,0.000015873238,0.0003644083,0.0003647705,5.775675e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004210341,0.000985262,0.87687695,0.00012036187,0.00051902235,0.000008085508,0.0015654137,0.007856753,0.089446306,0.000023885663,0.0028863347,0.019290617],"study_design_scores_gemma":[0.005354852,0.0017899146,0.051425684,0.00051735487,0.00018200658,4.5194753e-7,0.0033627825,0.0049889456,0.9298543,0.00091984565,0.0011598374,0.00044404957],"about_ca_topic_score_codex":0.053396095,"about_ca_topic_score_gemma":0.014860994,"teacher_disagreement_score":0.84040797,"about_ca_system_score_codex":0.00019466567,"about_ca_system_score_gemma":0.0008851776,"threshold_uncertainty_score":0.95290744},"labels":[],"label_agreement":null},{"id":"W2112663560","doi":"10.1158/1078-0432.ccr-05-2079","title":"Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"NONMEM; Pharmacokinetics; Cyclophosphamide; Medicine; Regimen; Mean squared error; Population; Bayesian probability; Statistics; Oncology; Chemotherapy; Pharmacology; Surgery; Mathematics","score_opus":0.07709430576573807,"score_gpt":0.44158611466975106,"score_spread":0.364491808904013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112663560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95338154,0.0017090309,0.001251933,0.0006666006,0.00012995057,0.005741902,0.00015043982,0.00006090924,0.03690769],"genre_scores_gemma":[0.98943317,0.0022928363,0.0034486027,0.00004468864,0.00026019447,0.0014436272,0.00012937514,0.00005962164,0.0028878746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99586064,0.0004938106,0.0013593838,0.0007329373,0.0008576815,0.0006955415],"domain_scores_gemma":[0.997142,0.0016690124,0.00017483266,0.00045581014,0.00030467808,0.00025363665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026227236,0.00023443841,0.0008582784,0.0002631907,0.000058269416,0.000011657248,0.00024012361,0.00024281471,0.0002720172],"category_scores_gemma":[0.000058735404,0.00020581017,0.00024760608,0.0006518342,0.00038113946,0.000058148285,0.000028254386,0.00053346955,0.000025936188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098320514,0.038178507,0.18681489,0.05507268,0.0012472051,0.0010762041,0.032395028,0.00356738,0.516674,0.0047702105,0.046812344,0.015071059],"study_design_scores_gemma":[0.12430457,0.010437396,0.2806909,0.008532952,0.0019766684,0.00022563104,0.00256525,0.042653874,0.515511,0.0059838137,0.0048649753,0.0022529853],"about_ca_topic_score_codex":0.00095097447,"about_ca_topic_score_gemma":0.00005261515,"teacher_disagreement_score":0.09387601,"about_ca_system_score_codex":0.00021455884,"about_ca_system_score_gemma":0.0006343546,"threshold_uncertainty_score":0.83926946},"labels":[],"label_agreement":null},{"id":"W2112732161","doi":"10.1158/1078-0432.ccr-07-4960","title":"Genomic Differences Between Pure Ductal Carcinoma <i>In Situ</i> of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; University of Manitoba; University Health Network","funders":"University Health Network","keywords":"Ductal carcinoma; Breast cancer; Comparative genomic hybridization; Biology; Metastasis; Pathology; Cancer; Lymph node; Lymph; Oncology; Medicine; Genome; Gene; Genetics","score_opus":0.10998153372340977,"score_gpt":0.3547301772067752,"score_spread":0.24474864348336542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112732161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983607,0.0005344706,6.307836e-7,0.00035217585,0.000033280343,0.0004389928,0.0002126337,0.0000030779756,0.00006401586],"genre_scores_gemma":[0.9992216,0.00024447922,0.0000023401892,0.000030266954,0.0001240755,0.00006285868,0.00003142906,0.000013093777,0.00026983526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982281,0.00060136337,0.00028195037,0.00034450108,0.00027928606,0.00026481872],"domain_scores_gemma":[0.99916625,0.00017906085,0.000094206196,0.00028598262,0.00015327499,0.0001212026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048934296,0.00011158298,0.00023711238,0.000034086203,0.00017055757,0.00001884806,0.00029617653,0.000099109435,0.000017618171],"category_scores_gemma":[0.00015477423,0.00007171574,0.000056110577,0.00019364973,0.0005923733,0.0000062228437,0.0003180167,0.00027911476,6.1080647e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002169621,0.00019710047,0.9967085,0.000012903825,0.00009047901,0.000015906311,0.00025441553,0.000005716673,0.0023276664,0.000005459005,0.000110114655,0.000054766646],"study_design_scores_gemma":[0.0010584356,0.0004008496,0.9961578,0.000031406325,0.000025073487,0.0000061319943,0.00063731853,0.00000353415,0.0015340635,0.000034356657,0.000016808443,0.00009418813],"about_ca_topic_score_codex":0.0005837171,"about_ca_topic_score_gemma":0.0026800719,"teacher_disagreement_score":0.0020963547,"about_ca_system_score_codex":0.000030202886,"about_ca_system_score_gemma":0.0007118844,"threshold_uncertainty_score":0.29244828},"labels":[],"label_agreement":null},{"id":"W2112967018","doi":"10.1158/1078-0432.ccr-11-1344","title":"Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of <i>HRAS</i> , <i>TP53</i> , and <i>TGFBR1</i>","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"HRAS; Sorafenib; Neuroblastoma RAS viral oncogene homolog; Cancer research; Keratinocyte; MAPK/ERK pathway; In vivo; Kinase; Malignant transformation; Medicine; Pathology; Biology; Cancer; KRAS; In vitro; Internal medicine; Hepatocellular carcinoma","score_opus":0.15463426291045915,"score_gpt":0.41440380203132415,"score_spread":0.259769539120865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112967018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678016,0.0010510205,0.00011792571,0.00016804019,0.00009809429,0.00039016453,0.00008445348,0.000010123383,0.0013000177],"genre_scores_gemma":[0.99768335,0.0012170003,0.0001602995,0.00022799545,0.00019237427,0.00011725771,0.00007532632,0.000028884779,0.0002975392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783736,0.00040194305,0.00052015315,0.0005668263,0.00029902387,0.00037469255],"domain_scores_gemma":[0.9987794,0.00020622561,0.00014985469,0.0003742089,0.00023659047,0.0002536828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013253068,0.00016005515,0.00029034083,0.00006810459,0.00013971106,0.000020984016,0.0002184168,0.00024220656,0.00005030596],"category_scores_gemma":[0.00041775967,0.00014693981,0.00007628073,0.00020610695,0.000495228,0.000013903411,0.00022403487,0.00039441304,0.000006401178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004928328,0.00024938828,0.006985602,0.000057204896,0.00005250755,0.0000031611912,0.00016760398,3.228012e-7,0.97368413,0.00016202834,0.0030469603,0.015098269],"study_design_scores_gemma":[0.0015563564,0.0018225125,0.013613399,0.00004898849,0.000017601304,0.0000055362048,0.00016624613,0.000011016254,0.9727517,0.00061012607,0.009183065,0.00021347929],"about_ca_topic_score_codex":0.00044690972,"about_ca_topic_score_gemma":0.00012727798,"teacher_disagreement_score":0.0148847895,"about_ca_system_score_codex":0.000016786242,"about_ca_system_score_gemma":0.00036076867,"threshold_uncertainty_score":0.59920317},"labels":[],"label_agreement":null},{"id":"W2113038794","doi":"10.1158/1078-0432.963.11.3","title":"Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations","year":2005,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Profiling (computer programming); Mass spectrometry; Computational biology; Medicine; Chemistry; Computer science; Biology; Chromatography","score_opus":0.2656850612986036,"score_gpt":0.5102683841393999,"score_spread":0.2445833228407963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113038794","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039615665,0.13143344,0.02432992,0.08726443,0.46592742,0.039284453,0.17658365,0.0034508691,0.032110132],"genre_scores_gemma":[0.0005527545,0.15757146,0.040881656,0.000047460977,0.6521704,0.12566285,0.0013708222,0.00022558188,0.021516979],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605954,0.000102878585,0.0009705572,0.0011200423,0.00092007715,0.00082689634],"domain_scores_gemma":[0.99028033,0.0072945426,0.00036599513,0.0006442676,0.0010501173,0.00036473153],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015913673,0.00037243564,0.00067129836,0.00015678794,0.00048675013,0.0001860817,0.0007243208,0.0013754333,0.00035107357],"category_scores_gemma":[0.0040928405,0.00037679137,0.00020707978,0.0002438198,0.0006710666,0.000135493,0.0002556002,0.0032227451,0.0000057309794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019781174,0.00015210791,0.0000839651,0.00074097986,0.00011106703,0.000002144057,0.000015347463,0.0000021692204,0.004229649,0.0006129713,0.9524001,0.041451722],"study_design_scores_gemma":[0.0007186496,0.00013446544,7.199066e-7,0.00055721524,0.00005528971,1.6063147e-7,0.00011248847,0.000111972855,0.046024878,0.003168646,0.94871455,0.00040097605],"about_ca_topic_score_codex":0.0001801616,"about_ca_topic_score_gemma":0.00019947688,"teacher_disagreement_score":0.186243,"about_ca_system_score_codex":0.00054720865,"about_ca_system_score_gemma":0.0015826138,"threshold_uncertainty_score":0.99992096},"labels":[],"label_agreement":null},{"id":"W2113128219","doi":"10.1158/1078-0432.ccr-04-0940","title":"Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Provincial Laboratory of Public Health; University of Toronto; Oncolytics Biotech (Canada); University of Calgary","funders":"","keywords":"Glioma; Antibody; Pathology; Virology; Biology; Reoviridae; Medicine; Immunology; Virus; Cancer research","score_opus":0.5094955707187374,"score_gpt":0.6364664885630844,"score_spread":0.126970917844347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113128219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185395,0.00333485,0.000002580777,0.003014931,0.000059480644,0.0008456286,0.000005974781,0.000007563224,0.0008750509],"genre_scores_gemma":[0.99503,0.0044525415,0.00013716213,0.00009951871,0.00015165428,0.0000555602,0.0000112157295,0.000011641677,0.00005071361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635583,0.0012848045,0.00075394404,0.0003410633,0.00079345907,0.00047090146],"domain_scores_gemma":[0.9984354,0.0002570809,0.00006324809,0.00029206523,0.00072679395,0.00022545639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013430248,0.00007767313,0.00046056116,0.00018705786,0.00006535454,0.000007684929,0.00013099994,0.00011837963,0.00035979276],"category_scores_gemma":[0.005528699,0.000064536434,0.00006235654,0.00035062985,0.0006421536,0.00003517641,0.0001638585,0.00082727784,0.000022783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02360804,0.0014868703,0.7185923,0.000331928,0.0001948075,0.00010394792,0.00024280974,0.00017731544,0.09344776,0.0013890375,0.0009844279,0.15944076],"study_design_scores_gemma":[0.011094637,0.004319475,0.9814719,0.0004221762,0.000017204058,0.0000074780883,0.00005776548,0.00007257696,0.0003888255,0.001372618,0.0007279228,0.000047442863],"about_ca_topic_score_codex":0.0015786907,"about_ca_topic_score_gemma":0.0006496873,"teacher_disagreement_score":0.26287958,"about_ca_system_score_codex":0.00030157866,"about_ca_system_score_gemma":0.0006185014,"threshold_uncertainty_score":0.66187686},"labels":[],"label_agreement":null},{"id":"W2113151539","doi":"10.1158/1078-0432.ccr-07-1037","title":"Molecular Alterations in Prostate Carcinomas that Associate with <i>In vivo</i> Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Docetaxel; Prostate cancer; Chemotherapy; Mitoxantrone; Medicine; Cancer research; Prostate; Prostatectomy; Cancer; Oncology; Biology; Pathology; Internal medicine","score_opus":0.07075281388575705,"score_gpt":0.40936318319274495,"score_spread":0.3386103693069879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113151539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952846,0.00026390364,0.00083987485,0.0016566392,0.00007899233,0.0017353595,0.00001947131,0.000015672746,0.00010548181],"genre_scores_gemma":[0.9991192,0.00017976672,0.000110436165,0.00015287558,0.000040861738,0.00016063398,0.000010368921,0.00002693211,0.00019891042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750584,0.00031806764,0.00064814277,0.0004214875,0.0007033324,0.00040312007],"domain_scores_gemma":[0.99867636,0.00026747072,0.00015760843,0.00023713919,0.00049961265,0.00016180589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002777553,0.00012300634,0.00032923184,0.0004314197,0.00006660649,0.00002607869,0.00011573048,0.00019369139,0.00003291869],"category_scores_gemma":[0.00042344222,0.00009635925,0.00007557064,0.0009549681,0.000100766476,0.00008393928,0.00004346554,0.00068709254,0.0000031241625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026082592,0.0003299003,0.60197335,0.00013912511,0.00011515393,0.00006853581,0.0027084944,0.000011354453,0.38967553,0.00019751597,0.000028853652,0.0021439095],"study_design_scores_gemma":[0.0022085004,0.00060894847,0.64167714,0.0002964348,0.000014143081,0.0000011850238,0.00047157553,0.00015383023,0.3540845,0.0003924904,0.000005101569,0.00008614521],"about_ca_topic_score_codex":0.0013093423,"about_ca_topic_score_gemma":0.0024066318,"teacher_disagreement_score":0.03970378,"about_ca_system_score_codex":0.0003986509,"about_ca_system_score_gemma":0.00025988012,"threshold_uncertainty_score":0.3929416},"labels":[],"label_agreement":null},{"id":"W2113171275","doi":"10.1158/1078-0432.ccr-07-2003","title":"Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; DNA methylation; Chromatin immunoprecipitation; Histone; Cancer research; Histone methylation; Methylation; Molecular biology; Endocrinology; Internal medicine; Gene expression; Promoter; Medicine; Genetics; Gene","score_opus":0.09073692824392346,"score_gpt":0.44820552559561105,"score_spread":0.35746859735168757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113171275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431044,0.0030968315,0.00013964318,0.0014351245,0.00004400511,0.0005626291,0.00013981442,0.000007731797,0.0002637535],"genre_scores_gemma":[0.9971298,0.001830254,0.00018369935,0.0000689535,0.00023133845,0.00014191552,0.00002531488,0.000029498824,0.00035920463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970225,0.00073619833,0.0005888961,0.00055277144,0.0005238583,0.00057578715],"domain_scores_gemma":[0.9982226,0.000576087,0.000098974284,0.00049159763,0.00041756895,0.00019320831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001353737,0.00015011535,0.00029146043,0.00010360643,0.00021473518,0.000017283712,0.00054726127,0.00020482183,0.000069710506],"category_scores_gemma":[0.0018066334,0.000117397496,0.00010694781,0.00034135694,0.0014959065,0.000011985775,0.0003030095,0.0007765899,0.000011504387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078542874,0.00023833851,0.5429869,0.00013347188,0.00008571157,0.00001864927,0.00019107088,0.00006209007,0.4452665,0.00016555171,0.008956071,0.0011102307],"study_design_scores_gemma":[0.0036845456,0.0012347309,0.92019415,0.00015129699,0.000009612905,0.000022272248,0.00017280376,0.0013251161,0.06707794,0.0003114287,0.0054416545,0.00037447308],"about_ca_topic_score_codex":0.000532348,"about_ca_topic_score_gemma":0.00012653519,"teacher_disagreement_score":0.37818855,"about_ca_system_score_codex":0.000056360223,"about_ca_system_score_gemma":0.00049993536,"threshold_uncertainty_score":0.551173},"labels":[],"label_agreement":null},{"id":"W2113325722","doi":"10.1158/1078-0432.ccr-11-1331","title":"Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":388,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Montreal General Hospital","funders":"","keywords":"Indoleamine 2,3-dioxygenase; Immune system; Medicine; Immunology; Immunotherapy; Cancer; Cancer immunotherapy; Clinical trial; Cancer research; Tryptophan Metabolism; Biology; Internal medicine; Tryptophan","score_opus":0.5876062187741322,"score_gpt":0.5994187160481229,"score_spread":0.011812497273990696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113325722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009850085,0.98584086,9.65852e-7,0.00006855378,0.00041689954,0.001525876,0.00006273164,0.00007249917,0.0021615091],"genre_scores_gemma":[0.0059155202,0.9914554,0.000031200132,0.00010149071,0.00067150424,0.0006061267,0.000006251828,0.0000891196,0.0011234164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.987462,0.006498568,0.0020389103,0.0022939227,0.00063070515,0.0010759125],"domain_scores_gemma":[0.99292994,0.0050451793,0.00043192855,0.0010500543,0.00016704263,0.00037586296],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0051841927,0.0005270166,0.0023834757,0.0006197078,0.0003255217,0.00011629671,0.0014988558,0.0011336585,0.00079257577],"category_scores_gemma":[0.0083137285,0.0003919663,0.00056173746,0.001317762,0.0040320866,0.00018188852,0.0012178662,0.0055276365,0.00013047358],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020691757,0.00069550594,0.00018630258,0.0025090808,0.000033184395,0.000133878,0.00025282436,1.0108037e-7,0.00010706525,0.0006043049,0.0020643454,0.9932065],"study_design_scores_gemma":[0.001800102,0.00085305143,0.0011849564,0.008562585,0.000019416186,0.0000098444525,0.00046487837,0.0000022904917,0.00021322093,0.00057357585,0.9856845,0.000631571],"about_ca_topic_score_codex":0.00043250542,"about_ca_topic_score_gemma":0.00022783485,"teacher_disagreement_score":0.99257493,"about_ca_system_score_codex":0.00033774038,"about_ca_system_score_gemma":0.0015275902,"threshold_uncertainty_score":0.9998532},"labels":[],"label_agreement":null},{"id":"W2113341349","doi":"10.1158/1078-0432.ccr-04-1951","title":"Targeting the Mevalonate Pathway Inhibits the Function of the Epidermal Growth Factor Receptor","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation","funders":"AstraZeneca","keywords":"Gefitinib; Epidermal growth factor receptor; Lovastatin; EGFR inhibitors; Protein kinase B; Cancer research; Epidermal growth factor; Biology; Erlotinib; Pharmacology; Signal transduction; Receptor; Endocrinology; Biochemistry; Cholesterol","score_opus":0.09143395515179983,"score_gpt":0.40995660071998064,"score_spread":0.3185226455681808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113341349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656032,0.010383665,0.00007354834,0.01434883,0.008077539,0.0006687574,0.00009576281,0.000010211661,0.00073853746],"genre_scores_gemma":[0.9657718,0.0044379807,0.000024552643,0.0012577394,0.025806697,0.000113116665,0.000012389576,0.000025232355,0.0025504988],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970705,0.0010840476,0.0005037583,0.0003760223,0.00054105534,0.0004246281],"domain_scores_gemma":[0.9983638,0.0003456369,0.00015087974,0.0005642386,0.00048465043,0.00009081037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033935434,0.00012636224,0.00018933076,0.000021505452,0.00037955985,0.000030860352,0.0006442168,0.00017956899,0.0002207485],"category_scores_gemma":[0.001815987,0.000059524347,0.00025324855,0.00024708622,0.00072799384,0.0000076215183,0.0004145573,0.0007333318,0.000024307323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096020184,0.00017267045,0.012013778,0.000052063646,0.0001787503,3.5051716e-8,0.00031960744,0.00011573546,0.44705173,0.00074492855,0.4304222,0.107968315],"study_design_scores_gemma":[0.00049617287,0.00012162378,0.018129408,0.000019373747,0.000013565742,5.514224e-7,0.00011417947,0.000033932953,0.06650779,0.00009619277,0.9143777,0.00008951387],"about_ca_topic_score_codex":0.00020971295,"about_ca_topic_score_gemma":0.00032273587,"teacher_disagreement_score":0.48395553,"about_ca_system_score_codex":0.00003254886,"about_ca_system_score_gemma":0.00047745762,"threshold_uncertainty_score":0.31860024},"labels":[],"label_agreement":null},{"id":"W2113586691","doi":"10.1158/1078-0432.ccr-07-5063","title":"Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institute on Aging","keywords":"CDKN2A; Cell cycle; Esophagus; Barrett's esophagus; Flow cytometry; Biology; Adenocarcinoma; Aneuploidy; Cancer; Pathology; Cell growth; Cancer research; Loss of heterozygosity; Gastroenterology; Internal medicine; Medicine; Molecular biology; Genetics; Gene; Allele","score_opus":0.10157212689956134,"score_gpt":0.4577409821482149,"score_spread":0.35616885524865355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113586691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97334844,0.02067285,0.0000020788511,0.00042717284,0.00008851305,0.005068748,0.00006260462,0.000037684615,0.000291888],"genre_scores_gemma":[0.9930688,0.0013865483,0.000037477465,0.00017897306,0.000305211,0.0022501827,0.000025532943,0.00005738784,0.002689891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99503005,0.0005571646,0.0007882542,0.0009478786,0.0017368242,0.0009398117],"domain_scores_gemma":[0.997362,0.00036564292,0.00010822874,0.0005470619,0.0009141066,0.00070294656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001405385,0.00028973696,0.00070898567,0.00029572778,0.00033879487,0.00006150999,0.00021912395,0.00014360303,0.00046973105],"category_scores_gemma":[0.00018556496,0.00020780799,0.00008277945,0.00073665276,0.000657162,0.00024107295,0.00021033142,0.0014290451,0.000033435077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054012584,0.0048101987,0.9857615,0.000269352,0.00010687484,0.00076222926,0.0011720103,0.00000701313,3.4459205e-7,0.0000034327277,0.0004310771,0.0012746901],"study_design_scores_gemma":[0.02028481,0.0073945094,0.97156245,0.000108547814,0.000048157843,0.000003945441,0.00018206857,0.000014815416,0.00018623241,0.000018168967,0.000011219263,0.00018505982],"about_ca_topic_score_codex":0.0029636468,"about_ca_topic_score_gemma":0.0022457982,"teacher_disagreement_score":0.019720335,"about_ca_system_score_codex":0.0008814296,"about_ca_system_score_gemma":0.0015662359,"threshold_uncertainty_score":0.8474164},"labels":[],"label_agreement":null},{"id":"W2113618415","doi":"10.1158/1078-0432.ccr-07-0471","title":"Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Human Genome Research Institute","keywords":"Pathology; Medicine; Adenocarcinoma; Cancer; Biology; Cancer research; Internal medicine","score_opus":0.1203055730905282,"score_gpt":0.45483293816342213,"score_spread":0.33452736507289393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113618415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98242766,0.011766202,0.000051800558,0.0014863444,0.00015284402,0.0010035855,0.000020971653,0.000029745024,0.0030608317],"genre_scores_gemma":[0.9765674,0.020272411,0.0008674891,0.00028586126,0.0008479118,0.00004085138,0.00001759252,0.000039598184,0.0010609133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99585044,0.00045024016,0.0010363571,0.00070716476,0.0010070382,0.00094875693],"domain_scores_gemma":[0.99403715,0.0040468634,0.0001239508,0.00048094845,0.0004604004,0.00085065636],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.006182361,0.0002281795,0.0011517452,0.0002817947,0.00020538684,0.000020310905,0.00021904116,0.0004083127,0.00025572174],"category_scores_gemma":[0.002467978,0.00018546752,0.00011964307,0.00045520067,0.0029193575,0.00007384915,0.00030807315,0.0013644777,0.000024602155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042314325,0.0002904072,0.9738951,0.000412418,0.0002549746,0.0004883674,0.0005624218,2.2822714e-7,0.0020278082,0.00015326432,0.0005915045,0.017092086],"study_design_scores_gemma":[0.0036252448,0.0030671712,0.9890474,0.0001421624,0.00017358095,0.000115411545,0.00070335035,0.00012256356,0.00021171216,0.0005354928,0.0020934008,0.0001625154],"about_ca_topic_score_codex":0.0018919391,"about_ca_topic_score_gemma":0.00040645534,"teacher_disagreement_score":0.01692957,"about_ca_system_score_codex":0.00016197431,"about_ca_system_score_gemma":0.0011476995,"threshold_uncertainty_score":0.9997941},"labels":[],"label_agreement":null},{"id":"W2113679067","doi":"10.1158/1078-0432.ccr-12-2155","title":"Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Congressionally Directed Medical Research Programs","keywords":"Fallopian tube; Serous fluid; Ovarian cancer; Germline mutation; Biology; Serous Cystadenoma; Population; Pathology; BRCA mutation; Cancer; Cancer research; Medicine; Internal medicine; Gynecology; Mutation; Genetics","score_opus":0.28016628688970757,"score_gpt":0.5606441821127327,"score_spread":0.28047789522302513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113679067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97403085,0.0015884158,0.000009635216,0.021438587,0.00023068128,0.0013262259,0.00003963165,0.0000052526043,0.0013306945],"genre_scores_gemma":[0.9959307,0.0009388659,0.00006343735,0.001740833,0.0005633379,0.0005529818,0.000013101077,0.000012314939,0.00018444368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973235,0.0006322848,0.00048088995,0.000215235,0.0009040574,0.00044401715],"domain_scores_gemma":[0.99837214,0.0007072925,0.000093511626,0.00044426802,0.00024990822,0.00013287393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003262828,0.00008809926,0.00023564343,0.00006498816,0.00010605428,0.000022891214,0.00015174651,0.00009683734,0.00032214195],"category_scores_gemma":[0.0005290651,0.0000458902,0.00014873265,0.0004995837,0.0002099683,0.00010279546,0.00005746663,0.0005268799,0.000022055749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013101614,0.0027122805,0.91487426,0.00010690633,0.00013561288,0.000015428182,0.002517545,0.000008413611,0.00014612514,0.00067033427,0.010250128,0.06725283],"study_design_scores_gemma":[0.006208186,0.00086111797,0.9542314,0.00016554983,0.00009044477,0.0000054798406,0.00025475884,0.0002022644,0.005117214,0.00009988395,0.032698467,0.000065229084],"about_ca_topic_score_codex":0.00090585585,"about_ca_topic_score_gemma":0.00036427955,"teacher_disagreement_score":0.0671876,"about_ca_system_score_codex":0.00020501483,"about_ca_system_score_gemma":0.0005628267,"threshold_uncertainty_score":0.35272282},"labels":[],"label_agreement":null},{"id":"W2114080249","doi":"10.1158/1078-0432.ccr-08-2024","title":"Role of Eotaxin-1 Signaling in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"CCL11; Ovarian cancer; Cancer research; Ovarian carcinoma; Chemokine; Cancer; Receptor; Ovarian tumor; Medicine; Biology; Internal medicine; Eotaxin","score_opus":0.18701482953628157,"score_gpt":0.5346850819076691,"score_spread":0.3476702523713875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114080249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98727566,0.0045456993,0.000008875051,0.0039018756,0.000103344064,0.00034768917,0.0000074783206,0.000014518329,0.0037948468],"genre_scores_gemma":[0.99645567,0.0015412534,0.0002067724,0.0003191426,0.0009057076,0.000036435566,0.0000038968537,0.000016984346,0.00051414495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975258,0.00020166743,0.0007308371,0.00037448172,0.000683176,0.0004840113],"domain_scores_gemma":[0.9985136,0.00050182216,0.00008141002,0.00028730463,0.00036927813,0.00024657766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028053971,0.00010760754,0.00052633294,0.00020475237,0.000048408845,0.000013285511,0.00018013673,0.00018433401,0.001791447],"category_scores_gemma":[0.00064344663,0.000090327005,0.0001663531,0.0007198551,0.00017269366,0.00004436214,0.000055273795,0.0010812404,0.0000134202955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016777323,0.00079199363,0.3539763,0.00012770997,0.00006933458,0.000039716277,0.00041688225,0.00012782868,0.4260884,0.00041756406,0.0019221803,0.21434435],"study_design_scores_gemma":[0.010578828,0.002454614,0.48994535,0.0030955165,0.00009661428,0.000009463306,0.0008785197,0.0020131262,0.45135823,0.006154922,0.03288539,0.00052939664],"about_ca_topic_score_codex":0.0016516945,"about_ca_topic_score_gemma":0.00017512511,"teacher_disagreement_score":0.21381496,"about_ca_system_score_codex":0.00018070557,"about_ca_system_score_gemma":0.0006982042,"threshold_uncertainty_score":0.99912107},"labels":[],"label_agreement":null},{"id":"W2114549720","doi":"10.1158/1078-0432.ccr-08-1325","title":"CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Core binding factor; Midostaurin; Myeloid leukemia; Cancer research; Biology; Autophosphorylation; Haematopoiesis; Exon; Leukemia; Fms-Like Tyrosine Kinase 3; Mutant; Tyrosine kinase; Protein kinase B; Molecular biology; Mutation; Transcription factor; Kinase; Signal transduction; Genetics; Gene; Protein kinase A; Stem cell","score_opus":0.14834580115023244,"score_gpt":0.45602768931853915,"score_spread":0.3076818881683067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114549720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885444,0.0006192889,0.000041613886,0.008147796,0.0002731932,0.0016535517,0.00006679679,0.00007410897,0.0005792473],"genre_scores_gemma":[0.991621,0.0045625623,0.00011277761,0.00073774916,0.00048579546,0.00015263083,0.000036299785,0.00006938818,0.002221754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9936259,0.0009684702,0.0010228248,0.0011107918,0.0017282327,0.0015437995],"domain_scores_gemma":[0.9942478,0.0035713972,0.00015870055,0.00085963076,0.0005058785,0.0006565956],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004905149,0.0003757957,0.0008700615,0.0006206294,0.00042239935,0.0001519075,0.0006323525,0.0005775581,0.00037647667],"category_scores_gemma":[0.0029588838,0.00025477732,0.00017765617,0.0015435249,0.00096156145,0.00029612405,0.00044975133,0.0044053462,0.00023053923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021497207,0.0009932148,0.3643413,0.0006830679,0.00087511673,0.0067699314,0.0022560281,0.00008755095,0.1164932,0.0004576455,0.009279021,0.4762667],"study_design_scores_gemma":[0.008560935,0.0033606174,0.96927774,0.0010689385,0.00008994296,0.00058437366,0.0004259328,0.004197269,0.0045473324,0.0007497962,0.0065969415,0.00054021017],"about_ca_topic_score_codex":0.0004618502,"about_ca_topic_score_gemma":0.0002877957,"teacher_disagreement_score":0.6049364,"about_ca_system_score_codex":0.0024251319,"about_ca_system_score_gemma":0.0023422174,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W2114553251","doi":"10.1158/1078-0432.ccr-07-0547","title":"Relationship of<i>EGFR</i>Mutations, Expression, Amplification, and Polymorphisms to Epidermal Growth Factor Receptor Inhibitors in the NCI60 Cell Lines","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Erlotinib; Epidermal growth factor receptor; Biology; EGFR inhibitors; Cancer research; Tyrosine kinase; Molecular biology; Gene; Lung cancer; Cancer; Genetics; Receptor; Medicine; Internal medicine","score_opus":0.1712660412785758,"score_gpt":0.5120324427055788,"score_spread":0.340766401427003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114553251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98021936,0.0016469379,0.00035816885,0.015304364,0.00020857998,0.0011787328,0.00005732502,0.000018961817,0.001007591],"genre_scores_gemma":[0.9962845,0.00026406057,0.0013382826,0.00062786555,0.0004524207,0.0002198142,0.000047698817,0.000020838936,0.00074455404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974399,0.00036402076,0.0008331235,0.0003859037,0.00062273967,0.00035428285],"domain_scores_gemma":[0.995142,0.0035079562,0.000120401484,0.00035568688,0.00060033565,0.00027361023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002746799,0.000119706136,0.00026441357,0.00031000786,0.00020828022,0.000028019658,0.00016597225,0.0001402074,0.00010955759],"category_scores_gemma":[0.0023819185,0.00008017542,0.00007730904,0.0009653197,0.0003021381,0.00010522688,0.000058848433,0.000552306,0.00003269309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003912537,0.00046851367,0.9734902,0.000085566266,0.000019602538,0.0000089245705,0.0028448324,0.000005022127,0.0034155657,0.0006779167,0.011389804,0.0072028446],"study_design_scores_gemma":[0.001512946,0.00034366577,0.9772239,0.000164191,0.000036730897,0.0000027599374,0.0013336197,0.0000050919016,0.0102019925,0.0005897403,0.008485396,0.00010001968],"about_ca_topic_score_codex":0.0006729902,"about_ca_topic_score_gemma":0.00018909019,"teacher_disagreement_score":0.016065126,"about_ca_system_score_codex":0.00016022428,"about_ca_system_score_gemma":0.00047311472,"threshold_uncertainty_score":0.3269459},"labels":[],"label_agreement":null},{"id":"W2114584615","doi":"10.1158/1078-0432.ccr-08-3114","title":"γH2AX Expression in Tumors Exposed to Cisplatin and Fractionated Irradiation","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Cisplatin; Clonogenic assay; Cervix; Cancer research; Biomarker; Biopsy; Medicine; Cancer; Radiation therapy; In vivo; Pathology; Chemotherapy; Chemistry; Biology; Internal medicine","score_opus":0.2669365559779408,"score_gpt":0.5548692426604351,"score_spread":0.28793268668249433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114584615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98818314,0.0007550651,0.000013156384,0.008030232,0.0001250859,0.00068131747,0.0000070240803,0.000027333743,0.0021776736],"genre_scores_gemma":[0.996666,0.00058750046,0.00032012092,0.0013290189,0.00037908138,0.00009947813,0.000014065347,0.00001074077,0.00059399277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99790716,0.00024935027,0.00046994732,0.00042310046,0.0006055755,0.0003448386],"domain_scores_gemma":[0.99838173,0.00076157274,0.00004425624,0.00020599514,0.00018111913,0.00042529905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012719743,0.00009948579,0.00033138884,0.00033076995,0.00007845976,0.000023814831,0.000079679055,0.00013665082,0.0005235697],"category_scores_gemma":[0.0016853779,0.00007722257,0.000054916145,0.0010398309,0.00006378031,0.00008293801,0.00004554424,0.0006180987,0.000059330094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010737026,0.0013060439,0.34592345,0.00006651012,0.000034454628,0.0001725683,0.00032461766,0.00003087462,0.026812254,0.00012078,0.005473813,0.6089976],"study_design_scores_gemma":[0.0053059338,0.0018212064,0.98353654,0.0002585981,0.000009124471,0.0000024932422,0.00006536566,0.00008550381,0.0039048418,0.0007451882,0.0041774204,0.00008776984],"about_ca_topic_score_codex":0.00023432019,"about_ca_topic_score_gemma":0.000078254176,"teacher_disagreement_score":0.6376131,"about_ca_system_score_codex":0.00026307712,"about_ca_system_score_gemma":0.00019709198,"threshold_uncertainty_score":0.5732721},"labels":[],"label_agreement":null},{"id":"W2114622090","doi":"10.1158/1078-0432.ccr-04-1284","title":"Antitumor Efficacy of <i>bcl-2</i> and <i>c-myc</i> Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro; Consiglio Nazionale delle Ricerche; Ministero della Salute","keywords":"Melanoma; Oligonucleotide; Cancer research; Cisplatin; Messenger RNA; Apoptosis; Molecular biology; Biology; N-Myc; Medicine; Chemotherapy; Cell culture; Gene; Internal medicine; Biochemistry; Neuroblastoma","score_opus":0.061269247467943856,"score_gpt":0.4245529808550566,"score_spread":0.36328373338711273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114622090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981712,0.00053247425,0.0000034171028,0.00058193994,0.000023518527,0.00023038767,0.000014965625,0.000002384401,0.0004396869],"genre_scores_gemma":[0.99885243,0.0006963492,0.00017224877,0.00004714237,0.00008564347,0.000014848859,0.000010985735,0.000011377391,0.00010899634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985873,0.00018059088,0.00047747206,0.00030296604,0.00025467548,0.00019698153],"domain_scores_gemma":[0.9992088,0.00014311433,0.00014632916,0.0003136362,0.00013906251,0.000049047485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009258968,0.00008767646,0.00019725943,0.000038771486,0.000044195676,0.000009714983,0.00022070321,0.000121631725,0.000006852218],"category_scores_gemma":[0.00030774926,0.00006735866,0.000039744347,0.0002603045,0.00069475966,0.00000969967,0.000104245846,0.00029117666,3.8106148e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007120925,0.00036269438,0.20218377,0.00009720182,0.000011599152,0.000005814179,0.00004919249,0.00003539187,0.7909656,0.00008413123,0.00026404893,0.0052284454],"study_design_scores_gemma":[0.0022301953,0.00063535734,0.1913318,0.00027077092,0.0000058323294,0.0000060537564,0.000055994824,0.00006613896,0.8037853,0.000052438154,0.0014603176,0.000099764],"about_ca_topic_score_codex":0.00009828541,"about_ca_topic_score_gemma":0.0007138107,"teacher_disagreement_score":0.012819706,"about_ca_system_score_codex":0.000022080683,"about_ca_system_score_gemma":0.00018392656,"threshold_uncertainty_score":0.27468067},"labels":[],"label_agreement":null},{"id":"W2114645683","doi":"10.1158/1078-0432.ccr-12-3114","title":"Blocked Autophagy Using Lysosomotropic Agents Sensitizes Resistant Prostate Tumor Cells to the Novel Akt Inhibitor AZD5363","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Astex Pharmaceuticals; AstraZeneca","keywords":"Autophagy; Protein kinase B; Prostate; Cancer research; PI3K/AKT/mTOR pathway; Medicine; Chemistry; Biology; Cell biology; Signal transduction; Cancer; Internal medicine; Apoptosis; Biochemistry","score_opus":0.27633364181972353,"score_gpt":0.5225578416554204,"score_spread":0.24622419983569688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114645683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909215,0.0023534778,0.000027413966,0.0035295628,0.0011556422,0.0015352881,0.00010553826,0.000066263616,0.0003053115],"genre_scores_gemma":[0.9884546,0.0003991466,0.00036713804,0.0036271757,0.003813495,0.00013797624,0.0000099683175,0.00007116991,0.0031193518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99567956,0.0005536667,0.0007601718,0.0005485896,0.0012503967,0.0012076369],"domain_scores_gemma":[0.9968718,0.00063952844,0.00011783939,0.0008759991,0.00049319526,0.0010015795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029026747,0.00023615868,0.0005225018,0.00015910329,0.00041274697,0.000067855144,0.00031438953,0.00014212549,0.00071340904],"category_scores_gemma":[0.0006577747,0.00015579489,0.0002543823,0.00069777214,0.0004665236,0.00010349968,0.00030780205,0.0009936965,0.0003915307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015898418,0.0051599406,0.030319788,0.00066088187,0.0011961281,0.00089312455,0.003131101,0.00010010321,0.83116984,0.00050201983,0.087628596,0.023340082],"study_design_scores_gemma":[0.010196982,0.0021730151,0.28082472,0.0010537714,0.00038600503,0.000054526623,0.00073423324,0.0014856956,0.40620235,0.00023236354,0.29589096,0.00076537713],"about_ca_topic_score_codex":0.00037950836,"about_ca_topic_score_gemma":0.000029169963,"teacher_disagreement_score":0.42496747,"about_ca_system_score_codex":0.0003159343,"about_ca_system_score_gemma":0.0008257922,"threshold_uncertainty_score":0.7811328},"labels":[],"label_agreement":null},{"id":"W2114721535","doi":"10.1158/1078-0432.672.11.2","title":"A Phase I and Pharmacokinetic Study of Ecteinascidin-743 (Yondelis) in Children with Refractory Solid Tumors. A Children's Oncology Group Study","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis and Biological Activity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"PharmaMar","keywords":"Pharmacokinetics; Medicine; Neutropenia; Refractory (planetary science); Transaminase; Toxicity; Gastroenterology; Internal medicine; Chemistry","score_opus":0.10661188160395,"score_gpt":0.5099653221440231,"score_spread":0.4033534405400731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114721535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741155,0.00062645244,0.000002395533,0.00015835601,0.000023413051,0.0015951219,0.00003375857,0.0000088388715,0.00014013615],"genre_scores_gemma":[0.99810034,0.00080896437,0.000038993614,0.0000891906,0.0006347856,0.00025966277,0.000015147435,0.000021125716,0.00003181574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612796,0.0015129657,0.0006303116,0.00087644224,0.0003822491,0.00047009677],"domain_scores_gemma":[0.99882007,0.0002492357,0.00016028654,0.00040877875,0.00016314707,0.0001985024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002750625,0.00020357159,0.0005751474,0.000116359704,0.00009543268,0.000019454103,0.00038145724,0.00019371598,0.0001064967],"category_scores_gemma":[0.0003877346,0.00013993321,0.00006883371,0.00029087454,0.00047512996,0.000010909885,0.00041510022,0.00070229056,0.0000023924729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027988194,0.027801061,0.7784572,0.000005274697,0.00023210428,0.000010730236,0.00009608727,0.000008308676,0.028351437,8.9042015e-7,0.00018365089,0.16205442],"study_design_scores_gemma":[0.011827212,0.045159087,0.9343223,0.00001960977,0.00004652463,0.000011055,0.0004218908,0.000023432567,0.006991977,0.000005052763,0.0009584292,0.00021343518],"about_ca_topic_score_codex":0.00072363165,"about_ca_topic_score_gemma":0.0015572165,"teacher_disagreement_score":0.16184099,"about_ca_system_score_codex":0.000054954828,"about_ca_system_score_gemma":0.0001764435,"threshold_uncertainty_score":0.570631},"labels":[],"label_agreement":null},{"id":"W2114722760","doi":"10.1158/1078-0432.ccr-07-4187","title":"MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Medicine; Biology; Mdm2; Genetics; Oncology; Cancer research; Cancer; Internal medicine; Bioinformatics; Gene","score_opus":0.2048309299605218,"score_gpt":0.47649832289413374,"score_spread":0.271667392933612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114722760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645083,0.0282961,0.000025678744,0.0048129195,0.00020847765,0.0012799499,0.000052874926,0.0000641723,0.0007515564],"genre_scores_gemma":[0.92409074,0.072077684,0.0002882236,0.00043073893,0.0006575262,0.00061432266,0.0000059825147,0.00006164779,0.0017731356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672943,0.00045146357,0.0005527485,0.0008049187,0.00078722835,0.00067421736],"domain_scores_gemma":[0.99788874,0.0005216829,0.00010292594,0.00046024655,0.00036146966,0.00066495355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015464266,0.00020661556,0.0005855436,0.00018788436,0.0003308834,0.000032466054,0.00012890749,0.00030512424,0.00046614982],"category_scores_gemma":[0.0010560893,0.00016886373,0.00012114785,0.00048380435,0.0014405234,0.00007512603,0.00023491058,0.0016292351,0.000036359328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012026919,0.0003258637,0.8746671,0.00025396195,0.00032549948,0.00037333163,0.00053773756,0.0000015653405,0.0021844066,0.00002794347,0.011185569,0.10891433],"study_design_scores_gemma":[0.0071067614,0.0021540823,0.9399579,0.0009601697,0.0004002904,0.00028284342,0.00007830964,0.0006033606,0.00438968,0.0002965109,0.043347195,0.00042289056],"about_ca_topic_score_codex":0.003985632,"about_ca_topic_score_gemma":0.0003790146,"teacher_disagreement_score":0.10849144,"about_ca_system_score_codex":0.00019165355,"about_ca_system_score_gemma":0.0009246812,"threshold_uncertainty_score":0.7078306},"labels":[],"label_agreement":null},{"id":"W2114735994","doi":"10.1158/1078-0432.ccr-12-0274","title":"Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast Cancers","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"PI3K/AKT/mTOR pathway; Breast cancer; Triple-negative breast cancer; Cancer research; Medicine; Targeted therapy; Cancer; Estrogen receptor; Bioinformatics; Phosphoinositide 3-kinase; Estrogen; Oncology; Biology; Computational biology; Internal medicine; Signal transduction; Genetics","score_opus":0.1061242414244697,"score_gpt":0.4365045039051222,"score_spread":0.3303802624806525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114735994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819524,0.005059962,0.00016959185,0.0012523843,0.00077912747,0.0012181946,0.00017804334,0.00002979367,0.003117678],"genre_scores_gemma":[0.9944967,0.0013835237,0.00025679325,0.0008451824,0.0009128781,0.0012140897,0.000048539398,0.000077617595,0.0007646751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99520653,0.00096913223,0.00080277526,0.0011357939,0.0007735567,0.0011122115],"domain_scores_gemma":[0.9974959,0.0003014822,0.00014660768,0.00083686446,0.00077494566,0.00044420108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023227774,0.0002978664,0.00045478027,0.00016471648,0.00013315925,0.00008420286,0.00083284377,0.0004883168,0.0008683147],"category_scores_gemma":[0.0012495685,0.00027905512,0.00024280329,0.0005959463,0.0007576731,0.000018835508,0.00043040165,0.0011455832,0.00018407399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001755381,0.00067237514,0.04695115,0.00016634804,0.0004241597,0.00017140419,0.00037295753,0.0012571248,0.7689591,0.00040891895,0.06889119,0.109969884],"study_design_scores_gemma":[0.012394938,0.003952046,0.08553645,0.0006494562,0.000039747687,0.000036044243,0.0009842371,0.001603017,0.80424714,0.0066646314,0.08162122,0.0022710552],"about_ca_topic_score_codex":0.005123755,"about_ca_topic_score_gemma":0.001352556,"teacher_disagreement_score":0.10769883,"about_ca_system_score_codex":0.00042673753,"about_ca_system_score_gemma":0.0019428373,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W2114871138","doi":"10.1158/1078-0432.ccr-03-0215","title":"The Expression of ERβcx in Human Breast Cancer and the Relationship to Endocrine Therapy and Survival","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Endocrine system; Estrogen receptor; Aromatase; Breast cancer; Internal medicine; Medicine; Estrogen receptor alpha; Oncology; Estrogen receptor beta; Immunohistochemistry; Estrogen; Cancer; Endocrinology; Cancer research; Hormone","score_opus":0.11496202055350736,"score_gpt":0.4873093557583002,"score_spread":0.37234733520479285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114871138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98316145,0.010852005,0.0000032297976,0.00540849,0.00006365768,0.00034784,0.000007998128,0.0000020051511,0.00015331531],"genre_scores_gemma":[0.98458314,0.014857743,0.000011087417,0.00006753033,0.00016256126,0.00010741273,0.000002451207,0.000009489476,0.00019858721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987112,0.00044360143,0.00023224286,0.0002242733,0.00018075533,0.00020787705],"domain_scores_gemma":[0.9990472,0.00051752455,0.00003718523,0.00022570016,0.0000886985,0.000083671184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018847352,0.000067089306,0.0001272168,0.00002662564,0.00021525513,0.000020882693,0.00016024311,0.00009895584,0.000004885451],"category_scores_gemma":[0.00029956657,0.00003418103,0.000039555292,0.00013691028,0.0006621536,0.0000026849902,0.00016966919,0.00040340054,6.545354e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080361795,0.0002282325,0.64050204,0.000043524273,0.00010514661,0.000008309101,0.00043172188,0.00018325575,0.3001115,0.0070553967,0.0011409078,0.04215379],"study_design_scores_gemma":[0.009517358,0.0006997805,0.912895,0.00019070113,0.0000091455995,0.000008330214,0.00020444128,0.000008475582,0.069344856,0.0031035263,0.003861082,0.00015730197],"about_ca_topic_score_codex":0.0007783271,"about_ca_topic_score_gemma":0.00047381697,"teacher_disagreement_score":0.272393,"about_ca_system_score_codex":0.000014298084,"about_ca_system_score_gemma":0.00011161351,"threshold_uncertainty_score":0.24397324},"labels":[],"label_agreement":null},{"id":"W2114919368","doi":"10.1158/1078-0432.ccr-08-0816","title":"The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via αv Integrin Ligation","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Wellcome Trust","keywords":"Colorectal cancer; Integrin; Metastasis; Adenocarcinoma; Cancer research; Pathology; Medicine; Internal medicine; Cancer; Receptor","score_opus":0.16585828433615218,"score_gpt":0.4558229190407099,"score_spread":0.2899646347045577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114919368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953692,0.0016379739,0.00016831512,0.0011282101,0.00038407225,0.00085204287,0.000008508616,0.000048923142,0.0004027344],"genre_scores_gemma":[0.9950452,0.0034048704,0.00015562959,0.00006523505,0.0004963383,0.0002189759,0.000020965552,0.00004800278,0.00054480915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942541,0.0018326977,0.00075519615,0.00065634795,0.0017228868,0.00077878154],"domain_scores_gemma":[0.9887208,0.009438574,0.000114635055,0.00040481077,0.00077089475,0.00055033225],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0058144713,0.0001988732,0.00049633667,0.00021279024,0.00087658514,0.00008824028,0.00027326823,0.0001450988,0.00010576721],"category_scores_gemma":[0.010967129,0.00013669909,0.000162383,0.00093956274,0.0016178082,0.00014579511,0.00032465663,0.0019751415,0.00009126388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039179805,0.0003086077,0.94010085,0.00020788805,0.00016548196,0.00053109525,0.00016695852,9.729941e-7,0.041168295,0.00025685003,0.00087882776,0.012296175],"study_design_scores_gemma":[0.0025089704,0.0032001673,0.9698906,0.00019859384,0.00008965477,0.00033309511,0.00045039586,0.0015667442,0.019963758,0.00038837266,0.0011885385,0.00022113617],"about_ca_topic_score_codex":0.001773479,"about_ca_topic_score_gemma":0.00046915215,"teacher_disagreement_score":0.029789705,"about_ca_system_score_codex":0.00039946547,"about_ca_system_score_gemma":0.00077442854,"threshold_uncertainty_score":0.9973639},"labels":[],"label_agreement":null},{"id":"W2115105515","doi":"10.1158/1078-0432.ccr-12-3946","title":"EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Adenocarcinoma; Immunohistochemistry; Carcinogenesis; EZH2; Lung cancer; Pathogenesis; Cancer research; Medicine; Pathology; Cancer; Oncology; Biology; Internal medicine; Gene expression; Gene","score_opus":0.04840865712471666,"score_gpt":0.39190574834231395,"score_spread":0.3434970912175973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115105515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176717,0.0060662334,0.00006550432,0.00043225096,0.00002592462,0.0014583166,0.000011240697,0.000004384911,0.00016898055],"genre_scores_gemma":[0.99714917,0.00045896086,0.0007799467,0.000026007276,0.000192501,0.0009852785,0.000010500294,0.00002622548,0.00037138478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806666,0.00048632067,0.00032675592,0.00042209233,0.0003658081,0.0003323506],"domain_scores_gemma":[0.99858886,0.00014042344,0.00017033056,0.00033072542,0.0006281942,0.00014147963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014817687,0.00012341562,0.00018706288,0.00003461136,0.00016729455,0.00005656935,0.00025211196,0.00015803134,0.000023125142],"category_scores_gemma":[0.00020126213,0.000072091694,0.00006250056,0.00015250438,0.00032442823,0.000005742805,0.00025901615,0.00027403442,0.0000028111904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087792,0.00008872842,0.42638478,0.000058233367,0.000013513241,9.888225e-7,0.000048845257,0.0000014799043,0.5674382,0.0000012660067,0.00034421048,0.0055319616],"study_design_scores_gemma":[0.0004286503,0.0008228689,0.40517494,0.000064146916,0.000010962776,1.4382688e-7,0.000061763065,0.000049935767,0.592693,0.000027671276,0.00058113213,0.000084834865],"about_ca_topic_score_codex":0.00025477723,"about_ca_topic_score_gemma":0.000059848855,"teacher_disagreement_score":0.02525476,"about_ca_system_score_codex":0.000012748274,"about_ca_system_score_gemma":0.00022453483,"threshold_uncertainty_score":0.2939814},"labels":[],"label_agreement":null},{"id":"W2115610792","doi":"10.1158/1078-0432.ccr-14-2650","title":"Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Hamilton General Hospital; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Ependymoma; Warburg effect; PKM2; Cancer research; Phenotype; Gene expression profiling; Downregulation and upregulation; Gene isoform; Biology; Medicine; Western blot; Glycolysis; Pyruvate kinase; Pathology; Gene expression; Gene; Internal medicine; Genetics; Metabolism","score_opus":0.5145980164788173,"score_gpt":0.5822764792221038,"score_spread":0.06767846274328648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115610792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969325,0.008809582,0.0000050164213,0.009444875,0.00042761516,0.00056759303,0.000010235633,0.00005626086,0.011353822],"genre_scores_gemma":[0.9956656,0.0012925509,0.00031873406,0.0005205166,0.0010144713,0.00018975096,0.000011720909,0.000031143067,0.000955519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969815,0.00034261594,0.0005018367,0.0005166457,0.0010321138,0.00062529393],"domain_scores_gemma":[0.9973193,0.0003576906,0.00005753256,0.00052906096,0.00070462713,0.0010317978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002690821,0.00015077203,0.00044396598,0.00014204728,0.00011025988,0.000043213964,0.0001863629,0.00017394611,0.0004983712],"category_scores_gemma":[0.0011232632,0.00011111712,0.0001801197,0.00049823214,0.0004311828,0.0000635615,0.00016668785,0.00079350895,0.0009096448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048569445,0.002504627,0.61920893,0.00010691375,0.00038154362,0.0039342176,0.00009647514,0.0000062071454,0.00048688374,0.00088863977,0.10273748,0.26479113],"study_design_scores_gemma":[0.020623332,0.013509598,0.6792081,0.0008769206,0.00035636834,0.00022733526,0.0005508379,0.00042546078,0.006145652,0.0053097946,0.27218768,0.0005789054],"about_ca_topic_score_codex":0.00058710476,"about_ca_topic_score_gemma":0.00009496688,"teacher_disagreement_score":0.26421222,"about_ca_system_score_codex":0.00024989288,"about_ca_system_score_gemma":0.00136099,"threshold_uncertainty_score":0.9998683},"labels":[],"label_agreement":null},{"id":"W2115824225","doi":"10.1158/1078-0432.ccr-05-1954","title":"Transcriptional Regulation of the Human Reduced Folate Carrier in Childhood Acute Lymphoblastic Leukemia Cells","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Children's Hospital of Michigan","keywords":"Promoter; Chromatin immunoprecipitation; Molecular biology; Biology; Genetics; Gene; Gene expression","score_opus":0.0873774477662076,"score_gpt":0.4447184123881267,"score_spread":0.3573409646219191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115824225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951077,0.00034173895,0.0000037587542,0.0011144909,0.00018982399,0.00072230014,0.00004697813,0.000013392192,0.0024598078],"genre_scores_gemma":[0.99294925,0.00017989226,0.000027383969,0.00006501831,0.00048381143,0.00006795987,0.000025259225,0.000028269382,0.006173168],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964108,0.00050505204,0.0008110814,0.00043170806,0.0012974165,0.0005439546],"domain_scores_gemma":[0.99844855,0.0003745742,0.00007928201,0.0005163016,0.00043023124,0.00015108801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00220013,0.00012751244,0.0003828345,0.00024795168,0.00016829054,0.000022684531,0.00032341763,0.00024600918,0.00053576584],"category_scores_gemma":[0.00019450535,0.00008841301,0.0002504323,0.00097498077,0.00065639213,0.000077422184,0.000105940155,0.0010798576,0.000023498453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008930819,0.00072002126,0.08628529,0.0001358115,0.00014520535,0.000033655706,0.00020237442,0.00017351453,0.8983299,0.001101923,0.00718899,0.004790203],"study_design_scores_gemma":[0.0033611162,0.00045448221,0.9519007,0.00024669108,0.000044213804,0.000005521708,0.0000267754,0.00036833814,0.040614247,0.0014665927,0.0014214489,0.000089829875],"about_ca_topic_score_codex":0.0023911612,"about_ca_topic_score_gemma":0.0006875172,"teacher_disagreement_score":0.8656154,"about_ca_system_score_codex":0.0005608248,"about_ca_system_score_gemma":0.0015698292,"threshold_uncertainty_score":0.586626},"labels":[],"label_agreement":null},{"id":"W2115961074","doi":"10.1158/1078-0432.ccr-14-1760","title":"The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Lapatinib; Medicine; Trastuzumab; Breast cancer; Oncology; Clinical trial; Internal medicine; Neoadjuvant therapy; Cancer; Clinical endpoint; Surrogate endpoint; Regimen; Hazard ratio; Confidence interval","score_opus":0.8736747486636635,"score_gpt":0.7238382028301892,"score_spread":0.14983654583347428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115961074","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20397723,0.012667488,0.044807963,0.7022912,0.014439908,0.015784657,0.0026775403,0.0002870779,0.0030669428],"genre_scores_gemma":[0.15101229,0.015918858,0.7584073,0.012064873,0.020376977,0.018484524,0.000007911376,0.0005045213,0.023222752],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.992092,0.002693349,0.0018874351,0.0007172502,0.0015670308,0.0010429425],"domain_scores_gemma":[0.8953916,0.101587705,0.00024666556,0.00095106405,0.0013600675,0.00046289593],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04894222,0.00023670313,0.0007173843,0.000060176946,0.00037848201,0.00014022841,0.0014519107,0.00028294392,0.00015881346],"category_scores_gemma":[0.05026502,0.00011897321,0.00021439782,0.00052226015,0.00096684566,0.00006206922,0.0005708784,0.0018625373,0.00003861993],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002723078,0.00040165972,0.0033664936,0.00013264423,0.0001500734,0.000006602229,0.0017636692,0.00010923847,0.000004241781,0.043612726,0.5091984,0.43853116],"study_design_scores_gemma":[0.0026094383,0.000075501164,0.0019548656,0.00018178565,0.00003259766,0.0000011594663,0.00069211685,0.011988101,0.0000780386,0.83899206,0.14316079,0.00023356211],"about_ca_topic_score_codex":0.00019385798,"about_ca_topic_score_gemma":0.0016014596,"teacher_disagreement_score":0.79537934,"about_ca_system_score_codex":0.00047933133,"about_ca_system_score_gemma":0.0027360562,"threshold_uncertainty_score":0.97931415},"labels":[],"label_agreement":null},{"id":"W2115962698","doi":"10.1158/1078-0432.ccr-07-0416","title":"Enhanced Antitumor Effect of Combined Triptolide and Ionizing Radiation","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Natural Compounds in Disease Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Triptolide; In vivo; Apoptosis; TUNEL assay; Chemistry; Pancreatic cancer; Cancer research; Propidium iodide; Programmed cell death; Molecular biology; Cancer; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.12753337280438087,"score_gpt":0.5602392752244691,"score_spread":0.4327059024200883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115962698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334735,0.0038378641,0.00003130851,0.00063610513,0.00023541397,0.0005990037,0.0000043225486,0.000026753181,0.0012819095],"genre_scores_gemma":[0.9981794,0.0008036833,0.00014043611,0.0000588032,0.00027141365,0.000031305754,0.000010783859,0.000014807552,0.00048940955],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99797434,0.00032021516,0.0004823955,0.00030342425,0.00058535585,0.00033429908],"domain_scores_gemma":[0.99645656,0.0026388206,0.00008298774,0.00027971872,0.00025327993,0.00028864213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041337954,0.000100051235,0.00043023855,0.00021751318,0.0000828092,0.000012345684,0.000088430366,0.00010281101,0.000120619734],"category_scores_gemma":[0.0019118437,0.00007274035,0.00011248761,0.0004866085,0.0003405577,0.00004754986,0.00007778178,0.00051773083,0.000011924924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023091352,0.0005853652,0.40194756,0.00060587004,0.0003016484,0.00017020247,0.00009434975,0.0000012745244,0.03863956,0.00031155048,0.002468393,0.53178287],"study_design_scores_gemma":[0.011140582,0.0049416474,0.7508595,0.0003383622,0.000121324454,0.0000055014566,0.000024395047,0.000074306095,0.23141609,0.00018990145,0.0007806177,0.0001077917],"about_ca_topic_score_codex":0.000099075005,"about_ca_topic_score_gemma":0.000018615843,"teacher_disagreement_score":0.5316751,"about_ca_system_score_codex":0.00018944927,"about_ca_system_score_gemma":0.00015617015,"threshold_uncertainty_score":0.29662654},"labels":[],"label_agreement":null},{"id":"W2115999357","doi":"10.1158/1078-0432.ccr-11-2599","title":"Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Oncology; Estrogen receptor; Medicine; Internal medicine; Young adult; Gene expression profiling; Proportional hazards model; Cancer; Adjuvant; Gene expression; Biology; Cancer research; Gene; Genetics","score_opus":0.21047814094491935,"score_gpt":0.5165689887103124,"score_spread":0.3060908477653931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115999357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916084,0.007550309,0.00007354495,0.00015700019,0.0001843603,0.00028453735,0.00007674211,0.000005554237,0.000059592283],"genre_scores_gemma":[0.9948168,0.0026668685,0.0014511141,0.000026352565,0.00069301366,0.00029631407,0.000012962912,0.000024911009,0.000011704795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978674,0.00038533588,0.00045292694,0.0004429342,0.00016558911,0.00068579224],"domain_scores_gemma":[0.9991619,0.0001330287,0.0001305582,0.00021641163,0.00020891982,0.00014917813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017751986,0.00014097961,0.00031560232,0.00009503579,0.00012863845,0.000012935742,0.00014136282,0.00019288692,0.00003138441],"category_scores_gemma":[0.00024286997,0.000119785414,0.000049446164,0.00023359105,0.00040748616,0.000014247045,0.0004564987,0.00029054694,6.602105e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024919907,0.00011233283,0.6828215,0.000044581015,0.00004673393,3.4531737e-7,0.00019797107,0.0000091384945,0.3081184,0.000004959645,0.000013332592,0.008381476],"study_design_scores_gemma":[0.0012391426,0.00012981161,0.6314589,0.0002319484,0.000018084398,0.000009401028,0.00066540815,0.00006448018,0.36583236,0.00004930946,0.0001090908,0.00019206398],"about_ca_topic_score_codex":0.0015557015,"about_ca_topic_score_gemma":0.00018403672,"teacher_disagreement_score":0.05771395,"about_ca_system_score_codex":0.00015095934,"about_ca_system_score_gemma":0.00020756946,"threshold_uncertainty_score":0.48847073},"labels":[],"label_agreement":null},{"id":"W2116138223","doi":"10.1158/1078-0432.ccr-12-1983","title":"<i>p53 Arg72Pro</i> Polymorphism, HPV Status and Initiation, Progression, and Development of Cervical Cancer: A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cervical cancer; Medicine; Meta-analysis; Oncology; Internal medicine; Odds ratio; Allele; Cervical intraepithelial neoplasia; Cancer; Cancer research; Biology; Gene; Genetics","score_opus":0.5859377676565747,"score_gpt":0.6116006165596907,"score_spread":0.025662848903115987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116138223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016438562,0.99178636,0.0000074801046,0.001070919,0.00004454893,0.006378683,0.00027130736,0.000025601494,0.00039867056],"genre_scores_gemma":[0.000439928,0.99217236,0.00027800121,0.0005063797,0.0002158707,0.005657172,0.00012202949,0.00008497013,0.0005232832],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9891506,0.0025270341,0.0036039397,0.0013042762,0.0022304356,0.0011837423],"domain_scores_gemma":[0.9919896,0.0027962974,0.0008454253,0.0010035868,0.0016760175,0.0016890526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0102091525,0.00064638676,0.012258555,0.00075700146,0.0002849222,0.00009505322,0.0003759697,0.0006261922,0.0058626053],"category_scores_gemma":[0.0014688334,0.00038996,0.0011336834,0.00222676,0.0011604453,0.00012737248,0.0009622313,0.002252733,0.000019733967],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007577023,0.00018691842,0.00056123803,0.7177188,0.040702235,0.0000081834,0.000097050804,8.116578e-9,4.050163e-8,0.000037804508,0.0002296103,0.24038234],"study_design_scores_gemma":[0.0010119895,0.00035671142,0.002114616,0.0330674,0.6904123,0.000026402866,0.000043906974,0.0000033024935,0.0000019336758,0.000025133226,0.27236316,0.00057318475],"about_ca_topic_score_codex":0.00033426264,"about_ca_topic_score_gemma":0.0004529621,"teacher_disagreement_score":0.6846514,"about_ca_system_score_codex":0.00035259104,"about_ca_system_score_gemma":0.0037257804,"threshold_uncertainty_score":0.9998552},"labels":[],"label_agreement":null},{"id":"W2116145684","doi":"10.1158/1078-0432.ccr-07-4959","title":"Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from <i>BRCA</i> Mutation Carriers Resemble High-Grade Serous Carcinoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"University Health Network","keywords":"Luteal phase; Biology; Serous carcinoma; Cancer research; Follicular phase; Pathology; Ovarian cancer; Internal medicine; Endocrinology; Genetics; Medicine; Cancer","score_opus":0.1903665756927608,"score_gpt":0.47073682850195914,"score_spread":0.28037025280919836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116145684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004626,0.0032410224,0.00003343015,0.004013187,0.0005092078,0.0011925017,0.00054236193,0.000046563742,0.0003754586],"genre_scores_gemma":[0.99206614,0.0032834874,0.0016724317,0.00024029904,0.0012468101,0.00053256715,0.0002585186,0.000059603415,0.00064014335],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99566007,0.0005951289,0.00093043543,0.0008601764,0.00130595,0.0006482566],"domain_scores_gemma":[0.9968447,0.0008920353,0.00018863156,0.00083597575,0.00062536635,0.0006133085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009915067,0.00024108854,0.0007755364,0.00019370379,0.00027468003,0.000020490628,0.00027527087,0.00029352534,0.0005366869],"category_scores_gemma":[0.00041355225,0.00019149823,0.00025682274,0.00051017967,0.00065440615,0.00012205421,0.00015416696,0.00081202906,0.000040171923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008463865,0.005972096,0.8170025,0.00035773334,0.00070745713,0.0025650302,0.0019963619,0.00007193226,0.07144038,0.00010222757,0.06241592,0.028904503],"study_design_scores_gemma":[0.022128569,0.0039643566,0.3403264,0.0005034934,0.00019277364,0.000030764608,0.00033337303,0.00018568824,0.62573475,0.00031790955,0.005985234,0.00029672042],"about_ca_topic_score_codex":0.011972283,"about_ca_topic_score_gemma":0.00032986168,"teacher_disagreement_score":0.55429435,"about_ca_system_score_codex":0.0004156101,"about_ca_system_score_gemma":0.0014517843,"threshold_uncertainty_score":0.9946071},"labels":[],"label_agreement":null},{"id":"W2116456322","doi":"10.1158/1078-0432.ccr-08-1708","title":"Preferential Killing of Breast Tumor Initiating Cells by <i>N,N</i> -Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Immunovaccine (Canada); University Health Network","funders":"","keywords":"CD44; CD24; Flow cytometry; Breast cancer; Doxorubicin; Medicine; Cancer research; In vitro; Cytotoxic T cell; Transplantation; Apoptosis; Mammary gland; Internal medicine; Cancer; Immunology; Oncology; Chemotherapy; Chemistry; Biochemistry","score_opus":0.183836946052417,"score_gpt":0.45905721270477623,"score_spread":0.2752202666523592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116456322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367083,0.011643246,0.00008821032,0.0010113359,0.00067693176,0.0008364083,0.00019609426,0.00008175996,0.0017951532],"genre_scores_gemma":[0.97941846,0.014589204,0.0003390796,0.00049388135,0.0023116136,0.00015455742,0.000057498204,0.00010612251,0.0025295955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99359703,0.0011305519,0.0016420818,0.00088405533,0.0016386925,0.0011075739],"domain_scores_gemma":[0.9946491,0.0023522535,0.0003672355,0.0009124311,0.0011105908,0.0006083787],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032993997,0.00035084723,0.0012312875,0.00028291417,0.00036096026,0.000028578155,0.0005248791,0.00031657115,0.0010105859],"category_scores_gemma":[0.0012173767,0.00031445653,0.00049765856,0.0008753545,0.0017073125,0.0001527142,0.00026435975,0.0018741039,0.00007463332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03726332,0.0065270043,0.15819514,0.0030991193,0.0014419868,0.00069814397,0.0025984643,0.000101076585,0.43390888,0.000060315484,0.18689123,0.16921535],"study_design_scores_gemma":[0.031621642,0.011966817,0.18065043,0.005763499,0.0007991463,0.0011199852,0.003425371,0.0028812764,0.52185065,0.00024779953,0.23706456,0.0026088224],"about_ca_topic_score_codex":0.0023500503,"about_ca_topic_score_gemma":0.000085223815,"teacher_disagreement_score":0.16660653,"about_ca_system_score_codex":0.00022377713,"about_ca_system_score_gemma":0.001752189,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W2116561474","doi":"10.1158/1078-0432.ccr-14-2391","title":"Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Canadian Institutes of Health Research; European Hematology Association","keywords":"Primary tumor; Somatic evolution in cancer; Metastasis; Mutation; Mutation frequency; Biology; Cancer research; Somatic cell; Germline mutation; Gene; Cancer; Genetics","score_opus":0.37024928076093,"score_gpt":0.4846348879119194,"score_spread":0.11438560715098939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116561474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738157,0.0017050775,0.000054431293,0.00010628998,0.00007918993,0.00049578823,0.000025855556,0.000003301112,0.00014852689],"genre_scores_gemma":[0.9990165,0.00016534691,0.00039244886,0.000059459417,0.000171521,0.00010254043,0.000022184573,0.000014226116,0.000055737826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806476,0.00046783185,0.0005237759,0.0003674157,0.0003326578,0.00024357699],"domain_scores_gemma":[0.99853736,0.00053061853,0.000112704896,0.00022301689,0.0004447061,0.00015157247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033014868,0.00008571011,0.00024290851,0.000089491856,0.000040972864,0.000017445105,0.00013422662,0.00006972963,0.0000032186265],"category_scores_gemma":[0.004113217,0.00008306506,0.00003125668,0.00028825933,0.0001856199,0.0000048612906,0.00020517445,0.00022794811,0.0000013793717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015702875,0.0013391001,0.938686,0.00015219687,0.000082846884,0.00006230723,0.0005556591,0.0009947363,0.034578517,0.000070217655,0.0015806082,0.02032749],"study_design_scores_gemma":[0.0042244517,0.0041194786,0.9865784,0.000092520015,0.00002783488,0.00000869203,0.0017590208,0.00068028935,0.0007673549,0.0013742311,0.00019298149,0.00017476601],"about_ca_topic_score_codex":0.0016588806,"about_ca_topic_score_gemma":0.0010098636,"teacher_disagreement_score":0.047892347,"about_ca_system_score_codex":0.00009923692,"about_ca_system_score_gemma":0.00075602886,"threshold_uncertainty_score":0.49242023},"labels":[],"label_agreement":null},{"id":"W2116636243","doi":"10.1158/1078-0432.ccr-0734-04","title":"The Effects of Standard Anthracycline-Based Chemotherapy on Soluble ICAM-1 and Vascular Endothelial Growth Factor Levels in Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Aging","keywords":"Chemotherapy; Von Willebrand factor; Breast cancer; Internal medicine; Vascular endothelial growth factor; Medicine; Anthracycline; Endocrinology; Cancer; Gastroenterology; Oncology; VEGF receptors; Platelet","score_opus":0.08710551742658029,"score_gpt":0.47499468835298125,"score_spread":0.38788917092640096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116636243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791275,0.0017693428,0.000045306988,0.017136266,0.00022357775,0.0014650847,0.00010809697,0.00002050319,0.00010430684],"genre_scores_gemma":[0.9823402,0.01609421,0.00008095073,0.0006119803,0.00033531824,0.00024013751,0.000002707082,0.000058887694,0.0002356159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995369,0.000628515,0.0006743596,0.00062880415,0.0018967703,0.0008025431],"domain_scores_gemma":[0.99339205,0.0048001283,0.000094187875,0.0006158317,0.0006809214,0.0004168782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027447338,0.00020677866,0.00063446455,0.00018861149,0.00019176667,0.000049547507,0.0003649377,0.00022347622,0.0003437854],"category_scores_gemma":[0.002645247,0.00013425571,0.00021892566,0.0006415576,0.001301909,0.000047170786,0.00014158624,0.0015467786,0.000013673124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029646466,0.0031268632,0.49576935,0.002661931,0.0005496192,0.00035814205,0.00045044936,0.000073709176,0.17578764,0.0004786262,0.0026937758,0.28840345],"study_design_scores_gemma":[0.028414456,0.0031839798,0.74946827,0.0015517791,0.000027285698,0.0000035254777,0.00005492046,0.00013230051,0.2104291,0.0005652656,0.005924459,0.00024464115],"about_ca_topic_score_codex":0.002039126,"about_ca_topic_score_gemma":0.00050857326,"teacher_disagreement_score":0.2881588,"about_ca_system_score_codex":0.00050373364,"about_ca_system_score_gemma":0.001818902,"threshold_uncertainty_score":0.67200696},"labels":[],"label_agreement":null},{"id":"W2116725504","doi":"10.1158/1078-0432.ccr-08-1002","title":"Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Hsp90 inhibitor; Melanoma; Kinase; Medicine; Protein kinase B; MAPK/ERK pathway; Cancer research; Heat shock protein; V600E; Cancer; Hsp90; Internal medicine; Biology; Mutation; Phosphorylation; Biochemistry","score_opus":0.1834560186482281,"score_gpt":0.5047167894168516,"score_spread":0.32126077076862347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116725504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963282,0.00042409656,0.00010527955,0.00027593377,0.00007219666,0.0016358896,0.00006562691,0.000004979451,0.0010878252],"genre_scores_gemma":[0.99548256,0.00048412773,0.0007481125,0.00006694684,0.0002516363,0.00035396754,0.000077241486,0.000038212267,0.002497193],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99518037,0.0013885158,0.0008635189,0.00069204665,0.0011395739,0.00073599257],"domain_scores_gemma":[0.9977727,0.0003505478,0.00010310311,0.0007761238,0.000699296,0.00029821313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004071217,0.00017892227,0.00050724956,0.00023180588,0.00016960799,0.000010638149,0.00057487533,0.00022403104,0.00027795593],"category_scores_gemma":[0.002331599,0.00014246443,0.0001413788,0.00061246677,0.0008034835,0.000009429969,0.0004825129,0.0008262851,0.000009855595],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52750957,0.041377462,0.21577497,0.00035296814,0.0010029292,0.0003141878,0.00045772546,0.00013175535,0.061499413,0.0000758143,0.050677557,0.10082566],"study_design_scores_gemma":[0.545384,0.1792063,0.080710374,0.00025493596,0.000056383997,0.0000074238133,0.00013121692,0.0001643078,0.13505879,0.00017433363,0.057828914,0.0010230669],"about_ca_topic_score_codex":0.00042180266,"about_ca_topic_score_gemma":0.00045787002,"teacher_disagreement_score":0.13782883,"about_ca_system_score_codex":0.000072170595,"about_ca_system_score_gemma":0.0013108063,"threshold_uncertainty_score":0.58095306},"labels":[],"label_agreement":null},{"id":"W2116773250","doi":"10.1158/1078-0432.ccr-07-4713","title":"Comparison of Nomograms With Other Methods for Predicting Outcomes in Prostate Cancer: A Critical Analysis of the Literature","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Prostate cancer; Medicine; Oncology; Cancer; Prostate; Internal medicine","score_opus":0.45754472748798086,"score_gpt":0.6962229096126618,"score_spread":0.2386781821246809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116773250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022603604,0.9914031,0.0000266939,0.0007721031,0.00018537673,0.0040351725,0.001259165,0.000010208718,0.0000478277],"genre_scores_gemma":[0.0019294353,0.9907389,0.0020493255,0.000057254005,0.0001316018,0.004779297,0.000065818436,0.000066672874,0.0001816531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944408,0.0014201067,0.0020153748,0.0007718167,0.0007558445,0.0005960577],"domain_scores_gemma":[0.9886384,0.008683953,0.0005898166,0.0008545761,0.0010229297,0.00021031128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002481753,0.00036357323,0.005224968,0.00055817585,0.00009249697,0.000024815665,0.00039333102,0.00035908425,0.000053336473],"category_scores_gemma":[0.0020189362,0.00017900215,0.0016435941,0.0035658458,0.0010306425,0.00003991869,0.00016681118,0.0015912931,3.385895e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003630575,0.0009202328,0.45928437,0.010968154,0.0036343387,0.000006499877,0.0003467532,0.000008874661,1.7071041e-7,0.000023731052,0.00018470758,0.5242591],"study_design_scores_gemma":[0.0041771815,0.0036298996,0.04241997,0.10413602,0.017419567,0.000007125463,0.00019611494,0.000410206,0.000055572225,0.000045230183,0.82704556,0.0004575688],"about_ca_topic_score_codex":0.0010238667,"about_ca_topic_score_gemma":0.0009415358,"teacher_disagreement_score":0.82686085,"about_ca_system_score_codex":0.0004604183,"about_ca_system_score_gemma":0.0020920031,"threshold_uncertainty_score":0.7299496},"labels":[],"label_agreement":null},{"id":"W2116831767","doi":"10.1158/1078-0432.ccr-09-1961","title":"Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Clinical trial; Medicine; Clinical study design; Population; Drug development; Investigational Drugs; Phases of clinical research; Patient safety; Intensive care medicine; Medical physics; Drug; Oncology; Pharmacology; Internal medicine; Health care","score_opus":0.9461285919310349,"score_gpt":0.6823623987532028,"score_spread":0.2637661931778321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116831767","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8349006,0.0000889661,0.1237226,0.014969151,0.01099216,0.014225092,0.00077038957,0.00010060667,0.00023044617],"genre_scores_gemma":[0.46026346,0.00012115963,0.526312,0.0013875957,0.008810285,0.0027317237,0.000028406326,0.00012100321,0.00022438452],"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9669268,0.019928068,0.007330248,0.0016004979,0.003449702,0.0007646853],"domain_scores_gemma":[0.63078904,0.3625194,0.0020937712,0.0017514935,0.0019644431,0.0008818351],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08384932,0.00042648168,0.0016278806,0.00014298798,0.0007671227,0.00016684132,0.0015559503,0.0007401212,0.00022389548],"category_scores_gemma":[0.56797373,0.0002660551,0.0005950127,0.0013745348,0.0036540248,0.00014471619,0.0008276859,0.0044926843,0.000013253789],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6702516,0.010222118,0.009353511,0.0000905517,0.0010107826,0.000028009257,0.0005926752,0.0015431251,0.0001660646,0.044744164,0.08223962,0.17975776],"study_design_scores_gemma":[0.2471476,0.010076497,0.01582357,0.00065408123,0.0005130778,0.0000053485637,0.00006326619,0.015563207,0.0004889071,0.7013312,0.00746499,0.0008682408],"about_ca_topic_score_codex":0.00033489257,"about_ca_topic_score_gemma":0.00053771574,"teacher_disagreement_score":0.65658706,"about_ca_system_score_codex":0.00020593913,"about_ca_system_score_gemma":0.0042982525,"threshold_uncertainty_score":0.99997914},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2116871245","doi":"10.1158/1078-0432.ccr-06-1805","title":"Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Melanoma; Medicine; Proinflammatory cytokine; Immunology; Vascular endothelial growth factor; Tumor necrosis factor alpha; Interferon; Macrophage inflammatory protein; Chemokine; Hepatocyte growth factor; Internal medicine; Cancer research; Inflammation; Receptor","score_opus":0.09514980259824807,"score_gpt":0.4932633248787742,"score_spread":0.39811352228052616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116871245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984491,0.00006624015,0.00083135575,0.00008983746,0.00001056894,0.00023268143,0.000060955063,0.000008475648,0.0002508003],"genre_scores_gemma":[0.9984263,0.0001986946,0.0010109917,0.000045110155,0.000052705367,0.000024155106,0.00008086775,0.000012380998,0.00014879441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987489,0.00008363179,0.0003816445,0.00034355937,0.00018138404,0.00026089905],"domain_scores_gemma":[0.99901426,0.000104799255,0.00008003599,0.00036232235,0.0003618538,0.0000767433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007875531,0.00008236486,0.00021738552,0.0001810239,0.00003602263,0.0000058570927,0.00018439947,0.00013355484,0.000016891545],"category_scores_gemma":[0.00014297695,0.00006335645,0.0000850043,0.00086890603,0.00026976166,0.0000023877951,0.00011988424,0.00019494971,0.0000010093411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007167445,0.00026049634,0.9549034,0.0000070096135,0.00014482408,0.000002217061,0.000009789902,0.000033073913,0.020491831,0.00001989518,0.0001481446,0.023262564],"study_design_scores_gemma":[0.00068933005,0.00092311227,0.8865474,0.000025086132,0.00004049934,1.7687371e-7,0.000027744421,0.00014054887,0.108359635,0.000020784059,0.0031252992,0.0001003903],"about_ca_topic_score_codex":0.00030397132,"about_ca_topic_score_gemma":0.0040828628,"teacher_disagreement_score":0.087867804,"about_ca_system_score_codex":0.000030697618,"about_ca_system_score_gemma":0.000047987316,"threshold_uncertainty_score":0.2583601},"labels":[],"label_agreement":null},{"id":"W2116985652","doi":"10.1158/1078-0432.ccr-10-3113","title":"Occult Tumor Burden Predicts Disease Recurrence in Lymph Node–Negative Colorectal Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Colorectal cancer; Occult; Internal medicine; Lymph node; Oncology; Histopathology; Cancer; Proportional hazards model; Gastroenterology; Primary tumor; Metastasis; Pathology","score_opus":0.28136083719521043,"score_gpt":0.5074077404730899,"score_spread":0.22604690327787946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116985652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820234,0.002735624,0.0000021107041,0.0015463058,0.00076622854,0.0017379655,0.0002522723,0.00009116347,0.01084493],"genre_scores_gemma":[0.9920819,0.0027198503,0.00015756034,0.00039343606,0.0008408728,0.0026135955,0.00002010411,0.00005779862,0.001114928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434626,0.00082819554,0.00095260603,0.0012426358,0.0014554838,0.0011748251],"domain_scores_gemma":[0.9956072,0.0014268397,0.00015209394,0.00057956803,0.0008135056,0.0014208187],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018968543,0.00033767323,0.0008479334,0.00029054156,0.00015395308,0.000034027682,0.0005000248,0.00021034734,0.0042089084],"category_scores_gemma":[0.003726715,0.00027310385,0.0002943252,0.0014880308,0.0012613911,0.0001853888,0.00043270088,0.0014323555,0.00027337152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01832006,0.0011165057,0.949512,0.00017202576,0.00016068765,0.0014295375,0.00074061635,0.0000074618524,0.000052655058,0.00005553768,0.0016120797,0.026820855],"study_design_scores_gemma":[0.00650276,0.00093568634,0.98669684,0.0010836817,0.00008973599,0.000007307521,0.0001598726,0.00054717023,0.00076927285,0.0006901873,0.0022296996,0.000287809],"about_ca_topic_score_codex":0.009404611,"about_ca_topic_score_gemma":0.0011494379,"teacher_disagreement_score":0.03718484,"about_ca_system_score_codex":0.0015133789,"about_ca_system_score_gemma":0.003062958,"threshold_uncertainty_score":0.9999721},"labels":[],"label_agreement":null},{"id":"W2117327517","doi":"10.1158/1078-0432.ccr-07-1720","title":"Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Lymphoma; International Prognostic Index; Oncology; Medicine; Gene expression profiling; Follicular phase; Internal medicine; Gene; Bioinformatics; Gene expression; Biology; Diffuse large B-cell lymphoma; Genetics","score_opus":0.3324872493807791,"score_gpt":0.5375851220581682,"score_spread":0.2050978726773891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117327517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949063,0.0022612752,0.000007826139,0.0012288338,0.00022442732,0.0006058487,0.000025226667,0.000031785665,0.00070844224],"genre_scores_gemma":[0.9968222,0.0015360729,0.00023308696,0.00041228585,0.00034918095,0.00019235103,0.000016508286,0.000030787265,0.00040757033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969798,0.0003875457,0.0007543994,0.0005531033,0.0007434678,0.00058168673],"domain_scores_gemma":[0.99784154,0.0011164601,0.000086861735,0.00037749545,0.00023954203,0.00033810103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001447413,0.00015483708,0.00053905934,0.00016347475,0.00017204038,0.000018721657,0.00014415882,0.00017332274,0.0001919412],"category_scores_gemma":[0.0010990072,0.000122035635,0.00021440558,0.00046857636,0.00030937965,0.00009773427,0.00016451617,0.0004138619,0.000054879565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050082477,0.0012869905,0.9801317,0.000025670055,0.00012909636,0.0009905975,0.0001786006,0.000009402444,0.00032180533,0.0000040116142,0.0020257619,0.014395579],"study_design_scores_gemma":[0.00904887,0.00069446326,0.9785145,0.00027291957,0.000051476913,0.00009749726,0.0002037728,0.0019171179,0.0042523635,0.00002305792,0.004767348,0.00015662938],"about_ca_topic_score_codex":0.0052684415,"about_ca_topic_score_gemma":0.00013182031,"teacher_disagreement_score":0.014238949,"about_ca_system_score_codex":0.0012875709,"about_ca_system_score_gemma":0.00063589844,"threshold_uncertainty_score":0.7964343},"labels":[],"label_agreement":null},{"id":"W2117384590","doi":"10.1158/1078-0432.ccr-04-2346","title":"The Farnesyltransferase Inhibitor L744832 Potentiates UCN-01–Induced Apoptosis in Human Multiple Myeloma Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Farnesyltransferase; Protein kinase B; Apoptosis; Cancer research; Signal transduction; Farnesyltransferase inhibitor; STAT3; Biology; Chemistry; Cell biology; Biochemistry","score_opus":0.18401171325008112,"score_gpt":0.49324428906053913,"score_spread":0.30923257581045804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117384590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866749,0.0011687832,0.000004844135,0.008831529,0.00026204195,0.0018025225,0.00003932505,0.000064445485,0.0011516128],"genre_scores_gemma":[0.9927191,0.0024001943,0.00014332627,0.0002499111,0.001283699,0.0006615062,0.000035958357,0.00006829369,0.0024379888],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937594,0.0010498381,0.0010894975,0.00087627536,0.0016373699,0.0015876497],"domain_scores_gemma":[0.9947916,0.002839431,0.000072218514,0.0009152366,0.00048898725,0.00089252164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040251655,0.00029519212,0.0006087547,0.00033056474,0.00077248906,0.00016010606,0.0005505776,0.00031466602,0.0006219034],"category_scores_gemma":[0.0016203847,0.00019717438,0.00035203338,0.00085839763,0.00071453856,0.00015495162,0.00024520326,0.0021294316,0.00046788578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058537875,0.0036244793,0.31820276,0.00019192007,0.00046503393,0.00027786675,0.0003435527,0.000019892625,0.19308877,0.00011814447,0.009946943,0.46786687],"study_design_scores_gemma":[0.026023624,0.0029835775,0.4089119,0.00056600873,0.00007616834,0.000009918195,0.00061763666,0.0020818082,0.5026648,0.00022277575,0.05525532,0.0005864075],"about_ca_topic_score_codex":0.0025411474,"about_ca_topic_score_gemma":0.0049118567,"teacher_disagreement_score":0.46728045,"about_ca_system_score_codex":0.0005174503,"about_ca_system_score_gemma":0.0006320519,"threshold_uncertainty_score":0.9251439},"labels":[],"label_agreement":null},{"id":"W2117535432","doi":"10.1158/1078-0432.ccr-13-0954","title":"The Mechanism of DAB2IP in Chemoresistance of Prostate Cancer Cells","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Clusterin; Gene knockdown; Cancer research; Prostate cancer; Prostate; Biology; Wnt signaling pathway; Cancer; Cell culture; Apoptosis; Molecular biology; Medicine; Cell biology; Signal transduction; Internal medicine","score_opus":0.18366842598862074,"score_gpt":0.5351700505050089,"score_spread":0.3515016245163881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117535432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897207,0.0025583224,0.0000038675043,0.00490522,0.00028800176,0.0011841219,0.00004424617,0.0000083691075,0.0012871511],"genre_scores_gemma":[0.9907094,0.005713732,0.00012052501,0.00016017492,0.00014529997,0.00065304793,0.0000020039258,0.000022753875,0.0024730111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973522,0.00038618917,0.0008347374,0.00033622037,0.00062158477,0.00046908014],"domain_scores_gemma":[0.9968336,0.0014614904,0.00015815947,0.00063951104,0.0007269487,0.00018028205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025148222,0.000096154574,0.00044936384,0.00009396595,0.00004802654,0.000009144936,0.00034767378,0.00012813158,0.0008249108],"category_scores_gemma":[0.0010619657,0.00006415158,0.00011218899,0.00044042876,0.0010999687,0.000036267327,0.00026888947,0.0006627974,0.000034590088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010889586,0.0021533757,0.49979153,0.003220415,0.0003131129,0.00017101702,0.0016479904,0.00005356825,0.29930598,0.0040968317,0.058522027,0.11983457],"study_design_scores_gemma":[0.0067496398,0.001186308,0.7831887,0.0013905847,0.00006375842,0.0000037886468,0.00074598734,0.0010703144,0.18724707,0.012875426,0.0052139377,0.000264472],"about_ca_topic_score_codex":0.0022151503,"about_ca_topic_score_gemma":0.0008984681,"teacher_disagreement_score":0.28339717,"about_ca_system_score_codex":0.0001255156,"about_ca_system_score_gemma":0.00069700764,"threshold_uncertainty_score":0.9032195},"labels":[],"label_agreement":null},{"id":"W2117677224","doi":"10.1158/1078-0432.ccr-09-1510","title":"Functional Imaging Using Diffuse Optical Spectroscopy of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Chemotherapy; Cancer; Oncology; Functional imaging; Diffuse optical imaging; Radiology; Internal medicine; Tomography","score_opus":0.05943641004008538,"score_gpt":0.48496892865497554,"score_spread":0.42553251861489017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117677224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98513234,0.00019556304,0.001018857,0.012512469,0.00017382352,0.0005824187,0.00002376968,0.0000795907,0.00028118386],"genre_scores_gemma":[0.9843564,0.00044040367,0.013612292,0.0007533855,0.0004026915,0.00019546127,0.0000018642895,0.00006825931,0.00016922335],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964027,0.00026156858,0.0007187013,0.00067959225,0.0009786284,0.0009588419],"domain_scores_gemma":[0.9972693,0.0008689658,0.00010223101,0.0005881736,0.0006713287,0.00050003425],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034432465,0.00022869317,0.000699867,0.00032370692,0.00009389441,0.00004419811,0.00023838805,0.00016732748,0.0009140599],"category_scores_gemma":[0.00058394525,0.00017298816,0.0000969885,0.0007444339,0.0016649766,0.000147955,0.00010696803,0.002545246,0.000006032817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093546815,0.0012899039,0.17646237,0.00007641205,0.000059406768,0.00011814778,0.00011384594,0.000024581288,0.7025582,0.00011381584,0.00032719897,0.025309276],"study_design_scores_gemma":[0.011014011,0.002207396,0.89328676,0.001061925,0.000033231427,0.000112179856,0.00022916697,0.004609501,0.08586978,0.00051734695,0.00070471765,0.00035399577],"about_ca_topic_score_codex":0.0004895628,"about_ca_topic_score_gemma":0.000106569394,"teacher_disagreement_score":0.71682435,"about_ca_system_score_codex":0.00055886497,"about_ca_system_score_gemma":0.0018289632,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W2117679726","doi":"10.1158/1078-0432.ccr-06-0158","title":"<i>CHEK2</i>-Positive Breast Cancers in Young Polish Women","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"CHEK2; Breast cancer; Odds ratio; Internal medicine; Population; Medicine; Oncology; Cancer; Mutation; Biology; Germline mutation; Genetics; Gene","score_opus":0.05196128539755703,"score_gpt":0.45219154977863046,"score_spread":0.40023026438107345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117679726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98337793,0.001503515,0.000037272912,0.0011791786,0.0004578519,0.00033647096,0.00019876198,0.000012530622,0.012896496],"genre_scores_gemma":[0.99316186,0.00082402694,0.000112613154,0.0003310115,0.0018451576,0.0005163669,0.00007537142,0.000039756735,0.003093838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717003,0.0004172043,0.00048954174,0.00068677973,0.0004321324,0.00080429675],"domain_scores_gemma":[0.9987877,0.000117364056,0.00006895136,0.000465059,0.00039722314,0.00016368167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018965692,0.00014936691,0.00022913778,0.00012287636,0.000120430064,0.000053993957,0.00042118676,0.00026892853,0.00022649676],"category_scores_gemma":[0.00018586917,0.0001533161,0.00009451281,0.00053948566,0.00058046484,0.000008126746,0.00025136903,0.00058811845,0.00003286611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020696113,0.0005658267,0.7428844,0.00007054207,0.0002069951,0.000048862632,0.0005501121,0.002022737,0.04898233,0.0005393119,0.167952,0.034107253],"study_design_scores_gemma":[0.0040193973,0.00070329563,0.87533003,0.000119825534,0.000014669705,0.00003563214,0.0010004204,0.00016059067,0.022763545,0.0018482144,0.09328623,0.00071816647],"about_ca_topic_score_codex":0.01030187,"about_ca_topic_score_gemma":0.016293421,"teacher_disagreement_score":0.13244559,"about_ca_system_score_codex":0.0013730392,"about_ca_system_score_gemma":0.0019339477,"threshold_uncertainty_score":0.9962886},"labels":[],"label_agreement":null},{"id":"W2117701024","doi":"10.1158/1078-0432.ccr-07-1310","title":"A Phase I Study of OGX-011, a 2′-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University Health Network; BC Cancer Agency","funders":"","keywords":"Clusterin; Docetaxel; Medicine; Internal medicine; Pharmacology; Cancer; Chills; Peripheral blood mononuclear cell; Pharmacokinetics; Oncology; Apoptosis; Biology; In vitro","score_opus":0.17631573474176207,"score_gpt":0.5407528954729974,"score_spread":0.36443716073123533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117701024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941574,0.0002742197,0.000023710802,0.00071494473,0.00012555979,0.0045223655,0.00004580165,0.000022545784,0.00011349225],"genre_scores_gemma":[0.9973551,0.00028274508,0.00049347593,0.00028700032,0.00004799035,0.0013030993,0.000012494347,0.000056152337,0.00016191603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954565,0.00086810114,0.0009850994,0.0008428304,0.0011915795,0.0006558895],"domain_scores_gemma":[0.9971439,0.0006133126,0.0001787553,0.00069999695,0.0009809928,0.00038300932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016987285,0.00023102337,0.00092755666,0.0005733205,0.00007155329,0.000008959781,0.00025402757,0.00014074723,0.000160267],"category_scores_gemma":[0.00093003456,0.00018036074,0.000054515607,0.0017485026,0.00053744775,0.000109170134,0.0002644044,0.0009863955,0.000009502572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057596367,0.017517667,0.90121996,0.00016276423,0.00006325943,0.0007075019,0.0020586562,0.00026087285,0.00024296838,0.0000017273893,0.00017354403,0.019994728],"study_design_scores_gemma":[0.075821295,0.024988567,0.897199,0.00063920644,0.000033459353,0.0000064029036,0.0004897701,0.00016992698,0.00030944915,0.0000086952805,0.0001419424,0.0001923292],"about_ca_topic_score_codex":0.0022953537,"about_ca_topic_score_gemma":0.0046852985,"teacher_disagreement_score":0.019802399,"about_ca_system_score_codex":0.00042358963,"about_ca_system_score_gemma":0.0007619981,"threshold_uncertainty_score":0.7354897},"labels":[],"label_agreement":null},{"id":"W2117783793","doi":"10.1158/1078-0432.ccr-07-1036","title":"A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Celgene; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Nomogram; Internal medicine; Hazard ratio; Prostate cancer; Proportional hazards model; Oncology; Docetaxel; Prostate-specific antigen; Multivariate analysis; Urology; Performance status; Mitoxantrone; Cancer; Gastroenterology; Chemotherapy; Confidence interval","score_opus":0.28410465965835746,"score_gpt":0.5593244166085639,"score_spread":0.27521975695020645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117783793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96198565,0.019051963,0.00023431769,0.0027345866,0.000100168516,0.013505388,0.000278416,0.00011914864,0.0019903712],"genre_scores_gemma":[0.9813671,0.003157349,0.00040076996,0.00014261923,0.0004382119,0.0066077067,0.00015216965,0.00009592705,0.007638125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933768,0.0006202278,0.0012011306,0.0012623715,0.0020108717,0.0015286183],"domain_scores_gemma":[0.9927779,0.0030844985,0.00025156612,0.00084646087,0.0019876133,0.0010520058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009598349,0.00038394477,0.00135294,0.00097231375,0.00041067105,0.00012341265,0.0003987309,0.0001523515,0.00017942543],"category_scores_gemma":[0.0008574719,0.0002483829,0.0004541868,0.0034488805,0.0009791956,0.00019483383,0.00018403394,0.0014066944,0.000022110697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037420366,0.00524957,0.8946458,0.00031728676,0.008968579,0.0008726385,0.0010919853,0.000012674978,0.0002046936,0.000007751049,0.013009553,0.038199067],"study_design_scores_gemma":[0.03619597,0.034786556,0.884329,0.00033715408,0.0042898413,0.0000065729964,0.0068845325,0.0007386583,0.00031963238,0.00008844836,0.03139326,0.00063034106],"about_ca_topic_score_codex":0.0039485255,"about_ca_topic_score_gemma":0.0023812347,"teacher_disagreement_score":0.03756873,"about_ca_system_score_codex":0.0006580883,"about_ca_system_score_gemma":0.0034809855,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W2117857186","doi":"10.1158/1078-0432.ccr-14-1108","title":"Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Prostate Cancer Canada; Prostate Cancer Foundation","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; splice; Cancer research; Cancer; Oligonucleotide; Biology; Medicine; Cell growth; Prostate; Internal medicine; Genetics; Gene","score_opus":0.2523537678405155,"score_gpt":0.4732531516307663,"score_spread":0.22089938379025081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117857186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380072,0.05012968,0.000001730998,0.00801902,0.0005048834,0.0018580661,0.00021375378,0.00005309321,0.0012125797],"genre_scores_gemma":[0.92687476,0.06638169,0.00013509364,0.00034867052,0.0016246843,0.00052656303,0.00006462847,0.00007148213,0.003972398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950029,0.0010722203,0.00071261224,0.00087007385,0.0013346054,0.0010075532],"domain_scores_gemma":[0.99606943,0.0007219581,0.00013202458,0.0004418844,0.0017801664,0.00085453095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004853507,0.00026999734,0.00053485995,0.000109651715,0.00052650046,0.00015204161,0.0003054162,0.0002108938,0.00036201914],"category_scores_gemma":[0.0012520916,0.00016969531,0.000120891076,0.0006112855,0.0005870413,0.00028476314,0.00037584745,0.0010223967,0.00007410153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018530015,0.0015481946,0.1457366,0.0014921118,0.0009507277,0.00060339906,0.005782611,0.00006101754,0.52352667,0.00039990086,0.2805408,0.020827942],"study_design_scores_gemma":[0.031828083,0.0059763114,0.045500472,0.0013518689,0.0006350247,0.000050889295,0.005891071,0.01040332,0.7903569,0.00066853466,0.10580291,0.0015346546],"about_ca_topic_score_codex":0.003085859,"about_ca_topic_score_gemma":0.00044356767,"teacher_disagreement_score":0.26683018,"about_ca_system_score_codex":0.00048603382,"about_ca_system_score_gemma":0.0015243539,"threshold_uncertainty_score":0.6919974},"labels":[],"label_agreement":null},{"id":"W2117878645","doi":"10.1158/1078-0432.ccr-09-0265","title":"Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1648,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; York University; Chemotherapy Foundation; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Abscopal effect; Radiation therapy; Medicine; CD8; Cancer research; Antibody; Immunotherapy; Growth inhibition; Nasopharyngeal carcinoma; Carcinoma; Dose fractionation; Regimen; Immune system; Oncology; Internal medicine; Immunology; Cell growth; Biology","score_opus":0.12192583124804135,"score_gpt":0.4906271966923983,"score_spread":0.36870136544435694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117878645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868281,0.00272725,0.00002518188,0.0075471997,0.00048254264,0.0015322489,0.000035616067,0.0001937503,0.0006281238],"genre_scores_gemma":[0.99268234,0.0028293477,0.00021588021,0.00234718,0.0008515308,0.00008144534,0.00022114861,0.000074432864,0.0006966804],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99473494,0.0011240487,0.00094822986,0.0008820029,0.0014091646,0.0009016391],"domain_scores_gemma":[0.99618536,0.0015777381,0.00022699975,0.000871111,0.00064229395,0.0004965005],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004085281,0.0003704131,0.0010272167,0.00037824115,0.000330253,0.00014582704,0.00045238013,0.00045285546,0.0011493141],"category_scores_gemma":[0.00055157,0.0002637548,0.000263881,0.0010139912,0.0009102729,0.00031348603,0.00003994117,0.0017744275,0.000047170863],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093185395,0.0018933241,0.026671974,0.00007414523,0.000557245,0.0002080646,0.00020583303,0.0000038114163,0.79587173,0.000007674221,0.0017302539,0.079590544],"study_design_scores_gemma":[0.03568558,0.05304797,0.7715359,0.0006714952,0.000113833565,0.00006426429,0.0001284587,0.00037127288,0.1254942,0.00005284534,0.01221507,0.00061912264],"about_ca_topic_score_codex":0.0016430228,"about_ca_topic_score_gemma":0.00007898942,"teacher_disagreement_score":0.7448639,"about_ca_system_score_codex":0.00042574634,"about_ca_system_score_gemma":0.0009944,"threshold_uncertainty_score":0.99998146},"labels":[],"label_agreement":null},{"id":"W2118010724","doi":"10.1158/1078-0432.ccr-10-0527","title":"“Contextual” Synthetic Lethality and/or Loss of Heterozygosity: Tumor Hypoxia and Modification of DNA Repair","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Synthetic lethality; Loss of heterozygosity; DNA repair; Cancer research; Carcinogenesis; Genome instability; Biology; Hypoxia (environmental); Phenotype; DNA damage; DNA mismatch repair; Context (archaeology); Tumor hypoxia; DNA; Genetics; Cancer; Medicine; Chemistry; Internal medicine; Gene; Radiation therapy","score_opus":0.2810343166911639,"score_gpt":0.5143855926620859,"score_spread":0.23335127597092203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118010724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046622165,0.9515841,0.000044074022,0.00007246009,0.00045498356,0.0008077643,0.0002064046,0.000008662703,0.00019940105],"genre_scores_gemma":[0.0050840275,0.9933445,0.00016780267,0.000038819217,0.00042135376,0.00012888815,0.000055096694,0.000027521868,0.0007320011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648935,0.0013285541,0.00097072026,0.00072630134,0.00023788736,0.00024716466],"domain_scores_gemma":[0.99775434,0.0006194358,0.0003592992,0.0007638391,0.00033538087,0.00016772326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027649293,0.0001943139,0.0010904454,0.00009591791,0.00006059817,0.000010510195,0.00025893588,0.0006992647,0.00008226048],"category_scores_gemma":[0.0024062372,0.0001439106,0.00032014155,0.00014284281,0.0013018106,0.000002859351,0.00031788842,0.00079794537,0.00000464356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010165088,0.00030838288,0.0007373752,0.012228186,0.00023597914,0.000015707185,0.000029578923,1.1345223e-7,0.007144296,0.00027334504,0.0016480384,0.97636247],"study_design_scores_gemma":[0.00039895024,0.0008542266,0.00022640935,0.0010553182,0.00013838302,0.000050237348,0.0000116535475,0.000003635298,0.0007628382,0.00005089664,0.9962747,0.00017272652],"about_ca_topic_score_codex":0.000096917734,"about_ca_topic_score_gemma":0.00014331886,"teacher_disagreement_score":0.9946267,"about_ca_system_score_codex":0.000013061758,"about_ca_system_score_gemma":0.0005084524,"threshold_uncertainty_score":0.5868504},"labels":[],"label_agreement":null},{"id":"W2118236177","doi":"10.1158/1078-0432.ccr-04-0657","title":"Species Differences in Troxacitabine Pharmacokinetics and Pharmacodynamics","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Pharmacology; Toxicity; Bolus (digestion); In vitro; Nucleoside; Dose–response relationship; Intracellular; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.30468296612125617,"score_gpt":0.5476224035942685,"score_spread":0.24293943747301233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118236177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98741716,0.002786151,0.000039264134,0.0060412674,0.00022123846,0.0007043421,0.000018185989,0.000035747806,0.002736625],"genre_scores_gemma":[0.9747916,0.021448119,0.00022020462,0.00033894012,0.00068809994,0.00011013273,0.000007141001,0.0000323455,0.0023634592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964207,0.00027733785,0.0006525303,0.00061006297,0.0011770847,0.0008622831],"domain_scores_gemma":[0.9976908,0.0010615438,0.000045518023,0.0003518963,0.00031698364,0.0005332637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025135977,0.00017231924,0.0005421956,0.00033067452,0.000097740296,0.00005609825,0.00028764465,0.00016920087,0.0005590924],"category_scores_gemma":[0.001020031,0.00013817912,0.000093173105,0.0008443856,0.0014266032,0.00008579301,0.00034151127,0.0016513594,0.000056864086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01226204,0.0045639807,0.76912457,0.0023288212,0.00063691975,0.004284491,0.0021565605,0.00024264018,0.019753994,0.0070027458,0.006961066,0.17068215],"study_design_scores_gemma":[0.20619106,0.0038768323,0.69835263,0.0017909245,0.00018589712,0.00027329577,0.0012648371,0.037181698,0.00854047,0.0064618783,0.03484965,0.0010308269],"about_ca_topic_score_codex":0.0014321078,"about_ca_topic_score_gemma":0.0004662495,"teacher_disagreement_score":0.19392902,"about_ca_system_score_codex":0.0050759143,"about_ca_system_score_gemma":0.005754984,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W2118325904","doi":"10.1158/1078-0432.ccr-13-0691","title":"Adrenomedullin Blockade Suppresses Growth of Human Hormone–Independent Prostate Tumor Xenograft in Mice","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Association pour la Recherche sur les Tumeurs de la Prostate; Institut National Du Cancer","keywords":"Adrenomedullin; DU145; Prostate cancer; Angiogenesis; Autocrine signalling; Cancer research; LNCaP; Lymphangiogenesis; Medicine; Internal medicine; Endocrinology; Paracrine signalling; Prostate; Androgen receptor; Cancer; Androgen; Metastasis; Receptor; Hormone","score_opus":0.19311970115876617,"score_gpt":0.46596091872972145,"score_spread":0.27284121757095525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118325904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972972,0.00018104003,1.5297766e-7,0.0006315506,0.00010763077,0.000762336,0.000026985737,0.000027026037,0.00096604845],"genre_scores_gemma":[0.9976902,0.0008063198,0.000016388343,0.00034552702,0.00022122056,0.00023635133,0.0000019941062,0.0000350838,0.0006468941],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99592,0.00094019104,0.0008632979,0.000817131,0.0006475183,0.00081186206],"domain_scores_gemma":[0.99755377,0.0014107932,0.00015538155,0.00034734712,0.0002820976,0.00025063052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093049183,0.00016720248,0.00044322424,0.00020960068,0.00013920256,0.00006563641,0.0008812167,0.00008846348,0.00057288783],"category_scores_gemma":[0.001399354,0.00013630661,0.00012463766,0.0006626198,0.0010790875,0.00019203279,0.0005658998,0.0012353081,0.0002534365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002410289,0.00046313697,0.011445334,0.000059262264,0.000004312204,0.000057078687,0.000080469144,0.0000053523713,0.98379296,0.00041065042,0.0024196617,0.0010207266],"study_design_scores_gemma":[0.0019187657,0.0028797605,0.3033963,0.000114395225,0.0000063699376,0.000006660765,0.00011926807,0.00012113025,0.6828404,0.0065287077,0.0017536974,0.00031449343],"about_ca_topic_score_codex":0.0027450074,"about_ca_topic_score_gemma":0.00020193835,"teacher_disagreement_score":0.30095255,"about_ca_system_score_codex":0.000043619588,"about_ca_system_score_gemma":0.00017232983,"threshold_uncertainty_score":0.627272},"labels":[],"label_agreement":null},{"id":"W2118385994","doi":"10.1158/1078-0432.ccr-14-2352","title":"ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Prostate; Cancer; Cancer research; Erg; Internal medicine; Biology; Oncology; Medicine; Neuroscience; Retina","score_opus":0.22095041484596406,"score_gpt":0.5114372484737918,"score_spread":0.29048683362782773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118385994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896634,0.007598535,0.00006954799,0.00085773045,0.00041781427,0.0008004856,0.00012081003,0.000011867931,0.0004598082],"genre_scores_gemma":[0.99166936,0.0028384274,0.00045614864,0.00029358905,0.001322108,0.00066609593,0.00009050803,0.000039837294,0.002623912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760306,0.00020742774,0.00053728546,0.00062540255,0.00035841102,0.0006683894],"domain_scores_gemma":[0.99850595,0.00016433753,0.000085225496,0.00035556543,0.0005365098,0.00035242498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002355436,0.00016644051,0.00031971457,0.000086284956,0.000102853985,0.000044249704,0.00031579018,0.00020837755,0.000052454277],"category_scores_gemma":[0.0005785118,0.00014613573,0.00012729628,0.00023239077,0.00047347782,0.000009056058,0.00022782068,0.00043208164,0.0000311608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081691295,0.0014631731,0.0860937,0.00071993546,0.00072796387,0.00016581125,0.0005383705,0.0030810502,0.68917525,0.00039637144,0.13472252,0.074746706],"study_design_scores_gemma":[0.0038258354,0.00081865257,0.00033857557,0.00015799489,0.000024101406,0.0000029225812,0.00027130076,0.0001802675,0.59011024,0.00044845938,0.40347213,0.00034949815],"about_ca_topic_score_codex":0.0005563363,"about_ca_topic_score_gemma":0.00095651223,"teacher_disagreement_score":0.2687496,"about_ca_system_score_codex":0.000087655404,"about_ca_system_score_gemma":0.001999483,"threshold_uncertainty_score":0.59592426},"labels":[],"label_agreement":null},{"id":"W2118421998","doi":"10.1158/1078-0432.ccr-05-2568","title":"Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Hepatocellular carcinoma; Doxorubicin; Cancer research; Cell growth; Cisplatin; Biology; Internal medicine; Medicine; Endocrinology; Chemotherapy","score_opus":0.5342079340183039,"score_gpt":0.48644512565081327,"score_spread":0.04776280836749064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118421998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290025,0.001988352,0.00025476754,0.00073548564,0.00008372434,0.0017595852,0.000060501145,0.000056294128,0.0021610525],"genre_scores_gemma":[0.9933547,0.00004119851,0.0020638634,0.00008004499,0.0009081078,0.0006447664,0.000085303735,0.00006541672,0.0027566443],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99665964,0.00022540845,0.0009801418,0.00061436254,0.00078575575,0.0007346731],"domain_scores_gemma":[0.9966565,0.0011819268,0.00014839385,0.0005749547,0.0011473566,0.00029086688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028577624,0.00020665243,0.00068952073,0.00024125821,0.00025462144,0.000028036791,0.00023625362,0.00025515267,0.00009178927],"category_scores_gemma":[0.0005068863,0.00017730522,0.00043708648,0.0006163506,0.0004764706,0.000079194346,0.00012700903,0.00056965154,0.000015815269],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039831465,0.00068314,0.9852756,0.0003820211,0.0000650265,0.00004807659,0.00010521929,0.000008128112,0.0052475506,0.0003597577,0.004588508,0.0028386444],"study_design_scores_gemma":[0.018200291,0.0061920243,0.3180173,0.0008332771,0.0008151783,0.000013494068,0.00019592987,0.5898911,0.048240025,0.009599553,0.007197041,0.00080482056],"about_ca_topic_score_codex":0.0023616857,"about_ca_topic_score_gemma":0.00009476355,"teacher_disagreement_score":0.6672583,"about_ca_system_score_codex":0.00015717711,"about_ca_system_score_gemma":0.00070385414,"threshold_uncertainty_score":0.72302973},"labels":[],"label_agreement":null},{"id":"W2118563466","doi":"10.1158/1078-0432.ccr-04-2352","title":"Induction of Apoptosis Using Inhibitors of Lysophosphatidic Acid Acyltransferase-β and Anti-CD20 Monoclonal Antibodies for Treatment of Human Non-Hodgkin's Lymphomas","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Rituximab; Lysophosphatidic acid; Apoptosis; Lymphoma; Cancer research; In vivo; Pharmacology; CD20; Monoclonal antibody; Chemistry; Medicine; Immunology; Antibody; Biology; Biochemistry; Receptor","score_opus":0.1477683575060193,"score_gpt":0.47111415806059675,"score_spread":0.32334580055457746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118563466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662316,0.0024585086,0.00031740815,0.00006880827,0.000096039585,0.00037265953,0.000043985954,0.0000017941512,0.000017620261],"genre_scores_gemma":[0.99295664,0.005330945,0.001210144,0.0000038572166,0.00037079753,0.00002490032,0.00003987523,0.000014633939,0.000048182636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987681,0.000078347606,0.0004994108,0.00027956412,0.00019743803,0.00017714706],"domain_scores_gemma":[0.9992735,0.00005163377,0.00013088052,0.00018436612,0.00029692415,0.00006269488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005216044,0.00009985244,0.0003284646,0.000081723396,0.0000835179,0.0000055460537,0.00007195178,0.0001872296,0.000014155384],"category_scores_gemma":[0.00003920487,0.00008382492,0.00015147052,0.00010609623,0.0003372359,0.000007010032,0.00003918365,0.00004034335,1.01853075e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030357382,0.00027488527,0.017886966,0.000106288004,0.00008753597,1.0034153e-7,0.00008159753,0.00008960619,0.9441616,0.000054259257,0.000023421355,0.036930177],"study_design_scores_gemma":[0.0016208321,0.0017035049,0.012153436,0.0000576735,0.000040853094,4.7252968e-7,0.00008672749,0.00026089675,0.98355055,0.000077240526,0.0003726209,0.000075210424],"about_ca_topic_score_codex":0.00027899488,"about_ca_topic_score_gemma":0.00005595696,"teacher_disagreement_score":0.039388943,"about_ca_system_score_codex":0.000032029362,"about_ca_system_score_gemma":0.00015197817,"threshold_uncertainty_score":0.3418281},"labels":[],"label_agreement":null},{"id":"W2118731629","doi":"10.1158/1078-0432.ccr-05-2286","title":"Expression of Carcinoembryonic Antigen Cell Adhesion Molecule 6 Oncoprotein in Atypical Ductal Hyperplastic Tissues Is Associated with the Development of Invasive Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Carcinoembryonic antigen; Breast cancer; Cancer; Immunohistochemistry; Medicine; Internal medicine; Colorectal cancer; Predictive marker; Oncology; Predictive value; Antigen; Pathology; Immunology","score_opus":0.11901408041275666,"score_gpt":0.46132421227370185,"score_spread":0.34231013186094517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118731629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643314,0.0010102676,0.000009907766,0.0014879839,0.00001552383,0.0005870624,0.000053246647,0.000008645912,0.00039421525],"genre_scores_gemma":[0.9987263,0.00022910419,0.00015318755,0.00004611013,0.00012586612,0.00022374427,0.000019591616,0.000017750433,0.0004583421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997812,0.00019311023,0.00060780696,0.00034741612,0.0007041234,0.00033556946],"domain_scores_gemma":[0.99819124,0.00085666304,0.00014380395,0.00026288224,0.000405302,0.00014013491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007701731,0.00012089296,0.0003860004,0.000054870714,0.00009664879,0.0000065945483,0.00021984942,0.00015923676,0.00032621584],"category_scores_gemma":[0.00020876355,0.00007631646,0.00006833802,0.00054750993,0.0005427954,0.000029373941,0.00010406837,0.0007126442,0.0000062800973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016103863,0.00091674755,0.25725406,0.0002382555,0.00003149869,0.000021163272,0.0002112208,0.00002455637,0.7377323,0.0000063691537,0.0013060035,0.0006474065],"study_design_scores_gemma":[0.0011568686,0.0000969905,0.36969352,0.00047587135,0.000018812683,0.0000022247054,0.000090501824,0.000044967095,0.62817276,0.000011938242,0.00017604681,0.000059519185],"about_ca_topic_score_codex":0.00035338962,"about_ca_topic_score_gemma":0.0002552114,"teacher_disagreement_score":0.11243944,"about_ca_system_score_codex":0.00019226689,"about_ca_system_score_gemma":0.0011347951,"threshold_uncertainty_score":0.3571835},"labels":[],"label_agreement":null},{"id":"W2118837528","doi":"10.1158/1078-0432.ccr-10-0395","title":"HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Bundesministerium für Bildung und Forschung","keywords":"Medulloblastoma; Histone deacetylase 5; Gene knockdown; Cancer research; Biology; Histone deacetylase; Immunology; Oncology; Medicine; Cell culture; Histone; Genetics","score_opus":0.04207828477692169,"score_gpt":0.43113763143858047,"score_spread":0.38905934666165876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118837528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751765,0.00062211475,0.000031293934,0.00040890873,0.00009332256,0.00069775357,0.00007373466,0.0000040345435,0.0005512012],"genre_scores_gemma":[0.9974826,0.0008471084,0.00062545575,0.000034144203,0.00026746513,0.00035710042,0.000025554005,0.000025407873,0.00033516687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790066,0.00027520856,0.00042228753,0.00065897446,0.00028251443,0.00046033313],"domain_scores_gemma":[0.998688,0.00048521088,0.00006385843,0.00030706738,0.00024205376,0.00021381589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004135638,0.00011563786,0.00019444607,0.00016195486,0.00009814511,0.000043512537,0.0002161147,0.0002506304,0.000019987912],"category_scores_gemma":[0.0024729325,0.00011331458,0.000045691377,0.00023086712,0.0006492792,0.000008909144,0.00018135959,0.000999298,0.0000035379871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013362875,0.00035447525,0.09307039,0.000102732825,0.0000114030145,0.0000049930245,0.00007853724,0.0000035877204,0.89549685,0.000120144774,0.0017303053,0.007690285],"study_design_scores_gemma":[0.011349626,0.0025348063,0.3483797,0.00010198162,0.000016420012,0.000015211401,0.0006890131,0.003581324,0.6001616,0.0013792533,0.031079002,0.00071204733],"about_ca_topic_score_codex":0.0008724088,"about_ca_topic_score_gemma":0.009716047,"teacher_disagreement_score":0.29533526,"about_ca_system_score_codex":0.0000385447,"about_ca_system_score_gemma":0.0004166359,"threshold_uncertainty_score":0.5421782},"labels":[],"label_agreement":null},{"id":"W2118922417","doi":"10.1158/1078-0432.ccr-11-2094","title":"Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Hepatocyte growth factor; Tirapazamine; Medicine; Head and neck cancer; Cisplatin; Oncology; Tumor hypoxia; Internal medicine; Radiation therapy; Cancer research; Cancer; Chemotherapy; Biology; In vitro; Cytotoxicity","score_opus":0.09141139621870341,"score_gpt":0.4533343857705327,"score_spread":0.3619229895518293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118922417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991104,0.0071765766,0.00002286955,0.00012894532,0.00013417505,0.0012911302,0.000104860024,0.000002116997,0.000035327765],"genre_scores_gemma":[0.9837634,0.014790324,0.00018453317,0.000029144048,0.0005546252,0.0005258564,0.000017750343,0.000016912374,0.00011744465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983657,0.00018179783,0.00047151788,0.00039430568,0.0002624761,0.00032422523],"domain_scores_gemma":[0.99908894,0.00022203023,0.00016219832,0.00017035697,0.00018804736,0.0001684037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010030312,0.00012967714,0.00045957445,0.00010089747,0.00002676435,0.00000749687,0.00008605183,0.00014904671,0.000008159091],"category_scores_gemma":[0.00047599984,0.000101102756,0.000025944351,0.0002579529,0.0006913071,0.000020347516,0.00008224697,0.0002581199,6.6919945e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33178735,0.0014327089,0.47079742,0.0004136256,0.000116472474,0.0000025684617,0.0007929943,0.00006294338,0.06689297,0.00003002005,0.00017751163,0.12749343],"study_design_scores_gemma":[0.32662806,0.016483838,0.6040484,0.0009585924,0.00012554653,0.000012778018,0.00068138586,0.0016640124,0.034518197,0.000067768065,0.014237405,0.0005740094],"about_ca_topic_score_codex":0.0005053341,"about_ca_topic_score_gemma":0.0031293596,"teacher_disagreement_score":0.13325098,"about_ca_system_score_codex":0.000026472015,"about_ca_system_score_gemma":0.00053832895,"threshold_uncertainty_score":0.41228506},"labels":[],"label_agreement":null},{"id":"W2118995187","doi":"10.1158/1078-0432.ccr-07-0618","title":"The Cancer/Testis Antigen Melanoma-Associated Antigen-A3/A6 Is a Novel Target of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Immunovaccine (Canada); University Health Network","funders":"","keywords":"Cancer research; Chromatin immunoprecipitation; Biology; DNA methylation; Thyroid cancer; Molecular biology; Carcinogenesis; Epigenetics; FGF10; Fibroblast growth factor receptor 2; Cancer; Fibroblast growth factor; Gene expression; Promoter; Receptor; Gene; Genetics","score_opus":0.13887603713944804,"score_gpt":0.4830170187010986,"score_spread":0.3441409815616505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118995187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98187256,0.010248246,0.00042932702,0.003621527,0.00039229603,0.0011494965,0.0017672732,0.000027064434,0.000492194],"genre_scores_gemma":[0.97569084,0.020480225,0.0005530692,0.00018807604,0.00058290374,0.0003887116,0.00012460945,0.000106949105,0.001884626],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99361527,0.00063863024,0.0014477456,0.0012690425,0.001369727,0.0016596096],"domain_scores_gemma":[0.9953562,0.0010501991,0.00040136994,0.0011026422,0.001696431,0.00039313594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037787035,0.00038086207,0.00063576404,0.0002141195,0.00050090323,0.000082095845,0.0016241004,0.0006620663,0.0005048077],"category_scores_gemma":[0.003082904,0.0003142535,0.00032024115,0.0015068357,0.0017121371,0.000035058856,0.0006799066,0.0014357344,0.000035057416],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010068067,0.00059047557,0.23513089,0.00008913451,0.00029941517,0.0000039642205,0.00040021853,0.000042164604,0.73462176,0.0001228393,0.025596749,0.0020955983],"study_design_scores_gemma":[0.0023900783,0.0009859303,0.54436123,0.00032629922,0.0000122115,0.0000012702353,0.00019393317,0.00016314957,0.41415575,0.0002264784,0.03666444,0.00051920715],"about_ca_topic_score_codex":0.013532819,"about_ca_topic_score_gemma":0.011227235,"teacher_disagreement_score":0.320466,"about_ca_system_score_codex":0.000621532,"about_ca_system_score_gemma":0.0021471882,"threshold_uncertainty_score":0.999931},"labels":[],"label_agreement":null},{"id":"W2119081353","doi":"10.1158/1078-0432.ccr-11-1122","title":"RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; U.S. Food and Drug Administration; Vanderbilt University Medical Center; Vanderbilt University; U.S. Department of Veterans Affairs","keywords":"Cancer research; Melanoma; MAPK/ERK pathway; Cell growth; V600E; Kinase; Cancer; Medicine; Apoptosis; Signal transduction; Mutation; Biology; Internal medicine; Gene; Cell biology","score_opus":0.15127478355897447,"score_gpt":0.4782351862684745,"score_spread":0.3269604027095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119081353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108624,0.002315514,0.000014224671,0.00037041583,0.00025551792,0.00027564378,0.000019920823,0.000006411467,0.0056560845],"genre_scores_gemma":[0.99685127,0.0003693871,0.000055484463,0.0001686729,0.0011598747,0.00009357476,0.000023959221,0.000021072807,0.0012567331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979773,0.00046577296,0.00041646732,0.00028145785,0.0003516707,0.00050732505],"domain_scores_gemma":[0.9987613,0.00016447876,0.00009393398,0.00048997294,0.00029284332,0.00019745727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026508349,0.00010524512,0.00020355127,0.00003852595,0.00016100118,0.000010599705,0.00043527293,0.00015681626,0.000119457465],"category_scores_gemma":[0.0007127712,0.00007115146,0.00013781017,0.00017562705,0.00050286355,0.0000056956906,0.00034095565,0.0003910168,0.000030552255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039434328,0.0003524546,0.20543516,0.00008463874,0.00008382843,0.00000310957,0.00015098245,0.0000021706849,0.7595587,0.004382703,0.01925763,0.01029431],"study_design_scores_gemma":[0.0011964827,0.0012239857,0.13512221,0.000055979133,0.000014633422,0.000005429416,0.00018284639,0.000002386213,0.79723173,0.0004952299,0.06426342,0.00020569045],"about_ca_topic_score_codex":0.00011017624,"about_ca_topic_score_gemma":0.000075839045,"teacher_disagreement_score":0.070312954,"about_ca_system_score_codex":0.000015113444,"about_ca_system_score_gemma":0.00016832244,"threshold_uncertainty_score":0.29014724},"labels":[],"label_agreement":null},{"id":"W2119283670","doi":"10.1158/1078-0432.ccr-05-0726","title":"High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"MSH6; MLH1; MSH2; Colorectal cancer; Microsatellite instability; Population; Genetics; Cancer; Lynch syndrome; DNA mismatch repair; Medicine; Biology; Oncology; Microsatellite; Gene; Allele","score_opus":0.17536262644779682,"score_gpt":0.4798452594927786,"score_spread":0.3044826330449818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119283670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843329,0.0090159075,0.0000095077585,0.0035623661,0.0011443307,0.0010819182,0.00018223056,0.000038434526,0.00063240936],"genre_scores_gemma":[0.9911252,0.003569851,0.001879509,0.00026717695,0.002302616,0.00036153325,0.000016906692,0.00005358699,0.0004235665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951997,0.00039701184,0.0013228445,0.00091649836,0.0012980358,0.00086595246],"domain_scores_gemma":[0.996391,0.0014248248,0.00016695826,0.00063142035,0.00094464445,0.00044115208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030882682,0.00026706044,0.0009146482,0.00029249984,0.00008684348,0.000021492697,0.00047303256,0.00045600763,0.0031004434],"category_scores_gemma":[0.0013614624,0.00022911461,0.00023463923,0.0009868296,0.0014378628,0.00012934126,0.00028266315,0.0015958921,0.000034217854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016448451,0.0008536691,0.9129442,0.00022652834,0.00010100265,0.000021900967,0.00020635973,0.00018579487,0.042549223,0.00005331087,0.0015239883,0.03968921],"study_design_scores_gemma":[0.0037356638,0.0012558687,0.981633,0.00033106175,0.00004184522,0.000006984567,0.00009793583,0.00023802793,0.010315887,0.00035218155,0.0017532824,0.0002382786],"about_ca_topic_score_codex":0.04717426,"about_ca_topic_score_gemma":0.19627407,"teacher_disagreement_score":0.14909981,"about_ca_system_score_codex":0.0014836433,"about_ca_system_score_gemma":0.0027514035,"threshold_uncertainty_score":0.99781084},"labels":[],"label_agreement":null},{"id":"W2119325428","doi":"10.1158/1078-0432.ccr-05-0252","title":"Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pregnane X receptor; Pharmacology; Paclitaxel; Nuclear receptor; Transcription factor; Biology; In vivo; Chemistry; Cell biology; Biochemistry; Cancer; Gene","score_opus":0.4170434883543968,"score_gpt":0.5987963018884374,"score_spread":0.18175281353404055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119325428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878824,0.00453583,0.00000491528,0.0046502138,0.00087457075,0.0008794209,0.00015912323,0.000020488516,0.0009930809],"genre_scores_gemma":[0.9886752,0.0063675977,0.00009553019,0.0012205943,0.00078482856,0.00009475276,0.000020159358,0.000035003643,0.0027063617],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955899,0.0020662926,0.00077450863,0.0005100469,0.00046006657,0.00059916987],"domain_scores_gemma":[0.9977477,0.0010048412,0.00024071548,0.00036376345,0.0003080366,0.00033492234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038244342,0.00019303209,0.00036666487,0.0000867337,0.00045272007,0.00003047844,0.0006000649,0.00036163226,0.0030765512],"category_scores_gemma":[0.00037363204,0.00015033707,0.00012988586,0.00034570773,0.0009690767,0.000109449684,0.00042073725,0.0018032677,0.00006460966],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004176266,0.00062653056,0.031421933,0.000107514024,0.00013547517,4.8085553e-7,0.0005385013,0.000047543097,0.81981915,0.000055738514,0.054824192,0.092005335],"study_design_scores_gemma":[0.0019498082,0.00012524344,0.0061694146,0.00007544794,0.00004573084,7.0374057e-7,0.00006119407,0.00018959286,0.47499242,0.000058342503,0.5161869,0.00014524235],"about_ca_topic_score_codex":0.00011181393,"about_ca_topic_score_gemma":0.000041752348,"teacher_disagreement_score":0.4613627,"about_ca_system_score_codex":0.00013278142,"about_ca_system_score_gemma":0.0001878095,"threshold_uncertainty_score":0.99783474},"labels":[],"label_agreement":null},{"id":"W2119413329","doi":"10.1158/1078-0432.ccr-06-2377","title":"A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Neutropenia; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Leukopenia; Population; Gastroenterology; Chemotherapy; Cancer; Phases of clinical research; Surgery","score_opus":0.3282812492929229,"score_gpt":0.6418834965688445,"score_spread":0.31360224727592156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119413329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829824,0.0030849061,0.000056897577,0.0049709682,0.00050420937,0.0077694817,0.00014237803,0.000027866892,0.00046090886],"genre_scores_gemma":[0.9880455,0.0058571897,0.0001263417,0.0003600206,0.0011299155,0.0021037424,0.000026732801,0.000055177745,0.0022953744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99603766,0.00027636517,0.0015310479,0.0006309626,0.0008516476,0.00067232124],"domain_scores_gemma":[0.99332607,0.0039056344,0.0004056447,0.00048712036,0.001505787,0.00036974912],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0058895927,0.00025684302,0.0017670041,0.00038826675,0.00017939725,0.000008076201,0.0002910228,0.00016398779,0.002494153],"category_scores_gemma":[0.0003539656,0.00019168366,0.00050252,0.0009169353,0.00079059997,0.00007275961,0.00012077654,0.0005933807,0.000004115503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87588924,0.016037734,0.009996717,0.000250852,0.0014124057,0.000020761707,0.00081426685,0.00002981369,0.002354492,0.000049431932,0.0016322349,0.09151205],"study_design_scores_gemma":[0.95967513,0.016833935,0.0010233143,0.00020534117,0.0006409567,0.000005885244,0.00035028692,0.0000914066,0.016528318,0.0001722397,0.0043092575,0.00016390232],"about_ca_topic_score_codex":0.006961498,"about_ca_topic_score_gemma":0.0063886372,"teacher_disagreement_score":0.09134815,"about_ca_system_score_codex":0.00024820364,"about_ca_system_score_gemma":0.00086054095,"threshold_uncertainty_score":0.99965125},"labels":[],"label_agreement":null},{"id":"W2119452594","doi":"10.1158/1078-0432.ccr-12-3661","title":"Infection and Cancer: Revaluation of the Hygiene Hypothesis","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Carcinogenesis; Cancer; Immune system; Immunology; Hygiene hypothesis; Inflammation; Biology; Immunity; Medicine; Bioinformatics; Genetics","score_opus":0.5861999431800313,"score_gpt":0.5690808140674459,"score_spread":0.017119129112585396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119452594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038972616,0.9913322,0.0000012498678,0.00011964802,0.0016231185,0.001357931,0.0008445619,0.000017498533,0.00080653135],"genre_scores_gemma":[0.0005807578,0.99346906,0.0000066980733,0.000031622367,0.00033553957,0.0007830357,0.000028482147,0.000034029268,0.004730803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99420786,0.0036244334,0.0009960285,0.0005481383,0.00017228263,0.0004512349],"domain_scores_gemma":[0.9956805,0.0025763568,0.0004529789,0.0006397234,0.00060702953,0.000043400465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003805103,0.00023726952,0.0012741964,0.00016941087,0.0003086982,0.000021553386,0.00044381386,0.0009354386,0.00086001685],"category_scores_gemma":[0.0030424641,0.00014168872,0.0003967221,0.0005899107,0.0011654744,0.00006324067,0.00037069464,0.0017507181,0.00032408195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023018178,0.00006224946,0.00046210235,0.003795784,0.00022618263,2.2021266e-7,0.00003442232,1.6349779e-7,0.000068221736,0.000057506346,0.01103047,0.98423964],"study_design_scores_gemma":[0.00034989312,0.00016962075,0.001445242,0.004521642,0.00031611396,0.0000052831515,0.000007280262,4.859351e-7,0.00016228094,0.00018387,0.99269193,0.00014633007],"about_ca_topic_score_codex":0.0028192922,"about_ca_topic_score_gemma":0.00044388644,"teacher_disagreement_score":0.9840933,"about_ca_system_score_codex":0.00018939305,"about_ca_system_score_gemma":0.0017091361,"threshold_uncertainty_score":0.9416582},"labels":[],"label_agreement":null},{"id":"W2119661337","doi":"10.1158/1078-0432.ccr-07-1254","title":"Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global<i>CD20</i>Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"CD20; Rituximab; Lymphoma; Medicine; Cancer research; Transfection; Immunology; Chemistry; Gene; Biochemistry","score_opus":0.14338762689709106,"score_gpt":0.40205136518796136,"score_spread":0.2586637382908703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119661337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236805,0.008832386,0.000004166317,0.0067594224,0.000032835178,0.0012962817,0.00031219746,0.000014083982,0.00038059356],"genre_scores_gemma":[0.9953881,0.0013974899,0.0002393291,0.0002517212,0.00006384657,0.00024114695,0.000052221083,0.000016060138,0.002350077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706703,0.00034349176,0.00062171294,0.00052595075,0.0010841271,0.0003577055],"domain_scores_gemma":[0.99860156,0.00032016885,0.00013097805,0.0002860297,0.00048592768,0.00017532753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011872945,0.00017798865,0.0004429662,0.00007357197,0.00024000164,0.000019047622,0.00009648706,0.00017569771,0.00014901061],"category_scores_gemma":[0.00013029303,0.000115199815,0.00008118288,0.00048846874,0.0010792281,0.000087711,0.00005729022,0.00014773087,0.0000036029123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010531087,0.004498494,0.95042676,0.0003098292,0.00045258645,0.00014772319,0.0007866511,0.000010139399,0.023877116,0.00049242645,0.0055692126,0.0028979878],"study_design_scores_gemma":[0.0145439645,0.00065216125,0.9706545,0.00052382355,0.00006218139,0.000017265458,0.00002328674,0.00006300021,0.011764775,0.0003505726,0.0012298569,0.00011462138],"about_ca_topic_score_codex":0.00053208956,"about_ca_topic_score_gemma":0.0015214127,"teacher_disagreement_score":0.020227745,"about_ca_system_score_codex":0.00062856113,"about_ca_system_score_gemma":0.0006574762,"threshold_uncertainty_score":0.4697712},"labels":[],"label_agreement":null},{"id":"W2119729273","doi":"10.1158/1078-0432.ccr-14-3370","title":"A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Everolimus; Renal cell carcinoma; Medicine; Carcinoma; Oncology; Phases of clinical research; Internal medicine; Cancer research; Clinical trial","score_opus":0.442022090306782,"score_gpt":0.5456514551660511,"score_spread":0.10362936485926905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119729273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908056,0.0014184581,0.000009920062,0.0009548123,0.0001450447,0.0018351433,0.00002560208,0.000014180228,0.0047912076],"genre_scores_gemma":[0.99658334,0.000113125054,0.0005572197,0.00008115327,0.00036155278,0.00034504244,0.000018220357,0.000039403505,0.0019009328],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953119,0.0008734429,0.000979932,0.0005802861,0.0016224529,0.0006319834],"domain_scores_gemma":[0.99681884,0.00084397243,0.00016140909,0.00070736976,0.00072852924,0.00073985854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00441684,0.00019889956,0.0008935294,0.00034454916,0.000050978026,0.000013018825,0.00024012748,0.00011915925,0.00018470874],"category_scores_gemma":[0.0008054581,0.00013558847,0.00018357104,0.0008379238,0.0005541145,0.00007309233,0.0001753363,0.0009859541,0.000037841346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87397516,0.03101694,0.048496783,0.0004999949,0.00028953675,0.0036536,0.0013999336,0.000057935613,0.0029898528,0.000060699214,0.010104104,0.02745545],"study_design_scores_gemma":[0.7544896,0.19359988,0.01600685,0.00033147447,0.0003663736,0.000046529705,0.00062933087,0.00033771116,0.027754718,0.00032887096,0.0057940846,0.0003145778],"about_ca_topic_score_codex":0.0018580956,"about_ca_topic_score_gemma":0.00037512212,"teacher_disagreement_score":0.16258293,"about_ca_system_score_codex":0.00046991854,"about_ca_system_score_gemma":0.0030642657,"threshold_uncertainty_score":0.5529138},"labels":[],"label_agreement":null},{"id":"W2119938419","doi":"10.1158/1078-0432.ccr-06-2476","title":"Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council","keywords":"Tumor progression; Bladder cancer; DNA methylation; Cancer; Oncology; Epigenetics; Medicine; Methylation; Proportional hazards model; Internal medicine; Cancer research; Biology; Gene; Gene expression; Genetics","score_opus":0.14459420340458817,"score_gpt":0.551341042201575,"score_spread":0.4067468387969868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119938419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98890114,0.008680483,0.0004738733,0.00030228417,0.0003883978,0.00043901594,0.000012811265,0.0000084090525,0.0007935812],"genre_scores_gemma":[0.98917395,0.008467241,0.00029298954,0.000035146415,0.0009317765,0.00011169951,0.00003187776,0.000025737889,0.00092959293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975061,0.0004938672,0.00053949887,0.00052950275,0.00046029768,0.00047075562],"domain_scores_gemma":[0.9988487,0.0001928368,0.00011437699,0.00034217667,0.00036220616,0.00013972865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067919134,0.0001124809,0.0001600203,0.00013935602,0.00012742488,0.000042536874,0.00020510016,0.00031659505,0.0001224369],"category_scores_gemma":[0.000966548,0.00009684198,0.00008950862,0.00032586063,0.00023933331,0.000007578195,0.00017297763,0.00054375204,0.000017588718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042311588,0.00018412547,0.5244249,0.000022073573,0.00004103897,0.000007456355,0.000088475485,0.000080300306,0.2113395,0.000011993994,0.0005729213,0.26280406],"study_design_scores_gemma":[0.00088906044,0.0003742724,0.6270119,0.000059526286,0.000012025141,2.9412413e-7,0.000059895257,0.00014823573,0.34637085,0.00089389004,0.023992239,0.00018779594],"about_ca_topic_score_codex":0.00050992524,"about_ca_topic_score_gemma":0.0030804262,"teacher_disagreement_score":0.26261628,"about_ca_system_score_codex":0.000053321914,"about_ca_system_score_gemma":0.00020579003,"threshold_uncertainty_score":0.39491013},"labels":[],"label_agreement":null},{"id":"W2120010339","doi":"10.1158/1078-0432.ccr-12-3654","title":"Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Medicine; Nausea; Dosing; Toxicity; Internal medicine; Bilirubin; Response Evaluation Criteria in Solid Tumors; Pharmacology; Gastroenterology; Pharmacodynamics; Phases of clinical research","score_opus":0.08924151496282696,"score_gpt":0.4542747164838444,"score_spread":0.3650332015210174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120010339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784076,0.00014902867,0.0000022823754,0.00020952872,0.00017754312,0.0014040298,0.000029016493,0.0000057121892,0.00018207473],"genre_scores_gemma":[0.9988256,0.00004911593,0.000014731569,0.0001264093,0.00027871525,0.00042922187,0.000008612977,0.000029549734,0.00023802566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697995,0.0006998773,0.00066437793,0.00054740586,0.0006358451,0.00047255968],"domain_scores_gemma":[0.99781644,0.00016283001,0.00013701867,0.0006546912,0.0010969199,0.00013207446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010650209,0.00016174716,0.00034232246,0.00006829172,0.00013222247,0.0000230896,0.0005114464,0.0001324835,0.000038595634],"category_scores_gemma":[0.0012431154,0.00009963112,0.00008742,0.00040179145,0.0005356373,0.0000063864063,0.0005171571,0.00054383226,0.000016412507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083383865,0.0067380276,0.96288955,0.00005667722,0.00012377388,0.0000052868218,0.0006674303,0.00003233571,0.015569748,0.0000053593567,0.0029165905,0.01016138],"study_design_scores_gemma":[0.025527174,0.019123962,0.8574903,0.0004019362,0.00002556754,5.985412e-7,0.0032737583,0.00006887053,0.09168537,0.0000631404,0.0018225529,0.000516766],"about_ca_topic_score_codex":0.00065433304,"about_ca_topic_score_gemma":0.0010265368,"teacher_disagreement_score":0.10539924,"about_ca_system_score_codex":0.000041077103,"about_ca_system_score_gemma":0.0003535982,"threshold_uncertainty_score":0.40628394},"labels":[],"label_agreement":null},{"id":"W2120067300","doi":"10.1158/1078-0432.ccr-07-1510","title":"Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute","keywords":"Oncolytic virus; Cyclophosphamide; Viral replication; Virus; Medicine; Toxicity; Virology; Chemotherapy; Immunology; Internal medicine","score_opus":0.10438848279109997,"score_gpt":0.4301367782182994,"score_spread":0.3257482954271994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120067300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898049,0.008272693,0.00000992044,0.000181724,0.00023597908,0.0005917193,0.00007632529,0.0000255818,0.0008011224],"genre_scores_gemma":[0.9841542,0.014019717,0.000118128766,0.0001863455,0.00039513866,0.000069778376,0.00005854256,0.00006335987,0.00093476294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953251,0.00087640015,0.00089652714,0.0008746108,0.0010293999,0.0009979943],"domain_scores_gemma":[0.99736047,0.00061960024,0.00012321191,0.00094358344,0.0005642479,0.0003888666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027711268,0.00025191292,0.0005527679,0.00017178671,0.00035001218,0.000023898938,0.0008861467,0.00027843643,0.00010150507],"category_scores_gemma":[0.0014509558,0.00023978273,0.00045697542,0.00054083695,0.0012513199,0.000008650471,0.0004128846,0.0008626262,0.00009110957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020380175,0.001114503,0.04301235,0.00012569211,0.0005403365,0.0017489594,0.0002978443,0.0005985559,0.8557906,0.000008978255,0.0037876,0.07259439],"study_design_scores_gemma":[0.005708222,0.021159768,0.025331298,0.00025147933,0.00003449336,0.00009635268,0.000304996,0.00012637892,0.9265306,0.0001191935,0.019390244,0.0009469752],"about_ca_topic_score_codex":0.0004334616,"about_ca_topic_score_gemma":0.00028134728,"teacher_disagreement_score":0.07164741,"about_ca_system_score_codex":0.000090745554,"about_ca_system_score_gemma":0.0014602378,"threshold_uncertainty_score":0.9778056},"labels":[],"label_agreement":null},{"id":"W2120160125","doi":"10.1158/1078-0432.ccr-06-2039","title":"A Phase I Study of Immunization Using Particle-Mediated Epidermal Delivery of Genes for gp100 and GM-CSF into Uninvolved Skin of Melanoma Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"NIH Clinical Center; National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Melanoma; Immunology; Cancer research","score_opus":0.17062146564313396,"score_gpt":0.49079584088996897,"score_spread":0.320174375246835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120160125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897639,0.009006784,0.0001311468,0.000021254362,0.00019369092,0.00083545357,0.00003753896,0.0000064323326,0.0000037789766],"genre_scores_gemma":[0.9987519,0.0010127345,0.00007899131,0.000012934741,0.000018366229,0.000025576783,0.00003965603,0.000017212715,0.000042628242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997015,0.0011752257,0.0011232597,0.00023474926,0.000113548886,0.0003382283],"domain_scores_gemma":[0.9951425,0.0031480244,0.0003328892,0.00029965056,0.0010484828,0.000028412018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003599118,0.000111348774,0.0005128933,0.00018937016,0.00014926777,0.000004516479,0.00022811528,0.00021128953,0.000065088985],"category_scores_gemma":[0.0010394301,0.00009715081,0.000091354894,0.0004053906,0.0007191198,0.00009335152,0.00014770606,0.00025536693,0.0000014590654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024775388,0.00540857,0.27196807,0.00012421102,0.0005252927,0.0000011066899,0.0029799906,0.000011013106,0.6135642,0.00002435315,0.000033132535,0.08058466],"study_design_scores_gemma":[0.02935793,0.013651428,0.26172486,0.0001517037,0.00009774617,0.0000012979198,0.0037780225,0.00021720037,0.6901954,0.000046983198,0.0006000813,0.00017733734],"about_ca_topic_score_codex":0.0026215427,"about_ca_topic_score_gemma":0.00028840615,"teacher_disagreement_score":0.08040732,"about_ca_system_score_codex":0.000038677914,"about_ca_system_score_gemma":0.0002095268,"threshold_uncertainty_score":0.39630058},"labels":[],"label_agreement":null},{"id":"W2120217529","doi":"10.1158/1078-0432.ccr-09-0312","title":"Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Wilms' tumor; Loss of heterozygosity; Histology; Immunohistochemistry; Stage (stratigraphy); Pathology; Nephrectomy; Tissue microarray; Gene expression; Biology; Oncology; Medicine; Gene; Allele; Internal medicine; Kidney; Genetics","score_opus":0.05383079192339157,"score_gpt":0.4405551571181337,"score_spread":0.3867243651947421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120217529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859791,0.012025463,0.000049047892,0.00049641373,0.00037052238,0.00026140278,0.00007126073,0.00001037132,0.0007364394],"genre_scores_gemma":[0.97350776,0.024563935,0.00023113066,0.00029539355,0.00070095254,0.000023031165,0.00003380777,0.0000151919485,0.0006287847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702746,0.000788813,0.0006524822,0.0007262564,0.00038121967,0.00042376187],"domain_scores_gemma":[0.9983204,0.00035128207,0.00022055247,0.00045809444,0.0003450151,0.00030466742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019502009,0.00017035636,0.0004237598,0.000051586663,0.00016152613,0.000019405408,0.00035668237,0.0004465087,0.000043141277],"category_scores_gemma":[0.0015618285,0.00012053204,0.0002432215,0.00016415422,0.0011893382,0.0000059313606,0.00020478951,0.001065413,0.000005955867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011688286,0.0014388631,0.44151253,0.00012423533,0.0005293442,0.00015143257,0.00009382438,0.00011727651,0.2171821,0.00007593621,0.14690402,0.18018216],"study_design_scores_gemma":[0.0037134506,0.0050259396,0.7561583,0.00026178255,0.000099383404,0.000026347423,0.000111150344,0.000057091176,0.21105313,0.0012513114,0.021727206,0.0005149145],"about_ca_topic_score_codex":0.00012955768,"about_ca_topic_score_gemma":0.000069477464,"teacher_disagreement_score":0.31464574,"about_ca_system_score_codex":0.000035711135,"about_ca_system_score_gemma":0.00033946635,"threshold_uncertainty_score":0.4915154},"labels":[],"label_agreement":null},{"id":"W2120223472","doi":"10.1158/1078-0432.ccr-08-2131","title":"Administration of Glucocorticoids to Ovarian Cancer Patients Is Associated with Expression of the Anti-apoptotic Genes <i>SGK1</i> and <i>MKP1/DUSP1</i> in Ovarian Tissues","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Dexamethasone; Glucocorticoid; Ovarian cancer; Biology; Glucocorticoid receptor; Apoptosis; Endocrinology; In situ hybridization; Internal medicine; Chemotherapy; Cancer; Pathology; Gene expression; Cancer research; Medicine; Gene","score_opus":0.051961531699529905,"score_gpt":0.4158934390545863,"score_spread":0.3639319073550564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120223472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949483,0.0030103684,0.000017837168,0.0010855185,0.00006205715,0.00065704726,0.00017214607,0.000003082537,0.000043615604],"genre_scores_gemma":[0.9983007,0.00094777177,0.00013211684,0.00034288826,0.00007946799,0.00007380569,0.000035570487,0.000014017427,0.000073680356],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802774,0.00030631787,0.00051274337,0.0004123559,0.00044815126,0.00029269923],"domain_scores_gemma":[0.99881226,0.000085275904,0.000185275,0.00039405838,0.00040496557,0.00011818453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072063424,0.00012555336,0.0002814352,0.0000478463,0.000067039524,0.000018407152,0.0003018934,0.00017272921,0.000023785036],"category_scores_gemma":[0.0007449044,0.000089204645,0.00004985224,0.0003804915,0.0002647596,0.0000100451725,0.0001805033,0.00021833445,4.7221494e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017771907,0.0007960303,0.50601333,0.00006295141,0.00004815641,0.000003964999,0.00011214476,0.00004050674,0.47541645,0.00006653057,0.0020973699,0.013565389],"study_design_scores_gemma":[0.0009257125,0.0010388545,0.3518622,0.00023264621,0.000009770082,2.5896594e-7,0.000010139114,0.0000044404633,0.6453258,0.000049375973,0.00046456864,0.00007627008],"about_ca_topic_score_codex":0.00046780446,"about_ca_topic_score_gemma":0.0005865314,"teacher_disagreement_score":0.16990931,"about_ca_system_score_codex":0.000031268188,"about_ca_system_score_gemma":0.0003900585,"threshold_uncertainty_score":0.36376598},"labels":[],"label_agreement":null},{"id":"W2120225336","doi":"10.1158/1078-0432.ccr-05-9010","title":"Localized Non–Small Cell Lung Cancer: Adjuvant Radiotherapy in the Era of Effective Systemic Therapy","year":2005,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Context (archaeology); Systemic therapy; Lung cancer; Randomized controlled trial; Cancer; Clinical trial; Oncology; Stage (stratigraphy); Intensive care medicine; Medical physics; Surgery; Internal medicine; Breast cancer","score_opus":0.16999701728562894,"score_gpt":0.5588199164230927,"score_spread":0.38882289913746376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120225336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037337453,0.981034,0.0000073391307,0.0009833218,0.00053019705,0.013160479,0.00014182022,0.000022344188,0.00038675565],"genre_scores_gemma":[0.0033440269,0.978428,0.000050717415,0.00042573127,0.0021027015,0.015169724,0.000041581992,0.00014230784,0.00029520414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99105024,0.0034966692,0.0020316697,0.0011932666,0.0012948418,0.0009333313],"domain_scores_gemma":[0.991109,0.006141791,0.000599615,0.0014285321,0.0004228008,0.00029821965],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006108838,0.00063767226,0.004604712,0.00032058207,0.00011274555,0.000049852584,0.0009228682,0.00074368477,0.0004735374],"category_scores_gemma":[0.00015525983,0.00034320285,0.0014448381,0.0013249423,0.00051004975,0.00004222626,0.00010912019,0.0037269043,0.00002507396],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076114596,0.0013826431,0.008729565,0.023050075,0.0010962276,0.00012314261,0.00041268545,0.000008868936,0.0000011557388,0.000008067129,0.0058350493,0.9585914],"study_design_scores_gemma":[0.009817835,0.0019360326,0.0020321857,0.08185877,0.001144215,0.000026516309,0.00006615141,0.00008062023,0.000016340387,0.000004509195,0.90264785,0.00036896457],"about_ca_topic_score_codex":0.0044207955,"about_ca_topic_score_gemma":0.00069737557,"teacher_disagreement_score":0.9582224,"about_ca_system_score_codex":0.0031525996,"about_ca_system_score_gemma":0.00417572,"threshold_uncertainty_score":0.999902},"labels":[],"label_agreement":null},{"id":"W2120286226","doi":"10.1158/1078-0432.ccr-11-2901","title":"Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Erg; Methylation; DNA methylation; TMPRSS2; Prostate cancer; Immunohistochemistry; Cancer; Biology; Cancer research; Internal medicine; Oncology; Gene expression; Medicine; Gene; Immunology; Genetics","score_opus":0.15345956948294687,"score_gpt":0.5082174998636494,"score_spread":0.3547579303807025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120286226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819245,0.014833334,0.000017241045,0.0009122603,0.00019335905,0.0011393174,0.000054216325,0.000017943961,0.0009078788],"genre_scores_gemma":[0.98669505,0.0112968115,0.00041329738,0.000030781677,0.00021319918,0.00020425259,0.000034570177,0.000024494939,0.0010875157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971363,0.000557194,0.00060981646,0.00036437972,0.0008470256,0.00048526167],"domain_scores_gemma":[0.99747026,0.0009188331,0.0002550153,0.00032181395,0.0007138823,0.00032018355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034605234,0.00014575623,0.0004936348,0.00024709813,0.0001003984,0.000006635575,0.00009937038,0.00021544454,0.00020100751],"category_scores_gemma":[0.0005720652,0.000089909874,0.0000987153,0.00057311426,0.0010836147,0.0001976663,0.0001249814,0.000625362,0.0000037112204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011010113,0.0004306352,0.91682714,0.00042339793,0.0001459336,0.0000097991515,0.0005414255,0.00001161771,0.021840045,0.00003973114,0.0010418023,0.047678374],"study_design_scores_gemma":[0.005072035,0.0018210905,0.94041914,0.0008367468,0.00011811006,0.00000526752,0.0005096526,0.000060594324,0.05002379,0.00007851133,0.00094070536,0.00011433983],"about_ca_topic_score_codex":0.00031289048,"about_ca_topic_score_gemma":0.000046939404,"teacher_disagreement_score":0.047564033,"about_ca_system_score_codex":0.00012381244,"about_ca_system_score_gemma":0.00052274275,"threshold_uncertainty_score":0.3992623},"labels":[],"label_agreement":null},{"id":"W2120365528","doi":"10.1158/1078-0432.ccr-05-0926","title":"Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of<i>ERBB2</i>rather than<i>EGFR</i>","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epidermal growth factor receptor; Cancer research; Tyrosine kinase; Mutation; Head and neck; Epidermal growth factor; Biology; Receptor tyrosine kinase; Medicine; Cancer; Receptor; Internal medicine; Genetics; Gene","score_opus":0.16865743541689038,"score_gpt":0.4874833173590821,"score_spread":0.31882588194219175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120365528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9307816,0.0027268035,0.00000787703,0.06453658,0.0003627177,0.0011595602,0.00022049861,0.00003192792,0.00017246277],"genre_scores_gemma":[0.9900442,0.0018880445,0.0010156275,0.0041397586,0.0011361308,0.00023509758,0.000008469331,0.00005670446,0.0014759927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9957454,0.00068060565,0.0011445879,0.0006955736,0.0010263491,0.0007074675],"domain_scores_gemma":[0.9957801,0.0018117324,0.00015180845,0.00045568572,0.0009816815,0.0008190086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003045337,0.00024961072,0.0010078212,0.00036801607,0.00013497355,0.000018262726,0.00020325737,0.00021744601,0.00024518804],"category_scores_gemma":[0.004284833,0.00020852542,0.00018476171,0.00090727326,0.00057462696,0.00015452033,0.00025031017,0.0006745704,0.000041617306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10280611,0.0015633524,0.26633993,0.0013985143,0.00059667527,0.00009989754,0.012051508,0.00009970836,0.28953776,0.00028164478,0.19755678,0.12766813],"study_design_scores_gemma":[0.009841374,0.013234095,0.62956125,0.0025404915,0.00009349731,0.0000071037866,0.00091503165,0.000062906816,0.1750307,0.000053038337,0.16806357,0.000596972],"about_ca_topic_score_codex":0.0024957429,"about_ca_topic_score_gemma":0.0011220055,"teacher_disagreement_score":0.3632213,"about_ca_system_score_codex":0.00056232297,"about_ca_system_score_gemma":0.0012871537,"threshold_uncertainty_score":0.850342},"labels":[],"label_agreement":null},{"id":"W2120620347","doi":"10.1158/1078-0432.ccr-06-1772","title":"Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Antigen; Immune system; Prostate-specific antigen; Medicine; Immunology; Immunotherapy; Autoantibody; Cancer; Hormonal therapy; Carcinoembryonic antigen; Cancer research; Radiation therapy; Internal medicine; Antibody","score_opus":0.2743677418458901,"score_gpt":0.5638471543117376,"score_spread":0.2894794124658475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120620347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529193,0.039615933,0.00000524534,0.0040981607,0.0006395444,0.0012471834,0.00008286025,0.000043214135,0.0013485546],"genre_scores_gemma":[0.880004,0.11335393,0.000110091474,0.00036009197,0.0004916639,0.00021252492,0.000014101969,0.0000503434,0.005403233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557304,0.00048230795,0.0011295625,0.00068667246,0.001098609,0.0010298257],"domain_scores_gemma":[0.99747896,0.0010114713,0.00012315734,0.0006182046,0.0004575071,0.0003107131],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008900846,0.00021650083,0.00062138785,0.0004676104,0.00017991653,0.000049695092,0.00025561222,0.00022862255,0.0013441618],"category_scores_gemma":[0.00033662605,0.00017216953,0.0002236215,0.0014022391,0.0007787144,0.000105516105,0.00010795732,0.0012429068,0.000050473656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09378262,0.00049188046,0.49077296,0.00004507589,0.00021807927,0.00047433452,0.00043848332,6.037462e-7,0.022856396,0.000019337713,0.004133473,0.38676676],"study_design_scores_gemma":[0.008158648,0.0013103796,0.7498134,0.0004790346,0.000009836628,0.000007987631,0.00033234095,0.0000017694632,0.017925702,0.00005393448,0.22174375,0.00016325293],"about_ca_topic_score_codex":0.0034581101,"about_ca_topic_score_gemma":0.001697426,"teacher_disagreement_score":0.3866035,"about_ca_system_score_codex":0.0012791165,"about_ca_system_score_gemma":0.0015370483,"threshold_uncertainty_score":0.99956876},"labels":[],"label_agreement":null},{"id":"W2120638451","doi":"10.1158/1078-0432.ccr-09-0192","title":"Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; McMaster University","funders":"National Cancer Institute","keywords":"Single-nucleotide polymorphism; Haplotype; Vascular endothelial growth factor; Internal medicine; Genotype; Hazard ratio; SNP; Angiogenesis; Biology; Gastroenterology; Confidence interval; Endocrinology; Medicine; VEGF receptors; Genetics; Gene","score_opus":0.10918280160559377,"score_gpt":0.4507385567829537,"score_spread":0.3415557551773599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120638451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706826,0.025766786,0.000059338065,0.0022486818,0.0002783975,0.00039383053,0.00014219208,0.000018551935,0.00040962012],"genre_scores_gemma":[0.96720225,0.027881563,0.00011472378,0.001106272,0.0023752924,0.00018632002,0.000016282254,0.000031127107,0.0010862019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975388,0.00027888088,0.00038076492,0.00073744776,0.00046805697,0.0005960658],"domain_scores_gemma":[0.99884444,0.00009969477,0.00006653313,0.00034381467,0.000329256,0.0003162601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084062404,0.00019014544,0.00028966792,0.00006675789,0.0002012533,0.000060873546,0.0003383277,0.0003009697,0.0003446838],"category_scores_gemma":[0.0002938026,0.0001592725,0.00023746565,0.00019716285,0.00039742302,0.000007846095,0.00016865617,0.0003453839,0.000014098234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010111048,0.00051593914,0.4987807,0.000066537934,0.00042657624,0.000030020863,0.00009684267,0.0000069063553,0.20218922,0.0005824102,0.027133903,0.26915985],"study_design_scores_gemma":[0.0027990392,0.002186879,0.65721655,0.000096684635,0.00006909431,0.0000057734815,0.000037100202,0.000050273455,0.19693592,0.000504167,0.13946216,0.0006363409],"about_ca_topic_score_codex":0.00044517667,"about_ca_topic_score_gemma":0.00011101736,"teacher_disagreement_score":0.2685235,"about_ca_system_score_codex":0.000045053006,"about_ca_system_score_gemma":0.0003753736,"threshold_uncertainty_score":0.6494944},"labels":[],"label_agreement":null},{"id":"W2120680169","doi":"10.1158/1078-0432.ccr-05-2081","title":"Novel Blood Biomarkers of Human Urinary Bladder Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Biology; Cancer research; Pathology; Oncology; Internal medicine","score_opus":0.22950828589444366,"score_gpt":0.5299358628931056,"score_spread":0.3004275769986619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120680169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701949,0.006115309,0.000011169028,0.0023199434,0.0003369173,0.0008159531,0.00017348673,0.000052174248,0.01998017],"genre_scores_gemma":[0.98939425,0.0011369038,0.00020681946,0.00025780016,0.0014232732,0.0003225198,0.00003013397,0.000058487294,0.007169824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675316,0.0001758655,0.00081304065,0.00061583583,0.0009921606,0.00064993836],"domain_scores_gemma":[0.99809635,0.00033387786,0.00012458324,0.0005967426,0.00055469514,0.00029377642],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011456361,0.00020169558,0.0005914463,0.00021886158,0.00017314286,0.000019083864,0.0002657418,0.00023891528,0.002542577],"category_scores_gemma":[0.00011168392,0.00016360034,0.00029900734,0.00063591194,0.00088831567,0.000066570836,0.00015465618,0.0006881626,0.000035478402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024630954,0.00806866,0.84813505,0.00042265296,0.0018892393,0.00020497947,0.00008920438,0.0000058192563,0.07963607,0.0005750954,0.044168077,0.014342042],"study_design_scores_gemma":[0.013876911,0.0039711026,0.9333556,0.00050038367,0.00063615973,0.000033065902,0.000091174006,0.000022443633,0.03104918,0.0007299538,0.0154239535,0.00031007006],"about_ca_topic_score_codex":0.018856285,"about_ca_topic_score_gemma":0.00079667143,"teacher_disagreement_score":0.08522053,"about_ca_system_score_codex":0.00016163306,"about_ca_system_score_gemma":0.0009842538,"threshold_uncertainty_score":0.9983692},"labels":[],"label_agreement":null},{"id":"W2120706978","doi":"10.1158/1078-0432.ccr-08-2999","title":"A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Kimberly-Clark","keywords":"Vorinostat; Pharmacokinetics; Medicine; Oxaliplatin; FOLFOX; Pharmacology; Cmax; Fluorouracil; Leukopenia; Internal medicine; Gastroenterology; Colorectal cancer; Oncology; Chemotherapy; Cancer; Chemistry; Histone deacetylase","score_opus":0.05236298826956668,"score_gpt":0.4732157032925411,"score_spread":0.4208527150229744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120706978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756294,0.00044121436,0.0000022529002,0.00028172135,0.000053469103,0.0015040785,0.000042222568,0.000007516118,0.000104567545],"genre_scores_gemma":[0.99870926,0.0006532202,0.000016525779,0.0000792985,0.00009695128,0.0002628732,0.000039091854,0.000027563585,0.000115196315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694544,0.00071359373,0.00040020968,0.00075804844,0.00068449223,0.00049822277],"domain_scores_gemma":[0.99902874,0.00018011079,0.00007620037,0.0002118383,0.00028780664,0.00021531689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012991601,0.00019846953,0.00029293078,0.00025375304,0.000095967065,0.000036374928,0.00016719344,0.0001209243,0.000021218988],"category_scores_gemma":[0.00016870674,0.00016099939,0.000020517296,0.00044111078,0.00033870386,0.000019836087,0.00010183138,0.0009272435,0.0000017948397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02055211,0.007913333,0.81401247,0.00003623335,0.00005672652,0.00008185997,0.00034941488,0.0000622778,0.020570619,0.0000032635894,0.0003103954,0.13605131],"study_design_scores_gemma":[0.039921343,0.03212273,0.91701156,0.00014352107,0.000015707326,0.0000014913544,0.00014961643,0.00042239996,0.009209303,0.0000076114557,0.00069318153,0.00030151673],"about_ca_topic_score_codex":0.0005460974,"about_ca_topic_score_gemma":0.0017489155,"teacher_disagreement_score":0.1357498,"about_ca_system_score_codex":0.00017442359,"about_ca_system_score_gemma":0.0003040318,"threshold_uncertainty_score":0.65653646},"labels":[],"label_agreement":null},{"id":"W2120775216","doi":"10.1158/1078-0432.ccr-05-0577","title":"Immunomodulatory Drug CC-5013 or CC-4047 and Rituximab Enhance Antitumor Activity in a Severe Combined Immunodeficient Mouse Lymphoma Model","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Pharmacology; In vivo; Immunology; Thalidomide; Cytokine; Biology","score_opus":0.1365087731726329,"score_gpt":0.48959190980645084,"score_spread":0.35308313663381796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120775216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167645,0.0030077319,0.00002311218,0.0025884502,0.000081193946,0.0015321998,0.000087673274,0.00006496043,0.00093822513],"genre_scores_gemma":[0.9835662,0.0047528013,0.00054761785,0.00022907763,0.00016237477,0.00042417072,0.000020917783,0.0000633449,0.010233465],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950006,0.00065193995,0.00078067614,0.0010423383,0.0012284372,0.0012960123],"domain_scores_gemma":[0.99681044,0.000997742,0.00010925476,0.0009967816,0.00045175618,0.0006340584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029678177,0.00032510032,0.0009143996,0.0003713957,0.00032097226,0.00010002233,0.00039181404,0.00022673464,0.00015672533],"category_scores_gemma":[0.0010994029,0.0002509518,0.0001841547,0.00064298726,0.00083166064,0.0003111974,0.0005476024,0.0012733609,0.00020763763],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07692573,0.17873263,0.06343898,0.0010548026,0.0007849802,0.0011028406,0.0015023103,0.00015388642,0.009798602,0.00019986829,0.006478847,0.6598265],"study_design_scores_gemma":[0.42605665,0.0037380375,0.29697433,0.0012653302,0.00010526495,0.0000994738,0.00051762443,0.24195707,0.021400185,0.0002483225,0.006454437,0.0011832519],"about_ca_topic_score_codex":0.0021619464,"about_ca_topic_score_gemma":0.0015598137,"teacher_disagreement_score":0.65864325,"about_ca_system_score_codex":0.0010545007,"about_ca_system_score_gemma":0.0019263616,"threshold_uncertainty_score":0.9999943},"labels":[],"label_agreement":null},{"id":"W2120998010","doi":"10.1158/1078-0432.ccr-09-1713","title":"Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Vitamin C and Antioxidants Research","field":"Nursing","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Connaught Fund; University of Toronto; U.S. Department of Veterans Affairs","keywords":"Pancreatic cancer; Clonogenic assay; In vivo; Cancer research; Cancer; Viability assay; Apoptosis; Cell culture; Pharmacology; Medicine; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.2205539197400399,"score_gpt":0.5355244103895571,"score_spread":0.3149704906495172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120998010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937097,0.00019052571,0.000024566953,0.002781083,0.0012010395,0.00069088006,0.000039108654,0.00003323457,0.0013298689],"genre_scores_gemma":[0.99791974,0.00041951466,0.000203603,0.00015467936,0.00039081226,0.00024861714,0.0000026279959,0.00004726753,0.0006131487],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99505854,0.00095652393,0.00091627013,0.0006810643,0.0013560494,0.0010315852],"domain_scores_gemma":[0.99641114,0.0018652461,0.00012765809,0.00068685325,0.0005724853,0.000336601],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006725819,0.00017920915,0.00062688626,0.00038160858,0.00016550242,0.00005623793,0.0008017507,0.0004001234,0.0017735814],"category_scores_gemma":[0.0027901498,0.00015321827,0.0001802741,0.0012094876,0.00060488435,0.0001572062,0.00028250663,0.0032150745,0.00009321868],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010009411,0.0006031081,0.14610969,0.000240341,0.00003721036,0.000031449094,0.00015439207,0.0000048845127,0.8095658,0.0012079709,0.0010520932,0.039992128],"study_design_scores_gemma":[0.002578628,0.0009921349,0.57273203,0.00058406946,0.000020389421,0.0000026509842,0.00024755308,0.000981832,0.4110284,0.00951574,0.0009857076,0.0003308487],"about_ca_topic_score_codex":0.010147722,"about_ca_topic_score_gemma":0.01107276,"teacher_disagreement_score":0.42662236,"about_ca_system_score_codex":0.00015567987,"about_ca_system_score_gemma":0.00056667905,"threshold_uncertainty_score":0.99913895},"labels":[],"label_agreement":null},{"id":"W2121042425","doi":"10.1158/1078-0432.ccr-12-3199","title":"Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Immune system; Leukemia; Immunology; Immunotherapy; Biology; Virology; Adoptive cell transfer; Splenocyte; Vaccination; T cell","score_opus":0.06954736455926046,"score_gpt":0.4524370846223443,"score_spread":0.3828897200630838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121042425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885446,0.00652706,0.0005019123,0.0010939278,0.00036387154,0.0019465092,0.00009960083,0.00003743759,0.0008850937],"genre_scores_gemma":[0.9572612,0.015615255,0.0006058777,0.0016310046,0.0021193295,0.0031642593,0.00015511648,0.0002004934,0.019247482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99517435,0.0007668937,0.0007555234,0.0011166262,0.0008212558,0.0013653595],"domain_scores_gemma":[0.9964837,0.0006644804,0.00013080712,0.001120546,0.0011137031,0.00048675202],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002824114,0.00033945753,0.00052215287,0.00016432641,0.00040465538,0.00016663072,0.0012125109,0.0005316594,0.0018229603],"category_scores_gemma":[0.00047408976,0.00029924064,0.0004840514,0.0004054708,0.00055717287,0.000016521724,0.0003376459,0.0007602026,0.00046775513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017326264,0.00018605131,0.0014311054,0.00007201983,0.0005803115,0.0000076711185,0.000057681555,0.000116902556,0.80510706,0.000028997456,0.116170846,0.05891508],"study_design_scores_gemma":[0.025012748,0.020866306,0.004568874,0.00008987809,0.00009766946,0.000014454346,0.000263139,0.0023169504,0.6157442,0.00122018,0.32846802,0.0013375737],"about_ca_topic_score_codex":0.0005193154,"about_ca_topic_score_gemma":0.00021607305,"teacher_disagreement_score":0.21229719,"about_ca_system_score_codex":0.0006041038,"about_ca_system_score_gemma":0.0032661976,"threshold_uncertainty_score":0.999946},"labels":[],"label_agreement":null},{"id":"W2121229095","doi":"10.1158/1078-0432.ccr-04-0506","title":"Characterization of a Gemcitabine-Resistant Murine Leukemic Cell Line","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ligue Contre le Cancer; Association pour la Recherche sur le Cancer","keywords":"Gemcitabine; Deoxycytidine kinase; Ribonucleotide reductase; In vivo; L1210 cells; Nucleoside analogue; Deoxycytidine; Biology; Nucleoside; Prodrug; Antimetabolite; Cell culture; Cancer research; Molecular biology; In vitro; Pharmacology; Cytotoxicity; Chemotherapy; Biochemistry; Gene; Protein subunit","score_opus":0.17151313713702143,"score_gpt":0.49568231001022267,"score_spread":0.32416917287320124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121229095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993307,0.0006849961,0.0001411283,0.0024202394,0.0002080822,0.0010132489,0.000050715757,0.000052646687,0.0021219347],"genre_scores_gemma":[0.9907293,0.0028862988,0.0002645197,0.00022276802,0.00094314845,0.00014171263,0.000076967066,0.000061958126,0.0046733804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953819,0.0002869713,0.001138112,0.00065068615,0.0017075039,0.00083485333],"domain_scores_gemma":[0.99658674,0.0006081507,0.00016311277,0.00091139594,0.001197668,0.0005329093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033078936,0.00018723462,0.00067055377,0.00033992185,0.000106547275,0.000026317612,0.000413344,0.00028117085,0.00076477655],"category_scores_gemma":[0.0013958948,0.00015494457,0.00024253232,0.0011377274,0.0008773396,0.00010191297,0.00034777418,0.0012299757,0.00022265088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0074264435,0.0017366352,0.0024699823,0.001700161,0.00014233236,0.00039121252,0.00027015473,0.00008470898,0.97634125,0.0005694627,0.0007514029,0.00811628],"study_design_scores_gemma":[0.11307306,0.00802036,0.065490104,0.0022673435,0.00018313173,0.000083373496,0.00021696568,0.0027916166,0.7809898,0.0013387605,0.024887778,0.0006576962],"about_ca_topic_score_codex":0.0022991307,"about_ca_topic_score_gemma":0.00012789095,"teacher_disagreement_score":0.1953514,"about_ca_system_score_codex":0.008470144,"about_ca_system_score_gemma":0.019774567,"threshold_uncertainty_score":0.9953362},"labels":[],"label_agreement":null},{"id":"W2121302081","doi":"10.1158/1078-0432.ccr-07-1934","title":"Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia Cells","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Romidepsin; Bortezomib; Cancer research; Histone deacetylase; Vorinostat; Apoptosis; Chronic lymphocytic leukemia; Transfection; Proteasome inhibitor; Chemistry; Biology; Molecular biology; Cell culture; Leukemia; Histone; Immunology; Biochemistry; Multiple myeloma","score_opus":0.16226796167219082,"score_gpt":0.4939002752768028,"score_spread":0.331632313604612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121302081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945744,0.0042917007,0.000013152919,0.00022691741,0.00011399728,0.00033741648,0.000039316445,0.00000907499,0.00039399002],"genre_scores_gemma":[0.98380375,0.012974607,0.000067785695,0.000058714882,0.00076441397,0.00008273638,0.000031427244,0.00003150897,0.0021850476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736893,0.0005079564,0.00049769087,0.0006809483,0.0003675866,0.0005769157],"domain_scores_gemma":[0.9985813,0.00046273667,0.0000485115,0.0003895809,0.00018319118,0.00033470793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015006555,0.0001433452,0.00028842094,0.00017945789,0.00022972403,0.00003203542,0.0002171436,0.0002363208,0.000057630226],"category_scores_gemma":[0.00055824744,0.00014202775,0.00006488241,0.0002739161,0.0011355322,0.000011378987,0.0004478671,0.00084402197,0.000037899354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012476257,0.00012413203,0.18085146,0.00026668512,0.00019665703,0.0003176312,0.00041531766,0.00030410546,0.7002672,0.000022159235,0.068253726,0.04773331],"study_design_scores_gemma":[0.009611118,0.0025629965,0.24626748,0.00035881868,0.00003213941,0.00010105829,0.00022189286,0.0022659353,0.47409615,0.0001302269,0.2634338,0.0009183792],"about_ca_topic_score_codex":0.0024113378,"about_ca_topic_score_gemma":0.0024616292,"teacher_disagreement_score":0.22617105,"about_ca_system_score_codex":0.0016492049,"about_ca_system_score_gemma":0.004009598,"threshold_uncertainty_score":0.7112855},"labels":[],"label_agreement":null},{"id":"W2121394959","doi":"10.1158/1078-0432.ccr-05-0398","title":"Hsp90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Prevents Synovial Sarcoma Proliferation via Apoptosis in <i>In vitro</i> Models","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Hokkaido University","keywords":"Synovial sarcoma; Cancer research; Tyrosine kinase; Platelet-derived growth factor receptor; Receptor tyrosine kinase; Imatinib mesylate; Tyrosine-kinase inhibitor; Growth factor receptor; Sarcoma; Imatinib; Biology; Medicine; Growth factor; Internal medicine; Receptor; Pathology; Cancer","score_opus":0.17569501786950167,"score_gpt":0.47618722829911164,"score_spread":0.30049221042960994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121394959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828941,0.0023552685,0.000095913565,0.010494947,0.0001967237,0.0022317844,0.000026814685,0.000042917418,0.0016614979],"genre_scores_gemma":[0.9915153,0.0013320401,0.0018924628,0.0012705557,0.0013252357,0.0015472425,0.000051960473,0.000054753433,0.001010481],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945903,0.0009406576,0.0013677132,0.00094186765,0.0012019249,0.0009575587],"domain_scores_gemma":[0.9973693,0.0012011088,0.00011421932,0.000624185,0.00026835885,0.00042281862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003987528,0.00028332503,0.00082328054,0.00048775738,0.00010802739,0.00005366859,0.00027172404,0.0003852393,0.00027360118],"category_scores_gemma":[0.0005475177,0.00024335294,0.00025797056,0.0008585462,0.00021396011,0.00026803746,0.00020783246,0.0013986856,0.000083437095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007957342,0.01453515,0.40959606,0.00022926525,0.00024024936,0.0002699302,0.00057109265,0.00077059184,0.011575251,0.00020969582,0.01773381,0.53631157],"study_design_scores_gemma":[0.07127852,0.0063506193,0.5120298,0.003503859,0.0004202966,0.00006251915,0.000404611,0.07155976,0.2956858,0.007574991,0.029040305,0.0020889202],"about_ca_topic_score_codex":0.0009615647,"about_ca_topic_score_gemma":0.0017090131,"teacher_disagreement_score":0.5342226,"about_ca_system_score_codex":0.0010114091,"about_ca_system_score_gemma":0.000626615,"threshold_uncertainty_score":0.99236447},"labels":[],"label_agreement":null},{"id":"W2121855882","doi":"10.1158/1078-0432.ccr-11-1104","title":"Achieving the Goals of Effective, Safe, and Individualized Cancer Care","year":2011,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society; American Association for Cancer Research","keywords":"Intensive care medicine; Medicine; Cancer; Internal medicine","score_opus":0.26429913025576557,"score_gpt":0.4561631805785194,"score_spread":0.19186405032275383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121855882","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17300889,0.34466764,0.00005805328,0.3306115,0.005532153,0.0048805834,0.007152456,0.000069836,0.13401888],"genre_scores_gemma":[0.38346577,0.21925284,0.0004076854,0.34388918,0.027177785,0.0048494916,0.00022252173,0.0006435477,0.020091174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954018,0.00042802768,0.0018228535,0.0011456269,0.0002019816,0.0009996879],"domain_scores_gemma":[0.99510956,0.002208038,0.0011064038,0.0010050166,0.00039248462,0.00017849712],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004421015,0.00040469776,0.0017610963,0.00040441396,0.00032190405,0.0001377525,0.0012340145,0.0013184354,0.0019721875],"category_scores_gemma":[0.0013486838,0.00034201978,0.0004501975,0.00040093786,0.0016698026,0.00021968539,0.00062889734,0.004733046,0.00018244874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024136032,0.000051057614,0.19152042,0.0009405895,0.0005613554,0.000018965537,0.0013580726,0.000002816029,0.0000017760134,0.004340032,0.72574264,0.07522093],"study_design_scores_gemma":[0.0009379256,0.0002415075,0.12205877,0.0003099005,0.0000405172,9.2675947e-7,0.0000623114,0.0000039507995,0.000015654168,0.004907291,0.87105256,0.0003686736],"about_ca_topic_score_codex":0.010506595,"about_ca_topic_score_gemma":0.0006494886,"teacher_disagreement_score":0.21045688,"about_ca_system_score_codex":0.00039210025,"about_ca_system_score_gemma":0.00046935107,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W2121968091","doi":"10.1158/1078-0432.ccr-14-3253","title":"The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Follicular lymphoma; Lymphoma; Cancer; Medicine; CD163; International agency; Oncology; Pathology; Internal medicine; Immunology; Biology; Macrophage","score_opus":0.14753129388764258,"score_gpt":0.5131827052500217,"score_spread":0.36565141136237916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121968091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720457,0.018012373,2.5071262e-7,0.004471236,0.00019591718,0.0050381464,0.00007566771,0.000011265615,0.00014941728],"genre_scores_gemma":[0.9929609,0.003917083,0.0000027243245,0.00010873755,0.0003496215,0.002396078,0.0000062027557,0.00002442541,0.00023422744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99318457,0.0035180594,0.00077880063,0.0005173415,0.0014711838,0.0005300473],"domain_scores_gemma":[0.9862505,0.011844878,0.00025757067,0.00065042946,0.0007726531,0.00022395141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008683898,0.00021377778,0.0006718054,0.000056307133,0.00034580173,0.00012246003,0.00037496226,0.000116746916,0.000037025766],"category_scores_gemma":[0.0050126947,0.00008569019,0.00023976654,0.00065661187,0.0005370928,0.00006412576,0.0003304918,0.00029202588,0.00001435373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030692592,0.004923912,0.9354058,0.0000056624162,0.0015538407,0.00012847091,0.006070724,0.000006314348,0.0000029569148,0.00001449308,0.0018012755,0.04701733],"study_design_scores_gemma":[0.030362029,0.0029875862,0.96019655,0.00012765377,0.00046060164,0.00000156197,0.00523788,0.00013450522,0.000025423513,0.0002665619,0.00011535161,0.000084315616],"about_ca_topic_score_codex":0.13027488,"about_ca_topic_score_gemma":0.014465101,"teacher_disagreement_score":0.11580978,"about_ca_system_score_codex":0.001920211,"about_ca_system_score_gemma":0.0018549265,"threshold_uncertainty_score":0.8755167},"labels":[],"label_agreement":null},{"id":"W2122036933","doi":"10.1158/1078-0432.ccr-07-0408","title":"Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; SKiN Health","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of British Columbia; Canadian Dermatology Foundation","keywords":"Melanoma; Medicine; Immunohistochemistry; Pathology; Tissue microarray; Cancer research; Apoptosis; Pathogenesis; Biology; Genetics","score_opus":0.07216867771073518,"score_gpt":0.44174279788655435,"score_spread":0.36957412017581914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122036933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977464,0.00039181992,0.00006430878,0.00007589734,0.000083417006,0.00028717416,0.000010715804,0.00000475012,0.0013354869],"genre_scores_gemma":[0.9986161,0.00034081846,0.0005154198,0.00004595982,0.00021051163,0.000017622866,0.00001576079,0.000025416932,0.00021238226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830234,0.00016535864,0.0005283712,0.0003682823,0.0002583791,0.0003772451],"domain_scores_gemma":[0.9990935,0.00016826797,0.00009686165,0.00035795802,0.00016778806,0.00011566273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018156825,0.000088911605,0.00018727654,0.000071480514,0.000069357135,0.000012700864,0.0003567061,0.00021605365,0.00005388525],"category_scores_gemma":[0.0004396485,0.000084268046,0.000072881674,0.00016319142,0.00030027982,0.0000018795266,0.00024420954,0.00036917842,0.0000057678308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028823383,0.00023168394,0.09667237,0.000058872436,0.00001362342,0.00003478452,0.000052754178,0.00006192841,0.89684975,0.00011882431,0.00069203257,0.0049251504],"study_design_scores_gemma":[0.004047919,0.0060071805,0.39866233,0.0006222828,0.00002649377,0.00003571542,0.00092807127,0.00088810467,0.5284653,0.0026708501,0.056693185,0.0009525796],"about_ca_topic_score_codex":0.0001157252,"about_ca_topic_score_gemma":0.0004892751,"teacher_disagreement_score":0.36838445,"about_ca_system_score_codex":0.000044298384,"about_ca_system_score_gemma":0.00013154132,"threshold_uncertainty_score":0.3436351},"labels":[],"label_agreement":null},{"id":"W2122045485","doi":"10.1158/1078-0432.ccr-04-1944","title":"<i>In vitro</i>Canine Distemper Virus Infection of Canine Lymphoid Cells: A Prelude to Oncolytic Therapy for Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Canine distemper; Measles virus; Biology; Virology; Canine Lymphoma; Oncolytic virus; Morbillivirus; Lymphoma; Virus; Mononegavirales; Paramyxoviridae; Propidium iodide; Programmed cell death; Apoptosis; Immunology; Viral disease; Measles","score_opus":0.09536830390652214,"score_gpt":0.4804342277136332,"score_spread":0.3850659238071111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122045485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939773,0.0021523552,0.000103625825,0.0015512051,0.00021576305,0.0015752335,0.00015140095,0.000011161975,0.00026194676],"genre_scores_gemma":[0.9865417,0.007197921,0.00024165017,0.0011224725,0.001646155,0.0011309248,0.000042575488,0.000073333205,0.0020032872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965677,0.0005720686,0.00073428405,0.0007553408,0.0005939826,0.000776619],"domain_scores_gemma":[0.9980018,0.0003205849,0.00009810781,0.0006997615,0.0005536113,0.0003261454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033676466,0.00020980525,0.00042048708,0.00021586189,0.00010733469,0.000031554482,0.0005000974,0.00028734838,0.00016625505],"category_scores_gemma":[0.00042261975,0.00019193906,0.0002357184,0.0005581741,0.0002933083,0.000011548892,0.00020664016,0.00024756603,0.000036712994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02640858,0.0007933177,0.0018912954,0.000044666518,0.000079299745,0.0000022373526,0.00005723311,0.00069477805,0.8755417,0.000003892034,0.008725974,0.08575703],"study_design_scores_gemma":[0.004719095,0.006871417,0.001084689,0.00003203928,0.000005601471,0.0000017403005,0.000011534276,0.00029749755,0.8673971,0.000023924933,0.119360514,0.00019479549],"about_ca_topic_score_codex":0.0027906024,"about_ca_topic_score_gemma":0.01155992,"teacher_disagreement_score":0.11063454,"about_ca_system_score_codex":0.0003411566,"about_ca_system_score_gemma":0.0013015223,"threshold_uncertainty_score":0.7827048},"labels":[],"label_agreement":null},{"id":"W2122227569","doi":"10.1158/1078-0432.ccr-1115-03","title":"Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Single-nucleotide polymorphism; Breast cancer; SNP; Biology; Genetics; Cancer; Genotype; Computational biology; Oncology; Bioinformatics; Medicine; Gene","score_opus":0.1299888912551065,"score_gpt":0.4278457033816551,"score_spread":0.29785681212654863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122227569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98372346,0.0012042106,0.008502461,0.0015479253,0.00068560714,0.001065439,0.003010785,0.00004660599,0.00021348865],"genre_scores_gemma":[0.9943778,0.00054600375,0.0015721915,0.00035201007,0.00196817,0.00058625365,0.000119961805,0.000067217814,0.00041038485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693507,0.0002638859,0.0005099244,0.0011061754,0.00047915618,0.00070577994],"domain_scores_gemma":[0.99782145,0.00028051843,0.00009792717,0.0007899759,0.00065902417,0.00035110218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013648163,0.00020324286,0.0003205695,0.000047945006,0.00019248031,0.00004611087,0.0005319423,0.00037554218,0.00017066822],"category_scores_gemma":[0.0005118503,0.00019052415,0.0002907746,0.00016196498,0.0005100135,0.000015862968,0.0003839866,0.00042574067,0.000017025224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005336061,0.0012596115,0.016280293,0.000045126126,0.000328173,0.000007839057,0.00013510938,0.004130168,0.9416477,0.00015685063,0.003992248,0.026680805],"study_design_scores_gemma":[0.011417085,0.0038821413,0.032414693,0.00027432354,0.00010949176,0.000005326997,0.0003566654,0.008154046,0.8940018,0.039257187,0.009154902,0.00097237114],"about_ca_topic_score_codex":0.0041153003,"about_ca_topic_score_gemma":0.004549916,"teacher_disagreement_score":0.04764595,"about_ca_system_score_codex":0.00026877254,"about_ca_system_score_gemma":0.0007848902,"threshold_uncertainty_score":0.776935},"labels":[],"label_agreement":null},{"id":"W2122267374","doi":"10.1158/1078-0432.ccr-06-1592","title":"Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Damon Runyon Cancer Research Foundation","keywords":"Pregnane X receptor; Ketoconazole; Pharmacology; Paclitaxel; CYP3A4; Pregnenolone; Transcription factor; Chemistry; In vivo; Biology; Drug metabolism; Nuclear receptor; Cytochrome P450; Drug; Gene; Biochemistry; Cancer; Metabolism; Steroid; Genetics; Antifungal; Hormone","score_opus":0.5732678557880453,"score_gpt":0.6682249783394519,"score_spread":0.09495712255140665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122267374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97630143,0.013227882,0.0001279336,0.0047794203,0.0015411087,0.0017943057,0.00047185202,0.000057613033,0.0016984795],"genre_scores_gemma":[0.9822339,0.007818783,0.0004397042,0.0033549445,0.0017771062,0.00048482968,0.00002974917,0.00005112313,0.0038098649],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964436,0.00069988734,0.00069434114,0.00066438876,0.0003720943,0.0011256613],"domain_scores_gemma":[0.994991,0.0031922276,0.00012673721,0.00021865788,0.0006643996,0.0008069698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008986418,0.00021520311,0.00044554455,0.00020767232,0.00044853383,0.000032872635,0.00044092326,0.0005584611,0.0033815457],"category_scores_gemma":[0.00077784795,0.00019696368,0.00015517249,0.000467795,0.00051234826,0.00009081733,0.00026142242,0.0017702556,0.00015000372],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082885,0.0014081616,0.02358515,0.0002661525,0.00084430026,0.000031893505,0.0008964981,0.000031730604,0.5425807,0.002240888,0.122041605,0.2977844],"study_design_scores_gemma":[0.0037408015,0.00030870427,0.003336607,0.000015696776,0.00005604771,0.0000016300617,0.0000517558,0.00092984614,0.29529393,0.0012367144,0.69482327,0.00020500147],"about_ca_topic_score_codex":0.000029169867,"about_ca_topic_score_gemma":0.000017893752,"teacher_disagreement_score":0.5727816,"about_ca_system_score_codex":0.00006974969,"about_ca_system_score_gemma":0.00031707674,"threshold_uncertainty_score":0.9975295},"labels":[],"label_agreement":null},{"id":"W2122298066","doi":"10.1158/1078-0432.ccr-08-2917","title":"A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Center for Research Resources; U.S. Public Health Service","keywords":"Docetaxel; Bevacizumab; Medicine; Oncology; Regimen; Breast cancer; Internal medicine; Chemotherapy; Cancer","score_opus":0.06158739226960218,"score_gpt":0.46876339262746486,"score_spread":0.40717600035786267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122298066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883552,0.007960594,0.00035259526,0.0011023997,0.00010140958,0.0014171842,0.00043275882,0.000015773498,0.00026205683],"genre_scores_gemma":[0.9929368,0.003935665,0.0009711887,0.00033191513,0.0006888544,0.00039575945,0.00006378562,0.000051964962,0.00062409363],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99707365,0.00027840686,0.00055174466,0.00086573354,0.0005253948,0.0007050973],"domain_scores_gemma":[0.99768263,0.00018604785,0.00021051755,0.0005704743,0.0010821472,0.00026816648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013644506,0.00029943915,0.000567816,0.000094203104,0.00018685644,0.00003697083,0.0004428557,0.00029626957,0.00012341274],"category_scores_gemma":[0.0002185226,0.00018349201,0.00049616664,0.0004215971,0.00041307806,0.000014895287,0.000083019186,0.00028747725,0.0000022268016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23359513,0.0018573295,0.17686024,0.0003879554,0.0055478257,0.00002492476,0.00032525026,0.006368581,0.22450173,0.0001402667,0.053295046,0.2970957],"study_design_scores_gemma":[0.047949035,0.080125794,0.46020037,0.0034474079,0.0008996658,0.000086965934,0.0012311426,0.0039519197,0.35632247,0.00038093232,0.041786768,0.0036175463],"about_ca_topic_score_codex":0.00022007662,"about_ca_topic_score_gemma":0.00025684285,"teacher_disagreement_score":0.29347816,"about_ca_system_score_codex":0.00015106518,"about_ca_system_score_gemma":0.0015187436,"threshold_uncertainty_score":0.7482587},"labels":[],"label_agreement":null},{"id":"W2122327814","doi":"10.1158/1078-0432.ccr-12-1818","title":"Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Sorafenib; Battle; Biomarker; Medicine; Oncology; Internal medicine; Clinical trial; Hepatocellular carcinoma; History; Biology; Archaeology","score_opus":0.4025781398296305,"score_gpt":0.5987744791664563,"score_spread":0.19619633933682584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122327814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819846,0.00072494027,0.000005510662,0.008547596,0.00011591764,0.0010732572,0.000037522816,0.0000052587156,0.0012915642],"genre_scores_gemma":[0.9983472,0.0005371539,0.00010397337,0.00016581581,0.00015435136,0.00021185339,0.000033107255,0.000006586786,0.00043993362],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979873,0.0004908456,0.00054074975,0.0002922952,0.00045456315,0.00023427658],"domain_scores_gemma":[0.9942072,0.0048934487,0.00007427868,0.00035873477,0.00035606435,0.00011024882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011919637,0.0000753225,0.00037054354,0.00023250749,0.00006685286,0.000026415066,0.00012074466,0.0000808239,0.000293834],"category_scores_gemma":[0.0011098668,0.00004333864,0.00014826324,0.0010044138,0.00045327816,0.00004237901,0.00005625732,0.00035508536,0.000022447757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15838906,0.007080824,0.34329337,0.00030188236,0.006307766,0.00014227557,0.003997171,0.00003737698,0.00081570965,0.00028191277,0.102380425,0.37697223],"study_design_scores_gemma":[0.054745115,0.0010037958,0.9335244,0.000044704604,0.000389131,0.0000010465576,0.00037772287,0.00020002939,0.000043885393,0.00009797277,0.009522232,0.00004992191],"about_ca_topic_score_codex":0.0053451387,"about_ca_topic_score_gemma":0.00041970512,"teacher_disagreement_score":0.59023106,"about_ca_system_score_codex":0.000054420783,"about_ca_system_score_gemma":0.00028417932,"threshold_uncertainty_score":0.80802864},"labels":[],"label_agreement":null},{"id":"W2122438358","doi":"10.1158/1078-0432.ccr-11-3149","title":"Molecular Pathways: Multimodal Cancer-Killing Mechanisms Employed by Oncolytic Vesiculoviruses","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Cancer; Medicine; Disease; Immune system; Cancer cell; Cancer research; Cancer therapy; Clinical trial; Immunotherapy; Immunology; Pathology; Internal medicine","score_opus":0.31984987580334523,"score_gpt":0.5399484884806124,"score_spread":0.22009861267726716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122438358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007893767,0.98741794,0.00014288965,0.00011979273,0.00078518025,0.0023936515,0.0010417082,0.0000521039,0.00015297739],"genre_scores_gemma":[0.0025304388,0.9898782,0.00012808548,0.00029919358,0.0023224738,0.0031210163,0.0006936531,0.00041598457,0.0006109807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98826456,0.0038101764,0.0017138121,0.0020674034,0.0018441544,0.0022999197],"domain_scores_gemma":[0.9951001,0.0007279062,0.0003391015,0.0019560736,0.0007450907,0.0011317674],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0063364203,0.0009165851,0.0022446923,0.0003196872,0.00038427406,0.0001701026,0.002299453,0.0018679267,0.00064671604],"category_scores_gemma":[0.0006800749,0.00078805594,0.00136577,0.00089710456,0.0008245639,0.000014624199,0.0012089412,0.003091399,0.0003415617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009715469,0.00052258326,0.00003424105,0.003199336,0.0009978744,0.000041074873,0.000017636326,0.000007901456,0.016025994,0.000025436935,0.005789548,0.9723668],"study_design_scores_gemma":[0.00097434997,0.0028109956,0.0000017752067,0.0022306459,0.00036204382,0.0000059922177,0.00001999997,0.000014798109,0.015331447,0.00006994885,0.97721934,0.00095867465],"about_ca_topic_score_codex":0.00055599445,"about_ca_topic_score_gemma":0.00037821452,"teacher_disagreement_score":0.97142977,"about_ca_system_score_codex":0.00054932287,"about_ca_system_score_gemma":0.0045192735,"threshold_uncertainty_score":0.99945706},"labels":[],"label_agreement":null},{"id":"W2122626752","doi":"10.1158/1557-3265.pms14-a04","title":"Abstract A04: Changes in matrix metalloproteinase expression in SN-38 resistant colorectal cancer cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Matrix metalloproteinase; TIMP1; MMP1; Metastasis; Cancer research; Colorectal cancer; Cancer; Extracellular matrix; Cell culture; Biology; Cancer cell; Proteolytic enzymes; Pathology; Medicine; Cell biology; Internal medicine; Biochemistry; Enzyme; Gene expression","score_opus":0.1531170009676041,"score_gpt":0.4788733247898995,"score_spread":0.3257563238222954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122626752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082947,0.0065040723,0.0000067256196,0.0007792801,0.00037312924,0.0007720332,0.000062336185,0.000009487599,0.00066346314],"genre_scores_gemma":[0.99472004,0.0026615814,0.00018219059,0.00010714297,0.0007920003,0.00081925746,0.000024454108,0.0000339737,0.0006593499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970794,0.0005116136,0.0005075055,0.00068745716,0.0005699665,0.0006441118],"domain_scores_gemma":[0.998866,0.00008314573,0.00009636444,0.00037978755,0.00024146787,0.00033318475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003776772,0.00017598554,0.00032252385,0.00015443542,0.000055524695,0.0000370132,0.00039408897,0.00040791545,0.00021358088],"category_scores_gemma":[0.0005996359,0.00015237671,0.00009243162,0.00032201392,0.00018251673,0.00001093955,0.00037154084,0.00073819456,0.000032698328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021715993,0.00023576502,0.001381387,0.00004766955,0.000012352962,0.000076590884,0.00005003673,0.000027627577,0.988605,0.000013077909,0.005353711,0.002025161],"study_design_scores_gemma":[0.0016114844,0.0007164237,0.0022884787,0.0001928873,0.0000032819812,5.8216455e-7,0.00014319876,0.000024071856,0.9783072,0.00031485577,0.016199637,0.00019791155],"about_ca_topic_score_codex":0.0017812876,"about_ca_topic_score_gemma":0.008312102,"teacher_disagreement_score":0.010845927,"about_ca_system_score_codex":0.00016494788,"about_ca_system_score_gemma":0.0008169286,"threshold_uncertainty_score":0.6213742},"labels":[],"label_agreement":null},{"id":"W2122664628","doi":"10.1158/1078-0432.ccr-04-0684","title":"Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":444,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Ligue Contre le Cancer","keywords":"Breast cancer; Infiltration (HVAC); Stage (stratigraphy); Medicine; Cancer; Pathology; Oncology; Biology; Internal medicine","score_opus":0.11111734512194295,"score_gpt":0.4492887814914478,"score_spread":0.33817143636950486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122664628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790477,0.0187435,0.000013919717,0.0011287458,0.0003315764,0.00036601306,0.00012634118,0.000020629917,0.00022153345],"genre_scores_gemma":[0.98589265,0.0111533245,0.000023516113,0.000092105314,0.000055451907,0.00014403468,0.000008066256,0.000018275048,0.002612592],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99798506,0.0006689708,0.0005058692,0.00030966967,0.000104277155,0.0004261215],"domain_scores_gemma":[0.9986759,0.0006203152,0.00010222369,0.00024655065,0.00031864134,0.000036394427],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013395386,0.00011698056,0.00030463876,0.00013195667,0.00019977993,0.000025187215,0.00023242157,0.00027432322,0.0010325123],"category_scores_gemma":[0.00013131123,0.00009926555,0.00009146142,0.0002656273,0.0011128103,0.00013135154,0.00009490765,0.00073993305,0.00006698404],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063455626,0.0009798238,0.26062694,0.00023819602,0.00032888018,0.000008736411,0.0011581228,0.000016032129,0.67215496,0.0009023038,0.0007984651,0.056441974],"study_design_scores_gemma":[0.0047805286,0.0013456478,0.66350234,0.00026440815,0.000032064392,0.000013280561,0.00032083708,8.444701e-7,0.31675074,0.00024090103,0.012537281,0.00021110251],"about_ca_topic_score_codex":0.0051284004,"about_ca_topic_score_gemma":0.00023681993,"teacher_disagreement_score":0.40287542,"about_ca_system_score_codex":0.000067412075,"about_ca_system_score_gemma":0.00060623494,"threshold_uncertainty_score":0.9998807},"labels":[],"label_agreement":null},{"id":"W2123098020","doi":"10.1158/1078-0432.ccr-07-0944","title":"Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mitoxantrone; Docetaxel; Prostate cancer; Quality of life (healthcare); Internal medicine; Oncology; Prostate-specific antigen; Cancer; Chemotherapy","score_opus":0.4838946235681214,"score_gpt":0.5233336333598677,"score_spread":0.039439009791746305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123098020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647816,0.027337467,0.0000016296827,0.003595945,0.000033439574,0.0039500427,0.00025103235,0.000013199701,0.000035665387],"genre_scores_gemma":[0.9236792,0.07447403,0.000045173267,0.000017752496,0.00015892925,0.0007264551,0.00002040889,0.000033776392,0.0008442825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9891401,0.0068703014,0.0012030213,0.00071159546,0.0014495568,0.00062543293],"domain_scores_gemma":[0.98964465,0.008352424,0.00026235456,0.00064707134,0.0007119,0.00038161202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012221822,0.00026455696,0.0010807755,0.0002972217,0.0003420563,0.000027868351,0.00019104149,0.00016611241,0.000032004777],"category_scores_gemma":[0.0017635139,0.000135958,0.00008800577,0.0009774604,0.002150425,0.0001272063,0.00009560067,0.0009623769,0.000001575416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09327546,0.0021306819,0.8872709,0.00013621768,0.0003229396,0.0001358627,0.008484083,0.0000020723996,0.00060453464,0.0000058858755,0.00035708176,0.0072742873],"study_design_scores_gemma":[0.016175725,0.019894486,0.9531374,0.00011791123,0.000050739327,0.0000031358738,0.007784576,0.00000859265,0.00012789904,0.000012461874,0.0025422159,0.0001448686],"about_ca_topic_score_codex":0.0048276633,"about_ca_topic_score_gemma":0.0022524884,"teacher_disagreement_score":0.07709973,"about_ca_system_score_codex":0.000281526,"about_ca_system_score_gemma":0.0023311428,"threshold_uncertainty_score":0.79233307},"labels":[],"label_agreement":null},{"id":"W2123137241","doi":"10.1158/1078-0432.ccr-07-1964","title":"The Use of Magnetic Resonance Imaging to Noninvasively Detect Genetic Signatures in Oligodendroglioma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Calgary Laboratory Services","keywords":"Oligodendroglioma; Magnetic resonance imaging; Medicine; Oligodendroglial Tumor; Glioma; Radiology; Pathology; Nuclear medicine; Astrocytoma; Cancer research","score_opus":0.23530621321954348,"score_gpt":0.4647090391620519,"score_spread":0.22940282594250844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123137241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95484567,0.04078433,0.0000025602417,0.0033131887,0.00010449106,0.00078515976,0.000013611935,0.000009180539,0.00014179725],"genre_scores_gemma":[0.9876483,0.010143998,0.0010023959,0.00034209588,0.00014570446,0.00031838068,7.4599154e-7,0.00002569753,0.00037268875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972124,0.00037545024,0.000613172,0.00044705707,0.00077463244,0.0005772545],"domain_scores_gemma":[0.99561167,0.0030813979,0.000053581058,0.00056217663,0.0004172202,0.00027397595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086274697,0.0001288303,0.00036043164,0.00024466228,0.00017579213,0.000027007394,0.0002490696,0.00008528007,0.00011672552],"category_scores_gemma":[0.0022516882,0.000085102714,0.00014084329,0.00092313177,0.0005972709,0.000038705704,0.00017174215,0.0005712966,0.00004411714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010310182,0.00039702505,0.7124593,0.000024738212,0.000021130965,0.0020814633,0.00014543347,0.00014379247,0.0016556215,0.000020306474,0.012157588,0.26986256],"study_design_scores_gemma":[0.0018923905,0.0008178793,0.94694144,0.00025345737,0.000016205768,0.000035876285,0.000022875523,0.00035630885,0.0067770225,0.000040008537,0.042760976,0.000085550644],"about_ca_topic_score_codex":0.0013250007,"about_ca_topic_score_gemma":0.0010921482,"teacher_disagreement_score":0.26977703,"about_ca_system_score_codex":0.00014556068,"about_ca_system_score_gemma":0.00045730206,"threshold_uncertainty_score":0.3470388},"labels":[],"label_agreement":null},{"id":"W2123158115","doi":"10.1158/1078-0432.ccr-06-1863","title":"Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Dosing; Nausea; Pharmacokinetics; Pharmacodynamics; Toxicity; Adverse effect; Tolerability; Pharmacology; Internal medicine; Anesthesia","score_opus":0.13591248393524,"score_gpt":0.5333629320324956,"score_spread":0.3974504480972556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123158115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958869,0.0012147543,0.0005189434,0.00016358288,0.00040013253,0.0009303127,0.00007033392,0.0000055231585,0.0008094689],"genre_scores_gemma":[0.9957701,0.0016780713,0.00044052242,0.00029828964,0.0005219382,0.000162613,0.000044934288,0.00003818813,0.0010453485],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973483,0.00021140475,0.0006870439,0.000572425,0.0005748924,0.00060589914],"domain_scores_gemma":[0.9984669,0.0001664502,0.0001581415,0.0005012062,0.0005087726,0.00019854707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031411736,0.00016342757,0.0003664894,0.00013220141,0.000057805573,0.000012251088,0.00035136094,0.0002505746,0.00015065337],"category_scores_gemma":[0.00019539156,0.00013671747,0.00011965003,0.00038974843,0.00027467904,0.000006194227,0.00014855961,0.00048154214,0.0000015774268],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3199419,0.004783577,0.022421433,0.00006919043,0.0002566349,0.000012143633,0.000098410106,0.0000912718,0.074237965,0.00015387918,0.0025489668,0.5753846],"study_design_scores_gemma":[0.44755483,0.04786097,0.043638475,0.00033379506,0.00008504049,6.010351e-7,0.00022557458,0.000054872085,0.24723957,0.00047057075,0.21159919,0.00093650917],"about_ca_topic_score_codex":0.00032052552,"about_ca_topic_score_gemma":0.002856604,"teacher_disagreement_score":0.5744481,"about_ca_system_score_codex":0.00008745882,"about_ca_system_score_gemma":0.00054103514,"threshold_uncertainty_score":0.55751765},"labels":[],"label_agreement":null},{"id":"W2123437999","doi":"10.1158/1078-0432.ccr-10-0822","title":"Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Tolerability; Medicine; Regimen; Lymphoma; Pharmacokinetics; Maximum tolerated dose; Antagonist; Nausea; Pharmacology; Toxicity; Internal medicine; Adverse effect; Oncology; Receptor","score_opus":0.12773900908343086,"score_gpt":0.48252961052984666,"score_spread":0.35479060144641583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123437999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820304,0.000705247,0.00004774792,0.00006385927,0.0002139174,0.0006164248,0.000038243445,0.0000073518504,0.000104185565],"genre_scores_gemma":[0.9973937,0.0012805001,0.00044139905,0.000062886254,0.0002027221,0.00012305043,0.000061959174,0.000032695094,0.0004010382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978147,0.00018876414,0.00059726706,0.000561079,0.0003837736,0.00045439845],"domain_scores_gemma":[0.9986058,0.0001352424,0.00016715098,0.00044769346,0.0005079035,0.00013620133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010695796,0.00017292844,0.00038976822,0.00010349981,0.00011917879,0.000020238604,0.00027684303,0.0002180538,0.000020365154],"category_scores_gemma":[0.00051883335,0.00012179679,0.00009075252,0.00030599124,0.00044723737,0.0000078858,0.00023559865,0.00032472852,0.0000032681912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012857646,0.0028354472,0.031876534,0.00021607304,0.00020316655,0.000049015576,0.0001797437,0.00009335117,0.72901076,0.00009591207,0.0004526127,0.22212973],"study_design_scores_gemma":[0.06549194,0.027323328,0.35524043,0.0008219541,0.00008931894,0.0000064274122,0.0013073635,0.0009860815,0.5354276,0.00042869683,0.011567942,0.0013089846],"about_ca_topic_score_codex":0.00009408067,"about_ca_topic_score_gemma":0.0008739087,"teacher_disagreement_score":0.3233639,"about_ca_system_score_codex":0.000048261525,"about_ca_system_score_gemma":0.0005441875,"threshold_uncertainty_score":0.4966729},"labels":[],"label_agreement":null},{"id":"W2123467424","doi":"10.1158/1078-0432.ccr-12-0078","title":"A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Aflibercept; Refractory (planetary science); Pharmacokinetics; Medicine; VEGF receptors; Solid tumor; Phase (matter); Oncology; Internal medicine; Clinical trial; Cancer; Bevacizumab; Chemotherapy; Chemistry; Materials science","score_opus":0.124022776189928,"score_gpt":0.5307793011535353,"score_spread":0.4067565249636073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123467424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941832,0.003447572,0.000014605272,0.00006525949,0.00016309448,0.0018762664,0.000054633347,0.000008584819,0.0001868223],"genre_scores_gemma":[0.9957133,0.0018596459,0.0000453188,0.00010012175,0.0015331116,0.0005278265,0.0000777145,0.000044763987,0.000098194076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614596,0.00092687487,0.0010450631,0.0007407377,0.00047152114,0.00066983263],"domain_scores_gemma":[0.99843824,0.00014552733,0.00032106502,0.0005356542,0.00020079021,0.00035874813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032543344,0.00022950514,0.0006480251,0.00015016226,0.00008993973,0.00001629442,0.00029007226,0.00025776788,0.0001593659],"category_scores_gemma":[0.0002516221,0.00018497357,0.0001306731,0.00030276622,0.00073285657,0.00001717817,0.00022063158,0.0005762746,0.0000021453172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08196143,0.03933584,0.73617965,0.000031625506,0.0008575031,0.00007309536,0.00046424507,0.000005230612,0.032098845,0.000004750874,0.002494785,0.106493],"study_design_scores_gemma":[0.3587663,0.09665934,0.51964056,0.000101194695,0.0003333924,0.00025512264,0.00095508085,0.000019196532,0.011417771,0.0000072167245,0.011078978,0.00076584495],"about_ca_topic_score_codex":0.00044273955,"about_ca_topic_score_gemma":0.00024081334,"teacher_disagreement_score":0.27680486,"about_ca_system_score_codex":0.00006304024,"about_ca_system_score_gemma":0.0004916323,"threshold_uncertainty_score":0.7543003},"labels":[],"label_agreement":null},{"id":"W2123476312","doi":"10.1158/1078-0432.ccr-08-1006","title":"A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Irinotecan; Medicine; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Internal medicine; Hsp90 inhibitor; Pharmacology; Oncology; Cancer; Gastroenterology; Progressive disease; Chemotherapy; Heat shock protein; Hsp90; Chemistry; Colorectal cancer","score_opus":0.12178086575357222,"score_gpt":0.482684104983306,"score_spread":0.3609032392297338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123476312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973183,0.00005920905,0.00008846565,0.00012655178,0.000016868205,0.0020842906,0.00001204686,0.0000050955123,0.00028913052],"genre_scores_gemma":[0.9989508,0.0000662764,0.00014382556,0.000023070865,0.000058199374,0.00036843924,0.000053798063,0.000032938628,0.00030265134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99575,0.00119326,0.0007518763,0.00066865823,0.0010737104,0.000562484],"domain_scores_gemma":[0.99824154,0.00018659633,0.000109560795,0.00055661553,0.00072879123,0.00017688776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027303493,0.00016338956,0.00040200228,0.00036192816,0.00009613402,0.000013438999,0.0003633781,0.00019349421,0.000048925438],"category_scores_gemma":[0.0007224139,0.00013150267,0.000040332296,0.0009568462,0.00042229798,0.000015745029,0.00021774607,0.0008324588,0.0000030600654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075554824,0.013193904,0.9643978,0.000041233827,0.000047719182,0.00005107228,0.00031988515,0.00036321793,0.0046033836,0.000003335724,0.00026551995,0.009157432],"study_design_scores_gemma":[0.023322964,0.030970778,0.9361432,0.00010439435,0.0000045830952,0.0000011203897,0.00021676917,0.00025473532,0.008650316,0.0000125098495,0.00013362238,0.00018496373],"about_ca_topic_score_codex":0.0015358236,"about_ca_topic_score_gemma":0.0067352597,"teacher_disagreement_score":0.028254569,"about_ca_system_score_codex":0.0001443596,"about_ca_system_score_gemma":0.0007885176,"threshold_uncertainty_score":0.5362523},"labels":[],"label_agreement":null},{"id":"W2123477611","doi":"10.1158/1078-0432.ccr-07-0780","title":"Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Irinotecan; Pharmacokinetics; Pharmacology; Chemistry; Camptothecin; Medicine; Internal medicine; Cancer; Biochemistry; Colorectal cancer","score_opus":0.2222694447999352,"score_gpt":0.4494059536909869,"score_spread":0.2271365088910517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123477611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977626,0.0009670803,0.0002938859,0.00009220276,0.00006588357,0.00053490157,0.000037982525,0.000008891123,0.00023657888],"genre_scores_gemma":[0.99741054,0.0017545937,0.00013498213,0.00008635381,0.00022592128,0.000057531448,0.00004428811,0.000044551656,0.00024122387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978508,0.00018521895,0.00062459183,0.0004560641,0.0004619095,0.00042145475],"domain_scores_gemma":[0.99833316,0.00007910136,0.00022960333,0.00058438693,0.0006259542,0.00014780549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000815952,0.00016768777,0.00038171283,0.00010772808,0.0001418422,0.000009858473,0.00037431106,0.00020204892,0.000025775353],"category_scores_gemma":[0.00004720415,0.00013754977,0.00018964014,0.0003278126,0.0005450695,0.0000054830316,0.00012880846,0.00034654787,0.0000010840158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016985189,0.00044809218,0.005479487,0.0000691865,0.00018224881,0.0000062368567,0.0001673085,0.00003751975,0.97529733,0.0002343019,0.00002758516,0.016352203],"study_design_scores_gemma":[0.004652474,0.007735719,0.05444461,0.00014471947,0.000046552344,0.000008054768,0.00012018519,0.0001814958,0.9294836,0.00019266983,0.0026664566,0.00032348462],"about_ca_topic_score_codex":0.000349389,"about_ca_topic_score_gemma":0.0005229731,"teacher_disagreement_score":0.048965123,"about_ca_system_score_codex":0.000034014167,"about_ca_system_score_gemma":0.0006053234,"threshold_uncertainty_score":0.56091166},"labels":[],"label_agreement":null},{"id":"W2123540640","doi":"10.1158/1078-0432.ccr-14-2424","title":"Higher Risk of Infections with PI3K–AKT–mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Medicine; Clinical trial; Pharmacology; Internal medicine; Incidence (geometry); Oncology; Biology; Signal transduction; Biochemistry","score_opus":0.24552592430868617,"score_gpt":0.554175465829488,"score_spread":0.3086495415208018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123540640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670106,0.00042824826,0.00005971537,0.0001809311,0.00081537035,0.0010576517,0.00022680365,0.000018287548,0.0005119092],"genre_scores_gemma":[0.99739987,0.00030524665,0.00019347722,0.0001463824,0.0012123327,0.00031163005,0.000070431095,0.00006911985,0.0002915252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99252564,0.0032735441,0.001601783,0.00095800083,0.0010134532,0.0006275929],"domain_scores_gemma":[0.9953992,0.0013572234,0.00066238444,0.00085698446,0.0011919547,0.0005322818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011753419,0.0002828908,0.0009649975,0.00017981204,0.00009387222,0.000029873547,0.00041395822,0.00041822036,0.000086859494],"category_scores_gemma":[0.007379157,0.00019910025,0.000244436,0.0005831615,0.00091338845,0.00001678412,0.00018893532,0.0013036745,0.000018795936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031255096,0.004993043,0.90404963,0.00004859402,0.00040420672,0.00002045417,0.00005155995,0.0013091337,0.002023929,0.000024844032,0.008809501,0.047010027],"study_design_scores_gemma":[0.14975528,0.20961082,0.33282387,0.0021247212,0.00032219867,0.0000035026856,0.00030067473,0.00014282086,0.1337748,0.000467203,0.1684216,0.0022525245],"about_ca_topic_score_codex":0.0002013362,"about_ca_topic_score_gemma":0.00035614643,"teacher_disagreement_score":0.57122576,"about_ca_system_score_codex":0.00016273618,"about_ca_system_score_gemma":0.0017915615,"threshold_uncertainty_score":0.88340735},"labels":[],"label_agreement":null},{"id":"W2123607020","doi":"10.1158/1078-0432.ccr-05-0564","title":"Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Medicine; Pancreatitis; CA19-9; Gastroenterology; Pancreas; Internal medicine; Adenocarcinoma; Osteopontin; Cancer; Receiver operating characteristic; Pancreatic disease; Pathology; Pancreatitis, chronic; Differential diagnosis","score_opus":0.06347453845517328,"score_gpt":0.40498768165852683,"score_spread":0.3415131432033536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123607020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853999,0.0018368898,5.830133e-7,0.00095051684,0.00046299546,0.0010560057,0.00003658502,0.00004545357,0.010211044],"genre_scores_gemma":[0.9938219,0.0002661996,0.00011189685,0.000087483626,0.0004925475,0.000099658784,0.000049706065,0.000060385253,0.0050101755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99566716,0.0005552626,0.00074703875,0.0007251826,0.0012669974,0.0010383888],"domain_scores_gemma":[0.9975557,0.00092965184,0.00009529624,0.0005852817,0.00045947626,0.0003746148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021805426,0.00022960684,0.00056327856,0.00036768024,0.0001609702,0.00003633255,0.00022840138,0.00041083974,0.00063069223],"category_scores_gemma":[0.0005634553,0.00016550504,0.00013207959,0.0012754572,0.0007394194,0.00010177127,0.00016090428,0.0018157305,0.00012888813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025730463,0.00067359,0.95368963,0.00015210522,0.00013042537,0.00035815043,0.000017874183,0.000011067327,0.00008629648,0.000009552107,0.016648106,0.0024927214],"study_design_scores_gemma":[0.022105424,0.002749598,0.9712577,0.0004397173,0.000077681536,0.0000027225506,0.000079113015,0.000056831745,0.00023309399,0.000029095403,0.002776635,0.00019238041],"about_ca_topic_score_codex":0.0040588886,"about_ca_topic_score_gemma":0.0011369532,"teacher_disagreement_score":0.017568057,"about_ca_system_score_codex":0.0006067215,"about_ca_system_score_gemma":0.0007386585,"threshold_uncertainty_score":0.7888546},"labels":[],"label_agreement":null},{"id":"W2123824015","doi":"10.1158/1078-0432.ccr-05-0607","title":"Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Radioimmunotherapy; DOTA; Biodistribution; Pretargeting; Biotin; Avidin; Medicine; Streptavidin; Fusion protein; Antibody; Chemistry; Chelation; Immunology; Biochemistry; Monoclonal antibody; In vitro; Recombinant DNA","score_opus":0.2334103874893006,"score_gpt":0.5694372802231085,"score_spread":0.33602689273380787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123824015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612725,0.0019597395,0.00011482402,0.029232562,0.00002864089,0.0011050102,0.00000996694,0.00007183649,0.006204971],"genre_scores_gemma":[0.9879025,0.0011786785,0.0021493193,0.00084807375,0.0016651653,0.0006758115,0.000014311399,0.000031352833,0.0055347853],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794984,0.0001429203,0.00039940613,0.00043473163,0.0006185261,0.0004545494],"domain_scores_gemma":[0.99861586,0.00023873948,0.00004108926,0.00047241722,0.00023203381,0.00039983756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012245786,0.0001216931,0.00028782996,0.00004205235,0.0001804509,0.00003043026,0.00019516802,0.00016124522,0.0022669376],"category_scores_gemma":[0.00013389759,0.000086749445,0.00009463718,0.0004066622,0.00067266624,0.00006542295,0.00004313817,0.0013356754,0.000104101025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011265405,0.0030079412,0.019465236,0.00035843463,0.00032810651,0.000076019816,0.00025900357,0.000044893903,0.48305556,0.0011059287,0.013843217,0.46719024],"study_design_scores_gemma":[0.005169556,0.0009741077,0.008218579,0.00024932183,0.00003860503,0.000035066685,0.00004797608,0.0009803817,0.18102045,0.00013842026,0.80290574,0.00022177478],"about_ca_topic_score_codex":0.000027969447,"about_ca_topic_score_gemma":0.0000071666195,"teacher_disagreement_score":0.78906256,"about_ca_system_score_codex":0.0001345238,"about_ca_system_score_gemma":0.00043323333,"threshold_uncertainty_score":0.9986451},"labels":[],"label_agreement":null},{"id":"W2124191068","doi":"10.1158/1078-0432.ccr-07-4282","title":"GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Prostate cancer; Gene knockdown; Cancer research; Prostate; Androgen deprivation therapy; Biology; Medicine; GLI2; Cancer; Apoptosis; Internal medicine; Hedgehog signaling pathway; Signal transduction; Cell biology","score_opus":0.22950828153090683,"score_gpt":0.47463158165338915,"score_spread":0.24512330012248232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124191068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962222,0.0023036029,0.0000058045935,0.000479659,0.00022819625,0.0005883976,0.00009242368,0.000015153696,0.00006458639],"genre_scores_gemma":[0.99056727,0.007808192,0.00038507069,0.00035880128,0.0005078198,0.00010026358,0.000009128691,0.000048443584,0.00021499342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967166,0.00053045806,0.00056322967,0.0009619669,0.00046035607,0.000767349],"domain_scores_gemma":[0.99851793,0.00013718054,0.00007874812,0.00043724885,0.0004049937,0.0004238718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017469933,0.0002321497,0.00043330566,0.00015134052,0.00030251362,0.00004823151,0.0002395653,0.00025238626,0.000019712725],"category_scores_gemma":[0.00045168964,0.00021865804,0.00008476236,0.00038339486,0.0005812686,0.000012961384,0.000493473,0.00050447776,0.00000914807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048627876,0.00021549672,0.06327139,0.00004779946,0.00007873067,0.000069091126,0.00072212995,0.0002154033,0.9263739,0.0000018290925,0.0008899556,0.007627993],"study_design_scores_gemma":[0.0012228126,0.00066019525,0.029637128,0.00012404514,0.000015197749,0.000013349615,0.00047631102,0.00012339462,0.96481717,0.000021868957,0.0025125146,0.0003760061],"about_ca_topic_score_codex":0.0026260617,"about_ca_topic_score_gemma":0.0015140858,"teacher_disagreement_score":0.03844327,"about_ca_system_score_codex":0.00008816809,"about_ca_system_score_gemma":0.0005196495,"threshold_uncertainty_score":0.89166164},"labels":[],"label_agreement":null},{"id":"W2124214040","doi":"10.1158/1078-0432.ccr-06-0099","title":"<i>Epidermal Growth Factor Receptor</i>Mutation Testing in the Care of Lung Cancer Patients","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Erlotinib; Gefitinib; Epidermal growth factor receptor; Medicine; Lung cancer; Oncology; Mutation; Clinical trial; Internal medicine; Cancer; Tyrosine kinase; Targeted therapy; T790M; Companion diagnostic; Cancer research; Biology; Genetics; Gene; Receptor","score_opus":0.3017331670672577,"score_gpt":0.6000678028015249,"score_spread":0.2983346357342672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124214040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041803974,0.9885276,0.0000012031911,0.00025547718,0.0004712752,0.0033780825,0.0007978835,0.000019334719,0.0023687468],"genre_scores_gemma":[0.007276263,0.98847395,0.00010044619,0.00010342275,0.0008770822,0.0020209583,0.0007531644,0.00007371622,0.00032100728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950116,0.0011332404,0.0015137716,0.0006381226,0.0011451968,0.0005580246],"domain_scores_gemma":[0.9940895,0.0033426073,0.00046536248,0.0004405876,0.0015181251,0.00014383964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010072938,0.00031480586,0.0014909527,0.00031645657,0.0001540553,0.000037699825,0.00037603042,0.00037467844,0.00015674377],"category_scores_gemma":[0.0016777267,0.00019107337,0.00044570238,0.001453547,0.0002904842,0.000083385334,0.00010083119,0.0015603348,0.000014619171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004836037,0.00045159744,0.09213295,0.01687115,0.00024385269,0.00002391362,0.00046442825,0.0000017697954,1.2860475e-7,0.000022539884,0.0068293936,0.8829099],"study_design_scores_gemma":[0.004128216,0.0011394704,0.063794196,0.041546542,0.002308556,0.0000047806298,0.00024153234,0.000017358876,0.0000043060218,0.000040847503,0.88628864,0.00048557427],"about_ca_topic_score_codex":0.0067637973,"about_ca_topic_score_gemma":0.00064465817,"teacher_disagreement_score":0.88242435,"about_ca_system_score_codex":0.0012609741,"about_ca_system_score_gemma":0.0035335147,"threshold_uncertainty_score":0.9998503},"labels":[],"label_agreement":null},{"id":"W2124813591","doi":"10.1158/1078-0432.ccr-08-1030","title":"Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"Wilms' tumor; Renal tumor; Medicine; Oncology; Histology; Internal medicine; Pathology; Kidney; Nephrectomy","score_opus":0.062452356122579676,"score_gpt":0.41973231450080195,"score_spread":0.3572799583782223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124813591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229026,0.0054710084,0.00007917173,0.001211652,0.0002681511,0.0003583854,0.00003196844,0.000006404298,0.00028302675],"genre_scores_gemma":[0.99771726,0.00056856504,0.00030089423,0.000586474,0.000596997,0.000034849603,0.00005127475,0.000014526125,0.00012918349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960781,0.0014334598,0.0009357426,0.00064749416,0.00044226737,0.00046295405],"domain_scores_gemma":[0.9980835,0.0003167663,0.00043157415,0.00086826313,0.00018656751,0.00011333977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028016986,0.0001522513,0.00046521044,0.000085979686,0.0002456515,0.000015373786,0.0007359419,0.00030134653,0.000042672385],"category_scores_gemma":[0.0008963023,0.000087871085,0.00033173236,0.0007762058,0.000714085,0.000006879758,0.00034381566,0.0012548044,0.0000010844376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012151026,0.00031288882,0.68659866,0.0000068109644,0.00044404503,0.00015984042,0.000098326665,0.0028315932,0.30170956,0.000008909977,0.0045679035,0.0020463795],"study_design_scores_gemma":[0.004022974,0.0018533008,0.8323041,0.00046551388,0.00059687754,0.00021708268,0.00034595298,0.0021710596,0.14652112,0.00088609196,0.010135368,0.0004805333],"about_ca_topic_score_codex":0.0041926336,"about_ca_topic_score_gemma":0.0011554089,"teacher_disagreement_score":0.15518844,"about_ca_system_score_codex":0.00015342534,"about_ca_system_score_gemma":0.00069712393,"threshold_uncertainty_score":0.6338036},"labels":[],"label_agreement":null},{"id":"W2124885699","doi":"10.1158/1078-0432.ccr-13-0029","title":"Relationship of Mammographic Density and Gene Expression: Analysis of Normal Breast Tissue Surrounding Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; National Institute of Environmental Health Sciences; Avon Foundation for Women","keywords":"Breast cancer; Breast tissue; MAMMOGRAPHIC DENSITY; Medicine; Gene expression; Breast density; Cancer; Mammary gland; Oncology; Mammography; Gene; Internal medicine; Pathology; Cancer research; Biology; Genetics","score_opus":0.11616570707329706,"score_gpt":0.4571665939511582,"score_spread":0.3410008868778612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124885699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607193,0.0012065562,0.00006643866,0.0014970402,0.000081229766,0.00032705566,0.00015531413,0.000017154309,0.00057728746],"genre_scores_gemma":[0.9987322,0.0004780618,0.00021728607,0.000046832298,0.00020735973,0.000058017155,0.000022157967,0.00001636213,0.00022172772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974297,0.00027179127,0.00072071294,0.0004165508,0.0007587088,0.000402499],"domain_scores_gemma":[0.9970299,0.00096897595,0.00017973664,0.00042708754,0.0010025796,0.00039174556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017153706,0.0001337559,0.00066802785,0.00093868794,0.00012110177,0.000041727748,0.0001681569,0.00014080672,0.0006710381],"category_scores_gemma":[0.00020961899,0.00010808509,0.0002941843,0.0030019865,0.0010272342,0.00030961566,0.00015452583,0.00058181427,0.00000409115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034209352,0.00020562614,0.9582075,0.00015931154,0.0004589951,0.000008466492,0.00006028116,0.000008341531,0.0045282333,0.00007343232,0.00037196508,0.035575766],"study_design_scores_gemma":[0.0007036489,0.00010992475,0.9958453,0.0002777018,0.00045588825,0.00003939436,0.000110532375,0.00017734528,0.0019874494,0.00015525558,0.000038458227,0.00009909383],"about_ca_topic_score_codex":0.0034345284,"about_ca_topic_score_gemma":0.00020544142,"teacher_disagreement_score":0.037637822,"about_ca_system_score_codex":0.000041684416,"about_ca_system_score_gemma":0.00021194229,"threshold_uncertainty_score":0.73473966},"labels":[],"label_agreement":null},{"id":"W2124890939","doi":"10.1158/1078-0432.ccr-11-1431","title":"Integrative Genomics Identified <i>RFC3</i> As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health; Wellcome Trust; University of Michigan","keywords":"Biology; Carcinogenesis; Cancer; Gene duplication; Oncogene; Copy-number variation; Gene knockdown; Candidate gene; Malignancy; Cancer research; CDKN2A; Barrett's esophagus; Comparative genomic hybridization; Genomics; Adenocarcinoma; Gene; Genome; Genetics; Cell cycle","score_opus":0.20908925067347603,"score_gpt":0.5412453445037941,"score_spread":0.3321560938303181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124890939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705478,0.0217481,0.00001616657,0.0016002329,0.00048602678,0.0017260172,0.00009117188,0.000058624242,0.003725877],"genre_scores_gemma":[0.98821205,0.0035656402,0.00023298695,0.0008047618,0.0017446171,0.00072303106,0.00013777094,0.00008193307,0.004497181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99335927,0.0012956463,0.0009940099,0.00094517163,0.0014677863,0.0019380935],"domain_scores_gemma":[0.9953065,0.0008796289,0.00011805974,0.0010062573,0.00057127513,0.0021182997],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0057629677,0.00034396342,0.0008684995,0.000478014,0.00024693107,0.00010755016,0.0005230397,0.00033206117,0.0015419342],"category_scores_gemma":[0.001047441,0.00027126967,0.00026101727,0.0010111218,0.00077009446,0.00041670157,0.00035525011,0.0023558468,0.0008066266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007329459,0.0024216755,0.950022,0.00013351355,0.0002939386,0.001160475,0.0016282871,0.0000032362043,0.0008750817,0.0013431122,0.0040553017,0.030733932],"study_design_scores_gemma":[0.009979754,0.004337641,0.9595425,0.00024743064,0.00010671481,0.00008092543,0.0012644477,0.000098978046,0.01581667,0.0016902294,0.0064146873,0.000420036],"about_ca_topic_score_codex":0.009375657,"about_ca_topic_score_gemma":0.0039873784,"teacher_disagreement_score":0.030313896,"about_ca_system_score_codex":0.0017597354,"about_ca_system_score_gemma":0.0024557065,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W2124992375","doi":"10.1158/1078-0432.ccr-08-1644","title":"Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma <i>In situ</i>","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Carcinoma in situ; Medicine; Autofluorescence; Dysplasia; Confidence interval; Receiver operating characteristic; Biopsy; Lung cancer; Bronchoscopy; Pathology; Area under the curve; Cancer; Nuclear medicine; Carcinoma; Radiology; Internal medicine; Fluorescence","score_opus":0.11451053429559621,"score_gpt":0.4942561034365501,"score_spread":0.37974556914095386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124992375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942899,0.001204543,0.000050197992,0.0025175058,0.00009427161,0.0014860827,0.000015484247,0.000013272024,0.00032873848],"genre_scores_gemma":[0.99748737,0.0015383561,0.00014570689,0.00013246176,0.00027243374,0.00019352214,0.0000033528422,0.000011503975,0.00021532514],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978865,0.0002526785,0.00048477642,0.00038841873,0.00051911175,0.00046853122],"domain_scores_gemma":[0.99780166,0.0012969943,0.000056113793,0.00024181516,0.00041666496,0.00018677558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025851275,0.000100467754,0.0004366267,0.00017656093,0.00010572426,0.000013657862,0.00013240188,0.00012749384,0.000015311143],"category_scores_gemma":[0.0018335294,0.00008357198,0.00008609374,0.000376191,0.0005824629,0.000060621493,0.00006455597,0.00062684773,0.0000020146047],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010661077,0.00037215446,0.025799472,0.00019540638,0.000043424483,0.000020627336,0.00023224523,0.0000020541365,0.8475942,0.00015374845,0.0006636221,0.114261955],"study_design_scores_gemma":[0.0076272907,0.0077784536,0.78509104,0.00019502784,0.000023461398,0.000007574579,0.0001803698,0.0023388285,0.19435795,0.0010084556,0.001263559,0.00012801295],"about_ca_topic_score_codex":0.0002561544,"about_ca_topic_score_gemma":0.0009552941,"teacher_disagreement_score":0.7592915,"about_ca_system_score_codex":0.00017989863,"about_ca_system_score_gemma":0.00043338133,"threshold_uncertainty_score":0.34079662},"labels":[],"label_agreement":null},{"id":"W2125078645","doi":"10.1158/1078-0432.ccr-04-0686","title":"A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; AstraZeneca","keywords":"Medicine; Budesonide; Placebo; Biopsy; Bronchoscopy; Gastroenterology; Inhalation; Lung; Dysplasia; Pathology; Internal medicine; Radiology; Anesthesia","score_opus":0.08740307409998185,"score_gpt":0.4709134309035914,"score_spread":0.38351035680360956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125078645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869267,0.0010328221,0.000020718031,0.004226563,0.00031820245,0.005556475,0.000092043636,0.0000143851485,0.0018120963],"genre_scores_gemma":[0.9971182,0.0006839401,0.00010144038,0.00006816149,0.00052540627,0.0006481544,0.000013155103,0.000051694606,0.0007898815],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99286187,0.0017353016,0.0015478821,0.0006911103,0.0023432188,0.0008206224],"domain_scores_gemma":[0.9951441,0.0022676066,0.00030693162,0.0010774658,0.00085364515,0.0003502055],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.007010973,0.0002397423,0.0016193886,0.00033881143,0.000094542265,0.000016946751,0.0006323264,0.00023788131,0.000690212],"category_scores_gemma":[0.0040683467,0.00014363987,0.0005979863,0.0015280556,0.0031710302,0.00009808432,0.00035422065,0.0018400709,0.000015153059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9548094,0.0042090234,0.032100596,0.0005085375,0.00027985836,0.00007988486,0.00026639883,0.000081167556,0.0006188798,0.0004434261,0.00017359442,0.006429188],"study_design_scores_gemma":[0.8873475,0.0016590751,0.10676187,0.0007675102,0.0001529548,0.000015232407,0.00018618611,0.00021952778,0.0015226755,0.00085035956,0.00036966926,0.00014744453],"about_ca_topic_score_codex":0.004171525,"about_ca_topic_score_gemma":0.0016742657,"teacher_disagreement_score":0.07466128,"about_ca_system_score_codex":0.00068065437,"about_ca_system_score_gemma":0.0064791096,"threshold_uncertainty_score":0.99954176},"labels":[],"label_agreement":null},{"id":"W2125181296","doi":"10.1158/1078-0432.ccr-10-1434","title":"Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Metabolistics (Canada); University of Alberta","funders":"","keywords":"Urine; Metabolite; Medicine; Breast cancer; Internal medicine; Oncology; Cancer","score_opus":0.0471323739682425,"score_gpt":0.4264624558984703,"score_spread":0.3793300819302278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125181296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956048,0.0025122524,0.000059591843,0.0007678279,0.00030335312,0.0001679927,0.0002298398,0.000004436392,0.00034987906],"genre_scores_gemma":[0.98536885,0.013204795,0.00031712189,0.00006203621,0.0005830513,0.000088068016,0.00002503585,0.000015835065,0.00033520506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980969,0.00020504423,0.00042169561,0.00054174534,0.0003423507,0.00039230188],"domain_scores_gemma":[0.9986912,0.00010655468,0.000105918036,0.00046873826,0.00040567154,0.0002218917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016943723,0.00013147216,0.00045621238,0.00021468414,0.000120114215,0.00003234868,0.00027873353,0.00018227559,0.00023145095],"category_scores_gemma":[0.0003999158,0.00011157301,0.00025500864,0.0006573136,0.00070284394,0.000004956302,0.00036669575,0.0004832661,0.0000020267805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005445785,0.00014506385,0.8472072,0.000030638173,0.0025314628,0.000004842353,0.000028946242,0.000016214039,0.13248192,0.00072505174,0.0009219632,0.015362129],"study_design_scores_gemma":[0.00090727233,0.000287175,0.9596949,0.0000044005333,0.00039126418,0.0000023638454,0.000036814796,0.000047459675,0.02179947,0.00017581398,0.016488107,0.00016493682],"about_ca_topic_score_codex":0.0029938826,"about_ca_topic_score_gemma":0.0019851534,"teacher_disagreement_score":0.11248773,"about_ca_system_score_codex":0.000011993605,"about_ca_system_score_gemma":0.00019591744,"threshold_uncertainty_score":0.45498154},"labels":[],"label_agreement":null},{"id":"W2125513860","doi":"10.1158/1078-0432.ccr-12-2965","title":"Quantitative Ultrasound Evaluation of Tumor Cell Death Response in Locally Advanced Breast Cancer Patients Receiving Chemotherapy","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Ultrasound; Cancer; Clinical trial; Internal medicine; Oncology; Urology; Surgery; Radiology","score_opus":0.10248189379294537,"score_gpt":0.44659841211131834,"score_spread":0.344116518318373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125513860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967433,0.00065111724,0.000068574154,0.00028013557,0.000120501914,0.0010990452,0.000071785726,0.00003888134,0.00092664565],"genre_scores_gemma":[0.9967135,0.0013057187,0.00045696256,0.000064932115,0.00006365603,0.0012511542,0.000008736541,0.000047300797,0.00008799829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724215,0.0006226069,0.0006161926,0.00033999668,0.0007647985,0.0004142759],"domain_scores_gemma":[0.99583465,0.0024477986,0.000077875964,0.0003190763,0.0011844779,0.00013615104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031941806,0.00014292296,0.0002921075,0.00016028839,0.00007001492,0.000035265784,0.00029259495,0.00010543909,0.0013355549],"category_scores_gemma":[0.000666417,0.0001323573,0.00007294661,0.0006016247,0.00017704687,0.00019766412,0.00002570564,0.0005491161,0.00006932227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003422275,0.0015640414,0.59589493,0.0002688655,0.00014781256,0.0000012448231,0.002459813,0.032512132,0.20939507,0.00010642418,0.0028232855,0.15140411],"study_design_scores_gemma":[0.002487466,0.00020674772,0.98131514,0.0001748793,0.000012821108,4.1136485e-7,0.0002791117,0.011643438,0.0029172844,0.00045030573,0.00032800905,0.00018438125],"about_ca_topic_score_codex":0.0008035187,"about_ca_topic_score_gemma":0.00046708004,"teacher_disagreement_score":0.38542023,"about_ca_system_score_codex":0.0004221279,"about_ca_system_score_gemma":0.00040116833,"threshold_uncertainty_score":0.99957734},"labels":[],"label_agreement":null},{"id":"W2125702108","doi":"10.1158/1078-0432.ccr-04-1036","title":"Antitumor Efficacy of Oblimersen Bcl-2 Antisense Oligonucleotide Alone and in Combination with Vinorelbine in Xenograft Models of Human Non–Small Cell Lung Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Vinorelbine; Lung cancer; Cancer research; Cancer; Pharmacology; Apoptosis; Paclitaxel; Medicine; Biology; Chemotherapy; Pathology; Internal medicine; Biochemistry; Cisplatin","score_opus":0.1256711117554593,"score_gpt":0.4880451359847064,"score_spread":0.3623740242292471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125702108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970133,0.0055749216,0.000017407756,0.0018869862,0.000048471487,0.0019773247,0.000026440059,0.000015149252,0.00075194944],"genre_scores_gemma":[0.9859526,0.013198312,0.00028662756,0.000049154598,0.00008469957,0.00017730704,0.000009998631,0.000047001573,0.00019427773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618864,0.00030252838,0.0010436805,0.0006544892,0.0010724503,0.00073818257],"domain_scores_gemma":[0.99764526,0.00062796805,0.0002041929,0.00048807746,0.0007639272,0.0002705602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025807193,0.00022009322,0.0010620863,0.0007747754,0.00008468722,0.000017129887,0.0002479264,0.0001479195,0.000040774485],"category_scores_gemma":[0.00033464585,0.00017923958,0.00009709821,0.0014709719,0.0013803156,0.00014789216,0.00030712067,0.0011781744,0.0000017275731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057219425,0.0031097084,0.9556516,0.0030022617,0.00022323559,0.00034278302,0.001571161,0.002084278,0.024979303,0.00018928245,0.00031109448,0.0028133795],"study_design_scores_gemma":[0.03413378,0.0029013737,0.93745625,0.0039473437,0.000101291655,0.0000044226485,0.00041822286,0.0017736102,0.018657366,0.00031400748,0.000037881895,0.00025442636],"about_ca_topic_score_codex":0.02399031,"about_ca_topic_score_gemma":0.013157922,"teacher_disagreement_score":0.028411837,"about_ca_system_score_codex":0.0005059302,"about_ca_system_score_gemma":0.0012268571,"threshold_uncertainty_score":0.982509},"labels":[],"label_agreement":null},{"id":"W2125702644","doi":"10.1158/1078-0432.ccr-14-1749","title":"Integrating RAS Status into Prognostic Signatures for Adenocarcinomas of the Lung","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Memorial Sloan-Kettering Cancer Center","keywords":"Lung cancer; Adenocarcinoma; Oncology; Medicine; Internal medicine; Mutation; Cancer research; Cancer; Gene; Biology; Genetics","score_opus":0.256740816745565,"score_gpt":0.5908408432994869,"score_spread":0.33410002655392196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125702644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96722233,0.016806003,0.00024994806,0.007576874,0.0008082386,0.0033651995,0.00006500345,0.0000323657,0.0038740216],"genre_scores_gemma":[0.99582326,0.00012177341,0.0013885672,0.00018935133,0.00043599054,0.0005519256,0.000017743418,0.000022819202,0.0014485825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998125,0.00023101777,0.00042103708,0.00027919494,0.0005773455,0.00036638213],"domain_scores_gemma":[0.9967029,0.001437562,0.000091967624,0.00034157335,0.0011365715,0.00028943646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013805241,0.00009264345,0.0002769904,0.000069470385,0.0001359191,0.000020427295,0.0001776287,0.00011077058,0.00004700374],"category_scores_gemma":[0.005710944,0.000051891217,0.00015793799,0.00037400756,0.0003921934,0.000045539076,0.000112017566,0.00055765675,0.000003969853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010057406,0.00039034017,0.907077,0.0003472657,0.00032184066,0.0000073247693,0.001968865,0.00002537847,0.0002628977,0.0024415797,0.05937792,0.026773859],"study_design_scores_gemma":[0.018560603,0.0060063545,0.8419644,0.0019220524,0.0011890092,0.000006761457,0.008217955,0.0036785337,0.0041625085,0.012858448,0.10104779,0.0003855814],"about_ca_topic_score_codex":0.0012259579,"about_ca_topic_score_gemma":0.00033453017,"teacher_disagreement_score":0.06511258,"about_ca_system_score_codex":0.00036507248,"about_ca_system_score_gemma":0.002780177,"threshold_uncertainty_score":0.6836946},"labels":[],"label_agreement":null},{"id":"W2125787669","doi":"10.1158/1078-0432.ccr-07-1224","title":"NOXA and PUMA Expression Add to Clinical Markers in Predicting Biochemical Recurrence of Prostate Cancer Patients in a Survival Tree Model","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Puma; Prostate cancer; Cancer; Biochemical recurrence; Oncology; breakpoint cluster region; Immunohistochemistry; Tissue microarray; Medicine; Internal medicine; Cancer research; Biology; Apoptosis; Prostatectomy; Receptor","score_opus":0.17325344452730862,"score_gpt":0.5258623476190568,"score_spread":0.3526089030917482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125787669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701416,0.0006046021,0.000021556043,0.00039005777,0.00029571724,0.0011932413,0.00004213506,0.000013965988,0.00042453548],"genre_scores_gemma":[0.99666834,0.0020827183,0.00050141837,0.00014378007,0.00028616507,0.00014413927,0.0000084707035,0.000027721087,0.00013723824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995632,0.0005361038,0.0014651171,0.0007243644,0.00089590915,0.0007465066],"domain_scores_gemma":[0.99511,0.0034853532,0.0001343316,0.0003324461,0.0003776907,0.00056022016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010795327,0.00016271016,0.0006842645,0.00035882613,0.000036764428,0.000010645724,0.00020885566,0.00030525617,0.000038296388],"category_scores_gemma":[0.007823206,0.00013396541,0.00010083354,0.0008751327,0.00039042122,0.000075719305,0.00032540245,0.0015500577,0.00000439894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009376669,0.0006783994,0.89810234,0.00020722051,0.000013929719,0.00002494405,0.00022470376,0.000022074662,0.0013219629,0.0000016530051,0.0013503801,0.088675745],"study_design_scores_gemma":[0.0075123087,0.0013084298,0.9810971,0.0023255397,0.000014411102,5.5985396e-7,0.00015223598,0.0035408211,0.0036602267,0.00007508945,0.00015975867,0.00015354603],"about_ca_topic_score_codex":0.0015192286,"about_ca_topic_score_gemma":0.001994869,"teacher_disagreement_score":0.088522196,"about_ca_system_score_codex":0.00020139992,"about_ca_system_score_gemma":0.0005285676,"threshold_uncertainty_score":0.93656725},"labels":[],"label_agreement":null},{"id":"W2125877270","doi":"10.1158/1078-0432.ccr-11-3007","title":"A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Onyx Pharmaceuticals","keywords":"Carfilzomib; Medicine; Adverse effect; Tolerability; Dosing; Multiple myeloma; Pharmacokinetics; Proteasome inhibitor; Pharmacology; Refractory (planetary science); Internal medicine; Oncology; Gastroenterology","score_opus":0.2172473456305167,"score_gpt":0.4730811051271257,"score_spread":0.255833759496609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125877270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260247,0.00026888002,0.0000017320165,0.000182095,0.00021312268,0.0064953133,0.00011430857,0.000017978546,0.000104089355],"genre_scores_gemma":[0.99825525,0.00004035207,0.00012544189,0.000040095798,0.00023112439,0.0006483167,0.000015250851,0.00005871248,0.0005854784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927383,0.0022433645,0.0012143987,0.0005840836,0.0022133817,0.0010064902],"domain_scores_gemma":[0.9941313,0.0028898618,0.00037036798,0.00095026474,0.0010451438,0.0006130363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031298345,0.00027723072,0.00090999255,0.00033343,0.00016982225,0.000020170073,0.00037578802,0.00020427497,0.00022670707],"category_scores_gemma":[0.007001357,0.00014006671,0.00015140597,0.0012827007,0.00095964846,0.00019217546,0.0003826765,0.0008559823,0.000011716962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08381479,0.049966518,0.8167045,0.00022390242,0.00035225842,0.000080568454,0.0018349574,5.941423e-7,0.0014750261,8.745345e-7,0.00027949692,0.045266494],"study_design_scores_gemma":[0.09018154,0.030360319,0.87067723,0.0009683006,0.00008362891,0.000002556637,0.0016459808,0.000050179075,0.0052678552,0.0000013535115,0.0006077599,0.0001533239],"about_ca_topic_score_codex":0.001774498,"about_ca_topic_score_gemma":0.0013371481,"teacher_disagreement_score":0.05397269,"about_ca_system_score_codex":0.0007863671,"about_ca_system_score_gemma":0.0017270357,"threshold_uncertainty_score":0.8381784},"labels":[],"label_agreement":null},{"id":"W2125955619","doi":"10.1158/1078-0432.ccr-13-0606","title":"<i>PIK3CA, BRAF</i>, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"PTEN; Cetuximab; Colorectal cancer; Medicine; Oncology; Internal medicine; Biomarker; Immunohistochemistry; Cancer; Tissue microarray; Cancer research; Biology","score_opus":0.13139375769860068,"score_gpt":0.4804904139291039,"score_spread":0.34909665623050323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125955619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543035,0.037121348,2.472525e-7,0.0038762041,0.00015214918,0.0017011205,0.00144808,0.000017419794,0.0013799199],"genre_scores_gemma":[0.9237413,0.073876105,0.000067531524,0.00025995908,0.0003221445,0.0010990379,0.000111458394,0.00002466048,0.00049784256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690086,0.00020948789,0.0007682614,0.00080260827,0.000662165,0.00065661524],"domain_scores_gemma":[0.9955541,0.0032693224,0.00014675947,0.00041033298,0.00031164996,0.00030787016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004633398,0.00027469263,0.0009225127,0.00010659927,0.00018130313,0.000060555965,0.00016241703,0.00016235259,0.0003780501],"category_scores_gemma":[0.00027292655,0.00016719312,0.000121696256,0.0003281461,0.0008669728,0.0001066751,0.00011421708,0.0003726146,0.000011366527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00993727,0.0013904524,0.5475085,0.00003435946,0.000532944,0.000058514812,0.00534688,0.00000626099,0.0007202106,0.000015705175,0.0017839344,0.432665],"study_design_scores_gemma":[0.015851678,0.004650081,0.96293706,0.0001897806,0.00013131459,0.0000013519573,0.0018976558,0.000122364,0.0008384095,0.00097042683,0.012244173,0.00016570404],"about_ca_topic_score_codex":0.10263931,"about_ca_topic_score_gemma":0.03468513,"teacher_disagreement_score":0.4324993,"about_ca_system_score_codex":0.0004321097,"about_ca_system_score_gemma":0.000317735,"threshold_uncertainty_score":0.98292935},"labels":[],"label_agreement":null},{"id":"W2126005827","doi":"10.1158/1078-0432.ccr-07-5268","title":"Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; Breast Cancer Alliance; Susan G. Komen for the Cure","keywords":"Breast cancer; Oncology; Cancer research; Cancer; Medicine; Internal medicine; Biology","score_opus":0.11859906226793113,"score_gpt":0.4550499644780676,"score_spread":0.3364509022101365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126005827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729776,0.0008511988,0.000052342304,0.00040675057,0.00016754933,0.00026633125,0.000635803,0.0000035290736,0.00031874859],"genre_scores_gemma":[0.98823386,0.010533103,0.00008426163,0.0001255694,0.00028908,0.00008063008,0.000022551421,0.000023066468,0.0006078808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977588,0.00036167394,0.0006018111,0.0004787901,0.000435134,0.00036380123],"domain_scores_gemma":[0.99860674,0.00013658732,0.00014134723,0.00045681823,0.00052968913,0.00012880811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009244464,0.00012431496,0.00036941055,0.00009141644,0.000052879554,0.000003957504,0.00038039964,0.0002967328,0.00017114215],"category_scores_gemma":[0.00019965184,0.00011039527,0.00015526338,0.00025310725,0.0005563113,0.0000058240335,0.00034750477,0.00043944444,0.0000031527484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022994108,0.00035288144,0.27790153,0.00008213719,0.000045143217,0.0000074260765,0.00015597347,0.000042310425,0.71275234,0.000008478388,0.004201265,0.002151084],"study_design_scores_gemma":[0.001756888,0.0004987075,0.33502418,0.0001966619,0.000011199107,0.000004389381,0.00013595642,0.00013505238,0.65829796,0.00002482197,0.0037492497,0.00016492365],"about_ca_topic_score_codex":0.0019918317,"about_ca_topic_score_gemma":0.00035571074,"teacher_disagreement_score":0.057122644,"about_ca_system_score_codex":0.00004435775,"about_ca_system_score_gemma":0.0008428363,"threshold_uncertainty_score":0.45017883},"labels":[],"label_agreement":null},{"id":"W2126142987","doi":"10.1158/1078-0432.ccr-04-1884","title":"P16 Loss and Mitotic Activity Predict Poor Survival in Patients with Peritoneal Malignant Mesothelioma","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Peritoneal mesothelioma; Medicine; Mesothelioma; Hazard ratio; Internal medicine; Histology; Gastroenterology; Oncology; Survival rate; Pathology; Confidence interval","score_opus":0.07645368928944643,"score_gpt":0.43531887056543644,"score_spread":0.35886518127599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126142987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617946,0.00027490055,0.0000013333098,0.0026166001,0.00006108453,0.00043860084,0.00008320755,0.000012555733,0.00033222817],"genre_scores_gemma":[0.9985816,0.00023572301,0.0000621,0.00016111226,0.0003691948,0.000055534834,0.000019168841,0.000018226745,0.00049734884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801767,0.00020747515,0.00024403541,0.00037502532,0.0008177127,0.0003381054],"domain_scores_gemma":[0.9990733,0.0003255032,0.000032167125,0.00018035118,0.00006771851,0.00032094776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006275549,0.00010413015,0.00025784664,0.000084706284,0.000071611634,0.000015902402,0.00007933064,0.000080629114,0.00034929992],"category_scores_gemma":[0.00015604521,0.00007212947,0.00004734268,0.00014599047,0.00053592335,0.00009915883,0.00010308068,0.00038988696,0.000039446975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005811114,0.0012459613,0.9713571,0.0000612818,0.0000353203,0.000026593687,0.000021924428,0.0000067537017,0.000044905,0.000009078924,0.00028940823,0.021090567],"study_design_scores_gemma":[0.003752121,0.0010934892,0.99330163,0.00013272556,0.000022811872,0.0000013115719,0.000018505298,0.00015978706,0.00010386979,0.000015962205,0.0013136792,0.000084129504],"about_ca_topic_score_codex":0.00030521094,"about_ca_topic_score_gemma":0.00029839962,"teacher_disagreement_score":0.021944515,"about_ca_system_score_codex":0.00017915275,"about_ca_system_score_gemma":0.00017723437,"threshold_uncertainty_score":0.38245893},"labels":[],"label_agreement":null},{"id":"W2126372889","doi":"10.1158/1078-0432.ccr-06-2610","title":"Correlation between Development of Rash and Efficacy in Patients Treated with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large Phase III Studies","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rash; Erlotinib; Internal medicine; Medicine; Gefitinib; Gemcitabine; Epidermal growth factor receptor; Erlotinib Hydrochloride; Hazard ratio; Gastroenterology; Oncology; Cancer; Confidence interval","score_opus":0.1488288453879716,"score_gpt":0.5328739408514896,"score_spread":0.38404509546351806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126372889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970117,0.0006252473,0.000024561903,0.00068733445,0.00006389796,0.0014691171,0.00004980177,0.00001071404,0.00005759998],"genre_scores_gemma":[0.99911946,0.00015483872,0.00017519771,0.000053816595,0.00013458321,0.000096669384,0.00009649489,0.000018307925,0.0001506115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977868,0.00022543476,0.00076769973,0.00033153422,0.0004912722,0.00039724892],"domain_scores_gemma":[0.99751955,0.001537474,0.00013327615,0.0001561693,0.0004968311,0.00015671542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018970611,0.00013579444,0.00046116635,0.0002186812,0.00012724928,0.000009495476,0.000060459413,0.00006917046,0.00003913179],"category_scores_gemma":[0.00064467115,0.00008062915,0.000035411893,0.0006426091,0.00029560173,0.000076154574,0.00007525795,0.0004719409,0.000003872217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026993982,0.0016495036,0.96338654,0.00005602279,0.00016456618,0.000010626625,0.0023804714,0.0000013391377,0.000036558384,0.000013135626,0.00025853282,0.02934329],"study_design_scores_gemma":[0.038544625,0.0009327852,0.9577301,0.00038846102,0.00005393369,1.7562726e-7,0.0004832623,0.000010398765,0.0011467432,0.0000038189264,0.0006235939,0.00008208451],"about_ca_topic_score_codex":0.0003520887,"about_ca_topic_score_gemma":0.0016220358,"teacher_disagreement_score":0.035845228,"about_ca_system_score_codex":0.00040238624,"about_ca_system_score_gemma":0.00039530112,"threshold_uncertainty_score":0.32879615},"labels":[],"label_agreement":null},{"id":"W2126466275","doi":"10.1158/1078-0432.573.11.2","title":"Age- and Disease-Related Methylation of Multiple Genes in Nonneoplastic Duodenum and in Duodenal Juice","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Methylation; Duodenum; Pancreatitis; DNA methylation; CpG site; Pancreatic disease; Pancreas; Gastroenterology; Internal medicine; Cancer; Medicine; Biology; Cancer research; Pathology; Gene; Gene expression; Genetics","score_opus":0.09255907806145015,"score_gpt":0.44987726667681255,"score_spread":0.3573181886153624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126466275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97959906,0.019430416,0.00008563406,0.00054559263,0.000044318924,0.00019428694,0.000011547776,0.0000018925786,0.00008726428],"genre_scores_gemma":[0.98846734,0.010847216,0.00038456457,0.000027669104,0.00011963891,0.000027226968,0.000020119365,0.000010945535,0.00009525814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847317,0.0003790082,0.00042506153,0.00033236903,0.0001894327,0.00020093874],"domain_scores_gemma":[0.9990966,0.00042956875,0.000053840835,0.00015315626,0.0001221893,0.00014464339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016377171,0.00007469618,0.00015962803,0.000108692955,0.000031348874,0.000012963346,0.00007854744,0.00014983586,0.000011007159],"category_scores_gemma":[0.0019205583,0.00007204336,0.000029655506,0.00017695692,0.00023330041,0.0000067221285,0.00012640837,0.0002173382,0.000001383884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012372029,0.00024910035,0.7252428,0.000072593895,0.000032854707,0.000018733612,0.00014781707,0.003376679,0.19275188,0.00006306737,0.000050692084,0.07675657],"study_design_scores_gemma":[0.0025952146,0.00027958443,0.96095586,0.00007212345,0.0000133599715,6.030073e-7,0.00006368042,0.008475887,0.022595625,0.00093272096,0.0038506528,0.00016471386],"about_ca_topic_score_codex":0.00021416036,"about_ca_topic_score_gemma":0.0025016314,"teacher_disagreement_score":0.23571303,"about_ca_system_score_codex":0.00001862225,"about_ca_system_score_gemma":0.00012596624,"threshold_uncertainty_score":0.2937843},"labels":[],"label_agreement":null},{"id":"W2126640098","doi":"10.1158/1078-0432.ccr-08-2480","title":"Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Sunitinib; Medicine; Hazard ratio; Placebo; Internal medicine; Biomarker; Gastroenterology; Tyrosine-kinase inhibitor; Imatinib; GiST; Adverse effect; Confidence interval; Oncology; Stromal cell; Cancer; Pathology","score_opus":0.40999426022985846,"score_gpt":0.5692956083639206,"score_spread":0.1593013481340621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126640098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937982,0.00008729897,0.00013161133,0.0026259292,0.00014241053,0.0024438275,0.00007740191,0.000050572806,0.000642773],"genre_scores_gemma":[0.98204195,0.000008625568,0.016988752,0.00020389118,0.00025732844,0.00019885322,0.00005816029,0.000059445316,0.0001829692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921245,0.00089870824,0.002726242,0.0010021599,0.0016130533,0.0016353359],"domain_scores_gemma":[0.9922761,0.0044136825,0.00042228305,0.0006402353,0.0013322991,0.00091545103],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009042358,0.00035684355,0.0013291395,0.0004367256,0.00021063272,0.00007472433,0.0004553942,0.00012983354,0.00026308594],"category_scores_gemma":[0.028230112,0.00030778535,0.0008793719,0.00084904424,0.00042995636,0.00020431423,0.00025354503,0.0018439293,0.000033031076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027685426,0.0022453659,0.9796712,0.00031072943,0.00009396629,0.00096558884,0.000043960383,0.00000682145,0.00074899255,0.00008926144,0.0003377924,0.012717799],"study_design_scores_gemma":[0.014749239,0.011295481,0.9676745,0.0038097496,0.000060686256,0.00015236923,0.00025792752,0.0007032517,0.00016190227,0.0008639833,0.000060431274,0.00021046646],"about_ca_topic_score_codex":0.00049598876,"about_ca_topic_score_gemma":0.00025010193,"teacher_disagreement_score":0.019187754,"about_ca_system_score_codex":0.00050919846,"about_ca_system_score_gemma":0.0017065034,"threshold_uncertainty_score":0.9999374},"labels":[],"label_agreement":null},{"id":"W2126702649","doi":"10.1158/1078-0432.ccr-14-2180","title":"RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK; Francis Crick Institute","keywords":"Synthetic lethality; Biology; Olaparib; RNA interference; Cancer; Mutant; Gene silencing; Small interfering RNA; Gene; Genetic screen; Mutation; Cancer research; Computational biology; Genetics; RNA; Poly ADP ribose polymerase","score_opus":0.2867914726154852,"score_gpt":0.6023166328049955,"score_spread":0.31552516018951027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126702649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100921,0.9964634,0.0004329921,0.0001731844,0.00045207806,0.0011148066,0.00011967999,0.000017055729,0.001125842],"genre_scores_gemma":[0.00047488848,0.9933954,0.0001118395,0.000073809315,0.00340241,0.00029200592,0.00013006538,0.00010731157,0.0020123096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99527794,0.0013390895,0.0009026946,0.000979183,0.0007345054,0.0007666158],"domain_scores_gemma":[0.99689025,0.0006590254,0.00018446447,0.0013730762,0.00055528455,0.00033791357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0054511786,0.00038850008,0.0011459002,0.00010683114,0.00015701042,0.00009169349,0.0011876114,0.0007394249,0.000104575854],"category_scores_gemma":[0.0020501388,0.00025636348,0.00066901336,0.00042463272,0.0005307572,0.000002360871,0.0010342249,0.0018602859,0.00012259862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041539704,0.00004363823,0.000019754585,0.002386583,0.00028226542,0.00002532979,0.000020527263,0.000022439568,0.0000372447,0.000028426064,0.024225663,0.9728666],"study_design_scores_gemma":[0.00021865976,0.00022317377,0.000010052619,0.002733678,0.00020790193,0.000029643546,0.00002701025,0.000032221575,0.000027163918,0.000017670425,0.99616635,0.00030648345],"about_ca_topic_score_codex":0.000058542522,"about_ca_topic_score_gemma":0.000034555098,"teacher_disagreement_score":0.9725601,"about_ca_system_score_codex":0.000103613165,"about_ca_system_score_gemma":0.001267085,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W2126709547","doi":"10.1158/1078-0432.ccr-11-3090","title":"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Medicine; Internal medicine; Oncology; Biomarker; Toxicity; Phases of clinical research; Clinical endpoint; Lung cancer; Clinical trial; Biology","score_opus":0.1977189728280281,"score_gpt":0.5160958239841599,"score_spread":0.3183768511561318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126709547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855751,0.009300147,0.0000021270364,0.00055850256,0.0003725081,0.0036219521,0.000042210228,0.000026240232,0.0005012303],"genre_scores_gemma":[0.99654746,0.0013309768,0.000050519815,0.000076688106,0.00024547265,0.00075874856,0.000012729965,0.000063572516,0.00091380713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948379,0.00075512443,0.0009432678,0.000720286,0.0015726754,0.0011707458],"domain_scores_gemma":[0.99647343,0.0011312707,0.00019374317,0.00062530994,0.0009253419,0.0006508805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033145314,0.0002812326,0.0008747581,0.00039121913,0.00024025567,0.000024820822,0.000268043,0.00018959219,0.00024394532],"category_scores_gemma":[0.0008549059,0.0002003439,0.00008864985,0.0010499676,0.00081435783,0.0001666914,0.0007010311,0.0013860929,0.000006023385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009951431,0.018455952,0.94969475,0.0005030707,0.00038305626,0.00002586403,0.0026167198,0.000003619044,0.00042389394,0.0000023353286,0.0035029398,0.014436337],"study_design_scores_gemma":[0.048077878,0.021722648,0.9253666,0.0009142729,0.00022315189,8.018309e-7,0.001252373,0.00012856118,0.00052746455,0.000005671146,0.0015105166,0.00027008425],"about_ca_topic_score_codex":0.0029419127,"about_ca_topic_score_gemma":0.0013261845,"teacher_disagreement_score":0.038126446,"about_ca_system_score_codex":0.00079376536,"about_ca_system_score_gemma":0.0006288863,"threshold_uncertainty_score":0.8169787},"labels":[],"label_agreement":null},{"id":"W2126993300","doi":"10.1158/1078-0432.520.11.2","title":"Expression and Signaling Activity of Wnt-5a/Discoidin Domain Receptor-1 and Syk Plays Distinct but Decisive Roles in Breast Cancer Patient Survival","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Kungliga Fysiografiska Sällskapet i Lund; Svenska Sällskapet för Medicinsk Forskning; Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Cancer Foundation","keywords":"Syk; Wnt signaling pathway; DDR1; Cancer research; Breast cancer; Cancer; Biology; Dishevelled; Signal transduction; Metastasis; Medicine; Frizzled; Internal medicine; Cell biology; Receptor tyrosine kinase; Tyrosine kinase","score_opus":0.06817285325885358,"score_gpt":0.41406976822184216,"score_spread":0.3458969149629886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126993300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945487,0.0040755915,0.000056274792,0.0006260449,0.00013665772,0.0003164462,0.00013203811,0.0000053163017,0.00010297004],"genre_scores_gemma":[0.99445844,0.0043198126,0.00034432497,0.00004511089,0.00046138265,0.00021007411,0.0000176758,0.000025187883,0.000117965596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997459,0.0004896529,0.0005021444,0.00064897904,0.00046520788,0.0004350167],"domain_scores_gemma":[0.9988632,0.00034856898,0.0001433173,0.00021798903,0.0002354662,0.0001914339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017061473,0.00018274089,0.00035039216,0.00008277973,0.00012719801,0.00003459003,0.00021500046,0.00024741254,0.00015469387],"category_scores_gemma":[0.0002051936,0.00015377256,0.00006716753,0.00016688101,0.0005052129,0.000016283046,0.00043057854,0.00043589761,0.000001969048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002321252,0.00017509938,0.20232973,0.0000561216,0.00005331048,0.0000038601265,0.00020776664,0.00008279586,0.7210718,0.000011462889,0.0013406238,0.072346225],"study_design_scores_gemma":[0.0030999621,0.00053929084,0.13843372,0.0007257497,0.00001744157,0.0000050291264,0.0006948067,0.00008053364,0.84934694,0.0002284417,0.0062975977,0.00053049525],"about_ca_topic_score_codex":0.0004295663,"about_ca_topic_score_gemma":0.0009165284,"teacher_disagreement_score":0.12827517,"about_ca_system_score_codex":0.00008574137,"about_ca_system_score_gemma":0.00034561963,"threshold_uncertainty_score":0.6270663},"labels":[],"label_agreement":null},{"id":"W2127003779","doi":"10.1158/1078-0432.ccr-11-0034","title":"<i>BRAF-KIAA1549</i> Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McMaster Children's Hospital; McGill University Health Centre; Hospital for Sick Children; Montreal Children's Hospital","funders":"","keywords":"Fusion gene; Medicine; Oncology; Internal medicine; Multivariate analysis; Cancer research; Pathology; Biology; Gene","score_opus":0.393667423146274,"score_gpt":0.5348865283983283,"score_spread":0.14121910525205428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127003779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907869,0.0011464447,0.000004613296,0.0038093682,0.00083297933,0.0011389904,0.000024552126,0.00006860243,0.0021875512],"genre_scores_gemma":[0.9905407,0.004356407,0.00056172535,0.0015670025,0.0022064021,0.00039248922,0.000020469031,0.000058271125,0.00029654597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938514,0.00089870585,0.0019515385,0.0010271793,0.0012165365,0.0010546136],"domain_scores_gemma":[0.99591655,0.0018021271,0.0001753929,0.0008908875,0.00031760064,0.0008974337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0049546356,0.00027504828,0.0009594528,0.00043157,0.000117635434,0.00003273013,0.00040800616,0.0004945709,0.0011997529],"category_scores_gemma":[0.0015354704,0.00020657865,0.0004899362,0.00091974967,0.0004597018,0.00011296898,0.0004132467,0.0021956335,0.0007677603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013817624,0.004078663,0.9588637,0.000115111536,0.00006414114,0.0011422458,0.00007387766,4.3487597e-7,0.000019151072,0.000029867797,0.012330464,0.021900631],"study_design_scores_gemma":[0.009057082,0.0027123732,0.9832162,0.00016019489,0.00011823373,0.0000128517395,0.000031184853,0.00005808949,0.00035631703,0.00016873075,0.0039321664,0.00017655903],"about_ca_topic_score_codex":0.00046662765,"about_ca_topic_score_gemma":0.00038910157,"teacher_disagreement_score":0.02435257,"about_ca_system_score_codex":0.0002179341,"about_ca_system_score_gemma":0.00050631457,"threshold_uncertainty_score":0.9997133},"labels":[],"label_agreement":null},{"id":"W2127159621","doi":"10.1158/1078-0432.ccr-08-0351","title":"Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Genotype; Bevacizumab; Ovarian cancer; Exact test; Gastroenterology; Internal medicine; Cyclophosphamide; Allele; Progression-free survival; Medicine; Biology; Oncology; Cancer; Chemotherapy; Gene; Genetics","score_opus":0.23775193141506812,"score_gpt":0.5075417239301775,"score_spread":0.2697897925151094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127159621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989791,0.005462114,0.0000052973546,0.0035267072,0.00016906028,0.0005949126,0.000017129223,0.000031399803,0.00040242146],"genre_scores_gemma":[0.97905207,0.018497854,0.00017208309,0.00033442394,0.00060283474,0.00010179795,0.000009200273,0.00004078937,0.0011889596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964874,0.00051601743,0.0010711278,0.0007018148,0.0006257964,0.00059788366],"domain_scores_gemma":[0.9973967,0.0012704756,0.00010611204,0.00034421505,0.00025130168,0.00063121057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030455757,0.00021037852,0.000873886,0.00017470375,0.00021052665,0.000024817391,0.00012212132,0.0002839484,0.00034674502],"category_scores_gemma":[0.0008611758,0.00014929434,0.000112667745,0.0005633175,0.0010935586,0.00006790518,0.00015550005,0.0022284975,0.000007719181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030031959,0.0003789371,0.93570465,0.00006983317,0.00008454851,0.00025418308,0.00012901911,8.431096e-7,0.00006712712,0.00001514195,0.0006764839,0.059616063],"study_design_scores_gemma":[0.008346587,0.0016125287,0.98485047,0.000450976,0.000061513936,0.00006937431,0.00007679883,0.00017104334,0.00026760384,0.00003945416,0.0038567965,0.00019684316],"about_ca_topic_score_codex":0.005852798,"about_ca_topic_score_gemma":0.0012821814,"teacher_disagreement_score":0.05941922,"about_ca_system_score_codex":0.00021584003,"about_ca_system_score_gemma":0.0006204513,"threshold_uncertainty_score":0.9681837},"labels":[],"label_agreement":null},{"id":"W2127206464","doi":"10.1158/1078-0432.ccr-06-3067","title":"Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":613,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Toxicity; Body surface area; Lean body mass; Fluorouracil; Population; Medicine; Chemotherapy; Internal medicine; Body weight","score_opus":0.3008704198020518,"score_gpt":0.6177990339498245,"score_spread":0.3169286141477727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127206464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236584,0.00019804532,0.00044169548,0.0046372567,0.00017574475,0.00062900706,0.000008693261,0.00003446156,0.0015092607],"genre_scores_gemma":[0.9946965,0.0003698673,0.0009720255,0.003153039,0.00056479557,0.000028710614,0.000017188879,0.000020304073,0.00017759601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997148,0.00031241967,0.0007693201,0.00034700427,0.00094748946,0.00047580103],"domain_scores_gemma":[0.99770075,0.0006381111,0.000116004194,0.00037889232,0.00062380166,0.00054244447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0068928273,0.000094032526,0.00037966325,0.00020649916,0.0001356632,0.000014293831,0.00015553807,0.00019714325,0.00093625014],"category_scores_gemma":[0.00020722784,0.00008173571,0.000114855124,0.00030787897,0.0003158334,0.00006188764,0.000035534296,0.00093745865,0.00003489501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022799643,0.007617776,0.4949119,0.0013779943,0.00008084702,0.00042315695,0.0004336215,0.000002750624,0.15163335,0.00094309624,0.0030997621,0.31667608],"study_design_scores_gemma":[0.009207463,0.005016729,0.7259624,0.00073468895,0.00002345901,0.000024988927,0.00021503078,0.0009073796,0.24816394,0.00079955894,0.008768016,0.00017636122],"about_ca_topic_score_codex":0.00038538364,"about_ca_topic_score_gemma":0.00013575537,"teacher_disagreement_score":0.3164997,"about_ca_system_score_codex":0.00024185539,"about_ca_system_score_gemma":0.00057357014,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W2127376103","doi":"10.1158/1078-0432.ccr-05-0754","title":"Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Research Manitoba","keywords":"Apoptosis; Trastuzumab; Etoposide; Cancer research; Cell culture; Medicine; Chemistry; Breast cancer; Biology; Cancer; Chemotherapy; Internal medicine","score_opus":0.19438652816364593,"score_gpt":0.5409689330364883,"score_spread":0.34658240487284236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127376103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786486,0.0011742507,0.0003400614,0.0066288877,0.00076594,0.0016437158,0.00010110813,0.00019053453,0.0105068805],"genre_scores_gemma":[0.97898287,0.00086373393,0.0029887839,0.00087502296,0.0029332908,0.00027490116,0.000046188507,0.0001747172,0.012860504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.990336,0.0015037721,0.0013993409,0.0016610717,0.0030524998,0.0020473301],"domain_scores_gemma":[0.9939799,0.002117963,0.00014584571,0.001420345,0.0010747313,0.0012612498],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0061304113,0.00040024004,0.0009956335,0.00044920674,0.0005568197,0.00027070876,0.00063882093,0.00052580616,0.0023894848],"category_scores_gemma":[0.001727669,0.00035581674,0.0003412188,0.0013004543,0.00082768826,0.00018000454,0.0007374668,0.0028161777,0.0008857065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074071385,0.000365575,0.0038625523,0.00021256547,0.000026636946,0.000032647305,0.00010462371,0.000077533645,0.56200045,0.000014204287,0.41470793,0.01785458],"study_design_scores_gemma":[0.0023813655,0.0009993502,0.004562179,0.002725702,0.000043693224,0.000010354993,0.00029839607,0.00047891864,0.8936335,0.00015339725,0.09421549,0.0004976992],"about_ca_topic_score_codex":0.006447995,"about_ca_topic_score_gemma":0.00006851084,"teacher_disagreement_score":0.33163303,"about_ca_system_score_codex":0.0009222298,"about_ca_system_score_gemma":0.0012110764,"threshold_uncertainty_score":0.99989223},"labels":[],"label_agreement":null},{"id":"W2127518288","doi":"10.1158/1078-0432.ccr-07-4886","title":"Improving the Quality of Abstract Reporting for Phase I Cancer Trials","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Confidence interval; Odds ratio; Presentation (obstetrics); Quality Score; Rating scale; Family medicine; Quality (philosophy); Scale (ratio); Medical physics; Internal medicine; Statistics; Surgery; Mathematics","score_opus":0.983076230406273,"score_gpt":0.8466821809333631,"score_spread":0.1363940494729099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127518288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726637,0.0028635056,0.00034078586,0.018835688,0.00066196866,0.0029917085,0.00014061577,0.000039234787,0.0014628043],"genre_scores_gemma":[0.98223805,0.008341631,0.00075285044,0.0006173271,0.0027351202,0.0010272646,0.000009996751,0.000052311647,0.004225444],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98258203,0.0023741352,0.00901131,0.0010178727,0.003941142,0.0010734829],"domain_scores_gemma":[0.51967347,0.45602104,0.0068968097,0.0034310974,0.012742367,0.0012352061],"candidate_categories":["metaresearch","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2788933,0.00017582263,0.0017591813,0.00014066187,0.0005473042,0.00003296575,0.0007095597,0.00065447355,0.000929973],"category_scores_gemma":[0.699976,0.0001067402,0.0010470697,0.0006345568,0.0029493493,0.000081875914,0.00037826295,0.0058035105,0.000013967677],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04070775,0.005545396,0.25125787,0.007194376,0.0014894177,0.0002413862,0.0011470189,0.000027405644,0.09384986,0.008753911,0.03586456,0.55392104],"study_design_scores_gemma":[0.08018564,0.014809216,0.6113585,0.005303144,0.0007525189,0.00006107184,0.0027420076,0.002342487,0.15193655,0.07150777,0.05751606,0.0014850423],"about_ca_topic_score_codex":0.0053756163,"about_ca_topic_score_gemma":0.0010383376,"teacher_disagreement_score":0.55243605,"about_ca_system_score_codex":0.00025518186,"about_ca_system_score_gemma":0.007972485,"threshold_uncertainty_score":0.9999833},"labels":[],"label_agreement":null},{"id":"W2127680641","doi":"10.1158/1078-0432.ccr-05-2255","title":"Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Medicine; Internal medicine; Mucositis; Neutropenia; Cyclophosphamide; Chemotherapy; Gastroenterology; Vinblastine; Regimen; Surgery; Clinical endpoint; Performance status; Phases of clinical research; Clinical trial","score_opus":0.07054438524096894,"score_gpt":0.4518263761429414,"score_spread":0.38128199090197246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127680641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605155,0.0018122733,0.000013201813,0.00025104557,0.00022958449,0.0012557114,0.00012139536,0.00001461537,0.00025059996],"genre_scores_gemma":[0.9948273,0.0020685794,0.00043109286,0.00012960358,0.0009161283,0.00032034673,0.00022043956,0.000059520306,0.0010270118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957941,0.00049004133,0.0012384993,0.0011956828,0.0005286011,0.00075303705],"domain_scores_gemma":[0.99815416,0.00025623155,0.00027280772,0.0005859127,0.00042493385,0.00030596237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017934598,0.00032277874,0.0006608588,0.000096253214,0.00024165028,0.000051458934,0.0002699108,0.0002962989,0.000025482295],"category_scores_gemma":[0.0003740058,0.00022437163,0.00015471836,0.00035157948,0.0007261411,0.000019766043,0.0002496109,0.00043236825,0.0000043157233],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44762582,0.009993664,0.43810228,0.000041963216,0.00017508373,0.00007058058,0.000038355658,0.00020998978,0.0011466349,0.00001573167,0.0037081358,0.09887177],"study_design_scores_gemma":[0.45337796,0.12689157,0.39248055,0.00037825838,0.00007170874,0.00000207526,0.00008685932,0.00017251026,0.0034934566,0.000038582446,0.022220874,0.00078559323],"about_ca_topic_score_codex":0.0006639612,"about_ca_topic_score_gemma":0.0028691995,"teacher_disagreement_score":0.1168979,"about_ca_system_score_codex":0.00012474571,"about_ca_system_score_gemma":0.00081529235,"threshold_uncertainty_score":0.9149609},"labels":[],"label_agreement":null},{"id":"W2127783189","doi":"10.1158/1078-0432.ccr-08-2076","title":"A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Mucositis; Tolerability; Pharmacokinetics; Medicine; Toxicity; Dosing; Pharmacodynamics; Pharmacology; Internal medicine; Phases of clinical research; Gastroenterology; Adverse effect; Oncology","score_opus":0.08724902439158091,"score_gpt":0.45578113637616813,"score_spread":0.36853211198458724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127783189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969198,0.0005862707,0.000032167973,0.00089134165,0.00012704378,0.0012630227,0.000056430858,0.0000056561157,0.00011823801],"genre_scores_gemma":[0.9987601,0.00021199313,0.00017146824,0.00043974046,0.00019662506,0.00013001065,0.000019433395,0.000016620152,0.000054014363],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99755645,0.0003748133,0.0006439736,0.000540156,0.00044683786,0.00043778436],"domain_scores_gemma":[0.9984958,0.0002152857,0.00010343559,0.0005415022,0.00047729295,0.00016665595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017494765,0.0001529427,0.00035892878,0.000067488654,0.0000819213,0.000025345085,0.0003662863,0.00015280725,0.000030130384],"category_scores_gemma":[0.0008206196,0.00010248652,0.00006537561,0.00037277944,0.00038676712,0.000008011766,0.00018371317,0.00033317282,0.0000014773655],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44877028,0.0035583992,0.078183286,0.000067991794,0.00009203435,0.000012910844,0.00023387157,0.0004724382,0.043175504,0.000026954345,0.0009350702,0.42447126],"study_design_scores_gemma":[0.35393244,0.13390452,0.40955785,0.00065024634,0.000068589616,0.0000042334627,0.00015956564,0.00024152025,0.07571976,0.0011058976,0.023559185,0.0010962172],"about_ca_topic_score_codex":0.00006842428,"about_ca_topic_score_gemma":0.0002893619,"teacher_disagreement_score":0.42337504,"about_ca_system_score_codex":0.000060814302,"about_ca_system_score_gemma":0.0003575731,"threshold_uncertainty_score":0.4179279},"labels":[],"label_agreement":null},{"id":"W2127839329","doi":"10.1158/1078-0432.ccr-09-0796","title":"Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Cancer Research UK","keywords":"Cytotoxicity; Cisplatin; In vivo; Melanoma; Propidium iodide; Cancer research; Oncolytic virus; Apoptosis; Combination therapy; Biology; Combination chemotherapy; In vitro; Chemotherapy; Immunology; Pharmacology; Programmed cell death","score_opus":0.06577905292304735,"score_gpt":0.46888945951222805,"score_spread":0.4031104065891807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127839329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929232,0.0050137937,0.000018200808,0.0008470209,0.0000669603,0.0005668367,0.000007630825,0.0000061630644,0.0005501849],"genre_scores_gemma":[0.9916144,0.006970214,0.00008040687,0.00033336753,0.00028290195,0.00006984916,0.000008580408,0.000025827663,0.000614448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972325,0.00065124297,0.0005213339,0.0005724012,0.00047577324,0.00054673996],"domain_scores_gemma":[0.9985127,0.0004737584,0.00007546293,0.00054340344,0.00018555165,0.00020915488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025882148,0.00015345583,0.0003712791,0.00015872072,0.000057982546,0.000019892981,0.00036140016,0.00023535771,0.00006487474],"category_scores_gemma":[0.0008691066,0.00013518009,0.00009033816,0.00036803458,0.0004314906,0.000004095327,0.00012778824,0.00047967947,0.000008481221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085009625,0.00048350275,0.01245482,0.00014518267,0.000060774193,0.00006729867,0.00004686739,0.00002141735,0.81913465,0.000070784095,0.00090564764,0.15810812],"study_design_scores_gemma":[0.006117422,0.020267546,0.086224005,0.00026321295,0.00001152788,0.0000032962355,0.000024354536,0.00024045556,0.8821812,0.00090182427,0.0034630746,0.0003020475],"about_ca_topic_score_codex":0.0001622299,"about_ca_topic_score_gemma":0.00043712612,"teacher_disagreement_score":0.15780607,"about_ca_system_score_codex":0.000055981673,"about_ca_system_score_gemma":0.0003949763,"threshold_uncertainty_score":0.5512484},"labels":[],"label_agreement":null},{"id":"W2127851311","doi":"10.1158/1078-0432.ccr-07-5134","title":"Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Haematopoiesis; Stem cell; Biology; Effector; Cell biology; Signal transduction; Hematopoietic stem cell; Myeloid; Stem cell factor; Cancer research; Immunology","score_opus":0.3565737676871354,"score_gpt":0.5070292293159093,"score_spread":0.15045546162877393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127851311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015454902,0.9936746,0.00007933343,0.00014772687,0.0004134028,0.0029914626,0.00027588385,0.000041760723,0.00083034334],"genre_scores_gemma":[0.00348876,0.9914385,0.00004750954,0.00003674768,0.00046228114,0.00033291167,0.00009853093,0.000117858326,0.0039769197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99188316,0.0020571211,0.0025186471,0.00081895007,0.0020763602,0.0006457418],"domain_scores_gemma":[0.9902533,0.0070241564,0.000651831,0.0011093505,0.00062344957,0.0003379035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030357088,0.0004163423,0.002556075,0.00023039912,0.00019133213,0.00003311154,0.0005892634,0.0008258243,0.0007350342],"category_scores_gemma":[0.00017257499,0.00026090324,0.00095694675,0.00090749667,0.0007679948,0.00005424977,0.000104481944,0.0022273222,0.00021516377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015833124,0.00036232773,0.0001192497,0.054015644,0.00047795798,0.000056576144,0.0005383109,0.000002275726,0.00075878866,0.00007453785,0.010110541,0.93332547],"study_design_scores_gemma":[0.0010675732,0.0004158916,0.000038735627,0.032331347,0.00048037572,0.00011342434,0.00012593101,0.0000135220425,0.005568513,0.000028176933,0.9594905,0.00032601313],"about_ca_topic_score_codex":0.00007560185,"about_ca_topic_score_gemma":0.0000062919476,"teacher_disagreement_score":0.94938,"about_ca_system_score_codex":0.00030900416,"about_ca_system_score_gemma":0.0022336105,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W2128021317","doi":"10.1158/1078-0432.ccr-06-0357","title":"Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Genetic heterogeneity; Gene expression; Gene expression profiling; Cervical cancer; Gene; Molecular biology; Biology; Gene ontology; Cancer research; Cancer; Pathology; Medicine; Phenotype; Genetics","score_opus":0.35996146327319045,"score_gpt":0.5445051033131305,"score_spread":0.18454364003994006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128021317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949201,0.0024217807,0.00007265784,0.0009837802,0.00027350287,0.000841408,0.00004802728,0.00003195322,0.000406795],"genre_scores_gemma":[0.9960401,0.0010310253,0.0007750463,0.00011016178,0.0012754875,0.0005331473,0.00007965817,0.000029355422,0.0001259984],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99633646,0.0006089224,0.0009812342,0.0006153588,0.00094286085,0.0005151654],"domain_scores_gemma":[0.99825746,0.00040853035,0.0001282638,0.00043675367,0.0004671542,0.00030185486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018217054,0.00016005037,0.0006076843,0.00026630118,0.00007909829,0.000021841843,0.00020572564,0.00022637699,0.00039789677],"category_scores_gemma":[0.00034591538,0.00012325947,0.00014977076,0.0010581298,0.00026402698,0.00032447546,0.00011961038,0.00075633585,0.000014587492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007950661,0.003231512,0.86759627,0.00032102395,0.000053756805,0.00008462148,0.000073634685,0.00039608873,0.07047367,0.0001534998,0.0003120749,0.049353167],"study_design_scores_gemma":[0.01000537,0.0020479404,0.3806816,0.00049888913,0.000054953394,0.0000030403444,0.00011748516,0.00035593874,0.6033126,0.0023084148,0.00037889183,0.00023482475],"about_ca_topic_score_codex":0.0044532698,"about_ca_topic_score_gemma":0.0027048592,"teacher_disagreement_score":0.53283894,"about_ca_system_score_codex":0.00034399773,"about_ca_system_score_gemma":0.00055992184,"threshold_uncertainty_score":0.6732041},"labels":[],"label_agreement":null},{"id":"W2128168096","doi":"10.1158/1078-0432.ccr-05-1167","title":"Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Ritonavir; Protein kinase B; Cell growth; Cancer research; Chemistry; Growth inhibition; Cyclin D1; Biology; Apoptosis; Biochemistry; Cell cycle; Virology; Virus; Viral load","score_opus":0.03742455038747397,"score_gpt":0.4229952260042277,"score_spread":0.38557067561675373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128168096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944994,0.0009355336,0.000020012083,0.0017344796,0.00010289805,0.0021799202,0.00008888614,0.000009298059,0.0004295952],"genre_scores_gemma":[0.99461704,0.00035202174,0.000044396245,0.00007414421,0.0011861566,0.0014574102,0.00005552962,0.00004311396,0.002170203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99602795,0.0011237571,0.00064436556,0.00070164324,0.0008423891,0.000659895],"domain_scores_gemma":[0.9984654,0.00021298982,0.000080064936,0.0004720758,0.0005672665,0.00020215938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020092556,0.00017616138,0.00030683642,0.00020325446,0.00009368323,0.000031228592,0.00035291637,0.0004125525,0.00008997797],"category_scores_gemma":[0.00043447042,0.00015584864,0.00011689923,0.0005481898,0.00037777418,0.0000086161135,0.00023629767,0.000853118,0.00003178217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002559802,0.0013015493,0.08524896,0.00044661848,0.000019969459,0.000026798152,0.000013689798,0.00024854572,0.89502966,0.000020891139,0.009024963,0.006058556],"study_design_scores_gemma":[0.0024630676,0.0006628054,0.08769,0.00023312871,0.0000044916364,0.0000011134156,0.000006071936,0.00017879833,0.9057703,0.00006980066,0.0027574252,0.0001629857],"about_ca_topic_score_codex":0.0023556056,"about_ca_topic_score_gemma":0.0004646802,"teacher_disagreement_score":0.010740657,"about_ca_system_score_codex":0.00015996242,"about_ca_system_score_gemma":0.0011014944,"threshold_uncertainty_score":0.6355323},"labels":[],"label_agreement":null},{"id":"W2128192445","doi":"10.1158/1078-0432.ccr-07-4619","title":"Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Eli Lilly and Company; National Cancer Institute; Ludwig Institute for Cancer Research; Damon Runyon Cancer Research Foundation; Cancer Research Institute","keywords":"ELISPOT; Medicine; Internal medicine; Adverse effect; Vaccination; Immunology; Immunogenicity; Gastroenterology; Cancer; Ovarian cancer; Oncology; Antigen; Immune system; T cell","score_opus":0.04623632557742297,"score_gpt":0.3742542925332915,"score_spread":0.32801796695586855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128192445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913211,0.0073469267,0.0000062226504,0.000131359,0.00016448645,0.0008395563,0.00015116303,0.00000897531,0.00003024688],"genre_scores_gemma":[0.9777589,0.021621639,0.000017914188,0.00001135658,0.000021059344,0.000051734896,0.0000143565385,0.000020280662,0.00048276738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639803,0.0016756679,0.00094500376,0.00043530285,0.00018171182,0.00036426293],"domain_scores_gemma":[0.99743646,0.0014225926,0.00032365357,0.00038017635,0.00040069662,0.000036396563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020769928,0.00017181078,0.00062514713,0.00020056707,0.0003689017,0.0000066573,0.00023957893,0.00026397206,0.00034184303],"category_scores_gemma":[0.0005681198,0.00013034364,0.000053616233,0.00035493178,0.0005577675,0.00012532255,0.00020172769,0.00086875446,0.0000025551794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03924604,0.0016393273,0.92831135,0.000044041593,0.00029467492,0.0000046282894,0.0021019774,0.00002421524,0.006021601,0.000010503399,0.00008691166,0.02221475],"study_design_scores_gemma":[0.015943393,0.003287711,0.97305965,0.00014473774,0.000034219367,0.000002466258,0.0004168855,0.0000069862454,0.0057333624,0.000026330204,0.0012076877,0.00013655078],"about_ca_topic_score_codex":0.028595489,"about_ca_topic_score_gemma":0.00456359,"teacher_disagreement_score":0.04474834,"about_ca_system_score_codex":0.0001097434,"about_ca_system_score_gemma":0.00027339908,"threshold_uncertainty_score":0.9778732},"labels":[],"label_agreement":null},{"id":"W2128407187","doi":"10.1158/1078-0432.ccr-13-3206","title":"U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Food and drug administration; Medicine; Drug; Administration (probate law); Drug administration; Clinical pharmacology; Pharmacology; Political science; Law","score_opus":0.8812733416136131,"score_gpt":0.7414920111272241,"score_spread":0.13978133048638908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128407187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005087737,0.9805425,0.000009252247,0.0060973815,0.0008617941,0.003050115,0.0021644132,0.000041977877,0.0021448683],"genre_scores_gemma":[0.0041499482,0.9895602,0.0012510439,0.00036495962,0.002807985,0.0002878522,0.00021740238,0.00011073049,0.0012498635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97633827,0.006576907,0.010121648,0.0022509487,0.0038678553,0.00084440096],"domain_scores_gemma":[0.79684085,0.18843128,0.0025149458,0.004102949,0.0049598464,0.0031501302],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.06609555,0.0005004894,0.0064151534,0.0006647834,0.0001503992,0.000056972327,0.0012020041,0.0025898775,0.0002546569],"category_scores_gemma":[0.28964382,0.00039646868,0.0015150631,0.0020383548,0.0042533427,0.00008066694,0.0012950344,0.012697908,0.00012898658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023709682,0.0014252196,0.0023784768,0.03979022,0.0010358633,0.000026561742,0.00010000577,2.883996e-7,9.170055e-7,0.003926208,0.029174807,0.9197705],"study_design_scores_gemma":[0.0022926785,0.0071574487,0.0023178337,0.06595061,0.00071414444,0.0000042723577,0.000038830007,0.0000069435937,0.00001773514,0.0066008344,0.9145788,0.00031984242],"about_ca_topic_score_codex":0.0017743224,"about_ca_topic_score_gemma":0.00470322,"teacher_disagreement_score":0.91945064,"about_ca_system_score_codex":0.00019876311,"about_ca_system_score_gemma":0.014952764,"threshold_uncertainty_score":0.9998487},"labels":[],"label_agreement":null},{"id":"W2128452890","doi":"10.1158/1078-0432.ccr-05-2148","title":"Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gefitinib; Protein kinase B; MAPK/ERK pathway; Epidermal growth factor receptor; Cancer research; Epidermal growth factor; Cell growth; EGFR inhibitors; PI3K/AKT/mTOR pathway; Tyrosine kinase; Kinase; Biology; Cell culture; Chemistry; Medicine; Phosphorylation; Internal medicine; Signal transduction; Cancer; Cell biology; Biochemistry","score_opus":0.08137028910011788,"score_gpt":0.3888915653661901,"score_spread":0.3075212762660722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128452890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961158,0.00014349318,0.00003394529,0.002258491,0.00006212148,0.00075777847,0.00011460941,0.0000053603894,0.0005083858],"genre_scores_gemma":[0.9985837,0.000532408,0.000046168636,0.00015177853,0.0004013223,0.000088406625,0.00005269129,0.000025107667,0.000118426105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997032,0.000736003,0.00053889514,0.0006557514,0.0006142177,0.00042316047],"domain_scores_gemma":[0.9979041,0.0009222098,0.00014177409,0.0002726561,0.00064085703,0.00011837954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012054754,0.00018375505,0.00025869717,0.00017329869,0.00016022375,0.000053314438,0.00022830885,0.00032311148,0.000038825627],"category_scores_gemma":[0.0018355509,0.00013937235,0.000055194017,0.00035167343,0.0006452087,0.000029167844,0.00034318204,0.000736162,0.000004540887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014831335,0.00021338886,0.21133439,0.00014153487,0.000014818429,8.8601604e-7,0.00010606365,0.0000054560232,0.7850124,0.0002034171,0.0006861702,0.00079833856],"study_design_scores_gemma":[0.0013540435,0.00075158,0.20442347,0.00009548582,0.0000028249442,7.6154373e-7,0.00007516809,0.000026456404,0.79274386,0.00018664838,0.00022220792,0.00011750061],"about_ca_topic_score_codex":0.0021377716,"about_ca_topic_score_gemma":0.00035202698,"teacher_disagreement_score":0.007731459,"about_ca_system_score_codex":0.00005876951,"about_ca_system_score_gemma":0.00045615475,"threshold_uncertainty_score":0.568344},"labels":[],"label_agreement":null},{"id":"W2128715593","doi":"10.1158/1078-0432.ccr-09-0051","title":"MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Oncolytic virus; LNCaP; Prostate cancer; Herpes simplex virus; microRNA; Biology; Amplicon; Cancer research; Viral replication; Virus; Virology; Untranslated region; Cancer; Cancer cell; Gene; Messenger RNA; Genetics","score_opus":0.1112225201738669,"score_gpt":0.49753326473474946,"score_spread":0.38631074456088255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128715593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469095,0.0029042065,0.00010611673,0.00064399675,0.00009392514,0.0011706431,0.00020389319,0.000006610185,0.00017965496],"genre_scores_gemma":[0.9930565,0.0050847083,0.0003015103,0.00013922072,0.00045142163,0.00017705995,0.00003704989,0.00003289037,0.00071967393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734634,0.00042216803,0.00066849927,0.0005347347,0.0004876333,0.0005405976],"domain_scores_gemma":[0.9975098,0.00032108516,0.00020763544,0.00043024425,0.0013835485,0.00014771895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025599296,0.00014455941,0.00036894451,0.00011704008,0.000104312436,0.000015326725,0.0003801896,0.00023576555,0.00006330483],"category_scores_gemma":[0.00032899785,0.00013412174,0.00021169266,0.0004051248,0.00042162524,0.0000072283497,0.00008470899,0.00027963266,0.000002875738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010121417,0.00023604961,0.0004928062,0.00007819629,0.0000957271,3.8260941e-7,0.00007926247,0.00041019073,0.8128713,0.000010028633,0.0037961502,0.17180854],"study_design_scores_gemma":[0.0015380097,0.006275932,0.0018579424,0.00007300884,0.000015604972,1.8373612e-7,0.00003955146,0.00035471973,0.9720665,0.0006205303,0.017022032,0.00013595211],"about_ca_topic_score_codex":0.000269587,"about_ca_topic_score_gemma":0.000838777,"teacher_disagreement_score":0.17167258,"about_ca_system_score_codex":0.0000951088,"about_ca_system_score_gemma":0.0011098122,"threshold_uncertainty_score":0.54693264},"labels":[],"label_agreement":null},{"id":"W2128766159","doi":"10.1158/1078-0432.ccr-08-2554","title":"Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Survivin; Medicine; Bladder cancer; Cystectomy; Oncology; Hazard ratio; Internal medicine; Concordance; Cancer; Proportional hazards model; Lymphadenectomy; Urology; Confidence interval","score_opus":0.18005516118753936,"score_gpt":0.513638916897088,"score_spread":0.33358375570954857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128766159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075747,0.00034222778,0.000046572615,0.0023251255,0.00040247286,0.0051400717,0.00005707932,0.000017624174,0.00091134704],"genre_scores_gemma":[0.9959066,0.00006669335,0.00010382254,0.0004436019,0.00068680133,0.0005762853,0.00000479486,0.00002864286,0.0021827572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671876,0.0006943836,0.0006511511,0.000487584,0.0009911219,0.00045699353],"domain_scores_gemma":[0.99753714,0.0008876203,0.00011831044,0.0005797234,0.00067542103,0.00020176919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021690861,0.00016135965,0.00041578306,0.00008990197,0.00015734255,0.000033858098,0.00030961886,0.00011402986,0.00045852063],"category_scores_gemma":[0.0015367045,0.0001017952,0.0002936133,0.00031832512,0.00023511873,0.000058827853,0.00009173998,0.00050296297,0.000029671359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00596363,0.0030115866,0.9638739,0.000056955505,0.00016837334,0.000013034263,0.00037568324,0.0000015049027,0.00088771153,0.000028229622,0.0009956135,0.024623781],"study_design_scores_gemma":[0.00962807,0.006030399,0.9783204,0.00017235006,0.00024377616,0.000004664076,0.00019531853,0.00012120398,0.0038475655,0.00040568685,0.00093358645,0.00009697358],"about_ca_topic_score_codex":0.0008969876,"about_ca_topic_score_gemma":0.00015730623,"teacher_disagreement_score":0.024526808,"about_ca_system_score_codex":0.00013038074,"about_ca_system_score_gemma":0.00087869336,"threshold_uncertainty_score":0.50204796},"labels":[],"label_agreement":null},{"id":"W2128830817","doi":"10.1158/1078-0432.ccr-05-2043","title":"Lost in (the Business of) Translation: Invest in the Youth","year":2006,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Enthusiasm; Publication; Teamwork; Public relations; Dream; Psychology; Medical education; Sociology; Medicine; Political science; Law; Social psychology","score_opus":0.7993934033838257,"score_gpt":0.6432055590149117,"score_spread":0.15618784436891398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128830817","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030282833,0.0023759904,0.0000043245964,0.95565736,0.00020507826,0.002152383,0.00009053665,0.000005837001,0.009225634],"genre_scores_gemma":[0.09268977,0.003803793,0.000025086307,0.89226884,0.009142234,0.0003108139,0.00044838825,0.00005345405,0.0012576178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98759234,0.0042236806,0.0014434704,0.00054598675,0.0044154455,0.0017790791],"domain_scores_gemma":[0.9853112,0.011954195,0.00013715394,0.0010838157,0.00072346616,0.00079018634],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.028571177,0.00021463244,0.00082545023,0.0005397415,0.00007645559,0.000043790595,0.0010265328,0.0011108576,0.00038019524],"category_scores_gemma":[0.032636344,0.00011109626,0.00017535838,0.002980804,0.0016251665,0.000056639085,0.000064623215,0.014022148,0.00010211578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003543537,0.0003244662,0.01197491,0.001530226,0.000012861578,0.0010910967,0.00094287144,9.1659535e-7,0.0000016151344,0.000009116836,0.9606239,0.023133622],"study_design_scores_gemma":[0.0025552982,0.00053231907,0.090510756,0.001589775,0.000026737218,0.0000084019175,0.00034588543,0.00001934527,0.0000023636892,0.00029601192,0.90400213,0.000110968234],"about_ca_topic_score_codex":0.0084105935,"about_ca_topic_score_gemma":0.002192081,"teacher_disagreement_score":0.07853585,"about_ca_system_score_codex":0.00026688538,"about_ca_system_score_gemma":0.014624324,"threshold_uncertainty_score":0.9981925},"labels":[],"label_agreement":null},{"id":"W2128851111","doi":"10.1158/1078-0432.ccr-07-1189","title":"Plasma Stromal Cell–Derived Factor-1: Host Derived Marker Predictive of Distant Metastasis in Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Breast cancer; Medicine; Stromal cell-derived factor 1; Metastasis; Oncology; Internal medicine; Hazard ratio; Stromal cell; CA15-3; Cancer; CA 15-3; CXCR4; Confidence interval; Receptor","score_opus":0.17050428201655832,"score_gpt":0.45566968099172406,"score_spread":0.28516539897516574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128851111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954172,0.0011876067,0.000025840447,0.0013210326,0.00023955031,0.0006435069,0.0005891574,0.000024581836,0.00055154174],"genre_scores_gemma":[0.99291843,0.0058110873,0.00015733624,0.00006274426,0.0004491966,0.00015393169,0.000021725862,0.00004904327,0.00037650578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996006,0.00045952952,0.0009826104,0.00066105276,0.0011609298,0.0007298604],"domain_scores_gemma":[0.99728674,0.0009925662,0.00017155222,0.00041743828,0.00067047647,0.00046122062],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011593428,0.00023421837,0.000921408,0.0002300845,0.00012519691,0.000013619617,0.00026015087,0.00024163093,0.0035668216],"category_scores_gemma":[0.00035479866,0.00018769052,0.00030396399,0.0006966078,0.00088225346,0.00009559998,0.00021262743,0.0013470787,0.000012059051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007018147,0.0009371402,0.84563994,0.0002686015,0.0002662696,0.00017270094,0.00067747344,0.00002453746,0.13752076,0.0000037434768,0.002036788,0.0054339226],"study_design_scores_gemma":[0.005539973,0.0005994619,0.9007971,0.00046715507,0.000068899295,0.00001796182,0.0005616738,0.00077391585,0.08990498,0.000009804055,0.0010436663,0.00021536955],"about_ca_topic_score_codex":0.0024692728,"about_ca_topic_score_gemma":0.00031170237,"teacher_disagreement_score":0.055157226,"about_ca_system_score_codex":0.00043967107,"about_ca_system_score_gemma":0.0013670265,"threshold_uncertainty_score":0.9973441},"labels":[],"label_agreement":null},{"id":"W2128942433","doi":"10.1158/1078-0432.ccr-07-1984","title":"Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"PDGFRA; GiST; Sunitinib; Cancer research; Imatinib; Tyrosine kinase; Exon; Dasatinib; Tyrosine-kinase inhibitor; Biology; Medicine; Stromal tumor; Imatinib mesylate; Stromal cell; Cancer; Internal medicine; Gene; Receptor; Genetics","score_opus":0.2226870164576549,"score_gpt":0.48617680277974806,"score_spread":0.2634897863220932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128942433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975013,0.00013192387,0.00016097352,0.00087966374,0.00003720881,0.00057039637,0.000031237378,0.00003390497,0.0006533563],"genre_scores_gemma":[0.9972496,0.00032436976,0.0012875611,0.00004353521,0.0004818461,0.00008585909,0.000045430184,0.000029718754,0.00045207472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667966,0.0003415973,0.0006468227,0.00042607522,0.0012420024,0.0006638446],"domain_scores_gemma":[0.9975717,0.00035047063,0.0001203301,0.00038633804,0.0009733542,0.0005978196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011288715,0.00014311717,0.00042956742,0.0002752135,0.00011674835,0.000009980514,0.0001946304,0.00004160053,0.0003796481],"category_scores_gemma":[0.0017069384,0.00011796871,0.00020351287,0.0006882693,0.00060179597,0.000061366554,0.00014472034,0.00087051035,0.00009078464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012750947,0.00091430556,0.9510243,0.0001276994,0.000031083502,0.0027600443,0.000014732603,0.0000018845799,0.04240693,0.00010837316,0.00029453327,0.0010410338],"study_design_scores_gemma":[0.0020556801,0.005378393,0.9831269,0.00019602233,0.000033757766,0.00093189406,0.000016005897,0.00012503621,0.007913185,0.000039814535,0.000101798876,0.00008151061],"about_ca_topic_score_codex":0.00013719304,"about_ca_topic_score_gemma":0.00000343148,"teacher_disagreement_score":0.034493744,"about_ca_system_score_codex":0.00012449238,"about_ca_system_score_gemma":0.001236911,"threshold_uncertainty_score":0.4810624},"labels":[],"label_agreement":null},{"id":"W2128973831","doi":"10.1158/1078-0432.ccr-07-0213","title":"L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; MUC1; Peptide vaccine; Oncology; Lung cancer; Internal medicine; Phases of clinical research; Clinical trial; Immunotherapy; Immunology; Cancer; Immune system; Antigen; Epitope","score_opus":0.26149908534422905,"score_gpt":0.5451270522815505,"score_spread":0.2836279669373214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128973831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003200731,0.9900771,0.000007735909,0.00009786991,0.001617179,0.0024598134,0.00015193071,0.0000522181,0.0023354506],"genre_scores_gemma":[0.00033948213,0.94886714,0.000009283334,0.00013348213,0.00047290372,0.001289604,0.00015154165,0.00015909638,0.048577476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98897594,0.0045933714,0.002736806,0.0013775227,0.00021779808,0.0020985883],"domain_scores_gemma":[0.9920536,0.0056598997,0.00053551444,0.0012386885,0.00039589027,0.00011635764],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.008817039,0.00076788425,0.00342288,0.0010945405,0.00032379566,0.000076857235,0.0017655973,0.0025211119,0.0061215134],"category_scores_gemma":[0.0004741942,0.0006097757,0.0010742024,0.0015784652,0.0006017423,0.00010549641,0.00054649485,0.007973143,0.0011453012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014168671,0.0005440105,0.00054165634,0.0072229416,0.0006415001,0.000103220525,0.000089288085,0.0000027804222,0.00014145041,0.000023029394,0.020885488,0.9683878],"study_design_scores_gemma":[0.002747953,0.00051818375,0.00073068496,0.011734728,0.00023933138,0.000020652218,0.00007651602,0.0000018418357,0.00013105203,0.000011012728,0.98315954,0.0006285018],"about_ca_topic_score_codex":0.0045129443,"about_ca_topic_score_gemma":0.0018216914,"teacher_disagreement_score":0.96775925,"about_ca_system_score_codex":0.0007242678,"about_ca_system_score_gemma":0.004402192,"threshold_uncertainty_score":0.99963534},"labels":[],"label_agreement":null},{"id":"W2129051737","doi":"10.1158/1078-0432.ccr-08-2080","title":"Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Medicine; Oncology; Adenocarcinoma; Nucleoside transporter; Internal medicine; Adjuvant therapy; Deoxycytidine; Nucleoside analogue; Chemoradiotherapy; Radiation therapy; Gastroenterology; Chemotherapy; Nucleoside; Cancer; Transporter; Biology","score_opus":0.0951877190489821,"score_gpt":0.43583357500775016,"score_spread":0.34064585595876806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129051737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949236,0.007820283,0.00004468537,0.00083025836,0.00006522501,0.00074305234,0.00007409837,0.000022473609,0.00090758206],"genre_scores_gemma":[0.99668485,0.001392186,0.000055931057,0.0005077872,0.0006416264,0.0001404463,0.00012554698,0.000046371362,0.0004052556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618626,0.0007066144,0.00088442815,0.00095021696,0.00049912586,0.000773365],"domain_scores_gemma":[0.99873614,0.00013408673,0.000105030325,0.00046920727,0.0002446388,0.00031088002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012693598,0.0003206574,0.00058639795,0.00012138259,0.00018141167,0.00005943572,0.00035429004,0.00036284185,0.0005559563],"category_scores_gemma":[0.00005259376,0.00027083038,0.00017441083,0.00029933843,0.00067133916,0.000029363939,0.000054129923,0.0008555543,0.0000031441177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004152654,0.0006229112,0.77913624,0.00004807841,0.00026861095,0.00033432574,0.001143399,0.000018120243,0.21011995,0.00033788546,0.0021890556,0.0016287871],"study_design_scores_gemma":[0.004492396,0.0036884027,0.9772033,0.00016729157,0.00003709229,0.0000039714,0.00023738854,0.00003113548,0.012024502,0.0006838163,0.0010650709,0.00036561175],"about_ca_topic_score_codex":0.00037068813,"about_ca_topic_score_gemma":0.0006496273,"teacher_disagreement_score":0.19809544,"about_ca_system_score_codex":0.000041071915,"about_ca_system_score_gemma":0.000196537,"threshold_uncertainty_score":0.99997437},"labels":[],"label_agreement":null},{"id":"W2129204208","doi":"10.1158/1078-0432.ccr-08-2138","title":"Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Changhai Hospital of Shanghai","keywords":"PI3K/AKT/mTOR pathway; Cancer; Cancer research; Angiogenesis; Lymph node; Malignancy; Immunohistochemistry; Medicine; Tissue microarray; Metastasis; RPTOR; Pathology; Biology; Internal medicine; Signal transduction","score_opus":0.04266997979009579,"score_gpt":0.4012280669517324,"score_spread":0.3585580871616366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129204208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433625,0.0044555524,0.00003974938,0.000111086716,0.00007167803,0.0004503314,0.0004334065,0.0000054431416,0.00009649717],"genre_scores_gemma":[0.99722415,0.0015953432,0.0007991862,0.000052863776,0.00011010168,0.00007068917,0.000057710506,0.000026204942,0.00006374265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736375,0.00030402147,0.00070555886,0.0005278294,0.0007200758,0.00037877166],"domain_scores_gemma":[0.9979199,0.00012876061,0.00036626696,0.00043891714,0.00095842,0.00018772847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095466006,0.00018975524,0.0005024969,0.00011459045,0.0000486153,0.000008077222,0.00034145164,0.00022658102,0.00012529694],"category_scores_gemma":[0.00046657282,0.00013891397,0.00011879691,0.0005203873,0.0005259046,0.00001068199,0.00016136107,0.0002509817,3.3731243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030122788,0.0005038886,0.8639965,0.00017694317,0.00016626542,8.6527155e-7,0.000041775642,0.00021024942,0.12355246,0.0000015623747,0.00073535764,0.007601838],"study_design_scores_gemma":[0.0030812682,0.0020430782,0.6733891,0.00040171284,0.000042741336,4.084217e-7,0.000013037222,0.000078230216,0.3203955,0.000052122105,0.00035421367,0.00014860737],"about_ca_topic_score_codex":0.00034585688,"about_ca_topic_score_gemma":0.000018497341,"teacher_disagreement_score":0.19684304,"about_ca_system_score_codex":0.00004105958,"about_ca_system_score_gemma":0.00048734903,"threshold_uncertainty_score":0.56647474},"labels":[],"label_agreement":null},{"id":"W2129219564","doi":"10.1158/1078-0432.ccr-05-1266","title":"Combination Bcl-2 Antisense and Radiation Therapy for Nasopharyngeal Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Radiation therapy; Nasopharyngeal carcinoma; Combination therapy; Cancer; Medicine; Cancer research; Apoptosis; In vitro; In vivo; Chemotherapy; Pharmacology; Internal medicine; Biology","score_opus":0.12311765098564023,"score_gpt":0.4946832448766778,"score_spread":0.3715655938910376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129219564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792936,0.016049445,0.00037727077,0.0032613645,0.00028746412,0.00059204665,0.000026941862,0.000008034415,0.00010382571],"genre_scores_gemma":[0.9363347,0.059627026,0.00019622072,0.00028778592,0.0015975367,0.00019500274,0.00007773177,0.000017514458,0.0016664376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989344,0.00013186966,0.0002171684,0.0003265386,0.00017621146,0.00021383534],"domain_scores_gemma":[0.99938905,0.000084842686,0.000050693918,0.00015072893,0.00023536565,0.000089335335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010604827,0.00007354203,0.00011334697,0.000041462266,0.00014851597,0.00003063573,0.0000780839,0.00017247863,0.00005139717],"category_scores_gemma":[0.000092337505,0.0000634162,0.0000614718,0.000074522766,0.00010810663,0.00000670313,0.000041677093,0.00012313375,0.0000027396152],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055395276,0.00012160625,0.00395619,0.000018501523,0.00003668408,3.384577e-7,0.000026822492,0.000041685496,0.13132164,0.00040350438,0.009155958,0.85436314],"study_design_scores_gemma":[0.0058863326,0.0014594368,0.08249126,0.00002721333,0.000014448005,0.0000018773104,0.000023240447,0.0045716353,0.11808422,0.0009124941,0.78628683,0.0002409845],"about_ca_topic_score_codex":0.000071179384,"about_ca_topic_score_gemma":0.00013633793,"teacher_disagreement_score":0.85412216,"about_ca_system_score_codex":0.000028192504,"about_ca_system_score_gemma":0.00012681416,"threshold_uncertainty_score":0.25860375},"labels":[],"label_agreement":null},{"id":"W2129272684","doi":"10.1158/1078-0432.ccr-11-0267","title":"BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Diffuse large B-cell lymphoma; Rituximab; Vincristine; Internal medicine; Oncology; CHOP; Lymphoma; Medicine; Germinal center; Survival analysis; Cohort; Cyclophosphamide; B cell; Immunology; Chemotherapy; Antibody","score_opus":0.18120615402389872,"score_gpt":0.4198209906312234,"score_spread":0.2386148366073247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129272684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891072,0.0032853698,0.0000013335336,0.00038116143,0.00017447614,0.0011006638,0.00008219963,0.000048562415,0.005819042],"genre_scores_gemma":[0.98464054,0.011935832,0.0000930565,0.00051267195,0.00022683885,0.0004354006,0.00003596056,0.000061503895,0.0020582224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996147,0.00052320486,0.0006129975,0.0008789068,0.00086290424,0.00097499165],"domain_scores_gemma":[0.997793,0.00056804024,0.00009563933,0.00063504174,0.0002719229,0.00063635857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013936913,0.0003121884,0.0007603606,0.00022073908,0.00014241556,0.00004765645,0.00021981905,0.00026760742,0.00040338817],"category_scores_gemma":[0.000055669967,0.00020535412,0.00014613324,0.00043332097,0.0004927563,0.00011003643,0.00016312557,0.0004659057,0.00008883904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008117849,0.053912535,0.9116398,0.00009067284,0.00012451934,0.0011169397,0.00043703595,2.216289e-8,0.000032296386,0.00001736054,0.0017060464,0.022804914],"study_design_scores_gemma":[0.15959056,0.003476397,0.8208601,0.00021688464,0.000055464687,0.000022405524,0.00016772775,0.000053848802,0.00085387676,0.000015721555,0.014482486,0.00020450687],"about_ca_topic_score_codex":0.002559373,"about_ca_topic_score_gemma":0.0009735265,"teacher_disagreement_score":0.15147272,"about_ca_system_score_codex":0.00031813307,"about_ca_system_score_gemma":0.0005634741,"threshold_uncertainty_score":0.8374098},"labels":[],"label_agreement":null},{"id":"W2129421122","doi":"10.1158/1078-0432.ccr-06-0417","title":"Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"U.S. Public Health Service","keywords":"Medicine; Prostate cancer; Prostatectomy; Biochemical recurrence; Urology; Cancer; Biopsy; Prostate; Hyperplasia; Internal medicine; Prostate-specific antigen; Gastroenterology","score_opus":0.06217896681813289,"score_gpt":0.45919158165975277,"score_spread":0.39701261484161987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129421122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926059,0.0033371907,0.0002129799,0.00045865457,0.00016213613,0.0019845355,0.000087531385,0.000012504979,0.0011385712],"genre_scores_gemma":[0.9920562,0.0009368319,0.0001975938,0.00016009847,0.0007604402,0.0019081347,0.0001407571,0.00003425359,0.0038057049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971571,0.00036040804,0.0005738416,0.0008248668,0.00040064234,0.0006831314],"domain_scores_gemma":[0.9985402,0.00033988472,0.00006841461,0.0003368061,0.0005485028,0.00016619779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025732173,0.00017632222,0.00029326542,0.00007975566,0.00012963364,0.00007011047,0.00033418302,0.00029590825,0.000104848055],"category_scores_gemma":[0.0019552317,0.00015497896,0.00013416364,0.0003349415,0.0004893015,0.000007634303,0.0002000121,0.0005600111,0.000026512971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018045964,0.00064632786,0.97498107,0.00024632382,0.00006724177,0.000039541716,0.000056061715,0.00003509353,0.007315707,0.00025644415,0.006441002,0.00811059],"study_design_scores_gemma":[0.008029702,0.0040479335,0.7050514,0.00048219148,0.00006628276,0.00003718012,0.00034852923,0.0008364219,0.123666935,0.005905776,0.15049212,0.0010355257],"about_ca_topic_score_codex":0.0004531299,"about_ca_topic_score_gemma":0.0018048658,"teacher_disagreement_score":0.26992968,"about_ca_system_score_codex":0.000055269647,"about_ca_system_score_gemma":0.0011702765,"threshold_uncertainty_score":0.63198584},"labels":[],"label_agreement":null},{"id":"W2129471398","doi":"10.1158/1078-0432.ccr-06-3085","title":"Imaging and Modulating Antisense Microdistribution in Solid Human Xenograft Tumor Models","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"University of Pennsylvania","keywords":"Biodistribution; Tumor microenvironment; Distribution (mathematics); Apoptosis; Necrosis; Cancer research; Tumor hypoxia; Hypoxia (environmental); Pathology; Chemistry; Medicine; Radiation therapy; Tumor cells; In vitro; Internal medicine; Biochemistry; Oxygen","score_opus":0.1504211699665401,"score_gpt":0.5180432461237009,"score_spread":0.3676220761571608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129471398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934891,0.004475096,0.0011050275,0.00019500052,0.00008889027,0.00017799909,0.000021066113,0.0000070932992,0.00044075475],"genre_scores_gemma":[0.9980732,0.00086726464,0.00014444858,0.00017255325,0.00057175884,0.000014638851,0.000035155295,0.000020424493,0.000100519115],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99817836,0.00015363266,0.00044465743,0.0004906861,0.00021171439,0.0005209234],"domain_scores_gemma":[0.99926937,0.0000713498,0.00006194234,0.0002476318,0.00020747226,0.00014225436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032220792,0.000105695144,0.0001771117,0.00007925771,0.0001735851,0.000036026926,0.00014289962,0.000108593544,0.000015630347],"category_scores_gemma":[0.0001502867,0.00010306631,0.0000817537,0.00018085013,0.00033878337,0.000007515664,0.0002218555,0.00028972284,0.0000022036909],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028893905,0.00012975247,0.33313316,0.00004300756,0.000027260081,0.000049554932,0.000045260775,0.00014277158,0.63312024,0.00020713973,0.0020050541,0.03080784],"study_design_scores_gemma":[0.003921617,0.0006455515,0.5391165,0.00031996262,0.000026488766,0.000038645143,0.0006081745,0.007561751,0.42947924,0.0020006604,0.015425498,0.0008558833],"about_ca_topic_score_codex":0.00045849304,"about_ca_topic_score_gemma":0.0006187865,"teacher_disagreement_score":0.20598337,"about_ca_system_score_codex":0.000052307463,"about_ca_system_score_gemma":0.000105069055,"threshold_uncertainty_score":0.4202922},"labels":[],"label_agreement":null},{"id":"W2129522972","doi":"10.1158/1078-0432.ccr-07-0318","title":"Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Leukemia and Lymphoma Society","keywords":"Medicine; Neutropenia; Tolerability; Depsipeptide; Pharmacology; Pharmacodynamics; Internal medicine; Leukemia; Myeloid leukemia; Oncology; Pharmacokinetics; Chemotherapy; Adverse effect; Biology","score_opus":0.12817282416867606,"score_gpt":0.4773455310330927,"score_spread":0.3491727068644166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129522972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967944,0.0019085596,0.000012196179,0.00014511438,0.00016252515,0.00080461346,0.00010863205,0.000010328566,0.00005364136],"genre_scores_gemma":[0.9838645,0.014608177,0.0005136004,0.000056247824,0.00011912903,0.00014587666,0.000042980722,0.0000498091,0.0005996827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964041,0.0005768585,0.0007362056,0.00080402324,0.0007877579,0.0006910448],"domain_scores_gemma":[0.9975719,0.00059638644,0.00013508169,0.0004661621,0.00096255506,0.00026793662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012434406,0.00024569948,0.00061462086,0.00019504312,0.00018283929,0.0000111593135,0.0003931981,0.00018819016,0.000033432396],"category_scores_gemma":[0.0012043915,0.00019039787,0.000080180755,0.0004959182,0.002322134,0.000014998977,0.0005498246,0.0007687675,0.000005932485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030091804,0.0016478077,0.80985934,0.000790572,0.0013922818,0.0006568055,0.00062603597,0.0013231112,0.122761674,0.000007825234,0.0054278453,0.02541493],"study_design_scores_gemma":[0.038783804,0.018636107,0.760138,0.000924161,0.00023534817,0.00019401418,0.0005651896,0.0010376559,0.16936207,0.000080571204,0.008336328,0.0017067452],"about_ca_topic_score_codex":0.00010805388,"about_ca_topic_score_gemma":0.00058615045,"teacher_disagreement_score":0.049721308,"about_ca_system_score_codex":0.00028209403,"about_ca_system_score_gemma":0.0011756694,"threshold_uncertainty_score":0.85559994},"labels":[],"label_agreement":null},{"id":"W2129567747","doi":"10.1158/1078-0432.ccr-09-2824","title":"Cancer Stem Cells and Self-renewal","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":474,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cancer; Cancer stem cell; Context (archaeology); Stem cell; Cancer cell; Biology; Cancer research; Confusion; Neuroscience; Cell biology; Psychology; Genetics","score_opus":0.4688566519017544,"score_gpt":0.611672748125227,"score_spread":0.14281609622347258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129567747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028738342,0.99256605,9.564827e-7,0.00051431573,0.0021994847,0.002004083,0.00036473825,0.00007421761,0.0019887914],"genre_scores_gemma":[0.000018991035,0.98227525,0.00017067863,0.00020297874,0.0044495203,0.0010752016,0.000020657184,0.00015424135,0.011632462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99428356,0.00076799316,0.0013961124,0.0013528134,0.0011773399,0.0010221995],"domain_scores_gemma":[0.9954299,0.0014915819,0.00030543757,0.0010792274,0.0005427154,0.0011511387],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003921059,0.00050925993,0.0032862583,0.0003404347,0.00019220728,0.00010386965,0.0004570511,0.0011625581,0.0016822764],"category_scores_gemma":[0.00012175125,0.00036408904,0.000896694,0.0007873966,0.0008829652,0.000049210917,0.00050182414,0.0053045503,0.00021623824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079958794,0.00025742536,0.00008801612,0.017465483,0.0004489498,0.00007873421,0.000025560248,2.9188177e-8,0.0000049455966,0.000028026108,0.015567106,0.9659558],"study_design_scores_gemma":[0.00096725445,0.0003347203,0.00001068529,0.009088081,0.0016915157,0.000025039555,0.0000128453485,0.0000011250868,0.000035007877,0.000018304627,0.9874794,0.00033603652],"about_ca_topic_score_codex":0.0014364881,"about_ca_topic_score_gemma":0.00091560005,"teacher_disagreement_score":0.97191226,"about_ca_system_score_codex":0.00045343474,"about_ca_system_score_gemma":0.005848042,"threshold_uncertainty_score":0.9998811},"labels":[],"label_agreement":null},{"id":"W2129726505","doi":"10.1158/1078-0432.ccr-05-1109","title":"Strategies for Delaying or Treating<i>In vivo</i>Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Trastuzumab; In vivo; Breast cancer; Medicine; Acquired resistance; Human breast; Oncology; Cancer; Internal medicine; Cancer research; Biology; Biotechnology","score_opus":0.276028954774144,"score_gpt":0.5780301207621373,"score_spread":0.3020011659879933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129726505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706702,0.0021063222,0.00009867468,0.013112736,0.00033454446,0.0043440294,0.0004569888,0.00009834551,0.008778142],"genre_scores_gemma":[0.97884136,0.0006017819,0.00077888614,0.00048332257,0.0021018318,0.0051357932,0.000020125479,0.0001396983,0.01189721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923752,0.00070558436,0.0017167472,0.0014034521,0.0017144032,0.0020846399],"domain_scores_gemma":[0.99554217,0.0020011417,0.00012946367,0.0008372295,0.00090653467,0.0005834792],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059699123,0.00036745946,0.0011030626,0.00087322557,0.00032231165,0.00019986345,0.0006886587,0.00038450176,0.0015840447],"category_scores_gemma":[0.000690495,0.0003116832,0.00024073392,0.0026794479,0.00067640364,0.00022483696,0.000214684,0.0012864138,0.000022266979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043593325,0.003503259,0.6226859,0.0035442866,0.00019956798,0.0012694254,0.0018008333,0.0011999657,0.03175789,0.0033765796,0.23968458,0.047384396],"study_design_scores_gemma":[0.034318686,0.00557103,0.7129303,0.0115643125,0.00011780632,0.000044294502,0.0060278773,0.0012039925,0.007958958,0.0050059007,0.21337196,0.0018848431],"about_ca_topic_score_codex":0.031468928,"about_ca_topic_score_gemma":0.25506195,"teacher_disagreement_score":0.22359303,"about_ca_system_score_codex":0.0024788608,"about_ca_system_score_gemma":0.004561378,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W2129802843","doi":"10.1158/1078-0432.ccr-06-0527","title":"Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Antigen; Urothelium; Immunohistochemistry; Cancer; Medicine; Bladder cancer; Cancer research; Cancer vaccine; Immunogenicity; Immunotherapy; Carcinoma; Pathology; Oncology; Urinary bladder; Immunology; Internal medicine","score_opus":0.10172343922386193,"score_gpt":0.43310771858183345,"score_spread":0.33138427935797155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129802843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803564,0.01784828,0.000031190903,0.00034504954,0.00042592117,0.00039947056,0.000027966153,0.000028317061,0.0005374193],"genre_scores_gemma":[0.993642,0.0014704585,0.000019425015,0.000038195452,0.0001497172,0.00012893602,0.000031400916,0.000026339634,0.0044935374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970087,0.0014056732,0.0004958951,0.00044442163,0.00012221633,0.0005231381],"domain_scores_gemma":[0.99844897,0.000993437,0.00009384088,0.00027964995,0.00015864635,0.000025477406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016378397,0.00015358269,0.00035027403,0.00018799216,0.00037431135,0.00003267865,0.0002104273,0.0003086691,0.0005225335],"category_scores_gemma":[0.00013648889,0.00011920248,0.0000507193,0.0002913235,0.00094332965,0.00011076881,0.000099597266,0.0009846266,0.00003326063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030962008,0.00018894204,0.6233353,0.000018668756,0.000025988564,0.000015799582,0.00012229847,0.000020182668,0.3637885,0.00030147936,0.00092689384,0.008159764],"study_design_scores_gemma":[0.0047900546,0.00076894776,0.919958,0.00022293947,0.000009543947,0.000008686362,0.00011700291,0.000011448652,0.057547893,0.00018006325,0.016185744,0.00019968467],"about_ca_topic_score_codex":0.014813185,"about_ca_topic_score_gemma":0.0024081205,"teacher_disagreement_score":0.3062406,"about_ca_system_score_codex":0.00008515212,"about_ca_system_score_gemma":0.0003060078,"threshold_uncertainty_score":0.99174726},"labels":[],"label_agreement":null},{"id":"W2129890171","doi":"10.1158/1078-0432.ccr-03-0561","title":"Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitors","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":381,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Bortezomib; Sodium butyrate; Apoptosis; Histone deacetylase inhibitor; Histone deacetylase; Proteasome inhibitor; Chemistry; Pharmacology; Cancer research; Biology; Multiple myeloma; Biochemistry; Histone; Immunology","score_opus":0.05259905812903075,"score_gpt":0.42632650504431585,"score_spread":0.3737274469152851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129890171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594486,0.001865041,0.000022891507,0.0007712507,0.00015364378,0.0010761099,0.00009585294,0.00000878882,0.00006156661],"genre_scores_gemma":[0.9977409,0.0009100753,0.00010050033,0.00004482757,0.00041612354,0.00037202163,0.00003754528,0.00004206766,0.00033592427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654746,0.00075920776,0.00074580585,0.0007836169,0.0006204309,0.00054350676],"domain_scores_gemma":[0.9984779,0.00025630713,0.00016077237,0.00049232726,0.0003447541,0.00026794532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027355244,0.00021512862,0.00036439506,0.00019763611,0.00028166047,0.00004045053,0.00029005943,0.0003788379,0.000013918218],"category_scores_gemma":[0.0014078398,0.00017778102,0.00008482685,0.00047064046,0.0022800427,0.000019448038,0.00047517318,0.001040809,0.00000416571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052606594,0.00032053379,0.0020136582,0.00008555764,0.000035147637,0.0000031510147,0.00018450218,0.000016153963,0.9872316,0.000031499985,0.0047566574,0.004795466],"study_design_scores_gemma":[0.0019809103,0.0010947451,0.0023543336,0.00013405833,0.000009843219,0.0000018861231,0.00026744787,0.000010253744,0.9914126,0.000102316364,0.0024342486,0.00019738253],"about_ca_topic_score_codex":0.0023220382,"about_ca_topic_score_gemma":0.00076385494,"teacher_disagreement_score":0.0045980834,"about_ca_system_score_codex":0.0002232664,"about_ca_system_score_gemma":0.00042991547,"threshold_uncertainty_score":0.8400912},"labels":[],"label_agreement":null},{"id":"W2130227695","doi":"10.1158/1078-0432.ccr-11-2893","title":"L1 Cell Adhesion Molecule Promotes Tumorigenicity and Metastatic Potential in Non–Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cell adhesion molecule; Cancer; Cell adhesion; Cancer research; Cell; Lung cancer; Medicine; Pathology; Lung; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.18954530492282795,"score_gpt":0.455530337104357,"score_spread":0.265985032181529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130227695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965099,0.0010861934,0.00012878454,0.0002351956,0.0007464631,0.00097406463,0.00003949322,0.000032476677,0.00024739295],"genre_scores_gemma":[0.99571913,0.0025270786,0.00011168439,0.00045782165,0.00032603065,0.00025620105,8.464966e-7,0.000059911603,0.00054128765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99469364,0.0016423969,0.000658184,0.00094535796,0.00085185707,0.0012085584],"domain_scores_gemma":[0.9972653,0.0015301129,0.00013826817,0.00038560832,0.00011411834,0.0005666214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020104076,0.00025068328,0.0004397677,0.00021546672,0.00027131013,0.00009986361,0.00048590897,0.000114910144,0.00027847724],"category_scores_gemma":[0.0008096157,0.00021655414,0.00012710842,0.000660852,0.00029366533,0.00020802762,0.0005511951,0.0011198559,0.000059757127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025076407,0.0008034869,0.01718749,0.00024173014,0.0000037434402,0.00014646462,0.0001301014,0.000031769512,0.98012656,0.000052100026,0.00029215834,0.0007336497],"study_design_scores_gemma":[0.0011275165,0.00036081826,0.014003709,0.000058812737,0.000033812335,0.0000063448433,0.000028238535,0.0035587205,0.98034173,0.000045372275,0.00020341451,0.00023153187],"about_ca_topic_score_codex":0.0005178097,"about_ca_topic_score_gemma":0.00012569934,"teacher_disagreement_score":0.003526951,"about_ca_system_score_codex":0.00009041575,"about_ca_system_score_gemma":0.00024676253,"threshold_uncertainty_score":0.88308215},"labels":[],"label_agreement":null},{"id":"W2130368065","doi":"10.1158/1078-0432.ccr-12-1175","title":"Optimizing Cancer Treatments to Induce an Acute Immune Response: Radiation Abscopal Effects, PAMPs, and DAMPs","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Abscopal effect; Immune system; Cancer; Medicine; Immunology; Bystander effect; Cancer research; Immunotherapy; Internal medicine","score_opus":0.2939837311303082,"score_gpt":0.6082649828642805,"score_spread":0.31428125173397237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130368065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028794874,0.9635724,0.000007781007,0.00092450937,0.0010364333,0.0053431764,0.00017774125,0.00008551287,0.000057599274],"genre_scores_gemma":[0.0011207847,0.98985356,0.0006881015,0.00027014423,0.002625877,0.0032479374,0.00024320095,0.00019985599,0.0017505502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901605,0.0048068147,0.0013844147,0.0012659748,0.0012407267,0.0011415598],"domain_scores_gemma":[0.9903322,0.0060268966,0.00040790316,0.0012866361,0.00040077546,0.0015456254],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00866685,0.0006123866,0.0028117844,0.0007580206,0.0002963078,0.00013112734,0.00049084227,0.0010745266,0.00024165632],"category_scores_gemma":[0.0026378708,0.00048179057,0.00045025247,0.0011269938,0.0003018344,0.0002957259,0.00033095942,0.0026770511,0.0002121664],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017925589,0.00032332246,0.0007607906,0.0056213643,0.0010976885,0.00008913267,0.00021376918,0.0000024432732,0.00006608889,0.000008436136,0.0010316453,0.98899275],"study_design_scores_gemma":[0.003136666,0.004109123,0.014347015,0.011985424,0.0030508363,0.000036494133,0.0000129159025,0.000018438346,0.00005449221,0.0000046247,0.9627098,0.0005342147],"about_ca_topic_score_codex":0.00051262474,"about_ca_topic_score_gemma":0.000042936124,"teacher_disagreement_score":0.9884586,"about_ca_system_score_codex":0.0015353359,"about_ca_system_score_gemma":0.002668591,"threshold_uncertainty_score":0.99976337},"labels":[],"label_agreement":null},{"id":"W2130493310","doi":"10.1158/1078-0432.ccr-07-1655","title":"Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non–Small Cell Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Massachusetts General Hospital","keywords":"Haplotype; Odds ratio; Genotype; Adenocarcinoma; Lung cancer; Internal medicine; Oncology; Vascular endothelial growth factor; Confidence interval; Angiogenesis; Risk factor; Metastasis; Biology; Adenocarcinoma of the lung; Medicine; Cancer; Gastroenterology; Genetics; VEGF receptors; Gene","score_opus":0.09929758452073889,"score_gpt":0.40676638897279505,"score_spread":0.30746880445205615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130493310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9286772,0.06916658,0.0003598521,0.00011576172,0.00026209382,0.0005143914,0.000220413,0.000006656042,0.0006770563],"genre_scores_gemma":[0.8095625,0.18822016,0.00014122696,0.00016972434,0.0009863357,0.00016663707,0.000009249411,0.000037301877,0.00070685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744004,0.0006263083,0.00046985695,0.0005746608,0.00042942647,0.00045972248],"domain_scores_gemma":[0.99830526,0.00036630355,0.0001562461,0.0005291457,0.0004644965,0.00017856891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015449318,0.0001824584,0.00037626995,0.00004700374,0.00029888243,0.000017138835,0.00045480626,0.00026928185,0.00017442228],"category_scores_gemma":[0.00040132867,0.000120949655,0.0003433801,0.00016797445,0.0011815946,0.0000044116778,0.00033514696,0.00045514968,0.000006053311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022741118,0.0002535565,0.9298299,0.0002724259,0.0009704691,0.000010684992,0.00045479074,0.00007820173,0.04272255,0.00014926812,0.016138822,0.006845246],"study_design_scores_gemma":[0.013278601,0.00089373474,0.70015126,0.00009141592,0.00044292305,0.0000093160215,0.00018943191,0.0010203836,0.17078501,0.000268821,0.11202324,0.0008458643],"about_ca_topic_score_codex":0.003199908,"about_ca_topic_score_gemma":0.0003179576,"teacher_disagreement_score":0.22967862,"about_ca_system_score_codex":0.000034281282,"about_ca_system_score_gemma":0.0006907807,"threshold_uncertainty_score":0.4932184},"labels":[],"label_agreement":null},{"id":"W2130626169","doi":"10.1158/1078-0432.ccr-08-2034","title":"Alternate Endpoints for Screening Phase II Studies","year":2009,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Surrogate endpoint; Clinical trial; Clinical endpoint; Medicine; Oncology; Phases of clinical research; Clinical study design; Endpoint Determination; Internal medicine; Progression-free survival; Intensive care medicine; Overall survival","score_opus":0.8305681950274587,"score_gpt":0.737661612883971,"score_spread":0.09290658214348768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130626169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030617457,0.99163884,0.000043237535,0.00072237384,0.0015675295,0.0046654805,0.00021278346,0.00007247384,0.0007711309],"genre_scores_gemma":[0.00007293603,0.98415935,0.0017361466,0.00033526498,0.0044136234,0.0023309428,0.000083056555,0.00014592838,0.006722745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99328005,0.00077417033,0.0019430472,0.0014054601,0.0013833257,0.0012139517],"domain_scores_gemma":[0.9918651,0.004740558,0.0004027469,0.001046484,0.0013283922,0.0006167043],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0063553792,0.00055895554,0.004045752,0.00044036144,0.00039202694,0.000045667326,0.0007358934,0.0007057393,0.00043007516],"category_scores_gemma":[0.0071768486,0.00040914826,0.0014944418,0.00071787403,0.00081551087,0.00004590295,0.00065590267,0.0029375972,0.00007562561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078779017,0.00041166184,0.000010245911,0.01221732,0.0009665313,0.000061017374,0.000040320734,3.1221947e-7,0.0000013471566,0.000016450023,0.03778391,0.9477031],"study_design_scores_gemma":[0.0035474403,0.008014404,0.000004850549,0.027043963,0.0010350879,0.000026481655,0.000027184473,0.000013474111,0.00001811201,0.00030571056,0.9596208,0.000342506],"about_ca_topic_score_codex":0.00003440493,"about_ca_topic_score_gemma":0.000038287282,"teacher_disagreement_score":0.9473606,"about_ca_system_score_codex":0.0007729799,"about_ca_system_score_gemma":0.0023222861,"threshold_uncertainty_score":0.999836},"labels":[],"label_agreement":null},{"id":"W2130742597","doi":"10.1158/1078-0432.ccr-06-1248","title":"Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Microsatellite instability; Comparative genomic hybridization; Genome instability; Chromosome instability; Biology; Cancer; Colorectal cancer; Fluorescence in situ hybridization; Chromosome; Microsatellite; Cancer research; Genetics; Gene; DNA","score_opus":0.16768312542311398,"score_gpt":0.5015137866955154,"score_spread":0.3338306612724014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130742597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979344,0.012266225,0.0000026409325,0.0023082783,0.0004465075,0.0011126493,0.00006974656,0.000038814298,0.004411102],"genre_scores_gemma":[0.99156296,0.004225548,0.0003070252,0.00026505545,0.0005809823,0.00044974792,0.00001393498,0.00004198481,0.0025527466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607456,0.0004490655,0.00083408924,0.00088216667,0.000785652,0.000974444],"domain_scores_gemma":[0.9976665,0.00095582724,0.00007840725,0.0005078406,0.00047794156,0.00031350213],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003037757,0.00020603855,0.00063459016,0.00018655224,0.00014215209,0.00006083889,0.00020958511,0.00033671313,0.0017287973],"category_scores_gemma":[0.0005985257,0.00018317312,0.00009518934,0.0008929925,0.001139722,0.00009650878,0.00027251837,0.0014022375,0.000029637667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015678982,0.0004775838,0.9575374,0.00027961997,0.000023838935,0.00004902236,0.00007913969,0.00003960054,0.022098517,0.000060107173,0.004927009,0.012860224],"study_design_scores_gemma":[0.0037924785,0.00087391434,0.8956933,0.00029642307,0.000027639284,0.000008318812,0.000091746384,0.00031429442,0.023127155,0.0009343563,0.074577875,0.00026251978],"about_ca_topic_score_codex":0.024289208,"about_ca_topic_score_gemma":0.015534461,"teacher_disagreement_score":0.069650866,"about_ca_system_score_codex":0.0009259381,"about_ca_system_score_gemma":0.0016309953,"threshold_uncertainty_score":0.9991838},"labels":[],"label_agreement":null},{"id":"W2130754064","doi":"10.1158/1078-0432.ccr-04-2326","title":"Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Placebo; Medicine; Lignan; Internal medicine; Endocrinology; Breast cancer; Cancer; Excretion; Estrogen receptor; Apoptosis; Gastroenterology; Pathology; Biology; Biochemistry","score_opus":0.22389807704100073,"score_gpt":0.5382547488973091,"score_spread":0.31435667185630833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130754064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96736485,0.0031332504,6.599907e-7,0.026287675,0.0002722161,0.0010954051,0.00010196614,0.000050311257,0.0016936854],"genre_scores_gemma":[0.99046963,0.0040186527,0.0001286753,0.0018917036,0.0021698312,0.00042597347,0.000020894182,0.000044863384,0.0008297464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99475676,0.0010602112,0.0007571259,0.0008747144,0.0011195022,0.0014316753],"domain_scores_gemma":[0.99690866,0.0012771442,0.0000642303,0.00051938556,0.00037086508,0.000859713],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048117116,0.000239123,0.00070102426,0.00033868026,0.00015906243,0.000041541127,0.0004276794,0.00025601414,0.00249858],"category_scores_gemma":[0.00064101565,0.0001618373,0.00021224732,0.00090220437,0.0011688193,0.00011673825,0.00034885807,0.0025441085,0.00026328806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012192478,0.001755624,0.69058526,0.00017520374,0.00022912852,0.00088409433,0.00006459765,0.00004093505,0.01701809,0.000029923865,0.01806609,0.2589586],"study_design_scores_gemma":[0.0040088664,0.0021529046,0.9797758,0.0003768016,0.000022193513,0.00007183399,0.0001064365,0.00096616114,0.0006920251,0.000057899546,0.011536012,0.00023308452],"about_ca_topic_score_codex":0.002267884,"about_ca_topic_score_gemma":0.0006434114,"teacher_disagreement_score":0.28919056,"about_ca_system_score_codex":0.00064175593,"about_ca_system_score_gemma":0.0012535413,"threshold_uncertainty_score":0.99975705},"labels":[],"label_agreement":null},{"id":"W2130808338","doi":"10.1158/1078-0432.ccr-09-1467","title":"MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":378,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"National Institutes of Health; Howard Hughes Medical Institute","keywords":"Adenocarcinoma; Tissue microarray; Medicine; Esophagus; microRNA; Cancer; Carcinogenesis; Oncology; Carcinoma; Stage (stratigraphy); Pathology; Internal medicine; Esophageal cancer; Biology; Gene","score_opus":0.06184540703168849,"score_gpt":0.3949153091517561,"score_spread":0.3330699021200676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130808338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886892,0.010291758,0.000011295326,0.0004796401,0.00004965605,0.00029121977,0.000029880208,0.0000023652547,0.00015498333],"genre_scores_gemma":[0.99940985,0.000092206916,0.00008111691,0.0000578074,0.00014307993,0.000016510303,0.000014278063,0.000010563115,0.00017459007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983946,0.0004645592,0.00029621503,0.00031989158,0.00028886017,0.00023589021],"domain_scores_gemma":[0.999141,0.00012487995,0.00010068523,0.0003602029,0.00018889303,0.00008437371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008650879,0.0000831188,0.00015111685,0.000043071374,0.00008022656,0.000014178756,0.0002325083,0.00015473655,0.000012430676],"category_scores_gemma":[0.00026919277,0.000058641344,0.00005990147,0.00021025045,0.00022625773,0.000004189524,0.00013098767,0.00026815763,8.929879e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024736117,0.0001462017,0.82834464,0.000017984197,0.0000036480608,0.0000020773116,0.00003955478,0.00002115358,0.17007035,0.00001078935,0.00064340065,0.00045285773],"study_design_scores_gemma":[0.00090624235,0.00026203203,0.8218706,0.000017884395,0.00000623744,5.979124e-7,0.000037097358,0.000016503382,0.17667228,0.00006438939,0.00008747617,0.000058662084],"about_ca_topic_score_codex":0.00009886045,"about_ca_topic_score_gemma":0.00018983484,"teacher_disagreement_score":0.010720645,"about_ca_system_score_codex":0.00004236648,"about_ca_system_score_gemma":0.00028720585,"threshold_uncertainty_score":0.23913246},"labels":[],"label_agreement":null},{"id":"W2131040288","doi":"10.1158/1078-0432.ccr-05-2249","title":"Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; NONMEM; Population; Body surface area; Renal function; Urology; Medicine; Creatinine; Population pharmacokinetics; Pharmacology; Internal medicine","score_opus":0.20776488926564352,"score_gpt":0.5311713751562727,"score_spread":0.32340648589062915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131040288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899803,0.0021320474,0.00003739462,0.0019828929,0.00020060163,0.00047238256,0.00008804115,0.000026473892,0.005079875],"genre_scores_gemma":[0.99650395,0.0009565673,0.00031355058,0.000102454775,0.0007316211,0.000080325975,0.00005712678,0.000020102221,0.001234299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980463,0.000090570225,0.00059056544,0.00031949917,0.00061323575,0.00033986793],"domain_scores_gemma":[0.9987005,0.00040674835,0.00008951754,0.00023244087,0.00045115507,0.00011966375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007467813,0.00011371647,0.00047896785,0.00013312465,0.00009015674,0.000010631286,0.00009479533,0.000087871595,0.0002539942],"category_scores_gemma":[0.00025746232,0.00008683039,0.00016316108,0.00047169888,0.00027880401,0.000035939065,0.0000832494,0.00038726602,0.000010442169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002122526,0.001235053,0.94690305,0.00014571266,0.00021115081,0.000028876682,0.00004079714,0.000034010798,0.004667074,0.0005276207,0.008745955,0.035338175],"study_design_scores_gemma":[0.0035585873,0.00096069044,0.9829649,0.00009022724,0.000102955695,0.0000036488823,0.000031179046,0.00029671236,0.0008475376,0.00024196698,0.010818048,0.000083590174],"about_ca_topic_score_codex":0.008044103,"about_ca_topic_score_gemma":0.0015349055,"teacher_disagreement_score":0.03606181,"about_ca_system_score_codex":0.00016767076,"about_ca_system_score_gemma":0.00013860686,"threshold_uncertainty_score":0.99856144},"labels":[],"label_agreement":null},{"id":"W2131053533","doi":"10.1158/1078-0432.ccr-04-2528","title":"Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Serous fluid; Carcinoma; Serous carcinoma; Endometrial cancer; Clear cell carcinoma; Ovarian cancer; Cancer; Ovarian carcinoma; Pathology; Internal medicine; Biomarker; Biology","score_opus":0.31802781249648887,"score_gpt":0.5754897536771071,"score_spread":0.2574619411806182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131053533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94259155,0.011574409,0.0002594793,0.04194384,0.0008684452,0.0016041055,0.00013374828,0.00015439617,0.0008700474],"genre_scores_gemma":[0.92885745,0.0027021552,0.0006937789,0.0022118324,0.007980831,0.00028168855,0.00005910021,0.000091402144,0.057121743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641585,0.00018018798,0.00089768815,0.000749355,0.0008178603,0.0009390531],"domain_scores_gemma":[0.9977069,0.00031943616,0.00012433167,0.00057757646,0.00053066673,0.0007410875],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017445487,0.0002434159,0.00058656174,0.00018420863,0.00035155183,0.000074984986,0.00030957675,0.0003097632,0.00471153],"category_scores_gemma":[0.00029349123,0.00021103442,0.00040608644,0.00041440406,0.0003469509,0.00014882178,0.00020323887,0.0005808231,0.000097869146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002233477,0.00055034447,0.1065289,0.0003591612,0.0004509265,0.00007339801,0.00018664025,0.00006120162,0.0063731386,0.0003071354,0.26614445,0.6167312],"study_design_scores_gemma":[0.006788619,0.00090813084,0.4552202,0.00030932872,0.0001175367,0.000016555081,0.000041457995,0.0020493332,0.001775774,0.0006988223,0.53174955,0.00032470797],"about_ca_topic_score_codex":0.0026878214,"about_ca_topic_score_gemma":0.00217402,"teacher_disagreement_score":0.6164065,"about_ca_system_score_codex":0.00025670012,"about_ca_system_score_gemma":0.0011494395,"threshold_uncertainty_score":0.9961983},"labels":[],"label_agreement":null},{"id":"W2131505683","doi":"10.1158/1078-0432.ccr-12-2745","title":"Changing the Way We Do Business: Recommendations to Accelerate Biomarker Development in Pancreatic Cancer","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Medicine; Pancreatic cancer; Food and drug administration; Pancreatic ductal adenocarcinoma; Cancer; Biomarker; Internal medicine; Adenocarcinoma; Disease; Oncology; Drug development; Drug; Pharmacology","score_opus":0.6160954965165775,"score_gpt":0.6202262790805119,"score_spread":0.004130782563934399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131505683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021337592,0.9675462,0.000023539977,0.021095451,0.0006043392,0.0065370044,0.00004572284,0.00003638345,0.001977552],"genre_scores_gemma":[0.00009664398,0.96562386,0.0005818431,0.00054432644,0.0009887649,0.01733134,0.00008086845,0.000108647306,0.014643721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991357,0.0024351631,0.0021455814,0.0011219459,0.0012246877,0.0017155774],"domain_scores_gemma":[0.99050844,0.006185784,0.00027906845,0.0010931697,0.0012425376,0.0006909952],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.011045068,0.0005038099,0.0031903442,0.0014039762,0.00051312783,0.00016494024,0.000986923,0.00069516234,0.007035111],"category_scores_gemma":[0.003305649,0.00029125618,0.00032882445,0.004998252,0.00055804604,0.000095508985,0.0009929253,0.0030663474,0.0016920939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011258259,0.00025024405,0.003741716,0.006312257,0.0005382937,0.00004624172,0.00038421567,2.5040592e-7,7.543634e-7,0.000027928301,0.033420827,0.9551647],"study_design_scores_gemma":[0.00078707363,0.000113301125,0.0050471863,0.03620135,0.00036737332,0.000011673231,0.0002558078,0.0000260157,9.4317244e-7,0.00003388611,0.95685786,0.0002975478],"about_ca_topic_score_codex":0.0010151479,"about_ca_topic_score_gemma":0.00083374424,"teacher_disagreement_score":0.9548671,"about_ca_system_score_codex":0.0017737143,"about_ca_system_score_gemma":0.008966599,"threshold_uncertainty_score":0.999954},"labels":[],"label_agreement":null},{"id":"W2131525679","doi":"10.1158/1078-0432.ccr-12-1315","title":"Vascular Endothelial Growth Factor Pathway Polymorphisms as Prognostic and Pharmacogenetic Factors in Cancer: A Systematic Review and Meta-analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; Memorial University of Newfoundland","funders":"","keywords":"Angiogenesis; Medicine; Cancer; Vascular endothelial growth factor; Pharmacogenetics; Internal medicine; Metastasis; Endostatin; Oncology; Cancer research; Meta-analysis; Pharmacology; Biology; VEGF receptors; Genotype; Genetics; Gene","score_opus":0.3506542912261175,"score_gpt":0.5183297164893457,"score_spread":0.16767542526322815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131525679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010101079,0.99398214,0.0000045511424,0.00009575928,0.00010979692,0.00376851,0.0009990316,0.000009209334,0.000020888618],"genre_scores_gemma":[0.0041788197,0.98986626,0.000011490391,0.0003228366,0.00034365215,0.004528276,0.00011827069,0.00010413645,0.0005262479],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99238646,0.0029018833,0.0017512129,0.0013808521,0.0007160485,0.00086353865],"domain_scores_gemma":[0.99692637,0.00085000903,0.00053784956,0.0008190927,0.00031756438,0.00054911507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003082595,0.0007065821,0.0063003222,0.00034187982,0.00013178015,0.00007771955,0.0006317483,0.00064280775,0.0007268831],"category_scores_gemma":[0.00096365163,0.00045750325,0.0027790267,0.00093529123,0.00044262677,0.000010181008,0.0005352651,0.0007689982,0.00001546964],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003636301,0.000319082,0.0045392993,0.8013832,0.17193347,0.000023219998,0.000044565742,4.943763e-7,0.000054922963,0.000016927317,0.0003065672,0.021341871],"study_design_scores_gemma":[0.0005333873,0.00038055688,0.00031677217,0.015867837,0.727818,0.000014411895,0.000015883077,0.0000016631716,0.00014212585,0.000009672527,0.2537095,0.001190191],"about_ca_topic_score_codex":0.000811813,"about_ca_topic_score_gemma":0.0003229591,"teacher_disagreement_score":0.78551537,"about_ca_system_score_codex":0.000109861154,"about_ca_system_score_gemma":0.0009303732,"threshold_uncertainty_score":0.9997877},"labels":[],"label_agreement":null},{"id":"W2131555383","doi":"10.1158/1078-0432.ccr-04-0224","title":"The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":425,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Adenocarcinoma; Nucleoside analogue; Immunohistochemistry; Medicine; Nucleoside transporter; Internal medicine; Oncology; Chemotherapy; Nucleoside; Cancer; Pathology; Cancer research; Gastroenterology; Biology; Transporter","score_opus":0.06715783176234653,"score_gpt":0.39105214755343554,"score_spread":0.323894315791089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131555383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839675,0.0005712774,0.000009537143,0.00029912396,0.000025455358,0.00035293528,0.000038284794,0.0000061045002,0.00030052633],"genre_scores_gemma":[0.99936527,0.00010358119,0.000019512314,0.00005859277,0.00009285618,0.000045989753,0.00007438023,0.000028751372,0.00021106497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791884,0.00029520487,0.0004391648,0.00043470878,0.00049059716,0.00042148778],"domain_scores_gemma":[0.99874234,0.00017118691,0.00013100525,0.0003574943,0.00048739396,0.00011055576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000888333,0.00014715183,0.00027465133,0.000043693854,0.00014355949,0.000021300673,0.00032836452,0.00015818124,0.000035456265],"category_scores_gemma":[0.0001319101,0.00009026466,0.000066764325,0.00037240624,0.00060386705,0.000009276426,0.00006506736,0.0004034909,0.0000014538109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021637678,0.0002960472,0.98972195,0.00001038181,0.00019172343,0.000014742865,0.00014636629,0.000053874035,0.0069031212,0.00006253567,0.00032049546,0.00011498992],"study_design_scores_gemma":[0.0041639744,0.002374351,0.9709043,0.00015953778,0.000019297353,3.2397216e-7,0.00011396813,0.000003699082,0.02192826,0.00011709615,0.000060484814,0.00015472062],"about_ca_topic_score_codex":0.00079557666,"about_ca_topic_score_gemma":0.0007958033,"teacher_disagreement_score":0.018817669,"about_ca_system_score_codex":0.000045935652,"about_ca_system_score_gemma":0.0003363734,"threshold_uncertainty_score":0.3680886},"labels":[],"label_agreement":null},{"id":"W2131593373","doi":"10.1158/1078-0432.ccr-08-0196","title":"Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1511,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous ovarian cancer; Ovarian cancer; Cancer; Medicine; Oncology; Ovary; Internal medicine; Biology; Cancer research; Pathology","score_opus":0.4324944750005766,"score_gpt":0.571834478133757,"score_spread":0.1393400031331804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131593373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783769,0.0050913896,0.00014173942,0.013580197,0.000665146,0.0012507336,0.00011228773,0.00003491781,0.00074668153],"genre_scores_gemma":[0.98179877,0.011789291,0.0023644632,0.0018680712,0.00088890747,0.00038407533,0.000007947798,0.000054077213,0.0008443767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955547,0.00033861317,0.0014871827,0.0009188719,0.001040998,0.0006596665],"domain_scores_gemma":[0.99508536,0.0022007194,0.0001666467,0.00076995254,0.0008211695,0.0009561336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003089142,0.00023319843,0.001191708,0.00034545758,0.00014168171,0.000021458907,0.00026610645,0.00032663322,0.00052732445],"category_scores_gemma":[0.002909845,0.000185897,0.00034466994,0.0010977971,0.00077555317,0.00005477591,0.0002976453,0.0010795342,0.000055455046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015857668,0.0014475946,0.95139426,0.00012716895,0.00046089594,0.00027133187,0.0001047839,0.000009527462,0.00069324765,0.00023160453,0.0027098139,0.040963985],"study_design_scores_gemma":[0.0083612725,0.0023948555,0.9657253,0.00023223906,0.00015441986,0.00003129343,0.000029585655,0.000030356023,0.00088833494,0.000048451213,0.0219179,0.00018601098],"about_ca_topic_score_codex":0.0037528651,"about_ca_topic_score_gemma":0.0003720825,"teacher_disagreement_score":0.040777978,"about_ca_system_score_codex":0.00024108107,"about_ca_system_score_gemma":0.0012133018,"threshold_uncertainty_score":0.758066},"labels":[],"label_agreement":null},{"id":"W2132257982","doi":"10.1158/1078-0432.ccr-08-0804","title":"Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chorioallantoic membrane; Doxorubicin; Medicine; Neuroblastoma; Angiogenesis; In vivo; Apoptosis; Neovascularization; Ovarian cancer; Immunohistochemistry; Pathology; Cancer research; Cancer; Debulking; Chemotherapy; Internal medicine; Biology; Cell culture","score_opus":0.21763588018107674,"score_gpt":0.49284517797519733,"score_spread":0.2752092977941206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132257982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994156,0.0016653962,0.0000747444,0.0007621122,0.0018215226,0.0007852428,0.000058142996,0.00013665875,0.0005401819],"genre_scores_gemma":[0.9950294,0.0015910076,0.00093177933,0.00026166724,0.0014354573,0.000079159276,0.0000090479525,0.000055700788,0.00060681783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9901271,0.0027517353,0.0026134208,0.0012572167,0.002013717,0.0012367957],"domain_scores_gemma":[0.9903563,0.005936296,0.00044817675,0.001440703,0.001134572,0.0006839475],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.010460378,0.00028186486,0.0012302385,0.00021448293,0.00035718444,0.000053288477,0.0012675265,0.000409137,0.0018387227],"category_scores_gemma":[0.007809041,0.0002351536,0.0006272845,0.0012131494,0.00305696,0.00029927588,0.00051575404,0.0015538727,0.001117161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025069888,0.002499244,0.035714667,0.00010179796,0.00008885605,0.0001684422,0.00016288315,0.00026674735,0.9447379,0.00022889113,0.008213701,0.005309862],"study_design_scores_gemma":[0.0048104157,0.00093612407,0.17230275,0.0001550784,0.00003775203,0.0000065131467,0.00003317824,0.0002163782,0.8185402,0.00013397334,0.002515419,0.00031219667],"about_ca_topic_score_codex":0.0006518031,"about_ca_topic_score_gemma":0.00009866019,"teacher_disagreement_score":0.13658808,"about_ca_system_score_codex":0.00010220202,"about_ca_system_score_gemma":0.0015735405,"threshold_uncertainty_score":0.9996606},"labels":[],"label_agreement":null},{"id":"W2132268633","doi":"10.1158/1078-0432.ccr-06-0812","title":"The Combi-Targeting Concept: <i>In vitro</i> and <i>In vivo</i> Fragmentation of a Stable Combi-Nitrosourea Engineered to Interact with the Epidermal Growth Factor Receptor while Remaining DNA Reactive","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cyclization and Aryne Chemistry","field":"Chemistry","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Canada; Royal Victoria Hospital; Royal Victoria Regional Health Centre","funders":"Cancer Research Society","keywords":"In vivo; DU145; Comet assay; Molecular biology; Epidermal growth factor receptor; In vitro; Biology; Chemistry; DNA damage; Cancer cell; Biochemistry; Receptor; DNA; Cancer; LNCaP","score_opus":0.05636942584909254,"score_gpt":0.39265585542737724,"score_spread":0.3362864295782847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132268633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994318,0.00029595743,0.00009315185,0.002619362,0.000067331566,0.0002909681,0.00008269752,0.000018917184,0.0022136006],"genre_scores_gemma":[0.99869573,0.00017559489,0.00012188416,0.00026723018,0.0001647542,0.00007069995,0.000028296015,0.00003074398,0.00044508706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975034,0.00020493298,0.0007459107,0.00041305437,0.0005523918,0.00058031065],"domain_scores_gemma":[0.9932834,0.0057481746,0.0001921139,0.00028343132,0.00030294064,0.00018992767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026950026,0.00016807372,0.0003394308,0.00006115155,0.00019449239,0.000072593495,0.00034353114,0.0001310488,0.00027613525],"category_scores_gemma":[0.0014602044,0.00011280803,0.000060020076,0.00050419464,0.0003939435,0.00012541555,0.00017153361,0.0011192532,0.0000024398792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036280404,0.00020573295,0.038203705,0.0001270183,0.000053224398,0.000011982287,0.0027216892,0.00006394796,0.9474578,0.00004627476,0.004829044,0.002651534],"study_design_scores_gemma":[0.0020800817,0.00007663531,0.0029978587,0.0003073479,0.0000067340166,0.0000015569634,0.006807792,0.0003095216,0.9800813,0.000032169017,0.0071161566,0.0001828009],"about_ca_topic_score_codex":0.0003796195,"about_ca_topic_score_gemma":0.0003550597,"teacher_disagreement_score":0.035205845,"about_ca_system_score_codex":0.0001948127,"about_ca_system_score_gemma":0.00016416691,"threshold_uncertainty_score":0.48626605},"labels":[],"label_agreement":null},{"id":"W2132365366","doi":"10.1158/1078-0432.ccr-09-2944","title":"Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Tolerability; Lung cancer; Regimen; Internal medicine; Response Evaluation Criteria in Solid Tumors; Adverse effect; Pharmacokinetics; Oncology; Pharmacology; Gastroenterology; Phases of clinical research; Chemotherapy; Cisplatin","score_opus":0.09942401494546313,"score_gpt":0.4720793940494459,"score_spread":0.3726553791039827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132365366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944774,0.0026807531,0.0000029414427,0.000041045347,0.0001850236,0.0022441335,0.00015077455,0.0000044023427,0.00021352185],"genre_scores_gemma":[0.99526334,0.0023118926,0.00007715425,0.000038237187,0.00020711852,0.0009794107,0.000043899418,0.000041320734,0.0010376107],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763,0.0002793572,0.0005505782,0.00077636197,0.0003115397,0.00045217166],"domain_scores_gemma":[0.99849874,0.000101713245,0.00016778147,0.00049063755,0.00051128486,0.00022984775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008572496,0.00022410975,0.00049302075,0.00014709558,0.00009896089,0.00004825043,0.00036275378,0.00021954287,0.00006926907],"category_scores_gemma":[0.000094385585,0.00016531296,0.000060000722,0.0004828608,0.000255747,0.000010232536,0.00033348484,0.00031062405,8.8665837e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004853616,0.020140855,0.8824349,0.00005381288,0.00019617149,0.000019651407,0.00024109094,0.0000024156511,0.05571605,7.4570994e-7,0.0015486691,0.03479204],"study_design_scores_gemma":[0.25890717,0.109635144,0.2939261,0.00035800037,0.00042176462,0.0000023898704,0.0011337906,0.00064067787,0.32209164,0.000006489976,0.011707567,0.0011692686],"about_ca_topic_score_codex":0.0066353865,"about_ca_topic_score_gemma":0.017308896,"teacher_disagreement_score":0.5885088,"about_ca_system_score_codex":0.00006113822,"about_ca_system_score_gemma":0.000543453,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W2132557004","doi":"10.1158/1078-0432.ccr-06-1539","title":"First Study of the Safety, Tolerability, and Pharmacokinetics of CP-724,714 in Patients with Advanced Malignant Solid HER2-Expressing Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Tolerability; Rash; Pharmacokinetics; Adverse effect; Gastroenterology; Internal medicine; Nausea; Dosing; Pharmacodynamics; Cmax; Toxicity; Pharmacology","score_opus":0.14627582029163708,"score_gpt":0.5347873946819192,"score_spread":0.38851157439028206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132557004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526775,0.00044235037,0.000008388403,0.0008391081,0.00013795504,0.0027838955,0.00002638375,0.000010177902,0.00048397822],"genre_scores_gemma":[0.99904436,0.00042678017,0.00011878908,0.00007225881,0.00011783486,0.00007864534,0.00000211555,0.000045397614,0.00009382299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939594,0.00072711846,0.0015242059,0.00066326646,0.002327927,0.0007980845],"domain_scores_gemma":[0.99558604,0.0018458064,0.00024546686,0.0009087343,0.0010694137,0.0003445519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007431003,0.0001951778,0.000836161,0.00023749155,0.00013720582,0.000017156655,0.00052195037,0.00012934706,0.00017319105],"category_scores_gemma":[0.001515948,0.0001255723,0.00008679118,0.0011982861,0.0014335493,0.000069814494,0.0007135029,0.0015358926,0.0000016444017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007918871,0.0030928773,0.95741993,0.0005726839,0.000060453527,0.000026554433,0.0008301279,0.00023079415,0.00047787366,0.000005057582,0.00013242109,0.029232351],"study_design_scores_gemma":[0.010113853,0.0049965,0.9763444,0.0015917792,0.00003119589,0.0000012743567,0.000831921,0.00013730589,0.0050423,0.00003684484,0.00074564666,0.00012699621],"about_ca_topic_score_codex":0.001307867,"about_ca_topic_score_gemma":0.0020583058,"teacher_disagreement_score":0.029105354,"about_ca_system_score_codex":0.000327796,"about_ca_system_score_gemma":0.00069697667,"threshold_uncertainty_score":0.66727746},"labels":[],"label_agreement":null},{"id":"W2133155058","doi":"10.1158/1078-0432.ccr-10-1161","title":"Primary CNS Lymphoma in Children and Adolescents: A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG)","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Chemotherapy; Methotrexate; Internal medicine; Univariate analysis; Hazard ratio; Odds ratio; Primary central nervous system lymphoma; Oncology; Retrospective cohort study; Radiation therapy; Lymphoma; Multivariate analysis; Pediatrics; Confidence interval","score_opus":0.10238581394737113,"score_gpt":0.40287852568233323,"score_spread":0.3004927117349621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133155058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957944,0.0047582653,0.000011385228,0.0020306078,0.00019242488,0.0011721728,0.00047139797,0.000029218885,0.0017550781],"genre_scores_gemma":[0.98929,0.0073492588,0.0003474059,0.0016058004,0.00043585978,0.00047341117,0.000329122,0.000035301433,0.00013381611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960183,0.00066310924,0.00077757303,0.00094133045,0.0010597066,0.0005399612],"domain_scores_gemma":[0.9974039,0.0009428492,0.00016090319,0.0006375525,0.00050146715,0.00035332196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001644057,0.00026701126,0.000772036,0.00034874873,0.0001812393,0.00009443458,0.00048465614,0.00021837276,0.0004224376],"category_scores_gemma":[0.00047244143,0.00018296878,0.00028173413,0.0015251971,0.0008245653,0.00016777372,0.00055322616,0.0003463505,0.000045429162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024467185,0.0028616763,0.8767389,0.000011267341,0.0022800092,0.00010999148,0.0012082242,3.8622096e-7,0.00003147099,0.00007517198,0.003291239,0.11094494],"study_design_scores_gemma":[0.009449547,0.0004755976,0.9868146,0.00028630745,0.00058449066,0.000007661742,0.0006113764,0.000043298667,0.000080817576,0.00017576972,0.0012977184,0.00017281117],"about_ca_topic_score_codex":0.015821576,"about_ca_topic_score_gemma":0.0042655226,"teacher_disagreement_score":0.11077213,"about_ca_system_score_codex":0.0016787372,"about_ca_system_score_gemma":0.001090964,"threshold_uncertainty_score":0.99073213},"labels":[],"label_agreement":null},{"id":"W2133164395","doi":"10.1158/1078-0432.ccr-05-2049","title":"An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Osteopontin; Medicine; Lung cancer; Lung; Tumor hypoxia; Tumor progression; Pathology; Hypoxia (environmental); Immunohistochemistry; Cancer; Internal medicine; Chemistry","score_opus":0.058019308844871754,"score_gpt":0.4131657608518553,"score_spread":0.3551464520069835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133164395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686176,0.0019250289,0.00008250513,0.000013429686,0.00018321458,0.0006666693,0.000053420747,0.0000027940673,0.00021119825],"genre_scores_gemma":[0.99817556,0.00052007975,0.00030549665,0.000024999863,0.0005599024,0.0001355338,0.000094419986,0.000020096704,0.00016390433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794716,0.0003871593,0.00034432416,0.00044867722,0.00060289935,0.0002697548],"domain_scores_gemma":[0.9987326,0.000031676038,0.0001194746,0.00030621528,0.00070867926,0.000101325844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020346993,0.000100887686,0.0001804133,0.00009195801,0.00005557479,0.000020653144,0.00014862343,0.00011896598,0.000028189399],"category_scores_gemma":[0.000079447855,0.00008665589,0.000033806682,0.00016983847,0.00015642225,0.000012512213,0.00006713232,0.0002047879,5.287762e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012669383,0.00031310107,0.7207188,0.0000648644,0.000012991003,4.744537e-7,0.00007835408,0.0014184132,0.26700827,0.000003060317,0.000628281,0.008486454],"study_design_scores_gemma":[0.0039178403,0.00057212834,0.8582338,0.000037611302,0.000019377967,6.824194e-8,0.000036482266,0.0005707473,0.13514243,0.000016596166,0.0013345991,0.00011832341],"about_ca_topic_score_codex":0.0028236196,"about_ca_topic_score_gemma":0.0028968796,"teacher_disagreement_score":0.137515,"about_ca_system_score_codex":0.000087619854,"about_ca_system_score_gemma":0.0006753328,"threshold_uncertainty_score":0.42684868},"labels":[],"label_agreement":null},{"id":"W2133312268","doi":"10.1158/1078-0432.ccr-06-1651","title":"Flaxseed and Its Lignans Inhibit Estradiol-Induced Growth, Angiogenesis, and Secretion of Vascular Endothelial Growth Factor in Human Breast Cancer Xenografts <i>In vivo</i>","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Enterolactone; Phytoestrogens; Angiogenesis; Endocrinology; Internal medicine; Vascular endothelial growth factor; In vivo; Biology; Kinase insert domain receptor; Estrogen receptor; Breast cancer; Medicine; Cancer research; Vascular endothelial growth factor A; Cancer; Estrogen; VEGF receptors","score_opus":0.09553616797418367,"score_gpt":0.4469377798305834,"score_spread":0.35140161185639973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133312268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936584,0.0038048679,0.0000031847712,0.0008548258,0.00013296153,0.0012182543,0.00014456337,0.000017720715,0.00016519705],"genre_scores_gemma":[0.9925803,0.00644504,0.000018037596,0.00007000725,0.0006585913,0.000107152795,0.000007525934,0.000046350608,0.00006700998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959198,0.0005488988,0.00084001065,0.000719459,0.0010301818,0.00094162277],"domain_scores_gemma":[0.9976429,0.0009025374,0.00009578453,0.00026308987,0.00051367405,0.0005820204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004546949,0.00023281861,0.0007522733,0.0006636033,0.00011952301,0.000029512064,0.00019068079,0.00037158633,0.000120984034],"category_scores_gemma":[0.00048621558,0.00018936451,0.00016872033,0.0010073283,0.00047822704,0.00013062832,0.00016969911,0.0011114472,0.0000019804893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009993328,0.00038962948,0.50850326,0.00055754883,0.0000830553,0.00014997151,0.00019483961,5.460048e-7,0.48474765,0.00011894889,0.00005224968,0.004202987],"study_design_scores_gemma":[0.00542704,0.0010275979,0.77856916,0.0008769062,0.000033778582,0.000025820653,0.00009558024,0.00008924943,0.21345271,0.00009333701,0.00010508444,0.00020373083],"about_ca_topic_score_codex":0.0075143045,"about_ca_topic_score_gemma":0.0032998559,"teacher_disagreement_score":0.27129492,"about_ca_system_score_codex":0.0002286834,"about_ca_system_score_gemma":0.00052155013,"threshold_uncertainty_score":0.9990947},"labels":[],"label_agreement":null},{"id":"W2133535272","doi":"10.1158/1078-0432.ccr-12-2117","title":"Sequential Binary Gene Ratio Tests Define a Novel Molecular Diagnostic Strategy for Malignant Pleural Mesothelioma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; U.S. Public Health Service; Vancouver Foundation","keywords":"Mesothelioma; Pleural disease; Computational biology; Medicine; Pathology; Oncology; Biology; Respiratory disease; Internal medicine; Lung","score_opus":0.2551047890606198,"score_gpt":0.5033452066928817,"score_spread":0.24824041763226196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133535272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278253,0.0014901147,0.00032023707,0.0031809886,0.0001343316,0.0015518244,0.00029300203,0.000029119163,0.00021786132],"genre_scores_gemma":[0.995159,0.0003436999,0.0006547093,0.0007361322,0.00056803186,0.0012684215,0.00025019376,0.000038510854,0.0009813218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997777,0.00014440255,0.00047623762,0.00045947713,0.00065340404,0.00048947264],"domain_scores_gemma":[0.9974084,0.001564313,0.000055668443,0.00030107703,0.00023432712,0.00043622142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006214352,0.00014764712,0.0002872942,0.00009477569,0.00014670393,0.00004593513,0.00015990838,0.00011710109,0.0015638339],"category_scores_gemma":[0.0014429301,0.000114340626,0.00019943221,0.0002058581,0.00040650374,0.00009642461,0.00012609735,0.00033822557,0.00025147648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036150014,0.0045295847,0.42221043,0.0006004257,0.00050290744,0.0003611696,0.000039989733,0.0010636647,0.5115693,0.0018515158,0.03234568,0.021310331],"study_design_scores_gemma":[0.00394158,0.0024796526,0.9774509,0.00015473063,0.00011631399,0.000019103185,0.00003883417,0.0025247438,0.01010265,0.0014381137,0.0015179239,0.00021543038],"about_ca_topic_score_codex":0.0005948126,"about_ca_topic_score_gemma":0.000025984105,"teacher_disagreement_score":0.5552405,"about_ca_system_score_codex":0.00013716311,"about_ca_system_score_gemma":0.0004124428,"threshold_uncertainty_score":0.9993489},"labels":[],"label_agreement":null},{"id":"W2133999831","doi":"10.1158/1078-0432.ccr-03-0785","title":"Rationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development","year":2004,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Drug development; Mechanism (biology); Surrogate endpoint; Medicine; Drug; Oncology; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.5913131394625564,"score_gpt":0.6546057634251068,"score_spread":0.06329262396255042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133999831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044822128,0.98571104,0.000031548036,0.0035317878,0.0005608471,0.008783014,0.00015508493,0.000034775665,0.0007436642],"genre_scores_gemma":[0.00007289586,0.98617595,0.0037633698,0.00016471608,0.00059084396,0.0064370786,0.00023574146,0.000133398,0.002425985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991773,0.0018212096,0.002067676,0.00147096,0.0015422689,0.001324899],"domain_scores_gemma":[0.9907318,0.0067810495,0.00026919524,0.0006344535,0.0007681117,0.00081538846],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015308747,0.00043874417,0.0026936815,0.0009710575,0.00021513063,0.00006528238,0.0005948842,0.00089641975,0.00085343537],"category_scores_gemma":[0.003421026,0.00036487254,0.0004281132,0.0010603642,0.0009090026,0.00006717769,0.0006144171,0.0028970544,0.00016776088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000549611,0.0003778575,0.00017085053,0.028450694,0.00040199643,0.00020177354,0.00022232407,3.2838264e-7,0.0000015358299,0.00050779537,0.004699688,0.96441555],"study_design_scores_gemma":[0.0036588877,0.00064172957,0.0001172525,0.022276606,0.00012405925,0.00003135523,0.00008572267,0.00001665273,0.000018175037,0.0008871986,0.97183317,0.00030918492],"about_ca_topic_score_codex":0.00046376593,"about_ca_topic_score_gemma":0.0022781072,"teacher_disagreement_score":0.96713346,"about_ca_system_score_codex":0.0048629325,"about_ca_system_score_gemma":0.031122355,"threshold_uncertainty_score":0.9998803},"labels":[],"label_agreement":null},{"id":"W2134076692","doi":"10.1158/1078-0432.ccr-0779-3","title":"Allelic Loss of a Common Microsatellite Marker<b><i>MYCL1</i></b>","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Loss of heterozygosity; Microsatellite; Colorectal cancer; Biology; Locus (genetics); Allele; Chromosome; Metastasis; Internal medicine; Cancer; Pathology; Oncology; Genetics; Medicine; Gene","score_opus":0.21348424118071532,"score_gpt":0.5328374061692768,"score_spread":0.3193531649885615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134076692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849234,0.004355031,0.000015485766,0.004282745,0.0004897187,0.0008618105,0.000033566066,0.00004052801,0.004997672],"genre_scores_gemma":[0.99143165,0.005240716,0.0009061711,0.00072038575,0.0004724356,0.00013909196,0.000010890602,0.000051170733,0.0010275121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963279,0.0003415433,0.0009318753,0.00058243936,0.0011172657,0.0006989854],"domain_scores_gemma":[0.9970527,0.00087695714,0.00012351849,0.00082547904,0.00067741907,0.00044391007],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028426764,0.00018137462,0.0006794777,0.0001710149,0.000090882124,0.000019988689,0.00041911914,0.00031004864,0.0013981829],"category_scores_gemma":[0.0008609424,0.00015386518,0.0002904243,0.000684328,0.0013992904,0.00003922954,0.00029999227,0.0013563687,0.00017127245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009249361,0.0025532078,0.83341026,0.0011360006,0.00045094223,0.0003588579,0.0006592207,0.00008344871,0.03271937,0.0008007536,0.011977226,0.106601365],"study_design_scores_gemma":[0.011304098,0.005152995,0.76007384,0.0012800395,0.00012579413,0.000085615604,0.00018394351,0.000030880154,0.074522436,0.009112349,0.137642,0.00048601793],"about_ca_topic_score_codex":0.001255939,"about_ca_topic_score_gemma":0.0005332965,"teacher_disagreement_score":0.12566477,"about_ca_system_score_codex":0.00038236793,"about_ca_system_score_gemma":0.0013083809,"threshold_uncertainty_score":0.9995147},"labels":[],"label_agreement":null},{"id":"W2134095592","doi":"10.1158/1078-0432.ccr-06-0909","title":"Setting the Bar in Phase II Trials: The Use of Historical Data for Determining “Go/No Go” Decision for Definitive Phase III Testing","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Null hypothesis; Clinical trial; Medicine; Null (SQL); Sample size determination; Protocol (science); Phase (matter); Statistics; Oncology; Research design; Internal medicine; Data mining; Computer science; Pathology; Alternative medicine; Mathematics","score_opus":0.991818251432903,"score_gpt":0.8241548003108323,"score_spread":0.1676634511220707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134095592","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000061183724,0.7244115,0.23751862,0.000478864,0.0040227207,0.02284996,0.010421112,0.0000722178,0.00016382102],"genre_scores_gemma":[0.0000032500247,0.46357277,0.5296381,0.00012248894,0.0035801055,0.0026030533,0.00006859809,0.0001787731,0.00023285697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9559845,0.022673076,0.014994461,0.002367519,0.0021975792,0.0017828658],"domain_scores_gemma":[0.06398237,0.92582625,0.0039911764,0.0035613687,0.0022288028,0.0004100262],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.28484434,0.000720015,0.008078989,0.00037367578,0.0008344031,0.00018628019,0.004170471,0.001280057,0.0001459333],"category_scores_gemma":[0.9634472,0.00038908233,0.0017148226,0.0014873343,0.0012994425,0.00018160827,0.0026925323,0.0044023637,0.000014387443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033539557,0.0012603337,0.000002781685,0.004776169,0.0002780509,0.000017175564,0.00004720825,5.397701e-7,5.3331667e-7,0.0012650036,0.04917443,0.9398238],"study_design_scores_gemma":[0.011556861,0.0030079966,4.574093e-7,0.0183481,0.001620355,0.000004850597,0.00003256501,0.0029017632,0.0000016761542,0.06354497,0.8985676,0.00041278746],"about_ca_topic_score_codex":0.000092265145,"about_ca_topic_score_gemma":0.00006235845,"teacher_disagreement_score":0.93941104,"about_ca_system_score_codex":0.000996003,"about_ca_system_score_gemma":0.003029011,"threshold_uncertainty_score":0.9998561},"labels":[],"label_agreement":null},{"id":"W2134311215","doi":"10.1158/1078-0432.ccr-14-3147","title":"Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor–Initiating Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Wnt signaling pathway; Cancer stem cell; In vivo; Cancer research; Stem cell; Biology; In silico; Cancer; Population; Tumor initiation; Glioblastoma; Glioma; Signal transduction; Medicine; Cell biology; Genetics; Carcinogenesis; Gene","score_opus":0.34221407580638186,"score_gpt":0.5561032548937777,"score_spread":0.2138891790873958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134311215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715709,0.0024189418,0.000017806486,0.006385056,0.0008599719,0.00081250595,0.000036183443,0.00006621435,0.017832387],"genre_scores_gemma":[0.9919773,0.00026721883,0.00032785177,0.0021845747,0.001833927,0.0001679514,0.000011087381,0.000065199005,0.003164941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953352,0.0007143094,0.0009908525,0.0007279726,0.0012440453,0.0009875951],"domain_scores_gemma":[0.9966707,0.0009948558,0.0001270718,0.0006184494,0.0006256728,0.00096321927],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008044535,0.00020130086,0.0007076493,0.00035799274,0.00012295018,0.000055743505,0.0003256361,0.00017702236,0.0010556354],"category_scores_gemma":[0.0021301543,0.00017971339,0.00021293203,0.00095845346,0.00047880542,0.00010788626,0.0003265417,0.0018093579,0.00024391683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070433766,0.003088136,0.17480373,0.000943301,0.00027571118,0.0031268408,0.0022233867,0.00012137995,0.045760024,0.0007225727,0.6719627,0.08992885],"study_design_scores_gemma":[0.024769923,0.008784738,0.040438287,0.0014420906,0.00011176938,0.000051561303,0.0030882123,0.0005027183,0.09186496,0.0021526327,0.82579356,0.0009995283],"about_ca_topic_score_codex":0.0024659971,"about_ca_topic_score_gemma":0.0025750815,"teacher_disagreement_score":0.1538309,"about_ca_system_score_codex":0.00050086575,"about_ca_system_score_gemma":0.00151077,"threshold_uncertainty_score":0.99985754},"labels":[],"label_agreement":null},{"id":"W2134318552","doi":"10.1158/1078-0432.ccr-07-4575","title":"Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Imatinib; Medicine; Systemic mastocytosis; Tyrosine kinase; Dermatofibrosarcoma protuberans; Imatinib mesylate; Tyrosine-kinase inhibitor; PDGFRA; Malignancy; Cancer research; Internal medicine; GiST; Oncology; Pathology; Cancer; Disease; Receptor; Stromal cell","score_opus":0.5138175632808544,"score_gpt":0.5818905854513831,"score_spread":0.06807302217052869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134318552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922057,0.00028741808,0.000007451571,0.0019778155,0.000056622936,0.004601985,0.00008603269,0.00003916118,0.000737841],"genre_scores_gemma":[0.9966508,0.00011518911,0.00079310994,0.00025869775,0.00014302172,0.0009394023,0.00002487949,0.000061941464,0.0010129373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933931,0.002047641,0.0011421292,0.0008681349,0.0016910972,0.0008578906],"domain_scores_gemma":[0.99076605,0.0063457056,0.0004350927,0.0007908248,0.0012945867,0.0003677572],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007996725,0.00032322475,0.001268242,0.00022815065,0.00072060106,0.000050303413,0.00047293273,0.00014267399,0.0001408374],"category_scores_gemma":[0.017566962,0.00020801117,0.0000903316,0.001744391,0.00072045304,0.00020407,0.0008616828,0.0012010115,0.000008475177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053040277,0.0913493,0.5923132,0.0002895213,0.002617165,0.0018549185,0.03446246,0.00031553637,0.039984036,0.00003261233,0.0025870192,0.18115398],"study_design_scores_gemma":[0.20630708,0.14837486,0.59541,0.0056219245,0.00067447935,0.00006237694,0.009467573,0.011650859,0.021582853,0.000027284905,0.00005504267,0.00076567876],"about_ca_topic_score_codex":0.007015721,"about_ca_topic_score_gemma":0.0027632536,"teacher_disagreement_score":0.1803883,"about_ca_system_score_codex":0.0013993805,"about_ca_system_score_gemma":0.0037285092,"threshold_uncertainty_score":0.99959666},"labels":[],"label_agreement":null},{"id":"W2134612158","doi":"10.1158/1078-0432.ccr-08-3120","title":"<i>p53 Arg72Pro</i> and <i>MDM2 T309G</i> Polymorphisms, Histology, and Esophageal Cancer Prognosis","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Hazard ratio; Medicine; Internal medicine; Confidence interval; Oncology; Prospective cohort study; Adenocarcinoma; Proportional hazards model; Cohort; Gastroenterology; Histology; Cancer; Carcinoma; Cohort study","score_opus":0.1494843578025383,"score_gpt":0.49128887674041244,"score_spread":0.3418045189378741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134612158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8500818,0.10016482,0.000030010242,0.044001944,0.0005758038,0.001685649,0.000074060146,0.00014825352,0.0032376465],"genre_scores_gemma":[0.9658909,0.024319552,0.00037341285,0.005635013,0.0010598957,0.00035147165,0.000016087357,0.000061378385,0.002292334],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959603,0.0003916279,0.00074046076,0.001106501,0.0008291137,0.00097199506],"domain_scores_gemma":[0.9975625,0.00044504524,0.00012801055,0.00056534016,0.00042593395,0.000873133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019065797,0.00029174605,0.0007942899,0.00024547108,0.00027850797,0.000060870276,0.0002286277,0.00051135954,0.00032534232],"category_scores_gemma":[0.00060547335,0.00026020716,0.00015945645,0.0006193405,0.0014542993,0.0001023826,0.00020660747,0.0020567598,0.000032810247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041356534,0.0011241105,0.16314937,0.00033716988,0.00039759526,0.0010850998,0.00044168785,0.000004524628,0.017474655,0.0014090457,0.13259505,0.6778461],"study_design_scores_gemma":[0.019270584,0.008784911,0.55363214,0.001527704,0.000744815,0.0005340829,0.00014778374,0.00054399314,0.01641395,0.0024518883,0.3947112,0.0012369327],"about_ca_topic_score_codex":0.0011239107,"about_ca_topic_score_gemma":0.00036149684,"teacher_disagreement_score":0.6766091,"about_ca_system_score_codex":0.00033723383,"about_ca_system_score_gemma":0.001079813,"threshold_uncertainty_score":0.99998504},"labels":[],"label_agreement":null},{"id":"W2134724478","doi":"10.1158/1078-0432.ccr-10-0948","title":"A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health","keywords":"Antigen; Autoantibody; Medicine; Immunology; Prostate-specific antigen; Prostate cancer; Cancer; Cancer vaccine; Vaccination; Western blot; Immunotherapy; Immune system; Antibody; Oncology; Internal medicine; Biology","score_opus":0.08730486969594273,"score_gpt":0.436091545109557,"score_spread":0.3487866754136143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134724478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916702,0.00433659,7.590387e-7,0.0007072889,0.0011186466,0.0018344981,0.00016909947,0.000046215155,0.00011671278],"genre_scores_gemma":[0.9921994,0.0064999135,0.00006908357,0.00010060187,0.000110433866,0.00043493684,0.000047306283,0.000046212113,0.0004920899],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956884,0.001278392,0.0011662344,0.0006519165,0.00021307524,0.001001975],"domain_scores_gemma":[0.997773,0.00087041035,0.00023933875,0.00057489163,0.00046244691,0.00007990108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035311375,0.00025959034,0.0007263916,0.000510789,0.0003063463,0.00004813731,0.0007344971,0.00038852767,0.0007149982],"category_scores_gemma":[0.00049218215,0.00022124425,0.00014188192,0.00082538807,0.0003594368,0.00020898647,0.00039041936,0.0021737923,0.00012742254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054030675,0.00043738796,0.37820837,0.0000419766,0.000114588554,0.0000066455573,0.002649667,0.0000029000912,0.5848985,0.00003496189,0.0008940375,0.02730791],"study_design_scores_gemma":[0.0038494398,0.0016020497,0.5859358,0.0003364342,0.0000066899233,0.0000018168374,0.00028061747,0.0000024505782,0.35005125,0.00006601175,0.057583336,0.00028411235],"about_ca_topic_score_codex":0.004607119,"about_ca_topic_score_gemma":0.0015248879,"teacher_disagreement_score":0.23484723,"about_ca_system_score_codex":0.00013232404,"about_ca_system_score_gemma":0.00051617617,"threshold_uncertainty_score":0.9444167},"labels":[],"label_agreement":null},{"id":"W2134912068","doi":"10.1158/1078-0432.ccr-06-2659","title":"The Biology of Metastasis to a Sanctuary Site","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; National Institutes of Health; Canada Research Chairs; California Breast Cancer Research Program; U.S. Department of Defense","keywords":"Metastasis; Brain metastasis; Angiogenesis; Biology; Disease; Cancer research; Blood–brain barrier; Medicine; Cancer; Central nervous system; Neuroscience; Pathology; Internal medicine","score_opus":0.7405054295768351,"score_gpt":0.7173850200839833,"score_spread":0.023120409492851768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134912068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008740559,0.99471873,0.000020083637,0.0013543152,0.000374655,0.0021051813,0.0003249071,0.000013542681,0.0010012062],"genre_scores_gemma":[0.000041767315,0.99653906,0.00047609568,0.00023178943,0.0007871676,0.00050052255,0.0000861965,0.000051968942,0.0012854241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946655,0.0017244803,0.0015144412,0.00067098305,0.0006634935,0.0007610703],"domain_scores_gemma":[0.9875572,0.010056048,0.00023287618,0.001167186,0.00048176196,0.00050496456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011333553,0.00028220844,0.0024820738,0.00031498683,0.00015900387,0.000018583432,0.0004316886,0.00038121155,0.00048236028],"category_scores_gemma":[0.0026447703,0.00013724106,0.0012093501,0.0011814323,0.00079259626,0.000011181762,0.00041643414,0.0016145917,0.00037323294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024209716,0.0002000734,0.00014245718,0.003139341,0.00091206696,0.00006058585,0.000009426892,3.2660914e-8,2.0011687e-7,0.00035770092,0.020675773,0.9742603],"study_design_scores_gemma":[0.00048861274,0.0014267599,0.00008128738,0.003968808,0.0009805495,0.000014166456,0.000013461996,2.480865e-7,0.0000029377768,0.00006702127,0.9928503,0.00010587011],"about_ca_topic_score_codex":0.00039300474,"about_ca_topic_score_gemma":0.00019180257,"teacher_disagreement_score":0.97415435,"about_ca_system_score_codex":0.00023051487,"about_ca_system_score_gemma":0.0015894216,"threshold_uncertainty_score":0.7014687},"labels":[],"label_agreement":null},{"id":"W2134970255","doi":"10.1158/1078-0432.ccr-12-0199","title":"Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Proinflammatory cytokine; Biology; Luteal phase; Transfection; Inflammation; Gene expression; Small interfering RNA; Luciferase; Molecular biology; Tumor necrosis factor alpha; Signal transduction; Cancer research; Cell biology; Follicular phase; Immunology; Gene; Endocrinology; Genetics","score_opus":0.280077492417682,"score_gpt":0.5072895510402354,"score_spread":0.22721205862255345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134970255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500675,0.0068457685,0.0000023938644,0.03672964,0.00045700299,0.002464313,0.00003898821,0.00005881229,0.0033355646],"genre_scores_gemma":[0.99190074,0.0013301758,0.0001834786,0.0035405806,0.0014347559,0.0011288165,0.000033926804,0.00006118008,0.00038632916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943547,0.0014331727,0.0009323201,0.000642869,0.0014159036,0.0012210308],"domain_scores_gemma":[0.9957889,0.002437986,0.00012705194,0.0008863701,0.00032777476,0.00043192555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008185978,0.0002685774,0.0006368555,0.00016218463,0.00022148177,0.000053136402,0.00041576682,0.00032681943,0.0009911717],"category_scores_gemma":[0.001310359,0.00017022865,0.00025783537,0.000777963,0.00059756776,0.00022635392,0.00015852088,0.0018233372,0.00023669955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009603493,0.0020732319,0.9732343,0.00023089623,0.00030812153,0.00024047049,0.004642553,0.000005406666,0.00046882036,0.0009814863,0.010101032,0.006753351],"study_design_scores_gemma":[0.005645249,0.0011457377,0.8526141,0.0005064296,0.0001300118,0.000022594751,0.0011796816,0.000035804263,0.0012981434,0.00021442656,0.13692367,0.00028416963],"about_ca_topic_score_codex":0.001070046,"about_ca_topic_score_gemma":0.0005457765,"teacher_disagreement_score":0.12682265,"about_ca_system_score_codex":0.00053432584,"about_ca_system_score_gemma":0.001163179,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W2135286184","doi":"10.1158/1078-0432.ccr-06-0054","title":"Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"U.S. Department of Defense","keywords":"Ovarian cancer; Medicine; Cancer; Cancer research; Internal medicine; Oncology","score_opus":0.06108880549184777,"score_gpt":0.5244778804454527,"score_spread":0.463389074953605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135286184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916758,0.0063427556,0.0000139691165,0.0011619299,0.00006310297,0.00036197933,0.00004192435,0.000003829187,0.00033468747],"genre_scores_gemma":[0.9934943,0.0054775197,0.00010500793,0.000016054635,0.00035218746,0.00013970194,0.00003940165,0.000019666853,0.000356216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978712,0.000380952,0.0004123637,0.0004926442,0.0004433256,0.00039949222],"domain_scores_gemma":[0.9990837,0.0001992469,0.00006382289,0.0002379574,0.00028109807,0.00013420243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016732418,0.00011077107,0.00022250549,0.00012611966,0.00006722632,0.00003842196,0.00018441163,0.00026947528,0.000056198674],"category_scores_gemma":[0.00045719108,0.000094855044,0.000039551338,0.0002466403,0.00069547346,0.000009490841,0.00031952382,0.00044127254,0.0000010159882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005549194,0.00019041791,0.5290357,0.00010229601,0.000017459013,0.0000061333794,0.00004825732,0.0000038102899,0.36532557,0.000085713116,0.0016148677,0.10301487],"study_design_scores_gemma":[0.0012413297,0.00063888344,0.7733615,0.0002279741,0.000006595809,0.0000026902537,0.000121340934,0.00021097343,0.21581173,0.00028527156,0.007910391,0.00018128718],"about_ca_topic_score_codex":0.0014756628,"about_ca_topic_score_gemma":0.004477797,"teacher_disagreement_score":0.24432583,"about_ca_system_score_codex":0.000042903062,"about_ca_system_score_gemma":0.00026610174,"threshold_uncertainty_score":0.38680765},"labels":[],"label_agreement":null},{"id":"W2135430006","doi":"10.1158/1078-0432.ccr-04-1106","title":"Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma after Autologous Stem Cell Transplant","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Hamilton Regional Laboratory Medicine Program; Ontario Institute for Cancer Research; McGill University; Université de Montréal; Western University; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Nova Scotia Cancer Centre; University Health Network","funders":"","keywords":"Thalidomide; Medicine; Prednisone; Maintenance therapy; Multiple myeloma; Tolerability; Discontinuation; Surgery; Clinical endpoint; Melphalan; Internal medicine; Randomized controlled trial; Gastroenterology; Adverse effect; Chemotherapy","score_opus":0.13535450184085993,"score_gpt":0.47176959708396127,"score_spread":0.3364150952431013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135430006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855895,0.0023348816,0.00025133553,0.0014560813,0.00015931609,0.009072533,0.0009941016,0.00002113052,0.00012113203],"genre_scores_gemma":[0.9885966,0.00688233,0.0012074282,0.000058404512,0.00019077807,0.002284713,0.00004949826,0.000039377297,0.00069083314],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953584,0.00081087404,0.0015599756,0.0006733362,0.00085614884,0.0007412572],"domain_scores_gemma":[0.9930332,0.004977808,0.00028438243,0.0005569607,0.00070800725,0.00043967855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005015266,0.00024054683,0.0015515636,0.00020858266,0.00011524837,0.000014863405,0.00021458368,0.00024153794,0.000040573395],"category_scores_gemma":[0.0015146935,0.00015677242,0.0005463308,0.00022127906,0.0013749874,0.000070223934,0.00009434802,0.00052292994,0.0000030549045],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9399756,0.006840011,0.0014166664,0.00039994574,0.00049550604,0.000107470536,0.0009928572,0.00000366527,0.0031689447,0.000013651856,0.0001336215,0.04645202],"study_design_scores_gemma":[0.94333917,0.016455881,0.0029503254,0.00052970526,0.00011454021,0.00000502949,0.000098546385,0.00078457507,0.03491944,0.00010656879,0.0005718784,0.000124336],"about_ca_topic_score_codex":0.00081530784,"about_ca_topic_score_gemma":0.00015788307,"teacher_disagreement_score":0.046327684,"about_ca_system_score_codex":0.00010975998,"about_ca_system_score_gemma":0.00068979076,"threshold_uncertainty_score":0.6392994},"labels":[],"label_agreement":null},{"id":"W2135432827","doi":"10.1158/1078-0432.ccr-07-4899","title":"Oxidation of Ovarian Epithelial Cancer Cells by Hypochlorous Acid Enhances Immunogenicity and Stimulates T Cells that Recognize Autologous Primary Tumor","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK","keywords":"Ovarian cancer; Antigen; Cancer research; Tumor antigen; Epitope; CD40; Hypochlorous acid; Ovarian tumor; Antigen-presenting cell; Medicine; Cytotoxic T cell; Immunology; Immunotherapy; Immune system; T cell; Biology; Cancer; Internal medicine; In vitro; Biochemistry","score_opus":0.10749293945849012,"score_gpt":0.3800637311833616,"score_spread":0.27257079172487153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135432827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318756,0.013740838,0.00008785351,0.00038891204,0.0011609532,0.0007113175,0.0005106456,0.000054372686,0.00015753585],"genre_scores_gemma":[0.97597545,0.021390786,0.00023996952,0.00032266937,0.00015588033,0.00016278963,0.000084574946,0.000042355292,0.0016255185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957208,0.0014326213,0.00087806303,0.00089616585,0.00024281489,0.0008295571],"domain_scores_gemma":[0.9973197,0.001284542,0.00033929714,0.00048627163,0.00045567082,0.0001145014],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018278764,0.00032036443,0.00088948756,0.00016088551,0.00051317946,0.00002435545,0.0005585627,0.00045144383,0.0013168382],"category_scores_gemma":[0.00019906016,0.0002686623,0.00018383272,0.0003294289,0.0019186735,0.0002002417,0.00038483136,0.0012116835,0.00020413876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018763132,0.00031833787,0.0014878113,0.000066798355,0.000264229,0.000027908201,0.00019504284,0.0000026055886,0.9766192,0.00002104823,0.004069357,0.015051381],"study_design_scores_gemma":[0.0024654248,0.00083685596,0.009172602,0.00010346226,0.000054670305,0.000019311627,0.00006628444,0.000003849184,0.98209476,0.00023959704,0.0046521383,0.00029104427],"about_ca_topic_score_codex":0.0018560961,"about_ca_topic_score_gemma":0.00009299432,"teacher_disagreement_score":0.014760337,"about_ca_system_score_codex":0.00013416659,"about_ca_system_score_gemma":0.00056217366,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W2135456387","doi":"10.1158/1078-0432.ccr-04-2109","title":"Up-Regulation of EphB4 in Mesothelioma and Its Biological Significance","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Mesothelioma; Gene knockdown; Cancer research; Apoptosis; Small interfering RNA; Protein kinase B; Cell growth; Biology; Tumor progression; Cell culture; Medicine; Pathology; Cancer; Internal medicine; Transfection","score_opus":0.5606383961043458,"score_gpt":0.5543797437522127,"score_spread":0.006258652352133187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135456387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617404,0.0009590134,0.000013467887,0.001836222,0.00009405722,0.00030080412,0.000010955705,0.000016653394,0.0005947862],"genre_scores_gemma":[0.9965967,0.0022915215,0.000030415029,0.0004112972,0.00025044687,0.00005276849,3.7338745e-7,0.000010494429,0.00035599692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99722075,0.00079623243,0.0005701279,0.0005387625,0.0004946584,0.00037943755],"domain_scores_gemma":[0.9969518,0.0025640836,0.000090793445,0.00016840112,0.000101512924,0.00012339951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022600347,0.00008914937,0.0002484089,0.00014171991,0.00008551111,0.000016863356,0.00029062803,0.00012428388,0.00034737165],"category_scores_gemma":[0.0025774534,0.0000718686,0.00005332247,0.0006261319,0.00047906535,0.000135165,0.00014619592,0.0005316968,0.000049007576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057990494,0.00017155676,0.022238381,0.000027686963,0.0000023818427,0.000009096712,0.0000988918,0.00013864937,0.9208535,0.0042142416,0.0003186439,0.051347073],"study_design_scores_gemma":[0.0012927072,0.0005314455,0.15906884,0.00011268469,0.0000025134907,0.0000037133004,0.00003507533,0.004473845,0.8218243,0.0021775558,0.010292192,0.0001851296],"about_ca_topic_score_codex":0.000040566763,"about_ca_topic_score_gemma":0.000043824468,"teacher_disagreement_score":0.13683046,"about_ca_system_score_codex":0.000046876292,"about_ca_system_score_gemma":0.00012657054,"threshold_uncertainty_score":0.3803476},"labels":[],"label_agreement":null},{"id":"W2135457855","doi":"10.1158/1078-0432.ccr-06-0625","title":"Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostatectomy; Prostate cancer; Biochemical recurrence; Medicine; Urology; Prostate-specific antigen; Proportional hazards model; Univariate analysis; Prostate; Internal medicine; Multivariate analysis; Surgical margin; Oncology; Cancer","score_opus":0.08217133761936016,"score_gpt":0.43020693889273276,"score_spread":0.34803560127337263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135457855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98425776,0.006704576,0.0000034474783,0.001102743,0.0000637224,0.007310599,0.00019714056,0.000035193847,0.00032479287],"genre_scores_gemma":[0.99192095,0.0006807673,0.00040775465,0.000028117254,0.00023236928,0.0051271347,0.000035176832,0.000057729303,0.0015100105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957079,0.0004871936,0.0011804416,0.0007450497,0.001135836,0.00074357155],"domain_scores_gemma":[0.99777406,0.00045623333,0.00026031522,0.0004137601,0.00072712253,0.00036848485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022434203,0.00026256937,0.0008304085,0.00027079086,0.000090448986,0.000028064038,0.00016086787,0.00023526148,0.00018380469],"category_scores_gemma":[0.00079301395,0.00020083247,0.00018046056,0.0006108562,0.0011164548,0.00012313954,0.00022148382,0.0008425592,0.000015095121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070019374,0.0024706172,0.9147713,0.005015904,0.00029865297,0.00037640185,0.00022723756,0.000003617206,0.05537882,0.0012896928,0.00039639545,0.012769393],"study_design_scores_gemma":[0.010111409,0.007952427,0.57979995,0.006555804,0.0002008533,0.000015451633,0.00009035985,0.00019611203,0.39022657,0.0011500452,0.0033146765,0.00038634366],"about_ca_topic_score_codex":0.00034185394,"about_ca_topic_score_gemma":0.00003204954,"teacher_disagreement_score":0.33497137,"about_ca_system_score_codex":0.00025854813,"about_ca_system_score_gemma":0.0011576395,"threshold_uncertainty_score":0.818971},"labels":[],"label_agreement":null},{"id":"W2135493854","doi":"10.1158/1078-0432.ccr-09-1135","title":"Loss of SNF5 Expression Correlates with Poor Patient Survival in Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Melanoma; Tissue microarray; Cancer research; Gene knockdown; Immunohistochemistry; Cancer; Medicine; Chromatin remodeling; Pathology; Biology; Apoptosis; Oncology; Gene expression; Internal medicine; Gene","score_opus":0.0783046504938187,"score_gpt":0.4430197915257031,"score_spread":0.3647151410318844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135493854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663436,0.0016310245,0.000063322586,0.00037411437,0.00010591651,0.00016748105,0.0000116069405,0.0000047590474,0.0010074151],"genre_scores_gemma":[0.9983786,0.00095098995,0.00016550465,0.000098600285,0.00016182546,0.000021620042,0.000015866319,0.0000115534895,0.00019547594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983709,0.0002470498,0.00038408715,0.0003511432,0.00036308973,0.0002837706],"domain_scores_gemma":[0.9992148,0.00009234323,0.00007322206,0.00030209453,0.0002205882,0.00009693982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008393058,0.00009086597,0.00020794373,0.000044601442,0.00003921491,0.000009374006,0.0001967246,0.00016657889,0.000053886117],"category_scores_gemma":[0.00020057529,0.00006734403,0.00006530489,0.00016437749,0.00019531991,0.0000028823638,0.00008167456,0.00032456522,0.0000039450524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007995276,0.0014720742,0.39928162,0.00012878278,0.00008622518,0.000062201936,0.00033930835,0.0028924278,0.40912417,0.00012051855,0.009710026,0.16878739],"study_design_scores_gemma":[0.008740885,0.014741559,0.1699852,0.0014036349,0.000027768618,0.000014553697,0.0007579717,0.0019290255,0.7809519,0.0012205298,0.019387927,0.00083901576],"about_ca_topic_score_codex":0.00013317235,"about_ca_topic_score_gemma":0.00015645481,"teacher_disagreement_score":0.37182778,"about_ca_system_score_codex":0.000027512859,"about_ca_system_score_gemma":0.00025878687,"threshold_uncertainty_score":0.27462098},"labels":[],"label_agreement":null},{"id":"W2135676046","doi":"10.1158/1078-0432.ccr-12-3066","title":"Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":295,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Bromodomain; Glioblastoma; Biology; Cancer research; Computational biology; Medicine; Genetics; Epigenetics; Gene","score_opus":0.0788149943909722,"score_gpt":0.42841887486752256,"score_spread":0.34960388047655033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135676046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963389,0.00057200494,0.00029956037,0.0007483477,0.00015628795,0.00043432048,0.000026378966,0.000008745981,0.001415456],"genre_scores_gemma":[0.99707645,0.00059244654,0.0005472328,0.00022536938,0.0005121731,0.00012885872,0.00003303063,0.000016791175,0.0008676428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980744,0.0004042878,0.0004295058,0.0003677078,0.00040465235,0.00031940747],"domain_scores_gemma":[0.99876016,0.00007812826,0.00007558849,0.00035135399,0.0005333495,0.00020142332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010798785,0.00009378984,0.00017052215,0.00006879865,0.000080790865,0.000023861629,0.00020707976,0.00021849913,0.0009006646],"category_scores_gemma":[0.0007187302,0.00008372262,0.00012437058,0.00018082153,0.00052852446,0.000007688373,0.00028929286,0.00027303776,0.0001472499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036019448,0.0002959436,0.008403907,0.000044521814,0.000055467637,0.000003957757,0.000026371566,0.000008923089,0.86084795,0.0002488425,0.0923467,0.037357233],"study_design_scores_gemma":[0.0013418215,0.0018411252,0.018184254,0.000051671046,0.000007579826,0.0000016313338,0.000091141774,0.000099643315,0.94073546,0.0012371449,0.036212254,0.00019625635],"about_ca_topic_score_codex":0.0001750895,"about_ca_topic_score_gemma":0.000071848466,"teacher_disagreement_score":0.07988753,"about_ca_system_score_codex":0.000021154328,"about_ca_system_score_gemma":0.00018083327,"threshold_uncertainty_score":0.9861646},"labels":[],"label_agreement":null},{"id":"W2136226205","doi":"10.1158/1078-0432.ccr-05-0343","title":"Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":440,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Doxorubicin; Bioavailability; Pharmacokinetics; Pharmacology; Liposome; In vivo; Medicine; Drug; Chemistry; Chemotherapy; Internal medicine; Biology; Biochemistry","score_opus":0.11191515615459292,"score_gpt":0.44853446946362974,"score_spread":0.3366193133090368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136226205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951082,0.00048875634,0.000004398403,0.0035544895,0.00013222663,0.0004542568,0.00016950499,0.00002031977,0.00006784148],"genre_scores_gemma":[0.9986772,0.00007049236,0.0003917516,0.00026174306,0.0002546386,0.00016258434,0.0000012023065,0.00002673131,0.00015364007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99622756,0.00069794303,0.0010480921,0.0006154545,0.0007216297,0.0006893395],"domain_scores_gemma":[0.99809575,0.0008772457,0.00016242858,0.00036064407,0.00029003422,0.000213895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051596942,0.0001513022,0.00047114686,0.0003358541,0.00006302787,0.000052424377,0.00040065218,0.00007260424,0.0010259675],"category_scores_gemma":[0.0005968648,0.00013918297,0.000050577575,0.0007439262,0.00067341013,0.00037589233,0.00029603226,0.0005419688,0.000093380346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096787733,0.00096061645,0.24958117,0.00020386773,0.0000038756702,0.00016083354,0.00039844125,0.0004388912,0.6985268,0.00008294688,0.000537509,0.04813717],"study_design_scores_gemma":[0.0030305549,0.00021576656,0.7046589,0.00057536317,0.000006395473,0.000013204154,0.0001711047,0.0054752496,0.28485826,0.0002468553,0.0005145769,0.00023373388],"about_ca_topic_score_codex":0.004763519,"about_ca_topic_score_gemma":0.0096666,"teacher_disagreement_score":0.45507777,"about_ca_system_score_codex":0.00039696932,"about_ca_system_score_gemma":0.0005778442,"threshold_uncertainty_score":0.9998872},"labels":[],"label_agreement":null},{"id":"W2136700890","doi":"10.1158/1078-0432.ccr-15-0263","title":"Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"CD137; Immunotherapy; Antibody; Medicine; Immune system; Cancer immunotherapy; Immunology; Cancer; Cancer research; Monoclonal antibody; Internal medicine","score_opus":0.4112265724873624,"score_gpt":0.5903691924447901,"score_spread":0.17914261995742775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136700890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018964338,0.9919101,0.0000085014835,0.00025264226,0.0023899232,0.0024989469,0.00022101746,0.00027775165,0.00054469565],"genre_scores_gemma":[0.000118934426,0.98627615,0.00002310831,0.0002339003,0.0006897261,0.0013245471,0.00029465684,0.0004517867,0.0105872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98621005,0.0076296013,0.0021405166,0.0015646843,0.00048100736,0.0019741415],"domain_scores_gemma":[0.9919036,0.004094316,0.0008589226,0.0018130759,0.0011928753,0.00013722434],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.008940814,0.0010488163,0.0045277113,0.000669939,0.0006893915,0.0001796243,0.0021548015,0.0019801357,0.0026337986],"category_scores_gemma":[0.0004416331,0.00067748997,0.0010738596,0.001527653,0.0026142031,0.00021687144,0.00036561277,0.005919219,0.00091677345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002462733,0.0004630307,0.0002852143,0.0011043148,0.0030447547,0.0000388755,0.00015546317,6.7221e-7,0.0006028809,0.00002939262,0.010559114,0.98125356],"study_design_scores_gemma":[0.003942246,0.0014991097,0.00017435342,0.01027917,0.00017875512,0.00008007754,0.000071338014,2.4943105e-7,0.00017397226,0.000021026688,0.9827081,0.0008716229],"about_ca_topic_score_codex":0.0017674869,"about_ca_topic_score_gemma":0.000049466675,"teacher_disagreement_score":0.9803819,"about_ca_system_score_codex":0.00049584836,"about_ca_system_score_gemma":0.0071807425,"threshold_uncertainty_score":0.9998611},"labels":[],"label_agreement":null},{"id":"W2136709806","doi":"10.1158/1078-0432.ccr-07-5110","title":"Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Hepatocyte growth factor; Prostate cancer; Internal medicine; Prostatectomy; Lymph node; Oncology; Metastasis; Urology; Cancer","score_opus":0.18182476130054928,"score_gpt":0.4641010617020106,"score_spread":0.28227630040146134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136709806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966089,0.00012765797,0.00001643637,0.00065524125,0.0002834211,0.0015288786,0.00052353623,0.000028389562,0.00022750869],"genre_scores_gemma":[0.99720126,0.0009869919,0.00014098764,0.0006292998,0.00024841912,0.00028002655,0.000033659733,0.000043682794,0.00043567066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951373,0.0012360614,0.0012001076,0.0008160966,0.0008601203,0.00075034006],"domain_scores_gemma":[0.99586695,0.001806304,0.00025665644,0.0005012505,0.0012088463,0.00036001683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009881898,0.00024790008,0.0010681369,0.00021445779,0.0001127219,0.0000048921697,0.00031862716,0.00046940963,0.00069549633],"category_scores_gemma":[0.00090826995,0.00017266127,0.0001777683,0.00052328943,0.002239047,0.0001271534,0.000210717,0.001956563,0.000045837085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024836574,0.0010240803,0.97012925,0.00014029013,0.00022640318,0.00008742512,0.00091818813,0.000014740229,0.00014841916,0.000014469258,0.00052214856,0.0019380273],"study_design_scores_gemma":[0.011977698,0.006416179,0.97959065,0.00031788572,0.00003601666,0.000002159134,0.000024593995,0.000117744195,0.0009763124,0.00012079976,0.00024691486,0.00017301297],"about_ca_topic_score_codex":0.0009101894,"about_ca_topic_score_gemma":0.00010529346,"teacher_disagreement_score":0.012858875,"about_ca_system_score_codex":0.00020385078,"about_ca_system_score_gemma":0.0016792648,"threshold_uncertainty_score":0.85004014},"labels":[],"label_agreement":null},{"id":"W2136802909","doi":"10.1158/1078-0432.ccr-06-2630","title":"Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Metastasis; Medicine; Uvea; Disease; Ocular Melanoma; Cancer; Pathology; Cancer research; Oncology; Internal medicine","score_opus":0.31595493502663785,"score_gpt":0.534959405665413,"score_spread":0.21900447063877515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136802909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020574702,0.97600305,0.0000012460813,0.000055000433,0.00016377245,0.0022031213,0.000105846746,0.000024068879,0.0008691843],"genre_scores_gemma":[0.0027767513,0.99544024,0.0002855495,0.00008977274,0.00024336015,0.000630618,0.00033835822,0.00009158837,0.00010374731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941519,0.0018459404,0.0010968369,0.00091290247,0.0012174706,0.0007749672],"domain_scores_gemma":[0.9967175,0.0015029949,0.0002663519,0.00068600953,0.0004021365,0.0004250105],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014992096,0.00039469328,0.0025762636,0.00042702595,0.00012545854,0.000014186827,0.00031454038,0.0007654869,0.00022886558],"category_scores_gemma":[0.0010436118,0.00025686267,0.00055830734,0.0008928328,0.00055212545,0.000053550582,0.00024365913,0.0027887714,0.00024623852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034254565,0.0011841475,0.07314611,0.002539491,0.0009641077,0.0033843454,0.00003332079,2.2343063e-7,1.2405179e-8,0.000015387523,0.00033468666,0.9180556],"study_design_scores_gemma":[0.010894157,0.0062220795,0.039410643,0.014012895,0.0018874101,0.000054554075,0.000016431497,0.0000051985066,0.000002942832,0.000022821443,0.92688966,0.0005811905],"about_ca_topic_score_codex":0.00017364981,"about_ca_topic_score_gemma":0.000080754406,"teacher_disagreement_score":0.926555,"about_ca_system_score_codex":0.0006670039,"about_ca_system_score_gemma":0.0027228883,"threshold_uncertainty_score":0.9999884},"labels":[],"label_agreement":null},{"id":"W2137025653","doi":"10.1158/1078-0432.ccr-08-1888","title":"A Simple and Accurate Model for Prediction of Cancer-Specific Mortality in Patients Treated with Surgery for Primary Penile Squamous Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genital Health and Disease","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Penectomy; Surveillance, Epidemiology, and End Results; Proportional hazards model; Receiver operating characteristic; Penile cancer; Stage (stratigraphy); Prognostic variable; Oncology; Surgery; Internal medicine; Epidemiology; Cancer; Cancer registry","score_opus":0.25719215037944554,"score_gpt":0.4846290437228462,"score_spread":0.22743689334340067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137025653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944262,0.0013238367,0.000047947553,0.00019747928,0.00003749799,0.0024679955,0.0013957,0.000013021927,0.00009030791],"genre_scores_gemma":[0.998413,0.00011260788,0.000051074054,0.00018487324,0.00012311137,0.00062601856,0.00032474755,0.000018219205,0.00014632306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979669,0.00009676208,0.00064587616,0.00041996565,0.00038909467,0.00048142183],"domain_scores_gemma":[0.9977483,0.0007855037,0.00010947765,0.0002525123,0.0006610505,0.0004431627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010185036,0.00011518577,0.00046187165,0.00013402711,0.000080191756,0.000009519189,0.00006246875,0.000120584264,0.000016284328],"category_scores_gemma":[0.00026572,0.00009125139,0.00010008254,0.00026041083,0.0001416136,0.00007353565,0.000020340876,0.00024052939,3.786716e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017764166,0.0009394723,0.97062284,0.0011914972,0.0000034443694,0.0000033468264,0.00004583369,0.000067538225,0.000037106332,0.0000029245048,0.0033071535,0.0060146973],"study_design_scores_gemma":[0.007389891,0.0024915512,0.9781444,0.000029149434,0.000046849676,1.3377881e-7,0.000021428617,0.01138398,0.00016208888,0.00014737077,0.00011011706,0.000073009185],"about_ca_topic_score_codex":0.0008604215,"about_ca_topic_score_gemma":0.00035061617,"teacher_disagreement_score":0.011316441,"about_ca_system_score_codex":0.00019475816,"about_ca_system_score_gemma":0.0013337996,"threshold_uncertainty_score":0.3721124},"labels":[],"label_agreement":null},{"id":"W2137130674","doi":"10.1158/1078-0432.ccr-04-2159","title":"Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":264,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Pancreatic cancer; Heme oxygenase; Cancer cell; Cancer research; Cancer; Gemcitabine; Transfection; Pancreas; Chemotherapy; Gene knockdown; Cell growth; Cell culture; Biology; Internal medicine; Medicine; Endocrinology; Heme; Enzyme; Biochemistry","score_opus":0.10618582911356644,"score_gpt":0.4645964321959659,"score_spread":0.35841060308239947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137130674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946724,0.0032948488,0.00003412007,0.0006615065,0.00009442038,0.00054956536,0.00026493781,0.000007423638,0.00042073274],"genre_scores_gemma":[0.9889498,0.007971338,0.00031617042,0.00031313274,0.000740308,0.00035441248,0.000025395877,0.000034534376,0.0012949411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971767,0.0005635672,0.0007371533,0.00056663645,0.00048303214,0.00047291175],"domain_scores_gemma":[0.9980168,0.0002710098,0.00014377908,0.0006113435,0.00063568307,0.0003214169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012876507,0.00018552874,0.00048212218,0.00013508213,0.00006396167,0.000011535048,0.00023397207,0.00020552194,0.00042260092],"category_scores_gemma":[0.00044486648,0.00015910469,0.00022557058,0.00037459144,0.00036305105,0.0000070254155,0.00017177998,0.00016551667,0.000023469698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002200181,0.0005232871,0.00791606,0.00007958272,0.00014414577,0.0000055730975,0.000059405804,0.0002626364,0.9672845,0.000023989604,0.0037585294,0.017742122],"study_design_scores_gemma":[0.0011437144,0.0014700408,0.010683628,0.00015725908,0.000041669187,7.517208e-7,0.00009651203,0.000032592834,0.9541851,0.000016889504,0.0320036,0.00016820652],"about_ca_topic_score_codex":0.0026807059,"about_ca_topic_score_gemma":0.0019474921,"teacher_disagreement_score":0.028245071,"about_ca_system_score_codex":0.00014268847,"about_ca_system_score_gemma":0.0010068739,"threshold_uncertainty_score":0.6488101},"labels":[],"label_agreement":null},{"id":"W2137134338","doi":"10.1158/1078-0432.ccr-031213","title":"Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Endocrine system; Breast cancer; Medicine; Cancer; Political science; Library science; Internal medicine; Computer science; Hormone","score_opus":0.06777746877021625,"score_gpt":0.448472388051013,"score_spread":0.3806949192807968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137134338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786926,0.004452913,5.0393623e-7,0.0054292926,0.00026010358,0.00018330017,0.000022216715,0.0000019032926,0.0017805332],"genre_scores_gemma":[0.88402086,0.11555574,0.000016444927,0.000028517969,0.00025358496,0.00003386249,0.000003305209,0.0000045465104,0.00008311624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928,0.00003596161,0.00020010902,0.00018169616,0.00019250091,0.00010973737],"domain_scores_gemma":[0.99944013,0.000019337811,0.00006867993,0.0000712481,0.00036585375,0.00003475523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029255534,0.000051427494,0.00009356133,0.00003771458,0.0000346088,0.000006149437,0.00013169822,0.00007587465,0.000022445394],"category_scores_gemma":[0.00007308977,0.00003437741,0.000032975273,0.00018780828,0.00020244751,0.000005542379,0.00008382864,0.00027877407,3.3010363e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035218804,0.0009465692,0.44741726,0.00025227264,0.0002148655,0.0000032615676,0.0002704472,0.00035810695,0.30632412,0.010738194,0.0010145837,0.22893842],"study_design_scores_gemma":[0.0033071917,0.0008834118,0.7508909,0.00054106413,0.000021423662,0.000018391136,0.00040715662,0.0000943931,0.17911173,0.0016927678,0.0628422,0.00018938167],"about_ca_topic_score_codex":0.00015685374,"about_ca_topic_score_gemma":0.00021866063,"teacher_disagreement_score":0.30347362,"about_ca_system_score_codex":0.000032032913,"about_ca_system_score_gemma":0.00013670552,"threshold_uncertainty_score":0.14018701},"labels":[],"label_agreement":null},{"id":"W2137434859","doi":"10.1158/1078-0432.ccr-05-0725","title":"Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a 90Y-Labeled Anti-CD22 Monoclonal Antibody","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Radioimmunotherapy; CD22; Monoclonal antibody; In vivo; Antibody; Cancer research; Bone marrow; Lymphoma; Medicine; Pathology; Immunology; Biology","score_opus":0.20793409613900835,"score_gpt":0.5765092146798357,"score_spread":0.36857511854082736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137434859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854226,0.002659747,0.00006278376,0.0062112813,0.000029086636,0.00055847666,0.000019158639,0.00002930073,0.0018879218],"genre_scores_gemma":[0.9944893,0.0018998558,0.0016246556,0.00044302375,0.00067312026,0.00012852669,0.000020918178,0.000036056477,0.0006845375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971997,0.00021649858,0.00079681375,0.0005270333,0.0006859336,0.00057402917],"domain_scores_gemma":[0.9979399,0.0008462892,0.00012086713,0.0005012175,0.0002848869,0.00030685734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017560862,0.00016526811,0.0005997542,0.00011575225,0.00011048059,0.000024189907,0.00031394148,0.00016400713,0.00059711514],"category_scores_gemma":[0.00027805712,0.00013219836,0.00011633679,0.0008153224,0.0009000821,0.00009293083,0.00006525342,0.0014480348,0.000023468283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033563306,0.0018682999,0.16820166,0.00028496512,0.00014197356,0.00007106998,0.00017107461,0.0001589887,0.8040031,0.00012594339,0.0014735586,0.020143008],"study_design_scores_gemma":[0.020137103,0.000995623,0.29589337,0.0020016865,0.00010491832,0.000089886555,0.00022892538,0.0063528507,0.5954186,0.00015625189,0.07806474,0.0005560573],"about_ca_topic_score_codex":0.00015368716,"about_ca_topic_score_gemma":0.0000147183355,"teacher_disagreement_score":0.20858456,"about_ca_system_score_codex":0.00016238357,"about_ca_system_score_gemma":0.00067657663,"threshold_uncertainty_score":0.65379924},"labels":[],"label_agreement":null},{"id":"W2137551916","doi":"10.1158/1078-0432.ccr-05-2215","title":"Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Gefitinib; Medicine; Sirolimus; Rash; Mucositis; Pharmacology; Dosing; Internal medicine; Glioma; Chemotherapy; Tyrosine-kinase inhibitor; Anaplastic astrocytoma; Epidermal growth factor receptor; Oncology; Gastroenterology; Cancer; Cancer research; Astrocytoma","score_opus":0.1872098037025844,"score_gpt":0.5209507669304803,"score_spread":0.33374096322789587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137551916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289036,0.0018323335,0.0000011724054,0.0018039907,0.00019747726,0.0017956315,0.000059538845,0.000016101072,0.0014034185],"genre_scores_gemma":[0.99765795,0.0007633423,0.000082154904,0.00003679856,0.000650624,0.00065724086,0.00003990301,0.00002477873,0.00008717504],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967474,0.00031134582,0.00090898963,0.0005197136,0.0009711973,0.00054136995],"domain_scores_gemma":[0.99791104,0.0008783145,0.00013358798,0.00045144063,0.00038844586,0.00023716876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016320386,0.00015266515,0.00065727875,0.00029566744,0.000046402118,0.000014767495,0.00014335987,0.00014303788,0.00024207405],"category_scores_gemma":[0.0003796297,0.00010044099,0.00016629626,0.0007543366,0.00037572783,0.000036696223,0.00007287351,0.0005212441,0.000025929652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78055286,0.039652057,0.05425608,0.0005353065,0.00018952704,0.0037483464,0.00019138423,0.000026335505,0.0007955694,0.0006001347,0.0078090606,0.11164334],"study_design_scores_gemma":[0.8693859,0.047173012,0.06530416,0.002889789,0.00012811836,0.000033865042,0.00018557272,0.0003726301,0.00743151,0.00029964463,0.0065286797,0.0002670952],"about_ca_topic_score_codex":0.0030261932,"about_ca_topic_score_gemma":0.0013893337,"teacher_disagreement_score":0.11137624,"about_ca_system_score_codex":0.0002484433,"about_ca_system_score_gemma":0.0006885635,"threshold_uncertainty_score":0.4574719},"labels":[],"label_agreement":null},{"id":"W2137737798","doi":"10.1158/1078-0432.ccr-06-1503","title":"Class III β-Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non–Small Cell Lung Cancer: Analysis of NCIC JBR.10","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Alberta","funders":"National Cancer Institute; Alberta Cancer Foundation; GlaxoSmithKline","keywords":"Vinorelbine; Medicine; Chemotherapy; Oncology; Internal medicine; Lung cancer; Cisplatin; Adjuvant; Cancer; Stage (stratigraphy); Immunohistochemistry; Biology","score_opus":0.038747437186724604,"score_gpt":0.41320546629958144,"score_spread":0.37445802911285686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137737798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901135,0.009343797,0.00046900776,0.00013721314,0.000093279385,0.00040171453,0.00013674337,0.0000047147896,0.00040218496],"genre_scores_gemma":[0.9762104,0.020385671,0.00049820595,0.00022835875,0.00028806058,0.000064880194,0.00018102907,0.000032920132,0.002110475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974301,0.000115980314,0.0008174696,0.0007678536,0.00031438106,0.00055424107],"domain_scores_gemma":[0.9984723,0.00026287136,0.00016091789,0.0005764721,0.00030555634,0.00022191057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018760267,0.00019630464,0.0006014108,0.00023825104,0.000083064675,0.000025209407,0.0003991282,0.00044431476,0.00048501266],"category_scores_gemma":[0.00008472314,0.0001752338,0.00019476617,0.00062766223,0.00021539544,0.000006825668,0.00029690264,0.0005229667,0.0000020515174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015993121,0.000281705,0.26753744,0.000059472866,0.00027731084,0.000007087002,0.00014185703,0.00063029706,0.711196,0.0000034278212,0.001364696,0.016901411],"study_design_scores_gemma":[0.0065152384,0.00065417326,0.27100462,0.00026388283,0.00030828995,4.6014512e-7,0.0002567918,0.016994962,0.6935103,0.0000387905,0.009942969,0.0005095279],"about_ca_topic_score_codex":0.0057367026,"about_ca_topic_score_gemma":0.014705941,"teacher_disagreement_score":0.017685693,"about_ca_system_score_codex":0.000077240846,"about_ca_system_score_gemma":0.00023958716,"threshold_uncertainty_score":0.86722165},"labels":[],"label_agreement":null},{"id":"W2137937825","doi":"10.1158/1078-0432.ccr-10-0457","title":"The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Cystectomy; Hazard ratio; Chemotherapy; Proportional hazards model; Bladder cancer; Internal medicine; Oncology; Adjuvant; Confidence interval; Urology; Cancer; Surgery","score_opus":0.06501876921638866,"score_gpt":0.4640252263772062,"score_spread":0.39900645716081756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137937825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9416716,0.00007463057,0.0000055212313,0.0005546388,0.00031002585,0.056464627,0.00010627452,0.000008327876,0.0008043367],"genre_scores_gemma":[0.95561326,0.00003247631,0.000052958978,0.00008681261,0.00032112258,0.04349578,0.0000037070208,0.000045729514,0.00034814034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732274,0.00056392624,0.0005033504,0.00036320067,0.0008453712,0.00040143172],"domain_scores_gemma":[0.9951694,0.0026088369,0.00016225131,0.000836119,0.0010818727,0.00014153171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025697341,0.00016069517,0.00046010347,0.000045280398,0.00022113296,0.000012338259,0.0004317284,0.00015324197,0.00012271533],"category_scores_gemma":[0.00061450276,0.00007229608,0.00026198165,0.0002901543,0.001315374,0.000036761183,0.00011067469,0.0007181204,0.000002605249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04440045,0.0017575115,0.90552366,0.00041325646,0.00027962026,0.0000016970826,0.00006467995,5.3028896e-7,0.001211323,0.00016730094,0.0006673369,0.04551266],"study_design_scores_gemma":[0.017714342,0.006220755,0.94592613,0.00020206433,0.0000669343,0.0000014869053,0.00002041427,0.000014666203,0.01574833,0.00034867556,0.013654689,0.000081528044],"about_ca_topic_score_codex":0.0002849236,"about_ca_topic_score_gemma":0.00009466965,"teacher_disagreement_score":0.045431133,"about_ca_system_score_codex":0.00006282786,"about_ca_system_score_gemma":0.0012143012,"threshold_uncertainty_score":0.48465505},"labels":[],"label_agreement":null},{"id":"W2138047541","doi":"10.1158/1078-0432.ccr-04-1169","title":"Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Cancer Institute; Samuel Waxman Cancer Research Foundation","keywords":"Erlotinib; Cyclin D1; Epidermal growth factor receptor; Cancer research; Cell cycle; Epidermal growth factor; Tyrosine kinase; Biology; Erlotinib Hydrochloride; Lung cancer; Cell growth; Cancer; Medicine; Internal medicine; Receptor","score_opus":0.16625342764581966,"score_gpt":0.5242624049371198,"score_spread":0.3580089772913002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138047541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781169,0.0020725378,0.000025263173,0.01610394,0.00058581226,0.001232713,0.00021265841,0.00006650484,0.0015836523],"genre_scores_gemma":[0.9920052,0.0042554033,0.00044511777,0.00077088084,0.00079178205,0.00056596106,0.00012129212,0.000046594047,0.0009977653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665916,0.00032672155,0.00080682634,0.0007901365,0.00072754524,0.0006895954],"domain_scores_gemma":[0.99747247,0.00081732107,0.00012589975,0.00040890675,0.0006135976,0.00056178065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010266898,0.0002148411,0.0005399397,0.000278764,0.00017892479,0.000045905985,0.0001262474,0.00023929562,0.0009816585],"category_scores_gemma":[0.0029004114,0.00017763581,0.0001799174,0.00083944906,0.0005088328,0.00025081265,0.00007544283,0.0011845148,0.00013259624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005707243,0.005253138,0.89866436,0.00056655286,0.00046616,0.0014254341,0.0029479766,0.0005705326,0.0074742,0.0012494506,0.018813325,0.05686162],"study_design_scores_gemma":[0.0151700135,0.002169418,0.9487103,0.0016422244,0.0001264703,0.000017492888,0.00051407365,0.000018127355,0.022334615,0.0016536724,0.0072550494,0.00038850395],"about_ca_topic_score_codex":0.017046943,"about_ca_topic_score_gemma":0.0025157914,"teacher_disagreement_score":0.056473114,"about_ca_system_score_codex":0.0023842265,"about_ca_system_score_gemma":0.0033289294,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W2138090961","doi":"10.1158/1078-0432.ccr-12-3283","title":"Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"TMPRSS2; Prostate; Medicine; Prostate cancer; Erg; Urinary system; Cohort; Baseline (sea); Cohort study; Oncology; Internal medicine; Urology; Cancer; Biology; Ophthalmology; Coronavirus disease 2019 (COVID-19)","score_opus":0.14102702987533422,"score_gpt":0.48799266167321287,"score_spread":0.34696563179787865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138090961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443377,0.0014398156,7.8288656e-7,0.00821209,0.0000877549,0.004468509,0.0010805419,0.000022383356,0.00025432944],"genre_scores_gemma":[0.9901904,0.005940828,0.00002790346,0.00038403078,0.00024419976,0.002645777,0.0004137818,0.000032049833,0.000121017794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917042,0.0038992655,0.0011174862,0.0014519955,0.0010257318,0.0008013155],"domain_scores_gemma":[0.9917995,0.0058107283,0.00020379078,0.0011206258,0.0006550075,0.00041036113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007066829,0.00030630842,0.0011083878,0.0004208399,0.0001538198,0.000097108255,0.00036200066,0.00016155318,0.00018830497],"category_scores_gemma":[0.0015868045,0.00020600912,0.00013694458,0.002276295,0.00046915165,0.00025204895,0.00022965038,0.0012819548,0.000015777656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065738736,0.0035448158,0.9531973,0.000019645315,0.00068252085,0.00056407583,0.0028112244,0.000056096753,0.000013738549,0.0000013187247,0.0009439598,0.0315914],"study_design_scores_gemma":[0.0075189173,0.0032067841,0.98334694,0.00008780638,0.00010444566,0.0000020627094,0.0036538683,0.0014402926,0.000033540913,0.000092789436,0.00030509895,0.00020744347],"about_ca_topic_score_codex":0.1257906,"about_ca_topic_score_gemma":0.23893441,"teacher_disagreement_score":0.113143824,"about_ca_system_score_codex":0.00065939553,"about_ca_system_score_gemma":0.0007121967,"threshold_uncertainty_score":0.8800309},"labels":[],"label_agreement":null},{"id":"W2138120234","doi":"10.1158/1078-0432.ccr-0974-3","title":"Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"LNCaP; Prostate cancer; Androgen; Cancer research; Endocrinology; Internal medicine; DU145; Prostate-specific antigen; Androgen receptor; Medicine; Biology; Cancer; Hormone","score_opus":0.18724392962339972,"score_gpt":0.48806405064692054,"score_spread":0.30082012102352085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138120234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944208,0.0020737315,0.0000010293625,0.00073971465,0.00013448659,0.0024953226,0.000053086413,0.000018667812,0.000063116466],"genre_scores_gemma":[0.9929712,0.0062385127,0.00006391381,0.000057084202,0.00008091033,0.00035802467,0.000033206066,0.00003163066,0.00016553349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970722,0.00026581675,0.000801711,0.0005752174,0.0007205934,0.0005644143],"domain_scores_gemma":[0.99864393,0.00013828962,0.00015427852,0.0002962483,0.0003319245,0.00043533373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00104792,0.00017265078,0.0004955739,0.00021258161,0.0001661521,0.000026885322,0.00008914216,0.00022485688,0.00009243845],"category_scores_gemma":[0.00008714357,0.00013060634,0.000060569608,0.00034719185,0.00030226237,0.00012291707,0.00010323707,0.0008114561,0.0000063873813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020483797,0.0007130431,0.77089685,0.00027564942,0.000024306562,0.000052901334,0.0015236202,0.00002018652,0.2184126,0.0000112079815,0.00007791696,0.005943365],"study_design_scores_gemma":[0.006793042,0.0014821658,0.5249251,0.00070898887,0.0000089577825,0.0000014849164,0.00024926232,0.0000034480731,0.46521464,0.00012915018,0.00038422004,0.00009951556],"about_ca_topic_score_codex":0.003129209,"about_ca_topic_score_gemma":0.0018049804,"teacher_disagreement_score":0.24680205,"about_ca_system_score_codex":0.00033339983,"about_ca_system_score_gemma":0.0009884211,"threshold_uncertainty_score":0.5325972},"labels":[],"label_agreement":null},{"id":"W2138228574","doi":"10.1158/1078-0432.ccr-10-0627","title":"System-Level Analysis of Neuroblastoma Tumor–Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; University of Toronto; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"Neuroblastoma; Tics; Cancer research; Transcriptome; Neural crest; Aurora kinase; Biology; Cancer; Medicine; Gene; Bioinformatics; Oncology; Internal medicine; Computational biology; Cell culture; Gene expression; Genetics; Neuroscience; Cell cycle","score_opus":0.1805011976891704,"score_gpt":0.5070562974969719,"score_spread":0.3265550998078015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138228574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355084,0.00005846395,0.00020051906,0.0011178636,0.00045168347,0.0021388778,0.00093060563,0.000120427096,0.0014306955],"genre_scores_gemma":[0.99465257,0.0000437747,0.002357797,0.00031475272,0.00050317746,0.00079645513,0.000059698377,0.00011725545,0.001154518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99364054,0.00045314865,0.0014932156,0.0013123037,0.0016666718,0.0014341351],"domain_scores_gemma":[0.9898291,0.0054819323,0.00038602564,0.0012751614,0.0018579639,0.0011697817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032030097,0.00038162383,0.0014165605,0.0011876922,0.00035742737,0.00009217424,0.0007272381,0.0002041642,0.00043170317],"category_scores_gemma":[0.0034721794,0.00031861663,0.0009983531,0.0027209525,0.00084426015,0.0001416106,0.00046191338,0.002058462,0.0001294851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012507592,0.005074196,0.040456597,0.002226899,0.0050518033,0.0006673263,0.00018993118,0.00023402972,0.91423,0.0017059504,0.009693519,0.007962137],"study_design_scores_gemma":[0.022250097,0.0153905805,0.3379346,0.00086485,0.0034748677,0.00022459457,0.0006150168,0.056709826,0.5462881,0.00031154102,0.014780949,0.0011549612],"about_ca_topic_score_codex":0.0010542042,"about_ca_topic_score_gemma":0.00054579094,"teacher_disagreement_score":0.36794192,"about_ca_system_score_codex":0.0001417533,"about_ca_system_score_gemma":0.0016351378,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W2138255741","doi":"10.1158/1078-0432.ccr-08-3041","title":"Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Bendamustine; Medicine; Block (permutation group theory); Oncology; Internal medicine; Lymphoma; Rituximab","score_opus":0.20114278304669014,"score_gpt":0.4986546305078373,"score_spread":0.29751184746114717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138255741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83027023,0.001409497,0.0000024454798,0.13831387,0.00024109185,0.0017630395,0.000010244816,0.000047863658,0.027941732],"genre_scores_gemma":[0.9470678,0.0021924868,0.00004218661,0.00702468,0.00183979,0.00010778671,0.0000044288076,0.000039735114,0.041681107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939932,0.00087200507,0.00082186016,0.00074610225,0.0022523205,0.0013144597],"domain_scores_gemma":[0.9915162,0.0058231587,0.00008214931,0.0016254591,0.00038832214,0.0005647433],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008201926,0.00022761404,0.0004956721,0.00019162367,0.0002563566,0.00009365814,0.0010798579,0.0002750055,0.0017111384],"category_scores_gemma":[0.005608089,0.00011743276,0.00024216634,0.0015163447,0.00081943424,0.000049973823,0.0003111755,0.0032579384,0.0008979446],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005674501,0.0016003656,0.0047561144,0.00015828335,0.000088796354,0.0006814996,0.00086230965,0.0001289515,0.0013461848,0.0060003437,0.9369992,0.041703425],"study_design_scores_gemma":[0.087628104,0.012063085,0.09025151,0.0028197956,0.0001392452,0.000141247,0.002489113,0.01011635,0.013441437,0.00811936,0.7717764,0.0010143416],"about_ca_topic_score_codex":0.0029281636,"about_ca_topic_score_gemma":0.00046639275,"teacher_disagreement_score":0.16522282,"about_ca_system_score_codex":0.0048870975,"about_ca_system_score_gemma":0.014121277,"threshold_uncertainty_score":0.99987996},"labels":[],"label_agreement":null},{"id":"W2138501761","doi":"10.1158/1078-0432.ccr-03-0463","title":"Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Celecoxib; Breast cancer; Internal medicine; Oncology; Regimen; Rash; Cancer","score_opus":0.1846703249882754,"score_gpt":0.5588671635938909,"score_spread":0.3741968386056155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138501761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989969,0.00141669,0.00000407746,0.0014707239,0.00011758747,0.006370603,0.0005236071,0.00002861287,0.00009910311],"genre_scores_gemma":[0.9938066,0.0006120263,0.00013624357,0.00015283444,0.00017101155,0.004655345,0.000026889387,0.00010399455,0.00033504303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922078,0.0010230208,0.0015937513,0.0012800952,0.0025790518,0.0013162759],"domain_scores_gemma":[0.9963981,0.00065482483,0.00021432886,0.000782755,0.0011235746,0.00082644547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026982678,0.00042029368,0.0013697597,0.0007057408,0.00021577382,0.00005868447,0.0004021233,0.00021158003,0.0008149935],"category_scores_gemma":[0.0005454462,0.0003375211,0.00019606903,0.0012519521,0.0010153807,0.00016608386,0.00027200536,0.0016163745,0.000009928872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018413788,0.06630662,0.73253495,0.000696503,0.0004787645,0.00040579826,0.002416289,0.000039058294,0.00011752381,0.0000023656346,0.0003404721,0.17824785],"study_design_scores_gemma":[0.108510435,0.04603155,0.8404961,0.0015098889,0.0002602902,0.0000057335174,0.00090790907,0.00040801495,0.0011526187,0.000060989223,0.0003147758,0.00034168706],"about_ca_topic_score_codex":0.0068572797,"about_ca_topic_score_gemma":0.0074469917,"teacher_disagreement_score":0.17790617,"about_ca_system_score_codex":0.0019925695,"about_ca_system_score_gemma":0.0037636552,"threshold_uncertainty_score":0.9999077},"labels":[],"label_agreement":null},{"id":"W2138666899","doi":"10.1158/1078-0432.ccr-11-2956","title":"Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; McMaster University; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Epirubicin; Medicine; Internal medicine; Anthracycline; Cyclophosphamide; Oncology; Breast cancer; Fluorouracil; Chemotherapy; Proportional hazards model; Cancer; Confidence interval","score_opus":0.149470228483138,"score_gpt":0.5124521046489711,"score_spread":0.36298187616583305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138666899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889839,0.006004661,0.000050812603,0.0027276028,0.00056878757,0.0014017923,0.000029989376,0.000004335878,0.00022808398],"genre_scores_gemma":[0.9948398,0.002641484,0.000072601426,0.00025950195,0.0013381261,0.00071506656,0.000025057974,0.000013345786,0.000095023664],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958647,0.0022586128,0.0006284591,0.00034071825,0.00044671234,0.0004607939],"domain_scores_gemma":[0.9974352,0.0015737048,0.00010405223,0.000478248,0.00029655494,0.00011221622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008909713,0.00013235968,0.000534403,0.00010532973,0.000097061304,0.000012160169,0.0003428832,0.00015036442,0.00004487352],"category_scores_gemma":[0.0046525206,0.000084039726,0.00019144735,0.0003756231,0.0007313381,0.000007505494,0.00022862676,0.00030526382,0.000019616373],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9594273,0.0006829045,0.026651075,0.000025521758,0.0001235001,0.0000042512625,0.00026526456,0.000012725964,0.0019269506,0.0003966664,0.0015394678,0.008944362],"study_design_scores_gemma":[0.65520734,0.0014364972,0.28580987,0.00014732096,0.00011267881,0.000005496128,0.00052606745,0.000005482326,0.023727428,0.00029985243,0.03241305,0.00030890276],"about_ca_topic_score_codex":0.00061858597,"about_ca_topic_score_gemma":0.0005266551,"teacher_disagreement_score":0.30421996,"about_ca_system_score_codex":0.000061586215,"about_ca_system_score_gemma":0.00031589807,"threshold_uncertainty_score":0.55698377},"labels":[],"label_agreement":null},{"id":"W2138717155","doi":"10.1158/1078-0432.ccr-09-2014","title":"Serum Prognostic Markers in Head and Neck Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Internal medicine; Medicine; Oncology; Hazard ratio; Quartile; Confidence interval; Head and neck cancer; Proportional hazards model; Cancer; Head and neck squamous-cell carcinoma; Incidence (geometry); Gastroenterology","score_opus":0.24941591033495822,"score_gpt":0.5694165880369855,"score_spread":0.3200006777020272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138717155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97019863,0.0038766235,2.706756e-7,0.019572753,0.00064034,0.00072633877,0.000019665804,0.000029921497,0.0049354658],"genre_scores_gemma":[0.9870267,0.008675301,0.000120272125,0.0008923487,0.0008169458,0.00046551257,0.0000017758815,0.000028241413,0.001972934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997573,0.00018129945,0.00047311618,0.00054378854,0.00053363893,0.000695114],"domain_scores_gemma":[0.9979628,0.0009715856,0.000036577618,0.0003222457,0.00028339977,0.00042343466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023309863,0.00013666907,0.00051979156,0.00015258013,0.00012952076,0.000027253835,0.00013579252,0.0002050531,0.00086612056],"category_scores_gemma":[0.0019016376,0.00010725901,0.00007267551,0.0005186918,0.00073775486,0.00006198905,0.000196494,0.0021464946,0.00003650626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077526603,0.00015911674,0.87101775,0.00016580883,0.000039270195,0.000063117004,0.00012479803,2.2077654e-7,0.00032489715,0.000047536116,0.008549215,0.11873301],"study_design_scores_gemma":[0.0028212168,0.0006837968,0.9366475,0.00049932784,0.000017747925,0.0000052581663,0.000094019844,0.00010009766,0.00009628241,0.00012912111,0.058793023,0.00011261433],"about_ca_topic_score_codex":0.0027657163,"about_ca_topic_score_gemma":0.021844938,"teacher_disagreement_score":0.118620396,"about_ca_system_score_codex":0.00010169835,"about_ca_system_score_gemma":0.000920733,"threshold_uncertainty_score":0.99600387},"labels":[],"label_agreement":null},{"id":"W2138777076","doi":"10.1158/1078-0432.ccr-06-0719","title":"The Thalidomide Analogue, CC-4047, Induces Apoptosis Signaling and Growth Arrest in Childhood Acute Lymphoblastic Leukemia Cells <i>In vitro</i> and <i>In vivo</i>","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Thalidomide; Apoptosis; In vivo; In vitro; Leukemia; Immunology; Cell culture; Biology; Cancer research; Medicine; Multiple myeloma; Biochemistry","score_opus":0.04908071187165018,"score_gpt":0.38682727263138134,"score_spread":0.33774656075973114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138777076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385625,0.0025735875,0.0000018602891,0.0016442345,0.00010674653,0.0010451213,0.00007083222,0.000015888902,0.0006854511],"genre_scores_gemma":[0.9914425,0.00738976,0.000096755095,0.00018256328,0.00029562486,0.00031365364,0.000019158368,0.000038379683,0.00022162579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954161,0.000820636,0.00089017925,0.00080930174,0.00088308833,0.001180707],"domain_scores_gemma":[0.9945635,0.004426521,0.000088072375,0.0003585728,0.00015218846,0.0004111402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033758814,0.00026026892,0.0006640728,0.000426658,0.00022227028,0.00013991258,0.00027082156,0.00024310203,0.000017681177],"category_scores_gemma":[0.00084801426,0.00018110187,0.000096437114,0.0010152917,0.00080770743,0.00013241901,0.00027105288,0.0013631628,0.000012808036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01111978,0.003544961,0.8653678,0.00028412518,0.00029986634,0.0012327981,0.00027288205,0.000034860055,0.09779941,0.00011219594,0.0018557751,0.018075487],"study_design_scores_gemma":[0.048121754,0.0008087733,0.77563965,0.00092065334,0.00008058923,0.000022741475,0.00034107477,0.0011433881,0.1703216,0.0016406741,0.00052358327,0.0004355407],"about_ca_topic_score_codex":0.012549593,"about_ca_topic_score_gemma":0.005112453,"teacher_disagreement_score":0.08972823,"about_ca_system_score_codex":0.00056851754,"about_ca_system_score_gemma":0.00083238736,"threshold_uncertainty_score":0.99402595},"labels":[],"label_agreement":null},{"id":"W2138902181","doi":"10.1158/1078-0432.ccr-09-1945","title":"Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Chinese University of Hong Kong; University of Hong Kong; Ontario Institute for Cancer Research","keywords":"Nicotinamide phosphoribosyltransferase; Radiation therapy; In vivo; NAD+ kinase; Cancer research; Nicotinamide; Cytotoxicity; Head and neck cancer; Radiosensitizer; Medicine; Pharmacology; In vitro; Chemistry; Internal medicine; Biology; Biochemistry; Enzyme","score_opus":0.22564228384680132,"score_gpt":0.5545886528281585,"score_spread":0.3289463689813572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138902181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943416,0.0011848648,0.000012115101,0.0027163634,0.00024279981,0.0010020407,0.000005323376,0.000014007384,0.00048084374],"genre_scores_gemma":[0.997116,0.0006566511,0.00030253813,0.00028007937,0.0011616319,0.000097166085,0.000016223143,0.000025595224,0.00034409095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845874,0.00009819876,0.0003922269,0.00030831096,0.00044815295,0.00029436607],"domain_scores_gemma":[0.9977939,0.0011289658,0.00007777086,0.00033015897,0.00042375206,0.00024542166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020216124,0.00009397631,0.00040166816,0.00011131184,0.00015226907,0.00001397527,0.00010484439,0.0001522236,0.00012486505],"category_scores_gemma":[0.00059653324,0.000058948903,0.00007168501,0.00020005327,0.00071238,0.000029689247,0.000030954103,0.000900063,0.0000012515748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00678476,0.00056496076,0.8413063,0.00014886342,0.00011543675,0.000013277851,0.00029766277,0.0000010863602,0.021483855,0.00072446355,0.0026014298,0.12595786],"study_design_scores_gemma":[0.023629438,0.008238893,0.9503125,0.00016421347,0.000033467528,0.0000058382952,0.00007567362,0.00018798503,0.0025199386,0.00014263125,0.014609555,0.00007984864],"about_ca_topic_score_codex":0.00039241268,"about_ca_topic_score_gemma":0.0001278928,"teacher_disagreement_score":0.12587802,"about_ca_system_score_codex":0.000019932251,"about_ca_system_score_gemma":0.00030795558,"threshold_uncertainty_score":0.3910376},"labels":[],"label_agreement":null},{"id":"W2139069376","doi":"10.1158/1078-0432.ccr-14-0513","title":"Preoperative<i>GNAS</i>and<i>KRAS</i>Testing in the Diagnosis of Pancreatic Mucinous Cysts","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Pancreas Foundation","keywords":"GNAS complex locus; KRAS; Medicine; Cyst; Adenocarcinoma; Intraductal papillary mucinous neoplasm; Cystadenocarcinoma; Pathology; Internal medicine; Gastroenterology; Pancreas; Cancer; Biology; Colorectal cancer; Gene","score_opus":0.33101797268851635,"score_gpt":0.5445068994625288,"score_spread":0.2134889267740125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139069376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808983,0.0017831733,0.00002161847,0.005050089,0.000059199567,0.0010895552,0.000006721776,0.0000146917855,0.011076649],"genre_scores_gemma":[0.9941464,0.0028701269,0.00059930765,0.0007204812,0.00040628342,0.00076054747,0.0000038170506,0.000019701947,0.00047334767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945978,0.0025786273,0.0008015998,0.00046438733,0.00093077007,0.0006268125],"domain_scores_gemma":[0.9794928,0.018996477,0.000096310505,0.00058153627,0.0005819089,0.00025101],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012487391,0.00014131358,0.00083060254,0.00017963188,0.00016989597,0.000027196362,0.0003446797,0.00019421091,0.00019219708],"category_scores_gemma":[0.01690978,0.00008642797,0.00008827026,0.0008215846,0.0012786096,0.00005639368,0.00019385325,0.0013800756,0.00003202083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034428152,0.00044764418,0.97632915,0.0002605883,0.00005606852,0.000037106107,0.00078820594,0.000001828211,0.00014663684,0.00042599067,0.0016821668,0.019480307],"study_design_scores_gemma":[0.0025857845,0.0025234153,0.9882609,0.00061471143,0.00009041728,0.000023710745,0.00041804867,0.0014746343,0.0001740967,0.0007942586,0.002945152,0.000094835654],"about_ca_topic_score_codex":0.0022755745,"about_ca_topic_score_gemma":0.00046268757,"teacher_disagreement_score":0.019385472,"about_ca_system_score_codex":0.00008719378,"about_ca_system_score_gemma":0.0006583526,"threshold_uncertainty_score":0.9913712},"labels":[],"label_agreement":null},{"id":"W2139093684","doi":"10.1158/1078-0432.ccr-08-1159","title":"Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Docetaxel; Metastatic breast cancer; Clusterin; Medicine; Breast cancer; Internal medicine; Regimen; Chemotherapy; Cancer; Oncology; Apoptosis; Biology","score_opus":0.2940175623616857,"score_gpt":0.5994853272054937,"score_spread":0.30546776484380805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139093684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98742056,0.00050185027,0.000010615208,0.009780544,0.00015660595,0.0014720395,0.000066839435,0.000012626682,0.0005783017],"genre_scores_gemma":[0.99812603,0.00058489386,0.00011984886,0.00034043385,0.0001894311,0.00031920586,0.0000151657005,0.000017174547,0.00028783534],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99678266,0.00069440727,0.0008872118,0.0004437616,0.00073348003,0.0004584494],"domain_scores_gemma":[0.99823964,0.0006193509,0.00012956021,0.00040510925,0.0003854804,0.00022086785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031294613,0.00012646285,0.00067947514,0.00042337002,0.000038708222,0.000008130923,0.00019518138,0.000112925336,0.00064306566],"category_scores_gemma":[0.0009087621,0.00010038155,0.00008877503,0.0009640925,0.0004816725,0.00007729044,0.000092173206,0.0008951483,0.000007347312],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5694852,0.04674298,0.091213144,0.00044283227,0.000124043,0.0009681998,0.0007393889,0.00008056267,0.00152814,0.00040519572,0.0024336413,0.2858367],"study_design_scores_gemma":[0.48757106,0.028938793,0.47847536,0.0010038645,0.00010666135,0.000033286316,0.00018848515,0.0011524908,0.00029915708,0.0014700752,0.00054509,0.0002156626],"about_ca_topic_score_codex":0.0011427735,"about_ca_topic_score_gemma":0.0014688965,"teacher_disagreement_score":0.38726223,"about_ca_system_score_codex":0.00029806318,"about_ca_system_score_gemma":0.0011169676,"threshold_uncertainty_score":0.7041118},"labels":[],"label_agreement":null},{"id":"W2139094645","doi":"10.1158/1078-0432.1237.11.3","title":"Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"ERCC1; Dacarbazine; Oncology; Internal medicine; Medicine; Melanoma; Single-nucleotide polymorphism; Chemotherapy; Genotype; Biology; Cancer research; Nucleotide excision repair; DNA repair; Gene; Genetics","score_opus":0.22751542823112494,"score_gpt":0.5138049049169285,"score_spread":0.2862894766858036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139094645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594593,0.0014886546,0.000013940574,0.00013243992,0.00025369172,0.0017861634,0.00028927624,0.000046682107,0.00004324024],"genre_scores_gemma":[0.9962878,0.0003707989,0.00005085138,0.0001836815,0.00016328045,0.00028605314,0.000098482225,0.00007345601,0.002485591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993721,0.0031758414,0.0014286485,0.0007272366,0.00020546996,0.0007417928],"domain_scores_gemma":[0.9958278,0.0021188722,0.00033162275,0.0009989381,0.00061978836,0.00010297137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045770807,0.0003066967,0.00092418527,0.00027576447,0.00027020264,0.000024439862,0.00064548984,0.00043993548,0.0009786566],"category_scores_gemma":[0.0004889487,0.00020328583,0.00042517582,0.00033314104,0.0009805942,0.00015798325,0.00006882529,0.0009598353,0.00010877617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059334446,0.00929538,0.87097144,0.000007148846,0.0012160289,0.0000030894403,0.000478345,0.000006497907,0.011378194,0.000008311114,0.0007821525,0.04651899],"study_design_scores_gemma":[0.021078056,0.073165745,0.8814588,0.00003544315,0.00004627558,9.751407e-7,0.00028440723,0.000004976895,0.01854979,0.00000342214,0.005084004,0.00028806986],"about_ca_topic_score_codex":0.00040233016,"about_ca_topic_score_gemma":0.00017179894,"teacher_disagreement_score":0.06387036,"about_ca_system_score_codex":0.00017394211,"about_ca_system_score_gemma":0.0005593404,"threshold_uncertainty_score":0.9999346},"labels":[],"label_agreement":null},{"id":"W2139161666","doi":"10.1158/1078-0432.12aacriaslc-b15","title":"Abstract B15: Genomic and epigenomic events in arsenic-related lung squamous cell carcinomas from smokers and never smokers","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Arsenic contamination and mitigation","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lung cancer; Carcinogenesis; Arsenic; Epigenomics; DNA methylation; Population; Cancer research; Epigenetics; Biology; Methylation; Oncology; Medicine; Cancer; Physiology; Genetics; Environmental health; Chemistry; Gene","score_opus":0.07254531636113877,"score_gpt":0.39422747808628955,"score_spread":0.3216821617251508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139161666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994934,0.0016705047,0.000003555862,0.0005543552,0.00022502366,0.00044765972,0.00001620693,0.000013788079,0.0021349015],"genre_scores_gemma":[0.9981464,0.0006775832,0.00004549344,0.00017245141,0.00007944513,0.000036399782,0.000013602095,0.000020740617,0.0008078925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779856,0.00032006414,0.0005081286,0.00046700396,0.0003644582,0.0005418084],"domain_scores_gemma":[0.9985776,0.00071507413,0.00009462989,0.00023309482,0.000015063916,0.00036455668],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022383032,0.00013344425,0.00021287367,0.000074708776,0.00014141062,0.000018406421,0.00017531835,0.00019102149,0.002155964],"category_scores_gemma":[0.00016548092,0.00013085775,0.00005211797,0.00017879315,0.00043303872,0.00032936656,0.0003153548,0.00066016265,0.00018204274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074395524,0.00009328839,0.97707266,0.000009337619,0.000008264125,0.000004406563,0.0009036935,0.000025912133,0.0036632973,0.000011452635,0.0005891363,0.01754413],"study_design_scores_gemma":[0.0015021113,0.00003782141,0.99456453,0.000013442941,0.000012066818,7.6925744e-7,0.00035306072,0.0005774224,0.00026060073,0.00019526287,0.0023335796,0.00014933647],"about_ca_topic_score_codex":0.009148333,"about_ca_topic_score_gemma":0.0015855221,"teacher_disagreement_score":0.01749184,"about_ca_system_score_codex":0.00051882706,"about_ca_system_score_gemma":0.000068671245,"threshold_uncertainty_score":0.99875623},"labels":[],"label_agreement":null},{"id":"W2139638366","doi":"10.1158/1078-0432.ccr-10-0093","title":"Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Induction chemotherapy; Oncology; Leukemia; Medicine; Chemotherapy; Univariate analysis; Internal medicine; Flow cytometry; Immunology; Multivariate analysis","score_opus":0.09079508066410974,"score_gpt":0.43003394922789573,"score_spread":0.339238868563786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139638366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876977,0.0003176146,0.000019335306,0.007053525,0.00040016518,0.0028954658,0.000093238865,0.00009583398,0.00035506242],"genre_scores_gemma":[0.99467427,0.0005837327,0.000989219,0.0007583544,0.0003997361,0.00070014095,0.000050603572,0.00012177845,0.0017221835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99257773,0.0019518596,0.0008835632,0.001024517,0.002014435,0.0015478875],"domain_scores_gemma":[0.99403334,0.002415977,0.00020581923,0.0009684161,0.0015903815,0.00078608],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009117911,0.00030820086,0.00081821403,0.00052167114,0.0002977931,0.00009479952,0.00047891185,0.0006447382,0.0003345637],"category_scores_gemma":[0.003818817,0.00023296225,0.00013769738,0.0024422344,0.00074602,0.00011538774,0.00030363645,0.0054377457,0.000086043794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.25463802,0.0022139216,0.31394696,0.00010217414,0.0006481982,0.0024240797,0.0019270581,0.0005457418,0.19808105,0.000012553945,0.03297508,0.19248518],"study_design_scores_gemma":[0.018589232,0.028973503,0.89829946,0.001124861,0.0000712495,0.00006038338,0.0010582815,0.00086998375,0.014921544,0.00020980854,0.035006233,0.00081547897],"about_ca_topic_score_codex":0.00041332797,"about_ca_topic_score_gemma":0.0033667856,"teacher_disagreement_score":0.5843525,"about_ca_system_score_codex":0.004482834,"about_ca_system_score_gemma":0.0058358437,"threshold_uncertainty_score":0.99980015},"labels":[],"label_agreement":null},{"id":"W2139734459","doi":"10.1158/1078-0432.ccr-04-0524","title":"Overexpression of G1-S Cyclins and Cyclin-Dependent Kinases during Multistage Human Pancreatic Duct Cell Carcinogenesis","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Pancreatic Intraepithelial Neoplasia; Cancer research; Cyclin-dependent kinase; Pancreatic cancer; Cyclin D; Biology; Carcinogenesis; Cyclin; Cyclin D1; Pancreatic duct; Cell cycle; Cyclin E; Pancreas; Cyclin B; Pathology; Cancer; Medicine; Endocrinology; Pancreatic ductal adenocarcinoma","score_opus":0.140467234971327,"score_gpt":0.47738595163333236,"score_spread":0.33691871666200535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139734459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923401,0.005114273,0.000019336832,0.00030920003,0.00015416979,0.0009115451,0.000074735835,0.00004981809,0.0010268419],"genre_scores_gemma":[0.99446857,0.0039176526,0.00022843774,0.000056513858,0.000402261,0.00010379664,0.000018712282,0.000072871015,0.0007312018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960807,0.0003551138,0.00096426083,0.0008294941,0.001130498,0.00063994166],"domain_scores_gemma":[0.99761695,0.00044257418,0.00019906904,0.00085030205,0.0003679722,0.00052315224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013131681,0.00023413879,0.0007264525,0.00026360067,0.00025849862,0.000026784099,0.00023433016,0.0003148678,0.00024793728],"category_scores_gemma":[0.000782261,0.00020829291,0.00023911249,0.00036253192,0.0006672015,0.00006911458,0.00036859573,0.0011300897,0.000023127988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011780511,0.00079853105,0.086949155,0.0010558616,0.00009995614,0.00032562405,0.00023903369,0.00014486384,0.90764564,0.000054384793,0.000111149864,0.0013977734],"study_design_scores_gemma":[0.009570909,0.0010312662,0.35986125,0.00167106,0.00014492014,0.000026191481,0.00021489298,0.000020390233,0.6267584,0.00020930056,0.0002544215,0.00023702909],"about_ca_topic_score_codex":0.0039841332,"about_ca_topic_score_gemma":0.0003959001,"teacher_disagreement_score":0.28088725,"about_ca_system_score_codex":0.00042451674,"about_ca_system_score_gemma":0.00059826206,"threshold_uncertainty_score":0.84939384},"labels":[],"label_agreement":null},{"id":"W2139763823","doi":"10.1158/1078-0432.ccr-08-2644","title":"Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"Radboud Universiteit","keywords":"Breast cancer; Gene expression; Grading (engineering); Oncology; Gene signature; DNA microarray; Multivariate analysis; Gene expression profiling; Significance analysis of microarrays; Gene; Microarray; Internal medicine; Medicine; Cancer; Biology; Genetics","score_opus":0.0632151097720133,"score_gpt":0.4312425097902956,"score_spread":0.36802740001828227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139763823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754417,0.00087182835,0.000116955096,0.0009232874,0.00007174504,0.0003293711,0.0001101254,0.0000030354465,0.000029504223],"genre_scores_gemma":[0.9977397,0.0015725136,0.00011294621,0.00024960504,0.00008243963,0.0001745884,0.00003739721,0.000009696864,0.000021167567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982813,0.0003124871,0.00039708076,0.00041266295,0.00026255366,0.00033393834],"domain_scores_gemma":[0.999326,0.000061304534,0.00005215207,0.00027950443,0.00020472513,0.0000763448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069381704,0.000106679996,0.0002015654,0.00009628573,0.000033518027,0.000007955403,0.0001663733,0.0001332119,0.000039228114],"category_scores_gemma":[0.00014379888,0.00009197048,0.000052105883,0.00024826822,0.0000845075,0.000010616412,0.00016333489,0.00022850573,0.0000032544747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003423251,0.00044310073,0.9517557,0.00001112231,0.000008304166,0.000004286388,0.00020120159,0.000016724356,0.0023630732,0.0000021230157,0.00012678666,0.041644342],"study_design_scores_gemma":[0.0016096064,0.0005970685,0.9841657,0.00018945851,0.0000012825158,4.616125e-7,0.000062278144,0.0000052491805,0.012905378,0.0000661466,0.00030780004,0.0000895385],"about_ca_topic_score_codex":0.00027900198,"about_ca_topic_score_gemma":0.0014487323,"teacher_disagreement_score":0.041554805,"about_ca_system_score_codex":0.00007401788,"about_ca_system_score_gemma":0.00011027264,"threshold_uncertainty_score":0.37504473},"labels":[],"label_agreement":null},{"id":"W2139830524","doi":"10.1158/1078-0432.ccr-10-2372","title":"Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; Abramson Cancer Center","keywords":"Autophagy; ATG5; Melanoma; Cancer research; Programmed cell death; Temozolomide; Small hairpin RNA; Medicine; Dacarbazine; Cell culture; Biology; Apoptosis; Pathology; Glioma; Gene knockdown","score_opus":0.2931685604140283,"score_gpt":0.46976088378464576,"score_spread":0.17659232337061748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139830524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883628,0.0028146564,0.0000072862113,0.00036930066,0.00014829347,0.0007230575,0.00001537937,0.000017824239,0.0075413845],"genre_scores_gemma":[0.99710673,0.0008256451,0.00030488765,0.00046081477,0.00015376991,0.00012692672,0.0000024197502,0.000030375386,0.0009884079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736714,0.00041008394,0.00059374253,0.00045800678,0.0007604462,0.00041057],"domain_scores_gemma":[0.9984772,0.0002885089,0.00007065075,0.00045243735,0.0003373575,0.00037380974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028877624,0.0001301533,0.00050221436,0.00017174531,0.000045577137,0.000007812342,0.00024669996,0.00010655328,0.00066913915],"category_scores_gemma":[0.00040565024,0.000111539244,0.00008629935,0.00044518587,0.000349102,0.000052813437,0.000099800614,0.00042646585,0.00001958009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008248749,0.0011023359,0.9775059,0.00038853908,0.00010076466,0.00014139478,0.00061052246,6.7714825e-7,0.00631993,0.000064404,0.0010894111,0.00442737],"study_design_scores_gemma":[0.0042661405,0.0008210388,0.8775702,0.0003328817,0.000017836026,8.801477e-7,0.000078178666,0.0000069475122,0.11539517,0.00040238854,0.0010036681,0.00010463051],"about_ca_topic_score_codex":0.00055238436,"about_ca_topic_score_gemma":0.00053737557,"teacher_disagreement_score":0.10907525,"about_ca_system_score_codex":0.000095485935,"about_ca_system_score_gemma":0.0006630673,"threshold_uncertainty_score":0.7326605},"labels":[],"label_agreement":null},{"id":"W2139995572","doi":"10.1158/1078-0432.ccr-09-2514","title":"Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Internal medicine; Oncology; Prednisone; Mitoxantrone; Chemotherapy; Cancer","score_opus":0.2418637237828623,"score_gpt":0.5093903416955697,"score_spread":0.26752661791270743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139995572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979437,0.003224146,0.000015978576,0.013121799,0.00013611821,0.00198067,0.00010679448,0.00003295206,0.0019445253],"genre_scores_gemma":[0.98746586,0.0089184875,0.00018888395,0.00010086708,0.0002433735,0.00037681608,0.000050058126,0.000032576747,0.0026230991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629986,0.00031501273,0.0007988058,0.0005532822,0.001364195,0.00066884374],"domain_scores_gemma":[0.99820656,0.00048181642,0.00011616863,0.00038594825,0.0005244524,0.0002850407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028115239,0.00019315323,0.00068706693,0.0002829388,0.0001277884,0.00003260246,0.00016931293,0.00010539023,0.00024062431],"category_scores_gemma":[0.00021259606,0.00013195169,0.0001557338,0.0011237412,0.000324158,0.00014853696,0.000031329266,0.00080196233,0.0000048812294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046867616,0.0031251027,0.8345305,0.0006995247,0.0010307073,0.0006930987,0.0017911057,0.00042504302,0.011957241,0.00015203991,0.0028604658,0.09586761],"study_design_scores_gemma":[0.0319323,0.010156757,0.9408838,0.0018914883,0.00018122917,0.0000040806303,0.0007425883,0.001481692,0.007841057,0.0006706858,0.0039408137,0.00027346858],"about_ca_topic_score_codex":0.002000482,"about_ca_topic_score_gemma":0.0020128414,"teacher_disagreement_score":0.106353395,"about_ca_system_score_codex":0.00047656152,"about_ca_system_score_gemma":0.0015609456,"threshold_uncertainty_score":0.5380834},"labels":[],"label_agreement":null},{"id":"W2140155875","doi":"10.1158/1078-0432.ccr-06-0486","title":"Acceleration of Telomere Loss by Chemotherapy Is Greater in Older Patients with Locally Advanced Head and Neck Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"Telomere; Head and neck cancer; Head and neck; Medicine; Cancer; Chemotherapy; Oncology; Head (geology); Internal medicine; Gerontology; Surgery; Biology; Genetics","score_opus":0.06570106926521715,"score_gpt":0.4436917247389739,"score_spread":0.37799065547375676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140155875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942049,0.0016480784,0.000012909609,0.0028283196,0.00006826814,0.000917697,0.00006197782,0.000017222716,0.0002406202],"genre_scores_gemma":[0.995011,0.0023749704,0.0001638717,0.00093716255,0.00016358841,0.00013716004,0.00003046219,0.00003981633,0.0011420208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733573,0.00012783516,0.00065322424,0.0005924446,0.0007818937,0.0005088878],"domain_scores_gemma":[0.9985659,0.00017542495,0.00011172463,0.00034360058,0.0006115834,0.00019176172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048873544,0.00018762573,0.00053833117,0.00015613766,0.0000703342,0.00002562854,0.00014262796,0.00018703021,0.0005676731],"category_scores_gemma":[0.000065318214,0.00013873837,0.0000564932,0.0005749621,0.00056389795,0.0001495644,0.000047987887,0.0005878351,0.0000061432656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00319012,0.00058335805,0.92317677,0.00016359906,0.000029665278,0.000010851761,0.00017908771,0.0000052511546,0.00062780693,0.0000065934664,0.0046669464,0.06735996],"study_design_scores_gemma":[0.010792791,0.00091050065,0.977302,0.000579491,0.00001214354,9.639433e-7,0.000038094026,0.00005508325,0.006268225,0.00003723173,0.0038399976,0.00016347702],"about_ca_topic_score_codex":0.0036176026,"about_ca_topic_score_gemma":0.0015021166,"teacher_disagreement_score":0.06719649,"about_ca_system_score_codex":0.00014979711,"about_ca_system_score_gemma":0.00036134894,"threshold_uncertainty_score":0.62156224},"labels":[],"label_agreement":null},{"id":"W2140210955","doi":"10.1158/1078-0432.ccr-10-0513","title":"Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"DNA damage; Chromatin; DNA repair; Biology; Cell biology; Cell cycle checkpoint; Histone; G2-M DNA damage checkpoint; Epigenetics; Cell cycle; DNA; Cancer research; Cell; Genetics; Gene","score_opus":0.288933985244428,"score_gpt":0.5364368782454557,"score_spread":0.24750289300102774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140210955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016768854,0.9806191,0.000024558625,0.000071462666,0.0002729801,0.0013920638,0.0000940708,0.000028397133,0.0007285371],"genre_scores_gemma":[0.0018265225,0.99432063,0.00044982138,0.000029310078,0.00071662787,0.0007635889,0.00015386661,0.00008936221,0.0016502955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956695,0.0009054881,0.0011030718,0.0012761058,0.0004119095,0.00063396496],"domain_scores_gemma":[0.9976305,0.00042482308,0.00018323725,0.0011949162,0.00023108856,0.00033545762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004403752,0.000327903,0.0010067736,0.000216366,0.0001390599,0.0000717347,0.0006537332,0.0012508053,0.00008608793],"category_scores_gemma":[0.00056967436,0.0002923509,0.00046937415,0.00039848825,0.00055017386,0.000004564344,0.00048463268,0.0019761242,0.00003221768],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024758614,0.00040155157,0.00020536776,0.0068124593,0.0002615703,0.00005584665,0.000034411813,0.0000068063623,0.0062851803,0.0003934657,0.001346657,0.9839491],"study_design_scores_gemma":[0.0007734723,0.00024673113,0.00005414984,0.0015957657,0.000105101506,0.0000092355995,0.000011603619,0.000020303924,0.0009650851,0.000140283,0.9957314,0.0003468772],"about_ca_topic_score_codex":0.00013932191,"about_ca_topic_score_gemma":0.0006394143,"teacher_disagreement_score":0.9943847,"about_ca_system_score_codex":0.000056114215,"about_ca_system_score_gemma":0.001224252,"threshold_uncertainty_score":0.99995285},"labels":[],"label_agreement":null},{"id":"W2140250503","doi":"10.1158/1078-0432.ccr-03-0376","title":"Improved Outcome When B-Cell Lymphoma Is Treated with Combinations of Immunoliposomal Anticancer Drugs Targeted to Both the CD19 and CD20 Epitopes","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lymphoma; Epitope; CD20; Liposome; CD19; Antigen; Doxorubicin; Cancer research; Vincristine; Pharmacology; Immunology; Chemotherapy; Internal medicine; Chemistry; Cyclophosphamide","score_opus":0.05950840233909255,"score_gpt":0.39944722818674544,"score_spread":0.3399388258476529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140250503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97738326,0.01518635,0.000045309444,0.0058493884,0.00022932468,0.00088142126,0.00009437021,0.000036484704,0.00029411944],"genre_scores_gemma":[0.99106246,0.0024244722,0.0000885843,0.00080764916,0.00003428531,0.00018732416,0.000015532309,0.000038181013,0.0053415024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970029,0.0009172556,0.0007612881,0.0004846692,0.00016964103,0.00066423375],"domain_scores_gemma":[0.997251,0.0014019152,0.00016518463,0.0006801561,0.0004424483,0.000059293336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017067554,0.00023350335,0.000569339,0.00018895513,0.0005184416,0.000047111622,0.00061377353,0.00027799324,0.00040607498],"category_scores_gemma":[0.00028444047,0.0001456049,0.00014655878,0.00050052284,0.0018098835,0.00011274039,0.00023666625,0.0006391199,0.00007734669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025665794,0.004946605,0.045687433,0.00013482243,0.0018989533,0.000013166244,0.00950447,0.000008787729,0.80934054,0.0016088444,0.0035030355,0.097687565],"study_design_scores_gemma":[0.038654428,0.0063027903,0.23337217,0.0002783296,0.0001462758,0.000022781376,0.0020614471,0.000008221993,0.6495516,0.0006034278,0.06838657,0.00061199284],"about_ca_topic_score_codex":0.005368653,"about_ca_topic_score_gemma":0.00012971427,"teacher_disagreement_score":0.18768473,"about_ca_system_score_codex":0.00012930362,"about_ca_system_score_gemma":0.00061415415,"threshold_uncertainty_score":0.81158334},"labels":[],"label_agreement":null},{"id":"W2140287543","doi":"10.1158/1078-0432.ccr-05-1170","title":"Mcl-1, Vascular Endothelial Growth Factor-R2, and 14-3-3σ Expression Might Predict Primary Response against Radiotherapy and Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radiation therapy; Medicine; Chemotherapy; Concomitant; Head and neck cancer; Cisplatin; Epidermoid carcinoma; Vascular endothelial growth factor; Immunohistochemistry; Pathology; Oncology; Cancer; Internal medicine; Primary tumor; Head and neck squamous-cell carcinoma; Metastasis; VEGF receptors","score_opus":0.020264201783638747,"score_gpt":0.34533881014885026,"score_spread":0.3250746083652115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140287543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467546,0.0036243564,0.000035128713,0.0005344778,0.000055939057,0.0009390232,0.00006617096,0.0000057477064,0.00006372213],"genre_scores_gemma":[0.99528944,0.0033452266,0.000538438,0.00035494292,0.00013838922,0.00009548035,0.000009452789,0.000037077934,0.00019155699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976492,0.00068156206,0.00038791428,0.0005586802,0.00039615587,0.00032649472],"domain_scores_gemma":[0.9987418,0.00032811414,0.00010848825,0.0004337154,0.00023377386,0.00015411392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007186403,0.00017744538,0.00027714795,0.00007345598,0.00011582605,0.000026286505,0.00022023423,0.00020919535,0.00001573977],"category_scores_gemma":[0.00033111725,0.00012135486,0.000065681365,0.00012980495,0.00057090854,0.00002013044,0.00017515515,0.00047440946,2.999123e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014543559,0.00043364384,0.70144624,0.0000795753,0.000033895103,0.0000015376361,0.00020669722,0.000021208345,0.2703726,0.000001102274,0.0002760735,0.0125838835],"study_design_scores_gemma":[0.010135576,0.001889375,0.84285855,0.00014089212,0.000005485871,0.0000011132774,0.000024669505,0.000029995903,0.13418634,0.000007720142,0.0105574485,0.00016281061],"about_ca_topic_score_codex":0.00007787513,"about_ca_topic_score_gemma":0.00012758655,"teacher_disagreement_score":0.14141233,"about_ca_system_score_codex":0.00007740061,"about_ca_system_score_gemma":0.00026023033,"threshold_uncertainty_score":0.49487075},"labels":[],"label_agreement":null},{"id":"W2140293999","doi":"10.1158/1078-0432.ccr-14-0861","title":"PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Brain metastasis; Melanoma; Gene knockdown; Metastasis; Cancer research; Immunofluorescence; Cell culture; Pathology; Biology; Tissue microarray; Medicine; Gene expression profiling; Viability assay; Gene expression; Cancer; Immunology; Immunohistochemistry; Internal medicine; Gene; Antibody","score_opus":0.19360210735127073,"score_gpt":0.5340645592303275,"score_spread":0.34046245187905677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140293999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97840255,0.0018868751,0.0000819593,0.017564435,0.00018324255,0.00048723203,0.00006343021,0.000017720533,0.001312549],"genre_scores_gemma":[0.996315,0.0007790292,0.00081769045,0.00063559454,0.0003387128,0.00007840609,0.000021005539,0.000025613146,0.0009889356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996889,0.00090959994,0.00054872275,0.0004532999,0.00079445523,0.0004049147],"domain_scores_gemma":[0.99671197,0.001973733,0.00008732103,0.0004512259,0.0002921069,0.00048366963],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052826293,0.00013080942,0.0005663189,0.0001626095,0.00008142557,0.000019944217,0.00012748186,0.00013234062,0.0017442046],"category_scores_gemma":[0.0028482939,0.000092046765,0.0002016579,0.00029898243,0.0006751433,0.00003863798,0.00017909345,0.00040054566,0.0000648049],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005331487,0.0016866261,0.092393294,0.0005576725,0.001956126,0.00031971224,0.00019140722,0.000001080359,0.0037702224,0.002774994,0.08202659,0.8089908],"study_design_scores_gemma":[0.026154691,0.013534808,0.59332526,0.0005003917,0.0011640425,0.0001753923,0.0005500404,0.0015980299,0.0118554775,0.0074261203,0.34315652,0.00055921066],"about_ca_topic_score_codex":0.00067707064,"about_ca_topic_score_gemma":0.00006255999,"teacher_disagreement_score":0.80843157,"about_ca_system_score_codex":0.000043182776,"about_ca_system_score_gemma":0.00031381447,"threshold_uncertainty_score":0.99916834},"labels":[],"label_agreement":null},{"id":"W2140334270","doi":"10.1158/1078-0432.ccr-10-1224","title":"Absence of MMP2 Expression Correlates with Poor Clinical Outcomes in Rectal Cancer, and Is Distinct from MMP1-Related Outcomes in Colon Cancer","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"MMP1; MMP2; Colorectal cancer; Oncology; Metastasis; Medicine; Stage (stratigraphy); Internal medicine; Cancer; Disease; Clinical significance; Biology; Gene expression; Gene; Genetics","score_opus":0.17669090695550047,"score_gpt":0.5056073819229776,"score_spread":0.3289164749674771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140334270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31862307,0.6787865,0.0000017089458,0.00010122033,0.00057180837,0.0012038901,0.0006239626,0.000008387008,0.000079451296],"genre_scores_gemma":[0.046554208,0.9509368,0.00007978085,0.00009029064,0.00025112202,0.001000498,0.000112114416,0.00008059045,0.0008946006],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938544,0.0013062614,0.0021772615,0.001471077,0.0005017549,0.00068922626],"domain_scores_gemma":[0.9969154,0.0010907714,0.00070046657,0.00073859614,0.0002446642,0.0003100964],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023919172,0.00052126526,0.002600923,0.00019540609,0.00007652567,0.00002746048,0.0007145774,0.0015156148,0.00036760807],"category_scores_gemma":[0.0011557873,0.00035500937,0.00047869398,0.0003957606,0.00080843864,0.000015832033,0.00070396,0.002171852,0.000010725415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013475044,0.0008527096,0.61067295,0.0017180578,0.00063117046,0.00006549421,0.00009274227,7.4836674e-7,0.00055289123,0.000015996848,0.0017629868,0.38228676],"study_design_scores_gemma":[0.019691583,0.009157544,0.14157204,0.099675655,0.0013175283,0.000016182454,0.00023163282,0.000079976984,0.01309371,0.001422378,0.70908886,0.0046529206],"about_ca_topic_score_codex":0.009584019,"about_ca_topic_score_gemma":0.007164014,"teacher_disagreement_score":0.7073259,"about_ca_system_score_codex":0.00012948294,"about_ca_system_score_gemma":0.0016426045,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W2140338938","doi":"10.1158/1078-0432.ccr-05-0262","title":"Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Adverse effect; Response Evaluation Criteria in Solid Tumors; Asymptomatic; Cancer; Metastasis; Pathology; Internal medicine; Oncology; Phases of clinical research; Chemotherapy","score_opus":0.1781517426797625,"score_gpt":0.588530311715438,"score_spread":0.4103785690356755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140338938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943231,0.00011844353,0.00009533888,0.0003142398,0.00013379028,0.004628132,0.00007166256,0.000012250876,0.00030304916],"genre_scores_gemma":[0.9961641,0.00022095608,0.002414083,0.000051148778,0.00043203094,0.00041276801,0.00013453187,0.000050077233,0.00012029646],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99423563,0.00087955775,0.0011871313,0.00074365496,0.002286215,0.00066777924],"domain_scores_gemma":[0.99506515,0.002665675,0.00024359184,0.000654531,0.0009842805,0.0003867503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006329474,0.00021892921,0.0009583925,0.0004557365,0.00008721982,0.000016750137,0.00037080797,0.00015169714,0.00035987378],"category_scores_gemma":[0.0017004033,0.00015571085,0.00019669562,0.00074872404,0.0005023808,0.00011000055,0.00022968967,0.0013128676,0.0000044921235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49239913,0.013973088,0.10738746,0.00043016716,0.000054468495,0.000042154566,0.00009390183,0.000083495615,0.066921376,0.000055909466,0.0006631969,0.31789568],"study_design_scores_gemma":[0.45473146,0.23946047,0.2360437,0.0024999548,0.000044221706,0.0000015387932,0.00013682139,0.003541118,0.056576904,0.00003470803,0.006585769,0.00034333105],"about_ca_topic_score_codex":0.00010276172,"about_ca_topic_score_gemma":0.00008983594,"teacher_disagreement_score":0.31755233,"about_ca_system_score_codex":0.00058472774,"about_ca_system_score_gemma":0.000978783,"threshold_uncertainty_score":0.6349704},"labels":[],"label_agreement":null},{"id":"W2140418236","doi":"10.1158/1078-0432.ccr-09-1065","title":"Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for <i>miR-562</i>","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Cancer Research UK","keywords":"Loss of heterozygosity; Wilms' tumor; Carcinogenesis; Biology; Tumor suppressor gene; Cancer research; Genetics; Tumor progression; Candidate gene; Gene; Allele","score_opus":0.0731258647060366,"score_gpt":0.46784506700075845,"score_spread":0.39471920229472185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140418236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939082,0.003572356,0.000034439556,0.00089695596,0.00012812523,0.00043257326,0.00007347118,0.000005036057,0.0009488048],"genre_scores_gemma":[0.99619675,0.0019884608,0.00007780467,0.00042990365,0.00027250926,0.00006495055,0.000046484773,0.0000144828255,0.0009086348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980866,0.00021763465,0.00047879014,0.00048207626,0.0002868936,0.0004480055],"domain_scores_gemma":[0.99908954,0.00012412897,0.00010614583,0.00028374404,0.00023303619,0.0001634347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012469795,0.00012046731,0.00030220425,0.00006347908,0.0000785607,0.000009290658,0.00030707373,0.00022837865,0.000024489149],"category_scores_gemma":[0.00022913655,0.00009980813,0.00019816699,0.00023196153,0.00045953892,0.000004669685,0.000116964686,0.00040660548,0.00000763552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021671109,0.0018025242,0.20984648,0.00036570683,0.0004429308,0.00013592097,0.00050808594,0.0015614706,0.6206769,0.0003976989,0.042412516,0.10017868],"study_design_scores_gemma":[0.009454333,0.0087915575,0.08468414,0.00036172185,0.00005056433,0.000024076411,0.00026009767,0.00046971266,0.7196337,0.006148547,0.16937011,0.000751456],"about_ca_topic_score_codex":0.00017141612,"about_ca_topic_score_gemma":0.00019013161,"teacher_disagreement_score":0.1269576,"about_ca_system_score_codex":0.00009248575,"about_ca_system_score_gemma":0.0002960198,"threshold_uncertainty_score":0.40700573},"labels":[],"label_agreement":null},{"id":"W2140427893","doi":"10.1158/1078-0432.ccr-04-0429","title":"Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Breast cancer; Oncology; Tissue microarray; Clinical significance; Hierarchical clustering; Survival analysis; Internal medicine; Lymph node; Pathology; Medicine; Cancer; Biology; Cluster analysis","score_opus":0.15052236807356562,"score_gpt":0.46971136932017393,"score_spread":0.3191890012466083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140427893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927018,0.001013918,0.004601098,0.0007255623,0.00015487801,0.00032009927,0.0002890895,0.000007187664,0.00018636392],"genre_scores_gemma":[0.99773055,0.0006683826,0.0007526666,0.000032385316,0.00021480248,0.00004782337,0.00040134156,0.000020930655,0.00013111542],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970336,0.0004072758,0.0008772801,0.0007583489,0.00055220665,0.00037129945],"domain_scores_gemma":[0.99749345,0.0001930215,0.00020911936,0.001353219,0.00058087544,0.00017032132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023389866,0.00013354178,0.00042044994,0.00026424057,0.000095988995,0.000032876484,0.001040078,0.00021042353,0.00008439867],"category_scores_gemma":[0.0008235996,0.0001193636,0.00015896678,0.00088579144,0.000798967,0.000010848444,0.0009173243,0.00038076728,0.0000030174278],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006894474,0.00027627085,0.024872348,0.000081062906,0.0004919289,0.0000042229617,0.00011484501,0.0002810342,0.9584917,0.000107582615,0.00042445594,0.014165146],"study_design_scores_gemma":[0.0021085022,0.0010113686,0.5458828,0.00018302634,0.0004887388,0.00000614022,0.0009556858,0.0008757832,0.44401276,0.0002576249,0.003830778,0.0003867706],"about_ca_topic_score_codex":0.00044340998,"about_ca_topic_score_gemma":0.00023495073,"teacher_disagreement_score":0.52101046,"about_ca_system_score_codex":0.000037056434,"about_ca_system_score_gemma":0.00066355505,"threshold_uncertainty_score":0.48675063},"labels":[],"label_agreement":null},{"id":"W2140484012","doi":"10.1158/1078-0432.ccr-1405-2","title":"Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"National Cancer Institute","keywords":"Pathology; Prostate; Medicine; Osteopontin; Metastasis; Immunohistochemistry; Carcinoma; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.20227700794819006,"score_gpt":0.5120730653074815,"score_spread":0.3097960573592915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140484012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949135,0.0025986705,0.00031336804,0.00078842434,0.000058073394,0.0008564139,0.000024310397,0.000020154233,0.00042709516],"genre_scores_gemma":[0.99753356,0.0003518641,0.0012461896,0.000062438216,0.000048587506,0.0001231015,0.0000029261819,0.000009043098,0.00062226277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980829,0.00022256906,0.00060346746,0.00031254036,0.00050798757,0.00027055905],"domain_scores_gemma":[0.99862707,0.00052200357,0.00016360557,0.0002494073,0.00033858858,0.00009930971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020885323,0.00009074342,0.0005022451,0.000041373496,0.000104914725,0.000006836762,0.000088228735,0.00014917403,0.000051954936],"category_scores_gemma":[0.0034241597,0.00006267114,0.00009283871,0.00019411762,0.0015061699,0.00007067984,0.0003558482,0.0006133422,0.0000045659094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011850344,0.001724219,0.7935999,0.0018158889,0.00009333718,0.00037144337,0.0024107103,0.00003305933,0.16457285,0.001146631,0.0010074769,0.02137414],"study_design_scores_gemma":[0.007971985,0.0053296927,0.8743584,0.0016222709,0.000032543026,0.000017157856,0.0032233605,0.000030137915,0.10133423,0.0040932684,0.0017982251,0.0001887384],"about_ca_topic_score_codex":0.0004976469,"about_ca_topic_score_gemma":0.00006977303,"teacher_disagreement_score":0.08075848,"about_ca_system_score_codex":0.00006434038,"about_ca_system_score_gemma":0.00017534077,"threshold_uncertainty_score":0.5549546},"labels":[],"label_agreement":null},{"id":"W2140641884","doi":"10.1158/1078-0432.ccr-09-1476","title":"Vascular Endothelial Growth Factor Concentration as a Predictive Marker: Ready for Primetime?","year":2010,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vascular endothelial growth factor; Medicine; Growth factor; Internal medicine; VEGF receptors; Receptor","score_opus":0.28725245569168745,"score_gpt":0.5549046254222392,"score_spread":0.2676521697305517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140641884","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019540189,0.0015729177,0.0001804495,0.95787334,0.0036204522,0.008988797,0.0048159654,0.00017147741,0.0032363995],"genre_scores_gemma":[0.018681483,0.0073271394,0.0007068461,0.8690766,0.081756935,0.0033650198,0.0022910764,0.00039862108,0.016396245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906585,0.0020967652,0.00196613,0.0016369552,0.0023837504,0.0012578821],"domain_scores_gemma":[0.965151,0.028046142,0.00066019525,0.0013004435,0.004197448,0.00064478646],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009174311,0.00048658944,0.0017343656,0.00015990266,0.00029800172,0.00019992035,0.00061799586,0.004749767,0.0031740775],"category_scores_gemma":[0.05107646,0.00039410804,0.00097308867,0.00036894946,0.0010788161,0.00021584357,0.0001881116,0.019628284,0.00036068188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0113776205,0.0005801284,0.0062816334,0.0009339373,0.0015245343,0.00021715053,0.000066531116,1.07285565e-7,0.0005911682,0.00027776766,0.96883035,0.009319071],"study_design_scores_gemma":[0.006935125,0.004073324,0.0026834458,0.00031558904,0.00067033275,0.000005434294,0.000021317195,0.00013671743,0.000255302,0.0007025508,0.98381954,0.00038131175],"about_ca_topic_score_codex":0.0008484979,"about_ca_topic_score_gemma":0.00007980415,"teacher_disagreement_score":0.08879672,"about_ca_system_score_codex":0.00033349948,"about_ca_system_score_gemma":0.0048986888,"threshold_uncertainty_score":0.9998511},"labels":[],"label_agreement":null},{"id":"W2140728431","doi":"10.1158/1078-0432.ccr-07-1489","title":"Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Colorectal cancer; Internal medicine; Oncology; DNA mismatch repair; Cancer; Cohort; V600E; Prospective cohort study; Mutation; Biology; Gene","score_opus":0.14970964905147943,"score_gpt":0.4622277157691086,"score_spread":0.31251806671762916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140728431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501854,0.0016921962,0.0000036272838,0.0004031343,0.00017532495,0.0021529591,0.000038015733,0.000033737288,0.00048249197],"genre_scores_gemma":[0.99695665,0.0012703311,0.0004079155,0.00014437291,0.00013224901,0.00071341364,0.0000051292473,0.0000407452,0.00032917372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966482,0.00042325308,0.00062992447,0.0007006953,0.0010414536,0.0005564762],"domain_scores_gemma":[0.99669385,0.0014483226,0.00013411352,0.00040010578,0.0010287528,0.00029487134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011499549,0.00018171917,0.00063858915,0.00017956452,0.0000933938,0.0000064868386,0.00015847021,0.00021273484,0.00023346345],"category_scores_gemma":[0.001616184,0.00014146471,0.000091741604,0.00083858724,0.0015096051,0.000055221186,0.00013248816,0.0010016534,0.000006296465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004992672,0.0006136239,0.988157,0.00027338584,0.00009089127,0.000032569573,0.00038715688,0.000022983508,0.0001902758,0.0000046833197,0.0014972114,0.0037375772],"study_design_scores_gemma":[0.0043858,0.0041148798,0.9887577,0.0005012427,0.000042478634,0.0000033641102,0.000060176648,0.000058490208,0.0012100948,0.000047424004,0.00066914764,0.00014916576],"about_ca_topic_score_codex":0.0025771142,"about_ca_topic_score_gemma":0.0019706767,"teacher_disagreement_score":0.0035884115,"about_ca_system_score_codex":0.00038973242,"about_ca_system_score_gemma":0.0015174351,"threshold_uncertainty_score":0.57687634},"labels":[],"label_agreement":null},{"id":"W2140778393","doi":"10.1158/1078-0432.ccr-05-1624","title":"The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"CDX2; Immunohistochemistry; Carcinogenesis; Colorectal cancer; Biology; Cancer research; Transcription factor; Reverse transcription polymerase chain reaction; Intestinal mucosa; Endogeny; Epithelium; Tumor suppressor gene; Pathology; Messenger RNA; Cancer; Medicine; Homeobox; Internal medicine; Gene; Immunology; Endocrinology","score_opus":0.09412990076868448,"score_gpt":0.4991898561619032,"score_spread":0.4050599553932187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140778393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97887003,0.0073125795,0.000009952654,0.0042395312,0.00022586895,0.00064966694,0.00018315145,0.000015017684,0.008494169],"genre_scores_gemma":[0.98652065,0.0009866828,0.000019180197,0.0006263142,0.0010149172,0.00020223366,0.0000565675,0.000034500197,0.010538937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967847,0.0008720863,0.00054076087,0.0006029852,0.0004958264,0.0007036432],"domain_scores_gemma":[0.99835896,0.00040181723,0.00011903974,0.00041871727,0.00040482954,0.0002966287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021961513,0.00015791261,0.00023678434,0.00003092616,0.0006855186,0.000077553086,0.000546958,0.00026592673,0.0001770117],"category_scores_gemma":[0.00043801466,0.000106043655,0.0001530795,0.00015773065,0.0008679223,0.0000064060378,0.00021161728,0.00076034723,0.000115118135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010307312,0.00034168782,0.018205436,0.00005191336,0.00023830793,0.0000110866295,0.00029927294,0.000011565505,0.30452642,0.00038567564,0.67116696,0.003730936],"study_design_scores_gemma":[0.0018335485,0.0015549614,0.020759126,0.00005578339,0.000015669599,0.000005857998,0.00031366997,0.000051753694,0.28076875,0.00018227778,0.69419837,0.0002602419],"about_ca_topic_score_codex":0.00023923015,"about_ca_topic_score_gemma":0.00015354952,"teacher_disagreement_score":0.023757659,"about_ca_system_score_codex":0.00007537356,"about_ca_system_score_gemma":0.00043970716,"threshold_uncertainty_score":0.5272524},"labels":[],"label_agreement":null},{"id":"W2140793516","doi":"10.1158/1078-0432.ccr-04-2517","title":"Anti-CD19-Targeted Liposomal Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxicity of Liposomes with Varying Drug Release Rates","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Liposome; Pharmacology; Doxorubicin; Pharmacokinetics; Toxicity; Drug; Chemistry; Therapeutic index; Biodistribution; In vivo; Drug carrier; Phosphatidylcholine; Medicine; Biology; In vitro; Biochemistry; Chemotherapy; Internal medicine; Phospholipid; Membrane","score_opus":0.05686369356701386,"score_gpt":0.3860456470176086,"score_spread":0.3291819534505947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140793516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722196,0.0052893083,0.0000021486342,0.006432108,0.000112137335,0.00084192696,0.000019142055,0.0000398051,0.000041440777],"genre_scores_gemma":[0.9976799,0.0011601193,0.00011852331,0.00050451915,0.0002928105,0.000073869865,0.0000016700466,0.000035904894,0.0001326979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952935,0.0016465266,0.00082905777,0.00064102723,0.0008143405,0.00077554304],"domain_scores_gemma":[0.9931389,0.0053724265,0.00021958181,0.00074436597,0.000341135,0.00018360783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050331284,0.0002335033,0.0004905143,0.00013231263,0.0003423908,0.00017182369,0.0008243024,0.000098287455,0.00011688729],"category_scores_gemma":[0.00057035097,0.000120731165,0.00008376403,0.00093401683,0.0018958431,0.00027967317,0.0003732781,0.00056132907,0.000042474272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001549686,0.0013605783,0.016593337,0.000074174735,0.000026754586,0.000017350147,0.0008255927,0.00070023834,0.96689075,0.000038956758,0.00023392178,0.011688631],"study_design_scores_gemma":[0.0037001553,0.00044911375,0.059015363,0.00012180585,0.000029440955,0.0000032531464,0.00036503415,0.0021987415,0.9336291,0.000095768635,0.00021133819,0.0001809188],"about_ca_topic_score_codex":0.0014332067,"about_ca_topic_score_gemma":0.0006065299,"teacher_disagreement_score":0.042422023,"about_ca_system_score_codex":0.000101129146,"about_ca_system_score_gemma":0.0005614638,"threshold_uncertainty_score":0.69853127},"labels":[],"label_agreement":null},{"id":"W2141170383","doi":"10.1158/1078-0432.ccr-07-0517","title":"Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Paclitaxel; Dendritic cell; Cancer research; Lewis lung carcinoma; Tumor microenvironment; Medicine; CD8; Cytokine; Lung cancer; In vivo; Lymph node; Immunology; Cancer; Immune system; Pathology; Biology; Internal medicine; Metastasis","score_opus":0.047189118033625084,"score_gpt":0.4168403109560373,"score_spread":0.3696511929224122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141170383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92793727,0.06718049,0.000088378714,0.0016692234,0.0018069351,0.00092504063,0.00005325812,0.000098740624,0.00024064929],"genre_scores_gemma":[0.98444676,0.008724359,0.00017464205,0.0011092995,0.00078704255,0.00018323331,0.000027422338,0.00007035183,0.004476902],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9947529,0.0012278699,0.0011180675,0.00085430284,0.00019724242,0.0018496263],"domain_scores_gemma":[0.9962693,0.0022664457,0.00013298671,0.00056079926,0.00054626656,0.00022424474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005402265,0.00036678446,0.00078304217,0.00027390107,0.0006391968,0.000084000734,0.0005769545,0.00051021535,0.0011663325],"category_scores_gemma":[0.00073639926,0.00031511558,0.0002087151,0.0008856196,0.0006689118,0.00018016993,0.00043408247,0.00216775,0.00014955852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04408646,0.0016005968,0.22425729,0.0005937837,0.001114892,0.00029873228,0.001222963,0.000066159715,0.5381496,0.001455284,0.10853046,0.078623794],"study_design_scores_gemma":[0.015291113,0.0053599207,0.69836444,0.0012388029,0.00020879968,0.00009673105,0.0005947405,0.00011079313,0.22424112,0.00091360096,0.052044727,0.0015351934],"about_ca_topic_score_codex":0.0012393988,"about_ca_topic_score_gemma":0.00067861594,"teacher_disagreement_score":0.47410718,"about_ca_system_score_codex":0.0002184917,"about_ca_system_score_gemma":0.00052388245,"threshold_uncertainty_score":0.9999301},"labels":[],"label_agreement":null},{"id":"W2141272738","doi":"10.1158/1078-0432.ccr-07-5234","title":"Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Denosumab; Medicine; Breast cancer; Internal medicine; Urology; Bisphosphonate; Adverse effect; Bone resorption; Creatinine; Zoledronic acid; Oncology; Gastroenterology; Cancer; Osteoporosis","score_opus":0.14421644474625697,"score_gpt":0.4772672333406095,"score_spread":0.33305078859435255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141272738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920545,0.004506198,8.82363e-7,0.0018662777,0.00007856441,0.0012584695,0.00015775909,0.000015714551,0.00006163165],"genre_scores_gemma":[0.9639928,0.035004277,0.00017379227,0.00033315725,0.00003497704,0.00016577284,0.000017023598,0.000032908276,0.00024533083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705535,0.00032572044,0.00072839664,0.00050767494,0.0008161774,0.0005666652],"domain_scores_gemma":[0.9976878,0.00092162425,0.00014116234,0.00032903024,0.0005064375,0.0004139098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011230216,0.00016795925,0.0006822688,0.00017004386,0.00016399694,0.0000071343748,0.00009385513,0.0001210361,0.0002944658],"category_scores_gemma":[0.00023634575,0.00011236546,0.00006334984,0.0005765595,0.0006128421,0.00007927423,0.00007206261,0.0006788681,0.000006065246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029101562,0.001649151,0.7635644,0.000086562824,0.00011834341,0.00007033216,0.00016141903,8.4561077e-7,0.000026072432,0.000003460567,0.0002189078,0.20499896],"study_design_scores_gemma":[0.024150696,0.0013829856,0.97247756,0.00047171713,0.000029051276,0.000014106009,0.000015061882,0.000011232563,0.00037322484,0.0000092451655,0.00096563814,0.000099496094],"about_ca_topic_score_codex":0.009377832,"about_ca_topic_score_gemma":0.0012441981,"teacher_disagreement_score":0.20891315,"about_ca_system_score_codex":0.00021249281,"about_ca_system_score_gemma":0.0012116366,"threshold_uncertainty_score":0.9972188},"labels":[],"label_agreement":null},{"id":"W2141275127","doi":"10.1158/1078-0432.ccr-12-0482","title":"A Phase II Pharmacodynamic Study of Preoperative Figitumumab in Patients with Localized Prostate Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Medicine; Prostatectomy; Prostate; Urology; Immunohistochemistry; Prostate-specific antigen; Cancer; Biopsy; Internal medicine; Prostate biopsy","score_opus":0.13249645557582498,"score_gpt":0.5120284825193231,"score_spread":0.3795320269434981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141275127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949186,0.00086988334,0.0000017653716,0.00024937847,0.00020256286,0.003367888,0.000084560226,0.000022313405,0.00028304663],"genre_scores_gemma":[0.99795496,0.00040977352,0.000022557675,0.00014280788,0.00018823206,0.0007542929,0.000030532025,0.000044628145,0.00045220705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996012,0.0005786341,0.00094082794,0.00048225521,0.0011688696,0.0008174679],"domain_scores_gemma":[0.99787873,0.00024048575,0.00015432239,0.0004015556,0.0008449936,0.0004799135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016461397,0.00022072112,0.0007481328,0.00029106162,0.000114443006,0.0000131154775,0.0002068415,0.000121901125,0.0004401378],"category_scores_gemma":[0.00033767163,0.00015067589,0.00008219227,0.0010382538,0.00039227214,0.00028889548,0.00020236523,0.0012319073,0.000014622162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01747773,0.026181482,0.93570346,0.00010766307,0.00022486462,0.000011120796,0.0047206986,0.0000074764002,0.00011030721,0.0000040065743,0.0008576708,0.014593546],"study_design_scores_gemma":[0.07330887,0.026399959,0.8960284,0.00029018745,0.00012702213,3.914264e-7,0.0009369847,0.00021996052,0.0006149177,0.0000061863043,0.0018495077,0.00021763533],"about_ca_topic_score_codex":0.00172968,"about_ca_topic_score_gemma":0.00032239876,"teacher_disagreement_score":0.05583114,"about_ca_system_score_codex":0.0002959464,"about_ca_system_score_gemma":0.000698379,"threshold_uncertainty_score":0.6144385},"labels":[],"label_agreement":null},{"id":"W2141284512","doi":"10.1158/1078-0432.ccr-10-1551","title":"Array-Based Comparative Genomic Hybridization Identifies <i>CDK4</i> and <i>FOXM1</i> Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University Health Network","funders":"","keywords":"Comparative genomic hybridization; Biology; FOXM1; Candidate gene; Malignant peripheral nerve sheath tumor; Tissue microarray; Cancer research; Fluorescence in situ hybridization; Microarray; Microarray analysis techniques; Copy-number variation; Cancer; Gene expression profiling; Gene; In situ hybridization; Immunohistochemistry; Pathology; Gene expression; Genetics; Cell cycle; Genome; Medicine; Chromosome; Immunology","score_opus":0.22293613027951611,"score_gpt":0.4414306515887627,"score_spread":0.2184945213092466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141284512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659353,0.0005457985,0.000049648123,0.0002712937,0.00032215822,0.00076304533,0.000065719156,0.00002096842,0.0013678443],"genre_scores_gemma":[0.99897206,0.00015616676,0.00015435701,0.00014827198,0.00018102511,0.0001284667,0.000030607745,0.000023996783,0.00020504826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679565,0.0007145139,0.0009325054,0.00052216504,0.0006662465,0.0003689081],"domain_scores_gemma":[0.99834615,0.00049346854,0.00014760488,0.00034769348,0.00039687302,0.00026818318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016775564,0.00016197487,0.00061234104,0.00020885492,0.000120079545,0.00004802023,0.00015929363,0.00007974673,0.0003079685],"category_scores_gemma":[0.00029788323,0.00013616901,0.00011961282,0.00035382537,0.000596657,0.00013127981,0.00009362887,0.0005462895,0.000011176899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021739628,0.0008242121,0.9436175,0.0001819398,0.00007165686,0.000271386,0.0011925319,0.000037004604,0.050138168,0.00036041005,0.0010052108,0.00012596489],"study_design_scores_gemma":[0.003913492,0.0023427492,0.8897842,0.00044891017,0.00006222689,0.000041259227,0.0009187539,0.000548668,0.100974396,0.00024279217,0.0005036733,0.0002188736],"about_ca_topic_score_codex":0.0015207855,"about_ca_topic_score_gemma":0.0007412714,"teacher_disagreement_score":0.053833347,"about_ca_system_score_codex":0.00009684928,"about_ca_system_score_gemma":0.00077359733,"threshold_uncertainty_score":0.5552811},"labels":[],"label_agreement":null},{"id":"W2141325836","doi":"10.1158/1078-0432.ccr-06-0252","title":"Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University Health Network; University of Toronto; BC Cancer Agency","funders":"BC Cancer Agency; Immunodeficiency Canada","keywords":"Pathology; Biology; Adenocarcinoma; Cancer; Carcinoma; Fluorescence in situ hybridization; Transplantation; Lung cancer; Carcinosarcoma; Cancer research; Adenosquamous carcinoma; Tumor progression; Medicine; Internal medicine; Chromosome","score_opus":0.06316110491169903,"score_gpt":0.40742697637299174,"score_spread":0.3442658714612927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141325836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847143,0.012866998,0.0000625245,0.000098950695,0.00008233007,0.0012370616,0.0008129367,0.0000064256924,0.00011846951],"genre_scores_gemma":[0.9970537,0.0014451459,0.000269652,0.000017993645,0.00013167346,0.00048491577,0.00048351003,0.000027024607,0.00008638454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746346,0.00024760075,0.00066016254,0.0005943035,0.0004697768,0.00056469685],"domain_scores_gemma":[0.99893004,0.00011289454,0.00017799993,0.00028668606,0.00037843324,0.00011395523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001133617,0.00017711254,0.00048162142,0.00012564765,0.00015494901,0.00003417305,0.0002995664,0.00013014469,0.000022526767],"category_scores_gemma":[0.000044188397,0.0001546398,0.00011697115,0.00028334506,0.00042416854,0.000019615294,0.00020606988,0.00030381465,1.5266315e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011010465,0.0033769603,0.10941612,0.0014169728,0.00062510325,0.00006124732,0.0004370704,0.002010573,0.8632277,0.000092913986,0.0014321341,0.006892702],"study_design_scores_gemma":[0.065298766,0.015545665,0.24134597,0.0033339718,0.00046278955,0.000029090523,0.0010424375,0.01405186,0.6520678,0.0043701134,0.00090520957,0.0015463526],"about_ca_topic_score_codex":0.02363311,"about_ca_topic_score_gemma":0.006360061,"teacher_disagreement_score":0.21115997,"about_ca_system_score_codex":0.00013931375,"about_ca_system_score_gemma":0.00071509765,"threshold_uncertainty_score":0.9828686},"labels":[],"label_agreement":null},{"id":"W2141410122","doi":"10.1158/1078-0432.ccr-07-0674","title":"Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Chimeric antigen receptor; Immunology; Adoptive cell transfer; Cancer research; T cell; Homing (biology); Medicine; Ex vivo; Systemic administration; CD28; Immunotherapy; Leukemia; In vivo; Biology; Immune system","score_opus":0.1267420617162681,"score_gpt":0.4841363589671988,"score_spread":0.35739429725093075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141410122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845899,0.003192235,0.00061326387,0.0012963796,0.0011216128,0.0019455784,0.00004053016,0.00017842489,0.0070220926],"genre_scores_gemma":[0.9621128,0.007220078,0.0006776449,0.00080833497,0.0031510056,0.00019392875,0.0000310269,0.00016025218,0.025644962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9911961,0.00085245975,0.0015730847,0.0012163129,0.002904716,0.0022573425],"domain_scores_gemma":[0.99191207,0.003335268,0.00013733798,0.0013864196,0.0013385512,0.0018903356],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.011821756,0.0003477754,0.0009728475,0.0006329559,0.00029357916,0.000107040665,0.00084886904,0.00061849743,0.0076338993],"category_scores_gemma":[0.0011018348,0.0002931771,0.00046737038,0.0017706598,0.0016430091,0.00007517867,0.0004421939,0.0027389629,0.0016570598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011012082,0.00062461843,0.024777928,0.000497378,0.0010198234,0.0021378682,0.00020985788,0.000032490825,0.81425464,0.00013653877,0.03509162,0.11020517],"study_design_scores_gemma":[0.031811245,0.011679098,0.19602393,0.002382375,0.00082670164,0.00091180525,0.00052733393,0.0044867448,0.37728387,0.0007110121,0.37135908,0.0019968005],"about_ca_topic_score_codex":0.00041974866,"about_ca_topic_score_gemma":0.00010916058,"teacher_disagreement_score":0.43697074,"about_ca_system_score_codex":0.0020586383,"about_ca_system_score_gemma":0.0035370728,"threshold_uncertainty_score":0.999952},"labels":[],"label_agreement":null},{"id":"W2141453591","doi":"10.1158/1078-0432.ccr-11-0859","title":"Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Docetaxel; Mitoxantrone; Medicine; Prostate cancer; Internal medicine; Prednisone; Oncology; Cancer; Chemotherapy; Urology; Surgery; Gastroenterology","score_opus":0.21425801524656538,"score_gpt":0.5016571026383948,"score_spread":0.2873990873918294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141453591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821239,0.0010051392,0.000011533338,0.0009605611,0.00036376942,0.01518225,0.00021955093,0.000030919535,0.000102357815],"genre_scores_gemma":[0.9905566,0.00086759264,0.0005321025,0.000123656,0.00027779368,0.0069273575,0.00008537269,0.00009606408,0.00053345994],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99194974,0.0022499196,0.0024119345,0.000995046,0.0014362652,0.0009571051],"domain_scores_gemma":[0.9955172,0.0015289243,0.0007363182,0.0007007124,0.0011119053,0.00040493856],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005787106,0.00045020485,0.002331097,0.00061640755,0.00011749684,0.000041451476,0.00030406428,0.00022587569,0.0021102915],"category_scores_gemma":[0.0018221132,0.00027199858,0.00022951585,0.0010830235,0.0017343943,0.00024010519,0.00016925056,0.0012809122,0.0000066325406],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95266914,0.01917854,0.015698146,0.00045418416,0.00037859273,0.00067850354,0.0011612269,0.000016854066,0.000038018796,0.000006482074,0.00005844946,0.009661867],"study_design_scores_gemma":[0.91820645,0.06345827,0.015413273,0.0012583482,0.00028525395,0.0000049385935,0.00011291179,0.00032428786,0.00036530668,0.00013914662,0.00013329544,0.00029849578],"about_ca_topic_score_codex":0.0014910111,"about_ca_topic_score_gemma":0.0077977753,"teacher_disagreement_score":0.04427973,"about_ca_system_score_codex":0.00034027168,"about_ca_system_score_gemma":0.0024400246,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W2141668657","doi":"10.1158/1078-0432.ccr-13-0128","title":"Use of the Proton Pump Inhibitor Pantoprazole to Modify the Distribution and Activity of Doxorubicin: A Potential Strategy to Improve the Therapy of Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pantoprazole; Doxorubicin; Pharmacology; Distribution (mathematics); Proton-pump inhibitor; Chemistry; Cancer research; Medicine; Chemotherapy; Internal medicine; Biochemistry; Omeprazole","score_opus":0.13406983096115255,"score_gpt":0.46313515347315026,"score_spread":0.3290653225119977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141668657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941022,0.00014687203,0.00011826039,0.0028793865,0.00005100848,0.0024264264,0.0002607293,0.0000016381822,0.0000134864995],"genre_scores_gemma":[0.99847376,0.0005812258,0.0000063004823,0.00008401455,0.00021523162,0.00047190752,0.000005943542,0.000011905531,0.0001497196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977868,0.0006469304,0.0003835671,0.00031369226,0.00053180946,0.00033715417],"domain_scores_gemma":[0.99824214,0.00026164888,0.000119045064,0.0006534719,0.000598397,0.00012531216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014976935,0.00010325019,0.00022116849,0.000022464654,0.00014068029,0.000032972763,0.00047745078,0.00012508941,0.00003283554],"category_scores_gemma":[0.00074766274,0.000048668448,0.00013275692,0.00026060618,0.0007650009,0.0000111436975,0.0005874755,0.00039825967,0.0000021357741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009456549,0.00016881556,0.0029941334,0.000035675952,0.000050679675,3.4274288e-7,0.0000416493,0.00011675031,0.9537298,0.000014589616,0.0010262607,0.04087563],"study_design_scores_gemma":[0.00034739924,0.0015035957,0.041561387,0.000038038103,0.0000046505324,3.9220942e-7,0.000117005126,0.00035968772,0.9541741,0.000060932936,0.0017731808,0.000059659666],"about_ca_topic_score_codex":0.0027888482,"about_ca_topic_score_gemma":0.00012190272,"teacher_disagreement_score":0.040815968,"about_ca_system_score_codex":0.000017038652,"about_ca_system_score_gemma":0.0003676095,"threshold_uncertainty_score":0.4215923},"labels":[],"label_agreement":null},{"id":"W2141762477","doi":"10.1158/1078-0432.ccr-031210","title":"Prevention Strategies with Aromatase Inhibitors","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Exemestane; Anastrozole; Medicine; Aromatase; Breast cancer; Tamoxifen; Letrozole; Aromatase inhibitor; Internal medicine; Oncology; Cancer; Clinical trial; Pharmacology","score_opus":0.08574232485257798,"score_gpt":0.49146827692662176,"score_spread":0.40572595207404377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141762477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957601,0.0019899376,0.00012937597,0.00040961764,0.00011092237,0.00026835772,0.000006542521,0.000013878758,0.001311274],"genre_scores_gemma":[0.99757874,0.0011284221,0.00020141956,0.00004495763,0.00048214005,0.000072739334,0.000054744778,0.000018674877,0.0004181526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986803,0.00019712398,0.00020553231,0.0003458236,0.00026967554,0.00030155794],"domain_scores_gemma":[0.99937576,0.000032612457,0.000039373746,0.00027900963,0.00012511421,0.0001481101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008623387,0.00009008088,0.00011446115,0.00003773752,0.00011116804,0.000044595738,0.00015751188,0.00021252492,0.000021484799],"category_scores_gemma":[0.00009043628,0.00006512068,0.00007857848,0.00017021815,0.00034598025,0.0000065196677,0.00008922982,0.00043510404,0.000044649518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010725318,0.0038476388,0.046132155,0.00040726693,0.0014505361,0.0005174319,0.0003128998,0.0052470337,0.77784926,0.0066839387,0.05171124,0.095115274],"study_design_scores_gemma":[0.013714754,0.022040162,0.02564941,0.00074712234,0.00010608529,0.00007707068,0.0012074515,0.000024327359,0.85279363,0.009114205,0.07347204,0.0010537141],"about_ca_topic_score_codex":0.00010765502,"about_ca_topic_score_gemma":0.00010705264,"teacher_disagreement_score":0.09406156,"about_ca_system_score_codex":0.000026203345,"about_ca_system_score_gemma":0.0007754992,"threshold_uncertainty_score":0.26555443},"labels":[],"label_agreement":null},{"id":"W2141933631","doi":"10.1158/1078-0432.ccr-08-1622","title":"Successes and Challenges in Translational Research: The Development of Targeted Therapy for Gastrointestinal Stromal Tumours","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"GiST; Imatinib; Imatinib mesylate; Medicine; Tyrosine-kinase inhibitor; Targeted therapy; Gastrointestinal tract; Stromal cell; Clinical trial; Oncology; Mesenchymal stem cell; Tyrosine kinase; Stomach; Stromal tumor; Internal medicine; Cancer research; Pathology; Cancer; Receptor","score_opus":0.5878703424315738,"score_gpt":0.5614306214041053,"score_spread":0.0264397210274685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141933631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94929147,0.009086881,0.00003915967,0.039598513,0.000016371545,0.0015473273,0.000016998483,0.000012286595,0.0003909956],"genre_scores_gemma":[0.98957884,0.0028592427,0.0069696778,0.000029361185,0.00017174767,0.00029229562,0.000014701215,0.000015218922,0.00006889677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962263,0.0006281966,0.0006424149,0.0004618726,0.0012387516,0.00080243713],"domain_scores_gemma":[0.99472463,0.0036276884,0.000057416106,0.00025810045,0.00101839,0.00031376322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008408903,0.00013546919,0.00036393153,0.0003021316,0.00022600188,0.000028052043,0.0002512116,0.00004455344,0.00007031392],"category_scores_gemma":[0.002126911,0.00008556368,0.00009088761,0.00044174035,0.00080086367,0.000058112444,0.00005384262,0.0009922824,0.0000033360366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017349204,0.0033076848,0.57516974,0.00038324506,0.000090605965,0.0001545284,0.0010195416,0.0000090158455,0.0036675383,0.0032552374,0.0005291841,0.39506447],"study_design_scores_gemma":[0.004099537,0.0068924674,0.9821048,0.000538547,0.000005149417,0.00005222284,0.0006832157,0.00011307828,0.001706042,0.0023474912,0.0013898774,0.000067604735],"about_ca_topic_score_codex":0.000083512365,"about_ca_topic_score_gemma":0.00048812348,"teacher_disagreement_score":0.40693504,"about_ca_system_score_codex":0.00009977504,"about_ca_system_score_gemma":0.001591496,"threshold_uncertainty_score":0.43110287},"labels":[],"label_agreement":null},{"id":"W2142019712","doi":"10.1158/1078-0432.ccr-07-1061","title":"Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; University of California, San Diego; National Institutes of Health","keywords":"Bendamustine; DNA damage; DNA repair; Biology; Nitrogen mustard; Mitotic catastrophe; Mechanism of action; Chlorambucil; Cancer research; DNA; Pharmacology; Chemotherapy; In vitro; Genetics; Leukemia; Chronic lymphocytic leukemia; Cyclophosphamide","score_opus":0.2350859728693352,"score_gpt":0.48595794570328527,"score_spread":0.2508719728339501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142019712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952978,0.0008048369,0.00014328677,0.00061628356,0.00004206966,0.0006400478,0.00012361728,0.000024111547,0.0023079286],"genre_scores_gemma":[0.9979407,0.0005789473,0.00018952116,0.00013302112,0.00016611711,0.00012391292,0.000013390633,0.000027612185,0.0008267686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980127,0.00018618366,0.00039654877,0.0004273221,0.0006116266,0.00036558384],"domain_scores_gemma":[0.998357,0.00071304385,0.00010838666,0.00025309031,0.0003392708,0.0002292069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000557129,0.00017276779,0.00061680883,0.000078901794,0.00028033098,0.000011317885,0.00009469981,0.00008479538,0.00023875566],"category_scores_gemma":[0.00032689967,0.00011063092,0.00007974534,0.00026428397,0.0007664407,0.000030185067,0.00015569614,0.0005032031,0.0000023408159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033357893,0.0005279786,0.98435473,0.000251577,0.00037178316,0.00018798058,0.00071773987,0.0000033993738,0.0003632689,0.000035562512,0.001388287,0.008461879],"study_design_scores_gemma":[0.003599187,0.0023798828,0.9912297,0.0004582189,0.000096971395,0.00004528318,0.00019153618,0.00025634828,0.00081083697,0.000051561154,0.0007483475,0.00013209833],"about_ca_topic_score_codex":0.0028355576,"about_ca_topic_score_gemma":0.0030877849,"teacher_disagreement_score":0.00832978,"about_ca_system_score_codex":0.000113260634,"about_ca_system_score_gemma":0.00023016271,"threshold_uncertainty_score":0.4511398},"labels":[],"label_agreement":null},{"id":"W2142088661","doi":"10.1158/1078-0432.ccr-06-0372","title":"Nomograms Provide Improved Accuracy for Predicting Survival after Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Cystectomy; Bladder cancer; Lymphovascular invasion; Urology; Lymphadenectomy; Proportional hazards model; Radiation therapy; Stage (stratigraphy); AJCC staging system; Carcinoma in situ; Lymph node; Surgery; Cancer; Oncology; Internal medicine; Metastasis","score_opus":0.14711538628860785,"score_gpt":0.4994884676199847,"score_spread":0.3523730813313769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142088661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800597,0.0028659876,0.0005419917,0.005735564,0.0011860443,0.0049823206,0.00022983713,0.00019795568,0.004200639],"genre_scores_gemma":[0.9854672,0.00018445397,0.0008583398,0.00039703128,0.0049690856,0.0033535145,0.00005741484,0.00008278719,0.00463015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961862,0.0003085264,0.00086142647,0.0008144061,0.0008310835,0.0009983542],"domain_scores_gemma":[0.9962496,0.0020529223,0.00010159543,0.000560235,0.0005947311,0.00044088348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023537162,0.00023401045,0.0006139862,0.00012415135,0.00021915948,0.000086370055,0.00024942105,0.00029874154,0.00047730096],"category_scores_gemma":[0.001553623,0.00018022068,0.00040207655,0.00040025476,0.00055258116,0.00012234466,0.00014235172,0.0009962565,0.000046227957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019622007,0.0020565805,0.80945265,0.0007808434,0.0004818263,0.00017111261,0.00013428465,0.0000027386363,0.0017887558,0.000111970534,0.014002017,0.1513952],"study_design_scores_gemma":[0.03569177,0.0066332715,0.49300328,0.0007271988,0.00051367737,0.0000335671,0.00016906607,0.0015410477,0.004072478,0.0017028193,0.45525387,0.00065797236],"about_ca_topic_score_codex":0.0039245025,"about_ca_topic_score_gemma":0.001068752,"teacher_disagreement_score":0.44125184,"about_ca_system_score_codex":0.00031143357,"about_ca_system_score_gemma":0.0012260663,"threshold_uncertainty_score":0.7349186},"labels":[],"label_agreement":null},{"id":"W2142306777","doi":"10.1158/1078-0432.ccr-12-2789","title":"Mammographic Breast Density Response to Aromatase Inhibition","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of General Medical Sciences; National Cancer Institute; Avon Foundation for Women","keywords":"Aromatase inhibitor; Aromatase; Medicine; Internal medicine; Breast cancer; Letrozole; Tamoxifen; Body mass index; Estrogen; Cancer; Endocrinology; Oncology","score_opus":0.11402935958682121,"score_gpt":0.4777098744885168,"score_spread":0.3636805149016956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142306777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716743,0.00012266022,0.000029894722,0.025649363,0.00013626946,0.00082426704,0.00006548371,0.00008483546,0.0014128884],"genre_scores_gemma":[0.99656457,0.000060998493,0.00020211742,0.0018039761,0.0004024564,0.00021517753,0.000023144781,0.00002514687,0.00070240017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971006,0.000492448,0.00045826496,0.00051979464,0.0007996312,0.0006292528],"domain_scores_gemma":[0.9969614,0.0008068915,0.000038850943,0.0005528863,0.0006837172,0.0009562344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003424481,0.00013380544,0.00031976806,0.00057488214,0.00015106864,0.00013693815,0.00014548232,0.00011759224,0.00066403375],"category_scores_gemma":[0.0010001829,0.000110580186,0.00024611063,0.0015910803,0.0005277941,0.00025917654,0.0001724569,0.0007930254,0.0010956494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0134239765,0.0012279837,0.50322723,0.00014053233,0.00014492635,0.00044215372,0.00009698288,0.0000013464912,0.014185217,0.0001686533,0.1362274,0.3307136],"study_design_scores_gemma":[0.0013061601,0.00073111313,0.98872936,0.00033941216,0.00002031766,0.00022405617,0.00009945674,0.000023464943,0.00076776854,0.0010469686,0.006566864,0.0001450711],"about_ca_topic_score_codex":0.0007227037,"about_ca_topic_score_gemma":0.000042506774,"teacher_disagreement_score":0.48550212,"about_ca_system_score_codex":0.00008261001,"about_ca_system_score_gemma":0.00027658461,"threshold_uncertainty_score":0.9996821},"labels":[],"label_agreement":null},{"id":"W2142308379","doi":"10.1158/1078-0432.ccr-07-4496","title":"Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"STAT3; Tissue microarray; Cancer research; Immunohistochemistry; STAT protein; Adenocarcinoma; Medicine; Cancer; Metastasis; Transcription factor; Pathology; Signal transduction; Biology; Internal medicine; Gene","score_opus":0.23121385549468268,"score_gpt":0.45240654009255904,"score_spread":0.22119268459787636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142308379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980435,0.00035161103,0.00021065382,0.0002783372,0.000061789324,0.0008933849,0.00013790483,0.0000043819655,0.000018476478],"genre_scores_gemma":[0.99824405,0.0007858083,0.00025707384,0.00003521589,0.00028033828,0.00022786965,0.00008088944,0.000015065223,0.00007366868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997882,0.00050996325,0.00070550933,0.00043595495,0.00020258415,0.00026397803],"domain_scores_gemma":[0.9989413,0.000323588,0.00015362097,0.0001732628,0.00023428623,0.00017394319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018021682,0.000101797355,0.00028061232,0.000098044344,0.000108390755,0.0000074487966,0.00010909604,0.00034588345,0.0000058861388],"category_scores_gemma":[0.00073668244,0.000095245894,0.00010526214,0.00013990508,0.0002589026,0.000014528909,0.000052504332,0.00035119176,4.5012183e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041844,0.00015616076,0.8738471,0.00006179669,0.000019794994,3.6530577e-7,0.000055246965,4.5164435e-7,0.11956336,0.0000045516963,0.00063024065,0.0052424707],"study_design_scores_gemma":[0.0029627576,0.0013216586,0.96033746,0.00004142877,0.000015486748,2.8691633e-7,0.00003807244,0.000005883901,0.034081776,0.000067996625,0.0010286568,0.00009855578],"about_ca_topic_score_codex":0.000048460788,"about_ca_topic_score_gemma":0.00004557065,"teacher_disagreement_score":0.08649032,"about_ca_system_score_codex":0.000057302168,"about_ca_system_score_gemma":0.00021113093,"threshold_uncertainty_score":0.38840148},"labels":[],"label_agreement":null},{"id":"W2142315632","doi":"10.1158/1078-0432.ccr-03-0634","title":"Phase I Study of Concomitant Chemoradiotherapy with Paclitaxel, Fluorouracil, Gemcitabine, and Twice-Daily Radiation in Patients with Poor-Prognosis Cancer of the Head and Neck","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Mucositis; Medicine; Gemcitabine; Concomitant; Antimetabolite; Fluorouracil; Chemoradiotherapy; Regimen; Neutropenia; Internal medicine; Radiation therapy; Head and neck cancer; Chemotherapy; Surgery; Gastroenterology; Phases of clinical research; Oncology","score_opus":0.1034947615815202,"score_gpt":0.4728574492912854,"score_spread":0.3693626877097652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142315632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093384,0.004027537,9.4095685e-7,0.003130332,0.000047290654,0.0017578439,0.000038088394,0.0000068817694,0.000057261634],"genre_scores_gemma":[0.99641854,0.0029549873,0.00006346597,0.00019879609,0.0000766828,0.00023765398,0.0000018060155,0.000023331742,0.00002473825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777436,0.00021230314,0.0005577591,0.00040175449,0.0007387784,0.00031503354],"domain_scores_gemma":[0.99859,0.0003312322,0.0001617119,0.00026698515,0.00049535313,0.00015475448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087012816,0.00015316992,0.0007513954,0.00010373487,0.0000949626,0.000011797321,0.000108112894,0.00007964894,0.00002075778],"category_scores_gemma":[0.00020987952,0.000085269996,0.00003646719,0.000619479,0.00074059074,0.000084977284,0.00006656398,0.0004962711,2.0130244e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091715725,0.0028515542,0.94954854,0.00016583847,0.00019647367,0.000005305412,0.0020851349,0.000006113713,0.00013398385,0.0000076269685,0.000099532845,0.03572832],"study_design_scores_gemma":[0.056451816,0.021379737,0.9195827,0.0007509843,0.00006502497,7.0006604e-7,0.000835421,0.00001575144,0.00064062705,0.000012475915,0.00016812635,0.00009661886],"about_ca_topic_score_codex":0.0050806385,"about_ca_topic_score_gemma":0.004673967,"teacher_disagreement_score":0.047280245,"about_ca_system_score_codex":0.00019000586,"about_ca_system_score_gemma":0.00054842304,"threshold_uncertainty_score":0.76804394},"labels":[],"label_agreement":null},{"id":"W2142727073","doi":"10.1158/1078-0432.ccr-14-1651","title":"Bromodomain Inhibition in Diffuse Large B-cell Lymphoma—Giving MYC a Brake","year":2014,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bromodomain; Epigenetics; Cancer research; Enhancer; Cancer; Lymphoma; Biology; Histone; Diffuse large B-cell lymphoma; Pathogenesis; Mef2; Gene; Genetics; Transcription factor; Immunology","score_opus":0.09706866988461825,"score_gpt":0.4317421091213841,"score_spread":0.33467343923676585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142727073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69868445,0.0035803868,0.00053766445,0.2859575,0.0014304501,0.0019513561,0.00034904075,0.00006575381,0.007443408],"genre_scores_gemma":[0.53032243,0.0036710792,0.00016799368,0.41677034,0.020218974,0.00084690383,0.002288986,0.00024669117,0.025466597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942869,0.0018337293,0.0008897505,0.0011561876,0.00082293147,0.0010105143],"domain_scores_gemma":[0.9980902,0.0003292693,0.00020906916,0.0009141148,0.0002752527,0.0001820687],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0038150558,0.00032152203,0.00049996993,0.00026725608,0.0001552545,0.00010697863,0.00045322892,0.0019373744,0.00018663652],"category_scores_gemma":[0.0011824378,0.000312244,0.0003061528,0.00033003034,0.00035972518,0.000008314365,0.0005413152,0.002322878,0.00016302733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001253516,0.0008408248,0.00072391116,0.00020584106,0.000023124005,0.00012129725,0.000014240357,5.370846e-7,0.00513565,0.000011528166,0.9902449,0.0025527894],"study_design_scores_gemma":[0.00663664,0.00034789144,0.00033463695,0.0002312393,0.0000072158177,0.0000057226716,0.000011684128,0.00004322233,0.013016166,0.000181558,0.97881097,0.00037306437],"about_ca_topic_score_codex":0.00023814445,"about_ca_topic_score_gemma":0.00038788814,"teacher_disagreement_score":0.16836204,"about_ca_system_score_codex":0.0001680802,"about_ca_system_score_gemma":0.0006200043,"threshold_uncertainty_score":0.9999788},"labels":[],"label_agreement":null},{"id":"W2142840053","doi":"10.1158/1078-0432.ccr-12-0694","title":"Metformin and Pancreatic Cancer: A Clue Requiring Investigation","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Metformin; Medicine; Cancer; Pancreatic cancer; Oncology; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.2437892454370035,"score_gpt":0.5144246904101659,"score_spread":0.2706354449731624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142840053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6715874,0.32739738,0.000017808958,0.000121383884,0.000326517,0.00018439452,0.000014866093,0.0000075997077,0.00034265057],"genre_scores_gemma":[0.7296723,0.26597482,0.00019099028,0.0005694772,0.0025919515,0.00033200186,0.000018980652,0.000027172815,0.00062227296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978423,0.00040935056,0.00037557216,0.00039869398,0.00033741968,0.00063665985],"domain_scores_gemma":[0.9988038,0.000143532,0.000077575125,0.00035399385,0.00020112378,0.0004200031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031441161,0.00013107836,0.00025912156,0.00005960856,0.00015509162,0.00003927199,0.00019966278,0.00021429882,0.00015421295],"category_scores_gemma":[0.00071817526,0.00011390946,0.00007790696,0.00020231381,0.0004793695,0.000018904426,0.0002254871,0.00037533394,0.000017517255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024598066,0.00008143539,0.30843997,0.0001652711,0.00015517481,0.0000012252074,0.0002291395,0.000006145483,0.029599503,0.00039418618,0.015660977,0.64502096],"study_design_scores_gemma":[0.0014058877,0.00031439427,0.049143787,0.00013693844,0.00007861939,0.0000034214045,0.0001848701,0.00007295526,0.116121426,0.0007865109,0.83137256,0.0003786468],"about_ca_topic_score_codex":0.00038473748,"about_ca_topic_score_gemma":0.00023023428,"teacher_disagreement_score":0.81571156,"about_ca_system_score_codex":0.000046114375,"about_ca_system_score_gemma":0.000323053,"threshold_uncertainty_score":0.4645093},"labels":[],"label_agreement":null},{"id":"W2142934889","doi":"10.1158/1078-0432.ccr-11-3314","title":"Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; Mount Sinai Hospital","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"CXCL10; CXCR3; Lymphocytic infiltration; Pathology; Cancer research; Medicine; CD8; Tumor microenvironment; Breast cancer; Chemokine; Chemokine receptor; Cancer; Biology; Immunology; Internal medicine; Immune system","score_opus":0.11481022475663079,"score_gpt":0.43370869248844135,"score_spread":0.3188984677318106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142934889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992877,0.0017506587,0.0000019157455,0.0040835785,0.00046781625,0.00043383145,0.00011424738,0.000008133716,0.00026283917],"genre_scores_gemma":[0.9963344,0.00095851615,0.000023812265,0.00033705082,0.0018416337,0.00008684516,0.0000140447355,0.000021060227,0.00038263513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756813,0.0002821182,0.0005814758,0.0003312553,0.00076579675,0.00047123898],"domain_scores_gemma":[0.99830526,0.0006100723,0.00015913336,0.00047398257,0.0002283899,0.00022316634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001647367,0.00014964538,0.00041141186,0.00004235,0.0001356833,0.000023870873,0.00026009214,0.00018344527,0.0008875351],"category_scores_gemma":[0.00022830073,0.00008343869,0.00012424043,0.00036957586,0.00063179125,0.00011374326,0.00022055565,0.0011090728,0.000002262421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012226304,0.00009304012,0.97194266,0.00005004867,0.000026911848,0.0000019700326,0.0008834588,0.000019546502,0.01563693,0.0000066724774,0.003528093,0.006588058],"study_design_scores_gemma":[0.0025467575,0.00004249435,0.9819182,0.0009428049,0.00004243695,0.000022556002,0.00036530505,0.00016452355,0.011560242,0.00003614682,0.0022567285,0.00010177778],"about_ca_topic_score_codex":0.33279616,"about_ca_topic_score_gemma":0.065925956,"teacher_disagreement_score":0.2668702,"about_ca_system_score_codex":0.0017547698,"about_ca_system_score_gemma":0.0027213744,"threshold_uncertainty_score":0.97178864},"labels":[],"label_agreement":null},{"id":"W2143134002","doi":"10.1158/1078-0432.ccr-08-2589","title":"Induction of Wilms' Tumor Protein (WT1)–Specific Antitumor Immunity Using a Truncated WT1-Expressing Adenovirus Vaccine","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Michigan State University Foundation; Osteopathic Heritage Foundation","keywords":"Wilms' tumor; Immunity; Virology; Cancer research; Biology; Adenoviridae; Immunology; Medicine; Immune system; Genetic enhancement; Gene; Genetics","score_opus":0.1624954002347909,"score_gpt":0.4704725585254231,"score_spread":0.3079771582906322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143134002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295825,0.0055734976,0.00008152803,0.00032275709,0.00022595373,0.00045439493,0.000014111763,0.000014960369,0.00035454024],"genre_scores_gemma":[0.9969686,0.0016361523,0.00027639963,0.000079777565,0.000675782,0.000024303841,0.000024698442,0.000023721273,0.00029051863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974126,0.0005307656,0.00065378397,0.0005060945,0.00042625787,0.00047047847],"domain_scores_gemma":[0.9985971,0.00003994512,0.0002076981,0.00050134276,0.000485942,0.00016798789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014873036,0.00016626154,0.00033804268,0.0001277192,0.00022815171,0.00003674166,0.00037246448,0.00028428575,0.00008233337],"category_scores_gemma":[0.00031496177,0.00013743516,0.00016419211,0.0005651319,0.0003039853,0.000013296179,0.00013230651,0.0009645461,0.000007436728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014725598,0.00021183437,0.0013784129,0.000040095667,0.000059821923,0.0000132575715,0.000024643676,0.00015832459,0.9818788,0.000016432752,0.0010435961,0.013702212],"study_design_scores_gemma":[0.0020454486,0.0015550277,0.019257626,0.00045054348,0.00002376547,0.000020458216,0.00011151007,0.00019118057,0.96721077,0.0002442911,0.008605099,0.0002842747],"about_ca_topic_score_codex":0.00045593234,"about_ca_topic_score_gemma":0.000020509784,"teacher_disagreement_score":0.017879212,"about_ca_system_score_codex":0.00008821613,"about_ca_system_score_gemma":0.0005600406,"threshold_uncertainty_score":0.5604443},"labels":[],"label_agreement":null},{"id":"W2143358417","doi":"10.1158/1078-0432.ccr-03-0041","title":"Improved Therapeutic Responses in a Xenograft Model of Human B Lymphoma (Namalwa) for Liposomal Vincristine<b><i>versus</i></b>Liposomal Doxorubicin Targeted via Anti-CD19 IgG2a or Fab′ Fragments","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Animal Health Research Institute","keywords":"Doxorubicin; Liposome; Vincristine; Pharmacology; In vivo; Medicine; Cytotoxicity; Pharmacokinetics; Monoclonal antibody; CD19; Chemistry; Cancer research; In vitro; Antibody; Chemotherapy; Immunology; Cyclophosphamide; Internal medicine; Biology; Biochemistry","score_opus":0.17424059401354755,"score_gpt":0.4634790582557968,"score_spread":0.2892384642422493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143358417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879333,0.0076476946,0.0005726304,0.00088998704,0.0008473538,0.0017198385,0.00025215748,0.00008250409,0.00005454443],"genre_scores_gemma":[0.99484646,0.0013268824,0.0002773022,0.0002843492,0.00011896506,0.0005735964,0.00009081822,0.00010227966,0.002379344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9936279,0.0018608805,0.0017560901,0.00096836337,0.0002716795,0.0015150644],"domain_scores_gemma":[0.9947588,0.0032362177,0.00036988713,0.00095693395,0.0005824903,0.00009570012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037469282,0.00046416582,0.0011762831,0.00062531815,0.00058709143,0.00004625844,0.0011297239,0.00088236784,0.00040881315],"category_scores_gemma":[0.0012599047,0.00038110584,0.00047940586,0.00076815236,0.0017124142,0.00021570518,0.00033213984,0.0011054655,0.000045468427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09622513,0.0018014545,0.0024047021,0.000114853254,0.0005664102,0.000012896907,0.0005369838,0.00012594569,0.8848631,0.00023152943,0.0001789861,0.012938006],"study_design_scores_gemma":[0.064133085,0.013897069,0.034197666,0.00047867632,0.00013884983,0.000021922877,0.0005695115,0.00076145836,0.8789836,0.001226991,0.0046905186,0.0009006196],"about_ca_topic_score_codex":0.0022791035,"about_ca_topic_score_gemma":0.0008036824,"teacher_disagreement_score":0.032092042,"about_ca_system_score_codex":0.00037610764,"about_ca_system_score_gemma":0.0018875117,"threshold_uncertainty_score":0.9998641},"labels":[],"label_agreement":null},{"id":"W2143894266","doi":"10.1158/1078-0432.ccr-05-2172","title":"Physiologic Levels of 2-Methoxyestradiol Interfere with Nongenomic Signaling of 17β-Estradiol in Human Breast Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"2-Methoxyestradiol; Human breast; Breast cancer; Cancer research; Cancer; Signal transduction; Estrogen; Internal medicine; Endocrinology; Biology; Medicine; Chemistry; Cell biology","score_opus":0.08229787583734517,"score_gpt":0.4416115170264622,"score_spread":0.359313641189117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143894266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968787,0.0021367297,0.000026750364,0.000064221225,0.00007016993,0.00035947713,0.00013262952,0.000005064973,0.00032626957],"genre_scores_gemma":[0.9986226,0.00059572933,0.00014938287,0.000015564712,0.00035293624,0.00005876401,0.000018384177,0.000028750486,0.00015791132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976743,0.0005281168,0.0006341841,0.00048664724,0.0002493974,0.0004273888],"domain_scores_gemma":[0.99899185,0.00016021496,0.00017974639,0.0003456119,0.00022619212,0.00009636063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011748623,0.00016896418,0.00044538642,0.00010643672,0.000052098865,0.000009169795,0.00037402,0.0003331449,0.00007578321],"category_scores_gemma":[0.000027762717,0.00012811387,0.00014973697,0.0002816591,0.00068762386,0.0000051438674,0.000108432316,0.00063896197,0.0000019767213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000656887,0.00025690487,0.03198273,0.00010502705,0.00009214925,0.00001189894,0.000018594967,0.001742293,0.96257734,0.000031477743,0.00022014118,0.002304536],"study_design_scores_gemma":[0.001446589,0.0013868049,0.130299,0.00026990197,0.000024164056,0.0000067512747,0.000048487458,0.000058285455,0.86610764,0.0001097679,0.000058622216,0.00018398608],"about_ca_topic_score_codex":0.0015066172,"about_ca_topic_score_gemma":0.00022977755,"teacher_disagreement_score":0.098316275,"about_ca_system_score_codex":0.00005157959,"about_ca_system_score_gemma":0.00037967393,"threshold_uncertainty_score":0.52243316},"labels":[],"label_agreement":null},{"id":"W2143908316","doi":"10.1158/1078-0432.ccr-06-0030","title":"Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Vancouver Coastal Health Research Institute; University of British Columbia; Quest University Canada; Vancouver Coastal Health","funders":"","keywords":"Melanoma; Cancer; Carcinogenesis; Medicine; Cancer research; Immunohistochemistry; Metastasis; Pathology; Breast cancer; Pancreatic cancer; Biology; Internal medicine","score_opus":0.11845292001450686,"score_gpt":0.4776809257349224,"score_spread":0.3592280057204155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143908316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929233,0.0029548125,0.00003823509,0.00016282493,0.00027171502,0.00033559115,0.000017817543,0.000008957529,0.0032867263],"genre_scores_gemma":[0.9937258,0.0008341051,0.00014531637,0.000079012316,0.00062570686,0.0001898184,0.00006579302,0.00002840912,0.0043060575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973351,0.000351072,0.00079356664,0.0005507431,0.000465284,0.00050428644],"domain_scores_gemma":[0.99895954,0.00010129845,0.00014807945,0.0003673811,0.00032465075,0.000099068595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002459967,0.00014087337,0.00034411292,0.000110898996,0.00013148172,0.00002168214,0.00038352745,0.00026235255,0.00024708043],"category_scores_gemma":[0.00022388197,0.00012917313,0.000120387784,0.0003045187,0.0003915514,0.0000056632944,0.00022399503,0.00027835954,0.000004703685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093965034,0.00010517267,0.084684856,0.00004658178,0.00002624717,0.000011909082,0.00007450716,0.00038727303,0.8803328,0.000031684303,0.032036692,0.0013226117],"study_design_scores_gemma":[0.0027395955,0.0006580682,0.02265278,0.00027237693,0.000008298517,0.0000010231171,0.0001946109,0.000038477763,0.9423237,0.00034000268,0.030510684,0.0002603675],"about_ca_topic_score_codex":0.0023625728,"about_ca_topic_score_gemma":0.0020265668,"teacher_disagreement_score":0.062032077,"about_ca_system_score_codex":0.00015091443,"about_ca_system_score_gemma":0.0007596827,"threshold_uncertainty_score":0.52675277},"labels":[],"label_agreement":null},{"id":"W2143918464","doi":"10.1158/1078-0432.ccr-09-1180","title":"c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Ovarian cancer; Cancer research; Debulking; Ovarian carcinoma; In vivo; Cancer; Medicine; Kinase; Apoptosis; Docetaxel; Cell growth; Internal medicine; Biology","score_opus":0.15785474597755314,"score_gpt":0.4952506165954008,"score_spread":0.3373958706178477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143918464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919183,0.0004942141,0.000121835634,0.0043455497,0.00029800175,0.000422325,0.000045502802,0.00001058897,0.0023436584],"genre_scores_gemma":[0.9954912,0.00084068405,0.00009464797,0.0011004587,0.0011215924,0.00014242096,0.00002255398,0.000016875003,0.0011695365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997728,0.00038275568,0.00032716492,0.00064429146,0.0003439352,0.00057385507],"domain_scores_gemma":[0.99898773,0.000060233004,0.000046584835,0.00043865814,0.00019091478,0.00027587143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016848255,0.00013595949,0.00024489555,0.00012257638,0.000101090875,0.000036593294,0.00023553094,0.00025092697,0.0001519902],"category_scores_gemma":[0.00044856413,0.00012881708,0.000098945646,0.0003965824,0.00012918827,0.0000082237775,0.00015559809,0.00053888216,0.000058640708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008752185,0.00030214945,0.03105179,0.000022216693,0.000010178407,0.000048842365,0.000028522625,0.000029470675,0.9072999,0.00017808535,0.014881752,0.04527188],"study_design_scores_gemma":[0.0015402576,0.0016883073,0.36170045,0.00011789943,0.0000061916085,0.0000026663479,0.000018655113,0.000028138147,0.58614826,0.0003123003,0.04814412,0.00029272426],"about_ca_topic_score_codex":0.0007874909,"about_ca_topic_score_gemma":0.0024058938,"teacher_disagreement_score":0.33064866,"about_ca_system_score_codex":0.00008629308,"about_ca_system_score_gemma":0.0004974687,"threshold_uncertainty_score":0.5253008},"labels":[],"label_agreement":null},{"id":"W2143985899","doi":"10.1158/1078-0432.ccr-09-2228","title":"Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; European union; General partnership; Medicine; Drug development; Political science; Drug; Business; Pharmacology; International trade; Pathology; Law","score_opus":0.2813594209494206,"score_gpt":0.57100025106528,"score_spread":0.28964083011585934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143985899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333906,0.0025957332,0.00008423109,0.0013803516,0.0008681635,0.00036983236,0.000196104,0.0000049797204,0.0011615409],"genre_scores_gemma":[0.9858716,0.010001128,0.00022141228,0.00020191132,0.0034832284,0.0000242047,0.000032717642,0.000030103787,0.00013370143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941032,0.0035401387,0.0011772617,0.00059384585,0.00031673332,0.0002688415],"domain_scores_gemma":[0.9955065,0.0029097348,0.0003205514,0.00065056584,0.00039013854,0.00022247428],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.033046205,0.00013303373,0.00043446635,0.000041053656,0.0001804847,0.00006098477,0.00043665347,0.0001898678,0.00014160038],"category_scores_gemma":[0.017621055,0.00009171101,0.00022735172,0.00012234246,0.0014584095,0.000005877159,0.0004427136,0.00095402764,0.0000068567256],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021485556,0.0014656979,0.19548494,0.000057747064,0.00069818617,0.000012212288,0.0012838942,0.000021579272,0.29554865,0.0016460004,0.018639669,0.48299286],"study_design_scores_gemma":[0.026366636,0.007850674,0.5500868,0.0003913313,0.00054535555,0.000012395468,0.010149571,0.001505545,0.08174373,0.0040300395,0.31596446,0.0013534751],"about_ca_topic_score_codex":0.0006549718,"about_ca_topic_score_gemma":0.0013054736,"teacher_disagreement_score":0.4816394,"about_ca_system_score_codex":0.000014197044,"about_ca_system_score_gemma":0.0005120281,"threshold_uncertainty_score":0.9956824},"labels":[],"label_agreement":null},{"id":"W2144239232","doi":"10.1158/1078-0432.ccr-05-1696","title":"Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Kallikrein; Aprotinin; Chemistry; Affinity chromatography; Plasmin; Trypsin; Biochemistry; Molecular biology; Enzyme; Proteases; Biology","score_opus":0.11183794272183109,"score_gpt":0.44982758942405837,"score_spread":0.3379896467022273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144239232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944307,0.001673841,0.000016261327,0.002796778,0.000111629015,0.0005878818,0.00021854806,0.000025571006,0.00013879781],"genre_scores_gemma":[0.99431944,0.0025608116,0.00008176454,0.00006507029,0.00049740024,0.00011642558,0.00043544162,0.00002615993,0.0018974604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979337,0.00018579363,0.0006569562,0.00048086603,0.00043656607,0.00030613542],"domain_scores_gemma":[0.9987659,0.00026764828,0.0001888484,0.00025082778,0.00033799218,0.00018882696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010127312,0.00013446351,0.0003714564,0.00014847788,0.00017780447,0.000052798816,0.000081125,0.0001600722,0.00025112275],"category_scores_gemma":[0.000110454,0.00011950084,0.00005321612,0.0003034702,0.0005052549,0.0001233778,0.00007094167,0.00023740425,0.0000027152628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074665446,0.00015526418,0.8097703,0.00014374279,0.000058017362,0.00000932782,0.00022876404,4.718324e-7,0.14565481,0.0003535334,0.00070821313,0.0421709],"study_design_scores_gemma":[0.002291398,0.00019987363,0.97684675,0.00032635755,0.00006574607,0.000002619181,0.000033118617,0.0010643635,0.013480771,0.00044152088,0.005127811,0.00011966979],"about_ca_topic_score_codex":0.02017662,"about_ca_topic_score_gemma":0.0034344725,"teacher_disagreement_score":0.16707645,"about_ca_system_score_codex":0.00006710139,"about_ca_system_score_gemma":0.0002798995,"threshold_uncertainty_score":0.9863481},"labels":[],"label_agreement":null},{"id":"W2144247813","doi":"10.1158/1078-0432.ccr-08-2132","title":"Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":485,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Oncology; Medicine; Basal (medicine); Immunohistochemistry; Internal medicine; Progesterone receptor; Estrogen receptor; Cancer; Metastasis; Pathology; Cancer research","score_opus":0.12067959121337787,"score_gpt":0.4911984173744459,"score_spread":0.370518826161068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144247813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98306173,0.0036393548,0.000027355603,0.010964723,0.00028160267,0.00036416345,0.0004936293,0.000025603274,0.001141844],"genre_scores_gemma":[0.99211425,0.0036107688,0.00014729667,0.00047059808,0.0031169597,0.00009680333,0.000036532183,0.000025700481,0.00038110872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749345,0.00035033817,0.00039410772,0.0007609818,0.0004002333,0.0006008823],"domain_scores_gemma":[0.99847776,0.00041631173,0.00009368967,0.00033523835,0.00040942017,0.0002675884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001123944,0.0002105298,0.00038231778,0.000059151487,0.00033419748,0.00006845011,0.0002889021,0.00020474549,0.00006320781],"category_scores_gemma":[0.0008171642,0.00017947875,0.00011188023,0.00024599663,0.00060784206,0.000009964964,0.0002711477,0.00051426986,0.000008668777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011161391,0.00014318929,0.851155,0.00002795919,0.00025678013,0.000011912766,0.00012474279,0.0000028593588,0.0008658174,0.00005760774,0.011959916,0.13427807],"study_design_scores_gemma":[0.0017684932,0.00040042584,0.9901189,0.000081874685,0.000045704943,0.0000032193857,0.00009134715,0.0000081125445,0.0024289747,0.00070121983,0.0041273697,0.00022434595],"about_ca_topic_score_codex":0.0018556168,"about_ca_topic_score_gemma":0.0008983714,"teacher_disagreement_score":0.13896391,"about_ca_system_score_codex":0.00009443064,"about_ca_system_score_gemma":0.0003517287,"threshold_uncertainty_score":0.7318931},"labels":[],"label_agreement":null},{"id":"W2144445863","doi":"10.1158/1078-0432.ccr-10-3266","title":"Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech; U.S. Public Health Service; Cancer Research UK; National Cancer Institute; Richard M. Schulze Family Foundation","keywords":"Oncolytic virus; Virology; Virus; Immune system; Neutralizing antibody; Internalization; Biology; Cell culture; Cell; Immunology","score_opus":0.17670751161946088,"score_gpt":0.47270838750832395,"score_spread":0.29600087588886304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144445863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495995,0.0021508643,0.00065850426,0.000094756244,0.00013612457,0.0007687563,0.000091697075,0.000010138427,0.0011292101],"genre_scores_gemma":[0.9969789,0.0014271368,0.000033580596,0.0001953704,0.00029972024,0.00021700584,0.00007797532,0.000043614225,0.0007267149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967499,0.0012341519,0.0005276689,0.0004951685,0.00057154003,0.00042157722],"domain_scores_gemma":[0.99840325,0.00012807989,0.00013525295,0.00069654756,0.00046083936,0.0001760213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019735496,0.00013633522,0.00020755523,0.00006918469,0.00019455221,0.00003126283,0.0007722017,0.00023880274,0.0004551361],"category_scores_gemma":[0.00033340478,0.00010844697,0.00012654936,0.00030234604,0.00070038147,0.000008006038,0.00022967825,0.00051492715,0.00002211421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025285778,0.00026894116,0.0072116684,0.000040783772,0.00008917742,0.000003855533,0.00026586698,0.000016727288,0.9800404,0.000034698995,0.005395093,0.0041042264],"study_design_scores_gemma":[0.0009627414,0.0031771213,0.0014642964,0.000040740626,0.000015562267,3.6950485e-7,0.00009234024,0.00006821735,0.98714054,0.0005972899,0.0063053817,0.00013539442],"about_ca_topic_score_codex":0.0039472086,"about_ca_topic_score_gemma":0.0031744067,"teacher_disagreement_score":0.007100162,"about_ca_system_score_codex":0.00006764005,"about_ca_system_score_gemma":0.00039271286,"threshold_uncertainty_score":0.59670246},"labels":[],"label_agreement":null},{"id":"W2144466430","doi":"10.1158/1078-0432.ccr-07-0330","title":"Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Prostate cancer; Prostatectomy; Epidermal growth factor receptor; Urology; Internal medicine; Metastasis; Prostate; Oncology; Lymphadenectomy; Cancer; Adenocarcinoma; Pathology","score_opus":0.10789014035487311,"score_gpt":0.47625994879743194,"score_spread":0.36836980844255884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144466430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898937,0.00084231695,0.00006263231,0.003967863,0.000111022,0.004822333,0.00022601678,0.000023026336,0.00005111329],"genre_scores_gemma":[0.9908779,0.004983264,0.001534458,0.00039546928,0.00018072723,0.0017667026,0.00006563196,0.000043264314,0.00015253866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699235,0.00022040542,0.000849692,0.0007757256,0.00050152355,0.00066029147],"domain_scores_gemma":[0.99549323,0.0026941118,0.00014655663,0.00020010567,0.0010106653,0.00045535443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022617707,0.00020497019,0.00055700855,0.00013746262,0.00014282926,0.000056452423,0.00007639897,0.00014964452,0.00006014198],"category_scores_gemma":[0.0014620261,0.00014297711,0.000050713945,0.00030269905,0.00059511536,0.00015866982,0.00009164211,0.00057842274,0.000002606998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01352947,0.0006714346,0.8902124,0.00025927354,0.00012005309,0.000008039787,0.0005105897,0.0000012910888,0.000010785356,0.000048870854,0.0003092245,0.09431857],"study_design_scores_gemma":[0.0151779195,0.0059202053,0.97548515,0.00073746475,0.00005578845,3.597194e-7,0.0001484041,0.0001364778,0.00068324874,0.00007239421,0.0014095345,0.00017303812],"about_ca_topic_score_codex":0.0005110383,"about_ca_topic_score_gemma":0.00047771932,"teacher_disagreement_score":0.09414553,"about_ca_system_score_codex":0.00034308276,"about_ca_system_score_gemma":0.0006120159,"threshold_uncertainty_score":0.5830437},"labels":[],"label_agreement":null},{"id":"W2144547786","doi":"10.1158/1078-0432.ccr-11-2436","title":"Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Temsirolimus; Sorafenib; Medicine; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Neuroblastoma RAS viral oncogene homolog; Cancer; Gastroenterology; Phases of clinical research; Toxicity; Surgery; Hepatocellular carcinoma; KRAS; Biology","score_opus":0.1270920474656933,"score_gpt":0.4640427284017923,"score_spread":0.336950680936099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144547786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989916,0.0002719877,0.0000033689562,0.000027222526,0.00006516679,0.0005142744,0.000017801844,7.138027e-7,0.00010786559],"genre_scores_gemma":[0.9998192,0.000030780397,0.000013513054,0.000011442973,0.00003249104,0.000035612476,0.00000788566,0.0000068804293,0.000042146454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987044,0.00044006485,0.00028149123,0.00014372401,0.00026416482,0.00016615464],"domain_scores_gemma":[0.9993608,0.000085025,0.000088792614,0.00024147239,0.00016601448,0.000057901834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011671105,0.00005338012,0.00015956417,0.00003766339,0.00002935644,0.0000031070144,0.00013038647,0.000043616044,0.00000815158],"category_scores_gemma":[0.00021891961,0.000032758664,0.000023457476,0.00013879775,0.0001815307,0.0000040286745,0.00012807033,0.00013890186,3.825145e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075946026,0.0043811486,0.98698705,0.00002775666,0.000039653027,2.762014e-7,0.00018290537,0.0000011164435,0.0029283715,0.000041843632,0.000079583544,0.004570846],"study_design_scores_gemma":[0.009968422,0.0066310135,0.9729035,0.000020258924,0.000018128674,1.9448896e-7,0.00024331725,0.000007601298,0.009858298,0.000029724653,0.00026643454,0.000053095293],"about_ca_topic_score_codex":0.00014513666,"about_ca_topic_score_gemma":0.00016415397,"teacher_disagreement_score":0.014083529,"about_ca_system_score_codex":0.000007667406,"about_ca_system_score_gemma":0.00007285788,"threshold_uncertainty_score":0.13358596},"labels":[],"label_agreement":null},{"id":"W2144614118","doi":"10.1158/1078-0432.ccr-04-0764","title":"Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Prostate Cancer Research Initiative","keywords":"Biochemical recurrence; Univariate analysis; Prostate cancer; Medicine; Prostatectomy; Confidence interval; Lymph node; Surgical margin; Proportional hazards model; Oncology; Immunohistochemistry; Internal medicine; Prostate-specific antigen; Prostate; Risk factor; Multivariate analysis; Pathology; Urology; Cancer","score_opus":0.04758190669353778,"score_gpt":0.39691658490330317,"score_spread":0.3493346782097654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144614118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981163,0.00029130012,0.00004876778,0.00030293773,0.00007502579,0.00064723974,0.0003795226,0.000009771313,0.00012912313],"genre_scores_gemma":[0.9987426,0.0006099677,0.00012011715,0.00021255629,0.00010987752,0.000049512455,0.000079583,0.000046693414,0.000029139614],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764276,0.0002286597,0.00044690032,0.00065859436,0.00059730513,0.0004257599],"domain_scores_gemma":[0.99849707,0.00005434352,0.00013595344,0.00034288838,0.00080536486,0.00016435342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043667672,0.00016125143,0.00026452573,0.000085683365,0.00007456844,0.000020576927,0.00031571623,0.00026618046,0.00014651234],"category_scores_gemma":[0.00031167822,0.00014041342,0.000069538866,0.0004003127,0.0006582233,0.000011939298,0.00022640027,0.0005207808,0.000013007122],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014288067,0.002452729,0.8617504,0.00027312618,0.00033487673,0.000014265942,0.0022067567,0.0011302446,0.10535795,0.00011950627,0.0035340637,0.008537967],"study_design_scores_gemma":[0.01205355,0.009150435,0.4312177,0.0020794887,0.00005190219,9.995816e-7,0.0003454458,0.00042017453,0.5400197,0.00034754717,0.003463221,0.0008498366],"about_ca_topic_score_codex":0.00046781238,"about_ca_topic_score_gemma":0.00006313997,"teacher_disagreement_score":0.43466175,"about_ca_system_score_codex":0.00017873321,"about_ca_system_score_gemma":0.0004959836,"threshold_uncertainty_score":0.57258934},"labels":[],"label_agreement":null},{"id":"W2144712720","doi":"10.1158/1078-0432.ccr-11-1403","title":"Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; National Institutes of Health","keywords":"Downregulation and upregulation; Abcg2; Dicer; Tamoxifen; Cancer research; Toremifene; Human breast; Breast cancer; Cancer; Medicine; Biology; Internal medicine; Cell culture; ATP-binding cassette transporter; Small interfering RNA; Transfection; Transporter; Genetics; Gene","score_opus":0.23712640514454647,"score_gpt":0.4819766399503201,"score_spread":0.24485023480577361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144712720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641765,0.0010476612,0.000030187563,0.0011250766,0.0003541636,0.00083520915,0.00015145371,0.000041556836,0.009997033],"genre_scores_gemma":[0.9940019,0.0014310427,0.00022238745,0.0001191346,0.0002639474,0.00015464738,0.000032282504,0.00004416832,0.0037304685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965553,0.0002852756,0.0010314673,0.00056728575,0.0009447866,0.0006158333],"domain_scores_gemma":[0.9980483,0.00025125494,0.00018178894,0.0005271596,0.0006512342,0.0003402819],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024109897,0.00017815527,0.00065664836,0.00027465593,0.00009401546,0.000009654027,0.00030904164,0.00030606508,0.0027057836],"category_scores_gemma":[0.000083742285,0.00014965497,0.00017665362,0.00078253215,0.0008030298,0.00009664797,0.000053235068,0.00091377203,0.000023912247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0148641355,0.002980238,0.7762935,0.0019715345,0.0003622845,0.00034996597,0.003624987,0.000014220342,0.17866895,0.0052135577,0.007031675,0.008624947],"study_design_scores_gemma":[0.00462386,0.00026580115,0.9559283,0.0012684546,0.00006473546,9.5016986e-7,0.00026703492,0.000039125345,0.032373235,0.0018567849,0.0030852614,0.0002264266],"about_ca_topic_score_codex":0.0034783897,"about_ca_topic_score_gemma":0.011531631,"teacher_disagreement_score":0.17963482,"about_ca_system_score_codex":0.00021386544,"about_ca_system_score_gemma":0.0007171838,"threshold_uncertainty_score":0.9982059},"labels":[],"label_agreement":null},{"id":"W2144823506","doi":"10.1158/1078-0432.ccr-06-0328","title":"Isolation of Human Prostatic Epithelial Plasma Membranes for Proteomics Using Mirror Image Tissue Banking of Radical Prostatectomy Specimens","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Caprion (Canada); McGill University Health Centre","funders":"","keywords":"Histology; Prostate cancer; Prostatectomy; Prostate; Pathology; Glutamate carboxypeptidase II; Antigen; Cancer; Medicine; Epithelium; Biology; Internal medicine; Immunology","score_opus":0.2061568061306547,"score_gpt":0.5199524363641375,"score_spread":0.3137956302334828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144823506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937618,0.0003869679,0.0011934611,0.00042710375,0.00015812484,0.0035069406,0.00021811128,0.000016359823,0.0003311349],"genre_scores_gemma":[0.95471096,0.00015386203,0.04364571,0.000019815529,0.0006002903,0.00025301203,0.000051040362,0.000055364468,0.0005099463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969959,0.00022050121,0.0011580626,0.0004311265,0.0007156867,0.00047871817],"domain_scores_gemma":[0.99782294,0.00059914216,0.0003115313,0.0003247952,0.0008015999,0.00014001815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024978216,0.00015148686,0.0007101761,0.00021361973,0.00013375326,0.000020973626,0.00014314422,0.00014991975,0.00032743663],"category_scores_gemma":[0.00045099406,0.00012943863,0.00020650799,0.0003937787,0.0008358312,0.00008268346,0.000073937976,0.00045616634,0.0000030726424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003178285,0.0005087709,0.00505553,0.0029726804,0.00007385568,0.000011167587,0.0001334917,0.000015827622,0.9839852,0.0002250521,0.0002450564,0.0035951184],"study_design_scores_gemma":[0.007704041,0.002075077,0.0057562897,0.00070052064,0.00018828138,0.000007828976,0.00009603532,0.0015086483,0.9759711,0.0015434632,0.0042743464,0.00017437917],"about_ca_topic_score_codex":0.0021125951,"about_ca_topic_score_gemma":0.0002875546,"teacher_disagreement_score":0.04245225,"about_ca_system_score_codex":0.00017613875,"about_ca_system_score_gemma":0.0007629369,"threshold_uncertainty_score":0.52783537},"labels":[],"label_agreement":null},{"id":"W2145145182","doi":"10.1158/1078-0432.ccr-06-1104","title":"Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Drug development; Clinical trial; Cancer prevention; Medicine; Biomarker; Intraepithelial neoplasia; Cancer; Drug; Personalized medicine; Precision medicine; Mechanism (biology); Disease; Bioinformatics; Pharmacology; Biology; Internal medicine; Pathology","score_opus":0.20237258777256706,"score_gpt":0.5620448995892942,"score_spread":0.3596723118167271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145145182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09510956,0.8943497,0.000055564265,0.0006353343,0.0001028838,0.009506523,0.00011237331,0.000009508023,0.00011855774],"genre_scores_gemma":[0.003453242,0.98676133,0.0015909069,0.000014512234,0.00019366342,0.006785495,0.00011223854,0.000055358913,0.0010332677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995343,0.0009456582,0.0017522635,0.0005979477,0.0007939669,0.0005671446],"domain_scores_gemma":[0.99686044,0.001562508,0.0004389638,0.00040299635,0.0005144702,0.00022060273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068545695,0.0002507982,0.002146151,0.00043553085,0.00007630522,0.000014784887,0.00037025718,0.00041789017,0.000037378846],"category_scores_gemma":[0.0009229535,0.00016567731,0.0003668183,0.0007716768,0.0007648132,0.00003197555,0.00023622323,0.000814708,0.0000025352954],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013807261,0.0004288408,0.013986953,0.029733583,0.00059466274,0.000010004669,0.00015305109,2.534382e-7,0.0000068710788,0.000036180798,0.0015872497,0.9520816],"study_design_scores_gemma":[0.0107005285,0.002849582,0.04408834,0.09800387,0.0025977062,0.000021741338,0.00024809997,0.00018945965,0.0007715486,0.0007726519,0.83908695,0.0006695023],"about_ca_topic_score_codex":0.00039400606,"about_ca_topic_score_gemma":0.00041869568,"teacher_disagreement_score":0.95141214,"about_ca_system_score_codex":0.00036495118,"about_ca_system_score_gemma":0.0042144605,"threshold_uncertainty_score":0.7476272},"labels":[],"label_agreement":null},{"id":"W2145263179","doi":"10.1158/1078-0432.ccr-05-2452","title":"Germ Line Mutations of Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Patients with Small Bowel Cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"MSH6; MLH1; PMS2; MSH2; DNA mismatch repair; Medicine; Colorectal cancer; Population; Cancer; Germline mutation; Lynch syndrome; Mutation; Internal medicine; Cancer research; Genetics; Biology; Gene","score_opus":0.07774063884718146,"score_gpt":0.42821451213250267,"score_spread":0.3504738732853212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145263179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967326,0.0015930482,0.000034353085,0.0019050839,0.0009381944,0.0040666936,0.0016077477,0.000059312122,0.00012229233],"genre_scores_gemma":[0.9865143,0.0002673275,0.0069274013,0.00010827334,0.0015820705,0.0039241444,0.00022734296,0.00008181325,0.00036734145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953501,0.00027067584,0.0012941755,0.00096199696,0.0013631177,0.00075992476],"domain_scores_gemma":[0.9935138,0.0016311278,0.00035209054,0.00033116524,0.0039063427,0.00026543473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014231903,0.0003448445,0.0008014617,0.00023624784,0.00020302703,0.000035748613,0.0004093604,0.00018222224,0.00027996436],"category_scores_gemma":[0.00055613165,0.0002934473,0.0003604859,0.0010957929,0.0010560234,0.00010558563,0.00020020365,0.0009715931,0.0000021884791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007855115,0.003541442,0.97145945,0.00020399764,0.00041754954,0.00006647953,0.00056714326,0.0015095139,0.0005203249,0.0000028187612,0.011185584,0.0026706103],"study_design_scores_gemma":[0.009599197,0.007469109,0.9760627,0.0006433979,0.00020800676,0.000009009335,0.0018594713,0.0017174275,0.0017155863,0.000054226617,0.000375275,0.00028657576],"about_ca_topic_score_codex":0.019606661,"about_ca_topic_score_gemma":0.050701927,"teacher_disagreement_score":0.031095264,"about_ca_system_score_codex":0.0012472119,"about_ca_system_score_gemma":0.0044602337,"threshold_uncertainty_score":0.9999518},"labels":[],"label_agreement":null},{"id":"W2145300105","doi":"10.1158/1078-0432.ccr-12-0087","title":"Profiling Three-Dimensional Nuclear Telomeric Architecture of Myelodysplastic Syndromes and Acute Myeloid Leukemia Defines Patient Subgroups","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Myelodysplastic syndromes; Myeloid leukemia; Telomere; Cytopenia; Internal medicine; International Prognostic Scoring System; Medicine; Oncology; Leukemia; Bone marrow failure; Bone marrow; Pathology; Biology; Stem cell; Genetics; Gene; Haematopoiesis","score_opus":0.09979247352306594,"score_gpt":0.40678059266492017,"score_spread":0.3069881191418542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145300105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922979,0.005474744,0.00002078857,0.0007527167,0.00044557068,0.00068172056,0.00004676455,0.00005941329,0.00022037019],"genre_scores_gemma":[0.99534166,0.0012730168,0.0022704273,0.00031376714,0.0005006099,0.00006126972,0.000020723415,0.00006430745,0.00015424332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960647,0.00029633695,0.00086987496,0.00059521105,0.0011953608,0.0009785007],"domain_scores_gemma":[0.9966246,0.0015155061,0.00017294126,0.00051297375,0.00043735074,0.0007366147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014561152,0.0002735401,0.00080999563,0.0003168199,0.00022744374,0.000024852849,0.00022427058,0.0002678262,0.0003319308],"category_scores_gemma":[0.0010982666,0.0002062537,0.00018604402,0.0007195634,0.0012155551,0.00013007461,0.0003599459,0.0013807656,0.000061598636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004355331,0.0008107642,0.780665,0.0010734863,0.0005787351,0.0001804923,0.00080912793,0.00004039905,0.023402812,0.00063823664,0.0020641726,0.18538149],"study_design_scores_gemma":[0.0035021664,0.003308976,0.97654414,0.001083026,0.0003315181,0.0005078013,0.00039516063,0.0008379793,0.0046091685,0.00039410434,0.00787426,0.00061169814],"about_ca_topic_score_codex":0.00027506184,"about_ca_topic_score_gemma":0.000048790098,"teacher_disagreement_score":0.19587918,"about_ca_system_score_codex":0.00017778864,"about_ca_system_score_gemma":0.0006165871,"threshold_uncertainty_score":0.84107816},"labels":[],"label_agreement":null},{"id":"W2145335139","doi":"10.1158/1078-0432.ccr-14-0114","title":"Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Heart and Stroke Foundation of Canada","keywords":"Medicine; Tolerability; Adverse effect; Nausea; Pharmacokinetics; Internal medicine; Pharmacodynamics; Refractory (planetary science); Gastroenterology; Anorexia; Response Evaluation Criteria in Solid Tumors; Anemia; Pharmacology; Phases of clinical research; Toxicity","score_opus":0.09062321050583509,"score_gpt":0.48918843589913574,"score_spread":0.39856522539330064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145335139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735695,0.00019761169,0.000013785326,0.00023890771,0.00012991695,0.0016272756,0.000021566571,0.000023762484,0.00039023955],"genre_scores_gemma":[0.99900323,0.00043502357,0.00007212259,0.00009002973,0.00018752397,0.00006171301,0.0000669583,0.00004210216,0.00004129043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995793,0.00046533023,0.0011674215,0.0007223055,0.0012774072,0.0005745711],"domain_scores_gemma":[0.99755174,0.00060246943,0.00022000763,0.0004977577,0.00069872953,0.00042928508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023550508,0.00023523068,0.0008977182,0.00043875712,0.00011325004,0.000026278007,0.00019407531,0.0001701186,0.000035783865],"category_scores_gemma":[0.001022543,0.00017481968,0.00007207765,0.0008575037,0.0005230915,0.0002051721,0.00014122798,0.0010163963,0.000007113303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008395144,0.0069246767,0.94541246,0.00010024441,0.000068622285,0.000022745016,0.00054060546,0.000011544014,0.0020765748,0.000010592418,0.00022779955,0.036209024],"study_design_scores_gemma":[0.033926412,0.01707314,0.9459526,0.0003071836,0.0000348497,5.957584e-7,0.0004920247,0.0007594019,0.0009288633,0.000028088683,0.00031898124,0.00017787541],"about_ca_topic_score_codex":0.00017994971,"about_ca_topic_score_gemma":0.00012928489,"teacher_disagreement_score":0.03603115,"about_ca_system_score_codex":0.00008556929,"about_ca_system_score_gemma":0.0002670793,"threshold_uncertainty_score":0.71289396},"labels":[],"label_agreement":null},{"id":"W2145788892","doi":"10.1158/1078-0432.ccr-03-0545","title":"Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre","funders":"","keywords":"Breast cancer; Methylation; Cancer research; Epigenetics; Biology; DNA methylation; Promoter; Estrogen receptor; Cancer; Bisulfite sequencing; Gene expression; Gene; Genetics","score_opus":0.050655132997275705,"score_gpt":0.41371867242001165,"score_spread":0.36306353942273595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145788892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983618,0.00044441878,0.000120946395,0.00019247363,0.00004856282,0.000544091,0.000018396724,0.0000024727533,0.00026683245],"genre_scores_gemma":[0.99923646,0.000101088364,0.00032766568,0.000022950175,0.00010881138,0.00006480733,0.000056928773,0.000018804138,0.00006248732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836254,0.00026344362,0.00035557552,0.00035443576,0.00037990694,0.0002840963],"domain_scores_gemma":[0.9989884,0.00006646632,0.00007904895,0.00027677222,0.00048085005,0.0001084855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012329179,0.00008898799,0.00014562241,0.00008312229,0.000036867445,0.000012288232,0.00013892926,0.00015239851,0.00003255546],"category_scores_gemma":[0.000502622,0.00007184621,0.000047926467,0.00025048057,0.00019427385,0.000005124588,0.00009411793,0.00023297704,0.000005823097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009607396,0.00038346543,0.98406947,0.00002693781,0.000019278765,0.0000026245232,0.000025324978,0.00012677202,0.0048293984,0.000022078442,0.000009778863,0.009524158],"study_design_scores_gemma":[0.0022876542,0.0015274825,0.97831863,0.000046419587,0.0000077901095,3.017522e-7,0.00000859361,0.000011883858,0.016989281,0.00041937278,0.0002917764,0.00009078359],"about_ca_topic_score_codex":0.0003153651,"about_ca_topic_score_gemma":0.00027148137,"teacher_disagreement_score":0.012159883,"about_ca_system_score_codex":0.00004174361,"about_ca_system_score_gemma":0.00041755263,"threshold_uncertainty_score":0.29298034},"labels":[],"label_agreement":null},{"id":"W2146218303","doi":"10.1158/1078-0432.ccr-08-2533","title":"Phosphorylation of the src Epithelial Substrate Trask Is Tightly Regulated in Normal Epithelia but Widespread in Many Human Epithelial Cancers","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of California, San Francisco","keywords":"Proto-oncogene tyrosine-protein kinase Src; Phosphorylation; Biology; Carcinogenesis; Kinase; Oncogene; Cancer research; Cell biology; Cancer; Cell; Cell cycle; Biochemistry","score_opus":0.07442720431742295,"score_gpt":0.4112289446642709,"score_spread":0.33680174034684796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146218303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598485,0.00095755875,0.000008065003,0.0012602878,0.00040853024,0.0005002242,0.00006498948,0.000008633793,0.0008068561],"genre_scores_gemma":[0.9956644,0.0011311268,0.00006331314,0.0003436983,0.0004085801,0.00007239006,0.000027681748,0.00002665611,0.002262123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654245,0.00050266023,0.0010064152,0.0006618159,0.0006308517,0.0006558177],"domain_scores_gemma":[0.998733,0.00010287317,0.00020759186,0.0005343022,0.00029888577,0.00012334013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025866614,0.0002228234,0.00037745645,0.0001427207,0.00013735644,0.000033553246,0.0007433587,0.00042121296,0.0002787001],"category_scores_gemma":[0.00020596488,0.00017938945,0.00019295748,0.0006500598,0.0005375822,0.000016643706,0.00013561596,0.00076719484,0.000009551737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019536144,0.00023036893,0.1526655,0.00003811499,0.00006462652,0.000012154416,0.0005234526,0.00046920354,0.82645994,0.00015535404,0.0033250363,0.014102657],"study_design_scores_gemma":[0.0018855616,0.0003701631,0.40787688,0.00017301724,0.0000094457655,0.0000010213646,0.000076060634,0.00010595072,0.5859455,0.00088769454,0.002450586,0.00021813899],"about_ca_topic_score_codex":0.002333237,"about_ca_topic_score_gemma":0.002866089,"teacher_disagreement_score":0.25521138,"about_ca_system_score_codex":0.00022335036,"about_ca_system_score_gemma":0.0010087322,"threshold_uncertainty_score":0.73152894},"labels":[],"label_agreement":null},{"id":"W2146441141","doi":"10.1158/1078-0432.ccr-07-5165","title":"Polymorphisms in<i>Cyclooxygenase-2</i>and<i>Epidermal Growth Factor Receptor</i>Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute; National Institutes of Health; European Commission; Dhont Family Foundation; University of Southern California","keywords":"Cetuximab; Colorectal cancer; Internal medicine; Epidermal growth factor receptor; Medicine; Irinotecan; Genotype; Oxaliplatin; Oncology; Cancer; Cancer research; Gastroenterology; Biology; Gene; Genetics","score_opus":0.12934169160089506,"score_gpt":0.40500517731353497,"score_spread":0.2756634857126399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146441141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942981,0.0021392903,5.630069e-7,0.0008715343,0.00013048764,0.0018945612,0.00039093243,0.000035005032,0.00023950722],"genre_scores_gemma":[0.99657875,0.0020321354,0.00006239824,0.00008346939,0.00007213969,0.0008780956,0.000057034013,0.00006501601,0.00017094321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945862,0.0007918723,0.0010029752,0.0008621987,0.0018559223,0.0009007756],"domain_scores_gemma":[0.996779,0.0011600556,0.0003591791,0.00031517004,0.0009993981,0.00038716453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088933535,0.0003987388,0.0014284659,0.00037327065,0.00018925034,0.000019992158,0.00024293744,0.00018666303,0.00017454216],"category_scores_gemma":[0.0012788607,0.00025637593,0.00012404955,0.0013149248,0.0011056017,0.00013699525,0.00026420076,0.0009864435,0.0000024675223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012575992,0.0047209696,0.9769117,0.000097960066,0.0005929995,0.00043598397,0.0008066744,0.000003841224,0.00024380661,0.0000027554386,0.0002816636,0.0033256544],"study_design_scores_gemma":[0.019956812,0.00780102,0.968316,0.001220674,0.000104114566,0.000006207148,0.00022251878,0.000018909483,0.0020154007,0.000009710388,0.000057312736,0.00027127832],"about_ca_topic_score_codex":0.0068374416,"about_ca_topic_score_gemma":0.027785478,"teacher_disagreement_score":0.020948036,"about_ca_system_score_codex":0.0011873798,"about_ca_system_score_gemma":0.0009432556,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W2146471206","doi":"10.1158/1078-0432.14aacriaslc-pr08","title":"Abstract PR08: Pro-surfactant protein B as a biomarker for lung cancer prediction.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Lung cancer; Medicine; National Lung Screening Trial; Logistic regression; Biomarker; Internal medicine; Lung cancer screening; Cancer; Oncology; Lung","score_opus":0.1640341854560385,"score_gpt":0.5196460299657452,"score_spread":0.3556118445097066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146471206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614677,0.0048156166,0.00017000076,0.012540854,0.0006482231,0.009897987,0.000657022,0.00018236882,0.009620242],"genre_scores_gemma":[0.97708064,0.00081106933,0.00036843258,0.00031164076,0.0023941265,0.008286824,0.00008934313,0.00014624157,0.010511668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930959,0.0005869332,0.0011023716,0.0013835446,0.0022690843,0.0015621955],"domain_scores_gemma":[0.9939676,0.0015446136,0.00017337702,0.0010973201,0.0019553534,0.0012617606],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0065090205,0.00033752582,0.0007700369,0.00032279757,0.0004442754,0.0001093384,0.00053819,0.000420363,0.005252718],"category_scores_gemma":[0.0049802666,0.00027766128,0.00046119257,0.00082040945,0.001137049,0.00022133956,0.0003256792,0.0017835813,0.00014154802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021889469,0.0032584025,0.41993397,0.009742925,0.0015510896,0.00019296179,0.0001756862,0.000036591486,0.0301887,0.0013702856,0.13489881,0.3767611],"study_design_scores_gemma":[0.0076683112,0.0010479925,0.8257763,0.0015417169,0.00014997603,0.000011711713,0.000108104054,0.023196079,0.0022725242,0.0012735121,0.13654323,0.00041053112],"about_ca_topic_score_codex":0.001552744,"about_ca_topic_score_gemma":0.00017913869,"teacher_disagreement_score":0.40584233,"about_ca_system_score_codex":0.00135726,"about_ca_system_score_gemma":0.0044438,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W2146684793","doi":"10.1158/1078-0432.ccr-05-1855","title":"Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers <i>In vitro</i> and in an Animal Model","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Cetuximab; Epidermal growth factor receptor; Cancer research; Pancreatic cancer; EGFR inhibitors; Monoclonal antibody; Cytotoxic T cell; Medicine; In vivo; CD3; Antibody; Cancer; Epidermal growth factor; Immunology; Receptor; Biology; Antigen; In vitro; Internal medicine; CD8","score_opus":0.1702311512438923,"score_gpt":0.505965953970119,"score_spread":0.3357348027262267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146684793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875036,0.0011254243,0.00004491007,0.005876692,0.00032614692,0.0026954531,0.00048017563,0.00009549132,0.0018521277],"genre_scores_gemma":[0.9936588,0.0027713194,0.00054764264,0.00049757503,0.0012764363,0.00034854366,0.000075883865,0.00017131,0.00065253465],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9896778,0.0017252596,0.0013928149,0.0023326678,0.0023350508,0.0025364086],"domain_scores_gemma":[0.99471223,0.001728541,0.00017224533,0.0010208058,0.0009526046,0.0014135578],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004961343,0.0005840177,0.0017506429,0.0012483873,0.00027119266,0.0002065222,0.00072546955,0.0006443388,0.00019775191],"category_scores_gemma":[0.0011134084,0.00056561216,0.0002268709,0.0027330902,0.0011823685,0.0005387428,0.00055343757,0.00388215,0.00009008827],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008602826,0.001508145,0.28357765,0.00043593632,0.000035797966,0.00051260856,0.00030649328,0.00027139767,0.6947602,0.000025011685,0.0054155756,0.0045483583],"study_design_scores_gemma":[0.008169197,0.0026891134,0.69902253,0.0009826558,0.000035036574,0.000015349562,0.00024386226,0.018415162,0.26815066,0.00009757449,0.0012402872,0.0009385694],"about_ca_topic_score_codex":0.0197066,"about_ca_topic_score_gemma":0.0046471623,"teacher_disagreement_score":0.42660952,"about_ca_system_score_codex":0.003349229,"about_ca_system_score_gemma":0.0040076384,"threshold_uncertainty_score":0.9996795},"labels":[],"label_agreement":null},{"id":"W2146913502","doi":"10.1158/1078-0432.ccr-08-1572","title":"Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Clinical trial; Multidisciplinary approach; Cancer; Translational research; Bioinformatics; Pathology; Biology; Internal medicine","score_opus":0.6217175520794711,"score_gpt":0.6371576173543072,"score_spread":0.015440065274836101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146913502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003466078,0.9729112,0.000009549744,0.0103283925,0.00085475214,0.006707492,0.008438279,0.00003973818,0.00036400475],"genre_scores_gemma":[0.000060847273,0.97289467,0.0007643462,0.0006693239,0.00079104834,0.008857559,0.0012064312,0.00009906074,0.014656701],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941838,0.0013849023,0.0017827797,0.0010291479,0.00055289874,0.0010664877],"domain_scores_gemma":[0.9819675,0.015085321,0.0004968213,0.0009900524,0.00067843625,0.0007818616],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014035064,0.0004949189,0.0030227029,0.00014627463,0.0006531341,0.00004550117,0.00026780812,0.00031958072,0.0013161049],"category_scores_gemma":[0.0012467821,0.0002883686,0.0009183502,0.0004573045,0.0005747738,0.000033355896,0.000106173786,0.0014745187,0.00014440804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000292805,0.00042924233,0.00021324062,0.002503043,0.0011279574,0.000097457225,0.00004579765,6.7208624e-8,9.284295e-8,0.000037476006,0.11538489,0.8798679],"study_design_scores_gemma":[0.0037616114,0.0010374612,0.00014322145,0.007678513,0.0013833329,0.00005514144,0.000054802378,0.000019891677,0.0000017582342,0.000045652643,0.9856046,0.00021403052],"about_ca_topic_score_codex":0.010362592,"about_ca_topic_score_gemma":0.013655334,"teacher_disagreement_score":0.87965393,"about_ca_system_score_codex":0.0015853656,"about_ca_system_score_gemma":0.013518043,"threshold_uncertainty_score":0.99995685},"labels":[],"label_agreement":null},{"id":"W2146915953","doi":"10.1158/1078-0432.ccr-11-3085","title":"Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Alberta; Alberta Health Services","funders":"","keywords":"Multiple myeloma; Oncolytic virus; Bone marrow; Population; Ex vivo; Cancer research; Haematopoiesis; In vivo; Medicine; Stem cell; Immunology; Biology; Immune system; Cell biology","score_opus":0.26589091370456647,"score_gpt":0.5385767344523856,"score_spread":0.27268582074781916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146915953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744529,0.02276055,0.00022894758,0.00077184214,0.00024367313,0.0012448466,0.0000426663,0.0000070864858,0.00024749056],"genre_scores_gemma":[0.98054403,0.014730712,0.00008220215,0.00016664466,0.0012563965,0.0010214127,0.000024657716,0.00003537002,0.0021385467],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978104,0.00049205835,0.00033635687,0.00032233362,0.00039596093,0.00064289133],"domain_scores_gemma":[0.99780303,0.00092483533,0.000065618675,0.000674711,0.00035659532,0.00017519828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002759401,0.00012235489,0.00020347985,0.00005042104,0.00021530002,0.00001885024,0.00036436407,0.00018007118,0.0001413111],"category_scores_gemma":[0.0003720272,0.00007917084,0.00023282508,0.00018848735,0.00044097932,0.0000054671364,0.000073209805,0.00017544671,0.00004454724],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023264984,0.0016048945,0.030688988,0.00004402609,0.00055665325,7.3081463e-7,0.00021308838,0.00008261205,0.4673484,0.00016852004,0.0016475844,0.47437954],"study_design_scores_gemma":[0.0026384245,0.015730763,0.004858465,0.000011708633,0.000030574392,0.0000013284023,0.00015170571,0.0003108841,0.5962865,0.0002202852,0.3796226,0.00013676628],"about_ca_topic_score_codex":0.00024990403,"about_ca_topic_score_gemma":0.00034763358,"teacher_disagreement_score":0.47424275,"about_ca_system_score_codex":0.00007859824,"about_ca_system_score_gemma":0.00035999867,"threshold_uncertainty_score":0.3228493},"labels":[],"label_agreement":null},{"id":"W2146934372","doi":"10.1158/1078-0432.ovca13-a28","title":"Abstract A28: Analyses of FOXM1 isoforms in ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"FOXM1; Ovarian cancer; Cancer research; Medicine; Carcinogenesis; Breast cancer; Cancer; Serous fluid; Oncology; Internal medicine; Cell cycle","score_opus":0.32849230393534345,"score_gpt":0.5638476740987607,"score_spread":0.23535537016341723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146934372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669594,0.0010231875,0.00006143922,0.00078866456,0.00016207587,0.0003232987,0.000024573776,0.0000044485914,0.00091638236],"genre_scores_gemma":[0.99743766,0.0013605186,0.000083018545,0.00008011103,0.00024364995,0.00015273996,0.000034389446,0.000016157052,0.00059173146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99829066,0.00014792095,0.0005392571,0.00035306753,0.0003419189,0.00032718715],"domain_scores_gemma":[0.99899995,0.00008240157,0.00008254204,0.00034296818,0.00037204067,0.00012007881],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093058613,0.000094852316,0.0002083732,0.00011339166,0.000039339568,0.000022014778,0.00025594165,0.00022264167,0.0016095317],"category_scores_gemma":[0.00027078376,0.00007862605,0.00012480507,0.00028207354,0.0002957536,0.000012279094,0.00006660764,0.00032528324,0.000043101485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001851146,0.000149096,0.16319397,0.000053572727,0.00006152126,9.563489e-7,0.000025836864,0.00023848476,0.8135298,0.000036177462,0.004169042,0.01835643],"study_design_scores_gemma":[0.0007775037,0.00019922972,0.8842268,0.000045274504,0.0000057785164,1.7424314e-7,0.000043638513,0.00008982414,0.11022062,0.00026886535,0.0040189484,0.000103366794],"about_ca_topic_score_codex":0.007783716,"about_ca_topic_score_gemma":0.0018926726,"teacher_disagreement_score":0.7210328,"about_ca_system_score_codex":0.00004434577,"about_ca_system_score_gemma":0.0002723213,"threshold_uncertainty_score":0.9993031},"labels":[],"label_agreement":null},{"id":"W2146948875","doi":"10.1158/1078-0432.ccr-08-2704","title":"The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Proportional hazards model; Radiation therapy; Oncology; Internal medicine; Immunohistochemistry; Multivariate analysis; Cohort; Metastasis; Prostate; Cancer; Pathology","score_opus":0.3069216573441769,"score_gpt":0.576214524932824,"score_spread":0.26929286758864707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146948875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449628,0.008031137,7.43553e-7,0.038943682,0.00019679955,0.007371167,0.000021584432,0.000014479927,0.00045763265],"genre_scores_gemma":[0.98694026,0.008032767,0.000055562883,0.00046210233,0.00025631153,0.0034722774,0.000016603155,0.000020336878,0.00074376236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951599,0.0011992798,0.0014071864,0.0005341447,0.0009445801,0.00075487787],"domain_scores_gemma":[0.99716085,0.0015117482,0.00019956239,0.0004924158,0.00034601486,0.00028938573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005951072,0.00015890166,0.00057044486,0.0003704294,0.00014493272,0.00002822363,0.00025638108,0.00018868764,0.00008513489],"category_scores_gemma":[0.0022706585,0.000101558915,0.00013132568,0.0015047448,0.00032939823,0.000091956696,0.00007110725,0.0014049102,0.0000113943115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0943586,0.0009716723,0.6018308,0.00002880881,0.000020741047,0.000082334285,0.0005513341,0.000014507715,0.0002724712,0.0002213769,0.00058636616,0.30106103],"study_design_scores_gemma":[0.06308445,0.015838604,0.8989577,0.00029114645,0.00000854014,9.831141e-7,0.0003086666,0.00008071155,0.00077179103,0.001945365,0.01855569,0.00015633304],"about_ca_topic_score_codex":0.0013863633,"about_ca_topic_score_gemma":0.0036843983,"teacher_disagreement_score":0.3009047,"about_ca_system_score_codex":0.0012497694,"about_ca_system_score_gemma":0.0017529852,"threshold_uncertainty_score":0.6103714},"labels":[],"label_agreement":null},{"id":"W2147132202","doi":"10.1158/1078-0432.ccr-05-0247","title":"Characterization of a Recurrent Germ Line Mutation of the <i>E-Cadherin</i> Gene: Implications for Genetic Testing and Clinical Management","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Missense mutation; Nonsense mutation; CDH1; Mutation; Family history; Breast cancer; Germline mutation; Cancer; Genetics; Medicine; Asymptomatic; Biology; Oncology; Internal medicine; Gene; Cadherin","score_opus":0.18286813188873155,"score_gpt":0.48107150095455475,"score_spread":0.29820336906582323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147132202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618334,0.00060279394,0.0013298305,0.00093179016,0.0001648546,0.0006595487,0.000049853963,0.0000039368224,0.00007405991],"genre_scores_gemma":[0.9888477,0.0031749508,0.006606657,0.00013658727,0.00057003106,0.00025929447,0.000042847205,0.00001676487,0.0003451877],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984638,0.0001635057,0.00069590675,0.00032549247,0.0001693306,0.00018196915],"domain_scores_gemma":[0.9987205,0.00020484558,0.00022845065,0.00027983089,0.0005067926,0.00005955276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014107244,0.00007768698,0.00015922976,0.000031007898,0.000088838664,0.000010645251,0.00024043421,0.00011656193,0.000009121718],"category_scores_gemma":[0.0004403366,0.00006170838,0.000093682196,0.00019784141,0.0002887397,0.0000039215947,0.00019079815,0.00014038329,7.553231e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032611028,0.00022966793,0.1715558,0.00014634088,0.00013226179,1.4402163e-7,0.000030071958,0.000056617027,0.3847344,0.00006063427,0.00067165203,0.44205633],"study_design_scores_gemma":[0.0011417373,0.00053186546,0.8647859,0.00009803606,0.000053804873,0.0000015862241,0.000011370231,0.0003834743,0.11959923,0.00024048412,0.013028542,0.00012396318],"about_ca_topic_score_codex":0.000008394303,"about_ca_topic_score_gemma":0.00002371153,"teacher_disagreement_score":0.6932301,"about_ca_system_score_codex":0.000019250645,"about_ca_system_score_gemma":0.00018524766,"threshold_uncertainty_score":0.2516395},"labels":[],"label_agreement":null},{"id":"W2147140054","doi":"10.1158/1078-0432.ccr-04-1610","title":"Endocrine Effects of Tamoxifen Plus Exemestane in Postmenopausal Women with Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Exemestane; Tamoxifen; Medicine; Breast cancer; Internal medicine; Endocrinology; Estrone; Cancer; Aromatase; Aromatase inhibitor; Estrogen; Oncology","score_opus":0.026152678972106595,"score_gpt":0.421814416130802,"score_spread":0.3956617371586954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147140054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920918,0.005987979,0.0000049151745,0.0008318977,0.00009819908,0.00051374675,0.000025422723,0.0000084617795,0.0004376028],"genre_scores_gemma":[0.9918234,0.0060689673,0.00008058744,0.00015635461,0.0005199691,0.00034881267,0.000012262499,0.000034878463,0.00095479784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977205,0.00036509524,0.0003806806,0.0004742073,0.0003873771,0.0006721418],"domain_scores_gemma":[0.9988916,0.00018741262,0.00007665389,0.00036807638,0.00022502491,0.00025124179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008510178,0.00015885007,0.00033674645,0.00009228925,0.00004902969,0.000012605938,0.0002948875,0.00020940414,0.000094629766],"category_scores_gemma":[0.000137238,0.000117518444,0.000049621234,0.00033283164,0.00041051576,0.000007220334,0.00019214345,0.0006284597,0.000012343446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019923061,0.001578996,0.10037364,0.00059579685,0.0006623422,0.0003508468,0.00039399302,0.00078777224,0.71153134,0.000112651534,0.0052746166,0.15841493],"study_design_scores_gemma":[0.026219845,0.018518103,0.40212685,0.0010733809,0.00010068775,0.00016649574,0.0002539612,0.00037568941,0.51422894,0.00013005559,0.035616856,0.0011891735],"about_ca_topic_score_codex":0.00044679115,"about_ca_topic_score_gemma":0.000274915,"teacher_disagreement_score":0.3017532,"about_ca_system_score_codex":0.00017064466,"about_ca_system_score_gemma":0.00067052856,"threshold_uncertainty_score":0.47922632},"labels":[],"label_agreement":null},{"id":"W2147195978","doi":"10.1158/1078-0432.ccr-09-1563","title":"Biomarkers in GIST: Partly Ready for Prime-Time Use","year":2009,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer","keywords":"GiST; Medicine; Cancer; Stromal cell; Oncology; Biomarker; Tyrosine kinase; Internal medicine; Cancer research; Biology","score_opus":0.510996129011477,"score_gpt":0.583929544555299,"score_spread":0.07293341554382204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147195978","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029272377,0.0015947858,0.000012566721,0.9588788,0.00025365737,0.0068542683,0.00057676446,0.00010401146,0.0024527807],"genre_scores_gemma":[0.027302094,0.006712635,0.011089842,0.68594044,0.03985089,0.010673376,0.009931997,0.001077274,0.20742145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99242806,0.0010229218,0.0012095454,0.0013869177,0.001872823,0.0020797455],"domain_scores_gemma":[0.9910027,0.005896295,0.00017140934,0.0011860634,0.001068943,0.0006745909],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0044481154,0.00043531554,0.0013098147,0.00070983573,0.00013253937,0.00014371108,0.0005111953,0.00075783837,0.00047539218],"category_scores_gemma":[0.0077015324,0.0003456445,0.0005274415,0.00068361097,0.0008572564,0.000097048265,0.00018810735,0.0061073955,0.00048082948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055381865,0.000622509,0.016101236,0.00034178968,0.0003507686,0.006407507,0.000007218797,3.5845787e-7,0.000063589454,0.00000590237,0.9554889,0.01507204],"study_design_scores_gemma":[0.0064435033,0.009449273,0.011201542,0.0017781493,0.00012639545,0.00008948332,0.000008873,0.00016150693,0.0001362564,0.0003645277,0.9699152,0.00032526389],"about_ca_topic_score_codex":0.0020421445,"about_ca_topic_score_gemma":0.00020656498,"teacher_disagreement_score":0.27293834,"about_ca_system_score_codex":0.0010616689,"about_ca_system_score_gemma":0.0025226811,"threshold_uncertainty_score":0.99989957},"labels":[],"label_agreement":null},{"id":"W2147263959","doi":"10.1158/1078-0432.ccr-05-0844","title":"Effects of Exercise Training on Antitumor Efficacy of Doxorubicin in MDA-MB-231 Breast Cancer Xenografts","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Doxorubicin; Medicine; Breast cancer; Chemotherapy; Cancer; Adjuvant; Internal medicine; Physical exercise; Oncology","score_opus":0.1489587679016724,"score_gpt":0.500114077743414,"score_spread":0.3511553098417416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147263959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928774,0.0015265228,0.0000055860583,0.0035948616,0.00018978931,0.0011090508,0.000026652999,0.000020828005,0.00064925995],"genre_scores_gemma":[0.9936769,0.004715097,0.00009301087,0.00027174628,0.000827774,0.00012912256,0.000005661919,0.000034790708,0.00024590408],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707836,0.00031019418,0.00078891846,0.0004471279,0.00087929395,0.00049608515],"domain_scores_gemma":[0.9974666,0.0014432447,0.00014780436,0.00037667342,0.00032408343,0.000241582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022569026,0.00015923893,0.000857135,0.000335432,0.000047474827,0.000008900474,0.00019746827,0.00030433826,0.00020417529],"category_scores_gemma":[0.00060329743,0.00013788474,0.0002680724,0.00080403395,0.00047339642,0.000074211086,0.000052499912,0.0012815023,0.000012681884],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060029184,0.0019756365,0.023883702,0.0013288215,0.0001565952,0.000054612792,0.0017521447,0.0001726548,0.38976836,0.00011981901,0.0014149004,0.5733698],"study_design_scores_gemma":[0.00892138,0.0005984431,0.3962035,0.0049044867,0.000059639948,0.0000055490646,0.00013979265,0.00012193859,0.5876243,0.000030014384,0.0012498511,0.00014110585],"about_ca_topic_score_codex":0.0009654527,"about_ca_topic_score_gemma":0.00022767794,"teacher_disagreement_score":0.5732287,"about_ca_system_score_codex":0.0002437987,"about_ca_system_score_gemma":0.00070045004,"threshold_uncertainty_score":0.5622776},"labels":[],"label_agreement":null},{"id":"W2147383407","doi":"10.1158/1078-0432.ccr-06-2974","title":"Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a <i>Phellodendron Amurense</i> Bark Extract","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis and Biological Activity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service; National Institutes of Health; Thomas Jefferson University","keywords":"Tramp; CREB; Prostate cancer; Protein kinase B; Cyclin D1; Cancer research; Prostate; PI3K/AKT/mTOR pathway; LNCaP; Cancer; Phosphorylation; Genetically modified mouse; Medicine; Transgene; Signal transduction; Endocrinology; Internal medicine; Biology; Cell cycle; Cell biology; Transcription factor; Biochemistry","score_opus":0.0986099828606956,"score_gpt":0.41832673369566714,"score_spread":0.31971675083497153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147383407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043435,0.0020045857,0.0020551016,0.0006931979,0.00009018143,0.00299092,0.0016880105,0.000015309155,0.000028369857],"genre_scores_gemma":[0.9940127,0.001497258,0.0011547826,0.00015881468,0.00030701878,0.0013419184,0.0004038344,0.00005304994,0.0010705834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955333,0.0004687212,0.0012266047,0.0010179018,0.0005293529,0.001224109],"domain_scores_gemma":[0.99792904,0.0006111898,0.00033502173,0.00035646043,0.0004851115,0.00028316386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006677866,0.0003099559,0.00058410934,0.000114548624,0.00014961109,0.000030873096,0.00026542982,0.0005096734,0.00006077474],"category_scores_gemma":[0.0010049032,0.0002523408,0.00027608694,0.00045212163,0.00043206874,0.00001816243,0.00016883638,0.00069651386,0.0000026075174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010978633,0.0008120603,0.015437242,0.00011667449,0.00008394061,0.0000042776296,0.000041842162,0.0008551281,0.96428204,0.000008315356,0.0025385243,0.004841345],"study_design_scores_gemma":[0.0038821392,0.0020668462,0.0033924528,0.00020179307,0.000024253262,0.0000013200597,0.000077047014,0.002719084,0.9830555,0.00013291965,0.0040326137,0.0004140687],"about_ca_topic_score_codex":0.00033091186,"about_ca_topic_score_gemma":0.0011249528,"teacher_disagreement_score":0.018773444,"about_ca_system_score_codex":0.00014935277,"about_ca_system_score_gemma":0.000595057,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W2147445587","doi":"10.1158/1078-0432.ccr-06-1599","title":"The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Cheng Kung University Hospital","keywords":"Photosensitizer; Imatinib mesylate; Photodynamic therapy; Abcg2; In vivo; Pharmacology; Chemistry; Tyrosine-kinase inhibitor; Cancer research; Tyrosine kinase; Imatinib; Medicine; Cancer; Biochemistry; Biology; Internal medicine; Receptor; ATP-binding cassette transporter; Transporter","score_opus":0.09949047583321888,"score_gpt":0.5060864885694308,"score_spread":0.40659601273621193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147445587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701319,0.019119421,0.000023940473,0.0068701683,0.00035069988,0.002009698,0.000047165235,0.000055269975,0.0013917587],"genre_scores_gemma":[0.9676363,0.029004278,0.00004234429,0.00037557175,0.0008086212,0.00021656223,0.000012663665,0.000061229824,0.0018424408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99343127,0.0010509896,0.0014425694,0.0006362604,0.0020704635,0.0013684445],"domain_scores_gemma":[0.9805685,0.016825216,0.00031068348,0.00089007727,0.0010584873,0.00034703317],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.021067578,0.00028615704,0.0006921529,0.0001506262,0.0009496996,0.000087106884,0.0008271283,0.00019024253,0.00017463184],"category_scores_gemma":[0.0058204904,0.00014445197,0.00036153215,0.0011936368,0.0043263324,0.00008730354,0.00040548618,0.0022471137,0.00003187744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009187586,0.0007414304,0.0019395038,0.00009765425,0.00043635635,0.000034993875,0.00062659546,0.0000016294083,0.798824,0.00013671498,0.01122264,0.17675087],"study_design_scores_gemma":[0.009771716,0.0031602196,0.046737693,0.00076469843,0.000045674326,0.000010934294,0.0016639356,0.0003047702,0.8838863,0.0006388208,0.05265213,0.00036312325],"about_ca_topic_score_codex":0.000801362,"about_ca_topic_score_gemma":0.00050035573,"teacher_disagreement_score":0.17638774,"about_ca_system_score_codex":0.00030848684,"about_ca_system_score_gemma":0.0007022202,"threshold_uncertainty_score":0.99838334},"labels":[],"label_agreement":null},{"id":"W2147619880","doi":"10.1158/1078-0432.ccr-10-1382","title":"Tumor Growth Inhibition by Olaparib in <i>BRCA2</i> Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Synthetic lethality; Cancer research; Carboplatin; BRCA mutation; Medicine; Cancer; Serous fluid; Serous carcinoma; In vivo; DNA repair; Biology; Internal medicine; Poly ADP ribose polymerase; Chemotherapy; Cisplatin; DNA; Genetics","score_opus":0.10164309985967723,"score_gpt":0.49531777570483054,"score_spread":0.3936746758451533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147619880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786165,0.0013935509,0.000035850568,0.014516016,0.0017491446,0.0017398468,0.0003197138,0.00015127107,0.0014781369],"genre_scores_gemma":[0.98913425,0.0019737969,0.00030188877,0.004330752,0.0018437658,0.0016551447,0.00018446836,0.00011622604,0.00045971124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99397707,0.0007211817,0.001499639,0.0011409019,0.0014378008,0.0012234036],"domain_scores_gemma":[0.99614507,0.00078434526,0.00026685788,0.00075638626,0.0012394888,0.0008078812],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027190787,0.00035841097,0.0008350736,0.00043264934,0.00023989283,0.000092309114,0.0003148884,0.00049115566,0.004001661],"category_scores_gemma":[0.0010514733,0.00033390897,0.00019130865,0.0016493996,0.0010876342,0.00026437512,0.00018118735,0.0040134597,0.00021398153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004538729,0.0014623512,0.04387299,0.00021728959,0.00012796657,0.00037076368,0.00051191094,0.000005808855,0.7817654,0.0001837962,0.13011022,0.036832757],"study_design_scores_gemma":[0.021679973,0.002557471,0.043749176,0.0011559466,0.00007324896,0.00006680326,0.00020687481,0.0002177035,0.7374649,0.001658355,0.19027601,0.00089351786],"about_ca_topic_score_codex":0.005489583,"about_ca_topic_score_gemma":0.0029023914,"teacher_disagreement_score":0.060165796,"about_ca_system_score_codex":0.00054288347,"about_ca_system_score_gemma":0.0014934336,"threshold_uncertainty_score":0.9999113},"labels":[],"label_agreement":null},{"id":"W2147621051","doi":"10.1158/1078-0432.ccr-11-2181","title":"Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada); Institute of Cancer Research","funders":"National Cancer Institute; Cancer Research UK","keywords":"Oncolytic virus; Carboplatin; Paclitaxel; Medicine; Chemotherapy; Oncology; Internal medicine; Cancer; Cisplatin","score_opus":0.06457057541320321,"score_gpt":0.4478147690360461,"score_spread":0.3832441936228429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147621051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748415,0.00080378685,0.000005956623,0.00016328797,0.000046535108,0.0013502755,0.000020039563,0.0000034947157,0.00012249824],"genre_scores_gemma":[0.9985081,0.0008541873,0.000104691164,0.00006228124,0.00010609518,0.0002186852,0.000028636863,0.00003157096,0.00008576425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975453,0.00052067824,0.00045607556,0.00037532276,0.0005574445,0.0005452024],"domain_scores_gemma":[0.99893165,0.00016563438,0.00010812259,0.00035539136,0.00028223175,0.00015700262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002561504,0.00014101621,0.00033307332,0.00016509183,0.0000604114,0.000011749484,0.00018794257,0.00016552168,0.000021802114],"category_scores_gemma":[0.00028627177,0.00011036832,0.00003285864,0.00042713934,0.0004887696,0.000016083908,0.00009342459,0.00042522943,8.847257e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6164546,0.010565756,0.14486727,0.0000767533,0.00007771134,0.000004174646,0.00047553456,0.00002594161,0.030254625,0.000029346043,0.00005126907,0.19711699],"study_design_scores_gemma":[0.44284874,0.2747777,0.18979658,0.00027320953,0.000013691345,9.5321997e-7,0.0002472165,0.000054034215,0.09015098,0.000100067584,0.0012776266,0.00045916365],"about_ca_topic_score_codex":0.00017774382,"about_ca_topic_score_gemma":0.0011601093,"teacher_disagreement_score":0.26421198,"about_ca_system_score_codex":0.00009489769,"about_ca_system_score_gemma":0.00043644247,"threshold_uncertainty_score":0.45006892},"labels":[],"label_agreement":null},{"id":"W2147660153","doi":"10.1158/1078-0432.ccr-07-5194","title":"Characterization of <i>TMPRSS2-ERG</i> Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institute on Aging","keywords":"TMPRSS2; Prostate cancer; Intraepithelial neoplasia; High-grade prostatic intraepithelial neoplasia; Erg; Prostate; Fusion gene; Medicine; Cancer; PCA3; Oncology; Internal medicine; Disease; Biology; Gene; Ophthalmology","score_opus":0.16540031438320849,"score_gpt":0.48039530901470073,"score_spread":0.3149949946314923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147660153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842985,0.0006071145,0.00009636692,0.012931294,0.000447847,0.0013094603,0.00021418779,0.000034271026,0.000060912655],"genre_scores_gemma":[0.9566171,0.04097749,0.0003003055,0.0003745931,0.00090792,0.00036856232,0.00016191044,0.000032468663,0.00025965253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685395,0.00041430068,0.0011225916,0.0006112126,0.0005797605,0.00041815723],"domain_scores_gemma":[0.99763125,0.0006497733,0.00020938035,0.00047638922,0.00059430447,0.00043890913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013116003,0.00016235642,0.00062341476,0.00012902769,0.00023890816,0.000020138326,0.00013753257,0.00022135062,0.00012658448],"category_scores_gemma":[0.0004518067,0.00012870232,0.00016869808,0.00040280275,0.0010658347,0.00010291987,0.00015825684,0.0006829492,0.00002416769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019786027,0.002749374,0.84086794,0.00022350266,0.00019818709,0.00010008454,0.0002108519,0.0000019912259,0.028615776,0.0006066237,0.0032077273,0.121239334],"study_design_scores_gemma":[0.0045341174,0.0022324547,0.98165154,0.00019847661,0.000107863074,0.000038481994,0.000019132282,0.00008867125,0.0053863088,0.0003719128,0.0052492507,0.00012181091],"about_ca_topic_score_codex":0.00025755324,"about_ca_topic_score_gemma":0.00003179433,"teacher_disagreement_score":0.14078358,"about_ca_system_score_codex":0.00010960846,"about_ca_system_score_gemma":0.00095559785,"threshold_uncertainty_score":0.5248328},"labels":[],"label_agreement":null},{"id":"W2147711165","doi":"10.1158/1078-0432.ccr-07-2028","title":"Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Chicoutimi; Hôpital Fleurimont; Centre Hospitalier Universitaire de Sherbrooke; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Université Laval; Hôpital Notre-Dame; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Cancer; Internal medicine; Oncology; Cyclooxygenase; Head and neck cancer; Confidence interval; Gastroenterology","score_opus":0.2442396820770942,"score_gpt":0.5209343141086445,"score_spread":0.2766946320315503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147711165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464965,0.0025492562,0.000004321416,0.0005371572,0.00026116444,0.0012112714,0.00001726268,0.000027120817,0.00074277713],"genre_scores_gemma":[0.994488,0.0033073367,0.00008001938,0.00016509814,0.00071788096,0.000557563,0.0000040467858,0.000033621436,0.00064644084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652445,0.0005772577,0.00078095717,0.0004821531,0.0010147503,0.000620418],"domain_scores_gemma":[0.99697745,0.0016667355,0.00012376075,0.0004472485,0.00041728863,0.00036749855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022716394,0.00015058217,0.00060104975,0.00021349623,0.00009488875,0.0000050933786,0.00017336279,0.00023123986,0.0005146622],"category_scores_gemma":[0.0024799162,0.00011755377,0.00014595181,0.0007036257,0.00071955787,0.00006825752,0.00010578938,0.0011061354,0.000053520347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017339317,0.0005603486,0.9591395,0.000766096,0.000037041955,0.00048517034,0.00023975736,0.00003630973,0.024301918,0.00004106886,0.0069636647,0.0056951675],"study_design_scores_gemma":[0.0034591723,0.00082955183,0.96307296,0.0027121825,0.00002091047,0.000013160813,0.00004529487,0.00057344243,0.025270542,0.00009392674,0.0037376306,0.00017120258],"about_ca_topic_score_codex":0.0013613771,"about_ca_topic_score_gemma":0.00015142016,"teacher_disagreement_score":0.0055239648,"about_ca_system_score_codex":0.00021301322,"about_ca_system_score_gemma":0.0015959163,"threshold_uncertainty_score":0.563519},"labels":[],"label_agreement":null},{"id":"W2147909933","doi":"10.1158/1078-0432.ccr-07-0268","title":"Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Circulating tumor cell; Prostate cancer; Medicine; Docetaxel; Antibody; Internal medicine; Prostate; Cancer; Chemotherapy; Prostate-specific antigen; Biomarker; Oncology; Antigen; Cancer research; Immunology; Biology; Metastasis","score_opus":0.15877099046722987,"score_gpt":0.4711906642311944,"score_spread":0.3124196737639645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147909933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97655356,0.0017776063,0.011529622,0.0029886106,0.0012227707,0.003907304,0.00014685074,0.00015089884,0.0017227882],"genre_scores_gemma":[0.99182725,0.00042498918,0.0017163585,0.001219645,0.003504406,0.000609619,0.000052962037,0.00008657339,0.00055817707],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953738,0.00029825338,0.0012456023,0.00080008013,0.0011261522,0.0011561204],"domain_scores_gemma":[0.9946757,0.0024584306,0.00023321279,0.00074777956,0.0012779821,0.0006069038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005119924,0.0002585393,0.0005321526,0.00023138168,0.0008671195,0.000116320756,0.0005493045,0.00029036825,0.00024567347],"category_scores_gemma":[0.0011685952,0.00018448326,0.00042782936,0.00086070545,0.0007194062,0.00015723861,0.00022870403,0.0017105137,0.00012773383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007430196,0.0028022644,0.11502233,0.001574439,0.00084401265,0.00013486638,0.0021167595,0.000025034695,0.483926,0.002531392,0.091146395,0.29244632],"study_design_scores_gemma":[0.012374067,0.0025092799,0.3044717,0.000607633,0.00036860642,0.000047684694,0.002772413,0.0013107131,0.11222709,0.003099662,0.5588645,0.001346666],"about_ca_topic_score_codex":0.0002238357,"about_ca_topic_score_gemma":0.000018094155,"teacher_disagreement_score":0.4677181,"about_ca_system_score_codex":0.00026443042,"about_ca_system_score_gemma":0.0006614913,"threshold_uncertainty_score":0.7523009},"labels":[],"label_agreement":null},{"id":"W2148021011","doi":"10.1158/1078-0432.ccr-12-1384","title":"Publication and Reporting Conduct for Pharmacodynamic Analyses of Tumor Tissue in Early-Phase Oncology Trials","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clinical trial; Cancer; Pharmacodynamics; Internal medicine; Oncology; Family medicine; Pharmacokinetics","score_opus":0.9837610538107621,"score_gpt":0.8569733973284804,"score_spread":0.12678765648228163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148021011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822393,0.000823072,0.01077172,0.0018340483,0.0008357739,0.002720111,0.00020427855,0.000031532407,0.00054018456],"genre_scores_gemma":[0.7705208,0.0002691336,0.22699083,0.000109905326,0.001098339,0.0007999885,0.000005184191,0.000037517624,0.00016831704],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97977585,0.010173644,0.008087139,0.00057605584,0.0006354237,0.00075189635],"domain_scores_gemma":[0.5600186,0.4323725,0.0049083056,0.0007123674,0.0013943699,0.0005938793],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.17893593,0.00015375827,0.0021914146,0.00028077594,0.00007685694,0.000035114503,0.0003085958,0.00026891968,0.0004897311],"category_scores_gemma":[0.8058114,0.00011993469,0.00022844013,0.000605679,0.0007456084,0.00016310197,0.00020730773,0.00087490655,0.0000062992212],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066123996,0.0055201147,0.047606807,0.0016280883,0.0006123107,0.000028711067,0.0005614895,0.0000021711173,0.051795244,0.032871995,0.014286787,0.83847386],"study_design_scores_gemma":[0.02738461,0.0047848094,0.019720696,0.00052606326,0.0008316242,0.000014539354,0.00041773324,0.002477992,0.07490445,0.8511744,0.017081572,0.00068149756],"about_ca_topic_score_codex":0.00023952995,"about_ca_topic_score_gemma":0.000026490687,"teacher_disagreement_score":0.8377924,"about_ca_system_score_codex":0.00015579135,"about_ca_system_score_gemma":0.00042573508,"threshold_uncertainty_score":0.84545827},"labels":[],"label_agreement":null},{"id":"W2148168351","doi":"10.1158/1078-0432.ccr-09-2878","title":"Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Genome Canada","keywords":"Vinorelbine; Medicine; Gemcitabine; Cisplatin; Docetaxel; Chemotherapy; Oncology; Lung cancer; Regimen; Internal medicine; Cancer; Chemotherapy regimen; Metastasis","score_opus":0.12519461811814736,"score_gpt":0.4642212352664629,"score_spread":0.33902661714831556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148168351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349076,0.0012946138,0.00086639903,0.00046918527,0.0003681829,0.0029142303,0.00047026938,0.000009950005,0.000116426716],"genre_scores_gemma":[0.9890189,0.0015620149,0.0036178918,0.00013321672,0.0016317397,0.0026384543,0.00026281452,0.000061023635,0.0010739029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768937,0.0001800718,0.0005132164,0.0006423161,0.0003588741,0.000616133],"domain_scores_gemma":[0.9975075,0.00081335707,0.00017291373,0.00042419924,0.00085538626,0.00022663838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017063068,0.00017290731,0.0002999489,0.00008227549,0.0003504301,0.00010063336,0.0002812308,0.00021306606,0.00006120568],"category_scores_gemma":[0.0017955174,0.00015673086,0.0002776129,0.00014478891,0.00034345165,0.000020284886,0.000111361216,0.00033664855,8.5041296e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007381697,0.0002585037,0.007694605,0.00028152773,0.00018553132,0.000001243804,0.00035877514,0.00002190616,0.94168717,0.000008013965,0.0093162665,0.03280478],"study_design_scores_gemma":[0.0077677066,0.00206337,0.0016722713,0.00008951966,0.000035434612,0.0000010130344,0.00019685748,0.0018205814,0.90356237,0.00002447313,0.08254417,0.00022225702],"about_ca_topic_score_codex":0.00090669346,"about_ca_topic_score_gemma":0.0042381724,"teacher_disagreement_score":0.073227905,"about_ca_system_score_codex":0.00010753031,"about_ca_system_score_gemma":0.0013667359,"threshold_uncertainty_score":0.63912994},"labels":[],"label_agreement":null},{"id":"W2148172443","doi":"10.1158/1078-0432.ccr-06-0133","title":"Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"LNCaP; Prostate cancer; Castration; Androgen; Medicine; Prostate; Cancer research; Immunohistochemistry; Cancer; Internal medicine; Oncology; Hormone","score_opus":0.09347425136553072,"score_gpt":0.45420048140919006,"score_spread":0.36072623004365933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148172443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626416,0.00078734517,0.000039090904,0.001197144,0.000018617226,0.0013061544,0.00020020347,0.0000046510845,0.0001826477],"genre_scores_gemma":[0.99547905,0.000082902894,0.0002904909,0.000017490678,0.000103537415,0.0008876985,0.000038398506,0.000029558967,0.0030708532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99572664,0.0014207427,0.0007236292,0.0004723098,0.001151655,0.0005049901],"domain_scores_gemma":[0.99751735,0.0003212911,0.00020645781,0.00053497695,0.0013060223,0.00011389321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050093126,0.00014464767,0.00027117506,0.000082116305,0.00022366761,0.000024573465,0.000466379,0.00021163904,0.0001135425],"category_scores_gemma":[0.0008871,0.00009206643,0.000076861674,0.00042973759,0.00071057386,0.0000080293985,0.0002721564,0.00048169418,0.0000022144166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007310875,0.00028696615,0.009225271,0.00008607026,0.00006389522,0.000004751322,0.00019284055,0.000058537174,0.97969973,0.000006800205,0.0016664303,0.0013978033],"study_design_scores_gemma":[0.0009843648,0.0007187749,0.048374813,0.0003660627,0.000005216079,1.9177367e-7,0.00016069661,0.000009401921,0.94472337,0.000015582742,0.0045296135,0.00011189967],"about_ca_topic_score_codex":0.0008721021,"about_ca_topic_score_gemma":0.004488736,"teacher_disagreement_score":0.03914954,"about_ca_system_score_codex":0.00010514164,"about_ca_system_score_gemma":0.003205453,"threshold_uncertainty_score":0.5686336},"labels":[],"label_agreement":null},{"id":"W2148543405","doi":"10.1158/1078-0432.ccr-09-1634","title":"Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Metastasis; Cancer research; Transforming growth factor; Antibody; Immune system; Tumor microenvironment; Cancer cell; Cancer; Primary tumor; Medicine; Cytokine; Immunology; Biology; Internal medicine","score_opus":0.08819860391322959,"score_gpt":0.4358811532673409,"score_spread":0.3476825493541113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148543405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931605,0.008384465,0.000035347693,0.00049328286,0.0005254025,0.0008287461,0.00026851596,0.000032130134,0.00011604092],"genre_scores_gemma":[0.99079823,0.0073808697,0.00037556456,0.00044669822,0.0006305411,0.00012615825,0.000099427605,0.00007646705,0.00006600986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967187,0.0004774797,0.00055969006,0.000993236,0.0005285731,0.00072230346],"domain_scores_gemma":[0.9980413,0.00070927123,0.00013429073,0.000509699,0.00026608695,0.00033940823],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096562394,0.000340515,0.0005475523,0.000089352136,0.0006022087,0.00012896425,0.00044910135,0.00028723254,0.00007021763],"category_scores_gemma":[0.0005950551,0.00028508174,0.00018755095,0.00020723412,0.0011856345,0.000025093826,0.00034888976,0.0010695247,0.000006337574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007920118,0.00047415946,0.0137471575,0.00025772053,0.00024386332,0.000009396369,0.000122014564,0.0000028967565,0.96759117,0.000025810428,0.0002587244,0.016475076],"study_design_scores_gemma":[0.002596462,0.0012697147,0.07035824,0.00017085545,0.000057943562,0.0000018027,0.000033150052,0.000016454569,0.9169139,0.00003298439,0.008150023,0.00039843965],"about_ca_topic_score_codex":0.00040802636,"about_ca_topic_score_gemma":0.00006273946,"teacher_disagreement_score":0.05661108,"about_ca_system_score_codex":0.000032276046,"about_ca_system_score_gemma":0.00057223346,"threshold_uncertainty_score":0.9999601},"labels":[],"label_agreement":null},{"id":"W2148833625","doi":"10.1158/1078-0432.ccr-06-0654","title":"Multistate Analysis of Skeletal Events in Patients with Bone Metastases","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Waterloo","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Clinical trial; Cancer; Pathology; Internal medicine","score_opus":0.30327506354956807,"score_gpt":0.6032553946682392,"score_spread":0.2999803311186711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148833625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022921383,0.9736116,0.0000013710944,0.000036263074,0.000075468226,0.0022860277,0.0009245238,0.000010456961,0.00013291315],"genre_scores_gemma":[0.0059078117,0.99060047,0.00012354509,0.000022317687,0.000053532283,0.00041869166,0.0019261495,0.000053091397,0.00089440454],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.994214,0.0011465779,0.0019059536,0.0007312238,0.0013127624,0.0006894719],"domain_scores_gemma":[0.9967019,0.0012215803,0.00048152579,0.00068200915,0.0005032425,0.0004097419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00211652,0.0003105288,0.0041725636,0.0013266354,0.00005042238,0.000005305818,0.00017108912,0.00030758174,0.00019428962],"category_scores_gemma":[0.00036848598,0.00019602782,0.00082979066,0.0033261646,0.0003068435,0.00003870657,0.00010661249,0.0013182617,0.00003581031],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005116826,0.0020923282,0.28964546,0.006901812,0.0027051815,0.00007114199,0.000003552785,8.921674e-7,1.3901464e-9,0.0000018305207,0.00030312844,0.69776297],"study_design_scores_gemma":[0.0069909533,0.0018261863,0.5091321,0.009952636,0.011921808,0.0000010161359,0.0000025842955,0.000010057947,9.327918e-8,0.0000056492436,0.4599195,0.00023742317],"about_ca_topic_score_codex":0.0062462194,"about_ca_topic_score_gemma":0.003261562,"teacher_disagreement_score":0.69752556,"about_ca_system_score_codex":0.0004373493,"about_ca_system_score_gemma":0.0016636171,"threshold_uncertainty_score":0.9442457},"labels":[],"label_agreement":null},{"id":"W2149055857","doi":"10.1158/1078-0432.ccr-14-0624","title":"On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Research Manitoba","funders":"","keywords":"Nicotinamide phosphoribosyltransferase; Biology; CD38; Chronic lymphocytic leukemia; Fludarabine; NAD+ kinase; Apoptosis; Cancer research; Programmed cell death; Viability assay; Cell biology; Leukemia; Biochemistry; Immunology; Stem cell; CD34; Enzyme; Chemotherapy","score_opus":0.026536041997663917,"score_gpt":0.39104190058066257,"score_spread":0.36450585858299867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149055857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559957,0.002574122,0.00013185396,0.00013339016,0.00017076444,0.0007220734,0.00009443974,0.000014994675,0.0005588131],"genre_scores_gemma":[0.99620533,0.002285224,0.000030197403,0.00020077494,0.00033562395,0.00026079058,0.00019300726,0.00006164129,0.0004274395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99492574,0.0014469019,0.0007565785,0.0009996039,0.000854556,0.0010166458],"domain_scores_gemma":[0.9974667,0.0010313523,0.00007661821,0.00074320915,0.00022442648,0.0004577231],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003891545,0.0003052379,0.000602102,0.00013656596,0.00008588761,0.00002991397,0.0007077604,0.0006267288,0.000118783],"category_scores_gemma":[0.0017571199,0.00025466998,0.00030831803,0.0004949481,0.0006143362,0.000005352747,0.0002738945,0.001087941,0.000063180705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025510865,0.0001342187,0.0020529577,0.00022634747,0.00006536911,0.0000050293534,0.00000863532,0.00018240858,0.97920865,0.000036722595,0.011327488,0.0042011],"study_design_scores_gemma":[0.004931872,0.0051254802,0.00024414848,0.00016955359,0.000011986722,7.2705285e-7,0.0000030001045,0.0010793281,0.9735757,0.0000705797,0.014529735,0.0002579045],"about_ca_topic_score_codex":0.0009687086,"about_ca_topic_score_gemma":0.00009753992,"teacher_disagreement_score":0.005632952,"about_ca_system_score_codex":0.0012131615,"about_ca_system_score_gemma":0.0021587647,"threshold_uncertainty_score":0.9999906},"labels":[],"label_agreement":null},{"id":"W2149134506","doi":"10.1158/1078-0432.ccr-03-0783","title":"Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and Treatment","year":2004,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Drug development; Clinical trial; Surrogate endpoint; Cancer; Cancer drugs; Clinical endpoint; Intensive care medicine; Drug; Clinical Oncology; Oncology; Internal medicine; Pharmacology","score_opus":0.8866212378948998,"score_gpt":0.7355782408196071,"score_spread":0.15104299707529267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149134506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021963746,0.98986566,0.0012100706,0.0007402093,0.00051708944,0.007005142,0.00035692696,0.000019057692,0.00006620567],"genre_scores_gemma":[0.00001307928,0.89458233,0.10038104,0.000013239058,0.0004045845,0.0039233956,0.000014827477,0.000058459045,0.0006090217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98939013,0.005722747,0.0028949897,0.00084750407,0.0006749629,0.00046965407],"domain_scores_gemma":[0.8666936,0.131423,0.00081206975,0.0004661012,0.00040919305,0.00019600776],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028686741,0.00036763298,0.0029076508,0.00013805885,0.00024309558,0.00008663478,0.00035162366,0.00044035586,0.00020427884],"category_scores_gemma":[0.04159534,0.00020674184,0.00050521933,0.0003150896,0.0015489794,0.00004815436,0.00029227507,0.0006414708,0.0000032634296],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055420195,0.0002119491,0.000016997083,0.012907014,0.00087126927,0.0000012097073,0.00010693028,4.2229562e-8,8.3371035e-8,0.01255917,0.0003934104,0.9723777],"study_design_scores_gemma":[0.007666476,0.00047350084,0.00005615069,0.02099758,0.0016734301,0.000002109537,0.000043013402,0.000016156406,0.000028474933,0.42793092,0.54076076,0.00035140518],"about_ca_topic_score_codex":0.00025979851,"about_ca_topic_score_gemma":0.0005428621,"teacher_disagreement_score":0.9720263,"about_ca_system_score_codex":0.00049760786,"about_ca_system_score_gemma":0.0025116985,"threshold_uncertainty_score":0.9942309},"labels":[],"label_agreement":null},{"id":"W2149167468","doi":"10.1158/1078-0432.ccr-06-2224","title":"Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Ovarian cancer; Tumor marker; Kallikrein; Biomarker; Ovarian carcinoma; Internal medicine; Cancer; Medicine; Oncology; Ovarian tumor; Pathology; Biology","score_opus":0.18694433161032287,"score_gpt":0.5010333615223433,"score_spread":0.3140890299120205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149167468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970266,0.00027194325,0.00011111491,0.0013771694,0.0001152366,0.00079291366,0.00004780571,0.0000117938425,0.00024537253],"genre_scores_gemma":[0.9979215,0.00032854418,0.00011245382,0.0001030852,0.00040456874,0.000083026374,0.00009983053,0.000022567629,0.00092437136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981339,0.0001260487,0.00074271706,0.0002911313,0.0004259693,0.00028022027],"domain_scores_gemma":[0.9977957,0.0009403853,0.00018435552,0.00024245343,0.00066277717,0.00017435565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033707998,0.00009026637,0.0003639728,0.00017899719,0.000095304196,0.00001242818,0.0000853929,0.00016093148,0.00036264266],"category_scores_gemma":[0.00074905617,0.00008291941,0.000117438096,0.00030229214,0.00027623854,0.00008295556,0.000057570207,0.00015923007,0.0000019980116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071375055,0.00019381742,0.95953727,0.00029546203,0.000039408456,0.0000023924733,0.00019476077,1.4428637e-7,0.012664407,0.0011775926,0.00017231572,0.025008656],"study_design_scores_gemma":[0.0018274857,0.0007848189,0.92182255,0.00018695727,0.000051443636,0.0000013937032,0.00005792564,0.00008431521,0.07284563,0.0004580114,0.0018114059,0.00006803567],"about_ca_topic_score_codex":0.0008350614,"about_ca_topic_score_gemma":0.00018458489,"teacher_disagreement_score":0.060181227,"about_ca_system_score_codex":0.000046455843,"about_ca_system_score_gemma":0.00020782152,"threshold_uncertainty_score":0.3970683},"labels":[],"label_agreement":null},{"id":"W2149286249","doi":"10.1158/1078-0432.ccr-06-1165","title":"A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Calcitriol; Gefitinib; Medicine; Pharmacology; Pharmacokinetics; Pharmacodynamics; Epidermal growth factor receptor; Tyrosine-kinase inhibitor; Vandetanib; Protein kinase B; Internal medicine; Dosing; Endocrinology; Tyrosine kinase; Cancer; Chemistry; Receptor; Signal transduction; Vitamin D and neurology","score_opus":0.060167436873666776,"score_gpt":0.480103932089061,"score_spread":0.4199364952153942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149286249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683243,0.0008820981,0.000018063938,0.00004173028,0.00020989504,0.0018695489,0.000018587121,0.000013611053,0.00011402462],"genre_scores_gemma":[0.9994124,0.00020739477,0.000024435998,0.000045838977,0.00001490207,0.000147934,0.000027280688,0.000030107265,0.00008970091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695,0.0007613554,0.000877517,0.0005168258,0.00021391286,0.0006804287],"domain_scores_gemma":[0.998354,0.00079428044,0.00019128878,0.00024575507,0.00036145083,0.000053229036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027752405,0.00018386157,0.00057297817,0.00042760326,0.000076272445,0.000007908163,0.0002764063,0.00013913012,0.00015686828],"category_scores_gemma":[0.00013704036,0.00014558222,0.00002426219,0.0007725779,0.0007824179,0.000099355086,0.00013150637,0.0014234289,0.0000068170702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04167564,0.02017128,0.6013944,0.000105786195,0.00018683172,0.00009657429,0.002090656,0.00014155399,0.012479002,0.000011744933,0.000045222794,0.3216013],"study_design_scores_gemma":[0.14703882,0.02540088,0.8139466,0.0003388128,0.000047340036,0.0000045869756,0.001400906,0.00007884673,0.011069157,0.000026741807,0.00032419976,0.0003231299],"about_ca_topic_score_codex":0.00092461635,"about_ca_topic_score_gemma":0.0018782325,"teacher_disagreement_score":0.32127818,"about_ca_system_score_codex":0.00021777193,"about_ca_system_score_gemma":0.00024194836,"threshold_uncertainty_score":0.61841697},"labels":[],"label_agreement":null},{"id":"W2149823386","doi":"10.1158/1078-0432.ccr-06-1213","title":"Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Statement (logic); Medicine; Bone cancer; Cancer; Multiple myeloma; Natural history; Library science; Internal medicine; Computer science; Philosophy","score_opus":0.29910109682118047,"score_gpt":0.5782517255290097,"score_spread":0.27915062870782925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149823386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70929927,0.17072542,0.0003877295,0.09953349,0.0010112526,0.009797608,0.0006476742,0.0000924269,0.008505138],"genre_scores_gemma":[0.9480646,0.042621914,0.0003898933,0.00066329725,0.00030697364,0.0037280917,0.000047184814,0.000029298533,0.004148733],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997207,0.00019143644,0.0008663289,0.0004380452,0.0005562318,0.00074097904],"domain_scores_gemma":[0.99615175,0.0028767565,0.00012717408,0.00031997942,0.00032776367,0.00019658759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024918693,0.0001435784,0.00047959003,0.000099124874,0.00028861454,0.000029910618,0.000135794,0.000060453567,0.00011841597],"category_scores_gemma":[0.00040889566,0.00009002954,0.000110587185,0.00037183453,0.00031384427,0.000097678785,0.000061765,0.00054094585,0.000014827597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031184072,0.0009685634,0.5824521,0.0009081907,0.000090637506,0.000108580854,0.00008395459,0.000094987096,0.0000103467655,0.0009136158,0.02852291,0.38272768],"study_design_scores_gemma":[0.012877184,0.001646115,0.36917523,0.0011047826,0.00016326271,0.0000052363016,0.0003176004,0.0029633713,0.00016942823,0.00063402316,0.61073315,0.00021061208],"about_ca_topic_score_codex":0.029156348,"about_ca_topic_score_gemma":0.05775102,"teacher_disagreement_score":0.58221024,"about_ca_system_score_codex":0.0004259976,"about_ca_system_score_gemma":0.0011578503,"threshold_uncertainty_score":0.9773086},"labels":[],"label_agreement":null},{"id":"W2150092010","doi":"10.1158/1078-0432.ccr-08-1355","title":"Uncovering Growth-Suppressive MicroRNAs in Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Dartmouth College","keywords":"microRNA; Lung cancer; Biology; Cancer research; Transfection; Cell growth; Molecular biology; Cancer; Cell culture; In situ hybridization; Pathology; Gene expression; Medicine; Gene; Genetics","score_opus":0.0656494295987841,"score_gpt":0.47502960030663327,"score_spread":0.40938017070784916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150092010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878307,0.009137927,0.00004709099,0.0015450573,0.00021393038,0.00035548327,0.000030308724,0.0000095930845,0.00082992786],"genre_scores_gemma":[0.9944936,0.003478939,0.00008767633,0.00043063285,0.0008507628,0.00009967379,0.000030102903,0.000020229523,0.0005084047],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979238,0.00031507845,0.00040756614,0.0005557567,0.00030886973,0.00048896135],"domain_scores_gemma":[0.9990003,0.00008025442,0.000070819,0.00036987022,0.0003040249,0.00017471182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010001252,0.0001255789,0.00019192092,0.000089974004,0.0000767011,0.000037289734,0.00034720256,0.00023732224,0.00017265836],"category_scores_gemma":[0.00055865076,0.00012292716,0.0001138141,0.0002839799,0.00016710647,0.000008107916,0.00016731501,0.00043420726,0.000010873319],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090183347,0.00026496424,0.15964106,0.00009082254,0.00007208953,0.000032152504,0.000054235537,0.0006080967,0.7839735,0.00008309665,0.038384117,0.015894024],"study_design_scores_gemma":[0.0029022216,0.0004057543,0.61958325,0.00034801118,0.000026004,0.0000033131132,0.000041826854,0.00039860082,0.33944753,0.0013053273,0.035039295,0.0004988725],"about_ca_topic_score_codex":0.000369397,"about_ca_topic_score_gemma":0.00034476444,"teacher_disagreement_score":0.4599422,"about_ca_system_score_codex":0.00014282587,"about_ca_system_score_gemma":0.00046572313,"threshold_uncertainty_score":0.50128245},"labels":[],"label_agreement":null},{"id":"W2150095362","doi":"10.1158/1078-0432.ccr-07-4430","title":"Monoclonal Antibody CC188 Binds a Carbohydrate Epitope Expressed on the Surface of Both Colorectal Cancer Stem Cells and their Differentiated Progeny","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institute of Biomedical Imaging and Bioengineering; China Scholarship Council","keywords":"Epitope; Monoclonal antibody; Cancer stem cell; Cancer research; Biology; Molecular biology; Colorectal cancer; CD44; Cancer cell; Antibody; Stem cell; Cancer; Pathology; Immunology; Cell; Medicine; Cell biology; Biochemistry","score_opus":0.2128003088883914,"score_gpt":0.44997734660162725,"score_spread":0.23717703771323584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150095362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912134,0.004569969,0.00000807035,0.0019416914,0.00036292901,0.0012438771,0.000364635,0.000028998447,0.0002664406],"genre_scores_gemma":[0.97770995,0.020630404,0.000022042086,0.00018832307,0.00034545184,0.00018319902,0.000011797948,0.000050636503,0.00085818436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996447,0.00072054536,0.00069539,0.00066784583,0.0008127578,0.0006564381],"domain_scores_gemma":[0.9971419,0.0013050728,0.00017904345,0.0005274193,0.00046109053,0.00038549968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016554686,0.00026308626,0.00080573163,0.0001081701,0.00026246783,0.000028683206,0.00030906912,0.0001941595,0.0004413754],"category_scores_gemma":[0.00009522391,0.00015202191,0.00024782922,0.00063713925,0.0014281524,0.000045991055,0.00022136733,0.0010788732,0.000010697642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00493127,0.0010062092,0.105100974,0.00027305906,0.00061074836,0.00007162357,0.000912285,0.000050569328,0.8686686,0.00007679652,0.0046625277,0.013635319],"study_design_scores_gemma":[0.0045158877,0.0020251134,0.10255532,0.0005623249,0.0001219014,0.000008524987,0.00032865166,0.0009957526,0.8799128,0.000054825483,0.008600089,0.00031880327],"about_ca_topic_score_codex":0.0026274144,"about_ca_topic_score_gemma":0.00026209067,"teacher_disagreement_score":0.016060434,"about_ca_system_score_codex":0.00013495861,"about_ca_system_score_gemma":0.001100784,"threshold_uncertainty_score":0.61992735},"labels":[],"label_agreement":null},{"id":"W2150115389","doi":"10.1158/1078-0432.ccr-10-1893","title":"Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Decitabine; Medicine; Vorinostat; Neutropenia; Tolerability; Febrile neutropenia; Leukopenia; Internal medicine; Maximum tolerated dose; Adverse effect; Pharmacokinetics; Gastroenterology; Pharmacology; Oncology; Toxicity","score_opus":0.0606253614671827,"score_gpt":0.4430309267504193,"score_spread":0.38240556528323655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150115389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985136,0.000092157745,0.000008973578,0.000019159388,0.00003066277,0.0011301647,0.000014550255,0.000002849925,0.00018788116],"genre_scores_gemma":[0.9994266,0.000091175985,0.00013717596,0.00000960379,0.000026274807,0.0002008648,0.000024588999,0.000027858092,0.000055824818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753946,0.00040527267,0.00050006673,0.00055495166,0.0005900146,0.00041023613],"domain_scores_gemma":[0.9987378,0.00010312742,0.00009381284,0.0003950719,0.0005172242,0.00015295783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013454126,0.00013266904,0.00032281535,0.00023799298,0.000048134738,0.000009470723,0.00022776052,0.00010248982,0.000018262324],"category_scores_gemma":[0.0003374973,0.00010539503,0.000021363729,0.00050702476,0.00045248185,0.000013996995,0.00019508094,0.00037391525,0.0000013889373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013047817,0.00936424,0.9577814,0.00004148939,0.000031569776,0.000038895636,0.00065267703,0.000013645284,0.0016983177,0.0000038280164,0.00005239265,0.017273745],"study_design_scores_gemma":[0.0409218,0.038016126,0.89708924,0.00014294393,0.000005490062,7.075675e-7,0.0006213405,0.000051141473,0.022882637,0.000014574067,0.000072126044,0.00018188512],"about_ca_topic_score_codex":0.0008374581,"about_ca_topic_score_gemma":0.003061478,"teacher_disagreement_score":0.060692154,"about_ca_system_score_codex":0.00007151637,"about_ca_system_score_gemma":0.00034530973,"threshold_uncertainty_score":0.42978847},"labels":[],"label_agreement":null},{"id":"W2150323133","doi":"10.1158/1078-0432.ccr-06-0608","title":"Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Cancer research; Inhibitor of apoptosis; Apoptosis; Docetaxel; Cancer; In vivo; Cancer cell; Medicine; Pharmacology; Biology; Programmed cell death; Internal medicine; Caspase; Biochemistry","score_opus":0.09553153310765983,"score_gpt":0.41868614835354495,"score_spread":0.3231546152458851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150323133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781436,0.00033802344,0.0006261689,0.00017528888,0.00044362523,0.000367,0.000066264554,0.000008282841,0.00016096568],"genre_scores_gemma":[0.99480724,0.0010214052,0.00055977545,0.00003475062,0.002029582,0.000030206611,0.00054692006,0.000027512007,0.0009425987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974369,0.00043882625,0.0010270012,0.00045481286,0.00036912956,0.00027334143],"domain_scores_gemma":[0.99853563,0.00010354378,0.0003135604,0.0003217968,0.0006419279,0.00008354133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018912931,0.000119515,0.00030905905,0.00008583367,0.00008916088,0.000018726396,0.0001581838,0.0003421915,0.00014991315],"category_scores_gemma":[0.00038967648,0.000110579545,0.00019087714,0.00023933535,0.00024560755,0.000010206677,0.00014051322,0.00023529572,0.000004392439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024368412,0.00020876253,0.004931908,0.000072075316,0.000029623994,4.844181e-7,0.000012379061,0.000057325266,0.98541194,0.000118000324,0.0013281548,0.007585642],"study_design_scores_gemma":[0.00081528636,0.0004956476,0.041603114,0.000049478116,0.000017113967,5.602372e-7,0.0000120918885,0.0009025055,0.94945544,0.00008786664,0.006434875,0.00012602791],"about_ca_topic_score_codex":0.000112448324,"about_ca_topic_score_gemma":0.00011057169,"teacher_disagreement_score":0.036671206,"about_ca_system_score_codex":0.000019651277,"about_ca_system_score_gemma":0.00018816885,"threshold_uncertainty_score":0.4509303},"labels":[],"label_agreement":null},{"id":"W2150413368","doi":"10.1158/1078-0432.ccr-03-0112","title":"Phospho-Serine-118 Estrogen Receptor-α Detection in Human Breast Tumors <b> <i>in Vivo</i> </b>","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Estrogen receptor; Breast cancer; Immunohistochemistry; In vivo; Progesterone receptor; Cancer; Biopsy; Kinase; Biology; Medicine; Pathology; Cancer research; Internal medicine","score_opus":0.041865629735090094,"score_gpt":0.4244489185982646,"score_spread":0.3825832888631745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150413368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663705,0.0015960911,0.0000125124125,0.00034542507,0.00018956624,0.00040167023,0.000015609705,0.00001579596,0.00078629504],"genre_scores_gemma":[0.9974898,0.0013634773,0.00004458376,0.00008615418,0.0004110328,0.00014908121,0.000020941983,0.000038431233,0.000396515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758023,0.00034802945,0.0005121342,0.00062423217,0.0003141487,0.0006212463],"domain_scores_gemma":[0.9991774,0.00005197418,0.00006175959,0.00038228164,0.00011469201,0.00021192497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016807672,0.00016454028,0.00025401334,0.00012807378,0.00010921822,0.00002831607,0.00032022598,0.00041761846,0.00007567337],"category_scores_gemma":[0.00016971116,0.00015511991,0.00013942672,0.0005186763,0.00030673965,0.0000077764425,0.0001957006,0.0010059447,0.000046118566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009456232,0.00045476615,0.039367605,0.000031755437,0.00003272163,0.000065599066,0.000033229993,0.00037850166,0.9470639,0.00010626636,0.0005663786,0.010953661],"study_design_scores_gemma":[0.0042393333,0.0012920687,0.013593827,0.00016130824,0.0000061515975,0.000028807735,0.000076176424,0.000019349807,0.97242296,0.00034522903,0.0075086225,0.00030616487],"about_ca_topic_score_codex":0.0017478287,"about_ca_topic_score_gemma":0.0012175634,"teacher_disagreement_score":0.025773777,"about_ca_system_score_codex":0.00017413704,"about_ca_system_score_gemma":0.00033114484,"threshold_uncertainty_score":0.6325606},"labels":[],"label_agreement":null},{"id":"W2150563430","doi":"10.1158/1078-0432.ccr-07-0073","title":"p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Lymphovascular invasion; Internal medicine; Colorectal cancer; Oncology; Cancer; Stage (stratigraphy); Hazard ratio; Proportional hazards model; Multivariate analysis; Disease; Prognostic variable; Survival analysis; Adjuvant therapy; Confidence interval; Metastasis; Biology","score_opus":0.3388416997744702,"score_gpt":0.5628151602963438,"score_spread":0.2239734605218736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150563430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99060977,0.0029102094,0.000088659166,0.0024458482,0.0002907479,0.0019757207,0.0001236389,0.000043873515,0.0015115457],"genre_scores_gemma":[0.99278295,0.00028980014,0.00008723637,0.00030567613,0.00038876716,0.0007411739,0.000016078591,0.00003897234,0.005349366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654967,0.00019229829,0.00073468185,0.0006519472,0.0010302735,0.00084111],"domain_scores_gemma":[0.99729276,0.0012425033,0.000118737174,0.0003318087,0.000472655,0.00054152566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022880526,0.00021823695,0.0005969525,0.0002238977,0.00019438287,0.00003629157,0.00014348864,0.00009525657,0.0007871113],"category_scores_gemma":[0.0011591602,0.00015318475,0.000117367534,0.0007550842,0.0004993676,0.000103468956,0.0001389564,0.0010374244,0.000023329429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00887469,0.0005584371,0.97269297,0.00017004224,0.00012828341,0.00076842966,0.00019250256,0.000100643156,0.000012844385,0.00005364428,0.0005275385,0.015919968],"study_design_scores_gemma":[0.004469115,0.0016374063,0.98901355,0.0004348767,0.00011371498,0.0000018601053,0.0003302952,0.00063691183,0.000022676688,0.00003000826,0.003141655,0.0001679182],"about_ca_topic_score_codex":0.0036260912,"about_ca_topic_score_gemma":0.03021668,"teacher_disagreement_score":0.026590591,"about_ca_system_score_codex":0.0011355329,"about_ca_system_score_gemma":0.0012974077,"threshold_uncertainty_score":0.9874793},"labels":[],"label_agreement":null},{"id":"W2150584794","doi":"10.1158/1078-0432.ccr-06-2788","title":"Molecular Characterization of Waldenstrom's Macroglobulinemia Reveals Frequent Occurrence of Two B-Cell Clones Having Distinct IgH VDJ Sequences","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"clone (Java method); Biology; Bone marrow; Somatic cell; Macroglobulinemia; Germline; Waldenstrom macroglobulinemia; B cell; Germline mutation; Antibody; Immunology; Genetics; Mutation; Gene; Lymphoma; Multiple myeloma","score_opus":0.13103462314872952,"score_gpt":0.5109195788758971,"score_spread":0.37988495572716763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150584794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536276,0.00097412005,0.00064563507,0.0004911995,0.00027301902,0.0009455615,0.00016960932,0.000030006677,0.0011080833],"genre_scores_gemma":[0.9974099,0.0009422867,0.00063247007,0.000084122286,0.00038173544,0.00004933489,0.00010685665,0.000031739884,0.00036158945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937741,0.00053900864,0.0017601576,0.0007307773,0.002224969,0.0009709684],"domain_scores_gemma":[0.99474937,0.0017143511,0.00042926156,0.00088246685,0.0017103173,0.0005142388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007957834,0.00022438786,0.00084764994,0.00029925583,0.00009781907,0.000026157122,0.0006040974,0.00025664974,0.0004253767],"category_scores_gemma":[0.002535747,0.00018973535,0.000272241,0.0010884466,0.0016172106,0.00010541018,0.00037611226,0.001098952,0.00003107117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015964926,0.00071803643,0.14332199,0.0017011752,0.00010784078,0.00061753026,0.00017976527,0.000013163599,0.8309565,0.00032836187,0.0003894155,0.020069709],"study_design_scores_gemma":[0.018673465,0.0021087627,0.09529804,0.0024550334,0.00016363441,0.000088579945,0.00018862721,0.0015269332,0.8769961,0.000492772,0.0015536179,0.00045443128],"about_ca_topic_score_codex":0.0023416982,"about_ca_topic_score_gemma":0.00012240467,"teacher_disagreement_score":0.04802395,"about_ca_system_score_codex":0.002928906,"about_ca_system_score_gemma":0.0069270553,"threshold_uncertainty_score":0.99870276},"labels":[],"label_agreement":null},{"id":"W2150765090","doi":"10.1158/1078-0432.ccr-05-0545","title":"Glioblastoma Patients Exhibit Circulating Tumor-Specific CD8+ T Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Dendritic cell; CD8; Cancer research; Peripheral blood mononuclear cell; Brain tumor; Antigen; Cytotoxic T cell; Immune system; Antigen-presenting cell; Medicine; Immunology; Pathology; Biology; T cell; In vitro","score_opus":0.10522315470737163,"score_gpt":0.42428494081525114,"score_spread":0.3190617861078795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150765090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808665,0.014578281,0.00001433452,0.00062766415,0.0013774196,0.00046221804,0.00003122018,0.00008443666,0.0019579276],"genre_scores_gemma":[0.9905864,0.0016865561,0.000051131417,0.00046026905,0.00038421107,0.00009159419,0.000018087663,0.000049179613,0.006672566],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99541074,0.0017868315,0.00093066925,0.0006361133,0.00021341165,0.001022226],"domain_scores_gemma":[0.9968735,0.0017824626,0.00015728906,0.0006637565,0.00045479796,0.00006816944],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0028198187,0.000222902,0.00045319897,0.00022565479,0.0005764863,0.000059410348,0.0006456897,0.0003406381,0.0065455344],"category_scores_gemma":[0.0004211386,0.00019605088,0.00026109492,0.00045600368,0.00091095874,0.00017611678,0.0002702286,0.0016890895,0.0054733735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00676087,0.0015217582,0.015032438,0.00003718634,0.00030240967,0.000021857828,0.0006686086,0.000029798888,0.5018044,0.0002900596,0.092221916,0.38130867],"study_design_scores_gemma":[0.003763309,0.0009789647,0.026781023,0.00010872395,0.000008645907,0.000008366094,0.00013435216,0.000007818882,0.17101398,0.000057053567,0.7968454,0.00029238846],"about_ca_topic_score_codex":0.00010470382,"about_ca_topic_score_gemma":0.000033667326,"teacher_disagreement_score":0.70462346,"about_ca_system_score_codex":0.00020125345,"about_ca_system_score_gemma":0.00026382142,"threshold_uncertainty_score":0.995301},"labels":[],"label_agreement":null},{"id":"W2150851460","doi":"10.1158/1078-0432.ccr-05-0661","title":"Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial Aggregation","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"National Cancer Institute","keywords":"PMS2; MSH6; MSH2; MLH1; Microsatellite instability; Lynch syndrome; Colorectal cancer; DNA mismatch repair; Biology; Medicine; Cancer research; Cancer; Pathology; Internal medicine; Genetics; Microsatellite","score_opus":0.11642444566557208,"score_gpt":0.46610188504871475,"score_spread":0.34967743938314266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150851460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946847,0.0024139676,0.000014290336,0.0007165228,0.00032938068,0.00086737645,0.000027999056,0.000020670743,0.00092506857],"genre_scores_gemma":[0.9957905,0.002545851,0.00084223325,0.0001456657,0.00035401172,0.00018159112,0.000010780998,0.000026879745,0.00010252972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969716,0.00039505173,0.0008217061,0.0005268165,0.0008173913,0.00046744247],"domain_scores_gemma":[0.9982747,0.0006299311,0.00013047764,0.0002774427,0.0004279664,0.00025950436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011728125,0.00015129373,0.00047603788,0.00022120356,0.00006166811,0.000013779709,0.00015398824,0.00030370886,0.0004218407],"category_scores_gemma":[0.0010354936,0.00012916734,0.000084324194,0.00055854983,0.00077510474,0.00008372852,0.00017294008,0.0009667985,0.000011348509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068153376,0.0005606333,0.6301103,0.00025862746,0.00006255876,0.00020734833,0.0017215412,0.00013769665,0.0924285,0.000024777699,0.0026001108,0.26507255],"study_design_scores_gemma":[0.008651534,0.0077868267,0.8547966,0.0019846256,0.000048227797,0.000028660143,0.00051297597,0.0027326772,0.11799802,0.0007636316,0.004257193,0.0004390679],"about_ca_topic_score_codex":0.0022635586,"about_ca_topic_score_gemma":0.003988424,"teacher_disagreement_score":0.26463348,"about_ca_system_score_codex":0.000731751,"about_ca_system_score_gemma":0.0009182172,"threshold_uncertainty_score":0.5267291},"labels":[],"label_agreement":null},{"id":"W2151119213","doi":"10.1158/1078-0432.ccr-07-1223","title":"Pretargeted Radioimmunotherapy for B-Cell Lymphomas","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Radioimmunotherapy; Medicine; Lymphoma; Monoclonal antibody; Pretargeting; Cancer research; Oncology; Refractory (planetary science); Internal medicine; Immunology; Antibody; Biology","score_opus":0.7771471648139743,"score_gpt":0.7280431915978613,"score_spread":0.04910397321611293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151119213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024314335,0.98881096,0.00011115748,0.0003953175,0.00023271576,0.0038853504,0.0001573185,0.00007116893,0.0063117235],"genre_scores_gemma":[0.000017044524,0.97782063,0.000623434,0.00028674802,0.002660822,0.0027443364,0.00025298435,0.0001247464,0.015469222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958513,0.0002874605,0.0014226271,0.00090767484,0.0006600419,0.0008709436],"domain_scores_gemma":[0.9931051,0.004601595,0.00020171242,0.0009704315,0.00047721606,0.0006439242],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004275985,0.00035160815,0.0020437583,0.00015858671,0.00021325359,0.0000402579,0.00051384827,0.00096448854,0.001073379],"category_scores_gemma":[0.0006404851,0.00026916346,0.001347155,0.00085570867,0.00066785,0.000026419426,0.00008028151,0.0022128457,0.00019476589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035480715,0.0006286243,0.000011771803,0.021394014,0.00028064242,0.000018923263,0.0000053577737,4.5539267e-8,0.000020476133,0.000087844695,0.019696038,0.9575015],"study_design_scores_gemma":[0.0023881728,0.00027447368,0.0000050025383,0.003664999,0.00057276076,0.000023138598,0.0000037929617,0.000018467434,0.00018504825,0.000077075536,0.9925377,0.00024938097],"about_ca_topic_score_codex":0.000011214757,"about_ca_topic_score_gemma":5.832156e-7,"teacher_disagreement_score":0.9728416,"about_ca_system_score_codex":0.00047454232,"about_ca_system_score_gemma":0.0024080477,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W2151325774","doi":"10.1158/1078-0432.ccr-09-0245","title":"Longitudinal Cytokine Expression during IMRT for Prostate Cancer and Acute Treatment Toxicity","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Cytokine; Toxicity; Biomarker; Oncology; Internal medicine; Tumor necrosis factor alpha; Cancer; Prostate; Radiation therapy; Urine; Acute toxicity; Interleukin 6; Urology; Gastroenterology; Biology","score_opus":0.17236568781552064,"score_gpt":0.5230518343101851,"score_spread":0.35068614649466445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151325774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909956,0.002638934,0.0000075067005,0.0056412593,0.00014289038,0.0019951137,0.00017240163,0.00006238409,0.00023997024],"genre_scores_gemma":[0.9880473,0.007371743,0.0005255759,0.00020113896,0.0008520844,0.0013184481,0.000019080588,0.00003011696,0.0016345356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973397,0.00014218681,0.0005195004,0.00070803764,0.0005427061,0.0007478297],"domain_scores_gemma":[0.9982422,0.00031372212,0.00008659212,0.00040111237,0.00042223235,0.00053414656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011235598,0.00020220972,0.00047191943,0.00013359089,0.0003505607,0.000049046288,0.00013124212,0.00017141919,0.00018135452],"category_scores_gemma":[0.00029033227,0.0001495974,0.00019370925,0.0002269533,0.00035652958,0.00010223195,0.00011908987,0.00035885844,0.0000069208186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024782376,0.0009664374,0.77288574,0.00038845022,0.00040826862,0.0002872367,0.00018764116,0.0000018862626,0.07158535,0.00002308254,0.0056508263,0.12283272],"study_design_scores_gemma":[0.008561827,0.0025521943,0.82508624,0.00063872756,0.0002449663,0.000013658068,0.000041144736,0.00014223401,0.15472774,0.0002597729,0.0075042695,0.00022723206],"about_ca_topic_score_codex":0.000058212518,"about_ca_topic_score_gemma":0.000044607106,"teacher_disagreement_score":0.12260549,"about_ca_system_score_codex":0.00048167826,"about_ca_system_score_gemma":0.00046599124,"threshold_uncertainty_score":0.6100405},"labels":[],"label_agreement":null},{"id":"W2151390901","doi":"10.1158/1078-0432.ccr-11-2465","title":"<i>Here, There Be Dragons</i> : Charting Autophagy-Related Alterations in Human Tumors","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Autophagy; Biology; Cancer; Carcinogenesis; Cell biology; Cancer research; Cancer cell; Function (biology); Lysosome; Genetics; Biochemistry; Apoptosis","score_opus":0.46429398715904197,"score_gpt":0.6077967453604527,"score_spread":0.14350275820141073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151390901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007059036,0.9831409,8.4851507e-7,0.00046668845,0.00041500133,0.0022079581,0.000075390155,0.00010224238,0.0065319496],"genre_scores_gemma":[0.010007894,0.9792177,0.00001513305,0.00036166757,0.001721993,0.0011416636,0.00026703312,0.00015956887,0.0071073296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99280345,0.0019087733,0.0022840735,0.00088576745,0.0009427353,0.0011752169],"domain_scores_gemma":[0.9960656,0.0014521657,0.0003961051,0.0010906316,0.00026942854,0.0007260445],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0050619952,0.0004639216,0.0024491218,0.00047219163,0.000338607,0.00007088103,0.00056132814,0.00085071137,0.003721567],"category_scores_gemma":[0.00054377306,0.00035724224,0.00094361743,0.0012678611,0.00059316115,0.0001277644,0.00025468206,0.0046094987,0.0004435738],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009283895,0.0012087512,0.0013423437,0.00754508,0.0005503363,0.00043807668,0.00018581262,5.5405104e-7,0.0000074596464,0.0011710236,0.002164545,0.98529315],"study_design_scores_gemma":[0.0015873334,0.00032051373,0.0010265147,0.01871766,0.0005358345,0.00002277241,0.00007219519,0.000011191901,0.000015508946,0.0003685314,0.9769252,0.0003967364],"about_ca_topic_score_codex":0.00026072274,"about_ca_topic_score_gemma":0.000099916004,"teacher_disagreement_score":0.9848964,"about_ca_system_score_codex":0.0004723583,"about_ca_system_score_gemma":0.0023559814,"threshold_uncertainty_score":0.99988794},"labels":[],"label_agreement":null},{"id":"W2151472455","doi":"10.1158/1078-0432.ccr-08-0480","title":"Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Colorectal cancer; Internal medicine; Medicine; Chemotherapy; Insulin-like growth factor-binding protein; Oncology; Endocrinology; Cancer; Insulin-like growth factor; Growth factor; Receptor","score_opus":0.24570754211453077,"score_gpt":0.44977571487353885,"score_spread":0.20406817275900807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151472455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890652,0.0018423673,0.0000073060833,0.001807944,0.0020800596,0.0038891232,0.00078671984,0.00015074458,0.00037054514],"genre_scores_gemma":[0.98912525,0.006901473,0.00035988042,0.00031309406,0.0011069282,0.0008051104,0.00030801256,0.00014452377,0.00093573285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98914087,0.0016004925,0.0034879528,0.0019819888,0.002083187,0.0017055124],"domain_scores_gemma":[0.99282575,0.003834936,0.000537351,0.00080740196,0.00071578985,0.0012787862],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004511811,0.00073875586,0.002190088,0.0010630649,0.00049853453,0.00011814857,0.00073488144,0.00072129595,0.00023425232],"category_scores_gemma":[0.008215714,0.0006059151,0.00046553244,0.0019556424,0.0015418077,0.0004899106,0.00069349975,0.004377058,0.00011169721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18135299,0.002346712,0.79477245,0.00028321394,0.00070340966,0.0011265688,0.0029740105,0.0000030730148,0.004754888,0.000077161196,0.0048704823,0.006735048],"study_design_scores_gemma":[0.23241581,0.009784799,0.7361854,0.0011720282,0.0003028197,0.00003865665,0.0012755621,0.00055145036,0.007708279,0.0004981725,0.008553515,0.001513544],"about_ca_topic_score_codex":0.016372956,"about_ca_topic_score_gemma":0.0022025523,"teacher_disagreement_score":0.05858707,"about_ca_system_score_codex":0.00096897816,"about_ca_system_score_gemma":0.0018296023,"threshold_uncertainty_score":0.9996392},"labels":[],"label_agreement":null},{"id":"W2151637779","doi":"10.1158/1078-0432.ccr-09-0095","title":"Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy","year":2009,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Disease; Cancer; Drug resistance; Host factors; Drug; Cancer research; Vascular endothelial growth factor; Tumor progression; Tumor microenvironment; Oncology; Immunology; VEGF receptors; Biology; Internal medicine; Pharmacology","score_opus":0.18026741778241065,"score_gpt":0.5179156002485141,"score_spread":0.3376481824661035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151637779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07467629,0.92362195,0.0000017329328,0.00028095476,0.000059854712,0.0010896266,0.00024329156,0.0000049262326,0.000021372956],"genre_scores_gemma":[0.01116863,0.9876423,0.00007405525,0.00016921604,0.00026973072,0.00035751727,0.00004609519,0.00004752824,0.00022494292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961054,0.0013772664,0.000788742,0.0009007837,0.00037776373,0.0004500589],"domain_scores_gemma":[0.99803835,0.00047249944,0.00019695741,0.0005696541,0.00020867783,0.0005138589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032669674,0.00027371073,0.0009462586,0.00022004098,0.00007023406,0.000028404102,0.000337538,0.00033201618,0.00001745547],"category_scores_gemma":[0.0016178016,0.00020858487,0.00028039262,0.0004952868,0.00041214676,0.0000038229964,0.00028365373,0.0003593788,0.0000034914594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007513702,0.00025986857,0.002397358,0.0023023593,0.000101614445,0.000069004716,0.000026468431,1.2703485e-7,0.0014846199,0.000010081261,0.0045321197,0.9813027],"study_design_scores_gemma":[0.00073167216,0.00080886914,0.012265465,0.00589699,0.000036995978,0.0000017427034,0.000010461014,7.273615e-7,0.0001154709,0.000019088166,0.97983205,0.00028048805],"about_ca_topic_score_codex":0.00001625907,"about_ca_topic_score_gemma":0.000065641754,"teacher_disagreement_score":0.9810222,"about_ca_system_score_codex":0.000045513883,"about_ca_system_score_gemma":0.0015354416,"threshold_uncertainty_score":0.85058445},"labels":[],"label_agreement":null},{"id":"W2151656051","doi":"10.1158/1078-0432.ccr-06-1563","title":"<i>In vivo</i> 19F Magnetic Resonance Spectroscopy and Chemical Shift Imaging of Tri-Fluoro-Nitroimidazole as a Potential Hypoxia Reporter in Solid Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Penticton Regional Hospital","funders":"National Cancer Institute","keywords":"In vivo; Tumor hypoxia; Chemistry; Hypoxia (environmental); Ex vivo; In vitro; Magnetic resonance imaging; Nuclear magnetic resonance; Nitroimidazole; Oxygen; Pathology; Biochemistry; Medicine; Biology; Internal medicine","score_opus":0.05478165907637512,"score_gpt":0.4959365768890489,"score_spread":0.4411549178126738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151656051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887194,0.0033053455,0.0007360407,0.003480438,0.000044139175,0.00090201665,0.000012246011,0.000032444754,0.0027679163],"genre_scores_gemma":[0.99075294,0.0013713972,0.006579777,0.0004596683,0.00029498007,0.00015422046,0.000003226941,0.000032317996,0.00035144828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969944,0.00007876236,0.0011347422,0.00060313666,0.00053242856,0.0006565729],"domain_scores_gemma":[0.99859864,0.0003969707,0.00012397996,0.00046391966,0.00015772897,0.00025873721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027193413,0.00014313377,0.0005239046,0.00022931428,0.000043284275,0.000013068405,0.00017958142,0.00013119637,0.00023202859],"category_scores_gemma":[0.000506813,0.00013478572,0.00009419201,0.00062590203,0.0006986151,0.00007972348,0.00017281712,0.0010129128,0.000004977357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005962687,0.0015729045,0.24261373,0.00020578597,0.000009120531,0.0020591323,0.00023500153,0.0000059218237,0.6788094,0.0013954812,0.005775438,0.061355393],"study_design_scores_gemma":[0.007525783,0.0012420239,0.32478392,0.0010949494,0.000042375475,0.00028680873,0.00029238488,0.0008860675,0.61957127,0.026194558,0.017580027,0.00049984705],"about_ca_topic_score_codex":0.0006420474,"about_ca_topic_score_gemma":0.00014473363,"teacher_disagreement_score":0.082170196,"about_ca_system_score_codex":0.00016356885,"about_ca_system_score_gemma":0.00030466306,"threshold_uncertainty_score":0.54964024},"labels":[],"label_agreement":null},{"id":"W2151698969","doi":"10.1158/1078-0432.ccr-04-2140","title":"Timing Is Everything: Preclinical Evidence Supporting Simultaneous Rather Than Sequential Chemohormonal Therapy for Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Paclitaxel; LNCaP; Prostate cancer; Medicine; Internal medicine; Oncology; Chemotherapy; Androgen; Cancer; Castration; Endocrinology; Cancer research; Hormone","score_opus":0.46391349536295806,"score_gpt":0.6067462781873147,"score_spread":0.14283278282435669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151698969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9187248,0.023908483,0.000064418084,0.051497806,0.000483199,0.004605832,0.00015633156,0.00013076556,0.0004284024],"genre_scores_gemma":[0.92871666,0.036140177,0.0009367894,0.0021268614,0.0045143226,0.0019682741,0.000042287153,0.0001302622,0.025424376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99306387,0.00048909633,0.0014307221,0.0013919111,0.001841261,0.0017831504],"domain_scores_gemma":[0.9910451,0.0054212087,0.00027036085,0.0007224277,0.001714568,0.00082632987],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007394899,0.00037953348,0.0008784138,0.00020571201,0.00053835113,0.00017306293,0.00054656266,0.0004378914,0.0024337214],"category_scores_gemma":[0.00355172,0.0002812431,0.0005978939,0.0005868196,0.00094748905,0.00034096482,0.00029116683,0.0019611283,0.000124088],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033937104,0.0014388013,0.15489826,0.00052043353,0.00092269335,0.00019364349,0.0023551947,0.0001445621,0.011059952,0.000021232478,0.03709826,0.7574099],"study_design_scores_gemma":[0.04850262,0.015549746,0.03579328,0.005658181,0.00062464987,0.0000878979,0.0010456035,0.056494527,0.15032226,0.0012586318,0.68242925,0.002233332],"about_ca_topic_score_codex":0.0006242441,"about_ca_topic_score_gemma":0.0001832198,"teacher_disagreement_score":0.75517654,"about_ca_system_score_codex":0.0008355611,"about_ca_system_score_gemma":0.0038624164,"threshold_uncertainty_score":0.999964},"labels":[],"label_agreement":null},{"id":"W2151860429","doi":"10.1158/1078-0432.ccr-11-2189","title":"<i>PTEN</i> Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Alberta Cancer Foundation; University of Calgary; University Health Network","funders":"Biotechnology and Biological Sciences Research Council","keywords":"PTEN; Cancer research; Prostate cancer; DU145; RAD51; Cancer; Clonogenic assay; Prostate; Biology; Medicine; DNA repair; Oncology; Internal medicine; Cell; PI3K/AKT/mTOR pathway; Apoptosis; Genetics","score_opus":0.11075015458791759,"score_gpt":0.4437701251567133,"score_spread":0.33301997056879573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151860429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324125,0.0023980387,0.00087249454,0.0020278057,0.00020989495,0.000909886,0.00022883345,0.000009607725,0.00010218131],"genre_scores_gemma":[0.9829282,0.013458523,0.0008345554,0.0007249653,0.000419121,0.0009770363,0.000018922054,0.000046097386,0.0005925407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983051,0.00017865302,0.00041634997,0.000530397,0.00019360539,0.00037591107],"domain_scores_gemma":[0.99874324,0.00015997207,0.00016285083,0.00034123065,0.00048723718,0.000105490304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014239901,0.00013606738,0.0002732668,0.00006184592,0.00009036638,0.000017112432,0.00021264823,0.0001842948,0.00007863798],"category_scores_gemma":[0.000063605796,0.00010202238,0.00007990544,0.00020566497,0.000513356,0.0000091300535,0.00004371732,0.00025542662,5.4501936e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012658014,0.00037157748,0.45281217,0.00016932408,0.0003469381,0.0000013792786,0.00031793735,0.00004260973,0.4697198,0.00013348139,0.003946983,0.059479777],"study_design_scores_gemma":[0.00857219,0.0038894445,0.1866951,0.00018417127,0.000050110324,0.00000237746,0.00008615565,0.00009629058,0.74363697,0.0010647571,0.055237167,0.00048525108],"about_ca_topic_score_codex":0.0005183892,"about_ca_topic_score_gemma":0.0009004501,"teacher_disagreement_score":0.27391717,"about_ca_system_score_codex":0.00009025164,"about_ca_system_score_gemma":0.0004132405,"threshold_uncertainty_score":0.4160352},"labels":[],"label_agreement":null},{"id":"W2152114243","doi":"10.1158/1078-0432.ccr-06-1807","title":"Chemosensitization of Cancer <i>In vitro</i> and <i>In vivo</i> by Nitric Oxide Signaling","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Canadian Prostate Cancer Research Initiative; Queen's University; Heart and Stroke Foundation of Canada","keywords":"Pharmacology; In vivo; Doxorubicin; Nitric oxide; Hypoxia (environmental); Clonogenic assay; Chemistry; Cancer research; Biology; Medicine; Internal medicine; Chemotherapy","score_opus":0.07419504929233707,"score_gpt":0.46986411549976376,"score_spread":0.3956690662074267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152114243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218136,0.005743115,0.000047569156,0.00061043084,0.000066214045,0.0004896959,0.000024684176,0.00001394919,0.00082299975],"genre_scores_gemma":[0.9942693,0.0041555003,0.00016463482,0.0005871998,0.000235394,0.000035646943,0.0000047452486,0.000027693539,0.0005198643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974791,0.00022808174,0.00075500977,0.00039945683,0.00057970773,0.0005586893],"domain_scores_gemma":[0.9969721,0.00225783,0.0000889815,0.00021129972,0.0002414926,0.00022833733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055752574,0.0001198136,0.00050411216,0.0003424662,0.000034566772,0.0000093531835,0.00009223071,0.00020193301,0.00009150546],"category_scores_gemma":[0.0009566424,0.00010731514,0.000069612746,0.0012382215,0.00025682,0.000056264373,0.000066694956,0.0008178918,0.0000046633613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025362067,0.00021166333,0.20284128,0.00020309203,0.000019405086,0.00007737752,0.000035955032,0.000017782157,0.7690307,0.000005242803,0.0012656179,0.023755666],"study_design_scores_gemma":[0.0047722417,0.00014697007,0.065395154,0.00047002672,0.000028134693,0.0000047237063,0.00013323742,0.00036176282,0.92607987,0.00010631865,0.0023570168,0.00014452361],"about_ca_topic_score_codex":0.0031536347,"about_ca_topic_score_gemma":0.00041460522,"teacher_disagreement_score":0.15704918,"about_ca_system_score_codex":0.00018135228,"about_ca_system_score_gemma":0.00027127864,"threshold_uncertainty_score":0.47673735},"labels":[],"label_agreement":null},{"id":"W2152209571","doi":"10.1158/1078-0432.ccr-07-0823","title":"Nutritional Modulation of Antitumor Efficacy and Diarrhea Toxicity Related to Irinotecan Chemotherapy in Rats Bearing the Ward Colon Tumor","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Crohn's and Colitis Foundation","keywords":"Diarrhea; Irinotecan; Gastroenterology; Medicine; Glutamine; Internal medicine; Chemotherapy; Toxicity; Bolus (digestion); Loperamide; Colorectal cancer; Cancer; Biology; Biochemistry","score_opus":0.09254496655887531,"score_gpt":0.46593629279175547,"score_spread":0.3733913262328802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152209571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698466,0.00056732603,0.00020835645,0.0014981142,0.00011895323,0.0005013625,0.000013222903,0.0000039846404,0.00010403579],"genre_scores_gemma":[0.9982815,0.00084676925,0.00013971263,0.00040310284,0.00017741563,0.000032641678,0.000009421206,0.00001542807,0.00009405829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858254,0.00014221437,0.00038557558,0.0003284418,0.00026416176,0.0002970825],"domain_scores_gemma":[0.9992518,0.00017830727,0.000057657868,0.00023638469,0.00016436246,0.00011152078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028215963,0.00008253197,0.00016679877,0.00007470397,0.00008129362,0.000015777667,0.00017705323,0.00011602397,0.000023464532],"category_scores_gemma":[0.0001720699,0.00006828715,0.00005223916,0.00027345115,0.00020218518,0.000003232971,0.00011745812,0.0003093005,0.0000015468152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019817443,0.0002863335,0.011987587,0.000025309746,0.000036213103,0.0000046603122,0.0000997265,0.00009460708,0.9585688,0.00049120246,0.00016248059,0.02626132],"study_design_scores_gemma":[0.0026282594,0.0013337197,0.36399418,0.000089156034,0.000005881124,0.0000038126839,0.000054522574,0.00025532438,0.6210425,0.0009906996,0.009446119,0.00015580154],"about_ca_topic_score_codex":0.00018946802,"about_ca_topic_score_gemma":0.00048296343,"teacher_disagreement_score":0.35200658,"about_ca_system_score_codex":0.000046610756,"about_ca_system_score_gemma":0.00014203865,"threshold_uncertainty_score":0.27846688},"labels":[],"label_agreement":null},{"id":"W2152452482","doi":"10.1158/1078-0432.795.11.2","title":"The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cetuximab; Epidermal growth factor receptor; Lung cancer; Cancer research; Medicine; Cancer; Cell cycle; EGFR inhibitors; In vivo; Oncology; Internal medicine; Biology; Colorectal cancer","score_opus":0.049015660487748455,"score_gpt":0.5172781675729077,"score_spread":0.4682625070851592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152452482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97496086,0.011933723,0.000005148666,0.011997215,0.000043113632,0.0009249459,0.000002607901,0.0000046364207,0.00012775119],"genre_scores_gemma":[0.9680521,0.030733926,0.000074337826,0.00020359177,0.00008477294,0.00035289762,0.000002303564,0.000010483694,0.00048560504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901575,0.00013374262,0.00024216309,0.00018559545,0.00024226398,0.00018045842],"domain_scores_gemma":[0.9985697,0.0010955958,0.000047431175,0.00011594151,0.0001040564,0.000067253015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006793214,0.00006008002,0.00020157649,0.00009306251,0.000057627487,0.0000137685065,0.000038911858,0.000056825324,0.000019847641],"category_scores_gemma":[0.00021420358,0.00003384824,0.000014407256,0.00031000745,0.0002191426,0.000064188505,0.0000167173,0.00025824472,3.3955288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024464421,0.0003871197,0.6149348,0.00021068021,0.00007093622,0.000008191284,0.00061529886,0.0000067926417,0.00010980854,0.00009393715,0.00039727733,0.3807187],"study_design_scores_gemma":[0.015966123,0.00086243893,0.9779535,0.00042608913,0.00003334536,0.000001224223,0.000072645584,0.0014649064,0.0006488875,0.00006517658,0.0024585354,0.00004711942],"about_ca_topic_score_codex":0.0017097417,"about_ca_topic_score_gemma":0.0071977945,"teacher_disagreement_score":0.3806716,"about_ca_system_score_codex":0.00025117895,"about_ca_system_score_gemma":0.00037299906,"threshold_uncertainty_score":0.40165383},"labels":[],"label_agreement":null},{"id":"W2152680582","doi":"10.1158/1078-0432.ccr-05-1387","title":"A Dynamic De-Escalating Dosing Strategy to Determine the Optimal Biological Dose for Antiangiogenic Drugs","year":2005,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Dosing; Medicine; Pharmacology; Intensive care medicine","score_opus":0.19948879983941725,"score_gpt":0.49760285566370926,"score_spread":0.298114055824292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152680582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68914926,0.017010748,0.0024010788,0.28649628,0.00086204783,0.002888106,0.000700377,0.000047383055,0.00044473202],"genre_scores_gemma":[0.5816964,0.008886142,0.0060240724,0.34795833,0.042616215,0.0030452567,0.001041617,0.00036736837,0.008364624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99535704,0.0007177754,0.0008045563,0.0012379864,0.00048629288,0.0013963571],"domain_scores_gemma":[0.9974246,0.0008731962,0.0001808331,0.00085302006,0.0004374242,0.00023089802],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033133307,0.00038840534,0.00053816015,0.00010891193,0.0004191158,0.0001530682,0.0011679662,0.0015645033,0.00016440813],"category_scores_gemma":[0.00064890744,0.00027021283,0.00084474694,0.0002850801,0.0005809312,0.0000046583223,0.0005864653,0.0016014689,0.000030157327],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072642264,0.00007754198,0.00079612865,0.000096732314,0.00032887186,0.00003218221,0.000047423793,0.00040070273,0.015107697,0.0000048213074,0.8131838,0.16919772],"study_design_scores_gemma":[0.0007871916,0.0016290986,0.0011784051,0.00013091117,0.00006908888,0.000014779411,0.0000634361,0.001312867,0.0016562036,0.000039356306,0.99260324,0.0005154025],"about_ca_topic_score_codex":0.00010943469,"about_ca_topic_score_gemma":0.00011402807,"teacher_disagreement_score":0.1794195,"about_ca_system_score_codex":0.0001868169,"about_ca_system_score_gemma":0.0009537847,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W2152723932","doi":"10.1158/1078-0432.ccr-10-2273","title":"Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada)","funders":"","keywords":"KRAS; Cetuximab; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Cancer research; Epidermal growth factor receptor; Neoadjuvant therapy","score_opus":0.3959506586468158,"score_gpt":0.560738633194411,"score_spread":0.1647879745475952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152723932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811478,0.0058899103,0.00018958011,0.0035105534,0.00083204673,0.0036645462,0.000098362725,0.0001038443,0.0045633554],"genre_scores_gemma":[0.9871098,0.002975004,0.0032560949,0.0012047815,0.00043265495,0.0038993785,0.00002532926,0.00010725653,0.000989714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99569607,0.00039705753,0.00091584615,0.001049623,0.0008287871,0.0011126255],"domain_scores_gemma":[0.9965826,0.0014543668,0.00012655143,0.00061679794,0.0006180818,0.0006015788],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002444674,0.0003005226,0.0008981284,0.00033930794,0.00011537933,0.000021073616,0.00036065927,0.00033315722,0.0018349711],"category_scores_gemma":[0.00091700477,0.00024788524,0.00042670825,0.0010998274,0.0007029531,0.000094479765,0.00008351332,0.0008889213,0.00003507283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06958711,0.0022258495,0.31159717,0.00025567887,0.00040311035,0.0002658965,0.00022630687,0.000016915168,0.0015802451,0.000046769666,0.0035748899,0.6102201],"study_design_scores_gemma":[0.10842282,0.019450793,0.7197184,0.002887679,0.00022492613,0.000018518223,0.00031851878,0.004879076,0.053226773,0.0016605213,0.08788058,0.0013113857],"about_ca_topic_score_codex":0.002285659,"about_ca_topic_score_gemma":0.0016994819,"teacher_disagreement_score":0.60890865,"about_ca_system_score_codex":0.001173222,"about_ca_system_score_gemma":0.002058623,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W2152770850","doi":"10.1158/1078-0432.ccr-07-1216","title":"TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Amphiregulin; Epidermal growth factor receptor; Ectodomain; Cancer research; Epidermal growth factor; TGF alpha; Tyrosine kinase; Receptor tyrosine kinase; Growth factor receptor; EGFR inhibitors; Transforming growth factor; Biology; Chemistry; Kinase; Signal transduction; Cell biology; Receptor; Biochemistry","score_opus":0.30923134052828233,"score_gpt":0.5201451766951082,"score_spread":0.21091383616682585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152770850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97482973,0.007463951,0.0000056136582,0.0146106575,0.00034842288,0.0021107267,0.0001011959,0.000025880388,0.0005038035],"genre_scores_gemma":[0.98881257,0.008562584,0.00018521758,0.00048448402,0.0005058483,0.00057844364,0.0000041637472,0.000061008977,0.00080565363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936633,0.0015543557,0.0010814205,0.0007797108,0.0018670855,0.0010541037],"domain_scores_gemma":[0.9960777,0.002006484,0.00016470601,0.0005039876,0.00076770334,0.00047941957],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035372577,0.00024672967,0.0009051337,0.0002664878,0.00028056905,0.000026899615,0.00052916206,0.0003039021,0.0015919142],"category_scores_gemma":[0.0019359234,0.00016838961,0.0002321086,0.00119184,0.0024875482,0.00009800028,0.0004887086,0.0025638505,0.000016716584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026590596,0.0005375446,0.9555396,0.00041575692,0.0001354406,0.00004990658,0.0012213629,0.000006953998,0.023610208,0.000032541655,0.0064642495,0.009327371],"study_design_scores_gemma":[0.00376742,0.0009469284,0.9608072,0.00096479134,0.000018571283,0.000026047566,0.00017811892,0.00056549074,0.022473935,0.00016252034,0.009875576,0.00021338287],"about_ca_topic_score_codex":0.0066302563,"about_ca_topic_score_gemma":0.0011143911,"teacher_disagreement_score":0.014126174,"about_ca_system_score_codex":0.00079627085,"about_ca_system_score_gemma":0.0032948873,"threshold_uncertainty_score":0.9999847},"labels":[],"label_agreement":null},{"id":"W2152963742","doi":"10.1158/1078-0432.ccr-08-2242","title":"Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sarcopenia; Capecitabine; Breast cancer; Internal medicine; Oncology; Metastatic breast cancer; Toxicity; Anthracycline; Cancer; Taxane; Chemotherapy; Surgery; Colorectal cancer","score_opus":0.13656555023818767,"score_gpt":0.5512843355968937,"score_spread":0.41471878535870604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152963742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822142,0.0006598968,7.409954e-7,0.015287658,0.00004134659,0.001477743,0.00003295877,0.00001231632,0.00027315316],"genre_scores_gemma":[0.99513966,0.001585761,0.0006138072,0.001777006,0.00012970628,0.00020791928,0.000004435501,0.00001704921,0.00052466075],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977558,0.00027910306,0.0006430959,0.00038981021,0.0004977645,0.00043437185],"domain_scores_gemma":[0.9986402,0.00033457327,0.000093629926,0.00020240499,0.00030611322,0.00042310465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013050947,0.00012465782,0.0005607127,0.00020964119,0.000072158306,0.000013897762,0.00008686858,0.00005213462,0.0009591759],"category_scores_gemma":[0.00031360696,0.00009039095,0.00005708165,0.00043060252,0.0001256874,0.00005239532,0.000039973987,0.00032708212,0.000030365392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004387282,0.0027826296,0.23491135,0.00021357472,0.00002022485,0.000046329333,0.00033443669,4.843026e-7,0.0031037715,0.000003873308,0.00094289903,0.75325316],"study_design_scores_gemma":[0.008138393,0.00520137,0.9778817,0.0027919447,0.000018603885,0.000012128483,0.00003457149,0.00022052381,0.003090684,0.000093396746,0.0024025426,0.000114125214],"about_ca_topic_score_codex":0.00065362774,"about_ca_topic_score_gemma":0.0002277585,"teacher_disagreement_score":0.753139,"about_ca_system_score_codex":0.00043116522,"about_ca_system_score_gemma":0.0004676725,"threshold_uncertainty_score":0.9999541},"labels":[],"label_agreement":null},{"id":"W2153129739","doi":"10.1158/1078-0432.ccr-13-0246","title":"Perioperative Influenza Vaccination Reduces Postoperative Metastatic Disease by Reversing Surgery-Induced Dysfunction in Natural Killer Cells","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Perioperative; Medicine; Vaccination; Disease; Reversing; Immunology; Natural history; Immunotherapy; Surgery; Internal medicine; Immune system","score_opus":0.14382753712063343,"score_gpt":0.46438189049404177,"score_spread":0.3205543533734083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153129739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98331445,0.005626793,0.0000028117204,0.00819181,0.0011065309,0.001514935,0.000008472945,0.000032041524,0.0002021222],"genre_scores_gemma":[0.9906087,0.0021587738,0.000039601193,0.001150934,0.0003774816,0.0004728131,0.000044183573,0.00004027239,0.005107231],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995367,0.0016728665,0.00085091457,0.0006642844,0.00081913284,0.00062583276],"domain_scores_gemma":[0.9959092,0.0021306502,0.0001314196,0.00037982332,0.0010370614,0.00041181123],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023207783,0.00024001778,0.0006676326,0.00039201588,0.00030134985,0.00014381835,0.00015715054,0.000115917486,0.0015712652],"category_scores_gemma":[0.0028619731,0.0001941132,0.0002223706,0.0008048538,0.00025556883,0.00057332765,0.00007438489,0.0012752281,0.00016613971],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034479626,0.0028381916,0.07782705,0.0007028241,0.0005985085,0.00036719968,0.005196096,0.00009362293,0.12905675,0.00004376305,0.3163236,0.43247277],"study_design_scores_gemma":[0.009881872,0.0017256222,0.8683603,0.0016443727,0.00017656897,0.00002461145,0.006116762,0.0028527495,0.03397088,0.000057471756,0.07426655,0.0009222732],"about_ca_topic_score_codex":0.0027771206,"about_ca_topic_score_gemma":0.0001870532,"teacher_disagreement_score":0.7905332,"about_ca_system_score_codex":0.00070064544,"about_ca_system_score_gemma":0.0013133844,"threshold_uncertainty_score":0.9993414},"labels":[],"label_agreement":null},{"id":"W2153518552","doi":"10.1158/1078-0432.ccr-06-0190","title":"Expression of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptors 1 and 2 in Melanoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; U.S. Public Health Service","keywords":"Melanoma; Tissue microarray; Receptor; Medicine; Receptor expression; Tumor necrosis factor alpha; Cancer research; Pathology; Necrosis; Apoptosis; Oncology; Immunohistochemistry; Internal medicine; Biology","score_opus":0.060662448574517,"score_gpt":0.40026709417671386,"score_spread":0.33960464560219683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153518552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981198,0.0011534942,0.000019860414,0.000103994986,0.00016575246,0.00017537338,0.0000074486534,0.000003941651,0.0002503342],"genre_scores_gemma":[0.9979083,0.0009841553,0.00012706961,0.000011365536,0.0001629925,0.000020949154,0.000024354784,0.000014520413,0.000746288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860597,0.00018808142,0.0004149638,0.00035663808,0.00020445055,0.0002299126],"domain_scores_gemma":[0.9994666,0.00008254584,0.00007995311,0.00019557416,0.00010622238,0.000069091526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081072346,0.00008304501,0.00017996602,0.00007872565,0.000060606944,0.00001552879,0.00010329663,0.00021537286,0.000056924888],"category_scores_gemma":[0.00013946021,0.0000691345,0.00005901358,0.00016745285,0.00015569538,0.0000045006473,0.00013662573,0.00023416962,0.0000016533957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016485418,0.00007675218,0.050971415,0.000026421585,0.0000062603012,8.3755174e-7,0.00002229897,0.00003263786,0.9417979,0.000023061973,0.000588632,0.006288889],"study_design_scores_gemma":[0.00074683747,0.00023910118,0.08893789,0.000090215224,0.0000036972338,7.1253436e-7,0.000032554897,0.00006624224,0.90721786,0.00034311437,0.0022304829,0.00009127248],"about_ca_topic_score_codex":0.0005079488,"about_ca_topic_score_gemma":0.00018251533,"teacher_disagreement_score":0.03796648,"about_ca_system_score_codex":0.000019171921,"about_ca_system_score_gemma":0.00008184296,"threshold_uncertainty_score":0.2819223},"labels":[],"label_agreement":null},{"id":"W2153554960","doi":"10.1158/1078-0432.ccr-08-2678","title":"Association of <i>MDM2</i> SNP309, Age of Onset, and Gender in Cutaneous Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Melanoma Research Alliance","keywords":"Medicine; Genotype; Melanoma; Incidence (geometry); Internal medicine; Age of onset; Epidemiology; Demography; Gynecology; Gastroenterology; Pediatrics; Genetics; Biology; Disease","score_opus":0.1579351492409101,"score_gpt":0.4779649724588059,"score_spread":0.32002982321789586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153554960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712784,0.00045735345,0.000010964668,0.0022489056,0.00011357588,0.0004077781,0.000007954633,0.000012712527,0.009612911],"genre_scores_gemma":[0.9936146,0.0016571005,0.00008535514,0.00032269474,0.000099942925,0.0000103307175,0.000004283673,0.000008045974,0.0041976282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812144,0.00025389355,0.0005579417,0.00024060182,0.00057495997,0.00025117502],"domain_scores_gemma":[0.998738,0.00060169864,0.00011284064,0.00022330522,0.00020396868,0.00012017318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017954753,0.00007021112,0.00037301646,0.00019985417,0.000025977608,0.000007564812,0.00007790322,0.00013888473,0.00021629473],"category_scores_gemma":[0.00095579145,0.000062956104,0.00007712166,0.00033208705,0.000118052485,0.000019954638,0.000053179006,0.00046821524,0.000007458442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004406504,0.00164815,0.7535361,0.00057757105,0.00029770864,0.0013405855,0.0009466596,0.0000166523,0.008989194,0.00040968606,0.020882979,0.20694819],"study_design_scores_gemma":[0.0047930633,0.0040651797,0.94896406,0.000252309,0.00011893072,0.00012680906,0.00030217273,0.00022674525,0.0036506508,0.003751399,0.033559516,0.00018915499],"about_ca_topic_score_codex":0.00025930686,"about_ca_topic_score_gemma":0.00042903153,"teacher_disagreement_score":0.20675904,"about_ca_system_score_codex":0.0001729136,"about_ca_system_score_gemma":0.00013039974,"threshold_uncertainty_score":0.25672752},"labels":[],"label_agreement":null},{"id":"W2153666475","doi":"10.1158/1078-0432.ccr-06-0536","title":"Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis of Tetrazole Derivatives","field":"Chemistry","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Ontario Genomics","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Small molecule; Chemistry; Cell; Chloride; Computational biology; Combinatorial chemistry; Cancer research; Biology; Biochemistry; Organic chemistry","score_opus":0.2570836665959272,"score_gpt":0.47444212376281886,"score_spread":0.21735845716689167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153666475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873548,0.0013711674,0.001974907,0.0012104205,0.00025194234,0.0003033829,0.0002825833,0.00012683807,0.007123973],"genre_scores_gemma":[0.9939791,0.00012615504,0.0013920614,0.00028218768,0.0011684105,0.00017020627,0.000060712347,0.00011952178,0.002701627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949153,0.00022713911,0.0010789655,0.0011570178,0.0014235144,0.0011980422],"domain_scores_gemma":[0.99553764,0.0022695498,0.00025665064,0.001026557,0.00054910267,0.00036049806],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024559563,0.00033739628,0.0005902004,0.00016516612,0.00035959983,0.00024647912,0.0011089774,0.00039605325,0.0021573629],"category_scores_gemma":[0.001123746,0.0003392551,0.0003563111,0.00060580083,0.00090206467,0.00012348637,0.0003701405,0.0013434456,0.00007945189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075702555,0.0012717209,0.019432034,0.00029429974,0.000102061975,0.000047350215,0.000027600905,0.0003189879,0.96110594,0.00003601254,0.014927713,0.0016792751],"study_design_scores_gemma":[0.0021728047,0.00005046306,0.002929201,0.00025617497,0.000049631497,0.0000011791361,0.0000998721,0.004729468,0.97913265,0.00006690711,0.010051914,0.00045972207],"about_ca_topic_score_codex":0.006904489,"about_ca_topic_score_gemma":0.0003759933,"teacher_disagreement_score":0.018026745,"about_ca_system_score_codex":0.00046451113,"about_ca_system_score_gemma":0.000843732,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W2153666842","doi":"10.1158/1078-0432.ccr-12-3064","title":"New Strategies in Hodgkin Lymphoma: Better Risk Profiling and Novel Treatments","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Lymphoma; Disease; Hodgkin lymphoma; Risk stratification; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.4180967346009461,"score_gpt":0.5835940175821612,"score_spread":0.16549728298121513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153666842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076692854,0.98725855,0.000006959517,0.00031317206,0.00021394831,0.0033072697,0.00010154087,0.000028962748,0.0011002914],"genre_scores_gemma":[0.00033196202,0.9935162,0.0013782822,0.00006201602,0.00089284877,0.0020236436,0.00009136454,0.00008071457,0.001622963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954503,0.0006130604,0.0012814624,0.0011258435,0.0007300613,0.00079923717],"domain_scores_gemma":[0.9961485,0.0021227687,0.000266087,0.0006873235,0.00016331208,0.00061195873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014619011,0.000497432,0.0025322349,0.00037915024,0.00011044011,0.0001787321,0.0002393075,0.0006758508,0.0003265802],"category_scores_gemma":[0.0004002556,0.0003153517,0.0004900297,0.0005588931,0.0002930702,0.00012707796,0.0002753158,0.00091543753,0.0002713682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000695185,0.000918067,0.024243137,0.002999362,0.0006446228,0.00014824155,0.000021283791,7.5551014e-8,2.048872e-7,0.00012664308,0.0023602988,0.96846855],"study_design_scores_gemma":[0.011755554,0.0013873592,0.035877272,0.019262448,0.0018282323,0.000050167357,0.00008337895,0.000011020446,0.0000052358646,0.0005561339,0.92871267,0.00047053423],"about_ca_topic_score_codex":0.0073631746,"about_ca_topic_score_gemma":0.00029243802,"teacher_disagreement_score":0.967998,"about_ca_system_score_codex":0.001053139,"about_ca_system_score_gemma":0.004513485,"threshold_uncertainty_score":0.99992985},"labels":[],"label_agreement":null},{"id":"W2153732710","doi":"10.1158/1078-0432.ccr-03-0470","title":"<b> <i>Skp2</i> </b> Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with <b> <i>ras</i> </b> Mutation Is a Poor Prognostic Marker","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; Cancer research; SKP2; Mutation; Cell cycle; Adenocarcinoma; Gene; Lung cancer; Copy-number variation; Gene mutation; Gene dosage; Gene expression; Cancer; Molecular biology; Pathology; Genetics; Medicine; Ubiquitin","score_opus":0.05996688744326527,"score_gpt":0.44183755208976144,"score_spread":0.38187066464649616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153732710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112934,0.0011176051,0.000027206737,0.003159154,0.000057918925,0.0023460286,0.0000824004,0.000024187195,0.002056177],"genre_scores_gemma":[0.99619955,0.0004382246,0.00048197905,0.0008382087,0.00013341125,0.000995089,0.000076938544,0.0000531652,0.00078346074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972848,0.0002251037,0.00066037144,0.0006795323,0.0005814232,0.0005687396],"domain_scores_gemma":[0.99838537,0.00047545985,0.00014281819,0.00030765502,0.00035154613,0.0003371371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007021191,0.00022687651,0.0004943213,0.00021015611,0.0001678572,0.000056156034,0.00012307764,0.00018934376,0.00014772889],"category_scores_gemma":[0.00015521166,0.00017891887,0.00006740373,0.0007946921,0.00018093096,0.0001788558,0.00009357753,0.00089886953,0.00003245292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009636707,0.0009659935,0.99326956,0.00038218775,0.000029803969,0.0004741313,0.0011265468,0.0001400163,0.0010052734,0.000022186465,0.0012078604,0.0004127605],"study_design_scores_gemma":[0.014088229,0.000665973,0.97178364,0.0026735005,0.000109432905,0.000040765757,0.00066943595,0.0007807702,0.008546052,0.00020716382,0.00018379583,0.00025124138],"about_ca_topic_score_codex":0.0035574571,"about_ca_topic_score_gemma":0.0033696075,"teacher_disagreement_score":0.021485928,"about_ca_system_score_codex":0.0006097663,"about_ca_system_score_gemma":0.0011816525,"threshold_uncertainty_score":0.72960997},"labels":[],"label_agreement":null},{"id":"W2153921055","doi":"10.1158/1078-0432.ccr-08-0529","title":"Phase II Trial of Short-Course CHOP-R Followed by 90Y-ibritumomab Tiuxetan and Extended Rituximab in Previously Untreated Follicular Lymphoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Rituximab; Medicine; Chemoimmunotherapy; Radioimmunotherapy; Follicular lymphoma; Ibritumomab tiuxetan; CHOP; Nuclear medicine; Vincristine; Lymphoma; Internal medicine; Gastroenterology; Cyclophosphamide; Chemotherapy; Immunology; Antibody","score_opus":0.1457220537021659,"score_gpt":0.4981432744785355,"score_spread":0.3524212207763696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153921055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319167,0.011630457,0.0000010113715,0.0017248611,0.00016543838,0.0024775253,0.00007855054,0.000038846076,0.0006916277],"genre_scores_gemma":[0.9850834,0.012851735,0.00006472164,0.00012861288,0.0002943367,0.00066265796,0.00006771962,0.000044074877,0.0008027293],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955082,0.00055486744,0.0012034439,0.00085652526,0.0010953572,0.00078160904],"domain_scores_gemma":[0.9975185,0.0007256342,0.00012190596,0.0007052921,0.00033030804,0.0005983861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017123474,0.00028652625,0.0012960095,0.00020410793,0.00021555499,0.000021363312,0.0002144424,0.00030939135,0.00018199804],"category_scores_gemma":[0.0007445407,0.0002266628,0.00034204073,0.00069258123,0.0008192689,0.00010359726,0.00018903517,0.00035636086,0.000016185655],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17974861,0.20263214,0.2042956,0.00027290196,0.0012802277,0.005045186,0.0006289476,7.6741435e-7,0.0015067853,0.00009751106,0.06143166,0.34305966],"study_design_scores_gemma":[0.84454757,0.035998087,0.097875886,0.0006310008,0.0004539073,0.00011182296,0.000098023374,0.00023729148,0.0057282797,0.00009047818,0.013832419,0.00039520915],"about_ca_topic_score_codex":0.0017343847,"about_ca_topic_score_gemma":0.00027280507,"teacher_disagreement_score":0.664799,"about_ca_system_score_codex":0.00040584657,"about_ca_system_score_gemma":0.0013032483,"threshold_uncertainty_score":0.92430407},"labels":[],"label_agreement":null},{"id":"W2154297950","doi":"10.1158/1078-0432.ccr-08-3291","title":"Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL–Positive Cells","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Novartis Pharma","keywords":"Imatinib; Oxidative phosphorylation; Glycolysis; K562 cells; Citric acid cycle; Glucose uptake; Biology; Imatinib mesylate; Biochemistry; Chemistry; Metabolism; Internal medicine; Endocrinology; Cancer research; Cell; Myeloid leukemia; Medicine; Insulin","score_opus":0.1295846495074042,"score_gpt":0.4863216507226815,"score_spread":0.3567370012152773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154297950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845013,0.0069637066,5.9489844e-7,0.0019774723,0.00009487621,0.0009160765,0.000043221706,0.000024850795,0.0054778764],"genre_scores_gemma":[0.99326646,0.0037280153,0.00022967134,0.00052887807,0.0002976016,0.0001174108,0.000021662163,0.000025164367,0.0017851117],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99621433,0.00059397856,0.0009873105,0.0006347727,0.00074716826,0.0008224134],"domain_scores_gemma":[0.9980457,0.00086316984,0.00008483353,0.00046872348,0.00019018499,0.00034738003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00325445,0.00021154214,0.00075650844,0.0003597665,0.000107191074,0.000048798353,0.0001955592,0.00022734984,0.0004074332],"category_scores_gemma":[0.0005152705,0.00017956569,0.000108612396,0.00056830776,0.00047192027,0.00013199127,0.00013009126,0.001390499,0.000040993775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023237085,0.011902682,0.26719406,0.0015429076,0.0008741133,0.010344246,0.015191514,0.00006458723,0.11414656,0.016788302,0.016819065,0.5218949],"study_design_scores_gemma":[0.011797212,0.0009758359,0.9715288,0.0006292156,0.000042079173,0.000008442533,0.0005299744,0.00009499938,0.0075564496,0.0016025505,0.0050314344,0.00020298579],"about_ca_topic_score_codex":0.004497627,"about_ca_topic_score_gemma":0.0024357263,"teacher_disagreement_score":0.70433474,"about_ca_system_score_codex":0.0010216602,"about_ca_system_score_gemma":0.0009057825,"threshold_uncertainty_score":0.7322476},"labels":[],"label_agreement":null},{"id":"W2154442758","doi":"10.1158/1078-0432.ccr-05-1331","title":"Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; Medicine; Prostate-specific antigen; Prostate; Macrophage migration inhibitory factor; Antigen; Cancer; Population; Immunoassay; Internal medicine; Pathology; Oncology; Cytokine; Immunology; Urology; Antibody","score_opus":0.12499139623553443,"score_gpt":0.4176536910026246,"score_spread":0.29266229476709016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154442758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844899,0.00992068,0.0000019322097,0.0023399908,0.0002817993,0.0019294214,0.00046172517,0.000032575597,0.0005419556],"genre_scores_gemma":[0.99064964,0.0073918966,0.000100287136,0.000049144066,0.0002762862,0.00046690975,0.000009701743,0.00005818691,0.0009979712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952623,0.00035700013,0.0011906319,0.0006098915,0.001886519,0.00069362123],"domain_scores_gemma":[0.9965858,0.00024350156,0.0003204423,0.00052583555,0.002051483,0.00027296622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003217812,0.00023986073,0.000786821,0.00024419985,0.00011300815,0.000018497161,0.00022292174,0.00026572237,0.00045972923],"category_scores_gemma":[0.00017127328,0.00015986276,0.00019595222,0.00090310996,0.0013746469,0.00007420023,0.00013562464,0.0009023424,0.000008791531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015057572,0.0016151668,0.7186718,0.0012450614,0.00053427415,0.000107066764,0.00017042267,0.000023722623,0.19617091,0.000020700236,0.010532361,0.05585096],"study_design_scores_gemma":[0.006062853,0.0033902393,0.74368834,0.0014275733,0.0000614789,0.0000015214099,0.000096667194,0.000018768256,0.23964055,0.00003998219,0.0054142373,0.00015777165],"about_ca_topic_score_codex":0.0019822791,"about_ca_topic_score_gemma":0.0005956431,"teacher_disagreement_score":0.055693187,"about_ca_system_score_codex":0.0002890174,"about_ca_system_score_gemma":0.0012562268,"threshold_uncertainty_score":0.6519014},"labels":[],"label_agreement":null},{"id":"W2154488022","doi":"10.1158/1078-0432.ccr-10-1869","title":"Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"National Cancer Institute","keywords":"Gefitinib; Tamoxifen; Medicine; Internal medicine; Breast cancer; Placebo; Oncology; Metastatic breast cancer; Cancer; Epidermal growth factor receptor; Pathology","score_opus":0.13883671522188215,"score_gpt":0.4788527990782955,"score_spread":0.34001608385641335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154488022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969537,0.00049830537,0.00006760738,0.0009855692,0.00008682843,0.008258254,0.00016100558,0.000042589567,0.00020445786],"genre_scores_gemma":[0.9938689,0.00038654945,0.0007393058,0.00019030785,0.0000983465,0.0041954643,0.000046065205,0.00008356496,0.00039149923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939038,0.0019153656,0.0011090155,0.00087610906,0.0013857849,0.00080991624],"domain_scores_gemma":[0.9961843,0.0015342967,0.0003012376,0.0005018764,0.0011270313,0.00035124805],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044364934,0.00034541675,0.0015813182,0.0004962795,0.00014903475,0.000023822453,0.00028404957,0.00011005324,0.00093057903],"category_scores_gemma":[0.00057592895,0.00021243704,0.000091665155,0.001548803,0.001072644,0.00032452206,0.00014939754,0.0013985039,0.0000126741825],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7565652,0.013974532,0.16972232,0.0000515158,0.00048405628,0.00012357348,0.004356192,0.000007261037,0.000013548714,0.000023391105,0.00006166049,0.05461674],"study_design_scores_gemma":[0.6195373,0.019548357,0.35802475,0.00073074026,0.0001569466,0.0000060415337,0.0014426537,0.00006467284,0.000050962288,0.00011004003,0.000068013804,0.00025951254],"about_ca_topic_score_codex":0.005320702,"about_ca_topic_score_gemma":0.0047229286,"teacher_disagreement_score":0.18830244,"about_ca_system_score_codex":0.0008296515,"about_ca_system_score_gemma":0.0012194231,"threshold_uncertainty_score":0.9999827},"labels":[],"label_agreement":null},{"id":"W2154638518","doi":"10.1158/1078-0432.ccr-04-1261","title":"Gain of OGP, an Estrogen-Regulated Oviduct-Specific Glycoprotein, Is Associated with the Development of Endometrial Hyperplasia and Endometrial Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Oviduct; Endometrium; Atypical hyperplasia; Endometrial cancer; Immunohistochemistry; PTEN; Endometrial hyperplasia; Tissue microarray; Hyperplasia; Biology; Internal medicine; Endometrial Polyp; Endocrinology; Cancer; Medicine; Apoptosis","score_opus":0.15676110840128546,"score_gpt":0.4450517754876193,"score_spread":0.2882906670863339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154638518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881931,0.010348317,0.00013435159,0.00037100236,0.00016500703,0.0006035064,0.00011683994,0.0000060833545,0.00006177902],"genre_scores_gemma":[0.9956246,0.0027725226,0.0005378875,0.000064916174,0.0006184377,0.00017931708,0.000037603542,0.00003537343,0.00012932128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971278,0.00038383476,0.0007113804,0.0005871301,0.0007400298,0.00044988137],"domain_scores_gemma":[0.99805886,0.0003041604,0.00027837884,0.00046118445,0.0007152281,0.00018221393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002802878,0.00019045951,0.00046242596,0.00014869217,0.00018649924,0.000027311664,0.00043343008,0.00028732003,0.00014378979],"category_scores_gemma":[0.0005612745,0.00012741466,0.00014876996,0.00085469737,0.00092923234,0.000008644115,0.00020335037,0.0002994969,0.000001493697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017728323,0.0013646818,0.08026425,0.00011233295,0.00229625,0.000012213841,0.0009874059,0.00040900143,0.7534021,0.00032767074,0.0033401516,0.1397556],"study_design_scores_gemma":[0.011907219,0.0028112575,0.022310127,0.00018138094,0.000069159345,0.000004336293,0.00029863266,0.000011512433,0.9304835,0.00007584523,0.031494185,0.00035279736],"about_ca_topic_score_codex":0.0003606114,"about_ca_topic_score_gemma":0.0006418727,"teacher_disagreement_score":0.17708144,"about_ca_system_score_codex":0.00010565605,"about_ca_system_score_gemma":0.0014985398,"threshold_uncertainty_score":0.519582},"labels":[],"label_agreement":null},{"id":"W2154670277","doi":"10.1158/1078-0432.ccr-05-0421","title":"Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Gefitinib; Erlotinib; Epidermal growth factor receptor; Erlotinib Hydrochloride; Glioma; Lung cancer; Cancer research; EGFR inhibitors; Medicine; Oncology; Biology; Internal medicine; Cancer","score_opus":0.12680459887152382,"score_gpt":0.4648447428145399,"score_spread":0.33804014394301607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154670277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918623,0.0011645082,0.000005011474,0.00442191,0.0000374707,0.0020455006,0.00039005876,0.000035660596,0.00003759103],"genre_scores_gemma":[0.99808747,0.0004009745,0.0002451353,0.00024716745,0.00040024886,0.000432701,0.00009736286,0.000048612183,0.00004035404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931459,0.0023309262,0.0016448785,0.0010246361,0.0012265793,0.0006270854],"domain_scores_gemma":[0.9935064,0.0039786366,0.00052594615,0.00068984105,0.00058550754,0.000713698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022146844,0.00033406948,0.0023164423,0.00062515633,0.00011701516,0.000055418084,0.00019238362,0.000092945964,0.00067585945],"category_scores_gemma":[0.0025190336,0.00021785477,0.00030719503,0.0024703073,0.00078851345,0.00007963516,0.00014060209,0.0004997616,0.000026503982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034497161,0.004039859,0.9686043,0.000030809453,0.004268012,0.0006992673,0.00027483812,0.000019382453,0.004558847,0.000003208703,0.0017679193,0.012283798],"study_design_scores_gemma":[0.010416737,0.008178671,0.9209215,0.000112072084,0.0018275694,0.0000044572575,0.0006543658,0.000067214045,0.056540474,0.0000030340145,0.0010274753,0.00024644827],"about_ca_topic_score_codex":0.021857439,"about_ca_topic_score_gemma":0.009291882,"teacher_disagreement_score":0.051981628,"about_ca_system_score_codex":0.00018668264,"about_ca_system_score_gemma":0.00031495027,"threshold_uncertainty_score":0.9846561},"labels":[],"label_agreement":null},{"id":"W2154736427","doi":"10.1158/1078-0432.ccr-06-0474","title":"High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cyclophosphamide; Chemotherapy; Phases of clinical research; Lymphoma; Oncology; Surgery","score_opus":0.03089044926751248,"score_gpt":0.3818962638238433,"score_spread":0.3510058145563308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154736427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989981,0.007431735,5.4865677e-7,0.0006703694,0.00011793056,0.0016104849,0.000035450612,0.00001508084,0.00013741845],"genre_scores_gemma":[0.9921208,0.0064843264,0.00016512058,0.00037556863,0.00016292091,0.00048283784,0.000039251085,0.000041766576,0.00012741721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997166,0.00049640663,0.0005003071,0.00091347564,0.00038378808,0.00054004934],"domain_scores_gemma":[0.99743927,0.0013881404,0.00020212778,0.0003959661,0.00022712038,0.00034737212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008134211,0.00026638494,0.00076994166,0.000234688,0.00015640081,0.000038569713,0.00009431214,0.0002581489,0.000064531785],"category_scores_gemma":[0.00017815101,0.0001901021,0.00005210761,0.00023976108,0.00087337417,0.00013706634,0.000106296764,0.00037165874,0.000006828018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008383481,0.001783595,0.7604776,0.00003805959,0.00012112779,0.00014446113,0.00014252891,7.9788435e-7,0.00003555015,0.00002351293,0.000599081,0.22825019],"study_design_scores_gemma":[0.040883273,0.008324616,0.9485381,0.00020364215,0.00004995187,0.0000055651585,0.000036617468,0.000022530321,0.000500364,0.00017757485,0.0010740238,0.0001837339],"about_ca_topic_score_codex":0.007839332,"about_ca_topic_score_gemma":0.0010442728,"teacher_disagreement_score":0.22806646,"about_ca_system_score_codex":0.00070638634,"about_ca_system_score_gemma":0.00033369364,"threshold_uncertainty_score":0.99876755},"labels":[],"label_agreement":null},{"id":"W2154796235","doi":"10.1158/1078-0432.ccr-07-0342","title":"Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Fas ligand; Prostate cancer; Bystander effect; Cancer research; Apoptosis; Prostate; Oncolytic virus; Systemic administration; In vivo; Biology; Antigen; Gene delivery; Genetic enhancement; Immune system; Cancer; Immunology; Medicine; Internal medicine; Programmed cell death; Gene","score_opus":0.0613555043708848,"score_gpt":0.4433051042977801,"score_spread":0.38194959992689526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154796235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907543,0.0069099828,0.0008193174,0.00036252168,0.00012021227,0.000508554,0.00003475168,0.000013382755,0.0004769827],"genre_scores_gemma":[0.9763164,0.020467965,0.0001392527,0.000100806305,0.00040017243,0.000025106478,0.00008839694,0.000020259364,0.002441647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980281,0.0001663275,0.00044670407,0.0006326286,0.0003080534,0.00041816497],"domain_scores_gemma":[0.99880254,0.00024267958,0.00009814174,0.00033731785,0.00030242885,0.00021688319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017079485,0.00012418239,0.00019694424,0.000057697685,0.00021539295,0.00003995899,0.00017748255,0.00023278268,0.000025499716],"category_scores_gemma":[0.00044599173,0.000102937694,0.000066171764,0.00025030033,0.0004127947,0.0000062893023,0.00020413344,0.00033611144,0.00001006068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022657858,0.00017272477,0.0027205409,0.00002386566,0.00005300844,0.000009983538,0.000043167445,0.000004725579,0.8948626,0.00007369305,0.003914167,0.09585572],"study_design_scores_gemma":[0.0021926688,0.001711823,0.074474975,0.000057586363,0.000018926166,0.000006153277,0.00009958663,0.00005615785,0.7298492,0.00011678098,0.19113964,0.0002764697],"about_ca_topic_score_codex":0.0001918441,"about_ca_topic_score_gemma":0.00014447464,"teacher_disagreement_score":0.18722548,"about_ca_system_score_codex":0.000028805613,"about_ca_system_score_gemma":0.0001675003,"threshold_uncertainty_score":0.41976774},"labels":[],"label_agreement":null},{"id":"W2154812064","doi":"10.1158/1078-0432.ccr-06-1653","title":"A Phase Ib and Pharmacokinetic Trial of Patupilone Combined with Carboplatin in Patients with Advanced Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Nausea; Pharmacokinetics; Vomiting; Adverse effect; Phases of clinical research; Area under the curve; Neutropenia; Internal medicine; Urology; Chemotherapy; Oncology; Gastroenterology; Pharmacology; Surgery; Cisplatin","score_opus":0.14233468841941216,"score_gpt":0.5699323937793035,"score_spread":0.42759770535989133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154812064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950335,0.000962738,0.0000034113605,0.0007128049,0.00020795621,0.0024849935,0.00004237149,0.00001479737,0.00053744664],"genre_scores_gemma":[0.99756384,0.0012019613,0.00010485264,0.00018368995,0.0002487829,0.00033546513,0.000024342642,0.000031726486,0.00030532267],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99753344,0.0001949366,0.0006132409,0.0004554225,0.0006712755,0.0005316958],"domain_scores_gemma":[0.9980976,0.0007758858,0.00014348676,0.00022183388,0.00043180375,0.00032939663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012741691,0.00017356245,0.00065411057,0.0002350502,0.000048447546,0.0000067224464,0.000095457915,0.00010765099,0.00039351656],"category_scores_gemma":[0.00009700919,0.00011818695,0.000048654307,0.0006873721,0.0005851569,0.00005799932,0.00005566335,0.0007439878,0.000001601948],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56677103,0.0052139224,0.3352522,0.000105443374,0.00017481593,0.0000668491,0.00012448001,0.0000054139737,0.0005600104,0.000005227066,0.0002706108,0.091449976],"study_design_scores_gemma":[0.6025347,0.05751822,0.33515394,0.00031540502,0.00019383739,9.911564e-7,0.000040754716,0.0000484003,0.0025101032,0.000013052879,0.0015141811,0.00015640944],"about_ca_topic_score_codex":0.00092846074,"about_ca_topic_score_gemma":0.0017717123,"teacher_disagreement_score":0.091293566,"about_ca_system_score_codex":0.00020249555,"about_ca_system_score_gemma":0.0005777428,"threshold_uncertainty_score":0.4819524},"labels":[],"label_agreement":null},{"id":"W2155041167","doi":"10.1158/1078-0432.ccr-12-2459","title":"Topotecan and Doxorubicin Combination to Treat Recurrent Ovarian Cancer: The Influence of Drug Exposure Time and Delivery Systems to Achieve Optimum Therapeutic Activity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Centre for Drug Research and Development","funders":"University of British Columbia; Canadian Institutes of Health Research; British Columbia Innovation Council","keywords":"Topotecan; Pharmacology; Medicine; Doxorubicin; Ovarian cancer; Pharmacokinetics; Combination therapy; Drug; Paclitaxel; Chemotherapy; Cancer; Internal medicine","score_opus":0.06097591290692741,"score_gpt":0.40184297557309395,"score_spread":0.34086706266616656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155041167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076015,0.0032864022,0.00006122688,0.0044872696,0.00014765045,0.001147934,0.000043963166,0.0000057084185,0.00005971915],"genre_scores_gemma":[0.9939963,0.004236659,0.000026192905,0.00046865892,0.00016829399,0.00042234542,0.0000044225494,0.000019282936,0.00065783586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982216,0.0004189256,0.00028472015,0.00045697019,0.00029763483,0.00032015762],"domain_scores_gemma":[0.99871165,0.00016890993,0.00007463594,0.00040072144,0.000413527,0.0002305379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011928878,0.00013829215,0.00024696343,0.000060613653,0.00014725611,0.0000764413,0.00026754025,0.00012896679,0.00002780038],"category_scores_gemma":[0.00006218935,0.000102377824,0.00004767242,0.00019148085,0.0001954851,0.000010646263,0.00028831934,0.00027483844,0.0000063515304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009777788,0.00012504759,0.0014175539,0.000068601374,0.00008718072,6.1073416e-7,0.00032494994,0.00052403286,0.79711133,0.0001689252,0.0007529539,0.19844106],"study_design_scores_gemma":[0.008927602,0.022452408,0.35069826,0.0010736355,0.00028511044,0.000017324981,0.0013037893,0.005428175,0.551035,0.0022217366,0.054759715,0.0017972644],"about_ca_topic_score_codex":0.005148984,"about_ca_topic_score_gemma":0.0005131654,"teacher_disagreement_score":0.3492807,"about_ca_system_score_codex":0.000058064914,"about_ca_system_score_gemma":0.00020020701,"threshold_uncertainty_score":0.7783758},"labels":[],"label_agreement":null},{"id":"W2155054198","doi":"10.1158/1078-0432.ccr-04-1439","title":"An 19F Magnetic Resonance–Based <i>In Vivo</i> Assay of Solid Tumor Methotrexate Resistance: Proof of Principle","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"In vivo; Methotrexate; Magnetic resonance imaging; Sarcoma; Pharmacokinetics; Chemotherapy; Antifolate; Medicine; Bolus (digestion); Pharmacology; Chemistry; Pathology; Nuclear magnetic resonance; Cancer research; Antimetabolite; Internal medicine; Biology","score_opus":0.14480404926727497,"score_gpt":0.48723478994590874,"score_spread":0.34243074067863377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155054198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934119,0.0028821132,0.00023238067,0.0006379328,0.00014120224,0.00058193284,0.0004298006,0.000025476646,0.0016572763],"genre_scores_gemma":[0.99272686,0.00012569249,0.0059707165,0.00017628324,0.0001912767,0.0001197821,0.000003979164,0.000024429823,0.00066095387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945791,0.0019977053,0.0012025689,0.00058742764,0.0010678425,0.0005654026],"domain_scores_gemma":[0.9971697,0.0011948042,0.00019475032,0.00071204605,0.00053542794,0.00019328338],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010474143,0.00014462769,0.00061248423,0.00018184706,0.00008051137,0.00002493952,0.0006875023,0.00009853296,0.0029447165],"category_scores_gemma":[0.0006465326,0.000119730124,0.00013389003,0.00065908185,0.0007967503,0.00020074431,0.000084250394,0.00042715349,0.000025458825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026290168,0.0012280343,0.005489204,0.0004529865,0.0000070728156,0.000035347788,0.00015365805,0.0005106132,0.980906,0.0011835602,0.0012105749,0.006193932],"study_design_scores_gemma":[0.0015212118,0.0006699341,0.008679297,0.0002956261,0.000012667201,6.0535683e-7,0.000027523067,0.0011061894,0.966307,0.0011869238,0.02003182,0.0001611905],"about_ca_topic_score_codex":0.00028910607,"about_ca_topic_score_gemma":0.0031003929,"teacher_disagreement_score":0.018821243,"about_ca_system_score_codex":0.00006901517,"about_ca_system_score_gemma":0.0005978272,"threshold_uncertainty_score":0.9979667},"labels":[],"label_agreement":null},{"id":"W2155244882","doi":"10.1158/1078-0432.ccr-11-2890","title":"Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase <i>In Vitro</i>","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Veliparib; Olaparib; PARP inhibitor; Poly ADP ribose polymerase; Cancer research; Pharmacology; Medicine; Biology; Polymerase; Biochemistry; Enzyme","score_opus":0.2767273602044271,"score_gpt":0.5716575263099984,"score_spread":0.2949301661055713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155244882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95782274,0.006238724,0.000060643793,0.029504575,0.0007354037,0.0011359394,0.00013143173,0.000051881234,0.0043186564],"genre_scores_gemma":[0.99050945,0.00045072282,0.00075132033,0.0039171684,0.002690667,0.00036660052,0.000020312391,0.000057355264,0.0012364053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953362,0.00061387534,0.0011358069,0.00052500254,0.0012418773,0.0011472816],"domain_scores_gemma":[0.9965621,0.001060228,0.00012532322,0.00078261667,0.00043662477,0.001033075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046514203,0.00020437695,0.00075747457,0.00048420942,0.00007756146,0.000017667155,0.00030300897,0.0003102723,0.0015138775],"category_scores_gemma":[0.0010255106,0.00018377442,0.00022910954,0.0015265268,0.0005522609,0.00017148802,0.00022228324,0.0015103398,0.00031919713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014864168,0.003139958,0.3297838,0.0004038825,0.00019917899,0.00007367979,0.0015066145,0.0000048666616,0.41513324,0.0007101289,0.14453319,0.0896473],"study_design_scores_gemma":[0.008217839,0.0011052078,0.053803224,0.00073742465,0.000037421585,0.000018783834,0.00041731764,0.000016180202,0.70351535,0.00020909132,0.23155408,0.0003680741],"about_ca_topic_score_codex":0.00097115943,"about_ca_topic_score_gemma":0.00012051736,"teacher_disagreement_score":0.28838214,"about_ca_system_score_codex":0.00040058806,"about_ca_system_score_gemma":0.00086919864,"threshold_uncertainty_score":0.9993989},"labels":[],"label_agreement":null},{"id":"W2155311753","doi":"10.1158/1078-0432.ccr-13-1049","title":"<i>TMPRSS2-ERG</i> Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"TMPRSS2; Erg; Prostate cancer; Medicine; Oncology; Prostate; Internal medicine; Cohort; Context (archaeology); Tissue microarray; Proportional hazards model; Cancer; Biology; Ophthalmology","score_opus":0.16376934668636645,"score_gpt":0.5108692551667048,"score_spread":0.34709990848033834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155311753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9286063,0.029009284,0.0000295494,0.034095816,0.0004565835,0.006943906,0.0005444183,0.00013807813,0.00017607334],"genre_scores_gemma":[0.85832375,0.114460565,0.0017099424,0.0034509674,0.00072226883,0.019097766,0.00009456908,0.00011354643,0.0020266355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959334,0.00020129731,0.0008096141,0.0010773197,0.0005818644,0.0013965053],"domain_scores_gemma":[0.9955148,0.0017632972,0.00014760837,0.00069086114,0.00088145776,0.0010019692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011202947,0.00028886265,0.00068442593,0.00016030949,0.00044378857,0.00013561863,0.00014221825,0.00020082398,0.00039642476],"category_scores_gemma":[0.00065259065,0.00022361618,0.00037403393,0.0004926382,0.0003924574,0.00021417113,0.00014964554,0.00061149686,0.00001943764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007146026,0.00046721366,0.7917726,0.00028124344,0.00042330485,0.000007178361,0.0005106,0.000003224962,0.0011816762,0.000078625046,0.044325627,0.16023408],"study_design_scores_gemma":[0.007843667,0.0026957204,0.7851536,0.00060676015,0.0002514217,0.00000251434,0.00017450728,0.0006876585,0.0010316294,0.00056598056,0.20066339,0.000323157],"about_ca_topic_score_codex":0.0046909563,"about_ca_topic_score_gemma":0.00030939514,"teacher_disagreement_score":0.15991092,"about_ca_system_score_codex":0.00077719445,"about_ca_system_score_gemma":0.0015638985,"threshold_uncertainty_score":0.9118803},"labels":[],"label_agreement":null},{"id":"W2155457708","doi":"10.1158/1078-0432.ccr-04-1130","title":"Dietary Flaxseed Enhances the Inhibitory Effect of Tamoxifen on the Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) in Nude Mice","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Ovariectomized rat; Tamoxifen; Estrogen; MCF-7; Breast cancer; Endocrinology; Internal medicine; Medicine; Implant; Estrogen receptor; Antiestrogen; Cancer; Human breast; Surgery","score_opus":0.11442193029961356,"score_gpt":0.5019148404907169,"score_spread":0.3874929101911033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155457708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864145,0.0023470842,5.149654e-7,0.008546794,0.0002523957,0.0017135864,0.000056099478,0.000013555604,0.00065545295],"genre_scores_gemma":[0.9965133,0.0016254786,0.0000047978588,0.00020483631,0.0009446613,0.000490716,0.0000051934844,0.000039539253,0.00017146558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99408513,0.0018668958,0.00085498893,0.0005564329,0.0018692085,0.00076732336],"domain_scores_gemma":[0.9946264,0.0037452441,0.00018325585,0.0007210274,0.0004737732,0.00025029358],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008410015,0.00023639783,0.00076866196,0.0002143924,0.00022737442,0.000021261225,0.0007791523,0.00021645935,0.00023273964],"category_scores_gemma":[0.00093412364,0.00011297851,0.00034679586,0.0008260781,0.0019844086,0.00006391051,0.00031450827,0.0023218496,0.000023150056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013119125,0.002720222,0.38998488,0.0017034723,0.00080266304,0.00021258023,0.0007959484,0.00017062046,0.57236147,0.0010083109,0.0024073888,0.014713347],"study_design_scores_gemma":[0.005345489,0.0053588017,0.39681405,0.0019898983,0.000088250934,0.000013820581,0.00017492616,0.00003137527,0.5892496,0.0006424834,0.0001163169,0.00017496895],"about_ca_topic_score_codex":0.009459813,"about_ca_topic_score_gemma":0.001415935,"teacher_disagreement_score":0.016888157,"about_ca_system_score_codex":0.00033782434,"about_ca_system_score_gemma":0.0010366491,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W2155724119","doi":"10.1158/1078-0432.ccr-05-1652","title":"Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Imatinib mesylate; Prostate cancer; Tissue microarray; Cancer research; Medicine; Cancer; Immunohistochemistry; Pathology; Laser capture microdissection; Gene expression; Oncology; Biology; Internal medicine; Imatinib; Gene","score_opus":0.27743457004309985,"score_gpt":0.5688233716791935,"score_spread":0.29138880163609365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155724119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756176,0.0041079298,0.0014630826,0.007979418,0.00025576414,0.009861013,0.00025952933,0.000043373257,0.0004122845],"genre_scores_gemma":[0.9847086,0.0034969635,0.0018085793,0.00026732564,0.00064557226,0.008159419,0.000040044248,0.000063382504,0.0008101207],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953185,0.0008280014,0.0012522116,0.0007483767,0.0009742841,0.00087866996],"domain_scores_gemma":[0.9924579,0.004711038,0.00024975277,0.000893357,0.0013611992,0.00032674422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004120099,0.00024301626,0.0009990076,0.00018810958,0.00015517822,0.000026671265,0.0005110753,0.0002487052,0.000108970446],"category_scores_gemma":[0.0015620195,0.00014260244,0.00035636761,0.0008800137,0.0010555034,0.000034753724,0.00020422562,0.00061008096,0.000023937182],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012847879,0.0023686816,0.20272064,0.0025803798,0.00047327092,0.00002688823,0.00047402046,0.0004185744,0.32048672,0.0011971667,0.016088596,0.44031718],"study_design_scores_gemma":[0.013381171,0.011744256,0.17871642,0.0013530577,0.00022099589,0.00000568357,0.0002024445,0.0022627565,0.61397886,0.0018539192,0.17586946,0.00041097272],"about_ca_topic_score_codex":0.008566867,"about_ca_topic_score_gemma":0.0006759658,"teacher_disagreement_score":0.4399062,"about_ca_system_score_codex":0.0005748531,"about_ca_system_score_gemma":0.0012850906,"threshold_uncertainty_score":0.9980352},"labels":[],"label_agreement":null},{"id":"W2155998628","doi":"10.1158/1078-0432.ccr-07-4117","title":"A Multiparametric Serum Kallikrein Panel for Diagnosis of Non–Small Cell Lung Carcinoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Medical University of South Carolina","keywords":"Kallikrein; Lung cancer; Proteases; Cancer; Receiver operating characteristic; Medicine; Pathology; Internal medicine; Oncology; Biology","score_opus":0.37173242829733394,"score_gpt":0.4890334696600283,"score_spread":0.11730104136269437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155998628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884102,0.00747298,0.00013187018,0.0010868453,0.00027036463,0.001722357,0.00008252914,0.000034341814,0.00078851776],"genre_scores_gemma":[0.9887081,0.0038033004,0.0010448061,0.00026702805,0.00083601376,0.00065487606,0.000022297863,0.000055512264,0.0046080663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675906,0.00019532272,0.00096095813,0.0006224082,0.00072093494,0.00074133923],"domain_scores_gemma":[0.99367666,0.0042670523,0.00017171491,0.0005055312,0.0009097447,0.00046930302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001906072,0.00019278264,0.0007433499,0.00037119127,0.00022069512,0.000014560244,0.00030705868,0.00028686336,0.00036287797],"category_scores_gemma":[0.0020771779,0.00016873355,0.0004727347,0.0010493065,0.00051212066,0.00006284857,0.0001460268,0.0005841647,0.00003307703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007118657,0.0006795581,0.96961856,0.00053741236,0.00006722585,0.000048640482,0.00033866867,0.00001930395,0.00017595984,0.00002463471,0.011528008,0.016250173],"study_design_scores_gemma":[0.0054231,0.0012587627,0.9681099,0.00018731064,0.00010684778,0.000009536079,0.00010731063,0.006893197,0.011045993,0.00006250727,0.0066030268,0.00019247396],"about_ca_topic_score_codex":0.0018655808,"about_ca_topic_score_gemma":0.00012880765,"teacher_disagreement_score":0.0160577,"about_ca_system_score_codex":0.00014392051,"about_ca_system_score_gemma":0.0010161551,"threshold_uncertainty_score":0.6880754},"labels":[],"label_agreement":null},{"id":"W2156013764","doi":"10.1158/1078-0432.ccr-04-2282","title":"High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"MALT lymphoma; Gastroenterology; Medicine; Lymphoma; Trisomy; Internal medicine; Mucosa-associated lymphoid tissue; Chemotherapy; Pathology; Biology","score_opus":0.1009771849710758,"score_gpt":0.4403394357388169,"score_spread":0.33936225076774107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156013764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906411,0.00065946457,7.4116144e-7,0.0066881385,0.00033086006,0.00095152954,0.000025511325,0.00003382385,0.0006688065],"genre_scores_gemma":[0.994323,0.0011244155,0.00018818828,0.0011106168,0.00056102435,0.00035214788,0.00004349428,0.00004324109,0.0022538821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965414,0.00041253646,0.00068138476,0.000660816,0.0009557152,0.0007481884],"domain_scores_gemma":[0.9976154,0.0007826368,0.000084097366,0.000585725,0.00043997847,0.0004921864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017436987,0.00019848139,0.0005834422,0.00019664629,0.0001205593,0.000037768026,0.00019366076,0.00019696896,0.00058310805],"category_scores_gemma":[0.00063525833,0.00013383692,0.0001313894,0.00057335733,0.00027250047,0.00013120561,0.00012264973,0.0003967629,0.00043569616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004725475,0.0022959146,0.84741277,0.000031232943,0.0001176267,0.00014393008,0.00007191607,0.000006955752,0.0000025047134,0.000056330966,0.008787435,0.1363479],"study_design_scores_gemma":[0.03776636,0.0017058667,0.9475651,0.00037129736,0.000045267854,0.0000013287121,0.000023895087,0.00003163654,0.00028047484,0.00003898269,0.012026573,0.00014325633],"about_ca_topic_score_codex":0.0013921794,"about_ca_topic_score_gemma":0.0013811594,"teacher_disagreement_score":0.13620465,"about_ca_system_score_codex":0.0008714973,"about_ca_system_score_gemma":0.00081780297,"threshold_uncertainty_score":0.6384624},"labels":[],"label_agreement":null},{"id":"W2156060932","doi":"10.1158/1078-0432.ccr-08-2502","title":"Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Alvin J. Siteman Cancer Center","keywords":"Melanoma; Lung; Pathology; Medicine; Human lung; Biology; Cancer research; Internal medicine","score_opus":0.09612453328570297,"score_gpt":0.45407500888261904,"score_spread":0.35795047559691606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156060932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936114,0.0010575515,0.000057507463,0.00045756038,0.0008402847,0.00036678743,0.000029830137,0.00002460457,0.0035545023],"genre_scores_gemma":[0.99490696,0.00027557666,0.000010676366,0.00010057204,0.00003169814,0.000034478457,0.000091618116,0.000009520666,0.0045389105],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99544764,0.0026616864,0.0008971519,0.0004175872,0.000121796525,0.00045412424],"domain_scores_gemma":[0.9980828,0.0009805212,0.00013472544,0.00043904985,0.00033055994,0.000032347845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0066326135,0.00013051172,0.00041509647,0.00022191432,0.0001654643,0.000016626042,0.00032667935,0.0002471973,0.0036788124],"category_scores_gemma":[0.0014431614,0.00011029858,0.00017746356,0.00035773622,0.00047867704,0.0001091659,0.00010016091,0.001220814,0.000081766804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002764302,0.0032828827,0.05410864,0.00008732441,0.00022732327,0.000008033741,0.00037004668,0.000009616782,0.8994279,0.0085186865,0.019039072,0.012156159],"study_design_scores_gemma":[0.00580164,0.0029228574,0.7581928,0.00018123747,0.00006469493,0.00000859223,0.0006042397,0.00011038457,0.2191843,0.0009874058,0.011523806,0.00041808758],"about_ca_topic_score_codex":0.0011282646,"about_ca_topic_score_gemma":0.0001083369,"teacher_disagreement_score":0.7040841,"about_ca_system_score_codex":0.0001785068,"about_ca_system_score_gemma":0.00015992727,"threshold_uncertainty_score":0.99723196},"labels":[],"label_agreement":null},{"id":"W2156223179","doi":"10.1158/1078-0432.ccr-03-0218","title":"High Expression of Methionine Aminopeptidase 2 in Human Colorectal Adenocarcinomas","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Immunohistochemistry; Biology; Western blot; Adenocarcinoma; Cancer research; Internal medicine; Immunology; Medicine; Cancer; Biochemistry; Gene; Genetics","score_opus":0.19351963609193693,"score_gpt":0.5280612397376486,"score_spread":0.3345416036457117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156223179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586135,0.00023021796,0.000024434104,0.0023830782,0.000029188062,0.0002991276,0.000016720895,0.00002225524,0.0011336032],"genre_scores_gemma":[0.9980763,0.00012208302,0.00042946066,0.00019138954,0.0002970658,0.00007437977,0.000037369115,0.00001821576,0.0007536983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723727,0.00038226464,0.00080512406,0.00041544012,0.0007858486,0.0003740806],"domain_scores_gemma":[0.9985365,0.0003376171,0.000100023964,0.00034206413,0.000387812,0.00029594768],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022695577,0.00011177717,0.00054158794,0.00041173675,0.00009039802,0.000011853483,0.0001577877,0.00019855828,0.0014962865],"category_scores_gemma":[0.0008093371,0.00008996858,0.00020994824,0.00086927175,0.00057639927,0.0000660258,0.00014098988,0.0010739578,0.000046998633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018321794,0.002578902,0.1610873,0.00029195173,0.0000769822,0.00052528514,0.00037823393,0.00015264346,0.82525116,0.00199804,0.0027029056,0.0031243877],"study_design_scores_gemma":[0.00895164,0.0015982541,0.378592,0.002338606,0.00003617455,0.0000071107856,0.0003033361,0.000023708477,0.6061394,0.0015661555,0.00028209644,0.00016149078],"about_ca_topic_score_codex":0.0017407248,"about_ca_topic_score_gemma":0.00045831682,"teacher_disagreement_score":0.21911177,"about_ca_system_score_codex":0.00022482715,"about_ca_system_score_gemma":0.00040299777,"threshold_uncertainty_score":0.9994165},"labels":[],"label_agreement":null},{"id":"W2156375860","doi":"10.1158/1078-0432.ccr-13-1877","title":"Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"CD8; Tumor-infiltrating lymphocytes; Serous fluid; Cancer research; Ovarian cancer; Immunotherapy; Intraepithelial lymphocyte; Biology; Antigen; Pathology; Cancer; Immunology; Medicine; Immune system; Internal medicine","score_opus":0.11773343481620593,"score_gpt":0.43122414660490305,"score_spread":0.31349071178869714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156375860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98502195,0.0033937914,0.0000045827455,0.008642268,0.00041564275,0.001638947,0.000037974583,0.00007235577,0.00077247206],"genre_scores_gemma":[0.993714,0.00096856535,0.000085240514,0.001492878,0.00079924776,0.0010620498,0.000020817259,0.00008273074,0.0017744944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935333,0.0021142731,0.0010275717,0.00077359803,0.0014958385,0.0010554185],"domain_scores_gemma":[0.99483585,0.0030552542,0.00035085413,0.000778399,0.00064091984,0.00033870165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059308074,0.00031646475,0.00079831027,0.00019677695,0.00041922994,0.00022931109,0.00049458415,0.00026082812,0.0025540118],"category_scores_gemma":[0.0017469829,0.0002010468,0.00014461628,0.0011594024,0.00094357843,0.00021797803,0.00017159902,0.001512545,0.000028342894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071066767,0.0005089479,0.93080187,0.00018600654,0.00062246306,0.000387453,0.0006939349,0.00004782065,0.013564349,0.000012182784,0.013628516,0.03243978],"study_design_scores_gemma":[0.0086175855,0.0004176127,0.98080176,0.0021179474,0.00006029064,0.000012811698,0.0014537534,0.00027398576,0.004511032,0.00007211429,0.0013708619,0.0002902537],"about_ca_topic_score_codex":0.16006236,"about_ca_topic_score_gemma":0.028014448,"teacher_disagreement_score":0.1320479,"about_ca_system_score_codex":0.0014497826,"about_ca_system_score_gemma":0.0021155851,"threshold_uncertainty_score":0.9983578},"labels":[],"label_agreement":null},{"id":"W2156520838","doi":"10.1158/1078-0432.ccr-09-1993","title":"An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; Clinical study design; Medicine; Drug development; Research design; Clinical endpoint; Medical physics; Drug; Pharmacology; Pathology","score_opus":0.9926679819552562,"score_gpt":0.8542575059713408,"score_spread":0.13841047598391543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156520838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051538594,0.9945278,0.0016695893,0.00008698593,0.00066555664,0.0022135729,0.00027860532,0.000010585262,0.000031887525],"genre_scores_gemma":[0.000014221297,0.8207671,0.17854135,0.000023491946,0.0004021041,0.00008085727,9.475081e-7,0.00006240941,0.00010750582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98134875,0.012058954,0.004265347,0.0006666847,0.0012189338,0.00044135007],"domain_scores_gemma":[0.7522355,0.24236524,0.0022237385,0.001728344,0.0011602904,0.0002869305],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.033205815,0.00037738428,0.0054857205,0.00013386564,0.00007898638,0.000018081775,0.0014916534,0.0008767074,0.00019915485],"category_scores_gemma":[0.12033307,0.00020980573,0.0007621432,0.0006559658,0.0041367197,0.0000430292,0.0006582412,0.0028493938,0.0000014905567],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030965122,0.00069021643,0.000020308931,0.024775516,0.00097460963,0.0000030988463,0.00017092805,6.3168994e-7,0.000019944633,0.006049582,0.0016799568,0.96530557],"study_design_scores_gemma":[0.0041294037,0.006019283,0.000017327106,0.056838628,0.004925226,0.0000068703794,0.00020025675,0.00006467158,0.0006113243,0.44198108,0.48461616,0.00058975606],"about_ca_topic_score_codex":0.000030021476,"about_ca_topic_score_gemma":0.000004540398,"teacher_disagreement_score":0.9647158,"about_ca_system_score_codex":0.000045029876,"about_ca_system_score_gemma":0.0021632672,"threshold_uncertainty_score":0.9994511},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2156564774","doi":"10.1158/1078-0432.ccr-07-4669","title":"Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Mucositis; Cheek pouch; Medicine; Placebo; Superoxide dismutase; Chemotherapy; Gastroenterology; Radiation therapy; Pharmacology; Toxicity; Hamster; Internal medicine; Pathology; Oxidative stress","score_opus":0.4876983976109072,"score_gpt":0.6040630978796575,"score_spread":0.11636470026875029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156564774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914579,0.00128822,0.0000017672106,0.0055205,0.0002389772,0.0012537551,0.000021543765,0.000017291139,0.00020005679],"genre_scores_gemma":[0.99716514,0.0013315189,0.0004169712,0.00041525898,0.00024068006,0.0002529817,0.000021313845,0.00003419341,0.000121956495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956465,0.0008234612,0.0012960698,0.0005589173,0.0008766554,0.00079844554],"domain_scores_gemma":[0.9963191,0.0024485104,0.000114791794,0.00049118034,0.00020343046,0.0004230006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030582256,0.00015628991,0.0007168683,0.00041806907,0.00008283954,0.0000067740484,0.00018489316,0.00019460241,0.00023050098],"category_scores_gemma":[0.0021324593,0.00014094786,0.00012928645,0.0011954808,0.00040231526,0.0000854279,0.00009754246,0.00114243,0.000050035036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017217131,0.000936572,0.9142307,0.00017402024,0.000029356333,0.00045153644,0.00060313824,0.00003089382,0.00046326662,0.000009673373,0.000606374,0.080742724],"study_design_scores_gemma":[0.011175257,0.001482246,0.9829162,0.00066002423,0.000016734428,0.000012897275,0.00015240817,0.00044880892,0.0025841468,0.000030620624,0.00040186566,0.00011881205],"about_ca_topic_score_codex":0.01266289,"about_ca_topic_score_gemma":0.0023892005,"teacher_disagreement_score":0.08062392,"about_ca_system_score_codex":0.0013320332,"about_ca_system_score_gemma":0.0017915792,"threshold_uncertainty_score":0.99391186},"labels":[],"label_agreement":null},{"id":"W2156636883","doi":"10.1158/1078-0432.ccr-13-1856","title":"Novel <i>MSH6</i> Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of <i>MGMT</i> Promoter Methylation","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Stem Cell Network; American Association for Cancer Research","keywords":"Temozolomide; MSH6; Glioma; Cancer research; Oligodendroglioma; Biology; Methyltransferase; Medicine; Methylation; DNA repair; DNA mismatch repair; Genetics; Astrocytoma; Gene","score_opus":0.09377303030076796,"score_gpt":0.45042246244682055,"score_spread":0.3566494321460526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156636883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299496,0.0006938084,0.00020268219,0.0038401564,0.00011057978,0.0014541827,0.00013119103,0.00002301686,0.00054939644],"genre_scores_gemma":[0.9977152,0.00028263783,0.00077621144,0.00018016364,0.00014983663,0.0005571535,0.000022095546,0.000031177715,0.00028551926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688464,0.00037192693,0.0008558274,0.00065597525,0.00069952017,0.0005321056],"domain_scores_gemma":[0.99603105,0.0023765306,0.00014246565,0.0004417772,0.0005687511,0.0004394439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017900548,0.00020581989,0.0007339095,0.00051043474,0.00010171643,0.000040980194,0.00012785639,0.0001915062,0.000041411797],"category_scores_gemma":[0.002038105,0.00016542262,0.00012644565,0.000976965,0.000286611,0.00010212138,0.000097913726,0.00034739188,0.000029642253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016708942,0.008979059,0.7949429,0.0005932593,0.0009638724,0.0004981871,0.0012067454,0.00031439832,0.07764617,0.0030412294,0.0026894326,0.09241581],"study_design_scores_gemma":[0.03478139,0.01389132,0.8013629,0.0014015627,0.00038600824,0.000054546075,0.00022987973,0.001429736,0.13349049,0.0014114195,0.0110682305,0.0004925427],"about_ca_topic_score_codex":0.00073716784,"about_ca_topic_score_gemma":0.012147072,"teacher_disagreement_score":0.09192327,"about_ca_system_score_codex":0.00034857946,"about_ca_system_score_gemma":0.00028723388,"threshold_uncertainty_score":0.6778351},"labels":[],"label_agreement":null},{"id":"W2156896944","doi":"10.1158/1078-0432.ccr-05-2185","title":"Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Tamoxifen; Medicine; Aromatase; Breast cancer; Quality of life (healthcare); Sexual function; Vasomotor; Randomized controlled trial; Oncology; Placebo; Internal medicine; Gynecology; Adjuvant therapy; Clinical trial; Adjuvant; Cancer; Alternative medicine; Pathology","score_opus":0.6761268946566242,"score_gpt":0.6797870358801116,"score_spread":0.0036601412234873454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156896944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020875058,0.98392993,3.1333107e-7,0.0020284664,0.00058004976,0.0033542877,0.00020109223,0.000037981154,0.007780377],"genre_scores_gemma":[0.0013628685,0.9913234,0.000024819443,0.0005534929,0.0012425672,0.0004332189,0.00020318647,0.000120508215,0.0047359318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99163544,0.002121253,0.0023506177,0.00091600016,0.0019828714,0.0009938143],"domain_scores_gemma":[0.9934535,0.003452933,0.0006234975,0.0012013442,0.00045756943,0.00081112434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033767277,0.00047927813,0.0034018678,0.0005069368,0.00016484398,0.00003168286,0.000376249,0.00035995126,0.00062834594],"category_scores_gemma":[0.0020453327,0.00029804514,0.00024402204,0.00060294813,0.0002777077,0.000033898243,0.00013671828,0.0021494818,0.0003732351],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015616847,0.0020613952,0.0029280912,0.01405835,0.00040365773,0.000049036804,0.000009980802,1.6471752e-7,5.372033e-8,0.00015379327,0.014328385,0.9644454],"study_design_scores_gemma":[0.0059663695,0.012152846,0.0038817888,0.016723238,0.00016750755,6.4835376e-7,0.000002614144,4.0266895e-7,0.0000016319987,0.00025236435,0.96064115,0.00020942504],"about_ca_topic_score_codex":0.0041689225,"about_ca_topic_score_gemma":0.00007085061,"teacher_disagreement_score":0.96423596,"about_ca_system_score_codex":0.00056093896,"about_ca_system_score_gemma":0.0015716077,"threshold_uncertainty_score":0.9999472},"labels":[],"label_agreement":null},{"id":"W2156902079","doi":"10.1158/1078-0432.ccr-11-0078","title":"Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Hospital for Sick Children; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Topotecan; Medicine; Pharmacology; Angiogenesis; In vivo; Neuroblastoma; Cancer research; Pharmacokinetics; Rhabdomyosarcoma; Cancer; Chemotherapy; Oncology; Sarcoma; Internal medicine; Cell culture; Biology; Sunitinib; Pathology","score_opus":0.3053773045261252,"score_gpt":0.4944461548165539,"score_spread":0.1890688502904287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156902079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973104,0.0003987014,0.000010823037,0.00018356736,0.00003538855,0.0010032539,0.0000962134,0.000023416133,0.00093822676],"genre_scores_gemma":[0.99736714,0.0010921146,0.0004119243,0.000089406996,0.00015987571,0.00018196549,0.000010273395,0.000057273355,0.0006300326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633336,0.00060353114,0.000582425,0.0007441992,0.0008629503,0.0008735576],"domain_scores_gemma":[0.9975092,0.0003059564,0.00028203017,0.0007268575,0.0005063941,0.0006695588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011141488,0.0002036974,0.0007057254,0.0006039347,0.0000745367,0.000015703454,0.0003857279,0.00012181684,0.0005660239],"category_scores_gemma":[0.0003221399,0.00015434416,0.00016962798,0.0008330503,0.00056045776,0.00026602432,0.00020633136,0.0009868474,0.00003795935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08119205,0.012358637,0.8478297,0.00054742786,0.0016526005,0.005578385,0.003567901,0.00006891185,0.005305234,0.00017713527,0.0026184262,0.039103586],"study_design_scores_gemma":[0.030824382,0.040392682,0.6325545,0.0005390817,0.0004593665,0.00010053166,0.0016401823,0.0029253408,0.28733036,0.002290642,0.00009982983,0.00084313453],"about_ca_topic_score_codex":0.0027806268,"about_ca_topic_score_gemma":0.00090854487,"teacher_disagreement_score":0.28202513,"about_ca_system_score_codex":0.00030404917,"about_ca_system_score_gemma":0.0015975819,"threshold_uncertainty_score":0.6293973},"labels":[],"label_agreement":null},{"id":"W2156924387","doi":"10.1158/1078-0432.ccr-1032-3","title":"Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Are Overexpressed in Squamous Cell Carcinoma of the Penis","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Immunohistochemistry; Carcinogenesis; Prostaglandin E2; Prostaglandin; Cyclooxygenase; Cancer research; Prostaglandin E2 receptor; Biology; Pathology; Prostaglandin E; Receptor; Medicine; Cancer; Internal medicine; Enzyme; Endocrinology; Biochemistry","score_opus":0.07663006170547743,"score_gpt":0.4129403872223207,"score_spread":0.33631032551684326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156924387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995683,0.0015376054,6.9390916e-7,0.0010937602,0.0001978752,0.0010560871,0.000043697684,0.0000096993135,0.0003775402],"genre_scores_gemma":[0.99898314,0.0001574454,0.00002411449,0.00015526527,0.0003099178,0.00010404484,0.0000028531995,0.000026185577,0.00023702063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754584,0.0004606709,0.0005178303,0.00039148764,0.0006054242,0.00047874128],"domain_scores_gemma":[0.998068,0.0009164367,0.00011880877,0.0004695976,0.00017952759,0.00024762691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020543963,0.00013673978,0.00043802575,0.00011252826,0.0001211353,0.00001629036,0.00019768685,0.00020762152,0.000082705774],"category_scores_gemma":[0.0013097946,0.00009002547,0.00012640498,0.00034658512,0.00062183663,0.000042388758,0.0001914074,0.0011630981,0.000011327594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011613128,0.00041659863,0.95917755,0.00071372406,0.000007144059,0.00015107024,0.00035603446,0.0000073182623,0.036730662,0.000029017145,0.00088337145,0.0003661751],"study_design_scores_gemma":[0.006669447,0.00054638955,0.8650925,0.00038304582,0.000017960976,0.000008714232,0.00018061293,0.000022129738,0.12632577,0.00008651058,0.0005683887,0.00009854368],"about_ca_topic_score_codex":0.0011634037,"about_ca_topic_score_gemma":0.00054324814,"teacher_disagreement_score":0.09408508,"about_ca_system_score_codex":0.00015822693,"about_ca_system_score_gemma":0.00074714,"threshold_uncertainty_score":0.5053147},"labels":[],"label_agreement":null},{"id":"W2157216556","doi":"10.1158/1078-0432.ccr-04-1353","title":"Stratification of Intermediate-Risk Endometrial Cancer Patients into Groups at High Risk or Low Risk for Recurrence Based on Tumor Gene Expression Profiles","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Cancer Institute; W. M. Keck Foundation","keywords":"Risk stratification; Endometrial cancer; Cancer; Oncology; Medicine; Internal medicine; Gene; Gene expression; Risk factor; Risk assessment; Biology; Genetics","score_opus":0.13065683072731443,"score_gpt":0.4747480442083266,"score_spread":0.3440912134810122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157216556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916994,0.0007696882,0.00018411617,0.00032453035,0.0011317595,0.0033967483,0.0024018309,0.00004106902,0.000050867708],"genre_scores_gemma":[0.98633146,0.0060281386,0.001775409,0.00012595773,0.0024397913,0.0026885609,0.00032984387,0.00005718334,0.00022367729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939466,0.0011887563,0.0014751628,0.0010674637,0.001641457,0.0006805609],"domain_scores_gemma":[0.989696,0.0069123767,0.0008951666,0.0007315322,0.0012121956,0.0005526747],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032022449,0.00032314015,0.00092281215,0.0005001979,0.00036200378,0.00003372806,0.00042455806,0.00027424202,0.0016224389],"category_scores_gemma":[0.015256362,0.00021274203,0.00037912786,0.001256498,0.00049460214,0.00013287259,0.00017272677,0.0011280453,0.000054783617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06073603,0.0030182148,0.61459154,0.00035610676,0.0001647622,0.0000043100176,0.00011949801,0.00014610389,0.0009135584,0.000006697285,0.002516187,0.31742698],"study_design_scores_gemma":[0.06416356,0.022612836,0.6784164,0.0015901515,0.00057706423,3.7763647e-7,0.000079005265,0.0029123302,0.2248979,0.00049914373,0.0037119242,0.0005393557],"about_ca_topic_score_codex":0.0032145348,"about_ca_topic_score_gemma":0.0014297869,"teacher_disagreement_score":0.31688762,"about_ca_system_score_codex":0.0011672062,"about_ca_system_score_gemma":0.0008993558,"threshold_uncertainty_score":0.9992902},"labels":[],"label_agreement":null},{"id":"W2157282974","doi":"10.1158/1078-0432.ccr-07-0901","title":"Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources","keywords":"Medicine; Nomogram; Endoglin; Prostatectomy; Prostate cancer; Lymph node; Confidence interval; Metastasis; Odds ratio; Stage (stratigraphy); Lymphadenectomy; Urology; Biochemical recurrence; Radiology; Cancer; Oncology; Internal medicine","score_opus":0.2588083980748202,"score_gpt":0.4676495572714807,"score_spread":0.20884115919666052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157282974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920179,0.0005581414,0.000034923283,0.0006376386,0.00013918645,0.0034915798,0.0030639193,0.000014648234,0.000042022766],"genre_scores_gemma":[0.985468,0.009431719,0.0018422442,0.00013523504,0.00009194067,0.0025939667,0.00015672376,0.000044395227,0.00023578764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960383,0.00040996316,0.0015166912,0.0006363864,0.0009025282,0.0004961344],"domain_scores_gemma":[0.99490255,0.00203502,0.00033397716,0.0004459665,0.002020598,0.00026188244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013719441,0.00020341031,0.0010148332,0.00020246296,0.00008143359,0.000009838879,0.00013479113,0.00016203744,0.00011753315],"category_scores_gemma":[0.0012562235,0.00014038308,0.00021077252,0.0005631497,0.0009047638,0.00016618523,0.00008581451,0.00041247727,0.0000021029039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03271316,0.0028697245,0.9470922,0.00033480264,0.00051217625,0.000014089146,0.00036051904,0.00040300892,0.000029534354,0.000013281718,0.0009776549,0.014679855],"study_design_scores_gemma":[0.025190068,0.007563831,0.9596863,0.0010104453,0.00018564296,7.1040483e-7,0.000050299128,0.0006082819,0.0043329834,0.000019751964,0.0012344235,0.00011726186],"about_ca_topic_score_codex":0.0015034961,"about_ca_topic_score_gemma":0.00020683174,"teacher_disagreement_score":0.014562593,"about_ca_system_score_codex":0.00040466737,"about_ca_system_score_gemma":0.0018329705,"threshold_uncertainty_score":0.5724656},"labels":[],"label_agreement":null},{"id":"W2157709503","doi":"10.1158/1078-0432.ccr-06-1593","title":"Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"FHIT; Sputum; Lung cancer; Biology; Cancer; Stage (stratigraphy); Pathology; Loss of heterozygosity; Lung; Cancer research; Medicine; Internal medicine; Gene; Carcinogenesis; Tumor suppressor gene; Genetics; Tuberculosis","score_opus":0.09187760573161653,"score_gpt":0.5262772465952479,"score_spread":0.43439964086363136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157709503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902692,0.0028581694,0.0020669168,0.0005192067,0.0004113417,0.002422401,0.000081454644,0.000016177188,0.0013551307],"genre_scores_gemma":[0.99187875,0.0021825957,0.00064082217,0.00013438096,0.00039117844,0.0011318142,0.000010515936,0.00003873054,0.0035912085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779695,0.000113780174,0.00068033044,0.00042407843,0.00041267334,0.00057219923],"domain_scores_gemma":[0.9960887,0.0026560558,0.000110655135,0.00030747306,0.0005496374,0.0002875059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015675995,0.00012716443,0.0003383789,0.00029653177,0.00011461008,0.000016379294,0.000118343756,0.00017106738,0.00026976605],"category_scores_gemma":[0.00096849335,0.000113510556,0.00016402615,0.00059640995,0.00020857019,0.000044867178,0.000049292838,0.00050874165,0.000012122585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019293838,0.00079108763,0.91845685,0.00068872934,0.000203281,0.000081272774,0.00045414944,0.00014778505,0.0026651025,0.000025112597,0.0008712746,0.073685974],"study_design_scores_gemma":[0.0048869587,0.001571935,0.98282164,0.00034822704,0.0002251428,0.0000013804612,0.0002966412,0.0005523005,0.0054243184,0.00007953927,0.0036655192,0.00012640648],"about_ca_topic_score_codex":0.01432575,"about_ca_topic_score_gemma":0.012107586,"teacher_disagreement_score":0.07355957,"about_ca_system_score_codex":0.00062843616,"about_ca_system_score_gemma":0.0012166562,"threshold_uncertainty_score":0.9922379},"labels":[],"label_agreement":null},{"id":"W2157717805","doi":"10.1158/1078-0432.ccr-08-0999","title":"A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Refractory (planetary science); Myeloid leukemia; Leukemia; Adverse effect; Internal medicine; Acute leukemia; Chemotherapy; Gastroenterology; Pharmacology; Oncology","score_opus":0.09721187264383828,"score_gpt":0.42839780003217226,"score_spread":0.33118592738833397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157717805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983686,0.0004570331,0.000009611387,0.000050261988,0.000119516255,0.00092645554,0.000009368329,0.0000039054,0.00005524451],"genre_scores_gemma":[0.9990698,0.00040943627,0.000038514227,0.00003568349,0.00006344342,0.000110652014,0.000009616268,0.000013784304,0.00024903176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982093,0.00033022522,0.0004037922,0.00036505444,0.00043186455,0.00025974374],"domain_scores_gemma":[0.99908096,0.0000486527,0.00010626652,0.00041406037,0.00029194198,0.000058146023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005779368,0.00010230829,0.00022651406,0.00004424888,0.000119118165,0.0000059031995,0.00023648248,0.00012455751,0.000008722991],"category_scores_gemma":[0.00014930911,0.000059786333,0.000064438005,0.00028548346,0.00027296017,0.00000449102,0.00019828219,0.00023834346,0.0000017513602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044713076,0.0073548597,0.88659424,0.00005870041,0.00008867704,0.00001924342,0.0003834021,0.00019071011,0.08245951,0.00004088757,0.0006967762,0.017641667],"study_design_scores_gemma":[0.016194358,0.010892909,0.94359136,0.00010244032,0.000013668313,0.0000018192056,0.00047086907,0.00004273546,0.026328111,0.000081911705,0.0020721138,0.00020771218],"about_ca_topic_score_codex":0.000106090265,"about_ca_topic_score_gemma":0.00024784054,"teacher_disagreement_score":0.056997094,"about_ca_system_score_codex":0.000026667765,"about_ca_system_score_gemma":0.00020270566,"threshold_uncertainty_score":0.2438016},"labels":[],"label_agreement":null},{"id":"W2157774521","doi":"10.1158/1078-0432.ccr-05-0319","title":"ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Vascular endothelial growth factor; Epidermal growth factor receptor; Angiogenesis; Cancer research; Epidermal growth factor; Receptor tyrosine kinase; Glioma; Growth factor receptor; Biology; Growth factor receptor inhibitor; Tyrosine kinase; Medicine; Internal medicine; Receptor; Endocrinology","score_opus":0.06965143392391154,"score_gpt":0.367977038097077,"score_spread":0.29832560417316545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157774521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901775,0.0061988123,0.00020697342,0.00038897136,0.00042853938,0.00078584324,0.0017064604,0.000027100132,0.00007977378],"genre_scores_gemma":[0.99298716,0.0028879517,0.0010201007,0.00014564762,0.0024184426,0.00017442845,0.0000802935,0.00010179218,0.00018421424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99511766,0.00055897626,0.0014681013,0.0010992214,0.0009104763,0.00084558927],"domain_scores_gemma":[0.99639904,0.0005304039,0.000454535,0.0006041617,0.0015047719,0.0005070632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015189381,0.0004209381,0.0009430411,0.0001960287,0.00017723831,0.00003883208,0.00056591,0.00043536787,0.00016721286],"category_scores_gemma":[0.002436242,0.0003650138,0.0005389761,0.00043044222,0.0009479626,0.000032173684,0.00054638745,0.00054188643,0.000017666162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014753303,0.0006045172,0.10462603,0.0008785901,0.00025598812,0.000004825552,0.00011064077,0.000006398605,0.8849431,0.00022787103,0.0031748717,0.0036918256],"study_design_scores_gemma":[0.003769613,0.0012301019,0.027477827,0.00045229128,0.000040166193,0.000007889579,0.00013869216,0.00009657614,0.95836097,0.000007420011,0.007949472,0.0004689511],"about_ca_topic_score_codex":0.0009903269,"about_ca_topic_score_gemma":0.00016642807,"teacher_disagreement_score":0.0771482,"about_ca_system_score_codex":0.00015476366,"about_ca_system_score_gemma":0.00065617694,"threshold_uncertainty_score":0.9998802},"labels":[],"label_agreement":null},{"id":"W2158378642","doi":"10.1158/1078-0432.ccr-08-1720","title":"Relationship Between Angiotensin-Converting Enzyme Gene Polymorphism and Body Composition, Functional Performance, and Blood Biomarkers in Advanced Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Lean body mass; Body mass index; Internal medicine; Angiotensin-converting enzyme; Medicine; Endocrinology; Hemoglobin; Cancer; Gastroenterology; Allele; Biology; Blood pressure; Gene; Genetics; Body weight","score_opus":0.14525124809194692,"score_gpt":0.43407056546787076,"score_spread":0.2888193173759238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158378642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879118,0.0058593955,0.000005346053,0.005062081,0.00018829052,0.0007288606,0.000025502115,0.000033555494,0.00018515815],"genre_scores_gemma":[0.997611,0.000971508,0.00022504047,0.00033811093,0.0005498629,0.000054115146,0.000044196957,0.000024480842,0.00018169264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969626,0.00031512658,0.00084930396,0.0006274685,0.00070371514,0.00054180453],"domain_scores_gemma":[0.99754155,0.0011306824,0.00014599034,0.0002524429,0.00062951184,0.0002998266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015893786,0.00019934915,0.0005890228,0.0003585262,0.00034263777,0.000031133608,0.00007615776,0.0002152206,0.000023577402],"category_scores_gemma":[0.000647096,0.00017538149,0.00008336746,0.0006322679,0.00046417117,0.0001667406,0.00011211919,0.00071718683,0.0000075150233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076838623,0.0001361201,0.9876277,0.00003404407,0.00014975978,0.000014556768,0.000110218934,0.0000032862265,0.0012192059,0.000011854921,0.0013916703,0.008533219],"study_design_scores_gemma":[0.0050964747,0.0008321671,0.99208003,0.00045708017,0.00011819483,0.000010838694,0.000019790321,0.00013360746,0.00082508335,0.00005473703,0.00020051049,0.00017150558],"about_ca_topic_score_codex":0.00023162106,"about_ca_topic_score_gemma":0.00003162627,"teacher_disagreement_score":0.009699182,"about_ca_system_score_codex":0.00017899761,"about_ca_system_score_gemma":0.00022728636,"threshold_uncertainty_score":0.7151849},"labels":[],"label_agreement":null},{"id":"W2158470474","doi":"10.1158/1078-0432.ccr-08-0515","title":"Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Irinotecan; Pharmacokinetics; Neutropenia; Floxuridine; Gastroenterology; Internal medicine; Diarrhea; Hypokalemia; Response Evaluation Criteria in Solid Tumors; Colorectal cancer; Phases of clinical research; Pharmacology; Cancer; Urology; Chemotherapy; Fluorouracil","score_opus":0.047884919946826886,"score_gpt":0.44910929243566855,"score_spread":0.4012243724888417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158470474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821234,0.0007953864,0.00005554682,0.00024467,0.00010547738,0.0003764138,0.000018952202,0.0000041256717,0.0001870993],"genre_scores_gemma":[0.99688923,0.0024814238,0.00010687109,0.00021527511,0.00016140388,0.000015319238,0.000022814287,0.000014718752,0.000092921546],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986027,0.00012648977,0.0003566983,0.00036316313,0.0002669179,0.00028403723],"domain_scores_gemma":[0.9992959,0.00005020629,0.00007641691,0.0002264454,0.00024027839,0.0001107626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006037971,0.00010010179,0.00021476205,0.00007710563,0.00004401846,0.00001054278,0.00014358532,0.00010081683,0.000020497697],"category_scores_gemma":[0.00008674087,0.00008594833,0.000041487812,0.00019605018,0.00016770755,0.0000045203897,0.00007768867,0.00028247133,9.636225e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018625202,0.001571089,0.07404829,0.00006473826,0.00011947552,0.0000047730505,0.00012958233,0.0006422172,0.15548216,0.00021584953,0.00028594365,0.7488107],"study_design_scores_gemma":[0.017057689,0.016233815,0.8224065,0.00021451255,0.000028710338,0.0000015299368,0.000050614715,0.00009824687,0.13107477,0.0005542293,0.011910645,0.00036873762],"about_ca_topic_score_codex":0.000040956995,"about_ca_topic_score_gemma":0.00006809909,"teacher_disagreement_score":0.74844193,"about_ca_system_score_codex":0.000031436077,"about_ca_system_score_gemma":0.00014403937,"threshold_uncertainty_score":0.3504871},"labels":[],"label_agreement":null},{"id":"W2158479847","doi":"10.1158/1078-0432.ccr-10-1113","title":"Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Receptor; Internal medicine; Endocrinology; Luteinizing hormone; Medicine; Hormone receptor; Hormone; Prostate; Cancer; Lymph node; Breast cancer","score_opus":0.1268379528435064,"score_gpt":0.47003412216019075,"score_spread":0.34319616931668434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158479847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98338836,0.008915547,0.00008287869,0.0035335924,0.0006144087,0.0029763202,0.000017295402,0.000056101617,0.00041550348],"genre_scores_gemma":[0.9902643,0.0041583176,0.0029479193,0.00010423749,0.0009363427,0.0007596313,0.000013608452,0.000120801335,0.00069485814],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9948254,0.00039389677,0.0011089948,0.0011505473,0.0014873628,0.0010337561],"domain_scores_gemma":[0.9956977,0.0015009294,0.0003017534,0.0009563569,0.0011734937,0.0003698071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005910486,0.00032336317,0.0010975928,0.00039367107,0.00022083867,0.000051913255,0.00038223874,0.00029440725,0.00004705046],"category_scores_gemma":[0.0035428545,0.00024123289,0.00033610527,0.0007523455,0.00079367484,0.00026820519,0.00013995575,0.002108244,0.000006747105],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020723063,0.00046105208,0.059250165,0.00011928527,0.00022565702,0.000067063826,0.0009892555,0.000025649551,0.78330946,0.00002947846,0.0027077019,0.13209218],"study_design_scores_gemma":[0.063437834,0.014633881,0.6084665,0.0025710769,0.00023735863,0.000039802457,0.0023100304,0.0008093238,0.19901717,0.00087089447,0.10610486,0.0015012877],"about_ca_topic_score_codex":0.0016017345,"about_ca_topic_score_gemma":0.00058700185,"teacher_disagreement_score":0.5842923,"about_ca_system_score_codex":0.00048591627,"about_ca_system_score_gemma":0.0020615025,"threshold_uncertainty_score":0.98371917},"labels":[],"label_agreement":null},{"id":"W2158629784","doi":"10.1158/1078-0432.ccr-04-0191","title":"Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Estrogen receptor; Tamoxifen; Estrogen; Progesterone receptor; Estrogen receptor alpha; Internal medicine; Breast cancer; Estrogen receptor beta; Endocrinology; Estrogen-related receptor alpha; Receptor; Medicine; Receptor expression; Cancer research; Biology; Cancer","score_opus":0.07671504173985719,"score_gpt":0.4255130496329013,"score_spread":0.34879800789304416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158629784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956371,0.00084221526,0.000008371602,0.0026748541,0.000043834778,0.0004796764,0.0001571459,0.00002529126,0.00013150378],"genre_scores_gemma":[0.99648947,0.0006101832,0.00016292871,0.0008230196,0.00021086373,0.00090403593,0.0001166947,0.000060630304,0.00062216114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711907,0.0002502068,0.00042705616,0.00084487355,0.000559417,0.0007993766],"domain_scores_gemma":[0.9985493,0.00010026281,0.00010893842,0.000561599,0.00028700128,0.00039291612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064921833,0.00027323587,0.00041672026,0.000074560056,0.00014667018,0.000036281668,0.00031522659,0.00018856717,0.00017858479],"category_scores_gemma":[0.00026425498,0.00018851577,0.00008741621,0.00044177787,0.00050483755,0.000012384084,0.0002475039,0.0004456892,0.000025895964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007327835,0.0006264489,0.98572564,0.000021227945,0.00026620744,0.00008299416,0.00014595158,0.000051394596,0.0020040865,0.0000028685981,0.0015362779,0.0022090536],"study_design_scores_gemma":[0.013589573,0.0017870785,0.944402,0.00043623263,0.00004675839,0.0000021154187,0.00020029796,0.0000032226314,0.030987283,0.000120379664,0.007905888,0.000519186],"about_ca_topic_score_codex":0.00063257257,"about_ca_topic_score_gemma":0.00037788713,"teacher_disagreement_score":0.04132367,"about_ca_system_score_codex":0.0004975877,"about_ca_system_score_gemma":0.0005004902,"threshold_uncertainty_score":0.768745},"labels":[],"label_agreement":null},{"id":"W2158732520","doi":"10.1158/1078-0432.ccr-05-1849","title":"Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Osteoblast; Osteoprotegerin; Prostate cancer; Osteocalcin; Cancer research; RANKL; LNCaP; Osteosarcoma; Osteopontin; Biology; Internal medicine; Endocrinology; Alkaline phosphatase; Activator (genetics); Cancer; Receptor; Medicine; In vitro","score_opus":0.09392863630694223,"score_gpt":0.4000807126062378,"score_spread":0.30615207629929553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158732520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96442604,0.0349413,0.000015576958,0.00010675944,0.0000632776,0.0003112553,0.00004948394,0.0000065101267,0.000079800455],"genre_scores_gemma":[0.9912749,0.0077966894,0.00011385584,0.000017230472,0.00040695854,0.00003588827,0.00018857645,0.000022685437,0.00014322833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798286,0.00029763646,0.00062549126,0.00048616558,0.00028046168,0.0003273907],"domain_scores_gemma":[0.99915487,0.00007062606,0.000114756825,0.00030152636,0.00025488663,0.00010331902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085078,0.0001321455,0.0002900348,0.00012657889,0.00009700346,0.000038968912,0.00015735475,0.00018650803,0.000015983844],"category_scores_gemma":[0.00007436443,0.00011902764,0.00007699205,0.00019612773,0.0003064141,0.000010132338,0.00022741614,0.00022576684,0.000001601472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003454066,0.00027024184,0.15754664,0.00007203029,0.0000065096333,0.0000024221536,0.00002384271,0.00009329756,0.8334629,0.000026460877,0.00018383004,0.007966404],"study_design_scores_gemma":[0.0021372102,0.00051392673,0.41855875,0.00007609323,0.000010560031,3.5151902e-7,0.00014909776,0.00031436904,0.57558936,0.0008661027,0.0015730227,0.0002111566],"about_ca_topic_score_codex":0.00097218325,"about_ca_topic_score_gemma":0.0010065596,"teacher_disagreement_score":0.2610121,"about_ca_system_score_codex":0.000011499168,"about_ca_system_score_gemma":0.000106137726,"threshold_uncertainty_score":0.48538062},"labels":[],"label_agreement":null},{"id":"W2158858339","doi":"10.1158/1078-0432.ccr-1044-3","title":"Synergistic Cytotoxicity of Pyrazoloacridine with Doxorubicin, Etoposide, and Topotecan in Drug-Resistant Tumor Cells","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Stemcell Technologies; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Topotecan; Cytotoxicity; Doxorubicin; Etoposide; Topoisomerase; Pharmacology; Clonogenic assay; Cancer research; Medicine; Chemistry; Chemotherapy; In vitro; Biochemistry; Internal medicine","score_opus":0.0633163827293256,"score_gpt":0.41743363077443707,"score_spread":0.35411724804511147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158858339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720037,0.0013526845,0.00015147336,0.0005132804,0.00008992644,0.0003282186,0.000053541124,0.0000048476454,0.00030566368],"genre_scores_gemma":[0.99731445,0.0017179198,0.0002531857,0.0002488649,0.00016709561,0.000065045984,0.000007681748,0.000024822351,0.00020094303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826807,0.00012769277,0.00040437875,0.00048638802,0.0003169596,0.0003965373],"domain_scores_gemma":[0.99908906,0.00008506311,0.00008226752,0.00037134078,0.00020581171,0.00016646834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001232242,0.0001320373,0.00029616544,0.00008279438,0.000062608735,0.000017919741,0.00022663795,0.000107212465,0.000025489242],"category_scores_gemma":[0.00008813869,0.00010968457,0.000059324917,0.00023780517,0.00052224327,0.0000032920711,0.00017114289,0.00036043717,0.0000015913959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015193763,0.00019369058,0.0008177665,0.00007150947,0.000040001203,0.000029638231,0.00004387624,0.0001761221,0.99479717,0.0011810324,0.00011063432,0.0010191543],"study_design_scores_gemma":[0.0021335494,0.0014022512,0.0028993308,0.00012573884,0.000013657363,0.0000023481482,0.00011545913,0.000013019242,0.9888074,0.0012871653,0.0030388713,0.00016120281],"about_ca_topic_score_codex":0.0024035336,"about_ca_topic_score_gemma":0.0075209234,"teacher_disagreement_score":0.005989792,"about_ca_system_score_codex":0.00006727103,"about_ca_system_score_gemma":0.0005411529,"threshold_uncertainty_score":0.4472807},"labels":[],"label_agreement":null},{"id":"W2158890671","doi":"10.1158/1078-0432.ccr-07-1416","title":"A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Adverse effect; Toxicity; Internal medicine; Nausea; Pharmacokinetics; Cancer; Tumor necrosis factor alpha; Gastroenterology; Monoclonal antibody; Pharmacology; Oncology; Antibody; Immunology","score_opus":0.10579520366800418,"score_gpt":0.49704933906458154,"score_spread":0.3912541353965774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158890671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987319,0.00012481396,0.00007329484,0.00003747653,0.00006584298,0.00086642755,0.000023339773,0.000004380263,0.00007252228],"genre_scores_gemma":[0.9990089,0.000118206975,0.00019460313,0.000032471,0.00011178022,0.000099495854,0.00007017712,0.000020991396,0.00034337363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804246,0.00019837554,0.00046724785,0.00047427244,0.00048286526,0.00033480374],"domain_scores_gemma":[0.99899477,0.000029012723,0.000079363934,0.00035004178,0.00041037487,0.00013645462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060159835,0.00011893673,0.0002714189,0.00011192757,0.00012107645,0.000008180364,0.00021760406,0.00011478338,0.000038081347],"category_scores_gemma":[0.00009002058,0.00009543511,0.00005729406,0.00026953328,0.00016199652,0.000005808079,0.00014103098,0.00021698137,0.0000028022682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010085202,0.015559296,0.41984892,0.00006609785,0.0001266079,0.000051768333,0.0009708165,0.00075212435,0.5167306,0.000045762135,0.0005149603,0.035247855],"study_design_scores_gemma":[0.017929163,0.03246414,0.92319846,0.000080849226,0.000011621801,0.0000010449274,0.00033881067,0.000037062087,0.023954926,0.00004065686,0.0016850164,0.00025822342],"about_ca_topic_score_codex":0.00016676882,"about_ca_topic_score_gemma":0.00044913767,"teacher_disagreement_score":0.50334954,"about_ca_system_score_codex":0.000027798143,"about_ca_system_score_gemma":0.0001775617,"threshold_uncertainty_score":0.3891731},"labels":[],"label_agreement":null},{"id":"W2158927044","doi":"10.1158/1078-0432.ccr-11-3284","title":"A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Sorafenib; Rash; Pharmacokinetics; Tolerability; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacodynamics; Refractory (planetary science); Adverse effect; Gastroenterology; Oncology; Pharmacology; Toxicity; Phases of clinical research; Hepatocellular carcinoma","score_opus":0.21090893836538757,"score_gpt":0.5746474152749125,"score_spread":0.3637384769095249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158927044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279547,0.001447697,8.968419e-7,0.00027771742,0.00015181943,0.0051444788,0.00003579117,0.000023566821,0.00012256384],"genre_scores_gemma":[0.99667716,0.0009499222,0.000046088448,0.00010092448,0.00082371355,0.0012549236,0.00004596944,0.000042535517,0.000058784895],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99541104,0.0009233162,0.001391345,0.0006876331,0.00083559623,0.0007510529],"domain_scores_gemma":[0.9970867,0.0010767338,0.00037319443,0.0005583957,0.0002427231,0.0006622629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003834675,0.00024742098,0.0011940104,0.0003708278,0.000090479254,0.000016755308,0.0001579462,0.00017481406,0.00032976194],"category_scores_gemma":[0.0010588265,0.00015959812,0.00010565168,0.00060716755,0.0006644966,0.000115524825,0.0001579651,0.0010942541,0.000006600514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14340976,0.09571054,0.7139347,0.000031233987,0.0007636181,0.0015183666,0.00044706362,0.0000010452625,0.0003174046,0.0000031198347,0.0009151756,0.042947933],"study_design_scores_gemma":[0.5064087,0.08314095,0.4070063,0.00016354883,0.00052395783,0.00060340593,0.0005456479,0.000016503713,0.0007153207,0.000003027499,0.00068162207,0.00019106195],"about_ca_topic_score_codex":0.0016175405,"about_ca_topic_score_gemma":0.00041039588,"teacher_disagreement_score":0.3629989,"about_ca_system_score_codex":0.000359344,"about_ca_system_score_gemma":0.0011447804,"threshold_uncertainty_score":0.6508222},"labels":[],"label_agreement":null},{"id":"W2159112711","doi":"10.1158/1078-0432.ccr-10-2075","title":"Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Telomerase; Telomere; Stem cell; Telomerase reverse transcriptase; Biology; Cancer research; Neural stem cell; Immunology; Cell biology; Genetics; DNA","score_opus":0.3038499232206262,"score_gpt":0.4603910254492899,"score_spread":0.1565411022286637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159112711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221915,0.00083766755,0.00006403048,0.0029641676,0.00043324332,0.0016093215,0.00038499254,0.00010722887,0.0013802031],"genre_scores_gemma":[0.9937929,0.0005310274,0.0013278462,0.0019766313,0.00083967537,0.00037793684,0.00007444525,0.00008472826,0.0009948121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954603,0.00042352872,0.0010755644,0.0010348653,0.000773261,0.0012325359],"domain_scores_gemma":[0.9958727,0.0015238312,0.00022611872,0.00056019844,0.00095474295,0.0008624061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026102816,0.00033311071,0.0007755896,0.00026460065,0.0004782165,0.000064438245,0.00023123102,0.00022401466,0.00047369377],"category_scores_gemma":[0.0028864087,0.0002803786,0.00023360494,0.00048701346,0.0012004292,0.00016560068,0.00020980433,0.0013511466,0.00001824155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015734458,0.0023024813,0.6539262,0.0029757076,0.000435971,0.0022802,0.0052311304,0.0000037295742,0.07046144,0.0011249455,0.0410367,0.20448706],"study_design_scores_gemma":[0.018430084,0.00721063,0.76404536,0.0020494582,0.00034997458,0.00023924478,0.005346291,0.004117416,0.17040567,0.0024506962,0.023524033,0.0018311575],"about_ca_topic_score_codex":0.0020013496,"about_ca_topic_score_gemma":0.0012476703,"teacher_disagreement_score":0.2026559,"about_ca_system_score_codex":0.00020190098,"about_ca_system_score_gemma":0.0006311606,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W2159122128","doi":"10.1158/1078-0432.ccr-04-1258","title":"Variance in the Expression of 5-Fluorouracil Pathway Genes in Colorectal Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Colorectal cancer; Gene; Gene expression; Biology; Fluorouracil; Thymidylate synthase; DPYD; Cancer; Cancer research; Genetics; Oncology; Internal medicine; Medicine; Genotype; Pharmacogenetics","score_opus":0.21335776997608874,"score_gpt":0.5192893717533912,"score_spread":0.30593160177730244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159122128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714874,0.01703098,0.0000014785074,0.007129871,0.00014163394,0.0007655298,0.000028614237,0.000009322578,0.0034051551],"genre_scores_gemma":[0.9859423,0.011816507,0.00010053524,0.00026881107,0.0005198648,0.00091531564,0.0000031672923,0.000014439135,0.0004190778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724835,0.00050614076,0.00064161705,0.0004062182,0.0007326648,0.00046502263],"domain_scores_gemma":[0.9982086,0.0011107888,0.00008261249,0.00026129704,0.0002450637,0.000091636655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024310802,0.00013449261,0.000498604,0.00013511912,0.00008657251,0.00001332629,0.00025047208,0.00013294654,0.00040370246],"category_scores_gemma":[0.0004487501,0.000080496895,0.00011723449,0.0007045685,0.00037788475,0.00007533586,0.00014241815,0.0007798724,0.0000117515465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003631859,0.0012028756,0.66645294,0.000097472264,0.000045314726,0.000089169436,0.001981579,0.000060472434,0.007125987,0.000095404386,0.0023280717,0.31688887],"study_design_scores_gemma":[0.0041812183,0.0011221264,0.9463163,0.0005527516,0.000019078754,0.0000043948417,0.0008283656,0.00014412825,0.019417612,0.00014414932,0.027138287,0.00013157687],"about_ca_topic_score_codex":0.0030123454,"about_ca_topic_score_gemma":0.014280352,"teacher_disagreement_score":0.3167573,"about_ca_system_score_codex":0.0003884788,"about_ca_system_score_gemma":0.00066190795,"threshold_uncertainty_score":0.79687715},"labels":[],"label_agreement":null},{"id":"W2159360580","doi":"10.1158/1078-0432.ccr-04-2245","title":"Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":831,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Imatinib; GiST; PDGFRA; Medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Mutation; Cancer research; Drug resistance; Exon; Stromal tumor; Tyrosine kinase; Gene mutation; Internal medicine; Stromal cell; Biology; Cancer; Gene; Genetics; Receptor","score_opus":0.1862819145099767,"score_gpt":0.5172058367657747,"score_spread":0.33092392225579803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159360580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97913414,0.00048166877,0.00019298974,0.014369474,0.000052626594,0.0014390688,0.00008582276,0.00006522665,0.004178972],"genre_scores_gemma":[0.9412784,0.00003929958,0.054716066,0.00079437275,0.0007326884,0.00048376794,0.000048839436,0.0000484209,0.0018581261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948777,0.00054776756,0.0009940777,0.00087161956,0.0013745455,0.0013343189],"domain_scores_gemma":[0.99672097,0.0010453478,0.00010447317,0.00058505393,0.0006886561,0.00085550104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026058701,0.00024834223,0.0005727046,0.00029404953,0.00015973876,0.00006918684,0.00033740414,0.000050915445,0.0011010601],"category_scores_gemma":[0.0036724932,0.00021722635,0.00017653665,0.0009176829,0.00047708844,0.00021238622,0.00022245855,0.0011742963,0.0005654086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037363928,0.0060376716,0.7981738,0.0008522987,0.00018472092,0.019610845,0.00089597015,0.00027339597,0.017848015,0.0010735055,0.058993097,0.058692753],"study_design_scores_gemma":[0.013710642,0.009873384,0.94605345,0.0031702514,0.00004056168,0.0013604015,0.0006385015,0.0006289557,0.010002166,0.001041568,0.013031238,0.00044889626],"about_ca_topic_score_codex":0.00040820893,"about_ca_topic_score_gemma":0.0016447008,"teacher_disagreement_score":0.14787963,"about_ca_system_score_codex":0.0008560398,"about_ca_system_score_gemma":0.0016026902,"threshold_uncertainty_score":0.99981207},"labels":[],"label_agreement":null},{"id":"W2159470156","doi":"10.1158/1078-0432.ccr-11-2147","title":"<i>NKX3.1</i> Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Haploinsufficiency; Medicine; Prostate cancer; Prostatectomy; Oncology; Radiation therapy; Internal medicine; Proportional hazards model; Image-guided radiation therapy; Prostate; Comparative genomic hybridization; Cancer; Gene; Biology; Genetics; Phenotype","score_opus":0.4063422715897345,"score_gpt":0.541383628515185,"score_spread":0.13504135692545044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159470156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541663,0.02313784,0.00013481834,0.010176578,0.0021432876,0.0075458474,0.00026959725,0.00024163537,0.0021840832],"genre_scores_gemma":[0.7877121,0.11809393,0.0048472416,0.0039847833,0.0039117807,0.015209264,0.00012935822,0.00051650073,0.065595046],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936046,0.00048595067,0.0012716838,0.0012953008,0.0014749567,0.0018675213],"domain_scores_gemma":[0.9925186,0.0037051241,0.00018476251,0.0008670564,0.001836688,0.000887787],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0056250617,0.0003923511,0.0011259665,0.00045073507,0.000528828,0.0001066937,0.00045645298,0.00033031704,0.0022041574],"category_scores_gemma":[0.004811542,0.0002632582,0.00083412084,0.0014302665,0.0009980804,0.00028472862,0.00016948997,0.0012047964,0.000083541556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025301944,0.0029822888,0.5689645,0.0017252684,0.001335541,0.0011422267,0.0033827364,0.0000010708686,0.0021434252,0.000040034953,0.31711212,0.075868875],"study_design_scores_gemma":[0.066609494,0.023613062,0.26616547,0.009548885,0.0016804611,0.00009654901,0.0022289963,0.0020446859,0.049190562,0.0022852602,0.57312113,0.0034154549],"about_ca_topic_score_codex":0.001591329,"about_ca_topic_score_gemma":0.00021838269,"teacher_disagreement_score":0.30279902,"about_ca_system_score_codex":0.00067409215,"about_ca_system_score_gemma":0.0065429,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W2159484131","doi":"10.1158/1078-0432.ccr-05-2208","title":"Ectopic Expression of the Proto-oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Center, University of Colorado; National Cancer Institute; National Institutes of Health; Bear Necessities Pediatric Cancer Foundation; West Virginia University; Louisiana State University; Children's Hospital of Michigan; McGill University; University of Oklahoma; University of Miami; National Childhood Cancer Foundation","keywords":"Lymphoblast; Molecular biology; Jurkat cells; Flow cytometry; Biology; CD3; Ectopic expression; Thymocyte; Phorbol; Western blot; T cell; Oncogene; Reverse transcription polymerase chain reaction; Cell culture; Immunology; Cell; CD8; Gene expression; Antigen; Kinase; Cell cycle; Immune system; Protein kinase C; Gene; Cell biology; Biochemistry","score_opus":0.06729700719109331,"score_gpt":0.4082430459181411,"score_spread":0.34094603872704776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159484131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929021,0.004690273,0.000009407559,0.00017837333,0.00044775166,0.0006786557,0.000011077011,0.00000963949,0.0010727353],"genre_scores_gemma":[0.9955889,0.00078683003,0.000011770558,0.000021423622,0.00017577891,0.00019927112,0.000011500767,0.000012870998,0.0031916678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976016,0.0009204619,0.00064748095,0.00030803942,0.00013716453,0.00038523425],"domain_scores_gemma":[0.99871415,0.00056441885,0.00015378091,0.00040047022,0.00014938362,0.000017798835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012657316,0.00010241375,0.00028980433,0.00012118626,0.00013966832,0.0000085463325,0.00041513672,0.00028831055,0.00030791177],"category_scores_gemma":[0.00016479523,0.0000658939,0.00013812861,0.0004862616,0.0003701858,0.000054631102,0.00025728554,0.00058255,0.00007648329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036398743,0.00029604204,0.20214057,0.000056913283,0.000014990228,0.0000016473529,0.000039981274,0.00007479844,0.78745633,0.0000555063,0.0067143934,0.0027848321],"study_design_scores_gemma":[0.0023116614,0.00014233343,0.4137066,0.000056841356,0.000022155456,0.0000015159992,0.000011506724,0.000017269427,0.579536,0.00026765664,0.0038471406,0.00007930319],"about_ca_topic_score_codex":0.000663691,"about_ca_topic_score_gemma":0.000101988626,"teacher_disagreement_score":0.21156602,"about_ca_system_score_codex":0.0001988288,"about_ca_system_score_gemma":0.0006094314,"threshold_uncertainty_score":0.33714178},"labels":[],"label_agreement":null},{"id":"W2159489772","doi":"10.1158/1078-0432.ccr-06-1817","title":"An Optimized Clinical Regimen for the Oncolytic Virus PV701","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Dosing; Regimen; Oncolytic virus; Bolus (digestion); Pharmacokinetics; Clinical trial; Toxicity; Adverse effect; Pharmacology; Internal medicine; Anesthesia; Urology; Cancer","score_opus":0.2683399938072698,"score_gpt":0.5974442074075578,"score_spread":0.32910421360028796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159489772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811768,0.005456818,0.0040235193,0.003817077,0.0009394646,0.002644792,0.00007952204,0.00004121998,0.0018208093],"genre_scores_gemma":[0.9745148,0.009705755,0.0012234394,0.0022617113,0.0069922605,0.0006523528,0.000074938805,0.00012604918,0.0044486923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944066,0.0014725848,0.0010524642,0.0010210905,0.00084262865,0.0012046418],"domain_scores_gemma":[0.99332434,0.00336994,0.00013381327,0.0016750183,0.0008770494,0.0006198171],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034709707,0.00021031541,0.00041152685,0.0000944189,0.00048465593,0.00010143597,0.001563599,0.0005333995,0.00024936817],"category_scores_gemma":[0.0028832352,0.00015041849,0.000446432,0.00037296207,0.0013993677,0.000008770658,0.00027110867,0.0012109523,0.00007333635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13806617,0.0020675058,0.008238642,0.000059411665,0.0008813686,0.000036651232,0.000091123424,0.00042954285,0.12433398,0.00018376215,0.09673708,0.6288748],"study_design_scores_gemma":[0.0135026295,0.038118713,0.0075159543,0.000050595983,0.00008713349,0.0000071863874,0.00037230412,0.002551127,0.16621307,0.0007141881,0.7701376,0.0007294954],"about_ca_topic_score_codex":0.00018740034,"about_ca_topic_score_gemma":0.00212107,"teacher_disagreement_score":0.6734005,"about_ca_system_score_codex":0.000089206405,"about_ca_system_score_gemma":0.0012772058,"threshold_uncertainty_score":0.9939695},"labels":[],"label_agreement":null},{"id":"W2159582600","doi":"10.1158/1078-0432.ccr-12-3139","title":"Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Erg; DNA methylation; CpG site; Biology; Cancer; Cancer research; Methylation; Prostate; PCA3; Differentially methylated regions; Oncology; Medicine; Gene expression; Genetics; Gene","score_opus":0.07008673684970736,"score_gpt":0.4448200420246015,"score_spread":0.37473330517489417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159582600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982771,0.015034181,0.00001562254,0.0007004494,0.000099584446,0.0012017417,0.00010283463,0.000009726924,0.00006488884],"genre_scores_gemma":[0.9832775,0.014765757,0.00014291386,0.000034460125,0.00019458904,0.0009748741,0.00011562136,0.000039806946,0.00045447523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970623,0.0006744263,0.00061712903,0.00065967883,0.00052222837,0.00046420158],"domain_scores_gemma":[0.9981762,0.00017807588,0.0003780315,0.0003332509,0.00074992183,0.00018448423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014235462,0.00019273983,0.00037373076,0.00011806107,0.00011013467,0.000051002742,0.00018270803,0.0002579488,0.000086911285],"category_scores_gemma":[0.00045845006,0.0001436176,0.000059238457,0.00034452052,0.00025565756,0.000022611543,0.00020647066,0.00038211257,0.0000013326925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008995975,0.00017614191,0.43200535,0.0000735961,0.0000625054,0.0000019041781,0.00015197937,0.00032321835,0.531632,8.2157777e-7,0.0003794791,0.03429339],"study_design_scores_gemma":[0.0021241275,0.0005735442,0.44128904,0.00046525948,0.000017696218,1.4298702e-7,0.000089183166,0.0004579386,0.5535072,0.00013786323,0.0011431338,0.00019486285],"about_ca_topic_score_codex":0.0011547034,"about_ca_topic_score_gemma":0.0033586717,"teacher_disagreement_score":0.03409853,"about_ca_system_score_codex":0.00006454064,"about_ca_system_score_gemma":0.00034682578,"threshold_uncertainty_score":0.58565557},"labels":[],"label_agreement":null},{"id":"W2159677222","doi":"10.1158/1078-0432.ccr-09-0641","title":"DNA Variants in Region for Noncoding Interfering Transcript of <i>Dihydrofolate Reductase</i> Gene and Outcome in Childhood Acute Lymphoblastic Leukemia","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Haplotype; Biology; Dihydrofolate reductase; Genetics; Promoter; Allele; Gene; Single-nucleotide polymorphism; Genotype; Gene expression","score_opus":0.12660202531230605,"score_gpt":0.45598286909941205,"score_spread":0.32938084378710597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159677222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936522,0.0007220858,0.0005781723,0.0028955902,0.00019745562,0.0015515339,0.000037736598,0.000026510288,0.00033868485],"genre_scores_gemma":[0.99588823,0.0022250589,0.0007463369,0.00038288644,0.00031823496,0.00014841289,0.000015209892,0.000051069033,0.00022453215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952407,0.00036531463,0.0016053886,0.00088843214,0.000786872,0.0011132965],"domain_scores_gemma":[0.9969691,0.0016158784,0.00013847223,0.000545053,0.00029336885,0.00043811064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040048375,0.00026123188,0.0010777698,0.00070889044,0.000083287094,0.0000359309,0.00040408052,0.00036427696,0.000024732755],"category_scores_gemma":[0.0022156653,0.00023362806,0.00018650944,0.0010839915,0.00044800638,0.00018395246,0.00016148738,0.0012338723,0.000005127911],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04548417,0.0035990395,0.3235487,0.0024371431,0.00067834643,0.0037736339,0.0050393133,0.00037686937,0.43564516,0.0008795264,0.00397204,0.17456603],"study_design_scores_gemma":[0.072751306,0.009379455,0.8261384,0.0051471284,0.0003035054,0.0005541585,0.0005085369,0.03386162,0.04642495,0.003258821,0.00071896624,0.0009531981],"about_ca_topic_score_codex":0.00046771014,"about_ca_topic_score_gemma":0.00011322577,"teacher_disagreement_score":0.50258964,"about_ca_system_score_codex":0.0021183041,"about_ca_system_score_gemma":0.002119364,"threshold_uncertainty_score":0.9527075},"labels":[],"label_agreement":null},{"id":"W2159724629","doi":"10.1158/1078-0432.ccr-06-2950","title":"Cross-Linking of Signal Transducer and Activator of Transcription 3—A Molecular Marker for the Photodynamic Reaction in Cells and Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency","keywords":"Photosensitizer; Photodynamic therapy; STAT protein; STAT3; Cancer research; Singlet oxygen; Reactive oxygen species; Chemistry; Biology; Biophysics; Pathology; Medicine; Cell biology; Photochemistry; Apoptosis; Biochemistry; Oxygen","score_opus":0.09854650017475727,"score_gpt":0.49607002460480465,"score_spread":0.39752352443004735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159724629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557704,0.002114902,0.0003495112,0.0004937674,0.000058128717,0.0012934547,0.000033248907,0.000005582906,0.00007435861],"genre_scores_gemma":[0.9958896,0.0036984698,0.000085447624,0.000045365872,0.000060847186,0.00009673357,0.000003059581,0.000021415104,0.00009903599],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99793726,0.0001957424,0.00060409086,0.00031753883,0.00055951497,0.00038583987],"domain_scores_gemma":[0.99678236,0.0024915228,0.00008258307,0.00019387106,0.00033860502,0.00011108503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072829067,0.00010369804,0.00039007535,0.0001938397,0.000079375866,0.000010929023,0.000105363084,0.00012855956,0.000042107185],"category_scores_gemma":[0.00028995602,0.000072681134,0.000111373854,0.0003238594,0.0011325694,0.00006810849,0.000035718786,0.0006842139,1.6537976e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008564552,0.00015884347,0.017726086,0.00045995717,0.00011679823,0.00000854577,0.00039761513,0.000004474449,0.937138,0.000027787544,0.0000073939937,0.035389934],"study_design_scores_gemma":[0.004086251,0.00091989426,0.58524877,0.00043259535,0.000037443107,0.000003924124,0.0004535622,0.0011836874,0.4068054,0.00033084495,0.00041247762,0.00008513229],"about_ca_topic_score_codex":0.000636436,"about_ca_topic_score_gemma":0.0003576841,"teacher_disagreement_score":0.5675227,"about_ca_system_score_codex":0.000103023915,"about_ca_system_score_gemma":0.000191663,"threshold_uncertainty_score":0.41729993},"labels":[],"label_agreement":null},{"id":"W2159753688","doi":"10.1158/1078-0432.ccr-07-0648","title":"An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; National Institutes of Health; U.S. Department of Veterans Affairs; U.S. Department of Defense","keywords":"Castration; Prostate cancer; Medicine; Androgen receptor; Androgen; Prostate; Internal medicine; Orchiectomy; Cancer; Endocrinology; Urology; Hormone","score_opus":0.16681916483910428,"score_gpt":0.5321808771038311,"score_spread":0.3653617122647268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159753688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787189,0.005803323,0.0000055075047,0.01214047,0.00085983926,0.002193342,0.00006312485,0.00004379436,0.00017171836],"genre_scores_gemma":[0.9837844,0.012843601,0.000044103253,0.00043299078,0.0010355336,0.0003196889,0.000049959774,0.00005356265,0.0014361547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99342775,0.0020139057,0.00093795196,0.0007986532,0.0015982627,0.0012234625],"domain_scores_gemma":[0.9945056,0.0029744944,0.0001530148,0.0006710713,0.0012432098,0.0004526551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014909662,0.00025927197,0.0004463028,0.00024486514,0.00060869945,0.00015121656,0.0006094997,0.0002492088,0.0006328717],"category_scores_gemma":[0.0019881185,0.00013631144,0.0001268623,0.0015131929,0.0007562109,0.0002242897,0.0001720961,0.002255452,0.000082742015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066795275,0.0010906168,0.47674727,0.00014656938,0.00027493906,0.0003381272,0.0048206947,0.0000124211665,0.41257226,0.00005360357,0.0023197036,0.034828514],"study_design_scores_gemma":[0.008336375,0.006859183,0.7845416,0.0005244099,0.00006364265,0.000014769628,0.005797454,0.00023352104,0.17424601,0.00019053242,0.01866441,0.0005280778],"about_ca_topic_score_codex":0.0031723818,"about_ca_topic_score_gemma":0.002201751,"teacher_disagreement_score":0.30779433,"about_ca_system_score_codex":0.0006776267,"about_ca_system_score_gemma":0.002846454,"threshold_uncertainty_score":0.9798942},"labels":[],"label_agreement":null},{"id":"W2159849977","doi":"10.1158/1078-0432.ccr-12-0060","title":"The Effects of Chemotherapy on Cognitive Function in a Mouse Model: A Prospective Study","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University; University of Toronto; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cognition; Frontal lobe; Prospective cohort study; Medicine; Associative learning; Psychology; Oncology; Audiology; Internal medicine; Neuroscience; Psychiatry","score_opus":0.13954201744766864,"score_gpt":0.519909629011882,"score_spread":0.38036761156421334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159849977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911852,0.0016389217,0.000026956917,0.0006959661,0.0002902708,0.0046546226,0.000008756805,0.000026931379,0.0014723885],"genre_scores_gemma":[0.99326825,0.002154362,0.0000037029222,0.00032406076,0.00039255276,0.0018122223,0.0000011504269,0.000033858218,0.0020098297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711347,0.00061893614,0.00046989985,0.00035781268,0.0008586517,0.0005812506],"domain_scores_gemma":[0.9941069,0.004687136,0.00009673517,0.00025626417,0.00069261907,0.00016037672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033159766,0.00014852746,0.00042896566,0.00016297892,0.0001757495,0.000011161033,0.00009811017,0.00010694884,0.000028812976],"category_scores_gemma":[0.003908139,0.000095906296,0.00011780767,0.0005823163,0.00059323723,0.00007210475,0.000100297446,0.0012442581,0.000027647273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029769909,0.007140034,0.91572374,0.00016750813,0.0008571514,0.000006305617,0.0031731476,0.0000062406693,0.00043035235,0.00009803427,0.001351596,0.041275952],"study_design_scores_gemma":[0.016504344,0.014158915,0.9599555,0.0006835816,0.00015785253,5.693008e-7,0.003095617,0.0002147512,0.004646597,0.00030431937,0.00014195502,0.00013599992],"about_ca_topic_score_codex":0.00019497419,"about_ca_topic_score_gemma":0.00022956764,"teacher_disagreement_score":0.044231728,"about_ca_system_score_codex":0.00036572808,"about_ca_system_score_gemma":0.00027933464,"threshold_uncertainty_score":0.54057515},"labels":[],"label_agreement":null},{"id":"W2159863629","doi":"10.1158/1078-0432.ccr-06-0839","title":"A Tracer Dose of Technetium-99m–Labeled Liposomes Can Estimate the Effect of Hyperthermia on Intratumoral Doxil Extravasation","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Extravasation; Liposome; Doxorubicin; Technetium; Hyperthermia; Biodistribution; Technetium-99m; Medicine; Pharmacokinetics; Nuclear medicine; Pharmacology; Chemistry; Chemotherapy; Scintigraphy; Pathology; In vitro; Surgery; Internal medicine","score_opus":0.06502978572385026,"score_gpt":0.44517376991814234,"score_spread":0.3801439841942921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159863629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966767,0.00053775456,0.000006305407,0.0013270569,0.00027090573,0.000809376,0.00005902227,0.00004604619,0.00026682822],"genre_scores_gemma":[0.9991065,0.00005215193,0.00011377703,0.00004199412,0.0002578115,0.0001886771,0.000004176446,0.000029163102,0.00020571858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954963,0.0015128083,0.00087259116,0.00046428136,0.0011006306,0.0005534191],"domain_scores_gemma":[0.9952727,0.0033500227,0.00023340632,0.0006946393,0.00033736473,0.000111868525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006275254,0.00017569613,0.00048933004,0.00013382679,0.00014123623,0.0000534207,0.00061759603,0.0001501297,0.0003949597],"category_scores_gemma":[0.0010110491,0.000109064815,0.00014048678,0.0006314339,0.0012766107,0.000090422174,0.00012729524,0.00054518407,0.000073225674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021086193,0.00026943593,0.011845864,0.00011544216,0.000013445265,0.000013553602,0.00005569002,0.0008378015,0.9728239,0.00024347876,0.0013086289,0.010364116],"study_design_scores_gemma":[0.001740554,0.0020008069,0.025502203,0.0001490432,0.00003100114,0.0000017478388,0.000017892797,0.0006448125,0.9692782,0.00034328204,0.00017053212,0.000119878234],"about_ca_topic_score_codex":0.0030185534,"about_ca_topic_score_gemma":0.0008249248,"teacher_disagreement_score":0.013656339,"about_ca_system_score_codex":0.00012477819,"about_ca_system_score_gemma":0.00037063178,"threshold_uncertainty_score":0.4703725},"labels":[],"label_agreement":null},{"id":"W2159875179","doi":"10.1158/1078-0432.ccr-08-0405","title":"Tris (Dibenzylideneacetone) Dipalladium, a<i>N</i>-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth<i>In vitro</i>and<i>In vivo</i>","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; National Institutes of Health; Emory University","keywords":"Tris; In vivo; Protein kinase B; Melanoma; Cancer research; PI3K/AKT/mTOR pathway; Phosphorylation; Signal transduction; Kinase; In vitro; Mechanism of action; Chemistry; Protein kinase A; Biology; Molecular biology; Biochemistry","score_opus":0.05516778673941028,"score_gpt":0.3757980825299887,"score_spread":0.32063029579057845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159875179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025697,0.006770505,0.00007289481,0.00096019637,0.00013915394,0.00090749876,0.000064837885,0.00001562525,0.0008123486],"genre_scores_gemma":[0.98968637,0.007851639,0.00011957244,0.0010043177,0.0005388843,0.00036799198,0.000028676315,0.000043805005,0.0003587671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996269,0.0008968032,0.0007136899,0.00091871293,0.00051832316,0.0006834777],"domain_scores_gemma":[0.99869907,0.00032219102,0.00006686458,0.00037216797,0.00023465035,0.00030506187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022865357,0.0002478926,0.0004649621,0.00023566798,0.0001879716,0.000030581105,0.000273316,0.0004177118,0.000056873832],"category_scores_gemma":[0.0005159722,0.0002431062,0.00019317107,0.00052505836,0.0005838439,0.00001402229,0.00017810693,0.0008049837,0.000014796434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032419756,0.0003512748,0.052123386,0.000100712765,0.000054779477,0.00020772275,0.00021720008,0.00003404974,0.93267965,0.000025164945,0.0032664388,0.00769765],"study_design_scores_gemma":[0.0040193503,0.0003878767,0.017277278,0.00012241182,0.000007213083,0.000011987258,0.00003510076,0.00016250946,0.961136,0.00012816183,0.01636194,0.00035019204],"about_ca_topic_score_codex":0.0005938043,"about_ca_topic_score_gemma":0.000369622,"teacher_disagreement_score":0.03484611,"about_ca_system_score_codex":0.000117083066,"about_ca_system_score_gemma":0.0003630364,"threshold_uncertainty_score":0.9913583},"labels":[],"label_agreement":null},{"id":"W2160257239","doi":"10.1158/1078-0432.ccr-08-0608","title":"Familial Non-VHL Clear Cell (Conventional) Renal Cell Carcinoma: Clinical Features, Segregation Analysis, and Mutation Analysis of <i>FLCN</i>","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; National Institutes of Health; Institut National Du Cancer; Ligue Contre le Cancer; National Institute for Health and Care Research","keywords":"Folliculin; Penetrance; Germline mutation; Germline; Medicine; Birt–Hogg–Dubé syndrome; Renal cell carcinoma; Mutation; Cancer; Clear cell renal cell carcinoma; Oncology; Genetics; Internal medicine; Cancer research; Biology; Phenotype; Surgery","score_opus":0.14348036675283019,"score_gpt":0.4542025237708297,"score_spread":0.31072215701799955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160257239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407583,0.0022745498,0.00020417469,0.00046161626,0.00016206881,0.00078314444,0.0001049183,0.000024258172,0.0019094604],"genre_scores_gemma":[0.9918318,0.0027176251,0.0009309858,0.00016325153,0.00043071326,0.00007960087,0.0005136889,0.0000369673,0.003295377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935236,0.0011623317,0.0018341659,0.0011472009,0.0017511578,0.00058156997],"domain_scores_gemma":[0.9949378,0.0018272282,0.0004686852,0.0008577359,0.0012534603,0.0006551236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037704876,0.00029063234,0.0015371139,0.0012893162,0.00026261577,0.00002885788,0.00025325865,0.00045744271,0.0003566227],"category_scores_gemma":[0.00043463113,0.0002458042,0.001445853,0.003935846,0.0011310565,0.00011913873,0.00018908754,0.0013505948,0.000036791298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003705628,0.001465285,0.9817692,0.00017449139,0.0029812362,0.00040140183,0.00020371022,0.00024855038,0.0017149681,0.000018793988,0.0042909975,0.0030257243],"study_design_scores_gemma":[0.0049034883,0.0020505025,0.9741647,0.000028307993,0.007393789,0.00001247234,0.000111590685,0.0028200597,0.00783621,0.000038149865,0.0004433489,0.00019734944],"about_ca_topic_score_codex":0.0032600032,"about_ca_topic_score_gemma":0.00082424126,"teacher_disagreement_score":0.007604482,"about_ca_system_score_codex":0.00027540076,"about_ca_system_score_gemma":0.0009778031,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2160270310","doi":"10.1158/1078-0432.ccr-06-0860","title":"Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"GPER; Estrogen receptor; Breast cancer; Metastasis; Estrogen; Internal medicine; Cancer research; Medicine; Cancer; Endocrinology; Biology; Oncology","score_opus":0.03277814508457424,"score_gpt":0.41069458192318486,"score_spread":0.37791643683861065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160270310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474376,0.004422678,0.0000021249907,0.000142837,0.00006329669,0.00041693184,0.00015344906,0.000005282949,0.00004965572],"genre_scores_gemma":[0.9973343,0.0021280067,0.000059717237,0.00001293585,0.0001506111,0.00010060118,0.000094964846,0.000015974632,0.00010287203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997872,0.00046845945,0.00056394795,0.0003872767,0.00036899152,0.00033930916],"domain_scores_gemma":[0.9989119,0.00016713186,0.00033597992,0.0001613224,0.0003472123,0.00007644925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022509405,0.00011900532,0.0003465087,0.000050861578,0.000055603043,0.000009157892,0.00014097926,0.00031400326,0.0000073562137],"category_scores_gemma":[0.00026412835,0.00008962292,0.00007033586,0.00026297223,0.00019971674,0.000009767993,0.00013697943,0.0004197817,0.0000011215184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014209107,0.00023833831,0.8602793,0.00014847335,0.000025265119,0.000010953358,0.000013076602,0.000037023354,0.12997928,0.0000058119563,0.00014911093,0.0076924264],"study_design_scores_gemma":[0.002075057,0.0012272634,0.74578,0.00058999093,0.00003269702,0.000013845198,0.000028027487,0.00015986453,0.24972065,0.000015519896,0.00020061828,0.00015649595],"about_ca_topic_score_codex":0.00017585256,"about_ca_topic_score_gemma":0.00005268712,"teacher_disagreement_score":0.11974137,"about_ca_system_score_codex":0.00009863633,"about_ca_system_score_gemma":0.00038475922,"threshold_uncertainty_score":0.36547166},"labels":[],"label_agreement":null},{"id":"W2160298696","doi":"10.1158/1078-0432.ccr-07-4543","title":"Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue Microarray Studies on a Lymph Node–Negative Cohort","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Tissue microarray; Breast cancer; Concordance; Oncology; Internal medicine; Medicine; Lymph node; Proportional hazards model; Progesterone receptor; Estrogen receptor; Basal (medicine); Cohort; Immunohistochemistry; Pathology; Univariate analysis; Cancer; Multivariate analysis","score_opus":0.10249135375368104,"score_gpt":0.45954335227857773,"score_spread":0.35705199852489666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160298696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98229754,0.014817076,0.0000072041835,0.00084987906,0.00039291361,0.0009115207,0.0005818658,0.000017370588,0.00012462628],"genre_scores_gemma":[0.98418367,0.01312639,0.00009092938,0.00039264807,0.0006462831,0.00074490666,0.00003974275,0.000051389587,0.0007240458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956904,0.0010103312,0.00064794277,0.0011725008,0.0008736119,0.00060520036],"domain_scores_gemma":[0.99535394,0.00268048,0.0002145845,0.00075729185,0.0007839244,0.00020980666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001453975,0.0003572264,0.00081144966,0.00008761136,0.00029269236,0.000017115985,0.0005075415,0.00024588424,0.00017408609],"category_scores_gemma":[0.0021439784,0.0002793384,0.00021444514,0.0003212741,0.0014731972,0.000012149021,0.00047340847,0.0003907863,0.00014760198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058248113,0.00024732357,0.9414,0.00014985273,0.0024858778,0.00007003587,0.0008605405,0.00008355092,0.019372316,4.525229e-7,0.023060322,0.0064449413],"study_design_scores_gemma":[0.003712477,0.0023944934,0.6732589,0.001263255,0.00029226573,0.00002131754,0.00025945995,0.000028167102,0.31778282,0.000041473857,0.0004497322,0.0004956602],"about_ca_topic_score_codex":0.0036314735,"about_ca_topic_score_gemma":0.0006297643,"teacher_disagreement_score":0.2984105,"about_ca_system_score_codex":0.00041363793,"about_ca_system_score_gemma":0.0007876393,"threshold_uncertainty_score":0.9999659},"labels":[],"label_agreement":null},{"id":"W2160363714","doi":"10.1158/1078-0432.ccr-08-1627","title":"Dose-Dependent Increases in Circulating TGF-α and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Cetuximab; Amphiregulin; Epidermal growth factor receptor; Epiregulin; In vivo; Cancer research; Epidermal growth factor; EGFR inhibitors; Monoclonal antibody; Transforming growth factor; Medicine; Pharmacology; Antibody; Cancer; Receptor; Internal medicine; Biology; Immunology","score_opus":0.18541814581743665,"score_gpt":0.5158474330850727,"score_spread":0.3304292872676361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160363714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926902,0.0048803487,0.0000047412063,0.0009017509,0.00005115575,0.0009838355,0.00004531941,0.000017418413,0.00042524427],"genre_scores_gemma":[0.9974581,0.0015948892,0.00014605516,0.00041341723,0.00017795332,0.00013627723,0.0000036995505,0.000017371238,0.000052210577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786764,0.0001588481,0.0005517992,0.00053591345,0.00040196063,0.0004838552],"domain_scores_gemma":[0.9982627,0.0010684977,0.00012908848,0.00014589449,0.00016642587,0.00022741889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018053382,0.00017382947,0.00065056566,0.00016061474,0.00013633745,0.000029808176,0.00009011415,0.00011733323,0.00007386741],"category_scores_gemma":[0.0009329346,0.00012637117,0.00010673022,0.00022365148,0.00037680467,0.000052555522,0.00013844199,0.0004818185,8.5901644e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012312335,0.00085370097,0.8902942,0.00016902569,0.00019815679,0.00016964645,0.00019023923,0.000011856709,0.0037114848,0.000035945275,0.0000711222,0.09198227],"study_design_scores_gemma":[0.010502758,0.0041112714,0.9812118,0.00047653823,0.00007699426,0.00004308712,0.00092383305,0.0011489338,0.0009012607,0.0002266869,0.00021226205,0.00016462067],"about_ca_topic_score_codex":0.0010608246,"about_ca_topic_score_gemma":0.0002676331,"teacher_disagreement_score":0.09181765,"about_ca_system_score_codex":0.00025054664,"about_ca_system_score_gemma":0.00021720643,"threshold_uncertainty_score":0.51532674},"labels":[],"label_agreement":null},{"id":"W2160378267","doi":"10.1158/1078-0432.ccr-11-3281","title":"Molecular Pathways: Tumor Cells Co-opt the Brain-Specific Metabolism Gene <i>CPT1C</i> to Promote Survival","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Gene; Biology; Metabolism; Cancer research; Brain cancer; Cancer; Genetics; Cell biology; Endocrinology","score_opus":0.25257633878264385,"score_gpt":0.4803918267372346,"score_spread":0.22781548795459072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160378267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001584257,0.9859492,0.000102161226,0.0004226273,0.0067733144,0.0031398197,0.0011208144,0.00003193777,0.0008758455],"genre_scores_gemma":[0.00010429999,0.97264016,0.00018823649,0.0011622648,0.021942127,0.0016032279,0.00036855153,0.00027767813,0.0017134482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896804,0.0032148915,0.0017012593,0.0019530234,0.0015084902,0.0019419002],"domain_scores_gemma":[0.9944388,0.0005677344,0.00043226528,0.0027697887,0.0006637358,0.001127652],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008979332,0.0008603714,0.002459046,0.0002152286,0.00033930226,0.00021521577,0.0025136934,0.0009313592,0.0002574313],"category_scores_gemma":[0.0006023119,0.000599675,0.0016854117,0.0007772634,0.00081255747,0.000010238295,0.0012869337,0.0024376214,0.0006059441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017608168,0.00026592583,0.0000015891119,0.0012296521,0.0004920817,0.000026233187,0.000043839664,0.0000036635934,0.015446511,0.0002505839,0.09674798,0.88531584],"study_design_scores_gemma":[0.00059907424,0.00020249841,0.000010964609,0.000504834,0.00033401273,0.000024066205,0.000016073527,3.3414287e-7,0.008001756,0.000039717455,0.9895454,0.000721245],"about_ca_topic_score_codex":0.00010906461,"about_ca_topic_score_gemma":0.000049654995,"teacher_disagreement_score":0.89279747,"about_ca_system_score_codex":0.00012129289,"about_ca_system_score_gemma":0.0023115345,"threshold_uncertainty_score":0.9998638},"labels":[],"label_agreement":null},{"id":"W2160463964","doi":"10.1158/1078-0432.ccr-14-2666","title":"Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":479,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Androgen receptor; Medicine; Cancer research; Prostate; Androgen; Cancer; Castration; Oncology; Internal medicine; Hormone","score_opus":0.2777102049017103,"score_gpt":0.5002984513579463,"score_spread":0.22258824645623598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160463964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96632457,0.021848954,0.000002486555,0.006688684,0.00020609824,0.0017643966,0.00015964519,0.000020551286,0.0029846393],"genre_scores_gemma":[0.9910774,0.0047311005,0.0004935679,0.00007491542,0.00018854311,0.000828277,0.00005086812,0.00004429282,0.002511033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954748,0.0007270283,0.001124717,0.000655677,0.0012300978,0.00078764925],"domain_scores_gemma":[0.9973515,0.00050428696,0.0001681909,0.00067465164,0.00088802027,0.00041332789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042281835,0.00019741838,0.000585645,0.00046220634,0.00010340126,0.000039485356,0.0003325237,0.00021001534,0.00019164452],"category_scores_gemma":[0.0007756774,0.00016398629,0.000121421865,0.0017951607,0.00062814093,0.00015366037,0.00014353069,0.0008565205,0.0000131180705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014288948,0.001833126,0.8154408,0.0009077794,0.00036755772,0.00037592795,0.004047058,0.00015702138,0.13946465,0.00019519833,0.0119435955,0.010978379],"study_design_scores_gemma":[0.060730107,0.003344798,0.80072844,0.0037307744,0.00018329576,0.0000081647495,0.00628937,0.0010280384,0.10290546,0.0056296913,0.014319476,0.0011023654],"about_ca_topic_score_codex":0.0035938337,"about_ca_topic_score_gemma":0.016524069,"teacher_disagreement_score":0.04644116,"about_ca_system_score_codex":0.001139066,"about_ca_system_score_gemma":0.004186588,"threshold_uncertainty_score":0.9220818},"labels":[],"label_agreement":null},{"id":"W2160506158","doi":"10.1158/1078-0432.ccr-07-0437","title":"A Phase I and Pharmacokinetic Trial of Erlotinib in Combination with Weekly Docetaxel in Patients with Taxane-Naive Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; Sanofi","keywords":"Docetaxel; Medicine; Erlotinib; Neutropenia; Taxane; Internal medicine; Pharmacokinetics; Gastroenterology; Oncology; Mucositis; Pharmacology; Chemotherapy; Cancer; Epidermal growth factor receptor; Breast cancer","score_opus":0.18398884871801144,"score_gpt":0.5254690886657982,"score_spread":0.34148023994778676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160506158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993986,0.00071597315,0.000002983912,0.001623445,0.000060635204,0.0031259917,0.00003340826,0.000012345945,0.00043917831],"genre_scores_gemma":[0.9966263,0.0021610775,0.000091424714,0.00007121467,0.00010657259,0.0005256159,0.000013906225,0.000026279342,0.00037757383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626064,0.0005028633,0.00066893204,0.0005049594,0.0014989491,0.00056363444],"domain_scores_gemma":[0.9976006,0.00089347304,0.00013739955,0.00027844388,0.0008704506,0.00021962264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020013822,0.00016313711,0.00069406745,0.00044614117,0.00008061589,0.000010899979,0.00015727735,0.00008815844,0.00007210907],"category_scores_gemma":[0.0011554722,0.00011125904,0.000043899818,0.0010899099,0.0016103032,0.0001236197,0.0001385334,0.0009645357,0.0000031595034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20781052,0.005276318,0.7762652,0.0002791257,0.00009743744,0.00014781393,0.0005991513,0.0000043783366,0.00006846455,0.000018015586,0.0009958212,0.008437728],"study_design_scores_gemma":[0.34188184,0.024551094,0.63165283,0.0006471326,0.000028116701,0.0000031354764,0.0001777472,0.000058381185,0.00029589402,0.000026521051,0.0005554267,0.00012187827],"about_ca_topic_score_codex":0.0010721756,"about_ca_topic_score_gemma":0.00048291203,"teacher_disagreement_score":0.14461239,"about_ca_system_score_codex":0.00024926043,"about_ca_system_score_gemma":0.0009286147,"threshold_uncertainty_score":0.59332293},"labels":[],"label_agreement":null},{"id":"W2160614740","doi":"10.1158/1078-0432.ccr-08-1007","title":"Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid Leukemia","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Romidepsin; Medicine; Myeloid leukemia; Histone deacetylase inhibitor; Leukemia; Myeloid; Bone marrow; Internal medicine; Oncology; Cohort; Hematology; Cancer research; Immunology; Histone deacetylase; Biology; Histone; Genetics","score_opus":0.32182533066670976,"score_gpt":0.5046025705707391,"score_spread":0.18277723990402933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160614740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929003,0.00040927017,0.000053151587,0.0035197872,0.00068700576,0.0015882934,0.00015138781,0.00012981011,0.0005609608],"genre_scores_gemma":[0.9854229,0.0029935462,0.00027806265,0.0001947256,0.0017466081,0.00032979588,0.0000593291,0.00013320899,0.00884184],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9919173,0.0009952021,0.001194654,0.0014472298,0.0024866136,0.0019589642],"domain_scores_gemma":[0.9947953,0.0019227009,0.0001838663,0.0011645033,0.00064020895,0.0012933707],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025715271,0.00045022974,0.0013566888,0.0009614749,0.00064554403,0.00008649693,0.0007331576,0.0008029817,0.0019534004],"category_scores_gemma":[0.0028536823,0.000391879,0.00044633806,0.0016941329,0.0026477126,0.00030957753,0.0008917321,0.006560183,0.00064543646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.025216106,0.0024350984,0.29792044,0.00052375376,0.0007656425,0.008276763,0.0013372658,0.000009400336,0.49237758,0.000067500514,0.112534225,0.058536228],"study_design_scores_gemma":[0.026071686,0.002919571,0.828287,0.00080852053,0.00012890414,0.00030333136,0.00018266871,0.0032917738,0.12056189,0.00007367661,0.016317504,0.001053484],"about_ca_topic_score_codex":0.0039331266,"about_ca_topic_score_gemma":0.0010343391,"teacher_disagreement_score":0.53036654,"about_ca_system_score_codex":0.008108083,"about_ca_system_score_gemma":0.008668175,"threshold_uncertainty_score":0.9998533},"labels":[],"label_agreement":null},{"id":"W2160767552","doi":"10.1158/1078-0432.ccr-10-2694","title":"STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Gary Bennett Family Fund; National Cancer Institute; Entertainment Industry Foundation","keywords":"Colorectal cancer; Microsatellite instability; KRAS; Cancer research; Immunohistochemistry; STAT3; Medicine; DNA methylation; Oncology; Angiogenesis; Biology; Cancer; Internal medicine; Gene expression; Signal transduction; Gene; Microsatellite; Genetics","score_opus":0.20603125582226103,"score_gpt":0.4858001389337855,"score_spread":0.2797688831115245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160767552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976806,0.0006373305,0.00003907327,0.00037108044,0.000103921004,0.00056508917,0.000089951944,0.0000126295145,0.0005003265],"genre_scores_gemma":[0.9978659,0.0012092068,0.00043603563,0.00004537229,0.00011996736,0.00022891209,0.000036134268,0.000016231152,0.000042215346],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983076,0.00024064316,0.00047738402,0.00031682564,0.00040499994,0.00025254773],"domain_scores_gemma":[0.9989374,0.00026673055,0.00008809443,0.00020647068,0.0003244935,0.0001768023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011359771,0.00008757371,0.00026704057,0.00019784003,0.000041504194,0.000010748802,0.00009577198,0.000100040874,0.00046431622],"category_scores_gemma":[0.0007241827,0.000071385984,0.000060767146,0.000266914,0.00017832355,0.00009554885,0.000119860335,0.0007210495,0.0000031066602],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031215034,0.0004048048,0.65665525,0.00047784913,0.000070560374,0.00017844899,0.0011707769,0.000005269126,0.31644702,0.00014427413,0.0024497567,0.018874478],"study_design_scores_gemma":[0.001997842,0.0012497273,0.41075307,0.0017160391,0.000030692456,0.000011455503,0.00047666315,0.00021622215,0.5822672,0.00008763652,0.0010775102,0.00011594445],"about_ca_topic_score_codex":0.0067740036,"about_ca_topic_score_gemma":0.0019894217,"teacher_disagreement_score":0.26582018,"about_ca_system_score_codex":0.00011365988,"about_ca_system_score_gemma":0.0004505186,"threshold_uncertainty_score":0.99983996},"labels":[],"label_agreement":null},{"id":"W2160890790","doi":"10.1158/1078-0432.ccr-09-2879","title":"Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Stage (stratigraphy); Disease; Lymphoma; Oncology; Medicine; Cutaneous T-cell lymphoma; Microarray; Internal medicine; Microarray analysis techniques; Survival analysis; Gene; Gene expression profiling; Gene expression; Biology; Mycosis fungoides; Genetics","score_opus":0.0916328320573467,"score_gpt":0.4531037524457182,"score_spread":0.36147092038837153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160890790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926262,0.00020167809,0.000006680751,0.0023994888,0.00023725955,0.0023394004,0.00023955887,0.000051429222,0.0018982971],"genre_scores_gemma":[0.99416816,0.00012615054,0.00019553534,0.00033910596,0.00042187062,0.0005177048,0.00012268001,0.000074416006,0.0040343837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99439174,0.00042882824,0.0008141996,0.0008904407,0.002469419,0.0010053616],"domain_scores_gemma":[0.99618137,0.00080235227,0.000066339584,0.00071430556,0.0011825224,0.001053105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014968616,0.00025307472,0.0005526285,0.00039395428,0.00018518834,0.00006756598,0.00041093677,0.00024248681,0.0018898267],"category_scores_gemma":[0.0017256261,0.00018882062,0.00018168677,0.00074472744,0.0012551737,0.00010937167,0.00012669576,0.0017336746,0.0001782912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013996125,0.0044325157,0.9686467,0.0002360399,0.000044551765,0.00050292775,0.00007132721,0.0000039022334,0.00031214757,0.000083820814,0.0013751094,0.01029485],"study_design_scores_gemma":[0.012612631,0.0016045324,0.97944367,0.000110040084,0.00002957452,0.00002091946,0.000053320586,0.0004915045,0.00009351744,0.000152762,0.005165049,0.00022245987],"about_ca_topic_score_codex":0.0003369399,"about_ca_topic_score_gemma":0.0007269534,"teacher_disagreement_score":0.010797006,"about_ca_system_score_codex":0.0003150435,"about_ca_system_score_gemma":0.0025830101,"threshold_uncertainty_score":0.9990226},"labels":[],"label_agreement":null},{"id":"W2161090963","doi":"10.1158/1078-0432.ccr-05-2070","title":"Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Myeloid leukemia; Diphtheria toxin; Progenitor cell; Biology; Molecular biology; Cytotoxicity; Leukemia; Fusion protein; Interleukin 3; Cancer research; Receptor; Immunology; Stem cell; Toxin; Interleukin 21; CD8; Cell biology; Immune system; Genetics; Gene; In vitro; Recombinant DNA","score_opus":0.043342469770564516,"score_gpt":0.35804099655516125,"score_spread":0.31469852678459675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161090963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921099,0.0005538125,0.0005907515,0.000398852,0.0009296824,0.002552775,0.00031771505,0.0002084314,0.0023380625],"genre_scores_gemma":[0.99067736,0.0005818049,0.0009834275,0.000282711,0.0006712029,0.0012128938,0.00027878478,0.0001037271,0.005208084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99346113,0.002111331,0.0012129075,0.001303195,0.00040409484,0.0015073124],"domain_scores_gemma":[0.99698186,0.00067845016,0.00036738458,0.0011065004,0.00068582135,0.0001799714],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0033516285,0.000512837,0.00092601427,0.00022550325,0.0009021587,0.00013387241,0.001046032,0.00096111174,0.0027558287],"category_scores_gemma":[0.00046719503,0.00038920323,0.0003225883,0.0005516616,0.0012473066,0.00022661897,0.0005746825,0.0027097256,0.00085824507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052524367,0.00084081816,0.0008880191,0.00003974354,0.00037773896,0.00006205519,0.00013730285,0.000007059835,0.9800257,0.00027381684,0.0048306254,0.0072647016],"study_design_scores_gemma":[0.0057000974,0.002667014,0.010754061,0.00029045943,0.000064826556,0.000021916061,0.00020378339,0.000016799873,0.9531226,0.00027115742,0.026275216,0.0006120384],"about_ca_topic_score_codex":0.004378717,"about_ca_topic_score_gemma":0.0019243899,"teacher_disagreement_score":0.02690305,"about_ca_system_score_codex":0.0008386063,"about_ca_system_score_gemma":0.0017290794,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W2161109798","doi":"10.1158/1078-0432.ccr-10-1282","title":"A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":824,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; BC Cancer Agency","keywords":"Breast cancer; Oncology; Immunohistochemistry; Internal medicine; Medicine; Estrogen receptor; Hazard ratio; Progesterone receptor; Tamoxifen; Proportional hazards model; Subtyping; Hormone receptor; Cancer; Confidence interval","score_opus":0.07446867362571363,"score_gpt":0.4895050496537869,"score_spread":0.41503637602807325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161109798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620384,0.002246396,0.000003441342,0.00047239676,0.00018736046,0.0005328968,0.00023972474,0.000013058768,0.00010085956],"genre_scores_gemma":[0.99747944,0.0015833622,0.00013012665,0.000028386761,0.00037310054,0.00021918585,0.00009384598,0.000040992985,0.000051587707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970893,0.00035061582,0.00081936084,0.0008305003,0.0003673026,0.0005428664],"domain_scores_gemma":[0.99785614,0.0006068649,0.00024124031,0.00046475077,0.00059427,0.00023673176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009553651,0.00027037755,0.0006731339,0.000079458456,0.00013660351,0.000026361668,0.00030518827,0.00040210978,0.000077379824],"category_scores_gemma":[0.00056955515,0.00021400316,0.00013007363,0.00035502488,0.0017314709,0.000010344181,0.00033862895,0.0011915754,0.0000026866605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002575222,0.0006135911,0.9529399,0.000052869753,0.00034947312,0.0000053517942,0.00011340758,0.0000024456376,0.031732313,0.000008856811,0.00027899313,0.011327541],"study_design_scores_gemma":[0.002136542,0.00057673757,0.9609632,0.00022575798,0.000071833056,0.0000067215938,0.00023780725,0.000011099502,0.03524931,0.000009604872,0.0002801559,0.0002312235],"about_ca_topic_score_codex":0.0028595144,"about_ca_topic_score_gemma":0.0023926024,"teacher_disagreement_score":0.011096318,"about_ca_system_score_codex":0.000098183526,"about_ca_system_score_gemma":0.0006460445,"threshold_uncertainty_score":0.8726796},"labels":[],"label_agreement":null},{"id":"W2161134408","doi":"10.1158/1078-0432.ccr-06-1526","title":"The Bcl-2 Family Protein Inhibitor, ABT-737, Has Substantial Antimyeloma Activity and Shows Synergistic Effect with Dexamethasone and Melphalan","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Multiple myeloma; Dexamethasone; Melphalan; Apoptosis; Cancer research; Medicine; Cell culture; Bone marrow; Pharmacology; Progenitor cell; Internal medicine; Stem cell; Chemistry; Biology; Biochemistry","score_opus":0.15956877610764686,"score_gpt":0.47939545742552253,"score_spread":0.31982668131787567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161134408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110234,0.0037378343,0.000103784056,0.001659184,0.00009154562,0.0025333008,0.000021276963,0.00005912727,0.0006915914],"genre_scores_gemma":[0.99657536,0.0014047163,0.00021548198,0.00003977946,0.00050568546,0.0002636786,0.0000066369607,0.00005047958,0.0009382002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949799,0.0010576418,0.0004568524,0.0008068892,0.001515968,0.0011827467],"domain_scores_gemma":[0.9917017,0.0062728887,0.000091238115,0.00058818,0.00039523336,0.00095073384],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.008823052,0.0002792415,0.00062710536,0.00017111443,0.0008145848,0.00021801978,0.00019631372,0.00023497801,0.00003028647],"category_scores_gemma":[0.0027391913,0.0001536917,0.00009281877,0.000536612,0.0027684977,0.00011371894,0.0002498035,0.0015820256,0.000018046228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03195798,0.000523709,0.49206054,0.00036086174,0.00048898585,0.0014296977,0.00007711854,2.0547442e-7,0.05157544,0.00007927193,0.000641621,0.4208046],"study_design_scores_gemma":[0.011094709,0.007252476,0.9441125,0.00048264422,0.000092690236,0.000045191824,0.00009163445,0.00034022643,0.03351325,0.00005153303,0.00268599,0.0002372001],"about_ca_topic_score_codex":0.0021215007,"about_ca_topic_score_gemma":0.0033779524,"teacher_disagreement_score":0.45205194,"about_ca_system_score_codex":0.00017840725,"about_ca_system_score_gemma":0.0006214828,"threshold_uncertainty_score":0.9999454},"labels":[],"label_agreement":null},{"id":"W2161384666","doi":"10.1158/1078-0432.ccr-08-2581","title":"Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Dental and Craniofacial Research; National Institutes of Health; Flight Attendant Medical Research Institute","keywords":"Oncology; Head and neck squamous-cell carcinoma; Cisplatin; Medicine; Internal medicine; Hazard ratio; Immunohistochemistry; Confidence interval; Head and neck cancer; Radiation therapy; Cancer research; Pathology; Chemotherapy","score_opus":0.08203433884347096,"score_gpt":0.4239287561051464,"score_spread":0.34189441726167547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161384666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970715,0.0012515086,0.00002152496,0.00047499375,0.00022686108,0.00058054645,0.000008560754,0.000010174164,0.00035435113],"genre_scores_gemma":[0.9977906,0.00046704875,0.00016386263,0.000102520506,0.00036780696,0.000080861944,0.000050037357,0.000019049734,0.00095824845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806696,0.00018017019,0.00047335468,0.0005805682,0.00028901003,0.0004099495],"domain_scores_gemma":[0.9992778,0.00009128148,0.000076897675,0.00028306057,0.00008054736,0.000190416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007270563,0.00016311272,0.00029126037,0.000092591516,0.0001299064,0.00003163522,0.00012585949,0.00028035065,0.000016559352],"category_scores_gemma":[0.00014035673,0.00014038345,0.00013116014,0.00017856044,0.00004469589,0.000009281293,0.000065261425,0.00023310987,0.0000030219192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075050263,0.0004557092,0.10486281,0.00003134964,0.000017712537,0.000020688149,0.000118256474,0.00011914873,0.721903,0.000014394612,0.00013360559,0.17157282],"study_design_scores_gemma":[0.011612123,0.007469501,0.47210127,0.00003211731,0.00005770784,0.0000025367926,0.000112450085,0.0017396718,0.504308,0.00021007108,0.0019012912,0.0004533121],"about_ca_topic_score_codex":0.00026568628,"about_ca_topic_score_gemma":0.00011689106,"teacher_disagreement_score":0.36723843,"about_ca_system_score_codex":0.000112199996,"about_ca_system_score_gemma":0.00015227853,"threshold_uncertainty_score":0.5724671},"labels":[],"label_agreement":null},{"id":"W2161520972","doi":"10.1158/1078-0432.ccr-08-2342","title":"Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Eastern Ontario; Toronto General Hospital; University of Calgary","funders":"","keywords":"Oncolytic virus; Vaccinia; Virotherapy; Glioma; Cancer research; Virology; Virus; Biology; Genetic enhancement; Medicine; Immunology","score_opus":0.10254567586752597,"score_gpt":0.4781078364417772,"score_spread":0.3755621605742512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161520972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105096,0.0034616948,0.0003503679,0.0019356062,0.00008129204,0.002833964,0.000092387374,0.000020152578,0.00017356033],"genre_scores_gemma":[0.98950815,0.0065613026,0.0001733089,0.0009002138,0.00027319256,0.00055011665,0.000072638395,0.00007158087,0.0018894809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956886,0.0008474894,0.0009176765,0.0009254223,0.00085939915,0.00076141267],"domain_scores_gemma":[0.99685305,0.00074675895,0.00025243236,0.00092031836,0.0009222173,0.00030521242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00313124,0.00028730842,0.0006020406,0.00013662796,0.00018667747,0.00005569817,0.0007941941,0.00037453792,0.00017880947],"category_scores_gemma":[0.00043374658,0.00020605631,0.0002384566,0.00056772446,0.0003604029,0.000010239368,0.00006174323,0.00044680957,0.00000885702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.146904,0.0011767455,0.0003381002,0.00007115424,0.00021747619,0.0000033908184,0.000079122365,0.00000629982,0.79072845,0.000022461896,0.004403663,0.056049153],"study_design_scores_gemma":[0.015050552,0.06607497,0.0014030323,0.00018637443,0.000012906825,0.0000023925952,0.000044680306,0.00005405253,0.9091722,0.00011273636,0.0076042227,0.00028192202],"about_ca_topic_score_codex":0.00004163464,"about_ca_topic_score_gemma":0.00009217618,"teacher_disagreement_score":0.13185346,"about_ca_system_score_codex":0.00010002552,"about_ca_system_score_gemma":0.001175559,"threshold_uncertainty_score":0.84027326},"labels":[],"label_agreement":null},{"id":"W2161551303","doi":"10.1158/1078-0432.ccr-10-1891","title":"Pancreatic Tumor Suppression by Benzyl Isothiocyanate Is Associated with Inhibition of PI3K/AKT/FOXO Pathway","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; National Cancer Institute; University of Pittsburgh","keywords":"Benzyl isothiocyanate; FOXO1; PI3K/AKT/mTOR pathway; Protein kinase B; Chemistry; Apoptosis; Cancer research; Western blot; Molecular biology; Isothiocyanate; Biology; Biochemistry","score_opus":0.13351204368015232,"score_gpt":0.4011759671457218,"score_spread":0.26766392346556944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161551303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975126,0.00055117294,0.00026660244,0.00014308533,0.00009594501,0.00035330566,0.00023067585,0.000015678017,0.00083093083],"genre_scores_gemma":[0.9984295,0.00023949472,0.00010502263,0.0001382404,0.00008238766,0.00006798832,0.000249119,0.00003321267,0.0006550628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977324,0.00041193527,0.00049299025,0.00047821447,0.000531313,0.00035315246],"domain_scores_gemma":[0.9986658,0.00008325897,0.00017180038,0.000393126,0.00052751333,0.00015852056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011912115,0.0001417985,0.00026290145,0.00006860008,0.00009696754,0.000015088709,0.00018845615,0.00024277871,0.00049172813],"category_scores_gemma":[0.00033711852,0.000115883144,0.00011070774,0.00024148656,0.00045453434,0.000013179551,0.000073133306,0.00034889346,0.000013764513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017345843,0.0005937504,0.053965997,0.00007434895,0.00016802174,0.000010236012,0.00020221894,0.0000038359008,0.9223911,0.00007670117,0.0182885,0.0024906853],"study_design_scores_gemma":[0.0019477544,0.001983784,0.05712662,0.00022698838,0.000029418097,0.0000018879479,0.00006756633,0.000049269158,0.9321999,0.00031535747,0.0058389227,0.0002125243],"about_ca_topic_score_codex":0.0003724493,"about_ca_topic_score_gemma":0.00018385774,"teacher_disagreement_score":0.012449577,"about_ca_system_score_codex":0.000045930567,"about_ca_system_score_gemma":0.00022610243,"threshold_uncertainty_score":0.5384078},"labels":[],"label_agreement":null},{"id":"W2161609794","doi":"10.1158/1078-0432.ccr-07-4921","title":"Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":605,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; European Commission","keywords":"Biology; Cancer research; Carcinogenesis; Epigenetics; Clear cell; Cancer; DNA methylation; Clear cell renal cell carcinoma; CpG site; Germline mutation; Mutation; Gene; Pathology; Renal cell carcinoma; Medicine; Genetics; Gene expression; Carcinoma","score_opus":0.2289285019524419,"score_gpt":0.47762697916421604,"score_spread":0.24869847721177413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161609794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962585,0.0008726262,0.00004984414,0.0009069416,0.00012785789,0.00085026864,0.000021635318,0.000017216835,0.00089514063],"genre_scores_gemma":[0.99447554,0.0010585398,0.00027899048,0.000064089116,0.00036220733,0.00016366942,0.00004560799,0.000028962648,0.0035223665],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967041,0.00043987704,0.0011838821,0.0005171462,0.0007375986,0.00041739154],"domain_scores_gemma":[0.99791014,0.00047580138,0.00016865155,0.0006195482,0.0005623282,0.00026354424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022344189,0.00012531548,0.0004307045,0.000292792,0.00011440116,0.000013566939,0.00019035481,0.00015134696,0.00023148443],"category_scores_gemma":[0.00057341764,0.000107772765,0.00017461664,0.0006153625,0.0004676837,0.00007536227,0.000094489296,0.0008160827,0.00008978113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058741644,0.00295025,0.21261103,0.00031706944,0.00010142082,0.0005267998,0.0011056571,0.00010109293,0.7649525,0.00007665225,0.0031847737,0.008198574],"study_design_scores_gemma":[0.0037660897,0.0018914965,0.5170361,0.0001222223,0.000036726127,0.000025157131,0.00011026082,0.0023587497,0.47391167,0.000091685244,0.00051933806,0.000130521],"about_ca_topic_score_codex":0.0011232101,"about_ca_topic_score_gemma":0.00018922192,"teacher_disagreement_score":0.30442503,"about_ca_system_score_codex":0.0003581319,"about_ca_system_score_gemma":0.0009795928,"threshold_uncertainty_score":0.4394846},"labels":[],"label_agreement":null},{"id":"W2161991320","doi":"10.1158/1078-0432.ccr-07-0122","title":"FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":289,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"National Cancer Institute; School of Medicine, Indiana University","keywords":"FOXA1; Breast cancer; Estrogen receptor; Medicine; Oncology; Immunohistochemistry; Internal medicine; Cancer; Cancer research","score_opus":0.0913976187551956,"score_gpt":0.457122373456357,"score_spread":0.3657247547011614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161991320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972518,0.000724438,0.00070967583,0.0005869745,0.00020937742,0.00021164176,0.000018016406,0.00000719951,0.0002808492],"genre_scores_gemma":[0.9982699,0.00075642177,0.00010333358,0.00004155381,0.00044758196,0.00003057621,0.000031872445,0.000017066512,0.00030164878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984532,0.00020948082,0.00028361866,0.00039728617,0.0003465471,0.0003098782],"domain_scores_gemma":[0.9993128,0.00008978841,0.000052240488,0.00019082685,0.0002168359,0.00013749153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018942561,0.000090838184,0.00013011895,0.00008453816,0.00007265757,0.000021363381,0.00010292336,0.00019465803,0.000059163056],"category_scores_gemma":[0.00007509253,0.00007601937,0.000031486095,0.0002212568,0.0002810271,0.0000105074105,0.000051439252,0.00034179245,0.000003621563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026538162,0.00007987655,0.8590943,0.0000237193,0.00001197275,0.000005528156,0.000043711807,0.000072030496,0.12461303,0.000031617084,0.00042730925,0.012943071],"study_design_scores_gemma":[0.0012341363,0.00024221449,0.98532,0.00007905689,0.000004551661,0.000004647075,0.00007731149,0.000094648174,0.0085692415,0.000028058286,0.00423683,0.00010936067],"about_ca_topic_score_codex":0.0005614669,"about_ca_topic_score_gemma":0.0046276725,"teacher_disagreement_score":0.12622564,"about_ca_system_score_codex":0.000052578944,"about_ca_system_score_gemma":0.0001899019,"threshold_uncertainty_score":0.309998},"labels":[],"label_agreement":null},{"id":"W2162110703","doi":"10.1158/1078-0432.ccr-03-1061","title":"Estrogen Receptor Status in <b> <i>BRCA1</i> </b>- and <b> <i>BRCA2</i> </b>-Related Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; BC Cancer Agency; Coalition for Research in Women's Health; Sunnybrook Health Science Centre; Hôtel-Dieu de Montréal; Health Sciences Centre; McGill University; University of Toronto; Jewish General Hospital","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Internal medicine; Cancer; Oncology","score_opus":0.06710784466175702,"score_gpt":0.45300722840408725,"score_spread":0.38589938374233024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162110703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97698396,0.015363147,0.000026995118,0.0054206764,0.00059639843,0.0005323503,0.00029068714,0.000024344416,0.0007614537],"genre_scores_gemma":[0.97228885,0.024602558,0.00044609868,0.0007317843,0.0007047659,0.00046479967,0.00006717398,0.00007188007,0.0006220891],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966001,0.00035871967,0.00068458944,0.0009775144,0.0004752947,0.00090376445],"domain_scores_gemma":[0.99843913,0.00011697813,0.00010109042,0.0005684508,0.00039242418,0.0003819463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015803204,0.00022371694,0.0003196609,0.00014705062,0.00016054425,0.00006250386,0.00038136716,0.00042907117,0.00031532825],"category_scores_gemma":[0.0002990625,0.00021868308,0.00011397711,0.0006623963,0.0008449208,0.000014389535,0.0003528392,0.0008818008,0.00005241334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026008128,0.0010850187,0.56048125,0.0001790575,0.0005154155,0.000052271236,0.000783339,0.0035974637,0.18593153,0.0018383204,0.033475187,0.2094603],"study_design_scores_gemma":[0.023373786,0.0017791783,0.24437247,0.000673862,0.00009811606,0.000086998996,0.0011333104,0.00010950518,0.123057656,0.0050336723,0.59834737,0.0019340438],"about_ca_topic_score_codex":0.0022698252,"about_ca_topic_score_gemma":0.001966426,"teacher_disagreement_score":0.5648722,"about_ca_system_score_codex":0.0006108141,"about_ca_system_score_gemma":0.002426537,"threshold_uncertainty_score":0.89176375},"labels":[],"label_agreement":null},{"id":"W2162340188","doi":"10.1158/1078-0432.ccr-09-0145","title":"Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Imatinib; Pharmacogenetics; Medicine; Clinical significance; Oncology; Gene; Bioinformatics; Immunology; Internal medicine; Biology; Genetics; Genotype","score_opus":0.1807922541795707,"score_gpt":0.5079772695143526,"score_spread":0.32718501533478195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162340188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982362,0.012635368,0.0001651431,0.0016370015,0.00013380409,0.0028000341,0.00006482929,0.000037691847,0.00016413697],"genre_scores_gemma":[0.9729668,0.015133887,0.009576217,0.00084685517,0.00056972477,0.0002583863,0.000009882847,0.000057857178,0.00058040343],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99296486,0.0019858908,0.0017408414,0.0012658281,0.0010511175,0.0009914507],"domain_scores_gemma":[0.9941334,0.0033659833,0.00019516284,0.0009960899,0.00042614352,0.000883203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009065558,0.00031597062,0.0011104095,0.00039633195,0.00012453254,0.000030318546,0.00044303,0.0002864939,0.00006634821],"category_scores_gemma":[0.0043269354,0.00027448358,0.0001841553,0.0012992217,0.0005025854,0.000086320826,0.0002248429,0.0011701384,0.000014909701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098993756,0.0011246625,0.3228037,0.00041969033,0.00026650482,0.00023695578,0.00074450107,0.0013455747,0.09314897,0.00000937251,0.0035847719,0.47732157],"study_design_scores_gemma":[0.03337395,0.008379229,0.9013364,0.0020116777,0.000093119925,0.000027697113,0.00012540877,0.01597733,0.014691279,0.00009825843,0.023313085,0.00057259493],"about_ca_topic_score_codex":0.0006046504,"about_ca_topic_score_gemma":0.00051505445,"teacher_disagreement_score":0.5785327,"about_ca_system_score_codex":0.0036762913,"about_ca_system_score_gemma":0.0063860537,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W2162630386","doi":"10.1158/1078-0432.ccr-05-0464","title":"Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":541,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Jonsson Cancer Center Foundation; National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Immune system; Dendritic cell; Cytotoxic T cell; Adverse effect; Vaccination; Immunotherapy; Tumor microenvironment; CTL*; T cell; Immunology; Pathology; CD8; Cancer research; Internal medicine; Biology; In vitro","score_opus":0.02518037491735347,"score_gpt":0.33009177011250956,"score_spread":0.3049113951951561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162630386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719561,0.025987655,0.000018963048,0.00051793293,0.0005001372,0.00088372413,0.00006546004,0.000033092605,0.000036952533],"genre_scores_gemma":[0.9967663,0.001457976,0.0000053564136,0.00013479225,0.00007984099,0.00014709348,0.000018423521,0.00003426797,0.0013559391],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9935746,0.0039057888,0.00092312327,0.000538162,0.00018949647,0.0008687964],"domain_scores_gemma":[0.99772567,0.0015473649,0.0001688173,0.00037941022,0.00011778682,0.000060957496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022343,0.00023487797,0.00042016135,0.00018404942,0.00038993024,0.00005911208,0.0004765067,0.0003461786,0.00016743707],"category_scores_gemma":[0.00017768805,0.00017589291,0.00009422935,0.00027140745,0.0005779791,0.00013780879,0.00019112609,0.0012637649,0.00017758945],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024775786,0.0023500193,0.026809888,0.00037366056,0.00016501179,0.000052635478,0.0014315579,0.00012108929,0.74401796,0.000020640478,0.005856672,0.19402505],"study_design_scores_gemma":[0.021137688,0.003923181,0.5897487,0.00074445084,0.00008107798,0.0002127387,0.004143278,0.00054441777,0.3530388,0.0000123997515,0.025608126,0.00080516975],"about_ca_topic_score_codex":0.00055795803,"about_ca_topic_score_gemma":0.00013110664,"teacher_disagreement_score":0.5629388,"about_ca_system_score_codex":0.00058971444,"about_ca_system_score_gemma":0.00020902426,"threshold_uncertainty_score":0.7172705},"labels":[],"label_agreement":null},{"id":"W2162692860","doi":"10.1158/1078-0432.ccr-13-1485","title":"Nab-Paclitaxel Is an Active Drug in Preclinical Model of Pediatric Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Paclitaxel; Rhabdomyosarcoma; In vivo; Neuroblastoma; Medicine; Cancer research; Chemotherapy; Pharmacology; Cell culture; Internal medicine; Sarcoma; Pathology; Biology","score_opus":0.24984792316112422,"score_gpt":0.5535701934128054,"score_spread":0.3037222702516812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162692860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963696,0.0010903368,0.000014309631,0.00069817074,0.00006887404,0.00077213655,0.00015403445,0.0000070859846,0.0008254811],"genre_scores_gemma":[0.9926051,0.004392752,0.0001981326,0.00017729275,0.0005793533,0.000524371,0.000044375403,0.000035091944,0.0014435479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635804,0.00060981273,0.00076648913,0.0008198016,0.00067703176,0.00076881226],"domain_scores_gemma":[0.9978025,0.00025414376,0.00011836613,0.0007302585,0.00059874146,0.00049599074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017685782,0.00017278615,0.00041030612,0.00016741958,0.0000788892,0.000035625162,0.00059734413,0.00024877058,0.00035080896],"category_scores_gemma":[0.000880094,0.00015070439,0.00020207005,0.00037249393,0.0004886507,0.000025018242,0.0004398215,0.0007784415,0.0000722179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064978288,0.006666049,0.7617949,0.00032267856,0.0005079287,0.00003574998,0.00094630435,0.00063694466,0.037540946,0.000091885006,0.08431954,0.100639194],"study_design_scores_gemma":[0.02464401,0.014810495,0.59026253,0.0002914515,0.00013767091,0.0000070033843,0.0016026795,0.023971545,0.31777814,0.019540088,0.0048581576,0.0020962628],"about_ca_topic_score_codex":0.003307611,"about_ca_topic_score_gemma":0.0017126171,"teacher_disagreement_score":0.2802372,"about_ca_system_score_codex":0.000091491755,"about_ca_system_score_gemma":0.0013025121,"threshold_uncertainty_score":0.6145547},"labels":[],"label_agreement":null},{"id":"W2162713325","doi":"10.1158/1078-0432.ccr-10-1264","title":"Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; University of Chicago","keywords":"FYN; Cancer research; Gene knockdown; Cell growth; DU145; Cell biology; Cancer; Biology; Chemistry; Cancer cell; Proto-oncogene tyrosine-protein kinase Src; Kinase; Cell culture; Biochemistry; Genetics","score_opus":0.2745063226434822,"score_gpt":0.4635810763183067,"score_spread":0.18907475367482451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162713325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996007,0.0021938847,9.854012e-7,0.00043519677,0.00013138726,0.00033447615,0.0000123581085,0.000004973493,0.00087968976],"genre_scores_gemma":[0.99831986,0.0008110438,0.00009370077,0.0003320849,0.00013385189,0.000020482921,0.0000012530376,0.000009308973,0.00027840913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982119,0.00069980475,0.0002724549,0.00032676774,0.00021097221,0.00027808532],"domain_scores_gemma":[0.9986196,0.000776053,0.000054059114,0.00028469812,0.000118445765,0.00014714483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018112573,0.000084435786,0.00035934994,0.00007707081,0.00005285434,0.000003292665,0.00013522166,0.00021861667,0.00039744892],"category_scores_gemma":[0.00028290454,0.000054053482,0.000059510356,0.00021334674,0.001137228,0.000028409344,0.00021766074,0.0007965464,0.0000096350295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017470191,0.00040526912,0.8079018,0.0003322198,0.00009702507,0.00012743572,0.0031832957,6.923726e-7,0.16764271,0.00019898811,0.0021595734,0.016203962],"study_design_scores_gemma":[0.004311753,0.0033063074,0.79150707,0.0003674724,0.00009030395,0.000010701951,0.0004284195,0.00016638094,0.19439211,0.0042025778,0.00106261,0.00015429666],"about_ca_topic_score_codex":0.00042667644,"about_ca_topic_score_gemma":0.000050100763,"teacher_disagreement_score":0.0267494,"about_ca_system_score_codex":0.00002038816,"about_ca_system_score_gemma":0.00020024551,"threshold_uncertainty_score":0.4351787},"labels":[],"label_agreement":null},{"id":"W2162804910","doi":"10.1158/1078-0432.ccr-04-1347","title":"Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Gefitinib; Paclitaxel; Pharmacology; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Medicine; Dosing; Chemotherapy; Internal medicine; Cancer","score_opus":0.17029377243080993,"score_gpt":0.516426543690462,"score_spread":0.34613277125965214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162804910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95747304,0.00034621792,0.00006475596,0.0346811,0.00043681244,0.0057137567,0.00089990045,0.000043875083,0.0003405207],"genre_scores_gemma":[0.9925739,0.0000973594,0.0008885485,0.0015059785,0.0024230857,0.0015082514,0.00002841178,0.00009475632,0.0008797048],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9931902,0.0013709588,0.001269062,0.0009560334,0.002056352,0.0011573776],"domain_scores_gemma":[0.9911189,0.0054425243,0.00026650884,0.0007824406,0.001718726,0.0006708893],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059227603,0.0002813584,0.0008659059,0.00019620793,0.00048133673,0.000076952005,0.00049089565,0.00025381387,0.00095492415],"category_scores_gemma":[0.009554314,0.00021600613,0.00047666288,0.0009589948,0.00079365144,0.00013647518,0.00037987027,0.0019455445,0.0000446572],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02729616,0.0022401316,0.24340545,0.0024882935,0.0006182552,0.000113867405,0.009580172,0.000033618464,0.2031779,0.00036420726,0.17071785,0.3399641],"study_design_scores_gemma":[0.0073030093,0.0096726185,0.28999886,0.0023268613,0.00011994269,0.000051396568,0.004705469,0.00079292664,0.6209002,0.00018212246,0.0632031,0.0007434808],"about_ca_topic_score_codex":0.000717657,"about_ca_topic_score_gemma":0.00019836285,"teacher_disagreement_score":0.4177223,"about_ca_system_score_codex":0.0009546887,"about_ca_system_score_gemma":0.0019429259,"threshold_uncertainty_score":0.99995834},"labels":[],"label_agreement":null},{"id":"W2162812530","doi":"10.1158/1078-0432.ccr-11-0244","title":"Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Medical Center, University of Pittsburgh; National Institutes of Health; University of Rochester","keywords":"Cyclin-dependent kinase 6; Amplicon; Biology; Cancer research; Tissue microarray; Gene knockdown; Gene duplication; Cyclin; Cell cycle; Cancer; Gene; Genetics; Polymerase chain reaction","score_opus":0.15895241496436774,"score_gpt":0.4577620976479351,"score_spread":0.29880968268356733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162812530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457475,0.04886684,0.0000084616695,0.0010822753,0.00022266991,0.0019241221,0.000025247033,0.000051745767,0.0020711215],"genre_scores_gemma":[0.9921412,0.00465375,0.00012528444,0.00031988462,0.00041297002,0.0006175691,0.000014389644,0.000062327745,0.0016526199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994658,0.0008958593,0.0007469451,0.0009972174,0.0014521478,0.0012498392],"domain_scores_gemma":[0.9972356,0.0007640559,0.0000841353,0.0005649383,0.00035902974,0.0009922355],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002706353,0.0002851448,0.0006260351,0.00040581822,0.00019084233,0.000071237184,0.00033287983,0.00026619487,0.0021056798],"category_scores_gemma":[0.00077269046,0.00022815782,0.00018969363,0.0005115783,0.0009594149,0.00015708496,0.0003285182,0.001714365,0.00025616848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008208086,0.0011653601,0.9428579,0.00016628258,0.00025226964,0.0064728004,0.0003893496,5.402779e-7,0.00005327472,0.00019737656,0.00028995395,0.039946772],"study_design_scores_gemma":[0.00548185,0.0058429083,0.9849632,0.00017588297,0.00008952497,0.00006685724,0.00020197438,0.00004394315,0.00071021885,0.0021609543,0.00008573496,0.0001769455],"about_ca_topic_score_codex":0.005132205,"about_ca_topic_score_gemma":0.00044669426,"teacher_disagreement_score":0.046393685,"about_ca_system_score_codex":0.00034512198,"about_ca_system_score_gemma":0.0010893097,"threshold_uncertainty_score":0.99880654},"labels":[],"label_agreement":null},{"id":"W2162885883","doi":"10.1158/1078-0432.ccr-05-1771","title":"Erythropoietin Biology in Cancer","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Erythropoietin receptor; Erythropoietin; Paracrine signalling; Cancer research; Erythropoiesis; Angiogenesis; Autocrine signalling; Haematopoiesis; Cancer; Hematopoietic growth factor; Medicine; Cytokine; Cancer cell; Ovarian cancer; Biology; Immunology; Internal medicine; Anemia; Receptor; Stem cell; Cell biology","score_opus":0.5925182864790159,"score_gpt":0.6841651057528677,"score_spread":0.09164681927385177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162885883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014084157,0.98738,7.1299854e-7,0.0030417845,0.00079521385,0.0018709094,0.00014222153,0.00005272973,0.0065755863],"genre_scores_gemma":[0.000038911046,0.9831218,0.0001277599,0.00016780724,0.0026917546,0.001810134,0.00024955886,0.00011730905,0.01167495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99354225,0.001528379,0.0018383185,0.0012968138,0.0006232204,0.001171013],"domain_scores_gemma":[0.9962046,0.0019752556,0.00025300833,0.00087220164,0.00030035627,0.00039458735],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003062223,0.0004922035,0.0034852403,0.00053772447,0.00011144642,0.000029431745,0.0004219323,0.0013061606,0.0030508547],"category_scores_gemma":[0.0005791538,0.00033746057,0.0009658257,0.0012531977,0.0013469702,0.000024430277,0.00032546392,0.004012351,0.00059260183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006689962,0.00076648593,0.0051616565,0.009573267,0.00017114071,0.00025658877,0.000009080031,1.4392428e-7,2.1665544e-7,0.000101145895,0.060778312,0.9231151],"study_design_scores_gemma":[0.0015380068,0.00059209665,0.0003469514,0.02176851,0.00033268583,0.000018286835,0.000014663163,0.0000013899918,9.88906e-7,0.00010784738,0.97499645,0.00028210966],"about_ca_topic_score_codex":0.0073335576,"about_ca_topic_score_gemma":0.0017528703,"teacher_disagreement_score":0.92283297,"about_ca_system_score_codex":0.0013970609,"about_ca_system_score_gemma":0.004145083,"threshold_uncertainty_score":0.99999034},"labels":[],"label_agreement":null},{"id":"W2162891536","doi":"10.1158/1078-0432.ccr-09-0557","title":"Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Trace Elements in Health","field":"Nursing","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada","keywords":"Pancreatic cancer; Gene silencing; Cancer research; Cancer; Small hairpin RNA; Metastasis; Nude mouse; In vivo; Tumor progression; Medicine; Biology; Pathology; Internal medicine; Cell culture; Gene knockdown; Biochemistry","score_opus":0.12165660850417004,"score_gpt":0.47294074354651955,"score_spread":0.3512841350423495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162891536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98206615,0.008186118,0.000027359576,0.007679782,0.0003431042,0.0011414299,0.00023661376,0.000033030297,0.0002864147],"genre_scores_gemma":[0.9933575,0.0053244033,0.00015753954,0.00034153194,0.00041944496,0.00021989415,0.000014690826,0.000040474682,0.00012455108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945549,0.00153515,0.0012053138,0.0006737035,0.0012555405,0.00077539514],"domain_scores_gemma":[0.9943531,0.0035287063,0.0005006825,0.0005641996,0.00076576485,0.0002875433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027648702,0.0002812578,0.0008122434,0.00017194077,0.00025846888,0.00005445604,0.00055401353,0.00018690727,0.00028189633],"category_scores_gemma":[0.0010631296,0.00019090688,0.0000887035,0.00095057196,0.0012904163,0.0002352626,0.00013009475,0.0009737942,0.0000023396315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010019094,0.0010968352,0.8126865,0.0014450877,0.00034645712,0.0000034144978,0.0018128934,0.00008760479,0.041298892,0.0004312955,0.0066262097,0.12414574],"study_design_scores_gemma":[0.0034086853,0.0031846096,0.9218415,0.003255282,0.00029418422,0.0000029530922,0.0006231358,0.00037858592,0.0653237,0.00082002586,0.00047537492,0.0003919448],"about_ca_topic_score_codex":0.05125668,"about_ca_topic_score_gemma":0.010640625,"teacher_disagreement_score":0.12375379,"about_ca_system_score_codex":0.000272909,"about_ca_system_score_gemma":0.0005745614,"threshold_uncertainty_score":0.9550611},"labels":[],"label_agreement":null},{"id":"W2162916961","doi":"10.1158/1078-0432.756.11.2","title":"Intracellular Localization and Trafficking of Fluorescein-Labeled Cisplatin in Human Ovarian Carcinoma Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Golgi apparatus; Vesicle; Brefeldin A; Endosome; Cell biology; Secretory pathway; Biology; Vesicular transport protein; Wortmannin; Cytoplasm; Organelle; Secretory Vesicle; Intracellular; Endoplasmic reticulum; Biochemistry; Signal transduction; PI3K/AKT/mTOR pathway; Membrane","score_opus":0.0681913804312433,"score_gpt":0.4035619845125073,"score_spread":0.335370604081264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162916961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526113,0.001500579,0.0026102997,0.00015212792,0.000051586332,0.00023778208,0.0000062762933,0.0000042515376,0.00017594364],"genre_scores_gemma":[0.9982694,0.0006689708,0.00016423248,0.000033949676,0.00030974933,0.00001632812,0.00034567824,0.000017793276,0.00017389041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983975,0.00023230443,0.0005018474,0.0003667601,0.00023699747,0.00026457311],"domain_scores_gemma":[0.999428,0.000044262295,0.00006305998,0.00022731269,0.00013833365,0.00009907903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015463985,0.00009245606,0.00019428939,0.000091666276,0.00007194807,0.000014697095,0.00014127302,0.00023802972,0.000060662973],"category_scores_gemma":[0.00006235636,0.00009352242,0.000056854133,0.00018586249,0.00026163,0.000005218675,0.00005359099,0.00030293947,0.000002045225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020664209,0.0003116957,0.05761589,0.000055299544,0.000013100591,0.0000065017643,0.00012618891,0.00024705657,0.93327785,0.00012999594,0.000064980835,0.007944824],"study_design_scores_gemma":[0.0066559166,0.00076274015,0.039809797,0.00010650595,0.000022702323,0.000001866048,0.0001259043,0.009187315,0.9151606,0.00009607201,0.027778283,0.00029232405],"about_ca_topic_score_codex":0.00025411847,"about_ca_topic_score_gemma":0.001274182,"teacher_disagreement_score":0.027713303,"about_ca_system_score_codex":0.000023807917,"about_ca_system_score_gemma":0.00010441981,"threshold_uncertainty_score":0.38137338},"labels":[],"label_agreement":null},{"id":"W2163045779","doi":"10.1158/1078-0432.ccr-10-2159","title":"A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Gemcitabine; Medicine; Asymptomatic; Oncolytic virus; Toxicity; Concomitant; Chemotherapy; Neutralizing antibody; Cancer; Antibody; Pharmacology; Gastroenterology; Internal medicine; Immunology","score_opus":0.06696256626864659,"score_gpt":0.476728483187022,"score_spread":0.4097659169183754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163045779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868613,0.0002734174,6.8548434e-7,0.00008349037,0.00009351315,0.0007995193,0.000014085833,0.0000016115855,0.000047554095],"genre_scores_gemma":[0.9994844,0.00029950347,0.000013608647,0.000018882221,0.000045382465,0.00007435302,0.000004987368,0.000016498105,0.000042383665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838,0.0003325749,0.00031598087,0.00029666224,0.00044245954,0.00023232639],"domain_scores_gemma":[0.9987005,0.00009086106,0.000091410555,0.00042452643,0.00062512123,0.00006759789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013038176,0.00007783143,0.00018719277,0.000071208575,0.000057561083,0.000007621668,0.00026856776,0.00009358576,0.000029231993],"category_scores_gemma":[0.00040179133,0.000053861106,0.000023806224,0.00037863178,0.0003781451,0.000004791584,0.00020945755,0.000537209,3.6320816e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0182417,0.0038045493,0.73292917,0.00003927681,0.00006931208,8.9259817e-7,0.00019064687,0.00004482364,0.14443968,0.000008042839,0.000023589977,0.10020835],"study_design_scores_gemma":[0.021417012,0.043065228,0.8275633,0.00006577,0.0000141835635,1.9742754e-7,0.00016702396,0.00006220484,0.10713449,0.00004973768,0.0003217154,0.00013913537],"about_ca_topic_score_codex":0.00065353693,"about_ca_topic_score_gemma":0.009596952,"teacher_disagreement_score":0.10006921,"about_ca_system_score_codex":0.000020615666,"about_ca_system_score_gemma":0.00039361053,"threshold_uncertainty_score":0.5355325},"labels":[],"label_agreement":null},{"id":"W2163214318","doi":"10.1158/1078-0432.ccr-03-0123","title":"Pharmacokinetics of O6-benzylguanine in Pediatric Patients with Central Nervous System Tumors","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Metabolite; Active metabolite; Pharmacology; Chemistry; Nitrosourea; High-performance liquid chromatography; Half-life; Medicine; Internal medicine; Chemotherapy; Chromatography","score_opus":0.04969822153573047,"score_gpt":0.4072209915819189,"score_spread":0.35752277004618843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163214318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840194,0.00044806718,0.00006752734,0.00007538852,0.0001926299,0.00045053702,0.00003938187,0.00001135145,0.0003131642],"genre_scores_gemma":[0.99872255,0.00031918584,0.00029862652,0.0000438366,0.00041531268,0.00005296762,0.00003599221,0.000031764986,0.000079733916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774307,0.00022757241,0.00051520235,0.00044586233,0.0005374484,0.00053087214],"domain_scores_gemma":[0.99892807,0.00004941746,0.00010864558,0.00035880358,0.00035597038,0.00019909294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008498606,0.00012616585,0.00024993293,0.00009862261,0.00003490649,0.00001074642,0.0003448314,0.0001477604,0.000021751415],"category_scores_gemma":[0.00019608038,0.00010521033,0.000078464815,0.00039229813,0.00015590714,0.0000038795188,0.00020702019,0.00037864674,0.0000073029937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020508985,0.0011806529,0.97370017,0.00048423116,0.00007027635,0.00006211736,0.0000697679,0.0024772566,0.014470054,0.00034048012,0.00068781094,0.004406312],"study_design_scores_gemma":[0.013574565,0.005556725,0.836052,0.00027957643,0.00006195998,0.000004192604,0.00016885457,0.00014583085,0.14193149,0.00011464672,0.0015854555,0.00052471],"about_ca_topic_score_codex":0.00015817798,"about_ca_topic_score_gemma":0.00015854673,"teacher_disagreement_score":0.13764815,"about_ca_system_score_codex":0.00010115007,"about_ca_system_score_gemma":0.0005020268,"threshold_uncertainty_score":0.42903528},"labels":[],"label_agreement":null},{"id":"W2163299200","doi":"10.1158/1078-0432.ccr-06-1892","title":"Phase I Pharmacokinetic and Pharmacodynamic Study of 17-<i>N</i>-Allylamino-17-Demethoxygeldanamycin in Pediatric Patients with Recurrent or Refractory Solid Tumors: A Pediatric Oncology Experimental Therapeutics Investigators Consortium Study","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Toxicity; Pharmacodynamics; Internal medicine; Hsp90 inhibitor; Adverse effect; Pediatric cancer; Pharmacology; Gastroenterology; Oncology; Heat shock protein; Cancer; Hsp90; Biology","score_opus":0.14863615986751028,"score_gpt":0.5409377296812757,"score_spread":0.39230156981376546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163299200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284065,0.0025253904,0.000015025017,0.00005167369,0.0001687732,0.004223969,0.00003580247,0.0000124140015,0.00012628624],"genre_scores_gemma":[0.9968496,0.0016054237,0.000091492526,0.00012368696,0.00057014276,0.00053266156,0.000022800497,0.000070009286,0.00013421317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99235624,0.0025896842,0.0015737481,0.0011777302,0.001249526,0.0010530782],"domain_scores_gemma":[0.997026,0.0008223209,0.00029867422,0.00059433887,0.0006579647,0.00060067954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006638972,0.0003637992,0.00072683813,0.00064236246,0.00015481526,0.00002824732,0.0006339098,0.00026907967,0.000105375715],"category_scores_gemma":[0.00064334105,0.00028760367,0.000075346965,0.0012242973,0.0005613072,0.000020287993,0.0006913893,0.0015599688,0.0000029584169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016849035,0.04366386,0.8855996,0.0001288264,0.00021050694,0.00020833558,0.0011535675,0.000016977208,0.030721186,3.1466854e-7,0.00062400824,0.020823767],"study_design_scores_gemma":[0.11126256,0.24883506,0.58254766,0.00007431851,0.0004489866,0.000009446219,0.009473624,0.000356723,0.042581227,0.000007629768,0.0029910314,0.001411702],"about_ca_topic_score_codex":0.0002328346,"about_ca_topic_score_gemma":0.0013066678,"teacher_disagreement_score":0.30305192,"about_ca_system_score_codex":0.00028028502,"about_ca_system_score_gemma":0.0018595264,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W2163299518","doi":"10.1158/1078-0432.ccr-07-0393","title":"<i>KIF14</i> Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Immunovaccine (Canada); University Health Network","funders":"National Cancer Institute","keywords":"Hazard ratio; Lung cancer; Biology; Proportional hazards model; Oncology; Internal medicine; Confidence interval; Carcinoma; Medicine; Pathology","score_opus":0.12241240031886057,"score_gpt":0.5210315122914074,"score_spread":0.39861911197254685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163299518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915223,0.004713388,0.0009506638,0.0008034731,0.0004738376,0.0010800179,0.00009789723,0.00000984506,0.00034854407],"genre_scores_gemma":[0.9919878,0.0029119055,0.00029897515,0.0010353256,0.00095662917,0.0005021186,0.000050144612,0.000047391783,0.0022096704],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726146,0.0001655883,0.00071113295,0.0006955327,0.0003906235,0.0007756796],"domain_scores_gemma":[0.9985463,0.00034171407,0.00009797508,0.00044186492,0.00035341812,0.00021874584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034228435,0.00016685187,0.00028571888,0.00011184937,0.00011430816,0.00003526834,0.0004350969,0.00045675578,0.00013438803],"category_scores_gemma":[0.0006951645,0.000147261,0.00017771208,0.00022567462,0.00017708531,0.0000074947484,0.00030511775,0.00064040953,0.0000075139856],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009659019,0.00028190753,0.5486918,0.00019387969,0.00005815033,0.000012169161,0.00007289663,0.000018088927,0.40954491,0.000025717429,0.02968906,0.010445527],"study_design_scores_gemma":[0.005727295,0.0007403689,0.13128679,0.00039319808,0.00005541834,0.0000031864656,0.00020616953,0.00047373195,0.67693937,0.00018460346,0.18323496,0.0007549345],"about_ca_topic_score_codex":0.0002557688,"about_ca_topic_score_gemma":0.0015275875,"teacher_disagreement_score":0.417405,"about_ca_system_score_codex":0.00009492777,"about_ca_system_score_gemma":0.00036513794,"threshold_uncertainty_score":0.6005129},"labels":[],"label_agreement":null},{"id":"W2163375473","doi":"10.1158/1078-0432.ccr-14-1437","title":"miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Multiple myeloma; Cancer research; Clonogenic assay; Apoptosis; microRNA; Transfection; Viability assay; In vivo; Plasma cell leukemia; Biology; Cell culture; Immunology; Gene; Genetics","score_opus":0.2832308845321098,"score_gpt":0.5013554029379498,"score_spread":0.21812451840583996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163375473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901917,0.0049808784,0.0000039111674,0.002834036,0.00014283323,0.0011384164,0.00010727832,0.000037219517,0.0005637094],"genre_scores_gemma":[0.99635005,0.0015512429,0.000456041,0.00016595039,0.00030225504,0.00031448476,0.00006899495,0.00004516633,0.00074582716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950864,0.0009144418,0.0007288027,0.0009249416,0.0012156429,0.0011297914],"domain_scores_gemma":[0.9953906,0.00199127,0.00007675137,0.00043928064,0.0005040599,0.0015980575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043711336,0.00024704004,0.00067996216,0.0002519177,0.00020248332,0.00009267993,0.00023974614,0.00028859708,0.00012808917],"category_scores_gemma":[0.0069574197,0.00020203738,0.00008364635,0.0005213824,0.00085543585,0.00018294324,0.0005172861,0.0015692239,0.00004562533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029897795,0.0007508973,0.9405604,0.00018489869,0.00012223302,0.00012357533,0.00041314747,6.7373793e-7,0.008150703,0.000010598658,0.024912037,0.021781027],"study_design_scores_gemma":[0.031849146,0.0029445195,0.87713736,0.000525552,0.000066901135,0.000031776144,0.0017278511,0.0027432328,0.04861922,0.00036204766,0.033369016,0.0006234021],"about_ca_topic_score_codex":0.0066299187,"about_ca_topic_score_gemma":0.0006645758,"teacher_disagreement_score":0.0634231,"about_ca_system_score_codex":0.0003118934,"about_ca_system_score_gemma":0.0005909811,"threshold_uncertainty_score":0.99998504},"labels":[],"label_agreement":null},{"id":"W2163409320","doi":"10.1158/1078-0432.ccr-04-0221","title":"Liposomal Irinotecan","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Irinotecan; Liposome; Pharmacology; Drug; Pharmacokinetics; In vivo; Medicine; Chemistry; SN-38; Saline; Internal medicine; Colorectal cancer; Biology; Cancer; Biochemistry","score_opus":0.2169374239171557,"score_gpt":0.5007776273332275,"score_spread":0.2838402034160718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163409320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254143,0.0006049499,0.00007970688,0.00419285,0.0008400628,0.0002719817,0.00001780292,0.00012008405,0.0013311252],"genre_scores_gemma":[0.99717325,0.00018922497,0.0005628469,0.00048317644,0.00094881846,0.00010118821,0.0000014074734,0.000026710059,0.00051339826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644357,0.0004979135,0.00055300095,0.000616487,0.0010301167,0.0008589185],"domain_scores_gemma":[0.9977614,0.0007424767,0.000058542493,0.0006363788,0.0003810314,0.00042011848],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0043493584,0.00011782761,0.00025280818,0.00010316941,0.0002472868,0.00012418444,0.0006883428,0.0001398341,0.0021098473],"category_scores_gemma":[0.0010284377,0.00010186936,0.000110587505,0.0005206611,0.0008904598,0.00019274942,0.00035644253,0.0006862944,0.0051890705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011371139,0.0016441923,0.011843165,0.00006783539,0.000025552537,0.0003041612,0.00044555686,0.0013744131,0.92649317,0.0070056464,0.007794304,0.04186488],"study_design_scores_gemma":[0.0033364985,0.001287174,0.011480192,0.00013774534,0.000014975142,0.0000062096237,0.00010954018,0.00006431417,0.9515157,0.007661833,0.0240237,0.00036215706],"about_ca_topic_score_codex":0.0017304267,"about_ca_topic_score_gemma":0.00047679245,"teacher_disagreement_score":0.04150272,"about_ca_system_score_codex":0.0002974942,"about_ca_system_score_gemma":0.0010202271,"threshold_uncertainty_score":0.99880236},"labels":[],"label_agreement":null},{"id":"W2163435127","doi":"10.1158/1078-0432.ccr-08-3329","title":"Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Immunohistochemistry; Medicine; Cancer; Internal medicine; Stage (stratigraphy); Univariate analysis; Lymph node; Metastasis; Tissue microarray; Carcinoma; Oncology; Multivariate analysis; Cancer research; Biology","score_opus":0.18603828043135331,"score_gpt":0.4983316477260869,"score_spread":0.31229336729473356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163435127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919132,0.0026570815,0.000006557921,0.0040651904,0.00005331363,0.00050189666,0.000015248253,0.000011205533,0.0007763044],"genre_scores_gemma":[0.9975478,0.0010291379,0.0001910218,0.00040156234,0.00023284733,0.000021943812,0.0000063921684,0.000013623526,0.00055566174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975702,0.00023090448,0.0005635019,0.00032656893,0.00097294274,0.0003358582],"domain_scores_gemma":[0.9978431,0.0006808167,0.00015321141,0.00025051477,0.00078905904,0.00028331822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018320926,0.00010847058,0.00061099004,0.00018068888,0.000056229674,0.0000057362004,0.00012066276,0.00017632252,0.00020798514],"category_scores_gemma":[0.0013272697,0.00006491508,0.00008506297,0.0006255833,0.00061291055,0.000032988963,0.000054495777,0.0006689333,0.0000011781101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024961273,0.00106486,0.9126837,0.00020436107,0.00010104629,0.000066613145,0.00024336753,9.451942e-7,0.03446658,0.000016651118,0.013827737,0.034827966],"study_design_scores_gemma":[0.005850548,0.009727667,0.9489182,0.0015491203,0.00011418319,0.0000066564066,0.00023045788,0.00016040688,0.032794315,0.00005807685,0.0005062573,0.00008408246],"about_ca_topic_score_codex":0.000118930366,"about_ca_topic_score_gemma":0.000009534259,"teacher_disagreement_score":0.036234483,"about_ca_system_score_codex":0.00004615378,"about_ca_system_score_gemma":0.00037179358,"threshold_uncertainty_score":0.29062197},"labels":[],"label_agreement":null},{"id":"W2163700401","doi":"10.1158/1078-0432.ccr-04-1235","title":"Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hypoxia (environmental); Bortezomib; Proteasome inhibitor; Estrogen receptor; Estrogen receptor alpha; Endocrinology; Internal medicine; Biology; Cancer research; HIF1A; Estrogen; Proteasome; Breast cancer; Medicine; Chemistry; Cancer; Cell biology; Angiogenesis","score_opus":0.08653163114555301,"score_gpt":0.42565729878708136,"score_spread":0.33912566764152835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163700401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528694,0.0024998381,0.000017712086,0.00048026154,0.0007007152,0.0006789274,0.00006480192,0.000007730756,0.00026305075],"genre_scores_gemma":[0.9959338,0.00072692015,0.00009925588,0.000051937754,0.002397191,0.00024391715,0.000056475077,0.000029124563,0.00046141044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99744064,0.00032606005,0.00067243044,0.00059124036,0.0005107698,0.00045886374],"domain_scores_gemma":[0.99877346,0.000033513243,0.0001436322,0.0005053003,0.00035117267,0.00019293457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016144858,0.0001567818,0.00032982067,0.00014673843,0.00008199375,0.00002540716,0.0004200301,0.000289754,0.00012533496],"category_scores_gemma":[0.00020637584,0.00014524793,0.00016941322,0.00025862455,0.00040723616,0.000010476162,0.00029020038,0.0005039005,0.000013679572],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064801204,0.0004545504,0.032989934,0.0000671139,0.000055493594,0.0000019052821,0.00010651911,0.00009433201,0.91815734,0.00026560287,0.0010041948,0.046155013],"study_design_scores_gemma":[0.0042439457,0.00075523823,0.6221903,0.00015756344,0.000019453655,0.000011550305,0.00018437594,0.0000042726992,0.35458183,0.0006893132,0.016858004,0.00030415272],"about_ca_topic_score_codex":0.0018581991,"about_ca_topic_score_gemma":0.0006592548,"teacher_disagreement_score":0.5892004,"about_ca_system_score_codex":0.00012146823,"about_ca_system_score_gemma":0.000661617,"threshold_uncertainty_score":0.5923039},"labels":[],"label_agreement":null},{"id":"W2163833439","doi":"10.1158/1078-0432.ccr-11-0998","title":"The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Insulin receptor; Metformin; Growth factor receptor; Insulin-Like Growth Factor Receptor; Clinical trial; Receptor tyrosine kinase; Insulin; Tyrosine kinase; Receptor; Insulin-like growth factor; Insulin-like growth factor 1 receptor; Oncology; Antibody; Cancer; Internal medicine; Pharmacology; Immunology; Growth factor; Insulin resistance","score_opus":0.21130708825562863,"score_gpt":0.4926170336702079,"score_spread":0.2813099454145793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163833439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93495166,0.03555515,0.00001826204,0.014813761,0.0038533949,0.0018488758,0.00005974536,0.00012446116,0.008774692],"genre_scores_gemma":[0.94435483,0.04510827,0.00028348985,0.0044365497,0.0026338398,0.00056155963,0.000047743444,0.00012323174,0.0024505106],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906059,0.002584348,0.0018213921,0.00092419254,0.0016982496,0.0023659165],"domain_scores_gemma":[0.9917438,0.0046914704,0.0002638985,0.0010236349,0.00096608856,0.0013110853],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008730186,0.00046606513,0.0011242523,0.00042963083,0.00052423147,0.000089346824,0.0009144896,0.00095211464,0.0014238972],"category_scores_gemma":[0.0047735255,0.0003139314,0.00043234485,0.0017849825,0.0013786099,0.00035086763,0.00043238804,0.00457255,0.0028017121],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012664926,0.0042943573,0.61768776,0.00020456532,0.00062219205,0.00006198745,0.003330202,7.7028784e-7,0.012357395,0.0037524109,0.11386139,0.23116204],"study_design_scores_gemma":[0.004118798,0.002436588,0.27911836,0.00010784032,0.000033374356,0.0000074956756,0.0009906696,0.000022629354,0.0013591818,0.0010215709,0.71043086,0.00035259724],"about_ca_topic_score_codex":0.0013282695,"about_ca_topic_score_gemma":0.00011055881,"teacher_disagreement_score":0.5965695,"about_ca_system_score_codex":0.0011642857,"about_ca_system_score_gemma":0.0024652632,"threshold_uncertainty_score":0.9999313},"labels":[],"label_agreement":null},{"id":"W2164077501","doi":"10.1158/1078-0432.ccr-05-0859","title":"The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Microsatellite instability; Loss of heterozygosity; Methylation; Colorectal cancer; DNA methylation; Biology; Cancer; Cancer research; Chromosome instability; Internal medicine; Oncology; Microsatellite; Medicine; Genetics; Gene; Chromosome; Gene expression; Allele","score_opus":0.36375649461039583,"score_gpt":0.5378855263739727,"score_spread":0.17412903176357686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164077501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875886,0.0059312135,0.00001196499,0.004907172,0.00021350833,0.00089269475,0.00014104693,0.000014773056,0.00029904358],"genre_scores_gemma":[0.99712026,0.001865484,0.00026456907,0.00006788154,0.00040684335,0.00012074438,0.000010208554,0.000016802189,0.00012722888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645644,0.0007853037,0.00096049346,0.00051337876,0.0007848008,0.0004995756],"domain_scores_gemma":[0.9941864,0.004619895,0.00015059346,0.00036626562,0.00043364876,0.00024316933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052723866,0.00015098236,0.00047254973,0.00009357712,0.00018270605,0.00003248587,0.0002403407,0.00028979202,0.00011214404],"category_scores_gemma":[0.002905161,0.000113750066,0.00010825746,0.00086541293,0.001699844,0.000086569235,0.00023632149,0.0011024352,0.0000087140215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010687913,0.00008708201,0.9241063,0.000084958476,0.000033954253,0.0000024031558,0.00014732528,0.000016363314,0.0003453842,0.00008101178,0.000108537606,0.07391789],"study_design_scores_gemma":[0.0014370237,0.00038957855,0.9913325,0.00012878461,0.00002947828,0.000002675023,0.00004274452,0.000055625507,0.002499391,0.0013446339,0.002637079,0.00010052068],"about_ca_topic_score_codex":0.0026182856,"about_ca_topic_score_gemma":0.0128257945,"teacher_disagreement_score":0.073817365,"about_ca_system_score_codex":0.0009774236,"about_ca_system_score_gemma":0.00093663175,"threshold_uncertainty_score":0.71570945},"labels":[],"label_agreement":null},{"id":"W2164243186","doi":"10.1158/1078-0432.ccr-05-2019","title":"Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, Irvine; U.S. Public Health Service; University of Alberta","keywords":"Cytokine-induced killer cell; Ovarian cancer; NKG2D; Antibody; Cancer research; Cytotoxic T cell; Immunotherapy; Medicine; CD8; Antigen; Cancer; Cancer cell; Immunology; CD3; Immune system; Biology; Internal medicine; In vitro","score_opus":0.10249766169932147,"score_gpt":0.4192407169054804,"score_spread":0.316743055206159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164243186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98625636,0.0032110952,0.00021008374,0.00038562733,0.005120107,0.0010581858,0.000020538526,0.00009321846,0.0036447775],"genre_scores_gemma":[0.9824815,0.0012453097,0.00006495021,0.00011994282,0.00030460753,0.00021572998,0.00008528025,0.00005253948,0.01543014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99455625,0.0018031442,0.0015664173,0.0009630537,0.00029152216,0.0008196342],"domain_scores_gemma":[0.99606806,0.0019543318,0.0004698811,0.00062032545,0.0008250094,0.0000623992],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031852068,0.000294346,0.00093002414,0.00022181192,0.00040461283,0.00003991246,0.00046057397,0.0005197096,0.002371887],"category_scores_gemma":[0.00031505912,0.00022990745,0.0002140194,0.00055976544,0.00068413647,0.00015219608,0.00020275333,0.0021862139,0.00017330336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006124699,0.0025827484,0.037320103,0.000083311665,0.0005364518,0.00001268783,0.00040233348,0.00005928635,0.880406,0.000021197777,0.057660602,0.014790567],"study_design_scores_gemma":[0.012696265,0.0071247355,0.122364275,0.0006526248,0.00023655452,0.000012353264,0.0024722402,0.00009441954,0.70672363,0.000042861444,0.1466295,0.00095052214],"about_ca_topic_score_codex":0.004891578,"about_ca_topic_score_gemma":0.00050328247,"teacher_disagreement_score":0.17368236,"about_ca_system_score_codex":0.00024136814,"about_ca_system_score_gemma":0.00051205925,"threshold_uncertainty_score":0.9985401},"labels":[],"label_agreement":null},{"id":"W2164358237","doi":"10.1158/1078-0432.ccr-13-1222","title":"Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clinical trial; Medicine; Drug development; Intensive care medicine; Phases of clinical research; Cancer; Clinical endpoint; Drug; Clinical study design; Anticancer drug; Drug trial; Standard of care; Randomized controlled trial; Oncology; Pharmacology; Internal medicine","score_opus":0.9689936851649781,"score_gpt":0.8078461069799944,"score_spread":0.1611475781849837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164358237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010661215,0.98129094,0.0053497734,0.0004956725,0.002303383,0.008687522,0.0010115393,0.000082487124,0.0007680183],"genre_scores_gemma":[0.000012444352,0.93451375,0.056721933,0.00010627921,0.0040399767,0.0030284128,0.000013872235,0.00021219977,0.0013511067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.91414315,0.0673845,0.012960392,0.0015191112,0.0026440236,0.0013488529],"domain_scores_gemma":[0.37241083,0.6186695,0.00434421,0.0024715625,0.0015997915,0.0005041243],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.1636382,0.0008082213,0.013775814,0.00030403878,0.00035157992,0.00018547135,0.003066088,0.0016126233,0.012890871],"category_scores_gemma":[0.57354414,0.00041987823,0.0034034026,0.0016962001,0.0049582087,0.00009088316,0.00081347534,0.005644711,0.0001554788],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032391114,0.000740446,6.924416e-7,0.00465955,0.0016449911,0.000009103938,0.00011888447,6.82079e-8,0.0000033230021,0.016879579,0.0692152,0.90640426],"study_design_scores_gemma":[0.0047910037,0.0009574584,3.5957416e-7,0.013041024,0.0017439525,0.0000015786432,0.000111734225,0.000012274367,0.00003342023,0.21032448,0.76854485,0.0004378799],"about_ca_topic_score_codex":0.00018051855,"about_ca_topic_score_gemma":0.000006194359,"teacher_disagreement_score":0.90596634,"about_ca_system_score_codex":0.000269285,"about_ca_system_score_gemma":0.0030883902,"threshold_uncertainty_score":0.9998253},"labels":[],"label_agreement":null},{"id":"W2164536651","doi":"10.1158/1078-0432.ccr-13-0283","title":"Genome-Wide Study of Hypomethylated and Induced Genes in Patients with Liver Cancer Unravels Novel Anticancer Targets","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Metastasis; Cancer; Biology; Cancer research; Wnt signaling pathway; Cancer cell; Epigenetics; Cell growth; DNA methylation; Liver cancer; Gene; Genetics; Gene expression","score_opus":0.10140815794137993,"score_gpt":0.4089392078616567,"score_spread":0.3075310499202768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164536651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709755,0.0018317626,0.000054196244,0.00008149784,0.00013952669,0.00068598293,0.000016250011,0.000006051941,0.00008719847],"genre_scores_gemma":[0.99765265,0.0014596302,0.00013167487,0.000114287446,0.0001951584,0.00020034664,0.000019523555,0.000037900925,0.00018882807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973564,0.00033191367,0.00055699627,0.0006962553,0.0005791775,0.000479228],"domain_scores_gemma":[0.99847853,0.00019559535,0.0001431575,0.00035674433,0.00066565047,0.0001603447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016961071,0.00019387214,0.0004032298,0.0001497742,0.00008905508,0.000024127416,0.0003332082,0.0002100219,0.000095995696],"category_scores_gemma":[0.00032175527,0.00015491698,0.000041834544,0.00044540523,0.0003101767,0.000009586995,0.00029746478,0.00039771595,0.0000023397763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010883952,0.0006637511,0.96158534,0.00004154652,0.00015944791,0.0000013258649,0.00019511883,0.00008213806,0.026348941,0.0000021774438,0.00008698428,0.009744821],"study_design_scores_gemma":[0.0046647345,0.0018496416,0.9736819,0.00005985034,0.000020713225,1.0143129e-7,0.00007804748,0.000029551571,0.017250929,0.000011772146,0.0021202534,0.00023249704],"about_ca_topic_score_codex":0.0008581837,"about_ca_topic_score_gemma":0.0011146734,"teacher_disagreement_score":0.012096554,"about_ca_system_score_codex":0.000057211848,"about_ca_system_score_gemma":0.00035137337,"threshold_uncertainty_score":0.6317331},"labels":[],"label_agreement":null},{"id":"W2164563042","doi":"10.1158/1078-0432.ccr-05-0621","title":"Metronomic Low-Dose Chemotherapy Boosts CD95-Dependent Antiangiogenic Effect of the Thrombospondin Peptide ABT-510: A Complementation Antiangiogenic Strategy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Angiogenesis; Docetaxel; Cisplatin; Cancer research; Endothelial stem cell; In vivo; Medicine; Fas receptor; Progenitor cell; Pharmacology; Apoptosis; Chemotherapy; Biology; Programmed cell death; Internal medicine; Stem cell; In vitro; Cell biology; Biochemistry","score_opus":0.08055689484300803,"score_gpt":0.4719427441858524,"score_spread":0.39138584934284437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164563042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118006,0.0064013447,0.00007807603,0.0006473576,0.00033867607,0.00084286305,0.000113732414,0.0000110366855,0.0003868347],"genre_scores_gemma":[0.99341995,0.0034398034,0.00008471887,0.00028229083,0.0014575181,0.00013241962,0.00006048747,0.000058236143,0.0010645565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964187,0.00088021514,0.00075494446,0.0007052925,0.0005955782,0.000645243],"domain_scores_gemma":[0.9983194,0.0002139271,0.00024237506,0.00082705,0.00023141905,0.00016582546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027552985,0.00025732876,0.0004426972,0.000101860816,0.00021050965,0.00004464238,0.0007873843,0.0002513795,0.0007121655],"category_scores_gemma":[0.0001110409,0.0001883628,0.00075347116,0.00036410755,0.000509986,0.000013781863,0.00030661965,0.0003112571,0.00005391452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022901436,0.0004721358,0.21025236,0.00013392032,0.0010985496,0.0000030450417,0.000085833766,0.00067589706,0.69588566,0.00009419742,0.027914025,0.06109422],"study_design_scores_gemma":[0.005035409,0.0018473121,0.24467893,0.000101629696,0.00012721843,0.0000056184017,0.00009630808,0.0002954855,0.72201,0.000032462285,0.025358738,0.00041083954],"about_ca_topic_score_codex":0.00036651295,"about_ca_topic_score_gemma":0.0007614288,"teacher_disagreement_score":0.06068338,"about_ca_system_score_codex":0.00014455304,"about_ca_system_score_gemma":0.0004682738,"threshold_uncertainty_score":0.77977127},"labels":[],"label_agreement":null},{"id":"W2164603058","doi":"10.1158/1078-0432.ccr-08-0276","title":"Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); Concordia University; McGill University; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Colorectal cancer; Chemotherapy; Cancer; Oncology; Internal medicine","score_opus":0.07841285888194537,"score_gpt":0.4210567814780933,"score_spread":0.3426439225961479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164603058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885159,0.00928929,0.000006501803,0.0011429739,0.00026357203,0.0006580978,0.000022862423,0.00002293846,0.00007782951],"genre_scores_gemma":[0.9889576,0.009028629,0.000023559918,0.0002920019,0.000024876743,0.00020433962,0.00003398445,0.000028887485,0.0014061481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973544,0.0011041583,0.00047892847,0.00040305345,0.00014131561,0.0005181466],"domain_scores_gemma":[0.99835217,0.0009886388,0.00009975874,0.00021949007,0.00030339984,0.000036562808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012890833,0.00016643314,0.00044463942,0.00020984856,0.00028372288,0.000014866912,0.000227862,0.00017880804,0.0010401593],"category_scores_gemma":[0.0002198592,0.00012483625,0.000056259756,0.00043079228,0.00065940915,0.00013477707,0.00007267578,0.00088032597,0.000048446564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01937965,0.0011756105,0.9298577,0.000024606656,0.00033278464,0.000009273117,0.0005867534,0.0000029308467,0.005900277,0.000047809997,0.0029334794,0.03974916],"study_design_scores_gemma":[0.016192567,0.0019536053,0.9631937,0.00007489666,0.00001145399,0.000005658636,0.00005499842,0.0000054323614,0.0077949446,0.000050707535,0.010496481,0.00016552974],"about_ca_topic_score_codex":0.001243033,"about_ca_topic_score_gemma":0.0003578884,"teacher_disagreement_score":0.03958363,"about_ca_system_score_codex":0.000120592245,"about_ca_system_score_gemma":0.0002986118,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W2164672043","doi":"10.1158/1078-0432.ccr-11-0544","title":"TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells<i>In Vitro</i>and Promotes Tumor Control by Radiation<i>In Vivo</i>","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; York University; U.S. Department of Defense","keywords":"Clonogenic assay; In vivo; Cancer research; Radiosensitivity; Growth inhibition; Cancer cell; Transforming growth factor; Radiation sensitivity; Cancer; Biology; In vitro; Chemistry; Medicine; Radiation therapy; Internal medicine; Endocrinology; Biochemistry; Irradiation","score_opus":0.04347169386366349,"score_gpt":0.3680141626137282,"score_spread":0.3245424687500647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164672043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938859,0.0042645205,0.00001297563,0.00040972448,0.00006400365,0.00051211636,0.000771896,0.0000061250685,0.00007279338],"genre_scores_gemma":[0.9982121,0.00091494515,0.000023228318,0.0003152806,0.00023618655,0.0002122228,0.000018866802,0.000021930386,0.000045257977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974378,0.00095051475,0.00048481108,0.0004583482,0.00029694472,0.00037159986],"domain_scores_gemma":[0.9987758,0.00044885036,0.00012551076,0.0003120697,0.00019532796,0.00014248457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019581525,0.00013582906,0.00027951619,0.00006714652,0.00007515105,0.0000191216,0.0001865275,0.00013039811,0.00007982442],"category_scores_gemma":[0.00046048692,0.00010731648,0.000083587496,0.00020502273,0.0007414287,0.000010988275,0.000116229625,0.00036808822,0.0000019876063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022439747,0.0006180755,0.08032631,0.00006663181,0.000043134547,0.000012780476,0.00007381738,0.000012319583,0.90939915,0.000006788401,0.003255488,0.0039415266],"study_design_scores_gemma":[0.002147277,0.0001756418,0.093199745,0.00009469237,0.000018304267,0.000004349123,0.000046273344,0.00013149835,0.9029181,0.00006844191,0.0010456231,0.00015005295],"about_ca_topic_score_codex":0.0049059954,"about_ca_topic_score_gemma":0.00095388794,"teacher_disagreement_score":0.012873434,"about_ca_system_score_codex":0.00004666477,"about_ca_system_score_gemma":0.00045002167,"threshold_uncertainty_score":0.741643},"labels":[],"label_agreement":null},{"id":"W2164815481","doi":"10.1158/1078-0432.ccr-04-1676","title":"Phase I Trial and Pharmacokinetic Study of Raltitrexed in Children with Recurrent or Refractory Leukemia: A Pediatric Oncology Group Study","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Raltitrexed; Medicine; Pharmacokinetics; Refractory (planetary science); Dosing; Toxicity; Internal medicine; Pharmacology; Gastroenterology; Leukemia; Thymidylate synthase; Chemotherapy; Oncology; Fluorouracil","score_opus":0.18595001990932006,"score_gpt":0.5569707131992239,"score_spread":0.37102069328990384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164815481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982537,0.0009936877,0.0000022081167,0.00037240735,0.00013747487,0.00849893,0.000016014726,0.000028310162,0.00012561158],"genre_scores_gemma":[0.99332815,0.0030915183,0.00010097771,0.00007442468,0.0020059277,0.0010696109,0.000008837571,0.000054031385,0.0002665188],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99253184,0.002324505,0.0014423247,0.0010138698,0.0018444246,0.00084302237],"domain_scores_gemma":[0.995185,0.0029089497,0.00023052814,0.000630469,0.00045737982,0.0005876349],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0063226866,0.00026531934,0.0011583284,0.0007499518,0.00010329879,0.000024109171,0.00042212225,0.00024128257,0.00044251155],"category_scores_gemma":[0.0018681842,0.00017488006,0.00007105883,0.0015717308,0.0005363116,0.00011903366,0.00045008343,0.0026394094,0.000020128973],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36996982,0.05661827,0.391145,0.00008506451,0.00036635128,0.0003640739,0.0010723248,0.000008064808,0.000053236916,9.244626e-7,0.0026564375,0.17766047],"study_design_scores_gemma":[0.58183557,0.19352077,0.22105676,0.00006605395,0.0003726252,0.000033650853,0.0014152381,0.00051423494,0.000015243849,0.000002177435,0.0009722164,0.00019545178],"about_ca_topic_score_codex":0.0015780173,"about_ca_topic_score_gemma":0.0027972441,"teacher_disagreement_score":0.21186578,"about_ca_system_score_codex":0.0023412043,"about_ca_system_score_gemma":0.0052449,"threshold_uncertainty_score":0.99966156},"labels":[],"label_agreement":null},{"id":"W2164846084","doi":"10.1158/1078-0432.ccr-10-3083","title":"Induction of HLA-DP4–Restricted Anti-Survivin Th1 and Th2 Responses Using an Artificial Antigen-Presenting Cell","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Survivin; Biology; CD8; Cancer research; Antigen; Immunology; Cancer immunotherapy; T cell; Immunotherapy; Cytotoxic T cell; Antigen-presenting cell; Cancer; Immune system; In vitro; Genetics","score_opus":0.4470129665054379,"score_gpt":0.49040526565864057,"score_spread":0.04339229915320264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164846084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916668,0.0066276104,0.00003688887,0.000052153606,0.0008887457,0.0003583056,0.000031268984,0.000040664712,0.00029755055],"genre_scores_gemma":[0.99588287,0.0032365192,0.00013713456,0.000022398151,0.00012643165,0.000017118864,0.000012883829,0.00003347927,0.0005311588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99408495,0.0036948172,0.0008786971,0.0005336457,0.00015420507,0.0006536553],"domain_scores_gemma":[0.99735117,0.0013515399,0.00025349253,0.0005637782,0.00042316495,0.000056853332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00388916,0.00018684338,0.00049584935,0.00039402605,0.0005018221,0.000034723456,0.00042248363,0.0004876461,0.0007420578],"category_scores_gemma":[0.0010255055,0.00016549436,0.00012523525,0.00057593646,0.0015396265,0.00025992785,0.00026017486,0.001108297,0.000038819337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004670377,0.0006679435,0.065194435,0.000029883804,0.00011903963,0.0000060669563,0.0010569209,0.0000014926029,0.9168614,0.000108280445,0.000092530325,0.0111915935],"study_design_scores_gemma":[0.0010465757,0.0006570161,0.33237785,0.00006548008,0.000024553656,0.000015503118,0.0010807696,0.00002145985,0.6623785,0.0002640152,0.0018751272,0.00019316481],"about_ca_topic_score_codex":0.0036205219,"about_ca_topic_score_gemma":0.00008866609,"teacher_disagreement_score":0.26718342,"about_ca_system_score_codex":0.0000355831,"about_ca_system_score_gemma":0.0005020254,"threshold_uncertainty_score":0.81250125},"labels":[],"label_agreement":null},{"id":"W2164885520","doi":"10.1158/1078-0432.ccr-04-0209","title":"Imaging Correlates of Molecular Signatures in Oligodendrogliomas","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Cancer Institute","keywords":"Oligodendroglioma; Magnetic resonance imaging; Pathology; Calcification; Oligodendroglial Tumor; Medicine; Biology; Glioma; Radiology; Astrocytoma; Cancer research","score_opus":0.09893873783720904,"score_gpt":0.49364948085259075,"score_spread":0.3947107430153817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164885520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823047,0.011929872,0.0000057408456,0.003616571,0.0001112571,0.00038068808,0.0000055570263,0.000013909019,0.0016317003],"genre_scores_gemma":[0.99840534,0.001031424,0.00017617244,0.00016382734,0.00007044359,0.00009428633,0.000003656468,0.000018534232,0.00003634172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981873,0.00012766622,0.0004529717,0.00031790254,0.00055114285,0.00036299112],"domain_scores_gemma":[0.9988071,0.00042285825,0.000048658923,0.00030207698,0.00024140294,0.00017790443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010075286,0.00009309807,0.0003492515,0.00028730286,0.000030233912,0.000010971931,0.00012561797,0.000104085884,0.00018728827],"category_scores_gemma":[0.00060562126,0.000073223346,0.00014836565,0.0006133826,0.00031822504,0.000034626795,0.00009018414,0.00061579363,0.000028438964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048696555,0.0018921541,0.96019405,0.000100234254,0.000111560366,0.0028250653,0.00013041579,0.0008744234,0.014648563,0.0026742024,0.00072089606,0.015341467],"study_design_scores_gemma":[0.013192564,0.0010136273,0.7851952,0.0013863476,0.00008547157,0.000020536276,0.00020856169,0.00025679494,0.19033068,0.0070636165,0.0010457387,0.00020086794],"about_ca_topic_score_codex":0.0011025586,"about_ca_topic_score_gemma":0.00013122588,"teacher_disagreement_score":0.17568213,"about_ca_system_score_codex":0.00017318642,"about_ca_system_score_gemma":0.00036513698,"threshold_uncertainty_score":0.29859614},"labels":[],"label_agreement":null},{"id":"W2165316988","doi":"10.1158/1078-0432.ccr-07-0946","title":"Is There a Human Homologue to the Murine Proteolysis-Inducing Factor?","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Proteolysis; Antibody; Monoclonal antibody; Biology; Cancer; Molecular biology; Skeletal muscle; Cancer research; Immunology; Biochemistry; Endocrinology","score_opus":0.2962211129013626,"score_gpt":0.572158495960484,"score_spread":0.27593738305912136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165316988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791067,0.0002492089,0.004217134,0.007142701,0.000029688008,0.0007879208,0.00006164209,0.000121207144,0.008283747],"genre_scores_gemma":[0.9895358,0.0001514851,0.0026450672,0.0004732159,0.0008677563,0.0010604161,0.0000066789744,0.00003789944,0.0052216575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779546,0.000065153064,0.0005205606,0.0005513966,0.00046236865,0.00060508447],"domain_scores_gemma":[0.9978249,0.00054546195,0.00008764688,0.0010241276,0.00027739067,0.00024046194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022774641,0.00013244101,0.00021222982,0.00005856612,0.0005433344,0.000052439147,0.0008749606,0.00020497612,0.0020946362],"category_scores_gemma":[0.0003057567,0.00009251436,0.00013899196,0.00044940892,0.0002607587,0.000040049086,0.00043458483,0.0015488965,0.00012762038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006573709,0.0011503539,0.122496575,0.0003558576,0.00028990422,0.000112406946,0.001907774,0.000042788477,0.42091098,0.009249074,0.040507022,0.40231988],"study_design_scores_gemma":[0.0004935637,0.00016983609,0.013832759,0.00013159226,0.000012281304,0.0000035077976,0.00030478262,0.000032050615,0.5895759,0.008983169,0.3861249,0.00033563608],"about_ca_topic_score_codex":0.00075128645,"about_ca_topic_score_gemma":0.0005698975,"teacher_disagreement_score":0.40198424,"about_ca_system_score_codex":0.00017287717,"about_ca_system_score_gemma":0.00011221869,"threshold_uncertainty_score":0.99881756},"labels":[],"label_agreement":null},{"id":"W2165424687","doi":"10.1158/1078-0432.ccr-05-2187","title":"Phosphatidylinositol 3′-Kinase/AKT Signaling Is Activated in Medulloblastoma Cell Proliferation and Is Associated with Reduced Expression of <i>PTEN</i>","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PTEN; Medulloblastoma; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Biology; Signal transduction; Cell biology","score_opus":0.04973267562810274,"score_gpt":0.39339771069056245,"score_spread":0.3436650350624597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165424687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971011,0.0015129115,0.000046980582,0.0003533944,0.000083519764,0.000515772,0.000058518126,0.000012850514,0.00031490572],"genre_scores_gemma":[0.9984275,0.00018909156,0.00017163377,0.00021344556,0.00028358554,0.00013645996,0.00006131221,0.000042157066,0.00047478356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971037,0.0004644762,0.00064889365,0.00070477364,0.0006276806,0.00045045896],"domain_scores_gemma":[0.9984127,0.00025770834,0.0002505121,0.00035909176,0.0005907232,0.00012922371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014247928,0.00019555005,0.00035789868,0.00010541429,0.000114790215,0.000040870887,0.0002532732,0.00041460086,0.000078312645],"category_scores_gemma":[0.00031223503,0.00016989495,0.00007628066,0.00044969315,0.00034916692,0.000015139416,0.00014582698,0.00053311803,0.0000020521327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013473802,0.00028926262,0.05443168,0.000055523804,0.000029497165,0.0000071273303,0.00008052277,0.0001233455,0.937575,0.0000024596775,0.005237321,0.0008208925],"study_design_scores_gemma":[0.002186728,0.00081535924,0.0057751923,0.00037037145,0.000015003728,9.338612e-7,0.00005189532,0.00018181272,0.9896045,0.000068595364,0.00072785607,0.00020175941],"about_ca_topic_score_codex":0.00042249387,"about_ca_topic_score_gemma":0.00017400467,"teacher_disagreement_score":0.052029505,"about_ca_system_score_codex":0.000092295006,"about_ca_system_score_gemma":0.00052780204,"threshold_uncertainty_score":0.6928115},"labels":[],"label_agreement":null},{"id":"W2165477627","doi":"10.1158/1078-0432.ccr-03-0426","title":"Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Sunnybrook Health Science Centre","funders":"","keywords":"Vascular endothelial growth factor; Hypoxia (environmental); In situ hybridization; Biology; Vascular endothelial growth factor A; Central nervous system; Pathology; Spinal cord; Endocrinology; Cancer research; Internal medicine; Medicine; Gene expression; Chemistry; Neuroscience; VEGF receptors","score_opus":0.0797703368587973,"score_gpt":0.4194308042309488,"score_spread":0.3396604673721515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165477627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97221607,0.024706684,0.00009133779,0.0004233215,0.0016528186,0.00046708406,0.00009862787,0.000019819227,0.0003242644],"genre_scores_gemma":[0.9804289,0.014715022,0.00020610292,0.00015525719,0.003963118,0.000119882294,0.0000428935,0.000037355734,0.00033151868],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971997,0.0003559854,0.0005394615,0.00074562454,0.00040009595,0.0007591278],"domain_scores_gemma":[0.9988603,0.00006767756,0.00008727875,0.00046261644,0.00017144291,0.0003506777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012227752,0.00018619378,0.00035186455,0.0001365534,0.00013582026,0.000064022286,0.00028748348,0.0003772364,0.00003347717],"category_scores_gemma":[0.00032463574,0.00017656438,0.00012007026,0.0003053672,0.00027699766,0.000014494216,0.00020965288,0.0005252017,0.000015164087],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019610673,0.0005511837,0.08370192,0.00040151726,0.00020234374,0.000028810719,0.00037296914,0.0007875843,0.47792268,0.0009298246,0.0090374565,0.42410263],"study_design_scores_gemma":[0.0045463345,0.0008639217,0.489169,0.00013942944,0.000025320278,0.000015729735,0.00034377814,0.00008246343,0.112789236,0.00040314536,0.39102435,0.00059730426],"about_ca_topic_score_codex":0.0013782537,"about_ca_topic_score_gemma":0.00053117715,"teacher_disagreement_score":0.42350534,"about_ca_system_score_codex":0.00016443201,"about_ca_system_score_gemma":0.0008423724,"threshold_uncertainty_score":0.7200087},"labels":[],"label_agreement":null},{"id":"W2165582512","doi":"10.1158/1078-0432.ccr-11-2102","title":"Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Ontario Institute for Cancer Research; Cancer Research Institute","keywords":"Gene knockdown; Clonogenic assay; Cancer research; microRNA; Metastasis; Biology; Viability assay; In vivo; Cancer; Downregulation and upregulation; Blot; Cell growth; Medicine; Oncology; Cell; Cell culture; Internal medicine; Gene","score_opus":0.35484614614979065,"score_gpt":0.5237625743841676,"score_spread":0.16891642823437697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165582512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98384804,0.013465332,0.000008692284,0.0010992406,0.00015812652,0.00064412993,0.000023841321,0.000014254767,0.0007383304],"genre_scores_gemma":[0.9828479,0.015011667,0.00050851435,0.00028092315,0.00015451723,0.00016922632,0.0000015647198,0.000030254443,0.0009954185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979453,0.00020778924,0.000576378,0.00050004694,0.0003508224,0.0004196826],"domain_scores_gemma":[0.998832,0.0002242442,0.00008985505,0.00032311014,0.00025488168,0.00027593764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016476678,0.00013680926,0.0005999217,0.0001592995,0.000046067806,0.000011844774,0.00012393962,0.00017363038,0.000918181],"category_scores_gemma":[0.00011802058,0.00011334694,0.00006983479,0.00046240454,0.0006216033,0.000063332875,0.000104927676,0.0006471334,0.0000033802792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011365827,0.0009669483,0.60629404,0.00074888585,0.0003878402,0.00014540122,0.002042884,0.000001587423,0.09907748,0.0021853498,0.0019195512,0.27486423],"study_design_scores_gemma":[0.00729182,0.0020246168,0.93683285,0.00071425433,0.000052833686,0.000008428717,0.00022492807,0.0001406612,0.036200043,0.0020790657,0.014206089,0.00022441025],"about_ca_topic_score_codex":0.012846712,"about_ca_topic_score_gemma":0.004058785,"teacher_disagreement_score":0.33053884,"about_ca_system_score_codex":0.000088105626,"about_ca_system_score_gemma":0.00042780087,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W2166056954","doi":"10.1158/1078-0432.ccr-07-1187","title":"<i>N</i>-Acetylcysteine Protects Melanocytes against Oxidative Stress/Damage and Delays Onset of Ultraviolet-Induced Melanoma in Mice","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Oxidative stress; Acetylcysteine; Glutathione; In vivo; Melanocyte; Melanoma; DNA damage; Pathogenesis; Cancer research; Pharmacology; Antioxidant; Chemistry; Medicine; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.0815463929412166,"score_gpt":0.44753918461439385,"score_spread":0.3659927916731772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166056954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616516,0.0018096598,0.000048342747,0.00026699307,0.00008261984,0.000601708,0.00010903493,0.0000061152573,0.00091038377],"genre_scores_gemma":[0.9971372,0.0019804898,0.00018136355,0.0001420904,0.0001920233,0.00006884015,0.00010171105,0.000019077503,0.00017722558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99719983,0.00077395194,0.00061300857,0.00061758346,0.00025427772,0.00054133224],"domain_scores_gemma":[0.9984764,0.0005354574,0.00015244955,0.0003415729,0.00032091682,0.00017324564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034823557,0.00017841309,0.0003677518,0.00013319074,0.00008938692,0.000013137266,0.0003793093,0.0004570221,0.000018821134],"category_scores_gemma":[0.0011317658,0.00015178662,0.00007804876,0.00030186755,0.0008550471,0.000007869877,0.00029258383,0.00070620596,0.0000038657367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016326113,0.00015639351,0.14741088,0.00005996019,0.00007928649,0.00003878093,0.00008462545,0.0000037473433,0.84075403,0.00003434135,0.00024706533,0.009498286],"study_design_scores_gemma":[0.0015066387,0.0012221736,0.1295548,0.00012278701,0.0000056149674,0.0000030372817,0.00039462096,0.000009265842,0.86600345,0.00006113238,0.0009552919,0.00016121345],"about_ca_topic_score_codex":0.00033658615,"about_ca_topic_score_gemma":0.0027323645,"teacher_disagreement_score":0.025249422,"about_ca_system_score_codex":0.00002776754,"about_ca_system_score_gemma":0.00022204634,"threshold_uncertainty_score":0.6189679},"labels":[],"label_agreement":null},{"id":"W2166065611","doi":"10.1158/1078-0432.ccr-07-1724","title":"CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15–Dependent Mechanism","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Ovarian cancer; Biology; IL-2 receptor; CD8; Ovarian tumor; Cancer research; Adoptive cell transfer; Cytotoxic T cell; Immune system; Cytokine; T cell; Immunology; Cancer; In vitro","score_opus":0.12861261439292754,"score_gpt":0.459709908561663,"score_spread":0.33109729416873546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166065611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637795,0.008181333,0.0005184953,0.00045659087,0.0025527226,0.0007409799,0.00034147565,0.00006330722,0.0007671708],"genre_scores_gemma":[0.9891287,0.0044535156,0.0001597094,0.00028702267,0.00011630025,0.000070072565,0.00009424626,0.000057141173,0.0056333086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941423,0.0022382655,0.0013965504,0.0007874589,0.0003060147,0.0011294052],"domain_scores_gemma":[0.9958223,0.0022419398,0.00038858753,0.0009551389,0.00046412757,0.00012790575],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007447533,0.00031397247,0.00076701,0.00030068107,0.00045181226,0.000029480514,0.0011023565,0.0007026089,0.0019303962],"category_scores_gemma":[0.0005272884,0.00025385513,0.00023182498,0.00045423963,0.0011435357,0.00020813661,0.00033573635,0.0020462698,0.0002016264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009421634,0.00036023324,0.00022024315,0.000036151807,0.0001976443,0.000014256111,0.00047854678,0.0000047378753,0.9033798,0.0003681437,0.0038441408,0.081674464],"study_design_scores_gemma":[0.0038517695,0.0022983088,0.0014295459,0.00028419314,0.000019078014,0.000011733155,0.0010815334,0.0000050698754,0.8696695,0.0003424879,0.120714225,0.00029254382],"about_ca_topic_score_codex":0.0031845672,"about_ca_topic_score_gemma":0.0010036135,"teacher_disagreement_score":0.11687008,"about_ca_system_score_codex":0.00038202154,"about_ca_system_score_gemma":0.0006963809,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W2166233649","doi":"10.1158/1078-0432.ccr-04-2507","title":"Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Cancer; Cancer research; Cancer cell; Cell culture; Ascites; Chemotherapy; Kinase; Biology; Medicine; Pathology; Immunology; Internal medicine; Cell biology","score_opus":0.1755694433709364,"score_gpt":0.505313710966786,"score_spread":0.3297442675958496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166233649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725057,0.0062256893,0.000041328414,0.005374185,0.00029152905,0.00040436734,0.00017594798,0.000044381883,0.0001919962],"genre_scores_gemma":[0.98770195,0.008424423,0.00042042072,0.00074965734,0.0014515065,0.000028988336,0.000015024978,0.00003069363,0.0011773044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967489,0.00062128296,0.0006847117,0.00061489764,0.0007598041,0.0005704029],"domain_scores_gemma":[0.9961226,0.0022604926,0.000091898415,0.00047608206,0.00058063935,0.0004682621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002124349,0.00017878704,0.00067080214,0.0001465111,0.000119250064,0.000028411117,0.0001439942,0.00024355031,0.00096815015],"category_scores_gemma":[0.0007516191,0.00014709389,0.00014266376,0.0004497718,0.0009603314,0.00011511757,0.00017882725,0.0010338163,0.000055857377],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024342437,0.00038681293,0.3360697,0.00015826922,0.00020054582,0.00008584488,0.0004303784,0.000013123037,0.4107386,0.000015845433,0.012403602,0.23706304],"study_design_scores_gemma":[0.0052130725,0.0011644771,0.67767787,0.0008173779,0.00016244057,0.000009673524,0.00028377154,0.016706346,0.25991657,0.000108593274,0.03748525,0.00045458056],"about_ca_topic_score_codex":0.010633582,"about_ca_topic_score_gemma":0.0040123872,"teacher_disagreement_score":0.34160814,"about_ca_system_score_codex":0.00012184935,"about_ca_system_score_gemma":0.000572831,"threshold_uncertainty_score":0.9999451},"labels":[],"label_agreement":null},{"id":"W2166246129","doi":"10.1158/1078-0432.ccr-04-0452","title":"Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"Docetaxel; Pharmacokinetics; Medicine; Neutropenia; Pharmacology; Dosing; Toxicity; Chemotherapy; Internal medicine; Urology; Oncology","score_opus":0.1295801785086009,"score_gpt":0.47364825405095895,"score_spread":0.3440680755423581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166246129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171424,0.0006865898,0.000027427976,0.0049172486,0.0000756109,0.0021882884,0.000006539591,0.000013780241,0.00037025637],"genre_scores_gemma":[0.99875206,0.00020466339,0.000085367625,0.000069728434,0.0000772424,0.0003793702,0.0000045604047,0.000022731496,0.00040430814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692017,0.00031600374,0.0007718147,0.0004086895,0.0011582056,0.00042510367],"domain_scores_gemma":[0.9987524,0.0002287687,0.00010495723,0.00044684293,0.0003560338,0.00011096248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043445276,0.00013206108,0.00049307186,0.00027477948,0.00008257192,0.000015974543,0.00023426395,0.00011509859,0.000045956564],"category_scores_gemma":[0.00018221582,0.00007754829,0.00006495889,0.0012745975,0.00047411275,0.000069344605,0.000045123757,0.0009678527,0.00000451387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18203421,0.1892002,0.42407352,0.0027992313,0.0005449428,0.0074427305,0.030511396,0.00066774344,0.103277214,0.016038526,0.0012710358,0.042139266],"study_design_scores_gemma":[0.2223933,0.057299037,0.6313805,0.0051802974,0.00013323946,0.00000840954,0.029398762,0.000050040195,0.045597266,0.0049509886,0.003036958,0.00057120546],"about_ca_topic_score_codex":0.0023175455,"about_ca_topic_score_gemma":0.0222367,"teacher_disagreement_score":0.20730698,"about_ca_system_score_codex":0.0002291733,"about_ca_system_score_gemma":0.0007682034,"threshold_uncertainty_score":0.99560493},"labels":[],"label_agreement":null},{"id":"W2166395740","doi":"10.1158/1078-0432.ccr-03-0795","title":"Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute; U.S. Public Health Service; National Institutes of Health","keywords":"Matrigel; Angiogenesis; Vascular endothelial growth factor; Human umbilical vein endothelial cell; Umbilical vein; Extracellular matrix; Cell biology; CD31; Biology; Fibroblast growth factor; Endothelial stem cell; Cancer research; Molecular biology; Chemistry; In vitro; Biochemistry","score_opus":0.2096314781247637,"score_gpt":0.4844562148011677,"score_spread":0.27482473667640395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166395740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98208565,0.013036429,0.00050182955,0.0014405955,0.00014692271,0.00084930635,0.000026947668,0.000015407357,0.001896943],"genre_scores_gemma":[0.99046767,0.0030181329,0.00079936633,0.00015073743,0.00073566503,0.00023723081,0.00001935071,0.00005734285,0.004514498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951951,0.0010327151,0.00085437804,0.00085359125,0.0011019642,0.0009622498],"domain_scores_gemma":[0.99735576,0.0001468975,0.00009153604,0.0010853522,0.00095677684,0.00036369712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060755964,0.00021490734,0.00044702174,0.00023302223,0.00018552356,0.000035732828,0.0009394047,0.00049050734,0.00023070714],"category_scores_gemma":[0.002689192,0.0001817503,0.0003483429,0.0006747831,0.0012654511,0.0000098214705,0.00078606163,0.00092908536,0.000065271626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058304373,0.00032193342,0.0038586198,0.00012264655,0.00016222916,0.000016892945,0.00006259685,0.000111371046,0.978985,0.00008562588,0.00484303,0.0108469715],"study_design_scores_gemma":[0.0014392212,0.0012653411,0.005541738,0.00013010025,0.000012333341,0.00000525731,0.000094718875,0.000010470484,0.9658442,0.0003021057,0.02512401,0.00023049285],"about_ca_topic_score_codex":0.0011686676,"about_ca_topic_score_gemma":0.0005302184,"teacher_disagreement_score":0.02028098,"about_ca_system_score_codex":0.000096748765,"about_ca_system_score_gemma":0.0017423857,"threshold_uncertainty_score":0.7411562},"labels":[],"label_agreement":null},{"id":"W2166455683","doi":"10.1158/1078-0432.ccr-13-2491","title":"Molecular Pathways: Epigenetic Modulation of Wnt–Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Biology; Cancer stem cell; Epigenetics; Cancer research; LRP6; Cancer; Stem cell; GSK-3; Signal transduction; LRP5; Cell biology; Genetics; Gene","score_opus":0.2676060883690465,"score_gpt":0.5161031545792915,"score_spread":0.24849706621024498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166455683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062052853,0.93372625,0.001654299,0.0000337776,0.0004298492,0.0016080604,0.00037295476,0.0000120574605,0.000109922075],"genre_scores_gemma":[0.07568456,0.92124546,0.00037158327,0.00004277394,0.0011510827,0.00072026544,0.00031671315,0.000157578,0.00031001493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931816,0.002013286,0.0018337818,0.0013504786,0.0008686542,0.00075221923],"domain_scores_gemma":[0.9965587,0.00035000814,0.0005939864,0.0011596737,0.0008429572,0.00049464416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038870214,0.00048862625,0.0016158926,0.00030142855,0.00018612763,0.000060991304,0.00088036695,0.0009786971,0.00013914816],"category_scores_gemma":[0.00032698148,0.00045302833,0.00080957945,0.00055665587,0.0003228731,0.000004179583,0.0005279697,0.00077027624,0.000032353688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069763344,0.0002060471,0.0000794429,0.0052303122,0.0003981657,0.000017804985,0.000026371155,0.0032338528,0.24053128,0.00006922191,0.00034103863,0.7497967],"study_design_scores_gemma":[0.0004110798,0.000983961,0.000021403017,0.003497974,0.00027688744,5.7677875e-7,0.000011097896,0.00008526909,0.20864068,0.00025543905,0.7851611,0.00065458514],"about_ca_topic_score_codex":0.00027930725,"about_ca_topic_score_gemma":0.000083932944,"teacher_disagreement_score":0.78482,"about_ca_system_score_codex":0.00014296727,"about_ca_system_score_gemma":0.0010387207,"threshold_uncertainty_score":0.99979216},"labels":[],"label_agreement":null},{"id":"W2166594813","doi":"10.1158/1078-0432.ccr-13-1869","title":"Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Marsden Fund; Pfizer; Prostate Cancer Foundation","keywords":"Medicine; Docetaxel; Prostate cancer; Clinical endpoint; Internal medicine; Adverse effect; Prednisone; Urology; Phases of clinical research; Oncology; Chemotherapy; Cancer; Randomized controlled trial; Surgery; Gastroenterology","score_opus":0.21302490922324202,"score_gpt":0.5482458703631305,"score_spread":0.33522096113988853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166594813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836788,0.0031454463,0.000058862977,0.0021199987,0.00010708445,0.008891455,0.0018143333,0.000027476297,0.00015654655],"genre_scores_gemma":[0.98934793,0.0019641495,0.00029254126,0.000098614495,0.00023120083,0.0048088823,0.00022794187,0.00005148213,0.0029772245],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99492025,0.00083992176,0.0011665577,0.00086037046,0.0013823245,0.0008305453],"domain_scores_gemma":[0.9943169,0.0026528186,0.00029552935,0.0005938513,0.001627518,0.00051343057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056007365,0.0003117931,0.0017485755,0.00026307744,0.00048719856,0.00010175961,0.00022007283,0.0001034929,0.0002198402],"category_scores_gemma":[0.0013886486,0.00019010625,0.00021475667,0.0005774335,0.0016631237,0.0001761309,0.0001660303,0.0007057824,0.0000030330043],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9515752,0.009695532,0.0031571116,0.0014455082,0.0024995813,0.00009357027,0.0023847169,0.000089927766,0.0017244968,0.00014161966,0.0072392984,0.019953432],"study_design_scores_gemma":[0.9513122,0.033263974,0.0020860406,0.00054016896,0.001048665,0.000008831468,0.000939734,0.0021519237,0.0020190359,0.00048172046,0.005824029,0.00032371996],"about_ca_topic_score_codex":0.0033744362,"about_ca_topic_score_gemma":0.002099833,"teacher_disagreement_score":0.02356844,"about_ca_system_score_codex":0.00024137762,"about_ca_system_score_gemma":0.001761835,"threshold_uncertainty_score":0.77523077},"labels":[],"label_agreement":null},{"id":"W2166760601","doi":"10.1158/1078-0432.ccr-05-0771","title":"Basic Fibroblast Growth Factor (FGF-2) Overexpression Is a Risk Factor for Esophageal Cancer Recurrence and Reduced Survival, which Is Ameliorated by Coexpression of the FGF-2 Antisense Gene","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Dalhousie University","funders":"Nova Scotia Health Research Foundation; Dalhousie University; Cancer Research Society","keywords":"Fibroblast growth factor; Cancer research; Basic fibroblast growth factor; Cancer; Esophageal cancer; Gene; Risk factor; Biology; Fibroblast growth factor receptor 3; Growth factor; Medicine; Internal medicine; Genetics","score_opus":0.09332772790006028,"score_gpt":0.44446837922420285,"score_spread":0.35114065132414257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166760601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832196,0.0029176623,0.000070971684,0.0016791775,0.00023111246,0.0013604072,0.010472084,0.000016707856,0.000032226668],"genre_scores_gemma":[0.9889484,0.008638545,0.000213966,0.00015667398,0.0006346917,0.00021848547,0.000055883924,0.000086383734,0.0010469705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942048,0.0013210078,0.00089953584,0.0013679852,0.0011997418,0.0010069149],"domain_scores_gemma":[0.9957505,0.0006870256,0.0003937257,0.0010082772,0.0016765087,0.00048397566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013163962,0.00039167487,0.00057687564,0.0001198872,0.00046123384,0.00010104512,0.00092855055,0.0006360593,0.0006529159],"category_scores_gemma":[0.0025032528,0.0002858813,0.0002642613,0.00071712333,0.00086358556,0.000038122253,0.0009802498,0.001192814,0.00000995191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014587583,0.00018457533,0.028833477,0.00020546555,0.00010923026,5.145398e-7,0.00018071018,0.000006069563,0.9091379,0.00000201455,0.049087826,0.010793442],"study_design_scores_gemma":[0.0020039834,0.0008044764,0.07526866,0.00049692864,0.000017164595,0.0000013025624,0.00003360532,0.00040853946,0.9152064,0.000031068765,0.005415501,0.00031238323],"about_ca_topic_score_codex":0.00082399946,"about_ca_topic_score_gemma":0.0002219255,"teacher_disagreement_score":0.04643518,"about_ca_system_score_codex":0.00011425666,"about_ca_system_score_gemma":0.0009349999,"threshold_uncertainty_score":0.99995935},"labels":[],"label_agreement":null},{"id":"W2166913340","doi":"10.1158/1078-0432.ccr-13-1215","title":"<i>Bim</i> Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Jewish General Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"MCL1; Genotype; Cohort; Apoptosis; Cancer; Leukemia; Gene isoform; Medicine; Oncology; Internal medicine; Cancer research; Immunology; Biology; Gene; Downregulation and upregulation; Genetics","score_opus":0.04711484774247606,"score_gpt":0.40126830346331366,"score_spread":0.3541534557208376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166913340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912405,0.00016623244,0.000041321764,0.0053545884,0.00005618922,0.0027838547,0.000024886094,0.000055397562,0.00027703439],"genre_scores_gemma":[0.9933707,0.0004962952,0.00021477719,0.0018969089,0.0002711795,0.0015307426,0.000010432874,0.00006646058,0.0021424827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951383,0.0007814674,0.0006199608,0.0010477526,0.0013425593,0.0010699872],"domain_scores_gemma":[0.99500626,0.0025783887,0.000063781576,0.0008022301,0.00047141922,0.0010779309],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019309727,0.00030567564,0.00060390506,0.0006451742,0.0001663555,0.00010247312,0.00026836907,0.00026622493,0.00031239857],"category_scores_gemma":[0.0014758112,0.00020794838,0.000078509314,0.0012438449,0.0007378659,0.00017707254,0.00023387566,0.0008640583,0.0008675401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08300718,0.00092227233,0.8398113,0.000037429603,0.0006729955,0.000368574,0.00028462737,0.0002861621,0.011035506,0.00009149676,0.0045447806,0.058937665],"study_design_scores_gemma":[0.011805519,0.015155173,0.9700096,0.00033286773,0.000073238145,0.00011011789,0.00006361703,0.00041550084,0.00080817426,0.00012822251,0.00087761506,0.00022030414],"about_ca_topic_score_codex":0.007630144,"about_ca_topic_score_gemma":0.00027266922,"teacher_disagreement_score":0.13019834,"about_ca_system_score_codex":0.005444398,"about_ca_system_score_gemma":0.005236576,"threshold_uncertainty_score":0.9999104},"labels":[],"label_agreement":null},{"id":"W2167244585","doi":"10.1158/1078-0432.ccr-1167-3","title":"Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":284,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; CA19-9; Medicine; Pancreatic disease; Internal medicine; Adenocarcinoma; Gastroenterology; Pancreas; Cancer; Pathology","score_opus":0.1290911887960914,"score_gpt":0.4591416555298894,"score_spread":0.330050466733798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167244585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97239447,0.0010461592,0.025511699,0.0003508625,0.000019499004,0.0002791468,0.00004942835,0.000049457216,0.00029927396],"genre_scores_gemma":[0.95784605,0.004743742,0.036955167,0.000019947884,0.00013981218,0.0001440879,0.000011255322,0.00002958029,0.00011034382],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984155,0.000063789135,0.00047530103,0.00040976238,0.0003245021,0.00031110627],"domain_scores_gemma":[0.99870074,0.00037124872,0.00014635586,0.00037114357,0.00027932654,0.00013119163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006361024,0.00011337669,0.00026224673,0.00006856329,0.00015558212,0.000028940582,0.0001902124,0.00018989398,0.0003477745],"category_scores_gemma":[0.0002823396,0.00011329058,0.000065611115,0.0005535941,0.0003175677,0.00010760286,0.00011178805,0.00050458557,0.000005897736],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020497291,0.00029624914,0.5287197,0.00040352307,0.00006544939,0.0000044236385,0.00009030712,0.002854609,0.46001357,0.0017913831,0.000042082,0.005513716],"study_design_scores_gemma":[0.00087911397,0.0001046944,0.010587996,0.00028483663,0.00003292392,0.0000017910585,0.00010840759,0.0008202048,0.9658015,0.021142041,0.00006700459,0.00016951127],"about_ca_topic_score_codex":0.00025145468,"about_ca_topic_score_gemma":0.000022362707,"teacher_disagreement_score":0.51813173,"about_ca_system_score_codex":0.0002583324,"about_ca_system_score_gemma":0.00016838145,"threshold_uncertainty_score":0.4619856},"labels":[],"label_agreement":null},{"id":"W2167290534","doi":"10.1158/1078-0432.ccr-06-1432","title":"Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Melanoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Pharmacokinetics; Adverse effect; Cohort; Progressive disease; Gastroenterology; Combination therapy; Chemotherapy; Hepatocellular carcinoma; Cancer research","score_opus":0.17133590328777443,"score_gpt":0.46470068394029906,"score_spread":0.29336478065252464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167290534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958482,0.00026943965,0.000023346358,0.00020784643,0.000055869317,0.0030424844,0.000022891334,0.0000081600465,0.00052181154],"genre_scores_gemma":[0.99815756,0.00007709201,0.0005237566,0.000034949637,0.0000640614,0.00019826843,0.00004065155,0.000038779584,0.00086486276],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995727,0.0005762405,0.0010399937,0.0005950871,0.0013803421,0.0006813496],"domain_scores_gemma":[0.99689806,0.0016345287,0.00020331635,0.00042430207,0.0004967861,0.00034303562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043269093,0.00021592679,0.0008208904,0.00056704145,0.000051769897,0.000021210617,0.000165201,0.000120163575,0.00018977816],"category_scores_gemma":[0.00046060878,0.00011943347,0.000060291368,0.0011477384,0.00043007123,0.000110902496,0.00009271737,0.0007185707,0.000004367644],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58387256,0.009970871,0.3952166,0.00030233033,0.000059067177,0.0011757504,0.00022139016,0.0000043590894,0.00019030621,0.000015384052,0.000093131996,0.008878217],"study_design_scores_gemma":[0.40298346,0.0966681,0.48903078,0.0004362253,0.00010342953,0.000008561787,0.0002750634,0.00008408753,0.010093804,0.000030619995,0.0001159025,0.00016995307],"about_ca_topic_score_codex":0.00223119,"about_ca_topic_score_gemma":0.005312554,"teacher_disagreement_score":0.18088911,"about_ca_system_score_codex":0.00043994022,"about_ca_system_score_gemma":0.0012624986,"threshold_uncertainty_score":0.48703554},"labels":[],"label_agreement":null},{"id":"W2167436791","doi":"10.1158/1078-0432.ccr-13-1787","title":"Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":316,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Turun Yliopistollinen Keskussairaala; University of Pennsylvania","keywords":"Metformin; Medicine; Tumor hypoxia; Radiation therapy; Hypoxia (environmental); Oxygenation; Internal medicine; Oncology; Cancer research; Pathology; Oxygen; Chemistry; Insulin","score_opus":0.06269851163208219,"score_gpt":0.4345203638725105,"score_spread":0.3718218522404283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167436791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7777976,0.2210985,0.000089551446,0.0002749676,0.00013369523,0.00050618174,0.0000067390306,0.000012616683,0.00008015094],"genre_scores_gemma":[0.85484195,0.1353726,0.003516575,0.0012991835,0.0017732227,0.0012995092,0.000021029107,0.00008130901,0.0017946411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973901,0.0006572265,0.0003733358,0.0006629712,0.0003992608,0.0005171298],"domain_scores_gemma":[0.9984557,0.00019984673,0.000095909934,0.00051863684,0.0004683538,0.00026153668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003732875,0.00015805232,0.00029488542,0.00008927837,0.00015244873,0.00012282192,0.0002519472,0.00015199455,0.00016465435],"category_scores_gemma":[0.0007234986,0.000116024916,0.000084224346,0.00024122462,0.00049780373,0.000019607725,0.0001160685,0.00035882718,0.000011591653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019322193,0.000080020356,0.0016889416,0.000028988014,0.00013226847,0.0000032401333,0.00007058205,0.0000018806236,0.12656555,0.000067236295,0.0037669777,0.8656621],"study_design_scores_gemma":[0.0020140558,0.00089897664,0.034187008,0.000026130994,0.000024253432,0.000006679071,0.00018422015,0.00009556923,0.059499044,0.000228255,0.90256894,0.0002668997],"about_ca_topic_score_codex":0.00033060196,"about_ca_topic_score_gemma":0.00007935793,"teacher_disagreement_score":0.8988019,"about_ca_system_score_codex":0.000027367652,"about_ca_system_score_gemma":0.00034917332,"threshold_uncertainty_score":0.4731359},"labels":[],"label_agreement":null},{"id":"W2167521129","doi":"10.1158/1078-0432.ccr-07-1561","title":"Fractionated versus Standard Continuous Light Delivery in Interstitial Photodynamic Therapy of Dunning Prostate Carcinomas","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Photodynamic therapy; Medicine; Prostate cancer; Prostate; Perfusion; Nuclear medicine; Magnetic resonance imaging; Cancer; Urology; Pathology; Internal medicine; Chemistry; Radiology","score_opus":0.12976499426975882,"score_gpt":0.5086043330160913,"score_spread":0.37883933874633247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167521129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897007,0.0052214167,0.000017221762,0.0010361824,0.00056362944,0.0014633154,0.000048966805,0.000044338,0.0019042352],"genre_scores_gemma":[0.98664457,0.012400927,0.000076544195,0.000089101486,0.00027211927,0.00011352109,0.000016636575,0.00004449457,0.00034207868],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9955186,0.00044653416,0.001100054,0.0005780175,0.0014017206,0.00095505395],"domain_scores_gemma":[0.9951972,0.0026433677,0.0001627737,0.00043673493,0.0012528886,0.00030704192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073570744,0.00020369235,0.0008200632,0.0006427186,0.00012807493,0.00002271642,0.00029570665,0.00021536685,0.0003671013],"category_scores_gemma":[0.0016951513,0.00016970634,0.0002576316,0.0009916923,0.00093572296,0.00011443112,0.00020564052,0.0019213867,0.000014204684],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4384454,0.0015488686,0.16889594,0.0004576243,0.0011851743,0.0014616698,0.0029043693,0.000023614397,0.26331854,0.00008131562,0.0019175028,0.11975999],"study_design_scores_gemma":[0.067238174,0.024965102,0.7550806,0.002459344,0.000060593462,0.000022453418,0.007131843,0.000471819,0.11719096,0.000276153,0.02440016,0.0007028122],"about_ca_topic_score_codex":0.0026214404,"about_ca_topic_score_gemma":0.003052291,"teacher_disagreement_score":0.5861846,"about_ca_system_score_codex":0.0009369488,"about_ca_system_score_gemma":0.0010607142,"threshold_uncertainty_score":0.83475757},"labels":[],"label_agreement":null},{"id":"W2167570951","doi":"10.1158/1078-0432.ccr-0571-03","title":"Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer <b> <i>In vitro</i> </b> and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Prostate cancer; Intraepithelial neoplasia; Prostate; Immunohistochemistry; Carcinogenesis; Cancer research; Cancer; Biology; Parthenolide; Pathology; Molecular biology; Medicine; Internal medicine; Apoptosis","score_opus":0.05589962748068334,"score_gpt":0.3906717512679411,"score_spread":0.3347721237872578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167570951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567086,0.0011925702,9.0676406e-7,0.001349132,0.00006769201,0.0011521374,0.00051828497,0.000004748738,0.000043677395],"genre_scores_gemma":[0.99736387,0.0019350462,0.000055204044,0.00037816065,0.00004647206,0.00012689087,0.000005711579,0.000031283413,0.000057382193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975356,0.0003572294,0.0005865703,0.00066802045,0.0003391176,0.0005134761],"domain_scores_gemma":[0.9991445,0.00013582238,0.00013147296,0.00031126512,0.00015384569,0.00012312776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008106087,0.00018774417,0.0003570984,0.00011082095,0.00006778197,0.00003727945,0.0002547434,0.00020907036,0.0000259512],"category_scores_gemma":[0.00037560516,0.00014923095,0.000053065778,0.0004054138,0.0011283553,0.000016724314,0.00033571036,0.0007685148,0.0000016310958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020830797,0.00014069473,0.25555634,0.00013304687,0.000021209167,0.000014781695,0.0017332779,0.00004078372,0.738067,0.000021953396,0.000062016625,0.0021258262],"study_design_scores_gemma":[0.0046391934,0.00034275313,0.18578234,0.0004043421,0.0000055791465,0.0000034880939,0.00024124674,0.000045517783,0.8074687,0.00034949568,0.00053466874,0.00018262745],"about_ca_topic_score_codex":0.0028565284,"about_ca_topic_score_gemma":0.0010967369,"teacher_disagreement_score":0.06977401,"about_ca_system_score_codex":0.00011454904,"about_ca_system_score_gemma":0.0010235399,"threshold_uncertainty_score":0.6085462},"labels":[],"label_agreement":null},{"id":"W2167689405","doi":"10.1158/1078-0432.ccr-07-1380","title":"Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Medicine; Univariate analysis; Oncology; Internal medicine; Stage (stratigraphy); Metastasis; Cancer; Immunohistochemistry; Multivariate analysis; Lymph node; Tissue microarray; Pathology; Cancer research; Biology","score_opus":0.056547800871899354,"score_gpt":0.3718547099314861,"score_spread":0.31530690905958675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167689405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398404,0.003188492,0.00010330324,0.00004820438,0.00010216587,0.0005896448,0.0019467814,0.000006363823,0.000031026808],"genre_scores_gemma":[0.9895938,0.009157224,0.00025441914,0.000020673511,0.00007982292,0.00029550437,0.00031917405,0.000026203788,0.00025317786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99618644,0.0010902111,0.00080501585,0.00075317983,0.0007211362,0.00044399756],"domain_scores_gemma":[0.99781954,0.00029710558,0.00036778123,0.00054569193,0.0006622358,0.00030766355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001527739,0.00020369932,0.0007160625,0.00016292704,0.00022803963,0.000013150114,0.00026555307,0.0002654812,0.00017396829],"category_scores_gemma":[0.001247495,0.00016462129,0.00032396615,0.00061947625,0.00096489326,0.000010620686,0.0005543754,0.00027769245,0.000001969412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002719632,0.0003388179,0.16201594,0.0000998963,0.0011741044,0.000008646609,0.00016096908,0.000044195855,0.83036876,0.000008553437,0.0024847735,0.0005757155],"study_design_scores_gemma":[0.0027036169,0.0004903156,0.089701265,0.00007712787,0.00033873104,3.2039117e-7,0.000106107436,0.0001029142,0.905297,0.000037278543,0.00096426037,0.00018107882],"about_ca_topic_score_codex":0.0059437007,"about_ca_topic_score_gemma":0.0010456704,"teacher_disagreement_score":0.07492824,"about_ca_system_score_codex":0.00008758189,"about_ca_system_score_gemma":0.00043326552,"threshold_uncertainty_score":0.8985137},"labels":[],"label_agreement":null},{"id":"W2168193627","doi":"10.1158/1078-0432.ccr-07-4723","title":"Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cohort; Distant metastasis; Cancer; Metastasis","score_opus":0.09167216163521853,"score_gpt":0.4584146057830925,"score_spread":0.366742444147874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168193627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954406,0.0018267635,0.000006255257,0.0014880493,0.00017252959,0.00039276804,0.00032123004,0.000004344926,0.00034743155],"genre_scores_gemma":[0.9941304,0.0045516742,0.000020574553,0.00014204494,0.00023210952,0.00038887092,0.000017836981,0.000018252174,0.00049823447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728733,0.00062604714,0.00052379066,0.000582616,0.00054148334,0.0004387587],"domain_scores_gemma":[0.9984847,0.00019942322,0.000120640965,0.00067836384,0.0004178031,0.000099121746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015232309,0.00014981958,0.00046038476,0.00014091383,0.00014428336,0.000008097422,0.0004727692,0.00016654347,0.00014610773],"category_scores_gemma":[0.00027706297,0.00010259872,0.00025965262,0.0011358742,0.0008050968,0.000003817916,0.00053634826,0.0003704592,0.000004011187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007208594,0.0003046703,0.98973846,0.000011745659,0.0014147109,0.000009298579,0.0000940376,0.00018414506,0.002335128,0.000011744576,0.0011360536,0.004039146],"study_design_scores_gemma":[0.0008510176,0.00009923671,0.9950704,0.00003255393,0.00021584162,0.0000057011325,0.000055892724,0.00005435322,0.0025744347,0.000012432734,0.00092137704,0.00010673134],"about_ca_topic_score_codex":0.004804431,"about_ca_topic_score_gemma":0.011859096,"teacher_disagreement_score":0.007054665,"about_ca_system_score_codex":0.00015198323,"about_ca_system_score_gemma":0.00064132735,"threshold_uncertainty_score":0.72628945},"labels":[],"label_agreement":null},{"id":"W2168295595","doi":"10.1158/1078-0432.ccr-08-1688","title":"Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Institutes of Health; National Cancer Institute; Richard M. Schulze Family Foundation; Mayo Foundation for Medical Education and Research","keywords":"Oncolytic virus; Medicine; Toxicity; Cyclophosphamide; Systemic administration; Pharmacology; Cancer research; Immunology; Chemotherapy; Internal medicine; In vivo; Immune system; Biology","score_opus":0.07224054727839395,"score_gpt":0.43033735699186704,"score_spread":0.3580968097134731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168295595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777967,0.0008423395,0.0002728316,0.0001365758,0.000054931228,0.00077445497,0.000034240795,0.000012899077,0.00009207129],"genre_scores_gemma":[0.9987196,0.0003333912,0.0003042924,0.00016743179,0.00021033296,0.00006352601,0.00004251463,0.000031069976,0.0001278854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972923,0.0006709753,0.0005772659,0.0005521272,0.000430898,0.00047643908],"domain_scores_gemma":[0.998225,0.00025236772,0.0001393142,0.0004559926,0.000646733,0.00028059393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024979387,0.00015824835,0.00033620687,0.00019672589,0.00016424965,0.00005696186,0.00028861192,0.00018444487,0.000026934766],"category_scores_gemma":[0.0006676655,0.00014071341,0.000067908055,0.0004966718,0.00027591767,0.000018194176,0.00012657193,0.0005203735,0.0000033089573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010107418,0.00013846281,0.007378107,0.0000763351,0.000078611505,0.000006988299,0.00012291395,0.0012669661,0.9427015,0.0000023376622,0.00013273592,0.0379876],"study_design_scores_gemma":[0.008982454,0.054117538,0.092342004,0.0017047498,0.00007229828,0.000056082365,0.00091246906,0.017176906,0.8230074,0.00026681644,0.0003475327,0.0010137659],"about_ca_topic_score_codex":0.00050337537,"about_ca_topic_score_gemma":0.000702486,"teacher_disagreement_score":0.11969414,"about_ca_system_score_codex":0.00015859405,"about_ca_system_score_gemma":0.0007902206,"threshold_uncertainty_score":0.57381266},"labels":[],"label_agreement":null},{"id":"W2168315857","doi":"10.1158/1078-0432.ccr-040019","title":"Molecularly Targeted Approaches to the Chemoprevention of Lung Cancer","year":2004,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Gefitinib; Erlotinib; Lung cancer; Medicine; Retinoid; Epidermal growth factor receptor; Cancer prevention; Cancer; Cancer research; Bexarotene; Isotretinoin; Fenretinide; Oncology; Internal medicine; Retinoic acid; Biology; Dermatology; Biochemistry","score_opus":0.39691480833262327,"score_gpt":0.5340960007000445,"score_spread":0.1371811923674212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168315857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056424737,0.9963003,0.0005240261,0.00026015626,0.00034371653,0.0014807557,0.00009270949,0.000007963444,0.0004261649],"genre_scores_gemma":[0.0012225481,0.99338686,0.00016361846,0.000056920017,0.0011977807,0.0015602194,0.00019271886,0.000081596154,0.0021377185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958822,0.00096120586,0.0010061916,0.0009234992,0.00067390176,0.00055298425],"domain_scores_gemma":[0.99797976,0.00014788675,0.00031570837,0.001003976,0.00035446908,0.00019820787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029904044,0.00032685878,0.0009778389,0.00010591499,0.0001442427,0.000050649596,0.0013283149,0.0007548438,0.00016709606],"category_scores_gemma":[0.00079446245,0.00021692227,0.0007777242,0.0007121488,0.00044348897,0.0000034635866,0.00062619545,0.0011278209,0.000024047526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011529523,0.00020817138,0.00009277627,0.025068892,0.0007780873,0.0000069483326,0.000043135602,0.00006683651,0.00035877852,0.00015166786,0.008015114,0.96509427],"study_design_scores_gemma":[0.00027624826,0.00023245715,0.000010469724,0.0055062133,0.00027848125,0.0000033378153,0.000013795798,0.0000065583877,0.0030393281,0.000065821,0.99028206,0.00028522583],"about_ca_topic_score_codex":0.00017571247,"about_ca_topic_score_gemma":0.000057415953,"teacher_disagreement_score":0.98226696,"about_ca_system_score_codex":0.000176361,"about_ca_system_score_gemma":0.0035513032,"threshold_uncertainty_score":0.88458335},"labels":[],"label_agreement":null},{"id":"W2168339179","doi":"10.1158/1078-0432.ccr-03-0740","title":"Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":326,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"RNA interference; Cancer research; Epidermal growth factor receptor; Genetic enhancement; Glioma; Gene silencing; Transferrin receptor; Cancer; Biology; Small hairpin RNA; Brain tumor; Medicine; Molecular biology; Receptor; Gene; RNA; Pathology; Internal medicine","score_opus":0.12506824874547218,"score_gpt":0.4455297765496041,"score_spread":0.3204615278041319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168339179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945343,0.0022972063,0.00013095031,0.0066106436,0.0007131157,0.00056960253,0.000064710934,0.000014180773,0.00014616443],"genre_scores_gemma":[0.989132,0.0070118182,0.000070893715,0.0009377907,0.0022019036,0.00029267767,0.00004455545,0.00004047613,0.0002678964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963821,0.0008559345,0.00073094724,0.00078306394,0.0004305924,0.00081733847],"domain_scores_gemma":[0.99855345,0.00024175282,0.00012967638,0.00043666872,0.00045982568,0.00017862381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025471016,0.00024295672,0.00035449496,0.000083651714,0.00026591698,0.00009213811,0.0009717603,0.00033618085,0.00041522487],"category_scores_gemma":[0.00084847567,0.00017593555,0.0001726084,0.00024129197,0.0006222932,0.000015822397,0.00033623198,0.0012310375,0.00003392612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014524879,0.0004367438,0.042176846,0.000030821117,0.00014996181,0.000033334658,0.0007724361,0.00009064167,0.88605833,0.000072903866,0.0038087044,0.0649168],"study_design_scores_gemma":[0.005862443,0.0044017853,0.14269455,0.00021360496,0.000012664697,0.000008448172,0.00059011544,0.000049875398,0.8329692,0.0015005117,0.010790327,0.0009065018],"about_ca_topic_score_codex":0.004602218,"about_ca_topic_score_gemma":0.0037823506,"teacher_disagreement_score":0.1005177,"about_ca_system_score_codex":0.00013122728,"about_ca_system_score_gemma":0.00069433,"threshold_uncertainty_score":0.71744436},"labels":[],"label_agreement":null},{"id":"W2168430622","doi":"10.1158/1078-0432.ccr-03-0165","title":"Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Medicine; Pancreatic disease; Adenocarcinoma; Pathology; CA19-9; Tissue microarray; Immunohistochemistry; Pancreas; Cancer; Pancreatitis; Internal medicine; Cancer research","score_opus":0.1025234701828855,"score_gpt":0.47666278675125373,"score_spread":0.37413931656836824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168430622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98212373,0.006494708,0.0000016069258,0.0025590984,0.00027808367,0.000552723,0.00003536486,0.000026705906,0.007927991],"genre_scores_gemma":[0.9910986,0.004491075,0.00013665804,0.0008290704,0.00040784862,0.00004703227,0.000003523083,0.000042083862,0.0029441023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975512,0.00027228965,0.00058465294,0.00044872452,0.0006570699,0.0004860319],"domain_scores_gemma":[0.9985555,0.0003356021,0.00008717676,0.00037572545,0.0002200442,0.00042595668],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019589732,0.00015158918,0.0005067637,0.00016044274,0.00010129494,0.000015085862,0.00012758734,0.00033783496,0.0010880097],"category_scores_gemma":[0.0004637347,0.00011185696,0.00015003026,0.00045207745,0.0012402495,0.000040206494,0.00013851422,0.000934818,0.000053473967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0112688765,0.0007500318,0.89666533,0.0015110021,0.0012781356,0.0010422057,0.0008642142,0.000029254994,0.037485793,0.00033683755,0.007977021,0.040791314],"study_design_scores_gemma":[0.017655473,0.0040582,0.88836116,0.0030702092,0.00036712392,0.00022391274,0.0010490994,0.000107507825,0.014236107,0.0015005398,0.06888823,0.00048246002],"about_ca_topic_score_codex":0.003998424,"about_ca_topic_score_gemma":0.00022535131,"teacher_disagreement_score":0.06091121,"about_ca_system_score_codex":0.00028503576,"about_ca_system_score_gemma":0.0013325185,"threshold_uncertainty_score":0.9998251},"labels":[],"label_agreement":null},{"id":"W2168482167","doi":"10.1158/1078-0432.ccr-03-0244","title":"Treatment of HER-2/<b> <i>neu</i> </b> Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/<b> <i>neu</i> </b> and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Gefitinib; Trastuzumab; Medicine; Cancer research; Epidermal growth factor receptor; In vivo; Estrogen receptor; Breast cancer; Growth inhibition; Cell growth; Cancer; Internal medicine; Pharmacology; Biology","score_opus":0.08032479363375436,"score_gpt":0.4131441111757406,"score_spread":0.33281931754198624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168482167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987444,0.0041265497,0.000120255914,0.004446451,0.00020163617,0.0027050925,0.00029352368,0.00009655385,0.0005659827],"genre_scores_gemma":[0.98263127,0.013965473,0.00090127974,0.00040957797,0.00060929917,0.00093502714,0.000031165047,0.00017080414,0.00034610907],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9930032,0.0010840138,0.0010795244,0.0016118299,0.0019484896,0.0012729318],"domain_scores_gemma":[0.994379,0.0024301629,0.0003764241,0.00063452235,0.001049795,0.0011301307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013821151,0.00063596515,0.0013733499,0.0004230391,0.0005490114,0.00019035558,0.00024780838,0.00037292382,0.00019911052],"category_scores_gemma":[0.00028054282,0.00048644838,0.00016933479,0.0007151874,0.001310902,0.0006338054,0.00021279322,0.00152051,0.000011235316],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037837155,0.012295036,0.42391104,0.012093493,0.0006934237,0.00058146723,0.006056848,0.00046229604,0.3295547,0.00041661717,0.0070089498,0.16908899],"study_design_scores_gemma":[0.07755496,0.028561393,0.20857987,0.013490973,0.00053816166,0.00037653776,0.0021006004,0.0019818689,0.6583262,0.0034214405,0.0028491998,0.0022187782],"about_ca_topic_score_codex":0.0061456785,"about_ca_topic_score_gemma":0.00020638277,"teacher_disagreement_score":0.32877153,"about_ca_system_score_codex":0.001256876,"about_ca_system_score_gemma":0.0012743612,"threshold_uncertainty_score":0.9997587},"labels":[],"label_agreement":null},{"id":"W2168565140","doi":"10.1158/1078-0432.ccr-06-1485","title":"Variants of the hK2 Protein Gene (<i>KLK2</i>) Are Associated with Serum hK2 Levels and Predict the Presence of Prostate Cancer at Biopsy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Prostate cancer; Prostate; Medicine; Oncology; Cancer; Biopsy; Gene; Internal medicine; Biology; Cancer research; Genetics","score_opus":0.11285458192423571,"score_gpt":0.4095499342154282,"score_spread":0.2966953522911925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168565140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873193,0.0037353951,0.000004809938,0.0061230287,0.00011386607,0.0018552763,0.00048846897,0.000020641437,0.00033923207],"genre_scores_gemma":[0.9834981,0.00028498232,0.000026938975,0.000068741094,0.00026484704,0.00022422556,0.0000087867775,0.000032982425,0.015590412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660635,0.0005397209,0.00073325,0.000456828,0.0011541457,0.0005097],"domain_scores_gemma":[0.99698806,0.00094122795,0.0004344205,0.00059434347,0.00089866784,0.00014328783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023774083,0.00017328479,0.00050158915,0.000063886226,0.0002661915,0.000023066541,0.00032394164,0.00017377861,0.00030616642],"category_scores_gemma":[0.0011971152,0.00009057369,0.000121847115,0.0007741213,0.0015591129,0.00007641199,0.00028842103,0.0005467859,0.0000015349348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009885901,0.00026428045,0.98893154,0.00017527942,0.00016604079,0.000006806744,0.00024332792,0.000051000912,0.004738208,0.00008737512,0.0024025694,0.0019449813],"study_design_scores_gemma":[0.0024515134,0.00038054865,0.9763764,0.0011345149,0.00008220957,0.000005838146,0.00006656946,0.00051814737,0.017415004,0.00032649765,0.0011385778,0.000104193685],"about_ca_topic_score_codex":0.0037561285,"about_ca_topic_score_gemma":0.003059106,"teacher_disagreement_score":0.015251179,"about_ca_system_score_codex":0.00013344469,"about_ca_system_score_gemma":0.00082678103,"threshold_uncertainty_score":0.57446164},"labels":[],"label_agreement":null},{"id":"W2168572010","doi":"10.1158/1078-0432.ccr-12-0234","title":"CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Antigen; CD20; Biology; CD8; Immunology; Tumor-infiltrating lymphocytes; Ovarian cancer; CD5; Cancer research; Cancer","score_opus":0.14974751668996145,"score_gpt":0.4592862070979238,"score_spread":0.30953869040796234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168572010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98867476,0.0063742213,0.000008128084,0.0018934392,0.0002515173,0.0014402557,0.000022651258,0.00004510469,0.0012899446],"genre_scores_gemma":[0.9941526,0.0014331848,0.0010355331,0.0008222764,0.0010854653,0.00054763467,0.000008539075,0.00007778152,0.00083698105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99596477,0.0006402156,0.000715738,0.00071315665,0.00082552235,0.0011405947],"domain_scores_gemma":[0.9979576,0.00050133886,0.00013443314,0.0004694541,0.00032395014,0.0006132109],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044572004,0.00027576188,0.00063643843,0.00018362058,0.00021645005,0.000091271235,0.00023719552,0.00025878914,0.0011049699],"category_scores_gemma":[0.00021706661,0.00020192095,0.000101676276,0.0006107337,0.00088154746,0.00033043293,0.00011570112,0.0011227177,0.000017546994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022709528,0.0011977644,0.85399616,0.00036409462,0.00027467287,0.00007942126,0.0021986794,0.000007919507,0.03142251,0.000033872882,0.00079545967,0.086919926],"study_design_scores_gemma":[0.01867274,0.0059556304,0.8619871,0.0021619303,0.00020088481,0.000074196214,0.002489716,0.0009659861,0.089592285,0.000113557595,0.016823763,0.00096217846],"about_ca_topic_score_codex":0.00964436,"about_ca_topic_score_gemma":0.0045910887,"teacher_disagreement_score":0.08595774,"about_ca_system_score_codex":0.0005120459,"about_ca_system_score_gemma":0.001442585,"threshold_uncertainty_score":0.99980813},"labels":[],"label_agreement":null},{"id":"W2168740323","doi":"10.1158/1078-0432.ccr-06-0551","title":"Celecoxib and Mucosal Protection: Translation from an Animal Model to a Phase I Clinical Trial of Celecoxib, Irinotecan, and 5-Fluorouracil","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Irinotecan; Medicine; Celecoxib; Pharmacokinetics; FOLFIRI; Diarrhea; Pharmacology; Regimen; Gastroenterology; Chemotherapy; Toxicity; Colorectal cancer; Fluorouracil; Internal medicine; Cancer","score_opus":0.4642957321047138,"score_gpt":0.6033448793573953,"score_spread":0.13904914725268153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168740323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930682,0.0004280131,0.0015816793,0.0016632285,0.00031679551,0.0026956077,0.000038521917,0.000040365274,0.0001675704],"genre_scores_gemma":[0.9951671,0.0003911295,0.0014941235,0.00020982261,0.0024639305,0.00015655885,0.000013879351,0.000037045513,0.000066445005],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959099,0.00064967695,0.0013268419,0.0007426681,0.00081868604,0.0005522082],"domain_scores_gemma":[0.9965487,0.0014396687,0.00014510423,0.00040279576,0.00043225527,0.0010314629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010564217,0.00018956758,0.00072879007,0.0002097934,0.00014210062,0.000031214437,0.00012890367,0.0004590826,0.00009041146],"category_scores_gemma":[0.0015130952,0.00016392638,0.00014421961,0.00034034613,0.00048323887,0.00015112596,0.0000772842,0.0013394777,0.000008859884],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28011537,0.0020867873,0.008497584,0.00016877224,0.000087814566,0.00007103775,0.00044747812,0.000005850973,0.013489996,0.000039458668,0.00042473632,0.6945651],"study_design_scores_gemma":[0.5009705,0.15631391,0.18696377,0.00072728266,0.0005602425,0.00003779146,0.00043793235,0.09554571,0.03879212,0.0012839558,0.017108196,0.0012586144],"about_ca_topic_score_codex":0.00050342025,"about_ca_topic_score_gemma":0.00068936875,"teacher_disagreement_score":0.6933065,"about_ca_system_score_codex":0.00007643196,"about_ca_system_score_gemma":0.00068363664,"threshold_uncertainty_score":0.66847235},"labels":[],"label_agreement":null},{"id":"W2168762256","doi":"10.1158/1078-0432.ccr-08-1081","title":"Expanding the Use of Retinoids in Acute Myeloid Leukemia: Spotlight on Bexarotene","year":2008,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Myeloid leukemia; Bexarotene; Medicine; Myeloid; Acute promyelocytic leukemia; Differentiation therapy; Oncology; Leukemia; Internal medicine; Retinoid; Cancer research; Chemotherapy; Minimal residual disease; Immunology; Tretinoin; Retinoic acid; Biology; Nuclear receptor; Cell culture","score_opus":0.1915147763695664,"score_gpt":0.44100509248774644,"score_spread":0.24949031611818004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168762256","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8565833,0.005231971,0.00003575293,0.13430028,0.0009773655,0.001140064,0.00016341667,0.00002112099,0.0015467498],"genre_scores_gemma":[0.21790819,0.2734032,0.000594629,0.40268594,0.030000301,0.001532454,0.0016363994,0.00062337605,0.07161553],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99443626,0.0013320617,0.0010818242,0.0011164737,0.0011339666,0.00089942716],"domain_scores_gemma":[0.9966899,0.0010405775,0.00030664075,0.0013894197,0.00046590262,0.00010752276],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0020088777,0.00038013706,0.0006821593,0.00020743268,0.00020313846,0.000062927524,0.0013056071,0.0021496504,0.00008011256],"category_scores_gemma":[0.0015017564,0.00026804363,0.0003990972,0.0004990452,0.001505041,0.000007667222,0.0005799964,0.0058182953,0.00002930917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061194785,0.000057662,0.0026998494,0.00018173127,0.00017282636,0.00040401047,0.0000408499,0.00006545758,0.011616846,0.0000054401703,0.9812833,0.0028600765],"study_design_scores_gemma":[0.00076044217,0.00075729727,0.0007415044,0.0003375857,0.000034321623,0.000020897654,0.000014473736,0.000012110891,0.08798538,0.00006109947,0.9089438,0.00033108855],"about_ca_topic_score_codex":0.00030475456,"about_ca_topic_score_gemma":0.000038323324,"teacher_disagreement_score":0.6386751,"about_ca_system_score_codex":0.00026381013,"about_ca_system_score_gemma":0.0017643373,"threshold_uncertainty_score":0.9999772},"labels":[],"label_agreement":null},{"id":"W2168805837","doi":"10.1158/1078-0432.ccr-05-2510","title":"Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Radioresistance; Epidermal growth factor receptor; Medicine; PTEN; EGFR inhibitors; Cancer research; Radiation therapy; Erlotinib; Radiosensitivity; Oncology; Radiosensitizer; Cancer; Pathology; Internal medicine; PI3K/AKT/mTOR pathway; Biology; Signal transduction","score_opus":0.22769211722499452,"score_gpt":0.5237699565291969,"score_spread":0.2960778393042024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168805837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962898,0.00013403835,0.00021417892,0.0016621732,0.00007545182,0.0015024267,0.00009512631,0.000014579574,0.000012236374],"genre_scores_gemma":[0.9985333,0.00007466955,0.0005404757,0.000045246994,0.00019114722,0.00047727773,0.000040718816,0.00002257021,0.00007459523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970959,0.0011802148,0.00060023787,0.0003206307,0.00054160366,0.00026144713],"domain_scores_gemma":[0.9907481,0.008064444,0.00019744092,0.00043524292,0.0004466865,0.00010809379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003031447,0.00011293358,0.0003738148,0.00017790849,0.00012125499,0.00003405212,0.0001130451,0.00013222345,0.000026958971],"category_scores_gemma":[0.0031523362,0.00006906526,0.00019713586,0.000310637,0.00023085266,0.00012844265,0.00002512552,0.000260803,0.000003281793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036729172,0.0022666156,0.7462574,0.0004262666,0.00019728644,0.000009599391,0.0001786271,0.0017634074,0.057166994,0.00045908435,0.0037005837,0.15084495],"study_design_scores_gemma":[0.0036407048,0.0064121163,0.7687978,0.00019946236,0.0000835476,0.0000010722931,0.000013335682,0.028366102,0.1913303,0.00009964578,0.00097387534,0.00008199558],"about_ca_topic_score_codex":0.0003852361,"about_ca_topic_score_gemma":0.000057390847,"teacher_disagreement_score":0.15076296,"about_ca_system_score_codex":0.00013812636,"about_ca_system_score_gemma":0.00022895531,"threshold_uncertainty_score":0.37738687},"labels":[],"label_agreement":null},{"id":"W2168841302","doi":"10.1158/1078-0432.ccr-06-0462","title":"Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":584,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Gefitinib; Erlotinib; Epidermal growth factor receptor; Lung cancer; Medicine; Exon; Erlotinib Hydrochloride; Internal medicine; Oncology; Mutation; Point mutation; Cancer research; Cancer; Biology; Genetics; Gene","score_opus":0.09555870628366898,"score_gpt":0.44217766275407155,"score_spread":0.3466189564704026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168841302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428266,0.0002213896,0.000019209607,0.00094712485,0.00010687072,0.0029218108,0.00074025535,0.00004927252,0.00071141403],"genre_scores_gemma":[0.9948967,0.00019183019,0.00019793805,0.000079234,0.0001903405,0.0014010714,0.0007243604,0.000070515336,0.002248019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631584,0.00055854867,0.0008835108,0.0006603707,0.00090320554,0.0006785153],"domain_scores_gemma":[0.99599904,0.0011902719,0.0004280214,0.00027516467,0.0018250649,0.00028243195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007054659,0.00027004906,0.000741532,0.00029448283,0.00017686583,0.000030737407,0.00015063967,0.00023937965,0.0004187336],"category_scores_gemma":[0.0006262294,0.00017552631,0.000106054904,0.0012598835,0.00035487907,0.00012747139,0.000041375566,0.00073229754,0.0000061782116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043380377,0.0025573536,0.9901222,0.00025737085,0.0002617722,0.000054667755,0.00032053885,0.000079796446,0.00011421998,0.000007793925,0.0009974502,0.0008888219],"study_design_scores_gemma":[0.0153547,0.0024405306,0.9791524,0.0009285022,0.0002869193,8.026468e-7,0.0002195647,0.0001865279,0.0010788998,0.000007956555,0.00013149648,0.00021171973],"about_ca_topic_score_codex":0.015361608,"about_ca_topic_score_gemma":0.03673966,"teacher_disagreement_score":0.021378051,"about_ca_system_score_codex":0.0009557963,"about_ca_system_score_gemma":0.0017446859,"threshold_uncertainty_score":0.9911952},"labels":[],"label_agreement":null},{"id":"W2168871518","doi":"10.1158/1078-0432.ccr-10-1638","title":"The<i>IFNG</i>(IFN-γ) Genotype Predicts Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Imatinib; Myeloid leukemia; Genotype; Cancer research; Immunology; Medicine; Angiogenesis; Biology; Myeloid; Oncology; Genetics; Gene","score_opus":0.09263302505358723,"score_gpt":0.4697962569955494,"score_spread":0.37716323194196216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168871518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828937,0.006654759,0.00000674565,0.0073549445,0.0003347483,0.002009202,0.00001575306,0.000046088997,0.00068405695],"genre_scores_gemma":[0.9880174,0.007810692,0.000372519,0.0008492237,0.0005932447,0.0006747558,0.0000068105314,0.00007451858,0.0016008723],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99533147,0.0008980686,0.00078803784,0.0008582493,0.001055936,0.0010682191],"domain_scores_gemma":[0.99464464,0.0029390785,0.00008229908,0.0012527012,0.0003505893,0.0007307183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064407657,0.00026300657,0.00050563464,0.00022538625,0.00026094,0.000088215216,0.00049074,0.00034136354,0.0003266317],"category_scores_gemma":[0.0032701795,0.00018639496,0.0001262871,0.0007626212,0.0008687109,0.000052520732,0.00035475718,0.0022424322,0.00016128633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028414533,0.00032322409,0.06344751,0.00011639115,0.0002990178,0.0006834977,0.00063338905,0.00006012676,0.44113904,0.00014550307,0.006641415,0.45809633],"study_design_scores_gemma":[0.02248304,0.0077411295,0.7211117,0.00042895574,0.000055029293,0.00007946932,0.000106228974,0.0010717091,0.03583499,0.00066744233,0.20994447,0.0004757927],"about_ca_topic_score_codex":0.0009184168,"about_ca_topic_score_gemma":0.002089754,"teacher_disagreement_score":0.65766424,"about_ca_system_score_codex":0.0023639963,"about_ca_system_score_gemma":0.008045397,"threshold_uncertainty_score":0.9975781},"labels":[],"label_agreement":null},{"id":"W2168960014","doi":"10.1158/1078-0432.ccr-04-2208","title":"A Haplotype Analysis of <i>HER-2</i> Gene Polymorphisms: Association with Breast Cancer Risk, HER-2 Protein Expression in the Tumor, and Disease Recurrence in Korea","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"College of Medicine, Seoul National University; Seoul National University","keywords":"Haplotype; Single-nucleotide polymorphism; Linkage disequilibrium; Breast cancer; Genetics; Biology; Tag SNP; Allele; SNP; Minor allele frequency; Case-control study; Cancer; Genotype; Oncology; Internal medicine; Medicine; Gene","score_opus":0.10833714557625322,"score_gpt":0.4753167939647972,"score_spread":0.36697964838854397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168960014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97538954,0.0050992337,0.000010320604,0.017271454,0.00003460726,0.0016179889,0.00037103638,0.000015558657,0.00019025795],"genre_scores_gemma":[0.99256027,0.004804438,0.00020707192,0.0004174981,0.00035325807,0.0012698863,0.000020136571,0.000035745823,0.00033171332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928603,0.002281813,0.00090059725,0.00080417277,0.002344476,0.00080864085],"domain_scores_gemma":[0.99629974,0.0014639288,0.0002935096,0.0007635967,0.00065854663,0.00052069145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009493703,0.00020764346,0.0007483145,0.0006645523,0.000121511956,0.000053539025,0.00046202433,0.00017555944,0.00048726785],"category_scores_gemma":[0.0027841807,0.00013471246,0.00014550383,0.0038106497,0.0005645939,0.00016033054,0.00019340479,0.0022100506,0.000009356355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041700467,0.00072437635,0.9633761,0.00011302392,0.00016810413,0.000074551936,0.00043804958,0.00014065308,0.0010906525,0.000008567797,0.0013603239,0.02833555],"study_design_scores_gemma":[0.0024859663,0.00038327748,0.9907979,0.0011189538,0.0002102214,0.0000023471712,0.00013835491,0.0019559264,0.0010395709,0.000069030095,0.001638628,0.00015981658],"about_ca_topic_score_codex":0.015308791,"about_ca_topic_score_gemma":0.020104846,"teacher_disagreement_score":0.028175734,"about_ca_system_score_codex":0.0011189687,"about_ca_system_score_gemma":0.002348733,"threshold_uncertainty_score":0.9977757},"labels":[],"label_agreement":null},{"id":"W2169039067","doi":"10.1158/1078-0432.ccr-13-2293","title":"Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Erlotinib; Vandetanib; Gemcitabine; Gefitinib; Cytotoxicity; Pharmacology; Cabozantinib; Medicine; Nucleoside; Cancer research; Cancer; Chemistry; Internal medicine; In vitro; Epidermal growth factor receptor; Hepatocellular carcinoma; Sorafenib; Biochemistry","score_opus":0.10489414162740847,"score_gpt":0.4375857204330001,"score_spread":0.33269157880559164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169039067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923591,0.0053907195,0.000050615494,0.0009717461,0.00008466433,0.00078692235,0.00010002528,0.000017478564,0.00023872904],"genre_scores_gemma":[0.99441844,0.0029491081,0.00017236736,0.0004675668,0.0009767659,0.00034539745,0.00003777872,0.000041725838,0.0005908667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765664,0.00026172976,0.00050223386,0.00076600193,0.0003104001,0.00050299347],"domain_scores_gemma":[0.9988806,0.00016028572,0.00008793346,0.0003216318,0.00021606112,0.00033344826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083676394,0.00020360075,0.00032905387,0.000051639432,0.00024070658,0.000085628766,0.00021770183,0.0002903966,0.00076268025],"category_scores_gemma":[0.000077357385,0.0001762026,0.000091191316,0.00012289331,0.00054538576,0.000014746163,0.00018522909,0.0005980844,0.0000108316135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024610697,0.00011515655,0.058844093,0.00007041792,0.00015171705,0.000013161268,0.00011440325,0.000009457647,0.92183095,0.0000146095845,0.012043601,0.0065463507],"study_design_scores_gemma":[0.0059172064,0.0018304088,0.2571105,0.0003445618,0.00012226582,0.000006898409,0.00036589528,0.0002523955,0.70971036,0.001196746,0.022119561,0.0010232116],"about_ca_topic_score_codex":0.0060978145,"about_ca_topic_score_gemma":0.00065222965,"teacher_disagreement_score":0.21212058,"about_ca_system_score_codex":0.000019690124,"about_ca_system_score_gemma":0.00013038216,"threshold_uncertainty_score":0.9218112},"labels":[],"label_agreement":null},{"id":"W2169180994","doi":"10.1158/1078-0432.ccr-09-2502","title":"Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Cancer Research UK","keywords":"Debulking; Ovarian cancer; Cancer research; Biology; Transforming growth factor beta; Signal transduction; Cancer; Oncology; Serous fluid; Medicine; Internal medicine; Transforming growth factor","score_opus":0.0938306591590965,"score_gpt":0.47774811023549074,"score_spread":0.38391745107639424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169180994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98791677,0.000066532266,0.009188714,0.0012244657,0.00006855319,0.0012600044,0.00022768724,0.000029778217,0.000017510472],"genre_scores_gemma":[0.95051885,0.0000805873,0.047464993,0.00044467082,0.0004126176,0.00059049914,0.00012981587,0.000044187662,0.00031380446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975037,0.00035683994,0.0005720841,0.00076584565,0.00039891357,0.00040262158],"domain_scores_gemma":[0.9980665,0.00010124553,0.00022190159,0.0007380191,0.0006056868,0.00026663404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002484047,0.00017641376,0.00037267778,0.00025248565,0.000216106,0.000027408978,0.00035751882,0.0002956678,0.00015517985],"category_scores_gemma":[0.00044068246,0.00016503327,0.00019666967,0.0010397868,0.00037388148,0.000013539901,0.00013029418,0.00062470994,0.0000023500472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053689894,0.00036332879,0.0007003501,0.000015930322,0.0001903815,0.000001601538,0.0000310774,0.0005672056,0.9744644,0.000019564508,0.00012990356,0.018147279],"study_design_scores_gemma":[0.0011968961,0.00069111504,0.0036647473,0.000044858814,0.0000589789,0.0000012296474,0.000030298643,0.00023197738,0.9836482,0.00012767588,0.010082263,0.00022179006],"about_ca_topic_score_codex":0.00022372829,"about_ca_topic_score_gemma":0.00016362387,"teacher_disagreement_score":0.038276277,"about_ca_system_score_codex":0.000082307764,"about_ca_system_score_gemma":0.0008784729,"threshold_uncertainty_score":0.67298615},"labels":[],"label_agreement":null},{"id":"W2169216883","doi":"10.1158/1078-0432.ccr-06-2385","title":"Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group Study","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Oxaliplatin; Medicine; Bilirubin; Gastroenterology; Internal medicine; Liver function tests; Liver function; Liver transplantation; Population; Cancer; Colorectal cancer; Transplantation","score_opus":0.21210268984697117,"score_gpt":0.5243792897065563,"score_spread":0.31227659985958517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169216883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454254,0.00043497235,0.0000068268187,0.00030574616,0.0009479346,0.0034999505,0.000013700571,0.000035920755,0.00021241228],"genre_scores_gemma":[0.9972874,0.00031805807,0.000027245042,0.0002703619,0.0008328736,0.001063142,0.000019377336,0.000033327466,0.00014821067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600744,0.00048188845,0.0009995919,0.00071428024,0.0012463178,0.00055048644],"domain_scores_gemma":[0.99739915,0.0008701696,0.00027135148,0.00016678049,0.0010414814,0.00025105002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027575586,0.0002392155,0.00062928913,0.0004194556,0.00023612117,0.000023387762,0.00012213587,0.0001435069,0.00054531056],"category_scores_gemma":[0.00024963194,0.00018305007,0.000056629,0.0014632489,0.0003156294,0.0001696229,0.00013411975,0.0010093468,0.0000025146676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015478,0.008719612,0.9396569,0.00009700676,0.0005522699,0.000044999935,0.0013566939,0.00011233426,0.00025523294,0.0000054156994,0.00027030605,0.033451214],"study_design_scores_gemma":[0.031961273,0.010506468,0.9549303,0.0002559903,0.00033122138,0.0000011442812,0.001348297,0.00029812334,0.000039857838,0.000015088341,0.0001489448,0.00016330415],"about_ca_topic_score_codex":0.013259808,"about_ca_topic_score_gemma":0.08664895,"teacher_disagreement_score":0.07338914,"about_ca_system_score_codex":0.00095147296,"about_ca_system_score_gemma":0.000653598,"threshold_uncertainty_score":0.993311},"labels":[],"label_agreement":null},{"id":"W2169394417","doi":"10.1158/1078-0432.ccr-07-0146","title":"<i>BRCA</i> Mutations in Women with Ductal Carcinoma <i>In situ</i>","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Ductal carcinoma; In situ; Carcinoma in situ; Carcinoma; Oncology; Medicine; Internal medicine; Cancer; Biology; Cancer research; Breast cancer; Chemistry","score_opus":0.07733633286611866,"score_gpt":0.45336700251550016,"score_spread":0.3760306696493815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169394417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269086,0.0010425881,0.00008852512,0.0008591229,0.00016930525,0.0003490605,0.000014534969,0.000007035512,0.0047789854],"genre_scores_gemma":[0.9975819,0.00028672974,0.00035176778,0.0004973386,0.00047357398,0.00028568064,0.000021634105,0.000031464195,0.00046994133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975507,0.00024351757,0.0004908577,0.0005883242,0.0003860625,0.0007405213],"domain_scores_gemma":[0.99886775,0.00023015242,0.00005136414,0.00042781566,0.00023880588,0.0001840848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034981107,0.00012185801,0.00019129888,0.00018456369,0.00007452878,0.000025149759,0.000318948,0.00020267435,0.00006912628],"category_scores_gemma":[0.0003273297,0.00011381481,0.000040478313,0.00078254903,0.00050865085,0.0000073379506,0.00014946243,0.00063444575,0.000021240547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051556467,0.00079027144,0.82669336,0.00006626024,0.000083924766,0.00035679893,0.0013492567,0.0010262626,0.1091442,0.00014226283,0.008361708,0.04683005],"study_design_scores_gemma":[0.004439931,0.001347093,0.8908619,0.000061469895,0.0000064987667,0.00002025599,0.0021712328,0.000029155499,0.05516092,0.0004849511,0.04501697,0.0003995615],"about_ca_topic_score_codex":0.0003512036,"about_ca_topic_score_gemma":0.011515162,"teacher_disagreement_score":0.0641686,"about_ca_system_score_codex":0.00047366376,"about_ca_system_score_gemma":0.0012321057,"threshold_uncertainty_score":0.64257306},"labels":[],"label_agreement":null},{"id":"W2169497913","doi":"10.1158/1078-0432.ccr-06-1567","title":"Amplification and Overexpression of <i>CACNA1E</i> Correlates with Relapse in Favorable Histology Wilms' Tumors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cancer Research UK","keywords":"Wilms' tumor; Loss of heterozygosity; Biology; Cancer research; Gene; Molecular biology; Genetics; Allele","score_opus":0.041125378315695627,"score_gpt":0.39483945158594624,"score_spread":0.3537140732702506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169497913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178326,0.005707144,0.000033340326,0.0003352493,0.0000594673,0.00018913823,0.000008062919,0.0000044147127,0.0018798936],"genre_scores_gemma":[0.99597347,0.0023935707,0.00008428631,0.00005337141,0.00010302165,0.00004506104,0.000029986124,0.000014271278,0.0013029426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985568,0.00022046163,0.0003780112,0.0003867775,0.00019897998,0.0002589696],"domain_scores_gemma":[0.9993282,0.00010903961,0.0001054676,0.00023849263,0.00014760288,0.000071181836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007087177,0.000088754874,0.00020089772,0.00006693125,0.00005784357,0.000008199096,0.00013854599,0.00024604058,0.000022712058],"category_scores_gemma":[0.000108908345,0.00006524566,0.000038271173,0.0002099788,0.00061107305,0.000005170176,0.00008290968,0.00042008204,0.000002796742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034433072,0.000392085,0.471981,0.00015836582,0.00005302444,0.000022679365,0.000050983923,0.0012624643,0.49750492,0.00094413955,0.018376634,0.0058103907],"study_design_scores_gemma":[0.012514212,0.0063642017,0.4646343,0.0022499384,0.00006630062,0.00009321259,0.00045349888,0.0007501499,0.41771653,0.0063682664,0.08769664,0.0010927405],"about_ca_topic_score_codex":0.0013686293,"about_ca_topic_score_gemma":0.0002765955,"teacher_disagreement_score":0.07978839,"about_ca_system_score_codex":0.000035031037,"about_ca_system_score_gemma":0.0002384972,"threshold_uncertainty_score":0.26606408},"labels":[],"label_agreement":null},{"id":"W2169508419","doi":"10.1158/1078-0432.ccr-10-2334","title":"Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"National Cancer Institute; National Institute on Aging; Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Breast cancer; EIF4E; Cancer research; Cancer; Medicine; Oncology; Metastasis; Biomarker; Gene knockdown; Internal medicine; Biology; Messenger RNA; Cell culture; Translation (biology); Gene","score_opus":0.22084065200133157,"score_gpt":0.4714431623378206,"score_spread":0.250602510336489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169508419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930285,0.0020732328,0.00014551265,0.00032607533,0.0009596966,0.0017032758,0.0006283869,0.000037018504,0.0010982999],"genre_scores_gemma":[0.9929235,0.0010925006,0.0003757565,0.00023052495,0.0025516388,0.0015902914,0.00006289729,0.000112608606,0.0010603077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960988,0.00045913953,0.00049585465,0.0012881528,0.0006135797,0.0010444832],"domain_scores_gemma":[0.9973574,0.00048201304,0.00018233764,0.00078573404,0.0007574747,0.00043504205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010358586,0.00040790226,0.00048915966,0.000114212584,0.00030219607,0.00007140638,0.00050109846,0.0003499581,0.000280884],"category_scores_gemma":[0.00021909976,0.0003104371,0.00023346976,0.0003793068,0.0007412669,0.000014509782,0.00015243674,0.0004481875,0.000020085326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068585016,0.002081291,0.47780883,0.00071961613,0.0019664986,0.00014162916,0.00031369316,0.00019760654,0.16178186,0.000066315275,0.03243613,0.2539015],"study_design_scores_gemma":[0.014092989,0.02033517,0.6008232,0.0030843245,0.0004427106,0.00012500439,0.00015396852,0.00047150446,0.28524223,0.00017987417,0.07319784,0.0018511284],"about_ca_topic_score_codex":0.0030263413,"about_ca_topic_score_gemma":0.0014402113,"teacher_disagreement_score":0.2520504,"about_ca_system_score_codex":0.000716012,"about_ca_system_score_gemma":0.0019256361,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W2169733452","doi":"10.1158/1078-0432.787.11.2","title":"Biodistribution of Yttrium-90–Labeled Anti-CD45 Antibody in a Nonhuman Primate Model","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Biodistribution; Radioimmunotherapy; Spleen; Lymph; Antibody; Pathology; Bone marrow; Medicine; Transplantation; Haematopoiesis; Lymph node; Nuclear medicine; Biology; Immunology; Internal medicine; In vivo; Stem cell; Monoclonal antibody","score_opus":0.39008598252390236,"score_gpt":0.6559256920686046,"score_spread":0.26583970954470226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169733452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888421,0.00060185627,0.00027963883,0.0074414248,0.00002208617,0.000519113,0.00009223366,0.000029084424,0.0021724117],"genre_scores_gemma":[0.99666226,0.0017861298,0.00035459455,0.0001847873,0.00031107405,0.00007987221,0.00008401397,0.000013998638,0.0005232649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977219,0.00011920337,0.0007729803,0.0004075052,0.00051632256,0.00046204976],"domain_scores_gemma":[0.99851704,0.00032769158,0.00008093319,0.00042161328,0.00036041558,0.00029229638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020821143,0.00010883249,0.00043357833,0.00009629826,0.00007923766,0.000012768563,0.00022169911,0.00019697567,0.0003019821],"category_scores_gemma":[0.0005372962,0.00009656699,0.000121240606,0.0006720162,0.0005483926,0.00006515643,0.00009272857,0.0010221166,0.00006146151],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019369764,0.003548338,0.080187954,0.0007238217,0.00008998298,0.00002800775,0.00008740417,0.0008853296,0.8921643,0.0022245022,0.003939593,0.014183797],"study_design_scores_gemma":[0.013774127,0.00053263555,0.08738546,0.0006666185,0.00013430053,0.000016306596,0.00006172036,0.21016078,0.6517117,0.00088681036,0.034204993,0.00046452854],"about_ca_topic_score_codex":0.0000449443,"about_ca_topic_score_gemma":0.00000986306,"teacher_disagreement_score":0.24045259,"about_ca_system_score_codex":0.00019892625,"about_ca_system_score_gemma":0.00047560557,"threshold_uncertainty_score":0.4440645},"labels":[],"label_agreement":null},{"id":"W2169820481","doi":"10.1158/1078-0432.ccr-07-4707","title":"Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources","keywords":"Prostatectomy; Endoglin; Medicine; Urology; Prostate cancer; Biochemical recurrence; Prostate-specific antigen; Prostate; Internal medicine; Cancer","score_opus":0.15548224058078014,"score_gpt":0.48034102634461123,"score_spread":0.3248587857638311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169820481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912431,0.006239731,0.00010600008,0.00049526605,0.00025931207,0.0007802213,0.00013307923,0.000025748921,0.00071752665],"genre_scores_gemma":[0.9908304,0.003343661,0.0006413479,0.00024915102,0.0018519587,0.001158926,0.000057523655,0.000050370167,0.0018166462],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965066,0.0005384508,0.0005752527,0.00093513384,0.00072392804,0.0007206629],"domain_scores_gemma":[0.998393,0.00015398605,0.00007407329,0.00052303314,0.00045560842,0.00040030738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012557714,0.0002278883,0.00032034368,0.00006550863,0.0002592303,0.000032054908,0.00041504862,0.00047965447,0.00052400574],"category_scores_gemma":[0.00059119385,0.00017531715,0.00025550072,0.00025759585,0.0015877375,0.00000927728,0.00044467556,0.00066926406,0.00007008042],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011710957,0.0016116522,0.5323942,0.0001972938,0.0005188768,0.0003422502,0.00030837985,0.000024260831,0.25302812,0.00008089563,0.1641496,0.03563353],"study_design_scores_gemma":[0.004173908,0.0025923192,0.13607118,0.000237314,0.000031056075,0.00006639034,0.00005600288,0.00020978229,0.68142885,0.000076283715,0.17443125,0.0006256904],"about_ca_topic_score_codex":0.0000234152,"about_ca_topic_score_gemma":0.000014076474,"teacher_disagreement_score":0.42840073,"about_ca_system_score_codex":0.00006830951,"about_ca_system_score_gemma":0.00095160917,"threshold_uncertainty_score":0.7149226},"labels":[],"label_agreement":null},{"id":"W2169923369","doi":"10.1158/1078-0432.ccr-13-2060","title":"Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"Pfizer; Canadian Institutes of Health Research; Pfizer Canada; Avon Foundation for Women","keywords":"Autophagy; Epirubicin; Anthracycline; Cancer research; Triple-negative breast cancer; Breast cancer; Medicine; Biology; Chemotherapy; Pharmacology; Cancer; Internal medicine; Apoptosis","score_opus":0.0743658566658117,"score_gpt":0.488136597543408,"score_spread":0.4137707408775963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169923369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911804,0.0021147905,0.000014994759,0.004528296,0.00023645363,0.0015424109,0.000094501374,0.000017882423,0.00027027776],"genre_scores_gemma":[0.98862076,0.00927284,0.00002233312,0.0007396846,0.00048339312,0.000422352,0.000007439584,0.000028889677,0.0004023188],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99663186,0.0010980383,0.00064952386,0.00052577665,0.0006189138,0.0004758589],"domain_scores_gemma":[0.9958112,0.0030725258,0.00015454202,0.0003991767,0.00034344735,0.00021905583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016083199,0.0002046662,0.00069060375,0.00016199374,0.00014056038,0.000016335654,0.00009499901,0.00015278938,0.0001657323],"category_scores_gemma":[0.0006767069,0.00012578307,0.00015296553,0.00048864196,0.001128371,0.00007434701,0.000078128876,0.00051786576,0.000009439968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04067742,0.0069246674,0.2570086,0.0015063761,0.0018328538,0.0006804239,0.0037559257,0.0000384098,0.103565246,0.0017436804,0.0024097764,0.5798566],"study_design_scores_gemma":[0.010435883,0.0016243159,0.8567749,0.0009677785,0.00012437324,0.0000047868157,0.00014895949,0.000540085,0.12806696,0.00076525315,0.00041863738,0.00012802864],"about_ca_topic_score_codex":0.005590655,"about_ca_topic_score_gemma":0.001021484,"teacher_disagreement_score":0.5997663,"about_ca_system_score_codex":0.0003565705,"about_ca_system_score_gemma":0.00054136897,"threshold_uncertainty_score":0.8451435},"labels":[],"label_agreement":null},{"id":"W2169961538","doi":"10.1158/1078-0432.ccr-11-0211","title":"Targeting the Hedgehog Pathway in Cancer: Can the Spines Be Smoothened?","year":2011,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Smoothened; Hedgehog signaling pathway; Hedgehog; Cancer research; Cancer; Patched; Vismodegib; Biology; Medicine; Signal transduction; Genetics","score_opus":0.28949148368323396,"score_gpt":0.4760581475419214,"score_spread":0.18656666385868742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169961538","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08495948,0.044620678,0.000011284991,0.8639678,0.002318884,0.0019051025,0.0004964188,0.000034383145,0.0016860246],"genre_scores_gemma":[0.17396772,0.045735434,0.000052700067,0.70225835,0.052892856,0.005469732,0.00046070435,0.00044966937,0.01871283],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99309474,0.0023330958,0.0010254281,0.0012614299,0.0008994997,0.0013858167],"domain_scores_gemma":[0.99656993,0.00096106617,0.00027763433,0.0014318809,0.0006424855,0.0001169962],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0059825783,0.00047591273,0.00066098076,0.00011664655,0.00057764346,0.00009766645,0.0022339597,0.0012279993,0.0002029507],"category_scores_gemma":[0.00226966,0.00027157768,0.00037836333,0.00047078842,0.001990603,0.0000034500556,0.0012385105,0.0054302504,0.000024395364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011014938,0.000054644115,0.0052699614,0.00013521484,0.00022763108,0.00008250761,0.00035883428,0.0000267408,0.00242201,0.0000111157005,0.98501855,0.0062826145],"study_design_scores_gemma":[0.00041905916,0.00027054132,0.0008844429,0.00019011484,0.000023030821,0.000001977385,0.00018167624,0.000010370558,0.004482374,0.0001563122,0.9930054,0.0003747262],"about_ca_topic_score_codex":0.007318678,"about_ca_topic_score_gemma":0.0069719665,"teacher_disagreement_score":0.1617094,"about_ca_system_score_codex":0.00014926407,"about_ca_system_score_gemma":0.0017112754,"threshold_uncertainty_score":0.99997365},"labels":[],"label_agreement":null},{"id":"W2169983495","doi":"10.1158/1078-0432.ccr-06-1005","title":"Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Epidermal growth factor receptor; Statement (logic); Lung cancer; Medicine; Cancer; Epidermal growth factor; Cancer research; Receptor; Oncology; Internal medicine; Political science","score_opus":0.1906762735697729,"score_gpt":0.5538509507929525,"score_spread":0.36317467722317964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169983495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96765417,0.023071444,0.000008738289,0.0044394815,0.00038713447,0.0021153907,0.00054168777,0.00001647424,0.0017654602],"genre_scores_gemma":[0.944114,0.052428134,0.00012660847,0.00023735936,0.0003715166,0.0012029994,0.00019475789,0.000030682895,0.001293919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964317,0.00043878934,0.0010820804,0.0005285229,0.00086262316,0.00065629004],"domain_scores_gemma":[0.99822444,0.0008180745,0.00017351712,0.00036682494,0.0002721143,0.00014504406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088582764,0.00021279955,0.0005697136,0.00027644148,0.00010531419,0.000022191418,0.00023519617,0.00012258404,0.000651807],"category_scores_gemma":[0.00014418966,0.0001376098,0.00017491452,0.0008611414,0.00027059665,0.00018440884,0.00004112826,0.00039427506,0.0000093031385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082778063,0.0040904065,0.9629512,0.00019425203,0.00016617338,0.00006099204,0.0008830589,0.00010462475,0.00013062521,0.0001201796,0.007472641,0.02299811],"study_design_scores_gemma":[0.009886021,0.0010894358,0.90019566,0.00041194243,0.00009172528,8.632988e-7,0.0002983311,0.00030650612,0.0006453751,0.00011534612,0.08680712,0.00015166646],"about_ca_topic_score_codex":0.020934261,"about_ca_topic_score_gemma":0.007976624,"teacher_disagreement_score":0.079334475,"about_ca_system_score_codex":0.0014103773,"about_ca_system_score_gemma":0.00082145684,"threshold_uncertainty_score":0.98558545},"labels":[],"label_agreement":null},{"id":"W2170104632","doi":"10.1158/1078-0432.ccr-07-4134","title":"Efficacy of Systemically Administered Mutant Vesicular Stomatitis Virus (VSVΔ51) Combined with Radiation for Nasopharyngeal Carcinoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Ottawa; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Nasopharyngeal carcinoma; Vesicular stomatitis virus; Virology; Mutant; Nasopharyngeal cancer; Medicine; Vesicular Stomatitis; Virus; Biology; Internal medicine; Radiation therapy; Genetics; Gene","score_opus":0.17976898122576723,"score_gpt":0.4703670472311288,"score_spread":0.2905980660053616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170104632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994737,0.0018503454,0.00004438159,0.0012102283,0.00013784671,0.0017212103,0.00010620382,0.00003744231,0.00015529915],"genre_scores_gemma":[0.9980617,0.00043710816,0.00013539435,0.00032843792,0.00036138218,0.0003360968,0.0000727226,0.000031577645,0.0002355544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741435,0.0004375889,0.0006975993,0.00043354637,0.0005995119,0.00041741686],"domain_scores_gemma":[0.9971935,0.0013515629,0.00015067752,0.00043928353,0.0004948829,0.0003700664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093540596,0.00014411488,0.0006586045,0.00012463724,0.0001806955,0.0000073230326,0.0001937144,0.00021140336,0.00012487291],"category_scores_gemma":[0.0012081389,0.00010813988,0.00021441838,0.00028368094,0.00082199665,0.000061019877,0.000054452972,0.0004359757,0.000022096085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14507538,0.004324534,0.801186,0.0027915705,0.00097488496,0.0012337668,0.00047601984,0.000019075742,0.018666618,0.00076712744,0.01296217,0.011522836],"study_design_scores_gemma":[0.017105827,0.013045556,0.9599055,0.00037434555,0.00019000571,0.00005015197,0.000039841903,0.00050532765,0.0076374733,0.000053099615,0.00094473053,0.00014811277],"about_ca_topic_score_codex":0.00014438314,"about_ca_topic_score_gemma":0.000038477647,"teacher_disagreement_score":0.15871951,"about_ca_system_score_codex":0.000098000404,"about_ca_system_score_gemma":0.0010982767,"threshold_uncertainty_score":0.44098163},"labels":[],"label_agreement":null},{"id":"W2170270019","doi":"10.1158/1078-0432.ccr-07-1330","title":"Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"National Cancer Institute","keywords":"Oncolytic virus; Vesicular stomatitis virus; Myxoma virus; Virus; Vesicular Stomatitis; Virology; In vivo; Biology; Cell culture; Cytopathic effect; Pathology; Medicine","score_opus":0.1560289831561946,"score_gpt":0.4741199758990431,"score_spread":0.31809099274284847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170270019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912131,0.0076933415,0.000008950695,0.00010856284,0.00008293353,0.00055603153,0.000023176712,0.0000053902295,0.0003085224],"genre_scores_gemma":[0.9911624,0.008207604,0.000086416236,0.000047801306,0.000097954544,0.000109677654,0.00001273161,0.00003675061,0.00023864958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967382,0.00076408323,0.0007772927,0.0005624089,0.0006559652,0.0005020681],"domain_scores_gemma":[0.9985634,0.0002744608,0.00012294871,0.00058168254,0.00024223696,0.00021529118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020008192,0.0001609458,0.00048124153,0.0001836896,0.00008867168,0.000008621107,0.00043234695,0.00021271774,0.00008545598],"category_scores_gemma":[0.00034029048,0.00015241465,0.0001482602,0.00036001715,0.0011922139,0.000010585964,0.00036048505,0.00045036743,0.0000058297987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074160076,0.0014809752,0.006314715,0.00007664821,0.00008958896,0.000073357114,0.00026823455,0.00028868337,0.97420394,0.000037366324,0.0010190492,0.0087314565],"study_design_scores_gemma":[0.003669007,0.008095605,0.013058608,0.00011358246,0.0000048200613,0.000011184685,0.00009756344,0.0006938073,0.9734223,0.00014398061,0.0005039777,0.00018554846],"about_ca_topic_score_codex":0.0012527785,"about_ca_topic_score_gemma":0.0007060512,"teacher_disagreement_score":0.008545908,"about_ca_system_score_codex":0.00007919082,"about_ca_system_score_gemma":0.00072966114,"threshold_uncertainty_score":0.6215289},"labels":[],"label_agreement":null},{"id":"W2170428165","doi":"10.1158/1078-0432.ccr-07-4932","title":"A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Flight Attendant Medical Research Institute","keywords":"Epidermal growth factor; Esophageal adenocarcinoma; Internal medicine; Adenocarcinoma; Epidermal growth factor receptor; Risk factor; Oncology; Medicine; Biology; Endocrinology; Cancer; Receptor","score_opus":0.33652662964346813,"score_gpt":0.4791541241929214,"score_spread":0.14262749454945328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170428165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95536554,0.035853293,0.000033562083,0.0067663174,0.0002044431,0.0009093058,0.00052385626,0.00006973805,0.00027396472],"genre_scores_gemma":[0.98678184,0.006319702,0.00020242498,0.0006666068,0.0012016515,0.00019357672,0.000018848305,0.0000601295,0.0045552477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99462014,0.00075212884,0.00082052214,0.0010656241,0.0015850568,0.00115652],"domain_scores_gemma":[0.99558574,0.0016942628,0.00011506465,0.00050038553,0.0005278553,0.0015767126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017865497,0.00032781146,0.0008033846,0.00032466938,0.00073115394,0.000059090617,0.0001917327,0.00029011432,0.0020351582],"category_scores_gemma":[0.0015795972,0.00025541987,0.00022513383,0.00047226856,0.0017125586,0.00021091058,0.00042533386,0.002153999,0.00014835133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017192698,0.00031085464,0.9783184,0.00014775326,0.00023899811,0.0015815328,0.00013774577,3.4945847e-7,0.000023308648,0.00014889216,0.0031173707,0.014255557],"study_design_scores_gemma":[0.006527001,0.0021179873,0.9893676,0.00005415833,0.00006910677,0.00034308707,0.000046474746,0.00006623652,0.0003721984,0.000366353,0.00047625846,0.00019351619],"about_ca_topic_score_codex":0.0020975564,"about_ca_topic_score_gemma":0.00018322357,"teacher_disagreement_score":0.031416293,"about_ca_system_score_codex":0.00033877377,"about_ca_system_score_gemma":0.001117576,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W2170476788","doi":"10.1158/1078-0432.ccr-10-0939","title":"Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Breast cancer; Triple-negative breast cancer; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Cancer; Synthetic lethality; Medicine; DNA repair; Targeted therapy; Polymerase; Biology; Internal medicine; DNA; Genetics","score_opus":0.4045928384629675,"score_gpt":0.609833792293307,"score_spread":0.20524095383033952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170476788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012624562,0.96887416,0.00004055159,0.009553727,0.00402899,0.008642315,0.007859602,0.00019390185,0.0006805388],"genre_scores_gemma":[0.00008493994,0.9511156,0.0003038234,0.0022247836,0.02184813,0.016876074,0.0005973419,0.00042193045,0.0065273703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890253,0.0017760644,0.0029417037,0.0022896172,0.0020651037,0.0019022223],"domain_scores_gemma":[0.98819286,0.0052427654,0.0009689691,0.0018107967,0.0023899772,0.0013946353],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0053802333,0.0011047226,0.004657219,0.000905507,0.00080179994,0.00022546793,0.0007963139,0.0022861667,0.009146569],"category_scores_gemma":[0.0010773274,0.00085331633,0.0026563692,0.0021005948,0.0026362918,0.00023188142,0.00023099336,0.007457322,0.0002954878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031675056,0.00073216285,0.00008932367,0.004765425,0.0008361611,0.000058759808,0.00007969396,4.921962e-8,0.000029801153,0.00010627554,0.07548891,0.9146459],"study_design_scores_gemma":[0.009848897,0.001098999,0.00017124983,0.017360514,0.0004900079,0.00011907388,0.000032747816,0.000005069485,0.00042302575,0.00043150233,0.9691887,0.0008302039],"about_ca_topic_score_codex":0.0012696406,"about_ca_topic_score_gemma":0.0002670619,"teacher_disagreement_score":0.91381574,"about_ca_system_score_codex":0.001512105,"about_ca_system_score_gemma":0.014491881,"threshold_uncertainty_score":0.99939173},"labels":[],"label_agreement":null},{"id":"W2170565025","doi":"10.1158/1078-0432.ccr-06-0269","title":"Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Hamilton Regional Laboratory Medicine Program; McMaster University; University of Waterloo","funders":"Massachusetts General Hospital","keywords":"Medicine; Internal medicine; N-terminal telopeptide; Prostate cancer; Oncology; Hazard ratio; Prostate-specific antigen; Endocrinology; Bone metastasis; Urology; Cancer; Confidence interval; Alkaline phosphatase; Osteocalcin; Biology","score_opus":0.12062218524287126,"score_gpt":0.4906579282345033,"score_spread":0.37003574299163206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170565025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677864,0.026146322,0.0000010558936,0.0025405348,0.0000588894,0.0010227096,0.000062468804,0.000011937051,0.0023697023],"genre_scores_gemma":[0.98233235,0.01424325,0.0002196629,0.00009222024,0.000084260464,0.00035015788,0.0000144479445,0.000029512074,0.0026341204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971727,0.0004388165,0.0006892305,0.00040626005,0.0007351206,0.0005578601],"domain_scores_gemma":[0.99838334,0.0006227362,0.00012408276,0.0002666409,0.0002860223,0.000317166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00244807,0.00013974655,0.0007175485,0.00020081623,0.00005674908,0.0000108055265,0.0000588583,0.00008201375,0.00009759014],"category_scores_gemma":[0.00017990253,0.000095331794,0.000055854125,0.00048811806,0.0005422227,0.00007702913,0.00005597088,0.00067354937,0.0000051904253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02022664,0.0012310818,0.9190388,0.0005090722,0.00027048626,0.00030198175,0.00014098965,0.000006749706,0.00040579267,0.00012922818,0.004480568,0.053258613],"study_design_scores_gemma":[0.010054337,0.0010815603,0.98088324,0.0001793323,0.00010484206,0.0000041899625,0.00012201389,0.000056684232,0.00010057474,0.00020128052,0.0071203285,0.00009162453],"about_ca_topic_score_codex":0.044401594,"about_ca_topic_score_gemma":0.008085627,"teacher_disagreement_score":0.06184444,"about_ca_system_score_codex":0.00013781492,"about_ca_system_score_gemma":0.001073358,"threshold_uncertainty_score":0.9619618},"labels":[],"label_agreement":null},{"id":"W2170602872","doi":"10.1158/1078-0432.ccr-06-3045","title":"Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Hazard ratio; Internal medicine; Oncology; Confidence interval; Cancer; Cohort; Proportional hazards model; Gynecology","score_opus":0.13123511639770377,"score_gpt":0.5259002702839296,"score_spread":0.3946651538862258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170602872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881,0.006998175,0.00006157717,0.0020091424,0.0006565486,0.00040229812,0.0006063332,0.000010277789,0.0004456286],"genre_scores_gemma":[0.9696975,0.027992487,0.00013521226,0.0002332888,0.0013598669,0.000087587694,0.00001914255,0.000024009189,0.00045091976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703723,0.00046694098,0.0007465251,0.000757386,0.0004413847,0.0005505235],"domain_scores_gemma":[0.9975478,0.0009073639,0.0001859005,0.0004354516,0.00064613787,0.0002773291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034071796,0.00018937206,0.0004561743,0.00007383918,0.0001435283,0.00001813836,0.0003255671,0.0002941618,0.00008401339],"category_scores_gemma":[0.0009079716,0.00015463565,0.0001793383,0.00023347538,0.0011154197,0.000006965329,0.0004451926,0.0006436908,0.0000038560547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021512937,0.00024619172,0.8175543,0.00004961474,0.00024559585,0.000007755688,0.00006920548,6.3665846e-7,0.00033726954,0.000050005256,0.006757478,0.17253068],"study_design_scores_gemma":[0.0020981405,0.00047062105,0.98817044,0.00013917778,0.00003568972,0.000011467741,0.00022264771,0.0000014282007,0.004686452,0.00011804683,0.003882282,0.00016362467],"about_ca_topic_score_codex":0.0026499757,"about_ca_topic_score_gemma":0.004660538,"teacher_disagreement_score":0.17236705,"about_ca_system_score_codex":0.000054387176,"about_ca_system_score_gemma":0.00037491161,"threshold_uncertainty_score":0.6305859},"labels":[],"label_agreement":null},{"id":"W2170814332","doi":"10.1158/1078-0432.ccr-05-1810","title":"Neosquamous Epithelium Does Not Typically Arise from Barrett's Epithelium","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epithelium; Microdissection; Biology; Barrett's esophagus; Progenitor cell; Pathology; Intestinal epithelium; Esophagus; CDX2; Dysplasia; Respiratory epithelium; CDKN2A; Stem cell; Adenocarcinoma; Medicine; Cancer; Anatomy; Gene; Genetics","score_opus":0.11364728829849473,"score_gpt":0.47803695330642143,"score_spread":0.3643896650079267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170814332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9351761,0.018791605,0.0001030527,0.034194235,0.0010103217,0.0020086805,0.00071033824,0.00024263863,0.00776308],"genre_scores_gemma":[0.97586036,0.0022462462,0.00070158363,0.0013677505,0.0047538173,0.0005182148,0.00012548789,0.000093491384,0.014333072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931281,0.0008608181,0.0010771937,0.001238707,0.0022122732,0.0014828796],"domain_scores_gemma":[0.99429196,0.0023307856,0.00012035384,0.0012372376,0.00090648717,0.0011131637],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0027267542,0.00034644382,0.00087696064,0.00025279683,0.0003399454,0.00013508963,0.00056772353,0.0004025334,0.0062057846],"category_scores_gemma":[0.0012263568,0.00022585955,0.00046615358,0.000607313,0.0011237372,0.00013328325,0.0003653731,0.0023042103,0.0015789144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016197996,0.003336425,0.78328794,0.00025700833,0.0006017403,0.0033166318,0.000115753326,0.000017313232,0.0030038457,0.0014955449,0.07471766,0.11365211],"study_design_scores_gemma":[0.010834537,0.0032512222,0.8937439,0.0003291396,0.00019748516,0.00001571394,0.00011801176,0.00024452183,0.025774864,0.010819652,0.054154325,0.0005166416],"about_ca_topic_score_codex":0.020584416,"about_ca_topic_score_gemma":0.0028783698,"teacher_disagreement_score":0.11313547,"about_ca_system_score_codex":0.0005930367,"about_ca_system_score_gemma":0.0015614113,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W2171046634","doi":"10.1158/1078-0432.ccr-08-0761","title":"Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Oxaliplatin; Pharmacokinetics; Tolerability; FOLFOX; Internal medicine; Colorectal cancer; Fluorouracil; Regimen; Dosing; Pharmacology; Oncology; Phases of clinical research; Gastroenterology; Toxicity; Chemotherapy; Cancer; Adverse effect","score_opus":0.08583454801042077,"score_gpt":0.48511259051821104,"score_spread":0.39927804250779025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171046634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966379,0.00048164732,4.041646e-7,0.00056415936,0.000038483486,0.0019228894,0.000021920456,0.000009011694,0.0003235956],"genre_scores_gemma":[0.9991042,0.00038001424,0.000047798334,0.000057275796,0.00003230657,0.00030781815,0.000012191324,0.0000121216635,0.000046256475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775356,0.00018577778,0.0004966448,0.00042363632,0.0008221365,0.00031826142],"domain_scores_gemma":[0.99878275,0.00034858516,0.00010192106,0.00013775926,0.0005060837,0.00012290619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000635799,0.00014922245,0.00055907527,0.00021592955,0.00007436672,0.0000100763955,0.0000704085,0.00006874369,0.00006528322],"category_scores_gemma":[0.00017238392,0.00009787278,0.000024047107,0.0007227762,0.00022921884,0.000102344464,0.00005457605,0.00051762344,4.82414e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032655418,0.010973005,0.8224384,0.000027631952,0.000059619553,0.000033522723,0.0010306162,0.000015258809,0.000040054518,0.000010225978,0.000029474055,0.13268673],"study_design_scores_gemma":[0.06211546,0.053200275,0.8834211,0.00029725046,0.000029143019,4.8263877e-7,0.0006518127,0.000059129314,0.000063422325,0.000032578682,0.00003455445,0.00009477813],"about_ca_topic_score_codex":0.0013849168,"about_ca_topic_score_gemma":0.009040262,"teacher_disagreement_score":0.13259195,"about_ca_system_score_codex":0.00030154968,"about_ca_system_score_gemma":0.0003415453,"threshold_uncertainty_score":0.5044678},"labels":[],"label_agreement":null},{"id":"W2171079592","doi":"10.1158/1078-0432.ccr-08-0810","title":"Retinoblastoma Tumor Suppressor Gene Expression Determines the Response to Sequential Flavopiridol and Doxorubicin Treatment in Small-Cell Lung Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Doxorubicin; Cancer research; Gene knockdown; Retinoblastoma protein; In vivo; Apoptosis; Cell cycle; Cell growth; Cell culture; Small interfering RNA; Biology; Cell cycle checkpoint; Retinoblastoma; Transfection; Chemotherapy; Gene; Biochemistry","score_opus":0.15630511695266835,"score_gpt":0.5023661816812044,"score_spread":0.34606106472853604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171079592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96964896,0.0033815484,0.000010632414,0.02340076,0.000172745,0.0030059232,0.000038338214,0.000043062668,0.00029802762],"genre_scores_gemma":[0.99322987,0.0009273378,0.00031489172,0.00093857327,0.00089154707,0.0008571466,0.0000048572942,0.000042308544,0.0027934816],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99396986,0.0020588185,0.00080401445,0.0010240364,0.0009674049,0.0011758676],"domain_scores_gemma":[0.9944614,0.0033900111,0.00008540738,0.0009666378,0.0004292592,0.0006672928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046198335,0.00031662174,0.00072869816,0.0003905202,0.000349336,0.00009611178,0.00043285405,0.00015433195,0.00011900585],"category_scores_gemma":[0.0028830713,0.00019569388,0.00017370224,0.0006922508,0.000579439,0.000077295925,0.00049813057,0.0010351107,0.00003089287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06186019,0.0011213374,0.21526317,0.00027692784,0.0000883763,0.0019943293,0.0028896458,0.00004417495,0.68713015,0.000006372446,0.015212444,0.01411288],"study_design_scores_gemma":[0.009575005,0.009103899,0.51588786,0.0006212914,0.00007939461,0.000041272626,0.00050767104,0.0006807557,0.45419326,0.00006766618,0.008906683,0.00033524894],"about_ca_topic_score_codex":0.001208348,"about_ca_topic_score_gemma":0.000869807,"teacher_disagreement_score":0.30062467,"about_ca_system_score_codex":0.0009210795,"about_ca_system_score_gemma":0.0011380562,"threshold_uncertainty_score":0.7980165},"labels":[],"label_agreement":null},{"id":"W2171351296","doi":"10.1158/1078-0432.ccr-04-2145","title":"A Phase II, Pharmacokinetic, and Biological Correlative Study of Oblimersen Sodium and Docetaxel in Patients with Hormone-Refractory Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Docetaxel; Medicine; Pharmacokinetics; Prostate cancer; Refractory (planetary science); Oncology; Pharmacology; Internal medicine; Pharmacodynamics; Cancer; Peripheral blood mononuclear cell; Gastroenterology; Urology; Chemistry; Biology; In vitro","score_opus":0.167860845813344,"score_gpt":0.5188297234039012,"score_spread":0.35096887759055717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171351296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835213,0.011777408,2.3977924e-7,0.0015134364,0.00004614523,0.0028288497,0.000080614685,0.000014061271,0.00021794252],"genre_scores_gemma":[0.96534795,0.03315498,0.000030592655,0.00007988215,0.00014720942,0.0004622253,0.00001822954,0.000023594986,0.00073531363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969725,0.0004262568,0.0005794502,0.0006594522,0.0007727327,0.00058960356],"domain_scores_gemma":[0.9982207,0.00047367925,0.00011583105,0.00023475927,0.00055096985,0.00040406067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012234137,0.00020499346,0.00061365013,0.0002757478,0.00014930489,0.000019351322,0.00011709685,0.0001317125,0.00015242884],"category_scores_gemma":[0.00016918694,0.00012614032,0.000040279854,0.0005448287,0.0011522364,0.00014065116,0.00028083482,0.0011045601,0.0000031606132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03320156,0.011620793,0.7628098,0.000049178358,0.00025424585,0.000040778006,0.0020408344,0.0000036126826,0.00032571223,0.0000024680721,0.0005750633,0.18907595],"study_design_scores_gemma":[0.081885196,0.039783146,0.87147194,0.00015930898,0.000088881156,0.000001037702,0.0009085542,0.00020584548,0.00013758929,0.0000112309535,0.005175448,0.0001718308],"about_ca_topic_score_codex":0.00075454265,"about_ca_topic_score_gemma":0.0002736367,"teacher_disagreement_score":0.1889041,"about_ca_system_score_codex":0.00019474965,"about_ca_system_score_gemma":0.00044206463,"threshold_uncertainty_score":0.5143853},"labels":[],"label_agreement":null},{"id":"W2171459779","doi":"10.1158/1078-0432.ccr-09-2917","title":"Targeting the Cytoprotective Chaperone, Clusterin, for Treatment of Advanced Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Clusterin; Medicine; Cancer research; Prostate cancer; Docetaxel; Gene knockdown; Cancer; Prostate; Oncology; Internal medicine; Apoptosis; Biology","score_opus":0.24486042154164997,"score_gpt":0.5755378547747337,"score_spread":0.33067743323308374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171459779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861776,0.001611698,0.00010857076,0.0074877706,0.00093386526,0.0030982497,0.00012979354,0.000027884034,0.00042455934],"genre_scores_gemma":[0.98906577,0.0017413474,0.0009534103,0.00026587612,0.001566329,0.005070164,0.000010449134,0.00004373063,0.00128294],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977779,0.00024290249,0.0005593418,0.00049805315,0.00039541177,0.000526426],"domain_scores_gemma":[0.99639183,0.0018676508,0.00012966222,0.00060946273,0.0007786045,0.00022276698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015949536,0.0001445716,0.00050561485,0.00007705523,0.00019311314,0.000010771747,0.00024556278,0.0001847943,0.00069295097],"category_scores_gemma":[0.002143455,0.0000897447,0.00022930805,0.00023691858,0.0009854479,0.000035191915,0.0001626143,0.0005118607,0.000013479404],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020765224,0.00198655,0.07127418,0.00065444317,0.0004808164,0.00005506296,0.0017137981,0.00016837862,0.29162037,0.0003400917,0.0036725353,0.6072686],"study_design_scores_gemma":[0.035523202,0.020265903,0.44176632,0.0006195252,0.00056727947,0.000048816215,0.0025277117,0.0071434863,0.07254497,0.0021303038,0.41604748,0.00081500324],"about_ca_topic_score_codex":0.00048161676,"about_ca_topic_score_gemma":0.0006483786,"teacher_disagreement_score":0.60645354,"about_ca_system_score_codex":0.00018617837,"about_ca_system_score_gemma":0.000657756,"threshold_uncertainty_score":0.75873274},"labels":[],"label_agreement":null},{"id":"W2172101615","doi":"10.1158/1078-0432.ccr-07-4150","title":"Mitogen-Activated Protein Kinase Activation in Lung Adenocarcinoma: A Comparative Study between Ever Smokers and Never Smokers","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Kinase; Adenocarcinoma; Medicine; MAPK/ERK pathway; Lung cancer; p38 mitogen-activated protein kinases; Protein kinase A; Internal medicine; Cisplatin; Lung; Cancer; Biology; Chemotherapy; Biochemistry","score_opus":0.35111240558703977,"score_gpt":0.5603538008838003,"score_spread":0.2092413952967605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172101615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935617,0.0006225031,0.000008578805,0.0017229259,0.000080820355,0.0035565053,0.000018321254,0.000032457407,0.000396222],"genre_scores_gemma":[0.99712044,0.00008409459,0.00007620188,0.00011417463,0.00024214906,0.00086332846,0.000035632984,0.000027740676,0.0014362368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970479,0.000587624,0.0005583961,0.0006388679,0.0007021451,0.00046506448],"domain_scores_gemma":[0.99829423,0.0005784652,0.00009330453,0.0003353517,0.0003734144,0.00032524683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083339517,0.00018825218,0.00055478717,0.00028590995,0.0002645212,0.000023897817,0.0001123026,0.00015129932,0.00014302426],"category_scores_gemma":[0.00030309113,0.00015395899,0.0000765259,0.00084072904,0.00045818323,0.00026923607,0.00010086163,0.00095140515,0.000013292543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014136774,0.0008616963,0.9893796,0.000052480358,0.00041165686,0.000096465694,0.0037118138,0.0000035069013,0.00074441876,0.000011354559,0.0018273059,0.0014860603],"study_design_scores_gemma":[0.008972064,0.0012793074,0.98391134,0.00017701168,0.00010189544,0.000002090484,0.0020794154,0.00004586344,0.0024420798,0.000034423465,0.00080484897,0.00014967438],"about_ca_topic_score_codex":0.005305179,"about_ca_topic_score_gemma":0.00023775737,"teacher_disagreement_score":0.007558386,"about_ca_system_score_codex":0.00072527333,"about_ca_system_score_gemma":0.0009842933,"threshold_uncertainty_score":0.8019879},"labels":[],"label_agreement":null},{"id":"W2172126351","doi":"10.1158/1078-0432.ccr-07-0688","title":"Inflammatory Breast Cancer as a Model Disease to Study Tumor Angiogenesis: Results of a Phase IB Trial of Combination SU5416 and Doxorubicin","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Doxorubicin; Breast cancer; Internal medicine; Cancer; Angiogenesis; Mastectomy; Oncology; Urology; Chemotherapy; Surgery","score_opus":0.1167378232532578,"score_gpt":0.5094048077838809,"score_spread":0.3926669845306231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172126351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957263,0.0018497328,0.00009741104,0.0004168464,0.0001428451,0.001276155,0.00041913477,0.0000057453703,0.000065826134],"genre_scores_gemma":[0.99794406,0.00090571056,0.000038640537,0.00013172475,0.0004554439,0.00025490802,0.000018870242,0.000028920991,0.0002217455],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971743,0.00030930495,0.0009238281,0.00059800403,0.00060974003,0.00038481763],"domain_scores_gemma":[0.9979075,0.00016561107,0.00021142027,0.0005157764,0.00078356033,0.00041609278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004215882,0.00015727397,0.00036183855,0.000154533,0.00008611158,0.00001308415,0.00029014153,0.000121467056,0.000027418817],"category_scores_gemma":[0.000563446,0.00013839739,0.00018022931,0.00032134607,0.00031441962,0.000007625105,0.00027839246,0.00014525061,0.000001770248],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5911371,0.008404511,0.122385345,0.00022139032,0.00060001935,0.000046829296,0.00039159026,0.0004099972,0.2060447,0.00014490358,0.0035183611,0.066695236],"study_design_scores_gemma":[0.2996108,0.022933984,0.44470876,0.00054121146,0.0005129932,0.000006636475,0.0015734059,0.0018798322,0.22194298,0.0004356045,0.004652996,0.0012007998],"about_ca_topic_score_codex":0.0006283599,"about_ca_topic_score_gemma":0.0005084379,"teacher_disagreement_score":0.3223234,"about_ca_system_score_codex":0.00004863248,"about_ca_system_score_gemma":0.0008149522,"threshold_uncertainty_score":0.5643681},"labels":[],"label_agreement":null},{"id":"W2176023620","doi":"10.1158/1078-0432.ccr-15-0190","title":"Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; U.S. Army; China Scholarship Council","keywords":"Prostate cancer; Cancer; Castration; Cancer stem cell; Medicine; Prostate; Cancer research; Stem cell; Oncology; Biology; Internal medicine; Hormone; Genetics","score_opus":0.40711258571478265,"score_gpt":0.5514625435392363,"score_spread":0.14434995782445365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176023620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596186,0.025820315,0.0000063245097,0.009163008,0.0016785525,0.0016452549,0.0002724337,0.00005386761,0.0017416405],"genre_scores_gemma":[0.96450746,0.020761397,0.0002307156,0.0006887293,0.0017687591,0.0012273075,0.000014886018,0.00007632754,0.010724423],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951594,0.0005254393,0.0010928692,0.0008292293,0.001364777,0.0010282834],"domain_scores_gemma":[0.9970062,0.00037657504,0.00016497944,0.0004691598,0.0011081924,0.00087492843],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004950149,0.00023597314,0.0007167815,0.00024075745,0.00011975991,0.00007788302,0.00025746835,0.00020413312,0.0009945432],"category_scores_gemma":[0.00024881415,0.00019561192,0.00016354237,0.0010585758,0.00048365176,0.00014425565,0.00016982846,0.0014543836,0.000084082574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013258144,0.0013930696,0.33821416,0.0013360257,0.00041575273,0.00084554503,0.0032197833,0.0028172832,0.07445543,0.00016685075,0.24440363,0.3194743],"study_design_scores_gemma":[0.018614903,0.0020627412,0.031084426,0.0023141713,0.00025302457,0.0000073282376,0.0047933403,0.0010709654,0.046060618,0.00031146032,0.89240825,0.0010187658],"about_ca_topic_score_codex":0.027305113,"about_ca_topic_score_gemma":0.013104952,"teacher_disagreement_score":0.64800465,"about_ca_system_score_codex":0.001221042,"about_ca_system_score_gemma":0.0050599966,"threshold_uncertainty_score":0.9999187},"labels":[],"label_agreement":null},{"id":"W2179851135","doi":"10.1158/1078-0432.ccr-15-1253","title":"The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association; Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; STAT3; CD44; Biology; Medicine; Cell; Phosphorylation; Cell biology","score_opus":0.17645243510206632,"score_gpt":0.47771892773123925,"score_spread":0.30126649262917293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179851135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945741,0.003133116,0.000018262072,0.00073979923,0.0001630881,0.00069534685,0.00013504639,0.000009213464,0.0005319741],"genre_scores_gemma":[0.99898976,0.00020524004,0.000036586593,0.00011418891,0.0001218203,0.00007790379,0.000022341286,0.000023005416,0.00040912928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699676,0.0007732876,0.0007076102,0.00032147285,0.00076075597,0.00044008516],"domain_scores_gemma":[0.99694693,0.0014311441,0.000184044,0.0004326893,0.0006467325,0.00035848655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026017989,0.000112001755,0.0003106289,0.00009458446,0.00015334295,0.000036256348,0.00016668759,0.00008223968,0.00015563519],"category_scores_gemma":[0.001203314,0.00006404893,0.000066679815,0.0003064155,0.00056895573,0.000114081144,0.00013205373,0.0009018753,0.0000035040075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02752601,0.0022268242,0.12960866,0.00039076206,0.000054883763,0.00007423328,0.0067081866,0.000059033402,0.7497266,0.00008678499,0.04921278,0.034325227],"study_design_scores_gemma":[0.009083301,0.01228958,0.06900206,0.00033799902,0.0000718239,0.0000104988485,0.008218432,0.0023928331,0.8760661,0.00058278703,0.02176312,0.00018145647],"about_ca_topic_score_codex":0.010025595,"about_ca_topic_score_gemma":0.00031697765,"teacher_disagreement_score":0.1263395,"about_ca_system_score_codex":0.00013218245,"about_ca_system_score_gemma":0.00090303353,"threshold_uncertainty_score":0.9965667},"labels":[],"label_agreement":null},{"id":"W2181264562","doi":"10.1158/1078-0432.ccr-15-0256","title":"Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Research Canada","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Prostate cancer; Medicine; Oncology; Metastasis; Internal medicine; Prostatectomy; Cancer","score_opus":0.16251123600554596,"score_gpt":0.4444655447820131,"score_spread":0.28195430877646716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181264562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869144,0.0056805788,0.0000097697075,0.0052307798,0.00025878067,0.0015781394,0.00019803687,0.000023320381,0.00010617042],"genre_scores_gemma":[0.99293983,0.0028373818,0.00009292473,0.0006532343,0.00015168283,0.0006300985,0.000031342774,0.00006743916,0.0025960412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567497,0.00092814345,0.0006902537,0.0007509931,0.0011710727,0.0007845743],"domain_scores_gemma":[0.9976914,0.00081527286,0.00017884102,0.0004963408,0.00031236812,0.00050579594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033347195,0.00026246923,0.00071149925,0.00011520519,0.000109155844,0.00005598457,0.0002811826,0.00011443124,0.0003181374],"category_scores_gemma":[0.0012054347,0.00016258947,0.000065877546,0.0005630406,0.00090313656,0.00007254861,0.0002862764,0.0014422562,0.000013555364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047270763,0.0008397301,0.970725,0.00011709566,0.0004107704,0.00027213123,0.0005044415,0.00016153642,0.0030761627,0.000002960718,0.013835128,0.0053279693],"study_design_scores_gemma":[0.008330452,0.0015576347,0.9842385,0.0005589245,0.00015583573,0.00001311606,0.000263381,0.0010603092,0.000881454,0.00021276939,0.0024772678,0.00025032615],"about_ca_topic_score_codex":0.001457979,"about_ca_topic_score_gemma":0.002960238,"teacher_disagreement_score":0.0135135325,"about_ca_system_score_codex":0.00061460224,"about_ca_system_score_gemma":0.0008878879,"threshold_uncertainty_score":0.6630206},"labels":[],"label_agreement":null},{"id":"W2182708897","doi":"10.1158/1078-0432.ccr-15-0481","title":"Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":353,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Princess Margaret Cancer Centre","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Medicine; Leukemia; Chronic lymphocytic leukemia; Internal medicine; Refractory (planetary science); Oncology; Clinical trial; Adverse effect; Chronic myelogenous leukemia; Pharmacodynamics; Acute promyelocytic leukemia; Acute lymphocytic leukemia; Pharmacokinetics; Immunology; Pharmacology; Cancer research; Biology; Retinoic acid; Lymphoblastic Leukemia; Cell culture","score_opus":0.402294990732033,"score_gpt":0.5563611615816644,"score_spread":0.15406617084963137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182708897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98567426,0.0010229696,0.000014615724,0.0024428237,0.00061188487,0.001582631,0.00009660548,0.0000139391905,0.008540246],"genre_scores_gemma":[0.9979301,0.0004308169,0.00006457312,0.00013781653,0.00042207615,0.00010234253,0.000014695444,0.000032887183,0.0008646917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954587,0.00093372114,0.0013962813,0.00048483803,0.0012526392,0.00047378178],"domain_scores_gemma":[0.99681664,0.0006780254,0.0002726377,0.0010792059,0.0008078238,0.00034567705],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0067289374,0.00013820108,0.0006576652,0.0001928218,0.000040805848,0.000010887721,0.00047565906,0.0003006631,0.000040882398],"category_scores_gemma":[0.008633126,0.000099721095,0.00029243084,0.0011877653,0.0010489688,0.000027716167,0.0003182906,0.0015305021,0.000014314721],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83760613,0.005837168,0.0034052217,0.00042093705,0.00033353036,0.00036553416,0.0012379817,0.00021954093,0.052629024,0.00038384018,0.055164102,0.042396992],"study_design_scores_gemma":[0.73945725,0.016814929,0.0036272241,0.0015659411,0.00016864593,0.000020319614,0.0005203425,0.0014664298,0.18573485,0.000422336,0.049862776,0.0003389526],"about_ca_topic_score_codex":0.0033639632,"about_ca_topic_score_gemma":0.0012997029,"teacher_disagreement_score":0.13310583,"about_ca_system_score_codex":0.0006636143,"about_ca_system_score_gemma":0.0067637297,"threshold_uncertainty_score":0.9997176},"labels":[],"label_agreement":null},{"id":"W2184282455","doi":"10.1158/1078-0432.ccr-15-1235","title":"Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Positron emission tomography; Head and neck cancer; Primary tumor; Photodynamic therapy; Metastasis; Cancer; Radiology; Lymphatic system; Fluorescence-lifetime imaging microscopy; Multimodal therapy; Head and neck squamous-cell carcinoma; Lymph; Pathology; Radiation therapy; Internal medicine","score_opus":0.268035425114945,"score_gpt":0.561841403148284,"score_spread":0.293805978033339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184282455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920316,0.010346455,0.000013567383,0.0073977755,0.00014789501,0.0017962119,0.00026337494,0.000041240593,0.0007902948],"genre_scores_gemma":[0.9913979,0.0039704507,0.001445585,0.0004399434,0.00024921243,0.0010271408,0.000038531198,0.000052846208,0.0013783767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953961,0.0009844207,0.0009053621,0.00087461,0.0009964389,0.0008430829],"domain_scores_gemma":[0.9960094,0.001830885,0.00007479355,0.00045784583,0.00052570173,0.0011013518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004616533,0.00023735294,0.0009784752,0.0003966728,0.00013636291,0.00008318128,0.0002663246,0.000090355505,0.0002584534],"category_scores_gemma":[0.002714807,0.0001955466,0.00016390317,0.00068760215,0.0011055849,0.00014926112,0.00080580614,0.0013974275,0.00002818006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051494583,0.008121621,0.60653925,0.004823167,0.0030372033,0.012317892,0.0090924045,0.00007758731,0.042525604,0.0004030503,0.038677484,0.22289017],"study_design_scores_gemma":[0.029888535,0.0037183147,0.94298154,0.0030250952,0.00013473559,0.00007703263,0.0013283066,0.0052379733,0.00037270033,0.0025961888,0.010082932,0.0005566413],"about_ca_topic_score_codex":0.023008121,"about_ca_topic_score_gemma":0.011316631,"teacher_disagreement_score":0.3364423,"about_ca_system_score_codex":0.0007462869,"about_ca_system_score_gemma":0.00096264563,"threshold_uncertainty_score":0.98349774},"labels":[],"label_agreement":null},{"id":"W2184558141","doi":"10.1158/1078-0432.ccr-15-2023","title":"Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; University of Victoria; Simon Fraser University; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"Follicular lymphoma; Lymphoma; CD8; Biology; Immunogenicity; Immunology; Immunotherapy; Cancer research; Antigen; Immune system","score_opus":0.26599864206247,"score_gpt":0.5073295551678475,"score_spread":0.24133091310537752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184558141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945546,0.002751344,0.00007248653,0.0031330057,0.00044074535,0.0015558515,0.0001419191,0.000048721296,0.002400469],"genre_scores_gemma":[0.9814984,0.0031337827,0.00016474497,0.00029786973,0.00023404222,0.00035539368,0.00014395872,0.00007043883,0.014101379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99402523,0.0014541937,0.0012516162,0.00058971083,0.0020972383,0.0005819949],"domain_scores_gemma":[0.9949307,0.001356075,0.00024446577,0.0007791598,0.0021357615,0.00055385253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053971102,0.00017827968,0.00067235576,0.00027213077,0.00012181656,0.00005893295,0.00039920164,0.00025589904,0.003970368],"category_scores_gemma":[0.0009910936,0.00015758013,0.00031121427,0.00087825925,0.0012401945,0.000111287845,0.00012244319,0.0006958544,0.00025053305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010216233,0.0025141968,0.0097872075,0.00015492832,0.00045595696,0.00003679154,0.0039571994,0.0000061508968,0.55952865,0.000051934225,0.076960444,0.33633032],"study_design_scores_gemma":[0.03837684,0.0055546653,0.016524354,0.00039550348,0.00015906627,0.000023774604,0.005058626,0.001326704,0.5099326,0.0019603122,0.42005497,0.0006326025],"about_ca_topic_score_codex":0.0016871104,"about_ca_topic_score_gemma":0.00004686025,"teacher_disagreement_score":0.34309453,"about_ca_system_score_codex":0.00063507917,"about_ca_system_score_gemma":0.0014407892,"threshold_uncertainty_score":0.99694014},"labels":[],"label_agreement":null},{"id":"W2185706465","doi":"10.1158/1078-0432.ccr-15-1250","title":"The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Prostate cancer; Prostatectomy; Medicine; Oncology; Cancer; Biomarker; Prostate; Internal medicine; Biology; Bioinformatics; Computational biology; Genetics","score_opus":0.21574197886550836,"score_gpt":0.508185454731571,"score_spread":0.29244347586606256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185706465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95227265,0.037062783,7.6902387e-7,0.008228974,0.00045711081,0.0014302478,0.00009736318,0.0000173843,0.00043270944],"genre_scores_gemma":[0.9169343,0.07973268,0.000051588562,0.00010970952,0.00040169296,0.0016847965,0.000011666156,0.00002909408,0.0010444501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968553,0.0004955944,0.00076872745,0.00043994485,0.0008434213,0.00059696636],"domain_scores_gemma":[0.99628997,0.0018380126,0.00016182146,0.00049238326,0.0008382292,0.00037956206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040719532,0.00014241881,0.00047363908,0.00010789616,0.00010378016,0.00003454931,0.00021777512,0.00011408434,0.00009500049],"category_scores_gemma":[0.002107912,0.0000815879,0.00010744103,0.00058746897,0.0005375049,0.000052407653,0.00016173965,0.00072845886,0.000036102134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013564882,0.0003897667,0.82938707,0.000060638813,0.000112262765,0.000040975712,0.00023720102,0.000047648784,0.000007642561,0.00006639386,0.009000852,0.15929307],"study_design_scores_gemma":[0.0072799874,0.0026926019,0.9371539,0.0004818079,0.00010730386,0.0000018723404,0.00048719536,0.0002019206,0.0008735722,0.0010831511,0.049501896,0.00013483815],"about_ca_topic_score_codex":0.005860537,"about_ca_topic_score_gemma":0.0040902356,"teacher_disagreement_score":0.15915823,"about_ca_system_score_codex":0.0002961682,"about_ca_system_score_gemma":0.0018084389,"threshold_uncertainty_score":0.8859418},"labels":[],"label_agreement":null},{"id":"W2185778972","doi":"10.1158/1078-0432.ccr-15-0916","title":"A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Diet and metabolism studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Clonogenic assay; In vivo; Population; Cancer research; Cancer; Biology; Neurosphere; Stem cell; Pharmacology; Medicine; In vitro; Internal medicine; Biochemistry; Cell biology; Biotechnology; Adult stem cell","score_opus":0.3180853962030638,"score_gpt":0.5431670512723747,"score_spread":0.22508165506931094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185778972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97234493,0.0061810818,0.000018692399,0.017336914,0.0011412031,0.0019581425,0.00015183863,0.000025319927,0.0008418619],"genre_scores_gemma":[0.98412687,0.00671336,0.00011365451,0.00015780574,0.0016799414,0.0010871646,0.000014423836,0.0000217554,0.0060850307],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980285,0.00015987638,0.00047868208,0.000289268,0.0005909113,0.00045274934],"domain_scores_gemma":[0.99686563,0.0013815372,0.00007004138,0.00043419973,0.0009857747,0.00026282322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015722428,0.00012106313,0.0005278736,0.00008083795,0.00010447862,0.000013375511,0.00015928819,0.000072597315,0.0001765157],"category_scores_gemma":[0.00093444204,0.000064658125,0.00022440914,0.00033674508,0.00053660007,0.000026751935,0.000084119034,0.00017970588,0.000033835386],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09985855,0.006765829,0.05011153,0.00043675394,0.0030934303,0.000055222452,0.004102209,0.000021626918,0.0026410625,0.002905945,0.69300747,0.13700034],"study_design_scores_gemma":[0.01384473,0.025251806,0.027075289,0.000109071334,0.0003713146,2.2821963e-7,0.0011020639,0.00022900701,0.0046820636,0.0008610496,0.92635286,0.0001205084],"about_ca_topic_score_codex":0.0006536244,"about_ca_topic_score_gemma":0.0006000476,"teacher_disagreement_score":0.23334537,"about_ca_system_score_codex":0.00011785334,"about_ca_system_score_gemma":0.0003649156,"threshold_uncertainty_score":0.2636682},"labels":[],"label_agreement":null},{"id":"W2186638557","doi":"10.1158/1078-0432.ccr-15-0822","title":"New Strategies in Stereotactic Radiotherapy for Oligometastases","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; SABR volatility model; Radiation therapy; Radiosurgery; Abscopal effect; Systemic therapy; Clinical trial; Oncology; Randomized controlled trial; Population; Surgery; Cancer; Internal medicine; Immunotherapy","score_opus":0.6590124990815568,"score_gpt":0.672304298957894,"score_spread":0.013291799876337218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186638557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002216115,0.9938915,0.00008789312,0.00072761707,0.00040723116,0.0042108786,0.00025625608,0.000026865553,0.00036959274],"genre_scores_gemma":[0.000011737967,0.99063635,0.0027182132,0.00009745486,0.001746776,0.001320398,0.0001685016,0.00010960276,0.0031909812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950413,0.0011921272,0.0013234746,0.00084212417,0.00080916757,0.0007917829],"domain_scores_gemma":[0.9942274,0.0036766184,0.00021828467,0.00081201096,0.0003462244,0.0007194432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005724558,0.00039721947,0.0032579808,0.000509619,0.000057106794,0.00011730328,0.00033957302,0.00041733874,0.0007293071],"category_scores_gemma":[0.00082344917,0.0002642702,0.00090434356,0.0008635156,0.00022679828,0.00008902921,0.00009256849,0.0014778184,0.000053653544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044463747,0.0003114104,0.000077981626,0.009811664,0.00078118255,0.00015529856,0.000018692936,4.4150312e-7,2.3437613e-8,0.00029086808,0.03618944,0.95191836],"study_design_scores_gemma":[0.0038023766,0.002081514,0.000047560006,0.008928103,0.0007138683,0.000029677103,0.000050436876,0.0000032872033,1.0792713e-7,0.00060140016,0.9835335,0.00020816104],"about_ca_topic_score_codex":0.00085047097,"about_ca_topic_score_gemma":0.00028567464,"teacher_disagreement_score":0.9517102,"about_ca_system_score_codex":0.00086279976,"about_ca_system_score_gemma":0.011576307,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W2189438879","doi":"10.1158/1078-0432.ccr-15-1506","title":"Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Pharmacodynamics; Monoclonal antibody; Cancer research; Solid tumor; Antibody; Medicine; Monoclonal; Cancer; Immunology; Pharmacokinetics; Pharmacology; Internal medicine","score_opus":0.06514888782452963,"score_gpt":0.45943845400067446,"score_spread":0.39428956617614486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189438879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989256,0.0003067728,0.000011066513,0.000033909735,0.00010586366,0.00043945792,0.00009330497,0.0000025609547,0.00008143691],"genre_scores_gemma":[0.9995865,0.000082671264,0.000081723665,0.000041034,0.0000878123,0.000024365712,0.000025389245,0.00002467589,0.000045782956],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975659,0.0005271174,0.00053951977,0.00042864436,0.00060578843,0.00033298632],"domain_scores_gemma":[0.9985342,0.00012956843,0.00022826254,0.00036500924,0.0005735706,0.0001694041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00141191,0.00014174565,0.00035221784,0.00006373171,0.00005480536,0.000011161325,0.0003793416,0.00013066737,0.000009081493],"category_scores_gemma":[0.00048754195,0.00009612899,0.000069280984,0.00020945935,0.000684593,0.0000093212975,0.00046228644,0.00039805533,0.000001408374],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011744403,0.0002778381,0.79759043,0.00004275453,0.00001924466,0.000008050469,0.00009717332,0.00007531104,0.19967183,0.0000023735786,0.00006379668,0.000976734],"study_design_scores_gemma":[0.0026102904,0.0016359094,0.47564238,0.00032114252,0.000010475387,0.0000023758298,0.00010088153,0.0001751577,0.51929617,0.000036305944,0.000050350856,0.00011856549],"about_ca_topic_score_codex":0.00017549456,"about_ca_topic_score_gemma":0.000077621175,"teacher_disagreement_score":0.32194805,"about_ca_system_score_codex":0.000029460074,"about_ca_system_score_gemma":0.00060922233,"threshold_uncertainty_score":0.39200264},"labels":[],"label_agreement":null},{"id":"W2191511762","doi":"10.1158/1078-0432.ccr-15-1349","title":"Gemtuzumab Ozogamicin Reduces Relapse Risk in <i>FLT3</i> /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Gemtuzumab ozogamicin; Medicine; Oncology; Myeloid leukemia; Internal medicine; Leukemia; Calicheamicin; Biology; CD33","score_opus":0.1479212835732433,"score_gpt":0.48909489567443043,"score_spread":0.34117361210118713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191511762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96068513,0.0046490585,0.000024749956,0.02457094,0.0008617919,0.0023518729,0.00017962296,0.00012650315,0.00655034],"genre_scores_gemma":[0.9688747,0.017433085,0.0010794849,0.0018827986,0.0045582713,0.0007559917,0.00035633898,0.00016331208,0.004896029],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9868598,0.0043643396,0.002133689,0.0018978681,0.0028570374,0.0018872513],"domain_scores_gemma":[0.9876007,0.0069243177,0.00047084666,0.0024397527,0.0011916585,0.001372739],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.022493836,0.0004515367,0.0014580934,0.00041990489,0.00037059016,0.00011747933,0.0016425687,0.0010877876,0.00040952227],"category_scores_gemma":[0.016370919,0.0003086986,0.00041605256,0.0021109716,0.0025404834,0.000258936,0.0015581608,0.010727244,0.0006736183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014310807,0.00082286116,0.42464536,0.000022726903,0.0010252584,0.0075976625,0.00096014136,0.000026190824,0.0009975564,0.00009362815,0.43248948,0.11700832],"study_design_scores_gemma":[0.02921784,0.0072060623,0.687429,0.00051273865,0.0006383045,0.0012012423,0.0021319264,0.00075919187,0.0015762122,0.0039908765,0.26448417,0.000852443],"about_ca_topic_score_codex":0.04596873,"about_ca_topic_score_gemma":0.0049709445,"teacher_disagreement_score":0.26278365,"about_ca_system_score_codex":0.0078706555,"about_ca_system_score_gemma":0.014154457,"threshold_uncertainty_score":0.9999365},"labels":[],"label_agreement":null},{"id":"W2192572578","doi":"10.1158/1078-0432.ccr-15-1681","title":"A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; Bayer HealthCare","keywords":"Sorafenib; Pharmacokinetics; Medicine; Tolerability; Pharmacodynamics; Dosing; Pharmacology; Internal medicine; Hepatocellular carcinoma; Adverse effect; Cancer; Oncology; Gastroenterology","score_opus":0.11807690024990147,"score_gpt":0.47949471591080817,"score_spread":0.3614178156609067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192572578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977988,0.0006334331,0.000012341171,0.00012467321,0.00010874432,0.0011541073,0.000058824382,0.0000023360044,0.000106725056],"genre_scores_gemma":[0.9984121,0.0012362902,0.000035347577,0.00004506826,0.000048316233,0.00011244222,0.00001759796,0.000018686513,0.000074207215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981512,0.00045436012,0.00038237325,0.00032363553,0.00048197055,0.0002064496],"domain_scores_gemma":[0.9986737,0.000069695714,0.00017090216,0.0002947808,0.0006870539,0.00010390717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010026739,0.00011051637,0.00025284514,0.00005194868,0.000039045037,0.000006256302,0.00024833335,0.00006779839,0.000009132166],"category_scores_gemma":[0.000103421604,0.00006718213,0.00002626142,0.00027187457,0.00034284292,0.0000063590287,0.00014877829,0.0002712519,1.3898322e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041270595,0.0071370043,0.87090266,0.00006753285,0.00020249649,0.000003004715,0.00073139754,0.00055183255,0.0153435925,0.000023131637,0.0002568461,0.063509904],"study_design_scores_gemma":[0.27458775,0.067548454,0.57053244,0.0002896227,0.0001035194,0.0000010709231,0.0014956939,0.0011928807,0.076256335,0.000077970915,0.007362084,0.0005521655],"about_ca_topic_score_codex":0.00030129086,"about_ca_topic_score_gemma":0.0005692803,"teacher_disagreement_score":0.30037022,"about_ca_system_score_codex":0.000040774426,"about_ca_system_score_gemma":0.0004622253,"threshold_uncertainty_score":0.2739608},"labels":[],"label_agreement":null},{"id":"W2192931230","doi":"10.1158/1078-0432.ccr-15-1221","title":"A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti–Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Response Evaluation Criteria in Solid Tumors; Peripheral edema; Pharmacodynamics; Adverse effect; Internal medicine; Angiopoietin receptor; Gastroenterology; Refractory (planetary science); Antibody; Pharmacology; Toxicity; Oncology; Angiogenesis; Phases of clinical research; Immunology","score_opus":0.11567495151876894,"score_gpt":0.5107361207049393,"score_spread":0.3950611691861704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192931230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777776,0.00080313697,0.00000762904,0.00008326658,0.00008829003,0.00098212,0.000039011287,0.0000074164645,0.00021139681],"genre_scores_gemma":[0.9990215,0.000121477715,0.000047353587,0.000044506505,0.00023808356,0.00021235253,0.000105909174,0.000048393755,0.00016043271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647844,0.00040709722,0.0008991081,0.00081374275,0.00075635844,0.00064524333],"domain_scores_gemma":[0.99817765,0.00006234375,0.00020587047,0.00063912343,0.0006512417,0.0002637973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017196386,0.00023631561,0.0005932693,0.00020654326,0.00011604193,0.000022996239,0.0005419403,0.00019138977,0.000050158007],"category_scores_gemma":[0.00019806829,0.00019948365,0.00013262033,0.00044483313,0.00037972652,0.000014320033,0.00036069885,0.00041023307,0.0000040697814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030399824,0.00744923,0.9791693,0.000048009035,0.00008643072,0.000037764516,0.00030169604,0.00030867654,0.0064018564,0.000011038674,0.0009327053,0.002213307],"study_design_scores_gemma":[0.041472174,0.028139425,0.91958934,0.0003133134,0.000029641238,0.0000011820352,0.0010663831,0.000057620917,0.0061025647,0.000057826284,0.0026378722,0.0005326781],"about_ca_topic_score_codex":0.0011805076,"about_ca_topic_score_gemma":0.0043065627,"teacher_disagreement_score":0.059579987,"about_ca_system_score_codex":0.00010551214,"about_ca_system_score_gemma":0.00044748842,"threshold_uncertainty_score":0.8134707},"labels":[],"label_agreement":null},{"id":"W2193707124","doi":"10.1158/1078-0432.ccr-15-2123","title":"Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Quebec - Clinical Research Organization in Cancer; Dalhousie University; University of British Columbia; McGill University; McGill Genome Centre; Hôpital du Sacré-Cœur de Montréal; Concordia University; BC Cancer Agency; Simon Fraser University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Exome sequencing; Biology; Mutation; Lymphoma; Diffuse large B-cell lymphoma; Cancer; Gene; Somatic evolution in cancer; Exome; Oncology; Medicine; Genetics; Immunology","score_opus":0.1875933151340006,"score_gpt":0.48015110530225413,"score_spread":0.29255779016825356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193707124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98134995,0.012963798,0.0000014442361,0.0009239362,0.00013646422,0.00033367806,0.000025094123,0.000017665092,0.004247979],"genre_scores_gemma":[0.9908833,0.0071303626,0.00017976266,0.00017518002,0.00027271107,0.000084329964,0.00000747792,0.000020165171,0.001246729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979578,0.0002693104,0.00043690932,0.00035253272,0.00062458025,0.00035885567],"domain_scores_gemma":[0.9978539,0.0007637366,0.000072934716,0.00040508842,0.00036168695,0.0005426958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013655944,0.000106132466,0.00040838533,0.00009736847,0.000051457137,0.000014912345,0.00010205889,0.00015338138,0.00012870753],"category_scores_gemma":[0.00066364807,0.000075165764,0.00009592807,0.00019153593,0.0002107571,0.00003359465,0.00015076344,0.00023741444,0.00005781083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011009864,0.0064311773,0.95483696,0.00012925126,0.000090905836,0.00015974724,0.00023460052,3.3397515e-7,0.0001534964,0.00009134647,0.020085307,0.01668589],"study_design_scores_gemma":[0.044867635,0.0031321445,0.8471973,0.00018493224,0.00011785952,0.000013391182,0.00028406281,0.00013427617,0.0014568545,0.00026908217,0.10220816,0.00013431303],"about_ca_topic_score_codex":0.0004054585,"about_ca_topic_score_gemma":0.00011500715,"teacher_disagreement_score":0.10763966,"about_ca_system_score_codex":0.00016009886,"about_ca_system_score_gemma":0.0007296347,"threshold_uncertainty_score":0.3065171},"labels":[],"label_agreement":null},{"id":"W2203142821","doi":"10.1158/1078-0432.ccr-15-0124","title":"Failures in Phase III: Causes and Consequences","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Drug development; Phases of clinical research; Population; Intensive care medicine; Cancer; Oncology; Pharmacology; Internal medicine; Drug","score_opus":0.9760698571292453,"score_gpt":0.8318534788750754,"score_spread":0.14421637825416989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203142821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045985642,0.99473894,0.00008775248,0.00044581786,0.0008347016,0.002444969,0.00040041524,0.000055175675,0.0009462239],"genre_scores_gemma":[0.000008222241,0.9667315,0.030211631,0.000053827804,0.001276472,0.00097464916,0.0000053084677,0.0000928845,0.0006455353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9765964,0.015299574,0.004337791,0.0013579235,0.0014468591,0.0009614156],"domain_scores_gemma":[0.7588247,0.23851924,0.0005855362,0.0008597636,0.00054185785,0.00066890096],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.055721767,0.00049495616,0.006051992,0.0004129699,0.00010983278,0.00016013315,0.0010261851,0.0012484115,0.0008185952],"category_scores_gemma":[0.32983065,0.00034849753,0.00045874505,0.0010389574,0.004338243,0.00007381505,0.000784234,0.0043193907,0.000095246425],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018053855,0.0003794768,0.000017658727,0.008595966,0.00015026054,0.00018723037,0.000028495562,1.2830635e-8,6.156448e-8,0.015293325,0.01860501,0.956562],"study_design_scores_gemma":[0.0018752938,0.00034213706,9.4621987e-7,0.008541184,0.00022683959,0.0000067195588,0.00003148792,0.0000019425988,4.1539298e-7,0.37325728,0.6154557,0.0002600799],"about_ca_topic_score_codex":0.00046608335,"about_ca_topic_score_gemma":0.00039509492,"teacher_disagreement_score":0.95630187,"about_ca_system_score_codex":0.00031187222,"about_ca_system_score_gemma":0.0034262082,"threshold_uncertainty_score":0.9998967},"labels":[],"label_agreement":null},{"id":"W2206903933","doi":"10.1158/1078-0432.ccr-15-1853","title":"Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Topotecan; Neuroblastoma; Rhabdomyosarcoma; Cancer research; Medicine; In vivo; Pharmacology; Chemotherapy; Cell culture; Internal medicine; Sarcoma; Biology; Pathology","score_opus":0.1878130194153975,"score_gpt":0.4377215972499732,"score_spread":0.24990857783457573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2206903933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906448,0.006775829,0.000036685247,0.001041609,0.00032343314,0.0007855198,0.000019609126,0.000017132106,0.00035537223],"genre_scores_gemma":[0.9873971,0.010604929,0.00030503204,0.00026929128,0.00078137394,0.00018115054,0.000013955514,0.000048638143,0.00039857658],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968884,0.0006921837,0.00054645183,0.0009265976,0.0003682524,0.0005781436],"domain_scores_gemma":[0.9983755,0.00022525353,0.000103595565,0.0005240279,0.00029993715,0.00047171337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024575284,0.00022606022,0.0005103052,0.00013773073,0.00008897818,0.00007262186,0.000293637,0.00024068812,0.000010612465],"category_scores_gemma":[0.00047858435,0.0001860306,0.00006761017,0.00029970516,0.000874323,0.000025599506,0.0003239521,0.00069840817,0.0000023705334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07850264,0.0036604463,0.20587032,0.00026282924,0.00086545513,0.000076654156,0.0008275715,0.0010848319,0.3130253,0.000969218,0.021815391,0.37303936],"study_design_scores_gemma":[0.06516768,0.023942837,0.5718547,0.00036643483,0.0001057319,0.00009137276,0.0008696752,0.0049493536,0.09618796,0.0048738876,0.22925408,0.0023362986],"about_ca_topic_score_codex":0.00059273717,"about_ca_topic_score_gemma":0.00083822064,"teacher_disagreement_score":0.37070307,"about_ca_system_score_codex":0.000040881852,"about_ca_system_score_gemma":0.0008171075,"threshold_uncertainty_score":0.7586108},"labels":[],"label_agreement":null},{"id":"W2207200267","doi":"10.1158/1078-0432.ccr-15-0039","title":"Advancing Clinical Trials to Streamline Drug Development","year":2015,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"National Cancer Institute; National Institutes of Health","keywords":"Clinical trial; Drug development; Medicine; Intensive care medicine; Clinical study design; Clinical research; Medical physics; Drug; Pharmacology; Internal medicine","score_opus":0.2816678969915981,"score_gpt":0.6088188489688697,"score_spread":0.3271509519772716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207200267","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023167197,0.0117240595,0.00022845624,0.0015143997,0.9587077,0.0019266192,0.0014518638,0.000034141573,0.0012455736],"genre_scores_gemma":[0.0011303374,0.0176907,0.0018552286,0.0005107519,0.9672428,0.000571955,0.001694578,0.00017486246,0.0091288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98752064,0.0035985312,0.0036901403,0.001972782,0.0019784665,0.0012394572],"domain_scores_gemma":[0.9822073,0.010596753,0.00061480486,0.0014750464,0.003417157,0.0016889157],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.07019507,0.0004951796,0.0018422145,0.0001976564,0.00020855265,0.00016845274,0.0013935361,0.0019306462,0.00015392932],"category_scores_gemma":[0.15847991,0.0004507026,0.00062351953,0.00033238853,0.00037801202,0.0000042847687,0.0014731581,0.0029391418,0.0002901437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015426514,0.00027059484,0.0005211894,0.00006707563,0.0002569809,0.000017226044,0.00003134133,0.000043661938,0.00011789529,0.0000029293774,0.9095827,0.08754577],"study_design_scores_gemma":[0.0022415838,0.0009970344,0.000111349866,0.00022473611,0.000065860106,3.4274927e-7,0.000061001956,0.000006281342,0.0007955466,0.00006599592,0.9948876,0.00054268865],"about_ca_topic_score_codex":0.00043027473,"about_ca_topic_score_gemma":0.0043847994,"teacher_disagreement_score":0.088284835,"about_ca_system_score_codex":0.00045632198,"about_ca_system_score_gemma":0.015316944,"threshold_uncertainty_score":0.9997945},"labels":[],"label_agreement":null},{"id":"W2208384071","doi":"10.1158/1078-0432.ccr-15-2361","title":"Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; University of Chicago; Connaught Fund; Universitätsspital Zürich; Universität Zürich; Berlin Institute of Health; University of Toronto","keywords":"T-cell receptor; Biology; Cancer research; Cancer; Antigen; Targeted therapy; Adoptive cell transfer; Cancer cell; Avidity; T cell; Molecular biology; Immunology; Immune system; Genetics","score_opus":0.22862007228663447,"score_gpt":0.49842278518530214,"score_spread":0.26980271289866764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208384071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806494,0.011268161,0.00029226753,0.0045196647,0.00018954411,0.0015465282,0.00009527584,0.00005477127,0.0013843947],"genre_scores_gemma":[0.9842748,0.008502679,0.0009959897,0.00028339305,0.0009968585,0.00050504756,0.00017426093,0.000105236635,0.0041617528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994563,0.00089529995,0.00093188137,0.0007250662,0.0020312567,0.0008534966],"domain_scores_gemma":[0.99567425,0.00068733667,0.00026755553,0.0006200592,0.00206969,0.0006810808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0067569367,0.0002099586,0.0006482357,0.00025528355,0.00013912778,0.00005167314,0.000343198,0.00020379985,0.0035306471],"category_scores_gemma":[0.00055967714,0.00016460074,0.00014741062,0.0010940869,0.0006107275,0.00013451638,0.00010092526,0.0012099695,0.000068550406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0101919025,0.0020993333,0.014376259,0.00011906174,0.0001360388,0.000032226384,0.0012979436,0.00002940786,0.8432313,0.000015581954,0.08823569,0.04023521],"study_design_scores_gemma":[0.016140727,0.008721692,0.002164106,0.00038712771,0.000024913254,0.000011561479,0.0016090473,0.00066678255,0.7697942,0.00013356647,0.1999818,0.0003644733],"about_ca_topic_score_codex":0.0011415726,"about_ca_topic_score_gemma":0.00009570317,"teacher_disagreement_score":0.1117461,"about_ca_system_score_codex":0.0008048518,"about_ca_system_score_gemma":0.0018608447,"threshold_uncertainty_score":0.99738026},"labels":[],"label_agreement":null},{"id":"W2214455720","doi":"10.1158/1078-0432.ccr-14-3215","title":"Next-Generation Sequencing to Guide Clinical Trials","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Computational biology; Intensive care medicine; Biology; Pathology","score_opus":0.87215389658377,"score_gpt":0.6872007949276112,"score_spread":0.18495310165615875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214455720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027182561,0.9923993,0.00019476899,0.00029991608,0.0031309875,0.0020420712,0.0003840128,0.000014424315,0.0012627266],"genre_scores_gemma":[0.000023727216,0.97135925,0.0006019869,0.00071949686,0.022585554,0.0007555827,0.0006427151,0.00012150145,0.0031902026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9861723,0.0066022393,0.004074072,0.0015971379,0.0007611366,0.0007930901],"domain_scores_gemma":[0.9927615,0.0028062668,0.0006259915,0.0014735588,0.0012619676,0.0010707385],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.054950323,0.0004349378,0.0029994561,0.0001956583,0.00015952253,0.00024682085,0.0010728999,0.0014352733,0.00013369159],"category_scores_gemma":[0.045121577,0.00035883745,0.001422582,0.0004753296,0.00031682497,0.0000052601176,0.0010551629,0.0015063342,0.00038847228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056615478,0.000047939295,0.000016929524,0.000378554,0.00016520407,0.000009018962,0.000004489051,0.000008541008,0.000054228323,0.00002601387,0.32786703,0.67136544],"study_design_scores_gemma":[0.00051870156,0.00087177573,0.0000020091604,0.0010994425,0.00026723248,0.000005093223,0.000016004265,0.000021633079,0.000034833978,0.00004162545,0.9967108,0.00041087402],"about_ca_topic_score_codex":0.00036403828,"about_ca_topic_score_gemma":0.0006874058,"teacher_disagreement_score":0.6709545,"about_ca_system_score_codex":0.0005855517,"about_ca_system_score_gemma":0.012537269,"threshold_uncertainty_score":0.99988633},"labels":[],"label_agreement":null},{"id":"W2216971459","doi":"10.1158/1078-0432.ccr-15-2239","title":"Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Adipose tissue; Breast cancer; Inflammation; Medicine; Stage (stratigraphy); Cancer; White adipose tissue; Pathology; Oncology; Mammary gland; Systemic inflammation; Internal medicine; Biology","score_opus":0.2086173912445005,"score_gpt":0.5151647425670107,"score_spread":0.3065473513225102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216971459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927752,0.0032551577,0.000010774448,0.0016981522,0.0005492029,0.00078691036,0.0001223085,0.00002687605,0.00077543844],"genre_scores_gemma":[0.9935134,0.0023837523,0.00001714816,0.000038639006,0.00071442197,0.0001707222,0.000012378866,0.000032979766,0.0031165753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969917,0.00032909308,0.00091924274,0.00039847987,0.00089981174,0.00046165357],"domain_scores_gemma":[0.9977551,0.0003158496,0.00017408316,0.00043559948,0.00086898345,0.00045039237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028234131,0.00013954555,0.0005878986,0.00028044838,0.000053063875,0.000019217721,0.00020437404,0.00025764847,0.00056726],"category_scores_gemma":[0.00047883132,0.000114798706,0.00009526643,0.00074563303,0.0003532455,0.00013664682,0.00017014593,0.0010236545,0.000067546665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017639337,0.00010328104,0.9684879,0.0002738432,0.000050583058,0.000041495514,0.0012932378,0.00018180667,0.0005532737,0.000053108673,0.001665883,0.025531633],"study_design_scores_gemma":[0.00393396,0.0006374451,0.98357713,0.0013922331,0.000045234672,0.000015904307,0.00050448836,0.0006021849,0.0008487161,0.000064988584,0.008217917,0.00015977959],"about_ca_topic_score_codex":0.02118371,"about_ca_topic_score_gemma":0.0043467423,"teacher_disagreement_score":0.025371853,"about_ca_system_score_codex":0.0005787489,"about_ca_system_score_gemma":0.0014241833,"threshold_uncertainty_score":0.98533434},"labels":[],"label_agreement":null},{"id":"W2220868592","doi":"10.1158/1078-0432.ccr-14-3246","title":"The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases","year":2015,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Wood Council; Jewish General Hospital; Ottawa Hospital","funders":"","keywords":"Intensive care medicine; Medicine","score_opus":0.7134583301985442,"score_gpt":0.6907358896432467,"score_spread":0.022722440555297485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220868592","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033239492,0.011821794,0.00044859332,0.36023334,0.6076693,0.014810436,0.0012480973,0.00008291255,0.0003616],"genre_scores_gemma":[0.0014496469,0.008859614,0.00036241848,0.0018717274,0.94346505,0.005263268,0.00069134455,0.00023633313,0.03780058],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9850624,0.0018844286,0.0023274228,0.0018786239,0.006870922,0.0019762015],"domain_scores_gemma":[0.92297715,0.05079005,0.00035124115,0.0020860785,0.018005235,0.00579025],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.037440933,0.00047383297,0.0016860662,0.0005219424,0.0010682248,0.0006418778,0.002269577,0.0028817356,0.000110602625],"category_scores_gemma":[0.081406355,0.00027866432,0.0009483942,0.0010975559,0.003511264,0.0001261519,0.0017998863,0.0063368944,0.00005949331],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016284566,0.00031522327,0.00017346212,0.00036986318,0.00031042253,0.000010992883,0.0003227749,6.5809655e-7,0.0000073983606,0.00015585814,0.7776823,0.2043665],"study_design_scores_gemma":[0.0050023897,0.0057859425,0.0010814484,0.0010470209,0.00013285512,7.62977e-7,0.0012017513,0.000049286202,0.000016904536,0.005102673,0.9802324,0.00034657438],"about_ca_topic_score_codex":0.0025284563,"about_ca_topic_score_gemma":0.0017024081,"teacher_disagreement_score":0.3583616,"about_ca_system_score_codex":0.0014610719,"about_ca_system_score_gemma":0.022424817,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W2223730291","doi":"10.1158/1078-0432.ccr-15-1071","title":"A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health","keywords":"Colorectal cancer; Cancer; Medicine; Oncology; Colonic disease; Survival analysis; Internal medicine; Overall survival; Biology; Cancer research; Pathology","score_opus":0.4281226969249695,"score_gpt":0.4948229130398226,"score_spread":0.0667002161148531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223730291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909989,0.0029956559,0.00011407001,0.0019274618,0.00031835408,0.0030931556,0.00035995137,0.00006680905,0.00012563456],"genre_scores_gemma":[0.9910445,0.0029249308,0.00056616147,0.000071537484,0.0005730106,0.003353641,0.00009898464,0.00006167239,0.0013055666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949898,0.0016699358,0.00073405815,0.00082951644,0.0008665463,0.00091013726],"domain_scores_gemma":[0.9918758,0.0064305896,0.00010417734,0.00036638518,0.0007667947,0.00045621247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004504879,0.00024070176,0.0006963784,0.00027795468,0.0001419321,0.000038060003,0.00023266012,0.00030694052,0.0014141616],"category_scores_gemma":[0.0054263268,0.00014707565,0.000290077,0.0005317063,0.00034850708,0.00012792734,0.0001762811,0.00052956276,0.00005678232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063921767,0.000839631,0.86535686,0.00014455323,0.0001727033,0.00022811125,0.00007815588,4.7897726e-7,0.08784599,0.000018557426,0.0042411587,0.034681637],"study_design_scores_gemma":[0.01883978,0.003008704,0.70871794,0.0017224789,0.00022442735,0.0000045502834,0.000044172764,0.001384228,0.2514157,0.00015098808,0.014084456,0.0004026021],"about_ca_topic_score_codex":0.0018457549,"about_ca_topic_score_gemma":0.0016409806,"teacher_disagreement_score":0.1635697,"about_ca_system_score_codex":0.00042326638,"about_ca_system_score_gemma":0.0008717199,"threshold_uncertainty_score":0.99949867},"labels":[],"label_agreement":null},{"id":"W2233214336","doi":"10.1158/1078-0432.ccr-15-1624","title":"The <i>MCT4</i> Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; DU145; Lactic acid; Cancer research; Glycolysis; Secretion; Cancer; Biology; Internal medicine; Metabolism; Medicine; Endocrinology; Genetics; LNCaP","score_opus":0.0851120495211847,"score_gpt":0.46553372426026896,"score_spread":0.3804216747390843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233214336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91865575,0.068333164,0.0013616163,0.0054473775,0.0035440964,0.0016524019,0.00085723755,0.000013576251,0.00013480811],"genre_scores_gemma":[0.6339799,0.34553042,0.0008985769,0.0005199228,0.0076288087,0.002223842,0.000031208205,0.00008273924,0.009104601],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976718,0.00018936415,0.0005187278,0.00056210306,0.00040953507,0.00064848084],"domain_scores_gemma":[0.99795455,0.00027511458,0.00015654888,0.00058646465,0.00085627707,0.00017107415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001976805,0.00015490911,0.00028423523,0.00003377514,0.000237157,0.000027078086,0.00053319643,0.00018880157,0.000053608128],"category_scores_gemma":[0.0005283411,0.00008657208,0.00027311253,0.00015484994,0.0007508642,0.000007705828,0.00017596415,0.00020659577,0.0000032837559],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035433748,0.00009655799,0.00060214964,0.000014239433,0.000107648295,1.9031599e-7,0.000016364005,0.000025555459,0.70847905,0.00006235424,0.020238372,0.26681417],"study_design_scores_gemma":[0.003442973,0.00056296354,0.0013963928,0.000025524108,0.000007105714,7.3702324e-7,0.000021076077,0.000007309926,0.2528472,0.00026110042,0.74130815,0.00011944387],"about_ca_topic_score_codex":0.00013225508,"about_ca_topic_score_gemma":0.0002309598,"teacher_disagreement_score":0.7210698,"about_ca_system_score_codex":0.00003040313,"about_ca_system_score_gemma":0.0009802257,"threshold_uncertainty_score":0.3530307},"labels":[],"label_agreement":null},{"id":"W2233600556","doi":"10.1158/1078-0432.ccr-15-2360","title":"Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Vancouver Coastal Health Research Institute; National Health Research Institutes; Canadian Urological Association; Urology Care Foundation","keywords":"Cancer research; Notch signaling pathway; Bladder cancer; Epithelial–mesenchymal transition; Oncogene; Cancer; Metastasis; Biology; Gene silencing; Tumor progression; Carcinogenesis; Cell cycle; Medicine; Internal medicine; Signal transduction; Cell biology","score_opus":0.3062541810693193,"score_gpt":0.5504529491950023,"score_spread":0.24419876812568303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233600556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.917469,0.015733464,0.00003334606,0.06458859,0.00006183972,0.001644145,0.00017689356,0.000013211628,0.00027948822],"genre_scores_gemma":[0.9654573,0.030669222,0.000030844683,0.0016472109,0.00016273835,0.0008725622,0.000008472325,0.000031535885,0.0011201233],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998052,0.0001870443,0.00051932456,0.00044256434,0.00035721916,0.00044186064],"domain_scores_gemma":[0.9971987,0.0014834944,0.00007126704,0.0004832038,0.0005920511,0.00017127344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017045676,0.00011935309,0.00036340285,0.00009894603,0.000073615236,0.000011444132,0.00023914628,0.00016259878,0.0006208346],"category_scores_gemma":[0.00065603055,0.000065532724,0.00019443911,0.00036307832,0.00035166732,0.000032028733,0.0000860446,0.00029387395,0.000011553266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029769265,0.00068613025,0.18876566,0.00009332754,0.00088493986,7.737884e-7,0.0009678895,0.00000471289,0.19243543,0.0005638935,0.011489439,0.6011309],"study_design_scores_gemma":[0.012755059,0.001267402,0.7863587,0.00018683804,0.000117784584,0.0000018575979,0.00024178505,0.00022763037,0.06507069,0.0028363895,0.13070957,0.00022630063],"about_ca_topic_score_codex":0.0014470061,"about_ca_topic_score_gemma":0.0012361547,"teacher_disagreement_score":0.6009046,"about_ca_system_score_codex":0.00006603319,"about_ca_system_score_gemma":0.0006205466,"threshold_uncertainty_score":0.6797703},"labels":[],"label_agreement":null},{"id":"W2234923158","doi":"10.1158/1078-0432.ccr-15-2762","title":"Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":606,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Battle Creek Community Foundation; U.S. Department of Defense","keywords":"Ovarian cancer; Biology; CD8; Antigen; CD20; Cancer research; Tumor-infiltrating lymphocytes; Cytotoxic T cell; Immunology; Cancer","score_opus":0.06570438379216074,"score_gpt":0.3745017896595933,"score_spread":0.30879740586743254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234923158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862896,0.0106392605,0.0000032062258,0.0016422842,0.0003679767,0.00071563397,0.00022061457,0.000047888534,0.00007350028],"genre_scores_gemma":[0.9909308,0.0032018041,0.00002648622,0.0002604326,0.000077165976,0.00038249337,0.000009080382,0.000058622652,0.00505313],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99394256,0.0032067164,0.00081262056,0.00077101233,0.00019357742,0.0010734852],"domain_scores_gemma":[0.9940491,0.0049710283,0.00023294573,0.00041218876,0.00025188137,0.00008287187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029013627,0.00030933294,0.0006470944,0.0002938493,0.00038969677,0.00006664778,0.00045779135,0.00046221403,0.001133981],"category_scores_gemma":[0.0012421069,0.00019694022,0.000103089566,0.00046154598,0.0014074566,0.00018413212,0.0001869317,0.0010675574,0.000048701026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093697,0.0002409591,0.42954662,0.000041517385,0.00019958185,0.000089578876,0.00021790396,0.0000011540089,0.54477406,0.000014435558,0.0009100961,0.014594363],"study_design_scores_gemma":[0.010052862,0.0009788014,0.5493817,0.0010163989,0.000031956406,0.00004798149,0.00031104436,0.0000050262497,0.4306022,0.000046938054,0.0071166237,0.0004084901],"about_ca_topic_score_codex":0.0015275145,"about_ca_topic_score_gemma":0.0012933597,"teacher_disagreement_score":0.119835064,"about_ca_system_score_codex":0.00034343475,"about_ca_system_score_gemma":0.0012551182,"threshold_uncertainty_score":0.9997791},"labels":[],"label_agreement":null},{"id":"W2238237545","doi":"10.1158/1078-0432.ccr-15-2233","title":"Endometrial Carcinomas with <i>POLE</i> Exonuclease Domain Mutations Have a Favorable Prognosis","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Oncology; Endometrial cancer; Medicine; Carcinoma; Stage (stratigraphy); Lymphovascular invasion; Cancer; Biology; Metastasis","score_opus":0.23122253905590462,"score_gpt":0.4839051951767981,"score_spread":0.25268265612089347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238237545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627785,0.0016469632,0.0001649877,0.017030962,0.00039046185,0.0023436921,0.00020480929,0.00012434745,0.01531529],"genre_scores_gemma":[0.9901055,0.0008471336,0.0008593838,0.0005325763,0.0015477642,0.0011091958,0.000018078334,0.00006422446,0.0049161213],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953087,0.00061070535,0.00073927856,0.00085689005,0.0015326826,0.0009517253],"domain_scores_gemma":[0.9940094,0.0034419685,0.00012464655,0.0006054771,0.0008069875,0.0010115298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022020617,0.0002460139,0.00072922074,0.00045910355,0.00028177048,0.0000620162,0.00027932416,0.00020808063,0.0024786997],"category_scores_gemma":[0.0024115941,0.00013140326,0.00030096836,0.0017521675,0.0009936942,0.00015707382,0.00015955698,0.000671994,0.00036142507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02015486,0.0020439376,0.77316767,0.00013936037,0.0006423256,0.00054748374,0.00011704233,8.71725e-7,0.0012350959,0.0005313149,0.0070212567,0.19439876],"study_design_scores_gemma":[0.18263035,0.031471908,0.35406992,0.00239083,0.0011324642,0.00009945452,0.0011372488,0.000020384976,0.017355226,0.006904849,0.40142918,0.0013582188],"about_ca_topic_score_codex":0.0012371902,"about_ca_topic_score_gemma":0.00042065972,"teacher_disagreement_score":0.41909778,"about_ca_system_score_codex":0.0005489008,"about_ca_system_score_gemma":0.0012535837,"threshold_uncertainty_score":0.9984332},"labels":[],"label_agreement":null},{"id":"W2243499413","doi":"10.1158/1557-3265.pms14-a57","title":"Abstract A57: Effects of pre-exposure to siRNA on silencing response: Do cells become resistant to siRNA silencing?","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gene silencing; Small interfering RNA; RNA interference; Internalization; Cancer research; Biology; Cell biology; Cell; Chemistry; Cell culture; Transfection; RNA; Genetics; Gene","score_opus":0.1041272549679348,"score_gpt":0.4626611717672729,"score_spread":0.3585339167993381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243499413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615204,0.0011185434,0.000030038604,0.0007436099,0.0006227544,0.00070920907,0.000053093056,0.000012573655,0.00055810617],"genre_scores_gemma":[0.99607086,0.0003190055,0.00014360117,0.00075150956,0.00067938445,0.00012397888,0.0000075289895,0.00004088904,0.0018632677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961857,0.0006526113,0.00074910413,0.00085873983,0.0008768742,0.00067695335],"domain_scores_gemma":[0.9963879,0.0008894346,0.00012323784,0.0009964439,0.0008631892,0.0007398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004982345,0.00022945536,0.00042622347,0.00020110802,0.00009500918,0.000056730933,0.00079322734,0.00033622855,0.000061223174],"category_scores_gemma":[0.004284669,0.00020165315,0.00019849629,0.0003720114,0.00016625172,0.000008279303,0.00047439008,0.00060623256,0.00018576099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01603502,0.00018379373,0.001301343,0.00011301382,0.000065380365,0.000041362608,0.00036819244,0.0007108733,0.9372682,0.000005297462,0.038596455,0.0053110546],"study_design_scores_gemma":[0.0009306278,0.013057726,0.045041878,0.00048829056,0.000013082475,8.7120515e-7,0.00026676993,0.000006664602,0.9283218,0.0000512362,0.011544707,0.0002763707],"about_ca_topic_score_codex":0.0004242339,"about_ca_topic_score_gemma":0.0002511176,"teacher_disagreement_score":0.043740537,"about_ca_system_score_codex":0.00017639098,"about_ca_system_score_gemma":0.0009976639,"threshold_uncertainty_score":0.8223177},"labels":[],"label_agreement":null},{"id":"W2252455678","doi":"10.1158/1078-0432.ccr-15-0035","title":"Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Concordance; Medicine; Clinical trial; Drug development; Task force; Steering committee; Clinical study design; Randomized controlled trial; Medical physics; Research design; Oncology; Investigational Drugs; Drug; Internal medicine; Pharmacology","score_opus":0.9426179993832116,"score_gpt":0.7345665705338479,"score_spread":0.20805142884936367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2252455678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522883,0.00015350888,0.0054932972,0.025327746,0.008257856,0.0061825607,0.0010338908,0.000031409672,0.0012313755],"genre_scores_gemma":[0.8956776,0.00010015457,0.10058645,0.0002626317,0.0013265823,0.0002120724,0.0000015518909,0.000071449824,0.0017614583],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.96794873,0.024718873,0.0043570944,0.00047282627,0.001983014,0.00051948376],"domain_scores_gemma":[0.6622519,0.33043483,0.0021090093,0.0024550273,0.002335514,0.00041375207],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06826295,0.00021302303,0.001185668,0.000060113383,0.00023798223,0.000026178124,0.002197323,0.0003747007,0.00021149538],"category_scores_gemma":[0.5207225,0.000102871665,0.001160694,0.0010012417,0.0056704003,0.000042340464,0.0013980528,0.0024687436,0.0000071705244],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030951418,0.00342385,0.11631773,0.00035154322,0.0013630962,0.000001658743,0.0008280137,0.0005782667,0.0005867694,0.0827606,0.747957,0.014880073],"study_design_scores_gemma":[0.0200624,0.0012978762,0.04492302,0.0005726587,0.00022196643,0.0000014044922,0.00018792285,0.0009015175,0.0014929619,0.9293329,0.0008201798,0.00018520051],"about_ca_topic_score_codex":0.00040722176,"about_ca_topic_score_gemma":0.0001263589,"teacher_disagreement_score":0.8465723,"about_ca_system_score_codex":0.00018495038,"about_ca_system_score_gemma":0.0042512743,"threshold_uncertainty_score":0.99983263},"labels":[],"label_agreement":null},{"id":"W2259127335","doi":"10.1158/1078-0432.ccr-15-2218","title":"Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute; Universitat de Girona; Astellas Pharma US","keywords":"Medicine; Erlotinib; Internal medicine; Pharmacodynamics; Adverse effect; Nausea; Epidermal growth factor receptor; Oncology; Insulin-like growth factor 1 receptor; Cohort; Vomiting; Cancer; Pharmacology; Pharmacokinetics; Gastroenterology; Receptor","score_opus":0.11269773919679285,"score_gpt":0.5568681410234685,"score_spread":0.44417040182667566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259127335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687624,0.000109214365,0.000009964662,0.0006673242,0.00006463721,0.001873147,0.000037878806,0.00001503116,0.00034654266],"genre_scores_gemma":[0.9990876,0.00012999536,0.00009194514,0.00004955346,0.00008758249,0.00022431108,0.000013286218,0.000022797218,0.00029295142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790806,0.00021727277,0.0005797739,0.00041640032,0.0005798752,0.00029863088],"domain_scores_gemma":[0.9982997,0.00057051703,0.00011777039,0.00029745317,0.0005079349,0.0002065891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007206132,0.00011135023,0.00040690327,0.00016855155,0.00006707672,0.000009523602,0.00007130003,0.00006297772,0.000097108794],"category_scores_gemma":[0.0004178386,0.000063823,0.000034818302,0.00036242398,0.00025472732,0.00011847615,0.000057201312,0.0002619917,0.0000066649523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055046845,0.0068810787,0.80467755,0.000036904272,0.0000932175,0.000015511336,0.00051712606,0.0000026420582,0.000106587795,0.00001600797,0.00007822144,0.18207046],"study_design_scores_gemma":[0.05747981,0.015840078,0.925254,0.00045231485,0.00006323127,4.148794e-7,0.00039743353,0.000016377424,0.00016110583,0.000040539515,0.0002148843,0.00007984562],"about_ca_topic_score_codex":0.00021848828,"about_ca_topic_score_gemma":0.00037507678,"teacher_disagreement_score":0.18199062,"about_ca_system_score_codex":0.00015433003,"about_ca_system_score_gemma":0.0003711381,"threshold_uncertainty_score":0.26026264},"labels":[],"label_agreement":null},{"id":"W2260128833","doi":"10.1158/1557-3265.hemmal14-b12","title":"Abstract B12: EIF4E deregulation drives simultaneous expression of B-cell lymphoma oncogenes.","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"EIF4E; Biology; Nuclear export signal; Cancer research; Oncogene; Eukaryotic translation; Translation (biology); EIF4A1; Messenger RNA; Molecular biology; Cell cycle; Cell biology; Gene; Cytoplasm; Cell nucleus; Genetics","score_opus":0.26007171454945693,"score_gpt":0.5127443101287255,"score_spread":0.2526725955792685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260128833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896121,0.0028673832,0.000007124462,0.00068662583,0.00021893834,0.00052415335,0.000018546101,0.000030074687,0.006035079],"genre_scores_gemma":[0.9967286,0.0011954701,0.00043855107,0.00009764456,0.00044625008,0.000088867564,0.000027157117,0.000026730017,0.0009507162],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99727017,0.00020919958,0.00064811105,0.0004334813,0.0010638238,0.0003751947],"domain_scores_gemma":[0.99621755,0.0017780819,0.00014388014,0.00050124776,0.0008119824,0.0005472738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013103196,0.00014144693,0.00044735518,0.00011763752,0.000072972296,0.000020689826,0.00016162072,0.00022049266,0.00030977817],"category_scores_gemma":[0.0011633408,0.000102953214,0.00017888709,0.00025496073,0.00032517442,0.000067163935,0.00012829922,0.00017631271,0.0001360732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005105601,0.011516141,0.44740498,0.000409862,0.00016815533,0.00069688936,0.0005676465,0.00031834262,0.028291345,0.000074945536,0.028316434,0.47712967],"study_design_scores_gemma":[0.025974926,0.0028477751,0.58843607,0.0008567968,0.0001293758,0.000017037979,0.00053704885,0.0009357796,0.3426929,0.00047914757,0.036797713,0.0002954319],"about_ca_topic_score_codex":0.00056560436,"about_ca_topic_score_gemma":0.000047375364,"teacher_disagreement_score":0.47683424,"about_ca_system_score_codex":0.0004053533,"about_ca_system_score_gemma":0.0011921925,"threshold_uncertainty_score":0.419831},"labels":[],"label_agreement":null},{"id":"W2261762138","doi":"10.1158/1078-0432.ccr-15-1784","title":"STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Novo Nordisk Fonden; Harvard University","keywords":"Mycosis fungoides; Medicine; Dermatology; Mycosis; Lymphoma; Cancer research; Pathology; Biology; Immunology","score_opus":0.18895620218587397,"score_gpt":0.5266381113907551,"score_spread":0.33768190920488117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261762138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98076415,0.0011728477,0.00031998678,0.013034128,0.00028562808,0.0017617382,0.00014111339,0.00004780299,0.0024726214],"genre_scores_gemma":[0.98524356,0.0023177762,0.00006512594,0.0004968517,0.00032211083,0.0005026867,0.0000086071705,0.00006234412,0.010980935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99341434,0.0013079336,0.00093773386,0.0010174545,0.0019481394,0.0013744063],"domain_scores_gemma":[0.9889414,0.008245112,0.000068530375,0.0007349057,0.0011664141,0.0008436454],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0046465606,0.00024641174,0.0007688884,0.000595984,0.00016369305,0.000076048535,0.00046167514,0.0002818617,0.0022771175],"category_scores_gemma":[0.010306507,0.0001612407,0.00017292063,0.00097488373,0.00050860643,0.000100088415,0.0006304872,0.0010009288,0.0009117938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010249282,0.0011938688,0.8134239,0.0002024321,0.000079584934,0.00029655834,0.00016437379,0.000014865389,0.118070014,0.00014715786,0.019266184,0.03689181],"study_design_scores_gemma":[0.038249254,0.00772327,0.740123,0.0057238066,0.00007357923,0.00004625719,0.0017198547,0.0004183575,0.13112928,0.0031686164,0.070485294,0.0011394696],"about_ca_topic_score_codex":0.0012686333,"about_ca_topic_score_gemma":0.0019927085,"teacher_disagreement_score":0.07330091,"about_ca_system_score_codex":0.0010622668,"about_ca_system_score_gemma":0.0016755769,"threshold_uncertainty_score":0.9998661},"labels":[],"label_agreement":null},{"id":"W2263864814","doi":"10.1158/1078-0432.ccr-15-2631","title":"Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University Hospital Foundation","funders":"National Cancer Institute","keywords":"TSC1; PI3K/AKT/mTOR pathway; TSC2; Medicine; Cancer; Cancer research; Oncology; Internal medicine; Renal cell carcinoma; Sirolimus; Biology; Genetics; Apoptosis","score_opus":0.1292294006372624,"score_gpt":0.4265416049270228,"score_spread":0.2973122042897604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263864814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948081,0.00018806302,0.000008030824,0.0032047895,0.00002633684,0.0015192825,0.00007337772,0.000014014381,0.00015802913],"genre_scores_gemma":[0.99788713,0.000019958416,0.00020820842,0.0001647172,0.000031070358,0.00039954804,0.000017150533,0.00004081142,0.001231408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586356,0.0013629808,0.00056033087,0.000651039,0.00093951524,0.00062258984],"domain_scores_gemma":[0.9952091,0.0032322335,0.000111311325,0.00040881045,0.0005446638,0.0004938742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026766956,0.00019277105,0.000563789,0.0005157784,0.00006618861,0.000022865446,0.00012895491,0.00010025024,0.000109784545],"category_scores_gemma":[0.0021251913,0.0001074163,0.00004835896,0.0009814914,0.00039521215,0.00008360338,0.00009187741,0.0005369278,0.000029877703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025249729,0.0009390425,0.9702409,0.000035959718,0.00004952335,0.00049653713,0.0002804055,0.0000057975317,0.00046581094,0.0000020168438,0.00031133572,0.0019229212],"study_design_scores_gemma":[0.019044887,0.006700673,0.9721551,0.0006675386,0.000052106774,0.000001930802,0.00015491614,0.000007014007,0.00091439846,0.000024862009,0.00013181138,0.00014474338],"about_ca_topic_score_codex":0.0005076406,"about_ca_topic_score_gemma":0.002692131,"teacher_disagreement_score":0.006204843,"about_ca_system_score_codex":0.00083780225,"about_ca_system_score_gemma":0.00083249854,"threshold_uncertainty_score":0.43803096},"labels":[],"label_agreement":null},{"id":"W2268068174","doi":"","title":"Bivalent binding properties of epidermal growth factor receptor targeted monoclonal antibodies: Factors contributing to differences in observed clinical profiles.","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Nimotuzumab; Cetuximab; Monoclonal antibody; Epidermal growth factor receptor; Antibody; Chemistry; Panitumumab; Cancer research; Cell culture; Molecular biology; Antibody-dependent cell-mediated cytotoxicity; A431 cells; Cell growth; Monoclonal; Cell; Receptor; Immunology; Cell cycle; Medicine; Biology; Biochemistry; Molecular medicine","score_opus":0.6654379160890438,"score_gpt":0.5353623484376453,"score_spread":0.1300755676513985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268068174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022776,0.0018801318,0.000011625006,0.0038725524,0.0007907136,0.0027335093,0.00029318422,0.00007821624,0.00011231414],"genre_scores_gemma":[0.99188745,0.00536453,0.00042389278,0.0001669517,0.0008866157,0.00035680266,0.000036963942,0.000080342405,0.00079642585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9877321,0.0027190477,0.0031389666,0.0013567242,0.0027803003,0.0022728406],"domain_scores_gemma":[0.99145186,0.004348836,0.0003296946,0.00074595213,0.0018824381,0.0012411914],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00965691,0.00042069497,0.0020711743,0.0007372042,0.0003966279,0.000048932925,0.0009120623,0.00057394296,0.0010736772],"category_scores_gemma":[0.028076975,0.00030844708,0.00051878224,0.0017893753,0.0021847037,0.00018669153,0.0009178454,0.003435248,0.00012930168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026390606,0.00085571164,0.9763698,0.0006334714,0.00017467211,0.00008857019,0.000813844,0.000001406441,0.013176118,0.000017746184,0.0029323846,0.0022972138],"study_design_scores_gemma":[0.003018601,0.0018462015,0.93575794,0.0018479018,0.000017273353,0.0000043321224,0.0007120272,0.00015108688,0.055408712,0.000012593316,0.00089169235,0.00033166612],"about_ca_topic_score_codex":0.0030467662,"about_ca_topic_score_gemma":0.0002204489,"teacher_disagreement_score":0.042232595,"about_ca_system_score_codex":0.0007429819,"about_ca_system_score_gemma":0.0036025373,"threshold_uncertainty_score":0.99993676},"labels":[],"label_agreement":null},{"id":"W2282026400","doi":"10.1158/1078-0432.ccr-15-2305","title":"Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Institut National Du Cancer","keywords":"Diffuse large B-cell lymphoma; DNA sequencing; Computational biology; Lymphoma; Divergence (linguistics); Cancer research; Biology; Medicine; Genetics; DNA; Pathology","score_opus":0.437137671494779,"score_gpt":0.4702727758321284,"score_spread":0.0331351043373494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282026400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925392,0.0031578836,0.000013254618,0.0028791355,0.00013646152,0.00093785377,0.000015518968,0.000024441464,0.00029624646],"genre_scores_gemma":[0.98952967,0.008588643,0.000020759726,0.00048789673,0.00018601549,0.00044113278,0.0000045424663,0.000023675217,0.00071766524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711245,0.0006294321,0.0005125578,0.0005829255,0.00066181715,0.00050082913],"domain_scores_gemma":[0.9983243,0.00063539634,0.00006238976,0.00043577005,0.00021673793,0.00032540204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016815492,0.00016187855,0.00038124426,0.00016966987,0.00013574417,0.0000501031,0.00013408002,0.00011753389,0.00014134964],"category_scores_gemma":[0.00018818854,0.00009699329,0.000081963946,0.00023796159,0.00018845321,0.000098095894,0.00016588914,0.00013155951,0.00003317797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070532627,0.017563377,0.81606525,0.00008769556,0.0002501851,0.002566564,0.0013409539,5.555565e-7,0.017662898,0.0011647926,0.00063011347,0.1419623],"study_design_scores_gemma":[0.13694006,0.008053604,0.8088249,0.0009339041,0.0003552935,0.00002875589,0.0037168094,0.0012531392,0.024568764,0.0007176982,0.013856099,0.0007509456],"about_ca_topic_score_codex":0.00102568,"about_ca_topic_score_gemma":0.00066730706,"teacher_disagreement_score":0.14121136,"about_ca_system_score_codex":0.00082862773,"about_ca_system_score_gemma":0.0008356574,"threshold_uncertainty_score":0.39552715},"labels":[],"label_agreement":null},{"id":"W2286693725","doi":"10.1158/1078-0432.ccr-15-2499","title":"Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Lapatinib; Trastuzumab emtansine; Trastuzumab; Capecitabine; Medicine; Cancer; Breast cancer; Metastatic breast cancer; Biomarker; Cancer research; Oncology; PTEN; Antibody-drug conjugate; Internal medicine; Antibody; Immunology; Biology; Monoclonal antibody; Apoptosis; Colorectal cancer","score_opus":0.3463970865185873,"score_gpt":0.593692150892299,"score_spread":0.24729506437371168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286693725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851156,0.0011751609,0.000010332964,0.0064906273,0.00008553887,0.003188279,0.00035347027,0.00002018746,0.00016487042],"genre_scores_gemma":[0.9980296,0.00059738406,0.000049283957,0.000059214864,0.00023376354,0.00067253155,0.000008703526,0.00006162274,0.0002879092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923195,0.0023755569,0.0016953027,0.0010210847,0.0016114158,0.0009771285],"domain_scores_gemma":[0.9884327,0.009506914,0.00017775562,0.00066019676,0.00062494626,0.00059745903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008415799,0.0002652148,0.0011924093,0.00096804084,0.000103433005,0.000026519316,0.00035813564,0.0001546754,0.0005441614],"category_scores_gemma":[0.00437605,0.0001912407,0.000115909264,0.0023546994,0.0012648732,0.00015861259,0.00026092213,0.0015210843,0.000016205513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077655492,0.004392078,0.91238755,0.00025649043,0.00019908267,0.0003963962,0.0011716684,0.0000019637375,0.00042405172,0.000012552454,0.0005464008,0.0724462],"study_design_scores_gemma":[0.041369718,0.0035658032,0.9510526,0.0019034639,0.00009412418,0.000012633605,0.0013737648,0.000040570038,0.00019878872,0.00010960202,0.00008933609,0.00018959332],"about_ca_topic_score_codex":0.01761047,"about_ca_topic_score_gemma":0.013888734,"teacher_disagreement_score":0.0722566,"about_ca_system_score_codex":0.0012494025,"about_ca_system_score_gemma":0.0024913414,"threshold_uncertainty_score":0.98893136},"labels":[],"label_agreement":null},{"id":"W2291969671","doi":"10.1158/1078-0432.ccr-15-1698","title":"Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Adenoid cystic carcinoma; Medicine; Carcinoma; Oncology; Pathology; Dermatology","score_opus":0.3352563750347625,"score_gpt":0.5488742793984507,"score_spread":0.21361790436368816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291969671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888759,0.004844797,0.000052557814,0.0043793325,0.00022683953,0.0010719042,0.000105359024,0.000018411149,0.00042486022],"genre_scores_gemma":[0.9932374,0.0029185514,0.00029741338,0.00005431937,0.0008384214,0.00078567775,0.00001533277,0.000025398243,0.0018275252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981466,0.00016676703,0.0005126575,0.00038368037,0.0003650299,0.00042526211],"domain_scores_gemma":[0.99554247,0.0034158272,0.00007358541,0.00033321156,0.0003756352,0.00025924612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008754636,0.00011727818,0.00049973646,0.00008996978,0.00007953415,0.000006740927,0.00008714511,0.00008904898,0.00044701458],"category_scores_gemma":[0.00095678674,0.00005974344,0.00024437616,0.0001417551,0.00023916323,0.000026546084,0.000034497774,0.00006449648,0.000046946854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017110964,0.0014167485,0.9532557,0.00009453198,0.00016138086,0.00006694251,0.000055685494,4.445408e-7,0.00064717064,0.00027178443,0.0051733498,0.037145175],"study_design_scores_gemma":[0.019287424,0.016056301,0.90983963,0.00045747065,0.00026115656,0.00001072299,0.000092433715,0.000061232015,0.019256251,0.00078127504,0.033722807,0.0001733132],"about_ca_topic_score_codex":0.00032418707,"about_ca_topic_score_gemma":0.000021733022,"teacher_disagreement_score":0.04341608,"about_ca_system_score_codex":0.0002679794,"about_ca_system_score_gemma":0.00038590867,"threshold_uncertainty_score":0.48944962},"labels":[],"label_agreement":null},{"id":"W2303705342","doi":"10.1158/1078-0432.ccr-15-1798","title":"Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Amgen (Canada); Ontario Institute for Cancer Research; Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Disulfiram; Temozolomide; Glioblastoma; Medicine; Pharmacology; Oncology; Cancer research","score_opus":0.13350458886721747,"score_gpt":0.4733294582649805,"score_spread":0.339824869397763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303705342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694188,0.007431629,0.00015440484,0.019832544,0.00019535741,0.0028171926,0.000022516264,0.000013151217,0.00011437198],"genre_scores_gemma":[0.9862077,0.010190157,0.00003983066,0.00021067302,0.00026108086,0.0020032325,7.026955e-7,0.000025808578,0.0010607971],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979439,0.000361678,0.00045112014,0.00030487817,0.0005803943,0.00035806358],"domain_scores_gemma":[0.98801506,0.010665023,0.00013939217,0.0006096857,0.00046938466,0.00010144553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013345317,0.00013671292,0.0005146558,0.000042973625,0.00013063705,0.000011180389,0.0002899239,0.00008484252,0.0001278808],"category_scores_gemma":[0.0003446405,0.00004275608,0.0002480398,0.00021858627,0.001427843,0.00003093587,0.000038134895,0.00014932825,0.000005424944],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043602888,0.0029674026,0.1143396,0.00065322244,0.0020213628,0.000004760833,0.0009897996,0.0000016474058,0.022894025,0.0007253775,0.00838221,0.8034177],"study_design_scores_gemma":[0.019791983,0.09964772,0.15043157,0.0013733387,0.00081332,0.0000026260607,0.0004046802,0.0000966371,0.65659636,0.00088632794,0.069748335,0.00020708425],"about_ca_topic_score_codex":0.0001917314,"about_ca_topic_score_gemma":0.00031254147,"teacher_disagreement_score":0.8032106,"about_ca_system_score_codex":0.00010742923,"about_ca_system_score_gemma":0.00036950572,"threshold_uncertainty_score":0.5260947},"labels":[],"label_agreement":null},{"id":"W2308342896","doi":"10.1158/1078-0432.ccr-15-0965","title":"Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"PTEN; Tensin; Trastuzumab; Breast cancer; Cancer research; Medicine; Cancer; Phosphatase; Internal medicine; Protein kinase B; Oncology; Biology; PI3K/AKT/mTOR pathway; Phosphorylation; Signal transduction","score_opus":0.08363033479904568,"score_gpt":0.47490335020492563,"score_spread":0.39127301540587994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308342896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530035,0.0013832123,0.00036774875,0.0010445231,0.000097678836,0.0007278577,0.000973876,0.0000072447383,0.00009748327],"genre_scores_gemma":[0.99646837,0.0012707512,0.00012807477,0.00007549513,0.0002783583,0.00082746235,0.000044370157,0.000028336728,0.00087875774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975403,0.00044219967,0.00053798925,0.000693656,0.00036244828,0.0004234128],"domain_scores_gemma":[0.99830735,0.0003067126,0.00013873227,0.0003788869,0.00068614545,0.0001821459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017093936,0.00015397789,0.00041159632,0.00021372736,0.00005918958,0.000017160735,0.0003123538,0.00031843304,0.00023810448],"category_scores_gemma":[0.00079955964,0.00010394041,0.0001733138,0.000578476,0.0005854277,0.000009538521,0.00021121983,0.00026158523,0.0000015497833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031265048,0.00015333934,0.17400806,0.000049616217,0.00052581896,0.000002645262,0.00005553953,0.000028021434,0.78817695,0.000021563192,0.0016140558,0.03223789],"study_design_scores_gemma":[0.0035381396,0.0014444782,0.17785163,0.0011499415,0.00020324282,0.0000013663591,0.00012761606,0.00030677445,0.8057965,0.00025386337,0.008949886,0.0003765862],"about_ca_topic_score_codex":0.0016328456,"about_ca_topic_score_gemma":0.0014292682,"teacher_disagreement_score":0.031861305,"about_ca_system_score_codex":0.00012474641,"about_ca_system_score_gemma":0.0006133593,"threshold_uncertainty_score":0.42385668},"labels":[],"label_agreement":null},{"id":"W2312246075","doi":"10.1158/1557-3265.hemmal14-b08","title":"Abstract B08: eIF4E3 forms a novel cap-binding complex for mRNA translation initiation.","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"EIF4G; EIF4E; eIF4A; Eukaryotic translation; Biology; Internal ribosome entry site; Messenger RNA; Translation (biology); RNA-binding protein; Initiation factor; Cell biology; Eukaryotic initiation factor; Translational regulation; Untranslated region; Molecular biology; Genetics; Gene","score_opus":0.6274882464662679,"score_gpt":0.5714631894365825,"score_spread":0.05602505702968541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312246075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822134,0.0019293263,0.0072377194,0.0017717761,0.0007953931,0.0011347422,0.0004242683,0.000035629022,0.0044577466],"genre_scores_gemma":[0.9946321,0.00024144395,0.001980992,0.00032870655,0.0017135517,0.0003518923,0.00036208477,0.000049283517,0.00033989738],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975817,0.000100313104,0.0005871545,0.00056602625,0.00060782285,0.00055698154],"domain_scores_gemma":[0.99796605,0.00035648872,0.00013097684,0.00039226632,0.00084675447,0.0003074873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036669371,0.00015516236,0.00024579206,0.00008735922,0.00017157591,0.0000695495,0.00040103614,0.00036003446,0.00011043417],"category_scores_gemma":[0.0010803514,0.00014424301,0.0001818328,0.00020657203,0.000266663,0.000016402879,0.00009050569,0.0004620567,0.00003211742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037375845,0.00064158987,0.014573203,0.0002582211,0.000331114,0.0000061631386,0.00037412526,0.0010355514,0.81683695,0.00052483566,0.09725896,0.06442168],"study_design_scores_gemma":[0.013256297,0.0029522832,0.019305456,0.00020263044,0.00006690337,0.000008814554,0.0004644308,0.0028665997,0.11774915,0.0024712484,0.83967555,0.0009806236],"about_ca_topic_score_codex":0.00014399135,"about_ca_topic_score_gemma":0.0002870853,"teacher_disagreement_score":0.7424166,"about_ca_system_score_codex":0.00014864307,"about_ca_system_score_gemma":0.0010210735,"threshold_uncertainty_score":0.58820593},"labels":[],"label_agreement":null},{"id":"W2315061030","doi":"10.1158/1078-0432.tcme10-b13","title":"Abstract B13: TIA1+ and FOXP3+ tumor infiltrating lymphocytes are positive prognostic factors in estrogen receptor negative breast cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Tissue microarray; FOXP3; Oncology; Estrogen receptor; Cancer; Internal medicine; Tumor-infiltrating lymphocytes; Pathology; Immune system; Immunology; Immunotherapy","score_opus":0.10158320996902187,"score_gpt":0.4645544918253545,"score_spread":0.36297128185633265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315061030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350005,0.0012763018,4.1851834e-7,0.0028936118,0.00043940608,0.0011187149,0.0003603726,0.00003814067,0.00037296664],"genre_scores_gemma":[0.9970858,0.0012125134,0.000104974846,0.00038236042,0.00071217224,0.0003024229,0.000020202118,0.00004708729,0.00013243186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996979,0.00025348985,0.0007291422,0.00068185746,0.0006455536,0.00071097584],"domain_scores_gemma":[0.9960997,0.0024974246,0.00021040083,0.00031200144,0.00048449164,0.00039596445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018112515,0.00025532267,0.00056868105,0.00020648903,0.00020081292,0.00009022092,0.00021257396,0.00027258476,0.0012836973],"category_scores_gemma":[0.0015146402,0.00019906418,0.00015543304,0.0005774831,0.0010941282,0.00018011706,0.000110931454,0.0019320012,0.000016627075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040272046,0.0002599936,0.9342728,0.00012486738,0.00016064565,0.000053537682,0.00045560673,7.447933e-7,0.019790003,0.000012614524,0.0007038238,0.040138144],"study_design_scores_gemma":[0.0035426768,0.00045099625,0.9826199,0.0009308379,0.000029099265,0.000024426528,0.0010724554,0.000034599114,0.010467437,0.000044664786,0.0005620095,0.0002209357],"about_ca_topic_score_codex":0.01318721,"about_ca_topic_score_gemma":0.006280788,"teacher_disagreement_score":0.048347045,"about_ca_system_score_codex":0.00040066178,"about_ca_system_score_gemma":0.0015381391,"threshold_uncertainty_score":0.99962926},"labels":[],"label_agreement":null},{"id":"W2329400486","doi":"10.1158/1078-0432.ccr-16-0316","title":"A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; National Institutes of Health; Institut Gustave-Roussy; Deutsche Krebshilfe; Associazione Italiana per la Ricerca sul Cancro; NordForsk; Hellenic Health Foundation; Stavros Niarchos Foundation; Institut National de la Santé et de la Recherche Médicale; World Health Organization; European Commission; Bundesministerium für Bildung und Forschung; Ligue Contre le Cancer; National Institute for Health and Care Research; Cancer Research UK; Cancerfonden; Fujirebio US; Deutsches Krebsforschungszentrum","keywords":"European Prospective Investigation into Cancer and Nutrition; EPIC; Prospective cohort study; Ovarian cancer; Cohort; Medicine; Cancer; Oncology; Cohort study; Gynecology; Internal medicine","score_opus":0.2989766636547487,"score_gpt":0.5522878446054476,"score_spread":0.2533111809506989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329400486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408663,0.0009568324,0.00009644518,0.006607099,0.00030625396,0.004347849,0.00007049544,0.000012199853,0.0035162142],"genre_scores_gemma":[0.99492383,0.00086836313,0.00003780441,0.00007661412,0.00053208775,0.0034193157,0.0000022674978,0.000023447641,0.000116242336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961855,0.0015709961,0.0004955962,0.00045626482,0.0009745615,0.0003170951],"domain_scores_gemma":[0.997099,0.0012992981,0.00011099042,0.00040218592,0.000994029,0.000094517374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015843226,0.000099406076,0.0002767276,0.00014255631,0.00008282897,0.000019189583,0.00015260982,0.000078019366,0.0003133885],"category_scores_gemma":[0.0013639417,0.000052381693,0.00014396009,0.00049121137,0.00024561147,0.000061974075,0.000037040503,0.00023108305,0.000014417597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009787771,0.00027844973,0.55240023,0.000027890579,0.00021953942,0.0000039479214,0.00019379327,0.0000013735216,0.0003315835,0.000068659,0.0004410742,0.44505465],"study_design_scores_gemma":[0.0075054765,0.0012094228,0.98731816,0.0003613744,0.00022162891,0.0000011579544,0.00009361104,0.00007604903,0.0013296286,0.0009822702,0.0008383244,0.000062881954],"about_ca_topic_score_codex":0.0017151496,"about_ca_topic_score_gemma":0.003080983,"teacher_disagreement_score":0.44499177,"about_ca_system_score_codex":0.0007575882,"about_ca_system_score_gemma":0.00071814697,"threshold_uncertainty_score":0.5490978},"labels":[],"label_agreement":null},{"id":"W2338520375","doi":"10.1158/1557-3265.ovcasymp14-poster-tech-1130","title":"Abstract POSTER-TECH-1130: Identification of putative genes involved in early steps of epithelial ovarian cancer pathogenesis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ovarian cancer; Transcription factor; Disease; Biology; Pathogenesis; Gene; Cancer; Chromatin immunoprecipitation; Biomarker; Cancer research; Bioinformatics; Medicine; Promoter; Gene expression; Immunology; Genetics; Internal medicine","score_opus":0.30147284438947997,"score_gpt":0.511912477007406,"score_spread":0.2104396326179261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338520375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915466,0.0037210973,0.000012200815,0.0025148944,0.00038610637,0.0010368489,0.0004483661,0.000013559787,0.00032036213],"genre_scores_gemma":[0.99492115,0.0038143012,0.0001419297,0.00005165285,0.0003499056,0.0005136192,0.000029074945,0.00003528389,0.00014306429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962307,0.00042118417,0.0013538765,0.0005657566,0.0010214638,0.00040698587],"domain_scores_gemma":[0.99684054,0.00069931085,0.0003683547,0.0005435983,0.0012156242,0.00033256854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037288987,0.0001690157,0.0006988164,0.00031763458,0.00003867011,0.000021514159,0.000243754,0.00022849516,0.00017360182],"category_scores_gemma":[0.0006335862,0.000140997,0.0001932606,0.0007445761,0.00047211442,0.00011907645,0.0001167967,0.0004406102,0.000025200568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022001027,0.0018386568,0.83125156,0.00027078664,0.00026172065,0.000043337037,0.00095341617,0.000051789313,0.011909351,0.00008469161,0.00023222037,0.15090239],"study_design_scores_gemma":[0.004510626,0.0010847726,0.9430868,0.00033496742,0.00008522313,5.7778584e-7,0.00033165904,0.000041907417,0.04948105,0.0004898261,0.0004397334,0.000112879454],"about_ca_topic_score_codex":0.013555102,"about_ca_topic_score_gemma":0.0024066642,"teacher_disagreement_score":0.15078951,"about_ca_system_score_codex":0.0004692441,"about_ca_system_score_gemma":0.0017901,"threshold_uncertainty_score":0.99301374},"labels":[],"label_agreement":null},{"id":"W2338707509","doi":"10.1158/1557-3265.pmsclingen15-pr03","title":"Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Markham Stouffville Hospital; Grand River Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Amplicon; Oncology; Clinical trial; Genotype; Molecular diagnostics; Genotyping; Molecular pathology; Response Evaluation Criteria in Solid Tumors; Bioinformatics; Gene; Genetics; Biology; Polymerase chain reaction; Phases of clinical research","score_opus":0.11951752050236168,"score_gpt":0.4952102138303327,"score_spread":0.375692693327971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338707509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208516,0.0038206365,0.00007461616,0.0022183964,0.0003126101,0.0010024017,0.00033318912,0.000009777223,0.00014323811],"genre_scores_gemma":[0.9875077,0.010833843,0.0005980721,0.00035137034,0.00024993735,0.00018281996,0.000023428835,0.000054931188,0.00019791465],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99575347,0.00065731717,0.0015585809,0.00088979426,0.0005368619,0.00060399843],"domain_scores_gemma":[0.9961243,0.0016248696,0.0005610264,0.00064472604,0.0006473024,0.00039774086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036877529,0.0002511157,0.00094780256,0.00005941039,0.00010162297,0.000028348488,0.00034285738,0.0002977415,0.00013733357],"category_scores_gemma":[0.0042605195,0.00015664136,0.00025711386,0.00012816378,0.0007474136,0.000008765611,0.00054000376,0.00034260252,0.0000062747763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005474107,0.00038997582,0.62708384,0.00015969906,0.00050524867,0.0000401625,0.000060734874,0.00016905658,0.22015864,0.0001166533,0.0013277805,0.14451411],"study_design_scores_gemma":[0.009936623,0.0027290334,0.32567027,0.00076099724,0.00013837875,0.0000043886635,0.00026371726,0.000028871495,0.62778234,0.00035865008,0.03149849,0.00082821515],"about_ca_topic_score_codex":0.00020326188,"about_ca_topic_score_gemma":0.00075961516,"teacher_disagreement_score":0.4076237,"about_ca_system_score_codex":0.00010307469,"about_ca_system_score_gemma":0.0009386107,"threshold_uncertainty_score":0.6387649},"labels":[],"label_agreement":null},{"id":"W2339497078","doi":"10.1158/1078-0432.ccr-15-2507","title":"Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Cancer Research UK","keywords":"Carcinoembryonic antigen; Medicine; Immunology; Vaccination; DNA vaccination; Adverse effect; Antigen; DNA; Virology; Cancer; Immunization; Biology; Internal medicine; Genetics","score_opus":0.09134343134888132,"score_gpt":0.43407437618502764,"score_spread":0.3427309448361463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339497078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98646367,0.006781855,0.00007441296,0.0048991037,0.0006607813,0.00073032355,0.000036473775,0.000085801046,0.0002676047],"genre_scores_gemma":[0.9799428,0.011326033,0.00013007982,0.0003968279,0.00015014809,0.00011843542,0.000016185346,0.000053461616,0.007866004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939867,0.0029197915,0.0009812546,0.00089855667,0.00023734983,0.00097630237],"domain_scores_gemma":[0.99266607,0.0057482203,0.00026960415,0.0007524397,0.00047834587,0.00008535319],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004804482,0.00033778822,0.0007991006,0.0002187114,0.00059479155,0.00001804033,0.0006004733,0.00056060555,0.0017522736],"category_scores_gemma":[0.0014905921,0.00017157628,0.00020020103,0.0003353134,0.0012651744,0.00020511812,0.00025602698,0.0015198268,0.0005036667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013173415,0.00041449026,0.9358946,0.0000178757,0.0010705953,0.00003146303,0.00007942853,0.0000024134545,0.0042176424,0.00012774898,0.000976004,0.043994345],"study_design_scores_gemma":[0.009060238,0.004899291,0.9507352,0.0002412066,0.000033876444,0.000018385748,0.00016749774,0.0000016453478,0.0029805123,0.00010869672,0.03142138,0.00033208198],"about_ca_topic_score_codex":0.00013733769,"about_ca_topic_score_gemma":0.000041556126,"teacher_disagreement_score":0.04366226,"about_ca_system_score_codex":0.00012579466,"about_ca_system_score_gemma":0.0006465969,"threshold_uncertainty_score":0.99916023},"labels":[],"label_agreement":null},{"id":"W2339885882","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1327","title":"Abstract POSTER-BIOL-1327: Small cell carcinoma of the ovary, hypercalcemic type displays frequent inactivating germline and somatic mutations in SMARCA4","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"SMARCA4; Biology; Germline; Exome sequencing; Germline mutation; Cancer research; Ovarian cancer; Small-cell carcinoma; Somatic cell; Mutation; Cancer; Carcinoma; Genetics; Chromatin remodeling; Epigenetics; Gene","score_opus":0.19202934675100566,"score_gpt":0.441347908459064,"score_spread":0.24931856170805836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339885882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594826,0.0019883,0.000014857887,0.00038620204,0.00017235479,0.00027419766,0.000023624094,0.000003740855,0.001188465],"genre_scores_gemma":[0.9990418,0.00024243351,0.00018534066,0.000082066545,0.00020051557,0.000032497588,0.000023795736,0.000020077508,0.00017147082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983644,0.00024645802,0.0005074727,0.00033842574,0.00025836407,0.00028490438],"domain_scores_gemma":[0.99886876,0.00020955212,0.000112732894,0.00039355014,0.00028047492,0.00013492437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013444752,0.000110852496,0.00020330939,0.00004797653,0.00006898095,0.000019083092,0.00027435244,0.00016865184,0.000022343858],"category_scores_gemma":[0.00068324007,0.00008207288,0.000072591036,0.00020084177,0.00028015743,0.000004915862,0.00026714342,0.0004458415,0.0000037529926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058052986,0.0004482043,0.45170528,0.00040538778,0.00003658436,0.000009065184,0.00050391664,0.00060196576,0.5315054,0.000022319316,0.001110476,0.013070889],"study_design_scores_gemma":[0.005304141,0.0014630454,0.7482311,0.0005434764,0.000047541427,0.000018929035,0.0014690078,0.0039080405,0.2359132,0.0011082928,0.0014499003,0.00054332276],"about_ca_topic_score_codex":0.0012768073,"about_ca_topic_score_gemma":0.00053068344,"teacher_disagreement_score":0.2965258,"about_ca_system_score_codex":0.00007687844,"about_ca_system_score_gemma":0.000688333,"threshold_uncertainty_score":0.3346835},"labels":[],"label_agreement":null},{"id":"W2340925103","doi":"10.1158/1557-3265.ovcasymp14-poster-ther-1415","title":"Abstract POSTER-THER-1415: Translational study of DPX-survivac peptide vaccine and metronomic cyclophosphamide using a novel HLA-A2/ survivin expressing ovarian tumor model to mimic phase I clinical data","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Dalhousie University; Immunovaccine (Canada)","funders":"","keywords":"Survivin; Ovarian cancer; Cancer research; Peptide vaccine; ELISPOT; Immune system; Immunology; Cytotoxic T cell; In vivo; Medicine; Cancer; Biology; T cell; Antigen; Internal medicine; In vitro; Epitope","score_opus":0.4938239212117624,"score_gpt":0.54292182611424,"score_spread":0.04909790490247762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340925103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018884,0.005914213,0.0008857563,0.00047803947,0.0006864351,0.0011347777,0.0005947125,0.000028485956,0.000088719375],"genre_scores_gemma":[0.9978772,0.00024378912,0.0011219858,0.0001534057,0.00016406558,0.000044804798,0.0001430445,0.00006435509,0.00018737755],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9934893,0.0021668011,0.0021275792,0.0011326175,0.0002953229,0.00078837253],"domain_scores_gemma":[0.9939057,0.0035847498,0.00036967781,0.0014550162,0.00048160218,0.00020320488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013753189,0.00033416692,0.001110456,0.0003212491,0.00031172464,0.00007190099,0.0012614038,0.00033395342,0.0004545506],"category_scores_gemma":[0.001917966,0.00029909535,0.0001638102,0.00039548194,0.00051262113,0.00038890808,0.0007763409,0.0014655177,0.00003563811],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11683314,0.02225798,0.15783761,0.00015743189,0.003448455,0.00003604888,0.005294307,0.0025126697,0.6006264,0.000054553275,0.005041391,0.085899994],"study_design_scores_gemma":[0.18471998,0.020016009,0.704348,0.0015399467,0.00093574246,0.0001471286,0.0128229065,0.017086156,0.023529897,0.0006779608,0.030934451,0.003241796],"about_ca_topic_score_codex":0.0037142797,"about_ca_topic_score_gemma":0.000644055,"teacher_disagreement_score":0.5770965,"about_ca_system_score_codex":0.000102253,"about_ca_system_score_gemma":0.0015144156,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W2343487664","doi":"","title":"The Kisspeptin and GPR54 ligand-receptor pair are associated with favorable prognosis and clear cell subtype in human ovarian carcinoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Kisspeptin; Biology; Ovarian carcinoma; Immunohistochemistry; Ovary; Tissue microarray; Cancer research; Internal medicine; Receptor; Ovarian cancer; Endocrinology; Oncology; Cancer; Medicine; Immunology; Genetics","score_opus":0.1264533606682524,"score_gpt":0.4374532210557041,"score_spread":0.3109998603874517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343487664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859325,0.0033076722,7.8044525e-7,0.008331977,0.000072355724,0.0010239771,0.000017853314,0.000026704683,0.0012861446],"genre_scores_gemma":[0.9965063,0.0014962113,0.000059673384,0.00023330726,0.0002583158,0.00017380908,0.000011295573,0.000041112846,0.0012199833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972442,0.00032404912,0.0005173053,0.0006036121,0.00058018946,0.0007306549],"domain_scores_gemma":[0.99707645,0.0017277487,0.00013361221,0.00033013485,0.00031637299,0.0004156581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048709763,0.00018001121,0.00045565647,0.0001210119,0.00041193422,0.00010782965,0.00012894846,0.00020868852,0.000093095725],"category_scores_gemma":[0.00046314686,0.00011325267,0.000060740793,0.00055750384,0.00062903506,0.000056723096,0.00012032021,0.0009438797,0.000011504866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012050649,0.00068405876,0.9855776,0.000064877466,0.00009023958,0.00012632784,0.00019543659,3.4309215e-7,0.00011076267,0.00009010481,0.0042090104,0.007646202],"study_design_scores_gemma":[0.0051250733,0.0024523162,0.9806046,0.0003987023,0.00005637771,0.0000025368463,0.00059362117,0.000017886803,0.0019923905,0.00006595808,0.008556017,0.00013454867],"about_ca_topic_score_codex":0.0020124884,"about_ca_topic_score_gemma":0.007635926,"teacher_disagreement_score":0.010573756,"about_ca_system_score_codex":0.00032264172,"about_ca_system_score_gemma":0.00035092726,"threshold_uncertainty_score":0.46183094},"labels":[],"label_agreement":null},{"id":"W2345499901","doi":"10.1158/1078-0432.ccr-15-2901","title":"Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Medical Research and Materiel Command; Canadian Institutes of Health Research","keywords":"Enzalutamide; Androgen receptor; Prostate cancer; Transactivation; LNCaP; Cancer research; In vivo; Biology; Mediator; Coactivator; Chemistry; Cancer; Transcription factor; Cell biology; Gene; Biochemistry; Genetics","score_opus":0.12729191842097548,"score_gpt":0.4604209835904444,"score_spread":0.33312906516946894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345499901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95897335,0.0012949712,0.0003376751,0.035227668,0.00028623102,0.0029604167,0.00016367876,0.00007407936,0.0006819344],"genre_scores_gemma":[0.9731711,0.0029748906,0.0008592063,0.0004047717,0.0005175627,0.002210475,0.000038763363,0.0000730492,0.01975015],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99559027,0.0004288965,0.000713423,0.00092276913,0.0013690949,0.00097555947],"domain_scores_gemma":[0.9970755,0.0008018051,0.00011700128,0.00045709932,0.0010062648,0.0005423501],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026995563,0.00023534858,0.00048801495,0.0003627836,0.00025393584,0.00006547633,0.0002031586,0.00018081079,0.0011951298],"category_scores_gemma":[0.000739537,0.00013990075,0.00008465392,0.0013097282,0.00030518352,0.00028606784,0.00010814706,0.00069434545,0.00011108614],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09608787,0.00097420125,0.22735316,0.0005709389,0.0004758428,0.0001645138,0.00091039774,0.00006082092,0.5849362,0.001183264,0.03041289,0.05686991],"study_design_scores_gemma":[0.043960776,0.0127135785,0.49768555,0.012398228,0.00017723725,0.000004914384,0.0020636264,0.00006253338,0.22859251,0.0055727246,0.19505619,0.0017121268],"about_ca_topic_score_codex":0.0010165138,"about_ca_topic_score_gemma":0.0024029317,"teacher_disagreement_score":0.3563437,"about_ca_system_score_codex":0.0013975713,"about_ca_system_score_gemma":0.0018762812,"threshold_uncertainty_score":0.9997179},"labels":[],"label_agreement":null},{"id":"W2346128427","doi":"10.1158/1078-0432.ccr-15-2488","title":"Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Calicheamicin; Medicine; Rituximab; Gastroenterology; Internal medicine; Neutropenia; Tolerability; Leukopenia; Lymphoma; Febrile neutropenia; Adverse effect; Chemotherapy","score_opus":0.16024338282444303,"score_gpt":0.5031085037615861,"score_spread":0.34286512093714305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346128427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375695,0.00036049806,0.000029118652,0.0013664863,0.00020734259,0.0032317166,0.00008229192,0.000032281318,0.000933321],"genre_scores_gemma":[0.9950095,0.0006278344,0.00014099557,0.00015176227,0.00034029878,0.0012273899,0.000014036377,0.00006109983,0.0024271018],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99639493,0.00034509934,0.00088909746,0.00075316813,0.0009791176,0.0006385693],"domain_scores_gemma":[0.99424964,0.0033386357,0.0002177586,0.0009216308,0.0008395215,0.00043281273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018146794,0.00024310502,0.00088461104,0.00021418609,0.00014053354,0.000018356397,0.0002876831,0.000190582,0.0002555977],"category_scores_gemma":[0.0005336778,0.0001330797,0.00021112431,0.00039120187,0.00047065777,0.00008866102,0.00014092139,0.00021626042,0.000060017752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069535606,0.11757798,0.41175786,0.00034458513,0.00093161804,0.0003409855,0.0006180587,9.773585e-7,0.0036401865,0.000077213226,0.026077151,0.3690978],"study_design_scores_gemma":[0.48840603,0.26546228,0.19229284,0.0011094868,0.0005768021,0.000007793114,0.0011238679,0.00007395344,0.030527737,0.00013392001,0.019854883,0.00043041186],"about_ca_topic_score_codex":0.0008078611,"about_ca_topic_score_gemma":0.00030566464,"teacher_disagreement_score":0.41887042,"about_ca_system_score_codex":0.0006614662,"about_ca_system_score_gemma":0.0013938985,"threshold_uncertainty_score":0.54268324},"labels":[],"label_agreement":null},{"id":"W2347062064","doi":"10.1158/1078-0432.ccr-15-3086","title":"Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Zoledronic acid; Denosumab; Bone remodeling; Internal medicine; N-terminal telopeptide; Cancer; Bone disease; Urology; Gastroenterology; Oncology; Osteoporosis; Endocrinology; Alkaline phosphatase; Osteocalcin","score_opus":0.18668600302445276,"score_gpt":0.5044671221239153,"score_spread":0.31778111909946255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2347062064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079025,0.0021365348,8.8365266e-7,0.0047177174,0.00007135591,0.001857825,0.00033963303,0.000021862852,0.000063944935],"genre_scores_gemma":[0.99161565,0.0056158095,0.00016729686,0.0005814698,0.000052887113,0.0003926685,0.000018962612,0.00005458679,0.0015006933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574697,0.0005965447,0.0009182761,0.0009881479,0.0008348791,0.00091517717],"domain_scores_gemma":[0.99662495,0.0016913088,0.00020414848,0.00041399972,0.00036798065,0.0006976037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018507885,0.00032287723,0.0013300013,0.00035079083,0.0000861592,0.000021798249,0.000077122815,0.00023299266,0.00020556191],"category_scores_gemma":[0.00071337813,0.00016825466,0.000064322805,0.00055259984,0.0009446258,0.00018142984,0.00014783368,0.00074846216,0.000008780215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016371198,0.0013306547,0.8423352,0.000083192266,0.00022305384,0.0003015205,0.00004010069,1.0261414e-7,0.000007745867,0.0000029589823,0.00017404708,0.13913019],"study_design_scores_gemma":[0.04038984,0.004385723,0.95269716,0.0011935284,0.00010625018,0.000004588584,0.000034612272,0.0000062087875,0.00004030732,0.000015214628,0.00092118443,0.00020538311],"about_ca_topic_score_codex":0.003228746,"about_ca_topic_score_gemma":0.028658066,"teacher_disagreement_score":0.1389248,"about_ca_system_score_codex":0.00029058103,"about_ca_system_score_gemma":0.00047016895,"threshold_uncertainty_score":0.9890664},"labels":[],"label_agreement":null},{"id":"W2368782122","doi":"10.1158/1078-0432.ccr-15-0414","title":"Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Cetuximab; KRAS; Internal medicine; Colorectal cancer; Medicine; Oncology; Hazard ratio; Progression-free survival; Cancer; Chemotherapy; Confidence interval","score_opus":0.2803279015445654,"score_gpt":0.525412478317876,"score_spread":0.24508457677331058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368782122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96953267,0.0088118715,5.9337526e-7,0.016345168,0.0005444224,0.0015130234,0.0001677905,0.000014784065,0.0030696946],"genre_scores_gemma":[0.95876634,0.037823733,0.00001810423,0.00025131932,0.00081184186,0.0008615897,0.0000052720966,0.000023825156,0.0014379557],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99657166,0.00077897054,0.00064785796,0.00051126507,0.00095214014,0.00053810887],"domain_scores_gemma":[0.99632746,0.0027706332,0.000115244926,0.0003319246,0.000296055,0.00015865386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003335549,0.00018618318,0.0007350623,0.00012996241,0.00014898236,0.000021353922,0.00025059326,0.00016337779,0.0011146792],"category_scores_gemma":[0.0007008979,0.00008878888,0.00017307802,0.00043956898,0.0012290684,0.000059208956,0.000120303455,0.000528491,0.000016232616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29348785,0.0017689535,0.33228293,0.000054500688,0.00046042737,0.000044084372,0.0010943321,1.4282215e-7,0.002722917,0.000149401,0.026038675,0.34189582],"study_design_scores_gemma":[0.15741913,0.017284889,0.7379293,0.00044503107,0.000077335,0.0000053279596,0.0007206021,0.0000061938545,0.0021247515,0.00024145385,0.08346506,0.00028094847],"about_ca_topic_score_codex":0.002778625,"about_ca_topic_score_gemma":0.002957681,"teacher_disagreement_score":0.40564635,"about_ca_system_score_codex":0.00027686663,"about_ca_system_score_gemma":0.00078955694,"threshold_uncertainty_score":0.9997984},"labels":[],"label_agreement":null},{"id":"W2388122605","doi":"10.1158/1078-0432.ccr-16-0381","title":"Testosterone in Androgen Receptor Signaling and DNA Repair: Enemy or <i>Frenemy</i>?","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Androgen receptor; Testosterone (patch); Androgen; Receptor; Signal transduction; Endocrinology; DNA repair; Internal medicine; Biology; DNA; Medicine; Cell biology; Genetics; Hormone; Cancer; Prostate cancer","score_opus":0.2828770154323315,"score_gpt":0.5202913688394077,"score_spread":0.23741435340707623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2388122605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97838175,0.007401997,0.000004228324,0.012151601,0.00015027676,0.0009506581,0.00004242429,0.00008189647,0.0008351803],"genre_scores_gemma":[0.9540366,0.02641096,0.00046326197,0.00037612813,0.0008308024,0.00045043865,0.00001117544,0.00006201411,0.017358653],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636114,0.0005195058,0.00064267113,0.00077833876,0.00082046504,0.0008778818],"domain_scores_gemma":[0.99636,0.002203698,0.000054255634,0.0004650745,0.00032794618,0.0005890182],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035432389,0.00017986493,0.0005358552,0.000283995,0.00013344253,0.00003325179,0.00018106718,0.00022808395,0.0015919473],"category_scores_gemma":[0.0015534712,0.00009588167,0.00013036543,0.0006355507,0.00088373723,0.00013083545,0.00027189904,0.0006642698,0.00012881726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011779535,0.0006996749,0.67270344,0.00033469245,0.00023293192,0.00052949495,0.00019834275,2.6792995e-7,0.05831023,0.000054852382,0.021308646,0.23384789],"study_design_scores_gemma":[0.066016175,0.016013991,0.20943148,0.008425959,0.00019367902,0.0001215573,0.0007707316,0.000104540304,0.16557573,0.0012809373,0.5308096,0.0012556514],"about_ca_topic_score_codex":0.00025767527,"about_ca_topic_score_gemma":0.00029925897,"teacher_disagreement_score":0.5095009,"about_ca_system_score_codex":0.00038199138,"about_ca_system_score_gemma":0.0011064339,"threshold_uncertainty_score":0.99932075},"labels":[],"label_agreement":null},{"id":"W2394766804","doi":"10.1158/1557-3265.ovca15-a33","title":"Abstract A33: Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Trichostatin A; Cancer research; Biology; Chromatin remodeling; Histone deacetylase; Chromatin; Histone; Genetics; Gene","score_opus":0.17639603994395195,"score_gpt":0.4095317544062311,"score_spread":0.23313571446227913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394766804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950659,0.0020123706,0.000020047504,0.0015947442,0.00018585252,0.00041547863,0.00038121955,0.000002744248,0.00032164366],"genre_scores_gemma":[0.99624133,0.002474112,0.00010347941,0.00017112882,0.00034732223,0.000019244384,0.000006953356,0.000021624508,0.00061481254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832565,0.00020083235,0.00043172386,0.0004485393,0.00028472816,0.00030852665],"domain_scores_gemma":[0.99815226,0.00055109506,0.0001428134,0.00053412217,0.00052164233,0.00009809227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091998174,0.00013670152,0.00026632138,0.000024513884,0.00013341177,0.000013428125,0.00027166927,0.00019650406,0.00003176297],"category_scores_gemma":[0.00025516617,0.0000734798,0.0001615422,0.00011219595,0.001225344,0.0000034265008,0.00040737883,0.00023326896,0.0000014036095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011224045,0.00013701414,0.059287008,0.00026901843,0.000070817434,0.0000020514549,0.000112344875,0.0000049351934,0.91186833,0.000064122985,0.011698576,0.015363348],"study_design_scores_gemma":[0.0022426373,0.000590101,0.4002526,0.00018454387,0.00003355118,0.000008991974,0.0001380736,0.00006985317,0.5816828,0.00031580133,0.0142964,0.00018463268],"about_ca_topic_score_codex":0.00036540665,"about_ca_topic_score_gemma":0.00016716954,"teacher_disagreement_score":0.34096563,"about_ca_system_score_codex":0.000030279642,"about_ca_system_score_gemma":0.00035475657,"threshold_uncertainty_score":0.4514831},"labels":[],"label_agreement":null},{"id":"W2394806078","doi":"10.1158/1557-3265.ovca15-a11","title":"Abstract A11: NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Loss of heterozygosity; PARP inhibitor; Ovarian cancer; Olaparib; Biology; Cancer research; Synthetic lethality; Single-nucleotide polymorphism; Cancer; Genetics; Genotype; DNA repair; Gene; Allele; Poly ADP ribose polymerase","score_opus":0.20544118528878735,"score_gpt":0.5203825821443089,"score_spread":0.3149413968555215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394806078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96303993,0.0011672036,0.00007289694,0.030084796,0.001699169,0.002243273,0.0011504185,0.000087044245,0.00045526944],"genre_scores_gemma":[0.98376936,0.0007443602,0.00027101874,0.0077498187,0.004788698,0.0017784876,0.00005126588,0.0001210471,0.0007259316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939996,0.00040797595,0.0013839345,0.0012367762,0.0017960216,0.0011756809],"domain_scores_gemma":[0.9932846,0.0030520242,0.00028814096,0.0012292963,0.0012744233,0.0008715308],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0032497756,0.00034945307,0.00073807937,0.00019049831,0.0004086194,0.00013868567,0.00077253074,0.00027746038,0.004501434],"category_scores_gemma":[0.001534211,0.00021227358,0.00033854588,0.00065007753,0.0006725979,0.00016991064,0.00027016576,0.0013456342,0.00083746575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064335004,0.0006832248,0.83069575,0.000102484344,0.00027670682,0.00004241616,0.00020638388,0.000033445718,0.049493708,0.00012615198,0.054508526,0.05739773],"study_design_scores_gemma":[0.00818752,0.00056839344,0.90361345,0.0018910422,0.00005573603,6.315067e-7,0.00004933702,0.000035236077,0.0365946,0.00075318204,0.047912586,0.00033826355],"about_ca_topic_score_codex":0.0036034165,"about_ca_topic_score_gemma":0.0010860395,"teacher_disagreement_score":0.07291775,"about_ca_system_score_codex":0.0011566898,"about_ca_system_score_gemma":0.0019563844,"threshold_uncertainty_score":0.9999405},"labels":[],"label_agreement":null},{"id":"W2394908773","doi":"10.1158/1557-3265.ovca15-b82","title":"Abstract B82: Application of modulated electro-hyperthermia for the cellular target therapy in ovarian cancer cells.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cancer research; Cancer cell; Cancer; Apoptosis; Hyperthermia; Medicine; Viability assay; Autophagy; PARP inhibitor; Chemistry; Internal medicine; Poly ADP ribose polymerase; Enzyme","score_opus":0.1456638070780321,"score_gpt":0.5015157636757647,"score_spread":0.3558519565977326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394908773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708931,0.0019391241,0.023389718,0.0024134791,0.00015567895,0.0010644677,0.000065366396,0.0000051878974,0.00007387834],"genre_scores_gemma":[0.9933108,0.004387393,0.000712838,0.00017781918,0.00045692164,0.0005227171,0.000014150178,0.000029673418,0.0003876613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832565,0.00033252273,0.00043255868,0.00040219913,0.00018059365,0.00032647917],"domain_scores_gemma":[0.99838156,0.00055759045,0.00012662301,0.00047374528,0.00040181566,0.000058682497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028304223,0.00010135798,0.00018754682,0.000049521626,0.0000686996,0.000010164637,0.0003950012,0.00023568595,0.00019363698],"category_scores_gemma":[0.00034149052,0.000060037204,0.000110498964,0.000222183,0.000243529,0.0000048309557,0.000058629346,0.00023112529,0.0000037692066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076157897,0.000088874454,0.0025957767,0.000013135572,0.000043632892,1.5765669e-7,0.000011604028,0.00007883583,0.9097478,0.00003608349,0.0013112738,0.085311286],"study_design_scores_gemma":[0.0011113875,0.0001824779,0.010521481,0.00001745245,0.0000029048945,7.157578e-8,0.0000072215844,0.00014806495,0.9314996,0.00045318776,0.055972528,0.00008364465],"about_ca_topic_score_codex":0.00082634384,"about_ca_topic_score_gemma":0.000155706,"teacher_disagreement_score":0.085227646,"about_ca_system_score_codex":0.000060223138,"about_ca_system_score_gemma":0.00033378418,"threshold_uncertainty_score":0.2448246},"labels":[],"label_agreement":null},{"id":"W2395110963","doi":"10.1158/1557-3265.pmsclingen15-02","title":"Abstract 02: Pan-cancer analysis of hotspot mutations in genes encoding the members of mitogen activated protein kinase (MAPK) and phosphoinosidtide-3 kinase (PI3K) pathways among smokers and non-smokers","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"KRAS; PTEN; Neuroblastoma RAS viral oncogene homolog; Medicine; Lung cancer; Cancer research; Oncology; CDKN2A; STK11; Internal medicine; Amplicon; PI3K/AKT/mTOR pathway; Cancer; Gene; Biology; Genetics; Colorectal cancer; Signal transduction","score_opus":0.11947682819167309,"score_gpt":0.46531219065385726,"score_spread":0.34583536246218416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395110963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350125,0.0030075687,0.0000066579646,0.0016018299,0.000080086305,0.0012794544,0.0002450227,0.000011945409,0.00026618422],"genre_scores_gemma":[0.9949832,0.0039977874,0.00006190072,0.00004185689,0.00005006324,0.0006033243,0.000017175716,0.000025663732,0.00021903252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974379,0.00021450692,0.00080253946,0.00053428876,0.00059575133,0.00041501442],"domain_scores_gemma":[0.9970912,0.0015318367,0.00027748835,0.00042760314,0.00045593592,0.00021593749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013499677,0.0001875575,0.00064688775,0.00047075562,0.00015250378,0.00002390774,0.00015853293,0.00015701813,0.00030787097],"category_scores_gemma":[0.00062386337,0.000110861365,0.00019410726,0.001384425,0.0012545048,0.00015988424,0.00010079125,0.00037729475,0.0000010468351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097346265,0.0003092186,0.7972529,0.00020953442,0.0020206284,0.00003833977,0.0015164288,0.000053157015,0.12043288,0.000044353867,0.0001102015,0.077038884],"study_design_scores_gemma":[0.0032072251,0.00027081254,0.89372283,0.0007040354,0.0008378502,4.3789532e-7,0.001261084,0.00013227774,0.09950402,0.00008302377,0.00015046171,0.00012597232],"about_ca_topic_score_codex":0.01865416,"about_ca_topic_score_gemma":0.004158077,"teacher_disagreement_score":0.0964699,"about_ca_system_score_codex":0.00027105582,"about_ca_system_score_gemma":0.00072099763,"threshold_uncertainty_score":0.9878807},"labels":[],"label_agreement":null},{"id":"W2396152701","doi":"10.1158/1557-3265.ovca15-ia06","title":"Abstract IA06: Regulation of BRCA1- and BRCA2-dependent DNA repair.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Olaparib; PALB2; Synthetic lethality; DNA repair; Cancer research; PARP inhibitor; Homologous recombination; Ovarian cancer; Cancer; DNA damage; Poly ADP ribose polymerase; BRCA2 Protein; Medicine; Biology; Polymerase; Mutation; DNA; Genetics; Gene; Germline mutation","score_opus":0.291583553690724,"score_gpt":0.5529012675953581,"score_spread":0.2613177139046341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396152701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98216736,0.0016150526,0.000053566848,0.009201571,0.00027607262,0.00052355934,0.000038592676,0.00006992907,0.006054307],"genre_scores_gemma":[0.9914963,0.003998658,0.00016315014,0.00024860507,0.00074286415,0.00008065887,0.0000030375911,0.000027894821,0.0032388037],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972381,0.00023957116,0.0007457297,0.0004941519,0.0009318782,0.0003505584],"domain_scores_gemma":[0.9970892,0.0013122923,0.00014199926,0.0005778479,0.00059075054,0.00028790513],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037818826,0.000106835425,0.00037336766,0.00014932704,0.00007272463,0.000010805888,0.00011852639,0.0001984259,0.0031057475],"category_scores_gemma":[0.0009920552,0.00007211127,0.00014946098,0.00022771019,0.0008166413,0.0001055587,0.00008564942,0.00041994642,0.000080465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066471645,0.0007317736,0.25047266,0.0005358389,0.00037221643,0.000053573083,0.0002245728,0.0000019361762,0.3402953,0.0022146697,0.057595298,0.34085497],"study_design_scores_gemma":[0.005989211,0.000774194,0.9098946,0.0009524918,0.000026309943,0.000012277738,0.000044746423,0.000019506586,0.047713194,0.0028677399,0.031570423,0.00013533857],"about_ca_topic_score_codex":0.0001608959,"about_ca_topic_score_gemma":0.000057770445,"teacher_disagreement_score":0.65942186,"about_ca_system_score_codex":0.00024738058,"about_ca_system_score_gemma":0.00047441846,"threshold_uncertainty_score":0.99780554},"labels":[],"label_agreement":null},{"id":"W2397394221","doi":"10.1158/1557-3265.ovca15-b51","title":"Abstract B51: Stress management: LKB1 controls growth and survival of dormant epithelial ovarian cancer spheroid cells.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Spheroid; Ovarian cancer; Biology; Cancer cell; Cancer research; Anoikis; Cell biology; Metastasis; Cancer; Cell culture; Genetics","score_opus":0.05861054569952125,"score_gpt":0.4069470954499852,"score_spread":0.34833654975046396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397394221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796698,0.00732549,0.00014870938,0.001223828,0.0067519234,0.0006609101,0.0009240585,0.000014539688,0.0032807367],"genre_scores_gemma":[0.9288519,0.058064,0.00006912542,0.00012053034,0.010868655,0.00014746217,0.000010987867,0.000037348946,0.0018299953],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973987,0.0002666849,0.0005898677,0.00065128924,0.00050237455,0.00059109495],"domain_scores_gemma":[0.99856734,0.00021211097,0.00014755191,0.00048440145,0.00030549275,0.0002831294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014115238,0.00018919307,0.000422765,0.000065079235,0.00009926154,0.000037506295,0.00041702643,0.00023779302,0.0003536873],"category_scores_gemma":[0.0001659642,0.00013456594,0.00016394795,0.0001306658,0.0006938388,0.000011664609,0.0003365767,0.00028460124,0.00001164715],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027528286,0.00028948148,0.021906542,0.00034433443,0.00044456538,0.000002524858,0.00004334934,0.000005946641,0.8241792,0.0010623714,0.016418891,0.13255002],"study_design_scores_gemma":[0.011066582,0.000579048,0.19103388,0.00036653178,0.000109264205,0.0000014132333,0.00015908251,0.0000066702723,0.2167549,0.0004994685,0.5788676,0.0005555609],"about_ca_topic_score_codex":0.0013845359,"about_ca_topic_score_gemma":0.0009998904,"teacher_disagreement_score":0.60742426,"about_ca_system_score_codex":0.000028628707,"about_ca_system_score_gemma":0.00023729807,"threshold_uncertainty_score":0.54874396},"labels":[],"label_agreement":null},{"id":"W2398137018","doi":"10.1158/1557-3265.ovca15-b72","title":"Abstract B72: Long-term survival and outcome update on patients (pts) with recurrent ovarian cancer who received Ipilimumab post GVAX vaccine.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ipilimumab; Medicine; Internal medicine; Ovarian cancer; Oncology; Cancer; Nivolumab; Cancer immunotherapy; Immunotherapy; Immunology","score_opus":0.15463686632635967,"score_gpt":0.48019858411441674,"score_spread":0.3255617177880571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398137018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781578,0.0013255227,0.0000043229275,0.017357735,0.001033407,0.0011359229,0.00025761625,0.00004943388,0.00067823794],"genre_scores_gemma":[0.98133326,0.015020779,0.000016588223,0.001028226,0.0007414777,0.00019886192,0.000038920276,0.00007427849,0.0015476173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559945,0.00037553016,0.000962415,0.0009874887,0.0012152146,0.0008599142],"domain_scores_gemma":[0.99653876,0.0010279114,0.0002225137,0.0007652547,0.00089601515,0.0005495497],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022663255,0.0003339691,0.0007622448,0.00021945775,0.00022398785,0.00007303149,0.00033106472,0.00026618852,0.0031065494],"category_scores_gemma":[0.0005238173,0.00018939721,0.00019040094,0.00040040625,0.00049440406,0.00016003191,0.00014608252,0.0010121702,0.00009413687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039588556,0.00047818586,0.61978894,0.00012398383,0.0002762336,0.000036419056,0.00003964997,1.3953321e-7,0.00039782087,0.000010582373,0.002233914,0.33702555],"study_design_scores_gemma":[0.019661821,0.003249132,0.9645742,0.0016331855,0.000062758205,0.000002615643,0.000025990537,0.0000018967951,0.00024990796,0.00001494998,0.01023358,0.00028992488],"about_ca_topic_score_codex":0.0012332977,"about_ca_topic_score_gemma":0.003646025,"teacher_disagreement_score":0.34478527,"about_ca_system_score_codex":0.0006271016,"about_ca_system_score_gemma":0.00068324467,"threshold_uncertainty_score":0.99780476},"labels":[],"label_agreement":null},{"id":"W2398467218","doi":"10.1158/1557-3265.ovca15-b27","title":"Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Biology; Single-nucleotide polymorphism; Small GTPase; Ovarian cancer; Gene; GTPase; Cancer; Cancer research; Rab; Ras superfamily; Odds ratio; Carcinogenesis; Genetics; Bioinformatics; Internal medicine; Oncology; Signal transduction; Genotype; Medicine; GTP'","score_opus":0.32991778770584873,"score_gpt":0.5111181086346965,"score_spread":0.1812003209288478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398467218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709115,0.0024718924,0.000008583097,0.024718367,0.00034500187,0.00067944947,0.00013029473,0.000018499988,0.0007164259],"genre_scores_gemma":[0.9857414,0.011798715,0.0002627195,0.00029388416,0.000908173,0.0005006159,0.0000070431893,0.000029687286,0.00045779021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732655,0.00025932063,0.00082398,0.0005410045,0.0005727123,0.00047644056],"domain_scores_gemma":[0.99736553,0.0012229162,0.0001445633,0.00048115297,0.0004145774,0.00037125935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002268116,0.00014631613,0.0005030701,0.00021366977,0.000052321026,0.0000141774335,0.0001837961,0.0002025817,0.0015089202],"category_scores_gemma":[0.00057076715,0.000093768394,0.00015502301,0.00045106988,0.0005453702,0.000072076444,0.000086484644,0.00041334584,0.000065458735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087655487,0.0003403778,0.738581,0.00013630145,0.00009872597,0.00007310157,0.00007497546,0.0000037400437,0.0076518655,0.00026990724,0.0013600508,0.25053343],"study_design_scores_gemma":[0.0058632987,0.0005242587,0.95832556,0.0012103479,0.000041774532,0.0000013914567,0.000024290493,0.000012909893,0.026958328,0.00089149154,0.0060357493,0.000110623805],"about_ca_topic_score_codex":0.0082817,"about_ca_topic_score_gemma":0.0045660282,"teacher_disagreement_score":0.2504228,"about_ca_system_score_codex":0.000476726,"about_ca_system_score_gemma":0.0016903515,"threshold_uncertainty_score":0.99940383},"labels":[],"label_agreement":null},{"id":"W2398536625","doi":"10.1158/1557-3265.ovca15-a27","title":"Abstract A27: Transcriptome analyses of human ampulla and fimbriae highlight similarities and differences.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transcriptome; Fallopian tube; Biology; Ampulla; Serous fluid; Andrology; Oviduct; Genetics; Gene; Gene expression; Medicine; Endocrinology; Anatomy","score_opus":0.4691759364194461,"score_gpt":0.5744284520348472,"score_spread":0.10525251561540105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398536625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98049015,0.00687047,0.000002881944,0.010960418,0.00009638933,0.00030918114,0.00008235061,0.000016004733,0.0011721762],"genre_scores_gemma":[0.97871566,0.019987186,0.00003759123,0.00012512438,0.00026129276,0.00007768761,0.0000033092238,0.000016650547,0.0007754705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802434,0.00013933035,0.0005371296,0.00046780318,0.00049691735,0.00033447944],"domain_scores_gemma":[0.99786866,0.0012034692,0.00007440217,0.00030742225,0.00023250534,0.00031355955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008747209,0.0001402041,0.00059718615,0.0001449773,0.0001112372,0.000031143252,0.000099213925,0.00014022904,0.0009395365],"category_scores_gemma":[0.00019365642,0.00007951048,0.000116695046,0.000154778,0.001077159,0.00006876803,0.000064254935,0.0002700595,0.0000047360504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005412473,0.00061393145,0.9209769,0.00051927456,0.00049855054,0.0000654715,0.00016191747,3.427235e-8,0.02126765,0.0010304967,0.004597027,0.049727492],"study_design_scores_gemma":[0.0034075729,0.0010208016,0.98567766,0.0007064678,0.00012234125,0.0000024775118,0.00006318186,0.0000013658845,0.005641479,0.00077814836,0.0024812014,0.00009732378],"about_ca_topic_score_codex":0.0010415982,"about_ca_topic_score_gemma":0.00030438698,"teacher_disagreement_score":0.06470073,"about_ca_system_score_codex":0.00006908596,"about_ca_system_score_gemma":0.00018214491,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W2398537820","doi":"10.1158/1557-3265.ovca15-b20","title":"Abstract B20: Uptake and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salpingectomy; Tubal ligation; Hysterectomy; Fallopian tube; Perioperative; Ovarian cancer; Odds ratio; Obstetrics; Gynecology; Blood transfusion; Surgery; Cancer; Population; Family planning; Internal medicine; Pregnancy","score_opus":0.24702994200356687,"score_gpt":0.5268873059424586,"score_spread":0.2798573639388917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398537820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655293,0.0012305258,0.000043656335,0.031000197,0.00015967623,0.0016401409,0.0001567804,0.000010362062,0.00022934176],"genre_scores_gemma":[0.9836231,0.014383973,0.00012020582,0.0003770963,0.0003068084,0.00083588564,0.000030421093,0.00001989079,0.0003026374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799246,0.00022209022,0.0006322796,0.00037655132,0.00040036853,0.00037622981],"domain_scores_gemma":[0.99739164,0.0017971118,0.00010683141,0.00032829904,0.00024539552,0.00013071545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003076196,0.00011261776,0.0003514876,0.00016602047,0.000074651434,0.000020074984,0.00013601723,0.000118794625,0.00038902232],"category_scores_gemma":[0.00033966292,0.000057394056,0.000116848016,0.0003945995,0.0002997452,0.00006012152,0.000046294026,0.00029215074,0.0000039542197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00669869,0.0010265436,0.5865796,0.0004058998,0.00038478948,0.000035729245,0.0005771472,0.000014108212,0.00029797349,0.0008674954,0.0070379185,0.39607406],"study_design_scores_gemma":[0.008769164,0.00087129045,0.9215968,0.0010368865,0.00006006209,0.0000016435583,0.000086396816,0.000057665442,0.0002620132,0.0012446686,0.0659381,0.00007530822],"about_ca_topic_score_codex":0.0034004017,"about_ca_topic_score_gemma":0.0016855916,"teacher_disagreement_score":0.39599875,"about_ca_system_score_codex":0.0002876748,"about_ca_system_score_gemma":0.0005697339,"threshold_uncertainty_score":0.5140413},"labels":[],"label_agreement":null},{"id":"W2398570616","doi":"10.1158/1078-0432.ccr-16-0506","title":"A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Cancer Research UK","keywords":"Glioblastoma; Temozolomide; Immunogenicity; Medicine; Adjuvant; Cancer; Oncology; Clinical trial; Chemoradiotherapy; Internal medicine; Antigen; Cancer research; Immunology","score_opus":0.10926358659076571,"score_gpt":0.46764253870010813,"score_spread":0.35837895210934245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398570616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342424,0.0029243645,0.0000066943026,0.0010651049,0.00030013654,0.0020578739,0.00012170535,0.000020690364,0.00007921499],"genre_scores_gemma":[0.9941453,0.0015449412,0.000009812501,0.000059502512,0.000100817364,0.0008392883,0.000014791213,0.00005633288,0.0032292386],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993177,0.0030340657,0.0013240752,0.00076963316,0.00040710784,0.0012881423],"domain_scores_gemma":[0.9909185,0.007253884,0.00021734592,0.0008154615,0.00072606496,0.00006873534],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0064103524,0.00027653252,0.00086272886,0.0008758966,0.00028661778,0.000025099695,0.00088687235,0.0005057383,0.003271201],"category_scores_gemma":[0.0014763594,0.00017811444,0.00016722076,0.001173188,0.0013370398,0.00016661083,0.0002706656,0.0016726374,0.00016604933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5779637,0.0072804242,0.12964153,0.000041599844,0.0003343003,0.000016293829,0.000582255,0.0000058224573,0.22218569,0.000042329062,0.0021501987,0.059755865],"study_design_scores_gemma":[0.55120987,0.02113511,0.36801246,0.0015364647,0.000021218044,0.0000011668229,0.00013354902,0.000005073237,0.040029038,0.0001049003,0.017359061,0.00045209282],"about_ca_topic_score_codex":0.005409571,"about_ca_topic_score_gemma":0.005710073,"teacher_disagreement_score":0.23837091,"about_ca_system_score_codex":0.0004351894,"about_ca_system_score_gemma":0.0009193739,"threshold_uncertainty_score":0.99763995},"labels":[],"label_agreement":null},{"id":"W2400235072","doi":"10.1158/1557-3265.ovca15-a01","title":"Abstract A01: A comparison of the mechanisms and cytotoxic activity of dianhydrogalactitol (VAL-083) to cisplatin in ovarian tumor models harboring wild-type and mutant p53.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Carboplatin; Cisplatin; Ovarian cancer; DNA damage; Cancer research; Medicine; Serous carcinoma; Ovarian carcinoma; Oncology; Mutant; Cancer; Internal medicine; Pharmacology; Biology; Chemotherapy; DNA; Genetics; Gene","score_opus":0.19226069816223063,"score_gpt":0.4747115077011167,"score_spread":0.28245080953888607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400235072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958943,0.00026875583,0.0004333276,0.001891372,0.00016952549,0.0010234434,0.00003232982,0.000010374161,0.00027658098],"genre_scores_gemma":[0.9992197,0.00029073193,0.00024904285,0.000050176186,0.00006851046,0.00005834968,3.9743955e-7,0.00003080956,0.000032281485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973989,0.00028004506,0.00066205335,0.0004975636,0.0007447231,0.00041670946],"domain_scores_gemma":[0.99779683,0.0008903522,0.00018368999,0.00055519195,0.00027948307,0.00029442017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021416878,0.00014928996,0.0006423613,0.00020840751,0.0000615468,0.000012730517,0.00019059546,0.00017613548,0.00006070618],"category_scores_gemma":[0.0016143322,0.00009627934,0.00008351068,0.00068842556,0.00038521763,0.00009478393,0.00030555035,0.00084271753,0.0000035086177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027025484,0.00035099642,0.023563597,0.00020645524,0.00007487083,0.000034042543,0.0003906553,0.000101540965,0.9521787,0.0003897516,0.000061696075,0.019945147],"study_design_scores_gemma":[0.0055869534,0.0015843502,0.3297427,0.0027670895,0.00007341823,0.000013621768,0.00014344433,0.0035240625,0.65471774,0.001414347,0.00019823718,0.0002340714],"about_ca_topic_score_codex":0.0015794429,"about_ca_topic_score_gemma":0.0010920241,"teacher_disagreement_score":0.30617908,"about_ca_system_score_codex":0.00021455737,"about_ca_system_score_gemma":0.0007374929,"threshold_uncertainty_score":0.39261577},"labels":[],"label_agreement":null},{"id":"W2400789541","doi":"10.1158/1557-3265.ovca15-b21","title":"Abstract B21: <i>BRCA</i> mutation status is not associated with better long-term survival from epithelial ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; BRCA mutation; Oncology; Cancer registry; Population; Mutation; Internal medicine; Disease; Cohort; Medical record; Gynecology; Genetics; Biology; Gene","score_opus":0.18987173276025182,"score_gpt":0.4788354603427074,"score_spread":0.2889637275824556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400789541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957836,0.00070335105,0.00003251891,0.03666318,0.0008179009,0.0008993614,0.0021304225,0.000071085,0.0008462338],"genre_scores_gemma":[0.98970574,0.0040486655,0.00007896461,0.0022405887,0.0020941966,0.00055622385,0.00013519362,0.00008830903,0.0010521165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949939,0.00040894706,0.0008130045,0.0010773242,0.0016280648,0.0010787126],"domain_scores_gemma":[0.9945856,0.0029173284,0.0002489672,0.0007181331,0.00081022026,0.00071977347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015116353,0.00031462865,0.000775578,0.00012877559,0.00020749666,0.000096411306,0.00024530475,0.0003434318,0.007797742],"category_scores_gemma":[0.00058912236,0.00019105701,0.00023887637,0.00041387184,0.0005653706,0.00018506224,0.00010728255,0.00085456646,0.00029655537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028393539,0.0007950535,0.8089692,0.000034319808,0.0010629377,0.0004498244,0.00012885605,8.1304796e-7,0.0008561022,0.000016206683,0.004885875,0.17996144],"study_design_scores_gemma":[0.0135198105,0.0009756467,0.973251,0.0012213971,0.0002604224,0.0000014411438,0.000018976998,0.000005467769,0.006243765,0.00012730637,0.0041114218,0.00026333545],"about_ca_topic_score_codex":0.010795351,"about_ca_topic_score_gemma":0.0076195067,"teacher_disagreement_score":0.1796981,"about_ca_system_score_codex":0.0012632575,"about_ca_system_score_gemma":0.0018168605,"threshold_uncertainty_score":0.99579185},"labels":[],"label_agreement":null},{"id":"W2401633919","doi":"10.1158/1557-3265.ovca15-a82","title":"Abstract A82: Ovarian cancer cells hijack immune functions of omental milky spots for metastatic colonization.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Biology; Ovarian cancer; Pathology; Immune system; Stromal cell; Peritoneal cavity; Homing (biology); Immunology; Cancer research; Cancer; Medicine; Anatomy","score_opus":0.20531678017353266,"score_gpt":0.4956104931747954,"score_spread":0.2902937130012627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401633919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841266,0.0015585177,0.00013512251,0.0101528,0.0009827091,0.0013568695,0.0007696813,0.00003082599,0.000886857],"genre_scores_gemma":[0.98823327,0.0016050169,0.00030487406,0.0002332479,0.0006388085,0.0004904055,0.000027105742,0.00003460897,0.008432691],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99757016,0.000112952446,0.0008097166,0.00038928085,0.0005785436,0.0005393359],"domain_scores_gemma":[0.9971923,0.0013501798,0.00015316493,0.00031203867,0.00074376573,0.00024854945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001543064,0.00013944317,0.00050422613,0.0001249727,0.0001840937,0.000017010234,0.00018887958,0.0001183113,0.004292307],"category_scores_gemma":[0.000403905,0.00008974763,0.00023309443,0.00037472937,0.0006683289,0.00009469681,0.00007789354,0.0003193425,0.0001185833],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008375273,0.0023747808,0.024385797,0.0016638422,0.0010107268,0.00007843828,0.00033431515,0.000025644731,0.7847716,0.0019567234,0.05893265,0.11609017],"study_design_scores_gemma":[0.016640212,0.003839332,0.4855643,0.0026024438,0.00047057285,0.000015789008,0.0007970417,0.00014201716,0.28944004,0.0011454937,0.19876947,0.0005733116],"about_ca_topic_score_codex":0.0010589313,"about_ca_topic_score_gemma":0.00017100832,"teacher_disagreement_score":0.49533162,"about_ca_system_score_codex":0.00019927819,"about_ca_system_score_gemma":0.0008339789,"threshold_uncertainty_score":0.9966179},"labels":[],"label_agreement":null},{"id":"W2401783873","doi":"10.1158/1078-0432.ccr-16-0143","title":"Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncolytic virus; Sunitinib; Immune system; Cancer research; Medicine; Immunotherapy; Renal cell carcinoma; Chemokine; Immunology; Oncology","score_opus":0.25016306034826696,"score_gpt":0.5153506754140655,"score_spread":0.2651876150657986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401783873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081206,0.0035701431,0.00065189495,0.00063865306,0.00008330137,0.0011720028,0.0001875731,0.000014184221,0.0028701841],"genre_scores_gemma":[0.98880965,0.0016086401,0.00026284647,0.00019549206,0.0006083698,0.0007687148,0.000036114758,0.000064482105,0.007645707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971884,0.00024364104,0.00040118376,0.00077119377,0.0005228218,0.0008727633],"domain_scores_gemma":[0.99789166,0.00043623618,0.00009543076,0.0006800905,0.0005635273,0.00033303822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013341621,0.00019484233,0.00026588663,0.00008918042,0.00024921322,0.00007663214,0.00041323173,0.00020223681,0.00016741113],"category_scores_gemma":[0.00026396566,0.00012468648,0.00017298492,0.00021225524,0.0005805878,0.00001110705,0.00015707247,0.00030668694,0.00003917819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017666724,0.0009074676,0.011705755,0.00010136753,0.00034377462,0.000056407804,0.00003577496,0.000009339315,0.76587397,0.00016361005,0.0037719829,0.19936381],"study_design_scores_gemma":[0.021315938,0.021173578,0.008004225,0.00026341114,0.00007495821,0.000039081737,0.000112250236,0.00002366396,0.68981427,0.0006783554,0.25790963,0.00059065537],"about_ca_topic_score_codex":0.0014017501,"about_ca_topic_score_gemma":0.0012109037,"teacher_disagreement_score":0.25413764,"about_ca_system_score_codex":0.00017994404,"about_ca_system_score_gemma":0.0020930648,"threshold_uncertainty_score":0.50845677},"labels":[],"label_agreement":null},{"id":"W2402661058","doi":"10.1158/1078-0432.ccr-15-1790","title":"The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute; Wellcome Trust","keywords":"Multiple myeloma; Epigenetics; Medicine; Genetics; Biology; Cancer research; Oncology; Computational biology; Internal medicine; Gene","score_opus":0.26439112371027307,"score_gpt":0.5900468396188847,"score_spread":0.32565571590861164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402661058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014884,0.0014391601,0.000021490965,0.006785415,0.000080727674,0.0007381708,0.000036669197,0.000008735832,0.0007407958],"genre_scores_gemma":[0.98684835,0.011231695,0.00005731482,0.000019883639,0.00023100393,0.00009958946,0.0000028491654,0.00001831864,0.0014909781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651,0.0009201986,0.0008284044,0.000407848,0.0006820667,0.00065146066],"domain_scores_gemma":[0.9907172,0.007886841,0.000075491895,0.00052920246,0.00027600664,0.0005152614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044904193,0.000109835375,0.00040650347,0.00015693303,0.00013059677,0.000022124495,0.00019957022,0.00014535974,0.00031986524],"category_scores_gemma":[0.005409927,0.00004981627,0.00024603325,0.00039553075,0.0017481842,0.000047886468,0.00016962638,0.00063491194,0.000070817274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015736369,0.00031331662,0.75746834,0.000012915501,0.00016480383,0.00005165074,0.000017979532,5.7251367e-7,0.00015181069,0.000085523025,0.0004283691,0.23973106],"study_design_scores_gemma":[0.0050149714,0.0020287079,0.9897846,0.00013972317,0.0000181886,0.0000050390536,0.000028054184,0.00023106232,0.00024044495,0.001902157,0.0005522694,0.000054771837],"about_ca_topic_score_codex":0.001286084,"about_ca_topic_score_gemma":0.0014018143,"teacher_disagreement_score":0.2396763,"about_ca_system_score_codex":0.00021228901,"about_ca_system_score_gemma":0.001100142,"threshold_uncertainty_score":0.6476579},"labels":[],"label_agreement":null},{"id":"W2403126261","doi":"10.1158/1557-3265.ovca15-a65","title":"Abstract A65: Nodal contributes to cisplatin resistance in ovarian cancer cells.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cisplatin; Clonogenic assay; Ovarian cancer; Stem cell; Cancer stem cell; Biology; NODAL; Cancer research; Metastasis; Stem cell marker; Cell growth; Cell culture; Molecular biology; Cancer; Cell biology; Chemotherapy; Anatomy","score_opus":0.172899734597248,"score_gpt":0.516692959167029,"score_spread":0.34379322456978095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403126261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8871327,0.018718777,0.0008049189,0.08899993,0.0015881145,0.0010044463,0.000089607376,0.000059907223,0.0016016127],"genre_scores_gemma":[0.9645278,0.0016884211,0.00039648992,0.00029184594,0.0015369003,0.00027797004,0.0000031186717,0.00003794997,0.031239508],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99725914,0.00016988105,0.000662646,0.0005644377,0.0006384766,0.00070539326],"domain_scores_gemma":[0.9973009,0.001330918,0.00004881515,0.000431914,0.00040601083,0.00048144627],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027598888,0.00016584463,0.00056222186,0.00027625205,0.000076898184,0.000016631833,0.00021167373,0.00019715514,0.0011045716],"category_scores_gemma":[0.001914653,0.00010033265,0.00008686273,0.00070827344,0.00035260222,0.00004230599,0.00008389004,0.00087038265,0.00016651122],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036098955,0.0005472224,0.2408627,0.00043322917,0.00022020799,0.000632816,0.0003594846,0.00008472642,0.4710839,0.0025470639,0.2051772,0.07444157],"study_design_scores_gemma":[0.005676346,0.00028244682,0.7089543,0.0028022288,0.000018992596,0.000001088403,0.000037160935,0.000016247252,0.029468635,0.00015200749,0.2524023,0.00018829611],"about_ca_topic_score_codex":0.0007225343,"about_ca_topic_score_gemma":0.0023361368,"teacher_disagreement_score":0.46809158,"about_ca_system_score_codex":0.0004357109,"about_ca_system_score_gemma":0.0005687627,"threshold_uncertainty_score":0.99980855},"labels":[],"label_agreement":null},{"id":"W2403652567","doi":"10.1158/1557-3265.ovca15-ia15","title":"Abstract IA15: Rarer, yet both interesting and relevant: Other ovarian cancers.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation","funders":"","keywords":"Ovarian cancer; Serous fluid; Medicine; Cancer; Germ cell tumors; Serous carcinoma; Oncology; Ovarian carcinoma; Gynecology; Pathology; Internal medicine; Cancer research; Chemotherapy","score_opus":0.3079086064732586,"score_gpt":0.5336703794071166,"score_spread":0.22576177293385802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403652567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.897036,0.0034153094,0.000027875727,0.072360754,0.0009586761,0.0011359829,0.00013842431,0.000104262734,0.024822721],"genre_scores_gemma":[0.98919874,0.005176323,0.00024698878,0.002192588,0.0008708876,0.0002263237,0.0000019381441,0.000056386372,0.002029795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973027,0.00018221785,0.0005428785,0.00074984954,0.0006072109,0.0006151233],"domain_scores_gemma":[0.9953117,0.0033100403,0.00009639092,0.0005758977,0.00020118803,0.0005048291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018287657,0.00018832281,0.0004520095,0.00013993279,0.00014974651,0.00005147154,0.00016296687,0.00018060322,0.0027390239],"category_scores_gemma":[0.0015923796,0.00011116407,0.00013372477,0.0002263767,0.00041840243,0.000079521546,0.00012077967,0.0006366752,0.00022771921],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002548766,0.000462143,0.3272792,0.0001320305,0.0003344464,0.00026617822,0.00010868426,7.3363645e-7,0.0004282777,0.0015976116,0.065257184,0.60158473],"study_design_scores_gemma":[0.009376866,0.0029624728,0.70871335,0.0039655236,0.000079077814,0.000014876669,0.00007234404,0.000021496793,0.0016551175,0.0013142958,0.27153766,0.0002868953],"about_ca_topic_score_codex":0.0020540385,"about_ca_topic_score_gemma":0.00061935163,"teacher_disagreement_score":0.60129786,"about_ca_system_score_codex":0.00058506825,"about_ca_system_score_gemma":0.0007362475,"threshold_uncertainty_score":0.9981726},"labels":[],"label_agreement":null},{"id":"W2403913515","doi":"10.1158/1557-3265.ovca15-b13","title":"Abstract B13: Discovery of novel subtype-specific ovarian cancer biomarkers via integrated tissue proteomics.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Serous fluid; Biomarker discovery; Clear cell; Ovarian cancer; Serous ovarian cancer; Proteomics; Biomarker; Serous Cystadenoma; Endometriosis; Proteome; Cancer; Clear cell carcinoma; Computational biology; Medicine; Bioinformatics; Cancer research; Biology; Carcinoma; Pathology; Internal medicine; Gene","score_opus":0.11385020745931351,"score_gpt":0.43932762014833027,"score_spread":0.32547741268901675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403913515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713011,0.008900951,0.0059478385,0.0018739436,0.009062776,0.0011086991,0.0008620159,0.000022635308,0.0009200649],"genre_scores_gemma":[0.9590595,0.02219791,0.0006084095,0.00012172794,0.013550518,0.00036403426,0.000056350014,0.00007299506,0.00396856],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971167,0.00021259139,0.000753492,0.0008064822,0.000474983,0.00063576363],"domain_scores_gemma":[0.9979912,0.00019573288,0.00020466332,0.0007592061,0.0006050741,0.00024413408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019810514,0.00022470149,0.00043412458,0.000121116565,0.0000961396,0.0000440651,0.0005789778,0.00043074827,0.0004590252],"category_scores_gemma":[0.00051321374,0.00015587136,0.00021348147,0.00034385355,0.0009530224,0.00002143822,0.0002485856,0.0004408832,0.000024200675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016864346,0.00023417504,0.0043243878,0.000044997745,0.00015485847,3.7891917e-7,0.000016442129,0.000002940437,0.8542383,0.00009264753,0.044448305,0.09475614],"study_design_scores_gemma":[0.0028042987,0.0003646049,0.038447727,0.00018868259,0.000018031371,0.0000019446927,0.000039618113,0.000004959289,0.2913395,0.00007855175,0.66642565,0.00028645768],"about_ca_topic_score_codex":0.002926351,"about_ca_topic_score_gemma":0.001620907,"teacher_disagreement_score":0.6219773,"about_ca_system_score_codex":0.00011145803,"about_ca_system_score_gemma":0.0011889098,"threshold_uncertainty_score":0.63562495},"labels":[],"label_agreement":null},{"id":"W2405826784","doi":"10.1158/1557-3265.pmsclingen15-pr02","title":"Abstract PR02: Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral and Maxillofacial Pathology","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; PTEN; Loss of heterozygosity; Copy-number variation; Comparative genomic hybridization; Cancer; Genome; Genetics; CDKN2A; Gene; Cancer research; Bioinformatics; Allele","score_opus":0.24833284982520185,"score_gpt":0.5041195481080826,"score_spread":0.2557866982828807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405826784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946178,0.0014687662,0.000029745042,0.00036699686,0.0007504915,0.00029329225,0.0005578293,0.000029403935,0.0018856263],"genre_scores_gemma":[0.99526745,0.0008299905,0.00003218636,0.000043839762,0.00021808255,0.00005718973,0.000025017769,0.000023495606,0.003502742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652016,0.0005498164,0.0010371561,0.00068063196,0.0005767107,0.00063551625],"domain_scores_gemma":[0.99733263,0.00083385396,0.00022929511,0.0006848025,0.0006278615,0.0002915504],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0026194311,0.00016885264,0.0007110737,0.00043436693,0.00008949464,0.00002619523,0.00062932743,0.00029986355,0.005742417],"category_scores_gemma":[0.00081343245,0.00010812538,0.00057314016,0.0012272818,0.0006915697,0.000078022094,0.00031527478,0.0006771366,0.00085541944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001294466,0.0005396344,0.75792044,0.000073262876,0.00051537517,0.00016914317,0.00007455556,0.000003149961,0.080148436,0.00013131638,0.0048527336,0.15427749],"study_design_scores_gemma":[0.0010728944,0.00035214052,0.9748735,0.0000356127,0.0002356619,0.0000014636718,0.000060687762,0.000024026722,0.0044855606,0.00015914108,0.01853699,0.00016236174],"about_ca_topic_score_codex":0.003369818,"about_ca_topic_score_gemma":0.004482889,"teacher_disagreement_score":0.21695301,"about_ca_system_score_codex":0.00023126896,"about_ca_system_score_gemma":0.00049373484,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W2406092735","doi":"10.1158/1557-3265.ovca15-b54","title":"Abstract B54: Single and collective cell dissemination modes in ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Ovarian cancer; Cancer research; Ascites; Spheroid; Cancer cell; Cancer; Biology; In vivo; Peritoneal cavity; Pathology; In vitro; Medicine; Internal medicine; Anatomy","score_opus":0.253045088764766,"score_gpt":0.5389415179272586,"score_spread":0.28589642916249264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406092735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97522134,0.003799931,0.00004359076,0.0072542815,0.00019046101,0.00061791117,0.000076544966,0.000015842943,0.012780079],"genre_scores_gemma":[0.9804937,0.008621956,0.000107615364,0.000103826496,0.0003880275,0.0002161699,0.0000027580904,0.000024555095,0.010041347],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99800265,0.00015741496,0.00042514145,0.00049652875,0.0004772109,0.00044105263],"domain_scores_gemma":[0.99772257,0.0013553326,0.00006831686,0.00024470236,0.00032043835,0.00028862272],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017893908,0.000114206974,0.00035674655,0.00018979146,0.00008452868,0.000029137933,0.000098503384,0.00014433872,0.0010576292],"category_scores_gemma":[0.0006416023,0.00007725861,0.000075502605,0.00047367215,0.00036302872,0.000097468714,0.000085870284,0.00045916328,0.000017884615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030099628,0.0010408385,0.1429352,0.00032245537,0.00006953863,0.00008085701,0.0004657635,0.0000036750012,0.24770236,0.00007413024,0.02064742,0.5836478],"study_design_scores_gemma":[0.008688667,0.0012295077,0.81470144,0.0019444624,0.00007282597,0.0000046852742,0.00053858047,0.000058657584,0.14827262,0.0013389677,0.022800062,0.00034950266],"about_ca_topic_score_codex":0.0020206438,"about_ca_topic_score_gemma":0.0021934395,"teacher_disagreement_score":0.6717663,"about_ca_system_score_codex":0.00070010393,"about_ca_system_score_gemma":0.0008482047,"threshold_uncertainty_score":0.9998555},"labels":[],"label_agreement":null},{"id":"W2407048108","doi":"10.1158/1557-3265.ovca15-a35","title":"Abstract A35: Elucidating mechanisms involved in long-term response to platinum-based chemotherapy in high-grade serous ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Debulking; Ovarian cancer; Chemotherapy; Cancer; Medicine; Pathology; Oncology; Internal medicine","score_opus":0.16630467607272914,"score_gpt":0.49017947605795675,"score_spread":0.3238747999852276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407048108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9302948,0.00040149983,0.00015984887,0.06681316,0.00034217918,0.001772969,0.000084834566,0.000052021664,0.000078667515],"genre_scores_gemma":[0.9931137,0.0010804003,0.0010038174,0.002249566,0.00046833424,0.0016636391,0.000013809108,0.00008963766,0.00031708632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948335,0.00072150124,0.0011659835,0.0011419471,0.0010354654,0.00110155],"domain_scores_gemma":[0.9947454,0.0033493945,0.0001590932,0.00085777236,0.0002648906,0.00062350015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005575369,0.00031809445,0.00085784326,0.0005665227,0.000099893005,0.00005897702,0.00037725468,0.00035177727,0.00215158],"category_scores_gemma":[0.0012213007,0.00022911724,0.00016816393,0.0011276768,0.00020330449,0.00011609442,0.000119397664,0.0009359838,0.00010987557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019175539,0.0017708367,0.7990264,0.00015194008,0.00012160975,0.0008615569,0.00020228032,0.000048535006,0.01755836,0.00012343684,0.0009864483,0.15997304],"study_design_scores_gemma":[0.02104326,0.0013197104,0.9542441,0.0028485146,0.000019101684,0.0000014053168,0.000039525698,0.00003245433,0.019276,0.00035036128,0.000562585,0.00026301233],"about_ca_topic_score_codex":0.0072369953,"about_ca_topic_score_gemma":0.0175124,"teacher_disagreement_score":0.15971003,"about_ca_system_score_codex":0.0022464718,"about_ca_system_score_gemma":0.0021811966,"threshold_uncertainty_score":0.9993739},"labels":[],"label_agreement":null},{"id":"W2407055211","doi":"10.1158/1557-3265.pmsclingen15-ia15","title":"Abstract IA15: “Next-gen” genomics-based clinical trials","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Druggability; Clinical trial; Genomics; Precision medicine; Profiling (computer programming); Computational biology; Bioinformatics; Medicine; Biology; Genome; Pathology; Genetics; Computer science; Gene","score_opus":0.5029259291989813,"score_gpt":0.5949847621123466,"score_spread":0.09205883291336536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407055211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846951,0.0043553915,0.0008074682,0.005110514,0.0019037916,0.00078296236,0.00040921883,0.000023968129,0.0019115852],"genre_scores_gemma":[0.9656603,0.024902066,0.00052458415,0.0018121167,0.0054794434,0.00019707652,0.000053484975,0.000076853314,0.0012940989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994187,0.0015005086,0.0019499073,0.0010747527,0.00048802196,0.0007998408],"domain_scores_gemma":[0.9916521,0.0057059326,0.0003366451,0.0011059227,0.00057488127,0.0006245224],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022481604,0.00023607672,0.0007292552,0.00009315378,0.00016809459,0.00010543757,0.0007718129,0.0006251203,0.0009139128],"category_scores_gemma":[0.018829465,0.00016622459,0.00073307625,0.00016269943,0.0009092886,0.0000069597795,0.00036795958,0.0006129569,0.00036189542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040357313,0.00079198286,0.05472554,0.000054840686,0.00034924338,0.00003640353,0.000008611561,0.000047717025,0.19318248,0.00030826166,0.22468752,0.52177167],"study_design_scores_gemma":[0.004802484,0.0011808736,0.03988478,0.000090387315,0.00004214825,0.0000013269674,0.000020249969,0.00004101269,0.031591523,0.00075640366,0.92117757,0.0004112602],"about_ca_topic_score_codex":0.00013979121,"about_ca_topic_score_gemma":0.00034151808,"teacher_disagreement_score":0.69649005,"about_ca_system_score_codex":0.00012986915,"about_ca_system_score_gemma":0.0022804462,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2407450722","doi":"10.1158/1557-3265.ovca15-b08","title":"Abstract B08: Genomics analyses of less common epithelial ovarian cancer subtypes.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; University of British Columbia","funders":"","keywords":"KRAS; Serous fluid; Neuroblastoma RAS viral oncogene homolog; CDKN2A; Serous carcinoma; Exome sequencing; Ovarian carcinoma; Mucinous carcinoma; Massive parallel sequencing; Ovarian cancer; Cancer; Exome; Carcinoma; Oncology; Biology; Internal medicine; Medicine; Adenocarcinoma; Mutation; Genetics; Colorectal cancer; DNA sequencing; Gene","score_opus":0.4500648755636732,"score_gpt":0.5782385353566344,"score_spread":0.1281736597929612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407450722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765947,0.003824368,0.000016481177,0.0154083455,0.0005399976,0.0005940053,0.00037345037,0.00002756771,0.0026210719],"genre_scores_gemma":[0.9790782,0.018112345,0.00011945637,0.000283571,0.0012692215,0.00022638877,0.000009906895,0.000045532888,0.0008553874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685466,0.00024078782,0.0009085426,0.00062079023,0.0007853384,0.0005899071],"domain_scores_gemma":[0.9965087,0.0014874776,0.00020888851,0.0007779486,0.0005865486,0.0004303928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018496272,0.00019377316,0.00081347313,0.0001815265,0.00010872957,0.000024277355,0.00030719175,0.00023449273,0.0026259765],"category_scores_gemma":[0.00033764605,0.00011767021,0.00033903628,0.00039367395,0.0006951844,0.00007643836,0.00014880617,0.0005191043,0.000110587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002374179,0.0011660521,0.5586483,0.00018639554,0.000901889,0.00011291393,0.00007118782,0.000008148941,0.018529827,0.00039597027,0.008590591,0.40901458],"study_design_scores_gemma":[0.005418023,0.0006119196,0.9234381,0.00068221876,0.00022137223,0.000002574792,0.00004588852,0.000011372913,0.04230686,0.00044514015,0.026650734,0.00016582494],"about_ca_topic_score_codex":0.009529179,"about_ca_topic_score_gemma":0.002003468,"teacher_disagreement_score":0.40884873,"about_ca_system_score_codex":0.0006512,"about_ca_system_score_gemma":0.0016167148,"threshold_uncertainty_score":0.9982858},"labels":[],"label_agreement":null},{"id":"W2407900667","doi":"10.1158/1557-3265.ovca15-b10","title":"Abstract B10: FOXL2 402C&amp;gt;G mutation can be identified in the circulating tumor DNA of patients with adult-type granulosa cell tumor.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Mutation; Internal medicine; Medicine; Mutation frequency; Mutation testing; Ovary; Pathology; Biology; Gastroenterology; Oncology; Molecular biology; Genetics","score_opus":0.08070958269579487,"score_gpt":0.40860588868994785,"score_spread":0.327896305994153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407900667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979727,0.0002141681,0.000021446716,0.0005050929,0.00017902096,0.00045496513,0.0001765866,0.0000034572297,0.00047252758],"genre_scores_gemma":[0.9987875,0.00029557405,0.00005631823,0.00034189768,0.0002565228,0.00006526391,0.00010251938,0.000026494039,0.00006791154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789035,0.00022539753,0.00054512004,0.00044975794,0.0005013477,0.0003880211],"domain_scores_gemma":[0.99781597,0.00063673686,0.00019880483,0.0005068672,0.000736077,0.000105569736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013098434,0.00013142367,0.00020809652,0.000063976375,0.00008827265,0.00003476982,0.00037447596,0.00009585661,0.000061100734],"category_scores_gemma":[0.0015809055,0.000082599916,0.00008335685,0.00023973262,0.00031935817,0.0000064456935,0.00012133052,0.00026310832,0.000007998678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029999237,0.0010734885,0.80698913,0.0002627033,0.00008866886,0.000055455508,0.00043874752,0.00013569603,0.16301152,0.0001668965,0.0067577697,0.018019972],"study_design_scores_gemma":[0.0045416723,0.00091486255,0.9555788,0.00019363993,0.000024177434,0.0000019595557,0.00017953511,0.0000120372815,0.03377248,0.0003292856,0.0041740984,0.00027742985],"about_ca_topic_score_codex":0.00087397936,"about_ca_topic_score_gemma":0.0046298173,"teacher_disagreement_score":0.14858967,"about_ca_system_score_codex":0.000059362035,"about_ca_system_score_gemma":0.00047203584,"threshold_uncertainty_score":0.3368327},"labels":[],"label_agreement":null},{"id":"W2408324580","doi":"10.1158/1557-3265.ovca15-pr07","title":"Abstract PR07: Synchronous ovarian and endometrial carcinomas: The case for pseudo-metastasis.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Metastasis; Massive parallel sequencing; Ovary; Ovarian cancer; Biology; Cancer; Endometrial cancer; Carcinoma; Ovarian carcinoma; Primary tumor; Endometrium; Cancer research; Oncology; Pathology; Medicine; Internal medicine; Gene; DNA sequencing; Genetics","score_opus":0.264980268446836,"score_gpt":0.5113102394665525,"score_spread":0.24632997101971654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408324580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9323552,0.005960675,0.00010645934,0.05583308,0.00086506887,0.003297652,0.000407931,0.000041744584,0.0011321874],"genre_scores_gemma":[0.99157506,0.0034862645,0.0004133226,0.00036801252,0.002348009,0.0013212317,0.0000051280317,0.00003996467,0.00044300745],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99729025,0.000278869,0.00062642084,0.000687185,0.0004558682,0.00066138594],"domain_scores_gemma":[0.98996663,0.008393492,0.00010443271,0.0006743734,0.00040054164,0.0004605393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00439568,0.00018255804,0.0005257206,0.00015494328,0.00034260427,0.00007799842,0.00017382923,0.00016157061,0.0008175408],"category_scores_gemma":[0.0026626447,0.00008774924,0.00025852624,0.0003374517,0.00069790304,0.000078399346,0.00013685037,0.00043584235,0.000047379344],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036529547,0.0008005688,0.069922976,0.00020682646,0.000735595,0.0020677047,0.00009669831,3.41716e-7,0.00019447229,0.0015303228,0.030654881,0.89013666],"study_design_scores_gemma":[0.06003808,0.008699008,0.60328096,0.0008727497,0.001046362,0.001394306,0.0004759013,0.00006284542,0.0022032154,0.0024777448,0.31884983,0.0005989818],"about_ca_topic_score_codex":0.0014641411,"about_ca_topic_score_gemma":0.0005937788,"teacher_disagreement_score":0.8895377,"about_ca_system_score_codex":0.00033906396,"about_ca_system_score_gemma":0.00084128877,"threshold_uncertainty_score":0.8951498},"labels":[],"label_agreement":null},{"id":"W2408535955","doi":"10.1158/1557-3265.ovca15-a53","title":"Abstract A53: Combining oncolytic virotherapy with immunotherapy for ovarian cancer treatment.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Immunotherapy; Medicine; Tumor microenvironment; Ovarian cancer; Antigen; Virotherapy; Cancer immunotherapy; CD8; Immune system; Tumor antigen; Cancer; Cancer research; Immunology; Adoptive cell transfer; Cytotoxic T cell; T cell; Combination therapy; Biology; Internal medicine","score_opus":0.1681519695379367,"score_gpt":0.5131536857754148,"score_spread":0.34500171623747805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408535955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874895,0.004325356,0.00030587934,0.00495524,0.00021474386,0.0017041457,0.00019029222,0.000030171523,0.0007846399],"genre_scores_gemma":[0.9665662,0.022384578,0.00020446582,0.00052224216,0.0015160163,0.0026624287,0.00002631594,0.00014306189,0.005974697],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966324,0.00040093577,0.00050113443,0.00090843515,0.0005646229,0.0009924455],"domain_scores_gemma":[0.99753696,0.0006675197,0.00011790629,0.0008998151,0.0004686037,0.0003092075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022414194,0.00028139105,0.00041359203,0.000117004325,0.0003075497,0.00007348947,0.0006080641,0.00030355935,0.00097301643],"category_scores_gemma":[0.00014278096,0.00017091456,0.00024738183,0.00024938973,0.000715754,0.000010719541,0.00006809813,0.00030001145,0.000042009626],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033961304,0.00054695044,0.011376177,0.000021279326,0.000646179,0.000007649246,0.000045146804,0.000017775972,0.49377102,0.000048972204,0.002773998,0.45678353],"study_design_scores_gemma":[0.028730335,0.042382564,0.013560998,0.00027861338,0.000029373714,0.000004086596,0.000071960574,0.0000376398,0.43449485,0.0004836952,0.47919163,0.0007342395],"about_ca_topic_score_codex":0.00054979563,"about_ca_topic_score_gemma":0.0030708287,"teacher_disagreement_score":0.47641763,"about_ca_system_score_codex":0.00029678,"about_ca_system_score_gemma":0.0017585742,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W2408568328","doi":"10.1158/1557-3265.ovca15-pr16","title":"Abstract PR16: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Serous fluid; Ovarian carcinoma; Oncology; Internal medicine; Serous carcinoma; Stage (stratigraphy); Cancer; Adjuvant; Surgery; Biology","score_opus":0.3802367171197038,"score_gpt":0.5335727253135414,"score_spread":0.15333600819383758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408568328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378839,0.002372688,0.019022774,0.038487993,0.0000796096,0.0012987556,0.000390899,0.000022535916,0.00044080472],"genre_scores_gemma":[0.99347043,0.0015416387,0.004070539,0.00013754921,0.00026308617,0.00039239723,0.000028099104,0.000023336306,0.00007292948],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857974,0.000058622976,0.00046114158,0.00037826295,0.00025092618,0.0002713279],"domain_scores_gemma":[0.99725074,0.0015837188,0.000076639735,0.0002612232,0.0006370171,0.00019065375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010465176,0.00009193586,0.00029125193,0.00009255122,0.00012388802,0.000016932281,0.0000918682,0.00009552023,0.00007854181],"category_scores_gemma":[0.00020658383,0.000060527334,0.00011526217,0.00013181509,0.00020879055,0.000055558874,0.00004750845,0.000166678,0.000002334515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008681601,0.00034154317,0.49500048,0.00007816521,0.00019253093,0.0000025028937,0.00004020305,0.00026491043,0.000097374184,0.0030412404,0.00045522366,0.49961767],"study_design_scores_gemma":[0.006542251,0.00072410854,0.9635111,0.00028417955,0.000038530212,0.0000044365943,0.000038346654,0.021931656,0.000057467627,0.006176299,0.000599821,0.00009179201],"about_ca_topic_score_codex":0.0004831143,"about_ca_topic_score_gemma":0.00009540857,"teacher_disagreement_score":0.49952587,"about_ca_system_score_codex":0.00013293292,"about_ca_system_score_gemma":0.00045212285,"threshold_uncertainty_score":0.24682331},"labels":[],"label_agreement":null},{"id":"W2411964580","doi":"10.1158/1078-0432.ccr-15-2644","title":"Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy","year":2016,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"Bristol-Myers Squibb; American Association for Cancer Research","keywords":"Medicine; Clinical trial; Maximum tolerated dose; Dosing; Adaptive design; Pharmacodynamics; Oncology; Medical physics; Pharmacokinetics; Pharmacology; Internal medicine","score_opus":0.9658752865274041,"score_gpt":0.7506138417031166,"score_spread":0.21526144482428744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411964580","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040067527,0.0018362047,0.087585784,0.058242146,0.8131582,0.032194365,0.0015538174,0.00012852527,0.0012941927],"genre_scores_gemma":[0.0027687575,0.0028183972,0.21475798,0.00066807686,0.76830477,0.009936489,0.000008658113,0.00028515668,0.0004517102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8828403,0.09981094,0.008007864,0.002030553,0.0054759285,0.0018344541],"domain_scores_gemma":[0.14363213,0.8509437,0.0014484971,0.00252856,0.0009582767,0.00048887444],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.36316845,0.0005817266,0.0043827607,0.00040965472,0.00031075504,0.00015733852,0.0042596557,0.002129004,0.00035893303],"category_scores_gemma":[0.83225155,0.0002719267,0.00083820155,0.0018000241,0.0014087779,0.00003054371,0.0010511313,0.007663295,0.00005861384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00907457,0.0007412325,0.000017702067,0.00017651379,0.0002978048,0.000032991742,0.0018621574,0.00013075108,0.00011192561,0.0028386158,0.82945997,0.15525578],"study_design_scores_gemma":[0.009841944,0.006652737,0.0005628344,0.0035479341,0.00026292316,0.0000014169339,0.0012541814,0.00019001811,0.0013469479,0.2921776,0.683099,0.001062495],"about_ca_topic_score_codex":0.00020784783,"about_ca_topic_score_gemma":0.000090419744,"teacher_disagreement_score":0.7511327,"about_ca_system_score_codex":0.00078721176,"about_ca_system_score_gemma":0.0032781756,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W2420141433","doi":"10.1158/1078-0432.ccr-16-0610","title":"Somatic and Germline <i>TP53</i> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Germline; Somatic cell; Cancer; Germline mutation; Medicine; Oncology; Biology; Cancer research; Internal medicine; Genetics; Mutation; Gene","score_opus":0.12969336034865328,"score_gpt":0.4616537037362212,"score_spread":0.33196034338756797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420141433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827064,0.007992654,0.00010772987,0.006794553,0.0006731821,0.00083793805,0.00032866726,0.00004449063,0.0005143371],"genre_scores_gemma":[0.9803195,0.01484821,0.00018204788,0.0005280062,0.0013697175,0.00046636144,0.000021116666,0.000064383064,0.0022006566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962512,0.00052163773,0.0009559391,0.00081674336,0.00074287324,0.00071161054],"domain_scores_gemma":[0.9963224,0.0021023084,0.000121792174,0.0006120183,0.0003267604,0.00051473366],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018676828,0.00021792679,0.0006119342,0.00032604596,0.00011440871,0.000044838067,0.00020515927,0.0003049686,0.0029374638],"category_scores_gemma":[0.0010771891,0.00014906342,0.00013641319,0.0007240802,0.00035929494,0.00012361305,0.00020583137,0.00095842045,0.00012614993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012813389,0.0005494132,0.9062919,0.0003294975,0.00017905555,0.00036457024,0.00044160584,0.000015314807,0.032842938,0.00011018053,0.009324574,0.04826961],"study_design_scores_gemma":[0.021628436,0.0016160966,0.9045296,0.002579569,0.0003650134,0.000037934482,0.00018991766,0.0011848145,0.019623235,0.0026591707,0.044577394,0.0010088214],"about_ca_topic_score_codex":0.007240311,"about_ca_topic_score_gemma":0.047899604,"teacher_disagreement_score":0.047260787,"about_ca_system_score_codex":0.0003601606,"about_ca_system_score_gemma":0.001363182,"threshold_uncertainty_score":0.9993706},"labels":[],"label_agreement":null},{"id":"W2422917950","doi":"10.1158/1078-0432.ccr-15-1314","title":"Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Biology; DNA damage; Kinase; Phosphorylation; Cancer research; Cancer cell; DNA repair; Protein kinase A; Cancer; Caspase; Cell biology; Apoptosis; Programmed cell death; Biochemistry; DNA; Genetics","score_opus":0.07282055038973116,"score_gpt":0.4010784169604375,"score_spread":0.3282578665707063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422917950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597883,0.0015320665,0.00015794458,0.00088314066,0.00016726655,0.00097273017,0.00019441768,0.000019440076,0.00009414835],"genre_scores_gemma":[0.99714524,0.0010260283,0.0006665558,0.00012006605,0.00014434333,0.00038663676,0.000005002152,0.00004632584,0.0004598106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956856,0.0014633826,0.00064921094,0.0010190799,0.0005640839,0.0006186838],"domain_scores_gemma":[0.9982773,0.00016316838,0.00010653965,0.0006759779,0.0003554366,0.00042156747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047163363,0.00021546315,0.00037519046,0.00015170695,0.000071473056,0.000021124526,0.0003262393,0.0003153204,0.00016716217],"category_scores_gemma":[0.0019330162,0.00017527169,0.00013001428,0.00030957343,0.00046824254,0.000012703244,0.0008649099,0.0003175699,0.000009765704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042978497,0.00016538563,0.001657132,0.00007962062,0.00003635568,0.00014203718,0.0000642552,0.000011431209,0.9902385,0.00014912184,0.000530952,0.0026273418],"study_design_scores_gemma":[0.0014485271,0.0019930413,0.0041131373,0.00022829743,0.00000821656,0.0000019180343,0.00015147225,0.00004901477,0.9883358,0.0006348067,0.0027826182,0.00025318685],"about_ca_topic_score_codex":0.00048992573,"about_ca_topic_score_gemma":0.00039558153,"teacher_disagreement_score":0.0028493225,"about_ca_system_score_codex":0.00004551795,"about_ca_system_score_gemma":0.0007070768,"threshold_uncertainty_score":0.71473724},"labels":[],"label_agreement":null},{"id":"W2465555849","doi":"10.1158/1078-0432.ccr-16-0549","title":"Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute; KWF Kankerbestrijding","keywords":"Epigenome; Prostate cancer; DNA methylation; Medicine; Cancer; Oncology; Cancer research; Prostate; Pathology; Biology; Internal medicine; Gene; Genetics","score_opus":0.09249531019013431,"score_gpt":0.4609511249069322,"score_spread":0.3684558147167979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465555849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915606,0.0036723565,0.0018650026,0.0006455344,0.00014851047,0.0018524117,0.00009775602,0.000013250232,0.0001446133],"genre_scores_gemma":[0.9907219,0.004679201,0.0030992124,0.000031868833,0.00016507677,0.0010088028,0.000054946388,0.00005593803,0.00018307097],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952595,0.0010120851,0.0014023789,0.0008934426,0.0007986868,0.0006338769],"domain_scores_gemma":[0.99615395,0.00170008,0.00048090407,0.00050279166,0.00093739515,0.00022489978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006681805,0.0002387243,0.0005048921,0.00019809003,0.000101283025,0.000042387124,0.000363078,0.00019190458,0.00005256761],"category_scores_gemma":[0.0046733604,0.00015449717,0.00014308907,0.0005395881,0.00082761503,0.000022831173,0.00024328743,0.0003254,0.000004685267],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030624447,0.00035669518,0.5650804,0.00011641522,0.00017256454,0.0000151419545,0.00007022224,0.00006155645,0.40056443,0.000014755441,0.000042277043,0.03044308],"study_design_scores_gemma":[0.008396692,0.0032849542,0.33892706,0.001005051,0.000098825796,5.158909e-7,0.0002772227,0.00024204455,0.64493906,0.00058277056,0.00173843,0.0005073914],"about_ca_topic_score_codex":0.00031233585,"about_ca_topic_score_gemma":0.0005556858,"teacher_disagreement_score":0.2443746,"about_ca_system_score_codex":0.00008459262,"about_ca_system_score_gemma":0.0010592561,"threshold_uncertainty_score":0.63002115},"labels":[],"label_agreement":null},{"id":"W2465921301","doi":"10.1158/1557-3265.ovcasymp14-poster-tech-1119","title":"Abstract POSTER-TECH-1119: Phylogenetic portraits of high grade serous ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Genome instability; Genetics; Microsatellite instability; CDKN2A; Germline mutation; Indel; Germline; ATRX; Somatic evolution in cancer; Mutation; Cancer; Gene; Genotype; DNA; DNA damage; Microsatellite","score_opus":0.16666152563998096,"score_gpt":0.4634385112940502,"score_spread":0.2967769856540693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465921301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889992,0.006662106,0.000039501534,0.0014562092,0.0007892898,0.00040446888,0.000502879,0.000010422,0.0011359599],"genre_scores_gemma":[0.99205536,0.005103548,0.00018944073,0.0004348185,0.0015327579,0.00013023987,0.00008333696,0.000052239957,0.0004182422],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99729276,0.00017457773,0.0006999066,0.00066444895,0.0005667337,0.00060157175],"domain_scores_gemma":[0.9976457,0.00018374283,0.00017980518,0.0006959154,0.0007924146,0.00050244783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016313804,0.00019634617,0.00038359305,0.00008825076,0.00007444149,0.00003975413,0.0005660411,0.00035878585,0.0001987577],"category_scores_gemma":[0.0007723414,0.0001875845,0.00016497314,0.0002659668,0.00048239768,0.000004651496,0.00038707012,0.00048548117,0.00001807902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004893761,0.0025024512,0.22756697,0.00049878703,0.0010412238,0.00018511403,0.0003921499,0.0028473386,0.36234963,0.0010248977,0.18741086,0.20928684],"study_design_scores_gemma":[0.008431549,0.003896593,0.54693997,0.00025619997,0.00012603682,0.00002226365,0.00025341238,0.000058615664,0.2606152,0.0040301764,0.17425576,0.0011142304],"about_ca_topic_score_codex":0.004525669,"about_ca_topic_score_gemma":0.0020489674,"teacher_disagreement_score":0.319373,"about_ca_system_score_codex":0.00009174149,"about_ca_system_score_gemma":0.0017407514,"threshold_uncertainty_score":0.7649474},"labels":[],"label_agreement":null},{"id":"W2469919626","doi":"10.1158/1078-0432.ccr-16-0067","title":"Physical Activity and Cancer Outcomes: A Precision Medicine Approach","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":300,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Cancer; Colorectal cancer; Internal medicine; Breast cancer; Confidence interval; Observational study; Relative risk; Cancer prevention; Gynecology","score_opus":0.5472715530470443,"score_gpt":0.6483473026894041,"score_spread":0.10107574964235977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469919626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011826841,0.9892566,0.000028361106,0.002094234,0.0011284087,0.002302662,0.00021137626,0.00007027718,0.003725398],"genre_scores_gemma":[0.00079811004,0.98275644,0.0000109493085,0.00015057717,0.005251443,0.0020584082,0.000027274189,0.00013681792,0.008809968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99290556,0.0016027912,0.0009251213,0.0016733453,0.0019603567,0.0009328556],"domain_scores_gemma":[0.9914454,0.005451337,0.00031735367,0.0012815732,0.00056986697,0.0009344501],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003954414,0.0006287432,0.0048124287,0.0003957914,0.00018751707,0.000043244872,0.00053201074,0.0008394262,0.00071414164],"category_scores_gemma":[0.0016609844,0.00032695098,0.0009452943,0.0009169469,0.0016727047,0.000098141114,0.00062923017,0.0034504032,0.000091501075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030902252,0.00034917484,0.00052305375,0.0140655665,0.00042230438,0.000024492123,0.00014273658,1.2076667e-8,0.0000010162692,0.000054449793,0.007880598,0.9762276],"study_design_scores_gemma":[0.0014916052,0.0005793243,0.00083064113,0.0315759,0.00080215686,0.000013895032,0.00004237136,0.000008933329,9.3967475e-7,0.00009218967,0.9642127,0.00034932827],"about_ca_topic_score_codex":0.003046975,"about_ca_topic_score_gemma":0.00043017737,"teacher_disagreement_score":0.97587824,"about_ca_system_score_codex":0.000736471,"about_ca_system_score_gemma":0.0023141298,"threshold_uncertainty_score":0.9999183},"labels":[],"label_agreement":null},{"id":"W2507865108","doi":"10.1158/1078-0432.ccr-16-0594","title":"Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; Broad Institute; National Human Genome Research Institute; Leukemia and Lymphoma Society; American Cancer Society","keywords":"Somatic cell; Chronic lymphocytic leukemia; Mutation; Somatic evolution in cancer; Biology; Germline mutation; Genetics; Survival analysis; Cancer research; Cancer; Oncology; Leukemia; Internal medicine; Medicine; Gene","score_opus":0.45392629328106837,"score_gpt":0.5684538915852584,"score_spread":0.11452759830419001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507865108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348646,0.00037391778,0.000095237505,0.003193889,0.00014521409,0.0005752778,0.000030633953,0.000023898063,0.0020754666],"genre_scores_gemma":[0.997221,0.0009831514,0.00021068144,0.00009723462,0.0003568325,0.000059104805,0.0000056835697,0.00003109765,0.0010352278],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963371,0.00067438866,0.0006811288,0.00049611204,0.0012512992,0.0005599513],"domain_scores_gemma":[0.99397236,0.004437952,0.000092922455,0.00058699184,0.0005044485,0.0004053447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004503364,0.00012353288,0.0005059444,0.00019972348,0.00009346424,0.000016955137,0.0002331207,0.00017192197,0.00066718576],"category_scores_gemma":[0.0029944794,0.00007863165,0.00011146387,0.00029325424,0.001516903,0.00005825565,0.00025581784,0.00051684945,0.00017996806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02164248,0.0023144698,0.31494564,0.0030181136,0.000756566,0.00081515545,0.0007813133,0.000014236452,0.040099327,0.018158246,0.008706425,0.58874804],"study_design_scores_gemma":[0.07761423,0.0066984496,0.8692829,0.0020429476,0.00012211583,0.00012356264,0.0003636629,0.0056807115,0.015568418,0.01770152,0.0043211645,0.00048032025],"about_ca_topic_score_codex":0.0011525697,"about_ca_topic_score_gemma":0.0005228013,"teacher_disagreement_score":0.5882677,"about_ca_system_score_codex":0.0036199656,"about_ca_system_score_gemma":0.0064223106,"threshold_uncertainty_score":0.99921036},"labels":[],"label_agreement":null},{"id":"W2507950939","doi":"10.1158/1078-0432.ccr-16-1192","title":"MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Deutsches Krebsforschungszentrum; McGill University","keywords":"Microphthalmia-associated transcription factor; Melanoma; MEK inhibitor; MAPK/ERK pathway; Cancer research; Gene knockdown; Medicine; Antibody-drug conjugate; Trametinib; Dabrafenib; Antibody; Monoclonal antibody; Cell culture; Immunology; Biology; Vemurafenib; Signal transduction; Tyrosinase; Metastatic melanoma; Cell biology","score_opus":0.08395417958845613,"score_gpt":0.44757959507761497,"score_spread":0.36362541548915883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507950939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994172,0.00048531962,0.0002683996,0.0022753642,0.00085524097,0.00050403865,0.0001783441,0.000040799772,0.0012205387],"genre_scores_gemma":[0.9926019,0.00063215056,0.00030742615,0.0007728611,0.003023595,0.000076899865,0.00008159002,0.00006674383,0.0024368728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956633,0.0009328768,0.0007272266,0.0011139212,0.0005788241,0.0009838432],"domain_scores_gemma":[0.99749863,0.0002354632,0.00010667052,0.000825792,0.0005381221,0.0007952965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039133094,0.00025333776,0.00038871562,0.00010710405,0.0002463467,0.00007220617,0.0005274666,0.0003140925,0.00021766679],"category_scores_gemma":[0.00133399,0.00017930342,0.00019298436,0.0002405368,0.00037244655,0.000015145066,0.0005964339,0.0004150106,0.0003262884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042082422,0.000115674135,0.008971483,0.000024174156,0.00004283716,0.00011434133,0.000053450578,0.0000019414038,0.9553922,0.0001486505,0.012971876,0.021742545],"study_design_scores_gemma":[0.0012468337,0.0013640573,0.0046880483,0.00011973979,0.0000077659,0.000013248355,0.000115210234,0.000013045069,0.7892384,0.00018296609,0.2026294,0.00038128506],"about_ca_topic_score_codex":0.00023950677,"about_ca_topic_score_gemma":0.00031473697,"teacher_disagreement_score":0.18965752,"about_ca_system_score_codex":0.0000591692,"about_ca_system_score_gemma":0.00057578465,"threshold_uncertainty_score":0.7311781},"labels":[],"label_agreement":null},{"id":"W2508835981","doi":"10.1158/1078-0432.ccr-16-1406","title":"Biospecimen Complexity—the Next Challenge for Cancer Research Biobanks?","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biobank; Translational research; Standardization; Medicine; Quality (philosophy); Data science; Medical research; Computer science; Bioinformatics; Pathology; Biology","score_opus":0.9717589302380174,"score_gpt":0.7845106315198176,"score_spread":0.1872482987181998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508835981","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24107084,0.011257668,0.0001307494,0.72499466,0.0015752689,0.0062416466,0.00038255565,0.00016177002,0.014184852],"genre_scores_gemma":[0.8343491,0.0939928,0.0006823091,0.0023987435,0.008848659,0.0046261144,0.000013345715,0.00019798819,0.054890923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98360187,0.0031280282,0.0018345435,0.0019910838,0.006456936,0.0029875492],"domain_scores_gemma":[0.85976887,0.1266336,0.00017236767,0.0028125562,0.009181219,0.0014313724],"candidate_categories":["metaresearch","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","sts","insufficient_payload"],"category_scores_codex":[0.08406459,0.0003373844,0.0010320218,0.0005101126,0.0013263737,0.00022559789,0.0024475197,0.0012651512,0.0061100023],"category_scores_gemma":[0.085288145,0.00018057397,0.00063223543,0.001806455,0.012733,0.00021708672,0.0018415516,0.0094585745,0.0013401255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0120996,0.00262725,0.035936464,0.0015010292,0.000843824,0.00012278772,0.0005228817,4.3588307e-7,0.009690628,0.16600566,0.24186443,0.528785],"study_design_scores_gemma":[0.007359843,0.0047444757,0.02805785,0.0022860963,0.00005024553,0.000005395615,0.0006098814,0.00006829688,0.0023781944,0.23787569,0.7161509,0.00041314366],"about_ca_topic_score_codex":0.0017543795,"about_ca_topic_score_gemma":0.0077648708,"teacher_disagreement_score":0.72259593,"about_ca_system_score_codex":0.0012457463,"about_ca_system_score_gemma":0.0057540867,"threshold_uncertainty_score":0.9999738},"labels":[],"label_agreement":null},{"id":"W2509844702","doi":"10.1158/1078-0432.ccr-16-1278","title":"High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"Forskerakademiet; Canadian Cancer Society","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Cyclophosphamide; Chemotherapy; Hazard ratio; Proportional hazards model; Tissue microarray; Cancer; Clinical endpoint; Randomized controlled trial; Confidence interval","score_opus":0.07161111733640327,"score_gpt":0.4182395047963901,"score_spread":0.3466283874599868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509844702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686375,0.0017186049,0.000029623181,0.0088175675,0.0028259836,0.0012752021,0.01659267,0.000034623456,0.00006818355],"genre_scores_gemma":[0.9737181,0.011628414,0.00020675425,0.0012844006,0.011339005,0.00085967657,0.0005210548,0.00009577946,0.0003468299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99310344,0.0013217182,0.0016172036,0.0018722792,0.0011120543,0.0009732786],"domain_scores_gemma":[0.99299014,0.003390597,0.00058170495,0.0014260845,0.0011947197,0.00041673827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023598007,0.0004761543,0.00081113604,0.00003975205,0.0004510383,0.000074957774,0.0010653562,0.0005504469,0.00058160356],"category_scores_gemma":[0.002300902,0.00027542154,0.00042699566,0.00022000975,0.0015109808,0.000016836888,0.0005959913,0.0008177791,0.000165928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22598678,0.0014299254,0.5661348,0.0000057261886,0.001139523,0.000007905986,0.000054871067,0.0000072892153,0.000643038,0.0000034431732,0.03537348,0.16921319],"study_design_scores_gemma":[0.10268958,0.0023550817,0.8645427,0.000228617,0.00018195587,2.248849e-7,0.00002369014,0.0000067502506,0.0023908247,0.00022138952,0.026961034,0.0003981118],"about_ca_topic_score_codex":0.02731157,"about_ca_topic_score_gemma":0.0072835176,"teacher_disagreement_score":0.2984079,"about_ca_system_score_codex":0.00028366304,"about_ca_system_score_gemma":0.0011089784,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W2510150379","doi":"10.1158/1078-0432.ccr-15-2899","title":"IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Nephelometry; Immunoglobulin M; Serum protein electrophoresis; Waldenstrom macroglobulinemia; Medicine; Immunology; Antibody; Immunoglobulin G; Monoclonal; Monoclonal antibody; Lymphoma","score_opus":0.29176124911133,"score_gpt":0.5591102016073598,"score_spread":0.2673489524960298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510150379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903597,0.0005427241,0.0004624481,0.0052410234,0.00014948449,0.0024467222,0.00008221222,0.00001543591,0.00070019835],"genre_scores_gemma":[0.9965685,0.00085620006,0.0007000197,0.00011488463,0.00026254848,0.00042308547,0.0000055187097,0.000034780773,0.0010344686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609584,0.0002710579,0.0005488452,0.00050027267,0.0019455688,0.0006384162],"domain_scores_gemma":[0.993225,0.0039517293,0.00010775214,0.000681731,0.001714223,0.00031961538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004204621,0.0001363939,0.00041319474,0.00008411187,0.00016805784,0.000024434694,0.00032364187,0.00013549151,0.000292835],"category_scores_gemma":[0.0018118868,0.00005970823,0.00010511774,0.00027507107,0.001390826,0.00006155528,0.00027029458,0.00042285802,0.000008507337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041343025,0.00046549403,0.83915114,0.00036662276,0.000420669,0.000013414554,0.000037783877,0.000001444936,0.00033697565,0.00021062794,0.007853802,0.14700772],"study_design_scores_gemma":[0.053318564,0.0031308827,0.9225746,0.00081242237,0.0001503524,0.0000070008487,0.000059020465,0.0006601499,0.0014368776,0.00023968349,0.017436882,0.0001735589],"about_ca_topic_score_codex":0.00030921857,"about_ca_topic_score_gemma":0.00013692859,"teacher_disagreement_score":0.14683416,"about_ca_system_score_codex":0.0034373703,"about_ca_system_score_gemma":0.0074870074,"threshold_uncertainty_score":0.9981396},"labels":[],"label_agreement":null},{"id":"W2511827811","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1349","title":"Abstract POSTER-BIOL-1349: The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; microRNA; Cancer research; Germline mutation; Somatic cell; Germline; Genetics; Gene; Mutation","score_opus":0.19655783500639704,"score_gpt":0.49370869882028373,"score_spread":0.29715086381388667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511827811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96696657,0.003390901,0.0000020820044,0.011842058,0.0002227689,0.001152516,0.00009898335,0.00001750845,0.016306624],"genre_scores_gemma":[0.9975624,0.0006647876,0.00014119846,0.000357027,0.0004734553,0.0003899843,0.00003603037,0.00003823603,0.00033688114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964763,0.00046011456,0.0009793642,0.00053437805,0.0009467388,0.00060308765],"domain_scores_gemma":[0.9965843,0.0014175624,0.0001797298,0.0007619996,0.0004885409,0.0005678541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034706676,0.00018782268,0.00055908266,0.00019648563,0.00011076054,0.000040328905,0.00035613374,0.00018130486,0.00066335197],"category_scores_gemma":[0.0005327085,0.00012560334,0.0002359236,0.00075226073,0.00051865954,0.00008655909,0.00016856639,0.0010221577,0.00015397365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064756474,0.009603513,0.8729704,0.00040032374,0.00061931065,0.0012867667,0.005600227,0.00014961735,0.005070286,0.0012668106,0.015635608,0.08092147],"study_design_scores_gemma":[0.015582783,0.002522969,0.93522525,0.0007010661,0.00015836771,0.000026519292,0.004522474,0.00007912066,0.013099438,0.004804201,0.022965211,0.00031258087],"about_ca_topic_score_codex":0.005978152,"about_ca_topic_score_gemma":0.0018248582,"teacher_disagreement_score":0.08060889,"about_ca_system_score_codex":0.00058353523,"about_ca_system_score_gemma":0.0025699418,"threshold_uncertainty_score":0.9037218},"labels":[],"label_agreement":null},{"id":"W2515679040","doi":"10.1158/1078-0432.ccr-16-1433","title":"Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Montréal; University Health Network; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; U.S. Department of Defense","keywords":"Immunotherapy; Chemotherapy; Cancer; Ovarian cancer; Medicine; Lymphocyte; Tumor-infiltrating lymphocytes; Oncology; Immunology; Pathology; Cancer research; Internal medicine","score_opus":0.1628242435155388,"score_gpt":0.48815544820918283,"score_spread":0.325331204693644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515679040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631433,0.0011272748,0.00059436867,0.03200662,0.00007679683,0.0017635934,0.0011435333,0.000016059037,0.0001284935],"genre_scores_gemma":[0.9937647,0.003216429,0.0006740498,0.00021368483,0.00021828484,0.0016482001,0.000010945067,0.000051699335,0.00020203608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970667,0.00028273102,0.0011373525,0.00059332757,0.00042889046,0.0004910093],"domain_scores_gemma":[0.9940073,0.0039422587,0.00035753503,0.0008343977,0.00068771036,0.00017077981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031250168,0.00018327254,0.00071217434,0.00018400834,0.000073893745,0.000011896202,0.00025085142,0.00011026172,0.00018506481],"category_scores_gemma":[0.00067570846,0.0001087509,0.00018380456,0.00044243515,0.00038279995,0.0000619787,0.000042099666,0.00021778862,0.0000016530239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06699656,0.0006707832,0.70027655,0.00010414927,0.00023071984,0.000008458319,0.00013796004,0.000004153593,0.006823818,0.0002761024,0.00021858433,0.22425215],"study_design_scores_gemma":[0.028180664,0.002906021,0.9516205,0.0018991674,0.00003484927,0.000003777928,0.0000390975,0.00002492592,0.012249066,0.00040611014,0.0025099218,0.0001258796],"about_ca_topic_score_codex":0.0037577462,"about_ca_topic_score_gemma":0.004071179,"teacher_disagreement_score":0.25134397,"about_ca_system_score_codex":0.00060787186,"about_ca_system_score_gemma":0.0020955317,"threshold_uncertainty_score":0.56806135},"labels":[],"label_agreement":null},{"id":"W2520704033","doi":"10.1158/1078-0432.ccr-16-0933","title":"Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Bristol-Myers Squibb; Cancer Research Institute","keywords":"TIGIT; Immune system; Cancer research; Immunotherapy; Cancer immunotherapy; Immunology; Downregulation and upregulation; Biology","score_opus":0.28179630753995233,"score_gpt":0.5304092569494819,"score_spread":0.2486129494095296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520704033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010119063,0.99199647,0.000107274085,0.00028714,0.005593921,0.0013594155,0.00010176503,0.00007975227,0.00037305334],"genre_scores_gemma":[0.00004675192,0.9843745,0.00001508217,0.00019082501,0.0004927741,0.0018950038,0.00013606944,0.00013127892,0.012717718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995794,0.0014001221,0.0011378604,0.0008240874,0.00010187205,0.00074207183],"domain_scores_gemma":[0.9961276,0.0025363343,0.0003545037,0.00045599876,0.00046624307,0.00005933818],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026823136,0.00035250242,0.0014156462,0.00023184819,0.00029299138,0.000060755654,0.00042726105,0.0010196707,0.0023231567],"category_scores_gemma":[0.0007529671,0.0002392726,0.0006683357,0.00019736284,0.0005701926,0.000093916686,0.00019425122,0.0016966991,0.00041871268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027160413,0.000062075,0.000008781743,0.0015594994,0.00058570935,0.0000020227537,0.000022496628,5.6828206e-8,0.0013620259,0.00018869685,0.05029738,0.94563967],"study_design_scores_gemma":[0.0010100418,0.00030823893,0.0000030362178,0.005340678,0.00009299244,0.0000064435944,0.000022054499,6.7569266e-7,0.00037859235,0.00008834202,0.99246,0.00028889754],"about_ca_topic_score_codex":0.00016222414,"about_ca_topic_score_gemma":0.000010417363,"teacher_disagreement_score":0.94535077,"about_ca_system_score_codex":0.00025082103,"about_ca_system_score_gemma":0.00082306465,"threshold_uncertainty_score":0.99858886},"labels":[],"label_agreement":null},{"id":"W2522167924","doi":"10.1158/1078-0432.ccr-16-0718","title":"<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Enzalutamide; Prostate cancer; Cancer research; Downregulation and upregulation; Apoptosis; Androgen receptor; Biology; Medicine; Cancer; Gene; Internal medicine; Genetics","score_opus":0.1496112798920293,"score_gpt":0.5339874969569492,"score_spread":0.38437621706492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522167924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9136805,0.03746237,0.000081530634,0.041424185,0.0010133524,0.004687036,0.00042912032,0.00014385907,0.0010780559],"genre_scores_gemma":[0.8480872,0.11246328,0.0003938738,0.000972421,0.0022294133,0.0044981604,0.000041855048,0.0001431747,0.031170638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942354,0.00044570587,0.00092991185,0.0011846884,0.0015054889,0.0016988165],"domain_scores_gemma":[0.9951323,0.0015316174,0.00016388013,0.00064749666,0.0017370817,0.00078760175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038004576,0.0003289216,0.0007285439,0.0002315628,0.0005101833,0.00008303038,0.00042675814,0.00027752985,0.001507866],"category_scores_gemma":[0.0013400222,0.0001885014,0.0004511903,0.0005727633,0.0010481369,0.000226488,0.00021189073,0.00083010946,0.00016339075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05819153,0.000779605,0.026150279,0.00030468297,0.0005280964,0.00019901295,0.00017283215,0.000007945274,0.2556107,0.00020146336,0.04120417,0.6166497],"study_design_scores_gemma":[0.05235934,0.0093798535,0.016017767,0.001844427,0.00012708941,0.000011879534,0.00046704445,0.00007362391,0.17089881,0.00470682,0.7433087,0.000804595],"about_ca_topic_score_codex":0.00058787223,"about_ca_topic_score_gemma":0.00008671214,"teacher_disagreement_score":0.70210457,"about_ca_system_score_codex":0.0007097334,"about_ca_system_score_gemma":0.0028227044,"threshold_uncertainty_score":0.9994049},"labels":[],"label_agreement":null},{"id":"W2522467111","doi":"10.1158/1078-0432.ccr-16-1333","title":"Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Cancer research; Apoptosis; Biology; Nuclear export signal; Cancer; Transcriptome; Tissue microarray; Cancer cell; Internal medicine; Oncology; Medicine; Gene expression; Cell nucleus; Gene; Biochemistry; Genetics","score_opus":0.08905943793458003,"score_gpt":0.4270692073350998,"score_spread":0.33800976940051974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522467111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330544,0.0005213127,0.00012811559,0.0037948976,0.0006744534,0.00054240716,0.00014991999,0.000008796625,0.0008746603],"genre_scores_gemma":[0.9957076,0.0006103632,0.00017453029,0.00045387266,0.00096521573,0.00011398296,0.000010809751,0.000034298424,0.0019293485],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853647,0.00020975634,0.00033658728,0.00035753564,0.00028432297,0.00027534578],"domain_scores_gemma":[0.9990062,0.000109531065,0.00011401183,0.0003962011,0.00029445742,0.00007956064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090168015,0.000094271694,0.00015600574,0.000026775677,0.0001496043,0.000013873887,0.0002113045,0.00021724017,0.00086118357],"category_scores_gemma":[0.00037933956,0.000052901298,0.0001545338,0.00012302432,0.00033519455,0.00000542869,0.0001271631,0.00018128494,0.000014270469],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022293897,0.000050632585,0.0035405012,0.00002929569,0.00008278929,3.1149855e-7,0.000036621834,0.000001094283,0.93935794,0.0008193374,0.020545017,0.03330708],"study_design_scores_gemma":[0.0021229151,0.0018986751,0.019599251,0.00014168717,0.000026797281,0.0000011158759,0.00009578774,0.000009754866,0.24043858,0.0033659968,0.73211586,0.00018358839],"about_ca_topic_score_codex":0.00012681997,"about_ca_topic_score_gemma":0.0000960336,"teacher_disagreement_score":0.71157086,"about_ca_system_score_codex":0.000044908895,"about_ca_system_score_gemma":0.00027004554,"threshold_uncertainty_score":0.9429356},"labels":[],"label_agreement":null},{"id":"W2523893120","doi":"","title":"Development and optimization of a protocol for automated, low-throughput RNA purification from whole blood using the PAXgene blood RNA system","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA; RNA extraction; DNA; Whole blood; Nucleic acid; Biology; Molecular biology; Chromatography; Chemistry; Biochemistry; Gene; Immunology","score_opus":0.14349242283400548,"score_gpt":0.5013129238549419,"score_spread":0.3578205010209364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523893120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75190777,0.00026852766,0.20687245,0.00024719245,0.000037450292,0.04041789,0.00007253435,0.00005588313,0.00012031661],"genre_scores_gemma":[0.6642723,0.00011528435,0.22887212,0.00012752626,0.0005310352,0.10568342,0.00024940443,0.00005455605,0.00009432508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846274,0.00014859557,0.00056049303,0.0004084054,0.00017170505,0.00024808027],"domain_scores_gemma":[0.9988775,0.000095410884,0.0001855786,0.00039563363,0.000371007,0.00007485612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020584913,0.00010020582,0.00015467149,0.000035163313,0.00021253106,0.000021958313,0.0002447965,0.00025208906,0.0000048965194],"category_scores_gemma":[0.00012484757,0.00007559012,0.00005976222,0.00014801357,0.00024944244,0.0000031742145,0.00014679345,0.00015045855,5.119188e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028637043,0.0002860934,0.00061548915,0.00014362267,0.00014684675,0.000001215945,0.000043365108,0.00038999788,0.991069,0.00024374083,0.0003908338,0.0063833785],"study_design_scores_gemma":[0.001287007,0.00024774316,0.0006097224,0.000110096276,0.000041762196,0.0000030576673,0.00009260454,0.005612196,0.9765275,0.000026623138,0.015318233,0.00012345068],"about_ca_topic_score_codex":0.00008254017,"about_ca_topic_score_gemma":0.000039351984,"teacher_disagreement_score":0.087635435,"about_ca_system_score_codex":0.000021665144,"about_ca_system_score_gemma":0.00025480648,"threshold_uncertainty_score":0.30824757},"labels":[],"label_agreement":null},{"id":"W2525038995","doi":"10.1158/1078-0432.ccr-16-0987","title":"A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Discontinuation; Dutasteride; Abiraterone acetate; Urology; Prednisone; Internal medicine; Clinical endpoint; Oncology; Enzalutamide; Cancer; Androgen receptor; Androgen deprivation therapy; Clinical trial","score_opus":0.26474424529358437,"score_gpt":0.5426248698811699,"score_spread":0.2778806245875855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525038995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979015,0.0006573063,0.00008845425,0.012372307,0.000095973985,0.0067090443,0.00067552936,0.000031568572,0.00035484383],"genre_scores_gemma":[0.97844774,0.0015816392,0.0005507081,0.00006472428,0.00031510965,0.0052948305,0.000051480394,0.00007163641,0.013622123],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99604034,0.00034250205,0.0008499817,0.00068381464,0.0012436302,0.0008397266],"domain_scores_gemma":[0.9961961,0.0010397079,0.00023029667,0.0005455258,0.0015171999,0.00047119794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022882458,0.00025275798,0.0008672278,0.00020809952,0.000249226,0.00003728834,0.00021158789,0.00008671465,0.00040649346],"category_scores_gemma":[0.00029535862,0.00011850398,0.00013768121,0.00052950013,0.0012445727,0.00016762414,0.00009349587,0.00036815603,0.000006768045],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9151374,0.004520669,0.0019086421,0.0005485825,0.001031969,0.00012291707,0.0002917078,0.0000025378367,0.031511225,0.000088107416,0.00362099,0.04121522],"study_design_scores_gemma":[0.70835,0.23266482,0.0016265119,0.0018778477,0.00046303472,0.000007872798,0.00036222447,0.000094017414,0.046651095,0.00027264454,0.007308485,0.00032142113],"about_ca_topic_score_codex":0.00055609434,"about_ca_topic_score_gemma":0.0007959097,"teacher_disagreement_score":0.22814415,"about_ca_system_score_codex":0.00033902135,"about_ca_system_score_gemma":0.0032672402,"threshold_uncertainty_score":0.5795944},"labels":[],"label_agreement":null},{"id":"W2525564587","doi":"10.1158/1078-0432.ccr-16-0844","title":"Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Pemetrexed; Mesothelioma; Cisplatin; Cancer; Pathology; Oncology; Chemotherapy; Pleural disease; Cancer research; Internal medicine; Respiratory disease; Lung","score_opus":0.1827863891041366,"score_gpt":0.49079579224057573,"score_spread":0.3080094031364391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525564587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925038,0.0007594365,0.000007845191,0.0049237343,0.00018117989,0.0004148351,0.0003064585,0.00004080287,0.00086186733],"genre_scores_gemma":[0.9964892,0.00054462056,0.00009495934,0.0006577278,0.0006001022,0.00015451865,0.000069721726,0.000027791371,0.0013613165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972926,0.000252086,0.0005088395,0.00050063594,0.0009879498,0.0004579216],"domain_scores_gemma":[0.9983152,0.00057832984,0.00006621671,0.00041715158,0.00011281211,0.00051024545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047966323,0.00013221912,0.0002807624,0.00009107595,0.00016607522,0.000027054177,0.00016157948,0.00009958794,0.0063834335],"category_scores_gemma":[0.000283927,0.00007710137,0.0001773685,0.00015749954,0.0005904583,0.00010165325,0.00023180265,0.00024992373,0.0005306788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016439896,0.0008739163,0.8050363,0.00002677136,0.00013362235,0.00010387815,0.000060636412,4.9779356e-7,0.10605718,0.0000827801,0.019204767,0.06677568],"study_design_scores_gemma":[0.0025094142,0.001163866,0.95190245,0.00030916472,0.000045795503,0.0000015833679,0.00009242317,0.000004877563,0.015396873,0.00093294075,0.027498387,0.00014223167],"about_ca_topic_score_codex":0.00082197343,"about_ca_topic_score_gemma":0.00007879826,"teacher_disagreement_score":0.14686616,"about_ca_system_score_codex":0.0002334679,"about_ca_system_score_gemma":0.0001546344,"threshold_uncertainty_score":0.9945249},"labels":[],"label_agreement":null},{"id":"W2525688488","doi":"10.1158/1078-0432.ccr-16-1224","title":"The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Université de Montréal","funders":"National Cancer Institute","keywords":"Prostate cancer; Context (archaeology); Oncology; Medicine; Proportional hazards model; Internal medicine; Population; Biomarker; Enumeration; Circulating tumor cell; Cancer; Metastasis; Biology; Mathematics","score_opus":0.17360426255789002,"score_gpt":0.5257510472557954,"score_spread":0.35214678469790534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525688488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886079,0.0012301557,0.000021389082,0.007140577,0.000121153025,0.0025988203,0.00006895945,0.000012844974,0.00019824631],"genre_scores_gemma":[0.99668527,0.00096895546,0.00043190247,0.000045313696,0.00010109823,0.0013402577,0.000014611368,0.000031806,0.0003808062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953703,0.0010822305,0.0011091746,0.0005206501,0.0012292742,0.00068831304],"domain_scores_gemma":[0.9968045,0.0018675003,0.00018680029,0.00028818953,0.00062817294,0.00022486223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006127142,0.00015666118,0.0004581699,0.0003436701,0.00019375398,0.00009510419,0.00015895818,0.00006866242,0.000093033304],"category_scores_gemma":[0.0016832406,0.00008990394,0.00009782694,0.0011840232,0.00025452283,0.00022605424,0.00008536765,0.0005063172,0.0000047275144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073569664,0.00028171422,0.8292583,0.00036512877,0.000069993206,0.00011120364,0.00051320967,0.00018054545,0.03494986,0.00007828693,0.000254101,0.12658067],"study_design_scores_gemma":[0.0064944876,0.0011784625,0.9736178,0.0023918473,0.00004032898,0.0000018249776,0.00085301214,0.00085823296,0.01362792,0.00043837514,0.0003308265,0.00016688638],"about_ca_topic_score_codex":0.00458052,"about_ca_topic_score_gemma":0.0055139204,"teacher_disagreement_score":0.14435948,"about_ca_system_score_codex":0.0012601716,"about_ca_system_score_gemma":0.001971434,"threshold_uncertainty_score":0.6924407},"labels":[],"label_agreement":null},{"id":"W2526793520","doi":"10.1158/1078-0432.ccr-16-0453","title":"The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Minority Health and Health Disparities; National Institute of Diabetes and Digestive and Kidney Diseases; Structural Genomics Consortium; Ontario Ministry of Economic Development and Innovation; National Institute of General Medical Sciences; Ontario Genomics Institute; Vanderbilt University; Wellcome Trust; National Cancer Institute; National Institutes of Health","keywords":"BET inhibitor; Bromodomain; Colorectal cancer; Cancer research; MAPK/ERK pathway; Cancer; Medicine; Epigenetics; Cell growth; Pharmacology; Signal transduction; Biology; Internal medicine; Biochemistry","score_opus":0.0648854301857114,"score_gpt":0.42844302759857616,"score_spread":0.36355759741286475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526793520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800743,0.0033320282,0.0000116919655,0.014615572,0.0005805799,0.00056408625,0.000043572545,0.000011996394,0.00076616986],"genre_scores_gemma":[0.9859314,0.0038128924,0.00004148063,0.00030850677,0.0011805501,0.0005930891,0.0000057684524,0.000025328367,0.008100964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741995,0.00051936164,0.00051122694,0.0005651644,0.00042518126,0.0005590936],"domain_scores_gemma":[0.9986156,0.0003627441,0.000070496775,0.00041006715,0.0003202389,0.00022083445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025883478,0.00012888454,0.0001756736,0.0000756141,0.00020137867,0.000050970903,0.00047591282,0.0002089798,0.00007367794],"category_scores_gemma":[0.0020423492,0.000075509146,0.000093393275,0.00041105438,0.0005089325,0.000007856825,0.00035261805,0.00032366547,0.0000520324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023172472,0.00011269503,0.05061243,0.000019724097,0.000045740635,0.000008812412,0.000049274026,0.0000031489544,0.52210176,0.0007059535,0.18287463,0.24114855],"study_design_scores_gemma":[0.00060351903,0.00021167325,0.024070684,0.00011489654,0.0000011611122,2.4166195e-7,0.000025077836,7.6163826e-7,0.51635236,0.0003202224,0.45818073,0.000118693504],"about_ca_topic_score_codex":0.00016502527,"about_ca_topic_score_gemma":0.0081095025,"teacher_disagreement_score":0.27530608,"about_ca_system_score_codex":0.0001413892,"about_ca_system_score_gemma":0.0005420781,"threshold_uncertainty_score":0.45252928},"labels":[],"label_agreement":null},{"id":"W2528447231","doi":"10.1158/1078-0432.ccr-16-1730","title":"Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Princess Margaret Cancer Centre","funders":"Terry Fox Research Institute","keywords":"Plerixafor; Medicine; Cervical cancer; Chemotherapy; CXCR4; Cancer; Primary tumor; Toxicity; Lymph node; Oncology; Cisplatin; Metastasis; Internal medicine; Cancer research; Receptor","score_opus":0.10958758333207723,"score_gpt":0.465174888907309,"score_spread":0.35558730557523177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528447231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815352,0.0036055855,0.0000054613206,0.013962522,0.000053730888,0.00063801644,0.000045841796,0.000035671866,0.00011800116],"genre_scores_gemma":[0.9909627,0.0051386384,0.00027409717,0.00059625076,0.00051455013,0.00028875627,0.000005183741,0.00005356548,0.0021662966],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99700165,0.00058840174,0.00055775995,0.0006551836,0.0006050491,0.0005919634],"domain_scores_gemma":[0.9965482,0.0023885528,0.00008201699,0.0003147936,0.00026565522,0.0004008124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031518086,0.00019721292,0.00068657787,0.0002133651,0.00008526625,0.00003458957,0.00014897328,0.00012934457,0.0011329051],"category_scores_gemma":[0.00071391015,0.00010529315,0.000098753546,0.0005089214,0.0007823984,0.00010194186,0.0000833957,0.0005703328,0.0000060640896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0703052,0.0005272836,0.32192487,0.0001948624,0.00022981866,0.00020730593,0.0001536148,5.519025e-7,0.39130396,0.000010172994,0.004543079,0.2105993],"study_design_scores_gemma":[0.019980323,0.0039433106,0.70292723,0.0019800174,0.000095067706,0.000052785315,0.0002158321,0.00006154448,0.2376667,0.0000658278,0.032577343,0.00043403992],"about_ca_topic_score_codex":0.00091394084,"about_ca_topic_score_gemma":0.0001817634,"teacher_disagreement_score":0.38100237,"about_ca_system_score_codex":0.00035809452,"about_ca_system_score_gemma":0.0010693474,"threshold_uncertainty_score":0.9997802},"labels":[],"label_agreement":null},{"id":"W2529309126","doi":"10.1158/1078-0432.ccr-16-0985","title":"Significance of <i>TP53</i> Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Anaplasia; Wilms' tumor; Wilms tumour; Immunohistochemistry; Mutation; Clinical significance; Medicine; Cancer; Oncology; Biology; Pathology; Cancer research; Internal medicine; Genetics; Gene","score_opus":0.046183534993365055,"score_gpt":0.4099504478028438,"score_spread":0.3637669128094787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529309126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995127,0.0010524394,0.000118416596,0.0026045814,0.00011702696,0.0004062854,0.00004675992,0.00000527788,0.0005222129],"genre_scores_gemma":[0.99605834,0.0027741608,0.00006973386,0.00018136253,0.00037137317,0.00015364002,0.000040705097,0.00001882355,0.0003318341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773115,0.0005126326,0.0005331586,0.00053204724,0.00035991275,0.0003310766],"domain_scores_gemma":[0.99856526,0.0005009468,0.00019550862,0.00046285545,0.00016765702,0.00010779986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013520649,0.00011338316,0.00025658135,0.000037824833,0.000060894465,0.0000091705515,0.00035254832,0.00024312123,0.000031767224],"category_scores_gemma":[0.00049074116,0.000055113705,0.000087839515,0.00027863315,0.0009808177,0.000005421597,0.00011174032,0.00043331162,0.0000052636638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056874533,0.0007039977,0.6930489,0.000023479477,0.00037630377,0.00045625222,0.000133272,0.00009520283,0.16269505,0.0000947843,0.010984058,0.12570123],"study_design_scores_gemma":[0.010301414,0.005558207,0.8502023,0.00067341706,0.000062101586,0.00011795236,0.00030136984,0.000020122628,0.08664016,0.0008131086,0.044837195,0.00047265922],"about_ca_topic_score_codex":0.0022850966,"about_ca_topic_score_gemma":0.0029667576,"teacher_disagreement_score":0.15715338,"about_ca_system_score_codex":0.0000752085,"about_ca_system_score_gemma":0.00063583505,"threshold_uncertainty_score":0.36138636},"labels":[],"label_agreement":null},{"id":"W2531125083","doi":"10.1158/1078-0432.ccr-15-3069","title":"Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent; Hôpital Notre-Dame","funders":"AbbVie","keywords":"Veliparib; Carboplatin; Medicine; Placebo; PARP inhibitor; Internal medicine; Lung cancer; Paclitaxel; Clinical endpoint; Oncology; Urology; Cancer; Surgery; Chemotherapy; Randomized controlled trial; Pathology; Cisplatin; Biology; Poly ADP ribose polymerase","score_opus":0.13960711677473045,"score_gpt":0.5230751276709501,"score_spread":0.3834680108962196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531125083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98038846,0.0033290263,0.0010570833,0.0019635106,0.00018342047,0.012702084,0.0000906733,0.000018186121,0.00026753958],"genre_scores_gemma":[0.983402,0.002485265,0.00050260936,0.00012842356,0.00015905855,0.011898413,0.000006015197,0.000051003586,0.0013671726],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956695,0.0010203872,0.0013434623,0.0006717451,0.0007497838,0.00054515933],"domain_scores_gemma":[0.99082124,0.007218292,0.0003853021,0.00042382994,0.0008947439,0.00025657058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070439093,0.00023641485,0.0016962247,0.0003489449,0.00013549469,0.00001637276,0.00016069645,0.00011428557,0.00016567014],"category_scores_gemma":[0.0013749937,0.00014368979,0.00015915796,0.00044035554,0.0006295765,0.00011810815,0.000079494144,0.00051320065,0.0000012747537],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.935886,0.004799736,0.015714705,0.00052074925,0.00043697143,0.000020086782,0.0013922087,0.00005970989,0.003238204,0.000060148315,0.00069413433,0.03717732],"study_design_scores_gemma":[0.9808166,0.010767542,0.0011489979,0.0011943768,0.00029519838,0.0000016200709,0.00072333496,0.0022639723,0.0020366495,0.00035317312,0.00020791795,0.00019064237],"about_ca_topic_score_codex":0.00070162455,"about_ca_topic_score_gemma":0.0011051238,"teacher_disagreement_score":0.04493055,"about_ca_system_score_codex":0.00033492805,"about_ca_system_score_gemma":0.00092067954,"threshold_uncertainty_score":0.58594996},"labels":[],"label_agreement":null},{"id":"W2532841680","doi":"10.1158/1078-0432.ccr-16-0184","title":"New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; SAIT Polytechnic","funders":"","keywords":"Multiple myeloma; Medicine; Immunotherapy; Cancer; Oncology; Immunology; Internal medicine","score_opus":0.262883191333897,"score_gpt":0.5140105323390389,"score_spread":0.25112734100514195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532841680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006636939,0.970881,0.00037702668,0.00032358474,0.0002536586,0.013940787,0.0006988317,0.00013809616,0.006750106],"genre_scores_gemma":[0.004534943,0.9782991,0.0032019697,0.000097213764,0.000998126,0.004072444,0.0005326117,0.0003671771,0.0078964345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891771,0.0011700703,0.002031413,0.0023713543,0.0028741246,0.0023759513],"domain_scores_gemma":[0.99019814,0.004435339,0.0003438632,0.0020145646,0.0009310439,0.0020770682],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021463397,0.0011065055,0.004066732,0.0013490814,0.00027745598,0.00024870754,0.0012080887,0.0010125003,0.00062734296],"category_scores_gemma":[0.002490719,0.00064282643,0.00087067724,0.00214856,0.0006488708,0.0002903015,0.00053427054,0.0028979848,0.0011139411],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007032399,0.0032014716,0.025485687,0.0044314885,0.00077611813,0.00014875326,0.00011523527,0.0000011056097,0.00000479432,0.00006174569,0.0020985343,0.9566427],"study_design_scores_gemma":[0.039850462,0.005086477,0.05621523,0.02519001,0.00023334831,0.00002937332,0.00012536686,0.000020688141,0.000008153566,0.000061274215,0.87212515,0.0010544775],"about_ca_topic_score_codex":0.005034265,"about_ca_topic_score_gemma":0.0009890348,"teacher_disagreement_score":0.95558816,"about_ca_system_score_codex":0.0017459824,"about_ca_system_score_gemma":0.009037091,"threshold_uncertainty_score":0.99966383},"labels":[],"label_agreement":null},{"id":"W2533101571","doi":"10.1158/1078-0432.ccr-16-1790","title":"A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Bicalutamide; Prostate cancer; Urology; Medicine; Testosterone (patch); Agonist; Antiandrogen; Goserelin; Luteinizing hormone; Androgen deprivation therapy; Dihydrotestosterone; Prostatectomy; Internal medicine; Leuprorelin; Hormone; Endocrinology; Androgen; Gonadotropin-releasing hormone; Cancer; Androgen receptor; Receptor","score_opus":0.2569833737468409,"score_gpt":0.5723141692703112,"score_spread":0.3153307955234703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533101571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718213,0.0012640433,0.0000026268735,0.0069905976,0.0005778321,0.018448412,0.00020818049,0.00003637699,0.0006506367],"genre_scores_gemma":[0.98064643,0.0038958127,0.00010903628,0.00015083795,0.00024047989,0.009313503,0.000027946739,0.000085172294,0.0055307928],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9915143,0.0016544804,0.0018744224,0.0013589464,0.002146227,0.001451613],"domain_scores_gemma":[0.9936177,0.002578612,0.0002512709,0.0008845752,0.0015865389,0.0010812997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006581646,0.0003869774,0.0019197579,0.00058679364,0.0003425579,0.00009270594,0.0009012342,0.00019713365,0.00066105643],"category_scores_gemma":[0.0035804808,0.00022270142,0.00017735008,0.0015450983,0.0014399278,0.00025064967,0.0015092255,0.0011605015,0.00007596894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70149314,0.037887536,0.04353072,0.00014759238,0.00046276228,0.0002344658,0.0013738304,9.901346e-7,0.0005945261,0.000020502135,0.0035244187,0.2107295],"study_design_scores_gemma":[0.9345669,0.04728045,0.0070669707,0.0014330382,0.00014136684,9.2116323e-7,0.00036762867,0.000042739946,0.0018402705,0.00008330138,0.0068617146,0.00031470117],"about_ca_topic_score_codex":0.004824019,"about_ca_topic_score_gemma":0.0022269175,"teacher_disagreement_score":0.23307374,"about_ca_system_score_codex":0.0012090547,"about_ca_system_score_gemma":0.0031603016,"threshold_uncertainty_score":0.90815},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2533262657","doi":"10.1158/1078-0432.ccr-16-1241","title":"An Open-Label, Dose–Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Adverse effect; Melanoma; Internal medicine; Cancer; Oncology; Monoclonal antibody; Refractory (planetary science); Maximum tolerated dose; Gastroenterology; Antibody; Pharmacology; Immunology; Cancer research","score_opus":0.1974395985532057,"score_gpt":0.5574835291935856,"score_spread":0.3600439306403799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533262657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972639,0.000048570826,0.0004937639,0.000085833264,0.00016794735,0.0017284339,0.0001409998,0.000006052416,0.000064502594],"genre_scores_gemma":[0.9980232,0.00020285601,0.0004891465,0.000040541567,0.00026307322,0.00022635034,0.00031150103,0.00003170889,0.000411605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975738,0.0005324505,0.0005443539,0.0006006556,0.00044865633,0.00030006762],"domain_scores_gemma":[0.9981381,0.00029675636,0.00019396181,0.00051116623,0.0006925978,0.00016741583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001565715,0.00013011135,0.00027669795,0.000063857995,0.00014104879,0.00003896626,0.00047282185,0.00016756811,0.0001046867],"category_scores_gemma":[0.00046995387,0.00007765854,0.00002972094,0.00015065345,0.00018797744,0.000029547136,0.0001533501,0.00014101078,0.000004006156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03319148,0.017690655,0.47577342,0.00004984171,0.00023262374,0.000005872338,0.00012252537,0.0000030073722,0.39755878,0.000030821586,0.0028386265,0.072502345],"study_design_scores_gemma":[0.13054962,0.2053177,0.60122573,0.00020946405,0.000105883075,0.0000013800959,0.00044205674,0.00023064525,0.050863806,0.00012486127,0.010292003,0.00063683314],"about_ca_topic_score_codex":0.00009058188,"about_ca_topic_score_gemma":0.00012812523,"teacher_disagreement_score":0.34669495,"about_ca_system_score_codex":0.000036803976,"about_ca_system_score_gemma":0.0003333532,"threshold_uncertainty_score":0.3166823},"labels":[],"label_agreement":null},{"id":"W2533419167","doi":"10.1158/1078-0432.ccr-16-0460","title":"Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Niche; Metastasis; Tumor microenvironment; Biology; Cancer research; Medicine; Cancer; Tumor cells; Ecology; Genetics","score_opus":0.21651350391828286,"score_gpt":0.49994288196650516,"score_spread":0.2834293780482223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533419167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013077873,0.9939355,0.0000021698397,0.0001987899,0.0009340721,0.0025695139,0.0008205514,0.000009409578,0.00022217224],"genre_scores_gemma":[0.0006201936,0.99232656,0.000057636837,0.000070936934,0.00011607474,0.0015235419,0.000030233985,0.000070687325,0.0051841293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908245,0.0053719836,0.0017575655,0.0009634669,0.00025021998,0.0008322662],"domain_scores_gemma":[0.99362475,0.0041827713,0.00045022584,0.0015770524,0.000104706014,0.000060524904],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0037817422,0.0003818034,0.002153183,0.00026815163,0.00010293485,0.000015332522,0.0020893158,0.000666192,0.005120432],"category_scores_gemma":[0.0010184441,0.00021259607,0.00072526955,0.00056703255,0.0013479316,0.00004352911,0.0017427768,0.002366913,0.0018623422],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015750689,0.0002629449,0.00015494307,0.0014810917,0.00071450043,0.0000029211858,0.0001778592,3.6859674e-7,0.0009784896,0.000014102741,0.004048941,0.9920063],"study_design_scores_gemma":[0.0005686491,0.0001758845,0.00092361035,0.012671873,0.0002784286,0.0000022679035,0.0000410214,6.423167e-8,0.001611952,0.00013121337,0.9833682,0.00022684259],"about_ca_topic_score_codex":0.0011004574,"about_ca_topic_score_gemma":0.00033181946,"teacher_disagreement_score":0.9917795,"about_ca_system_score_codex":0.00057052844,"about_ca_system_score_gemma":0.0011547435,"threshold_uncertainty_score":0.9999347},"labels":[],"label_agreement":null},{"id":"W2540213618","doi":"10.1158/1557-3265.hemmal14-a19","title":"Abstract A19: MALT1 inhibition as an anchor for combinatorial therapy of ABC-DLBCL.","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal","funders":"","keywords":"Cancer research; breakpoint cluster region; Diffuse large B-cell lymphoma; Chemistry; Cell growth; Biology; Lymphoma; Molecular biology; Cell biology; Receptor; Biochemistry; Immunology","score_opus":0.7850792158000355,"score_gpt":0.6958353942198646,"score_spread":0.08924382158017086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540213618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987335,0.0011464597,0.0000116462215,0.001395038,0.0035618974,0.0008467446,0.00015161558,0.000030363522,0.0029828714],"genre_scores_gemma":[0.9943081,0.002281427,0.000059045444,0.0006482708,0.0021444713,0.0001936441,0.00004461906,0.000027461929,0.000292976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971451,0.000878916,0.0005778075,0.00043147037,0.00044469011,0.0005219917],"domain_scores_gemma":[0.99681216,0.0011664465,0.00015982785,0.00024749446,0.0010459636,0.00056809676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0063257325,0.00014585031,0.00035657253,0.00008399364,0.00022355819,0.0000316615,0.0003345246,0.00042366397,0.0009536217],"category_scores_gemma":[0.0006012387,0.0001269754,0.00016328889,0.00023989262,0.0008006728,0.00016765553,0.00009137276,0.001152775,0.00007070229],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060004517,0.021490674,0.1774952,0.00036448648,0.0009022372,0.00012663467,0.0012231716,0.00004548359,0.06387815,0.02561027,0.3270511,0.3218081],"study_design_scores_gemma":[0.028594617,0.006725105,0.04530979,0.000086733606,0.000039885825,0.0000039958436,0.0004070419,0.0004301516,0.083960846,0.04139673,0.7926006,0.00044456238],"about_ca_topic_score_codex":0.0001918901,"about_ca_topic_score_gemma":0.000037463473,"teacher_disagreement_score":0.46554947,"about_ca_system_score_codex":0.00010315171,"about_ca_system_score_gemma":0.00069567695,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W2550395684","doi":"10.1158/1078-0432.ccr-16-1640","title":"BRM Promoter Polymorphisms and Survival of Advanced Non–Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Biology; Epigenetics; Promoter; Chromatin immunoprecipitation; Lung cancer; Cancer research; Hazard ratio; Gene; Genetics; Oncology; Internal medicine; Gene expression; Medicine; Confidence interval","score_opus":0.06154146814150814,"score_gpt":0.42101119650562585,"score_spread":0.3594697283641177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550395684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548703,0.0022242032,0.00003384237,0.0005647074,0.00034722712,0.0010038131,0.00006475818,0.0000033894937,0.0002710373],"genre_scores_gemma":[0.9921095,0.006522083,0.000050010105,0.000085427375,0.00036328653,0.00026636137,0.000010332806,0.00001964121,0.0005733674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773943,0.0004097871,0.00049024815,0.00055281754,0.00043400697,0.00037368108],"domain_scores_gemma":[0.9989296,0.0002379555,0.00011793882,0.000363745,0.00023949548,0.000111236484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020373815,0.00014113917,0.00028910447,0.000042431944,0.00007052145,0.000023949351,0.00031551713,0.00021164918,0.00003611009],"category_scores_gemma":[0.0002468686,0.000084278945,0.00006807408,0.00011463983,0.00040178673,0.000007385067,0.00024955373,0.0002980426,6.9322823e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007888223,0.00037894366,0.92489874,0.00016566583,0.000062231185,0.0000026792338,0.00015519233,0.000007424571,0.025182158,0.000008799487,0.0012853579,0.039964598],"study_design_scores_gemma":[0.06783522,0.0034921921,0.8764741,0.0006970533,0.00008341581,0.0000017879267,0.00016303315,0.00030138824,0.041390415,0.00018710729,0.00873337,0.0006409364],"about_ca_topic_score_codex":0.00069631176,"about_ca_topic_score_gemma":0.0011359274,"teacher_disagreement_score":0.05994699,"about_ca_system_score_codex":0.00004039902,"about_ca_system_score_gemma":0.00035340842,"threshold_uncertainty_score":0.34367958},"labels":[],"label_agreement":null},{"id":"W2550646651","doi":"10.1158/1078-0432.ccr-16-1700","title":"TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Lawson Health Research Institute; Western University; Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Phagocytosis; Cancer research; Macrophage; Immune system; Innate immune system; In vivo; Flow cytometry; Immunology; Antibody; Biology; Cancer cell; Cancer; In vitro; Biochemistry","score_opus":0.10955072930007535,"score_gpt":0.4224291831128441,"score_spread":0.31287845381276874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550646651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150103,0.0051234434,0.00005127674,0.0020189201,0.00047749138,0.00044891558,0.000042284326,0.00005860542,0.00027802304],"genre_scores_gemma":[0.9945081,0.0024590902,0.000046027835,0.00002927212,0.00022309911,0.00009445111,0.000009184902,0.000038401682,0.0025924041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966857,0.0008373263,0.0006690789,0.00075194566,0.000193507,0.0008624305],"domain_scores_gemma":[0.9978792,0.0009914944,0.0002454462,0.00047991527,0.00031187825,0.000092072216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00293906,0.00024580077,0.0006091797,0.0002334044,0.0005192311,0.00006661817,0.00030594878,0.000364698,0.00038126358],"category_scores_gemma":[0.0005810641,0.00015474262,0.00014367398,0.00038407373,0.0015510086,0.00035976805,0.00048162512,0.00094970426,0.00016894931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024633673,0.00019977395,0.025876455,0.000046620833,0.00019325162,0.000012263422,0.00009337801,2.7951498e-7,0.896908,0.00007298716,0.00047200877,0.07366162],"study_design_scores_gemma":[0.005228966,0.0011365308,0.30568403,0.0007459715,0.000035172056,0.000042917814,0.00008430826,0.000010082493,0.6739209,0.000052009105,0.012744046,0.00031504512],"about_ca_topic_score_codex":0.00042729994,"about_ca_topic_score_gemma":0.00013434923,"teacher_disagreement_score":0.27980757,"about_ca_system_score_codex":0.0001972411,"about_ca_system_score_gemma":0.00038765787,"threshold_uncertainty_score":0.6310221},"labels":[],"label_agreement":null},{"id":"W2553214654","doi":"10.1158/1078-0432.ccr-16-1357","title":"Neoadjuvant Enzalutamide Prior to Prostatectomy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Enzalutamide; Prostatectomy; Medicine; Prostate cancer; Urology; Oncology; Internal medicine; Cancer","score_opus":0.306227843421037,"score_gpt":0.5871699679220427,"score_spread":0.2809421245010057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553214654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92562115,0.0018077277,0.000070805094,0.06475573,0.0003861358,0.0024746307,0.000068198504,0.000119134405,0.0046964767],"genre_scores_gemma":[0.9334502,0.00424565,0.00042065003,0.0010529581,0.0012168115,0.0011245861,0.0000068990526,0.00007138065,0.058410842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954885,0.00040411117,0.0006171364,0.0008522674,0.0013989902,0.0012389927],"domain_scores_gemma":[0.995729,0.0012801139,0.000046886846,0.0007729409,0.0009471005,0.0012239205],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003388207,0.00019266066,0.0005143446,0.00034050105,0.00022002382,0.000050437175,0.00034541442,0.0001831217,0.0019329591],"category_scores_gemma":[0.0020317023,0.000101971535,0.00020120115,0.0008885065,0.00066379696,0.00010783912,0.00037937777,0.0007736254,0.0021595594],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008481487,0.0005906802,0.15076543,0.00013597621,0.00018165614,0.00042179096,0.00018358357,4.180193e-7,0.026220229,0.0001762188,0.06353972,0.7493028],"study_design_scores_gemma":[0.014823129,0.005561126,0.25048855,0.0015552038,0.000053553547,0.000022578835,0.00013238318,0.000011103158,0.05106805,0.0009846932,0.6749081,0.00039155863],"about_ca_topic_score_codex":0.00026814244,"about_ca_topic_score_gemma":0.000092256385,"teacher_disagreement_score":0.74891126,"about_ca_system_score_codex":0.00065786147,"about_ca_system_score_gemma":0.0017017674,"threshold_uncertainty_score":0.9989794},"labels":[],"label_agreement":null},{"id":"W2553293645","doi":"10.1158/1078-0432.ccr-16-1617","title":"E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Institute on Deafness and Other Communication Disorders; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Antibody; Stage (stratigraphy); Biomarker; Internal medicine; Oncology; Disease; Gastroenterology; Cancer; Papillomaviridae; Human papillomavirus; Immunology; Cervical cancer; Biology","score_opus":0.10375449504864877,"score_gpt":0.46487705244048677,"score_spread":0.361122557391838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553293645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548495,0.0019870843,0.000008180166,0.0005635031,0.00014251613,0.00085386186,0.00036415717,0.000013597446,0.00058216974],"genre_scores_gemma":[0.99849683,0.00076928147,0.00006276559,0.00007553456,0.000118778575,0.00006200232,0.000011914124,0.000031793257,0.00037111808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679744,0.00037622606,0.00065733684,0.0007146415,0.0008173132,0.00063703745],"domain_scores_gemma":[0.9978567,0.0005942162,0.0001799555,0.00037585298,0.0006770015,0.00031632322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010056769,0.00021040441,0.0007834355,0.00020809681,0.00015378992,0.000011382597,0.00017957507,0.00014417969,0.00015499599],"category_scores_gemma":[0.00029654003,0.0001323864,0.00008566811,0.00042428862,0.0012161618,0.00013846678,0.00023115658,0.0005247651,0.00000696919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005066353,0.0005961974,0.95900077,0.00029471415,0.000041672254,0.00012168114,0.000153228,3.1323637e-7,0.006702025,0.000009425949,0.00031024995,0.027703356],"study_design_scores_gemma":[0.012045306,0.0051787077,0.977006,0.00084911135,0.00003053847,7.4928886e-7,0.00015655962,0.0000032895316,0.0043055955,0.000018709516,0.00022856222,0.00017685721],"about_ca_topic_score_codex":0.00057744037,"about_ca_topic_score_gemma":0.00035664657,"teacher_disagreement_score":0.027526498,"about_ca_system_score_codex":0.00020552421,"about_ca_system_score_gemma":0.00037948645,"threshold_uncertainty_score":0.5398561},"labels":[],"label_agreement":null},{"id":"W2556245106","doi":"10.1158/1078-0432.ccr-16-1708","title":"Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Center of Competence in Research Chemical Biology; Swiss Cancer Research Foundation; Ludwig Institute for Cancer Research; Centre Hospitalier Universitaire Vaudois; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research Institute; National Science Foundation","keywords":"Effector; Stem cell; Melanoma; Immunology; Biology; Cancer research; Medicine; Cell biology","score_opus":0.049189110276810596,"score_gpt":0.372197245648685,"score_spread":0.3230081353718744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556245106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773895,0.021173662,0.000006559201,0.0002095747,0.0005430808,0.0005981248,0.00002327529,0.000019661657,0.000036535206],"genre_scores_gemma":[0.98577285,0.0108247865,0.0000020194295,0.000045048782,0.000027624503,0.00008341816,0.000013339443,0.000020399506,0.0032104955],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99621016,0.0023302496,0.00050342234,0.0004381664,0.00007892823,0.0004390896],"domain_scores_gemma":[0.99684775,0.0025774874,0.00010559836,0.00026929873,0.00015620192,0.000043646203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00160131,0.00015637744,0.00038950334,0.00018931185,0.0001539596,0.000028285885,0.00019858418,0.0003380332,0.0005310362],"category_scores_gemma":[0.00017223056,0.00010395902,0.00005830757,0.00013975521,0.00043363572,0.00011279515,0.00019015842,0.0004890134,0.00011968022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031977282,0.00022649477,0.33458823,0.000053468564,0.00005916527,0.000002958457,0.0001918748,6.5327486e-9,0.324935,0.0000025550305,0.00032617516,0.33641636],"study_design_scores_gemma":[0.009041683,0.0009404868,0.75953263,0.00015411245,0.00001023214,8.5831493e-7,0.00002536489,5.5193937e-7,0.22849895,0.000014320245,0.001650482,0.00013032483],"about_ca_topic_score_codex":0.00016733255,"about_ca_topic_score_gemma":0.00008372945,"teacher_disagreement_score":0.42494443,"about_ca_system_score_codex":0.00007824876,"about_ca_system_score_gemma":0.00008123464,"threshold_uncertainty_score":0.58144736},"labels":[],"label_agreement":null},{"id":"W2558481997","doi":"10.1158/1078-0432.ccr-16-0133","title":"Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Reprogramming; Effector; Cancer; Phenotype; Medicine; Macrophage; Cancer research; Bioinformatics; Immunology; Biology; Cell; In vitro; Internal medicine; Gene; Genetics","score_opus":0.20808815734506164,"score_gpt":0.4914011704334131,"score_spread":0.28331301308835144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558481997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012411577,0.9934391,0.000640689,0.00015248675,0.0026511014,0.0015557251,0.00035530818,0.000062556275,0.0010189187],"genre_scores_gemma":[0.0007529341,0.98929876,0.00033502793,0.00010914966,0.00016904922,0.0010233581,0.00003595873,0.00017039916,0.00810537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916708,0.003529278,0.0019891884,0.0012320724,0.00032951147,0.0012491486],"domain_scores_gemma":[0.993813,0.0031532575,0.0005307109,0.0017024181,0.0006809235,0.00011973635],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.004959399,0.00054448453,0.0027732635,0.0003728483,0.00021013843,0.000029007064,0.0020648057,0.001427962,0.003417652],"category_scores_gemma":[0.0014943214,0.00038989066,0.0009437781,0.00087193155,0.0011054911,0.000052590836,0.0010079475,0.0023587977,0.0017380699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026156043,0.00011453504,0.0000029057203,0.0046631647,0.0010166276,0.00003849952,0.00009021631,3.9020773e-7,0.012730341,0.0016813355,0.0072705587,0.9721299],"study_design_scores_gemma":[0.00062087155,0.00026796033,0.000005961521,0.017320184,0.00011233504,0.0000036222268,0.00003513437,2.359602e-8,0.011404767,0.0013258889,0.968488,0.00041530188],"about_ca_topic_score_codex":0.000058072455,"about_ca_topic_score_gemma":0.00003968968,"teacher_disagreement_score":0.97171456,"about_ca_system_score_codex":0.00046327148,"about_ca_system_score_gemma":0.0016165165,"threshold_uncertainty_score":0.9999428},"labels":[],"label_agreement":null},{"id":"W2560151975","doi":"10.1158/1078-0432.ccr-16-1922","title":"Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Diffuse large B-cell lymphoma; Mutant; Cancer research; Lymphoma; Mutation; Biology; Gene; Genetics; Computational biology; Immunology","score_opus":0.17577848966985388,"score_gpt":0.49663357487402604,"score_spread":0.32085508520417216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560151975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557424,0.0022937756,0.000009276891,0.00095615984,0.00005928565,0.00048886216,0.0005271348,0.00000922367,0.000082057144],"genre_scores_gemma":[0.97494686,0.024492044,0.00007301176,0.00009686172,0.00006234849,0.00007325917,0.000038318154,0.000014106234,0.00020317224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963998,0.0007726205,0.0013695374,0.0006398255,0.00037277673,0.0004454049],"domain_scores_gemma":[0.98971504,0.008911161,0.00026252,0.00040134962,0.00039530953,0.0003146409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029211228,0.00016279983,0.0011711869,0.00033904632,0.000075872886,0.000011342489,0.000121412,0.00030065965,0.00011279567],"category_scores_gemma":[0.0046143467,0.00009908298,0.00026870522,0.0008752257,0.0009054963,0.00005529376,0.00020922789,0.0002112604,0.000008274426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011596306,0.009214923,0.9736028,0.00003061549,0.0007054388,0.00013863966,0.00006654304,6.916087e-7,0.00091305,0.000023144883,0.0002792151,0.013865316],"study_design_scores_gemma":[0.022945102,0.0017624942,0.97286147,0.0002041913,0.0004990307,0.0000029474766,0.000057010977,0.0004996725,0.00072761753,0.000051086514,0.00028498497,0.000104417224],"about_ca_topic_score_codex":0.00086739764,"about_ca_topic_score_gemma":0.0017815224,"teacher_disagreement_score":0.02219827,"about_ca_system_score_codex":0.00024566046,"about_ca_system_score_gemma":0.00041169277,"threshold_uncertainty_score":0.5524137},"labels":[],"label_agreement":null},{"id":"W2560331278","doi":"10.1158/1078-0432.ccr-16-1968","title":"Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non–Small Cell Lung Cancer Patients","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Nintedanib; Vandetanib; Ramucirumab; Sunitinib; Bevacizumab; Erlotinib; Lung cancer; Oncology; Aflibercept; Sorafenib; Internal medicine; Vascular endothelial growth factor; Population; Cancer; Cancer research; Epidermal growth factor receptor; Hepatocellular carcinoma; Idiopathic pulmonary fibrosis; Lung; Chemotherapy; VEGF receptors","score_opus":0.42812998280999054,"score_gpt":0.5598813256620567,"score_spread":0.1317513428520662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560331278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020108176,0.96769327,0.00001559435,0.00027724195,0.00077061343,0.008734515,0.0022104967,0.000018702172,0.00017138732],"genre_scores_gemma":[0.0022510707,0.9767144,0.000020369496,0.000033021628,0.00078634184,0.014841669,0.00017676137,0.00012550502,0.005050905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963324,0.00038825517,0.0010246132,0.00071270874,0.00079296774,0.0007490545],"domain_scores_gemma":[0.99164367,0.005559261,0.0006768696,0.00088892673,0.0009883677,0.00024292046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010888265,0.00042776964,0.0016093623,0.00015554033,0.00049707235,0.000039133218,0.00046402126,0.00021718012,0.00015637033],"category_scores_gemma":[0.00029470408,0.00016163402,0.0011739214,0.00064485177,0.00036725122,0.000056633515,0.00008778115,0.00049790053,0.000014111282],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025859015,0.0012640075,0.018070059,0.0019966878,0.0057966304,0.000005517118,0.00031734654,0.0000041442254,8.033345e-8,0.0000037387856,0.001551317,0.97073185],"study_design_scores_gemma":[0.0068957363,0.0033569532,0.01882003,0.017148562,0.014465984,5.15743e-7,0.00006124981,0.000038731505,0.000010460565,0.0000071865975,0.93892795,0.00026661344],"about_ca_topic_score_codex":0.0015731003,"about_ca_topic_score_gemma":0.00091350765,"teacher_disagreement_score":0.97046524,"about_ca_system_score_codex":0.0016502612,"about_ca_system_score_gemma":0.002321612,"threshold_uncertainty_score":0.6591244},"labels":[],"label_agreement":null},{"id":"W2561130337","doi":"10.1158/1078-0432.ccr-16-1952","title":"A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Medical Research Council; Cancerfonden; University of Leeds; Breast Cancer Research Trust; Breast Cancer Campaign","keywords":"Breast cancer; Transcriptome; Oncology; Medicine; Cancer; Biology; Internal medicine; Cancer research; Genetics; Gene; Gene expression","score_opus":0.24958663724412217,"score_gpt":0.5293314118989004,"score_spread":0.27974477465477826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561130337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723305,0.0057285577,0.000029550069,0.018817566,0.0005352507,0.0015930322,0.00016431334,0.000048924267,0.0007522859],"genre_scores_gemma":[0.98959565,0.0046864375,0.00006289043,0.00038399006,0.0007216039,0.0005544635,0.000005024372,0.00005139509,0.00393856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99516016,0.00076930935,0.0011127396,0.0008976021,0.00096020097,0.001099983],"domain_scores_gemma":[0.9971247,0.0011279644,0.00012478161,0.0004382082,0.00053908775,0.0006453025],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033892756,0.00025917732,0.0009101784,0.0003049438,0.00023809815,0.00005064173,0.00020917122,0.00028316092,0.002517237],"category_scores_gemma":[0.0007494394,0.0001816011,0.00014680922,0.00046377274,0.0012676979,0.0001466539,0.00022950978,0.0011140768,0.000106011095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057157166,0.00037328844,0.91964185,0.0008247992,0.00019961206,0.0021728377,0.00042331667,0.0000012582528,0.0007316388,0.00002340847,0.016842142,0.053050116],"study_design_scores_gemma":[0.0057782084,0.0003463048,0.9881937,0.00094465545,0.00012449347,0.0018787213,0.0010124646,0.0002483544,0.000045319546,0.00013027269,0.0010752222,0.00022227711],"about_ca_topic_score_codex":0.013821813,"about_ca_topic_score_gemma":0.008754363,"teacher_disagreement_score":0.06855184,"about_ca_system_score_codex":0.00037872398,"about_ca_system_score_gemma":0.0011310278,"threshold_uncertainty_score":0.9983946},"labels":[],"label_agreement":null},{"id":"W2562462106","doi":"10.1158/1557-3265.ovcasymp14-poster-ther-1410","title":"Abstract POSTER-THER-1410: Combining small molecule drugs and standard chemotherapy for treatment of granulosa cell tumour cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain Tumour Foundation of Canada; University of Alberta","funders":"","keywords":"XIAP; Carboplatin; Apoptosis; Viability assay; Programmed cell death; Cancer cell; Inhibitor of apoptosis; Cell culture; In vitro; Chemistry; Cancer research; Chemotherapy; Cell; Cancer; Pharmacology; Caspase; Biology; Cisplatin; Medicine; Biochemistry; Internal medicine","score_opus":0.13943149301767244,"score_gpt":0.4645891736443152,"score_spread":0.32515768062664274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562462106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915454,0.005178024,0.000043190794,0.0004908197,0.00010527776,0.00093947764,0.00033892115,0.000007777544,0.0013511288],"genre_scores_gemma":[0.9934556,0.0048514903,0.0002715157,0.000075266325,0.00025177762,0.00024898243,0.00007700281,0.000045180477,0.0007232051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979173,0.00017499622,0.0004039027,0.0005551437,0.00039956527,0.0005490947],"domain_scores_gemma":[0.9983757,0.00019755177,0.00010073961,0.0003813599,0.00049389066,0.00045075544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011033181,0.00018728238,0.0003814016,0.00006949892,0.00009297099,0.00004671847,0.0002196639,0.00016681995,0.000038229955],"category_scores_gemma":[0.00008732789,0.00015420103,0.00018245986,0.00010916875,0.00035957762,0.000005342747,0.00010382562,0.0001316994,0.0000061351975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032592654,0.0036566667,0.022794072,0.0004692862,0.0009499504,0.00005418853,0.0011488944,0.000023881106,0.7596971,0.00003017011,0.019464558,0.15911861],"study_design_scores_gemma":[0.013979146,0.010684042,0.0017175156,0.000043949534,0.000029341025,0.0000014455019,0.00027349903,0.000017689508,0.94675446,0.00022262713,0.02606934,0.00020696022],"about_ca_topic_score_codex":0.0010511841,"about_ca_topic_score_gemma":0.00034207208,"teacher_disagreement_score":0.18705738,"about_ca_system_score_codex":0.00010848632,"about_ca_system_score_gemma":0.00074295735,"threshold_uncertainty_score":0.6288135},"labels":[],"label_agreement":null},{"id":"W2563017322","doi":"10.1158/1557-3265.ovcasymp14-as18","title":"Abstract AS18: The somatic mutational landscape of endometriosis associated ovarian cancers and precursor lesions","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Université de Montréal; BC Cancer Agency; University of British Columbia","funders":"","keywords":"ARID1A; Biology; Endometriosis; Somatic cell; Cancer research; Mutation; Somatic evolution in cancer; Ovarian cancer; Genetics; Gene; Cancer; Pathology; Medicine","score_opus":0.34112812295943756,"score_gpt":0.5212013930610312,"score_spread":0.18007327010159363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563017322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97127134,0.005140775,0.0000037013526,0.015636606,0.00029153065,0.000883289,0.00013938005,0.00002142065,0.006611935],"genre_scores_gemma":[0.9967319,0.0019651656,0.00012069726,0.00021990227,0.00026312267,0.00028950916,0.000024863622,0.00001920086,0.00036563183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975247,0.00030511583,0.00054485246,0.00032817313,0.00095974177,0.00033746194],"domain_scores_gemma":[0.9938163,0.0046651782,0.00015526621,0.00031561838,0.00066063757,0.0003869937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032477973,0.00011547296,0.00041904312,0.00015629276,0.00012878007,0.000035602185,0.00014828486,0.00013238766,0.00048487567],"category_scores_gemma":[0.0054736077,0.00007236745,0.00012446559,0.0006840842,0.00040526694,0.00005818889,0.00008522703,0.0005284729,0.000026792188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011934167,0.0014547785,0.8552476,0.00018720714,0.0013226264,0.00007872116,0.0010044005,0.00007331462,0.00005400678,0.0007818973,0.05822134,0.080380686],"study_design_scores_gemma":[0.0059358226,0.0008758757,0.98627716,0.0003566362,0.00017602126,0.000005560577,0.00049289863,0.00019406964,0.00019727893,0.0009759831,0.004423245,0.00008945249],"about_ca_topic_score_codex":0.0018947239,"about_ca_topic_score_gemma":0.0006995353,"teacher_disagreement_score":0.13102955,"about_ca_system_score_codex":0.00037982184,"about_ca_system_score_gemma":0.0021116952,"threshold_uncertainty_score":0.6552815},"labels":[],"label_agreement":null},{"id":"W2563952521","doi":"10.1158/1078-0432.ccr-16-2809","title":"Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institute of Mental Health","keywords":"Ototoxicity; Hearing loss; Genetics; Mendelian inheritance; Biology; Gene; Cisplatin; Medicine; Audiology; Chemotherapy","score_opus":0.325807192970612,"score_gpt":0.4829229424264863,"score_spread":0.1571157494558743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563952521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592906,0.0001187152,0.000033284367,0.0018259034,0.00016390371,0.00066788733,0.00013837752,0.00007783314,0.0010450071],"genre_scores_gemma":[0.9966598,0.0005251341,0.00004190045,0.0011017134,0.0001422044,0.00012172472,8.68123e-7,0.00007408694,0.0013325582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937119,0.0020043768,0.00076113467,0.0011290115,0.0012177193,0.0011758546],"domain_scores_gemma":[0.9942691,0.004113566,0.00026297214,0.00056399964,0.00036157557,0.00042881077],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005198985,0.0002455824,0.00053304987,0.00022068445,0.0002718951,0.000121332145,0.0006017849,0.00037596704,0.0002728646],"category_scores_gemma":[0.01329955,0.00017072064,0.00006077984,0.0012773873,0.0009747787,0.0001418022,0.00042898403,0.00096329727,0.00007137844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037941863,0.00044882364,0.9413029,0.000020792004,0.000027577938,0.000107331485,0.00013167634,0.000010730117,0.04756111,0.000103328326,0.00073779,0.009168517],"study_design_scores_gemma":[0.004803849,0.00050682516,0.9532248,0.0008263845,0.00001451621,0.0000045894203,0.00006962145,0.00047052134,0.03513767,0.00075053435,0.0037149282,0.0004757562],"about_ca_topic_score_codex":0.00064675487,"about_ca_topic_score_gemma":0.0068859486,"teacher_disagreement_score":0.012423442,"about_ca_system_score_codex":0.00035599907,"about_ca_system_score_gemma":0.00057684083,"threshold_uncertainty_score":0.99501187},"labels":[],"label_agreement":null},{"id":"W2564624504","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1312","title":"Abstract POSTER-BIOL-1312: The role of BRCA and CEBPD in serous ovarian cancer carcinogenesis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ovarian cancer; Cancer research; Carcinogenesis; Fallopian tube; Tissue microarray; Ovarian carcinoma; Serous fluid; Serous carcinoma; Biology; Medicine; Cancer; Pathology; Immunohistochemistry; Internal medicine; Gynecology","score_opus":0.2830037735646006,"score_gpt":0.5131848304737923,"score_spread":0.23018105690919166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564624504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960046,0.021326141,2.6693021e-7,0.013230538,0.00022402103,0.0007782887,0.00007666685,0.000011897054,0.004306209],"genre_scores_gemma":[0.9924335,0.006080113,0.000032612435,0.00036323201,0.0005138886,0.00036396465,0.000006448505,0.000029437311,0.00017679922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739856,0.00028816925,0.000623033,0.0005023244,0.0006961843,0.00049175473],"domain_scores_gemma":[0.9976621,0.0007988131,0.00010344766,0.0005530065,0.00046431425,0.00041831404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002539274,0.00015808582,0.0005220327,0.00012977289,0.00007219154,0.000032246277,0.00021576232,0.00017771628,0.0003881278],"category_scores_gemma":[0.0003571861,0.000101193626,0.00011188288,0.00046325685,0.00045505882,0.00006039133,0.0001794958,0.0006275708,0.000020090978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009918307,0.00045309565,0.86318886,0.00007174792,0.00012927967,0.000060040475,0.0004759116,0.000007628655,0.00028341444,0.0001264797,0.0014719155,0.1327398],"study_design_scores_gemma":[0.003951745,0.0006532707,0.97736275,0.00030095343,0.000072024384,0.000007238829,0.00058836804,0.000034569144,0.0029369548,0.0004901114,0.013494986,0.000107027954],"about_ca_topic_score_codex":0.026173308,"about_ca_topic_score_gemma":0.0058883466,"teacher_disagreement_score":0.13263278,"about_ca_system_score_codex":0.00035992597,"about_ca_system_score_gemma":0.0013909717,"threshold_uncertainty_score":0.9803115},"labels":[],"label_agreement":null},{"id":"W2565248748","doi":"10.1158/1557-3265.ovcasymp14-as01","title":"Abstract AS01: Molecular genetic approaches to understanding ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; McGill University and Génome Québec Innovation Centre; Jewish General Hospital","funders":"","keywords":"Sanger sequencing; COLD-PCR; Ovarian cancer; Biology; Cancer research; Exome sequencing; Mutation; Carboplatin; Metastasis; Cancer; Chemotherapy; Genetics; Gene; Point mutation","score_opus":0.7612715649881563,"score_gpt":0.5303225873727327,"score_spread":0.23094897761542355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565248748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546802,0.0076808124,0.013131129,0.0107916845,0.0006772124,0.000861431,0.00006933113,0.000027956952,0.01208023],"genre_scores_gemma":[0.9951041,0.0009659797,0.00081473426,0.0005334681,0.00093926175,0.00049469527,0.000020953908,0.000045413846,0.0010814387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974962,0.00024296076,0.0004160253,0.0007265259,0.000554574,0.0005637223],"domain_scores_gemma":[0.99836594,0.0000518703,0.000064649874,0.00069017656,0.00021455082,0.00061278645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018250602,0.00015657303,0.00021002762,0.00009550696,0.00014352406,0.00009356876,0.0005073085,0.00024001481,0.0001579232],"category_scores_gemma":[0.0003218427,0.00014531703,0.000120699246,0.00037550463,0.0002645851,0.00000603427,0.00025003988,0.00041060586,0.0000691042],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004271631,0.0017085624,0.11637452,0.00031864943,0.0013600951,0.00014923395,0.0009699961,0.019067055,0.24386543,0.035272535,0.33419713,0.24244516],"study_design_scores_gemma":[0.007867571,0.0027602618,0.18013437,0.00035354664,0.0001429702,0.00001635689,0.0029191216,0.001096316,0.081712134,0.0235775,0.6970043,0.002415552],"about_ca_topic_score_codex":0.000753931,"about_ca_topic_score_gemma":0.00050099666,"teacher_disagreement_score":0.36280715,"about_ca_system_score_codex":0.00025979837,"about_ca_system_score_gemma":0.0010682609,"threshold_uncertainty_score":0.5925857},"labels":[],"label_agreement":null},{"id":"W2566145140","doi":"10.1158/1557-3265.ovcasymp14-poster-tech-1101","title":"Abstract POSTER-TECH-1101: Characterization of genomic landscapes of BRCA1 and BRCA2 implicated ovarian cancer specimens from a founder french canadian population","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Biology; Ovarian cancer; Genetics; BRCA2 Protein; Founder effect; Germline mutation; Missense mutation; Population; Cancer; Mutation; Genotype; Gene; Medicine; Haplotype","score_opus":0.12755855170975594,"score_gpt":0.43322890527687047,"score_spread":0.30567035356711453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566145140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615395,0.0011054263,0.000035936726,0.0009382162,0.00025576536,0.00035506993,0.0007736275,0.0000057008406,0.00037629792],"genre_scores_gemma":[0.9975484,0.00078818056,0.00013722917,0.00010485088,0.0005374316,0.00007160418,0.0006910139,0.000029608906,0.00009165134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981905,0.00015809778,0.00057375163,0.00047863528,0.00028815126,0.00031083613],"domain_scores_gemma":[0.9984012,0.00006964534,0.00019974251,0.0004249591,0.00061816804,0.00028623178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083146413,0.00012717083,0.00026755844,0.000140884,0.00006667208,0.000029511026,0.0002508691,0.00028917837,0.00031192566],"category_scores_gemma":[0.00017540966,0.00012704113,0.00006163895,0.0002066756,0.00019165652,0.000012469674,0.00012598296,0.00023954392,0.000006179187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030403756,0.00008444419,0.27778682,0.000046509136,0.00022069945,0.0000022351533,0.0002751682,0.000068505535,0.69585305,0.00002350041,0.0014030252,0.023931986],"study_design_scores_gemma":[0.00094521,0.00015749488,0.9703041,0.00003807707,0.000022831859,0.0000011092858,0.00005325858,0.00008105112,0.023271795,0.00025824358,0.004730688,0.00013615047],"about_ca_topic_score_codex":0.2474149,"about_ca_topic_score_gemma":0.19545516,"teacher_disagreement_score":0.6925173,"about_ca_system_score_codex":0.0002971087,"about_ca_system_score_gemma":0.0016875754,"threshold_uncertainty_score":0.81922567},"labels":[],"label_agreement":null},{"id":"W2567870461","doi":"10.1158/1557-3265.pmccavuln16-b18","title":"Abstract B18: Development of human STING agonists for prostate cancer immunotherapy","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Prostate cancer; Sting; Immunotherapy; Cancer research; Cancer immunotherapy; Cytotoxic T cell; Medicine; Cancer cell; Immune system; In vivo; Pharmacology; In silico; Innate immune system; In vitro; Immunology; Biology; Internal medicine; Biochemistry","score_opus":0.3306226409225515,"score_gpt":0.574342886797812,"score_spread":0.24372024587526048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567870461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071413,0.006095285,0.000011192108,0.00074771675,0.0009120421,0.0006597349,0.00005486503,0.000032019434,0.00077300216],"genre_scores_gemma":[0.98882884,0.0011719334,0.000098134304,0.00005294636,0.00011870169,0.00044931262,0.00001818988,0.000041515017,0.009220433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977776,0.0002628198,0.00084155484,0.00038389282,0.00010368684,0.0006304778],"domain_scores_gemma":[0.99764687,0.0007669121,0.00036145796,0.0006189773,0.0005690073,0.000036757912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035701378,0.00014829206,0.0004434592,0.000097163844,0.0012315095,0.00006807592,0.00082997,0.00025342076,0.00085791975],"category_scores_gemma":[0.0007890847,0.000121985795,0.00017300267,0.000045092518,0.0011391185,0.000090128226,0.00024045896,0.0007287521,0.00006075687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039121583,0.00027794333,0.016034488,0.0001322905,0.00038441183,0.0000018640978,0.0008686934,5.0187066e-7,0.67147756,0.00014559936,0.0050110957,0.30175343],"study_design_scores_gemma":[0.003118631,0.0005151217,0.30404577,0.0003641549,0.000008561114,8.905787e-7,0.00018341593,0.0000010979605,0.46827012,0.00012186781,0.22318639,0.00018397623],"about_ca_topic_score_codex":0.0012260445,"about_ca_topic_score_gemma":0.0006640756,"teacher_disagreement_score":0.30156946,"about_ca_system_score_codex":0.000117013245,"about_ca_system_score_gemma":0.00094328995,"threshold_uncertainty_score":0.94719},"labels":[],"label_agreement":null},{"id":"W2570267880","doi":"10.1158/1557-3265.pmccavuln16-a25","title":"Abstract A25: COTI-2, a novel small molecule that is effective against multiple human cancer cell lines in vitro and in vivo","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"In vivo; Cancer; Flow cytometry; In silico; Cancer cell; In vitro; Cell growth; Cell culture; Apoptosis; PI3K/AKT/mTOR pathway; Cancer research; Viability assay; Pharmacology; Drug discovery; Chemistry; Biology; Biochemistry; Molecular biology; Genetics","score_opus":0.2372363984106822,"score_gpt":0.5182743531454814,"score_spread":0.2810379547347992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570267880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98962355,0.004789803,0.000012840923,0.0022442713,0.0002186467,0.0015039287,0.00015209499,0.00002780879,0.0014270435],"genre_scores_gemma":[0.99417824,0.0026288787,0.00022490163,0.0008079141,0.00054942624,0.0008259242,0.0000068620607,0.00007327125,0.00070456555],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996861,0.0001662916,0.00060799654,0.0009329207,0.0005819548,0.0008498761],"domain_scores_gemma":[0.9971136,0.001106635,0.00022809132,0.00086838583,0.00032122715,0.00036206495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017805863,0.0002874504,0.0007968669,0.00019514396,0.00029373897,0.000093761235,0.00046459842,0.00029864756,0.00021829651],"category_scores_gemma":[0.0007696811,0.0002539955,0.00013915595,0.00018629589,0.0010363302,0.00022751128,0.0003749411,0.0016105416,0.000009647074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005908849,0.00096272305,0.4368486,0.0004817093,0.000098404074,0.0001691986,0.00069122505,0.000027642433,0.49043512,0.000004037358,0.00020843481,0.06416403],"study_design_scores_gemma":[0.013210117,0.00025357355,0.72447836,0.0009195543,0.000020934827,0.0000023801604,0.00028565075,0.00043380447,0.25692034,0.00008027341,0.0030976296,0.000297339],"about_ca_topic_score_codex":0.020102873,"about_ca_topic_score_gemma":0.033046197,"teacher_disagreement_score":0.28762978,"about_ca_system_score_codex":0.00066062465,"about_ca_system_score_gemma":0.0004437834,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W2570635734","doi":"10.1158/1557-3265.pmccavuln16-b03","title":"Abstract B03: Development of retroviral replicating vectors expressing codon-optimized nitroreductase for prodrug activator gene therapy in human glioma models","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytosine deaminase; Prodrug; Genetic enhancement; Biology; Cytotoxicity; Glioma; Viral vector; Activator (genetics); Vector (molecular biology); Cancer research; Nitroreductase; Gene; Molecular biology; In vitro; Pharmacology; Biochemistry; Recombinant DNA","score_opus":0.2909986533785346,"score_gpt":0.5285114433284737,"score_spread":0.23751278994993907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570635734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971091,0.00081334234,0.00012938632,0.00030893003,0.00008464703,0.0012936388,0.000050437593,0.000010732755,0.00019974589],"genre_scores_gemma":[0.9943627,0.00036310861,0.0036795763,0.00003111265,0.00047263343,0.0008201102,0.000073090574,0.00007178627,0.00012584068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635166,0.00038062796,0.00093788997,0.00093208574,0.0006298957,0.00076786167],"domain_scores_gemma":[0.99704903,0.00022053333,0.00038959764,0.0015284558,0.00059022143,0.00022216132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060672658,0.00021895705,0.00045661977,0.00016259417,0.0007108918,0.00011837194,0.001218773,0.00029239058,0.00003845769],"category_scores_gemma":[0.0012021026,0.00020014074,0.00019304882,0.00013728839,0.00068574736,0.00002798777,0.00040950178,0.00061885867,0.0000015847842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011097313,0.00034341376,0.0023786689,0.0000617678,0.000103433646,0.000004237531,0.0001424912,0.00013714585,0.9418502,0.0000066423063,0.00025824193,0.043616485],"study_design_scores_gemma":[0.004082392,0.0014430258,0.004567802,0.0000975665,0.0000029961543,5.889128e-7,0.0000680945,0.00024010567,0.9885682,0.000304243,0.00039952013,0.0002254753],"about_ca_topic_score_codex":0.0002449249,"about_ca_topic_score_gemma":0.0002419514,"teacher_disagreement_score":0.04671803,"about_ca_system_score_codex":0.00012765905,"about_ca_system_score_gemma":0.0013171182,"threshold_uncertainty_score":0.81615025},"labels":[],"label_agreement":null},{"id":"W2571057012","doi":"10.1158/1078-0432.ccr-16-1496","title":"Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC)","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Rash; Gastroenterology; Nausea; Cohort; Anemia; Metastatic breast cancer; Pharmacokinetics; Diarrhea; Vomiting; Neutropenia; Breast cancer; Cancer; Toxicity","score_opus":0.18753899173105087,"score_gpt":0.5709110171428204,"score_spread":0.38337202541176957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571057012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198097,0.00025582864,0.0000038111682,0.00097170105,0.00019173231,0.006181102,0.00016738649,0.000036887755,0.00021059644],"genre_scores_gemma":[0.9962891,0.00043974366,0.00021776008,0.00011459969,0.0003005383,0.0021419667,0.00003421227,0.00016540707,0.00029670703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9893198,0.0015838173,0.0017730126,0.0016949826,0.004015847,0.0016125648],"domain_scores_gemma":[0.9935072,0.0005326508,0.000516418,0.0025281007,0.0019261908,0.0009894167],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006181791,0.000495707,0.0019227545,0.0006676975,0.00033650704,0.00013611195,0.0011138429,0.0002091668,0.0005169245],"category_scores_gemma":[0.0010326224,0.0003606832,0.000113380825,0.0011860424,0.0014980742,0.00063728885,0.00050036877,0.0029980275,0.000015849517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03307132,0.021993479,0.88279307,0.0003911526,0.00021583219,0.0006117907,0.0009782274,0.00011280914,0.00013342273,0.0000025318159,0.00023989605,0.059456468],"study_design_scores_gemma":[0.051866103,0.031625446,0.9101379,0.0031788696,0.00008426544,0.000006702971,0.0017972414,0.00028872772,0.00042353716,0.000024052542,0.00017317015,0.0003940011],"about_ca_topic_score_codex":0.059950996,"about_ca_topic_score_gemma":0.112648055,"teacher_disagreement_score":0.059062466,"about_ca_system_score_codex":0.0014711567,"about_ca_system_score_gemma":0.0044925725,"threshold_uncertainty_score":0.9998845},"labels":[],"label_agreement":null},{"id":"W2573357968","doi":"10.1158/1078-0432.ccr-16-2265","title":"Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation Transfer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute","keywords":"Necrosis; Magnetization transfer; Medicine; Radiosurgery; Nuclear medicine; Tumor progression; Magnetic resonance imaging; Radiation therapy; Pathology; Nuclear magnetic resonance; Radiology; Internal medicine; Cancer","score_opus":0.35350923040369303,"score_gpt":0.5312767104444008,"score_spread":0.1777674800407078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573357968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974395,0.00029102762,0.00070017006,0.00082365423,0.00026087873,0.00034089776,0.00005313213,0.000027656493,0.00006310135],"genre_scores_gemma":[0.9985648,0.0002192009,0.00031940697,0.0000361679,0.00075148774,0.00004650047,0.000025007459,0.000013270658,0.000024197301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998064,0.00036864082,0.0003553684,0.0003945986,0.0005237102,0.00029372546],"domain_scores_gemma":[0.9990279,0.00026572344,0.00008016649,0.00029873452,0.00017503349,0.00015242865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018324255,0.00009734869,0.00023528308,0.00005800352,0.00070885406,0.00043461722,0.00024193816,0.00010711349,0.0003420987],"category_scores_gemma":[0.00028618285,0.000076140066,0.000060229602,0.00006739768,0.0003996958,0.000474499,0.000096236115,0.000291034,0.000022012624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023457993,0.00006738861,0.052354254,0.00011583076,0.00001271871,0.0000033700787,0.0001701052,7.9335774e-7,0.899377,0.0001481589,0.000101989615,0.047413826],"study_design_scores_gemma":[0.0012831669,0.00016248625,0.4498209,0.00016459131,0.00004925735,0.0000016503117,0.000016157235,0.00083664764,0.5452837,0.001721109,0.0004733256,0.00018705],"about_ca_topic_score_codex":0.00036630494,"about_ca_topic_score_gemma":0.000055142726,"teacher_disagreement_score":0.39746666,"about_ca_system_score_codex":0.00005155286,"about_ca_system_score_gemma":0.000072439296,"threshold_uncertainty_score":0.5452004},"labels":[],"label_agreement":null},{"id":"W2576009444","doi":"10.1158/1078-0432.ccr-16-2353","title":"Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Myeloid leukemia; Oncology; Myeloid; Flow cytometry; Internal medicine; Leukemia; Cancer; Cancer research; Receptor expression; Cell; Receptor; Immunology; Biology","score_opus":0.09331618270559418,"score_gpt":0.4623432076157812,"score_spread":0.369027024910187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576009444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98163855,0.0014451075,0.00003714365,0.013744752,0.00021350302,0.002082805,0.0003921437,0.000025495146,0.00042047526],"genre_scores_gemma":[0.97483975,0.021573845,0.000917956,0.00016329401,0.0013274716,0.0003079443,0.00025258306,0.00005334843,0.000563822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953202,0.0008539697,0.0011834769,0.0009752549,0.00091687375,0.0007502291],"domain_scores_gemma":[0.99172705,0.0041753445,0.00057242776,0.0021031052,0.0006671703,0.0007549221],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0041488074,0.0002274504,0.00075174274,0.00012853091,0.0005535086,0.000096428485,0.0010193407,0.00039288282,0.000174478],"category_scores_gemma":[0.010125364,0.00015937391,0.00015720338,0.00035611255,0.0014271067,0.00016082561,0.0012956327,0.0026490607,0.000040150604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017774457,0.00042251727,0.96948373,0.00009549618,0.00006124391,0.0002583172,0.00012992258,6.545968e-7,0.007674079,0.00001821076,0.012261782,0.007816583],"study_design_scores_gemma":[0.0028068624,0.00045234285,0.9934215,0.0001615626,0.0001695037,0.00001618995,0.000053168347,0.00008495326,0.0004357778,0.00022443544,0.0020256147,0.00014808694],"about_ca_topic_score_codex":0.0015346913,"about_ca_topic_score_gemma":0.00016026956,"teacher_disagreement_score":0.023937754,"about_ca_system_score_codex":0.00081524055,"about_ca_system_score_gemma":0.004234533,"threshold_uncertainty_score":0.99965185},"labels":[],"label_agreement":null},{"id":"W2584563327","doi":"10.1158/1078-0432.ccr-16-2266","title":"Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute on Aging; American Federation for Aging Research","keywords":"Taxane; Anthracycline; Medicine; Chemotherapy; Oncology; Toxicity; Stage (stratigraphy); Breast cancer; Internal medicine; Cancer; Mammary gland; Paclitaxel; Biology","score_opus":0.19338898375264835,"score_gpt":0.5625247914972552,"score_spread":0.36913580774460686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584563327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98583263,0.00005953126,0.000051985044,0.01254186,0.00011208603,0.0011389441,0.00013139487,0.000013812593,0.000117776755],"genre_scores_gemma":[0.99750936,0.0005967764,0.00043209357,0.0008729472,0.00025776817,0.00021446712,0.000013407861,0.000017166978,0.0000860037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822956,0.00014760603,0.000542346,0.00032259428,0.0004144006,0.00034346193],"domain_scores_gemma":[0.99818426,0.0005114287,0.00019442836,0.00032325016,0.0005266475,0.00025998816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00197636,0.000083902996,0.0003640241,0.00011927932,0.00027322673,0.000030210673,0.00013961429,0.0001068215,0.00026244952],"category_scores_gemma":[0.000564161,0.00007404349,0.000062253086,0.000100848076,0.0004442006,0.00011093061,0.00005070752,0.00042987266,0.0000016795383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065010646,0.00076276064,0.973611,0.00040253217,0.000013523839,0.0000024651358,0.00007018709,9.985471e-7,0.0029814465,0.000023667135,0.00018197364,0.015448407],"study_design_scores_gemma":[0.013881988,0.00088206236,0.97818464,0.0008551625,0.00000706418,4.8669176e-7,0.000020598469,0.0014845404,0.004171986,0.00009197127,0.0003544597,0.00006503309],"about_ca_topic_score_codex":0.0017195102,"about_ca_topic_score_gemma":0.00028728237,"teacher_disagreement_score":0.015383374,"about_ca_system_score_codex":0.00013595146,"about_ca_system_score_gemma":0.00026617598,"threshold_uncertainty_score":0.3019406},"labels":[],"label_agreement":null},{"id":"W2586956252","doi":"10.1158/1078-0432.ccr-16-2814","title":"An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Head and neck squamous-cell carcinoma; Medicine; Oncology; Biomarker; microRNA; Head and neck cancer; Internal medicine; Gene signature; Cancer research; Cancer; Bioinformatics; Biology; Gene; Gene expression","score_opus":0.1128784340432035,"score_gpt":0.4708680782620183,"score_spread":0.35798964421881485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586956252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736774,0.0018517216,0.00018558252,0.000083026556,0.00011095753,0.00022166624,0.000030824896,0.0000029274947,0.00014557569],"genre_scores_gemma":[0.9991386,0.0003991107,0.00013305625,0.000011461728,0.00015850094,0.000043529417,0.000055307173,0.000012148365,0.000048264155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983614,0.00035246945,0.00035194526,0.00044731816,0.00024208966,0.0002447449],"domain_scores_gemma":[0.9987274,0.0000635443,0.000106862324,0.00067741104,0.00026174195,0.00016308717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014469465,0.00008757664,0.00018946658,0.00006428539,0.00010669867,0.00005011986,0.0004450212,0.00020127589,0.000016692644],"category_scores_gemma":[0.00091628224,0.00007887322,0.000047284862,0.000082949125,0.0011745914,0.00001205399,0.00023318433,0.00029315238,0.0000015844674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000948039,0.00038392204,0.9166739,0.00016630489,0.000021042768,0.000007631337,0.00008793142,0.00004819482,0.03717655,0.000059984894,0.0010788889,0.043347623],"study_design_scores_gemma":[0.001104564,0.00037642987,0.9659637,0.00005215473,0.0000060980424,0.0000013234588,0.00018449462,0.0011229,0.030169774,0.00012593556,0.0007766968,0.0001158787],"about_ca_topic_score_codex":0.0012775705,"about_ca_topic_score_gemma":0.0012112183,"teacher_disagreement_score":0.04928986,"about_ca_system_score_codex":0.000029514013,"about_ca_system_score_gemma":0.00034083647,"threshold_uncertainty_score":0.43278307},"labels":[],"label_agreement":null},{"id":"W2587481375","doi":"10.1158/1078-0432.ccr-16-1859","title":"CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Mediprobe Research (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute; American College of Radiology Imaging Network","keywords":"Ovarian cancer; Medicine; Biomarker; Oncology; Cancer; Internal medicine; Biology","score_opus":0.21568864824237696,"score_gpt":0.5951311830547018,"score_spread":0.3794425348123248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587481375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437946,0.0005002727,0.0000019999281,0.0031944867,0.00022247013,0.0010764824,0.0000072869466,0.000019054703,0.0005985111],"genre_scores_gemma":[0.9960714,0.002561927,0.00016674688,0.00008612682,0.00027922302,0.0001285271,0.0000059124422,0.000035437206,0.0006647059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969889,0.0006896972,0.00057580776,0.00070500997,0.00056947337,0.000471142],"domain_scores_gemma":[0.9975939,0.0004704679,0.00014811689,0.0010068113,0.0001924947,0.0005882231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034786046,0.00016609342,0.0006188452,0.00018249314,0.00032196994,0.0000903499,0.00037219535,0.00008207168,0.00022837397],"category_scores_gemma":[0.0020807572,0.00012371884,0.00007810867,0.00015875288,0.0006926003,0.00018931045,0.00022081072,0.00088726106,0.0000058885357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013051202,0.001454827,0.5464817,0.00002129492,0.000038299393,0.00014302597,0.0005171186,0.0000058946325,0.0012635702,0.000016721533,0.000020672773,0.44873175],"study_design_scores_gemma":[0.011296987,0.006889751,0.97617054,0.0002653869,0.000047548307,0.000006186234,0.00042497087,0.002856666,0.00014318169,0.000060822582,0.0017185607,0.00011939048],"about_ca_topic_score_codex":0.04620477,"about_ca_topic_score_gemma":0.0027583628,"teacher_disagreement_score":0.44861236,"about_ca_system_score_codex":0.00023041137,"about_ca_system_score_gemma":0.0006012303,"threshold_uncertainty_score":0.9601466},"labels":[],"label_agreement":null},{"id":"W2589712516","doi":"10.1158/1078-0432.ccr-16-2615","title":"Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Oncology; Ovarian cancer; Internal medicine; BRCA mutation; Serous ovarian cancer; PARP inhibitor; Cancer research; Cancer; Biology; Genetics","score_opus":0.2561304436178418,"score_gpt":0.5529180762777554,"score_spread":0.29678763265991354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589712516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95603925,0.00052491657,0.00012546047,0.040444598,0.0011395278,0.0011389132,0.00008296238,0.00004837543,0.00045597888],"genre_scores_gemma":[0.97771907,0.015365151,0.00009734306,0.0037036275,0.0012582401,0.00044107146,0.000043976965,0.000073045216,0.0012985044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99468845,0.0011044771,0.0012108834,0.0011597514,0.0009938309,0.0008425947],"domain_scores_gemma":[0.99637735,0.0007819505,0.00036359622,0.0014624638,0.00043427193,0.0005803661],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005394236,0.00026710585,0.0008515648,0.0002789211,0.00038377414,0.00018488296,0.00055575796,0.0005005356,0.00036782608],"category_scores_gemma":[0.0019878717,0.00024141796,0.00017829669,0.00033792882,0.0018751133,0.00022448358,0.00024574716,0.002332507,0.000055245266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007784562,0.00055917905,0.90714514,0.00013038276,0.00012342473,0.0006050309,0.00007722843,0.0000033732588,0.005773637,0.0010325194,0.0013281831,0.07543732],"study_design_scores_gemma":[0.011613166,0.000965272,0.9789668,0.0013006348,0.000029943356,0.000010902988,0.000014713826,0.000115997405,0.0019236406,0.00057245407,0.0042420058,0.00024448754],"about_ca_topic_score_codex":0.0011090843,"about_ca_topic_score_gemma":0.0007410409,"teacher_disagreement_score":0.07519283,"about_ca_system_score_codex":0.00043881434,"about_ca_system_score_gemma":0.0009940321,"threshold_uncertainty_score":0.9999691},"labels":[],"label_agreement":null},{"id":"W2591962416","doi":"10.1158/1557-3265.pdx16-a10","title":"Abstract A10: Plerixafor inhibits myeloid cell recruitment and improves the radioresponse in patient-derived cervix cancer xenograft models","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cervical cancer; Cervix; Cancer; Radiation therapy; Plerixafor; Oncology; Pathology; Cancer research; CXCR4; Internal medicine","score_opus":0.19943615139642307,"score_gpt":0.4146981631303971,"score_spread":0.21526201173397402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591962416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98464215,0.010953629,0.000077573655,0.0015130104,0.0006505295,0.0016001698,0.00016703621,0.0000832425,0.00031265672],"genre_scores_gemma":[0.96902496,0.028759936,0.000085821994,0.00018491842,0.0002802529,0.0013687683,0.000002508588,0.000097789685,0.00019504015],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967502,0.00018590305,0.00086903456,0.0005372384,0.00066307175,0.0009945875],"domain_scores_gemma":[0.99688816,0.0019233424,0.0000873858,0.0005926802,0.00018263077,0.0003258293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018688297,0.0002958345,0.00043058948,0.00019832198,0.00015505058,0.00008601694,0.00048000316,0.0002620563,0.00021488623],"category_scores_gemma":[0.00020123388,0.00017729438,0.00012516556,0.00045996523,0.00052274385,0.00035329873,0.00023400933,0.0009342111,0.000029576453],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001339492,0.00011495036,0.0010615374,0.0001915014,0.000094184485,0.000028638482,0.0009808083,0.0012106946,0.46994627,0.000039240447,0.0021497286,0.52284294],"study_design_scores_gemma":[0.017551549,0.0019871695,0.066900425,0.0022525385,0.000099346995,0.000010947981,0.0012244935,0.0124438815,0.7365913,0.009658703,0.14896083,0.0023188319],"about_ca_topic_score_codex":0.00074844627,"about_ca_topic_score_gemma":0.0013359226,"teacher_disagreement_score":0.52052414,"about_ca_system_score_codex":0.0006084483,"about_ca_system_score_gemma":0.00036737812,"threshold_uncertainty_score":0.7229855},"labels":[],"label_agreement":null},{"id":"W2592672980","doi":"10.1158/1557-3265.pdx16-b32","title":"Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network","funders":"","keywords":"Transcriptome; Cancer research; Biology; Lung cancer; Cancer; Gene; Proteome; Exome sequencing; Exome; Pathology; Medicine; Gene expression; Mutation; Bioinformatics; Genetics","score_opus":0.05526853431076217,"score_gpt":0.4230242684744786,"score_spread":0.36775573416371643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592672980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386466,0.0047927313,0.0000160947,0.00023471212,0.00015322746,0.00041907735,0.00034039555,0.000001940443,0.0001771407],"genre_scores_gemma":[0.9879913,0.01151611,0.00015216816,0.000042883057,0.00019020498,0.00004819161,0.000008629401,0.000017444194,0.00003310599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983651,0.000114331124,0.00064046995,0.00036186667,0.0002437985,0.00027444094],"domain_scores_gemma":[0.99842477,0.00029719385,0.0002678665,0.00042427678,0.0004540333,0.00013188772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082213286,0.000108136344,0.0003230336,0.00006021955,0.000035349673,0.0000058731116,0.00024032734,0.00017854,0.00007549665],"category_scores_gemma":[0.00075303356,0.00008142712,0.00012659232,0.000080286634,0.00082855305,0.000004538397,0.00028058578,0.00016639759,7.502666e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094516197,0.00006819518,0.03188734,0.00015314274,0.000086917345,8.415192e-7,0.00004258348,0.000014200737,0.93816763,0.00003632401,0.0027391121,0.025858574],"study_design_scores_gemma":[0.0011086882,0.00068295497,0.40172273,0.00013279184,0.000015788637,6.409863e-7,0.000038606966,0.0000026647533,0.5936869,0.00018575936,0.0023151415,0.00010737334],"about_ca_topic_score_codex":0.0019156449,"about_ca_topic_score_gemma":0.00063534686,"teacher_disagreement_score":0.36983538,"about_ca_system_score_codex":0.0000618201,"about_ca_system_score_gemma":0.0007888282,"threshold_uncertainty_score":0.33205014},"labels":[],"label_agreement":null},{"id":"W2593067736","doi":"10.1158/1078-0432.ccr-16-2796","title":"A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Germline; Medicine; Cancer research; Germline mutation; Ovarian carcinoma; Internal medicine; Oncology; Cancer; Mutation; Poly ADP ribose polymerase; Biology; Genetics; DNA; Polymerase","score_opus":0.24196756652240917,"score_gpt":0.5440788431986607,"score_spread":0.3021112766762516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593067736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937222,0.000065539614,0.0000023892867,0.002244046,0.0004094722,0.0029679819,0.00011809471,0.000024454353,0.0004458282],"genre_scores_gemma":[0.9973487,0.00002209593,0.000043313506,0.00053090416,0.0005140903,0.00045564136,0.000009544421,0.000073469106,0.0010021972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948798,0.00083856593,0.001250955,0.0007391693,0.0015752668,0.0007162833],"domain_scores_gemma":[0.99596846,0.00037126598,0.0005155681,0.0018572981,0.00095280726,0.0003346178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028266762,0.00026412096,0.0009271092,0.00019196332,0.00056674,0.000061932704,0.00079286663,0.00018392391,0.0007598149],"category_scores_gemma":[0.0010834886,0.00015155661,0.00014059187,0.0006159633,0.0013493771,0.00016371856,0.00042745564,0.0015010977,0.00001377856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033247806,0.014953321,0.9400382,0.000074353586,0.0001693859,0.00008691428,0.001086474,0.000008601511,0.000302668,0.000011306224,0.0031967987,0.006824173],"study_design_scores_gemma":[0.100829765,0.025381243,0.8667176,0.0007753988,0.00007338111,0.0000033962453,0.00039785236,0.000117793556,0.002906216,0.0000631034,0.0024855589,0.00024869177],"about_ca_topic_score_codex":0.0035715557,"about_ca_topic_score_gemma":0.0040575685,"teacher_disagreement_score":0.0733206,"about_ca_system_score_codex":0.0003265453,"about_ca_system_score_gemma":0.0015399139,"threshold_uncertainty_score":0.83194405},"labels":[],"label_agreement":null},{"id":"W2593592874","doi":"10.1158/1557-3265.pdx16-b08","title":"Abstract B08: Patient-derived xenografts of oral squamous cell carcinoma: A model system for the identification of prognostic molecular signatures and for preclinical assessment of targeted therapies","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical significance; Oncology; Internal medicine; Lymph node; Basal cell; Cancer; Disease; Biomarker; Histology; Personalized medicine; Pathology; Bioinformatics; Biology","score_opus":0.10694029556156544,"score_gpt":0.46894997873096766,"score_spread":0.36200968316940224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593592874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98690516,0.006370841,0.0035348095,0.00024060255,0.00007261472,0.00214571,0.0007130968,0.000003517852,0.000013634509],"genre_scores_gemma":[0.9977555,0.00050351827,0.00054794445,0.0000089704145,0.000048943035,0.0010483176,0.000038039456,0.00002298423,0.000025767866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978916,0.00021384603,0.0007889682,0.00040049633,0.00039886232,0.00030622797],"domain_scores_gemma":[0.997046,0.0011821536,0.00032457203,0.00041677596,0.0009319181,0.00009861241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016258749,0.00011860781,0.00030725964,0.000055349763,0.000076406,0.000013013925,0.00027877322,0.00016773953,0.0000048869033],"category_scores_gemma":[0.0008369856,0.0000694871,0.00021934047,0.00008926364,0.00056599354,0.0000081925045,0.00012835236,0.00012858596,1.2249674e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002159255,0.00046180142,0.010315939,0.00063987635,0.00018341218,6.790924e-7,0.000043850632,0.00013662444,0.9741731,0.00008800606,0.00032382202,0.011473621],"study_design_scores_gemma":[0.004638191,0.003623998,0.03932936,0.00008600649,0.00008928843,3.3090814e-7,0.00015158251,0.0019633817,0.9494888,0.00028639188,0.00022459778,0.000118056625],"about_ca_topic_score_codex":0.00018115243,"about_ca_topic_score_gemma":0.000086402644,"teacher_disagreement_score":0.029013421,"about_ca_system_score_codex":0.000035090838,"about_ca_system_score_gemma":0.0005473941,"threshold_uncertainty_score":0.28336018},"labels":[],"label_agreement":null},{"id":"W2593824144","doi":"10.1158/1557-3265.pdx16-b09","title":"Abstract B09: Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; Cell culture; Cancer research; Renal cell carcinoma; Biology; Cancer; Cell; Medicine; Oncology; Pathology; Internal medicine; Genetics","score_opus":0.19953860731325393,"score_gpt":0.4357282740736187,"score_spread":0.23618966676036476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593824144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866672,0.0069608223,0.00010272541,0.0016997175,0.00019812789,0.0026594892,0.00031586466,0.000022057804,0.0013739723],"genre_scores_gemma":[0.9916228,0.004600558,0.0014130332,0.00017651821,0.0006996273,0.0003188341,0.00017652141,0.000081419545,0.00091069593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9922747,0.0008875174,0.0020286625,0.0014449884,0.0023393375,0.0010248108],"domain_scores_gemma":[0.9903728,0.004901644,0.00044211952,0.000794125,0.0025854718,0.00090388075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052848,0.00037884238,0.0011502908,0.00030918108,0.00031572251,0.000043782402,0.0003022773,0.00045868487,0.00024185935],"category_scores_gemma":[0.000935592,0.00022562398,0.0002468683,0.0003102683,0.0020521623,0.00013678275,0.00041873727,0.0009795851,0.000015698555],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06322726,0.009559185,0.11380042,0.0032746033,0.00032452037,0.00023593781,0.005855901,0.00009074223,0.7243946,0.000167557,0.029298285,0.049770948],"study_design_scores_gemma":[0.1055464,0.08092766,0.4150512,0.0032751826,0.00086552027,0.000012931423,0.00309156,0.0051768115,0.37593383,0.0024340723,0.0061305393,0.0015542961],"about_ca_topic_score_codex":0.0011004326,"about_ca_topic_score_gemma":0.000043337004,"teacher_disagreement_score":0.3484608,"about_ca_system_score_codex":0.00044657255,"about_ca_system_score_gemma":0.0007791173,"threshold_uncertainty_score":0.9200679},"labels":[],"label_agreement":null},{"id":"W2593859985","doi":"10.1158/1557-3265.pdx16-b31","title":"Abstract B31: Establishment and molecular characterization of patient-derived tumor xenografts from resected tumors or ascites fluids of patients with pancreatic/ampullary/bile duct carcinomas","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Medicine; Pancreas; Pancreatic cancer; Bile duct; Adenocarcinoma; Cancer; Context (archaeology); Ampulla of Vater; Population; Cancer research; Oncology; Internal medicine; Pathology; Carcinoma; Biology","score_opus":0.031859893377286376,"score_gpt":0.33634338311578704,"score_spread":0.30448348973850065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593859985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975065,0.0005496642,0.000054515454,0.000117762735,0.00010996675,0.00057292666,0.0010545971,0.000005312281,0.000028774442],"genre_scores_gemma":[0.9977133,0.0013718863,0.0002335083,0.000068205285,0.00015048875,0.000082312195,0.00032573423,0.000036883474,0.000017627877],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99777377,0.00018953402,0.0006601529,0.00054874446,0.0004787069,0.00034908875],"domain_scores_gemma":[0.9977866,0.0003902792,0.0002669463,0.00051216263,0.0008386033,0.00020545184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040626831,0.00017590927,0.00038389515,0.00008966268,0.00005949943,0.000027423868,0.00023224893,0.00012623466,0.00013109461],"category_scores_gemma":[0.0010641745,0.0001155664,0.00007648978,0.00021514333,0.0005307416,0.000013858366,0.00027195402,0.00013247282,0.0000011895106],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024251372,0.00023398927,0.26757404,0.0000532689,0.00009008676,0.000008866797,0.000044820288,0.0000016189815,0.72428805,0.0000055829973,0.00016501352,0.005109516],"study_design_scores_gemma":[0.001757911,0.0018212261,0.5299673,0.00018006758,0.000025105923,3.5324453e-7,0.00003799288,0.0000033556091,0.4649349,0.000033765897,0.001092723,0.00014532958],"about_ca_topic_score_codex":0.0005957541,"about_ca_topic_score_gemma":0.00021064885,"teacher_disagreement_score":0.26239324,"about_ca_system_score_codex":0.000044484597,"about_ca_system_score_gemma":0.000492353,"threshold_uncertainty_score":0.4712661},"labels":[],"label_agreement":null},{"id":"W2593868250","doi":"10.1158/1557-3265.pdx16-a09","title":"Abstract A09: PDXovo: Ultra-fast in vivo drug sensitivity matrices for renal cell carcinoma patients prior to administration of targeted therapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Context (archaeology); In vivo; Cancer; Sunitinib; Renal cell carcinoma; Cancer research; Oncology; Internal medicine; Pathology; Biology","score_opus":0.1315724551539969,"score_gpt":0.4790096325894567,"score_spread":0.3474371774354598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593868250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894891,0.00024714673,0.000029234809,0.0067256102,0.0002683194,0.0022463866,0.00036760088,0.00001852482,0.0006081053],"genre_scores_gemma":[0.9963713,0.0014578771,0.00036097434,0.00029785375,0.00050868053,0.00049402233,0.000014046615,0.000040668132,0.00045451903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964601,0.00037948904,0.00095344416,0.00066403294,0.00094416755,0.0005987576],"domain_scores_gemma":[0.9933913,0.0045042927,0.00020862288,0.00049556384,0.0010124196,0.00038782528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036649047,0.00018008273,0.0005528492,0.0002686994,0.000070769056,0.000019902382,0.00020306885,0.00019287429,0.00073382875],"category_scores_gemma":[0.0011545275,0.00012807797,0.00019304547,0.0005169287,0.00024954116,0.00011923512,0.000049428625,0.00042578392,0.000032014126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013016597,0.001903,0.7799641,0.00040920355,0.000040724142,0.000035499874,0.00034231573,0.0000043155133,0.087312676,0.000006991888,0.03974463,0.07721994],"study_design_scores_gemma":[0.005219342,0.0018195435,0.6322006,0.00033529475,0.000012391599,5.237355e-7,0.000054297758,0.0000088407905,0.3530395,0.00003074673,0.0071474947,0.00013145123],"about_ca_topic_score_codex":0.0011006803,"about_ca_topic_score_gemma":0.0015586576,"teacher_disagreement_score":0.2657268,"about_ca_system_score_codex":0.0003827385,"about_ca_system_score_gemma":0.0011199806,"threshold_uncertainty_score":0.80349106},"labels":[],"label_agreement":null},{"id":"W2597783812","doi":"10.1158/1078-0432.ccr-15-2440","title":"Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Blockade; Medicine; Cancer research; Fusion protein; Cytokine; Chimeric antigen receptor; T cell; Cancer; Antibody; Immunology; Immunotherapy; Antigen; Receptor; Biology; Immune system; Internal medicine; Gene","score_opus":0.6778716969775834,"score_gpt":0.676147262922812,"score_spread":0.0017244340547714065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597783812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002227662,0.9852117,0.000027467338,0.0005843633,0.001027023,0.008738006,0.00017014654,0.0000625878,0.0019510933],"genre_scores_gemma":[0.0002258419,0.9782235,0.00026348673,0.0002035635,0.004921459,0.0043219766,0.00032170152,0.00032927177,0.011189171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862432,0.004900676,0.0018984271,0.0017000156,0.0035511055,0.0017065669],"domain_scores_gemma":[0.9883167,0.0036857317,0.0005993628,0.004470748,0.002089537,0.0008379147],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.032838363,0.0006147731,0.0030755703,0.00039610855,0.0011684266,0.00041979717,0.0027632376,0.0011854733,0.0042759376],"category_scores_gemma":[0.008146278,0.0003942833,0.002530152,0.00047537917,0.00214401,0.00012935264,0.00096367486,0.0056129596,0.00027403858],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013349771,0.00029610292,0.0000111970085,0.006483961,0.0009071432,0.00015750868,0.00003883609,0.0000026743414,0.00023505033,0.00021298375,0.0020201071,0.9882994],"study_design_scores_gemma":[0.0021314253,0.0041925213,0.000053988002,0.0065739723,0.0007187736,0.0000622117,0.00005527186,0.00041777367,0.000036917023,0.0016678998,0.9836831,0.0004061336],"about_ca_topic_score_codex":0.00050974265,"about_ca_topic_score_gemma":0.000028338856,"teacher_disagreement_score":0.98789334,"about_ca_system_score_codex":0.000748864,"about_ca_system_score_gemma":0.010986206,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W2604205643","doi":"10.1158/1078-0432.ccr-16-3230","title":"Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"HRAS; CDKN2A; PTEN; Oncology; Cancer research; Vulvar Carcinoma; Vulva; Fibroblast growth factor receptor 3; Papillomaviridae; Internal medicine; Medicine; Cancer; Biology; Carcinoma; Pathology; KRAS; Cervical cancer; Genetics; PI3K/AKT/mTOR pathway; Receptor; Fibroblast growth factor","score_opus":0.2127881975698915,"score_gpt":0.5204065018682588,"score_spread":0.30761830429836723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604205643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727098,0.0021338162,0.000017909982,0.0028812347,0.0006967964,0.0016571055,0.0011229513,0.000096468204,0.018683935],"genre_scores_gemma":[0.98859996,0.0005580417,0.000106758955,0.00018806965,0.0027859644,0.0005759966,0.00026107632,0.00011269046,0.006811446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917754,0.00076615805,0.0011326626,0.0014048576,0.0031448738,0.0017760509],"domain_scores_gemma":[0.99126834,0.002668659,0.0003042997,0.0014182626,0.0023972031,0.0019432349],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001986222,0.00040536735,0.00090769137,0.00033305294,0.0018891107,0.0006481594,0.0011865379,0.00029275368,0.030229116],"category_scores_gemma":[0.011397788,0.00034046645,0.00052908773,0.00044596955,0.0021737267,0.00044827018,0.0015281781,0.002343362,0.001231954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007223716,0.0013681658,0.917407,0.0020889798,0.00016296147,0.00045220822,0.00051857287,0.0000035959079,0.0025847366,0.00036713004,0.024072537,0.04375042],"study_design_scores_gemma":[0.0071279784,0.0016854596,0.976932,0.000108184715,0.0000871827,0.000008279414,0.00034385166,0.0001887798,0.0064230682,0.0013087403,0.00537041,0.00041604895],"about_ca_topic_score_codex":0.008542823,"about_ca_topic_score_gemma":0.0011784628,"teacher_disagreement_score":0.05952504,"about_ca_system_score_codex":0.0010454736,"about_ca_system_score_gemma":0.00429645,"threshold_uncertainty_score":0.9999583},"labels":[],"label_agreement":null},{"id":"W2605009867","doi":"10.1158/1078-0432.ccr-16-2818","title":"A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; American Association for Cancer Research","keywords":"Lenalidomide; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Neutropenia; Clinical endpoint; Oncology; Rituximab; Thalidomide; Phases of clinical research; Febrile neutropenia; Gastroenterology; Surgery; Lymphoma; Multiple myeloma; Randomized controlled trial; Clinical trial; Chemotherapy","score_opus":0.2495991745781395,"score_gpt":0.5288692121540582,"score_spread":0.27927003757591873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605009867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896305,0.00035404667,5.026469e-7,0.0016640648,0.00019368577,0.007865031,0.00008012475,0.000008815111,0.00020322467],"genre_scores_gemma":[0.9980468,0.00040160993,0.0000749613,0.00039103863,0.00010436535,0.00073985185,0.000015454638,0.000032077136,0.00019385146],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99570405,0.0014087041,0.00090091483,0.00064809184,0.00084733486,0.0004909279],"domain_scores_gemma":[0.9892906,0.007989343,0.0003295303,0.0012993371,0.0004446337,0.0006465695],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040759286,0.00022860728,0.0012138091,0.00010635096,0.00043137398,0.00013964623,0.00071115646,0.00006275326,0.00004128037],"category_scores_gemma":[0.01118907,0.00011586141,0.00006843005,0.0002039774,0.0008563204,0.0001513487,0.000892966,0.0003724166,0.0000132376745],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49255162,0.10926642,0.3908052,0.00004267538,0.00026359543,0.00005271456,0.00048533344,1.8501439e-7,0.0000024651597,0.000005895207,0.00097255793,0.0055513005],"study_design_scores_gemma":[0.60975873,0.006169539,0.38157165,0.0003573147,0.00016169497,1.2510787e-7,0.00020387633,0.000038662984,0.000035815643,0.0000010694364,0.0016165111,0.00008500413],"about_ca_topic_score_codex":0.006343098,"about_ca_topic_score_gemma":0.005167111,"teacher_disagreement_score":0.11720711,"about_ca_system_score_codex":0.00032997676,"about_ca_system_score_gemma":0.00082749146,"threshold_uncertainty_score":0.9971401},"labels":[],"label_agreement":null},{"id":"W2605062205","doi":"10.1158/1078-0432.ccr-16-2354","title":"Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cohort; Confidence interval; Internal medicine; Clinical trial; Cohort study; Logistic regression; Phases of clinical research; Oncology","score_opus":0.935117757440753,"score_gpt":0.7769513201782015,"score_spread":0.15816643726255153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605062205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918848,0.00015851503,0.0016690338,0.0010163666,0.00042987024,0.0040980414,0.00066505844,0.000009850887,0.0000684176],"genre_scores_gemma":[0.9083074,0.00101643,0.08966181,0.000029753981,0.00025971272,0.0006218148,0.0000022311037,0.00003393378,0.00006691867],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98632145,0.0061649396,0.0049879476,0.00089564006,0.0010068245,0.00062322844],"domain_scores_gemma":[0.7582783,0.23780954,0.0013301469,0.001421021,0.0008886888,0.00027231083],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09633612,0.00020559793,0.003057814,0.00020786555,0.00016658717,0.00006537418,0.0006787531,0.00040691555,0.00023103945],"category_scores_gemma":[0.66285944,0.00016210534,0.00028756663,0.00029024683,0.0026078087,0.00023483323,0.0006257729,0.00087947166,5.378539e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046391353,0.019023485,0.13302107,0.0042187218,0.00023334238,0.000029114948,0.0008060846,0.0000057161847,0.0038651177,0.026884414,0.002353184,0.7631684],"study_design_scores_gemma":[0.036739483,0.00419836,0.017719768,0.0017012623,0.00012077582,3.0336443e-7,0.00006479455,0.0014163903,0.012544171,0.92475903,0.00044909675,0.00028659185],"about_ca_topic_score_codex":0.001068904,"about_ca_topic_score_gemma":0.0005704527,"teacher_disagreement_score":0.8978746,"about_ca_system_score_codex":0.00011253251,"about_ca_system_score_gemma":0.00063017866,"threshold_uncertainty_score":0.960858},"labels":[],"label_agreement":null},{"id":"W2606582837","doi":"","title":"Impact of sustained versus intermittent chemotherapy on rate of tumor repopulation in a xenograft model of human ovarian cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Medicine; Chemotherapy; Paclitaxel; Clonogenic assay; Ovarian cancer; Apoptosis; In vitro; Radiation therapy; Pharmacology; Andrology; Cancer; Internal medicine; Biology","score_opus":0.21183272815032642,"score_gpt":0.5754557536500886,"score_spread":0.3636230254997622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606582837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986604,0.00029546514,0.000041423787,0.00009913925,0.000047958372,0.0004515277,0.00007287849,0.000002370932,0.00032885722],"genre_scores_gemma":[0.99900734,0.0005491216,0.000041044656,0.000017202658,0.00010433959,0.000055931785,0.000035248428,0.000021401298,0.0001683754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979143,0.00021431154,0.00071729464,0.00036662695,0.00036147633,0.00042594832],"domain_scores_gemma":[0.99857086,0.00013154667,0.00021733217,0.00044485737,0.0004922531,0.000143131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021585783,0.000121895064,0.0003415992,0.0002147797,0.000033215307,0.0000059826975,0.00024440975,0.00012372033,0.00006653413],"category_scores_gemma":[0.00036740644,0.00010101039,0.00024176051,0.00033832842,0.0003307588,0.0000054672055,0.000109002256,0.0002812797,4.6361615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050169695,0.0017228394,0.4763097,0.00017024745,0.0005811006,0.000021938164,0.00016963956,0.0017556851,0.43966874,0.00016306725,0.0006844647,0.028582899],"study_design_scores_gemma":[0.016246723,0.011148099,0.61593544,0.00026570528,0.000022537126,5.5208744e-7,0.00014164008,0.0012726671,0.3541288,0.0005185983,0.000095912714,0.00022329194],"about_ca_topic_score_codex":0.0122762825,"about_ca_topic_score_gemma":0.0061530247,"teacher_disagreement_score":0.13962579,"about_ca_system_score_codex":0.0002376625,"about_ca_system_score_gemma":0.000717084,"threshold_uncertainty_score":0.9943011},"labels":[],"label_agreement":null},{"id":"W2606664616","doi":"10.1158/1078-0432.ccr-16-2895","title":"The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Memorial Sloan-Kettering Cancer Center; International Myeloma Foundation; Multiple Myeloma Research Foundation; Foundation for the National Institutes of Health","keywords":"Medicine; Multiple myeloma; Minimal residual disease; Oncology; Disease; Bone marrow; Drug development; Internal medicine; Intensive care medicine; Immunology; Drug; Pharmacology","score_opus":0.16667201864935197,"score_gpt":0.5103978063235773,"score_spread":0.34372578767422535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606664616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832968,0.012686481,0.0000010914507,0.0024474373,0.00003415247,0.0011239735,0.000019153387,0.0000091918355,0.0003817341],"genre_scores_gemma":[0.9905954,0.007415898,0.00038959726,0.000004824595,0.000520516,0.0008298983,0.000009583477,0.000012894386,0.00022138434],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981518,0.00024454846,0.000363556,0.00038153792,0.0004764867,0.0003820712],"domain_scores_gemma":[0.99778146,0.00108802,0.00009321899,0.00036532516,0.00025962907,0.0004123447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013459162,0.00010884001,0.00022419191,0.00009107269,0.00086185976,0.00008093004,0.00014300893,0.000050297014,0.000009912168],"category_scores_gemma":[0.0009859892,0.00006884236,0.00003293467,0.000144958,0.0005051602,0.00006336603,0.0001802962,0.00038804588,0.0000037621783],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064690824,0.0002015138,0.4970432,0.000041041287,0.000031384734,0.000005338546,0.00007419731,1.627261e-7,0.000048479436,0.00011243041,0.000023960854,0.5017714],"study_design_scores_gemma":[0.0022289325,0.0002512696,0.95272267,0.00011733659,0.000022312846,0.0000021054955,0.00014552282,0.00044323722,0.0004867247,0.00036926166,0.04315437,0.0000562617],"about_ca_topic_score_codex":0.0006721546,"about_ca_topic_score_gemma":0.0012257728,"teacher_disagreement_score":0.5017151,"about_ca_system_score_codex":0.00017544036,"about_ca_system_score_gemma":0.00097352895,"threshold_uncertainty_score":0.66288155},"labels":[],"label_agreement":null},{"id":"W2607628501","doi":"10.1158/1078-0432.ccr-17-0257","title":"Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of <i>TP53</i> Missense Mutation in Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health","keywords":"Missense mutation; Prostate cancer; DU145; Biochemical recurrence; Cancer research; Immunohistochemistry; Prostate; Medicine; Prostatectomy; Pathology; Cancer; Immunostaining; Mutation; Biology; Oncology; Internal medicine; LNCaP; Genetics; Gene","score_opus":0.29749477977787564,"score_gpt":0.5982011123550526,"score_spread":0.30070633257717694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607628501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927529,0.0016741947,0.00003736451,0.002716107,0.00022056248,0.0022484919,0.000077627294,0.000009471092,0.00026325352],"genre_scores_gemma":[0.986232,0.011694154,0.00012964621,0.000025511657,0.00027708092,0.00033968795,0.000024231167,0.000027050488,0.0012506718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657464,0.00041248227,0.0013033091,0.00056546624,0.0007089404,0.00043518847],"domain_scores_gemma":[0.99555707,0.0016696837,0.0004945664,0.00060218474,0.0014209197,0.00025555966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006662155,0.00014396319,0.00087122514,0.00030712268,0.00018178007,0.00005518046,0.0001927126,0.00020472071,0.000052081654],"category_scores_gemma":[0.0042385766,0.000111580106,0.00025534316,0.00028598463,0.0011752348,0.00021512221,0.00012721118,0.0006151946,0.0000022486724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017926954,0.00076499506,0.8110209,0.0011331167,0.00047926154,0.00004822682,0.00025031978,0.000023505489,0.007856401,0.000030720355,0.0003573493,0.16010824],"study_design_scores_gemma":[0.024687618,0.004473949,0.82127696,0.0013487857,0.0005445262,0.000007881776,0.00041077388,0.0075842356,0.13708681,0.0012324892,0.0011047019,0.00024125446],"about_ca_topic_score_codex":0.0024591926,"about_ca_topic_score_gemma":0.001174736,"teacher_disagreement_score":0.15986697,"about_ca_system_score_codex":0.00019296882,"about_ca_system_score_gemma":0.0009659678,"threshold_uncertainty_score":0.5074278},"labels":[],"label_agreement":null},{"id":"W2619129176","doi":"10.1158/1078-0432.ccr-16-2540","title":"Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Roswell Park Cancer Institute","keywords":"Lung cancer; Biomarker; Cancer; Transcriptome; Biology; Pathology; Medicine; Cancer research; Oncology; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.13029225750471282,"score_gpt":0.4961929541292279,"score_spread":0.3659006966245151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619129176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430585,0.0037811233,0.00048775278,0.000506058,0.00015784305,0.00045622597,0.000019047708,0.000004164465,0.00028195462],"genre_scores_gemma":[0.9958702,0.0026332818,0.0006012127,0.000023544508,0.00049107097,0.00010658157,0.0000058600785,0.000016896118,0.00025138306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981443,0.0003569909,0.00035747918,0.00049905974,0.00030366646,0.00033849082],"domain_scores_gemma":[0.9981224,0.00026259501,0.00022947001,0.0009339524,0.00030949354,0.00014207403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018119062,0.00011237772,0.00019359849,0.000023016953,0.0006967773,0.000058265232,0.00071463827,0.00018004775,0.00001710308],"category_scores_gemma":[0.0020707315,0.00007214609,0.00008824478,0.000039186554,0.0011645901,0.000008600672,0.0012042902,0.0003880858,0.0000014836398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002449266,0.00005935106,0.040004175,0.000055409208,0.000021312862,0.0000014863215,0.00005969314,0.0000044090343,0.926011,0.000005374098,0.0007385729,0.032794252],"study_design_scores_gemma":[0.00041393217,0.00024231932,0.0295768,0.00019023035,0.000008742765,0.0000017400725,0.0000624332,0.00015925136,0.9677717,0.00018282977,0.0012942757,0.00009571344],"about_ca_topic_score_codex":0.000088111985,"about_ca_topic_score_gemma":0.000058908656,"teacher_disagreement_score":0.041760694,"about_ca_system_score_codex":0.000011881103,"about_ca_system_score_gemma":0.00013518083,"threshold_uncertainty_score":0.5359118},"labels":[],"label_agreement":null},{"id":"W2619606660","doi":"","title":"Real-time quantitative PCR for rapid detection of translocations, amplifications, polymorphisms, and viral/bacterial load in blood or formalin-fixed paraffin embedded tissues","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Biology; Genotyping; Real-time polymerase chain reaction; TaqMan; Amplicon; Molecular biology; Chronic myelogenous leukemia; Leukemia; Concordance; Polymerase chain reaction; Genotype; Virology; Gene; Immunology; Genetics","score_opus":0.16673668296149532,"score_gpt":0.49122057125903,"score_spread":0.3244838882975347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619606660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423546,0.0018660849,0.0005199843,0.00087414915,0.0001309964,0.002108439,0.00010092324,0.000038124086,0.00012585537],"genre_scores_gemma":[0.9861011,0.0060580005,0.0060651805,0.000032350046,0.00029922786,0.00047734287,0.00010121064,0.00003986487,0.0008257442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969984,0.0003102097,0.0011309624,0.0005106876,0.0005337897,0.0005159075],"domain_scores_gemma":[0.99576116,0.0028350446,0.00018461258,0.0004161462,0.0005702868,0.00023273798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004288127,0.00016764544,0.0005797779,0.00029331216,0.00012336587,0.000020365937,0.00014555755,0.00025695626,0.0002523454],"category_scores_gemma":[0.0018501575,0.00014013409,0.000110412126,0.00053946784,0.00046104737,0.00012856192,0.000038694707,0.00039757584,0.000018233384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054834824,0.0028872269,0.010705462,0.0007215387,0.0006310463,0.00005379426,0.0026070639,0.000004819357,0.7388935,0.0011242288,0.0008387601,0.18669774],"study_design_scores_gemma":[0.06279516,0.015085344,0.21482144,0.0011343936,0.00068143976,0.000050882154,0.0015140128,0.0013085085,0.69309074,0.0009539748,0.007891968,0.0006721245],"about_ca_topic_score_codex":0.0027857178,"about_ca_topic_score_gemma":0.0028962295,"teacher_disagreement_score":0.20411597,"about_ca_system_score_codex":0.00056599604,"about_ca_system_score_gemma":0.001690625,"threshold_uncertainty_score":0.57145023},"labels":[],"label_agreement":null},{"id":"W2619858742","doi":"10.1158/1078-0432.ccr-17-0515","title":"Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Magnetic resonance imaging; Modalities; Pediatric cancer; Medical physics; Cancer; Childhood cancer; Radiology; Internal medicine","score_opus":0.46189219952699734,"score_gpt":0.644978539981934,"score_spread":0.18308634045493666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619858742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005142527,0.9873129,0.000009275647,0.0036234274,0.0016535746,0.0021233025,0.00033061163,0.00007786041,0.0048176073],"genre_scores_gemma":[0.0003671388,0.97612935,0.000014392367,0.0003089929,0.014411221,0.0011933869,0.00015174669,0.00013063732,0.0072931563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939757,0.0011502419,0.0013745424,0.0011798386,0.0014930116,0.0008266716],"domain_scores_gemma":[0.9946312,0.0019358955,0.0006289411,0.0015884165,0.0005426673,0.00067287945],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0040170434,0.00045037622,0.0022355046,0.0007285327,0.00046026654,0.00017817275,0.00076961605,0.00074810826,0.0012898712],"category_scores_gemma":[0.0012350655,0.00033729913,0.0010588195,0.0006860699,0.0004446278,0.0001369081,0.0001695733,0.0038735452,0.0009942442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032776003,0.0003248276,0.002824086,0.0056990134,0.00021947212,0.00009395556,0.000011498543,4.7172406e-7,2.5006523e-7,0.000063717875,0.08418329,0.90625167],"study_design_scores_gemma":[0.001427022,0.0005366363,0.0025537654,0.008157527,0.00089764246,0.000010030355,0.000002849495,0.000025879486,0.0000026005691,0.00014828556,0.98592633,0.00031141844],"about_ca_topic_score_codex":0.0003306719,"about_ca_topic_score_gemma":0.000020141606,"teacher_disagreement_score":0.90594023,"about_ca_system_score_codex":0.00081763434,"about_ca_system_score_gemma":0.003928934,"threshold_uncertainty_score":0.9999079},"labels":[],"label_agreement":null},{"id":"W2620621399","doi":"","title":"Caulobacter in cancer immunotherapy","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"In vivo; Biology; Immunotherapy; Cell culture; Molecular biology; Cancer immunotherapy; Cancer research; Microbiology; Immunology; Immune system","score_opus":0.20529653708355172,"score_gpt":0.595213787108048,"score_spread":0.38991725002449623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620621399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776907,0.008826954,0.00003558033,0.0008778887,0.00026628832,0.00040205222,0.000029976323,0.000013503767,0.0017787074],"genre_scores_gemma":[0.98018676,0.015873237,0.00005038943,0.00040511411,0.00090265676,0.00023136179,0.000023248795,0.000047159643,0.0022800453],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997407,0.00025479973,0.00042097896,0.0005494716,0.00048629442,0.00088146253],"domain_scores_gemma":[0.99885714,0.00014328676,0.000041517837,0.00046115177,0.0002394774,0.00025741145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031467779,0.00013034182,0.00020462472,0.00013809536,0.00007541638,0.00003526032,0.0003615686,0.00021645412,0.0003442049],"category_scores_gemma":[0.00020316038,0.00011252804,0.00012771662,0.000395121,0.0003382782,0.0000056860804,0.00018278995,0.0005828037,0.000037523092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034201988,0.00055272126,0.6988344,0.000022587257,0.00016609527,0.000085565654,0.000052748786,0.000008448918,0.048478268,0.000041851956,0.014644488,0.23369262],"study_design_scores_gemma":[0.0039143665,0.0008715856,0.46771345,0.00005950182,0.000004030159,0.0000028382558,0.00006027536,0.000006427602,0.043083508,0.0002155506,0.48383236,0.00023611408],"about_ca_topic_score_codex":0.0084107835,"about_ca_topic_score_gemma":0.03839478,"teacher_disagreement_score":0.4691879,"about_ca_system_score_codex":0.00019755561,"about_ca_system_score_gemma":0.0005994841,"threshold_uncertainty_score":0.9981923},"labels":[],"label_agreement":null},{"id":"W2620853632","doi":"10.1158/1078-0432.ccr-17-0574","title":"Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"PMS2; MSH6; MSH2; Proofreading; DNA mismatch repair; MLH1; Medicine; Lynch syndrome; Cancer; DNA repair; Germline mutation; Genetics; Mutation; Biology; Cancer research; Gene; Polymerase","score_opus":0.51746341951559,"score_gpt":0.62373909157499,"score_spread":0.10627567205939992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620853632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006287402,0.98439944,0.0000015092277,0.00057172414,0.0009705219,0.0033486185,0.0001220147,0.00004589428,0.0042528966],"genre_scores_gemma":[0.0018853386,0.9940829,0.0011706447,0.00009843935,0.00043729215,0.0007183859,0.000048188667,0.00008387501,0.0014749067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914566,0.0022130497,0.0032535861,0.0013945493,0.0009442402,0.0007379342],"domain_scores_gemma":[0.9931824,0.0033393276,0.00078421825,0.0018165626,0.00046073418,0.0004167426],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011985482,0.00039669147,0.0033885646,0.00051467697,0.00015838988,0.000042194533,0.00077548483,0.00060696894,0.0002472483],"category_scores_gemma":[0.0040931255,0.00032471502,0.00082789076,0.00084990996,0.0013492083,0.000044616958,0.0009430504,0.0030795503,0.00004154219],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014131762,0.00072605,0.042495873,0.013369751,0.00022651107,0.00008109906,0.000028255248,1.08467e-7,5.027319e-8,0.000025127027,0.010705809,0.9322001],"study_design_scores_gemma":[0.0014457299,0.0007568239,0.124650456,0.016586967,0.00020000058,0.000020645746,0.00003377499,0.000007269037,1.6787801e-7,0.00007321379,0.85597277,0.00025219686],"about_ca_topic_score_codex":0.00025231886,"about_ca_topic_score_gemma":0.00048566796,"teacher_disagreement_score":0.9319478,"about_ca_system_score_codex":0.000344285,"about_ca_system_score_gemma":0.0018498967,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W2620901258","doi":"10.1158/1078-0432.ccr-17-0408","title":"Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":521,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Institute for Health and Care Research","keywords":"Li–Fraumeni syndrome; Medicine; Psychosocial; Cancer; Germline; Germline mutation; Pediatric cancer; Oncology; Internal medicine; Mutation; Gene; Genetics; Psychiatry; Biology","score_opus":0.7166226886873909,"score_gpt":0.659810640990961,"score_spread":0.05681204769642989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620901258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003355614,0.9846251,0.0004581072,0.005047883,0.00057821185,0.006820696,0.0014297818,0.00009251996,0.0009141643],"genre_scores_gemma":[0.000023536846,0.9767385,0.003932413,0.00022385575,0.0012823718,0.010503379,0.0006526462,0.000327216,0.006316052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99341404,0.0007308216,0.0015089952,0.0015903913,0.001455889,0.0012998851],"domain_scores_gemma":[0.9926839,0.0024167318,0.00087911345,0.0020522883,0.0011508918,0.0008170914],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047856816,0.00062747113,0.0035018704,0.00064025255,0.0007547497,0.00022499698,0.0010320088,0.0010536619,0.0009929087],"category_scores_gemma":[0.0014664356,0.00043636793,0.00088974915,0.0008294027,0.0009705205,0.00014163821,0.00041124408,0.004463636,0.00009091689],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032922285,0.00016710078,0.0002524318,0.008354612,0.0022186479,0.00017329515,0.000024965275,0.0000022507227,1.263017e-7,0.000032810978,0.033121,0.9553235],"study_design_scores_gemma":[0.0030815268,0.0019476747,0.00009168623,0.073272474,0.0023353456,0.00019375508,0.000019077292,0.000008331047,0.0000016730972,0.000020902931,0.91854733,0.000480236],"about_ca_topic_score_codex":0.000711845,"about_ca_topic_score_gemma":0.0006600876,"teacher_disagreement_score":0.9548433,"about_ca_system_score_codex":0.00086333393,"about_ca_system_score_gemma":0.008650294,"threshold_uncertainty_score":0.9999203},"labels":[],"label_agreement":null},{"id":"W2621081192","doi":"10.1158/1078-0432.ccr-17-0702","title":"Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Human Genome Research Institute; National Institutes of Health; General Motors Foundation","keywords":"Cancer; Medicine; Genetic predisposition; Pediatric cancer; Genetic testing; Family medicine; Internal medicine; Disease","score_opus":0.6250210048115101,"score_gpt":0.6573310754797627,"score_spread":0.03231007066825253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621081192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052273944,0.9823283,0.0000040159625,0.0054720095,0.0010339699,0.0039302562,0.0017711276,0.00008754032,0.00014537312],"genre_scores_gemma":[0.00026351868,0.9872973,0.00008640323,0.00057562214,0.00816958,0.001431503,0.00034208666,0.00016079844,0.0016731985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899712,0.0029142862,0.0020361666,0.002098989,0.001814301,0.0011650597],"domain_scores_gemma":[0.99214745,0.002460433,0.00069802906,0.0019123857,0.0008399078,0.001941816],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011885725,0.00068511226,0.0043510543,0.00056307955,0.00052465306,0.00032127515,0.0007392795,0.0010317278,0.0003112954],"category_scores_gemma":[0.0036507023,0.00057629036,0.0005312395,0.00080269214,0.0006149889,0.00024031477,0.0008380779,0.0028959285,0.000063978485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005258225,0.0002581431,0.013810054,0.031875607,0.00030805546,0.000055697306,0.00017997292,1.3435748e-7,2.7198394e-7,0.000016812934,0.037470922,0.9154985],"study_design_scores_gemma":[0.0019305166,0.0013900978,0.041360904,0.01197954,0.000685992,0.000030118721,0.000025404857,0.000008717868,3.1078562e-7,0.000069982765,0.9419382,0.0005801965],"about_ca_topic_score_codex":0.0058865147,"about_ca_topic_score_gemma":0.0062082964,"teacher_disagreement_score":0.9149183,"about_ca_system_score_codex":0.00056580233,"about_ca_system_score_gemma":0.0036196464,"threshold_uncertainty_score":0.99966884},"labels":[],"label_agreement":null},{"id":"W2621474688","doi":"10.1158/1557-3265.ovcasymp16-ntoc-093","title":"Abstract NTOC-093: SYNTHETIC LETHAL APPROACHES TO TARGET ARID1A DEFICIENT OVARIAN CANCERS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ARID1A; Synthetic lethality; Cancer research; Ovarian cancer; Clear cell carcinoma; Clear cell; Serous fluid; Biology; Cancer; Endometrial cancer; Ovarian carcinoma; Medicine; DNA repair; Carcinoma; Mutation; Internal medicine; Gene; Genetics","score_opus":0.4763574319646575,"score_gpt":0.5026225866717711,"score_spread":0.026265154707113547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621474688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757072,0.0017028645,0.0006685528,0.0036992063,0.00082245405,0.00054937234,0.000077730285,0.000021360858,0.016751315],"genre_scores_gemma":[0.99464965,0.00042815294,0.0009655506,0.00026614752,0.001451387,0.00026446325,0.000020764788,0.000047399713,0.0019064685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697113,0.00018520223,0.0004963489,0.0009612858,0.0006197102,0.000766351],"domain_scores_gemma":[0.9975226,0.00010567616,0.0001427538,0.0015551371,0.00022537583,0.0004484825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028677725,0.00020534567,0.00031334924,0.00006259559,0.0006696603,0.00022051657,0.0011141584,0.00031036214,0.00024645662],"category_scores_gemma":[0.0012399172,0.00018384136,0.00022094353,0.00007522935,0.00059283525,0.000007762401,0.0005701,0.00065310224,0.00010754503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006737477,0.0019237141,0.06932031,0.0009334933,0.001195947,0.0002891372,0.0010744544,0.03580329,0.17664716,0.0021621122,0.13702321,0.5668897],"study_design_scores_gemma":[0.005935276,0.0027601938,0.20775501,0.0008961516,0.00010861902,0.00004513017,0.0007952469,0.0078247385,0.1171022,0.0029173712,0.6513354,0.0025246083],"about_ca_topic_score_codex":0.0028323925,"about_ca_topic_score_gemma":0.0010827455,"teacher_disagreement_score":0.5643651,"about_ca_system_score_codex":0.00017724429,"about_ca_system_score_gemma":0.0010781572,"threshold_uncertainty_score":0.7496833},"labels":[],"label_agreement":null},{"id":"W2621682721","doi":"10.1158/1557-3265.ovcasymp16-ap12","title":"Abstract AP12: CYSTEINE METABOLISM IN CLEAR CELL OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Proteomics; ARID1A; Ovarian cancer; Biology; Tissue microarray; Clear cell; Serous fluid; Cancer research; Computational biology; Gene expression profiling; Bioinformatics; Cancer; Gene; Gene expression; Genetics; Biochemistry; Carcinoma","score_opus":0.1896733283505102,"score_gpt":0.5253544161814757,"score_spread":0.3356810878309655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621682721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97984093,0.0095406845,0.000021286058,0.0013831834,0.00054736686,0.0002723508,0.00003691374,0.0000051738025,0.008352107],"genre_scores_gemma":[0.9815332,0.014648987,0.00013538501,0.0000900108,0.0014824852,0.00010021735,0.000018446624,0.000031409934,0.0019598203],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99788696,0.00023500052,0.00046225273,0.00056718243,0.00036856404,0.0004800647],"domain_scores_gemma":[0.9983596,0.00008879595,0.00015329334,0.00092663785,0.0002718186,0.00019981997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028544143,0.000128531,0.00024536243,0.00006895467,0.0002711712,0.00011979151,0.0006435459,0.00031850146,0.00022960569],"category_scores_gemma":[0.0007403354,0.00011799636,0.000120354285,0.00008321123,0.00032018064,0.000008630658,0.00036152446,0.00059067213,0.000043619613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013628356,0.0005241807,0.19408236,0.0001180776,0.00010812521,0.000040335693,0.00008503982,0.00027635304,0.66921836,0.00020791579,0.0044075795,0.1295688],"study_design_scores_gemma":[0.0018349694,0.0002387008,0.69258493,0.00003969689,0.000010838688,1.4966861e-7,0.000022661861,0.00007042817,0.12705295,0.00047025815,0.17746158,0.00021285743],"about_ca_topic_score_codex":0.0033809491,"about_ca_topic_score_gemma":0.0030556305,"teacher_disagreement_score":0.54216546,"about_ca_system_score_codex":0.000033446395,"about_ca_system_score_gemma":0.00037591642,"threshold_uncertainty_score":0.51110065},"labels":[],"label_agreement":null},{"id":"W2621869975","doi":"10.1158/1557-3265.ovcasymp16-tmem-035","title":"Abstract TMEM-035: GLYCOMARKERS FOR PREDICTING PLATINUM–DRUG RESPONSE IN OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cancer; Drug resistance; Cancer research; Cell culture; Drug; Chemotherapy; Flow cytometry; Cell; Medicine; Cancer cell; Oncology; Biology; Internal medicine; Pharmacology; Immunology; Genetics","score_opus":0.17852880795052598,"score_gpt":0.5318410715277939,"score_spread":0.35331226357726797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621869975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894208,0.0007509208,0.000052359825,0.005955921,0.0003805043,0.0011909438,0.00016021107,0.000011081858,0.0020772582],"genre_scores_gemma":[0.9920405,0.0008954654,0.00022812236,0.00014230801,0.0009793339,0.0009409326,0.00003562284,0.000046257734,0.004691457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649036,0.00057349313,0.0006432735,0.00080501125,0.0006349337,0.00085294835],"domain_scores_gemma":[0.99712133,0.0007921027,0.00019058037,0.0010514606,0.00052631524,0.00031820746],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010014292,0.00017601387,0.00029167658,0.00015684827,0.00069754984,0.00021395697,0.0009757104,0.00032159506,0.00038823392],"category_scores_gemma":[0.008999147,0.00016521926,0.0001916473,0.00013426997,0.00055190217,0.000021012069,0.00047916503,0.0008904816,0.000024120325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06275923,0.0004995121,0.6295207,0.00026317697,0.00024063887,0.00007318085,0.0001842999,0.00027734,0.18905888,0.00010110231,0.04039415,0.076627806],"study_design_scores_gemma":[0.00532668,0.0005675071,0.85453093,0.00021110782,0.000007238365,0.0000017370489,0.00014403033,0.00084743666,0.023181897,0.00024565056,0.11463348,0.00030228577],"about_ca_topic_score_codex":0.0030070418,"about_ca_topic_score_gemma":0.005608532,"teacher_disagreement_score":0.22501026,"about_ca_system_score_codex":0.0001256992,"about_ca_system_score_gemma":0.0012249165,"threshold_uncertainty_score":0.99934846},"labels":[],"label_agreement":null},{"id":"W2622097897","doi":"10.1158/1557-3265.ovcasymp16-ap28","title":"Abstract AP28: <i>BRCA1</i> and <i>RAD51C</i> Promoter Hypermethylation Confer Sensitivity to PARP Inhibitors in Patients with Platinum Sensitive Ovarian Carcinoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Ovarian cancer; Loss of heterozygosity; Methylation; DNA methylation; Biology; Germline mutation; PARP inhibitor; Germline; Cancer; Oncology; Medicine; Mutation; Genetics; Gene; Poly ADP ribose polymerase; Polymerase; Gene expression; Allele","score_opus":0.07066324461844924,"score_gpt":0.40642818289501065,"score_spread":0.3357649382765614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622097897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727356,0.000089913505,0.00008738802,0.0008372337,0.00013923361,0.0007154612,0.000051185114,0.0000047243,0.00080126873],"genre_scores_gemma":[0.9989921,0.00006635401,0.0002216778,0.00012575813,0.00038590145,0.000037110218,0.000058119003,0.000028597795,0.0000843915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978061,0.00036710952,0.00036709764,0.0006677499,0.0003929569,0.0003989841],"domain_scores_gemma":[0.9984078,0.00016681857,0.00013440535,0.0005581252,0.0004973703,0.0002354878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023250948,0.00016222915,0.00024844045,0.00007427088,0.00027226904,0.00012701255,0.00012446387,0.00025467746,0.000007986658],"category_scores_gemma":[0.0008527995,0.00013990258,0.00004702623,0.00008154585,0.00033371837,0.000017787039,0.0002713181,0.0004259429,0.0000075059884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096739316,0.00015310664,0.93115425,0.000020849866,0.00003024259,0.000017931281,0.00009378496,0.000038944112,0.040607437,0.000010064567,0.0001552685,0.026750749],"study_design_scores_gemma":[0.001713557,0.0006072811,0.9471825,0.00004745387,0.0000071060795,3.66657e-7,0.000018218987,0.00006175676,0.048538778,0.000051359442,0.00158467,0.00018700118],"about_ca_topic_score_codex":0.0008718734,"about_ca_topic_score_gemma":0.0014710698,"teacher_disagreement_score":0.026563747,"about_ca_system_score_codex":0.00003966071,"about_ca_system_score_gemma":0.0001958958,"threshold_uncertainty_score":0.57050616},"labels":[],"label_agreement":null},{"id":"W2622153623","doi":"10.1158/1557-3265.ovcasymp16-mip-059","title":"Abstract MIP-059: MITOCHONDRIAL DYNAMICS AND DYSFUNCTION IN OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mitochondrial fission; mitochondrial fusion; Biology; Cancer research; Ovarian cancer; Mitochondrion; DNM1L; Cancer; Programmed cell death; Apoptosis; Cell biology; Mitochondrial DNA; Gene; Genetics","score_opus":0.12732443554963552,"score_gpt":0.4762068126604482,"score_spread":0.34888237711081266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622153623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855707,0.0008981773,0.00026319866,0.0037287038,0.004448716,0.00042765998,0.00007084872,0.000008347137,0.0045836326],"genre_scores_gemma":[0.9855412,0.004696122,0.0001909792,0.00031730204,0.003846145,0.00019088104,0.00005549044,0.000029690997,0.005132163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980531,0.0002528131,0.00039359264,0.000651084,0.00023599816,0.00041343644],"domain_scores_gemma":[0.9987087,0.00011092897,0.000120451856,0.00067045697,0.00019634524,0.00019306429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011782651,0.00013085947,0.00023422927,0.00007931406,0.00033981708,0.00011078971,0.0003426629,0.00045355476,0.00042709935],"category_scores_gemma":[0.001365581,0.00012201516,0.00008606883,0.000068061396,0.0005330458,0.000011619851,0.00028112563,0.00068215566,0.00002781118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006212612,0.0003689428,0.5107388,0.000109672386,0.0001295703,0.00007490098,0.00007358681,0.00005118363,0.2951561,0.0010967359,0.041770242,0.14421766],"study_design_scores_gemma":[0.0064407387,0.000801158,0.85802424,0.00011303914,0.000021883221,0.00001018526,0.00010025827,0.00043048966,0.008392325,0.0007153551,0.12450132,0.00044902213],"about_ca_topic_score_codex":0.0024869277,"about_ca_topic_score_gemma":0.020171259,"teacher_disagreement_score":0.34728542,"about_ca_system_score_codex":0.00006172907,"about_ca_system_score_gemma":0.0003310755,"threshold_uncertainty_score":0.9977081},"labels":[],"label_agreement":null},{"id":"W2622400237","doi":"10.1158/1557-3265.ovcasymp16-ntoc-083","title":"Abstract NTOC-083: TARGETED APPROACH WITH MOMELOTINIB TREATMENT ATTENUATES PACLITAXEL–INDUCED ENRICHMENT OF CANCER STEM CELLS (CSC)–LIKE AND SUPPRESSES OVARIAN CANCER TUMORIGENESIS AND RECURRENCE","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Paclitaxel; Ovarian cancer; Medicine; In vivo; Cancer; Immunohistochemistry; Chemotherapy; Internal medicine; Oncology; Cancer research; Biology","score_opus":0.24230385602564472,"score_gpt":0.48325985584467324,"score_spread":0.24095599981902852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622400237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97327393,0.017587198,0.0000028797822,0.005175929,0.00045521578,0.0022331763,0.0007078217,0.000030267309,0.0005335742],"genre_scores_gemma":[0.93932027,0.056612823,0.00030797248,0.000082526305,0.00048297763,0.0024839665,0.000023100945,0.0000637319,0.0006226546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956149,0.00026209553,0.0008779164,0.0013884719,0.0009779757,0.00087864115],"domain_scores_gemma":[0.9960422,0.0007984555,0.00050946925,0.0012205995,0.0006790092,0.0007502671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012086577,0.00047642086,0.0012708857,0.0001737672,0.0005668681,0.00019268111,0.00035510233,0.00024926855,0.00034499395],"category_scores_gemma":[0.0000909563,0.00032034708,0.00016164237,0.00025343083,0.0011954635,0.00019744522,0.00024096016,0.00056843105,0.000007482974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025444673,0.001884117,0.8231603,0.0008244614,0.0013907792,0.00010635653,0.000540394,0.000016899334,0.0023846484,0.000046317848,0.0015926567,0.16550863],"study_design_scores_gemma":[0.008316139,0.0029344081,0.9520142,0.0011252589,0.0005441733,0.000006211529,0.00040380794,0.000090734684,0.029323235,0.00003010904,0.0048246626,0.00038704879],"about_ca_topic_score_codex":0.032918666,"about_ca_topic_score_gemma":0.0037432136,"teacher_disagreement_score":0.16512157,"about_ca_system_score_codex":0.0005534326,"about_ca_system_score_gemma":0.0014951827,"threshold_uncertainty_score":0.99992484},"labels":[],"label_agreement":null},{"id":"W2622451667","doi":"10.1158/1557-3265.ovcasymp16-ntoc-084","title":"Abstract NTOC-084: THE PROMISE OF COMBINATIONAL TREATMENT OF HISTONE DEACETYLASE 6 INHIBITOR ACY-1215 AND PROTEASOME INHIBITOR BORTEZOMIB IN SCCOHT","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bortezomib; Proteasome inhibitor; Proteasome; Cancer research; Biology; Histone deacetylase inhibitor; Cancer; Pharmacology; Histone deacetylase; Cell biology; Multiple myeloma; Immunology; Biochemistry; Histone","score_opus":0.24554270286648328,"score_gpt":0.5711893694116348,"score_spread":0.3256466665451515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622451667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875129,0.0006300015,8.821898e-7,0.009604687,0.000045874804,0.0012050287,0.00007059797,0.000008048526,0.00092201727],"genre_scores_gemma":[0.99752533,0.00063511165,0.000045259283,0.000055195447,0.00032825302,0.00032338788,0.000015261512,0.00001637144,0.0010558174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974256,0.00021479101,0.0008600836,0.00038665763,0.0008101436,0.00030268927],"domain_scores_gemma":[0.99763197,0.00055184565,0.0003429934,0.00067430804,0.0005521126,0.0002467634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021906735,0.00014186294,0.0005862354,0.00020435288,0.0002166473,0.000036554407,0.00020209378,0.00015496842,0.00034281056],"category_scores_gemma":[0.0016621627,0.00009315949,0.00018805805,0.00019400641,0.0015954869,0.00011959963,0.00012541782,0.00048443917,0.00001181051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0130431885,0.021503074,0.5743122,0.001802609,0.0010576193,0.0004358594,0.0016541097,0.000011459456,0.15489893,0.0013559441,0.012709407,0.2172156],"study_design_scores_gemma":[0.011647747,0.0016629334,0.9403809,0.001203314,0.0000704973,0.000005451783,0.00016665459,0.00017400723,0.042183015,0.00042268456,0.0019464128,0.00013641083],"about_ca_topic_score_codex":0.0015493374,"about_ca_topic_score_gemma":0.00065112725,"teacher_disagreement_score":0.36606866,"about_ca_system_score_codex":0.0002636765,"about_ca_system_score_gemma":0.00081670465,"threshold_uncertainty_score":0.5878638},"labels":[],"label_agreement":null},{"id":"W2622532295","doi":"10.1158/1078-0432.ccr-16-0115","title":"Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Precision medicine; Epigenetics; Medicine; Personalized medicine; Cancer; Disease; Genomics; Bioinformatics; Targeted therapy; Oncology; Computational biology; Internal medicine; Biology; Pathology; Genome; Gene; Genetics","score_opus":0.55646142280636,"score_gpt":0.6598406016677948,"score_spread":0.10337917886143477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622532295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009359644,0.98823917,0.000003387493,0.0020417676,0.00037420075,0.0034089922,0.000033635893,0.000036000212,0.004926866],"genre_scores_gemma":[0.00045591992,0.99184036,0.00035066553,0.000034700402,0.0020571519,0.0011829229,0.00007535968,0.00012502914,0.003877889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912837,0.0029206334,0.0019999403,0.0012659068,0.0014518256,0.0010779606],"domain_scores_gemma":[0.99093664,0.006298403,0.0004941896,0.0013010228,0.00030947552,0.00066024734],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0073420103,0.00052099786,0.0042534224,0.0010586343,0.0003808591,0.00008875151,0.0009652307,0.00076964457,0.0014233928],"category_scores_gemma":[0.004793844,0.00032345176,0.0007397524,0.00071843114,0.0015285675,0.00015347962,0.00048593458,0.0043442594,0.00036091747],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015033642,0.00044397832,0.0006609316,0.008252241,0.0002807179,0.0007657119,0.0001941566,4.057898e-7,0.0000010102209,0.0000057676043,0.0016195403,0.98627216],"study_design_scores_gemma":[0.006611672,0.0035043373,0.0011835549,0.013804989,0.00056647114,0.000028501188,0.000042752097,0.000009816446,6.879047e-7,0.00023870193,0.9737491,0.00025942244],"about_ca_topic_score_codex":0.0008994667,"about_ca_topic_score_gemma":0.0004906923,"teacher_disagreement_score":0.98601276,"about_ca_system_score_codex":0.0010414365,"about_ca_system_score_gemma":0.0058368547,"threshold_uncertainty_score":0.99992174},"labels":[],"label_agreement":null},{"id":"W2622925394","doi":"10.1158/1557-3265.ovcasymp16-ntoc-108","title":"Abstract NTOC-108: ACTIVITY OF DIANHYDROGALACTITOL (VAL–083) IN OVARIAN TUMOR MODELS, SENSITIVE OR RESISTANT TO CISPLATIN","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Cisplatin; Carboplatin; Ovarian cancer; Cytotoxicity; Cancer research; MTT assay; DNA damage; Pharmacology; Chemistry; Biology; Medicine; Cell culture; Cancer; In vitro; Internal medicine; DNA; Chemotherapy; Biochemistry; Genetics","score_opus":0.3315009651501813,"score_gpt":0.5394924676631716,"score_spread":0.2079915025129903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622925394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771427,0.00011534801,0.00015294465,0.0055447565,0.00041138343,0.0018318107,0.00013899196,0.00002958033,0.014632521],"genre_scores_gemma":[0.99772716,0.00029184786,0.00039321772,0.00018991502,0.0004447726,0.00018413445,0.00000556823,0.00006889684,0.0006944687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99554557,0.00042924777,0.0009032218,0.00092392723,0.0013392922,0.0008587279],"domain_scores_gemma":[0.99537134,0.0011965217,0.00033268332,0.0017365878,0.00067043107,0.00069242984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043978114,0.0002484975,0.0009390366,0.00039541,0.00025916722,0.00007642796,0.000502823,0.00033574676,0.00031993014],"category_scores_gemma":[0.0063243904,0.0002128401,0.00025217875,0.0005084155,0.0006548199,0.00023055112,0.0004522749,0.0022606924,0.000081293096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1953802,0.005935689,0.031009847,0.0020847549,0.0011433433,0.015589912,0.002700002,0.0019523116,0.55521166,0.0013881206,0.016100552,0.17150362],"study_design_scores_gemma":[0.011427075,0.003155378,0.85809207,0.0033591555,0.00011640733,0.000036088728,0.00028369506,0.004552863,0.11252198,0.0005817413,0.0052502886,0.00062327436],"about_ca_topic_score_codex":0.015456721,"about_ca_topic_score_gemma":0.016458016,"teacher_disagreement_score":0.8270822,"about_ca_system_score_codex":0.0007466473,"about_ca_system_score_gemma":0.0026963577,"threshold_uncertainty_score":0.9910994},"labels":[],"label_agreement":null},{"id":"W2623044754","doi":"10.1158/1557-3265.ovcasymp16-ap09","title":"Abstract AP09: GENOMIC ALTERATIONS IN ENDOMETRIOSIS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Endometriosis; KRAS; Clear cell; Stromal cell; Cancer research; Stroma; Ovarian cancer; Somatic cell; Endometrial cancer; Pathology; Cancer; Biology; Medicine; Oncology; Carcinoma; Internal medicine; Gene; Immunohistochemistry; Genetics; Colorectal cancer","score_opus":0.44060986255906176,"score_gpt":0.6133139086823258,"score_spread":0.17270404612326407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623044754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963199,0.002383377,0.00000393184,0.009151941,0.00020397431,0.0011107199,0.00003367034,0.000020595053,0.023892777],"genre_scores_gemma":[0.9824112,0.013949781,0.00019487127,0.00014256836,0.00058683986,0.0004979145,0.00001261237,0.000025985426,0.0021782229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679697,0.00025163215,0.00062954956,0.00054247293,0.0009958966,0.0007834777],"domain_scores_gemma":[0.9910686,0.0066205687,0.00010068236,0.0011894327,0.00040493032,0.00061580277],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004518529,0.0001307016,0.0004918484,0.0007791267,0.0005124246,0.00022642172,0.0004928429,0.00015213582,0.0016600746],"category_scores_gemma":[0.036655214,0.00010266211,0.00022491148,0.00052113767,0.000574429,0.0001640211,0.00030728654,0.0013941284,0.000660415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013879479,0.0015495317,0.74621475,0.00010499068,0.00020791827,0.0005871034,0.000051886633,0.000003382647,0.0020350097,0.0002353308,0.0050798147,0.24254234],"study_design_scores_gemma":[0.005759522,0.00060985045,0.96177,0.00015871573,0.0000136744075,0.000004441586,0.00003345032,0.00004324276,0.001340594,0.00023596523,0.029937176,0.0000933608],"about_ca_topic_score_codex":0.0034617893,"about_ca_topic_score_gemma":0.0018961508,"teacher_disagreement_score":0.24244899,"about_ca_system_score_codex":0.00057100353,"about_ca_system_score_gemma":0.0008722536,"threshold_uncertainty_score":0.99925256},"labels":[],"label_agreement":null},{"id":"W2623437396","doi":"10.1158/1557-3265.ovcasymp16-tmem-036","title":"Abstract TMEM-036: INTERFERON INDUCED STAT1 ASSOCIATES WITH DIFFERENTIAL CHEMOTHERAPY RESPONSE IN HIGH-GRADE SEROUS OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"STAT1; Ovarian cancer; Tumor microenvironment; Cancer research; Biology; Immune system; Gene signature; Gene knockdown; Chemotherapy; Small hairpin RNA; Cancer; Immunology; Interferon; Gene expression; Cell culture; Gene","score_opus":0.22922710584305234,"score_gpt":0.5245707499841041,"score_spread":0.2953436441410518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623437396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648205,0.0002679128,0.0000014163554,0.0325197,0.0008016535,0.0011225301,0.00011017475,0.00003729681,0.00031878866],"genre_scores_gemma":[0.99545556,0.001305115,0.0000710736,0.00046062758,0.000819892,0.0006373231,0.000012787741,0.00008663064,0.0011509841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957929,0.0005221622,0.00071740546,0.00095873844,0.0010814447,0.0009273114],"domain_scores_gemma":[0.9967743,0.0007784695,0.00032942725,0.0012972946,0.00034666274,0.0004738459],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00191004,0.0003213068,0.0008971903,0.00020020627,0.00037020553,0.00022207969,0.00057920837,0.00040261264,0.0014452036],"category_scores_gemma":[0.0006709762,0.00023563534,0.00020865879,0.0002623263,0.00045077782,0.00017381574,0.00024173233,0.0017315223,0.0000352293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031204835,0.002414664,0.9249935,0.00010725468,0.0005636569,0.00030624116,0.00034129588,0.0000051925854,0.0027404015,0.000044429424,0.0017608018,0.035517707],"study_design_scores_gemma":[0.017042104,0.0022901339,0.97189945,0.0013025276,0.00006823322,0.0000023149835,0.000047420228,0.000018395129,0.00543604,0.0001305168,0.0015202868,0.00024258818],"about_ca_topic_score_codex":0.02370837,"about_ca_topic_score_gemma":0.012884241,"teacher_disagreement_score":0.046905924,"about_ca_system_score_codex":0.0021409146,"about_ca_system_score_gemma":0.0024004905,"threshold_uncertainty_score":0.9994676},"labels":[],"label_agreement":null},{"id":"W2623453429","doi":"10.1158/1557-3265.ovcasymp16-ap27","title":"Abstract AP27: FEASIBILITY OF MONITORING RESPONSE TO THE PARP INHIBITOR RUCAPARIB WITH TARGETED DEEP SEQUENCING OF CIRCULATING TUMOR DNA (CTDNA) IN WOMEN WITH HIGH GRADE OVARIAN CARCINOMA ON THE ARIEL2 TRIAL","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Internal medicine; Oncology; Cancer; Interquartile range; Cancer research; Biology; Gene; Genetics; Poly ADP ribose polymerase","score_opus":0.3201574844223511,"score_gpt":0.4925623626280325,"score_spread":0.1724048782056814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623453429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881981,0.00008303024,0.000010785119,0.0083585465,0.00035817348,0.0027376665,0.000040330935,0.000018579565,0.00019479374],"genre_scores_gemma":[0.9976132,0.000017855597,0.00019925584,0.00019110252,0.0010823932,0.00081218936,0.0000017607472,0.0000488981,0.000033327113],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9943192,0.0013957276,0.0011381636,0.0007106875,0.001677582,0.0007586546],"domain_scores_gemma":[0.99211097,0.004361596,0.0006154144,0.0019637258,0.0006187471,0.00032952326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014476553,0.00024477704,0.00078944414,0.0001938486,0.000491177,0.000081940685,0.00074102863,0.00015543995,0.00012615739],"category_scores_gemma":[0.0054924097,0.00013567007,0.00011619171,0.0005445086,0.0012932998,0.0001259452,0.00016684085,0.0017881237,0.0000044492617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5615221,0.00062711316,0.37921935,0.00020002767,0.00018592528,0.0001711356,0.003628268,0.00040063972,0.05157398,0.00011336154,0.00012051746,0.002237554],"study_design_scores_gemma":[0.029518222,0.0049418663,0.9187985,0.0013530421,0.000023456152,0.0000062419767,0.00210633,0.0000657918,0.042630818,0.0002833669,0.00009462274,0.00017774104],"about_ca_topic_score_codex":0.0034682832,"about_ca_topic_score_gemma":0.000520208,"teacher_disagreement_score":0.53957915,"about_ca_system_score_codex":0.0013263191,"about_ca_system_score_gemma":0.002472995,"threshold_uncertainty_score":0.7768607},"labels":[],"label_agreement":null},{"id":"W2623526312","doi":"10.1158/1557-3265.ovcasymp16-ntoc-110","title":"Abstract NTOC-110: UNEXPECTED ROLES FOR KDM4A: PROTEIN SYNTHESIS AND MTOR INHIBITOR SENSITIVITY","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"","keywords":"PI3K/AKT/mTOR pathway; Biology; Protein biosynthesis; Translation (biology); Translational regulation; Cancer research; Cell biology; Biochemistry; Messenger RNA; Signal transduction; Gene","score_opus":0.12485655307155465,"score_gpt":0.46529569942321425,"score_spread":0.3404391463516596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623526312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950613,0.0011031489,0.00005132185,0.0020529535,0.00022638515,0.0008018821,0.00031056523,0.0000086376795,0.00038383206],"genre_scores_gemma":[0.9952741,0.0013303166,0.00029674158,0.000086604,0.0020747234,0.0005352281,0.000018547466,0.000034688735,0.00034901843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982628,0.00013417854,0.00032382473,0.00061536697,0.00022339703,0.00044038412],"domain_scores_gemma":[0.99786985,0.0006605369,0.00013796646,0.00072718784,0.00036317535,0.00024129458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019959204,0.00014479602,0.00026792925,0.000037421833,0.000531596,0.00020242378,0.00026608666,0.00027914578,0.000027055163],"category_scores_gemma":[0.0067106225,0.00013524726,0.00013457192,0.000029079518,0.0006308258,0.0000075160333,0.00040776466,0.00029263285,0.000008433263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021371406,0.0003289967,0.020132462,0.00018276261,0.00016839145,0.000025464306,0.000034032884,0.0000055815367,0.85200506,0.00024959457,0.017998993,0.10673152],"study_design_scores_gemma":[0.0021811149,0.0008170593,0.16848576,0.00019696877,0.000040154402,0.0000032788257,0.00010122387,0.00011902326,0.7225448,0.00063596497,0.1043815,0.0004931853],"about_ca_topic_score_codex":0.0005748509,"about_ca_topic_score_gemma":0.0025796266,"teacher_disagreement_score":0.1483533,"about_ca_system_score_codex":0.000040700877,"about_ca_system_score_gemma":0.00042300698,"threshold_uncertainty_score":0.8033727},"labels":[],"label_agreement":null},{"id":"W2623577366","doi":"10.1158/1557-3265.ovcasymp16-ap32","title":"Abstract AP32: THE METHYLTRANSFERASE EZH2 IS A VULNERABLE TARGET IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE (SCCOHT)","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; SMARCA4; EZH2; Cancer research; Chromatin; Chromatin remodeling; Histone methyltransferase; Cell cycle checkpoint; Cell biology; Cell cycle; Genetics; Cell; Gene","score_opus":0.17924978000521433,"score_gpt":0.461124827851324,"score_spread":0.2818750478461097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623577366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906153,0.0038700514,0.00001310504,0.0019180888,0.00033555433,0.0003178298,0.000040940406,0.0000029453283,0.002886182],"genre_scores_gemma":[0.99611604,0.0016953336,0.000083193445,0.0004049716,0.00039151558,0.000048740032,0.0000060190973,0.00002470434,0.0012294962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798846,0.00040410372,0.0004528648,0.00044195054,0.00030522016,0.00040737225],"domain_scores_gemma":[0.9979066,0.00022321253,0.000108774104,0.0013860698,0.00028211533,0.00009320358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003038493,0.00013181302,0.00023446177,0.000026761696,0.0003997172,0.00005160591,0.0012397447,0.00024088468,0.00021742877],"category_scores_gemma":[0.0006928926,0.00007938528,0.00020401756,0.00012329563,0.0005959103,0.00000487131,0.00032142847,0.0009909591,0.00001244105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001591058,0.0005477653,0.28481406,0.0002869609,0.0001172013,0.000014465101,0.0005031837,0.00062615395,0.66918445,0.00004173504,0.022873547,0.0193994],"study_design_scores_gemma":[0.002636646,0.00052449433,0.27041656,0.00013591308,0.000033232755,0.000003356191,0.00017619722,0.0011746577,0.6961837,0.0007347466,0.027652923,0.00032758835],"about_ca_topic_score_codex":0.0053181034,"about_ca_topic_score_gemma":0.0013687676,"teacher_disagreement_score":0.026999222,"about_ca_system_score_codex":0.000038442147,"about_ca_system_score_gemma":0.0007790983,"threshold_uncertainty_score":0.80394167},"labels":[],"label_agreement":null},{"id":"W2623871371","doi":"10.1158/1557-3265.ovcasymp16-ntoc-086","title":"Abstract NTOC-086: PAC–1 COMBINATION WITH TRAIL ENHANCES APOPTOSIS IN CELL–LINE AND PRIMARY CULTURED ADULT GRANULOSA CELL TUMOUR CELLS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Apoptosis; In vivo; Programmed cell death; In vitro; Cell culture; Cancer research; Cell; Chemistry; Cancer cell; Cell biology; Caspase; Pharmacology; Cancer; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.06219226028149043,"score_gpt":0.4304599824405146,"score_spread":0.36826772215902415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623871371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927633,0.0014778711,0.00000959811,0.0009300546,0.00009943022,0.0006731778,0.00010278189,0.000007624691,0.003936168],"genre_scores_gemma":[0.9865323,0.0111759445,0.00013352359,0.0000928315,0.000261581,0.00026764665,0.000109008746,0.000029273315,0.0013979444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742573,0.00021027318,0.000386022,0.0007528886,0.0006000174,0.00062506675],"domain_scores_gemma":[0.99842566,0.00011249557,0.00016083042,0.00058240193,0.00039868514,0.00031995072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010374464,0.00020714672,0.0003205735,0.00007981464,0.00036540546,0.00019471627,0.00048525925,0.0002318624,0.00005148434],"category_scores_gemma":[0.00017359198,0.00015991634,0.0000948858,0.000108999026,0.0006706542,0.000027280408,0.0002472641,0.00061419344,0.000017788214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004349236,0.0019557925,0.052406024,0.00046875564,0.00010834548,0.000060896244,0.00013798717,0.000008351634,0.90581256,0.000011671494,0.006763019,0.027917337],"study_design_scores_gemma":[0.0064682965,0.0018293004,0.12977344,0.000114677074,0.000015608966,0.0000010997057,0.00010148408,0.000011740903,0.8589105,0.00011871654,0.002404684,0.00025047362],"about_ca_topic_score_codex":0.002890426,"about_ca_topic_score_gemma":0.005660254,"teacher_disagreement_score":0.07736742,"about_ca_system_score_codex":0.00008362447,"about_ca_system_score_gemma":0.00044526102,"threshold_uncertainty_score":0.6521199},"labels":[],"label_agreement":null},{"id":"W2624138802","doi":"10.1158/1557-3265.ovcasymp16-mip-049","title":"Abstract MIP-049: ATR–DEPENDENT REGULATION OF THE OVARIAN CANCER PROTEIN PALB2 AT DNA DOUBLE–STRAND BREAKS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"PALB2; RAD51; Homologous recombination; DNA repair; BRCA2 Protein; DNA damage; Biology; Cancer research; Ovarian cancer; Genetics; Cell biology; DNA; Cancer; Mutation; Germline mutation; Gene","score_opus":0.1409290364741854,"score_gpt":0.46880232414752576,"score_spread":0.32787328767334034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624138802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925669,0.0004702882,0.000012462143,0.002295349,0.00048467424,0.0009803682,0.000075157084,0.0000084836165,0.0031063205],"genre_scores_gemma":[0.98769176,0.0003143388,0.000051622705,0.00005239369,0.0007437281,0.0002600291,0.000014873962,0.000033055752,0.010838224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974076,0.00024218422,0.0005315517,0.000625912,0.000739899,0.0004528601],"domain_scores_gemma":[0.99740463,0.00005562954,0.00032672184,0.0016363831,0.00040139252,0.00017525916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024711958,0.0001561073,0.0002528117,0.000030173598,0.00049595715,0.000076637065,0.0010481564,0.0003897527,0.00046916562],"category_scores_gemma":[0.00041648978,0.00011474623,0.00024132045,0.00006709402,0.0006295974,0.000008998074,0.0007865454,0.00047676763,0.000017124505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013053546,0.00012126449,0.020878049,0.00008994888,0.00010901801,0.0000037598195,0.000025648786,0.000028696366,0.9590549,0.00014430095,0.0017645151,0.016474552],"study_design_scores_gemma":[0.0019409021,0.00016717399,0.2673183,0.00012121523,0.00001655017,0.0000016574622,0.000011385229,0.000021227563,0.71786773,0.00034648838,0.012049205,0.0001381686],"about_ca_topic_score_codex":0.002343837,"about_ca_topic_score_gemma":0.0070831873,"teacher_disagreement_score":0.24644026,"about_ca_system_score_codex":0.000096491334,"about_ca_system_score_gemma":0.00056344125,"threshold_uncertainty_score":0.51370347},"labels":[],"label_agreement":null},{"id":"W2624569919","doi":"10.1158/1557-3265.ovcasymp16-dpoc-014","title":"Abstract DPOC-014: BEYOND CODING MUTATIONS: USING RETROTRANSPOSONS TO PREDICT OVARIAN CANCER DEVELOPMENT","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Ovarian cancer; Sanger sequencing; Endometriosis; Biology; Cancer research; Frameshift mutation; Cancer; Epigenetics; Retrotransposon; Massive parallel sequencing; Genetics; Mutation; Medicine; DNA sequencing; Gene; Genome; Pathology","score_opus":0.2348676825987793,"score_gpt":0.5157947380122851,"score_spread":0.2809270554135058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624569919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924,0.0011954607,0.00080964214,0.0021140596,0.0009200867,0.0005862291,0.00025848823,0.000011070032,0.0017049834],"genre_scores_gemma":[0.9925728,0.0023025414,0.002273173,0.00044969498,0.0016000328,0.00025676636,0.000051216153,0.000045038872,0.0004487235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764544,0.00008445718,0.00054079446,0.0006824567,0.00043251936,0.0006143077],"domain_scores_gemma":[0.9979655,0.00017113476,0.00014591355,0.00082044705,0.00047253224,0.0004244752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016536873,0.00017044524,0.00025121664,0.000083709885,0.0009767015,0.00023677108,0.0007246709,0.0002444752,0.00022176866],"category_scores_gemma":[0.001368208,0.00017387886,0.00011720108,0.00010250475,0.00034560682,0.000011211336,0.00038456364,0.00046232544,0.000029763094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002266529,0.0006611203,0.44651014,0.0003198696,0.0008417084,0.000111096306,0.0007093358,0.0038832268,0.29420415,0.0006865636,0.03623868,0.21356758],"study_design_scores_gemma":[0.0025562057,0.00046147063,0.62154865,0.00042619102,0.000062367435,0.000003740496,0.00013745947,0.00038475788,0.08017996,0.00038184333,0.29313022,0.0007271197],"about_ca_topic_score_codex":0.0016784905,"about_ca_topic_score_gemma":0.003780833,"teacher_disagreement_score":0.25689155,"about_ca_system_score_codex":0.0001939282,"about_ca_system_score_gemma":0.0019390029,"threshold_uncertainty_score":0.75120974},"labels":[],"label_agreement":null},{"id":"W2625162530","doi":"10.1158/1078-0432.ccr-17-0629","title":"<i>PTEN, DICER1, FH</i>, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Amgen (Canada); University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; PTEN; Cowden syndrome; Thyroid cancer; Cancer; Thyroid; Pathology; Oncology; Cancer syndrome; Endometrial cancer; Internal medicine; Germline mutation; Mutation; PI3K/AKT/mTOR pathway; Biology","score_opus":0.5654025693032506,"score_gpt":0.6253678440929122,"score_spread":0.05996527478966163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625162530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053548915,0.9849891,0.0000011135411,0.006187934,0.00081665465,0.0016296097,0.00040743826,0.000048371512,0.0005648548],"genre_scores_gemma":[0.0039435974,0.9930242,0.00007072824,0.00052123674,0.00079620903,0.0002461112,0.00021816292,0.000065499255,0.0011142852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98951864,0.005242677,0.0021964782,0.0016176793,0.00052260794,0.0009018944],"domain_scores_gemma":[0.98525083,0.011660523,0.0006111522,0.0012644496,0.00045996695,0.00075305975],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.021756358,0.00050671736,0.00443593,0.00024734734,0.00047889058,0.00009549214,0.00051570334,0.0009560677,0.00010033292],"category_scores_gemma":[0.028116561,0.00034073426,0.00048547157,0.00035605713,0.004113313,0.00004728688,0.0009094771,0.0066362107,0.000023431749],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004358023,0.00046250573,0.20773849,0.0022707542,0.00036590055,0.00012683429,0.00006509306,3.954772e-9,1.969116e-8,0.0000019617712,0.018864026,0.77006084],"study_design_scores_gemma":[0.00168249,0.00044550118,0.32046273,0.009954928,0.00017612535,0.00010074076,0.00005959544,0.0000047451026,2.707817e-8,0.00010586136,0.6667335,0.00027378593],"about_ca_topic_score_codex":0.00030455858,"about_ca_topic_score_gemma":0.0020496417,"teacher_disagreement_score":0.7697871,"about_ca_system_score_codex":0.0001839388,"about_ca_system_score_gemma":0.0016896189,"threshold_uncertainty_score":0.99990445},"labels":[],"label_agreement":null},{"id":"W2625265855","doi":"10.1158/1078-0432.ccr-17-0631","title":"Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Costello syndrome; Medicine; PTPN11; Noonan syndrome; Cancer; KRAS; Family history; Genetic testing; Pediatrics; Oncology; Internal medicine; Colorectal cancer","score_opus":0.285208259087977,"score_gpt":0.5512515786068394,"score_spread":0.2660433195188624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625265855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020259551,0.9721871,0.000031857326,0.00039184562,0.0001114537,0.002879538,0.022331225,0.000010980053,0.000030033578],"genre_scores_gemma":[0.0013934104,0.9823718,0.00061512005,0.00013038801,0.00064436044,0.013534446,0.00094135856,0.00011662898,0.00025249485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960519,0.0011434417,0.00073399214,0.0011061514,0.00033478928,0.00062970934],"domain_scores_gemma":[0.99687016,0.00088035356,0.0006295249,0.000949026,0.00043227195,0.00023865717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021309275,0.00040723346,0.001232325,0.00017031086,0.00043961048,0.0001445157,0.0006615229,0.00045939558,0.00016610682],"category_scores_gemma":[0.0012003741,0.0002941874,0.00016197439,0.00026942347,0.0010757734,0.000011627205,0.0003015138,0.00087686436,0.0000033112817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003965629,0.0001781655,0.20488746,0.004147228,0.0008891823,0.0000100632615,0.00002324711,0.000011774895,0.0000037242798,0.00005252249,0.020063858,0.7693362],"study_design_scores_gemma":[0.0016085268,0.0005178349,0.00845798,0.0061804554,0.00020798256,0.0000061881206,0.000012500654,0.0000026889763,0.00008105462,0.000056475074,0.98242944,0.00043884592],"about_ca_topic_score_codex":0.0076642283,"about_ca_topic_score_gemma":0.03515645,"teacher_disagreement_score":0.9623656,"about_ca_system_score_codex":0.00011068346,"about_ca_system_score_gemma":0.0028252986,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W2625448727","doi":"10.1158/1078-0432.ccr-17-0438","title":"<i>In Situ</i> Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Toronto General Hospital","funders":"","keywords":"Medicine; Radiation therapy; Immune system; Immunotherapy; Mesothelioma; Immune checkpoint; Blockade; Surgery; Oncology; Internal medicine; Immunology; Pathology","score_opus":0.2499333826277477,"score_gpt":0.5176092521322413,"score_spread":0.2676758695044936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625448727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458546,0.0014441938,0.000009257211,0.012869988,0.00014169812,0.0004804049,0.000010621595,0.00001452287,0.00044383018],"genre_scores_gemma":[0.98693466,0.009762239,0.000034622477,0.0010793541,0.00016718921,0.0002359882,0.000010505103,0.000021162492,0.0017542552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998102,0.0002472218,0.0005395299,0.00038684966,0.00039720177,0.0003272146],"domain_scores_gemma":[0.998589,0.0005717105,0.00011650775,0.0003892337,0.00021816888,0.000115399285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034418227,0.00010327691,0.0003235623,0.00040701445,0.00012971544,0.00009647865,0.000115457646,0.00021110536,0.00026663317],"category_scores_gemma":[0.00089235714,0.00009227448,0.000078932295,0.00030051943,0.00015338678,0.00050215086,0.00005822439,0.0006092683,0.000011165189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029269058,0.0007441892,0.619084,0.00015821074,0.00010188253,0.00013827595,0.00024280058,0.000031475614,0.031359226,0.000024589333,0.009023085,0.30982324],"study_design_scores_gemma":[0.0047015357,0.00010000152,0.9781411,0.00012445262,0.000008450083,0.0000033645508,0.000024850708,0.0059915595,0.007172367,0.00021667924,0.0033935711,0.000122015554],"about_ca_topic_score_codex":0.0020533588,"about_ca_topic_score_gemma":0.0022164246,"teacher_disagreement_score":0.3590572,"about_ca_system_score_codex":0.00032001745,"about_ca_system_score_gemma":0.00052350666,"threshold_uncertainty_score":0.37628442},"labels":[],"label_agreement":null},{"id":"W2625567931","doi":"10.1158/1078-0432.ccr-17-0547","title":"Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"SDHD; SDHB; SDHA; Pheochromocytoma; Medicine; Paraganglioma; Cancer; Von Hippel–Lindau disease; Disease; Oncology; Stromal tumor; Internal medicine; Germline mutation; Pathology; Bioinformatics; Stromal cell; Genetics; Biology; Mutation; Gene","score_opus":0.4547394839743073,"score_gpt":0.6025139689033184,"score_spread":0.14777448492901113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625567931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013176907,0.98061776,8.564266e-7,0.0019574428,0.0011453723,0.0020228743,0.00034965092,0.00004701042,0.000682108],"genre_scores_gemma":[0.004052231,0.98995966,0.00013083984,0.00015578922,0.002935942,0.00024500297,0.00037249457,0.00011817798,0.0020298527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99133724,0.0025799887,0.0024845535,0.0017374458,0.00083242316,0.0010283783],"domain_scores_gemma":[0.99172246,0.0048886477,0.00062291307,0.0014252723,0.00034202437,0.000998702],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008887034,0.0006201941,0.004021377,0.0005656349,0.00039638102,0.00014993813,0.0006874697,0.0013426376,0.00032019187],"category_scores_gemma":[0.0041139885,0.00047999673,0.0006094364,0.00061826693,0.0018319095,0.00010591312,0.00083425496,0.0056675645,0.00010328658],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019846154,0.000470576,0.0053457515,0.0042545423,0.00033458121,0.008966984,0.000047872585,5.4956462e-8,5.649085e-9,0.000023945287,0.015676828,0.9646804],"study_design_scores_gemma":[0.003243076,0.0012427124,0.116216324,0.018590508,0.0002997294,0.008493435,0.000042317068,0.000011581626,2.0015484e-7,0.00023849511,0.851026,0.0005956296],"about_ca_topic_score_codex":0.00031423845,"about_ca_topic_score_gemma":0.0010894787,"teacher_disagreement_score":0.96408474,"about_ca_system_score_codex":0.000211851,"about_ca_system_score_gemma":0.0026447054,"threshold_uncertainty_score":0.9999538},"labels":[],"label_agreement":null},{"id":"W2625687193","doi":"10.1158/1078-0432.ccr-16-3224","title":"Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Common Fund; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; NIH Office of the Director; National Human Genome Research Institute; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Institutes of Health; Université de Genève; University of Pennsylvania; RIKEN; Broad Institute; Harvard University; National Institute on Drug Abuse; University of Miami","keywords":"Medicine; Internal medicine; Cancer; Imputation (statistics); Peripheral neuropathy; Cisplatin; Genome-wide association study; Oncology; Diabetes mellitus; Body mass index; Single-nucleotide polymorphism; Genotype; Chemotherapy; Endocrinology; Genetics; Gene; Biology","score_opus":0.28480858156993494,"score_gpt":0.5834587144445557,"score_spread":0.2986501328746207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625687193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473804,0.00097486854,0.0000014815953,0.0024991548,0.00041808453,0.0005205245,0.00012732075,0.000007649895,0.00071286684],"genre_scores_gemma":[0.9877505,0.010886219,0.000038885493,0.0003156018,0.0003050785,0.00010546451,0.000015756343,0.000023493576,0.0005590589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618757,0.00086635223,0.0013220756,0.00062870927,0.00053802616,0.00045726507],"domain_scores_gemma":[0.99575686,0.0020737213,0.00039517588,0.00078539975,0.00064602616,0.0003428038],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003077583,0.0001664371,0.0013725732,0.00039497556,0.00012826094,0.000020602745,0.000363581,0.00024394567,0.000985344],"category_scores_gemma":[0.0021810355,0.00013871622,0.00038490933,0.0006266143,0.0014436089,0.00007357995,0.00028148474,0.0010097871,0.0000029979815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037311816,0.0006299384,0.97730476,0.00011275633,0.0010122547,0.00007261262,0.00021350851,0.000011696751,0.00081951526,0.000011744586,0.0002480281,0.015832027],"study_design_scores_gemma":[0.0048372224,0.0013085424,0.99115115,0.000094533716,0.0007683776,9.4702665e-7,0.000060407125,0.0006816685,0.00028531117,0.000028987455,0.00067633495,0.0001064989],"about_ca_topic_score_codex":0.0195747,"about_ca_topic_score_gemma":0.03467747,"teacher_disagreement_score":0.015725529,"about_ca_system_score_codex":0.00010291206,"about_ca_system_score_gemma":0.0007851131,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W2625944954","doi":"10.1158/1078-0432.ccr-17-0589","title":"Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Neurofibromatosis; Rhabdomyosarcoma; Population; Pediatrics; Malignancy; Neurocognitive; Cancer; Pediatric cancer; Pilocytic astrocytoma; Pathology; Intensive care medicine; Sarcoma; Internal medicine; Glioma; Astrocytoma; Psychiatry","score_opus":0.38658817522756533,"score_gpt":0.5440567199945632,"score_spread":0.15746854476699784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625944954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050914653,0.9444906,1.1770807e-7,0.0003376711,0.0012087385,0.0020697971,0.00029810864,0.00007946358,0.00060086645],"genre_scores_gemma":[0.011408506,0.9840933,0.000014902397,0.000052959836,0.0026467636,0.00094016956,0.000028724719,0.00016269012,0.00065196963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919242,0.0017856313,0.0020831993,0.0016252286,0.0011451594,0.0014365577],"domain_scores_gemma":[0.9941132,0.0024880022,0.0006759418,0.0014753388,0.00030594785,0.00094158534],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002704849,0.0005990854,0.0043259505,0.0006105102,0.0003138105,0.00025203347,0.00074334256,0.00054428144,0.00008838006],"category_scores_gemma":[0.0016872941,0.00045527212,0.00074600877,0.00079656095,0.0005562853,0.00011231259,0.00063572644,0.002911207,0.00007378872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026472606,0.00021275277,0.15601909,0.10061593,0.00012904874,0.0037017053,0.00001353063,2.5583614e-7,6.0243076e-7,0.000052648862,0.008766541,0.7302232],"study_design_scores_gemma":[0.0012438366,0.0004682319,0.15812747,0.023329908,0.00040659428,0.0004518212,0.000012874298,0.000023769024,7.098733e-7,0.0000029451276,0.8154468,0.00048501027],"about_ca_topic_score_codex":0.0014835274,"about_ca_topic_score_gemma":0.00032445608,"teacher_disagreement_score":0.80668026,"about_ca_system_score_codex":0.00046193754,"about_ca_system_score_gemma":0.003307894,"threshold_uncertainty_score":0.9997899},"labels":[],"label_agreement":null},{"id":"W2626568439","doi":"10.1158/1078-0432.ccr-15-1636","title":"Molecular Pathways: Targeting the Microenvironment of Liver Metastases","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Colorectal cancer; Paracrine signalling; Medicine; Cancer; Autocrine signalling; Cancer research; Metastasis; Gastrointestinal tract; Tumor microenvironment; Liver cancer; Internal medicine; Receptor","score_opus":0.6281386272263334,"score_gpt":0.6151416007931797,"score_spread":0.012997026433153702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626568439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008442138,0.994184,0.000010013173,0.0004378529,0.00013656821,0.0023304238,0.00015734362,0.000010031269,0.001889554],"genre_scores_gemma":[0.00033872685,0.9958545,0.00025050546,0.00007669371,0.00063266023,0.00069949677,0.00005996761,0.000064183405,0.002023294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923252,0.0032681667,0.0015045602,0.00070767343,0.0013968921,0.0007974949],"domain_scores_gemma":[0.9920302,0.004960203,0.0005751046,0.0017079347,0.00035602774,0.0003705399],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012738544,0.00031101308,0.003386844,0.0001910351,0.00034766953,0.00003879264,0.0011482441,0.00052257837,0.0010645945],"category_scores_gemma":[0.005743389,0.00016897422,0.0011380855,0.00021991208,0.0030166332,0.00003205732,0.00093600055,0.003067398,0.00028457693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013366799,0.0003921137,0.0007747764,0.013072635,0.0012405759,0.0004938145,0.000036260884,1.1343497e-7,0.000013841909,0.00011920693,0.0097799795,0.973943],"study_design_scores_gemma":[0.000556091,0.0006067319,0.00028430152,0.008879046,0.0017109908,0.00002346004,0.000033566055,0.000010902446,0.000020859772,0.000046955927,0.98768973,0.000137364],"about_ca_topic_score_codex":0.00043272975,"about_ca_topic_score_gemma":0.000017768734,"teacher_disagreement_score":0.97790974,"about_ca_system_score_codex":0.00030001087,"about_ca_system_score_gemma":0.0034222722,"threshold_uncertainty_score":0.99984854},"labels":[],"label_agreement":null},{"id":"W2626586502","doi":"10.1158/1078-0432.ccr-17-0590","title":"Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Hospital for Sick Children; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Neurofibromatosis; Medicine; Cancer; Central nervous system; Nervous system; Pathology; Internal medicine; Psychiatry","score_opus":0.21737772456651003,"score_gpt":0.5003276220571397,"score_spread":0.2829498974906296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626586502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.114563376,0.8816396,4.9375583e-8,0.00047881817,0.00077157374,0.0017913908,0.00016480376,0.000063171836,0.00052723126],"genre_scores_gemma":[0.0359128,0.9622224,0.000007406819,0.000024661358,0.00065429613,0.0005207459,0.000024397139,0.00013182002,0.00050144916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933072,0.0015371027,0.0017749534,0.0014746037,0.0007859438,0.0011202119],"domain_scores_gemma":[0.9953108,0.0021900642,0.00056910474,0.000990085,0.00015921256,0.00078077224],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021332607,0.0005292916,0.0033411046,0.0005153658,0.00031401755,0.0001925718,0.00043435948,0.0005298244,0.000053801894],"category_scores_gemma":[0.0013969893,0.00040764053,0.00044654112,0.0006940485,0.0007196752,0.00011149232,0.00053583266,0.0025123418,0.000021795382],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002091223,0.00014118936,0.19876659,0.060883593,0.00013507152,0.0012908444,0.000022986731,2.5008293e-7,3.7448234e-7,0.000051753956,0.0023408297,0.7361574],"study_design_scores_gemma":[0.002206681,0.00066536764,0.35367906,0.021614391,0.0005573705,0.0005501488,0.000028386248,0.000060470098,2.6171512e-7,0.000015295518,0.62000126,0.0006213169],"about_ca_topic_score_codex":0.0014678991,"about_ca_topic_score_gemma":0.00047962542,"teacher_disagreement_score":0.7355361,"about_ca_system_score_codex":0.00024992658,"about_ca_system_score_gemma":0.0016326073,"threshold_uncertainty_score":0.9998375},"labels":[],"label_agreement":null},{"id":"W2725653968","doi":"10.1158/1078-0432.ccr-17-0174","title":"FDG PET and FES PET Predict PFS on Endocrine Therapy—Letter","year":2017,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Standardized uptake value; Fluorodeoxyglucose; Nuclear medicine; Positron emission tomography; Hormonal therapy; Cancer; Metastatic breast cancer; Predictive value; Breast cancer; Progression-free survival; Oncology; Internal medicine; Overall survival; Radiology","score_opus":0.3725870187245502,"score_gpt":0.5908566526554052,"score_spread":0.21826963393085502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725653968","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012033214,0.000797879,0.000013341377,0.9792524,0.00035437517,0.0015091173,0.0001810598,0.0001710629,0.005687539],"genre_scores_gemma":[0.010900934,0.023771904,0.0009045356,0.88416666,0.030474043,0.0018353396,0.00034862332,0.00017589788,0.04742205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515796,0.00045430884,0.00077838614,0.0011371996,0.0015798606,0.0008922803],"domain_scores_gemma":[0.9951207,0.0018353814,0.00021444973,0.001969496,0.00041168768,0.00044827576],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024834536,0.00034835635,0.000905918,0.00022324428,0.00036065435,0.00015680803,0.0008020386,0.0003810079,0.0014503797],"category_scores_gemma":[0.0016457023,0.00024712124,0.00026825158,0.00013541532,0.0020008052,0.00004923017,0.0004035923,0.009571984,0.00016862269],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019511259,0.00014627121,0.0013667094,0.00022054139,0.00010515902,0.002405197,0.000007588941,1.2088098e-8,0.000052952724,0.000027656997,0.97516936,0.020303419],"study_design_scores_gemma":[0.001443329,0.00086005026,0.002349914,0.0007571784,0.000053935375,0.00015749365,0.0000023946106,0.00006571704,0.00014163679,0.00060175813,0.99334365,0.00022296877],"about_ca_topic_score_codex":0.000351676,"about_ca_topic_score_gemma":0.0000069693133,"teacher_disagreement_score":0.09508574,"about_ca_system_score_codex":0.000120389166,"about_ca_system_score_gemma":0.000547888,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2725857922","doi":"10.1158/1078-0432.ccr-17-0652","title":"Retinoblastoma and Neuroblastoma Predisposition and Surveillance","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; American Association for Cancer Research","keywords":"Retinoblastoma; Neuroblastoma; Medicine; Genetic predisposition; Pathology; Biology; Cancer research; Genetics; Gene; Disease; Cell culture","score_opus":0.5637842129581868,"score_gpt":0.6469697183172912,"score_spread":0.0831855053591044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725857922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050460934,0.99031377,5.6383175e-7,0.0006163867,0.0002326833,0.002229975,0.00017497008,0.000061937746,0.0013236195],"genre_scores_gemma":[0.0019087062,0.9933025,0.000033946057,0.000049359125,0.00082750403,0.0004891757,0.00004315325,0.000112810536,0.0032328386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99415374,0.001538833,0.00091041165,0.0014068986,0.0010623595,0.00092776597],"domain_scores_gemma":[0.99464756,0.002374818,0.0003003946,0.0011597212,0.00040780578,0.0011096958],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026327546,0.00045660758,0.0023282915,0.00040050456,0.0005085987,0.0002475857,0.00036213078,0.0005515849,0.000110006],"category_scores_gemma":[0.0024050397,0.00033890214,0.00037564294,0.0002935587,0.0017621957,0.000119378,0.0008212721,0.0027390604,0.00013146228],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052370114,0.00019162933,0.0012824221,0.0117209125,0.00026277482,0.0008126374,0.0000056145705,7.0992963e-9,0.0000012853028,0.000017947985,0.0033713041,0.98180974],"study_design_scores_gemma":[0.0016213957,0.002672813,0.012691933,0.011520161,0.0002118,0.00044947886,0.0000027080828,0.000013570519,0.0000018133451,0.00003822447,0.9705229,0.0002532464],"about_ca_topic_score_codex":0.00008519149,"about_ca_topic_score_gemma":0.00008355163,"teacher_disagreement_score":0.98155653,"about_ca_system_score_codex":0.00015777879,"about_ca_system_score_gemma":0.001193049,"threshold_uncertainty_score":0.9999063},"labels":[],"label_agreement":null},{"id":"W2726357279","doi":"10.1158/1078-0432.ccr-17-0595","title":"Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute for Health and Care Research","keywords":"Cancer; Medicine; Pathology; Internal medicine","score_opus":0.3089927966369647,"score_gpt":0.5738066049425926,"score_spread":0.2648138083056279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726357279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05532043,0.94272023,0.000005902288,0.00012837695,0.00034280375,0.0009671419,0.00032499636,0.000013982093,0.00017612509],"genre_scores_gemma":[0.019177923,0.9775986,0.000044387267,0.00004209563,0.0005338917,0.0010918888,0.00017144007,0.00009713574,0.0012426471],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563456,0.0008528002,0.0009539102,0.0013134349,0.0005242673,0.00072101876],"domain_scores_gemma":[0.9977455,0.00026271227,0.00036861905,0.0010757969,0.00027691276,0.00027045826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029025467,0.0004133868,0.0016059777,0.0001638665,0.00021710263,0.00012692773,0.0007491541,0.00063594553,0.00008140788],"category_scores_gemma":[0.00044726767,0.00032734318,0.0002968175,0.00023770929,0.00067769305,0.000009353008,0.00045892075,0.0013620271,0.00002071653],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022999551,0.00015911697,0.003301534,0.010693636,0.0003217385,0.00042126686,0.00000952157,0.000026545556,0.000017183802,0.000005296968,0.0019228938,0.98289126],"study_design_scores_gemma":[0.0010903047,0.000852005,0.0034894429,0.017753119,0.00010576977,0.0004648841,0.000009773928,0.00006584675,0.0000066635694,0.000031074374,0.9754383,0.00069281086],"about_ca_topic_score_codex":0.0010270712,"about_ca_topic_score_gemma":0.0022111738,"teacher_disagreement_score":0.9821985,"about_ca_system_score_codex":0.00022137804,"about_ca_system_score_gemma":0.0020384977,"threshold_uncertainty_score":0.99991786},"labels":[],"label_agreement":null},{"id":"W2726739357","doi":"10.1158/1078-0432.ccr-17-0900","title":"Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Puma Biotechnology","keywords":"Neratinib; Metastatic breast cancer; Breast cancer; Circulating tumor DNA; Cancer; Medicine; Oncology; Trastuzumab; Cancer research; Internal medicine; Biology","score_opus":0.3070330761576317,"score_gpt":0.5647289912994085,"score_spread":0.25769591514177675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726739357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897965,0.0010568409,0.000054592165,0.005432061,0.00036433557,0.001661185,0.00015993003,0.000035305424,0.0014392154],"genre_scores_gemma":[0.99660516,0.0010652096,0.00026793737,0.0002601653,0.0006400277,0.0006817181,0.000010200407,0.00007677731,0.0003928278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99448013,0.000877032,0.0012898702,0.0009229042,0.0014900691,0.0009399622],"domain_scores_gemma":[0.99493855,0.0018939076,0.00036885642,0.00117031,0.0010547255,0.00057367596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058668125,0.00025508052,0.00090572744,0.00036154347,0.0006100952,0.00018995118,0.00052445167,0.0001771446,0.0005109431],"category_scores_gemma":[0.004641225,0.00023043052,0.00016491098,0.00065991847,0.0017203668,0.00024851953,0.00038898186,0.0020350958,0.000028511127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034432462,0.001461157,0.45222336,0.001851092,0.00037091173,0.0003545384,0.00086545426,0.00015991628,0.09006707,0.00021110251,0.0010621486,0.44792998],"study_design_scores_gemma":[0.00893107,0.0007930194,0.9745264,0.0016633142,0.00011643617,0.00007761574,0.00036283483,0.0028422978,0.007861794,0.0004504242,0.0020416018,0.00033319008],"about_ca_topic_score_codex":0.013578699,"about_ca_topic_score_gemma":0.007450227,"teacher_disagreement_score":0.52230304,"about_ca_system_score_codex":0.00043929243,"about_ca_system_score_gemma":0.0019918522,"threshold_uncertainty_score":0.99298996},"labels":[],"label_agreement":null},{"id":"W2727107256","doi":"10.1158/1078-0432.ccr-17-0548","title":"Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"MEN1; Penetrance; Multiple endocrine neoplasia; Medicine; Germline mutation; Cancer; Germline; Genetic testing; Cowden syndrome; Pheochromocytoma; Hyperparathyroidism; Genetic counseling; Pathology; Internal medicine; Mutation; Genetics; Biology; Gene","score_opus":0.40401425315292894,"score_gpt":0.6033101247625904,"score_spread":0.19929587160966145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727107256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009344981,0.98214275,3.9609853e-7,0.0028990156,0.0006432768,0.0039952355,0.0004256029,0.00006116453,0.00048756116],"genre_scores_gemma":[0.0034946215,0.9911087,0.00043222916,0.00017069682,0.00102073,0.00088046445,0.00018539756,0.00017954462,0.0025275734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98831105,0.0036578628,0.0027701198,0.0023681503,0.0012091501,0.0016836391],"domain_scores_gemma":[0.9839195,0.011538516,0.0006223067,0.0019919267,0.0004899059,0.0014378721],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0056232475,0.0007407699,0.0046534087,0.000764766,0.0004543686,0.00028867417,0.001021217,0.00019914734,0.00013735254],"category_scores_gemma":[0.021993356,0.00059461576,0.0005760109,0.0006514022,0.002397575,0.00018527203,0.0016496982,0.007728277,0.000092903014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002861365,0.00068983703,0.071182065,0.0049817995,0.00023628044,0.0045208344,0.000011540109,1.2325279e-7,3.2786133e-7,0.0000148470735,0.012711798,0.9053644],"study_design_scores_gemma":[0.0038740628,0.001330971,0.06364966,0.006248415,0.000113340146,0.0032794357,0.000028654369,0.000011301398,7.629069e-7,0.00006876564,0.9209507,0.0004439181],"about_ca_topic_score_codex":0.00055124925,"about_ca_topic_score_gemma":0.0037247739,"teacher_disagreement_score":0.9082389,"about_ca_system_score_codex":0.0002450311,"about_ca_system_score_gemma":0.0027139848,"threshold_uncertainty_score":0.99965054},"labels":[],"label_agreement":null},{"id":"W2729499120","doi":"10.1158/1078-0432.ccr-17-0387","title":"DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Public Health Agency of Canada; American Institute for Cancer Research","keywords":"KLF4; Pancreatic cancer; Cancer research; Epigenetics; DNA methylation; Biology; Carcinogenesis; Cancer; DNA methyltransferase; Gene silencing; Cellular differentiation; Cancer cell; Transcription factor; SOX2; Gene expression; Genetics","score_opus":0.22113515894677874,"score_gpt":0.5153545929712718,"score_spread":0.29421943402449313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729499120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963939,0.0015311887,0.00024163221,0.0002151482,0.00053098635,0.0005376937,0.0003045009,0.000007117626,0.00023784261],"genre_scores_gemma":[0.9897297,0.0089760395,0.00016405934,0.00002766209,0.0004929822,0.0001202677,0.000034765115,0.00004289858,0.0004116406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99606717,0.0007303347,0.0008165064,0.00069941895,0.0010591723,0.0006274087],"domain_scores_gemma":[0.99679285,0.0004312368,0.00034550158,0.0012750482,0.0009304325,0.00022489828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013933422,0.00021494186,0.00054283976,0.00010447701,0.00027944084,0.00006322352,0.0011291873,0.00045037994,0.000543589],"category_scores_gemma":[0.001401167,0.00017889262,0.00025643676,0.00014606686,0.00095733016,0.000034468594,0.000553504,0.0006940458,0.000009085527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005308743,0.00019967,0.07117424,0.00022351867,0.000118874064,0.000001978675,0.00017216025,0.000008356974,0.9204185,0.0000058221717,0.0010664342,0.0060795546],"study_design_scores_gemma":[0.000980451,0.0004945022,0.085429884,0.00027643147,0.000024865909,2.1580419e-7,0.0001328524,0.000020833928,0.91175896,0.000077701334,0.0006409572,0.00016233636],"about_ca_topic_score_codex":0.0033066212,"about_ca_topic_score_gemma":0.0006952655,"teacher_disagreement_score":0.014255639,"about_ca_system_score_codex":0.00007180449,"about_ca_system_score_gemma":0.0008547972,"threshold_uncertainty_score":0.7295029},"labels":[],"label_agreement":null},{"id":"W2731009462","doi":"10.1158/1078-0432.ccr-17-0790","title":"Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill Genome Centre; Hospital for Sick Children","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Medicine; Cancer; Gastrointestinal cancer; Childhood cancer; Intensive care medicine; Internal medicine; Colorectal cancer","score_opus":0.6863700664617289,"score_gpt":0.6628334277154109,"score_spread":0.02353663874631806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731009462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005912699,0.9872712,0.000009898366,0.0015408675,0.00093503273,0.0032082372,0.00036171143,0.00003417293,0.000726167],"genre_scores_gemma":[0.0012196339,0.9915936,0.0027433166,0.00009005967,0.00083280716,0.0019171796,0.00006921762,0.00013627166,0.0013978936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917112,0.0014327741,0.0031545397,0.0015448213,0.0011326248,0.0010240574],"domain_scores_gemma":[0.99403805,0.002377851,0.0010204677,0.0013157879,0.0006188315,0.00062899827],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059802826,0.00057115353,0.0037908265,0.0006143128,0.00022268585,0.00007893616,0.00091932685,0.0006149057,0.0014889416],"category_scores_gemma":[0.0014987387,0.000479373,0.00078667636,0.0008784502,0.001578639,0.00008827952,0.0011850395,0.004419884,0.000016712647],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023329211,0.00044172374,0.06169216,0.010095771,0.0008167672,0.00013428656,0.000020829872,0.0000011685606,1.5947202e-7,0.0000085699785,0.003435074,0.9231202],"study_design_scores_gemma":[0.0025969145,0.0010010712,0.1698076,0.17410897,0.0012083929,0.0000775123,0.00006593979,0.000028783457,5.0112686e-7,0.000034204004,0.6506494,0.00042068097],"about_ca_topic_score_codex":0.0023911325,"about_ca_topic_score_gemma":0.0019030557,"teacher_disagreement_score":0.9226995,"about_ca_system_score_codex":0.0006467874,"about_ca_system_score_gemma":0.0028875808,"threshold_uncertainty_score":0.9997658},"labels":[],"label_agreement":null},{"id":"W2731855054","doi":"10.1158/1078-0432.ccr-17-0834","title":"Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Genetic counseling; Genetic predisposition; Medicine; Cancer; Genetic testing; Family medicine; Population; Pediatric cancer; Pediatric oncology; Internal medicine; Genetics; Disease; Environmental health","score_opus":0.6558376855245642,"score_gpt":0.6763505522947697,"score_spread":0.020512866770205473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731855054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023638718,0.9738482,0.000011818813,0.013004014,0.0012758983,0.008690887,0.0006028315,0.000016602837,0.00018585227],"genre_scores_gemma":[0.0009394573,0.9826141,0.00015652481,0.0005776865,0.0035329065,0.011729978,0.0003025215,0.000058997528,0.00008782827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98970425,0.005469674,0.001850792,0.0009878887,0.0013824237,0.00060499826],"domain_scores_gemma":[0.98803425,0.008724279,0.00084195234,0.0009998411,0.0011693173,0.00023038914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0203261,0.00031005612,0.0018447037,0.00032440727,0.00041690265,0.0001055958,0.00052596227,0.0006000845,0.00018259618],"category_scores_gemma":[0.004748914,0.00022216627,0.00038069743,0.0004724219,0.0004014774,0.000077285156,0.00014740966,0.0018040877,0.000014561097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019546223,0.00029257452,0.00424134,0.0069360733,0.000106026106,0.0000051426878,0.00048331733,8.8003094e-7,1.821148e-8,0.000010458935,0.023661233,0.96406746],"study_design_scores_gemma":[0.0017006003,0.001093727,0.0131875705,0.003683741,0.00063513935,0.000016590291,0.000117060365,0.00007845389,3.0595874e-8,0.00018033809,0.9790868,0.00021992899],"about_ca_topic_score_codex":0.0014811256,"about_ca_topic_score_gemma":0.0070478646,"teacher_disagreement_score":0.9638475,"about_ca_system_score_codex":0.0010879601,"about_ca_system_score_gemma":0.006661252,"threshold_uncertainty_score":0.99897003},"labels":[],"label_agreement":null},{"id":"W2739459975","doi":"","title":"Different response of breast cancer cell lines to PMA treatment","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Breast cancer; Cell culture; Cancer; Cancer research; Integrin; Cell; Cancer cell; Cell adhesion; Medicine; Biology; Immunology; Oncology; Internal medicine; Genetics","score_opus":0.25816404293991924,"score_gpt":0.5800651535950977,"score_spread":0.32190111065517846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739459975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869749,0.0017100623,0.000036517125,0.0085081365,0.00022306787,0.0012519592,0.00010619407,0.000030768013,0.0011584047],"genre_scores_gemma":[0.97739613,0.0043443497,0.00016484743,0.0003560472,0.00080506946,0.00022559093,0.0000070590704,0.000058795544,0.016642105],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9947197,0.000793127,0.0009775673,0.00072305516,0.0017571907,0.0010293602],"domain_scores_gemma":[0.99297005,0.0034820002,0.000085851396,0.0009029158,0.0012772494,0.0012819269],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005308122,0.00022416248,0.0007066907,0.00027071682,0.00010998712,0.000022458407,0.00036444643,0.00023335022,0.0039330116],"category_scores_gemma":[0.0010379758,0.00015583649,0.0003126335,0.0008210611,0.00045273185,0.000034302397,0.0003474708,0.00071863097,0.00019147804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09339248,0.004169646,0.25455052,0.00032612187,0.0001994456,0.000449382,0.00041475423,0.000012317242,0.38276616,0.000017788052,0.013644359,0.25005704],"study_design_scores_gemma":[0.0036971993,0.0042369696,0.7587878,0.00025612707,0.000042568478,0.000010061857,0.00024978386,0.000051558716,0.20534262,0.000011982936,0.027150624,0.00016271613],"about_ca_topic_score_codex":0.004693194,"about_ca_topic_score_gemma":0.002575165,"teacher_disagreement_score":0.5042373,"about_ca_system_score_codex":0.0012383726,"about_ca_system_score_gemma":0.0010788938,"threshold_uncertainty_score":0.9969775},"labels":[],"label_agreement":null},{"id":"W2739763269","doi":"10.1158/1078-0432.ccr-16-2882","title":"Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Neutropenia; Anemia; Internal medicine; Toxicity; Gastroenterology; Surgery","score_opus":0.18848043433589654,"score_gpt":0.5543462899047323,"score_spread":0.3658658555688358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739763269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931965,0.0003948239,6.539805e-7,0.00032157876,0.00039479876,0.005229388,0.00006275509,0.00001909809,0.00038039422],"genre_scores_gemma":[0.99844605,0.00039277316,0.000011384465,0.000023373746,0.0006334037,0.00033190424,0.000012473632,0.00003936461,0.00010928289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932522,0.0017691151,0.0019258435,0.00079529505,0.001394599,0.00086292805],"domain_scores_gemma":[0.99584645,0.0011660719,0.00094908685,0.0011345063,0.00034432448,0.0005595423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004221117,0.00023890646,0.0013467927,0.00036592165,0.00035894505,0.00003341904,0.0006073354,0.00014353644,0.000038670816],"category_scores_gemma":[0.0031861393,0.0001651304,0.00022224718,0.0004892435,0.0009763489,0.000089604226,0.000778148,0.0014397621,0.0000018813589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14196698,0.02633148,0.79598695,0.0006612178,0.0003802815,0.008481831,0.00030715123,0.0000036016777,0.002780502,0.000012330584,0.00055123697,0.022536408],"study_design_scores_gemma":[0.2758328,0.026417606,0.69531333,0.00033580518,0.00029900845,0.00024122495,0.00027112188,0.000108101456,0.0010100335,0.000009164495,0.000033284898,0.0001285381],"about_ca_topic_score_codex":0.0023077307,"about_ca_topic_score_gemma":0.00027149747,"teacher_disagreement_score":0.13386582,"about_ca_system_score_codex":0.00043874295,"about_ca_system_score_gemma":0.0019777657,"threshold_uncertainty_score":0.6733823},"labels":[],"label_agreement":null},{"id":"W2741219503","doi":"10.1158/1078-0432.ccr-17-1140","title":"Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; BC Cancer Agency; University of British Columbia","funders":"","keywords":"ARID1A; Bladder cancer; Somatic hypermutation; Cancer research; Metastasis; Targeted therapy; Cancer; Exome; Medicine; Biology; Exome sequencing; Oncology; Gene; Mutation; Internal medicine; Immunology; Genetics","score_opus":0.2092261080348713,"score_gpt":0.5197973101985911,"score_spread":0.3105712021637198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741219503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930423,0.0024348327,0.00012774771,0.0009775072,0.0005780532,0.00050620886,0.00019683962,0.0000076150545,0.0021289284],"genre_scores_gemma":[0.99107987,0.0048658047,0.0007120706,0.0004080908,0.0013065713,0.00023644933,0.000028421156,0.000050236864,0.001312511],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99675894,0.00031364907,0.0011281823,0.0006824831,0.00051874516,0.00059799483],"domain_scores_gemma":[0.9963284,0.00065703905,0.0006130789,0.0013574283,0.00075513904,0.0002888784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003561421,0.00018373574,0.0005218959,0.00006745558,0.0004697993,0.00012567312,0.0009110169,0.00016161412,0.00044101517],"category_scores_gemma":[0.006031583,0.00017355841,0.00028781377,0.0001054331,0.0007818462,0.000013204821,0.0006630541,0.000491263,0.000029410437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015361699,0.0011563629,0.25877133,0.0008986236,0.0016966255,0.000114072485,0.00018685852,0.0013455779,0.68107057,0.00078221445,0.018036084,0.03440553],"study_design_scores_gemma":[0.010083508,0.0038988965,0.7868704,0.000900736,0.0005829184,0.000040464325,0.000621474,0.0015359569,0.058768693,0.012313249,0.12246218,0.0019215272],"about_ca_topic_score_codex":0.0009416639,"about_ca_topic_score_gemma":0.00046463867,"teacher_disagreement_score":0.6223019,"about_ca_system_score_codex":0.00007876218,"about_ca_system_score_gemma":0.001309419,"threshold_uncertainty_score":0.7220804},"labels":[],"label_agreement":null},{"id":"W2743213992","doi":"10.1158/1078-0432.ccr-17-0700","title":"<i>In Vivo</i> Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; Centre for Drug Research and Development; BC Cancer Agency","funders":"","keywords":"Cisplatin; In vivo; Lung cancer; Cancer research; Adenocarcinoma; Chemotherapy; Medicine; Carboplatin; Cancer; Pharmacology; Oncology; Biology; Internal medicine","score_opus":0.13762338989949802,"score_gpt":0.4927778633327871,"score_spread":0.3551544734332891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743213992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912645,0.0030190244,0.00016095689,0.0022238162,0.00035135332,0.00036204644,0.00005549058,0.0000055817154,0.0025572143],"genre_scores_gemma":[0.99296075,0.0037567802,0.00018254563,0.00028406637,0.00035536857,0.00012278545,0.00001705223,0.0000305112,0.0022901143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977792,0.00026466453,0.00057996385,0.000557863,0.0004082733,0.00041006014],"domain_scores_gemma":[0.9980291,0.0001355744,0.00025992867,0.0009966282,0.00044491995,0.00013383478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022048578,0.00014048288,0.00028434687,0.00006733494,0.00029809642,0.000087093096,0.000527706,0.00023270749,0.00038963408],"category_scores_gemma":[0.00080330315,0.00013103156,0.00013724691,0.00014631853,0.0005597975,0.00001919219,0.00023631913,0.00038030776,0.00002757755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014480457,0.00044287983,0.052195653,0.00007489846,0.0001239006,0.00003235395,0.00008876656,0.00012206904,0.9086726,0.00058231293,0.009725528,0.026491003],"study_design_scores_gemma":[0.0012557026,0.00038600905,0.014670828,0.000089279434,0.000014010393,0.0000033210754,0.00006865884,0.00013759271,0.9348957,0.00084462255,0.047446907,0.00018735668],"about_ca_topic_score_codex":0.0016213038,"about_ca_topic_score_gemma":0.00015268651,"teacher_disagreement_score":0.037721377,"about_ca_system_score_codex":0.000046975365,"about_ca_system_score_gemma":0.0004342341,"threshold_uncertainty_score":0.53433114},"labels":[],"label_agreement":null},{"id":"W2749663845","doi":"10.1158/1078-0432.ccr-17-1034","title":"Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Docetaxel; Prostate cancer; Androgen deprivation therapy; Medicine; Oncology; Internal medicine; Neoadjuvant therapy; Cancer; Transcriptome; Genomics; Biology; Gene; Genetics; Genome; Breast cancer; Gene expression","score_opus":0.17695288912995027,"score_gpt":0.5022077878579497,"score_spread":0.32525489872799945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749663845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863543,0.00985999,0.0000010964325,0.0016561633,0.000034897843,0.0018167543,0.00018411671,0.000012330686,0.00008035427],"genre_scores_gemma":[0.7285373,0.27089873,0.000035278077,0.000034488123,0.00008886558,0.00019952093,0.000015517979,0.000032412983,0.00015784006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997652,0.0002664313,0.00047170298,0.00059712323,0.00049091637,0.0005218269],"domain_scores_gemma":[0.99819064,0.0003569869,0.000200371,0.0005932724,0.00036651528,0.00029219393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015779304,0.00021771026,0.0006170355,0.00022059186,0.0002741332,0.000093010036,0.00019112635,0.00017135694,0.000054721182],"category_scores_gemma":[0.00015729837,0.00012745245,0.00009119051,0.0002061219,0.0010683028,0.0001413404,0.00005414805,0.00080957956,0.0000012099036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024178706,0.00035702015,0.7273858,0.000034989,0.00030652244,0.000033345772,0.00042165854,0.000013635251,0.002565631,0.000009455208,0.000054979584,0.24463825],"study_design_scores_gemma":[0.02347139,0.0064914483,0.96189463,0.0002533598,0.00002686657,0.0000033429826,0.000041561896,0.00023660355,0.006844339,0.00019877186,0.00040156403,0.00013614185],"about_ca_topic_score_codex":0.01847598,"about_ca_topic_score_gemma":0.0012504108,"teacher_disagreement_score":0.26103875,"about_ca_system_score_codex":0.0003316157,"about_ca_system_score_gemma":0.0009456444,"threshold_uncertainty_score":0.98806006},"labels":[],"label_agreement":null},{"id":"W2749893104","doi":"10.1158/1078-0432.ccr-17-1098","title":"Synergy of WEE1 and mTOR Inhibition in Mutant <i>KRAS</i> -Driven Lung Cancers","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"KRAS; PI3K/AKT/mTOR pathway; Wee1; Cancer research; Mutant; Medicine; Discovery and development of mTOR inhibitors; Lung; Lung cancer; Biology; Cancer; Oncology; Internal medicine; Signal transduction; Genetics; Cell cycle; Colorectal cancer","score_opus":0.11755136203765608,"score_gpt":0.4947710386391381,"score_spread":0.37721967660148203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749893104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519444,0.0023129676,0.000036374884,0.0007246268,0.00035296314,0.00024254658,0.00007759669,0.0000049608116,0.0010535397],"genre_scores_gemma":[0.993946,0.004773932,0.00007808219,0.00013575642,0.0006278598,0.00010875394,0.000017848723,0.000025687423,0.00028606757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794036,0.00025833715,0.0004664786,0.0005568783,0.00036561702,0.00041232532],"domain_scores_gemma":[0.9985325,0.00016040969,0.00018430145,0.00068887573,0.0002698392,0.00016412673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016083552,0.00012543981,0.00028575462,0.000069833,0.00017158767,0.00004850775,0.00033454236,0.0002708938,0.0000698304],"category_scores_gemma":[0.0011233975,0.00011960769,0.000085784835,0.00009100449,0.00097076816,0.000011307466,0.00042276309,0.0004480813,0.0000027714248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013091711,0.00015351971,0.244043,0.00022255666,0.0001327464,0.000055180837,0.00009964743,0.00035117668,0.72586864,0.00020049987,0.011034694,0.016529161],"study_design_scores_gemma":[0.0067169406,0.002082708,0.14702024,0.0010949331,0.00004948602,0.000011842754,0.00017370387,0.0017398424,0.76559025,0.00064062787,0.07411533,0.0007640669],"about_ca_topic_score_codex":0.0026494192,"about_ca_topic_score_gemma":0.0033589662,"teacher_disagreement_score":0.09702275,"about_ca_system_score_codex":0.00013964516,"about_ca_system_score_gemma":0.00069148524,"threshold_uncertainty_score":0.487746},"labels":[],"label_agreement":null},{"id":"W2751623946","doi":"10.1158/1078-0432.ccr-17-0895","title":"Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Academy of Medical Sciences; Cancer Research UK; Wellcome Trust","keywords":"Cyclophosphamide; Colorectal cancer; Medicine; Cytotoxic T cell; Immunology; T cell; Cancer research; Cancer; Granzyme B; Internal medicine; Immune system; Chemotherapy; Biology; In vitro","score_opus":0.13246427819783974,"score_gpt":0.4599727787529263,"score_spread":0.32750850055508657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751623946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98683345,0.0021339385,0.0000024713972,0.0016863624,0.0048774253,0.0004815291,0.000033585547,0.000032994223,0.00391827],"genre_scores_gemma":[0.9721003,0.0029023017,0.000011288592,0.0001192749,0.00012310078,0.00025177773,0.000030030133,0.00003370218,0.024428235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957375,0.001975415,0.00065996737,0.00062434253,0.0002148325,0.0007879374],"domain_scores_gemma":[0.99680316,0.0016026673,0.00035443707,0.000546575,0.00062171975,0.00007144097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004596382,0.00021035715,0.00056801137,0.00019885981,0.00077658164,0.00014240836,0.000647305,0.0002873914,0.0022629213],"category_scores_gemma":[0.0024604832,0.00016758575,0.00010686933,0.00031332174,0.0007590792,0.000308235,0.00026114556,0.0022913401,0.0006171302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035487995,0.0020959384,0.6292606,0.00013388965,0.00066995365,0.00016733428,0.00054361945,0.000035068373,0.29102916,0.00012844567,0.0238103,0.016637713],"study_design_scores_gemma":[0.0067915046,0.0011288926,0.80380845,0.00028162787,0.000044562876,0.0000075286425,0.00048735135,0.000014685678,0.15591861,0.000045752957,0.031129558,0.0003414844],"about_ca_topic_score_codex":0.010424593,"about_ca_topic_score_gemma":0.014545725,"teacher_disagreement_score":0.17454785,"about_ca_system_score_codex":0.00031065644,"about_ca_system_score_gemma":0.001227875,"threshold_uncertainty_score":0.9986491},"labels":[],"label_agreement":null},{"id":"W2751649617","doi":"10.1158/1078-0432.ccr-16-3066","title":"Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University College of the North","funders":"National Cancer Institute","keywords":"Dosing; Clinical trial; Medicine; Clinical study design; Intensive care medicine; Cancer; Immunotherapy; Oncology; Precision medicine; Internal medicine; Pathology","score_opus":0.8329008721661434,"score_gpt":0.6316473128910778,"score_spread":0.2012535592750656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751649617","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007816823,0.17802237,0.000007741365,0.017140657,0.791244,0.0029600784,0.00015798908,0.00008145122,0.009604049],"genre_scores_gemma":[0.0001793727,0.5362309,0.00012861613,0.00019387798,0.45225507,0.0005679458,0.00013082821,0.00007440624,0.010238938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.987869,0.005098272,0.002563447,0.0014392181,0.0020596846,0.00097034295],"domain_scores_gemma":[0.95875245,0.03577537,0.0009001258,0.0018527458,0.0019573814,0.00076192745],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.036237545,0.00047507422,0.0022979896,0.00036721112,0.0005891684,0.00019167953,0.0009376512,0.0041504935,0.00039275314],"category_scores_gemma":[0.026795661,0.0003980137,0.0007616279,0.000097547374,0.0044611692,0.00015298184,0.0005250778,0.0063718213,0.000051541032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15513246,0.00040963746,0.000006024536,0.00015536927,0.000576506,0.00013751714,0.00006615728,1.2670466e-8,0.0000030654728,0.000018095849,0.47196034,0.37153482],"study_design_scores_gemma":[0.07251761,0.018590346,0.00035651913,0.0008056182,0.0003125245,0.000007669758,0.00025780496,0.000006233068,0.000003095571,0.00022210674,0.90656984,0.00035061254],"about_ca_topic_score_codex":0.00033109012,"about_ca_topic_score_gemma":0.00044364028,"teacher_disagreement_score":0.43460953,"about_ca_system_score_codex":0.0005726833,"about_ca_system_score_gemma":0.017269112,"threshold_uncertainty_score":0.9998472},"labels":[],"label_agreement":null},{"id":"W2752475919","doi":"10.1158/1078-0432.ccr-16-3064","title":"From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Immunotherapy; Medicine; Clinical trial; Cancer immunotherapy; Cancer; Intensive care medicine; Immune system; Oncology; Immunology; Internal medicine","score_opus":0.4070754855804582,"score_gpt":0.6245596429953687,"score_spread":0.2174841574149105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752475919","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06884628,0.011200786,0.00021645256,0.014026607,0.89820325,0.0046129287,0.0018895693,0.0001395868,0.00086454913],"genre_scores_gemma":[0.00570349,0.025076618,0.0005356763,0.0006531398,0.9496882,0.0011565295,0.0014237292,0.0002483726,0.015514264],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891413,0.0021420436,0.0026532842,0.0015230995,0.0034925293,0.0010477309],"domain_scores_gemma":[0.98205763,0.011329877,0.0009923705,0.0020515837,0.0029847145,0.00058383564],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.021438874,0.0005775013,0.0028510108,0.00057005143,0.0006114971,0.00051606045,0.0014051839,0.002031035,0.0013284651],"category_scores_gemma":[0.025974128,0.00048060584,0.00094033644,0.00054405374,0.00078439264,0.00017493802,0.0003521474,0.003799337,0.00030219508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03677268,0.00044566373,0.00019030752,0.000111241236,0.0010378059,0.000058483587,0.00019856995,6.03403e-8,0.0013197578,0.0000050620547,0.7207076,0.23915277],"study_design_scores_gemma":[0.029375443,0.0034706667,0.0045040264,0.002554595,0.00015947658,7.4393205e-7,0.000045518766,0.000004815288,0.00070746784,0.00035885765,0.95829684,0.0005215632],"about_ca_topic_score_codex":0.010650214,"about_ca_topic_score_gemma":0.00053509074,"teacher_disagreement_score":0.2386312,"about_ca_system_score_codex":0.0014546892,"about_ca_system_score_gemma":0.007761404,"threshold_uncertainty_score":0.99976456},"labels":[],"label_agreement":null},{"id":"W2753016068","doi":"10.1158/1078-0432.ccr-17-1259","title":"Chemogenomic Landscape of <i>RUNX1</i> -mutated AML Reveals Importance of <i>RUNX1</i> Allele Dosage in Genetics and Glucocorticoid Sensitivity","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"","keywords":"RUNX1; Biology; Myeloid leukemia; Leukemia; Myeloid; Allele; Pharmacogenomics; Glucocorticoid receptor; Cancer research; Gene; Genetics; Transcription factor","score_opus":0.1365045459684899,"score_gpt":0.48259546705936207,"score_spread":0.34609092109087214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753016068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911474,0.0028707597,0.000006784742,0.0023305416,0.000083433064,0.0013613896,0.00010292735,0.000014591484,0.0020821444],"genre_scores_gemma":[0.98873305,0.009591804,0.000375613,0.0002205581,0.0002447717,0.00005807085,0.000024794663,0.000056946457,0.00069438486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99516034,0.00065003004,0.0013869781,0.000821045,0.0010849222,0.0008967132],"domain_scores_gemma":[0.9949542,0.0016188385,0.00049973675,0.0017371374,0.0007431516,0.00044691234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008281244,0.00023194878,0.0012656682,0.00024717467,0.00014262596,0.000042593838,0.0005146236,0.0003680904,0.00019845915],"category_scores_gemma":[0.0035444256,0.00020705721,0.00018407946,0.00035532663,0.0017732488,0.00011534732,0.0008733381,0.001647636,0.000025547964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021990044,0.00029931497,0.8776708,0.0006213715,0.00011513481,0.00031048447,0.00011699126,0.000011817761,0.10737306,0.000026069652,0.0028485784,0.008407347],"study_design_scores_gemma":[0.0070282803,0.00077610544,0.9533734,0.000336602,0.000049718266,0.000031778338,0.00013658515,0.0017834513,0.034951646,0.00017401396,0.0011501813,0.0002082434],"about_ca_topic_score_codex":0.0013383403,"about_ca_topic_score_gemma":0.0012410192,"teacher_disagreement_score":0.07570256,"about_ca_system_score_codex":0.00024942245,"about_ca_system_score_gemma":0.0015943842,"threshold_uncertainty_score":0.8443548},"labels":[],"label_agreement":null},{"id":"W2753127471","doi":"10.1158/1078-0432.ccr-16-3079","title":"Challenges and Opportunities in Adapting Clinical Trial Design for Immunotherapies","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Immunotherapy; Cancer; Cancer immunotherapy; Pillar; Clinical study design; Biomarker; Oncology; Intensive care medicine; Internal medicine; Biology","score_opus":0.7863942232871721,"score_gpt":0.6191165422598202,"score_spread":0.16727768102735197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753127471","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041275104,0.2667951,0.000028881463,0.008662346,0.7122771,0.0060162707,0.00018667048,0.00006876948,0.0018373276],"genre_scores_gemma":[0.0010080468,0.51378024,0.00025236304,0.00009870239,0.47931617,0.0012286204,0.00005100439,0.00010191886,0.0041629532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918614,0.0021970696,0.0022701952,0.0013092847,0.0014094,0.00095266814],"domain_scores_gemma":[0.96853024,0.028123412,0.0006763166,0.0012717192,0.0010580522,0.0003402733],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.04119349,0.000433352,0.0020567102,0.00038748223,0.00038279814,0.00018815506,0.00072762894,0.002406235,0.00010009399],"category_scores_gemma":[0.015603025,0.00036135936,0.00066878414,0.00007779284,0.0023052366,0.0001380604,0.00026625663,0.004016875,0.0000051306683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24460153,0.00026001484,0.000028969132,0.00035829068,0.00039221274,0.000036832564,0.00011496728,5.5092226e-8,0.000003887472,0.000016649647,0.36745614,0.38673046],"study_design_scores_gemma":[0.09527685,0.010380708,0.0008365698,0.002192768,0.00010700726,0.0000018126816,0.00028326444,0.000023825662,0.0000058062515,0.00036197502,0.8901853,0.0003441146],"about_ca_topic_score_codex":0.0005061265,"about_ca_topic_score_gemma":0.0007596428,"teacher_disagreement_score":0.52272916,"about_ca_system_score_codex":0.0002926795,"about_ca_system_score_gemma":0.0061210096,"threshold_uncertainty_score":0.99988383},"labels":[],"label_agreement":null},{"id":"W2753890414","doi":"10.1158/1078-0432.ccr-16-3065","title":"Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Surrogate endpoint; Oncology; Clinical endpoint; Milestone; Clinical study design; Drug development; Cancer; Internal medicine; Phases of clinical research; Biomarker; Pharmacology; Drug","score_opus":0.511372098794355,"score_gpt":0.6422053277657701,"score_spread":0.13083322897141514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753890414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9030439,0.0003373207,0.000015991107,0.013554793,0.002110073,0.0021429393,0.000017473176,0.00008835318,0.078689106],"genre_scores_gemma":[0.9633348,0.00400308,0.00020907295,0.0004073657,0.0063394825,0.00045569614,0.0000063196026,0.00009796595,0.025146196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919903,0.0016980945,0.0014168121,0.0012474027,0.0021408382,0.0015065483],"domain_scores_gemma":[0.9883782,0.0058701737,0.00044737625,0.0031118153,0.001189172,0.0010032252],"candidate_categories":["metaresearch","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.025028601,0.0002862738,0.0013394756,0.0002575161,0.0010941455,0.0003064385,0.0016216218,0.00080046174,0.013606792],"category_scores_gemma":[0.02363364,0.0002415108,0.0007229679,0.00024254191,0.0028686011,0.0002665557,0.0015210538,0.0051580397,0.00055244594],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3001928,0.0019131192,0.0232401,0.00012161291,0.0004962969,0.00056078524,0.0002267145,6.9220334e-7,0.03344724,0.00009192,0.009246812,0.6304619],"study_design_scores_gemma":[0.22179502,0.020158924,0.15382552,0.0006340812,0.00016876322,0.00005544645,0.00035037845,0.00024791388,0.012170314,0.0014114528,0.58843094,0.0007512478],"about_ca_topic_score_codex":0.0024703627,"about_ca_topic_score_gemma":0.000727298,"teacher_disagreement_score":0.6297107,"about_ca_system_score_codex":0.00094006315,"about_ca_system_score_gemma":0.0036602442,"threshold_uncertainty_score":0.999845},"labels":[],"label_agreement":null},{"id":"W2754100498","doi":"10.1158/1078-0432.ccr-17-0901","title":"Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"FOXM1; Prostate cancer; Enzalutamide; Cancer research; In vivo; Cancer; Cancer cell; Medicine; Biology; Androgen receptor; Internal medicine; Cell cycle","score_opus":0.13766782737854977,"score_gpt":0.4794562398448544,"score_spread":0.34178841246630465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754100498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212927,0.0029337374,0.00013412302,0.0029624081,0.00057182554,0.0004707905,0.0002161316,0.000018685176,0.00056301674],"genre_scores_gemma":[0.9913076,0.0033049844,0.00006625928,0.0001671673,0.0008402391,0.00020934414,0.0002717691,0.000035705165,0.0037969172],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786294,0.00025969735,0.00040106982,0.0005725416,0.00042758434,0.0004761897],"domain_scores_gemma":[0.9985779,0.000042049152,0.00016172856,0.000575208,0.00046006963,0.00018306343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016724196,0.00013298313,0.00017552605,0.000036091722,0.0005601011,0.00014775002,0.0003105511,0.0002716374,0.00021262832],"category_scores_gemma":[0.00065474823,0.00012410982,0.00011007569,0.000066832086,0.0005044619,0.000021873735,0.000160485,0.00044695198,0.00004073226],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005570579,0.00010197836,0.09406919,0.000049946055,0.000041924377,0.0000031740553,0.000039492326,0.000029573099,0.80606323,0.0000446139,0.075998284,0.023001548],"study_design_scores_gemma":[0.0021638665,0.0006159673,0.062337708,0.0001246686,0.000013159352,9.090522e-7,0.000051678147,0.0001849423,0.38936722,0.00032779327,0.54443526,0.00037681172],"about_ca_topic_score_codex":0.0007323652,"about_ca_topic_score_gemma":0.00055589364,"teacher_disagreement_score":0.46843702,"about_ca_system_score_codex":0.00006747784,"about_ca_system_score_gemma":0.00033154394,"threshold_uncertainty_score":0.5061052},"labels":[],"label_agreement":null},{"id":"W2755035474","doi":"10.1158/1078-0432.ccr-17-0811","title":"Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression <i>In Vitro</i> and <i>In Vivo</i>","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Choriocarcinoma; Trophoblast; Vascular endothelial growth factor; Receptor; Cancer research; Biology; Internal medicine; Endocrinology; Medicine; Placenta; Fetus; Pregnancy; VEGF receptors","score_opus":0.16042562393736792,"score_gpt":0.5321193465435675,"score_spread":0.3716937226061996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755035474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988354,0.0032986416,0.0000022330908,0.005583802,0.0003278911,0.0014389078,0.000074911135,0.0000095598425,0.0009100327],"genre_scores_gemma":[0.9925431,0.0054766033,0.00044882987,0.00015841753,0.00028930063,0.00050386135,0.000011966227,0.000026938733,0.00054098625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976723,0.00018654155,0.0005718499,0.00049031386,0.00063519896,0.00044379913],"domain_scores_gemma":[0.99756527,0.0011865093,0.00015318138,0.00041108797,0.0004609946,0.00022295295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018844526,0.00013588833,0.0005226945,0.00015653406,0.00019234305,0.00003131879,0.00021914713,0.00012531773,0.000078036115],"category_scores_gemma":[0.0029868335,0.000105950465,0.00010576977,0.00014970826,0.0009834098,0.00008086493,0.00015278216,0.00044820784,0.0000047135172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03963608,0.0016653591,0.76875633,0.0006052332,0.00013661255,0.00012456748,0.00040110914,0.0000017566127,0.09260284,0.00024168656,0.006972594,0.08885583],"study_design_scores_gemma":[0.014356009,0.002310652,0.8871931,0.0006644651,0.000024681094,0.0000027037577,0.00031075347,0.00014336899,0.0805632,0.0019109991,0.0123290755,0.00019103065],"about_ca_topic_score_codex":0.00038459213,"about_ca_topic_score_gemma":0.00006732868,"teacher_disagreement_score":0.11843673,"about_ca_system_score_codex":0.00008229453,"about_ca_system_score_gemma":0.0006039137,"threshold_uncertainty_score":0.43205345},"labels":[],"label_agreement":null},{"id":"W2755675304","doi":"10.1158/1078-0432.ccr-17-0413","title":"TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Prostate cancer; Medicine; Oncology; Metastasis; Internal medicine; Prostate; Cancer; EZH2; Cancer research; Biology; Gene expression; Gene","score_opus":0.22242729292081326,"score_gpt":0.5604947531443503,"score_spread":0.338067460223537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755675304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884714,0.0056471126,0.0000024484787,0.003317916,0.0002922219,0.0014748562,0.00006761233,0.000028519022,0.0006979379],"genre_scores_gemma":[0.97949475,0.014364476,0.000052466825,0.000054832166,0.0006660251,0.00060275354,0.000008664237,0.000039225157,0.0047168196],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968834,0.00033428462,0.00050813705,0.00067742175,0.00092586107,0.00067093124],"domain_scores_gemma":[0.99695283,0.00031867213,0.0003258805,0.0009040553,0.00092805614,0.0005704983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021167048,0.00017189719,0.00051489385,0.00017549419,0.0006068042,0.00015312561,0.00034547233,0.00021636399,0.00014356646],"category_scores_gemma":[0.0011687772,0.00012503809,0.00011488389,0.0001694655,0.0018269374,0.00037033102,0.0003179541,0.0010408991,0.000013200439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00694756,0.0003443544,0.4774749,0.00038131018,0.00018328617,0.0001967392,0.0004590655,6.0938703e-7,0.013616002,0.000025739393,0.0002592027,0.5001112],"study_design_scores_gemma":[0.0063638594,0.0041892696,0.9318888,0.0007381377,0.000081444006,0.000010768564,0.00017641443,0.00019649066,0.05072126,0.0005439278,0.0049065244,0.0001830613],"about_ca_topic_score_codex":0.0090095345,"about_ca_topic_score_gemma":0.0021497884,"teacher_disagreement_score":0.49992818,"about_ca_system_score_codex":0.00021639674,"about_ca_system_score_gemma":0.0009420913,"threshold_uncertainty_score":0.9975895},"labels":[],"label_agreement":null},{"id":"W2760759644","doi":"10.1158/1078-0432.ccr-17-0618","title":"Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; University of Victoria; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Epitope; Prostate cancer; Biology; Major histocompatibility complex; Human leukocyte antigen; Fusion gene; MHC class I; CD8; Immune system; In silico; Gene; Cancer research; Cancer; Prostate; Antigen; Genetics; Immunology","score_opus":0.0985425850999792,"score_gpt":0.44648004340706077,"score_spread":0.34793745830708156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760759644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574265,0.040270038,0.000007399722,0.0006363063,0.00026980552,0.0004295912,0.00079816463,0.00000800257,0.00015421743],"genre_scores_gemma":[0.98336,0.01439624,0.00004100404,0.00003256621,0.000026818076,0.00013214874,0.00008938309,0.000015689844,0.001906152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99720687,0.00078913185,0.0009629105,0.00041446468,0.00017853388,0.00044807055],"domain_scores_gemma":[0.9962953,0.0020237453,0.00047444363,0.00063172966,0.0005369491,0.000037879112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018696935,0.0001573089,0.0007566198,0.00060278695,0.00034377695,0.000027072725,0.0006198424,0.0003823835,0.0006169934],"category_scores_gemma":[0.0013033459,0.00013035722,0.00020947172,0.0006447145,0.0019361285,0.00011779023,0.00025684247,0.0009132913,0.0000034553068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059654047,0.0007839762,0.15326089,0.0000670256,0.0015309881,0.0000071108384,0.0007558217,0.0003108527,0.82842153,0.000106645995,0.00037287027,0.008416851],"study_design_scores_gemma":[0.0037717388,0.00038808445,0.86843836,0.000115363444,0.00016599585,8.4890564e-7,0.00014738443,0.0001510097,0.12484768,0.00004191354,0.0018089245,0.00012271022],"about_ca_topic_score_codex":0.00794706,"about_ca_topic_score_gemma":0.0012638756,"teacher_disagreement_score":0.7151775,"about_ca_system_score_codex":0.000049540762,"about_ca_system_score_gemma":0.00072892266,"threshold_uncertainty_score":0.99865913},"labels":[],"label_agreement":null},{"id":"W2762066258","doi":"10.1158/1078-0432.ccr-16-2433","title":"Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Doxorubicin; Clinical endpoint; Radiofrequency ablation; Confidence interval; Internal medicine; Gemcitabine; Urology; Target lesion; Surrogate endpoint; Population; Progression-free survival; Gastroenterology; Oncology; Chemotherapy; Surgery; Ablation; Randomized controlled trial","score_opus":0.2560754220210897,"score_gpt":0.4613457821156232,"score_spread":0.20527036009453353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762066258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991821,0.00034512387,0.000013291007,0.0009774332,0.00016880102,0.005187098,0.00004867775,0.000039354065,0.001399224],"genre_scores_gemma":[0.997945,0.000066870714,0.00013395998,0.00010098718,0.00040065055,0.00059705635,0.00007848741,0.00007241631,0.00060453505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949373,0.0008581242,0.00082413136,0.0010369525,0.0013773581,0.00096615596],"domain_scores_gemma":[0.9963948,0.00056602014,0.00012573575,0.0013094259,0.00085817656,0.00074580323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027460698,0.0003222069,0.00087933027,0.0004428151,0.00086069986,0.00017429725,0.0004288831,0.0002179043,0.0002941593],"category_scores_gemma":[0.00089209055,0.0002508533,0.00016892448,0.0006015771,0.00033314107,0.00028461544,0.0002893414,0.0010592918,0.000085036554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007971761,0.0051353187,0.96139956,0.000037090078,0.00016831272,0.0009775489,0.00078190456,0.0000023112693,0.000672522,0.000015662361,0.00023523382,0.022602797],"study_design_scores_gemma":[0.035153974,0.012744955,0.94668514,0.0003882121,0.00016367,0.0000023528135,0.00035869246,0.0014663975,0.002303823,0.00001770102,0.0004228126,0.00029227257],"about_ca_topic_score_codex":0.009172384,"about_ca_topic_score_gemma":0.0009772842,"teacher_disagreement_score":0.027182214,"about_ca_system_score_codex":0.0006117642,"about_ca_system_score_gemma":0.0006924082,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W2764050294","doi":"10.1158/1078-0432.ccr-17-1401","title":"Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"National Center for Advancing Translational Sciences; U.S. Department of Defense; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; American Cancer Society; Canadian Cancer Society Research Institute; National Cancer Institute; National Institutes of Health","keywords":"Genotype; Lung cancer; Internal medicine; Single-nucleotide polymorphism; Minor allele frequency; Allele; Hazard ratio; Oncology; Biology; Medicine; Confidence interval; Gastroenterology; Immunology; Genetics; Gene","score_opus":0.09920181072574709,"score_gpt":0.45440136907321255,"score_spread":0.35519955834746547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764050294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099034,0.0014891523,0.000058213438,0.002508019,0.0026808828,0.0014875811,0.00033628158,0.000007969808,0.0004415673],"genre_scores_gemma":[0.9939475,0.0018018231,0.000023486145,0.0010798121,0.0011869161,0.0009334334,0.000066438806,0.000047169553,0.00091339264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969944,0.00046427385,0.0006097412,0.00079012814,0.00062249624,0.0005190104],"domain_scores_gemma":[0.9979415,0.00022689109,0.00025124874,0.0009240091,0.00044892932,0.00020741412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016822729,0.00020986988,0.00030092095,0.00006123633,0.00039214766,0.00022060296,0.001310951,0.0002147832,0.00026473674],"category_scores_gemma":[0.00026196655,0.00017050165,0.0001338832,0.000104812505,0.00023464847,0.00001863585,0.0009283357,0.00069839513,0.0000057736106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010568222,0.0005449439,0.982149,0.0000072960365,0.00018982096,0.000004823484,0.0003942714,0.00009443079,0.008062108,0.000009023723,0.002482929,0.0050045536],"study_design_scores_gemma":[0.0041874605,0.00028838898,0.9791508,0.00011555861,0.000063020474,3.5064826e-8,0.0001975285,0.0010915922,0.0062672747,0.000023440407,0.008363034,0.000251916],"about_ca_topic_score_codex":0.04419393,"about_ca_topic_score_gemma":0.12289844,"teacher_disagreement_score":0.078704506,"about_ca_system_score_codex":0.00026309458,"about_ca_system_score_gemma":0.00040519802,"threshold_uncertainty_score":0.96217084},"labels":[],"label_agreement":null},{"id":"W2765304775","doi":"10.1158/1078-0432.ccr-17-1621","title":"Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; BC Cancer Agency","funders":"Medical Research and Materiel Command; National Health and Medical Research Council; Canadian Institutes of Health Research; Cancer Institute NSW; Cancer Australia; National Breast Cancer Foundation","keywords":"Homologous recombination; Serous fluid; Ovarian cancer; Retinoblastoma; Biology; DNA repair; Homologous chromosome; Serous ovarian cancer; Cancer; Cancer research; Genetics; DNA; Gene; Biochemistry","score_opus":0.17617826697787467,"score_gpt":0.4742512406429381,"score_spread":0.29807297366506347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765304775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828325,0.0002682384,0.000022168868,0.014386545,0.00043108375,0.0014410932,0.00014948563,0.00011284827,0.00035604485],"genre_scores_gemma":[0.9947388,0.00077050057,0.00011776251,0.00018429289,0.0007369611,0.0013074742,0.00005900277,0.000058574158,0.0020266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953838,0.001140886,0.00071742525,0.0008992512,0.0012021294,0.000656526],"domain_scores_gemma":[0.9970317,0.0005841102,0.00047439744,0.00074475544,0.0008480088,0.00031704246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004820575,0.0002346188,0.00063727575,0.00021924065,0.0005533808,0.000111645844,0.00026833516,0.00043103873,0.00043538457],"category_scores_gemma":[0.0019699621,0.00020174962,0.00011173648,0.00035335516,0.0013063505,0.00026088243,0.0001512534,0.0015630575,0.000016213546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055056494,0.0010963193,0.972224,0.00017966582,0.0002078723,0.0004965131,0.00021761029,0.000014654504,0.0018603158,0.0005901156,0.00093337067,0.01667389],"study_design_scores_gemma":[0.01017367,0.0012801641,0.98244435,0.0017382151,0.000023379696,0.000016146218,0.00009554218,0.0001648844,0.0011757644,0.0019468326,0.00069724186,0.00024379321],"about_ca_topic_score_codex":0.0025196644,"about_ca_topic_score_gemma":0.010066917,"teacher_disagreement_score":0.016430099,"about_ca_system_score_codex":0.0011563508,"about_ca_system_score_gemma":0.0009247758,"threshold_uncertainty_score":0.82271105},"labels":[],"label_agreement":null},{"id":"W2765485679","doi":"10.1158/1078-0432.ccr-17-2260","title":"A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i> -Mutated Breast and Gynecologic Cancers","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Institute for Health and Care Research; Cancer Research UK; Astex Pharmaceuticals; Imperial Experimental Cancer Medicine Centre; AstraZeneca","keywords":"Medicine; Tolerability; Adverse effect; Common Terminology Criteria for Adverse Events; Pharmacodynamics; Pharmacokinetics; Dosing; Rash; Internal medicine; Nausea; Breast cancer; Oncology; Regimen; Phases of clinical research; Pharmacology; Toxicity; Cancer","score_opus":0.2654129356727883,"score_gpt":0.5986973071580772,"score_spread":0.33328437148528894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765485679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946463,0.000744785,0.0000063278903,0.00097339967,0.000237112,0.0032564446,0.00008132395,0.0000024520448,0.000051819938],"genre_scores_gemma":[0.99830997,0.0001692408,0.000059892966,0.00015405707,0.00017868068,0.0010290392,0.0000073306924,0.000022513412,0.00006925444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997125,0.0007295848,0.00060456,0.0007229178,0.00040508792,0.00041283082],"domain_scores_gemma":[0.99823725,0.00030087176,0.00023752247,0.0006496798,0.00044883366,0.0001258428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007679082,0.00014167897,0.00036797885,0.00008550356,0.00025750013,0.00016100844,0.0007627581,0.0001412523,0.000008940492],"category_scores_gemma":[0.0031577256,0.000114443195,0.000036098358,0.0002057252,0.00048782947,0.000022566106,0.0010808033,0.00035551813,4.183825e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014521027,0.0053916792,0.38276717,0.00021695353,0.0002191484,0.000021949812,0.0013314491,0.00032631916,0.45477495,0.000007745968,0.0041782763,0.13624336],"study_design_scores_gemma":[0.13421738,0.015624065,0.6892203,0.0017055207,0.00016690165,0.000015071069,0.003075662,0.006278567,0.14684752,0.0009228101,0.0009440292,0.0009821702],"about_ca_topic_score_codex":0.003282016,"about_ca_topic_score_gemma":0.015465122,"teacher_disagreement_score":0.30792743,"about_ca_system_score_codex":0.00023741508,"about_ca_system_score_gemma":0.001137158,"threshold_uncertainty_score":0.86299014},"labels":[],"label_agreement":null},{"id":"W2766484571","doi":"10.1158/1078-0432.ccr-17-2026","title":"The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Cancer; Context (archaeology); Medicine; Genetic predisposition; Disease; Etiology; Pathology; Internal medicine; Biology","score_opus":0.12615118626318184,"score_gpt":0.5348646910486844,"score_spread":0.40871350478550256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766484571","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02067571,0.13753791,0.00000536261,0.11485033,0.7175835,0.004049541,0.0018831515,0.00003307937,0.003381459],"genre_scores_gemma":[0.16314068,0.08391444,0.000009657083,0.0007326332,0.7499936,0.00075401214,0.000103150174,0.00008872582,0.0012630833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9861155,0.004422468,0.0022901301,0.0009291191,0.005316563,0.0009262151],"domain_scores_gemma":[0.96200895,0.03056449,0.0014649697,0.0032697972,0.0025438475,0.00014796585],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02379404,0.00041945826,0.0016819522,0.000084775515,0.0007630841,0.00014872802,0.0033906535,0.0011718981,0.0001285118],"category_scores_gemma":[0.009932103,0.00020790182,0.00067296246,0.00058143825,0.004242723,0.000118936965,0.0005974555,0.007139727,0.000008490456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030371998,0.00024250807,0.012671883,0.0009478718,0.00043473588,0.00001853992,0.003352102,0.000002605222,0.0000045573806,0.0003132645,0.9596789,0.019295853],"study_design_scores_gemma":[0.0027811213,0.00061436096,0.027695833,0.002525821,0.00010980168,0.0000017021797,0.0038236894,0.000009991081,0.000040254195,0.0005042801,0.9616854,0.00020775138],"about_ca_topic_score_codex":0.027413217,"about_ca_topic_score_gemma":0.12078725,"teacher_disagreement_score":0.14246498,"about_ca_system_score_codex":0.00040251797,"about_ca_system_score_gemma":0.0059346217,"threshold_uncertainty_score":0.9997008},"labels":[],"label_agreement":null},{"id":"W2767090199","doi":"10.1158/1078-0432.ccr-17-2228","title":"Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canadian Cancer Society; Leukemia and Lymphoma Society","keywords":"Myeloid leukemia; Immunotherapy; Leukemia; Medicine; Immunology; Myeloid; Cancer research; Biology; Immune system","score_opus":0.42368212276545314,"score_gpt":0.5829602507286331,"score_spread":0.15927812796317997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767090199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854968,0.00097007275,0.00039523438,0.004196801,0.00040940332,0.0038730218,0.000070807844,0.00005771279,0.0045301514],"genre_scores_gemma":[0.9313386,0.006981146,0.0011040671,0.00068148295,0.00078052125,0.0011091036,0.00001782866,0.0001532751,0.057833996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958571,0.00020512514,0.00065636414,0.000993298,0.0011657745,0.0011223123],"domain_scores_gemma":[0.99567616,0.001320245,0.00020213045,0.0012246015,0.0009881785,0.00058869884],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0050267004,0.00027736,0.00078104745,0.00022346056,0.001554144,0.00036013924,0.0008682583,0.00040760767,0.0020405005],"category_scores_gemma":[0.00049077417,0.000238284,0.0003109917,0.00019101093,0.00089353893,0.00020440391,0.00049839047,0.001563965,0.000076719596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007945402,0.00020021237,0.00038127098,0.00011358202,0.00079407246,0.000041625743,0.00026362418,0.000001899547,0.96222275,0.0030835203,0.0008121982,0.024139851],"study_design_scores_gemma":[0.051257584,0.008751714,0.015125735,0.0005375049,0.00022598924,0.000046645288,0.00047780116,0.0009342236,0.86964417,0.01902127,0.033212405,0.0007649453],"about_ca_topic_score_codex":0.0020555966,"about_ca_topic_score_gemma":0.00046652337,"teacher_disagreement_score":0.09257856,"about_ca_system_score_codex":0.0006588538,"about_ca_system_score_gemma":0.0016217539,"threshold_uncertainty_score":0.9997457},"labels":[],"label_agreement":null},{"id":"W2769972801","doi":"10.1158/1078-0432.ccr-17-1590","title":"A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Veliparib; Topotecan; Medicine; PARP inhibitor; Internal medicine; Neutropenia; Olaparib; Oncology; Febrile neutropenia; Gastroenterology; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Surgery; Pharmacology; Clinical trial; Chemotherapy; Poly ADP ribose polymerase; Biology","score_opus":0.2537814787584608,"score_gpt":0.5781930088015869,"score_spread":0.32441153004312606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769972801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557276,0.0003563994,0.0000041266344,0.010408313,0.0010379275,0.001916827,0.00010634679,0.000015808257,0.0005815134],"genre_scores_gemma":[0.996033,0.0003504369,0.00005647352,0.0005833582,0.002227594,0.0002021178,0.000007921826,0.000043337503,0.0004957694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948389,0.0009285781,0.001557159,0.0007284014,0.001323645,0.00062330323],"domain_scores_gemma":[0.9958495,0.0010044975,0.00056491356,0.0015533973,0.000536579,0.0004911117],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0048343753,0.00021270287,0.0009469802,0.00015744986,0.00037594856,0.0000741093,0.00058337295,0.00029250004,0.00019053594],"category_scores_gemma":[0.0033327267,0.00014036596,0.00023284153,0.00029652668,0.0031756137,0.00015374458,0.00037601357,0.0019018562,0.000009251147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24125555,0.0063201305,0.6428423,0.00009291596,0.00014799404,0.000036639085,0.00015668692,3.7922814e-7,0.00019607498,0.00006147293,0.0046023335,0.10428755],"study_design_scores_gemma":[0.35656843,0.016191103,0.6173348,0.0011369064,0.00006131913,0.0000025735342,0.00007486863,0.000042769272,0.0032854523,0.00021127584,0.0048535103,0.00023703754],"about_ca_topic_score_codex":0.00097084546,"about_ca_topic_score_gemma":0.00032413303,"teacher_disagreement_score":0.115312874,"about_ca_system_score_codex":0.000177166,"about_ca_system_score_gemma":0.0017350502,"threshold_uncertainty_score":0.99953717},"labels":[],"label_agreement":null},{"id":"W2770347143","doi":"10.1158/1078-0432.ccr-17-2484","title":"Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Royal College of Physicians and Surgeons of Canada; Conquer Cancer Foundation","keywords":"KRAS; Splenic flexure; Colorectal cancer; Medicine; Mutation; GNAS complex locus; Internal medicine; Cancer; Rectum; Oncology; Cancer research; Gastroenterology; Biology; Genetics; Gene; Colonoscopy","score_opus":0.1301473757666578,"score_gpt":0.4891342404451145,"score_spread":0.3589868646784567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770347143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98017615,0.007750572,0.0000029502091,0.009600994,0.00028292966,0.0010800753,0.000036188725,0.000023750326,0.0010463853],"genre_scores_gemma":[0.9962779,0.0015140721,0.000037451293,0.0001226541,0.0002027842,0.0008488026,0.000011200265,0.000027654158,0.000957431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978769,0.00026095478,0.0004275259,0.0005582456,0.0004516729,0.00042472532],"domain_scores_gemma":[0.99836564,0.00046340353,0.00016775547,0.0002739954,0.00055381,0.0001754118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009665174,0.00016985647,0.00049311924,0.00009948245,0.00040220958,0.0001083311,0.00013467605,0.0001243343,0.00006411365],"category_scores_gemma":[0.0010248927,0.00012970067,0.000064175816,0.00017010223,0.00094079174,0.00007572746,0.00013635893,0.00046019844,0.00000772476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004812913,0.00044430452,0.9503385,0.0002641682,0.0002804542,0.0005011125,0.00070780783,0.000002007584,0.011794235,0.00020591416,0.0049812496,0.025667341],"study_design_scores_gemma":[0.0050202664,0.0009329814,0.96791214,0.00054214906,0.000078197285,0.00001116482,0.0004744185,0.00028030027,0.021373382,0.00030534426,0.0028704233,0.00019924915],"about_ca_topic_score_codex":0.0064427713,"about_ca_topic_score_gemma":0.013373667,"teacher_disagreement_score":0.025468092,"about_ca_system_score_codex":0.00031464655,"about_ca_system_score_gemma":0.0005970256,"threshold_uncertainty_score":0.97395855},"labels":[],"label_agreement":null},{"id":"W2771217224","doi":"10.1158/1078-0432.ccr-17-1941","title":"Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; Infrastructure Canada; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Mutation; Cancer; Genetics; Biology; Gene","score_opus":0.12065816621638803,"score_gpt":0.49762456415821293,"score_spread":0.3769663979418249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771217224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951265,0.0011617017,0.000023849056,0.0025233575,0.00029755005,0.00038399364,0.000041753286,0.000010213591,0.00043109184],"genre_scores_gemma":[0.9955859,0.0029717882,0.00019676388,0.00021711744,0.00009696642,0.00026361737,0.000009088147,0.000021662967,0.0006370791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822825,0.00026213765,0.00030289826,0.00055357517,0.00027346754,0.00037967195],"domain_scores_gemma":[0.99877995,0.00013749249,0.00011577405,0.00064076914,0.00021626631,0.00010974486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016784016,0.00011976868,0.0002239834,0.00006684211,0.00025079367,0.00006735985,0.00044309229,0.00021540532,0.00008149883],"category_scores_gemma":[0.0006685867,0.00010134512,0.00007202926,0.00006754938,0.00038267887,0.000010587198,0.00020429106,0.00034703795,0.0000049009095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070324837,0.00030717152,0.67651206,0.000020664358,0.000020921932,0.000010782519,0.000020830916,0.000033580563,0.04102311,0.000095672855,0.00025957738,0.28099236],"study_design_scores_gemma":[0.003870863,0.0007085694,0.9646969,0.000048144,0.00000350527,0.000002602314,0.000030714724,0.00026168276,0.027830767,0.00095212925,0.0013893937,0.00020473875],"about_ca_topic_score_codex":0.0006465776,"about_ca_topic_score_gemma":0.0012674185,"teacher_disagreement_score":0.2881848,"about_ca_system_score_codex":0.000052806678,"about_ca_system_score_gemma":0.00033226036,"threshold_uncertainty_score":0.4132734},"labels":[],"label_agreement":null},{"id":"W2772855375","doi":"10.1158/1078-0432.ccr-17-0866","title":"CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Dental and Craniofacial Research; Ministère de l'Éducation, du Loisir et du Sport Québec","keywords":"Slug; Downregulation and upregulation; Head and neck squamous-cell carcinoma; Head and neck; Phenotype; Basal cell; Carcinoma; Pathology; Medicine; Cancer research; Head and neck cancer; Cancer; Biology; Internal medicine; Gene; Surgery","score_opus":0.3318697800946926,"score_gpt":0.5207519200272349,"score_spread":0.18888213993254233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772855375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910906,0.0042135897,0.000015776674,0.0017502699,0.0001146253,0.00062025146,0.000045378878,0.0000038300764,0.0021456587],"genre_scores_gemma":[0.9970895,0.0018641653,0.00038972724,0.00011935987,0.00015106224,0.000028593,0.000006493905,0.000017621127,0.00033349585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981665,0.00030129493,0.00047162423,0.00033489827,0.00047233232,0.00025332006],"domain_scores_gemma":[0.99743044,0.00092478975,0.00024254648,0.00074108987,0.00048116775,0.00017998359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015094377,0.00010565533,0.00048622378,0.00004570515,0.00021137184,0.000036384277,0.00020287962,0.00007189504,0.00014535814],"category_scores_gemma":[0.00086773693,0.00007058775,0.000080433616,0.00009393383,0.0016198369,0.0001309224,0.00018353335,0.00037444782,0.0000016357312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008006737,0.0012132146,0.79569834,0.0038675766,0.00028455092,0.000053884352,0.0066331476,0.000027140126,0.024734097,0.0026441244,0.0034211667,0.15341605],"study_design_scores_gemma":[0.008235334,0.00377048,0.94798416,0.00021654848,0.0003833656,0.0000060390607,0.0018017009,0.00025179665,0.030423556,0.0021184175,0.0046452247,0.00016340465],"about_ca_topic_score_codex":0.009064024,"about_ca_topic_score_gemma":0.0021064691,"teacher_disagreement_score":0.15325265,"about_ca_system_score_codex":0.000032208583,"about_ca_system_score_gemma":0.00056261604,"threshold_uncertainty_score":0.9975347},"labels":[],"label_agreement":null},{"id":"W2773306487","doi":"10.1158/1557-3265.aacrahns17-08","title":"Abstract 08: Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Cancer research; Methylation; Carcinogenesis; Histone H3; DNA methylation; Histone; Biology; Cancer; Chromatin; Gene; Genetics; Gene expression","score_opus":0.18787474886431765,"score_gpt":0.4845795257798759,"score_spread":0.29670477691555824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773306487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879667,0.009658591,0.000029212617,0.0003566669,0.00014616753,0.00023561179,0.000041335603,0.000003896381,0.0015618239],"genre_scores_gemma":[0.9960853,0.0029277634,0.00022799072,0.000018269584,0.0003455228,0.00002765485,0.000036479356,0.000019114565,0.00031194705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841195,0.00017895145,0.00042495798,0.00041675815,0.0002831992,0.00028420464],"domain_scores_gemma":[0.99839747,0.00019660224,0.00020072877,0.00067025615,0.00037952085,0.00015544209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018942632,0.00010933658,0.00022120055,0.000049615406,0.0002471637,0.00005815224,0.00028577147,0.00024454083,0.000036547066],"category_scores_gemma":[0.0012211186,0.00009891105,0.00010313239,0.00005274301,0.00042435783,0.0000075318785,0.00024338314,0.00024810826,0.000005579586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046240134,0.00015785809,0.5542093,0.00011318965,0.000025129639,0.0000034609227,0.000046056768,0.000024092062,0.4286355,0.000028899565,0.0006643502,0.015629755],"study_design_scores_gemma":[0.0010486124,0.0005528461,0.7985004,0.000014825677,0.000010965458,2.2671745e-7,0.000017394776,0.000061056984,0.19501583,0.00043364955,0.0042390143,0.00010516381],"about_ca_topic_score_codex":0.0011925825,"about_ca_topic_score_gemma":0.0007116959,"teacher_disagreement_score":0.24429113,"about_ca_system_score_codex":0.000014368003,"about_ca_system_score_gemma":0.00021028315,"threshold_uncertainty_score":0.40334755},"labels":[],"label_agreement":null},{"id":"W2780727948","doi":"10.1158/1078-0432.ccr-17-2994","title":"Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":636,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Health Network; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; Canadian Friends of Tel Aviv University; Ontario Institute for Cancer Research; Division of Cancer Prevention, National Cancer Institute","keywords":"Pancreatic cancer; Transcriptome; Medicine; Clinical endpoint; Oncology; FOLFIRINOX; Biopsy; Cancer; Precision medicine; Internal medicine; Biology; Pathology; Gene; Clinical trial; Gene expression; Genetics","score_opus":0.4546718383273811,"score_gpt":0.6054100502091737,"score_spread":0.1507382118817926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780727948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9203951,0.0020814724,0.00010887438,0.066852845,0.0013231401,0.0052095493,0.00047834194,0.000036257075,0.003514456],"genre_scores_gemma":[0.9663473,0.013401864,0.0010414707,0.0006286595,0.008760463,0.0023794048,0.00010184335,0.000065908534,0.0072730887],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9941498,0.0009769722,0.0014513242,0.0010188159,0.0014005655,0.0010024961],"domain_scores_gemma":[0.97538954,0.019999566,0.0004898312,0.002333515,0.0011710703,0.0006164634],"candidate_categories":["metaresearch","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.009345494,0.00025720114,0.0014901764,0.000103868595,0.0015751476,0.00012270287,0.0015185336,0.00039564166,0.0005951469],"category_scores_gemma":[0.02517926,0.00015227067,0.00030270522,0.00016666185,0.002907869,0.00013377718,0.00051854434,0.0017173813,0.00009498359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4804159,0.0005797304,0.25983277,0.000095290714,0.00090006366,0.000057672383,0.0010402084,0.000009903395,0.0012078978,0.00024043678,0.12081101,0.13480909],"study_design_scores_gemma":[0.20970793,0.008330631,0.63694805,0.0013286867,0.00056418945,0.0000023658517,0.00034140216,0.002730445,0.00017076991,0.0029750182,0.13663681,0.00026371254],"about_ca_topic_score_codex":0.01544387,"about_ca_topic_score_gemma":0.0026259583,"teacher_disagreement_score":0.37711528,"about_ca_system_score_codex":0.0005090208,"about_ca_system_score_gemma":0.002223183,"threshold_uncertainty_score":0.9998056},"labels":[],"label_agreement":null},{"id":"W2786732655","doi":"10.1158/1078-0432.ccr-18-2521","title":"Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Fonds De La Recherche Scientifique - FNRS; National Breast Cancer Foundation; Breast Cancer Research Foundation; Pfizer; GlaxoSmithKline","keywords":"Digital polymerase chain reaction; Medicine; Circulating tumor DNA; Internal medicine; Breast cancer; Oncology; Nat; Neoadjuvant therapy; Cancer; Odds ratio; Gastroenterology; Polymerase chain reaction; Biology; Genetics; Gene","score_opus":0.19049809849347235,"score_gpt":0.5213238206696866,"score_spread":0.3308257221762143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786732655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383664,0.0013566228,0.0000070745073,0.0016526023,0.0006155523,0.0016940124,0.00026487187,0.0000036206698,0.0005690313],"genre_scores_gemma":[0.9971651,0.00093049585,0.000016916103,0.00014918705,0.00105737,0.00032920632,0.000025523203,0.000033243334,0.00029296192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959908,0.00088574894,0.0008495937,0.0006882724,0.0009334016,0.00065216457],"domain_scores_gemma":[0.99754447,0.00078710646,0.00013713041,0.0007231548,0.0006427355,0.000165377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005440919,0.0001449645,0.00037509107,0.00012157458,0.00016247737,0.00004367008,0.0006931033,0.00019959632,0.00035047796],"category_scores_gemma":[0.0006825339,0.00011860192,0.00022200614,0.0006503374,0.00052429223,0.000006307048,0.0003524448,0.0009497675,0.000010828076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15414494,0.0048717526,0.5065193,0.0003676088,0.00040925285,0.000041045645,0.00093772425,0.0024606565,0.26361108,0.0015301635,0.010205051,0.05490142],"study_design_scores_gemma":[0.3775938,0.007196934,0.50796527,0.0012530278,0.00009558111,0.000034114433,0.0018179134,0.003228171,0.039363597,0.0034048362,0.05657125,0.0014755114],"about_ca_topic_score_codex":0.0036799726,"about_ca_topic_score_gemma":0.0042128116,"teacher_disagreement_score":0.22424747,"about_ca_system_score_codex":0.00011700571,"about_ca_system_score_gemma":0.0023547015,"threshold_uncertainty_score":0.5563042},"labels":[],"label_agreement":null},{"id":"W2789460069","doi":"10.1158/1078-0432.ccr-17-3771","title":"Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Prostatectomy; Histopathology; Medicine; Prostate cancer; Lymph node; Dissection (medical); Biochemical recurrence; Urology; Lymph; Cancer; Internal medicine; Pathology; Surgery","score_opus":0.08283417945246835,"score_gpt":0.45806292069891635,"score_spread":0.375228741246448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789460069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906571,0.0013907773,0.000310466,0.0015417206,0.0002689245,0.0050242227,0.00023970808,0.00007200469,0.00049510296],"genre_scores_gemma":[0.992239,0.0021873557,0.0007347713,0.00010121476,0.0003971165,0.0032416524,0.0003176654,0.00010535143,0.0006758808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946298,0.0004297104,0.0009482738,0.0010589677,0.0016304888,0.0013027759],"domain_scores_gemma":[0.9943383,0.00093281793,0.00027605862,0.0006026387,0.0032203188,0.00062989705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014332324,0.00031799808,0.00064034335,0.00032659655,0.00037732432,0.000086761494,0.0002483274,0.00024356038,0.00016562523],"category_scores_gemma":[0.0012639166,0.0002284814,0.00018018854,0.0010682573,0.0017883937,0.0002015988,0.00011324088,0.0005632028,0.000018746085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021640614,0.0021093546,0.9323837,0.0017525443,0.00050038396,0.000032333057,0.00045203403,0.000033061882,0.005057724,0.00017939688,0.00037106904,0.03548778],"study_design_scores_gemma":[0.028569033,0.007089034,0.916304,0.0022157517,0.00032104758,0.000006556505,0.0004290476,0.0019346952,0.04105086,0.00083845144,0.0007882017,0.0004533582],"about_ca_topic_score_codex":0.00057749957,"about_ca_topic_score_gemma":0.0001834118,"teacher_disagreement_score":0.035993133,"about_ca_system_score_codex":0.0010210323,"about_ca_system_score_gemma":0.0048986305,"threshold_uncertainty_score":0.9317201},"labels":[],"label_agreement":null},{"id":"W2789664849","doi":"10.1158/1078-0432.ccr-17-3473","title":"Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research","keywords":"Trastuzumab; Medicine; Tissue microarray; Hazard ratio; Internal medicine; Breast cancer; Cyclin D1; Oncology; Clinical endpoint; Proportional hazards model; Cancer; Clinical trial; Cell cycle; Confidence interval","score_opus":0.14554333420835522,"score_gpt":0.5289420088485274,"score_spread":0.3833986746401722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789664849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005437,0.0025461072,0.0000033301887,0.0041411673,0.00019846464,0.0022072436,0.00060668343,0.000020373114,0.0002222653],"genre_scores_gemma":[0.99029994,0.0070990864,0.000069316455,0.00007077615,0.00077426236,0.00062678574,0.000013454393,0.000047772188,0.0009986024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99502736,0.0008911798,0.00092982745,0.0009606467,0.0014630508,0.0007279235],"domain_scores_gemma":[0.99648154,0.0016400033,0.00015453382,0.00044808397,0.0007890194,0.00048683674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030994166,0.00024389796,0.00095375074,0.00026385058,0.00016016563,0.00005905662,0.00019619569,0.00032060037,0.0007179419],"category_scores_gemma":[0.00031230733,0.00019380951,0.000105555846,0.00057128165,0.00063258957,0.0001259352,0.00015496521,0.0010259631,0.000011767645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048433277,0.0016494247,0.83570266,0.000059132206,0.00024160359,0.000048559865,0.004739661,9.599429e-7,0.0028928656,0.000002608222,0.0003512282,0.14946799],"study_design_scores_gemma":[0.010055056,0.007281224,0.9770231,0.0009119156,0.000106431406,0.0000025274667,0.0011597297,0.00013085768,0.002541415,0.0001816507,0.00044466113,0.00016138164],"about_ca_topic_score_codex":0.07317,"about_ca_topic_score_gemma":0.03253352,"teacher_disagreement_score":0.14930661,"about_ca_system_score_codex":0.0015320451,"about_ca_system_score_gemma":0.00079751445,"threshold_uncertainty_score":0.98512024},"labels":[],"label_agreement":null},{"id":"W2790461643","doi":"10.1158/1078-0432.ccr-17-1199","title":"The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Cancer Institute NSW; National Breast Cancer Foundation; National Health and Medical Research Council; Susan G. Komen for the Cure","keywords":"Breast cancer; Androgen receptor; Oncology; Disease; Medicine; Outcome (game theory); Internal medicine; Magnitude (astronomy); Cancer; Androgen; Prostate cancer; Hormone; Mathematics; Physics; Astrophysics","score_opus":0.2428120515914355,"score_gpt":0.5623552974058443,"score_spread":0.31954324581440885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790461643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012207406,0.98417884,0.0000059416257,0.0014866516,0.00045135262,0.0012386342,0.011353055,0.000004677998,0.000060099603],"genre_scores_gemma":[0.0023263004,0.9940566,0.00006480286,0.000047231257,0.0010384863,0.0019692099,0.00014382828,0.00004983856,0.00030372845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965925,0.0005526506,0.0011617356,0.0007321412,0.00043764187,0.0005233133],"domain_scores_gemma":[0.9967051,0.0010952485,0.0002538947,0.0006894291,0.0010689507,0.00018737685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002235041,0.00026389654,0.0010718318,0.00007815603,0.00016450426,0.000017955272,0.0004832147,0.00036979283,0.00006173528],"category_scores_gemma":[0.0012301197,0.00017733773,0.0006040685,0.0002905092,0.0014383079,0.000005939407,0.00040982626,0.00041580194,0.0000048707534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062698503,0.0014549141,0.15548989,0.026496328,0.0017510128,0.0000038505036,0.000034703455,0.0000010253576,0.000031405136,0.00012067193,0.091190755,0.7171556],"study_design_scores_gemma":[0.0011191043,0.0005164362,0.014115942,0.005343208,0.00059084373,0.0000018643985,0.000020298165,0.0000054906304,0.00012377082,0.00010461018,0.9778286,0.00022980598],"about_ca_topic_score_codex":0.00063833507,"about_ca_topic_score_gemma":0.00023198772,"teacher_disagreement_score":0.88663787,"about_ca_system_score_codex":0.0001827943,"about_ca_system_score_gemma":0.0016267087,"threshold_uncertainty_score":0.7231623},"labels":[],"label_agreement":null},{"id":"W2790799851","doi":"10.1158/1078-0432.ccr-17-2810","title":"Further Investigation of the Role of <i>ACYP2</i> and <i>WFS1</i> Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; Vancouver General Hospital; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Ototoxicity; Pharmacogenomics; Testicular cancer; Cisplatin; Medicine; Oncology; Hearing loss; Internal medicine; Cancer; Pharmacology; Chemotherapy; Audiology","score_opus":0.1073215202032255,"score_gpt":0.43381164654845283,"score_spread":0.32649012634522734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790799851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986982,0.00044944434,0.0000071054656,0.00011964958,0.000096198346,0.0004892701,0.000026514032,6.4673407e-7,0.00011301624],"genre_scores_gemma":[0.9992461,0.0002576924,0.000096570555,0.00020935293,0.00008189399,0.00008646628,0.0000036343145,0.000010611747,0.000007662815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836874,0.0003584131,0.00053257716,0.00024072165,0.00030379233,0.00019572854],"domain_scores_gemma":[0.9991709,0.000100170204,0.0001722784,0.0002457611,0.0002688237,0.000042090145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018048694,0.0000828855,0.00017862016,0.000044046094,0.00004284437,0.0000050885624,0.00031664877,0.00010676386,0.000016062417],"category_scores_gemma":[0.00012618904,0.00005531804,0.000042256786,0.0002683722,0.0003408078,0.0000038348426,0.00018439264,0.00020965356,3.4094492e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001909711,0.00010323969,0.24041645,0.000024351233,0.000023722481,8.20514e-8,0.0007562662,0.0000025044462,0.7467793,0.000018022998,0.000012716257,0.01167236],"study_design_scores_gemma":[0.0009954995,0.00023551991,0.2131452,0.00007355754,0.000008231175,1.2763927e-7,0.00010557509,0.000054911212,0.7843262,0.0003437799,0.00065566896,0.000055725373],"about_ca_topic_score_codex":0.0005412531,"about_ca_topic_score_gemma":0.0017965554,"teacher_disagreement_score":0.03754689,"about_ca_system_score_codex":0.000031778938,"about_ca_system_score_gemma":0.0005534073,"threshold_uncertainty_score":0.22558042},"labels":[],"label_agreement":null},{"id":"W2790809604","doi":"10.1158/1078-0432.ccr-18-0380","title":"Biomarker Discovery from We to Me: Is Learning from Each Patient a New Approach?","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Cancer; Ovarian cancer; Biomarker discovery; Identification (biology); Mechanism (biology); Medicine; Biomarker; Computational biology; Immunotherapy; Internal medicine; Biology; Proteomics","score_opus":0.3369151465285287,"score_gpt":0.49592690996692385,"score_spread":0.15901176343839513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790809604","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061432436,0.012255719,0.00040725057,0.91497654,0.0029736303,0.002527368,0.000985804,0.00013809114,0.004303191],"genre_scores_gemma":[0.0058859284,0.011256022,0.0016976638,0.8096716,0.046868827,0.00069697335,0.002667606,0.00043425997,0.120821156],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907025,0.0014086685,0.0015019072,0.0023240438,0.0026979973,0.0013648953],"domain_scores_gemma":[0.9942819,0.0024363603,0.0003223025,0.0018007343,0.0004947551,0.000663948],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0019824726,0.0006182115,0.001496076,0.00045076612,0.00028046325,0.00034285162,0.00093020586,0.001961489,0.011913776],"category_scores_gemma":[0.0010114317,0.0004899897,0.0009122762,0.0009762749,0.0009024439,0.00015338731,0.00072049827,0.007567962,0.0013208035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007737494,0.00017844282,0.0034475313,0.00011154681,0.0013578008,0.0001713802,0.0008428606,3.66523e-7,0.0005852858,2.7824402e-7,0.874122,0.11144501],"study_design_scores_gemma":[0.0030754486,0.0013023624,0.0051833056,0.0015397355,0.0002172427,0.0000034532509,0.00024106572,0.00007227932,0.00032715476,0.00013015166,0.9873441,0.00056370284],"about_ca_topic_score_codex":0.03198869,"about_ca_topic_score_gemma":0.00023607384,"teacher_disagreement_score":0.11651796,"about_ca_system_score_codex":0.0008799328,"about_ca_system_score_gemma":0.002602023,"threshold_uncertainty_score":0.9997552},"labels":[],"label_agreement":null},{"id":"W2791308824","doi":"10.1158/1078-0432.ccr-17-3452","title":"Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Breast cancer; Internal medicine; Oncology; Adverse effect; Cancer; Response Evaluation Criteria in Solid Tumors; Estrogen receptor; Nausea; Gastroenterology; Phases of clinical research; Toxicity; Immunotherapy","score_opus":0.06109298004932549,"score_gpt":0.4370445413124408,"score_spread":0.3759515612631153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791308824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526644,0.00032026606,0.0000062422714,0.0017581183,0.00020244041,0.0012121259,0.00085594814,0.000021141974,0.0003572971],"genre_scores_gemma":[0.9975245,0.0014366736,0.00013854347,0.00016546085,0.00034931063,0.00009610609,0.000025744328,0.00004557508,0.00021806554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652165,0.0006016206,0.0006928317,0.0007261695,0.00081446784,0.0006432359],"domain_scores_gemma":[0.9972336,0.00057777815,0.00025982285,0.0003676374,0.0012625448,0.00029858548],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010278584,0.0002537565,0.0007856857,0.00021306821,0.00021267125,0.00002157816,0.00020703168,0.00018722023,0.0017766523],"category_scores_gemma":[0.0002780981,0.00019244803,0.0001247299,0.0007265909,0.0022720117,0.0002583296,0.00014340741,0.0008487088,0.000008762104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1027604,0.000735931,0.7898188,0.00014189919,0.00027764754,0.000004444007,0.00027629075,2.6983219e-7,0.007446384,0.00002485278,0.00040170358,0.098111324],"study_design_scores_gemma":[0.016126547,0.0035893533,0.9632673,0.0006955278,0.000027128328,0.000002130673,0.00006103801,0.000008211175,0.015413017,0.000013517358,0.00058453286,0.00021168613],"about_ca_topic_score_codex":0.0039902194,"about_ca_topic_score_gemma":0.0008644076,"teacher_disagreement_score":0.17344846,"about_ca_system_score_codex":0.0005867533,"about_ca_system_score_gemma":0.0007950383,"threshold_uncertainty_score":0.99913585},"labels":[],"label_agreement":null},{"id":"W2791469985","doi":"10.1158/1078-0432.ccr-17-1715","title":"Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Structural Genomics Consortium; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Government of Canada","keywords":"Prodrug; Colorectal cancer; Hypoxia (environmental); Tumor hypoxia; Medicine; Cancer research; In vivo; Cancer cell; Cancer; Radiation therapy; Chemoradiotherapy; Combination therapy; Pharmacology; Oncology; Internal medicine; Chemistry; Biology","score_opus":0.16995247305556574,"score_gpt":0.4820761485974125,"score_spread":0.3121236755418467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791469985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760887,0.021445367,0.000058015885,0.00028850077,0.0009843095,0.0007409851,0.00025461052,0.0000070140304,0.0001324862],"genre_scores_gemma":[0.97155255,0.025970057,0.00018138623,0.00016245763,0.0012950221,0.0006093554,0.000022284945,0.00003269047,0.00017417665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99650365,0.000602367,0.0011858564,0.0007079659,0.00052295165,0.00047718902],"domain_scores_gemma":[0.9980802,0.0003173527,0.00036232648,0.00029524817,0.000787356,0.00015753007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020949554,0.00021424131,0.0006105988,0.00010553075,0.000077842604,0.000021041575,0.00028002213,0.0003190308,0.0002539946],"category_scores_gemma":[0.0002480011,0.00018539983,0.00018031166,0.0002718729,0.0012066158,0.000028443412,0.00015058089,0.00046195526,0.0000013506291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009753531,0.00053181965,0.07097805,0.00015663716,0.00023014136,0.0000016575474,0.0002477422,0.000054386932,0.87935525,0.00004154202,0.0002703134,0.038378924],"study_design_scores_gemma":[0.0030010815,0.001614623,0.19420686,0.000189561,0.00003510294,0.0000013487999,0.000106842555,0.00059067353,0.79516387,0.00041681764,0.0043935427,0.00027966461],"about_ca_topic_score_codex":0.0009381309,"about_ca_topic_score_gemma":0.0033612608,"teacher_disagreement_score":0.12322882,"about_ca_system_score_codex":0.000048767048,"about_ca_system_score_gemma":0.0012566342,"threshold_uncertainty_score":0.75603855},"labels":[],"label_agreement":null},{"id":"W2792399344","doi":"10.1158/1078-0432.ccr-17-2776","title":"Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre","funders":"European Molecular Biology Organization","keywords":"Tamoxifen; Breast cancer; Pharmacology; Medicine; Cancer research; Drug resistance; Cancer; Internal medicine; Biology","score_opus":0.07550429526998252,"score_gpt":0.4344719173807309,"score_spread":0.35896762211074834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792399344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476945,0.0004343196,0.0015380132,0.0011807231,0.00026753772,0.0006129203,0.0006219538,0.000006656791,0.0005684415],"genre_scores_gemma":[0.99576837,0.00031596434,0.00018556461,0.0001612059,0.0005875982,0.00029213197,0.00021191695,0.000021890653,0.002455336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817705,0.00018811262,0.00048458212,0.0005287489,0.0003105229,0.0003109705],"domain_scores_gemma":[0.99842703,0.00018558218,0.00017352159,0.00030071224,0.0008254307,0.00008771928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001418649,0.00010930713,0.00020535923,0.000076835604,0.00013079248,0.000020235639,0.00011496852,0.00023272817,0.000055158285],"category_scores_gemma":[0.00046863774,0.00010295132,0.000086592394,0.00029139785,0.00035196324,0.00002188643,0.00010097616,0.00021047544,0.0000023013263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048114066,0.00034327133,0.013856857,0.00007011176,0.00005306711,6.990247e-7,0.00018288338,0.00001568247,0.95160306,0.00010487912,0.024013137,0.0049449434],"study_design_scores_gemma":[0.003364392,0.0004442811,0.1023789,0.00043171746,0.000010299435,0.0000015855858,0.00011696027,0.00028269686,0.86057657,0.00041343938,0.031751625,0.00022755022],"about_ca_topic_score_codex":0.0011013065,"about_ca_topic_score_gemma":0.0025542357,"teacher_disagreement_score":0.091026515,"about_ca_system_score_codex":0.00014411146,"about_ca_system_score_gemma":0.0003135369,"threshold_uncertainty_score":0.41982332},"labels":[],"label_agreement":null},{"id":"W2792841925","doi":"10.1158/1078-0432.ccr-17-3089","title":"<i>DICER1</i> and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Identification (biology); Environmental health; Medicine; Risk assessment; Computer security; Computer science; Biology","score_opus":0.3394422382492218,"score_gpt":0.5825319509312992,"score_spread":0.24308971268207735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792841925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024963062,0.9704783,8.316598e-7,0.0003388132,0.00017652923,0.0016147475,0.0016989,0.000030731146,0.0006980918],"genre_scores_gemma":[0.0075247977,0.99059665,0.000019667184,0.000028282882,0.00022010558,0.0004542484,0.00024458682,0.000044193075,0.0008674663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99406934,0.0022417798,0.00186763,0.0006884207,0.0007304277,0.0004023998],"domain_scores_gemma":[0.9892553,0.008200556,0.00089853845,0.0005160826,0.0008927798,0.00023672346],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009728348,0.00027279113,0.002200659,0.00025040354,0.00025504472,0.00007620128,0.000195345,0.00047189766,0.00022802822],"category_scores_gemma":[0.010398084,0.0002167672,0.00023929936,0.00058284774,0.0014641351,0.00007886382,0.00049145415,0.0010803455,0.000054067437],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010527664,0.00037452547,0.05194972,0.025378007,0.0030438881,0.0000123542795,0.00031868482,1.7570004e-8,0.0000037674172,0.000074662035,0.030754734,0.88798434],"study_design_scores_gemma":[0.0018927634,0.00073109724,0.1342107,0.013451062,0.0015101944,0.000016430406,0.0003542235,0.000008552504,0.0000028859922,0.0011962004,0.8462191,0.0004067655],"about_ca_topic_score_codex":0.00019048287,"about_ca_topic_score_gemma":0.00073906744,"teacher_disagreement_score":0.8875776,"about_ca_system_score_codex":0.00022440321,"about_ca_system_score_gemma":0.0008875305,"threshold_uncertainty_score":0.99793774},"labels":[],"label_agreement":null},{"id":"W2793003004","doi":"10.1158/1078-0432.ccr-17-2243","title":"A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Hospital for Sick Children","funders":"National Institute of Mental Health","keywords":"Medulloblastoma; DNA methylation; Biology; Cancer research; Microarray; Methylation; Computational biology; DNA microarray; Oncology; Bioinformatics; Medicine; DNA; Gene; Genetics; Gene expression","score_opus":0.31684663531270923,"score_gpt":0.5993657968865472,"score_spread":0.282519161573838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793003004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96525896,0.001983828,0.020930847,0.00799048,0.00035605178,0.0016924108,0.000058171692,0.00003107871,0.0016981774],"genre_scores_gemma":[0.9536302,0.00022208002,0.044396043,0.00049673254,0.000613338,0.0004893543,0.0000073434358,0.00003237851,0.00011254663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979424,0.0001770064,0.0004994802,0.00041131838,0.0005466893,0.00042313148],"domain_scores_gemma":[0.99642634,0.0017498665,0.00007988343,0.00042777252,0.0010562104,0.0002598971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032634141,0.00010069477,0.0004516197,0.00015376744,0.00008237646,0.000011695955,0.00015297857,0.00013307568,0.0003466593],"category_scores_gemma":[0.0019063164,0.00007692623,0.00027321884,0.0004069511,0.00043649753,0.00002459978,0.00010437373,0.00025982532,0.000024934781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058159814,0.0044699446,0.03748087,0.00059036165,0.001253348,0.000091763904,0.00029641777,0.000004430747,0.4642653,0.006006886,0.01799209,0.46173263],"study_design_scores_gemma":[0.022019342,0.016411066,0.08078457,0.0010793891,0.0004370872,0.00004984497,0.00024211172,0.0039568273,0.7884052,0.001802887,0.0844751,0.00033660664],"about_ca_topic_score_codex":0.00037206433,"about_ca_topic_score_gemma":0.00008838645,"teacher_disagreement_score":0.461396,"about_ca_system_score_codex":0.000089230205,"about_ca_system_score_gemma":0.00035717257,"threshold_uncertainty_score":0.37956762},"labels":[],"label_agreement":null},{"id":"W2793031031","doi":"10.1158/1078-0432.ccr-18-1740","title":"USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Cancer Institute; National Institutes of Health; Associazione Italiana per la Ricerca sul Cancro; York University; European Hematology Association; Northwestern University","keywords":"Demethylase; Deubiquitinating enzyme; Biology; Cancer research; Leukemia; Chromatin; Druggability; Cell growth; Transcription factor; Epigenetics; Gene; Ubiquitin; Genetics","score_opus":0.12625554376420625,"score_gpt":0.46814042109286663,"score_spread":0.34188487732866035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793031031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932462,0.00065123284,0.00007183442,0.0015170188,0.00011212894,0.0009837246,0.000029113575,0.000011273245,0.0033774928],"genre_scores_gemma":[0.9946462,0.0003394121,0.00054267346,0.0009425481,0.001085473,0.0007508041,0.00002411015,0.000023631666,0.001645163],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979994,0.00040468667,0.00027949098,0.00049097073,0.00034543633,0.00047998433],"domain_scores_gemma":[0.9988599,0.000108234904,0.000027831864,0.00036981085,0.0004483587,0.00018587802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00165398,0.00011699897,0.00015004333,0.000043538384,0.00016483855,0.000053433083,0.00044490627,0.0001665482,0.00022069461],"category_scores_gemma":[0.00019085799,0.00007445305,0.00006980749,0.00037120518,0.000702079,0.0000035343944,0.00013394872,0.0005123498,0.0001267133],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068682907,0.0010251119,0.05071211,0.00008452322,0.00014484883,0.000032015134,0.00084411516,0.00009701305,0.74711335,0.00046835252,0.028500166,0.16411012],"study_design_scores_gemma":[0.0021304335,0.007585853,0.016373634,0.00007749349,0.0000106866855,0.0000046366495,0.00020812565,0.00014607853,0.3825373,0.00010262696,0.59053797,0.0002851576],"about_ca_topic_score_codex":0.00026013647,"about_ca_topic_score_gemma":0.0029314396,"teacher_disagreement_score":0.5620378,"about_ca_system_score_codex":0.00006444247,"about_ca_system_score_gemma":0.001041275,"threshold_uncertainty_score":0.30361074},"labels":[],"label_agreement":null},{"id":"W2793442391","doi":"10.1158/1078-0432.ccr-17-2644","title":"Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Biomarker; Oncology; Internal medicine; Paclitaxel; Head and neck squamous-cell carcinoma; Head and neck cancer; Carcinoma; Chemotherapy; Cancer; Biology","score_opus":0.09891533955088294,"score_gpt":0.45176606395237323,"score_spread":0.3528507244014903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793442391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963166,0.0014175967,0.000004981439,0.0011847314,0.000050221926,0.00044860496,0.00005252474,0.0000040098303,0.0005207206],"genre_scores_gemma":[0.9994381,0.00010746817,0.000070936134,0.00019680816,0.000076740325,0.000030586165,0.000009024349,0.000011627205,0.00005867495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827456,0.0002657464,0.00037142253,0.00038366066,0.00044482027,0.00025977346],"domain_scores_gemma":[0.9984895,0.0005349523,0.000056776596,0.0003868656,0.00037894154,0.00015294805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051031314,0.00009867225,0.00043937535,0.0001405494,0.00012264501,0.000016932678,0.000096348376,0.00007621834,0.000072098475],"category_scores_gemma":[0.00032774624,0.00005971138,0.00006953394,0.0008857251,0.00088778103,0.000032735534,0.00017320807,0.00031236652,0.0000016487563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001011726,0.0003662039,0.99400496,0.000027037144,0.00011237127,0.000004668551,0.00035479869,0.0000013499451,0.00017298516,0.0000044055173,0.0003215709,0.0036179002],"study_design_scores_gemma":[0.0048097614,0.0012284509,0.9922184,0.000075608754,0.00016934458,1.1058865e-7,0.000050905644,0.00019519654,0.000798113,0.000012090693,0.00037760602,0.00006441094],"about_ca_topic_score_codex":0.0037017323,"about_ca_topic_score_gemma":0.0039425325,"teacher_disagreement_score":0.0037980357,"about_ca_system_score_codex":0.000045792396,"about_ca_system_score_gemma":0.00020629227,"threshold_uncertainty_score":0.5595937},"labels":[],"label_agreement":null},{"id":"W2793448070","doi":"10.1158/1078-0432.ccr-17-2651","title":"Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Deutsche Krebshilfe; Else Kröner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft; Deutsches Krebsforschungszentrum","keywords":"Oncolytic virus; Medicine; Immunotherapy; In vivo; Cancer research; Antigen; Immunology; Cancer; Virotherapy; Immune system; Internal medicine; Biology","score_opus":0.13834220553939205,"score_gpt":0.5154351187130839,"score_spread":0.37709291317369187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793448070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995123,0.0024368751,0.000054337856,0.0005144784,0.00032686698,0.00077207136,0.00007279197,0.000038907692,0.00066067156],"genre_scores_gemma":[0.9930395,0.0014469806,0.000055207234,0.0010577561,0.0020101126,0.00020734331,0.00019181946,0.00009921576,0.0018920591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943516,0.0017134014,0.000644328,0.0011159059,0.001037182,0.0011375818],"domain_scores_gemma":[0.9971058,0.0002218863,0.000114460825,0.0012196866,0.00067313423,0.0006650706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003421322,0.00026849547,0.00037296864,0.00013172532,0.00043762464,0.000105570165,0.001099288,0.00037949128,0.0006009781],"category_scores_gemma":[0.00057297124,0.00022972304,0.0001793337,0.0004712273,0.0011867916,0.000014865572,0.00043808157,0.0008512796,0.00027031923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068647694,0.00066527154,0.0017416668,0.000015987993,0.00009598457,0.000007621036,0.000056802273,0.000010090251,0.92541236,0.0000020484622,0.016760863,0.04836653],"study_design_scores_gemma":[0.0028250318,0.013979507,0.002972174,0.00007922119,0.000008995818,0.0000010387264,0.000053194686,0.00033378738,0.927674,0.000065582586,0.051658206,0.00034924338],"about_ca_topic_score_codex":0.00006469286,"about_ca_topic_score_gemma":0.00020623764,"teacher_disagreement_score":0.04801729,"about_ca_system_score_codex":0.00013220763,"about_ca_system_score_gemma":0.00092992274,"threshold_uncertainty_score":0.9367834},"labels":[],"label_agreement":null},{"id":"W2795460644","doi":"10.1158/1078-0432.ccr-18-0101","title":"Cell-Free DNA Modification Dynamics in Abiraterone Acetate-Treated Prostate Cancer Patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; Public Health Ontario; BC Cancer Agency; Centre for Addiction and Mental Health","funders":"Lietuvos Mokslo Taryba","keywords":"Prostate cancer; Abiraterone acetate; Internal medicine; Oncology; Medicine; Cancer; DNA methylation; Abiraterone; Cancer research; Biology; Genetics; Gene; Androgen deprivation therapy; Androgen receptor; Gene expression","score_opus":0.17158423012631732,"score_gpt":0.507320787629032,"score_spread":0.3357365575027147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795460644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98593605,0.0014250836,0.0000030651931,0.005689628,0.0003763907,0.0022323225,0.00023552487,0.000068254405,0.0040337066],"genre_scores_gemma":[0.9783042,0.0071910135,0.00006377493,0.00019561787,0.00052857836,0.0010955114,0.0002584655,0.00007575352,0.012287053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99515164,0.0005430877,0.0008767712,0.0009542521,0.0012777027,0.0011965502],"domain_scores_gemma":[0.9962515,0.00031364532,0.00013312213,0.00094226864,0.001832503,0.0005269503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020121194,0.00026563706,0.00056985364,0.0004362308,0.00024682004,0.00007784635,0.0005090497,0.0003046995,0.0006319859],"category_scores_gemma":[0.00048160058,0.00020440214,0.00012540628,0.0014275757,0.0012644267,0.000190056,0.00036679613,0.0012404115,0.0002939462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061256783,0.0017308624,0.9483684,0.0002363132,0.00009336122,0.00004987606,0.0003646614,0.000003940658,0.0010368184,0.000042867563,0.014947783,0.026999453],"study_design_scores_gemma":[0.026452957,0.0045671514,0.93736005,0.00066813186,0.000082342194,0.0000012642059,0.0003488142,0.0045764325,0.018474126,0.00069175166,0.0063144783,0.0004624853],"about_ca_topic_score_codex":0.0038880075,"about_ca_topic_score_gemma":0.003546182,"teacher_disagreement_score":0.026536968,"about_ca_system_score_codex":0.0022849557,"about_ca_system_score_gemma":0.0011424068,"threshold_uncertainty_score":0.83352774},"labels":[],"label_agreement":null},{"id":"W2800246113","doi":"10.1158/1557-3265.sarcomas17-a13","title":"Abstract A13: Genome-wide transcriptional analysis of HDAC inhibition-induced apoptosis in synovial sarcoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Synovial sarcoma; Cancer research; CDKN2A; Transcriptome; Apoptosis; Biology; Cell cycle; Sarcoma; Programmed cell death; Cell cycle checkpoint; Cancer; Medicine; Pathology; Gene expression; Genetics; Gene","score_opus":0.25348705596299875,"score_gpt":0.5041732476739577,"score_spread":0.2506861917109589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800246113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932915,0.00065296347,0.000006567816,0.0036379534,0.00014088726,0.0005078283,0.000092045375,0.000016867563,0.0016534191],"genre_scores_gemma":[0.9979903,0.0006721641,0.000106602856,0.00039705198,0.0004448702,0.00021389693,0.00008814149,0.000021749232,0.00006519263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966054,0.0002615552,0.001031875,0.00057286327,0.0010213644,0.0005069423],"domain_scores_gemma":[0.99689907,0.0015592449,0.000109043714,0.0004719013,0.00065809867,0.0003026203],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022664308,0.0001559658,0.0007789701,0.00090101326,0.0000992641,0.00002149887,0.00015494146,0.00021533972,0.0036288518],"category_scores_gemma":[0.00068508467,0.00013022918,0.0005106104,0.0020959366,0.00055443164,0.00007276607,0.000060077044,0.0006392884,0.00010043784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012750423,0.00296912,0.971183,0.000057819125,0.0012700688,0.00005495395,0.00018142887,0.0000047474477,0.010466265,0.0001665789,0.00057195127,0.01179905],"study_design_scores_gemma":[0.0028521162,0.00079777336,0.9867144,0.00013802233,0.00041742515,8.415212e-7,0.000090606365,0.00005895989,0.007470316,0.00015041759,0.0012013778,0.00010772338],"about_ca_topic_score_codex":0.0024246408,"about_ca_topic_score_gemma":0.002511331,"teacher_disagreement_score":0.015531445,"about_ca_system_score_codex":0.00033084876,"about_ca_system_score_gemma":0.0005198102,"threshold_uncertainty_score":0.99728197},"labels":[],"label_agreement":null},{"id":"W2801249627","doi":"10.1158/1078-0432.ccr-17-3775","title":"ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Medical Research Council; Public Health Agency; Friends of the Cancer Centre; Queen's University Belfast; U.S. Department of Veterans Affairs","keywords":"Slug; Epithelial–mesenchymal transition; Head and neck squamous-cell carcinoma; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Effector; Biology; Cancer; Signal transduction; Head and neck cancer; Cell biology; Metastasis; Genetics","score_opus":0.16786761900950808,"score_gpt":0.4941545636897182,"score_spread":0.32628694468021013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801249627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846068,0.0010288173,0.0005526877,0.008573869,0.00085871416,0.002021906,0.00007296097,0.000106277104,0.0021779754],"genre_scores_gemma":[0.9940885,0.0003106592,0.0006618023,0.0012982416,0.0024919093,0.00041291272,0.000021227277,0.00009405121,0.0006207407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945435,0.0007102929,0.0010392809,0.0011062475,0.001378699,0.0012219572],"domain_scores_gemma":[0.99669814,0.0007378149,0.000093166746,0.000746921,0.0009491754,0.00077478646],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043511055,0.00027386175,0.0006989182,0.0005661667,0.00021719179,0.000054527598,0.00036121163,0.000451361,0.0015032564],"category_scores_gemma":[0.002359021,0.00025851742,0.0002641463,0.001865706,0.0008959929,0.000107499036,0.00013834922,0.0020028683,0.0005127563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025107212,0.0024752438,0.02468213,0.0011884838,0.00062018685,0.0019852289,0.01266212,0.0016471309,0.5979285,0.00041999665,0.026300155,0.3049836],"study_design_scores_gemma":[0.045397077,0.040934112,0.09891041,0.009219853,0.00062270084,0.00023504361,0.0026515063,0.018526943,0.61610407,0.0032711986,0.16080855,0.0033185484],"about_ca_topic_score_codex":0.0067397496,"about_ca_topic_score_gemma":0.005068091,"teacher_disagreement_score":0.30166504,"about_ca_system_score_codex":0.0014398796,"about_ca_system_score_gemma":0.0027212696,"threshold_uncertainty_score":0.9999867},"labels":[],"label_agreement":null},{"id":"W2801510798","doi":"10.1158/1078-0432.ccr-17-2386","title":"Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Merck","keywords":"Medicine; Pembrolizumab; Internal medicine; Logistic regression; Univariate analysis; Proportional hazards model; Oncology; Post-hoc analysis; Gastroenterology; Stage (stratigraphy); Multivariate analysis; Cancer; Immunotherapy","score_opus":0.12898013682164816,"score_gpt":0.4481364110601866,"score_spread":0.31915627423853843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801510798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606884,0.000105323365,0.00001965093,0.0007629272,0.00012742428,0.0024257281,0.00027451126,0.000036344205,0.00017923646],"genre_scores_gemma":[0.9973089,0.000052720272,0.00019879857,0.0006844335,0.0005265549,0.00034895932,0.000055987173,0.00006485641,0.0007587506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964729,0.00039380603,0.0005961107,0.0007610591,0.0010626463,0.00071346975],"domain_scores_gemma":[0.99667716,0.0011460991,0.00011665542,0.00053870527,0.0011741526,0.00034721193],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016513901,0.00023110138,0.0005555735,0.00015225887,0.00012840406,0.000050915718,0.00023866922,0.00015428438,0.0015474298],"category_scores_gemma":[0.0006496999,0.00014605004,0.00010026581,0.00049277645,0.00060513115,0.00012732307,0.00005177764,0.0005851606,0.000014026254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.123967186,0.0011837363,0.8597389,0.000081488324,0.00018472243,0.000026272799,0.00015586683,2.5886138e-7,0.00009614134,0.0000032605808,0.00057700824,0.013985192],"study_design_scores_gemma":[0.03276578,0.024293136,0.9382862,0.00031328673,0.000046110752,0.0000026228192,0.000056282177,0.00013786109,0.0005639842,0.000012084991,0.0033127975,0.00020987412],"about_ca_topic_score_codex":0.0016880957,"about_ca_topic_score_gemma":0.0034523068,"teacher_disagreement_score":0.09120141,"about_ca_system_score_codex":0.0003577612,"about_ca_system_score_gemma":0.0010731944,"threshold_uncertainty_score":0.99936527},"labels":[],"label_agreement":null},{"id":"W2803586475","doi":"10.1158/1078-0432.ccr-18-1089","title":"Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Tenovus; Cancer Research UK; Cancer Research Wales","keywords":"Oncolytic virus; Tropism; Virotherapy; Oncolytic adenovirus; Cancer research; Ex vivo; Biology; Genetic enhancement; In vivo; Adenoviridae; Transgene; Gene delivery; Integrin; Immunology; Immune system; Cell; Virus; Gene","score_opus":0.1777316418186462,"score_gpt":0.5172641653514678,"score_spread":0.3395325235328216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803586475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849871,0.0048643304,0.0009517229,0.0038709755,0.0008082206,0.002118465,0.00038602564,0.00004494171,0.0019682415],"genre_scores_gemma":[0.9789418,0.0045827804,0.000233932,0.0010926779,0.007850735,0.0022154555,0.00003727869,0.00012849552,0.0049168356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945622,0.0011318268,0.00072018924,0.0013062824,0.00086785393,0.0014116307],"domain_scores_gemma":[0.996029,0.0005942239,0.00014502743,0.0008568536,0.0019203038,0.0004545847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040251096,0.00034614903,0.00053259457,0.00021205087,0.00055975147,0.00012644785,0.001183047,0.00057897845,0.000695343],"category_scores_gemma":[0.0012656308,0.0002946079,0.00038517648,0.00060050405,0.0018313425,0.000013896595,0.00040900928,0.0011561387,0.0001385194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06833492,0.0008067897,0.0025531503,0.00010022124,0.0011360378,0.000012006485,0.00054969836,0.00004295225,0.63945603,0.00039234036,0.03559585,0.25102],"study_design_scores_gemma":[0.009244281,0.030585526,0.0042364155,0.00014210326,0.0000643346,0.00000581691,0.00030079944,0.00054176856,0.6515461,0.0026404322,0.29985926,0.00083316414],"about_ca_topic_score_codex":0.0012543184,"about_ca_topic_score_gemma":0.010085294,"teacher_disagreement_score":0.26426342,"about_ca_system_score_codex":0.0003116804,"about_ca_system_score_gemma":0.0027752281,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W2803839803","doi":"10.1158/1078-0432.ccr-17-3262","title":"Tumor Elastography and Its Association with Collagen and the Tumor Microenvironment","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound Imaging and Elastography","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"University of California, San Francisco; Zoetis","keywords":"Extracellular matrix; Tumor microenvironment; Stromal cell; Ex vivo; Stroma; Pathology; Elastography; Hyaluronic acid; Collagenase; Myofibroblast; In vivo; Chemistry; Biomedical engineering; Ultrasound; Medicine; Cancer; Fibrosis; Immunohistochemistry; Anatomy; Biology; In vitro; Internal medicine; Radiology; Biochemistry","score_opus":0.052591849489150876,"score_gpt":0.4077563775703006,"score_spread":0.35516452808114973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803839803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98621523,0.0027411627,0.000013052822,0.009453944,0.0000927245,0.0005485785,0.000010950174,0.000019410509,0.0009049413],"genre_scores_gemma":[0.99505144,0.0014519059,0.00023642604,0.0015202577,0.0005145854,0.00009949518,0.0000018692239,0.000019303192,0.0011047241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980549,0.0003664936,0.0002552593,0.00036168034,0.00057248725,0.000389129],"domain_scores_gemma":[0.9980458,0.0012005593,0.00008075034,0.00020768298,0.00024013668,0.00022507668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031487942,0.00010333574,0.00027784906,0.000106658255,0.0003248078,0.00006182098,0.00008772502,0.000048134847,0.00011363707],"category_scores_gemma":[0.0006505836,0.000059145386,0.000065743436,0.00040928266,0.001579693,0.000046166417,0.000081977334,0.00045070623,0.000030766438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003302896,0.00014876806,0.9812094,0.000060127877,0.00026190147,0.0000070224232,0.00041140322,1.699693e-7,0.0019491813,0.00006409399,0.010147641,0.0024374009],"study_design_scores_gemma":[0.007061864,0.0018267891,0.8142161,0.00018489361,0.00015970913,0.000045479133,0.0004141045,0.000069674206,0.0006799305,0.00016440982,0.17504191,0.00013515355],"about_ca_topic_score_codex":0.00013345126,"about_ca_topic_score_gemma":0.00008002161,"teacher_disagreement_score":0.16699332,"about_ca_system_score_codex":0.00006344772,"about_ca_system_score_gemma":0.00011405315,"threshold_uncertainty_score":0.5820445},"labels":[],"label_agreement":null},{"id":"W2804058066","doi":"10.1158/1078-0432.ccr-17-2745","title":"Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"National Cancer Institute","keywords":"Prostatectomy; Prostate cancer; Androgen deprivation therapy; Medicine; Oncology; Propensity score matching; Biochemical recurrence; Internal medicine; Metastasis; Proportional hazards model; Cancer; Urology","score_opus":0.1901585316872817,"score_gpt":0.4922202416215116,"score_spread":0.3020617099342299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804058066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879538,0.006246886,0.0000039053652,0.0023521269,0.0002888562,0.0028070952,0.00007558266,0.000056106182,0.0002156775],"genre_scores_gemma":[0.9895328,0.0039295396,0.0005865525,0.00007787009,0.00044996428,0.0011834386,0.000040804847,0.00006232273,0.0041367006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954074,0.0007601172,0.00073973415,0.0008644502,0.0013119405,0.0009163838],"domain_scores_gemma":[0.9973595,0.0007912388,0.00014830648,0.00046233658,0.00060074776,0.00063783635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003696305,0.0002886031,0.0006914488,0.00036182487,0.00036075877,0.00006557488,0.00020114696,0.00030391925,0.00022095807],"category_scores_gemma":[0.0004207313,0.00020146885,0.00018452824,0.00061821245,0.0012619877,0.00015444678,0.00022393536,0.0007609268,0.00003116889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07433496,0.0011079079,0.7287999,0.00042926584,0.0014390073,0.00036372434,0.008380097,0.000002247318,0.04083828,0.000021319733,0.001212797,0.14307052],"study_design_scores_gemma":[0.019602273,0.00825963,0.58550435,0.0013309611,0.00021778057,0.000010920422,0.00048502468,0.00007122125,0.33090657,0.0001157976,0.053133953,0.0003614927],"about_ca_topic_score_codex":0.00045092055,"about_ca_topic_score_gemma":0.000093661365,"teacher_disagreement_score":0.2900683,"about_ca_system_score_codex":0.0010672031,"about_ca_system_score_gemma":0.004025847,"threshold_uncertainty_score":0.8215661},"labels":[],"label_agreement":null},{"id":"W2804378061","doi":"10.1158/1078-0432.ccr-18-0613","title":"Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Fulvestrant; Breast cancer; Cancer; Medicine; Internal medicine; Oncology; Hormone receptor; Phases of clinical research; Hormone; Metastatic breast cancer; Toxicity; Estrogen receptor","score_opus":0.06313931023451126,"score_gpt":0.4699763740301713,"score_spread":0.40683706379566004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804378061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946063,0.0002791872,0.000026658292,0.0012595656,0.00010767035,0.0033023236,0.00026857198,0.000027271635,0.00012244718],"genre_scores_gemma":[0.99807674,0.00023415161,0.00040502351,0.000119059085,0.00018328287,0.0007289858,0.000038765134,0.000070357055,0.00014363784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952964,0.00064403086,0.00094886986,0.00089403463,0.0014825922,0.0007340545],"domain_scores_gemma":[0.9960667,0.0005037224,0.00030247789,0.0005637462,0.0022746082,0.00028874693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013350891,0.00031116934,0.0009033605,0.0004294661,0.0001590629,0.000015788068,0.00028221466,0.00014699694,0.0003376637],"category_scores_gemma":[0.00021780406,0.00022901324,0.000051747527,0.0020155532,0.0014472777,0.0003595022,0.00013298423,0.0012114606,0.000006302949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15315293,0.031115556,0.62847304,0.00008868419,0.0003267944,0.000041084768,0.004075808,0.00006818168,0.00060131965,0.00001706926,0.00014374571,0.1818958],"study_design_scores_gemma":[0.0948814,0.0651626,0.83507276,0.0011496327,0.000048259335,0.0000020555588,0.0021188206,0.000046374116,0.0010119313,0.00005936733,0.00019122503,0.0002555989],"about_ca_topic_score_codex":0.0046783807,"about_ca_topic_score_gemma":0.009776035,"teacher_disagreement_score":0.20659971,"about_ca_system_score_codex":0.0007832727,"about_ca_system_score_gemma":0.0008360128,"threshold_uncertainty_score":0.93388885},"labels":[],"label_agreement":null},{"id":"W2807016784","doi":"10.1158/1078-0432.ccr-18-0481","title":"Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency; London Health Sciences Centre; Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Toxicity; Refractory (planetary science); Renal cell carcinoma; Pharmacology; Internal medicine; Gastroenterology; Urology","score_opus":0.2753566075983032,"score_gpt":0.5755549612296069,"score_spread":0.3001983536313037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807016784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649573,0.008725662,0.000014433175,0.0012613377,0.000521725,0.0008644462,0.0000731608,0.000033302495,0.0020101902],"genre_scores_gemma":[0.9919513,0.0035174892,0.0001994772,0.00021601206,0.001662359,0.000043069376,0.00005976219,0.00004127671,0.0023092872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944919,0.001189112,0.0020724274,0.00066725066,0.0009038614,0.0006754803],"domain_scores_gemma":[0.9939104,0.0036561498,0.00041890983,0.0006547317,0.0009673721,0.0003924788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010880146,0.00020793952,0.0013962034,0.00038181138,0.00012676134,0.0000244221,0.0002938669,0.00021761442,0.0015593189],"category_scores_gemma":[0.0047014356,0.00016907102,0.00036580866,0.00076251384,0.0012565606,0.00015829124,0.00014050862,0.0008168453,0.000072670846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013695824,0.0052789543,0.53632843,0.0006104286,0.00018407914,0.00016775928,0.0012389176,0.000007140164,0.35405028,0.00025283176,0.0156209525,0.07256442],"study_design_scores_gemma":[0.04660604,0.008449414,0.45894316,0.0018170384,0.00018346694,0.000008292988,0.0006124161,0.0006425108,0.3902257,0.00091437105,0.09105293,0.0005446625],"about_ca_topic_score_codex":0.0012732351,"about_ca_topic_score_gemma":0.00030857912,"teacher_disagreement_score":0.077385284,"about_ca_system_score_codex":0.000116626965,"about_ca_system_score_gemma":0.00123922,"threshold_uncertainty_score":0.9993534},"labels":[],"label_agreement":null},{"id":"W2807849948","doi":"10.1158/1078-0432.ccr-18-0415","title":"Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Lung cancer; Confidence interval; Oncology; Melanoma; Proportional hazards model; Cachexia; Cancer; Immunotherapy; Cancer research","score_opus":0.1687627955113297,"score_gpt":0.5617169475500441,"score_spread":0.3929541520387144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807849948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97482085,0.017337363,0.000006281041,0.006180206,0.00042503307,0.0005263289,0.00011135321,0.000025768551,0.00056683744],"genre_scores_gemma":[0.97293556,0.021643037,0.000036445974,0.0005415429,0.00065918546,0.00016426736,0.000008652796,0.000033850676,0.0039774454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963646,0.000926727,0.00066695135,0.000505419,0.0009968766,0.00053944223],"domain_scores_gemma":[0.997331,0.00092738017,0.0002323105,0.00041904108,0.000855519,0.0002347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055498565,0.00015228368,0.00051404734,0.00012877313,0.00016914077,0.00002888966,0.0002000689,0.0002958771,0.0007193754],"category_scores_gemma":[0.00080204953,0.00013215448,0.00012573384,0.00046565253,0.0007789263,0.00009494197,0.00009968134,0.0007115397,0.000018221353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.112657554,0.0007272585,0.53081423,0.00026402881,0.00086396013,0.000009168268,0.0007584654,2.4412398e-7,0.06612864,0.000021595752,0.049461506,0.23829332],"study_design_scores_gemma":[0.009050836,0.0027803918,0.8732132,0.00026644074,0.00006606457,0.0000021466283,0.00014839343,0.00006740574,0.0086392015,0.000029415092,0.105574936,0.00016162248],"about_ca_topic_score_codex":0.0028449905,"about_ca_topic_score_gemma":0.0010736417,"teacher_disagreement_score":0.34239888,"about_ca_system_score_codex":0.00054959604,"about_ca_system_score_gemma":0.0008912818,"threshold_uncertainty_score":0.7876656},"labels":[],"label_agreement":null},{"id":"W2807902048","doi":"10.1158/1078-0432.ccr-18-1475","title":"Unexpected Benefits of Aging for Favorable Responses to PD-1 Blockade in Melanoma?","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Blockade; Immunosenescence; Melanoma; Immune checkpoint; Cancer; Medicine; Immune system; CD8; PD-L1; Immunotherapy; Cancer research; Oncology; Immunology; Internal medicine; Receptor","score_opus":0.30777271043350346,"score_gpt":0.5352811957631706,"score_spread":0.2275084853296671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807902048","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3982045,0.0073798555,0.0000089582845,0.5897037,0.00088721904,0.002720478,0.0004710543,0.00004142378,0.00058284175],"genre_scores_gemma":[0.11343835,0.012075507,0.0026354727,0.72171277,0.04490271,0.0048564007,0.00069940893,0.00069857144,0.09898082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994742,0.00070064055,0.0013827119,0.0009734941,0.0011336701,0.001067496],"domain_scores_gemma":[0.99339104,0.0041099396,0.00022039798,0.00096602214,0.0011120088,0.0002005977],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005166763,0.0003011691,0.0012062707,0.0009770694,0.000109700544,0.000038785234,0.00059885444,0.001079377,0.000703854],"category_scores_gemma":[0.0024622586,0.00025979837,0.00043017,0.0013130037,0.0006616719,0.00004192728,0.00020336655,0.0026213177,0.000035531724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01817964,0.0001641152,0.010200167,0.0008494367,0.00031227153,0.00007929662,0.00020187633,0.0000013560447,0.0013705553,0.000003190925,0.9535571,0.015081041],"study_design_scores_gemma":[0.004763089,0.0033421344,0.023118531,0.0030115244,0.0000707429,0.0000069308608,0.00007297772,0.000012971098,0.0057259323,0.000073444695,0.9594948,0.00030687317],"about_ca_topic_score_codex":0.0024838634,"about_ca_topic_score_gemma":0.0008672566,"teacher_disagreement_score":0.28476614,"about_ca_system_score_codex":0.00054995756,"about_ca_system_score_gemma":0.0020816135,"threshold_uncertainty_score":0.9999854},"labels":[],"label_agreement":null},{"id":"W2808608845","doi":"10.1158/1078-0432.ccr-17-3384","title":"Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Nickel Institute; Montreal General Hospital; McGill University; McGill University Health Centre","funders":"Melanoma Research Alliance; Canadian Institutes of Health Research; V Foundation for Cancer Research; U.S. Department of Defense","keywords":"Mutant; Melanoma; Cancer research; Class (philosophy); MAPK/ERK pathway; Medicine; Biology; Genetics; Computer science; Gene; Kinase","score_opus":0.21338425190616878,"score_gpt":0.49637302213594536,"score_spread":0.2829887702297766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808608845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968555,0.00044756156,0.00027282248,0.00027147876,0.00022368695,0.00081601646,0.0002628429,0.000008744427,0.0008413271],"genre_scores_gemma":[0.99719393,0.00018001799,0.00006592979,0.00028087717,0.0014382001,0.00027268467,0.00012671121,0.000027717713,0.0004139264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978791,0.00044338766,0.00040154462,0.00056027423,0.00028726525,0.0004284351],"domain_scores_gemma":[0.9986128,0.0001455074,0.00009679329,0.00044945427,0.0005234463,0.0001719874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018644028,0.0001341086,0.00025676354,0.0000592762,0.00019260602,0.000020971684,0.00019059327,0.00032478257,0.00012609627],"category_scores_gemma":[0.00020721338,0.000113166025,0.00015073453,0.00014925172,0.0006324961,0.0000075915495,0.00015444325,0.00025421425,0.00001273775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021217435,0.00042343873,0.0023104083,0.00007446863,0.00014313769,0.0000055535247,0.00019276918,0.000001264941,0.9452845,0.0008569443,0.0042061103,0.044379696],"study_design_scores_gemma":[0.0020869668,0.018451124,0.012645702,0.00003903359,0.000026368953,0.000005688834,0.00014371703,0.00017691696,0.9316084,0.0020937375,0.032530848,0.00019150574],"about_ca_topic_score_codex":0.000119629745,"about_ca_topic_score_gemma":0.00048162916,"teacher_disagreement_score":0.04418819,"about_ca_system_score_codex":0.000027296917,"about_ca_system_score_gemma":0.00034519672,"threshold_uncertainty_score":0.46147767},"labels":[],"label_agreement":null},{"id":"W2808639537","doi":"10.1158/1557-3265.hemmal17-45","title":"Abstract 45: BTM-3528 potently induces G1/G0 cell cycle arrest and is efficacious in preclinical models of diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Cell growth; Cell cycle; Cancer research; Cell cycle checkpoint; Cell culture; Biology; Cell; Biochemistry","score_opus":0.18941580753380277,"score_gpt":0.48094813316957546,"score_spread":0.2915323256357727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808639537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499763,0.00410444,0.000018870593,0.0020131308,0.00049251894,0.0010686821,0.00015022089,0.00003513655,0.0071193674],"genre_scores_gemma":[0.9911712,0.0071258117,0.00012475366,0.00031605145,0.00048739955,0.00010148535,0.000013847538,0.00008434562,0.0005751157],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99474365,0.0003798279,0.0014410287,0.0011433449,0.0012619366,0.0010302443],"domain_scores_gemma":[0.9953205,0.0011936899,0.000445195,0.0018112628,0.00044917845,0.000780154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041602664,0.00030770162,0.0010386206,0.00026467355,0.00028907822,0.00010570063,0.00078082096,0.00082080206,0.00017069167],"category_scores_gemma":[0.0018100378,0.00027835328,0.00033255082,0.00025929612,0.0011603393,0.00019856577,0.0007310291,0.0020740414,0.000078131525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036697004,0.11729907,0.2607066,0.0069047245,0.001230856,0.0052716383,0.0061394894,0.00056308875,0.10835926,0.0005786834,0.031106316,0.42514327],"study_design_scores_gemma":[0.13219401,0.004150367,0.77944213,0.0029419798,0.00033081084,0.000023896477,0.00056866085,0.010794495,0.05612144,0.0028734533,0.009263521,0.0012952529],"about_ca_topic_score_codex":0.0019281476,"about_ca_topic_score_gemma":0.0007134769,"teacher_disagreement_score":0.5187355,"about_ca_system_score_codex":0.000234389,"about_ca_system_score_gemma":0.0012599434,"threshold_uncertainty_score":0.99996686},"labels":[],"label_agreement":null},{"id":"W2809695328","doi":"10.1158/1078-0432.ccr-18-1552","title":"Two Weeks' Notice from Allogeneic Sources","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"T-cell receptor; Human leukocyte antigen; Medicine; Notice; Cancer; Immunology; T cell; Antigen; Biology; Internal medicine; Immune system; Political science","score_opus":0.34897601776317844,"score_gpt":0.565567767512028,"score_spread":0.21659174974884954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809695328","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10821459,0.0070385197,0.000010217373,0.8507562,0.0027568392,0.0025367932,0.0006699199,0.00020450374,0.027812421],"genre_scores_gemma":[0.0021520657,0.00735483,0.00042761478,0.5479647,0.15365145,0.0006354092,0.0010803546,0.00048472267,0.28624886],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9859701,0.0030672175,0.0014674328,0.0022453258,0.004936511,0.0023134039],"domain_scores_gemma":[0.9848171,0.009165163,0.00023877432,0.0028389853,0.0021096973,0.00083031534],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.007600634,0.0005956691,0.0017840972,0.0006370624,0.00034442253,0.00024965854,0.001825929,0.002510994,0.0974199],"category_scores_gemma":[0.003120634,0.0004941483,0.00090825965,0.0009903456,0.0033912668,0.00007971909,0.0011331976,0.018241711,0.0059945034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017896538,0.00020538825,0.012106249,0.00025727702,0.00088936667,0.0017204212,0.000080489706,4.3991193e-7,0.0018144008,0.0000028073584,0.9579489,0.023184579],"study_design_scores_gemma":[0.0035349377,0.0014878658,0.0035562988,0.0006107467,0.00020978773,0.000016270005,0.00004178567,0.000037016984,0.0010394143,0.00045284248,0.9885457,0.0004673263],"about_ca_topic_score_codex":0.0090472875,"about_ca_topic_score_gemma":0.0008698774,"teacher_disagreement_score":0.3027915,"about_ca_system_score_codex":0.00080200797,"about_ca_system_score_gemma":0.003255842,"threshold_uncertainty_score":0.99975103},"labels":[],"label_agreement":null},{"id":"W2810239069","doi":"10.1158/1078-0432.ccr-18-0784","title":"Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Association for Cancer Research","keywords":"Ovarian carcinoma; Serous fluid; Serous carcinoma; Medicine; Carcinoma; Oncology; Ovarian cancer; Pathology; Internal medicine; Cancer","score_opus":0.21726211750262264,"score_gpt":0.5089269287165084,"score_spread":0.2916648112138857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810239069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97585183,0.00085448497,0.0000065665045,0.017226862,0.00047960348,0.00061398523,0.000052045347,0.000026302972,0.004888343],"genre_scores_gemma":[0.99674034,0.00031122915,0.00045134657,0.0008489616,0.00093771424,0.00011045351,0.0000098196815,0.000037296246,0.00055283844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971678,0.00038523035,0.0005529092,0.00058657996,0.0008084634,0.0004989723],"domain_scores_gemma":[0.9971389,0.0009113807,0.000093700204,0.0007884621,0.00070417684,0.0003633661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001283171,0.00015468943,0.0005469069,0.00015800963,0.000101343416,0.00001709349,0.00018312989,0.00019058227,0.00095012895],"category_scores_gemma":[0.00055357267,0.00012008572,0.00018058314,0.0004599147,0.0010032521,0.000013832993,0.00009891967,0.00056827185,0.00021007596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008998574,0.004854999,0.81169283,0.00035763808,0.0011444222,0.0016672108,0.00029284312,0.000010329465,0.0028735125,0.022086013,0.068042964,0.07797863],"study_design_scores_gemma":[0.0082543595,0.009979801,0.8944212,0.00039825513,0.00017900726,0.000018648256,0.00006670218,0.00005377642,0.06428864,0.0017964168,0.02034485,0.00019830912],"about_ca_topic_score_codex":0.0033597632,"about_ca_topic_score_gemma":0.00027925285,"teacher_disagreement_score":0.08272837,"about_ca_system_score_codex":0.0002211974,"about_ca_system_score_gemma":0.00084162975,"threshold_uncertainty_score":0.99996316},"labels":[],"label_agreement":null},{"id":"W2810785104","doi":"10.1158/1557-3265.tcm17-a09","title":"Abstract A09: Development of epigenetic-based strategies for blocking breast cancer growth, invasion, and metastasis in vitro and in vivo","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; In vivo; Cancer research; Biology; Breast cancer; Cancer; Mammary tumor; Cell growth; Epigenetics; Gene; Genetics","score_opus":0.1484753244992321,"score_gpt":0.47218790880765593,"score_spread":0.32371258430842387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810785104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954299,0.0033668992,0.00040780666,0.00028661822,0.000054622684,0.00031865895,0.0000657045,0.0000017514005,0.000068061614],"genre_scores_gemma":[0.99550617,0.002096402,0.002039602,0.000038895196,0.00014531279,0.00013644849,0.0000098570035,0.000015197871,0.000012089157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984503,0.00015486112,0.0005059331,0.00040713366,0.00019060868,0.00029117463],"domain_scores_gemma":[0.9990478,0.00024986087,0.00008364847,0.00015029806,0.0003729289,0.00009547752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024843756,0.000103484315,0.00021718629,0.00012514743,0.0000729312,0.000028832957,0.000118383425,0.00015619132,0.0000275224],"category_scores_gemma":[0.00026197103,0.00009489019,0.0000341735,0.00016821026,0.00036041212,0.0000058535456,0.000105668834,0.00015145743,2.2655892e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011339388,0.00011714651,0.069439106,0.00015683229,0.00003470232,9.688346e-7,0.00012822794,0.000037738777,0.8664702,0.000014670893,0.000038748025,0.062427714],"study_design_scores_gemma":[0.0010721475,0.00014954359,0.19486348,0.000073987925,0.000006123338,1.6645615e-7,0.00012151077,0.00015050836,0.8019689,0.0004373749,0.0010431666,0.000113099515],"about_ca_topic_score_codex":0.00055576186,"about_ca_topic_score_gemma":0.0059329374,"teacher_disagreement_score":0.12542437,"about_ca_system_score_codex":0.000028644314,"about_ca_system_score_gemma":0.0007546056,"threshold_uncertainty_score":0.38695097},"labels":[],"label_agreement":null},{"id":"W2811276423","doi":"10.1158/1078-0432.ccr-17-3284","title":"Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada; National Foundation for Cancer Research; American Association for Cancer Research","keywords":"Tumor microenvironment; In vivo; Pancreatic cancer; Tumor hypoxia; Pathology; Cancer research; Malignancy; Pancreatic tumor; Hypoxia (environmental); Cancer; Tumor progression; Medicine; Chemistry; Biology; Radiation therapy; Internal medicine","score_opus":0.23243685116403362,"score_gpt":0.5415738840743519,"score_spread":0.3091370329103183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811276423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970562,0.00091790804,0.00012471533,0.00019034822,0.000080880396,0.0005948086,0.00005840011,0.0000045249353,0.0009722458],"genre_scores_gemma":[0.9976811,0.00024289846,0.0009652022,0.000092431976,0.00036150144,0.00008327756,0.000009830618,0.00002293408,0.00054083235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977082,0.00041139647,0.00047520574,0.00045928755,0.0005586438,0.00038727987],"domain_scores_gemma":[0.9983725,0.00012569397,0.00014503073,0.0004307583,0.00074645225,0.00017957081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019544072,0.00011289361,0.00025830738,0.00010001598,0.00011027463,0.000016155635,0.0003334822,0.00013693415,0.00019249352],"category_scores_gemma":[0.0007095099,0.000092385,0.00008513327,0.00027408,0.0016401352,0.000006270923,0.00036845845,0.00019366851,0.000007432981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059969947,0.0005819105,0.3991036,0.00035579444,0.00017741912,0.000014591753,0.0001829136,0.000021960685,0.507873,0.00037395512,0.008866459,0.0764514],"study_design_scores_gemma":[0.005193162,0.012534742,0.1613374,0.00038506612,0.00003165843,0.00001065266,0.00031115673,0.001331863,0.6463118,0.0006058673,0.17149758,0.00044902298],"about_ca_topic_score_codex":0.00032880896,"about_ca_topic_score_gemma":0.00027962442,"teacher_disagreement_score":0.2377662,"about_ca_system_score_codex":0.000021273365,"about_ca_system_score_gemma":0.0005076071,"threshold_uncertainty_score":0.6043146},"labels":[],"label_agreement":null},{"id":"W2884100356","doi":"10.1158/1078-0432.ccr-18-1481","title":"Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":523,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Networks of Centres of Excellence of Canada; Michael Smith Health Research BC","keywords":"Cancer; Tumor cells; Cancer research; Medicine; Pathology; Human plasma; Cancer cell; Biology; Internal medicine; Chemistry","score_opus":0.3274036531060941,"score_gpt":0.5512920413785712,"score_spread":0.22388838827247715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884100356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023014009,0.9719826,8.5498954e-7,0.00009712668,0.00059526565,0.0033670818,0.00025304104,0.000024752628,0.00066524016],"genre_scores_gemma":[0.0032215777,0.99297166,0.00010781481,0.00008071696,0.0011426011,0.0011279923,0.000020976186,0.00010430271,0.0012223523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935822,0.0011193007,0.002343433,0.0011402236,0.0009396507,0.0008751816],"domain_scores_gemma":[0.9949513,0.0028711543,0.00066876353,0.0007286244,0.00045061304,0.0003295083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005096012,0.0004588871,0.0027812182,0.0004669187,0.0001446847,0.000052870775,0.00049876585,0.00055427814,0.0007304748],"category_scores_gemma":[0.00046673467,0.00035818308,0.0005424988,0.0012421305,0.0020238967,0.00006296892,0.00022052249,0.0022698005,0.000022323407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001127916,0.00052512425,0.0042198836,0.05519702,0.0005757733,0.00014387185,0.00015472368,5.617988e-7,0.0018602049,0.000011897588,0.008855876,0.92732716],"study_design_scores_gemma":[0.0023961454,0.0016681782,0.0007901482,0.06416312,0.00044746517,0.000013368416,0.00006858286,0.000017660703,0.001698837,0.000021955815,0.9282327,0.00048181726],"about_ca_topic_score_codex":0.0028949778,"about_ca_topic_score_gemma":0.0011486404,"teacher_disagreement_score":0.9268453,"about_ca_system_score_codex":0.0004908446,"about_ca_system_score_gemma":0.0033836,"threshold_uncertainty_score":0.999887},"labels":[],"label_agreement":null},{"id":"W2884214860","doi":"10.1158/1078-0432.ccr-18-0551","title":"Brain Development and Heart Function after Systemic Single-Agent Chemotherapy in a Mouse Model of Childhood Leukemia Treatment","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Ontario Institute for Cancer Research; University of Toronto; University of Waterloo; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute","keywords":"Vincristine; Medicine; Chemotherapy; Cardiotoxicity; Methotrexate; Doxorubicin; Chemotherapy regimen; In vivo; Childhood leukemia; Oncology; Internal medicine; Acute lymphocytic leukemia; Leukemia; Cyclophosphamide; Biology; Lymphoblastic Leukemia","score_opus":0.13574354777783376,"score_gpt":0.43165048476670753,"score_spread":0.29590693698887377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884214860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592227,0.00063957507,0.00028148034,0.0016060262,0.00007260139,0.0011715117,0.000014790149,0.000026513399,0.00026521322],"genre_scores_gemma":[0.9940769,0.000469193,0.0009998268,0.0007204409,0.00036384928,0.0004480868,0.000006793365,0.000049808517,0.0028650824],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99656695,0.00033063604,0.00084587827,0.0006524238,0.00094595354,0.0006581811],"domain_scores_gemma":[0.9979786,0.00063508144,0.00007277391,0.00048929075,0.0004397778,0.00038447525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023333936,0.0001989376,0.0006055067,0.00033553079,0.00008096708,0.000024959092,0.00013520279,0.00025675414,0.00015650681],"category_scores_gemma":[0.0004523581,0.00015252961,0.00009820294,0.00041263594,0.00069113186,0.00006602943,0.0001517077,0.0004913802,0.000055534074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05496362,0.008241332,0.28335688,0.0018244218,0.0014167386,0.00015561724,0.015148297,0.00025113873,0.20277129,0.000118933305,0.012767416,0.41898432],"study_design_scores_gemma":[0.095910825,0.033516403,0.49735573,0.004883482,0.00018492009,0.00017290475,0.0017791464,0.06637411,0.27288172,0.0004395166,0.02508245,0.0014187776],"about_ca_topic_score_codex":0.0004442798,"about_ca_topic_score_gemma":0.0003706261,"teacher_disagreement_score":0.41756555,"about_ca_system_score_codex":0.0042687324,"about_ca_system_score_gemma":0.0045953696,"threshold_uncertainty_score":0.9995537},"labels":[],"label_agreement":null},{"id":"W2884876277","doi":"10.1158/1078-0432.ccr-18-0981","title":"Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Genentech; F. Hoffmann-La Roche","keywords":"PTEN; Prostate cancer; Medicine; Abiraterone; Blockade; Oncology; Cancer; Randomized controlled trial; Prostate; Internal medicine; Metastatic breast cancer; PI3K/AKT/mTOR pathway; Breast cancer; Androgen receptor; Biology; Receptor; Apoptosis","score_opus":0.18489000572405279,"score_gpt":0.5496204690412394,"score_spread":0.3647304633171866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884876277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718953,0.00055683334,0.000011007559,0.0013786016,0.00003439306,0.010658537,0.00006117197,0.000030918905,0.00007902663],"genre_scores_gemma":[0.99438936,0.00028604764,0.00036158346,0.00008744035,0.000082443854,0.0039503835,0.000088685185,0.000087914785,0.0006661367],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99310243,0.0016773992,0.0008753008,0.0011165784,0.0021953902,0.0010328938],"domain_scores_gemma":[0.9964599,0.0006186811,0.00024878976,0.0005413256,0.0017040261,0.0004272623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058900057,0.00040099464,0.0013954899,0.0005352701,0.00032615327,0.00009962976,0.00020651842,0.000088581444,0.00013291715],"category_scores_gemma":[0.00033460237,0.00020412244,0.00003795171,0.0015360877,0.0024032611,0.00031780792,0.00016356894,0.0011918878,0.000004917354],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4399385,0.004276763,0.54506594,0.00013315138,0.00042134264,0.000111852714,0.001872556,0.000018440638,0.000016050737,0.0000020157984,0.000018780249,0.008124634],"study_design_scores_gemma":[0.6841337,0.071520045,0.2397518,0.0016148064,0.00035138763,0.0000047612216,0.00089659577,0.0010454021,0.00033406535,0.000028993954,0.000025134961,0.00029329135],"about_ca_topic_score_codex":0.004413332,"about_ca_topic_score_gemma":0.013730198,"teacher_disagreement_score":0.30531412,"about_ca_system_score_codex":0.0004598112,"about_ca_system_score_gemma":0.0018417415,"threshold_uncertainty_score":0.88549155},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2884963065","doi":"10.1158/1078-0432.ccr-18-1187","title":"Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Queen's University; University of Toronto; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Prostate cancer; Medicine; Androgen deprivation therapy; Internal medicine; Oncology; Androstenediol; Testosterone (patch); Hormonal therapy; Cancer; Proportional hazards model; Biochemical recurrence; Androgen; Cohort; Dehydroepiandrosterone; Endocrinology; Prostatectomy; Hormone","score_opus":0.1535565012202698,"score_gpt":0.5071333865013424,"score_spread":0.3535768852810727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884963065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98584855,0.0027494617,0.0000017427988,0.0024794582,0.00048825933,0.008024566,0.00027301308,0.000017813509,0.0001171318],"genre_scores_gemma":[0.9896526,0.0069531007,0.00003500718,0.00019025538,0.00037269644,0.0022584933,0.000109115615,0.000038429294,0.00039030626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557674,0.000808403,0.0009500092,0.00071959326,0.0012222014,0.000723025],"domain_scores_gemma":[0.9961674,0.0010805619,0.00024910242,0.0006098784,0.0016623801,0.00023064719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003768663,0.00020060092,0.00067557,0.0005233934,0.00023411088,0.000050100254,0.00038268627,0.00018938225,0.00014220548],"category_scores_gemma":[0.0015478181,0.00012518419,0.0003783602,0.0027522815,0.000796593,0.000104812105,0.00020230567,0.00054977933,0.0000049127693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14269884,0.0008351464,0.67187697,0.000091295275,0.0013280838,0.0000014188563,0.00045205196,0.0000019145693,0.00010963618,0.0000029198402,0.00086126756,0.18174048],"study_design_scores_gemma":[0.08875803,0.021446247,0.880467,0.0006003422,0.00044926815,2.224532e-7,0.00019467784,0.00048426006,0.0038222119,0.00013323124,0.0034445084,0.00020000557],"about_ca_topic_score_codex":0.0006917309,"about_ca_topic_score_gemma":0.0019870012,"teacher_disagreement_score":0.20859003,"about_ca_system_score_codex":0.00054908486,"about_ca_system_score_gemma":0.0018219244,"threshold_uncertainty_score":0.5104863},"labels":[],"label_agreement":null},{"id":"W2885095998","doi":"10.1158/1557-3265.ovca17-b46","title":"Abstract B46: DICER1 and FOXL2 mutations correlate with clinicopathologic features of ovarian Sertoli-Leydig cell tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Mutation; Pathology; Sexual differentiation; Cancer research; Internal medicine; Medicine; Genetics; Gene","score_opus":0.15577223194139478,"score_gpt":0.49851166330251695,"score_spread":0.34273943136112217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885095998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97513396,0.0019207756,0.000013426953,0.004455925,0.00027251206,0.00086816686,0.00006622041,0.000038119793,0.017230883],"genre_scores_gemma":[0.9950967,0.0018973902,0.0006729649,0.00039545927,0.0005819034,0.00016865371,0.000020311478,0.00003805758,0.0011285524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972605,0.00022540912,0.0007032824,0.000673441,0.00062911835,0.0005082487],"domain_scores_gemma":[0.99670947,0.0013982432,0.00021067642,0.00055717316,0.0007011089,0.00042331842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017030671,0.00019557607,0.00061523437,0.00016090814,0.00021411122,0.000041495867,0.00016992929,0.00022097601,0.00071671145],"category_scores_gemma":[0.00042766155,0.00013223634,0.00013042535,0.00047694694,0.0016368447,0.00007994519,0.00011495438,0.00093752536,0.00007331173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047897645,0.00246694,0.89962137,0.00045091982,0.0003441662,0.0007540229,0.0007513861,0.0000073770716,0.000326911,0.0007532565,0.010051055,0.079682834],"study_design_scores_gemma":[0.0047550513,0.004562438,0.9853029,0.0005173245,0.00016596072,0.000039405888,0.00023795174,0.000030784955,0.0011263185,0.00038875616,0.002729306,0.0001438017],"about_ca_topic_score_codex":0.0011168625,"about_ca_topic_score_gemma":0.00065866165,"teacher_disagreement_score":0.085681535,"about_ca_system_score_codex":0.00010692409,"about_ca_system_score_gemma":0.00090085197,"threshold_uncertainty_score":0.7847488},"labels":[],"label_agreement":null},{"id":"W2885129203","doi":"10.1158/1557-3265.sarcomas17-b32","title":"Abstract B32: Lymphocytes and immune checkpoint biomarker expression in sarcomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tumor-infiltrating lymphocytes; Sarcoma; Immune checkpoint; Cancer research; Tumor microenvironment; CD8; Immune system; Pathology; FOXP3; Liposarcoma; Immunotherapy; Medicine; Biology; Immunology","score_opus":0.2638934910241973,"score_gpt":0.5311568172637428,"score_spread":0.26726332623954546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885129203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761417,0.016155649,8.95457e-7,0.003266321,0.00016644735,0.0004805539,0.0000067002175,0.000022977945,0.003758761],"genre_scores_gemma":[0.99365497,0.0051004197,0.00023067063,0.0001828848,0.0003884662,0.00018472943,0.0000069139614,0.000024495168,0.00022643301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997675,0.00019994141,0.000625687,0.00050789095,0.0005052973,0.00048616345],"domain_scores_gemma":[0.99784184,0.0011198941,0.00006155209,0.00045194992,0.00023052229,0.00029422063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024195977,0.00013607515,0.00040633528,0.00019030475,0.000116853684,0.000036140893,0.00012495003,0.00017542134,0.0011975202],"category_scores_gemma":[0.0008256597,0.00009631946,0.0001162082,0.00033490022,0.00075104024,0.000064728294,0.00022423698,0.00042125932,0.00016860763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001616554,0.0011987702,0.7703431,0.00007441996,0.0000581557,0.00024201935,0.00012551226,5.3770258e-8,0.015221754,0.000027967397,0.0023646457,0.20872705],"study_design_scores_gemma":[0.0045125447,0.00042885108,0.9491299,0.00060223375,0.000013048389,0.000010241884,0.0000952417,0.00004477148,0.036400676,0.0002864207,0.008383451,0.00009264497],"about_ca_topic_score_codex":0.0012443758,"about_ca_topic_score_gemma":0.00024492823,"teacher_disagreement_score":0.2086344,"about_ca_system_score_codex":0.0002505676,"about_ca_system_score_gemma":0.0003196973,"threshold_uncertainty_score":0.9997155},"labels":[],"label_agreement":null},{"id":"W2885351104","doi":"10.1158/1078-0432.ccr-18-0269","title":"Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Cancer Institute","keywords":"PI3K/AKT/mTOR pathway; Renal cell carcinoma; Chromosomal translocation; Cancer research; TFE3; Medicine; Targeted therapy; Pathology; Biology; Internal medicine; Cancer; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.24536082572216666,"score_gpt":0.4940059777601674,"score_spread":0.24864515203800075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885351104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98737377,0.005362722,0.00004821893,0.0015668076,0.0001962622,0.000804289,0.0000091753745,0.000018352848,0.004620394],"genre_scores_gemma":[0.9969173,0.0005877783,0.0003605365,0.00014327312,0.0008307177,0.00012842231,0.000015496118,0.00003986156,0.0009766268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962936,0.0006571126,0.0009626412,0.00057733536,0.00090744975,0.000601831],"domain_scores_gemma":[0.99744874,0.0008660601,0.0001209996,0.00054671767,0.0007429208,0.0002745866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003422788,0.0001687119,0.0005409633,0.0002750664,0.000087859546,0.000014195864,0.00024855716,0.00021607288,0.0008573262],"category_scores_gemma":[0.00035566208,0.00013439238,0.00019956652,0.000744898,0.00075450924,0.00006253998,0.00006873698,0.0008181712,0.00010908216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060986257,0.0018644002,0.72414565,0.0006042584,0.0001177089,0.00015575183,0.001925823,0.000008484079,0.16200073,0.000109335815,0.0037758858,0.09919336],"study_design_scores_gemma":[0.005357897,0.0051635816,0.66325444,0.00028450717,0.00006697939,0.000005583002,0.00036966364,0.00047661568,0.3205921,0.00027555221,0.003961263,0.00019180164],"about_ca_topic_score_codex":0.0015752517,"about_ca_topic_score_gemma":0.00038633938,"teacher_disagreement_score":0.15859139,"about_ca_system_score_codex":0.00040117977,"about_ca_system_score_gemma":0.0009483241,"threshold_uncertainty_score":0.93871206},"labels":[],"label_agreement":null},{"id":"W2885352041","doi":"10.1158/1557-3265.ovca17-a17","title":"Abstract A17: NUAK1 acts as a growth suppressor in epithelial ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Western University","funders":"","keywords":"AMPK; Cancer research; Cell biology; Cell growth; Biology; Viability assay; Kinase; Ovarian cancer; Protein kinase A; Chemistry; Cell; Cancer; Biochemistry","score_opus":0.11707324732153512,"score_gpt":0.48821201102926753,"score_spread":0.3711387637077324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885352041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803573,0.0043523214,0.000010434279,0.0024521817,0.0033045246,0.0005232509,0.00016687707,0.000017788661,0.008815334],"genre_scores_gemma":[0.96761495,0.011376423,0.00007635629,0.0009837594,0.01687706,0.0003215308,0.000030114348,0.000055779255,0.0026640077],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965389,0.00037068644,0.0006137295,0.00092149095,0.00059291127,0.00096232747],"domain_scores_gemma":[0.99800396,0.00016861038,0.00010548483,0.00065714086,0.00065275375,0.0004120281],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002418853,0.0002225062,0.00039535706,0.0001381232,0.00017012225,0.00007283921,0.0006790747,0.00047895144,0.0014799505],"category_scores_gemma":[0.0014707616,0.00020264812,0.00019755111,0.00039080315,0.00086524937,0.00001410203,0.00037309452,0.00085354404,0.00020237028],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060844123,0.00081305706,0.019177627,0.0001523217,0.00027005307,0.000034464174,0.00039993372,0.000011186667,0.77054507,0.00084010186,0.12699927,0.07467248],"study_design_scores_gemma":[0.0028712375,0.00052373356,0.11105979,0.00009294204,0.00001788026,0.000003766616,0.000057382284,0.00001199388,0.15191825,0.00070431706,0.7324119,0.00032678255],"about_ca_topic_score_codex":0.007028152,"about_ca_topic_score_gemma":0.008750223,"teacher_disagreement_score":0.61862683,"about_ca_system_score_codex":0.000080657686,"about_ca_system_score_gemma":0.0015571321,"threshold_uncertainty_score":0.99958414},"labels":[],"label_agreement":null},{"id":"W2885529712","doi":"10.1158/1557-3265.ovca17-pr13","title":"Abstract PR13: TERT is frequently mutated in adult-type granulosa cell tumors of the ovary compared to other malignant sex cord-stromal tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Telomerase; Biology; Telomerase reverse transcriptase; Carcinogenesis; Telomere; Somatic cell; Cancer research; Mutation; Granulosa cell; Molecular biology; Ovary; Cancer; Gene; Genetics","score_opus":0.1600306288318013,"score_gpt":0.46779032296318385,"score_spread":0.30775969413138254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885529712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935085,0.00018230334,0.0000023722614,0.0024468806,0.00038097054,0.0011825763,0.000093997616,0.00003763744,0.0021647206],"genre_scores_gemma":[0.99523157,0.00009613669,0.00014866302,0.0021888074,0.00047496223,0.00004841001,0.000009704574,0.000056186895,0.0017455383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954586,0.00044284193,0.0012347923,0.00075143104,0.001220182,0.0008921389],"domain_scores_gemma":[0.996846,0.0005591266,0.00018843167,0.0009817955,0.0009357374,0.00048888166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019476464,0.00025203734,0.0007570924,0.00025980422,0.00013693664,0.000027853308,0.0007125909,0.00018834638,0.001518448],"category_scores_gemma":[0.0007768919,0.00017246438,0.00020002063,0.001329841,0.001246114,0.00006585159,0.00023514932,0.0011662444,0.00023688718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005741688,0.0010274862,0.93183297,0.0003328386,0.000061193175,0.00023443346,0.0013632273,0.0000041330013,0.041029938,0.000022055689,0.013759202,0.0045908103],"study_design_scores_gemma":[0.0026855976,0.0015913754,0.9109143,0.0011943226,0.000022224453,0.000012985379,0.0006221183,0.00016341184,0.07941986,0.000065638684,0.0030738895,0.00023427472],"about_ca_topic_score_codex":0.010822586,"about_ca_topic_score_gemma":0.0020318087,"teacher_disagreement_score":0.038389925,"about_ca_system_score_codex":0.00018184751,"about_ca_system_score_gemma":0.0012876618,"threshold_uncertainty_score":0.9993943},"labels":[],"label_agreement":null},{"id":"W2885788384","doi":"10.1158/1078-0432.ccr-18-0554","title":"Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Institute of Cancer Research; Government of Canada; Ontario Institute for Cancer Research; Garron Family Cancer Centre","keywords":"Phenotype; FOXP3; Melanoma; Ovarian cancer; Biology; Cancer research; Transcription factor; Immunology; Cancer; Immune tolerance; Immune system; Gene; Genetics","score_opus":0.10270236954902545,"score_gpt":0.40393007527106684,"score_spread":0.3012277057220414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885788384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907824,0.0018207051,0.00000970749,0.0011501166,0.004814283,0.0004664897,0.00009616456,0.000036217636,0.0008239221],"genre_scores_gemma":[0.98731107,0.00074067235,0.0000044385038,0.00044901154,0.0003752742,0.000261838,0.00016699742,0.00003118385,0.010659493],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965071,0.0014589858,0.00063807116,0.00065223704,0.00012624105,0.0006173552],"domain_scores_gemma":[0.99832976,0.0007630759,0.00019771092,0.00043508213,0.00021695143,0.000057431564],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013276285,0.00018733954,0.00048839895,0.00021696098,0.00015669128,0.000034315075,0.00035422095,0.00053447124,0.012805575],"category_scores_gemma":[0.00021482453,0.00016615688,0.00009370989,0.00042783568,0.000603182,0.00017841296,0.00017203104,0.0016546997,0.0010823924],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060581877,0.00038536356,0.09434403,0.000014805082,0.0000986598,0.0000083707855,0.00019831577,2.1399212e-7,0.85150987,0.000010033393,0.036642857,0.010729298],"study_design_scores_gemma":[0.0032812408,0.000230317,0.4326565,0.00018017263,0.000008480479,5.02892e-7,0.00014915156,0.0000067457554,0.28530648,0.00003910262,0.27796116,0.0001801566],"about_ca_topic_score_codex":0.013118008,"about_ca_topic_score_gemma":0.0042597284,"teacher_disagreement_score":0.5662034,"about_ca_system_score_codex":0.00039914297,"about_ca_system_score_gemma":0.0002614498,"threshold_uncertainty_score":0.99969536},"labels":[],"label_agreement":null},{"id":"W2885806694","doi":"10.1158/1557-3265.ovca17-ia23","title":"Abstract IA23: How does the immune system contend with intratumoral heterogeneity in ovarian cancer?","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immune system; Biology; Ovarian cancer; Antibody; Antigen; Immunology; Cancer research; Cancer; Genetics","score_opus":0.1845318137194227,"score_gpt":0.4851670211719057,"score_spread":0.30063520745248296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885806694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679496,0.005389872,0.000009110897,0.023333758,0.00092306355,0.0011670818,0.00005101001,0.00004418491,0.0011322715],"genre_scores_gemma":[0.99531263,0.0013618035,0.00003486299,0.0004613469,0.0017690414,0.00039298402,0.000006243786,0.000040267463,0.00062081584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664336,0.00048748736,0.00065625156,0.00060461054,0.0008306978,0.0007776127],"domain_scores_gemma":[0.99766964,0.0005379496,0.00015827706,0.00080545427,0.0006015718,0.00022713158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004566342,0.00021431672,0.0005881046,0.0001300566,0.00028716147,0.00012708172,0.00046215896,0.00020796146,0.00042068516],"category_scores_gemma":[0.00019882838,0.0001044575,0.00018442245,0.0007451593,0.0021366256,0.000109578024,0.00011167134,0.001362596,0.000023189612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08228239,0.0009039847,0.69346255,0.0010963132,0.0015400883,0.00068994536,0.00092997187,0.0000026800112,0.04614947,0.0005769121,0.006885433,0.16548026],"study_design_scores_gemma":[0.0074751116,0.001665924,0.9457055,0.0015589901,0.00004928661,0.00003969418,0.0014187939,0.000100879806,0.02561692,0.00002174505,0.016105484,0.00024172626],"about_ca_topic_score_codex":0.01371496,"about_ca_topic_score_gemma":0.025737833,"teacher_disagreement_score":0.2522429,"about_ca_system_score_codex":0.0005990039,"about_ca_system_score_gemma":0.0011794069,"threshold_uncertainty_score":0.9928528},"labels":[],"label_agreement":null},{"id":"W2885953918","doi":"10.1158/1557-3265.sarcomas17-b06","title":"Abstract B06: Targeting PI3K/mTOR in mouse rhabdomyosarcoma models driven by FGFR4 activation","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Protein kinase B; Rhabdomyosarcoma; Biology; Oncogene; Cell culture; Cell; Cell cycle; Sarcoma; Signal transduction; Medicine; Cell biology; Pathology","score_opus":0.1384394694771033,"score_gpt":0.4746343058332434,"score_spread":0.3361948363561401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885953918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963433,0.00030021553,0.00027401285,0.0008784702,0.0001257551,0.0005258626,0.00006342537,0.000021094162,0.001467858],"genre_scores_gemma":[0.9961922,0.00047967327,0.00027726582,0.00014350563,0.0011247426,0.00015232504,0.00012344283,0.00006470515,0.0014421298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99604577,0.0005791853,0.0006671146,0.00089505763,0.00083119905,0.000981692],"domain_scores_gemma":[0.998005,0.00035657067,0.00007650795,0.000603949,0.00063592766,0.0003220739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029641923,0.00019950025,0.0002816455,0.00016689803,0.00020057778,0.000084538806,0.0007286656,0.00044647732,0.00033440508],"category_scores_gemma":[0.00164045,0.00019123637,0.00012679478,0.00040556522,0.0007901183,0.000032147193,0.00055127364,0.001144885,0.00011788842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000885631,0.00025287337,0.021223836,0.000046493235,0.000037753187,0.0000038434837,0.00005310309,0.000065242624,0.9276696,0.000031921478,0.04640581,0.0033239084],"study_design_scores_gemma":[0.0023900406,0.0015702983,0.02598267,0.00013352945,0.000003371746,0.0000010029771,0.00015951795,0.002381402,0.93361986,0.00045493912,0.03281083,0.0004925517],"about_ca_topic_score_codex":0.0007389685,"about_ca_topic_score_gemma":0.0003038412,"teacher_disagreement_score":0.0135949785,"about_ca_system_score_codex":0.00015511242,"about_ca_system_score_gemma":0.00050692365,"threshold_uncertainty_score":0.7798393},"labels":[],"label_agreement":null},{"id":"W2886002467","doi":"10.1158/1557-3265.ovca17-b22","title":"Abstract B22: Capturing L1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers as a way to track tumor development","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Ovarian cancer; Cancer research; Biology; Frameshift mutation; Cancer; Retrotransposon; DNA damage; Endometriosis; Gene; DNA; Genome; Mutation; Genetics; Medicine; Pathology; Transposable element","score_opus":0.12378981065637598,"score_gpt":0.46363467851319345,"score_spread":0.33984486785681745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886002467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994342,0.0002633894,0.000064957196,0.0018432261,0.0006403801,0.00091168756,0.00010770863,0.000035518482,0.0017910869],"genre_scores_gemma":[0.99633926,0.0002997926,0.0004295327,0.00041702174,0.00077125756,0.0008202389,0.00007358652,0.00005653662,0.00079277996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99624884,0.00038583868,0.00090810616,0.0009115304,0.00063275394,0.0009129072],"domain_scores_gemma":[0.99777126,0.00049370463,0.000113108326,0.0004857773,0.0006686238,0.0004675398],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026712571,0.00023090643,0.00035821158,0.0004104835,0.00030421434,0.00006947894,0.00053054316,0.00033193122,0.0011029198],"category_scores_gemma":[0.005685793,0.00023703004,0.00017219162,0.001301433,0.00034927475,0.000017273736,0.00010166757,0.001077757,0.00028549135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039634234,0.0013122723,0.033844057,0.00010491842,0.00081253453,0.00010974565,0.002208981,0.00016829242,0.91852653,0.000025794754,0.010540401,0.028383045],"study_design_scores_gemma":[0.0032409092,0.0014313915,0.32747978,0.00044222517,0.000026691907,0.0000084528665,0.0004850146,0.00002287266,0.5198223,0.000052650215,0.14633514,0.0006525557],"about_ca_topic_score_codex":0.0050117513,"about_ca_topic_score_gemma":0.029652983,"teacher_disagreement_score":0.39870423,"about_ca_system_score_codex":0.00079556316,"about_ca_system_score_gemma":0.0015264142,"threshold_uncertainty_score":0.9998102},"labels":[],"label_agreement":null},{"id":"W2886023759","doi":"10.1158/1557-3265.ovca17-b12","title":"Abstract B12: Differences in neoplastic transformation potential between OSE and FTE","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Ovarian cancer; Cancer research; Cell culture; Immortalised cell line; Serous fluid; Biology; In vivo; Transfection; Fallopian tube; Cancer; BRCA mutation; Neoplastic transformation; Mutation; Pathology; Medicine; Carcinogenesis; Genetics; Gene","score_opus":0.2956874030233323,"score_gpt":0.5332519298147181,"score_spread":0.23756452679138584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886023759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908979,0.00051834073,0.00003154125,0.006368244,0.0002025149,0.0004488745,0.000027941527,0.0000150264805,0.0014896068],"genre_scores_gemma":[0.9965527,0.0020042104,0.00004688608,0.00011087306,0.0010828351,0.00009183103,0.000010340421,0.0000117602285,0.000088546476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982545,0.00012531973,0.00046397955,0.00033759893,0.00045930635,0.00035932564],"domain_scores_gemma":[0.9987046,0.0006584566,0.000041228173,0.0001776131,0.0001648786,0.00025318598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011398365,0.00010096759,0.0003436325,0.0001431335,0.000100963036,0.000044455854,0.00008198738,0.00013667214,0.00066908787],"category_scores_gemma":[0.00019203189,0.00007502416,0.00006293707,0.00024516668,0.00046897662,0.00009356591,0.00003816916,0.0005121259,0.00008471013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056330085,0.00025972453,0.7849773,0.000096559765,0.00007339637,0.000038555037,0.00028072562,2.4803862e-7,0.00003743078,0.00007371956,0.00066248357,0.21293655],"study_design_scores_gemma":[0.0029171533,0.0011028172,0.9928127,0.0002741321,0.000044641234,0.0000020999285,0.000071691575,0.00008656357,0.00019965794,0.0004046366,0.0020116654,0.00007223173],"about_ca_topic_score_codex":0.0008599461,"about_ca_topic_score_gemma":0.00067863276,"teacher_disagreement_score":0.21286431,"about_ca_system_score_codex":0.00011577058,"about_ca_system_score_gemma":0.00029154497,"threshold_uncertainty_score":0.7326043},"labels":[],"label_agreement":null},{"id":"W2886034558","doi":"10.1158/1557-3265.ovca17-a12","title":"Abstract A12: The metabolic stress mediator LKB1 is required for ovarian cancer metastasis","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Metastasis; Ovarian cancer; Biology; Cytotoxic T cell; Cancer; Cancer cell; Cell culture; Cell growth; Paclitaxel; In vitro; Biochemistry; Genetics","score_opus":0.18856077519838738,"score_gpt":0.5073003857449753,"score_spread":0.3187396105465879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886034558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8703006,0.0961643,0.0003137242,0.014673105,0.010643995,0.002461655,0.003394615,0.00004892809,0.0019990723],"genre_scores_gemma":[0.8774816,0.06507391,0.0004602419,0.0033525587,0.04628925,0.0021912155,0.0001179366,0.00013032937,0.0049029854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962123,0.00038785252,0.00071707356,0.000972681,0.0007141794,0.0009959111],"domain_scores_gemma":[0.9967265,0.00038647954,0.00019000497,0.0011299757,0.0011647551,0.0004022874],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038411333,0.00026893508,0.0005090178,0.000088628134,0.00050864817,0.00011330415,0.0010275599,0.00037466656,0.0011476271],"category_scores_gemma":[0.001261094,0.00019056286,0.00044846808,0.00039878857,0.0012627185,0.000014855222,0.00036572746,0.00055753026,0.000056046116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024645124,0.00035637154,0.003499952,0.000121038815,0.0012579676,0.000001948508,0.00039527635,0.0000069510693,0.077738725,0.000663338,0.5493549,0.36413902],"study_design_scores_gemma":[0.0014905903,0.00023696224,0.012342321,0.000029603749,0.000115700524,9.345608e-7,0.00012956063,0.000020211739,0.11147893,0.0002722904,0.8736487,0.00023416847],"about_ca_topic_score_codex":0.0015653477,"about_ca_topic_score_gemma":0.0035158908,"teacher_disagreement_score":0.36390483,"about_ca_system_score_codex":0.00004049297,"about_ca_system_score_gemma":0.0013493316,"threshold_uncertainty_score":0.99976546},"labels":[],"label_agreement":null},{"id":"W2886216115","doi":"10.1158/1557-3265.sarcomas17-b10","title":"Abstract B10: Modulation of mRNA translation regulation in highly metastatic ssteosarcoma cells increases their sensitivity to redox stress","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Metastasis; Osteosarcoma; Cell culture; Cancer research; Tumor microenvironment; Oxidative stress; Nitrotyrosine; Cell; Medicine; Biology; Chemistry; Cancer; Internal medicine; Biochemistry; Nitric oxide","score_opus":0.1538964346618831,"score_gpt":0.45963426921157086,"score_spread":0.3057378345496877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886216115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969087,0.0002939431,0.0013145525,0.00038527735,0.00010731181,0.0004646851,0.00014095558,0.000006503259,0.0003780451],"genre_scores_gemma":[0.99838424,0.00030763663,0.0005848741,0.000047692494,0.00039440027,0.000066196764,0.000093066934,0.000018400353,0.00010350318],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99785924,0.0005490528,0.0005522889,0.0004434165,0.0003284034,0.00026762337],"domain_scores_gemma":[0.9985194,0.00024665886,0.00011778752,0.00046410682,0.0005346446,0.00011736342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023422677,0.00010997412,0.00021383446,0.00013771262,0.000082130275,0.000022733017,0.00015045232,0.00013255785,0.00006527717],"category_scores_gemma":[0.00025117723,0.0000999703,0.000087196924,0.0003797978,0.00027289824,0.000014708079,0.000058263162,0.0001879928,0.000011401559],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070369645,0.00028842245,0.009099854,0.000044704946,0.00003421239,0.0000013848767,0.00010631402,0.001321544,0.9091466,0.00005918579,0.0005305398,0.078663535],"study_design_scores_gemma":[0.00071061816,0.000438591,0.53748107,0.00009648988,0.000009024889,5.9897167e-7,0.00009431811,0.0026861057,0.45575035,0.00027833073,0.0023112057,0.00014329473],"about_ca_topic_score_codex":0.0015362864,"about_ca_topic_score_gemma":0.0030393326,"teacher_disagreement_score":0.5283812,"about_ca_system_score_codex":0.000049107613,"about_ca_system_score_gemma":0.00022102096,"threshold_uncertainty_score":0.40766704},"labels":[],"label_agreement":null},{"id":"W2886228434","doi":"10.1158/1078-0432.ccr-18-0717","title":"Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in <i>PIK3CA</i> -Mutant Lung Squamous Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"PI3K/AKT/mTOR pathway; In vivo; Cancer research; Medicine; Mutant; Lung cancer; Biology; Oncology; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.09080625717076041,"score_gpt":0.46307274969746887,"score_spread":0.37226649252670846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886228434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980966,0.0029880286,0.00028248093,0.0126877725,0.0005556707,0.0014956068,0.00003734817,0.000066081506,0.0009210225],"genre_scores_gemma":[0.9928765,0.00014561391,0.00033716555,0.002634074,0.0023849637,0.000551278,0.0000074866543,0.0000751474,0.000987733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99397856,0.0016973577,0.0010050832,0.0009262534,0.0012298526,0.0011629193],"domain_scores_gemma":[0.9945619,0.0031270918,0.00014919759,0.0008242658,0.00088539504,0.0004521242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009045387,0.00026679834,0.0005510381,0.00029189506,0.00039737817,0.000063338804,0.00036069247,0.00021978283,0.0005974892],"category_scores_gemma":[0.0031535472,0.00018983262,0.00015334546,0.0014330853,0.0011469955,0.00016037283,0.00036699596,0.0016118517,0.00026230243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052441876,0.0007824435,0.045749903,0.00028526882,0.000034069224,0.0005214685,0.0050234552,0.000073485855,0.84458375,0.00007107117,0.006939474,0.043493725],"study_design_scores_gemma":[0.010687978,0.007134661,0.104433626,0.00085648976,0.00004795302,0.000051861025,0.0048558516,0.0008342374,0.7343206,0.000901828,0.13509443,0.0007804747],"about_ca_topic_score_codex":0.0008138866,"about_ca_topic_score_gemma":0.000713124,"teacher_disagreement_score":0.12815496,"about_ca_system_score_codex":0.00077980297,"about_ca_system_score_gemma":0.0013067562,"threshold_uncertainty_score":0.7741149},"labels":[],"label_agreement":null},{"id":"W2886242456","doi":"10.1158/1557-3265.ovca17-pr06","title":"Abstract PR06: ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC)","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; BRCA mutation; Internal medicine; PARP inhibitor; Clinical endpoint; Oncology; Placebo; Population; Cancer; Ovarian cancer; Clinical trial; Pathology; Biology; Genetics; Poly ADP ribose polymerase","score_opus":0.3540392569924878,"score_gpt":0.5998549478083863,"score_spread":0.24581569081589855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886242456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96874326,0.0004981131,0.000895557,0.011992643,0.0015293965,0.015671028,0.00016025451,0.000080997015,0.00042876066],"genre_scores_gemma":[0.98306185,0.00015656573,0.0010041194,0.0016865972,0.002274299,0.010761644,0.000026029762,0.00012658698,0.00090230873],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99230933,0.0014115708,0.0021734906,0.0012362576,0.0018290923,0.0010402374],"domain_scores_gemma":[0.98743695,0.00840083,0.00047274664,0.0011798827,0.0017223845,0.0007871784],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.020835971,0.0004142078,0.001937849,0.00061480934,0.00037167288,0.00008719212,0.0005458688,0.00036607307,0.0017341604],"category_scores_gemma":[0.0032337576,0.00034756772,0.0007252524,0.0011920739,0.0008818436,0.00010256909,0.000096669035,0.0012178635,0.00003731296],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9480087,0.0049426146,0.0013806435,0.00015803638,0.0008773056,0.000022307267,0.0021017245,0.000030578816,0.006112043,0.000027017255,0.009048767,0.027290253],"study_design_scores_gemma":[0.9318844,0.017241942,0.001763801,0.0011590844,0.00023960747,0.000001435955,0.00045950012,0.00056345423,0.024265433,0.00015010183,0.021885106,0.00038615047],"about_ca_topic_score_codex":0.0014648727,"about_ca_topic_score_gemma":0.0011662274,"teacher_disagreement_score":0.026904102,"about_ca_system_score_codex":0.00073283154,"about_ca_system_score_gemma":0.0038036176,"threshold_uncertainty_score":0.99989766},"labels":[],"label_agreement":null},{"id":"W2886291380","doi":"10.1158/1557-3265.hemmal17-39","title":"Abstract 39: XPO1 inhibitor, KPT-8602, is well tolerated and highly active against AML blasts and LICs","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Oncology; Pharmacology; Chemotherapy; Leukemia; Cancer research; Adverse effect","score_opus":0.08652697351121018,"score_gpt":0.4459001832331325,"score_spread":0.3593732097219223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886291380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124634,0.0006072924,0.0000020151206,0.0014627619,0.0003741164,0.00018293582,0.000038140228,0.000007691965,0.006078717],"genre_scores_gemma":[0.9923407,0.0045324867,0.000041620962,0.0005235797,0.0011818227,0.00001333745,0.000020288771,0.000023972601,0.0013222077],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859744,0.00008882101,0.00024056544,0.0005389657,0.00022239727,0.0003118111],"domain_scores_gemma":[0.9988825,0.00006517016,0.00009967599,0.00048851,0.00024539654,0.00021875958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056483265,0.0001292051,0.00018662176,0.00003423316,0.00041852472,0.00016903953,0.00020668774,0.00034330398,0.00008798175],"category_scores_gemma":[0.0003368187,0.00011170341,0.00005765879,0.000041086376,0.0006191505,0.000012098671,0.00035768084,0.0005456748,0.000026851803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036632752,0.00021940526,0.058907975,0.00014939513,0.00032830026,0.00004480817,0.00022165912,0.0000034218194,0.40537688,0.0000868902,0.11243798,0.41856],"study_design_scores_gemma":[0.0018909367,0.0008241162,0.4994896,0.00006707497,0.000017810868,0.00000380369,0.00009367652,0.00006785232,0.08063758,0.00021818983,0.41641295,0.00027639105],"about_ca_topic_score_codex":0.00021626058,"about_ca_topic_score_gemma":0.00024017433,"teacher_disagreement_score":0.44058162,"about_ca_system_score_codex":0.000018932447,"about_ca_system_score_gemma":0.0001316474,"threshold_uncertainty_score":0.4555133},"labels":[],"label_agreement":null},{"id":"W2886737665","doi":"10.1158/1557-3265.hemmal17-pr07","title":"Abstract PR07: MicroRNA-130a regulates hematopoietic stem cell self-renewal and erythroid differentiation","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cell biology; Hematopoietic stem cell; microRNA; Cancer research; Bone marrow; Myeloid; Immunology; Genetics; Gene","score_opus":0.07848085978517919,"score_gpt":0.4226937424081225,"score_spread":0.34421288262294336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886737665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949764,0.0031489474,0.000015785248,0.00063530233,0.00023540128,0.00037489185,0.00002853728,0.000018550987,0.00056617724],"genre_scores_gemma":[0.99609166,0.002094108,0.0001035747,0.000033835182,0.00066016044,0.00005596887,0.00004602918,0.000035297853,0.00087937777],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99796647,0.00019734378,0.0004344905,0.0006477598,0.00034122975,0.0004126883],"domain_scores_gemma":[0.9982141,0.000096435026,0.00023388478,0.00094833656,0.00027903626,0.00022817128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010928507,0.00016492489,0.0002264707,0.00004998717,0.00047873447,0.00022560176,0.0004532408,0.00031041447,0.000071397946],"category_scores_gemma":[0.0001347935,0.00015292024,0.00012590051,0.00004432202,0.00044143395,0.000014174822,0.00045792534,0.00030538352,0.000029428687],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036860845,0.000346425,0.06467571,0.0003365175,0.00012549838,0.000008455677,0.000084323816,0.0000051557713,0.9190898,0.00004916052,0.006165239,0.008745139],"study_design_scores_gemma":[0.0015957906,0.00022913916,0.5162461,0.00010222668,0.000042692223,0.0000049665878,0.000052690855,0.00007217389,0.4735631,0.0005482488,0.007237147,0.0003057418],"about_ca_topic_score_codex":0.00008595828,"about_ca_topic_score_gemma":0.000102803264,"teacher_disagreement_score":0.4515704,"about_ca_system_score_codex":0.000048112448,"about_ca_system_score_gemma":0.00023996475,"threshold_uncertainty_score":0.62359065},"labels":[],"label_agreement":null},{"id":"W2886785709","doi":"10.1158/1557-3265.ovca17-ia19","title":"Abstract IA19: Granulosa cell and other rare ovarian cancers: Genomic-derived diagnostics and emergent management strategies","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Pathognomonic; Cancer; Medicine; Cancer research; Granulosa cell; Ovary; Oncology; Internal medicine; Biology; Disease","score_opus":0.1702701235940406,"score_gpt":0.4768807712659098,"score_spread":0.3066106476718692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886785709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658067,0.00966136,0.000021179287,0.004905078,0.0005279493,0.0013527315,0.0001279399,0.000043947704,0.017553065],"genre_scores_gemma":[0.9511825,0.045364555,0.00050687406,0.0008832828,0.0012030174,0.00034079602,0.000010756634,0.00005139595,0.00045686544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973566,0.00014285096,0.0005559097,0.0007997529,0.0005201165,0.00062480307],"domain_scores_gemma":[0.9980973,0.00048206563,0.00009684852,0.00051710935,0.00026208104,0.00054461503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000991062,0.00024153026,0.00046582997,0.00013683675,0.0002724482,0.00013905147,0.0001525496,0.0001669975,0.0019904252],"category_scores_gemma":[0.000078306,0.00019571291,0.00009549821,0.00022797067,0.00091332453,0.00008567105,0.00023768278,0.0004948568,0.000077694334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047206236,0.0025342072,0.6392221,0.0023858736,0.0022308365,0.001186972,0.0024014798,0.0000125574625,0.001546624,0.004595212,0.100012034,0.2391515],"study_design_scores_gemma":[0.0059228647,0.00133684,0.85795295,0.00044793574,0.00024099322,0.000006544496,0.0013811014,0.00004533741,0.0008549081,0.00092852156,0.13060212,0.00027989558],"about_ca_topic_score_codex":0.002689187,"about_ca_topic_score_gemma":0.0013857414,"teacher_disagreement_score":0.23887159,"about_ca_system_score_codex":0.00029838382,"about_ca_system_score_gemma":0.00048576028,"threshold_uncertainty_score":0.9989219},"labels":[],"label_agreement":null},{"id":"W2887007511","doi":"10.1158/1557-3265.ovca17-b39","title":"Abstract B39: The origins of endometriosis-associated cancers","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Clear cell; Histogenesis; Biology; Ovarian cancer; Clear cell carcinoma; Pathology; Cell of origin; Context (archaeology); Ovary; Cancer research; Endometriosis; Carcinoma; Cancer; Immunohistochemistry; Endocrinology; Medicine; Genetics; Immunology","score_opus":0.3315301287534566,"score_gpt":0.5830435419013121,"score_spread":0.2515134131478555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887007511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774178,0.002894063,0.000003322065,0.0049223187,0.00036065988,0.0011826385,0.00007781081,0.000035263074,0.013106123],"genre_scores_gemma":[0.98744524,0.0099537335,0.000048359565,0.0002942422,0.0008514582,0.00024448286,0.0000111225045,0.000030221896,0.0011211173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99537677,0.00054741,0.0007592466,0.00045920972,0.0019701344,0.0008872251],"domain_scores_gemma":[0.9803623,0.016201125,0.00016300194,0.0007963591,0.0019347245,0.0005425126],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006688827,0.00015467523,0.0005935869,0.00047667703,0.00029321303,0.000035744495,0.00046940916,0.00017984668,0.0026320145],"category_scores_gemma":[0.0358818,0.000089274494,0.0003340991,0.003021651,0.0020332537,0.000062425795,0.00019606212,0.0012927235,0.00028643658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066975337,0.003638244,0.57743657,0.00031256228,0.0032715346,0.00020199348,0.00043945815,0.0000033846964,0.004915926,0.0016614762,0.08175645,0.3196649],"study_design_scores_gemma":[0.009294584,0.0060008997,0.6777725,0.00045245752,0.000118835116,0.00000508765,0.00027626992,0.000058453672,0.019774755,0.00030048983,0.2857642,0.00018143612],"about_ca_topic_score_codex":0.009847307,"about_ca_topic_score_gemma":0.0023421012,"teacher_disagreement_score":0.31948346,"about_ca_system_score_codex":0.0017537212,"about_ca_system_score_gemma":0.002374299,"threshold_uncertainty_score":0.9982797},"labels":[],"label_agreement":null},{"id":"W2887168129","doi":"10.1158/1557-3265.ovca17-a63","title":"Abstract A63: Estrogen receptor signaling in fallopian tube epithelia of BRCA mutation carriers","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Estrogen receptor; Serous carcinoma; Biology; Cancer research; Carcinogenesis; Fallopian tube; Ovarian cancer; Estrogen; Serous fluid; BRCA mutation; Tissue microarray; Laser capture microdissection; Cancer; Pathology; Medicine; Breast cancer; Gene expression; Genetics; Gene","score_opus":0.20567328374580335,"score_gpt":0.5237894266931445,"score_spread":0.3181161429473412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887168129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919532,0.0009560119,0.0000048971965,0.003335788,0.000343821,0.0006221705,0.00005125765,0.000016648319,0.0027162312],"genre_scores_gemma":[0.9972849,0.000816859,0.00044700655,0.00018407416,0.00086454506,0.00015439477,0.000020557829,0.000028379704,0.00019928788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974705,0.00020784626,0.0007397562,0.00047034124,0.0006596471,0.00045193065],"domain_scores_gemma":[0.9979588,0.00069721136,0.00010940468,0.0003751512,0.0005592079,0.00030023776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022529536,0.00012507025,0.00044033435,0.00019102925,0.00007551989,0.00001924929,0.00015647615,0.00017868204,0.0022017814],"category_scores_gemma":[0.00074157986,0.00010464594,0.00015797053,0.0005182611,0.0005611028,0.00006608896,0.000055329903,0.000555783,0.00012113022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019889064,0.00090630626,0.8739312,0.00023420452,0.00030105803,0.00012675257,0.0008220394,0.00002121286,0.004854185,0.00057787413,0.0046092686,0.11162696],"study_design_scores_gemma":[0.009451234,0.0042574396,0.88786995,0.0017077076,0.00011466974,0.000005632166,0.00084071065,0.00013861779,0.06660668,0.0006618474,0.028051056,0.00029444904],"about_ca_topic_score_codex":0.0035556755,"about_ca_topic_score_gemma":0.0008326901,"teacher_disagreement_score":0.111332506,"about_ca_system_score_codex":0.00039979338,"about_ca_system_score_gemma":0.0010230406,"threshold_uncertainty_score":0.99871033},"labels":[],"label_agreement":null},{"id":"W2887314135","doi":"10.1158/1557-3265.ovca17-a45","title":"Abstract A45: Treatment patterns and outcomes among platinum-refractory/resistant ovarian cancer patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fallopian tube; Ovarian cancer; Refractory (planetary science); Internal medicine; Fallopian tube cancer; Medical record; Cancer; Proportional hazards model; Stage (stratigraphy); Gynecology","score_opus":0.1824123986265077,"score_gpt":0.5047659988453095,"score_spread":0.3223536002188018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887314135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919746,0.0005486033,0.0000015385324,0.0032416666,0.0006761885,0.001185983,0.00034412698,0.000047665573,0.001979622],"genre_scores_gemma":[0.99227005,0.0039160526,0.000056699548,0.0004350326,0.0012209195,0.00075550604,0.000041189716,0.00006102726,0.0012434919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641037,0.00019019989,0.000791156,0.00092733157,0.0009000093,0.0007809285],"domain_scores_gemma":[0.9969716,0.0008957474,0.00017417595,0.0006406693,0.00059718697,0.00072060956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079396303,0.00032403663,0.00076759595,0.00016588248,0.00031859695,0.00009750702,0.00016497295,0.0002489807,0.0035124586],"category_scores_gemma":[0.00028190683,0.00021993555,0.00022545597,0.0002443539,0.0007046909,0.00012728843,0.00013779209,0.00054472237,0.00010434046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000869026,0.0018046636,0.8979766,0.00006847975,0.00052680157,0.00006489213,0.00022713226,2.2156586e-7,0.000015410407,0.000029556655,0.0026619118,0.09575533],"study_design_scores_gemma":[0.0077637737,0.0036827314,0.9686177,0.00038458093,0.00015939957,5.3885077e-7,0.00006564613,0.000012754199,0.00029604428,0.00005128291,0.01876213,0.00020342327],"about_ca_topic_score_codex":0.023285013,"about_ca_topic_score_gemma":0.014109185,"teacher_disagreement_score":0.09555191,"about_ca_system_score_codex":0.00094628206,"about_ca_system_score_gemma":0.0006229676,"threshold_uncertainty_score":0.9973985},"labels":[],"label_agreement":null},{"id":"W2887473711","doi":"10.1158/1557-3265.ovca17-ia27","title":"Abstract IA27: Functional genetic architecture of serous ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Kinome; Cancer; Serous fluid; Serous ovarian cancer; Biology; Proteomics; RNA interference; Cancer research; Gene; Bioinformatics; Genetics; RNA","score_opus":0.2532353941073682,"score_gpt":0.531655943034265,"score_spread":0.2784205489268968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887473711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98322546,0.0017584692,0.00021066825,0.006013471,0.0005270945,0.0008054931,0.00004940479,0.000040620667,0.007369318],"genre_scores_gemma":[0.9889662,0.0013124852,0.0008076794,0.00055183267,0.0032643606,0.0001739836,0.0000132454325,0.00006132749,0.0048488425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950964,0.00039035475,0.0008268181,0.000740098,0.0021102915,0.0008360746],"domain_scores_gemma":[0.99546826,0.0010484678,0.00011245252,0.0008259247,0.0018839708,0.000660946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023816861,0.00018262267,0.00051560596,0.00025523422,0.00018742621,0.000030823845,0.00040309323,0.00031350713,0.019172048],"category_scores_gemma":[0.001458944,0.00014572682,0.0002590431,0.0009377988,0.0018267165,0.00003480196,0.00033579985,0.0019527852,0.00047903505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008780973,0.0012035241,0.21601489,0.00075531116,0.00046755286,0.00028178186,0.00022796041,0.000081274135,0.08733586,0.00011563206,0.06442597,0.6203093],"study_design_scores_gemma":[0.0025598137,0.0013803021,0.9119328,0.00028661755,0.00003801144,0.000021306756,0.000046306486,0.00016760506,0.011972863,0.0004712742,0.07095908,0.00016401177],"about_ca_topic_score_codex":0.0021701832,"about_ca_topic_score_gemma":0.00090227503,"teacher_disagreement_score":0.6959179,"about_ca_system_score_codex":0.00022913534,"about_ca_system_score_gemma":0.0019605586,"threshold_uncertainty_score":0.98172456},"labels":[],"label_agreement":null},{"id":"W2887662642","doi":"10.1158/1557-3265.hemmal17-ia06","title":"Abstract IA06: Intratumor heterogeneity and its role in therapeutic escape in multiple myeloma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD38; Unfolded protein response; Biology; Plasma cell; Cancer research; Bortezomib; XBP1; Multiple myeloma; Bone marrow; Stem cell; Endoplasmic reticulum; Immunology; CD34; Cell biology","score_opus":0.2986004711141817,"score_gpt":0.5336421423536849,"score_spread":0.2350416712395032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887662642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912429,0.004226852,5.822255e-7,0.0021076389,0.00009553816,0.0010942786,0.000024677542,0.000016565877,0.001190959],"genre_scores_gemma":[0.99752694,0.0015487772,0.000027034963,0.00008479697,0.00023683364,0.00028961568,0.000007929307,0.000031077805,0.00024701166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966994,0.00036681557,0.00057772634,0.0006921792,0.0007438395,0.00092003384],"domain_scores_gemma":[0.99736124,0.0010119226,0.00008822507,0.0007649468,0.00021218004,0.0005614673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003035971,0.00018210085,0.00053104263,0.00026903528,0.0002797815,0.00013491057,0.0004063482,0.00022310723,0.00019497503],"category_scores_gemma":[0.002858333,0.00014527443,0.00010132688,0.00019499176,0.00050532277,0.00019482018,0.00033855604,0.0015396493,0.00012207893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022595786,0.00067572825,0.88248706,0.00009143187,0.00006139165,0.00049099524,0.000051849576,0.0000018499092,0.0025697497,0.000036395417,0.000039391627,0.111234576],"study_design_scores_gemma":[0.007539456,0.00038549298,0.98698455,0.0002473361,0.000007104283,0.000007708515,0.000068800065,0.0020208806,0.0019855544,0.00033406264,0.00029870844,0.00012033539],"about_ca_topic_score_codex":0.0029330284,"about_ca_topic_score_gemma":0.013309191,"teacher_disagreement_score":0.11111424,"about_ca_system_score_codex":0.00028155636,"about_ca_system_score_gemma":0.00055434793,"threshold_uncertainty_score":0.74268407},"labels":[],"label_agreement":null},{"id":"W2887696598","doi":"10.1158/1557-3265.sarcomas17-ia23","title":"Abstract IA23: Variation in the immune cell infiltrate and expression of PD-L1 in sarcoma subtypes","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Immunohistochemistry; Sarcoma; Pathology; Leiomyosarcoma; Immune system; Immune checkpoint; Undifferentiated Pleomorphic Sarcoma; Cancer research; Tumor microenvironment; Medicine; Soft tissue sarcoma; Liposarcoma; Immunotherapy; Biology; Immunology","score_opus":0.1783881133905404,"score_gpt":0.4959678738169798,"score_spread":0.31757976042643943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887696598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212766,0.0034933297,7.0313365e-7,0.0018882409,0.000062293184,0.00044633503,0.0000050125204,0.0000039422384,0.0019724942],"genre_scores_gemma":[0.99724317,0.0022666254,0.00006900488,0.00010483384,0.00017084372,0.000093879,0.000004034695,0.000008668098,0.000038939004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982809,0.00034656352,0.0004966117,0.0002443383,0.00039380105,0.00023778493],"domain_scores_gemma":[0.9977792,0.0016229157,0.000074196556,0.0003125984,0.00014723989,0.00006384196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003027066,0.00007390676,0.00025781358,0.00013086168,0.00004593663,0.000016181317,0.00012452026,0.00010865989,0.0002409273],"category_scores_gemma":[0.00043699838,0.000044903612,0.00004939901,0.00032890573,0.00029328954,0.000050866234,0.000065849476,0.00046114868,0.000019969919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010883358,0.001417449,0.9683795,0.00008646171,0.000010869072,0.000050682964,0.00083033775,8.6217426e-7,0.013888688,0.00008096688,0.00045782144,0.013708013],"study_design_scores_gemma":[0.0022548968,0.0005253292,0.97740585,0.00027350805,0.000008601743,0.0000015140763,0.00018013803,0.000027925898,0.018314186,0.0003678922,0.00060024974,0.000039882092],"about_ca_topic_score_codex":0.0024857873,"about_ca_topic_score_gemma":0.00061704736,"teacher_disagreement_score":0.013668131,"about_ca_system_score_codex":0.000056648063,"about_ca_system_score_gemma":0.00016595966,"threshold_uncertainty_score":0.37577832},"labels":[],"label_agreement":null},{"id":"W2887701123","doi":"10.1158/1557-3265.ovca17-pr03","title":"Abstract PR03: Arginine deprivation as a potential targeted therapy for clear cell ovarian carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer research; Biology; Clear cell; Arginine; Proteome; Ovarian cancer; Cancer; Transcriptome; ARID1A; Clear cell carcinoma; Targeted therapy; Carcinoma; Bioinformatics; Biochemistry; Gene expression; Gene; Genetics; Mutation; Amino acid","score_opus":0.11223018719703866,"score_gpt":0.4853299066377258,"score_spread":0.37309971944068715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887701123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412584,0.0016381112,0.00018391735,0.0009895285,0.00029154422,0.0010851827,0.00012661284,0.000015403393,0.0015438776],"genre_scores_gemma":[0.9927354,0.0016506702,0.00029640994,0.00028909475,0.0027864175,0.00043463107,0.00025639462,0.000048361915,0.0015026155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752414,0.00019860396,0.00037420134,0.0007063072,0.00049057155,0.00070617476],"domain_scores_gemma":[0.9981946,0.00010346566,0.00008026599,0.00053876394,0.0007655617,0.00031738632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013426463,0.00015869101,0.00020223019,0.00008807118,0.00030194642,0.00007843118,0.00039622348,0.00025402894,0.0006306283],"category_scores_gemma":[0.000406839,0.0001379726,0.00019887816,0.00021262032,0.00045137623,0.000009331052,0.00016909902,0.00034638762,0.00013581433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039584383,0.0020110197,0.05997931,0.000115703326,0.0005398376,0.00005668627,0.00013756866,0.000013511373,0.6490701,0.00013275622,0.098262705,0.15009643],"study_design_scores_gemma":[0.011680172,0.011749283,0.24069878,0.000026960757,0.000018567242,0.000004626203,0.00008026623,0.00016226525,0.47901857,0.000981467,0.25519094,0.00038809708],"about_ca_topic_score_codex":0.0017986514,"about_ca_topic_score_gemma":0.00045828102,"teacher_disagreement_score":0.18071947,"about_ca_system_score_codex":0.00006791829,"about_ca_system_score_gemma":0.0008824146,"threshold_uncertainty_score":0.6904938},"labels":[],"label_agreement":null},{"id":"W2887768917","doi":"10.1158/1557-3265.sarcomas17-b39","title":"Abstract B39: Investigation of the effects of alterations in the glutamate receptor, GRIK2, on osteosarcoma tumorigenesis","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Health PEI; University of Toronto","funders":"","keywords":"Osteosarcoma; Cancer research; Biology; Carcinogenesis; Tumor suppressor gene; Cancer; Genetics","score_opus":0.07634274441964216,"score_gpt":0.43592124257357495,"score_spread":0.3595784981539328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887768917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789566,0.00035375776,0.0000041480066,0.00080010615,0.00023603415,0.0004803013,0.000019624495,0.000001913304,0.00020845125],"genre_scores_gemma":[0.9991079,0.0001687137,0.000028444781,0.00014121878,0.00039546742,0.00007563752,0.000018243487,0.000009703547,0.000054656553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813354,0.0007403171,0.00038387495,0.00022541195,0.00034966724,0.00016718099],"domain_scores_gemma":[0.9985883,0.0004413423,0.00012891596,0.00051348616,0.00028273184,0.000045176275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016445213,0.00006914702,0.0001129534,0.000044516062,0.00008863553,0.000011962384,0.00037877358,0.00010802836,0.000033676217],"category_scores_gemma":[0.0013131539,0.000042882657,0.00009067442,0.00029130845,0.0006760534,0.0000039750103,0.0000956927,0.00018917065,0.000008449999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025483605,0.00011743968,0.03929909,0.00012168527,0.000022450491,4.2766467e-7,0.00014003449,0.0000137765755,0.9531898,0.00015146357,0.0037130036,0.002975973],"study_design_scores_gemma":[0.0002761882,0.0003126872,0.45592025,0.00010846648,0.0000048291035,1.8674855e-7,0.00001928384,0.000011817581,0.54225373,0.00023846718,0.0008198137,0.000034271405],"about_ca_topic_score_codex":0.00015534583,"about_ca_topic_score_gemma":0.00024190183,"teacher_disagreement_score":0.41662118,"about_ca_system_score_codex":0.000025785746,"about_ca_system_score_gemma":0.00026501785,"threshold_uncertainty_score":0.24909468},"labels":[],"label_agreement":null},{"id":"W2887944091","doi":"10.1158/1078-0432.ccr-18-1244","title":"A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Phases of clinical research; Clear cell carcinoma; Phase (matter); Oncology; Ovarian cancer; Internal medicine; Clinical trial; Carcinoma; Gynecology; Cancer; Chemistry","score_opus":0.14065275832213786,"score_gpt":0.5115108080783575,"score_spread":0.3708580497562196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887944091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971685,0.0005011633,0.000028790977,0.00028493186,0.0003711758,0.0012584357,0.00004868389,0.0000042870406,0.000334049],"genre_scores_gemma":[0.99876916,0.00024089233,0.00010600483,0.00011943173,0.00044314377,0.00008912469,0.0000070858796,0.000028719836,0.0001964329],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954529,0.0014796462,0.0013339558,0.0007374905,0.0005723534,0.00042368314],"domain_scores_gemma":[0.99796796,0.00016319298,0.0002822424,0.00091293093,0.00048309576,0.00019056167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004619926,0.00017741603,0.0005674143,0.0000711233,0.00018755524,0.000014942718,0.00060625275,0.00031890444,0.00007459669],"category_scores_gemma":[0.00093185453,0.00013515692,0.00020992002,0.00034129908,0.0015495758,0.0000058670407,0.0010298282,0.00066091405,0.0000010214774],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33686697,0.07259041,0.16807239,0.00045329478,0.0005986655,0.000077129735,0.002552045,0.000049059498,0.3388075,0.0001365211,0.0061069443,0.07368909],"study_design_scores_gemma":[0.51223254,0.20506522,0.016847137,0.00025323735,0.0002357964,0.0000067700225,0.0016423998,0.0022313176,0.24577309,0.00034869785,0.014599859,0.0007639209],"about_ca_topic_score_codex":0.00086365134,"about_ca_topic_score_gemma":0.00066173734,"teacher_disagreement_score":0.17536558,"about_ca_system_score_codex":0.000024488605,"about_ca_system_score_gemma":0.00087279687,"threshold_uncertainty_score":0.57094765},"labels":[],"label_agreement":null},{"id":"W2887969083","doi":"10.1158/1557-3265.ovca17-a01","title":"Abstract A01: Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Cancer research; DNA repair; DNA damage; Ovarian cancer; Homologous recombination; Cancer; Cancer cell; Biology; Genome instability; DNA; Medicine; Genetics","score_opus":0.25897635765149857,"score_gpt":0.5231007719225399,"score_spread":0.26412441427104133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887969083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330443,0.00025702745,0.00018652719,0.0021872863,0.0007009713,0.0009877326,0.000029316392,0.00005258782,0.002294135],"genre_scores_gemma":[0.9967635,0.0014491857,0.00012124553,0.00013309799,0.0010123529,0.0001633795,0.000022737962,0.000055711545,0.0002787828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99610746,0.00040023285,0.0009669188,0.0005397002,0.0015064271,0.0004792833],"domain_scores_gemma":[0.9962839,0.00084515195,0.00046507872,0.0006332284,0.0014917481,0.00028091384],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030320608,0.00020631684,0.00059168413,0.00031550834,0.00016133918,0.000023380475,0.00022306436,0.0002168843,0.0010554147],"category_scores_gemma":[0.00035944098,0.00016361591,0.00018468747,0.0007501305,0.0012750522,0.00018884166,0.00006246624,0.0008405569,0.000038350634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0246887,0.006018648,0.3417281,0.0012393467,0.0010704692,0.00010209816,0.0023588801,0.000015311667,0.3755227,0.003044238,0.011084051,0.23312744],"study_design_scores_gemma":[0.010119275,0.005607402,0.30231225,0.0013661654,0.000053446307,0.000012106708,0.00038034553,0.00015930178,0.67068666,0.0018309607,0.0071989996,0.00027309888],"about_ca_topic_score_codex":0.0006991866,"about_ca_topic_score_gemma":0.00023847194,"teacher_disagreement_score":0.29516393,"about_ca_system_score_codex":0.00037312208,"about_ca_system_score_gemma":0.0008100377,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W2888359685","doi":"10.1158/1078-0432.ccr-18-0110","title":"Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Temozolomide; Internal medicine; Rash; Adverse effect; Discontinuation; Phases of clinical research; Radiation therapy; Surgery; Oncology; Clinical trial","score_opus":0.16392363722883577,"score_gpt":0.5337312416333149,"score_spread":0.36980760440447913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888359685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969502,0.000085378975,0.000019378585,0.00045980167,0.00017804977,0.0019764306,0.000027861164,0.000022863725,0.000280036],"genre_scores_gemma":[0.9987128,0.000056017907,0.000051745217,0.000181284,0.0004539617,0.00042122614,0.000014925737,0.00003231725,0.000075727476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967347,0.00036673647,0.00070383603,0.0005127844,0.00127253,0.00040940693],"domain_scores_gemma":[0.997255,0.00046292547,0.00019755549,0.00048492066,0.0013441124,0.00025547793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013768878,0.00014998611,0.00052817335,0.00026733818,0.00011012502,0.000012938042,0.00017479454,0.00010151443,0.00044371097],"category_scores_gemma":[0.00035377583,0.000107268905,0.000039948154,0.0011187928,0.0008148972,0.000106559004,0.00007894264,0.00069900847,0.000016997794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037111185,0.023417499,0.87236756,0.000059508522,0.00013752388,0.000028238903,0.0017606213,0.000010483199,0.00006368912,0.000014484014,0.0029227019,0.062106535],"study_design_scores_gemma":[0.17742948,0.21033816,0.6058908,0.0006125494,0.000048750484,8.228952e-7,0.0005550313,0.00015267004,0.0020131425,0.000017425216,0.0027505767,0.00019056942],"about_ca_topic_score_codex":0.0004322942,"about_ca_topic_score_gemma":0.0015936585,"teacher_disagreement_score":0.26647672,"about_ca_system_score_codex":0.00030323735,"about_ca_system_score_gemma":0.00076202943,"threshold_uncertainty_score":0.4858324},"labels":[],"label_agreement":null},{"id":"W2890008571","doi":"10.1158/1557-3265.aacriaslc18-a02","title":"Abstract A02: Oncogenic drivers of lung cancer induce production of CCL5 and recruitment of regulatory T-cells","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Immune system; Cancer research; Biology; Carcinogenesis; Chemokine; Lung cancer; Tumor microenvironment; Adenocarcinoma; KRAS; Cytokine; Immunology; Oncogene; Cancer; Medicine; Pathology; Cell cycle","score_opus":0.23750262096241123,"score_gpt":0.5197486930926917,"score_spread":0.2822460721302804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890008571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484205,0.0036884898,0.0000069512093,0.00031788505,0.00035086749,0.00043829362,0.000037703445,0.00000205571,0.00031567205],"genre_scores_gemma":[0.98887444,0.009754334,0.00009110357,0.000018844312,0.00043829897,0.000102035294,0.0000055787814,0.000012879826,0.00070250646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850154,0.00013401326,0.00048815607,0.00037837843,0.00031078956,0.00018709477],"domain_scores_gemma":[0.9983787,0.00004625283,0.00022690944,0.0004700236,0.0007945918,0.00008352584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013482912,0.00007921385,0.00021357596,0.00006332216,0.000053172596,0.0000039932083,0.00019209785,0.00016527301,0.000096824115],"category_scores_gemma":[0.00015408314,0.00007169613,0.00008293472,0.00018438033,0.0010659569,0.0000058156656,0.00011167287,0.00017924984,9.766851e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032858158,0.00015708942,0.014609265,0.0001397695,0.000119349614,1.7541714e-7,0.00008258555,0.000014854545,0.94937134,0.0000496373,0.006719947,0.028407384],"study_design_scores_gemma":[0.0004749703,0.0004309312,0.08010816,0.0001129084,0.00002549365,3.046363e-7,0.00008868661,0.000013640824,0.90599924,0.000028436441,0.012639059,0.00007814916],"about_ca_topic_score_codex":0.00039956206,"about_ca_topic_score_gemma":0.00015005805,"teacher_disagreement_score":0.065498896,"about_ca_system_score_codex":0.000047306377,"about_ca_system_score_gemma":0.0005876255,"threshold_uncertainty_score":0.39275625},"labels":[],"label_agreement":null},{"id":"W2890307745","doi":"10.1158/1557-3265.aacriaslc18-b21","title":"Abstract B21: Investigating targeted driver mutations and PD-L1 expression for improved therapy of non-small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"KRAS; Lung cancer; Medicine; ROS1; Targeted therapy; Immunotherapy; Cancer research; Immunohistochemistry; Oncology; Cancer; Adenocarcinoma; Internal medicine; Pathology; Colorectal cancer","score_opus":0.15439677921671938,"score_gpt":0.5357251731605476,"score_spread":0.3813283939438282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890307745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920668,0.0030263967,0.00018706809,0.001539574,0.0002702972,0.0018720856,0.00015717301,0.000023440867,0.0008571766],"genre_scores_gemma":[0.990139,0.0021757567,0.004645854,0.00035083364,0.0007438566,0.0009044382,0.000052323292,0.000041131923,0.0009467954],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982656,0.00008212004,0.00053547823,0.00045325965,0.00027012383,0.00039338655],"domain_scores_gemma":[0.9973507,0.000847538,0.000173234,0.00029102596,0.0010304645,0.0003070617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075976073,0.00014188969,0.00035290944,0.00011786276,0.00029108534,0.000028188675,0.00012066229,0.00015842346,0.00035941598],"category_scores_gemma":[0.0003455944,0.00010618151,0.000115732946,0.0002715537,0.0006608447,0.00009037056,0.0000626273,0.00038039678,0.0000033682127],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018854204,0.00094859954,0.28028983,0.0008515051,0.0005470881,0.0000060296034,0.004248607,0.0000172377,0.5940271,0.00003501375,0.017551081,0.09959249],"study_design_scores_gemma":[0.016255775,0.0026227825,0.7029414,0.0012378359,0.0002466189,0.000001178611,0.0007477226,0.0056509264,0.25788155,0.00061878125,0.011459359,0.0003360208],"about_ca_topic_score_codex":0.0015374108,"about_ca_topic_score_gemma":0.00028435737,"teacher_disagreement_score":0.42265162,"about_ca_system_score_codex":0.00013975342,"about_ca_system_score_gemma":0.0012508793,"threshold_uncertainty_score":0.43299565},"labels":[],"label_agreement":null},{"id":"W2890545119","doi":"10.1158/1078-0432.ccr-18-1106","title":"Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Bladder cancer; Chemotherapy; Cancer; Medicine; Neoadjuvant therapy; Oncology; Pathology; Cancer research; Internal medicine; Breast cancer","score_opus":0.30430948962792254,"score_gpt":0.5521982739499504,"score_spread":0.24788878432202782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890545119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96840334,0.0014436721,0.000012963501,0.026499497,0.00074918446,0.0014729003,0.00008202499,0.000055362758,0.0012810768],"genre_scores_gemma":[0.9803913,0.0057469043,0.00018708035,0.0075994018,0.002095491,0.0008594096,0.0000065704526,0.00005241686,0.003061385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99554485,0.00089161587,0.00070106477,0.0009971414,0.00085459487,0.0010107113],"domain_scores_gemma":[0.9967116,0.0010989642,0.00006221744,0.0006623028,0.0006871628,0.00077774836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002904909,0.00025722955,0.00065243384,0.00030632765,0.00017884579,0.000033581906,0.00037039316,0.00031693844,0.00668538],"category_scores_gemma":[0.0015345801,0.00018603055,0.00021249111,0.0010456366,0.0008056359,0.000057369874,0.0002656454,0.0008812585,0.00069323333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0660243,0.0027217548,0.5934778,0.00005869542,0.00046201068,0.0004797654,0.0021634004,0.000005186928,0.021542156,0.000045942936,0.06577838,0.24724059],"study_design_scores_gemma":[0.008393999,0.006010667,0.8514041,0.00032474866,0.00002884523,0.0000042032716,0.00022367801,0.000016170745,0.007100114,0.00020659265,0.12604104,0.0002458565],"about_ca_topic_score_codex":0.0033027444,"about_ca_topic_score_gemma":0.0023194123,"teacher_disagreement_score":0.2579263,"about_ca_system_score_codex":0.000700324,"about_ca_system_score_gemma":0.0017401626,"threshold_uncertainty_score":0.99422264},"labels":[],"label_agreement":null},{"id":"W2891851777","doi":"10.1158/1557-3265.aacriaslc18-b36","title":"Abstract B36: Novel miRNAs as tissue-of-origin markers for distinguishing malignant pleural mesothelioma from lung adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"BAP1; microRNA; Biology; Gene; Mesothelioma; Cancer research; Computational biology; Pathology; Genetics; Medicine","score_opus":0.38594165304862765,"score_gpt":0.587748639821873,"score_spread":0.20180698677324532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891851777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815252,0.004352966,0.00038689148,0.0072230794,0.0012824038,0.0007995152,0.00019861602,0.000053961183,0.004177385],"genre_scores_gemma":[0.9897456,0.00030088666,0.0029031897,0.0007560503,0.0036886176,0.00014238738,0.00003845527,0.000048338232,0.0023764442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965328,0.00020536887,0.0009054397,0.00072651333,0.0008492244,0.00078065344],"domain_scores_gemma":[0.9932305,0.0046737595,0.0001847186,0.0005524756,0.0008851339,0.00047340174],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043378067,0.00020188221,0.0007479217,0.00014947807,0.00028084038,0.000032034954,0.00037919584,0.0002462701,0.0008648718],"category_scores_gemma":[0.012306979,0.00015368851,0.00020956816,0.0003101242,0.002251768,0.00005396707,0.00021829651,0.0009603658,0.000084329964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053794784,0.00056378235,0.8240513,0.000646075,0.00066649885,0.00039628547,0.0012233062,3.1845542e-7,0.015930614,0.00027023887,0.10705979,0.043812264],"study_design_scores_gemma":[0.0061582974,0.0021980111,0.9184172,0.0018093241,0.00027439703,0.000036795416,0.0008004641,0.0006219145,0.0072123455,0.00095184904,0.06117268,0.00034668154],"about_ca_topic_score_codex":0.002841295,"about_ca_topic_score_gemma":0.00016167456,"teacher_disagreement_score":0.094365895,"about_ca_system_score_codex":0.00010692981,"about_ca_system_score_gemma":0.0005606918,"threshold_uncertainty_score":0.9960128},"labels":[],"label_agreement":null},{"id":"W2892162567","doi":"10.1158/1557-3265.aacriaslc18-a26","title":"Abstract A26: Identification of a novel therapeutic target in lung adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Toronto Western Hospital","funders":"","keywords":"Gene knockdown; Cancer research; Biology; Adenocarcinoma; Transcription factor; Lung cancer; Cancer; Internal medicine; Medicine; Gene; Genetics","score_opus":0.20470871919288708,"score_gpt":0.518514897499439,"score_spread":0.31380617830655194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892162567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935295,0.0037330412,0.0009766608,0.0004966605,0.0001941189,0.00026627755,0.000033420794,0.0000038824037,0.0007664381],"genre_scores_gemma":[0.9977394,0.0007704722,0.00011876474,0.00008953976,0.0005481,0.000118724885,0.000021663196,0.000016140553,0.0005772022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984,0.00011865476,0.00054605264,0.00039984507,0.00026873135,0.00026676065],"domain_scores_gemma":[0.9987802,0.000066285356,0.00011012924,0.00051519217,0.0004563414,0.0000718631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002063093,0.00007510285,0.00014194637,0.000085082596,0.00006715225,0.00002019232,0.00035027065,0.00016450787,0.00017663071],"category_scores_gemma":[0.00023231053,0.00006913287,0.00007712088,0.0002885687,0.0005046705,0.00000568565,0.00008716499,0.00025065,0.000016971242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039206698,0.00045009155,0.15065712,0.000053690248,0.000051731655,7.5654486e-7,0.00007918811,0.000025164238,0.8348924,0.00035597707,0.0028960574,0.01014575],"study_design_scores_gemma":[0.0009491686,0.0002563244,0.86941946,0.000034311546,0.0000065037725,6.580827e-7,0.00008841863,0.0007164855,0.11905885,0.0002196801,0.009128876,0.0001212549],"about_ca_topic_score_codex":0.00022650544,"about_ca_topic_score_gemma":0.0001817507,"teacher_disagreement_score":0.71876234,"about_ca_system_score_codex":0.000040181527,"about_ca_system_score_gemma":0.00035066952,"threshold_uncertainty_score":0.28191563},"labels":[],"label_agreement":null},{"id":"W2894741998","doi":"10.1158/1078-0432.ccr-18-0729","title":"Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Prostate cancer; Neuroendocrine differentiation; Rest (music); Prostate; Medicine; Cancer; Castration; Cancer research; Oncology; Biology; Internal medicine; Hormone","score_opus":0.08203419535733544,"score_gpt":0.4303867489776065,"score_spread":0.34835255362027107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894741998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454486,0.000779123,0.00000104635,0.0020528026,0.00015588113,0.0022127787,0.00014536563,0.0000076127176,0.00010051025],"genre_scores_gemma":[0.9952074,0.0038346471,0.000016935968,0.000017658022,0.0002211389,0.00044929903,0.000068879264,0.000023149974,0.0001608571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969834,0.0004952677,0.0010021576,0.00034541826,0.00078449585,0.00038923288],"domain_scores_gemma":[0.9977077,0.00023698801,0.00036037294,0.00041204604,0.0011686069,0.00011424496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006471344,0.00012885388,0.00044391895,0.00025457988,0.00008981849,0.00001242626,0.00019482123,0.00006204847,0.00018257079],"category_scores_gemma":[0.00022891114,0.00008164128,0.000100525634,0.0007288967,0.00094827317,0.000089749556,0.00011942983,0.0003754821,0.0000031531233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063032415,0.0004936002,0.13449432,0.00023627668,0.000081089376,0.00000747523,0.0008108412,0.000002102737,0.84455776,0.000076456265,0.000023785884,0.012913023],"study_design_scores_gemma":[0.0016763164,0.0016360262,0.4605122,0.0003028262,0.000024672021,6.793496e-7,0.00012819191,0.00010020751,0.534788,0.00008560723,0.00069819175,0.00004710092],"about_ca_topic_score_codex":0.0020008753,"about_ca_topic_score_gemma":0.0011635982,"teacher_disagreement_score":0.32601786,"about_ca_system_score_codex":0.00014569325,"about_ca_system_score_gemma":0.0008471199,"threshold_uncertainty_score":0.3493952},"labels":[],"label_agreement":null},{"id":"W2895037322","doi":"10.1158/1557-3265.aacriaslc18-a07","title":"Abstract A07: Alterations in G2/M phase associated transcriptional networks highlight lung cancer predisposition in COPD patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"COPD; Lung cancer; Medicine; Cancer; Internal medicine; Adenocarcinoma; Lung; Oncology; Pulmonary function testing; Pathology","score_opus":0.14603581078943673,"score_gpt":0.5227637700563039,"score_spread":0.3767279592668672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895037322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903556,0.0015999292,0.000035198813,0.0047211824,0.00082602573,0.001178007,0.00016887173,0.000031035077,0.0010841185],"genre_scores_gemma":[0.99429876,0.0019869085,0.00002189469,0.0007473759,0.0013017376,0.001044571,0.0002539694,0.000033178567,0.000311626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650466,0.00038104883,0.0009652061,0.0005946362,0.0008666267,0.00068782317],"domain_scores_gemma":[0.9981608,0.00034907382,0.00010889167,0.00025685763,0.00084017083,0.00028421485],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019542456,0.0001692496,0.0004485718,0.0002693114,0.0001698729,0.00005664439,0.0001818157,0.00032234023,0.0026948827],"category_scores_gemma":[0.0003074596,0.00015285265,0.00014354792,0.0009908625,0.000397212,0.00020382213,0.000044990356,0.0012436092,0.000020368996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037701963,0.0049723526,0.9384832,0.00009876367,0.00013003916,0.000020463574,0.0004019424,0.00015739205,0.0007192912,0.000119622164,0.032036614,0.019090125],"study_design_scores_gemma":[0.01013226,0.0009793804,0.97287124,0.0009910861,0.00004228692,2.2849058e-7,0.000025797832,0.011187732,0.00024214249,0.000032774624,0.0033341662,0.00016093136],"about_ca_topic_score_codex":0.0022002475,"about_ca_topic_score_gemma":0.007874581,"teacher_disagreement_score":0.034388017,"about_ca_system_score_codex":0.001036067,"about_ca_system_score_gemma":0.00067641103,"threshold_uncertainty_score":0.9982168},"labels":[],"label_agreement":null},{"id":"W2895906214","doi":"10.1158/1078-0432.ccr-18-2820","title":"Thyroid Nodule DNA Methylation Signatures: An Important Diagnostic Annotation","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Faculty of Medicine, McGill University","keywords":"DNA methylation; Thyroid cancer; Thyroid nodules; Thyroid; Methylation; Biology; Computational biology; DNA; Somatic cell; Cancer research; Pathology; Medicine; Genetics; Gene; Gene expression","score_opus":0.19653227359316308,"score_gpt":0.5191612934268579,"score_spread":0.32262901983369485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895906214","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1689013,0.023142759,0.000026336134,0.7977867,0.00318872,0.0043717828,0.00069328677,0.00025475209,0.0016343538],"genre_scores_gemma":[0.22095416,0.053434372,0.0006447456,0.6046792,0.09961579,0.0052523934,0.007486087,0.0006171875,0.007316005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919316,0.0013051162,0.0015444494,0.0016765918,0.0023408525,0.0012013752],"domain_scores_gemma":[0.9904291,0.0054244613,0.00046145322,0.0015157182,0.0016439484,0.0005253324],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0038560976,0.00051381375,0.0011729305,0.00045599855,0.00031328277,0.00015481368,0.00048668223,0.0018212303,0.0017734161],"category_scores_gemma":[0.0039311913,0.0004068161,0.0004917264,0.0007102325,0.00077190145,0.0001938413,0.00016948002,0.005441964,0.00040005776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042289885,0.0005749572,0.010377988,0.00027577698,0.0003966785,0.0010029038,0.000115274386,0.0000024830417,0.0001317963,0.00002133969,0.97175086,0.014927036],"study_design_scores_gemma":[0.003350218,0.0062836087,0.056064025,0.00086373225,0.0005470608,0.000011484336,0.000043989603,0.000086987515,0.0010040461,0.0010901255,0.9301328,0.0005219146],"about_ca_topic_score_codex":0.0008562149,"about_ca_topic_score_gemma":0.0004574846,"teacher_disagreement_score":0.19310746,"about_ca_system_score_codex":0.0009362452,"about_ca_system_score_gemma":0.0017586558,"threshold_uncertainty_score":0.99983835},"labels":[],"label_agreement":null},{"id":"W2896250667","doi":"10.1158/1078-0432.ccr-18-0320","title":"Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal; Sanofi (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Taxane; Medicine; Androgen receptor; Circulating tumor cell; Oncology; Cancer; Internal medicine; Prostate; Cabazitaxel; Androgen deprivation therapy; Metastatic breast cancer; Cancer research; Metastasis; Breast cancer","score_opus":0.1444049626610932,"score_gpt":0.4881122768051551,"score_spread":0.3437073141440619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896250667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390197,0.0019127644,0.0000019502202,0.001543248,0.00002964351,0.0021707902,0.00003458361,0.000013847256,0.00039119364],"genre_scores_gemma":[0.9944171,0.002992283,0.0002490621,0.000111764784,0.000045506767,0.0009876034,0.000010793596,0.00004730514,0.0011385821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964635,0.00052358006,0.0007406963,0.0006931537,0.0008023867,0.0007767078],"domain_scores_gemma":[0.9979135,0.00089380954,0.0001396027,0.00034634388,0.0004074861,0.00029926433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018454161,0.00024205318,0.00088268105,0.0006360591,0.000064623535,0.000029922121,0.00016336076,0.00008594396,0.00022645072],"category_scores_gemma":[0.00023585155,0.00013820978,0.000042614363,0.0015284503,0.00079300307,0.00012267425,0.00011229993,0.00076987373,0.0000053029244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013898567,0.00056051865,0.95397145,0.0001691763,0.000083369436,0.00039763728,0.0018134811,0.00009712459,0.014216876,0.000004036388,0.00012905744,0.014658681],"study_design_scores_gemma":[0.021496117,0.0065428154,0.8922902,0.0034897611,0.00002484309,0.0000064156634,0.0017207229,0.0006708511,0.073214754,0.0000732802,0.00020274655,0.00026753746],"about_ca_topic_score_codex":0.013834913,"about_ca_topic_score_gemma":0.010850053,"teacher_disagreement_score":0.061681323,"about_ca_system_score_codex":0.0003397608,"about_ca_system_score_gemma":0.00073556905,"threshold_uncertainty_score":0.99273205},"labels":[],"label_agreement":null},{"id":"W2896608282","doi":"10.1158/1078-0432.ccr-18-0704","title":"Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Terry Fox Foundation; Camargo Foundation; Agence Nationale de la Recherche","keywords":"Taxane; Translation (biology); Prostate cancer; Prostate; Cancer; Biology; Internal medicine; Cancer research; Medicine; Genetics; Messenger RNA; Breast cancer; Gene","score_opus":0.2187812640927564,"score_gpt":0.4967308246524777,"score_spread":0.2779495605597213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896608282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945714,0.0021330365,0.000076843746,0.0017154502,0.00012485475,0.00079187227,0.00024918508,0.0000079715965,0.00032939235],"genre_scores_gemma":[0.9979032,0.00054164283,0.000078827834,0.00020216689,0.00050384126,0.00032203633,0.00017820856,0.000023919309,0.00024613622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975094,0.0006657016,0.0005874179,0.0004298134,0.00048692396,0.00032070823],"domain_scores_gemma":[0.99858093,0.00019190021,0.0001682813,0.00041268268,0.0005509736,0.000095200674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022065004,0.00011302553,0.00017197998,0.00005695553,0.0001291135,0.00002508177,0.00028815054,0.00016193946,0.00025184965],"category_scores_gemma":[0.00052895484,0.00009018931,0.00008201592,0.00037149165,0.00076259207,0.00000974502,0.000075190685,0.00027548475,0.000007215584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025556316,0.00021128583,0.027350303,0.0000692929,0.000036848855,0.0000010305744,0.00025152208,0.00010685146,0.9280775,0.000025542075,0.012229359,0.029084839],"study_design_scores_gemma":[0.0044750785,0.0017528038,0.20667592,0.00029247106,0.000042631425,9.212317e-7,0.0002477366,0.002520243,0.738467,0.000872129,0.044254243,0.00039888045],"about_ca_topic_score_codex":0.00066500745,"about_ca_topic_score_gemma":0.0015382846,"teacher_disagreement_score":0.18961054,"about_ca_system_score_codex":0.000059611557,"about_ca_system_score_gemma":0.00046249814,"threshold_uncertainty_score":0.36778134},"labels":[],"label_agreement":null},{"id":"W2896952615","doi":"10.1158/1078-0432.ccr-18-1854","title":"Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Occupational Cancer Research Centre; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Posaconazole; Ketoconazole; Glioma; Azole; Cancer research; Biology; Pharmacology; In vivo; In vitro; Biochemistry; Itraconazole; Genetics","score_opus":0.07158397649095095,"score_gpt":0.4482799889607672,"score_spread":0.37669601246981627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896952615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875182,0.007061871,0.0003110002,0.00046987445,0.0014298101,0.0004576043,0.000068965805,0.00002223021,0.0026604333],"genre_scores_gemma":[0.9822712,0.0021964768,0.0004142603,0.00039345765,0.010038282,0.00013774254,0.0000111819045,0.00004819276,0.004489226],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974286,0.00038398054,0.00037951613,0.0007606143,0.00037226925,0.00067503983],"domain_scores_gemma":[0.99843085,0.00012688036,0.000080448364,0.0004131016,0.0006041173,0.00034462824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001591552,0.00017698837,0.00028979548,0.00008390522,0.00031700413,0.00008402335,0.00032769435,0.00029249387,0.00036409934],"category_scores_gemma":[0.0003352828,0.00016559144,0.000114145325,0.00024123934,0.0010850921,0.00001107985,0.00040607367,0.00050245377,0.00005383594],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013614276,0.00015232037,0.0045901807,0.00003667078,0.0001022901,0.000001917893,0.00010032647,0.000004763432,0.85268945,0.00009754695,0.1120214,0.028841691],"study_design_scores_gemma":[0.0010976437,0.0007706042,0.0066524195,0.00002707,0.000011662606,0.000004829563,0.00004016431,0.00007259614,0.3655464,0.000260339,0.6253232,0.00019307915],"about_ca_topic_score_codex":0.00014983294,"about_ca_topic_score_gemma":0.0003598178,"teacher_disagreement_score":0.5133018,"about_ca_system_score_codex":0.000030528347,"about_ca_system_score_gemma":0.0005617199,"threshold_uncertainty_score":0.6752623},"labels":[],"label_agreement":null},{"id":"W2897073503","doi":"10.1158/1078-0432.ccr-18-1640","title":"Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14–mutant Non–small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"KRAS; Cancer research; Lung cancer; Crizotinib; Medicine; Targeted therapy; Exon; Mutation; Cancer; Biology; Oncology; Internal medicine; Colorectal cancer; Gene; Genetics","score_opus":0.14412588355530465,"score_gpt":0.5362777339219142,"score_spread":0.3921518503666096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897073503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883282,0.0024701266,0.000058683094,0.004237653,0.00037177085,0.0016611991,0.000075592405,0.000022546259,0.0027742302],"genre_scores_gemma":[0.9900613,0.003609316,0.00078900624,0.0006393205,0.00073170435,0.0008305097,0.00002291902,0.00004048173,0.0032754827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727494,0.00026018565,0.0006936356,0.0005565837,0.0006901918,0.00052446],"domain_scores_gemma":[0.9972807,0.00070570316,0.00013667814,0.00046074638,0.0011170858,0.0002990822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001473824,0.00016336465,0.00049377367,0.0003039525,0.00010914699,0.000019816585,0.00022075207,0.00017103471,0.00081663165],"category_scores_gemma":[0.00055140874,0.00012582235,0.00010526691,0.0011296228,0.0002935575,0.00008638478,0.000072872,0.0005105789,0.00002333783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009783451,0.0020118996,0.79023844,0.0005772836,0.00057148095,0.000046671714,0.0065794303,0.000045916662,0.11463139,0.00013380636,0.027067514,0.048312724],"study_design_scores_gemma":[0.010862186,0.0033142616,0.536241,0.0014292758,0.00012148857,4.6843246e-7,0.00067394477,0.0002532746,0.4152236,0.00034921285,0.031190729,0.000340566],"about_ca_topic_score_codex":0.0034884196,"about_ca_topic_score_gemma":0.00492706,"teacher_disagreement_score":0.3005922,"about_ca_system_score_codex":0.000601604,"about_ca_system_score_gemma":0.0016689801,"threshold_uncertainty_score":0.89415437},"labels":[],"label_agreement":null},{"id":"W2897369942","doi":"10.1158/1078-0432.ccr-18-2014","title":"A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"AbbVie","keywords":"Veliparib; Carboplatin; Medicine; Etoposide; Internal medicine; Tolerability; Oncology; Pharmacokinetics; Chemotherapy; Pharmacology; Adverse effect; Surgery; Cisplatin","score_opus":0.12093273205170117,"score_gpt":0.5074382325365686,"score_spread":0.3865055004848674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897369942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949991,0.00077095896,0.0000042031593,0.00039571256,0.000046053603,0.0033555909,0.00004892122,0.000017398255,0.00036203623],"genre_scores_gemma":[0.99851286,0.00021084277,0.00008135827,0.00013853246,0.00015406693,0.0004355146,0.0000046794908,0.00005155732,0.00041060237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965677,0.0004035649,0.00063846924,0.0007225983,0.0010594663,0.00060817297],"domain_scores_gemma":[0.9971013,0.0006285072,0.00017721932,0.00042937114,0.0013362318,0.00032738587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015210904,0.00022496148,0.0007819926,0.00027739326,0.00016019709,0.00003331428,0.00013691791,0.00009813926,0.00007630039],"category_scores_gemma":[0.00039900123,0.00015097651,0.000028157696,0.0006655385,0.0012978069,0.000084734056,0.00025427405,0.0008364676,0.000001200919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02353952,0.0028395515,0.9665294,0.0004083154,0.00021628178,0.000039212373,0.0028191134,0.000009755403,0.00017435144,0.0000052141127,0.00023049585,0.003188761],"study_design_scores_gemma":[0.04678887,0.029869737,0.91928273,0.00079933397,0.00010808019,6.1260056e-7,0.0013281689,0.00094971014,0.0005812052,0.0000069802068,0.00010469617,0.0001798986],"about_ca_topic_score_codex":0.0079716705,"about_ca_topic_score_gemma":0.015852226,"teacher_disagreement_score":0.04724672,"about_ca_system_score_codex":0.00024148668,"about_ca_system_score_gemma":0.00068736664,"threshold_uncertainty_score":0.99863434},"labels":[],"label_agreement":null},{"id":"W2897588250","doi":"10.1158/1557-3265.tcm17-b43","title":"Abstract B43: Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Cancer; Cancer research; Biology; Cancer cell; Transfection; Druggability; Gene knockdown; Cell culture; Epithelial–mesenchymal transition; Metastasis; Genetics; Gene","score_opus":0.23979882175580491,"score_gpt":0.5339322935763673,"score_spread":0.2941334718205624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897588250","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24837022,0.00044308018,0.7444744,0.003257686,0.0017323057,0.0014762641,0.000059041562,0.000030013158,0.0001569662],"genre_scores_gemma":[0.98389596,0.00019651765,0.014734508,0.00006008206,0.00088098476,0.00020560816,0.000006076772,0.000011711584,0.00000858139],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99739414,0.0007293292,0.00062851177,0.00034234408,0.000617652,0.00028804553],"domain_scores_gemma":[0.99419814,0.003816928,0.00024524762,0.00023520662,0.0014533033,0.00005118583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067253374,0.0000884916,0.00022725755,0.000119069795,0.0001249809,0.00005852258,0.0006258336,0.000102810925,0.000114871604],"category_scores_gemma":[0.00029609865,0.00006807459,0.00009573731,0.0012318518,0.00031017853,0.00023963979,0.000077929544,0.0002968534,7.6750354e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008043267,0.0001982902,0.009563052,0.000023681694,0.000025885878,1.1853712e-7,0.00004867926,0.9412459,0.00011784621,0.0028128775,0.0005805132,0.044578787],"study_design_scores_gemma":[0.001536504,0.0003662117,0.10659361,0.000061458515,0.0000031606282,1.8849312e-7,0.0000067840856,0.87828463,0.0026706713,0.010158356,0.00024424258,0.00007416822],"about_ca_topic_score_codex":0.00077837094,"about_ca_topic_score_gemma":0.000084253654,"teacher_disagreement_score":0.7355257,"about_ca_system_score_codex":0.00011991482,"about_ca_system_score_gemma":0.0014915693,"threshold_uncertainty_score":0.2776001},"labels":[],"label_agreement":null},{"id":"W2898267235","doi":"10.1158/1078-0432.ccr-18-1775","title":"Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; St. Jude Children's Research Hospital","keywords":"Medicine; Breast cancer; Cancer; Childhood cancer; Cohort; Demography; Cohort study; Oncology; Gerontology; Internal medicine","score_opus":0.06764580768560206,"score_gpt":0.47175850113078166,"score_spread":0.4041126934451796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898267235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028385,0.0036695823,0.000021831267,0.0009792057,0.0009340943,0.0025077749,0.001526931,0.000009240374,0.000067521716],"genre_scores_gemma":[0.98698515,0.007253143,0.00004639552,0.00019124936,0.002139342,0.002919685,0.00002160752,0.00006697836,0.0003764804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551415,0.0010531683,0.0009803177,0.000988359,0.0006893081,0.0007746815],"domain_scores_gemma":[0.99694395,0.00043168428,0.00030391858,0.0010752797,0.0010578972,0.00018728903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005522108,0.00024410318,0.0004919527,0.0001256314,0.00031415356,0.000039256443,0.0010290968,0.00026874035,0.00028163832],"category_scores_gemma":[0.0007198562,0.00018753267,0.00022141078,0.0006239184,0.0011588795,0.000009482674,0.00044336866,0.00060604257,0.000009211105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008351228,0.0005646559,0.96798545,0.000026287576,0.00031634222,0.0000015297474,0.00030400668,0.00008355028,0.001211682,0.000003090848,0.0039544706,0.024713838],"study_design_scores_gemma":[0.0019507791,0.0010221326,0.98391795,0.00006972581,0.00007770693,0.0000024062347,0.0003765131,0.00016873982,0.006581108,0.000066792,0.0055284807,0.00023764998],"about_ca_topic_score_codex":0.024797248,"about_ca_topic_score_gemma":0.15891637,"teacher_disagreement_score":0.13411911,"about_ca_system_score_codex":0.0003577145,"about_ca_system_score_gemma":0.0027262548,"threshold_uncertainty_score":0.9816967},"labels":[],"label_agreement":null},{"id":"W2899903837","doi":"10.1158/1078-0432.ccr-18-2312","title":"Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; National Institute of Neurological Disorders and Stroke; Friedberg Charitable Foundation; Making Headway Foundation","keywords":"Isocitrate dehydrogenase; Glioma; Mutant; Ligand (biochemistry); Notch signaling pathway; IDH1; Cancer research; Cell; Chemistry; Biology; Cell biology; Biochemistry; Enzyme; Signal transduction; Receptor; Gene","score_opus":0.20052542380987765,"score_gpt":0.5100328340572646,"score_spread":0.309507410247387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899903837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821553,0.006131711,0.0000040156638,0.008783361,0.0002328541,0.0008497532,0.000043600863,0.000032338332,0.0017670245],"genre_scores_gemma":[0.9952752,0.0019024046,0.00019212213,0.0014397961,0.0005335371,0.00013166733,0.00000806555,0.000048859856,0.00046832254],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964453,0.00039006845,0.00067974714,0.00073742965,0.00085649133,0.00089098624],"domain_scores_gemma":[0.99750435,0.0008380157,0.00008063283,0.00062303536,0.0004950733,0.0004588884],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002343452,0.00021412634,0.00057716406,0.00017493682,0.00016430447,0.000058580863,0.0002502637,0.0002641447,0.0013612678],"category_scores_gemma":[0.0001822027,0.00016090613,0.00022318684,0.0010941414,0.00063460635,0.000060947586,0.0001356073,0.0007993213,0.0008299776],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026431675,0.0048722676,0.7268347,0.00018509084,0.00038655463,0.0017428731,0.0012194937,0.000010155071,0.23150966,0.00008987545,0.02515345,0.0053527076],"study_design_scores_gemma":[0.00910398,0.003289171,0.0660775,0.0003060167,0.000090098736,0.000021432385,0.00024738887,0.0012545348,0.8953987,0.0011714961,0.022733347,0.0003063446],"about_ca_topic_score_codex":0.0011442221,"about_ca_topic_score_gemma":0.00036233343,"teacher_disagreement_score":0.66388905,"about_ca_system_score_codex":0.000280063,"about_ca_system_score_gemma":0.0007322423,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W2900294328","doi":"10.1158/1078-0432.ccr-18-2474","title":"Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody–Drug Conjugate Mirvetuximab Soravtansine","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"ImmunoGen","keywords":"Eye drop; Medicine; Corticosteroid; Conjugate; Drug; Ophthalmology; Eye disease; Antibody; Dermatology; Surgery; Immunology; Pharmacology","score_opus":0.35554043263166224,"score_gpt":0.549723792954956,"score_spread":0.19418336032329375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900294328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929137,0.00044789733,0.000012401871,0.0026483338,0.00020556022,0.0023199304,0.000034390818,0.000009868873,0.0014078845],"genre_scores_gemma":[0.99878794,0.00019490966,0.00004937057,0.00031243116,0.00017452816,0.0001196087,0.000020350299,0.000025243067,0.00031559603],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9915031,0.0033491284,0.0010954296,0.00042240095,0.0031497874,0.00048011777],"domain_scores_gemma":[0.99537593,0.0009670134,0.00029659926,0.0010041494,0.0022466462,0.000109668814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023380654,0.00015864786,0.0004777832,0.00013432222,0.000119987926,0.000047391706,0.00050397683,0.0001213944,0.00013464385],"category_scores_gemma":[0.0016425024,0.00009294338,0.00012861715,0.0008077991,0.0014387303,0.00015576166,0.00021826723,0.0010142423,0.000023822886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016060093,0.012608272,0.3154672,0.0040935124,0.0032103385,0.00027601718,0.01231078,0.000036535657,0.3379337,0.0017710349,0.006791065,0.28944144],"study_design_scores_gemma":[0.01065238,0.0022693025,0.92622846,0.0009382618,0.0007674535,0.000010545207,0.003020059,0.0038748055,0.050428502,0.0006856804,0.0008804752,0.00024406223],"about_ca_topic_score_codex":0.0021635187,"about_ca_topic_score_gemma":0.0006542577,"teacher_disagreement_score":0.6107612,"about_ca_system_score_codex":0.0002265822,"about_ca_system_score_gemma":0.0006764755,"threshold_uncertainty_score":0.81033146},"labels":[],"label_agreement":null},{"id":"W2903219008","doi":"10.1158/1557-3265.sarcomas17-pr12","title":"Abstract PR12: Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Methyltransferase; Methylation; Histone H3; Histone methylation; EZH2; Cancer research; Histone; Histone methyltransferase; Epigenetics; Biology; Genetics; DNA methylation; Gene; Gene expression","score_opus":0.1913232032067228,"score_gpt":0.5394218543045863,"score_spread":0.34809865109786353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903219008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853146,0.006383693,0.0020959051,0.0010578991,0.00062456424,0.00048960507,0.000055861165,0.000024960083,0.0039529186],"genre_scores_gemma":[0.99127066,0.0025073246,0.0018568035,0.00009039789,0.0023352946,0.00011771065,0.00024483338,0.00004476696,0.0015321997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727225,0.0004077459,0.00063405494,0.00070119504,0.00051217043,0.0004725954],"domain_scores_gemma":[0.9979607,0.00017754614,0.00016198434,0.00063640927,0.0008802858,0.00018310988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022871112,0.00016892838,0.00024390107,0.000090018315,0.0003203516,0.00005125847,0.0003235583,0.00031500237,0.0005249877],"category_scores_gemma":[0.0009446858,0.00016006368,0.00015306137,0.0003167959,0.000541469,0.000014403237,0.00017492114,0.00035940515,0.00010630863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007029791,0.00053242076,0.016134761,0.00008361651,0.00019406682,0.0000064562764,0.0004545598,0.000067546825,0.872873,0.00013066876,0.008550914,0.10026901],"study_design_scores_gemma":[0.0017238929,0.0016228346,0.1899247,0.000052979092,0.000053896074,0.0000015726303,0.00011221179,0.00032156063,0.5886569,0.0026293849,0.2144394,0.00046067982],"about_ca_topic_score_codex":0.00040273924,"about_ca_topic_score_gemma":0.0005996767,"teacher_disagreement_score":0.2842161,"about_ca_system_score_codex":0.0000776875,"about_ca_system_score_gemma":0.000384281,"threshold_uncertainty_score":0.65272075},"labels":[],"label_agreement":null},{"id":"W2903639063","doi":"10.1158/1078-0432.ccr-18-3241","title":"Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Carcinoma; Endometrial cancer; Biology; Medicine; Oncology; Internal medicine; Immunology; Cancer; Cancer research","score_opus":0.1818455456843697,"score_gpt":0.5098285662629609,"score_spread":0.3279830205785912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903639063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706627,0.0022757463,0.0000016655241,0.0060315426,0.0009752393,0.001456945,0.000030368672,0.000037117254,0.0021250974],"genre_scores_gemma":[0.9940473,0.00054144714,0.00007141487,0.0006488732,0.00032345884,0.00020999298,0.000012891314,0.00004704443,0.004097601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944715,0.0014774821,0.0010188322,0.00077588885,0.0014137372,0.0008425621],"domain_scores_gemma":[0.9920272,0.0062214555,0.00010654104,0.0008458976,0.00036088182,0.0004380035],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0055714566,0.00023085288,0.0011367468,0.00085761485,0.0000632755,0.000039244027,0.00038102537,0.00029424077,0.002304445],"category_scores_gemma":[0.0080583235,0.00017285364,0.0004651822,0.0021338523,0.00031142397,0.000086141576,0.00029851022,0.001378422,0.00079001865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05556972,0.00079527154,0.9189228,0.00007136353,0.00017260724,0.00040892157,0.000061136314,0.0000044642597,0.01307404,0.00013943434,0.00011062479,0.010669644],"study_design_scores_gemma":[0.024607643,0.003360094,0.95654476,0.00010425553,0.00004275008,0.0000038019564,0.00007378021,0.000020435395,0.010436369,0.00014759877,0.0044812458,0.00017724297],"about_ca_topic_score_codex":0.0016790779,"about_ca_topic_score_gemma":0.00006352338,"teacher_disagreement_score":0.03762201,"about_ca_system_score_codex":0.0005338699,"about_ca_system_score_gemma":0.00095455744,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W2905948744","doi":"10.1158/1078-0432.ccr-18-1726","title":"SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Office of Extramural Research, National Institutes of Health; National Cancer Institute; Society of Memorial Sloan Kettering; National Institute of Diabetes and Digestive and Kidney Diseases; Stand Up To Cancer; Association for Academic Surgery; Memorial Sloan-Kettering Cancer Center; American Society of Colon and Rectal Surgeons; American College of Surgeons; U.S. Department of Veterans Affairs; Dana-Farber/Harvard Cancer Center; Howard Hughes Medical Institute","keywords":"Cohort; Medicine; Interquartile range; Colorectal cancer; Internal medicine; Oncology; Cancer; Immune system; Chemotherapy; Gastroenterology; Adjuvant therapy; Immunology","score_opus":0.07200764511862745,"score_gpt":0.4443375698646952,"score_spread":0.37232992474606774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905948744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260354,0.004618774,0.0000014747241,0.00063308945,0.0003231203,0.00069433433,0.00006314968,0.000013890465,0.001048597],"genre_scores_gemma":[0.9918363,0.0072297244,0.00005044018,0.00011519595,0.00022026725,0.00015775122,0.000015454365,0.00002700291,0.00034787858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973528,0.00020132329,0.0007964709,0.00050273584,0.0006318182,0.0005148796],"domain_scores_gemma":[0.9979593,0.0005057284,0.00018822883,0.00027158266,0.00090228225,0.0001728569],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0015998702,0.00017195738,0.00056600856,0.00017586257,0.00009823287,0.00001990132,0.00020954217,0.0002012166,0.00044668658],"category_scores_gemma":[0.00033170698,0.00012728863,0.000083459905,0.0010622471,0.0033519387,0.00009751474,0.000097294054,0.00076846196,0.0000072100565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026796978,0.00044123264,0.9488724,0.00018601528,0.000119323115,0.00001990301,0.00029509387,3.743788e-7,0.0016663241,0.000020748212,0.000972412,0.020609204],"study_design_scores_gemma":[0.0075122993,0.0032840152,0.97143954,0.0013274578,0.000025054516,0.000004785317,0.00008703711,0.000033628963,0.013849329,0.00006577809,0.0022054298,0.00016563987],"about_ca_topic_score_codex":0.0022376762,"about_ca_topic_score_gemma":0.003252111,"teacher_disagreement_score":0.022567153,"about_ca_system_score_codex":0.00021008665,"about_ca_system_score_gemma":0.00085661263,"threshold_uncertainty_score":0.9993604},"labels":[],"label_agreement":null},{"id":"W2906736778","doi":"10.1158/1557-3265.tcm17-b01","title":"Abstract B01: MicroRNA expression in tumors and liquid biopsy samples from patients with pancreatic ductal adenocarcinoma: Identification of clinically relevant pathways","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"microRNA; Pancreatic cancer; Adenocarcinoma; Medicine; Cancer; Carcinogenesis; Cancer research; Oncology; Disease; Biopsy; TaqMan; Pancreas; Pathology; Internal medicine; Real-time polymerase chain reaction; Gene; Biology; Genetics","score_opus":0.06847028850402621,"score_gpt":0.3833829684711695,"score_spread":0.3149126799671433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906736778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731165,0.0015968425,0.000063242405,0.00010455035,0.00014786635,0.00035959444,0.0003656458,0.0000042997144,0.000046287336],"genre_scores_gemma":[0.9965889,0.0020206997,0.00058544934,0.000051755396,0.00049070385,0.000050150724,0.0001696778,0.00002820224,0.000014499306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749005,0.00017917492,0.0010156173,0.00067380455,0.00031792576,0.00032344874],"domain_scores_gemma":[0.9980073,0.0005173451,0.0002889806,0.0005225144,0.00049638585,0.00016747549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013294282,0.00014222719,0.00030812388,0.00007522239,0.00008331557,0.000034265817,0.0002870878,0.00020935717,0.000038765877],"category_scores_gemma":[0.0015295072,0.000118554475,0.00006439947,0.00015092571,0.00081455434,0.000008459824,0.00027746405,0.00030982847,0.0000072541934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003845767,0.00028364966,0.6207645,0.000034542176,0.000025406398,0.0000058465866,0.000089710345,0.0000025415573,0.3735322,0.000009439391,0.00028612211,0.0011203036],"study_design_scores_gemma":[0.0016485163,0.0020026665,0.9141792,0.00018513085,0.000015132541,9.2064016e-7,0.00009588925,0.000010055575,0.0812159,0.00017757977,0.00031293926,0.00015604151],"about_ca_topic_score_codex":0.0006860997,"about_ca_topic_score_gemma":0.00039690654,"teacher_disagreement_score":0.29341474,"about_ca_system_score_codex":0.000037572372,"about_ca_system_score_gemma":0.0003740659,"threshold_uncertainty_score":0.48345113},"labels":[],"label_agreement":null},{"id":"W2907345836","doi":"10.1158/1078-0432.ccr-18-2366","title":"Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lapatinib; Metastatic breast cancer; Metastasis; Brain metastasis; Internal medicine; Oncology; Breast cancer; Trastuzumab; Cancer","score_opus":0.08659103759164789,"score_gpt":0.42443793086899023,"score_spread":0.33784689327734235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907345836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180835,0.0007504928,0.000013177194,0.000941216,0.0003911595,0.001648435,0.0042976798,0.000032377036,0.00011707979],"genre_scores_gemma":[0.9979249,0.00059260393,0.00024388243,0.00012765056,0.00040675898,0.00033489562,0.00024808044,0.000058380625,0.000062850006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956292,0.0011775086,0.00074094505,0.0008469845,0.00076445163,0.00084092934],"domain_scores_gemma":[0.9973649,0.00069170044,0.00019226219,0.0004869563,0.00063627114,0.00062795554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007775647,0.00033098666,0.0010517458,0.00015786305,0.00018052469,0.000070487324,0.00011961061,0.00009627469,0.00033640658],"category_scores_gemma":[0.00009169102,0.00021372,0.00013645494,0.00040400127,0.0007066744,0.000090538226,0.0000967551,0.00040920585,0.000024476783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064872955,0.0017743966,0.8305501,0.000112569316,0.0014088466,0.00021322217,0.00043906335,0.0000017852956,0.0000041963312,0.000040483614,0.00014413659,0.15882394],"study_design_scores_gemma":[0.008259614,0.0061019273,0.98235875,0.0007898676,0.00061121734,0.000008184818,0.000762261,0.000102551756,0.000076047676,0.000006969864,0.0007162859,0.00020630403],"about_ca_topic_score_codex":0.02792624,"about_ca_topic_score_gemma":0.0033331558,"teacher_disagreement_score":0.15861765,"about_ca_system_score_codex":0.0012268365,"about_ca_system_score_gemma":0.00054415344,"threshold_uncertainty_score":0.97854686},"labels":[],"label_agreement":null},{"id":"W2907461092","doi":"10.1158/1078-0432.ccr-17-3177","title":"TAp73 Modifies Metabolism and Positively Regulates Growth of Cancer Stem–Like Cells in a Redox-Sensitive Manner","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Izaak Walton Killam Health Centre; Hamilton Health Sciences; Dalhousie University","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Government of Canada","keywords":"Stem cell; Cancer stem cell; Biology; Cancer research; Homeobox protein NANOG; Gene knockdown; PIN1; Cancer cell; Radioresistance; Stem cell marker; Cell biology; Cancer; Embryonic stem cell; Cell culture; Induced pluripotent stem cell; Biochemistry; Genetics; Enzyme","score_opus":0.08704335735485506,"score_gpt":0.4470245646643515,"score_spread":0.3599812073094964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907461092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973984,0.008795207,0.00004195758,0.00042810442,0.00021683707,0.000272334,0.000079347636,0.000003446834,0.00042292918],"genre_scores_gemma":[0.9863414,0.011795978,0.0001877913,0.00009579824,0.00053165207,0.000049223294,0.000009545312,0.000021367086,0.0009672533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979435,0.0004945734,0.00043216665,0.00050555967,0.00028608582,0.0003380874],"domain_scores_gemma":[0.9985339,0.00015931884,0.00009609187,0.0002522278,0.00083734567,0.00012109793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015855662,0.0001232923,0.00028152863,0.00010681557,0.000078031095,0.00002245403,0.00015548544,0.00023795136,0.000021884487],"category_scores_gemma":[0.00016165937,0.000108318854,0.00007138682,0.0002342398,0.0010808121,0.000006467108,0.0002374176,0.0002518239,0.000003400086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009112565,0.00011313141,0.029300231,0.00005433241,0.00011659717,0.0000050439357,0.00028521215,0.0000179997,0.957058,0.000267878,0.0007882304,0.011082095],"study_design_scores_gemma":[0.00069455395,0.00038828855,0.14263076,0.000059997885,0.000017208211,2.6410038e-7,0.00009588532,0.00011985927,0.85238785,0.0006134966,0.0028605864,0.000131239],"about_ca_topic_score_codex":0.0017569527,"about_ca_topic_score_gemma":0.0013001538,"teacher_disagreement_score":0.11333052,"about_ca_system_score_codex":0.000021369795,"about_ca_system_score_gemma":0.00018998072,"threshold_uncertainty_score":0.4417115},"labels":[],"label_agreement":null},{"id":"W2908547172","doi":"10.1158/1078-0432.ccr-18-1593","title":"Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"Copy-number variation; Cell-free fetal DNA; Lung cancer; Cancer; Oncology; Internal medicine; Gene dosage; Digital polymerase chain reaction; Medicine; Biology; Cancer research; Genome; Genetics; Gene; Polymerase chain reaction; Gene expression","score_opus":0.05407335958969898,"score_gpt":0.4347490197746901,"score_spread":0.3806756601849911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908547172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331915,0.0037967016,0.000019120269,0.00035437554,0.0005278997,0.0010812278,0.00030617544,0.000008089302,0.00058725476],"genre_scores_gemma":[0.99036837,0.008075022,0.00015123571,0.00025400065,0.00047930787,0.00024681425,0.000100692676,0.00006973118,0.00025482662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567634,0.0005622725,0.001365454,0.0010678413,0.00044535974,0.00088274013],"domain_scores_gemma":[0.9972523,0.00093999464,0.0002970192,0.0009464763,0.0003222908,0.0002419564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004119151,0.00026436284,0.00074981916,0.0001593283,0.00006248877,0.000049856426,0.0007987349,0.00054745213,0.00022436334],"category_scores_gemma":[0.0009979237,0.00027987346,0.00021695149,0.0004498487,0.0003882731,0.000009519161,0.00071374344,0.0010525014,0.000026061347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032066822,0.00018550344,0.8098257,0.00022878604,0.00005220078,0.000025857102,0.000082241,0.0017165393,0.18574539,0.0000101547075,0.00023273205,0.0015741831],"study_design_scores_gemma":[0.007266657,0.0008995351,0.9619887,0.0005378961,0.00006473067,0.000008002239,0.0006931862,0.0078285765,0.01769542,0.00027795983,0.0018714819,0.0008678943],"about_ca_topic_score_codex":0.0024531567,"about_ca_topic_score_gemma":0.025129082,"teacher_disagreement_score":0.16804996,"about_ca_system_score_codex":0.00056534645,"about_ca_system_score_gemma":0.0019661617,"threshold_uncertainty_score":0.99996537},"labels":[],"label_agreement":null},{"id":"W2909211125","doi":"10.1158/1078-0432.ccr-18-0220","title":"Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Guelph","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Oncolytic virus; Ovarian cancer; Medicine; Stage (stratigraphy); Immunotherapy; Normalization (sociology); Oncology; Cancer research; Cancer; Internal medicine; Biology","score_opus":0.14686448932855425,"score_gpt":0.510548833969384,"score_spread":0.36368434464082977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909211125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952226,0.0022062052,0.00096076855,0.00018458902,0.000117273725,0.000777732,0.00005758483,0.000014612733,0.00045860757],"genre_scores_gemma":[0.98710936,0.010240115,0.0008484562,0.00027680467,0.0004685879,0.00044898424,0.000039038925,0.00007384108,0.00049481186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99549645,0.001127388,0.00085878564,0.0008983126,0.0008786794,0.00074039673],"domain_scores_gemma":[0.9974459,0.00019813233,0.00019083094,0.0009911588,0.0009296553,0.00024434517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004881004,0.00022250557,0.0004821543,0.00018141071,0.00016659926,0.000041828935,0.0007932,0.00033823733,0.00028727512],"category_scores_gemma":[0.00033142426,0.00019250896,0.00013471705,0.0006473034,0.0012846113,0.000032704414,0.00020235904,0.0006982214,0.000008277593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04821929,0.0013063843,0.023600306,0.00010146604,0.00032219957,0.0000064705864,0.00052618835,0.013171233,0.8293303,0.000106072424,0.00012287988,0.08318717],"study_design_scores_gemma":[0.014445122,0.048813097,0.011931791,0.00048304215,0.00003332,0.0000013592821,0.0003782128,0.049907416,0.86459064,0.0004990361,0.008045056,0.00087193],"about_ca_topic_score_codex":0.0009909671,"about_ca_topic_score_gemma":0.019657003,"teacher_disagreement_score":0.082315244,"about_ca_system_score_codex":0.00011356296,"about_ca_system_score_gemma":0.0019538193,"threshold_uncertainty_score":0.9982317},"labels":[],"label_agreement":null},{"id":"W2909651539","doi":"10.1158/1078-0432.ccr-18-2792","title":"Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Stockholms Läns Landsting; Radiumhemmets Forskningsfonder; Magnus Bergvalls Stiftelse; Cancerfonden","keywords":"Biology; Immunohistochemistry; Extracellular matrix; Phenotype; Cancer research; Pathology; Gene expression; Leiomyosarcoma; Sarcoma; Copy-number variation; Gene; Medicine; Genetics; Immunology","score_opus":0.11585057728458059,"score_gpt":0.5068512462304975,"score_spread":0.3910006689459169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909651539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951469,0.00081870944,0.00013604763,0.0013398287,0.00018829067,0.000814249,0.00009226092,0.00004784938,0.0014158915],"genre_scores_gemma":[0.99457943,0.0010112856,0.0008200248,0.0003182431,0.000051199208,0.00005720624,0.00021479002,0.000049501985,0.0028983152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995267,0.00076850905,0.0015245577,0.0008125788,0.0010270518,0.00060031057],"domain_scores_gemma":[0.9963788,0.00073716044,0.0002498448,0.0012160295,0.001000636,0.00041753222],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002197456,0.00024628686,0.0014588528,0.00060485856,0.000040961808,0.000029827117,0.00036245422,0.00027654704,0.0027639326],"category_scores_gemma":[0.00091866724,0.0001822558,0.0007736191,0.0022911069,0.00034591125,0.000045778736,0.00032040698,0.0008992211,0.00016601988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031936748,0.0015051366,0.90578306,0.00023476027,0.007966046,0.00058111665,0.000034683446,0.000025689895,0.068346724,0.0005802085,0.00037950964,0.011369402],"study_design_scores_gemma":[0.0069401963,0.005210718,0.9637739,0.0004599297,0.0026118623,0.00000786419,0.000047574886,0.002338118,0.010493131,0.00060216745,0.007169883,0.00034464974],"about_ca_topic_score_codex":0.0006423084,"about_ca_topic_score_gemma":0.000052601532,"teacher_disagreement_score":0.05799086,"about_ca_system_score_codex":0.0001376583,"about_ca_system_score_gemma":0.0003942282,"threshold_uncertainty_score":0.99814767},"labels":[],"label_agreement":null},{"id":"W2910164268","doi":"10.1158/1078-0432.ccr-18-0432","title":"CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":672,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Deutsche Krebshilfe","keywords":"Cancer; Antigen; Medicine; Cancer research; Solid tumor; Pathology; Immunology; Internal medicine","score_opus":0.14806278979406062,"score_gpt":0.49720794026348103,"score_spread":0.3491451504694204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910164268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98533994,0.003253832,0.000011214311,0.005847967,0.0007036951,0.0028150387,0.00008756288,0.00011041553,0.0018303266],"genre_scores_gemma":[0.9643725,0.023320084,0.0001365617,0.0008407559,0.0028754768,0.00029052596,0.00001821236,0.00015300633,0.007992871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9897418,0.0021695541,0.0016056048,0.0019224073,0.0024334837,0.0021271661],"domain_scores_gemma":[0.99078,0.005341197,0.000333242,0.0011309152,0.00097449234,0.0014401298],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0120682465,0.000493136,0.0016050391,0.0004776772,0.00036345836,0.00018081201,0.0006691451,0.00059570256,0.0033313602],"category_scores_gemma":[0.0026596524,0.00042389758,0.0005544425,0.001371895,0.0011931608,0.0002350091,0.00082770333,0.004511038,0.00035074525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004396376,0.00085009594,0.6721124,0.0007020161,0.00024655715,0.00032217364,0.00018414264,0.00004701467,0.19367912,0.00000780114,0.01127073,0.11618153],"study_design_scores_gemma":[0.018024659,0.006515795,0.8512455,0.0014247593,0.00021923435,0.0000481983,0.0009443463,0.0068663,0.07905229,0.0002894633,0.033522423,0.0018469803],"about_ca_topic_score_codex":0.0011319362,"about_ca_topic_score_gemma":0.0002001922,"teacher_disagreement_score":0.17913312,"about_ca_system_score_codex":0.00051293004,"about_ca_system_score_gemma":0.0030548908,"threshold_uncertainty_score":0.9998213},"labels":[],"label_agreement":null},{"id":"W2910189085","doi":"10.1158/1557-3265.sarcomas17-ia02","title":"Abstract IA02: Modeling sarcoma susceptibility: The Li-Fraumeni syndrome paradigm","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Sarcoma; Cancer; Germline; Rhabdomyosarcoma; Medicine; Germline mutation; Mutation; Phenotype; Disease; Genetics; Cancer research; Biology; Gene; Internal medicine; Pathology","score_opus":0.35550486910566403,"score_gpt":0.5366505580109427,"score_spread":0.1811456889052787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910189085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97316706,0.0035886052,0.000019945366,0.018744113,0.0003766496,0.0009587924,0.000016612137,0.000061831546,0.0030663668],"genre_scores_gemma":[0.99532014,0.0015276239,0.00010132497,0.00096327526,0.0013079089,0.00031060172,0.0000093897115,0.00004339673,0.0004163206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962005,0.0003504582,0.00076087576,0.00076722045,0.001097952,0.0008229986],"domain_scores_gemma":[0.9958164,0.0019089819,0.0000690028,0.0012931664,0.00045235452,0.0004600828],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0042819316,0.00019941965,0.0005185246,0.00010929356,0.00043469502,0.00008766489,0.00041730533,0.00021090233,0.0023157755],"category_scores_gemma":[0.0009293928,0.000119172786,0.00032150763,0.00047416496,0.0010963297,0.00008114934,0.0002442369,0.0012029286,0.0010833989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016596327,0.003382249,0.8268946,0.00014527257,0.00063309434,0.00086707296,0.00033859466,0.000032278185,0.00013623995,0.0010807296,0.01909753,0.14573272],"study_design_scores_gemma":[0.0039594383,0.0025889718,0.9530624,0.0004815301,0.00015709306,0.00011166797,0.0003038321,0.0057484563,0.0002950794,0.0054493826,0.02756224,0.00027990763],"about_ca_topic_score_codex":0.002421769,"about_ca_topic_score_gemma":0.0012986482,"teacher_disagreement_score":0.14545281,"about_ca_system_score_codex":0.00031524495,"about_ca_system_score_gemma":0.0005974145,"threshold_uncertainty_score":0.99969435},"labels":[],"label_agreement":null},{"id":"W2910269253","doi":"10.1158/1078-0432.ccr-18-2847","title":"Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Swim Across America; U.S. Food and Drug Administration; Herbert Irving Comprehensive Cancer Center, Columbia University","keywords":"Medicine; Oncology; Melanoma; Internal medicine; Proportional hazards model; Stage (stratigraphy); Receiver operating characteristic; Survival analysis; Cohort; Population; Area under the curve; Immunotherapy; Cancer; Cancer research; Biology","score_opus":0.14415378547743973,"score_gpt":0.45528315525464214,"score_spread":0.3111293697772024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910269253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871614,0.0046755127,0.000078125966,0.0010361725,0.0008356307,0.0049850023,0.00033550966,0.000057912606,0.0008347289],"genre_scores_gemma":[0.98468584,0.0014204831,0.0003721995,0.00006715707,0.00051421847,0.0010465168,0.00038196563,0.000057765472,0.011453832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99624866,0.00028721933,0.0013510594,0.0006257509,0.0008934489,0.00059386133],"domain_scores_gemma":[0.9969385,0.00085285114,0.00032895867,0.000781194,0.00093069585,0.00016776168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00446489,0.00020362892,0.0007357683,0.00024386561,0.00019877387,0.000029039054,0.00030692067,0.00031281222,0.0023640601],"category_scores_gemma":[0.0006705961,0.00016811001,0.0004199855,0.000636325,0.00041303196,0.00014443924,0.00017017697,0.0006300911,0.000034187695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048093945,0.0016764328,0.3549527,0.0019298854,0.0011883794,0.000015140898,0.0005990407,0.000016022941,0.5256692,0.00016024162,0.0034901414,0.062208842],"study_design_scores_gemma":[0.025049148,0.017768037,0.4424938,0.0016432038,0.00024980164,0.00001762549,0.000424066,0.0013088515,0.48516592,0.00013395303,0.025350496,0.00039508045],"about_ca_topic_score_codex":0.0006388122,"about_ca_topic_score_gemma":0.000023321127,"teacher_disagreement_score":0.0875411,"about_ca_system_score_codex":0.00028077565,"about_ca_system_score_gemma":0.0011000272,"threshold_uncertainty_score":0.9985479},"labels":[],"label_agreement":null},{"id":"W2910527546","doi":"10.1158/1078-0432.ccr-18-3042","title":"Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"National Cancer Institute","keywords":"Carcinogenesis; Pancreatic cancer; Transcriptome; Biology; Cohort; Oncology; Cancer; Adenocarcinoma; Gene; Somatic cell; Medicine; Population; Bioinformatics; Cancer research; Internal medicine; Genetics; Gene expression","score_opus":0.12479651735188922,"score_gpt":0.48326242158549404,"score_spread":0.3584659042336048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910527546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818438,0.0011268174,0.0000010468334,0.00076800404,0.00043042033,0.0013841831,0.000024140676,0.000012592371,0.014408962],"genre_scores_gemma":[0.9919294,0.00096824276,0.00011014054,0.00021201854,0.00026525505,0.00017100283,0.000031883596,0.000036705293,0.0062753316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962088,0.0006545319,0.000898781,0.0005771813,0.00090598426,0.0007547621],"domain_scores_gemma":[0.9960863,0.0023573986,0.0001092197,0.00072655326,0.00042311114,0.00029740855],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0026130266,0.0001622676,0.0010244055,0.000362918,0.000045865218,0.000016996084,0.00034181768,0.00029406077,0.008306407],"category_scores_gemma":[0.00077844,0.00011098819,0.00016662104,0.0005031993,0.00053963007,0.00008505381,0.00026473784,0.0011587071,0.0011032649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005065742,0.000643826,0.9894697,0.00038611234,0.00015791118,0.00006410595,0.0002222867,7.31913e-7,0.00022044194,0.00006752879,0.0025061497,0.0011954274],"study_design_scores_gemma":[0.011958652,0.001604436,0.9845681,0.00032238258,0.00007622755,0.0000013346114,0.00034857693,0.00010261786,0.000051084844,0.00011788697,0.0007326384,0.00011604257],"about_ca_topic_score_codex":0.0007886075,"about_ca_topic_score_gemma":0.00015234757,"teacher_disagreement_score":0.010085586,"about_ca_system_score_codex":0.0002803895,"about_ca_system_score_gemma":0.00075649266,"threshold_uncertainty_score":0.9996745},"labels":[],"label_agreement":null},{"id":"W2910852524","doi":"10.1158/1078-0432.ccr-18-2291","title":"Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Adoptive cell transfer; Cancer; Medicine; Cancer therapy; Cell therapy; Cancer research; Immunology; Biology; Immune system; T cell; Internal medicine; Stem cell; Cell biology","score_opus":0.36519421318107037,"score_gpt":0.542524949221723,"score_spread":0.17733073604065264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910852524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644063,0.0059941164,0.00033253036,0.015283828,0.0011261635,0.009059391,0.00010704806,0.00007063107,0.0036199768],"genre_scores_gemma":[0.8187601,0.041050468,0.0023216256,0.00611473,0.004399923,0.0074647595,0.000062738654,0.0003887909,0.119436875],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99375004,0.0005338191,0.00094071357,0.0012732494,0.001940065,0.0015620947],"domain_scores_gemma":[0.990608,0.0051478394,0.00018512602,0.0011593734,0.0023765117,0.00052318786],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0067208875,0.0003785853,0.00094018976,0.00028050062,0.0003913191,0.00012540272,0.0009594478,0.0004419573,0.0076122913],"category_scores_gemma":[0.0005428852,0.0002631546,0.0005598579,0.0011749506,0.0010239171,0.00012370135,0.00038888725,0.0021953383,0.00048323654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04804274,0.0011120002,0.018140547,0.0005095295,0.002018608,0.000049622897,0.0019083981,0.00010769222,0.7129293,0.0021653045,0.008500462,0.20451578],"study_design_scores_gemma":[0.02193878,0.003314281,0.0048551112,0.00043088107,0.00006234949,0.0000066085718,0.00083528925,0.00053002726,0.43608773,0.0009029275,0.5305254,0.0005106109],"about_ca_topic_score_codex":0.0028174631,"about_ca_topic_score_gemma":0.0004880824,"teacher_disagreement_score":0.5220249,"about_ca_system_score_codex":0.0010721728,"about_ca_system_score_gemma":0.005262537,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W2910893459","doi":"10.1158/1078-0432.ccr-18-2435","title":"Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Seattle Genetics; Takeda Oncology; Takeda Pharmaceutical Company","keywords":"Brentuximab vedotin; Medicine; Chemotherapy; Stage (stratigraphy); Oncology; Lymphoma; Internal medicine; Hodgkin lymphoma; Biology","score_opus":0.10157173452621963,"score_gpt":0.4519525788486962,"score_spread":0.35038084432247657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910893459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312806,0.00049849204,0.0000028330041,0.002910955,0.00015864644,0.0020430125,0.000034517918,0.00005720744,0.0011662539],"genre_scores_gemma":[0.9892487,0.0041629947,0.0002098298,0.0015610282,0.00037594818,0.0006371791,0.000036979134,0.00007733804,0.0036900265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956858,0.00041270285,0.0007098716,0.0009805424,0.0011868617,0.0010242031],"domain_scores_gemma":[0.9960841,0.002004022,0.00017389297,0.00090505916,0.00028619435,0.00054672797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011487041,0.0003092531,0.0011035334,0.0002632662,0.00008764718,0.000067291134,0.0003334742,0.00012382942,0.0011153216],"category_scores_gemma":[0.00030363924,0.00019818563,0.00017390552,0.0016776329,0.0006064898,0.00009486029,0.0001339398,0.00051265064,0.0002829284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014844126,0.0023374748,0.8278401,0.00008754152,0.00017574732,0.0010161548,0.0003092595,0.000023801509,0.000015182132,0.00001884908,0.0018943916,0.15143737],"study_design_scores_gemma":[0.05769704,0.0060188514,0.9196406,0.000252753,0.000032250173,0.000009174149,0.00042241852,0.00026030574,0.00033418598,0.0000029242117,0.015088581,0.00024094031],"about_ca_topic_score_codex":0.015485543,"about_ca_topic_score_gemma":0.038362157,"teacher_disagreement_score":0.15119644,"about_ca_system_score_codex":0.0013402706,"about_ca_system_score_gemma":0.0030369554,"threshold_uncertainty_score":0.9997978},"labels":[],"label_agreement":null},{"id":"W2911100812","doi":"10.1158/1078-0432.ccr-18-3102","title":"Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Susan G. Komen; National Center for Research Resources; U.S. Department of Defense","keywords":"Breast cancer; CD8; Cancer; Medicine; Immunology; Human breast; Cytotoxic T cell; Virology; Biology; Cancer research; Immune system; Internal medicine; Genetics; In vitro","score_opus":0.14847070663198816,"score_gpt":0.48826244016385645,"score_spread":0.3397917335318683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911100812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913128,0.0024893866,0.000002549426,0.0019774607,0.0013525893,0.0024859272,0.000095032054,0.00006250415,0.0002217266],"genre_scores_gemma":[0.98758656,0.00045837837,0.000018698005,0.00046792932,0.0002860877,0.0004953498,0.00001911984,0.00006910387,0.010598792],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9922185,0.0034439801,0.0018268349,0.0011308074,0.0003023451,0.0010775281],"domain_scores_gemma":[0.99627,0.002066005,0.00019463888,0.0009399248,0.00040693997,0.00012251873],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0070648035,0.00032542492,0.0009912808,0.00041196763,0.00037992047,0.00007702367,0.0009834236,0.0005956069,0.004464268],"category_scores_gemma":[0.00022396159,0.00028671694,0.00031223896,0.00061693153,0.00023552652,0.00022645219,0.00030010982,0.002645595,0.00084368954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013264312,0.0030400904,0.30869907,0.00004930329,0.00040748663,0.000019314422,0.0015457477,0.000088416054,0.59451646,0.000026541516,0.0023420304,0.07600123],"study_design_scores_gemma":[0.018591115,0.0036922123,0.9035157,0.000447981,0.000045951685,0.000011316973,0.001808495,0.000015642607,0.052910127,0.000076705815,0.018168218,0.00071651465],"about_ca_topic_score_codex":0.006048653,"about_ca_topic_score_gemma":0.0031729497,"teacher_disagreement_score":0.5948166,"about_ca_system_score_codex":0.00019320974,"about_ca_system_score_gemma":0.0009032173,"threshold_uncertainty_score":0.9999585},"labels":[],"label_agreement":null},{"id":"W2911174524","doi":"10.1158/1078-0432.ccr-18-3325","title":"Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Gefitinib; Internal medicine; Erlotinib; T790M; Hazard ratio; Lung cancer; Oncology; Erlotinib Hydrochloride; Tyrosine-kinase inhibitor; Performance status; Epidermal growth factor receptor; Confidence interval; Cancer","score_opus":0.0551726375942707,"score_gpt":0.5012714979434845,"score_spread":0.44609886034921375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911174524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882358,0.0027395901,0.0000073824044,0.00064080267,0.00052098127,0.00670318,0.0003999114,0.000039458493,0.0007129362],"genre_scores_gemma":[0.9958505,0.00056033075,0.0007250443,0.00009478209,0.000071583614,0.0012789182,0.0003348346,0.00008302377,0.0010009762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667144,0.00017302658,0.0008036978,0.0007548008,0.0008283732,0.0007686403],"domain_scores_gemma":[0.9961764,0.00090792705,0.00025657887,0.0005654616,0.001779818,0.00031376453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005137073,0.00028192977,0.00092986546,0.00023080423,0.00011512441,0.000026738553,0.00022649136,0.0002105204,0.0003092714],"category_scores_gemma":[0.0002686874,0.00019128811,0.00019709747,0.00065982813,0.00018748481,0.00011873177,0.00009805129,0.0005674524,0.000012364152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05153014,0.00064176286,0.91694653,0.00093790976,0.0003573116,0.000010156693,0.0007340385,0.00012948351,0.00003964879,0.0000070425704,0.000324972,0.028340977],"study_design_scores_gemma":[0.10408544,0.020800985,0.8652087,0.0028908679,0.00066616706,1.7259394e-7,0.0008433943,0.00024385477,0.0020684479,0.000011807637,0.0028046668,0.0003755092],"about_ca_topic_score_codex":0.0007480595,"about_ca_topic_score_gemma":0.0010976826,"teacher_disagreement_score":0.0525553,"about_ca_system_score_codex":0.0011778381,"about_ca_system_score_gemma":0.0020918911,"threshold_uncertainty_score":0.7800503},"labels":[],"label_agreement":null},{"id":"W2912476769","doi":"10.1158/1078-0432.ccr-18-0716","title":"Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Institute on Deafness and Other Communication Disorders; National Cancer Institute; National Institutes of Health","keywords":"Head and neck squamous-cell carcinoma; microRNA; Cancer research; Biology; DNA methylation; Suppressor; Methylation; Cell growth; Cancer; Head and neck cancer; Gene; Gene expression; Genetics","score_opus":0.056148427722121245,"score_gpt":0.41274236913526746,"score_spread":0.3565939414131462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912476769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787548,0.019907951,0.000017177063,0.00072295393,0.00013314844,0.00037273375,0.000060821018,0.000004628465,0.000025788457],"genre_scores_gemma":[0.99572015,0.0029764045,0.000023887666,0.0002306467,0.0001984626,0.000069348054,0.000089166635,0.000018158758,0.0006737905],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981985,0.0002761634,0.0003678075,0.0006296057,0.000228412,0.00029949707],"domain_scores_gemma":[0.9992371,0.00008702645,0.00007214939,0.00024829817,0.00019184551,0.00016353503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007945044,0.00013741855,0.00029963697,0.00018201664,0.00007444092,0.00006412477,0.00010426811,0.00014738624,0.0005887677],"category_scores_gemma":[0.00010478695,0.00011788479,0.00007120342,0.0002800121,0.00046443427,0.000009597953,0.00020717594,0.00029144387,0.000009080501],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009910057,0.00005831764,0.26124412,0.00006373796,0.000346511,0.000006395756,0.00003163027,0.000040640953,0.73463964,0.0000061123205,0.00042077416,0.0021511004],"study_design_scores_gemma":[0.0020919298,0.00025925649,0.98262453,0.000058824353,0.00012832542,0.000007002344,0.000094619296,0.0007251363,0.00980637,0.0001244653,0.0039270218,0.00015251728],"about_ca_topic_score_codex":0.0011489344,"about_ca_topic_score_gemma":0.0009435257,"teacher_disagreement_score":0.7248333,"about_ca_system_score_codex":0.000050286584,"about_ca_system_score_gemma":0.00027869976,"threshold_uncertainty_score":0.6446594},"labels":[],"label_agreement":null},{"id":"W2913581799","doi":"10.1158/1078-0432.ccr-18-3205","title":"Tissue 2-Hydroxyglutarate as a Biomarker for <i>Isocitrate Dehydrogenase</i> Mutations in Gliomas","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Isocitrate dehydrogenase; Glioma; Biomarker; IDH1; Medicine; Internal medicine; Pathology; Oncology; Mutation; Biology; Cancer research; Genetics; Enzyme; Gene; Biochemistry","score_opus":0.21092626147187787,"score_gpt":0.550235907418832,"score_spread":0.3393096459469541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913581799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846794,0.0017823965,0.000006005441,0.0069456617,0.0002560082,0.0025643988,0.000063150634,0.00003306787,0.0036699094],"genre_scores_gemma":[0.99512357,0.0005299075,0.00020850316,0.0006118402,0.00017205255,0.0015229654,0.00006577881,0.000044958873,0.0017204183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972627,0.00026256416,0.00062888156,0.00062880304,0.00053675566,0.0006802499],"domain_scores_gemma":[0.99713886,0.0016076821,0.00007129293,0.0004630965,0.00036211242,0.0003569799],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019715398,0.00016353135,0.0004971467,0.00030462694,0.00009996485,0.00004588262,0.00016147726,0.00020853228,0.0012150371],"category_scores_gemma":[0.00058955274,0.00013341015,0.00021519167,0.00092165975,0.00022946286,0.00007824796,0.000075221134,0.00043366695,0.0012736527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050640674,0.006015598,0.80422455,0.00060081034,0.00088439387,0.001301554,0.00047729383,0.000118309465,0.06703158,0.001973463,0.028635098,0.0836733],"study_design_scores_gemma":[0.059608415,0.010224692,0.42138824,0.0014518761,0.0004128723,0.00011746318,0.0006943297,0.007906049,0.19553836,0.011529025,0.29005232,0.0010763649],"about_ca_topic_score_codex":0.00095401634,"about_ca_topic_score_gemma":0.00049523613,"teacher_disagreement_score":0.3828363,"about_ca_system_score_codex":0.00024324917,"about_ca_system_score_gemma":0.0006867287,"threshold_uncertainty_score":0.999698},"labels":[],"label_agreement":null},{"id":"W2914383329","doi":"10.1158/1078-0432.ccr-18-2700","title":"Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ottawa Hospital","funders":"","keywords":"Nomogram; Medicine; Resection; Sarcoma; Overall survival; Oncology; Surgery; Radiology; Pathology","score_opus":0.1877519679765976,"score_gpt":0.48272904545825895,"score_spread":0.29497707748166135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914383329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943774,0.000701696,0.0000126439745,0.0005955318,0.00072104076,0.003383128,0.000060732225,0.00002374072,0.00012413948],"genre_scores_gemma":[0.99833775,0.00029131968,0.00020153791,0.000051899104,0.0004313099,0.0005386837,0.000051314106,0.000035371224,0.000060830247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969164,0.0003558334,0.00067422003,0.0007702069,0.0007876757,0.0004956491],"domain_scores_gemma":[0.99612486,0.0027878212,0.00008575721,0.00037513662,0.00039134754,0.00023507337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023116902,0.00015611465,0.0005232443,0.00016429428,0.00012120018,0.00005621115,0.00012088539,0.00014573442,0.000057291465],"category_scores_gemma":[0.0014073648,0.0001264351,0.00010534159,0.00033798662,0.000114005496,0.0000800048,0.0002102049,0.0007588699,0.000012250507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006219927,0.0057717836,0.950171,0.000074418735,0.00014217908,0.000010859552,0.00023645793,0.00000304705,0.000017153205,0.000010489518,0.00013426185,0.037208434],"study_design_scores_gemma":[0.021331698,0.013313831,0.96241957,0.0004727755,0.000048286707,4.265578e-7,0.0007960914,0.0011436224,0.000023627366,0.00005110061,0.0002897863,0.00010915709],"about_ca_topic_score_codex":0.0040174215,"about_ca_topic_score_gemma":0.011154327,"teacher_disagreement_score":0.037099276,"about_ca_system_score_codex":0.00043389425,"about_ca_system_score_gemma":0.00032217125,"threshold_uncertainty_score":0.6224376},"labels":[],"label_agreement":null},{"id":"W2914742512","doi":"10.1158/1078-0432.ccr-18-1122","title":"Keratinocyte Carcinomas: Current Concepts and Future Research Priorities","year":2019,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; National Cancer Institute; National Institutes of Health; LEO Pharma; Galderma; Cancer Research UK; Castle Biosciences; Regeneron Pharmaceuticals; Sanofi; Valeant Pharmaceuticals International; Pfizer","keywords":"Basal cell carcinoma; Keratinocyte; Microbiome; Skin cancer; Carcinogenesis; Immune system; Immunology; Immunosuppression; Medicine; Carcinoma; Cancer research; Biology; Cancer; Oncology; Bioinformatics; Internal medicine; Basal cell; Genetics","score_opus":0.7242988999928114,"score_gpt":0.699467554352779,"score_spread":0.02483134564003242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914742512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023951326,0.985242,3.6020512e-7,0.0014216166,0.0033898947,0.004677423,0.00021236874,0.000049189468,0.0047676363],"genre_scores_gemma":[0.000066052904,0.97406924,0.000069685884,0.000063424355,0.017680652,0.0017027389,0.000062270694,0.00017581396,0.006110126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9879403,0.0037881574,0.0018489715,0.0020538438,0.0025773067,0.0017914161],"domain_scores_gemma":[0.98826736,0.0070635607,0.00028084035,0.0017095787,0.0018975293,0.0007811545],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009665141,0.0006812281,0.0045771557,0.00077352964,0.00059220416,0.00020273936,0.00078426715,0.0009970845,0.0006083595],"category_scores_gemma":[0.0015795341,0.0005001058,0.0007924895,0.0014393987,0.003392784,0.00011063653,0.001793265,0.010443042,0.00058606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018345616,0.000108880515,0.0038850885,0.047983583,0.0003774727,0.000084985,0.00017803426,6.220046e-9,5.6181978e-8,0.00033532604,0.04768245,0.89918065],"study_design_scores_gemma":[0.0013115617,0.0010004863,0.00271847,0.023865508,0.00046056692,0.000047803704,0.00028589804,0.000001264004,5.824772e-7,0.000071841445,0.9698133,0.00042275226],"about_ca_topic_score_codex":0.00023565507,"about_ca_topic_score_gemma":0.00010985954,"teacher_disagreement_score":0.9221308,"about_ca_system_score_codex":0.0013144127,"about_ca_system_score_gemma":0.008381177,"threshold_uncertainty_score":0.9997451},"labels":[],"label_agreement":null},{"id":"W2915611428","doi":"10.1158/1078-0432.ccr-18-4099","title":"Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Novo Nordisk Fonden; University of Alberta; Kræftens Bekæmpelse; Canadian Dermatology Foundation","keywords":"Lymphoma; Biology; Receptor; Cell; Immunology; Cancer research; Genetics","score_opus":0.09349993334393683,"score_gpt":0.4264704848692246,"score_spread":0.33297055152528776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915611428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843856,0.0023700725,0.0000024647238,0.0030373768,0.00053516147,0.0023206556,0.00012341609,0.000017944547,0.0072073075],"genre_scores_gemma":[0.97558016,0.0018235695,0.000048680424,0.0002228741,0.00021085235,0.000048301732,0.000011578758,0.00004033737,0.022013653],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948132,0.0012519194,0.00073294487,0.00060092664,0.001916232,0.00068479695],"domain_scores_gemma":[0.9934348,0.0029221463,0.0002758403,0.0013470517,0.001789256,0.00023093786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023809958,0.00021867231,0.00069991214,0.00012893735,0.00032810096,0.000026552445,0.0012864548,0.00033054454,0.0017707873],"category_scores_gemma":[0.0013466093,0.00012214601,0.0004171337,0.0012175547,0.0016978629,0.000052842493,0.0013520258,0.0012248419,0.00030204296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012462587,0.002249602,0.89568454,0.001112454,0.00019462546,0.00002970787,0.0012329792,0.000055927736,0.036086015,0.00016351433,0.04516402,0.0055640168],"study_design_scores_gemma":[0.03727715,0.014413261,0.19835852,0.0022947036,0.0006147992,0.0002745161,0.008107035,0.0033719582,0.57864004,0.00198823,0.15320276,0.0014570302],"about_ca_topic_score_codex":0.0010975153,"about_ca_topic_score_gemma":0.00019074304,"teacher_disagreement_score":0.697326,"about_ca_system_score_codex":0.0003184283,"about_ca_system_score_gemma":0.002283287,"threshold_uncertainty_score":0.99914175},"labels":[],"label_agreement":null},{"id":"W2917891638","doi":"10.1158/1078-0432.ccr-18-2599","title":"Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"Hellenic Cooperative Oncology Group; National Cancer Institute; National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute of General Medical Sciences; Breast Cancer Research Foundation","keywords":"Trastuzumab; Cytotoxic T cell; Medicine; Cancer research; Mass cytometry; CD8; PI3K/AKT/mTOR pathway; Antibody; Immune system; Internal medicine; Oncology; Cancer; Immunology; Breast cancer; Biology; Signal transduction; Cell biology; Phenotype","score_opus":0.3013185643104747,"score_gpt":0.5159816777818874,"score_spread":0.2146631134714127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917891638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948581,0.001798973,0.000042136846,0.0001931117,0.000267431,0.0023028294,0.000054248238,0.000028067705,0.0004551044],"genre_scores_gemma":[0.9979281,0.00053049845,0.0009567487,0.000087199085,0.00018199829,0.000097429845,0.00001106137,0.00008294591,0.00012400569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923411,0.0010613869,0.0013356962,0.0009729372,0.0031107136,0.0011781821],"domain_scores_gemma":[0.99577665,0.0011240495,0.00018666442,0.0006532119,0.001713199,0.0005462487],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008977371,0.00027130745,0.000961677,0.0009055065,0.00010035534,0.000050419487,0.00035746174,0.0002341553,0.0010337282],"category_scores_gemma":[0.0018617553,0.00024542338,0.00017165462,0.0015127683,0.0005714693,0.00014131005,0.0002986577,0.0017510789,0.000047806025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009814305,0.00035455628,0.5755311,0.00045779324,0.000054905297,0.00003301521,0.00009064583,0.000059696133,0.41688398,0.0000011310891,0.00020337058,0.005348318],"study_design_scores_gemma":[0.018048313,0.0019516218,0.60344243,0.003801576,0.00007352586,0.0000038329467,0.0006129326,0.0113854585,0.35890418,0.00007100735,0.0011398381,0.00056527054],"about_ca_topic_score_codex":0.0022350803,"about_ca_topic_score_gemma":0.00012051358,"teacher_disagreement_score":0.057979815,"about_ca_system_score_codex":0.0016722522,"about_ca_system_score_gemma":0.0013162567,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W2921298834","doi":"10.1158/1078-0432.ccr-18-3767","title":"PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Rosetrees Trust; Royal College of Surgeons of England; National Institute for Health and Care Research; Sarcoma UK; Cancer Research UK; Wellcome Trust; Wellcome","keywords":"Oncolytic virus; Sarcoma; Medicine; Soft tissue sarcoma; Cancer research; Blockade; Vaccinia; Immune checkpoint; In vivo; Ex vivo; Immune system; Immunology; Immunotherapy; Pathology; Internal medicine; Biology; Receptor","score_opus":0.04330766504549396,"score_gpt":0.4263609598860653,"score_spread":0.3830532948405714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921298834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939925,0.0043881442,0.0001676849,0.00033804172,0.00012317894,0.00077820907,0.000029120238,0.000011716497,0.00017142078],"genre_scores_gemma":[0.99602073,0.002045237,0.00006814279,0.00007233456,0.00014705818,0.000059796293,0.000033617252,0.000060423317,0.0014926317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964234,0.0007530419,0.00054865127,0.00082504365,0.00079008244,0.00065976067],"domain_scores_gemma":[0.99822897,0.0002668244,0.00010251572,0.000801773,0.00027995592,0.0003199727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024223712,0.00020721443,0.00041992348,0.00010829677,0.00014058113,0.000035137306,0.0004922819,0.00033445944,0.00025377914],"category_scores_gemma":[0.0002328429,0.00016595057,0.00013786543,0.00035078137,0.000390859,0.000009911305,0.0005308451,0.0007572126,0.000036320125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031458143,0.00039653003,0.0396053,0.0001061648,0.00019780714,0.000033509907,0.00006845558,0.000051554536,0.879501,0.0000040457094,0.00046176778,0.048115727],"study_design_scores_gemma":[0.00890333,0.06112269,0.013101542,0.0004204768,0.00006186583,0.000015442838,0.00025583841,0.0016241054,0.8945411,0.00013653364,0.01915947,0.0006576211],"about_ca_topic_score_codex":0.00027968327,"about_ca_topic_score_gemma":0.0006964503,"teacher_disagreement_score":0.06072616,"about_ca_system_score_codex":0.000056403613,"about_ca_system_score_gemma":0.000547609,"threshold_uncertainty_score":0.67672676},"labels":[],"label_agreement":null},{"id":"W2922113267","doi":"10.1158/1078-0432.ccr-18-3791","title":"HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"National Natural Science Foundation of China","keywords":"Autophagy; Cancer research; Downregulation and upregulation; U87; Biology; Temozolomide; Glioma; Epithelial–mesenchymal transition; Brain tumor; Pathology; Medicine; Apoptosis; Gene","score_opus":0.12349272573939302,"score_gpt":0.4866531611964809,"score_spread":0.36316043545708787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922113267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944245,0.0012669653,0.0000033395563,0.002197109,0.00015585046,0.0010449536,0.000008340591,0.00005771884,0.0008411856],"genre_scores_gemma":[0.99674094,0.0007062427,0.000045224948,0.0003817608,0.00023495522,0.00015327713,0.000021897347,0.0000304515,0.0016852367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975367,0.0003312957,0.00051561295,0.0005295098,0.00065582985,0.00043100351],"domain_scores_gemma":[0.99822974,0.00074989034,0.00008806069,0.00035689003,0.0003271169,0.00024829485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020785672,0.00013657217,0.00038032007,0.00021859474,0.00006673844,0.000037248366,0.00013890002,0.00022974808,0.0006055223],"category_scores_gemma":[0.0009920334,0.00011912439,0.0000710422,0.00056281657,0.00018037147,0.0001468668,0.000071038776,0.0007744388,0.00014986703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013690856,0.0027211034,0.59683317,0.001478748,0.00027387842,0.00039848013,0.0010405027,0.0000036885376,0.16015819,0.0020094602,0.0028836958,0.21850823],"study_design_scores_gemma":[0.006406931,0.0015850225,0.9266144,0.0004907203,0.000019873884,0.0000053866934,0.00015331236,0.0018554004,0.060146566,0.0012282161,0.001292988,0.000201185],"about_ca_topic_score_codex":0.00014813326,"about_ca_topic_score_gemma":0.00019125173,"teacher_disagreement_score":0.32978123,"about_ca_system_score_codex":0.00020127925,"about_ca_system_score_gemma":0.0005162485,"threshold_uncertainty_score":0.66300446},"labels":[],"label_agreement":null},{"id":"W2925764871","doi":"10.1158/1078-0432.ccr-18-2811","title":"Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; AstraZeneca; Genentech; Institute of Cancer Research; National Cancer Institute; Radiological Society of North America; U.S. Department of Veterans Affairs","keywords":"Cancer research; Stromal cell; Tumor microenvironment; Fibrosis; Stroma; Tumor progression; In vivo; Radiation therapy; Pancreatic tumor; Pancreatic cancer; Medicine; Biology; Immunology; Pathology; Cancer; Internal medicine; Tumor cells; Immunohistochemistry","score_opus":0.12917069821093818,"score_gpt":0.4312660463519997,"score_spread":0.30209534814106154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925764871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970363,0.00038270923,0.00008299766,0.0012741558,0.00017954754,0.0006467354,0.00001606096,0.000027418266,0.0003540675],"genre_scores_gemma":[0.99636257,0.0018828991,0.000015326415,0.0009099806,0.000121777484,0.00008199419,0.000011856162,0.00001955056,0.0005940333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973696,0.00064771547,0.00041481794,0.00058259146,0.0006591266,0.00032615638],"domain_scores_gemma":[0.9984556,0.0010448844,0.000118740136,0.00020467941,0.000046547062,0.00012958868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012833282,0.00010434998,0.00018312989,0.00008649169,0.00018887469,0.00006878303,0.00011188201,0.000073963434,0.00030033445],"category_scores_gemma":[0.0005186454,0.00010006791,0.000045949313,0.00024696309,0.00021509598,0.00027574602,0.00010012596,0.00044755105,0.0002509524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023226227,0.00019201754,0.04610278,0.000051917264,0.0000041237927,0.0000062763174,0.000058174974,0.00008969978,0.92453104,0.00053321983,0.0023093536,0.02588913],"study_design_scores_gemma":[0.0042475127,0.0013845563,0.247283,0.00021566382,0.000017991091,0.000010163697,0.00007806388,0.015706714,0.7068969,0.0041195727,0.019612843,0.00042701804],"about_ca_topic_score_codex":0.00006404305,"about_ca_topic_score_gemma":0.0000032662533,"teacher_disagreement_score":0.21763414,"about_ca_system_score_codex":0.00014604015,"about_ca_system_score_gemma":0.000053152573,"threshold_uncertainty_score":0.4080651},"labels":[],"label_agreement":null},{"id":"W2928679018","doi":"10.1158/1078-0432.ccr-18-2683","title":"Ultra-sensitive <i>EGFR</i> T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring <i>EGFR</i> del19 Mutations and Treated with First-generation TKIs","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"T790M; Lung cancer; Mutation; Medicine; Digital polymerase chain reaction; Internal medicine; Oncology; Cancer; Incidence (geometry); Clinical significance; Tyrosine kinase; Cancer research; Epidermal growth factor receptor; Biology; Gene; Polymerase chain reaction; Gefitinib; Genetics","score_opus":0.06552080965534572,"score_gpt":0.4572230571841265,"score_spread":0.39170224752878074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928679018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928944,0.0003760919,0.00026976966,0.0008398395,0.00031328487,0.0044971933,0.0002060425,0.00006086635,0.00054248155],"genre_scores_gemma":[0.99412733,0.00062654377,0.00022624654,0.00033467603,0.0004396644,0.0026087903,0.000355497,0.00006970676,0.0012115578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725246,0.0002196146,0.0004926735,0.0008278847,0.00068439153,0.0005229601],"domain_scores_gemma":[0.9968645,0.0008274253,0.00014216178,0.00030026273,0.0014709643,0.00039468426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006406319,0.00023444546,0.00039234952,0.00018555697,0.0004507811,0.00011204604,0.00008106965,0.0001903486,0.00013074325],"category_scores_gemma":[0.0003910658,0.00018293233,0.00009273639,0.00044064273,0.00018707808,0.00032681733,0.000030250152,0.00046763528,0.000012783633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00253646,0.0008110918,0.9759237,0.00028882484,0.0005988481,0.000016312033,0.0006355761,0.00024813035,0.001581379,0.000044470835,0.00043815046,0.01687701],"study_design_scores_gemma":[0.019312402,0.008297063,0.9358913,0.0009446575,0.0014182616,0.00001619386,0.0006252087,0.015357412,0.014929166,0.000044782595,0.0026008803,0.00056272425],"about_ca_topic_score_codex":0.002916731,"about_ca_topic_score_gemma":0.006436573,"teacher_disagreement_score":0.0400325,"about_ca_system_score_codex":0.0007646872,"about_ca_system_score_gemma":0.0008347569,"threshold_uncertainty_score":0.7459764},"labels":[],"label_agreement":null},{"id":"W2932040760","doi":"10.1158/1078-0432.ccr-18-3179","title":"Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research","keywords":"Tinnitus; Medicine; Cisplatin; Genome-wide association study; Internal medicine; Logistic regression; Vertigo; SNP; Oncology; Audiology; Single-nucleotide polymorphism; Chemotherapy; Surgery; Genetics; Biology; Genotype","score_opus":0.37200874438749126,"score_gpt":0.5347343641947591,"score_spread":0.1627256198072678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932040760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578106,0.00012515097,0.00046495738,0.0006427353,0.000344051,0.0010382627,0.00007906424,0.00005437242,0.0014703427],"genre_scores_gemma":[0.995908,0.00090608397,0.001108889,0.0008593732,0.00019203985,0.00007805058,0.000005428207,0.000061203886,0.0008809103],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99258745,0.0012443222,0.0019926722,0.0016886086,0.001417456,0.0010695197],"domain_scores_gemma":[0.9872708,0.009620527,0.0003939685,0.0015194901,0.0005312423,0.00066400453],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008442847,0.00027478827,0.0011907078,0.0006503576,0.00020124929,0.00011405728,0.001143081,0.00047048,0.0008493778],"category_scores_gemma":[0.010910057,0.00025432438,0.0004459334,0.0029160762,0.0010138222,0.000110693465,0.0012080388,0.0018272682,0.00028857178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031259452,0.00045030628,0.37150547,0.000077047465,0.00022613448,0.000010520853,0.00009819128,0.00007841899,0.6193132,0.0011208152,0.00009686179,0.006710426],"study_design_scores_gemma":[0.0019221148,0.0012343444,0.93094283,0.000054905584,0.00022631921,0.0000032442051,0.000077131706,0.0050634835,0.055893663,0.0010915789,0.003075949,0.00041446197],"about_ca_topic_score_codex":0.0003163749,"about_ca_topic_score_gemma":0.00014571355,"teacher_disagreement_score":0.5634195,"about_ca_system_score_codex":0.00008221457,"about_ca_system_score_gemma":0.00063227874,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2933974970","doi":"10.1158/1078-0432.ccr-18-3558","title":"Molecular Characterization of Neuroendocrine-like Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada); University of British Columbia","funders":"","keywords":"Bladder cancer; Cystectomy; Medicine; Cohort; Oncology; Internal medicine; Subtyping; Cancer; Neuroendocrine tumors; Pathology; Prospective cohort study","score_opus":0.13018276175129784,"score_gpt":0.49513753211973555,"score_spread":0.3649547703684377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933974970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909763,0.00079101045,0.000012307255,0.003140613,0.00080861663,0.00102033,0.00007896391,0.00003233415,0.003139554],"genre_scores_gemma":[0.9891341,0.0031313268,0.000020399719,0.0013483503,0.00037522457,0.0002196237,0.000035866215,0.00005103354,0.005684105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737465,0.00025167892,0.0005465936,0.0005155108,0.0008395749,0.00047196282],"domain_scores_gemma":[0.99836403,0.0001612006,0.00010222965,0.00056999613,0.0005439694,0.0002585521],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004367883,0.00015084863,0.00049483596,0.00014562091,0.000043642853,0.000016490892,0.00019598716,0.00008404851,0.003593887],"category_scores_gemma":[0.00010603667,0.00012345408,0.0001987448,0.0004993185,0.00022200635,0.000081750164,0.00012141327,0.0006111681,0.00019244997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027794011,0.00091714057,0.6598097,0.0004542861,0.00058484025,0.00017222647,0.0001026212,0.000011420145,0.28049037,0.00023971147,0.0027260263,0.05171226],"study_design_scores_gemma":[0.009016347,0.0028000963,0.7541106,0.00049037323,0.00026036202,0.000019797499,0.000053775362,0.00028988783,0.12898067,0.00013219705,0.103524774,0.00032112657],"about_ca_topic_score_codex":0.0006768441,"about_ca_topic_score_gemma":0.000027174263,"teacher_disagreement_score":0.15150972,"about_ca_system_score_codex":0.00011184917,"about_ca_system_score_gemma":0.00078668015,"threshold_uncertainty_score":0.99731696},"labels":[],"label_agreement":null},{"id":"W2937760511","doi":"10.1158/1078-0432.ccr-18-3818","title":"Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Alberta; Western University","funders":"","keywords":"Biomarker; Serous fluid; Ovarian cancer; Ovarian carcinoma; Proteomics; Medicine; Oncology; Serous carcinoma; Carcinoma; Pathology; Internal medicine; Cancer; Biology","score_opus":0.15454026730898407,"score_gpt":0.4503316551360649,"score_spread":0.2957913878270808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937760511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916533,0.00042697875,0.002255317,0.0025639988,0.000108649336,0.0020699024,0.0001279761,0.00012178343,0.00067204994],"genre_scores_gemma":[0.97558117,0.0011580123,0.01872265,0.00016175896,0.00030599625,0.0024494377,0.00002611238,0.00007039945,0.0015244866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968434,0.00014626009,0.0006970016,0.0010659057,0.00053871545,0.0007087272],"domain_scores_gemma":[0.99421275,0.0038316979,0.00014047229,0.0010193323,0.00030637468,0.0004893816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013367961,0.00024045551,0.00045929296,0.0001900807,0.00022867722,0.00012842508,0.00064065575,0.0003859514,0.0005095596],"category_scores_gemma":[0.002599658,0.00021563463,0.000111942994,0.000645213,0.0003024912,0.000115588016,0.0007600176,0.0011841937,0.00013105564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056889176,0.00024353205,0.042328246,0.00018013862,0.000041789885,0.0000113260385,0.000060803563,0.000005843948,0.8618409,0.00062471436,0.0010446387,0.093049176],"study_design_scores_gemma":[0.0049545453,0.0009608537,0.18802983,0.00044852833,0.000046549172,0.000016023663,0.00020295441,0.0011102693,0.7492273,0.016020093,0.03796728,0.0010157743],"about_ca_topic_score_codex":0.0008377452,"about_ca_topic_score_gemma":0.00004931138,"teacher_disagreement_score":0.14570159,"about_ca_system_score_codex":0.00023794327,"about_ca_system_score_gemma":0.0002559986,"threshold_uncertainty_score":0.8793325},"labels":[],"label_agreement":null},{"id":"W2939485990","doi":"10.1158/1078-0432.ccr-19-0624","title":"Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":597,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Medicine; Cancer; Cell-free fetal DNA; Cell; Oncology; Pathology; Bioinformatics; Internal medicine; Biology; Genetics","score_opus":0.06481302330116015,"score_gpt":0.4362565269020118,"score_spread":0.37144350360085165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939485990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497914,0.0018103687,0.00017871195,0.00014587434,0.00040511938,0.001627651,0.0005942362,0.0000046011164,0.00025428535],"genre_scores_gemma":[0.9958008,0.0023771608,0.0007666412,0.00038467618,0.00015825707,0.00018402707,0.00014140482,0.000047595626,0.0001394671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955755,0.00065893744,0.0012995212,0.0011907862,0.0005738269,0.00070142176],"domain_scores_gemma":[0.9957336,0.0011281488,0.00031606414,0.0014682981,0.0009143928,0.0004394838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020646802,0.00027233787,0.00091021747,0.00030672274,0.000061978004,0.000047076788,0.0009552669,0.00025574357,0.00027920003],"category_scores_gemma":[0.00044141855,0.0002476141,0.00042643637,0.0010481003,0.00035995737,0.000007767684,0.0008939533,0.0005577331,0.000021860204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002437199,0.00080716907,0.98258317,0.00017463377,0.0010331902,0.000007814171,0.000050972736,0.0012189243,0.0040892567,0.0000011040506,0.005362188,0.0022343965],"study_design_scores_gemma":[0.007293513,0.0011375098,0.9851413,0.000056669793,0.00040073905,5.1669335e-8,0.0001329243,0.00067240425,0.0027833208,0.000011592806,0.0020626285,0.00030739536],"about_ca_topic_score_codex":0.0039652367,"about_ca_topic_score_gemma":0.007022989,"teacher_disagreement_score":0.004856314,"about_ca_system_score_codex":0.00012143835,"about_ca_system_score_gemma":0.0011241676,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W2939906752","doi":"10.1158/1078-0432.ccr-17-0375","title":"High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Optometric Education Trust Fund; Dalhousie University; Izaak Walton Killam Health Centre","funders":"National Cancer Institute; Pediatric Cancer Research Foundation","keywords":"Sarcoma; Ewing's sarcoma; Cancer research; Medicine; Focal adhesion; Aurora inhibitor; Aurora kinase; Kinase; Malignancy; Aurora B kinase; Cell growth; Internal medicine; Pathology; Cell; Biology; Cancer; Cell cycle; Cell biology; Biochemistry","score_opus":0.07070187374029319,"score_gpt":0.4188239804210002,"score_spread":0.34812210668070703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939906752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976,0.0009938917,0.00017963983,0.0004431809,0.00016555343,0.0004903348,0.000017987186,0.000010740206,0.00009867018],"genre_scores_gemma":[0.99706346,0.0016377105,0.00021057672,0.00012269162,0.00023340623,0.00010346117,0.000202853,0.000026691829,0.00039912778],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978732,0.00034277517,0.00043861778,0.00066143763,0.00028747207,0.0003965228],"domain_scores_gemma":[0.9991019,0.00019830294,0.000070145004,0.00033274648,0.00015399297,0.00014294375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096062355,0.00016112803,0.00026981303,0.00010612627,0.00009233878,0.000067667235,0.0001242069,0.00028956894,0.000046188794],"category_scores_gemma":[0.00040170937,0.00015162358,0.00009361642,0.00018040916,0.00023299809,0.000015348804,0.00035562084,0.00034554038,0.000028804292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008215315,0.00046054582,0.012835169,0.00007988551,0.000039473118,0.00004364499,0.00005959013,0.00003343886,0.9517677,0.0004521192,0.00040306343,0.033003833],"study_design_scores_gemma":[0.007817635,0.0031581507,0.01787332,0.00049231015,0.000041299903,0.0000110322735,0.00030512235,0.0016896878,0.96275836,0.0017482792,0.0036145528,0.0004902353],"about_ca_topic_score_codex":0.0012035626,"about_ca_topic_score_gemma":0.00032736035,"teacher_disagreement_score":0.032513596,"about_ca_system_score_codex":0.00012539733,"about_ca_system_score_gemma":0.00016403654,"threshold_uncertainty_score":0.618303},"labels":[],"label_agreement":null},{"id":"W2940145740","doi":"10.1158/1078-0432.ccr-18-3691","title":"Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"Medical Research and Materiel Command; National Health and Medical Research Council","keywords":"Clear cell carcinoma; Oncology; Medicine; Clear cell; Ovarian cancer; Clear-cell adenocarcinoma; Internal medicine; Olaparib; Chemotherapy; Exome sequencing; ARID1A; Exome; Cancer; Serous fluid; Carcinoma; Progression-free survival; Biology; Mutation; Gene","score_opus":0.19237824006158244,"score_gpt":0.4506798602280149,"score_spread":0.25830162016643243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940145740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888229,0.00031446622,0.0000031103827,0.0055099777,0.00025316374,0.0008456105,0.000022354117,0.000014570582,0.00421387],"genre_scores_gemma":[0.997633,0.00018033833,0.00013419286,0.0005956448,0.00011516667,0.00010451727,0.00001727117,0.00003614778,0.0011837379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971217,0.000434277,0.000585188,0.00061150355,0.00081245805,0.00043490395],"domain_scores_gemma":[0.9980399,0.0008499809,0.00014754015,0.00050747825,0.00027328022,0.00018182586],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023705943,0.00014940105,0.00066189363,0.0001277018,0.00004574608,0.000015531772,0.0001720286,0.00019053034,0.0011085168],"category_scores_gemma":[0.00025471588,0.00010960665,0.00019286579,0.000552804,0.00018513938,0.000044324945,0.000044866094,0.0007033712,0.000060605194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031484673,0.0015168643,0.9899474,0.000067226,0.00008040809,0.0001381968,0.00021018319,0.0000020830828,0.0019084534,0.00007803903,0.0008108277,0.0020919002],"study_design_scores_gemma":[0.009322752,0.0029144613,0.9804506,0.00021577961,0.000046878336,8.065663e-7,0.0001216749,0.00009560136,0.004749347,0.000032005715,0.0019326101,0.000117502794],"about_ca_topic_score_codex":0.0007110084,"about_ca_topic_score_gemma":0.00015085924,"teacher_disagreement_score":0.009496771,"about_ca_system_score_codex":0.0005628304,"about_ca_system_score_gemma":0.00070672325,"threshold_uncertainty_score":0.9998046},"labels":[],"label_agreement":null},{"id":"W2942128858","doi":"10.1158/1078-0432.ccr-19-0404","title":"Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Prostate Cancer Foundation","keywords":"Cancer; Prostate cancer; Oncology; DNA methylation; Gene signature; Transcriptome; Internal medicine; Breast cancer; Medicine; Biology; Cancer research; Gene; Gene expression; Genetics","score_opus":0.23426778806581544,"score_gpt":0.5628657953480856,"score_spread":0.3285980072822701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942128858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684463,0.004353965,0.0000059481313,0.021960372,0.0010523548,0.002074322,0.000722964,0.000114490875,0.001269242],"genre_scores_gemma":[0.9462982,0.005934433,0.000057315377,0.0033213536,0.0007409779,0.00039158636,0.00008781301,0.0001219064,0.043046445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99304783,0.00056138245,0.001141535,0.001375653,0.0021439188,0.0017296819],"domain_scores_gemma":[0.9940617,0.0024553903,0.00019410347,0.0008876863,0.0015220975,0.0008790261],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005035189,0.000417242,0.0015038511,0.00016968537,0.00030419187,0.0001392221,0.0006367046,0.0008567582,0.0033583492],"category_scores_gemma":[0.00094640243,0.000262211,0.0006376005,0.0011025545,0.0015425055,0.00019258154,0.00018370575,0.0040436997,0.00042729592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069788373,0.0014679942,0.9623464,0.00016527732,0.0019238564,0.00015483882,0.00035139566,0.0000057076622,0.001222579,0.000029282572,0.016727395,0.008626484],"study_design_scores_gemma":[0.027123606,0.0034048606,0.926375,0.0010309083,0.00026935028,0.000010438387,0.00034266507,0.00022194786,0.0019618338,0.000083819425,0.03864215,0.0005334674],"about_ca_topic_score_codex":0.0016063141,"about_ca_topic_score_gemma":0.0016159675,"teacher_disagreement_score":0.0417772,"about_ca_system_score_codex":0.0006897625,"about_ca_system_score_gemma":0.0027802857,"threshold_uncertainty_score":0.999983},"labels":[],"label_agreement":null},{"id":"W2942271214","doi":"10.1158/1078-0432.ccr-18-3143","title":"Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Society for Women’s Health Research","keywords":"Medicine; Breast cancer; Body mass index; Cancer; Randomized controlled trial; Internal medicine; Oncology; Physical therapy","score_opus":0.11206343466306762,"score_gpt":0.5397543559851399,"score_spread":0.42769092132207226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942271214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879255,0.0040764664,0.000006454102,0.0027817558,0.0002627235,0.0040079844,0.00085383956,0.000017162689,0.00006810283],"genre_scores_gemma":[0.99431247,0.0035981236,0.000011622988,0.00018852249,0.00048361692,0.00061696867,0.000066739216,0.000027768025,0.00069418835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573356,0.0014730551,0.0008251067,0.0008001968,0.00081675476,0.00035130448],"domain_scores_gemma":[0.997182,0.0009677976,0.00021415914,0.00061693677,0.00065927464,0.00035981022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026731524,0.00021243912,0.00066790194,0.000089930414,0.00020527464,0.000085431115,0.00016580266,0.00013613688,0.00033234397],"category_scores_gemma":[0.00032676023,0.0001235845,0.00014911073,0.00028851564,0.00029454587,0.00016708396,0.0002230633,0.0009404723,0.0000051888996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051728625,0.0013874276,0.86399984,0.00015211565,0.00028314113,0.000005194426,0.032501746,0.00003575133,0.0010358747,0.00000623753,0.0027492794,0.046114746],"study_design_scores_gemma":[0.0074256705,0.009436389,0.9753088,0.002147266,0.000047154317,0.0000025253744,0.0042267786,0.00035030747,0.0008198824,0.000021512607,0.00008551779,0.00012819415],"about_ca_topic_score_codex":0.035040244,"about_ca_topic_score_gemma":0.006891065,"teacher_disagreement_score":0.11130894,"about_ca_system_score_codex":0.0003044756,"about_ca_system_score_gemma":0.0010165088,"threshold_uncertainty_score":0.9713855},"labels":[],"label_agreement":null},{"id":"W2942554478","doi":"10.1158/1078-0432.ccr-18-2867","title":"Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Interim analysis; Placebo; Breast cancer; Internal medicine; Asymptomatic; Adverse effect; Surgery; Erythema; Biopsy; Cancer; Randomized controlled trial; Gastroenterology; Pathology","score_opus":0.11000180835145747,"score_gpt":0.5228560650361491,"score_spread":0.41285425668469167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942554478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739702,0.017489906,0.000046271474,0.0018111952,0.0022817797,0.003922282,0.00037877186,0.00002543618,0.000074154465],"genre_scores_gemma":[0.9547785,0.04064169,0.000023471915,0.00030822644,0.00022054318,0.00040202914,0.000074627664,0.000028037653,0.0035228813],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9878952,0.0074060177,0.002757961,0.00094007666,0.00024128464,0.0007594661],"domain_scores_gemma":[0.9862498,0.011659676,0.00047008155,0.00089876476,0.0005748128,0.00014685643],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015785785,0.00028874818,0.002621606,0.00055499555,0.00020116339,0.000032422413,0.0006682016,0.000517496,0.0065941913],"category_scores_gemma":[0.0024352302,0.00021461924,0.00092173665,0.0011700368,0.0009108783,0.000102485494,0.00041984057,0.0014972271,0.00016114375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8078462,0.002909865,0.0028290749,0.000025967198,0.0053543015,0.0000021048638,0.0002341671,0.000014817716,0.0032162636,0.000036083984,0.0016461347,0.175885],"study_design_scores_gemma":[0.9314612,0.003906793,0.027685266,0.0003031615,0.0011978691,0.0000041801254,0.00011775874,0.00012498756,0.001075269,0.000011788655,0.033802435,0.0003092983],"about_ca_topic_score_codex":0.0018677871,"about_ca_topic_score_gemma":0.00017054997,"teacher_disagreement_score":0.1755757,"about_ca_system_score_codex":0.00009327245,"about_ca_system_score_gemma":0.00058888644,"threshold_uncertainty_score":0.9943139},"labels":[],"label_agreement":null},{"id":"W2942989498","doi":"10.1158/1078-0432.ccr-18-3270","title":"Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Obinutuzumab; Follicular lymphoma; CHOP; Medicine; Rituximab; Lymphoma; Internal medicine; Vincristine; Diffuse large B-cell lymphoma; Non-Hodgkin's lymphoma; Hazard ratio; Oncology; Immunology; Chemotherapy; Cyclophosphamide; Confidence interval","score_opus":0.024021417322887904,"score_gpt":0.3592285603756434,"score_spread":0.33520714305275545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942989498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403393,0.0038595553,0.0000010571397,0.000035939865,0.0007961404,0.00074572576,0.00001105818,0.00001723265,0.00049937365],"genre_scores_gemma":[0.99015635,0.0011780232,0.0000035789742,0.00007180583,0.000017085164,0.00005342505,0.000113061884,0.000029473398,0.008377216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782014,0.0005795275,0.0005161834,0.0004256631,0.00013378297,0.00052473124],"domain_scores_gemma":[0.9985429,0.0005685945,0.00015875022,0.0003478157,0.00034095562,0.000040993295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006990505,0.00019204135,0.00043822767,0.0001976701,0.000085394575,0.000022157814,0.0001893348,0.0002842379,0.00091652834],"category_scores_gemma":[0.0000935684,0.00013127681,0.00014943069,0.00032066728,0.000247507,0.00012306632,0.00008772957,0.0004307059,0.0002152926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067503573,0.0057826554,0.9532475,0.000056519777,0.00016858119,0.0000036959045,0.00019801338,0.0000013498036,0.027654756,0.0000057844436,0.0024055159,0.003725259],"study_design_scores_gemma":[0.042170774,0.0030678657,0.92985827,0.00012868237,0.000019381205,0.0000038406506,0.0001320257,0.000067513385,0.014860532,0.000003656625,0.009493437,0.00019404436],"about_ca_topic_score_codex":0.001612352,"about_ca_topic_score_gemma":0.00006877415,"teacher_disagreement_score":0.035420414,"about_ca_system_score_codex":0.00026516753,"about_ca_system_score_gemma":0.00025144374,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W2944179533","doi":"10.1158/1078-0432.ccr-19-0191","title":"<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Lunenfeld-Tanenbaum Research Institute; Vancouver General Hospital; Ontario Institute for Cancer Research; Simon Fraser University; Princess Margaret Cancer Centre; BC Cancer Agency; Pancreas Centre (Canada); Canada's Michael Smith Genome Sciences Centre","funders":"BC Cancer Foundation; Genome British Columbia; Pfizer; Eli Lilly and Company","keywords":"KRAS; Afatinib; Adenocarcinoma; Pancreatic cancer; Cancer research; Medicine; Fusion gene; Oncology; ERBB3; Neuregulin 1; Cancer; Biology; Gene; Internal medicine; Erlotinib; Genetics; Epidermal growth factor receptor; Receptor; Colorectal cancer","score_opus":0.22018577451081692,"score_gpt":0.5155043420277728,"score_spread":0.29531856751695595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944179533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97736305,0.0045722844,0.0000077611285,0.0047476604,0.0011155152,0.0023416122,0.000053678606,0.000064179025,0.009734282],"genre_scores_gemma":[0.95417345,0.022323817,0.0011149389,0.0013358486,0.0014728565,0.00041658964,0.0001141466,0.00008780043,0.018960534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99188536,0.0015775067,0.001782521,0.0013559508,0.0018724034,0.0015262535],"domain_scores_gemma":[0.9933218,0.0029364948,0.00027666806,0.0013520624,0.0011952451,0.00091775804],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00804536,0.00033115817,0.0015707039,0.00046666162,0.00026589734,0.000056255638,0.00063628383,0.0006374682,0.0045961575],"category_scores_gemma":[0.0041241054,0.00028226618,0.00031820548,0.0016845487,0.00078455714,0.00017452435,0.000587564,0.0032584628,0.0023446977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005466649,0.0013795258,0.96287245,0.00021282297,0.00027732048,0.00037351018,0.000098760014,0.0000038097282,0.0036598374,0.000033339733,0.023595925,0.0020260594],"study_design_scores_gemma":[0.0076660295,0.003418401,0.9691888,0.00061506435,0.00018621891,0.000060696613,0.0003493491,0.00040552526,0.00023299588,0.00033056238,0.017240966,0.0003053934],"about_ca_topic_score_codex":0.0010433893,"about_ca_topic_score_gemma":0.0003281425,"teacher_disagreement_score":0.023189558,"about_ca_system_score_codex":0.0006742559,"about_ca_system_score_gemma":0.0026827427,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W2944276509","doi":"10.1158/1557-3265.tcm17-b30","title":"Abstract B30: PTEN loss associates with type I and II IFN response in prostate cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; Biology; Prostate cancer; Cancer research; Tumor microenvironment; Cancer; Transcriptome; Immune system; Gene; Gene expression; Immunology; PI3K/AKT/mTOR pathway; Genetics; Signal transduction","score_opus":0.08638003052394248,"score_gpt":0.4790214721481295,"score_spread":0.392641441624187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944276509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885537,0.0074136998,8.095259e-7,0.0014968949,0.0015920836,0.00032303945,0.000064419924,0.000009164704,0.0005461931],"genre_scores_gemma":[0.9724957,0.014491664,0.000040312807,0.00041027128,0.008111042,0.00012988625,0.000013425257,0.000034410084,0.00427334],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978096,0.0003322219,0.00034652365,0.0005987157,0.00034078734,0.0005721878],"domain_scores_gemma":[0.99848545,0.00017602005,0.000079292346,0.0003510325,0.0006987235,0.0002094582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030316988,0.00014560299,0.00027623324,0.000078075194,0.00018551222,0.000044231696,0.00022834801,0.00020573768,0.00013298086],"category_scores_gemma":[0.0009188506,0.00011605139,0.000044637334,0.0003643429,0.0009394862,0.000009105509,0.0002602661,0.0004888755,0.000014579759],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07141753,0.00059565104,0.44241205,0.00013344898,0.0003398382,0.000010927831,0.0010798622,0.000024002638,0.19145311,0.000043785873,0.21362294,0.07886683],"study_design_scores_gemma":[0.0016771439,0.0013268791,0.43247128,0.00007998885,0.000009972408,0.0000018282012,0.00009552385,0.0000073966107,0.0035658206,0.00005618228,0.5605312,0.00017680983],"about_ca_topic_score_codex":0.0018499416,"about_ca_topic_score_gemma":0.006698433,"teacher_disagreement_score":0.34690824,"about_ca_system_score_codex":0.000065960485,"about_ca_system_score_gemma":0.0012484891,"threshold_uncertainty_score":0.47324383},"labels":[],"label_agreement":null},{"id":"W2945998739","doi":"10.1158/1078-0432.ccr-19-0585","title":"Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Science and Technology Planning Project of Guangdong Province; National Key Research and Development Program of China; Sun Yat-sen University; National Natural Science Foundation of China","keywords":"Lung cancer; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer; Copy-number variation; Cancer research; Gene; Biology; Genetics; Genome","score_opus":0.1172463546394366,"score_gpt":0.4609627422534374,"score_spread":0.3437163876140008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945998739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834629,0.0112720765,0.000018027786,0.0013248784,0.00093311403,0.0027527944,0.000083991035,0.000022584443,0.00012957392],"genre_scores_gemma":[0.9910864,0.0051751337,0.0003609245,0.00047915752,0.00033248737,0.0003226272,0.0000059653553,0.000060913346,0.0021763647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99629164,0.000491383,0.0010757202,0.0007254059,0.0007228604,0.0006930192],"domain_scores_gemma":[0.99697244,0.0012955498,0.00016853434,0.00070063,0.00063228543,0.00023057169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027222876,0.00022832275,0.00077618106,0.0004990139,0.00007278147,0.0000381609,0.00043534389,0.00023964504,0.00059417204],"category_scores_gemma":[0.00018640707,0.00019489217,0.00024395791,0.0009013387,0.00042083114,0.000060278206,0.00023989352,0.0008393432,0.00003398605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016302342,0.00021091539,0.4861114,0.0005203045,0.00016544532,0.000011877378,0.0009629649,0.00015522687,0.49295104,6.4310285e-7,0.00043737204,0.0021704766],"study_design_scores_gemma":[0.005979656,0.0009808459,0.94597685,0.0008403871,0.00004160662,0.0000024377948,0.0009574824,0.00038652742,0.040340394,0.000004927283,0.0042840946,0.00020481108],"about_ca_topic_score_codex":0.0034891386,"about_ca_topic_score_gemma":0.0004859866,"teacher_disagreement_score":0.45986545,"about_ca_system_score_codex":0.00044655442,"about_ca_system_score_gemma":0.0014932383,"threshold_uncertainty_score":0.7947472},"labels":[],"label_agreement":null},{"id":"W2946829725","doi":"10.1158/1078-0432.ccr-18-3212","title":"Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK; Astex Pharmaceuticals","keywords":"Abiraterone acetate; Prostate cancer; Pharmacodynamics; Abiraterone; Medicine; Cancer; Prostate; Oncology; Internal medicine; Pharmacology; Pharmacokinetics; Androgen deprivation therapy; Androgen receptor","score_opus":0.15383574239290693,"score_gpt":0.5354631624239391,"score_spread":0.38162742003103217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946829725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819137,0.0013116348,1.3895104e-7,0.004978815,0.00029685994,0.0048602633,0.00022581796,0.000013200224,0.000121908335],"genre_scores_gemma":[0.9923242,0.004853456,0.000014390467,0.00010238085,0.00014355715,0.00045306145,0.000039890936,0.000037135287,0.0020319403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99460393,0.0013568562,0.0013614831,0.00090923737,0.001172929,0.0005955709],"domain_scores_gemma":[0.997239,0.001238856,0.00023326087,0.00057553005,0.00046884245,0.00024454427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045823855,0.00020996481,0.00078576326,0.00027588822,0.00010058436,0.000028992657,0.00028752195,0.000142593,0.0001162481],"category_scores_gemma":[0.00037807308,0.00012464935,0.00008459351,0.001091954,0.00075428595,0.00014577853,0.00041394634,0.0019256979,0.000009431659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052936558,0.0095339175,0.8965112,0.000120696495,0.00020895577,0.00011347482,0.0018475504,0.000028194756,0.0016315752,0.0000029968726,0.000258527,0.036806338],"study_design_scores_gemma":[0.14689845,0.015492312,0.8317275,0.0011922077,0.000073620635,0.0000013084497,0.0011263271,0.001769454,0.00090236735,0.0000681349,0.0005832872,0.00016504651],"about_ca_topic_score_codex":0.0077588097,"about_ca_topic_score_gemma":0.012700949,"teacher_disagreement_score":0.0939619,"about_ca_system_score_codex":0.00040867654,"about_ca_system_score_gemma":0.0012859821,"threshold_uncertainty_score":0.9988486},"labels":[],"label_agreement":null},{"id":"W2947885304","doi":"10.1158/1078-0432.ccr-18-3720","title":"Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Government of Canada","keywords":"Epithelial ovarian cancer; Ovarian cancer; Methylation; Biology; DNA methylation; Computational biology; Cancer research; Oncology; Pathology; Cancer; Medicine; Gene; Genetics; Gene expression","score_opus":0.5404776784566071,"score_gpt":0.5762779312042575,"score_spread":0.03580025274765042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947885304","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05998175,0.0033699824,0.0012419552,0.921034,0.0031313638,0.008966281,0.0016717454,0.0000580954,0.00054485037],"genre_scores_gemma":[0.79577965,0.004477116,0.0019270147,0.16773659,0.015892787,0.011041322,0.0016014529,0.00037926305,0.0011648312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99321795,0.0013487667,0.001228193,0.0014551368,0.002024455,0.0007255009],"domain_scores_gemma":[0.9889268,0.007079883,0.0005442421,0.0014563213,0.0018125686,0.00018016947],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045732525,0.00039251446,0.0012687355,0.00036369875,0.00010969092,0.00004870432,0.00042227816,0.0012251996,0.0002688152],"category_scores_gemma":[0.0025758753,0.0003229147,0.0007691935,0.00049056724,0.00036623672,0.00006671661,0.00008048839,0.00249394,0.000037444683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020903407,0.002895299,0.27005076,0.01240633,0.003205288,0.00028000603,0.00007034646,0.0012637164,0.013350479,0.0006442745,0.58307064,0.09185944],"study_design_scores_gemma":[0.022872578,0.012915893,0.21567419,0.012998425,0.002872626,0.0000023564403,0.000026379616,0.019528084,0.12834883,0.00053571945,0.5827316,0.0014933072],"about_ca_topic_score_codex":0.0008679556,"about_ca_topic_score_gemma":0.00008704163,"teacher_disagreement_score":0.7532974,"about_ca_system_score_codex":0.0010988604,"about_ca_system_score_gemma":0.0040002135,"threshold_uncertainty_score":0.9999223},"labels":[],"label_agreement":null},{"id":"W2951103000","doi":"10.1158/1557-3265.sarcomas17-a04","title":"Abstract A04: Molecular characterization of undifferentiated pleomorphic sarcomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Somatic cell; Biology; KRAS; Gene; Sarcoma; Exome sequencing; Cancer research; ATRX; Exome; Genome; Cancer; Genetics; Mutation; Pathology; Medicine","score_opus":0.26131973651851625,"score_gpt":0.5247509745961815,"score_spread":0.2634312380776652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951103000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563736,0.00050928333,0.000020203162,0.0021285617,0.00019642622,0.00048635234,0.00003531753,0.000025127103,0.0009613718],"genre_scores_gemma":[0.99814534,0.00081761973,0.00004706639,0.00024214879,0.00037389522,0.00008274817,0.00008952631,0.00002525165,0.00017640837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979346,0.00018645117,0.00054659584,0.00034635904,0.000647229,0.00033875715],"domain_scores_gemma":[0.9981758,0.00033444175,0.00011193797,0.0004413649,0.0007115095,0.00022496197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009245395,0.0001085398,0.00038097837,0.000148803,0.00007358809,0.000017555914,0.0001365486,0.00014778819,0.0022127426],"category_scores_gemma":[0.00037997228,0.00008430332,0.00015374742,0.0004045112,0.00053661724,0.000038439717,0.00008630415,0.0003759732,0.00019156832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009046643,0.0022602645,0.7367158,0.00013086923,0.0003298691,0.00014665377,0.00007091437,8.900955e-8,0.20813699,0.00041117647,0.0008876179,0.050005075],"study_design_scores_gemma":[0.0017663613,0.0007185979,0.9147488,0.00021397701,0.000055814347,0.0000028981374,0.000010854007,0.00003506256,0.07952559,0.00015902039,0.0026959467,0.000067113426],"about_ca_topic_score_codex":0.00026618308,"about_ca_topic_score_gemma":0.000043160442,"teacher_disagreement_score":0.17803295,"about_ca_system_score_codex":0.00008696507,"about_ca_system_score_gemma":0.00028368577,"threshold_uncertainty_score":0.99869937},"labels":[],"label_agreement":null},{"id":"W2951414864","doi":"10.1158/1078-0432.ccr-18-1897","title":"Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hyundai Hope On Wheels; Hyundai Motor Group; National Cancer Institute; St. Baldrick's Foundation","keywords":"Gemtuzumab ozogamicin; Medicine; Exon; Myeloid leukemia; Mutation; Internal medicine; Core binding factor; Cancer research; Oncology; Targeted therapy; Tyrosine kinase; Transfection; Cytokine; CD33; Cancer; Biology; Receptor; Gene; Genetics; Stem cell; CD34","score_opus":0.1810267263433989,"score_gpt":0.45773596769156527,"score_spread":0.2767092413481664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951414864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891753,0.00026801266,0.000020157579,0.008299139,0.00022786784,0.0017811839,0.00008876378,0.000042612144,0.00009694721],"genre_scores_gemma":[0.99287796,0.00048514502,0.00012169216,0.00097055204,0.00015974202,0.00022677975,0.000035724446,0.00006542088,0.0050569833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932618,0.0021887305,0.0012816007,0.0008133748,0.0016652078,0.0007892701],"domain_scores_gemma":[0.99266,0.004625615,0.00020707893,0.000645999,0.0013674081,0.0004939294],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0062906174,0.0002552858,0.0011261388,0.00049742026,0.00012411166,0.000049474456,0.00032402066,0.00043203324,0.00032276314],"category_scores_gemma":[0.0045520305,0.00017344038,0.00020687496,0.0011447709,0.0011622967,0.000117498355,0.00037095862,0.002470398,0.000085129315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037187476,0.0005611512,0.94269544,0.00007947664,0.00085420883,0.00006176391,0.00028882053,0.000028644212,0.014280661,0.000015620068,0.001308817,0.002637892],"study_design_scores_gemma":[0.01006827,0.0025695926,0.9829148,0.0004868133,0.000118344695,0.000005777197,0.0004825273,0.0005670054,0.001809796,0.000031903648,0.0007463036,0.00019888915],"about_ca_topic_score_codex":0.00032542186,"about_ca_topic_score_gemma":0.0005221958,"teacher_disagreement_score":0.040219307,"about_ca_system_score_codex":0.0010041316,"about_ca_system_score_gemma":0.004316982,"threshold_uncertainty_score":0.99983096},"labels":[],"label_agreement":null},{"id":"W2952952213","doi":"10.1158/1078-0432.ccr-18-3399","title":"Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"KRAS; Farnesyltransferase; Cancer research; Pancreatic cancer; Prenylation; Cancer; PI3K/AKT/mTOR pathway; Carcinogenesis; EGFR inhibitors; Apoptosis; Mutant; Biology; Epidermal growth factor receptor; Medicine; Colorectal cancer; Internal medicine; Biochemistry","score_opus":0.05554643379333524,"score_gpt":0.383106300371298,"score_spread":0.32755986657796277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952952213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597025,0.0020486477,0.00007250379,0.0005768556,0.0001931329,0.00083759334,0.0000522584,0.000019760082,0.00022898529],"genre_scores_gemma":[0.9977376,0.0009014669,0.00011602027,0.0003182529,0.00049815106,0.00012744965,0.00005751072,0.000037544847,0.0002060346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972589,0.0005344177,0.0005362764,0.00069939106,0.0004634041,0.00050758343],"domain_scores_gemma":[0.99876153,0.00017380583,0.000068739304,0.0004171078,0.0002573296,0.0003214641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009764827,0.00019072095,0.0003365374,0.00008067426,0.00016615374,0.000065696586,0.00014692367,0.00024039204,0.00032302857],"category_scores_gemma":[0.0003208533,0.00016680965,0.00014818745,0.00017615332,0.00035110782,0.0000104441415,0.00015477095,0.00044459436,0.000045199373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007688739,0.00012911888,0.009415008,0.00008742176,0.00006775514,0.00003554911,0.00012868627,0.000051882438,0.9723739,0.00008220941,0.00033620422,0.016523391],"study_design_scores_gemma":[0.0053516272,0.0026377374,0.013740843,0.00037740133,0.000041227086,0.000034286913,0.00033392923,0.00095307577,0.9330822,0.0002977009,0.042446136,0.00070382317],"about_ca_topic_score_codex":0.00008819124,"about_ca_topic_score_gemma":0.000054075368,"teacher_disagreement_score":0.042109933,"about_ca_system_score_codex":0.000030371484,"about_ca_system_score_gemma":0.0003159496,"threshold_uncertainty_score":0.68023},"labels":[],"label_agreement":null},{"id":"W2953124185","doi":"10.1158/1078-0432.ccr-17-1928","title":"Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Terry Fox Research Institute","keywords":"Ponatinib; Biology; SMARCA4; Cancer research; Ovarian cancer; Kinase; Pharmacology; Cancer; Dasatinib; Cell biology; Genetics; Epigenetics","score_opus":0.17615831490822006,"score_gpt":0.4495610062936092,"score_spread":0.2734026913853891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953124185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966593,0.00086370995,0.000048727317,0.00033351395,0.00034868444,0.00033396969,0.000035081004,0.0000052948444,0.001371748],"genre_scores_gemma":[0.9978959,0.0004764654,0.00021942226,0.00023350588,0.0005918953,0.00003292652,0.000010915218,0.00002221701,0.0005167687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980614,0.00045318686,0.00038197977,0.0004684867,0.0002849226,0.00035000584],"domain_scores_gemma":[0.9987342,0.000100647536,0.00009894794,0.0005568254,0.0004388406,0.00007054516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012296846,0.00012043524,0.00020567149,0.00003644839,0.000108506865,0.000012952031,0.00030443445,0.00022218755,0.00009917728],"category_scores_gemma":[0.00040451056,0.00009044795,0.00013618525,0.00030684497,0.00058632245,0.000005840968,0.00036098133,0.0005027614,0.000016379772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001271909,0.00048268356,0.047685068,0.00010251323,0.000017913302,0.00000718873,0.00012506625,0.00006191041,0.93724686,0.000012684294,0.0032812783,0.009704951],"study_design_scores_gemma":[0.0016837035,0.000883633,0.07867926,0.000102383405,0.000011424705,0.000003658778,0.00008452541,0.0010491373,0.91448295,0.00017662991,0.0026710515,0.00017165604],"about_ca_topic_score_codex":0.0013168296,"about_ca_topic_score_gemma":0.0015723336,"teacher_disagreement_score":0.030994194,"about_ca_system_score_codex":0.00007314357,"about_ca_system_score_gemma":0.0006288131,"threshold_uncertainty_score":0.36883605},"labels":[],"label_agreement":null},{"id":"W2954314696","doi":"10.1158/1078-0432.ccr-19-0673","title":"Photodynamic Therapy for the Treatment of Vertebral Metastases: A Phase I Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Cancer Society","keywords":"Medicine; Photodynamic therapy; Surgery; Clinical trial; Internal medicine","score_opus":0.4374585812987268,"score_gpt":0.6301222492284765,"score_spread":0.1926636679297497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954314696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810148,0.0031040816,0.00012634018,0.0031906948,0.0011964354,0.010680627,0.00021649183,0.000024412564,0.0004461517],"genre_scores_gemma":[0.97586185,0.014208545,0.00042729217,0.00094544643,0.0011035309,0.0022269853,0.00008931297,0.000057696558,0.005079368],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954454,0.0010038442,0.0013791637,0.0006348129,0.0010097753,0.0005270603],"domain_scores_gemma":[0.9907476,0.0071062795,0.00022434583,0.0011932561,0.0003887241,0.00033984357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007736865,0.0001927941,0.000988837,0.00012999293,0.000093430965,0.000030453977,0.00037205385,0.000116534524,0.0029417775],"category_scores_gemma":[0.001353754,0.00010803805,0.0010424845,0.00031354505,0.000612772,0.00005190689,0.0000635119,0.00039187257,0.00010877384],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4577364,0.021054091,0.0057530827,0.00018775956,0.0022843964,0.000024635769,0.000106550484,0.0000037208677,0.00013721165,0.00038118323,0.016737606,0.49559337],"study_design_scores_gemma":[0.5569347,0.07827386,0.006423408,0.000092077746,0.0008270663,8.873545e-7,0.00042880856,0.005816276,0.0003125332,0.00039064378,0.35031107,0.00018865129],"about_ca_topic_score_codex":0.00018641223,"about_ca_topic_score_gemma":0.000029753939,"teacher_disagreement_score":0.49540472,"about_ca_system_score_codex":0.000114877206,"about_ca_system_score_gemma":0.0009469533,"threshold_uncertainty_score":0.9979697},"labels":[],"label_agreement":null},{"id":"W2955120427","doi":"10.1158/1078-0432.ccr-18-2387","title":"DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; American Association for Cancer Research; Evans Medical Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Wnt signaling pathway; Cancer research; Kinase; Tumor progression; Biology; Cancer; Transcription factor; Prostate; Signal transduction; Gene; Cell biology; Genetics","score_opus":0.15762695585381784,"score_gpt":0.49066662108902065,"score_spread":0.3330396652352028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955120427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97852194,0.004954527,0.0000069151865,0.010291661,0.000413646,0.004833049,0.00008866628,0.00003465981,0.0008549356],"genre_scores_gemma":[0.9831406,0.0011612971,0.0001394953,0.000092878996,0.00042822052,0.001247132,0.000031376414,0.000045141565,0.013713846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948846,0.0007365903,0.0007743339,0.0006829752,0.0022402448,0.00068125856],"domain_scores_gemma":[0.99773806,0.0002666483,0.00019637775,0.00058117276,0.0009988997,0.00021886667],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023563297,0.00020499321,0.00048131845,0.000113598355,0.0002505673,0.000042926793,0.0003419508,0.0002218447,0.0015268037],"category_scores_gemma":[0.00021250955,0.00011829243,0.0002965087,0.00066157064,0.0009685338,0.00019529651,0.00019011559,0.0011689247,0.0000449631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007057925,0.0010112254,0.16447298,0.0010806919,0.00024265402,0.000022576436,0.0011881791,0.00010559996,0.7850469,0.0012739019,0.0005371406,0.037960246],"study_design_scores_gemma":[0.008689349,0.0019788465,0.1612725,0.0041661523,0.000068738875,0.0000039077318,0.00046200526,0.00024528187,0.80810463,0.0031753548,0.011564858,0.00026835332],"about_ca_topic_score_codex":0.00038269017,"about_ca_topic_score_gemma":0.00008349353,"teacher_disagreement_score":0.037691895,"about_ca_system_score_codex":0.0004429654,"about_ca_system_score_gemma":0.0022050529,"threshold_uncertainty_score":0.99938595},"labels":[],"label_agreement":null},{"id":"W2955283109","doi":"10.1158/1078-0432.ccr-18-3944","title":"Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institutes of Health; Ono Pharmaceutical; National Cancer Institute; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Cetuximab; Nivolumab; Medicine; Head and neck; Head and neck squamous-cell carcinoma; Oncology; Basal cell; Internal medicine; Head and neck cancer; Cancer; Surgery; Immunotherapy; Colorectal cancer","score_opus":0.09167109629543041,"score_gpt":0.41982478930838263,"score_spread":0.3281536930129522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955283109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504226,0.0022436131,2.7928422e-7,0.00057378557,0.00009598887,0.0019086768,0.000060988343,0.0000041391568,0.00007023924],"genre_scores_gemma":[0.99828255,0.0008046416,0.00004339584,0.00013417976,0.000015675943,0.00003947626,0.000008388321,0.000022201966,0.00064950756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759626,0.00041150252,0.00063232833,0.00042843123,0.0005449632,0.0003865361],"domain_scores_gemma":[0.9982165,0.000987891,0.00011834567,0.00040810983,0.00014662526,0.00012253912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013388391,0.00013970291,0.00050500757,0.00010902085,0.000049714166,0.000022702396,0.00014806922,0.000086200336,0.00012967607],"category_scores_gemma":[0.0003283913,0.000079258716,0.00005107414,0.0005278035,0.00047685127,0.00008561914,0.00013701434,0.00067030935,0.0000021342532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05462401,0.0011061247,0.91308784,0.00034443822,0.000022973065,0.0000056080517,0.00026806723,7.969841e-7,0.00018824697,9.3027626e-7,0.00046117842,0.029889783],"study_design_scores_gemma":[0.04304227,0.0044501633,0.9495954,0.0004693466,0.000021347021,0.0000012061877,0.00008004104,0.000053323944,0.00027226252,0.0000023540424,0.0019128108,0.00009949439],"about_ca_topic_score_codex":0.0025820297,"about_ca_topic_score_gemma":0.0017482607,"teacher_disagreement_score":0.03650754,"about_ca_system_score_codex":0.00019576371,"about_ca_system_score_gemma":0.00052150653,"threshold_uncertainty_score":0.39032736},"labels":[],"label_agreement":null},{"id":"W2955389905","doi":"10.1158/1078-0432.ccr-19-0823","title":"Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies","year":2019,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Ectodomain; PTEN; Medicine; Acquired resistance; Cancer; Cancer research; PI3K/AKT/mTOR pathway; Signal transduction; Biology; Internal medicine; Receptor; Genetics","score_opus":0.5085590877799051,"score_gpt":0.5932886371081418,"score_spread":0.08472954932823673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955389905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015607827,0.9911398,0.0000038769,0.001297633,0.00021276524,0.0046814387,0.00015664671,0.00001625673,0.0023354867],"genre_scores_gemma":[0.0010448867,0.9968215,0.00006875957,0.00009115453,0.00012934902,0.0010494835,0.0000116946785,0.00007592737,0.0007072144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956118,0.0009282212,0.0012525163,0.0008896825,0.0008676903,0.00045009988],"domain_scores_gemma":[0.9959192,0.0015310558,0.00046360257,0.0008633153,0.0010009281,0.00022186892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002696593,0.00044329878,0.0043353154,0.00030305237,0.00007878877,0.000011070964,0.00032636686,0.00022198405,0.00012313505],"category_scores_gemma":[0.00043126865,0.00024674227,0.00049234764,0.000950964,0.0004542508,0.000027388294,0.00026029802,0.0007411603,0.000017583818],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018376759,0.0005568617,0.000020863743,0.1313932,0.0008899477,0.000009461988,0.00017622307,4.461962e-9,0.0000012703822,0.00041152554,0.0019073292,0.86279565],"study_design_scores_gemma":[0.0012084723,0.004843957,0.00019916974,0.2999151,0.00043101783,0.0000019768652,0.000026904016,6.960444e-8,0.000013248431,0.0001665597,0.69302005,0.00017349087],"about_ca_topic_score_codex":0.000035523077,"about_ca_topic_score_gemma":0.00016197018,"teacher_disagreement_score":0.86262214,"about_ca_system_score_codex":0.00028882513,"about_ca_system_score_gemma":0.0014263404,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W2956922351","doi":"10.1158/1078-0432.ccr-19-0298","title":"Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Spinal Cord Injury BC; Canadian Cancer Society; Espace pour la vie","funders":"Innate Pharma","keywords":"Medicine; Nausea; Vomiting; Pharmacodynamics; Internal medicine; Adverse effect; Cohort; Tolerability; Gastroenterology; Cancer; Cervical cancer; Endometrial cancer; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Clinical trial; Phases of clinical research","score_opus":0.14237343410683095,"score_gpt":0.4662813181220757,"score_spread":0.32390788401524473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956922351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042696,0.0011327744,1.6945589e-7,0.00044678999,0.000519734,0.007288494,0.000057093333,0.000005716393,0.00012227427],"genre_scores_gemma":[0.99822456,0.000839178,0.000013520883,0.00014679873,0.00008340895,0.00049117947,0.0000067883166,0.000024110806,0.00017046089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534655,0.0012793315,0.0012557127,0.0005053491,0.0011196655,0.00049339357],"domain_scores_gemma":[0.996943,0.0014125683,0.0004110415,0.00057219283,0.0004809484,0.00018022401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068125497,0.0001733922,0.0011067021,0.00028926454,0.000117212265,0.000017151786,0.00027616255,0.00020885297,0.00036269412],"category_scores_gemma":[0.0011006856,0.000100652105,0.00015705284,0.00091562135,0.0004598754,0.000077952805,0.000105410145,0.00065581704,0.0000012729753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13723756,0.0009783863,0.8309926,0.00010830068,0.00023401923,0.000003887546,0.00043590815,0.000016254291,0.00030420852,0.0000053052545,0.00008359016,0.02959996],"study_design_scores_gemma":[0.12788081,0.009769474,0.8604103,0.0005619153,0.00007279093,2.446798e-7,0.000586656,0.000015518728,0.00009064453,0.000014658646,0.00049214886,0.00010485086],"about_ca_topic_score_codex":0.16626701,"about_ca_topic_score_gemma":0.36601573,"teacher_disagreement_score":0.19974874,"about_ca_system_score_codex":0.0006002825,"about_ca_system_score_gemma":0.0021459328,"threshold_uncertainty_score":0.8392849},"labels":[],"label_agreement":null},{"id":"W2959088509","doi":"10.1158/1078-0432.ccr-19-0113","title":"Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cisplatin; Medicine; Internal medicine; Single-nucleotide polymorphism; Creatinine; Oncology; Genome-wide association study; Chemotherapy; Gastroenterology; Endocrinology; Genotype; Biology; Genetics; Gene","score_opus":0.15595138802417136,"score_gpt":0.5000697512846275,"score_spread":0.34411836326045614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959088509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930801,0.00033002187,0.0000940227,0.0048179985,0.00012588224,0.00087491394,0.00010507436,0.000033319066,0.00053868245],"genre_scores_gemma":[0.9942189,0.00033274965,0.0007982803,0.0027854212,0.00032989256,0.000037201946,0.00002064893,0.000057305235,0.0014196377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99575585,0.00054820906,0.0013773779,0.0008136507,0.0010009424,0.000503997],"domain_scores_gemma":[0.99459356,0.0032824539,0.00023910998,0.00088364194,0.0005911142,0.00041013354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005062244,0.00020502173,0.001190826,0.00049962517,0.000053534823,0.000029600807,0.00022028568,0.0004504787,0.008529225],"category_scores_gemma":[0.0011110922,0.00017886332,0.00048560716,0.0015625611,0.00079196756,0.000071968025,0.00009137456,0.0012339092,0.00007188938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015219856,0.0002957627,0.9691432,0.00013928227,0.0009458978,0.000009335914,0.0001398107,0.000019949133,0.006069691,0.0000065562936,0.00015384586,0.021554701],"study_design_scores_gemma":[0.005150518,0.00078189507,0.98064667,0.00012766254,0.00029770244,6.8281844e-7,0.000053633612,0.002196806,0.009248427,0.00006981731,0.0012575457,0.0001686553],"about_ca_topic_score_codex":0.000082545615,"about_ca_topic_score_gemma":0.00013843946,"teacher_disagreement_score":0.021386046,"about_ca_system_score_codex":0.00012608117,"about_ca_system_score_gemma":0.0007054154,"threshold_uncertainty_score":0.9923771},"labels":[],"label_agreement":null},{"id":"W2960549986","doi":"10.1158/1078-0432.ccr-18-3373","title":"Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Imatinib; Medicine; Discontinuation; Chronic myelogenous leukemia; Internal medicine; Imatinib mesylate; Oncology; Tyrosine-kinase inhibitor; Cancer; Leukemia","score_opus":0.2040924732734839,"score_gpt":0.5438174705927702,"score_spread":0.3397249973192863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960549986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301577,0.002167758,0.00008718601,0.0007533508,0.00015982687,0.0034308126,0.0003396726,0.000010045575,0.000035578774],"genre_scores_gemma":[0.99828625,0.0003220047,0.000069319394,0.00003275005,0.0001488388,0.00093538966,0.00015861748,0.000023549797,0.000023293438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621135,0.00058419234,0.00073735614,0.0005911769,0.0014813028,0.0003945999],"domain_scores_gemma":[0.9957408,0.001870105,0.00013423814,0.00037576258,0.0015922564,0.00028686976],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0031435022,0.00015028988,0.0004055223,0.00016875233,0.000053780896,0.00001682444,0.000093739785,0.00013935508,0.00026691303],"category_scores_gemma":[0.013771113,0.00012901914,0.00008937601,0.0002446537,0.00030417205,0.0001566872,0.00010027704,0.00045988403,0.00000637206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010642371,0.0018545688,0.9568453,0.0016503817,0.00014690781,0.000020047351,0.00046712538,0.00024032196,0.00030715394,0.00004453916,0.00020192233,0.02757938],"study_design_scores_gemma":[0.031458605,0.005021862,0.902926,0.0025420007,0.00041507094,3.8746887e-7,0.00014730787,0.0551908,0.0011657237,0.0008678175,0.00008533413,0.00017904378],"about_ca_topic_score_codex":0.00009217254,"about_ca_topic_score_gemma":0.0001704846,"teacher_disagreement_score":0.05495048,"about_ca_system_score_codex":0.0022645257,"about_ca_system_score_gemma":0.0024106044,"threshold_uncertainty_score":0.99453634},"labels":[],"label_agreement":null},{"id":"W2960863027","doi":"10.1158/1078-0432.ccr-19-1605","title":"Targeting TGFβ Pathway in Adult Granulosa Cell Tumor: Opening Pandora's Box?","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Granulosa cell; Transforming growth factor; Malignancy; Cancer research; Biology; TGF beta signaling pathway; Mutation; Ovary; Cell biology; Pathology; Medicine; Endocrinology; Genetics; Gene","score_opus":0.08824008247851232,"score_gpt":0.43422665896527324,"score_spread":0.3459865764867609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960863027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8807004,0.022687946,0.00007299674,0.08361867,0.0032626523,0.0035512794,0.0009993715,0.00009811293,0.005008538],"genre_scores_gemma":[0.6031405,0.0031484477,0.0006117644,0.33611232,0.032102868,0.0013992502,0.0043967953,0.00063024304,0.018457811],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928871,0.0017145635,0.001235394,0.0016747279,0.00110629,0.001381928],"domain_scores_gemma":[0.99665976,0.00093737204,0.0003238059,0.0011734067,0.0007028802,0.00020280617],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0031090276,0.000454363,0.0007881874,0.00021590374,0.00016421404,0.00014691103,0.0014838408,0.0013715997,0.0003210053],"category_scores_gemma":[0.0028214832,0.00043253577,0.00039770384,0.0003062575,0.00047282188,0.00000807935,0.0010289347,0.0049639614,0.0002706141],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046284657,0.0001531175,0.017833067,0.0006585976,0.00006513837,0.00043796806,0.000029983255,0.00008740458,0.014828296,0.0000010001822,0.9641581,0.0012844857],"study_design_scores_gemma":[0.0019789913,0.00043263045,0.0004206557,0.0005103167,0.000018276141,0.0000025616825,0.00004984951,0.00005170286,0.02759989,0.00003194752,0.9682464,0.00065675913],"about_ca_topic_score_codex":0.00052812434,"about_ca_topic_score_gemma":0.000118061165,"teacher_disagreement_score":0.27755994,"about_ca_system_score_codex":0.00013003474,"about_ca_system_score_gemma":0.0020177383,"threshold_uncertainty_score":0.99992484},"labels":[],"label_agreement":null},{"id":"W2963730372","doi":"10.1158/1078-0432.ccr-19-0261","title":"A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":272,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institutes of Health","keywords":"Placebo; Glioblastoma; Medicine; Double blind; Cancer vaccine; Dendritic cell; Oncology; Internal medicine; Cancer; Pathology; Immunotherapy; Cancer research; Immunology; Immune system; Alternative medicine","score_opus":0.05922027509363901,"score_gpt":0.41901466526934705,"score_spread":0.359794390175708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963730372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98464376,0.0049582734,0.0000055685196,0.00026607836,0.0010397894,0.00852598,0.00002747149,0.000023992825,0.0005091122],"genre_scores_gemma":[0.9913277,0.0011927912,0.000009601422,0.00007629619,0.00007490891,0.0013650146,0.000038449554,0.000042619915,0.0058725877],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.991893,0.004661295,0.0017414832,0.0005997395,0.00027152506,0.0008329716],"domain_scores_gemma":[0.98780143,0.010538518,0.00040031466,0.0006821455,0.0005167147,0.000060850034],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0070245075,0.0002950592,0.0021797167,0.00054144254,0.00017986557,0.000025843161,0.00058962754,0.00050079025,0.0029719083],"category_scores_gemma":[0.0013294916,0.0002024625,0.00045881615,0.0006052129,0.0006239797,0.00014597969,0.00019859707,0.001447365,0.0002366887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9804954,0.006929686,0.0016487848,0.000048777136,0.0005908025,0.00000967117,0.00033869458,0.000009834371,0.006043623,0.000034511824,0.00051017234,0.003340077],"study_design_scores_gemma":[0.9668732,0.01930584,0.00040003448,0.00019846506,0.000087397166,0.0000010407957,0.00009554318,0.000011745621,0.010180325,0.000022864884,0.002598079,0.00022546532],"about_ca_topic_score_codex":0.000582874,"about_ca_topic_score_gemma":0.00020862102,"teacher_disagreement_score":0.013622166,"about_ca_system_score_codex":0.000095472,"about_ca_system_score_gemma":0.0007677114,"threshold_uncertainty_score":0.9979395},"labels":[],"label_agreement":null},{"id":"W2964344648","doi":"10.1158/1078-0432.ccr-19-1797","title":"DNA Methylation as a Robust Classifier of Epithelial Ovarian Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Epigenetics; DNA methylation; Methylation; Ovarian cancer; Epithelial ovarian cancer; Biology; Cancer research; DNA; Cancer; Bioinformatics; Genetics; Gene; Gene expression","score_opus":0.3528946916214223,"score_gpt":0.5280786966631082,"score_spread":0.17518400504168596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964344648","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013701889,0.0052445424,0.000020453585,0.96013737,0.0035388872,0.0029633522,0.0008726827,0.000053316897,0.01346749],"genre_scores_gemma":[0.080715604,0.04468127,0.0008377747,0.68721825,0.06984268,0.004940847,0.0012665616,0.0006942105,0.1098028],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99257725,0.0010877093,0.001496344,0.0014309306,0.0023659961,0.0010417898],"domain_scores_gemma":[0.9933205,0.0029590237,0.00051096734,0.0014932313,0.0014277166,0.00028851873],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0028754466,0.00047085944,0.001800439,0.00049008656,0.00012346532,0.000064687076,0.00049572345,0.0020104267,0.009719677],"category_scores_gemma":[0.0009454539,0.00036998268,0.0008052554,0.0007515907,0.00070037233,0.00009114698,0.00025619476,0.005774674,0.0006538896],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010754664,0.00042240613,0.014723396,0.0009890763,0.001352618,0.0003872561,0.00007273355,0.000017128192,0.00011170195,0.000088457076,0.93962866,0.041131128],"study_design_scores_gemma":[0.005176482,0.001528402,0.025590032,0.0017732409,0.00069334457,0.000007649442,0.000020554613,0.000062336745,0.0010550178,0.00033768345,0.96340686,0.00034840484],"about_ca_topic_score_codex":0.0063285604,"about_ca_topic_score_gemma":0.0003115593,"teacher_disagreement_score":0.27291915,"about_ca_system_score_codex":0.0011648932,"about_ca_system_score_gemma":0.005538135,"threshold_uncertainty_score":0.9998752},"labels":[],"label_agreement":null},{"id":"W2964673115","doi":"10.1158/1078-0432.ccr-19-1423","title":"The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Prostate cancer; Lineage (genetic); Cancer; Resistance (ecology); Medicine; Cancer therapy; Biology; Internal medicine; Genetics; Ecology","score_opus":0.1459517182911886,"score_gpt":0.5267830732056228,"score_spread":0.3808313549144342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964673115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529132,0.034904804,2.946393e-7,0.0040988466,0.00021648472,0.0018349888,0.000051338848,0.000018048137,0.005961963],"genre_scores_gemma":[0.897692,0.079332754,0.000022026845,0.00008909259,0.00026123473,0.00054026465,0.0000058448118,0.000032419037,0.022024358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963215,0.00049281213,0.00071271247,0.00052434934,0.0011330774,0.0008155328],"domain_scores_gemma":[0.9961531,0.002272468,0.00011270347,0.0005258939,0.00070478674,0.00023102036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002765472,0.0001542473,0.0005032504,0.0001508555,0.00014720592,0.00003697764,0.00038111754,0.00013409986,0.00049572485],"category_scores_gemma":[0.00051229104,0.00008895103,0.00015373764,0.00087822106,0.00086107437,0.00007439348,0.00015825646,0.0013723809,0.00006975241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018340385,0.000498871,0.9152297,0.0001732034,0.00015363669,0.000034814326,0.0003384478,0.000014127524,0.0062279017,0.00035948333,0.0024615254,0.056167908],"study_design_scores_gemma":[0.013378122,0.0018529337,0.56480604,0.00117773,0.000021184549,0.0000013682836,0.0008698072,0.00048189086,0.06101418,0.0014453077,0.35468966,0.00026179035],"about_ca_topic_score_codex":0.0012415062,"about_ca_topic_score_gemma":0.0018633045,"teacher_disagreement_score":0.35222813,"about_ca_system_score_codex":0.00031822844,"about_ca_system_score_gemma":0.0016791795,"threshold_uncertainty_score":0.59623885},"labels":[],"label_agreement":null},{"id":"W2964970606","doi":"10.1158/1078-0432.ccr-19-0545","title":"CD45+CD326+ Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Institute of Aging","funders":"Japan Society for the Promotion of Science","keywords":"Lung cancer; Malignant pleural effusion; Cancer; Medicine; Pathology; Population; Metastasis; Cancer cell; Cancer research; Pleural effusion; Cell; Carcinoma; Mesenchymal stem cell; Internal medicine; Biology","score_opus":0.10912920161323457,"score_gpt":0.46691263736841004,"score_spread":0.35778343575517546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964970606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918736,0.002582679,0.000005668167,0.0007164393,0.000890244,0.0030262757,0.0003311332,0.000017412307,0.0032428051],"genre_scores_gemma":[0.9901337,0.004923415,0.000105824554,0.00028106783,0.00039843956,0.00065967464,0.000019370598,0.000057353547,0.0034211695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591935,0.00034050233,0.0010011622,0.0008228179,0.0011124171,0.00080373744],"domain_scores_gemma":[0.9971058,0.0006508339,0.00028326744,0.0004582164,0.0010796743,0.00042224128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018838198,0.00022457936,0.00093084044,0.00031030338,0.000048722923,0.000019944144,0.00034833534,0.00023552786,0.0020513078],"category_scores_gemma":[0.00023637117,0.00018718441,0.00030023634,0.000819824,0.0002928062,0.00008165815,0.00028560997,0.0013117263,0.00007483485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002048993,0.0016540504,0.96754116,0.0015162694,0.00012168451,0.000022605635,0.00024738268,0.000051555133,0.003039989,0.0000017232933,0.011910711,0.011843876],"study_design_scores_gemma":[0.014142772,0.0034078832,0.85836416,0.002721537,0.00028555605,6.225003e-7,0.0005526121,0.0011400447,0.10800651,0.000022358396,0.010945317,0.00041063185],"about_ca_topic_score_codex":0.0037420196,"about_ca_topic_score_gemma":0.0009399932,"teacher_disagreement_score":0.109177,"about_ca_system_score_codex":0.00049351214,"about_ca_system_score_gemma":0.0011744879,"threshold_uncertainty_score":0.99886096},"labels":[],"label_agreement":null},{"id":"W2967929450","doi":"10.1158/1078-0432.ccr-19-1832","title":"Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Head and neck cancer; Confidence interval; Internal medicine; Radiation therapy; Relative risk; Cancer; Body mass index; Oncology; Surgery","score_opus":0.2688763782354809,"score_gpt":0.555436189361305,"score_spread":0.2865598111258241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967929450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95504886,0.006029765,0.0000072777434,0.034682263,0.00038181542,0.0030629316,0.00015463922,0.000015746613,0.0006167037],"genre_scores_gemma":[0.97562534,0.01204749,0.0002655303,0.003254498,0.00065893895,0.0023177955,0.000009404008,0.000035010024,0.0057859696],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980409,0.0000649758,0.00046687407,0.00049497397,0.0004563309,0.00047594294],"domain_scores_gemma":[0.99586797,0.0014379517,0.0000699486,0.00042120865,0.0019202951,0.00028261912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072171533,0.00015054103,0.00067585247,0.000079605416,0.00011646607,0.000011539765,0.0001523732,0.00009446873,0.00012909042],"category_scores_gemma":[0.0007480322,0.000087162305,0.00017767475,0.00029420757,0.00039649356,0.000033448654,0.0001436844,0.00030607515,0.000014092136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012676428,0.00040542686,0.4570436,0.00039674112,0.0005951587,0.0000073554465,0.0012001164,0.00005850511,0.0010284248,0.0003872924,0.02385186,0.50234914],"study_design_scores_gemma":[0.011250951,0.019922698,0.5943524,0.0016048264,0.00013065062,0.0000043495697,0.0012382665,0.00032079362,0.0010637526,0.00033449355,0.36957556,0.00020119455],"about_ca_topic_score_codex":0.0012239626,"about_ca_topic_score_gemma":0.0024617808,"teacher_disagreement_score":0.5021479,"about_ca_system_score_codex":0.0002303633,"about_ca_system_score_gemma":0.0006269694,"threshold_uncertainty_score":0.35543755},"labels":[],"label_agreement":null},{"id":"W2969447018","doi":"10.1158/1078-0432.ccr-19-1030","title":"Quantitative Ultrasound Spectroscopy for Differentiation of Hepatocellular Carcinoma from At-Risk and Normal Liver Parenchyma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grand Challenges Canada","keywords":"Hepatocellular carcinoma; Parenchyma; Cirrhosis; Medicine; Ultrasound; Liver parenchyma; Carcinoma; Liver cancer; Pathology; Internal medicine; Gastroenterology; Radiology","score_opus":0.22830731858467443,"score_gpt":0.4259238565567501,"score_spread":0.19761653797207565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969447018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906833,0.006502968,0.00018292773,0.00015836836,0.00016974738,0.0017172757,0.00036075318,0.000015543843,0.00020910322],"genre_scores_gemma":[0.99413407,0.003347433,0.0012896066,0.000029606983,0.00022001025,0.00018682038,0.00024659932,0.000030806044,0.0005150225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756616,0.00039951593,0.0005405854,0.0005608859,0.00052065286,0.00041217508],"domain_scores_gemma":[0.9956485,0.0031483944,0.0001636591,0.00037947425,0.0004135003,0.0002464672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011643734,0.00016661413,0.00057584187,0.00011962893,0.00012801442,0.000023439665,0.00011487777,0.0001968337,0.0010721041],"category_scores_gemma":[0.0005447393,0.00013574907,0.00023893506,0.00019850185,0.0003054125,0.00007631843,0.00010277855,0.00041960026,0.00007345467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031105885,0.00025070997,0.97783476,0.00019176878,0.00021308287,0.000014616078,0.00036052233,1.4582893e-7,0.0153366495,0.00011743682,0.000461851,0.0021078892],"study_design_scores_gemma":[0.0041065784,0.0034871264,0.91953903,0.00010671225,0.00026644563,0.0000017845675,0.00014007714,0.0070401477,0.06398501,0.00036560444,0.0008192786,0.00014219758],"about_ca_topic_score_codex":0.002624203,"about_ca_topic_score_gemma":0.0002347488,"teacher_disagreement_score":0.058295704,"about_ca_system_score_codex":0.0001438138,"about_ca_system_score_gemma":0.00021542594,"threshold_uncertainty_score":0.99984103},"labels":[],"label_agreement":null},{"id":"W2970734757","doi":"10.1158/1078-0432.ccr-18-4121","title":"Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Genentech; Pharmacyclics; Eisai; National Institutes of Health; Cancer Research UK; Gilead Sciences; GlaxoSmithKline; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Nausea; Adverse effect; Pharmacokinetics; Response Evaluation Criteria in Solid Tumors; Pharmacodynamics; Regimen; Progressive disease; Internal medicine; Dosing; Gastroenterology; Toxicity; Pharmacology; Chemotherapy; Oncology","score_opus":0.05720851192970894,"score_gpt":0.45829613041150136,"score_spread":0.4010876184817924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970734757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834496,0.0005681316,0.000009822959,0.00003526497,0.00008960516,0.0008521733,0.000017494245,0.0000012949614,0.00008123599],"genre_scores_gemma":[0.99957883,0.00017775779,0.00005806658,0.000012963623,0.00003246865,0.00004661532,0.00000606491,0.000011886704,0.00007536731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841285,0.00023519088,0.00046879723,0.0003555731,0.00031987432,0.00020769794],"domain_scores_gemma":[0.9989333,0.000117971606,0.00017306328,0.00040255635,0.00032018416,0.00005293502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008727074,0.000090389396,0.00028195974,0.000048227852,0.000032001466,0.0000054449292,0.00020229816,0.00010893225,0.000013003589],"category_scores_gemma":[0.00030236744,0.00005831448,0.000040216335,0.00021264607,0.00026494675,0.0000041238864,0.00023724874,0.00024134538,7.4067947e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012970611,0.002542364,0.84787786,0.000049662565,0.00003475539,4.544224e-7,0.00010874532,0.00010244408,0.14413309,0.000006719983,0.000009413998,0.0038374106],"study_design_scores_gemma":[0.011639822,0.011872399,0.6841937,0.00010302868,0.00001186261,1.5252188e-7,0.0002469998,0.000028114715,0.29156858,0.000053510892,0.00015550986,0.00012635856],"about_ca_topic_score_codex":0.00006067822,"about_ca_topic_score_gemma":0.0001914549,"teacher_disagreement_score":0.16368422,"about_ca_system_score_codex":0.000013553279,"about_ca_system_score_gemma":0.00014204699,"threshold_uncertainty_score":0.23779954},"labels":[],"label_agreement":null},{"id":"W2971665889","doi":"10.1158/1078-0432.ccr-19-1543","title":"Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University Health Network; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Ontario Institute for Cancer Research; University of British Columbia; Pancreas Centre (Canada)","funders":"Terry Fox Research Institute","keywords":"Glycolysis; Pancreatic cancer; Cancer; Biology; KRAS; Cancer research; Internal medicine; Oncology; Gene expression profiling; Gene expression; Medicine; Bioinformatics; Gene; Genetics; Colorectal cancer; Metabolism","score_opus":0.12556273716900995,"score_gpt":0.4358670415102314,"score_spread":0.31030430434122147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971665889","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7884736,0.015169979,0.000026899881,0.18234862,0.009480849,0.0027874613,0.00130464,0.00003464793,0.00037329938],"genre_scores_gemma":[0.24399504,0.04878169,0.00010401555,0.47662842,0.17689513,0.009313224,0.0010278125,0.00067236566,0.042582292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924289,0.0021192539,0.0012191687,0.0016053646,0.0013412122,0.0012860876],"domain_scores_gemma":[0.99549675,0.0014989695,0.00046490683,0.0018281814,0.0005447694,0.00016644187],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0030833983,0.0005497948,0.0013170522,0.00020716332,0.00021473484,0.00014273258,0.0013794999,0.0017035535,0.00045725564],"category_scores_gemma":[0.0016282356,0.00036241536,0.00048512514,0.00049545575,0.00066278095,0.000012621125,0.0005451468,0.003763378,0.000046431316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005957231,0.00009349321,0.11581297,0.00016515343,0.00045315127,0.00000581167,0.00007455267,0.0000253841,0.005256576,1.7844236e-7,0.8746284,0.0028885885],"study_design_scores_gemma":[0.0019248984,0.00027304047,0.043782614,0.0008841327,0.00023399784,0.000003906349,0.0000437478,0.000018976787,0.006257496,0.0000081592825,0.9459781,0.00059092464],"about_ca_topic_score_codex":0.0055715656,"about_ca_topic_score_gemma":0.0057836953,"teacher_disagreement_score":0.54447854,"about_ca_system_score_codex":0.0002951951,"about_ca_system_score_gemma":0.0013229824,"threshold_uncertainty_score":0.99988276},"labels":[],"label_agreement":null},{"id":"W2972480782","doi":"10.1158/1078-0432.ccr-19-1268","title":"Metastatic Breast Carcinoma–Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Stromal cell; Cancer research; Breast cancer; Metastasis; Cancer-Associated Fibroblasts; Cell growth; Tumor microenvironment; Cancer; Biology; Breast carcinoma; In vivo; Pathology; Medicine; Internal medicine","score_opus":0.15152028010092838,"score_gpt":0.46180800441028413,"score_spread":0.31028772430935575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972480782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99015045,0.0010511624,0.000012461901,0.0016145916,0.00044092987,0.004210847,0.00009890857,0.00010268373,0.002317954],"genre_scores_gemma":[0.9822912,0.00023231964,0.00022371368,0.00039224725,0.00022267926,0.00091159955,0.000049212005,0.00009615563,0.01558087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99391127,0.0010932682,0.0011643019,0.0011202444,0.0015708565,0.0011400386],"domain_scores_gemma":[0.9961103,0.0005586465,0.000197376,0.0009898958,0.0011556591,0.0009881306],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0036939243,0.00032963578,0.0010774727,0.0003384002,0.00019324948,0.00006965617,0.00039239338,0.00022713147,0.0029643467],"category_scores_gemma":[0.0014173703,0.0002443877,0.00037698259,0.0010273003,0.00030814443,0.00015027233,0.00037557326,0.0014719418,0.0008321923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015109299,0.002275177,0.1341357,0.001452844,0.00070923875,0.00017159055,0.001605425,0.00008532278,0.79571253,0.00003270785,0.016746957,0.031963248],"study_design_scores_gemma":[0.026510745,0.0086930785,0.3164724,0.007323884,0.0005528829,0.00009384702,0.0021332959,0.00067901606,0.6167934,0.00031809177,0.018929826,0.0014995346],"about_ca_topic_score_codex":0.0028496317,"about_ca_topic_score_gemma":0.00040258133,"teacher_disagreement_score":0.18233672,"about_ca_system_score_codex":0.0006772195,"about_ca_system_score_gemma":0.001770947,"threshold_uncertainty_score":0.99994576},"labels":[],"label_agreement":null},{"id":"W2972559932","doi":"10.1158/1078-0432.ccr-17-3572","title":"A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation–Positive Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Brain Tumour Charity; National Cancer Institute; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Refractory (planetary science); Pharmacokinetics; Medicine; Dabrafenib; Solid tumor; Mutation; Oncology; Internal medicine; Cancer; Genetics; Biology; Gene","score_opus":0.05948289162910631,"score_gpt":0.45527820933167135,"score_spread":0.39579531770256504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972559932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979689,0.00046644796,0.0000025318577,0.00002757999,0.000059206566,0.0013441823,0.00009042474,0.0000028950994,0.0000378103],"genre_scores_gemma":[0.9992425,0.0003762229,0.0000185286,0.00006743438,0.00006685867,0.00006231016,0.00008145723,0.000017011902,0.000067692345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981774,0.00039077693,0.00037575074,0.00049757736,0.00030184857,0.00025664328],"domain_scores_gemma":[0.9992659,0.000068553236,0.0000990268,0.00021558005,0.0002020081,0.0001489057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005859234,0.00012381433,0.00026999266,0.00007494165,0.000039212304,0.000015176541,0.00012980743,0.00007649022,0.00003458556],"category_scores_gemma":[0.00009709056,0.00008958468,0.000023397808,0.00014281682,0.00019239151,0.00000778066,0.00018534734,0.00033093765,0.0000019748459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007560905,0.0059123253,0.9205705,0.00006815961,0.000097895514,0.000013255484,0.00024447576,0.0000047258536,0.0064646853,0.0000014057048,0.00032895576,0.058732737],"study_design_scores_gemma":[0.022109486,0.020864498,0.951618,0.00014157096,0.000025873958,0.0000034923476,0.00017980186,0.00002721546,0.004646792,0.0000042418583,0.00021530088,0.00016369295],"about_ca_topic_score_codex":0.000091130125,"about_ca_topic_score_gemma":0.0001379416,"teacher_disagreement_score":0.058569044,"about_ca_system_score_codex":0.000019257517,"about_ca_system_score_gemma":0.00017731267,"threshold_uncertainty_score":0.36531574},"labels":[],"label_agreement":null},{"id":"W2972890374","doi":"10.1158/1078-0432.ccr-19-1050","title":"Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Mercator Research Center Ruhr; Astellas Pharma; Gilead Sciences; Sirtex Medical; Pfizer; Deutsche Forschungsgemeinschaft; Eli Lilly and Company","keywords":"Prostate cancer; Glutamate carboxypeptidase II; Positron emission tomography; Medicine; Castration; Prostate; Antigen; Cancer; Oncology; Internal medicine; Nuclear medicine; Immunology; Hormone","score_opus":0.09734563871892155,"score_gpt":0.4529922809155325,"score_spread":0.35564664219661096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972890374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773841,0.009377801,0.0000017461632,0.0051260116,0.00015245649,0.0045456737,0.00011965646,0.000049968163,0.0032425765],"genre_scores_gemma":[0.9622724,0.025090793,0.0002170576,0.0001051317,0.0002306634,0.0009481093,0.00011864648,0.000088266526,0.010928905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942345,0.00052234164,0.0009250031,0.0011631468,0.0018439984,0.0013110022],"domain_scores_gemma":[0.997172,0.0005455901,0.0001531941,0.0007290957,0.0007496296,0.00065050105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027648325,0.00035247568,0.00085677835,0.000608495,0.00021691182,0.00014403395,0.0003043845,0.00020651433,0.0007789399],"category_scores_gemma":[0.00007807176,0.00023417089,0.00017388392,0.0018909923,0.0006279218,0.00026646582,0.00014265913,0.0015666998,0.000103639606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030126937,0.0009880897,0.8336318,0.0008319799,0.0003356781,0.0005647411,0.0011013458,0.000054596163,0.11315555,0.000034381268,0.004259956,0.01491491],"study_design_scores_gemma":[0.030159786,0.0083713485,0.825186,0.0040451214,0.00011550786,0.000021788836,0.0018693904,0.0005051193,0.10111202,0.0002439528,0.0275607,0.0008092792],"about_ca_topic_score_codex":0.001863176,"about_ca_topic_score_gemma":0.0006934695,"teacher_disagreement_score":0.023300743,"about_ca_system_score_codex":0.0005782951,"about_ca_system_score_gemma":0.0020119098,"threshold_uncertainty_score":0.9549211},"labels":[],"label_agreement":null},{"id":"W2973096717","doi":"10.1158/1078-0432.ccr-19-1587","title":"Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"National Institutes of Health; National Cancer Institute; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Androgen receptor; Medicine; Oncology; Prostatectomy; Docetaxel; Internal medicine; Cancer; Androgen deprivation therapy; Biochemical recurrence; Androgen; Cancer research; Hormone","score_opus":0.147179231300564,"score_gpt":0.48289782879195847,"score_spread":0.33571859749139443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973096717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867038,0.0052268095,0.000001383752,0.003018658,0.00031414683,0.0032598155,0.0005623907,0.00003565505,0.0008773556],"genre_scores_gemma":[0.9659401,0.029040249,0.000058162466,0.00015278174,0.00023420418,0.0013643282,0.0000652268,0.00006751562,0.0030774088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953485,0.0007927382,0.0007234491,0.0009739261,0.0009715166,0.001189862],"domain_scores_gemma":[0.99741954,0.0007474549,0.00015228851,0.000658305,0.0005260557,0.00049637037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017425764,0.00033549138,0.001170564,0.000320979,0.00009336769,0.00003021121,0.00027879258,0.0003195097,0.0005165472],"category_scores_gemma":[0.00013076582,0.00025118928,0.0003939762,0.0008946484,0.00070022163,0.00018463073,0.0001231413,0.0010803144,0.00006971427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031701524,0.0027514463,0.77068,0.00090566836,0.0005397347,0.00009939221,0.0007513319,0.000023174875,0.104594715,0.000007784502,0.00043354477,0.087511696],"study_design_scores_gemma":[0.026259251,0.0060983524,0.49279588,0.0012191931,0.00013148585,0.000013490234,0.0002520539,0.00019550712,0.4616331,0.000081687045,0.010868144,0.00045184718],"about_ca_topic_score_codex":0.004800032,"about_ca_topic_score_gemma":0.0021359976,"teacher_disagreement_score":0.35703838,"about_ca_system_score_codex":0.0029451798,"about_ca_system_score_gemma":0.004822368,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W2973452239","doi":"10.1158/1078-0432.ccr-19-0955","title":"Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Cancer Research Society","keywords":"Temozolomide; Cancer research; Epidermal growth factor receptor; Neurosphere; Mesenchymal stem cell; Biology; Chemistry; In vitro; Glioma; Receptor; Cell biology; Endothelial stem cell; Biochemistry; Adult stem cell","score_opus":0.10371424020935101,"score_gpt":0.44745250896401023,"score_spread":0.34373826875465924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973452239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653417,0.001010405,0.0000044041494,0.000946855,0.00013627998,0.0009878902,0.000061126266,0.000013953383,0.00030493792],"genre_scores_gemma":[0.9981748,0.00067594025,0.00032372636,0.000050140356,0.0000486726,0.00006340078,9.61905e-7,0.000024272891,0.0006380773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748284,0.0003094768,0.00057127123,0.0005203707,0.00070588215,0.00041016543],"domain_scores_gemma":[0.99744445,0.0012637891,0.0001643366,0.00045878874,0.00037437445,0.0002942461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018524688,0.00014703852,0.0007469502,0.00020325658,0.000053434836,0.000015419482,0.00015484744,0.00012735349,0.00018367666],"category_scores_gemma":[0.00016390426,0.00011567498,0.00014181444,0.0004882284,0.00021235115,0.000073263516,0.00020934237,0.00036939586,0.000030495947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005500662,0.0012348894,0.07376053,0.0010349619,0.00018929677,0.00014317164,0.00009510736,0.000026151212,0.90847415,0.0007438145,0.00259636,0.0062009273],"study_design_scores_gemma":[0.003441207,0.005190515,0.18552104,0.0009312692,0.000055016568,0.0000027618132,0.00035567884,0.000101745216,0.80334324,0.00020115018,0.00071039144,0.00014596063],"about_ca_topic_score_codex":0.00030459082,"about_ca_topic_score_gemma":0.00016705501,"teacher_disagreement_score":0.11176051,"about_ca_system_score_codex":0.00011696534,"about_ca_system_score_gemma":0.00033742076,"threshold_uncertainty_score":0.47170886},"labels":[],"label_agreement":null},{"id":"W2974027076","doi":"10.1158/1078-0432.ccr-19-0751","title":"Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Breast cancer; Biomarker; Cyclin-dependent kinase 4; Oncology; Metastatic breast cancer; Medicine; Internal medicine; Cancer; Fulvestrant; Cancer research; Biology; Estrogen receptor; Cell cycle; Tamoxifen; Cyclin-dependent kinase 2","score_opus":0.26475433294806805,"score_gpt":0.543597462485185,"score_spread":0.278843129537117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974027076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7325886,0.0048609637,0.000010541067,0.25901705,0.00015248002,0.0023318427,0.00097354985,0.000027898483,0.00003710277],"genre_scores_gemma":[0.83529115,0.019515313,0.00046802053,0.12995909,0.0021318973,0.005852422,0.00015249623,0.00039026674,0.006239331],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9926385,0.00190299,0.0012497002,0.0014055059,0.0015633607,0.0012399416],"domain_scores_gemma":[0.99421453,0.0030883828,0.00036892504,0.001086247,0.00086857367,0.0003733123],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022657602,0.00061009795,0.002020563,0.001290552,0.0000849119,0.00004746317,0.00025346526,0.00036986658,0.0010531091],"category_scores_gemma":[0.00031189877,0.0004168844,0.00019302197,0.0012682676,0.0009942503,0.00014672278,0.00016696451,0.0021165877,0.000024609657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3665779,0.0017242212,0.037079785,0.001303355,0.0041125445,0.0046090023,0.0011482033,0.0001014053,0.035935614,0.0000014594102,0.02145264,0.5259539],"study_design_scores_gemma":[0.07245899,0.026963074,0.6071531,0.0081056785,0.0007516331,0.00049847347,0.0014263191,0.000054936554,0.013438523,0.0003090666,0.2669629,0.0018772952],"about_ca_topic_score_codex":0.005869604,"about_ca_topic_score_gemma":0.00056820206,"teacher_disagreement_score":0.5700733,"about_ca_system_score_codex":0.0022175156,"about_ca_system_score_gemma":0.0021167018,"threshold_uncertainty_score":0.99986005},"labels":[],"label_agreement":null},{"id":"W2976929154","doi":"10.1158/1078-0432.ccr-19-1223","title":"Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cabozantinib; Chemotherapy; Melanoma; Medicine; Oncology; Randomized controlled trial; Metastatic melanoma; Alliance; Internal medicine; Cancer; Cancer research","score_opus":0.17381039171810975,"score_gpt":0.5433237727058784,"score_spread":0.36951338098776865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976929154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916873,0.0014875876,0.0000131386505,0.0037245043,0.0005030498,0.0020116342,0.000069500784,0.000014040141,0.00048923225],"genre_scores_gemma":[0.9968225,0.0009762556,0.0004494485,0.00024975292,0.00034193738,0.00026522792,0.0001285366,0.000018556313,0.0007478374],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99648887,0.0011583135,0.0007440915,0.00061776186,0.0005866987,0.00040424228],"domain_scores_gemma":[0.9945752,0.0046021324,0.0001461475,0.00033552712,0.00011914583,0.00022183804],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035202836,0.00016042426,0.0013906342,0.00022708315,0.000093535265,0.000021431957,0.00012842484,0.00012362274,0.0033257667],"category_scores_gemma":[0.0008978385,0.000121959616,0.00035297853,0.0006972737,0.0005161915,0.00007194157,0.000065318556,0.00069239334,0.0001010347],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92140126,0.0019919535,0.06872969,0.0000169143,0.0036254188,0.00029252836,0.00012785956,0.0000052959667,0.000022837485,0.00011502971,0.00013719144,0.0035340437],"study_design_scores_gemma":[0.95358807,0.004057595,0.0382254,0.00003886326,0.0009466245,0.0000015101812,0.00006258367,0.001454691,0.00012652986,0.00055924687,0.0008284193,0.00011045056],"about_ca_topic_score_codex":0.0012369946,"about_ca_topic_score_gemma":0.00077211915,"teacher_disagreement_score":0.032186847,"about_ca_system_score_codex":0.0001249092,"about_ca_system_score_gemma":0.00064558105,"threshold_uncertainty_score":0.99758536},"labels":[],"label_agreement":null},{"id":"W2977198565","doi":"10.1158/1078-0432.ccr-19-1038","title":"Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada); Ontario Genomics","funders":"Anna och Edwin Bergers Stiftelse; Fru Berta Kamprads Stiftelse; Medicinska Fakulteten, Lunds Universitet; Gunnar Nilssons Cancerstiftelse; Cancerfonden","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant therapy; Cohort; Radiation therapy; Adjuvant; Subgroup analysis; Endocrine system; Cancer; Meta-analysis; Hormone","score_opus":0.12392909294632232,"score_gpt":0.44988547125275363,"score_spread":0.3259563783064313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977198565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829058,0.012177002,0.00000356937,0.001329126,0.0012096133,0.001279315,0.00086192886,0.000025430185,0.0002081972],"genre_scores_gemma":[0.98022884,0.016516134,0.000016052887,0.000499479,0.0007032738,0.000639102,0.00017603197,0.00006699968,0.0011540792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963872,0.00054019876,0.00062754616,0.0010141773,0.00068985764,0.000741008],"domain_scores_gemma":[0.997793,0.00016899913,0.00014418803,0.00064337905,0.0010585646,0.00019183398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005629812,0.00030745458,0.0005963267,0.00008743433,0.00021223005,0.0000660541,0.0005003422,0.00026268192,0.00025542418],"category_scores_gemma":[0.000048827074,0.0002515978,0.00026424488,0.00024154165,0.00046583236,0.000015315018,0.0002500453,0.00048114304,0.00006962383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029069826,0.00037090876,0.94050485,0.00023489013,0.0006857732,0.0000045531006,0.0002242855,0.00004045651,0.03670683,0.000016900545,0.00873794,0.0095656235],"study_design_scores_gemma":[0.0077812728,0.0006567891,0.9403071,0.00045835404,0.000053630694,0.0000085698675,0.0007323985,0.000031304993,0.03265393,0.000035061807,0.016746009,0.0005356252],"about_ca_topic_score_codex":0.0012262735,"about_ca_topic_score_gemma":0.00033749288,"teacher_disagreement_score":0.009029998,"about_ca_system_score_codex":0.00019377348,"about_ca_system_score_gemma":0.00046017722,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W2977439680","doi":"10.1158/1557-3265.sarcomas17-b03","title":"Abstract B03: The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype promoting lung metastasis in Ewing sarcoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metastasis; Cancer research; Medicine; Sarcoma; RNA interference; Pathogenesis; Pathology; Biology; Cancer; Internal medicine; RNA; Gene","score_opus":0.231150645613191,"score_gpt":0.5121321965991278,"score_spread":0.2809815509859368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977439680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884803,0.0024875232,0.0000030036051,0.0055992287,0.00016258642,0.002481713,0.000021142927,0.00004829834,0.00071618235],"genre_scores_gemma":[0.9971153,0.00035126842,0.0001749919,0.00029076872,0.0010019303,0.0007910726,0.000032698652,0.000056340028,0.00018561458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99543583,0.0008803949,0.0008672132,0.0007702023,0.0009918589,0.0010544809],"domain_scores_gemma":[0.9965742,0.0014425615,0.00015354379,0.00079642667,0.0006228576,0.00041036864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035756654,0.0002485038,0.000607148,0.00025862755,0.00039872742,0.00013321203,0.00037426583,0.00017202125,0.0010382951],"category_scores_gemma":[0.002371609,0.00015885105,0.00021197493,0.0008256368,0.0007192505,0.00018249567,0.00028982246,0.0014145774,0.00009767395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020961543,0.0051449197,0.8227329,0.00045444976,0.0006019463,0.001423843,0.0024574478,0.0000017733031,0.0068727024,0.0006938834,0.0015165409,0.1560034],"study_design_scores_gemma":[0.0050618327,0.0016124799,0.97280365,0.0008894151,0.00013798104,0.000015544,0.0012148884,0.00023066303,0.015761012,0.0007656403,0.001268324,0.00023859549],"about_ca_topic_score_codex":0.0033510185,"about_ca_topic_score_gemma":0.0054601594,"teacher_disagreement_score":0.1557648,"about_ca_system_score_codex":0.0005278897,"about_ca_system_score_gemma":0.00094289216,"threshold_uncertainty_score":0.9998749},"labels":[],"label_agreement":null},{"id":"W2978136097","doi":"10.1158/1078-0432.ccr-19-0526","title":"An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Agonist; Medicine; Blockade; Receptor; Pharmacology; CD8; Cancer research; Oncology; Internal medicine; Immunology; Immune system","score_opus":0.07808303389853102,"score_gpt":0.4868528207522376,"score_spread":0.4087697868537066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978136097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946736,0.00008498422,0.000025813566,0.00032991078,0.000084567866,0.0014717933,0.00003581555,0.0000131097295,0.003280419],"genre_scores_gemma":[0.9978789,0.00010104221,0.0012036598,0.00016693644,0.000055941888,0.000109428904,0.00008029662,0.000019690911,0.00038407088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997725,0.00013822276,0.0006586088,0.00040190152,0.00071196957,0.00036428],"domain_scores_gemma":[0.9985545,0.00016460079,0.0001194415,0.00041279336,0.0005649767,0.00018364158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012273018,0.00014324898,0.00051130814,0.00021310954,0.00005749269,0.000026529646,0.00020959578,0.00010828943,0.00011952707],"category_scores_gemma":[0.00017088527,0.00009746341,0.000079946876,0.00072945113,0.00041073505,0.0001952751,0.000049365706,0.0005644457,0.000011273023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10290026,0.0022532262,0.82291806,0.00025325062,0.0001349957,0.000005760794,0.0014381456,0.0001335175,0.0017249268,0.00012673555,0.00026237196,0.06784875],"study_design_scores_gemma":[0.006456227,0.015604177,0.97006536,0.00054594385,0.0000103448365,0.0000010719618,0.0016363028,0.00023190725,0.0041120825,0.000006903108,0.0011715599,0.00015812153],"about_ca_topic_score_codex":0.0002475866,"about_ca_topic_score_gemma":0.00021574776,"teacher_disagreement_score":0.1471473,"about_ca_system_score_codex":0.00020178175,"about_ca_system_score_gemma":0.0008921721,"threshold_uncertainty_score":0.39744425},"labels":[],"label_agreement":null},{"id":"W2979808878","doi":"10.1158/1078-0432.ccr-19-0603","title":"Metformin Abrogates Age-Associated Ovarian Fibrosis","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Metformin; Ovulation; Fibrosis; Medicine; Ovary; Oncology; Internal medicine; Cohort; Endocrinology; Cancer; Physiology; Diabetes mellitus; Hormone","score_opus":0.321253355543479,"score_gpt":0.5347019113503512,"score_spread":0.21344855580687216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979808878","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005852282,0.005946635,0.0000019950664,0.9647266,0.0024884772,0.0029407144,0.00069486856,0.00016068826,0.017187715],"genre_scores_gemma":[0.020002516,0.016518388,0.00056594244,0.7959498,0.024489827,0.002677923,0.0032421527,0.0005314965,0.13602194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920937,0.0010326301,0.0013220521,0.001627512,0.002295261,0.0016288634],"domain_scores_gemma":[0.9917554,0.0049601346,0.00033498928,0.0016417276,0.0009264054,0.0003813205],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0033771906,0.00056538876,0.001995132,0.0004563566,0.00022341216,0.00019545689,0.0006318538,0.002504857,0.0058529903],"category_scores_gemma":[0.0018173604,0.00044492097,0.0010214247,0.00091256096,0.00062996056,0.00009432427,0.0002922181,0.00821399,0.002078344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032689955,0.00051007775,0.020784581,0.0005079939,0.0016124357,0.0029374268,0.000047403624,6.207917e-7,0.000006267493,0.000021110749,0.9579516,0.015293554],"study_design_scores_gemma":[0.0045112134,0.0017872833,0.026737925,0.001752237,0.0006067947,0.000011655137,0.000019398984,0.000014693637,0.00009711443,0.00025658953,0.96379954,0.0004055673],"about_ca_topic_score_codex":0.003010677,"about_ca_topic_score_gemma":0.00026395786,"teacher_disagreement_score":0.16877681,"about_ca_system_score_codex":0.0017323738,"about_ca_system_score_gemma":0.0024839677,"threshold_uncertainty_score":0.99980026},"labels":[],"label_agreement":null},{"id":"W2981115842","doi":"10.1158/1078-0432.ccr-19-1164","title":"Lucitanib for the Treatment of HR+/HER2− Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Institut de Recherches Servier; Servier","keywords":"Medicine; Internal medicine; Clinical endpoint; Oncology; Breast cancer; Metastatic breast cancer; Fibroblast growth factor receptor 1; Cohort; Cancer; Adverse effect; Randomized controlled trial; Receptor","score_opus":0.1920115313090569,"score_gpt":0.5330753072108346,"score_spread":0.3410637759017777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981115842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98615986,0.002363264,0.000025055777,0.0034637423,0.00034288017,0.0040118676,0.003587137,0.0000075291605,0.00003866264],"genre_scores_gemma":[0.99320036,0.0024697343,0.000050542443,0.00006785649,0.0007623931,0.0013236587,0.00013061328,0.00004781232,0.0019470194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614924,0.0008219018,0.0007713306,0.0008471648,0.0007825202,0.0006278421],"domain_scores_gemma":[0.99393225,0.0034918594,0.00015849524,0.0014747656,0.00077553187,0.00016711134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027710174,0.00022584405,0.00044268227,0.000043282023,0.00032949544,0.000051457322,0.0009562588,0.00012503524,0.00027076405],"category_scores_gemma":[0.00095002004,0.00011892222,0.0002932038,0.00031949763,0.0005319907,0.000007791639,0.00033828287,0.0003647113,0.000021775853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08176089,0.027841454,0.3552704,0.00020399073,0.006933634,0.00002552945,0.003382617,0.0006061377,0.23658414,0.000058442314,0.03786344,0.24946935],"study_design_scores_gemma":[0.08370458,0.064440355,0.5537151,0.00026779005,0.00068195874,0.000005647461,0.005166382,0.0040266183,0.07482174,0.00021042535,0.21200049,0.0009588811],"about_ca_topic_score_codex":0.008355353,"about_ca_topic_score_gemma":0.003409965,"teacher_disagreement_score":0.24851047,"about_ca_system_score_codex":0.0001099161,"about_ca_system_score_gemma":0.0007255498,"threshold_uncertainty_score":0.9982481},"labels":[],"label_agreement":null},{"id":"W2981358604","doi":"10.1158/1078-0432.ccr-19-1495","title":"Deep Learning Based on Standard H&amp;E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Yale SPORE in Lung Cancer; Swim Across America; Yale Cancer Center; U.S. Food and Drug Administration; Melanoma Research Alliance","keywords":"Medicine; Cohort; Receiver operating characteristic; Melanoma; Population; Adjuvant therapy; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Cutoff; Artificial intelligence; Computer science; Cancer research; Biology","score_opus":0.08991842467784979,"score_gpt":0.43549719619626676,"score_spread":0.345578771518417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981358604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953866,0.0003060468,0.0002816407,0.0002604874,0.00030213446,0.0012396976,0.000050240556,0.000025578936,0.002147544],"genre_scores_gemma":[0.9919027,0.00074357446,0.00026297916,0.00011287404,0.00010328691,0.000093328774,0.000037219987,0.00002411137,0.006719892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774283,0.0003211316,0.00044821255,0.00045873833,0.0007136603,0.00031542868],"domain_scores_gemma":[0.9976457,0.0012872195,0.00015285793,0.00030404323,0.00043924138,0.0001709554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019459692,0.00011526995,0.00041269016,0.00016744595,0.00016168422,0.000029062296,0.00010427207,0.000080118705,0.0004453209],"category_scores_gemma":[0.0014966853,0.00009479134,0.00012582728,0.00014751243,0.00016582097,0.000034644137,0.00015623357,0.00055255735,0.00003633331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010221809,0.00020296944,0.89704573,0.00060615735,0.00006105291,0.000007918621,0.000081057835,0.00010742134,0.00018452354,0.000011144482,0.0028989227,0.0885713],"study_design_scores_gemma":[0.00670418,0.0076862522,0.9329988,0.0005247143,0.00007608461,0.0000028896688,0.00008424852,0.0016284472,0.0015440651,0.00011572676,0.048447914,0.00018667648],"about_ca_topic_score_codex":0.00012803542,"about_ca_topic_score_gemma":0.00010552416,"teacher_disagreement_score":0.08838463,"about_ca_system_score_codex":0.0002753585,"about_ca_system_score_gemma":0.0001306931,"threshold_uncertainty_score":0.48759517},"labels":[],"label_agreement":null},{"id":"W2982361973","doi":"10.1158/1078-0432.ccr-19-1611","title":"MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Key Research and Development Program of China; Health and Medical Research Fund","keywords":"Chromosome instability; Colorectal cancer; Cancer research; Carcinogenesis; Cancer; Knockout mouse; Microsatellite instability; Genome instability; Mouse model of colorectal and intestinal cancer; Biology; Azoxymethane; Aneuploidy; Chromosome; Genetics; DNA damage; Gene","score_opus":0.03641800314611702,"score_gpt":0.3696162983407031,"score_spread":0.33319829519458605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982361973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975452,0.0005053707,0.0000024481587,0.00011823788,0.00016932229,0.000792234,0.00066583324,0.000008534433,0.00019283096],"genre_scores_gemma":[0.998203,0.0010749553,0.000021285254,0.000093702125,0.00011642598,0.00011354071,0.00019025082,0.00004203193,0.00014480927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743325,0.00039238925,0.00044232054,0.0006788061,0.00054060196,0.0005126116],"domain_scores_gemma":[0.9982417,0.00026788336,0.00017541168,0.00025797897,0.0008679618,0.00018904464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009479058,0.00020819884,0.00048189028,0.00006039763,0.000096291915,0.0000295603,0.00027592786,0.00028585075,0.00018582048],"category_scores_gemma":[0.00023793108,0.00015652864,0.00008903362,0.00030416722,0.0008715749,0.00001197775,0.00025435127,0.00039223093,0.000003972226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040694606,0.00044683227,0.9769558,0.00007563676,0.00030218047,0.0000041195913,0.000056654037,0.0000072204107,0.017154347,0.000008154101,0.00022820484,0.0006914152],"study_design_scores_gemma":[0.00519751,0.0048598694,0.9134043,0.00013044012,0.00005264134,0.0000012791836,0.00009723938,0.000055971395,0.0749075,0.00001341389,0.00095650763,0.00032332045],"about_ca_topic_score_codex":0.00048726515,"about_ca_topic_score_gemma":0.0026033127,"teacher_disagreement_score":0.06355146,"about_ca_system_score_codex":0.000090662914,"about_ca_system_score_gemma":0.00088704936,"threshold_uncertainty_score":0.63830525},"labels":[],"label_agreement":null},{"id":"W2987428409","doi":"10.1158/1078-0432.ccr-19-1376","title":"Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; Artificial Intelligence in Medicine (Canada); Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Organoid; Lung cancer; Biomarker; Exome sequencing; Cancer research; Medicine; Cancer; Targeted therapy; Pathology; Exome; Biology; Oncology; Internal medicine; Gene; Mutation; Genetics","score_opus":0.22099516130879326,"score_gpt":0.5530273713961305,"score_spread":0.3320322100873372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987428409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9520043,0.0127973715,0.000059504135,0.0027940099,0.0009798186,0.0017585244,0.00008570322,0.00003569369,0.029485064],"genre_scores_gemma":[0.9437361,0.022192769,0.000608673,0.0009669994,0.0011642752,0.00025133693,0.000015655867,0.00007500691,0.030989215],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99554986,0.0003578291,0.00116964,0.00091240037,0.0012088618,0.0008014307],"domain_scores_gemma":[0.9960031,0.0010211454,0.00021765934,0.00097276975,0.001142212,0.0006431277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003037728,0.00024159631,0.0010707205,0.00016099124,0.00008175725,0.00003158442,0.00048410654,0.00040257061,0.0070524327],"category_scores_gemma":[0.00043882502,0.0001843898,0.0004959008,0.000670238,0.00045105588,0.0001007674,0.00036489716,0.0017425381,0.0002395927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0132566495,0.0044337525,0.5292805,0.007445563,0.0014094076,0.00014200828,0.0019334896,0.0015409683,0.08797239,0.00071885664,0.24037075,0.111495666],"study_design_scores_gemma":[0.045330945,0.010833887,0.08686672,0.005673585,0.002326152,0.000033477136,0.0019188194,0.013284788,0.3394079,0.0024957575,0.48956883,0.0022591653],"about_ca_topic_score_codex":0.004238294,"about_ca_topic_score_gemma":0.00044596317,"teacher_disagreement_score":0.44241378,"about_ca_system_score_codex":0.00023657229,"about_ca_system_score_gemma":0.002775317,"threshold_uncertainty_score":0.99385524},"labels":[],"label_agreement":null},{"id":"W2988731068","doi":"10.1158/1078-0432.ccr-19-2078","title":"Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute on Aging; Cancer Prevention and Research Institute of Texas","keywords":"Pembrolizumab; Medicine; Oncolytic virus; Gemcitabine; Chemotherapy; Pancreatic cancer; Internal medicine; Oncology; Irinotecan; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Gastroenterology; Progressive disease; Cancer; Colorectal cancer","score_opus":0.04132572632792689,"score_gpt":0.4330337923661132,"score_spread":0.3917080660381863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988731068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557084,0.00077564723,0.000003012172,0.00051608984,0.000023929228,0.0029823233,0.000009999144,0.000005591781,0.00011259301],"genre_scores_gemma":[0.9986223,0.00039373295,0.000013082033,0.00017720416,0.000046711535,0.00046705105,0.000022814827,0.000045054017,0.00021202353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967435,0.00095043523,0.00035137063,0.0007061556,0.0007261725,0.00052239525],"domain_scores_gemma":[0.9985819,0.00024843644,0.00007897334,0.00066894677,0.0002979812,0.00012376418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021699495,0.00018196226,0.00033528433,0.00014897856,0.000085488704,0.000048536138,0.00038321715,0.00011882656,0.000065639746],"category_scores_gemma":[0.000119106735,0.000116778974,0.000034736717,0.00056028157,0.00036856392,0.000014165424,0.00013902163,0.0006991902,0.000009527736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06989825,0.002787106,0.90370816,0.000029923835,0.000077470475,0.000011609849,0.00033501926,0.000051912582,0.0015055443,0.0000037603425,0.000051209394,0.021540029],"study_design_scores_gemma":[0.055331282,0.066909246,0.8749322,0.00006776083,0.000010874994,9.2025067e-7,0.00054575125,0.00017109615,0.0014791857,0.000023977493,0.00031433778,0.00021332884],"about_ca_topic_score_codex":0.000291474,"about_ca_topic_score_gemma":0.005105033,"teacher_disagreement_score":0.06412214,"about_ca_system_score_codex":0.00013441296,"about_ca_system_score_gemma":0.00048202754,"threshold_uncertainty_score":0.47621083},"labels":[],"label_agreement":null},{"id":"W2988973848","doi":"10.1158/1078-0432.ccr-18-3717","title":"A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"GlaxoSmithKline Biologicals; Agence Nationale de la Recherche","keywords":"Melanoma; Medicine; Gene signature; Oncology; Lymph node; Immunotherapy; Internal medicine; Lung cancer; Cancer; Adjuvant therapy; Cancer research; Gene expression; Gene; Biology","score_opus":0.06522862528922822,"score_gpt":0.42706495668085354,"score_spread":0.3618363313916253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988973848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97689027,0.014230866,0.0000032526586,0.0049373675,0.00037309754,0.0027637756,0.00015204784,0.000012997484,0.00063632755],"genre_scores_gemma":[0.98797584,0.008116467,0.00012117215,0.0012057055,0.000422365,0.00054515933,0.000016026546,0.000047805333,0.0015494776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99517065,0.0009846959,0.0010776158,0.0007526338,0.0011046889,0.00090970186],"domain_scores_gemma":[0.9956949,0.0027110341,0.0002572013,0.00081956753,0.0003766208,0.00014069748],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007521993,0.00023494389,0.00078502035,0.00031274417,0.00009175678,0.00003928035,0.0006438605,0.0004100164,0.0009818603],"category_scores_gemma":[0.000597988,0.00015731079,0.00023192655,0.001448186,0.00027403134,0.00007763695,0.00019853802,0.0027054357,0.000021879587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008208222,0.00046505852,0.93916774,0.00075827155,0.00012872634,0.00007920092,0.0018702613,0.000056107627,0.028631989,0.0000043356695,0.004254971,0.016375143],"study_design_scores_gemma":[0.009762331,0.0014320454,0.95456576,0.0015229703,0.000086120606,0.000004846535,0.0009869281,0.0019166339,0.027936986,0.000044918386,0.0014932654,0.00024720666],"about_ca_topic_score_codex":0.039068934,"about_ca_topic_score_gemma":0.010035667,"teacher_disagreement_score":0.029033268,"about_ca_system_score_codex":0.0004008488,"about_ca_system_score_gemma":0.00146403,"threshold_uncertainty_score":0.9999314},"labels":[],"label_agreement":null},{"id":"W2989987839","doi":"10.1158/1078-0432.ccr-19-2853","title":"Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"National Cancer Institute; Dana-Farber/Harvard Cancer Center; American Cancer Society","keywords":"Prostate cancer; Medicine; PTEN; Oncology; Internal medicine; Statin; Prostate; Cancer; Proportional hazards model; Relative risk; Disease; Confidence interval; Biology; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.07824013329194157,"score_gpt":0.43781383465050205,"score_spread":0.3595737013585605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989987839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930053,0.0037828758,0.000007057997,0.00034993654,0.0014676052,0.00051505904,0.0006063762,0.0000069735197,0.0002588141],"genre_scores_gemma":[0.9628111,0.022569489,0.0000659017,0.00028708417,0.0021644267,0.00011671637,0.000039450122,0.000044972363,0.011900822],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765396,0.00042975557,0.00036456645,0.00060554314,0.00046750362,0.00047864643],"domain_scores_gemma":[0.99823284,0.00025152345,0.00018524882,0.0004462676,0.00068364973,0.000200473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015891123,0.00015467795,0.0003814562,0.000053568147,0.000072805364,0.000038750262,0.00019613269,0.00022478277,0.0003123035],"category_scores_gemma":[0.0006802724,0.000120120414,0.00010121332,0.00020977156,0.00053382124,0.0000114955665,0.00019173605,0.00054253277,0.000008940821],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003741727,0.00025764597,0.8661428,0.000087282206,0.0005001749,0.0000010724204,0.00026744636,0.00004975159,0.022633573,0.000022937531,0.08935088,0.016944705],"study_design_scores_gemma":[0.0059456136,0.0020664015,0.32265767,0.00022162659,0.00010587419,0.0000019352692,0.00017471213,0.00014511314,0.00986576,0.00007402555,0.6583105,0.00043081192],"about_ca_topic_score_codex":0.0028394088,"about_ca_topic_score_gemma":0.0021214099,"teacher_disagreement_score":0.5689596,"about_ca_system_score_codex":0.000035066136,"about_ca_system_score_gemma":0.00067498005,"threshold_uncertainty_score":0.48983684},"labels":[],"label_agreement":null},{"id":"W2990519743","doi":"10.1158/1078-0432.ccr-19-2350","title":"Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Breast cancer; Chemotherapy; Oncology; Population; Cancer; Hormone therapy; Confidence interval; Gastroenterology","score_opus":0.04489257946605979,"score_gpt":0.42035268426264466,"score_spread":0.37546010479658487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990519743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845344,0.0020877593,0.000026594642,0.0026624145,0.00019113148,0.0017411994,0.008713028,0.00002900069,0.000014461921],"genre_scores_gemma":[0.9927157,0.0044765356,0.00021484653,0.000542264,0.000172659,0.00044406438,0.0005885556,0.000086422435,0.00075891416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633706,0.00053682266,0.0006787686,0.00084283145,0.00083051086,0.0007740269],"domain_scores_gemma":[0.99729973,0.0010283367,0.00018442856,0.00048774536,0.0005186738,0.00048106353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063443615,0.0003335171,0.0010802664,0.00013713818,0.00006411563,0.000044081302,0.00013422886,0.000112340065,0.001239414],"category_scores_gemma":[0.00011308499,0.00022528584,0.000084681786,0.00025455223,0.00034653043,0.00016854372,0.00008297974,0.000646837,0.00005317841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009308584,0.0010861063,0.8624397,0.00006374681,0.0005316766,0.000013990241,0.00025801387,0.0000019337695,0.00012267083,0.0000013734789,0.00017716637,0.12599507],"study_design_scores_gemma":[0.014284978,0.0023828028,0.9792819,0.00056889973,0.00009821387,9.1358214e-7,0.0003284276,0.000041771356,0.00008893948,0.000007916138,0.0026678145,0.00024739493],"about_ca_topic_score_codex":0.020079192,"about_ca_topic_score_gemma":0.0010289651,"teacher_disagreement_score":0.12574767,"about_ca_system_score_codex":0.0012173932,"about_ca_system_score_gemma":0.00046591964,"threshold_uncertainty_score":0.9996736},"labels":[],"label_agreement":null},{"id":"W2990636802","doi":"10.1158/1078-0432.ccr-19-3645","title":"Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment?","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Metformin; Medicine; PI3K/AKT/mTOR pathway; Diabetes mellitus; Type 2 diabetes; Drug; Cancer; Internal medicine; Oncology; Pharmacology; Endocrinology; Signal transduction; Biology","score_opus":0.29951833120537447,"score_gpt":0.527646728476705,"score_spread":0.22812839727133055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990636802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23619828,0.71180516,0.00009789683,0.0414513,0.0025585839,0.006342459,0.00040574497,0.000021632197,0.0011189525],"genre_scores_gemma":[0.0061530015,0.76746833,0.0009830821,0.12848115,0.02763533,0.004704647,0.001591439,0.00023164872,0.06275134],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965712,0.0005398241,0.00061473966,0.001103603,0.0003262554,0.000844386],"domain_scores_gemma":[0.99835545,0.0005828977,0.00018226924,0.00055894884,0.00018969407,0.00013071272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016875642,0.0003028433,0.00074140436,0.00015107683,0.00008692313,0.00008327334,0.00041822283,0.0012631303,0.00023005252],"category_scores_gemma":[0.0007247413,0.0002558803,0.0002837838,0.00017556545,0.00021753777,0.0000105166955,0.00021474391,0.0010795462,0.000015021142],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033121515,0.000035609923,0.0015840979,0.00012383277,0.00015510728,0.000009018502,0.000022348799,0.00000781033,0.00019194071,0.0000036032222,0.5304525,0.46708292],"study_design_scores_gemma":[0.0032782927,0.0018787958,0.0004197742,0.00013321766,0.00006246195,0.0000011758838,0.000025722844,0.00002118475,0.0013589163,0.00037279163,0.992159,0.00028868296],"about_ca_topic_score_codex":0.001221147,"about_ca_topic_score_gemma":0.0034560626,"teacher_disagreement_score":0.46679425,"about_ca_system_score_codex":0.00030886987,"about_ca_system_score_gemma":0.0024507637,"threshold_uncertainty_score":0.99998933},"labels":[],"label_agreement":null},{"id":"W2991225937","doi":"10.1158/1078-0432.ccr-19-1623","title":"Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Jewish General Hospital; Montreal General Hospital; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada; Government of Canada; Prostate Cancer Foundation","keywords":"Somatic hypermutation; Biology; Cancer research; MSH2; MLH1; Prostate cancer; DNA repair; DNA mismatch repair; MSH6; Microsatellite instability; Cancer; Genetics; Allele; Gene; Microsatellite; Antibody","score_opus":0.09185235799688074,"score_gpt":0.4557856532562543,"score_spread":0.36393329525937357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991225937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464939,0.012886552,0.000021687385,0.036267992,0.0006090692,0.0011461994,0.0025199826,0.000007045878,0.00004755742],"genre_scores_gemma":[0.8491824,0.078228846,0.00026288014,0.05971475,0.004764013,0.0015911193,0.0024987299,0.00019834453,0.003558906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687517,0.00056511373,0.00087311707,0.0008962657,0.00041724645,0.00037307167],"domain_scores_gemma":[0.99755484,0.0009517274,0.0003403832,0.00057327666,0.0005200521,0.000059727543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014755814,0.00020015745,0.0004914942,0.00014445289,0.000037198006,0.00003323635,0.0002533043,0.0005311445,0.000040448977],"category_scores_gemma":[0.001118355,0.00019892663,0.00016795259,0.00020359461,0.00035301945,0.000006157695,0.00022774137,0.0011655701,0.000011370072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096497533,0.00019383794,0.08691815,0.0009931804,0.0005881172,0.00005666207,0.00044590607,0.0002829698,0.03427852,0.0000108475215,0.8629988,0.012268027],"study_design_scores_gemma":[0.004638991,0.0012068538,0.108973905,0.00078810164,0.00035424804,0.000003602091,0.00028307972,0.00096459093,0.028752789,0.0027945684,0.8502082,0.0010310509],"about_ca_topic_score_codex":0.0050019,"about_ca_topic_score_gemma":0.001776429,"teacher_disagreement_score":0.0973115,"about_ca_system_score_codex":0.00012800563,"about_ca_system_score_gemma":0.00092230726,"threshold_uncertainty_score":0.81119925},"labels":[],"label_agreement":null},{"id":"W2992828409","doi":"10.1158/1078-0432.ccr-19-2177","title":"Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Brain Tumour Charity","keywords":"Refractory (planetary science); Medicine; Glioma; Dabrafenib; Mutation; Internal medicine; Oncology; Cancer research; Cancer; Biology; Genetics; Gene; Metastatic melanoma","score_opus":0.0816485706614812,"score_gpt":0.46173054034874544,"score_spread":0.38008196968726427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992828409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463356,0.0004992284,4.8808585e-7,0.0005344777,0.000117569754,0.0036243612,0.0004449152,0.000017112412,0.00012826273],"genre_scores_gemma":[0.9987569,0.00047850655,0.00006536494,0.00005062947,0.00015896543,0.0001640504,0.00022567132,0.000035800273,0.000064102736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588895,0.0006925713,0.0010670202,0.00084908644,0.0010869693,0.00041542505],"domain_scores_gemma":[0.99309236,0.005223556,0.0002526497,0.0005975946,0.00050632015,0.00032751609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013780321,0.00020893273,0.00072984316,0.0003566681,0.00007653259,0.000023976007,0.00015682165,0.00016022443,0.00014309201],"category_scores_gemma":[0.001405082,0.00013614075,0.000073811774,0.0010946883,0.00022281735,0.00011831754,0.00013743479,0.0007268624,0.00003255276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08926941,0.030062731,0.86895907,0.000074727286,0.00024718454,0.0006942721,0.0012328393,0.000007051032,0.00009437452,0.0000033738215,0.00031610296,0.009038857],"study_design_scores_gemma":[0.1501333,0.014113103,0.83446604,0.00033244916,0.00016524237,0.0000011632513,0.00025874568,0.00001956009,0.00029900525,0.000006316253,0.00008050781,0.00012456991],"about_ca_topic_score_codex":0.0011587045,"about_ca_topic_score_gemma":0.00061073405,"teacher_disagreement_score":0.060863893,"about_ca_system_score_codex":0.00020842829,"about_ca_system_score_gemma":0.0005555151,"threshold_uncertainty_score":0.5551658},"labels":[],"label_agreement":null},{"id":"W2993443964","doi":"10.1158/1557-3265.ovcasymp18-ap11","title":"Abstract AP11: IDENTIFYING FUNCTIONAL NONCODING SOMATIC MUTATIONS IN OVARIAN CANCER","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Somatic cell; Epigenetics; Ovarian cancer; Epigenomics; Germline; Genetics; Transcriptome; Germline mutation; Gene; Cancer research; Cancer; Mutation; DNA methylation; Gene expression","score_opus":0.39906320040213733,"score_gpt":0.5608800758984523,"score_spread":0.16181687549631502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993443964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774169,0.0017887014,0.00003025382,0.010685353,0.0013071665,0.0011681935,0.000033848413,0.000033131422,0.007536482],"genre_scores_gemma":[0.99479216,0.0014329923,0.000178989,0.00039643957,0.0008168516,0.0007632158,0.000030261268,0.000036057325,0.0015530076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702305,0.0001632307,0.00074180955,0.0006162773,0.0008863672,0.0005692438],"domain_scores_gemma":[0.9976285,0.0013000162,0.00010278043,0.0004240408,0.000262521,0.00028213815],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019892019,0.00015195778,0.00046483384,0.0003031413,0.00013413864,0.000076054195,0.0001412002,0.00016716067,0.0120422095],"category_scores_gemma":[0.00028704756,0.0001306737,0.00018914403,0.00059676066,0.0001633288,0.00016635128,0.00009121794,0.001015689,0.00096049585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035093055,0.0007045749,0.970752,0.00034457893,0.00018848422,0.00011128265,0.00019092148,0.00021993676,0.0010154542,0.00047909806,0.003065065,0.022577647],"study_design_scores_gemma":[0.004640637,0.00016985815,0.98931384,0.0009833334,0.000053266293,0.000004201504,0.00022969926,0.00031572592,0.0005101207,0.0006604423,0.0029861925,0.00013269567],"about_ca_topic_score_codex":0.0027589472,"about_ca_topic_score_gemma":0.0014572254,"teacher_disagreement_score":0.022444952,"about_ca_system_score_codex":0.0009055264,"about_ca_system_score_gemma":0.0013722627,"threshold_uncertainty_score":0.9998174},"labels":[],"label_agreement":null},{"id":"W2995708246","doi":"10.1158/1078-0432.ccr-19-2898","title":"Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Cancer Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"Agrin; Pathology; Muscularis mucosae; Hyperplastic Polyp; Biomarker; Cancer; Medicine; Biology; Internal medicine; Colorectal cancer; Receptor","score_opus":0.24666628707058716,"score_gpt":0.5181322915281089,"score_spread":0.2714660044575218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995708246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987473,0.0010975165,0.000017996645,0.0030234659,0.0006195291,0.0007042162,0.000024562225,0.000065409164,0.0069743213],"genre_scores_gemma":[0.99717057,0.00016096688,0.00006514036,0.00046682198,0.0005721857,0.00015878477,0.000035670837,0.000027898172,0.0013419572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963866,0.0010358003,0.00052732404,0.0006171087,0.0009172025,0.00051600335],"domain_scores_gemma":[0.9953959,0.003435,0.00007882396,0.0005959162,0.00027947768,0.00021485369],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003253497,0.00015452328,0.0004020769,0.00017598798,0.00019682173,0.00011141863,0.00032189078,0.00024108021,0.0013130015],"category_scores_gemma":[0.0040843696,0.000103265076,0.00018277598,0.001211933,0.00020223983,0.00009059278,0.00018980178,0.0017383602,0.000339268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012637101,0.00073044066,0.8506174,0.00018301331,0.00022481539,0.0003296457,0.0014740177,0.000034119395,0.0058706095,0.000056728222,0.01085701,0.1169851],"study_design_scores_gemma":[0.00227349,0.0014550801,0.9781352,0.00059765496,0.00004575944,0.000017191182,0.0011428059,0.0046989555,0.0003186818,0.00021254312,0.010939014,0.00016361281],"about_ca_topic_score_codex":0.029697565,"about_ca_topic_score_gemma":0.0045397608,"teacher_disagreement_score":0.1275178,"about_ca_system_score_codex":0.00019630938,"about_ca_system_score_gemma":0.00059853925,"threshold_uncertainty_score":0.99959993},"labels":[],"label_agreement":null},{"id":"W2996090129","doi":"10.1158/1078-0432.ccr-19-1638","title":"A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; V Foundation for Cancer Research","keywords":"Carboplatin; Gemcitabine; Internal medicine; Medicine; Topotecan; Neutropenia; Ovarian cancer; Clinical endpoint; Oncology; Leukopenia; Phases of clinical research; Chemotherapy; Cancer; Gastroenterology; Clinical trial; Cisplatin","score_opus":0.11383850301501602,"score_gpt":0.48292877681981006,"score_spread":0.36909027380479403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996090129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902446,0.008194629,0.00009481294,0.0002796358,0.00021596646,0.0016709091,0.000032985157,0.0000032278488,0.00048337385],"genre_scores_gemma":[0.9924692,0.0062241796,0.0003393281,0.00001741477,0.00028900598,0.00028427248,0.000027560154,0.000025403608,0.000323663],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997018,0.0008179429,0.00081750454,0.000561635,0.00043002266,0.0003549256],"domain_scores_gemma":[0.99849105,0.0005172946,0.00021288781,0.00038182878,0.00026249772,0.00013442004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041266535,0.00015337697,0.00060286873,0.000121178564,0.00006635284,0.000019616586,0.00017636539,0.00020919858,0.00009670677],"category_scores_gemma":[0.00088601495,0.00011995615,0.00009041198,0.0002592882,0.0003602549,0.000004643807,0.00018958755,0.0003692257,9.995932e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7637039,0.00065007637,0.0049484097,0.00010438308,0.0001492772,0.000003275466,0.0002085821,0.00014812013,0.18168506,0.00008272609,0.000030780368,0.04828545],"study_design_scores_gemma":[0.91419417,0.010340859,0.0039928607,0.00028044783,0.00006172389,3.37102e-7,0.000075344404,0.00092128996,0.06663801,0.0003627044,0.0028277738,0.00030450345],"about_ca_topic_score_codex":0.00071241404,"about_ca_topic_score_gemma":0.001212321,"teacher_disagreement_score":0.1504903,"about_ca_system_score_codex":0.000034312983,"about_ca_system_score_gemma":0.00049643376,"threshold_uncertainty_score":0.48916698},"labels":[],"label_agreement":null},{"id":"W2996325740","doi":"10.1158/1078-0432.ccr-19-2202","title":"Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"Grantová Agentura České Republiky; Cancer Research UK; Bloodwise; Kay Kendall Leukaemia Fund; Blood Cancer UK; Gilead Sciences","keywords":"Activator (genetics); Cancer research; Signal transduction; PI3K/AKT/mTOR pathway; Phosphatase; Chemistry; Medicine; Cell biology; Biology; Phosphorylation; Internal medicine; Receptor","score_opus":0.26786961306371754,"score_gpt":0.5193038078117423,"score_spread":0.2514341947480248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996325740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919823,0.0050602094,0.00028951364,0.00013153117,0.00017655804,0.0018567059,0.00047236303,0.0000027910096,0.000028020491],"genre_scores_gemma":[0.9978756,0.00026336053,0.00097204343,0.00004983389,0.00017579405,0.00039798813,0.00020620401,0.000022510985,0.00003671606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971492,0.0004436589,0.0008795038,0.00052945886,0.00067761104,0.00032051196],"domain_scores_gemma":[0.99756247,0.0006929244,0.0002570849,0.00047039296,0.0009236707,0.000093459625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00959863,0.00011027037,0.00032662577,0.00007873301,0.0000248801,0.000010677187,0.0002418036,0.00025209432,0.000121685705],"category_scores_gemma":[0.0031931933,0.00010328558,0.00015815193,0.00022414954,0.00023982409,0.000010850154,0.00019796568,0.00026324575,0.0000042658817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027326692,0.0007501742,0.009728458,0.00021774512,0.000043809803,3.9274e-7,0.000016102786,0.0006848202,0.9768113,0.00047100667,0.00077092444,0.0077726226],"study_design_scores_gemma":[0.004488941,0.0012063546,0.0023751438,0.00027319556,0.000022934031,1.9850465e-7,0.000034301698,0.0013306222,0.9890716,0.00030664934,0.0007796362,0.000110387686],"about_ca_topic_score_codex":0.00019007213,"about_ca_topic_score_gemma":0.000059961832,"teacher_disagreement_score":0.012260361,"about_ca_system_score_codex":0.000055524208,"about_ca_system_score_gemma":0.00088944443,"threshold_uncertainty_score":0.42118636},"labels":[],"label_agreement":null},{"id":"W2999416926","doi":"10.1158/1078-0432.ccr-19-0374","title":"Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Biomedical Imaging and Bioengineering; NIH Clinical Center; National Cancer Institute; National Institutes of Health; National Natural Science Foundation of China; Radiological Society of North America","keywords":"Medicine; Renal cell carcinoma; Deep learning; Radiomics; Artificial intelligence; Radiology; Pathology; Computer science","score_opus":0.2554288077278997,"score_gpt":0.48534024218560434,"score_spread":0.22991143445770462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999416926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94645005,0.00086949265,0.0009953972,0.045051366,0.00019806289,0.00095949677,0.000035841942,0.00013843249,0.0053018318],"genre_scores_gemma":[0.99154234,0.00007738011,0.0014597079,0.0041264333,0.0018878698,0.00014791387,0.00008718454,0.00006878294,0.0006023865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533015,0.00080402975,0.0007087436,0.0010433008,0.0013532467,0.000760547],"domain_scores_gemma":[0.99512315,0.0023802554,0.00008937122,0.00054948404,0.0004639461,0.001393798],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016924394,0.00023307886,0.00059041585,0.0001387348,0.00028964097,0.00007334366,0.0003084422,0.000110487665,0.0014419896],"category_scores_gemma":[0.0073081465,0.00018359977,0.0002702985,0.0006471749,0.00020961967,0.000031963973,0.00028067708,0.0017457178,0.0005399878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009988077,0.000919411,0.794786,0.0001452253,0.000194703,0.0037328429,0.00099929,0.004047375,0.011313169,0.00007101963,0.018862745,0.15494017],"study_design_scores_gemma":[0.0110205775,0.0086816335,0.7610772,0.0019402923,0.000319153,0.000008582865,0.00091375003,0.13023736,0.015089066,0.0001427593,0.06980097,0.00076864107],"about_ca_topic_score_codex":0.0013190446,"about_ca_topic_score_gemma":0.000096346164,"teacher_disagreement_score":0.15417154,"about_ca_system_score_codex":0.00039323047,"about_ca_system_score_gemma":0.0005084666,"threshold_uncertainty_score":0.99947083},"labels":[],"label_agreement":null},{"id":"W3000030645","doi":"10.1158/1078-0432.ccr-19-0098","title":"Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"Prostate cancer; SOX2; Cancer research; Gene knockdown; Medicine; Prostate; Cancer stem cell; Cancer; Androgen deprivation therapy; Transcription factor; Biology; Internal medicine; Cell culture","score_opus":0.29335312432817967,"score_gpt":0.5166158266727627,"score_spread":0.22326270234458306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000030645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9256123,0.023703562,0.000021667409,0.047723383,0.00022895519,0.0018677978,0.00022751588,0.000050795537,0.00056407327],"genre_scores_gemma":[0.96123016,0.030640256,0.00040566403,0.0041079805,0.00047548342,0.00097432185,0.000016911401,0.000049872408,0.0020993594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606746,0.0004444672,0.0007844164,0.00092499884,0.0009825351,0.000796132],"domain_scores_gemma":[0.9978012,0.00036061936,0.00005988309,0.00040950987,0.00042969853,0.0009391302],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016946502,0.00020960184,0.00066138816,0.0001518472,0.000107313834,0.0000369109,0.0002581769,0.00012003907,0.0014317503],"category_scores_gemma":[0.0005213416,0.00016313994,0.00019829527,0.0012463023,0.00025216263,0.000079401,0.00009677713,0.0010280584,0.00007299788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053840026,0.0011872427,0.17361642,0.0011441223,0.0002364006,0.0004989841,0.013241351,0.00026436156,0.23103401,0.000026449341,0.17180473,0.3531059],"study_design_scores_gemma":[0.0078021344,0.0018206032,0.047160845,0.0007828627,0.000021531618,9.336489e-7,0.00077703537,0.00004570743,0.10891372,0.000068588844,0.83226806,0.00033795612],"about_ca_topic_score_codex":0.0008675679,"about_ca_topic_score_gemma":0.0013925084,"teacher_disagreement_score":0.66046333,"about_ca_system_score_codex":0.00024130606,"about_ca_system_score_gemma":0.000923632,"threshold_uncertainty_score":0.9994811},"labels":[],"label_agreement":null},{"id":"W3000192411","doi":"10.1158/1078-0432.ccr-19-3359","title":"Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Meta-analysis; Oncology; Cochrane Library; Chemoradiotherapy; Randomized controlled trial; Radiation therapy; Confidence interval; Subgroup analysis","score_opus":0.35345175243092775,"score_gpt":0.5265643516734971,"score_spread":0.1731125992425694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000192411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028741176,0.9852061,0.000007915978,0.0006081914,0.00004886456,0.013714846,0.00010619693,0.000013438239,0.0000070001333],"genre_scores_gemma":[0.0010724312,0.9857971,0.00014610376,0.00027066522,0.0001783668,0.012368474,0.000062477484,0.00007701267,0.000027358059],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931771,0.002246838,0.0019630904,0.0010016988,0.0009522917,0.0006589421],"domain_scores_gemma":[0.9904475,0.007115437,0.000689085,0.0008395182,0.00059532124,0.00031313408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059363125,0.00049685367,0.010555562,0.00021679694,0.00017307144,0.00010211166,0.00039029468,0.00022445746,0.000063099375],"category_scores_gemma":[0.0016241415,0.00021178077,0.0024362656,0.0018512023,0.00020649908,0.00004630324,0.00018931388,0.0010894547,0.0000063423727],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003266359,0.0006176165,0.0036833405,0.57634604,0.11886012,0.000079105615,0.00003167241,0.0000033144586,1.8537721e-9,0.000006877404,0.0003115999,0.29973367],"study_design_scores_gemma":[0.0042815832,0.006567099,0.0011169697,0.10066128,0.84582776,0.0000045677552,0.00002038248,0.00008516853,5.194979e-8,0.0000035049804,0.04099025,0.0004413998],"about_ca_topic_score_codex":0.00007537652,"about_ca_topic_score_gemma":0.0003053324,"teacher_disagreement_score":0.72696763,"about_ca_system_score_codex":0.00018819542,"about_ca_system_score_gemma":0.0006476531,"threshold_uncertainty_score":0.86361694},"labels":[],"label_agreement":null},{"id":"W3000205532","doi":"10.1158/1078-0432.ccr-19-1606","title":"A Combinatorial Strategy for Targeting <i>BRAF</i> V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Intramural Research Program; National Institutes of Health","keywords":"Ponatinib; Tyrosine-kinase inhibitor; Cancer research; Tyrosine kinase; MEK inhibitor; Medicine; Mutant; Kinase; Dasatinib; Cancer; Pharmacology; Biology; Imatinib; Internal medicine; Myeloid leukemia; Genetics; Receptor; MAPK/ERK pathway","score_opus":0.11930498942149106,"score_gpt":0.41560940435192795,"score_spread":0.2963044149304369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000205532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281806,0.002178681,0.00016495038,0.0022711297,0.0006705192,0.001067554,0.00029890478,0.000030351144,0.0004998357],"genre_scores_gemma":[0.99232614,0.00060773647,0.00032144706,0.00080117513,0.00528206,0.00033985707,0.00013588111,0.00006652954,0.0001191749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693406,0.00030575297,0.00058506185,0.00097216526,0.00049267296,0.00071031065],"domain_scores_gemma":[0.99814254,0.00027526816,0.00013879903,0.00029356114,0.00053233624,0.0006174936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013549816,0.00025888675,0.00042286137,0.000046029636,0.00027486158,0.00010454681,0.0003097968,0.00032323564,0.000044684995],"category_scores_gemma":[0.001087576,0.00021403328,0.00012364205,0.0002792828,0.00051324733,0.000013819796,0.00029203529,0.0006044165,0.0000064676774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012944015,0.00037215758,0.009904033,0.00060250645,0.00025879566,0.000095575,0.00026521063,0.00012070355,0.8814103,0.0018557266,0.07273737,0.019433608],"study_design_scores_gemma":[0.016443886,0.019086575,0.0008656999,0.00022659794,0.00007832597,0.00001148182,0.0006537411,0.00085359754,0.55280894,0.00057569257,0.40739465,0.0010008013],"about_ca_topic_score_codex":0.00018546605,"about_ca_topic_score_gemma":0.00017425751,"teacher_disagreement_score":0.33465728,"about_ca_system_score_codex":0.0000612054,"about_ca_system_score_gemma":0.0012584229,"threshold_uncertainty_score":0.8728024},"labels":[],"label_agreement":null},{"id":"W3000411451","doi":"10.1158/1078-0432.ccr-19-3023","title":"Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institutes of Health; Prostate Cancer Foundation of Australia; National Cancer Institute; National Institute for Health and Care Research; U.S. Department of Veterans Affairs","keywords":"Androgen receptor; Prostate cancer; Cancer research; Prostate; Cancer; Gene; Biology; Medicine; Oncology; Internal medicine; Genetics","score_opus":0.26812945031345203,"score_gpt":0.5093051652964752,"score_spread":0.24117571498302315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000411451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9209989,0.010634294,0.0000034047391,0.063012265,0.00046847214,0.0035156596,0.0004727784,0.00007511185,0.00081911316],"genre_scores_gemma":[0.9330304,0.044504113,0.0010206841,0.00562428,0.0019340292,0.003343647,0.00016257017,0.00016310181,0.010217125],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938547,0.0007408629,0.0009959213,0.0012082077,0.0018850177,0.001315266],"domain_scores_gemma":[0.9966109,0.0004629162,0.00011188772,0.00051468186,0.0006992396,0.0016003853],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002837774,0.00030462875,0.00083914155,0.00033010615,0.00019822163,0.00007307638,0.00044135016,0.00015101673,0.0012899744],"category_scores_gemma":[0.0012886239,0.00024380634,0.00019985769,0.0023616261,0.0004975674,0.00017700065,0.00048303747,0.0013947156,0.00053046516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028392209,0.00095902494,0.579851,0.0010873898,0.00066146045,0.0013132707,0.0044328407,0.000047147532,0.018860346,0.00002140294,0.2996707,0.06470328],"study_design_scores_gemma":[0.035608865,0.0046137045,0.08058766,0.0025779894,0.00030004318,0.0000036281851,0.0029656233,0.00016838487,0.07756598,0.00027376667,0.794106,0.0012283404],"about_ca_topic_score_codex":0.0009221166,"about_ca_topic_score_gemma":0.001623019,"teacher_disagreement_score":0.4992633,"about_ca_system_score_codex":0.0007644653,"about_ca_system_score_gemma":0.0015948411,"threshold_uncertainty_score":0.999623},"labels":[],"label_agreement":null},{"id":"W3000415041","doi":"10.1158/1078-0432.ccr-19-2027","title":"Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Kindai University; AstraZeneca Canada","keywords":"Lung cancer; Medicine; Cancer; Immune system; Cancer research; Mutation; Tumor microenvironment; Immunology; Oncology; Biology; Internal medicine; Gene; Genetics","score_opus":0.12114822744041158,"score_gpt":0.4691180432962325,"score_spread":0.34796981585582093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000415041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759808,0.0069478005,0.0000050207764,0.0138615295,0.0001102122,0.0018436522,0.00015580725,0.000010097451,0.0010850531],"genre_scores_gemma":[0.9893064,0.0075996295,0.000024446988,0.0016793843,0.00031665727,0.00049576786,0.000019161378,0.000038944516,0.0005196217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971783,0.00045968423,0.0007793339,0.00051950733,0.0005434102,0.00051974447],"domain_scores_gemma":[0.99798095,0.0010487356,0.00017726651,0.00043149566,0.00012706744,0.00023449189],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011155258,0.00022442588,0.0005736648,0.0000945285,0.000103051854,0.000022083806,0.00026571273,0.00010479863,0.0016213333],"category_scores_gemma":[0.00012374588,0.00013620021,0.0004719896,0.0005411593,0.0004791407,0.000034662884,0.00008654963,0.0007381081,0.000031593674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07961844,0.005638181,0.516837,0.00060739013,0.0025032524,0.0006521664,0.008424393,0.0008263494,0.26387787,0.000021485574,0.018205307,0.10278815],"study_design_scores_gemma":[0.014144946,0.01120249,0.8633884,0.00085748045,0.00016951948,0.000005099148,0.00075154577,0.00108411,0.10486306,0.000012629021,0.0032358132,0.00028487726],"about_ca_topic_score_codex":0.009786208,"about_ca_topic_score_gemma":0.0003548993,"teacher_disagreement_score":0.34655142,"about_ca_system_score_codex":0.0017525492,"about_ca_system_score_gemma":0.0011808086,"threshold_uncertainty_score":0.9992913},"labels":[],"label_agreement":null},{"id":"W3001389567","doi":"10.1158/1078-0432.ccr-19-2485","title":"PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Western University; Princess Margaret Cancer Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Head and neck squamous-cell carcinoma; Mutant; Radioresistance; Cancer research; PI3K/AKT/mTOR pathway; Biology; Downregulation and upregulation; Cell culture; Cell; Cancer; Gene; Cell biology; Signal transduction; Head and neck cancer; Genetics","score_opus":0.1176647177057211,"score_gpt":0.40948098520557774,"score_spread":0.2918162674998567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001389567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949205,0.0032096787,0.00004931666,0.0007804896,0.00018958225,0.00027141327,0.000030262454,0.000008630717,0.0005401152],"genre_scores_gemma":[0.99819857,0.00048599238,0.00003501892,0.000298295,0.0006749592,0.000040203322,0.000022863944,0.000026492085,0.00021760764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976044,0.0004463109,0.0005443095,0.00061710726,0.00038277832,0.00040508562],"domain_scores_gemma":[0.998996,0.00015515632,0.00008045412,0.00027866053,0.00019185996,0.0002978262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013654226,0.00013827992,0.0002724521,0.00006348512,0.00007341543,0.000022700331,0.00020907553,0.00027539665,0.000057121077],"category_scores_gemma":[0.00060236646,0.00012827586,0.00010166953,0.00024225845,0.00024942256,0.0000048286124,0.00023755195,0.00064080564,0.00001856944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016595382,0.00027163798,0.1795137,0.00019042366,0.000015096069,0.000042624153,0.00026951497,0.00013567565,0.81004316,0.000016758206,0.0010168037,0.006825063],"study_design_scores_gemma":[0.006930571,0.008995665,0.03401986,0.00010757691,0.000034139957,0.0000048913107,0.00074761367,0.0010093919,0.9209719,0.000200701,0.026433432,0.0005442678],"about_ca_topic_score_codex":0.0005785219,"about_ca_topic_score_gemma":0.00027250568,"teacher_disagreement_score":0.14549384,"about_ca_system_score_codex":0.000029066527,"about_ca_system_score_gemma":0.0003892833,"threshold_uncertainty_score":0.52309376},"labels":[],"label_agreement":null},{"id":"W3001423058","doi":"10.1158/1078-0432.ccr-19-3258","title":"ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Medicine; Taxane; Clinical endpoint; Metastatic breast cancer; Paclitaxel; Cancer; Internal medicine; Phases of clinical research; Population; Breast cancer; Meningeal carcinomatosis; Oncology; Response Evaluation Criteria in Solid Tumors; Cerebrospinal fluid; Chemotherapy; Clinical trial","score_opus":0.11517241701475196,"score_gpt":0.43399114336250183,"score_spread":0.3188187263477499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001423058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965165,0.00087579293,0.000007447645,0.031667374,0.000050264982,0.0014668499,0.00062695943,0.000035941794,0.00010433859],"genre_scores_gemma":[0.99677825,0.00019179747,0.00039709796,0.0017681096,0.00024021909,0.00040631444,0.000052687832,0.000057792422,0.00010773518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956443,0.00094063225,0.0005387038,0.0010018485,0.0011065216,0.0007680284],"domain_scores_gemma":[0.996737,0.0015166305,0.00016344147,0.00034730087,0.00042156968,0.00081407867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001759112,0.00032932995,0.0008557632,0.0001493866,0.00018313313,0.000088694185,0.00015948707,0.00008333611,0.00044715632],"category_scores_gemma":[0.00040307635,0.00021719236,0.00010404365,0.0007585601,0.00056175445,0.00020126668,0.00019105518,0.0011794269,0.0000067704214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009648003,0.0007992235,0.9390305,0.0002963867,0.00037086447,0.00015012127,0.00042428818,0.000013656607,0.00007758936,0.000014981707,0.0066344505,0.042539895],"study_design_scores_gemma":[0.011966116,0.0036748215,0.98110247,0.0006016884,0.0001507813,0.000010404873,0.00030542575,0.00023226344,0.00019465288,0.0000052539285,0.0014862986,0.00026980156],"about_ca_topic_score_codex":0.0033474271,"about_ca_topic_score_gemma":0.005834347,"teacher_disagreement_score":0.042270094,"about_ca_system_score_codex":0.00027027473,"about_ca_system_score_gemma":0.0008970599,"threshold_uncertainty_score":0.8856847},"labels":[],"label_agreement":null},{"id":"W3001655014","doi":"10.1158/1078-0432.ccr-19-1431","title":"First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"AbbVie","keywords":"Medicine; Neutropenia; Leukopenia; Pharmacokinetics; Adverse effect; Internal medicine; Gastroenterology; Toxicity","score_opus":0.13314455515717813,"score_gpt":0.4959936230890403,"score_spread":0.3628490679318622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001655014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962456,0.00029264353,0.0000019583604,0.000614257,0.000036195033,0.0026387093,0.000051673298,0.000025666644,0.00009328791],"genre_scores_gemma":[0.999055,0.00023306347,0.00012674961,0.00007971421,0.00013636136,0.00014949376,0.00011614953,0.00005186432,0.000051559156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949149,0.0010256353,0.0010396047,0.0009316887,0.0013155028,0.0007726671],"domain_scores_gemma":[0.9968766,0.0011448901,0.00016349745,0.00048240562,0.0005089247,0.0008237022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002239678,0.00023794292,0.0008507204,0.00031753085,0.00017489797,0.00003529527,0.00026751027,0.00012512965,0.00017253784],"category_scores_gemma":[0.002260406,0.00018251303,0.00006404848,0.0007513813,0.00046754078,0.00022236978,0.00024513956,0.0014701211,0.000010250298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018747633,0.009855193,0.96083844,0.00026151232,0.00013089842,0.000476952,0.0018172323,0.000016788183,0.0006088563,0.0000024045316,0.00013757123,0.0071065323],"study_design_scores_gemma":[0.07054771,0.017405558,0.9079335,0.00032377138,0.000025721243,3.821089e-7,0.0011124176,0.0019379179,0.00023304968,0.0000089314735,0.00030852703,0.0001625321],"about_ca_topic_score_codex":0.0038402618,"about_ca_topic_score_gemma":0.003348028,"teacher_disagreement_score":0.052904937,"about_ca_system_score_codex":0.0001752712,"about_ca_system_score_gemma":0.0003223037,"threshold_uncertainty_score":0.74426657},"labels":[],"label_agreement":null},{"id":"W3002753972","doi":"10.1158/1078-0432.ccr-19-2803","title":"A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University; McGill University Health Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Friends of Hebrew University; National Cancer Institute; Pancreatic Cancer Canada Foundation; Canadian Institutes of Health Research; Alexander von Humboldt-Stiftung","keywords":"Pancreatic cancer; Phenotype; Chemokine; Medicine; Signature (topology); Cancer; Metastasis; Cancer research; Pathology; Biology; Immunology; Inflammation; Internal medicine; Gene; Genetics","score_opus":0.22700519688983825,"score_gpt":0.4832452065972855,"score_spread":0.2562400097074472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002753972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96378475,0.005001497,0.000020022206,0.026252719,0.000035427754,0.0014790586,0.000051854633,0.000040566058,0.003334096],"genre_scores_gemma":[0.98438716,0.00574923,0.0004438159,0.00600184,0.0003041193,0.00054210133,0.000027422817,0.00005743351,0.0024869025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99552083,0.0008436295,0.00072370935,0.0007857753,0.0012419631,0.0008840758],"domain_scores_gemma":[0.99495167,0.0032009894,0.00013609599,0.00034577795,0.00057513156,0.00079031783],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026082469,0.0002452408,0.0013743063,0.00017952206,0.00012148575,0.000036776448,0.00024392057,0.0003034043,0.0013274909],"category_scores_gemma":[0.0030826586,0.00017616217,0.000098587705,0.0013009375,0.0008813399,0.0000838048,0.00021809731,0.0026298654,0.00003494535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051165516,0.0005347192,0.97142494,0.0007629489,0.0005823059,0.00087807386,0.001193177,0.0000039192064,0.0020136635,0.000016024358,0.009821305,0.007652368],"study_design_scores_gemma":[0.018614061,0.003376567,0.9665131,0.0012153682,0.0006421436,0.000012437162,0.00035785258,0.0045874054,0.00035209657,0.00022602742,0.0037409512,0.0003620203],"about_ca_topic_score_codex":0.0008806247,"about_ca_topic_score_gemma":0.0004622771,"teacher_disagreement_score":0.020602375,"about_ca_system_score_codex":0.00041687192,"about_ca_system_score_gemma":0.0025307436,"threshold_uncertainty_score":0.9996711},"labels":[],"label_agreement":null},{"id":"W3003699744","doi":"10.1158/1078-0432.ccr-19-2576","title":"Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Alberta Cancer Foundation; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Cabozantinib; Endometrial cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.3313439728088638,"score_gpt":0.548327161618752,"score_spread":0.21698318880988815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003699744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98791635,0.002877478,0.0000017385491,0.0032660044,0.00061163155,0.0046697897,0.0004175732,0.000014190548,0.00022526906],"genre_scores_gemma":[0.9958637,0.0026344643,0.000025894647,0.00019108737,0.0006431689,0.00053918746,0.000008760563,0.000028909444,0.000064876825],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99381036,0.0014600401,0.0018582626,0.0007359956,0.0015975042,0.00053783465],"domain_scores_gemma":[0.99559754,0.0025084522,0.00044834567,0.00049590145,0.00046314165,0.0004866398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030333526,0.00023937516,0.0014765516,0.00029618212,0.00013976906,0.000017817132,0.0004479604,0.00013631668,0.0006217446],"category_scores_gemma":[0.008071634,0.00015182717,0.00026646268,0.0032020302,0.00078370824,0.000055993565,0.0005833449,0.0012782164,0.0000037305615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45661342,0.02780955,0.34885153,0.00083543756,0.0009187555,0.000089857655,0.0015234336,0.000006821386,0.00066528836,0.00005231211,0.00075330434,0.16188027],"study_design_scores_gemma":[0.84736705,0.0835464,0.05456348,0.0007358738,0.0007713929,0.0000032743203,0.0011221258,0.00020267912,0.0025727828,0.0001366522,0.0086656185,0.00031267697],"about_ca_topic_score_codex":0.004230069,"about_ca_topic_score_gemma":0.0017764247,"teacher_disagreement_score":0.39075363,"about_ca_system_score_codex":0.00012766533,"about_ca_system_score_gemma":0.0012836993,"threshold_uncertainty_score":0.9663083},"labels":[],"label_agreement":null},{"id":"W3004063334","doi":"10.1158/1078-0432.ccr-19-1945","title":"Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Academy of Finland; Mayo Clinic; Breast Cancer Research Foundation; Syöpäjärjestöt; Canadian Cancer Society","keywords":"Capecitabine; Medicine; Oncology; Internal medicine; Hazard ratio; Triple-negative breast cancer; Taxane; Breast cancer; Adjuvant; Proportional hazards model; Cancer; Confidence interval; Colorectal cancer","score_opus":0.20394803757435861,"score_gpt":0.5027236238608903,"score_spread":0.29877558628653167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004063334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96952164,0.0020898674,0.000041250307,0.021565672,0.0006599632,0.003302988,0.0025498094,0.00001322902,0.0002555832],"genre_scores_gemma":[0.9885449,0.0039548883,0.00007126975,0.0011184437,0.0027407089,0.0032901345,0.0000632234,0.000043669887,0.00017279692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529326,0.0010699984,0.0011425745,0.0011541162,0.0005600679,0.0007799633],"domain_scores_gemma":[0.99696624,0.0017607976,0.00018629817,0.00047022567,0.00037050343,0.00024592446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003546568,0.00027973027,0.0006656318,0.00008663288,0.00015527775,0.000043869775,0.0007084791,0.0003622177,0.000115075105],"category_scores_gemma":[0.0022514348,0.00020190026,0.00036661167,0.00062154775,0.00085117103,0.000014384701,0.00036016296,0.00089451286,0.000009049587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3281113,0.0015430265,0.5925778,0.00010422272,0.0008608995,0.000047525944,0.0013057244,0.00014320036,0.0001923305,0.00007590962,0.014765385,0.060272656],"study_design_scores_gemma":[0.079781465,0.0038363682,0.9048693,0.00009246985,0.000066913286,0.000001319366,0.001093997,0.0003831356,0.0002727223,0.00018309357,0.009099114,0.0003200611],"about_ca_topic_score_codex":0.003488538,"about_ca_topic_score_gemma":0.010109024,"teacher_disagreement_score":0.3122915,"about_ca_system_score_codex":0.00017084008,"about_ca_system_score_gemma":0.0007663329,"threshold_uncertainty_score":0.82332534},"labels":[],"label_agreement":null},{"id":"W3004420993","doi":"10.1158/1078-0432.ccr-19-2427","title":"Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Carcinoma; Phases of clinical research; Toxicity","score_opus":0.25170793116755175,"score_gpt":0.4626059476047845,"score_spread":0.21089801643723277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004420993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946103,0.00020118969,0.0000019843412,0.0016669275,0.00002182948,0.0031594008,0.000033239536,0.0000051329043,0.00029996943],"genre_scores_gemma":[0.99946386,0.000083584724,0.000041827974,0.0000882609,0.000029264049,0.0001676908,0.000024930336,0.000027047387,0.00007351679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570614,0.00095092604,0.0010032438,0.00048575463,0.0015344309,0.0003195149],"domain_scores_gemma":[0.99731135,0.00092928595,0.00029218147,0.0005198924,0.0007576413,0.0001896604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014282068,0.00017272987,0.0006412838,0.000179881,0.000045850742,0.000008322452,0.00029106182,0.00006033167,0.00005937133],"category_scores_gemma":[0.00052498997,0.000094885174,0.00006923449,0.0013861872,0.00033572412,0.00006169127,0.00009973222,0.0007990312,0.000002584222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08524453,0.015099836,0.89029914,0.00017093695,0.000089423105,0.00016092406,0.0033866656,0.0002993401,0.00015531346,0.0000043128707,0.000116088275,0.0049734702],"study_design_scores_gemma":[0.100209616,0.08773487,0.802131,0.00026124393,0.00005755644,7.2201715e-7,0.0011696956,0.00025223166,0.008024501,0.000015963695,0.00005097229,0.000091649315],"about_ca_topic_score_codex":0.0042888257,"about_ca_topic_score_gemma":0.0022712897,"teacher_disagreement_score":0.08816818,"about_ca_system_score_codex":0.00019474926,"about_ca_system_score_gemma":0.00081928907,"threshold_uncertainty_score":0.64834505},"labels":[],"label_agreement":null},{"id":"W3005735196","doi":"10.1158/1078-0432.ccr-19-3924","title":"Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Cancer Research UK","keywords":"Glioblastoma; Key (lock); Clinical Oncology; Medicine; Medical physics; Oncology; Cancer; Computer science; Internal medicine; Cancer research","score_opus":0.256009561707791,"score_gpt":0.5487617880853866,"score_spread":0.29275222637759557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005735196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92510945,0.00045357854,0.00011721232,0.07262236,0.00016364649,0.0010909956,0.000021186921,0.000041687,0.00037990347],"genre_scores_gemma":[0.9964509,0.00009915046,0.0012627331,0.001186895,0.00037620758,0.0004905425,0.0000030907668,0.000023072025,0.00010739708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771833,0.00006906525,0.00044003403,0.0005880491,0.000658241,0.0005263059],"domain_scores_gemma":[0.99768215,0.001052115,0.00004987998,0.00028165703,0.0004032666,0.00053091586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001452803,0.00012176501,0.00042239405,0.000096636766,0.00032595982,0.000085738495,0.00023844399,0.00006962623,0.00017744601],"category_scores_gemma":[0.0033278374,0.00008394718,0.0002256571,0.00070933066,0.0009770578,0.00013943881,0.00012099687,0.0003742064,0.00004129423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043736957,0.0010146912,0.6217113,0.0004714233,0.00025598076,0.00007117378,0.0020864063,0.00001047669,0.026317807,0.0010659434,0.0033261518,0.33929494],"study_design_scores_gemma":[0.049867272,0.046448436,0.60131717,0.0009660114,0.000586437,0.0000116936,0.004137556,0.023343915,0.1631677,0.0039011373,0.1050314,0.001221283],"about_ca_topic_score_codex":0.00015571846,"about_ca_topic_score_gemma":0.00016821576,"teacher_disagreement_score":0.33807367,"about_ca_system_score_codex":0.00013616803,"about_ca_system_score_gemma":0.0011314503,"threshold_uncertainty_score":0.39839727},"labels":[],"label_agreement":null},{"id":"W3006614516","doi":"10.1158/1078-0432.ccr-19-2230","title":"<i>Kdm6a</i> Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with <i>p53</i> Dysfunction","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Macrophage; Inflammation; Macrophage polarization; Cancer; Cancer research; Bladder cancer; Medicine; Immunology; Biology; Internal medicine; In vitro; Genetics","score_opus":0.1170406606635378,"score_gpt":0.41247045517879666,"score_spread":0.29542979451525886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006614516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876932,0.003942709,0.000067228706,0.006265459,0.00013076574,0.0013080265,0.000086332,0.000060053848,0.00044623716],"genre_scores_gemma":[0.99438936,0.002740934,0.00006663723,0.001540396,0.0005143067,0.00039600974,0.00002515687,0.000052973774,0.00027421015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734056,0.00031886683,0.0005224121,0.0007046766,0.000632225,0.0004812663],"domain_scores_gemma":[0.998499,0.00025246307,0.0000871921,0.0002392982,0.000530819,0.00039127088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006222457,0.00021913236,0.000414595,0.00011921504,0.0002075975,0.000080087026,0.00011335042,0.00019806308,0.00039510295],"category_scores_gemma":[0.00042133956,0.00016244529,0.00004805306,0.000830104,0.00040632553,0.00021370733,0.00008814878,0.000858083,0.000022640123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033059546,0.0004470405,0.929139,0.0003669612,0.00013650686,0.00011870646,0.0010790424,0.00005781772,0.040491823,0.00012407283,0.0011613402,0.023571696],"study_design_scores_gemma":[0.01767585,0.0070774257,0.89126676,0.00094118295,0.0002996093,0.000030171095,0.0010878413,0.0011363607,0.07015791,0.00018189687,0.009386208,0.000758751],"about_ca_topic_score_codex":0.0012287514,"about_ca_topic_score_gemma":0.0012055468,"teacher_disagreement_score":0.037872247,"about_ca_system_score_codex":0.00019379522,"about_ca_system_score_gemma":0.0014094297,"threshold_uncertainty_score":0.6624327},"labels":[],"label_agreement":null},{"id":"W3006773245","doi":"10.1158/1078-0432.ccr-19-3091","title":"Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society; National Institute of General Medical Sciences; Breast Cancer Research Foundation","keywords":"Anastrozole; Breast cancer; Estrogen receptor; Estrogen; Medicine; Oncology; Cancer; Internal medicine; Tamoxifen","score_opus":0.14223765566882268,"score_gpt":0.451958645979411,"score_spread":0.3097209903105883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006773245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922931,0.002020789,0.000010242708,0.0046291146,0.00005455975,0.00047010827,0.0005081623,0.0000055449373,0.000008332478],"genre_scores_gemma":[0.9974206,0.0016378372,0.0001950026,0.00012648966,0.0003861998,0.00009175622,0.000049368256,0.00002365264,0.00006905889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983469,0.0002216923,0.00037163624,0.0004648761,0.0002480627,0.00034683652],"domain_scores_gemma":[0.99902016,0.00021523888,0.00011770679,0.00015890754,0.000191523,0.00029643564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008687121,0.00012737275,0.00034176462,0.000044486587,0.00009005576,0.00004022709,0.0001488074,0.0003699787,0.0000091735865],"category_scores_gemma":[0.00031373472,0.000107049476,0.00008546818,0.00013285107,0.00019402697,0.000013674745,0.00016683695,0.00036279418,0.0000011752298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006425148,0.000057077654,0.9301413,0.000050826005,0.00015854435,7.6735205e-7,0.00014462852,0.0000018887085,0.053658657,0.0000046594473,0.001326535,0.013812543],"study_design_scores_gemma":[0.0036187856,0.0023187716,0.85813105,0.00008915908,0.00007565447,7.19285e-7,0.00009334129,0.0001505779,0.1322462,0.000046334542,0.003012456,0.00021696671],"about_ca_topic_score_codex":0.000468641,"about_ca_topic_score_gemma":0.00004426767,"teacher_disagreement_score":0.07858755,"about_ca_system_score_codex":0.000032895216,"about_ca_system_score_gemma":0.00022317389,"threshold_uncertainty_score":0.4365351},"labels":[],"label_agreement":null},{"id":"W3006968198","doi":"10.1158/1078-0432.ccr-19-3136","title":"Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"European Society for Medical Oncology; Merck; AstraZeneca","keywords":"Clinical trial; Drug development; Task force; Medicine; Immunotherapy; Task (project management); Cancer; Test (biology); Intensive care medicine; Drug; Pharmacology; Internal medicine; Political science; Management","score_opus":0.8178733737580474,"score_gpt":0.6530636985540562,"score_spread":0.16480967520399115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006968198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90669495,0.02454242,0.005358321,0.059163503,0.00035894095,0.0036219864,0.0002073793,0.0000123835125,0.000040122904],"genre_scores_gemma":[0.86983854,0.0938328,0.028809117,0.0035002893,0.00095007446,0.0015643823,0.000030557923,0.00010426114,0.0013699855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99338603,0.003509334,0.0016101688,0.00046556772,0.00067768816,0.0003512105],"domain_scores_gemma":[0.9247774,0.07192757,0.00042885428,0.00051296566,0.0022518367,0.00010139926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016748182,0.0001669699,0.0010434503,0.00008741489,0.00019957214,0.000011115896,0.00051894574,0.00017331312,0.00058616156],"category_scores_gemma":[0.0058643343,0.000088981324,0.00018048396,0.00074921024,0.0027003067,0.000041457737,0.00024741393,0.0011195249,0.0000019690358],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03454178,0.00043606973,0.041985832,0.00019396866,0.007338792,0.0000010454504,0.028053636,0.000018385304,0.113695726,0.0004065689,0.021182748,0.75214547],"study_design_scores_gemma":[0.03483527,0.033726834,0.4044024,0.0023761932,0.00051534205,0.0000017071933,0.039146196,0.0007362431,0.2964731,0.00717431,0.17985645,0.0007559456],"about_ca_topic_score_codex":0.00063812616,"about_ca_topic_score_gemma":0.00014062008,"teacher_disagreement_score":0.7513895,"about_ca_system_score_codex":0.00008256897,"about_ca_system_score_gemma":0.0017812472,"threshold_uncertainty_score":0.99493927},"labels":[],"label_agreement":null},{"id":"W3009312185","doi":"10.1158/1078-0432.ccr-19-3087","title":"Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Health and Care Research Wales; Cancer Research Wales; Cancer Research UK; Wellcome Trust; Medical Research Council; Wellcome","keywords":"Antigen; Cancer; Biology; RNA; Immunology; Immunity; Cancer research; Immune system; Gene; Genetics","score_opus":0.13254637811976525,"score_gpt":0.4114010023717912,"score_spread":0.278854624252026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009312185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.920599,0.07368597,0.00003768534,0.0041807806,0.00046304864,0.00045409592,0.00036617627,0.00002625129,0.00018700736],"genre_scores_gemma":[0.9328004,0.059563227,0.000018536837,0.0013316965,0.00010249567,0.00008245214,0.000019027362,0.00003765565,0.0060445075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962658,0.0012280694,0.00089658855,0.0006685486,0.00017769611,0.00076325436],"domain_scores_gemma":[0.99793595,0.0011071941,0.00021388661,0.00040602684,0.0002473357,0.00008962592],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017780339,0.00023036725,0.00071823836,0.00009756045,0.00027511673,0.0000534033,0.000526333,0.00039510528,0.0013015813],"category_scores_gemma":[0.00027527794,0.00018026895,0.00018901657,0.000384167,0.0011559526,0.00020713387,0.00030408392,0.00096993556,0.000104071805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032229815,0.00009601383,0.0020282755,0.00010498768,0.00038840272,0.000013426075,0.00090656336,0.000002302846,0.9604454,0.00005636611,0.025039418,0.007695875],"study_design_scores_gemma":[0.0019666825,0.00070972723,0.0015132948,0.00019088616,0.000027111468,0.0000028129416,0.00039577825,0.000009257437,0.9099008,0.000037269503,0.08503305,0.00021335168],"about_ca_topic_score_codex":0.0031673787,"about_ca_topic_score_gemma":0.00002680989,"teacher_disagreement_score":0.059993632,"about_ca_system_score_codex":0.00008839501,"about_ca_system_score_gemma":0.0008592166,"threshold_uncertainty_score":0.9996114},"labels":[],"label_agreement":null},{"id":"W3010406759","doi":"10.1158/1078-0432.ccr-19-0514","title":"PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; National Institutes of Health; National Institute of Dental and Craniofacial Research; U.S. Department of Veterans Affairs","keywords":"Olaparib; Head and neck squamous-cell carcinoma; Cancer research; PARP inhibitor; Gene knockdown; DNA damage; Biology; Radiation therapy; Head and neck cancer; Medicine; Poly ADP ribose polymerase; Cell culture; Internal medicine; Gene; DNA; Genetics","score_opus":0.31904800252865156,"score_gpt":0.5218961593901456,"score_spread":0.202848156861494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010406759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806692,0.0140009625,0.00006737003,0.0023905053,0.00010238413,0.00086908706,0.000026414304,0.000032458986,0.0018416414],"genre_scores_gemma":[0.9961949,0.0017574787,0.00020685146,0.00088901556,0.00053983956,0.00023732347,0.00001836429,0.000040060364,0.00011618874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968969,0.00040523207,0.00086488,0.00065351103,0.00071829103,0.0004611485],"domain_scores_gemma":[0.9986565,0.00034742334,0.00012628276,0.0002994897,0.00019015122,0.00038013016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094845024,0.00018139069,0.00062462874,0.00017025703,0.00010026841,0.00002346807,0.00012408184,0.00017971054,0.0004267785],"category_scores_gemma":[0.00006108555,0.00016466333,0.00013753172,0.00049184967,0.0007173028,0.000115785755,0.00006974012,0.000661978,0.0000071280933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073542693,0.0025736382,0.07461534,0.0005647431,0.00004561273,0.00010997202,0.008148375,0.0004548092,0.89789706,0.0006900912,0.003170071,0.0043760375],"study_design_scores_gemma":[0.023736682,0.012318635,0.015914008,0.00041533646,0.000018472218,0.0000075367675,0.0014624171,0.0047594314,0.93613535,0.0006433426,0.004217641,0.00037116025],"about_ca_topic_score_codex":0.0008633077,"about_ca_topic_score_gemma":0.000105648825,"teacher_disagreement_score":0.058701333,"about_ca_system_score_codex":0.00038074297,"about_ca_system_score_gemma":0.0004037805,"threshold_uncertainty_score":0.67147756},"labels":[],"label_agreement":null},{"id":"W3011022719","doi":"10.1158/1078-0432.ccr-19-3797","title":"Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; Jewish General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; Spinal Cord Injury BC; McGill University; McGill University Health Centre","funders":"H2020 European Research Council; National Cancer Institute; Canadian Institutes of Health Research; Cancer Research UK; U.S. Department of Defense","keywords":"SMARCA4; Biology; Cancer; Ovarian cancer; Chromatin remodeling; Cancer research; Genetics; Epigenetics; Gene","score_opus":0.4798473550500737,"score_gpt":0.5424238971364708,"score_spread":0.06257654208639707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011022719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023229392,0.9954073,0.00002308073,0.00024535388,0.0006749424,0.0009934165,0.00007676059,0.0000059837507,0.0002502259],"genre_scores_gemma":[0.0005237276,0.9954386,0.00038726086,0.000059917813,0.0014997502,0.000102432656,0.00007389541,0.00006076645,0.0018536872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969604,0.00045458964,0.0010082842,0.00083610474,0.00036212016,0.00037851484],"domain_scores_gemma":[0.99827284,0.00008992202,0.0002298219,0.0008492163,0.0003029486,0.00025526687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006219387,0.0003380618,0.0009198988,0.000051118295,0.00009099534,0.000025999943,0.00066462415,0.0003192931,0.000038746417],"category_scores_gemma":[0.00015274371,0.00021379333,0.0005223676,0.00026958177,0.000256935,0.0000010778349,0.0008537249,0.0004901122,0.000013970785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050130377,0.00007963734,0.00015842136,0.003299048,0.0001551108,0.0000028865657,0.000010052015,0.0000057369916,0.000032123513,0.000004905679,0.021093665,0.97510827],"study_design_scores_gemma":[0.0005801505,0.00045233432,0.00004675093,0.001467192,0.00035831318,0.0000033284034,0.000011375989,0.00004067956,0.00021210438,0.000025865795,0.99659306,0.00020887016],"about_ca_topic_score_codex":0.00019669933,"about_ca_topic_score_gemma":0.00006300456,"teacher_disagreement_score":0.9754994,"about_ca_system_score_codex":0.00011546964,"about_ca_system_score_gemma":0.0018035325,"threshold_uncertainty_score":0.8718239},"labels":[],"label_agreement":null},{"id":"W3011562658","doi":"10.1158/1078-0432.ccr-19-3724","title":"GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University Health Centre; McGill University; University Health Network; Kingston General Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Pancreatic Cancer Canada Foundation; Canadian Cancer Society Research Institute; Hebrew University of Jerusalem; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Pancreatic cancer; GATA6; In situ hybridization; Biology; Basal (medicine); Internal medicine; FOLFIRINOX; Oncology; KRAS; Cancer research; Pathology; Medicine; Cancer; Gene expression; Gene; Genetics; Colorectal cancer","score_opus":0.26176401326758264,"score_gpt":0.5403275624752844,"score_spread":0.2785635492077017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011562658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964618,0.0053198277,0.000024050927,0.025625134,0.00014928442,0.00088419014,0.000022698714,0.000046693687,0.0033101083],"genre_scores_gemma":[0.984184,0.009834072,0.0007016143,0.0017151402,0.0009626903,0.00050537125,0.000012702762,0.000041417057,0.0020429895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588805,0.0008028215,0.0007408954,0.00084549753,0.00090041594,0.0008223117],"domain_scores_gemma":[0.99515104,0.003099877,0.000081048645,0.00037241407,0.00035329128,0.00094233995],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021629375,0.00019541147,0.0009942559,0.00012824599,0.00016252085,0.000037013182,0.00025435156,0.00029451677,0.001009178],"category_scores_gemma":[0.006819094,0.00014849662,0.000099965444,0.0006429129,0.00109945,0.00009333575,0.00037575728,0.0018892847,0.00006374352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003880388,0.00024539992,0.960317,0.00037877695,0.000054121156,0.00022941334,0.000389925,0.0000025444551,0.0028175043,0.000057407786,0.0129332915,0.018694233],"study_design_scores_gemma":[0.0062104943,0.0018100198,0.95713615,0.00117145,0.00009005749,0.0000055620535,0.00061862567,0.004345213,0.000729043,0.0004904456,0.027134163,0.00025877616],"about_ca_topic_score_codex":0.00096230826,"about_ca_topic_score_gemma":0.0005551918,"teacher_disagreement_score":0.023909993,"about_ca_system_score_codex":0.00020287777,"about_ca_system_score_gemma":0.0011801379,"threshold_uncertainty_score":0.99990404},"labels":[],"label_agreement":null},{"id":"W3013049033","doi":"10.1158/1078-0432.ccr-19-3519","title":"Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Institut Gustave-Roussy; National Cancer Institute; National Institutes of Health; Fondation ARC pour la Recherche sur le Cancer; Division of Arctic Sciences; CNIB","keywords":"Trametinib; Cancer research; MAPK/ERK pathway; Trisomy; Leukemia; Medicine; Biology; Immunology; Signal transduction; Genetics","score_opus":0.15015795195833076,"score_gpt":0.4291317123065044,"score_spread":0.2789737603481736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013049033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879655,0.0007046657,0.0002799012,0.0065579847,0.000029923893,0.0012759462,0.000041651958,0.000027491384,0.0031169364],"genre_scores_gemma":[0.9956802,0.0014493327,0.00042678008,0.0015630594,0.00011316982,0.00017586052,0.000012501948,0.000038129794,0.0005409421],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962304,0.00048261308,0.0007395034,0.00072576734,0.0011575507,0.00066416257],"domain_scores_gemma":[0.9951522,0.0029319313,0.00009830609,0.00035431396,0.0008957218,0.0005675472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017862291,0.00020372107,0.0007748891,0.00019492515,0.00009727632,0.000044038523,0.00026220994,0.00027680327,0.0005365396],"category_scores_gemma":[0.001513038,0.00014605629,0.00007063605,0.0012719296,0.0016848823,0.00019208576,0.00023331563,0.0015252584,0.00005097407],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.084372245,0.0042806235,0.62459475,0.005412256,0.0017504625,0.0034693824,0.010223766,0.00030856818,0.1857569,0.0036164848,0.01972311,0.056491423],"study_design_scores_gemma":[0.13513596,0.039668962,0.1510682,0.005802262,0.00033339797,0.00024960004,0.009276674,0.023747817,0.59684527,0.0008113425,0.035247985,0.0018125246],"about_ca_topic_score_codex":0.0007323758,"about_ca_topic_score_gemma":0.000034297573,"teacher_disagreement_score":0.4735266,"about_ca_system_score_codex":0.00074520934,"about_ca_system_score_gemma":0.0074223955,"threshold_uncertainty_score":0.9982046},"labels":[],"label_agreement":null},{"id":"W3013575560","doi":"10.1158/1078-0432.ccr-19-1714","title":"Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Blood Cancer UK; Cancer Research UK; Canadian Institute for Theoretical Astrophysics","keywords":"Immune system; CD8; Multiple myeloma; Bone marrow; Immunology; Medicine; FOXP3; IL-2 receptor; Cytotoxic T cell; T cell; Cancer research; Biology; In vitro","score_opus":0.07903201766159101,"score_gpt":0.37426237699981585,"score_spread":0.29523035933822483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013575560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571675,0.0001741347,0.000026074387,0.0019287369,0.00008634512,0.00169255,0.00008333307,0.000019855484,0.0002722049],"genre_scores_gemma":[0.99863374,0.00016303256,0.00032258208,0.00018905252,0.00014708552,0.0001744391,0.000024991441,0.000039208484,0.00030586668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995819,0.0006875376,0.00056423445,0.00063830626,0.0016614202,0.00062951626],"domain_scores_gemma":[0.99413425,0.0040556076,0.00015012517,0.00043325062,0.0006331745,0.0005936068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013810906,0.0002144565,0.00054201874,0.00010613612,0.00016988721,0.000042658055,0.00024393591,0.00013951586,0.0002383249],"category_scores_gemma":[0.001280654,0.00012434094,0.00007251502,0.0006642755,0.0011406259,0.00013660555,0.00021733492,0.0012347016,0.0000232643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015167292,0.0004592524,0.9738314,0.00018945344,0.00016164777,0.000108676824,0.00029709248,0.00013814798,0.0009419805,0.000010223593,0.0010561023,0.007638727],"study_design_scores_gemma":[0.015263503,0.0033463796,0.97632796,0.0002834932,0.00003243177,9.076401e-7,0.00021996199,0.00193459,0.0019023177,0.0000035477947,0.00055213436,0.00013275749],"about_ca_topic_score_codex":0.0008457238,"about_ca_topic_score_gemma":0.00075023074,"teacher_disagreement_score":0.0075059696,"about_ca_system_score_codex":0.00010136016,"about_ca_system_score_gemma":0.000818431,"threshold_uncertainty_score":0.53642327},"labels":[],"label_agreement":null},{"id":"W3014043586","doi":"10.1158/1078-0432.ccr-19-1627","title":"Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"CRISPR; Cancer research; Organoid; Biology; Immunotherapy; Immune checkpoint; Genome editing; Cancer; Immunology; Immune system; Gene; Cell biology; Genetics","score_opus":0.1164828579181202,"score_gpt":0.46028509772617604,"score_spread":0.34380223980805585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014043586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88622934,0.0048194244,0.10596088,0.00024010333,0.00038291977,0.0022484441,0.000096811,0.0000068050254,0.000015251028],"genre_scores_gemma":[0.9965692,0.0009779633,0.0007592993,0.00006554805,0.0009466059,0.000538545,0.000030407356,0.00004556302,0.00006687237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983776,0.00011364951,0.00055300514,0.0003720277,0.00029360078,0.00029007325],"domain_scores_gemma":[0.998557,0.00034996428,0.00008128439,0.0003666755,0.0005420606,0.00010303157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091125414,0.00012822771,0.00027605376,0.000027747747,0.00008523954,0.000015396912,0.00040493012,0.00015069009,0.000014039784],"category_scores_gemma":[0.0003345883,0.00010541363,0.00015931763,0.00013535464,0.000099349156,0.000003291746,0.0000966649,0.00018575507,1.3728742e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014168876,0.00026529323,0.00044313492,0.00019178452,0.00017314432,2.0955854e-7,0.00047980298,0.14821738,0.8425345,0.000060918017,0.004671447,0.0015455252],"study_design_scores_gemma":[0.006598375,0.003775276,0.00015942837,0.000006504111,0.00007077078,1.09785994e-7,0.0003220973,0.3564292,0.63010114,0.000029696554,0.0023276855,0.00017971963],"about_ca_topic_score_codex":0.00012682872,"about_ca_topic_score_gemma":0.000064304266,"teacher_disagreement_score":0.21243332,"about_ca_system_score_codex":0.00003321804,"about_ca_system_score_gemma":0.0003445339,"threshold_uncertainty_score":0.42986432},"labels":[],"label_agreement":null},{"id":"W3016549455","doi":"10.1158/1078-0432.ccr-19-3979","title":"FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Endometrial cancer; Internal medicine; Oncology; Expanded access; Clinical trial; Cancer; Thyroid cancer; Immunotherapy","score_opus":0.44594234753397727,"score_gpt":0.5660444547712383,"score_spread":0.12010210723726106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016549455","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23617318,0.21972348,0.0013842954,0.40879753,0.008625078,0.052574947,0.00551946,0.000617359,0.06658466],"genre_scores_gemma":[0.88556373,0.066168465,0.0018673618,0.019536857,0.013450478,0.007050186,0.00081584643,0.00016897033,0.0053781243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949381,0.00063791475,0.0011219879,0.0010066918,0.00160018,0.0006951495],"domain_scores_gemma":[0.9936962,0.0032711045,0.00021555221,0.00039128948,0.0018152162,0.000610644],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023365873,0.0002834945,0.0012191868,0.00027656223,0.0001767483,0.00006785509,0.0005029151,0.00022299042,0.0012587155],"category_scores_gemma":[0.011573323,0.00021214657,0.0005127707,0.0030864524,0.0003868821,0.00013164151,0.00030377545,0.0010336568,0.00008003221],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1450994,0.0020264264,0.032643072,0.0073105646,0.00306194,0.0002663601,0.00060593965,0.000011506534,0.00034150624,0.0023569153,0.60538435,0.20089203],"study_design_scores_gemma":[0.09859522,0.013211205,0.0072607337,0.0020487178,0.00074555323,0.000014761629,0.00061520794,0.0005921701,0.00079544546,0.0005428038,0.87495124,0.0006269566],"about_ca_topic_score_codex":0.000580779,"about_ca_topic_score_gemma":0.00006990241,"teacher_disagreement_score":0.6493905,"about_ca_system_score_codex":0.00077871955,"about_ca_system_score_gemma":0.0041876743,"threshold_uncertainty_score":0.9996543},"labels":[],"label_agreement":null},{"id":"W3019679892","doi":"10.1158/1078-0432.ccr-19-3925","title":"Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"Cancer Council Queensland; Amgen Australia; Melanoma Institute Australia; Omeros Corporation; Compass Therapeutics; QIMR Berghofer Medical Research Institute; Bristol-Myers Squibb; Tizona Therapeutics; National Health and Medical Research Council; Amgen","keywords":"Immunotherapy; Melanoma; Metastatic melanoma; Medicine; Cancer research; Nivolumab; Cancer; Immunology; Oncology; Internal medicine","score_opus":0.20826737304915743,"score_gpt":0.48994314227045405,"score_spread":0.2816757692212966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019679892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96237195,0.0038777553,0.000041409017,0.031138651,0.00010793678,0.0012272471,0.00006244418,0.00005524422,0.0011173855],"genre_scores_gemma":[0.98365515,0.0012028039,0.00046337122,0.012296144,0.00020878081,0.00025267553,0.000013344074,0.00006458648,0.0018431138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960319,0.00065267633,0.0008045644,0.0007406994,0.0010922668,0.00067788863],"domain_scores_gemma":[0.99778026,0.0008270161,0.00013183465,0.00048837095,0.00034862585,0.0004239127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025718766,0.00021200461,0.0007642633,0.00017214249,0.00012446112,0.0000532943,0.00036007524,0.00010972187,0.001434624],"category_scores_gemma":[0.0009510818,0.0001553851,0.0001690386,0.0017378383,0.00034048618,0.00009255274,0.00009129603,0.0010149378,0.00006753934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16627014,0.0023979212,0.37687862,0.00062581233,0.00150605,0.0022600058,0.005406681,0.000018346489,0.18594414,0.00004910994,0.20444718,0.054196004],"study_design_scores_gemma":[0.02808632,0.0063724783,0.6943004,0.0038035365,0.00007046949,0.000009911388,0.00082994526,0.00014098639,0.051527508,0.000119393415,0.21401946,0.0007195775],"about_ca_topic_score_codex":0.0003087744,"about_ca_topic_score_gemma":0.0005066825,"teacher_disagreement_score":0.3174218,"about_ca_system_score_codex":0.00032874392,"about_ca_system_score_gemma":0.0008572536,"threshold_uncertainty_score":0.9994782},"labels":[],"label_agreement":null},{"id":"W3020750541","doi":"10.1158/1078-0432.ccr-19-2541","title":"Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Seventh Framework Programme; Kurt Weill Foundation for Music; KWF Kankerbestrijding; European Commission; European Federation of Pharmaceutical Industries and Associations; Innovative Medicines Initiative","keywords":"Circulating tumor cell; Medicine; Lung cancer; Cancer; Pathology; Lung cancer surgery; Lung; Cardiothoracic surgery; Pulmonary vein; Primary tumor; Aneuploidy; Internal medicine; Oncology; Surgery; Metastasis; Biology","score_opus":0.15786400504802434,"score_gpt":0.4797961012943811,"score_spread":0.32193209624635677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020750541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942367,0.0023805706,0.00006652799,0.0003364989,0.0005948985,0.0014349546,0.00023338145,0.000021296984,0.00069518766],"genre_scores_gemma":[0.9938909,0.0019566643,0.00026261192,0.00019585415,0.00058738445,0.00036542804,0.000035481564,0.0000608218,0.0026448523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996235,0.00021891703,0.0011690139,0.00079004676,0.0007817054,0.00080532325],"domain_scores_gemma":[0.9947009,0.002905083,0.0003315253,0.00075785874,0.0008956069,0.00040901138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035005352,0.000194857,0.0014146391,0.0006539592,0.000108595385,0.000026823584,0.00022070375,0.00014963112,0.0019372752],"category_scores_gemma":[0.00042600508,0.00017379134,0.0011709473,0.0018570177,0.0001648807,0.000053969867,0.00013017005,0.0006873167,0.000016271368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017182946,0.0003430956,0.9029567,0.0039512822,0.0015199874,0.00003157752,0.00014747451,0.0007561525,0.08021741,0.0000031556244,0.0026985805,0.0056562354],"study_design_scores_gemma":[0.009079772,0.000569076,0.7169127,0.0019161069,0.006048617,0.0000023771715,0.0005523411,0.023916053,0.23047422,0.000012514257,0.009764992,0.00075124286],"about_ca_topic_score_codex":0.0037352971,"about_ca_topic_score_gemma":0.00052212295,"teacher_disagreement_score":0.18604405,"about_ca_system_score_codex":0.00034248488,"about_ca_system_score_gemma":0.0016067361,"threshold_uncertainty_score":0.9989751},"labels":[],"label_agreement":null},{"id":"W3021570777","doi":"10.1158/1078-0432.ccr-20-0152","title":"NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Breast cancer; Oncology; Trastuzumab; Medicine; Internal medicine; Estrogen receptor; Proportional hazards model; Cancer; Biology; Cancer research","score_opus":0.49011177305954695,"score_gpt":0.5634234850545039,"score_spread":0.07331171199495695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021570777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9257446,0.010221117,0.000046668156,0.05778149,0.00020266349,0.0050689285,0.00010915534,0.00016974872,0.00065565633],"genre_scores_gemma":[0.9869486,0.0054548006,0.0003251998,0.0039586136,0.0009909401,0.0011504219,0.000025839343,0.000098313314,0.001047279],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9843787,0.009875239,0.0011618313,0.0011922529,0.0022603506,0.0011316446],"domain_scores_gemma":[0.9774397,0.01920848,0.00021445254,0.0006644411,0.0011726809,0.0013002465],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.024061235,0.00032318535,0.0019803713,0.00023447847,0.0002965376,0.00013699052,0.00048383753,0.0004789707,0.00086407026],"category_scores_gemma":[0.0443049,0.00021144607,0.00033471352,0.0012156793,0.0030693866,0.0000748284,0.00045199544,0.0032222252,0.00007442014],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96652067,0.0003099462,0.0031164004,0.00013088815,0.0003374583,0.001305395,0.00034820844,0.000009791777,0.0027897656,0.00005580522,0.012035609,0.013040071],"study_design_scores_gemma":[0.9239476,0.015264655,0.015470735,0.0007400778,0.00023263096,0.000025466905,0.00031546966,0.0020767949,0.0005428323,0.00037398294,0.040540896,0.00046891536],"about_ca_topic_score_codex":0.00024621165,"about_ca_topic_score_gemma":0.00010860631,"teacher_disagreement_score":0.061204024,"about_ca_system_score_codex":0.00027465686,"about_ca_system_score_gemma":0.0021795405,"threshold_uncertainty_score":0.9996437},"labels":[],"label_agreement":null},{"id":"W3023810398","doi":"10.1158/1078-0432.ccr-19-3402","title":"Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec; BC Cancer Agency","funders":"Janssen Research and Development; Cancer Research UK","keywords":"Abiraterone acetate; Prednisone; Prostate cancer; Medicine; Pharmacokinetics; Pharmacology; Adverse effect; Enzalutamide; Internal medicine; Antiandrogen; Cancer; Urology; Oncology; Androgen receptor; Androgen deprivation therapy","score_opus":0.17911497121785097,"score_gpt":0.5338944760008876,"score_spread":0.3547795047830366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023810398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98197186,0.0064349845,0.000008259477,0.0054146117,0.000070847454,0.0057102004,0.00027312557,0.000031837877,0.00008430167],"genre_scores_gemma":[0.98786694,0.010534868,0.00008084598,0.00009473047,0.00015964606,0.00073159544,0.00003811997,0.000058237085,0.00043504525],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99476683,0.0012367662,0.0010613521,0.00088019995,0.0012778342,0.0007770219],"domain_scores_gemma":[0.9974846,0.0008511619,0.00018137375,0.00034831025,0.0004834831,0.0006510264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003037877,0.00031338123,0.0012490244,0.0002361131,0.00013594877,0.000060048536,0.00022456818,0.00006565214,0.00021402426],"category_scores_gemma":[0.00039692863,0.0002063354,0.00008488099,0.0011019949,0.0009820511,0.00014735061,0.00020058115,0.0010950359,0.000008869347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34593496,0.0033429426,0.52861303,0.0045156474,0.0017254906,0.003390483,0.0053236894,0.00056843285,0.04458682,0.000010038604,0.0006449842,0.061343465],"study_design_scores_gemma":[0.37360084,0.14718914,0.37110233,0.002757542,0.0018450489,0.000034486024,0.0030054683,0.011104197,0.08574064,0.000036514804,0.0025557384,0.001028052],"about_ca_topic_score_codex":0.0023299714,"about_ca_topic_score_gemma":0.0013053444,"teacher_disagreement_score":0.1575107,"about_ca_system_score_codex":0.000307986,"about_ca_system_score_gemma":0.0014692751,"threshold_uncertainty_score":0.84141135},"labels":[],"label_agreement":null},{"id":"W3024176153","doi":"10.1158/1078-0432.ccr-19-4088","title":"FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Translational Research Institute Australia; Cancer Australia","keywords":"Endometrial cancer; Oncology; Internal medicine; Cohort; Proportional hazards model; Medicine; Biomarker; Cancer; Risk stratification; Biology","score_opus":0.1229546010085618,"score_gpt":0.43718025295547,"score_spread":0.31422565194690816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024176153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924905,0.0018170325,0.000089367815,0.0043232567,0.000082531886,0.00080858567,0.00022013855,0.000021893573,0.0001467445],"genre_scores_gemma":[0.99666786,0.0014734275,0.00026934862,0.00035682638,0.00038771165,0.00036952275,0.00006367499,0.00006246025,0.00034915764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958165,0.0010721487,0.0005379086,0.0009987584,0.00097003585,0.00060460845],"domain_scores_gemma":[0.99792135,0.00035163507,0.00021888514,0.00034290762,0.00072191365,0.00044331854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020841078,0.00023668728,0.00035831923,0.00010335431,0.00020973585,0.00012337368,0.00038231982,0.0003851635,0.00025898515],"category_scores_gemma":[0.0042378725,0.00017899499,0.00011265052,0.00071966235,0.00058580656,0.00002011187,0.00027845436,0.0009185353,0.000012836553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037142867,0.00021368316,0.23417264,0.000092083756,0.00035375133,0.00001291599,0.00029727013,0.000033507815,0.749258,0.000028018208,0.007837837,0.003986042],"study_design_scores_gemma":[0.0043002605,0.004014166,0.04673257,0.00018796588,0.0000669025,0.0000019326344,0.00026357186,0.00044107626,0.9381722,0.000117350915,0.0052109757,0.00049099495],"about_ca_topic_score_codex":0.0004325887,"about_ca_topic_score_gemma":0.0003442456,"teacher_disagreement_score":0.18891427,"about_ca_system_score_codex":0.000055441298,"about_ca_system_score_gemma":0.0006422735,"threshold_uncertainty_score":0.7299204},"labels":[],"label_agreement":null},{"id":"W3025061287","doi":"10.1158/1078-0432.ccr-19-1905","title":"Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Centre for Advancing Health Outcomes; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Ovarian cancer; Cancer research; Biology; Cancer; Serous carcinoma; Ovarian carcinoma; Ovary; Clear cell carcinoma; Medicine; Internal medicine; Endocrinology","score_opus":0.1806472035196014,"score_gpt":0.41809896221176307,"score_spread":0.23745175869216167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025061287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988592,0.006571144,0.00001526524,0.0031815006,0.00014206965,0.0008695529,0.00009840399,0.000009018765,0.0005210382],"genre_scores_gemma":[0.9937105,0.00487989,0.00006358348,0.00052967813,0.00035297565,0.00025262637,0.000030498206,0.000050644365,0.00012956158],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968024,0.00057799515,0.00050266215,0.00078876736,0.00062843977,0.00069973955],"domain_scores_gemma":[0.9983947,0.00016893081,0.00014503443,0.00048514694,0.00048583126,0.00032035558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008900602,0.00023063405,0.00038316863,0.000095720025,0.00016157373,0.000033559256,0.00067253475,0.0001530796,0.00010192852],"category_scores_gemma":[0.00041124853,0.00015799489,0.0001447908,0.00097241625,0.00039256277,0.000008881786,0.00037155554,0.00077469414,0.0000093623785],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009155189,0.0007387394,0.8959457,0.00017276476,0.00014753614,0.000078623714,0.00021223848,0.00017839254,0.08575439,0.00004652289,0.0020129038,0.0055569974],"study_design_scores_gemma":[0.01381195,0.008066009,0.45869055,0.00033429486,0.000051790383,0.000012045624,0.00026709205,0.00062902225,0.50713503,0.000065271575,0.010367782,0.00056916155],"about_ca_topic_score_codex":0.006917532,"about_ca_topic_score_gemma":0.0032574723,"teacher_disagreement_score":0.43725514,"about_ca_system_score_codex":0.00014963874,"about_ca_system_score_gemma":0.001429115,"threshold_uncertainty_score":0.9996955},"labels":[],"label_agreement":null},{"id":"W3025233783","doi":"10.1158/1078-0432.1065.11.3","title":"Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Diffuse large B-cell lymphoma; Tissue microarray; Lymphoma; Internal medicine; Immunohistochemistry; Survival analysis; Oncology; Biology; Medicine; Pathology; Cancer research","score_opus":0.08804545974782862,"score_gpt":0.40457450689216684,"score_spread":0.3165290471443382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025233783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766505,0.00015994333,0.0000021511892,0.0007791533,0.00006559334,0.0008925046,0.00017116468,0.000012254155,0.00025216103],"genre_scores_gemma":[0.9991119,0.0001226247,0.000024201741,0.000121442856,0.00008075944,0.00012365117,0.000025414223,0.00002556937,0.00036443767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972218,0.0003913873,0.00044939792,0.0003707259,0.0011289363,0.0004376972],"domain_scores_gemma":[0.9984913,0.00041635006,0.00012569694,0.00041467638,0.00037964288,0.00017232727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061725633,0.00014871881,0.00041693068,0.000077711346,0.000087412795,0.000017229593,0.00016021257,0.00015119807,0.0001999897],"category_scores_gemma":[0.0001821949,0.00007529708,0.00011408954,0.000370077,0.00019882071,0.00009199842,0.00006129217,0.0002861237,0.000007852751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002483984,0.016012924,0.9746264,0.00003157854,0.000058658206,0.0000045862917,0.0003189066,0.0000018026409,0.00013618375,0.0000047653466,0.0003565874,0.005963623],"study_design_scores_gemma":[0.05177707,0.0016125643,0.9397447,0.0004892124,0.00004187041,8.762209e-8,0.00006496814,0.000028602242,0.0051677944,0.000001911415,0.0009882711,0.00008296682],"about_ca_topic_score_codex":0.00033015155,"about_ca_topic_score_gemma":0.0015075925,"teacher_disagreement_score":0.049293086,"about_ca_system_score_codex":0.00052694656,"about_ca_system_score_gemma":0.00049798726,"threshold_uncertainty_score":0.30705258},"labels":[],"label_agreement":null},{"id":"W3025611427","doi":"10.1158/1557-3265.ovcasymp18-dp-002","title":"Abstract DP-002: COMPARISON OF POTENTIAL OVARIAN CANCER BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMIC ANALYSIS OF RESIDUAL PAP TEST FLUID, CERVICAL SWABS, AND TUMOR TISSUE FROM AN OVARIAN CANCER PATIENT","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ovarian cancer; Cervical cancer; Medicine; Cancer; Oncology; Cervix; Biomarker; Pap test; Fallopian tube; Fallopian tube cancer; Proteomics; Population; Pathology; Internal medicine; Biology; Gynecology","score_opus":0.04006122757461836,"score_gpt":0.4393047707121899,"score_spread":0.3992435431375715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025611427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922293,0.0018721888,0.0013663012,0.0011357797,0.00007380911,0.00096868543,0.0022715216,0.000017619755,0.00006479931],"genre_scores_gemma":[0.99523145,0.00053517526,0.0028349035,0.00016322367,0.00016129042,0.00038031285,0.0006170867,0.00004217422,0.000034363027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967685,0.0003702903,0.0009423205,0.000976862,0.0004749818,0.00046708554],"domain_scores_gemma":[0.99796355,0.00016717367,0.00036990372,0.00085084455,0.0003813385,0.00026717654],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008929271,0.00023420143,0.0006907466,0.00021133084,0.0000995024,0.00003145196,0.0005073733,0.00042919655,0.0009532501],"category_scores_gemma":[0.00014386176,0.00021331864,0.00019619512,0.0006629012,0.0005801305,0.000007841505,0.00020514581,0.00046935695,0.0000034349964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005925361,0.00040936415,0.22770905,0.000042103547,0.00057727384,0.0000021867536,0.000012413566,0.00009816294,0.7660785,0.000012348617,0.0015212176,0.0029448527],"study_design_scores_gemma":[0.0010814319,0.0012995919,0.26430994,0.00005360692,0.00028031878,2.8512838e-7,0.000053728472,0.0015110634,0.72911865,0.00005563293,0.0019684895,0.00026727206],"about_ca_topic_score_codex":0.0154075185,"about_ca_topic_score_gemma":0.0017107868,"teacher_disagreement_score":0.036959857,"about_ca_system_score_codex":0.00006751881,"about_ca_system_score_gemma":0.0004985043,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W3026647982","doi":"10.1158/1557-3265.ovcasymp18-gmm-048","title":"Abstract GMM-048: CTDNA RESPONSE TO THE PARP INHIBITOR RUCAPARIB PREDICTS PROGRESSION-FREE SURVIVAL AND BEST OVERALL RESPONSE ON THE ARIEL2 TRIAL","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"PARP inhibitor; Loss of heterozygosity; Oncology; Medicine; Internal medicine; Ovarian cancer; Progression-free survival; Cancer; Biology; Allele; Chemotherapy; Genetics; Poly ADP ribose polymerase; DNA; Gene","score_opus":0.2549700596045747,"score_gpt":0.530908562304738,"score_spread":0.27593850270016335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026647982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8349172,0.0005831151,0.0000021901399,0.15484604,0.0020576692,0.0046338215,0.00014727455,0.00006130989,0.0027514114],"genre_scores_gemma":[0.98123604,0.00062210177,0.000047489015,0.003651664,0.0038270785,0.0014472498,0.000009772834,0.000087235836,0.009071354],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892244,0.004690808,0.001123068,0.0010604205,0.0029204052,0.0009809512],"domain_scores_gemma":[0.9704145,0.025649322,0.00021758238,0.002401064,0.00058539683,0.0007321149],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03125756,0.0003372736,0.00068858487,0.00022519004,0.0005106737,0.00021047525,0.00093898544,0.00041467196,0.0022908212],"category_scores_gemma":[0.018298497,0.00018576124,0.00026792093,0.00061979675,0.0011036597,0.00011999954,0.00055944885,0.0029427155,0.0007480009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7824968,0.00082313624,0.0042280667,0.00005037052,0.0001232,0.00004514238,0.00041728158,0.000008557956,0.0045046704,0.00035274084,0.20143902,0.0055110115],"study_design_scores_gemma":[0.0763294,0.02051868,0.15751682,0.0018029356,0.000053067964,0.000013801522,0.00068258675,0.00005319034,0.0029036314,0.0009967405,0.7387104,0.0004187261],"about_ca_topic_score_codex":0.00017401484,"about_ca_topic_score_gemma":0.00009816674,"teacher_disagreement_score":0.7061674,"about_ca_system_score_codex":0.00042696265,"about_ca_system_score_gemma":0.0022934633,"threshold_uncertainty_score":0.9993575},"labels":[],"label_agreement":null},{"id":"W3026903046","doi":"10.1158/1078-0432.ccr-19-4121","title":"EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; Ozmosis Research (Canada); Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Olaparib; Ovarian cancer; Medicine; PARP inhibitor; Oncology; Clinical trial; Internal medicine; Phases of clinical research; Open label; Cancer; Cancer research; Poly ADP ribose polymerase; Biology","score_opus":0.5458711143040862,"score_gpt":0.62167981321802,"score_spread":0.07580869891393383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026903046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94828486,0.0026751184,0.0011469733,0.03691716,0.0010640423,0.008640682,0.0009018842,0.000060888695,0.00030840017],"genre_scores_gemma":[0.983943,0.0015548,0.0035781588,0.0030165538,0.003955021,0.0035664786,0.00012863145,0.00007642555,0.00018094719],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99428284,0.000778546,0.0020409615,0.0011009494,0.0011750057,0.0006216764],"domain_scores_gemma":[0.9957126,0.0015464411,0.00035644035,0.00040399417,0.0011712228,0.00080930267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004188747,0.00027734102,0.0010935552,0.0001296122,0.00026110653,0.000083451145,0.00028212962,0.00047284534,0.0012856182],"category_scores_gemma":[0.0014489915,0.00023451506,0.0002736668,0.00050041545,0.0012661506,0.00031601786,0.00026797023,0.0012710129,0.000008370742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7895216,0.0148142995,0.0057904455,0.0006438408,0.0003690317,0.00003593486,0.0009254917,0.0000039570946,0.006766545,0.00015949218,0.013736011,0.16723338],"study_design_scores_gemma":[0.8546994,0.050029717,0.0037945085,0.0021770792,0.00033529336,0.0000043527584,0.00011060966,0.0076446673,0.005471082,0.0007259474,0.07452828,0.0004790997],"about_ca_topic_score_codex":0.00009941899,"about_ca_topic_score_gemma":0.00008686982,"teacher_disagreement_score":0.16675428,"about_ca_system_score_codex":0.0001510928,"about_ca_system_score_gemma":0.0017408725,"threshold_uncertainty_score":0.99962735},"labels":[],"label_agreement":null},{"id":"W3026964763","doi":"10.1158/1078-0432.ccr-19-2881","title":"A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Key Research and Development Program of China; Natural Science Foundation of Zhejiang Province; National Natural Science Foundation of China","keywords":"Medicine; Cancer; Solid tumor; Cancer vaccine; Cancer research; Immunology; Oncology; Immunotherapy; Internal medicine","score_opus":0.1010132812869398,"score_gpt":0.46083688428528996,"score_spread":0.35982360299835014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026964763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643253,0.016916526,0.0000042119445,0.015489012,0.0006178792,0.002349767,0.00020652609,0.00003141763,0.00005935178],"genre_scores_gemma":[0.95151687,0.017345496,0.00006848396,0.02492098,0.000738176,0.0008915536,0.00026899626,0.0002519607,0.0039975126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9888994,0.005823185,0.0028257857,0.0011241207,0.00042077713,0.0009067186],"domain_scores_gemma":[0.99228746,0.004780314,0.001154408,0.0008516762,0.00088167377,0.000044476754],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022584477,0.0005081967,0.0027975962,0.00042366947,0.00016598734,0.000018814633,0.0010862525,0.0010727153,0.0016025743],"category_scores_gemma":[0.00102564,0.00038111274,0.0003883479,0.0009179702,0.001050126,0.00009425124,0.00024979364,0.005677994,0.000039117363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.104312666,0.0058081253,0.68235457,0.0004635198,0.0050376216,0.00017070843,0.00396166,0.000030329198,0.0027038015,0.0000030310446,0.066012986,0.12914099],"study_design_scores_gemma":[0.07933424,0.037824016,0.52219266,0.0027983144,0.00036052777,0.000004493609,0.0016111024,0.000011184346,0.00216929,0.00005151861,0.35239288,0.001249808],"about_ca_topic_score_codex":0.002421531,"about_ca_topic_score_gemma":0.00030989895,"teacher_disagreement_score":0.28637987,"about_ca_system_score_codex":0.00013197675,"about_ca_system_score_gemma":0.001397763,"threshold_uncertainty_score":0.9998641},"labels":[],"label_agreement":null},{"id":"W3033000728","doi":"10.1158/1557-3265.liqbiop20-pr03","title":"Abstract PR03: Genome-wide 5-hydroxymethylcytosine profiles in circulating cell-free DNA and survival in patients with multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Multiple myeloma; Proportional hazards model; Cell-free fetal DNA; Oncology; Internal medicine; Population; 5-Hydroxymethylcytosine; Digital polymerase chain reaction; Gene; DNA methylation; Polymerase chain reaction; Biology; Gene expression; Genetics","score_opus":0.06360966468007413,"score_gpt":0.3646550897543313,"score_spread":0.3010454250742572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033000728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717206,0.0009382755,0.0000124247945,0.0007820223,0.00006846045,0.0005650583,0.00009940998,0.0000053202334,0.00035699632],"genre_scores_gemma":[0.9983164,0.0006806799,0.00015735788,0.00028749046,0.00034396988,0.0000755169,0.00008676159,0.000035986195,0.00001582155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792993,0.00016251083,0.0004829011,0.0006406694,0.0003271777,0.0004568043],"domain_scores_gemma":[0.9986735,0.00049389456,0.00008503026,0.0003471176,0.0001653297,0.00023510618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000922308,0.00015136847,0.00028424157,0.000066091605,0.000060318216,0.00004514022,0.00031150895,0.00017452873,0.000026804282],"category_scores_gemma":[0.0021590965,0.00013986493,0.00004607707,0.00027128018,0.00021665875,0.0000069863086,0.00044776828,0.0005152719,0.0000041194585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010277615,0.00018880484,0.98410535,0.00008780378,0.00001580609,0.000015982672,0.0000831097,0.00025208062,0.011369696,0.0000029381752,0.00022892962,0.002621736],"study_design_scores_gemma":[0.0044097714,0.0007563449,0.9876323,0.000039677365,0.0000040505474,1.1040279e-7,0.00007035164,0.00015045209,0.004706381,0.00002873051,0.0020095946,0.00019224377],"about_ca_topic_score_codex":0.00038335822,"about_ca_topic_score_gemma":0.001736835,"teacher_disagreement_score":0.006663315,"about_ca_system_score_codex":0.000056386478,"about_ca_system_score_gemma":0.00032576232,"threshold_uncertainty_score":0.5703526},"labels":[],"label_agreement":null},{"id":"W3033003220","doi":"10.1158/1557-3265.liqbiop20-a59","title":"Abstract A59: Biologic rationale for radiation-induced release of circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Head and neck squamous-cell carcinoma; Apoptosis; Cell culture; Medicine; Radiation therapy; In vivo; Molecular biology; Pathology; Cancer; Cisplatin; Biology; Chemistry; Head and neck cancer; Internal medicine; Chemotherapy","score_opus":0.2742260958633189,"score_gpt":0.48633998003640105,"score_spread":0.21211388417308213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033003220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955607,0.001087667,0.00020262686,0.001980299,0.00015373096,0.0005106254,0.00019420686,0.0000056583854,0.00030447083],"genre_scores_gemma":[0.9964634,0.000650803,0.00024477043,0.0008898717,0.0014342939,0.00013914649,0.00013557714,0.000018222489,0.000023912247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986242,0.00008344616,0.00046898553,0.00039390253,0.00017987142,0.0002495804],"domain_scores_gemma":[0.99842453,0.00065547705,0.00013652314,0.0002168488,0.0003823953,0.00018425075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088165584,0.00008514809,0.00019256548,0.000026740925,0.000090283975,0.000019887999,0.00022108485,0.00012313317,0.000076493794],"category_scores_gemma":[0.005453204,0.00008199298,0.00015296819,0.00013370975,0.00012524817,0.0000030368549,0.00010634255,0.0001958534,0.000008977349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008427472,0.00018597432,0.015880728,0.00016220355,0.00009241303,0.0000048363486,0.00006768458,0.00049465394,0.94184065,0.00046354695,0.014315184,0.02564938],"study_design_scores_gemma":[0.007056529,0.004036437,0.10278085,0.00009494462,0.000054121756,0.0000025762106,0.00038484597,0.0030436704,0.716401,0.0017817457,0.16365232,0.0007110004],"about_ca_topic_score_codex":0.00006472895,"about_ca_topic_score_gemma":0.000034637407,"teacher_disagreement_score":0.22543968,"about_ca_system_score_codex":0.00002630384,"about_ca_system_score_gemma":0.0007168961,"threshold_uncertainty_score":0.65283877},"labels":[],"label_agreement":null},{"id":"W3033918338","doi":"10.1158/1557-3265.liqbiop20-a39","title":"Abstract A39: Concordance of 5-hydroxymethylcytosine-modified genes from circulating cell-free DNA and positron emission tomography in multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Concordance; Medicine; Positron emission tomography; Digital polymerase chain reaction; Epigenetics; Cell-free fetal DNA; Oncology; Internal medicine; Nuclear medicine; Pathology; Gene; Polymerase chain reaction; Biology; Genetics","score_opus":0.1038816234453874,"score_gpt":0.402363634402437,"score_spread":0.2984820109570496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033918338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627955,0.011991921,0.00010477184,0.00067815476,0.000118543176,0.00027987617,0.00020341582,0.0000060027155,0.00033774698],"genre_scores_gemma":[0.99357,0.005014764,0.00044625963,0.00025315877,0.00058721233,0.000033161126,0.00005893497,0.00002685985,0.000009623178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998037,0.00015742403,0.0005833762,0.0006135088,0.0002756304,0.00033307858],"domain_scores_gemma":[0.9983836,0.0006384904,0.00013894326,0.00041484818,0.00016255445,0.0002615538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006540178,0.00014442705,0.00032409868,0.000056292527,0.00007282073,0.000029569661,0.00037483755,0.00022730966,0.000017531218],"category_scores_gemma":[0.0012333574,0.00014485128,0.000117826574,0.00023506187,0.00029519762,0.0000057011794,0.00045718768,0.0003901519,0.0000013790557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060714316,0.000087516884,0.19487166,0.00007699755,0.000025958894,0.000010263402,0.00007636096,0.00014644969,0.78608066,0.000006371365,0.0007612885,0.017249316],"study_design_scores_gemma":[0.0038865267,0.0006409272,0.3026994,0.00012557364,0.00001724479,5.618888e-7,0.00014008077,0.001769461,0.6861134,0.00039865077,0.003915123,0.00029305898],"about_ca_topic_score_codex":0.0015242331,"about_ca_topic_score_gemma":0.00051918876,"teacher_disagreement_score":0.10782774,"about_ca_system_score_codex":0.000023234847,"about_ca_system_score_gemma":0.0002497073,"threshold_uncertainty_score":0.5906863},"labels":[],"label_agreement":null},{"id":"W3034497617","doi":"10.1158/1557-3265.aacrahns19-a35","title":"Abstract A35: Diagnostic performance and timing of post-treatment 18F-FDG PET/CT for head and neck cancer surveillance: A meta-analysis of reported studies","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Head and neck cancer; Head and neck; Nuclear medicine; Meta-analysis; Cancer; Internal medicine; Confidence interval; Oncology; Surgery","score_opus":0.46416252462490215,"score_gpt":0.5781511218199314,"score_spread":0.1139885971950293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034497617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95923305,0.026207749,0.000008315875,0.013710763,0.00005774783,0.0006201296,0.0000956415,0.000012571064,0.000054057007],"genre_scores_gemma":[0.96402854,0.034671385,0.00042048388,0.00038709014,0.00013259576,0.0001974954,0.000021659165,0.00002162337,0.000119122924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746776,0.00016258628,0.0009758992,0.00053365825,0.00052836095,0.00033172162],"domain_scores_gemma":[0.9926109,0.0056836926,0.000306438,0.00028063657,0.00079957064,0.00031881902],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025653935,0.00016717608,0.0018163493,0.00016499554,0.000107784486,0.00001556352,0.0000977811,0.00002222925,0.00017263301],"category_scores_gemma":[0.010725668,0.00011253602,0.00044648856,0.00054219225,0.00067960104,0.000047822392,0.00010863777,0.00046427842,5.244013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001366869,0.00030053186,0.8716874,0.0020451313,0.08337262,0.0002885161,0.00075159076,0.0005729383,0.00049426575,0.000010673644,0.001149105,0.037960358],"study_design_scores_gemma":[0.0039530685,0.003111511,0.90765536,0.0002622299,0.041485608,0.000032378408,0.0005738795,0.0381606,0.00038643245,0.000021572732,0.004120469,0.00023689265],"about_ca_topic_score_codex":0.0021949355,"about_ca_topic_score_gemma":0.000347872,"teacher_disagreement_score":0.04188701,"about_ca_system_score_codex":0.000067904395,"about_ca_system_score_gemma":0.00034273264,"threshold_uncertainty_score":0.9976074},"labels":[],"label_agreement":null},{"id":"W3034627609","doi":"10.1158/1557-3265.advprecmed20-26","title":"Abstract 26: A novel electronic platform to improve clinical trial workflow and screening","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Scientific Computing and Data Management","field":"Decision Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Workflow; Computer science; Web application; Medicine; Password; Workload; Android (operating system); World Wide Web; Phone; Medical physics; Database; Pathology; Operating system","score_opus":0.7814822954328613,"score_gpt":0.6425963769664341,"score_spread":0.13888591846642717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034627609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487956,0.00033287506,0.016510358,0.027950335,0.0028215214,0.0016070409,0.000053405158,0.00013602486,0.0017928295],"genre_scores_gemma":[0.9901689,0.00012594528,0.0025433425,0.0026920687,0.0032615834,0.000067465764,0.000003908377,0.0000281943,0.0011085725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.990527,0.00044489707,0.002279497,0.0023102148,0.0033161496,0.0011222941],"domain_scores_gemma":[0.9833436,0.013267604,0.0002645979,0.0013772389,0.00046639473,0.0012805657],"candidate_categories":["metaresearch","scholarly_communication","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06291292,0.00017990115,0.00062480255,0.00025040735,0.0004058619,0.0012159643,0.002169746,0.0001847491,0.0005296989],"category_scores_gemma":[0.051855315,0.00013406845,0.00028094463,0.0020724118,0.0005036806,0.0002945606,0.0024132358,0.0018255498,0.00089524424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012139456,0.00018166332,0.0033436343,0.0000060720736,0.00004097915,0.000009619909,0.00009661447,0.000050164075,0.000036404042,0.00034148456,0.10174936,0.88200456],"study_design_scores_gemma":[0.030507179,0.004026061,0.062355652,0.00008772863,0.000024907307,9.737151e-7,0.0006278384,0.022655258,0.000031300962,0.0049939095,0.8742165,0.0004727188],"about_ca_topic_score_codex":0.00017876577,"about_ca_topic_score_gemma":0.00020721817,"teacher_disagreement_score":0.88153183,"about_ca_system_score_codex":0.0000643131,"about_ca_system_score_gemma":0.00062903576,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W3035208766","doi":"10.1158/1078-0432.ccr-20-0621","title":"Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sierra Oncology; Australian Government; Eisai; BeiGene; Sanofi; Clovis Oncology; AstraZeneca; Bristol-Myers Squibb; Amgen","keywords":"Nivolumab; Ipilimumab; Medicine; Clinical endpoint; Internal medicine; Clinical trial; Response Evaluation Criteria in Solid Tumors; Progressive disease; Neuroendocrine tumors; Immunotherapy; Gastroenterology; Oncology; Phases of clinical research; Surgery; Cancer; Chemotherapy","score_opus":0.14580141064000737,"score_gpt":0.4961921606803399,"score_spread":0.3503907500403325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035208766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093646,0.0007371737,0.0000075641588,0.0037312096,0.00014590856,0.0041845352,0.00019757535,0.000017014103,0.000042570755],"genre_scores_gemma":[0.9970787,0.0015344231,0.00017243213,0.00045834424,0.0001833995,0.00040297525,0.000021347636,0.000056439312,0.000091898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937112,0.0011530054,0.001866436,0.0009472796,0.0014917443,0.000830356],"domain_scores_gemma":[0.99405116,0.0032049376,0.00046033095,0.0008381965,0.0009859144,0.00045947396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014704217,0.00024419278,0.0017044917,0.0003599932,0.00009303367,0.000018541901,0.0006137465,0.000031140986,0.00011059534],"category_scores_gemma":[0.0066084852,0.00016149579,0.00053454563,0.0029093253,0.0015967028,0.00013669157,0.00032804252,0.001402714,7.528396e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29366553,0.00078337383,0.6875437,0.00028764148,0.00058914657,0.00006400538,0.00006950834,0.000110850786,0.00010833201,0.000016996635,0.000290285,0.016470682],"study_design_scores_gemma":[0.18385103,0.025875792,0.78538734,0.00028203952,0.0003110554,0.000002682378,0.00019588156,0.00081193715,0.00069161406,0.000039963565,0.002360493,0.00019015493],"about_ca_topic_score_codex":0.00070279377,"about_ca_topic_score_gemma":0.0012278502,"teacher_disagreement_score":0.10981447,"about_ca_system_score_codex":0.00017493516,"about_ca_system_score_gemma":0.001408621,"threshold_uncertainty_score":0.79114515},"labels":[],"label_agreement":null},{"id":"W3035251856","doi":"10.1158/1557-3265.aacrahns19-a07","title":"Abstract A07: Improved prognosis of HPV-positive oropharyngeal cancers is associated with a suppression of TGF-β-mediated immune evasion","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Oncology; Cancer research; Carcinogenesis; Internal medicine; HPV infection; Cancer; Cervical cancer","score_opus":0.08140809866806785,"score_gpt":0.4213435920293677,"score_spread":0.33993549336129986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035251856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134266,0.0033391917,0.00023791713,0.0019134823,0.00014264134,0.001616179,0.00074394466,0.000023249986,0.0006407297],"genre_scores_gemma":[0.9960188,0.0027423073,0.000107895234,0.00025023418,0.00020499717,0.00019889673,0.00028308496,0.0000761846,0.00011756318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99561036,0.0006018639,0.00093863887,0.0009120748,0.0012102224,0.00072685396],"domain_scores_gemma":[0.9964799,0.00036410306,0.00040814318,0.0005277346,0.0017727065,0.00044741356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001679993,0.0002616844,0.0006764195,0.00012274217,0.00011835321,0.000024035422,0.00066728814,0.00056389277,0.00063560205],"category_scores_gemma":[0.0022283727,0.00022100187,0.0002897301,0.00088325614,0.0007612143,0.000013523371,0.00052498095,0.001133571,0.000008203294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006673643,0.00031973937,0.0009178435,0.00017817767,0.00054884196,0.000022749531,0.00016597476,0.00008037475,0.9783855,0.0000033576546,0.0030630531,0.00964071],"study_design_scores_gemma":[0.0038328427,0.0050572813,0.013967821,0.0003084855,0.000058065776,0.000001141427,0.00013840303,0.0010575318,0.9742852,0.000009845047,0.0010281006,0.00025528844],"about_ca_topic_score_codex":0.0014670399,"about_ca_topic_score_gemma":0.00023266871,"teacher_disagreement_score":0.013049978,"about_ca_system_score_codex":0.00018398397,"about_ca_system_score_gemma":0.0022372873,"threshold_uncertainty_score":0.9012195},"labels":[],"label_agreement":null},{"id":"W3035309353","doi":"10.1158/1557-3265.aacrahns19-ia02","title":"Abstract IA02: Utilizing patient-derived xenografts for prognostication and biomarker discovery","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Biomarker; Hazard ratio; Radiation therapy; Cohort; Cancer; Precision medicine; Personalized medicine; Bioinformatics; Head and neck cancer; Pathology; Biology; Confidence interval","score_opus":0.4849151068034955,"score_gpt":0.5792740164811869,"score_spread":0.09435890967769145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035309353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94923526,0.005443335,0.00012634,0.040781453,0.0002035964,0.0030057316,0.000099952515,0.0000740163,0.0010303162],"genre_scores_gemma":[0.99318427,0.0036514367,0.0004071644,0.0009228558,0.00077122875,0.0009068025,0.000030172165,0.0000414679,0.00008462843],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99703586,0.00017207128,0.00056718657,0.0007078575,0.0008432687,0.00067376904],"domain_scores_gemma":[0.9960313,0.002323829,0.000084003594,0.00029257283,0.00069833297,0.0005699725],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014888551,0.00015572175,0.00043174854,0.000101131875,0.00025960576,0.000112108704,0.00016437145,0.00012788735,0.00008624694],"category_scores_gemma":[0.008466089,0.00012162919,0.00014754331,0.00043889252,0.0008424864,0.00021092879,0.00033690906,0.0007070367,0.000023239829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0143745765,0.0007578254,0.25633514,0.0036942007,0.0009634045,0.00009606825,0.0018096409,0.0000014909468,0.06730869,0.00035345368,0.09533289,0.5589726],"study_design_scores_gemma":[0.0071582333,0.0044074613,0.8691749,0.00088776066,0.00015159367,0.0000047448257,0.0018338648,0.00090001384,0.010437223,0.00042375794,0.104213245,0.0004072113],"about_ca_topic_score_codex":0.00013583171,"about_ca_topic_score_gemma":0.000039529456,"teacher_disagreement_score":0.61283976,"about_ca_system_score_codex":0.00013794981,"about_ca_system_score_gemma":0.00060393795,"threshold_uncertainty_score":0.99988604},"labels":[],"label_agreement":null},{"id":"W3035392667","doi":"10.1158/1557-3265.advprecmed20-14","title":"Abstract 14: Computer-aided discovery of small-molecule inhibitors targeting neural transcription factor BRN2 in neuroendocrine prostate tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; SOX2; Androgen receptor; Cancer research; LNCaP; Enzalutamide; Transcription factor; Medicine; Bioinformatics; Biology; Cancer; Internal medicine; Gene; Genetics","score_opus":0.19186769514599047,"score_gpt":0.45159321359909393,"score_spread":0.25972551845310343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035392667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849602,0.0013845167,0.000018138673,0.011589795,0.000267132,0.0015278771,0.00009236791,0.0000499632,0.000110012355],"genre_scores_gemma":[0.9969468,0.0014840944,0.000079756486,0.00035309282,0.0006908376,0.00011913686,0.00007280762,0.00005613826,0.00019732438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570835,0.0004452639,0.0011750816,0.00078310445,0.0009946034,0.0008935964],"domain_scores_gemma":[0.99820185,0.00047925176,0.0001442433,0.00028335032,0.0003802689,0.00051106245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000839328,0.00024397338,0.00072719506,0.00024119008,0.00009049536,0.00006863297,0.0002807153,0.0000869567,0.00016001258],"category_scores_gemma":[0.00041961248,0.0001920521,0.00028267637,0.0009141628,0.0005296768,0.00024487244,0.00018997872,0.0018501832,0.000018444043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013164877,0.0015529091,0.6916604,0.0023972325,0.00020133056,0.0032736673,0.0014828392,0.0001826921,0.21555051,0.000022722104,0.003988758,0.06652203],"study_design_scores_gemma":[0.016122129,0.0067628315,0.81120473,0.00097306503,0.000046762612,0.0000149100315,0.0007473552,0.004599161,0.15795535,0.000052419975,0.0010532251,0.00046803814],"about_ca_topic_score_codex":0.0009974263,"about_ca_topic_score_gemma":0.000115443334,"teacher_disagreement_score":0.11954433,"about_ca_system_score_codex":0.00019292677,"about_ca_system_score_gemma":0.0007811283,"threshold_uncertainty_score":0.8038228},"labels":[],"label_agreement":null},{"id":"W3035473078","doi":"10.1158/1078-0432.ccr-20-1345","title":"A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bendamustine; Rituximab; Lenalidomide; Medicine; Bortezomib; Follicular lymphoma; Internal medicine; Oncology; Lymphoma; Follicular phase; Multiple myeloma","score_opus":0.25055410467248995,"score_gpt":0.5022630588164514,"score_spread":0.25170895414396144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035473078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880613,0.004253999,0.00002938418,0.0022997698,0.00006401775,0.0051447568,0.000018138875,0.00004428443,0.00008431909],"genre_scores_gemma":[0.9915735,0.0061132093,0.00012932335,0.00012211718,0.00023542563,0.0017017977,0.000042940366,0.000039363073,0.000042283922],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99552464,0.0009010842,0.0014192142,0.0007660699,0.00092643854,0.00046255],"domain_scores_gemma":[0.99685,0.0015006646,0.00028967424,0.00041483736,0.0005741471,0.00037068484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025635008,0.00026853246,0.002020216,0.00024916348,0.00013453775,0.00003131235,0.00016566721,0.00016855914,0.00044612898],"category_scores_gemma":[0.0021183183,0.00016168956,0.00025178023,0.0013095384,0.00037398763,0.00011490719,0.00013941377,0.0003602607,0.000022243335],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58262545,0.04567091,0.052386083,0.00029713125,0.0015893127,0.0011749844,0.0015935138,0.000023110455,0.0000919058,0.000050149905,0.00042254498,0.3140749],"study_design_scores_gemma":[0.9518841,0.023654327,0.018001487,0.0006742706,0.0009847151,0.000019149884,0.0011061596,0.0014443699,0.000775661,0.000032824828,0.0012076081,0.0002153386],"about_ca_topic_score_codex":0.004762179,"about_ca_topic_score_gemma":0.0026862274,"teacher_disagreement_score":0.36925864,"about_ca_system_score_codex":0.00037784356,"about_ca_system_score_gemma":0.0010834477,"threshold_uncertainty_score":0.7199022},"labels":[],"label_agreement":null},{"id":"W3035482294","doi":"10.1158/1557-3265.aacrahns19-ia20","title":"Abstract IA20: Radiotherapy plus cetuximab or cisplatin in human papilloma-virus positive oropharyngeal cancer (NRG 1016): A randomized multicenter noninferiority trial*","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cetuximab; Medicine; Radiation therapy; Internal medicine; Cisplatin; Oncology; Randomized controlled trial; Cancer; Toxicity; Chemotherapy; Colorectal cancer","score_opus":0.2837699504210207,"score_gpt":0.5554884715866064,"score_spread":0.2717185211655857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035482294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625285,0.00918506,0.000020157246,0.018105663,0.0005836195,0.005769212,0.0001953045,0.0000869133,0.0035255621],"genre_scores_gemma":[0.97303164,0.016471421,0.00016630148,0.0037711493,0.0032934202,0.0018350465,0.000024669886,0.00009825196,0.0013081095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99302673,0.0014642782,0.0018805983,0.0011716392,0.00127521,0.0011815365],"domain_scores_gemma":[0.99424034,0.0036233095,0.00026309595,0.00047933648,0.00053984334,0.0008540594],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046974416,0.0004329341,0.003282432,0.00020392468,0.00032197518,0.00008078731,0.00039883444,0.0003783977,0.0074941223],"category_scores_gemma":[0.0027296888,0.00030381512,0.0006037196,0.0007626418,0.0011751831,0.0001646503,0.00023370294,0.0026845024,0.000112357964],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9586358,0.0009783106,0.0050135064,0.00037315697,0.0006517372,0.0007325598,0.0025405833,0.000007974701,0.0041812193,0.000019785757,0.0069958908,0.019869486],"study_design_scores_gemma":[0.9394371,0.0040416527,0.041302074,0.0010489142,0.00015820215,0.0000029942385,0.00031470953,0.0009384522,0.0017469726,0.000020873082,0.010535327,0.00045275287],"about_ca_topic_score_codex":0.008760559,"about_ca_topic_score_gemma":0.0035635296,"teacher_disagreement_score":0.036288567,"about_ca_system_score_codex":0.0010827235,"about_ca_system_score_gemma":0.0023723675,"threshold_uncertainty_score":0.9999414},"labels":[],"label_agreement":null},{"id":"W3035496509","doi":"10.1158/1078-0432.ccr-20-0224","title":"<i>ESR1</i> Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute for Health and Care Research; Cancer Research UK; AstraZeneca","keywords":"Fulvestrant; Exemestane; Oncology; Breast cancer; Medicine; Internal medicine; Hormone receptor; Estrogen receptor; Oestrogen receptor; Cancer; Aromatase","score_opus":0.22071949580049685,"score_gpt":0.5247294331244319,"score_spread":0.304009937323935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035496509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97798914,0.0030203878,0.000041763444,0.016214779,0.00021181387,0.001432048,0.0009639049,0.000024559795,0.000101596575],"genre_scores_gemma":[0.99281496,0.0059971893,0.00009464566,0.00048564412,0.00022640312,0.00024363365,0.000047732636,0.00003396296,0.00005582886],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99549675,0.0013437537,0.0010978676,0.0007282161,0.00085764064,0.00047579652],"domain_scores_gemma":[0.99372023,0.0047102193,0.00031520682,0.00039277293,0.00044586207,0.00041570474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002543433,0.00024698715,0.0015920291,0.00023130586,0.00014598535,0.00002702932,0.0002068719,0.0001462723,0.0001766702],"category_scores_gemma":[0.0016608608,0.00017545343,0.00030082415,0.0018580816,0.0010424468,0.00012264449,0.00014276418,0.0010234263,0.0000013734758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5414643,0.0021696768,0.075500466,0.00031150907,0.006865925,0.00008856709,0.0031481914,0.0011918319,0.054465927,0.0007898055,0.00041988664,0.31358388],"study_design_scores_gemma":[0.15152904,0.00911658,0.82649666,0.00078611815,0.0024591992,0.0000055886617,0.001549572,0.0024593978,0.0034700853,0.0002697023,0.0013311254,0.0005269199],"about_ca_topic_score_codex":0.0009857628,"about_ca_topic_score_gemma":0.00081670796,"teacher_disagreement_score":0.7509962,"about_ca_system_score_codex":0.00025737582,"about_ca_system_score_gemma":0.0006120249,"threshold_uncertainty_score":0.71547836},"labels":[],"label_agreement":null},{"id":"W3035783198","doi":"10.1158/1557-3265.liqbiop20-pr12","title":"Abstract PR12: Detection of EV-based signatures in prostate cancer using microflow cytometry and machine learning","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Circulating tumor cell; Oncology; Disease; Internal medicine; Metastasis","score_opus":0.12890442906112817,"score_gpt":0.4540095612408493,"score_spread":0.32510513217972115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035783198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98201317,0.01688001,0.00011915839,0.000499899,0.000097171345,0.00026729266,0.000087196364,0.0000045646248,0.000031513966],"genre_scores_gemma":[0.99157757,0.007612433,0.00012362972,0.0002761553,0.00031852096,0.00003235358,0.000014585101,0.000024379648,0.000020385858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985854,0.00014747001,0.00036933974,0.00041479693,0.00020258395,0.00028038005],"domain_scores_gemma":[0.999208,0.00021475935,0.00010225099,0.00013328863,0.0001911204,0.00015059153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008169834,0.0001069827,0.00021732775,0.00008650407,0.000067073466,0.000026037398,0.00013369674,0.00016154317,0.000040023668],"category_scores_gemma":[0.000995882,0.000104251136,0.000066240464,0.00031326705,0.00021639501,0.000003861543,0.0001156349,0.0006410854,7.26719e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011191388,0.000055502107,0.14184497,0.00015087248,0.000027127759,0.0000075736543,0.00003745715,0.006269663,0.830765,0.0000010169099,0.00012425163,0.019597407],"study_design_scores_gemma":[0.0028746806,0.0011422819,0.10471616,0.00016992628,0.000023157865,7.365457e-7,0.00008606083,0.014120561,0.85889333,0.000026611826,0.01763855,0.00030791716],"about_ca_topic_score_codex":0.0016981368,"about_ca_topic_score_gemma":0.0011126978,"teacher_disagreement_score":0.037128806,"about_ca_system_score_codex":0.000050697414,"about_ca_system_score_gemma":0.00045161805,"threshold_uncertainty_score":0.42512378},"labels":[],"label_agreement":null},{"id":"W3035811149","doi":"10.1158/1557-3265.liqbiop20-a09","title":"Abstract A09: Cerebrospinal fluid (CSF) as a source of ctDNA for diagnosis and monitoring of pediatric patients with midline diffuse gliomas","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PDGFRA; Medicine; Liquid biopsy; Digital polymerase chain reaction; Glioma; Biopsy; Pathology; Cerebrospinal fluid; Exome sequencing; DNA sequencing; KRAS; Oncology; Mutation; Internal medicine; Cancer research; Gene; Polymerase chain reaction; Biology; Cancer; Genetics","score_opus":0.19299139592350156,"score_gpt":0.47066060735530274,"score_spread":0.2776692114318012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035811149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944076,0.0023778365,0.0000041075714,0.0018876896,0.00006997479,0.0011411298,0.000064476066,0.000014233074,0.000032978853],"genre_scores_gemma":[0.99628466,0.00217819,0.00032941124,0.000061116014,0.00068139023,0.00040171953,0.000013221018,0.000036060872,0.000014209259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770296,0.000068199195,0.00064948516,0.00045205714,0.0007674006,0.00035988342],"domain_scores_gemma":[0.99684775,0.0014498805,0.0001790985,0.0002610596,0.0007831139,0.00047908654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000481213,0.00015518774,0.000583388,0.00014027469,0.00007427648,0.000016968941,0.00013379799,0.00011925439,0.00008019525],"category_scores_gemma":[0.0015894886,0.000111552006,0.00015528608,0.00048970326,0.0002485236,0.000058429203,0.00011467888,0.00031402727,0.0000053953972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032071762,0.0022783757,0.98247546,0.00071667734,0.0001733312,0.00001795726,0.00012907328,0.0000045735856,0.00021043645,0.000007731734,0.00087433285,0.0099048745],"study_design_scores_gemma":[0.010962478,0.006764947,0.97326237,0.00025219208,0.00023205047,5.195454e-7,0.00008144263,0.000027670207,0.007583036,0.000017969785,0.0007151792,0.00010016228],"about_ca_topic_score_codex":0.00040278636,"about_ca_topic_score_gemma":0.00001232497,"teacher_disagreement_score":0.009804713,"about_ca_system_score_codex":0.000051678107,"about_ca_system_score_gemma":0.00022805488,"threshold_uncertainty_score":0.45489588},"labels":[],"label_agreement":null},{"id":"W3035885874","doi":"10.1158/1557-3265.liqbiop20-b02","title":"Abstract B02: Genomic and transcriptomic profiling of urine in prostate cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Prostate cancer; Biopsy; Liquid biopsy; Prostate; Oncology; Internal medicine; Cancer; Urology","score_opus":0.2969214302281731,"score_gpt":0.5315786752484376,"score_spread":0.23465724502026453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035885874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655595,0.01570468,9.925631e-7,0.016472923,0.00008917832,0.0014595933,0.00009188561,0.000022888396,0.00059837947],"genre_scores_gemma":[0.96826625,0.030272614,0.000110447654,0.00028121466,0.00032719728,0.00030367324,0.00001600189,0.000038492355,0.00038410167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972206,0.00017352852,0.00074614916,0.0006069399,0.0006178434,0.00063494005],"domain_scores_gemma":[0.99856156,0.00033388173,0.00007513538,0.00023028937,0.00029309053,0.00050605054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015839263,0.00015939245,0.0006101116,0.0001820803,0.00006332603,0.00002265303,0.00018042266,0.00012356509,0.0004310493],"category_scores_gemma":[0.00029033702,0.00012335321,0.0001142156,0.00058327254,0.00064545794,0.0000843714,0.00012576378,0.0012774129,0.00001792553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008905435,0.0003483498,0.8403761,0.001657955,0.00015616529,0.00021230038,0.00092551525,0.000019746247,0.10576283,0.000039384544,0.0008101455,0.040786076],"study_design_scores_gemma":[0.011472335,0.0014835693,0.942392,0.00067699846,0.000050752777,0.0000036596186,0.00047880982,0.0005926833,0.038399335,0.00016580144,0.0040717465,0.00021229686],"about_ca_topic_score_codex":0.0011894502,"about_ca_topic_score_gemma":0.00025993807,"teacher_disagreement_score":0.10201591,"about_ca_system_score_codex":0.00021469824,"about_ca_system_score_gemma":0.0013472078,"threshold_uncertainty_score":0.55497944},"labels":[],"label_agreement":null},{"id":"W3036029166","doi":"10.1158/1557-3265.liqbiop20-a03","title":"Abstract A03: Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for liquid biopsy profiling","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Liquid biopsy; Cell-free fetal DNA; Cancer; Biopsy; Cancer research; Medicine; Breast cancer; Circulating tumor cell; Pathology; Oncology; Biology; Internal medicine; Metastasis; Genetics","score_opus":0.2808353810248177,"score_gpt":0.5125716169410852,"score_spread":0.23173623591626752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036029166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983502,0.007217329,0.0001454846,0.005547316,0.000535927,0.0012371675,0.0004836172,0.0000052314185,0.0013259415],"genre_scores_gemma":[0.99359024,0.0031100565,0.00028450185,0.0005605731,0.0017970864,0.0004829877,0.000042386248,0.000031934876,0.00010026168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778897,0.00026826398,0.00052254426,0.00047983337,0.00061109447,0.00032929255],"domain_scores_gemma":[0.9974799,0.00049495895,0.00017778152,0.00060256786,0.0010980201,0.00014676989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034704546,0.00011908835,0.0002216776,0.000015629132,0.00011314252,0.000024459141,0.00067771086,0.00020806765,0.00014450455],"category_scores_gemma":[0.0047546034,0.00009196247,0.00023077811,0.00016515177,0.00024672755,0.0000042222487,0.00044443595,0.0003041358,0.000003768125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002702723,0.00029660063,0.00769988,0.00028733237,0.00014280959,7.0486954e-7,0.000080300815,0.0009830195,0.9166199,0.00014390802,0.042400576,0.02864225],"study_design_scores_gemma":[0.00460125,0.0015131222,0.013813725,0.000092108756,0.00013844391,4.3446784e-7,0.00017684873,0.0024084751,0.9194955,0.00044706842,0.05701889,0.0002940951],"about_ca_topic_score_codex":0.00032089447,"about_ca_topic_score_gemma":0.00043834507,"teacher_disagreement_score":0.028348153,"about_ca_system_score_codex":0.000093147726,"about_ca_system_score_gemma":0.0015706981,"threshold_uncertainty_score":0.5692048},"labels":[],"label_agreement":null},{"id":"W3036225830","doi":"10.1158/1557-3265.liqbiop20-b64","title":"Abstract B64: Translating the ClarityDxProstate microflow cytometry extracellular vesicle assay to the clinic: A real-world experience in progress","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Micralyne","funders":"","keywords":"Workflow; Test (biology); Medical physics; Sample (material); Medicine; Prostate cancer; Data collection; Work flow; Medical education; Computer science; Cancer; Internal medicine; Database; Sociology; Engineering; Biology","score_opus":0.21281164757609514,"score_gpt":0.509439539924372,"score_spread":0.2966278923482768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036225830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624934,0.008210366,0.00019653582,0.026641201,0.00020778734,0.00136586,0.000056621175,0.000025630912,0.00080260565],"genre_scores_gemma":[0.99479324,0.0009378295,0.00043950122,0.0016379267,0.0010222463,0.00046605544,0.000022540433,0.00006037399,0.00062029756],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948855,0.0013628055,0.0010263498,0.0010577556,0.0007720506,0.0008955138],"domain_scores_gemma":[0.99742734,0.00065700704,0.00014516283,0.0010337561,0.00023439893,0.0005023599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072301305,0.0002396764,0.00031398944,0.00007675885,0.00033674538,0.00016989392,0.0015881188,0.00023214286,0.00020774141],"category_scores_gemma":[0.0019480311,0.00016424713,0.00024944867,0.0012509868,0.0010272963,0.00001545646,0.0005580316,0.0016311246,0.00013174867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003477312,0.000819552,0.31876302,0.00022127762,0.00014045039,0.00027165067,0.003925449,0.00016942121,0.5146961,0.00010034229,0.024450568,0.13296483],"study_design_scores_gemma":[0.0039164736,0.0014535169,0.27895844,0.0003372713,0.000057782854,0.000005756241,0.004523262,0.0015494014,0.21281898,0.000320208,0.49482402,0.0012348738],"about_ca_topic_score_codex":0.00023598231,"about_ca_topic_score_gemma":0.0011875454,"teacher_disagreement_score":0.47037345,"about_ca_system_score_codex":0.00006341972,"about_ca_system_score_gemma":0.00048909354,"threshold_uncertainty_score":0.70865154},"labels":[],"label_agreement":null},{"id":"W3036323339","doi":"10.1158/1557-3265.liqbiop20-a26","title":"Abstract A26: Defining VALUE: Routine liquid biopsy in NSCLC diagnosis—a Canadian trial in progress","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Ottawa Hospital; Spinal Cord Injury BC; Juravinski Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Lung cancer; Oncology; Internal medicine; Genotyping; Liquid biopsy; Cancer; Clinical trial; Cohort study; Genotype; Gene","score_opus":0.15421329737390355,"score_gpt":0.4722666979571562,"score_spread":0.31805340058325265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036323339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836365,0.0048432886,0.000001979995,0.009278136,0.00037701704,0.00071753305,0.00012458669,0.000006778745,0.0010141626],"genre_scores_gemma":[0.9935172,0.0032080424,0.00009558627,0.0012276069,0.0013238634,0.00048697495,0.000081775775,0.00003853961,0.000020401054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971696,0.0002495163,0.0007306199,0.00072906,0.00031438554,0.00080681965],"domain_scores_gemma":[0.9984309,0.00037205277,0.000079103265,0.00034681134,0.00014189362,0.0006292034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020691871,0.0001659999,0.00033305085,0.00014364219,0.000075823096,0.00006860161,0.00047809913,0.00035243656,0.00014063399],"category_scores_gemma":[0.0030994494,0.00017257432,0.00012518767,0.00050468266,0.00027759993,0.000005555191,0.00025998015,0.0008387875,0.000046431654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070967846,0.0010340598,0.8415082,0.00017437998,0.00012090398,0.00063208444,0.00047171663,0.00067048665,0.0025645832,0.00089380203,0.029495187,0.051466722],"study_design_scores_gemma":[0.1147385,0.012732216,0.5021624,0.00074775517,0.000044639837,0.0000075393446,0.00065310526,0.0007458453,0.013035441,0.00037803603,0.35271877,0.0020357394],"about_ca_topic_score_codex":0.050310228,"about_ca_topic_score_gemma":0.14426744,"teacher_disagreement_score":0.3393458,"about_ca_system_score_codex":0.0001833527,"about_ca_system_score_gemma":0.002446611,"threshold_uncertainty_score":0.95601386},"labels":[],"label_agreement":null},{"id":"W3036403360","doi":"10.1158/1557-3265.liqbiop20-a07","title":"Abstract A07: Sequential ctDNA analysis detected preclinical relapse in patients with metastatic colorectal cancer from the Exactis trial (NCT00984048)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Genome British Columbia","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; Colorectal cancer; Internal medicine; Oncology; Cetuximab; Cancer; Clinical trial","score_opus":0.14013004500586354,"score_gpt":0.4502684330671032,"score_spread":0.3101383880612396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036403360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468476,0.0011313129,0.00005375435,0.0017091678,0.00044153933,0.001102232,0.00079735345,0.000011239756,0.00006865329],"genre_scores_gemma":[0.9950924,0.0018880995,0.00011048503,0.00070199225,0.0014412989,0.00035916618,0.00033904158,0.00004251275,0.000025023699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961038,0.00071522477,0.0009183103,0.0009911701,0.00070431305,0.00056716567],"domain_scores_gemma":[0.9968416,0.0016307385,0.00022993842,0.00051863235,0.00040782135,0.0003712717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013820514,0.0002350977,0.00056749646,0.00006959357,0.00014775252,0.000107290834,0.0006395861,0.00026526768,0.00069854606],"category_scores_gemma":[0.0031129464,0.00016824283,0.00033543177,0.0008925578,0.00049230986,0.000010186484,0.00036232767,0.0011051866,0.000022394925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14028579,0.00095759996,0.82611096,0.00002471408,0.0027861209,0.000032499673,0.00019996191,0.0014508573,0.0019422465,0.000007777341,0.0087658195,0.017435677],"study_design_scores_gemma":[0.03851834,0.003404558,0.94436663,0.000041323066,0.00063823536,1.1404591e-7,0.00007628229,0.00039546372,0.002212987,0.00005229341,0.009892545,0.00040122823],"about_ca_topic_score_codex":0.0051359185,"about_ca_topic_score_gemma":0.019197876,"teacher_disagreement_score":0.1182557,"about_ca_system_score_codex":0.000115272975,"about_ca_system_score_gemma":0.0011589619,"threshold_uncertainty_score":0.9986992},"labels":[],"label_agreement":null},{"id":"W3036427315","doi":"10.1158/1078-0432.ccr-20-0103","title":"Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; BC Cancer Agency; Foothills Medical Centre; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital; Alberta Health Services; University of British Columbia","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council Victoria; Horizon 2020 Framework Programme; Peter MacCallum Foundation; BC Cancer Foundation; University College London Hospitals NHS Foundation Trust; Medical Research and Materiel Command; Eisai; Canada Excellence Research Chairs, Government of Canada; Bundesministerium für Bildung und Forschung; Canada Research Chairs; Canadian Institutes of Health Research; Cancer Institute NSW; Cancer Australia; Mayo Clinic; Ovarian Cancer Action; Michael Smith Health Research BC; National Health and Medical Research Council; AstraZeneca; Invitae; Daiichi-Sankyo; MacroGenics; National Institute for Health and Care Research; Clovis Oncology; Cancer Research UK; University College London; Cancer Council NSW; Ovarian Cancer Australia; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Celgene; Carrick Therapeutics; Ignyta; U.S. Department of Defense; Eli Lilly and Company; Cancer Council South Australia; Deutsches Krebsforschungszentrum; Pfizer; European Commission; Breast Cancer Research Foundation; American Oil Chemists' Society; National Center for Advancing Translational Sciences; Medical Research Council; Teva Pharmaceutical Industries; American Cancer Society","keywords":"Serous fluid; Ovarian carcinoma; Serous carcinoma; Oncology; Ovarian cancer; Serous ovarian cancer; Gene expression; Gene expression profiling; Clinical trial; Internal medicine; Gene; Medicine; Bioinformatics; Biology; Cancer; Genetics","score_opus":0.18082035205129865,"score_gpt":0.4301660530588109,"score_spread":0.24934570100751224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036427315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905172,0.0010052855,0.000052842515,0.007383245,0.00010843999,0.0008119141,0.000024572584,0.000008783866,0.000087747074],"genre_scores_gemma":[0.9970385,0.0002517744,0.0021407518,0.00022047159,0.0001589857,0.00012573268,0.000011859754,0.00001791176,0.000034038887],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980475,0.0002437586,0.0005046022,0.00034772579,0.000659147,0.00019726565],"domain_scores_gemma":[0.9988644,0.00018745438,0.00013015707,0.00032815558,0.00027379833,0.00021601674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006464295,0.00009659314,0.000338134,0.00003905433,0.00006228209,0.00000853208,0.0001456256,0.00014215107,0.00012160785],"category_scores_gemma":[0.00031874565,0.00006234417,0.00007581049,0.00030201374,0.00020609814,0.000026938265,0.00019693779,0.00039225243,0.0000034880375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014939719,0.00067553134,0.91968596,0.0005967536,0.00024620446,0.000045023662,0.0010110162,0.000022507305,0.061529543,0.00043838524,0.0014157465,0.012839382],"study_design_scores_gemma":[0.0019686946,0.00042965962,0.43648237,0.00016115088,0.00004930768,0.0000011833818,0.00003337798,0.000023626346,0.5594809,0.000063210835,0.0012630463,0.00004348362],"about_ca_topic_score_codex":0.00030170198,"about_ca_topic_score_gemma":0.000013011731,"teacher_disagreement_score":0.49795136,"about_ca_system_score_codex":0.00008763888,"about_ca_system_score_gemma":0.00074923265,"threshold_uncertainty_score":0.2542321},"labels":[],"label_agreement":null},{"id":"W3036495611","doi":"10.1158/1557-3265.liqbiop20-a45","title":"Abstract A45: HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cervix; Minimal residual disease; Chemoradiotherapy; Cancer; Precision medicine; Adjuvant; Personalized medicine; Cervical cancer; Disease; Stage (stratigraphy); Pathology; Bioinformatics; Biology","score_opus":0.16988952353825193,"score_gpt":0.43819685596189784,"score_spread":0.2683073324236459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036495611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963671,0.0010491075,0.00025505963,0.0004253054,0.00016066065,0.00025523457,0.00016408465,0.000010162746,0.001313307],"genre_scores_gemma":[0.9977162,0.000865464,0.00009333319,0.00039831764,0.0008231111,0.00002782018,0.000031256764,0.000023610892,0.0000208916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981398,0.00016062113,0.00052905036,0.00051243143,0.0003015644,0.00035652937],"domain_scores_gemma":[0.99836314,0.0005531575,0.00012711671,0.00025233818,0.00046439777,0.00023986504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010571781,0.00012266153,0.00025071992,0.0000369961,0.00010701968,0.000026949387,0.00018602701,0.00013906635,0.00013506235],"category_scores_gemma":[0.0037653001,0.00012417982,0.00016498641,0.00020169943,0.0003192851,0.0000059265503,0.00015048754,0.00043624715,0.000018921091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034561683,0.000035709705,0.0027740598,0.00010107706,0.00006209174,0.000020716374,0.00016631074,0.00044201818,0.959817,0.000015412337,0.00038788925,0.035832092],"study_design_scores_gemma":[0.0008300251,0.00087403855,0.04640871,0.000031605112,0.000018085764,0.000004321136,0.0008695575,0.00063500844,0.94497955,0.00011615457,0.005002277,0.00023065326],"about_ca_topic_score_codex":0.0006020702,"about_ca_topic_score_gemma":0.00024330542,"teacher_disagreement_score":0.04363465,"about_ca_system_score_codex":0.00007909904,"about_ca_system_score_gemma":0.00056590926,"threshold_uncertainty_score":0.5063906},"labels":[],"label_agreement":null},{"id":"W3036558735","doi":"10.1158/1557-3265.liqbiop20-pr13","title":"Abstract PR13: Comprehensive detection of ctDNA in localized head and neck cancer by genome- and methylome-based analysis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA methylation; Head and neck squamous-cell carcinoma; Differentially methylated regions; CpG site; Methylation; Biology; Cancer research; Oncology; Deep sequencing; Methylated DNA immunoprecipitation; Cancer; Bisulfite sequencing; Head and neck cancer; Internal medicine; Medicine; Gene; Genome; Genetics; Gene expression","score_opus":0.11981526546952159,"score_gpt":0.4595226261646075,"score_spread":0.3397073606950859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036558735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97652143,0.021458875,0.0003201991,0.0011263109,0.00003999689,0.00027084627,0.00022247493,0.0000033343586,0.000036501344],"genre_scores_gemma":[0.98064953,0.018335689,0.0000982999,0.00061711157,0.00015321854,0.00006938619,0.000047761463,0.00001632781,0.000012695455],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99828863,0.00018587998,0.00050882436,0.00052966195,0.00021795208,0.00026902798],"domain_scores_gemma":[0.99881727,0.00037336754,0.000111986716,0.00020559637,0.00024937032,0.00024240144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058693957,0.00012441799,0.00047635316,0.000101809106,0.000050894345,0.000027683682,0.00013344472,0.00018640369,0.000055352193],"category_scores_gemma":[0.00046251694,0.00011905813,0.00012065888,0.0004923888,0.00036490939,0.0000034186423,0.00015003848,0.00032594797,0.0000010222057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022756727,0.00017769366,0.22216678,0.00025248053,0.00059931533,0.0000071366862,0.000087892695,0.0020248622,0.73597234,0.000005529894,0.00084081315,0.035589505],"study_design_scores_gemma":[0.005868327,0.0018952973,0.76504016,0.000068172936,0.0002693197,4.3128284e-7,0.00017399162,0.0044641877,0.14405486,0.000066823886,0.07764095,0.0004574519],"about_ca_topic_score_codex":0.003841684,"about_ca_topic_score_gemma":0.004323912,"teacher_disagreement_score":0.59191746,"about_ca_system_score_codex":0.00003849084,"about_ca_system_score_gemma":0.00026419788,"threshold_uncertainty_score":0.5807503},"labels":[],"label_agreement":null},{"id":"W3036571224","doi":"10.1158/1557-3265.liqbiop20-ia11","title":"Abstract IA11: Clinical applications of liquid biopsy in multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Liquid biopsy; Genetic heterogeneity; Exome sequencing; Biopsy; Somatic evolution in cancer; Circulating tumor cell; Biology; Multiple myeloma; Tumour heterogeneity; Exome; Pathology; Medicine; Cancer; Gene; Genetics; Mutation; Immunology; Metastasis; Phenotype","score_opus":0.39895135993122754,"score_gpt":0.5661026930599158,"score_spread":0.16715133312868824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036571224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852352,0.0011106012,0.00006752334,0.009033345,0.00007880286,0.0019260121,0.0001059652,0.000047179896,0.0023953565],"genre_scores_gemma":[0.9949241,0.002112863,0.00087643665,0.00036424483,0.00084527256,0.00058346416,0.000050006278,0.000038643688,0.00020491984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952839,0.00051387236,0.0015565995,0.0007982883,0.0011170893,0.00073023816],"domain_scores_gemma":[0.99397343,0.003413828,0.00014751352,0.00066605734,0.0006220217,0.001177127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00340978,0.00017108776,0.0007936302,0.00021955739,0.00009210981,0.00001902409,0.0004340493,0.00031554716,0.0010176226],"category_scores_gemma":[0.005991662,0.00014035605,0.00034810498,0.0011882972,0.0009953876,0.00007616718,0.00029148234,0.0018816132,0.0005200202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0090751555,0.0019217785,0.85780627,0.00033353543,0.00017800485,0.0002370662,0.000083164814,0.0000032840283,0.0019077299,0.000068741414,0.0023873656,0.12599789],"study_design_scores_gemma":[0.007948838,0.0022587061,0.9662287,0.00017707318,0.00002303407,0.000003898045,0.00014192214,0.0005757466,0.0016068954,0.00006399042,0.020835549,0.00013562528],"about_ca_topic_score_codex":0.0008020202,"about_ca_topic_score_gemma":0.00021727795,"teacher_disagreement_score":0.12586226,"about_ca_system_score_codex":0.00012340624,"about_ca_system_score_gemma":0.0011501606,"threshold_uncertainty_score":0.9998956},"labels":[],"label_agreement":null},{"id":"W3036616154","doi":"10.1158/1557-3265.liqbiop20-a24","title":"Abstract A24: Identifying the genomic and clinical features of AKT1/PIK3CA mutant metastatic prostate cancer using circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hôpital Saint-Luc; Juravinski Cancer Centre; Spinal Cord Injury BC","funders":"","keywords":"Prostate cancer; AKT1; PTEN; Cancer research; Medicine; Population; Androgen receptor; Oncology; PI3K/AKT/mTOR pathway; Internal medicine; Biology; Genetics; Cancer; Signal transduction","score_opus":0.25000678003527,"score_gpt":0.5076130006979055,"score_spread":0.2576062206626355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036616154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845767,0.012441276,0.000039902246,0.0017219274,0.00034135176,0.0005919257,0.00019200724,0.0000069661055,0.00008796649],"genre_scores_gemma":[0.98830354,0.008953907,0.00029843187,0.0009021808,0.0014036811,0.00004963636,0.000015508798,0.000048111444,0.000025014426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99698055,0.0003745171,0.001013412,0.0007214846,0.000405574,0.0005044726],"domain_scores_gemma":[0.99778414,0.00081428693,0.0003275789,0.00041680713,0.00034396155,0.00031321333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024223311,0.0001917908,0.00045293255,0.000040407154,0.0002393805,0.00011116912,0.0004385608,0.00012606406,0.00006204467],"category_scores_gemma":[0.0021420384,0.00014920134,0.00023760462,0.00022748142,0.00078982307,0.000008566298,0.0006097183,0.000784482,0.0000037081986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001843489,0.00026615392,0.15828888,0.00070019456,0.00091248413,0.000111575224,0.000748419,0.001486509,0.77716017,0.000120134966,0.0042661997,0.05409579],"study_design_scores_gemma":[0.0068655848,0.0019854924,0.8743524,0.0006701357,0.000614558,0.000050846327,0.00256727,0.005680697,0.07721347,0.000999191,0.027749183,0.0012511904],"about_ca_topic_score_codex":0.001103573,"about_ca_topic_score_gemma":0.0004447266,"teacher_disagreement_score":0.7160635,"about_ca_system_score_codex":0.000052459534,"about_ca_system_score_gemma":0.0010429223,"threshold_uncertainty_score":0.6084254},"labels":[],"label_agreement":null},{"id":"W3036626624","doi":"10.1158/1557-3265.liqbiop20-pr09","title":"Abstract PR09: Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutations","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"PTEN; Cancer research; Prostate cancer; Mutation; Cancer; CDKN2A; Germline mutation; Biology; DNA repair; Germline; DNA damage; Somatic cell; Gene; Medicine; Genetics; DNA; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.3145723633926266,"score_gpt":0.5531282130071178,"score_spread":0.23855584961449117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036626624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95919144,0.0057992307,0.000020636113,0.03102089,0.00007493931,0.0021769695,0.00048310505,0.0000384654,0.0011943179],"genre_scores_gemma":[0.98551697,0.01076047,0.00079592003,0.00053409446,0.00025807542,0.00075261877,0.000081147344,0.000047797475,0.0012529151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675876,0.0003940762,0.00067582045,0.0006994238,0.00080002967,0.0006718865],"domain_scores_gemma":[0.9962654,0.0015513445,0.00015506509,0.00027964867,0.0010721629,0.000676375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011049483,0.00021031401,0.0007226338,0.00014608576,0.0001797768,0.00003314316,0.00017926558,0.0001282289,0.001355314],"category_scores_gemma":[0.00081873895,0.0001273607,0.00009975726,0.00084092614,0.0019493953,0.00013859362,0.00012443215,0.0011386481,0.00002959962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060539752,0.0020607559,0.7741523,0.0041788383,0.0037790628,0.002526393,0.007812994,0.00007047172,0.014511373,0.0007381183,0.008326413,0.12130354],"study_design_scores_gemma":[0.025917519,0.02337631,0.9248656,0.0020235733,0.0007673039,0.00006094161,0.0031486878,0.00039965284,0.012690231,0.0012860545,0.0048157545,0.0006483826],"about_ca_topic_score_codex":0.0018684671,"about_ca_topic_score_gemma":0.00078005716,"teacher_disagreement_score":0.1507133,"about_ca_system_score_codex":0.00018015968,"about_ca_system_score_gemma":0.0029720378,"threshold_uncertainty_score":0.99955755},"labels":[],"label_agreement":null},{"id":"W3036776981","doi":"10.1158/1557-3265.liqbiop20-a18","title":"Abstract A18: Plasma circulating tumor DNA is scarce and confounded by clonal hematopoiesis in metastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; BAP1; Concordance; Internal medicine; Cancer; Liquid biopsy; Somatic cell; Cell-free fetal DNA; Carcinoma; Cancer research; Gene; Biology; Genetics","score_opus":0.12766778935219425,"score_gpt":0.41968372821671307,"score_spread":0.2920159388645188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036776981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382263,0.002675034,0.000025143323,0.0021232876,0.00007286331,0.00029441688,0.000223808,0.0000052947116,0.0007575437],"genre_scores_gemma":[0.99699295,0.0007022942,0.0001732431,0.0015407157,0.0003607361,0.000059296653,0.00005569124,0.00003299423,0.00008209245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977108,0.00015780023,0.0005846294,0.0006956476,0.0003617235,0.00048936275],"domain_scores_gemma":[0.9985879,0.00050285785,0.00010691713,0.00026228873,0.00016013501,0.00037987265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009512586,0.00016949546,0.00033220628,0.000044628883,0.00010645084,0.000083246996,0.0002763657,0.0001223398,0.00018085256],"category_scores_gemma":[0.0007465228,0.00017293912,0.000109439075,0.00019175796,0.00034691545,0.0000061682463,0.00032136816,0.00052032556,0.000017220647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016988362,0.00039274408,0.123129174,0.0006301458,0.00013944146,0.0002346621,0.00055955834,0.000107009946,0.791306,0.0001195315,0.07385672,0.007826182],"study_design_scores_gemma":[0.011775855,0.0024988109,0.12866986,0.00017955327,0.000097531105,0.0000350661,0.0012749982,0.0038194293,0.75679463,0.000808571,0.09264332,0.0014023989],"about_ca_topic_score_codex":0.0006291771,"about_ca_topic_score_gemma":0.0002579988,"teacher_disagreement_score":0.03451138,"about_ca_system_score_codex":0.00005489904,"about_ca_system_score_gemma":0.0006435513,"threshold_uncertainty_score":0.7052252},"labels":[],"label_agreement":null},{"id":"W3036855997","doi":"10.1158/1078-0432.ccr-20-1024","title":"Population-based Screening for <i>BRAF</i> V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Vancouver Coastal Health","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Colorectal cancer; Cohort; Oncology; Population; Cancer","score_opus":0.2893940405667775,"score_gpt":0.5203612844790028,"score_spread":0.23096724391222528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036855997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692571,0.0061830007,0.000033555385,0.021113114,0.000071316295,0.002954046,0.00026374354,0.000041172076,0.000082931016],"genre_scores_gemma":[0.9914592,0.0014716602,0.0010503025,0.0019555504,0.00031366796,0.003566982,0.0000341654,0.000035857756,0.00011260611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971205,0.0003680048,0.000665302,0.00071851705,0.0005846862,0.0005429796],"domain_scores_gemma":[0.99661744,0.0023423026,0.00011114374,0.00012297774,0.00039002596,0.00041612532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015245032,0.00019614624,0.00073826424,0.000118293014,0.00020006171,0.000042018422,0.000130924,0.00009338809,0.00019076289],"category_scores_gemma":[0.0026848244,0.00015708349,0.00015316594,0.0006436962,0.00026321708,0.000081358725,0.00010900081,0.00049455336,0.0000027330964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060181883,0.00024743204,0.9648104,0.00096609344,0.00017290679,0.000027364918,0.0001419288,0.000018758767,0.00027219875,0.000015492235,0.002008087,0.02530116],"study_design_scores_gemma":[0.0067973514,0.002569925,0.9836123,0.0006669282,0.00021412727,0.0000011646893,0.00009452619,0.0038340162,0.00056314917,0.00008091882,0.0013833063,0.00018226508],"about_ca_topic_score_codex":0.004172126,"about_ca_topic_score_gemma":0.0021389974,"teacher_disagreement_score":0.025118895,"about_ca_system_score_codex":0.00022805556,"about_ca_system_score_gemma":0.000560573,"threshold_uncertainty_score":0.64056784},"labels":[],"label_agreement":null},{"id":"W3037199155","doi":"10.1158/1078-0432.ccr-20-1376","title":"Measurement Tool of Chemotherapy Sensitivity in Advanced Ovarian Cancer","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ovarian cancer; Chemotherapy; Medicine; Cancer; Oncology; Sensitivity (control systems); Internal medicine; Gynecology; Engineering","score_opus":0.29676594274671286,"score_gpt":0.5097095074310191,"score_spread":0.2129435646843062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037199155","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018006,0.0054394533,0.000012431311,0.9719967,0.000830173,0.0025209242,0.00023082312,0.00004154939,0.0009219461],"genre_scores_gemma":[0.36470908,0.027925443,0.00039631926,0.59335136,0.01022414,0.0022665453,0.00009477427,0.00023426312,0.0007980907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99254024,0.0009558011,0.0013849196,0.0013736488,0.0027953119,0.00095008215],"domain_scores_gemma":[0.9963636,0.0008094094,0.00032089854,0.0009998416,0.0012367532,0.00026954233],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034407212,0.00044263722,0.0018996202,0.00029476307,0.00007117794,0.000031894393,0.00027111094,0.00085895794,0.0011856077],"category_scores_gemma":[0.00080296176,0.0003754653,0.0005367058,0.0008814178,0.0004918959,0.00006126726,0.0001673155,0.005290995,0.00004890666],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021623115,0.0007692784,0.09137287,0.0014380381,0.00086726196,0.0025452534,0.000109492474,0.0000101842115,0.00025853925,0.000012719097,0.7721851,0.12826896],"study_design_scores_gemma":[0.010339278,0.001287795,0.17706439,0.0040985527,0.0002188678,0.0000056643516,0.00002182367,0.00006275913,0.001675626,0.00016862185,0.80463094,0.00042568133],"about_ca_topic_score_codex":0.0041380776,"about_ca_topic_score_gemma":0.0015675048,"teacher_disagreement_score":0.37864536,"about_ca_system_score_codex":0.0020518892,"about_ca_system_score_gemma":0.004106551,"threshold_uncertainty_score":0.9998697},"labels":[],"label_agreement":null},{"id":"W3037825755","doi":"10.1158/1557-3265.ovcasymp18-nt-111","title":"Abstract NT-111: THE ANTIPROGESTIN/ANTIGLUCOCORTICOID MIFEPRISTONE AND THE HIV PROTEASE INHIBITOR NELFINAVIR CAUSE ENDOPLASMIC RETICULUM STRESS AND POTENTIATE THE TOXICITY OF PROTEASOME INHIBITION IN HIGH-GRADE SEROUS EPITHELIAL OVARIAN CANCER CELLS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Unfolded protein response; Nelfinavir; Medicine; Proteasome inhibitor; Antiglucocorticoid; Internal medicine; Mifepristone; Cancer research; Pharmacology; Endoplasmic reticulum; Immunology; Biology; Glucocorticoid receptor; Multiple myeloma; Viral load; Glucocorticoid; Cell biology","score_opus":0.03140910232338638,"score_gpt":0.35399222389871887,"score_spread":0.3225831215753325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037825755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885106,0.0024317943,0.000006537115,0.005340976,0.00022049944,0.0030315437,0.00041135083,0.0000084084095,0.000038280752],"genre_scores_gemma":[0.99280566,0.0056442255,0.000024096893,0.00022325847,0.0003519511,0.0007363039,0.00002908558,0.000032877506,0.00015256922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963036,0.0009953731,0.00076280953,0.0007355668,0.00059390406,0.0006086989],"domain_scores_gemma":[0.9979776,0.00045897966,0.00030269646,0.00075306697,0.0002532574,0.00025438325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024734505,0.00025677914,0.00042324356,0.00005590984,0.00025996842,0.00010899005,0.0003378469,0.00023215836,0.00004220579],"category_scores_gemma":[0.00079151103,0.00013828595,0.00014173778,0.0002461185,0.002064437,0.000019694922,0.00049540243,0.0009159126,0.000007113698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0088848425,0.0011354483,0.3305408,0.0010092417,0.0003014267,0.00012828471,0.00046277698,0.00065308646,0.6516334,0.00053468446,0.0010208254,0.003695211],"study_design_scores_gemma":[0.010738856,0.00050499156,0.239152,0.0006676837,0.00011555491,0.000019945574,0.0004970672,0.0006621399,0.74621594,0.0004634579,0.0005691408,0.00039323262],"about_ca_topic_score_codex":0.0030442544,"about_ca_topic_score_gemma":0.00070043764,"teacher_disagreement_score":0.09458255,"about_ca_system_score_codex":0.00003316469,"about_ca_system_score_gemma":0.0005153207,"threshold_uncertainty_score":0.76065034},"labels":[],"label_agreement":null},{"id":"W3038401324","doi":"10.1158/1078-0432.ccr-20-2224","title":"COVID-19 Testing in Patients with Cancer: Does One Size Fit All?","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Cancer; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Virology; Internal medicine; Disease; Outbreak; Infectious disease (medical specialty)","score_opus":0.7817379536491433,"score_gpt":0.6893391093756028,"score_spread":0.0923988442735405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038401324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070425123,0.9655111,0.0000011772717,0.02785051,0.00036795205,0.0048153126,0.0004162434,0.00010092136,0.00023252564],"genre_scores_gemma":[0.0005586945,0.98468363,0.00015151902,0.010823072,0.0019276255,0.0010172287,0.00007862795,0.00014557395,0.0006140327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99158734,0.0014748357,0.0019482375,0.001492361,0.0021030388,0.0013941902],"domain_scores_gemma":[0.9715217,0.0219885,0.000539993,0.0010350413,0.0009991565,0.003915636],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041943924,0.0005305299,0.0038316152,0.0003788871,0.00018171256,0.00007228984,0.00062761334,0.00078251824,0.0015597186],"category_scores_gemma":[0.06880841,0.0003141807,0.00038494982,0.0023457147,0.0005360768,0.00007896096,0.00046191548,0.0056841504,0.00010659381],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010301381,0.00043784876,0.100793816,0.059665818,0.00024485282,0.00025390205,0.00008866579,8.9195606e-7,3.22568e-8,0.0000045264287,0.0060746274,0.83140486],"study_design_scores_gemma":[0.003427282,0.0019473872,0.02226325,0.03084436,0.00038480206,0.0000020425957,0.000013956222,0.0000049524333,7.760846e-8,0.00003363059,0.94073135,0.00034691684],"about_ca_topic_score_codex":0.020946823,"about_ca_topic_score_gemma":0.0074182344,"teacher_disagreement_score":0.93465674,"about_ca_system_score_codex":0.00479933,"about_ca_system_score_gemma":0.049167592,"threshold_uncertainty_score":0.99993104},"labels":[],"label_agreement":null},{"id":"W3038487399","doi":"10.1158/1078-0432.ccr-20-0219","title":"A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i> -mutant Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"Merck; AstraZeneca","keywords":"Carboplatin; Medicine; Tolerability; Internal medicine; Chemotherapy; Oncology; Adverse effect; Ovarian cancer; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Placebo; Clinical endpoint; Hazard ratio; Pemetrexed; Cancer; Progression-free survival; Randomized controlled trial; Surgery; Phases of clinical research; Confidence interval; Cisplatin; Pathology","score_opus":0.20556782163680917,"score_gpt":0.4904681500289786,"score_spread":0.2849003283921694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038487399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643668,0.0017801836,0.00020543934,0.023773499,0.00028263975,0.007965884,0.0006277967,0.000043849646,0.0009538906],"genre_scores_gemma":[0.9893754,0.0025041308,0.00060046493,0.0010916502,0.0009954246,0.005062074,0.000032679454,0.00007124059,0.00026689822],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995133,0.0007627894,0.001323507,0.0010055561,0.0009605706,0.000814587],"domain_scores_gemma":[0.99279225,0.004625434,0.0003819276,0.0004435196,0.0008335452,0.00092330703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037712574,0.00034889954,0.0022072569,0.00013465533,0.00023608565,0.000043783,0.00016167203,0.0002565789,0.00030988484],"category_scores_gemma":[0.0024472582,0.00023741736,0.000304521,0.0006738101,0.0010337714,0.00008975728,0.00018327378,0.0006684265,0.000002922988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94221807,0.0016059588,0.000692351,0.00040167008,0.0019653037,0.000116248164,0.0026088157,0.000007668042,0.0015741043,0.00023213052,0.00180158,0.04677611],"study_design_scores_gemma":[0.9621296,0.025057225,0.00090996746,0.00045318907,0.0006254366,0.000005720431,0.0008411531,0.0024855467,0.0017973825,0.00026204766,0.005140094,0.00029262772],"about_ca_topic_score_codex":0.0016243628,"about_ca_topic_score_gemma":0.00031463002,"teacher_disagreement_score":0.04648348,"about_ca_system_score_codex":0.0005196455,"about_ca_system_score_gemma":0.0025454669,"threshold_uncertainty_score":0.9681599},"labels":[],"label_agreement":null},{"id":"W3038927235","doi":"10.1158/1557-3265.ovca19-b67","title":"Abstract B67: Analysis of function and inhibition of PGE2 pathway members MRP4 and EP4 in treatment of ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Autocrine signalling; Cancer research; Cancer; Paracrine signalling; Tissue microarray; Medicine; Prostaglandin E2 receptor; Tumor progression; Biology; Internal medicine; Receptor","score_opus":0.1835258073397451,"score_gpt":0.47528489579623057,"score_spread":0.29175908845648546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038927235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697423,0.0015936643,0.0000043163363,0.0007122137,0.000056157503,0.00041941588,0.000043896158,0.0000041498893,0.00019195203],"genre_scores_gemma":[0.9968582,0.0028437767,0.00001812919,0.000049800212,0.00013358843,0.000055317178,0.000013400087,0.000008857497,0.00001897489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840134,0.000180244,0.00060631236,0.0002666007,0.00037660022,0.0001689018],"domain_scores_gemma":[0.99875116,0.0005531299,0.00015224426,0.00014381639,0.00019987844,0.00019977591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011425029,0.00008603522,0.000645377,0.00025025543,0.000019847232,0.000003337084,0.00002625373,0.00012982757,0.0003226611],"category_scores_gemma":[0.00032965068,0.00006609193,0.00011422606,0.00072503055,0.00029861316,0.00004169996,0.000027468197,0.00021359991,6.2020166e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041311,0.0003422866,0.9024994,0.0007989715,0.0006602434,0.000027102025,0.0008843589,0.000060031223,0.02844962,0.00007366921,0.00009528629,0.06197797],"study_design_scores_gemma":[0.0035129718,0.0018833483,0.97592896,0.00020025203,0.00036757163,1.7482071e-7,0.00017610147,0.0012118471,0.016272904,0.00002945398,0.00036049171,0.00005590625],"about_ca_topic_score_codex":0.0034276536,"about_ca_topic_score_gemma":0.0015876264,"teacher_disagreement_score":0.073429614,"about_ca_system_score_codex":0.00008006155,"about_ca_system_score_gemma":0.00029292336,"threshold_uncertainty_score":0.51816094},"labels":[],"label_agreement":null},{"id":"W3039237605","doi":"10.1158/1078-0432.ccr-19-2717","title":"Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Homoharringtonine; Cancer research; Cell culture; In vivo; Cancer; Biology; Medicine; Pathology; Myeloid leukemia; Internal medicine; Genetics","score_opus":0.1933720482402241,"score_gpt":0.46582339799895034,"score_spread":0.2724513497587262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039237605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712124,0.0007114118,0.0007264452,0.026059156,0.000120508375,0.00067209365,0.000046735506,0.000019959138,0.0004312873],"genre_scores_gemma":[0.9941829,0.00015976548,0.0002785441,0.002119459,0.002688425,0.00014959206,0.000017019665,0.00002707388,0.00037726405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981145,0.00033014934,0.00032362476,0.0005022781,0.0004009352,0.00032851068],"domain_scores_gemma":[0.998955,0.00007250265,0.000056667202,0.00031317867,0.0003456085,0.00025703025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010988232,0.00011046606,0.00016819469,0.000020612735,0.00017896897,0.000043975833,0.00027070715,0.00012185943,0.000047720845],"category_scores_gemma":[0.00078917993,0.00008112872,0.00011470466,0.0002752285,0.0001633962,0.0000030493375,0.00018496599,0.0004899401,0.000083744984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002594416,0.00015881196,0.0038736614,0.00018562851,0.00015139637,0.000029661522,0.00087508,0.0029496616,0.8002455,0.000041678453,0.074442044,0.114452444],"study_design_scores_gemma":[0.0018250414,0.0019415165,0.0067009013,0.00036790187,0.000022996875,0.000004658099,0.00084509363,0.0038908334,0.6426052,0.00005507752,0.34122324,0.0005175643],"about_ca_topic_score_codex":0.00008335684,"about_ca_topic_score_gemma":0.00016634447,"teacher_disagreement_score":0.2667812,"about_ca_system_score_codex":0.000027979062,"about_ca_system_score_gemma":0.00028143224,"threshold_uncertainty_score":0.3308333},"labels":[],"label_agreement":null},{"id":"W3039765753","doi":"10.1158/1557-3265.ovca19-a74","title":"Abstract A74: The HIV protease inhibitor nelfinavir, alone or in combination with the proteasome inhibitor bortezomib, is cytotoxic to high-grade serous ovarian cancer cells regardless of platinum sensitivity","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bortezomib; Unfolded protein response; Nelfinavir; Proteasome inhibitor; Proteasome; Cancer research; Medicine; Pharmacology; Ovarian cancer; Cancer; Multiple myeloma; Immunology; Endoplasmic reticulum; Biology; Internal medicine; Cell biology","score_opus":0.11290561721237395,"score_gpt":0.40891170304770197,"score_spread":0.296006085835328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039765753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77822375,0.00008445623,0.00001916813,0.21578355,0.000088479675,0.005571898,0.0001384244,0.000030387504,0.000059889797],"genre_scores_gemma":[0.99271446,0.00012534036,0.00030541405,0.001956505,0.00061542704,0.0019236372,0.000025566136,0.000057845617,0.0022758134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533033,0.0007891108,0.0008855315,0.00076613884,0.0015294957,0.0006993662],"domain_scores_gemma":[0.9968697,0.0012243586,0.00024857486,0.0005803892,0.000488683,0.0005883309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033490676,0.00030447284,0.00076275744,0.0001362128,0.00023521422,0.00006393499,0.00027510035,0.00020431564,0.00026731074],"category_scores_gemma":[0.0008307781,0.00015589368,0.00012173312,0.0012277402,0.0004827843,0.000119745266,0.00023045085,0.0015165239,0.00009813624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08446542,0.011536178,0.37291515,0.0031234976,0.0019484486,0.004385301,0.029192932,0.0003576236,0.115820415,0.00023468815,0.3266762,0.049344145],"study_design_scores_gemma":[0.036406666,0.00472562,0.52642334,0.0035347918,0.0003273242,0.000025278852,0.0029330442,0.0010566545,0.39549926,0.00009827002,0.027968785,0.0010009313],"about_ca_topic_score_codex":0.0020429553,"about_ca_topic_score_gemma":0.0021577282,"teacher_disagreement_score":0.29870743,"about_ca_system_score_codex":0.00046417094,"about_ca_system_score_gemma":0.0024736272,"threshold_uncertainty_score":0.6588626},"labels":[],"label_agreement":null},{"id":"W3040096066","doi":"10.1158/1078-0432.ccr-19-3884","title":"Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Cancer Research UK; Exelixis","keywords":"Cabozantinib; Medicine; Placebo; Hepatocellular carcinoma; Internal medicine; Gastroenterology; Confidence interval; Alpha-fetoprotein; Oncology; Cancer; Pathology","score_opus":0.36167135628376856,"score_gpt":0.4810952114332623,"score_spread":0.11942385514949372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040096066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917396,0.0003160639,0.0000025164152,0.0017330215,0.00011524185,0.0059573944,0.00004811005,0.000014383659,0.000073724965],"genre_scores_gemma":[0.9990627,0.00007758856,0.00006521737,0.00017494426,0.00015106586,0.00038615442,0.000019887591,0.00003823127,0.00002418041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99429405,0.001669168,0.0013916929,0.0008409054,0.00120022,0.0006039587],"domain_scores_gemma":[0.9963448,0.0022267888,0.00018925294,0.0005482007,0.00030109237,0.00038988187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00334624,0.00027776056,0.0011661663,0.00013926327,0.00009307163,0.000027253393,0.00034178907,0.0002110298,0.000109021414],"category_scores_gemma":[0.0011707828,0.0001767046,0.00016275997,0.0007460079,0.0004717507,0.00010314715,0.00021136244,0.0014855871,0.0000087969765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0407232,0.005678506,0.93684506,0.00007884903,0.00017050865,0.0005311743,0.0012583291,7.2491343e-7,0.000011219451,0.0000056015892,0.000034224606,0.014662619],"study_design_scores_gemma":[0.12794183,0.02182699,0.8479031,0.00007479894,0.00012640987,4.9229493e-7,0.0011305144,0.00056289125,0.000120171775,0.0000033811655,0.00015603733,0.00015340134],"about_ca_topic_score_codex":0.0014031584,"about_ca_topic_score_gemma":0.0009874522,"teacher_disagreement_score":0.08894196,"about_ca_system_score_codex":0.000072990646,"about_ca_system_score_gemma":0.00049275707,"threshold_uncertainty_score":0.72058046},"labels":[],"label_agreement":null},{"id":"W3040374725","doi":"10.1158/1557-3265.ovca19-a56","title":"Abstract A56: Novel L-sugar linked glycosylated antitumor ether lipids for killing platinum-resistant human epithelial ovarian cancer cells","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cancer research; Serous fluid; Ovarian cancer; Apoptosis; Cell culture; In vivo; Cancer cell; Cell; Chemistry; Medicine; Cancer; Biology; Internal medicine; Biochemistry","score_opus":0.20815642011168242,"score_gpt":0.48736925114549595,"score_spread":0.27921283103381356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040374725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897,0.0017952262,0.00050516124,0.0034056525,0.0005067462,0.0016434729,0.0018352561,0.00004448648,0.0005640031],"genre_scores_gemma":[0.99145764,0.0015470136,0.00070482056,0.0006122753,0.0039684987,0.0005949315,0.00024156261,0.00010909378,0.00076414685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99605435,0.00019625726,0.00077720254,0.0011529671,0.00071916066,0.0011000688],"domain_scores_gemma":[0.99764067,0.00027907488,0.0001667019,0.00054548157,0.00062864483,0.00073942496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001431406,0.00030743598,0.0004920269,0.000080718775,0.00044472818,0.00013099788,0.00066388317,0.00041449117,0.00065902184],"category_scores_gemma":[0.0005513344,0.00027207035,0.00032139418,0.000345196,0.00042684472,0.000013139755,0.00032209707,0.0008967556,0.000058795315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004578341,0.00029961282,0.0017801293,0.00017298588,0.00040331724,0.00002233139,0.00007557912,0.00009960394,0.97613716,0.000069764705,0.008557337,0.007803814],"study_design_scores_gemma":[0.017246738,0.0055437787,0.016476408,0.00032793108,0.000110229244,0.0000017397523,0.00013323392,0.0007297332,0.6154103,0.00035795174,0.34263802,0.0010238913],"about_ca_topic_score_codex":0.0033992585,"about_ca_topic_score_gemma":0.0022446506,"teacher_disagreement_score":0.36072683,"about_ca_system_score_codex":0.0001413513,"about_ca_system_score_gemma":0.0011111828,"threshold_uncertainty_score":0.9999732},"labels":[],"label_agreement":null},{"id":"W3041199890","doi":"10.1158/1557-3265.ovcasymp18-nt-117","title":"Abstract NT-117: INHIBITION OF PARG, SENSITIZES OVARIAN CANCER CELLS TO PARP INHIBITORS AND DNA DAMAGING AGENTS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Poly ADP ribose polymerase; Synthetic lethality; DNA repair; Cancer research; Biology; Molecular biology; PARP inhibitor; Cisplatin; DNA damage; Blot; Ovarian cancer; Cell culture; Cancer; Chemistry; DNA; Polymerase; Biochemistry; Genetics; Gene; Chemotherapy","score_opus":0.18412665830304098,"score_gpt":0.5119869042786367,"score_spread":0.3278602459755957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041199890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868347,0.00076264073,0.000012276221,0.0070810425,0.0010570934,0.0013908439,0.00013265356,0.000052734475,0.0026760094],"genre_scores_gemma":[0.9932821,0.0022491547,0.00020621408,0.0019427789,0.0011876347,0.00018165563,0.000020621172,0.000066147855,0.00086372346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995772,0.00035396704,0.0010638522,0.0008466651,0.0012313062,0.0007322283],"domain_scores_gemma":[0.9968866,0.00085630565,0.00021644573,0.00064695056,0.0007397636,0.0006539425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003093004,0.00024681457,0.00073616585,0.00036467926,0.00012752229,0.00005358771,0.00014977808,0.00027087724,0.002434478],"category_scores_gemma":[0.00027171528,0.00022801266,0.00018169844,0.00071664026,0.00049758656,0.00016657946,0.00020331782,0.0010984519,0.00021792228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038803325,0.0006172041,0.18226123,0.0010876138,0.00032921447,0.00015438836,0.0013473739,0.00014905402,0.69636726,0.00016532048,0.06834954,0.045291502],"study_design_scores_gemma":[0.010228982,0.0011900042,0.41444123,0.004156691,0.000086259366,0.000013112623,0.0007287006,0.00020719566,0.523092,0.00055938313,0.044706967,0.0005895137],"about_ca_topic_score_codex":0.0015689124,"about_ca_topic_score_gemma":0.00017646316,"teacher_disagreement_score":0.23218,"about_ca_system_score_codex":0.00036986926,"about_ca_system_score_gemma":0.0007991061,"threshold_uncertainty_score":0.99847746},"labels":[],"label_agreement":null},{"id":"W3042708039","doi":"10.1158/1078-0432.ccr-20-1695","title":"Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; National Human Genome Research Institute; National Institutes of Health","keywords":"Medicine; Head and neck cancer; Pembrolizumab; Adjuvant; Oncology; Head and neck; Human papillomavirus; Clinical trial; Cancer; Phases of clinical research; Internal medicine; Surgery; Immunotherapy","score_opus":0.26414410117852,"score_gpt":0.5533957850436777,"score_spread":0.2892516838651577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042708039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464129,0.036235277,0.0000023977964,0.0138761895,0.00029404776,0.0022541182,0.000064133266,0.00007224924,0.000788672],"genre_scores_gemma":[0.9531597,0.042967934,0.00009173771,0.0016149302,0.0008371362,0.0006284661,0.000014864629,0.0000627249,0.00062249997],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950313,0.00051471224,0.0012561192,0.0012215081,0.0008726107,0.0011037627],"domain_scores_gemma":[0.9973928,0.00062271603,0.00013624025,0.0004021921,0.0003753181,0.0010707875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016157717,0.0003402396,0.0014773315,0.00018742848,0.00051386544,0.00005376041,0.00023073256,0.00029809488,0.00032421574],"category_scores_gemma":[0.0014530717,0.0002829574,0.0001414951,0.0007157328,0.00088191114,0.00018298137,0.00065269484,0.002187944,0.000013653466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50451034,0.0032547952,0.058389902,0.0008039951,0.0003360609,0.00085556216,0.0028348032,0.000013155767,0.007746928,0.00008575946,0.0094638225,0.41170487],"study_design_scores_gemma":[0.74665344,0.07730617,0.048642486,0.004108212,0.00018414833,0.00001524765,0.0009753043,0.0035004362,0.0010302968,0.00014630075,0.11664807,0.0007899054],"about_ca_topic_score_codex":0.0037698536,"about_ca_topic_score_gemma":0.0043654935,"teacher_disagreement_score":0.41091496,"about_ca_system_score_codex":0.00028034346,"about_ca_system_score_gemma":0.0008470595,"threshold_uncertainty_score":0.9999623},"labels":[],"label_agreement":null},{"id":"W3043818052","doi":"10.1158/1078-0432.ccr-20-1170","title":"Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Rosetrees Trust; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Amgen","keywords":"Medicine; Pembrolizumab; Head and neck; Head and neck squamous-cell carcinoma; Oncology; Basal cell; Head and neck cancer; Internal medicine; Radiology; Pathology; Cancer research; Cancer; Immunotherapy; Surgery","score_opus":0.2267127426001978,"score_gpt":0.5082349306894123,"score_spread":0.2815221880892145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043818052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908168,0.006721794,0.0000031263826,0.00076650316,0.00006671418,0.0014798405,0.000085883505,0.000003959708,0.00005539668],"genre_scores_gemma":[0.9982775,0.0009709222,0.000031020343,0.00024524325,0.00013827394,0.00017541059,0.000008425575,0.000034896315,0.000118323536],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959794,0.0016146026,0.0006285842,0.0007384903,0.0005461293,0.0004927433],"domain_scores_gemma":[0.9985376,0.00028205,0.000103662176,0.00053971336,0.00021432179,0.00032268197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016325269,0.00018548474,0.0003909919,0.000067561195,0.000110040644,0.00003866187,0.00047575444,0.00009761596,0.00006610011],"category_scores_gemma":[0.00075615227,0.00012793098,0.00009244871,0.00039143272,0.00053255016,0.000006512953,0.000752769,0.00059380697,0.0000031046723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22978464,0.015886249,0.45430958,0.0010387078,0.0002652393,0.00022599539,0.0031251644,0.00004553269,0.17594983,0.0000029236446,0.00201275,0.1173534],"study_design_scores_gemma":[0.19785622,0.29021737,0.12645711,0.0002576621,0.00021527348,0.000021100412,0.0061663673,0.0057217455,0.3603839,0.00004426837,0.01139766,0.001261329],"about_ca_topic_score_codex":0.0003728922,"about_ca_topic_score_gemma":0.003994268,"teacher_disagreement_score":0.32785246,"about_ca_system_score_codex":0.000034846995,"about_ca_system_score_gemma":0.00050597504,"threshold_uncertainty_score":0.5216874},"labels":[],"label_agreement":null},{"id":"W3043953022","doi":"10.1158/1557-3265.ovcasymp18-gmm-047","title":"Abstract GMM-047: GENOMIC CHARACTERIZATION OF ADULT-TYPE GRANULOSA CELL TUMORS: IMPLICATIONS FOR PATHOGENESIS AND TREATMENT OF RECURRENT DISEASE","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Missense mutation; Debulking; Carcinogenesis; Biology; Somatic cell; Disease; Germline mutation; Mutation; Cancer research; Pathogenesis; Internal medicine; Oncology; Ovarian cancer; Medicine; Cancer; Genetics; Gene; Immunology","score_opus":0.1611342047733008,"score_gpt":0.47134396792011934,"score_spread":0.3102097631468186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043953022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992751,0.0014789765,0.0000064345013,0.0025603278,0.0001468909,0.0020770798,0.00090185093,0.00000808711,0.00006937276],"genre_scores_gemma":[0.98324233,0.015426156,0.000102884194,0.00004146861,0.00020086083,0.00055835914,0.00025597546,0.000024315934,0.00014765738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847895,0.00007161757,0.0005830566,0.00042172553,0.00020691914,0.00023772546],"domain_scores_gemma":[0.9979621,0.00047840708,0.00018390201,0.0004686204,0.0006318464,0.00027509613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030941048,0.00012251914,0.00045487133,0.000100897916,0.00004849652,0.000009915691,0.00007671964,0.0000701681,0.0001530082],"category_scores_gemma":[0.00010226595,0.00009487881,0.00017077022,0.0001877818,0.00016481814,0.000036278125,0.000032091964,0.00008258393,0.000011982344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027616075,0.0024859828,0.8575228,0.0006564473,0.00011633502,0.000002518207,0.00008580467,0.0000014637018,0.04319298,0.00019589139,0.00012997379,0.09284821],"study_design_scores_gemma":[0.0034528053,0.0025574383,0.9863905,0.00022818966,0.00014852798,3.9923782e-7,0.000019903424,0.000036006542,0.005170135,0.00008804548,0.0018327059,0.00007535135],"about_ca_topic_score_codex":0.00011351782,"about_ca_topic_score_gemma":0.000017626537,"teacher_disagreement_score":0.12886772,"about_ca_system_score_codex":0.00019036683,"about_ca_system_score_gemma":0.0006195239,"threshold_uncertainty_score":0.38690457},"labels":[],"label_agreement":null},{"id":"W3045112382","doi":"10.1158/1557-3265.ovca19-ia05","title":"Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Oncology; Internal medicine; Disease; Serous fluid; Serous carcinoma; Stage (stratigraphy); Cancer; Biology","score_opus":0.25871876786432835,"score_gpt":0.5325381897356704,"score_spread":0.273819421871342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045112382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93968946,0.0018012049,0.000024115232,0.05738089,0.00011554523,0.0005247094,0.00023168729,0.00002017039,0.00021222194],"genre_scores_gemma":[0.9951807,0.0021312062,0.00023895167,0.0015957649,0.0003383069,0.00035743613,0.00004469491,0.000031230993,0.000081703496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961259,0.0005944873,0.0009251903,0.0007402913,0.0011176538,0.00049647916],"domain_scores_gemma":[0.9971716,0.0012954561,0.00014099803,0.00047733547,0.000387486,0.00052713836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023323225,0.00017587378,0.0009166015,0.00045635825,0.00005180292,0.00002350052,0.00023739254,0.00021373865,0.0044945623],"category_scores_gemma":[0.00087105174,0.00015144733,0.0004168305,0.0026925898,0.0003195485,0.000056722627,0.000118297656,0.0008934033,0.00004223221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021260403,0.0022114168,0.9334934,0.00022771733,0.004337785,0.0011262638,0.0004910185,0.0030673384,0.006417381,0.0005539684,0.0045186803,0.022294626],"study_design_scores_gemma":[0.004405544,0.00088682695,0.989123,0.0001629899,0.0005950709,6.6088404e-7,0.00006691123,0.00047066674,0.0014174844,0.00009596732,0.0026459892,0.00012891293],"about_ca_topic_score_codex":0.005763592,"about_ca_topic_score_gemma":0.0009307276,"teacher_disagreement_score":0.055785123,"about_ca_system_score_codex":0.00047974897,"about_ca_system_score_gemma":0.0014134508,"threshold_uncertainty_score":0.99641544},"labels":[],"label_agreement":null},{"id":"W3045600614","doi":"10.1158/1078-0432.ccr-19-2303","title":"Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Stand Up To Cancer; National Institutes of Health; U.S. National Library of Medicine; U.S. Department of Defense","keywords":"Enzalutamide; Prostate cancer; Biology; Cancer research; Transcriptome; Cancer; Internal medicine; Androgen receptor; Gene; Medicine; Genetics; Gene expression","score_opus":0.2182588947202795,"score_gpt":0.504447810987608,"score_spread":0.28618891626732856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045600614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631809,0.004407936,0.0000017114984,0.029323611,0.000037591217,0.001996627,0.00043897872,0.000028808896,0.00058384385],"genre_scores_gemma":[0.9890906,0.006970894,0.0002349088,0.0005156694,0.000103922,0.00085846486,0.000039320294,0.000053697368,0.0021324884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547076,0.0005943317,0.00090551254,0.00081210694,0.0014263977,0.0007908852],"domain_scores_gemma":[0.996883,0.0010447548,0.00020656222,0.0002397574,0.0010568606,0.0005690766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019375338,0.00024528799,0.00087749143,0.00013578054,0.00013338921,0.000056144632,0.00019801756,0.00013812046,0.0006157205],"category_scores_gemma":[0.0010395444,0.00017662827,0.00010631765,0.0015426425,0.0012078304,0.00015322624,0.00012229063,0.0010956393,0.000013993861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016864298,0.0005852094,0.96989995,0.0009500684,0.0005569236,0.00070273015,0.0014893155,0.000005809427,0.0016652432,0.00006452374,0.004910037,0.0023058823],"study_design_scores_gemma":[0.03989555,0.0056746555,0.876625,0.006333154,0.00062137225,0.000015159632,0.0022585606,0.00043475645,0.058793843,0.00070391,0.007748894,0.00089512585],"about_ca_topic_score_codex":0.0013301348,"about_ca_topic_score_gemma":0.0036307182,"teacher_disagreement_score":0.09327494,"about_ca_system_score_codex":0.00038689116,"about_ca_system_score_gemma":0.0022617914,"threshold_uncertainty_score":0.7202692},"labels":[],"label_agreement":null},{"id":"W3046405914","doi":"10.1158/1078-0432.ccr-20-1268","title":"Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control; Calgary Laboratory Services; BC Cancer Agency; McMaster University; University of British Columbia","funders":"BC Cancer Foundation; Terry Fox Research Institute; Barts Charity","keywords":"Endometrial cancer; Oncology; Internal medicine; Carcinoma; Ovarian cancer; Microsatellite instability; Subtyping; Medicine; Stage (stratigraphy); Cohort; Multivariate analysis; Cancer; Biology; Gene","score_opus":0.3531191638856132,"score_gpt":0.5288495869320633,"score_spread":0.1757304230464501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046405914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93530595,0.015541614,0.0024744505,0.033734057,0.0012452111,0.00821878,0.001491435,0.00016922159,0.0018192999],"genre_scores_gemma":[0.98644686,0.0031669238,0.00111831,0.0025004903,0.003530329,0.0026842132,0.00008806022,0.00008409389,0.00038072278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99410564,0.0007121196,0.0012597009,0.0012856884,0.0016556478,0.0009811915],"domain_scores_gemma":[0.9910546,0.0054506515,0.00029541785,0.00059433444,0.0013569637,0.0012480342],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002752232,0.00032575964,0.0010137393,0.00047083717,0.00028597625,0.000118039396,0.0004728199,0.0003569062,0.0021941105],"category_scores_gemma":[0.020038864,0.0002658057,0.0006408014,0.0037989996,0.00035247675,0.000117379735,0.00017001634,0.0013305749,0.00013249884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031714864,0.0016536714,0.51070505,0.0009593001,0.0016773946,0.00016128186,0.00052038004,0.000030222858,0.0072950795,0.0010624608,0.012198117,0.43202215],"study_design_scores_gemma":[0.18292432,0.045936238,0.45192978,0.00075305416,0.0044912784,0.000015763995,0.00068462297,0.004609214,0.09579097,0.0064723985,0.20416927,0.0022230945],"about_ca_topic_score_codex":0.0017263618,"about_ca_topic_score_gemma":0.000071327144,"teacher_disagreement_score":0.42979905,"about_ca_system_score_codex":0.00042180903,"about_ca_system_score_gemma":0.0017877275,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W3046570011","doi":"10.1158/1078-0432.ccr-20-0389","title":"Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research; Susan G. Komen; Cancer Research Society; U.S. Department of Defense","keywords":"Medicine; Breast cancer; Stimulation; Cancer research; Cancer; Oncogene; Breast tumor; Immunology; Oncology; Internal medicine; Cell cycle","score_opus":0.15730860877575703,"score_gpt":0.45464304760665103,"score_spread":0.297334438830894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046570011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795565,0.0048333975,0.000026990345,0.013342162,0.00027462747,0.001185928,0.00019997779,0.00006377787,0.00051664957],"genre_scores_gemma":[0.98654914,0.009812649,0.00030465215,0.0018295373,0.00083418225,0.0000886463,0.00003113215,0.000059512015,0.00049052056],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99588037,0.0006192822,0.0012041498,0.0007624657,0.0008807926,0.0006529327],"domain_scores_gemma":[0.9962041,0.0016375581,0.00028829565,0.00046865674,0.0010286488,0.00037274693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002376689,0.0002582979,0.0008597502,0.00014603754,0.00024187166,0.000086958054,0.00026048016,0.00017064896,0.0010925141],"category_scores_gemma":[0.00075512374,0.0002181831,0.00019918822,0.0012613327,0.00050116953,0.0002595678,0.00016789784,0.0008335652,0.000008235044],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11730168,0.000727006,0.28169578,0.0013455603,0.00049055275,0.00025914717,0.0014197914,0.00015512898,0.5333665,0.00007205671,0.032991756,0.030175025],"study_design_scores_gemma":[0.05577928,0.008884287,0.55482197,0.0026753377,0.0002815752,0.000047984347,0.006763488,0.0052606314,0.28686735,0.00021208252,0.07710496,0.0013010808],"about_ca_topic_score_codex":0.0014531456,"about_ca_topic_score_gemma":0.00014070439,"teacher_disagreement_score":0.27312616,"about_ca_system_score_codex":0.00026940386,"about_ca_system_score_gemma":0.001399039,"threshold_uncertainty_score":0.99982065},"labels":[],"label_agreement":null},{"id":"W3048696534","doi":"10.1158/1557-3265.advprecmed20-ia23","title":"Abstract IA23: ctDNA as predictive biomarkers for response and toxicity with immunotherapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Immunotherapy; Biomarker; Cancer; Circulating tumor DNA; Confidence interval; Clinical endpoint; Antibody; Phases of clinical research; Toxicity; Clinical trial; Immunology; Biology","score_opus":0.10845599450065652,"score_gpt":0.4648178219648009,"score_spread":0.3563618274641444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048696534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958623,0.0027111925,0.00034590907,0.00607594,0.00007962429,0.00061391096,0.00022830111,0.000008698272,0.00035016134],"genre_scores_gemma":[0.9924831,0.00473724,0.0002856625,0.0015792032,0.00056866533,0.00018233847,0.000025679674,0.000032949287,0.000105187486],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985364,0.00015148097,0.0002581772,0.0005267846,0.00020485999,0.00032230673],"domain_scores_gemma":[0.9983897,0.000758085,0.000059609276,0.00025303653,0.00026407294,0.0002754593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013824082,0.000117539705,0.00018506643,0.000027761404,0.0001300416,0.000051416526,0.00020867043,0.00016638801,0.000050892206],"category_scores_gemma":[0.0015718435,0.00009953107,0.00008201583,0.00011690853,0.00045685135,0.0000037947245,0.00012602509,0.00023954808,0.0000052961796],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19525222,0.0003247372,0.022482736,0.00011452405,0.0007252456,0.00002505563,0.000271798,0.00008003457,0.6972026,0.000089367575,0.038780656,0.04465101],"study_design_scores_gemma":[0.01089644,0.027399497,0.18318062,0.0001067791,0.000049580347,0.000008043206,0.0005760363,0.00040142454,0.2899763,0.0006420153,0.4860644,0.00069888576],"about_ca_topic_score_codex":0.00011590491,"about_ca_topic_score_gemma":0.000074104304,"teacher_disagreement_score":0.44728374,"about_ca_system_score_codex":0.000032601318,"about_ca_system_score_gemma":0.00068852183,"threshold_uncertainty_score":0.40587592},"labels":[],"label_agreement":null},{"id":"W3048778838","doi":"10.1158/1557-3265.bladder19-b07","title":"Abstract B07: A long noncoding RNA-based genomic classifier identifies a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Genome British Columbia","funders":"","keywords":"Bladder cancer; Cystectomy; Subtyping; Long non-coding RNA; Biology; Gene expression profiling; Transcriptome; Oncology; Bioinformatics; Cancer research; Cancer; Gene expression; Medicine; Internal medicine; RNA; Gene; Genetics","score_opus":0.11645136599012818,"score_gpt":0.41645603578359797,"score_spread":0.3000046697934698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048778838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488693,0.001350975,0.00049587444,0.0012255985,0.00022408049,0.0012590628,0.00027772546,0.000019804596,0.00025992698],"genre_scores_gemma":[0.9966083,0.001191459,0.00015148964,0.00040292306,0.0006634849,0.00055141473,0.00015191492,0.00010005542,0.00017892348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953346,0.00044351333,0.00079113134,0.0011610239,0.0013259238,0.0009437546],"domain_scores_gemma":[0.99683005,0.00026741764,0.00027841324,0.000563185,0.0015157626,0.00054515305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012748598,0.00030400974,0.0005102767,0.00016088127,0.00021653023,0.00010716423,0.0007658052,0.0004163919,0.00057523],"category_scores_gemma":[0.0009305433,0.00027282743,0.00028466995,0.00067833037,0.0007742719,0.000019940528,0.0004320773,0.0011292194,0.000030860567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057508755,0.0010368126,0.08907377,0.0009881048,0.0010219557,0.000097544216,0.00023823646,0.0020277882,0.87183213,0.000009604258,0.01403421,0.0138889905],"study_design_scores_gemma":[0.0068509686,0.0038028026,0.22195773,0.0006591697,0.00015580132,9.681786e-7,0.00029702694,0.0004934493,0.7581648,0.000022019276,0.00681052,0.0007847081],"about_ca_topic_score_codex":0.0007642522,"about_ca_topic_score_gemma":0.001791476,"teacher_disagreement_score":0.13288397,"about_ca_system_score_codex":0.00017943559,"about_ca_system_score_gemma":0.0028275712,"threshold_uncertainty_score":0.9999724},"labels":[],"label_agreement":null},{"id":"W3048885656","doi":"10.1158/1557-3265.advprecmed20-33","title":"Abstract 33: Drug sensitivity prediction modeling from genomics, transcriptomics and inferred protein activity","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genomics; Proteomics; Computational biology; Copy-number variation; Precision medicine; Systems biology; Computer science; Drug response; DNA microarray; Personalized medicine; Bioinformatics; Biology; Genome; Drug; Gene; Genetics; Gene expression","score_opus":0.3413089172699922,"score_gpt":0.48297643960563164,"score_spread":0.14166752233563945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048885656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6878501,0.00013140666,0.30396855,0.007190615,0.00019297781,0.00039321027,0.00011472501,0.000083416584,0.0000749709],"genre_scores_gemma":[0.9845784,0.0001670884,0.014286758,0.0002845703,0.00060007116,0.00004550596,0.000007912911,0.000018705443,0.000011015945],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99607307,0.0013680399,0.00048853934,0.00095208845,0.00072277867,0.00039549675],"domain_scores_gemma":[0.9970081,0.0018295483,0.0000818973,0.0003888418,0.00028349063,0.00040815177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044883415,0.00015837916,0.0003351307,0.000074621224,0.00021250214,0.000291026,0.00047122638,0.00012859523,0.000017039376],"category_scores_gemma":[0.0010013278,0.00016315699,0.00011136918,0.00038823273,0.00020912864,0.0007398908,0.0005229065,0.0012926916,0.000017532238],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019084493,0.0006611546,0.0076064514,0.00025214528,0.0002731105,0.00012777813,0.0050549884,0.23139246,0.08803266,0.0035486608,0.0013250278,0.6598171],"study_design_scores_gemma":[0.0005823459,0.00005963576,0.025236377,0.000038828537,0.0000051928328,6.774067e-7,0.000029275769,0.9633165,0.002203696,0.007822675,0.0005557213,0.00014910346],"about_ca_topic_score_codex":0.001650968,"about_ca_topic_score_gemma":0.00019989346,"teacher_disagreement_score":0.731924,"about_ca_system_score_codex":0.00016929749,"about_ca_system_score_gemma":0.0007717795,"threshold_uncertainty_score":0.66533494},"labels":[],"label_agreement":null},{"id":"W3048908406","doi":"10.1158/1557-3265.bladder19-pr08","title":"Abstract PR08: The genomic landscape of metastatic urothelial carcinoma from circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PTEN; ARID1A; Somatic cell; Cancer research; Bladder cancer; Cancer; Medicine; DNA sequencing; Circulating tumor cell; Oncology; Germline mutation; Gene; Mutation; Biology; Internal medicine; Metastasis; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.288795444234291,"score_gpt":0.4772809954703104,"score_spread":0.1884855512360194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048908406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867163,0.0024407434,0.000011644762,0.006312259,0.00018706566,0.0009130395,0.00024996878,0.000027977867,0.0031410446],"genre_scores_gemma":[0.99649835,0.00017159496,0.00012511972,0.0014945276,0.0014409847,0.000116144576,0.000021717839,0.000046642595,0.000084927306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997129,0.00032738736,0.00075116917,0.0005106328,0.00084223587,0.00043956027],"domain_scores_gemma":[0.9974715,0.0012685756,0.00014845363,0.00048335653,0.00025391186,0.00037419522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010860732,0.00016719972,0.0005964505,0.00005089396,0.00013321909,0.00003237367,0.00034764886,0.000068590314,0.0021452454],"category_scores_gemma":[0.0008233407,0.00010708946,0.00027195376,0.0003433794,0.0003718415,0.000048865022,0.00015122074,0.0008930357,0.00015855813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063115275,0.00076097046,0.8925493,0.0005845366,0.0012754651,0.00059809664,0.0026994331,0.00004588028,0.036747072,0.0001003334,0.009924065,0.048403367],"study_design_scores_gemma":[0.0060942546,0.0011400318,0.97990984,0.00014781675,0.0003048665,0.000007789841,0.0006663923,0.0006852319,0.0060272506,0.00037829706,0.004468395,0.00016984437],"about_ca_topic_score_codex":0.0025718394,"about_ca_topic_score_gemma":0.00008966671,"teacher_disagreement_score":0.087360576,"about_ca_system_score_codex":0.00008129502,"about_ca_system_score_gemma":0.0012908332,"threshold_uncertainty_score":0.9987669},"labels":[],"label_agreement":null},{"id":"W3049131576","doi":"10.1158/1078-0432.ccr-20-1412","title":"Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Romidepsin; Medicine; Pharmacokinetics; Cancer; Internal medicine; Cohort; Organ dysfunction; Adverse effect; Dosing; Malignancy; Oncology","score_opus":0.13290511353278187,"score_gpt":0.4682802849682226,"score_spread":0.3353751714354407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049131576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667096,0.0009694121,0.00001185762,0.00039069215,0.00021666287,0.0016601426,0.000038759656,0.000008134151,0.00003338984],"genre_scores_gemma":[0.99806297,0.00059212465,0.000014831924,0.0001117675,0.0005120872,0.0005811419,0.000030317127,0.000033028293,0.00006171892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673545,0.00055698125,0.0005614943,0.00080358225,0.0009978078,0.0003446807],"domain_scores_gemma":[0.99873596,0.0001123271,0.000117240925,0.00019497598,0.00058429665,0.00025520043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012235432,0.00017898074,0.0003441318,0.00015637671,0.00015643817,0.000039746432,0.00017998052,0.00010914867,0.00008167715],"category_scores_gemma":[0.00043382507,0.00015599726,0.000029068415,0.0007114465,0.0003995015,0.00002278437,0.00029773824,0.0006341053,0.0000014971671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066645415,0.00430389,0.9530496,0.000093034614,0.0002190203,0.000013272656,0.00067131576,0.00018444993,0.0068453774,0.0000012508256,0.00077396986,0.027180264],"study_design_scores_gemma":[0.07069437,0.028387913,0.8877824,0.0002811678,0.00013682782,0.0000012561343,0.001401495,0.0013071087,0.0036215088,0.000007891697,0.005812569,0.00056547805],"about_ca_topic_score_codex":0.0023340422,"about_ca_topic_score_gemma":0.009048203,"teacher_disagreement_score":0.0652672,"about_ca_system_score_codex":0.00014755268,"about_ca_system_score_gemma":0.0004715429,"threshold_uncertainty_score":0.6361384},"labels":[],"label_agreement":null},{"id":"W3049165631","doi":"10.1158/1557-3265.bladder19-b23","title":"Abstract B23: <i>FGFR3</i> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Fibroblast growth factor receptor 3; Cystectomy; Immunohistochemistry; Bladder cancer; Medicine; Cancer research; Internal medicine; Oncology; Pathology; Cancer; Gastroenterology; Fibroblast growth factor; Receptor","score_opus":0.26661711812524264,"score_gpt":0.5438236918028955,"score_spread":0.27720657367765283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049165631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95916706,0.0022988894,0.00031454442,0.032836586,0.000186322,0.0039474946,0.00086770643,0.00006882739,0.00031254673],"genre_scores_gemma":[0.9897894,0.004104413,0.00045163598,0.002184303,0.0008342547,0.0022146206,0.00011711018,0.000066344386,0.00023791307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961768,0.0003436658,0.0012887111,0.001135676,0.0003608493,0.00069432385],"domain_scores_gemma":[0.99588263,0.0021660822,0.00014902094,0.00044584525,0.0003149535,0.001041451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014721953,0.00030675254,0.00092051027,0.00017493838,0.00032601395,0.00007064746,0.00017167094,0.0003798132,0.0002519938],"category_scores_gemma":[0.0012318569,0.00022520797,0.00024550108,0.0005471504,0.00039931966,0.0001625286,0.00015247447,0.0008397371,0.000024332832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014271004,0.00074218266,0.9631812,0.000106496576,0.00024367751,0.00001273044,0.0005473879,0.0000071500153,0.0013788604,0.000050607014,0.0023631684,0.029939435],"study_design_scores_gemma":[0.010966717,0.0015849071,0.9660955,0.00017923137,0.00017429002,0.000004955638,0.00018687278,0.0002775745,0.00028083837,0.00019226257,0.019845348,0.0002114828],"about_ca_topic_score_codex":0.0007544842,"about_ca_topic_score_gemma":0.00074579834,"teacher_disagreement_score":0.030652285,"about_ca_system_score_codex":0.0002805471,"about_ca_system_score_gemma":0.00076711,"threshold_uncertainty_score":0.91837144},"labels":[],"label_agreement":null},{"id":"W3049182325","doi":"10.1158/1078-0432.ccr-20-2429","title":"Moving Beyond BRCA—Incorporating Molecular Assays into Ovarian Cancer Trials","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Ovarian cancer; Oncology; Medicine; Prospective cohort study; Clinical trial; Internal medicine; Cancer; Serous fluid; Gynecology; Bioinformatics; Biology","score_opus":0.2014871628831764,"score_gpt":0.5089592626528809,"score_spread":0.3074720997697046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049182325","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037872028,0.013126165,0.00088074466,0.94140476,0.0013978294,0.0020911202,0.00038615262,0.00006625586,0.0027749715],"genre_scores_gemma":[0.05158969,0.0131292315,0.0036106964,0.83171093,0.07455634,0.0029747507,0.0024043964,0.0007566871,0.019267296],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98618317,0.0058302428,0.0019868312,0.0021566956,0.0021888083,0.0016542766],"domain_scores_gemma":[0.99425095,0.0014986142,0.00061106496,0.0018104204,0.0011255814,0.00070337835],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.011727509,0.0005989651,0.001613168,0.00027276744,0.00051632297,0.0003961033,0.0024436591,0.0020685506,0.00052748836],"category_scores_gemma":[0.018772272,0.00053891283,0.00093434565,0.00070146605,0.0008852165,0.000013798026,0.0022260034,0.007912785,0.00011022252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037161677,0.000038595143,0.00091782515,0.00034522527,0.0005322676,0.00082576857,0.000019135048,0.000025514059,0.16683415,0.000032008553,0.810806,0.01925194],"study_design_scores_gemma":[0.0019462,0.0009784149,0.00009358694,0.00040355936,0.00010942806,0.0000064948676,0.000051333212,0.00037392369,0.028719168,0.0027964746,0.9636246,0.0008968314],"about_ca_topic_score_codex":0.0027579141,"about_ca_topic_score_gemma":0.00049472874,"teacher_disagreement_score":0.15281864,"about_ca_system_score_codex":0.0002812476,"about_ca_system_score_gemma":0.0040044915,"threshold_uncertainty_score":0.99970627},"labels":[],"label_agreement":null},{"id":"W3049239269","doi":"10.1158/1078-0432.ccr-20-1439","title":"A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Queen's University; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; McGill University; McGill Genome Centre; Ontario Institute for Cancer Research; McGill University and Génome Québec Innovation Centre; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Cancer Research Society; McGill University Health Centre; Terry Fox Research Institute; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Transcriptome; Pancreatic cancer; Homologous recombination; PARP inhibitor; Cancer research; Biology; Genome instability; Cancer; Medicine; Oncology; Internal medicine; Gene; Genetics; Poly ADP ribose polymerase; DNA damage; Gene expression; DNA","score_opus":0.2549166930190127,"score_gpt":0.5434493464092846,"score_spread":0.28853265339027184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049239269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97476673,0.0052939965,0.00010239787,0.014151272,0.000693297,0.0041310554,0.00012359777,0.00008180795,0.00065585953],"genre_scores_gemma":[0.9870759,0.007469226,0.00012773677,0.0020975827,0.0004354601,0.0026154867,0.000042338943,0.000052073137,0.0000841927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99356407,0.0016831832,0.0015443836,0.0012036529,0.0013234087,0.00068130373],"domain_scores_gemma":[0.9961338,0.0016944031,0.0002391699,0.00043284657,0.00079823774,0.0007015529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035140389,0.0002462684,0.0008613643,0.00027664282,0.00014127539,0.000072279174,0.00023243937,0.00036745914,0.000634583],"category_scores_gemma":[0.0038630434,0.00022334566,0.00020750544,0.001333448,0.0010168757,0.00012572386,0.0002105218,0.0016561048,0.00003479377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20939255,0.0025456839,0.7046978,0.0003679617,0.0015125567,0.0005703047,0.0017567589,0.00008779618,0.0017713307,0.00006794794,0.0196827,0.05754662],"study_design_scores_gemma":[0.15510017,0.02108954,0.8026633,0.0014910277,0.0003961218,0.000021070695,0.00073445815,0.0073444294,0.0023374807,0.00095818087,0.007202698,0.00066147],"about_ca_topic_score_codex":0.0010363731,"about_ca_topic_score_gemma":0.000101970865,"teacher_disagreement_score":0.09796557,"about_ca_system_score_codex":0.0006403758,"about_ca_system_score_gemma":0.0013583673,"threshold_uncertainty_score":0.91077715},"labels":[],"label_agreement":null},{"id":"W3049299021","doi":"10.1158/1557-3265.bladder19-b10","title":"Abstract B10: A simple immunohistochemical algorithm to evaluate molecular subtypes and clinical associations in non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Immunohistochemistry; Subtyping; Tissue microarray; Antibody; Algorithm; Stage (stratigraphy); Transcriptome; Cancer; Oncology; Pathology; Medicine; Internal medicine; Biology; Immunology; Gene expression; Gene; Computer science","score_opus":0.17980585000074653,"score_gpt":0.5288131608495097,"score_spread":0.34900731084876313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049299021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97777516,0.0023904517,0.000048072747,0.016442934,0.00022544811,0.0016232649,0.0002470121,0.000042941752,0.0012047035],"genre_scores_gemma":[0.9887866,0.0030596275,0.00058618793,0.0058227386,0.0009057824,0.0005572322,0.000049131544,0.00006536654,0.00016738128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573475,0.00039586428,0.0011189617,0.0010029098,0.0009986399,0.0007488776],"domain_scores_gemma":[0.9964487,0.0013792736,0.00012003577,0.0004200297,0.0006142642,0.0010176932],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021567214,0.00024939564,0.00084883923,0.00013178361,0.00013090984,0.000056076202,0.00028001168,0.00035938993,0.00097381603],"category_scores_gemma":[0.0032358,0.00022364795,0.00026782838,0.00077857514,0.00037843693,0.00009107055,0.00030244933,0.0016737666,0.0001662153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002975848,0.001994,0.5519196,0.00022313968,0.0014097576,0.0006488674,0.0014977263,0.00003964081,0.016859576,0.000025120395,0.038555086,0.38385168],"study_design_scores_gemma":[0.007174951,0.0016916101,0.9819791,0.00021411454,0.00021714918,0.000001880901,0.00018613164,0.00055637764,0.0021992817,0.00030065427,0.005165982,0.00031277153],"about_ca_topic_score_codex":0.0041855774,"about_ca_topic_score_gemma":0.0007341798,"teacher_disagreement_score":0.43005952,"about_ca_system_score_codex":0.0004974025,"about_ca_system_score_gemma":0.0018973794,"threshold_uncertainty_score":0.99993944},"labels":[],"label_agreement":null},{"id":"W3049302966","doi":"10.1158/1557-3265.bladder19-ia10","title":"Abstract IA10: Developing rational combination therapy with checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Dasatinib; Cabozantinib; Medicine; Immunotherapy; Cancer research; In vivo; Druggability; Combination therapy; Cancer; Cancer immunotherapy; Melanoma; Pharmacology; Internal medicine; Imatinib; Biology; Myeloid leukemia","score_opus":0.3418735799590187,"score_gpt":0.5133392790341231,"score_spread":0.17146569907510445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049302966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91357464,0.0012106835,0.000099497935,0.082679644,0.00018027634,0.0006921201,0.000006549689,0.00005364736,0.0015029206],"genre_scores_gemma":[0.9911356,0.002957846,0.000340579,0.004294934,0.0008901107,0.000109353125,0.000028678158,0.000028071163,0.00021484811],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977632,0.0001334803,0.0005348074,0.0003901215,0.00086896506,0.00030942148],"domain_scores_gemma":[0.9986297,0.00036577487,0.000091230715,0.00017578478,0.0005136456,0.00022389521],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017139452,0.00011870718,0.00026795012,0.000074062154,0.00015275394,0.000049369984,0.00013729144,0.00012607998,0.0009921599],"category_scores_gemma":[0.00028813293,0.000084517735,0.00012386376,0.00058659643,0.00038138972,0.0000995254,0.000038920836,0.00074736524,0.00005599969],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06620624,0.0012246604,0.2765354,0.00047972065,0.0010373505,0.00016469616,0.0013950914,0.000015111387,0.05256697,0.0012694778,0.055455714,0.5436496],"study_design_scores_gemma":[0.012043951,0.0027792898,0.8194012,0.00038484053,0.00001305701,0.0000068253926,0.00020683896,0.00012926766,0.026632374,0.00018738446,0.13796355,0.0002514236],"about_ca_topic_score_codex":0.00021050226,"about_ca_topic_score_gemma":0.00004394141,"teacher_disagreement_score":0.54339814,"about_ca_system_score_codex":0.00020972795,"about_ca_system_score_gemma":0.0014806687,"threshold_uncertainty_score":0.9999211},"labels":[],"label_agreement":null},{"id":"W3049491040","doi":"10.1158/1557-3265.bladder19-ia22","title":"Abstract IA22: Realizing the potential of targeted therapy in non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Targeted therapy; Disease; Cancer; Immune checkpoint; Clinical trial; Immunotherapy; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.23171613068035943,"score_gpt":0.4963890871256152,"score_spread":0.2646729564452558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049491040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96713,0.00565746,0.0000070533674,0.02319962,0.00024878583,0.0013193712,0.000095143325,0.000024128694,0.0023184184],"genre_scores_gemma":[0.9778442,0.017665947,0.000032230073,0.0028031345,0.0011267025,0.0003211226,0.000013274076,0.000045988363,0.00014740096],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969219,0.00029985784,0.00075287465,0.00054999656,0.00090978143,0.00056559895],"domain_scores_gemma":[0.9980217,0.0006372609,0.00013293998,0.00042673104,0.0004478831,0.0003334647],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012053512,0.00018542378,0.00055878435,0.0000950139,0.00011599023,0.000026703992,0.0003752103,0.00019550386,0.0023131093],"category_scores_gemma":[0.0005178829,0.000119930235,0.00024503423,0.00076627394,0.000510771,0.00008422305,0.00013170933,0.0012485288,0.000042631513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014322367,0.0020993946,0.38360712,0.0006271747,0.0016442055,0.0005980543,0.0048067304,0.0003520197,0.10233685,0.000067574394,0.055759992,0.43377852],"study_design_scores_gemma":[0.0067830333,0.0014579522,0.97438705,0.00028980974,0.000058562546,0.0000014744263,0.0009315152,0.00016174739,0.010676916,0.00016719225,0.0049216743,0.00016308062],"about_ca_topic_score_codex":0.010509162,"about_ca_topic_score_gemma":0.0012047807,"teacher_disagreement_score":0.59077996,"about_ca_system_score_codex":0.00014877402,"about_ca_system_score_gemma":0.0015848217,"threshold_uncertainty_score":0.99859893},"labels":[],"label_agreement":null},{"id":"W3049491391","doi":"10.1158/1557-3265.bladder19-ia21","title":"Abstract IA21: Intravesical gene therapy for NMIBC","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"College of Physicians and Surgeons of Ontario","funders":"","keywords":"Medicine; Oncolytic virus; Genetic enhancement; Oncology; Clinical trial; Bladder cancer; Refractory (planetary science); Internal medicine; Urothelium; Cystectomy; Gene; Cancer; Urinary system","score_opus":0.4833733599109263,"score_gpt":0.5783440767573926,"score_spread":0.09497071684646635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049491391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9149598,0.0050611864,0.0002484294,0.07064849,0.00051187706,0.0029475118,0.00019112266,0.00012708898,0.005304489],"genre_scores_gemma":[0.982612,0.004531991,0.00057327095,0.00692516,0.0041872603,0.00050564547,0.000031644347,0.000057033023,0.00057600375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975761,0.000110926194,0.0005046003,0.0005949861,0.0006418576,0.00057148834],"domain_scores_gemma":[0.9977714,0.00073943834,0.000047395417,0.00032392875,0.00037784854,0.0007400068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009505533,0.00015652158,0.0004739358,0.0000492144,0.00013345736,0.00003838518,0.00023050654,0.00019773598,0.0016893006],"category_scores_gemma":[0.00064709253,0.00011578818,0.000290353,0.00028765804,0.00031828327,0.000052758973,0.00006206598,0.0008203944,0.00021637541],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025133185,0.0017242229,0.05397095,0.00032750933,0.00082996127,0.00017355985,0.00054880464,0.0000037630623,0.0145251,0.0003581636,0.14957324,0.7528315],"study_design_scores_gemma":[0.024818424,0.011658243,0.397635,0.00014510329,0.00011592376,0.000009031064,0.00014834781,0.00027375808,0.039471183,0.0015161247,0.5237833,0.00042552472],"about_ca_topic_score_codex":0.00015373454,"about_ca_topic_score_gemma":0.000012263073,"teacher_disagreement_score":0.752406,"about_ca_system_score_codex":0.00010215337,"about_ca_system_score_gemma":0.0009400956,"threshold_uncertainty_score":0.9992233},"labels":[],"label_agreement":null},{"id":"W3049551640","doi":"10.1158/1557-3265.bladder19-a04","title":"Abstract A04: DNA damage repair gene mutations and associated tumor immune landscape as biomarkers of response to immunotherapy in muscle-invasive urothelial cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"TIGIT; Immune system; Immunotherapy; Biology; Immune checkpoint; Cancer research; Bladder cancer; Cancer; Transcriptome; Cancer immunotherapy; Tumor microenvironment; Biomarker; DNA repair; Immunology; Gene; Gene expression; Genetics","score_opus":0.11395063758917365,"score_gpt":0.4625871172768211,"score_spread":0.34863647968764744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049551640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827548,0.0025980293,0.0000013948778,0.012040931,0.00015344522,0.001428674,0.0004271798,0.000060324764,0.0005351885],"genre_scores_gemma":[0.99500203,0.0021049369,0.00011562354,0.0017760142,0.00023598014,0.00041901896,0.000027724733,0.00006424698,0.00025440022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963598,0.0007091123,0.0009547003,0.0006745394,0.000751061,0.0005507485],"domain_scores_gemma":[0.99669063,0.0017663072,0.00016138822,0.00041062012,0.00046398322,0.0005070666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024030444,0.0002248852,0.00072801544,0.00027449618,0.00011843279,0.00002877874,0.00022679083,0.00018036044,0.0012888566],"category_scores_gemma":[0.0031178247,0.00019772562,0.00024151607,0.0010868262,0.00037380695,0.000085975866,0.00012573651,0.00070732593,0.000044579447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07307072,0.0014482237,0.37145716,0.00031088118,0.0015725918,0.0007598743,0.0040837717,0.000042793934,0.5291729,0.000010331196,0.004084782,0.013986],"study_design_scores_gemma":[0.0095934095,0.002580937,0.9640806,0.00041402443,0.00007109963,0.0000024389615,0.0005846035,0.00006097349,0.020647995,0.00004711399,0.0017236012,0.00019323033],"about_ca_topic_score_codex":0.005922681,"about_ca_topic_score_gemma":0.0009801268,"teacher_disagreement_score":0.5926234,"about_ca_system_score_codex":0.0002862416,"about_ca_system_score_gemma":0.0023245623,"threshold_uncertainty_score":0.9996241},"labels":[],"label_agreement":null},{"id":"W3064306546","doi":"10.1158/1078-0432.ccr-20-2081","title":"Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Power Generation","funders":"Key Technology Research and Development Program of Shandong; Shandong Academy of Medical Sciences; Shandong First Medical University; AstraZeneca","keywords":"Osimertinib; T790M; Medicine; Internal medicine; Lung cancer; Oncology; Adverse effect; Cancer; Erlotinib; Epidermal growth factor receptor; Adenocarcinoma; ROS1","score_opus":0.07101337098720283,"score_gpt":0.45536085617458893,"score_spread":0.3843474851873861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3064306546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991721,0.0016063678,0.000008812111,0.0023699645,0.00010916213,0.0036415618,0.00031991847,0.00001709376,0.00020615477],"genre_scores_gemma":[0.99877495,0.00015846096,0.000054986212,0.00025704666,0.000113286434,0.00047711428,0.000021424354,0.000038105412,0.00010463058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963357,0.0011577602,0.0006691444,0.00058788445,0.0007369895,0.0005125119],"domain_scores_gemma":[0.99727356,0.0012805007,0.00018582176,0.00037490804,0.00046751922,0.00041765696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013210188,0.00019667168,0.0005720665,0.00012198434,0.00015388943,0.000033893426,0.00020170523,0.000086359294,0.000052307685],"category_scores_gemma":[0.00033131952,0.00011603452,0.00009282482,0.0007338417,0.000367177,0.000072113406,0.00013690487,0.00061794784,0.0000028156946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03268033,0.0016185527,0.9551606,0.00033438596,0.0009503577,0.00009546704,0.004278827,0.000027123426,0.00010369625,0.000002931348,0.0007999802,0.003947757],"study_design_scores_gemma":[0.013505136,0.0062889513,0.9726901,0.00045357202,0.00065767544,5.5249393e-7,0.005431059,0.00025605748,0.0002828713,4.920199e-7,0.00030969846,0.00012384767],"about_ca_topic_score_codex":0.0051858258,"about_ca_topic_score_gemma":0.00055357005,"teacher_disagreement_score":0.019175194,"about_ca_system_score_codex":0.00052699534,"about_ca_system_score_gemma":0.0014062969,"threshold_uncertainty_score":0.78394514},"labels":[],"label_agreement":null},{"id":"W3064741431","doi":"10.1158/1078-0432.ccr-20-0037","title":"Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; Canadian Association of Thoracic Surgeons; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; FUJIFILM Pharmaceuticals U.S.A.; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; National Cancer Institute; National Institutes of Health","keywords":"Radioimmunotherapy; Medicine; Pharmacokinetics; Response Evaluation Criteria in Solid Tumors; Antibody; Dosimetry; Monoclonal antibody; Cancer; Toxicity; Internal medicine; Cancer research; Pathology; Oncology; Nuclear medicine; Phases of clinical research; Immunology","score_opus":0.35263451389578604,"score_gpt":0.6222635232220715,"score_spread":0.2696290093262854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3064741431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924664,0.0007214852,0.000033793538,0.004984769,0.0000220914,0.0011660637,0.000023570272,0.000032462573,0.00054940017],"genre_scores_gemma":[0.9979709,0.0005646762,0.00012807675,0.00047802762,0.0004172485,0.00023632293,0.00002025378,0.000032521853,0.00015198508],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99725986,0.00024831996,0.00081367313,0.0005469228,0.0006980562,0.0004331688],"domain_scores_gemma":[0.9983093,0.00045853792,0.00009582376,0.0004081572,0.00026501284,0.0004631268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010600697,0.0001534513,0.00064655003,0.00006428514,0.00007490351,0.000014569043,0.00028948518,0.00010690738,0.00075237046],"category_scores_gemma":[0.00031247622,0.000120702694,0.000093121955,0.0010695376,0.00050057826,0.000049486633,0.000068609304,0.0014457011,0.00002095313],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03952724,0.030308735,0.34218895,0.0006354156,0.00072536746,0.00074782845,0.002637871,0.00021382757,0.5507039,0.00007547643,0.0025477891,0.029687587],"study_design_scores_gemma":[0.20003413,0.060965043,0.3540182,0.0011546486,0.00036748595,0.000056111767,0.007407143,0.018987287,0.31532076,0.00019465212,0.040146858,0.0013476936],"about_ca_topic_score_codex":0.00016159278,"about_ca_topic_score_gemma":0.000009517966,"teacher_disagreement_score":0.23538315,"about_ca_system_score_codex":0.00007572333,"about_ca_system_score_gemma":0.0005153444,"threshold_uncertainty_score":0.8237929},"labels":[],"label_agreement":null},{"id":"W3080756819","doi":"10.1158/1078-0432.ccr-20-1916","title":"Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; American Cancer Society; Canadian Institutes of Health Research; Comprehensive Cancer Center, City of Hope; Cancer Prevention and Research Institute of Texas; National Heart, Lung, and Blood Institute; U.S. Department of Defense","keywords":"Itraconazole; Medicine; Pharmacokinetics; Lung cancer; Internal medicine; Pharmacodynamics; Urology; Pharmacology","score_opus":0.06980497137660392,"score_gpt":0.42388596198538864,"score_spread":0.35408099060878473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080756819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828436,0.015716769,0.00011190919,0.000458468,0.00012825098,0.0005723329,0.000023246928,0.000004810183,0.00014060886],"genre_scores_gemma":[0.9916112,0.0075552277,0.000056648703,0.00022785147,0.0003391765,0.000109509165,0.0000054751226,0.000019567518,0.000075357086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814934,0.00030720505,0.00039856374,0.00050883053,0.000281933,0.0003541446],"domain_scores_gemma":[0.99911344,0.0002162946,0.00007219891,0.00019573384,0.0002268855,0.00017544176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008087316,0.00012139171,0.0003136379,0.000028885766,0.000060771123,0.000020241998,0.00021513276,0.00014849583,0.000015864951],"category_scores_gemma":[0.0005411383,0.00011332162,0.000083986604,0.00018103188,0.00029625045,0.0000046870487,0.0002468472,0.00038874813,0.0000031231455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017650191,0.000094890136,0.45913556,0.0005020242,0.000079991594,0.000030366307,0.00031806872,0.00005250826,0.53787977,0.0000059237877,0.00047354645,0.0012508156],"study_design_scores_gemma":[0.0024699918,0.0006152115,0.21131623,0.00017318076,0.000030151452,3.2338306e-7,0.00009461284,0.00038322422,0.7839181,0.000007936696,0.0008057363,0.00018529737],"about_ca_topic_score_codex":0.0005175466,"about_ca_topic_score_gemma":0.00017194948,"teacher_disagreement_score":0.24781935,"about_ca_system_score_codex":0.000021069854,"about_ca_system_score_gemma":0.00033575908,"threshold_uncertainty_score":0.46211216},"labels":[],"label_agreement":null},{"id":"W3081113288","doi":"10.1158/1078-0432.ccr-20-1064","title":"Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of <i>HOXA9</i> and <i>MEIS1</i> Expression","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Gilead Sciences","keywords":"Myeloid leukemia; Induction chemotherapy; Medicine; Chemotherapy; Leukemia; Oncology; Induction therapy; Cancer research; Internal medicine; Immunology","score_opus":0.07628086996969083,"score_gpt":0.41372091109930226,"score_spread":0.33744004112961146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081113288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144305,0.0007232545,0.00005516445,0.01526537,0.000024125318,0.0023109277,0.000034707737,0.000028137847,0.00011526808],"genre_scores_gemma":[0.990707,0.0076476783,0.00030160614,0.00056625245,0.00011339194,0.00036444096,0.0000242954,0.000047101163,0.00022824104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953619,0.0015039397,0.00077905797,0.00086069515,0.0009337056,0.00056068256],"domain_scores_gemma":[0.9971631,0.0014300197,0.00016232162,0.0003306423,0.00048169662,0.00043222043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004208655,0.00021221452,0.00071234687,0.00033538122,0.00006825365,0.000030045427,0.00019379087,0.00034953555,0.000048858445],"category_scores_gemma":[0.0015701844,0.0001697841,0.00004377219,0.001485321,0.0010743078,0.00020659599,0.00019179864,0.002003694,0.000002970295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21372725,0.0006765107,0.550188,0.0006540188,0.00015310671,0.0002644396,0.0049076686,0.000049200677,0.20073888,0.000024043156,0.0036699087,0.02494697],"study_design_scores_gemma":[0.035380665,0.012347477,0.8753924,0.0015103095,0.000054818374,0.000027143236,0.0012280168,0.0031391587,0.06796302,0.00011558097,0.0025371455,0.0003042876],"about_ca_topic_score_codex":0.00056685344,"about_ca_topic_score_gemma":0.00010448123,"teacher_disagreement_score":0.32520437,"about_ca_system_score_codex":0.00072943565,"about_ca_system_score_gemma":0.0016331727,"threshold_uncertainty_score":0.8705165},"labels":[],"label_agreement":null},{"id":"W3081537514","doi":"10.1158/1557-3265.ovca19-ia12","title":"Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Ovarian cancer; Medicine; Oncology; Serous ovarian cancer; Internal medicine; Survival analysis; Stage (stratigraphy); Cancer; Gene signature; Gene expression profiling; Cancer research; Gene; Pathology; Gene expression; Biology","score_opus":0.10911010935483385,"score_gpt":0.4338333837737218,"score_spread":0.324723274418888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081537514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9191825,0.013160037,0.0016217855,0.05194454,0.005392065,0.0044650557,0.003537475,0.00007657313,0.0006199868],"genre_scores_gemma":[0.9790742,0.0019425512,0.00044684217,0.001350721,0.015172344,0.0009479049,0.00028511835,0.00007136586,0.0007089637],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953244,0.00056622986,0.0012118116,0.0012314074,0.00078584295,0.0008803339],"domain_scores_gemma":[0.9966982,0.00048566944,0.00041252634,0.00081158325,0.0010715496,0.00052048103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024690737,0.00036061465,0.0009412254,0.00013233938,0.00033466835,0.00011855565,0.0010187256,0.0005573174,0.0006865116],"category_scores_gemma":[0.0011160941,0.00027791222,0.00058087346,0.0012078116,0.00075676694,0.000016213238,0.0002589748,0.0010989743,0.0000082245415],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006202705,0.0009994156,0.018637622,0.00070934003,0.005562079,0.000008184653,0.00067527423,0.0021415274,0.6254005,0.0022915239,0.29633525,0.041036602],"study_design_scores_gemma":[0.0066875117,0.001717954,0.24627495,0.00014082216,0.0017971663,0.000003666006,0.00077171106,0.00038744375,0.24538878,0.0006109675,0.49511808,0.0011009489],"about_ca_topic_score_codex":0.005617738,"about_ca_topic_score_gemma":0.0058804937,"teacher_disagreement_score":0.38001168,"about_ca_system_score_codex":0.000057074434,"about_ca_system_score_gemma":0.0017391639,"threshold_uncertainty_score":0.9999673},"labels":[],"label_agreement":null},{"id":"W3081572286","doi":"10.1158/1557-3265.ovca19-b25","title":"Abstract B25: SMARCA4/BRG1 and AP-1 co-regulate an epithelial-like signature in small-cell carcinoma of ovary, hypercalcemic type (SCCOHT)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Biology; Carcinogenesis; Transcription factor; Chromatin immunoprecipitation; Gene; Cancer research; Chromatin remodeling; Molecular biology; Gene expression; Cell biology; Genetics; Promoter","score_opus":0.14489329157898453,"score_gpt":0.4363896479653528,"score_spread":0.2914963563863683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081572286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276733,0.0056584226,0.000011566352,0.000525267,0.00013065632,0.00028419436,0.0000750743,0.000009823441,0.0005376874],"genre_scores_gemma":[0.9959397,0.0025203617,0.00016288829,0.0005007064,0.00055392034,0.000020485015,0.00007505732,0.000040051564,0.00018686084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977646,0.0002777034,0.00055239606,0.0006983621,0.00028311365,0.00042386207],"domain_scores_gemma":[0.9987552,0.00012844942,0.000094545954,0.00043114254,0.0002707852,0.00031984205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011751185,0.00017521005,0.00035064825,0.00005656004,0.000061829865,0.000025039646,0.00039386985,0.00042468068,0.0001230388],"category_scores_gemma":[0.00024374209,0.00015864597,0.00010429157,0.00024678145,0.00036191297,0.000006682507,0.00020865058,0.00079296477,0.000012012471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021873948,0.00026473354,0.042646416,0.00031858397,0.000043647575,0.000026192438,0.00021640121,0.00030457135,0.93358153,0.0000079139245,0.0036293378,0.016773308],"study_design_scores_gemma":[0.010466349,0.006778073,0.35582566,0.0003084305,0.0000821697,0.000014212973,0.0006545213,0.0061444347,0.58597744,0.00048596857,0.031935323,0.0013273971],"about_ca_topic_score_codex":0.0007479701,"about_ca_topic_score_gemma":0.0003545283,"teacher_disagreement_score":0.34760404,"about_ca_system_score_codex":0.000032186894,"about_ca_system_score_gemma":0.0005610968,"threshold_uncertainty_score":0.64693946},"labels":[],"label_agreement":null},{"id":"W3081580576","doi":"10.1158/1557-3265.ovca19-b15","title":"Abstract B15: BRCA haploinsufficiency promotes gluconeogenesis in fallopian tube epithelial cells","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cancer research; Ovarian cancer; Cancer; Genetics","score_opus":0.27079254864067154,"score_gpt":0.48897631166554273,"score_spread":0.2181837630248712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081580576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534131,0.0019169066,0.000006109102,0.03942097,0.00031579734,0.0012659562,0.00009106971,0.00005932834,0.0035107257],"genre_scores_gemma":[0.99288726,0.0036057758,0.00017577891,0.0015940196,0.0011625375,0.00027670985,0.000012165856,0.000047843063,0.00023794005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962934,0.00024746056,0.0008652663,0.0009155288,0.0009171335,0.000761159],"domain_scores_gemma":[0.99759215,0.00085838855,0.00008287003,0.00045201243,0.00026866252,0.00074593123],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016099449,0.00021506802,0.00066202215,0.00014118147,0.000109686545,0.00005858369,0.00030908603,0.00022748458,0.0021543095],"category_scores_gemma":[0.00078303175,0.00017267736,0.0002550141,0.0007959834,0.00035905011,0.00007614446,0.00015805222,0.0010347734,0.0005321616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004597529,0.0077800537,0.6116831,0.0010520766,0.00047237458,0.0025778413,0.0015857812,0.00012163178,0.018671488,0.0004461772,0.014874063,0.33613792],"study_design_scores_gemma":[0.009269932,0.0038486063,0.87707484,0.00046834245,0.00009309068,0.0000054457255,0.00022321944,0.0004674647,0.035843078,0.00016114209,0.07215856,0.00038625786],"about_ca_topic_score_codex":0.001538088,"about_ca_topic_score_gemma":0.00045561194,"teacher_disagreement_score":0.33575168,"about_ca_system_score_codex":0.0003009293,"about_ca_system_score_gemma":0.0013054723,"threshold_uncertainty_score":0.99875784},"labels":[],"label_agreement":null},{"id":"W3081585330","doi":"10.1158/1078-0432.ccr-20-1037","title":"Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i> -Mutant Metastatic Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; CNIB","keywords":"Cancer research; Medicine; Lung cancer; Targeted therapy; Cancer; Mutant; Mutation; MAPK/ERK pathway; Oncology; MEK inhibitor; Internal medicine; Kinase; Biology; Gene; Genetics","score_opus":0.03991987997554902,"score_gpt":0.3516546455948795,"score_spread":0.3117347656193305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081585330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937472,0.0016368227,0.001872056,0.0009752458,0.00016953146,0.0011070713,0.00041476544,0.000006744377,0.00007056459],"genre_scores_gemma":[0.9950291,0.00048671453,0.0023682108,0.001444555,0.00030933914,0.00018096015,0.000056443783,0.00006851731,0.000056147503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971104,0.00025187602,0.000773027,0.0007895837,0.0004671702,0.0006079297],"domain_scores_gemma":[0.9983621,0.00013815897,0.00022606575,0.00042373763,0.00051037077,0.00033956725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008616428,0.00022975558,0.00049009983,0.00007877464,0.00009921795,0.000045732417,0.0004913203,0.00011423967,0.00004337443],"category_scores_gemma":[0.00036221428,0.00021185038,0.00013215719,0.0004409696,0.00015700859,0.0000071683526,0.00035506627,0.00043010956,0.0000030868728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006617562,0.0006894159,0.090842105,0.00076298456,0.00038478218,0.00010098029,0.0009564432,0.006588488,0.8862636,0.00007441711,0.003861516,0.0028576844],"study_design_scores_gemma":[0.022070566,0.0075121135,0.18738735,0.0008713757,0.00035413596,0.000002634139,0.0012271872,0.0027351044,0.76762456,0.00078338885,0.0072965827,0.0021349904],"about_ca_topic_score_codex":0.00037514008,"about_ca_topic_score_gemma":0.0013181516,"teacher_disagreement_score":0.118639044,"about_ca_system_score_codex":0.00013190413,"about_ca_system_score_gemma":0.0010704558,"threshold_uncertainty_score":0.8639008},"labels":[],"label_agreement":null},{"id":"W3081683990","doi":"10.1158/1557-3265.ovca19-a20","title":"Abstract A20: Characterizing chromosome instability in chemonaïve, chemosensitive, and chemoresistant high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chromosome instability; Serous fluid; Cancer research; Cancer; Biology; Fluorescence in situ hybridization; Ovarian cancer; Aneuploidy; Chromosome; Genome instability; Cell; Pathology; Medicine; Genetics; Gene; DNA damage","score_opus":0.21575253268963548,"score_gpt":0.46320195287107513,"score_spread":0.24744942018143964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081683990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91609186,0.0018676664,7.7381327e-7,0.07993469,0.00020655083,0.0011367468,0.00017277093,0.000060246053,0.0005286757],"genre_scores_gemma":[0.9871215,0.0075231674,0.00018020632,0.0033190353,0.0012098172,0.0004687685,0.000044130014,0.00006692472,0.000066448825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569356,0.00022852974,0.0009934066,0.0013263947,0.00087152544,0.0008865789],"domain_scores_gemma":[0.99734104,0.0007271878,0.00016010873,0.0005338264,0.0003304258,0.00090742315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015805577,0.0003388377,0.0010893766,0.00012159556,0.00015421704,0.000088709276,0.00020780027,0.0003179258,0.0010595173],"category_scores_gemma":[0.00067807024,0.00029289804,0.0001755625,0.00083210727,0.0006100566,0.00016898972,0.0002782531,0.001659571,0.00004235258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005737922,0.0027015274,0.84026253,0.0017545945,0.0005416397,0.0018364501,0.0013307787,0.0000053081985,0.045723766,0.00025658813,0.0029862495,0.09686262],"study_design_scores_gemma":[0.006615066,0.00045474825,0.9620413,0.0005606555,0.000065743625,0.0000069682874,0.00015943153,0.000072438845,0.023578905,0.00008823824,0.006081425,0.00027506138],"about_ca_topic_score_codex":0.0047643986,"about_ca_topic_score_gemma":0.001205354,"teacher_disagreement_score":0.121778764,"about_ca_system_score_codex":0.0008114794,"about_ca_system_score_gemma":0.0011297406,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W3081728205","doi":"10.1158/1557-3265.ovca19-b23","title":"Abstract B23: CDK4/6 and MEK inhibitor combination in low-grade serous ovarian cancer cell lines","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University; University of British Columbia","funders":"","keywords":"Palbociclib; Trametinib; CDKN2A; Cancer research; Cyclin-dependent kinase 6; MEK inhibitor; Ovarian cancer; Medicine; Cancer; Oncology; Cell cycle; Internal medicine; Biology; Cyclin-dependent kinase; Breast cancer; Kinase; MAPK/ERK pathway; Metastatic breast cancer; Genetics","score_opus":0.21134993783408693,"score_gpt":0.5066971788215023,"score_spread":0.2953472409874154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081728205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529343,0.008666321,0.000027293387,0.036442168,0.0003489681,0.0009085091,0.00004740725,0.00007201865,0.0005529748],"genre_scores_gemma":[0.98999065,0.005346127,0.00025584293,0.002099905,0.0016336655,0.00027138783,0.00001571651,0.000062656494,0.00032406862],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968819,0.00023085884,0.0007447647,0.0007389288,0.0007830695,0.0006204632],"domain_scores_gemma":[0.99787897,0.0007051983,0.00012551478,0.00030883378,0.00041478119,0.00056670146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011671941,0.00021600747,0.0005813172,0.000107613734,0.00010825242,0.000048679,0.00021938242,0.00024810486,0.00065735704],"category_scores_gemma":[0.00057333236,0.00019186785,0.000096188116,0.0006290027,0.0004826658,0.00023884473,0.00017423338,0.0014672057,0.00003826626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013519173,0.0026761664,0.37414262,0.0036371355,0.00028914603,0.00059796206,0.004553046,0.00028914466,0.051701654,0.00033795126,0.006109953,0.542146],"study_design_scores_gemma":[0.022331052,0.0017717858,0.9042588,0.0015961174,0.000068230445,0.000011144119,0.0014509484,0.0017233294,0.021066103,0.0012440395,0.043831397,0.0006470926],"about_ca_topic_score_codex":0.002911651,"about_ca_topic_score_gemma":0.0017462737,"teacher_disagreement_score":0.54149896,"about_ca_system_score_codex":0.0003847703,"about_ca_system_score_gemma":0.0007098034,"threshold_uncertainty_score":0.7824144},"labels":[],"label_agreement":null},{"id":"W3081752008","doi":"10.1158/1557-3265.ovca19-b17","title":"Abstract B17: Modeling ovarian cancer in mice using in vivo electroporation and CRISPR-mediated genome editing","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Spinal Cord Injury BC; McGill University","funders":"","keywords":"Ovarian cancer; Biology; Cancer research; Metastasis; Cancer; Fallopian tube; Serous fluid; Ovarian carcinoma; Electroporation; Carcinogenesis; Pathology; Medicine; Gene; Genetics","score_opus":0.129065900603426,"score_gpt":0.49461079838572136,"score_spread":0.3655448977822954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081752008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926093,0.003324732,0.0026161603,0.0010567917,0.000075508535,0.00021404745,0.00002260952,0.000006851613,0.00007396871],"genre_scores_gemma":[0.99568784,0.0028299885,0.0002474634,0.00017791521,0.000973967,0.000033011187,0.000017898217,0.000023795716,0.000008132917],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984297,0.00010081154,0.00042763897,0.0004513911,0.0001922944,0.00039815996],"domain_scores_gemma":[0.99953324,0.000054915217,0.000038208535,0.00011014557,0.00011024766,0.00015322177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009850214,0.0001052888,0.00018149572,0.00007441986,0.000049368336,0.000033372085,0.00013368524,0.00018141513,0.000058394115],"category_scores_gemma":[0.00048002176,0.00011300096,0.000035103407,0.00029150533,0.000059160717,0.0000079003985,0.000116221316,0.0005489114,0.0000013743551],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017223932,0.00002753756,0.014455846,0.00006721847,0.000015096911,0.000011837434,0.00013410748,0.06200479,0.9214001,0.0000033231127,0.0000884739,0.0016194133],"study_design_scores_gemma":[0.0031609868,0.00042173325,0.040668048,0.00017352657,0.000016935319,0.0000032410978,0.000670376,0.8490096,0.10186243,0.00008203398,0.0033374506,0.00059363653],"about_ca_topic_score_codex":0.0014521668,"about_ca_topic_score_gemma":0.0022930647,"teacher_disagreement_score":0.8195377,"about_ca_system_score_codex":0.00005979832,"about_ca_system_score_gemma":0.000248273,"threshold_uncertainty_score":0.46080455},"labels":[],"label_agreement":null},{"id":"W3081872965","doi":"10.1158/1557-3265.ovca19-b78","title":"Abstract B78: Improving chemotherapy response of immunologically cold high-grade serous ovarian cancer with loss of PTEN using STING agonist","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; Ovarian cancer; Cancer research; CD8; Carboplatin; Tumor microenvironment; Biology; Immune system; Chemotherapy; Medicine; Cancer; Immunology; Cisplatin; Internal medicine; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.17442062526095364,"score_gpt":0.44368292081746646,"score_spread":0.2692622955565128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081872965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919941,0.00406296,0.000080914506,0.002893057,0.00025896876,0.00048895314,0.00012078638,0.00004290395,0.000057361907],"genre_scores_gemma":[0.99819225,0.0006953412,0.0002569421,0.00032782956,0.00008390098,0.000044804085,0.000007733658,0.000047010406,0.0003441717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957661,0.0016075242,0.0010995744,0.0005891438,0.00021100695,0.00072663033],"domain_scores_gemma":[0.99593705,0.0023684942,0.00047684181,0.00046983405,0.0006647604,0.00008300079],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030424288,0.00024680898,0.00085076643,0.00013827426,0.0002454889,0.000029734965,0.00072700385,0.0004677486,0.0012665791],"category_scores_gemma":[0.0014446885,0.0001882158,0.00019244952,0.0005017835,0.0016984617,0.00009778047,0.00028591443,0.0015745324,0.000025111854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05705502,0.00029426365,0.007522577,0.00014305176,0.0004592223,0.00003196707,0.00040601226,0.0000644868,0.92590237,0.00012992497,0.00018486776,0.007806217],"study_design_scores_gemma":[0.006631212,0.0037957258,0.1313022,0.0005260488,0.00006071187,0.000016047788,0.0006844134,0.00008448756,0.8524287,0.000019347855,0.0041012936,0.00034981276],"about_ca_topic_score_codex":0.0052757068,"about_ca_topic_score_gemma":0.00010918911,"teacher_disagreement_score":0.12377962,"about_ca_system_score_codex":0.00015246059,"about_ca_system_score_gemma":0.0014207494,"threshold_uncertainty_score":0.9996464},"labels":[],"label_agreement":null},{"id":"W3081919169","doi":"10.1158/1557-3265.ovca19-b74","title":"Abstract B74: Identifying conserved properties of the epithelial-mesenchymal transition in cancer using highly multiplexed single-cell RNA sequencing","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Epithelial–mesenchymal transition; Biology; Vimentin; Cancer research; Metastasis; Cancer; Genetics; Immunology","score_opus":0.37256042302417275,"score_gpt":0.4425755350657491,"score_spread":0.07001511204157634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081919169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929586,0.0036504748,0.00021395019,0.0018316996,0.00023654323,0.0008863085,0.000068156405,0.0000122371885,0.00014202003],"genre_scores_gemma":[0.9978504,0.0009001241,0.00016826761,0.00032932396,0.00045545658,0.0001097845,0.000009199298,0.00005877912,0.00011865213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960273,0.00085363776,0.00083804043,0.0007364069,0.0008726853,0.00067192613],"domain_scores_gemma":[0.9984568,0.000103864,0.00018334814,0.0004713576,0.00055870437,0.00022594826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018194944,0.00020578897,0.0003688452,0.00010461114,0.00018004962,0.000060847826,0.00064763124,0.0003706261,0.00015048556],"category_scores_gemma":[0.0009326784,0.00016839147,0.00027215242,0.00065726583,0.00059907604,0.00001783477,0.00038084207,0.0011608533,0.000009371102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087333535,0.000119157216,0.0002361871,0.00033361188,0.000055352233,0.0000140684315,0.00031864588,0.005189914,0.99059075,0.0000026144126,0.00011484338,0.0021515188],"study_design_scores_gemma":[0.0016988636,0.0002546136,0.0005736949,0.00045439348,0.000019680954,0.0000016324353,0.0003539872,0.003742196,0.99204373,0.000015924736,0.00064342073,0.00019785378],"about_ca_topic_score_codex":0.004488714,"about_ca_topic_score_gemma":0.00130513,"teacher_disagreement_score":0.004891803,"about_ca_system_score_codex":0.00029978002,"about_ca_system_score_gemma":0.0018734998,"threshold_uncertainty_score":0.6866805},"labels":[],"label_agreement":null},{"id":"W3081960426","doi":"10.1158/1557-3265.ovca19-b09","title":"Abstract B09: Single-cell RNA sequencing of normal endometrial organoids uncovers novel cell-type markers for prognostication of primary tumor samples","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Biology; Pathology; Population; Organoid; Staining; Epithelium; Cell type; Cell; Clear cell; Immunohistochemistry; Cell biology; Immunology; Medicine","score_opus":0.35111697221303606,"score_gpt":0.460006824660809,"score_spread":0.10888985244777294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081960426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898342,0.001364244,0.00034066875,0.001229799,0.00019400021,0.0030063493,0.0003225108,0.000027349191,0.003680906],"genre_scores_gemma":[0.9927584,0.0010255079,0.00512674,0.00015347099,0.0005208655,0.00014054742,0.00011457812,0.00004557183,0.00011431248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596936,0.00020313264,0.0011218649,0.0005459347,0.0015117984,0.0006478954],"domain_scores_gemma":[0.9808589,0.016221091,0.00031324165,0.0003689806,0.001616816,0.00062096544],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003142644,0.0001809268,0.00080133846,0.00041374835,0.00008500018,0.000024204674,0.00030955285,0.00014572144,0.0004015652],"category_scores_gemma":[0.036958825,0.00014866938,0.0003180717,0.0018377674,0.00050624664,0.000108816166,0.00017327834,0.0007050515,0.000016813561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030321788,0.0029178935,0.07923831,0.0038443597,0.000406693,0.000040994364,0.00016300684,0.000044485034,0.8581447,0.000040224655,0.0037572028,0.021080319],"study_design_scores_gemma":[0.026743205,0.018421888,0.037109785,0.00041258425,0.00022567206,0.000003064658,0.0004599087,0.00015143096,0.90982324,0.000034707366,0.0063641802,0.00025031174],"about_ca_topic_score_codex":0.0004883822,"about_ca_topic_score_gemma":0.000018367879,"teacher_disagreement_score":0.051678542,"about_ca_system_score_codex":0.00057822303,"about_ca_system_score_gemma":0.003355801,"threshold_uncertainty_score":0.97115326},"labels":[],"label_agreement":null},{"id":"W3082003040","doi":"10.1158/1557-3265.ovca19-a61","title":"Abstract A61: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Ovarian cancer; Cisplatin; Wnt signaling pathway; Cancer; Cancer cell; KRAS; Chemotherapy; Biology; Signal transduction; Medicine; Internal medicine; Cell biology; Colorectal cancer","score_opus":0.10917654808904187,"score_gpt":0.452831612145723,"score_spread":0.3436550640566811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082003040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686573,0.0046699336,0.00012756925,0.02245713,0.0018628864,0.0007459566,0.00015648175,0.000029196457,0.0012935293],"genre_scores_gemma":[0.9592132,0.011267302,0.00020109276,0.003915018,0.022112498,0.00024044006,0.000014914381,0.00005963672,0.0029759274],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972532,0.00023138976,0.0004127555,0.00096708775,0.00045368046,0.0006818797],"domain_scores_gemma":[0.99823195,0.00014808573,0.000096109914,0.00048486542,0.00035951205,0.0006794567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001116447,0.00022018218,0.00041951428,0.00005841216,0.00019495029,0.00008510481,0.000407124,0.00029722744,0.00032518027],"category_scores_gemma":[0.00079798995,0.00021085737,0.00013348636,0.0003918023,0.00038155887,0.0000132773675,0.0003208249,0.00048734082,0.00001593589],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007954861,0.0001845686,0.011771522,0.00022893633,0.00021345545,0.0000026225987,0.0005066529,0.000025527386,0.34661332,0.00014031983,0.37656346,0.25579473],"study_design_scores_gemma":[0.0018282192,0.00024854433,0.16443254,0.00004041951,0.000011722409,4.268527e-7,0.00010165971,0.000009448731,0.016149024,0.000044559092,0.8168731,0.00026037783],"about_ca_topic_score_codex":0.00071121834,"about_ca_topic_score_gemma":0.002224589,"teacher_disagreement_score":0.44030958,"about_ca_system_score_codex":0.00008066253,"about_ca_system_score_gemma":0.00087946147,"threshold_uncertainty_score":0.8598514},"labels":[],"label_agreement":null},{"id":"W3082009283","doi":"10.1158/1557-3265.ovca19-a29","title":"Abstract A29: Anticancer effects of polo-like kinase-4 inhibitor (CFI-400945) in ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ovarian cancer; Biology; Cell cycle; Cancer research; Cancer; Mitosis; Carcinogenesis; Propidium iodide; Cell growth; Viability assay; Mitotic catastrophe; BUB1; Cancer cell; Molecular biology; Cell; Apoptosis; Cell biology; Programmed cell death; Genetics; Gene","score_opus":0.08396940545288109,"score_gpt":0.4509874401042446,"score_spread":0.3670180346513635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082009283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045974,0.005435932,0.00004812069,0.002476689,0.0005178152,0.0005813986,0.00009635795,0.00000930858,0.0003746533],"genre_scores_gemma":[0.98769045,0.009099301,0.00009469245,0.00136483,0.0013131569,0.0001603084,0.000035999736,0.000043809214,0.00019742896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972882,0.0002895605,0.0006651849,0.0007316904,0.00041409067,0.000611271],"domain_scores_gemma":[0.99859804,0.00023598131,0.00012189819,0.00043829088,0.00028413982,0.0003216737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009147865,0.00019239524,0.0004318229,0.000078094476,0.00006162809,0.000024397372,0.00048540882,0.00039617062,0.00018675454],"category_scores_gemma":[0.00081295974,0.00018020575,0.00017552821,0.00045169363,0.00043386422,0.000007924883,0.0003547933,0.0007896923,0.000020494213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009912421,0.00030595556,0.06561155,0.00049152697,0.00010823172,0.00003784251,0.0000936835,0.000049177328,0.89992654,0.000053870524,0.019346753,0.012983634],"study_design_scores_gemma":[0.0045980434,0.0014278291,0.19286957,0.00047414852,0.00004132067,0.0000012136636,0.000098250384,0.00015701832,0.71179324,0.000080899474,0.08792311,0.00053533685],"about_ca_topic_score_codex":0.0013834324,"about_ca_topic_score_gemma":0.0011906867,"teacher_disagreement_score":0.18813328,"about_ca_system_score_codex":0.00006204749,"about_ca_system_score_gemma":0.0007891197,"threshold_uncertainty_score":0.73485774},"labels":[],"label_agreement":null},{"id":"W3082195774","doi":"10.1158/1557-3265.ovca19-b20","title":"Abstract B20: Endometrial cancer molecular risk stratification in endometrioid ovarian cancers: A novel application of precision medicine","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Internal medicine; Cohort; Biomarker; Ovarian cancer; Risk stratification; Stage (stratigraphy); Carcinoma; Cancer; Gynecology; Biology","score_opus":0.2736672719692938,"score_gpt":0.5276586418675896,"score_spread":0.2539913698982958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082195774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569124,0.014248849,0.0040503484,0.014914227,0.0007330744,0.0051454203,0.00047190444,0.000085788524,0.0034380152],"genre_scores_gemma":[0.9863178,0.009963475,0.00056940434,0.00043117895,0.0016014086,0.0009524481,0.00007588447,0.000048946225,0.000039451843],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9939272,0.00043680373,0.001902691,0.0010916764,0.0020150293,0.0006266362],"domain_scores_gemma":[0.9935937,0.003540243,0.0005643975,0.0006548114,0.00091752777,0.0007293029],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0040084654,0.00028790263,0.001210535,0.000870029,0.00009411165,0.000024131017,0.00047920243,0.00035568513,0.001419786],"category_scores_gemma":[0.012167446,0.0002269158,0.00028318833,0.006441734,0.00053678243,0.00013879518,0.00013965767,0.0015651294,0.000036906065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023517545,0.0016040764,0.23925775,0.000659062,0.00057849556,0.000049198592,0.000521518,0.00050290546,0.11910738,0.00062669866,0.00072386157,0.6128515],"study_design_scores_gemma":[0.086278655,0.008514042,0.83019865,0.0014338462,0.00064678356,0.0000044536678,0.00056075293,0.0031241206,0.04689238,0.0017251574,0.019907767,0.0007134026],"about_ca_topic_score_codex":0.027367013,"about_ca_topic_score_gemma":0.0010380121,"teacher_disagreement_score":0.6121381,"about_ca_system_score_codex":0.0008662366,"about_ca_system_score_gemma":0.0013165578,"threshold_uncertainty_score":0.99949306},"labels":[],"label_agreement":null},{"id":"W3082323076","doi":"10.1158/1557-3265.aacrahns19-pr02","title":"Abstract PR02: Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Western University","funders":"","keywords":"Cohort; Hazard ratio; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Medicine; Biomarker; Head and neck cancer; Cancer; Biology; Genetics; Confidence interval","score_opus":0.14664713453045164,"score_gpt":0.46046830920406023,"score_spread":0.3138211746736086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082323076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408734,0.0037555085,0.000091119095,0.00062896847,0.000030674673,0.00015438706,0.00031771528,0.000003669932,0.00093059876],"genre_scores_gemma":[0.9985064,0.00061541784,0.00007309431,0.00019780024,0.0001502052,0.000042446212,0.0002420601,0.000012473145,0.00016009508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984059,0.00012581128,0.00041840607,0.0004507816,0.00032972722,0.0002693971],"domain_scores_gemma":[0.99899787,0.00013829963,0.000102024096,0.00023760769,0.00028533966,0.00023886339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004887862,0.00008849379,0.0002176229,0.000056208493,0.000084689804,0.000032211185,0.00016793153,0.0001359089,0.00022526053],"category_scores_gemma":[0.0002200983,0.000083736886,0.00011733889,0.00040912244,0.00024985225,0.000005010383,0.00008052429,0.00027310743,0.0000019989832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010400239,0.000420687,0.634555,0.00017880969,0.00046947936,0.000007633435,0.00031085283,0.000975284,0.32487267,0.00011517905,0.017746223,0.01930816],"study_design_scores_gemma":[0.0015481954,0.00074043346,0.93960756,0.0000066359808,0.00014817006,2.3014236e-7,0.00026798883,0.0011666126,0.042530976,0.000036917987,0.013751332,0.00019494748],"about_ca_topic_score_codex":0.0005857046,"about_ca_topic_score_gemma":0.00018941636,"teacher_disagreement_score":0.30505258,"about_ca_system_score_codex":0.000020468611,"about_ca_system_score_gemma":0.00037822587,"threshold_uncertainty_score":0.3414691},"labels":[],"label_agreement":null},{"id":"W3082378104","doi":"10.1158/1557-3265.ovca19-b30","title":"Abstract B30: The effect of OCP use on the incidence of precancerous p53 lesions in fallopian tube fimbria","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Serous fluid; Fallopian tube; Immunohistochemistry; Serous carcinoma; Cohort; Ovarian cancer; Fimbria; Gynecology; Cancer; Internal medicine; Gastroenterology; Oncology; Biology","score_opus":0.3328179012131451,"score_gpt":0.5237653982364876,"score_spread":0.19094749702334252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082378104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963843,0.0011332274,0.0000010588682,0.032320853,0.00013315158,0.0014467811,0.00005232251,0.000009690813,0.0010599165],"genre_scores_gemma":[0.9956194,0.0026555632,0.000015582678,0.00094387884,0.00028586813,0.00036743394,0.0000032382557,0.000021307938,0.00008773996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685377,0.0007668677,0.00071615144,0.0004273361,0.0008781063,0.00035774166],"domain_scores_gemma":[0.9878123,0.01096115,0.00014199212,0.0006683656,0.00021033597,0.0002058856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029255825,0.00014829123,0.00056802965,0.000060173756,0.00008948768,0.000023290577,0.00041019914,0.00012515923,0.0004621556],"category_scores_gemma":[0.0042171576,0.00007210715,0.00022230818,0.00064648176,0.0006281985,0.00005248573,0.0001672798,0.0011281929,0.000032903492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005306978,0.00055043545,0.9101522,0.00038869306,0.00025929898,0.000095123134,0.000595843,0.00017526101,0.00052611023,0.0006261363,0.01631977,0.065004125],"study_design_scores_gemma":[0.0024369725,0.0039790547,0.9817422,0.0009656304,0.00005947843,8.7460825e-7,0.00007931105,0.00012098465,0.0054497854,0.00005316153,0.005042945,0.000069576265],"about_ca_topic_score_codex":0.004810486,"about_ca_topic_score_gemma":0.0011854103,"teacher_disagreement_score":0.07159,"about_ca_system_score_codex":0.00017951966,"about_ca_system_score_gemma":0.0006433484,"threshold_uncertainty_score":0.7272048},"labels":[],"label_agreement":null},{"id":"W3082463050","doi":"10.1158/1557-3265.ovca19-b68","title":"Abstract B68: Characterization of microtentacle phenotype and function in ovarian carcinomas","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Ovarian cancer; Cancer research; Paclitaxel; Phenotype; Cell; Clear cell; Biology; Cell culture; Ovary; Clear cell carcinoma; Cancer; Pathology; Medicine; Carcinoma; Internal medicine; Endocrinology; Genetics","score_opus":0.09823373659038087,"score_gpt":0.39928781956033993,"score_spread":0.30105408296995906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082463050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982176,0.00041319148,0.00020227033,0.0007300049,0.0000725455,0.00019618847,0.000027849836,0.0000023688813,0.00013799299],"genre_scores_gemma":[0.9978556,0.0013318486,0.000035583776,0.0003158848,0.00029822678,0.000016169357,0.00008402457,0.000011879221,0.000050757208],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905425,0.00010170595,0.0002836976,0.00028757355,0.000108741435,0.00016402884],"domain_scores_gemma":[0.99958676,0.00002396578,0.00005257493,0.00013587717,0.00010892731,0.00009189345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004834061,0.00006055342,0.00013022732,0.000030871928,0.000029325643,0.000011541149,0.00010101765,0.00014120914,0.000050028535],"category_scores_gemma":[0.00012782065,0.000059693386,0.000038501264,0.00013007884,0.000112834525,0.0000044447397,0.000112493544,0.00022768263,0.0000051508855],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050029135,0.000048421596,0.08240777,0.00004934216,0.000013897453,0.0000011680484,0.000034966615,0.0000022402296,0.9100821,0.00002506752,0.00011515223,0.0067195897],"study_design_scores_gemma":[0.0008069525,0.00041011334,0.86974597,0.000021939259,0.000006179538,3.2480486e-7,0.000036773443,0.000081771854,0.119572684,0.000025760302,0.009208865,0.00008264327],"about_ca_topic_score_codex":0.00017509233,"about_ca_topic_score_gemma":0.000120765435,"teacher_disagreement_score":0.7905094,"about_ca_system_score_codex":0.000010315928,"about_ca_system_score_gemma":0.00012089145,"threshold_uncertainty_score":0.24342255},"labels":[],"label_agreement":null},{"id":"W3082472664","doi":"10.1158/1557-3265.aacrahns19-b13","title":"Abstract B13: Utilizing metabolic reprogramming to regulate fibroblast phenotype and reduce radiation fibrosis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Extracellular matrix; Cell biology; Fibrosis; Fibroblast; Extracellular; Catabolism; Biology; Chemistry; Cancer research; Biochemistry; Metabolism; Internal medicine; Medicine","score_opus":0.15286944115330237,"score_gpt":0.459307420152495,"score_spread":0.3064379789991926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082472664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97442544,0.020580553,0.00007719974,0.0033552398,0.0004990601,0.0005052788,0.000036306807,0.000029517225,0.0004914149],"genre_scores_gemma":[0.9816679,0.010133145,0.00086831243,0.00081332965,0.006017906,0.00010232445,0.00003404787,0.00004583576,0.00031719255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974956,0.00022448946,0.0004763524,0.0008943792,0.00037115967,0.0005380266],"domain_scores_gemma":[0.9985312,0.000112074624,0.00008846245,0.0004437476,0.00023968381,0.0005847896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014573345,0.00016491649,0.00032274434,0.0000615709,0.00018088278,0.000103044804,0.0002809395,0.00023891333,0.00008155197],"category_scores_gemma":[0.0015132115,0.00016209371,0.00013560196,0.0004077524,0.0002177515,0.000012521449,0.0003356864,0.0004759503,0.00003314112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010208441,0.00004681544,0.0016463458,0.00008076156,0.00008206542,0.0000014518831,0.00024394284,0.000059279762,0.40864167,0.00008244933,0.017180806,0.57091355],"study_design_scores_gemma":[0.00087559246,0.00049055694,0.05902315,0.00005928228,0.000026630225,0.0000013835364,0.00014858716,0.00005198819,0.06611207,0.000050330273,0.8729099,0.00025055476],"about_ca_topic_score_codex":0.00026565883,"about_ca_topic_score_gemma":0.00008539878,"teacher_disagreement_score":0.85572904,"about_ca_system_score_codex":0.000017961109,"about_ca_system_score_gemma":0.00027841303,"threshold_uncertainty_score":0.660999},"labels":[],"label_agreement":null},{"id":"W3082502320","doi":"10.1158/1557-3265.ovca19-b80","title":"Abstract B80: Predictive treatment response models for epithelial ovarian cancer: Comparison of 2D, 3D, and in vivo models","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Carboplatin; Clonogenic assay; In vivo; Medicine; Flow cytometry; Ovarian cancer; Oncology; Cancer research; Cell culture; Cancer; Internal medicine; Chemotherapy; Immunology; Biology; Cisplatin","score_opus":0.4434920125753466,"score_gpt":0.5492669548155007,"score_spread":0.1057749422401541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082502320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978829,0.0061799595,0.0011202636,0.009060735,0.00018307316,0.002309174,0.0016215149,0.000024921155,0.0006713096],"genre_scores_gemma":[0.98885274,0.008426213,0.000881678,0.00026187222,0.00054019946,0.00073266524,0.000009881876,0.000040790354,0.00025395004],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969129,0.0003312824,0.0009348576,0.0006908271,0.000602717,0.0005274438],"domain_scores_gemma":[0.99686164,0.0017191155,0.00015042773,0.0003224316,0.0003988646,0.0005475069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020873162,0.00019730387,0.0010049582,0.00015208543,0.00008090857,0.000020371112,0.00015726511,0.00020219319,0.0002529225],"category_scores_gemma":[0.00044356313,0.00016056013,0.00020784659,0.00036806375,0.00040374385,0.000116699484,0.00010110567,0.00057851966,0.0000020720324],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44105306,0.003930663,0.04067367,0.001829608,0.0012750285,0.000114476046,0.0115894405,0.052219063,0.035609443,0.00042978924,0.011651259,0.39962453],"study_design_scores_gemma":[0.06977317,0.025569089,0.044100106,0.001953986,0.0010017665,0.000005756427,0.003577921,0.68828,0.086501725,0.00378035,0.074451454,0.0010046976],"about_ca_topic_score_codex":0.005054942,"about_ca_topic_score_gemma":0.0012666594,"teacher_disagreement_score":0.63606095,"about_ca_system_score_codex":0.00042007514,"about_ca_system_score_gemma":0.0016531576,"threshold_uncertainty_score":0.7641594},"labels":[],"label_agreement":null},{"id":"W3082625691","doi":"10.1158/1557-3265.ovca19-a03","title":"Abstract A03: PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Oncology; Ovarian cancer; Ovarian carcinoma; Subtyping; Serous carcinoma; Internal medicine; Medicine; Serous ovarian cancer; Bioinformatics; Biology; Cancer","score_opus":0.21686505764707673,"score_gpt":0.4494716190603984,"score_spread":0.23260656141332167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082625691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95116645,0.0034836465,0.00021525279,0.04046069,0.00044192869,0.003806869,0.00032687155,0.000024932011,0.00007337027],"genre_scores_gemma":[0.9942526,0.0012770781,0.0021419183,0.000598453,0.00046759399,0.0010816572,0.00005153643,0.000079915044,0.000049198155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99413973,0.0007227518,0.00227433,0.000935911,0.0013001984,0.00062707],"domain_scores_gemma":[0.99311566,0.003627944,0.0007969119,0.0009218239,0.0010797794,0.0004578925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031780496,0.00035865806,0.0013494092,0.00010173655,0.0001892924,0.000038730992,0.0005253224,0.00047989227,0.00021750577],"category_scores_gemma":[0.0016895668,0.00022456051,0.00039858537,0.0006864085,0.001232672,0.0000471959,0.00023373196,0.0012132133,0.0000059657277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014617582,0.0041058823,0.86720216,0.003585176,0.0068314797,0.0002977839,0.0021644763,0.000469784,0.009829302,0.0111045465,0.006641597,0.0731502],"study_design_scores_gemma":[0.010949677,0.0020270166,0.8887587,0.00047569483,0.0009060862,0.0000074011314,0.00031645613,0.00034980098,0.09014885,0.0008136499,0.0049654827,0.0002811457],"about_ca_topic_score_codex":0.005470538,"about_ca_topic_score_gemma":0.00046230765,"teacher_disagreement_score":0.080319546,"about_ca_system_score_codex":0.00016893676,"about_ca_system_score_gemma":0.0028980284,"threshold_uncertainty_score":0.9157312},"labels":[],"label_agreement":null},{"id":"W3082626489","doi":"10.1158/1557-3265.aacrahns19-a36","title":"Abstract A36: Impact of feeding tube use on swallowing-related quality of life and weight in oropharyngeal cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Swallowing; Feeding tube; Head and neck cancer; Dysphagia; Quality of life (healthcare); Gastrostomy; Internal medicine; Medical record; Radiation therapy; Weight change; Cancer; Weight loss; Physical therapy; Surgery; Obesity","score_opus":0.4824869306125832,"score_gpt":0.5807312704666258,"score_spread":0.09824433985404257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082626489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870281,0.0052316813,2.8015214e-7,0.006211945,0.00013760934,0.00041822303,0.00008049682,0.000014521128,0.0008771151],"genre_scores_gemma":[0.98978376,0.009357482,0.000015141499,0.00039926256,0.00031109512,0.00003861974,0.000003725612,0.000025611478,0.00006531917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664074,0.0003186873,0.0012826285,0.0004958685,0.0007969689,0.000465104],"domain_scores_gemma":[0.996752,0.0018910659,0.00016878106,0.00024124637,0.00039098278,0.0005558936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024382228,0.00016785668,0.0012843478,0.0001440424,0.000056430406,0.000011634087,0.00014853169,0.00020163835,0.0006374903],"category_scores_gemma":[0.0047277734,0.00012379736,0.00025395254,0.00066838425,0.0005208702,0.00010756561,0.00015580122,0.0013138832,0.000007146953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006839401,0.0003292308,0.96552765,0.00061304984,0.00033540803,0.000029511855,0.0008953584,0.000019926441,0.013453222,0.00003170909,0.003672446,0.0082530975],"study_design_scores_gemma":[0.004407037,0.0018345302,0.99123394,0.0007104145,0.00002204775,2.3718059e-7,0.00013895016,0.00014259154,0.001198031,0.00002207514,0.0001802175,0.0001099366],"about_ca_topic_score_codex":0.014471391,"about_ca_topic_score_gemma":0.00076744717,"teacher_disagreement_score":0.025706293,"about_ca_system_score_codex":0.00023110915,"about_ca_system_score_gemma":0.0012214332,"threshold_uncertainty_score":0.99209136},"labels":[],"label_agreement":null},{"id":"W3082964825","doi":"10.1158/1557-3265.ovca19-b29","title":"Abstract B29: Ovarian hormones regulate C/EBPD induced EMT/MET transition in the human fallopian tube epithelia","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fallopian tube; Biology; Epithelial–mesenchymal transition; Ovarian cancer; Luteal phase; Estrogen receptor; Estrogen; Follicular phase; Internal medicine; Oviduct; Vimentin; Progesterone receptor; Cancer research; Immunohistochemistry; Endocrinology; Downregulation and upregulation; Breast cancer; Cancer; Medicine; Immunology; Gene; Genetics; Anatomy","score_opus":0.41849112727763477,"score_gpt":0.535127154435102,"score_spread":0.11663602715746718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082964825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363331,0.00037500757,0.0000047360973,0.060493022,0.00011731164,0.00082480686,0.000015827245,0.000031919004,0.0018042459],"genre_scores_gemma":[0.99650735,0.0002082993,0.00002427349,0.0020095082,0.0010249475,0.00010413716,0.000031002015,0.00001712346,0.00007333952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647665,0.0011299716,0.0006729482,0.00075149385,0.0005096328,0.0004592751],"domain_scores_gemma":[0.9983484,0.00048568356,0.000046622652,0.00062939327,0.00025383834,0.00023601977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006317007,0.00014416393,0.00043051134,0.00007982005,0.00020559401,0.00002636193,0.00035549628,0.0003343593,0.0004358538],"category_scores_gemma":[0.0014387415,0.00009360261,0.00016932139,0.0005485579,0.0006180978,0.000087360975,0.000061836065,0.002176683,0.00007844838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04053604,0.002644017,0.46615252,0.0006765501,0.00050024997,0.00072488294,0.012783405,0.000011706028,0.37099597,0.0020748843,0.009949885,0.092949875],"study_design_scores_gemma":[0.001535464,0.0011233258,0.9895255,0.00006206545,0.000021309861,0.0000038350104,0.0004194639,0.000023059714,0.0024466321,0.0015170926,0.0032226346,0.000099638295],"about_ca_topic_score_codex":0.0008295609,"about_ca_topic_score_gemma":0.00021487506,"teacher_disagreement_score":0.52337295,"about_ca_system_score_codex":0.00007158028,"about_ca_system_score_gemma":0.00027360016,"threshold_uncertainty_score":0.9456725},"labels":[],"label_agreement":null},{"id":"W3083506235","doi":"10.1158/1078-0432.ccr-20-1967","title":"Statins as Anticancer Agents in the Era of Precision Medicine","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canadian Cancer Society","keywords":"Mevalonate pathway; Medicine; HMG-CoA reductase; Statin; Limiting; Cancer; Pharmacology; Reductase; Precision medicine; Clinical trial; Bioinformatics; Oncology; Internal medicine; Enzyme; Biology; Pathology","score_opus":0.38114504290175316,"score_gpt":0.6128752310255142,"score_spread":0.23173018812376106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083506235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029977603,0.9924567,0.000009266783,0.00097416673,0.0035105334,0.0011885227,0.00013384027,0.0000036447016,0.0014236006],"genre_scores_gemma":[0.00016070217,0.97838706,0.000027079877,0.00046848843,0.01992293,0.00033599447,0.00012511612,0.000047029804,0.00052557106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99444234,0.0019778558,0.0013160724,0.000806616,0.0009835792,0.00047356228],"domain_scores_gemma":[0.99746454,0.00088694,0.00030588076,0.0008592632,0.00028903395,0.00019436865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00457393,0.0002756827,0.0015159157,0.00009817395,0.0000657038,0.000019144165,0.0011889575,0.00046785086,0.0003800203],"category_scores_gemma":[0.0032711285,0.00016577054,0.00043098407,0.0007114197,0.0007988543,0.0000032838443,0.00040999704,0.0017802852,0.00003790359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014500634,0.00008427625,0.00007118611,0.0015824694,0.00009045294,0.0000013846532,0.00008738359,4.6817433e-7,0.00001883279,0.000052816387,0.14219451,0.8556712],"study_design_scores_gemma":[0.000671077,0.0006356747,0.00026071884,0.0035412745,0.00011885147,0.0000034787445,0.00006461619,0.0000016891379,0.000008084464,0.00008328479,0.9944543,0.00015695098],"about_ca_topic_score_codex":0.0008327493,"about_ca_topic_score_gemma":0.0003997051,"teacher_disagreement_score":0.8555143,"about_ca_system_score_codex":0.000057827703,"about_ca_system_score_gemma":0.0021638856,"threshold_uncertainty_score":0.7734552},"labels":[],"label_agreement":null},{"id":"W3085958492","doi":"10.1158/1078-0432.ccr-20-1781","title":"Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Bristol-Myers Squibb Canada","keywords":"Pomalidomide; Daratumumab; Multiple myeloma; Lenalidomide; Medicine; Immunology; Immune system; CD8; Cancer research; T cell; Oncology; Internal medicine","score_opus":0.15593329845042367,"score_gpt":0.4489423615434022,"score_spread":0.2930090630929786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085958492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950066,0.0009591535,0.0000116352585,0.001604359,0.000044389646,0.0016300057,0.000047509307,0.000047287536,0.0006490365],"genre_scores_gemma":[0.99795616,0.0006170487,0.00045137052,0.00021987189,0.00015851458,0.00020224882,0.00013957026,0.00005088334,0.00020432749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996161,0.00070028944,0.00060962304,0.0007853617,0.0010448784,0.0006988872],"domain_scores_gemma":[0.9966423,0.0014903975,0.000091880385,0.00040610597,0.0005804413,0.0007888943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010561895,0.00021732753,0.0005718465,0.00023164516,0.00016785196,0.000055714656,0.00016416279,0.00021576438,0.00022331065],"category_scores_gemma":[0.0032789947,0.0001597732,0.00007992667,0.0008724349,0.00050328136,0.00020462823,0.00018771368,0.0013378349,0.00008157266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015903298,0.0007092573,0.925104,0.00008786763,0.0001347889,0.00018689866,0.00013202343,0.000004702779,0.0002808841,0.000007577653,0.00037460303,0.057074085],"study_design_scores_gemma":[0.024244439,0.0033184583,0.96821046,0.00019209542,0.000024830022,0.0000018147045,0.00005809313,0.0014710447,0.000296733,0.000016004253,0.0020172228,0.00014880528],"about_ca_topic_score_codex":0.001342071,"about_ca_topic_score_gemma":0.00054263877,"teacher_disagreement_score":0.05692528,"about_ca_system_score_codex":0.00026603744,"about_ca_system_score_gemma":0.00038092467,"threshold_uncertainty_score":0.6515362},"labels":[],"label_agreement":null},{"id":"W3087061153","doi":"10.1158/1078-0432.ccr-20-1042","title":"Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Canada's Michael Smith Genome Sciences Centre; Pancreas Centre (Canada); Spinal Cord Injury BC; Ontario Institute for Cancer Research; Ottawa Hospital; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Foundation; National Human Genome Research Institute; Canada Foundation for Innovation; Canadian Institutes of Health Research; Genome British Columbia","keywords":"CDKN2A; Biology; Pancreatic cancer; Cancer research; Indel; Age of onset; Cancer; Oncology; Genetics; Gene; Internal medicine; Medicine; Single-nucleotide polymorphism; Genotype","score_opus":0.29224385595906394,"score_gpt":0.5175891987228776,"score_spread":0.22534534276381363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087061153","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46283296,0.0031270687,0.0000051215266,0.5307762,0.00043549264,0.0015931715,0.000067169734,0.00006656755,0.0010962565],"genre_scores_gemma":[0.63576955,0.010262922,0.0011791161,0.2802235,0.024316153,0.002110867,0.00046011823,0.00036328126,0.04531451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9885444,0.0031055876,0.0014484484,0.0019218008,0.002831044,0.002148704],"domain_scores_gemma":[0.9891603,0.007562169,0.00024153182,0.0014294973,0.0007127258,0.0008937517],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004179589,0.00060695206,0.0029984298,0.0008137534,0.00031589816,0.00020602482,0.0011681311,0.002196438,0.0016542142],"category_scores_gemma":[0.0077693197,0.0004413832,0.0005800462,0.0013009339,0.0026903863,0.00014080826,0.0010027251,0.01858031,0.0005842702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006745423,0.00012277914,0.5052156,0.0010658539,0.00032091842,0.024599068,0.00034152874,4.7915197e-8,0.000015817288,0.0000030939973,0.467003,0.00063774904],"study_design_scores_gemma":[0.0067388285,0.0038519695,0.65468144,0.002717374,0.00079936424,0.0001637027,0.0005241232,0.0003217127,0.000029475528,0.002447026,0.3267713,0.00095365086],"about_ca_topic_score_codex":0.0056689116,"about_ca_topic_score_gemma":0.0010255722,"teacher_disagreement_score":0.2505527,"about_ca_system_score_codex":0.0011612045,"about_ca_system_score_gemma":0.004047374,"threshold_uncertainty_score":0.9998038},"labels":[],"label_agreement":null},{"id":"W3088801732","doi":"10.1158/1078-0432.ccr-20-1966","title":"Autoantibody Landscape in Patients with Advanced Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; Vetenskapsrådet","keywords":"Autoantibody; Medicine; Prostate cancer; Cancer; Prostate; Oncology; Internal medicine; Immunology; Antibody","score_opus":0.11474085859844223,"score_gpt":0.4903821128765842,"score_spread":0.37564125427814193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088801732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98017496,0.0024892888,0.0000017771101,0.015049554,0.00016530516,0.0011741645,0.00005123028,0.00004508688,0.0008486443],"genre_scores_gemma":[0.9927298,0.003519954,0.00008009282,0.0025256134,0.0003024937,0.00023665422,0.000030759413,0.000041029332,0.0005335908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737215,0.00019040193,0.00051541545,0.0005628596,0.00079802395,0.00056116283],"domain_scores_gemma":[0.9987224,0.00020474612,0.000077948906,0.00028205672,0.00038078433,0.00033208667],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008312282,0.00014974154,0.0004405556,0.000103159044,0.00007226038,0.000027795317,0.0001889822,0.00011706602,0.0011827819],"category_scores_gemma":[0.0002396588,0.000104603925,0.00009488028,0.0010062542,0.0003150102,0.000100615594,0.00008206607,0.00095395575,0.000036550315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032995064,0.00028199452,0.8565352,0.00012375813,0.00009099812,0.00002802099,0.00025465005,0.000013746919,0.0002134556,0.000003939393,0.005166457,0.104292706],"study_design_scores_gemma":[0.015465193,0.0027624364,0.934831,0.00038413823,0.000018198902,3.0346118e-7,0.00010316638,0.00012540846,0.00020549563,0.0000069095518,0.04594295,0.00015475904],"about_ca_topic_score_codex":0.0004206472,"about_ca_topic_score_gemma":0.0002984907,"teacher_disagreement_score":0.10413794,"about_ca_system_score_codex":0.00015397344,"about_ca_system_score_gemma":0.0008685526,"threshold_uncertainty_score":0.9997303},"labels":[],"label_agreement":null},{"id":"W3089217886","doi":"10.1158/1557-3265.covid-19-po-041","title":"Abstract PO-041: The impact of the COVID-19 pandemic on cancer patients","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Cancer; Breast cancer; Coronavirus disease 2019 (COVID-19); Lung cancer; Colorectal cancer; Health care; Family medicine; Internal medicine; Disease","score_opus":0.713070638420338,"score_gpt":0.6866610436061756,"score_spread":0.026409594814162385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089217886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87222534,0.00060307496,0.00000131486,0.12501946,0.000242905,0.0011422402,0.0001811568,0.000028297778,0.0005562101],"genre_scores_gemma":[0.9643709,0.0021134517,0.0000011350288,0.032218605,0.0009948168,0.00008281297,0.000006357879,0.000029090548,0.00018282284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623585,0.00060897344,0.0007168775,0.00045762752,0.001335181,0.0006454937],"domain_scores_gemma":[0.99309504,0.0042129466,0.00020231829,0.0006777984,0.0005563651,0.001255504],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027492542,0.00016752169,0.00047555915,0.00006553096,0.00027498032,0.000024388357,0.00057225407,0.00021575454,0.0017442774],"category_scores_gemma":[0.015532738,0.000077786186,0.00044048455,0.00075804617,0.0006584295,0.000042523978,0.000226043,0.002287581,0.00006801417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00280113,0.0002525965,0.89180964,0.00027195524,0.000093787276,0.000006794012,0.00059837196,0.0000951675,0.00012320046,0.000012736704,0.083771504,0.020163098],"study_design_scores_gemma":[0.002412194,0.0017439788,0.96602714,0.0001709906,0.000026358392,8.2494853e-7,0.00006241926,0.00005578614,0.00006203267,0.00011972317,0.029237421,0.000081126105],"about_ca_topic_score_codex":0.0261027,"about_ca_topic_score_gemma":0.001625166,"teacher_disagreement_score":0.092800856,"about_ca_system_score_codex":0.0011571402,"about_ca_system_score_gemma":0.008738759,"threshold_uncertainty_score":0.9991683},"labels":[],"label_agreement":null},{"id":"W3090217457","doi":"10.1158/1078-0432.ccr-20-1693","title":"A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Exemestane; Medicine; Cohort; Breast cancer; Internal medicine; Population; Oncology; Placebo; Adverse effect; Prostate cancer; Clinical endpoint; Metastatic breast cancer; Cancer; Randomized controlled trial; Androgen receptor; Aromatase; Pathology","score_opus":0.07947601488622333,"score_gpt":0.46731957051276596,"score_spread":0.3878435556265426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090217457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013764,0.0016269522,0.000047858324,0.0012106113,0.000109181616,0.0065623475,0.00010243697,0.000019560293,0.00018342036],"genre_scores_gemma":[0.9946674,0.0013555336,0.0002080939,0.00035087593,0.0006852161,0.0020814051,0.00011208225,0.00006775346,0.00047165464],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99403095,0.0026269555,0.0008472057,0.0008942761,0.0009186566,0.0006819335],"domain_scores_gemma":[0.99744636,0.0007837468,0.00028105028,0.00031453435,0.0007274641,0.00044687392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038440118,0.00032142733,0.0012899275,0.00007701765,0.00022100248,0.000050680137,0.00030726302,0.00035010627,0.00014706733],"category_scores_gemma":[0.0016433798,0.00018319815,0.00020553714,0.00048358936,0.00071071874,0.000014568846,0.00020346294,0.0010856518,0.000008168329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98153055,0.0011181451,0.002460002,0.000022786551,0.0007367061,0.000018939858,0.00020438526,0.00006634677,0.0047421167,0.0000030096057,0.0007412633,0.008355764],"study_design_scores_gemma":[0.9591832,0.036978453,0.00036000216,0.00019194178,0.00018237588,0.0000020023156,0.00006953073,0.0012664605,0.0012757594,0.0000025105417,0.00017933853,0.00030841492],"about_ca_topic_score_codex":0.0002830007,"about_ca_topic_score_gemma":0.000120537305,"teacher_disagreement_score":0.035860308,"about_ca_system_score_codex":0.000100652716,"about_ca_system_score_gemma":0.0014584379,"threshold_uncertainty_score":0.74706036},"labels":[],"label_agreement":null},{"id":"W3091368850","doi":"10.1158/1078-0432.ccr-20-3331","title":"DNA Methylation Profiling of Premalignant Lesions as a Path to Ovarian Cancer Early Detection","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Serous fluid; DNA methylation; Methylation; Biology; Cancer research; Ovarian cancer; Fallopian tube; Epithelial ovarian cancer; DNA; Pathology; Cancer; Medicine; Genetics; Gene; Gene expression","score_opus":0.2878266441754698,"score_gpt":0.5183152205383363,"score_spread":0.23048857636286652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091368850","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07898599,0.0025129751,0.00018140777,0.91025895,0.0014556021,0.004924997,0.0004694295,0.00009758299,0.0011130861],"genre_scores_gemma":[0.6996944,0.00820954,0.0016056921,0.2568736,0.021906769,0.008039221,0.00025962866,0.00036771936,0.003043412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936775,0.00090181944,0.0013202302,0.0013784758,0.0019068611,0.0008151073],"domain_scores_gemma":[0.99569964,0.0013292119,0.00035358436,0.0008727229,0.0011895181,0.0005552994],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016005771,0.00038791573,0.0012793954,0.00041778642,0.00020355615,0.0000667625,0.00033889202,0.0009259443,0.00083213544],"category_scores_gemma":[0.0014561823,0.00031446503,0.00051908987,0.0011852231,0.00024977257,0.000076510965,0.00026197545,0.003750876,0.00019052006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004198067,0.00085266214,0.02500832,0.0041340943,0.0025925706,0.0024953606,0.00082051323,0.000021446245,0.009131092,0.00011352658,0.68551934,0.26511303],"study_design_scores_gemma":[0.0074242065,0.012113815,0.07871204,0.009313365,0.0019651616,0.000023011833,0.0001225364,0.00019114473,0.092154466,0.0012206945,0.7956838,0.0010757451],"about_ca_topic_score_codex":0.0071321353,"about_ca_topic_score_gemma":0.00030272262,"teacher_disagreement_score":0.65338534,"about_ca_system_score_codex":0.0009846445,"about_ca_system_score_gemma":0.0029653586,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W3091465868","doi":"10.1158/1557-3265.covid-19-po-068","title":"Abstract PO-068: Efforts to define biochemical and pharmacologic pathways potentially beneficial to both cancer and COVID-19 patients","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Windsor","funders":"","keywords":"Cancer; Medicine; Oncogene; Hydroxychloroquine; Drug repositioning; Pharmacology; Coronavirus disease 2019 (COVID-19); Drug; Bioinformatics; Biology; Cell cycle; Internal medicine; Disease","score_opus":0.32684767632827366,"score_gpt":0.539831035403601,"score_spread":0.21298335907532734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091465868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9416147,0.0015297389,0.000092856484,0.0541408,0.00031567996,0.0015488003,0.00037683835,0.00007569059,0.0003049033],"genre_scores_gemma":[0.94750893,0.0028008386,0.00037464924,0.047149744,0.0015448137,0.00047186922,0.000033750293,0.00004749792,0.00006791594],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99637014,0.00015330338,0.00074159674,0.0010313562,0.0009834978,0.00072012964],"domain_scores_gemma":[0.9957207,0.00063284324,0.000093649556,0.00025457022,0.00040071868,0.0028975324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012729806,0.00024488586,0.00059240486,0.00015581271,0.00022367222,0.00006367444,0.00022543705,0.0002495844,0.0014366],"category_scores_gemma":[0.0017103243,0.00021509804,0.00010793987,0.00059940724,0.00039112938,0.00006569418,0.00030326104,0.0009623197,0.000064409964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025881464,0.0012076426,0.2829701,0.0011414898,0.0003410121,0.00031336214,0.0012733313,0.0001773399,0.13348486,0.000108254004,0.39400786,0.15909328],"study_design_scores_gemma":[0.029845087,0.008816742,0.62124807,0.00068795576,0.00023644723,0.000016233356,0.00019956393,0.00023697082,0.036115553,0.0007765982,0.3005682,0.0012526067],"about_ca_topic_score_codex":0.0005743307,"about_ca_topic_score_gemma":0.00009520322,"teacher_disagreement_score":0.33827794,"about_ca_system_score_codex":0.00041770295,"about_ca_system_score_gemma":0.0011933383,"threshold_uncertainty_score":0.9994762},"labels":[],"label_agreement":null},{"id":"W3091560225","doi":"10.1158/1078-0432.ccr-20-2682","title":"Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; University of Chicago","keywords":"Cisplatin; Medicine; Cancer; Oncology; Internal medicine; Chemotherapy","score_opus":0.3250167528719663,"score_gpt":0.5483750320847276,"score_spread":0.2233582792127613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091560225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804283,0.0009937751,0.0000024143915,0.009251306,0.00022127196,0.00093316403,0.0002326556,0.000024939414,0.00029764284],"genre_scores_gemma":[0.98735696,0.008538584,0.000054057484,0.0030237925,0.00043943286,0.00026200726,0.000040957555,0.00003090701,0.00025327667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572796,0.0010749525,0.0013062034,0.0007823781,0.00057686056,0.0005316292],"domain_scores_gemma":[0.9933073,0.0051393276,0.0001751587,0.00032930687,0.00045772103,0.0005912138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018182466,0.0002070951,0.0013506976,0.00037268674,0.00007361331,0.000016608694,0.00022493121,0.0002709273,0.0013130473],"category_scores_gemma":[0.0025527542,0.00017323672,0.00037435256,0.0018893612,0.00072228006,0.000063133084,0.00023213062,0.0013643907,0.000011498611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004842412,0.00040311654,0.9848922,0.00016778064,0.001201668,0.00009109753,0.0005166045,0.0000551048,0.0007415866,0.000005427946,0.00090082065,0.0061822175],"study_design_scores_gemma":[0.005743787,0.0014413579,0.98658174,0.00006573296,0.0007154476,0.0000011296298,0.0002381805,0.0027161776,0.0003684376,0.000014637558,0.0019598617,0.00015352682],"about_ca_topic_score_codex":0.010169239,"about_ca_topic_score_gemma":0.030673318,"teacher_disagreement_score":0.020504078,"about_ca_system_score_codex":0.00010572771,"about_ca_system_score_gemma":0.0007434132,"threshold_uncertainty_score":0.9995999},"labels":[],"label_agreement":null},{"id":"W3091570384","doi":"10.1158/1078-0432.ccr-20-1163","title":"Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pancreas Centre (Canada); University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canada Foundation for Innovation","keywords":"Pembrolizumab; Context (archaeology); Medicine; Immune checkpoint; Nivolumab; Oncology; Cancer; Internal medicine; Immunotherapy; Transcriptome; Population; Tumor microenvironment; Lung cancer; Cancer research; Biology; Gene; Gene expression; Genetics","score_opus":0.1321516415974539,"score_gpt":0.4743217142130647,"score_spread":0.3421700726156108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091570384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963534,0.0056943432,0.00000791568,0.029306415,0.00013369894,0.0010835553,0.00003308179,0.000024589912,0.00018238516],"genre_scores_gemma":[0.99653286,0.001957479,0.00019011612,0.00084827526,0.00015617129,0.00011954395,0.0000045642623,0.00003706181,0.00015391543],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963723,0.0005660112,0.0013085318,0.00059088354,0.00062590616,0.0005363738],"domain_scores_gemma":[0.99820924,0.00059084554,0.000102687074,0.000347601,0.00022189744,0.00052770396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005126199,0.00016985938,0.0007333111,0.00033564316,0.000056621462,0.00001673799,0.00022850734,0.00015388003,0.00028199083],"category_scores_gemma":[0.0014968117,0.00014896138,0.00022957684,0.0014591293,0.0006598955,0.00007264744,0.00012669525,0.0007193542,0.000013861661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11348456,0.00015808834,0.013815309,0.00021672765,0.000114410854,0.00006707713,0.0013323007,0.0000052876453,0.84607947,0.0000015920187,0.00012275497,0.02460244],"study_design_scores_gemma":[0.011188149,0.005854154,0.8862417,0.0007554172,0.000023917113,0.0000077441855,0.0014326825,0.00005900103,0.073985696,0.000025035439,0.020167992,0.0002585449],"about_ca_topic_score_codex":0.0004573751,"about_ca_topic_score_gemma":0.00007170694,"teacher_disagreement_score":0.87242633,"about_ca_system_score_codex":0.00020981659,"about_ca_system_score_gemma":0.000696298,"threshold_uncertainty_score":0.60744685},"labels":[],"label_agreement":null},{"id":"W3091625009","doi":"10.1158/1078-0432.ccr-20-1068","title":"Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2− Advanced Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Novartis","keywords":"Exemestane; Everolimus; Postmenopausal women; Clinical trial; Breast cancer; Phases of clinical research; Cancer","score_opus":0.10019270655209407,"score_gpt":0.48215270754783834,"score_spread":0.3819600009957443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091625009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98742867,0.0008096924,0.000050449118,0.009401512,0.0000712596,0.0020597863,0.000071542505,0.000034282926,0.000072788454],"genre_scores_gemma":[0.99681383,0.0011851933,0.00037509802,0.00049037184,0.0002376695,0.0007513501,0.000019603413,0.000060301383,0.00006654986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963327,0.00040957972,0.0008477235,0.00073095376,0.001037917,0.00064111006],"domain_scores_gemma":[0.997913,0.0005532812,0.00022232092,0.00032100343,0.00055393885,0.00043648147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012664602,0.00024153288,0.0008582244,0.00024027692,0.000061821265,0.000019098432,0.00016642043,0.00016263471,0.00020449077],"category_scores_gemma":[0.00023657177,0.00018315786,0.000032470176,0.0013625787,0.0006971323,0.00031960823,0.00009174522,0.0010477935,0.0000024121537],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6187199,0.0025508236,0.055227485,0.00028256525,0.00009390579,0.000121661025,0.0015938865,0.00021364768,0.0042313933,0.0000421169,0.000018470682,0.31690416],"study_design_scores_gemma":[0.47767553,0.04208178,0.47381127,0.0013540116,0.000048688365,0.000028468094,0.0017116189,0.00095072674,0.0007245824,0.00032018268,0.0009080495,0.00038507834],"about_ca_topic_score_codex":0.0008234541,"about_ca_topic_score_gemma":0.00087765796,"teacher_disagreement_score":0.41858378,"about_ca_system_score_codex":0.0006232455,"about_ca_system_score_gemma":0.0011368308,"threshold_uncertainty_score":0.746896},"labels":[],"label_agreement":null},{"id":"W3091793382","doi":"10.1158/1078-0432.ccr-20-1835","title":"Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"Genentech","keywords":"KRAS; Adenocarcinoma; Cancer research; Biology; Druggability; Phenotype; Lung cancer; Population; Cancer; Medicine; Oncology; Genetics; Gene; Colorectal cancer","score_opus":0.20612529336943977,"score_gpt":0.5282688890374881,"score_spread":0.3221435956680484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091793382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96910536,0.0036915422,0.00005428901,0.025776079,0.000105919666,0.00083532656,0.000083924584,0.000026559908,0.00032100698],"genre_scores_gemma":[0.9961671,0.00029448405,0.00026408274,0.002288825,0.00043320525,0.00033510147,0.00003114023,0.000019633837,0.00016640621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790823,0.00028159385,0.0004540241,0.00052425225,0.00050023274,0.00033164897],"domain_scores_gemma":[0.9987421,0.00036109446,0.000028249675,0.00016512717,0.00024009407,0.0004633561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008765127,0.00010888887,0.00030605705,0.00012756836,0.00011895922,0.00004651983,0.000056852285,0.000074481955,0.00025883268],"category_scores_gemma":[0.00056493276,0.00009378224,0.00008769914,0.00040647903,0.00024681818,0.0001080333,0.00006637095,0.00054143585,0.00003141708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021992687,0.0003103355,0.9822314,0.00044980284,0.00012787129,0.00025002286,0.0022380087,0.000027702423,0.0031091343,0.00064744835,0.005726699,0.0026823487],"study_design_scores_gemma":[0.0028236855,0.00087990286,0.9897864,0.00018635401,0.00006313458,0.000009447502,0.0005410043,0.00022567005,0.0016451838,0.00037852742,0.0033500153,0.00011066973],"about_ca_topic_score_codex":0.0007956088,"about_ca_topic_score_gemma":0.0012048006,"teacher_disagreement_score":0.02706177,"about_ca_system_score_codex":0.000250173,"about_ca_system_score_gemma":0.00046373258,"threshold_uncertainty_score":0.38243288},"labels":[],"label_agreement":null},{"id":"W3091923748","doi":"10.1158/1078-0432.ccr-20-2831","title":"Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University Health Network; University of Calgary; Canada's Michael Smith Genome Sciences Centre; Ontario Institute for Cancer Research; Ottawa Hospital; BC Cancer Agency; University of British Columbia; Pancreas Centre (Canada)","funders":"BC Cancer Foundation","keywords":"Subtyping; KRAS; Oncology; Internal medicine; Adenocarcinoma; Biology; Medicine; Cancer; Cancer research; Colorectal cancer","score_opus":0.22815498509106677,"score_gpt":0.50826000173129,"score_spread":0.28010501664022325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091923748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97785455,0.0023087142,0.00010025239,0.017288212,0.0002674176,0.0010286222,0.000045628487,0.00006197681,0.0010446523],"genre_scores_gemma":[0.98827755,0.005659991,0.00046844408,0.002855148,0.0018638495,0.000150417,0.000034327793,0.000064160646,0.0006260953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939661,0.0014631039,0.0014875842,0.001034934,0.0010706,0.0009776847],"domain_scores_gemma":[0.99452466,0.002344966,0.00016619949,0.0005904946,0.00055023475,0.0018234343],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004534444,0.0002697857,0.0015726932,0.0001417517,0.00017444557,0.000068902766,0.00041209412,0.00030022927,0.0008899329],"category_scores_gemma":[0.009795209,0.0002151619,0.0002805903,0.0004958352,0.0030387002,0.000083003375,0.00064330763,0.0029120708,0.00034070705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030114679,0.0003083187,0.98164135,0.0003190421,0.00030931117,0.0030165378,0.00016874797,5.156442e-8,0.0005887363,0.00024437415,0.0043527805,0.006039285],"study_design_scores_gemma":[0.003513655,0.003930791,0.98733556,0.00028021308,0.00027169316,0.00009925771,0.00026935904,0.0017003781,0.00010586217,0.00024383672,0.002029073,0.00022030441],"about_ca_topic_score_codex":0.00013902958,"about_ca_topic_score_gemma":0.000017889579,"teacher_disagreement_score":0.014433063,"about_ca_system_score_codex":0.0000978916,"about_ca_system_score_gemma":0.001796603,"threshold_uncertainty_score":0.99967444},"labels":[],"label_agreement":null},{"id":"W3091967376","doi":"","title":"Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Workforce; Pandemic; Health care; Cancer; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.7988329319751516,"score_gpt":0.7403036557498638,"score_spread":0.05852927622528781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091967376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393404,0.002205014,8.232099e-7,0.056408107,0.0001967966,0.001642373,0.00011125736,0.000008229396,0.00008700735],"genre_scores_gemma":[0.99016964,0.0014901166,0.0000029454734,0.007364233,0.0007645579,0.00015834287,0.000009779844,0.000020928323,0.000019433966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914005,0.004605298,0.00089892367,0.0005591846,0.0018888512,0.0006472707],"domain_scores_gemma":[0.98345476,0.013504618,0.00014365952,0.00037299792,0.0006081799,0.0019157511],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0123107545,0.00015211114,0.00080764556,0.00008819143,0.00014633175,0.000013510945,0.0003190857,0.00020442551,0.0008531524],"category_scores_gemma":[0.05547851,0.00009313744,0.00008491379,0.0008660389,0.00036908675,0.000023383678,0.00025841984,0.0021414834,0.0000022274994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014727347,0.00017013334,0.8509913,0.00021725903,0.00007250798,0.00015977967,0.0043646395,0.0003975053,0.000007092089,0.0000023152174,0.0041212076,0.12476893],"study_design_scores_gemma":[0.006961126,0.015319047,0.9700392,0.00019461497,0.000024287712,0.0000021115275,0.004045019,0.0016302788,0.0000034409786,0.000007997369,0.0016830297,0.000089880006],"about_ca_topic_score_codex":0.9921324,"about_ca_topic_score_gemma":0.9945752,"teacher_disagreement_score":0.14715771,"about_ca_system_score_codex":0.0052577,"about_ca_system_score_gemma":0.15241542,"threshold_uncertainty_score":0.99856097},"labels":[],"label_agreement":null},{"id":"W3092102011","doi":"","title":"Performance comparison of fiveextraction kits for SARS-CoV-2 RNA extraction","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleic acid; RNA; RNA extraction; Nucleic acid methods; Medicine; Virology; Biology; Biochemistry","score_opus":0.6460183383802717,"score_gpt":0.6232131681331471,"score_spread":0.022805170247124584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092102011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331564,0.00028808595,0.00061947346,0.002059716,0.0004900466,0.00072132406,0.000008466328,0.00007873211,0.0024185004],"genre_scores_gemma":[0.9969469,0.00012049736,0.00056210044,0.0009890925,0.0011660052,0.000109456254,0.00000583902,0.0000289955,0.00007116308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977237,0.00015890652,0.000777257,0.0004095714,0.00059064804,0.00033991196],"domain_scores_gemma":[0.9973427,0.0013381998,0.00021300628,0.00021788283,0.0007877353,0.00010048265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015470962,0.00011274334,0.00044428476,0.00011899852,0.00016041716,0.000019296956,0.00012521433,0.00019225449,0.0000452131],"category_scores_gemma":[0.0037176292,0.00010389716,0.00017776205,0.0005405906,0.0002051494,0.00014818838,0.000048221573,0.0010843746,0.000069381866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002858869,0.00027522954,0.04287678,0.00041330326,0.000051345112,0.000003218619,0.00021535925,0.000008361242,0.76390445,0.00001595341,0.0056404043,0.18373673],"study_design_scores_gemma":[0.002115735,0.0021498143,0.01451694,0.00017776128,0.000045608176,0.0000057063744,0.00020095964,0.047527026,0.892544,0.00002196841,0.040592805,0.00010169724],"about_ca_topic_score_codex":0.00015355629,"about_ca_topic_score_gemma":0.000040732735,"teacher_disagreement_score":0.18363503,"about_ca_system_score_codex":0.00011233255,"about_ca_system_score_gemma":0.00029960755,"threshold_uncertainty_score":0.47111285},"labels":[],"label_agreement":null},{"id":"W3092148112","doi":"10.1158/1078-0432.ccr-20-2065","title":"Intratumoral Injection of <i>Clostridium novyi</i> -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Sepsis; Gastroenterology; Pathology; Biology","score_opus":0.06962906226986716,"score_gpt":0.4379649103277885,"score_spread":0.36833584805792136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092148112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978698,0.0006034071,0.0000057651832,0.0003524398,0.00007299459,0.0006730715,0.00013151621,0.000008387893,0.00028262375],"genre_scores_gemma":[0.9982514,0.00086723815,0.000050814466,0.00010633937,0.0002725228,0.0001584314,0.00016614833,0.00003087559,0.00009625828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764645,0.00025824248,0.0004659132,0.0005970224,0.000515862,0.00051653496],"domain_scores_gemma":[0.9988287,0.0000714899,0.000112488386,0.000321807,0.00033960812,0.0003259012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032639483,0.00017615898,0.0003644541,0.00008558944,0.000061940154,0.000019216472,0.0002343968,0.00012485194,0.00006757155],"category_scores_gemma":[0.00028763255,0.00013497504,0.000104499966,0.00042616154,0.00037430422,0.000013975249,0.00014024257,0.00038159802,0.00001149561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019665776,0.0017698618,0.9264029,0.0000716753,0.00019111374,0.000038421153,0.00008815025,0.00017640366,0.011642372,0.000007639674,0.0019201454,0.038025532],"study_design_scores_gemma":[0.028427353,0.06535354,0.6074912,0.00022410222,0.000040645988,0.0000024025737,0.00023650659,0.00005563946,0.2801132,0.00006461765,0.017402688,0.0005880859],"about_ca_topic_score_codex":0.0009997978,"about_ca_topic_score_gemma":0.0012960362,"teacher_disagreement_score":0.3189117,"about_ca_system_score_codex":0.00015657186,"about_ca_system_score_gemma":0.0008104562,"threshold_uncertainty_score":0.5504122},"labels":[],"label_agreement":null},{"id":"W3092243224","doi":"10.1158/1078-0432.ccr-20-3292","title":"Project Orbis: Global Collaborative Review Program","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Excellence; Confidentiality; Center of excellence; Regulatory science; Marketing authorization; Global health; Program evaluation","score_opus":0.6066273559795285,"score_gpt":0.7039953562276421,"score_spread":0.09736800024811354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092243224","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0089259045,0.08761716,0.000045803125,0.8830042,0.00036070007,0.006174699,0.00008393121,0.00021482982,0.013572805],"genre_scores_gemma":[0.49913517,0.4108294,0.004707359,0.07388536,0.0069568628,0.0023948716,0.00021166868,0.00008030231,0.0017990333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996891,0.0005732576,0.00054613565,0.00045366547,0.0011771483,0.00035877427],"domain_scores_gemma":[0.99767953,0.0002561975,0.000069860806,0.00023427593,0.0012183925,0.00054172415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027851094,0.000098212826,0.00044574472,0.000024128823,0.00009504018,0.00002630497,0.00016977315,0.000267056,0.00045477744],"category_scores_gemma":[0.00275167,0.00006477165,0.00013260468,0.002222946,0.0015796776,0.000037332036,0.0001456052,0.0012332597,0.00011858345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007053813,0.0004264037,0.004995315,0.003151304,0.000109823704,0.00006442523,0.000085033236,1.145494e-7,0.00002903154,0.001386798,0.30975994,0.6792864],"study_design_scores_gemma":[0.0014388375,0.0027911463,0.01408375,0.0023815525,0.00006746962,0.0000036691172,0.00007882188,0.0003667851,0.00001833669,0.00045555213,0.9782094,0.000104708066],"about_ca_topic_score_codex":0.00012393956,"about_ca_topic_score_gemma":0.000044070683,"teacher_disagreement_score":0.8091188,"about_ca_system_score_codex":0.000119933604,"about_ca_system_score_gemma":0.0030515755,"threshold_uncertainty_score":0.58203876},"labels":[],"label_agreement":null},{"id":"W3092313383","doi":"10.1158/1557-3265.covid-19-po-026","title":"Abstract PO-026: Minimize impact of pandemic on radiation oncology department: Experience from a moderate-sized regional cancer program in the battle against COVID-19 virus","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Windsor Regional Hospital; Western University","funders":"","keywords":"Personal protective equipment; Medicine; Pandemic; Radiation oncology; Cancer; Family medicine; Coronavirus disease 2019 (COVID-19); Battle; Medical emergency; Radiation therapy; Surgery; Disease; Internal medicine","score_opus":0.3772477089078819,"score_gpt":0.6440477560393814,"score_spread":0.26680004713149946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092313383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97325283,0.0039414885,0.0000793935,0.020543367,0.00030781477,0.0013629595,0.00012590694,0.000038251063,0.00034799756],"genre_scores_gemma":[0.96435064,0.023024818,0.00035505235,0.009839032,0.0011356521,0.0011832642,0.00006549591,0.000022293698,0.000023733632],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966013,0.0009843148,0.0007448217,0.0005757522,0.0006253787,0.00046845726],"domain_scores_gemma":[0.98936886,0.009502279,0.0002241531,0.00034123848,0.00013901763,0.00042443155],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015505844,0.00017380739,0.00065965566,0.0000858507,0.00014551474,0.000014226122,0.00038679724,0.0003638748,0.0009861183],"category_scores_gemma":[0.003318553,0.00010962713,0.00022724026,0.00046950232,0.0010772884,0.000079928264,0.000043758384,0.001427895,0.000014773688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08468121,0.003909778,0.3852302,0.000119810786,0.00052291516,0.00043522866,0.010429963,0.005859845,0.003083384,0.000049188642,0.038270384,0.46740806],"study_design_scores_gemma":[0.033319317,0.012026332,0.7190851,0.00027787278,0.00007881858,0.000010995647,0.0016016746,0.008637952,0.0007676456,0.00070301065,0.22302495,0.00046635125],"about_ca_topic_score_codex":0.0019817739,"about_ca_topic_score_gemma":0.0008381737,"teacher_disagreement_score":0.4669417,"about_ca_system_score_codex":0.0012454403,"about_ca_system_score_gemma":0.0034952338,"threshold_uncertainty_score":0.9999271},"labels":[],"label_agreement":null},{"id":"W3092318104","doi":"10.1158/1557-3265.covid-19-s12-01","title":"Abstract S12-01: High mortality among hospital-acquired COVID-19 infection in patients with cancer: An observational cohort study from Quebec and British Columbia","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Hôpital Charles-Le Moyne; Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cancer; Incidence (geometry); Intensive care unit; Population; Cohort study; Coronavirus disease 2019 (COVID-19); Emergency medicine; Observational study; Cohort; Pediatrics; Internal medicine; Intensive care medicine; Disease; Infectious disease (medical specialty); Environmental health","score_opus":0.355947358486343,"score_gpt":0.5422539438001731,"score_spread":0.1863065853138301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092318104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905512,0.00012509497,0.0000030521644,0.0054407753,0.00020664559,0.0032309766,0.00036066014,0.00006655638,0.000015058069],"genre_scores_gemma":[0.99453425,0.0005256167,0.000012777917,0.0034822787,0.0006031162,0.00043675274,0.00031115467,0.00003529945,0.000058724454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958628,0.00049421756,0.0008148064,0.00096626824,0.0013588794,0.0005030733],"domain_scores_gemma":[0.9965066,0.0007961429,0.00016897974,0.00037655377,0.0006098288,0.0015419401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019164993,0.00014902485,0.00065642607,0.00005876075,0.0002651509,0.00024566092,0.0001472855,0.00022328112,0.0014217311],"category_scores_gemma":[0.0031615323,0.0001771858,0.000054278695,0.0006172978,0.00049069175,0.00036607267,0.00012545659,0.0008962931,0.0000042756747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00113,0.0014245722,0.986741,0.00021869187,0.00013423954,0.00011052853,0.00043160515,0.000019283165,0.0000014816625,8.535454e-7,0.0035638988,0.0062238337],"study_design_scores_gemma":[0.0067919944,0.002838212,0.9891566,0.00018201825,0.000058626774,1.3369372e-7,0.00011445005,0.00006520087,5.9691456e-7,0.000051889718,0.00055327645,0.00018701702],"about_ca_topic_score_codex":0.9866183,"about_ca_topic_score_gemma":0.98219854,"teacher_disagreement_score":0.0060368166,"about_ca_system_score_codex":0.001157745,"about_ca_system_score_gemma":0.0042716186,"threshold_uncertainty_score":0.9994911},"labels":[],"label_agreement":null},{"id":"W3092334961","doi":"10.1158/1078-0432.ccr-20-2380","title":"Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Neutropenia; Lymphoma; Refractory (planetary science); Gastroenterology; Cancer; Context (archaeology); Oncology; Chemotherapy","score_opus":0.08114341508681919,"score_gpt":0.43927453802527827,"score_spread":0.35813112293845906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092334961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972044,0.001726385,0.000058533977,0.000107137595,0.000079687736,0.0007249104,0.000025483483,0.0000048229094,0.000068625166],"genre_scores_gemma":[0.99792963,0.001430152,0.00016508801,0.00005197022,0.00025308802,0.000070614675,0.00004188297,0.000034514243,0.000023074692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973456,0.00045129715,0.0006864245,0.0006864631,0.0004960238,0.0003341368],"domain_scores_gemma":[0.9986271,0.00015776574,0.00016678043,0.0003728351,0.00041354392,0.0002619486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010334193,0.00016429069,0.0003750151,0.000094006486,0.00007257444,0.000020787365,0.00021594595,0.0001594216,0.00001389425],"category_scores_gemma":[0.0004767325,0.00014190043,0.000052052834,0.0003936306,0.0002606935,0.000010451967,0.00022523747,0.00031191943,0.0000027799042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017824043,0.027741043,0.5354749,0.00012456712,0.00017984604,0.000037085534,0.00089615653,0.0002064249,0.12208204,0.0000048781503,0.0007512272,0.2946778],"study_design_scores_gemma":[0.15790565,0.08496115,0.5582027,0.00017878968,0.000051165523,2.3709849e-7,0.0012478293,0.00035204866,0.18110944,0.000063863285,0.015113024,0.0008141044],"about_ca_topic_score_codex":0.000058525802,"about_ca_topic_score_gemma":0.00010085735,"teacher_disagreement_score":0.29386368,"about_ca_system_score_codex":0.00003278866,"about_ca_system_score_gemma":0.00021449942,"threshold_uncertainty_score":0.5786531},"labels":[],"label_agreement":null},{"id":"W3092540063","doi":"","title":"Factors affecting COVID-19 outcomes incancer patients: A first report from Guy's Cancer Centre inLondon","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Internal medicine; Cancer; Disease; Pediatrics; Infectious disease (medical specialty)","score_opus":0.6203812390119073,"score_gpt":0.6331490667619192,"score_spread":0.01276782775001184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092540063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8282413,0.0011926484,0.000024814446,0.16751644,0.00091869175,0.001394682,0.0003311942,0.00016128743,0.0002189299],"genre_scores_gemma":[0.96318686,0.0015252104,0.000031255648,0.03243997,0.0019272208,0.00011015602,0.00015992016,0.00008017968,0.0005392088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937992,0.0005388037,0.0013516129,0.001298774,0.00183333,0.0011782615],"domain_scores_gemma":[0.9879522,0.0065572774,0.00036310116,0.00079155486,0.0009081672,0.0034277255],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019407881,0.00036312858,0.0011834383,0.00017813292,0.00048813375,0.000082617895,0.0003991642,0.0004245826,0.0041346224],"category_scores_gemma":[0.043029156,0.000272736,0.00040502692,0.00096781756,0.00038911297,0.00017107517,0.00047410504,0.002328436,0.00008308227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011959113,0.00026751915,0.91712403,0.0006330256,0.00019985174,0.00028694898,0.0026577525,0.000015455085,0.000015967946,0.0000027599835,0.06997276,0.0076280027],"study_design_scores_gemma":[0.0037382264,0.0004767258,0.780884,0.00028703926,0.00007490067,6.823774e-7,0.000647295,0.000055315006,0.00010180946,0.000039621053,0.21346411,0.0002302367],"about_ca_topic_score_codex":0.089076206,"about_ca_topic_score_gemma":0.027903525,"teacher_disagreement_score":0.14349134,"about_ca_system_score_codex":0.0023430642,"about_ca_system_score_gemma":0.006524187,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W3092571841","doi":"","title":"Operationalizing a prioritized COVID-19testing strategy at a Canadian tertiary care cancer center","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Internal medicine; Lung cancer; Population; Neutropenia; Surgery; Chemotherapy","score_opus":0.6061589732590208,"score_gpt":0.6413230180004906,"score_spread":0.035164044741469835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092571841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7365823,0.0081333015,0.00001040292,0.25080255,0.00033102714,0.0017023992,0.0003859368,0.00010713309,0.0019449515],"genre_scores_gemma":[0.93116516,0.0014126136,0.000077619654,0.064313516,0.0022082888,0.00022379868,0.00008896052,0.000048831538,0.0004612162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960853,0.00048286363,0.00070901134,0.0007501934,0.0008996662,0.0010729561],"domain_scores_gemma":[0.9939163,0.0010920328,0.00006587255,0.00033413747,0.0010145687,0.0035770875],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001215793,0.00019097675,0.0004828192,0.00016815317,0.00057963986,0.00009381065,0.00025498483,0.000254441,0.0028181942],"category_scores_gemma":[0.00493975,0.00017010537,0.0001610818,0.000560537,0.00026479244,0.00010616817,0.0001934937,0.0014373,0.00013427807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095323473,0.000052030817,0.9326987,0.0012361631,0.00007332298,0.00065835315,0.0021204124,0.000046374083,0.0005213552,0.000053920183,0.03274778,0.028838318],"study_design_scores_gemma":[0.007054653,0.00077916763,0.55687976,0.0010120608,0.00006103677,0.000026654292,0.0010373999,0.0011504793,0.0002309408,0.00003550011,0.43134707,0.00038530206],"about_ca_topic_score_codex":0.39736375,"about_ca_topic_score_gemma":0.52141017,"teacher_disagreement_score":0.3985993,"about_ca_system_score_codex":0.0031410619,"about_ca_system_score_gemma":0.02389881,"threshold_uncertainty_score":0.99809337},"labels":[],"label_agreement":null},{"id":"W3092635944","doi":"10.1158/1078-0432.ccr-20-2925","title":"Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"National Cancer Institute; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Proinflammatory cytokine; Transcriptome; Immune system; Prostate; Cancer; Cancer research; Tumor microenvironment; Medicine; Biology; Immunology; Inflammation; Gene; Internal medicine; Gene expression; Genetics","score_opus":0.34410766421591554,"score_gpt":0.5275851019976024,"score_spread":0.1834774377816869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092635944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576682,0.0038222137,0.0000049397577,0.026558146,0.000057071175,0.0028125197,0.00019516892,0.00007054259,0.008811231],"genre_scores_gemma":[0.9874835,0.007927956,0.00020054633,0.00060489087,0.0005184047,0.0016793717,0.000056043635,0.000057129644,0.0014721296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948052,0.0009147596,0.00090198946,0.0010454057,0.0010905598,0.0012420805],"domain_scores_gemma":[0.9966659,0.0010483066,0.00022608139,0.00047829727,0.00066144223,0.0009199758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001817057,0.00031584932,0.001376283,0.00019231651,0.00021603328,0.00007088792,0.0004531242,0.00012735989,0.000417542],"category_scores_gemma":[0.00042043126,0.00020921585,0.00016199576,0.002036426,0.0022210693,0.00010491997,0.0003550986,0.0020838205,0.00009103243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05003782,0.0012480624,0.8740198,0.00042955295,0.00063268305,0.0012189469,0.009527575,0.00009284055,0.007984705,0.000060122617,0.012338579,0.042409305],"study_design_scores_gemma":[0.014436746,0.014002126,0.9213706,0.0006006746,0.00012818452,0.000008875096,0.00969919,0.0014389255,0.0042169075,0.0002562787,0.03320258,0.0006388889],"about_ca_topic_score_codex":0.003211262,"about_ca_topic_score_gemma":0.0011626199,"teacher_disagreement_score":0.047350816,"about_ca_system_score_codex":0.0013665498,"about_ca_system_score_gemma":0.0030583136,"threshold_uncertainty_score":0.9053279},"labels":[],"label_agreement":null},{"id":"W3092636096","doi":"10.1158/1078-0432.ccr-20-2868","title":"A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"European Regional Development Fund; Instituto de Salud Carlos III; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; Generalitat de Catalunya; Ministerio de Economía y Competitividad; National Institutes of Health; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya","keywords":"Cyclin D1; Mantle cell lymphoma; Cancer research; Cyclin D; Biology; Cyclin; Cyclin A2; Cyclin B; Cell cycle; Chromatin; Cyclin D2; Lymphoma; Gene; Genetics; Immunology","score_opus":0.4512327535473243,"score_gpt":0.5734693192376064,"score_spread":0.12223656569028207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092636096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652419,0.0020577176,0.000007652688,0.02592807,0.00065999426,0.0021875482,0.00008570112,0.00012062502,0.0037107952],"genre_scores_gemma":[0.98943293,0.0030767322,0.0004864258,0.002949923,0.0016553698,0.001051976,0.000054265787,0.00004721914,0.0012451514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99396455,0.00078820577,0.0018620074,0.0010770478,0.001465428,0.00084275816],"domain_scores_gemma":[0.99660844,0.0013302647,0.00011733676,0.00048408067,0.0002782893,0.0011816206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033170087,0.00024925644,0.00093752076,0.00013115353,0.00009822739,0.00006131901,0.0003561057,0.00040858297,0.00093074975],"category_scores_gemma":[0.0010886436,0.0001946804,0.00054224586,0.0005755753,0.00050437875,0.00008576763,0.00018898475,0.0009970512,0.0006914364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023229509,0.00942485,0.8531904,0.00018658303,0.000110024346,0.0008726597,0.00010733436,0.000004469846,0.000029941568,0.00007504405,0.01020624,0.12346946],"study_design_scores_gemma":[0.02290866,0.0040110066,0.9023491,0.00014865321,0.00009064664,0.000007713516,0.00010071697,0.0006253516,0.0001887344,0.00008314785,0.069303684,0.00018257988],"about_ca_topic_score_codex":0.00043099298,"about_ca_topic_score_gemma":0.00020807801,"teacher_disagreement_score":0.12328688,"about_ca_system_score_codex":0.0004136204,"about_ca_system_score_gemma":0.0012382495,"threshold_uncertainty_score":0.99998254},"labels":[],"label_agreement":null},{"id":"W3092934524","doi":"10.1158/1557-3265.ovcasymp18-dp-005","title":"Abstract DP-005: RNA-SEQUENCING OF FALLOPIAN TUBE – FIMBRIA AND HGSC FROM BRCA MUTATION CARRIERS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fallopian tube; Biology; BRCA mutation; Internal medicine; Laser capture microdissection; Medicine; Gynecology; Pathology; Genetics; Gene; Cancer; Ovarian cancer; Gene expression","score_opus":0.21271193833168642,"score_gpt":0.5040314976737521,"score_spread":0.29131955934206566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092934524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927072,0.0013917425,0.000004398943,0.0016541037,0.000360353,0.00050006894,0.000039358987,0.0000146178845,0.0033281795],"genre_scores_gemma":[0.9983666,0.0003943343,0.0000821785,0.00016107933,0.00039664912,0.000019147523,0.00002515495,0.0000114716895,0.00054337486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980045,0.00028511253,0.00049362524,0.0005841946,0.0003517266,0.00028086058],"domain_scores_gemma":[0.997922,0.00095252664,0.00008388078,0.00048471877,0.00035889985,0.00019796721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028078016,0.000091559916,0.00040032712,0.00006582479,0.00006076931,0.000009109324,0.000117226984,0.00024013728,0.00090282236],"category_scores_gemma":[0.002298556,0.00007270929,0.0000893211,0.00015591185,0.00071373297,0.00007442903,0.000078808574,0.00084297755,0.00004176047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063886773,0.00010219051,0.90041375,0.000199226,0.00019054535,0.000030244073,0.0004608164,0.0000055400433,0.056835484,0.00006831924,0.0007728137,0.03453237],"study_design_scores_gemma":[0.0012517968,0.00045409676,0.98694,0.000120840545,0.000021655183,0.0000019387992,0.0003318492,0.00007161303,0.008102715,0.0008220991,0.0018124391,0.00006895191],"about_ca_topic_score_codex":0.0031791003,"about_ca_topic_score_gemma":0.0001997472,"teacher_disagreement_score":0.08652623,"about_ca_system_score_codex":0.00013299222,"about_ca_system_score_gemma":0.00061220175,"threshold_uncertainty_score":0.9885272},"labels":[],"label_agreement":null},{"id":"W3093653710","doi":"10.1158/1078-0432.ccr-20-2669","title":"Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint Inhibitors","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Pembrolizumab; Adverse effect; Internal medicine; Toxicity; Oncology; Renal cell carcinoma; Incidence (geometry); Melanoma; Clinical trial; Lung cancer; Cancer; Immunotherapy; Cancer research","score_opus":0.6305114855276522,"score_gpt":0.6382727501066128,"score_spread":0.007761264578960536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093653710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00668963,0.9596933,0.0002445197,0.001524141,0.0040411246,0.02750054,0.00016797832,0.00008664865,0.000052133604],"genre_scores_gemma":[0.0004471088,0.98225576,0.00050387974,0.00009591874,0.011865957,0.004165304,0.00016018408,0.0001468995,0.00035899112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98447895,0.0052317013,0.0062074917,0.0018852269,0.0012516576,0.00094498845],"domain_scores_gemma":[0.981611,0.014756089,0.0010387172,0.0010860736,0.0006419189,0.00086619146],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.036283724,0.0006219337,0.005055153,0.00028192627,0.0002991983,0.00017618937,0.00051162136,0.0017288985,0.00033723103],"category_scores_gemma":[0.012936607,0.00046301205,0.0035581442,0.0009781067,0.0016521822,0.00012662099,0.0002995317,0.0037683477,0.00004053489],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4586735,0.0010577618,0.000009982554,0.00272558,0.0005442383,0.000011904152,0.000020797048,1.3450136e-8,0.0000025266365,0.0000036857869,0.0018015599,0.53514844],"study_design_scores_gemma":[0.3406413,0.030472284,0.00006838964,0.0031779902,0.00089817605,0.0000040864425,0.000010781018,0.000025613606,0.000005464177,0.000063306485,0.6243293,0.00030327364],"about_ca_topic_score_codex":0.00023450864,"about_ca_topic_score_gemma":0.000013553282,"teacher_disagreement_score":0.6225278,"about_ca_system_score_codex":0.0006624081,"about_ca_system_score_gemma":0.0065312604,"threshold_uncertainty_score":0.99978215},"labels":[],"label_agreement":null},{"id":"W3093953010","doi":"10.1158/1557-3265.covid-19-po-075","title":"Abstract PO-075: Performance comparison of five extraction kits for SARS-CoV-2 RNA extraction","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"","keywords":"Nucleic acid; Nucleic acid methods; RNA; RNA extraction; Medicine; Coronavirus disease 2019 (COVID-19); Virology; Biology; Infectious disease (medical specialty); Disease; Internal medicine; Biochemistry","score_opus":0.5439409312405266,"score_gpt":0.5992797718588352,"score_spread":0.05533884061830863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093953010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257994,0.00039547196,0.00042204026,0.001831943,0.00060514273,0.0008963129,0.000019834253,0.000098517354,0.0031507888],"genre_scores_gemma":[0.9967631,0.00016585308,0.00047409075,0.0009285616,0.0014036658,0.00012796046,0.00001134795,0.000041322863,0.000084091414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707115,0.00013421422,0.0010373052,0.0005382731,0.0007661396,0.0004529399],"domain_scores_gemma":[0.996402,0.0018605557,0.00033088814,0.00028313644,0.0009812715,0.00014212725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001890598,0.00016216983,0.0005624071,0.00015690237,0.00020309418,0.00003232509,0.0001726085,0.0002705511,0.00008209092],"category_scores_gemma":[0.0041983724,0.00015088604,0.00021508739,0.0006198621,0.00024586706,0.00022825,0.000057638015,0.0015626706,0.00010086241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004099091,0.00044078403,0.019070731,0.00062684546,0.00008228901,0.000009382279,0.00031947094,0.000018541603,0.78179276,0.000014982592,0.0070284703,0.18649665],"study_design_scores_gemma":[0.002692711,0.0017747062,0.040033206,0.00029874346,0.000056151417,0.000008792411,0.00039065542,0.018972702,0.9072179,0.00003155507,0.028365402,0.00015743902],"about_ca_topic_score_codex":0.00035100305,"about_ca_topic_score_gemma":0.00007657606,"teacher_disagreement_score":0.18633921,"about_ca_system_score_codex":0.00016474855,"about_ca_system_score_gemma":0.00044049683,"threshold_uncertainty_score":0.6789113},"labels":[],"label_agreement":null},{"id":"W3093968467","doi":"10.1158/1557-3265.ovcasymp18-nt-101","title":"Abstract NT-101: QUADRA: A PHASE 2, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE SINGLE-AGENT NIRAPARIB TREATMENT IN PATIENTS WITH RELAPSED OVARIAN CANCER (ROC) WHO HAVE RECEIVED ≥3 PRIOR CHEMOTHERAPY REGIMENS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Population; Ovarian cancer; Clinical endpoint; Progressive disease; Progression-free survival; Carboplatin; Oncology; Refractory (planetary science); Gastroenterology; Phases of clinical research; Surgery; Clinical trial; Cancer; Cisplatin","score_opus":0.3252451303081464,"score_gpt":0.5403688162190448,"score_spread":0.21512368591089837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093968467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720783,0.0004663058,0.000006484614,0.008397825,0.0005738482,0.015681874,0.00014468942,0.000074694275,0.0025759547],"genre_scores_gemma":[0.9848803,0.0006327195,0.0003602996,0.0022169894,0.00048947695,0.003378873,0.000065477885,0.0002125377,0.0077632815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909943,0.0012227667,0.0017809789,0.0021104463,0.0024249032,0.0014666317],"domain_scores_gemma":[0.9942658,0.0009604765,0.000466275,0.0018475003,0.001459989,0.0009999863],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043511055,0.0006490672,0.0017401542,0.00054034434,0.00026750786,0.00023650232,0.00080337847,0.00031070336,0.0040067434],"category_scores_gemma":[0.0003814683,0.00050460384,0.00016379001,0.0013044274,0.0003800422,0.00029869296,0.00025314032,0.001449931,0.00026712718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16593961,0.13604744,0.49402216,0.0001699078,0.001666092,0.00020529727,0.007129106,0.00013063088,0.005873239,0.0000099006265,0.011259001,0.17754763],"study_design_scores_gemma":[0.3802533,0.13829848,0.42235005,0.0031381508,0.00025645606,0.00000341705,0.0014758795,0.0002070377,0.0062988596,0.000095377705,0.0464077,0.0012153016],"about_ca_topic_score_codex":0.005240074,"about_ca_topic_score_gemma":0.0053406497,"teacher_disagreement_score":0.21431367,"about_ca_system_score_codex":0.0056487457,"about_ca_system_score_gemma":0.0025257648,"threshold_uncertainty_score":0.99974054},"labels":[],"label_agreement":null},{"id":"W3094254214","doi":"10.1158/1078-0432.ccr-20-2710","title":"Expanded Low Allele Frequency <i>RAS</i> and <i>BRAF</i> V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society; Ottawa Hospital; Spinal Cord Injury BC; University of British Columbia; University of British Columbia Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cetuximab; Colorectal cancer; Medicine; Oncology; Randomized controlled trial; Internal medicine; Cancer","score_opus":0.2660523858537944,"score_gpt":0.5230790893976734,"score_spread":0.257026703543879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094254214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96402746,0.007390026,0.000013987458,0.015570983,0.00018814768,0.009298875,0.00017459635,0.000033555494,0.0033023527],"genre_scores_gemma":[0.9843512,0.002735514,0.00025615544,0.0018660162,0.00055884477,0.010094978,0.000029915596,0.00003576905,0.0000716124],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953641,0.0013454367,0.0010387594,0.00078228954,0.0007705117,0.00069887016],"domain_scores_gemma":[0.9874037,0.011646155,0.00016417025,0.00019089405,0.00032724437,0.00026786517],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0051339697,0.00026874474,0.0014381739,0.00013816841,0.00022776137,0.000064484826,0.00023777907,0.00013054984,0.00011780974],"category_scores_gemma":[0.009083633,0.0001684906,0.0002589227,0.00085563376,0.0010382339,0.00009797977,0.0001479372,0.00088150485,0.000003660417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94108564,0.0008896705,0.026955761,0.0002564463,0.0008238589,0.00017646601,0.0033353686,0.000008731846,0.00032000884,0.000038204278,0.007847963,0.018261867],"study_design_scores_gemma":[0.9652148,0.012783359,0.011685973,0.00041859143,0.0004144747,0.0000098244145,0.003390535,0.0022126313,0.0003627506,0.0018546355,0.0013450751,0.00030736963],"about_ca_topic_score_codex":0.0032049452,"about_ca_topic_score_gemma":0.0031712868,"teacher_disagreement_score":0.024129128,"about_ca_system_score_codex":0.00032050244,"about_ca_system_score_gemma":0.0012959556,"threshold_uncertainty_score":0.9992633},"labels":[],"label_agreement":null},{"id":"W3094745505","doi":"10.1158/1078-0432.ccr-20-1830","title":"OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Ottawa Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"Ono Pharmaceutical; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Medicine; Combination therapy; Internal medicine; Rash; Adverse effect; Pharmacodynamics; Oncology; Clinical endpoint; Pharmacology; Cancer; Pharmacokinetics; Clinical trial; Immunotherapy","score_opus":0.11479046437595773,"score_gpt":0.4554999773211006,"score_spread":0.34070951294514285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094745505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943764,0.00040284803,0.000006825195,0.00839047,0.000058228175,0.0014439625,0.000016147651,0.000028409044,0.00021544806],"genre_scores_gemma":[0.9968228,0.0009292173,0.00020007443,0.0012958592,0.00009094301,0.00020114527,0.000031545685,0.00004190348,0.0003865633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970307,0.00029569684,0.0006947367,0.00062161544,0.00083389616,0.00052337575],"domain_scores_gemma":[0.99854064,0.00048121644,0.00011524612,0.00028593032,0.00029804863,0.00027891848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010998598,0.00018218628,0.00062499644,0.00017311829,0.000093779985,0.00003929869,0.00017396842,0.00012660888,0.0002773978],"category_scores_gemma":[0.000506395,0.00011298886,0.000044271663,0.0012497968,0.00064821483,0.00014573416,0.00008678449,0.00094496546,0.000008631142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30553705,0.0013331607,0.59342045,0.00029988523,0.000091259295,0.00022471344,0.0006511422,0.00000960158,0.00014766263,0.000008522201,0.0010228031,0.09725379],"study_design_scores_gemma":[0.06454004,0.021055402,0.90819436,0.0010837952,0.000019708075,0.000004528206,0.00065363746,0.00026919373,0.00034671844,0.000013582392,0.003577817,0.00024121205],"about_ca_topic_score_codex":0.0008170835,"about_ca_topic_score_gemma":0.0040592067,"teacher_disagreement_score":0.31477395,"about_ca_system_score_codex":0.00036078176,"about_ca_system_score_gemma":0.0011253983,"threshold_uncertainty_score":0.46075523},"labels":[],"label_agreement":null},{"id":"W3096094105","doi":"10.1158/1078-0432.ccr-20-3299","title":"Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics","funders":"Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer; Cancerfonden","keywords":"Immune system; Breast cancer; Medicine; Radiation therapy; Adjuvant; Oncology; CD8; FOXP3; Immunohistochemistry; Cancer; Primary tumor; Internal medicine; Pathology; Cancer research; Immunology; Metastasis","score_opus":0.1057210141369547,"score_gpt":0.45448103614844715,"score_spread":0.3487600220114925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096094105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91073644,0.01807792,0.0000031405752,0.064414084,0.0004985428,0.0054694545,0.00043483538,0.000020978658,0.00034459913],"genre_scores_gemma":[0.96672577,0.025494011,0.000014630678,0.004604599,0.001898139,0.0011213853,0.00005453288,0.00003858338,0.000048323443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98855996,0.0067820293,0.00212503,0.00065335864,0.0012915822,0.00058805913],"domain_scores_gemma":[0.98095685,0.017589413,0.0003593243,0.00077521935,0.00015908634,0.00016011267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022214716,0.00026342235,0.0017955562,0.00011335238,0.00009108847,0.000046996804,0.0008517926,0.00019838898,0.00034425902],"category_scores_gemma":[0.002830824,0.00012766667,0.00058978697,0.0012449266,0.0014423629,0.00008161168,0.00010733815,0.0019993647,0.0000052198416],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94353753,0.00027671095,0.015860653,0.00011131293,0.0003503377,0.00006879252,0.0014828589,0.0000143472325,0.0036929569,0.000004335466,0.0047766436,0.02982352],"study_design_scores_gemma":[0.7985456,0.0024761646,0.19284213,0.0008981619,0.00009211548,0.0000056509984,0.00017236249,0.0005334245,0.00076551945,0.0000310764,0.0034938587,0.0001439089],"about_ca_topic_score_codex":0.020581767,"about_ca_topic_score_gemma":0.0007372589,"teacher_disagreement_score":0.17698148,"about_ca_system_score_codex":0.00030269058,"about_ca_system_score_gemma":0.0015357189,"threshold_uncertainty_score":0.9859403},"labels":[],"label_agreement":null},{"id":"W3096456848","doi":"10.1158/1557-3265.covid-19-po-005","title":"Abstract PO-005: Barriers to implementation of virtual collection of patient-reported data in the COVID-19 era","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anxiety; Ambulatory; Depression (economics); Cohort; Distress; Family medicine; Hospital Anxiety and Depression Scale; Coronavirus disease 2019 (COVID-19); Disease; Psychiatry; Internal medicine","score_opus":0.5865058885918766,"score_gpt":0.658088010241047,"score_spread":0.07158212164917044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096456848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8822745,0.00009057978,0.000032689204,0.115981966,0.000097755066,0.0012614932,0.00017122697,0.000009570176,0.00008023574],"genre_scores_gemma":[0.9814743,0.0002591499,0.000031759384,0.017898781,0.00018778809,0.000051713763,0.000076178505,0.000011118073,0.000009259072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966468,0.00049758685,0.0010729005,0.00039803807,0.0010700782,0.00031458697],"domain_scores_gemma":[0.99578285,0.002134696,0.00019506048,0.00060760457,0.0003220209,0.00095775357],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0049676765,0.000079091515,0.0003417317,0.00017549553,0.00009185938,0.000011307212,0.00032157713,0.00009880494,0.0010714715],"category_scores_gemma":[0.022762885,0.000059199287,0.000060209233,0.0012322993,0.00017369539,0.00007904498,0.00018607418,0.0007171155,0.0000054459965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006663243,0.0002454135,0.7995761,0.0007337314,0.00009804321,0.00008185418,0.010934263,0.000049909075,0.0016593408,0.0000511174,0.112491205,0.06741579],"study_design_scores_gemma":[0.004275537,0.0052060615,0.928061,0.00010349064,0.000041204104,0.0000037305774,0.013174913,0.000106964704,0.0010919077,0.000063757674,0.047772985,0.00009842773],"about_ca_topic_score_codex":0.027467787,"about_ca_topic_score_gemma":0.008331511,"teacher_disagreement_score":0.12848493,"about_ca_system_score_codex":0.0002875291,"about_ca_system_score_gemma":0.009083481,"threshold_uncertainty_score":0.9998417},"labels":[],"label_agreement":null},{"id":"W3096511412","doi":"10.1158/1078-0432.ccr-20-2657","title":"Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i> -Mutant Cancers","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Genentech; F. Hoffmann-La Roche","keywords":"Mutant; Cancer; Gene isoform; Medicine; Cancer research; Chemistry; Internal medicine; Biochemistry; Gene","score_opus":0.11630573657272726,"score_gpt":0.4793883154789074,"score_spread":0.3630825789061802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096511412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776375,0.00032251724,0.00003039997,0.00017967435,0.00016430368,0.0011609737,0.0002154935,0.000012756564,0.0001501258],"genre_scores_gemma":[0.9983753,0.0001398749,0.000054474694,0.0004554642,0.00058621226,0.00023912732,0.00007746314,0.00005567476,0.000016412698],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959853,0.000731169,0.00074815436,0.00100264,0.00091454125,0.00061819004],"domain_scores_gemma":[0.99788195,0.00013948609,0.00018495471,0.0005657292,0.00082182814,0.00040607026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014158958,0.00023307184,0.00047613992,0.00009493374,0.00009624601,0.000028778884,0.00058941334,0.00021969908,0.00007893021],"category_scores_gemma":[0.0005904815,0.00019930174,0.000082452076,0.00077652436,0.00040083608,0.000020090496,0.00025955896,0.0008269081,0.0000048737465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032641876,0.010005912,0.8653419,0.00012778408,0.00040886496,0.000033921,0.0016502524,0.0011061047,0.05751146,0.00000657225,0.010643279,0.0205221],"study_design_scores_gemma":[0.120197445,0.31680757,0.1682182,0.00046643315,0.00019385108,0.0000016081411,0.0041412227,0.001321595,0.36408758,0.0000998748,0.022334822,0.0021298132],"about_ca_topic_score_codex":0.0013395117,"about_ca_topic_score_gemma":0.0019511878,"teacher_disagreement_score":0.6971237,"about_ca_system_score_codex":0.00021700602,"about_ca_system_score_gemma":0.0015433291,"threshold_uncertainty_score":0.8127289},"labels":[],"label_agreement":null},{"id":"W3097004036","doi":"10.1158/1078-0432.ccr-20-2558","title":"Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centro de Investigación Biomédica en Red de Cáncer; Ministerio de Ciencia e Innovación; Canadian Institutes of Health Research; Generalitat de Catalunya","keywords":"Lymphoma; DNA; Population; Cell; Circulating tumor DNA; Cancer research; Biology; Cancer; Medicine; Computational biology; Genetics; Immunology; Environmental health","score_opus":0.09376157918107385,"score_gpt":0.4439612368853415,"score_spread":0.35019965770426764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097004036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908058,0.0008968315,0.0000012783217,0.006737225,0.000038662565,0.0011130391,0.00010012278,0.000019000016,0.00028803732],"genre_scores_gemma":[0.99813884,0.00008255323,0.000040833766,0.0008830154,0.00017632754,0.0004564585,0.00011118586,0.000024486342,0.00008630075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972217,0.00045865847,0.0005883538,0.0005757601,0.00074973766,0.00040578863],"domain_scores_gemma":[0.99757814,0.0015900098,0.00006724898,0.0002906423,0.00011953517,0.0003544435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011029685,0.00014603575,0.00045316172,0.00014528289,0.00006656262,0.000047771762,0.00016875571,0.00009120301,0.00020731748],"category_scores_gemma":[0.00086548773,0.000120334844,0.00006743086,0.0005379169,0.000049791743,0.00005454513,0.00013598405,0.00028520354,0.000025350986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009474004,0.016981246,0.97682244,0.00009854509,0.000021045624,0.0005425404,0.00027769117,0.0000076022425,0.000046499026,0.0000070895258,0.003315307,0.00093261077],"study_design_scores_gemma":[0.08410899,0.0011604115,0.91035664,0.00006520414,0.000026313892,6.942742e-7,0.000496021,0.0028747583,0.00013755933,0.000030291676,0.0006344915,0.00010862557],"about_ca_topic_score_codex":0.0024520524,"about_ca_topic_score_gemma":0.0012849318,"teacher_disagreement_score":0.08316159,"about_ca_system_score_codex":0.0002595894,"about_ca_system_score_gemma":0.0006386708,"threshold_uncertainty_score":0.49071127},"labels":[],"label_agreement":null},{"id":"W3097296206","doi":"10.1158/1078-0432.ccr-20-1900","title":"Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Pancreas Centre (Canada); Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Ipsen; BC Cancer Foundation; Vancouver Coastal Health Research Institute; Eisai; Amgen; Pfizer; Canada Research Chairs; AstraZeneca; Eli Lilly and Company","keywords":"Transcriptome; RNA-Seq; Computational biology; Gene; Fusion gene; Biology; Genome; RNA; Cancer; Contig; Breakpoint; Genetics; Bioinformatics; Gene expression; Chromosomal translocation","score_opus":0.11794533500012697,"score_gpt":0.4254958928007959,"score_spread":0.307550557800669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097296206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345607,0.00328417,0.0012804781,0.0009869774,0.00012586906,0.00047773737,0.00023572732,0.000008914509,0.00014404538],"genre_scores_gemma":[0.979308,0.014978531,0.004525631,0.0006561178,0.0003193855,0.000071495306,0.000052297142,0.00004367306,0.00004487028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977519,0.00022630197,0.00073455955,0.00063365186,0.00027120224,0.0003823985],"domain_scores_gemma":[0.99849254,0.00034547521,0.00014189974,0.00031641556,0.00034608433,0.00035760365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011470527,0.00016364102,0.0004066963,0.0000461966,0.00009572074,0.000030917985,0.00029569305,0.00012404323,0.00003891217],"category_scores_gemma":[0.0009532802,0.00013500106,0.000112084286,0.0002570083,0.0005583359,0.0000046277983,0.000212249,0.00052385405,0.0000033685626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051768627,0.00012115273,0.05174514,0.00022390277,0.00039228957,0.000026670186,0.00021930697,0.0030455117,0.92096454,0.00008287379,0.0014604451,0.016541312],"study_design_scores_gemma":[0.025477678,0.03273027,0.07002951,0.0009064168,0.0008975302,0.000048557155,0.0035320986,0.011342653,0.7370893,0.0013751042,0.113885805,0.0026851264],"about_ca_topic_score_codex":0.00051575305,"about_ca_topic_score_gemma":0.0005691815,"teacher_disagreement_score":0.18387529,"about_ca_system_score_codex":0.00006716106,"about_ca_system_score_gemma":0.0017594825,"threshold_uncertainty_score":0.55051833},"labels":[],"label_agreement":null},{"id":"W3099373597","doi":"10.1158/1557-3265.covid-19-s02-01","title":"Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Cancer; Lung cancer; Renal cell carcinoma; Gastroenterology","score_opus":0.46103567889242325,"score_gpt":0.5935201240567259,"score_spread":0.1324844451643027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099373597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96232677,0.001438823,0.0000016247293,0.034083452,0.00020400136,0.0014016402,0.00046890473,0.00004028812,0.00003452326],"genre_scores_gemma":[0.98602307,0.0072310446,0.000014779715,0.0059029725,0.0004728215,0.00010128217,0.00008480466,0.000053491396,0.00011571574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947082,0.00048674745,0.0021839566,0.0008250136,0.0010703693,0.0007257041],"domain_scores_gemma":[0.99306345,0.0026155892,0.00042046854,0.00049224397,0.0005533711,0.0028548562],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0027113329,0.0002826025,0.0013549286,0.00018778014,0.00010496003,0.000029499322,0.00023363908,0.00029867192,0.00049087923],"category_scores_gemma":[0.011577001,0.00020558255,0.00023774138,0.00059394294,0.0009485615,0.00010983777,0.00023959087,0.0018367773,0.00002364913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013454771,0.0011399484,0.9573737,0.0010759998,0.00011398491,0.00018536836,0.00023039336,0.0000021806816,0.00007501917,0.000004835616,0.0007234004,0.02562043],"study_design_scores_gemma":[0.008213256,0.0023800628,0.98389196,0.0005241895,0.00008513869,4.216278e-7,0.00005753334,0.00006051069,0.000058233767,0.000013745386,0.0045137717,0.00020119881],"about_ca_topic_score_codex":0.019710736,"about_ca_topic_score_gemma":0.0014363985,"teacher_disagreement_score":0.02818048,"about_ca_system_score_codex":0.0005699244,"about_ca_system_score_gemma":0.0054059615,"threshold_uncertainty_score":0.9967489},"labels":[],"label_agreement":null},{"id":"W3100080748","doi":"10.1158/1078-0432.ccr-20-3305","title":"Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb; AstraZeneca; York University; Syndax Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Genentech; Parker Institute for Cancer Immunotherapy; Damon Runyon Cancer Research Foundation; Roswell Park Cancer Institute","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.18471186659029343,"score_gpt":0.4600124273515743,"score_spread":0.2753005607612809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100080748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908598,0.002082131,0.000012647372,0.0039320583,0.00004616072,0.0023946445,0.000028644996,0.00005297596,0.00059090566],"genre_scores_gemma":[0.9940203,0.0030690543,0.000111213376,0.0020382912,0.00013981498,0.00021810703,0.000054069944,0.00006563696,0.00028355658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620265,0.00053900084,0.00066326436,0.00071441557,0.0011402224,0.0007404676],"domain_scores_gemma":[0.99809885,0.00042611128,0.0001270251,0.0004430478,0.0004891442,0.0004157921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010383175,0.00024976896,0.0007571877,0.00016092008,0.00009764968,0.000056151566,0.0002646439,0.000104594095,0.00074247713],"category_scores_gemma":[0.00019232719,0.00015215688,0.00013494858,0.0013381597,0.0006004386,0.00012080848,0.000059079022,0.00095621403,0.00003274246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13904816,0.00074494735,0.8017967,0.00015240285,0.00049000693,0.00014848738,0.00054533477,0.000008987016,0.0001222495,0.0000043378795,0.0022849126,0.054653484],"study_design_scores_gemma":[0.06528573,0.012701097,0.9057915,0.00055980944,0.0000706888,0.0000041162198,0.00017253442,0.0001041215,0.0005225693,0.000005111255,0.0145103885,0.0002723007],"about_ca_topic_score_codex":0.0010547055,"about_ca_topic_score_gemma":0.0002403482,"teacher_disagreement_score":0.10399484,"about_ca_system_score_codex":0.00029286384,"about_ca_system_score_gemma":0.0012206185,"threshold_uncertainty_score":0.8129604},"labels":[],"label_agreement":null},{"id":"W3105254545","doi":"10.1158/1078-0432.ccr-20-2845","title":"AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Digital Payment Technologies (Canada)","funders":"Amgen","keywords":"Cancer research; Medicine; Cell; Lung cancer; Ligand (biochemistry); Small molecule; T cell; Oncology; Internal medicine; Receptor; Chemistry; Immunology; Immune system","score_opus":0.307856614907692,"score_gpt":0.5039285427276453,"score_spread":0.1960719278199533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105254545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939313,0.034239903,0.00018183806,0.020768305,0.0003396539,0.0028230925,0.00023393729,0.00009549858,0.002004766],"genre_scores_gemma":[0.9560607,0.039254457,0.0006836053,0.0011252426,0.0011124257,0.0005331397,0.000019359351,0.00010697693,0.0011040777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98992854,0.0026544046,0.0019193218,0.0018539152,0.0020893512,0.0015544413],"domain_scores_gemma":[0.9906326,0.0051140497,0.0002903727,0.0009389529,0.0013605412,0.0016634637],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008414973,0.00047240694,0.001931319,0.00036356924,0.00025039772,0.00006347625,0.00042819127,0.0005300268,0.0005858615],"category_scores_gemma":[0.005570857,0.0004057207,0.00037241267,0.0015162727,0.0016836927,0.00021959093,0.001215853,0.0049802037,0.000022833927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03532979,0.007590272,0.7524678,0.014770391,0.0016653356,0.0032488618,0.006367546,0.0026548847,0.048446115,0.0006205225,0.068659425,0.058179066],"study_design_scores_gemma":[0.0637829,0.010733522,0.658531,0.004376822,0.0010609574,0.000029448245,0.0039660498,0.2149931,0.025728453,0.0020675866,0.011887179,0.0028429742],"about_ca_topic_score_codex":0.0100149065,"about_ca_topic_score_gemma":0.003776318,"teacher_disagreement_score":0.21233822,"about_ca_system_score_codex":0.0005223888,"about_ca_system_score_gemma":0.0036020502,"threshold_uncertainty_score":0.9998395},"labels":[],"label_agreement":null},{"id":"W3107160425","doi":"10.1158/1557-3265.covid-19-po-016","title":"Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Medical Association; London Health Sciences Centre; Juravinski Cancer Centre; Dalhousie University; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Family medicine; Workforce; Pandemic; Cancer; Telemedicine; Descriptive statistics; Coronavirus disease 2019 (COVID-19); Health care; Internal medicine; Disease","score_opus":0.7351629325218344,"score_gpt":0.7154716212251118,"score_spread":0.019691311296722636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107160425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94543743,0.0021516923,5.8740704e-7,0.050159577,0.00021900547,0.0017098526,0.00016028009,0.000010046829,0.00015151886],"genre_scores_gemma":[0.99131584,0.0014992054,0.0000022888798,0.006123826,0.00085989735,0.00014300388,0.000013941449,0.000025492373,0.000016487831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99241304,0.003095871,0.0010671902,0.0006194163,0.002063802,0.00074067496],"domain_scores_gemma":[0.9823531,0.014317146,0.00018953565,0.00040806996,0.00065487606,0.002077294],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012686208,0.00018248145,0.0008834773,0.00010168785,0.00016269903,0.000018043205,0.00035976377,0.00024755104,0.0013047223],"category_scores_gemma":[0.04982722,0.00011347142,0.000103667364,0.00080714864,0.0003812821,0.000031563977,0.00023856226,0.0025439654,0.0000036385234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015410162,0.00022125458,0.83983386,0.00028852592,0.00008891155,0.00023631919,0.0038125883,0.00036523282,0.000012121514,0.0000015688776,0.005009938,0.13471954],"study_design_scores_gemma":[0.0062371613,0.010259661,0.97742707,0.00023605826,0.000022707032,0.000002133532,0.0039980505,0.0005472612,0.0000047481653,0.000007835395,0.0011576873,0.00009965706],"about_ca_topic_score_codex":0.99144065,"about_ca_topic_score_gemma":0.99270326,"teacher_disagreement_score":0.13982143,"about_ca_system_score_codex":0.0054137567,"about_ca_system_score_gemma":0.14523518,"threshold_uncertainty_score":0.99975723},"labels":[],"label_agreement":null},{"id":"W3107233990","doi":"10.1158/1557-3265.covid-19-po-010","title":"Abstract PO-010: Changes in lung cancer treatment as a result of the COVID19 pandemic: A prospective observational study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer; Internal medicine; Oncology; Disease; Chemotherapy; Observational study","score_opus":0.5394165053367164,"score_gpt":0.6014951800348053,"score_spread":0.06207867469808892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107233990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94748724,0.0026673449,1.5772432e-7,0.04525811,0.0001665213,0.0036555391,0.00012473446,0.000020219852,0.00062016904],"genre_scores_gemma":[0.98932654,0.005310523,0.000010107616,0.0011951327,0.00061059877,0.0030594128,0.000008701889,0.000025721854,0.00045327505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697137,0.0003141297,0.0006455701,0.0006586388,0.0010096446,0.00040065325],"domain_scores_gemma":[0.99755925,0.0011401573,0.00015460051,0.0004163783,0.00047075527,0.0002588572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001119115,0.0001805633,0.00059662224,0.00006889352,0.00010295437,0.000020505277,0.00023341949,0.00012086451,0.00061984244],"category_scores_gemma":[0.0009385769,0.00010621939,0.0001737914,0.00076966995,0.0002619791,0.000046209392,0.00015158724,0.00066215935,0.000012274381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026069742,0.002387388,0.982352,0.00014978444,0.00047509474,0.000054549062,0.0021840637,0.000029553847,0.00010740647,0.000037969312,0.0029106122,0.0067045568],"study_design_scores_gemma":[0.008244471,0.0029815112,0.98440796,0.00042851298,0.00014162183,8.3607756e-7,0.0006541919,0.00007319662,0.00084401324,0.00005147973,0.002079495,0.00009273359],"about_ca_topic_score_codex":0.015448243,"about_ca_topic_score_gemma":0.018902542,"teacher_disagreement_score":0.044062976,"about_ca_system_score_codex":0.0017260483,"about_ca_system_score_gemma":0.0023943845,"threshold_uncertainty_score":0.99899995},"labels":[],"label_agreement":null},{"id":"W3108011737","doi":"10.1158/1557-3265.ovcasymp18-ap17","title":"Abstract AP17: MOLECULAR AND FUNCTIONAL HETEROGENEITY OF CANCER ASSOCIATED FIBROBLASTS IN HIGH-GRADE SEROUS OVARIAN CANCER","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Ovarian cancer; Cancer-Associated Fibroblasts; Cancer research; Fibroblast activation protein, alpha; Stromal cell; Biology; Serous fluid; Cancer cell; Gene signature; Cancer; Gene expression profiling; Medicine; Pathology; Gene expression; Gene; Genetics","score_opus":0.09476513747629156,"score_gpt":0.4506435567951621,"score_spread":0.35587841931887054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108011737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076414,0.00792926,0.000023266664,0.0004100818,0.00030129554,0.00033771366,0.00011123721,0.0000047858425,0.0001182423],"genre_scores_gemma":[0.9943987,0.0048683225,0.000049111582,0.00008517157,0.00019782154,0.00009819503,0.0000613201,0.000026856651,0.00021451643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978167,0.00030629596,0.0004985409,0.00056210323,0.000430538,0.0003858237],"domain_scores_gemma":[0.9989286,0.00014944379,0.00014358133,0.00031013245,0.00032483457,0.000143405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014002841,0.00013922303,0.00029109995,0.0000853508,0.000047464007,0.000021374097,0.00015933535,0.00035004952,0.00019508504],"category_scores_gemma":[0.00025261362,0.00013435412,0.00009573939,0.00024203662,0.000187252,0.000006589884,0.00017886916,0.00042156948,0.000004490876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026460557,0.00013920023,0.50631535,0.00005168588,0.000114314,0.0000026034552,0.000011046996,0.0017451715,0.48636732,0.00002862851,0.00013057758,0.0048294696],"study_design_scores_gemma":[0.0013984006,0.0002416516,0.77488345,0.00007458929,0.000010715248,1.2884263e-7,0.000008943959,0.00012245034,0.22178611,0.0002189116,0.0011169345,0.00013769735],"about_ca_topic_score_codex":0.0064193807,"about_ca_topic_score_gemma":0.00810428,"teacher_disagreement_score":0.2685681,"about_ca_system_score_codex":0.00007939391,"about_ca_system_score_gemma":0.00041632127,"threshold_uncertainty_score":0.9704226},"labels":[],"label_agreement":null},{"id":"W3108808294","doi":"10.1158/1557-3265.covid-19-s09-03","title":"Abstract S09-03: Factors affecting COVID-19 outcomes in cancer patients: A first report from Guy’s Cancer Centre in London","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Proportional hazards model; Logistic regression; Infectious disease (medical specialty)","score_opus":0.49247092586206714,"score_gpt":0.6148091543827036,"score_spread":0.12233822852063642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108808294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8809671,0.0017851539,0.0000017163053,0.11443708,0.00066965935,0.0016061076,0.00032083842,0.00007213076,0.00014023262],"genre_scores_gemma":[0.9834129,0.0035719841,0.000014033953,0.011559602,0.0008886555,0.00017758962,0.000097791206,0.0000685665,0.00020887738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937252,0.00047250575,0.0017310877,0.0012870725,0.0014970357,0.0012871005],"domain_scores_gemma":[0.99026597,0.006266415,0.00034416065,0.00058346835,0.00044941914,0.0020905451],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023910047,0.0003483388,0.0012672311,0.00033401154,0.00018656345,0.00006148106,0.00036597374,0.0004620727,0.0035061773],"category_scores_gemma":[0.029559657,0.00028498497,0.00027318468,0.001195942,0.00025855246,0.00018516395,0.0002885136,0.0029826916,0.000054014083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001602026,0.0006172266,0.97384316,0.00090481807,0.00008116311,0.0009529996,0.0036172802,0.00010720098,0.000033448337,0.0000011483827,0.011570519,0.006669008],"study_design_scores_gemma":[0.0055754385,0.00033452266,0.9595319,0.00084470795,0.00002772091,5.6245904e-7,0.00076135807,0.00007721209,0.00009747821,0.00003056319,0.032459687,0.0002588166],"about_ca_topic_score_codex":0.44127098,"about_ca_topic_score_gemma":0.38109908,"teacher_disagreement_score":0.102877475,"about_ca_system_score_codex":0.004010095,"about_ca_system_score_gemma":0.007057269,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W3109580766","doi":"10.1158/1557-3265.covid-19-po-065","title":"Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Biobank; Receipt; Staffing; Clinical trial; Pandemic; Medicine; Tissue bank; Family medicine; Coronavirus disease 2019 (COVID-19); Business; Disease; Pathology; Bioinformatics; Nursing; Accounting; Biology","score_opus":0.857763410917281,"score_gpt":0.7006660696538014,"score_spread":0.15709734126347963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109580766","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40956372,0.0038724418,0.00041444262,0.58101326,0.0015531908,0.0016841185,0.000049958846,0.00016638247,0.001682506],"genre_scores_gemma":[0.9566061,0.004808765,0.000093095725,0.022991532,0.0150921345,0.00006775026,0.000026562017,0.000028188304,0.0002858664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911017,0.0030953714,0.00221223,0.0006912446,0.0022943725,0.00060509803],"domain_scores_gemma":[0.9770444,0.020071037,0.00037587006,0.00035476053,0.0007085197,0.0014454329],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.070005365,0.000148794,0.000776548,0.00006764364,0.0005341026,0.00007289924,0.00039868226,0.00073141465,0.0018411622],"category_scores_gemma":[0.052768473,0.0000870029,0.0005239617,0.00082220655,0.0021719446,0.000053184885,0.00028231402,0.0036846646,0.000112750815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008575647,0.00052024826,0.628396,0.0008949485,0.00076939084,0.00014310732,0.0004238693,0.0004499287,0.0011166807,0.0033097381,0.20949855,0.14590195],"study_design_scores_gemma":[0.0064836866,0.0005117799,0.5642896,0.00023153082,0.00008441857,0.000018422772,0.00008670185,0.0018388178,0.000016094924,0.008364995,0.41786286,0.00021107445],"about_ca_topic_score_codex":0.00016662199,"about_ca_topic_score_gemma":0.00012140073,"teacher_disagreement_score":0.5580217,"about_ca_system_score_codex":0.00026994728,"about_ca_system_score_gemma":0.003538032,"threshold_uncertainty_score":0.9990713},"labels":[],"label_agreement":null},{"id":"W3109674153","doi":"10.1158/1078-0432.ccr-20-3609","title":"A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Tamoxifen; Breast cancer; Placebo; Population; Clinical endpoint; Cancer; Internal medicine; Urology; Adverse effect; Oncology; Randomized controlled trial; Pathology","score_opus":0.15704947367863586,"score_gpt":0.5059863750775024,"score_spread":0.3489369013988666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109674153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851347,0.005815968,0.000010837662,0.003167142,0.00029175208,0.0032664395,0.0022530986,0.000017431612,0.000042597927],"genre_scores_gemma":[0.981054,0.012236399,0.00002420928,0.00028544117,0.0008503848,0.005252964,0.00006202867,0.000068312314,0.00016624232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99503505,0.0014791032,0.0010866459,0.001110938,0.00055012875,0.00073810713],"domain_scores_gemma":[0.99721724,0.0009339057,0.00033907764,0.0005005517,0.00065490475,0.00035434164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025433493,0.0003302559,0.0012370502,0.00010055447,0.00019026962,0.000021020498,0.00049757154,0.00025052257,0.00029050818],"category_scores_gemma":[0.0013083469,0.0002716706,0.00036221626,0.0006148384,0.0007170009,0.000009688659,0.00049816543,0.0004978727,0.0000061315554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50495595,0.003651114,0.45136645,0.00030503442,0.0020287852,0.000017193479,0.0020779262,0.0005203755,0.0036897017,0.0000040483137,0.0040584924,0.027324926],"study_design_scores_gemma":[0.6717413,0.0023614466,0.3142951,0.00020240279,0.00045217268,0.0000015610676,0.0010925381,0.0011094379,0.004499322,0.000051408446,0.0035401764,0.00065309653],"about_ca_topic_score_codex":0.030135838,"about_ca_topic_score_gemma":0.05807876,"teacher_disagreement_score":0.16678537,"about_ca_system_score_codex":0.00024215708,"about_ca_system_score_gemma":0.00073153374,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W3110393829","doi":"10.1158/1557-3265.covid-19-po-029","title":"Abstract PO-029: Operationalizing a prioritized COVID-19 testing strategy at a Canadian tertiary care cancer center","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Internal medicine; Population; Lung cancer; Neutropenia; Febrile neutropenia; Emergency medicine; Chemotherapy","score_opus":0.644612724772619,"score_gpt":0.6324277666012751,"score_spread":0.012184958171343907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110393829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7459881,0.0070695113,0.0000069712664,0.24142088,0.00031821523,0.0018975227,0.00067387155,0.00012684234,0.0024980989],"genre_scores_gemma":[0.9264492,0.0010508194,0.000088810506,0.06948632,0.0022185438,0.0002233403,0.00011936042,0.00005666421,0.00030696427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99558365,0.00037828035,0.00087718084,0.00087693095,0.0010486061,0.0012353542],"domain_scores_gemma":[0.9910949,0.0018770184,0.00009600655,0.00039611757,0.0011391329,0.005396813],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015650615,0.00023730879,0.00055277784,0.00020513985,0.0007005787,0.00012398667,0.000312065,0.0003199487,0.0037951972],"category_scores_gemma":[0.010237927,0.00021215277,0.00017450318,0.00068279577,0.00030276316,0.00013286783,0.000193024,0.0017663676,0.00015600637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011811418,0.000078169716,0.91207814,0.0020301822,0.000089882604,0.0011667621,0.001900519,0.00010692705,0.00077332946,0.000026629965,0.044795554,0.03577274],"study_design_scores_gemma":[0.0050556646,0.0004971463,0.76749027,0.0006659825,0.000040792936,0.000024829458,0.0008124527,0.00040938586,0.000115708564,0.000031868232,0.22454211,0.00031380667],"about_ca_topic_score_codex":0.5559446,"about_ca_topic_score_gemma":0.5417826,"teacher_disagreement_score":0.1804611,"about_ca_system_score_codex":0.004400838,"about_ca_system_score_gemma":0.03822358,"threshold_uncertainty_score":0.9994211},"labels":[],"label_agreement":null},{"id":"W3112621369","doi":"10.1158/1078-0432.ccr-20-3310","title":"Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"DOD Prostate Cancer Research Program; Congressionally Directed Medical Research Programs; University of Alberta; University of California, San Francisco; University of Virginia; National Cancer Institute; National Institutes of Health; Prostate Cancer Foundation; UVA Cancer Center; U.S. Department of Defense","keywords":"Prostate cancer; Cancer; Prostate; Medicine; Pathology; Internal medicine","score_opus":0.13616052490480357,"score_gpt":0.45134942868840977,"score_spread":0.3151889037836062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112621369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762557,0.020049937,0.0010220017,0.00082746765,0.000661575,0.00049365766,0.000101726546,0.00015108187,0.00043681558],"genre_scores_gemma":[0.99473685,0.003603489,0.000753409,0.0002493819,0.00044863476,0.00006613083,0.0000067836913,0.000117072355,0.000018227085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972477,0.00011755872,0.000846044,0.00037999154,0.0006817071,0.0007269867],"domain_scores_gemma":[0.9986308,0.00029160015,0.000088653855,0.00030642215,0.00040044147,0.0002820825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012043371,0.0001982801,0.00045398588,0.0000986184,0.00009706675,0.00005214607,0.0004903815,0.000104841434,0.00027363165],"category_scores_gemma":[0.00042906543,0.00019431622,0.00016235541,0.0008028116,0.0003124757,0.00019899847,0.00022054423,0.0010780448,0.000021141794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004374488,0.000051166327,0.05790955,0.00094963005,0.00031789183,0.00009444906,0.0010490627,0.087146536,0.8110734,0.00009659009,0.003997468,0.036876764],"study_design_scores_gemma":[0.0040727914,0.0003260816,0.0019843557,0.0010002947,0.00012808453,0.0000031436357,0.00075806,0.4018191,0.5393913,0.00086056336,0.048520785,0.0011354344],"about_ca_topic_score_codex":0.00047151037,"about_ca_topic_score_gemma":0.000014155085,"teacher_disagreement_score":0.3146726,"about_ca_system_score_codex":0.00025298152,"about_ca_system_score_gemma":0.00037038632,"threshold_uncertainty_score":0.7923986},"labels":[],"label_agreement":null},{"id":"W3115651269","doi":"10.1158/1078-0432.ccr-20-2563","title":"LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mood Disorders Association of British Columbia; Aegera Therapeutics (Canada)","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; In vivo; Biology; Cancer research; Mutant; MAPK/ERK pathway; Kinase; Cell culture; Mutation; Cell biology; Genetics; Gene","score_opus":0.19876116464915,"score_gpt":0.45473027212063105,"score_spread":0.25596910747148105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115651269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948496,0.0031954201,0.00015334603,0.001034017,0.00004591045,0.0005473553,0.00005753742,0.0000023772996,0.00011443379],"genre_scores_gemma":[0.99569684,0.0034784,0.00015067929,0.000071975504,0.0003734085,0.000115168856,0.0000068058894,0.000010749976,0.000095965595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901557,0.00010441731,0.00026005998,0.0003023954,0.0001328926,0.0001846731],"domain_scores_gemma":[0.9992103,0.00028125278,0.000065032975,0.00015123501,0.0001710447,0.00012116609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034108304,0.00007862941,0.00021711533,0.000017771052,0.000067327106,0.000008846512,0.00009983652,0.00008681327,0.000004364355],"category_scores_gemma":[0.00027727173,0.000052330837,0.000080229715,0.000073000454,0.00031515816,0.0000019040883,0.00010658658,0.00009842481,3.721844e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060009332,0.0006879275,0.1519182,0.0005550864,0.00071418314,0.000015271049,0.0016204244,0.000084620144,0.6517745,0.0003580395,0.005454129,0.18081664],"study_design_scores_gemma":[0.005562606,0.022214323,0.08129831,0.00010310603,0.00010307866,0.0000063924317,0.00061452616,0.0018028724,0.8334768,0.00026570895,0.05429011,0.00026218133],"about_ca_topic_score_codex":0.000112187416,"about_ca_topic_score_gemma":0.00009150099,"teacher_disagreement_score":0.18170224,"about_ca_system_score_codex":0.000011865695,"about_ca_system_score_gemma":0.0001566646,"threshold_uncertainty_score":0.21339896},"labels":[],"label_agreement":null},{"id":"W3118147665","doi":"10.1158/1078-0432.ccr-20-3313","title":"Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; Instituto de Salud Carlos III; Gobierno de Navarra; Universidad de Navarra; European Commission; U.S. Department of Defense","keywords":"Oncolytic virus; Proinflammatory cytokine; Oncolytic adenovirus; Immune system; Biology; Cancer research; Medicine; Immunology; Inflammation","score_opus":0.18617702485926932,"score_gpt":0.45050545955993476,"score_spread":0.26432843470066547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118147665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98612124,0.012265336,0.000019793866,0.0006701423,0.000027156018,0.0006583326,0.00006258535,0.000011829754,0.00016357838],"genre_scores_gemma":[0.9919669,0.007214109,0.0001474998,0.000089197725,0.0003109281,0.000087352106,0.000054747015,0.00004802407,0.00008122413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99637556,0.0010250835,0.00069485157,0.00078728393,0.00057242106,0.00054479035],"domain_scores_gemma":[0.99842685,0.000262633,0.000097799704,0.00046451075,0.00031016715,0.00043805077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037618717,0.00018746372,0.00046240364,0.000106264495,0.00011561858,0.00004308563,0.00039606105,0.00027098588,0.000050138548],"category_scores_gemma":[0.00081576384,0.00017400213,0.00007226879,0.00027859316,0.00056393334,0.000023263312,0.0007226624,0.0006261935,0.0000032283879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037887353,0.000682583,0.13421156,0.00069457403,0.00022386547,0.000060216742,0.0004932964,0.0015623143,0.78138214,0.00009510461,0.00050891604,0.04219807],"study_design_scores_gemma":[0.029135462,0.055840243,0.05537131,0.00096121215,0.00013598352,0.000049403046,0.002035584,0.2851691,0.5585431,0.0034103221,0.0066847284,0.0026635905],"about_ca_topic_score_codex":0.0005671638,"about_ca_topic_score_gemma":0.0026444641,"teacher_disagreement_score":0.28360677,"about_ca_system_score_codex":0.000041016174,"about_ca_system_score_gemma":0.00074359094,"threshold_uncertainty_score":0.7095601},"labels":[],"label_agreement":null},{"id":"W3118507153","doi":"10.1158/1078-0432.ccr-20-3706","title":"Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada); Spinal Cord Injury BC; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Refractory (planetary science); Chills; Rituximab; Lymphoma; Internal medicine; Clinical endpoint; Gastroenterology; Adverse effect; Nivolumab; Phases of clinical research; Surgery; Chemotherapy; Cancer; Clinical trial; Immunotherapy","score_opus":0.159802523185442,"score_gpt":0.4642106808345872,"score_spread":0.3044081576491452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118507153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997073,0.0016118224,7.506932e-7,0.00025761203,0.00032848536,0.00059832976,0.00001558892,0.000009164964,0.000105277395],"genre_scores_gemma":[0.99775153,0.00013829577,0.000006687688,0.000055066812,0.000017295746,0.00008698756,0.000016679007,0.0000125476945,0.0019149181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653846,0.001883251,0.000656377,0.00038246205,0.00018534614,0.00035412257],"domain_scores_gemma":[0.9979167,0.00077117357,0.00016676736,0.0006083321,0.00051412213,0.000022901248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012993125,0.00011291144,0.00043275638,0.00007556784,0.00016084849,0.000010811765,0.00032604195,0.00021242954,0.0006695032],"category_scores_gemma":[0.0009731129,0.00006062134,0.000076683704,0.00061959896,0.0005106606,0.00006790177,0.0002794426,0.0008226318,0.000022630056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005775746,0.01569373,0.9528498,0.000045762936,0.00023041907,0.000019495033,0.0008283821,0.000005087811,0.013599495,0.000057057445,0.0026938824,0.008201145],"study_design_scores_gemma":[0.01997417,0.004520383,0.9499443,0.00019375033,0.00003165395,0.0000027224298,0.0012840366,0.0000025665217,0.018842274,0.000039738872,0.0050416845,0.00012268049],"about_ca_topic_score_codex":0.00016961945,"about_ca_topic_score_gemma":0.0005478845,"teacher_disagreement_score":0.014198423,"about_ca_system_score_codex":0.00008221669,"about_ca_system_score_gemma":0.00050285226,"threshold_uncertainty_score":0.73305905},"labels":[],"label_agreement":null},{"id":"W3118514290","doi":"10.1158/1078-0432.ccr-20-2378","title":"Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College; CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; City of Hope","keywords":"Diffuse large B-cell lymphoma; Rituximab; Vincristine; Lymphoma; Germinal center; Cell of origin; Oncology; Medicine; Internal medicine; PTEN; Cancer research; Cyclophosphamide; Biology; B cell; Cancer; Immunology; Chemotherapy; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.06245815259684164,"score_gpt":0.3858503799449771,"score_spread":0.3233922273481355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118514290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931623,0.0008517512,0.0000011676915,0.0008623156,0.00012057955,0.0010226215,0.00020720366,0.000047486912,0.0037246079],"genre_scores_gemma":[0.99410355,0.00052298553,0.000069503025,0.0005565242,0.00023760862,0.00025616682,0.00036551274,0.000075299686,0.0038128246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955703,0.00041056663,0.0005394672,0.00087711244,0.0015866214,0.0010159243],"domain_scores_gemma":[0.9968449,0.00052861916,0.00011505083,0.0006357012,0.0013316998,0.00054403767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066668086,0.00035126175,0.00077881035,0.00015720521,0.00015601257,0.000091165064,0.00019320597,0.00026994818,0.0003349164],"category_scores_gemma":[0.00008002273,0.00020485502,0.000100365345,0.0010052242,0.00037159535,0.0001567586,0.0001515624,0.00064592256,0.00003958006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03516868,0.020758543,0.9368461,0.00018031594,0.00030769763,0.002829199,0.00016612944,0.0000025121208,0.0000041882863,0.000033465865,0.0017853377,0.0019178473],"study_design_scores_gemma":[0.14851747,0.0059934384,0.835402,0.00081669405,0.0001676907,0.000026039821,0.00025086806,0.000015961397,0.0007783251,0.0000028107954,0.0077645485,0.00026412218],"about_ca_topic_score_codex":0.00085653155,"about_ca_topic_score_gemma":0.002704923,"teacher_disagreement_score":0.1133488,"about_ca_system_score_codex":0.0005236683,"about_ca_system_score_gemma":0.0017607728,"threshold_uncertainty_score":0.8353746},"labels":[],"label_agreement":null},{"id":"W3119089372","doi":"10.1158/1078-0432.ccr-20-4576","title":"A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Vrije Universiteit Amsterdam; Victoria University; ZonMw; Worldwide Cancer Research","keywords":"Chronic lymphocytic leukemia; Cancer research; T cell; Antigen; Immunotherapy; Leukemia; Immunology; Antibody; Population; Medicine; Immune system","score_opus":0.27903878791525544,"score_gpt":0.531461172556048,"score_spread":0.25242238464079253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119089372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95947504,0.021483248,0.000016400882,0.007335443,0.00045466612,0.00074077817,0.00006555367,0.00007908915,0.010349806],"genre_scores_gemma":[0.9545927,0.0143470075,0.00041336598,0.0006671297,0.0014324636,0.0001429596,0.0000923966,0.00008048055,0.028231505],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913293,0.0021919915,0.001299737,0.0013484334,0.0019732693,0.0018572639],"domain_scores_gemma":[0.9932978,0.0038813557,0.00011156104,0.000981688,0.000868816,0.000858765],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0045447433,0.00035219357,0.0010993339,0.0005724019,0.00026546407,0.00012984732,0.0005848243,0.0005006251,0.0024203225],"category_scores_gemma":[0.0022186576,0.00030028893,0.0004344508,0.001925689,0.0014591151,0.000112767724,0.0007769121,0.002644448,0.00087292166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.036323722,0.0022464292,0.25556144,0.00409225,0.0005101687,0.04781782,0.0013425137,0.0002086555,0.51008534,0.0014149158,0.05501669,0.085380055],"study_design_scores_gemma":[0.017924206,0.00682133,0.32193252,0.0024449928,0.00008287201,0.00072688656,0.0011618828,0.004418643,0.07430175,0.0019959265,0.5670269,0.0011620416],"about_ca_topic_score_codex":0.0024990935,"about_ca_topic_score_gemma":0.0010402623,"teacher_disagreement_score":0.5120103,"about_ca_system_score_codex":0.0105846375,"about_ca_system_score_gemma":0.029418254,"threshold_uncertainty_score":0.9999449},"labels":[],"label_agreement":null},{"id":"W3119730599","doi":"10.1158/1078-0432.ccr-20-3241","title":"Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute; Dana-Farber Cancer Institute; University of Texas MD Anderson Cancer Center; Stanford University; Language Literacy and Culture, University of Maryland, Baltimore County","keywords":"Cancer; Biomarker; Clinical trial; Medicine; Harmonization; Cancer immunotherapy; Cancer biomarkers; Immunotherapy; Oncology; Computational biology; Internal medicine; Biology","score_opus":0.36760951917107715,"score_gpt":0.5418912594727787,"score_spread":0.17428174030170157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119730599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53410405,0.44743702,0.00031443872,0.012239147,0.0018700615,0.0020635668,0.0018449522,0.00009940439,0.00002735897],"genre_scores_gemma":[0.50040793,0.48629478,0.0022698678,0.000998571,0.0021452825,0.005109997,0.00054805516,0.00024688157,0.0019786302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939747,0.00054142583,0.0015130384,0.0017528934,0.00067460677,0.0015433693],"domain_scores_gemma":[0.99382687,0.0024666796,0.0003902015,0.0017452367,0.0012465781,0.00032444735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004765711,0.00050508924,0.0016462875,0.00033449492,0.00088834175,0.00026478854,0.0007579893,0.00049087196,0.00039629254],"category_scores_gemma":[0.0004643034,0.00044732762,0.000590805,0.0019690562,0.0011844566,0.00028291365,0.00077380816,0.0010960666,8.9419297e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019356158,0.00032271622,0.48410195,0.0006027044,0.012933602,0.00002077367,0.00022269986,0.000060859005,0.05368742,0.000024637431,0.004477756,0.4241887],"study_design_scores_gemma":[0.020077812,0.000964268,0.73417294,0.0023455697,0.0035598557,0.00001737539,0.0010714165,0.0069742044,0.0073385015,0.00032333256,0.2219822,0.001172532],"about_ca_topic_score_codex":0.015739508,"about_ca_topic_score_gemma":0.0033240924,"teacher_disagreement_score":0.4230162,"about_ca_system_score_codex":0.0006264261,"about_ca_system_score_gemma":0.0016603626,"threshold_uncertainty_score":0.9997978},"labels":[],"label_agreement":null},{"id":"W3120084637","doi":"10.1158/1078-0432.ccr-20-2404","title":"ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; BC Cancer Agency","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"ARID1A; Colorectal cancer; Microsatellite instability; Biology; Cancer research; DNA mismatch repair; Cancer; Frameshift mutation; MSH2; Mutation; Gene; Genetics; Microsatellite","score_opus":0.06817987287177463,"score_gpt":0.43061713285217196,"score_spread":0.36243725998039733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120084637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675447,0.002164342,0.000041211835,0.00022767182,0.00014840627,0.00029012843,0.000090509275,0.000010975768,0.00027230452],"genre_scores_gemma":[0.99594474,0.0023628052,0.0003144112,0.00017231193,0.00019303994,0.00017399993,0.00041556224,0.000029102368,0.0003940573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975406,0.0004952433,0.00039231108,0.0007027549,0.00037654812,0.0004925666],"domain_scores_gemma":[0.9985153,0.00009943763,0.00008377435,0.00032869083,0.0008410715,0.00013171026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007574944,0.00014904096,0.000256222,0.000046787805,0.000116129915,0.000055502034,0.00022457835,0.00026168657,0.00022340074],"category_scores_gemma":[0.00026197472,0.00012356165,0.000069127076,0.0003521692,0.0002916079,0.000013402957,0.00016355007,0.00055629894,0.00000859897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008736719,0.0015284315,0.72313637,0.000069396774,0.00020932495,0.00004700287,0.0001950442,0.0013588633,0.14080155,0.000032841835,0.00057065336,0.12331381],"study_design_scores_gemma":[0.00406282,0.0018528665,0.84462583,0.00011301446,0.000017327578,0.0000025078793,0.00018533679,0.00021703892,0.14422962,0.00012135947,0.0042481073,0.00032417293],"about_ca_topic_score_codex":0.0009797339,"about_ca_topic_score_gemma":0.0041115503,"teacher_disagreement_score":0.12298963,"about_ca_system_score_codex":0.00016053516,"about_ca_system_score_gemma":0.00092810707,"threshold_uncertainty_score":0.5038698},"labels":[],"label_agreement":null},{"id":"W3120833111","doi":"10.1158/1078-0432.ccr-20-3708","title":"<i>BRCA2</i> , <i>ATM</i> , and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Alberta Cancer Foundation; BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada; Government of Canada; Prostate Cancer Foundation","keywords":"Biology; Prostate cancer; Cancer research; Context (archaeology); Cancer; Genome instability; Allele; PTEN; Primary tumor; Chromoplexy; Mutation; Copy-number variation; Genetics; DNA damage; Gene; Metastasis; Genome; DNA; Apoptosis","score_opus":0.13646479669692277,"score_gpt":0.48600994150724286,"score_spread":0.34954514481032006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120833111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96234894,0.02965768,0.000006055874,0.0051857554,0.0005251064,0.0012297655,0.00008962295,0.00006548625,0.00089160685],"genre_scores_gemma":[0.8150584,0.17631613,0.00039452917,0.0019441172,0.0012004043,0.00019016571,0.00009571306,0.000101476566,0.004699034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939791,0.0011712665,0.0010909752,0.0014768087,0.0011371594,0.0011447002],"domain_scores_gemma":[0.994834,0.0019519283,0.00016258413,0.0007215812,0.0009729653,0.0013569555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003250598,0.0003429032,0.0010097262,0.00015154987,0.00045846857,0.00020772986,0.00023080732,0.00035199814,0.00044268183],"category_scores_gemma":[0.0013721227,0.00025746707,0.0002957062,0.00055929803,0.0019360349,0.00015578524,0.0011000357,0.0023004557,0.000069866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049206377,0.0012484728,0.79458386,0.000560486,0.00043382918,0.0022959593,0.00018049628,3.1957453e-7,0.008336329,0.0000735902,0.013392509,0.17397353],"study_design_scores_gemma":[0.034838546,0.0056449603,0.7765776,0.0035043717,0.0006548567,0.0003403365,0.00043587384,0.0009863027,0.016040776,0.001607067,0.15834494,0.0010243898],"about_ca_topic_score_codex":0.00008705969,"about_ca_topic_score_gemma":0.00018632985,"teacher_disagreement_score":0.17294914,"about_ca_system_score_codex":0.00022269128,"about_ca_system_score_gemma":0.0022237685,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W3121885177","doi":"10.1158/1078-0432.ccr-19-2163","title":"CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pancreatic Cancer Research Fund; Cancer Research UK; Pancreatic Cancer UK","keywords":"Cancer research; Pancreatic cancer; In vivo; Pancreas; Adenocarcinoma; Pancreatic ductal adenocarcinoma; Cancer; Antigen; Cell culture; Medicine; Cell; Biology; Immunology; Internal medicine","score_opus":0.3368971767084059,"score_gpt":0.5813869141696257,"score_spread":0.24448973746121982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121885177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861213,0.008329338,0.00007500593,0.002780808,0.00006485585,0.0010367713,0.00012287487,0.000017867442,0.0014511705],"genre_scores_gemma":[0.99345577,0.002176834,0.0007544753,0.00043100954,0.00081937003,0.0007151315,0.000054851032,0.000027118964,0.0015654169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980497,0.00025228606,0.00041804058,0.0005110753,0.00040058247,0.0003683228],"domain_scores_gemma":[0.99676543,0.0014980457,0.000055350523,0.00051353086,0.0007648569,0.00040278072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00111422,0.00011166384,0.0004315224,0.000031660587,0.000108130684,0.000013387698,0.00017514746,0.00016930765,0.00087371166],"category_scores_gemma":[0.0005316878,0.00009432339,0.00022313216,0.0003679901,0.00043961545,0.000039320003,0.000049115908,0.000677523,0.000015474405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048623797,0.0036739467,0.25513044,0.0012790214,0.000501798,0.00010230703,0.00052673614,0.0000057629113,0.6934968,0.0004122708,0.0147965215,0.025212012],"study_design_scores_gemma":[0.0046682917,0.0014183853,0.06390479,0.000076433396,0.000079749014,0.000014305047,0.00023239187,0.00045431464,0.9019785,0.0010726604,0.025964692,0.00013548591],"about_ca_topic_score_codex":0.00003618275,"about_ca_topic_score_gemma":0.0000013493503,"teacher_disagreement_score":0.2084817,"about_ca_system_score_codex":0.00007502351,"about_ca_system_score_gemma":0.0005520607,"threshold_uncertainty_score":0.956653},"labels":[],"label_agreement":null},{"id":"W3126582315","doi":"10.1158/1557-3265.endomet20-ia006","title":"Abstract IA006: Endocrine therapy and ER/PR combinations","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Endocrine system; Cancer; Medicine; Endometrial cancer; Cancer therapy; Oncology; Targeted therapy; Internal medicine; Hormone","score_opus":0.16414589948594605,"score_gpt":0.5076604830383367,"score_spread":0.3435145835523906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126582315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97304034,0.020949693,0.0000061070523,0.0025126042,0.00017810233,0.00015351194,0.000012041537,0.000008638752,0.003138931],"genre_scores_gemma":[0.9570928,0.03985724,0.00008036434,0.000314333,0.0003315152,0.000048190414,0.000052831594,0.00001716552,0.0022055241],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998685,0.0002412979,0.00021380553,0.00036558905,0.00020681851,0.0002874975],"domain_scores_gemma":[0.99905324,0.0001870546,0.000027839033,0.0002879606,0.00027872567,0.0001651605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007221763,0.00008174502,0.0001328974,0.000029095934,0.00014200981,0.000039013372,0.00012666373,0.00016934707,0.00015583464],"category_scores_gemma":[0.00037697464,0.00006895276,0.00008450431,0.00014956754,0.0002782382,0.000003894732,0.00015782859,0.00051306514,0.000026866333],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065029674,0.0013845759,0.030522306,0.00006741457,0.0004551225,0.00023460784,0.00004657916,0.000010684011,0.62780076,0.0020735702,0.04846613,0.28828794],"study_design_scores_gemma":[0.005093694,0.0012137826,0.13531114,0.000058884183,0.000015812073,0.00004002207,0.000100132194,0.00003479494,0.35172874,0.001057083,0.50502694,0.00031899996],"about_ca_topic_score_codex":0.00004583414,"about_ca_topic_score_gemma":0.000023280594,"teacher_disagreement_score":0.4565608,"about_ca_system_score_codex":0.000010923309,"about_ca_system_score_gemma":0.000288305,"threshold_uncertainty_score":0.2811812},"labels":[],"label_agreement":null},{"id":"W3127425164","doi":"10.1158/1557-3265.endomet20-ia017","title":"Abstract IA017: Molecular classification and stratification: Diving deeper","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Categorization; Homogeneous; Risk stratification; Stratification (seeds); Context (archaeology); Endometrial cancer; Clinical Practice; Computational biology; Cancer; Medicine; Bioinformatics; Oncology; Biology; Computer science; Internal medicine; Artificial intelligence; Family medicine","score_opus":0.18706746734110394,"score_gpt":0.4963170204378261,"score_spread":0.3092495530967222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127425164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581415,0.007523916,0.0004370992,0.0027056271,0.00021435488,0.00015483185,0.000029693256,0.000006609015,0.0031137129],"genre_scores_gemma":[0.98965687,0.008431444,0.00042920298,0.00039056118,0.00054377184,0.00006990425,0.00008862601,0.000019787576,0.00036982566],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984949,0.0001395509,0.00032239838,0.0005377179,0.0002428554,0.000262533],"domain_scores_gemma":[0.9986136,0.0001997359,0.000054924367,0.0004823636,0.00047518022,0.0001742084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094999763,0.000089063156,0.00012795236,0.000027892032,0.00013463467,0.00010681676,0.00016054246,0.0001790967,0.00013017892],"category_scores_gemma":[0.0010979503,0.000092767485,0.00006987208,0.00013754604,0.00024311738,0.000004223448,0.00018841882,0.00030440724,0.000017319748],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013332737,0.00025222456,0.05345933,0.00007454707,0.00010144351,0.000038656184,0.000041673466,0.000051660227,0.83847505,0.007152143,0.011037494,0.08918245],"study_design_scores_gemma":[0.0012180073,0.0002882789,0.65378195,0.00007304678,0.00003179611,0.000011828834,0.0003821169,0.00017387581,0.15328753,0.0037197995,0.18660444,0.00042733827],"about_ca_topic_score_codex":0.000055898436,"about_ca_topic_score_gemma":0.00026334974,"teacher_disagreement_score":0.6851875,"about_ca_system_score_codex":0.000029792072,"about_ca_system_score_gemma":0.00056712923,"threshold_uncertainty_score":0.37829483},"labels":[],"label_agreement":null},{"id":"W3127454388","doi":"10.1158/1078-0432.ccr-20-3260","title":"Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"Medical Research Council; Imperial Experimental Cancer Medicine Centre; Royal Marsden NHS Foundation Trust; Department of Health and Social Care; National Institute for Health and Care Research; Cancer Council NSW; Cancer Research UK; Academy of Medical Sciences; Prostate Cancer Canada; Prostate Cancer Foundation; Movember Foundation; Prostate Cancer UK; U.S. Department of Defense","keywords":"Enzalutamide; Prostate cancer; Cancer; Medicine; Prostate; Oncology; Resistance (ecology); Internal medicine; Biology; Androgen receptor","score_opus":0.13677567847113423,"score_gpt":0.4662400923479494,"score_spread":0.32946441387681513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127454388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814594,0.016692694,0.000009349094,0.00083988183,0.00007678489,0.00020288094,0.000105583706,0.000005269075,0.000608191],"genre_scores_gemma":[0.9846289,0.011404052,0.00017234859,0.00018743728,0.00008545046,0.00011316178,0.000018277882,0.000023360246,0.003366977],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758244,0.00046105296,0.00045140073,0.0006046332,0.0004841413,0.00041630986],"domain_scores_gemma":[0.9984327,0.00021465028,0.00011459173,0.00036346776,0.0007542812,0.000120301156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001791247,0.00011895981,0.0002843649,0.000048481015,0.00007123694,0.00001981366,0.00021450732,0.00015915776,0.00020076313],"category_scores_gemma":[0.001393625,0.00010527063,0.000054255226,0.00045999527,0.00048280653,0.000006092808,0.00022710259,0.00042715727,0.000002068662],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011838634,0.00026139297,0.5665591,0.00019897554,0.00018647507,0.00013432042,0.0005022152,0.000043967313,0.41938242,0.000085692154,0.007482846,0.0039787656],"study_design_scores_gemma":[0.002826044,0.0006580513,0.140627,0.0009944688,0.00003278754,0.00000383163,0.0007483754,0.0000527005,0.8403112,0.0008130168,0.012485408,0.00044709267],"about_ca_topic_score_codex":0.0004663284,"about_ca_topic_score_gemma":0.023104304,"teacher_disagreement_score":0.42593205,"about_ca_system_score_codex":0.00003209469,"about_ca_system_score_gemma":0.001130975,"threshold_uncertainty_score":0.9947215},"labels":[],"label_agreement":null},{"id":"W3127498707","doi":"10.1158/1557-3265.endomet20-ia002","title":"Abstract IA002: Histopathological classification of endometrial cancers and surrogate markers of genomic subtypes","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute","funders":"","keywords":"Serous carcinoma; Carcinoma; Endometrial cancer; Serous fluid; Pathology; Clear cell carcinoma; Hematopathology; Biology; Medicine; Cancer; Oncology; Internal medicine; Cytogenetics; Ovarian cancer; Gene; Genetics","score_opus":0.308582051854038,"score_gpt":0.5043293247517843,"score_spread":0.1957472728977463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127498707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857917,0.007861514,0.0000031991538,0.0010056983,0.0003736861,0.00037790768,0.00008189038,0.00001241225,0.004492027],"genre_scores_gemma":[0.9888033,0.010074533,0.00020841956,0.000066598004,0.00033068805,0.000053611388,0.000024941603,0.000016645801,0.00042122713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714065,0.00040766736,0.00088488916,0.0005132715,0.0007117926,0.00034175822],"domain_scores_gemma":[0.99590945,0.002472955,0.00021354566,0.00037524683,0.000736038,0.00029277432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025188637,0.00012633328,0.0007396951,0.00023527122,0.00005936068,0.000010652309,0.00013669569,0.00021175847,0.0013650556],"category_scores_gemma":[0.0035049687,0.000099515,0.0002313184,0.00087527285,0.0008462694,0.000043483346,0.0001288597,0.0005720498,0.00001317516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019493984,0.00095383456,0.70857084,0.0007174876,0.00039416502,0.00019700096,0.00008220317,0.0000045347,0.10173293,0.0005473757,0.00097450387,0.16633111],"study_design_scores_gemma":[0.0065879817,0.0012466643,0.9812921,0.00013501056,0.00010516678,0.000007814572,0.00016352664,0.000011222275,0.007319038,0.0003233426,0.0027201308,0.00008799926],"about_ca_topic_score_codex":0.0009590867,"about_ca_topic_score_gemma":0.00018743645,"teacher_disagreement_score":0.27272123,"about_ca_system_score_codex":0.00038584997,"about_ca_system_score_gemma":0.0012275559,"threshold_uncertainty_score":0.99954784},"labels":[],"label_agreement":null},{"id":"W3128925387","doi":"10.1158/1557-3265.endomet20-pr002","title":"Abstract PR002: Global proteomic profiling of endometrial carcinomas identify prognostic markers","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; Genome British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Endometrial cancer; Oncology; Cohort; Internal medicine; Medicine; Disease; Ovarian cancer; Microsatellite instability; Overall survival; Bioinformatics; Cancer; Biology; Gene; Genetics; Microsatellite","score_opus":0.12846969803580674,"score_gpt":0.4809768805282262,"score_spread":0.3525071824924194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128925387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798273,0.010918497,0.00005321719,0.00023370312,0.0064368937,0.00091075856,0.00017946622,0.00001114306,0.0014290408],"genre_scores_gemma":[0.9787102,0.0035967364,0.0004612578,0.00005947957,0.01629928,0.0002676469,0.000088009336,0.000029073226,0.0004883686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99664986,0.00050772616,0.00078524055,0.00076656236,0.00067944935,0.00061115716],"domain_scores_gemma":[0.9978156,0.00024174854,0.00016492688,0.0006096853,0.0009044566,0.00026358638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027919034,0.0001685243,0.00042652022,0.00007260358,0.00010374276,0.000054363794,0.0004079836,0.00031656164,0.00019137548],"category_scores_gemma":[0.005489488,0.00016224754,0.00033525744,0.00059478544,0.00048674116,0.000008164917,0.0003962891,0.00052419154,0.00001812943],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033790036,0.0005329829,0.442432,0.00047968485,0.00041431873,0.0000072330163,0.000021993925,0.000018980074,0.50136536,0.00018042818,0.02405925,0.02710879],"study_design_scores_gemma":[0.0056613637,0.0007414329,0.62251145,0.00019033681,0.000108277585,0.000012198656,0.0001788543,0.000021033897,0.24528448,0.00036045455,0.12449532,0.00043479344],"about_ca_topic_score_codex":0.0003650671,"about_ca_topic_score_gemma":0.00035223208,"teacher_disagreement_score":0.25608087,"about_ca_system_score_codex":0.00007897831,"about_ca_system_score_gemma":0.0024958847,"threshold_uncertainty_score":0.6616262},"labels":[],"label_agreement":null},{"id":"W3129520566","doi":"10.1158/1078-0432.ccr-20-4573","title":"Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; National Institutes of Health; Progenics Pharmaceuticals","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Biochemical recurrence; Oncology; Radiology; Internal medicine; Prostatectomy","score_opus":0.14964507020304046,"score_gpt":0.5127410395060567,"score_spread":0.3630959693030162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129520566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807198,0.007864477,3.0750437e-7,0.006637994,0.00018698204,0.0035304974,0.00058388273,0.00002222905,0.0004538522],"genre_scores_gemma":[0.9695565,0.02651633,0.000041314124,0.00014471584,0.00032795334,0.0013767809,0.00021549783,0.00004327989,0.0017775911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943357,0.0009087537,0.0012666726,0.0010445423,0.0015574618,0.0008868723],"domain_scores_gemma":[0.99144405,0.00566479,0.000205157,0.0009929626,0.00130004,0.00039298288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030659726,0.0002744923,0.0008313131,0.00012613891,0.00017342385,0.000056754096,0.0004513106,0.000034961504,0.00040597265],"category_scores_gemma":[0.0027812228,0.00015898622,0.00013331907,0.0011338096,0.0010154202,0.00010779217,0.00039091214,0.0017433595,0.000020186164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077678405,0.008320112,0.8634253,0.00023408943,0.0007238716,0.0043467875,0.0019770896,0.000029298237,0.0013951971,0.0000021016933,0.0081634065,0.033704314],"study_design_scores_gemma":[0.31686997,0.019935979,0.5470556,0.008694903,0.00070480694,0.000054937005,0.012332016,0.004669157,0.07810613,0.000049627444,0.010618008,0.0009088471],"about_ca_topic_score_codex":0.005992009,"about_ca_topic_score_gemma":0.0026505687,"teacher_disagreement_score":0.31636968,"about_ca_system_score_codex":0.0004708965,"about_ca_system_score_gemma":0.002765632,"threshold_uncertainty_score":0.9058165},"labels":[],"label_agreement":null},{"id":"W3129637558","doi":"10.1158/1078-0432.ccr-20-4834","title":"A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Johns Hopkins University; International Association for the Study of Lung Cancer; Bristol-Myers Squibb","keywords":"Microbiome; Metagenomics; Biomarker; Computational biology; Immune system; Gut microbiome; Biology; Medicine; Cancer; Bioinformatics; Oncology; Immunology; Internal medicine; Genetics; Gene","score_opus":0.15755910695582312,"score_gpt":0.4892872831924687,"score_spread":0.33172817623664563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129637558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478126,0.000433498,0.00054689054,0.0028437662,0.000241941,0.00053422945,0.0001481589,0.000007995296,0.00046227974],"genre_scores_gemma":[0.98333263,0.00010198742,0.013111265,0.000887821,0.0005498969,0.00007511322,0.00024472125,0.000037213464,0.0016593225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718606,0.00049791613,0.00085967075,0.0006818994,0.0002648895,0.0005095663],"domain_scores_gemma":[0.9980069,0.00025316403,0.00010850546,0.00045315808,0.0008429417,0.00033537738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035232396,0.00015307848,0.00032593065,0.00016458666,0.00013873928,0.000030429514,0.00029516593,0.00021448446,0.000032590757],"category_scores_gemma":[0.001754581,0.00014451046,0.00019058216,0.0006564966,0.00019932642,0.0000028803288,0.00047631524,0.00036070103,0.000025870479],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024179358,0.0003281955,0.00083031144,0.00012368862,0.000063977306,0.0000052202636,0.0000854422,0.00014782565,0.9844228,0.000014734828,0.0057723178,0.0057875616],"study_design_scores_gemma":[0.0030090774,0.0030758262,0.053526174,0.00040774007,0.000019758003,0.00002450617,0.0006602436,0.0003221005,0.88849676,0.00006754544,0.0498444,0.0005458581],"about_ca_topic_score_codex":0.00027457427,"about_ca_topic_score_gemma":0.00009316683,"teacher_disagreement_score":0.09592602,"about_ca_system_score_codex":0.000092252034,"about_ca_system_score_gemma":0.0012677715,"threshold_uncertainty_score":0.5892966},"labels":[],"label_agreement":null},{"id":"W3130253087","doi":"10.1158/1078-0432.ccr-20-4338","title":"FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"U.S. Food and Drug Administration; National Institutes of Health","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Chemotherapy; Cancer; Lung cancer; Internal medicine; Immunotherapy; Intensive care medicine","score_opus":0.14277968763737794,"score_gpt":0.5034665726369157,"score_spread":0.3606868849995378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130253087","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34801948,0.60352623,0.00029850058,0.030455949,0.0004955545,0.014004759,0.00057486823,0.00008537498,0.0025393043],"genre_scores_gemma":[0.03319548,0.92260766,0.007059762,0.009449191,0.0007908839,0.007724126,0.00015266113,0.00020001017,0.018820211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962588,0.00055486214,0.00076498627,0.0009809615,0.00071340526,0.0007269999],"domain_scores_gemma":[0.99609447,0.001060881,0.00019976601,0.0006032634,0.0017748328,0.00026677625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030020245,0.0003003256,0.0011089639,0.00012144566,0.00024352084,0.00008225176,0.0002160019,0.00014503756,0.0004956704],"category_scores_gemma":[0.00037745154,0.0002198559,0.000240654,0.0016383207,0.00063232525,0.000093885654,0.00009369054,0.00078450004,0.0000023484404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06830473,0.0023656746,0.02840776,0.038001206,0.004024669,0.00035647865,0.0016389199,0.0000021969902,0.004780983,0.000042311814,0.470227,0.38184807],"study_design_scores_gemma":[0.07012782,0.009706341,0.008915745,0.021653142,0.0018052593,0.00009010796,0.0025111053,0.0013084705,0.011073893,0.000081149265,0.8715393,0.0011876733],"about_ca_topic_score_codex":0.0016109751,"about_ca_topic_score_gemma":0.002380299,"teacher_disagreement_score":0.4013123,"about_ca_system_score_codex":0.00040462046,"about_ca_system_score_gemma":0.0083870515,"threshold_uncertainty_score":0.99723446},"labels":[],"label_agreement":null},{"id":"W3130683366","doi":"10.1158/1078-0432.ccr-20-3365","title":"Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario; McGill University; McGill University Health Centre","funders":"Terry Fox Research Institute; Canadian Cancer Society","keywords":"Oncolytic virus; Melanoma; Cancer research; Vesicular stomatitis virus; Herpes simplex virus; Biology; Immune checkpoint; RNA interference; Virology; Immune system; Immunology; Medicine; Virus; Immunotherapy; Gene; RNA","score_opus":0.18968747413423104,"score_gpt":0.5040336254214045,"score_spread":0.31434615128717347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130683366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696056,0.000898076,0.000015009948,0.024212083,0.00016075991,0.002275517,0.00007248379,0.000022430417,0.0027380139],"genre_scores_gemma":[0.99040294,0.00063572824,0.00025161848,0.00087482407,0.00043820764,0.0007973677,0.000034889745,0.000052796873,0.0065116505],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9919252,0.003521517,0.0011186876,0.0009165563,0.0014822464,0.0010358203],"domain_scores_gemma":[0.9925597,0.004980408,0.00006540147,0.0011177016,0.00064898137,0.00062785594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010387347,0.00023994033,0.00074201974,0.0005073361,0.00020721549,0.00011554384,0.00019433435,0.00018699556,0.000749322],"category_scores_gemma":[0.0061539365,0.00018557187,0.00024555347,0.003199948,0.00032375238,0.00007851061,0.00030885078,0.001490841,0.00014253959],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014938117,0.0058032237,0.081111275,0.00028663257,0.00023620932,0.028346183,0.01254849,0.00044648434,0.71194893,0.00015751006,0.0020501805,0.14212674],"study_design_scores_gemma":[0.013025393,0.0039879763,0.59586906,0.0022170777,0.00007161384,0.0001435103,0.0075861947,0.0004808122,0.25824553,0.00048449202,0.11714828,0.00074005337],"about_ca_topic_score_codex":0.027786134,"about_ca_topic_score_gemma":0.22317065,"teacher_disagreement_score":0.51475775,"about_ca_system_score_codex":0.003056139,"about_ca_system_score_gemma":0.0035851828,"threshold_uncertainty_score":0.97868794},"labels":[],"label_agreement":null},{"id":"W3133560731","doi":"10.1158/1557-3265.adi21-po-025","title":"Abstract PO-025: Differentiation of benign from clinically significant prostate cancer tissues using convolution neural networks on raw micro-ultrasound data","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Medicine; Biopsy; Ultrasound; Prostate; Radiology; Cancer; Convolutional neural network; Prostate biopsy; Artificial intelligence; Computer science; Internal medicine","score_opus":0.22390549835778356,"score_gpt":0.5266286732634722,"score_spread":0.3027231749056886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133560731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895102,0.0033323693,0.0010287357,0.0041211112,0.0011099095,0.0005338946,0.00022238777,0.00003621476,0.00010521336],"genre_scores_gemma":[0.98750454,0.0077369614,0.0009804794,0.0006732256,0.0019383115,0.000025572805,0.0008480902,0.000055911732,0.00023692912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99494535,0.0008422115,0.0014566182,0.0010550704,0.0010655774,0.00063517265],"domain_scores_gemma":[0.99318564,0.004102125,0.00038885864,0.0011211293,0.00077060645,0.00043165236],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036843163,0.00021916078,0.00079902686,0.00010576637,0.00019630848,0.000099600635,0.00048812354,0.0002885929,0.0010806489],"category_scores_gemma":[0.005087511,0.00018546401,0.00018258175,0.00036415446,0.0007413577,0.00013579939,0.00034698137,0.0026141384,0.000011550708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031891973,0.001205534,0.77139807,0.00027257804,0.0005508883,0.00022696864,0.00021775578,0.0062501817,0.066809446,0.000034469136,0.0071365447,0.14270835],"study_design_scores_gemma":[0.0042128414,0.0005346725,0.7009279,0.001324297,0.00029047125,0.000006705387,0.00020802957,0.28681785,0.0027196337,0.0002509983,0.0023852258,0.00032134278],"about_ca_topic_score_codex":0.0042832186,"about_ca_topic_score_gemma":0.00014292511,"teacher_disagreement_score":0.28056768,"about_ca_system_score_codex":0.00019087162,"about_ca_system_score_gemma":0.0009609207,"threshold_uncertainty_score":0.9998325},"labels":[],"label_agreement":null},{"id":"W3133660616","doi":"10.1158/1557-3265.adi21-po-005","title":"Abstract PO-005: An efficient digitized annotation platform for pathology-oriented dataset generation in AI research","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Annotation; Computer science; Digital pathology; Workflow; Prostate cancer; Artificial intelligence; Grading (engineering); Pathology; Pattern recognition (psychology); Cancer; Medicine; Biology; Database","score_opus":0.33612034587353407,"score_gpt":0.6047761300816308,"score_spread":0.2686557842080967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133660616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817883,0.00040444458,0.00082909304,0.015099956,0.00039341353,0.0008818594,0.000348922,0.000029883015,0.00022414415],"genre_scores_gemma":[0.9862378,0.0005058541,0.0015891655,0.0014929447,0.0014858932,0.00033718435,0.007944468,0.00004275857,0.00036387797],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9959711,0.000647416,0.0007933819,0.00080568244,0.0010006003,0.0007818603],"domain_scores_gemma":[0.995967,0.0018056597,0.00006798407,0.0005913032,0.0011331536,0.00043493186],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014239195,0.0001225927,0.00040219695,0.00034239635,0.0002921454,0.000109109846,0.00020088472,0.00023442451,0.00025543952],"category_scores_gemma":[0.012198981,0.00010802206,0.00009071292,0.00080871035,0.000516918,0.00014548816,0.00015192443,0.0025933466,0.000028484033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069996845,0.00656143,0.06130003,0.0009394005,0.00018388778,0.0034358576,0.0017388767,0.0041877036,0.06054052,0.004043274,0.32119405,0.5288753],"study_design_scores_gemma":[0.023545349,0.0027291612,0.23481454,0.00073370687,0.000062718325,0.000116841045,0.0013560891,0.4828096,0.005908417,0.0029814257,0.24435504,0.00058711687],"about_ca_topic_score_codex":0.0003108566,"about_ca_topic_score_gemma":0.00029342424,"teacher_disagreement_score":0.5282882,"about_ca_system_score_codex":0.00028843043,"about_ca_system_score_gemma":0.0011283059,"threshold_uncertainty_score":0.9997077},"labels":[],"label_agreement":null},{"id":"W3133947338","doi":"10.1158/1557-3265.adi21-pr-06","title":"Abstract PR-06: Utilizing biological domain knowledge and machine learning methods to improve cellular segmentation on multiplex fluorescence and imaging mass cytometry datasets improves the quality of single-cell data obtained","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Computer science; Segmentation; Artificial intelligence; Pipeline (software); Multiplex; Pattern recognition (psychology); Image segmentation; Machine learning; Bioinformatics; Biology","score_opus":0.29188449620046086,"score_gpt":0.5077303671023771,"score_spread":0.2158458709019162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133947338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98522735,0.0063645355,0.0067440006,0.00043470506,0.00017153872,0.00041338758,0.0005401691,0.000010351389,0.00009398531],"genre_scores_gemma":[0.9817729,0.0014931092,0.015403845,0.00011121598,0.00021190071,0.000023901239,0.0009166306,0.00002223567,0.000044282988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99613637,0.00168202,0.0006107221,0.0009393574,0.00025544746,0.00037609585],"domain_scores_gemma":[0.99707013,0.0016606667,0.00013690625,0.00072978385,0.00021563961,0.00018685669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006750735,0.0001762569,0.00031264382,0.000058055095,0.00022798362,0.00008471979,0.00046141338,0.00016208073,0.000013985833],"category_scores_gemma":[0.0033681067,0.00013040387,0.00006332415,0.00023973407,0.0004891236,0.0000148111985,0.00080931175,0.00063446397,0.0000016195023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047150216,0.00022831744,0.021576414,0.00013076651,0.000032874792,0.000004611737,0.00006896936,0.0000027761655,0.9014872,0.000008368107,0.000108411135,0.07587983],"study_design_scores_gemma":[0.0014801398,0.000508729,0.02120705,0.00005956909,0.000016924,0.0000013747248,0.0006456575,0.0014471894,0.96802926,0.000061740684,0.006317429,0.00022491856],"about_ca_topic_score_codex":0.00023213957,"about_ca_topic_score_gemma":0.00009439789,"teacher_disagreement_score":0.07565491,"about_ca_system_score_codex":0.00002910086,"about_ca_system_score_gemma":0.00015917285,"threshold_uncertainty_score":0.53177154},"labels":[],"label_agreement":null},{"id":"W3134000566","doi":"10.1158/1557-3265.adi21-po-053","title":"Abstract PO-053: Machine learning CADx process for classification of lung nodules below the Lung-RADS 4A threshold in LDCT scans","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Nodule (geology); Medicine; Artificial intelligence; Radiology; Lung; Lung cancer; Parenchyma; Lung cancer screening; Computer science; Computed tomography; Pathology; Internal medicine","score_opus":0.17894207556434416,"score_gpt":0.5377358738865021,"score_spread":0.35879379832215796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134000566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549625,0.0072103227,0.0004925296,0.034030244,0.00030487112,0.00091876753,0.000022044474,0.00003605411,0.0020226494],"genre_scores_gemma":[0.9952378,0.0021804506,0.00016188285,0.0004293674,0.00063530233,0.00021451498,0.000060900562,0.000051554056,0.0010281717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658114,0.00035630583,0.0009242755,0.00059841445,0.00094490714,0.00059493387],"domain_scores_gemma":[0.9962975,0.0020166156,0.00019338509,0.0004802157,0.0007662994,0.00024599687],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0068013784,0.00016185915,0.0005524851,0.0001697335,0.00024863004,0.00005223017,0.00038349867,0.00020398741,0.00032009874],"category_scores_gemma":[0.008157566,0.00011526075,0.0002122523,0.0007471886,0.00059189316,0.00008254025,0.00012021487,0.0030569474,0.000005739917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085109676,0.00056619005,0.9356883,0.0015743333,0.00015853312,0.00006664003,0.0006103726,0.0010925258,0.0046173143,0.000656197,0.0051903534,0.048928108],"study_design_scores_gemma":[0.0032612951,0.00024083702,0.6933084,0.0011684874,0.0000843148,0.000014298296,0.0005125198,0.2925483,0.0009180942,0.00045375846,0.0073069003,0.00018277887],"about_ca_topic_score_codex":0.0005086117,"about_ca_topic_score_gemma":0.0003121403,"teacher_disagreement_score":0.29145578,"about_ca_system_score_codex":0.00019136714,"about_ca_system_score_gemma":0.0012040549,"threshold_uncertainty_score":0.999243},"labels":[],"label_agreement":null},{"id":"W3134516012","doi":"10.1158/1557-3265.adi21-po-033","title":"Abstract PO-033: The impact of the variation of CT scanner on the prediction of HPV status in head &amp; neck cancer patients","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Scanner; Radiomics; Medicine; Cancer imaging; Artificial intelligence; Head and neck; Head and neck squamous-cell carcinoma; Head and neck cancer; Robustness (evolution); Cancer; Radiology; Computer science; Medical physics; Nuclear medicine; Radiation therapy; Internal medicine; Surgery","score_opus":0.1461867473918891,"score_gpt":0.5199791602515118,"score_spread":0.3737924128596227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134516012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903655,0.00040049883,0.0000061659516,0.0070011094,0.00032318983,0.00046843925,0.00009954707,0.0000038970643,0.0013316383],"genre_scores_gemma":[0.99809074,0.0011861963,0.000015954629,0.00022140137,0.00021028641,0.00003918794,0.000015684795,0.000016421573,0.00020413035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698424,0.0007031812,0.00074370066,0.00024139065,0.0010089991,0.00031846948],"domain_scores_gemma":[0.9965767,0.0018636228,0.0002666425,0.0005418452,0.00064459245,0.000106600266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030649044,0.00009398412,0.00033580424,0.00007285754,0.00008484084,0.0000117739355,0.00024824688,0.00007166655,0.00091655046],"category_scores_gemma":[0.007030038,0.000042269592,0.00022941448,0.0006677609,0.00052218535,0.0000365721,0.000116280244,0.0014977017,0.0000023828811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005702676,0.00068306713,0.94819653,0.000109447516,0.00013644659,0.000002099835,0.0005095445,0.0017538506,0.0013116607,0.000072098155,0.0053104665,0.041344497],"study_design_scores_gemma":[0.0014567212,0.0002887621,0.9940259,0.00043800942,0.000025441279,6.408316e-7,0.000059971782,0.0018725791,0.00047324807,0.00020471336,0.0011213212,0.000032693762],"about_ca_topic_score_codex":0.018061254,"about_ca_topic_score_gemma":0.0006456827,"teacher_disagreement_score":0.045829345,"about_ca_system_score_codex":0.0002485124,"about_ca_system_score_gemma":0.0013594559,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W3134562253","doi":"10.1158/1557-3265.adi21-ia-03","title":"Abstract IA-03: Unsupervised resolution of intra- and inter-tumoral heterogeneity using deep learning","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Artificial intelligence; Deep learning; Computer science; Context (archaeology); Machine learning; Artificial neural network; Deep neural networks; Cancer; Scalability; Medicine; Biology; Database","score_opus":0.28727151812221824,"score_gpt":0.514604831551338,"score_spread":0.22733331342911972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134562253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95780236,0.0021017906,0.03834326,0.00068693265,0.0005896027,0.00015513328,0.000002580432,0.000054050142,0.00026429462],"genre_scores_gemma":[0.99289715,0.0008936897,0.00577796,0.000066911525,0.0002949302,0.000017771972,0.0000015923285,0.000015582615,0.000034415938],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996654,0.0009018504,0.00063644047,0.00070390385,0.0006389527,0.00046490805],"domain_scores_gemma":[0.99767876,0.0007673501,0.00013989404,0.0005394762,0.0006735239,0.00020098954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003379399,0.00012048594,0.00032105745,0.00013670992,0.00024106569,0.00014221406,0.00051200285,0.0001630698,0.0000849962],"category_scores_gemma":[0.0009549195,0.00012280059,0.000114208175,0.00078605424,0.00043224441,0.00038266793,0.00079357345,0.0011960405,0.000011440651],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004686489,0.0003420403,0.120972075,0.00042528435,0.00015220378,0.00014212505,0.0007960654,0.003359383,0.048736528,0.00079216954,0.00031247118,0.823501],"study_design_scores_gemma":[0.0030378588,0.001258501,0.35731158,0.00075302174,0.00003581352,0.000077561876,0.00048387374,0.5314614,0.09471969,0.0040321243,0.006123623,0.0007049485],"about_ca_topic_score_codex":0.0006018647,"about_ca_topic_score_gemma":0.0005512738,"teacher_disagreement_score":0.82279605,"about_ca_system_score_codex":0.00026521378,"about_ca_system_score_gemma":0.00047745925,"threshold_uncertainty_score":0.51962674},"labels":[],"label_agreement":null},{"id":"W3134750715","doi":"10.1158/1557-3265.adi21-ia-15","title":"Abstract IA-15: Platforms to improve reproducibility in artificial intelligence research","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Reproducibility; Computer science; Transparency (behavior); Artificial intelligence; Field (mathematics); Data science; Mathematics","score_opus":0.3980621339270541,"score_gpt":0.6218056127994603,"score_spread":0.22374347887240625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134750715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530389,0.00081520306,0.00017675218,0.04108513,0.000756889,0.00082450546,0.000008333973,0.000039587616,0.0032547128],"genre_scores_gemma":[0.99333674,0.00082004425,0.0011933374,0.0010157318,0.0019239832,0.00017138691,0.000012941788,0.000042591208,0.0014832735],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99275327,0.00056780095,0.0013346074,0.002365255,0.0017191955,0.0012598739],"domain_scores_gemma":[0.99163926,0.0034126486,0.00006161225,0.0023908163,0.0015587028,0.00093694933],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.054157764,0.0001582714,0.0006001259,0.0004082994,0.00023138545,0.0001187986,0.0004791037,0.00026557728,0.0015236005],"category_scores_gemma":[0.08735937,0.0001320048,0.00017784502,0.0022005178,0.00089319784,0.00010054695,0.0006993415,0.0066139903,0.00045195804],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001637199,0.0013148196,0.0779585,0.00031773365,0.000049439717,0.0011241295,0.00065169117,0.00009759716,0.016253648,0.0015582453,0.0072300103,0.89180696],"study_design_scores_gemma":[0.0022549275,0.0027136412,0.73833007,0.0027686271,0.000037690734,0.000067297195,0.0039472813,0.009642879,0.060149714,0.11300646,0.066210195,0.00087122276],"about_ca_topic_score_codex":0.00163206,"about_ca_topic_score_gemma":0.0008534882,"teacher_disagreement_score":0.8909358,"about_ca_system_score_codex":0.00049339054,"about_ca_system_score_gemma":0.0020051321,"threshold_uncertainty_score":0.9993892},"labels":[],"label_agreement":null},{"id":"W3134874642","doi":"10.1158/1557-3265.adi21-po-018","title":"Abstract PO-018: Computational staining of tumor hypoxia from H&amp;E images using convolutional neural networks","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Domtar (Canada); University of Toronto","funders":"","keywords":"Hypoxia (environmental); Stain; H&E stain; Tumor hypoxia; Staining; Pathology; Biology; Convolutional neural network; Necrosis; Chemistry; Medicine; Internal medicine; Radiation therapy; Artificial intelligence; Oxygen; Computer science","score_opus":0.21495130912935417,"score_gpt":0.5289596260580025,"score_spread":0.31400831692864833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134874642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981048,0.0030993037,0.010795326,0.0038102143,0.0005201357,0.00016675587,0.000058898448,0.000028785418,0.00047259952],"genre_scores_gemma":[0.9855619,0.00017061077,0.011395716,0.0009432028,0.0015388345,0.000009257095,0.00017408877,0.00003349551,0.0001728935],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967305,0.00042029403,0.00081557425,0.00049334235,0.0010451049,0.000495154],"domain_scores_gemma":[0.9948373,0.0033169491,0.00016881966,0.0002823975,0.0010155557,0.00037896947],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024270616,0.00013368098,0.00051841425,0.00010454275,0.00018407464,0.00005222904,0.00018118603,0.00011485115,0.0015901646],"category_scores_gemma":[0.0038386118,0.000123196,0.00020702241,0.00038788115,0.0008624856,0.00007858894,0.000208252,0.0020455904,0.0000112360285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017343115,0.0011191816,0.69248044,0.00034001443,0.00072336016,0.001237131,0.00022076193,0.16538322,0.012704858,0.0006084213,0.02087308,0.102575235],"study_design_scores_gemma":[0.002292916,0.00008403889,0.47266877,0.00039311813,0.00005714516,0.000043510707,0.00011959303,0.5202287,0.0001186326,0.0013982896,0.0024462526,0.00014903556],"about_ca_topic_score_codex":0.0009794353,"about_ca_topic_score_gemma":0.000020181633,"teacher_disagreement_score":0.35484546,"about_ca_system_score_codex":0.00014257911,"about_ca_system_score_gemma":0.0012928181,"threshold_uncertainty_score":0.99932253},"labels":[],"label_agreement":null},{"id":"W3134979252","doi":"10.1158/1557-3265.adi21-po-052","title":"Abstract PO-052: Exploring patient derived xenografts based pharmacogenomic data for precision oncology","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pharmacogenomics; Precision medicine; Personalized medicine; Drug response; Metadata; Computational biology; Cancer; Medicine; Visualization; Bioinformatics; Oncology; Computer science; Cancer research; Biology; Drug; Internal medicine; Pharmacology; Data mining; Pathology; World Wide Web","score_opus":0.5907452067820693,"score_gpt":0.6136193960953055,"score_spread":0.02287418931323615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134979252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732725,0.002480935,0.001779429,0.018830676,0.0018111939,0.0008799656,0.000102480095,0.000056351422,0.0007864866],"genre_scores_gemma":[0.9813403,0.0036330826,0.009058732,0.002735636,0.0022405924,0.0003399802,0.0004217931,0.00007062424,0.00015927522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640125,0.0004738354,0.00080536224,0.00090815814,0.0007302206,0.00068115257],"domain_scores_gemma":[0.99338394,0.00425112,0.000120762765,0.001007446,0.00062392413,0.00061280344],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051800963,0.00015034908,0.0005372911,0.00013790894,0.000232966,0.000057409467,0.0004921557,0.00015666263,0.00094948674],"category_scores_gemma":[0.008650069,0.00012955679,0.00018254534,0.00031137877,0.0003112732,0.00012273564,0.000546614,0.0017512788,0.00004631743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016994512,0.0007493806,0.005619256,0.0002329208,0.00013853646,0.00037163403,0.00009249584,0.000098443576,0.042935297,0.000008020403,0.034627408,0.9134272],"study_design_scores_gemma":[0.008015338,0.0010982339,0.018528074,0.00058232725,0.00013087493,0.000022587377,0.00025540267,0.028450666,0.019344188,0.0001135966,0.9232082,0.00025053983],"about_ca_topic_score_codex":0.00012711377,"about_ca_topic_score_gemma":0.000025952557,"teacher_disagreement_score":0.9131766,"about_ca_system_score_codex":0.00028352346,"about_ca_system_score_gemma":0.0022950645,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W3135064215","doi":"10.1158/1557-3265.adi21-po-031","title":"Abstract PO-031: Evaluating clinical utility of organs-at-risk segmentation in head &amp; neck cancer by simple open-source 3D CNNs","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Segmentation; Contouring; Computer science; Artificial intelligence; Deep learning; Workflow; Medical physics; Benchmark (surveying); Test set; Source code; Machine learning; Medicine","score_opus":0.3223459396933597,"score_gpt":0.6205568415552344,"score_spread":0.2982109018618747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135064215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877188,0.002627478,0.00026231445,0.006546091,0.00041132464,0.00083056156,0.00009765871,0.000029452673,0.0014762749],"genre_scores_gemma":[0.9856757,0.006671439,0.0027886925,0.0013833974,0.0006642836,0.00013348769,0.00021043843,0.000070168426,0.002402389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99223727,0.0022743703,0.0021459886,0.0010617785,0.0015078709,0.00077272346],"domain_scores_gemma":[0.99279255,0.004480813,0.0004307067,0.000817492,0.00086524215,0.00061319495],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019666139,0.00021192088,0.0010340716,0.00011234101,0.0002487614,0.00008044126,0.00051878183,0.00032799374,0.0073865186],"category_scores_gemma":[0.021228848,0.0001905634,0.00023578265,0.00085620244,0.00075480784,0.0001328504,0.0007976382,0.0037122662,0.000057906876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083450315,0.00069455773,0.6654772,0.00017201596,0.00009247172,0.000026175896,0.0001869752,0.00008479586,0.0023958748,0.0000018225544,0.027323974,0.3027096],"study_design_scores_gemma":[0.008850357,0.0004986551,0.9024761,0.00073835644,0.00010946306,0.0000073431556,0.00031200316,0.013420848,0.0011367517,0.00019824297,0.071999885,0.00025202092],"about_ca_topic_score_codex":0.016275756,"about_ca_topic_score_gemma":0.005360513,"teacher_disagreement_score":0.3024576,"about_ca_system_score_codex":0.0003949138,"about_ca_system_score_gemma":0.0022758904,"threshold_uncertainty_score":0.99858624},"labels":[],"label_agreement":null},{"id":"W3135160265","doi":"10.1158/1557-3265.adi21-po-060","title":"Abstract PO-060: Individualized prediction of meningioma recurrence risk over prolonged time periods","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Meningioma; Medicine; Grading (engineering); Cohort; Internal medicine; Oncology; Proportional hazards model; Surgery; Radiology","score_opus":0.1284431035524994,"score_gpt":0.5132298910673004,"score_spread":0.384786787514801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135160265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932797,0.002087101,0.00006038945,0.0029648438,0.00041130895,0.0003903122,0.00009204364,0.0000509891,0.004615018],"genre_scores_gemma":[0.9934145,0.0025506571,0.0014193106,0.00021100481,0.00081683823,0.000068848654,0.000083002655,0.00003243875,0.0014033832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996019,0.00079029344,0.0008563687,0.0005775352,0.0012712032,0.0004855978],"domain_scores_gemma":[0.99684656,0.0013567639,0.00021963898,0.0005119508,0.000664308,0.00040077072],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00675307,0.0001394533,0.0005758016,0.00015889427,0.00017109848,0.00004539145,0.00022217636,0.0002321117,0.0031554482],"category_scores_gemma":[0.011375825,0.00011755996,0.00023450569,0.0006435268,0.0006708619,0.0000816925,0.00019716001,0.002500287,0.00006139785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011633878,0.0007261509,0.69565845,0.00034203997,0.00039558814,0.00025834507,0.0005567842,0.000019555242,0.008630353,0.000050878996,0.025133695,0.26706478],"study_design_scores_gemma":[0.00446796,0.00061688735,0.9376274,0.0007809584,0.00013581829,0.000031828833,0.00007476723,0.004911451,0.0018640214,0.00028694514,0.04906465,0.0001373507],"about_ca_topic_score_codex":0.00027998848,"about_ca_topic_score_gemma":0.000008936475,"teacher_disagreement_score":0.26692745,"about_ca_system_score_codex":0.00010472583,"about_ca_system_score_gemma":0.0011345657,"threshold_uncertainty_score":0.999801},"labels":[],"label_agreement":null},{"id":"W3135237341","doi":"10.1158/1557-3265.adi21-po-010","title":"Abstract PO-010: Feature pyramid network for revealing tumour infiltrating lymphocyte presence and distribution in a whole slide image","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Pyramid (geometry); Breast cancer; Artificial intelligence; Computer science; Segmentation; Convolutional neural network; Feature (linguistics); Ductal carcinoma; Medicine; Cancer; Pathology; Internal medicine","score_opus":0.08339589710955707,"score_gpt":0.4877396388125088,"score_spread":0.40434374170295173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135237341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94178563,0.007862152,0.0023346657,0.046140175,0.00043594945,0.00081212743,0.000077872275,0.000048782833,0.00050261745],"genre_scores_gemma":[0.98691595,0.002192789,0.006475739,0.0008654119,0.002068052,0.00013953306,0.0002298844,0.00004091427,0.0010717177],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99727106,0.00029969504,0.0005845758,0.00059949775,0.00052149314,0.0007236652],"domain_scores_gemma":[0.9962242,0.002568579,0.00010552171,0.00028892397,0.00044814294,0.0003646314],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0055669774,0.00014065129,0.00046652227,0.000052822885,0.00023652989,0.00013639804,0.00014897426,0.00019921792,0.000044206256],"category_scores_gemma":[0.014238696,0.00012566448,0.000119473385,0.00051281624,0.00038579627,0.00011624461,0.00016711942,0.0020065666,0.0000049091354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028278762,0.0006128554,0.34986922,0.0026180204,0.0001963484,0.001712338,0.0005092318,0.0017289538,0.0546646,0.00076500484,0.17534845,0.4091471],"study_design_scores_gemma":[0.009726151,0.00052481896,0.78362936,0.0053358064,0.000078246085,0.00014145173,0.0006349546,0.07691917,0.003098326,0.0027736048,0.11663509,0.0005030413],"about_ca_topic_score_codex":0.00039890897,"about_ca_topic_score_gemma":0.00013455172,"teacher_disagreement_score":0.4337601,"about_ca_system_score_codex":0.00022177662,"about_ca_system_score_gemma":0.0008968216,"threshold_uncertainty_score":0.9940648},"labels":[],"label_agreement":null},{"id":"W3135323275","doi":"10.1158/1557-3265.adi21-po-051","title":"Abstract PO-051: Development of web-based quality-assurance tool for radiotherapy target delineation for head and neck cancer: Quality evaluation of nasopharyngeal carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Nasopharyngeal carcinoma; Cavernous sinus; Clivus; Head and neck cancer; Radiation therapy; Radiology; Surgery; Skull","score_opus":0.42138889878580277,"score_gpt":0.5952276152792926,"score_spread":0.1738387164934898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135323275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97262603,0.019422885,0.0012152173,0.0040640733,0.0002764857,0.0019636133,0.000358809,0.000013393104,0.00005949512],"genre_scores_gemma":[0.9815026,0.0018794617,0.014055704,0.0003304599,0.0004516051,0.0015230954,0.00011278434,0.000029207577,0.00011507954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561244,0.0005542234,0.0015999095,0.0005772944,0.0012411089,0.000415039],"domain_scores_gemma":[0.9913958,0.0030457121,0.00031514151,0.00034757043,0.0047352943,0.00016048743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012468001,0.00016611135,0.0009968948,0.000097196826,0.00018212735,0.000013237452,0.000111964815,0.00017354019,0.00017159672],"category_scores_gemma":[0.0036261342,0.00014847281,0.00021474522,0.0003135589,0.00026642767,0.00006881018,0.000036174064,0.00028879853,4.3847393e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00984199,0.000816887,0.60058856,0.0050370437,0.00036945322,0.0000014943357,0.0007175179,0.00013183204,0.026482124,0.00008129476,0.0034562226,0.35247555],"study_design_scores_gemma":[0.017861545,0.0007693597,0.9166524,0.0006405489,0.000076942626,3.3204682e-7,0.00015155153,0.0037312934,0.049515136,0.00010963823,0.010315264,0.00017600432],"about_ca_topic_score_codex":0.00059145736,"about_ca_topic_score_gemma":0.0021938898,"teacher_disagreement_score":0.35229957,"about_ca_system_score_codex":0.00045479444,"about_ca_system_score_gemma":0.008893867,"threshold_uncertainty_score":0.9967248},"labels":[],"label_agreement":null},{"id":"W3135388836","doi":"10.1158/1557-3265.adi21-po-094","title":"Abstract PO-094: Socioeconomic status and utilization of cancer surgeries in the United States, Canada, and Australia","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Socioeconomic status; Residence; Demography; Population; Census; Gerontology; Environmental health","score_opus":0.48982473848663044,"score_gpt":0.5658570414180496,"score_spread":0.07603230293141916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135388836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891323,0.0057990486,7.536564e-7,0.004555793,0.00012258899,0.00019183547,0.000106768806,0.0000035382297,0.00008737426],"genre_scores_gemma":[0.9772155,0.021465978,0.000013495143,0.0008265238,0.0000954587,0.000033254655,0.00006221042,0.000008500274,0.00027907843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981441,0.00024582536,0.0004874605,0.00028951428,0.00043757944,0.00039550604],"domain_scores_gemma":[0.9982142,0.00092761754,0.000080063095,0.00019939446,0.00039822762,0.00018053174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016964893,0.00008903411,0.00030744393,0.00007654759,0.00008134715,0.000035053497,0.000082217724,0.00009240008,0.0005828412],"category_scores_gemma":[0.0004799463,0.000068409514,0.000032382086,0.0003565429,0.00044294202,0.00006783471,0.00006721874,0.00058208907,9.95791e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031060362,0.000030898645,0.98240674,0.00014412167,0.000038444796,0.00007324019,0.00036806014,0.00004206215,0.00004978462,0.00009940979,0.008656365,0.0077802725],"study_design_scores_gemma":[0.0007078849,0.00008184224,0.9755528,0.00018438035,0.000018974222,0.0000035038938,0.002477393,0.00008371798,0.000296382,0.00019802146,0.020327387,0.000067686065],"about_ca_topic_score_codex":0.9202443,"about_ca_topic_score_gemma":0.93990654,"teacher_disagreement_score":0.019662235,"about_ca_system_score_codex":0.000250938,"about_ca_system_score_gemma":0.002602642,"threshold_uncertainty_score":0.63817024},"labels":[],"label_agreement":null},{"id":"W3135511891","doi":"10.1158/1557-3265.adi21-pr-07","title":"Abstract PR-07: ORCESTRA: A platform for orchestrating and sharing high-throughput multimodal data analyses","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Computer science; Pipeline (software); Bioconductor; Data sharing; Cloud computing; Interface (matter); Open science; Biological data; Data science; Bioinformatics; Biology","score_opus":0.6543166387282022,"score_gpt":0.6159407247364818,"score_spread":0.03837591399172047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135511891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933542,0.0028701015,0.001527147,0.0009533585,0.0002290176,0.00033536655,0.00015879679,0.000014008621,0.0005579874],"genre_scores_gemma":[0.99136937,0.0023747906,0.0035363715,0.00015370257,0.0010326467,0.0001347704,0.000583179,0.000025471276,0.0007896784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775046,0.00008311164,0.0004598041,0.0010323448,0.00029545178,0.0003788511],"domain_scores_gemma":[0.9981614,0.0002131903,0.00010190559,0.0009546603,0.0003790685,0.000189803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015765156,0.00012673686,0.00021387638,0.000039078866,0.00022814813,0.00012931411,0.0005036488,0.00023346716,0.00010950871],"category_scores_gemma":[0.0014076473,0.00011360498,0.00007174286,0.00017266917,0.00021663212,0.00001970109,0.00068025076,0.00037711023,0.000005830733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069166487,0.00030933833,0.022475453,0.00029186317,0.0002420429,0.000015302332,0.000067522975,0.00011305299,0.86271816,0.00041105243,0.018443804,0.09422074],"study_design_scores_gemma":[0.006988603,0.0009937473,0.26766828,0.0004356928,0.0001301167,0.000018802024,0.0019119808,0.009864496,0.5032189,0.0021534308,0.20556815,0.0010478293],"about_ca_topic_score_codex":0.00024364947,"about_ca_topic_score_gemma":0.00038857159,"teacher_disagreement_score":0.35949928,"about_ca_system_score_codex":0.000026198373,"about_ca_system_score_gemma":0.000671114,"threshold_uncertainty_score":0.46326768},"labels":[],"label_agreement":null},{"id":"W3135512879","doi":"10.1158/1557-3265.adi21-po-066","title":"Abstract PO-066: Data standardization, integration and meta-analysis of preclinical pharmacogenomics studies for gene expression biomarker discovery","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Pharmacogenomics; Precision medicine; Biomarker discovery; Medicine; Biomarker; Computational biology; Drug; Gene expression profiling; Meta-analysis; Bioinformatics; Drug response; Drug discovery; Oncology; Biology; Gene expression; Gene; Pharmacology; Internal medicine; Proteomics; Genetics; Pathology","score_opus":0.5378205243746687,"score_gpt":0.5835645967090327,"score_spread":0.04574407233436406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135512879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.709243,0.1257726,0.14963147,0.0030224337,0.0006361134,0.0014342568,0.010065233,0.000012683439,0.00018220847],"genre_scores_gemma":[0.96713156,0.024654208,0.0049070357,0.00022771099,0.0002816678,0.00008276888,0.002247998,0.00001960783,0.0004474498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787277,0.00023718196,0.0008693541,0.0005454777,0.0002570381,0.00021817928],"domain_scores_gemma":[0.9974448,0.00062203134,0.00021146961,0.0007535468,0.0008726941,0.000095443895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035056993,0.00012091654,0.00065176643,0.00006586856,0.00011386238,0.00006279196,0.00030906152,0.00018159408,0.000057462727],"category_scores_gemma":[0.0012407014,0.00008998923,0.00036967354,0.00026127193,0.00032207486,0.000021542808,0.0007172967,0.00019539258,4.3404512e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004037561,0.0008049459,0.004099963,0.0005611074,0.26286596,0.0000073093247,0.00032266512,0.002263646,0.58185863,0.00021743144,0.08495054,0.05801024],"study_design_scores_gemma":[0.005906687,0.0010280042,0.014142904,0.0000698184,0.14622392,0.0000048950346,0.0017755231,0.020565301,0.7089302,0.0024974467,0.09762543,0.0012298785],"about_ca_topic_score_codex":0.000011713374,"about_ca_topic_score_gemma":0.00017151941,"teacher_disagreement_score":0.25788856,"about_ca_system_score_codex":0.000016962626,"about_ca_system_score_gemma":0.00032754737,"threshold_uncertainty_score":0.36696544},"labels":[],"label_agreement":null},{"id":"W3135515631","doi":"10.1158/1557-3265.adi21-ia-22","title":"Abstract IA-22: Automated treatment planning and quality assurance in radiation oncology","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radiation oncology; Medical physics; Quality assurance; Radiation treatment planning; Medicine; Radiation therapy; Process (computing); Radiation Therapist; Quality (philosophy); Radiation dose; Computer science; Nuclear medicine; Radiology; Pathology","score_opus":0.2702572538348785,"score_gpt":0.6378806920907509,"score_spread":0.36762343825587246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135515631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97584486,0.0050255777,0.000022053755,0.014397489,0.00023454415,0.00022097223,0.0000050350277,0.000065266926,0.0041841846],"genre_scores_gemma":[0.9935982,0.0042845304,0.0005378722,0.00060197845,0.00038123853,0.000053440577,0.00002665988,0.000015570451,0.00050045986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975311,0.000718983,0.0005785754,0.00042271093,0.00037965935,0.00036897007],"domain_scores_gemma":[0.99641854,0.0028424584,0.0000784004,0.0002199136,0.0001623488,0.00027834004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041286764,0.00009159803,0.00046186327,0.000102872786,0.00008563613,0.000031945463,0.00006285251,0.00017196895,0.00022873268],"category_scores_gemma":[0.004923093,0.000075944256,0.00006522588,0.00031111087,0.00025515014,0.000046563247,0.000052286658,0.0010756202,0.000014440692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035091565,0.00039205464,0.70343256,0.00011108757,0.000056855275,0.0005972257,0.00025231272,0.000116991316,0.0015881048,0.00006959933,0.0024204503,0.29061186],"study_design_scores_gemma":[0.0036465044,0.00031169804,0.943026,0.00022227716,0.000012475711,0.000015618883,0.0001300725,0.008786632,0.00024119498,0.000071989765,0.043462195,0.00007333233],"about_ca_topic_score_codex":0.0012704274,"about_ca_topic_score_gemma":0.00019790327,"teacher_disagreement_score":0.29053852,"about_ca_system_score_codex":0.00043317053,"about_ca_system_score_gemma":0.0011976673,"threshold_uncertainty_score":0.5893758},"labels":[],"label_agreement":null},{"id":"W3135664299","doi":"10.1158/1557-3265.adi21-po-049","title":"Abstract PO-049: Pseudo-alignment resolution in discriminating mouse reads","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Computational biology; Genome; Computer science; Transcriptome; Reference genome; Genomics; Biology; Cancer; Human genome; Genetics; Gene; Gene expression","score_opus":0.1622169808329385,"score_gpt":0.5192425174540776,"score_spread":0.35702553662113906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135664299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144596,0.00089371856,0.00091341796,0.0025999886,0.00006508992,0.00028451695,0.000034302597,0.000016443057,0.0037465529],"genre_scores_gemma":[0.9925815,0.0031464081,0.0015570789,0.00036044267,0.00027212905,0.00031124635,0.00018061783,0.00002113293,0.00156945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797285,0.00034601698,0.0004393533,0.00060426653,0.00023292062,0.0004045755],"domain_scores_gemma":[0.99893856,0.00007966656,0.00006010004,0.00057434576,0.0002277288,0.00011962481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018034974,0.00010273943,0.0001607784,0.00004823186,0.000115087045,0.000026653417,0.00026044733,0.00029495225,0.00010363868],"category_scores_gemma":[0.00059183215,0.00009897032,0.000106971,0.00022098339,0.00024094706,0.00000295976,0.0003461184,0.00050729106,0.000015906793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010672773,0.00041972433,0.011048753,0.000034225413,0.000029998542,0.00003835533,0.000026783322,0.000029890094,0.95205873,0.0013151517,0.013735228,0.021156432],"study_design_scores_gemma":[0.0010323095,0.00040455337,0.06149414,0.00010342084,0.000011574068,0.000011529133,0.00028119388,0.00013984318,0.84340686,0.0015970074,0.091152474,0.000365093],"about_ca_topic_score_codex":0.00024522832,"about_ca_topic_score_gemma":0.0005516743,"teacher_disagreement_score":0.10865187,"about_ca_system_score_codex":0.000063456784,"about_ca_system_score_gemma":0.00028974435,"threshold_uncertainty_score":0.40358925},"labels":[],"label_agreement":null},{"id":"W3135672875","doi":"10.1158/1557-3265.adi21-ia-17","title":"Abstract IA-17: Plumbing the depths of the non-coding cancer genome","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Exome; Exome sequencing; Cancer; Genomics; Computational biology; Biology; Human genome; Cancer genome sequencing; Gene; Genetics; Evolutionary biology; Mutation","score_opus":0.13169538982336648,"score_gpt":0.4832118392757842,"score_spread":0.3515164494524177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135672875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812717,0.009485337,0.00004918078,0.0038546692,0.00077116076,0.00029847596,0.00012108685,0.0000033454028,0.004145046],"genre_scores_gemma":[0.98146117,0.014467018,0.00003368477,0.0009811183,0.0013819243,0.00010221299,0.000013313012,0.000026912458,0.0015326577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981036,0.00017147929,0.00045863667,0.00044338856,0.00039262432,0.00043023963],"domain_scores_gemma":[0.99798864,0.00045724268,0.00012404111,0.000812355,0.0005033431,0.00011437606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014793061,0.000114180046,0.00021040406,0.000020202824,0.0002665384,0.00005805173,0.00066972256,0.0001747367,0.00030166438],"category_scores_gemma":[0.0010767959,0.000077073346,0.0002509978,0.00028843273,0.00049477007,0.0000030044741,0.0007354636,0.0006115754,0.000007543352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032282408,0.00028459987,0.07963667,0.0001658019,0.00037357927,0.000023688452,0.00022333223,0.0016680364,0.8376164,0.00027146627,0.052362464,0.027051162],"study_design_scores_gemma":[0.0012916276,0.00016712089,0.46096408,0.00018046366,0.00005560326,0.00000534539,0.00035786058,0.000117992124,0.21577395,0.0003605602,0.32041717,0.00030823142],"about_ca_topic_score_codex":0.0009929191,"about_ca_topic_score_gemma":0.0037219007,"teacher_disagreement_score":0.62184244,"about_ca_system_score_codex":0.00007027117,"about_ca_system_score_gemma":0.001520808,"threshold_uncertainty_score":0.33030134},"labels":[],"label_agreement":null},{"id":"W3135698840","doi":"10.1158/1557-3265.adi21-po-034","title":"Abstract PO-034: The prediction of mandibular osteoradionecrosis in head and neck cancer patients using CT-derived radiomics features","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Osteoradionecrosis; Medicine; Head and neck cancer; Mandible (arthropod mouthpart); Radiation therapy; Radiation treatment planning; Cancer; Complication; Radiology; Surgery; Internal medicine","score_opus":0.19789527404879495,"score_gpt":0.48880836885793605,"score_spread":0.29091309480914107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135698840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804649,0.014677061,0.0000012139758,0.003537161,0.0004048918,0.0005045102,0.00012373785,0.000010619211,0.0002759019],"genre_scores_gemma":[0.97488636,0.024185611,0.00007233236,0.0002984287,0.00031500246,0.00007946969,0.000016509592,0.000023153887,0.00012312332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764407,0.00025361252,0.00062073354,0.0004382918,0.00061971624,0.00042358084],"domain_scores_gemma":[0.99830526,0.00056427286,0.000097668,0.00031985829,0.00053785933,0.00017508905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010709759,0.0001361476,0.0005743004,0.00010474184,0.00019834784,0.000028574177,0.00011137084,0.00011818713,0.00012265139],"category_scores_gemma":[0.0007530272,0.00009708254,0.00010848427,0.00054065586,0.0005293995,0.000074394375,0.00016555887,0.00092550536,0.0000014268626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010065757,0.00038963958,0.9633915,0.00033859507,0.00015883132,0.000053932607,0.0005844954,0.000026570524,0.0062602693,0.000010572091,0.0030628883,0.024716152],"study_design_scores_gemma":[0.0037347798,0.00038053375,0.9858869,0.00093263475,0.000051514224,0.000006979712,0.00028129516,0.00012158029,0.0057151346,0.000044608543,0.0027633929,0.00008069756],"about_ca_topic_score_codex":0.0036009387,"about_ca_topic_score_gemma":0.0021893498,"teacher_disagreement_score":0.024635453,"about_ca_system_score_codex":0.0003001658,"about_ca_system_score_gemma":0.00076963863,"threshold_uncertainty_score":0.5443566},"labels":[],"label_agreement":null},{"id":"W3135782998","doi":"10.1158/1078-0432.ccr-20-4948","title":"Amplifying the Voice of the Whispering Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cancer; Serous ovarian cancer; Ovarian cancer; Serous fluid; Disease; DNA sequencing; Clinical Practice","score_opus":0.20949564679357313,"score_gpt":0.5149692730327153,"score_spread":0.3054736262391422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135782998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97604483,0.015749497,0.000052417494,0.005284232,0.0009136166,0.00017973813,0.00006204487,0.0000027062629,0.001710932],"genre_scores_gemma":[0.9803021,0.015592736,0.000043187865,0.000998877,0.0012267983,0.000088501336,0.0000048420266,0.000019435995,0.0017235252],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984856,0.00027298863,0.00031016147,0.00032770247,0.00030462403,0.0002988719],"domain_scores_gemma":[0.9982594,0.00039776144,0.000071388786,0.00069880317,0.00049718405,0.000075419484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011105912,0.0000776227,0.00014149844,0.000011959051,0.00021033977,0.000037374906,0.0005100678,0.00011223805,0.00012563188],"category_scores_gemma":[0.001489934,0.000048568396,0.00016539522,0.00026898575,0.0004328868,0.0000016881537,0.0007522917,0.00042792223,0.0000059801964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042629917,0.0002960037,0.36702782,0.00020276419,0.00039423097,0.000012252668,0.00030039993,0.0017679216,0.44205764,0.0015329219,0.08611982,0.09986194],"study_design_scores_gemma":[0.00060804776,0.00009795949,0.075663485,0.00010501646,0.000028127693,0.0000031772672,0.00025849792,0.00007921295,0.19382402,0.00033438357,0.7288536,0.0001444886],"about_ca_topic_score_codex":0.00068824715,"about_ca_topic_score_gemma":0.004018243,"teacher_disagreement_score":0.64273375,"about_ca_system_score_codex":0.000040681516,"about_ca_system_score_gemma":0.001074128,"threshold_uncertainty_score":0.22422738},"labels":[],"label_agreement":null},{"id":"W3135830244","doi":"10.1158/1557-3265.adi21-po-030","title":"Abstract PO-030: Radiomics for head and neck cancer prognostication: results from the RADCURE machine learning challenge","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radiomics; Medicine; Head and neck cancer; Medical physics; Head and neck; Retrospective cohort study; Radiological weapon; Radiation therapy; Machine learning; Cohort; Artificial intelligence; Cancer; Radiology; Internal medicine; Computer science; Surgery","score_opus":0.20398189249554993,"score_gpt":0.515686907057502,"score_spread":0.31170501456195204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135830244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64840555,0.039038163,0.00023006882,0.30893514,0.0006742345,0.0010774097,0.00025768275,0.00007227675,0.0013094532],"genre_scores_gemma":[0.9373344,0.051177297,0.0020206333,0.002772545,0.0039662346,0.00032179753,0.00036956635,0.00007973485,0.001957765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967696,0.00040438122,0.0007509874,0.0008133497,0.0006765873,0.00058509334],"domain_scores_gemma":[0.9911685,0.007088884,0.00015366089,0.00051917025,0.00063419447,0.00043558225],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040144706,0.00018394274,0.0005062555,0.000051938274,0.0004955623,0.00012719491,0.00026897423,0.00022280026,0.00028723414],"category_scores_gemma":[0.015949558,0.0001290284,0.00016929505,0.0003128624,0.00060118746,0.00006751983,0.00020247308,0.002965626,0.0000104725395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003807968,0.0005916562,0.17303687,0.00033911964,0.00051899976,0.00019668062,0.0012799101,0.00018475327,0.0006818265,0.00055195374,0.03869182,0.78011847],"study_design_scores_gemma":[0.010244332,0.00054978865,0.26846895,0.001147493,0.00015779668,0.000021255706,0.00030508355,0.029329333,0.00019461165,0.00096064137,0.68835276,0.00026793397],"about_ca_topic_score_codex":0.0019751845,"about_ca_topic_score_gemma":0.00054644555,"teacher_disagreement_score":0.77985054,"about_ca_system_score_codex":0.00012248021,"about_ca_system_score_gemma":0.00094664114,"threshold_uncertainty_score":0.9993346},"labels":[],"label_agreement":null},{"id":"W3136029171","doi":"10.1158/1078-0432.ccr-21-0533","title":"Back from the Brink: EGFR Inhibition in Gastroesophageal Cancer","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Imperial College London; Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; European Commission; Royal Marsden NHS Foundation Trust","keywords":"Gastroesophageal Junction; Medicine; Cancer; Internal medicine; Randomized controlled trial; Oncology; EGFR inhibitors; Adenocarcinoma; Epidermal growth factor receptor","score_opus":0.28612898814509646,"score_gpt":0.5044456923864901,"score_spread":0.2183167042413936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136029171","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050687287,0.008997231,0.000008568981,0.93319035,0.001862357,0.0013837601,0.00027507084,0.000029768944,0.003565629],"genre_scores_gemma":[0.013012701,0.019259503,0.00011308032,0.85721326,0.044568922,0.00090838736,0.0013121592,0.00016255066,0.06344946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934078,0.0011489292,0.0011416735,0.0012287651,0.0018707378,0.0012021217],"domain_scores_gemma":[0.99567306,0.0023246242,0.00020122931,0.0011351758,0.00046516262,0.00020073226],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022328072,0.00037642434,0.0011151382,0.0002525889,0.00013699045,0.00016621249,0.000450646,0.0008758181,0.020069104],"category_scores_gemma":[0.0005708833,0.00027253563,0.0005124904,0.0011006936,0.00064213696,0.00008784946,0.0006741033,0.0096563455,0.0004978388],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002501981,0.00007365711,0.14286558,0.00022147583,0.00019312403,0.0020779234,0.000050382914,0.0000036871538,0.000005897498,0.0000037370853,0.84393704,0.010317303],"study_design_scores_gemma":[0.0028970703,0.00016791931,0.17662023,0.001375947,0.00014346286,0.0000048747843,0.000072775685,0.000024093615,0.000030011002,0.000105310835,0.8183687,0.00018964912],"about_ca_topic_score_codex":0.017415104,"about_ca_topic_score_gemma":0.006881583,"teacher_disagreement_score":0.07597709,"about_ca_system_score_codex":0.0010578844,"about_ca_system_score_gemma":0.0015752802,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W3137074789","doi":"10.1158/1078-0432.ccr-20-4731","title":"Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Atypical teratoid rhabdoid tumor; Relevance (law); Germline; Medicine; Clinical significance; Prospective cohort study; Pathology; Oncology; Pediatrics; Biology; Genetics; Immunohistochemistry; Political science; Gene","score_opus":0.08958350623803407,"score_gpt":0.43671492812234936,"score_spread":0.3471314218843153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137074789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170417,0.0049148975,0.0014841333,0.00033499493,0.00012551459,0.00058132596,0.0007395599,0.000010754324,0.000104638304],"genre_scores_gemma":[0.99316126,0.0016834217,0.0037328051,0.00018699773,0.0005345301,0.00017431348,0.00040737653,0.000028767949,0.00009055108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958152,0.0010835073,0.0010698168,0.0009976379,0.0006187356,0.0004150694],"domain_scores_gemma":[0.99773324,0.0006246364,0.00020502061,0.00063957454,0.00062398816,0.00017353722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002613786,0.00019983659,0.0006258407,0.000055265096,0.000089668196,0.00003594376,0.00033106882,0.000238065,0.00005424428],"category_scores_gemma":[0.007286271,0.00015781731,0.00021408821,0.00036742404,0.00055299076,0.000008884164,0.00023263894,0.00069696957,0.0000059686313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021393096,0.0027210168,0.44887337,0.00008075935,0.0010339984,0.00036696374,0.0002153546,0.008913337,0.48762077,0.00031885022,0.0033008563,0.025161618],"study_design_scores_gemma":[0.028770348,0.0011866676,0.46701413,0.00068633666,0.00006581996,0.000023175206,0.0001336351,0.0011286347,0.49712637,0.0006918671,0.0025836797,0.0005893206],"about_ca_topic_score_codex":0.0006633415,"about_ca_topic_score_gemma":0.0012375584,"teacher_disagreement_score":0.024572298,"about_ca_system_score_codex":0.00011114486,"about_ca_system_score_gemma":0.0016882415,"threshold_uncertainty_score":0.87228733},"labels":[],"label_agreement":null},{"id":"W3137264502","doi":"10.1158/1557-3265.covid-19-21-p12","title":"Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Telehealth; Staffing; Family medicine; Quarter (Canadian coin); Psychological intervention; Cancer screening; Nursing; Telemedicine; Health care; Cancer","score_opus":0.18931332140737395,"score_gpt":0.5115773748071514,"score_spread":0.32226405339977743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137264502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784647,0.011895019,0.000052055282,0.0033492814,0.0008639374,0.0008001803,0.0000764208,0.00015488038,0.004343521],"genre_scores_gemma":[0.9890635,0.006187671,0.000376817,0.0011336884,0.0017043264,0.0004833553,0.00009702972,0.000073990086,0.00087964063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944372,0.0006665998,0.0012079338,0.0012796887,0.0013679701,0.0010406023],"domain_scores_gemma":[0.995796,0.001508193,0.00018122327,0.00059813156,0.0008315453,0.0010848545],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031071717,0.00028100278,0.0008482049,0.00038377388,0.00047430952,0.000097385484,0.00029019566,0.00051837246,0.0009972753],"category_scores_gemma":[0.0031779064,0.00028260925,0.0003934642,0.0016432338,0.00046464877,0.00014704015,0.0004202178,0.0034502065,0.000037313213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019030016,0.00031942787,0.8633262,0.0014758637,0.00014409986,0.0011232065,0.0007656897,0.00051104074,0.0016947418,0.000008364384,0.0010561114,0.110545225],"study_design_scores_gemma":[0.006395881,0.0009831291,0.97043,0.0009516816,0.000052778516,0.0000511015,0.0015086657,0.0002455947,0.00248847,0.000045622193,0.01651491,0.00033214307],"about_ca_topic_score_codex":0.0047235545,"about_ca_topic_score_gemma":0.0145760365,"teacher_disagreement_score":0.11021308,"about_ca_system_score_codex":0.0019226267,"about_ca_system_score_gemma":0.005856123,"threshold_uncertainty_score":0.9999626},"labels":[],"label_agreement":null},{"id":"W3137853903","doi":"10.1158/1078-0432.ccr-21-0315","title":"Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Center for Advancing Translational Sciences; Virginia-Maryland College of Veterinary Medicine; Ohio State University; Cancer Center, University of Colorado; National Cancer Institute; National Institutes of Health; University of California, Davis; Morris Animal Foundation","keywords":"Medicine; Carboplatin; Osteosarcoma; Sirolimus; Internal medicine; Clinical endpoint; Oncology; Adjuvant therapy; Adverse effect; Population; Clinical trial; Chemotherapy; Surgery; Pathology; Cisplatin","score_opus":0.1637366620973989,"score_gpt":0.5384553562192401,"score_spread":0.3747186941218412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137853903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97986317,0.0033211154,0.000046098394,0.0047942586,0.000754891,0.010421494,0.00031896023,0.000026750084,0.00045324038],"genre_scores_gemma":[0.99027956,0.003437338,0.0016761646,0.00011377144,0.0005624269,0.0028687746,0.00003763575,0.00007116518,0.0009531621],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9907935,0.0031583088,0.002279277,0.001036556,0.0017606572,0.0009716756],"domain_scores_gemma":[0.9858692,0.009910848,0.00035164083,0.0009569653,0.0025854441,0.00032587408],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016625542,0.00027946298,0.0032612148,0.00041409847,0.00012416358,0.000032422664,0.0004786101,0.00035711753,0.00045303267],"category_scores_gemma":[0.016133815,0.00018708882,0.0009767084,0.0007386557,0.0016724858,0.00010296605,0.00047168258,0.0018899271,0.0000055128007],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8878648,0.0011830215,0.0750571,0.0012040783,0.00037602583,0.0005878508,0.0005717456,0.0000014353956,0.013192733,0.000085410335,0.00006270501,0.019813081],"study_design_scores_gemma":[0.9481535,0.023048336,0.0118451305,0.0005098529,0.000099062854,0.000045701796,0.000820904,0.000115485054,0.013183223,0.00073480693,0.0012253117,0.00021866985],"about_ca_topic_score_codex":0.0003699228,"about_ca_topic_score_gemma":0.00046724337,"teacher_disagreement_score":0.06321196,"about_ca_system_score_codex":0.00056594994,"about_ca_system_score_gemma":0.0033373102,"threshold_uncertainty_score":0.9921537},"labels":[],"label_agreement":null},{"id":"W3138826270","doi":"10.1158/1557-3265.covid-19-21-p06","title":"Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"RNA; In vitro; Viral replication; Mechanism of action; Pharmacology; RNA polymerase; Biology; Nucleoside analogue; Polymerase; Virology; Nucleoside; Virus; Enzyme; Cancer research; Chemistry; Biochemistry; Gene","score_opus":0.24367581103339855,"score_gpt":0.5114422097861301,"score_spread":0.26776639875273156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138826270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810808,0.001422045,0.0013833902,0.014573853,0.00016687161,0.00084426074,0.000225511,0.0000058948076,0.00029740162],"genre_scores_gemma":[0.9938983,0.0017608074,0.00009855539,0.003040716,0.0004254898,0.0004918509,0.000063536776,0.000019619169,0.00020117206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976319,0.00038580937,0.00056055625,0.0006724368,0.0004800344,0.00026926122],"domain_scores_gemma":[0.9972572,0.00023286598,0.00014867021,0.0009724669,0.00111982,0.00026898147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022650608,0.00011062101,0.0002459061,0.00006900369,0.00017548738,0.00003274878,0.00028315416,0.00014636961,0.00015467362],"category_scores_gemma":[0.003256267,0.00008939405,0.00015913507,0.00049456157,0.00030707964,0.0000066700895,0.0002646973,0.00025093803,0.000013688969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061384524,0.00022734316,0.00045798096,0.00008374793,0.00007617322,0.0000069179487,0.000089502195,0.0011986564,0.9591695,0.00011473644,0.014637106,0.02332446],"study_design_scores_gemma":[0.0005628905,0.000380864,0.03797007,0.000056799443,0.000018407898,0.0000016192649,0.00013927446,0.000030409561,0.8875379,0.000070207825,0.073118344,0.00011323719],"about_ca_topic_score_codex":0.00029899465,"about_ca_topic_score_gemma":0.00039403,"teacher_disagreement_score":0.071631655,"about_ca_system_score_codex":0.00010781778,"about_ca_system_score_gemma":0.0011391554,"threshold_uncertainty_score":0.38982907},"labels":[],"label_agreement":null},{"id":"W3139290764","doi":"10.1158/1078-0432.ccr-20-4068","title":"Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Imperial Biomedical Research Centre; Medical Research Council; Sierra Oncology; National Institute for Health and Care Research; Cancer Research UK; NuCana; Ovarian Cancer Action; AstraZeneca; UK Research and Innovation; Wellcome Trust; Pancreatic Cancer UK; Beatson Cancer Charity; Pfizer","keywords":"Serous fluid; Biology; Ovarian carcinoma; Serous carcinoma; Structural variation; Homologous recombination; Somatic cell; Ovarian cancer; Homologous chromosome; Genome; Genetics; Carcinoma; Cancer; Cancer research; Gene","score_opus":0.17509979765269706,"score_gpt":0.46818482929358285,"score_spread":0.2930850316408858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139290764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802388,0.0064228354,0.000012934951,0.011180545,0.00043314893,0.00066527416,0.00008585356,0.000056718873,0.0009039138],"genre_scores_gemma":[0.99463195,0.0006493807,0.0001504134,0.0015697695,0.00048594465,0.00015831464,0.00003555121,0.000047878424,0.0022707842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99425787,0.0017987165,0.0011293446,0.0008096136,0.0012044166,0.0008000129],"domain_scores_gemma":[0.99573505,0.0017629664,0.00024891194,0.0013318363,0.00064600003,0.00027525003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030988732,0.00021405637,0.0008047559,0.00014795402,0.00028464256,0.000026309053,0.0004278604,0.0003227088,0.001266953],"category_scores_gemma":[0.00091634283,0.00015935762,0.0003025775,0.0013661798,0.001347289,0.00006256555,0.0004499645,0.0018288459,0.0000378169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022398666,0.000511862,0.9680157,0.00028434125,0.00010900067,0.0011390052,0.0007250892,0.0001839229,0.0025685928,0.0004253809,0.018432103,0.00536519],"study_design_scores_gemma":[0.006691748,0.0006946221,0.978565,0.000318303,0.00005112478,0.0003217104,0.00066635926,0.0004197538,0.0065936055,0.0012685192,0.004193568,0.00021571077],"about_ca_topic_score_codex":0.00518851,"about_ca_topic_score_gemma":0.006434599,"teacher_disagreement_score":0.014393188,"about_ca_system_score_codex":0.0007667385,"about_ca_system_score_gemma":0.0012875805,"threshold_uncertainty_score":0.999646},"labels":[],"label_agreement":null},{"id":"W3144540201","doi":"10.1158/1078-0432.ccr-20-4928","title":"Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor–Positive Advanced Breast Cancer (EVERMET)","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Exemestane; Medicine; Everolimus; Oncology; Internal medicine; Cancer; Breast cancer; Hormone receptor; Hormone; Metformin; Gynecology; Tamoxifen; Insulin","score_opus":0.0373254637907493,"score_gpt":0.42699258617912095,"score_spread":0.38966712238837165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144540201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97017646,0.028234696,0.0000022683146,0.0001330258,0.00010423584,0.00045061795,0.0007945614,0.0000044168837,0.000099723264],"genre_scores_gemma":[0.89706033,0.10187543,0.000048231104,0.00021601412,0.0002496373,0.00012753917,0.00020275153,0.00003572729,0.00018431449],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972769,0.00051085517,0.0004346501,0.00076656445,0.000493903,0.0005171397],"domain_scores_gemma":[0.9981059,0.0002886454,0.00011573908,0.00050276547,0.0007185279,0.00026843738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005508771,0.00024803213,0.0005055199,0.00008167601,0.00006456887,0.000018535282,0.00015513695,0.00019523922,0.00022815005],"category_scores_gemma":[0.00029826481,0.00017441482,0.00014792675,0.0003625649,0.00029895545,0.0000085469255,0.000105380874,0.00036681825,0.0000055286446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037082788,0.0034391147,0.26065868,0.000033427463,0.0005282699,0.0000148507825,0.000075629345,0.0006076131,0.0062133204,0.0000121420135,0.0026195697,0.6887146],"study_design_scores_gemma":[0.0133347735,0.007714443,0.95714617,0.00022902341,0.000035685516,7.1360495e-7,0.00002325228,0.000018061979,0.013350518,0.000008238916,0.007870723,0.00026838898],"about_ca_topic_score_codex":0.0004442679,"about_ca_topic_score_gemma":0.00033003697,"teacher_disagreement_score":0.6964875,"about_ca_system_score_codex":0.0002847998,"about_ca_system_score_gemma":0.00095530524,"threshold_uncertainty_score":0.71124303},"labels":[],"label_agreement":null},{"id":"W3152686641","doi":"10.1158/1078-0432.ccr-20-4117","title":"Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Nomogram; Medicine; Concordance; Confidence interval; Cancer; Internal medicine; Proportional hazards model; Oncology; Bootstrapping (finance); Cohort; Mathematics","score_opus":0.4392417437457821,"score_gpt":0.5518497954606548,"score_spread":0.1126080517148727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152686641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545467,0.0024240667,0.00006514626,0.0006624266,0.00015512992,0.0007431824,0.00025535762,0.0000037426566,0.00023629957],"genre_scores_gemma":[0.9905067,0.004645952,0.0037704308,0.00003032198,0.00010150419,0.00066824834,0.00012133542,0.000014069194,0.00014140585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998095,0.000106303465,0.0008105038,0.00028303688,0.0005225836,0.00018261938],"domain_scores_gemma":[0.99799216,0.00084134226,0.0001583427,0.00017645303,0.0007444054,0.00008728635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018178552,0.0000748882,0.0005429471,0.00013291111,0.000022782115,0.0000044463372,0.0000519488,0.00010325326,0.00007217875],"category_scores_gemma":[0.0004391938,0.00006485917,0.00008712601,0.00040431507,0.00019408308,0.000031852494,0.00008555334,0.00017268558,1.1564348e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015529424,0.0031483213,0.8543327,0.0015972136,0.0003295667,0.000003160055,0.0006310727,0.00001961941,0.0055629187,0.00024073332,0.0002725892,0.1323092],"study_design_scores_gemma":[0.011409895,0.00066001754,0.8746015,0.0010702265,0.0000999858,8.532153e-7,0.00015773374,0.00007181225,0.10202981,0.000039861316,0.009800638,0.0000576633],"about_ca_topic_score_codex":0.0008749305,"about_ca_topic_score_gemma":0.0010987737,"teacher_disagreement_score":0.13225153,"about_ca_system_score_codex":0.0002185604,"about_ca_system_score_gemma":0.0018764858,"threshold_uncertainty_score":0.33288053},"labels":[],"label_agreement":null},{"id":"W3152849619","doi":"10.1158/1557-3265.radsci21-po-091","title":"Abstract PO-091: Does volumetric-modulated arc therapy improve anal cancer treatment outcome and reduce toxicity: A single institution experience","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Regional Hospital","funders":"","keywords":"Medicine; Anal cancer; Anal canal; Radiation therapy; Rectum; Cancer; Surgery; Radiology; Internal medicine","score_opus":0.34585747750921897,"score_gpt":0.5328197080830454,"score_spread":0.18696223057382638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152849619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884497,0.0058769,0.0000043132336,0.0037501135,0.0005065491,0.00049263635,0.000047100362,0.000039757837,0.0008329203],"genre_scores_gemma":[0.98765683,0.008031778,0.00004535552,0.00034826243,0.0008132071,0.00018123031,0.00001371463,0.000020061723,0.002889562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726313,0.0001771171,0.00060017325,0.00076093996,0.00066337903,0.00053526927],"domain_scores_gemma":[0.9980961,0.00040895582,0.00008665152,0.00036558553,0.0005900188,0.00045266855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069096964,0.00019506407,0.0005388465,0.00017251445,0.0002476351,0.00008604787,0.00011893683,0.00018887369,0.0008353116],"category_scores_gemma":[0.00070652924,0.00012609555,0.00020105917,0.0009102001,0.0005788212,0.00012229827,0.00010257263,0.00062464376,0.00001159371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020549987,0.0012306345,0.4430841,0.000080269005,0.00015332851,0.00039899352,0.0005270393,0.00000309281,0.15859155,0.000022151344,0.00012645216,0.3937274],"study_design_scores_gemma":[0.003978168,0.0024522897,0.8677818,0.00016671742,0.000043036525,0.000019099683,0.0005891505,0.00026358818,0.113270424,0.00008786947,0.011110815,0.00023703708],"about_ca_topic_score_codex":0.0047348277,"about_ca_topic_score_gemma":0.0036837342,"teacher_disagreement_score":0.4246977,"about_ca_system_score_codex":0.00062803214,"about_ca_system_score_gemma":0.0011616879,"threshold_uncertainty_score":0.91460764},"labels":[],"label_agreement":null},{"id":"W3153749982","doi":"10.1158/1557-3265.radsci21-ia-016","title":"Abstract IA-016: Metabolic deregulation drives a redox vulnerability in pancreatic cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Biology; DNA damage; NOX4; Reactive oxygen species; Pancreatic cancer; Cell biology; NADPH oxidase; Cancer research; Cancer; Biochemistry; Genetics; DNA","score_opus":0.11444656588045558,"score_gpt":0.4888990426172907,"score_spread":0.3744524767368351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153749982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788303,0.017462725,0.00005044655,0.0025362617,0.00025437662,0.00026063202,0.00006240345,0.00000945588,0.0005334334],"genre_scores_gemma":[0.9845415,0.013278511,0.00011539071,0.00028109847,0.00063358096,0.00022403579,0.00007313156,0.000025479658,0.0008272707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719167,0.00067014917,0.0005751373,0.00068929873,0.00037496447,0.0004987706],"domain_scores_gemma":[0.9986225,0.00024851147,0.000048879763,0.00053989945,0.00034316294,0.00019709555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016978952,0.00014913727,0.00033433462,0.000061258936,0.00011957727,0.00004490549,0.00021916625,0.00026660328,0.00088036124],"category_scores_gemma":[0.0006324025,0.00013671524,0.00018990488,0.00037076222,0.00030300283,0.000008772664,0.00011119139,0.00059742614,0.000020422533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010661966,0.0007872359,0.5226436,0.00016906137,0.00022560163,0.00007691884,0.00018950462,0.00065554027,0.3925933,0.0005308504,0.0032490767,0.077813104],"study_design_scores_gemma":[0.0013806246,0.00013489093,0.8997719,0.00009055724,0.000026115047,0.0000034265347,0.00008447179,0.00009003149,0.07103339,0.0006741736,0.026486201,0.00022417108],"about_ca_topic_score_codex":0.0019386678,"about_ca_topic_score_gemma":0.006685189,"teacher_disagreement_score":0.37712833,"about_ca_system_score_codex":0.000043651882,"about_ca_system_score_gemma":0.0008878948,"threshold_uncertainty_score":0.9639338},"labels":[],"label_agreement":null},{"id":"W3153994123","doi":"10.1158/1557-3265.radsci21-po-021","title":"Abstract PO-021: Single-cell DNA sequencing as a means to directly examine the size and frequency of radiation-induced mutations - An exploratory study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ionizing radiation; Copy-number variation; DNA sequencing; DNA; Population; Mutation frequency; Irradiation; Biology; Molecular biology; Genetics; Mutation; Genome; Gene; Medicine","score_opus":0.16537739625218054,"score_gpt":0.4388811372250284,"score_spread":0.2735037409728479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153994123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965434,0.0014826611,0.000017927823,0.00055785733,0.00018070733,0.00046525593,0.00006753243,0.000005670055,0.0006789538],"genre_scores_gemma":[0.99813944,0.00062670436,0.00011514834,0.0003507645,0.00044355725,0.00014031705,0.000029538098,0.000026476766,0.00012802756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799323,0.0004210427,0.00046429972,0.0005171691,0.00032420034,0.00028002943],"domain_scores_gemma":[0.9974735,0.0010832631,0.00009008731,0.0005772709,0.00053769845,0.00023821168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016091778,0.00011720405,0.00021372686,0.000041806867,0.00017290076,0.000069027854,0.00024785148,0.00011425354,0.00008085198],"category_scores_gemma":[0.0036751204,0.00010221153,0.00006520891,0.00028571233,0.00015881972,0.000009238349,0.0002023339,0.00029092695,0.000005649186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010293355,0.0005690217,0.011823048,0.000023690834,0.000070179245,0.000026284477,0.0014836856,0.000086754095,0.97131866,0.000025141924,0.0002955259,0.0141750965],"study_design_scores_gemma":[0.0020220308,0.0035917347,0.1287339,0.000050967385,0.000068831265,0.000004892346,0.009595955,0.000023759589,0.8523701,0.00048317804,0.002700622,0.0003540556],"about_ca_topic_score_codex":0.0010868808,"about_ca_topic_score_gemma":0.007847526,"teacher_disagreement_score":0.118948564,"about_ca_system_score_codex":0.00008196309,"about_ca_system_score_gemma":0.0013781198,"threshold_uncertainty_score":0.4399728},"labels":[],"label_agreement":null},{"id":"W3154186241","doi":"10.1158/1557-3265.radsci21-ia-014","title":"Abstract IA-014: Strategies to enhance the immunogenicity of radiation therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunogenicity; Immune system; Cancer research; Cancer; Immunology; Medicine; CD8; Immune checkpoint; Immunotherapy; Oncolytic virus; Cancer immunotherapy; Internal medicine","score_opus":0.1999027175686072,"score_gpt":0.5693669929650879,"score_spread":0.36946427539648063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154186241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626944,0.021177571,0.000030073297,0.012514898,0.0003637273,0.000538024,0.000020002366,0.000017414945,0.002643877],"genre_scores_gemma":[0.96973044,0.027515898,0.000047563724,0.0011893963,0.00047213925,0.00010022331,0.000009223466,0.000018094423,0.00091701513],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975601,0.00035762537,0.0006408825,0.00036211326,0.0007245657,0.00035471708],"domain_scores_gemma":[0.99744666,0.001015824,0.00010102207,0.00067351625,0.00064026564,0.00012270291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033137389,0.00010853286,0.00033135936,0.00006369221,0.00014323869,0.00005558547,0.00027488853,0.00013377891,0.0019473163],"category_scores_gemma":[0.00048197145,0.00007140855,0.00025912217,0.0007270424,0.00043771084,0.00007770826,0.00007385249,0.0006840073,0.00004243021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008915168,0.00043880037,0.009664833,0.00008096324,0.0004116668,0.000022178761,0.0005458636,0.000008683183,0.230529,0.00013195297,0.011294346,0.7379565],"study_design_scores_gemma":[0.0016520689,0.0006847401,0.62177515,0.00014929837,0.000014944263,0.0000043200976,0.0006943062,0.0000073241595,0.27318838,0.00024421987,0.10147938,0.00010589951],"about_ca_topic_score_codex":0.0016363862,"about_ca_topic_score_gemma":0.00039723443,"teacher_disagreement_score":0.73785067,"about_ca_system_score_codex":0.00012836287,"about_ca_system_score_gemma":0.0018741194,"threshold_uncertainty_score":0.998965},"labels":[],"label_agreement":null},{"id":"W3154268917","doi":"10.1158/1557-3265.radsci21-ia-018","title":"Abstract IA-018: Molecular landmarks of tumor hypoxia across cancer types","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Hypoxia (environmental); PTEN; Tumor hypoxia; Cancer; Metastasis; Cancer research; Chromosome instability; Tumor progression; Medicine; Pathology; Biology; Internal medicine; Apoptosis; Gene; PI3K/AKT/mTOR pathway; Radiation therapy; Genetics; Chemistry; Oxygen","score_opus":0.09560782771025017,"score_gpt":0.5008821585949651,"score_spread":0.40527433088471493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154268917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462026,0.048677094,0.000022038772,0.0006617098,0.0015600544,0.00020859294,0.0002731778,0.000010130317,0.0023846042],"genre_scores_gemma":[0.97113633,0.022386603,0.00012787651,0.0005883776,0.003114532,0.00013797448,0.0000661018,0.000049365237,0.0023928243],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971447,0.00028650157,0.00059373176,0.0007242493,0.00055917265,0.0006916367],"domain_scores_gemma":[0.9977654,0.0001423747,0.00013364728,0.00073858956,0.00093941164,0.00028055534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00158599,0.0001822152,0.00044150112,0.000040232742,0.000116799245,0.000045150413,0.00043731494,0.00027890276,0.0006976863],"category_scores_gemma":[0.00094904064,0.00017000637,0.00031092696,0.00033231743,0.00051610125,0.0000067852425,0.00033935727,0.00061949313,0.000025589685],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007127972,0.00031225753,0.009915522,0.00018225361,0.00029244015,0.000045234476,0.00006649214,0.0000935415,0.9080936,0.000080357495,0.03286912,0.047336433],"study_design_scores_gemma":[0.0013864768,0.00015614249,0.056729037,0.00009105756,0.00003206375,0.0000069595176,0.0001193191,0.00000796593,0.4475147,0.00017025402,0.49353337,0.00025263792],"about_ca_topic_score_codex":0.0009241868,"about_ca_topic_score_gemma":0.0015918299,"teacher_disagreement_score":0.46066424,"about_ca_system_score_codex":0.00003705741,"about_ca_system_score_gemma":0.00141153,"threshold_uncertainty_score":0.7639175},"labels":[],"label_agreement":null},{"id":"W3154990503","doi":"10.1158/1557-3265.radsci21-po-100","title":"Abstract PO-100: Theragnostic tumor-targeted manganese dioxide-loaded polymer-lipid nanoparticles for magnetic resonance image-guided radiation therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Biodistribution; Magnetic resonance imaging; Radiation therapy; Tumor hypoxia; MRI contrast agent; Gadolinium; Ex vivo; Biomedical engineering; Materials science; Cancer research; In vitro; Chemistry; Medicine; Radiology; Biochemistry","score_opus":0.10425540994843938,"score_gpt":0.40709329249065185,"score_spread":0.30283788254221244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154990503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.896732,0.098874874,0.00013170484,0.00087962515,0.0014129467,0.0011005115,0.00021344068,0.00030864766,0.00034624976],"genre_scores_gemma":[0.9818414,0.014158469,0.00042421924,0.00043101862,0.0013789362,0.0007855534,0.00006487691,0.00021090712,0.0007046297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99568415,0.0002270703,0.0011717158,0.0007541967,0.00089270744,0.0012701831],"domain_scores_gemma":[0.99495655,0.0029942011,0.00010238571,0.00088143186,0.00066663546,0.00039877451],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017812941,0.0003829247,0.0006256213,0.00017723469,0.0002755765,0.0001939162,0.0006077502,0.00026313873,0.0010759835],"category_scores_gemma":[0.0014486865,0.00036358417,0.00032697708,0.00097102905,0.00036552863,0.00033239613,0.00009151086,0.00096081785,0.00016238353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006313195,0.00021868349,0.0020005892,0.00020515789,0.00010788079,0.000106719286,0.00018780984,0.00022674371,0.8049248,0.00009128082,0.010321438,0.18097761],"study_design_scores_gemma":[0.004529246,0.00042494372,0.038323272,0.00017113645,0.000029663397,0.000011125806,0.0000987786,0.0012472845,0.9117826,0.0011160711,0.04171279,0.0005530745],"about_ca_topic_score_codex":0.00017719217,"about_ca_topic_score_gemma":0.00010785558,"teacher_disagreement_score":0.18042454,"about_ca_system_score_codex":0.00037812736,"about_ca_system_score_gemma":0.0005859595,"threshold_uncertainty_score":0.9998816},"labels":[],"label_agreement":null},{"id":"W3155830986","doi":"10.1158/1557-3265.radsci21-po-077","title":"Abstract PO-077: Study evaluating metastatic castrate resistant prostate cancer (mCRPC) treatment using 177Lu-PNT2002 PSMA therapy after second-line hormonal treatment (SPLASH) - Trial in progress","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Enzalutamide; Clinical endpoint; Prostate cancer; Radionuclide therapy; Oncology; Cabazitaxel; Internal medicine; Hormonal therapy; Docetaxel; Androgen deprivation therapy; Abiraterone acetate; Metastatic breast cancer; Clinical trial; Progression-free survival; Prednisone; Chemotherapy; Cancer; Breast cancer; Androgen receptor","score_opus":0.5805525165238268,"score_gpt":0.6232808433027445,"score_spread":0.04272832677891769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155830986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95363367,0.033502154,4.6551898e-7,0.002242406,0.0005296838,0.009335271,0.0005089057,0.00005335577,0.00019408848],"genre_scores_gemma":[0.9695365,0.014322843,0.0003477502,0.000087532564,0.0013144364,0.008816678,0.00012445166,0.00014366652,0.0053061396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9894558,0.0022396927,0.002067946,0.0018994805,0.002382421,0.0019546319],"domain_scores_gemma":[0.99520785,0.0012602078,0.0003165711,0.0010682377,0.0013038322,0.0008433259],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004581742,0.00072911556,0.0017349563,0.0004999656,0.00041293897,0.00029379842,0.00028010012,0.00025105226,0.0037077977],"category_scores_gemma":[0.00030236007,0.0004966289,0.00054805854,0.0014883428,0.0007459231,0.00025218294,0.00018837859,0.0013321489,0.000049339367],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.4788779,0.028047265,0.18044952,0.00038057243,0.0038182468,0.014507289,0.0037215329,0.00017138729,0.0062588714,0.0000031152058,0.00023471781,0.28352958],"study_design_scores_gemma":[0.47286737,0.09893325,0.39664823,0.0017180844,0.0010609248,0.000072408446,0.005097099,0.001790212,0.015689172,0.00023568705,0.00458735,0.001300227],"about_ca_topic_score_codex":0.004673292,"about_ca_topic_score_gemma":0.011236687,"teacher_disagreement_score":0.28222936,"about_ca_system_score_codex":0.004255229,"about_ca_system_score_gemma":0.009926135,"threshold_uncertainty_score":0.9997485},"labels":[],"label_agreement":null},{"id":"W3156003299","doi":"10.1158/1557-3265.radsci21-ia-027","title":"Abstract IA-027: Dysregulated metabolic and immune pathways underlying radiation fibrosis and lymphedema","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lymphedema; Downregulation and upregulation; Fibrosis; Medicine; Cancer research; Extracellular matrix; Bioinformatics; Cell biology; Cancer; Internal medicine; Biology; Breast cancer; Biochemistry","score_opus":0.14173307935739887,"score_gpt":0.4551732197972243,"score_spread":0.31344014043982543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156003299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85674655,0.14134416,0.00002868677,0.00059898535,0.0005693029,0.00018300969,0.000041461728,0.000011945822,0.00047589326],"genre_scores_gemma":[0.9045539,0.09299239,0.00013516574,0.00019785135,0.0013480702,0.000053617827,0.000078427285,0.000029669813,0.00061090174],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99783844,0.00030499266,0.0004515673,0.000655781,0.00030814987,0.0004410419],"domain_scores_gemma":[0.998761,0.00017772435,0.00008556953,0.00041481716,0.0003033801,0.00025751177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014481951,0.00015335633,0.00034323553,0.00006060404,0.0002297903,0.00010899138,0.00014156272,0.000300985,0.000110142115],"category_scores_gemma":[0.00063589093,0.00014861203,0.00011798969,0.00024309468,0.0003470854,0.000012635513,0.0002740152,0.00022638791,0.00000643155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023958404,0.00008390582,0.00317037,0.00007301374,0.00015104638,0.000004957312,0.00006918611,0.000010761795,0.69897956,0.00034096264,0.0018642276,0.2950124],"study_design_scores_gemma":[0.0027274212,0.00018193506,0.5996453,0.00007179149,0.0000657279,0.00001835817,0.00021814619,0.00010710778,0.12885143,0.00072404486,0.26704434,0.0003443693],"about_ca_topic_score_codex":0.0002716865,"about_ca_topic_score_gemma":0.00019239953,"teacher_disagreement_score":0.59647495,"about_ca_system_score_codex":0.00002143957,"about_ca_system_score_gemma":0.00056017115,"threshold_uncertainty_score":0.6060223},"labels":[],"label_agreement":null},{"id":"W3156148127","doi":"10.1158/1078-0432.ccr-20-4746","title":"Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":348,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Internal medicine; Adverse effect; Melanoma; Cancer; Antibody; Lung cancer; Gastroenterology; Oncology; Colorectal cancer; Ovarian cancer; Immunology; Cancer research","score_opus":0.15449859783446931,"score_gpt":0.553803520585191,"score_spread":0.3993049227507217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156148127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498016,0.002359276,0.00001813899,0.0005660085,0.0008346785,0.0009371916,0.00007459218,0.000030453239,0.00019953169],"genre_scores_gemma":[0.9928138,0.006046572,0.000075117154,0.00012201937,0.00016392369,0.000080501595,0.00053635257,0.000040565763,0.00012115158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915034,0.00406882,0.0019116525,0.0013219957,0.00021993626,0.000974181],"domain_scores_gemma":[0.99701506,0.001084438,0.0003694702,0.00077147165,0.0005856935,0.00017386753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0053601377,0.00030057604,0.0016082723,0.00037645947,0.00016730635,0.00003753573,0.00046305693,0.00071971846,0.0003123016],"category_scores_gemma":[0.0010274706,0.00026347145,0.00014468963,0.0010066886,0.0020995736,0.00031337398,0.00028076943,0.0019852086,0.000015806783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.107489906,0.01746177,0.6581275,0.00013644912,0.00020446032,0.00041032032,0.00027724617,0.000028471846,0.16280088,0.00040320237,0.00014734128,0.052512463],"study_design_scores_gemma":[0.26606092,0.03276844,0.6683549,0.0004873524,0.00005587136,0.00011025082,0.00086876046,0.00021948817,0.027572744,0.00047637348,0.0024005487,0.00062433013],"about_ca_topic_score_codex":0.0012536326,"about_ca_topic_score_gemma":0.006090857,"teacher_disagreement_score":0.15857099,"about_ca_system_score_codex":0.00008279824,"about_ca_system_score_gemma":0.001316458,"threshold_uncertainty_score":0.99998176},"labels":[],"label_agreement":null},{"id":"W3156560386","doi":"10.1158/1557-3265.radsci21-po-086","title":"Abstract PO-086: Selective radiosensitization in preclinical models of HPV-negative squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radioresistance; Cancer research; Clonogenic assay; Cell cycle; Radiosensitivity; Medicine; Cancer; Viability assay; Flow cytometry; Radiation therapy; Cell culture; Oncology; Pharmacology; Biology; Immunology; Internal medicine","score_opus":0.25444523328433466,"score_gpt":0.5329115100054382,"score_spread":0.2784662767211036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156560386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616677,0.005845373,0.000049077258,0.002722855,0.0002753277,0.0012766359,0.00007197391,0.00003209173,0.028058933],"genre_scores_gemma":[0.99461585,0.0026373302,0.00039462876,0.00021890066,0.000657013,0.00019896448,0.000024450295,0.000053412023,0.0011994323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99367106,0.0013434881,0.0013178813,0.0008961499,0.0017317146,0.0010397289],"domain_scores_gemma":[0.9886868,0.0070866793,0.00018469495,0.00066923414,0.0028652872,0.0005073162],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005077474,0.00022790661,0.0010430855,0.00032490262,0.00012488799,0.000025998657,0.00024284708,0.00034602798,0.00044935098],"category_scores_gemma":[0.01061,0.0002055665,0.00029728387,0.0017087482,0.0009800686,0.00021791783,0.00040099325,0.0025155854,0.0000304667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117543,0.007041513,0.89083743,0.003009607,0.00044868005,0.0013705532,0.005535138,0.001299116,0.005505873,0.0005189194,0.03437301,0.038305838],"study_design_scores_gemma":[0.007546195,0.001357265,0.9345992,0.00024253732,0.00006427323,0.000012643293,0.0013409429,0.001765735,0.050593995,0.0018877921,0.0003304294,0.00025894324],"about_ca_topic_score_codex":0.0018023251,"about_ca_topic_score_gemma":0.0008796267,"teacher_disagreement_score":0.04508812,"about_ca_system_score_codex":0.0009585643,"about_ca_system_score_gemma":0.004058363,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W3156631419","doi":"10.1158/1557-3265.radsci21-po-071","title":"Abstract PO-071: Characterizing transcriptomic indicators of radiosensitivity in cancer and identifying sensitizing therapeutic agents","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Radiosensitivity; Transcriptome; Computational biology; Cancer; Radiogenomics; Personalized medicine; Precision medicine; Radiation therapy; Cancer research; Gene signature; Gene; Medicine; Bioinformatics; Biology; Oncology; Gene expression; Genetics; Internal medicine; Radiomics","score_opus":0.20042949771509042,"score_gpt":0.5208171468069441,"score_spread":0.3203876490918537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156631419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870625,0.004689,0.000038398575,0.0071960716,0.00040033454,0.00026908857,0.000012186229,0.000020377915,0.00031203686],"genre_scores_gemma":[0.98836195,0.009748041,0.00014213903,0.0012078447,0.00034315532,0.00002133596,0.000010429476,0.000039410403,0.00012569553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969242,0.0004949427,0.00076511886,0.0005714849,0.000689715,0.0005545265],"domain_scores_gemma":[0.99811554,0.0009284978,0.00013808544,0.00029526567,0.00019287138,0.0003297277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042772004,0.00015395318,0.00068446394,0.0003528218,0.000117229654,0.000051025178,0.00011076735,0.00017887536,0.00018951752],"category_scores_gemma":[0.00095625105,0.00014352692,0.00015304539,0.00068329764,0.00054158695,0.00010866682,0.000103406426,0.002125847,0.0000038627395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029669746,0.00027132712,0.54597634,0.00067305716,0.00017428053,0.0008243536,0.00087360566,0.0000065744466,0.14263059,0.000041295054,0.00014516109,0.3080867],"study_design_scores_gemma":[0.0021394177,0.00006264197,0.9823178,0.0013776611,0.000054855456,0.000039912808,0.0003504769,0.0011572941,0.010704989,0.00008456135,0.0015711257,0.0001392546],"about_ca_topic_score_codex":0.001057994,"about_ca_topic_score_gemma":0.00018088002,"teacher_disagreement_score":0.43634146,"about_ca_system_score_codex":0.00018185505,"about_ca_system_score_gemma":0.0006870809,"threshold_uncertainty_score":0.92358655},"labels":[],"label_agreement":null},{"id":"W3158848810","doi":"10.1158/1078-0432.ccr-20-4394","title":"Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Victoria; Spinal Cord Injury BC; University of British Columbia","funders":"CIHR Skin Research Training Centre; BC Cancer Foundation; Terry Fox Research Institute; Canadian Cancer Society; Michael Smith Health Research BC; Paul G. Allen Frontiers Group; Canadian Institutes of Health Research; Cancer Research Society","keywords":"TIGIT; Biology; CD8; Tumor-infiltrating lymphocytes; Ovarian cancer; Immunology; Cancer research; Immune system; Immunotherapy; Cancer","score_opus":0.1289289768247405,"score_gpt":0.44337428432989584,"score_spread":0.3144453075051553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158848810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814512,0.01634976,0.000007255448,0.00021802422,0.00060787174,0.00025379896,0.000014906641,0.000013311444,0.0010838835],"genre_scores_gemma":[0.99649847,0.0015555045,0.00005196188,0.000065098284,0.000072743125,0.00006864324,0.000023562507,0.000016982247,0.0016470497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764955,0.0008775243,0.0005783595,0.00041478645,0.000079111596,0.00040068154],"domain_scores_gemma":[0.99783784,0.001439221,0.00014563288,0.00018730131,0.0003416605,0.0000483268],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010731756,0.00013190697,0.00036558954,0.00013231709,0.00016327373,0.00005313034,0.00009393867,0.00019216478,0.0013263884],"category_scores_gemma":[0.0013186515,0.000111749825,0.00008155376,0.00028059917,0.0005274076,0.00014318035,0.00016196209,0.0007553192,0.000013429917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005361741,0.00023576172,0.31027403,0.00010476672,0.000060666654,0.000012025877,0.0002433871,0.000008191689,0.67858285,0.000016324826,0.0013642345,0.0085615935],"study_design_scores_gemma":[0.004096265,0.00093953905,0.4152114,0.00091682514,0.00003510711,0.00006074545,0.0010410573,0.00016768604,0.57353103,0.000059262675,0.003697776,0.0002432897],"about_ca_topic_score_codex":0.0027382206,"about_ca_topic_score_gemma":0.00019145392,"teacher_disagreement_score":0.1050518,"about_ca_system_score_codex":0.00016223427,"about_ca_system_score_gemma":0.00073891657,"threshold_uncertainty_score":0.9995865},"labels":[],"label_agreement":null},{"id":"W3159120388","doi":"10.1158/1078-0432.ccr-20-4259","title":"Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Oncology; Lung cancer; Chemotherapy; Clinical endpoint; Surgery; Confidence interval; Clinical trial; Pathology; Cisplatin; Biology","score_opus":0.11156764103209474,"score_gpt":0.509988089102433,"score_spread":0.3984204480703383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159120388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858175,0.0052617006,0.0000059297568,0.0016406385,0.000072878654,0.0066491016,0.000050999526,0.000021602935,0.00047964885],"genre_scores_gemma":[0.9912095,0.0040043625,0.00011453521,0.00011749382,0.00008658539,0.0029171533,0.00003994296,0.000051114475,0.001459322],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943473,0.0018403681,0.00081188505,0.0009990735,0.001206944,0.0007944386],"domain_scores_gemma":[0.9950894,0.002478661,0.00014366252,0.0005113344,0.0014339024,0.0003429985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027152298,0.00029618337,0.0014957208,0.00038323703,0.00014191015,0.00006720112,0.00013196921,0.0001212577,0.0001157459],"category_scores_gemma":[0.0013566855,0.00019632264,0.00008416266,0.0011701012,0.0006845252,0.00010820387,0.00021139534,0.0011391385,0.000002104914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14762661,0.006149598,0.8355177,0.00025572843,0.00040595292,0.00079317915,0.0021202713,0.00003453331,0.000031912394,0.0000094466905,0.00010402196,0.0069510494],"study_design_scores_gemma":[0.5311423,0.0064454223,0.45846206,0.0006289083,0.00020173716,0.0000010749633,0.001617204,0.00083329255,0.00032378535,0.000011983095,0.00013470522,0.00019754026],"about_ca_topic_score_codex":0.014017739,"about_ca_topic_score_gemma":0.03874834,"teacher_disagreement_score":0.3835157,"about_ca_system_score_codex":0.0013186805,"about_ca_system_score_gemma":0.002323743,"threshold_uncertainty_score":0.992548},"labels":[],"label_agreement":null},{"id":"W3165701213","doi":"10.1158/1078-0432.ccr-21-1625","title":"Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbotsford Veterinary Clinic; University of the Fraser Valley; Interior Health; BC Cancer Agency; Spinal Cord Injury BC; Island Health; University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canadian Cancer Society; Prostate Cancer Canada; Institute of Cancer Research; Jane ja Aatos Erkon Säätiö; Prostate Cancer Foundation; Government of Canada; Academy of Finland","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Somatic cell; Cancer research; Oncology; Biology; Genotype; Mutation; Internal medicine; Cancer; Abiraterone; Exome sequencing; Medicine; Gene; Genetics","score_opus":0.1548736304656693,"score_gpt":0.48229699450883784,"score_spread":0.3274233640431685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165701213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863022,0.00885129,0.0000023795997,0.0027817471,0.000269004,0.0009239693,0.00029027983,0.000022748265,0.0005563872],"genre_scores_gemma":[0.9878634,0.0076840953,0.00006710328,0.000021594717,0.00048562625,0.00045436577,0.00010151874,0.000031293795,0.0032909987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962072,0.0006092866,0.0008398048,0.00062013726,0.00107176,0.0006518173],"domain_scores_gemma":[0.99779963,0.00021708549,0.000113275324,0.0003602912,0.0012246578,0.0002850553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017429724,0.0001509062,0.00046142284,0.00027696256,0.00014948787,0.00003565354,0.00009141338,0.0002047751,0.0013231345],"category_scores_gemma":[0.00045428364,0.00012999293,0.00016341647,0.0011945469,0.00046627215,0.00015714542,0.0001451173,0.00091072894,0.000026213145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00775181,0.0008903385,0.2740348,0.000926775,0.00015918919,0.00062601233,0.00045862573,0.00006434966,0.703849,0.00019332676,0.00069346424,0.010352323],"study_design_scores_gemma":[0.011540123,0.0009289392,0.31393215,0.0019693656,0.000046894907,0.000015560614,0.00091122976,0.00013086105,0.6673664,0.00044173858,0.0024706123,0.0002461359],"about_ca_topic_score_codex":0.0020445047,"about_ca_topic_score_gemma":0.003078786,"teacher_disagreement_score":0.03989736,"about_ca_system_score_codex":0.001492351,"about_ca_system_score_gemma":0.0047808364,"threshold_uncertainty_score":0.9995898},"labels":[],"label_agreement":null},{"id":"W3166074522","doi":"10.1158/1078-0432.ccr-20-4175","title":"Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"National Center for Advancing Translational Sciences; Council for Science, Technology and Innovation; A.P. Giannini Foundation; Svenska Läkaresällskapet; National Cancer Institute; National Institutes of Health; Vetenskapsrådet; Giannini Foundation of Agricultural Economics","keywords":"Urothelial cancer; Cancer; Oncology; Medicine; Internal medicine; Cancer research; Bladder cancer; Biology","score_opus":0.15900562498021772,"score_gpt":0.5352728762811759,"score_spread":0.37626725130095817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166074522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325496,0.002732907,0.000037202815,0.0019832384,0.00046458025,0.0007292808,0.0002713394,0.000027447237,0.00049902877],"genre_scores_gemma":[0.9960764,0.0016012896,0.00021386525,0.0009291083,0.0004985454,0.00029428164,0.000019446083,0.00004817001,0.00031887984],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99578017,0.0008621714,0.0007450659,0.00079927174,0.0010328904,0.00078042503],"domain_scores_gemma":[0.997239,0.00078131474,0.000091553484,0.000631911,0.00077275856,0.000483452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023056094,0.00021471556,0.0007733117,0.00010825421,0.000100563,0.00002787836,0.00016132073,0.00024436633,0.0003872282],"category_scores_gemma":[0.0014009788,0.00018411844,0.0002510192,0.00081408635,0.0002987391,0.00006996703,0.00036471122,0.0008516919,0.000034148346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003913328,0.0011359247,0.6754897,0.00027590833,0.00016365144,0.00095458346,0.00057450787,0.00012509368,0.2836309,0.000015559384,0.0010308537,0.03268994],"study_design_scores_gemma":[0.00370143,0.00055252184,0.19907519,0.0005628997,0.000036894427,0.000011716415,0.00015628866,0.00003714038,0.7922989,0.00006531983,0.0033317509,0.00016994202],"about_ca_topic_score_codex":0.0050477297,"about_ca_topic_score_gemma":0.008705201,"teacher_disagreement_score":0.508668,"about_ca_system_score_codex":0.00026380838,"about_ca_system_score_gemma":0.0018458549,"threshold_uncertainty_score":0.7630691},"labels":[],"label_agreement":null},{"id":"W3166259184","doi":"10.1158/1078-0432.ccr-21-0358","title":"Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"Janssen Research and Development","keywords":"Prostate cancer; Androgen receptor; Medicine; Androgen deprivation therapy; Enzalutamide; Internal medicine; Oncology; Biomarker; Proportional hazards model; Metastasis; Cancer; Androgen; Antiandrogen; Biology; Hormone","score_opus":0.07527895759064986,"score_gpt":0.42445680304503575,"score_spread":0.3491778454543859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166259184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793477,0.0050281333,0.0000019630595,0.0031471194,0.000033293923,0.0033906326,0.00039056333,0.000032292504,0.000041236217],"genre_scores_gemma":[0.99024236,0.006343835,0.00037915897,0.00015533171,0.00005457867,0.001886814,0.00030483978,0.000071212926,0.00056185125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99544895,0.0007957002,0.0005959646,0.0009881104,0.0013925701,0.0007786816],"domain_scores_gemma":[0.99687207,0.0004791023,0.00013661475,0.00053727813,0.0011770783,0.0007978368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011758587,0.00031002925,0.0006155711,0.0003307528,0.00022644195,0.00015310963,0.00013417771,0.00006411939,0.00025710886],"category_scores_gemma":[0.00032375666,0.00018676507,0.00006504122,0.0013397894,0.00044516817,0.00017596595,0.000094976975,0.00060065946,0.000011820251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036808208,0.0018060799,0.92898667,0.00020898221,0.0008277086,0.00093138823,0.00030829245,0.000034162833,0.00018712824,0.000015779777,0.000075485,0.029810097],"study_design_scores_gemma":[0.023727274,0.0040487,0.96904576,0.0006687856,0.0003074821,0.000004830043,0.00021378318,0.000079420446,0.0013204109,0.00012233891,0.00021242787,0.00024880873],"about_ca_topic_score_codex":0.0022416152,"about_ca_topic_score_gemma":0.0030019763,"teacher_disagreement_score":0.04005905,"about_ca_system_score_codex":0.00019208775,"about_ca_system_score_gemma":0.0020668753,"threshold_uncertainty_score":0.76160586},"labels":[],"label_agreement":null},{"id":"W3166273369","doi":"10.1158/1557-3265.ovcasymp18-gmm-020","title":"Abstract GMM-020: CELL OF ORIGIN, MUTATION AND MICROENVIRONMENT: MODELING EARLY EVENTS OF ENDOMETRIOSIS ASSOCIATED CANCERS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Clear cell; Histogenesis; Ovarian cancer; Cell of origin; Pathology; Cancer research; Cell; Clear cell carcinoma; Carcinoma; Cancer; Immunohistochemistry; Medicine; Immunology; Genetics","score_opus":0.15687738574329968,"score_gpt":0.4777591788075257,"score_spread":0.32088179306422604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166273369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938109,0.0038435976,0.000009386328,0.00023413888,0.0000764096,0.0011090075,0.000086389344,0.000008963659,0.0008212001],"genre_scores_gemma":[0.9831693,0.015958507,0.00012795244,0.000023808458,0.00004893356,0.00007331313,0.000025691761,0.000027669128,0.0005448324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965635,0.00027999055,0.0008059181,0.00044869675,0.0013833543,0.00051854184],"domain_scores_gemma":[0.9946848,0.0039446135,0.00021044789,0.00035434423,0.00045699283,0.0003487776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026486577,0.00014162733,0.0006539415,0.0005449869,0.000053520296,0.0000112299695,0.00016178857,0.00016301761,0.0008372968],"category_scores_gemma":[0.003368049,0.00011719575,0.00019588138,0.00091132626,0.00022261341,0.000085836946,0.00012031416,0.0006819693,0.00006039169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020454358,0.0012381019,0.9583609,0.0006687786,0.00058596866,0.00003532111,0.00017557591,0.00033440467,0.016732767,0.000009530151,0.00017540855,0.01963782],"study_design_scores_gemma":[0.02501439,0.0067701354,0.925265,0.0012221492,0.00021239417,0.000003578487,0.0003318139,0.0032184587,0.036637,0.00021024117,0.00081506144,0.00029976628],"about_ca_topic_score_codex":0.0060302448,"about_ca_topic_score_gemma":0.000119272016,"teacher_disagreement_score":0.033095878,"about_ca_system_score_codex":0.0005968989,"about_ca_system_score_gemma":0.0005446079,"threshold_uncertainty_score":0.91678125},"labels":[],"label_agreement":null},{"id":"W3166889753","doi":"10.1158/1557-3265.ovcasymp18-dp-006","title":"Abstract DP-006: THE EFFECT OF AGE AND OCP USE ON THE INCIDENCE OF PRE-CANCEROUS P53 LESIONS AND THE DEVELOPMENT OF HIGH GRADE SEROUS OVARIAN CARCINOMA","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Serous carcinoma; Incidence (geometry); Ovarian cancer; Cohort; Cancer; Hysterectomy; Immunohistochemistry; Gynecology; Internal medicine; Oncology; Pathology","score_opus":0.16101491038278817,"score_gpt":0.45373327138641445,"score_spread":0.29271836100362625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166889753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910452,0.0015939577,0.000001797022,0.004891874,0.00012833452,0.0020915738,0.000033376473,0.000004900656,0.00020902799],"genre_scores_gemma":[0.9977207,0.0015004715,0.00007164371,0.00013983474,0.00008811643,0.00029498004,0.0000033290746,0.00001908753,0.00016180567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704033,0.00072845636,0.00073129905,0.0003899559,0.00080827094,0.00030170663],"domain_scores_gemma":[0.9865381,0.012129487,0.00024666215,0.0007751019,0.00018839198,0.00012227475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044249194,0.00016669172,0.00066291227,0.00006202163,0.00016277499,0.000026271655,0.00029382767,0.00011347033,0.00012603655],"category_scores_gemma":[0.0008763935,0.00006906178,0.00011629294,0.00027223374,0.0013179225,0.000044053108,0.00024478015,0.00066957,0.0000044552103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00832306,0.00044026476,0.93089885,0.0006965299,0.0005794846,0.000034585093,0.002366359,0.00002590762,0.0003995881,0.0021246513,0.00093964516,0.05317108],"study_design_scores_gemma":[0.005059868,0.0016178453,0.98592895,0.0006410466,0.00011401726,0.0000037113464,0.000119816075,0.000027882605,0.0057611833,0.00018254059,0.000478717,0.00006441817],"about_ca_topic_score_codex":0.007940401,"about_ca_topic_score_gemma":0.0013240057,"teacher_disagreement_score":0.05503011,"about_ca_system_score_codex":0.00011241835,"about_ca_system_score_gemma":0.00053766795,"threshold_uncertainty_score":0.9986658},"labels":[],"label_agreement":null},{"id":"W3167506735","doi":"10.1158/1557-3265.ovcasymp18-nt-118","title":"Abstract NT-118: SEQUENTIAL THERAPEUTIC TARGETING OF OVARIAN CANCER HARBORING DYSFUNCTIONAL BRCA1","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Ovarian cancer; Olaparib; Chemotherapy; Medicine; Cancer research; Cisplatin; Paclitaxel; Debulking; Cancer; Oncology; PARP inhibitor; Carboplatin; Doxorubicin; Internal medicine; Biology; Poly ADP ribose polymerase","score_opus":0.2990487219853393,"score_gpt":0.5437371260757348,"score_spread":0.24468840409039544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167506735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766812,0.0053667803,0.00007739773,0.0053582983,0.0027125082,0.0009875125,0.00008440554,0.000064808744,0.0086671],"genre_scores_gemma":[0.9913685,0.0025875983,0.00019997996,0.00084251905,0.0028689946,0.0002488876,0.00003180334,0.00006357638,0.0017881739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568903,0.0003169986,0.0010600114,0.0007028237,0.0015126806,0.00071847416],"domain_scores_gemma":[0.9969362,0.0009843073,0.0002456065,0.0005680796,0.00094287266,0.00032295616],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038566464,0.00020371561,0.0006201316,0.0002261759,0.00014239701,0.000037458976,0.00029725724,0.00028180014,0.034664437],"category_scores_gemma":[0.00027124718,0.00018007586,0.00031790687,0.0005955502,0.0005056408,0.00015665121,0.00011502965,0.0016777868,0.00025476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007676911,0.0008620077,0.6572781,0.0010448729,0.001100706,0.00005289901,0.0003090564,0.00045459488,0.25500476,0.0016761288,0.021098765,0.053441197],"study_design_scores_gemma":[0.0144944,0.0012228016,0.7785622,0.0018341289,0.00013286846,0.000011410851,0.000295423,0.0007897843,0.048471406,0.0016252619,0.15198101,0.00057931687],"about_ca_topic_score_codex":0.0014384689,"about_ca_topic_score_gemma":0.00006178303,"teacher_disagreement_score":0.20653336,"about_ca_system_score_codex":0.0005550015,"about_ca_system_score_gemma":0.0019918876,"threshold_uncertainty_score":0.966218},"labels":[],"label_agreement":null},{"id":"W3167814974","doi":"10.1158/1078-0432.ccr-21-0180","title":"Clinical and Functional Characterization of Atypical <i>KRAS</i> / <i>NRAS</i> Mutations in Metastatic Colorectal Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; American Society of Clinical Oncology","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Colorectal cancer; Cancer research; Mutation; Cancer; Biology; Exon; HRAS; Medicine; Oncology; Genetics; Gene","score_opus":0.22248604584047627,"score_gpt":0.5158019717685142,"score_spread":0.2933159259280379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167814974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907176,0.0028006977,0.000025521644,0.0047021704,0.000506463,0.000518787,0.00019572071,0.000015803802,0.00051725615],"genre_scores_gemma":[0.98574793,0.011950307,0.00015084636,0.0004522956,0.00040149898,0.0004063201,0.00012216944,0.000021147214,0.00074745517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968435,0.00060163665,0.00101213,0.0005801158,0.00060337764,0.0003592093],"domain_scores_gemma":[0.9972044,0.001396199,0.00011514958,0.00018677293,0.000856561,0.0002409146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014728234,0.0001450315,0.0007418684,0.0001234836,0.00012183355,0.000021689004,0.000060305247,0.00013728002,0.0007482395],"category_scores_gemma":[0.0011331118,0.00012026024,0.00017880937,0.0007778519,0.0009728494,0.00008629619,0.00016699487,0.00076759973,0.000009617049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030638967,0.0010828854,0.9469039,0.00012755157,0.000316464,0.00010584856,0.00013934777,0.0000030676829,0.0049884603,0.00018775856,0.0007964072,0.042284418],"study_design_scores_gemma":[0.003853394,0.0006966209,0.9868607,0.00019917739,0.000137991,0.000013515626,0.00016807705,0.00012592091,0.0016279799,0.00022029692,0.0059936764,0.00010263938],"about_ca_topic_score_codex":0.000277932,"about_ca_topic_score_gemma":0.0021718175,"teacher_disagreement_score":0.04218178,"about_ca_system_score_codex":0.00014256069,"about_ca_system_score_gemma":0.0014756924,"threshold_uncertainty_score":0.8192698},"labels":[],"label_agreement":null},{"id":"W3168019520","doi":"10.1158/1557-3265.ovcasymp18-gmm-027","title":"Abstract GMM-027: DYNLL1 INHIBITS DNA END RESECTION IN BRCA1-DEFICIENT CELLS AND REGULATES PARP INHIBITOR SENSITIVITY","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Olaparib; Cancer research; Homologous recombination; DNA repair; PARP inhibitor; Genome instability; Ovarian cancer; Cisplatin; Chemistry; Molecular biology; Germline; Ovarian carcinoma; DNA damage; DNA; Poly ADP ribose polymerase; Cancer; Biology; Polymerase; Genetics; Gene; Chemotherapy","score_opus":0.04839840193250962,"score_gpt":0.44204335009585777,"score_spread":0.39364494816334816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168019520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699306,0.0013826187,0.00002407528,0.00027117005,0.00041150182,0.0003601132,0.000027862068,0.000009679575,0.0005198865],"genre_scores_gemma":[0.9974715,0.0013814322,0.00004048814,0.000046151566,0.00044137973,0.000024235202,0.000027414513,0.000024225646,0.000543148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980057,0.00021231778,0.0003793613,0.0006218672,0.00032578158,0.00045501092],"domain_scores_gemma":[0.9990573,0.00023745591,0.000043071333,0.00037331568,0.00012884654,0.0001599909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026178437,0.00013576905,0.00021732046,0.00008064174,0.000060255028,0.00004394302,0.00009740837,0.0002746314,0.00006862209],"category_scores_gemma":[0.00024617097,0.0001308316,0.00007474263,0.00018088588,0.00018504831,0.0000061322257,0.0002496073,0.0005383453,0.000038440896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034758844,0.000112871414,0.019354215,0.00010512216,0.000019406603,0.000010849328,0.00005004125,0.00082624186,0.9672397,0.000010759549,0.0019731736,0.009950023],"study_design_scores_gemma":[0.0009976658,0.0004321663,0.1862629,0.000106665895,0.000004089173,0.000004820575,0.00010476567,0.00051756727,0.7981575,0.00003478784,0.013168653,0.00020838412],"about_ca_topic_score_codex":0.0003044846,"about_ca_topic_score_gemma":0.001091457,"teacher_disagreement_score":0.16908218,"about_ca_system_score_codex":0.000046719433,"about_ca_system_score_gemma":0.00013215067,"threshold_uncertainty_score":0.5335158},"labels":[],"label_agreement":null},{"id":"W3170342365","doi":"10.1158/1557-3265.ovcasymp18-nt-089","title":"Abstract NT-089: TRAIL-EXPRESSING ONCOLYTIC VACCINIA VIRUS COMBINED WITH SMALL-MOLECULE DRUG PAC1 IS A POTENTIALLY EFFECTIVE TREATMENT ALTERNATIVE FOR OVARIAN CANCERS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Oncolytic virus; Vaccinia; Ovarian cancer; Apoptosis; Carboplatin; Cancer research; Cancer; Pharmacology; Medicine; Cancer cell; Virus; Virology; Biology; Immunology; Internal medicine; Recombinant DNA; Chemotherapy","score_opus":0.0821276485905985,"score_gpt":0.44772578225851367,"score_spread":0.36559813366791516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170342365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209946,0.0009008248,0.00016893103,0.001076622,0.0002590887,0.0041375575,0.0002733574,0.000024032435,0.0010601252],"genre_scores_gemma":[0.9931749,0.0009733047,0.00028168524,0.00046363266,0.00072994677,0.001776793,0.000103528015,0.00012680775,0.0023694183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99546343,0.00072133634,0.00057702465,0.001366663,0.0007357628,0.0011357728],"domain_scores_gemma":[0.99694216,0.0006882289,0.00019990855,0.00094631553,0.0007613216,0.000462084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021998985,0.00040056673,0.0006214285,0.0001572857,0.0002977227,0.00015377969,0.00070967345,0.00029027442,0.00038646112],"category_scores_gemma":[0.00020608566,0.0003193711,0.00036883244,0.00031550016,0.00037550824,0.00001550632,0.00019544536,0.0006630458,0.00006799955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14860645,0.0012993123,0.004297969,0.00023437974,0.0024427464,0.000073163385,0.00075357937,0.000788498,0.70616883,0.000019154448,0.0035476775,0.13176827],"study_design_scores_gemma":[0.018114433,0.045355245,0.0050004856,0.00023942295,0.00008696481,0.0000035682622,0.00024973828,0.000582378,0.91658896,0.00013319883,0.012990151,0.0006554337],"about_ca_topic_score_codex":0.0030620636,"about_ca_topic_score_gemma":0.008060153,"teacher_disagreement_score":0.21042018,"about_ca_system_score_codex":0.00066435477,"about_ca_system_score_gemma":0.0025517144,"threshold_uncertainty_score":0.99992585},"labels":[],"label_agreement":null},{"id":"W3171679244","doi":"10.1158/1078-0432.ccr-21-0748","title":"Relevance of Platinum-free Interval and <i>BRCA</i> Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g <i>BRCA</i> Advanced Breast Cancer (BROCADE3 Crossover)","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AbbVie","keywords":"Carboplatin; Veliparib; Medicine; Paclitaxel; BRCA mutation; Oncology; Breast cancer; Internal medicine; Cancer; Chemotherapy; Cisplatin; Genetics; Biology; DNA","score_opus":0.14512049466977472,"score_gpt":0.5106776394598908,"score_spread":0.36555714479011603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171679244","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.110548355,0.03736978,0.001026561,0.80038184,0.004351501,0.015556552,0.029965144,0.00021439478,0.0005858853],"genre_scores_gemma":[0.09826736,0.07060445,0.024772817,0.6678613,0.04114138,0.0682902,0.0051449044,0.0018766338,0.022040972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992355,0.00057284674,0.0019781978,0.001983603,0.0018400257,0.0012703254],"domain_scores_gemma":[0.9880903,0.006326867,0.0008782112,0.0015516994,0.0027751569,0.0003777915],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018932301,0.00070969976,0.0018939155,0.00036760242,0.0003690028,0.00010682782,0.0006076981,0.0016760437,0.0004984306],"category_scores_gemma":[0.0017004055,0.0006360888,0.00082675874,0.0006489152,0.00144524,0.00023351988,0.00026973398,0.0041716597,0.000005550939],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040733274,0.00045991462,0.0025648805,0.004071218,0.0006106929,0.00008027786,0.0003200464,0.00003537323,0.002600848,0.00003411929,0.87192327,0.07656607],"study_design_scores_gemma":[0.033185966,0.004481231,0.004516601,0.014316314,0.00037240167,0.00004182284,0.00015307066,0.00030146525,0.008162313,0.0022161915,0.9312529,0.0009997323],"about_ca_topic_score_codex":0.00023690473,"about_ca_topic_score_gemma":0.00017418338,"teacher_disagreement_score":0.13252056,"about_ca_system_score_codex":0.00096164044,"about_ca_system_score_gemma":0.0020360597,"threshold_uncertainty_score":0.99961996},"labels":[],"label_agreement":null},{"id":"W3172767700","doi":"10.1158/1557-3265.ovcasymp18-gmm-030","title":"Abstract GMM-030: MODELS AND ANALYTIC TECHNIQUES OF MULLERIAN TISSUE-DERIVED ORGANOIDS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Organoid; Matrigel; Biology; Carcinogenesis; Ovarian cancer; Cancer research; Serous fluid; Progenitor cell; Stem cell; Cellular differentiation; Cell biology; Cancer; Angiogenesis; Genetics; Gene","score_opus":0.2760829646416126,"score_gpt":0.5471925888043477,"score_spread":0.27110962416273515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172767700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909172,0.0013210981,0.000025796131,0.0018649145,0.00010310921,0.00071970245,0.000009761554,0.000031843694,0.005006588],"genre_scores_gemma":[0.9968886,0.0012085697,0.00027672507,0.000095417585,0.00023453237,0.000030688487,0.000005585356,0.000014919648,0.0012449755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812263,0.00022266302,0.00048749626,0.00057263905,0.00030270935,0.00029185053],"domain_scores_gemma":[0.998122,0.00045191537,0.000072219795,0.0006545945,0.0005251156,0.00017416143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003186058,0.000099427554,0.000503622,0.00010033903,0.00004870513,0.000007628645,0.00014980487,0.00026588453,0.0010879915],"category_scores_gemma":[0.00091699726,0.000074155956,0.00007410367,0.00022943222,0.00094836944,0.00007161352,0.00014609464,0.00076076674,0.000043860877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011913023,0.0007400258,0.45352292,0.0007253171,0.00028188544,0.00002886031,0.0002736503,0.0000031973416,0.42639935,0.00023937014,0.0021776878,0.103694715],"study_design_scores_gemma":[0.0007701846,0.0010429209,0.9139017,0.000118449185,0.000022718668,0.0000031615186,0.00007620782,0.00009040251,0.07947509,0.0018134234,0.002598206,0.00008754128],"about_ca_topic_score_codex":0.00034182417,"about_ca_topic_score_gemma":0.000023242384,"teacher_disagreement_score":0.46037877,"about_ca_system_score_codex":0.000051495153,"about_ca_system_score_gemma":0.0003093971,"threshold_uncertainty_score":0.9998251},"labels":[],"label_agreement":null},{"id":"W3173401695","doi":"10.1158/1078-0432.ccr-21-0809","title":"5-Year Outcomes with Cobimetinib plus Vemurafenib in <i>BRAF</i> V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Vemurafenib; Medicine; Placebo; Internal medicine; Melanoma; Gastroenterology; Surgery; Metastatic melanoma; Pathology; Cancer research; Cancer","score_opus":0.0778736949624746,"score_gpt":0.4348568937526744,"score_spread":0.3569831987901998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173401695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965411,0.0006368361,0.000032440315,0.00034880466,0.00031778766,0.0008168751,0.00007059364,0.000006155453,0.0012294003],"genre_scores_gemma":[0.99584323,0.0001362072,0.00017135797,0.0001626468,0.00010027079,0.00019394257,0.00003989774,0.000028143162,0.0033242747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685264,0.0010508079,0.0005422798,0.0006223972,0.0005375666,0.00039433065],"domain_scores_gemma":[0.99811363,0.00033662986,0.00012992439,0.0006841945,0.00061429787,0.000121313096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012648999,0.00016132797,0.00041516442,0.00004879119,0.00011490483,0.000023169472,0.00041758924,0.00015492173,0.000065490174],"category_scores_gemma":[0.00082978274,0.00011045699,0.00016169653,0.0004530596,0.00035854246,0.0000067928445,0.000381615,0.00049086567,0.0000085272395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034106942,0.0018380508,0.9442267,0.00007029144,0.00040222198,0.00022919757,0.0008137942,0.00007468402,0.040604122,0.00022690845,0.0006065638,0.0074967803],"study_design_scores_gemma":[0.013450773,0.0021713453,0.88079786,0.000084795945,0.00004193392,0.000007860197,0.0022063062,0.000010522348,0.09946365,0.000050416882,0.001491461,0.0002231029],"about_ca_topic_score_codex":0.00015351725,"about_ca_topic_score_gemma":0.0039200094,"teacher_disagreement_score":0.06342886,"about_ca_system_score_codex":0.000042701515,"about_ca_system_score_gemma":0.0011813078,"threshold_uncertainty_score":0.4504305},"labels":[],"label_agreement":null},{"id":"W3173510214","doi":"10.1158/1078-0432.ccr-20-4027","title":"Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Vector Institute; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canadian Hematology Society; BC Cancer Foundation; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation; Leukemia and Lymphoma Society of Canada","keywords":"Lenalidomide; Cancer research; Vorinostat; EZH2; Medicine; Diffuse large B-cell lymphoma; Panobinostat; Epigenetics; Biology; Lymphoma; Immunology; Histone deacetylase; Multiple myeloma; Histone; Genetics; Gene","score_opus":0.08207514444780283,"score_gpt":0.4472204411841452,"score_spread":0.3651452967363424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173510214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967963,0.0008454615,0.0010211767,0.00058720005,0.00012576315,0.00026514663,0.000026112692,0.000005518007,0.00032730453],"genre_scores_gemma":[0.99560034,0.002921315,0.00017890036,0.00014455488,0.00019530169,0.0000732247,0.00008508616,0.000016724818,0.00078456616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981444,0.00047395224,0.0002808424,0.0005196663,0.0002544305,0.00032669806],"domain_scores_gemma":[0.9990994,0.00012450709,0.00004789873,0.00029305075,0.000277191,0.00015797214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001139869,0.00009647424,0.0001749908,0.000070215705,0.00009684025,0.000048685026,0.00007917698,0.00018268958,0.000019260506],"category_scores_gemma":[0.00069487,0.000100084304,0.000050655526,0.00030342757,0.00008543349,0.000007728262,0.00023555839,0.00019038412,0.000010895056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003337983,0.0013068208,0.021457974,0.000028786773,0.0000060891707,0.000007887983,0.000027888498,0.0000050230838,0.96131146,0.000030447456,0.00018691969,0.015296899],"study_design_scores_gemma":[0.0045589125,0.00040568382,0.10962335,0.000026611982,0.00000370892,1.9548547e-7,0.000026167652,0.00007106617,0.8830305,0.00012462804,0.0020135862,0.000115603245],"about_ca_topic_score_codex":0.00008455077,"about_ca_topic_score_gemma":0.0011542195,"teacher_disagreement_score":0.08816537,"about_ca_system_score_codex":0.00004692243,"about_ca_system_score_gemma":0.0002680827,"threshold_uncertainty_score":0.40813193},"labels":[],"label_agreement":null},{"id":"W3173578209","doi":"10.1158/1078-0432.ccr-21-0110","title":"Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Head and neck squamous-cell carcinoma; DNA methylation; Methylation; CpG site; Cancer research; Head and neck cancer; Biology; Oncology; Internal medicine; Cancer; DNA; Medicine; Gene; Genetics; Gene expression","score_opus":0.08902114054578578,"score_gpt":0.4266173834050939,"score_spread":0.3375962428593081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173578209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312997,0.005420245,0.000015620817,0.00016245265,0.00015861359,0.00025725935,0.00006125539,0.000003024125,0.00079158955],"genre_scores_gemma":[0.9980937,0.00037078897,0.0007653531,0.00017532549,0.00039585354,0.000051788807,0.0000339844,0.000027387108,0.00008581901],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795485,0.00023039467,0.00055295037,0.0005857836,0.00024671134,0.00042932862],"domain_scores_gemma":[0.9985993,0.00039624475,0.00009275885,0.0003822204,0.00035773823,0.00017173665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009855332,0.000121691475,0.00029218418,0.00005766034,0.0000683413,0.000029810544,0.00017435294,0.0001227933,0.00003128733],"category_scores_gemma":[0.0016020627,0.00012913173,0.00009752631,0.00021926695,0.00024563435,0.0000034683796,0.0004224258,0.0004303016,0.0000025566849],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032812028,0.0003069317,0.6750617,0.0002570495,0.000011231593,0.00017857336,0.00007721922,0.0002528617,0.31948364,0.00007266425,0.00025519417,0.0037148227],"study_design_scores_gemma":[0.004374038,0.0008606321,0.3497358,0.00009555948,0.000015815891,0.000021399437,0.0004520111,0.0020507025,0.63989794,0.00024726638,0.0019191896,0.00032966287],"about_ca_topic_score_codex":0.0008803447,"about_ca_topic_score_gemma":0.0010763959,"teacher_disagreement_score":0.32532588,"about_ca_system_score_codex":0.000052871284,"about_ca_system_score_gemma":0.0010451388,"threshold_uncertainty_score":0.5265839},"labels":[],"label_agreement":null},{"id":"W3174618187","doi":"10.1158/1078-0432.ccr-21-0649","title":"A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Princess Margaret Cancer Centre; D2L (Canada)","funders":"Canadian Cancer Society Research Institute","keywords":"Multiple myeloma; Cancer; Ideal (ethics); Myeloma protein; Immunopathology","score_opus":0.12011536654454748,"score_gpt":0.46543167783069944,"score_spread":0.345316311286152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174618187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920556,0.00030123748,0.00019749509,0.0042122905,0.00009173364,0.0022118418,0.00011355158,0.000042521482,0.000773711],"genre_scores_gemma":[0.98377854,0.000035143985,0.01129912,0.00031935654,0.00030069,0.0008535219,0.00010985902,0.00006692368,0.0032368647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99343455,0.001255954,0.0006014627,0.0010248367,0.0024337557,0.0012494276],"domain_scores_gemma":[0.99504745,0.0014702616,0.000060467602,0.00080821756,0.0013838252,0.0012297806],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022510446,0.00025538716,0.0007173229,0.0005141523,0.00015423016,0.000083820974,0.00027971278,0.00020486143,0.0017141058],"category_scores_gemma":[0.0065036304,0.00019510329,0.0001960417,0.0021267328,0.00034251998,0.000080297235,0.00017592443,0.0013876371,0.00033332527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013956516,0.0021334304,0.9618356,0.00012864919,0.00018869508,0.0010393977,0.00004129931,0.0000046825135,0.0031414293,0.000015845784,0.000667971,0.016846472],"study_design_scores_gemma":[0.025864793,0.002625791,0.9598389,0.00053310575,0.000021682956,0.0000012788763,0.00009984325,0.00043310135,0.008196706,0.000030872096,0.0021408633,0.00021305673],"about_ca_topic_score_codex":0.00061108154,"about_ca_topic_score_gemma":0.0006600302,"teacher_disagreement_score":0.016633416,"about_ca_system_score_codex":0.00086680066,"about_ca_system_score_gemma":0.00150345,"threshold_uncertainty_score":0.99919844},"labels":[],"label_agreement":null},{"id":"W3176956457","doi":"10.1158/1078-0432.ccr-21-0793","title":"Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Ipilimumab; Pembrolizumab; Medicine; Cohort; Regimen; Internal medicine; Adverse effect; Dosing; Melanoma; Incidence (geometry); Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.13851459770828084,"score_gpt":0.5370049475480762,"score_spread":0.3984903498397953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176956457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410195,0.009804783,0.00003834669,0.00089322665,0.0006530744,0.003717332,0.00007440849,0.000048774844,0.0006681141],"genre_scores_gemma":[0.9902312,0.0075738216,0.00033282264,0.00019327135,0.00035350092,0.0006955503,0.000032607706,0.0000745653,0.00051262835],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.991369,0.0024526634,0.0022268773,0.0011407303,0.0019072664,0.0009034808],"domain_scores_gemma":[0.99439615,0.0025637806,0.00034181698,0.0011512998,0.0011732357,0.00037371612],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009666056,0.00035310202,0.0024313454,0.00043201356,0.0001773556,0.000075622534,0.0004242089,0.0002180675,0.0009423708],"category_scores_gemma":[0.0026670045,0.0002919344,0.0005695787,0.0013517503,0.0010455651,0.0001684927,0.0003229406,0.0016258382,0.000012394876],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8799222,0.004602927,0.038600005,0.00023605017,0.0011799731,0.00091181626,0.0007334172,0.000047660684,0.010835889,0.00006536082,0.00018467974,0.062680006],"study_design_scores_gemma":[0.9643909,0.005056378,0.012508957,0.0010459065,0.0003015014,0.000029737712,0.0017362374,0.0009295655,0.012178508,0.0003423729,0.0011111076,0.0003688801],"about_ca_topic_score_codex":0.0035723501,"about_ca_topic_score_gemma":0.0026102425,"teacher_disagreement_score":0.08446863,"about_ca_system_score_codex":0.0010456366,"about_ca_system_score_gemma":0.0034886494,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W3180432673","doi":"10.1158/1078-0432.ccr-21-2052","title":"Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"Mass cytometry; Immune system; Flow cytometry; Harmonization; Profiling (computer programming); Medicine; Immunology; Biology; Computer science","score_opus":0.1634933270471794,"score_gpt":0.46553082141990565,"score_spread":0.30203749437272626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180432673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97750986,0.0055103274,0.014418174,0.0005341003,0.0009950473,0.00021633477,0.00006721652,0.000018556406,0.0007303854],"genre_scores_gemma":[0.99121046,0.0026469862,0.0031309912,0.00040561138,0.001122945,0.000077941884,0.0002451165,0.00003555299,0.0011243795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99735415,0.0005505555,0.0005045439,0.0007109324,0.0004411321,0.00043868276],"domain_scores_gemma":[0.99830973,0.00022576089,0.000060439015,0.0005637065,0.00065394794,0.00018641165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010485534,0.00013754755,0.00023536646,0.00004139558,0.000177567,0.00009773399,0.00039089663,0.00027611048,0.00050022115],"category_scores_gemma":[0.0012606346,0.00013251789,0.00016051874,0.00034975077,0.00030439053,0.0000084417525,0.00022672061,0.00044382777,0.000040030875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002456478,0.0001694245,0.13710955,0.000018768396,0.000058458474,0.000027548342,0.000059501173,0.0000111433465,0.8557855,0.000012173549,0.00043560533,0.0060667023],"study_design_scores_gemma":[0.0012496624,0.00012181249,0.013771934,0.000050476334,0.000011937132,0.0000011247286,0.00024832904,0.0007987283,0.96245456,0.000061278544,0.021026857,0.00020332087],"about_ca_topic_score_codex":0.00017693406,"about_ca_topic_score_gemma":0.00005948219,"teacher_disagreement_score":0.12333762,"about_ca_system_score_codex":0.00004361158,"about_ca_system_score_gemma":0.00038539263,"threshold_uncertainty_score":0.5477071},"labels":[],"label_agreement":null},{"id":"W3182408948","doi":"10.1158/1078-0432.ccr-20-4607","title":"Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Canada Digital Adoption Program; National Research Foundation","keywords":"T790M; Transcriptome; Biology; Cancer research; Exome; EGFR inhibitors; Gene expression profiling; Exome sequencing; Genetics; Gene; Bioinformatics; KRAS; Epidermal growth factor receptor; Mutation; Cancer; Gene expression","score_opus":0.3480102590733958,"score_gpt":0.5620181373188999,"score_spread":0.21400787824550416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182408948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98038965,0.0057197046,0.0001802565,0.007729105,0.00012923502,0.00097120454,0.00022451629,0.000027757638,0.004628538],"genre_scores_gemma":[0.9899218,0.0054869154,0.00091295555,0.0006280105,0.00018928025,0.00022196132,0.00010939997,0.000024577286,0.0025050654],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997718,0.00061768235,0.00054496055,0.00039466014,0.00044680308,0.0002779076],"domain_scores_gemma":[0.9961543,0.0014358376,0.00010162797,0.00023381163,0.0018627768,0.00021163697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009254165,0.00013777905,0.0004935493,0.00011497906,0.00014341179,0.000025804347,0.00006305718,0.00013056763,0.0003682596],"category_scores_gemma":[0.00071802957,0.00010093704,0.00013678042,0.0003980626,0.00066870573,0.00007924881,0.000042649346,0.000610785,0.0000046786727],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015272921,0.007454317,0.13315332,0.004973712,0.012661318,0.0034177473,0.102674425,0.000072217124,0.093127735,0.019617941,0.006379935,0.6011944],"study_design_scores_gemma":[0.036394566,0.012772661,0.25202477,0.010125163,0.0035321517,0.00019687602,0.22554858,0.0028491232,0.4319576,0.018888263,0.004429622,0.0012806216],"about_ca_topic_score_codex":0.0002965266,"about_ca_topic_score_gemma":0.0001288503,"teacher_disagreement_score":0.5999138,"about_ca_system_score_codex":0.00017399655,"about_ca_system_score_gemma":0.0017902164,"threshold_uncertainty_score":0.4116093},"labels":[],"label_agreement":null},{"id":"W3182557860","doi":"10.1158/1078-0432.ccr-21-1509","title":"MRN Complex and Cancer Risk: Old Bottles, New Wine","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Jewish General Hospital; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute; Université du Québec à Montréal","funders":"Canadian Institutes of Health Research; “la Caixa” Foundation","keywords":"Cancer; Breast cancer; Germline; Gene; PALB2; Germline mutation; Mutation; Haematopoiesis","score_opus":0.20197259521193967,"score_gpt":0.502888515363479,"score_spread":0.30091592015153934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182557860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97423613,0.019140467,0.00015418816,0.00434819,0.00039756746,0.00024131191,0.0001122933,0.000020994834,0.0013488607],"genre_scores_gemma":[0.8666692,0.07315695,0.003343183,0.0020808952,0.0055039814,0.00015132522,0.00014786584,0.00009352572,0.048853107],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976349,0.00047226527,0.00033624377,0.0007181937,0.00036891334,0.0004694972],"domain_scores_gemma":[0.9984949,0.00014326564,0.000062047,0.00057676306,0.00033443136,0.00038859705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012498694,0.00012934528,0.00024578246,0.000030491548,0.00013842955,0.000053067706,0.00025744713,0.00023661806,0.0011772172],"category_scores_gemma":[0.0008981298,0.00012139981,0.000112274654,0.00020534969,0.00027867415,0.0000036255133,0.0005858935,0.0005308304,0.000029627043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006020988,0.00022023996,0.05801179,0.00007344691,0.0002697405,0.000062949286,0.00005099308,0.000021422895,0.35987616,0.00039187275,0.3437991,0.23662016],"study_design_scores_gemma":[0.0018187091,0.0005265748,0.035606455,0.000054206947,0.0000317317,0.000009080442,0.000070132395,0.00015142973,0.102037296,0.0009738093,0.85845846,0.00026212685],"about_ca_topic_score_codex":0.0011330319,"about_ca_topic_score_gemma":0.0013688423,"teacher_disagreement_score":0.51465935,"about_ca_system_score_codex":0.000037244117,"about_ca_system_score_gemma":0.0008955748,"threshold_uncertainty_score":0.99973583},"labels":[],"label_agreement":null},{"id":"W3185088911","doi":"10.1158/1078-0432.ccr-21-2180","title":"Liquid Biopsy Goes Viral: Next-Generation Sequencing to Enhance HPV Detection","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Liquid biopsy; DNA sequencing; Biopsy; DNA; Virology; Human papillomavirus; Papillomaviridae; Identification (biology); Medicine; Biology; Computational biology; Cancer; Pathology; Cervical cancer; Genetics; Internal medicine","score_opus":0.46929229180281046,"score_gpt":0.5522497215502418,"score_spread":0.08295742974743131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185088911","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05563292,0.007923631,0.0008384875,0.916036,0.0037545434,0.0031583402,0.00014944393,0.00024296818,0.012263629],"genre_scores_gemma":[0.15584747,0.010932746,0.00067350356,0.66860336,0.12191209,0.002934151,0.0009536699,0.00046948515,0.037673514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895429,0.0016882316,0.0014177437,0.0021284448,0.0034532936,0.0017694003],"domain_scores_gemma":[0.9926623,0.0014508775,0.0001560812,0.0015510307,0.003316116,0.00086356775],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.004780252,0.000491376,0.0013100868,0.0007068934,0.0004567992,0.00039705506,0.0006828209,0.0019492958,0.014990648],"category_scores_gemma":[0.0043368647,0.0004407955,0.00061608636,0.0018338575,0.0005672354,0.00019554423,0.0006899105,0.011939276,0.00085402094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015897811,0.000102485894,0.000085953,0.0010468849,0.00020062622,0.0012262629,0.00009496586,0.000006621124,0.044054933,0.000005263413,0.72182673,0.22975951],"study_design_scores_gemma":[0.0007977493,0.00291996,0.0009637431,0.00036312218,0.000108830325,0.000041774292,0.000074457246,0.00033976205,0.05666484,0.000063494335,0.9370973,0.0005649789],"about_ca_topic_score_codex":0.003144622,"about_ca_topic_score_gemma":0.0015337877,"teacher_disagreement_score":0.24743266,"about_ca_system_score_codex":0.0026334198,"about_ca_system_score_gemma":0.004297714,"threshold_uncertainty_score":0.99992394},"labels":[],"label_agreement":null},{"id":"W3185315144","doi":"10.1158/1078-0432.ccr-21-1034","title":"FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Lung cancer; Oncology; Population; Placebo; non-small cell lung cancer (NSCLC); Cancer; Surgery; Family medicine; Pathology; Adenocarcinoma; Alternative medicine; Environmental health","score_opus":0.20001285098560964,"score_gpt":0.5691318612122892,"score_spread":0.3691190102266796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185315144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3068692,0.6363301,0.00009581448,0.018303718,0.0009970064,0.021543028,0.0031195628,0.00010482378,0.012636727],"genre_scores_gemma":[0.106021784,0.8147887,0.0048055844,0.0012171821,0.0015700083,0.023086632,0.0012817706,0.00019245653,0.047035888],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957118,0.00068740686,0.0011722435,0.0009460575,0.00075299066,0.0007295092],"domain_scores_gemma":[0.99290055,0.0017730381,0.0002775469,0.0007205254,0.0039507854,0.00037755075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012672038,0.00029384412,0.0013910839,0.00014492356,0.00020935704,0.000032774868,0.0001913689,0.00020605036,0.0006160833],"category_scores_gemma":[0.0009780552,0.00020997346,0.00048132928,0.0017572466,0.0003201687,0.00006201161,0.00010107924,0.0004059671,0.0000067762835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018725691,0.0179068,0.13969555,0.030522924,0.00777931,0.0012526877,0.0036097758,0.000029313518,0.004984134,0.00029496907,0.43733564,0.33786318],"study_design_scores_gemma":[0.043258067,0.014954532,0.015841728,0.01523431,0.0053965356,0.00002078091,0.001256627,0.001119194,0.031870324,0.000092861104,0.8701428,0.00081220345],"about_ca_topic_score_codex":0.0031228596,"about_ca_topic_score_gemma":0.0020014774,"teacher_disagreement_score":0.43280718,"about_ca_system_score_codex":0.0009133601,"about_ca_system_score_gemma":0.014619359,"threshold_uncertainty_score":0.99096686},"labels":[],"label_agreement":null},{"id":"W3185777435","doi":"10.1158/1078-0432.ccr-21-0310","title":"Niraparib for Advanced Breast Cancer with Germline <i>BRCA1</i> and <i>BRCA2</i> Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Institute of Cancer Research","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; Eisai; Cancer Research UK; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; National Cancer Research Institute; GlaxoSmithKline; Celgene; Amgen; University of Texas MD Anderson Cancer Center; Pfizer; MacroGenics; Cancer Research Institute","keywords":"Breast cancer; Oncology; Medicine; Germline; Internal medicine; Cancer; Germline mutation; Mutation; Genetics; Biology; Gene","score_opus":0.22352135960730762,"score_gpt":0.525599806114159,"score_spread":0.3020784465068514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185777435","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04881354,0.02720599,0.00017485868,0.9030826,0.0018484278,0.0135896625,0.0038489786,0.00025800357,0.0011779564],"genre_scores_gemma":[0.04480616,0.029451508,0.0009259933,0.7840386,0.04498702,0.042004656,0.002290016,0.0012347562,0.050261308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9878877,0.0018841837,0.0022125638,0.0028182538,0.0032560509,0.001941266],"domain_scores_gemma":[0.9853313,0.0067263492,0.0007651956,0.0024109685,0.0041521746,0.0006139982],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005018974,0.0010072682,0.0023101293,0.00041183503,0.0009967473,0.0003787512,0.0010268018,0.0012338526,0.004486023],"category_scores_gemma":[0.0009488176,0.0006970374,0.0005820193,0.0015146283,0.0027662287,0.00026744712,0.00041868936,0.00824138,0.00007345202],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006141113,0.0010579642,0.010466132,0.0011641944,0.0020164244,0.0005528374,0.00050496386,0.000047716097,0.00017244973,0.000015719612,0.9532294,0.024631046],"study_design_scores_gemma":[0.019882677,0.0035284746,0.008949834,0.0026150746,0.00093796017,0.00020294932,0.0008449562,0.00008322529,0.00024617312,0.00035911272,0.9613668,0.0009828062],"about_ca_topic_score_codex":0.0011882962,"about_ca_topic_score_gemma":0.0014862415,"teacher_disagreement_score":0.119044,"about_ca_system_score_codex":0.0010108046,"about_ca_system_score_gemma":0.0056110923,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W3186399416","doi":"10.1158/1078-0432.ccr-21-1059","title":"Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; bluebird bio; Agios Pharmaceuticals; TG Therapeutics; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Gilead Sciences; Sanofi; Legend Biotech; Celgene; AstraZeneca; Pfizer; Amgen; GlaxoSmithKline; Multiple Myeloma Research Foundation; Foundation for the National Institutes of Health","keywords":"Multiple myeloma; Medicine; Drug; Residual; Intensive care medicine; Minimal residual disease; Disease; Internal medicine; Pharmacology; Computer science","score_opus":0.3248483922535994,"score_gpt":0.5827453539241509,"score_spread":0.25789696167055154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186399416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719969,0.0107671125,0.000074691576,0.014391378,0.00011943626,0.0019122825,0.0000937548,0.000026996722,0.0006174454],"genre_scores_gemma":[0.98524547,0.0065317904,0.0016784678,0.00021579709,0.0014840866,0.0006501324,0.00036266205,0.000031255902,0.0038003575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641347,0.0006180136,0.0008038203,0.00087824365,0.0007480093,0.0005384649],"domain_scores_gemma":[0.9953081,0.0021922784,0.00007417328,0.0005612312,0.0007591938,0.0011050323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024195304,0.00013319963,0.00042333704,0.00011726174,0.00013937584,0.00005617395,0.00013114802,0.0001696991,0.00007933344],"category_scores_gemma":[0.005974604,0.000118026575,0.00015847896,0.00037323716,0.00038409347,0.00008653885,0.00015169177,0.0007685636,0.000026705191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005545774,0.0004558039,0.68972415,0.00029566349,0.00005406955,0.00020060438,0.000107031316,8.493309e-7,0.00006792024,0.00021159273,0.014954755,0.28838181],"study_design_scores_gemma":[0.009513898,0.0006751573,0.9515816,0.00019128797,0.000050679246,0.000003167418,0.00033455514,0.00040967495,0.0002849308,0.00064231077,0.036196545,0.000116219104],"about_ca_topic_score_codex":0.00076015474,"about_ca_topic_score_gemma":0.0026055297,"teacher_disagreement_score":0.2882656,"about_ca_system_score_codex":0.00019970206,"about_ca_system_score_gemma":0.003840469,"threshold_uncertainty_score":0.715259},"labels":[],"label_agreement":null},{"id":"W3188472626","doi":"10.1158/1078-0432.ccr-21-1497","title":"Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Pharmacyclics","keywords":"Ibrutinib; Medicine; Rituximab; Waldenstrom macroglobulinemia; Internal medicine; Macroglobulinemia; Refractory (planetary science); Gastroenterology; Phases of clinical research; Progression-free survival; Neutropenia; Response Evaluation Criteria in Solid Tumors; Surgery; Clinical trial; Oncology; Lymphoma; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.4036895078357418,"score_gpt":0.5643537866182178,"score_spread":0.16066427878247597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188472626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915822,0.0013340059,0.000036687725,0.0031688046,0.0008076644,0.00237716,0.00025041657,0.000013020912,0.0004300159],"genre_scores_gemma":[0.9952658,0.00034977682,0.00010203335,0.00026970403,0.0007067187,0.0002122158,0.000041360727,0.000037092665,0.0030153373],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99256676,0.0012462358,0.0019667991,0.0007769224,0.002600999,0.0008422645],"domain_scores_gemma":[0.99005497,0.004292528,0.0003976116,0.0019835185,0.0030133966,0.00025800726],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006392154,0.0002204115,0.0013714049,0.00026874573,0.000258571,0.000035056193,0.0010059803,0.0003506904,0.0009971323],"category_scores_gemma":[0.008356546,0.00012942823,0.001326192,0.004779534,0.0019469975,0.000046461842,0.000995605,0.0016171006,0.000007000505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.55861115,0.060883116,0.040537164,0.0030295576,0.021386089,0.00055682025,0.002560172,0.00044601032,0.07143686,0.0013109581,0.054090198,0.18515189],"study_design_scores_gemma":[0.8062527,0.005260787,0.01150403,0.0006888447,0.003919569,0.000030358782,0.0012360656,0.009136311,0.1267989,0.00015564924,0.034647226,0.0003695593],"about_ca_topic_score_codex":0.0012346121,"about_ca_topic_score_gemma":0.00087495655,"teacher_disagreement_score":0.24764153,"about_ca_system_score_codex":0.0038421669,"about_ca_system_score_gemma":0.023097595,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W3190925155","doi":"10.1158/1557-3265.adi21-po-070","title":"Abstract PO-070: Bimodality of gene expression in cancer patient tumors as interpretable biomarkers for drug sensitivity","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Interpretability; Machine learning; Artificial intelligence; Cancer; Medicine; Computational biology; Computer science; Bioinformatics; Internal medicine; Biology; Pharmacology","score_opus":0.18362114788459208,"score_gpt":0.5302001339865907,"score_spread":0.34657898610199867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190925155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610991,0.000945569,0.033610914,0.002536021,0.0007177312,0.000542742,0.000115347,0.000025530242,0.00040704064],"genre_scores_gemma":[0.9762606,0.00017030364,0.022956008,0.0002085419,0.000112141395,0.0002004429,0.000010186549,0.000016482098,0.0000652938],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944713,0.0021184457,0.00093404134,0.00093291386,0.0009864396,0.0005568329],"domain_scores_gemma":[0.990831,0.0071456106,0.00020658175,0.0007070687,0.0008862975,0.00022341355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007920362,0.00015599745,0.00047063967,0.00019371172,0.000109748005,0.00009627617,0.0005677358,0.000105955434,0.00010960367],"category_scores_gemma":[0.0027200654,0.00014671836,0.00022885425,0.00091747043,0.00027181898,0.00037930635,0.00084052247,0.0005824416,0.00000831341],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024949766,0.003179336,0.07896521,0.0009329934,0.00026741927,0.00047043498,0.003027748,0.054420162,0.1047347,0.0027274115,0.008599763,0.74017984],"study_design_scores_gemma":[0.0020145015,0.00028317986,0.30629912,0.0011232015,0.000010630817,0.000008047935,0.00037377785,0.11470955,0.5531671,0.019760672,0.0017352637,0.00051493867],"about_ca_topic_score_codex":0.0034615954,"about_ca_topic_score_gemma":0.00094309787,"teacher_disagreement_score":0.7396649,"about_ca_system_score_codex":0.00034530225,"about_ca_system_score_gemma":0.0026575022,"threshold_uncertainty_score":0.5983001},"labels":[],"label_agreement":null},{"id":"W3194677003","doi":"10.1158/1078-0432.ccr-20-4504","title":"Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Research UK; Novartis; Pfizer","keywords":"Renal cell carcinoma; Medicine; Oncology; Targeted therapy; Clear cell renal cell carcinoma; Internal medicine; Cancer","score_opus":0.1068312780066365,"score_gpt":0.4086008308021558,"score_spread":0.3017695527955193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194677003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438226,0.0010620332,0.0000017961951,0.0008865905,0.0000886673,0.0010729231,0.000038905862,0.00003163463,0.0024351897],"genre_scores_gemma":[0.9931888,0.00019444834,0.00018362465,0.00034388542,0.00011595814,0.0001626844,0.00015568569,0.00008628613,0.005568632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953798,0.0006802933,0.00064597797,0.0008662292,0.0015620844,0.0008656345],"domain_scores_gemma":[0.99648046,0.00086599257,0.00014666803,0.0007364332,0.001329296,0.0004411613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010057492,0.00030764716,0.0008736728,0.00022194392,0.0001168545,0.00004804952,0.00022060827,0.00023842104,0.0005466747],"category_scores_gemma":[0.00028390947,0.00019255736,0.00019862167,0.0011418762,0.0003380056,0.000083048246,0.00012495877,0.0011964086,0.000047704285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053818733,0.0033370887,0.98726416,0.000049589482,0.00015323069,0.00086416834,0.00014520818,0.000012184714,0.00068265054,8.1057425e-7,0.0011347668,0.00097429164],"study_design_scores_gemma":[0.020419313,0.0067306412,0.9545641,0.00014463472,0.000059870097,0.0000011425708,0.00010245297,0.000026154616,0.017363245,0.000006237378,0.0003619751,0.00022024065],"about_ca_topic_score_codex":0.0006575006,"about_ca_topic_score_gemma":0.00054740265,"teacher_disagreement_score":0.032700043,"about_ca_system_score_codex":0.00052763545,"about_ca_system_score_gemma":0.0013440223,"threshold_uncertainty_score":0.7852261},"labels":[],"label_agreement":null},{"id":"W3194849531","doi":"10.1158/1078-0432.ccr-21-0573","title":"Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Biology; microRNA; PI3K/AKT/mTOR pathway; Wnt signaling pathway; Cancer research; BCL6; Epigenetics; GATA3; Gene expression profiling; Lymphoma; T cell; Protein kinase B; Signal transduction; Immunology; B cell; Gene expression; Transcription factor; Genetics; Gene","score_opus":0.1145110103807511,"score_gpt":0.4535532877613276,"score_spread":0.33904227738057646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194849531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536444,0.01034438,0.000025259771,0.00068676274,0.00011588166,0.00042255575,0.000022363465,0.000011245537,0.0030071365],"genre_scores_gemma":[0.99477524,0.0026580645,0.0015159684,0.00013326253,0.00015272044,0.00012364356,0.000033733973,0.000027189655,0.0005801825],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715847,0.00039348402,0.0007351874,0.00046365216,0.0008635723,0.00038563553],"domain_scores_gemma":[0.9974569,0.0006907138,0.00012974754,0.00059907703,0.000852471,0.0002710844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010176,0.00012775163,0.0005828787,0.00008131918,0.000054986405,0.000011987122,0.00015940334,0.00016260472,0.0006149059],"category_scores_gemma":[0.00068052293,0.00010058103,0.00031276984,0.0003905821,0.00030972352,0.00003652837,0.00022052621,0.00021358985,0.000015639209],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008527385,0.0035369666,0.57820636,0.0005291047,0.00013070973,0.00054667494,0.00011926498,0.000011322006,0.4067546,0.00006168961,0.00039704647,0.008853539],"study_design_scores_gemma":[0.005201483,0.0006129307,0.23107801,0.00030111082,0.00005010548,0.0000045231204,0.00017055708,0.000025481388,0.7609223,0.000082762104,0.0014763133,0.00007438454],"about_ca_topic_score_codex":0.00018119175,"about_ca_topic_score_gemma":0.0000141510445,"teacher_disagreement_score":0.35416773,"about_ca_system_score_codex":0.00023926387,"about_ca_system_score_gemma":0.0013302233,"threshold_uncertainty_score":0.67327887},"labels":[],"label_agreement":null},{"id":"W3197412385","doi":"10.1158/1078-0432.ccr-21-1864","title":"Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous <i>KIT/PDGFRA</i> Mutations in the Phase III INVICTUS Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; U.S. Food and Drug Administration; Deciphera Pharmaceuticals","keywords":"PDGFRA; Medicine; Exon; GiST; Internal medicine; Stromal tumor; Placebo; Tyrosine-kinase inhibitor; Mutation; Oncology; Gastroenterology; Cancer research; Pathology; Stromal cell; Biology; Cancer; Genetics; Gene","score_opus":0.14031149998290443,"score_gpt":0.5113444287207737,"score_spread":0.37103292873786925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197412385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996844,0.00009643274,0.000021367307,0.0004340328,0.000052227984,0.002295741,0.00005904079,0.000016236929,0.00018090715],"genre_scores_gemma":[0.9983512,0.00002846019,0.0008881739,0.000078984485,0.00011258868,0.00044424448,0.000031548672,0.000033376124,0.000031426825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99289095,0.0023799245,0.0012623168,0.0008549411,0.0016845189,0.0009273444],"domain_scores_gemma":[0.9944896,0.0030564324,0.0002142538,0.00079730817,0.0009875537,0.00045481382],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004106299,0.00024479156,0.0008545095,0.0002250085,0.00011798903,0.00004148253,0.00036100645,0.000045356115,0.00014983026],"category_scores_gemma":[0.0044834316,0.00016734478,0.0001943443,0.0011565171,0.0007132885,0.000107940614,0.00024997082,0.002342203,0.000012493287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014717489,0.023681762,0.9442618,0.000065251945,0.000069069356,0.00421814,0.00012215554,0.00006172303,0.00013368511,0.00000348948,0.000028260787,0.012637199],"study_design_scores_gemma":[0.036846913,0.026712842,0.9342983,0.0006768672,0.00005098203,0.000091812326,0.0006489751,0.00019658296,0.00030737175,0.000020425949,0.000036580248,0.00011235195],"about_ca_topic_score_codex":0.00060291094,"about_ca_topic_score_gemma":0.0019841874,"teacher_disagreement_score":0.022129424,"about_ca_system_score_codex":0.0002507617,"about_ca_system_score_gemma":0.0014703468,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W3197498721","doi":"10.1158/1078-0432.ccr-21-0261","title":"Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company","keywords":"Antibody; Cancer; Combination therapy; Microsatellite; Immunotherapy; Clinical trial","score_opus":0.05442876539091771,"score_gpt":0.44188418583987726,"score_spread":0.38745542044895953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197498721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965103,0.0008432282,0.000020052748,0.00097369635,0.000079225494,0.0013575116,0.00004809286,0.000024093206,0.00014378168],"genre_scores_gemma":[0.99572265,0.0035026048,0.00020850718,0.00017998129,0.000027327056,0.000035300538,0.000094077346,0.00003800133,0.00019152461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961414,0.0007147439,0.0008884938,0.0008183777,0.0009151222,0.0005218854],"domain_scores_gemma":[0.99773073,0.0006005766,0.00019673302,0.00061405386,0.0006985078,0.00015939628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028882362,0.00022447265,0.00086405076,0.00029476872,0.00009386234,0.000034875764,0.00014112663,0.00017028493,0.00019611215],"category_scores_gemma":[0.00031203887,0.00015525639,0.00009818825,0.0017399102,0.00096154644,0.00016514218,0.00009748605,0.0008284141,0.0000021442006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109439075,0.0032885144,0.86147994,0.00036277558,0.00011058915,0.00013554902,0.00035819298,0.000007749352,0.010356427,0.00003006306,0.000010415239,0.014420721],"study_design_scores_gemma":[0.021469865,0.0047164815,0.96311647,0.0015994108,0.000018696779,0.000008885331,0.0002461072,0.00009517681,0.007890589,0.000023139848,0.000620967,0.00019421618],"about_ca_topic_score_codex":0.0041910363,"about_ca_topic_score_gemma":0.0021791705,"teacher_disagreement_score":0.10163654,"about_ca_system_score_codex":0.0003595045,"about_ca_system_score_gemma":0.0015541697,"threshold_uncertainty_score":0.6335621},"labels":[],"label_agreement":null},{"id":"W3198912637","doi":"10.1158/1078-0432.ccr-21-1466","title":"FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Food and Drug Administration; National Institutes of Health","keywords":"Nivolumab; Ipilimumab; Regimen; Pemetrexed; Carboplatin; Gemcitabine; Chemotherapy regimen; Clinical trial","score_opus":0.17917776392836887,"score_gpt":0.4791178402547532,"score_spread":0.2999400763263843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198912637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916177,0.0034638932,0.0000266718,0.003271951,0.000077158234,0.0009450001,0.00009688684,0.0000071444188,0.00049362256],"genre_scores_gemma":[0.99244094,0.0025478872,0.00016085543,0.000076049124,0.00012152652,0.0004809532,0.000091655034,0.000016877324,0.004063274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984528,0.00016743458,0.0003091704,0.00028606912,0.0005224987,0.00026207155],"domain_scores_gemma":[0.99820334,0.0012103716,0.00004445027,0.00026697488,0.00017380634,0.00010104983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053023035,0.00008469468,0.00026124046,0.000059218684,0.00008928431,0.000012503271,0.0000849791,0.00005441654,0.0002791905],"category_scores_gemma":[0.0001665008,0.000048400027,0.000115309784,0.00031801147,0.0003258179,0.00004082827,0.000036172903,0.00013133528,0.000005905666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021036051,0.0074928296,0.90253276,0.0003037992,0.0003224838,0.000098971665,0.0001899804,0.00014514489,0.0019720127,0.00069622515,0.002832003,0.06237772],"study_design_scores_gemma":[0.014562472,0.007519382,0.95165837,0.00025087624,0.000118282354,0.000007169926,0.00057879253,0.0021588905,0.0059879343,0.00065558264,0.016393807,0.00010845381],"about_ca_topic_score_codex":0.000645914,"about_ca_topic_score_gemma":0.000733043,"teacher_disagreement_score":0.062269267,"about_ca_system_score_codex":0.00027651817,"about_ca_system_score_gemma":0.0005097092,"threshold_uncertainty_score":0.30569404},"labels":[],"label_agreement":null},{"id":"W3198937635","doi":"10.1158/1078-0432.ccr-21-1834","title":"Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"Medical Research Council; University College London; Barts Health NHS Trust; Cancer Research UK; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Royal Marsden NHS Foundation Trust; King's College London; Queen Mary University of London","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); NODAL; Radiology; Nuclear medicine; Cervical cancer; Prospective cohort study; Neuroradiology; Carcinoma; Diffusion MRI; PET-CT; Cancer; Histology; Positron emission tomography; Magnetic resonance imaging; Internal medicine","score_opus":0.10909551798548808,"score_gpt":0.4453468425651754,"score_spread":0.3362513245796873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198937635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076223,0.006865119,0.0000029872315,0.000864481,0.00018513264,0.00093733,0.0001418909,0.000013846499,0.00022698299],"genre_scores_gemma":[0.9849688,0.01436747,0.000094211544,0.000058329275,0.0001849363,0.00016919502,0.00004926087,0.000028752349,0.000079045596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476504,0.0014049727,0.0014715942,0.00080219883,0.00097838,0.0005778326],"domain_scores_gemma":[0.97656333,0.021835359,0.00020279478,0.00040636264,0.0005251036,0.00046702032],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021294795,0.00025400586,0.0014257974,0.0008064587,0.00006764821,0.000027782624,0.00015234509,0.000032620897,0.0006338224],"category_scores_gemma":[0.015443156,0.00019669028,0.00022080961,0.0032810478,0.00061130803,0.000109894965,0.00035252044,0.00095318607,0.0000039959327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008793111,0.0022724334,0.9414262,0.0005170791,0.00017818047,0.010835632,0.000027927103,0.0000016995571,0.0034520207,0.00004366462,0.000024867171,0.032427162],"study_design_scores_gemma":[0.037875354,0.002428494,0.93382025,0.00056155503,0.0002127043,0.00057536736,0.00015701709,0.0002329099,0.022930827,0.00030371797,0.0006893282,0.00021248632],"about_ca_topic_score_codex":0.010035521,"about_ca_topic_score_gemma":0.0043882295,"teacher_disagreement_score":0.032214675,"about_ca_system_score_codex":0.00023489352,"about_ca_system_score_gemma":0.0005834974,"threshold_uncertainty_score":0.99655676},"labels":[],"label_agreement":null},{"id":"W3200301921","doi":"10.1158/1078-0432.ccr-21-1157","title":"Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Science Fund for Distinguished Young Scholars; Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Epigenome; Immune system; Intrahepatic Cholangiocarcinoma; Genetic heterogeneity; Cancer; Immunotherapy","score_opus":0.17541128769535624,"score_gpt":0.4786505103527479,"score_spread":0.30323922265739167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200301921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97180325,0.025018781,0.000014509553,0.0022277175,0.00017568209,0.00050456723,0.00005223909,0.000030412551,0.00017282058],"genre_scores_gemma":[0.9966117,0.0019751047,0.00022556288,0.00040730674,0.0003216668,0.00015783227,0.000063292064,0.000029967096,0.00020755203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597955,0.0008228585,0.0009471257,0.0009514679,0.00061738404,0.00068162446],"domain_scores_gemma":[0.9966688,0.001454905,0.00010586712,0.00066968525,0.00073600817,0.00036470065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001380379,0.00023932192,0.0012255275,0.00038904906,0.00018303053,0.000064442516,0.00017478067,0.00014792872,0.00018129508],"category_scores_gemma":[0.0012683539,0.00020889552,0.0004204395,0.0016735512,0.00069815834,0.00007432097,0.0004438261,0.001109529,0.00002901643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006847401,0.00036998506,0.98867357,0.00021446978,0.0009158413,0.0007586598,0.00022879946,0.000005103833,0.002256806,0.000013427744,0.0003102141,0.0055683553],"study_design_scores_gemma":[0.0031090793,0.00027538254,0.9929747,0.00016397325,0.00044179492,0.000031555744,0.00033481495,0.00076206075,0.0011512121,0.000059084527,0.0004986253,0.0001977368],"about_ca_topic_score_codex":0.0025355392,"about_ca_topic_score_gemma":0.008653271,"teacher_disagreement_score":0.024808446,"about_ca_system_score_codex":0.0002692081,"about_ca_system_score_gemma":0.00038097732,"threshold_uncertainty_score":0.8518512},"labels":[],"label_agreement":null},{"id":"W3201084964","doi":"10.1158/1078-0432.ccr-21-1504","title":"First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center; National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute; Eli Lilly and Company","keywords":"Gemcitabine; Pancreatic cancer; Cancer; Phases of clinical research; Receptor; Pancreatic disease; Chemotherapy","score_opus":0.16789559233049986,"score_gpt":0.4950953371301059,"score_spread":0.327199744799606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201084964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972415,0.0017222116,0.000003969454,0.00012080902,0.00016947376,0.0006662917,0.000053711326,0.0000057068355,0.000016321854],"genre_scores_gemma":[0.99836373,0.00036359424,0.00011966117,0.000069408175,0.00031624327,0.00044183794,0.00014815458,0.000033964596,0.00014342884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970818,0.00055604544,0.0006975596,0.0007190273,0.0005517364,0.00039384156],"domain_scores_gemma":[0.99827796,0.000094217656,0.00011699761,0.0005325612,0.0008188608,0.0001594223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007334059,0.00015323846,0.00033528195,0.00007816227,0.000102110855,0.00003156821,0.00027472473,0.00014667989,0.0002910176],"category_scores_gemma":[0.0006774716,0.00013994066,0.00005865152,0.00051797205,0.00020739897,0.000014022963,0.00020314103,0.00039536713,0.0000031603286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002118733,0.009384901,0.92767215,0.0000705225,0.000082799444,0.000016934755,0.00020862509,0.001197859,0.047877114,0.000002126441,0.0029682228,0.0084],"study_design_scores_gemma":[0.06726506,0.017995426,0.6201123,0.00092194154,0.00006609539,4.0248045e-7,0.0013858099,0.00021338808,0.2628454,0.000026242766,0.028079374,0.0010885611],"about_ca_topic_score_codex":0.00046496358,"about_ca_topic_score_gemma":0.011475277,"teacher_disagreement_score":0.30755985,"about_ca_system_score_codex":0.00010171154,"about_ca_system_score_gemma":0.00075033936,"threshold_uncertainty_score":0.6403474},"labels":[],"label_agreement":null},{"id":"W3201522366","doi":"10.1158/1078-0432.ccr-21-2681","title":"Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma","year":2021,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Immunotherapy; Clinical trial; Glioblastoma; Medicine; Evasion (ethics); Immunosuppression; Immune system; Immunology; Cancer research; Internal medicine","score_opus":0.7811385410991778,"score_gpt":0.7086286206520389,"score_spread":0.07250992044713889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201522366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048364007,0.9788498,0.0044404725,0.0015945882,0.0018176516,0.0128668705,0.00029457154,0.000052126696,0.000035513476],"genre_scores_gemma":[0.000031469426,0.96348506,0.011720668,0.00028817198,0.0039491937,0.019651933,0.0003171115,0.00019503203,0.00036136442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98554826,0.006581248,0.0046709995,0.001401608,0.0008986147,0.0008992438],"domain_scores_gemma":[0.867818,0.12753151,0.0011333218,0.0011168342,0.001864453,0.0005358887],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04820959,0.0004936422,0.007566102,0.00039384392,0.0003164222,0.00017435441,0.00042707386,0.001808422,0.0003851488],"category_scores_gemma":[0.0695774,0.00034987682,0.0056528253,0.00084638136,0.00037938228,0.0000473695,0.00015140264,0.0022669819,0.00005169589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013718393,0.0020975205,0.00013340464,0.007466665,0.0025471044,0.000044745135,0.000013755006,9.1024944e-8,5.6127874e-7,0.0021813808,0.023760708,0.9603822],"study_design_scores_gemma":[0.007578001,0.005444721,0.000030058962,0.0368252,0.0023496759,0.000010362442,0.00002793359,0.00001754312,0.000019605108,0.0023403896,0.9450697,0.00028684942],"about_ca_topic_score_codex":0.000022091717,"about_ca_topic_score_gemma":0.000012687689,"teacher_disagreement_score":0.9600954,"about_ca_system_score_codex":0.0005280216,"about_ca_system_score_gemma":0.0039857086,"threshold_uncertainty_score":0.99989533},"labels":[],"label_agreement":null},{"id":"W3202236569","doi":"10.1158/1078-0432.ccr-21-1181","title":"Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody–drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre","funders":"Ono Pharmaceutical; Università degli Studi di Milano; Bristol-Myers Squibb","keywords":"Nivolumab; Maximum tolerated dose; Clinical trial; Solid tumor; Immunotherapy; Phases of clinical research; Cytotoxic T cell","score_opus":0.14198669748668777,"score_gpt":0.559179952943152,"score_spread":0.41719325545646424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202236569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994075,0.00028437155,0.00001529737,0.0017430076,0.00019057651,0.0032598716,0.00009350176,0.000030805728,0.00030757493],"genre_scores_gemma":[0.9967209,0.0010386829,0.00046558256,0.00019612037,0.0002154651,0.00034365468,0.0002290838,0.00009896249,0.00069153594],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99131846,0.0019053859,0.0017433604,0.0011534652,0.0027766072,0.0011027025],"domain_scores_gemma":[0.9942938,0.0013591697,0.00029302962,0.0010760658,0.002414386,0.00056354055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061661736,0.00029803065,0.0015086611,0.000643865,0.00010205536,0.000057631416,0.00046567063,0.00022526542,0.0007845024],"category_scores_gemma":[0.0030453352,0.00022032617,0.00010545052,0.0027724775,0.0010937267,0.00033669884,0.00021372289,0.0021680456,0.000020426089],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42115337,0.024596613,0.5117179,0.0006555646,0.00012712885,0.0011163111,0.0004590781,0.00008540271,0.0017704631,0.000039673498,0.0005393014,0.03773921],"study_design_scores_gemma":[0.5910782,0.050065637,0.3415013,0.0037255164,0.000046832465,0.00001032217,0.00078426616,0.0008759049,0.010085095,0.00009330082,0.0012514195,0.00048220478],"about_ca_topic_score_codex":0.001685918,"about_ca_topic_score_gemma":0.0066113574,"teacher_disagreement_score":0.17021662,"about_ca_system_score_codex":0.00061278313,"about_ca_system_score_gemma":0.0063776877,"threshold_uncertainty_score":0.99925524},"labels":[],"label_agreement":null},{"id":"W3202714042","doi":"10.1158/1078-0432.ccr-19-2384","title":"HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto; Princess Margaret Cancer Foundation; Cancer Research Society; Conquer Cancer Foundation","keywords":"Digital polymerase chain reaction; Genotyping; Oncology; Medicine; Internal medicine; Cancer; Cervical cancer; DNA sequencing; Liquid biopsy; DNA; Genotype; Polymerase chain reaction; Biology; Gene; Genetics","score_opus":0.15038175896277925,"score_gpt":0.4312074346837192,"score_spread":0.28082567572093997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202714042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436514,0.0109757595,0.00040392706,0.03670511,0.0021197083,0.0010810752,0.0017158382,0.000026389675,0.0033207906],"genre_scores_gemma":[0.93337214,0.005082596,0.00015593896,0.04905259,0.010285174,0.00015779497,0.0009360819,0.000115982984,0.0008416925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99608725,0.0007357814,0.00087165943,0.0010207649,0.00061393843,0.00067062746],"domain_scores_gemma":[0.9962235,0.0013544803,0.0002803723,0.00073135557,0.0012720323,0.00013824362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016964193,0.0002752038,0.0005955276,0.000120224606,0.00015296649,0.000060962626,0.00033339064,0.0008589451,0.00021350225],"category_scores_gemma":[0.0043228287,0.00028906326,0.00041888253,0.00027712094,0.00059306715,0.0000044315234,0.0003433682,0.0022615704,0.00001339955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032274268,0.00009546828,0.0011556922,0.0010235024,0.0006391361,0.0008524441,0.00017392618,0.00023434786,0.69329774,0.000008345174,0.24952222,0.052674405],"study_design_scores_gemma":[0.0009704518,0.00096627994,0.0021527654,0.0002409723,0.000100461686,0.000046887697,0.0004790622,0.00014266717,0.53108656,0.0001958961,0.46292543,0.00069256884],"about_ca_topic_score_codex":0.0012043947,"about_ca_topic_score_gemma":0.0005074023,"teacher_disagreement_score":0.2134032,"about_ca_system_score_codex":0.00026444555,"about_ca_system_score_gemma":0.0019293149,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W3202810469","doi":"10.1158/1078-0432.ccr-21-1942","title":"Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Advancing Health Outcomes; McMaster University Medical Centre; Queen's University; University of British Columbia","funders":"Canadian Cancer Society","keywords":"Breast cancer; Tamoxifen; Anthracycline; Internal medicine; Basal (medicine); Oncology; Medicine; Nestin; Placebo; Chemotherapy; Cancer; Tissue microarray; Biology; Pathology","score_opus":0.41819848585384484,"score_gpt":0.5558475683230675,"score_spread":0.13764908246922264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202810469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7840955,0.03532743,0.00062499184,0.04032079,0.004212223,0.0072217714,0.12784362,0.000045322668,0.0003083211],"genre_scores_gemma":[0.9383037,0.04618159,0.0009837153,0.0017400556,0.0067282473,0.0039135464,0.0014611033,0.00009891689,0.0005891059],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98526025,0.008184495,0.0030734676,0.0018081391,0.0007108086,0.00096286455],"domain_scores_gemma":[0.98380286,0.011649557,0.00096928235,0.0011872755,0.0015516084,0.0008394228],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.025713501,0.00042245214,0.0021797733,0.000077088065,0.00060159265,0.00012382037,0.00069358223,0.0006716853,0.00025518407],"category_scores_gemma":[0.012732087,0.00030276965,0.0007140789,0.0003349984,0.0016560161,0.000025130443,0.0003676595,0.0008032925,0.0000017505487],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26926765,0.0033295606,0.043236542,0.0002019244,0.01148158,0.000101526224,0.0010549565,0.00042683855,0.013068785,0.00015024199,0.15479524,0.50288516],"study_design_scores_gemma":[0.32506305,0.008240528,0.38104218,0.0017491062,0.005313458,0.000026574566,0.0049241534,0.0033543694,0.0348213,0.002801561,0.22979172,0.002872005],"about_ca_topic_score_codex":0.2849095,"about_ca_topic_score_gemma":0.53515494,"teacher_disagreement_score":0.5000131,"about_ca_system_score_codex":0.00030528783,"about_ca_system_score_gemma":0.006169771,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W3204661301","doi":"10.1158/1078-0432.ccr-21-2160","title":"First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Merck","keywords":"Pembrolizumab; Immunotherapy; Antibody; Mechanism (biology); Cancer; Mechanism of action; Inflammation; Tumor cells","score_opus":0.058578049202519425,"score_gpt":0.41581195227931544,"score_spread":0.35723390307679603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204661301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98140913,0.011483571,0.00003581178,0.004207513,0.00066019065,0.0014061425,0.00012276725,0.000056465506,0.00061840616],"genre_scores_gemma":[0.9785079,0.017880518,0.0004965853,0.000718562,0.00018648256,0.00023643715,0.00010707363,0.000092208764,0.0017742559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938823,0.0005759504,0.0014613243,0.0013033209,0.0014915306,0.0012855759],"domain_scores_gemma":[0.99697465,0.0006570377,0.00017921907,0.0010358095,0.00083434157,0.0003189274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023210766,0.00038289564,0.0011750759,0.00037474954,0.0002237091,0.00007238849,0.0004743231,0.00032617807,0.0008416321],"category_scores_gemma":[0.00029169949,0.0003270262,0.00028543506,0.0022744164,0.0007044917,0.0002230535,0.00012085207,0.001783122,0.000043486343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116329044,0.0069708438,0.79365844,0.0015316358,0.00070031977,0.0029031604,0.0017054506,0.0000956583,0.041274853,0.00052505324,0.005529503,0.02877604],"study_design_scores_gemma":[0.026144313,0.0016835502,0.89050835,0.0035615258,0.000028669287,0.000006676451,0.0006381433,0.000043639524,0.006557407,0.00031061273,0.070006035,0.00051105436],"about_ca_topic_score_codex":0.00034372264,"about_ca_topic_score_gemma":0.0047794576,"teacher_disagreement_score":0.09684993,"about_ca_system_score_codex":0.00078608585,"about_ca_system_score_gemma":0.0013179018,"threshold_uncertainty_score":0.99991816},"labels":[],"label_agreement":null},{"id":"W3207287416","doi":"10.1158/1078-0432.ccr-21-0158","title":"Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Carboplatin; Chemotherapy; Toxicity; Phases of clinical research; Combination chemotherapy","score_opus":0.247773716913073,"score_gpt":0.5161284923830547,"score_spread":0.26835477546998165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207287416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98660713,0.0005617847,0.0000027160183,0.007190701,0.00017508908,0.0042649903,0.00018288387,0.000041285082,0.0009733993],"genre_scores_gemma":[0.99114126,0.0009945056,0.0011612992,0.0020277433,0.00045517046,0.002192685,0.00014165991,0.0001338727,0.0017517874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939768,0.0007484853,0.0009836869,0.0015798799,0.0017310081,0.000980181],"domain_scores_gemma":[0.9961293,0.0005549563,0.00017340922,0.0012459011,0.0011286152,0.0007678404],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015351317,0.00041877688,0.0012575071,0.00017252461,0.00041868686,0.00021367798,0.0005649185,0.00019676327,0.0023431706],"category_scores_gemma":[0.00018814937,0.00026975363,0.000050017625,0.0013916062,0.00036468983,0.0003322559,0.00041804538,0.0012287188,0.0000078806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09804856,0.07239356,0.7175564,0.00013704243,0.0008830558,0.001962785,0.0007494324,0.000008527328,0.0000712174,0.00003625921,0.0018360944,0.106317036],"study_design_scores_gemma":[0.13317855,0.10026809,0.75388193,0.00085224805,0.00017570393,0.0000061700875,0.00042465792,0.000042730455,0.00016964033,0.000013279204,0.0106133595,0.00037364618],"about_ca_topic_score_codex":0.0056085843,"about_ca_topic_score_gemma":0.035264082,"teacher_disagreement_score":0.10594339,"about_ca_system_score_codex":0.0012058929,"about_ca_system_score_gemma":0.006286513,"threshold_uncertainty_score":0.99997544},"labels":[],"label_agreement":null},{"id":"W3207996654","doi":"10.1158/1078-0432.ccr-21-0299","title":"Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Fundamental Research Funds for the Central Universities; National Key Research and Development Program of China; East China Normal University; China Postdoctoral Science Foundation; Chinese Academy of Sciences; Government of Jiangxi Province; Shanghai Municipal Education Commission; National Natural Science Foundation of China","keywords":"Prostate cancer; Immunotherapy; Prostate; Immune system; Infiltration (HVAC); Tumor microenvironment; Cancer immunotherapy","score_opus":0.1351798117403934,"score_gpt":0.46384618897005325,"score_spread":0.32866637722965986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207996654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94609046,0.04663979,0.00035951068,0.0027272264,0.0014467569,0.0010816145,0.00013490954,0.000050220544,0.0014695241],"genre_scores_gemma":[0.95110935,0.007577426,0.0014990348,0.0010645408,0.00033816582,0.00074357673,0.000111695335,0.000071350325,0.037484888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959354,0.0011342625,0.0008650517,0.0009649173,0.00019055977,0.0009098396],"domain_scores_gemma":[0.99587286,0.0020493504,0.00018574604,0.00068362954,0.0011025766,0.00010581797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034454882,0.00023678187,0.00070278713,0.00030193102,0.00048080063,0.00010921755,0.00027623153,0.00039544384,0.00086450536],"category_scores_gemma":[0.0008066236,0.00023589104,0.0002667772,0.0011874426,0.00036490557,0.00011983442,0.0002513941,0.000988447,0.000093617826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015586211,0.00024370143,0.017940786,0.0001402944,0.0006341414,0.000019212512,0.0013767737,0.00019188474,0.94726384,0.00004031765,0.0070816986,0.023508754],"study_design_scores_gemma":[0.0033794942,0.0009119836,0.004326522,0.00015880833,0.00020192063,0.000007072469,0.00062042696,0.000029278197,0.68857455,0.00039858907,0.30096468,0.0004266805],"about_ca_topic_score_codex":0.001215595,"about_ca_topic_score_gemma":0.00047096616,"teacher_disagreement_score":0.293883,"about_ca_system_score_codex":0.00045502727,"about_ca_system_score_gemma":0.0011060416,"threshold_uncertainty_score":0.96193576},"labels":[],"label_agreement":null},{"id":"W3209155643","doi":"10.1158/1078-0432.ccr-21-2057","title":"Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Canada's Michael Smith Genome Sciences Centre; Children's & Women's Health Centre of British Columbia; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; University of British Columbia; Russian Science Foundation; Hannah's Heroes Foundation; Stand Up To Cancer; Killam Trusts; Entertainment Industry Foundation; St. Baldrick's Foundation; American Association for Cancer Research","keywords":"Medulloblastoma; Risk stratification; Immunohistochemistry; Outcome (game theory); Profiling (computer programming)","score_opus":0.26778158282489006,"score_gpt":0.5644021618732276,"score_spread":0.2966205790483375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209155643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356925,0.00014728478,0.000010910716,0.002349672,0.0004223926,0.0019291718,0.000056116252,0.000024717412,0.0014904704],"genre_scores_gemma":[0.99750054,0.00028380787,0.00027438233,0.0004131462,0.00030016093,0.00079427345,0.000029100887,0.00004351639,0.00036108232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940766,0.00077295164,0.001980504,0.00093204057,0.0016012072,0.00063667883],"domain_scores_gemma":[0.9937557,0.0038046355,0.00016856614,0.00094039214,0.00086321676,0.0004674732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005913907,0.00022326829,0.0010967184,0.0003466184,0.000090475754,0.000030782994,0.00022329325,0.00029282208,0.00070671196],"category_scores_gemma":[0.0043523475,0.00017849216,0.0003674557,0.0010618113,0.00025993236,0.0000632646,0.00014590003,0.0014154033,0.00008483903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026087516,0.02194037,0.9595229,0.000111924506,0.0002084596,0.0009887497,0.00012259808,0.00015908937,0.0005739125,0.000003310982,0.0010548811,0.012705055],"study_design_scores_gemma":[0.015856612,0.0076069883,0.96715933,0.00052265474,0.00014304616,0.0000031918903,0.00044496066,0.0058353143,0.0018561366,0.000013590477,0.0004451748,0.00011299945],"about_ca_topic_score_codex":0.0011537892,"about_ca_topic_score_gemma":0.0011500895,"teacher_disagreement_score":0.01433338,"about_ca_system_score_codex":0.00036142176,"about_ca_system_score_gemma":0.0013397506,"threshold_uncertainty_score":0.7738},"labels":[],"label_agreement":null},{"id":"W3211458171","doi":"10.1158/1078-0432.ccr-21-1688","title":"Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute; Merck KGaA; Pfizer","keywords":"Medicine; Avelumab; Axitinib; Sunitinib; Internal medicine; Renal cell carcinoma; Renal carcinoma; Oncology; Lymphocyte; Gastroenterology; Urology; Nivolumab; Immunotherapy; Cancer","score_opus":0.08944128772444122,"score_gpt":0.41519119164430157,"score_spread":0.32574990391986036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211458171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993577,0.0002791127,0.00001676953,0.0017086288,0.000093159186,0.0036191936,0.00010904753,0.000009090776,0.00058802095],"genre_scores_gemma":[0.9977685,0.00017630434,0.00028792172,0.00014519368,0.00030571246,0.00045019572,0.00025305868,0.000049091715,0.0005640134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929807,0.0016705333,0.0016743621,0.0007593253,0.0022109053,0.0007041346],"domain_scores_gemma":[0.99312174,0.0035765425,0.0005325777,0.00081929436,0.0016685679,0.00028124824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033848258,0.00029523697,0.0012516053,0.00037924797,0.00009180331,0.00002725523,0.00033458316,0.00022712366,0.00025108084],"category_scores_gemma":[0.0021056822,0.00019297704,0.00021466146,0.0016877732,0.00025088975,0.00008448223,0.00013362287,0.0011155485,0.00001092012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7583847,0.010353884,0.21747263,0.00028690355,0.0002122183,0.0006226594,0.0013589481,0.002078324,0.00075061416,0.000009628455,0.00043079647,0.008038707],"study_design_scores_gemma":[0.49512008,0.030021923,0.45711637,0.0005917052,0.00017224601,0.0000035624996,0.00022085688,0.00029897326,0.01565356,0.000008211687,0.00057402067,0.00021849675],"about_ca_topic_score_codex":0.000683866,"about_ca_topic_score_gemma":0.0016802668,"teacher_disagreement_score":0.26326463,"about_ca_system_score_codex":0.0012802839,"about_ca_system_score_gemma":0.0031769532,"threshold_uncertainty_score":0.78693753},"labels":[],"label_agreement":null},{"id":"W4200069316","doi":"10.1158/1078-0432.ccr-21-3032","title":"Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Novartis Institutes for BioMedical Research; Astex Pharmaceuticals; Novartis Pharmaceuticals Corporation","keywords":"Overall survival; Randomized controlled trial; Endocrine system; Clinical trial; Breast cancer; Cancer","score_opus":0.12727510173342405,"score_gpt":0.5170188085085538,"score_spread":0.3897437067751297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200069316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97959673,0.011444998,0.000018931836,0.0024137388,0.00093087705,0.005080567,0.0003406804,0.000052714415,0.000120745906],"genre_scores_gemma":[0.9586929,0.037614033,0.00033131253,0.0003170473,0.0008100839,0.0015091414,0.00017650137,0.00013137826,0.00041758866],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98894805,0.0035277414,0.002920198,0.0015717287,0.0017566711,0.001275609],"domain_scores_gemma":[0.9914144,0.005003305,0.00058074715,0.0009530833,0.0014626784,0.00058573374],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004591967,0.00059356855,0.0036760513,0.0003670712,0.00010677682,0.000046091114,0.00041135217,0.00027448818,0.0014615267],"category_scores_gemma":[0.0011455237,0.00044985552,0.00036353283,0.0012026199,0.002015034,0.00034224568,0.00027961252,0.0023050783,0.0000028689212],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8002751,0.0052463436,0.053089235,0.000058881607,0.00084181735,0.00023228052,0.000283044,0.000101707345,0.00092350703,0.00005458034,0.000032365893,0.13886115],"study_design_scores_gemma":[0.85868305,0.006350848,0.13048802,0.00041561585,0.000070674236,0.000011793826,0.00012646226,0.00025280245,0.00085772714,0.0001024411,0.0022464346,0.00039415582],"about_ca_topic_score_codex":0.00319495,"about_ca_topic_score_gemma":0.002516824,"teacher_disagreement_score":0.138467,"about_ca_system_score_codex":0.00060535036,"about_ca_system_score_gemma":0.0028770396,"threshold_uncertainty_score":0.99999666},"labels":[],"label_agreement":null},{"id":"W4200169768","doi":"10.1158/1078-0432.ccr-21-3762","title":"Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"Prostate cancer; DNA methylation; Methylation; DNA; Prostate; PCA3; Cancer","score_opus":0.2299962849316558,"score_gpt":0.5587790777569874,"score_spread":0.3287827928253316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200169768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455202,0.017645277,0.00011010997,0.023587503,0.0005933159,0.001528331,0.00014007563,0.00013812915,0.010737051],"genre_scores_gemma":[0.91472155,0.050520048,0.0007198025,0.0005794413,0.00094110245,0.0007832723,0.00016445619,0.00007483911,0.03149552],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99413866,0.00074869546,0.0009887951,0.0010523632,0.0017880717,0.0012834412],"domain_scores_gemma":[0.99464244,0.0016593183,0.00016747828,0.0012348634,0.0017432389,0.0005526853],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016264401,0.00027712886,0.0008817541,0.0003947943,0.00043638906,0.0001421829,0.00039544055,0.00014240065,0.00242108],"category_scores_gemma":[0.0026211224,0.00022112147,0.00044261542,0.004331041,0.0004771828,0.0002784144,0.00061080384,0.0017122849,0.00009488864],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076826876,0.0018130105,0.46708247,0.0021871096,0.004915697,0.0044069723,0.0018233623,0.00038399553,0.0359141,0.00013092809,0.02806517,0.4455945],"study_design_scores_gemma":[0.017058004,0.002123719,0.17209256,0.00047462079,0.002279706,0.000035517834,0.00115944,0.0013667234,0.6364155,0.0015404538,0.16474788,0.00070591737],"about_ca_topic_score_codex":0.0017416724,"about_ca_topic_score_gemma":0.0028476864,"teacher_disagreement_score":0.60050136,"about_ca_system_score_codex":0.0006677393,"about_ca_system_score_gemma":0.0031602536,"threshold_uncertainty_score":0.99849087},"labels":[],"label_agreement":null},{"id":"W4200186763","doi":"10.1158/1078-0432.ccr-21-3329","title":"Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck","keywords":"Pembrolizumab; Biology; Cancer research; Oncology; Angiogenesis; Internal medicine; Cancer; Medicine; Immunotherapy; Genetics","score_opus":0.2046272144022776,"score_gpt":0.5705772446636609,"score_spread":0.3659500302613833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200186763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911678,0.0035807493,0.000013183259,0.004009355,0.00042957845,0.00049373694,0.00008549199,0.00002540808,0.0001947212],"genre_scores_gemma":[0.99176246,0.002255149,0.00014500714,0.0014934698,0.00030096993,0.00011177522,0.0000032213109,0.00004527983,0.0038826477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99654454,0.00073997525,0.0008388556,0.00054131536,0.0006927658,0.00064254267],"domain_scores_gemma":[0.9973509,0.000859788,0.00008135725,0.00068617245,0.00070221105,0.00031960855],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039585074,0.00015014768,0.00065608614,0.00011845311,0.00012544663,0.00003314955,0.0002750625,0.00015244416,0.0011594165],"category_scores_gemma":[0.00093653373,0.0001273407,0.0003378305,0.0007770016,0.0004984604,0.000051190767,0.00008155576,0.0005656156,0.000059228732],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26915067,0.00078624656,0.107024066,0.00025527444,0.00031679097,0.00037667304,0.0014967395,0.0000039167167,0.4712641,0.0000056345575,0.00532274,0.14399713],"study_design_scores_gemma":[0.013013328,0.0032706705,0.5284836,0.0007171267,0.00003802354,0.0000742333,0.00057474425,0.000084065374,0.38143098,0.000065374465,0.07199391,0.00025393415],"about_ca_topic_score_codex":0.00036329537,"about_ca_topic_score_gemma":0.0008933676,"teacher_disagreement_score":0.42145956,"about_ca_system_score_codex":0.00020820647,"about_ca_system_score_gemma":0.001881987,"threshold_uncertainty_score":0.99975365},"labels":[],"label_agreement":null},{"id":"W4200296775","doi":"10.1158/1078-0432.ccr-21-1798","title":"ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NorQuest College","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; NIH Clinical Center; National Institutes of Health","keywords":"Pancreatic cancer; Ovarian cancer; Medicine; Antibody; Cancer; Cancer research; Radioimmunotherapy; Oncology; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.11579354080471728,"score_gpt":0.4892384749472916,"score_spread":0.37344493414257435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200296775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850747,0.011455629,0.0004944591,0.0014615919,0.00007456979,0.00041155552,0.00007907778,0.000007289366,0.0009411419],"genre_scores_gemma":[0.98931617,0.007065264,0.00044723004,0.00021350586,0.00020112986,0.00013960467,0.000080184844,0.000031226667,0.0025056805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976266,0.00042259178,0.00039201268,0.0005608866,0.0005450792,0.00045283872],"domain_scores_gemma":[0.9980254,0.00016711056,0.00007773677,0.0005511207,0.000986897,0.00019172466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013306282,0.00013711215,0.00031118692,0.00007531059,0.00013387218,0.000049686998,0.00024163784,0.00019293012,0.00049761654],"category_scores_gemma":[0.00046390685,0.00010765981,0.000080377395,0.0004740371,0.0005933026,0.0000069384973,0.0002618768,0.0004896071,0.0000058274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015121064,0.00034738216,0.063958414,0.00013809024,0.0003614423,0.00004492147,0.000054151733,0.000021398067,0.9177375,0.00026744473,0.0003590574,0.015198101],"study_design_scores_gemma":[0.008116371,0.002476489,0.39405444,0.00040248514,0.00008097974,0.00007777788,0.00043532287,0.0006559636,0.51130456,0.0002464382,0.081577964,0.00057120796],"about_ca_topic_score_codex":0.000983092,"about_ca_topic_score_gemma":0.00079192466,"teacher_disagreement_score":0.40643293,"about_ca_system_score_codex":0.000025810117,"about_ca_system_score_gemma":0.0012312272,"threshold_uncertainty_score":0.54485524},"labels":[],"label_agreement":null},{"id":"W4200388798","doi":"10.1158/1078-0432.ccr-21-1090","title":"The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma; National Institute for Health and Care Research; Prostate Cancer Foundation of Australia; Pfizer; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation; Prostate Cancer Foundation","keywords":"Enzalutamide; Prostate cancer; Multivariate analysis; Clinical trial; Outcome (game theory); Cancer; Phases of clinical research","score_opus":0.19438336259119904,"score_gpt":0.5706155863813225,"score_spread":0.37623222379012344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200388798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890631,0.0035707948,0.0000024906878,0.0032603052,0.00045607032,0.0032711546,0.00014885428,0.00001442955,0.00021281297],"genre_scores_gemma":[0.990914,0.0028122368,0.000010418139,0.000048993392,0.00019131828,0.0013991495,0.000028174592,0.000036153582,0.004559552],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99402505,0.0017562277,0.0011164958,0.00065128633,0.0017323813,0.00071857753],"domain_scores_gemma":[0.9928045,0.004902367,0.00029758867,0.0011371974,0.0005791147,0.00027918819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033670515,0.00026697048,0.0013727988,0.00020879682,0.00037225167,0.000049660306,0.00031866436,0.00014005376,0.00014315998],"category_scores_gemma":[0.0010710211,0.00010818077,0.0010626623,0.0022982934,0.00085026404,0.00004617679,0.00019279582,0.0007918705,0.000003345547],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35604805,0.001927149,0.5237157,0.00015486126,0.012706862,0.0002289762,0.000521809,0.00014094666,0.0043945913,0.000014435606,0.00012084667,0.1000258],"study_design_scores_gemma":[0.60446346,0.060467552,0.1722972,0.0013472221,0.012299208,0.0000038037442,0.00056913804,0.001880503,0.14130776,0.000021412234,0.0049344003,0.00040834333],"about_ca_topic_score_codex":0.0020119387,"about_ca_topic_score_gemma":0.0017054486,"teacher_disagreement_score":0.35141847,"about_ca_system_score_codex":0.0006804554,"about_ca_system_score_gemma":0.0017898834,"threshold_uncertainty_score":0.4411484},"labels":[],"label_agreement":null},{"id":"W4200437646","doi":"10.1158/1078-0432.ccr-21-3238","title":"From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Summit; Kidney cancer; Renal cell carcinoma; Translational research; Kidney; Basic research; Cancer; Kidney disease","score_opus":0.42649645808653047,"score_gpt":0.5751800096660913,"score_spread":0.1486835515795608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200437646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8901672,0.0072265337,0.000009232972,0.09449675,0.0018756512,0.0019002513,0.0008613647,0.00004058237,0.0034224761],"genre_scores_gemma":[0.96919364,0.0059070135,0.00058165507,0.0070773256,0.0060951672,0.0017178096,0.00023219705,0.000098885015,0.009096311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9850206,0.003401425,0.0023604042,0.0028100805,0.004606107,0.0018014113],"domain_scores_gemma":[0.98017216,0.010225215,0.00022180157,0.0027360306,0.003299147,0.003345629],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022728888,0.00036085575,0.0011855947,0.00043648685,0.0005867252,0.00027580257,0.0012123197,0.0004855701,0.012844557],"category_scores_gemma":[0.021491032,0.00026535173,0.0004410901,0.0046637547,0.0026921255,0.00025447956,0.00076919585,0.004750091,0.00041974726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028241307,0.00080155465,0.7577235,0.00009862208,0.0002462731,0.0027634788,0.000965227,0.00001168521,0.007769322,0.000014358653,0.1697275,0.057054326],"study_design_scores_gemma":[0.0053163515,0.0006216696,0.64602286,0.0018571329,0.00011299915,0.0000114053055,0.0006777828,0.0002620322,0.01840308,0.00072403695,0.3256543,0.0003363446],"about_ca_topic_score_codex":0.066711314,"about_ca_topic_score_gemma":0.043774746,"teacher_disagreement_score":0.15592678,"about_ca_system_score_codex":0.0022063237,"about_ca_system_score_gemma":0.031690277,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W4200557046","doi":"10.1158/1078-0432.ccr-21-1291","title":"Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Discontinuation; Regimen; Medicine; Internal medicine; Gastroenterology; Toxicity; Surgery","score_opus":0.16442287932536198,"score_gpt":0.49352622930669265,"score_spread":0.3291033499813307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200557046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918659,0.0035811798,0.00018618433,0.00030511423,0.000051864165,0.0030231096,0.0009660341,0.000012957551,0.0000076862825],"genre_scores_gemma":[0.99807525,0.00041515456,0.0006571673,0.000016204363,0.00011405265,0.00027818204,0.00025847013,0.000043729142,0.00014181838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688625,0.00042733256,0.00096185924,0.0006423714,0.0007134746,0.000368703],"domain_scores_gemma":[0.99381006,0.003702614,0.000416724,0.0005081683,0.0013770337,0.00018537581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005895206,0.00023483028,0.0009709372,0.00007860696,0.00013047973,0.00001618069,0.00013128889,0.00009840094,0.00011210575],"category_scores_gemma":[0.0005845305,0.00011760478,0.00008201719,0.00040787034,0.0010574103,0.000058938618,0.00005613084,0.00029439796,1.425004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22382987,0.019213928,0.5750394,0.00040380048,0.0034003097,0.000047250393,0.0065217353,0.000016344682,0.0016604917,0.0000040805007,0.000076124765,0.16978666],"study_design_scores_gemma":[0.2132986,0.065950565,0.570528,0.0013570987,0.0014247436,0.000003475367,0.0067238254,0.0009149091,0.13835292,0.00007864035,0.001005273,0.00036194758],"about_ca_topic_score_codex":0.000581437,"about_ca_topic_score_gemma":0.00071367115,"teacher_disagreement_score":0.16942471,"about_ca_system_score_codex":0.00007841765,"about_ca_system_score_gemma":0.0005221503,"threshold_uncertainty_score":0.47957838},"labels":[],"label_agreement":null},{"id":"W4205484767","doi":"10.1158/1078-0432.ccr-21-3261","title":"Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Neutropenia; Lymphoma; Internal medicine; Adverse effect; Phases of clinical research; Diffuse large B-cell lymphoma; Rituximab; Nausea; Gastroenterology; Pharmacokinetics; Oncology; Chemotherapy","score_opus":0.11104047886958199,"score_gpt":0.516506773739555,"score_spread":0.405466294869973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205484767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194425,0.00022705544,0.0000058293726,0.00096430787,0.00031444433,0.004636184,0.0000799618,0.000049364553,0.0017786191],"genre_scores_gemma":[0.99318486,0.00021528768,0.00003277567,0.00028192915,0.0003555292,0.00068061566,0.00017282383,0.00010940691,0.0049667642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9905149,0.0022723805,0.0011251753,0.0012014365,0.0037045241,0.0011816124],"domain_scores_gemma":[0.9961572,0.001201748,0.00017204885,0.0010886112,0.0008281203,0.0005522558],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008992269,0.0002956557,0.0009380728,0.00070690643,0.00046693784,0.0000869693,0.0006226296,0.00011561905,0.0060165613],"category_scores_gemma":[0.00036506946,0.0002507533,0.00018202032,0.002342799,0.00053212064,0.00016276792,0.00075023755,0.0022908002,0.000107774715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020472972,0.024707241,0.9140695,0.00009290611,0.0001394708,0.0003531364,0.0006761297,0.00006437748,0.0028651017,0.000003143101,0.0026404476,0.03391561],"study_design_scores_gemma":[0.081803255,0.0132837575,0.89122796,0.00008893358,0.00005112049,0.0000030876581,0.0010301512,0.0008780451,0.00059191865,0.000020034144,0.010714802,0.00030694253],"about_ca_topic_score_codex":0.0025691653,"about_ca_topic_score_gemma":0.00030044597,"teacher_disagreement_score":0.061330285,"about_ca_system_score_codex":0.0009780086,"about_ca_system_score_gemma":0.0016206908,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W4205646635","doi":"10.1158/1078-0432.ccr-21-3530","title":"Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Loxo Oncology; Eli Lilly Japan; Chugai Pharmaceutical; EMD Serono; Genentech; Ignyta; Eli Lilly and Company; Ono Pharmaceutical; Sanofi; Kyowa Hakko Kirin; Teijin Pharma; Daiichi-Sankyo; Halozyme; Mirati Therapeutics; National Center for Advancing Translational Sciences; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Pfizer; Symphogen; Bristol-Myers Squibb; AstraZeneca; Shire; Taiho Pharmaceutical; F. Hoffmann-La Roche; Novartis Pharma; AbbVie; Spectrum Pharmaceuticals; Medtronic Japan; Amgen; Bayer","keywords":"Osimertinib; Adjuvant; Lung cancer; Quality of life (healthcare); Clinical trial; Phases of clinical research; Epidermal growth factor receptor","score_opus":0.16964995954985748,"score_gpt":0.5233249970360567,"score_spread":0.3536750374861992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205646635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98154503,0.0012361897,0.000002439584,0.009573547,0.00044176518,0.00623273,0.00077379576,0.000026560447,0.0001679216],"genre_scores_gemma":[0.99528056,0.00044951492,0.000033783886,0.00086234923,0.00010056078,0.002279633,0.00036811488,0.000051171937,0.0005742842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98990345,0.0042752777,0.0025313632,0.0007751803,0.0016514377,0.00086327456],"domain_scores_gemma":[0.99492115,0.0026891653,0.0007027645,0.00061074615,0.0006823768,0.00039381257],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047357525,0.0002803436,0.0015601498,0.00039153302,0.00032380762,0.00002404678,0.00045307455,0.00015475976,0.0012589932],"category_scores_gemma":[0.0016253745,0.00018177158,0.0002148374,0.001795667,0.0003265549,0.0001050356,0.00018303833,0.002194719,0.0000032761939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1306965,0.005993937,0.8510994,0.00022075385,0.0003764029,0.000019826446,0.004129267,0.00007921787,0.000031652908,0.0000063960915,0.0033675819,0.003979079],"study_design_scores_gemma":[0.22094664,0.005539727,0.7715831,0.00021738808,0.0000734526,2.028966e-7,0.0009327356,0.0001971368,0.00005112932,0.000012510989,0.00026434925,0.00018164013],"about_ca_topic_score_codex":0.051515773,"about_ca_topic_score_gemma":0.005506632,"teacher_disagreement_score":0.090250134,"about_ca_system_score_codex":0.001286843,"about_ca_system_score_gemma":0.004790456,"threshold_uncertainty_score":0.999654},"labels":[],"label_agreement":null},{"id":"W4206499749","doi":"10.1158/1078-0432.ccr-21-0664","title":"Single-Cell Immune Mapping of Melanoma Sentinel Lymph Nodes Reveals an Actionable Immunotolerant Microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Melanoma; Lymph; Immune system; Immunity; Antibody; Immunotherapy; Stage (stratigraphy); Clinical trial","score_opus":0.16042761551657023,"score_gpt":0.4227069855418419,"score_spread":0.2622793700252717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206499749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98619,0.008997316,0.000017929378,0.002296936,0.0003745478,0.00058928464,0.000065270346,0.00002830753,0.0014403659],"genre_scores_gemma":[0.98879296,0.0018818835,0.00024187726,0.0004942643,0.00026301618,0.0002946198,0.00006783726,0.00004912882,0.0079143895],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99586093,0.0008038731,0.00110137,0.0005566143,0.001090686,0.000586539],"domain_scores_gemma":[0.9982065,0.0004167046,0.00025562246,0.0007799656,0.00016731265,0.00017391049],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044800853,0.00016992143,0.0005723494,0.00023075847,0.00043090933,0.000026595113,0.00039636815,0.00010578209,0.004560753],"category_scores_gemma":[0.00008359653,0.00015920855,0.0003406763,0.0005736449,0.0005141655,0.00008533083,0.00038525477,0.00081578986,0.000020299662],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064911097,0.0021773751,0.07743539,0.00021662717,0.00022502233,0.00005098478,0.000284828,0.000024506075,0.89292043,0.000008404428,0.0012170125,0.018948285],"study_design_scores_gemma":[0.014325793,0.0018977465,0.76782477,0.00038495188,0.00008123954,0.0001047483,0.0039474885,0.00031930231,0.0764682,0.00011937748,0.13406791,0.00045850576],"about_ca_topic_score_codex":0.0013239946,"about_ca_topic_score_gemma":0.0000037267394,"teacher_disagreement_score":0.81645226,"about_ca_system_score_codex":0.000764277,"about_ca_system_score_gemma":0.00047133968,"threshold_uncertainty_score":0.9963492},"labels":[],"label_agreement":null},{"id":"W4206901398","doi":"10.1158/1078-0432.ccr-21-3284","title":"Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Radioligand; CXCR4; Medicine; Mantle cell lymphoma; Cancer research; Chemokine receptor; Biodistribution; Lymphoma; Pathology; Receptor; Internal medicine; Chemokine; Biology; In vivo","score_opus":0.20004507388978945,"score_gpt":0.4930952004430603,"score_spread":0.2930501265532709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206901398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96972466,0.026665512,0.0000054578577,0.0018976593,0.00048490395,0.00076196756,0.000042679036,0.000027803037,0.00038933964],"genre_scores_gemma":[0.9850625,0.011506739,0.0006806852,0.0006896888,0.00086575944,0.00032646942,0.00005379648,0.00004852159,0.0007658625],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979751,0.00021202349,0.0003842326,0.0004886815,0.00047661376,0.00046335327],"domain_scores_gemma":[0.99831676,0.00085778267,0.0000844311,0.0002647299,0.00025440857,0.00022190475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020935736,0.00012984262,0.00035957107,0.0001050133,0.00048575638,0.00003464567,0.00012261956,0.000056082245,0.0006979833],"category_scores_gemma":[0.00026168535,0.00010690327,0.000113982765,0.0002903024,0.00017111887,0.000049646966,0.00019299284,0.00027397063,0.000006959846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007744016,0.0037060485,0.44666052,0.00024020125,0.00028015432,0.00014006226,0.00046795356,0.000024703084,0.03854071,0.0000504994,0.096811555,0.40533358],"study_design_scores_gemma":[0.026764676,0.0032407364,0.031221516,0.00011853133,0.00009141921,0.000035752273,0.000873575,0.004142563,0.018481465,0.0001341166,0.9145459,0.0003497547],"about_ca_topic_score_codex":0.00027459158,"about_ca_topic_score_gemma":0.0000012516799,"teacher_disagreement_score":0.81773436,"about_ca_system_score_codex":0.0005472145,"about_ca_system_score_gemma":0.00063324964,"threshold_uncertainty_score":0.7642428},"labels":[],"label_agreement":null},{"id":"W4206906266","doi":"10.1158/1078-0432.ccr-21-3213","title":"Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Ono Pharmaceutical","keywords":"Nivolumab; Colorectal cancer; Microsatellite; Microsatellite instability; Chemoradiotherapy","score_opus":0.06211335748150452,"score_gpt":0.40588523366044776,"score_spread":0.3437718761789432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206906266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98765075,0.0075533334,0.0000020671948,0.0009973013,0.00034300637,0.0028546357,0.00037174087,0.000053538584,0.00017360007],"genre_scores_gemma":[0.9924529,0.0030632399,0.00021469037,0.00050144276,0.00014986334,0.0019275307,0.00018672252,0.00010014166,0.0014034257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99413747,0.0009747435,0.000991323,0.0014006292,0.0013775321,0.0011183345],"domain_scores_gemma":[0.9969736,0.0010337604,0.00017432083,0.0006266519,0.0006864496,0.0005052572],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022298938,0.00038860386,0.0013465581,0.0003059975,0.00040883594,0.00007535348,0.00026526258,0.0001768335,0.0017824074],"category_scores_gemma":[0.00026554527,0.00031701033,0.00017393628,0.0016930618,0.0010027403,0.00023560449,0.00041100202,0.0018674181,0.000007132867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03485708,0.0011571118,0.85233384,0.00017275667,0.00019383723,0.000115796,0.00073508924,0.000104491504,0.00010775871,0.0000059552967,0.00013514634,0.110081114],"study_design_scores_gemma":[0.016646396,0.0048033684,0.9655051,0.00050907535,0.000042602012,0.000007907369,0.00021679801,0.00009538403,0.0010490854,0.00006079904,0.01067432,0.0003891347],"about_ca_topic_score_codex":0.004472464,"about_ca_topic_score_gemma":0.0038227313,"teacher_disagreement_score":0.113171265,"about_ca_system_score_codex":0.0034847786,"about_ca_system_score_gemma":0.002625723,"threshold_uncertainty_score":0.9999282},"labels":[],"label_agreement":null},{"id":"W4210277591","doi":"10.1158/1078-0432.ccr-21-2572","title":"Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Susan G. Komen; Breast Cancer Research Foundation","keywords":"Somatic cell; Germline; Breast cancer; Gene; Germline mutation; Young adult","score_opus":0.06363039054810755,"score_gpt":0.43218876076061347,"score_spread":0.3685583702125059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210277591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361855,0.0028439104,0.000004900604,0.0027003435,0.00012290968,0.0002945112,0.0002573053,0.000006990197,0.00015056142],"genre_scores_gemma":[0.9944922,0.0021729846,0.00003870026,0.00025266354,0.00035940672,0.0021503074,0.000027879581,0.000025391586,0.00048052132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981959,0.00032194154,0.00027699614,0.0004817232,0.00028643862,0.00043703723],"domain_scores_gemma":[0.9993531,0.00009443702,0.000050230312,0.00027741815,0.00010662758,0.00011819711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008274403,0.00011964745,0.00021762148,0.00007744609,0.00031130057,0.000028412109,0.00017950695,0.00004913052,0.00031006103],"category_scores_gemma":[0.00003917419,0.00010242231,0.000029981611,0.0002402419,0.00029977752,0.000005912624,0.00048113952,0.00037825407,0.0000031345685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033122506,0.000445775,0.9690892,0.000058988513,0.0003130219,0.000035313784,0.0007920161,0.0005612342,0.0070190933,0.000025798505,0.0020276108,0.01631967],"study_design_scores_gemma":[0.0023430963,0.00047349723,0.9921288,0.00002952658,0.00001534698,0.000035758938,0.0008119131,0.00007942868,0.00019108866,0.00009329284,0.003619963,0.00017829661],"about_ca_topic_score_codex":0.001599692,"about_ca_topic_score_gemma":0.0034116942,"teacher_disagreement_score":0.023039563,"about_ca_system_score_codex":0.00032980324,"about_ca_system_score_gemma":0.0005181824,"threshold_uncertainty_score":0.41766605},"labels":[],"label_agreement":null},{"id":"W4210342713","doi":"10.1158/1078-0432.ccr-21-3940","title":"Tumor Genomic Testing for &amp;gt;4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; National Institute for Health and Care Research; Merck; AstraZeneca","keywords":"Olaparib; Prostate cancer; Homologous recombination; Cancer; Clinical trial; Homologous chromosome; Prostate","score_opus":0.4004069388603253,"score_gpt":0.5604908869630105,"score_spread":0.16008394810268523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210342713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97504705,0.0027848093,0.000009015417,0.007404959,0.0002011243,0.012731285,0.0007348672,0.00003491509,0.0010519713],"genre_scores_gemma":[0.96394145,0.00031670445,0.00040140355,0.00034432852,0.0007422807,0.028075859,0.00017621099,0.00007738431,0.0059243757],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99386346,0.0012958559,0.0010218796,0.0008626879,0.0017795634,0.0011765446],"domain_scores_gemma":[0.9950444,0.0031637275,0.00022168,0.000613192,0.0006547572,0.00030226202],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009197658,0.00026301757,0.0007029075,0.0002885746,0.0009853375,0.0001545717,0.0005077369,0.000050096416,0.00092429033],"category_scores_gemma":[0.0009137746,0.00016082548,0.00015753495,0.0014571806,0.0006412605,0.00012142698,0.00020433909,0.0017248661,0.000008978225],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87878126,0.0059641334,0.020249315,0.0008062629,0.000869167,0.00095983734,0.0041792607,0.00048244753,0.010852509,0.0002146484,0.020159256,0.05648193],"study_design_scores_gemma":[0.7822445,0.05378617,0.023272308,0.00074017956,0.0008541077,0.000107494045,0.009364329,0.003923767,0.00079382444,0.0012843254,0.12263087,0.0009981347],"about_ca_topic_score_codex":0.002984677,"about_ca_topic_score_gemma":0.0022088382,"teacher_disagreement_score":0.10247161,"about_ca_system_score_codex":0.0012027962,"about_ca_system_score_gemma":0.0053338152,"threshold_uncertainty_score":0.999989},"labels":[],"label_agreement":null},{"id":"W4211106526","doi":"10.1158/1078-0432.ccr-21-3045","title":"Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; National Institutes of Health; Breast Cancer Alliance; Sierra Oncology; Ipsen; Genentech; Deutsche Krebshilfe; G1 Therapeutics; Stand Up To Cancer; EMD Serono; Mersana Therapeutics; Merck KGaA; Dana-Farber/Harvard Cancer Center; GlaxoSmithKline; Breast Cancer Research Foundation; Pfizer; Symphogen; Carrick Therapeutics; American Association for Cancer Research; AstraZeneca; Eli Lilly and Company; Astex Pharmaceuticals","keywords":"Olaparib; PARP inhibitor; Clinical trial; Breast cancer; Cancer; Phases of clinical research; Poly ADP ribose polymerase","score_opus":0.2879403571378599,"score_gpt":0.59430337590085,"score_spread":0.3063630187629901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211106526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766904,0.0005687833,0.00023406897,0.0060924855,0.0021349543,0.010166166,0.0034235776,0.00011898346,0.0005705669],"genre_scores_gemma":[0.97138363,0.0011149074,0.0010222828,0.0028317133,0.0034822319,0.017080456,0.00028981475,0.00018784394,0.0026071398],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9914276,0.0015025913,0.0017277364,0.0015344536,0.002620842,0.0011867568],"domain_scores_gemma":[0.9911167,0.004059516,0.00056428794,0.0009921896,0.0023921411,0.0008751495],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005262504,0.0003990364,0.0014121989,0.00026851238,0.0007924484,0.000060941373,0.00057475176,0.00023086795,0.0031555414],"category_scores_gemma":[0.0011843863,0.00029371833,0.0004282995,0.0013171684,0.0014481533,0.00024041953,0.00025532235,0.002987245,0.000020079664],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8375576,0.011500262,0.016856601,0.00009673581,0.00065126125,0.000039085593,0.00020976679,0.00009600284,0.00001795593,0.00007446827,0.035281856,0.09761837],"study_design_scores_gemma":[0.8135908,0.07038568,0.017915614,0.00036463072,0.00024212807,0.00001173389,0.00039894783,0.00041512572,0.000101726866,0.00022054014,0.09582731,0.0005257607],"about_ca_topic_score_codex":0.00043230798,"about_ca_topic_score_gemma":0.00029756656,"teacher_disagreement_score":0.097092606,"about_ca_system_score_codex":0.0016660623,"about_ca_system_score_gemma":0.0058660917,"threshold_uncertainty_score":0.9999515},"labels":[],"label_agreement":null},{"id":"W4211162951","doi":"10.1158/1078-0432.ccr-21-3385","title":"Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Ontario Institute for Cancer Research; Cancer Research UK; BioTheranostics; Breast Cancer Research Foundation","keywords":"Tamoxifen; Medicine; Oncology; Breast cancer; Biomarker; Cancer; Internal medicine; Gynecology; Biology","score_opus":0.1883936244206094,"score_gpt":0.4851362055094422,"score_spread":0.2967425810888328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211162951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804045,0.00393988,0.0000070725005,0.0013454205,0.000111372035,0.00072139374,0.005794538,0.00000424568,0.00003560251],"genre_scores_gemma":[0.99612737,0.0024450764,0.000005842233,0.000107105305,0.0000934121,0.0009479358,0.00003700406,0.000020590027,0.00021564777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972522,0.00059585343,0.00057389075,0.0006779448,0.0005994282,0.00030066023],"domain_scores_gemma":[0.9985571,0.00023376656,0.00019284025,0.0006427926,0.00028168914,0.000091804795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068746577,0.00019621443,0.00060339045,0.00012944493,0.00025038113,0.000010248933,0.00038856748,0.00008756506,0.0005736899],"category_scores_gemma":[0.00002553865,0.00013002004,0.0003842143,0.00081130577,0.00056750426,0.0000043485593,0.00044449343,0.00023578321,1.8498923e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004377963,0.001396143,0.9600994,0.0000063297875,0.0076818867,0.0000016457119,0.0010515864,0.00014271955,0.0010817666,0.0000019015424,0.00016934285,0.023989337],"study_design_scores_gemma":[0.003717959,0.0012849921,0.9914425,0.000009424852,0.0008008735,8.424477e-7,0.0010049086,0.00015555024,0.0008479195,0.000048037633,0.00057507027,0.00011193923],"about_ca_topic_score_codex":0.019826228,"about_ca_topic_score_gemma":0.0053536273,"teacher_disagreement_score":0.031343106,"about_ca_system_score_codex":0.00020667294,"about_ca_system_score_gemma":0.00037554395,"threshold_uncertainty_score":0.98670083},"labels":[],"label_agreement":null},{"id":"W4211216207","doi":"10.1158/1078-0432.ccr-21-3597","title":"Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Solid tumor; Cancer; Clinical trial; Disease; Chemotherapy","score_opus":0.042792781397966974,"score_gpt":0.4593572099433715,"score_spread":0.4165644285454045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211216207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733347,0.00013806604,0.0000021718972,0.00076730404,0.000056190314,0.00086350477,0.0003652992,0.0000048718434,0.00046913605],"genre_scores_gemma":[0.99928445,0.000075698845,0.000023335095,0.00011391353,0.000012222632,0.00007106156,0.00017057087,0.0000100794105,0.00023868177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997843,0.0005293255,0.0005187362,0.0002773313,0.00063323515,0.00019835019],"domain_scores_gemma":[0.9983334,0.00066981214,0.00015201236,0.00027978668,0.00047399887,0.00009101151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008031439,0.000080407546,0.0004670046,0.0002601886,0.00014100222,0.0000047597277,0.00012468967,0.000034659606,0.0006060767],"category_scores_gemma":[0.00027425616,0.00004686618,0.000094705545,0.0027107634,0.0003533479,0.000023573322,0.00018831047,0.0005432741,4.2902042e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061964206,0.0012664504,0.98159933,0.000015145285,0.0012135912,0.000005521855,0.00078155857,0.0003467422,0.00003662507,0.000030307512,0.0003293593,0.008178953],"study_design_scores_gemma":[0.0063465764,0.0012835396,0.99007773,0.0001067411,0.0006643334,3.0251414e-7,0.00058809086,0.00019470043,0.00020407168,0.000009451846,0.00047849806,0.000045975437],"about_ca_topic_score_codex":0.0020303822,"about_ca_topic_score_gemma":0.0005196754,"teacher_disagreement_score":0.008478395,"about_ca_system_score_codex":0.0002481633,"about_ca_system_score_gemma":0.00067448703,"threshold_uncertainty_score":0.6636115},"labels":[],"label_agreement":null},{"id":"W4212771317","doi":"10.1158/1078-0432.ccr-21-0885","title":"Natural History and Characteristics of <i>ERBB2</i> -mutated Hormone Receptor–positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case–control Study from AACR Project GENIE","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; Unicancer; Vanderbilt University; Institut Gustave-Roussy; Puma Biotechnology; Princess Margaret Cancer Foundation; Memorial Sloan-Kettering Cancer Center; University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; American Association for Cancer Research","keywords":"Natural history; Retrospective cohort study; Metastatic breast cancer; Hormone; Cancer; Breast cancer","score_opus":0.11103847282270961,"score_gpt":0.4503884108544883,"score_spread":0.33934993803177865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212771317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964132,0.019734174,0.000111758614,0.0009736484,0.00085029245,0.003031576,0.011079649,0.00006226854,0.000024615963],"genre_scores_gemma":[0.995563,0.0008420459,0.0005998186,0.00038419952,0.00055828237,0.001535566,0.00010386518,0.000065290114,0.00034797055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943569,0.0015428688,0.0010183741,0.0010174835,0.0014327354,0.00063164206],"domain_scores_gemma":[0.996413,0.0010980594,0.0003986371,0.00048627213,0.0013133622,0.00029067296],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022240912,0.00033987642,0.0012395226,0.000279157,0.00047176227,0.000019524623,0.00026833257,0.00008400354,0.0009104467],"category_scores_gemma":[0.00055123016,0.00029246963,0.00020597145,0.0006583034,0.0014735045,0.00017901657,0.0003588285,0.0023150097,0.0000047027447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09940443,0.011445193,0.6339927,0.00030470744,0.0107035935,0.00976296,0.014015237,0.00009591322,0.03400801,0.00012674031,0.0039321017,0.18220845],"study_design_scores_gemma":[0.022079207,0.0034611614,0.9644031,0.00015148136,0.00070301007,0.00079587405,0.0037163463,0.0013044142,0.00009820196,0.00004895125,0.0028087161,0.00042952516],"about_ca_topic_score_codex":0.012944859,"about_ca_topic_score_gemma":0.0008010604,"teacher_disagreement_score":0.33041045,"about_ca_system_score_codex":0.0043915757,"about_ca_system_score_gemma":0.002977123,"threshold_uncertainty_score":0.9999867},"labels":[],"label_agreement":null},{"id":"W4212829041","doi":"10.1158/1078-0432.ccr-16-0732","title":"CD103 and Intratumoral Immune Response in Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Breast cancer; Tumor-infiltrating lymphocytes; Internal medicine; CD8; Cancer; Context (archaeology); Immune system; Oncology; Basal (medicine); Confidence interval; Gastroenterology; Immunotherapy; Immunology; Biology","score_opus":0.15605407737987972,"score_gpt":0.5203377031857345,"score_spread":0.3642836258058547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212829041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91986644,0.0055300673,0.0000018274342,0.073588215,0.00030603269,0.00039964326,0.00006106246,0.000023862636,0.00022284928],"genre_scores_gemma":[0.975889,0.019432876,0.000023135835,0.00075784075,0.00044969236,0.00019581133,0.0000012015095,0.000028051154,0.0032223403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970666,0.00072779687,0.00062025886,0.0004949135,0.00050002575,0.0005903857],"domain_scores_gemma":[0.9978974,0.0011276252,0.0000605738,0.00041084565,0.0002422796,0.00026127303],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005728413,0.00013669505,0.0004187247,0.00022119247,0.00008217259,0.000029019302,0.00017328079,0.0001855063,0.0019322123],"category_scores_gemma":[0.00047721312,0.00008393573,0.00011407496,0.0005535786,0.0010783335,0.00010190351,0.00012882637,0.0006685374,0.00003307473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14270346,0.00025925835,0.4245318,0.00006598163,0.00010242919,0.0001451239,0.00011226866,9.8814496e-8,0.08437802,0.00003907121,0.0073947012,0.3402678],"study_design_scores_gemma":[0.0071755685,0.0006653841,0.9672217,0.000830381,0.000011454822,0.000039376562,0.000060496026,0.000007868451,0.0012828083,0.00011280996,0.02246169,0.00013047764],"about_ca_topic_score_codex":0.002476382,"about_ca_topic_score_gemma":0.00031236262,"teacher_disagreement_score":0.5426899,"about_ca_system_score_codex":0.00043762222,"about_ca_system_score_gemma":0.0011306335,"threshold_uncertainty_score":0.99898016},"labels":[],"label_agreement":null},{"id":"W4213348369","doi":"10.1158/1078-0432.ccr-21-0344","title":"Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Weill Cornell Medical College; Canada Foundation for Innovation; National Center for Advancing Translational Sciences; Temerty Faculty of Medicine, University of Toronto; Ontario Institute for Cancer Research; Lung Cancer Research Foundation; National Cancer Institute; University of Toronto; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; Cancer Research Society; National Institutes of Health; Conquer Cancer Foundation","keywords":"Lung cancer; Cancer; Gene; Therapeutic approach; Cell culture; Targeted therapy","score_opus":0.27928867953338987,"score_gpt":0.5313512002930797,"score_spread":0.2520625207596898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213348369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7968825,0.118904546,0.001076012,0.05781335,0.0031772787,0.01972089,0.0010814333,0.00024548275,0.0010984748],"genre_scores_gemma":[0.9783406,0.0018294841,0.00008934122,0.0017108549,0.0049313433,0.00949768,0.000017797038,0.00013671334,0.0034461373],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9912789,0.0023208947,0.0010787011,0.0010497025,0.0025551359,0.0017166899],"domain_scores_gemma":[0.994657,0.002407104,0.0002997274,0.00097301585,0.0013192026,0.00034396874],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011659,0.0003465353,0.00074672815,0.00017383858,0.0034840342,0.00022633011,0.0011870237,0.00016143502,0.0009863853],"category_scores_gemma":[0.0006048675,0.00020411881,0.00051370834,0.0011368799,0.0010429241,0.00009253652,0.0014467853,0.0034157294,0.0000098632545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039195303,0.004035157,0.11804515,0.02502589,0.011417294,0.0009747541,0.017065683,0.030123072,0.106699936,0.0033239971,0.5432755,0.10081828],"study_design_scores_gemma":[0.03544613,0.010058734,0.007993625,0.003183864,0.0035943883,0.00018669575,0.100309156,0.45803806,0.015866924,0.0010733731,0.3616059,0.002643156],"about_ca_topic_score_codex":0.0038366609,"about_ca_topic_score_gemma":0.00014666349,"teacher_disagreement_score":0.42791498,"about_ca_system_score_codex":0.0021692605,"about_ca_system_score_gemma":0.004055696,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W4220672244","doi":"10.1158/1078-0432.ccr-21-3087","title":"A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Institute of Cancer Research","funders":"National Cancer Institute; Ipsen; Shionogi; Astellas Pharma; Eisai; National Institute for Health and Care Research; Cancer Research UK; Genentech; MEI Pharma; Incyte; Taiho Pharmaceutical; F. Hoffmann-La Roche; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; G1 Therapeutics; Celgene; Carrick Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tolerability; Medicine; Adverse effect; Abiraterone acetate; Prostate cancer; Pharmacodynamics; Rash; Pharmacokinetics; Internal medicine; Pharmacology; Cancer; Oncology; Androgen deprivation therapy","score_opus":0.07900168100914737,"score_gpt":0.477995984189011,"score_spread":0.3989943031798636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220672244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982166,0.00047966975,0.000006322939,0.00008458139,0.0000951565,0.0009947523,0.000063094216,0.0000060162565,0.000053798085],"genre_scores_gemma":[0.9989213,0.000032744083,0.00013887386,0.00010644498,0.00012723402,0.00057581934,0.000022166854,0.000031956795,0.00004350822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969082,0.0007915282,0.0005486421,0.00065694825,0.0006917054,0.00040300746],"domain_scores_gemma":[0.99880093,0.00015807578,0.00016992625,0.0003222249,0.00038884822,0.00016001146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019547003,0.0001398519,0.00032817607,0.00011558072,0.00016670104,0.000014221677,0.00027176988,0.00006463588,0.000024587001],"category_scores_gemma":[0.00072647765,0.00012798056,0.000046535486,0.0005130933,0.00039271286,0.00000705126,0.0005660394,0.0007492885,4.6074496e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054826224,0.0042067855,0.932306,0.000055714452,0.00014001438,0.000015659478,0.00071988476,0.0009111647,0.035781022,0.000004154734,0.0005527383,0.019824235],"study_design_scores_gemma":[0.07663561,0.16350515,0.63171333,0.0004767757,0.00008434335,0.000005492163,0.0056251013,0.000722932,0.117715515,0.0003302,0.001931799,0.0012537666],"about_ca_topic_score_codex":0.00020277822,"about_ca_topic_score_gemma":0.00015734967,"teacher_disagreement_score":0.3005927,"about_ca_system_score_codex":0.00013921282,"about_ca_system_score_gemma":0.0006957162,"threshold_uncertainty_score":0.52188957},"labels":[],"label_agreement":null},{"id":"W4220783948","doi":"10.1158/1078-0432.ccr-21-3089","title":"Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Pembrolizumab; Clinical trial; Tumor microenvironment; Urothelial cancer; Biomarker; Immunotherapy","score_opus":0.31333517696105834,"score_gpt":0.554651027683863,"score_spread":0.24131585072280465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220783948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776546,0.005522825,0.000010914621,0.008459273,0.0006329064,0.0025302079,0.004065483,0.000030470439,0.0010933147],"genre_scores_gemma":[0.98932546,0.006928472,0.00020349356,0.00080360315,0.0008966378,0.0010387696,0.00011722087,0.00006781003,0.0006185195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900837,0.003740251,0.002613589,0.0012506704,0.0015761484,0.0007356511],"domain_scores_gemma":[0.9821307,0.015477717,0.000641456,0.0008578802,0.00046783686,0.00042438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012991195,0.00032467677,0.0018641601,0.00018518184,0.00033432397,0.000036593665,0.0005097459,0.00021853296,0.0008000374],"category_scores_gemma":[0.0054929303,0.00020201881,0.00037027127,0.0009801371,0.0012196931,0.00009868771,0.00045008765,0.002108569,0.000007200068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27329102,0.0010821067,0.51386553,0.000065062,0.0013382224,0.0001837414,0.001356681,0.00025843031,0.00015543065,0.00006077211,0.0027381221,0.20560485],"study_design_scores_gemma":[0.08885782,0.008286047,0.8819689,0.00049140415,0.00047284004,0.000011711626,0.0017655515,0.00039512076,0.0005752849,0.0016022002,0.0151969725,0.00037610694],"about_ca_topic_score_codex":0.025257293,"about_ca_topic_score_gemma":0.0048191976,"teacher_disagreement_score":0.36810338,"about_ca_system_score_codex":0.00038241103,"about_ca_system_score_gemma":0.0026044045,"threshold_uncertainty_score":0.9812336},"labels":[],"label_agreement":null},{"id":"W4220938340","doi":"10.1158/1078-0432.ccr-21-4283","title":"Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i> -wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medac; Brain Tumour Charity; Cancer Australia; National Health and Medical Research Council; Cancer Research UK; Y-mAbs Therapeutics; Agios Pharmaceuticals; Seagen; Douglas Pharmaceuticals; Pfizer; NRG Oncology; Teva Pharmaceutical Industries; Medical Research Council; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Temozolomide; Medicine; Oncology; Radiation therapy; Internal medicine; IDH1; O-6-methylguanine-DNA methyltransferase; Anaplastic astrocytoma; Glioma; Chemoradiotherapy; Isocitrate dehydrogenase; Dacarbazine; Cancer research; Chemotherapy; Methyltransferase; Astrocytoma; Methylation; Biology; Mutation; Gene","score_opus":0.05724010652066623,"score_gpt":0.44655402154756285,"score_spread":0.3893139150268966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220938340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879951,0.005191107,0.0000033216822,0.002492337,0.00034258032,0.0038003712,0.00010528244,0.000012731192,0.00005718351],"genre_scores_gemma":[0.99506235,0.0029187265,0.00006439232,0.00050650834,0.00014369331,0.0011254294,0.000046469853,0.00003668008,0.00009576492],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99482334,0.0018514226,0.00095351116,0.00059586874,0.001329422,0.00044646757],"domain_scores_gemma":[0.9954555,0.0030712555,0.00028672707,0.0006901354,0.00027712446,0.00021926805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038792836,0.00021229494,0.0016909845,0.0005175876,0.00023776953,0.000025632944,0.000274178,0.00010062532,0.00056189735],"category_scores_gemma":[0.00036011866,0.0001264184,0.0004979295,0.0022400757,0.000821782,0.00004863956,0.00013100498,0.0007676979,6.679136e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8871625,0.004254423,0.093064554,0.000013092529,0.0034747752,0.000030016396,0.00024489735,0.00010456656,0.00008623408,0.000019527688,0.0010296535,0.010515728],"study_design_scores_gemma":[0.9582396,0.015523141,0.020733925,0.000040091138,0.0011120868,9.68413e-7,0.00008529767,0.00036480965,0.00018764444,0.0000047785293,0.003573968,0.00013365141],"about_ca_topic_score_codex":0.0017289526,"about_ca_topic_score_gemma":0.0012113695,"teacher_disagreement_score":0.07233063,"about_ca_system_score_codex":0.00046005906,"about_ca_system_score_gemma":0.00054507906,"threshold_uncertainty_score":0.6152382},"labels":[],"label_agreement":null},{"id":"W4223610239","doi":"10.1158/1078-0432.ccr-22-0591","title":"Report of the First International Symposium on NUT Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Nut; Bromodomain; Cancer; Carcinoma; Prioritization; Brazil nut; Disease","score_opus":0.1017946249134702,"score_gpt":0.45095810889381865,"score_spread":0.34916348398034847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223610239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756474,0.00016000049,0.00000436289,0.01454124,0.0012573391,0.00022914045,0.00003775644,0.000003242223,0.008119555],"genre_scores_gemma":[0.9929068,0.00008853891,0.00000875582,0.00057221315,0.0005170431,0.00013871469,0.000027261536,0.000008582846,0.005732096],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985597,0.0002217566,0.00028875534,0.00026246381,0.00053435174,0.00013293262],"domain_scores_gemma":[0.9992093,0.000052133644,0.000087176275,0.0004394152,0.0001689854,0.000042997774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013932213,0.00004628893,0.00007328227,0.000022942488,0.00018802151,0.000009013075,0.0005015141,0.00004983253,0.0003451288],"category_scores_gemma":[0.00048477112,0.000034913443,0.000114404036,0.00013107677,0.0001933248,0.000001396618,0.0006362348,0.0003638015,0.000004257175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011009265,0.00065943424,0.49492827,0.000028506998,0.000108754706,0.000041482326,0.000052200143,0.00028585288,0.04413577,0.000824019,0.4526449,0.005189853],"study_design_scores_gemma":[0.0003909351,0.0003690055,0.027330946,0.00000800976,0.0000021666565,0.000008900472,0.00003218413,0.00003522685,0.07779789,0.00005075359,0.89392143,0.000052523934],"about_ca_topic_score_codex":0.00011637542,"about_ca_topic_score_gemma":0.000047310587,"teacher_disagreement_score":0.46759734,"about_ca_system_score_codex":0.000050362385,"about_ca_system_score_gemma":0.0002293734,"threshold_uncertainty_score":0.37789184},"labels":[],"label_agreement":null},{"id":"W4223960133","doi":"10.1158/1078-0432.ccr-22-0470","title":"Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; Wipe Out Kids' Cancer; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Sarcoma Foundation of America","keywords":"Enzyme; Enzyme inducer; Antioxidant; Medicine; Sarcoma; Synovial sarcoma; Biology; Immunology; Cancer research; Pathology; Biochemistry","score_opus":0.13912075405950103,"score_gpt":0.43691397312854974,"score_spread":0.2977932190690487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223960133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419016,0.0009011146,0.000050324386,0.0031695664,0.00020643116,0.0011711976,0.000060539533,0.00006340356,0.00018725065],"genre_scores_gemma":[0.99739003,0.00051275635,0.0001929924,0.00048294239,0.0003654922,0.00089970435,0.000006211943,0.000040262425,0.00010960287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946595,0.0015211705,0.00060934795,0.0009825989,0.0015253425,0.0007020738],"domain_scores_gemma":[0.9978179,0.0007468035,0.00010056259,0.0005069113,0.00031221518,0.0005156295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00520744,0.00021033519,0.00063571765,0.00031888418,0.00040185038,0.00006779146,0.0002041544,0.00012446575,0.00021655906],"category_scores_gemma":[0.00047724094,0.00017769789,0.00008721137,0.0013592322,0.00037221954,0.00014313615,0.0005963902,0.0015327525,0.0000174574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007708735,0.0011947827,0.9328961,0.00055093237,0.00011808491,0.0008034161,0.00040172559,0.00015284902,0.010290535,0.00029067675,0.0014986584,0.044093553],"study_design_scores_gemma":[0.0025411306,0.0036253172,0.9843107,0.0009094748,0.000057772104,0.00024408347,0.002893466,0.0007632882,0.002166384,0.000014115725,0.0021442876,0.00032997073],"about_ca_topic_score_codex":0.013200458,"about_ca_topic_score_gemma":0.0033536297,"teacher_disagreement_score":0.051414657,"about_ca_system_score_codex":0.000804532,"about_ca_system_score_gemma":0.0007815196,"threshold_uncertainty_score":0.9933707},"labels":[],"label_agreement":null},{"id":"W4224035803","doi":"10.1158/1078-0432.ccr-21-3807","title":"Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Pembrolizumab; Phases of clinical research; Clinical trial; Adverse effect; Immunotherapy; Expanded access; Hepatocellular cancer","score_opus":0.6690422892842558,"score_gpt":0.5552228490778292,"score_spread":0.11381944020642665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224035803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95925146,0.014320603,0.00006016175,0.009627426,0.00069018744,0.0133132255,0.0023642394,0.000078357436,0.00029434694],"genre_scores_gemma":[0.9796154,0.0018714777,0.0005160688,0.001100377,0.0015235016,0.008233104,0.0037775466,0.00013263943,0.003229918],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9927829,0.0019840284,0.0011778118,0.0016645065,0.0013188984,0.0010718458],"domain_scores_gemma":[0.9924941,0.0033684985,0.00024559983,0.0029634822,0.0004178553,0.00051044184],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006213373,0.00037458836,0.0010686722,0.000121948455,0.0018795979,0.0001781933,0.0028687017,0.0002058223,0.0031109608],"category_scores_gemma":[0.0011034608,0.00026903173,0.00027370735,0.00079737266,0.00042419168,0.00023643064,0.0029237801,0.0015731986,0.000038967875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5800749,0.012229565,0.16928752,0.00007543428,0.0010945348,0.00043597244,0.0005994203,0.0000018616447,0.0010283211,0.00012893295,0.09177833,0.1432652],"study_design_scores_gemma":[0.4841991,0.03601209,0.0008997753,0.00008170025,0.0006141944,0.000008771477,0.00023740313,0.02720053,0.00092216936,0.00053372,0.44888192,0.0004086112],"about_ca_topic_score_codex":0.0038210521,"about_ca_topic_score_gemma":0.00020469383,"teacher_disagreement_score":0.3571036,"about_ca_system_score_codex":0.0004921134,"about_ca_system_score_gemma":0.0023913905,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W4225423587","doi":"10.1158/1078-0432.ccr-21-4115","title":"A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ipsen; Eisai; Rijksuniversiteit Groningen; Medical Research Council; G1 Therapeutics; Genentech; Janssen Scientific Affairs; Advanced Accelerator Applications; EMD Serono; Karyopharm Therapeutics; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Exelixis; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma; Celldex Therapeutics; Pfizer","keywords":"Durvalumab; Nivolumab; Renal cell carcinoma; Phases of clinical research; Kidney cancer; Immunotherapy","score_opus":0.1397838591136135,"score_gpt":0.45797407594542655,"score_spread":0.31819021683181303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225423587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136627,0.00044987962,0.0000041843455,0.00020051117,0.00010109241,0.007582348,0.000024080007,0.000014693431,0.00025691703],"genre_scores_gemma":[0.99651444,0.00009503089,0.0002332598,0.000035248664,0.000023647115,0.0024708214,0.000055371955,0.00006714176,0.0005050293],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918564,0.003244512,0.0012354498,0.00078276964,0.0023108637,0.0005699943],"domain_scores_gemma":[0.99607605,0.0021833277,0.00035319792,0.00064625713,0.00050509215,0.00023604972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004224725,0.0002714503,0.0014622082,0.00058472226,0.00017489433,0.000013394569,0.00029778882,0.000058598584,0.0006929279],"category_scores_gemma":[0.00033982855,0.00018001937,0.00012837519,0.001407275,0.0003917965,0.00010333575,0.00020622257,0.0012806375,0.000003840961],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88473237,0.037019875,0.06892899,0.00011679848,0.00017440185,0.0004125363,0.0025793319,0.0003504665,0.00006604014,0.0000023607497,0.00006394777,0.0055529075],"study_design_scores_gemma":[0.7803021,0.16847508,0.04679135,0.00007194802,0.00017303729,0.0000012751894,0.0029242004,0.00060797326,0.00043849822,0.000010173435,0.000042226045,0.00016214469],"about_ca_topic_score_codex":0.002607287,"about_ca_topic_score_gemma":0.0018790055,"teacher_disagreement_score":0.1314552,"about_ca_system_score_codex":0.0010495712,"about_ca_system_score_gemma":0.0012351144,"threshold_uncertainty_score":0.75870746},"labels":[],"label_agreement":null},{"id":"W4226061009","doi":"10.1158/1078-0432.ccr-21-3594","title":"Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro; Trent University; Nottingham Trent University; Università di Bologna; European Hematology Association","keywords":"Bone marrow; Immune system; Myeloid leukemia; Myeloid cells; Cancer research; Myeloid; Tumor microenvironment; Leukemia; Medicine; Immunology; Biology","score_opus":0.04421120546019155,"score_gpt":0.3496647265720719,"score_spread":0.3054535211118804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226061009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735316,0.019784933,0.00004460362,0.00089298736,0.00419586,0.0005469899,0.00021274673,0.00004063764,0.00074961357],"genre_scores_gemma":[0.8691272,0.006207202,0.000023207405,0.0005259607,0.00006662619,0.00016604489,0.00032729228,0.000053455708,0.12350299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99510103,0.0019577495,0.0012012774,0.0007314791,0.00029893295,0.0007095524],"domain_scores_gemma":[0.99802667,0.0005651286,0.00037624023,0.0008149761,0.00013188235,0.00008509971],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031683526,0.000224692,0.0005643068,0.00017588661,0.0006147372,0.000018491244,0.0005480864,0.00033482345,0.011186538],"category_scores_gemma":[0.00008057566,0.00023075404,0.00029149154,0.00030286232,0.00072140497,0.00012870488,0.0007121388,0.0028991122,0.0005013318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011807962,0.00025147825,0.00006233182,0.000014074106,0.00014370603,0.000004021496,0.00008494321,0.00006360535,0.5902517,0.0000060601233,0.40487957,0.0030576966],"study_design_scores_gemma":[0.0013379508,0.0005523587,0.00016759789,0.000021726693,0.000032591266,0.000008384888,0.00028205532,0.000028659488,0.5972421,0.000013339001,0.40016267,0.00015054375],"about_ca_topic_score_codex":0.0011302516,"about_ca_topic_score_gemma":0.000005249661,"teacher_disagreement_score":0.122753374,"about_ca_system_score_codex":0.001028158,"about_ca_system_score_gemma":0.0003902948,"threshold_uncertainty_score":0.9994012},"labels":[],"label_agreement":null},{"id":"W4226541608","doi":"10.1158/1078-0432.ccr-22-0336","title":"Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Genomics; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"University of Toronto; Ontario Institute for Cancer Research","keywords":"Ovarian cancer; Biology; Serous ovarian cancer; Stage (stratigraphy); Serous fluid; Cancer; Genome; Genetics; Gene","score_opus":0.3034459126468498,"score_gpt":0.49461046412122717,"score_spread":0.1911645514743774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226541608","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06254017,0.015556989,0.000003873953,0.90326685,0.0047777765,0.0027718402,0.0048924633,0.0002177529,0.005972271],"genre_scores_gemma":[0.07933813,0.026299015,0.00075145334,0.62988997,0.12680379,0.018967316,0.012620409,0.001303172,0.10402675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893282,0.0009158102,0.0017915145,0.0027021554,0.0032137088,0.0020486244],"domain_scores_gemma":[0.99326265,0.002422309,0.0005139113,0.002118103,0.00094817614,0.0007348495],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0027541486,0.0007975332,0.0021757772,0.00051100453,0.00072129344,0.00048723893,0.0011705521,0.0014355495,0.027070127],"category_scores_gemma":[0.0003691328,0.0006955959,0.00092494296,0.0012843637,0.00069671514,0.00015503702,0.00096986594,0.012647939,0.00044141227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034577174,0.0005954456,0.0678424,0.00040978842,0.0023945468,0.004442037,0.0004409012,0.000029907313,0.000029121189,0.000027178656,0.9116519,0.008679021],"study_design_scores_gemma":[0.0103045115,0.0011364843,0.042730484,0.0007261673,0.00078588014,0.000005351107,0.000043628443,0.000023095801,0.00002187105,0.00033304776,0.9432549,0.00063459034],"about_ca_topic_score_codex":0.06841059,"about_ca_topic_score_gemma":0.0012103363,"teacher_disagreement_score":0.27337688,"about_ca_system_score_codex":0.0027367335,"about_ca_system_score_gemma":0.0039555314,"threshold_uncertainty_score":0.9998608},"labels":[],"label_agreement":null},{"id":"W4233779081","doi":"10.1158/1078-0432.ccr-15-2119","title":"Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"Enzalutamide; PI3K/AKT/mTOR pathway; Prostate cancer; Androgen receptor; Protein kinase B; Cancer research; Everolimus; Cancer; Biology; Medicine; Pharmacology; Signal transduction; Internal medicine; Cell biology","score_opus":0.3324940879289064,"score_gpt":0.5156486817377322,"score_spread":0.18315459380882576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233779081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484509,0.040080767,0.000016740498,0.0072693317,0.00032353125,0.0032417492,0.00044056616,0.0000216425,0.00015475886],"genre_scores_gemma":[0.96278393,0.029063998,0.00069191394,0.00008485956,0.0012061236,0.0023893823,0.000058910417,0.000055828074,0.0036650777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971961,0.00029685925,0.00061179587,0.0005180396,0.00076240813,0.0006147994],"domain_scores_gemma":[0.9958458,0.0018745719,0.00013437425,0.00039599626,0.00126958,0.00047965802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029264393,0.00017969085,0.00048867066,0.000093895695,0.00029396894,0.000045136272,0.000174694,0.00012867474,0.00013731781],"category_scores_gemma":[0.0007658349,0.00010304183,0.00014188868,0.00036322186,0.0005827678,0.00009200835,0.00007928006,0.0003004283,0.0000071272316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0737349,0.004023396,0.31777042,0.0015493828,0.0032163435,0.00015124422,0.011355362,0.00013695104,0.13297024,0.000341909,0.022464942,0.43228492],"study_design_scores_gemma":[0.075131826,0.044321068,0.04186906,0.0022034263,0.0010766743,0.000022383752,0.012693512,0.0048447866,0.28174898,0.0015757994,0.53340364,0.0011088545],"about_ca_topic_score_codex":0.0019723864,"about_ca_topic_score_gemma":0.00034591122,"teacher_disagreement_score":0.5109387,"about_ca_system_score_codex":0.0004638279,"about_ca_system_score_gemma":0.0023047347,"threshold_uncertainty_score":0.4201924},"labels":[],"label_agreement":null},{"id":"W4245892875","doi":"10.1158/1078-0432.ccr-10-0612","title":"Prognostic Gene Expression Signature for Squamous Cell Carcinoma of Lung","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Lung cancer; Gene signature; Oncology; Proportional hazards model; Microarray; Medicine; Internal medicine; Biology; Gene expression; Gene; Genetics","score_opus":0.08483545460264628,"score_gpt":0.45442803077028016,"score_spread":0.36959257616763386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245892875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498534,0.0020385133,0.0007403601,0.00032906237,0.0005863051,0.0006928255,0.00006370822,0.0000069379107,0.00055695616],"genre_scores_gemma":[0.99544656,0.00014981271,0.000788792,0.00008083975,0.00091421505,0.000443447,0.00009501266,0.00002896764,0.0020523304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824923,0.00018122731,0.00038239916,0.0005339725,0.00032498664,0.000328205],"domain_scores_gemma":[0.9982838,0.00022769433,0.00012204714,0.00057962723,0.00060778076,0.00017906248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011696486,0.000110236055,0.00017224035,0.00006595733,0.00011437706,0.000017747157,0.000379297,0.0004069554,0.00014760664],"category_scores_gemma":[0.0008952883,0.00009174227,0.00014968852,0.0001563737,0.00024657507,0.000003676183,0.00016750449,0.00054274185,0.000003824011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040955032,0.0001707162,0.037653696,0.00009031171,0.000004175893,5.365443e-7,0.000015784613,0.0000070176256,0.9160557,0.000017622891,0.042508435,0.003066476],"study_design_scores_gemma":[0.0010543219,0.00043959153,0.01838151,0.000013444844,0.000010130557,5.605379e-7,0.00003284343,0.00008903864,0.93657565,0.0000734228,0.043216858,0.00011263898],"about_ca_topic_score_codex":0.000018743816,"about_ca_topic_score_gemma":0.000036105273,"teacher_disagreement_score":0.020519959,"about_ca_system_score_codex":0.000012463504,"about_ca_system_score_gemma":0.00046448916,"threshold_uncertainty_score":0.37411413},"labels":[],"label_agreement":null},{"id":"W4253016827","doi":"10.1158/1078-0432.ccr-14-1648","title":"Correction: <i>Bim</i> Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Oncology; Gain of function; Cancer research; Immunology; Leukemia; Biology; Genetics; Mutation; Gene","score_opus":0.04091675697615162,"score_gpt":0.39659206627390964,"score_spread":0.35567530929775804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253016827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429303,0.0000914794,0.000239312,0.0030327565,0.00022732306,0.001456518,0.000015212957,0.000065306485,0.00057903683],"genre_scores_gemma":[0.9934154,0.00033348892,0.00012740165,0.0016216772,0.00051610096,0.0006030131,0.0000103942975,0.000060930615,0.0033116017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951352,0.0010916447,0.000574189,0.0010441695,0.0012692644,0.00088551897],"domain_scores_gemma":[0.9940051,0.003907205,0.00006933392,0.00075951876,0.0003813351,0.00087754324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031002644,0.0002877128,0.0005946431,0.000614525,0.000208454,0.0000729125,0.0002231301,0.00026101526,0.000106190695],"category_scores_gemma":[0.0027563074,0.00020531288,0.00007825469,0.0012847467,0.00066105137,0.00010958634,0.00017692089,0.0009123587,0.00028803098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15795884,0.00081399607,0.734056,0.00003072188,0.0005218397,0.00021874874,0.00024931453,0.00092173094,0.0034750379,0.000110094545,0.006809722,0.09483394],"study_design_scores_gemma":[0.012527733,0.02206552,0.95766175,0.0004411303,0.00009632426,0.00019224387,0.00004442322,0.0018835173,0.0008671226,0.000068006935,0.0039238157,0.00022839542],"about_ca_topic_score_codex":0.0026811368,"about_ca_topic_score_gemma":0.00043712743,"teacher_disagreement_score":0.22360575,"about_ca_system_score_codex":0.0052138404,"about_ca_system_score_gemma":0.0042400695,"threshold_uncertainty_score":0.99860495},"labels":[],"label_agreement":null},{"id":"W4255988408","doi":"10.1158/1078-0432.ccr-18-3495","title":"DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies—Response","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Identification (biology); Medicine; Environmental health; Biology","score_opus":0.18028178170922693,"score_gpt":0.5100405164702307,"score_spread":0.3297587347610038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255988408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7607054,0.0035399229,0.0000012836125,0.2314758,0.00025410848,0.0013211385,0.0023247916,0.000029880064,0.00034765145],"genre_scores_gemma":[0.9382978,0.018505417,0.000025253887,0.03011562,0.0008974801,0.00049731485,0.0008273881,0.000103180006,0.010730516],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9924899,0.0037135014,0.0013895222,0.0007604215,0.0011260378,0.000520649],"domain_scores_gemma":[0.9777057,0.019878998,0.0006668821,0.0006446423,0.00096795656,0.00013583066],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01137188,0.0002631141,0.001195847,0.00032857462,0.00020394963,0.000088577006,0.00020932761,0.00089233136,0.00042661242],"category_scores_gemma":[0.016406279,0.00023381689,0.00014938132,0.0003881104,0.0010563307,0.0000876907,0.00045345185,0.0030141904,0.000071994335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007819169,0.00011268388,0.30692068,0.00081619987,0.000987276,0.00004289361,0.000272507,1.8074181e-7,0.00022555285,0.000003892223,0.68693215,0.0029040668],"study_design_scores_gemma":[0.0023725142,0.0005471389,0.88686574,0.00045180906,0.00019278056,0.0000064053556,0.00024302654,0.000033054563,0.000025064915,0.00048449362,0.10855994,0.00021803667],"about_ca_topic_score_codex":0.0003439459,"about_ca_topic_score_gemma":0.00033660926,"teacher_disagreement_score":0.5799451,"about_ca_system_score_codex":0.00030152017,"about_ca_system_score_gemma":0.00084320817,"threshold_uncertainty_score":0.9992859},"labels":[],"label_agreement":null},{"id":"W4280651407","doi":"10.1158/1078-0432.ccr-21-3811","title":"VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital; Sunnybrook Health Science Centre","funders":"Roche","keywords":"Fulvestrant; Venetoclax; Internal medicine; Medicine; Metastatic breast cancer; Oncology; Cancer; Clinical endpoint; Breast cancer; Hazard ratio; Estrogen receptor; Randomized controlled trial; Confidence interval; Leukemia; Chronic lymphocytic leukemia","score_opus":0.11383709289944145,"score_gpt":0.5007041477483942,"score_spread":0.3868670548489528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280651407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98068357,0.0076432857,0.0000053402073,0.0060159555,0.00023014606,0.0041622682,0.0011654991,0.000024576137,0.00006934868],"genre_scores_gemma":[0.9959809,0.0024476522,0.000063398526,0.00018830273,0.00014852546,0.0009069135,0.000041426058,0.000056163375,0.00016670545],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9925726,0.0028211318,0.0016960829,0.0009939309,0.0012427707,0.00067346485],"domain_scores_gemma":[0.9943175,0.0039458456,0.00034037986,0.0005241305,0.0004872963,0.0003848924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077094906,0.00029685194,0.001665104,0.0004464665,0.00038692786,0.000021458049,0.00024379347,0.00008599925,0.00029194722],"category_scores_gemma":[0.0009939471,0.00024560108,0.00016795199,0.0009980707,0.0016539671,0.0001250778,0.0007560672,0.0014046265,0.0000010311812],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79553854,0.004352515,0.0032587335,0.00014339596,0.00097165257,0.00023252766,0.00415129,0.00021740331,0.0020090654,0.00003136621,0.000107663705,0.18898582],"study_design_scores_gemma":[0.8150595,0.014251287,0.15981013,0.00066272035,0.0005052732,0.00012513997,0.006206076,0.0007668412,0.0002502483,0.00016778464,0.0017784197,0.0004165972],"about_ca_topic_score_codex":0.0070374887,"about_ca_topic_score_gemma":0.0012244688,"teacher_disagreement_score":0.18856923,"about_ca_system_score_codex":0.0007795745,"about_ca_system_score_gemma":0.0014870804,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W4282922005","doi":"10.1158/1078-0432.ccr-20-4774","title":"Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Human Genome Research Institute; National Cancer Institute; National Institutes of Health; Eli Lilly and Company; Universitätsklinikum Erlangen; National Institute of General Medical Sciences; Sanofi; AstraZeneca; Chugai Pharmaceutical; Breast Cancer Research Foundation","keywords":"Genome-wide association study; Biology; Locus (genetics); Genotyping; Breast cancer; Genotype; Chemotherapy; Genetic association; Genetics; Gene; Oncology; Cancer; Medicine; Single-nucleotide polymorphism","score_opus":0.06316643415099286,"score_gpt":0.4527562737164417,"score_spread":0.38958983956544885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282922005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703985,0.00020952494,0.00000630313,0.0013870546,0.000098070275,0.00094886357,0.00016288203,0.000015162626,0.00013227451],"genre_scores_gemma":[0.9968749,0.000168955,0.00001082485,0.00036498188,0.000107503474,0.0014629982,0.000023370776,0.00004076964,0.00094564655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729395,0.00038858617,0.00052464806,0.00042645418,0.0010126182,0.00035372758],"domain_scores_gemma":[0.9985281,0.00014032828,0.0001608634,0.00037539186,0.0006628057,0.00013247377],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010034704,0.00011303161,0.00035697973,0.0001743435,0.00012456758,0.000018666371,0.00017669312,0.00004994831,0.0028974942],"category_scores_gemma":[0.000032918553,0.0000862185,0.00006311389,0.0011383627,0.00032889447,0.00006689371,0.00008670875,0.0008450206,0.000007036801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006484591,0.00097516313,0.9830439,0.00003051534,0.00012932766,0.000012957215,0.00012351174,0.00020552034,0.00017445105,0.0000057451966,0.00080253696,0.00801177],"study_design_scores_gemma":[0.008841773,0.0010893466,0.98875386,0.00010969246,0.000050992152,0.000002327567,0.000049437946,0.000039147075,0.00019907474,0.000021954242,0.0007373654,0.00010500954],"about_ca_topic_score_codex":0.0019447022,"about_ca_topic_score_gemma":0.0026999952,"teacher_disagreement_score":0.007906761,"about_ca_system_score_codex":0.000728243,"about_ca_system_score_gemma":0.00095853553,"threshold_uncertainty_score":0.998014},"labels":[],"label_agreement":null},{"id":"W4282935821","doi":"10.1158/1078-0432.ccr-21-4020","title":"First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Genentech","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Pharmacokinetics; Cancer; Nausea; Agonist; Oncology; Gastroenterology; Receptor","score_opus":0.11390939730489072,"score_gpt":0.5092122895520722,"score_spread":0.3953028922471815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282935821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606186,0.00023712995,1.3366703e-7,0.001100923,0.00016825707,0.00207729,0.0000306047,0.000008338787,0.00031545127],"genre_scores_gemma":[0.9987268,0.000056352408,0.000004538237,0.00019461596,0.000052413703,0.00056897476,0.000007821744,0.000025481684,0.0003629976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996557,0.00061758363,0.0007787962,0.00042833362,0.0012005259,0.00041778217],"domain_scores_gemma":[0.99866635,0.00030406183,0.0001447334,0.0006235627,0.00016995159,0.00009135447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002301362,0.00011874686,0.00045363395,0.0001852914,0.00029031045,0.000010873201,0.00041833657,0.00004160403,0.00063617475],"category_scores_gemma":[0.00017663221,0.000078692974,0.00009933233,0.0012299254,0.00043420042,0.000042690543,0.00029449537,0.0012070327,0.0000011481793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027541308,0.0100447405,0.949754,0.00005919481,0.00007483109,0.00003896402,0.0008995294,0.0001661751,0.00015294501,0.0000073866763,0.00044671312,0.010814191],"study_design_scores_gemma":[0.04085121,0.013695395,0.9397453,0.00018968566,0.000014391892,6.4323706e-7,0.0021693662,0.000038515813,0.00013048641,0.00001998012,0.0030432937,0.00010172983],"about_ca_topic_score_codex":0.0022945367,"about_ca_topic_score_gemma":0.00541274,"teacher_disagreement_score":0.013309901,"about_ca_system_score_codex":0.0005309102,"about_ca_system_score_gemma":0.00050873467,"threshold_uncertainty_score":0.69656676},"labels":[],"label_agreement":null},{"id":"W4282937035","doi":"10.1158/1078-0432.ccr-21-3648","title":"Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"National Cancer Institute","keywords":"Lenalidomide; Medicine; Internal medicine; Rituximab; Hazard ratio; Clinical endpoint; Propensity score matching; Diffuse large B-cell lymphoma; Oncology; Cohort; Surgery; Lymphoma; Multiple myeloma; Clinical trial; Confidence interval","score_opus":0.3554271189949901,"score_gpt":0.5253473410827839,"score_spread":0.16992022208779384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096596,0.0013234626,0.0000050698013,0.0011062401,0.0007520624,0.0054097464,0.00022560213,0.00004549831,0.00016633404],"genre_scores_gemma":[0.9927821,0.0003222973,0.000113205875,0.00010121697,0.00052447856,0.005373432,0.0001405282,0.000055418604,0.00058729335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99514794,0.0009907102,0.0010231513,0.0008588265,0.0014835994,0.00049578067],"domain_scores_gemma":[0.99345756,0.00411504,0.0003058615,0.0008568737,0.0010019582,0.00026272796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054589943,0.00021345,0.0009782689,0.00015973636,0.0004120277,0.000031203723,0.00036104568,0.00013040396,0.0004914759],"category_scores_gemma":[0.0017522849,0.00017532977,0.00033192348,0.0004698551,0.0002834873,0.000116492774,0.00024224831,0.00072185183,0.0000064956735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04293278,0.009583791,0.93823403,0.00010859475,0.0017948445,0.00005013164,0.0016501365,0.000030459121,0.0005874795,0.00024692208,0.0020618602,0.0027189644],"study_design_scores_gemma":[0.059344236,0.016564954,0.916034,0.000074811265,0.00032858827,0.0000037132133,0.0061656656,0.00026162542,0.00019622152,0.000062680236,0.0008045196,0.00015899588],"about_ca_topic_score_codex":0.001472124,"about_ca_topic_score_gemma":0.00026491037,"teacher_disagreement_score":0.02220005,"about_ca_system_score_codex":0.00283812,"about_ca_system_score_gemma":0.0019329552,"threshold_uncertainty_score":0.74215853},"labels":[],"label_agreement":null},{"id":"W4282945728","doi":"10.1158/1078-0432.ccr-22-0541","title":"PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NYU Grossman School of Medicine; York University; U.S. Department of Veterans Affairs","keywords":"Immunotherapy; Agonism; Cancer immunotherapy; Tumor microenvironment; Immune system; Cancer research; Medicine; Immunology; Political science","score_opus":0.3209360935131581,"score_gpt":0.5552180262642052,"score_spread":0.23428193275104714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282945728","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043083083,0.053193815,0.000012499386,0.8836982,0.0033066794,0.0028232858,0.00030342554,0.00014051373,0.013438487],"genre_scores_gemma":[0.008358395,0.058644045,0.0001838447,0.74262196,0.021649437,0.00067091297,0.0006434643,0.00046756913,0.1667604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914151,0.0011719309,0.001959029,0.0012341075,0.0029289972,0.0012908672],"domain_scores_gemma":[0.9948268,0.0019632806,0.0005602646,0.0016753632,0.0006114957,0.0003628015],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0049497657,0.0004931762,0.0016198765,0.00053596625,0.00037238962,0.00013382132,0.0011866904,0.0015404546,0.0385412],"category_scores_gemma":[0.0006044136,0.00043381873,0.0012556341,0.0011346891,0.0014974703,0.00008543195,0.00036700763,0.011212972,0.0001075354],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013034952,0.0001956169,0.0006140188,0.00043178035,0.0010923116,0.0006466089,0.00019872612,0.000002002122,0.0014564095,0.000015803344,0.8474661,0.13484564],"study_design_scores_gemma":[0.0062319604,0.0037101517,0.002589101,0.0006574402,0.000095124626,0.00005352543,0.00011163514,0.0000054984307,0.0005409688,0.00089818635,0.98470587,0.0004005249],"about_ca_topic_score_codex":0.012755331,"about_ca_topic_score_gemma":0.00011061499,"teacher_disagreement_score":0.1533219,"about_ca_system_score_codex":0.000842826,"about_ca_system_score_gemma":0.012247872,"threshold_uncertainty_score":0.99981135},"labels":[],"label_agreement":null},{"id":"W4285026485","doi":"10.1158/1078-0432.ccr-21-3817","title":"Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; BC Cancer Foundation; Servier; Cancer Institute NSW; Department of Health and Social Care; Evans Medical Foundation; National Institute for Health and Care Research; National Health and Medical Research Council; American Society of Hematology; Cancer Research UK; Michael Smith Health Research BC; Cycle for Survival; Bristol-Myers Squibb; AstraZeneca; Damon Runyon Cancer Research Foundation; NIHR Cambridge Biomedical Research Centre; Breast Cancer Research Foundation","keywords":"Disease; Ovarian carcinoma; Ovarian cancer; Carcinoma; Medicine; Oncology; Pathology; Internal medicine; Biology; Cancer","score_opus":0.08317223521178556,"score_gpt":0.4592187793860846,"score_spread":0.376046544174299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285026485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956304,0.0034218486,0.000008220662,0.00032087296,0.00006824392,0.00023166598,0.00018684863,0.0000047275826,0.00012719075],"genre_scores_gemma":[0.99878275,0.00062899315,0.000018987881,0.00016472103,0.00006977276,0.00011085678,0.000024328423,0.000023760664,0.0001758128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984629,0.0003578336,0.0002497854,0.0004077649,0.0002719341,0.0002497896],"domain_scores_gemma":[0.99912286,0.00012724413,0.00005596661,0.00037291425,0.0000944757,0.00022656334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079538906,0.00012218609,0.00021677562,0.00004910882,0.00014530787,0.000019600791,0.00018120822,0.00006483076,0.00008361874],"category_scores_gemma":[0.00012520321,0.00008970085,0.00013822014,0.00009203702,0.00025513704,0.0000021382973,0.0003873891,0.0003414367,6.550358e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030025488,0.0006564627,0.8818665,0.00012580804,0.000096811375,0.00003739447,0.00010327485,0.00046913847,0.097926654,0.00006238659,0.001794554,0.013858482],"study_design_scores_gemma":[0.002347789,0.0033336915,0.9546573,0.000021770195,0.000049603314,0.0000044379917,0.00036664432,0.00081883627,0.03465214,0.00022140316,0.0032259652,0.00030041672],"about_ca_topic_score_codex":0.00028453083,"about_ca_topic_score_gemma":0.000012269913,"teacher_disagreement_score":0.07279082,"about_ca_system_score_codex":0.000033740427,"about_ca_system_score_gemma":0.0003307374,"threshold_uncertainty_score":0.36578944},"labels":[],"label_agreement":null},{"id":"W4286716459","doi":"10.1158/1078-0432.ccr-22-1780","title":"WNT Medulloblastoma Limbo: How Low Can We Go?","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Medicine; Biology; Internet privacy; Cancer research; Computer science; Genetics","score_opus":0.256441914147651,"score_gpt":0.5087600331448544,"score_spread":0.2523181189972034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286716459","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026142033,0.0063558654,2.412069e-7,0.96204334,0.0016660452,0.001680916,0.00043037598,0.000094149866,0.0015870014],"genre_scores_gemma":[0.064253435,0.027464855,0.0000851391,0.810402,0.02763014,0.0068120267,0.0012538298,0.00044300788,0.06165557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913731,0.0013432052,0.0008292307,0.001561957,0.0033282016,0.0015642976],"domain_scores_gemma":[0.99367934,0.0032998226,0.00022173037,0.0015108974,0.000621564,0.00066667056],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00222266,0.0005083208,0.0014759518,0.00055042346,0.00037297822,0.00015309882,0.00075864344,0.0011687552,0.011686703],"category_scores_gemma":[0.001280383,0.00040106033,0.00087965146,0.00088494696,0.00077665685,0.000039407754,0.00078740274,0.010762994,0.00048936805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041939912,0.0007390207,0.004695247,0.00054606877,0.00064886844,0.01168559,0.00005287808,9.786015e-7,0.000013886059,0.000014459279,0.9611454,0.02003818],"study_design_scores_gemma":[0.002858859,0.0030607998,0.0025199156,0.0007280353,0.00025307664,0.00006216069,0.000057302153,0.000012589609,0.00020040033,0.00016726663,0.98973525,0.0003443614],"about_ca_topic_score_codex":0.0013834046,"about_ca_topic_score_gemma":0.00061078824,"teacher_disagreement_score":0.15164137,"about_ca_system_score_codex":0.0015982284,"about_ca_system_score_gemma":0.0024581028,"threshold_uncertainty_score":0.99984413},"labels":[],"label_agreement":null},{"id":"W4290975632","doi":"10.1158/1078-0432.ccr-22-1623","title":"Taking the Road Less Traveled: Following Molecular Trail Markers","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Scope (computer science); Medicine; Targeted therapy; Cancer; Internal medicine","score_opus":0.2958377884899446,"score_gpt":0.5160971397425603,"score_spread":0.22025935125261575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290975632","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027014209,0.010430254,0.000007160705,0.9411117,0.002345304,0.0021962114,0.00013165684,0.00006290128,0.016700616],"genre_scores_gemma":[0.22899142,0.005141457,0.000107271895,0.73685026,0.011880336,0.005332218,0.00038285714,0.00036010108,0.010954073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913162,0.0019834035,0.0010196517,0.0013736886,0.003004624,0.0013024154],"domain_scores_gemma":[0.9952087,0.0024930453,0.00028538288,0.0015043474,0.0002306739,0.0002778463],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005233734,0.0004411711,0.0011735809,0.00025481777,0.0005854573,0.00015938217,0.0009093252,0.00078620925,0.0103436215],"category_scores_gemma":[0.00081227167,0.00030416198,0.0014533715,0.00080197107,0.00051578187,0.000046269743,0.00043014932,0.0105090765,0.0000769602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041281493,0.00020498357,0.003654856,0.00021150385,0.001624681,0.008297182,0.000097312484,0.0000044540907,0.0000067104706,0.00002253206,0.80678636,0.17867662],"study_design_scores_gemma":[0.0029135183,0.0010230901,0.02224173,0.0005734667,0.00068765355,0.000025416663,0.00023647975,0.000027491751,0.000031029296,0.0000992147,0.97181594,0.00032496854],"about_ca_topic_score_codex":0.003592885,"about_ca_topic_score_gemma":0.00013916157,"teacher_disagreement_score":0.20426142,"about_ca_system_score_codex":0.0012907019,"about_ca_system_score_gemma":0.0023010038,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W4293145363","doi":"10.1158/1078-0432.1319.11.3","title":"Transcriptional Profiling Identifies Gene Expression Changes Associated with IFN-α Tolerance in Hepatitis C–Related Hepatocellular Carcinoma Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Hepatocellular carcinoma; Hepatitis C virus; Biology; Gene expression; Gene expression profiling; DNA microarray; Cell culture; Microarray; Hepatitis B virus; Gene; Microarray analysis techniques; Interferon; Fold change; Virology; Cancer research; Cytotoxic T cell; Molecular biology; Virus; Genetics; In vitro","score_opus":0.09923167277216344,"score_gpt":0.38477752177957,"score_spread":0.28554584900740654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293145363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867222,0.010840258,0.000017571185,0.0009322892,0.0005906496,0.00053148833,0.00007491155,0.0000505426,0.00024013473],"genre_scores_gemma":[0.98746794,0.0016972543,0.000049502196,0.00013113234,0.00009794263,0.00023104827,0.00010991499,0.000032677224,0.010182565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99607456,0.0017506597,0.00065784925,0.0005691603,0.00020559954,0.000742152],"domain_scores_gemma":[0.9984272,0.0007556879,0.00011695578,0.00030841047,0.00033652625,0.000055231605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022672154,0.00019952371,0.00045673852,0.00025337038,0.00025102703,0.00003782734,0.00037890102,0.00046795735,0.0012249734],"category_scores_gemma":[0.00029006167,0.00016394611,0.00011204462,0.0003843674,0.0006767119,0.00013853693,0.000100302066,0.0014475081,0.00026920624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002008073,0.0008950017,0.09459373,0.000027278187,0.00009318551,0.000043805514,0.00057074986,0.000031912237,0.89785576,0.00004772394,0.0012012499,0.002631508],"study_design_scores_gemma":[0.005272583,0.00057116343,0.06995904,0.0003676215,0.000014010747,0.000008142431,0.00014795408,0.00027923897,0.91757345,0.00002851021,0.005548118,0.00023016908],"about_ca_topic_score_codex":0.0006900624,"about_ca_topic_score_gemma":0.0017604105,"teacher_disagreement_score":0.024634698,"about_ca_system_score_codex":0.00021624571,"about_ca_system_score_gemma":0.00029967047,"threshold_uncertainty_score":0.999688},"labels":[],"label_agreement":null},{"id":"W4293253462","doi":"10.1158/1078-0432.ccr-22-1183","title":"Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Venetoclax; Azacitidine; Cytogenetics; Medicine; Oncology; Genetics; Internal medicine; Biology; Leukemia; DNA methylation; Gene; Chromosome; Chronic lymphocytic leukemia","score_opus":0.10386829991800524,"score_gpt":0.45484040116070207,"score_spread":0.35097210124269684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293253462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952337,0.00013570455,0.00001801093,0.0015520408,0.00002163506,0.002391724,0.00023831526,0.000047424513,0.00036142088],"genre_scores_gemma":[0.99433917,0.00031070758,0.00094825553,0.00039139687,0.00007763236,0.001086199,0.00012200023,0.0001051484,0.0026194747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99475205,0.00090275024,0.00057097594,0.0008509965,0.0020402502,0.0008829842],"domain_scores_gemma":[0.99667615,0.0012575847,0.00013866044,0.0006398338,0.0007467979,0.00054096425],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017909498,0.00027604474,0.0007963125,0.00043735275,0.00044798764,0.00005234032,0.0003045771,0.0001125292,0.0004664743],"category_scores_gemma":[0.0004920615,0.00015983818,0.00004892613,0.001780649,0.0011510359,0.00009055087,0.00035000904,0.002465609,0.000010719497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02592536,0.00054198777,0.9672383,0.000061917955,0.00026194853,0.000286796,0.00017990565,0.00029027276,0.000013026807,0.000007674547,0.00054384104,0.004648944],"study_design_scores_gemma":[0.025486609,0.017716229,0.951796,0.00013995379,0.00014539197,0.00003106933,0.0005918828,0.0007066701,0.00012879768,0.000015605554,0.0029683998,0.00027339853],"about_ca_topic_score_codex":0.0025040607,"about_ca_topic_score_gemma":0.0029367367,"teacher_disagreement_score":0.01717424,"about_ca_system_score_codex":0.0012398007,"about_ca_system_score_gemma":0.0033146678,"threshold_uncertainty_score":0.9998357},"labels":[],"label_agreement":null},{"id":"W4293493167","doi":"10.1158/1078-0432.ccr-22-1665","title":"A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; London Health Sciences Centre; Ontario Institute for Cancer Research; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Radiological Society of North America","keywords":"Metformin; Medicine; Tumor hypoxia; Clinical endpoint; Cervical cancer; Internal medicine; Cancer; Phases of clinical research; Hypoxia (environmental); Randomized controlled trial; Nuclear medicine; Gastroenterology; Clinical trial; Radiation therapy; Insulin","score_opus":0.09879995500953231,"score_gpt":0.4950499952168761,"score_spread":0.3962500402073438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293493167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951651,0.045429144,0.000067987625,0.00021609053,0.00039870274,0.0018982211,0.000095040596,0.000007802166,0.00023602598],"genre_scores_gemma":[0.9477174,0.044977322,0.00022450993,0.00039995424,0.0007386287,0.004876231,0.00006625555,0.000042604177,0.0009570632],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957677,0.0013067756,0.00090830744,0.00063900737,0.000855508,0.0005227036],"domain_scores_gemma":[0.99843705,0.00031561058,0.00025106734,0.00047264257,0.00033793988,0.00018570137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0055567245,0.00018082168,0.0009506626,0.00013493134,0.00016861221,0.000014615711,0.00045219992,0.00015369756,0.0011003832],"category_scores_gemma":[0.00093552645,0.00013185637,0.00021009371,0.00061321264,0.0005266819,0.0000107757605,0.00035522136,0.00067961763,0.0000013945553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75627905,0.0012372755,0.00027793602,0.000044838205,0.00011192615,0.000004524431,0.00009528466,0.0002478184,0.0016526848,0.000029570578,0.0006749386,0.23934415],"study_design_scores_gemma":[0.8591546,0.0076785204,0.00002821674,0.000043685308,0.000057030396,0.0000012510135,0.00016995665,0.00079365895,0.012177588,0.000097267686,0.1195713,0.00022696628],"about_ca_topic_score_codex":0.0006292549,"about_ca_topic_score_gemma":0.001480971,"teacher_disagreement_score":0.23911718,"about_ca_system_score_codex":0.00011666014,"about_ca_system_score_gemma":0.0020737324,"threshold_uncertainty_score":0.9998127},"labels":[],"label_agreement":null},{"id":"W4293755987","doi":"10.1158/1078-0432.ccr-22-0931","title":"Detection of <i>BRCA1</i> , <i>BRCA2</i> , and <i>ATM</i> Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; BC Cancer Agency","funders":"MSD K.K.; Merck Sharp and Dohme; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Cancer; Prostate cancer; Concordance; Prostate; Oncology; Internal medicine; Cancer research; Frameshift mutation; Pathology; Gene; Mutation; Biology; Genetics","score_opus":0.07236811365894866,"score_gpt":0.42781302760158463,"score_spread":0.355444913942636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293755987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327385,0.0021630516,0.0000014310095,0.0013353896,0.000067559,0.0029153654,0.000095506824,0.000013005183,0.00013483081],"genre_scores_gemma":[0.9968532,0.00055109395,0.0000572635,0.00018146007,0.000058958998,0.002001251,0.000036527694,0.00004011224,0.00022016652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963249,0.00064198155,0.00079139683,0.00068696233,0.0009107217,0.00064401125],"domain_scores_gemma":[0.99868554,0.00042256596,0.00013804025,0.00027016885,0.00027578263,0.00020789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023722397,0.00018112067,0.00058347575,0.00048830983,0.00018715016,0.000037942256,0.00011938081,0.000060081686,0.00007832194],"category_scores_gemma":[0.00022795073,0.00015091748,0.000031765918,0.0014748651,0.0004602154,0.00017717535,0.00027967533,0.0012753903,9.03971e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007922601,0.00074439356,0.96999997,0.00037354996,0.00003637042,0.0001302128,0.00086961454,0.00008622089,0.004610151,0.00000924159,0.000028967823,0.015188703],"study_design_scores_gemma":[0.01687388,0.00249278,0.9738167,0.000588354,0.000020482708,0.0000074308446,0.0007363914,0.00060438295,0.0041905446,0.00012411398,0.00035698726,0.0001879508],"about_ca_topic_score_codex":0.006675632,"about_ca_topic_score_gemma":0.010091564,"teacher_disagreement_score":0.015000752,"about_ca_system_score_codex":0.00067594636,"about_ca_system_score_gemma":0.0009133814,"threshold_uncertainty_score":0.999939},"labels":[],"label_agreement":null},{"id":"W4295279694","doi":"10.1158/1078-0432.ccr-22-2365","title":"Multi-omics Uncovering Different Faces of Clear Cell Ovarian Cancer","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Histopathology; Transcriptome; Omics; Cancer; Bioinformatics; Medicine; Computational biology; Biology; Oncology; Pathology; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.29137582988529676,"score_gpt":0.5071514451621641,"score_spread":0.2157756152768674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295279694","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15714885,0.018902972,0.000014179764,0.8093775,0.004965855,0.003948943,0.0029687625,0.0001103692,0.0025625855],"genre_scores_gemma":[0.30470318,0.1834592,0.0012033287,0.42239153,0.028127417,0.009429453,0.001607366,0.001046625,0.048031904],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99323916,0.0008361027,0.0013649716,0.0013776375,0.002086653,0.0010954872],"domain_scores_gemma":[0.99572486,0.0017016558,0.0004412279,0.0012895418,0.00049000466,0.00035270784],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001438277,0.00050133694,0.0017369471,0.0003687279,0.00024208403,0.00006393846,0.0006754154,0.0009242793,0.010904157],"category_scores_gemma":[0.00024390129,0.00040533362,0.0007536298,0.0005269486,0.00054138905,0.000051606425,0.0007762808,0.007277746,0.000054741562],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014576567,0.001466942,0.06623958,0.0020602194,0.0010759267,0.00083691033,0.00015521569,0.00008857042,0.0000951159,0.0000065552595,0.9142271,0.012290175],"study_design_scores_gemma":[0.0058848197,0.0021051823,0.03490962,0.00071956636,0.00048724347,0.000003828765,0.00008936404,0.000099059136,0.00095009344,0.000035201836,0.95432067,0.00039533785],"about_ca_topic_score_codex":0.0067549446,"about_ca_topic_score_gemma":0.00044215602,"teacher_disagreement_score":0.38698596,"about_ca_system_score_codex":0.0018686856,"about_ca_system_score_gemma":0.002102565,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W4295926274","doi":"10.1158/1557-3265.sarcomas22-ia004","title":"Abstract IA004: Mesenchymal progenitors and sarcomagenesis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mesenchymal stem cell; Biology; Malignancy; Progenitor cell; Synovial sarcoma; Cancer research; Oncogene; Gene expression profiling; Sarcoma; Pathology; Cell; Gene expression; Cell biology; Stem cell; Medicine; Gene; Cell cycle; Genetics","score_opus":0.3176879498878943,"score_gpt":0.5495010493922831,"score_spread":0.23181309950438878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787275,0.01047912,2.5660927e-7,0.008117278,0.00024116118,0.0006706992,0.0000337389,0.00003527475,0.0016949428],"genre_scores_gemma":[0.9956416,0.0016314619,0.00012468047,0.00039321146,0.0004612718,0.0009997473,0.000012517725,0.00002737462,0.0007081159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973785,0.00032377843,0.0003918727,0.0004894765,0.00096838456,0.00044795207],"domain_scores_gemma":[0.9980787,0.0009870447,0.000046075056,0.0003589472,0.00015681748,0.00037242105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021868667,0.00011168493,0.00032306268,0.00013907667,0.00042148124,0.00003108764,0.000143997,0.00006349408,0.0030465815],"category_scores_gemma":[0.0003455494,0.00009062233,0.00015571598,0.00037923688,0.00030272244,0.000035296194,0.0003817723,0.0008149841,0.000055723445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045117384,0.0011326438,0.7959325,0.00004457122,0.00013503975,0.0004939233,0.000059707058,0.0000013338348,0.0001824922,0.00007810818,0.012616593,0.1888719],"study_design_scores_gemma":[0.001956292,0.00078626163,0.9224299,0.000027949047,0.000053555214,0.00004058777,0.00028355618,0.000027237451,0.000552086,0.00017526417,0.073569015,0.000098281715],"about_ca_topic_score_codex":0.0006201773,"about_ca_topic_score_gemma":0.000042462954,"teacher_disagreement_score":0.18877363,"about_ca_system_score_codex":0.00021810777,"about_ca_system_score_gemma":0.0004432086,"threshold_uncertainty_score":0.9978648},"labels":[],"label_agreement":null},{"id":"W4295926377","doi":"10.1158/1557-3265.sarcomas22-ia013","title":"Abstract IA013: Rhabdomyosarcoma: visions through the looking glass","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Skeletal muscle; Rhabdomyosarcoma; Biology; Reprogramming; Myogenesis; Progenitor cell; Transdifferentiation; PAX3; Cell biology; Hedgehog signaling pathway; Cancer research; Pathology; Stem cell; Endocrinology; Sarcoma; Cell; Medicine; Genetics; Signal transduction; Transcription factor","score_opus":0.3047955314711789,"score_gpt":0.5562692599534251,"score_spread":0.25147372848224625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9046514,0.010974195,0.0000052468276,0.068426885,0.00072888023,0.0011597681,0.000053559794,0.00006450632,0.013935527],"genre_scores_gemma":[0.9928156,0.001745189,0.000097221986,0.002374852,0.0007254536,0.0011588417,0.000017513477,0.000036372498,0.0010289229],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632007,0.00047770527,0.0005687916,0.0005319168,0.0014752316,0.00062629225],"domain_scores_gemma":[0.99518085,0.0034775245,0.00008343159,0.00082802936,0.00021333584,0.00021684088],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030494472,0.0001406669,0.00037088981,0.000075572854,0.0011526687,0.000054381137,0.00044453432,0.000075153315,0.0057554585],"category_scores_gemma":[0.0006062649,0.00008763285,0.0003351179,0.0006314253,0.00046425383,0.00005845948,0.00069023884,0.0020268983,0.00021023187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012843573,0.005404219,0.53895867,0.00007488132,0.00058320747,0.0014033436,0.00078859,0.00007896504,0.00015035637,0.0044605965,0.2473703,0.19944252],"study_design_scores_gemma":[0.0023111894,0.0006005226,0.46514973,0.000068508234,0.00006583807,0.000032820666,0.0008994886,0.00006010352,0.00011606442,0.0015018232,0.52908754,0.00010634395],"about_ca_topic_score_codex":0.0017021789,"about_ca_topic_score_gemma":0.00013069059,"teacher_disagreement_score":0.28171724,"about_ca_system_score_codex":0.00040755508,"about_ca_system_score_gemma":0.0006218199,"threshold_uncertainty_score":0.9951534},"labels":[],"label_agreement":null},{"id":"W4295926608","doi":"10.1158/1557-3265.sarcomas22-pr009","title":"Abstract PR009: A new invasive zebrafish model of ewing sarcoma reveals EWSR1-FLI1-driven dysregulation of heparan sulfate proteoglycan metabolism and ERK signaling in developing tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Biology; Tumor microenvironment; Sarcoma; Cancer research; FLI1; Angiogenesis; Metastasis; Oncogene; Cancer; Extracellular matrix; Tumor progression; Pathology; Cell biology; Medicine; Genetics; Cell cycle; Gene; Transcription factor","score_opus":0.2603058729008565,"score_gpt":0.46422186871624077,"score_spread":0.20391599581538428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296576,0.0023282287,0.000021509926,0.0028535733,0.000044959317,0.001630699,0.000041871055,0.0000130524495,0.0001003747],"genre_scores_gemma":[0.99606425,0.0005751673,0.0025551124,0.00015909794,0.00010584705,0.00042689734,0.000022586044,0.000033505537,0.00005755164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963736,0.00044153407,0.001232367,0.0005157268,0.000983842,0.00045292897],"domain_scores_gemma":[0.9975722,0.0012360073,0.00032424336,0.0003302657,0.0003021987,0.0002351193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028957431,0.0001692204,0.00085808936,0.00039315553,0.00014170872,0.000018253495,0.00020604274,0.000092768416,0.00012319509],"category_scores_gemma":[0.0008734569,0.0001540638,0.00015381971,0.00070544984,0.00021961424,0.00011376289,0.00030868227,0.00071861816,0.0000011282345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029286058,0.0011408761,0.9062933,0.00089899317,0.00035967014,0.00017018916,0.0022491924,0.006918816,0.042569112,0.001268038,0.0005282901,0.034674924],"study_design_scores_gemma":[0.0052607656,0.0004469383,0.96143,0.0012653418,0.00008117919,0.000007778518,0.0004152537,0.0026210328,0.024984382,0.0031726838,0.00012417245,0.00019046837],"about_ca_topic_score_codex":0.0026054236,"about_ca_topic_score_gemma":0.0004315382,"teacher_disagreement_score":0.055136714,"about_ca_system_score_codex":0.00031394532,"about_ca_system_score_gemma":0.0017591234,"threshold_uncertainty_score":0.62825394},"labels":[],"label_agreement":null},{"id":"W4295926931","doi":"10.1158/1557-3265.sarcomas22-b017","title":"Abstract B017: Tumor-secreted collagen VI weakens endothelium and promotes metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intravasation; Extravasation; Metastasis; Sarcoma; Alveolar soft part sarcoma; Pathology; Cancer research; Synovial sarcoma; Extracellular matrix; Cancer; Tumor microenvironment; Medicine; Biology; Internal medicine; Cell biology","score_opus":0.11993578108711443,"score_gpt":0.4463411391255693,"score_spread":0.32640535803845483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751747,0.019417418,0.000009178413,0.0011473802,0.0011566038,0.0006407079,0.00050633436,0.000021043268,0.0019266361],"genre_scores_gemma":[0.9867469,0.0064664083,0.00012454805,0.0005824266,0.0025039935,0.00055130303,0.00008282654,0.000053189866,0.0028883684],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968767,0.0006197569,0.0004719069,0.000774811,0.0006280061,0.0006288247],"domain_scores_gemma":[0.99854964,0.00020874794,0.00010935624,0.00056045444,0.00025001165,0.0003217938],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032843007,0.00017686095,0.0003504048,0.000097598306,0.00046777996,0.0000695859,0.00044640165,0.00010960347,0.001174883],"category_scores_gemma":[0.00072780583,0.00016926309,0.00018146097,0.0003084252,0.0004475976,0.00000639967,0.000784076,0.00056877924,0.000015996611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002360693,0.0005713699,0.009403735,0.00017953194,0.0005679196,0.00004911907,0.00021578517,0.000045636458,0.76475704,0.00019883503,0.12981062,0.09183971],"study_design_scores_gemma":[0.0013702787,0.00057197723,0.017533489,0.000010908756,0.000036562604,0.000018262037,0.0002561497,0.000019059422,0.02830035,0.00016199434,0.951479,0.0002419537],"about_ca_topic_score_codex":0.0005345361,"about_ca_topic_score_gemma":0.0003605806,"teacher_disagreement_score":0.8216684,"about_ca_system_score_codex":0.000050418847,"about_ca_system_score_gemma":0.000762331,"threshold_uncertainty_score":0.99973816},"labels":[],"label_agreement":null},{"id":"W4295927922","doi":"10.1158/1557-3265.sarcomas22-a017","title":"Abstract A017: Multiple intratumoral sources of kit ligand promote oncogenic kit signaling in gastrointestinal stomal tumor","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"GiST; Cancer research; Biology; Imatinib; Sarcoma; Receptor tyrosine kinase; Proto-Oncogene Proteins c-kit; Tyrosine kinase; Stromal cell; Signal transduction; Haematopoiesis; Medicine; Pathology; Cell biology; Stem cell factor; Stem cell","score_opus":0.1788180577479082,"score_gpt":0.4708245986269581,"score_spread":0.29200654087904987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295927922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614495,0.0006052084,0.0000050939216,0.001368576,0.00007635618,0.0013148835,0.00009666199,0.00004416646,0.0003440749],"genre_scores_gemma":[0.9972656,0.000024324478,0.0013678434,0.00007185878,0.00034007555,0.00044995052,0.000031563875,0.000056354496,0.0003924386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939141,0.00066378847,0.0012259361,0.00081197586,0.002064373,0.0013198195],"domain_scores_gemma":[0.9962537,0.0017072794,0.00023958719,0.0005205489,0.0005299527,0.0007489116],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0054482906,0.0002661134,0.0007942881,0.00047116567,0.00029176654,0.00004744667,0.00051851367,0.000039945364,0.0012307807],"category_scores_gemma":[0.003615764,0.00023388803,0.0003262094,0.0009980492,0.00074994116,0.000089498644,0.000620323,0.003263705,0.000045885696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009052485,0.003157604,0.9217585,0.00036468846,0.000083823696,0.008452738,0.00014001351,0.0002540918,0.050994623,0.000031112064,0.0006898135,0.005020552],"study_design_scores_gemma":[0.014403127,0.023136774,0.91982836,0.002260811,0.00006913093,0.002679864,0.00156942,0.0021053096,0.03168448,0.00041233978,0.001432748,0.0004176595],"about_ca_topic_score_codex":0.0026230193,"about_ca_topic_score_gemma":0.00036870595,"teacher_disagreement_score":0.01997917,"about_ca_system_score_codex":0.0006444317,"about_ca_system_score_gemma":0.0022033495,"threshold_uncertainty_score":0.99968225},"labels":[],"label_agreement":null},{"id":"W4295928022","doi":"10.1158/1557-3265.sarcomas22-a029","title":"Abstract A029: SQ3370: CAPAC platform enables tumor-localized therapy and minimizes systemic toxicities","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fibrosarcoma; Melanoma; Doxorubicin; Cardiotoxicity; Cancer research; Cancer; Tumor progression; Sarcoma; Pharmacology; Toxicity; Immune system; Chemotherapy; Pathology; Internal medicine; Immunology","score_opus":0.1882774525846776,"score_gpt":0.4036110118378102,"score_spread":0.21533355925313258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295928022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96835387,0.026351113,0.000025907548,0.00013542897,0.0012757888,0.0007219376,0.00023741862,0.00026834614,0.002630185],"genre_scores_gemma":[0.98607665,0.011825457,0.000103893035,0.00018837565,0.0005120914,0.00069821876,0.000015952894,0.0001141245,0.0004652369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966187,0.0001417967,0.0008495528,0.0004628004,0.001043638,0.00088354625],"domain_scores_gemma":[0.9973283,0.0016537318,0.000080162456,0.0005045198,0.00014521519,0.0002880751],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028296835,0.00027701928,0.0005963049,0.00024342918,0.00048781149,0.00012874349,0.0005946772,0.00013639133,0.0015738592],"category_scores_gemma":[0.00017989438,0.00025141574,0.00016239921,0.00046786648,0.000478527,0.00021755781,0.0002532564,0.0016110699,0.000032020413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015636003,0.0013607302,0.042366304,0.0061313487,0.003895696,0.0013254852,0.011954067,0.04557172,0.16273038,0.0086878715,0.19525589,0.5050845],"study_design_scores_gemma":[0.031360403,0.0045192735,0.013732279,0.0015171681,0.00015226583,0.00035133227,0.025584914,0.02257833,0.055782575,0.029656367,0.81022817,0.004536917],"about_ca_topic_score_codex":0.00052343914,"about_ca_topic_score_gemma":0.00010033619,"teacher_disagreement_score":0.6149723,"about_ca_system_score_codex":0.0005568468,"about_ca_system_score_gemma":0.00032440116,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W4295941831","doi":"10.1158/1557-3265.sarcomas22-pr005","title":"Abstract PR005: PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PRC2; Cancer research; Biology; Context (archaeology); EZH2; Cancer; Epigenetics; Genetics","score_opus":0.1878447620197086,"score_gpt":0.5002895845280105,"score_spread":0.31244482250830197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989485,0.00075390155,0.000020519412,0.004157311,0.00024629675,0.00345814,0.000074480675,0.000069836504,0.0017344787],"genre_scores_gemma":[0.9910409,0.0004233605,0.0007068633,0.0012296431,0.00036504798,0.0030592429,0.000058153015,0.00013676772,0.0029800574],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9899815,0.0035171222,0.001468396,0.0013072019,0.0020562722,0.0016695347],"domain_scores_gemma":[0.9940558,0.003972596,0.00015792249,0.0009112062,0.0004144413,0.0004880065],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01128455,0.0003502593,0.00089104305,0.0007873459,0.00042253255,0.00009920953,0.0007091783,0.00020510767,0.009609915],"category_scores_gemma":[0.0020143632,0.00033145375,0.0002649796,0.0024693417,0.0003271965,0.00021134515,0.0005257987,0.0049109985,0.000046193963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054363586,0.0022117659,0.060823165,0.00008165554,0.00005969528,0.0009798914,0.004829666,0.0009518134,0.86625296,0.000024393185,0.00088013936,0.008541291],"study_design_scores_gemma":[0.018513078,0.008683684,0.81183374,0.00043241182,0.000010862889,0.000035292018,0.0066883625,0.0007049505,0.1295875,0.0006380948,0.02208127,0.0007907528],"about_ca_topic_score_codex":0.00843441,"about_ca_topic_score_gemma":0.0009812365,"teacher_disagreement_score":0.75101054,"about_ca_system_score_codex":0.0031207204,"about_ca_system_score_gemma":0.003332015,"threshold_uncertainty_score":0.99991375},"labels":[],"label_agreement":null},{"id":"W4295941875","doi":"10.1158/1557-3265.sarcomas22-ia030","title":"Abstract IA030: A population-based, whole genome sequencing approach to mapping the genetic basis of mesenchymal malignancies","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer; Sarcoma; Population; Germline; Cancer research; Genetics; Medicine; Pathology; Gene","score_opus":0.345362259371808,"score_gpt":0.46008287812621484,"score_spread":0.11472061875440687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901254,0.0029867385,0.000038507194,0.0055921637,0.00010316916,0.0010920034,0.00010195019,0.000019155834,0.0010537624],"genre_scores_gemma":[0.99607044,0.00008063227,0.0011702282,0.00083224423,0.00025971813,0.0013101195,0.000044433375,0.000027533424,0.00020465099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967934,0.0004010655,0.00065526826,0.00046777035,0.0012154427,0.00046704785],"domain_scores_gemma":[0.99755627,0.0012670425,0.000104877894,0.0006023419,0.00024893254,0.00022051281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028100992,0.00012624226,0.00039177708,0.00021277415,0.00042720878,0.00002876343,0.00031955368,0.000057055662,0.00063200603],"category_scores_gemma":[0.0005243343,0.000089028494,0.00023584685,0.00085572095,0.00015832283,0.000023858185,0.00026543037,0.00064046803,0.000025021596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030074982,0.0009558872,0.9686683,0.00019448428,0.00016856064,0.000083621926,0.00058605854,0.008036986,0.0019656755,0.00013491265,0.0014275609,0.017477203],"study_design_scores_gemma":[0.0008656286,0.00033357285,0.9902983,0.00007235839,0.00004008809,0.000008366909,0.001206373,0.0006870861,0.00017839385,0.00009330392,0.0061226063,0.00009397668],"about_ca_topic_score_codex":0.0036908162,"about_ca_topic_score_gemma":0.00007413244,"teacher_disagreement_score":0.021629946,"about_ca_system_score_codex":0.00065237784,"about_ca_system_score_gemma":0.00081264274,"threshold_uncertainty_score":0.69200224},"labels":[],"label_agreement":null},{"id":"W4295941886","doi":"10.1158/1557-3265.sarcomas22-b019","title":"Abstract B019: BRCA1:NRF2 pathway as a new therapeutic target in ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNA damage; FLI1; PARP1; Cancer research; Biology; Transcription factor; Context (archaeology); Phenotype; RNA interference; Sarcoma; Cell biology; Bioinformatics; Medicine; Genetics; RNA; DNA; Gene; Pathology; Poly ADP ribose polymerase; Polymerase","score_opus":0.16525420234078558,"score_gpt":0.4926300326044087,"score_spread":0.3273758302636231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705804,0.0057464936,0.000029973351,0.0035237754,0.00020067992,0.0004274205,0.000023714354,0.000012249804,0.0029776571],"genre_scores_gemma":[0.9875838,0.0010052532,0.00007391528,0.001148598,0.0006290594,0.00019478802,0.00004289561,0.00004113036,0.009280555],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962029,0.0007873375,0.00050311524,0.0006946254,0.0008938608,0.0009181604],"domain_scores_gemma":[0.9984355,0.00031022786,0.000059696977,0.0005707089,0.00012163572,0.0005022408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004655972,0.00014432345,0.00025650806,0.00015358605,0.00031603928,0.00006598479,0.00077974994,0.00014906212,0.001762357],"category_scores_gemma":[0.0011728434,0.00013804348,0.00017524257,0.00047109803,0.00019544567,0.0000075865423,0.0008086185,0.0016008226,0.000073090916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025673877,0.00066227495,0.08790134,0.000059422975,0.0001480987,0.00026609152,0.00016089402,0.00046092898,0.6933464,0.00040140434,0.03366658,0.18035918],"study_design_scores_gemma":[0.005044128,0.0033249492,0.09453866,0.000077257435,0.000006291142,0.00002280261,0.00084530923,0.00052494154,0.05053831,0.0037816088,0.8406663,0.0006294376],"about_ca_topic_score_codex":0.002898702,"about_ca_topic_score_gemma":0.0005077704,"teacher_disagreement_score":0.80699974,"about_ca_system_score_codex":0.00014602291,"about_ca_system_score_gemma":0.0025180853,"threshold_uncertainty_score":0.99915016},"labels":[],"label_agreement":null},{"id":"W4295941939","doi":"10.1158/1557-3265.sarcomas22-a009","title":"Abstract A009: Proteogenomic prioritization of immunotherapeutic targets in rhabdomyosarcoma nominate MEGF10 for preclinical development","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computational biology; Fusion gene; Proteogenomics; Fusion protein; Computer science; Bioinformatics; Medicine; Gene; Biology; Gene expression; Transcriptome; Genetics","score_opus":0.29701397235758425,"score_gpt":0.5497866693933298,"score_spread":0.2527726970357455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934563,0.0010120433,0.00013412327,0.002951198,0.00007747622,0.0018816236,0.00005263917,0.000020323181,0.0004142914],"genre_scores_gemma":[0.9957785,0.00017252508,0.0011781725,0.0003252636,0.00014445795,0.0013815269,0.000078063014,0.00002980879,0.00091165275],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967436,0.00039265252,0.0013115649,0.0004562508,0.0006795194,0.00041637357],"domain_scores_gemma":[0.9980486,0.0009454318,0.00019239252,0.00030897438,0.00035602762,0.00014859365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0062206695,0.00011523725,0.0005192379,0.00033945052,0.00019526434,0.0000133441035,0.00022188651,0.00010741073,0.0015644543],"category_scores_gemma":[0.0007071197,0.00011050128,0.0002456431,0.0005431012,0.00023201854,0.000045897774,0.00016732127,0.0009062131,0.000015613658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024486316,0.011414812,0.21839365,0.002414247,0.0011112008,0.00015597047,0.002031549,0.00045559896,0.16071427,0.00060786627,0.004382576,0.5738319],"study_design_scores_gemma":[0.019689238,0.002784425,0.8041963,0.0012094348,0.00009723804,0.000011542267,0.000800635,0.002750823,0.04187884,0.0013476554,0.12467839,0.00055549823],"about_ca_topic_score_codex":0.0000974258,"about_ca_topic_score_gemma":0.00008031188,"teacher_disagreement_score":0.5858026,"about_ca_system_score_codex":0.00043817045,"about_ca_system_score_gemma":0.0014950644,"threshold_uncertainty_score":0.9993482},"labels":[],"label_agreement":null},{"id":"W4295941942","doi":"10.1158/1557-3265.sarcomas22-ia015","title":"Abstract IA015: ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"TFE3; Enhancer; Chromatin; Biology; Transcription factor; Fusion gene; Chromosomal translocation; Cell biology; Molecular biology; Gene; Genetics","score_opus":0.12438702366991018,"score_gpt":0.4627755114023473,"score_spread":0.3383884877324371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838685,0.010746096,0.00013994225,0.0016757181,0.0009899979,0.000481279,0.0002788147,0.00002541072,0.0017942666],"genre_scores_gemma":[0.9891316,0.0062534446,0.00009095693,0.0007137002,0.0011179845,0.000409781,0.00030414623,0.000061395134,0.0019169576],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708116,0.0002863391,0.00054643815,0.00085340027,0.0006133116,0.00061935734],"domain_scores_gemma":[0.9985626,0.00017224997,0.000102281374,0.00063729123,0.00027439956,0.00025118442],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026864486,0.0001618667,0.00023588297,0.00005622956,0.00046657954,0.00008477933,0.0005451048,0.00017720902,0.0015573775],"category_scores_gemma":[0.0004997926,0.00017432029,0.00018822293,0.00035744443,0.00027549526,0.000005835475,0.00043819472,0.0009633914,0.00004333187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076017063,0.00056332594,0.0049245213,0.000040377403,0.00011061859,0.000022325074,0.000086607855,0.00012379044,0.64966846,0.00008563667,0.22845463,0.115159534],"study_design_scores_gemma":[0.0011911523,0.0010311329,0.0028040998,0.000014302133,0.00001816642,0.000005941067,0.00027451807,0.000027815131,0.06649021,0.00025842545,0.9275856,0.00029861435],"about_ca_topic_score_codex":0.00077232666,"about_ca_topic_score_gemma":0.00033026226,"teacher_disagreement_score":0.699131,"about_ca_system_score_codex":0.00017371941,"about_ca_system_score_gemma":0.00057452905,"threshold_uncertainty_score":0.9993553},"labels":[],"label_agreement":null},{"id":"W4295942126","doi":"10.1158/1557-3265.sarcomas22-a020","title":"Abstract A020: Combined inhibition of SHP2 and CDK4/6 is active in preclinical models of NF1-associated malignant peripheral nerve sheath tumor","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; MAPK/ERK pathway; Kinase; CDKN2A; Cell growth; Cyclin-dependent kinase; Cell cycle; Biology; Medicine; Cell biology; Cancer; Internal medicine","score_opus":0.2322144808109041,"score_gpt":0.47092321202846615,"score_spread":0.23870873121756206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590725,0.00045947952,7.914235e-7,0.0018962456,0.00009917162,0.0007441668,0.00035099094,0.000014540363,0.00052737235],"genre_scores_gemma":[0.9990237,0.0002567489,0.000038390313,0.00026175645,0.000058463218,0.00016257702,0.00003302838,0.0000290306,0.00013635086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99590564,0.0008035577,0.0012949317,0.0005511945,0.0010324153,0.0004122708],"domain_scores_gemma":[0.99729735,0.0014993064,0.00027685697,0.00033916946,0.00037183144,0.00021551797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032350107,0.0001447134,0.0008489234,0.00019106628,0.00010971081,0.000013415085,0.0001476831,0.00012041202,0.0008742088],"category_scores_gemma":[0.00078201824,0.00012817871,0.00022437809,0.0005498508,0.0005282538,0.00011088193,0.00036338484,0.001311112,0.0000013170214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06452819,0.019340476,0.77188736,0.0019376612,0.0007892315,0.0027910613,0.004063912,0.00038205084,0.100793585,0.0015871681,0.014290789,0.017608484],"study_design_scores_gemma":[0.011819359,0.009930063,0.94963723,0.00088101276,0.000083919294,0.000032816843,0.0013221562,0.0052083065,0.018344808,0.0022966685,0.00017658246,0.0002670482],"about_ca_topic_score_codex":0.0012503201,"about_ca_topic_score_gemma":0.00008343259,"teacher_disagreement_score":0.17774987,"about_ca_system_score_codex":0.00020276153,"about_ca_system_score_gemma":0.0006878132,"threshold_uncertainty_score":0.9571973},"labels":[],"label_agreement":null},{"id":"W4295942147","doi":"10.1158/1557-3265.sarcomas22-a030","title":"Abstract A030: Investigating the feasibility of <i>in-vivo</i> histotripsy ablation for osteosarcoma using an orthotopic murine model and a canine model of spontaneous disease","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteosarcoma; Ablation; Amputation; In vivo; Cancer; Surgery; Pathology; Urology; Internal medicine","score_opus":0.30618471270867514,"score_gpt":0.49112171373625557,"score_spread":0.18493700102758043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720454,0.0010108548,0.00009421625,0.00028022533,0.000025168805,0.0009846339,0.0003671795,0.0000032506116,0.000029950432],"genre_scores_gemma":[0.99888253,0.0001516517,0.00042807363,0.00009623807,0.00007507859,0.00019031696,0.000035342047,0.000025639009,0.000115118506],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99759436,0.0005065084,0.0005729172,0.0004791002,0.0005082348,0.00033885892],"domain_scores_gemma":[0.9985329,0.000252486,0.00014414405,0.0005746434,0.0003061373,0.00018967106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041744485,0.000108155946,0.00023975114,0.00007786348,0.00021269446,0.000010828907,0.00036750388,0.00007173035,0.000032618518],"category_scores_gemma":[0.000655999,0.00009490932,0.000099081095,0.00020020061,0.0005307893,0.000008022077,0.00032110495,0.0004196347,4.2478643e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009371021,0.00042857186,0.031438656,0.00020470744,0.00002848899,0.000008245672,0.0001405069,0.332386,0.6229743,0.00004250457,0.00005568523,0.002921346],"study_design_scores_gemma":[0.0026187985,0.003412381,0.0068421746,0.0000408384,0.000022571656,0.000005840662,0.00015522663,0.96320343,0.020873725,0.0025496082,0.00006996066,0.00020544087],"about_ca_topic_score_codex":0.0006287658,"about_ca_topic_score_gemma":0.0028820203,"teacher_disagreement_score":0.6308175,"about_ca_system_score_codex":0.000121164776,"about_ca_system_score_gemma":0.001473212,"threshold_uncertainty_score":0.38702896},"labels":[],"label_agreement":null},{"id":"W4295942165","doi":"10.1158/1557-3265.sarcomas22-b026","title":"Abstract B026: Expression levels of chaperonin containing TCP1 in cancer are among the highest in sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Cancer; Biology; Immunohistochemistry; Cancer research; Rhabdomyosarcoma; Pathology; Carcinogenesis; Chaperonin; Medicine; Gene; Genetics","score_opus":0.23654894479987706,"score_gpt":0.5082964728689009,"score_spread":0.2717475280690238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925102,0.0037948997,0.000004057699,0.0021636174,0.000120022836,0.0007842777,0.00009967285,0.0000041668336,0.000519105],"genre_scores_gemma":[0.9969831,0.0008189599,0.000016209195,0.00011157598,0.00024409605,0.0013352566,0.000011920283,0.000034473014,0.000444412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534947,0.0015725039,0.0007304144,0.0006326175,0.0009641981,0.000750812],"domain_scores_gemma":[0.9983415,0.0005478561,0.00012677733,0.0006312316,0.00020257654,0.00015005407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006938884,0.00014009986,0.0003336679,0.00018393798,0.00022960447,0.00002347561,0.0009380883,0.00019441037,0.001056247],"category_scores_gemma":[0.0012038596,0.00011178167,0.00010827531,0.0005895527,0.0005878622,0.000009441053,0.0013504127,0.0019790332,0.0000041589074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011149498,0.0003720549,0.61522996,0.00007855574,0.000024894553,0.000060930975,0.00025712184,0.0010084212,0.36810875,0.00002243224,0.0016623255,0.012059596],"study_design_scores_gemma":[0.0015445827,0.0005554837,0.87056285,0.00018763106,0.0000016985457,9.684343e-7,0.0008983229,0.00010983786,0.1110162,0.00006036265,0.014900088,0.00016196624],"about_ca_topic_score_codex":0.0060688285,"about_ca_topic_score_gemma":0.008150132,"teacher_disagreement_score":0.25709257,"about_ca_system_score_codex":0.0002618259,"about_ca_system_score_gemma":0.00095617055,"threshold_uncertainty_score":0.99985695},"labels":[],"label_agreement":null},{"id":"W4295942177","doi":"10.1158/1557-3265.sarcomas22-b029","title":"Abstract B029: Flip-flopping of fusion-positive rhabdomyosarcoma regulating intratumoral heterogeneity for metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Rhabdomyosarcoma; Fusion gene; Biology; Cancer research; Cell fusion; Phenotype; Sarcoma; Motility; Cancer; Cell; Gene; Cell biology; Pathology; Medicine; Genetics","score_opus":0.15936884543052762,"score_gpt":0.48096175701511606,"score_spread":0.32159291158458847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474555,0.0022578337,0.00020829464,0.00062576466,0.0004396485,0.00058250193,0.0008532079,0.0000059777312,0.00028122755],"genre_scores_gemma":[0.9966916,0.00059568847,0.0010587875,0.0002448128,0.00073773094,0.00037075294,0.000181048,0.000034662826,0.00008493517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976114,0.00030005624,0.0006306433,0.0005650107,0.00042175598,0.00047114101],"domain_scores_gemma":[0.99802184,0.00073442707,0.00018968614,0.0004538684,0.0004360992,0.0001641003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029794888,0.00013479771,0.0003166524,0.000078845995,0.00041702687,0.000030950712,0.0004278255,0.0001002887,0.00013409137],"category_scores_gemma":[0.0011434348,0.00014195558,0.00029244536,0.00022677856,0.00028027638,0.0000042474517,0.0008233154,0.00044756872,0.0000014116384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068304455,0.001451913,0.031179035,0.00029674004,0.00076640886,0.00002794275,0.0002133299,0.0026181312,0.6934813,0.0015554636,0.035161946,0.22641729],"study_design_scores_gemma":[0.0084762005,0.0073377904,0.09160769,0.00016772629,0.0001559717,0.000022850189,0.0012042837,0.0014655689,0.7077007,0.002799257,0.17792375,0.0011381885],"about_ca_topic_score_codex":0.00030861364,"about_ca_topic_score_gemma":0.00026687814,"teacher_disagreement_score":0.22527911,"about_ca_system_score_codex":0.000105872125,"about_ca_system_score_gemma":0.0006448429,"threshold_uncertainty_score":0.57887805},"labels":[],"label_agreement":null},{"id":"W4295942202","doi":"10.1158/1557-3265.sarcomas22-a036","title":"Abstract A036: Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Immune system; Cancer research; Fusion protein; Biology; Transcriptome; Cell; Medicine; Immunology; Pathology; Gene expression; Gene; Sarcoma","score_opus":0.2516707009864865,"score_gpt":0.5368047343414423,"score_spread":0.2851340333549558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97976595,0.0147553375,4.4413054e-7,0.002971457,0.00028352204,0.0012152372,0.00011775141,0.000020447673,0.0008698653],"genre_scores_gemma":[0.9956877,0.0028589324,0.0002726273,0.000100134675,0.00018549377,0.0005268083,0.000040061503,0.00003850029,0.00028972898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950581,0.0006071161,0.0014246904,0.00050234626,0.001900312,0.0005074046],"domain_scores_gemma":[0.99486846,0.0031665955,0.00033640288,0.00075321295,0.00058231014,0.00029302706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006530046,0.00015650269,0.00089289993,0.00023678495,0.0002473441,0.000007038634,0.00035195975,0.000121426485,0.0033613462],"category_scores_gemma":[0.0021809665,0.0001269329,0.00042580388,0.000703317,0.00040383174,0.00004648805,0.00066723727,0.00096182426,0.00003190347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030708367,0.004152095,0.92367387,0.0005814576,0.00037586287,0.0002865744,0.00023911668,0.000020293392,0.039425425,0.00029868164,0.0027267837,0.025149032],"study_design_scores_gemma":[0.006565942,0.0037156267,0.88586926,0.0005669633,0.00014465812,0.00002296011,0.00093127467,0.000039823266,0.09483449,0.0008642751,0.006248956,0.00019573639],"about_ca_topic_score_codex":0.0013493968,"about_ca_topic_score_gemma":0.000023227962,"teacher_disagreement_score":0.055409066,"about_ca_system_score_codex":0.00029878799,"about_ca_system_score_gemma":0.00097259437,"threshold_uncertainty_score":0.9975497},"labels":[],"label_agreement":null},{"id":"W4295942208","doi":"10.1158/1557-3265.sarcomas22-ia001","title":"Abstract IA001: An overview of applying discovery science to care for patients in need: working together to advance our understanding and treatment of sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Malignancy; GiST; Medicine; Sarcoma; Immunotherapy; Clear-cell sarcoma; Bioinformatics; Stromal cell; Pathology; Cancer; Biology; Internal medicine","score_opus":0.4855192293999712,"score_gpt":0.5612200227417874,"score_spread":0.07570079334181617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199796,0.004757664,0.000010447632,0.00065300084,0.00012188078,0.0022887762,0.000071728544,0.0000043945306,0.0000941233],"genre_scores_gemma":[0.9968684,0.0012023931,0.00044907638,0.00010097171,0.00005767087,0.0012795778,0.000008628708,0.00001831752,0.00001498173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978992,0.000096033546,0.00044924053,0.0004668645,0.00071162294,0.00037709158],"domain_scores_gemma":[0.9986578,0.00056131696,0.000076976015,0.00031206678,0.00015837334,0.00023343826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010831688,0.00010459152,0.0004295827,0.00031054456,0.00019415471,0.000022022177,0.00015495188,0.000029295545,0.000015156129],"category_scores_gemma":[0.00025982934,0.00008548624,0.000084486885,0.00077295286,0.00011043844,0.00008860389,0.00019510022,0.00014610411,4.5429985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011166902,0.0013372079,0.8357746,0.00011636251,0.000020090481,0.0000085455395,0.0014363552,0.000108557455,0.00018809328,0.00028968777,0.000021403974,0.15958242],"study_design_scores_gemma":[0.004682226,0.0067231944,0.9635435,0.0006995829,0.00003314959,6.2091783e-7,0.01976284,0.000032402473,0.00092084566,0.0002677622,0.0032014884,0.00013242995],"about_ca_topic_score_codex":0.0010449688,"about_ca_topic_score_gemma":0.0010193692,"teacher_disagreement_score":0.15945,"about_ca_system_score_codex":0.0014343035,"about_ca_system_score_gemma":0.0003587416,"threshold_uncertainty_score":0.3750654},"labels":[],"label_agreement":null},{"id":"W4295942215","doi":"10.1158/1557-3265.sarcomas22-a016","title":"Abstract A016: Selective delivery of fibroblast activation protein conjugated dual phosphoinositide 3-kinase–AKT Kinase-mTOR inhibitor associated with decreased tumor proliferation and on-target toxicity in high-grade soft-tissue sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fibroblast activation protein, alpha; PI3K/AKT/mTOR pathway; Protein kinase B; HT1080; Cancer research; Fibrosarcoma; Flow cytometry; Biology; Cell growth; Fibroblast; Cell culture; Molecular biology; Medicine; Cancer; Pathology; Phosphorylation; Cell biology; Signal transduction; Internal medicine; Biochemistry","score_opus":0.05381510034112087,"score_gpt":0.3746805325944472,"score_spread":0.32086543225332637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594223,0.000046073506,0.000014660621,0.0018528529,0.0000127355615,0.0017129972,0.0002804073,0.00005070549,0.0000873084],"genre_scores_gemma":[0.99805075,0.000006481739,0.00011604936,0.0004251832,0.0001642514,0.0006524646,0.00038272282,0.000038512913,0.00016358128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956582,0.0010180089,0.0008338419,0.00067545776,0.0013202775,0.0004941942],"domain_scores_gemma":[0.9972667,0.0011178154,0.0003293748,0.00025078075,0.00071414496,0.00032114593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020874527,0.00022858135,0.00064350915,0.00042818452,0.0003203056,0.000040706247,0.00010113488,0.00014263424,0.0005423196],"category_scores_gemma":[0.0019347575,0.0002048151,0.000100897516,0.0013041256,0.00039300218,0.00016679965,0.000105832456,0.0015247094,0.0000052597525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023485288,0.0069495216,0.08135283,0.00039308684,0.00043655973,0.00058130996,0.00038049713,0.0006456914,0.88002354,0.00012689324,0.0035742726,0.0020505036],"study_design_scores_gemma":[0.0074327495,0.004521771,0.19819823,0.0022991027,0.0000315937,0.000005328666,0.00030698453,0.0010894481,0.7856465,0.00013974056,0.00008181805,0.00024675071],"about_ca_topic_score_codex":0.0019960497,"about_ca_topic_score_gemma":0.0008021785,"teacher_disagreement_score":0.11684541,"about_ca_system_score_codex":0.0008736491,"about_ca_system_score_gemma":0.001322518,"threshold_uncertainty_score":0.8352117},"labels":[],"label_agreement":null},{"id":"W4295942218","doi":"10.1158/1557-3265.sarcomas22-b020","title":"Abstract B020: Multimodal single-cell analyses reveal identification of unique transcriptional subgroups in ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Biology; Epigenomics; Carcinogenesis; Computational biology; Genetics; Gene; RNA-Seq; Gene expression; Gene expression profiling; Context (archaeology); DNA methylation","score_opus":0.39169184515969646,"score_gpt":0.5312422513209689,"score_spread":0.13955040616127246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932593,0.0028451905,0.000012155084,0.0025413465,0.00014452831,0.00058680493,0.000087759916,0.000016105261,0.0005067845],"genre_scores_gemma":[0.99841446,0.000390557,0.0001681,0.00014374904,0.00014390703,0.00040616357,0.00009062715,0.000023129422,0.00021933168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964372,0.0006153599,0.0010621313,0.00046946038,0.0010560305,0.0003598421],"domain_scores_gemma":[0.997423,0.0016415014,0.00014844176,0.0003679241,0.00025702035,0.00016214822],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034812859,0.00011514279,0.00042528802,0.0003519274,0.0001471647,0.000018642828,0.00021350638,0.00008819806,0.0011284401],"category_scores_gemma":[0.0004223592,0.00010653583,0.0002563682,0.0007244769,0.00022528309,0.000069365735,0.00009543876,0.0009541395,0.00001398956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014799368,0.008410504,0.8002491,0.00019009427,0.00011854795,0.00023066752,0.00031931896,0.00026630898,0.16105954,0.00014068716,0.0012597998,0.026275516],"study_design_scores_gemma":[0.0031945577,0.0005468751,0.97478676,0.00008493871,0.000048853977,0.000005717338,0.00039584073,0.00031907132,0.019145634,0.00022013202,0.001158155,0.00009347349],"about_ca_topic_score_codex":0.0020509053,"about_ca_topic_score_gemma":0.00022903093,"teacher_disagreement_score":0.17453767,"about_ca_system_score_codex":0.0005504219,"about_ca_system_score_gemma":0.00042688957,"threshold_uncertainty_score":0.99978465},"labels":[],"label_agreement":null},{"id":"W4295942221","doi":"10.1158/1557-3265.sarcomas22-a006","title":"Abstract A006: Defining the microenvironment of alveolar soft part sarcoma &amp; it’s role in therapeutic outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Calgary","funders":"","keywords":"Carfilzomib; Tumor microenvironment; Cancer research; In vivo; Proteasome inhibitor; Medicine; Biology; Immunology; Multiple myeloma; Tumor cells","score_opus":0.14790023389142132,"score_gpt":0.4477827533221845,"score_spread":0.29988251943076316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9162576,0.07163137,0.000007810924,0.007913757,0.0017362614,0.00066780415,0.00012109855,0.000021464033,0.0016427947],"genre_scores_gemma":[0.9921422,0.0013993706,0.000013978119,0.00119595,0.00004091478,0.00044385556,0.000029619125,0.00003369021,0.0047004465],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956019,0.0019061988,0.000956871,0.0004942182,0.00028022178,0.00076058815],"domain_scores_gemma":[0.995355,0.0035049077,0.00019957281,0.0008525398,0.000058741196,0.000029206942],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0066817654,0.00017127054,0.00047639472,0.0001316106,0.0004599522,0.000014401598,0.0011283664,0.00018356982,0.010957955],"category_scores_gemma":[0.000314394,0.00012891696,0.00024211826,0.00029298587,0.0012226783,0.000043076387,0.0009793824,0.002871565,0.00051131763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014430315,0.0013672829,0.8489157,0.000059456794,0.000592145,0.000012909973,0.0016962365,0.0004650265,0.059930377,0.0008638692,0.028195111,0.056458846],"study_design_scores_gemma":[0.0017288799,0.00022316666,0.31977558,0.000037432157,0.000021447291,0.0000050277,0.00145904,0.0000023232326,0.0036813128,0.0008214258,0.6720783,0.00016606627],"about_ca_topic_score_codex":0.0014344709,"about_ca_topic_score_gemma":0.000609041,"teacher_disagreement_score":0.64388317,"about_ca_system_score_codex":0.00038266424,"about_ca_system_score_gemma":0.00041158803,"threshold_uncertainty_score":0.99942887},"labels":[],"label_agreement":null},{"id":"W4295942229","doi":"10.1158/1557-3265.sarcomas22-b011","title":"Abstract B011: Two epigenetically distinct cellular states in osteosarcoma are regulated by a cluster-specific set of pioneer transcription factors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Transcription factor; Chromatin; Genetics; Epigenetics; Osteosarcoma; Wnt signaling pathway; Cancer research; Cell biology; Signal transduction; Gene","score_opus":0.11942672350961929,"score_gpt":0.4228259930126541,"score_spread":0.3033992695030348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923428,0.005145122,0.00021603664,0.0008588514,0.00018143568,0.00044782873,0.00070135103,0.0000083227715,0.00009820308],"genre_scores_gemma":[0.99658006,0.0015553744,0.000025405032,0.00004744295,0.0001335934,0.00024108104,0.0007931735,0.000034635534,0.0005892302],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99695235,0.00064976007,0.00075578305,0.0006190963,0.000581752,0.00044127376],"domain_scores_gemma":[0.9987398,0.00015538903,0.00015154255,0.000551784,0.0002456028,0.00015588522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018014264,0.00015497241,0.00028625704,0.00010301074,0.00017717847,0.000027463411,0.00046048296,0.0001360619,0.00070445205],"category_scores_gemma":[0.00009699115,0.00014803147,0.0001591205,0.00039478103,0.00037089078,0.000006239694,0.00018404376,0.0006375704,0.0000047467893],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013846984,0.0006539907,0.07214169,0.0000701269,0.00007349278,0.000009698871,0.00021456322,0.0016596178,0.89522463,0.000037799455,0.017638287,0.010891389],"study_design_scores_gemma":[0.005469026,0.0018199474,0.45792544,0.00008947653,0.000027021908,0.0000023284513,0.0022089416,0.00070913,0.20182921,0.00056604843,0.32865688,0.0006965257],"about_ca_topic_score_codex":0.0005385675,"about_ca_topic_score_gemma":0.00037498266,"teacher_disagreement_score":0.69339544,"about_ca_system_score_codex":0.00011288747,"about_ca_system_score_gemma":0.00020588755,"threshold_uncertainty_score":0.7713256},"labels":[],"label_agreement":null},{"id":"W4296122525","doi":"10.1158/1557-3265.sarcomas22-b005","title":"Abstract B005: Hypoxic sarcoma spheroid on a chip: Insights into treatment response","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Polytechnique Montréal","funders":"","keywords":"Tirapazamine; Hypoxia (environmental); Cancer research; Tumor hypoxia; Metastasis; Sarcoma; Spheroid; Soft tissue sarcoma; Pathology; Biology; Cell culture; Radiation therapy; Medicine; Cancer; In vitro; Internal medicine; Chemistry; Cytotoxicity","score_opus":0.11701635820593707,"score_gpt":0.4561327114930263,"score_spread":0.3391163532870892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296122525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791869,0.015616416,0.0000031584325,0.0013498996,0.001593774,0.00054127496,0.000058304504,0.000021260574,0.0016290348],"genre_scores_gemma":[0.9810168,0.008339169,0.000051448846,0.00075845426,0.0033796623,0.0007717861,0.000062487554,0.000055892277,0.005564308],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958739,0.0013230266,0.0005133894,0.00091426,0.000755853,0.0006195246],"domain_scores_gemma":[0.9980378,0.00041895156,0.00009929802,0.00093267567,0.00015281007,0.00035847927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002272413,0.00023039315,0.00035714396,0.00013094494,0.0005634914,0.000044236916,0.0005572761,0.00018403349,0.00086898054],"category_scores_gemma":[0.00056675513,0.00020138462,0.00031301653,0.00034011633,0.00034846796,0.0000049389323,0.00046154097,0.00077594444,0.00009214518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03748919,0.0026093398,0.0016793503,0.000040604256,0.00036858412,0.00007623537,0.0007139398,0.0003301741,0.6002212,0.00015942653,0.080114745,0.27619722],"study_design_scores_gemma":[0.0024934467,0.0038180312,0.024434237,0.000012753983,0.00001495276,0.000004673566,0.00021816543,0.00001162281,0.026981583,0.0002575309,0.9415152,0.00023777076],"about_ca_topic_score_codex":0.00058803504,"about_ca_topic_score_gemma":0.000753958,"teacher_disagreement_score":0.8614005,"about_ca_system_score_codex":0.00030541158,"about_ca_system_score_gemma":0.001282735,"threshold_uncertainty_score":0.95147276},"labels":[],"label_agreement":null},{"id":"W4296122547","doi":"10.1158/1557-3265.sarcomas22-a024","title":"Abstract A024: <i>In vitro</i> efficacy of a novel dual PARP-HDAC inhibitor in ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Olaparib; PARP1; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Histone deacetylase; Viability assay; Biology; DNA damage; DNA repair; Histone; Molecular biology; Pharmacology; In vitro; Polymerase; Biochemistry; DNA","score_opus":0.31842042250211033,"score_gpt":0.5424239836674453,"score_spread":0.22400356116533493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296122547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897305,0.0016516845,0.0000056182175,0.004949321,0.0005602698,0.0010010565,0.00014533738,0.000031298394,0.0019249489],"genre_scores_gemma":[0.99680495,0.0004158327,0.0002144794,0.00083951873,0.00076916727,0.000612445,0.000025389032,0.000054099415,0.0002641313],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.994327,0.00055857835,0.0015020147,0.00072130456,0.0020795993,0.0008114838],"domain_scores_gemma":[0.9959602,0.0026618624,0.00018583913,0.00061358797,0.0003026209,0.00027593336],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0086395135,0.00018326154,0.0007628028,0.00057310425,0.00012938083,0.000017510634,0.00032844135,0.00016339976,0.0014506842],"category_scores_gemma":[0.0013794424,0.00018380208,0.0002509166,0.0016092478,0.0005226641,0.000091540096,0.00037125967,0.0030822663,0.000022809847],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04852177,0.016209353,0.12835771,0.000853625,0.00022036771,0.0012061,0.002090362,0.0007805876,0.6898959,0.0003495936,0.039507583,0.072007045],"study_design_scores_gemma":[0.09060924,0.0037037213,0.6616084,0.002020959,0.000046501555,0.000080042904,0.001876035,0.001084293,0.12645377,0.00054547575,0.11108528,0.0008862982],"about_ca_topic_score_codex":0.0014931422,"about_ca_topic_score_gemma":0.00018968672,"teacher_disagreement_score":0.5634421,"about_ca_system_score_codex":0.001250718,"about_ca_system_score_gemma":0.002110906,"threshold_uncertainty_score":0.9994621},"labels":[],"label_agreement":null},{"id":"W4296122564","doi":"10.1158/1557-3265.sarcomas22-b030","title":"Abstract B030: Induction chemotherapy plus concurrent chemoradiotherapy led to clinical complete response in locally advanced sinonasal rhabdosarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Induction chemotherapy; Ifosfamide; Chemotherapy; Epirubicin; Chemoradiotherapy; Radiation therapy; Surgery; Regimen; Chemotherapy regimen; Mucositis; Oncology; Internal medicine; Cisplatin; Cyclophosphamide","score_opus":0.28195634774366884,"score_gpt":0.548296853707072,"score_spread":0.2663405059634032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296122564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95659727,0.0027037787,0.000023876615,0.036705438,0.0012153677,0.0024421338,0.00007260684,0.0000710479,0.00016849989],"genre_scores_gemma":[0.9900583,0.001950436,0.0003771446,0.00451372,0.0008396835,0.001752126,0.000045196735,0.00008902216,0.00037437375],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9924896,0.001992026,0.001691344,0.0012323636,0.0016350239,0.00095967704],"domain_scores_gemma":[0.9943674,0.0034340965,0.0001971133,0.0008739182,0.0003747029,0.0007527769],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009966052,0.00032365212,0.0012687517,0.00043288065,0.00032007822,0.000053584732,0.00048971124,0.00021891747,0.0026554544],"category_scores_gemma":[0.001217405,0.00029393996,0.00044673128,0.0012188458,0.0005250557,0.00008461073,0.00029553138,0.002690221,0.00012573552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09111628,0.0070541906,0.31669262,0.00006346888,0.00029423294,0.0008534735,0.00047285735,0.00039574353,0.002546788,0.00007916621,0.013653328,0.5667778],"study_design_scores_gemma":[0.02238767,0.005710922,0.8256663,0.00016054032,0.000019112023,0.000026011046,0.0003094172,0.00035813183,0.00034093673,0.000070144786,0.14467388,0.00027692018],"about_ca_topic_score_codex":0.000526965,"about_ca_topic_score_gemma":0.0001789011,"teacher_disagreement_score":0.5665009,"about_ca_system_score_codex":0.0020492896,"about_ca_system_score_gemma":0.0021320514,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W4296130292","doi":"10.1158/1557-3265.sarcomas22-a025","title":"Abstract A025: Profiling tumor infiltrating immune cells for better understanding tumor status and better response to therapeutic strategy in soft tissue sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Tumor microenvironment; Cytotoxic T cell; CD8; Immunotherapy; Population; Soft tissue sarcoma; Cancer research; Biology; Immunology; Pathology; Sarcoma; Medicine","score_opus":0.19018373584370069,"score_gpt":0.4578564706370328,"score_spread":0.2676727347933321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819381,0.009805342,0.00018214782,0.0041585867,0.0011309183,0.0023735445,0.00015518226,0.0000463792,0.00020978185],"genre_scores_gemma":[0.9958582,0.00009675869,0.00026499573,0.0016386401,0.00014110947,0.0010851149,0.000035143443,0.00007766807,0.00080238405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99434733,0.0019351711,0.0011104209,0.0008855716,0.00025132755,0.0014701998],"domain_scores_gemma":[0.9932873,0.0057207933,0.00020487569,0.0005449727,0.00014358718,0.00009846499],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009569999,0.0002709736,0.000610649,0.00033681496,0.00086741947,0.00010195396,0.00056547584,0.00017608532,0.0023557022],"category_scores_gemma":[0.0005610689,0.00027625824,0.00012217791,0.00045574945,0.00065246597,0.00012959432,0.00062047323,0.0026546835,0.0000852685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011553722,0.0002558266,0.013689899,0.00017855312,0.000169162,0.00009887739,0.0014217893,0.00035804493,0.9395149,0.00010788947,0.003540662,0.029110728],"study_design_scores_gemma":[0.024918724,0.011228269,0.14842375,0.0008523022,0.00014078274,0.00013379825,0.04021075,0.00037445128,0.4810377,0.012080541,0.27775276,0.0028461812],"about_ca_topic_score_codex":0.0007277693,"about_ca_topic_score_gemma":0.0002793983,"teacher_disagreement_score":0.45847714,"about_ca_system_score_codex":0.00082680525,"about_ca_system_score_gemma":0.0009525384,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W4296130312","doi":"10.1158/1557-3265.sarcomas22-b015","title":"Abstract B015: Targeting hexosamine biosynthesis pathway for the treatment of desmoid tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Cancer research; Glycosylation; Pentose phosphate pathway; Glycolysis; Glutamine; Enzyme; Cancer; Cancer cell; In vivo; Biochemistry; Amino acid; Genetics","score_opus":0.3603920543739465,"score_gpt":0.5343802714644572,"score_spread":0.1739882170905107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732876,0.016387908,0.00000584354,0.007585212,0.0003528952,0.0016991538,0.00022821083,0.000037969723,0.00041521701],"genre_scores_gemma":[0.993341,0.002454862,0.00020628303,0.00011977306,0.00066155166,0.0019381708,0.000016769725,0.000041169653,0.0012203957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972896,0.00026234187,0.0006932091,0.0004187252,0.0008187868,0.0005173094],"domain_scores_gemma":[0.98851526,0.010348776,0.00014075123,0.00047815943,0.00036671106,0.00015032229],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036878267,0.00014384548,0.00056258123,0.00011063036,0.00060314586,0.000009879851,0.00023273597,0.00004183004,0.0012232958],"category_scores_gemma":[0.0031725406,0.00009119225,0.0003484539,0.00043617262,0.0005994701,0.000019708677,0.00016309755,0.00044426703,0.000013498465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014546695,0.0076633664,0.23419113,0.000950976,0.002283777,0.0008506822,0.003696979,0.00015573039,0.019319717,0.00033668897,0.060031354,0.6559729],"study_design_scores_gemma":[0.006823961,0.013451884,0.2838653,0.00018136766,0.00029135356,0.00002852875,0.008824995,0.00034939573,0.030573556,0.00027668235,0.6550094,0.00032355406],"about_ca_topic_score_codex":0.0007336413,"about_ca_topic_score_gemma":0.000073099356,"teacher_disagreement_score":0.65564936,"about_ca_system_score_codex":0.00039283987,"about_ca_system_score_gemma":0.00052960747,"threshold_uncertainty_score":0.9996897},"labels":[],"label_agreement":null},{"id":"W4296130327","doi":"10.1158/1557-3265.sarcomas22-pr001","title":"Abstract PR001: Oncogene-induced matrix reorganization controls CD8+ T cell immunity in the UPS microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; YAP1; Cancer research; Cell biology; T cell; CD8; Biology; Extracellular matrix; Cytotoxic T cell; Immunology; Immune system","score_opus":0.19123344588355604,"score_gpt":0.507720672679515,"score_spread":0.316487226795959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98296946,0.0014441921,0.0000030806204,0.009878872,0.00020517278,0.002319124,0.00003815615,0.0000244298,0.0031174885],"genre_scores_gemma":[0.989648,0.001780389,0.00003234997,0.0008532346,0.00051886146,0.0006512517,0.000061372484,0.0000633503,0.0063912137],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9925644,0.0028863738,0.0008645756,0.00059006823,0.0022620515,0.000832537],"domain_scores_gemma":[0.9958808,0.0023398534,0.00012142475,0.0012044745,0.00020358298,0.00024985237],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014746562,0.00017613439,0.00046608233,0.00025607887,0.00051609497,0.00007267567,0.00093192025,0.00015532327,0.019736357],"category_scores_gemma":[0.00078760064,0.0001378709,0.00019834515,0.0011528404,0.0003216961,0.00005842687,0.0005701826,0.0042898194,0.00020870844],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005373232,0.0031991398,0.079455435,0.00015549698,0.00010487906,0.00038589246,0.0011526027,0.00010953978,0.86834633,0.000043200056,0.012289603,0.029384632],"study_design_scores_gemma":[0.01649173,0.004698574,0.5929034,0.00010908486,0.00007220164,0.000061108585,0.0052612014,0.00034893816,0.04712284,0.0003710328,0.33208627,0.00047367506],"about_ca_topic_score_codex":0.0021959292,"about_ca_topic_score_gemma":0.00024149384,"teacher_disagreement_score":0.8212235,"about_ca_system_score_codex":0.0013304792,"about_ca_system_score_gemma":0.00090240437,"threshold_uncertainty_score":0.9980073},"labels":[],"label_agreement":null},{"id":"W4296130351","doi":"10.1158/1557-3265.sarcomas22-b022","title":"Abstract B022: Subclonal somatic copy number alterations emerge and dominate in relapsed/refractory osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Osteosarcoma; Copy-number variation; Copy number analysis; Biology; Primary tumor; Cancer; PTEN; Oncology; Cancer research; Genome; Medicine; Bioinformatics; Metastasis; Genetics; Gene","score_opus":0.08365818104733569,"score_gpt":0.45483999030479816,"score_spread":0.37118180925746247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404854,0.0023842822,0.000006193107,0.0012264708,0.0004026745,0.00031934044,0.00017637965,0.0000052842706,0.0014308272],"genre_scores_gemma":[0.99502707,0.0029446904,0.000087217224,0.0003771963,0.00040842357,0.00035501987,0.00010142197,0.000028444321,0.00067051436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788547,0.0003294339,0.0005100867,0.0005016878,0.00036010123,0.0004132355],"domain_scores_gemma":[0.9987977,0.00045972344,0.00007974813,0.00036717977,0.000118820346,0.00017681437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001890365,0.00012047021,0.00020830311,0.00007170717,0.0002925463,0.000046320707,0.00027757004,0.00011203267,0.001060934],"category_scores_gemma":[0.00050702837,0.00012903193,0.00008900523,0.00019588986,0.00024774193,0.0000047227677,0.0005752282,0.0007716733,0.00002478896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002662586,0.0018813192,0.79606265,0.0001847837,0.00018025297,0.00020376555,0.00040332455,0.0007235048,0.060483936,0.0013155674,0.09377856,0.04211975],"study_design_scores_gemma":[0.008396156,0.0021782375,0.47117028,0.00007730181,0.000034569257,0.0000390215,0.0007209301,0.0005900611,0.0073552285,0.0036512322,0.50494164,0.0008453683],"about_ca_topic_score_codex":0.00051110296,"about_ca_topic_score_gemma":0.0012146647,"teacher_disagreement_score":0.41116306,"about_ca_system_score_codex":0.00010472225,"about_ca_system_score_gemma":0.00055043446,"threshold_uncertainty_score":0.99985224},"labels":[],"label_agreement":null},{"id":"W4296130369","doi":"10.1158/1557-3265.sarcomas22-b007","title":"Abstract B007: Patterns and quantitation of migration and metastasis in a zebrafish xenograft model of ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Cancer research; mCherry; Metastasis; Biology; Cancer; Sarcoma; Cell culture; Medicine; Pathology; Green fluorescent protein; Gene; Genetics","score_opus":0.18096489866269738,"score_gpt":0.4893366989973695,"score_spread":0.3083718003346721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691826,0.00087274465,0.00043727306,0.0011812316,0.000013806235,0.00031822224,0.00020276703,0.000002272007,0.00005343493],"genre_scores_gemma":[0.9975624,0.0017233687,0.00038097554,0.000051215524,0.00003096757,0.00014875378,0.000067987385,0.000011033656,0.000023298038],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981438,0.00031053065,0.00047035853,0.00033284692,0.0005155062,0.00022697533],"domain_scores_gemma":[0.9990591,0.000316288,0.000093581104,0.00023068557,0.00017881079,0.0001215527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031063333,0.00006419281,0.00018365019,0.00016170426,0.00008052044,0.000012395165,0.00019626485,0.00007558058,0.00004624581],"category_scores_gemma":[0.0008748647,0.00006424262,0.000050691942,0.00029563924,0.00038536586,0.000007852659,0.00040104418,0.00036929216,2.915487e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009882286,0.0008424366,0.20198008,0.0003996492,0.00012403066,0.0000037011507,0.00035877214,0.00045811632,0.72363263,0.0006535292,0.0016859558,0.06887283],"study_design_scores_gemma":[0.0042191935,0.0025902428,0.86260206,0.00013651607,0.000035436733,0.0000037565485,0.0021288965,0.028949652,0.09056411,0.0032823756,0.0051165055,0.00037126095],"about_ca_topic_score_codex":0.001284189,"about_ca_topic_score_gemma":0.0018219776,"teacher_disagreement_score":0.660622,"about_ca_system_score_codex":0.000023876813,"about_ca_system_score_gemma":0.0002510742,"threshold_uncertainty_score":0.2619738},"labels":[],"label_agreement":null},{"id":"W4296130372","doi":"10.1158/1557-3265.sarcomas22-pr013","title":"Abstract PR013: Novel mechanisms of ezrin function in osteosarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezrin; Moesin; Radixin; Cell biology; Cancer research; Metastasis; Cytoplasm; Osteosarcoma; Biology; Chemistry; Cytoskeleton; Cell; Cancer; Biochemistry","score_opus":0.30703902764628305,"score_gpt":0.49338982125546393,"score_spread":0.1863507936091809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952237,0.0005037897,0.000043732667,0.0019465891,0.00033529865,0.0005698253,0.00009814265,0.00002140851,0.0012575046],"genre_scores_gemma":[0.9986044,0.000082432394,0.00024974626,0.00025831407,0.00011215575,0.00026781423,0.000017208342,0.000027365782,0.00038054798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99681264,0.00038107115,0.00079693506,0.00044550028,0.0011720549,0.000391772],"domain_scores_gemma":[0.99815035,0.0009190513,0.00011750079,0.00043570093,0.00019372169,0.0001836957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042725755,0.000104299485,0.00046597054,0.00031615907,0.00012714979,0.00001380239,0.0002075334,0.000068714755,0.0030945574],"category_scores_gemma":[0.0006114999,0.00009307042,0.00020225802,0.0008160271,0.00016282877,0.0000600791,0.00034070198,0.0012334113,0.000020647434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02398288,0.011517059,0.18393314,0.0013942213,0.0005331124,0.0015208112,0.00027663296,0.00020954695,0.5735508,0.019863425,0.02416412,0.1590542],"study_design_scores_gemma":[0.007984065,0.00796495,0.9135335,0.00022123546,0.00009621917,0.00009074452,0.0011140537,0.00025378703,0.03306455,0.0026810903,0.03271868,0.00027714262],"about_ca_topic_score_codex":0.0007098857,"about_ca_topic_score_gemma":0.00009471202,"teacher_disagreement_score":0.72960037,"about_ca_system_score_codex":0.00013789698,"about_ca_system_score_gemma":0.0004913852,"threshold_uncertainty_score":0.99781674},"labels":[],"label_agreement":null},{"id":"W4296130403","doi":"10.1158/1557-3265.sarcomas22-ia011","title":"Abstract IA011: Identifying tumor-restricted target antigens for adoptive cellular immunotherapy to treat Ewing Sarcoma using multi-omic discovery platforms","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Major histocompatibility complex; Immunotherapy; Antigen; Biology; Transcriptome; Cancer research; Sarcoma; Computational biology; Immunology; Medicine; Immune system; Gene; Gene expression; Genetics; Pathology","score_opus":0.3662698473752391,"score_gpt":0.5264424264069669,"score_spread":0.16017257903172782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893138,0.0021871221,0.0024233244,0.00070023804,0.0006794785,0.004065088,0.0003667077,0.00008927073,0.00017501733],"genre_scores_gemma":[0.98681694,0.00062136,0.0029130364,0.0006085272,0.0011268249,0.0010221837,0.0001436118,0.00023364674,0.0065138773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.993062,0.000419627,0.0012899215,0.0012680086,0.0021726363,0.0017878158],"domain_scores_gemma":[0.9952019,0.0022330855,0.00020607503,0.001055633,0.0006487143,0.00065461505],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0054417457,0.00038562232,0.0010099352,0.00086277846,0.0012727713,0.00025719323,0.0008563163,0.00018089535,0.0041758],"category_scores_gemma":[0.0010025289,0.00035297236,0.00070799864,0.0016317476,0.00041447414,0.0003482981,0.0007555692,0.0027550354,0.00004687508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015460799,0.0013254021,0.040255565,0.00030739582,0.00041821098,0.00055181957,0.0009641191,0.00074657984,0.92102885,0.00003108477,0.002191707,0.016718468],"study_design_scores_gemma":[0.062790774,0.013412616,0.36590973,0.0015631533,0.00032383957,0.00019357186,0.011622391,0.024711322,0.39723346,0.001333735,0.117802896,0.0031025433],"about_ca_topic_score_codex":0.0029609108,"about_ca_topic_score_gemma":0.00008127847,"teacher_disagreement_score":0.5237954,"about_ca_system_score_codex":0.002454952,"about_ca_system_score_gemma":0.001936264,"threshold_uncertainty_score":0.99989223},"labels":[],"label_agreement":null},{"id":"W4296130404","doi":"10.1158/1557-3265.sarcomas22-a039","title":"Abstract A039: IGFBP5 is induced by tumor-suppressive naïve stromal cells and regulates GAS2-associated apoptosis in rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stromal cell; Cancer research; Rhabdomyosarcoma; Mesenchymal stem cell; Growth factor; Biology; CTGF; Paracrine signalling; Pathology; Sarcoma; Medicine; Internal medicine; Receptor","score_opus":0.13515736810277104,"score_gpt":0.45796195318848537,"score_spread":0.3228045850857143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874265,0.003165347,4.7698702e-8,0.007273511,0.00019813378,0.0010034646,0.00039192283,0.000036029753,0.0005050057],"genre_scores_gemma":[0.99678904,0.0008047767,0.000029204868,0.0008918881,0.00011808396,0.00090138987,0.00007302571,0.0000525299,0.0003400862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954649,0.0006923279,0.0008259756,0.00088035443,0.0012651136,0.0008713202],"domain_scores_gemma":[0.99674183,0.0018832815,0.00018253384,0.00050110894,0.00022788711,0.00046336348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002246688,0.00025022725,0.00074941345,0.00024640848,0.00034579897,0.00006405975,0.00028930622,0.00017314506,0.0022629136],"category_scores_gemma":[0.0005034989,0.00022373714,0.00020512285,0.0006849885,0.00032397764,0.000084254694,0.0005221755,0.0018912889,0.000031933276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022461151,0.0068538827,0.8135587,0.00011409196,0.00047411618,0.0006960062,0.000745567,0.000006252758,0.026165696,0.000039041213,0.115399346,0.033701196],"study_design_scores_gemma":[0.010055371,0.002285237,0.9341313,0.00028324532,0.000098650686,0.000016122212,0.0011905611,0.00012902835,0.044855505,0.00033986877,0.0062651057,0.00034997458],"about_ca_topic_score_codex":0.003203523,"about_ca_topic_score_gemma":0.00014318571,"teacher_disagreement_score":0.12057264,"about_ca_system_score_codex":0.0007108319,"about_ca_system_score_gemma":0.00048816658,"threshold_uncertainty_score":0.9986492},"labels":[],"label_agreement":null},{"id":"W4296130406","doi":"10.1158/1557-3265.sarcomas22-a013","title":"Abstract A013: CDK2 and CDK4/6 inhibition in GIST: Mechanisms of response and resistance","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cyclin D1; Cancer research; Cyclin-dependent kinase; Palbociclib; Cyclin-dependent kinase 2; Cell cycle; GiST; Biology; Cell growth; Hyperphosphorylation; Kinase; Cell culture; Cell; Cell biology; Cancer; Biochemistry; Genetics","score_opus":0.1671865645841084,"score_gpt":0.511879329938308,"score_spread":0.34469276535419957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98740053,0.00462207,0.000049205944,0.0068596564,0.00008607569,0.00050380465,0.000067496556,0.00001777647,0.0003934052],"genre_scores_gemma":[0.9971324,0.00077591435,0.00066109747,0.00032611119,0.00007829299,0.00023811324,0.0000053118674,0.000026817585,0.0007559401],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972596,0.00060487265,0.0005656284,0.00047871054,0.00074173254,0.00034941753],"domain_scores_gemma":[0.99779177,0.001414378,0.00011166679,0.00032450096,0.00018166608,0.00017599428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005622254,0.000106775326,0.00039082585,0.00025140762,0.00014850823,0.000011368088,0.00007963269,0.000080575424,0.00039953017],"category_scores_gemma":[0.00088853936,0.00010415441,0.000048931546,0.00050601544,0.0006497242,0.00008205772,0.00025817368,0.0010887322,0.0000021116214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44169077,0.0022803375,0.0860861,0.0022871704,0.00028173285,0.0019092072,0.0039058311,0.00008833367,0.30136964,0.015813185,0.0031146407,0.14117305],"study_design_scores_gemma":[0.01041461,0.0024171956,0.9044039,0.0006833515,0.000023411945,0.000056121295,0.0021207384,0.00004153363,0.0077337413,0.045717355,0.026115915,0.00027210702],"about_ca_topic_score_codex":0.0002324452,"about_ca_topic_score_gemma":0.00032850818,"teacher_disagreement_score":0.81831783,"about_ca_system_score_codex":0.0002822567,"about_ca_system_score_gemma":0.00042538522,"threshold_uncertainty_score":0.473006},"labels":[],"label_agreement":null},{"id":"W4296130421","doi":"10.1158/1557-3265.sarcomas22-a023","title":"Abstract A023: Identifying new therapeutic indications for afamitresgene autoleucel (“afami-cel” [formerly ADP-A2M4]) in adult and pediatric sarcomas using MAGE-A4 immunohistochemistry","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leiomyosarcoma; Sarcoma; Medicine; Immunohistochemistry; Synovial sarcoma; Undifferentiated Pleomorphic Sarcoma; Liposarcoma; Tissue microarray; Pathology; Cancer; Dermatofibrosarcoma protuberans; Cancer research; Soft tissue sarcoma; Internal medicine","score_opus":0.2983232906111273,"score_gpt":0.5464183236075497,"score_spread":0.24809503299642244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97831994,0.015825685,0.00010562565,0.0024255156,0.00031160752,0.0019940059,0.000081175924,0.000055725115,0.0008807017],"genre_scores_gemma":[0.98474383,0.005787629,0.00064732257,0.0003719849,0.001023978,0.00087690016,0.0000719719,0.000117765056,0.0063585923],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99461085,0.0004199542,0.0011790595,0.00097328523,0.0016592346,0.0011576214],"domain_scores_gemma":[0.99588394,0.0019739303,0.00022648004,0.0008546607,0.00048681124,0.0005741918],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004832448,0.0002716154,0.00064005784,0.00071251293,0.000710812,0.0001244357,0.00064629834,0.00025721747,0.0032852658],"category_scores_gemma":[0.0009043204,0.00028041084,0.00030208848,0.001540857,0.00038163338,0.00015325233,0.0005488743,0.0030670788,0.000019790801],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064431177,0.0017595497,0.2627071,0.0014448483,0.00042990275,0.00018710927,0.0011304725,0.000076201686,0.46508887,0.0001335029,0.0057935286,0.2548058],"study_design_scores_gemma":[0.02480821,0.0025427581,0.9263146,0.00044579507,0.0004130782,0.00011082887,0.0031211225,0.0040201703,0.008628465,0.0028994193,0.025503254,0.0011922981],"about_ca_topic_score_codex":0.0033080329,"about_ca_topic_score_gemma":0.00018793164,"teacher_disagreement_score":0.6636075,"about_ca_system_score_codex":0.0012950446,"about_ca_system_score_gemma":0.003851179,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W4296130424","doi":"10.1158/1557-3265.sarcomas22-pr003","title":"Abstract PR003: YAP1 is a key regulator of EWS-FLI1-dependent malignant transformation upon IGF1 mediated reprogramming of bone mesenchymal stem cell-like cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesenchymal stem cell; Biology; Reprogramming; Cancer research; Cre recombinase; Cell biology; Embryonic stem cell; Conditional gene knockout; Carcinogenesis; Progenitor cell; Stem cell; YAP1; Phenotype; Transcription factor; Transgene; Genetically modified mouse; Genetics; Cell; Cancer; Gene","score_opus":0.0930435449656888,"score_gpt":0.40128951716136296,"score_spread":0.3082459721956742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960007,0.0020378912,0.00006268202,0.0002873903,0.00029041438,0.0006078198,0.0002795609,0.00001524148,0.00041827196],"genre_scores_gemma":[0.99765277,0.00087772944,0.000103574064,0.00006556124,0.00015902834,0.00016995815,0.00012396416,0.00003754204,0.00080986286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956473,0.00062913314,0.0013026969,0.0006487948,0.0012197102,0.00055235985],"domain_scores_gemma":[0.9980471,0.00020467554,0.00038110622,0.00068238814,0.00045480896,0.00022990267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058934153,0.0001833481,0.00046159138,0.0001484656,0.0001964649,0.000020517391,0.00044116608,0.00026561233,0.00040871892],"category_scores_gemma":[0.00009586592,0.0001720885,0.0003178777,0.00038300775,0.00023718909,0.000009736687,0.00025687442,0.0007049958,0.000013728335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010600922,0.00047515493,0.0007185382,0.00029850038,0.000081960585,0.000016486469,0.00075531885,0.00025371273,0.9816843,0.0000131572615,0.0006080409,0.014034692],"study_design_scores_gemma":[0.0014150178,0.0015390095,0.0005976308,0.00007042628,0.000027504928,0.000004305612,0.001109714,0.00022305203,0.9665644,0.000028088669,0.02820655,0.00021427876],"about_ca_topic_score_codex":0.0004702453,"about_ca_topic_score_gemma":0.00006863298,"teacher_disagreement_score":0.027598508,"about_ca_system_score_codex":0.000070387614,"about_ca_system_score_gemma":0.0007140737,"threshold_uncertainty_score":0.70175654},"labels":[],"label_agreement":null},{"id":"W4296130436","doi":"10.1158/1557-3265.sarcomas22-pr006","title":"Abstract PR006: Multi-modal single-cell profiling of sarcomas from archival tissue reveals mechanisms of resistance to immune checkpoint inhibitors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer research; Sarcoma; Melanoma; Immune checkpoint; Gene expression profiling; Immune system; Genetics; Immunotherapy; Pathology; Medicine; Gene; Gene expression","score_opus":0.09436888889503806,"score_gpt":0.4111122386363418,"score_spread":0.3167433497413037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930603,0.0028785772,0.0008792679,0.00042545947,0.00045314155,0.00074752973,0.0009923917,0.000006607936,0.0005567467],"genre_scores_gemma":[0.99075204,0.0003598744,0.0075551323,0.00007907012,0.00037617827,0.00018893818,0.0001347058,0.000048090777,0.00050594355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676484,0.00032804304,0.001140216,0.00066880137,0.0006354859,0.00046263792],"domain_scores_gemma":[0.9979428,0.00046659546,0.0003150802,0.00072562875,0.0003338037,0.00021605844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024020365,0.00016677746,0.00044354174,0.000104688435,0.00014551978,0.00001791001,0.0006442532,0.00011832485,0.0001236686],"category_scores_gemma":[0.0010554086,0.00017947856,0.00021439863,0.00027006568,0.00025149167,0.000003588667,0.0011004178,0.00059196004,0.0000054418533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012726543,0.0006597922,0.0017095862,0.00010234189,0.000046453606,0.0000088894485,0.00008694421,0.0003411307,0.9921275,0.00010554847,0.0009131457,0.0026260596],"study_design_scores_gemma":[0.0011800565,0.0011723619,0.008489559,0.000072395276,0.000013934463,4.3259396e-7,0.00022897637,0.000018730396,0.9815607,0.0011784564,0.0058891564,0.00019523333],"about_ca_topic_score_codex":0.0008947176,"about_ca_topic_score_gemma":0.0003007664,"teacher_disagreement_score":0.010566747,"about_ca_system_score_codex":0.00011221795,"about_ca_system_score_gemma":0.0005865668,"threshold_uncertainty_score":0.73189235},"labels":[],"label_agreement":null},{"id":"W4296130466","doi":"10.1158/1557-3265.sarcomas22-a002","title":"Abstract A002: Dynamic single cell imaging of cancer stem cells and clonality in fusion-negative rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Cancer research; Cancer stem cell; Biology; Rhabdomyosarcoma; Zebrafish; Mesenchymal stem cell; Pathology; Immunology; Medicine; Sarcoma; Cell biology; Genetics","score_opus":0.07259922346754358,"score_gpt":0.4318356706227993,"score_spread":0.3592364471552557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882211,0.009426826,0.000008779772,0.0006886784,0.0003125992,0.000336506,0.0005334783,0.0000034619723,0.00046857065],"genre_scores_gemma":[0.9934901,0.0056214454,0.000070504575,0.00020904925,0.00013971099,0.00016168911,0.000017875613,0.000025851397,0.00026377384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779487,0.00031513054,0.00054091745,0.00056792836,0.000382425,0.00039873197],"domain_scores_gemma":[0.99862367,0.0005403102,0.00015009368,0.00034829977,0.00019550737,0.00014213583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017174202,0.00012769275,0.00026948494,0.0000882358,0.00015266406,0.000024426508,0.00032430023,0.00008150665,0.00022492648],"category_scores_gemma":[0.00011313571,0.00013469876,0.00009922274,0.00024150261,0.00048424603,0.0000044369667,0.0008699977,0.0005981924,0.0000016754329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014911747,0.0010732351,0.2427364,0.00022728351,0.000061356186,0.00004459071,0.00026463473,0.0012630841,0.6733342,0.000042715583,0.0045198766,0.07494146],"study_design_scores_gemma":[0.0074456437,0.0018405544,0.4503845,0.0001866823,0.000052326774,0.0000057259053,0.0026502998,0.001980426,0.4640333,0.0017892949,0.068652004,0.0009792309],"about_ca_topic_score_codex":0.0034687575,"about_ca_topic_score_gemma":0.002950871,"teacher_disagreement_score":0.20930089,"about_ca_system_score_codex":0.0001872478,"about_ca_system_score_gemma":0.00061087415,"threshold_uncertainty_score":0.5492856},"labels":[],"label_agreement":null},{"id":"W4296130467","doi":"10.1158/1557-3265.sarcomas22-a031","title":"Abstract A031: Interplay of YAP1, β-catenin and the SS18-SSX fusion protein in synovial sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"YAP1; Gene knockdown; Biology; Luciferase; Cancer research; Fusion protein; Immunoprecipitation; Fusion gene; Catenin; Wnt signaling pathway; Transcription factor; Molecular biology; Cell biology; Cell culture; Transfection; Signal transduction; Gene; Genetics","score_opus":0.06392768346209672,"score_gpt":0.45270183964580657,"score_spread":0.38877415618370986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994591,0.0023261453,0.00001132571,0.001777661,0.00016262771,0.0007038812,0.00002621528,0.000003941723,0.000397206],"genre_scores_gemma":[0.99823207,0.00051880215,0.000025327505,0.000051364343,0.00025642413,0.000311636,0.00002647941,0.000017577542,0.000560317],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975672,0.0008453438,0.000494086,0.00038991694,0.00043287652,0.0002705885],"domain_scores_gemma":[0.9991681,0.00021302211,0.00011365778,0.0003247147,0.00011585353,0.00006465706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00472584,0.000089205445,0.00020528717,0.0000854929,0.00013984075,0.000015696452,0.00031384648,0.00013370033,0.00024495373],"category_scores_gemma":[0.0004713673,0.00006994545,0.00009537747,0.0002577138,0.0006071058,0.0000037331074,0.00069063914,0.0007299859,0.0000029489756],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017868696,0.0005321131,0.02557172,0.00013752104,0.0001409422,0.00001478906,0.00035032647,0.0008554222,0.80791724,0.0004925321,0.0072073466,0.13891137],"study_design_scores_gemma":[0.031442422,0.005895126,0.46994257,0.0004967335,0.00006375394,0.000043763786,0.0015196982,0.0050193975,0.3341537,0.0049195816,0.14541095,0.0010922997],"about_ca_topic_score_codex":0.0010390856,"about_ca_topic_score_gemma":0.0009349127,"teacher_disagreement_score":0.47376353,"about_ca_system_score_codex":0.00007434786,"about_ca_system_score_gemma":0.00033334678,"threshold_uncertainty_score":0.3171466},"labels":[],"label_agreement":null},{"id":"W4296130470","doi":"10.1158/1557-3265.sarcomas22-a027","title":"Abstract A027: Characterization of WEE1 kinase activity in myxoid liposarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wee1; Biology; Cancer research; Cell cycle; Cell biology; RNA interference; Kinase; Cell; Genetics; Cyclin-dependent kinase 1; Gene","score_opus":0.12478293002885647,"score_gpt":0.46489507755022913,"score_spread":0.34011214752137264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979608,0.00018322153,0.000015762495,0.0008580222,0.00021016227,0.00027627684,0.00007146513,0.0000045302104,0.00041972628],"genre_scores_gemma":[0.99842346,0.00039008062,0.000013726478,0.00009249067,0.00024742435,0.00016585978,0.00010119867,0.000012696339,0.0005530904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982939,0.00047437657,0.0003260244,0.0003130229,0.00037014115,0.0002225823],"domain_scores_gemma":[0.99935186,0.00006032141,0.00009740241,0.00029784098,0.00011603862,0.00007654363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001990542,0.000066542525,0.00014131491,0.000092553004,0.00009591447,0.00001075971,0.0002547675,0.00009020055,0.0004556303],"category_scores_gemma":[0.0003510494,0.00006868508,0.00007679038,0.00028541213,0.00015110342,0.000006363151,0.00033411232,0.0005103919,0.0000058071196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052403036,0.00039444875,0.020686304,0.000023247832,0.000010178053,0.000004109813,0.000014391379,0.00000789126,0.9499586,0.000028208726,0.0008314086,0.027517172],"study_design_scores_gemma":[0.0008231736,0.00062056945,0.36590216,0.000016543667,0.0000017916873,6.8005846e-7,0.000031886615,0.00005503035,0.57407457,0.000047055324,0.05831662,0.000109902525],"about_ca_topic_score_codex":0.00022997831,"about_ca_topic_score_gemma":0.000089272675,"teacher_disagreement_score":0.37588403,"about_ca_system_score_codex":0.00005131129,"about_ca_system_score_gemma":0.00032314908,"threshold_uncertainty_score":0.49888325},"labels":[],"label_agreement":null},{"id":"W4296130471","doi":"10.1158/1557-3265.sarcomas22-ia022","title":"Abstract IA022: Arginine, serine, xCT and ME, the therapeutic metabolism of different sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Arginine; Downregulation and upregulation; Cancer research; Biology; Argininosuccinate synthase; Arginine deiminase; Osteosarcoma; Metabolic pathway; Cell biology; Metabolism; Biochemistry; Arginase; Amino acid","score_opus":0.12441773565574786,"score_gpt":0.4802922963051505,"score_spread":0.35587456064940265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976743,0.019878028,0.0000042933752,0.0017006734,0.00015608121,0.00046912197,0.0001404511,0.000005522126,0.00090283464],"genre_scores_gemma":[0.99070805,0.007417385,0.00000957484,0.00018425671,0.0002733662,0.00044412777,0.000037200425,0.00002412874,0.00090192386],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975106,0.0005661014,0.0003470642,0.00043801722,0.00068887847,0.00044931003],"domain_scores_gemma":[0.99879795,0.00026782465,0.00007713166,0.00054153,0.00014496996,0.0001705646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015365984,0.00013215032,0.00025248967,0.00006190865,0.00032046653,0.00003002897,0.00048727437,0.000062944804,0.0005163064],"category_scores_gemma":[0.00014264499,0.00008635774,0.00015238713,0.00021338715,0.0005366411,0.000003807368,0.000806628,0.00066717877,0.0000037745344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010581644,0.0033668822,0.30573845,0.00028993067,0.0029678305,0.00008149187,0.00041028048,0.00008941835,0.2516681,0.0034312583,0.033375137,0.3879996],"study_design_scores_gemma":[0.0034527632,0.0017730118,0.68363935,0.00001649117,0.000050569157,0.000011942075,0.00036940054,0.000052249194,0.028058583,0.0018219294,0.2805065,0.0002472189],"about_ca_topic_score_codex":0.00086537545,"about_ca_topic_score_gemma":0.0005199426,"teacher_disagreement_score":0.38775238,"about_ca_system_score_codex":0.000038043912,"about_ca_system_score_gemma":0.00029495778,"threshold_uncertainty_score":0.56531924},"labels":[],"label_agreement":null},{"id":"W4296130475","doi":"10.1158/1557-3265.sarcomas22-b013","title":"Abstract B013: STEAP1 facilitates iron transport in ewing sarcoma to support mitochondrial activity","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Gene knockdown; Mitochondrion; Cancer research; Cell biology; Extracellular; Intracellular; Biology; Transmembrane protein; Chemistry; Biochemistry; Apoptosis; Receptor","score_opus":0.13688262544019467,"score_gpt":0.4913750992696567,"score_spread":0.35449247382946203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579793,0.00014821434,0.00031864038,0.0017062617,0.00014886567,0.0007567698,0.00021497234,0.000018818258,0.0008895211],"genre_scores_gemma":[0.9965809,0.00018237862,0.00037287714,0.00037745672,0.00024011535,0.0013304967,0.0001483806,0.00002326147,0.00074414874],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99763185,0.00037043038,0.00040844904,0.00073396263,0.00034964536,0.00050566526],"domain_scores_gemma":[0.9990356,0.00009764165,0.000048931983,0.0005451921,0.00008531359,0.00018733862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018308844,0.00013102341,0.00022243723,0.00010179403,0.00022539403,0.000012786795,0.0005358102,0.00017842017,0.0005938535],"category_scores_gemma":[0.00015706875,0.00013565214,0.00015581958,0.0003051786,0.00018959881,0.0000037331913,0.00039515298,0.00085462723,0.000018936873],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011033412,0.0005564955,0.032301106,0.000026320813,0.000028182103,0.000032795648,0.00006928994,0.00014088827,0.9120045,0.000065165696,0.0126708895,0.04100108],"study_design_scores_gemma":[0.0016567566,0.0030968266,0.21388435,0.000018485054,0.000011024802,0.0000074564423,0.00019840134,0.000023966111,0.121091194,0.00030281133,0.6592132,0.0004955624],"about_ca_topic_score_codex":0.00066129834,"about_ca_topic_score_gemma":0.00059735513,"teacher_disagreement_score":0.7909132,"about_ca_system_score_codex":0.00008491765,"about_ca_system_score_gemma":0.00034919698,"threshold_uncertainty_score":0.6502279},"labels":[],"label_agreement":null},{"id":"W4296130477","doi":"10.1158/1557-3265.sarcomas22-a038","title":"Abstract A038: Enrollment of pediatric and adolescent patients with MAGE-A4+ advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel (“afami-cel” [formerly ADP-A2M4])","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Synovial sarcoma; Sarcoma; Cohort; Internal medicine; Soft tissue sarcoma; Oncology; Surgery; Pathology","score_opus":0.0989514237550265,"score_gpt":0.48197742497487267,"score_spread":0.3830260012198462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923232,0.0017346413,0.000007847954,0.00034370832,0.00029519014,0.004371426,0.0002784126,0.000020479287,0.00062508037],"genre_scores_gemma":[0.9953151,0.002771667,0.0002189745,0.000058098874,0.00045987594,0.00042636515,0.00007948578,0.00007634356,0.0005940856],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9911725,0.00081740104,0.001954527,0.0008684559,0.0043590968,0.0008280559],"domain_scores_gemma":[0.995314,0.0011787078,0.00060427113,0.000965842,0.0013572657,0.0005799084],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005594085,0.00030691642,0.0013932764,0.0006649657,0.00017621735,0.000016808335,0.00053873466,0.00018561144,0.002809503],"category_scores_gemma":[0.0007613061,0.00025636886,0.00034176456,0.0012590719,0.0010599986,0.00010598307,0.00062478223,0.0019916652,0.000005154216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4187276,0.016300514,0.3868354,0.0015474848,0.00056292623,0.00007657357,0.00032039612,0.000035795387,0.017858172,0.000010676784,0.0014341485,0.15629032],"study_design_scores_gemma":[0.2653978,0.05770312,0.6623216,0.00034082262,0.0003368639,0.0000036965394,0.000454117,0.00014443748,0.007825543,0.00006537569,0.004998312,0.00040830043],"about_ca_topic_score_codex":0.0010234457,"about_ca_topic_score_gemma":0.000085307074,"teacher_disagreement_score":0.27548623,"about_ca_system_score_codex":0.0005385306,"about_ca_system_score_gemma":0.0024963946,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W4296130482","doi":"10.1158/1557-3265.sarcomas22-b009","title":"Abstract B009: Establishing new cell lines from undifferentiated pleomorphic sarcoma for sarcoma research","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Cell culture; Undifferentiated Pleomorphic Sarcoma; In vivo; Fusion gene; Cancer; Pathology; Immunohistochemistry; Soft tissue sarcoma; Cell; Cancer research; Biology; Mesenchymal stem cell; Medicine; Gene; Internal medicine; Genetics","score_opus":0.46337885103049303,"score_gpt":0.5448217628848551,"score_spread":0.08144291185436203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692228,0.011400669,0.000017583832,0.0146586,0.0007754885,0.002353428,0.0005640463,0.00009718906,0.0009102245],"genre_scores_gemma":[0.9888935,0.0016654063,0.0007322514,0.00054936693,0.0023445454,0.0016934382,0.000641968,0.00012169456,0.0033578011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992324,0.0012769887,0.0011243054,0.0013168538,0.0024483358,0.001509521],"domain_scores_gemma":[0.9831686,0.013503551,0.0001670009,0.0011738015,0.00097412406,0.0010129497],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006968731,0.00030101385,0.00086498546,0.00056983135,0.0012141396,0.00025603853,0.00073810254,0.0002542329,0.007727788],"category_scores_gemma":[0.0025696454,0.0002617396,0.00048746323,0.0013509564,0.00043600608,0.00014162056,0.0010069432,0.0034589057,0.0001446604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067141326,0.008146084,0.482724,0.0002742761,0.0005956534,0.0010515037,0.00057780335,0.00002639745,0.0041501867,0.00028700713,0.3769668,0.11848615],"study_design_scores_gemma":[0.0162468,0.0033099847,0.7659581,0.00032815023,0.00019069144,0.000014198197,0.0011461993,0.00070237357,0.0045233383,0.0076993285,0.19943485,0.00044604068],"about_ca_topic_score_codex":0.017308533,"about_ca_topic_score_gemma":0.001145358,"teacher_disagreement_score":0.28323403,"about_ca_system_score_codex":0.0008478749,"about_ca_system_score_gemma":0.0020946132,"threshold_uncertainty_score":0.9999835},"labels":[],"label_agreement":null},{"id":"W4296130495","doi":"10.1158/1557-3265.sarcomas22-ia025","title":"Abstract IA025: Using genetically engineered mouse models to study sarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Metastasis; Sarcoma; Cancer research; Biology; Pathology; Undifferentiated Pleomorphic Sarcoma; Lung; Soft tissue sarcoma; Medicine; Cancer; Internal medicine; Genetics","score_opus":0.5064369323713099,"score_gpt":0.550279210240197,"score_spread":0.04384227786888706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298984,0.0020108316,0.000070210146,0.0023238196,0.00016671947,0.0019841592,0.00010690241,0.000050731585,0.00029677633],"genre_scores_gemma":[0.9955902,0.00021154512,0.0018412529,0.0006095107,0.00025582153,0.0012272852,0.0000112584075,0.00006225981,0.00019087744],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99556583,0.0005892747,0.0007333184,0.0007430653,0.0016722158,0.0006963119],"domain_scores_gemma":[0.99714017,0.0009920101,0.000049957467,0.0008046589,0.00033615236,0.00067704316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033272335,0.00019137638,0.0005930792,0.00029503132,0.0003757187,0.000048355305,0.0003533205,0.00006234316,0.0026277166],"category_scores_gemma":[0.00033137074,0.0001645753,0.00025338837,0.00077021244,0.00009858143,0.0000459015,0.0006686845,0.0010499076,0.00006252146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007290186,0.05414503,0.41853732,0.00016125098,0.0040693986,0.0048597264,0.0022968808,0.03840547,0.005634887,0.00046920867,0.014648798,0.44948184],"study_design_scores_gemma":[0.024589548,0.016018879,0.9027383,0.00014505011,0.0012438395,0.00008855167,0.006129949,0.020994218,0.0060797576,0.0011472296,0.019650336,0.0011743745],"about_ca_topic_score_codex":0.0013706564,"about_ca_topic_score_gemma":0.00008459805,"teacher_disagreement_score":0.48420095,"about_ca_system_score_codex":0.0005398641,"about_ca_system_score_gemma":0.0005192076,"threshold_uncertainty_score":0.99828404},"labels":[],"label_agreement":null},{"id":"W4296131107","doi":"10.1158/1557-3265.sarcomas22-ia020","title":"Abstract IA020: Reprogramming of myogenic transcription factors in rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcription factor; Biology; Chromatin; Cellular differentiation; Progenitor cell; Rhabdomyosarcoma; Chromatin immunoprecipitation; Reprogramming; Enhancer; MYF5; Skeletal muscle; Cell biology; PAX3; Myogenic regulatory factors; Promoter; Cancer research; Genetics; Gene expression; Gene; Stem cell; Myogenin; Endocrinology; Pathology; Sarcoma; Medicine","score_opus":0.34312296318789337,"score_gpt":0.5313530501840579,"score_spread":0.1882300869961645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926741,0.0040240875,9.0114116e-7,0.0018638843,0.0001936411,0.0007214634,0.000028758926,0.000020684813,0.0004724944],"genre_scores_gemma":[0.99825996,0.0008193663,0.0000707165,0.00007750274,0.000098401775,0.0005106262,0.000029633176,0.00002312337,0.00011066922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970441,0.00037540056,0.0007461732,0.00046019081,0.0009422288,0.0004319493],"domain_scores_gemma":[0.99821895,0.0009523036,0.000086963,0.00042935903,0.00013082492,0.00018160275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029405411,0.00010761862,0.0004417204,0.0002640412,0.00012534378,0.000010794563,0.00018201099,0.00007953427,0.0021188161],"category_scores_gemma":[0.0003775289,0.000091295835,0.0002990888,0.00070513046,0.00021371184,0.000041036932,0.00011034186,0.0010613156,0.000010170298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007632061,0.002303278,0.8945317,0.00007323075,0.00008038084,0.0001717148,0.00026974903,0.0000117611535,0.0018142072,0.000081267375,0.00049864757,0.09940084],"study_design_scores_gemma":[0.002732772,0.0009244457,0.98154277,0.00008309872,0.000031964653,0.000005494737,0.00086045195,0.000022009379,0.002558519,0.00016258618,0.010996363,0.00007953356],"about_ca_topic_score_codex":0.0025365888,"about_ca_topic_score_gemma":0.00033034015,"teacher_disagreement_score":0.099321306,"about_ca_system_score_codex":0.000391121,"about_ca_system_score_gemma":0.0003688168,"threshold_uncertainty_score":0.99879336},"labels":[],"label_agreement":null},{"id":"W4296131108","doi":"10.1158/1557-3265.sarcomas22-b023","title":"Abstract B023: Prospective clinical genomic profiling of ewing sarcoma: <i>ERF</i> and <i>FGFR1</i> mutations as recurrent secondary alterations of potential biological and therapeutic relevance","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Cancer research; Clonogenic assay; Biology; Sarcoma; Gene expression profiling; Epigenetics; Amplicon; Gene knockdown; Medicine; Oncology; Bioinformatics; Genetics; Cancer; Gene; In vivo; Gene expression; Pathology; Polymerase chain reaction","score_opus":0.1993466371871482,"score_gpt":0.49573992973248443,"score_spread":0.2963932925453362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797813,0.016849888,0.000009455187,0.0014682065,0.00021970012,0.0012130083,0.00015525239,0.000013037765,0.00029012506],"genre_scores_gemma":[0.99275833,0.005825516,0.0005417221,0.00018721448,0.00020378959,0.00040818317,0.00003057495,0.000020036943,0.000024647148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968407,0.0006286582,0.0011039247,0.00061099656,0.0004948697,0.00032083702],"domain_scores_gemma":[0.99627227,0.002698994,0.00022815797,0.00029621404,0.0002981723,0.00020616947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026426371,0.00014379992,0.0006056416,0.00012043535,0.0003326157,0.000019748793,0.00012965554,0.000105158884,0.00038628193],"category_scores_gemma":[0.00070275494,0.000116203446,0.0001923604,0.0002740715,0.0009500814,0.00004707054,0.0003079183,0.0012261245,0.000004245573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018663448,0.0026902985,0.8542569,0.00013274926,0.00036580855,0.00008131252,0.00024592387,0.000031133095,0.0062937182,0.0005418099,0.00014877965,0.13334517],"study_design_scores_gemma":[0.004026854,0.0033570356,0.9862381,0.00011117435,0.00012584531,0.000045782064,0.00055601826,0.0002656316,0.0021679988,0.002234759,0.00074577046,0.00012499031],"about_ca_topic_score_codex":0.00011494282,"about_ca_topic_score_gemma":0.000020391159,"teacher_disagreement_score":0.13322018,"about_ca_system_score_codex":0.00012225841,"about_ca_system_score_gemma":0.00063689076,"threshold_uncertainty_score":0.53269684},"labels":[],"label_agreement":null},{"id":"W4296131130","doi":"10.1158/1557-3265.sarcomas22-pr010","title":"Abstract PR010: Development of a pre-clinical metastatic model of human sarcoma to identify therapeutic targets","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Medicine; Metastasis; Disease; Mesenchymal stem cell; Cancer research; In vivo; Radiation therapy; Cancer; Oncology; Pathology; Bioinformatics; Internal medicine; Biology","score_opus":0.32255989377809996,"score_gpt":0.5619909653106611,"score_spread":0.2394310715325611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969538,0.0009920824,0.0006659667,0.00027425785,0.00015182552,0.0006033772,0.000051903335,0.0000056083295,0.00030117205],"genre_scores_gemma":[0.9967321,0.000097974524,0.0016128916,0.00021136069,0.00010064937,0.00029168706,0.000055519537,0.000022015494,0.00087578973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996744,0.0005758922,0.001191326,0.00045441033,0.00072939444,0.00030501312],"domain_scores_gemma":[0.9986876,0.00014240498,0.00021101882,0.0004643629,0.00031568357,0.00017891257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053740107,0.00010816979,0.00031957062,0.00010268319,0.00018386153,0.000011208401,0.0005686422,0.0000838929,0.00057583646],"category_scores_gemma":[0.00048645225,0.00010124787,0.00018300257,0.00022069494,0.00025773316,0.0000046142745,0.00065947324,0.00050697144,0.000007323717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015046003,0.0018395971,0.009205274,0.0001758498,0.00039727174,0.000003328934,0.00042099747,0.0007205041,0.91531545,0.00020554542,0.01425372,0.055957876],"study_design_scores_gemma":[0.0033832353,0.0039200177,0.1535154,0.00009320467,0.00004803545,0.0000016029796,0.00044537705,0.0008872638,0.78323144,0.001824474,0.052105658,0.0005442987],"about_ca_topic_score_codex":0.00005102613,"about_ca_topic_score_gemma":0.00008106082,"teacher_disagreement_score":0.14431012,"about_ca_system_score_codex":0.000042312324,"about_ca_system_score_gemma":0.0009160985,"threshold_uncertainty_score":0.63050056},"labels":[],"label_agreement":null},{"id":"W4296131173","doi":"10.1158/1557-3265.sarcomas22-a015","title":"Abstract A015: Biochemical and preclinical anti-tumor activity of a bi-steric mTORC1-selective inhibitor in fusion positive rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"mTORC1; Allosteric regulation; Cancer research; Rhabdomyosarcoma; PI3K/AKT/mTOR pathway; In vivo; Medicine; Cancer; Pharmacology; Biology; Internal medicine; Sarcoma; Signal transduction; Pathology; Cell biology; Receptor","score_opus":0.09778614397781617,"score_gpt":0.463755349017009,"score_spread":0.36596920503919284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957589,0.002401196,0.000019889123,0.00044822562,0.0003126758,0.00061289826,0.0002082651,0.000010815345,0.00022711599],"genre_scores_gemma":[0.9982285,0.0005456707,0.00007910191,0.00016477764,0.00054833427,0.00029072622,0.0000307485,0.00004165312,0.00007049636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957462,0.001102168,0.00075348234,0.0010474615,0.00074389076,0.00060680445],"domain_scores_gemma":[0.9978397,0.0008882286,0.00023388428,0.00048033177,0.00032192536,0.00023594612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035865007,0.00021579143,0.00052520883,0.00017237318,0.00018455728,0.000024670366,0.0004754078,0.0002661012,0.00016411641],"category_scores_gemma":[0.001359855,0.0002172278,0.00019230618,0.00060078996,0.00087537075,0.000012019099,0.0010192202,0.0015872264,0.0000032920568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040496066,0.000866408,0.051154975,0.0000750136,0.000077516575,0.00003529567,0.00007091719,0.00003184438,0.93224466,0.000011088444,0.0029517915,0.008430897],"study_design_scores_gemma":[0.0032157684,0.0037385416,0.27282554,0.0001485943,0.000022557933,0.000020214771,0.000114261915,0.00014455797,0.7160289,0.00023364049,0.0030899826,0.0004173998],"about_ca_topic_score_codex":0.0005744273,"about_ca_topic_score_gemma":0.00010439407,"teacher_disagreement_score":0.22167055,"about_ca_system_score_codex":0.00021665425,"about_ca_system_score_gemma":0.0010690035,"threshold_uncertainty_score":0.88582927},"labels":[],"label_agreement":null},{"id":"W4296131175","doi":"10.1158/1557-3265.sarcomas22-a007","title":"Abstract A007: Resident memory T cells express PD-1 in high grade liposarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; Liposarcoma; Population; Cancer research; Pembrolizumab; Immunotherapy; Immune system; Medicine; Immunology; Biology; Pathology; Sarcoma","score_opus":0.25340882664836867,"score_gpt":0.5239702194661223,"score_spread":0.27056139281775365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97988284,0.0023804097,0.0000012662055,0.00885769,0.0009336365,0.0017841841,0.00006790044,0.000059801307,0.0060322783],"genre_scores_gemma":[0.95156723,0.0025270798,0.00007678119,0.0007079918,0.0014429208,0.0011651993,0.000028088369,0.00010646901,0.042378243],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9903912,0.0020445986,0.0012328089,0.0011299043,0.0037374871,0.00146399],"domain_scores_gemma":[0.99393165,0.0034634795,0.00011853166,0.0014007111,0.00034744025,0.0007381735],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012548595,0.00024760567,0.0008031624,0.00072011724,0.00038042464,0.00007863662,0.0010420361,0.0002264963,0.07207244],"category_scores_gemma":[0.00080955034,0.00023700297,0.00034543392,0.0014238027,0.0007368358,0.0001028951,0.0013229806,0.0060516647,0.00038047024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02452108,0.0060970816,0.11139312,0.0008492127,0.00043006783,0.0072210887,0.0017641536,0.000657195,0.4308006,0.0003015652,0.30677176,0.10919311],"study_design_scores_gemma":[0.019939244,0.0043971133,0.48384532,0.00042718282,0.00005093784,0.00005695366,0.0028147665,0.00028705795,0.0626141,0.002208493,0.42254877,0.00081006304],"about_ca_topic_score_codex":0.010478064,"about_ca_topic_score_gemma":0.0008163461,"teacher_disagreement_score":0.3724522,"about_ca_system_score_codex":0.0013546795,"about_ca_system_score_gemma":0.0018020615,"threshold_uncertainty_score":0.9962414},"labels":[],"label_agreement":null},{"id":"W4296131180","doi":"10.1158/1557-3265.sarcomas22-ia007","title":"Abstract IA007: B cell immunity generation in tertiary lymphoid structures, a major determinant of sarcoma immune response to immunotherapy","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Immunotherapy; CD8; Immune system; Cancer immunotherapy; Cancer research; Biology; Immunology; Cancer; Medicine; Pathology; Internal medicine","score_opus":0.0796667208367007,"score_gpt":0.4202296403562986,"score_spread":0.34056291951959794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610881,0.03566559,0.000008111039,0.0008623107,0.0010611032,0.0010450454,0.0001548456,0.000029666071,0.000085181695],"genre_scores_gemma":[0.9947391,0.0016928125,0.00006892535,0.00039645034,0.00006826688,0.00056115503,0.00008831965,0.000063468586,0.0023214808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98810977,0.008220859,0.0017221443,0.0006550891,0.00032883912,0.0009633001],"domain_scores_gemma":[0.9955612,0.0025885657,0.00031494937,0.0012309715,0.0002456187,0.000058739206],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012110054,0.00030281502,0.0007498668,0.00079131307,0.00079301925,0.000035344576,0.0013597821,0.00033476754,0.0054467684],"category_scores_gemma":[0.00066520297,0.0002840971,0.00034107658,0.00087172777,0.00063639024,0.00012810223,0.0007193649,0.0021812678,0.00009694254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04623234,0.0008794853,0.0059760544,0.000028824721,0.00012228014,0.000034996512,0.0011067227,0.000071673705,0.8973536,0.00001821302,0.0015478544,0.04662796],"study_design_scores_gemma":[0.007360105,0.0022207268,0.4353172,0.000051410556,0.000010805742,0.000047422785,0.0007239455,0.000010803613,0.4991163,0.000099709585,0.054677345,0.00036423843],"about_ca_topic_score_codex":0.005308442,"about_ca_topic_score_gemma":0.00015007475,"teacher_disagreement_score":0.42934114,"about_ca_system_score_codex":0.0005199904,"about_ca_system_score_gemma":0.0012386177,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W4296131254","doi":"10.1158/1557-3265.sarcomas22-a005","title":"Abstract A005: STING activation overcomes immune escape in osteosarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Sting; Stimulator of interferon genes; Cancer research; Metastasis; Immune system; Cancer; Tumor microenvironment; Cancer cell; Downregulation and upregulation; Medicine; Immunotherapy; Innate immune system; Immunology; Biology; Internal medicine; Gene","score_opus":0.22584793915273674,"score_gpt":0.49713505180733997,"score_spread":0.27128711265460326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877583,0.006688649,0.000002948614,0.0019891458,0.0008494157,0.00038168885,0.000047144753,0.00004113816,0.0022415894],"genre_scores_gemma":[0.99493897,0.00044678763,0.0000143395355,0.00019658572,0.00005902647,0.00028289066,0.000057633508,0.00002657978,0.0039771637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9949754,0.0027818356,0.0008474413,0.00046905575,0.00020522809,0.0007210707],"domain_scores_gemma":[0.99611515,0.0031327268,0.00014233853,0.0004288144,0.00014676286,0.000034179953],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006494899,0.00015008521,0.00043194098,0.00040277536,0.00054332055,0.000032703872,0.0006048385,0.000165038,0.014013794],"category_scores_gemma":[0.001537283,0.00014135485,0.00019650166,0.0005989085,0.00037255287,0.00013990187,0.00075589947,0.002763023,0.00033079542],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009799374,0.0013287386,0.02644218,0.00007136266,0.00039064063,0.00005086803,0.00080692116,0.00006959783,0.6666941,0.0008151546,0.012701034,0.28083006],"study_design_scores_gemma":[0.005585654,0.0018712218,0.53440285,0.00015600311,0.000022073817,0.000026790183,0.0048218616,0.000022700568,0.15946424,0.00034313663,0.29282397,0.0004595112],"about_ca_topic_score_codex":0.0021253503,"about_ca_topic_score_gemma":0.00012061045,"teacher_disagreement_score":0.5079607,"about_ca_system_score_codex":0.00034217158,"about_ca_system_score_gemma":0.00043585687,"threshold_uncertainty_score":0.99953765},"labels":[],"label_agreement":null},{"id":"W4296131270","doi":"10.1158/1557-3265.sarcomas22-a037","title":"Abstract A037: TT-00420, a novel kinase inhibitor potentially benefiting c-Myc amplified/overexpressed osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Cancer research; Clonogenic assay; Immunohistochemistry; Kinase; Medicine; Oncogene; Aurora A kinase; In vivo; Biology; Internal medicine; Cancer; Cell cycle","score_opus":0.11173200425652956,"score_gpt":0.42800626540463466,"score_spread":0.3162742611481051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454826,0.0014701695,0.000231915,0.00071615726,0.000607612,0.00055323256,0.0005395922,0.000026339167,0.0013067265],"genre_scores_gemma":[0.99456304,0.0006076367,0.00042271236,0.0007449997,0.0015726024,0.0003343279,0.00033588457,0.00006989041,0.0013488808],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963916,0.0003019664,0.00072900864,0.0009631012,0.00077825045,0.0008360665],"domain_scores_gemma":[0.99816567,0.00021794082,0.00016939457,0.0007830104,0.0003570985,0.00030691674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024455746,0.00022602179,0.00031376965,0.00010504358,0.0006236701,0.00010286607,0.0008359357,0.00025366127,0.00061008584],"category_scores_gemma":[0.00055579393,0.00023558282,0.00031711755,0.00029165793,0.00028185983,0.000009116722,0.0015245199,0.0012749548,0.000030191015],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008539896,0.00064058864,0.0027861258,0.00005883694,0.00009877946,0.000031113123,0.000034759043,0.00028801317,0.9658741,0.00016131772,0.011918783,0.017253645],"study_design_scores_gemma":[0.00731686,0.0024072418,0.02248502,0.00015152254,0.000061604835,0.00004198845,0.0008996546,0.00040338218,0.2080594,0.00031736624,0.7566607,0.001195251],"about_ca_topic_score_codex":0.00055979483,"about_ca_topic_score_gemma":0.00032982638,"teacher_disagreement_score":0.75781465,"about_ca_system_score_codex":0.00010927143,"about_ca_system_score_gemma":0.00068990386,"threshold_uncertainty_score":0.9606789},"labels":[],"label_agreement":null},{"id":"W4296131277","doi":"10.1158/1557-3265.sarcomas22-b014","title":"Abstract B014: Metabolic reprogramming in high-grade sarcomas: repurposing anti-cholesterol agents as a novel therapeutic strategy","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Mount Sinai Hospital; SickKids Foundation; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Simvastatin; PI3K/AKT/mTOR pathway; Mevalonate pathway; Pharmacology; Cancer research; Doxorubicin; In vivo; Protein kinase B; Cell growth; Statin; Medicine; Biology; Chemotherapy; Signal transduction; Internal medicine; Cell biology; Enzyme; Biochemistry","score_opus":0.1915888944670585,"score_gpt":0.48370998691447675,"score_spread":0.29212109244741824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744917,0.020074224,0.000028216637,0.0006291531,0.0035256653,0.00076469674,0.000062431405,0.00002497031,0.0003989513],"genre_scores_gemma":[0.9848363,0.0067424546,0.000085370775,0.0008195119,0.0060301325,0.00059579755,0.00007567892,0.00007004836,0.0007447532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954361,0.0006950491,0.0008826049,0.0011721106,0.0008623663,0.00095181307],"domain_scores_gemma":[0.9982755,0.00015175212,0.00018650714,0.00094784383,0.0001690531,0.00026933363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00430299,0.00024806688,0.00051694666,0.00020990992,0.00036097647,0.00012376174,0.00075246353,0.00022411825,0.00030732615],"category_scores_gemma":[0.0003039658,0.00025068983,0.00026642912,0.0005969057,0.00034935394,0.000015715108,0.0006247204,0.0014754676,0.000015991187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001692665,0.0030965686,0.07879209,0.00014191194,0.00051826646,0.000017199973,0.0004020126,0.0019285622,0.43299606,0.0009376438,0.010621438,0.46885556],"study_design_scores_gemma":[0.0030933036,0.00047377704,0.21537535,0.000033733944,0.000031056115,0.000017517455,0.00043695632,0.00005064031,0.0043078777,0.00026588107,0.7755849,0.00032902544],"about_ca_topic_score_codex":0.0040390515,"about_ca_topic_score_gemma":0.0007872622,"teacher_disagreement_score":0.76496345,"about_ca_system_score_codex":0.000099821,"about_ca_system_score_gemma":0.00082072656,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W4296131311","doi":"10.1158/1557-3265.sarcomas22-b021","title":"Abstract B021: Long non-coding RNAs that are required for robust cell growth in ewing Sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Sarcoma; Long non-coding RNA; Cancer research; Ewing's sarcoma; Cell growth; Oncogene; Phenotype; GAS5; FLI1; Synovial sarcoma; Downregulation and upregulation; Cell; Gene; Genetics; Cell cycle; Medicine; Pathology; Transcription factor","score_opus":0.19794022146894258,"score_gpt":0.4504245992308467,"score_spread":0.25248437776190413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515176,0.0073269294,0.027640754,0.0035457485,0.0016627803,0.0041519995,0.00035760275,0.00005504707,0.0037415747],"genre_scores_gemma":[0.99427474,0.0015725679,0.00038735356,0.00029587257,0.00066334306,0.0013048238,0.00012628415,0.00010906419,0.0012659346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951945,0.0006086787,0.0006610773,0.00117142,0.0011149995,0.001249323],"domain_scores_gemma":[0.9979988,0.00042533225,0.00017364098,0.0006925123,0.00039435746,0.00031537047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005841324,0.00023885375,0.0004122844,0.00030982585,0.0005423892,0.00009888281,0.0010434306,0.00032813783,0.00034858575],"category_scores_gemma":[0.00094472733,0.00026417823,0.00033361334,0.0006454005,0.00024381095,0.000014527149,0.0013236551,0.001801927,0.000014441954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068584317,0.0015039793,0.015762955,0.00097211776,0.00030155198,0.00061166927,0.00023970849,0.006462066,0.89400643,0.00013422809,0.04353079,0.0296161],"study_design_scores_gemma":[0.009537248,0.0023947668,0.023846747,0.0002959075,0.000034631907,0.0000205151,0.0014325896,0.003619056,0.92582524,0.000556044,0.03138402,0.001053264],"about_ca_topic_score_codex":0.0005661607,"about_ca_topic_score_gemma":0.0005846453,"teacher_disagreement_score":0.042757194,"about_ca_system_score_codex":0.0004448611,"about_ca_system_score_gemma":0.0009467214,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W4296131321","doi":"10.1158/1557-3265.sarcomas22-pr012","title":"Abstract PR012: Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Biology; Epigenetics; Liposarcoma; Sarcoma; Undifferentiated Pleomorphic Sarcoma; Chondrosarcoma; Receptor tyrosine kinase; Leiomyosarcoma; Chromatin remodeling; Pathology; Soft tissue sarcoma; Genetics; Medicine; Gene; Signal transduction","score_opus":0.14971942415406328,"score_gpt":0.4294639470151369,"score_spread":0.27974452286107365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92724204,0.06913732,0.000013477121,0.0020058258,0.0002259064,0.0011431179,0.00012666627,0.000025383919,0.00008026924],"genre_scores_gemma":[0.99453557,0.0040154736,0.00029637536,0.00040643752,0.0002508269,0.00025574604,0.000048093993,0.000047390444,0.00014411485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607366,0.0006823298,0.0008957639,0.00065761816,0.0011028862,0.0005877679],"domain_scores_gemma":[0.99777406,0.000886841,0.00021470946,0.00049576705,0.00023296147,0.0003956697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024235544,0.00021325605,0.00073306286,0.00019489437,0.00033863517,0.000038931816,0.00017188505,0.00013460012,0.00074147905],"category_scores_gemma":[0.00020720028,0.00018329655,0.00013114551,0.0002511861,0.00041660844,0.000052348027,0.00047877885,0.0010103773,0.000007426534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002758523,0.002106494,0.7023904,0.00068329263,0.0007694085,0.002004599,0.0009859354,0.000086822714,0.045509506,0.00009844718,0.0038344383,0.23877214],"study_design_scores_gemma":[0.004886572,0.0020530312,0.9855249,0.00014670665,0.0001766756,0.00018646778,0.00062858715,0.00031751394,0.0022809699,0.00077951845,0.002798448,0.00022063231],"about_ca_topic_score_codex":0.0010841951,"about_ca_topic_score_gemma":0.00012515586,"teacher_disagreement_score":0.2831345,"about_ca_system_score_codex":0.0003131828,"about_ca_system_score_gemma":0.00054291263,"threshold_uncertainty_score":0.81186754},"labels":[],"label_agreement":null},{"id":"W4296131396","doi":"10.1158/1557-3265.sarcomas22-a019","title":"Abstract A019: Phase 1, first-in-human, dose-expansion study of oral TP-1287, a cyclin dependent kinase 9 (CDK9) inhibitor, in patients with sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sarcoma; Internal medicine; Cancer; Oncology; Synovial sarcoma; Neutropenia; Chemotherapy; Gastroenterology; Pathology","score_opus":0.13262587911092769,"score_gpt":0.5003120973935415,"score_spread":0.36768621828261383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957153,0.00046871006,0.0000028082934,0.0005525306,0.00022682213,0.002842667,0.00007103219,0.00003076118,0.00008934266],"genre_scores_gemma":[0.99846965,0.000052858883,0.000073895026,0.00012525878,0.00014878705,0.0008847288,0.000041144005,0.000073399366,0.00013025748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99375343,0.00073109154,0.0013877614,0.00093827536,0.0023945984,0.00079485256],"domain_scores_gemma":[0.9974793,0.00066212454,0.00026475155,0.0008508223,0.0004216213,0.00032138024],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032857666,0.0002702635,0.0009052093,0.00059657346,0.00023903137,0.000018142944,0.00044602357,0.00011723321,0.0010799558],"category_scores_gemma":[0.00034874005,0.00022978835,0.0001136744,0.0012142165,0.00038068008,0.00016339919,0.00051518675,0.0024709275,0.000008471774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032180525,0.028511722,0.88938993,0.00014934198,0.000093655,0.0004903864,0.0011412087,0.00091263076,0.00041943407,0.0000059582762,0.00014632194,0.0465589],"study_design_scores_gemma":[0.0674361,0.015989142,0.9120143,0.00033744882,0.000029263949,0.0000023773753,0.002259578,0.000053878015,0.00027367898,0.00009707997,0.001269236,0.00023788527],"about_ca_topic_score_codex":0.005763538,"about_ca_topic_score_gemma":0.010374398,"teacher_disagreement_score":0.046321016,"about_ca_system_score_codex":0.001121917,"about_ca_system_score_gemma":0.00071855786,"threshold_uncertainty_score":0.99983317},"labels":[],"label_agreement":null},{"id":"W4296131397","doi":"10.1158/1557-3265.sarcomas22-pr011","title":"Abstract PR011: Characterization of the precancerous and cancer microenvironment in a zebrafish sarcoma model","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Biology; Sarcoma; Zebrafish; Cancer research; Cancer; Transcriptome; Population; Cancer cell; Pathology; Medicine; Gene expression; Genetics; Gene","score_opus":0.15388921823071502,"score_gpt":0.4630678657189183,"score_spread":0.30917864748820323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935989,0.0006238209,0.0000013313929,0.0041332464,0.00009066204,0.0011237338,0.00017464084,0.0000071730747,0.0002465174],"genre_scores_gemma":[0.995016,0.0026697048,0.000014188581,0.00032782985,0.000069880756,0.0008732,0.000010816236,0.000024176621,0.0009942153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974508,0.0003714921,0.00043456285,0.00040268802,0.00092468894,0.0004157421],"domain_scores_gemma":[0.99908495,0.00020795896,0.00009550952,0.0003637954,0.000072034134,0.00017577373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010447185,0.00010098975,0.00028257896,0.000118187534,0.00017411899,0.000012882689,0.00022294912,0.000050060782,0.0007270369],"category_scores_gemma":[0.00012656153,0.00007441367,0.00008169632,0.00038360176,0.0003860426,0.000054897297,0.00053241977,0.0010610756,0.0000031425852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049495907,0.0027152814,0.66024655,0.00037948234,0.00016027263,0.00010578912,0.0004442669,0.0004423944,0.23840444,0.000028102919,0.0014548517,0.090668984],"study_design_scores_gemma":[0.0027918245,0.0005434525,0.9859079,0.00013146059,0.000015274898,0.00000576979,0.000034118748,0.0016145529,0.006753348,0.00008029856,0.002056485,0.00006548438],"about_ca_topic_score_codex":0.0007779875,"about_ca_topic_score_gemma":0.00026067748,"teacher_disagreement_score":0.3256614,"about_ca_system_score_codex":0.00046206193,"about_ca_system_score_gemma":0.0007009771,"threshold_uncertainty_score":0.7960544},"labels":[],"label_agreement":null},{"id":"W4296131408","doi":"10.1158/1557-3265.sarcomas22-ia017","title":"Abstract IA017: Impact of oxygen and nutrient availability on sarcoma tumor neighborhood","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypoxia (environmental); Bioenergetics; Biology; Mitochondrion; Reactive oxygen species; Glycolysis; Oxidative stress; Cellular respiration; Cell biology; Metabolism; Oxygen; Biochemistry; Chemistry","score_opus":0.10030697199652322,"score_gpt":0.4633063034763304,"score_spread":0.3629993314798072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904052,0.0067571634,0.0000032713226,0.00028232354,0.0005415569,0.00041614936,0.00031375515,0.000006435591,0.0012741497],"genre_scores_gemma":[0.9955421,0.0025004135,0.000015608506,0.00018105817,0.0011985616,0.00015364662,0.000033253873,0.00002380383,0.0003515697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974593,0.000435276,0.00048718796,0.00061983726,0.0005540035,0.0004444032],"domain_scores_gemma":[0.998544,0.00021022637,0.00012055721,0.0006378484,0.00022265814,0.00026471945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026623528,0.00014142935,0.00032426487,0.00007534528,0.00019704102,0.000019607987,0.00036591841,0.00009186146,0.00088434236],"category_scores_gemma":[0.0006312884,0.00012251601,0.00027353986,0.00021863561,0.0004139063,0.0000038026178,0.0005342334,0.00069067185,0.000007682422],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016646847,0.004526631,0.25485483,0.00031577755,0.0007352615,0.000024484913,0.00028087787,0.0003252983,0.39048254,0.00068294356,0.18294305,0.14818148],"study_design_scores_gemma":[0.0029652468,0.0040714773,0.7351145,0.000022607474,0.00002217422,0.000008197646,0.00014486062,0.00003867699,0.011084972,0.0007566677,0.24549477,0.00027585885],"about_ca_topic_score_codex":0.0006672225,"about_ca_topic_score_gemma":0.00006898997,"teacher_disagreement_score":0.48025966,"about_ca_system_score_codex":0.00009688692,"about_ca_system_score_gemma":0.0008643495,"threshold_uncertainty_score":0.96829283},"labels":[],"label_agreement":null},{"id":"W4296131450","doi":"10.1158/1557-3265.sarcomas22-a021","title":"Abstract A021: Chimeric antigen receptor armored natural killer cell immunotherapy for osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Immunotherapy; NK-92; Immunology; Antibody-dependent cell-mediated cytotoxicity; Cancer immunotherapy; Cancer research; Antigen; Biology; Immune system; Natural killer T cell; T cell; Antibody; Medicine; Monoclonal antibody","score_opus":0.17991780428112386,"score_gpt":0.5114094580274091,"score_spread":0.33149165374628525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96993506,0.01045333,0.000008589687,0.009180427,0.0024936884,0.0036402205,0.000115300376,0.000106889456,0.004066482],"genre_scores_gemma":[0.9095518,0.0061512594,0.00061890023,0.0013521387,0.0021382032,0.0023165208,0.00023504457,0.00020923786,0.077426895],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99348104,0.00085606024,0.0009715959,0.001019054,0.0022447319,0.0014275366],"domain_scores_gemma":[0.9951066,0.0025665427,0.00015696633,0.0010975727,0.0005791697,0.00049316784],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0069546406,0.00028427778,0.0007853723,0.00040157218,0.00079569826,0.000086636486,0.0009051275,0.00018789785,0.055025112],"category_scores_gemma":[0.00049419235,0.00025251767,0.00069420045,0.0011587887,0.00066282845,0.000090197784,0.00048509665,0.0036209023,0.00021891648],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026817814,0.0018546338,0.021154325,0.0002587258,0.00050638255,0.00009447501,0.00047473272,0.00001260486,0.4420086,0.000049043723,0.18984218,0.31692648],"study_design_scores_gemma":[0.009642179,0.003232195,0.06466754,0.00004896378,0.000017632157,0.000014438907,0.00048737074,0.0002051365,0.011934178,0.00016546072,0.9092385,0.00034641882],"about_ca_topic_score_codex":0.00069975614,"about_ca_topic_score_gemma":0.000035416404,"teacher_disagreement_score":0.7193963,"about_ca_system_score_codex":0.0006996395,"about_ca_system_score_gemma":0.0015829947,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W4296131451","doi":"10.1158/1557-3265.sarcomas22-ia006","title":"Abstract IA006: Immunobiology of sarcomas and therapeutic implications","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Immunotherapy; Immune system; Immunosuppression; Chemokine; Biology; Cancer; Cancer immunotherapy; Myeloid; Immunology; Medicine; Cancer research","score_opus":0.22327808832325258,"score_gpt":0.5027934221824263,"score_spread":0.2795153338591737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87404567,0.11792744,0.0000072094267,0.0030364357,0.0012394025,0.00047700616,0.00016392865,0.000032249285,0.0030706844],"genre_scores_gemma":[0.99372745,0.003042231,0.000013535103,0.00028876268,0.000048685633,0.00037834025,0.000033144584,0.000020898993,0.0024469695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99728477,0.0011095235,0.00061896077,0.00041678658,0.00008330186,0.00048667568],"domain_scores_gemma":[0.9969593,0.0020832994,0.00013762657,0.00059173995,0.00020036109,0.000027666181],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003116668,0.0001084942,0.00034774834,0.00014025564,0.0005205501,0.0000071431414,0.00061773387,0.00018059202,0.0073339865],"category_scores_gemma":[0.00017925593,0.000100277495,0.00011142804,0.00032086458,0.0017168085,0.000024126353,0.0007486801,0.0016852819,0.00009282794],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011527436,0.0006656281,0.09464689,0.000057661215,0.00042311352,0.0000033791384,0.00042837637,0.000012436768,0.5927816,0.0077144057,0.017085766,0.28502798],"study_design_scores_gemma":[0.0018854738,0.00075704895,0.4956531,0.00001641678,0.000026395308,0.000026958529,0.00047689973,0.0000018815354,0.011665721,0.0032252716,0.48608062,0.00018424285],"about_ca_topic_score_codex":0.00060457963,"about_ca_topic_score_gemma":0.0000337545,"teacher_disagreement_score":0.5811159,"about_ca_system_score_codex":0.00011654363,"about_ca_system_score_gemma":0.00040314073,"threshold_uncertainty_score":0.9935734},"labels":[],"label_agreement":null},{"id":"W4296131454","doi":"10.1158/1557-3265.sarcomas22-a022","title":"Abstract A022: Targeting of soft tissue sarcoma cancer stem cells improves doxorubicin-sensitivity <i>in vitro</i>","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer stem cell; Cancer research; Biology; EZH2; Population; Stem cell; Doxorubicin; Stem cell marker; Side population; Cancer; Epigenetics; Medicine; Chemotherapy; Genetics; Gene","score_opus":0.13738816973783124,"score_gpt":0.46875047331177977,"score_spread":0.3313623035739485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817767,0.011720387,0.0000016833235,0.0041867187,0.00051007787,0.0010575637,0.00021681022,0.000030640404,0.0004994323],"genre_scores_gemma":[0.9962142,0.0016485513,0.000086516106,0.0004929353,0.00041943768,0.00067646906,0.000019618006,0.00005144889,0.00039080568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99544895,0.00070004584,0.0010042388,0.0007486877,0.0012948356,0.00080326106],"domain_scores_gemma":[0.99612737,0.0025119677,0.00021269202,0.0005350752,0.00030328502,0.00030963312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004849668,0.00021233418,0.0008762711,0.00022400681,0.00023049717,0.00002154923,0.00022463025,0.00012526053,0.0009707445],"category_scores_gemma":[0.000140713,0.00018457703,0.00025942654,0.0006669968,0.00041074894,0.000064182284,0.0004568686,0.0015990158,0.000028535558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002642238,0.0031600008,0.21901172,0.00035773488,0.0001856459,0.0010295744,0.00022328776,0.00013778108,0.46607655,0.000029189308,0.0075895004,0.29955676],"study_design_scores_gemma":[0.004549347,0.0009093269,0.27983117,0.00021354237,0.00009633713,0.0000095284295,0.0007088454,0.00026202184,0.68754363,0.00005797596,0.025558706,0.000259562],"about_ca_topic_score_codex":0.010083009,"about_ca_topic_score_gemma":0.00058060855,"teacher_disagreement_score":0.2992972,"about_ca_system_score_codex":0.00065835024,"about_ca_system_score_gemma":0.0008418906,"threshold_uncertainty_score":0.9999425},"labels":[],"label_agreement":null},{"id":"W4296131459","doi":"10.1158/1557-3265.sarcomas22-pr007","title":"Abstract PR007: A single cysteine in PAX3-FOXO1 is relevant for transactivation and survival of rhabdomyosarcoma cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transactivation; Druggability; PAX3; Transcription factor; Rhabdomyosarcoma; Alveolar rhabdomyosarcoma; Cancer research; Fusion protein; Biology; Fusion gene; Gene; Computational biology; Genetics; Medicine; Sarcoma; Pathology","score_opus":0.18265198724247023,"score_gpt":0.46694751755715164,"score_spread":0.2842955303146814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957753,0.0016116083,0.00033293507,0.0012120015,0.00014190054,0.00051617716,0.00019579228,0.0000027104281,0.00021161244],"genre_scores_gemma":[0.99755013,0.0011449439,0.00015148008,0.000078549325,0.00013824116,0.0004114763,0.000032289678,0.000014805555,0.00047809907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848706,0.0002014187,0.00042460844,0.00037305977,0.00027931388,0.00023454339],"domain_scores_gemma":[0.9991813,0.00022292227,0.000087122564,0.00026976116,0.00017455439,0.00006436791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020224731,0.0000730478,0.00018043384,0.00006859571,0.00010803469,0.0000120492805,0.00018360786,0.00008608884,0.00009201643],"category_scores_gemma":[0.00012770783,0.00007177086,0.00008292739,0.00018685785,0.00016653158,0.000004409048,0.00007855687,0.00027037936,5.1256507e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014610438,0.00044158494,0.0037481599,0.00011584571,0.000036277044,0.0000013667437,0.0001216193,0.0001177089,0.94267255,0.000072612194,0.0019254715,0.04928576],"study_design_scores_gemma":[0.0069115334,0.0050148233,0.043008454,0.00009148154,0.000024617502,0.0000025622912,0.000983647,0.0006947495,0.55827177,0.00083652494,0.3837366,0.0004232512],"about_ca_topic_score_codex":0.00025571903,"about_ca_topic_score_gemma":0.00022104947,"teacher_disagreement_score":0.3844008,"about_ca_system_score_codex":0.000050044233,"about_ca_system_score_gemma":0.0002437228,"threshold_uncertainty_score":0.29267308},"labels":[],"label_agreement":null},{"id":"W4296131466","doi":"10.1158/1557-3265.sarcomas22-b004","title":"Abstract B004: ATR-CHK1-WEE1 pathway is a critical dependency in the context of DNA damage and replicative stress in osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Cancer research; In vivo; Context (archaeology); Combination therapy; Wee1; Apoptosis; Osteosarcoma; DNA damage; Medicine; Biology; Cell cycle; Pharmacology; Cancer; Internal medicine; DNA; Genetics","score_opus":0.14914140813665563,"score_gpt":0.4927554206707957,"score_spread":0.34361401253414003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944247,0.0031767767,0.00000409636,0.0056099566,0.00004340839,0.00038858288,0.00029523135,0.0000020456703,0.0010374325],"genre_scores_gemma":[0.9977428,0.00089833536,0.000017341912,0.0005000276,0.00009272878,0.00054504635,0.000026798403,0.000012790387,0.0001641815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750054,0.0007377572,0.0005040516,0.0005244722,0.00041995614,0.00031321784],"domain_scores_gemma":[0.99848974,0.0005528111,0.00007016437,0.0006418404,0.00016812305,0.000077327015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002869351,0.000093467,0.00019875866,0.00007346567,0.0001368006,0.000023879857,0.0005324353,0.00010832476,0.00023255654],"category_scores_gemma":[0.00065033505,0.00007600787,0.000076793214,0.0002930857,0.0005505439,0.0000064207898,0.00036875054,0.00077776576,0.0000022953857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033469847,0.0042131124,0.5056271,0.00040664314,0.00014693828,0.00018758685,0.0045413906,0.000041424875,0.23114905,0.009754964,0.01704186,0.22354293],"study_design_scores_gemma":[0.0036844588,0.002804183,0.8423937,0.00012890041,0.000016711503,0.000013423707,0.021134455,0.0001555067,0.059639085,0.0023375198,0.06721662,0.00047542978],"about_ca_topic_score_codex":0.0011024385,"about_ca_topic_score_gemma":0.002018664,"teacher_disagreement_score":0.3367666,"about_ca_system_score_codex":0.000051792827,"about_ca_system_score_gemma":0.00039486372,"threshold_uncertainty_score":0.33790484},"labels":[],"label_agreement":null},{"id":"W4296131467","doi":"10.1158/1557-3265.sarcomas22-pr004","title":"Abstract PR004: Fusion protein-driven IGF-IR signals deregulate hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"YAP1; Hippo signaling pathway; Biology; Transcriptome; Cell biology; Cancer research; Signal transduction; Molecular biology; Gene expression; Transcription factor; Genetics; Gene","score_opus":0.1123395446283583,"score_gpt":0.42786766692127537,"score_spread":0.31552812229291705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635786,0.0017115987,0.000048260503,0.00049140514,0.000118446114,0.0009015869,0.00011985289,0.000016956645,0.00023406268],"genre_scores_gemma":[0.99780643,0.000280947,0.00015620145,0.000080657104,0.0004406118,0.00036008854,0.00012785892,0.00003878418,0.00070840295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966172,0.00088790356,0.000701839,0.00068982714,0.00063734077,0.00046589857],"domain_scores_gemma":[0.998556,0.0001727657,0.00020652913,0.00041842135,0.00043404198,0.00021219478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040127733,0.00016719103,0.00031217228,0.0000889588,0.00048099054,0.000042401534,0.0003490878,0.00020642852,0.00044285963],"category_scores_gemma":[0.00064829824,0.00015643693,0.00014255835,0.000256618,0.00030979287,0.000008418092,0.0005800377,0.00074592297,0.000007665176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004275822,0.00023979213,0.0014526787,0.00010652233,0.00005501918,0.000013025882,0.0001470101,0.00038468148,0.9719763,0.00002331629,0.00023964465,0.024934439],"study_design_scores_gemma":[0.0017929669,0.0032778478,0.0031287048,0.00016868924,0.000019907591,0.000010919183,0.00019870153,0.0012000168,0.9696783,0.000261297,0.019902257,0.0003603931],"about_ca_topic_score_codex":0.00015587876,"about_ca_topic_score_gemma":0.00008459096,"teacher_disagreement_score":0.024574045,"about_ca_system_score_codex":0.000059699236,"about_ca_system_score_gemma":0.0009532594,"threshold_uncertainty_score":0.6379313},"labels":[],"label_agreement":null},{"id":"W4296131473","doi":"10.1158/1557-3265.sarcomas22-ia014","title":"Abstract IA014: Stem cell and developmental hierarchies in rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Biology; Embryonic stem cell; Stem cell; Progenitor cell; PAX3; Myogenesis; Alveolar rhabdomyosarcoma; Cell; Cancer; Cancer research; Myocyte; Cell biology; Pathology; Sarcoma; Genetics; Medicine; Gene","score_opus":0.22868827506617864,"score_gpt":0.4833754516739351,"score_spread":0.2546871766077564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449755,0.0068335864,2.1692478e-7,0.0034078597,0.00011676804,0.0005801362,0.000026953088,0.000019021754,0.004517918],"genre_scores_gemma":[0.995597,0.0020905843,0.00017330857,0.000401258,0.00010628336,0.0007128005,0.000011558355,0.000022782453,0.0008844079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975296,0.00032313756,0.0004840613,0.00046521646,0.0007397631,0.00045818364],"domain_scores_gemma":[0.99791306,0.0015261363,0.000039561677,0.00020743694,0.00005935038,0.00025447967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020603759,0.000116322095,0.00034545394,0.00024378716,0.00025096387,0.00002752432,0.00014934212,0.00005646445,0.0014772742],"category_scores_gemma":[0.00007238077,0.00009942909,0.0000836881,0.00039411918,0.00026672563,0.00004058744,0.00045445265,0.001119958,0.000053385185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000593317,0.001306856,0.8260769,0.00006615957,0.000033555803,0.0006858487,0.000324657,0.0000016048557,0.00014724153,0.00006998679,0.0045583444,0.16613552],"study_design_scores_gemma":[0.003594527,0.0005117665,0.93972045,0.000058364778,0.000011203975,0.000030044594,0.0016243575,0.000016519609,0.0005991931,0.00014436925,0.053579643,0.00010958368],"about_ca_topic_score_codex":0.0006101105,"about_ca_topic_score_gemma":0.00019658958,"teacher_disagreement_score":0.16602594,"about_ca_system_score_codex":0.00043596508,"about_ca_system_score_gemma":0.00058462366,"threshold_uncertainty_score":0.9994355},"labels":[],"label_agreement":null},{"id":"W4296131477","doi":"10.1158/1557-3265.sarcomas22-a004","title":"Abstract A004: Radiation-induced changes to the immune microenvironment in an immunocompetent mouse model of Ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Sarcoma; Tumor microenvironment; Cancer research; Medicine; Ewing's sarcoma; Humanized mouse; Cancer; Flow cytometry; Radiation therapy; Pathology; Immunology; Biology; Internal medicine","score_opus":0.27151079211520096,"score_gpt":0.47744228893006985,"score_spread":0.2059314968148689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97495645,0.003955647,0.0000014242285,0.019577181,0.00010243166,0.0012652032,0.00006279404,0.000010138732,0.00006871812],"genre_scores_gemma":[0.9959334,0.0013850388,0.00010057383,0.0007306125,0.00012533632,0.0015419349,0.000026110065,0.000029070554,0.00012787998],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972741,0.00041585392,0.0006034314,0.00041025082,0.00085997937,0.00043637195],"domain_scores_gemma":[0.9983502,0.0005730113,0.00009293367,0.00073187135,0.000070970906,0.00018099307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029226437,0.00012342838,0.00039063476,0.00019160841,0.00022081903,0.000018580471,0.0003789985,0.000052261963,0.0005359898],"category_scores_gemma":[0.00013547747,0.00009127253,0.00014116288,0.00031400024,0.000095515155,0.00003677327,0.00041294083,0.00081912143,0.000020556346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028858427,0.010146163,0.28725767,0.00010405016,0.00034028562,0.00010692757,0.00321571,0.010253916,0.22011635,0.00016285577,0.0012489146,0.4641613],"study_design_scores_gemma":[0.0038244717,0.0019290752,0.94582134,0.000086542736,0.00003920172,0.000002865059,0.0013241727,0.0024437972,0.04032366,0.000047893605,0.0039989753,0.00015801805],"about_ca_topic_score_codex":0.002007383,"about_ca_topic_score_gemma":0.0005468544,"teacher_disagreement_score":0.6585637,"about_ca_system_score_codex":0.0006558455,"about_ca_system_score_gemma":0.0002667372,"threshold_uncertainty_score":0.58687127},"labels":[],"label_agreement":null},{"id":"W4296131481","doi":"10.1158/1557-3265.sarcomas22-a011","title":"Abstract A011: Emergence of persister cells following bromodomain inhibition in Ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bromodomain; Epigenetics; Reprogramming; Biology; Cancer research; Sarcoma; Population; BRD4; Metastasis; Bioinformatics; Cell; Medicine; Cancer; Genetics; Pathology; Gene","score_opus":0.14420935822956252,"score_gpt":0.46009484590988436,"score_spread":0.3158854876803219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693096,0.00086080603,0.00002925752,0.000400854,0.0003460651,0.00024786647,0.000023734296,0.000004255286,0.0011561802],"genre_scores_gemma":[0.9988405,0.00020795899,0.00008654539,0.00013548177,0.00016993536,0.00010823124,0.00003580433,0.000014932684,0.00040061426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979153,0.00046062106,0.00048393558,0.0003704338,0.00047964716,0.00029002415],"domain_scores_gemma":[0.99940956,0.00008142503,0.000079013385,0.00027324495,0.000076012766,0.000080760845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002907375,0.00007742987,0.00015697248,0.00010430598,0.00014142614,0.000011395994,0.00019273655,0.00009031671,0.0006824819],"category_scores_gemma":[0.00026139242,0.00008221927,0.0001858098,0.0003003286,0.00012401397,0.000007453211,0.00036911614,0.0004973097,0.000007060936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027496633,0.0002530392,0.011552464,0.00003556552,0.000026311547,0.00002357687,0.000089082496,0.00013697219,0.9714095,0.000029055927,0.010735398,0.0054340563],"study_design_scores_gemma":[0.0021028875,0.00092673313,0.02168373,0.00009595048,0.000008115691,0.0000025476754,0.0013267571,0.00012351011,0.93761474,0.00029392427,0.035522003,0.0002990835],"about_ca_topic_score_codex":0.00023424625,"about_ca_topic_score_gemma":0.00009506139,"teacher_disagreement_score":0.033794753,"about_ca_system_score_codex":0.000046436133,"about_ca_system_score_gemma":0.00021065958,"threshold_uncertainty_score":0.74726987},"labels":[],"label_agreement":null},{"id":"W4296131621","doi":"10.1158/1557-3265.sarcomas22-a018","title":"Abstract A018: YAP signaling promotes resistance to MEK and AKT inhibition in NF1-related MPNSTs","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hippo signaling pathway; Cancer research; Protein kinase B; MAPK/ERK pathway; PI3K/AKT/mTOR pathway; Biology; Regulator; YAP1; Signal transduction; Medicine; Transcription factor; Cell biology; Genetics","score_opus":0.11617355183190625,"score_gpt":0.4548698895354254,"score_spread":0.33869633770351915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949008,0.0021465558,0.000012653115,0.0015276846,0.00013321139,0.0004171329,0.000055248398,0.000015210867,0.0007914547],"genre_scores_gemma":[0.99777436,0.00020651697,0.00012189757,0.00025588216,0.00020568284,0.0002520274,0.00005722168,0.000028664592,0.0010977717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727285,0.00057274476,0.000530529,0.0006812838,0.0004717659,0.0004708298],"domain_scores_gemma":[0.9990438,0.00021457145,0.000069997644,0.00029743655,0.00015964876,0.00021450069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004368534,0.00012592728,0.00021572763,0.00013351825,0.00028398505,0.00004144207,0.0001807652,0.00015906552,0.00023313421],"category_scores_gemma":[0.00074876833,0.00012989399,0.000074077805,0.0004404976,0.00018507463,0.0000054031198,0.00035227268,0.00084731565,0.00001703833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008020958,0.00021456179,0.0053736917,0.000063455285,0.000031951702,0.00008280818,0.0002662942,0.000419829,0.98576796,0.00006783319,0.0017038488,0.0052056485],"study_design_scores_gemma":[0.005514041,0.003607419,0.03007627,0.0006754711,0.000027577353,0.000020912184,0.0012194319,0.00019561197,0.82694614,0.004428479,0.12606667,0.001221989],"about_ca_topic_score_codex":0.00016980874,"about_ca_topic_score_gemma":0.0004475824,"teacher_disagreement_score":0.15882185,"about_ca_system_score_codex":0.00007522148,"about_ca_system_score_gemma":0.00033194458,"threshold_uncertainty_score":0.52969235},"labels":[],"label_agreement":null},{"id":"W4296131712","doi":"10.1158/1557-3265.sarcomas22-a008","title":"Abstract A008: Mechanisms of immune escape in NF1-associated peripheral nerve sheath tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurofibromatosis; Tumor microenvironment; Immune system; Plexiform neurofibroma; Pathology; Malignant peripheral nerve sheath tumor; Neurofibroma; Malignant transformation; Cancer research; Immunology","score_opus":0.1600386488271176,"score_gpt":0.4603252899569611,"score_spread":0.3002866411298435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946869,0.00091628643,0.0000012154254,0.0018094039,0.00028317038,0.00054537714,0.00007822507,0.000031484975,0.0016479162],"genre_scores_gemma":[0.99840516,0.00011907579,0.000055015622,0.00018145502,0.00010235075,0.00021827973,0.00003142728,0.000041495805,0.0008457571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569434,0.0007266054,0.0011835509,0.00049614283,0.0012957046,0.000603644],"domain_scores_gemma":[0.9981,0.0007792095,0.00017434738,0.00047320756,0.00024000276,0.00023324993],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005001215,0.00014467427,0.000730184,0.00023034387,0.0001890171,0.000021306618,0.00033618367,0.000106690095,0.0051325746],"category_scores_gemma":[0.0011034211,0.0001312239,0.00032164078,0.00089993596,0.00023824017,0.000060739774,0.0004080451,0.0018223284,0.00001340781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017435083,0.014249432,0.5477008,0.0011001073,0.0006058898,0.010932384,0.0013623359,0.00045723616,0.3431855,0.0060948883,0.027847487,0.029028792],"study_design_scores_gemma":[0.005010819,0.0040076682,0.9775049,0.00032267201,0.00002708303,0.00004483268,0.0010359356,0.0004681596,0.008688833,0.0012492852,0.0014148087,0.00022498799],"about_ca_topic_score_codex":0.002014749,"about_ca_topic_score_gemma":0.000104160885,"teacher_disagreement_score":0.4298041,"about_ca_system_score_codex":0.00033952892,"about_ca_system_score_gemma":0.00085054367,"threshold_uncertainty_score":0.9957769},"labels":[],"label_agreement":null},{"id":"W4296131773","doi":"10.1158/1557-3265.sarcomas22-ia012","title":"Abstract IA012: Intratumoral activation of double-stranded RNA sensors induces systemic immune response to irradiated sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Immune system; Myeloid; Population; Medicine; Flow cytometry; Sarcoma; Immunotherapy; Myeloid leukemia; Myeloid sarcoma; Immunology; Pathology","score_opus":0.14683342578410435,"score_gpt":0.43717555549101444,"score_spread":0.2903421297069101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244756,0.00068324996,0.0000032592825,0.0018418832,0.0034705268,0.00069010444,0.000025542608,0.000055706525,0.0007822004],"genre_scores_gemma":[0.9926686,0.00011078233,0.000004198457,0.00012188204,0.00008426859,0.00023205705,0.00008798849,0.000026688402,0.0066635255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99527895,0.0024619007,0.0010582826,0.00045517937,0.00024244213,0.00050323486],"domain_scores_gemma":[0.99734247,0.0014541582,0.0002685891,0.00045230205,0.00041722239,0.00006525786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005667533,0.0001597693,0.0004487503,0.00045766623,0.00049403845,0.000026753194,0.00043114414,0.00023374672,0.0066288887],"category_scores_gemma":[0.0006986691,0.00015302791,0.00018517321,0.00076399586,0.00027181383,0.00014195169,0.00022945636,0.0022178495,0.0003415165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055010706,0.00035254998,0.00045441947,0.000035106765,0.00014967033,0.0000064847814,0.00046850197,0.00022782291,0.9293827,0.000056722824,0.010096726,0.0037586237],"study_design_scores_gemma":[0.010737046,0.0036602295,0.22077937,0.00026984644,0.000036440004,0.00006519311,0.0054859887,0.000016804603,0.67964756,0.000047137608,0.07880678,0.00044758114],"about_ca_topic_score_codex":0.001315483,"about_ca_topic_score_gemma":0.000013876689,"teacher_disagreement_score":0.24973509,"about_ca_system_score_codex":0.0003863554,"about_ca_system_score_gemma":0.00051025214,"threshold_uncertainty_score":0.9942792},"labels":[],"label_agreement":null},{"id":"W4296131779","doi":"10.1158/1557-3265.sarcomas22-ia009","title":"Abstract IA009: Oncogenic transcription factors drive highly tumor-specific LincRNA","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; FLI1; Polyadenylation; Gene; Genetics; Transcription factor; Reprogramming; Cancer research; Computational biology; RNA","score_opus":0.1973601308724714,"score_gpt":0.4642146375165321,"score_spread":0.2668545066440607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163496,0.004546453,0.00007492885,0.00088946114,0.0007607339,0.00036975546,0.00019242533,0.000020017664,0.001511287],"genre_scores_gemma":[0.9927207,0.003920243,0.00003273508,0.00023318079,0.0008967367,0.0004274414,0.00019269201,0.000040378658,0.001535858],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971209,0.00044394936,0.0005315205,0.0007304237,0.0006756835,0.0004974837],"domain_scores_gemma":[0.99864376,0.00010622618,0.00010505804,0.0006545769,0.00026676906,0.00022362664],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018153226,0.00015292052,0.00021546379,0.000096844284,0.0005790585,0.000053911972,0.00061729195,0.00012421164,0.002067562],"category_scores_gemma":[0.000096779266,0.00014615295,0.0002784926,0.00034515874,0.00031030225,0.0000074916697,0.0002141773,0.0009754825,0.00005108099],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079384045,0.00056575105,0.010889243,0.000023567678,0.00012135574,0.000016927534,0.00013697095,0.0003572443,0.9064286,0.0003428064,0.052222718,0.028101005],"study_design_scores_gemma":[0.0010030137,0.00072547054,0.07311252,0.00001035932,0.000011607103,0.0000032533526,0.0005178248,0.00002269327,0.048299156,0.00017667173,0.8758499,0.00026755125],"about_ca_topic_score_codex":0.00024784412,"about_ca_topic_score_gemma":0.00007798493,"teacher_disagreement_score":0.85812944,"about_ca_system_score_codex":0.00018584641,"about_ca_system_score_gemma":0.00055335596,"threshold_uncertainty_score":0.9988447},"labels":[],"label_agreement":null},{"id":"W4296131781","doi":"10.1158/1557-3265.sarcomas22-ia019","title":"Abstract IA019: How to target lung metastasis: dynamic changes in chromatin accessibility during osteosarcoma lung metastasis expose vulnerabilities","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Reprogramming; Osteosarcoma; Chromatin; Cancer research; Biology; Transcription factor; Lung cancer; Epigenomics; Context (archaeology); Cancer; Medicine; Pathology; Cell; DNA methylation; Genetics; Gene expression","score_opus":0.07549966012525675,"score_gpt":0.4429263766585873,"score_spread":0.3674267165333306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98327565,0.009425188,0.000029666522,0.004552739,0.00046009617,0.0010680256,0.0010096915,0.000020228432,0.00015872832],"genre_scores_gemma":[0.9946828,0.0016168968,0.0004635977,0.0003579612,0.00041710946,0.0017658033,0.00016886496,0.000064460364,0.00046251266],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953096,0.0009982456,0.0007179702,0.0012360503,0.00076845207,0.0009697174],"domain_scores_gemma":[0.9975666,0.00060197286,0.00016008885,0.0010364064,0.00025940838,0.0003755243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005072762,0.00028701386,0.0005517568,0.0002694135,0.00046102554,0.0001667097,0.000828671,0.00015498519,0.00087437447],"category_scores_gemma":[0.0020867367,0.0002966318,0.00023758135,0.00062279426,0.00026596824,0.000016799018,0.0019752008,0.0010338011,0.000005981332],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010703874,0.003787853,0.21114272,0.0028299748,0.0014763023,0.0010002811,0.0024150752,0.010665801,0.63266534,0.00015572298,0.036223125,0.08693391],"study_design_scores_gemma":[0.0092017995,0.004726401,0.63355637,0.00030308714,0.00019292418,0.00006820331,0.008715426,0.0028615105,0.24611428,0.0010161205,0.090560056,0.0026838116],"about_ca_topic_score_codex":0.00069162843,"about_ca_topic_score_gemma":0.006084416,"teacher_disagreement_score":0.42241368,"about_ca_system_score_codex":0.00062410615,"about_ca_system_score_gemma":0.00071417977,"threshold_uncertainty_score":0.99994856},"labels":[],"label_agreement":null},{"id":"W4296131819","doi":"10.1158/1557-3265.sarcomas22-ia010","title":"Abstract IA010: Novel targeted therapy approaches in NF1-MPNST","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; CDKN2A; Medicine; Targeted therapy; MAPK/ERK pathway; MEK inhibitor; Kinase; Cancer; Small molecule; Trametinib; Receptor tyrosine kinase; Internal medicine; Biology; Receptor; Cell biology","score_opus":0.5848092251588513,"score_gpt":0.5210043826787708,"score_spread":0.06380484248008045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872608,0.0025164976,0.0000013049773,0.005826812,0.0002836895,0.0007007508,0.000077621895,0.00004045256,0.0032920567],"genre_scores_gemma":[0.99698156,0.0005847478,0.000100480116,0.00071255007,0.00038613842,0.000511347,0.000036854006,0.000041377818,0.0006449376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966451,0.00039360474,0.00067630725,0.0006077889,0.0010994824,0.00057775155],"domain_scores_gemma":[0.9980182,0.001011828,0.00007505102,0.00051847193,0.00010889222,0.00026755882],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038757818,0.00013699598,0.00045068047,0.00024649483,0.0002435141,0.00003735645,0.00032304935,0.000096870215,0.0033192062],"category_scores_gemma":[0.00052984967,0.00011455761,0.00019697545,0.0008328215,0.00031248762,0.00006179232,0.0002878317,0.002130722,0.00004237063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011007189,0.009571172,0.74095005,0.00028089344,0.00022549399,0.0017151639,0.0006213143,0.00018493374,0.047453817,0.0015592973,0.063653715,0.12277697],"study_design_scores_gemma":[0.00499335,0.0014927072,0.89842254,0.00005617885,0.000006484116,0.00004047243,0.00055438007,0.00032610822,0.0020378446,0.0001333008,0.09175025,0.00018635842],"about_ca_topic_score_codex":0.0005374894,"about_ca_topic_score_gemma":0.000049658745,"teacher_disagreement_score":0.15747254,"about_ca_system_score_codex":0.00016986465,"about_ca_system_score_gemma":0.0007212096,"threshold_uncertainty_score":0.9975919},"labels":[],"label_agreement":null},{"id":"W4296131821","doi":"10.1158/1557-3265.sarcomas22-ia005","title":"Abstract IA005: On the use of stem cells to generate sarcomas in vitro models","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Mesenchymal stem cell; Sarcoma; Cancer research; Palbociclib; Biology; Cancer; Stem cell; Pathology; Medicine; Breast cancer; Genetics; Metastatic breast cancer","score_opus":0.6391396871612506,"score_gpt":0.5202599128007791,"score_spread":0.11887977436047148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857743,0.0008348543,0.0000016349694,0.01176751,0.00015089697,0.0009983244,0.00011180578,0.000009110796,0.00035157762],"genre_scores_gemma":[0.9957258,0.00055471435,0.00008697461,0.0020484133,0.00012005547,0.00084413413,0.000005271367,0.000024437953,0.00059021084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970787,0.0005961225,0.0005437065,0.0003979889,0.0009815183,0.00040196508],"domain_scores_gemma":[0.9958568,0.0031220461,0.000059629863,0.000607368,0.00014759753,0.00020656566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024248683,0.00010583217,0.00036433912,0.0001697898,0.00012978856,0.00002228181,0.00024166473,0.000051772313,0.0006399223],"category_scores_gemma":[0.000103939085,0.000068700356,0.0001583976,0.00052226736,0.00011907315,0.000034370176,0.00028782463,0.0009332884,0.00004948775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022057919,0.016876698,0.10239052,0.00019981642,0.0006151848,0.0018009264,0.0013312295,0.044591773,0.039891712,0.0027037752,0.17126365,0.5962768],"study_design_scores_gemma":[0.014100331,0.007633126,0.39098832,0.00065665867,0.00015116557,0.000013591595,0.0015301246,0.016773408,0.3508657,0.0013814871,0.21515137,0.00075472286],"about_ca_topic_score_codex":0.001537752,"about_ca_topic_score_gemma":0.00009986827,"teacher_disagreement_score":0.59552205,"about_ca_system_score_codex":0.00035255883,"about_ca_system_score_gemma":0.0003430582,"threshold_uncertainty_score":0.70067},"labels":[],"label_agreement":null},{"id":"W4296132037","doi":"10.1158/1557-3265.sarcomas22-a003","title":"Abstract A003: ASAP1 regulates myogenic differentiation in rhabdomyosarcoma by modulating YAP localization","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Gene knockdown; Cancer research; Biology; Differentiation therapy; Cellular differentiation; C2C12; Transcription factor; Cell biology; Myocyte; Myogenesis; Medicine; Cell culture; Sarcoma; Pathology; Genetics; Gene","score_opus":0.07127616747834303,"score_gpt":0.4317119212047263,"score_spread":0.36043575372638326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945814,0.0030902545,0.00048809624,0.00069684803,0.0003832596,0.0004982188,0.000051410305,0.000019367828,0.00019114502],"genre_scores_gemma":[0.9970925,0.00063271413,0.00004037525,0.00009631572,0.00043079807,0.0002793663,0.0006624912,0.00004546017,0.00071997615],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99678123,0.0006715936,0.00069357536,0.0006900204,0.0006907938,0.00047276818],"domain_scores_gemma":[0.99892926,0.00013592475,0.0001710969,0.0004528617,0.00019361314,0.00011725022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021551587,0.00014923316,0.00021759841,0.0001503091,0.00033096795,0.00004289279,0.00032508158,0.00022907364,0.0005015908],"category_scores_gemma":[0.00035184648,0.0001669423,0.00012876223,0.0005900262,0.00015850952,0.000011528758,0.00039046592,0.00067358644,0.000008812084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015364513,0.00073295814,0.1727092,0.00010288387,0.00017200694,0.0000068311283,0.00014928597,0.10507557,0.5484616,0.00009796429,0.0452858,0.12566942],"study_design_scores_gemma":[0.0070234695,0.0016336779,0.6556906,0.0001528441,0.000048866117,0.000011116178,0.00039798563,0.0961904,0.13094659,0.0021148748,0.10461796,0.0011715904],"about_ca_topic_score_codex":0.00045834619,"about_ca_topic_score_gemma":0.00042611657,"teacher_disagreement_score":0.48298144,"about_ca_system_score_codex":0.00032786044,"about_ca_system_score_gemma":0.00030700737,"threshold_uncertainty_score":0.680771},"labels":[],"label_agreement":null},{"id":"W4296132068","doi":"10.1158/1557-3265.sarcomas22-b008","title":"Abstract B008: Investigating the evolution of undifferentiated soft tissue sarcomas in a genetically engineered mouse model","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Cancer; Biology; Computational biology; Cell; Cancer research; Genetically engineered; Evolutionary biology; Genetics; Gene; Gene expression","score_opus":0.21958898226071574,"score_gpt":0.47666652990306135,"score_spread":0.2570775476423456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198365,0.0035882755,0.000058897534,0.0032939098,0.000060876282,0.0007306625,0.00004841928,0.000021105563,0.0002141819],"genre_scores_gemma":[0.99840415,0.00026953078,0.0002864071,0.00013079468,0.00007830739,0.0005410896,0.000020348034,0.000026185353,0.00024319084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729156,0.00039238756,0.0006670141,0.0003440485,0.00090250233,0.0004024661],"domain_scores_gemma":[0.9978823,0.0012370214,0.00008218629,0.00043594372,0.00018197332,0.00018058898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020455322,0.000111867506,0.0003454504,0.00016806877,0.00015542576,0.000013500991,0.00025241135,0.00008039883,0.00040535908],"category_scores_gemma":[0.0009185495,0.00008090974,0.00011026819,0.0005500993,0.00031481584,0.000023443632,0.0002749308,0.0010942505,0.000009909403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097440125,0.0049844333,0.8690879,0.0002837847,0.00032405896,0.00010859771,0.00085145986,0.021994423,0.03933816,0.0022990282,0.0032751772,0.05647862],"study_design_scores_gemma":[0.0041123177,0.0008168511,0.91570026,0.0001585637,0.00006988357,0.000005139327,0.0004956046,0.070311554,0.0051875277,0.002501251,0.0004849674,0.00015607366],"about_ca_topic_score_codex":0.002106301,"about_ca_topic_score_gemma":0.00036447277,"teacher_disagreement_score":0.056322545,"about_ca_system_score_codex":0.0006036196,"about_ca_system_score_gemma":0.0008411837,"threshold_uncertainty_score":0.47540343},"labels":[],"label_agreement":null},{"id":"W4296132074","doi":"10.1158/1557-3265.sarcomas22-a028","title":"Abstract A028: Growth factor signaling and kinase inhibitors regulate oncogenesis in desmoid fibromatosis by modulating activity of the beta-catenin transcription target ABL1","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Carcinogenesis; Biology; HIF1A; Small hairpin RNA; Gene knockdown; Cell growth; Ectopic expression; Molecular biology; Gene expression; Cell culture; Angiogenesis; Gene; Genetics","score_opus":0.15152071865197944,"score_gpt":0.43058453969579924,"score_spread":0.27906382104381977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935672,0.0027644802,0.0000037096258,0.0025612726,0.0001762623,0.00072340673,0.0001281881,0.000026732008,0.00004870588],"genre_scores_gemma":[0.99912316,0.00025125346,0.00008628676,0.00004951565,0.00013039012,0.00020331451,0.0000076266506,0.000039412484,0.00010903274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964164,0.00080200145,0.00071610924,0.00053678034,0.0010639101,0.00046479388],"domain_scores_gemma":[0.9978454,0.0013037664,0.00018914661,0.00029749676,0.00020080408,0.0001633902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028237829,0.00017501236,0.00058924843,0.00016636142,0.00038370537,0.00001687589,0.00018777518,0.000099995756,0.00022787362],"category_scores_gemma":[0.0009238469,0.00013933559,0.00020035972,0.00079477567,0.0005166219,0.0001006604,0.00028600649,0.0011797717,0.0000013826943],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009740318,0.00032437636,0.4826268,0.00034913735,0.00010264471,0.000037772923,0.0007191904,0.000082035695,0.5049222,0.0000054848865,0.0005884252,0.009267928],"study_design_scores_gemma":[0.0015850414,0.00040652158,0.6528992,0.00022981652,0.000043181088,0.000005744881,0.00048268086,0.00023390219,0.34363598,0.00012534528,0.00021038289,0.00014221805],"about_ca_topic_score_codex":0.002928517,"about_ca_topic_score_gemma":0.00010407813,"teacher_disagreement_score":0.17027241,"about_ca_system_score_codex":0.0003454418,"about_ca_system_score_gemma":0.00027029173,"threshold_uncertainty_score":0.56819403},"labels":[],"label_agreement":null},{"id":"W4296132100","doi":"10.1158/1557-3265.sarcomas22-ia024","title":"Abstract IA024: Identification of a “hypoxic secretome” and its role in metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intravasation; Extravasation; Metastasis; Biology; Primary tumor; Zebrafish; In vivo; Tumor microenvironment; Cell migration; Cancer research; Angiogenesis; Cell; Cancer; Immunology; Tumor cells; Genetics; Gene","score_opus":0.11420576854677382,"score_gpt":0.4668150607762514,"score_spread":0.35260929222947757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97159404,0.026987573,0.000003873201,0.00027138038,0.0004104003,0.00028252078,0.00015952201,0.0000037248349,0.00028699788],"genre_scores_gemma":[0.9891429,0.009272725,0.000015242862,0.00006692698,0.00050078804,0.0002556422,0.000038819468,0.000017028598,0.00068990985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979213,0.00038118317,0.00053297787,0.000449901,0.00042284332,0.00029177906],"domain_scores_gemma":[0.99918276,0.000104529194,0.00011509354,0.00031512618,0.00017050715,0.00011196149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003631342,0.0000841787,0.00022994564,0.00013592736,0.000105207735,0.000016819044,0.00028041124,0.000090778914,0.00027402086],"category_scores_gemma":[0.00047551855,0.000087381115,0.00009489864,0.00034612065,0.00015336167,0.0000059738836,0.00038065345,0.0004509817,0.0000045579095],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077574886,0.00032925783,0.0072566746,0.000101594735,0.00009097248,0.0000031223901,0.0001754995,0.00012143081,0.91415524,0.0001764351,0.003890286,0.07292371],"study_design_scores_gemma":[0.0030031144,0.0006809966,0.30661228,0.0000315367,0.000047064314,0.000009259933,0.0013436615,0.00028641624,0.19523475,0.000836505,0.4915313,0.00038309145],"about_ca_topic_score_codex":0.00034722092,"about_ca_topic_score_gemma":0.00031051273,"teacher_disagreement_score":0.7189205,"about_ca_system_score_codex":0.000034229317,"about_ca_system_score_gemma":0.0003479132,"threshold_uncertainty_score":0.35632986},"labels":[],"label_agreement":null},{"id":"W4296132170","doi":"10.1158/1557-3265.sarcomas22-b010","title":"Abstract B010: The NuRD subunit CHD4 is essential for ewing sarcoma cell survival as it regulates global chromatin architecture","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Chromatin remodeling; Chromatin; Cancer research; Cell biology; Enhancer; Gene silencing; Transcription factor; Genetics; Gene","score_opus":0.11532073987946757,"score_gpt":0.48042341452219844,"score_spread":0.3651026746427309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982719,0.0025601636,0.0001562144,0.009806163,0.0005026497,0.0006706493,0.00046670056,0.000012354784,0.003106084],"genre_scores_gemma":[0.9941882,0.00055977626,0.0001054764,0.00079583185,0.0012188795,0.00044072815,0.00015329172,0.000027546446,0.0025103043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733055,0.00043534263,0.00045153365,0.00062362244,0.00061149144,0.0005474866],"domain_scores_gemma":[0.9984555,0.00027938365,0.00012156025,0.00074457575,0.00026038286,0.00013858432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022664492,0.00015784599,0.00020693711,0.0000329379,0.00083412015,0.00009435992,0.00088780234,0.00015059045,0.0013892113],"category_scores_gemma":[0.0002369486,0.00012610143,0.0002762234,0.00030183318,0.0003937368,0.0000044761564,0.00038870366,0.0006500007,0.000020349753],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069158454,0.0014218414,0.01889855,0.00038207622,0.0007031992,0.000027933116,0.00070692046,0.0028493176,0.34412256,0.0009810178,0.39307302,0.22991772],"study_design_scores_gemma":[0.002828154,0.001618284,0.05933947,0.000034638764,0.0000556131,0.000013406515,0.0013052725,0.00037970315,0.076596774,0.003567722,0.85371673,0.0005442378],"about_ca_topic_score_codex":0.0007588979,"about_ca_topic_score_gemma":0.00038775857,"teacher_disagreement_score":0.46064368,"about_ca_system_score_codex":0.00008141224,"about_ca_system_score_gemma":0.0007255544,"threshold_uncertainty_score":0.99952364},"labels":[],"label_agreement":null},{"id":"W4296132225","doi":"10.1158/1557-3265.sarcomas22-a014","title":"Abstract A014: The novel anti-inflammatory agent GML (GM1-targeted linoleate-containing TLR2 ligand) inhibits sarcoma metastasis to the lung","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Calgary; Jewish General Hospital","funders":"","keywords":"Medicine; Osteosarcoma; Metastasis; Sarcoma; Cancer; Lung cancer; Cancer research; Lung; Inflammation; Oncology; Immunology; Internal medicine; Pathology","score_opus":0.14012707583881473,"score_gpt":0.4314698483256254,"score_spread":0.2913427724868107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485587,0.03013679,0.00003738499,0.013693656,0.0045722197,0.0016009222,0.00023157125,0.00009591497,0.0010728586],"genre_scores_gemma":[0.99170613,0.0010218726,0.000023488394,0.0025109886,0.0004719014,0.0010469179,0.000054680244,0.00007594569,0.0030880661],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936454,0.0022068052,0.001231945,0.0009409893,0.0005408071,0.0014340095],"domain_scores_gemma":[0.99414,0.0036001436,0.00027507794,0.0014492731,0.00042312065,0.00011238356],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01308159,0.00033165535,0.0006215794,0.00020691319,0.0025459859,0.00010163511,0.0022448879,0.00028597543,0.0045027942],"category_scores_gemma":[0.001185877,0.00021601495,0.00041032713,0.0008628021,0.0010435957,0.000096399264,0.0024928504,0.005175409,0.00088903814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055380617,0.0012946358,0.03578175,0.00017373632,0.0029855983,0.00013267965,0.006327416,0.0026500663,0.43961978,0.0010242664,0.42262197,0.08185007],"study_design_scores_gemma":[0.0027695657,0.0005712169,0.09794139,0.00009050436,0.00010181404,0.000028625165,0.0025237447,0.00003508659,0.077494234,0.000060087114,0.8179401,0.00044363478],"about_ca_topic_score_codex":0.0010238307,"about_ca_topic_score_gemma":0.00032238205,"teacher_disagreement_score":0.39531815,"about_ca_system_score_codex":0.00057421176,"about_ca_system_score_gemma":0.0010881978,"threshold_uncertainty_score":0.9998889},"labels":[],"label_agreement":null},{"id":"W4296132263","doi":"10.1158/1557-3265.sarcomas22-ia029","title":"Abstract IA029: The origins of leiomyosarcoma: implications for prognosis and defining new therapeutic options","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Biology; Subtyping; Leiomyosarcoma; Disease; Homologous recombination; Somatic evolution in cancer; Computational biology; Cancer research; Bioinformatics; Cancer; Genetics; Gene; Pathology; Medicine","score_opus":0.40296244925285774,"score_gpt":0.5583171902239384,"score_spread":0.1553547409710807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88289964,0.023258764,0.000027376373,0.091151856,0.00014179056,0.0019860552,0.00019717508,0.000024723484,0.00031264144],"genre_scores_gemma":[0.99351716,0.0023604606,0.00045497576,0.0003465086,0.00013291767,0.0030104313,0.000024419756,0.000019530684,0.00013358159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985735,0.00014491567,0.00038901335,0.00029496514,0.00031418423,0.0002834111],"domain_scores_gemma":[0.9960056,0.0032025175,0.000079719146,0.000356873,0.00019407141,0.00016125206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015537168,0.00007997432,0.00024421726,0.000086145476,0.0005131648,0.000022427732,0.00017713287,0.000041361556,0.00026100583],"category_scores_gemma":[0.00025542837,0.000053193693,0.00016285603,0.00038149455,0.00026761647,0.000026067804,0.00014749868,0.0004567569,0.0000040827385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026765728,0.0011218903,0.7209497,0.000055295295,0.00024742528,0.000001904905,0.00013405933,0.0000089144705,0.00018553807,0.044723947,0.010803739,0.22149992],"study_design_scores_gemma":[0.0016745889,0.0006585056,0.88071626,0.00003506272,0.00012373863,0.000008787924,0.00023808342,0.000032343658,0.00009827286,0.004204212,0.112156905,0.000053258605],"about_ca_topic_score_codex":0.0009495613,"about_ca_topic_score_gemma":0.00008813527,"teacher_disagreement_score":0.22144666,"about_ca_system_score_codex":0.0002025179,"about_ca_system_score_gemma":0.0007490524,"threshold_uncertainty_score":0.39469004},"labels":[],"label_agreement":null},{"id":"W4296229618","doi":"10.1158/1557-3265.sarcomas22-b012","title":"Abstract B012: Visualization of EWSR1’s colocalization with phosphorylated RNA-Polymerase II reveals its concentration at a subset of active regions of transcription in ewing sarcoma cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Nucleoplasm; Chromatin; Transcription (linguistics); Colocalization; Cell biology; Molecular biology; RNA polymerase II; Gene; Gene expression; Nucleolus; Genetics; Nucleus; Promoter","score_opus":0.10457179872516426,"score_gpt":0.4295636478471105,"score_spread":0.32499184912194623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296229618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970661,0.0015473786,0.00027278494,0.00014456146,0.000069860755,0.0005509995,0.00021625543,0.0000033338788,0.00012876926],"genre_scores_gemma":[0.9972576,0.002009782,0.000015729081,0.00003160061,0.000033268498,0.0001610331,0.00024082277,0.000017527633,0.00023262895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978742,0.0004626951,0.0006977028,0.0003306087,0.00043552427,0.0001992462],"domain_scores_gemma":[0.99863046,0.00008019632,0.00043698636,0.0002622998,0.00052872585,0.00006133853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011142298,0.00009115609,0.00025794635,0.00009157899,0.00014990526,0.000004451822,0.00017695622,0.00012096318,0.00018460036],"category_scores_gemma":[0.00010928,0.00009067831,0.000075873446,0.0005970029,0.00024948985,0.000014048665,0.000076032215,0.00019758231,3.5122108e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002593912,0.000445844,0.00809606,0.000090778034,0.000048674974,0.0000011970928,0.00039735882,0.0023330043,0.983745,0.00023639444,0.0005625962,0.0014491776],"study_design_scores_gemma":[0.001582115,0.0009829663,0.035637397,0.00010339318,0.000019472347,6.5703557e-7,0.00044657267,0.00060962304,0.9595686,0.000030377274,0.00091549166,0.00010332192],"about_ca_topic_score_codex":0.0003986293,"about_ca_topic_score_gemma":0.0003767306,"teacher_disagreement_score":0.02754134,"about_ca_system_score_codex":0.00013725848,"about_ca_system_score_gemma":0.00037457215,"threshold_uncertainty_score":0.3697754},"labels":[],"label_agreement":null},{"id":"W4296230819","doi":"10.1158/1557-3265.sarcomas22-pr002","title":"Abstract PR002: Antigen presentation and processing pathway is associated with early relapse after neoadjuvant immune checkpoint blockade (ICB) in dedifferentiated liposarcomas (DDLPS)","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Ipilimumab; Nivolumab; Immune checkpoint; Cancer research; Immunotherapy; Cancer","score_opus":0.12053491375295862,"score_gpt":0.42974891539985205,"score_spread":0.30921400164689344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559177,0.009622769,9.298918e-7,0.0031520426,0.00008453253,0.0012785817,0.00006435346,0.000044670833,0.00016036455],"genre_scores_gemma":[0.9968839,0.0010205979,0.000044492128,0.00013568586,0.00011036562,0.0013027544,0.00007546389,0.000056902285,0.00036979426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995954,0.00052163313,0.000871762,0.0007327015,0.0012517599,0.00066817185],"domain_scores_gemma":[0.9981987,0.00062734744,0.00020671256,0.00037089287,0.0003110564,0.00028529015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020996854,0.0002278931,0.0006028913,0.00028263582,0.0002911386,0.000094432515,0.00016624713,0.00015255371,0.00083103566],"category_scores_gemma":[0.0003842789,0.00017703683,0.00013282461,0.0007908108,0.00028854882,0.00013042675,0.000293137,0.0015353414,0.000012285907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002825745,0.0026362273,0.95953894,0.0000873208,0.0002294695,0.0011652765,0.0013776043,0.000005198772,0.0016098332,0.0000023344749,0.00013824583,0.030383788],"study_design_scores_gemma":[0.0066089635,0.0012636742,0.98616606,0.0005983631,0.0000684169,0.00001725923,0.0003800179,0.00031380376,0.003902306,0.00008858534,0.00040462217,0.00018791883],"about_ca_topic_score_codex":0.0019852987,"about_ca_topic_score_gemma":0.0005137473,"teacher_disagreement_score":0.03019587,"about_ca_system_score_codex":0.00045398937,"about_ca_system_score_gemma":0.0006167447,"threshold_uncertainty_score":0.90992576},"labels":[],"label_agreement":null},{"id":"W4296230849","doi":"10.1158/1557-3265.sarcomas22-a012","title":"Abstract A012: Targeting the dysregulation of transcription and splicing in Ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FLI1; RNA splicing; Sarcoma; Cancer research; Biology; Pediatric cancer; Transcription (linguistics); Alternative splicing; Transcription factor; RNA polymerase II; RNA; Medicine; Cancer; Genetics; Gene expression; Messenger RNA; Gene; Promoter; Pathology","score_opus":0.24553507439983985,"score_gpt":0.5033545763057851,"score_spread":0.2578195019059452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851734,0.00532709,0.0000023597788,0.005338208,0.000081549515,0.00043012545,0.0000056027966,0.0000067709975,0.00029096627],"genre_scores_gemma":[0.9987489,0.0007397677,0.000050943232,0.00012662978,0.000118967604,0.00016480427,0.000008046338,0.000010734416,0.0000311903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983301,0.0003070655,0.00042873714,0.00021944236,0.0005011194,0.00021352507],"domain_scores_gemma":[0.9986011,0.0010534874,0.000055879675,0.00016041462,0.00007009189,0.00005903865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037718941,0.000056553272,0.00020491224,0.000104308136,0.00018470878,0.0000108878185,0.00007384252,0.000035816498,0.00028897636],"category_scores_gemma":[0.00024620094,0.000040176314,0.000070264134,0.0003164808,0.00013549496,0.000038043418,0.000075154414,0.0005999452,0.0000014382307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004452126,0.0004666632,0.84674597,0.00008676128,0.000035646946,0.000033148808,0.00063000876,0.00011346986,0.008193126,0.00020410298,0.00041742693,0.14262845],"study_design_scores_gemma":[0.0015229079,0.0002349232,0.9931933,0.000110349516,0.000018267618,0.0000034959291,0.0008654609,0.00066159084,0.0013695346,0.000271153,0.0017113055,0.000037692666],"about_ca_topic_score_codex":0.0014846744,"about_ca_topic_score_gemma":0.00015543963,"teacher_disagreement_score":0.14644733,"about_ca_system_score_codex":0.00016328885,"about_ca_system_score_gemma":0.0001053647,"threshold_uncertainty_score":0.31640884},"labels":[],"label_agreement":null},{"id":"W4296230868","doi":"10.1158/1557-3265.sarcomas22-ia023","title":"Abstract IA023: Therapeutic efficacy of trametinib and ganitumab in RAS-mutated rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Rhabdomyosarcoma; MEK inhibitor; Cancer research; Insulin-like growth factor 1 receptor; MAPK/ERK pathway; Growth inhibition; Medicine; Cell culture; Pharmacology; Biology; Kinase; Internal medicine; Receptor; Pathology; Sarcoma; Growth factor; Cell biology","score_opus":0.27523679926290046,"score_gpt":0.5358248635606823,"score_spread":0.2605880642977818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864275,0.008418663,3.272562e-7,0.0035488568,0.00009766705,0.0008285625,0.000026547961,0.000017608287,0.00063430535],"genre_scores_gemma":[0.9974156,0.0017473848,0.0000469452,0.00024051548,0.00007903779,0.00034687892,0.000014530424,0.000027184746,0.000081899074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972317,0.00048839435,0.00067125156,0.0004401641,0.0007574124,0.00041104245],"domain_scores_gemma":[0.99606323,0.003159458,0.000085885986,0.00036578064,0.00013098642,0.000194648],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026898142,0.00012159912,0.000516677,0.00024177796,0.0001201989,0.000014526157,0.00016700965,0.00007699194,0.001651058],"category_scores_gemma":[0.00049950375,0.00009943152,0.0001428974,0.0006424337,0.00037192047,0.000026702643,0.00017819497,0.0010884312,0.00001380912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027768062,0.0046241106,0.66675895,0.00008819242,0.00017054164,0.00040255304,0.00025410048,0.000011257356,0.0006900809,0.0001869862,0.0006475472,0.32338887],"study_design_scores_gemma":[0.008775511,0.0012696843,0.98307645,0.000088403016,0.000044247357,0.000016283884,0.00036309726,0.000059084698,0.0006664722,0.00034465056,0.0052088723,0.0000872254],"about_ca_topic_score_codex":0.0010056956,"about_ca_topic_score_gemma":0.00009860562,"teacher_disagreement_score":0.32330164,"about_ca_system_score_codex":0.0001990348,"about_ca_system_score_gemma":0.00044303923,"threshold_uncertainty_score":0.99926156},"labels":[],"label_agreement":null},{"id":"W4296230870","doi":"10.1158/1557-3265.sarcomas22-b016","title":"Abstract B016: Cytokines derived from tumor-initiating osteosarcoma cells mediate a novel self-seeding mechanism relevant to growth of primary and metastatic tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Primary tumor; Metastasis; Medicine; Cancer research; Cytokine; Pathology; Cancer; Immunology; Internal medicine","score_opus":0.16208994367974286,"score_gpt":0.4220858515937117,"score_spread":0.25999590791396887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388963,0.0013881103,0.000019389336,0.0024652681,0.00023139421,0.0011906445,0.0005407946,0.000052993248,0.00022176465],"genre_scores_gemma":[0.9910769,0.0005900665,0.0062983595,0.00091363466,0.00026622016,0.00072703086,0.000051538802,0.00006218007,0.000014107214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9957609,0.0003648107,0.0010713058,0.00075298833,0.001426306,0.00062368583],"domain_scores_gemma":[0.9935417,0.0049142414,0.00025791003,0.00038591848,0.0003736428,0.00052654056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029565953,0.00023870605,0.0009363967,0.00029785835,0.00029424034,0.0000386377,0.00028160674,0.000051826464,0.00044861695],"category_scores_gemma":[0.0011239165,0.00020218597,0.0001981333,0.00055654667,0.00015895697,0.000078412326,0.00076075003,0.00093721226,0.000017110011],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043034516,0.0092973355,0.4084286,0.0018785669,0.0021374482,0.0042665335,0.004417541,0.000023178376,0.5418487,0.0012231304,0.0013789858,0.020796508],"study_design_scores_gemma":[0.009918853,0.0032035657,0.84084797,0.00096051703,0.0004985825,0.000060934355,0.0026522556,0.00044011918,0.13883859,0.0017680426,0.00034196838,0.00046861943],"about_ca_topic_score_codex":0.0020716009,"about_ca_topic_score_gemma":0.00008259178,"teacher_disagreement_score":0.43241933,"about_ca_system_score_codex":0.0003984755,"about_ca_system_score_gemma":0.00067836815,"threshold_uncertainty_score":0.8244904},"labels":[],"label_agreement":null},{"id":"W4296230878","doi":"10.1158/1557-3265.sarcomas22-a026","title":"Abstract A026: PROX1 transcription factor regulates rhabdomyosarcoma growth, myogenic properties and therapeutic targets","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Gene silencing; Cancer research; Transcription factor; Fibroblast growth factor receptor; Medicine; Cancer; Cell growth; Soft tissue sarcoma; Internal medicine; Biology; Fibroblast growth factor; Receptor; Sarcoma; Pathology; Gene; Genetics","score_opus":0.31319916886824317,"score_gpt":0.45291315579706715,"score_spread":0.13971398692882397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94352907,0.045358356,6.0372815e-7,0.009237372,0.00017623625,0.0013483905,0.000034384997,0.00005622947,0.00025933946],"genre_scores_gemma":[0.9934668,0.0033352976,0.000032097472,0.00050809537,0.00024980423,0.0014436591,0.00001757057,0.000043337473,0.00090332015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694437,0.00043786733,0.00051327137,0.0005856214,0.0009360297,0.00058282464],"domain_scores_gemma":[0.99859756,0.000450016,0.00006547858,0.00034734985,0.00026209812,0.0002774771],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014237311,0.00017866766,0.00042488181,0.00016287748,0.00051258795,0.000056225235,0.00018080296,0.00009918529,0.0019574868],"category_scores_gemma":[0.00018369708,0.00012945947,0.00021028212,0.00030782446,0.0004131718,0.000073761716,0.00015708056,0.00096557266,0.000027755994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005864902,0.0054895324,0.65775067,0.0007831591,0.0011194093,0.00056707964,0.0020045647,0.0000057008947,0.038988642,0.00089497014,0.004868792,0.28166258],"study_design_scores_gemma":[0.003629835,0.0017955981,0.9597855,0.00010149816,0.00010366582,0.000039515664,0.0006519114,0.00007629855,0.010574609,0.0010090895,0.022021793,0.00021064412],"about_ca_topic_score_codex":0.00050879735,"about_ca_topic_score_gemma":0.00004225186,"teacher_disagreement_score":0.30203488,"about_ca_system_score_codex":0.0002724808,"about_ca_system_score_gemma":0.00034570845,"threshold_uncertainty_score":0.99895483},"labels":[],"label_agreement":null},{"id":"W4296230882","doi":"10.1158/1557-3265.sarcomas22-ia008","title":"Abstract IA008: Altering the T cell receptor repertoire in the sarcoma tumor immune microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; T-cell receptor; Immune system; Tumor microenvironment; Sarcoma; T cell; Medicine; Pathology; Cancer research; Immunology","score_opus":0.09819048760532795,"score_gpt":0.4058954515903464,"score_spread":0.30770496398501845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9313873,0.05620402,9.013028e-7,0.010002252,0.000966298,0.00071876054,0.000041692736,0.000018813927,0.0006599507],"genre_scores_gemma":[0.98806447,0.003532573,0.000006331734,0.0012918019,0.000098827724,0.0007950936,0.000027898683,0.000032048352,0.0061509386],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99269384,0.0049304343,0.0008374565,0.0004803192,0.00024808134,0.0008098526],"domain_scores_gemma":[0.995548,0.003210493,0.00015592822,0.0010275415,0.000037907866,0.000020117017],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009934849,0.00018227463,0.00033165872,0.00011270587,0.0015533122,0.00004920639,0.0017212618,0.000108293185,0.00911285],"category_scores_gemma":[0.00026618715,0.000110719055,0.00025020042,0.00039122542,0.0010625167,0.00006191507,0.00072312896,0.0034384723,0.0005124694],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00499748,0.0011590878,0.0035322907,0.000029285393,0.0001230508,0.000055344677,0.0024395345,0.000042256746,0.9164934,0.00006168891,0.03240158,0.038665008],"study_design_scores_gemma":[0.0018882563,0.0006751902,0.07230944,0.000035923218,0.000007753128,0.000040050094,0.004060462,0.0000022832799,0.047972497,0.00005168726,0.8727824,0.00017404604],"about_ca_topic_score_codex":0.0012827098,"about_ca_topic_score_gemma":0.00004158641,"teacher_disagreement_score":0.8685209,"about_ca_system_score_codex":0.00025093672,"about_ca_system_score_gemma":0.00027342056,"threshold_uncertainty_score":0.9997465},"labels":[],"label_agreement":null},{"id":"W4296230891","doi":"10.1158/1557-3265.sarcomas22-b006","title":"Abstract B006: Development of a NF1-MPNST-PDX liquid biopsy model using whole-genome sequencing and quantitative PCR of mouse-derived cell-free DNA","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Context (archaeology); Biopsy; Minimal residual disease; Cancer research; Medicine; Digital polymerase chain reaction; Metastasis; Pathology; Cancer; Biology; Internal medicine; Polymerase chain reaction; Gene; Genetics","score_opus":0.40742507552583124,"score_gpt":0.4962657346942285,"score_spread":0.08884065916839728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945294,0.0036619469,0.000066077286,0.00055083167,0.00004985981,0.0006588824,0.00020783303,0.00001566745,0.0002594511],"genre_scores_gemma":[0.9899916,0.00042038257,0.009110296,0.000070452246,0.000040627478,0.00019903987,0.000027325534,0.000040972867,0.00009929028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968428,0.00024320313,0.00097050227,0.0005070367,0.0009960876,0.00044037233],"domain_scores_gemma":[0.99777836,0.0008140052,0.00025008697,0.00049434224,0.0004171867,0.00024604276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002316845,0.00016824644,0.00064246065,0.0002462528,0.0002541458,0.000012107311,0.00026760224,0.00009354191,0.00022581461],"category_scores_gemma":[0.0003663362,0.0001479904,0.00014382302,0.0003686883,0.0004448368,0.000057373876,0.0006391852,0.0006530129,0.0000045521556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035272446,0.00223409,0.017394839,0.00068280543,0.0004658753,0.00016053014,0.0044240816,0.0031459783,0.96476823,0.00011901199,0.00019608339,0.0028812012],"study_design_scores_gemma":[0.033263374,0.011185928,0.16634107,0.0017271918,0.0006920031,0.000073628195,0.028286614,0.026587512,0.7270346,0.0010208143,0.00229446,0.0014927936],"about_ca_topic_score_codex":0.00058060396,"about_ca_topic_score_gemma":0.00008739,"teacher_disagreement_score":0.23773365,"about_ca_system_score_codex":0.0006550384,"about_ca_system_score_gemma":0.0022316484,"threshold_uncertainty_score":0.6034873},"labels":[],"label_agreement":null},{"id":"W4296230896","doi":"10.1158/1557-3265.sarcomas22-ia026","title":"Abstract IA026: Epigenetic and genomic features define distinct cellular states with possible therapeutic relevance in osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Epigenetics; Cancer research; Wnt signaling pathway; Epigenome; Osteosarcoma; Genetics; Chromatin; DNA methylation; Signal transduction; Gene; Gene expression","score_opus":0.05614931332798369,"score_gpt":0.39189029388011654,"score_spread":0.33574098055213286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95339596,0.044741336,0.000023637895,0.00086181454,0.00013029759,0.00040297653,0.00014518284,0.000006607155,0.00029219998],"genre_scores_gemma":[0.9876367,0.010880153,0.00011655251,0.00028646688,0.00024036372,0.000245374,0.00009028441,0.00004672101,0.0004573894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977943,0.00026405253,0.00038444018,0.00067330716,0.0003449455,0.00053897686],"domain_scores_gemma":[0.99861276,0.00056024524,0.00008604466,0.00046490913,0.00010674732,0.00016931003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013287235,0.00016818341,0.00025258842,0.0000843123,0.00026195703,0.00006288797,0.0003657216,0.00009607575,0.00013158942],"category_scores_gemma":[0.00021372229,0.00015154264,0.000063646105,0.0002413003,0.0003957295,0.0000035252297,0.0005187816,0.0007315414,0.0000048545726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066943034,0.0010139333,0.6500914,0.00024318145,0.00025870965,0.00031027407,0.00034979,0.0050319913,0.18346141,0.000365902,0.0068057263,0.14537339],"study_design_scores_gemma":[0.0033333136,0.003254886,0.84514886,0.000050297294,0.000029007344,0.00002255143,0.00039176,0.00014772442,0.01369218,0.0019818733,0.13140239,0.0005451702],"about_ca_topic_score_codex":0.00089741556,"about_ca_topic_score_gemma":0.0030182372,"teacher_disagreement_score":0.19505747,"about_ca_system_score_codex":0.00010505483,"about_ca_system_score_gemma":0.0005163132,"threshold_uncertainty_score":0.61797297},"labels":[],"label_agreement":null},{"id":"W4296230903","doi":"10.1158/1557-3265.sarcomas22-b027","title":"Abstract B027: The development of a multiscale transcriptional atlas of sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; Mount Sinai Hospital; SickKids Foundation","funders":"","keywords":"Sarcoma; KRAS; Pediatric cancer; Biology; Cancer; Synovial sarcoma; Pathology; Computational biology; Bioinformatics; Medicine; Genetics","score_opus":0.44633063959098834,"score_gpt":0.5580363148271056,"score_spread":0.11170567523611724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298227,0.0011735568,0.0000096090735,0.0031877682,0.00012925797,0.00039499038,0.000052579304,0.000007692742,0.002062291],"genre_scores_gemma":[0.99810207,0.00008143315,0.00053660944,0.00015391062,0.00015979567,0.00018689087,0.000010355738,0.000008533037,0.000760393],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99744254,0.00028073345,0.0007279509,0.00021737898,0.0010826873,0.000248684],"domain_scores_gemma":[0.9980708,0.0012434977,0.00009398726,0.00021760978,0.00024673837,0.00012737847],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003502502,0.00006496867,0.00031939603,0.000059571994,0.00021157353,0.0000037793661,0.0002558519,0.000049305956,0.005346727],"category_scores_gemma":[0.0004913613,0.00003905133,0.00017465361,0.00031142164,0.000579057,0.000015907515,0.00018450602,0.0008980943,0.000009384016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012665138,0.0076672304,0.44610322,0.00070521754,0.00019862487,0.0002515787,0.0022643262,0.00008702791,0.037575558,0.0018355678,0.024420917,0.46622562],"study_design_scores_gemma":[0.0013812013,0.00090804364,0.90812504,0.00004035709,0.000012998346,0.0000072912044,0.00052092545,0.000030157627,0.0021193675,0.00018881384,0.086621076,0.000044733526],"about_ca_topic_score_codex":0.00019483936,"about_ca_topic_score_gemma":0.00014911959,"teacher_disagreement_score":0.4661809,"about_ca_system_score_codex":0.000118381635,"about_ca_system_score_gemma":0.0011525784,"threshold_uncertainty_score":0.9955625},"labels":[],"label_agreement":null},{"id":"W4296230941","doi":"10.1158/1557-3265.sarcomas22-pr008","title":"Abstract PR008: The 3D epigenome of rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epigenome; Enhancer; Computational biology; Epigenomics; Biology; Rhabdomyosarcoma; CRISPR; Genomics; BRD4; Cancer; Cancer research; Transcription factor; Genetics; Gene; Acetylation; Genome; Medicine; Sarcoma; Bromodomain; Gene expression; DNA methylation; Pathology","score_opus":0.1983545853358762,"score_gpt":0.5093861959494298,"score_spread":0.3110316106135536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687357,0.0088956645,0.00004694545,0.0010391874,0.0002543505,0.0002793611,0.000050545073,0.000003431611,0.0025569233],"genre_scores_gemma":[0.99629813,0.002169608,0.0000864301,0.000101609694,0.00042007404,0.00014314153,0.000030202888,0.000017134633,0.0007336394],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979348,0.00055621954,0.00040727318,0.00030975117,0.0005102707,0.00028166085],"domain_scores_gemma":[0.99879664,0.0002900133,0.000102624275,0.0005186405,0.00021311494,0.000078945464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043796357,0.00007094665,0.00013536935,0.000041494073,0.00030345877,0.000013556212,0.00051034987,0.00007563635,0.00056334754],"category_scores_gemma":[0.0003259166,0.000054460572,0.00012357201,0.00021839415,0.00033696144,0.000001461273,0.0005439722,0.0005191394,0.000008483714],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010790249,0.00072025956,0.13654788,0.00006895893,0.00021386155,0.000011196685,0.00021716133,0.0015519597,0.6895405,0.000533055,0.009130347,0.16038579],"study_design_scores_gemma":[0.00088336767,0.0013903222,0.24669482,0.000008164873,0.00001447018,8.703512e-7,0.00024286333,0.000067993096,0.07060996,0.0014925433,0.6783988,0.0001958436],"about_ca_topic_score_codex":0.00016558464,"about_ca_topic_score_gemma":0.000061895385,"teacher_disagreement_score":0.6692684,"about_ca_system_score_codex":0.000026819633,"about_ca_system_score_gemma":0.00034221448,"threshold_uncertainty_score":0.61682606},"labels":[],"label_agreement":null},{"id":"W4296230942","doi":"10.1158/1557-3265.sarcomas22-b018","title":"Abstract B018: A robust system to study human soft-tissue sarcoma lung metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pathology; Metastasis; Liposarcoma; Soft tissue sarcoma; Sarcoma; Population; Medicine; Cancer research; Cell sorting; Rhabdomyosarcoma; Cancer; Immunology; Internal medicine; Flow cytometry","score_opus":0.20738427786761057,"score_gpt":0.5370896528250181,"score_spread":0.3297053749574075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937209,0.0022029113,0.000042110612,0.0005175585,0.00024507847,0.0018887006,0.00030881152,0.00003176249,0.0010421653],"genre_scores_gemma":[0.99499685,0.00008213418,0.00007357352,0.00011710123,0.0005954868,0.0026341437,0.00009818265,0.00005902199,0.0013434874],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949092,0.0011702265,0.00059621705,0.001060834,0.0013524753,0.0009110414],"domain_scores_gemma":[0.99788874,0.00014957543,0.000080836675,0.0009771584,0.00030897243,0.0005946935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004110021,0.00021158796,0.00038549656,0.00018682098,0.0010351359,0.000105646024,0.0009306931,0.00008846718,0.0011824296],"category_scores_gemma":[0.00027533463,0.00020055051,0.00018907167,0.00059672416,0.00016062647,0.000006262832,0.0017087937,0.0008575402,0.000078932266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010330877,0.014608349,0.37823159,0.00062565785,0.0050839405,0.002579804,0.00093543244,0.002743001,0.08913928,0.00025769396,0.24398692,0.25147745],"study_design_scores_gemma":[0.022381868,0.040111087,0.3435871,0.00018031169,0.000355201,0.0000856579,0.012152971,0.00019759175,0.04172266,0.000120518576,0.5369543,0.0021507654],"about_ca_topic_score_codex":0.004976741,"about_ca_topic_score_gemma":0.0025253692,"teacher_disagreement_score":0.29296735,"about_ca_system_score_codex":0.00042728276,"about_ca_system_score_gemma":0.00052283093,"threshold_uncertainty_score":0.99973065},"labels":[],"label_agreement":null},{"id":"W4296709146","doi":"10.1158/1078-0432.ccr-22-0979","title":"CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation; Ministry of Health, Ontario","keywords":"Tumor-infiltrating lymphocytes; Immune system; CD8; Cohort; Oncology; Medicine; T-cell receptor; Internal medicine; T cell; Biology; Immunology","score_opus":0.13594631134784171,"score_gpt":0.4920593935842087,"score_spread":0.35611308223636695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296709146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706406,0.017137043,0.0000020949133,0.008261802,0.00060570106,0.0015826738,0.00027791955,0.00005302505,0.0014391263],"genre_scores_gemma":[0.985746,0.003966548,0.000070949,0.0059133116,0.00069775153,0.002389524,0.000026361075,0.00006136966,0.0011281325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947886,0.0008643026,0.0009716491,0.00090149767,0.001509918,0.000964058],"domain_scores_gemma":[0.99740505,0.0013439343,0.00020600187,0.00048254724,0.0002279837,0.00033450907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003958364,0.0002292243,0.00062373426,0.0003575851,0.0005803426,0.00005468976,0.0004763619,0.0001159589,0.006043793],"category_scores_gemma":[0.0005421887,0.00021599364,0.00026218846,0.0016119692,0.0006916729,0.00011064877,0.00036867533,0.0020250226,0.000041726154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019411886,0.0010716125,0.8436421,0.0003012248,0.00038435016,0.00080452184,0.0018092351,0.000020477626,0.0052684327,0.000052633775,0.014757531,0.11247598],"study_design_scores_gemma":[0.015319993,0.00354333,0.90105253,0.0010815315,0.00008383336,0.00010236745,0.0011729782,0.00073682104,0.004892481,0.00013898568,0.07131001,0.0005651513],"about_ca_topic_score_codex":0.0067670443,"about_ca_topic_score_gemma":0.0008862691,"teacher_disagreement_score":0.11191083,"about_ca_system_score_codex":0.0021843866,"about_ca_system_score_gemma":0.004538974,"threshold_uncertainty_score":0.999847},"labels":[],"label_agreement":null},{"id":"W4300690741","doi":"10.1158/1078-0432.ccr-22-1389","title":"Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Renal cell carcinoma; Blockade; Medicine; Immune checkpoint; Oncology; Internal medicine; Receptor","score_opus":0.0864684432790599,"score_gpt":0.40851093129502614,"score_spread":0.32204248801596624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300690741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945778,0.0005743329,0.000004939275,0.0007330622,0.00006337945,0.0026882982,0.0005333076,0.000059159804,0.0007657189],"genre_scores_gemma":[0.99573505,0.00010903352,0.000477906,0.00007025319,0.00014181735,0.00047459122,0.0010875001,0.000092794646,0.0018110288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99289894,0.0019458452,0.0013183266,0.0010575961,0.001989914,0.0007893826],"domain_scores_gemma":[0.99545395,0.0020421809,0.0004910456,0.0007490785,0.0005833071,0.0006804604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022623122,0.00041046596,0.0013266912,0.00027026562,0.0007201892,0.00008072188,0.00025175166,0.00015733449,0.0002545979],"category_scores_gemma":[0.0001286592,0.0002744702,0.00036918622,0.00063841895,0.00068876764,0.00010523031,0.0003663416,0.0020602546,0.000015141797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003970794,0.003559756,0.98995364,0.00006254077,0.00092405715,0.00024795596,0.00014613668,0.000021195734,0.00011255245,0.0000016763901,0.0003820486,0.0006176385],"study_design_scores_gemma":[0.016037187,0.018993832,0.9597476,0.00005819878,0.0015340502,0.000006429148,0.0001513641,0.000035560814,0.0030675451,0.000009726651,0.00008684695,0.0002716223],"about_ca_topic_score_codex":0.0038221518,"about_ca_topic_score_gemma":0.00018685657,"teacher_disagreement_score":0.03020601,"about_ca_system_score_codex":0.0012028294,"about_ca_system_score_gemma":0.000584859,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W4304695096","doi":"10.1158/1078-0432.ccr-22-2576","title":"hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre; Nova Scotia Cancer Centre; Princess Margaret Cancer Centre; Cancer Care South East; Ontario Institute for Cancer Research; Dalhousie University; University of Toronto","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Pancreatic Cancer Canada Foundation; Ministère des Services à l'enfance et des Services sociaux et communautaires, Gouvernement de l’Ontario; QEII Foundation; Princess Margaret Cancer Foundation","keywords":"Gemcitabine; Nab-paclitaxel; Pancreatic ductal adenocarcinoma; Paclitaxel; Medicine; Oncology; Adenocarcinoma; Internal medicine; Pancreatic cancer; Cancer research; Chemotherapy; Cancer","score_opus":0.0802004714635329,"score_gpt":0.4485903897248844,"score_spread":0.3683899182613515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304695096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98349345,0.0139406435,0.000026220952,0.0017662558,0.0001550485,0.00045655516,0.000045858767,0.000012354242,0.00010362228],"genre_scores_gemma":[0.9962434,0.0006165687,0.00022669414,0.0003735554,0.00036450688,0.0004751645,0.000029525558,0.000028647255,0.001641937],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99670696,0.0012519034,0.00041811907,0.00066807494,0.0004755243,0.0004794084],"domain_scores_gemma":[0.9987885,0.0003811048,0.000049417948,0.00040732577,0.0001091374,0.00026455426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030796877,0.00012917587,0.00023246699,0.00014304336,0.00022442846,0.000021933965,0.0003148577,0.000100735095,0.00016795225],"category_scores_gemma":[0.0011948801,0.00012421982,0.00006218468,0.0003597857,0.00014789194,0.000006625196,0.0010327647,0.0005855996,0.000005906049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023224154,0.00035039824,0.41095057,0.000061223174,0.00005504807,0.00020324904,0.0004181251,0.0008075014,0.51915014,0.000021549871,0.04295752,0.0018005262],"study_design_scores_gemma":[0.008827073,0.009818967,0.82844484,0.00023666024,0.000034810142,0.0000733715,0.0024262848,0.00033579746,0.03665,0.0003458357,0.11202855,0.0007777925],"about_ca_topic_score_codex":0.000107628344,"about_ca_topic_score_gemma":0.000018585708,"teacher_disagreement_score":0.48250014,"about_ca_system_score_codex":0.000070817994,"about_ca_system_score_gemma":0.00028982258,"threshold_uncertainty_score":0.5065537},"labels":[],"label_agreement":null},{"id":"W4304758122","doi":"10.1158/1078-0432.ccr-22-1206","title":"Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; BC Cancer Agency; Foothills Medical Centre; Alberta Health Services; University of British Columbia; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council South Australia; BC Cancer Foundation; National Center for Advancing Translational Sciences; Medical Research Council; Peter MacCallum Foundation; Medical Research and Materiel Command; NSW Ministry of Health; Cancer Council Victoria; University of New South Wales; Canadian Institutes of Health Research; Cancer Institute NSW; Ovarian Cancer Research Fund; Cancer Australia; University of Cambridge; University of Pittsburgh; Calgary Laboratory Services; Ovarian Cancer Action; Michael Smith Health Research BC; Faculty of Medicine and Health, University of Sydney; Translational Cancer Research Network; Korea Health Industry Development Institute; National Institute for Health and Care Research; Cancer Council NSW; Ovarian Cancer Australia; National Institutes of Health; U.S. Department of Defense; National Health and Medical Research Council; Cancer Research UK; National Science Foundation","keywords":"Gene expression profiling; Ovarian cancer; Oncology; Gene expression; Cancer research; Biology; Pathology; Medicine; Internal medicine; Gene; Cancer; Genetics","score_opus":0.09656373803480299,"score_gpt":0.427403472762598,"score_spread":0.330839734727795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304758122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968296,0.00035812432,0.0000122661195,0.0014508275,0.000059406568,0.0008882737,0.00007101982,0.000025833777,0.00030461533],"genre_scores_gemma":[0.99746203,0.00006197998,0.0015098948,0.00012379329,0.000054556644,0.00031183285,0.000029904497,0.000037428035,0.00040857008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969073,0.00043522698,0.0005705315,0.0006212853,0.0010089366,0.0004567395],"domain_scores_gemma":[0.997789,0.0009554508,0.00022921574,0.00032898545,0.00039202734,0.00030531903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017653074,0.00019531975,0.0007020615,0.00016503279,0.0003176524,0.000028642047,0.000117172196,0.00004328504,0.00035119423],"category_scores_gemma":[0.0005140964,0.00013147602,0.00007862233,0.00034779625,0.0006550135,0.00007149236,0.00033473835,0.00083081593,0.0000012770408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004943172,0.0009200989,0.9914396,0.0001052807,0.00021549029,0.00039869163,0.00015124699,0.00006362352,0.0002666242,0.000016383365,0.00075360003,0.000726206],"study_design_scores_gemma":[0.0060609393,0.005597627,0.9836394,0.001152901,0.00013234834,0.0000831347,0.0015971727,0.00019777086,0.0013231427,0.000023214181,0.000048488797,0.00014383833],"about_ca_topic_score_codex":0.00057134987,"about_ca_topic_score_gemma":0.00018927372,"teacher_disagreement_score":0.0078001595,"about_ca_system_score_codex":0.00024945659,"about_ca_system_score_gemma":0.000620258,"threshold_uncertainty_score":0.53614366},"labels":[],"label_agreement":null},{"id":"W4307230056","doi":"10.1158/1078-0432.ccr-22-2235","title":"Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; Novartis Pharmaceuticals UK Limited; University of Texas MD Anderson Cancer Center; F. Hoffmann-La Roche; Genentech; AstraZeneca; Novartis Pharmaceuticals Corporation; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Tolerability; Adverse effect; Sting; Internal medicine; Pharmacodynamics; Gastroenterology; Agonist; Refractory (planetary science); Pharmacokinetics; Pharmacology; Oncology; Receptor","score_opus":0.28112111726796624,"score_gpt":0.5536109955576296,"score_spread":0.27248987828966337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307230056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952947,0.0015732436,0.0000013201594,0.00036525144,0.0007456814,0.0018071306,0.000100163714,0.000014040453,0.00009850397],"genre_scores_gemma":[0.99674916,0.00014926837,0.000018289767,0.00013360742,0.00001901624,0.0005175093,0.000027137485,0.0000261794,0.0023598124],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99232686,0.0054340526,0.0009903479,0.000534302,0.0002093994,0.0005050161],"domain_scores_gemma":[0.997512,0.0014398947,0.00025367702,0.0005185065,0.00022669816,0.000049269267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00442124,0.00016432103,0.00053654006,0.00018426075,0.00068956596,0.00006101007,0.0009663473,0.00006705501,0.0007545086],"category_scores_gemma":[0.0017651367,0.000119506876,0.000043065833,0.0004938142,0.00077977416,0.00019304926,0.0017341363,0.0010251054,0.000012932671],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23459287,0.10182315,0.09652131,0.00044579347,0.00092173886,0.0003539421,0.013192413,0.00008071185,0.3228215,0.00068985345,0.0061811428,0.22237557],"study_design_scores_gemma":[0.34529167,0.16718352,0.22070979,0.0015512021,0.00026643812,0.00017133374,0.10738315,0.0018230871,0.119951315,0.0005735914,0.033500094,0.001594822],"about_ca_topic_score_codex":0.0011897233,"about_ca_topic_score_gemma":0.0010809046,"teacher_disagreement_score":0.22078076,"about_ca_system_score_codex":0.00023063904,"about_ca_system_score_gemma":0.00065132126,"threshold_uncertainty_score":0.826134},"labels":[],"label_agreement":null},{"id":"W4307341849","doi":"10.1158/1078-0432.ccr-22-2429","title":"Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nicotine; Medicine; Smoking cessation; Tobacco industry; Tobacco harm reduction; Environmental health; Addiction; Tobacco control; Public health; Tobacco smoke; Surgeon general; Psychiatry; Pathology","score_opus":0.3783230909307632,"score_gpt":0.6267669960401643,"score_spread":0.24844390510940106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307341849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94775105,0.0007401232,0.000014197898,0.04901518,0.00026452026,0.001785897,0.0003593017,0.000023496654,0.000046213492],"genre_scores_gemma":[0.9834802,0.009967933,0.000025389263,0.0018207588,0.0017907186,0.0018680516,0.00020142902,0.000038364116,0.00080713496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9875696,0.007481259,0.001383502,0.00065721426,0.0020237146,0.00088476524],"domain_scores_gemma":[0.9841117,0.012294651,0.0009820833,0.00063772936,0.0017451957,0.00022863164],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.041836478,0.00013864263,0.0009887232,0.00011277681,0.00080058,0.000055822544,0.0005234067,0.000109824265,0.00013364632],"category_scores_gemma":[0.0017486851,0.00008748304,0.0002795089,0.0014874283,0.002679516,0.000060212576,0.0004312615,0.0030532463,0.0000011720175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014447696,0.0010395253,0.82366586,0.000032101674,0.0007583727,0.000001579045,0.0007929059,0.00005214563,0.00039544623,0.00073742674,0.07785516,0.080221765],"study_design_scores_gemma":[0.0092900945,0.01025002,0.7650042,0.000043768494,0.00028084734,0.0000014686844,0.011590386,0.002437357,0.0001109652,0.0006344989,0.20020215,0.0001542284],"about_ca_topic_score_codex":0.12159868,"about_ca_topic_score_gemma":0.0029652119,"teacher_disagreement_score":0.122347,"about_ca_system_score_codex":0.0027494072,"about_ca_system_score_gemma":0.0054396344,"threshold_uncertainty_score":0.9992468},"labels":[],"label_agreement":null},{"id":"W4307492599","doi":"10.1158/1078-0432.ccr-22-2145","title":"Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Oncology; Randomized controlled trial; Progressive disease; Soft tissue sarcoma; Phases of clinical research; Tyrosine-kinase inhibitor; Surgery; Clinical trial; Gastroenterology; Adverse effect; Cancer; Chemotherapy; Soft tissue","score_opus":0.41087224671313327,"score_gpt":0.5635958806909772,"score_spread":0.15272363397784394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307492599","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3154979,0.009186096,0.0000011092549,0.65772337,0.0026010133,0.01147395,0.000797966,0.00006492499,0.0026536733],"genre_scores_gemma":[0.14319989,0.07225297,0.000304157,0.6350713,0.057262328,0.04491517,0.005874702,0.0008540845,0.040265452],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98657966,0.005656059,0.00279066,0.0011302115,0.002735035,0.0011083897],"domain_scores_gemma":[0.9755196,0.021924954,0.0004854616,0.0012554275,0.0005041993,0.00031038604],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012896443,0.00045184558,0.0038930264,0.00073038944,0.00022695021,0.000032307198,0.00062330667,0.0009927605,0.024158455],"category_scores_gemma":[0.009511416,0.00031371033,0.0014485704,0.0009500206,0.0012489022,0.00005117068,0.00060746283,0.007718417,0.00004589683],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5133597,0.0052276743,0.0003820987,0.00023186611,0.000529766,0.00348622,0.00006462218,2.191811e-7,0.0000010718875,0.000009395659,0.46282336,0.013883972],"study_design_scores_gemma":[0.5012938,0.0066716773,0.000031443084,0.0003859945,0.00030308412,0.00000901339,0.000030124354,0.000010452948,0.000023284298,0.0000950731,0.4909964,0.00014968307],"about_ca_topic_score_codex":0.001678476,"about_ca_topic_score_gemma":0.00019938679,"teacher_disagreement_score":0.17229801,"about_ca_system_score_codex":0.00048819766,"about_ca_system_score_gemma":0.0028516434,"threshold_uncertainty_score":0.9999315},"labels":[],"label_agreement":null},{"id":"W4307498458","doi":"10.1158/1078-0432.ccr-21-3143","title":"Meta-Analysis of the Test–Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response","year":2022,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Repeatability; Reproducibility; Medicine; Nuclear medicine; Standardized uptake value; Generalizability theory; Fluorodeoxyglucose; Coefficient of variation; Positron emission tomography; Statistics; Mathematics","score_opus":0.7496982872703446,"score_gpt":0.6773012996534533,"score_spread":0.07239698761689128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307498458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062319345,0.96303886,0.0010353223,0.007280414,0.00007802735,0.010249586,0.017354738,0.000055385342,0.00028445775],"genre_scores_gemma":[0.0015299239,0.9731916,0.013383828,0.000113565395,0.00007736244,0.010808444,0.0002523209,0.000069398295,0.00057351886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898739,0.0031799413,0.003917409,0.00097419985,0.0016390494,0.00041550703],"domain_scores_gemma":[0.94803494,0.04326043,0.0018631453,0.004461959,0.0020667783,0.00031272895],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.032656804,0.00030346247,0.0062762564,0.0004852369,0.00020568173,0.000012023991,0.0013668644,0.00019723893,0.0018141529],"category_scores_gemma":[0.031820457,0.00018027249,0.00689948,0.0040396014,0.0018022485,0.000025934945,0.00076203176,0.0017491796,4.5295303e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024451613,0.011513669,0.007919774,0.06276246,0.270636,0.0000076132205,0.00014435212,0.0000138917585,0.00040898708,0.004629797,0.040060367,0.5994579],"study_design_scores_gemma":[0.00046512752,0.00066577166,0.0035874865,0.0006335915,0.20942916,0.0000026956648,0.000020824891,0.00010791907,0.00003929531,0.0006110858,0.7842986,0.00013845091],"about_ca_topic_score_codex":0.00016910548,"about_ca_topic_score_gemma":0.000016276366,"teacher_disagreement_score":0.7442382,"about_ca_system_score_codex":0.0004723725,"about_ca_system_score_gemma":0.0070574516,"threshold_uncertainty_score":0.9990983},"labels":[],"label_agreement":null},{"id":"W4307970770","doi":"10.1158/1078-0432.ccr-21-3577","title":"Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and <i>BRCA1, BRCA2</i> , or <i>ATM</i> Alterations Identified by Testing Circulating Tumor DNA","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Juravinski Cancer Centre; Institute of Cancer Research","funders":"Medical Research Council; National Institute for Health and Care Research; AstraZeneca","keywords":"Olaparib; Medicine; Enzalutamide; Hazard ratio; Internal medicine; Oncology; Cohort; Prostate cancer; Population; Cancer; Confidence interval; Progression-free survival; PARP inhibitor; Chemotherapy; Poly ADP ribose polymerase; Biology; Genetics","score_opus":0.18852185491737347,"score_gpt":0.46875579997177996,"score_spread":0.28023394505440646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307970770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921794,0.0017388995,0.0000020177679,0.0021791225,0.0001397985,0.0029718825,0.0005433431,0.000043542055,0.00020199653],"genre_scores_gemma":[0.9943897,0.00022820728,0.00021282726,0.00037669,0.00011450478,0.0022246225,0.00026669967,0.000068323694,0.0021184147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947241,0.00074249436,0.0009573887,0.00094381755,0.0016897297,0.0009424589],"domain_scores_gemma":[0.9964579,0.0017898972,0.00020094069,0.00042341283,0.00069505454,0.0004328195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025824532,0.0002622158,0.00060765265,0.0002683679,0.0009190499,0.00018832607,0.00022371463,0.000048149977,0.00044859914],"category_scores_gemma":[0.0010676319,0.00019155192,0.00006611072,0.0017363636,0.0005001222,0.00023033911,0.00030236092,0.0015035344,0.0000062427325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014472854,0.0033846179,0.9432483,0.0005882742,0.00043022388,0.0006803665,0.0013696624,0.00034921692,0.0061722607,0.000028710689,0.006795404,0.022480143],"study_design_scores_gemma":[0.05532954,0.008501424,0.92249537,0.0012576901,0.0003251297,0.00003401272,0.0014575034,0.0016441467,0.0014939876,0.00011633959,0.0065314416,0.0008134172],"about_ca_topic_score_codex":0.0024385606,"about_ca_topic_score_gemma":0.0012056569,"teacher_disagreement_score":0.040856685,"about_ca_system_score_codex":0.000805454,"about_ca_system_score_gemma":0.0025124303,"threshold_uncertainty_score":0.7811261},"labels":[],"label_agreement":null},{"id":"W4308523453","doi":"10.1158/1078-0432.ccr-22-2191","title":"Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Capecitabine; Internal medicine; Oncology; Medicine; Breast cancer; Triple-negative breast cancer; Basal (medicine); Cancer; Colorectal cancer","score_opus":0.07225856200408001,"score_gpt":0.42869648930679166,"score_spread":0.3564379273027116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308523453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747171,0.008312969,0.000021715992,0.006615866,0.001615741,0.0008591796,0.0070836754,0.000035992503,0.00073778006],"genre_scores_gemma":[0.9875235,0.0041762786,0.000086934764,0.00080882275,0.0025297927,0.0022849008,0.0003756924,0.00007882075,0.0021352516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995615,0.00054311205,0.0006341869,0.001272804,0.0010423122,0.0008925834],"domain_scores_gemma":[0.9976425,0.00043157168,0.00017959983,0.00079033995,0.00060583197,0.0003501585],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011057196,0.00032545434,0.00056463125,0.000099868186,0.00068152935,0.000039360293,0.00072381337,0.00019214021,0.002985795],"category_scores_gemma":[0.0003118792,0.00029548508,0.00026707834,0.00050947536,0.0006293321,0.000010412957,0.0013307391,0.0010018012,0.000038490554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02508905,0.0029262505,0.60189825,0.000086224456,0.0026472362,0.00017955103,0.00093698385,0.00067726464,0.019162772,0.00007384171,0.18515302,0.16116953],"study_design_scores_gemma":[0.007112105,0.0010738329,0.96102244,0.00006431263,0.00011674069,0.0000075402286,0.00065913144,0.00017182133,0.005671835,0.00081798283,0.022788893,0.00049339386],"about_ca_topic_score_codex":0.011997455,"about_ca_topic_score_gemma":0.005040977,"teacher_disagreement_score":0.35912412,"about_ca_system_score_codex":0.00044659467,"about_ca_system_score_gemma":0.0011843033,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W4308684444","doi":"10.1158/1078-0432.ccr-22-2781","title":"Molecular Monitoring in Endometrial Cancer—Ready for Prime Time?","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Endometrial cancer; Cancer; Oncology; Disease; Medicine; Risk stratification; Internal medicine; Stage (stratigraphy); Bioinformatics; Biology","score_opus":0.2103175373538921,"score_gpt":0.5118544432595084,"score_spread":0.3015369059056162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308684444","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39423665,0.10412646,0.0001985548,0.4556476,0.020104507,0.01111653,0.011117165,0.00008518562,0.0033673716],"genre_scores_gemma":[0.08317168,0.16126168,0.001499954,0.38254648,0.27367902,0.044228744,0.013582241,0.0020114058,0.038018793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951769,0.0006386294,0.0008953382,0.0013319567,0.0008285627,0.0011285752],"domain_scores_gemma":[0.99666774,0.0015844554,0.00021894049,0.0009194019,0.00043415942,0.00017531481],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002813761,0.0003482392,0.00070976396,0.0003563986,0.00017615242,0.00009888144,0.001076467,0.0011353077,0.00045096135],"category_scores_gemma":[0.0027813097,0.00038382653,0.00043917107,0.00048476362,0.00027783963,0.000003396064,0.0008978968,0.0031158116,0.0000217082],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013703129,0.00012926363,0.002821986,0.00015037697,0.00025582223,0.00016403524,0.000013173109,0.00025272183,0.011865014,0.000008892182,0.96930367,0.0136647625],"study_design_scores_gemma":[0.0024347473,0.0011080027,0.00016145475,0.000076036435,0.000046656984,0.0000016043734,0.000009073508,0.000035382956,0.011534651,0.00012567188,0.98404086,0.0004258347],"about_ca_topic_score_codex":0.0014981991,"about_ca_topic_score_gemma":0.00013351126,"teacher_disagreement_score":0.31106496,"about_ca_system_score_codex":0.00052923354,"about_ca_system_score_gemma":0.0023179026,"threshold_uncertainty_score":0.99986136},"labels":[],"label_agreement":null},{"id":"W4309093661","doi":"10.1158/1078-0432.ccr-22-2074","title":"A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Imperial Experimental Cancer Medicine Centre; National Institute for Health and Care Research; Sierra Oncology; Cancer Research UK","keywords":"Gemcitabine; Medicine; Neutropenia; Internal medicine; Cancer; Tolerability; Nausea; Lung cancer; Cervical cancer; Gastroenterology; Oncology; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Adverse effect; Chemotherapy","score_opus":0.12067813214337975,"score_gpt":0.5118891438458054,"score_spread":0.39121101170242567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309093661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201137,0.00034139663,0.0000058622595,0.0033141258,0.00039487277,0.003475367,0.00016351897,0.000024756477,0.0002687172],"genre_scores_gemma":[0.9954701,0.00029640188,0.00011319722,0.00031852804,0.00018623708,0.003186846,0.000105815874,0.000056914465,0.00026594847],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99481153,0.0008315366,0.0010717999,0.0006920616,0.0019738742,0.000619188],"domain_scores_gemma":[0.99784946,0.00041477,0.00029411374,0.0005032042,0.0007135443,0.00022488803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026719018,0.00021343496,0.00080706377,0.0005834158,0.00016167342,0.000011993289,0.00027025337,0.0001117337,0.0012054339],"category_scores_gemma":[0.00028898992,0.00017617848,0.0000918916,0.0020834256,0.00055783207,0.00018519131,0.00021403731,0.0017334961,0.0000033956042],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65185124,0.02488641,0.25068676,0.00017397689,0.000106874475,0.00006816259,0.00059718516,0.0005878715,0.00047607743,0.000064357715,0.0018842296,0.06861686],"study_design_scores_gemma":[0.7711384,0.086033694,0.13100867,0.00093445426,0.000033918444,0.0000013342541,0.00026994367,0.0002774267,0.0011841753,0.00016984648,0.008631717,0.0003163828],"about_ca_topic_score_codex":0.0015905362,"about_ca_topic_score_gemma":0.0014598152,"teacher_disagreement_score":0.11967809,"about_ca_system_score_codex":0.0014132045,"about_ca_system_score_gemma":0.0020903854,"threshold_uncertainty_score":0.9997076},"labels":[],"label_agreement":null},{"id":"W4310153812","doi":"10.1158/1078-0432.ccr-21-1888","title":"Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Interface Biologics (Canada)","funders":"National Institutes of Health; Fundación BBVA; Fundación Ramón Areces; Fundación Científica Asociación Española Contra el Cáncer; Mitacs; Canada Research Chairs","keywords":"Immunosuppression; Tumor microenvironment; Macrophage; Cancer research; Medicine; Immunology; Tumor cells; Biology; In vitro","score_opus":0.11709788437567349,"score_gpt":0.45783317048563105,"score_spread":0.34073528610995757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310153812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921307,0.0042229267,0.000025512594,0.0023533693,0.00044101707,0.00043508474,0.00010094711,0.000008916068,0.00028155278],"genre_scores_gemma":[0.9985804,0.00030208752,0.00003160167,0.00026606958,0.000121219266,0.000085119675,0.0000129536875,0.000020670184,0.0005798661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972577,0.0007039966,0.0006739377,0.00024234813,0.0008539514,0.00026804884],"domain_scores_gemma":[0.9981974,0.00097507297,0.0001891653,0.00041350583,0.00013937888,0.00008551168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018568416,0.000084676394,0.00031936847,0.00007904946,0.00023557652,0.0000050402264,0.00030223175,0.00004097418,0.004221557],"category_scores_gemma":[0.00044317258,0.000055485245,0.00026034773,0.00035880518,0.0005772152,0.000023219969,0.0005559449,0.0012940377,0.000009348343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015975906,0.0010327146,0.09105977,0.00013567985,0.00014791153,0.000017066244,0.00025142127,0.00033107915,0.8897979,0.00005323589,0.007953591,0.0076219994],"study_design_scores_gemma":[0.003289085,0.0023727114,0.2827466,0.00043279893,0.000095950374,0.00002105606,0.002274131,0.0019363264,0.5753102,0.00012335203,0.13124341,0.00015438753],"about_ca_topic_score_codex":0.00038403794,"about_ca_topic_score_gemma":0.0000046620776,"teacher_disagreement_score":0.31448776,"about_ca_system_score_codex":0.00019168267,"about_ca_system_score_gemma":0.00034885225,"threshold_uncertainty_score":0.9966887},"labels":[],"label_agreement":null},{"id":"W4310961831","doi":"10.1158/1078-0432.ccr-22-1983","title":"Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; AstraZeneca","keywords":"Tremelimumab; Durvalumab; Hepatocellular carcinoma; Medicine; Oncology; Carcinoma; Internal medicine; Cancer; Immunotherapy; Nivolumab","score_opus":0.3085699116471894,"score_gpt":0.45173078754274426,"score_spread":0.14316087589555487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310961831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963213,0.00095215475,0.000005856977,0.0006057409,0.000036507754,0.0019257305,0.000031912292,0.000015385718,0.000105416606],"genre_scores_gemma":[0.9980851,0.00011029273,0.00010364904,0.00006664932,0.000025779214,0.00088765624,0.00006803396,0.000049805476,0.0006030619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99418175,0.0023489844,0.0007622807,0.0005724383,0.0016052526,0.00052928616],"domain_scores_gemma":[0.9976215,0.0010949216,0.00014777273,0.0005219554,0.00043760735,0.00017626357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0040073344,0.00019667414,0.00071805005,0.0007750047,0.00012871838,0.000019295785,0.00025256333,0.000099857214,0.0009479813],"category_scores_gemma":[0.00028537872,0.00013460897,0.00010827839,0.0022517699,0.00026354316,0.00009695145,0.00011541132,0.0008617446,0.0000036607266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13252613,0.0032667073,0.8584133,0.00007187644,0.00011246646,0.00039552734,0.00034736085,0.00003841111,0.0002465238,0.000005975387,0.00006401947,0.004511711],"study_design_scores_gemma":[0.03377048,0.022498496,0.93799454,0.00012818303,0.00005517079,0.0000024651827,0.00032022886,0.0021630297,0.002486424,0.000017221362,0.00040453539,0.00015921297],"about_ca_topic_score_codex":0.004817836,"about_ca_topic_score_gemma":0.0008930632,"teacher_disagreement_score":0.09875565,"about_ca_system_score_codex":0.0006533779,"about_ca_system_score_gemma":0.0014110267,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W4313453191","doi":"10.1158/1078-0432.ccr-22-2323","title":"Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; Genentech; National Institutes of Health; Institut National de la Santé et de la Recherche Médicale; Regeneron Pharmaceuticals; BeiGene; Daiichi Sankyo Europe; Sanofi; Université de Paris; G1 Therapeutics; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Resampling; Phase (matter); Decision support system; Computer science; Artificial intelligence; Chemistry","score_opus":0.2819218439402065,"score_gpt":0.627311248327568,"score_spread":0.34538940438736154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987425,0.00013795195,0.0031103522,0.0030532167,0.00066856586,0.0051987483,0.00024746422,0.00006275538,0.00009594128],"genre_scores_gemma":[0.9969908,0.00016539007,0.0003428201,0.0005555723,0.00009930027,0.0013121109,0.000055789715,0.000050725877,0.0004274618],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99535644,0.0004363368,0.0011662068,0.0007560271,0.001742968,0.0005420002],"domain_scores_gemma":[0.99377483,0.0034244738,0.00030119673,0.00093883334,0.0014049177,0.00015575881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011057015,0.00021509983,0.0007559963,0.0003918975,0.00057659054,0.000027008655,0.00038845415,0.00011519927,0.00011477634],"category_scores_gemma":[0.0025204,0.00014605353,0.0004502412,0.0015195287,0.00054216426,0.000054654993,0.00017276518,0.00081779587,0.0000027954131],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5262448,0.07652066,0.054705866,0.0013951011,0.002982493,0.00018012442,0.0033083276,0.007651735,0.02540604,0.00027548126,0.047996238,0.2533331],"study_design_scores_gemma":[0.14365256,0.046571143,0.03801555,0.0010488923,0.00021690666,7.1521725e-7,0.0018432008,0.7652455,0.0012706432,0.00095337443,0.00092426717,0.00025725394],"about_ca_topic_score_codex":0.00009546328,"about_ca_topic_score_gemma":0.00018406258,"teacher_disagreement_score":0.75759375,"about_ca_system_score_codex":0.0014280736,"about_ca_system_score_gemma":0.002420395,"threshold_uncertainty_score":0.59558904},"labels":[],"label_agreement":null},{"id":"W4313453618","doi":"10.1158/1078-0432.ccr-22-1768","title":"Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institute of Dental and Craniofacial Research; U.S. Department of Veterans Affairs","keywords":"Head and neck cancer; Neoadjuvant therapy; Oncology; Medicine; Head and neck; Internal medicine; Overall survival; Cancer; Surgery; Breast cancer","score_opus":0.36083228052320226,"score_gpt":0.5684159966494018,"score_spread":0.20758371612619952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93866426,0.005706657,5.7343266e-7,0.05327539,0.0005537257,0.00097046414,0.000059005288,0.000074228,0.00069569657],"genre_scores_gemma":[0.9430592,0.04553777,0.000051189883,0.002615494,0.00043636572,0.00078576064,0.000008157715,0.000052809988,0.007453265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962754,0.0005841315,0.000611118,0.0007433588,0.00079633953,0.0009896326],"domain_scores_gemma":[0.9967858,0.0017047756,0.00003198143,0.000419266,0.0004631677,0.00059501466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006037305,0.00019223384,0.0008235322,0.00038764562,0.00020961526,0.000043420707,0.00020246583,0.00017975995,0.00058078155],"category_scores_gemma":[0.0015508545,0.00015239537,0.00009468789,0.0016497994,0.00034607324,0.00006444873,0.0002628953,0.000980206,0.0001340742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034936696,0.0002783603,0.7452746,0.00010183412,0.00016614483,0.00029865396,0.0022270116,0.000076747085,0.0069692554,0.000058373975,0.0395839,0.17002843],"study_design_scores_gemma":[0.0061668092,0.0024664572,0.84509623,0.0005065288,0.000006338039,0.0000012376325,0.0006282226,0.00023341973,0.0005146254,0.00005921489,0.14414474,0.00017617605],"about_ca_topic_score_codex":0.009129916,"about_ca_topic_score_gemma":0.008136211,"teacher_disagreement_score":0.16985226,"about_ca_system_score_codex":0.000296106,"about_ca_system_score_gemma":0.0011627936,"threshold_uncertainty_score":0.99746835},"labels":[],"label_agreement":null},{"id":"W4313597888","doi":"10.1158/1078-0432.ccr-22-0794","title":"LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Departamento de Salud, Gobierno de Navarra; Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España; National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Ministerio de Ciencia e Innovación","keywords":"Biology; Effector; Cancer research; Gene expression profiling; Gene expression; Gene; Cell biology; Genetics","score_opus":0.1630158994598232,"score_gpt":0.46739954534286066,"score_spread":0.30438364588303746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313597888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895737,0.0050852685,0.000010664388,0.0033337795,0.00086770236,0.0005295714,0.00009422637,0.00009114474,0.00041390434],"genre_scores_gemma":[0.9817889,0.0045342594,0.000017742683,0.00020509877,0.00019339145,0.0004270595,0.00013620233,0.000029408826,0.012667974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974115,0.0006929536,0.00048748084,0.00053197064,0.0001648943,0.000711205],"domain_scores_gemma":[0.99839205,0.0009295504,0.000050114213,0.00025348147,0.00026468094,0.0001101291],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002727153,0.00015592249,0.00042848007,0.00024229859,0.0003377614,0.000040407936,0.00024769656,0.00026986463,0.00219109],"category_scores_gemma":[0.00045192675,0.0001296672,0.00012089181,0.0007225392,0.00045684044,0.0001293982,0.00015188384,0.000571262,0.00086153974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012623493,0.0001929912,0.2756151,0.00020290985,0.00047573468,0.000009140582,0.0005286863,0.00004068198,0.54696506,0.0022529846,0.13688338,0.035570987],"study_design_scores_gemma":[0.0016613897,0.00066819554,0.8454107,0.00012746414,0.000046066212,0.0000039057254,0.00006114676,0.000037416437,0.044070125,0.0009106159,0.106785566,0.00021741561],"about_ca_topic_score_codex":0.0012456297,"about_ca_topic_score_gemma":0.00026675436,"teacher_disagreement_score":0.5697956,"about_ca_system_score_codex":0.000092418166,"about_ca_system_score_gemma":0.00026550225,"threshold_uncertainty_score":0.99991643},"labels":[],"label_agreement":null},{"id":"W4317254563","doi":"10.1158/1078-0432.ccr-22-2263","title":"A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Medical Research Council; Cancer Research UK","keywords":"Cancer; Monocarboxylate transporter; Medicine; Transporter; Pharmacology; Internal medicine; Oncology; Chemistry; Biochemistry","score_opus":0.11840909832250741,"score_gpt":0.4943255930660395,"score_spread":0.3759164947435321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317254563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973455,0.0007473799,0.0000056640542,0.000071905924,0.0006570663,0.0010351596,0.00008474143,0.000016019352,0.000036536934],"genre_scores_gemma":[0.99639946,0.002110168,0.000024991728,0.000047919468,0.000697571,0.00040186133,0.00011639227,0.000041004445,0.00016063175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973185,0.00036159842,0.000596011,0.00066832156,0.00057494926,0.0004806077],"domain_scores_gemma":[0.99876964,0.000042799547,0.00010789554,0.00048121583,0.00040334772,0.00019512464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011775009,0.0001642786,0.00037846336,0.00016432717,0.00006636333,0.000015968317,0.00025375286,0.00017616551,0.000043491422],"category_scores_gemma":[0.00007763269,0.00013844683,0.00007634323,0.00073317543,0.00019637986,0.000020239948,0.00007844472,0.0003987232,0.0000034002655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013310136,0.0064635617,0.60984933,0.00006203409,0.00015516691,0.0000058951314,0.0007929525,0.0009109106,0.018404087,0.0000027075985,0.0009580501,0.34908515],"study_design_scores_gemma":[0.02731395,0.009851131,0.947508,0.000081961356,0.00004072798,7.688671e-8,0.0003754206,0.00017002375,0.0031349063,0.000023284232,0.011221964,0.0002785751],"about_ca_topic_score_codex":0.00094982306,"about_ca_topic_score_gemma":0.007677848,"teacher_disagreement_score":0.3488066,"about_ca_system_score_codex":0.000039678653,"about_ca_system_score_gemma":0.00039709627,"threshold_uncertainty_score":0.5645698},"labels":[],"label_agreement":null},{"id":"W4318925936","doi":"10.1158/1078-0432.ccr-22-3484","title":"Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in <i>EGFR</i> -Mutant Lung Adenocarcinomas","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; Royal College of Physicians and Surgeons of Canada; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Pfizer","keywords":"Osimertinib; T790M; Medicine; Lung cancer; Combination therapy; Oncology; Gefitinib; Acquired resistance; Internal medicine; Epidermal growth factor receptor; Regimen; Afatinib; Pharmacology; Cancer; Erlotinib","score_opus":0.10603535078340894,"score_gpt":0.498558414973884,"score_spread":0.39252306419047506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318925936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790759,0.003226942,0.0000064189253,0.013213621,0.00012546462,0.0011514828,0.000053476662,0.000035292738,0.003111415],"genre_scores_gemma":[0.9945504,0.0014462852,0.00017687157,0.0004632243,0.00009669319,0.0002709085,0.00006594753,0.000027206039,0.002902478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750435,0.00022248703,0.00077835703,0.00055527396,0.0005511369,0.00038836928],"domain_scores_gemma":[0.9980011,0.00089433836,0.00011570776,0.00035797185,0.00032233188,0.0003085606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021308432,0.00011760357,0.00045931686,0.00027413055,0.000103054175,0.000030063638,0.000089003195,0.00011062132,0.00003259354],"category_scores_gemma":[0.0009899162,0.000104667684,0.00005392378,0.0009629838,0.0003828166,0.00008499939,0.00017467457,0.00027228275,0.000005449115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024325885,0.0004755354,0.9506709,0.0010135554,0.00020630365,0.0012282002,0.0017229948,0.0000037379687,0.0062512713,0.0013734462,0.016631832,0.017989611],"study_design_scores_gemma":[0.0045095338,0.000427278,0.98446465,0.0006741598,0.0000736505,0.000015243171,0.00019242801,0.00011694517,0.0010836052,0.0006880119,0.007643887,0.000110616544],"about_ca_topic_score_codex":0.00042262455,"about_ca_topic_score_gemma":0.00035667903,"teacher_disagreement_score":0.033793718,"about_ca_system_score_codex":0.000214113,"about_ca_system_score_gemma":0.00055926957,"threshold_uncertainty_score":0.42682245},"labels":[],"label_agreement":null},{"id":"W4318926335","doi":"10.1158/1078-0432.ccr-22-1989","title":"Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Trastuzumab; Breast cancer; Medicine; Oncology; Adjuvant; Biomarker; Internal medicine; Adjuvant therapy; Neoadjuvant therapy; Cancer; Biology","score_opus":0.5670680553339,"score_gpt":0.6237006534623429,"score_spread":0.0566325981284429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318926335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9251647,0.0051926333,0.00002877383,0.01971531,0.00092986977,0.0112236645,0.037624825,0.00007588407,0.000044328353],"genre_scores_gemma":[0.9731987,0.00893465,0.000058192756,0.0005020146,0.0028342821,0.011634754,0.0017553815,0.00019121147,0.0008908267],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9918769,0.0012703526,0.001361095,0.0018078033,0.0022774525,0.0014063909],"domain_scores_gemma":[0.98012537,0.014142146,0.00023408863,0.002732961,0.0019109457,0.00085447694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006860819,0.00042159017,0.001155841,0.00024822005,0.00040998348,0.00010071856,0.0017694108,0.00022671546,0.0016543095],"category_scores_gemma":[0.0032295373,0.00028181507,0.00035251156,0.0012550994,0.0012621799,0.00016208449,0.0011316333,0.0011597576,0.000043142736],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40267673,0.0068808617,0.050640464,0.00037435137,0.0028806054,0.00033353042,0.0023047011,0.000015501493,0.0011796891,0.00001168735,0.27015042,0.26255146],"study_design_scores_gemma":[0.13165727,0.017679874,0.7690491,0.0015614318,0.0007944045,0.0000032167843,0.007828035,0.0031727217,0.00078255066,0.00030747685,0.066468686,0.0006952224],"about_ca_topic_score_codex":0.0112012,"about_ca_topic_score_gemma":0.00991831,"teacher_disagreement_score":0.71840864,"about_ca_system_score_codex":0.0005161459,"about_ca_system_score_gemma":0.004781779,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W4319338186","doi":"10.1158/1078-0432.ccr-22-3032","title":"Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Hope Foundation; Ohio State University; National Cancer Institute; St. Baldrick's Foundation","keywords":"Neuroblastoma; Histology; Internal medicine; Univariate analysis; Oncology; Medicine; Multivariate analysis; Stage (stratigraphy); Cog; Confidence interval; Biology; Genetics","score_opus":0.1945378628366252,"score_gpt":0.525337744972106,"score_spread":0.3307998821354807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319338186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722254,0.00012939726,0.000006465411,0.00026056744,0.00004173602,0.0017843362,0.00020193872,0.00003669703,0.00031633806],"genre_scores_gemma":[0.9981112,0.000925657,0.00014638995,0.000032936376,0.00006988307,0.00007112513,0.00008530962,0.00006298616,0.0004945269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99525934,0.00081780995,0.0014381147,0.0009553085,0.0008721355,0.0006573146],"domain_scores_gemma":[0.9954057,0.0019976276,0.0006235785,0.00090757903,0.0004302387,0.000635302],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002205248,0.00028268914,0.0015166653,0.00046011608,0.000098640674,0.00001254456,0.00024828382,0.00024904255,0.0000815709],"category_scores_gemma":[0.0009764272,0.00017956586,0.0002164941,0.00067806756,0.0028817134,0.00006866668,0.00025317504,0.0011934036,0.000006949487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013072799,0.0013886128,0.98040193,0.00011860185,0.0009956685,0.0005163953,0.000050780964,0.000013565949,0.000917914,0.000020885289,0.00029740215,0.0022054578],"study_design_scores_gemma":[0.007416772,0.03796015,0.9536475,0.000121217345,0.00016830344,0.00017884279,0.00003408562,0.000025083693,0.00024013162,0.000016018636,0.000068092675,0.00012383952],"about_ca_topic_score_codex":0.0028615294,"about_ca_topic_score_gemma":0.0007463168,"teacher_disagreement_score":0.036571536,"about_ca_system_score_codex":0.00015452424,"about_ca_system_score_gemma":0.0009887535,"threshold_uncertainty_score":0.99983186},"labels":[],"label_agreement":null},{"id":"W4319341650","doi":"10.1158/1078-0432.ccr-22-3298","title":"Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics","year":2023,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Janssen Pharmaceuticals; Loxo Oncology; Genentech; Sierra Oncology; PharmaMar; European Society for Medical Oncology; Astellas Pharma; Generalitat de Catalunya; Fundación Científica Asociación Española Contra el Cáncer; MacroGenics; Menarini Group; F-star Therapeutics; Banco Bilbao Vizcaya Argentaria; BeiGene; Agios Pharmaceuticals; Merck KGaA; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Principia Biopharma; Fundació la Marató de TV3; Fundación BBVA; Symphogen; Pfizer; Incyte; F. Hoffmann-La Roche; Ministerio de Ciencia e Innovación; European Commission; Sanofi; Centres de Recerca de Catalunya; GlaxoSmithKline; Instituto de Salud Carlos III; Amgen; Celgene; Agència de Gestió d'Ajuts Universitaris i de Recerca; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Antigen; Immunosurveillance; Immunogenicity; Cancer; Cancer research; Biology; T cell; Cancer immunotherapy; Immune system; Immunology; Immunotherapy; Genetics","score_opus":0.5256608444183113,"score_gpt":0.4866425423422372,"score_spread":0.039018302076074096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319341650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7347168,0.041021973,0.0000143584175,0.20639373,0.013570677,0.0030234216,0.0005278467,0.00019575063,0.0005354905],"genre_scores_gemma":[0.30608526,0.13669676,0.000096170705,0.2526455,0.020094128,0.017539214,0.0016686303,0.0016794064,0.26349494],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909474,0.0037869196,0.0021104608,0.0010746111,0.00045777622,0.0016228061],"domain_scores_gemma":[0.9874442,0.009102389,0.0005893512,0.0021245044,0.0007088491,0.00003067318],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0077043404,0.000512344,0.0014181864,0.0002744245,0.0008187126,0.00009570258,0.0028045212,0.0013129666,0.0012067946],"category_scores_gemma":[0.0019767627,0.00036364773,0.0010520227,0.00095582585,0.003801897,0.00020394905,0.0011619951,0.011670946,0.0017853905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052206167,0.0002461242,0.0002883288,0.00030234663,0.002887119,0.00020167712,0.0010058187,0.0000024121132,0.04314658,0.00011178737,0.93595773,0.010629437],"study_design_scores_gemma":[0.0017062089,0.0007459276,0.0040370557,0.00048958004,0.00011893216,0.000034000775,0.0002687874,5.605073e-7,0.074455574,0.00024745936,0.917467,0.00042893493],"about_ca_topic_score_codex":0.003079881,"about_ca_topic_score_gemma":0.00006359537,"teacher_disagreement_score":0.42863148,"about_ca_system_score_codex":0.00024869543,"about_ca_system_score_gemma":0.0019632143,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W4319461346","doi":"10.1158/1078-0432.ccr-22-2206","title":"<i>CCNE1</i> and <i>PLK1</i> Mediate Resistance to Palbociclib in HR+/HER2− Metastatic Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Napoli Federico II; AstraZeneca; Pfizer","keywords":"Palbociclib; Medicine; Capecitabine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Estrogen receptor; Cancer; Cancer research; Colorectal cancer","score_opus":0.21797034272938606,"score_gpt":0.5550666118599532,"score_spread":0.3370962691305671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319461346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91405797,0.007714196,0.000028714921,0.07436894,0.00063402014,0.0016798305,0.00042031112,0.00022911266,0.00086688716],"genre_scores_gemma":[0.96711177,0.015505255,0.0006805418,0.005665531,0.0012951879,0.0020412542,0.000024925097,0.00017408104,0.0075014713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9943813,0.0006096604,0.0010192968,0.0011833084,0.0013853507,0.0014210698],"domain_scores_gemma":[0.99572194,0.0018903799,0.00011833382,0.0007702858,0.0005550521,0.0009439967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004399402,0.00032262996,0.0009831757,0.0003978108,0.00018306753,0.000061347164,0.00040725656,0.00017423341,0.0005978863],"category_scores_gemma":[0.0009689299,0.00027964747,0.00014699817,0.0033017455,0.0008216057,0.00019991837,0.00039865894,0.0015077422,0.00029320043],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015441739,0.00065821386,0.439079,0.001419323,0.0004964862,0.0011755028,0.0020423292,0.00019460726,0.0049118875,0.0004958056,0.049524583,0.48456052],"study_design_scores_gemma":[0.009796588,0.00048757167,0.77668357,0.0020098756,0.0000964972,0.00003736836,0.0009172572,0.00015242651,0.0009301432,0.0036773016,0.2045538,0.00065762136],"about_ca_topic_score_codex":0.0010873859,"about_ca_topic_score_gemma":0.0077867326,"teacher_disagreement_score":0.4839029,"about_ca_system_score_codex":0.0004992488,"about_ca_system_score_gemma":0.0008191423,"threshold_uncertainty_score":0.99996555},"labels":[],"label_agreement":null},{"id":"W4321367032","doi":"10.1158/1078-0432.ccr-22-2765","title":"Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Durvalumab; Tremelimumab; Medicine; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Confidence interval; Head and neck cancer; Chemotherapy; Hazard ratio; Immunotherapy; Cancer; Nivolumab","score_opus":0.27141715895329493,"score_gpt":0.5069175933917128,"score_spread":0.2355004344384179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321367032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930429,0.0025219114,5.626388e-7,0.0025803929,0.00011706451,0.0011574952,0.000117578966,0.000025744603,0.00043638106],"genre_scores_gemma":[0.99435997,0.0023519506,0.000108437176,0.000049453392,0.00022169204,0.00052460097,0.000020284006,0.000030719475,0.0023329207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970295,0.00041392024,0.0006460071,0.00056104467,0.0008401788,0.00050935225],"domain_scores_gemma":[0.99658793,0.0024727953,0.00008149631,0.00023902602,0.0002883553,0.000330418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013211771,0.00018968323,0.00086198316,0.00025134016,0.0001013006,0.000016670418,0.000084412895,0.0000559357,0.00023264938],"category_scores_gemma":[0.0009409333,0.00011079721,0.00006591989,0.0007588381,0.0005335757,0.000046042394,0.000114372306,0.00038418444,0.000014420436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10061151,0.0028371648,0.780489,0.003388489,0.00040436405,0.0046003386,0.009351685,0.000030630985,0.0001961671,0.00007505708,0.0028488366,0.095166706],"study_design_scores_gemma":[0.031688564,0.03714381,0.9220824,0.00061955635,0.00016446739,0.000053373944,0.003385168,0.0012885906,0.00026814046,0.00009271992,0.0030047854,0.00020840923],"about_ca_topic_score_codex":0.004022488,"about_ca_topic_score_gemma":0.007898904,"teacher_disagreement_score":0.14159335,"about_ca_system_score_codex":0.00024735843,"about_ca_system_score_gemma":0.0021807915,"threshold_uncertainty_score":0.60808253},"labels":[],"label_agreement":null},{"id":"W4321611729","doi":"10.1158/1078-0432.ccr-22-1936","title":"Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"NIHR Cambridge Biomedical Research Centre; European Commission; Fonds de Recherche du Québec - Santé; Kidney Foundation of Canada; National Institute for Health and Care Research; Cancer Research Society; Cancer Research UK; Ministère de l'Éducation et de l'Enseignement supérieur; McGill University; World Health Organization","keywords":"Medicine; Renal cell carcinoma; Cohort; Oncology; Internal medicine; Clear cell renal cell carcinoma; Adjuvant therapy; Cancer","score_opus":0.3207378210906531,"score_gpt":0.4987843110072705,"score_spread":0.17804648991661742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321611729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942805,0.00059725373,0.00013523332,0.0016408972,0.000067971516,0.0028493989,0.000039177296,0.000024306639,0.00036526468],"genre_scores_gemma":[0.99642694,0.00036541457,0.0006392801,0.00010310005,0.00018661791,0.0018382928,0.00010507861,0.000032895925,0.00030240827],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974624,0.00021073187,0.0008261009,0.0005451585,0.0005404327,0.00041515863],"domain_scores_gemma":[0.9979532,0.00065446884,0.00012021539,0.00056330056,0.00049134647,0.00021748275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021426082,0.00011916028,0.00038635425,0.000350589,0.00005705223,0.000010254224,0.00016098442,0.00011710535,0.00003715619],"category_scores_gemma":[0.00020750104,0.00009837914,0.00012723736,0.00078040117,0.00010032655,0.000029300683,0.000066920344,0.00032897812,0.00007281444],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003334555,0.00037864462,0.086666785,0.00023852907,0.000026320264,0.000023283174,0.0007397252,0.00045920123,0.69266224,0.000103020146,0.0017774864,0.21359022],"study_design_scores_gemma":[0.0031723664,0.0052936436,0.7397349,0.00008353442,0.000018110915,0.0000015801556,0.00036076375,0.0023540368,0.2457525,0.00034093086,0.0027575921,0.00013006252],"about_ca_topic_score_codex":0.0011561789,"about_ca_topic_score_gemma":0.00022914975,"teacher_disagreement_score":0.65306807,"about_ca_system_score_codex":0.00070845353,"about_ca_system_score_gemma":0.0007383213,"threshold_uncertainty_score":0.40117848},"labels":[],"label_agreement":null},{"id":"W4321748193","doi":"10.1158/1078-0432.ccr-22-2955","title":"Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Lymphoma; Follicular lymphoma; Angioimmunoblastic T-cell lymphoma; T cell; Internal medicine; Adverse effect; Oncology; Peripheral T-cell lymphoma; Refractory (planetary science); Pharmacodynamics; Gastroenterology; Immunology; Pharmacokinetics; Immune system","score_opus":0.07551008948559883,"score_gpt":0.395376646050156,"score_spread":0.31986655656455715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321748193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991787,0.0030769904,0.0000051499283,0.0007350814,0.0002864528,0.0020175308,0.00002352923,0.00008457111,0.0019836996],"genre_scores_gemma":[0.9860142,0.0020559889,0.00006528013,0.00031991818,0.0004879023,0.0002719331,0.00006634114,0.00015579746,0.010562662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99343276,0.0011090108,0.0008605512,0.0010948601,0.0020468177,0.0014560247],"domain_scores_gemma":[0.99507165,0.0024648544,0.00013526605,0.0010524726,0.0007427418,0.00053303724],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005207708,0.00035819845,0.0007063154,0.00043222064,0.00041224377,0.00014278338,0.0005568498,0.00038302256,0.0016863599],"category_scores_gemma":[0.00084290083,0.0002429018,0.00017901396,0.0021422638,0.0009187142,0.00016159809,0.00054263894,0.0021362004,0.00032234422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014878745,0.004481699,0.8934972,0.00067744975,0.00019520245,0.00037148187,0.001390897,0.000569884,0.04414655,0.00000976225,0.017130423,0.022650653],"study_design_scores_gemma":[0.071248785,0.01012606,0.8235779,0.00078123854,0.00015619311,0.0000048724382,0.0018615011,0.0064773965,0.005281871,0.0001118922,0.079235464,0.0011368433],"about_ca_topic_score_codex":0.0008347227,"about_ca_topic_score_gemma":0.00007447839,"teacher_disagreement_score":0.06991936,"about_ca_system_score_codex":0.0006155497,"about_ca_system_score_gemma":0.0012369034,"threshold_uncertainty_score":0.9992262},"labels":[],"label_agreement":null},{"id":"W4324132617","doi":"10.1158/1078-0432.ccr-22-3291","title":"Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of California, San Francisco; U.S. Department of Defense; U.S. Department of Energy; University of California, Davis; University of Alberta; DOD Prostate Cancer Research Program; School of Veterinary Medicine, University of California, Davis","keywords":"Radioimmunotherapy; Prostate cancer; Medicine; Cancer; Antibody; Immunotherapy; Cancer research; Oncology; Monoclonal antibody; Internal medicine; Immunology","score_opus":0.34073345702044033,"score_gpt":0.5932641462564825,"score_spread":0.25253068923604216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324132617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814589,0.003629938,0.0000029779537,0.013395675,0.000051705694,0.00083375693,0.000065227025,0.0000809636,0.00048083675],"genre_scores_gemma":[0.97059566,0.020043138,0.00006279815,0.00013060488,0.00032326207,0.0012812739,0.000024537116,0.000031249216,0.0075074574],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980756,0.00011793456,0.00043402033,0.0003869611,0.00049171713,0.0004937567],"domain_scores_gemma":[0.99835396,0.00052154384,0.00005994902,0.00044801607,0.00029647409,0.00032005375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057331356,0.000121570105,0.00038334553,0.0000456875,0.00011797573,0.000013170478,0.000118657066,0.00008874391,0.0008272266],"category_scores_gemma":[0.000086413886,0.0000819051,0.00011510357,0.0010742155,0.00063478184,0.000035001223,0.000024252322,0.00032489465,0.00007527974],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011081898,0.002619475,0.5156575,0.00039095775,0.000962992,0.00016386062,0.00087315653,0.00018485864,0.23740979,0.00025312745,0.008854681,0.22154775],"study_design_scores_gemma":[0.0142397005,0.004333268,0.1886148,0.00023850433,0.00017671197,0.00001177023,0.00029345925,0.00326063,0.5318339,0.00019778329,0.2565232,0.00027628485],"about_ca_topic_score_codex":0.00030924944,"about_ca_topic_score_gemma":0.00001803367,"teacher_disagreement_score":0.32704267,"about_ca_system_score_codex":0.0001663262,"about_ca_system_score_gemma":0.0005665634,"threshold_uncertainty_score":0.9057551},"labels":[],"label_agreement":null},{"id":"W4361190864","doi":"10.1158/1078-0432.ccr-22-2535","title":"A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Saskatchewan Cancer Agency; Centre hospitalier de l'Université Laval; Saskatoon Medical Imaging; University of Saskatchewan; Centre hospitalier universitaire de Québec; Royal University Hospital","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; National Cancer Institute; Genome Canada","keywords":"Bispecific antibody; EPH receptor A2; Cancer; Medicine; Antibody; Cancer therapy; Epidermal growth factor receptor; Cancer research; Antibody therapy; Oncology; Internal medicine; Immunology; Monoclonal antibody; Receptor","score_opus":0.700667143084389,"score_gpt":0.6785639125598978,"score_spread":0.022103230524491257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361190864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707557,0.001682598,0.00007156829,0.0058290297,0.0005213379,0.0040633287,0.00011493269,0.000116852716,0.00052479963],"genre_scores_gemma":[0.9870713,0.0066012223,0.00048305787,0.00019106954,0.00082089985,0.0024470887,0.00021136271,0.00010667287,0.0020673631],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99327135,0.0010640095,0.0014102607,0.0009003414,0.0021913538,0.001162698],"domain_scores_gemma":[0.99296725,0.002924127,0.00020719829,0.001006644,0.0024582632,0.00043653417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0142568825,0.00025903582,0.0007478258,0.0004399376,0.00055047474,0.00010127282,0.00087501446,0.00029160068,0.00072882907],"category_scores_gemma":[0.0016974361,0.00017798443,0.00023419021,0.0020241952,0.0010860076,0.00014032752,0.0002056713,0.0012118235,0.000070018825],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046964693,0.0018094361,0.09765708,0.00082885916,0.00050636684,0.000037125734,0.0018332853,0.00014016965,0.056581058,0.0003145171,0.03017615,0.8054195],"study_design_scores_gemma":[0.013517522,0.0034088593,0.78426677,0.00080089184,0.000042306896,0.0000025308755,0.0023007232,0.009907722,0.057984672,0.000586378,0.12673528,0.00044637325],"about_ca_topic_score_codex":0.0011874913,"about_ca_topic_score_gemma":0.0014341845,"teacher_disagreement_score":0.8049731,"about_ca_system_score_codex":0.00053711585,"about_ca_system_score_gemma":0.0052620033,"threshold_uncertainty_score":0.9334568},"labels":[],"label_agreement":null},{"id":"W4362451642","doi":"10.1158/1078-0432.ccr-22-3136","title":"Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Gilead Sciences","keywords":"Medicine; Chemoimmunotherapy; Clinical endpoint; Internal medicine; Adverse effect; Oncology; Randomized controlled trial; Surgery; Lymphoma; Rituximab","score_opus":0.10425728756673605,"score_gpt":0.4631420898558782,"score_spread":0.3588848022891421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362451642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627805,0.0009867362,9.770783e-7,0.00011581149,0.00011321125,0.0010171102,0.00024150436,0.000015103383,0.0012315026],"genre_scores_gemma":[0.99167687,0.0056707864,0.000052706026,0.000015244415,0.00008576008,0.00002974003,0.000055602304,0.000052443833,0.0023608438],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9957775,0.00051972864,0.0008608291,0.0004849845,0.0017776184,0.0005793806],"domain_scores_gemma":[0.995661,0.002416512,0.0001540723,0.00066368026,0.00083614007,0.00026857617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002840907,0.0001418173,0.0008675065,0.00043177186,0.000039600982,0.0000072176867,0.00026528997,0.00022707474,0.00076058053],"category_scores_gemma":[0.001319446,0.00011231091,0.00013237982,0.0013618869,0.00081824634,0.00004587193,0.0003182619,0.0006548512,0.000009004572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47259638,0.0035510631,0.2684242,0.0020567828,0.0002959027,0.0003130044,0.0026902242,0.000011603755,0.002892339,0.000024433639,0.0019208934,0.24522316],"study_design_scores_gemma":[0.09835338,0.021386765,0.8583246,0.0007420632,0.00004253005,3.4343915e-7,0.0011047048,0.000016416523,0.004617418,0.000004896298,0.015266697,0.00014023256],"about_ca_topic_score_codex":0.00038161685,"about_ca_topic_score_gemma":0.00087296695,"teacher_disagreement_score":0.5899003,"about_ca_system_score_codex":0.0003034369,"about_ca_system_score_gemma":0.0013417441,"threshold_uncertainty_score":0.8327823},"labels":[],"label_agreement":null},{"id":"W4362456136","doi":"10.1158/1078-0432.ccr-22-3207","title":"SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Melanoma; Adjuvant therapy; Adjuvant; Radiation therapy; Surgery; Oncology; Gastroenterology; Cancer; Immunotherapy","score_opus":0.2984597270626484,"score_gpt":0.5228688469826615,"score_spread":0.22440911992001306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362456136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832977,0.00060261885,0.000016860242,0.004544769,0.000881338,0.0027601847,0.000028007738,0.00012218129,0.0027142777],"genre_scores_gemma":[0.98586047,0.0035909098,0.00007123218,0.00020746431,0.0010190867,0.00043290557,0.000026227282,0.000046569086,0.008745149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714303,0.000333621,0.0006750077,0.00052987493,0.0007693308,0.00054911297],"domain_scores_gemma":[0.99687636,0.0017883881,0.00010122774,0.0004533288,0.0004834034,0.00029731262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031724114,0.00013426822,0.00054115313,0.00034069456,0.0001455671,0.000033294302,0.00016556852,0.00018735894,0.0004785309],"category_scores_gemma":[0.0024198177,0.00011018436,0.00020490613,0.0006999543,0.00039984184,0.000033148634,0.00016646058,0.00050198066,0.0000615963],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33134052,0.002038619,0.0012176678,0.00031985203,0.0003910749,0.00015076285,0.00022287853,0.0000017826293,0.008209917,0.00033022746,0.042562984,0.6132137],"study_design_scores_gemma":[0.33568916,0.12413329,0.024449026,0.00043163786,0.00018103197,0.000067046574,0.0012645302,0.0015566037,0.015504351,0.0036289194,0.4925635,0.0005309219],"about_ca_topic_score_codex":0.00039694845,"about_ca_topic_score_gemma":0.0002451258,"teacher_disagreement_score":0.61268276,"about_ca_system_score_codex":0.00012827248,"about_ca_system_score_gemma":0.00043042624,"threshold_uncertainty_score":0.5239578},"labels":[],"label_agreement":null},{"id":"W4362457702","doi":"10.1158/1078-0432.ccr-22-2998","title":"Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Cilag; Astellas Pharma; Killam Trusts; ZonMw; Prostate Cancer Foundation","keywords":"Enzalutamide; Abiraterone; Prostate cancer; Medicine; Oncology; Cancer; Internal medicine; Prostate; Androgen receptor","score_opus":0.3526424261395648,"score_gpt":0.5554773306580965,"score_spread":0.20283490451853164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362457702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806573,0.0006339941,4.0432343e-7,0.015719997,0.00012532678,0.002645875,0.00010792135,0.000048906357,0.00006031614],"genre_scores_gemma":[0.9890419,0.0033031574,0.00005674777,0.00026123683,0.00018358558,0.0031788452,0.000022162372,0.000052200172,0.0039001382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565285,0.0010136775,0.00065643544,0.0008228807,0.00089654006,0.00095763616],"domain_scores_gemma":[0.9965497,0.0023227553,0.00007828296,0.00035755034,0.00024467538,0.00044701164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041850125,0.0002422891,0.00061784,0.0010028298,0.00016415124,0.000093887764,0.00010914799,0.00009210764,0.0002025857],"category_scores_gemma":[0.0013566107,0.00016485655,0.000059576185,0.0020248704,0.00023513357,0.00011150234,0.00010346319,0.00070906995,0.00009107001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1885377,0.0014741098,0.50849956,0.00067974307,0.00034922487,0.009617701,0.007438469,0.00043598944,0.14318323,0.000025406676,0.00084817735,0.13891068],"study_design_scores_gemma":[0.008395419,0.006941693,0.97339624,0.0011794878,0.00003027117,0.0000070006504,0.0014216352,0.00039461174,0.006248586,0.000103765466,0.0016762614,0.00020505155],"about_ca_topic_score_codex":0.008262617,"about_ca_topic_score_gemma":0.024028575,"teacher_disagreement_score":0.46489665,"about_ca_system_score_codex":0.002050305,"about_ca_system_score_gemma":0.0017886342,"threshold_uncertainty_score":0.99834144},"labels":[],"label_agreement":null},{"id":"W4365504267","doi":"10.1158/1078-0432.ccr-22-3145","title":"Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pharmacyclics; EMD Serono; Eli Lilly and Company; Ono Pharmaceutical; Eisai; Seagen; Castle Biosciences; University of Miami; Pfizer; Incyte; BeiGene; Regeneron Pharmaceuticals; Mylan; Les Laboratories Pierre Fabre; Sun Pharma; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Qbiotics; Samsung; Bristol-Myers Squibb; AstraZeneca; PharmaMar; Jounce Therapeutics; Celgene","keywords":"Ipilimumab; Nivolumab; Medicine; Adjuvant; Melanoma; Oncology; Stage (stratigraphy); Internal medicine; Biomarker; Cancer; Immunotherapy; Cancer research; Biology","score_opus":0.26881148328013926,"score_gpt":0.49505869565078864,"score_spread":0.22624721237064938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365504267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861242,0.00046712556,0.0000021232313,0.0034996336,0.0009578987,0.0011350026,0.00015613159,0.00021899094,0.0074388697],"genre_scores_gemma":[0.97860295,0.003244027,0.000046063542,0.00009103559,0.00043754085,0.00011152507,0.00012512105,0.00005299954,0.017288718],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99563867,0.0005920144,0.00095912436,0.001017879,0.0009815913,0.00081072556],"domain_scores_gemma":[0.9957955,0.002589538,0.00010622527,0.00081475836,0.00023966566,0.00045429627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036641732,0.00020851337,0.0006005234,0.0005856025,0.00016994127,0.000075379816,0.00024920428,0.00027190088,0.0008121379],"category_scores_gemma":[0.0032692035,0.00018594571,0.00011623839,0.0015686849,0.00042609056,0.000064449865,0.0005448973,0.0011801964,0.00053177954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3807085,0.0020254273,0.023161612,0.0005110126,0.0013292654,0.008296186,0.0020668483,0.00004331972,0.0111997295,0.00022231086,0.22779632,0.34263948],"study_design_scores_gemma":[0.1125282,0.0036003839,0.6941756,0.00060154713,0.000112834095,0.000008934843,0.00223845,0.004277679,0.0012059866,0.00013170419,0.18059427,0.0005244014],"about_ca_topic_score_codex":0.0056710234,"about_ca_topic_score_gemma":0.0042593256,"teacher_disagreement_score":0.671014,"about_ca_system_score_codex":0.00034051758,"about_ca_system_score_gemma":0.00032209503,"threshold_uncertainty_score":0.88923407},"labels":[],"label_agreement":null},{"id":"W4366982411","doi":"10.1158/1078-0432.ccr-22-3413","title":"Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Canadian Institutes of Health Research; Chugai Pharmaceutical; EMD Serono; Genentech; Mirati Therapeutics; National Cancer Institute; Royal College of Physicians and Surgeons of Canada; Conquer Cancer Foundation; Gilead Sciences; Merck KGaA; Regeneron Pharmaceuticals; Prostate Cancer Foundation; American Society of Clinical Oncology; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Pfizer; Takeda Oncology; Amgen","keywords":"KRAS; Cancer research; Lung cancer; STK11; Microsatellite instability; Biology; Adenocarcinoma; Missense mutation; Cancer; Medicine; Pathology; Mutation; Gene; Internal medicine; Colorectal cancer; Genetics","score_opus":0.12049070787620193,"score_gpt":0.5108255109347748,"score_spread":0.3903348030585729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366982411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985503,0.008598712,0.000007319344,0.0016261882,0.00029203048,0.0010460373,0.0001152504,0.000037433332,0.0027740241],"genre_scores_gemma":[0.9836703,0.012302297,0.00020758048,0.00025075316,0.00023178551,0.00068305514,0.000053248583,0.00003364554,0.0025673525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777895,0.00022422266,0.00073167484,0.0004852022,0.00030367746,0.00047624123],"domain_scores_gemma":[0.99799734,0.0010394064,0.000114929535,0.0003589659,0.00029490495,0.00019447655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017020733,0.00013536005,0.0004947104,0.00031274394,0.00012118791,0.000020384588,0.00015233588,0.00017203027,0.00032639512],"category_scores_gemma":[0.00025937194,0.00011040595,0.00011412083,0.00092906837,0.0003237068,0.00004937132,0.00017021404,0.00065538246,0.00004877197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003572923,0.00034700643,0.97565776,0.0003377355,0.000095042844,0.00009025845,0.0009000836,0.000101856305,0.0021760396,0.000044960336,0.0031705573,0.01672141],"study_design_scores_gemma":[0.004896228,0.0004656515,0.99018943,0.00023020306,0.00016230287,0.0000018140904,0.0006071632,0.00083722296,0.00034327118,0.0002582357,0.0018916455,0.00011683783],"about_ca_topic_score_codex":0.0012625556,"about_ca_topic_score_gemma":0.00074787793,"teacher_disagreement_score":0.016604573,"about_ca_system_score_codex":0.0001614584,"about_ca_system_score_gemma":0.001003755,"threshold_uncertainty_score":0.4502224},"labels":[],"label_agreement":null},{"id":"W4367601287","doi":"10.1158/1078-0432.ccr-23-0411","title":"Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"Hospital for Sick Children; Stand Up To Cancer; St. Baldrick's Foundation","keywords":"Nivolumab; Medicine; Mutation; Refractory (planetary science); Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy; Biology; Genetics","score_opus":0.12479639771476266,"score_gpt":0.47622004907038723,"score_spread":0.3514236513556246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949633,0.0015772324,4.7717117e-7,0.0024310353,0.0000677624,0.00063264463,0.000008981739,0.000044610922,0.00027397848],"genre_scores_gemma":[0.99519616,0.0040769596,0.00009187871,0.000021646207,0.00023718341,0.00018901099,0.000012658652,0.00001755379,0.00015696048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980707,0.00015741042,0.00041826337,0.0004016515,0.00060183974,0.0003500923],"domain_scores_gemma":[0.9980912,0.0011831154,0.00006471888,0.00026255735,0.0002330703,0.00016533559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013175394,0.000088016895,0.00032648048,0.00034117457,0.000055942975,0.000009942582,0.00007373264,0.000090146306,0.00006236171],"category_scores_gemma":[0.0006066401,0.000064795524,0.00006359093,0.0015592071,0.00022945002,0.00003483836,0.0000504239,0.00032663267,0.000024194851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011418348,0.00027305144,0.97702426,0.00027929991,0.000041531952,0.00043101935,0.00044267494,0.00028057737,0.000044077322,0.000064229025,0.0022117554,0.01776569],"study_design_scores_gemma":[0.00652026,0.0013474608,0.99074274,0.00015922297,0.0000646579,0.0000053012172,0.00029039395,0.00033965174,0.00016679114,0.0000638183,0.00023160694,0.00006810624],"about_ca_topic_score_codex":0.008577806,"about_ca_topic_score_gemma":0.0011160776,"teacher_disagreement_score":0.017697584,"about_ca_system_score_codex":0.0002078094,"about_ca_system_score_gemma":0.0006521354,"threshold_uncertainty_score":0.99802417},"labels":[],"label_agreement":null},{"id":"W4367602020","doi":"10.1158/1078-0432.ccr-22-2595","title":"Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Hospital; Université de Montréal; University of Calgary; MEG-3 (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Ovarian cancer; Clinical trial; Confidence interval; Phases of clinical research; Cyclophosphamide; Population; Progressive disease; Surgery; Cancer; Randomized controlled trial; Gastroenterology; Chemotherapy","score_opus":0.34198666322784144,"score_gpt":0.5729524062175213,"score_spread":0.23096574298967987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367602020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859231,0.0018993113,0.0000059024132,0.0064567174,0.0012168061,0.004030192,0.00011565138,0.000110338355,0.00024198278],"genre_scores_gemma":[0.9892238,0.0051079732,0.00026860763,0.0008000084,0.001556787,0.0020829062,0.00010277567,0.00011052061,0.00074665603],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9933782,0.0010459559,0.0018933588,0.0012147585,0.0013705373,0.0010971901],"domain_scores_gemma":[0.99563193,0.0018816967,0.00035131956,0.0007971989,0.00074148894,0.0005963608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008491022,0.0003302286,0.0010966952,0.00046116827,0.0004592009,0.00009882063,0.00032909968,0.00032939372,0.00089921814],"category_scores_gemma":[0.0012435196,0.00026069107,0.00022903687,0.0016080533,0.0007715551,0.00016049792,0.00018907392,0.0022781529,0.000024877158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26323843,0.006463065,0.34813917,0.00017528779,0.00022705123,0.00004377717,0.00042538578,0.000030153506,0.00020941184,0.000027192025,0.0038206459,0.37720042],"study_design_scores_gemma":[0.5411429,0.032767665,0.40007448,0.0035825705,0.00007468209,0.0000021921055,0.00023629155,0.0015843606,0.0005249038,0.00029548648,0.019070566,0.0006439149],"about_ca_topic_score_codex":0.0012361535,"about_ca_topic_score_gemma":0.00047854846,"teacher_disagreement_score":0.37655652,"about_ca_system_score_codex":0.00058547204,"about_ca_system_score_gemma":0.002914177,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W4367840089","doi":"10.1158/1078-0432.ccr-23-0252","title":"Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute on Deafness and Other Communication Disorders; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Medicine; Acetylcysteine; Cisplatin; Adverse effect; Ototoxicity; Confidence interval; Internal medicine; Surgery; Chemotherapy; Antioxidant","score_opus":0.33838107767748327,"score_gpt":0.5554029596086443,"score_spread":0.217021881931161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367840089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872251,0.00006730654,0.000043160013,0.002732098,0.00089351216,0.008437432,0.000030912543,0.00015887091,0.00041160974],"genre_scores_gemma":[0.99455863,0.00043641607,0.000078937774,0.0005472849,0.0013436072,0.0016869663,0.0000053164053,0.00008452191,0.001258312],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98901856,0.004006962,0.0020349834,0.0014638773,0.0017643159,0.0017112797],"domain_scores_gemma":[0.9911117,0.0067412197,0.00019496206,0.0009730925,0.00022502223,0.00075401383],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015137403,0.00031458391,0.0014482368,0.0007073285,0.00030682105,0.00019176137,0.001005281,0.0003064905,0.0002851554],"category_scores_gemma":[0.033433124,0.00028652156,0.00034490757,0.0026864174,0.0003125817,0.00009022781,0.0008621537,0.0019954094,0.0007922676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6552825,0.0063664475,0.002493645,0.0000907672,0.00012961616,0.00053740403,0.0012193751,0.0010772437,0.2581268,0.00013880106,0.0021966782,0.07234073],"study_design_scores_gemma":[0.92283833,0.00913591,0.004032691,0.00031059142,0.00003809855,0.00001880548,0.00006866732,0.0054205605,0.05518739,0.00027325095,0.0020223341,0.0006533491],"about_ca_topic_score_codex":0.0006527823,"about_ca_topic_score_gemma":0.00027612058,"teacher_disagreement_score":0.26755586,"about_ca_system_score_codex":0.00031228777,"about_ca_system_score_gemma":0.0011702905,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W4376132428","doi":"10.1158/1078-0432.ccr-23-0447","title":"Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"Janssen Pharmaceuticals; Genentech; Ipsen; Eisai; Daiichi-Sankyo; Revolution Medicines; National Institutes of Health; ECOG-ACRIN Cancer Research Group; Chugai Pharmaceutical; Seagen; Agios Pharmaceuticals; Parker Institute for Cancer Immunotherapy; Novocure; Pharmavite; American College of Radiology Imaging Network; Celgene; Eli Lilly and Company; AstraZeneca; National Cancer Institute; Amylin Pharmaceuticals; Pfizer; Array BioPharma; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Colorectal cancer; Gastroenterology; Vitamin D and neurology; Proportional hazards model; Confidence interval; Oncology; Cancer","score_opus":0.33032852930551826,"score_gpt":0.5443492344998098,"score_spread":0.2140207051942915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376132428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98130065,0.002779152,0.0000028688057,0.012171646,0.00067178166,0.0013345061,0.0005870204,0.00012366113,0.0010286864],"genre_scores_gemma":[0.95116746,0.024178952,0.000055616045,0.00019642594,0.00079940725,0.00078725175,0.000046166995,0.000077758654,0.02269093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99275976,0.00092007354,0.0010529661,0.001341977,0.002171199,0.0017540358],"domain_scores_gemma":[0.991655,0.0062548993,0.000094906834,0.00068794115,0.00053790415,0.00076933845],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007321893,0.00033525613,0.0012500818,0.00046537683,0.0003725993,0.00009540459,0.00053994486,0.0004421216,0.0011610712],"category_scores_gemma":[0.0055578263,0.00028835307,0.00016779057,0.0021547666,0.001733474,0.00016665588,0.0012127784,0.0029262123,0.0002974271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007207715,0.0003094348,0.9304706,0.00045902657,0.00032241942,0.0011699467,0.0011717412,0.000023490773,0.004472245,0.000105797844,0.04073739,0.020037154],"study_design_scores_gemma":[0.007922809,0.00071024976,0.9628303,0.0008089837,0.000031351603,0.0000013857484,0.0012671857,0.0017497075,0.0010746109,0.0002031491,0.023107307,0.00029294024],"about_ca_topic_score_codex":0.013933806,"about_ca_topic_score_gemma":0.01944467,"teacher_disagreement_score":0.03235974,"about_ca_system_score_codex":0.0007806019,"about_ca_system_score_gemma":0.0012927878,"threshold_uncertainty_score":0.99995685},"labels":[],"label_agreement":null},{"id":"W4376640530","doi":"10.1158/1078-0432.ccr-23-0652","title":"An Attempt to Stretch the Benefit: Rechallenge with PARP Inhibitors in Ovarian Cancer","year":2023,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Ovarian cancer; Poly ADP ribose polymerase; Synthetic lethality; PARP inhibitor; Medicine; Homologous recombination; BRCA mutation; Cancer; Cancer research; Oncology; Internal medicine; Biology; DNA repair; Genetics; Gene; Polymerase","score_opus":0.29480428928941865,"score_gpt":0.5911166845717124,"score_spread":0.29631239528229375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376640530","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05447722,0.0045248335,0.000007449843,0.061317116,0.871847,0.0048937122,0.0015966555,0.00027911947,0.0010568913],"genre_scores_gemma":[0.019350871,0.027371073,0.00008526603,0.00093989604,0.9402401,0.007490422,0.00031600543,0.00046679156,0.0037396161],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98821455,0.0014664301,0.0017010252,0.0021983078,0.004687482,0.001732183],"domain_scores_gemma":[0.9856052,0.008425736,0.00031830647,0.0023812845,0.0021428145,0.001126665],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.010959757,0.0006401838,0.0015648444,0.00073088077,0.00033496734,0.00017414086,0.0013622185,0.001967872,0.0014252199],"category_scores_gemma":[0.0029102694,0.00043658557,0.0002929233,0.0028326854,0.0009165653,0.00015213639,0.0003669967,0.009534179,0.00031748452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005620459,0.00037749077,0.006107424,0.0003017003,0.00026275567,0.0002353458,0.00069526926,0.00009876369,0.000052038613,0.0000292261,0.95644116,0.029778386],"study_design_scores_gemma":[0.005528883,0.0031531486,0.0061141057,0.005008196,0.0000907982,0.0000015952783,0.0005462062,0.00003476119,0.00018815968,0.00035176627,0.97839224,0.0005901132],"about_ca_topic_score_codex":0.011533755,"about_ca_topic_score_gemma":0.048467208,"teacher_disagreement_score":0.06839306,"about_ca_system_score_codex":0.002385455,"about_ca_system_score_gemma":0.0070402618,"threshold_uncertainty_score":0.9998086},"labels":[],"label_agreement":null},{"id":"W4377940137","doi":"10.1158/1078-0432.ccr-23-0580","title":"The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; National Institutes of Health; Revolution Medicines; National Center for Advancing Translational Sciences; Seagen; Gilead Sciences; Sanofi; G1 Therapeutics; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; American Association for Cancer Research","keywords":"Medicine; Oncology; KRAS; Internal medicine; Cohort; Cancer; Lung cancer; Response Evaluation Criteria in Solid Tumors; Docetaxel; Confidence interval; Ramucirumab; Nivolumab; ROS1; Immunotherapy; Clinical trial; Adenocarcinoma; Phases of clinical research; Colorectal cancer","score_opus":0.1501539766493789,"score_gpt":0.5403167405984413,"score_spread":0.39016276394906235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377940137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780733,0.0019461566,0.000057301964,0.0022883767,0.0008091949,0.004283261,0.0009110528,0.000076608936,0.0018207205],"genre_scores_gemma":[0.9514829,0.019109769,0.0017188092,0.0005445356,0.0029486485,0.004221893,0.001115194,0.00015297078,0.018705266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960296,0.00042401813,0.0010525964,0.0010421401,0.0007270302,0.00072458026],"domain_scores_gemma":[0.9929143,0.0043304954,0.0002366183,0.001113347,0.00095772435,0.00044750457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046247025,0.00022283375,0.00063272164,0.00010432792,0.00087256666,0.00015774071,0.0004744186,0.00015162093,0.000036126457],"category_scores_gemma":[0.00075864914,0.00012191183,0.00014822365,0.0005751927,0.00064948754,0.000098812234,0.0005037863,0.0009453287,0.0000070079095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029467945,0.00018867316,0.90839356,0.00014962873,0.0006919736,0.000023870036,0.00012559483,0.000003879627,0.000033328783,0.000020921429,0.041587297,0.045834493],"study_design_scores_gemma":[0.010507156,0.0009707449,0.937008,0.00044211157,0.0008707983,8.9382684e-7,0.0002586092,0.0025871017,0.000037338792,0.000045400335,0.047069304,0.00020249373],"about_ca_topic_score_codex":0.0038156796,"about_ca_topic_score_gemma":0.011430324,"teacher_disagreement_score":0.045631997,"about_ca_system_score_codex":0.00043291372,"about_ca_system_score_gemma":0.0028044672,"threshold_uncertainty_score":0.67111653},"labels":[],"label_agreement":null},{"id":"W4377940540","doi":"10.1158/1078-0432.ccr-22-3929","title":"Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health; Incyte","keywords":"Downregulation and upregulation; Myeloid leukemia; Myeloid; Cancer research; PIM1; Medicine; Kinase; Cancer; Biology; Phosphorylation; Internal medicine; Biochemistry; Gene","score_opus":0.14336709991185606,"score_gpt":0.4944972494709286,"score_spread":0.3511301495590725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377940540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809311,0.00048074915,0.000028092396,0.015637623,0.00024871717,0.0020638267,0.000018160841,0.00013122389,0.00046048715],"genre_scores_gemma":[0.9917189,0.0005877122,0.00082450814,0.0005549246,0.0013514064,0.0013056205,0.000027204997,0.0000884509,0.0035412838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643975,0.00023810382,0.0006278274,0.0007393189,0.0010192429,0.00093576784],"domain_scores_gemma":[0.9983284,0.0003002511,0.000063858846,0.00045943,0.0003544429,0.000493638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039533083,0.00018504894,0.0005254749,0.00042653424,0.00013952915,0.00005191963,0.00023560005,0.00019059464,0.00054004986],"category_scores_gemma":[0.00058266026,0.00013701535,0.00010349581,0.0022630417,0.00020589224,0.00007170568,0.00020599688,0.0010497195,0.00019122942],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02310419,0.0023712302,0.1147148,0.001253255,0.0006818609,0.0027038683,0.0050067916,0.001271223,0.2373673,0.0032811954,0.087938406,0.5203059],"study_design_scores_gemma":[0.018372437,0.018861568,0.16337475,0.0064905784,0.00007068193,0.000024225905,0.0020453772,0.0022701041,0.08804203,0.0047068144,0.6943055,0.0014359383],"about_ca_topic_score_codex":0.0022815212,"about_ca_topic_score_gemma":0.0017810398,"teacher_disagreement_score":0.6063671,"about_ca_system_score_codex":0.00028688536,"about_ca_system_score_gemma":0.0007990555,"threshold_uncertainty_score":0.5913167},"labels":[],"label_agreement":null},{"id":"W4378746656","doi":"10.1158/1078-0432.ccr-22-3971","title":"The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"Nanfang Hospital; Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Haloperidol; Autophagy; Endoplasmic reticulum; Temozolomide; Antagonist; Glioblastoma; Pharmacology; Medicine; Cancer research; Internal medicine; Chemistry; Biology; Receptor; Cell biology; Dopamine; Apoptosis","score_opus":0.09647110070336866,"score_gpt":0.45152724862333127,"score_spread":0.3550561479199626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378746656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701869,0.00044842347,0.0000011889144,0.02632837,0.00052527804,0.001841583,0.00014391205,0.00018630517,0.00033804445],"genre_scores_gemma":[0.9943611,0.0021270136,0.000023224951,0.0005892165,0.000702724,0.0012837908,0.000028257444,0.00008754034,0.000797134],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9922465,0.0023333794,0.0011927128,0.0011468645,0.0015147319,0.0015658245],"domain_scores_gemma":[0.99299866,0.0045108567,0.0001451654,0.00084565184,0.0005650204,0.0009346316],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012434122,0.0003280576,0.00081521115,0.00032256398,0.00066220085,0.000216845,0.00045295944,0.0003144114,0.00012388422],"category_scores_gemma":[0.008775333,0.00023611351,0.00024552073,0.002527776,0.0006047429,0.000116666386,0.0006789549,0.0020002036,0.00031551576],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069741914,0.0015630967,0.49247283,0.00066181435,0.00034772212,0.0010988037,0.0015582438,0.000038339756,0.2449917,0.000061188024,0.086119026,0.16411306],"study_design_scores_gemma":[0.0050305543,0.0036882896,0.17329484,0.0016605011,0.000096174095,0.00003117176,0.00272845,0.0095994,0.78609663,0.00005665028,0.017003182,0.0007141214],"about_ca_topic_score_codex":0.004552423,"about_ca_topic_score_gemma":0.006543739,"teacher_disagreement_score":0.541105,"about_ca_system_score_codex":0.00046899598,"about_ca_system_score_gemma":0.00097309286,"threshold_uncertainty_score":0.9995742},"labels":[],"label_agreement":null},{"id":"W4379535356","doi":"10.1158/1078-0432.ccr-22-3897","title":"A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; iCo Therapeutics (Canada); University of British Columbia","funders":"Mitacs; National Research Council Canada; St. Baldrick's Foundation","keywords":"Olaparib; PARP inhibitor; PARP1; Cancer research; DNA damage; Vorinostat; Biology; Comet assay; Ex vivo; Histone deacetylase; Poly ADP ribose polymerase; Molecular biology; In vivo; Biochemistry; Histone; DNA","score_opus":0.4469852012513099,"score_gpt":0.5868546534968304,"score_spread":0.1398694522455205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379535356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98243815,0.00026468723,0.000035689365,0.013575564,0.0004493824,0.00065080414,0.000026650689,0.00014478112,0.002414271],"genre_scores_gemma":[0.9934936,0.000851754,0.00009900806,0.0006268729,0.0016400894,0.0006445778,0.000016265965,0.00004871669,0.002579097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628747,0.0005120301,0.0004750904,0.00065544,0.0013247391,0.00074525044],"domain_scores_gemma":[0.9971468,0.0016293399,0.0000666047,0.0004592418,0.00036210797,0.0003359052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004031973,0.00015236446,0.0004401956,0.0004873792,0.0001565259,0.000034918707,0.00015881527,0.00019859757,0.0009011696],"category_scores_gemma":[0.0006078214,0.000120681885,0.00012466805,0.0024041103,0.0006010743,0.00014074956,0.0001263522,0.001712104,0.00044107097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0141017875,0.0009573043,0.8148704,0.00030388587,0.00017179959,0.00061846804,0.000270029,0.00006789815,0.012043083,0.00025551996,0.0691185,0.08722132],"study_design_scores_gemma":[0.010889672,0.0018681681,0.9064074,0.0011084208,0.000018063718,0.000022319087,0.00020437202,0.0007166299,0.007845671,0.0008762182,0.06976475,0.00027827887],"about_ca_topic_score_codex":0.00044394383,"about_ca_topic_score_gemma":0.00040858777,"teacher_disagreement_score":0.091537036,"about_ca_system_score_codex":0.0005384676,"about_ca_system_score_gemma":0.0013893822,"threshold_uncertainty_score":0.9867176},"labels":[],"label_agreement":null},{"id":"W4380992939","doi":"10.1158/1078-0432.ccr-23-0797","title":"Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Eisai; Seagen; Ontario Institute for Cancer Research; Novocure; Regeneron Pharmaceuticals; Princess Margaret Cancer Foundation; Genentech; PharmaMar; AstraZeneca","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Cancer research; Cancer; Medicine; Oncology; DNA; Pharmacology; Internal medicine; Poly ADP ribose polymerase; Biology; Genetics; Polymerase","score_opus":0.2764266495127368,"score_gpt":0.565274280103611,"score_spread":0.2888476305908742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380992939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916794,0.0015400782,0.00027820762,0.000951237,0.0006627017,0.003915971,0.0007407492,0.000052311516,0.00017935707],"genre_scores_gemma":[0.9943608,0.00052522,0.00077521167,0.00007176474,0.0006292227,0.001945934,0.000101102254,0.000078838035,0.0015119244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940232,0.0005289482,0.0022475668,0.000760699,0.0017071825,0.0007323881],"domain_scores_gemma":[0.9955599,0.001747357,0.00082314276,0.00061725447,0.0009932106,0.00025915474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069999634,0.00022561793,0.0012799696,0.00045094694,0.00018213126,0.000012216259,0.00033606015,0.0002772786,0.0005256517],"category_scores_gemma":[0.002080801,0.00020853772,0.00035876044,0.0017119077,0.0005917461,0.0001270787,0.00026731845,0.0006680423,0.0000067508986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1658381,0.0015660763,0.0007436206,0.0021754345,0.00018636903,0.000031583062,0.0009878214,0.000026511234,0.80080307,0.00020243599,0.020839365,0.006599613],"study_design_scores_gemma":[0.2813635,0.0077798655,0.0011683006,0.010134283,0.00013902165,0.0000024817384,0.0004617761,0.0036558479,0.68759215,0.0036362761,0.0036497456,0.00041673635],"about_ca_topic_score_codex":0.00032235557,"about_ca_topic_score_gemma":0.0002402669,"teacher_disagreement_score":0.11552541,"about_ca_system_score_codex":0.0007796123,"about_ca_system_score_gemma":0.0016572012,"threshold_uncertainty_score":0.85039216},"labels":[],"label_agreement":null},{"id":"W4381434619","doi":"10.1158/1078-0432.ccr-22-3815","title":"The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Occupational Cancer Research Centre; Vancouver General Hospital; University of British Columbia","funders":"U.S. Army Medical Research and Development Command; National Cancer Institute; AstraZeneca; Novocure; National Health and Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Janet D. Cottrelle Foundation; Medical Research Council; PharmaMar; Medical Research and Materiel Command; Eisai; European Commission; BC Cancer Foundation; Seagen; Deutsche Forschungsgemeinschaft; VGH and UBC Hospital Foundation; Marshfield Clinic Research Foundation; Amgen; Mersana Therapeutics; Stryker; Victorian Cancer Agency; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center","keywords":"Immune system; Serous fluid; Biology; Serous carcinoma; Clear cell; Carcinoma; Clear cell carcinoma; Ovarian carcinoma; Pathology; Cancer research; Immunohistochemistry; Ovarian cancer; Immunology; Medicine; Cancer","score_opus":0.10071752740082382,"score_gpt":0.4737054319116363,"score_spread":0.37298790451081243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381434619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101627,0.0037555692,0.0000024803853,0.0017473707,0.00031866308,0.0011711925,0.000007730312,0.000026565862,0.0019541513],"genre_scores_gemma":[0.9959012,0.002978711,0.00000622212,0.000066361485,0.00012780065,0.0002695658,0.000019328023,0.000025811036,0.0006049516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667287,0.0009968863,0.0007055794,0.0003294552,0.0008192979,0.00047589585],"domain_scores_gemma":[0.99278516,0.0063094404,0.000103105776,0.00051421934,0.00018536269,0.00010274405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008911067,0.000121424026,0.00037583118,0.00040379952,0.000111981,0.000027376444,0.00025323985,0.00015849565,0.00009622548],"category_scores_gemma":[0.003392447,0.00007755837,0.00021920244,0.0024846662,0.00037059988,0.000029446092,0.00007798142,0.0008629229,0.000055298864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034426346,0.0003547995,0.6502146,0.0004746641,0.00019223739,0.00025121297,0.00016045611,0.000027803697,0.17926033,0.00013525874,0.0012825375,0.13321972],"study_design_scores_gemma":[0.0071021225,0.0059280363,0.84513974,0.00025786372,0.00003180145,0.000002761073,0.00006002737,0.00013191589,0.1372023,0.00006163595,0.003981125,0.00010065122],"about_ca_topic_score_codex":0.0011495432,"about_ca_topic_score_gemma":0.00019979484,"teacher_disagreement_score":0.19492513,"about_ca_system_score_codex":0.00016433687,"about_ca_system_score_gemma":0.00052060385,"threshold_uncertainty_score":0.4061321},"labels":[],"label_agreement":null},{"id":"W4381597538","doi":"10.1158/1078-0432.ccr-23-0563","title":"Assessment of Homologous Recombination Deficiency in Ovarian Cancer","year":2023,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Ovarian cancer; Homologous recombination; Homologous chromosome; Biomarker; Chemotherapy; Medicine; Cancer; Oncology; Cancer research; Internal medicine; Biology; Genetics; DNA; Gene","score_opus":0.42896126329092593,"score_gpt":0.6229724124775339,"score_spread":0.19401114918660795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381597538","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033041768,0.002750585,0.00005116743,0.9451723,0.004051446,0.0024517875,0.00037514156,0.00010586487,0.011999912],"genre_scores_gemma":[0.2792708,0.074920334,0.001130518,0.5402228,0.025832739,0.012776034,0.0013510151,0.00083051494,0.0636652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926214,0.0014614915,0.0016966548,0.0010904109,0.0021642146,0.0009658346],"domain_scores_gemma":[0.9946514,0.0026602505,0.00041027117,0.00095415494,0.0011627256,0.00016121929],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006686168,0.00029250386,0.0012222634,0.001118346,0.00009451629,0.000029523737,0.0005405081,0.0014746492,0.0024741131],"category_scores_gemma":[0.00083366997,0.00027242006,0.00033902813,0.0020030097,0.00084895664,0.00006652172,0.00020298289,0.008258368,0.00008718916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020506173,0.00035384315,0.050862532,0.0010069992,0.00011169409,0.0006141861,0.00006162646,0.000021632022,0.00021894342,0.00012116195,0.9353174,0.01110493],"study_design_scores_gemma":[0.00972134,0.0024164722,0.47075894,0.005348297,0.00014099636,0.00002080599,0.00007934561,0.00032149348,0.0005826338,0.0056761247,0.5042464,0.0006871445],"about_ca_topic_score_codex":0.004006858,"about_ca_topic_score_gemma":0.0006914363,"teacher_disagreement_score":0.43107098,"about_ca_system_score_codex":0.0021016067,"about_ca_system_score_gemma":0.0050104265,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W4382138807","doi":"10.1158/1078-0432.ccr-22-3915","title":"Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency; University of British Columbia Hospital; McGill University Health Centre","funders":"Eisai; AstraZeneca","keywords":"Endometrial cancer; Microsatellite instability; Medicine; Internal medicine; Interim analysis; Biomarker; Cancer; Interim; Oncology; Clinical trial; Microsatellite; Biology; Gene","score_opus":0.39387890691050975,"score_gpt":0.5904624695724283,"score_spread":0.19658356266191856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382138807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955079,0.0006233668,3.4613217e-7,0.00078261335,0.0002718484,0.0019913623,0.00049226097,0.000013957149,0.00031637627],"genre_scores_gemma":[0.99825054,0.0012420977,0.000010732679,0.000031864034,0.0001001474,0.000121674435,0.00004076104,0.00002214708,0.00018004907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564034,0.0008445835,0.0012122593,0.0005436912,0.0013377761,0.00042137876],"domain_scores_gemma":[0.9952077,0.003248407,0.00025482182,0.0005530631,0.0005302729,0.0002057204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029286514,0.00016867384,0.0008938332,0.0006589858,0.00007705974,0.000012779073,0.00028653172,0.00010341033,0.00018430079],"category_scores_gemma":[0.0038424877,0.00009144069,0.00014042453,0.0051342417,0.0007357614,0.000048356655,0.00040917963,0.00053232827,0.0000034268448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13339622,0.0051284134,0.7663062,0.000102614824,0.0006104434,0.000018421973,0.00020957294,0.0000088906245,0.00025434748,0.0000017284199,0.00046235125,0.093500756],"study_design_scores_gemma":[0.1250476,0.009539286,0.86343956,0.00034963957,0.00018449858,1.759868e-7,0.00020325229,0.00002046173,0.00074512017,0.000012211641,0.00038029224,0.000077877],"about_ca_topic_score_codex":0.0071908794,"about_ca_topic_score_gemma":0.0010574623,"teacher_disagreement_score":0.09713334,"about_ca_system_score_codex":0.00017878714,"about_ca_system_score_gemma":0.00043199264,"threshold_uncertainty_score":0.99942034},"labels":[],"label_agreement":null},{"id":"W4382363527","doi":"10.1158/1078-0432.ccr-22-3146","title":"Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Osimertinib; Lung cancer; Erlotinib; Medicine; T790M; Gefitinib; Internal medicine; Oncology; Epidermal growth factor receptor; Tyrosine-kinase inhibitor; Confidence interval; Genotyping; Cancer; Genotype; Biology","score_opus":0.1159411974898816,"score_gpt":0.4822468623266429,"score_spread":0.3663056648367613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382363527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513924,0.00094264507,0.000012636777,0.0011901249,0.00025155075,0.001098671,0.0010165329,0.000042609994,0.000305976],"genre_scores_gemma":[0.99565005,0.0023210272,0.00022190163,0.00013002884,0.00014873466,0.00065598876,0.00011309213,0.000044537264,0.00071465387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644893,0.00034059767,0.0012340534,0.00069544563,0.0007732345,0.0005077632],"domain_scores_gemma":[0.99632347,0.0020034201,0.00030363022,0.00045666532,0.0005642827,0.00034851415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007296104,0.00021842914,0.000965529,0.0006733413,0.000102403064,0.000019119572,0.00021482055,0.00019233642,0.00033034856],"category_scores_gemma":[0.00075259095,0.00018743199,0.00026872498,0.0024068533,0.00037887858,0.00014883318,0.00010722721,0.0007296068,0.000029889494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019049877,0.00042861604,0.98623675,0.00029780003,0.00086891913,0.000029620125,0.002634131,0.00037635054,0.0022133782,0.00001909329,0.00046320522,0.004527135],"study_design_scores_gemma":[0.006259111,0.0009702265,0.9819222,0.00047649353,0.0006312671,1.4643983e-7,0.0008230351,0.0016776964,0.006773418,0.00006034795,0.0002374336,0.00016861151],"about_ca_topic_score_codex":0.0064177797,"about_ca_topic_score_gemma":0.0014086684,"teacher_disagreement_score":0.0050091115,"about_ca_system_score_codex":0.0002638791,"about_ca_system_score_gemma":0.00082799915,"threshold_uncertainty_score":0.97018063},"labels":[],"label_agreement":null},{"id":"W4384120297","doi":"10.1158/1078-0432.ccr-22-3273","title":"Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"National Natural Science Foundation of China","keywords":"Mesenchymal stem cell; Cancer research; Paracrine signalling; Biology; Tumor microenvironment; PI3K/AKT/mTOR pathway; Tumor progression; Reprogramming; Stem cell; STAT3; Signal transduction; Cell; Cell biology; Cancer; Receptor; Genetics; Tumor cells","score_opus":0.0687867065602474,"score_gpt":0.409275471952482,"score_spread":0.3404887653922346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991718,0.0065611335,5.865928e-7,0.00030680277,0.0006556598,0.00038907406,0.00013240213,0.000028390265,0.00020796293],"genre_scores_gemma":[0.9948619,0.00217356,0.0000035070886,0.00005028726,0.00003358838,0.00007172031,0.0000051937495,0.000028911649,0.002771356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99573386,0.001921656,0.000925644,0.0004258427,0.00021481996,0.0007781552],"domain_scores_gemma":[0.9950923,0.0039080926,0.00024771836,0.0004166461,0.00029736123,0.00003789041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006696626,0.00015308394,0.0005584395,0.00025132825,0.00014886147,0.000013805204,0.00047451965,0.00021003629,0.00027588703],"category_scores_gemma":[0.00037651922,0.00011671893,0.00011283456,0.0009988656,0.0019262239,0.00005218268,0.00071931264,0.001403713,0.00010177232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004582276,0.0005210321,0.102003396,0.00022610756,0.0007242054,0.00014795572,0.005413592,0.0004590012,0.7915697,0.0002768964,0.012484899,0.0815909],"study_design_scores_gemma":[0.005928179,0.0023898869,0.15801574,0.0005422406,0.000047287405,0.000012949133,0.007829734,0.00029110958,0.8092876,0.001642195,0.013619816,0.00039321763],"about_ca_topic_score_codex":0.0009916987,"about_ca_topic_score_gemma":0.00075017824,"teacher_disagreement_score":0.08119769,"about_ca_system_score_codex":0.00011108671,"about_ca_system_score_gemma":0.00041677261,"threshold_uncertainty_score":0.7097252},"labels":[],"label_agreement":null},{"id":"W4384126750","doi":"10.1158/1078-0432.ccr-23-0731","title":"Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; London Health Sciences Centre; Western University; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Cabazitaxel; Medicine; Prostate cancer; Abiraterone acetate; Prostatectomy; Urology; Neoadjuvant therapy; Interquartile range; Internal medicine; Taxane; Cancer; Oncology; Surgery; Androgen deprivation therapy","score_opus":0.14416452154978565,"score_gpt":0.49555460349638536,"score_spread":0.3513900819465997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384126750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98495567,0.0014039697,9.874822e-7,0.0055694305,0.0010002026,0.005831669,0.0010068113,0.00013500715,0.000096254735],"genre_scores_gemma":[0.97095233,0.020446097,0.000057758607,0.00033932523,0.0008031254,0.004622237,0.00033324215,0.00011893721,0.0023269316],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99360234,0.000615786,0.00135816,0.0013032813,0.0015576086,0.0015628495],"domain_scores_gemma":[0.99664724,0.00077607564,0.00031818874,0.000850354,0.0006657857,0.0007423311],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029101516,0.0004164335,0.001216163,0.00045188368,0.00035848847,0.000082352846,0.0003378242,0.00024064338,0.0003646361],"category_scores_gemma":[0.00064391707,0.0002923583,0.00020145529,0.0014150573,0.0005985686,0.00021307435,0.000401126,0.0016707534,0.00021954351],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23455137,0.0047585135,0.540202,0.00021536407,0.00053418305,0.0005245181,0.0008531045,0.00034976235,0.000030268246,0.000017215309,0.01740697,0.2005567],"study_design_scores_gemma":[0.5098627,0.041265268,0.42670357,0.0012026556,0.00027381032,0.0000011919976,0.00017753887,0.0003962939,0.0009786524,0.00026528715,0.018331802,0.0005411777],"about_ca_topic_score_codex":0.009481496,"about_ca_topic_score_gemma":0.0032138042,"teacher_disagreement_score":0.27531138,"about_ca_system_score_codex":0.0015244447,"about_ca_system_score_gemma":0.0023275113,"threshold_uncertainty_score":0.99995285},"labels":[],"label_agreement":null},{"id":"W4384338565","doi":"10.1158/1078-0432.ccr-22-3645","title":"Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Stand Up To Cancer; Kom op tegen Kanker; KWF Kankerbestrijding; H2020 European Research Council; Genentech; Fonds Wetenschappelijk Onderzoek; European Commission","keywords":"Breast cancer; CD8; Involution (esoterism); Medicine; Lactation; Breastfeeding; Mammary gland; Metastasis; Oncology; Immunohistochemistry; Internal medicine; Cancer; Pathology; Immune system; Immunology; Pregnancy; Biology","score_opus":0.1374312629244737,"score_gpt":0.4961736187855473,"score_spread":0.3587423558610736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384338565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868434,0.0009856593,2.0454952e-7,0.010714344,0.00018788298,0.0006046992,0.00038084362,0.00005973238,0.0002232446],"genre_scores_gemma":[0.9957853,0.0015279294,0.0000026085659,0.0008243321,0.00009959828,0.000190847,0.000052915115,0.000038762995,0.0014776844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724174,0.00025086463,0.00047577385,0.0005690078,0.0007743894,0.0006882153],"domain_scores_gemma":[0.9984547,0.0005018721,0.00009017514,0.00028282116,0.0004092674,0.0002611683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011714926,0.00017821147,0.00055183715,0.00023087292,0.000107179294,0.000043302603,0.00016545992,0.0002247905,0.0003450317],"category_scores_gemma":[0.00077269616,0.00012223735,0.00009916614,0.0011304542,0.0004846899,0.000056648587,0.00020914074,0.0012494513,0.000025860285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014327408,0.00023746239,0.9813283,0.000052799023,0.000119626966,0.00014903994,0.00010166368,0.000001730954,0.000080193284,0.0000073669676,0.00499822,0.011490819],"study_design_scores_gemma":[0.0035510398,0.0006768779,0.9940354,0.0003438398,0.000037686565,0.0000029836128,0.00007939753,0.00004012889,0.00007916374,0.00004801611,0.0009544009,0.00015106786],"about_ca_topic_score_codex":0.006293885,"about_ca_topic_score_gemma":0.0020282888,"teacher_disagreement_score":0.012707061,"about_ca_system_score_codex":0.00036261318,"about_ca_system_score_gemma":0.0003666732,"threshold_uncertainty_score":0.9514513},"labels":[],"label_agreement":null},{"id":"W4384664196","doi":"10.1158/1078-0432.ccr-22-3493","title":"Learning Individual Survival Models from PanCancer Whole Transcriptome Data","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Alberta Health; University of Alberta; Northern Alberta Institute of Technology","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research","keywords":"Non-negative matrix factorization; Computer science; Probabilistic logic; Survival analysis; Cancer; Artificial intelligence; Logistic regression; Concordance; Machine learning; Matrix decomposition; Medicine; Internal medicine","score_opus":0.6870446561583559,"score_gpt":0.5744614016642153,"score_spread":0.11258325449414053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384664196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761439,0.0038017028,0.00008509129,0.013713077,0.0012312422,0.00069452694,0.0011404542,0.00032668232,0.0028633107],"genre_scores_gemma":[0.98041886,0.010944988,0.00014186873,0.0005615471,0.0024916846,0.00031873074,0.0012157531,0.000090767826,0.0038158037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994062,0.00079159666,0.0007793497,0.0012705061,0.0020792102,0.0010173066],"domain_scores_gemma":[0.99639523,0.001237351,0.00008214438,0.0013193062,0.00041537354,0.0005506225],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006355799,0.0002171227,0.0007289148,0.00023500095,0.00030692204,0.00012736784,0.0010874821,0.00030864985,0.0016737015],"category_scores_gemma":[0.0007788307,0.00018655797,0.00020592968,0.0015272942,0.00051592937,0.00032753826,0.0008418991,0.002458981,0.0006413723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020873696,0.00060668355,0.32686132,0.00024911558,0.0010080007,0.00015046306,0.0014784746,0.00050322147,0.0021160005,0.00016796264,0.2194219,0.44534948],"study_design_scores_gemma":[0.006776317,0.0015349146,0.41127983,0.0007646032,0.00035180882,0.0000018845536,0.0027191695,0.027864857,0.00041421226,0.0017567099,0.54593676,0.0005989654],"about_ca_topic_score_codex":0.0027312164,"about_ca_topic_score_gemma":0.0005428542,"teacher_disagreement_score":0.44475052,"about_ca_system_score_codex":0.00013911385,"about_ca_system_score_gemma":0.0010216382,"threshold_uncertainty_score":0.9998424},"labels":[],"label_agreement":null},{"id":"W4384923460","doi":"10.1158/1078-0432.ccr-23-0757","title":"Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception","year":2023,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Oncology; Disease; Clinical trial; Internal medicine; Minimal residual disease; Cancer; Immunotherapy; Leukemia","score_opus":0.20596612864847821,"score_gpt":0.5311124960904527,"score_spread":0.32514636744197456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384923460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01602953,0.9818694,0.000012387402,0.0003239737,0.00043872278,0.0008145912,0.00047565988,0.000013260035,0.000022480825],"genre_scores_gemma":[0.01002697,0.98730606,0.0000031866068,0.00011389251,0.0012465104,0.00093202345,0.000101488964,0.00009785891,0.00017198842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968687,0.0007078464,0.0007013083,0.0009218637,0.0003123059,0.00048796262],"domain_scores_gemma":[0.9985829,0.00030139546,0.00013906618,0.00051503646,0.00016988225,0.00029174698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014974753,0.00027931997,0.00071009324,0.00023132603,0.00008445216,0.00007760613,0.00033838552,0.0004813518,0.00003597288],"category_scores_gemma":[0.00033213614,0.0002537248,0.00027010308,0.00042476994,0.0003320431,0.0000027182907,0.00050252664,0.00090689486,0.000028378108],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002502868,0.00006346421,0.0007504187,0.0024684626,0.00012709125,0.000030161447,0.000007790676,0.000020922384,0.00010879782,0.000015929836,0.0005156149,0.99564105],"study_design_scores_gemma":[0.00075909187,0.00029070172,0.0056323144,0.0055040573,0.00029249565,0.0000074272148,0.000022718094,0.00007053364,0.00002891646,0.00029553907,0.98653895,0.0005572733],"about_ca_topic_score_codex":0.00090937904,"about_ca_topic_score_gemma":0.0019856172,"teacher_disagreement_score":0.9950838,"about_ca_system_score_codex":0.00021028097,"about_ca_system_score_gemma":0.0011925352,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W4384926137","doi":"10.1158/1078-0432.ccr-23-1044","title":"A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; Varian Medical Systems; AstraZeneca; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Toxicity; Confidence interval; Hepatocellular carcinoma; Liver function; Cumulative incidence; Internal medicine; Liver cancer; Phases of clinical research; Radiation therapy; Nuclear medicine; Urology; Oncology; Gastroenterology; Cohort","score_opus":0.522405078117951,"score_gpt":0.5322347014615424,"score_spread":0.009829623343591387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384926137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971766,0.0018043781,0.000105085805,0.0011224458,0.00019648681,0.006645542,0.00013129888,0.00010157531,0.00017554873],"genre_scores_gemma":[0.99250513,0.0008147481,0.0013091952,0.000076468255,0.0004480282,0.0030737522,0.00010743628,0.000077051234,0.0015881623],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955935,0.00089672365,0.0009909851,0.0007377145,0.0010509035,0.00073015696],"domain_scores_gemma":[0.99613535,0.0018682001,0.00015887056,0.00067384116,0.0007459937,0.00041776442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005070442,0.0002381962,0.0011118728,0.00050357706,0.0003122545,0.000022338314,0.0003033838,0.00023362656,0.0004250205],"category_scores_gemma":[0.0006320642,0.00019234014,0.000487482,0.0014273927,0.00033516466,0.000060406303,0.000190071,0.0005731551,0.000022684277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026679363,0.014233525,0.8886971,0.00019177292,0.0015656012,0.00040474083,0.0035244718,0.0000037092493,0.0014639228,0.000061879226,0.009761099,0.053412803],"study_design_scores_gemma":[0.43143398,0.29363522,0.05576133,0.00047900074,0.001798015,0.000013051041,0.0069421986,0.1537222,0.015098852,0.00054009137,0.0395569,0.0010191546],"about_ca_topic_score_codex":0.00057813356,"about_ca_topic_score_gemma":0.000021468935,"teacher_disagreement_score":0.8329358,"about_ca_system_score_codex":0.00015500975,"about_ca_system_score_gemma":0.0007053847,"threshold_uncertainty_score":0.7843403},"labels":[],"label_agreement":null},{"id":"W4385264542","doi":"10.1158/1078-0432.ccr-23-0092","title":"Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Pharmacokinetics; Dosing; Toxicity; Internal medicine; Refractory (planetary science); Oncology; Pharmacology; Gastroenterology","score_opus":0.1257635174782911,"score_gpt":0.530262130136968,"score_spread":0.4044986126586769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968251,0.00059733674,0.000025819854,0.0004357386,0.00019373263,0.0017682412,0.00003834308,0.000023909104,0.0000917787],"genre_scores_gemma":[0.9974884,0.0004671471,0.00004067391,0.000018899449,0.00042887943,0.0007605633,0.00006950418,0.00004352483,0.00068242307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964968,0.0007325069,0.0009103553,0.0007202125,0.00060629676,0.00053383154],"domain_scores_gemma":[0.99864286,0.00014124917,0.00010334458,0.0005901838,0.00035150954,0.00017086309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030370955,0.00016436228,0.00041400426,0.00029482215,0.00007258435,0.000014345288,0.0003169209,0.00022867271,0.0000611224],"category_scores_gemma":[0.0008501022,0.00016151238,0.00012355002,0.0013537033,0.0002545275,0.00000836544,0.00019918998,0.00060607615,0.000019306532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004314002,0.0028899116,0.0059174523,0.00009327532,0.00011166458,0.000038391136,0.00031400562,0.0025902083,0.92216223,0.00001068397,0.0014527573,0.06010542],"study_design_scores_gemma":[0.031465996,0.019587765,0.022736639,0.00039448604,0.000033002194,0.0000022586698,0.0015606768,0.0013876798,0.9139119,0.00026337404,0.008099556,0.00055670016],"about_ca_topic_score_codex":0.00039205642,"about_ca_topic_score_gemma":0.0015362016,"teacher_disagreement_score":0.05954872,"about_ca_system_score_codex":0.00007251139,"about_ca_system_score_gemma":0.0006203917,"threshold_uncertainty_score":0.65862834},"labels":[],"label_agreement":null},{"id":"W4385294482","doi":"10.1158/1078-0432.ccr-23-0348","title":"A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Matthew Larson Foundation for Pediatric Brain Tumors","keywords":"Medicine; Medulloblastoma; Radiation therapy; Chemotherapy; Clinical endpoint; Surgery; Pediatrics; Randomized controlled trial; Pathology","score_opus":0.22181997310335447,"score_gpt":0.5000883141730914,"score_spread":0.27826834106973697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940947,0.00037334888,2.1910606e-7,0.0024205109,0.00005871536,0.0029156446,0.0000140125585,0.000035069275,0.000087774315],"genre_scores_gemma":[0.9964535,0.0016045363,0.000014153429,0.000051881198,0.0002264902,0.0015479205,0.000029087454,0.000024481798,0.00004789711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711925,0.00075289764,0.00050023675,0.0004130763,0.0008059685,0.00040854907],"domain_scores_gemma":[0.9963739,0.0028115895,0.000096428244,0.00042645,0.00015927007,0.00013238011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018091868,0.00014089308,0.0004460387,0.00028157388,0.00010581017,0.000024824785,0.00015014443,0.000040330182,0.000060748927],"category_scores_gemma":[0.0005398293,0.000074785865,0.00008181776,0.0016480746,0.00018149361,0.000038713726,0.000032886423,0.00029531124,0.00003808863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018604841,0.012029234,0.9263841,0.000010539969,0.00035365668,0.00026580354,0.001194927,0.00004656419,0.00025041023,0.0000078546045,0.00058718305,0.05700926],"study_design_scores_gemma":[0.015571363,0.03677015,0.944578,0.000102390106,0.00008595563,0.000003440608,0.0011382267,0.000059462436,0.0014486507,0.000011596739,0.00016710619,0.000063657135],"about_ca_topic_score_codex":0.006980223,"about_ca_topic_score_gemma":0.0029451393,"teacher_disagreement_score":0.056945607,"about_ca_system_score_codex":0.00024366466,"about_ca_system_score_gemma":0.00030291575,"threshold_uncertainty_score":0.99963236},"labels":[],"label_agreement":null},{"id":"W4385294836","doi":"10.1158/1078-0432.ccr-23-0538","title":"Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Uppsala Multidisciplinary Center for Advanced Computational Science; National Cancer Institute; Radiumhemmets Forskningsfonder; Vetenskapsrådet; Karolinska Institutet; Associazione Italiana per la Ricerca sul Cancro; Cancerfonden; Knut och Alice Wallenbergs Stiftelse; Science for Life Laboratory; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"Transcriptome; Myelodysplastic syndromes; Biology; Myeloid; Genetics; NPM1; Computational biology; Cancer research; Bioinformatics; Gene; Oncology; Bone marrow; Medicine; Immunology; Gene expression; Karyotype; Chromosome","score_opus":0.16458143430260408,"score_gpt":0.4683414891179336,"score_spread":0.3037600548153295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635005,0.00065662706,0.00021998442,0.0018124359,0.0000196434,0.0007228602,0.00007992393,0.000051969277,0.00008652446],"genre_scores_gemma":[0.9893936,0.00956227,0.0002572522,0.000019066349,0.000078982484,0.0001520843,0.00008992801,0.000028826344,0.00041802568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726605,0.00052716624,0.00058219506,0.00063377054,0.0005999404,0.0003908801],"domain_scores_gemma":[0.9973818,0.0009877814,0.00012562994,0.00049575156,0.0005307798,0.00047825134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031090323,0.00013365116,0.0004557352,0.0006883318,0.00015188451,0.000055985445,0.00014543219,0.00012578066,0.00004950281],"category_scores_gemma":[0.0009244087,0.00009954645,0.000091954855,0.0021490217,0.0009927143,0.000101136604,0.00007662404,0.00093715155,0.000011484139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036706452,0.00012409082,0.856968,0.0003849085,0.001012633,0.000020324274,0.00034073472,0.000047814563,0.08112072,0.00017454241,0.0003396973,0.05579588],"study_design_scores_gemma":[0.0015224512,0.00038760636,0.9378579,0.00008923031,0.00052309217,0.0000010876681,0.0006479899,0.05796006,0.00062994915,0.00016190432,0.00012981001,0.00008892361],"about_ca_topic_score_codex":0.0012268351,"about_ca_topic_score_gemma":0.0008371522,"teacher_disagreement_score":0.08088989,"about_ca_system_score_codex":0.0001969247,"about_ca_system_score_gemma":0.000985996,"threshold_uncertainty_score":0.40715092},"labels":[],"label_agreement":null},{"id":"W4385442241","doi":"10.1158/1078-0432.ccr-23-0887","title":"hENT1 as a Predictive Biomarker in PDAC—Response","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Biomarker; Medicine; Oncology; FOLFIRINOX; Population; Biomarker discovery; Internal medicine; Computational biology; Bioinformatics; Biology; Cancer; Gene; Genetics; Colorectal cancer","score_opus":0.4565912749497369,"score_gpt":0.650337593659994,"score_spread":0.1937463187102571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385442241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676408,0.0005213354,0.000007786171,0.018259095,0.0002150758,0.0011150425,0.00002270033,0.00009278187,0.012125362],"genre_scores_gemma":[0.96968293,0.0028850758,0.000056769724,0.0005173085,0.00027706372,0.0007585738,0.000017318227,0.000034403176,0.025770552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939914,0.002374855,0.00067947275,0.0006294463,0.001284561,0.0010402875],"domain_scores_gemma":[0.9903768,0.007948755,0.000044285523,0.000566109,0.00047932958,0.0005847244],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.017534092,0.00013315237,0.0006496035,0.0007738347,0.00013786588,0.000023310879,0.00029246308,0.00034498435,0.0025440683],"category_scores_gemma":[0.014461127,0.00010657358,0.0001562948,0.0023805182,0.0011255513,0.00006158838,0.0003694709,0.0016155012,0.0033702198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041862406,0.0005456023,0.8752805,0.00008701924,0.0001758206,0.0015494466,0.00035112025,0.0000019566526,0.0011108962,0.00009977776,0.061832055,0.01710338],"study_design_scores_gemma":[0.004324211,0.0024776729,0.9607561,0.00024783344,0.00002788112,0.000015742415,0.00052920607,0.0026963395,0.000063596766,0.0012312673,0.027534623,0.00009549087],"about_ca_topic_score_codex":0.0009473818,"about_ca_topic_score_gemma":0.00017423238,"teacher_disagreement_score":0.085475616,"about_ca_system_score_codex":0.00044547394,"about_ca_system_score_gemma":0.0030785475,"threshold_uncertainty_score":0.9983677},"labels":[],"label_agreement":null},{"id":"W4385483365","doi":"10.1158/1078-0432.ccr-23-0917","title":"The New NCI Precision Medicine Trials","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Precision medicine; Clinical trial; Medicine; Medical physics; Targeted therapy; Matching (statistics); Intensive care medicine; Oncology; Cancer; Internal medicine; Pathology","score_opus":0.4534873555288127,"score_gpt":0.6143864141593111,"score_spread":0.16089905863049836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385483365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80802286,0.04844233,0.00064922223,0.12142224,0.007869582,0.002173835,0.00012849967,0.0000825517,0.011208906],"genre_scores_gemma":[0.60493547,0.31437263,0.000106625346,0.001734217,0.023596372,0.0003222841,0.00015655455,0.00008786452,0.054688],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734503,0.00066271017,0.0006612735,0.00041094265,0.00047369377,0.0004463757],"domain_scores_gemma":[0.99430335,0.0044464758,0.00009215312,0.00061774644,0.00027421556,0.00026604743],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014215669,0.00009403361,0.0002725877,0.000052144747,0.000279083,0.000052157324,0.00052158255,0.00017277808,0.00015670099],"category_scores_gemma":[0.025784526,0.000056694636,0.0001504651,0.00039893252,0.0004254457,0.0000014579934,0.00043389515,0.0003439189,0.00017456744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004325173,0.000012562807,0.00085680146,0.0000041360267,0.000037969985,0.0000028892675,0.000017166498,0.000025260706,0.007811649,0.00029467425,0.8097491,0.18075523],"study_design_scores_gemma":[0.0010515746,0.00058501575,0.004753248,0.000028906325,0.000011128688,5.8926133e-7,0.000065501445,0.00005019079,0.0037019441,0.0036740697,0.98599917,0.00007867832],"about_ca_topic_score_codex":0.00036289945,"about_ca_topic_score_gemma":0.00065741583,"teacher_disagreement_score":0.2659303,"about_ca_system_score_codex":0.000030744737,"about_ca_system_score_gemma":0.0007842582,"threshold_uncertainty_score":0.9824217},"labels":[],"label_agreement":null},{"id":"W4385575581","doi":"10.1158/1078-0432.ccr-22-3361","title":"Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"ZonMw; Leids Universitair Medisch Centrum; Amsterdam University Medical Centers","keywords":"Medicine; Anal cancer; Rash; Internal medicine; Vaccination; Immune system; Gastroenterology; Confidence interval; Cancer; Immunology","score_opus":0.3443210838136157,"score_gpt":0.570862439480992,"score_spread":0.22654135566737632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385575581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750295,0.00339617,0.000027840273,0.015267251,0.0003133413,0.002867655,0.00008580237,0.000058160193,0.0029542553],"genre_scores_gemma":[0.9746186,0.021126576,0.000014265542,0.00019064048,0.0010211746,0.0006446097,0.00008830766,0.000037402595,0.0022584286],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970044,0.00037901776,0.00064273144,0.0004448156,0.0008782493,0.00065078813],"domain_scores_gemma":[0.99607897,0.002633901,0.00006521995,0.0004793175,0.0005385374,0.00020403422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025900668,0.00014491916,0.0005068237,0.00031675867,0.00020444144,0.000030917712,0.00029463487,0.00017626255,0.0015295794],"category_scores_gemma":[0.0003485544,0.00009019876,0.0002060699,0.001305372,0.00027837706,0.000040988027,0.000070429945,0.00055530143,0.00006716952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006701746,0.0012051038,0.07131573,0.0001978952,0.0003135618,0.000027492544,0.00044096392,0.000055190398,0.0013940209,0.0016527977,0.010292018,0.9064035],"study_design_scores_gemma":[0.010087759,0.0050153197,0.92131853,0.00004391118,0.000058306257,7.272502e-7,0.00039775757,0.0018329045,0.0027735909,0.003147209,0.055195928,0.00012804696],"about_ca_topic_score_codex":0.0021439434,"about_ca_topic_score_gemma":0.0027151613,"teacher_disagreement_score":0.90627545,"about_ca_system_score_codex":0.0006533447,"about_ca_system_score_gemma":0.0006214268,"threshold_uncertainty_score":0.99938315},"labels":[],"label_agreement":null},{"id":"W4385716931","doi":"10.1158/1078-0432.ccr-22-2181","title":"HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Cancer research; Reprogramming; Biology; Tumor microenvironment; Immunotherapy; T cell; CD8; Cell; Cytotoxic T cell; Transcriptome; Immunology; Immune system","score_opus":0.2326283083407908,"score_gpt":0.5135318852890013,"score_spread":0.2809035769482105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385716931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898601,0.00034471534,0.000013437833,0.0031250154,0.00049037253,0.0012942979,0.00003215324,0.000146409,0.00469348],"genre_scores_gemma":[0.9290815,0.003730841,0.000031974185,0.0002969527,0.0015633339,0.00027447095,0.00012030491,0.000087193665,0.06481341],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9945649,0.0006526508,0.0007358324,0.000809533,0.0021929047,0.0010441635],"domain_scores_gemma":[0.99755895,0.00077832554,0.000088663044,0.00074598734,0.00026919047,0.00055887713],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004759167,0.00020931555,0.0004634765,0.00047642304,0.000271406,0.00008540202,0.0003732625,0.00023501771,0.015691023],"category_scores_gemma":[0.0005499245,0.000191725,0.0002469079,0.0011772953,0.00040676058,0.0001380253,0.00047393987,0.001606673,0.0042387024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027139764,0.0006111987,0.097414725,0.00029594166,0.00012100595,0.0004886728,0.00023462331,0.000100712445,0.8296211,0.000031971624,0.033521485,0.034844622],"study_design_scores_gemma":[0.020648291,0.005175411,0.44272828,0.00054382026,0.00015595176,0.00010044877,0.002610889,0.0069346325,0.29444283,0.00039977187,0.22526759,0.0009920655],"about_ca_topic_score_codex":0.00101307,"about_ca_topic_score_gemma":0.00006620549,"teacher_disagreement_score":0.53517824,"about_ca_system_score_codex":0.00076683663,"about_ca_system_score_gemma":0.00052642945,"threshold_uncertainty_score":0.9965366},"labels":[],"label_agreement":null},{"id":"W4385751197","doi":"10.1158/1078-0432.ccr-23-1137","title":"Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Olaparib; Immunotherapy; Response Evaluation Criteria in Solid Tumors; Immune system; Internal medicine; Oncology; Tumor microenvironment; Toxicity; Immunology; Phases of clinical research; Nivolumab; Biology","score_opus":0.3288032443135986,"score_gpt":0.5626271940113787,"score_spread":0.23382394969778014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385751197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98730147,0.00026555473,0.0000023057955,0.007276246,0.00043342213,0.003551713,0.000049734,0.000030030393,0.0010895401],"genre_scores_gemma":[0.9859798,0.01023892,0.000072140414,0.00006145027,0.00020254607,0.00016945503,0.000013498285,0.000043558754,0.0032186627],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9874795,0.0058880537,0.0030723573,0.0010213887,0.0017380071,0.0008006849],"domain_scores_gemma":[0.9812695,0.0159745,0.00047844864,0.0013109444,0.0007223842,0.00024427296],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.038338665,0.00022521091,0.0016056406,0.0004798289,0.00009863581,0.00001912088,0.0006652566,0.0006112918,0.00025322108],"category_scores_gemma":[0.020299884,0.00013611685,0.00033428092,0.0029816304,0.0031857088,0.00013342507,0.0008028259,0.0038739902,0.000012039882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48492816,0.0031913002,0.28436086,0.00013463724,0.00015969123,0.00006885542,0.00011711072,0.000009215815,0.001408776,0.000051570372,0.00042110548,0.22514871],"study_design_scores_gemma":[0.17736806,0.011658852,0.8056377,0.0005460176,0.000029823259,0.0000041570243,0.00027136042,0.00044798356,0.0006007409,0.00018811977,0.0031151846,0.00013198408],"about_ca_topic_score_codex":0.0017123721,"about_ca_topic_score_gemma":0.0053501865,"teacher_disagreement_score":0.52127683,"about_ca_system_score_codex":0.00026874655,"about_ca_system_score_gemma":0.002177177,"threshold_uncertainty_score":0.99952704},"labels":[],"label_agreement":null},{"id":"W4385791542","doi":"10.1158/1078-0432.ccr-23-0370","title":"Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shared Health","funders":"National Institute of Environmental Health Sciences; Cancer Research UK; National Cancer Institute; National Institute for Health and Care Research; Myriad Genetics","keywords":"Carboplatin; Docetaxel; Immune system; Oncology; Medicine; Internal medicine; Breast cancer; Triple-negative breast cancer; Cancer; Chemotherapy; Immunology; Cancer research; Cisplatin","score_opus":0.21338475753544037,"score_gpt":0.5400903936612291,"score_spread":0.32670563612578873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385791542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968863,0.0011959337,0.0000011531665,0.006129471,0.00027531837,0.0021426838,0.00048843544,0.000018448363,0.000059894217],"genre_scores_gemma":[0.9956726,0.0030444236,0.000031800453,0.00011435893,0.000086348744,0.0004798658,0.000016029464,0.000031922722,0.00052267505],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9869589,0.009000946,0.0017524117,0.000560153,0.001153701,0.00057385437],"domain_scores_gemma":[0.9838715,0.0146224415,0.00030060372,0.0006190108,0.00043667032,0.00014975322],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.029895283,0.00023166431,0.0010333058,0.0011411305,0.00007534841,0.000024592811,0.0004186254,0.00019147685,0.000549328],"category_scores_gemma":[0.010306526,0.000149543,0.00029877032,0.0042852834,0.0018214661,0.00010619332,0.00014784641,0.0011813059,0.0000040350124],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9167264,0.00057249435,0.024565127,0.00013055181,0.00053036475,0.00013969399,0.0020728607,0.000024697763,0.04593255,0.0000028942695,0.00076389324,0.008538462],"study_design_scores_gemma":[0.06642567,0.004209254,0.91618747,0.0008220216,0.0001071108,0.000006842736,0.00625457,0.0008024384,0.00475643,0.000057871774,0.00023358979,0.00013672841],"about_ca_topic_score_codex":0.024707215,"about_ca_topic_score_gemma":0.002467333,"teacher_disagreement_score":0.89162236,"about_ca_system_score_codex":0.00036329057,"about_ca_system_score_gemma":0.0028071278,"threshold_uncertainty_score":0.99892694},"labels":[],"label_agreement":null},{"id":"W4385827803","doi":"10.1158/1078-0432.ccr-23-0621","title":"Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Pfizer","keywords":"Medicine; Neuroblastoma RAS viral oncogene homolog; KRAS; Internal medicine; Oncology; Progression-free survival; Confidence interval; MEK inhibitor; Proportional hazards model; Ovarian cancer; Selumetinib; Chemotherapy; Logistic regression; Cancer; MAPK/ERK pathway; Biology; Colorectal cancer; Signal transduction","score_opus":0.2301253681193695,"score_gpt":0.5375087817184303,"score_spread":0.3073834135990608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865959,0.0021531484,0.000001252057,0.008022388,0.0007501561,0.0019134337,0.00045848853,0.000022842614,0.00008237636],"genre_scores_gemma":[0.99276423,0.006027874,0.000020638816,0.00016277574,0.00044604798,0.0004358144,0.00006461416,0.000043416516,0.00003459762],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99563754,0.00085033843,0.0010867637,0.0008417861,0.0010758027,0.00050775206],"domain_scores_gemma":[0.99615556,0.0022183897,0.00027267612,0.0008157976,0.00031776636,0.0002197878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022920875,0.00022607193,0.0007587345,0.00023409071,0.00009725504,0.00003257097,0.00033460214,0.00014978828,0.00007873183],"category_scores_gemma":[0.0006372171,0.00016645427,0.00018851228,0.0015872993,0.00046657957,0.000052209718,0.00018814049,0.00063830795,0.000007225126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1127178,0.028456172,0.21595816,0.00049348123,0.0076321033,0.0005853588,0.006554817,0.00016812408,0.021653466,0.000044252905,0.020320443,0.58541584],"study_design_scores_gemma":[0.105770975,0.005902905,0.8709866,0.00095501455,0.00041151152,3.3903262e-7,0.00225669,0.0005582059,0.01106676,0.00008155414,0.0017764728,0.00023298667],"about_ca_topic_score_codex":0.025933616,"about_ca_topic_score_gemma":0.0036889706,"teacher_disagreement_score":0.6550284,"about_ca_system_score_codex":0.00018512392,"about_ca_system_score_gemma":0.0004781715,"threshold_uncertainty_score":0.9805528},"labels":[],"label_agreement":null},{"id":"W4386691447","doi":"10.1158/1078-0432.ccr-23-1953","title":"Rerouting the GPS Directing Immunotherapy in Endometrial Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Endometrial cancer; Immunotherapy; Global Positioning System; Cancer; Medicine; Cancer immunotherapy; Cancer research; Oncology; Internal medicine; Computer science; Telecommunications","score_opus":0.3971738174280782,"score_gpt":0.5891527291047443,"score_spread":0.19197891167666603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386691447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96654314,0.010274339,0.0000028129707,0.01813997,0.001711125,0.0010290144,0.000015054062,0.00012107296,0.002163474],"genre_scores_gemma":[0.95608795,0.035243634,0.0000266396,0.0011243377,0.0024337047,0.0006117087,0.0000056787685,0.00005824126,0.0044081067],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995757,0.0008874432,0.0009115405,0.0005503405,0.0009847442,0.00090897054],"domain_scores_gemma":[0.9941632,0.004759631,0.00012101277,0.00058101997,0.00024425908,0.00013086777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014299382,0.00016119932,0.0004927934,0.00046976955,0.00034879387,0.00007455208,0.00041046334,0.00020250898,0.0011246639],"category_scores_gemma":[0.0026172458,0.0001055254,0.0003060087,0.004441846,0.0005686087,0.000069172194,0.00016723826,0.0017205593,0.00009484379],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010367891,0.00014840168,0.29747635,0.0000639241,0.00027809408,0.00007199874,0.0008888101,0.000018483252,0.009039347,0.000035967867,0.014219365,0.66739136],"study_design_scores_gemma":[0.015583191,0.00077114213,0.70152324,0.0009084405,0.000031131825,0.000008895144,0.0015008175,0.0006061392,0.0029087784,0.0002628814,0.27558225,0.00031308597],"about_ca_topic_score_codex":0.008990774,"about_ca_topic_score_gemma":0.0016317762,"teacher_disagreement_score":0.66707826,"about_ca_system_score_codex":0.00052741665,"about_ca_system_score_gemma":0.0008736626,"threshold_uncertainty_score":0.99978846},"labels":[],"label_agreement":null},{"id":"W4386708615","doi":"10.1158/1078-0432.ccr-23-0873","title":"Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; National Institute of General Medical Sciences; University of California, San Francisco; National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation; Rally Foundation","keywords":"Cancer research; Metastasis; Drug; Medicine; Osteosarcoma; Genome; Cancer; Oncology; Biology; Internal medicine; Pharmacology; Gene; Genetics","score_opus":0.423596895930628,"score_gpt":0.5438498985017948,"score_spread":0.12025300257116678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386708615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494704,0.010581809,0.022115257,0.007556275,0.00040863937,0.007343544,0.00092444924,0.00044215086,0.0011574851],"genre_scores_gemma":[0.9766034,0.0027532827,0.010434537,0.0005956804,0.0010724147,0.00505296,0.0017105204,0.0001681844,0.001609007],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99227667,0.0014859389,0.0015639248,0.0014754063,0.0019324328,0.0012656243],"domain_scores_gemma":[0.9940622,0.0024058402,0.00031460222,0.0008802776,0.0018319737,0.0005051282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010424749,0.00038723485,0.0010460247,0.00025914505,0.0003963784,0.00007560125,0.00036178302,0.00038551138,0.00025846701],"category_scores_gemma":[0.0013700823,0.00034151573,0.0005133287,0.0016232674,0.0008603625,0.0004877006,0.00026888077,0.0014956098,0.00009216878],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05057494,0.009232031,0.0057337983,0.0043852553,0.0027861719,0.00009973347,0.0057770023,0.019508801,0.17873229,0.0007514916,0.046252977,0.6761655],"study_design_scores_gemma":[0.09491298,0.010407251,0.0097097345,0.0011842638,0.0026180882,0.00005393817,0.008662642,0.48144558,0.16245069,0.17429584,0.051125333,0.0031336646],"about_ca_topic_score_codex":0.000114724324,"about_ca_topic_score_gemma":0.000043186254,"teacher_disagreement_score":0.67303187,"about_ca_system_score_codex":0.00053044525,"about_ca_system_score_gemma":0.0011263796,"threshold_uncertainty_score":0.9999037},"labels":[],"label_agreement":null},{"id":"W4386784013","doi":"10.1158/1557-3265.aacrahns23-pr09","title":"Abstract PR09: Detection of minimal residual disease in post-surgical drain fluid can predict locoregional recurrence in HPV-negative head and neck cancer patients","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymph; Head and neck squamous-cell carcinoma; Internal medicine; Head and neck cancer; Oncology; Cancer; Minimal residual disease; Adjuvant therapy; Pathology","score_opus":0.16329571815896235,"score_gpt":0.49489171245945446,"score_spread":0.33159599430049214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221843,0.001824206,8.439239e-8,0.0040342133,0.00028091457,0.0009938681,0.00037100018,0.000024559964,0.00025272332],"genre_scores_gemma":[0.99256,0.0061190403,0.000009064815,0.00010531607,0.0004505306,0.0005575242,0.00003673128,0.000024658168,0.00013710475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623203,0.0004190065,0.0008948542,0.00063738995,0.001061532,0.00075519364],"domain_scores_gemma":[0.99684155,0.0017598855,0.00010562832,0.00022724533,0.00052610296,0.0005395809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020984795,0.0001888867,0.0006356248,0.00041672264,0.00009890178,0.000012950608,0.00014103389,0.00017602448,0.00010867242],"category_scores_gemma":[0.0034581055,0.00016072918,0.00009667182,0.0012056588,0.0008721888,0.00011027951,0.00021832515,0.0011141973,0.000008070376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093695335,0.0006437221,0.9435284,0.00035488466,0.000045931178,0.00013969686,0.00092954724,0.000010456574,0.00015252616,0.000008206401,0.001443151,0.043373905],"study_design_scores_gemma":[0.0053902403,0.0015671568,0.99001306,0.0012389693,0.000015269296,8.24467e-7,0.00024399837,0.00022125719,0.00028258885,0.00007687818,0.00080870395,0.00014107193],"about_ca_topic_score_codex":0.007359183,"about_ca_topic_score_gemma":0.013248467,"teacher_disagreement_score":0.046484604,"about_ca_system_score_codex":0.00039414247,"about_ca_system_score_gemma":0.001514742,"threshold_uncertainty_score":0.9992509},"labels":[],"label_agreement":null},{"id":"W4386784015","doi":"10.1158/1557-3265.aacrahns23-po-097","title":"Abstract PO-097: Tumor-associated extracellular vesicles from HPV+ oropharyngeal cancer lymphatic fluid trigger an anti-tumor response through activation of the cGAS-STING pathway","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymph; Cancer research; Immune system; Lymphatic system; Cancer; Lymph node; Innate immune system; Medicine; Biology; Immunology; Pathology; Internal medicine","score_opus":0.12806657144046976,"score_gpt":0.4386644268716819,"score_spread":0.3105978554312121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390155,0.0035780417,0.000025422512,0.0007551341,0.0004367747,0.00067523605,0.0004807653,0.000050194343,0.000096857584],"genre_scores_gemma":[0.9972128,0.00068267516,0.00005565174,0.00025166993,0.00077516487,0.00018690931,0.000186664,0.000098447774,0.00055001513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.993837,0.0022214036,0.0010694371,0.0009937794,0.0010637362,0.000814642],"domain_scores_gemma":[0.9962351,0.001275938,0.00044979822,0.001199112,0.00056647515,0.00027360182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00497738,0.00029185298,0.000495275,0.000093178984,0.00039126084,0.00007982621,0.0010717288,0.00030348756,0.00036463287],"category_scores_gemma":[0.005578794,0.00024056714,0.0003387039,0.0008834563,0.00076575816,0.000046437854,0.00051906065,0.0006157302,0.000037159152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021104289,0.00047580685,0.020584255,0.000065622895,0.00014373822,0.000065082124,0.00014805782,0.0002673617,0.96906006,0.000014825159,0.0023686842,0.0046960507],"study_design_scores_gemma":[0.0014886505,0.0002516191,0.36154446,0.00018870569,0.0000356235,8.50206e-7,0.000268967,0.00057341915,0.6332618,0.0003803388,0.0017509589,0.0002546279],"about_ca_topic_score_codex":0.0014184887,"about_ca_topic_score_gemma":0.00016245698,"teacher_disagreement_score":0.3409602,"about_ca_system_score_codex":0.00019224154,"about_ca_system_score_gemma":0.0017771879,"threshold_uncertainty_score":0.9810043},"labels":[],"label_agreement":null},{"id":"W4386784019","doi":"10.1158/1557-3265.aacrahns23-pr05","title":"Abstract PR05: Changing the radiation and immune-oncology paradigm in patients with head and neck squamous cell carcinoma (HNSCC) with the radioenhancer NBTXR3: From bench to bedside","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Radiation therapy; Cancer; Abscopal effect; Head and neck cancer; Immunotherapy; Cancer research","score_opus":0.10090439691586149,"score_gpt":0.46654931991425297,"score_spread":0.36564492299839146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758554,0.001194041,0.00000553957,0.021086449,0.000034838195,0.0012537973,0.000028749853,0.000020201087,0.0005209863],"genre_scores_gemma":[0.9978948,0.00030910884,0.000031721356,0.0006488764,0.00030852077,0.0005564836,0.000036600984,0.000023057408,0.00019082823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810594,0.0001534416,0.00033985617,0.0004628585,0.00042868088,0.00050924387],"domain_scores_gemma":[0.9971828,0.0019968878,0.000067756686,0.00037999608,0.00010100831,0.00027158824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012494805,0.00013612052,0.00030072388,0.000084127016,0.00027528362,0.000041926312,0.00018154194,0.00011710585,0.00007568254],"category_scores_gemma":[0.00016401614,0.00007353793,0.000032086977,0.0008373543,0.00048750074,0.000053665215,0.000106456086,0.0009880277,0.000018409046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00588698,0.0005437682,0.9363099,0.00017804012,0.000073174844,0.00006320984,0.0028180876,0.00013587672,0.002328641,0.000065999644,0.0030328915,0.048563477],"study_design_scores_gemma":[0.004751493,0.00082549243,0.98416275,0.000059985046,0.000041681244,0.000002058425,0.00041544135,0.0003138326,0.0022027825,0.000071741975,0.0070447614,0.000107988584],"about_ca_topic_score_codex":0.000513251,"about_ca_topic_score_gemma":0.00020187497,"teacher_disagreement_score":0.048455488,"about_ca_system_score_codex":0.00014006563,"about_ca_system_score_gemma":0.00026673713,"threshold_uncertainty_score":0.42925438},"labels":[],"label_agreement":null},{"id":"W4386784022","doi":"10.1158/1557-3265.aacrahns23-pr11","title":"Abstract PR11: Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ipilimumab; Internal medicine; Oncology; Regimen; Cohort; Immunotherapy; Cyclophosphamide; Cancer; Chemotherapy; Gastroenterology","score_opus":0.19200859287251712,"score_gpt":0.5151618163253213,"score_spread":0.3231532234528042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97991747,0.009347669,0.0000051078887,0.0037423333,0.0009897737,0.0054561705,0.00016165285,0.0001440531,0.00023579905],"genre_scores_gemma":[0.9486013,0.0299154,0.00035727338,0.0012147631,0.0012436236,0.003361755,0.000115117,0.00016414792,0.01502663],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953621,0.00022145701,0.0008475624,0.0012061809,0.0011295557,0.0012331625],"domain_scores_gemma":[0.996724,0.0012101176,0.00019082753,0.0007300276,0.00064972707,0.0004952981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022908302,0.00044750923,0.0010631284,0.00025114344,0.0005415239,0.00014376274,0.0003573884,0.0002816943,0.00069524726],"category_scores_gemma":[0.00015262538,0.0002636218,0.0002089032,0.0010596286,0.0011654566,0.00022447127,0.00008472662,0.0012411427,0.000014822282],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8202909,0.0010941946,0.005873309,0.0004645777,0.0005680465,0.00011333975,0.00033569458,0.000017682552,0.011009421,0.0000015189012,0.013788664,0.14644265],"study_design_scores_gemma":[0.6235305,0.04903773,0.009447827,0.0011907064,0.00017238046,0.000046085064,0.001267841,0.0005174092,0.007831359,0.000021070462,0.3060412,0.00089589163],"about_ca_topic_score_codex":0.002390269,"about_ca_topic_score_gemma":0.0067182435,"teacher_disagreement_score":0.29225254,"about_ca_system_score_codex":0.00034077867,"about_ca_system_score_gemma":0.0031387794,"threshold_uncertainty_score":0.9999816},"labels":[],"label_agreement":null},{"id":"W4386784024","doi":"10.1158/1557-3265.aacrahns23-pr12","title":"Abstract PR12: High-dimensional spatial analysis of the tumor-microenvironment to determine metastatic disease progression and response and resistance to therapy in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Tumor microenvironment; Medicine; CD8; Head and neck squamous-cell carcinoma; Cancer; Primary tumor; Head and neck cancer; Tumor progression; Mass cytometry; Cytotoxic T cell; T cell; Cancer research; Pathology; Oncology; Internal medicine; Immunology; Metastasis; Biology; Phenotype","score_opus":0.1293566082335363,"score_gpt":0.4868440163052318,"score_spread":0.35748740807169543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768088,0.0044668876,8.298155e-7,0.01734013,0.00006886918,0.0011613441,0.0001408912,0.000008508271,0.0000037714262],"genre_scores_gemma":[0.9945136,0.0037383107,0.00012985004,0.000934589,0.000049252656,0.00031531736,0.0000059453923,0.000018447301,0.00029469634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744743,0.0004421281,0.0005378988,0.000547237,0.00067462976,0.0003506845],"domain_scores_gemma":[0.99819905,0.0008834879,0.00008578684,0.00037799324,0.00008391468,0.00036978893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027303954,0.00014220185,0.00046953905,0.00036780463,0.000112939764,0.00002492767,0.00011692643,0.00003859027,0.00012939534],"category_scores_gemma":[0.0004737401,0.00009128109,0.00009073473,0.00130355,0.00048257367,0.000035610003,0.00021023785,0.00029405512,0.0000015911861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14043896,0.0003415488,0.6785192,0.00019177671,0.0005227672,0.00015313324,0.00044404564,0.00006536879,0.03845275,0.000003193194,0.0013028722,0.13956438],"study_design_scores_gemma":[0.002856658,0.00062160695,0.992167,0.0006730451,0.000097383396,7.996847e-7,0.000037448648,0.00016593002,0.0011138478,0.00002786971,0.0021396035,0.000098828175],"about_ca_topic_score_codex":0.0016634009,"about_ca_topic_score_gemma":0.005486252,"teacher_disagreement_score":0.31364778,"about_ca_system_score_codex":0.0001581885,"about_ca_system_score_gemma":0.00036319473,"threshold_uncertainty_score":0.37223345},"labels":[],"label_agreement":null},{"id":"W4386784036","doi":"10.1158/1557-3265.aacrahns23-po-098","title":"Abstract PO-098: Development of radioimmunotherapy using IL7 and FLT3 in a murine HPV related head and neck squamous cell carcinoma model","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Radioimmunotherapy; Immunotherapy; Cancer research; Head and neck cancer; Radiation therapy; Oncology; Cancer; Pathology; Internal medicine; Antibody; Immunology; Monoclonal antibody","score_opus":0.17343725823923717,"score_gpt":0.4806751162262364,"score_spread":0.3072378579869992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290174,0.006255907,0.0000072540147,0.00011109987,0.00003422846,0.00037204125,0.000029370183,0.000006867103,0.0002814614],"genre_scores_gemma":[0.99581146,0.0032605527,0.00034805943,0.000018899103,0.000043231143,0.000063586434,0.000037792277,0.000028826835,0.00038760208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806064,0.00012783484,0.00048888446,0.0004917745,0.0003291684,0.0005016882],"domain_scores_gemma":[0.9992564,0.0001063691,0.000060255545,0.00027934555,0.00011187391,0.0001857847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012152041,0.00013298563,0.00026094096,0.00016663849,0.00010944092,0.000023450148,0.00014846776,0.00018038918,0.00003925113],"category_scores_gemma":[0.0000976818,0.00012196391,0.000054708744,0.0003261166,0.00029534395,0.000007085447,0.00026380373,0.00036562403,0.000003933253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049561006,0.0009529524,0.6176818,0.00055829674,0.0001838501,0.00016162577,0.0009621614,0.0011796741,0.26599148,0.000012742223,0.00096171745,0.106397614],"study_design_scores_gemma":[0.012225639,0.0011579109,0.9062033,0.000108769476,0.000011575254,0.000007924665,0.00017762733,0.0070184125,0.07021814,0.0002445092,0.0022598964,0.00036629787],"about_ca_topic_score_codex":0.0016402687,"about_ca_topic_score_gemma":0.0010425347,"teacher_disagreement_score":0.28852153,"about_ca_system_score_codex":0.000083749495,"about_ca_system_score_gemma":0.00079121505,"threshold_uncertainty_score":0.4973544},"labels":[],"label_agreement":null},{"id":"W4386784049","doi":"10.1158/1557-3265.aacrahns23-po-082","title":"Abstract PO-082: Antigen presentation and inflammatory effects on immune surveillance: Window of opportunity metformin monotherapy trial for squamous cell carcinoma of the head and neck (HNSCC)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Metformin; Oncology; Tumor microenvironment; Internal medicine; Cancer; Cancer research; Head and neck cancer","score_opus":0.191521908110743,"score_gpt":0.489257773891176,"score_spread":0.297735865780433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930613,0.002392245,4.3447375e-7,0.0009926403,0.00024495693,0.0030706027,0.00008455143,0.000010636206,0.00014263911],"genre_scores_gemma":[0.99456805,0.0044912463,0.00001056269,0.000050619245,0.0002715037,0.00042564239,0.000019801495,0.000023704917,0.00013884775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980469,0.0002557792,0.00059914845,0.00031710617,0.00049870746,0.00028240186],"domain_scores_gemma":[0.9951137,0.0038946632,0.00019989308,0.00038564744,0.00023138105,0.00017477431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022630244,0.00012529276,0.0005241441,0.00011899268,0.00010410029,0.00001355671,0.000108098386,0.00012871985,0.000031422518],"category_scores_gemma":[0.00076200196,0.00008395294,0.00018309848,0.00026070024,0.00029221358,0.000039825685,0.00007633839,0.00030074545,0.0000012520643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043479916,0.0007073174,0.8734168,0.0013169163,0.00012350144,0.000017772967,0.00030083835,0.000008068297,0.003579786,0.000032706543,0.00153807,0.07547835],"study_design_scores_gemma":[0.047444697,0.0037233182,0.9042702,0.00015030592,0.000027986045,5.852014e-7,0.0000673779,0.000034823413,0.04359845,0.000113621085,0.00050529063,0.00006337973],"about_ca_topic_score_codex":0.0016238255,"about_ca_topic_score_gemma":0.0003217389,"teacher_disagreement_score":0.07541497,"about_ca_system_score_codex":0.000074947806,"about_ca_system_score_gemma":0.0005229129,"threshold_uncertainty_score":0.34235016},"labels":[],"label_agreement":null},{"id":"W4386784057","doi":"10.1158/1557-3265.aacrahns23-pr06","title":"Abstract PR06: Cooperative HPV and YAP-mediated oncogenic reprogramming of oral progenitors into cancer stem cells at single cell resolution","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer research; Carcinogenesis; Progenitor cell; Reprogramming; Stem cell; Ectopic expression; Cancer stem cell; SOX2; Cell cycle; Cell biology; Cell; Cancer; Cell culture; Transcription factor; Genetics; Gene","score_opus":0.18493714544601422,"score_gpt":0.4691208612884535,"score_spread":0.2841837158424393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936488,0.0047858846,0.000015945998,0.00039765207,0.0002517574,0.0005823962,0.00008608221,0.000023166687,0.00020826387],"genre_scores_gemma":[0.98833305,0.008147229,0.00010452042,0.00003467675,0.00029427922,0.00042278398,0.00008007112,0.0000351767,0.002548222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976165,0.0002897964,0.00055608276,0.0006907439,0.00039075696,0.00045607865],"domain_scores_gemma":[0.9984513,0.00014596403,0.00015816085,0.0004476679,0.0005920938,0.00020482848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016904786,0.00014560291,0.00025490634,0.00009044463,0.00023195386,0.00003738973,0.00024214735,0.00027265216,0.00009699239],"category_scores_gemma":[0.00014185703,0.00013047083,0.00010872997,0.0005555076,0.0006976874,0.00000961075,0.00031327415,0.00033262363,0.000032825606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051159726,0.0002145737,0.010012029,0.000121263045,0.0000804638,0.0000049179375,0.00015971778,0.00015008969,0.9074048,0.0000049791092,0.009040751,0.07229487],"study_design_scores_gemma":[0.0010317015,0.00083114323,0.0103218425,0.00005214334,0.000024480703,6.9964096e-7,0.00038102322,0.00023981725,0.89607996,0.00001557054,0.0907991,0.00022251504],"about_ca_topic_score_codex":0.00071315747,"about_ca_topic_score_gemma":0.0010313094,"teacher_disagreement_score":0.08175835,"about_ca_system_score_codex":0.00015295256,"about_ca_system_score_gemma":0.0005272275,"threshold_uncertainty_score":0.5320446},"labels":[],"label_agreement":null},{"id":"W4386784072","doi":"10.1158/1557-3265.aacrahns23-po-086","title":"Abstract PO-086: Generation of HPV-negative tobacco-associated oral cancer models using <i>p53</i> and <i>Cdkn2a</i> mutant mice","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Carcinogenesis; Cancer research; Cancer; Head and neck squamous-cell carcinoma; Mutant; Biology; Mutation; Pathology; Medicine; Head and neck cancer; Genetics; Gene","score_opus":0.45212773899170855,"score_gpt":0.5253322490276097,"score_spread":0.07320451003590112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323744,0.002580047,0.00008896211,0.0012846203,0.00061671785,0.00096691883,0.0002752101,0.000086678185,0.0008633924],"genre_scores_gemma":[0.99117523,0.0069488953,0.00021819229,0.00044408542,0.00065012154,0.00013842602,0.00006467484,0.000079845566,0.00028053817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958068,0.00044204196,0.0009672237,0.00068921025,0.0012233744,0.00087131036],"domain_scores_gemma":[0.9970357,0.00076559035,0.00026553936,0.000421694,0.0010607655,0.00045071513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035744312,0.00023781967,0.0007346866,0.0002904275,0.00020501003,0.000043514407,0.00018772326,0.00043011634,0.0002701116],"category_scores_gemma":[0.0014896152,0.00022243049,0.00020670156,0.0015242472,0.000564722,0.00021440098,0.00023740344,0.0013512288,0.000018569095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003973352,0.0014243188,0.040112734,0.0006122502,0.00174917,0.00037578464,0.0022915122,0.015882509,0.7736944,0.0002350518,0.042826332,0.116822615],"study_design_scores_gemma":[0.030208562,0.0032013138,0.16956955,0.0037225657,0.0012629944,0.000058369762,0.002039074,0.27723065,0.5029819,0.0023878438,0.0051812204,0.0021559454],"about_ca_topic_score_codex":0.008107479,"about_ca_topic_score_gemma":0.0025523244,"teacher_disagreement_score":0.27071247,"about_ca_system_score_codex":0.0007164697,"about_ca_system_score_gemma":0.0017234196,"threshold_uncertainty_score":0.9984976},"labels":[],"label_agreement":null},{"id":"W4386784082","doi":"10.1158/1557-3265.aacrahns23-po-085","title":"Abstract PO-085: Inhibition of ATR as a therapeutic strategy to enhance immunotherapy in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Immunotherapy; In vivo; Tumor microenvironment; Medicine; Cancer; Head and neck cancer; Immune system; Bone marrow; Cancer immunotherapy; Cancer cell; Immunology; Biology; Internal medicine","score_opus":0.17252176993906557,"score_gpt":0.5376926346770885,"score_spread":0.36517086473802296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98238057,0.013854318,0.000002115387,0.0022205708,0.00034534742,0.00046004314,0.000040619372,0.000032129745,0.0006642862],"genre_scores_gemma":[0.9810095,0.01369041,0.0000032018077,0.0003795584,0.000052530042,0.0002115615,0.00001277354,0.000023948602,0.0046165152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99752766,0.0006846021,0.00065063225,0.00042821586,0.000115369854,0.00059353583],"domain_scores_gemma":[0.99821,0.0011595519,0.000081136386,0.00030259107,0.00020001085,0.00004669626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020858294,0.00014428937,0.00040878437,0.0003189415,0.00010607019,0.000022672764,0.000228572,0.00029603968,0.0020720684],"category_scores_gemma":[0.00029593924,0.00012412107,0.00009389965,0.000636878,0.0005085108,0.00007842127,0.00013225945,0.0009280903,0.0006329723],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007075449,0.00022117287,0.008257234,0.000063631014,0.00012776919,0.000014401699,0.000598197,0.000015620806,0.7205541,0.0001924102,0.003308617,0.25957137],"study_design_scores_gemma":[0.0025266914,0.0029801144,0.602712,0.00066554005,0.00000702804,0.000004877269,0.00066962093,0.000004558133,0.35651323,0.0007455432,0.03291444,0.00025638455],"about_ca_topic_score_codex":0.0056803995,"about_ca_topic_score_gemma":0.0018915668,"teacher_disagreement_score":0.5944547,"about_ca_system_score_codex":0.00009339377,"about_ca_system_score_gemma":0.00047084337,"threshold_uncertainty_score":0.99884015},"labels":[],"label_agreement":null},{"id":"W4386784084","doi":"10.1158/1557-3265.aacrahns23-pr08","title":"Abstract PR08: Personalized therapeutic mRNA nano-vaccines are effective across multiple preclinical and translational models of head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Immune system; Metastasis; Head and neck cancer; Immunotherapy; Head and neck squamous-cell carcinoma; Cancer research; Thyroid cancer; Lung cancer; Pathology; Oncology; Immunology; Internal medicine","score_opus":0.22381519966349672,"score_gpt":0.5364004730391201,"score_spread":0.31258527337562336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98178667,0.015124945,0.000014437979,0.0016478805,0.00010052595,0.00090972206,0.0003294416,0.000018513228,0.000067877736],"genre_scores_gemma":[0.98111933,0.017411062,0.00003773807,0.00013796154,0.0004054166,0.00046567305,0.000037175865,0.00004663186,0.0003390354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665666,0.0006198193,0.0005418348,0.00079134334,0.0007568814,0.00063344045],"domain_scores_gemma":[0.9972788,0.0013074807,0.0001122282,0.0003700738,0.0006695691,0.0002618638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040078633,0.00019728614,0.00044799267,0.00008219761,0.0002249793,0.000044789544,0.0002945064,0.0003445218,0.000088520144],"category_scores_gemma":[0.00065524824,0.000168077,0.0001680778,0.00035089304,0.0009523336,0.000015865939,0.00022363066,0.00060444674,0.0000060635457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038662057,0.0005259184,0.5455322,0.00055716874,0.00085296534,0.0000134661295,0.00076366996,0.0012170661,0.19836137,0.000033805543,0.00153773,0.21194258],"study_design_scores_gemma":[0.012658757,0.004616369,0.9178724,0.00035010278,0.00003731245,0.000003846005,0.00036334127,0.007384835,0.048508067,0.0016541418,0.006027264,0.0005235278],"about_ca_topic_score_codex":0.00037484017,"about_ca_topic_score_gemma":0.0037488302,"teacher_disagreement_score":0.37234023,"about_ca_system_score_codex":0.00002626252,"about_ca_system_score_gemma":0.00046283426,"threshold_uncertainty_score":0.6853981},"labels":[],"label_agreement":null},{"id":"W4386784088","doi":"10.1158/1557-3265.aacrahns23-po-089","title":"Abstract PO-089: Opioid-mediated suppression of anti-tumor immunity via peripheral OPRM1 signaling in head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Tumor microenvironment; Cancer; Immunosurveillance; Immune system; CD8; Opioid; Opioid receptor; Cancer research; Head and neck cancer; Pharmacology; Immunology; Internal medicine; Receptor","score_opus":0.10647650643643697,"score_gpt":0.44080423744586267,"score_spread":0.3343277310094257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924431,0.005460156,0.000001166041,0.00070764177,0.0002952617,0.0007305576,0.000043920485,0.00005218406,0.00026603806],"genre_scores_gemma":[0.9963204,0.0024159714,0.000027893479,0.00011646289,0.0004562605,0.000087307715,0.00006221878,0.00005630178,0.0004571543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592745,0.00070827745,0.0010794192,0.00057845627,0.000855502,0.0008509187],"domain_scores_gemma":[0.9959345,0.0025301296,0.00016888168,0.0006272817,0.00035562497,0.00038357207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034069563,0.00023727011,0.000881045,0.00042940202,0.00018182241,0.0000386677,0.00032421568,0.00027234695,0.00055673893],"category_scores_gemma":[0.0013672574,0.00020668497,0.00020593559,0.0010302494,0.00074047304,0.000118550604,0.00025841486,0.0016839965,0.000040643426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010799902,0.0009865671,0.79343194,0.0015365334,0.00002943236,0.00074744906,0.0011805553,0.00008050917,0.17538369,0.0000016828245,0.0029856698,0.012836073],"study_design_scores_gemma":[0.005957403,0.0012185393,0.9677974,0.0005277511,0.000021215717,0.000017745368,0.00082160096,0.0008666519,0.019919721,0.000027707034,0.0026204744,0.00020378317],"about_ca_topic_score_codex":0.009342142,"about_ca_topic_score_gemma":0.00033231327,"teacher_disagreement_score":0.17436548,"about_ca_system_score_codex":0.00019746658,"about_ca_system_score_gemma":0.0011286379,"threshold_uncertainty_score":0.9972547},"labels":[],"label_agreement":null},{"id":"W4386784091","doi":"10.1158/1557-3265.aacrahns23-pr10","title":"Abstract PR10: A decade in the making: Screening ctDNA detection in HPV-associated HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Digital polymerase chain reaction; Medicine; Biobank; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Liquid biopsy; Cancer; Head and neck cancer; Bioinformatics; Biology; Polymerase chain reaction; Gene; Genetics","score_opus":0.2335351691490474,"score_gpt":0.5510196840192118,"score_spread":0.3174845148701644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995317,0.00026445626,0.00032664972,0.0024041194,0.000040543047,0.0005109326,0.000013015375,0.00002816826,0.0010951095],"genre_scores_gemma":[0.9977419,0.0007833452,0.000074344825,0.00044436392,0.0001492223,0.00061179884,0.000058646798,0.00001670171,0.00011972095],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980401,0.00049463345,0.0003759995,0.00042939038,0.00022657326,0.00043333342],"domain_scores_gemma":[0.9992524,0.00019300623,0.000061461804,0.00036766336,0.00008738981,0.000038114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045624883,0.00008980469,0.00013361817,0.00013251098,0.00011569283,0.00002737729,0.00043274538,0.00034848406,0.00002498692],"category_scores_gemma":[0.00093991356,0.00007203163,0.000090263355,0.0008909304,0.00018982824,0.0000026435819,0.00018500401,0.0007769779,0.000018243274],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072089524,0.00072062877,0.18432447,0.00005408019,0.00010188247,0.00010828447,0.00023711103,0.00023088043,0.43896684,0.00039133357,0.022197412,0.3519462],"study_design_scores_gemma":[0.00084821973,0.00031894277,0.92189735,0.00006432798,0.000004863511,0.0000026879804,0.00020455853,0.00048537887,0.01854939,0.0008354294,0.056599464,0.00018936115],"about_ca_topic_score_codex":0.00031392794,"about_ca_topic_score_gemma":0.0032971352,"teacher_disagreement_score":0.7375729,"about_ca_system_score_codex":0.000035810506,"about_ca_system_score_gemma":0.00010763574,"threshold_uncertainty_score":0.33756256},"labels":[],"label_agreement":null},{"id":"W4386784097","doi":"10.1158/1557-3265.aacrahns23-po-092","title":"Abstract PO-092: Molecular characterization of the salivary adenoid cystic carcinoma tumor immune landscape by anatomic subsite","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adenoid cystic carcinoma; Salivary gland; Immune system; Antibody-dependent cell-mediated cytotoxicity; Perineural invasion; Ductal cells; Pathology; Biology; Cancer research; Medicine; Cancer; Carcinoma; Immunology; Internal medicine; Immunohistochemistry; Antibody; Monoclonal antibody","score_opus":0.07939533876808473,"score_gpt":0.43014877345654523,"score_spread":0.3507534346884605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324435,0.0019714115,0.0000011511909,0.0031907633,0.00029248506,0.00069678447,0.00020558429,0.000045673278,0.00035182555],"genre_scores_gemma":[0.9975484,0.0010341883,0.0000036958625,0.00026231734,0.00020583166,0.00017089325,0.00030075503,0.00004230439,0.0004316089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973427,0.00031391,0.00066742435,0.00042099785,0.00078927557,0.00046568966],"domain_scores_gemma":[0.99810904,0.0006491712,0.00015229096,0.00063616247,0.00024598092,0.00020733965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014018213,0.00015729775,0.0004678051,0.00015380002,0.00012449817,0.000025230984,0.00028121375,0.00010942308,0.0005435849],"category_scores_gemma":[0.0004406276,0.00010295023,0.00025628603,0.0009165702,0.00023740207,0.000050035982,0.00017868898,0.0005859988,0.00016092652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050449854,0.0004958534,0.9522726,0.0001811273,0.00013358805,0.00034159308,0.000068820606,0.0000019997015,0.04077346,0.000040251703,0.003998381,0.0011878621],"study_design_scores_gemma":[0.0018554791,0.00030769975,0.96397674,0.0002328385,0.00007326588,0.000011390472,0.000038200942,0.000116757474,0.03259542,0.000050647235,0.00064734183,0.000094227726],"about_ca_topic_score_codex":0.000515754,"about_ca_topic_score_gemma":0.000010594734,"teacher_disagreement_score":0.011704166,"about_ca_system_score_codex":0.00009351762,"about_ca_system_score_gemma":0.000376786,"threshold_uncertainty_score":0.5951873},"labels":[],"label_agreement":null},{"id":"W4386784100","doi":"10.1158/1557-3265.aacrahns23-po-090","title":"Abstract PO-090: Characterizing the intra-tumoral microbiome of laryngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Microbiome; Biology; Pathology; Cancer; Fluorescence in situ hybridization; Fusobacterium; Fusobacteria; Bacteria; Cancer research; Medicine; Internal medicine; 16S ribosomal RNA; Gene; Bacteroides; Bioinformatics; Bacteroidetes","score_opus":0.24568409128979568,"score_gpt":0.4928071972130673,"score_spread":0.24712310592327164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97796816,0.001942106,2.765968e-7,0.0152341155,0.0006483759,0.000540724,0.00008193668,0.000056813784,0.0035274918],"genre_scores_gemma":[0.9946993,0.0013738598,0.000012693627,0.000658093,0.0011228313,0.0001088639,0.000024179353,0.000038677066,0.0019614825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970321,0.0002490514,0.0007616941,0.0004621654,0.00068814156,0.00080684037],"domain_scores_gemma":[0.9972056,0.0014840432,0.00011243529,0.00054769637,0.00039431592,0.00025590733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034899684,0.00016225394,0.00064295856,0.0001910648,0.00024516755,0.000025893853,0.0003587495,0.00015379352,0.0004504032],"category_scores_gemma":[0.00054915436,0.000107287466,0.00024311704,0.0009901712,0.0008182315,0.000057597663,0.0003250092,0.001315894,0.00028452883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003154113,0.00095035974,0.4426848,0.0022583727,0.00015218247,0.0007872595,0.0024001151,0.0000017531403,0.25297007,0.000056331293,0.24336135,0.05122329],"study_design_scores_gemma":[0.002009982,0.00097511313,0.9380978,0.00015933199,0.00003454803,0.000007031601,0.0005618412,0.000025018582,0.023897326,0.000035097073,0.03406331,0.00013359677],"about_ca_topic_score_codex":0.0008970118,"about_ca_topic_score_gemma":0.00014447654,"teacher_disagreement_score":0.495413,"about_ca_system_score_codex":0.00012667065,"about_ca_system_score_gemma":0.000731775,"threshold_uncertainty_score":0.5716978},"labels":[],"label_agreement":null},{"id":"W4386784280","doi":"10.1158/1557-3265.aacrahns23-po-057","title":"Abstract PO-057: Systemic delivery of miR-27a* using ultrasound-targeted microbubble cavitation causes tumor regression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Microbubbles; In vivo; PI3K/AKT/mTOR pathway; microRNA; Head and neck squamous-cell carcinoma; Medicine; Epidermal growth factor receptor; Small interfering RNA; AKT1; Biology; RNA; Pathology; Radiation therapy; Cancer; Ultrasound; Signal transduction; Gene; Head and neck cancer; Internal medicine; Cell biology","score_opus":0.18205564370450825,"score_gpt":0.4512908888412515,"score_spread":0.26923524513674324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968527,0.0018292572,0.00004027035,0.000049969207,0.00032232795,0.00038589924,0.00014184491,0.00022746895,0.00015026584],"genre_scores_gemma":[0.99751115,0.0016289699,0.00022412543,0.00001844035,0.00026107384,0.00010220278,0.00006624204,0.000059783866,0.00012804227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978716,0.00014462895,0.0006938208,0.0003337038,0.0004685429,0.00048773084],"domain_scores_gemma":[0.9971646,0.0018144748,0.000088324785,0.00039835207,0.00037618956,0.00015802342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012966015,0.0001537027,0.00034065195,0.00024821315,0.00019271129,0.00004775677,0.00031143604,0.00016435904,0.0001648459],"category_scores_gemma":[0.00036370626,0.00013781243,0.0001329005,0.0009957666,0.00020781891,0.00013253756,0.00004964842,0.00060060323,0.00018743305],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043337815,0.000059663293,0.018809114,0.00042914794,0.00007403858,0.000010964614,0.000249801,0.0048796567,0.9683327,0.00002184453,0.005695353,0.0013943465],"study_design_scores_gemma":[0.0044813147,0.00038813183,0.5285379,0.005555659,0.0002668864,0.000113582435,0.0060561504,0.020695202,0.4111929,0.0015699118,0.019106619,0.0020357468],"about_ca_topic_score_codex":0.0009476488,"about_ca_topic_score_gemma":0.00017229574,"teacher_disagreement_score":0.5571398,"about_ca_system_score_codex":0.00018699569,"about_ca_system_score_gemma":0.00024057597,"threshold_uncertainty_score":0.5619828},"labels":[],"label_agreement":null},{"id":"W4386784286","doi":"10.1158/1557-3265.aacrahns23-po-072","title":"Abstract PO-072: Durvalumab in combination with radioactive iodine in recurrent/metastatic thyroid cancers: Update on clinical and correlative analyses","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Durvalumab; Clinical endpoint; Thyroid cancer; Cancer; Internal medicine; Oncology; Clinical trial; Adverse effect; Response Evaluation Criteria in Solid Tumors; Thyroid; Phases of clinical research; Immunotherapy; Pembrolizumab","score_opus":0.3937507872669719,"score_gpt":0.5837503913856752,"score_spread":0.1899996041187033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98849684,0.002637145,0.000003870125,0.0061228895,0.00028117467,0.0014037234,0.00009187335,0.00004143487,0.000921072],"genre_scores_gemma":[0.97262335,0.025890803,0.00007468245,0.0002740692,0.00017065465,0.00060432026,0.00008810122,0.000039080453,0.0002349484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954285,0.0009026569,0.0010954627,0.0009643809,0.0009459392,0.0006630351],"domain_scores_gemma":[0.9949571,0.0037473545,0.00020163089,0.00041749774,0.00030861708,0.00036779913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004194117,0.00025836448,0.00096292706,0.0006961065,0.0001014375,0.00004743402,0.0001547863,0.00016126073,0.00018137053],"category_scores_gemma":[0.0012544073,0.00019116812,0.0001415207,0.0018724493,0.0007889377,0.00015535417,0.00009723728,0.0018506027,0.0001111262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012892355,0.002569037,0.85306525,0.00012709085,0.00049678667,0.0009130244,0.00044011316,0.00030878268,0.00002039267,0.00025517007,0.0057969443,0.12311505],"study_design_scores_gemma":[0.0188261,0.006608155,0.9701782,0.0010695477,0.00009884772,0.00000410578,0.0006622016,0.0008990595,0.00012231694,0.00053850515,0.000793611,0.0001993735],"about_ca_topic_score_codex":0.0033116685,"about_ca_topic_score_gemma":0.0066266037,"teacher_disagreement_score":0.12291568,"about_ca_system_score_codex":0.0009704257,"about_ca_system_score_gemma":0.0010933676,"threshold_uncertainty_score":0.8040051},"labels":[],"label_agreement":null},{"id":"W4386784291","doi":"10.1158/1557-3265.aacrahns23-po-076","title":"Abstract PO-076: Adrenergic regulation of the anti-tumor immune response in <i>p53</i>-deficient tumors","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Adrenergic; Cancer research; Biology; Signal transduction; Carcinogenesis; Immunotherapy; Tumor progression; Cell biology; Receptor; Cancer; Immunology; Genetics","score_opus":0.1329765041863686,"score_gpt":0.4631956074872942,"score_spread":0.33021910330092563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968166,0.0026527348,6.7450907e-7,0.0057371715,0.00047596218,0.00080912444,0.000023709943,0.00005385744,0.0005651223],"genre_scores_gemma":[0.9947546,0.0016428625,0.000007080824,0.00016063085,0.00039467958,0.00013313067,0.000012785237,0.000048177353,0.0028460643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99461097,0.0013773701,0.0013340312,0.00056140096,0.0013615654,0.00075469085],"domain_scores_gemma":[0.99518895,0.0028063026,0.00025569164,0.0011405897,0.00042612012,0.00018235062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010505376,0.00019365686,0.0007113396,0.0005315381,0.00018344459,0.000029954806,0.0005036366,0.00018044324,0.00041187397],"category_scores_gemma":[0.0041374816,0.00013976794,0.00039943538,0.0025458124,0.0009983408,0.000078289115,0.000260534,0.0011969169,0.00011329512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15804164,0.0031302345,0.40189666,0.0015906204,0.00026362707,0.0009879016,0.0020905482,0.004529969,0.33491808,0.00040743567,0.03063391,0.06150938],"study_design_scores_gemma":[0.0023812456,0.00052858907,0.97301704,0.0010167503,0.000018959987,0.000021297188,0.00044033772,0.0003277804,0.011631229,0.00007942418,0.01040102,0.0001363443],"about_ca_topic_score_codex":0.0015747314,"about_ca_topic_score_gemma":0.00012393984,"teacher_disagreement_score":0.5711204,"about_ca_system_score_codex":0.000303888,"about_ca_system_score_gemma":0.001965953,"threshold_uncertainty_score":0.56995714},"labels":[],"label_agreement":null},{"id":"W4386784297","doi":"10.1158/1557-3265.aacrahns23-po-079","title":"Abstract PO-079: The impact of statin use on anti-PD-1 monotherapy for recurrent head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Medicine; Tumor microenvironment; Cancer research; Immunotherapy; Internal medicine; Cancer; Head and neck cancer","score_opus":0.1962131180835801,"score_gpt":0.5101702422875223,"score_spread":0.3139571242039422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406207,0.003042671,0.00000846099,0.0004225744,0.0012061538,0.0006718371,0.0004678829,0.000008111233,0.00011023332],"genre_scores_gemma":[0.9876918,0.007481668,0.000027621378,0.000108531436,0.0038139548,0.00014533331,0.00006586621,0.000035620906,0.0006296118],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981613,0.0002065842,0.00040995597,0.00046754256,0.00027461027,0.0004799718],"domain_scores_gemma":[0.9983032,0.00067479763,0.00010351823,0.0004889874,0.00025782522,0.00017169112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014841462,0.00014885605,0.00028713874,0.00007167788,0.00012923797,0.000044448527,0.00026168523,0.00016326584,0.000039368464],"category_scores_gemma":[0.000501246,0.000099774166,0.00025986455,0.00020253795,0.00030622477,0.0000055948994,0.0001022564,0.00035079417,0.0000071877425],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011356289,0.0008241093,0.11965926,0.0002812112,0.00015431648,0.0000012366403,0.00047871814,0.0004746254,0.13426614,0.0000651047,0.6086692,0.12376975],"study_design_scores_gemma":[0.0035030597,0.0036655187,0.81977636,0.000029007297,0.000012990364,6.2231044e-7,0.00010709903,0.00015238127,0.014097596,0.00012325692,0.15834534,0.00018676158],"about_ca_topic_score_codex":0.0017829614,"about_ca_topic_score_gemma":0.00037542603,"teacher_disagreement_score":0.7001171,"about_ca_system_score_codex":0.00003200729,"about_ca_system_score_gemma":0.00048541176,"threshold_uncertainty_score":0.40686724},"labels":[],"label_agreement":null},{"id":"W4386784301","doi":"10.1158/1557-3265.aacrahns23-po-078","title":"Abstract PO-078: Tissue-resident memory CD8+ T cells correlate with anti-PD-1 response in head and neck cancer and expand upon cDC1 activation in tumor-draining lymph nodes to overcome PD-1 resistance","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Immunotherapy; CD8; Cytotoxic T cell; Adoptive cell transfer; Medicine; Flow cytometry; Lymph node; Antigen; T cell; Cancer; Immunology; Immune system; Biology; Head and neck cancer; In vitro; Internal medicine","score_opus":0.09185202323616003,"score_gpt":0.4365398006842508,"score_spread":0.34468777744809076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986131,0.009639471,0.0000036820425,0.002908291,0.00035736276,0.00074915116,0.00004207451,0.00005212337,0.000116849966],"genre_scores_gemma":[0.9874197,0.0054495274,0.000023172932,0.00031177947,0.000052551168,0.0002634409,0.000013342468,0.000053680404,0.0064127934],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9954433,0.0016610264,0.0008472237,0.0008466847,0.0002257839,0.0009759689],"domain_scores_gemma":[0.9947184,0.0044082305,0.00016031155,0.00046254578,0.000155823,0.000094713236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0054913755,0.00029173685,0.00068322616,0.0007443395,0.00032210868,0.0000867688,0.00031909024,0.00036087513,0.00027030907],"category_scores_gemma":[0.0010298587,0.00025660967,0.000051347077,0.001107221,0.00062316627,0.0002749781,0.00025258542,0.0012449975,0.00009777195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09735672,0.00020290242,0.04987871,0.00017799198,0.0001290585,0.00020314795,0.00462341,0.00033829937,0.83309954,0.000020174428,0.0014153201,0.012554711],"study_design_scores_gemma":[0.0056823953,0.00053548155,0.9217457,0.0016190382,0.000007956002,0.0000070972947,0.0012112372,0.000009608228,0.062730566,0.000055721925,0.0060682697,0.00032693762],"about_ca_topic_score_codex":0.005859466,"about_ca_topic_score_gemma":0.002174161,"teacher_disagreement_score":0.871867,"about_ca_system_score_codex":0.00032112154,"about_ca_system_score_gemma":0.00073340186,"threshold_uncertainty_score":0.9999886},"labels":[],"label_agreement":null},{"id":"W4386784303","doi":"10.1158/1557-3265.aacrahns23-po-074","title":"Abstract PO-074: The evolution of the tumor immune microenvironment in immunosuppressed patients with cutaneous squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunosuppression; Tumor microenvironment; Immunotherapy; Immune system; Medicine; Merkel cell carcinoma; Immunology; Cancer; Cancer research; Pathology; Carcinoma; Internal medicine","score_opus":0.052667563233526574,"score_gpt":0.375440506160833,"score_spread":0.32277294292730646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233985,0.0026718643,4.91219e-7,0.0020803728,0.0003035847,0.001491756,0.00005479166,0.000014472793,0.0010428419],"genre_scores_gemma":[0.9986307,0.00021604818,0.00000959935,0.00007241186,0.00014107113,0.00025288545,0.000008059839,0.000040704985,0.000628525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662405,0.00037216005,0.0007498826,0.0004518523,0.001169165,0.00063290773],"domain_scores_gemma":[0.9971066,0.0014291771,0.00019308824,0.0009828105,0.00019998381,0.00008834317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013946812,0.00017524908,0.00044228605,0.00012348582,0.00021911715,0.00001417373,0.00054607453,0.00007704758,0.00021451115],"category_scores_gemma":[0.00042522475,0.00009369,0.000147774,0.0008308633,0.0011382279,0.00003684089,0.00052018824,0.0011944172,0.00007380108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024649305,0.0006392843,0.99083763,0.00018860622,0.000037380654,0.000076502736,0.00027930742,0.00007271636,0.0020712155,0.0000035423282,0.0021130159,0.0012158909],"study_design_scores_gemma":[0.0035149578,0.0010937303,0.99032795,0.00016115881,0.000034071374,0.000004597713,0.0005271113,0.000023724955,0.0033883457,0.00003097218,0.00079409307,0.00009927489],"about_ca_topic_score_codex":0.0039028511,"about_ca_topic_score_gemma":0.0004929203,"teacher_disagreement_score":0.00629087,"about_ca_system_score_codex":0.00086311676,"about_ca_system_score_gemma":0.0005488801,"threshold_uncertainty_score":0.58999693},"labels":[],"label_agreement":null},{"id":"W4386784309","doi":"10.1158/1557-3265.aacrahns23-po-071","title":"Abstract PO-071: Pseudonormal morphology of adenoid cystic carcinoma cells subverts the antitumor reactivity of immune cells","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Adenoid cystic carcinoma; Cancer research; Cancer; Biology; Cancer cell; Jurkat cells; Immunology; T cell; Carcinoma","score_opus":0.17708490283718875,"score_gpt":0.46790349730647524,"score_spread":0.2908185944692865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946021,0.0012673554,8.9711244e-7,0.0018180669,0.0005271983,0.000704107,0.00012993863,0.000026615096,0.00092371757],"genre_scores_gemma":[0.99630344,0.0026770523,0.000017254792,0.000077248216,0.0002946615,0.00011054869,0.00002771408,0.00003129576,0.0004608039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996776,0.00044303903,0.00095802866,0.0004542971,0.0007640797,0.0006045628],"domain_scores_gemma":[0.9933862,0.004957181,0.00024401497,0.0008287814,0.0003732955,0.00021051559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003467619,0.0001735905,0.0007807339,0.00020095368,0.00011519948,0.000011233344,0.00033427106,0.0001632469,0.0004979159],"category_scores_gemma":[0.00064827496,0.000109911496,0.00035402508,0.00070111215,0.0008450003,0.00005358484,0.00023991558,0.0008239691,0.00018996028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002094016,0.004686876,0.914671,0.0005880289,0.00030231083,0.0013693696,0.00021457947,0.000022234668,0.058010064,0.00008476039,0.014573053,0.0033837259],"study_design_scores_gemma":[0.0031123105,0.0010019328,0.8046402,0.00013926269,0.000089148896,0.000016878432,0.00011324257,0.00003995589,0.19033735,0.000062958454,0.00036944225,0.000077343],"about_ca_topic_score_codex":0.005274806,"about_ca_topic_score_gemma":0.00009084159,"teacher_disagreement_score":0.13232727,"about_ca_system_score_codex":0.00008750165,"about_ca_system_score_gemma":0.00056352175,"threshold_uncertainty_score":0.7973964},"labels":[],"label_agreement":null},{"id":"W4386784314","doi":"10.1158/1557-3265.aacrahns23-po-068","title":"Abstract PO-068: Harmony between transdifferentiated neuron and immunosuppressive tumor microenvironment","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Biology; Cancer research; Microvesicles; Cancer cell; Tumor progression; Immune system; Cell biology; microRNA; Cancer; Immunology","score_opus":0.1254023933263422,"score_gpt":0.449786883796585,"score_spread":0.32438449047024276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447715,0.0033497987,0.000015209023,0.0013154803,0.00014129451,0.00038185128,0.00017479986,0.000027715105,0.000116717536],"genre_scores_gemma":[0.9948264,0.0031242005,0.000024149622,0.00014121218,0.0004648039,0.00009470454,0.00022531925,0.000050103583,0.0010491232],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974919,0.0003731362,0.000452201,0.0007118281,0.00038779507,0.0005831495],"domain_scores_gemma":[0.9987746,0.0002114413,0.000071373695,0.0005440043,0.0000705022,0.00032811993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010623436,0.00016919193,0.00023112303,0.00007290218,0.00016864193,0.000055683915,0.00041620623,0.00017047103,0.00020096594],"category_scores_gemma":[0.0002844759,0.00016103614,0.00014272572,0.00017356365,0.0006054017,0.0000057710195,0.00041570264,0.000576215,0.00012842033],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045260813,0.00017912257,0.0846326,0.000101355174,0.00015130498,0.00010599924,0.000040592557,0.000011531528,0.87595797,0.0000037995999,0.0210083,0.017354818],"study_design_scores_gemma":[0.001148971,0.0002949721,0.82838535,0.00004329255,0.000030452096,0.0000016212534,0.000049409497,0.000022179309,0.14586826,0.00012104385,0.02383362,0.00020083795],"about_ca_topic_score_codex":0.000045455654,"about_ca_topic_score_gemma":0.000012637392,"teacher_disagreement_score":0.7437527,"about_ca_system_score_codex":0.000024314872,"about_ca_system_score_gemma":0.000118782154,"threshold_uncertainty_score":0.6566863},"labels":[],"label_agreement":null},{"id":"W4386784320","doi":"10.1158/1557-3265.aacrahns23-po-066","title":"Abstract PO-066: Complete pathological response following neoadjuvant chemotherapy and recurrence free survival in patients with p16-positive oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Docetaxel; Lymphovascular invasion; Neoadjuvant therapy; Oncology; Regimen; Neck dissection; Cancer; Surgery; Internal medicine; Radiation therapy; Adverse effect; Chemotherapy; Metastasis; Breast cancer","score_opus":0.2170873572515408,"score_gpt":0.49979107848798054,"score_spread":0.2827037212364397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871496,0.0014058378,0.0000015125923,0.009313792,0.00042305113,0.00094073603,0.00023458512,0.000057928817,0.00047297237],"genre_scores_gemma":[0.9943278,0.0041471547,0.00006075403,0.0006166077,0.00028311304,0.00026879756,0.000026198022,0.0000425581,0.000227008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995636,0.0007393265,0.0006369886,0.0008747155,0.001190959,0.0009220122],"domain_scores_gemma":[0.99583095,0.0028565328,0.00008376521,0.00045598738,0.0003838924,0.00038886082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046509546,0.00024997257,0.0009828827,0.00023029925,0.00024534127,0.000037885235,0.00027205984,0.00019929303,0.00019991743],"category_scores_gemma":[0.0016675045,0.00017732692,0.00012996235,0.0010244482,0.00069770607,0.00010392441,0.00031581792,0.001453431,0.000030528347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024140943,0.00035539994,0.91316533,0.000078654404,0.00011876169,0.0005828243,0.0005954635,0.000002119995,0.00029954716,0.000008847571,0.0031952641,0.057456836],"study_design_scores_gemma":[0.010207734,0.002715499,0.984337,0.00089951215,0.000021231705,0.0000010044257,0.00023495803,0.000031440453,0.00006777143,0.00007929346,0.0011943013,0.00021030939],"about_ca_topic_score_codex":0.0010668547,"about_ca_topic_score_gemma":0.0009202746,"teacher_disagreement_score":0.07117161,"about_ca_system_score_codex":0.00030414865,"about_ca_system_score_gemma":0.0006439177,"threshold_uncertainty_score":0.7231182},"labels":[],"label_agreement":null},{"id":"W4386784328","doi":"10.1158/1557-3265.aacrahns23-po-046","title":"Abstract PO-046: Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV DNA before head and neck cancer diagnosis","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Serology; Cancer; Incidence (geometry); Biomarker; Head and neck cancer; Oncology; Population; Internal medicine; Antibody; Multiplex; Disease; Antigen; Pathology; Immunology; Bioinformatics; Biology","score_opus":0.31103649288256346,"score_gpt":0.5347342473916546,"score_spread":0.22369775450909118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98632234,0.0018465079,0.0000044907397,0.008589281,0.00016197754,0.00081887486,0.00012989448,0.0000847983,0.002041816],"genre_scores_gemma":[0.9958309,0.0018202885,0.0000793742,0.00019752952,0.000546253,0.0008258156,0.00001860561,0.00005180098,0.00062946056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967712,0.00024356315,0.0007095767,0.0006498735,0.0009347497,0.0006910369],"domain_scores_gemma":[0.99609274,0.0023722248,0.00015024707,0.00042811836,0.000563187,0.00039350745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022448178,0.00020495657,0.0008009643,0.00020927897,0.00036520243,0.000030147574,0.00014206962,0.00016586341,0.0003065322],"category_scores_gemma":[0.0015907374,0.0001570702,0.000102635604,0.0011261046,0.0007615667,0.00012534048,0.00018923382,0.0011250967,0.000026978056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007275526,0.00017422978,0.9310933,0.00072392815,0.00014690423,0.00015507315,0.00062827044,0.00003836833,0.0002845113,0.00009618118,0.003112616,0.062819116],"study_design_scores_gemma":[0.0023125317,0.0011513036,0.99184066,0.001333564,0.000067002846,0.000006512273,0.00023744428,0.00020316661,0.0012938555,0.00025096504,0.001148065,0.0001549313],"about_ca_topic_score_codex":0.005174314,"about_ca_topic_score_gemma":0.00560327,"teacher_disagreement_score":0.06266418,"about_ca_system_score_codex":0.00022157661,"about_ca_system_score_gemma":0.0007965025,"threshold_uncertainty_score":0.782205},"labels":[],"label_agreement":null},{"id":"W4386784339","doi":"10.1158/1557-3265.aacrahns23-po-050","title":"Abstract PO-050: Preliminary results from an early-phase, open-label study of tolinapant and radiation in cisplatin-ineligible patients with previously untreated, locally advanced head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck cancer; Cisplatin; Radiation therapy; Adjuvant; Cancer; Phases of clinical research; Oncology; Toxicity; Internal medicine; Chemotherapy; Surgery; Gastroenterology; Urology","score_opus":0.17596785457609776,"score_gpt":0.530724536578169,"score_spread":0.3547566820020712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666256,0.00035154287,9.758813e-7,0.00075902336,0.000023037728,0.0017479664,0.00031997496,0.000028040655,0.00010687565],"genre_scores_gemma":[0.99698275,0.001976184,0.000063256324,0.00010227969,0.00007977206,0.00021399559,0.00030969907,0.00002888483,0.00024317339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968698,0.00030023072,0.00095053454,0.0007703286,0.00070108566,0.00040800372],"domain_scores_gemma":[0.9978291,0.00066218316,0.00021054919,0.00042912073,0.0004911738,0.00037787555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012993284,0.00017377245,0.0006369085,0.00031699095,0.00011178448,0.00006283047,0.0001702268,0.00013156068,0.00006363254],"category_scores_gemma":[0.00057064736,0.0001344632,0.000026638441,0.0010485848,0.00022099375,0.00028652413,0.00020511061,0.00057317683,0.000006862531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04585867,0.006516017,0.8349822,0.000111724985,0.00015773483,0.00013790335,0.0012149299,0.00015726683,0.00021468753,0.000001621143,0.0006188142,0.11002844],"study_design_scores_gemma":[0.069030434,0.01294102,0.9137477,0.0016927999,0.00006887414,3.7652467e-7,0.0004952449,0.00167137,0.00013863728,0.00002683629,0.00004483494,0.00014183832],"about_ca_topic_score_codex":0.022347534,"about_ca_topic_score_gemma":0.009786482,"teacher_disagreement_score":0.1098866,"about_ca_system_score_codex":0.00010293319,"about_ca_system_score_gemma":0.0003633898,"threshold_uncertainty_score":0.98416275},"labels":[],"label_agreement":null},{"id":"W4386784341","doi":"10.1158/1557-3265.aacrahns23-po-048","title":"Abstract PO-048: Baseline blood DNA methylation-based immune profiles are associated with survival outcomes in head and neck cancer patients on immune checkpoint therapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Immunotherapy; Immune system; Hazard ratio; Biomarker; Ipilimumab; DNA methylation; Pembrolizumab; Proportional hazards model; Cancer; Head and neck cancer; Immunology; Confidence interval; Biology","score_opus":0.16669272135349594,"score_gpt":0.47080515836399994,"score_spread":0.304112437010504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673105,0.0023755974,5.271308e-7,0.008518496,0.00033941446,0.0015476105,0.0002441989,0.000096604104,0.000146487],"genre_scores_gemma":[0.99296194,0.0048484597,0.000015769896,0.00046489926,0.00016946426,0.0005624082,0.00023887522,0.00007849638,0.0006596552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99530107,0.00067172037,0.0011977012,0.0007359691,0.0013162106,0.0007773546],"domain_scores_gemma":[0.99543864,0.002850737,0.00032998328,0.0005155479,0.0006440832,0.00022101213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005691783,0.00032321946,0.0009988659,0.0004252661,0.0002010884,0.000057910143,0.00023531022,0.00029808393,0.0006070034],"category_scores_gemma":[0.0017193162,0.0002255821,0.00024949518,0.0014646011,0.0004753068,0.00008668078,0.00006690596,0.001240416,0.00001786512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015481348,0.0021085376,0.95065355,0.00010859134,0.00060216954,0.000052233772,0.000115466966,0.000026357884,0.0038375608,0.0000020862265,0.00023633435,0.026775772],"study_design_scores_gemma":[0.024332453,0.002147603,0.96290827,0.0013271002,0.000035817,1.7643619e-7,0.000117761265,0.0001436448,0.008186351,0.000016703043,0.0005270638,0.00025706142],"about_ca_topic_score_codex":0.0057583516,"about_ca_topic_score_gemma":0.0037907602,"teacher_disagreement_score":0.02651871,"about_ca_system_score_codex":0.00035914293,"about_ca_system_score_gemma":0.0008993813,"threshold_uncertainty_score":0.91989714},"labels":[],"label_agreement":null},{"id":"W4386784343","doi":"10.1158/1557-3265.aacrahns23-po-058","title":"Abstract PO-058: Piloting a novel strategy to rapidly implement smoking cessation treatment for newly-diagnosed head and neck cancer patients","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Smoking cessation; Head and neck cancer; Abstinence; Pharmacotherapy; Survivorship curve; Cancer; Population; Internal medicine; Physical therapy; Oncology; Family medicine; Psychiatry; Pathology","score_opus":0.44375714622356643,"score_gpt":0.5787604659957757,"score_spread":0.13500331977220925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891103,0.0008289427,0.000013758471,0.006719598,0.0004234696,0.002386847,0.0003032083,0.000073880845,0.00033923527],"genre_scores_gemma":[0.990803,0.0045371144,0.00011823627,0.00057925074,0.0010048697,0.0024149923,0.00007548339,0.000049991693,0.0004170396],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99677163,0.00007936991,0.0007741496,0.0007386697,0.00070832437,0.00092784024],"domain_scores_gemma":[0.99703574,0.0014819416,0.00010625033,0.000266223,0.0006201745,0.00048968394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017128501,0.00022158785,0.0006199806,0.00023148123,0.00040637897,0.00006784718,0.00011811348,0.00012257465,0.00017296696],"category_scores_gemma":[0.00083007145,0.00017703637,0.00013878343,0.0006371462,0.000101638914,0.00008576097,0.00014528954,0.00035916225,0.000016893424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018228419,0.00073108455,0.46921393,0.0003496606,0.0003029818,0.000015642445,0.0010361931,0.000059347098,0.0006459736,0.000038314432,0.01669558,0.50908846],"study_design_scores_gemma":[0.0143015385,0.0069271917,0.9455115,0.0006882544,0.00006418993,3.1038863e-7,0.0005929487,0.0001960561,0.0005573608,0.000053625266,0.030906882,0.00020012328],"about_ca_topic_score_codex":0.0070299674,"about_ca_topic_score_gemma":0.006701007,"teacher_disagreement_score":0.5088883,"about_ca_system_score_codex":0.00069777877,"about_ca_system_score_gemma":0.00082545844,"threshold_uncertainty_score":0.9995823},"labels":[],"label_agreement":null},{"id":"W4386784346","doi":"10.1158/1557-3265.aacrahns23-po-049","title":"Abstract PO-049: The neural landscape is associated with functional outcomes for patients with oropharyngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dysphagia; Swallowing; Cancer; Internal medicine; Oncology; Tumor microenvironment; Pathology; Surgery","score_opus":0.1884219372258508,"score_gpt":0.4529086158012062,"score_spread":0.26448667857535546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869703,0.00027488734,9.646633e-7,0.009799921,0.00031423743,0.0010804429,0.00021447451,0.0000675629,0.0012772027],"genre_scores_gemma":[0.99365073,0.00006919872,0.00000644325,0.0012182138,0.00043189598,0.00045150024,0.00011598614,0.0000481525,0.004007901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709547,0.00012437576,0.00040147724,0.0004921362,0.0011638042,0.0007227332],"domain_scores_gemma":[0.99511987,0.0032940605,0.00009205317,0.00033490008,0.0009156525,0.00024348481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012438578,0.00018602205,0.00054886384,0.00010239646,0.0004477408,0.00003613002,0.00017914495,0.00012089087,0.00041229092],"category_scores_gemma":[0.0007296261,0.00009250159,0.00015895285,0.00062652037,0.0003660758,0.00006104969,0.0001016845,0.00082806015,0.00005871349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032364924,0.00035452496,0.8920404,0.000081910184,0.00010867414,0.000034221095,0.00016211213,0.000007370077,0.0000040607306,0.0000023999557,0.10155244,0.002415411],"study_design_scores_gemma":[0.008954281,0.003001821,0.9839797,0.000048409107,0.00007626246,6.3394003e-7,0.00019740828,0.00015690237,0.000024316574,0.000013164341,0.003420118,0.00012697186],"about_ca_topic_score_codex":0.00022876626,"about_ca_topic_score_gemma":0.0004401589,"teacher_disagreement_score":0.09813233,"about_ca_system_score_codex":0.00012747447,"about_ca_system_score_gemma":0.00061954267,"threshold_uncertainty_score":0.45142967},"labels":[],"label_agreement":null},{"id":"W4386784348","doi":"10.1158/1557-3265.aacrahns23-po-061","title":"Abstract PO-061: Utilizing T cell receptor-based therapy to treat anaplastic thyroid cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epitope; Biology; Cancer research; Chimeric antigen receptor; Major histocompatibility complex; Antigen; Cancer; Immunotherapy; Immunology; Genetics","score_opus":0.21965958097910038,"score_gpt":0.47337040580110656,"score_spread":0.2537108248220062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920144,0.0025487093,0.000028742998,0.0017106748,0.00034766187,0.0004809927,0.0000885597,0.00003710504,0.0027431438],"genre_scores_gemma":[0.98616046,0.01019233,0.000118313656,0.00057026587,0.00069714803,0.0003330036,0.00013399072,0.000051875544,0.0017425918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976804,0.0001418647,0.0005324799,0.0005077728,0.00041961964,0.00071780855],"domain_scores_gemma":[0.99853253,0.00025016323,0.000080084304,0.0005850051,0.00027344783,0.00027876397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015985847,0.00019762888,0.00026826092,0.00014415926,0.00021330755,0.000088109286,0.000521717,0.00024167025,0.00040646756],"category_scores_gemma":[0.00031365614,0.00016102195,0.00018618579,0.000617335,0.00011591847,0.000008034686,0.00022513556,0.0004667605,0.00033080744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031622653,0.00039646935,0.01504727,0.00026131267,0.00011686318,0.000007871108,0.00016992792,0.00212689,0.5845152,0.000021734992,0.27161804,0.122556105],"study_design_scores_gemma":[0.0056233527,0.0038861975,0.05912742,0.00019337624,0.000021658674,8.454251e-7,0.0009012757,0.0014657706,0.51463354,0.000057767986,0.4132204,0.0008683902],"about_ca_topic_score_codex":0.00034978022,"about_ca_topic_score_gemma":0.000126922,"teacher_disagreement_score":0.14160235,"about_ca_system_score_codex":0.00005829923,"about_ca_system_score_gemma":0.00054283027,"threshold_uncertainty_score":0.65662843},"labels":[],"label_agreement":null},{"id":"W4386784350","doi":"10.1158/1557-3265.aacrahns23-po-053","title":"Abstract PO-053: Chemical suppression of DHFR induces NRF2 inhibition and tumor regression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"In vivo; Cancer research; Head and neck squamous-cell carcinoma; In vitro; Bystander effect; Transcription factor; Biology; Effector; Cancer; Cell culture; Medicine; Immunology; Head and neck cancer; Gene; Genetics","score_opus":0.1969939012870086,"score_gpt":0.513957397760949,"score_spread":0.31696349647394034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684364,0.0014171266,0.0000053641706,0.00084198674,0.00013504676,0.00017655047,0.00004373506,0.00001281153,0.000523732],"genre_scores_gemma":[0.99365413,0.0052840644,0.0000415791,0.000058088066,0.00040974125,0.000085543186,0.000093819246,0.000017373815,0.00035565635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984274,0.00014220896,0.00037942964,0.00043099135,0.0003459406,0.00027403177],"domain_scores_gemma":[0.999043,0.00012768479,0.000092840586,0.00033843005,0.0002559123,0.00014214189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013304176,0.000092364746,0.00016991228,0.000078594014,0.00009940794,0.00002175927,0.00015916231,0.00020135955,0.000104231396],"category_scores_gemma":[0.0005262235,0.00007255201,0.00007361051,0.00027063227,0.00039760917,0.000007506262,0.0002542539,0.00035072156,0.000017917084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025500043,0.000074783915,0.0041356776,0.000058695205,0.000013699351,0.0000039251445,0.000020241841,0.0000033065885,0.9475018,0.000027467118,0.020474967,0.027430445],"study_design_scores_gemma":[0.00068132055,0.00019306282,0.07297545,0.0002316361,0.0000060601237,0.0000019941879,0.00011360769,0.000033540946,0.9138201,0.00033436797,0.011486462,0.0001224009],"about_ca_topic_score_codex":0.00008571961,"about_ca_topic_score_gemma":0.000010248832,"teacher_disagreement_score":0.06883977,"about_ca_system_score_codex":0.000017501476,"about_ca_system_score_gemma":0.00019728608,"threshold_uncertainty_score":0.2958585},"labels":[],"label_agreement":null},{"id":"W4386784365","doi":"10.1158/1557-3265.aacrahns23-po-042","title":"Abstract PO-042: Next generation liquid biopsy for diagnosis and prognostication in HPV+OPSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Digital polymerase chain reaction; Concordance; Genotyping; Medicine; Whole genome sequencing; Oncology; DNA sequencing; Ion semiconductor sequencing; Genome; Computational biology; Internal medicine; Cancer; Gene; Biology; Genotype; Polymerase chain reaction; Genetics","score_opus":0.3277659022950732,"score_gpt":0.5108360468936506,"score_spread":0.1830701445985774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936074,0.0022847024,0.0000619443,0.0027028911,0.0002998026,0.00078113755,0.00011799536,0.000011844461,0.00013226017],"genre_scores_gemma":[0.9715714,0.024677081,0.00018582208,0.00021170796,0.0013876122,0.0014896382,0.0003205156,0.000028039005,0.00012822355],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984238,0.00008549462,0.00039434602,0.00052834797,0.00018084263,0.00038716831],"domain_scores_gemma":[0.99862194,0.0006440111,0.00005645154,0.00027789603,0.00025703237,0.0001426738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017665016,0.00010212068,0.00015815461,0.00011191914,0.00011389656,0.00008054477,0.00016870431,0.00021838045,0.00003720907],"category_scores_gemma":[0.0027480589,0.00010281176,0.00006723623,0.00029112556,0.000180194,0.0000075255516,0.0001725969,0.00020655041,0.000019948397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023729883,0.0007711482,0.20097093,0.0003601119,0.0001323967,0.000026869995,0.00019321287,0.00043494182,0.3213544,0.0009835612,0.11794049,0.35445896],"study_design_scores_gemma":[0.0047891294,0.004230898,0.58659405,0.00017135366,0.00004749089,0.0000046004307,0.0002845817,0.0040171635,0.15574795,0.0014214877,0.24182811,0.00086320663],"about_ca_topic_score_codex":0.0002442102,"about_ca_topic_score_gemma":0.00079598196,"teacher_disagreement_score":0.38562307,"about_ca_system_score_codex":0.000042936183,"about_ca_system_score_gemma":0.00030495584,"threshold_uncertainty_score":0.41925418},"labels":[],"label_agreement":null},{"id":"W4386784370","doi":"10.1158/1557-3265.aacrahns23-po-024","title":"Abstract PO-024: Analysis of the NOTCH pathway in HNSCC: A target with a wide prognostic and therapeutic potential","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"HES1; Notch signaling pathway; Cyclin D1; Cancer research; Transcriptome; Internal medicine; CDKN2A; Medicine; Survival analysis; Gene expression; Gene; Oncology; Biology; Cancer; Cell cycle; Genetics","score_opus":0.12500469046507554,"score_gpt":0.47096878238817874,"score_spread":0.3459640919231032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500424,0.000687843,0.0000039487,0.0031424956,0.00008031723,0.000583642,0.000036903417,0.000017007002,0.0004436226],"genre_scores_gemma":[0.9989579,0.000365014,0.000010972883,0.00016410742,0.000111189096,0.000088589644,0.000009591293,0.000018927982,0.00027372656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778116,0.00025279415,0.0004341997,0.00036442376,0.00077601965,0.0003914102],"domain_scores_gemma":[0.9979635,0.0011919744,0.00007104409,0.00040523242,0.00022295797,0.00014532082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002616829,0.00009813487,0.00055728847,0.0003252404,0.00006785896,0.000021765742,0.00014048464,0.00009399649,0.00017811725],"category_scores_gemma":[0.0006725219,0.000056467466,0.00024736827,0.002809216,0.0005456967,0.00002314468,0.00013818165,0.00076503877,0.000010165282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083742995,0.00020044243,0.99076265,0.00010240904,0.0006561788,0.00015806881,0.00016764592,0.00017324155,0.00079142686,0.000035412355,0.00031292002,0.005802159],"study_design_scores_gemma":[0.0012600997,0.0002928644,0.99588925,0.00016310156,0.00025830916,0.0000029715814,0.00018112909,0.0008881066,0.00029117643,0.00022627163,0.00048146694,0.000065247834],"about_ca_topic_score_codex":0.0010599205,"about_ca_topic_score_gemma":0.0009057851,"teacher_disagreement_score":0.005736911,"about_ca_system_score_codex":0.000049747814,"about_ca_system_score_gemma":0.00053909374,"threshold_uncertainty_score":0.33237553},"labels":[],"label_agreement":null},{"id":"W4386784371","doi":"10.1158/1557-3265.aacrahns23-po-031","title":"Abstract PO-031: Integrated bioinformatics and functional spatial analysis platform for the discovery of predictive biomarkers in oral cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Proportional hazards model; Immunotherapy; Cancer; Oncology; Tumor microenvironment; Medicine; Survival analysis; Cancer immunotherapy; Internal medicine; Bioinformatics; Biology; Immunology","score_opus":0.24601114962425674,"score_gpt":0.4923340481755268,"score_spread":0.24632289855127004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926554,0.0009953405,0.00075417745,0.0032830753,0.00032898557,0.0011015164,0.00065557036,0.00002488839,0.00020104687],"genre_scores_gemma":[0.99341506,0.0051443325,0.000062740415,0.00012340603,0.00021377759,0.00071746705,0.000119344426,0.000016677945,0.00018720783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776965,0.00006322255,0.00076729513,0.00031194827,0.0006806179,0.00040726401],"domain_scores_gemma":[0.99696714,0.0020486317,0.0001361953,0.00025764006,0.0004635905,0.00012683374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030549688,0.00012916594,0.0005056009,0.0004738014,0.00011946942,0.000045835786,0.00014069211,0.00016031682,0.00026333999],"category_scores_gemma":[0.0007642649,0.0000784334,0.00026747264,0.0022417016,0.0006534958,0.00017356333,0.00011986728,0.0005752482,0.0000035599073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00767766,0.00021373796,0.8071813,0.0003433249,0.0033194933,0.0000039121,0.0002986559,0.000534611,0.00014064409,0.000039484054,0.012467649,0.1677795],"study_design_scores_gemma":[0.002102332,0.00050607004,0.94250435,0.00019117724,0.00041662503,3.1788898e-7,0.0013947934,0.050933953,0.00037789723,0.0000688934,0.0014169157,0.00008667967],"about_ca_topic_score_codex":0.008922877,"about_ca_topic_score_gemma":0.0075626136,"teacher_disagreement_score":0.16769283,"about_ca_system_score_codex":0.00020849615,"about_ca_system_score_gemma":0.000846657,"threshold_uncertainty_score":0.9976768},"labels":[],"label_agreement":null},{"id":"W4386784375","doi":"10.1158/1557-3265.aacrahns23-po-032","title":"Abstract PO-032: Association of a polymorphic variant in <i>JMJD1C</i> with tumor recurrence after adjuvant chemoradiation therapy in head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Radiation therapy; Single-nucleotide polymorphism; Head and neck cancer; Chemotherapy; Cancer research; Genotype; Biology; Gene; Genetics","score_opus":0.07027693472209179,"score_gpt":0.39758671297690823,"score_spread":0.32730977825481644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582154,0.002769996,0.0000032696307,0.00075167895,0.00006272529,0.00034375265,0.000048829803,0.000004420165,0.0001937707],"genre_scores_gemma":[0.9963379,0.002854451,0.000026340836,0.000103572296,0.00012843538,0.00028784145,0.000034247947,0.000017002363,0.00021020006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983093,0.00020278299,0.0004138666,0.00042640115,0.00031021168,0.000337407],"domain_scores_gemma":[0.9991844,0.0001477457,0.0001265252,0.00027735063,0.00018297236,0.000080974976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001738766,0.00010045968,0.00020985959,0.00012978165,0.000036616468,0.00002207214,0.00014918257,0.00014694638,0.000032659427],"category_scores_gemma":[0.00020280865,0.00008665874,0.00004197465,0.00055606634,0.00010727471,0.0000099274,0.000058231133,0.00035031448,0.0000058740325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018168576,0.00032682985,0.95196545,0.00007753068,0.000010019216,0.00004342429,0.00016789009,0.00008231142,0.02617236,0.0000070627207,0.0008279787,0.01850229],"study_design_scores_gemma":[0.0024009508,0.0005685941,0.98648596,0.000045537272,0.000002654387,0.0000011540405,0.00006105367,0.00014849377,0.009189764,0.000042351807,0.00094144174,0.000112039386],"about_ca_topic_score_codex":0.0013729873,"about_ca_topic_score_gemma":0.002010434,"teacher_disagreement_score":0.034520518,"about_ca_system_score_codex":0.0000926159,"about_ca_system_score_gemma":0.0004069925,"threshold_uncertainty_score":0.3533841},"labels":[],"label_agreement":null},{"id":"W4386784380","doi":"10.1158/1557-3265.aacrahns23-po-038","title":"Abstract PO-038: Metabolic-inflammatory investigation of head and neck cancer patient reported neuropsychological factors via multiomics integration of the plasma metabolome, lipidome, and circulating inflammation cytokines","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metabolome; Lipidome; Inflammation; Medicine; Internal medicine; Immunology; Cytokine; Oncology; Bioinformatics; Metabolite; Lipid metabolism; Biology","score_opus":0.19252822911477752,"score_gpt":0.4591610412550331,"score_spread":0.2666328121402556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653924,0.0010856698,0.00000819441,0.000781672,0.0005154719,0.0009786995,0.000027191469,0.000037258695,0.000026609412],"genre_scores_gemma":[0.9936852,0.005786997,0.00006083627,0.000044774104,0.00027877375,0.00007798266,0.00002769939,0.000023258217,0.000014488611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654514,0.0005269729,0.00133665,0.00043264378,0.00084329804,0.0003152991],"domain_scores_gemma":[0.9973,0.00083450857,0.0005116503,0.0004154787,0.00067230983,0.00026604175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002575553,0.00016379499,0.0006321108,0.0002718541,0.0001598328,0.000017716977,0.000092731505,0.00025277026,0.000013857597],"category_scores_gemma":[0.0034067049,0.000102778125,0.00022161902,0.00095888454,0.00064256205,0.000115764335,0.00011848124,0.0007920765,0.0000010832586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045784086,0.000032208143,0.85739785,0.0003048082,0.00015426957,0.0000054225166,0.00068914844,0.00012398066,0.05321757,0.000028760045,0.000055518827,0.0875326],"study_design_scores_gemma":[0.0012919115,0.00014332254,0.9801825,0.00024340315,0.00009849574,0.0000070281626,0.00020377978,0.0011912477,0.015953705,0.000071853574,0.0005265324,0.000086181026],"about_ca_topic_score_codex":0.0017510372,"about_ca_topic_score_gemma":0.00035579954,"teacher_disagreement_score":0.122784674,"about_ca_system_score_codex":0.000054667362,"about_ca_system_score_gemma":0.00037179975,"threshold_uncertainty_score":0.41911703},"labels":[],"label_agreement":null},{"id":"W4386784381","doi":"10.1158/1557-3265.aacrahns23-po-012","title":"Abstract PO-012: Spatial transcriptomic analysis of HPV-related and HPV-unrelated head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Transcriptome; Biology; Cell; Tumor microenvironment; Stroma; Cell type; Phenotype; Computational biology; Cancer research; Cancer; Pathology; Head and neck cancer; Gene; Medicine; Gene expression; Immunohistochemistry; Genetics; Immunology","score_opus":0.09196648190980143,"score_gpt":0.40242211420409635,"score_spread":0.3104556322942949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507195,0.002951081,0.000027266537,0.00033345702,0.00022561492,0.00029144503,0.00014841808,0.000023689707,0.0009270671],"genre_scores_gemma":[0.99641234,0.0025383234,0.000022311962,0.000071763614,0.00013445938,0.000022830991,0.00020237436,0.000038719692,0.00055690383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973321,0.00027510038,0.0007580238,0.0007294182,0.00036787908,0.00053745724],"domain_scores_gemma":[0.9986819,0.000279251,0.000104430575,0.00040751128,0.00023494281,0.00029196704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001391957,0.00020411084,0.00052765396,0.00031630354,0.00014903022,0.000039521157,0.0002579654,0.0005043185,0.00025883474],"category_scores_gemma":[0.00020334618,0.00019201127,0.00026937056,0.0009344748,0.0006094588,0.0000075045955,0.000116775926,0.0006363112,0.0000103619095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022321208,0.0005162078,0.5756268,0.00029639518,0.00078461284,0.000050574956,0.00047098263,0.0003567144,0.37776902,0.000018970391,0.0017687889,0.0401088],"study_design_scores_gemma":[0.0031166885,0.0008860093,0.96056163,0.000013477899,0.0003022601,0.0000015006848,0.0000827878,0.0027849223,0.030629992,0.000054478332,0.0013096386,0.00025662335],"about_ca_topic_score_codex":0.0036977208,"about_ca_topic_score_gemma":0.0023514277,"teacher_disagreement_score":0.3849348,"about_ca_system_score_codex":0.000026162345,"about_ca_system_score_gemma":0.00022418467,"threshold_uncertainty_score":0.7829992},"labels":[],"label_agreement":null},{"id":"W4386784382","doi":"10.1158/1557-3265.aacrahns23-po-017","title":"Abstract PO-017: Targeting murine oral tumors by pharmacological inhibition of b-catenin/CBP epigenetic activity","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Immune system; Wnt signaling pathway; Biology; Cancer research; 4-Nitroquinoline 1-oxide; Cell; Carcinogen; Catenin; Phenotype; Epigenetics; Fibroblast; Cancer; Immunology; Cell culture; Medicine; Carcinogenesis; Cell biology; Genetics; Signal transduction","score_opus":0.30353936019203775,"score_gpt":0.5424886403528237,"score_spread":0.23894928016078598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915312,0.00088878523,0.000007840042,0.0056702844,0.00025259447,0.00069101836,0.00007946361,0.00010450304,0.0007743266],"genre_scores_gemma":[0.9939278,0.0042901817,0.000053277094,0.00023995015,0.0005663439,0.00031794806,0.00006320311,0.00004032683,0.00050101016],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962319,0.0004379704,0.00080422283,0.00065441505,0.0010816075,0.00078987365],"domain_scores_gemma":[0.99786437,0.0008432603,0.00017205693,0.0002466643,0.00044182182,0.0004318046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044523333,0.00018351707,0.00065102946,0.00018363383,0.00016440456,0.000025549203,0.00020336511,0.00023369667,0.0029659423],"category_scores_gemma":[0.0009951477,0.00014760077,0.00027371323,0.0011047646,0.00065065635,0.000087948654,0.000264145,0.0013843761,0.00017773721],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032482056,0.0019227862,0.13173847,0.0006216838,0.00023914251,0.00016792481,0.000089104265,0.000035856872,0.5134746,0.000013494481,0.219308,0.12914073],"study_design_scores_gemma":[0.0035823307,0.0017801597,0.60797346,0.0003454619,0.00009050718,0.0000023630137,0.00015148235,0.00045282283,0.37787822,0.00012130462,0.0073711234,0.00025073576],"about_ca_topic_score_codex":0.00074304006,"about_ca_topic_score_gemma":0.000027330721,"teacher_disagreement_score":0.476235,"about_ca_system_score_codex":0.00018374431,"about_ca_system_score_gemma":0.00044818918,"threshold_uncertainty_score":0.9979455},"labels":[],"label_agreement":null},{"id":"W4386784391","doi":"10.1158/1557-3265.aacrahns23-po-026","title":"Abstract PO-026: Intra-tumor heterogeneity of HPV integration and its association with focal genomic instability in oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogenesis; Cancer; Genome instability; Biology; Genome; Somatic cell; Genetics; Cancer research; Phylogenetic tree; Gene; Oncology; Medicine; DNA; DNA damage","score_opus":0.09390790174029202,"score_gpt":0.45111336547855396,"score_spread":0.35720546373826195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965723,0.0015479204,0.00007221125,0.0006473561,0.00015654301,0.0006994115,0.00012770182,0.000012902971,0.00016365985],"genre_scores_gemma":[0.9945543,0.0046048374,0.000029509756,0.00007779731,0.00024330597,0.00028502362,0.000054274213,0.000036653033,0.00011432145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968066,0.0005590991,0.0005881686,0.0007219638,0.00071960344,0.0006045229],"domain_scores_gemma":[0.9984699,0.000225283,0.0001516638,0.0003489121,0.0006052135,0.00019904388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039694975,0.00016299172,0.00035553402,0.00018913552,0.0000895753,0.00003480295,0.00028543972,0.00033905386,0.00015911525],"category_scores_gemma":[0.001132772,0.00014634838,0.00009138175,0.0006703174,0.00021864816,0.000014915834,0.00031235113,0.0009319104,0.0000131345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028329736,0.00026288352,0.05381546,0.00023286381,0.00018137232,0.000034458764,0.00009683156,0.0005892664,0.8854762,0.00003583021,0.00095587363,0.055486012],"study_design_scores_gemma":[0.0019649756,0.00090196956,0.4867609,0.00007479842,0.000014654623,0.00000196809,0.000106947184,0.0011094053,0.5080556,0.00008018024,0.0007185568,0.00021000854],"about_ca_topic_score_codex":0.0013436656,"about_ca_topic_score_gemma":0.009324276,"teacher_disagreement_score":0.43294546,"about_ca_system_score_codex":0.00042948252,"about_ca_system_score_gemma":0.0010275163,"threshold_uncertainty_score":0.5967914},"labels":[],"label_agreement":null},{"id":"W4386784394","doi":"10.1158/1557-3265.aacrahns23-po-035","title":"Abstract PO-035: Immune profiles of long-term survivors of patients with head and neck squamous carcinoma on immune checkpoint inhibitor therapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Head and neck squamous-cell carcinoma; Medicine; Immune system; Cancer; Oncology; Head and neck cancer; Pembrolizumab; CD8; Internal medicine; Immune checkpoint; Immunology; Cancer research","score_opus":0.11894448955992439,"score_gpt":0.4381471259585031,"score_spread":0.3192026363985787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936259,0.0036435246,2.4525804e-7,0.0007665413,0.0002566429,0.0013848623,0.00010173929,0.000033390166,0.00018717437],"genre_scores_gemma":[0.99550545,0.003724685,0.000011293159,0.00004967383,0.00017974054,0.00007992478,0.000078984114,0.000054483033,0.00031576265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657065,0.00022128724,0.0011308027,0.000496344,0.0010618789,0.0005190636],"domain_scores_gemma":[0.9974544,0.0008105409,0.00029136814,0.0006416682,0.00062589307,0.00017613318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022727589,0.00022010974,0.00076024485,0.00029622452,0.00009959983,0.000017873565,0.00023032949,0.00020657465,0.0003498457],"category_scores_gemma":[0.00026361004,0.00015129289,0.00023944536,0.0008329381,0.0010473502,0.00006844321,0.000112050846,0.00071598584,0.00001147167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039402075,0.0010363685,0.8945817,0.0005704352,0.000203308,0.000030149657,0.00025308543,0.0000011058263,0.012946462,0.0000028694737,0.00016884335,0.050803628],"study_design_scores_gemma":[0.010905942,0.0061784987,0.9292024,0.0007947113,0.000016676797,0.0000010868597,0.00010173374,0.000004931534,0.052491847,0.000007533796,0.00015123702,0.00014342666],"about_ca_topic_score_codex":0.0037430346,"about_ca_topic_score_gemma":0.00030373616,"teacher_disagreement_score":0.0506602,"about_ca_system_score_codex":0.00011136845,"about_ca_system_score_gemma":0.00050371734,"threshold_uncertainty_score":0.61695445},"labels":[],"label_agreement":null},{"id":"W4386784398","doi":"10.1158/1557-3265.aacrahns23-po-025","title":"Abstract PO-025: The effect of tissue of origin on oncogenesis in HPV-related malignancies: Comparative analysis of molecular and immune signatures in HPV-positive head and neck cancer and cervical cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogenesis; CDKN2A; Head and neck cancer; Cervical cancer; Cancer; HPV infection; Medicine; Cancer research; Immune system; Somatic cell; Biology; Oncology; Internal medicine; Gene; Immunology; Genetics","score_opus":0.11250546472890705,"score_gpt":0.5185266317447995,"score_spread":0.40602116701589247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617178,0.034807127,2.2680751e-7,0.001905258,0.00006058149,0.00088658417,0.00018778755,0.0000075063253,0.00042715014],"genre_scores_gemma":[0.98521554,0.014330207,0.0000055321084,0.0000680158,0.000033614586,0.00024118694,0.000009064195,0.000016019025,0.00008082107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968541,0.0006161106,0.0009420506,0.00053108693,0.0006346339,0.00042197638],"domain_scores_gemma":[0.99527806,0.0038135236,0.0001897063,0.00027732315,0.00029894273,0.00014243183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024016157,0.00021637481,0.0017108914,0.0005830154,0.00006650478,0.000008918992,0.00014208068,0.00022749614,0.00016830725],"category_scores_gemma":[0.00038288257,0.00014235075,0.00013451559,0.0023636166,0.0011676389,0.000040200517,0.00017866648,0.00080537715,8.714039e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007631258,0.00028218568,0.90953654,0.0012580454,0.00245404,0.00012605311,0.003806598,0.0013337003,0.030851588,0.00008184696,0.00031455033,0.04232362],"study_design_scores_gemma":[0.0032803775,0.001992486,0.9435995,0.0011646056,0.00035343674,4.0326546e-7,0.00040674966,0.00050665106,0.048475478,0.000023863004,0.00008093048,0.00011549718],"about_ca_topic_score_codex":0.026708625,"about_ca_topic_score_gemma":0.013529714,"teacher_disagreement_score":0.04220812,"about_ca_system_score_codex":0.000148594,"about_ca_system_score_gemma":0.00033883765,"threshold_uncertainty_score":0.9797726},"labels":[],"label_agreement":null},{"id":"W4386784411","doi":"10.1158/1557-3265.aacrahns23-po-043","title":"Abstract PO-043: Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Head and neck squamous-cell carcinoma; Head and neck cancer; Radiomics; Cancer; Radiology; Internal medicine","score_opus":0.13507518765071339,"score_gpt":0.4879719196419132,"score_spread":0.35289673199119986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979053,0.00019472024,0.00014034557,0.0005266392,0.00007487269,0.00094574667,0.000044875625,0.00010358591,0.0000639117],"genre_scores_gemma":[0.9937932,0.0006741076,0.0047553484,0.00018850763,0.000078018034,0.00022264342,0.00020370065,0.000039095077,0.00004540042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971716,0.00018347823,0.00072665454,0.00060752284,0.00079976104,0.00051097455],"domain_scores_gemma":[0.9983336,0.00040763113,0.00013310663,0.00021649628,0.00044038641,0.00046883404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021325469,0.00016820022,0.00047777814,0.00044531407,0.00012593741,0.000025191906,0.00017291274,0.00014386434,0.000012462974],"category_scores_gemma":[0.0009276364,0.00013735812,0.000039515988,0.0010158222,0.0002993787,0.00013336593,0.00011821931,0.0009432492,0.0000032986486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018086002,0.0005021251,0.7552671,0.00020449047,0.00006760245,0.000026178013,0.0009926022,0.004442541,0.0002923005,0.0000029617975,0.00047992813,0.23591362],"study_design_scores_gemma":[0.003358466,0.0003355605,0.65432787,0.00072752626,0.0000113895585,0.0000010920107,0.000048087928,0.34087417,0.00012823084,0.000006362921,0.000085971886,0.0000953013],"about_ca_topic_score_codex":0.0013426263,"about_ca_topic_score_gemma":0.0005698252,"teacher_disagreement_score":0.33643162,"about_ca_system_score_codex":0.0005113321,"about_ca_system_score_gemma":0.0015139944,"threshold_uncertainty_score":0.5601302},"labels":[],"label_agreement":null},{"id":"W4386784419","doi":"10.1158/1557-3265.aacrahns23-po-016","title":"Abstract PO-016: SSTR2 use and molecular profile in EBV-positive nasopharyngeal carcinoma: A single institution experience","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatostatin receptor 2; Immunohistochemistry; Medicine; Nasopharyngeal carcinoma; Malignancy; Microsatellite instability; Internal medicine; Oncology; Biopsy; Pathology; Cancer research; Somatostatin receptor; Receptor; Biology; Radiation therapy; Microsatellite; Gene; Genetics","score_opus":0.2902034492759341,"score_gpt":0.5352508114987602,"score_spread":0.24504736222282608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095297,0.0018631894,0.0000042892393,0.0037189922,0.00018700588,0.0013912045,0.000062528925,0.000080394755,0.0017394216],"genre_scores_gemma":[0.9963462,0.001617983,0.00007345707,0.00023795955,0.00029243104,0.000753614,0.000030418365,0.00003381315,0.0006141292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959957,0.00034980098,0.00057681097,0.0008442447,0.0012548686,0.0009785863],"domain_scores_gemma":[0.997247,0.0012047032,0.000059461217,0.00044392314,0.0005951293,0.0004497819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021882036,0.00019181431,0.0005000492,0.0004324372,0.00021956365,0.000101662634,0.00021881159,0.00018627978,0.00013205188],"category_scores_gemma":[0.0040893364,0.0001652208,0.00010342195,0.0014604575,0.0015132971,0.0003373395,0.0005539355,0.0014045173,0.000107192056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00367438,0.00080948224,0.9160891,0.0006776949,0.00015563694,0.0047396137,0.002836822,0.000014110793,0.033074494,0.00030477365,0.0101814205,0.02744246],"study_design_scores_gemma":[0.0028283752,0.00090572966,0.9812729,0.000514263,0.00001498249,0.0000104906185,0.0007535883,0.00019622674,0.011665475,0.00011052991,0.0015490165,0.00017845647],"about_ca_topic_score_codex":0.0037594165,"about_ca_topic_score_gemma":0.00052082125,"teacher_disagreement_score":0.06518376,"about_ca_system_score_codex":0.0006851137,"about_ca_system_score_gemma":0.0009798881,"threshold_uncertainty_score":0.6737509},"labels":[],"label_agreement":null},{"id":"W4386784420","doi":"10.1158/1557-3265.aacrahns23-po-045","title":"Abstract PO-045: Utility of circulating tumor tissue modified viral (TTMV)-HPV DNA to resolve clinically indeterminate findings in patients following definitive treatment for HPV-driven oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Indeterminate; Internal medicine; Retrospective cohort study; Cancer; Oncology; Disease; Cohort study; Pathology","score_opus":0.310588114899989,"score_gpt":0.5418097745061936,"score_spread":0.2312216596062046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926798,0.00022658851,0.000008114525,0.0012910658,0.0006131746,0.0029483852,0.0004594393,0.000055156925,0.0017182858],"genre_scores_gemma":[0.99656224,0.00045282012,0.00022077888,0.00033843133,0.00039254173,0.0016012893,0.00006056863,0.000071203176,0.00030011332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99424285,0.00034092093,0.001955719,0.0011351167,0.0010742293,0.0012511956],"domain_scores_gemma":[0.99444944,0.0035857407,0.00022292545,0.0005191173,0.0007010124,0.0005217959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035789567,0.00033903858,0.0016433179,0.0004152864,0.0002588791,0.000029702574,0.00031697494,0.00027208563,0.00019069662],"category_scores_gemma":[0.0042651556,0.00029037573,0.0004968333,0.0009982846,0.00034087236,0.00012052691,0.0003428666,0.0008794209,0.000038655886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009034111,0.0011236357,0.75747246,0.0005130404,0.0003610778,0.0002458426,0.0021296572,0.00003558346,0.0010295251,0.000013867345,0.0017051985,0.22633602],"study_design_scores_gemma":[0.010014786,0.00544041,0.97942847,0.0008941157,0.00009263248,3.9654464e-7,0.0003653119,0.00060558156,0.0021102657,0.00014125032,0.0006378457,0.00026891506],"about_ca_topic_score_codex":0.0028036698,"about_ca_topic_score_gemma":0.0013210147,"teacher_disagreement_score":0.2260671,"about_ca_system_score_codex":0.0007690831,"about_ca_system_score_gemma":0.0012838759,"threshold_uncertainty_score":0.9999548},"labels":[],"label_agreement":null},{"id":"W4386784425","doi":"10.1158/1557-3265.aacrahns23-po-039","title":"Abstract PO-039: Discovery and validation of methylated DNA markers of human papillomavirus associated oropharyngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"NOP; Medicine; Internal medicine; Pathology; Receptor","score_opus":0.20127442093818648,"score_gpt":0.4931162133207433,"score_spread":0.2918417923825568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937784,0.0016462465,2.87886e-7,0.00059088785,0.00016902019,0.00047320678,0.00012235864,0.000036744736,0.0031828478],"genre_scores_gemma":[0.9966799,0.001587774,0.0000059210092,0.00003982101,0.00013943083,0.000045437293,0.00006274204,0.000032533942,0.0014064186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695283,0.00040351955,0.0008934349,0.00043096478,0.0008436907,0.00047557784],"domain_scores_gemma":[0.9969775,0.001776421,0.00021118624,0.0003169912,0.000508452,0.0002094313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035786985,0.00014760821,0.00083322293,0.00024631975,0.00014184481,0.000015816668,0.00014427406,0.00020880523,0.00018971442],"category_scores_gemma":[0.0012861057,0.00012303278,0.00017182065,0.0008570771,0.0006190135,0.00010313013,0.00019664303,0.0006595709,0.00001275615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036008318,0.0008927705,0.73884284,0.001698629,0.00029612056,0.00016026698,0.0007188022,0.0000057964303,0.22650754,0.000028219696,0.015400837,0.011847315],"study_design_scores_gemma":[0.003363198,0.002180748,0.9183405,0.00018861338,0.000080981445,4.2921215e-7,0.0003627333,0.000022699674,0.0750726,0.00011157492,0.00016445771,0.00011147007],"about_ca_topic_score_codex":0.002691161,"about_ca_topic_score_gemma":0.00020133905,"teacher_disagreement_score":0.17949763,"about_ca_system_score_codex":0.00014546492,"about_ca_system_score_gemma":0.0004498029,"threshold_uncertainty_score":0.5017131},"labels":[],"label_agreement":null},{"id":"W4386784429","doi":"10.1158/1557-3265.aacrahns23-po-036","title":"Abstract PO-036: A deep learning alternative to regional molecular testing for HPV status","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Digital pathology; Cancer; Pathology; Cohort; Oncology; Digital image analysis; Artificial intelligence; Internal medicine; Computer science","score_opus":0.29081775354541795,"score_gpt":0.5751571198133621,"score_spread":0.2843393662679442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96924293,0.0005453769,0.0024735194,0.022356266,0.00042002273,0.0010689349,0.000010285326,0.00020285058,0.0036798264],"genre_scores_gemma":[0.9879174,0.00042917609,0.005453109,0.002269599,0.001596683,0.00037837954,0.000059101283,0.00008913114,0.0018074097],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99648565,0.00024626928,0.0005560588,0.00065007014,0.0010217859,0.0010401565],"domain_scores_gemma":[0.9931498,0.004895415,0.00009158886,0.00027798826,0.00074006803,0.0008451377],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00536703,0.0001483887,0.00040692702,0.00032429016,0.00028196434,0.00006936884,0.00025640617,0.00010128022,0.00019871708],"category_scores_gemma":[0.029319834,0.00012992862,0.00018163444,0.0010175366,0.00029465609,0.000049169397,0.00021213178,0.0021602502,0.00018990529],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009781352,0.00016512722,0.092846915,0.00028762463,0.0001970672,0.00050177024,0.0005256639,0.0047834874,0.006101911,0.0003691388,0.019855062,0.8733881],"study_design_scores_gemma":[0.0059743975,0.002566388,0.5534354,0.0009979864,0.000077602024,0.000024749363,0.00081636116,0.12906379,0.00055933616,0.0036861452,0.30228958,0.00050828955],"about_ca_topic_score_codex":0.0008900142,"about_ca_topic_score_gemma":0.00002162447,"teacher_disagreement_score":0.8728798,"about_ca_system_score_codex":0.0001990153,"about_ca_system_score_gemma":0.00047774267,"threshold_uncertainty_score":0.9788566},"labels":[],"label_agreement":null},{"id":"W4386784459","doi":"10.1158/1557-3265.aacrahns23-po-008","title":"Abstract PO-008: Association of plasma Epstein-Barr virus DNA and clinical response in patients with recurrent and/or metastatic nasopharyngeal cancer treated with pembrolizumab or standard-of-care chemotherapy in KEYNOTE-122","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Pembrolizumab; Oncology; Gemcitabine; Viral load; Clinical trial; Chemotherapy; Cancer; Immunology; Virus; Immunotherapy","score_opus":0.0866717300103274,"score_gpt":0.457640037991458,"score_spread":0.3709683079811306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574494,0.0008402829,3.7199104e-7,0.0014027607,0.00008850388,0.0013978374,0.00044569874,0.00002475416,0.000054846212],"genre_scores_gemma":[0.9900563,0.009276008,0.000031897576,0.000099748046,0.000051077604,0.00016830147,0.000049260656,0.00005375566,0.00021367524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99522316,0.0009733632,0.0012329161,0.00064922695,0.0012992598,0.00062206504],"domain_scores_gemma":[0.9952694,0.0029908859,0.000450591,0.0002846099,0.0007274116,0.00027710095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004148408,0.00024470926,0.0012491372,0.00041946227,0.000069674854,0.000023760547,0.00014155539,0.00028170823,0.00018985505],"category_scores_gemma":[0.0022591809,0.00015893436,0.00010026736,0.0014642554,0.00045395328,0.00010834065,0.000064954525,0.0010630246,0.00000221325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35385478,0.000727091,0.60406053,0.00030291607,0.00025162415,0.000056902,0.00051526964,0.000015896996,0.00002137507,9.4318614e-7,0.00044913669,0.039743554],"study_design_scores_gemma":[0.07114025,0.019076547,0.90679204,0.0012316891,0.00010519963,4.3786548e-7,0.00082026457,0.00012219115,0.0002039792,0.000012180845,0.00031580395,0.00017943679],"about_ca_topic_score_codex":0.0019383235,"about_ca_topic_score_gemma":0.01494792,"teacher_disagreement_score":0.30273148,"about_ca_system_score_codex":0.00097200286,"about_ca_system_score_gemma":0.0024950865,"threshold_uncertainty_score":0.83412904},"labels":[],"label_agreement":null},{"id":"W4386784474","doi":"10.1158/1557-3265.aacrahns23-po-005","title":"Abstract PO-005: Phase 1/2 study of Ad/PNP with fludarabine for the treatment of head &amp; neck squamous cell carcinoma (HNSCC)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Antimetabolite; Prodrug; Gemcitabine; Fludarabine; Cytosine deaminase; Adverse effect; Nucleoside analogue; Internal medicine; Head and neck squamous-cell carcinoma; Head and neck cancer; Toxicity; Chemotherapy; Oncology; Pharmacology; Cancer; Gastroenterology; Nucleoside; Genetic enhancement; Biology","score_opus":0.24518795781810954,"score_gpt":0.5326432941716704,"score_spread":0.2874553363535609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934585,0.0032908528,0.000011221261,0.00051150424,0.000087830296,0.0022795901,0.00023584835,0.000010777265,0.00011385977],"genre_scores_gemma":[0.99491066,0.0021792236,0.00002790573,0.000027440125,0.0003152239,0.00082461716,0.00009679927,0.00005717274,0.0015609723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969975,0.00036748458,0.0006285606,0.00063166703,0.00072869024,0.00064614334],"domain_scores_gemma":[0.99697965,0.0009381708,0.00013790591,0.001148776,0.0005981102,0.00019736514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020888553,0.00020052317,0.00042624405,0.00012724419,0.00020134232,0.000019876925,0.00058735244,0.0001554707,0.00012646688],"category_scores_gemma":[0.00023138829,0.00012664023,0.00022187055,0.0005492304,0.0005088334,0.000003838982,0.00012465638,0.00028067574,0.00001777274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16774835,0.02821666,0.052114736,0.00053159025,0.000908968,0.000054923086,0.0015895934,0.0014068035,0.52890396,0.0000031257039,0.015357136,0.20316416],"study_design_scores_gemma":[0.047894552,0.26631656,0.044172525,0.00003835509,0.00012989562,0.0000019516428,0.0017148949,0.00026866427,0.5796957,0.00003928834,0.05929945,0.00042815655],"about_ca_topic_score_codex":0.0008231968,"about_ca_topic_score_gemma":0.006082,"teacher_disagreement_score":0.23809992,"about_ca_system_score_codex":0.00006266036,"about_ca_system_score_gemma":0.0007425986,"threshold_uncertainty_score":0.5164239},"labels":[],"label_agreement":null},{"id":"W4386784480","doi":"10.1158/1557-3265.aacrahns23-po-003","title":"Abstract PO-003: Lenvatinib with or without pembrolizumab versus chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: Phase 2 LEAP-009","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Lenvatinib; Cetuximab; Oncology; Internal medicine; Docetaxel; Head and neck squamous-cell carcinoma; Chemotherapy; Head and neck cancer; Radiation therapy; Immunotherapy; Cancer; Colorectal cancer","score_opus":0.43604045562691957,"score_gpt":0.5483569098400536,"score_spread":0.11231645421313402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861375,0.0074003194,0.000002077159,0.0023433943,0.00016274872,0.0035525966,0.00014004143,0.000054052063,0.00020726991],"genre_scores_gemma":[0.97273,0.024284294,0.00029924983,0.00014808527,0.00023212151,0.0012804269,0.00003140162,0.0000862163,0.00090821896],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99714524,0.0001691631,0.0006085549,0.0007182,0.00067771366,0.0006811128],"domain_scores_gemma":[0.99609125,0.0027638462,0.00019003938,0.0004414134,0.0002370632,0.0002764093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087146857,0.00034962394,0.0012143626,0.00019103571,0.00023080614,0.00004108226,0.00012045863,0.00011673994,0.00017498761],"category_scores_gemma":[0.00015399947,0.00019046963,0.00013411063,0.00044542926,0.0006148368,0.00006210067,0.00002908093,0.00030671555,0.0000037232244],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44543388,0.0032676007,0.02853107,0.0007246561,0.0004432162,0.000087458204,0.002733321,0.0000011101941,0.000749349,0.000005180333,0.0014484738,0.5165747],"study_design_scores_gemma":[0.41255966,0.34790584,0.17347099,0.00097523845,0.00020592292,0.000017735683,0.002585861,0.0005301919,0.02552901,0.00003791568,0.03553699,0.00064466405],"about_ca_topic_score_codex":0.00033631423,"about_ca_topic_score_gemma":0.000496104,"teacher_disagreement_score":0.51593006,"about_ca_system_score_codex":0.0001721389,"about_ca_system_score_gemma":0.0009469187,"threshold_uncertainty_score":0.7767126},"labels":[],"label_agreement":null},{"id":"W4386784489","doi":"10.1158/1557-3265.aacrahns23-po-009","title":"Abstract PO-009: Phase 3 KEYNOTE-630 study of adjuvant pembrolizumab in high-risk locally advanced cutaneous squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Perineural invasion; Pembrolizumab; Lymph node; Radiation therapy; Cancer; Surgery; Oncology; Pathology; Internal medicine; Immunotherapy","score_opus":0.12783249203628913,"score_gpt":0.4910254474834192,"score_spread":0.36319295544713004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916558,0.0027948923,0.0000029270539,0.0006415986,0.000651476,0.0025893836,0.00015764496,0.00009615339,0.0014101024],"genre_scores_gemma":[0.99513686,0.0025898279,0.00005183412,0.000075886244,0.0005701034,0.0005344998,0.000024549106,0.000112848604,0.0009035671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927524,0.00071110134,0.0018755388,0.0012956981,0.0020078716,0.0013574235],"domain_scores_gemma":[0.9932891,0.003794551,0.00035304972,0.0013008422,0.00074584776,0.00051658356],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029748026,0.00039379,0.0015578547,0.0005813,0.00021224732,0.000026605201,0.0006327167,0.00029260395,0.00048192564],"category_scores_gemma":[0.0022909853,0.00034522527,0.0002576221,0.00200343,0.00069544633,0.000095957315,0.0006128792,0.002570497,0.00026720224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022238547,0.00785532,0.82007414,0.0007136809,0.00014192585,0.006673842,0.0016292881,0.0006278135,0.0007553227,0.000006126733,0.004917826,0.13436617],"study_design_scores_gemma":[0.04204543,0.014803002,0.93612623,0.00021583757,0.00011706593,0.000019243944,0.0033646214,0.00029663477,0.001610696,0.00013535174,0.00091397046,0.0003519436],"about_ca_topic_score_codex":0.009084088,"about_ca_topic_score_gemma":0.004965627,"teacher_disagreement_score":0.13401422,"about_ca_system_score_codex":0.00064536015,"about_ca_system_score_gemma":0.0013191251,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W4386784494","doi":"10.1158/1557-3265.aacrahns23-po-001","title":"Abstract PO-001: Circulating tumor-tissue modified HPV DNA testing in the clinical workup of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Otorhinolaryngology; Tonsil; Internal medicine; Cancer; Prospective cohort study; Head and neck cancer; Oncology; Pathology; Surgery","score_opus":0.40623413109106743,"score_gpt":0.5660215393564944,"score_spread":0.15978740826542692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872334,0.001288189,0.00000241273,0.0026290617,0.0007268145,0.0046250043,0.0002592903,0.00005519646,0.001690698],"genre_scores_gemma":[0.99443257,0.0015220477,0.00003257897,0.00049806945,0.0014460476,0.0016961176,0.000032119093,0.00006795258,0.00027248173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99214286,0.0018254798,0.0022154367,0.0010083151,0.0016563014,0.0011515995],"domain_scores_gemma":[0.9706214,0.026502099,0.0005206381,0.0008538276,0.0012317102,0.0002703283],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.016367326,0.0003115142,0.0012953727,0.00018341525,0.00083636714,0.00004984703,0.0007207421,0.00019689856,0.00021771246],"category_scores_gemma":[0.015549951,0.00018629381,0.0003033734,0.0018442768,0.00091114786,0.00008704289,0.0006056195,0.0023277302,0.000042697502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002168355,0.0012029376,0.7694675,0.0001846576,0.00025815223,0.000091189926,0.0016770934,0.00011427856,0.000037302634,0.000008195962,0.0060994145,0.21869095],"study_design_scores_gemma":[0.0070294947,0.0027511015,0.9852401,0.00037012037,0.00015388995,0.0000010993589,0.00214625,0.00074620836,0.0000661808,0.00016877033,0.0011334089,0.00019339766],"about_ca_topic_score_codex":0.006904741,"about_ca_topic_score_gemma":0.003942675,"teacher_disagreement_score":0.21849754,"about_ca_system_score_codex":0.0004144009,"about_ca_system_score_gemma":0.00086599763,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W4386784510","doi":"10.1158/1557-3265.aacrahns23-po-002","title":"Abstract PO-002: Pembrolizumab as neoadjuvant and adjuvant therapy in combination with standard of care in resectable, locally advanced head and neck squamous cell carcinoma: Phase 3 KEYNOTE-689","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Head and neck squamous-cell carcinoma; Adjuvant; Radiation therapy; Neoadjuvant therapy; Internal medicine; Larynx; Oncology; Adjuvant therapy; Stage (stratigraphy); Head and neck cancer; Surgery; Cancer; Immunotherapy","score_opus":0.09353327907684729,"score_gpt":0.47623034522521074,"score_spread":0.38269706614836346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732218,0.022144983,0.000001095804,0.0017208318,0.000081344966,0.0013646465,0.000061349325,0.000029444564,0.0013745407],"genre_scores_gemma":[0.9817972,0.017541774,0.00004035279,0.000102519785,0.00006957788,0.00020388521,0.000025193915,0.000043253076,0.00017620181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664086,0.00025680044,0.00078435644,0.0006899408,0.0009229932,0.0007050754],"domain_scores_gemma":[0.99758375,0.00102211,0.00010763232,0.00035746445,0.00063369615,0.00029537466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016478559,0.00022497533,0.0010218505,0.00045026,0.000116507676,0.000024326426,0.00013572627,0.00018485627,0.00005765267],"category_scores_gemma":[0.00053002697,0.00017387478,0.000059489434,0.0010772235,0.00056505913,0.000120462995,0.00014301404,0.0011104426,0.0000048435554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13483576,0.0013493503,0.5067705,0.0017142246,0.000038076356,0.001145727,0.00613771,0.0000634477,0.0023625013,0.00004354327,0.0007676209,0.34477153],"study_design_scores_gemma":[0.09049555,0.03859143,0.85903925,0.0012481168,0.000015560488,0.000008015413,0.0036104894,0.00020736415,0.004335693,0.00015669239,0.0020408842,0.00025095296],"about_ca_topic_score_codex":0.0033148178,"about_ca_topic_score_gemma":0.008828513,"teacher_disagreement_score":0.35226876,"about_ca_system_score_codex":0.00036215555,"about_ca_system_score_gemma":0.0013117736,"threshold_uncertainty_score":0.7090408},"labels":[],"label_agreement":null},{"id":"W4386784545","doi":"10.1158/1557-3265.aacrahns23-po-099","title":"Abstract PO-099: Short-term outcomes of an extended endoscopic endonasal resection of a clival giant cell tumor with adjuvant RANK-L inhibitor therapy: Case report","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endoscopic endonasal surgery; Magnetic resonance imaging; Radiology; Neurosurgery; Clivus; Surgery; Skull; Denosumab; Adjuvant therapy; Headaches; Pathology; Chemotherapy","score_opus":0.2127769529602967,"score_gpt":0.5049925198938775,"score_spread":0.2922155669335808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966422,0.00063342013,6.4832767e-7,0.00046481247,0.00030633574,0.0013323613,0.00009664783,0.00006043396,0.00046317477],"genre_scores_gemma":[0.99761176,0.00091780093,0.00011331216,0.000035604793,0.00029272988,0.0003521281,0.00006233125,0.00006358757,0.0005507527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956464,0.00035217786,0.0013321976,0.0007386412,0.0013207454,0.0006098178],"domain_scores_gemma":[0.99656814,0.001168027,0.00029391426,0.0009113398,0.00061886,0.0004397179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029113465,0.0002413773,0.00103338,0.0003351814,0.00012042404,0.000021136528,0.00017070865,0.000119253746,0.00030228737],"category_scores_gemma":[0.0005251235,0.00015992788,0.00028086276,0.000651552,0.0005570457,0.00011954785,0.00010801804,0.0008398033,0.000018228759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058264737,0.003967022,0.83748776,0.00036383196,0.00038551964,0.12458075,0.00017721641,0.0000036895797,0.007235025,0.0000075723683,0.00048314253,0.01948201],"study_design_scores_gemma":[0.0075530824,0.0069414843,0.93650466,0.00036294604,0.00009384554,0.0011630919,0.0003211705,0.000029172574,0.046780385,0.000031240685,0.00008956808,0.00012936631],"about_ca_topic_score_codex":0.0028367809,"about_ca_topic_score_gemma":0.001151782,"teacher_disagreement_score":0.12341765,"about_ca_system_score_codex":0.00013508601,"about_ca_system_score_gemma":0.00093774725,"threshold_uncertainty_score":0.6521669},"labels":[],"label_agreement":null},{"id":"W4386784548","doi":"10.1158/1557-3265.aacrahns23-pr04","title":"Abstract PR04: Deciphering radiotherapy resistance mechanisms in HPV negative and positive head and neck cancers","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Radioresistance; Medicine; Radiation therapy; Head and neck cancer; Cancer research; Oncology; Cancer; Biomarker; Internal medicine; Biology","score_opus":0.11592758785667295,"score_gpt":0.48270314275624726,"score_spread":0.3667755548995743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908459,0.00647327,0.00011181094,0.0012011243,0.000114345385,0.00033738787,0.000050911985,0.000010815713,0.0008544148],"genre_scores_gemma":[0.9670645,0.030436698,0.00058401417,0.00020991416,0.00024772767,0.00021181814,0.000014921673,0.00002643082,0.0012039588],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984105,0.00016874025,0.0002821641,0.00049703027,0.00021767897,0.0004238507],"domain_scores_gemma":[0.99921167,0.00020448891,0.000051187682,0.00024463452,0.00012032574,0.00016766801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013224008,0.00011182542,0.00018654593,0.00007577322,0.00013715,0.000044990964,0.00014230839,0.00015651558,0.000038003094],"category_scores_gemma":[0.00024840364,0.00010662047,0.000039916795,0.0003528045,0.00032700668,0.000011126823,0.000104350926,0.00033083497,0.0000033102601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007950998,0.00044979894,0.15568444,0.0004018713,0.0006334593,0.00010137238,0.00292412,0.00078681594,0.43795848,0.004982704,0.038885925,0.34924003],"study_design_scores_gemma":[0.0020257854,0.00037096394,0.9654298,0.00016625729,0.000005106006,0.0000015121778,0.00051239046,0.00020212746,0.012741873,0.0015065832,0.016760683,0.00027694632],"about_ca_topic_score_codex":0.0008824266,"about_ca_topic_score_gemma":0.0035270662,"teacher_disagreement_score":0.8097453,"about_ca_system_score_codex":0.000118314885,"about_ca_system_score_gemma":0.0002808814,"threshold_uncertainty_score":0.43478566},"labels":[],"label_agreement":null},{"id":"W4386784562","doi":"10.1158/1557-3265.aacrahns23-pr01","title":"Abstract PR01: Lymph node colonization promotes distant tumor metastasis through the induction of tumor-specific immune tolerance","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Immune system; Cancer research; Tumor progression; Immunotherapy; Lymphatic system; Biology; Immunology; Adoptive cell transfer; Cancer; FOXP3; Primary tumor; Medicine; T cell; Internal medicine","score_opus":0.2273694373695485,"score_gpt":0.4783466230660269,"score_spread":0.25097718569647837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98206836,0.0060827713,0.00003300299,0.009106688,0.00083811337,0.0011153187,0.00006877412,0.00007824802,0.0006087101],"genre_scores_gemma":[0.9920115,0.0062567093,0.0001006882,0.0002401389,0.0005687381,0.00027311035,0.000046806956,0.000042080766,0.0004602665],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966198,0.0003650093,0.0010151578,0.0004892295,0.0010100128,0.0005007639],"domain_scores_gemma":[0.9975079,0.0008488538,0.00026244682,0.0006859266,0.0006046243,0.00009023745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040360596,0.00016249961,0.00049244915,0.00012233797,0.0002882717,0.000049619,0.00033111562,0.00010131773,0.00067307905],"category_scores_gemma":[0.00061448984,0.000107029045,0.00025900162,0.001993416,0.0010330892,0.0001401753,0.000110989386,0.0006728379,0.00006878829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05395304,0.003472906,0.09834905,0.0028322437,0.0021159563,0.0004210611,0.00466292,0.00030512403,0.4158401,0.0014279116,0.07098316,0.34563655],"study_design_scores_gemma":[0.0044140755,0.00065702264,0.8579882,0.0008531217,0.00006896762,0.000021874619,0.0012943762,0.00022714055,0.04836345,0.0006438084,0.08522915,0.00023886116],"about_ca_topic_score_codex":0.0011433942,"about_ca_topic_score_gemma":0.00005471946,"teacher_disagreement_score":0.7596391,"about_ca_system_score_codex":0.00026883517,"about_ca_system_score_gemma":0.0006638443,"threshold_uncertainty_score":0.73697436},"labels":[],"label_agreement":null},{"id":"W4386784564","doi":"10.1158/1557-3265.aacrahns23-po-095","title":"Abstract PO-095: TGF-β carrying exosomes in plasma of HNSCC as potential biomarkers of disease progression in patients with HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Transforming growth factor; Flow cytometry; Cancer; Tumor progression; Carcinogenesis; Microvesicles; Plasma cell; Head and neck squamous-cell carcinoma; Biology; Medicine; Pathology; Head and neck cancer; Molecular biology; Antibody; Internal medicine; Immunology; microRNA; Gene","score_opus":0.05410638398017381,"score_gpt":0.4489318950366423,"score_spread":0.3948255110564685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811554,0.0007861109,0.000001436096,0.00016327026,0.00010570794,0.0005748445,0.000093425006,0.000008010331,0.00015168499],"genre_scores_gemma":[0.9990782,0.0004400867,0.000056962966,0.000012749071,0.00007821232,0.00008482849,0.00014454861,0.000032922664,0.00007150081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972419,0.00033963632,0.00066482404,0.00054412376,0.00073536317,0.00047415344],"domain_scores_gemma":[0.9986717,0.00015063847,0.00015895453,0.0004913991,0.0002588017,0.0002685057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015003078,0.00014022551,0.0002695468,0.0002511946,0.000039542916,0.000012869903,0.00039643655,0.00018308489,0.000055262448],"category_scores_gemma":[0.0010176825,0.0001206146,0.00012384284,0.0006255332,0.00057585747,0.000010767206,0.00033752882,0.00034156386,0.0000096768645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010142641,0.00083236984,0.9383097,0.0002952324,0.00006518488,0.00007961926,0.000032559343,0.000299539,0.029026233,0.000006178589,0.000417355,0.02049334],"study_design_scores_gemma":[0.0039655995,0.0006396463,0.96945405,0.00041102874,0.0000126644545,1.3204648e-7,0.000106141466,0.00013219085,0.02485546,0.00009959111,0.000164269,0.00015922321],"about_ca_topic_score_codex":0.00019755361,"about_ca_topic_score_gemma":0.00013437445,"teacher_disagreement_score":0.031144306,"about_ca_system_score_codex":0.00004456268,"about_ca_system_score_gemma":0.00064250734,"threshold_uncertainty_score":0.49185207},"labels":[],"label_agreement":null},{"id":"W4386784566","doi":"10.1158/1557-3265.aacrahns23-po-100","title":"Abstract PO-100: <i>Fusobacterium nucleatum</i> promotes epithelial-mesenchymal transition (EMT) of oral squamous cell carcinoma (OSCC) via INHBA-dependent SMAD/Laminin332/PI3K/AKT pathway","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusobacterium nucleatum; Transcriptome; Biology; Cancer research; Carcinogenesis; Epithelial–mesenchymal transition; SNAI1; Microbiology; Downregulation and upregulation; Gene expression; Cancer; Gene; Porphyromonas gingivalis; Genetics; Bacteria","score_opus":0.16724656185439732,"score_gpt":0.4586291961713074,"score_spread":0.29138263431691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916952,0.00040468757,0.000012253815,0.0014415787,0.001960497,0.0012828527,0.001048661,0.00019681966,0.0019574265],"genre_scores_gemma":[0.9952362,0.00018091447,0.00010058382,0.00019300009,0.0006076593,0.0003114978,0.00021933802,0.00010415671,0.0030466146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99257344,0.0015138958,0.0018180539,0.0012163065,0.0013484925,0.001529839],"domain_scores_gemma":[0.9958219,0.0016648459,0.0003774469,0.00096812757,0.0006573438,0.000510322],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0052534062,0.00042172795,0.0009449194,0.00043947072,0.00044690122,0.00006274565,0.00066350447,0.0008294823,0.0018424209],"category_scores_gemma":[0.00044243532,0.000376018,0.00040716832,0.0012170397,0.0008359921,0.00023265778,0.00032295156,0.0020736887,0.00286572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017553715,0.01960625,0.5078262,0.009802253,0.0005566004,0.029209208,0.008138665,0.00017522488,0.15774421,0.0007450527,0.03828534,0.21035728],"study_design_scores_gemma":[0.008826345,0.0052643428,0.8709618,0.00020166767,0.00013340602,0.000083876774,0.0008134173,0.00025723214,0.10802545,0.0015913553,0.003092943,0.0007481883],"about_ca_topic_score_codex":0.0028178445,"about_ca_topic_score_gemma":0.0013912302,"teacher_disagreement_score":0.36313558,"about_ca_system_score_codex":0.00038185457,"about_ca_system_score_gemma":0.0010700973,"threshold_uncertainty_score":0.99986917},"labels":[],"label_agreement":null},{"id":"W4386784570","doi":"10.1158/1557-3265.aacrahns23-po-093","title":"Abstract PO-093: Crenolanib improves PD-1 response and overall survival in immune checkpoint inhibitor resistant murine models of oral squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tumor microenvironment; Cancer research; Head and neck squamous-cell carcinoma; Cancer; Immunotherapy; Head and neck cancer; Internal medicine","score_opus":0.1850307409278701,"score_gpt":0.45823194634657,"score_spread":0.27320120541869986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989415,0.0044813743,4.5537098e-7,0.0036107022,0.00024658992,0.00092236325,0.000130762,0.000038600734,0.0006749787],"genre_scores_gemma":[0.99551284,0.0027279088,0.00004729861,0.00005008966,0.00022640995,0.00024796205,0.00002927359,0.000054834272,0.0011033796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959134,0.0004611847,0.0012262434,0.00073186343,0.0009258522,0.00074147736],"domain_scores_gemma":[0.99620634,0.0022639544,0.00015726555,0.0006573623,0.00033954778,0.00037550504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005535988,0.00023563852,0.0008755136,0.0004083116,0.00008640574,0.000037236598,0.00018805428,0.00022504247,0.0001824086],"category_scores_gemma":[0.00083211396,0.00019347465,0.00023854864,0.0005489911,0.00041482155,0.00009874218,0.00035265018,0.0009304916,0.000025215157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18326283,0.007867731,0.4412714,0.0036650372,0.0003053357,0.003608479,0.0021275682,0.00020913442,0.32524455,0.0002713956,0.008527142,0.023639414],"study_design_scores_gemma":[0.010072926,0.0028392186,0.9590172,0.0002694291,0.00004024102,0.0000024121694,0.0002540343,0.0003502464,0.025804687,0.00044385955,0.0007300747,0.00017565495],"about_ca_topic_score_codex":0.017017541,"about_ca_topic_score_gemma":0.002336464,"teacher_disagreement_score":0.5177458,"about_ca_system_score_codex":0.0004448395,"about_ca_system_score_gemma":0.0009894521,"threshold_uncertainty_score":0.98952824},"labels":[],"label_agreement":null},{"id":"W4386784577","doi":"10.1158/1557-3265.aacrahns23-pr02","title":"Abstract PR02: Tumor sequestered, neoantigen specific T cells are dynamically increased in circulation following neoadjuvant immunotherapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; CD8; Tumor microenvironment; Immune checkpoint; T cell; T-cell receptor; Immunotherapy; Cancer research; Transcriptome; Antigen; Memory T cell; Cytotoxic T cell; Immunology; Immune system; Gene; Genetics","score_opus":0.18612098032476052,"score_gpt":0.48044560482625437,"score_spread":0.2943246245014939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921628,0.002459671,0.000010517538,0.002300846,0.00084245106,0.0012763607,0.000038325124,0.00014868156,0.00076035253],"genre_scores_gemma":[0.99305224,0.0049475734,0.00007602292,0.00060516543,0.00055492984,0.0001790432,0.000066539345,0.00008318617,0.00043529016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99544305,0.00048258202,0.0012213078,0.000791483,0.0011459655,0.00091562205],"domain_scores_gemma":[0.9975456,0.0010210193,0.00018962575,0.00073754846,0.00023269982,0.000273489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005773168,0.00024969017,0.0007067558,0.0005437494,0.00017477256,0.0001055677,0.00036613567,0.00026298882,0.0011183146],"category_scores_gemma":[0.00026156538,0.00022007393,0.00049026404,0.0017425445,0.00032121592,0.00015076634,0.00010017124,0.0012740805,0.00038666063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011557127,0.00066552946,0.52948767,0.0002738449,0.00038517994,0.0021434133,0.00033297786,0.00006335271,0.3424693,0.00001989148,0.005908294,0.1066934],"study_design_scores_gemma":[0.0067045214,0.00029636177,0.974633,0.0009978514,0.000012795525,0.000007498822,0.00028552365,0.00077777036,0.0019091015,0.00018433099,0.013927579,0.0002637114],"about_ca_topic_score_codex":0.0017573108,"about_ca_topic_score_gemma":0.0003689544,"teacher_disagreement_score":0.44514525,"about_ca_system_score_codex":0.00070101273,"about_ca_system_score_gemma":0.0007937335,"threshold_uncertainty_score":0.9997948},"labels":[],"label_agreement":null},{"id":"W4386784603","doi":"10.1158/1557-3265.aacrahns23-pr07","title":"Abstract PR07: Oncogene addition to MYB-NFIB in adenoid cystic carcinomas induced in transgenic mice","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MYB; Cancer research; Biology; Adenoid cystic carcinoma; Oncogene; Cancer; Carcinoma; Cell cycle; Transcription factor; Genetics; Gene","score_opus":0.3975003673302855,"score_gpt":0.5573241507492802,"score_spread":0.15982378341899472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908049,0.0006181103,3.8456363e-7,0.005937786,0.00030505075,0.0012564809,0.000063081636,0.000047131787,0.0009670351],"genre_scores_gemma":[0.99645656,0.001062842,0.000025401345,0.00034597717,0.0006232208,0.0010705383,0.000118427844,0.00003803512,0.00025901134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679846,0.0003314959,0.00076578185,0.0006511787,0.00071927096,0.0007338103],"domain_scores_gemma":[0.99725115,0.0017501039,0.00004172282,0.00037591037,0.00014301654,0.00043806888],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025140913,0.00016570534,0.0005177654,0.00062934903,0.00006024795,0.000022988783,0.00018264032,0.00020042965,0.0007923038],"category_scores_gemma":[0.00092208193,0.00014029755,0.00014461421,0.0018234765,0.00007883156,0.000056559227,0.0000701128,0.00097119936,0.00080599287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019255679,0.0014942011,0.96495014,0.00019244156,0.000069160626,0.0014662711,0.0005293544,0.000054918626,0.0026504432,0.000030410538,0.007535963,0.019101122],"study_design_scores_gemma":[0.0041388106,0.001131054,0.98982984,0.00056687085,0.000019932451,0.000005295194,0.00017222515,0.00004416303,0.0023268478,0.00012473561,0.0015068246,0.00013342102],"about_ca_topic_score_codex":0.003930376,"about_ca_topic_score_gemma":0.006758983,"teacher_disagreement_score":0.024879673,"about_ca_system_score_codex":0.0005284771,"about_ca_system_score_gemma":0.0006655189,"threshold_uncertainty_score":0.999972},"labels":[],"label_agreement":null},{"id":"W4386784615","doi":"10.1158/1557-3265.aacrahns23-po-080","title":"Abstract PO-080: Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Medicine; Tumor microenvironment; Immunotherapy; Cisplatin; Cancer research; Immunogenic cell death; Cancer; Combination therapy; Immune system; Statin; Internal medicine; Head and neck cancer; Immunology; Chemotherapy","score_opus":0.05841426286036372,"score_gpt":0.3942780151165683,"score_spread":0.3358637522562046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931044,0.0052701114,0.000033415043,0.00027503713,0.00038996188,0.000687987,0.000103337414,0.0000053340123,0.00013044504],"genre_scores_gemma":[0.9946656,0.0030914599,0.00022632955,0.00006635606,0.0005223699,0.00023127973,0.00009639815,0.00003320426,0.0010669584],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983335,0.00013340815,0.0004749492,0.00041001817,0.00024989937,0.00039821793],"domain_scores_gemma":[0.9991753,0.00021428046,0.00011666456,0.00030385682,0.000110471716,0.000079433004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00141358,0.00012442896,0.00029216736,0.00009581481,0.000076271004,0.000020115083,0.00016929518,0.00010817058,0.000034869892],"category_scores_gemma":[0.000098537945,0.00011140528,0.00007167856,0.00018649442,0.0002811525,0.000006228525,0.00008269831,0.0002455459,0.0000035186126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056163594,0.0007301157,0.13542667,0.00050494616,0.000040616105,0.0000019821923,0.00035158865,0.0003234094,0.8149893,0.000038567483,0.009886509,0.032089904],"study_design_scores_gemma":[0.009421332,0.002256194,0.83103263,0.00006019163,0.000009268811,0.0000010742192,0.0003591864,0.000118743425,0.0933379,0.00015852731,0.063035,0.0002099385],"about_ca_topic_score_codex":0.0011874213,"about_ca_topic_score_gemma":0.0007161612,"teacher_disagreement_score":0.72165143,"about_ca_system_score_codex":0.000038744456,"about_ca_system_score_gemma":0.00025378354,"threshold_uncertainty_score":0.45429754},"labels":[],"label_agreement":null},{"id":"W4386784622","doi":"10.1158/1557-3265.aacrahns23-po-091","title":"Abstract PO-091: Leveraging tissue-resident CD103+ NK cells for adoptive cell therapy in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; NK-92; Cancer research; Adoptive cell transfer; Granzyme; Perforin; Biology; Granzyme B; Lymphokine-activated killer cell; Population; Immunotherapy; Immunology; Interleukin 21; Cancer; T cell; Medicine; Head and neck cancer; CD8; Immune system","score_opus":0.23225291198068368,"score_gpt":0.4944557688991713,"score_spread":0.26220285691848766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857479,0.006845599,0.000011373247,0.0017127243,0.003791902,0.0008074823,0.000025728294,0.000057109646,0.0010001933],"genre_scores_gemma":[0.94314694,0.021535894,0.000010674702,0.00038106053,0.0002237352,0.0004175328,0.00005526586,0.000033798227,0.034195118],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772644,0.00038543617,0.0005623294,0.0005515381,0.000103094775,0.00067116064],"domain_scores_gemma":[0.9981193,0.0012195777,0.00010075369,0.0002481296,0.00025690743,0.000055326138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019196616,0.00016256243,0.0003433211,0.0002700664,0.0002630326,0.0000475995,0.00021539442,0.00031139658,0.0030804041],"category_scores_gemma":[0.00014268854,0.00014384017,0.00010540918,0.00036260654,0.00027413075,0.0001318862,0.00012381839,0.0011692892,0.0006599968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051171635,0.00039728472,0.019033462,0.00015518637,0.00016570018,0.000019410352,0.0018552303,0.00013304847,0.51292884,0.000036234862,0.3199291,0.14022934],"study_design_scores_gemma":[0.006024716,0.0011050485,0.15058647,0.00022048854,0.000010364204,0.0000018358883,0.0012544643,0.000058726397,0.29834342,0.00014752889,0.54195386,0.0002930695],"about_ca_topic_score_codex":0.0043835426,"about_ca_topic_score_gemma":0.00066246156,"teacher_disagreement_score":0.22202477,"about_ca_system_score_codex":0.00016889955,"about_ca_system_score_gemma":0.00026928628,"threshold_uncertainty_score":0.9978309},"labels":[],"label_agreement":null},{"id":"W4386784641","doi":"10.1158/1557-3265.aacrahns23-po-075","title":"Abstract PO-075: Immunosuppression allows for proliferation of alternative splicing events in a murine model of tobacco-associated oral cavity squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA splicing; Immunosuppression; Alternative splicing; Biology; Cancer research; Carcinogenesis; Cancer; Immune system; Molecular biology; Gene isoform; Gene; Immunology; Genetics; RNA","score_opus":0.17678999382888944,"score_gpt":0.47423213055533747,"score_spread":0.29744213672644804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846303,0.00020840733,0.00013249592,0.00013384274,0.000082804894,0.0006605124,0.00020472675,0.000004606162,0.000109561974],"genre_scores_gemma":[0.99847126,0.00034141986,0.00006838203,0.000016310427,0.00008486514,0.00031018507,0.00018386303,0.00001958217,0.0005041475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830496,0.0001741115,0.0005742873,0.00035195396,0.00030021512,0.0002944871],"domain_scores_gemma":[0.99876755,0.00014699221,0.00018876883,0.0003082756,0.00052783143,0.000060570626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018611152,0.00009373717,0.00024060978,0.00009943377,0.000061059356,0.0000055485757,0.0002578684,0.00017790202,0.000011794167],"category_scores_gemma":[0.00050808047,0.000086110136,0.00011189917,0.0002645049,0.00009547245,0.000008662253,0.00014329147,0.00023026334,0.0000014839235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014068714,0.0006512953,0.18517908,0.00014593815,0.00003033318,0.0000010075668,0.00014829185,0.011990749,0.79478,0.000021403897,0.0011543686,0.004490656],"study_design_scores_gemma":[0.004254355,0.00088570983,0.43221354,0.00010039446,0.000016381893,1.3437423e-7,0.00014896973,0.033282686,0.5283113,0.0004247398,0.00016437241,0.00019741952],"about_ca_topic_score_codex":0.0014677065,"about_ca_topic_score_gemma":0.0008793771,"teacher_disagreement_score":0.2664687,"about_ca_system_score_codex":0.00007353348,"about_ca_system_score_gemma":0.00041816023,"threshold_uncertainty_score":0.35114694},"labels":[],"label_agreement":null},{"id":"W4386784647","doi":"10.1158/1557-3265.aacrahns23-po-088","title":"Abstract PO-088: TRPV1+ sensory neurons provide a tumor supportive environment through recruitment of MDSCs","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Université de Montréal","funders":"","keywords":"Immune system; Tumor microenvironment; Cancer research; Flow cytometry; Population; Cancer; Biology; Tumor progression; Head and neck squamous-cell carcinoma; Pathology; Immunology; Medicine; Head and neck cancer; Internal medicine","score_opus":0.44478725668513786,"score_gpt":0.5335756045926386,"score_spread":0.08878834790750079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98358095,0.0021156247,0.000004925862,0.009015039,0.00036336266,0.002519036,0.000120159566,0.00009361634,0.0021872907],"genre_scores_gemma":[0.9603847,0.02290284,0.000114208444,0.0007274015,0.0012636299,0.0012058765,0.000052829604,0.00010527642,0.013243237],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995035,0.00064392464,0.0012101696,0.0007856536,0.0013865232,0.00093871925],"domain_scores_gemma":[0.9960094,0.0022130345,0.00025652192,0.000938497,0.00021448302,0.00036807032],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031277773,0.00024949622,0.00082461885,0.00021539508,0.00016065151,0.00002462956,0.00031351644,0.00017809191,0.0013903275],"category_scores_gemma":[0.0014265926,0.00020988415,0.00042517253,0.00054126634,0.0011725173,0.00010550041,0.00023776662,0.0012469161,0.00060878845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05426142,0.0068402844,0.11847211,0.0036647862,0.0014663157,0.0065281983,0.0053218915,0.00026504882,0.050124258,0.00034566762,0.24551639,0.5071936],"study_design_scores_gemma":[0.003626591,0.0029389884,0.51066107,0.0005374516,0.00010973843,0.000047123714,0.0013321341,0.000075065545,0.013920107,0.00019778017,0.466268,0.0002859651],"about_ca_topic_score_codex":0.001130663,"about_ca_topic_score_gemma":0.00006519986,"teacher_disagreement_score":0.50690764,"about_ca_system_score_codex":0.00036964312,"about_ca_system_score_gemma":0.0015673852,"threshold_uncertainty_score":0.9995225},"labels":[],"label_agreement":null},{"id":"W4386784651","doi":"10.1158/1557-3265.aacrahns23-pr03","title":"Abstract PR03: Cholinergic modulation of tumor infiltrating lymphocytes in oral squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Cancer research; Immune system; T cell; Acetylcholine; Cholinergic; Cancer; Cytotoxic T cell; Biology; Immunotherapy; Immunology; Medicine; Internal medicine; Endocrinology; In vitro","score_opus":0.1762293950171087,"score_gpt":0.47428584431576953,"score_spread":0.2980564492986608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955325,0.0017023715,7.98947e-7,0.0006467845,0.00021612839,0.0005611638,0.000015296197,0.00004997281,0.0012749599],"genre_scores_gemma":[0.9972144,0.00068424485,0.000040723105,0.00008685839,0.00071532134,0.00011925936,0.000030083353,0.00004163321,0.0010675173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666595,0.00037807887,0.0010426611,0.00046258923,0.00081816735,0.0006325572],"domain_scores_gemma":[0.99684435,0.0019217236,0.00017084928,0.00049035985,0.00036649176,0.00020621378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003465971,0.00016105281,0.0005938735,0.00048017048,0.00008743178,0.00002645646,0.00022923408,0.00017189173,0.00028846192],"category_scores_gemma":[0.001928686,0.00014376201,0.00019918766,0.0013158966,0.0003891481,0.000106379375,0.000097566146,0.0007909426,0.0000783656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00701127,0.00071869907,0.919888,0.0011693601,0.000020369689,0.00041476273,0.00064974074,0.0017872314,0.024260934,0.000020022038,0.004431511,0.039628096],"study_design_scores_gemma":[0.0042914483,0.0006227377,0.9796586,0.00021162358,0.000013633809,0.000010327013,0.00044623401,0.006274876,0.0063688336,0.000044389166,0.0019208158,0.0001364948],"about_ca_topic_score_codex":0.0049683736,"about_ca_topic_score_gemma":0.0003997195,"teacher_disagreement_score":0.059770584,"about_ca_system_score_codex":0.00030197506,"about_ca_system_score_gemma":0.0015815853,"threshold_uncertainty_score":0.75107276},"labels":[],"label_agreement":null},{"id":"W4386784656","doi":"10.1158/1557-3265.aacrahns23-po-084","title":"Abstract PO-084: Deletion of macrophage migration inhibitory factor promotes antitumoral T cell infiltration and inhibits MDSC recruitment to the head and neck cancer microenvironment","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Macrophage migration inhibitory factor; Tumor microenvironment; Head and neck squamous-cell carcinoma; Cancer research; Immune system; Immunotherapy; Cytokine; Cancer; Immunology; Metastasis; Tumor progression; T cell; Biology; Medicine; Head and neck cancer; Internal medicine","score_opus":0.18603205683042648,"score_gpt":0.4403780744964843,"score_spread":0.2543460176660578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989328,0.0046037496,0.000018348714,0.0032387367,0.0006082637,0.0018196312,0.00031307663,0.00004083145,0.00002930638],"genre_scores_gemma":[0.99431324,0.0034164,0.00003943758,0.00016344784,0.00021613053,0.0005277173,0.00009248542,0.000026535496,0.0012046159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972853,0.0006367841,0.0007667583,0.0005984528,0.00022998593,0.0004826849],"domain_scores_gemma":[0.99867815,0.0005000296,0.00020109922,0.00032625062,0.00018809803,0.000106370375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014648078,0.00020735309,0.00033075683,0.00019610455,0.00036405434,0.000059604754,0.00018099269,0.00027465128,0.00060823845],"category_scores_gemma":[0.00022787192,0.00015803683,0.00007672873,0.0003638853,0.0005667967,0.00014449586,0.00023452898,0.00072931865,0.0002204144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003934652,0.00018205844,0.052899826,0.00015761082,0.000047708563,0.0000048417596,0.0014025865,0.000031008098,0.90600437,0.0000136654535,0.017520798,0.021342037],"study_design_scores_gemma":[0.0012256628,0.0006679638,0.38632637,0.00017304118,0.000016579139,0.000002622461,0.00027500227,0.000020587891,0.5783851,0.000026938189,0.0327018,0.0001783462],"about_ca_topic_score_codex":0.0012900017,"about_ca_topic_score_gemma":0.0023528428,"teacher_disagreement_score":0.33342654,"about_ca_system_score_codex":0.00013952542,"about_ca_system_score_gemma":0.00019663697,"threshold_uncertainty_score":0.66597843},"labels":[],"label_agreement":null},{"id":"W4386784698","doi":"10.1158/1557-3265.aacrahns23-po-081","title":"Abstract PO-081: Patterns of immune susceptibility in young, non-smoking, oral cancer patients","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunology; Disease; Cancer; Cellulitis; Internal medicine","score_opus":0.19162552331834976,"score_gpt":0.51452188487533,"score_spread":0.32289636155698026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540627,0.00028094367,0.0000029273758,0.0009459727,0.0007843548,0.0005941837,0.00015663942,0.00003455533,0.00179417],"genre_scores_gemma":[0.99613804,0.0021321508,0.0000051083375,0.00009287813,0.00024821475,0.00017147348,0.00011038318,0.000026808995,0.0010749219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971047,0.00015883798,0.0009021001,0.00047605392,0.00077808736,0.000580226],"domain_scores_gemma":[0.9982301,0.00048443963,0.00010346323,0.00049258786,0.00047919067,0.00021023996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025949152,0.00012972626,0.00049327215,0.00026912708,0.000086351305,0.000015011609,0.0002024226,0.00020265438,0.0028866152],"category_scores_gemma":[0.0008427851,0.000105063686,0.00021103038,0.0009078236,0.00023879654,0.0000714441,0.00017538514,0.0009839357,0.00007714554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007807796,0.000858814,0.98105246,0.0001982192,0.000053115884,0.000014887376,0.00017790696,0.000011371127,0.00009963143,0.000006113917,0.006079502,0.010667208],"study_design_scores_gemma":[0.0037239217,0.00054276816,0.9938564,0.0002732258,0.000019830177,2.2908732e-7,0.00029901986,0.00007501079,0.000096561045,0.00011692411,0.0008958483,0.00010029019],"about_ca_topic_score_codex":0.03963164,"about_ca_topic_score_gemma":0.013717843,"teacher_disagreement_score":0.025913795,"about_ca_system_score_codex":0.00016658269,"about_ca_system_score_gemma":0.0005061696,"threshold_uncertainty_score":0.9980249},"labels":[],"label_agreement":null},{"id":"W4386784705","doi":"10.1158/1557-3265.aacrahns23-po-077","title":"Abstract PO-077: High-throughput 3D-spheroid invasion assay: A powerful tool to identify novel drugs targeting tumor micro-environment in HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Structural Genomics Consortium; University Health Network","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer; Cancer research; Cancer cell; Metastasis; Tumor microenvironment; Cancer-Associated Fibroblasts; Cell; Tumor progression; Medicine; Biology; Head and neck cancer; Internal medicine","score_opus":0.15989032263657513,"score_gpt":0.4776897109230515,"score_spread":0.31779938828647636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97886074,0.00083753123,0.000043810775,0.017190728,0.0006657524,0.0015554694,0.00007285412,0.000105338295,0.0006677969],"genre_scores_gemma":[0.9897778,0.0031856296,0.0014791532,0.0022474607,0.0011035843,0.00062286336,0.00007147369,0.00011445436,0.0013975697],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9934765,0.00036001173,0.0014896739,0.0013743268,0.0019030744,0.0013963814],"domain_scores_gemma":[0.99697995,0.0011852843,0.00016464818,0.0008209113,0.00026011933,0.00058906147],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.010008454,0.00032248013,0.00083668885,0.0003666118,0.00019986217,0.00012699187,0.0005320369,0.00029044517,0.0031997468],"category_scores_gemma":[0.0019859278,0.000288,0.00028006814,0.0015159638,0.0003217682,0.00018117513,0.00084494386,0.0019955868,0.002981997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049242666,0.0033993549,0.25878984,0.0010704034,0.00032048498,0.00068902783,0.0015783848,0.00052704074,0.28059304,0.000071005205,0.290193,0.15784416],"study_design_scores_gemma":[0.00618232,0.0011312313,0.86418253,0.001385697,0.000052684587,0.0000052181276,0.0013152641,0.00021552108,0.017706048,0.00016247644,0.10705895,0.0006020327],"about_ca_topic_score_codex":0.0027425028,"about_ca_topic_score_gemma":0.00015951373,"teacher_disagreement_score":0.6053927,"about_ca_system_score_codex":0.0009777951,"about_ca_system_score_gemma":0.00072622864,"threshold_uncertainty_score":0.9999572},"labels":[],"label_agreement":null},{"id":"W4386784719","doi":"10.1158/1557-3265.aacrahns23-po-096","title":"Abstract PO-096: Cytokines in the lumen of exosomes are undetectable by immunoassays distorting cytokine profiles in HNC patients and healthy donors","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytokine; Proinflammatory cytokine; Immune system; Flow cytometry; Medicine; Immunology; Chemistry; Molecular biology; Biology; Inflammation","score_opus":0.08385418372164645,"score_gpt":0.44326365749828817,"score_spread":0.35940947377664173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426895,0.00396153,0.0000010669086,0.0009039718,0.00007066024,0.0004814427,0.00016503395,0.0000068321015,0.00014051884],"genre_scores_gemma":[0.99531156,0.004062426,0.000013243391,0.00008984116,0.00010293916,0.0001668288,0.00011130791,0.000023012948,0.00011885085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758327,0.00047221858,0.00064180605,0.00044129294,0.00039038257,0.00047104672],"domain_scores_gemma":[0.9988526,0.0003794468,0.00016267135,0.00038354433,0.00012533866,0.00009639981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030349544,0.00011936351,0.00024393185,0.00010363314,0.00008580986,0.000026275973,0.00040860986,0.00016146532,0.000022448488],"category_scores_gemma":[0.0014174675,0.00009439118,0.00006546498,0.00046558754,0.00035721165,0.000009502884,0.000302592,0.00046050092,0.000005710678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063051825,0.00043121408,0.94050264,0.00021780877,0.00001967993,0.000013522042,0.0001012145,0.000016435988,0.04295419,0.0000066462844,0.0052005327,0.009905583],"study_design_scores_gemma":[0.001788558,0.00039872952,0.9789943,0.000113791924,0.000004714806,3.5240092e-7,0.0007433237,0.000037562804,0.0148142595,0.00028448,0.0026688096,0.00015107996],"about_ca_topic_score_codex":0.0006855258,"about_ca_topic_score_gemma":0.0009978712,"teacher_disagreement_score":0.038491685,"about_ca_system_score_codex":0.000052497246,"about_ca_system_score_gemma":0.00017895318,"threshold_uncertainty_score":0.38491607},"labels":[],"label_agreement":null},{"id":"W4386784726","doi":"10.1158/1557-3265.aacrahns23-po-087","title":"Abstract PO-087: Single-cell transcriptome analysis reveals functional changes in tumor-infiltrating macrophages after nutraceutical momordicine-I treatment in head &amp; neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Transcriptome; Cancer; Immune system; Monocyte; Cancer research; Head and neck cancer; Medicine; Macrophage; Head and neck squamous-cell carcinoma; Cancer cell; Biology; Immunology; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.24839053509630055,"score_gpt":0.47687369616853587,"score_spread":0.22848316107223532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740572,0.019233733,0.0000054185216,0.0036345017,0.0012255231,0.00080754096,0.00023080772,0.000085421016,0.00071985496],"genre_scores_gemma":[0.983415,0.004995626,0.000029595636,0.00043499545,0.00035207707,0.0016624347,0.00017479225,0.00006173741,0.0088737095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99435747,0.001165313,0.0013244172,0.0011839808,0.0003376306,0.0016312109],"domain_scores_gemma":[0.99662894,0.0021675455,0.00015871943,0.0006819701,0.00023712477,0.00012570014],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0032611107,0.00040427514,0.0011441852,0.0012045954,0.00019490637,0.000055436405,0.0004329327,0.0005615008,0.009853692],"category_scores_gemma":[0.00031080638,0.00035405828,0.00039970144,0.0032028998,0.0008746373,0.00011819995,0.00014606139,0.0020717336,0.0008017401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003968529,0.0015557724,0.63736427,0.00026079488,0.0007938855,0.00036399567,0.0010109134,0.0007854647,0.3313925,0.000010207635,0.004551684,0.017941946],"study_design_scores_gemma":[0.0058912365,0.0006742999,0.9427561,0.00039380728,0.00020523659,0.00000660163,0.00042750215,0.000037037447,0.022128625,0.000118713215,0.026867911,0.0004929092],"about_ca_topic_score_codex":0.0072531467,"about_ca_topic_score_gemma":0.045850776,"teacher_disagreement_score":0.30926389,"about_ca_system_score_codex":0.0011143185,"about_ca_system_score_gemma":0.00052924093,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W4386784744","doi":"10.1158/1557-3265.aacrahns23-po-070","title":"Abstract PO-070: New patient-derived head and neck cancer xenograft (PDX) panel for drug development, immuno-oncology and translational research","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cetuximab; Medicine; Head and neck squamous-cell carcinoma; Oncology; Radiation therapy; Internal medicine; Head and neck cancer; Docetaxel; Cancer; Cancer research; Colorectal cancer","score_opus":0.35876907313791295,"score_gpt":0.5591379491896306,"score_spread":0.2003688760517176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839744,0.00973991,0.0000132292225,0.0043236143,0.0001813584,0.0012403881,0.0002236662,0.000022826354,0.00028058686],"genre_scores_gemma":[0.9750295,0.020099098,0.00044580968,0.00014076549,0.00068118743,0.0012931277,0.00034928892,0.000059276314,0.00190191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623597,0.0003956592,0.0005651885,0.00094389875,0.000679661,0.0011796344],"domain_scores_gemma":[0.997502,0.00085143227,0.00007023152,0.00034410993,0.0006073106,0.00062488293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026342133,0.00020995495,0.00034426202,0.00024412789,0.000621993,0.00011138208,0.0003152217,0.00029557117,0.00016190903],"category_scores_gemma":[0.00054309383,0.00019020932,0.00011024243,0.0004908426,0.0007764507,0.00001887826,0.00042413457,0.0006710453,0.000028323748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055002864,0.00038296622,0.05948894,0.00023074505,0.00057271257,0.00003910796,0.0013242743,0.00001467331,0.07342141,0.000036742465,0.07329237,0.7856958],"study_design_scores_gemma":[0.008411346,0.0019854035,0.26112017,0.00017309497,0.000020290887,0.000006786716,0.00061021466,0.000053509026,0.039952032,0.0011828849,0.68605846,0.00042581768],"about_ca_topic_score_codex":0.003815411,"about_ca_topic_score_gemma":0.013842607,"teacher_disagreement_score":0.78527,"about_ca_system_score_codex":0.00011485446,"about_ca_system_score_gemma":0.0028845067,"threshold_uncertainty_score":0.7756511},"labels":[],"label_agreement":null},{"id":"W4386784745","doi":"10.1158/1557-3265.aacrahns23-po-060","title":"Abstract PO-060: Novel combination of TRIP13 and Aurora kinase A inhibition demonstrated extensive DNA damage and immunogenic cell death in RB-deficient cancers","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Apoptosis; Retinoblastoma; Retinoblastoma protein; DNA damage; Cell cycle checkpoint; Programmed cell death; Cancer; Cancer cell; Cell growth; Mitosis; Mad2; Chemistry; Cell cycle; Biology; Cell biology; DNA; Genetics","score_opus":0.08942050629643282,"score_gpt":0.4157472379388378,"score_spread":0.32632673164240494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977155,0.0013644682,0.00002432162,0.00018908737,0.00007080045,0.0003902459,0.00010000723,0.0000070077435,0.00013859489],"genre_scores_gemma":[0.99342334,0.0061099646,0.0000391036,0.000075081065,0.00003971055,0.000050748575,0.00014155304,0.00001753562,0.00010293208],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984487,0.00013230479,0.00042605904,0.00043496653,0.00020229256,0.00035564922],"domain_scores_gemma":[0.9991424,0.00012964422,0.00009782456,0.00022031686,0.00029539876,0.00011443591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001406202,0.000112541864,0.00020808703,0.00015467354,0.00007568644,0.000025150817,0.000097109536,0.00021626969,0.000010350625],"category_scores_gemma":[0.00027440765,0.00011202672,0.000055798766,0.0003689062,0.00031251693,0.000007694705,0.00018129099,0.00033599779,0.0000028677455],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037559966,0.00018063466,0.010018597,0.000097059055,0.000020610572,0.000013852929,0.00007488821,0.000065995395,0.98657215,0.000044961238,0.0003384993,0.0021971494],"study_design_scores_gemma":[0.0061669867,0.0012143689,0.6037192,0.00024087424,0.000029010524,0.000005003244,0.0008316172,0.0022149915,0.38411,0.00023382061,0.0008965697,0.0003375815],"about_ca_topic_score_codex":0.0010526829,"about_ca_topic_score_gemma":0.0008642966,"teacher_disagreement_score":0.6024621,"about_ca_system_score_codex":0.00007137216,"about_ca_system_score_gemma":0.0004212524,"threshold_uncertainty_score":0.4568317},"labels":[],"label_agreement":null},{"id":"W4386784760","doi":"10.1158/1557-3265.aacrahns23-po-047","title":"Abstract PO-047: A novel saliva miRNA panel of promising diagnostic biomarkers for oral cancer: The association of miR-21 with smoking history","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Saliva; Receiver operating characteristic; Medicine; Internal medicine; Cancer; microRNA; Area under the curve; Confidence interval; Oncology; Basal cell; Head and neck cancer; Carcinogenesis; Gastroenterology; Biology; Gene","score_opus":0.20641294505106358,"score_gpt":0.45435106100955214,"score_spread":0.24793811595848855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996215,0.0017745333,0.000065421824,0.0007712866,0.00019673993,0.000726628,0.00018249327,0.000009215496,0.00005868171],"genre_scores_gemma":[0.99828625,0.0006731554,0.00010156312,0.000039154605,0.00024489927,0.000260781,0.0000907892,0.000030474697,0.00027295176],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99820834,0.00017419008,0.00046665204,0.000342157,0.0004693909,0.00033924793],"domain_scores_gemma":[0.99733907,0.0012930153,0.00033882677,0.00032322374,0.000626592,0.00007926074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029271378,0.00010144548,0.00022052758,0.00007331425,0.00007750755,0.000011505177,0.0002675594,0.00019008633,0.000039383773],"category_scores_gemma":[0.0026228218,0.00007737625,0.00014551687,0.00025572232,0.0003093142,0.000006167198,0.00010384398,0.00019231788,0.0000011568299],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018453264,0.00027561744,0.23185699,0.00057378015,0.0007567348,0.0000022528463,0.00013739342,0.0003548426,0.71864086,0.000029025166,0.0346579,0.010869264],"study_design_scores_gemma":[0.0022885653,0.00037382558,0.90619963,0.0003590653,0.000106643194,5.4902e-7,0.00010451939,0.000291747,0.06729022,0.000067280256,0.02273698,0.00018098105],"about_ca_topic_score_codex":0.00066913106,"about_ca_topic_score_gemma":0.00047787649,"teacher_disagreement_score":0.67434263,"about_ca_system_score_codex":0.00032866653,"about_ca_system_score_gemma":0.00097129855,"threshold_uncertainty_score":0.3155312},"labels":[],"label_agreement":null},{"id":"W4386784763","doi":"10.1158/1557-3265.aacrahns23-po-063","title":"Abstract PO-063: Environment-induced YAP1 transcriptional reprogramming drives head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"YAP1; Carcinogenesis; Reprogramming; Biology; Epigenetics; Cancer research; Chromatin; Context (archaeology); Cancer; Genetics; Transcription factor; Gene","score_opus":0.21282331511592836,"score_gpt":0.5013046931243521,"score_spread":0.28848137800842377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916836,0.005980893,0.000010032334,0.00137082,0.00023889245,0.00034103348,0.00008775023,0.000033030457,0.00025392763],"genre_scores_gemma":[0.9861113,0.011603345,0.00006407313,0.00016748652,0.0009119883,0.00032812147,0.00010571469,0.00004096498,0.0006670342],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974826,0.00019503901,0.0004005664,0.0008269307,0.0005188215,0.0005760657],"domain_scores_gemma":[0.99890167,0.00013820238,0.000055045122,0.00049437897,0.00009049212,0.00032019053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012573252,0.00015150513,0.00020436032,0.00007666135,0.00020901264,0.00006455986,0.00029812564,0.00023219513,0.0003566662],"category_scores_gemma":[0.00042471016,0.00014921236,0.00017555701,0.00019808204,0.000481019,0.000008565001,0.00024308666,0.0004520724,0.00006921991],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005735384,0.00034012576,0.28024256,0.00013956605,0.00027374923,0.00006199456,0.00007812998,0.00007981563,0.50106925,0.00008117505,0.0078083463,0.20925175],"study_design_scores_gemma":[0.0012535235,0.00031540694,0.86779076,0.00008799214,0.00002324715,0.0000027504009,0.00012635432,0.000039589933,0.014081971,0.00027578056,0.115735,0.00026760413],"about_ca_topic_score_codex":0.0003686168,"about_ca_topic_score_gemma":0.00025955535,"teacher_disagreement_score":0.5875482,"about_ca_system_score_codex":0.00005057753,"about_ca_system_score_gemma":0.00030108923,"threshold_uncertainty_score":0.6084703},"labels":[],"label_agreement":null},{"id":"W4386784804","doi":"10.1158/1557-3265.aacrahns23-po-044","title":"Abstract PO-044: Correlation between circulating tumor DNA and tumor volume in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck cancer; Cancer; Primary tumor; Tonsil; Oncology; Radiation therapy; Pathology; Internal medicine; Metastasis","score_opus":0.1378141845069413,"score_gpt":0.4696687542100075,"score_spread":0.33185456970306615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559826,0.002457751,0.000008441743,0.0009461487,0.00023336204,0.00031241964,0.00012280035,0.000012232565,0.00030860948],"genre_scores_gemma":[0.9948992,0.0034604906,0.000032068845,0.00020331306,0.000990245,0.00010474791,0.000067758454,0.000031479623,0.00021067967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814284,0.000111941474,0.00046053517,0.0005743583,0.00024094654,0.0004693768],"domain_scores_gemma":[0.9989094,0.00040960984,0.00008468741,0.00024301052,0.00013789094,0.00021538966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014925048,0.0001285675,0.00025375283,0.00010589456,0.00012942767,0.00006595175,0.00012221531,0.0001454336,0.000050258022],"category_scores_gemma":[0.0010137161,0.00013339995,0.000052731975,0.00030114787,0.00026107382,0.000007711917,0.00030931164,0.00046727853,0.000018328727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013018545,0.00002847672,0.96539,0.00006901885,0.00002618758,0.000035071764,0.000051197614,0.00021115104,0.005783952,0.000020244293,0.0033046408,0.02494983],"study_design_scores_gemma":[0.0010334525,0.00020679607,0.98494387,0.00011079538,0.000009165697,0.0000025268262,0.00006400781,0.0008728497,0.0007595467,0.00027329708,0.011552789,0.00017087752],"about_ca_topic_score_codex":0.0024809258,"about_ca_topic_score_gemma":0.0021757183,"teacher_disagreement_score":0.024778953,"about_ca_system_score_codex":0.00006787024,"about_ca_system_score_gemma":0.0004088885,"threshold_uncertainty_score":0.5439892},"labels":[],"label_agreement":null},{"id":"W4386784819","doi":"10.1158/1557-3265.aacrahns23-po-056","title":"Abstract PO-056: The effect of timing of post-operative radiation on outcomes in anaplastic thyroid cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Cancer; Surgery; Regimen; Stage (stratigraphy); Thyroid cancer; Thyroidectomy; Anaplastic thyroid cancer; Thyroid; Internal medicine","score_opus":0.16533171795332535,"score_gpt":0.5509622340987879,"score_spread":0.3856305161454625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891888,0.0018770441,2.5846907e-7,0.007038287,0.00026377582,0.0010236286,0.000103743296,0.000015791626,0.00048865424],"genre_scores_gemma":[0.9942234,0.004573611,0.0000028213135,0.00014338686,0.00017604983,0.000575568,0.000017659151,0.000022581231,0.00026493092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747735,0.00042229524,0.00062928174,0.0003465828,0.0007565159,0.0003679751],"domain_scores_gemma":[0.99197465,0.0071864706,0.00013365175,0.000362552,0.00022798266,0.00011469574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024087552,0.00014382934,0.0006293446,0.0002555325,0.00007112217,0.000011205535,0.00017054302,0.000109922286,0.0003361269],"category_scores_gemma":[0.0017962467,0.00007994878,0.00019734436,0.0007375583,0.0002875981,0.000044397097,0.000070972405,0.0006340108,0.000049856768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035265277,0.0003679745,0.90739506,0.00024694146,0.00030751748,0.00004402912,0.0004476838,0.00077444525,0.0014453457,0.00004551909,0.004211213,0.08118773],"study_design_scores_gemma":[0.003925123,0.005083497,0.97247934,0.00050006434,0.000055682147,2.819834e-7,0.00013092191,0.00018468431,0.017305166,0.000017249453,0.00025171926,0.00006624499],"about_ca_topic_score_codex":0.0035701485,"about_ca_topic_score_gemma":0.0015585234,"teacher_disagreement_score":0.08112149,"about_ca_system_score_codex":0.00031049154,"about_ca_system_score_gemma":0.00042963005,"threshold_uncertainty_score":0.53970206},"labels":[],"label_agreement":null},{"id":"W4386784857","doi":"10.1158/1557-3265.aacrahns23-po-018","title":"Abstract PO-018: Pathological analysis of newly established immunocompetent mice with full HPV16 genome integration","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Carcinogenesis; Genome; Transgene; Phenotype; Gene; CRISPR; Genetically modified mouse; Cancer research; Locus (genetics); Virology; Genetics","score_opus":0.24909723091226774,"score_gpt":0.5202106468539504,"score_spread":0.2711134159416826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836483,0.0009028339,0.00019300714,0.0038724404,0.00011434181,0.0009087049,0.00012120976,0.000104844294,0.010134329],"genre_scores_gemma":[0.99469894,0.0027675636,0.00022784995,0.00021363808,0.0004056412,0.00023395113,0.00029976008,0.000036558547,0.0011160878],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946226,0.0004792971,0.0010699752,0.0008425286,0.0020660684,0.00091953506],"domain_scores_gemma":[0.99451447,0.0019450901,0.0001439654,0.0008239791,0.0020103364,0.00056216685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006097017,0.00021243715,0.0010648057,0.0011103358,0.00016720955,0.00008459781,0.0005165985,0.00029404127,0.01019013],"category_scores_gemma":[0.0016041378,0.00014140517,0.00050417654,0.006558918,0.00094689464,0.00012094488,0.00033172677,0.001969098,0.00021244456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047694318,0.0035099222,0.2450032,0.0012187089,0.0061425227,0.0014585002,0.0012704978,0.0014831942,0.07896372,0.00067108084,0.008949199,0.60363513],"study_design_scores_gemma":[0.002309887,0.0020971221,0.98913044,0.00006049882,0.0003776598,0.0000040495192,0.00053510204,0.0013459293,0.00057168875,0.00012689781,0.0032753327,0.00016540715],"about_ca_topic_score_codex":0.0017319528,"about_ca_topic_score_gemma":0.0014885326,"teacher_disagreement_score":0.7441272,"about_ca_system_score_codex":0.00031202481,"about_ca_system_score_gemma":0.0009592714,"threshold_uncertainty_score":0.99071467},"labels":[],"label_agreement":null},{"id":"W4386784868","doi":"10.1158/1557-3265.aacrahns23-po-040","title":"Abstract PO-040: Comparing digital image analysis with a manual scoring approach for quantification of p63 and BRCA1 protein expression in oropharyngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tissue microarray; Biomarker; Context (archaeology); Immunohistochemistry; Medicine; Oncology; Digital image analysis; Digital pathology; Digital polymerase chain reaction; Rank correlation; Pathology; Internal medicine; Biology; Gene; Polymerase chain reaction; Computer science","score_opus":0.13791106912026352,"score_gpt":0.46955963288802705,"score_spread":0.3316485637677635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565774,0.00022798333,0.002119844,0.00037959614,0.000024747585,0.00094568764,0.000016329926,0.00003064517,0.00059740973],"genre_scores_gemma":[0.9971851,0.000040636653,0.0020292203,0.0000114319755,0.00014737548,0.00020640314,0.00010460128,0.000030914285,0.00024430777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765635,0.000120160104,0.00061379786,0.0005697288,0.00060576113,0.00043420595],"domain_scores_gemma":[0.9983897,0.0007132136,0.00013773228,0.0003137328,0.00021563725,0.00022994784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002872675,0.0001251116,0.00058229524,0.0005090365,0.00010039643,0.00007381692,0.00016901312,0.000095859905,0.000015009203],"category_scores_gemma":[0.0008689248,0.00009677631,0.00010911038,0.0010407659,0.000392082,0.00013547673,0.00013126254,0.000904408,0.0000025913253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002043604,0.0004925522,0.94001913,0.0015662443,0.00006524501,0.00006370741,0.00030528996,0.0009279547,0.03847969,0.000015164192,0.00024357555,0.015777817],"study_design_scores_gemma":[0.0037242507,0.00046481908,0.88213605,0.00021730647,0.000087898785,0.0000023620119,0.0004982645,0.10682073,0.005825923,0.000031504307,0.00005697386,0.00013393565],"about_ca_topic_score_codex":0.0005174287,"about_ca_topic_score_gemma":0.00002718765,"teacher_disagreement_score":0.10589278,"about_ca_system_score_codex":0.000071769166,"about_ca_system_score_gemma":0.00019660873,"threshold_uncertainty_score":0.39464232},"labels":[],"label_agreement":null},{"id":"W4386784870","doi":"10.1158/1557-3265.aacrahns23-po-034","title":"Abstract PO-034: Optimizing chemotherapeutic regimen through metabolic interrogation to maximize radiosensitizing effects in HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regimen; Medicine; Head and neck squamous-cell carcinoma; Cisplatin; Oncology; Clonogenic assay; Internal medicine; Cancer research; Cancer; Chemotherapy; Pharmacology; Head and neck cancer; Cell; Chemistry","score_opus":0.1402687006411864,"score_gpt":0.4750643421025106,"score_spread":0.3347956414613242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851521,0.008408222,0.00023816426,0.0023459431,0.0017708796,0.000811749,0.000013842388,0.000052077106,0.0012069682],"genre_scores_gemma":[0.97653043,0.015292802,0.0011638569,0.0015209019,0.0037376813,0.0003216545,0.000053409025,0.000084067775,0.0012952025],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690026,0.000421015,0.00056194107,0.0008198932,0.00046466987,0.0008322213],"domain_scores_gemma":[0.9985418,0.00032950687,0.00008562083,0.00060649164,0.00020424502,0.00023233627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002872455,0.00021219159,0.00046690134,0.00022127945,0.00012429178,0.000070576156,0.00039855432,0.00029727287,0.00004545382],"category_scores_gemma":[0.00061962544,0.00020928052,0.00020662011,0.0009119713,0.00018562803,0.00001697411,0.00031571146,0.00065383984,0.00013243678],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020569484,0.00025508768,0.0013902412,0.00025003785,0.00031632016,0.000038803973,0.0014639184,0.001220884,0.6792362,0.00023418377,0.026661625,0.28687575],"study_design_scores_gemma":[0.006797914,0.00060860784,0.07804968,0.00048517884,0.00006743539,0.0000131752095,0.0011412599,0.0004416106,0.28313047,0.00083548203,0.62756866,0.00086055347],"about_ca_topic_score_codex":0.00058778806,"about_ca_topic_score_gemma":0.00036010152,"teacher_disagreement_score":0.600907,"about_ca_system_score_codex":0.000092072085,"about_ca_system_score_gemma":0.00043128183,"threshold_uncertainty_score":0.8534212},"labels":[],"label_agreement":null},{"id":"W4386784873","doi":"10.1158/1557-3265.aacrahns23-po-022","title":"Abstract PO-022: Characterizing genetic and molecular differences in head and neck cancer based on history of smoking","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology; Copy-number variation; Head and neck cancer; Gene; Biology; Genetics; Genome","score_opus":0.14606455084829548,"score_gpt":0.44436361362577276,"score_spread":0.2982990627774773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138796,0.0067448528,0.000045705663,0.0008356964,0.00024216191,0.0003995251,0.000035583398,0.000012792903,0.00029572268],"genre_scores_gemma":[0.9894977,0.009415559,0.00005095633,0.0003358011,0.00015157896,0.00021365813,0.000020596886,0.000045431756,0.00026870225],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99711376,0.00036858328,0.0004914411,0.00077586254,0.00064280647,0.00060755323],"domain_scores_gemma":[0.99883837,0.00022549496,0.000097491815,0.00042879494,0.00018124473,0.00022860737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015610134,0.00018234742,0.00035058334,0.00033888544,0.000060070426,0.000027809263,0.00028678647,0.00032013017,0.00010492685],"category_scores_gemma":[0.00051694206,0.00018031229,0.000088566456,0.00037037162,0.0004870173,0.000005885139,0.00031197158,0.0007728385,0.0000035514615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012020997,0.00018974497,0.07662118,0.00038871774,0.00010095976,0.00013576445,0.00009725165,0.000251144,0.8512712,0.000038738348,0.0014165972,0.068286605],"study_design_scores_gemma":[0.003108982,0.0013939717,0.89877635,0.000801334,0.000019832649,0.000002514871,0.000069157,0.0034744467,0.08009205,0.00012268127,0.011698219,0.0004404345],"about_ca_topic_score_codex":0.0012125295,"about_ca_topic_score_gemma":0.00048510722,"teacher_disagreement_score":0.8221552,"about_ca_system_score_codex":0.00019445714,"about_ca_system_score_gemma":0.0008614811,"threshold_uncertainty_score":0.73529214},"labels":[],"label_agreement":null},{"id":"W4386784876","doi":"10.1158/1557-3265.aacrahns23-po-021","title":"Abstract PO-021: TCGA differentially expressed genes between Caucasians and African Americans at variable analytic stringencies","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gene; False positive paradox; Biology; Genetics; Gene expression profiling; Gene expression; Genome","score_opus":0.18565194679647956,"score_gpt":0.48402737358175113,"score_spread":0.29837542678527157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951672,0.0006663588,0.0010069503,0.0011793828,0.000045794855,0.00036497077,0.00024332048,0.00005669948,0.0012693434],"genre_scores_gemma":[0.99067056,0.0059295706,0.00044472527,0.00009380298,0.00042026493,0.0002995047,0.00025795074,0.0000335638,0.001850041],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99784935,0.00020958635,0.0003991576,0.00071925856,0.00026079535,0.0005618679],"domain_scores_gemma":[0.99868333,0.00020814802,0.00008843095,0.00059888087,0.0001710004,0.000250194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010232878,0.00016179505,0.00028904778,0.00010311093,0.0002921401,0.00004397257,0.00041440965,0.0002701053,0.00012239578],"category_scores_gemma":[0.00022931802,0.00014522504,0.0001126752,0.00047311038,0.0006524484,0.0000032283244,0.0006402957,0.00034440475,0.000024984589],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012553106,0.00009506974,0.12728406,0.00005655189,0.00023194528,0.00001250298,0.00003559492,0.000017331224,0.827523,0.00016903618,0.018735357,0.025714003],"study_design_scores_gemma":[0.00088581425,0.0008205814,0.5303276,0.000056945617,0.00009494626,0.0000034301079,0.00024594675,0.000102581296,0.17338918,0.0012350631,0.29222003,0.0006178494],"about_ca_topic_score_codex":0.0004774183,"about_ca_topic_score_gemma":0.00018810798,"teacher_disagreement_score":0.65413386,"about_ca_system_score_codex":0.000036881833,"about_ca_system_score_gemma":0.0002147505,"threshold_uncertainty_score":0.59221053},"labels":[],"label_agreement":null},{"id":"W4386784878","doi":"10.1158/1557-3265.aacrahns23-po-020","title":"Abstract PO-020: Gene regulatory network connectivity analysis identifies novel candidate effectors of HNSC tumorigenesis","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computational biology; Biology; Gene regulatory network; In silico; Gene; Genomics; Centrality; Effector; Bioinformatics; Genetics; Genome; Gene expression","score_opus":0.07971410392852883,"score_gpt":0.4296161905851667,"score_spread":0.34990208665663786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611163,0.0018035105,0.0007489148,0.0001510997,0.000497783,0.000290616,0.00014549801,0.000020062262,0.00023086484],"genre_scores_gemma":[0.9946682,0.0033501175,0.000121641766,0.000056219258,0.0010072152,0.000062700296,0.00019046784,0.00002740966,0.00051604985],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99738395,0.00021778425,0.00075805525,0.0005112686,0.00047331507,0.0006556148],"domain_scores_gemma":[0.9979911,0.00045248514,0.00022068895,0.00078146404,0.00033288525,0.00022137494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005428051,0.00017189959,0.00049842487,0.00018231745,0.00020123566,0.000045026565,0.00045202713,0.00030699378,0.00015910609],"category_scores_gemma":[0.0003177437,0.0001557454,0.0004298713,0.001340242,0.00046568463,0.0000066314574,0.00042513502,0.00039153264,0.000033354634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023875264,0.0005741178,0.3541773,0.00066960225,0.0076419534,0.000038330083,0.00021871118,0.06197469,0.39032507,0.0003108268,0.11952848,0.062153403],"study_design_scores_gemma":[0.0012485103,0.00035256764,0.92558426,0.00008043268,0.00027116033,0.0000014764803,0.00008482903,0.003911783,0.06247588,0.00035682763,0.0051953034,0.00043695065],"about_ca_topic_score_codex":0.0007638913,"about_ca_topic_score_gemma":0.0018157373,"teacher_disagreement_score":0.571407,"about_ca_system_score_codex":0.000039838083,"about_ca_system_score_gemma":0.00029436554,"threshold_uncertainty_score":0.63511133},"labels":[],"label_agreement":null},{"id":"W4386784884","doi":"10.1158/1557-3265.aacrahns23-po-023","title":"Abstract PO-023: The AP-1 transcription factor component, JunB, regulates the expression of HPV genes in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Head and neck squamous-cell carcinoma; Medicine; Cancer; Demethylating agent; Oncology; Head and neck cancer; Internal medicine; Biology; DNA methylation; Gene expression; Gene","score_opus":0.23566906724455877,"score_gpt":0.49256622737408556,"score_spread":0.2568971601295268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98547715,0.009927243,0.000005471036,0.003847781,0.00017650568,0.00035262518,0.00008025426,0.0000068940753,0.00012607274],"genre_scores_gemma":[0.9665404,0.032198116,0.000008865242,0.00008567736,0.00029421307,0.00024070161,0.000026249832,0.000015734902,0.00059007073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99842435,0.00026650738,0.0003814644,0.0003488897,0.00029172705,0.00028708152],"domain_scores_gemma":[0.99908984,0.00018349465,0.00007574709,0.00043228123,0.00015122486,0.00006740648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011593326,0.00009634641,0.00015804662,0.00005132737,0.00017355985,0.000031101194,0.00033414978,0.00014836948,0.00015579196],"category_scores_gemma":[0.00009511288,0.000055821074,0.00008556026,0.00028618818,0.00048710813,0.0000070065694,0.00011331395,0.00033334136,0.000005310273],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039049992,0.00008476204,0.030890858,0.000060180097,0.000029406305,0.0000011008249,0.0001949835,0.00021211113,0.8533316,0.000027494321,0.006299668,0.108477294],"study_design_scores_gemma":[0.0005720749,0.00008735235,0.83855426,0.000060545706,0.000005161131,3.8478908e-7,0.0002103583,0.0000956198,0.12793192,0.00013348888,0.03226642,0.000082423765],"about_ca_topic_score_codex":0.0012968717,"about_ca_topic_score_gemma":0.001376825,"teacher_disagreement_score":0.8076634,"about_ca_system_score_codex":0.000023576795,"about_ca_system_score_gemma":0.00016717143,"threshold_uncertainty_score":0.22763173},"labels":[],"label_agreement":null},{"id":"W4386784887","doi":"10.1158/1557-3265.aacrahns23-po-028","title":"Abstract PO-028: Clinical and genomic correlates of intratumoral HPV for oropharyngeal and cervical cancers","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cervical cancer; Immunohistochemistry; Adenocarcinoma; Papillomaviridae; HPV infection; Cancer; Cancer research","score_opus":0.30706306598563743,"score_gpt":0.5526484824295512,"score_spread":0.2455854164439138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864913,0.00575936,0.0000019814802,0.005313995,0.0006825594,0.0008442605,0.00013838617,0.000051949,0.0007161678],"genre_scores_gemma":[0.96748537,0.030179743,0.000106152365,0.00034102955,0.0010907566,0.00017423012,0.000019525809,0.0000408271,0.0005623423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968525,0.00019060637,0.0010973376,0.00069551624,0.00046941137,0.00069462566],"domain_scores_gemma":[0.9951942,0.0034128388,0.00011137525,0.00030116062,0.0004160184,0.00056439376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004207566,0.00018094058,0.0010992786,0.00015882833,0.00019247763,0.000025634024,0.00015857744,0.0002856529,0.00022235251],"category_scores_gemma":[0.0015987761,0.0001452942,0.00019246836,0.0004165369,0.0019679645,0.00006169992,0.00029649786,0.0011553245,0.00003178421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048599485,0.00016972783,0.7807595,0.00096154213,0.000290947,0.00007672284,0.00027472602,0.0000033849492,0.00034971163,0.0001804246,0.038954657,0.17311868],"study_design_scores_gemma":[0.0045034,0.0023005614,0.98069775,0.00023927307,0.00007910773,0.000006445055,0.0003177123,0.0006579264,0.00008885588,0.0003951775,0.010564408,0.000149391],"about_ca_topic_score_codex":0.000671804,"about_ca_topic_score_gemma":0.00046492193,"teacher_disagreement_score":0.19993821,"about_ca_system_score_codex":0.000109362074,"about_ca_system_score_gemma":0.0011385081,"threshold_uncertainty_score":0.7251047},"labels":[],"label_agreement":null},{"id":"W4386784892","doi":"10.1158/1557-3265.aacrahns23-po-037","title":"Abstract PO-037: Biomarkers for early diagnosis of human papillomavirus-related oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concordance; Cancer; Internal medicine; Incidence (geometry); Oncology; Population; Digital polymerase chain reaction; HPV infection; Cervical cancer; Immunology; Polymerase chain reaction; Biology","score_opus":0.35943467488921416,"score_gpt":0.5758789169351914,"score_spread":0.2164442420459773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98232067,0.0053597074,3.9117046e-7,0.0067660813,0.00068882183,0.0013075952,0.0002943556,0.00010365901,0.0031587519],"genre_scores_gemma":[0.97684944,0.017732272,0.00001988489,0.00021840807,0.0006813835,0.0020050174,0.000036107875,0.0000711292,0.0023863402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615926,0.00018308927,0.0011093481,0.00069017085,0.00092196814,0.0009361653],"domain_scores_gemma":[0.99587995,0.0022472444,0.00015910789,0.00048196013,0.00079837145,0.0004333533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032730966,0.00021319136,0.0010272966,0.0003381986,0.00033558218,0.000021153886,0.00030373415,0.00029592117,0.0014754299],"category_scores_gemma":[0.0011639468,0.0001743722,0.00043439414,0.0013325593,0.00091120484,0.000084127525,0.00020483126,0.0008206471,0.00011957638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023101151,0.00048726282,0.6870737,0.0009920228,0.001175993,0.00009670406,0.0004976294,0.0000021197484,0.0072438656,0.000102695776,0.1950706,0.104947306],"study_design_scores_gemma":[0.0048371796,0.0021226234,0.9699609,0.00094614417,0.00012069931,5.598287e-7,0.00023292913,0.000023228578,0.0064602224,0.00040509604,0.014683516,0.00020687415],"about_ca_topic_score_codex":0.0058571706,"about_ca_topic_score_gemma":0.0009500566,"teacher_disagreement_score":0.28288725,"about_ca_system_score_codex":0.00023229055,"about_ca_system_score_gemma":0.0007396475,"threshold_uncertainty_score":0.99943733},"labels":[],"label_agreement":null},{"id":"W4386784919","doi":"10.1158/1557-3265.aacrahns23-po-027","title":"Abstract PO-027: Clinical and genetic associations of biological sex and survival in head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Larynx; Medicine; Hazard ratio; Oncology; Head and neck cancer; Proportional hazards model; Internal medicine; Immune system; Cancer; Population; Immunology; Confidence interval; Surgery","score_opus":0.43370994652978534,"score_gpt":0.5522812862250743,"score_spread":0.11857133969528899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074334,0.0046879114,3.008519e-7,0.0028203316,0.00016209898,0.0004126385,0.000060962928,0.000022729744,0.0010896631],"genre_scores_gemma":[0.9856368,0.013525709,0.00005332887,0.00013455583,0.00032991683,0.000045465724,0.000007968927,0.000016277218,0.00025001957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971299,0.0004946828,0.00090035395,0.0005670675,0.00040709364,0.0005008708],"domain_scores_gemma":[0.9945864,0.0045847245,0.00008107585,0.00021732994,0.00018564315,0.00034479608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003745478,0.00013143617,0.00082370057,0.00015270771,0.00011781509,0.000017496492,0.000088652,0.00029746196,0.000047602578],"category_scores_gemma":[0.002445661,0.00010329419,0.000082023944,0.00044915837,0.0010881163,0.000028561217,0.0003024614,0.00096349267,0.000009792122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000304043,0.00022084292,0.9811003,0.00014947179,0.000020029456,0.0000874968,0.00018521078,4.2887578e-7,0.00018704735,0.000012812966,0.0014245787,0.016307745],"study_design_scores_gemma":[0.0037823187,0.0015059173,0.9931319,0.00006488457,0.00001704941,0.0000025428303,0.00029417174,0.00007615607,0.00005844213,0.00018350169,0.0007852159,0.00009790821],"about_ca_topic_score_codex":0.0013479523,"about_ca_topic_score_gemma":0.001247535,"teacher_disagreement_score":0.016209837,"about_ca_system_score_codex":0.000046365356,"about_ca_system_score_gemma":0.00034486342,"threshold_uncertainty_score":0.42122146},"labels":[],"label_agreement":null},{"id":"W4386784925","doi":"10.1158/1557-3265.aacrahns23-po-007","title":"Abstract PO-007: A phase 2 open-label study of conditionally active biologic, ozuriftamab vedotin (BA3021) in PD-1/L1 failure patients with recurrent or metastatic squamous cell carcinoma of the head and neck","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Cancer; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Head and neck cancer; Cancer research; Clinical trial","score_opus":0.3121192668751875,"score_gpt":0.541136698782141,"score_spread":0.2290174319069535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940914,0.00023314804,1.7176424e-7,0.0014591871,0.00007571358,0.0031926373,0.00066253793,0.000007134091,0.0002780707],"genre_scores_gemma":[0.99869937,0.00015814335,0.000045262732,0.000072021336,0.00006265973,0.0002876785,0.00009927908,0.000022855103,0.00055271917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99587137,0.00080467435,0.00088681624,0.0005853868,0.0012931161,0.00055866694],"domain_scores_gemma":[0.99537647,0.0029082259,0.00023586539,0.00041558367,0.0007995456,0.00026429255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002057606,0.00019963924,0.0007684608,0.00026045094,0.00015969688,0.000025581805,0.00055463595,0.00010056859,0.00042882824],"category_scores_gemma":[0.0011555082,0.00010482319,0.000072080664,0.0012088111,0.00085289474,0.00008879472,0.0007214212,0.0012319178,0.000015075943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05832356,0.027920032,0.89169717,0.00073962903,0.00019112878,0.00023520288,0.0009601038,0.000007882008,0.000504863,0.000029047276,0.0030793196,0.016312048],"study_design_scores_gemma":[0.03795388,0.020512206,0.9384949,0.00028712896,0.000043293338,0.000002177829,0.0013965726,0.00005495436,0.0006509964,0.00008831221,0.00039561093,0.00011996356],"about_ca_topic_score_codex":0.0031737052,"about_ca_topic_score_gemma":0.0038305286,"teacher_disagreement_score":0.046797715,"about_ca_system_score_codex":0.000094105155,"about_ca_system_score_gemma":0.0011712514,"threshold_uncertainty_score":0.5352138},"labels":[],"label_agreement":null},{"id":"W4386784930","doi":"10.1158/1557-3265.aacrahns23-ia09","title":"Abstract IA09: Characterization of hypoxic tumor microenvironment in HPV-negative HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Tumor microenvironment; Cancer research; Cetuximab; Proinflammatory cytokine; Pembrolizumab; Immune system; Tumor hypoxia; Epidermal growth factor receptor; Biology; Medicine; Immunotherapy; Immunology; Cancer; Antibody; Internal medicine; Radiation therapy; Inflammation; Head and neck cancer","score_opus":0.10285606595722134,"score_gpt":0.43867301735123265,"score_spread":0.3358169513940113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971292,0.00087212084,0.0000072785683,0.00032731803,0.00074589817,0.00036044113,0.00011634602,0.000008024638,0.00043337574],"genre_scores_gemma":[0.9825805,0.0143051855,0.000029874307,0.00015745829,0.0016328822,0.00015503,0.000120285855,0.000027707847,0.0009910698],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99799,0.00023666985,0.00052022934,0.00041749974,0.0003541687,0.00048143262],"domain_scores_gemma":[0.9991632,0.00012663443,0.00011491533,0.00035074513,0.00009728059,0.00014721778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018820395,0.000115323965,0.00026527964,0.00013556113,0.000049913873,0.000012497395,0.00024873935,0.00014710405,0.0002292638],"category_scores_gemma":[0.00053293863,0.00011134265,0.000121343466,0.0003979893,0.00032679745,0.000007711232,0.00022037403,0.00034894134,0.000067577996],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037988357,0.00018990613,0.013898789,0.000057892572,0.000033668908,0.0000027172177,0.00008415491,0.000017571108,0.9592337,0.00001087065,0.003627088,0.022463746],"study_design_scores_gemma":[0.00094147585,0.00015228108,0.7200158,0.00003982912,0.0000054433376,6.992189e-7,0.000086569766,0.000016321399,0.19294451,0.00004319561,0.08563321,0.00012061452],"about_ca_topic_score_codex":0.00016938777,"about_ca_topic_score_gemma":0.000120828874,"teacher_disagreement_score":0.7662892,"about_ca_system_score_codex":0.000046659232,"about_ca_system_score_gemma":0.00025549548,"threshold_uncertainty_score":0.45404214},"labels":[],"label_agreement":null},{"id":"W4386784950","doi":"10.1158/1557-3265.aacrahns23-po-010","title":"Abstract PO-010: Operationalizing the health care system electronic medical record to create head and neck cancer research and screening databases","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Head and neck cancer; Database; Medical record; Cancer; Internal medicine; Environmental health; Computer science","score_opus":0.4936907479239351,"score_gpt":0.6245566259056378,"score_spread":0.13086587798170268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87244004,0.031593874,0.000009784987,0.093469135,0.00023413646,0.0012826575,0.00011733862,0.00009303134,0.0007599774],"genre_scores_gemma":[0.9411889,0.05318594,0.00009668251,0.0019202066,0.0017493276,0.00089877774,0.000047762856,0.00005461396,0.00085780415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99368787,0.0008283486,0.0007853442,0.00094649254,0.002224712,0.0015272145],"domain_scores_gemma":[0.9940233,0.0034147238,0.000057613972,0.0005321587,0.0009486937,0.0010234576],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011954603,0.00019818092,0.00071411626,0.00030358505,0.0014974241,0.00011526891,0.0003051276,0.00014149121,0.00022388705],"category_scores_gemma":[0.0025917045,0.0001336534,0.00006967526,0.0013575782,0.00079508295,0.00010407167,0.00077035546,0.002436592,0.000052259802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004308066,0.00016123774,0.29344505,0.0029415719,0.00043857534,0.00027431542,0.0035600518,0.000010823799,0.00015592677,0.0019027019,0.18915813,0.5036436],"study_design_scores_gemma":[0.0041076355,0.004277951,0.63761264,0.00908164,0.00003632525,0.000036647434,0.013866097,0.0005132288,0.00012246064,0.000046963556,0.32993904,0.0003593405],"about_ca_topic_score_codex":0.028042182,"about_ca_topic_score_gemma":0.034877013,"teacher_disagreement_score":0.5032842,"about_ca_system_score_codex":0.00066909887,"about_ca_system_score_gemma":0.0041285865,"threshold_uncertainty_score":0.9998648},"labels":[],"label_agreement":null},{"id":"W4386784974","doi":"10.1158/1557-3265.aacrahns23-ia03","title":"Abstract IA03: Head and Neck Cancer Takes a Nerve, Cancer neuroscience: emerging hallmark of cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Neuroscience; Head and neck cancer; Medicine; Disease; Bioinformatics; Internal medicine; Psychology; Biology","score_opus":0.2724653147544931,"score_gpt":0.5583761924075247,"score_spread":0.2859108776530316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9361697,0.045421533,0.0000011446634,0.01504247,0.0014746904,0.0008724832,0.00017807826,0.00011470474,0.0007251866],"genre_scores_gemma":[0.8246647,0.16310671,0.000022061768,0.00081330095,0.0022435368,0.0010480959,0.000011274473,0.00010222838,0.007988096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99400103,0.00040135137,0.0012613717,0.0011988658,0.001709964,0.0014274092],"domain_scores_gemma":[0.9961374,0.0012189237,0.00031140668,0.0008142082,0.00083181687,0.0006862864],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030543017,0.00037789374,0.001132759,0.0005543589,0.00042819028,0.00009731581,0.0005673604,0.00032225996,0.0015487265],"category_scores_gemma":[0.0013300468,0.00031983235,0.00036126067,0.0023350844,0.0018449752,0.0002426703,0.0002605482,0.0015693755,0.00002896551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005722888,0.00038339297,0.6306812,0.0014047248,0.00019856037,0.0002507228,0.00081900216,0.00037815975,0.015378815,0.00003426076,0.05008976,0.2946585],"study_design_scores_gemma":[0.0027406053,0.00051141623,0.8408176,0.0018321873,0.000094995004,0.000009731545,0.00041484402,0.0008667706,0.0017262194,0.00003598467,0.1506379,0.0003117889],"about_ca_topic_score_codex":0.051999893,"about_ca_topic_score_gemma":0.010334895,"teacher_disagreement_score":0.29434672,"about_ca_system_score_codex":0.00035367275,"about_ca_system_score_gemma":0.0034273164,"threshold_uncertainty_score":0.9999254},"labels":[],"label_agreement":null},{"id":"W4386784975","doi":"10.1158/1557-3265.aacrahns23-ia12","title":"Abstract IA12: Fluorescence guided surgery: Rapidly evolving applications","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Head and neck cancer; Head and neck; Head and neck squamous-cell carcinoma; Positron emission tomography; Population; In vivo; Fluorescence-lifetime imaging microscopy; Nuclear medicine; Radiology; Pathology; Fluorescence; Surgery; Internal medicine","score_opus":0.25158662532294557,"score_gpt":0.4744027410106534,"score_spread":0.22281611568770782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94325286,0.010236185,0.0029174532,0.003396194,0.0065296944,0.004132955,0.00045593607,0.006070229,0.023008507],"genre_scores_gemma":[0.9869054,0.00960492,0.00028268507,0.00006318368,0.0013144545,0.00091685413,0.00004440127,0.00012529355,0.0007427915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693745,0.000065484644,0.00080894935,0.0004341556,0.0008123475,0.00094161223],"domain_scores_gemma":[0.99521226,0.003319942,0.00004894136,0.00072447956,0.00036356278,0.0003308213],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037625586,0.0001808677,0.00037475277,0.00035067438,0.000230102,0.00010865094,0.000606348,0.0002184449,0.0005829393],"category_scores_gemma":[0.00087543955,0.00017818702,0.00020929208,0.002018481,0.00029604536,0.00021088414,0.00014506305,0.0010620803,0.0019296969],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068075904,0.00009669601,0.023975806,0.00067080726,0.00022213723,0.00005188205,0.00015364516,0.0040990333,0.025366696,0.00035400048,0.6434313,0.30150995],"study_design_scores_gemma":[0.0015756987,0.00010389669,0.21583772,0.0006974024,0.000046165842,0.0000045777447,0.00024048198,0.028312009,0.018933058,0.007824066,0.7250809,0.0013440439],"about_ca_topic_score_codex":0.00013006778,"about_ca_topic_score_gemma":0.0000726773,"teacher_disagreement_score":0.3001659,"about_ca_system_score_codex":0.0002948924,"about_ca_system_score_gemma":0.00036538587,"threshold_uncertainty_score":0.9988474},"labels":[],"label_agreement":null},{"id":"W4386784985","doi":"10.1158/1557-3265.aacrahns23-ia04","title":"Abstract IA04: Evaluating the therapeutic potential of ATR inhibitor BAY 1895344 and radiation therapy for head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Medicine; Head and neck squamous-cell carcinoma; DNA damage; Clonogenic assay; Bay; Cell cycle; Cell; Radiation therapy; Pathology; Biology; Head and neck cancer; Cancer; Internal medicine; DNA","score_opus":0.15207032718322125,"score_gpt":0.4795662263999439,"score_spread":0.3274958992167226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228114,0.00595204,0.000023825298,0.0007037859,0.00020278609,0.00075439864,0.00003053426,0.000009276601,0.000042240023],"genre_scores_gemma":[0.9967148,0.0019828721,0.00007709435,0.0001181882,0.00060986576,0.00015915415,0.000026426665,0.000026568125,0.00028507976],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99837226,0.0002891242,0.0003273395,0.0003956002,0.00031190575,0.00030378887],"domain_scores_gemma":[0.998801,0.0005244646,0.00008795963,0.00029094305,0.00021127987,0.00008435578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031081948,0.00009865758,0.0001577648,0.00004297337,0.00016521112,0.00003503732,0.00016721977,0.00016960772,0.000018255529],"category_scores_gemma":[0.00038042502,0.00007186557,0.00009703529,0.00012941142,0.00023014717,0.0000048113416,0.00013406592,0.00021889899,0.0000025815968],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013492863,0.00008790114,0.013977854,0.00010081593,0.000033382148,0.0000015959423,0.0001021824,0.00003730613,0.8376628,0.000022921666,0.0013313668,0.1452926],"study_design_scores_gemma":[0.007560759,0.008783361,0.5088735,0.000032370157,0.00004072028,0.0000033416368,0.00038247905,0.0055392273,0.46047983,0.0014320347,0.006567776,0.00030457322],"about_ca_topic_score_codex":0.00008941965,"about_ca_topic_score_gemma":0.000045082666,"teacher_disagreement_score":0.4948957,"about_ca_system_score_codex":0.000013555611,"about_ca_system_score_gemma":0.00022147234,"threshold_uncertainty_score":0.2930593},"labels":[],"label_agreement":null},{"id":"W4386784997","doi":"10.1158/1557-3265.aacrahns23-po-015","title":"Abstract PO-015: The genetic landscape of head and neck cancer using brush biopsy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biopsy; Cancer; Medicine; Dysplasia; Head and neck cancer; Pathology; Brush; Carcinoma; Internal medicine","score_opus":0.18345076807742708,"score_gpt":0.49816070425210146,"score_spread":0.31470993617467435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880032,0.009919186,0.000008203505,0.0010063936,0.0003273852,0.00023370891,0.00015451689,0.000006994199,0.0003404341],"genre_scores_gemma":[0.9719631,0.026475111,0.0000870702,0.0001914994,0.000955267,0.000053593234,0.000018150127,0.000024911355,0.00023127273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840844,0.00010401435,0.00038850924,0.0004088813,0.0002785693,0.0004115994],"domain_scores_gemma":[0.9987712,0.00032325066,0.00008570928,0.00042742112,0.0002445852,0.00014784992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010449791,0.00011220948,0.00020510092,0.0000629526,0.00014870933,0.00004149621,0.00030022368,0.0001699647,0.000104940955],"category_scores_gemma":[0.00043221295,0.00008575421,0.000098337485,0.0003401059,0.0004495472,0.0000025320705,0.00037582585,0.00030288857,0.0000108772865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008415019,0.00018268848,0.73204803,0.00023376009,0.0002759973,0.000036544563,0.00015708132,0.0019942606,0.14117107,0.00009829694,0.044974465,0.07798626],"study_design_scores_gemma":[0.0012902998,0.00036554757,0.93574584,0.000112517075,0.000032672244,0.0000063770535,0.00015413087,0.0008566111,0.008829306,0.00029851735,0.052079286,0.00022890202],"about_ca_topic_score_codex":0.002173798,"about_ca_topic_score_gemma":0.0011092409,"teacher_disagreement_score":0.20369777,"about_ca_system_score_codex":0.000022299808,"about_ca_system_score_gemma":0.00056037004,"threshold_uncertainty_score":0.34969553},"labels":[],"label_agreement":null},{"id":"W4386785088","doi":"10.1158/1557-3265.aacrahns23-po-011","title":"Abstract PO-011: Analysis of nuclear receptor expression in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nuclear receptor; Retinoic acid receptor; Thyroid hormone receptor; Receptor; Biology; Calcitriol receptor; Peroxisome proliferator-activated receptor gamma; Retinoic acid receptor beta; Cancer research; Head and neck squamous-cell carcinoma; Peroxisome proliferator-activated receptor; Internal medicine; Retinoic acid; Retinoid X receptor; Endocrinology; Cancer; Head and neck cancer; Transcription factor; Gene; Medicine; Genetics","score_opus":0.136762165708987,"score_gpt":0.4933823949709415,"score_spread":0.35662022926195447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386785088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974368,0.001260781,7.7554023e-7,0.0006358517,0.000154267,0.00019154014,0.00009411791,0.000014651682,0.00021120076],"genre_scores_gemma":[0.98640245,0.012808395,0.00005380906,0.000091949056,0.0002257159,0.00008239412,0.000062187384,0.000029744793,0.00024335708],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978296,0.00028282407,0.0004984501,0.0005828875,0.00037299294,0.00043321805],"domain_scores_gemma":[0.9989788,0.00016010963,0.00009265771,0.0003715743,0.00020148359,0.00019536579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014828935,0.00012414517,0.00037351466,0.00036099541,0.00007518323,0.000022329203,0.0002774989,0.00033395702,0.00064004253],"category_scores_gemma":[0.00058305665,0.00010937113,0.00014248665,0.0014415785,0.0003198682,0.000008426787,0.00033551987,0.0005259607,0.000022939326],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006471424,0.000116926356,0.26420516,0.000045915465,0.00023947413,0.0000028035975,0.000075653305,0.00013621253,0.7153729,0.0000028411093,0.009886697,0.0092682345],"study_design_scores_gemma":[0.0013389646,0.00038961123,0.6115985,0.0001854283,0.0000435829,1.8413219e-7,0.00021841565,0.00024419662,0.34164473,0.000024200679,0.044053793,0.00025840322],"about_ca_topic_score_codex":0.00066095433,"about_ca_topic_score_gemma":0.00059306406,"teacher_disagreement_score":0.37372822,"about_ca_system_score_codex":0.000050987175,"about_ca_system_score_gemma":0.00022027748,"threshold_uncertainty_score":0.70080173},"labels":[],"label_agreement":null},{"id":"W4386785090","doi":"10.1158/1557-3265.aacrahns23-ia05","title":"Abstract IA05: Nodal and systemic Immune effects of radiation in HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunotherapy; Metastasis; Medicine; Lymph; Cancer; Lymph node; Cancer research; Radiation therapy; Antigen; Immunology; Pathology; Internal medicine","score_opus":0.1254624242287148,"score_gpt":0.5101282871669741,"score_spread":0.38466586293825933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386785090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860235,0.011500347,8.7491094e-7,0.0011798869,0.00033925037,0.00063270325,0.0000062147647,0.000024924808,0.00029232583],"genre_scores_gemma":[0.98021567,0.018980427,0.0000047064514,0.000059246257,0.00020377057,0.00009553065,0.000008978667,0.000015799369,0.00041587968],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99822,0.0002057675,0.0005819356,0.00025934257,0.00042872995,0.00030418538],"domain_scores_gemma":[0.9978589,0.0016254303,0.000076256685,0.00024436592,0.00009912746,0.000095922886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034999503,0.00007613759,0.00036106262,0.00027183405,0.000039656275,0.000011258087,0.00009637088,0.00015135731,0.00008543565],"category_scores_gemma":[0.0007778057,0.0000629493,0.00009781611,0.00079540716,0.00031264412,0.000044633176,0.000056805544,0.0005068211,0.000029718869],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006654485,0.0002223108,0.28240886,0.002857746,0.00016196482,0.00013462619,0.00040314544,0.0000040284394,0.13496907,0.000032116885,0.0030547346,0.5690969],"study_design_scores_gemma":[0.0050539686,0.00049301126,0.9832217,0.0011457357,0.000011697935,0.0000049736645,0.000113935326,0.00008797189,0.008419297,0.00004647497,0.0013375357,0.0000637182],"about_ca_topic_score_codex":0.0014136272,"about_ca_topic_score_gemma":0.00007715611,"teacher_disagreement_score":0.7008128,"about_ca_system_score_codex":0.00013607119,"about_ca_system_score_gemma":0.00032403332,"threshold_uncertainty_score":0.2566998},"labels":[],"label_agreement":null},{"id":"W4387157118","doi":"10.1158/1078-0432.ccr-23-1397","title":"Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Leids Universitair Medisch Centrum; KWF Kankerbestrijding; Universiteit Leiden","keywords":"PTEN; Stage (stratigraphy); Medicine; Internal medicine; Oncology; Microsatellite instability; Endometrial cancer; Disease; Immunohistochemistry; Carcinoma; Retrospective cohort study; Cohort; Gynecology; Pathology; Cancer; Biology; Gene","score_opus":0.2405595691848712,"score_gpt":0.5248642001528636,"score_spread":0.2843046309679924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387157118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893557,0.0055200914,0.000008898585,0.0007598413,0.0010129865,0.0015411666,0.0002468402,0.00010309244,0.0014513878],"genre_scores_gemma":[0.985864,0.010088549,0.00019495656,0.00021074532,0.0013844939,0.00039202685,0.0000821754,0.00006657965,0.0017164982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99304307,0.0010789526,0.0019799385,0.00089346315,0.0019522362,0.0010523393],"domain_scores_gemma":[0.9905294,0.0067318445,0.00026448382,0.0007818843,0.00061047997,0.001081887],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0075897314,0.000300286,0.0015002757,0.0014528356,0.00014888722,0.000047410827,0.00039833636,0.00047119663,0.0012576225],"category_scores_gemma":[0.007550784,0.00023706944,0.0006747578,0.0054802974,0.0010318932,0.00010017853,0.0005854937,0.0016616479,0.00014537924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050968635,0.001358774,0.92074865,0.00032468166,0.0003784788,0.00079757214,0.000049843875,0.0000020559858,0.001799478,0.00012929205,0.0013424989,0.067971796],"study_design_scores_gemma":[0.037336178,0.006664373,0.9351798,0.00020632926,0.0004262986,0.0000168823,0.00028520188,0.000059281152,0.00624853,0.00010405059,0.0131436,0.0003294717],"about_ca_topic_score_codex":0.0006940981,"about_ca_topic_score_gemma":0.00004620275,"teacher_disagreement_score":0.06764232,"about_ca_system_score_codex":0.00012717507,"about_ca_system_score_gemma":0.00077033584,"threshold_uncertainty_score":0.99965537},"labels":[],"label_agreement":null},{"id":"W4387296735","doi":"10.1158/1078-0432.ccr-23-1735","title":"Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Canada Foundation for Innovation; Mitacs; Canada Research Chairs","keywords":"Chimeric antigen receptor; Medicine; Antigen; Population; Cancer research; Cancer stem cell; Metastasis; Immunotherapy; Immunology; Oncology; Cancer; Internal medicine; Immune system","score_opus":0.20659055628028922,"score_gpt":0.5196007385964388,"score_spread":0.31301018231614963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257493,0.0016323437,0.0000064415335,0.0024158156,0.00043637466,0.0013434242,0.00014014768,0.00012172558,0.0013287993],"genre_scores_gemma":[0.97593004,0.009147096,0.00036766217,0.00024056624,0.0013959099,0.00026282654,0.00012678765,0.00011934073,0.012409804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99302953,0.0023363137,0.000920219,0.0008340622,0.001701668,0.0011782005],"domain_scores_gemma":[0.99123484,0.006525034,0.00013944623,0.0006339784,0.00088941597,0.0005773085],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010646242,0.00024277321,0.0009666143,0.0006247214,0.00019677317,0.000045224802,0.00044784186,0.00022151356,0.006939824],"category_scores_gemma":[0.003238428,0.00020170647,0.00044676408,0.0029335297,0.0010991418,0.00010642716,0.00040815116,0.0016849921,0.0007153779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041161175,0.00044960502,0.03664734,0.00033504213,0.00040387723,0.00017525473,0.00020176118,0.00001355581,0.7083953,0.000018914827,0.13853724,0.110705964],"study_design_scores_gemma":[0.008161984,0.006689226,0.1165526,0.0006952602,0.000103271035,0.000009906421,0.0008606778,0.00082541374,0.7366648,0.00020708055,0.12868743,0.00054239156],"about_ca_topic_score_codex":0.0015536465,"about_ca_topic_score_gemma":0.00006112466,"teacher_disagreement_score":0.11016358,"about_ca_system_score_codex":0.00025143352,"about_ca_system_score_gemma":0.0011780793,"threshold_uncertainty_score":0.99396795},"labels":[],"label_agreement":null},{"id":"W4387297143","doi":"10.1158/1078-0432.ccr-23-2260","title":"Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"Ontario Institute for Cancer Research","keywords":"PALB2; Olaparib; Pancreatic cancer; PARP inhibitor; Reversion; Medicine; Cancer; Oncology; Clinical trial; Poly ADP ribose polymerase; DNA repair; Cancer research; BRCA mutation; Internal medicine; Bioinformatics; Mutation; Biology; Genetics; Germline mutation; DNA; Breast cancer; Phenotype; Polymerase","score_opus":0.49625347445507545,"score_gpt":0.5922869451710471,"score_spread":0.09603347071597162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387297143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96783006,0.00076976715,0.000039535124,0.02813271,0.00055267767,0.0010908268,0.000040649695,0.00012168419,0.0014220853],"genre_scores_gemma":[0.9879465,0.0047640493,0.00006485677,0.0030304056,0.0013658522,0.0015374029,0.0000060283865,0.00005064956,0.0012342673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99601054,0.0008328663,0.0006271812,0.0006125402,0.0010318486,0.00088501564],"domain_scores_gemma":[0.9954082,0.003092126,0.00005449772,0.0007076892,0.00034289694,0.00039461907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008321794,0.00015647696,0.00049034867,0.00023270214,0.00019860931,0.000043179116,0.00021896476,0.00015526044,0.0006870371],"category_scores_gemma":[0.0015828799,0.00011195161,0.00014884365,0.0024552117,0.00038962337,0.00005936917,0.00024198108,0.0013500156,0.0006250715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024757222,0.00025788843,0.79046416,0.00019000405,0.00014799277,0.0006475768,0.00177179,0.0011754349,0.014431988,0.0003331685,0.06899883,0.11910546],"study_design_scores_gemma":[0.002598461,0.0003618593,0.9298522,0.0010142156,0.000022169743,0.00000881242,0.000606768,0.001576332,0.0032311217,0.0009680905,0.059541892,0.00021807238],"about_ca_topic_score_codex":0.0025547699,"about_ca_topic_score_gemma":0.004227927,"teacher_disagreement_score":0.13938805,"about_ca_system_score_codex":0.0006140995,"about_ca_system_score_gemma":0.0009695697,"threshold_uncertainty_score":0.8034238},"labels":[],"label_agreement":null},{"id":"W4387439283","doi":"10.1158/1078-0432.ccr-23-0229","title":"Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; L. K. Whittier Foundation","keywords":"Medicine; Multiple myeloma; Oncolytic virus; Bone marrow; Immune system; Bortezomib; Cytotoxic T cell; Thalidomide; Cytokine; Immunology; Tumor microenvironment; Dexamethasone; Internal medicine; Cancer research; Biology; In vitro","score_opus":0.2025749589462749,"score_gpt":0.4697949480140262,"score_spread":0.26721998906775135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387439283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887464,0.0072213933,0.000005309757,0.00085884787,0.0004182608,0.0025974773,0.000042732896,0.000022903356,0.000086662476],"genre_scores_gemma":[0.9911411,0.006364858,0.000043221164,0.00032388177,0.0005040395,0.0011505538,0.000100457895,0.00007255991,0.00029934628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947721,0.0017034155,0.0008648084,0.0008209449,0.00085429003,0.0009844602],"domain_scores_gemma":[0.9976627,0.0010126745,0.00012025482,0.00087718474,0.00014454154,0.00018263324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030349737,0.00024793218,0.00041353988,0.0001690417,0.00031516055,0.000075604024,0.0007072455,0.00024208224,0.000056496054],"category_scores_gemma":[0.0005311106,0.00018677105,0.00038121446,0.00065007847,0.00047203025,0.00000727056,0.0005583562,0.00087446143,0.00010224232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07925932,0.0012716359,0.0014210471,0.000019536432,0.00010222384,0.00004937739,0.00015227981,0.00024045317,0.85247296,5.5047866e-7,0.0005712829,0.06443933],"study_design_scores_gemma":[0.06054552,0.024029111,0.0010110947,0.000056356505,0.000008115588,0.000001232702,0.000607932,0.00058296963,0.88051826,0.000040528645,0.03227749,0.00032139826],"about_ca_topic_score_codex":0.0002405333,"about_ca_topic_score_gemma":0.00043293624,"teacher_disagreement_score":0.06411793,"about_ca_system_score_codex":0.00016550891,"about_ca_system_score_gemma":0.00047005404,"threshold_uncertainty_score":0.76163024},"labels":[],"label_agreement":null},{"id":"W4387449703","doi":"10.1158/1078-0432.ccr-23-2187","title":"Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Stand Up To Cancer; National Cancer Institute; National Institutes of Health; BC Cancer Foundation; Lotte and John Hecht Memorial Foundation; American Association for Cancer Research; St. Baldrick's Foundation; Michael Smith Health Research BC; Cancer Prevention and Research Institute of Texas","keywords":"Sarcoma; Proteome; Ewing's sarcoma; Biology; Computational biology; Cancer research; Medicine; Bioinformatics; Pathology","score_opus":0.3823527999098875,"score_gpt":0.5881203503505607,"score_spread":0.20576755044067313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387449703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97942567,0.013437534,0.000002977423,0.0049837246,0.00008039409,0.0015609993,0.000028020879,0.00005733156,0.00042336844],"genre_scores_gemma":[0.9941717,0.0040301285,0.00025181271,0.00028531867,0.000099203724,0.00024596974,0.000006735434,0.00003168589,0.0008774662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718416,0.0004649324,0.00047410894,0.0006102727,0.0006647939,0.00060172967],"domain_scores_gemma":[0.9984196,0.0007851327,0.00006199832,0.00033939825,0.00015525361,0.00023863735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002339612,0.00017076936,0.0004793841,0.00011602492,0.00017927456,0.000096797325,0.00011675866,0.00016484897,0.00025384917],"category_scores_gemma":[0.00042454683,0.0001360715,0.00009399187,0.0010545185,0.00034686012,0.000106151136,0.00019422425,0.00053178467,0.000110746056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063247344,0.0004755277,0.98198116,0.00013117552,0.00025216155,0.00020531457,0.00013260226,0.000031186566,0.0053892382,0.000052443444,0.00043460605,0.010282136],"study_design_scores_gemma":[0.0033799987,0.00049686944,0.9829546,0.0003323626,0.0000497869,0.000018951516,0.0003203352,0.0002880109,0.0043719187,0.001120297,0.0065176594,0.00014919373],"about_ca_topic_score_codex":0.008497145,"about_ca_topic_score_gemma":0.00070872693,"teacher_disagreement_score":0.014746028,"about_ca_system_score_codex":0.00028116532,"about_ca_system_score_gemma":0.0003686135,"threshold_uncertainty_score":0.99810535},"labels":[],"label_agreement":null},{"id":"W4387526419","doi":"10.1158/1078-0432.ccr-23-2005","title":"A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"Stand Up To Cancer; Genentech; Ipsen; Seagen; National Cancer Institute; Bayer; Servier; Pfizer; Incyte; Moderna; Revolution Medicines; Merck KGaA; Boston Scientific Corporation; National Institutes of Health; Helsinn; Bristol-Myers Squibb; Dana-Farber/Harvard Cancer Center; Pharmavite; American Association for Cancer Research; Amgen; EMD Serono; Lustgarten Foundation; Hale Family Center for Pancreatic Cancer Research; AstraZeneca; Eli Lilly and Company; Celgene","keywords":"Gemcitabine; Medicine; Internal medicine; Oncology; Cohort; Biomarker; Adverse effect; Pancreatic cancer; Cancer; Gastroenterology; Biology","score_opus":0.17277172623650477,"score_gpt":0.5296481500083204,"score_spread":0.35687642377181567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387526419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108887,0.000290522,0.0000036202077,0.0012821024,0.000058397687,0.0070956494,0.000020950642,0.00002072138,0.00013917025],"genre_scores_gemma":[0.99831486,0.00022523223,0.00006697464,0.000077787176,0.00011172601,0.00064840144,0.000017467688,0.00003979818,0.00049775303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927424,0.002592294,0.0009843565,0.0006558579,0.0023351081,0.00068995997],"domain_scores_gemma":[0.991839,0.0059918663,0.0001947707,0.00093720003,0.00078117644,0.00025599072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011944166,0.00021241716,0.0010283958,0.00024072253,0.00033100054,0.000025801532,0.0003435025,0.000090100424,0.00011547489],"category_scores_gemma":[0.0045343377,0.000095122115,0.00007800288,0.0020583046,0.0014636006,0.000068680034,0.00039833755,0.0013211595,0.000015042221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022807935,0.003363253,0.9649179,0.00018216479,0.00036607386,0.000050514645,0.00095097907,0.00001538682,0.000047334503,0.000007807216,0.00013121162,0.0071594603],"study_design_scores_gemma":[0.041109223,0.019487726,0.9348425,0.000706349,0.0004362756,0.000003388186,0.0012855683,0.0019788705,0.00001801281,0.000018409904,0.000012240783,0.00010138085],"about_ca_topic_score_codex":0.0008303872,"about_ca_topic_score_gemma":0.00040501502,"teacher_disagreement_score":0.030075325,"about_ca_system_score_codex":0.00020972599,"about_ca_system_score_gemma":0.0017978777,"threshold_uncertainty_score":0.5739854},"labels":[],"label_agreement":null},{"id":"W4387798496","doi":"10.1158/1078-0432.ccr-22-3627","title":"Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; McMaster University; BC Cancer Agency","funders":"EMD Serono; Genentech; Servier; Loxo Oncology; Astellas Pharma; Daiichi-Sankyo; Natera; National Center for Advancing Translational Sciences; Seagen; G1 Therapeutics; Sanofi; Exelixis; Jazz Pharmaceuticals; Advanced Accelerator Applications; Regeneron Pharmaceuticals; Helsinn; CTI Biopharma; Gilead Sciences; Bristol-Myers Squibb; Myriad Genetics; AstraZeneca; Mereo BioPharma; Pfizer","keywords":"Medicine; Pharmacokinetics; Adverse effect; Nausea; Internal medicine; Tolerability; Oncology; Population; Cancer; Urology; Pharmacology; Gastroenterology","score_opus":0.17311337001717203,"score_gpt":0.5108023116460696,"score_spread":0.33768894162889757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387798496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970907,0.00014005728,0.0000032161888,0.00036389002,0.00009301007,0.0021103201,0.00008483426,0.00000857023,0.00010541517],"genre_scores_gemma":[0.9992575,0.00034138907,0.000016452821,0.00005509172,0.0000602241,0.00009093721,0.000007839765,0.000024306808,0.00014626497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976287,0.00047653282,0.0005851284,0.00028725222,0.0007841868,0.00023818969],"domain_scores_gemma":[0.9987756,0.00040338482,0.00011134554,0.0003205156,0.00028913957,0.00009998614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001004287,0.00010847437,0.0004148338,0.00015504709,0.000054581542,0.0000058068663,0.00012911546,0.00004276334,0.000080877035],"category_scores_gemma":[0.00012358432,0.00006426857,0.000055941353,0.00090143265,0.00029793128,0.000036669826,0.0000756843,0.00035583548,0.0000021077226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015874384,0.004137441,0.9437573,0.0000850249,0.000166675,0.000007174889,0.000913011,0.000029557166,0.00016546078,0.000004503654,0.00009400436,0.034765452],"study_design_scores_gemma":[0.055746473,0.0077868174,0.9349209,0.0000836128,0.00010771202,2.2634185e-7,0.00024764473,0.00027821003,0.00058488245,0.000031057643,0.00015866903,0.000053797932],"about_ca_topic_score_codex":0.000910465,"about_ca_topic_score_gemma":0.0002086697,"teacher_disagreement_score":0.039872088,"about_ca_system_score_codex":0.00006721104,"about_ca_system_score_gemma":0.00030513885,"threshold_uncertainty_score":0.26207963},"labels":[],"label_agreement":null},{"id":"W4387866093","doi":"10.1158/1078-0432.ccr-23-1013","title":"Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK","keywords":"Medicine; Internal medicine; Oncology; Tissue microarray; Cohort; Biomarker; Chemoradiotherapy; Confidence interval; Retrospective cohort study; Radiation therapy; Head and neck squamous-cell carcinoma; Head and neck cancer; Cancer","score_opus":0.3880223645681154,"score_gpt":0.5308270891723218,"score_spread":0.1428047246042064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387866093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924207,0.0007285081,0.0001287731,0.0020223968,0.00021503217,0.0037977917,0.00006789817,0.00004768974,0.0005712304],"genre_scores_gemma":[0.9961391,0.00037700843,0.00028137967,0.00004353102,0.0004896417,0.0018873472,0.000017761306,0.000029237433,0.0007349946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974333,0.00040033797,0.0006209463,0.00050037063,0.00054780435,0.0004972106],"domain_scores_gemma":[0.99345213,0.0054222587,0.0001032703,0.0002754716,0.0005966766,0.00015019659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028338768,0.00014986737,0.00056974863,0.00011831392,0.00041230433,0.000022190685,0.00011505976,0.000104669496,0.000017338518],"category_scores_gemma":[0.0021193838,0.00009204269,0.00009384579,0.0005880401,0.00033324704,0.000051696024,0.00019715099,0.00030123306,0.000004487848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002106137,0.0007493654,0.9698099,0.0004293341,0.00016321798,0.000022596629,0.004732606,0.000019460735,0.00056765997,0.00004967161,0.0020302918,0.019319758],"study_design_scores_gemma":[0.010124133,0.011487462,0.957589,0.00018002381,0.00026711804,0.0000015425541,0.0069880136,0.009207738,0.0021233396,0.00013705924,0.0017633834,0.00013120308],"about_ca_topic_score_codex":0.000691619,"about_ca_topic_score_gemma":0.00015940481,"teacher_disagreement_score":0.019188555,"about_ca_system_score_codex":0.0002730884,"about_ca_system_score_gemma":0.0009533262,"threshold_uncertainty_score":0.3753392},"labels":[],"label_agreement":null},{"id":"W4387950431","doi":"10.1158/1078-0432.ccr-23-1079","title":"A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Sierra Oncology; University of Pennsylvania; AstraZeneca","keywords":"Cancer research; Ovarian cancer; Medicine; Antibody-drug conjugate; Flow cytometry; Cancer; Antibody; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.1463424974379257,"score_gpt":0.5155802340373745,"score_spread":0.3692377365994488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923175,0.0023942855,0.00005480585,0.003193916,0.00023085444,0.001152266,0.00009596987,0.00016209476,0.00039829058],"genre_scores_gemma":[0.9940658,0.0031592795,0.00047924853,0.0002581349,0.0005628123,0.00034701344,0.000030460104,0.00009604312,0.00100117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948737,0.00066174415,0.0007484986,0.0011712107,0.0012843434,0.0012605241],"domain_scores_gemma":[0.99653804,0.001715476,0.0002091971,0.0006103639,0.000386686,0.00054022024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038724411,0.00034313972,0.0009537619,0.00041168914,0.00033018528,0.00007269975,0.00028947814,0.00018041507,0.0002807312],"category_scores_gemma":[0.0008064861,0.00026264956,0.00010361005,0.0015037603,0.0012192358,0.00031616882,0.00033343452,0.0019180159,0.000030532865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028528184,0.00032555315,0.6069339,0.0009736595,0.00021421297,0.0012416658,0.0012169853,0.0003290995,0.30773953,0.000062190615,0.0027964956,0.049638547],"study_design_scores_gemma":[0.022631556,0.0027962283,0.8587341,0.007377082,0.00010577534,0.000044518107,0.004288142,0.0035900795,0.06343932,0.0008642614,0.034828715,0.0013002608],"about_ca_topic_score_codex":0.0037466064,"about_ca_topic_score_gemma":0.0035614201,"teacher_disagreement_score":0.25180018,"about_ca_system_score_codex":0.00055488,"about_ca_system_score_gemma":0.0011031758,"threshold_uncertainty_score":0.9999826},"labels":[],"label_agreement":null},{"id":"W4388487685","doi":"10.1158/1078-0432.ccr-23-2249","title":"Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Clinical endpoint; Cohort; Bevacizumab; Internal medicine; Oncology; Durvalumab; PARP inhibitor; Adverse effect; Cancer; Clinical trial; Chemotherapy; Nivolumab; Poly ADP ribose polymerase; Biology","score_opus":0.317749283599929,"score_gpt":0.5762641648363642,"score_spread":0.25851488123643523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388487685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438394,0.00031421424,0.000014879536,0.0034973864,0.0008478394,0.009322258,0.00023775731,0.00032328194,0.0010584175],"genre_scores_gemma":[0.97054577,0.0024440263,0.00022426891,0.00051597925,0.0013405891,0.009153813,0.00011086421,0.00018755811,0.01547713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9904517,0.0017580045,0.0017483114,0.0020225674,0.002412559,0.001606842],"domain_scores_gemma":[0.99450654,0.00181538,0.0003319439,0.0013652327,0.0010681212,0.00091278774],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052511273,0.00063508196,0.001968741,0.0008179876,0.0006482223,0.000092150236,0.00036588046,0.00046138166,0.0012482639],"category_scores_gemma":[0.0011135763,0.000457449,0.0002668944,0.0032810534,0.0010379736,0.000221224,0.00029740197,0.0022531399,0.00033260314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.14034532,0.015423232,0.7681303,0.00017529808,0.0022269753,0.0062575475,0.0152668515,0.00037910452,0.0010889955,0.00003565286,0.006846633,0.04382408],"study_design_scores_gemma":[0.41945982,0.09432239,0.42679745,0.003399825,0.0007806589,0.00016028975,0.016960537,0.009540199,0.008329791,0.00011156054,0.01835691,0.0017805749],"about_ca_topic_score_codex":0.021857075,"about_ca_topic_score_gemma":0.028001003,"teacher_disagreement_score":0.34133288,"about_ca_system_score_codex":0.0045085982,"about_ca_system_score_gemma":0.0072982516,"threshold_uncertainty_score":0.99978775},"labels":[],"label_agreement":null},{"id":"W4388488241","doi":"10.1158/1078-0432.ccr-23-2365","title":"Methodical Manipulation of the TME in Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Bevacizumab; Tumor microenvironment; Chemotherapy; Medicine; Cancer; Cancer research; Oncology; Biology; Internal medicine","score_opus":0.5819015776579184,"score_gpt":0.6383872710847307,"score_spread":0.05648569342681231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388488241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94317037,0.0011963805,0.0000114642135,0.05123031,0.00075904233,0.0010607088,0.00003514712,0.000028450822,0.0025081523],"genre_scores_gemma":[0.994383,0.0029686268,0.00011695604,0.00033746625,0.00046026305,0.00049378397,0.000006293807,0.000021304819,0.0012123398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972408,0.000620569,0.00057091546,0.0003808539,0.00079026195,0.00039663116],"domain_scores_gemma":[0.99790967,0.0011638975,0.00007372185,0.00048673808,0.00021116108,0.0001548368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034790009,0.00009096004,0.00037533793,0.00017588255,0.000075857424,0.0000121596995,0.00019377365,0.00015819632,0.0008956364],"category_scores_gemma":[0.00088026375,0.000057425415,0.00018007823,0.0016281869,0.0003086816,0.000033687127,0.00017570108,0.0006957787,0.000056674602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003604318,0.00031281673,0.9391942,0.000096735545,0.000087195986,0.00003859063,0.00012335171,0.000082473896,0.00025235038,0.0012985568,0.009217665,0.04893561],"study_design_scores_gemma":[0.0022516544,0.00017181771,0.9846754,0.00036231067,0.000039967505,9.800709e-7,0.000050128463,0.00046944869,0.0012020854,0.0010351713,0.009687319,0.000053689702],"about_ca_topic_score_codex":0.0043319846,"about_ca_topic_score_gemma":0.0016789809,"teacher_disagreement_score":0.05121262,"about_ca_system_score_codex":0.0003270465,"about_ca_system_score_gemma":0.0008733838,"threshold_uncertainty_score":0.98065907},"labels":[],"label_agreement":null},{"id":"W4388775253","doi":"10.1158/1078-0432.ccr-23-2580","title":"PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the Room","year":2023,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency; University of British Columbia Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Colorectal cancer; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.18643439741669132,"score_gpt":0.5258799573231061,"score_spread":0.3394455599064148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388775253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52232426,0.029364374,2.829007e-7,0.44080657,0.00087627454,0.0038991263,0.00037333826,0.000025188909,0.0023306184],"genre_scores_gemma":[0.9142735,0.0306327,0.000012581737,0.04173487,0.005639945,0.0049825413,0.00018878112,0.00013700596,0.002398082],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9935782,0.0018877933,0.0010528105,0.00081114535,0.0017959564,0.0008741272],"domain_scores_gemma":[0.9924128,0.006070898,0.00022392956,0.00057801016,0.0006452213,0.00006913194],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029988266,0.00033407164,0.0011540131,0.00033054096,0.00022800607,0.000060016548,0.0006876869,0.0006522816,0.00010621173],"category_scores_gemma":[0.0010769296,0.00017201519,0.00034984175,0.001444333,0.0008029865,0.000045404693,0.00046104728,0.0056119408,0.000012778773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00620533,0.00038718714,0.13771354,0.00083420466,0.0005276317,0.0015938545,0.011443917,0.000033937144,0.00005178293,0.0000040802597,0.7224436,0.11876096],"study_design_scores_gemma":[0.0043902933,0.003811507,0.7577491,0.005646691,0.00026686114,0.000008980772,0.006196966,0.00010292688,0.00027679466,0.00016482266,0.22104044,0.00034465405],"about_ca_topic_score_codex":0.021115009,"about_ca_topic_score_gemma":0.030098828,"teacher_disagreement_score":0.6200355,"about_ca_system_score_codex":0.0011587223,"about_ca_system_score_gemma":0.0016133047,"threshold_uncertainty_score":0.99668217},"labels":[],"label_agreement":null},{"id":"W4388897642","doi":"10.1158/1078-0432.ccr-23-0133","title":"A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor–positive/HER2-negative Advanced or Metastatic Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Dysgeusia; Fulvestrant; Medicine; Metastatic breast cancer; Internal medicine; Breast cancer; Tolerability; Exemestane; Aromatase inhibitor; Oncology; Cancer; Pharmacodynamics; Adverse effect; Estrogen receptor; Pharmacokinetics; Aromatase","score_opus":0.07633842613163684,"score_gpt":0.4556095102528649,"score_spread":0.37927108412122806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388897642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720055,0.000084275365,0.000008330857,0.00042444575,0.000062193525,0.0018426329,0.00032286692,0.000013261022,0.000041428673],"genre_scores_gemma":[0.9979522,0.00044717122,0.00011710987,0.000050999995,0.00006421954,0.000708462,0.00012004315,0.000035014462,0.000504739],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99723107,0.0005749445,0.0005262976,0.0005880073,0.00065691903,0.00042275264],"domain_scores_gemma":[0.9984392,0.00016208875,0.00016118801,0.00036535098,0.0006988265,0.0001733711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092087954,0.00018408825,0.00039224225,0.00014516638,0.00012501917,0.000016993048,0.0002613364,0.00008325631,0.00010391307],"category_scores_gemma":[0.00026088467,0.00012019647,0.00004745008,0.0010772829,0.00040622803,0.000017076922,0.00017438516,0.0004025925,0.0000054208317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.419752,0.0528799,0.29505667,0.0002775691,0.0020140375,0.00011002924,0.002543572,0.0005628687,0.046142627,0.000030019095,0.011391232,0.16923945],"study_design_scores_gemma":[0.10799492,0.19861758,0.6498295,0.0005367464,0.00008544091,0.0000013861961,0.003256145,0.00010502774,0.037754353,0.000029492974,0.0011075684,0.00068183907],"about_ca_topic_score_codex":0.0008291794,"about_ca_topic_score_gemma":0.0026518758,"teacher_disagreement_score":0.3547728,"about_ca_system_score_codex":0.00006364467,"about_ca_system_score_gemma":0.0006054962,"threshold_uncertainty_score":0.49014696},"labels":[],"label_agreement":null},{"id":"W4389057791","doi":"10.1158/1078-0432.ccr-23-1601","title":"Modulating Gut Microbiota Prevents Anastomotic Leak to Reduce Local Implantation and Dissemination of Colorectal Cancer Cells after Surgery","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada; Institut Du Cancer de Montréal; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Colorectal cancer; Anastomosis; Medicine; Gut flora; Cancer; Metastasis; Internal medicine; Downregulation and upregulation; Colorectal surgery; Gastroenterology; Surgery; Cancer research; Oncology; Immunology; Abdominal surgery; Biology","score_opus":0.08448730452799805,"score_gpt":0.4939471788505934,"score_spread":0.40945987432259534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389057791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832326,0.0004336919,0.000050783194,0.00038726756,0.0002664687,0.00036239412,0.00015353532,0.000007777582,0.00001481696],"genre_scores_gemma":[0.9972807,0.0017422952,0.000063682135,0.000066942805,0.00019469137,0.00010026354,0.00007069995,0.000021263368,0.00045943997],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983503,0.00021212753,0.00042608022,0.00043683872,0.00018262975,0.00039198832],"domain_scores_gemma":[0.99904543,0.00033026384,0.00007911217,0.00016718876,0.0002141192,0.00016390356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014365059,0.00009849799,0.00021870999,0.00013099496,0.00008496514,0.00001706448,0.00011412425,0.0001750166,0.00004647931],"category_scores_gemma":[0.00029911273,0.00009558224,0.00007028537,0.00037199887,0.00019204113,0.0000053438907,0.00020361728,0.00020603003,0.000013515898],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004831303,0.000048615973,0.029047716,0.0001719814,0.000020711643,0.0000033463211,0.000105754974,0.00007067561,0.9427401,0.0000010720664,0.009907605,0.017399333],"study_design_scores_gemma":[0.00022286511,0.0002734585,0.72822315,0.000352128,0.000011833912,0.0000028533284,0.00011638999,0.0001863826,0.26974496,0.000011566513,0.0007118046,0.00014258403],"about_ca_topic_score_codex":0.0004166232,"about_ca_topic_score_gemma":0.0009381629,"teacher_disagreement_score":0.6991755,"about_ca_system_score_codex":0.000052878746,"about_ca_system_score_gemma":0.0003122481,"threshold_uncertainty_score":0.38977307},"labels":[],"label_agreement":null},{"id":"W4389573510","doi":"10.1158/1078-0432.ccr-23-2080","title":"Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Anemia; Medicine; Hemoglobin; Erythropoietin; Adverse effect; Nomogram; Oncology; Internal medicine","score_opus":0.0934636605667614,"score_gpt":0.4507604682030388,"score_spread":0.35729680763627736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389573510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984809,0.000103145794,0.00002611918,0.0001505504,0.00003985301,0.0010487514,0.000021664106,0.000017182068,0.00011182339],"genre_scores_gemma":[0.9930266,0.00018920904,0.0047031045,0.000027634309,0.00003352843,0.00052114,0.00019605971,0.000032346303,0.0012703845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817467,0.00018396448,0.000431499,0.00048454406,0.0003390377,0.000386262],"domain_scores_gemma":[0.9992535,0.0001281492,0.000073435745,0.00022420568,0.0001924323,0.00012828429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013892392,0.000116295145,0.00021646543,0.00012336885,0.000065084816,0.000014195548,0.00012142262,0.0001784446,0.000015174182],"category_scores_gemma":[0.00029741038,0.00009487541,0.000051420644,0.00039254487,0.00021137885,0.0000045477227,0.00021203299,0.00020013259,0.0000058518253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029679095,0.0027158868,0.7169925,0.0011017041,0.0013397351,0.0001564212,0.0009392057,0.00001411523,0.069261074,0.0005403138,0.015797012,0.16146293],"study_design_scores_gemma":[0.036706015,0.008166186,0.721508,0.0005855562,0.00015219732,0.0000075329854,0.0014458841,0.0006598841,0.13967726,0.00017929921,0.089913264,0.0009988963],"about_ca_topic_score_codex":0.000031833788,"about_ca_topic_score_gemma":0.00014796552,"teacher_disagreement_score":0.16046405,"about_ca_system_score_codex":0.000052128373,"about_ca_system_score_gemma":0.0002396607,"threshold_uncertainty_score":0.3868907},"labels":[],"label_agreement":null},{"id":"W4390535948","doi":"10.1158/1078-0432.ccr-23-3275","title":"Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; Canadian Cancer Society; Queen's University; Spinal Cord Injury BC; University of British Columbia; University of British Columbia Hospital","funders":"Daiichi Sankyo Europe; Ipsen; Astellas Pharma; Eisai; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Genentech; Coherus Biosciences; Agios Pharmaceuticals; Michael Smith Health Research BC; Canadian Cancer Society; GlaxoSmithKline","keywords":"Cetuximab; Colorectal cancer; Medicine; KRAS; Internal medicine; Oncology; Transverse colon; Oxaliplatin; Randomized controlled trial; Confidence interval; Cancer; Gastroenterology","score_opus":0.2936647154532566,"score_gpt":0.5987890595446822,"score_spread":0.3051243440914256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390535948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95756847,0.03173424,0.00003012935,0.004371366,0.00035295967,0.0036733707,0.00040302347,0.00004511648,0.0018213069],"genre_scores_gemma":[0.9740255,0.022604087,0.00006277183,0.00029908158,0.00016252098,0.0018927731,0.00012586305,0.00003514498,0.0007922862],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9880565,0.0063023963,0.0030378047,0.0009897102,0.0010644576,0.00054916827],"domain_scores_gemma":[0.9738663,0.024523452,0.00032276553,0.00031036374,0.00060335733,0.00037376687],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.034534138,0.00030159924,0.0044071306,0.0010135365,0.00011540805,0.00007067987,0.0001656864,0.0002000481,0.0012391257],"category_scores_gemma":[0.009135228,0.00020880024,0.0011646592,0.0029299122,0.0019585332,0.000104914725,0.00008540418,0.0009472357,0.0000148688805],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6746848,0.0026150509,0.10749165,0.0016935964,0.044221994,0.0008823188,0.0017864577,0.000039763054,0.0017783991,0.00010960364,0.013910131,0.15078622],"study_design_scores_gemma":[0.35233968,0.006826149,0.5488995,0.002459964,0.04021257,0.00002544209,0.0014290301,0.033553302,0.0009659523,0.0005366562,0.011984822,0.0007669737],"about_ca_topic_score_codex":0.0042034253,"about_ca_topic_score_gemma":0.005293985,"teacher_disagreement_score":0.4414078,"about_ca_system_score_codex":0.0005854491,"about_ca_system_score_gemma":0.002841959,"threshold_uncertainty_score":0.9996739},"labels":[],"label_agreement":null},{"id":"W4390618089","doi":"10.1158/1078-0432.ccr-23-2085","title":"An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Terry Fox Research Institute","keywords":"Medicine; Immune system; Oncology; Internal medicine; Cohort; Proportional hazards model; Framingham Risk Score; Cervical cancer; Hazard ratio; Immune checkpoint; Cancer; Immunotherapy; Immunology; Disease; Confidence interval","score_opus":0.22604172941150627,"score_gpt":0.556202302323792,"score_spread":0.33016057291228573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390618089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8230824,0.1565215,0.004846145,0.00467303,0.002219339,0.004531432,0.0038962904,0.00017404581,0.000055803317],"genre_scores_gemma":[0.95025796,0.025829716,0.0046712826,0.0005726174,0.0054926565,0.011524652,0.00025311648,0.00015254559,0.001245449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99588,0.0004421097,0.0008657397,0.0011079727,0.000840673,0.0008634815],"domain_scores_gemma":[0.99509066,0.002936394,0.0000797686,0.0006814819,0.00053363695,0.00067806663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028410105,0.00028828325,0.0008487683,0.000245499,0.0002514328,0.00014411377,0.00030562535,0.0002684863,0.0023078436],"category_scores_gemma":[0.00068046077,0.00018858949,0.0007075065,0.0007340076,0.00036195468,0.0001641372,0.00008202161,0.0007857869,0.000016387205],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.110005975,0.0033232053,0.104412414,0.0032031834,0.002699749,0.00023812748,0.00042495545,0.000045948014,0.03910667,0.00037947734,0.017201219,0.7189591],"study_design_scores_gemma":[0.041869387,0.022102054,0.10754085,0.0034356709,0.002163096,0.000016515407,0.0002358051,0.0052177943,0.15659326,0.0071331775,0.6524256,0.0012667774],"about_ca_topic_score_codex":0.00091683585,"about_ca_topic_score_gemma":0.0002794296,"teacher_disagreement_score":0.7176923,"about_ca_system_score_codex":0.0005479152,"about_ca_system_score_gemma":0.0008341339,"threshold_uncertainty_score":0.9986042},"labels":[],"label_agreement":null},{"id":"W4391100668","doi":"10.1158/1078-0432.ccr-23-3504","title":"KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Pharmacyclics; Syöpäsäätiö; Mersana Therapeutics; Fonds Wetenschappelijk Onderzoek; Seagen; Incyte; Massachusetts General Hospital; Vlaamse regering; Leukemia and Lymphoma Society; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Lymphoma; Cancer research; Cell; Medicine; Biology; Immunology; Genetics","score_opus":0.09780909894217026,"score_gpt":0.44468662170203926,"score_spread":0.346877522759869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391100668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860363,0.0060430826,0.0000035797177,0.0014644259,0.00016049092,0.0008188272,0.000032483727,0.00004344239,0.005397391],"genre_scores_gemma":[0.99597704,0.0011733485,0.000031183317,0.00040423605,0.00020081048,0.00023567925,0.000049781895,0.00004230877,0.0018856359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976407,0.00015244643,0.00036925357,0.0005829587,0.0007865423,0.00046805793],"domain_scores_gemma":[0.9985931,0.00057090214,0.00003450353,0.0003439427,0.00023059464,0.00022697943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007106927,0.0001670909,0.00032229236,0.00017586334,0.000061464874,0.00008933558,0.00012700612,0.00021240664,0.00036269924],"category_scores_gemma":[0.00004753282,0.0001064341,0.000107828135,0.0005874733,0.00016707141,0.00007328865,0.000056291534,0.00044463703,0.0002647947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030444178,0.006971503,0.91887623,0.0004148457,0.00013329198,0.00027611354,0.000119700046,0.0000112467715,0.00011748933,0.00035370328,0.0032486785,0.06643279],"study_design_scores_gemma":[0.011544302,0.003135104,0.97189337,0.00046851145,0.00007822834,0.0000035240628,0.00007425687,0.00015691629,0.0008427596,0.0001669036,0.011494882,0.0001412539],"about_ca_topic_score_codex":0.0013573102,"about_ca_topic_score_gemma":0.00027753387,"teacher_disagreement_score":0.06629154,"about_ca_system_score_codex":0.0004998523,"about_ca_system_score_gemma":0.0011764539,"threshold_uncertainty_score":0.43402565},"labels":[],"label_agreement":null},{"id":"W4391100943","doi":"10.1158/1078-0432.ccr-23-3018","title":"Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cancer; Odds ratio; Univariate analysis; Bioinformatics; Biology; Multivariate analysis","score_opus":0.12913537536461436,"score_gpt":0.5055657955285745,"score_spread":0.3764304201639601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391100943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913989,0.005215562,0.0000010712635,0.0016683341,0.00063664647,0.00076102745,0.00003297138,0.000029734842,0.0002557615],"genre_scores_gemma":[0.98994917,0.008935769,0.00006470284,0.00009443856,0.00054419367,0.00018046165,0.000005523875,0.00003004181,0.00019570482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694943,0.00046745868,0.0010147974,0.00060859113,0.00055480073,0.00040491624],"domain_scores_gemma":[0.9961569,0.0028860474,0.00005067684,0.00036068214,0.00014171356,0.0004040377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003168994,0.00013529116,0.0005824817,0.00032621433,0.000034830373,0.000005474199,0.00013352855,0.00022434212,0.000260961],"category_scores_gemma":[0.0011727329,0.00010285643,0.00024057779,0.0005660055,0.00057861226,0.000059539758,0.00019828993,0.00087553996,0.00008440758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009259062,0.0009280187,0.9673377,0.00019489613,0.00019957626,0.0006537613,0.00009108396,0.0000044168564,0.00009881173,0.00007703354,0.0024106246,0.027078122],"study_design_scores_gemma":[0.0050951093,0.001943652,0.9848654,0.0008698521,0.000080216494,0.00000766865,0.00007806664,0.00035226133,0.00015187239,0.00019521087,0.006282078,0.000078567784],"about_ca_topic_score_codex":0.00053837855,"about_ca_topic_score_gemma":0.00059504906,"teacher_disagreement_score":0.026999554,"about_ca_system_score_codex":0.00013439836,"about_ca_system_score_gemma":0.0006254394,"threshold_uncertainty_score":0.41943634},"labels":[],"label_agreement":null},{"id":"W4391219346","doi":"10.1158/1078-0432.ccr-23-0131","title":"Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Protein Therapeutics, University at Buffalo; National Center for Advancing Translational Sciences; Division of Chemical, Bioengineering, Environmental, and Transport Systems; National Cancer Institute; Medical Research Council; National Institutes of Health; Queen's University; Cancer Research UK; Queen's University Belfast; Health and Social Care Northern Ireland; State University of New York; University at Buffalo; National Science Foundation; New York State Department of Health; New York State Stem Cell Science; Roswell Park Cancer Institute; Science Foundation Ireland","keywords":"Pancreatic cancer; Medicine; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.2801648771054774,"score_gpt":0.5619495589661623,"score_spread":0.2817846818606849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391219346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96994674,0.022788554,0.00007575363,0.0034799285,0.00025066,0.0019894312,0.000092713766,0.00004423086,0.0013319777],"genre_scores_gemma":[0.9889007,0.0075114896,0.00025111763,0.00012867598,0.000521896,0.0014494522,0.000021641326,0.000056180954,0.001158797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569243,0.0006859027,0.0011913818,0.00063629507,0.0008427129,0.0009512758],"domain_scores_gemma":[0.994278,0.0043498487,0.0000921677,0.00035275292,0.0006101286,0.0003171113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004472007,0.00019001043,0.0010176884,0.00040587215,0.000109323366,0.000039416664,0.00020053162,0.00027242405,0.001491119],"category_scores_gemma":[0.0012629284,0.00014487527,0.0002537594,0.00097465457,0.0008374656,0.00008224969,0.00012091776,0.0013205545,0.000031070143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060655465,0.00129747,0.6531071,0.004939796,0.0013089265,0.0006385445,0.0022598892,0.00009871805,0.031903032,0.0014339366,0.011047303,0.2858997],"study_design_scores_gemma":[0.020359932,0.024609225,0.787407,0.014203791,0.0014386757,0.00006856782,0.01054371,0.06462029,0.019359523,0.015800929,0.040140264,0.0014481009],"about_ca_topic_score_codex":0.0020541735,"about_ca_topic_score_gemma":0.0004764184,"teacher_disagreement_score":0.2844516,"about_ca_system_score_codex":0.0003545917,"about_ca_system_score_gemma":0.0032843864,"threshold_uncertainty_score":0.99942166},"labels":[],"label_agreement":null},{"id":"W4391486548","doi":"10.1158/1078-0432.ccr-23-3414","title":"Antibody–Drug Conjugates: Advancing from Magic Bullet to Biological Missile","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Magic bullet; Drug; Conjugate; Missile; Medicine; Antibody-drug conjugate; Virology; Antibody; Pharmacology; Immunology; Biology; Engineering; Monoclonal antibody; Bioinformatics","score_opus":0.39801736688730605,"score_gpt":0.6481958773268562,"score_spread":0.2501785104395502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391486548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8744975,0.032761615,0.000345655,0.073633485,0.0024516112,0.0021918325,0.0004098124,0.00044354473,0.013264971],"genre_scores_gemma":[0.9550888,0.014495746,0.0018437208,0.004568854,0.0062599634,0.0004469438,0.00020319354,0.00016108959,0.016931698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927588,0.001033857,0.0010426643,0.0016420546,0.0018871696,0.0016354729],"domain_scores_gemma":[0.99166334,0.0047982363,0.000038807702,0.0010284049,0.00071544887,0.0017557767],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.007553097,0.00030017365,0.0008630058,0.0004337872,0.0002008316,0.0002496694,0.00074146804,0.00034008356,0.01824127],"category_scores_gemma":[0.005499321,0.0002245801,0.00034855027,0.0015921838,0.00089736376,0.00009564758,0.00071709853,0.0035439413,0.007584492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002692209,0.0005641281,0.10268682,0.00078346336,0.00035856635,0.0031503278,0.0006826918,0.000013856761,0.046910387,0.00035453023,0.7231647,0.11863832],"study_design_scores_gemma":[0.0011771822,0.0013342575,0.017452678,0.0022927453,0.000035824072,0.000018816609,0.0003892279,0.0008110654,0.0032823458,0.0014997991,0.9713779,0.00032812494],"about_ca_topic_score_codex":0.0035267926,"about_ca_topic_score_gemma":0.00025997023,"teacher_disagreement_score":0.24821323,"about_ca_system_score_codex":0.0006980226,"about_ca_system_score_gemma":0.002497063,"threshold_uncertainty_score":0.9987549},"labels":[],"label_agreement":null},{"id":"W4391755468","doi":"10.1158/1078-0432.ccr-23-2436","title":"Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Research Canada; University of Toronto; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Hormone receptor; Internal medicine; Oestrogen receptor; Postmenopausal women; Gynecology","score_opus":0.047094359813305994,"score_gpt":0.41680607250780793,"score_spread":0.3697117126945019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391755468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178964,0.0028489847,4.7173359e-7,0.002360769,0.0005113723,0.0013026557,0.0010668626,0.000004368572,0.00011484815],"genre_scores_gemma":[0.99291986,0.005310002,0.0000028899794,0.00007731511,0.00054026593,0.0010225907,0.000048042784,0.000025001093,0.000054053067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703145,0.00071805535,0.00065915287,0.0005017808,0.0006847088,0.00040484848],"domain_scores_gemma":[0.99865836,0.0003509887,0.00014226133,0.00035267608,0.0004451783,0.00005054685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001417549,0.00018170767,0.0003164693,0.00010516972,0.000086895736,0.000024229505,0.00047525385,0.0001842459,0.00004819876],"category_scores_gemma":[0.00016749676,0.00010949549,0.00011433562,0.00077586726,0.00060074887,0.000018506144,0.0002894287,0.0005799067,0.0000027184572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01910142,0.0008973387,0.95879847,0.00011618775,0.00018294014,0.0000011539886,0.00043423046,0.00009615211,0.0027216065,0.000011046375,0.0019302015,0.015709268],"study_design_scores_gemma":[0.0068394067,0.0008083946,0.98791367,0.00048055168,0.00004019431,0.0000019719655,0.000115456336,0.000055915058,0.0034060432,0.000017161467,0.0002031964,0.00011806829],"about_ca_topic_score_codex":0.0057548513,"about_ca_topic_score_gemma":0.0017993194,"teacher_disagreement_score":0.029115187,"about_ca_system_score_codex":0.00024409514,"about_ca_system_score_gemma":0.0008850067,"threshold_uncertainty_score":0.8699652},"labels":[],"label_agreement":null},{"id":"W4391954074","doi":"10.1158/1078-0432.ccr-23-1977","title":"Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; BioTheranostics; Breast Cancer Research Foundation","keywords":"Aromatase inhibitor; Oncology; Breast cancer; Medicine; Internal medicine; Cancer; Aromatase; Oestrogen receptor; Hormone receptor; Mammary gland; Clinical trial; Gynecology","score_opus":0.052693379451328,"score_gpt":0.4262709043848459,"score_spread":0.37357752493351787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391954074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363761,0.053769905,0.0000034511093,0.0035794384,0.0008514239,0.00092131726,0.004422989,0.000015825173,0.00005956911],"genre_scores_gemma":[0.92024446,0.07619124,0.000008007417,0.00013237234,0.0025693544,0.0005364991,0.00016696077,0.0000375104,0.00011359713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99710006,0.00069512,0.000597455,0.0007413492,0.0004270962,0.00043891667],"domain_scores_gemma":[0.9985929,0.0005275886,0.00010329374,0.0003570994,0.00022735847,0.00019174772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016263463,0.00021156755,0.00037704385,0.00008582066,0.00012670374,0.000055542354,0.00028560174,0.000651151,0.000144111],"category_scores_gemma":[0.0000683008,0.00014225389,0.00016116108,0.00038118416,0.00073242903,0.000017536893,0.00022312075,0.0011851456,0.000006247202],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17541955,0.0010775423,0.03502103,0.00006239262,0.0012639702,0.00004935925,0.00045753084,0.000055626995,0.25738212,0.00004985075,0.037254706,0.49190632],"study_design_scores_gemma":[0.056792762,0.0062096654,0.8698955,0.0012767221,0.00017755447,0.000055879824,0.0004906649,0.0009595591,0.044094644,0.00051687757,0.018871116,0.0006590217],"about_ca_topic_score_codex":0.0058350526,"about_ca_topic_score_gemma":0.00080584985,"teacher_disagreement_score":0.8348745,"about_ca_system_score_codex":0.00017853291,"about_ca_system_score_gemma":0.0009351675,"threshold_uncertainty_score":0.8820893},"labels":[],"label_agreement":null},{"id":"W4392200462","doi":"10.1158/1078-0432.ccr-23-3683","title":"Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents—To Test or not to Test?","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; National Cancer Institute; Bundesministerium für Bildung und Forschung","keywords":"Cancer; Test (biology); Medicine; Internal medicine; Biology","score_opus":0.1519779809321879,"score_gpt":0.5388848803922281,"score_spread":0.38690689946004025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392200462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9381053,0.001783021,0.000011224937,0.05645807,0.00048121685,0.0021665997,0.0008016953,0.00013276737,0.000060107093],"genre_scores_gemma":[0.9870354,0.0027416062,0.00016760408,0.006596778,0.0016340157,0.00059641316,0.000033529846,0.00008428125,0.0011103534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950582,0.00040163336,0.0010243012,0.0012586996,0.0013792746,0.0008779165],"domain_scores_gemma":[0.9950812,0.0027321917,0.000049534443,0.00063716294,0.00040579907,0.0010941373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029384142,0.00027785366,0.00071912125,0.00055308564,0.00012226826,0.00016246353,0.00035493163,0.00025904115,0.0004517973],"category_scores_gemma":[0.007851917,0.00022902618,0.00013137232,0.0017191245,0.00024113989,0.00014589995,0.00041857702,0.0016351612,0.00028895025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027993803,0.001126714,0.91202515,0.0009677726,0.00010976342,0.00015506888,0.0011017803,0.000008772719,0.00024977955,0.000015446038,0.05291488,0.028525477],"study_design_scores_gemma":[0.0019270835,0.0029252258,0.98266155,0.008696079,0.00006089999,0.000057019373,0.00014270272,0.00015471023,0.00035501362,0.00005036227,0.0026791852,0.00029015148],"about_ca_topic_score_codex":0.008764293,"about_ca_topic_score_gemma":0.01452233,"teacher_disagreement_score":0.0706364,"about_ca_system_score_codex":0.00057665125,"about_ca_system_score_gemma":0.0015071433,"threshold_uncertainty_score":0.9978364},"labels":[],"label_agreement":null},{"id":"W4392284408","doi":"10.1158/1078-0432.ccr-23-3211","title":"Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Risk stratification; Colorectal cancer; Biomarker; Medicine; Stage (stratigraphy); Oncology; Internal medicine; Stratification (seeds); Pathology; Cancer; Cancer research; Biology","score_opus":0.2804708397165649,"score_gpt":0.5291300416129961,"score_spread":0.24865920189643126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392284408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537344,0.0046666637,0.0008491116,0.0023684425,0.00206564,0.0035170037,0.0005683294,0.0001940291,0.00039736088],"genre_scores_gemma":[0.9935692,0.0005796895,0.0013972389,0.0001385961,0.0007693699,0.0014383283,0.000050214432,0.00008308195,0.001974291],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995926,0.00039222662,0.0009069015,0.0010778902,0.00080987194,0.00088710396],"domain_scores_gemma":[0.9960512,0.0020955012,0.00015031957,0.0006818843,0.0007184947,0.00030262538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004469342,0.00026212292,0.00046481244,0.00018297335,0.0005678033,0.00017519678,0.0003587538,0.00035859708,0.00026657758],"category_scores_gemma":[0.002722122,0.00017723316,0.00044884824,0.0008572537,0.0013375148,0.0001000403,0.0002648953,0.0013550819,0.00001928823],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02134862,0.0017093697,0.1484927,0.0038321437,0.00222312,0.0002529766,0.004475208,0.00034640773,0.47918612,0.0014606847,0.053617086,0.28305557],"study_design_scores_gemma":[0.0054723793,0.011109266,0.04427785,0.0011375912,0.00052728434,0.00009001287,0.0030826214,0.72687876,0.035586182,0.0008005365,0.16996223,0.0010752596],"about_ca_topic_score_codex":0.0005522821,"about_ca_topic_score_gemma":0.00035480625,"teacher_disagreement_score":0.7265324,"about_ca_system_score_codex":0.0012261474,"about_ca_system_score_gemma":0.0037108108,"threshold_uncertainty_score":0.7227359},"labels":[],"label_agreement":null},{"id":"W4392353979","doi":"10.1158/1557-3265.endo24-a023","title":"Abstract A023: Assessing the reproducibility crisis in vaginal microbiome studies for clinical applications in endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Microbiome; Endometrial cancer; Cancer; Medicine; Gynecology; Reproducibility; Gynecologic cancer; Oncology; Obstetrics; Bioinformatics; Biology; Internal medicine; Ovarian cancer; Chemistry","score_opus":0.6871145669750996,"score_gpt":0.7213390838931715,"score_spread":0.03422451691807182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392353979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79264796,0.12428043,0.00009479555,0.07199934,0.0021122617,0.0067647267,0.00022833161,0.000106688494,0.001765441],"genre_scores_gemma":[0.95893764,0.0310278,0.00015031689,0.00050329196,0.00454131,0.0043358156,0.000024297722,0.00005426141,0.00042525033],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99242604,0.0010343698,0.0020679974,0.0023406525,0.0010694878,0.0010614763],"domain_scores_gemma":[0.9745302,0.021799112,0.00010340392,0.001810901,0.0013757241,0.00038062214],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.040481247,0.00023374603,0.0010454064,0.000679792,0.00025219223,0.00022970658,0.00059454946,0.000323652,0.0011881915],"category_scores_gemma":[0.014508207,0.00015181782,0.0005066963,0.0035592117,0.0013889775,0.0001829178,0.00042639443,0.0037518907,0.000042898424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028547316,0.001388858,0.41980648,0.002415165,0.00041803299,0.000070392336,0.00041875345,0.000009679106,0.0003487894,0.0002722152,0.050414868,0.521582],"study_design_scores_gemma":[0.0040141637,0.00044621635,0.85601825,0.0004105566,0.00008602585,0.0000025410427,0.0012948462,0.00018368388,0.00027374062,0.0034361556,0.13362564,0.00020819902],"about_ca_topic_score_codex":0.0028831365,"about_ca_topic_score_gemma":0.003555297,"teacher_disagreement_score":0.5213738,"about_ca_system_score_codex":0.0011376862,"about_ca_system_score_gemma":0.0030210495,"threshold_uncertainty_score":0.99972486},"labels":[],"label_agreement":null},{"id":"W4392354575","doi":"10.1158/1557-3265.endo24-ia021","title":"Abstract IA021: Novel genomic features of POLE-mutant tumors: the utility for tumor classification and identification of new driver alleles","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Identification (biology); Allele; Mutant; Genetics; Computational biology; Biology; Gene","score_opus":0.3565290860206652,"score_gpt":0.559035939852931,"score_spread":0.2025068538322658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392354575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834633,0.003474274,0.00036384826,0.011178876,0.00006063278,0.0008939051,0.00018236732,0.00001929951,0.00036349424],"genre_scores_gemma":[0.99799865,0.00068268477,0.00015572361,0.000063226245,0.0003917711,0.00013414188,0.000023916138,0.0000136695635,0.0005361961],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984154,0.00004273785,0.00066161546,0.0003640265,0.00032691972,0.00018928591],"domain_scores_gemma":[0.99774134,0.0013377905,0.000106052576,0.0003734299,0.000277149,0.00016425728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019308547,0.00008227156,0.00023686048,0.00004492197,0.00008292295,0.00003062009,0.0001945107,0.00008570184,0.000112270776],"category_scores_gemma":[0.0007187866,0.000056212208,0.00012747126,0.00025017493,0.00071886985,0.00004642699,0.00004874839,0.00052483316,0.0000043103764],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005874431,0.0002309679,0.0024623314,0.0009938156,0.00009507973,0.000001360776,0.00014133549,0.0000018222795,0.95839787,0.0029385563,0.00544282,0.028706629],"study_design_scores_gemma":[0.0008460875,0.00009885022,0.7953891,0.00025113736,0.0001105335,0.000010107825,0.00028834943,0.0034328334,0.18065104,0.0018269307,0.017015599,0.00007938714],"about_ca_topic_score_codex":0.00009982666,"about_ca_topic_score_gemma":0.000010516071,"teacher_disagreement_score":0.7929268,"about_ca_system_score_codex":0.00005346543,"about_ca_system_score_gemma":0.00058755977,"threshold_uncertainty_score":0.26487058},"labels":[],"label_agreement":null},{"id":"W4392354872","doi":"10.1158/1557-3265.endo24-b012","title":"Abstract B012: Application of shallow whole genome sequencing to identify therapeutic opportunities in p53abn endometrial cancers","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endometrial cancer; Computational biology; Genome; DNA sequencing; Biology; Whole genome sequencing; Medicine; Cancer; Oncology; Genetics; Gene","score_opus":0.3042572367857805,"score_gpt":0.5198236201400745,"score_spread":0.21556638335429407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392354872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832031,0.012760864,0.00044798007,0.0010207316,0.00051400845,0.00060519564,0.00027310223,0.00001069275,0.0011643243],"genre_scores_gemma":[0.9902335,0.007708049,0.00005985669,0.0002682514,0.0010248114,0.0002774684,0.00008345152,0.000034364282,0.00031025088],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979744,0.000119522825,0.00060384127,0.00053989084,0.00036323452,0.00039911404],"domain_scores_gemma":[0.9986539,0.00047464168,0.00005928219,0.0004045942,0.0002241612,0.00018343657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023968099,0.00012426812,0.0002524293,0.00027886042,0.000050854618,0.00007616481,0.00038065657,0.00018446977,0.00008701863],"category_scores_gemma":[0.00047196224,0.00012429769,0.00013655248,0.0004988907,0.00020874705,0.000007719322,0.00020447423,0.00039364537,0.00002982552],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069155934,0.00008843148,0.008764852,0.0002718378,0.00015890811,0.000034385455,0.00023192774,0.0024095862,0.8403347,0.0005123317,0.0020753208,0.14442614],"study_design_scores_gemma":[0.0029232602,0.0019086491,0.15219091,0.00049754744,0.00007188759,0.0000060853913,0.0015236648,0.0011777217,0.049036946,0.0028723355,0.7868865,0.00090449245],"about_ca_topic_score_codex":0.0025957117,"about_ca_topic_score_gemma":0.0030994662,"teacher_disagreement_score":0.7912978,"about_ca_system_score_codex":0.00036617336,"about_ca_system_score_gemma":0.0017496749,"threshold_uncertainty_score":0.5068712},"labels":[],"label_agreement":null},{"id":"W4392356397","doi":"10.1158/1557-3265.endo24-pr002","title":"Abstract PR002: Proteomic profiling of endometrial carcinomas","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Profiling (computer programming); Endometrial cancer; Pathology; Medicine; Biology; Oncology; Cancer research; Internal medicine; Cancer; Computer science","score_opus":0.1807300411545962,"score_gpt":0.5319758282461884,"score_spread":0.35124578709159215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392356397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895097,0.00602591,0.0008514465,0.00049645134,0.0001851181,0.00085643446,0.00006890408,0.000028836688,0.0019771764],"genre_scores_gemma":[0.9950921,0.0017929039,0.0014020826,0.000036369165,0.0007762936,0.00051115314,0.00005889714,0.00002382682,0.00030640175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984122,0.00016456409,0.00043112278,0.00049369375,0.00021348025,0.00028496567],"domain_scores_gemma":[0.99911267,0.00013029159,0.00004705146,0.0004171412,0.0001984246,0.00009442206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002095176,0.00009317369,0.00017413685,0.00010850664,0.000061426654,0.000024619812,0.00031889117,0.0002685228,0.000079473146],"category_scores_gemma":[0.0005040312,0.00007793901,0.00018127276,0.00032586724,0.00038798607,0.000002273112,0.0002033074,0.00048079895,0.000019112673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017918384,0.00008259257,0.005976399,0.00010989584,0.000080606565,0.0000061183105,0.00000515499,0.0000028009779,0.971254,0.0014096291,0.0034810277,0.01741262],"study_design_scores_gemma":[0.0003561492,0.0005103283,0.0055595064,0.000065289336,0.000014289556,0.0000022247998,0.000008899437,0.000042610616,0.9231636,0.0006717858,0.06948217,0.00012316395],"about_ca_topic_score_codex":0.00009125637,"about_ca_topic_score_gemma":0.000012137759,"teacher_disagreement_score":0.06600114,"about_ca_system_score_codex":0.00002083039,"about_ca_system_score_gemma":0.0004610857,"threshold_uncertainty_score":0.31782606},"labels":[],"label_agreement":null},{"id":"W4392365779","doi":"10.1158/1557-3265.endo24-a012","title":"Abstract A012: Genomic landscape of somatic alterations identified in endometrial cancer using liquid biopsy","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Somatic cell; Endometrial cancer; Liquid biopsy; Biopsy; Medicine; Cancer; Biology; Pathology; Cancer research; Internal medicine; Genetics; Gene","score_opus":0.18547459517312048,"score_gpt":0.5091650082183805,"score_spread":0.32369041304526003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392365779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97926277,0.018310808,0.00009872884,0.0002801183,0.0012102872,0.0003354746,0.00022347808,0.0000070177393,0.0002713351],"genre_scores_gemma":[0.9889304,0.008926679,0.00012479266,0.000045006414,0.0016559814,0.00010162836,0.000045204953,0.000032835727,0.00013747966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979955,0.00014055209,0.00072298595,0.00048598746,0.00027896513,0.00037598543],"domain_scores_gemma":[0.9987266,0.0005340005,0.000073390795,0.0003572696,0.00018253339,0.0001261969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016687439,0.00012291946,0.00027688383,0.00028852848,0.000066709814,0.00009576603,0.0002825336,0.00019674865,0.00034178398],"category_scores_gemma":[0.00079934107,0.00011823128,0.00016938748,0.000519675,0.00020129335,0.000008031026,0.00021741775,0.0003919965,0.000017004424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010686037,0.00022383757,0.015956912,0.00036526387,0.00020114356,0.000040336574,0.00012198948,0.0030539813,0.9687693,0.00017929937,0.0032944328,0.006724903],"study_design_scores_gemma":[0.017516349,0.004455997,0.21021324,0.004084005,0.00045136642,0.00005069421,0.0009063783,0.03219478,0.6198308,0.0029071546,0.10462884,0.0027604178],"about_ca_topic_score_codex":0.0015828274,"about_ca_topic_score_gemma":0.001654581,"teacher_disagreement_score":0.34893852,"about_ca_system_score_codex":0.00010857075,"about_ca_system_score_gemma":0.0013085403,"threshold_uncertainty_score":0.48213318},"labels":[],"label_agreement":null},{"id":"W4392366210","doi":"10.1158/1557-3265.endo24-b031","title":"Abstract B031: High risk no specific molecular profile (HR-NSMP) endometrial cancer can be stratified into three subgroups based on tumor grade and estrogen receptor status with differing clinicopathologic characteristics and outcomes","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Endometrial cancer; Cancer; Oncology; Medicine; Estrogen; Internal medicine; Estrogen receptor; Gynecology; Biology; Breast cancer","score_opus":0.12428776110260238,"score_gpt":0.43816423849051256,"score_spread":0.3138764773879102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902893,0.0040694713,0.000026280106,0.002419008,0.0010493807,0.0018639505,0.0012784014,0.000116004696,0.00014857533],"genre_scores_gemma":[0.9891068,0.0072213383,0.0008968899,0.000402032,0.0012074838,0.0007831674,0.00016132106,0.00010054494,0.00012046177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477565,0.0004522833,0.0010537293,0.0013875024,0.0013549264,0.0009759036],"domain_scores_gemma":[0.9938256,0.0041102413,0.00020971455,0.0006030937,0.00033767556,0.0009136737],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020628325,0.00048159895,0.0012453259,0.00046473672,0.0002558693,0.00026050102,0.00021991841,0.0002704703,0.0011020734],"category_scores_gemma":[0.0020040213,0.000314138,0.00022863735,0.0010147669,0.00080519594,0.00009128543,0.00015987486,0.002072404,0.000034973265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013004805,0.0007822187,0.83639526,0.0007562268,0.000496838,0.0010704423,0.00008196723,0.0000055221935,0.0022519692,0.00016596331,0.00027488449,0.14471388],"study_design_scores_gemma":[0.014165257,0.008403782,0.9690615,0.00081863196,0.0003443958,0.00000643481,0.000071239985,0.00030690894,0.002240453,0.00033024373,0.0037470625,0.0005041013],"about_ca_topic_score_codex":0.0040617636,"about_ca_topic_score_gemma":0.00058158673,"teacher_disagreement_score":0.14420979,"about_ca_system_score_codex":0.0005347717,"about_ca_system_score_gemma":0.00088692765,"threshold_uncertainty_score":0.9999311},"labels":[],"label_agreement":null},{"id":"W4392366211","doi":"10.1158/1557-3265.endo24-b026","title":"Abstract B026: Substratification of mismatch repair deficient (MMRd) endometrial cancers can provide prognostic and predictive refinement","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Internal medicine; Cancer research; Cancer","score_opus":0.20691190906621246,"score_gpt":0.4939742819427068,"score_spread":0.2870623728764944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98316395,0.008817928,0.000021031403,0.0023482256,0.0011529641,0.00238438,0.00022859446,0.00010499428,0.0017779528],"genre_scores_gemma":[0.99524987,0.0023134944,0.00035798326,0.00006064693,0.0006446668,0.0008065015,0.000030083884,0.00004347927,0.0004932797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579597,0.00024617423,0.0010767337,0.0009076569,0.0014184277,0.0005550495],"domain_scores_gemma":[0.99573,0.002498094,0.00012924186,0.0005214927,0.0007365724,0.0003846265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035645384,0.00020382424,0.0005159313,0.0003676571,0.00010306576,0.000056581724,0.00018619573,0.00023207147,0.0005635877],"category_scores_gemma":[0.003679832,0.00016536297,0.00020616075,0.0010761986,0.00088447944,0.000051782845,0.00012715042,0.0010879876,0.000011306525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019038292,0.0019429328,0.5468488,0.01216652,0.0022165056,0.00039534245,0.0043312195,0.0005655313,0.06373496,0.00074617687,0.08719445,0.26081932],"study_design_scores_gemma":[0.0061004357,0.011792111,0.871499,0.004096639,0.0007060097,0.00003545224,0.0015360258,0.005178223,0.050836217,0.00072926463,0.046842746,0.00064789975],"about_ca_topic_score_codex":0.0020766503,"about_ca_topic_score_gemma":0.0010108508,"teacher_disagreement_score":0.32465023,"about_ca_system_score_codex":0.0009801821,"about_ca_system_score_gemma":0.0035853186,"threshold_uncertainty_score":0.67433065},"labels":[],"label_agreement":null},{"id":"W4392366375","doi":"10.1158/1557-3265.endo24-pr006","title":"Abstract PR006: ARID1A/B mutations retarget mSWI/SNF chromatin remodeler activity and define a spectrum of dedifferentiation in endometrial carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ARID1A; Chromatin; Cancer research; Biology; Mutation; Chromatin remodeling; Genetics; Gene; Medicine","score_opus":0.12941386280768014,"score_gpt":0.4651211312747568,"score_spread":0.33570726846707666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934823,0.0045599956,0.00036475676,0.0005537321,0.00027665158,0.0003103169,0.00007358032,0.000012953123,0.00036572697],"genre_scores_gemma":[0.9973123,0.0016007776,0.00019463964,0.000015008279,0.0005773492,0.00006121225,0.00006285428,0.000024245359,0.00015158832],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980342,0.00023231904,0.0005122428,0.00052774104,0.00037742336,0.00031608331],"domain_scores_gemma":[0.9990513,0.000357279,0.00007555361,0.00028749558,0.00012507525,0.00010332212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017598629,0.0001261786,0.00027932492,0.00020010286,0.00006032836,0.000049174312,0.00014842268,0.00022606365,0.00010489086],"category_scores_gemma":[0.00075729133,0.00011471151,0.00011933111,0.00041521722,0.00022758682,0.000011348475,0.00012742313,0.0005030426,0.000005372147],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019415921,0.00058867084,0.0685158,0.001098016,0.0002403787,0.000030764575,0.00029575228,0.00072337204,0.83530396,0.00029843114,0.0031172577,0.08784597],"study_design_scores_gemma":[0.004478274,0.0012070546,0.7180036,0.000539447,0.00006624666,0.000012262164,0.00008835396,0.03296139,0.23656473,0.0035695885,0.0020071692,0.0005019068],"about_ca_topic_score_codex":0.0011955346,"about_ca_topic_score_gemma":0.0012076333,"teacher_disagreement_score":0.6494878,"about_ca_system_score_codex":0.00007738037,"about_ca_system_score_gemma":0.0005423248,"threshold_uncertainty_score":0.46777996},"labels":[],"label_agreement":null},{"id":"W4393221527","doi":"10.1158/1078-0432.ccr-23-3689","title":"Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Vancouver Coastal Health Research Institute; Canadian Cancer Society","keywords":"Endometrial cancer; Medicine; Carcinosarcoma; Serous fluid; Ovarian cancer; Whole genome sequencing; DNA sequencing; Cancer; Oncology; Internal medicine; Cancer research; Biology; Genome; Gene; Carcinoma; Genetics","score_opus":0.5458716065322252,"score_gpt":0.5526852119305065,"score_spread":0.006813605398281242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393221527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9018618,0.08016004,0.00004011063,0.011823543,0.0017806797,0.0010811007,0.00018282974,0.00016298561,0.0029069057],"genre_scores_gemma":[0.96256715,0.029463856,0.00004932261,0.0010112429,0.0016599786,0.00045834345,0.000043623397,0.0000662384,0.004680225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99596715,0.00062860973,0.0008901279,0.00076795,0.0010141445,0.0007320475],"domain_scores_gemma":[0.99673134,0.0021290984,0.000060028862,0.00039866127,0.00030458532,0.00037630321],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052436963,0.00021377025,0.00060602574,0.00095074775,0.00014667126,0.00021061867,0.00021890974,0.0002424028,0.0015232712],"category_scores_gemma":[0.00058476476,0.00018736244,0.00017428263,0.0013038502,0.0010608705,0.00024499267,0.00012478424,0.0016749821,0.00006785899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015148541,0.0005750089,0.108986765,0.0052305902,0.002940831,0.0067416728,0.0110052,0.0003291148,0.35278368,0.0050456855,0.024227235,0.46698567],"study_design_scores_gemma":[0.026587792,0.0047299573,0.113613494,0.0077474616,0.0003675349,0.00022442552,0.011986341,0.0040597967,0.0091804005,0.022628685,0.7970505,0.00182363],"about_ca_topic_score_codex":0.0016333249,"about_ca_topic_score_gemma":0.0008546784,"teacher_disagreement_score":0.7728232,"about_ca_system_score_codex":0.0017107072,"about_ca_system_score_gemma":0.003435253,"threshold_uncertainty_score":0.99938947},"labels":[],"label_agreement":null},{"id":"W4393307842","doi":"10.1158/1078-0432.ccr-23-3840","title":"Solid Organ Transplant Recipients Exhibit More <i>TET2</i> -Mutant Clonal Hematopoiesis of Indeterminate Potential Not Driven by Increased Transplantation Risk","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Vanderbilt University Medical Center; NIH Office of the Director; National Institute for Occupational Safety and Health; Centers for Disease Control and Prevention; National Cancer Institute; National Institutes of Health; Edward P. Evans Foundation; Canadian Institutes of Health Research; Leukemia and Lymphoma Society; Burroughs Wellcome Fund","keywords":"Transplantation; Population; Biobank; Malignancy; Haematopoiesis; Internal medicine; Biology; Oncology; Medicine; Immunology; Bioinformatics; Genetics; Stem cell","score_opus":0.06296916830744788,"score_gpt":0.46586794977371754,"score_spread":0.4028987814662697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393307842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131787,0.00083350536,0.00045679175,0.0031644404,0.00037844267,0.00111415,0.002421826,0.0001064053,0.00020656949],"genre_scores_gemma":[0.98572767,0.011905506,0.00021366052,0.00022000559,0.00055843923,0.00018311306,0.00037902477,0.00010806934,0.00070454215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99278575,0.0010693048,0.0014242119,0.0010781221,0.0025974738,0.0010451585],"domain_scores_gemma":[0.99591064,0.0018569054,0.0001448003,0.00064335525,0.00068905036,0.0007552597],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044586766,0.0003264107,0.0009209701,0.00051638496,0.00022938117,0.00008705651,0.0005710311,0.000517612,0.0011126386],"category_scores_gemma":[0.0006012653,0.00026863648,0.0004516889,0.001146892,0.0011728794,0.0001978369,0.00013898537,0.0030681442,0.00013864586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030655924,0.0018199398,0.12278354,0.0045866356,0.001757689,0.0074355765,0.003494386,0.00005455454,0.7511339,0.00007433872,0.024549669,0.05165385],"study_design_scores_gemma":[0.017119378,0.0040852316,0.13995571,0.0059294035,0.0014633852,0.000687891,0.0004983868,0.02252453,0.8005834,0.00035082534,0.0057709957,0.0010308427],"about_ca_topic_score_codex":0.0017169614,"about_ca_topic_score_gemma":0.0001143601,"teacher_disagreement_score":0.05062301,"about_ca_system_score_codex":0.0005581798,"about_ca_system_score_gemma":0.0022132862,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W4393950098","doi":"10.1158/1078-0432.ccr-23-4033","title":"Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; Hospital Research Foundation; Bundesministerium für Bildung und Forschung; St. Baldrick's Foundation","keywords":"Genetic predisposition; Context (archaeology); Germline; Medicine; Cancer; Li–Fraumeni syndrome; Brain tumor; Germline mutation; Neurofibromatosis; Family history; Disease; Pathology; Mutation; Internal medicine; Biology; Genetics","score_opus":0.34623046507544936,"score_gpt":0.5982013689547085,"score_spread":0.2519709038792592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393950098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015639116,0.99233896,0.000037255963,0.0022944943,0.00078947615,0.0013148942,0.0015580747,0.000032416956,0.00007054383],"genre_scores_gemma":[0.0003737035,0.99077076,0.00012032734,0.0005629645,0.0036864046,0.0017307099,0.00062733283,0.00013546114,0.001992319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605376,0.00048683575,0.0010969571,0.0013431459,0.0004426779,0.00057661324],"domain_scores_gemma":[0.9979319,0.00041818898,0.00019824297,0.00061783346,0.00060935697,0.00022445078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029608286,0.00042364214,0.0011746791,0.00013693425,0.00016999603,0.00012171158,0.00044916957,0.0006209625,0.000040984127],"category_scores_gemma":[0.0014778276,0.00031491625,0.00059301005,0.00027504333,0.00028561376,0.0000039729093,0.00031926492,0.0008458733,0.000027219898],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008023046,0.000054779593,0.000015758127,0.00712915,0.00032734819,0.000004837847,0.00000588669,0.000014370509,0.000011085237,0.00003336729,0.20823239,0.7840908],"study_design_scores_gemma":[0.0004076298,0.000494973,0.000031464344,0.010287725,0.00014528356,0.0000152655,0.0000065119884,0.00011398338,0.000016464925,0.00017278329,0.9879312,0.0003767033],"about_ca_topic_score_codex":0.000091106165,"about_ca_topic_score_gemma":0.00017667729,"teacher_disagreement_score":0.7837141,"about_ca_system_score_codex":0.000114090464,"about_ca_system_score_gemma":0.0015034002,"threshold_uncertainty_score":0.99993026},"labels":[],"label_agreement":null},{"id":"W4396813958","doi":"10.1158/1078-0432.ccr-24-0268","title":"Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"BC Cancer Foundation; Michael Smith Health Research BC; AstraZeneca","keywords":"Durvalumab; Medicine; Colorectal cancer; Microsatellite instability; Tremelimumab; Internal medicine; Pembrolizumab; Immunotherapy; Oncology; Biomarker; Cancer; Gastroenterology; Ipilimumab; Biology; Allele; Microsatellite","score_opus":0.1396367048201123,"score_gpt":0.5080197485062736,"score_spread":0.3683830436861613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396813958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071527,0.0018179395,9.089186e-7,0.0037142173,0.0007221998,0.0025267904,0.00018640945,0.000024748495,0.00029151211],"genre_scores_gemma":[0.99820775,0.0003348892,0.00003353548,0.00010253269,0.0002595177,0.0007901775,0.00003247869,0.000048598104,0.00019051663],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9943232,0.0018700762,0.0009836829,0.0005739765,0.0017231953,0.00052584975],"domain_scores_gemma":[0.99286354,0.0063007483,0.00011660861,0.00031145738,0.000278316,0.00012930857],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0069105453,0.00020438759,0.00057847897,0.0005224383,0.00007864849,0.000059292295,0.00033462228,0.00011814418,0.0012019775],"category_scores_gemma":[0.0014618989,0.00013199655,0.0001615265,0.0015760432,0.0009426455,0.000106874504,0.000051124505,0.00092786085,0.000034588782],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9587912,0.00048356666,0.0049294108,0.0001640847,0.0005635133,0.00032908734,0.0011728451,0.000057452315,0.00038926615,0.000018519635,0.0014536494,0.031647414],"study_design_scores_gemma":[0.46440715,0.040495142,0.47143745,0.0019638787,0.00028025467,0.000018520339,0.002861397,0.0017462963,0.0016547813,0.000091314854,0.014562686,0.00048111007],"about_ca_topic_score_codex":0.004990965,"about_ca_topic_score_gemma":0.0026146222,"teacher_disagreement_score":0.49438405,"about_ca_system_score_codex":0.0010720583,"about_ca_system_score_gemma":0.005022617,"threshold_uncertainty_score":0.99971104},"labels":[],"label_agreement":null},{"id":"W4397012901","doi":"10.1158/1557-3265.bladder24-a007","title":"Abstract A007: Circulating tumor DNA and tissue staining analyses reveal heterogeneous <i>ERBB2</i>/HER2 status in urothelial cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Urothelial cancer; Cancer; Staining; Pathology; DNA; Cancer research; Medicine; Biology; Bladder cancer; Internal medicine; Genetics","score_opus":0.2944178235038861,"score_gpt":0.5736665748808023,"score_spread":0.2792487513769162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96002257,0.034426995,0.000006821771,0.0013970388,0.000660061,0.00095970184,0.00019897023,0.00009875803,0.0022291108],"genre_scores_gemma":[0.9902825,0.0059627234,0.00009741463,0.0005501468,0.0017946357,0.000392569,0.000017603375,0.000096434575,0.0008060256],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956055,0.0003495626,0.00094787567,0.0010361656,0.00095507276,0.0011058185],"domain_scores_gemma":[0.9976173,0.0010597125,0.000077083176,0.00041151908,0.00023241257,0.0006019425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018320103,0.0002963272,0.0007471618,0.00035455817,0.00016708809,0.00017941394,0.00016757337,0.00019242785,0.0012332572],"category_scores_gemma":[0.0005190175,0.0002439509,0.0001784642,0.00079956866,0.0004169954,0.00014783777,0.00016292467,0.0014506856,0.00005884063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031020571,0.0006272158,0.29959932,0.002025307,0.0010441282,0.007189168,0.0020205472,0.00027049542,0.028945472,0.000039835304,0.0034515099,0.65168494],"study_design_scores_gemma":[0.019277554,0.0055859108,0.75095874,0.010276528,0.0010257845,0.0003409527,0.0014274354,0.0032733185,0.038138345,0.0020744742,0.16570133,0.0019196344],"about_ca_topic_score_codex":0.015311378,"about_ca_topic_score_gemma":0.002287074,"teacher_disagreement_score":0.6497653,"about_ca_system_score_codex":0.0005891764,"about_ca_system_score_gemma":0.0019263397,"threshold_uncertainty_score":0.99967974},"labels":[],"label_agreement":null},{"id":"W4397012914","doi":"10.1158/1557-3265.bladder24-pr003","title":"Abstract PR003: T cell receptor repertoire and diversity are prognostic markers in bladder cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Bladder cancer; Cancer; Receptor; Repertoire; Biology; Medicine; Cancer research; Pathology; Internal medicine","score_opus":0.17832695203342278,"score_gpt":0.480906556418253,"score_spread":0.3025796043848302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623533,0.0235958,9.539543e-7,0.007431,0.0007162073,0.0011326651,0.00013993577,0.00007753385,0.004552623],"genre_scores_gemma":[0.977938,0.015236742,0.00004019232,0.0004044154,0.0006471898,0.00030454388,0.000011615822,0.000044136887,0.0053731953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971521,0.000205094,0.00044942254,0.0008470447,0.0007400471,0.00060627644],"domain_scores_gemma":[0.99816555,0.00082546513,0.000045288012,0.00032721725,0.00021569038,0.00042077372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00139822,0.00019750487,0.00043560512,0.00020951744,0.00020688397,0.000076240925,0.0001680137,0.00024676323,0.0027539437],"category_scores_gemma":[0.00038763843,0.00015577115,0.00013840267,0.000587923,0.00046420208,0.00013028964,0.0003512248,0.0013681508,0.00012349422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015460991,0.00041873087,0.8725291,0.00089972117,0.00021264859,0.00054928457,0.00038841565,0.0000017700801,0.00026276396,0.000008207497,0.050086137,0.07309715],"study_design_scores_gemma":[0.00279748,0.00061333406,0.95645756,0.001773977,0.00013331723,0.0000055406113,0.00042731198,0.000102406986,0.00040955897,0.00013392804,0.036917042,0.00022852248],"about_ca_topic_score_codex":0.0049025775,"about_ca_topic_score_gemma":0.0014644822,"teacher_disagreement_score":0.08392851,"about_ca_system_score_codex":0.0004642664,"about_ca_system_score_gemma":0.0010000487,"threshold_uncertainty_score":0.9981577},"labels":[],"label_agreement":null},{"id":"W4397012996","doi":"10.1158/1557-3265.bladder24-a021","title":"Abstract A021: The role of MGAT5 in sex-dependent regulation of CD8+ T cells in muscle-invasive bladder cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Cytotoxic T cell; Cancer research; CD8; Medicine; Biology; Pathology; Immunology; Internal medicine; Immune system; In vitro; Genetics","score_opus":0.12674183756787558,"score_gpt":0.4799487102532005,"score_spread":0.3532068726853249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795981,0.0122494325,0.0000013657982,0.001915521,0.00035344405,0.0010121001,0.00013920758,0.000014953242,0.004715867],"genre_scores_gemma":[0.99142367,0.0064262617,0.000015787205,0.00009134725,0.00038150835,0.0002701172,0.000007077247,0.000034290857,0.0013499407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996997,0.00029031295,0.0008929785,0.00048243013,0.00092259987,0.00041465877],"domain_scores_gemma":[0.99771947,0.0013676467,0.00009016349,0.00045160722,0.00024484497,0.00012627552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021593892,0.00014703671,0.00048143847,0.00027198705,0.00003337975,0.000019285142,0.00023087666,0.00020368023,0.0015570741],"category_scores_gemma":[0.00021104336,0.00010022483,0.0001714005,0.0006997287,0.0003927274,0.00008391553,0.00010369304,0.0010067943,0.000028769322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028690659,0.0018039898,0.3970076,0.0015644724,0.0006597999,0.00021259543,0.0046779783,0.000645438,0.20189366,0.00043791288,0.002869027,0.38535845],"study_design_scores_gemma":[0.0033418715,0.0006673636,0.81255615,0.0019128345,0.00010081771,0.0000021556798,0.0013633022,0.0004731125,0.17137204,0.0028355424,0.005205952,0.00016888244],"about_ca_topic_score_codex":0.015367216,"about_ca_topic_score_gemma":0.00872224,"teacher_disagreement_score":0.41554853,"about_ca_system_score_codex":0.0003542216,"about_ca_system_score_gemma":0.0017529213,"threshold_uncertainty_score":0.9993556},"labels":[],"label_agreement":null},{"id":"W4397013178","doi":"10.1158/1557-3265.bladder24-a004","title":"Abstract A004: Clinical test design affects tumor tissue and ctDNA FGFR gene status in metastatic urothelial cancer: a prospective study","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Jewish General Hospital; University of Calgary; University of Alberta; Baker Hughes (Canada); Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Urothelial cancer; Cancer; Medicine; Oncology; Circulating tumor DNA; Prospective cohort study; Internal medicine; Cancer research; Bladder cancer","score_opus":0.25675409485827455,"score_gpt":0.5592329056097901,"score_spread":0.30247881075151556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397013178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96568906,0.02261106,0.000045206187,0.0017185737,0.0010552626,0.007507325,0.00031743763,0.00014465647,0.00091142085],"genre_scores_gemma":[0.98675793,0.007354069,0.0004161472,0.00030438305,0.0014469668,0.0025090033,0.000008603594,0.00012062785,0.0010822444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935991,0.0012143921,0.0012262238,0.0015719015,0.0012169803,0.0011713817],"domain_scores_gemma":[0.99206156,0.006071196,0.00010214437,0.00058513583,0.00031929996,0.00086064474],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0060698735,0.00040318517,0.001214178,0.0003760291,0.00016738514,0.00018671787,0.00025034547,0.00017888373,0.0008426123],"category_scores_gemma":[0.0024693166,0.00030954927,0.00019567795,0.0010669392,0.000756928,0.0001816192,0.0002096327,0.0023705508,0.00016873566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044697616,0.004575185,0.8244949,0.00050880655,0.0008187543,0.0042511355,0.0008798391,0.000012405472,0.0006084778,0.000026870479,0.0032204334,0.15613346],"study_design_scores_gemma":[0.012711423,0.012688069,0.962966,0.00088758004,0.00048344958,0.000035536337,0.00046823666,0.00030637352,0.0014749698,0.00056668743,0.007018757,0.00039289385],"about_ca_topic_score_codex":0.0066603357,"about_ca_topic_score_gemma":0.002814562,"teacher_disagreement_score":0.15574056,"about_ca_system_score_codex":0.0007314054,"about_ca_system_score_gemma":0.0043028314,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W4399367382","doi":"10.1158/1078-0432.ccr-23-3552","title":"Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Vancouver General Hospital; Alberta Health Services; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"HORIZON EUROPE European Research Council; Medical Research Council; National Center for Advancing Translational Sciences; National Cancer Institute; U.S. Army Medical Research and Development Command; Cancer Institute NSW; Canadian Institutes of Health Research; Janet D. Cottrelle Foundation; Krebsliga Schweiz; Medical Research and Materiel Command; Eisai; Ovarian Cancer Action; AstraZeneca; National Health and Medical Research Council; Cancer Research UK; Swedish Cancer Foundation; Bundesministerium für Bildung und Forschung; Michael Smith Health Research BC; Genentech; Victorian Cancer Agency; Clovis Oncology; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; U.S. Department of Defense","keywords":"Ovarian carcinoma; Ovarian cancer; Biology; Cancer research; Germline; CD8; Transcriptome; Serous carcinoma; Cancer; Immunology; Immune system; Gene expression; Genetics; Gene","score_opus":0.14307757489155112,"score_gpt":0.46852175686945,"score_spread":0.3254441819778989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399367382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946066,0.042440422,0.00001638458,0.009165177,0.00093414047,0.0010808696,0.000096635675,0.000067073444,0.00013328927],"genre_scores_gemma":[0.9833327,0.015316777,0.000026647675,0.00015380837,0.00038025947,0.00042608505,0.000018923784,0.000042798434,0.00030202258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99553376,0.0010273004,0.0007444075,0.0011651752,0.000718437,0.00081091735],"domain_scores_gemma":[0.9959916,0.0028274513,0.000056644494,0.0005119748,0.00018179024,0.00043054673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035667035,0.0002792522,0.00069979025,0.0002972571,0.00014836606,0.00017790157,0.00019451375,0.00028633568,0.00019154523],"category_scores_gemma":[0.0006559868,0.00021657172,0.00010934731,0.00071390317,0.0010105439,0.000115863884,0.0003247067,0.0013373004,0.000034336434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00299538,0.0009380571,0.90515935,0.0006269116,0.00016551426,0.0025904034,0.0004604595,0.000002119651,0.00080672506,0.0007522183,0.00040484458,0.08509804],"study_design_scores_gemma":[0.0060572964,0.0027570263,0.98786485,0.001085654,0.00009273446,0.000058200298,0.000083587205,0.00008407677,0.00083702034,0.00017620852,0.000700816,0.00020252654],"about_ca_topic_score_codex":0.0011354643,"about_ca_topic_score_gemma":0.00064317096,"teacher_disagreement_score":0.084895514,"about_ca_system_score_codex":0.0005244781,"about_ca_system_score_gemma":0.0011384233,"threshold_uncertainty_score":0.8831538},"labels":[],"label_agreement":null},{"id":"W4399430519","doi":"10.1158/1078-0432.ccr-23-3720","title":"Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair–Deficient Uterine Leiomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Health and Medical Research Fund; Eisai; Gilead Sciences; Food and Health Bureau; GlaxoSmithKline; Agios Pharmaceuticals; AstraZeneca; Servier; Pfizer","keywords":"Leiomyosarcoma; DNA damage; Cancer research; DNA repair; Biology; Kinase; DNA; Medicine; Pathology; Cell biology; Genetics","score_opus":0.06411064824331272,"score_gpt":0.4521222992991124,"score_spread":0.3880116510557997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399430519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935104,0.0023567418,0.0011297256,0.0003921656,0.0004072128,0.0011969481,0.0008242873,0.000024650895,0.00015782517],"genre_scores_gemma":[0.9950525,0.0016929993,0.00025044545,0.0001463974,0.0005844132,0.00057054154,0.00022828153,0.000037889993,0.0014365383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979516,0.0002524657,0.0004420783,0.0006976232,0.00025309835,0.0004031011],"domain_scores_gemma":[0.9989025,0.00016835949,0.000056185323,0.00047767014,0.00026826988,0.00012703794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089481845,0.00016919132,0.00028281723,0.00010334569,0.00009796864,0.00003983362,0.0001468279,0.00024071924,0.00008585554],"category_scores_gemma":[0.00011574296,0.00014218985,0.00047137667,0.00017828014,0.00029215825,0.000006548804,0.00019711601,0.00020476081,0.0000093856925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001661518,0.0005374555,0.00034446755,0.0003530817,0.0002745729,0.0000320475,0.00009523574,0.000018782011,0.9718732,0.000101032616,0.01296088,0.011747704],"study_design_scores_gemma":[0.0028690088,0.0057377517,0.0022372724,0.00024620508,0.000085911364,0.0000067203327,0.00007245025,0.00277799,0.832375,0.00020038255,0.15313481,0.00025651787],"about_ca_topic_score_codex":0.00026978995,"about_ca_topic_score_gemma":0.00011469507,"teacher_disagreement_score":0.14017393,"about_ca_system_score_codex":0.000097497155,"about_ca_system_score_gemma":0.00030580783,"threshold_uncertainty_score":0.5798334},"labels":[],"label_agreement":null},{"id":"W4399527680","doi":"10.1158/1078-0432.ccr-24-0237","title":"Neuroblastoma Predisposition and Surveillance—An Update from the 2023 AACR Childhood Cancer Predisposition Workshop","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McGill University; University of Toronto; Jewish General Hospital","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Bundesministerium für Bildung und Forschung; Servier; Moderna; National Cancer Institute; Deutsche Kinderkrebsstiftung; Incyte; Hospital Research Foundation; Alexion Pharmaceuticals; AstraZeneca; St. Baldrick's Foundation; Sanofi","keywords":"Genetic predisposition; Medicine; Neuroblastoma; Germline; Cancer; Genetic testing; Costello syndrome; Li–Fraumeni syndrome; Disease; Hypoventilation; Pediatric cancer; Genetics; Germline mutation; Internal medicine; Gene; Mutation; Biology","score_opus":0.22640092945184542,"score_gpt":0.5568631645452621,"score_spread":0.33046223509341666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399527680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010648495,0.977215,0.0000031065758,0.0035500857,0.0011791218,0.003786417,0.00329577,0.00014747877,0.00017450904],"genre_scores_gemma":[0.0033921637,0.98673314,0.000017582073,0.00032591855,0.004398042,0.0022616917,0.0013472626,0.00021501177,0.0013091608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99082804,0.0029133656,0.0012797369,0.0019988215,0.0017787572,0.0012013095],"domain_scores_gemma":[0.99354964,0.0033497624,0.00023258386,0.001373514,0.00043465977,0.0010598551],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023478407,0.0006896198,0.0019901379,0.00032534244,0.00044663003,0.00044479288,0.00069776905,0.0006881204,0.00068624795],"category_scores_gemma":[0.000815185,0.00041046695,0.0007099383,0.001403567,0.00091279874,0.00021360557,0.0008066267,0.0049929335,0.00052544894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007892223,0.0006768431,0.00042529474,0.0038917875,0.0013866333,0.00061710743,0.000055281274,7.326867e-7,0.0000040929517,0.000034345456,0.042903718,0.94921494],"study_design_scores_gemma":[0.0024645932,0.0022752392,0.018290138,0.03396161,0.002330338,0.00012939466,0.000042147793,0.000114177434,0.000005264985,0.00034777678,0.9394161,0.00062320306],"about_ca_topic_score_codex":0.0008844796,"about_ca_topic_score_gemma":0.0016748363,"teacher_disagreement_score":0.94859177,"about_ca_system_score_codex":0.0004716809,"about_ca_system_score_gemma":0.0021708477,"threshold_uncertainty_score":0.9998347},"labels":[],"label_agreement":null},{"id":"W4399533928","doi":"10.1158/1078-0432.ccr-23-3994","title":"Clinical Updates and Surveillance Recommendations for DNA Replication Repair Deficiency Syndromes in Children and Young Adults","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Servier; Alexion Pharmaceuticals","keywords":"Medicine; Replication (statistics); Pediatrics; Virology","score_opus":0.31294531001535014,"score_gpt":0.5912576726138743,"score_spread":0.27831236259852415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399533928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013646843,0.97302914,0.000005053567,0.0068089906,0.0007277365,0.004775546,0.00075840234,0.00015243623,0.00009583212],"genre_scores_gemma":[0.0012410926,0.993859,0.00056676543,0.00025426593,0.001223984,0.0013844008,0.00078828365,0.00011949332,0.0005627294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904992,0.0021176322,0.0033901492,0.002557482,0.0007079409,0.00072757585],"domain_scores_gemma":[0.99099433,0.0060501276,0.00045522454,0.0015600476,0.0004344779,0.00050579035],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02251047,0.0004501766,0.002899621,0.00050790847,0.00019373297,0.000114907074,0.00040030075,0.00080006337,0.000052692507],"category_scores_gemma":[0.010487958,0.00036924548,0.0007470968,0.0010895616,0.00087949523,0.000111160465,0.0005446634,0.002776298,0.000037933405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020251091,0.00031627697,0.11501758,0.016032606,0.00032616218,0.0000076561455,0.000099761346,1.1369981e-8,1.39493315e-8,0.00018216467,0.037544433,0.8302708],"study_design_scores_gemma":[0.0021200827,0.0011551979,0.12876505,0.028530587,0.0005777059,0.00016305546,0.00009410795,0.000042434152,8.5482284e-8,0.0004348714,0.83757627,0.00054058974],"about_ca_topic_score_codex":0.0010709047,"about_ca_topic_score_gemma":0.0017547583,"teacher_disagreement_score":0.8297302,"about_ca_system_score_codex":0.00028789774,"about_ca_system_score_gemma":0.0016515636,"threshold_uncertainty_score":0.99987596},"labels":[],"label_agreement":null},{"id":"W4400582488","doi":"10.1158/1078-0432.ccr-24-0255","title":"Circulating Tumor DNA Dynamics Reveal <i>KRAS G12C</i> Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Roche (Canada)","funders":"National Center for Advancing Translational Sciences","keywords":"KRAS; Circulating tumor DNA; Cancer research; Mutation; Dynamics (music); DNA; Medicine; Biology; Cancer; Internal medicine; Genetics; Colorectal cancer; Psychology","score_opus":0.06284397043373981,"score_gpt":0.44475733961434427,"score_spread":0.3819133691806045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400582488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929982,0.0021768743,0.00011136476,0.0035924541,0.00018551403,0.0007025698,0.00014060191,0.000012010805,0.0000804536],"genre_scores_gemma":[0.9975962,0.0006586361,0.00011016623,0.00046927622,0.0005991897,0.00030869746,0.000042475338,0.00004253803,0.00017283853],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997594,0.00049517467,0.00042978756,0.00071187055,0.0003065867,0.00046255277],"domain_scores_gemma":[0.99834335,0.0008210038,0.00005262945,0.00040187401,0.00015661158,0.00022455718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021473316,0.00019309677,0.0002673794,0.00009397109,0.00016629408,0.00016138096,0.00019276948,0.000116394054,0.0000061483925],"category_scores_gemma":[0.00062378217,0.00013458481,0.00009242154,0.00034163386,0.00029261477,0.000006978493,0.00023907331,0.00034992458,0.000009409795],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027856126,0.0012855771,0.23903051,0.00059825997,0.0008611256,0.00312689,0.0027049594,0.0055330335,0.47380185,0.0006159504,0.011197334,0.2333884],"study_design_scores_gemma":[0.0138710225,0.037122753,0.51232904,0.002476153,0.0003470512,0.0006019446,0.0036760385,0.020724898,0.27998322,0.0011863649,0.124512404,0.003169093],"about_ca_topic_score_codex":0.0006198301,"about_ca_topic_score_gemma":0.00771426,"teacher_disagreement_score":0.27329856,"about_ca_system_score_codex":0.00037887963,"about_ca_system_score_gemma":0.000923939,"threshold_uncertainty_score":0.548821},"labels":[],"label_agreement":null},{"id":"W4400582528","doi":"10.1158/1078-0432.ccr-24-0103","title":"CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Deciphera Pharmaceuticals","keywords":"Tolerability; Medicine; Response Evaluation Criteria in Solid Tumors; Adverse effect; Pharmacodynamics; Internal medicine; Pharmacokinetics; Cancer; Oncology; Phases of clinical research; Gastroenterology; Clinical trial","score_opus":0.09549809635702675,"score_gpt":0.5008536952762315,"score_spread":0.4053555989192047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400582528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609286,0.00022862862,0.000003263399,0.00019220792,0.00019353363,0.00241152,0.000095336094,0.00003974282,0.00074291235],"genre_scores_gemma":[0.9985592,0.00008902062,0.00004995945,0.00006286828,0.00021764802,0.0003399373,0.000048949492,0.000047062887,0.00058536895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635583,0.00032464133,0.0009871706,0.0006339234,0.0011287394,0.0005697091],"domain_scores_gemma":[0.9984035,0.00044980893,0.00010374205,0.00037332688,0.0003723182,0.0002973438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010974021,0.00020756228,0.0006809972,0.0003013811,0.00007950103,0.000032631026,0.00010133767,0.00008329959,0.0006357052],"category_scores_gemma":[0.00025516364,0.00012747018,0.000122878,0.00095027423,0.00027171941,0.00014883984,0.0001393329,0.0008407952,0.000040433508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.082638,0.07217706,0.6510138,0.0034921844,0.0006197317,0.0058850204,0.0025404668,0.00005050105,0.0007711767,0.00007515459,0.0013700381,0.17936686],"study_design_scores_gemma":[0.11314444,0.14892644,0.72272646,0.0046447306,0.00029553162,0.000015325966,0.0032059576,0.00048130818,0.0031265689,0.00013056691,0.0026748795,0.0006277913],"about_ca_topic_score_codex":0.0012798441,"about_ca_topic_score_gemma":0.0006910631,"teacher_disagreement_score":0.17873907,"about_ca_system_score_codex":0.00025200908,"about_ca_system_score_gemma":0.0007387084,"threshold_uncertainty_score":0.6960526},"labels":[],"label_agreement":null},{"id":"W4400881768","doi":"10.1158/1078-0432.ccr-24-1165","title":"Update on Genetic Counselor Practice and Recommendations for Pediatric Cancer Predisposition Evaluation and Surveillance","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Genetic testing; Genetic predisposition; Medicine; Pediatric cancer; Genetic counseling; Cancer; Psychosocial; Referral; Li–Fraumeni syndrome; Germline mutation; Family medicine; Internal medicine; Genetics; Disease; Mutation; Psychiatry; Biology","score_opus":0.436359363290116,"score_gpt":0.649259299999234,"score_spread":0.21289993670911805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400881768","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000408879,0.96382785,0.000026263102,0.027016861,0.0014992321,0.0058031785,0.0012378339,0.000059484595,0.000120437806],"genre_scores_gemma":[0.00012417405,0.9872841,0.00046931545,0.001081843,0.0051501286,0.004896392,0.00050321623,0.00012613628,0.0003646826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921641,0.0027995063,0.0015627447,0.0014250976,0.001494241,0.00055433385],"domain_scores_gemma":[0.98829204,0.008665828,0.00047513674,0.0006229851,0.0015041681,0.00043986517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015107399,0.0004087417,0.0016344631,0.00043325408,0.0002731753,0.00018831404,0.00020351364,0.00052838156,0.00019372547],"category_scores_gemma":[0.005909219,0.0003371412,0.0003113975,0.00083886855,0.0002896821,0.00013244338,0.00016552428,0.0019664788,0.00005881704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004178932,0.00017961617,0.00022348498,0.02631647,0.0004092069,0.0000061686014,0.00011872237,6.4846915e-7,4.465188e-8,0.0000741778,0.08748447,0.8847691],"study_design_scores_gemma":[0.0014094647,0.00083656114,0.00088170386,0.009030687,0.0034142206,0.000025693249,0.000053029347,0.0001793639,1.11990644e-7,0.00029206692,0.9835571,0.00032001178],"about_ca_topic_score_codex":0.00039522062,"about_ca_topic_score_gemma":0.00052959716,"teacher_disagreement_score":0.8960726,"about_ca_system_score_codex":0.0006630352,"about_ca_system_score_gemma":0.0037295655,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W4401123275","doi":"10.1158/1078-0432.ccr-24-1317","title":"Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; Dalhousie University; Provincial Health Services Authority; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; eFFECTOR Therapeutics; Alex's Lemonade Stand Foundation for Childhood Cancer; Conquer Cancer Foundation","keywords":"Osteosarcoma; Metastasis; Medicine; Cancer research; Cancer; Internal medicine","score_opus":0.15312296505146408,"score_gpt":0.5063316279496912,"score_spread":0.35320866289822717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401123275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99098754,0.004905694,0.000140205,0.0019527053,0.0003072098,0.0005034118,0.00027503248,0.00001529131,0.0009128839],"genre_scores_gemma":[0.9953901,0.0021838816,0.00035713892,0.00021998287,0.0007357256,0.0003666742,0.00002681997,0.000026598023,0.000693045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975987,0.00047577856,0.0005190752,0.0006580246,0.00033915325,0.00040926688],"domain_scores_gemma":[0.9985548,0.0004909951,0.000052781314,0.00035852066,0.00030884365,0.00023403083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019543678,0.00014502923,0.0002905998,0.00011127695,0.0000665985,0.000034959747,0.00031647028,0.0001820404,0.00045399176],"category_scores_gemma":[0.0012035215,0.00012620712,0.00024080955,0.000295743,0.00033216347,0.000004506622,0.00042995453,0.00038451573,0.00004951111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036272893,0.0003026595,0.00077440107,0.00015488865,0.00022192523,0.00001182723,0.00004190299,0.00002311496,0.9225607,0.000041169857,0.032266542,0.043238137],"study_design_scores_gemma":[0.00017630399,0.00048184398,0.0006311042,0.00013741844,0.000047829377,0.0000014770637,0.000053937205,0.000023479031,0.94654536,0.00029532838,0.05146425,0.00014165905],"about_ca_topic_score_codex":0.000080767626,"about_ca_topic_score_gemma":0.00005876841,"teacher_disagreement_score":0.04309648,"about_ca_system_score_codex":0.00005463545,"about_ca_system_score_gemma":0.00029428245,"threshold_uncertainty_score":0.5146577},"labels":[],"label_agreement":null},{"id":"W4401384858","doi":"10.1158/1078-0432.ccr-24-0154","title":"Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cytotoxicity; Genotype; Radiation therapy; Medicine; Cancer research; Biology; Pharmacology; Genetics; Internal medicine; Gene; In vitro","score_opus":0.0734370622179909,"score_gpt":0.44233275585148085,"score_spread":0.36889569363348995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401384858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931474,0.004406434,0.0009219205,0.00039032428,0.00016097244,0.00032540364,0.000030150983,0.000052838823,0.0005645594],"genre_scores_gemma":[0.9953483,0.0018515456,0.00094448816,0.00007325325,0.00043050628,0.00008342283,0.000018163171,0.00003918594,0.0012111715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982208,0.00036382308,0.0002877273,0.00048087453,0.00036766936,0.00027913117],"domain_scores_gemma":[0.9990528,0.00017558262,0.00003431728,0.00039059581,0.0002381906,0.00010848561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015197775,0.00009915776,0.00018336666,0.00007228129,0.000047780573,0.000026611478,0.00015961239,0.00019253866,0.00021969393],"category_scores_gemma":[0.00025865808,0.00007706848,0.00011084468,0.00030160698,0.00035257323,0.000003636444,0.00008445471,0.00033673164,0.000017256136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076160894,0.00011645629,0.0008536805,0.000120968136,0.00014531244,0.00002338457,0.000031700638,0.000020776759,0.9809102,0.00022950975,0.003851002,0.012935411],"study_design_scores_gemma":[0.0006348673,0.0019388228,0.0013839948,0.00022125701,0.000018557632,0.000011188969,0.000021727004,0.0007035528,0.9710612,0.0003037629,0.02353454,0.00016647916],"about_ca_topic_score_codex":0.000088673856,"about_ca_topic_score_gemma":0.00011351278,"teacher_disagreement_score":0.019683538,"about_ca_system_score_codex":0.000047681326,"about_ca_system_score_gemma":0.00042315174,"threshold_uncertainty_score":0.31427613},"labels":[],"label_agreement":null},{"id":"W4401626626","doi":"10.1158/1078-0432.ccr-24-1170","title":"Oxygen-Enhanced MRI Detects Incidence, Onset, and Heterogeneity of Radiation-Induced Hypoxia Modification in HPV-Associated Oropharyngeal Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; Manchester Biomedical Research Centre; Cancer Research UK Manchester Centre; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Royal Marsden NHS Foundation Trust","keywords":"Hypoxia (environmental); Incidence (geometry); Radiation tolerance; Radiation therapy; Medicine; Oxygen; Cancer; Pathology; Internal medicine; Chemistry; Physics","score_opus":0.10142531751398728,"score_gpt":0.4581648820716775,"score_spread":0.3567395645576902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401626626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96482253,0.032924805,0.00006959267,0.0003594855,0.001106529,0.00048622786,0.000095946445,0.000015626423,0.00011924567],"genre_scores_gemma":[0.95424247,0.043949857,0.000029903702,0.000110262954,0.0010139064,0.00032315147,0.00003794784,0.00003311968,0.00025935817],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971241,0.0005375271,0.00064425525,0.000773635,0.00044574245,0.00047476948],"domain_scores_gemma":[0.9987305,0.00024640025,0.00011212176,0.00039140822,0.00031676455,0.0002028273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020572057,0.00017365898,0.00039539,0.00018877687,0.0000802178,0.00004998588,0.00028288213,0.00036701385,0.00005395401],"category_scores_gemma":[0.0007948701,0.00016845432,0.00013122184,0.00062698836,0.0002793237,0.000018754843,0.00018032252,0.00055469124,0.0000059247955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060898555,0.00017837744,0.014903951,0.00016594709,0.00016588587,0.0000043084615,0.00020929515,0.000094198695,0.7829852,0.00002782356,0.0027355282,0.19792052],"study_design_scores_gemma":[0.0017182835,0.00044593276,0.52706647,0.00017141327,0.00004340883,0.0000021827093,0.000061578685,0.0009603016,0.45936897,0.00019390683,0.009657938,0.00030958423],"about_ca_topic_score_codex":0.0022321262,"about_ca_topic_score_gemma":0.0062672747,"teacher_disagreement_score":0.51216257,"about_ca_system_score_codex":0.00013403723,"about_ca_system_score_gemma":0.0011122418,"threshold_uncertainty_score":0.6869368},"labels":[],"label_agreement":null},{"id":"W4401715124","doi":"10.1158/1078-0432.ccr-24-1023","title":"Novel <i>ERBB2</i> Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody–Based Therapy in <i>ERBB2</i> -Amplified Metastatic Colorectal Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; National Cancer Center Japan; Institute of Genetics; Daiichi Sankyo Company; Japan Agency for Medical Research and Development; Clinical Trial Center, China Medical University Hospital","keywords":"Medicine; Colorectal cancer; Targeted therapy; Monoclonal antibody; Oncology; Internal medicine; Trastuzumab; Monoclonal; Cancer; Acquired resistance; Antibody; Immunology; Breast cancer","score_opus":0.15744454983030268,"score_gpt":0.4806459276473874,"score_spread":0.3232013778170847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611158,0.021381978,0.00021802052,0.009680292,0.0008163818,0.0022638885,0.0007652858,0.00019651449,0.0035618483],"genre_scores_gemma":[0.9819486,0.01205964,0.00054378115,0.0014178319,0.00043282437,0.0011977922,0.00018970827,0.00012986461,0.0020799567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993937,0.0005628741,0.001098136,0.0014195588,0.0017099509,0.0012724444],"domain_scores_gemma":[0.9959898,0.0021161053,0.00016136777,0.00046262343,0.00085657137,0.0004135216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030107142,0.0005053235,0.0013348067,0.00040152564,0.00033530215,0.00020909293,0.00035812252,0.0002448092,0.00033279974],"category_scores_gemma":[0.0005697992,0.00035706905,0.0003706064,0.002354818,0.00091059756,0.00017165621,0.0001397039,0.0017445139,0.00002315543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08333128,0.01846711,0.5046867,0.0023442423,0.016482959,0.019112732,0.002808512,0.0018094659,0.087116726,0.0011261769,0.038478617,0.22423546],"study_design_scores_gemma":[0.03930279,0.008295572,0.8437107,0.009229969,0.0008517551,0.00003194119,0.00050904223,0.0055254893,0.0038222028,0.00034725232,0.08663313,0.0017401068],"about_ca_topic_score_codex":0.0025288602,"about_ca_topic_score_gemma":0.014056283,"teacher_disagreement_score":0.33902404,"about_ca_system_score_codex":0.0011370677,"about_ca_system_score_gemma":0.004138069,"threshold_uncertainty_score":0.9998881},"labels":[],"label_agreement":null},{"id":"W4401910107","doi":"10.1158/1078-0432.ccr-24-0953","title":"Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Cancer; Medicine; Genetic predisposition; Childhood cancer; Oncology; Internal medicine; Disease","score_opus":0.1835065454047581,"score_gpt":0.48948358941619763,"score_spread":0.30597704401143955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401910107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88635856,0.08679944,0.00028877633,0.020203141,0.0028145923,0.0016365414,0.0014986065,0.00029986247,0.000100502795],"genre_scores_gemma":[0.9262722,0.04697046,0.000737016,0.0022539373,0.021382535,0.0018036908,0.00024256988,0.0002104668,0.00012710276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98903036,0.002539613,0.0019126638,0.0021525498,0.0026226756,0.0017421109],"domain_scores_gemma":[0.99267197,0.0044049635,0.0003358405,0.0012193613,0.00044284304,0.0009249963],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007955024,0.0006120992,0.0011626481,0.00047122914,0.00057528494,0.00036975887,0.0010831503,0.0003788739,0.0028001969],"category_scores_gemma":[0.0012617098,0.0004806739,0.00048565495,0.0026349775,0.00069383456,0.0005802288,0.00055231084,0.006299029,0.00007413348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013093872,0.00056681834,0.89755386,0.0003515564,0.00041857635,0.0004886566,0.0017353717,0.00050006463,0.000031236537,0.000045383436,0.015777923,0.08122116],"study_design_scores_gemma":[0.0028991145,0.00070353405,0.9749164,0.009610055,0.00055144296,0.000054898268,0.0010374597,0.0035050213,0.000020040174,0.0006464064,0.0055030123,0.0005526392],"about_ca_topic_score_codex":0.1704684,"about_ca_topic_score_gemma":0.10947483,"teacher_disagreement_score":0.080668524,"about_ca_system_score_codex":0.0010330457,"about_ca_system_score_gemma":0.0030796982,"threshold_uncertainty_score":0.9997645},"labels":[],"label_agreement":null},{"id":"W4401978856","doi":"10.1158/1078-0432.ccr-24-1611","title":"Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Manchester Biomedical Research Centre; National Institute for Health and Care Research; American Lebanese Syrian Associated Charities; National Cancer Institute; National Institutes of Health; Alexion Pharmaceuticals","keywords":"Costello syndrome; Noonan syndrome; Medicine; Neurofibromatosis; Genetic counseling; Cancer; Pediatrics; Population; Internal medicine; Pathology; Genetics; Colorectal cancer","score_opus":0.10647572175923184,"score_gpt":0.4623505615400932,"score_spread":0.3558748397808613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401978856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013996233,0.97571814,0.0000019445915,0.00043018087,0.0012700623,0.0033092732,0.0051857764,0.000051596697,0.000036795613],"genre_scores_gemma":[0.008646379,0.9841668,0.000106202024,0.00009008989,0.00019681944,0.0021894127,0.003381106,0.0002472019,0.0009759772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944717,0.00092868845,0.0013093209,0.0018081896,0.0006166001,0.0008654888],"domain_scores_gemma":[0.9966046,0.00089651736,0.00045154497,0.0010312407,0.0006346259,0.000381433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016636734,0.00066880113,0.0016221763,0.0003697595,0.00030825895,0.00017274173,0.000743977,0.0007475804,0.00010873363],"category_scores_gemma":[0.0011792204,0.00051143393,0.0003709356,0.0013758016,0.0004426734,0.000018076777,0.00069848023,0.0013458119,0.00012172704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002168917,0.0016245608,0.027832609,0.06475295,0.004005583,0.00074230426,0.000018986719,0.000010291876,0.0000028950756,0.0005818603,0.30538818,0.59287083],"study_design_scores_gemma":[0.0013027791,0.005162142,0.0028683483,0.0068457723,0.0008248746,0.00018659957,0.0000031064826,0.0000026307289,0.000010967677,0.00010397048,0.98176354,0.0009252492],"about_ca_topic_score_codex":0.000085305575,"about_ca_topic_score_gemma":0.000058315418,"teacher_disagreement_score":0.6763754,"about_ca_system_score_codex":0.00015714209,"about_ca_system_score_gemma":0.0013190394,"threshold_uncertainty_score":0.99973375},"labels":[],"label_agreement":null},{"id":"W4402484216","doi":"10.1158/1078-0432.ccr-24-1098","title":"Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; National Cancer Institute; Bundesministerium für Bildung und Forschung; St. Baldrick's Foundation","keywords":"Bloom syndrome; Xeroderma pigmentosum; Genome instability; Nijmegen breakage syndrome; Cancer; Ataxia-telangiectasia; Chromosome instability; Medicine; Fanconi anemia; Genetics; Oncology; DNA repair; Internal medicine; Biology; DNA damage; Chromosome","score_opus":0.1827902056911555,"score_gpt":0.5230871474230745,"score_spread":0.340296941731919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402484216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010756673,0.98496175,0.000056413977,0.00082772906,0.0001877195,0.0022001045,0.00094844366,0.000015053589,0.00004609262],"genre_scores_gemma":[0.0017972627,0.99448794,0.00035761314,0.00008072455,0.00038182412,0.002063779,0.00051213265,0.0000874,0.00023132465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690866,0.00064982096,0.0005965699,0.0011694293,0.00020592524,0.00046959965],"domain_scores_gemma":[0.99881554,0.0002747586,0.00011759504,0.00055749255,0.00009547414,0.00013912868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028062793,0.00027737403,0.00075361924,0.00014247598,0.00009991415,0.0000618706,0.00039394433,0.00038487357,0.000031979],"category_scores_gemma":[0.00031606527,0.00020963808,0.0002301415,0.0003118264,0.00027003026,0.00000383922,0.00038539828,0.00094186876,0.000006999242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014254509,0.00006372644,0.0043558115,0.0012490121,0.0002859479,4.627177e-7,0.0000044817743,0.0000039074876,0.000003376371,0.00004597318,0.0019807138,0.991864],"study_design_scores_gemma":[0.0005285204,0.000474108,0.0010918963,0.0017084571,0.00007075737,0.0000016543673,0.000007321485,0.000015725547,0.000007148586,0.00012211864,0.99568915,0.00028311252],"about_ca_topic_score_codex":0.00033396127,"about_ca_topic_score_gemma":0.0059362124,"teacher_disagreement_score":0.9937085,"about_ca_system_score_codex":0.0001222261,"about_ca_system_score_gemma":0.0008523423,"threshold_uncertainty_score":0.85487926},"labels":[],"label_agreement":null},{"id":"W4402510201","doi":"10.1158/1078-0432.ccr-24-1883","title":"Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society; Canada's Michael Smith Genome Sciences Centre; Ottawa Hospital; Queen's University; University of British Columbia","funders":"","keywords":"Response Evaluation Criteria in Solid Tumors; Medicine; Biomarker; Oncology; Internal medicine; Cancer; Chemotherapy; Progressive disease; Biology","score_opus":0.4827449657168289,"score_gpt":0.6010260226461113,"score_spread":0.11828105692928237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402510201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043771775,0.99074525,0.0000032087792,0.0005176787,0.0009758934,0.0023151748,0.0003680355,0.000007864034,0.0006897243],"genre_scores_gemma":[0.0020267118,0.9897957,0.000025545938,0.00011255947,0.0006244056,0.0040097293,0.00048617038,0.00010514933,0.0028140235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923389,0.0038284385,0.0011629107,0.0012457551,0.00074968266,0.0006743134],"domain_scores_gemma":[0.99561906,0.0027645428,0.00022529528,0.000992066,0.00019336591,0.00020564483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011135089,0.00043263126,0.0010087653,0.0002202048,0.00015665614,0.0001991542,0.0006718555,0.00045553624,0.00014049286],"category_scores_gemma":[0.002924319,0.00027989532,0.00061505556,0.00081674114,0.0005452945,0.000003309366,0.00041897528,0.0009194682,0.00012773692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010295655,0.0001182803,0.000011509942,0.0005052564,0.00048031288,0.000032223692,0.000035796413,0.0000060950583,0.000035181205,0.000014407554,0.04342608,0.9543053],"study_design_scores_gemma":[0.00092142366,0.0008540374,0.000012318295,0.0029442206,0.0007176103,0.000012702225,0.000063692656,0.00012214277,0.000015809557,0.00013824913,0.9939018,0.00029602472],"about_ca_topic_score_codex":0.0023215588,"about_ca_topic_score_gemma":0.005717618,"teacher_disagreement_score":0.9540093,"about_ca_system_score_codex":0.0019983072,"about_ca_system_score_gemma":0.006312517,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W4402558603","doi":"10.1158/1078-0432.ccr-24-1374","title":"Update on Whole-Body MRI Surveillance for Pediatric Cancer Predisposition Syndromes","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cancer; Multidisciplinary approach; Childhood cancer; Genetic predisposition; Pathology; Internal medicine; Disease","score_opus":0.38083414348320976,"score_gpt":0.6134111564983921,"score_spread":0.2325770130151823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402558603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024445215,0.9718512,0.000026857579,0.011737919,0.00476242,0.0061829197,0.004538936,0.00026162283,0.00039366298],"genre_scores_gemma":[0.00016509945,0.9677827,0.000073915064,0.00082956516,0.01817464,0.006044543,0.0010318359,0.00038047772,0.005517265],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98830193,0.0020675554,0.0029558481,0.0025671658,0.0025583724,0.0015491316],"domain_scores_gemma":[0.98993826,0.005799674,0.00060558564,0.0017435224,0.00097631686,0.00093663187],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010415913,0.00091650645,0.0046957484,0.0009501573,0.00030213135,0.00022614442,0.0010069011,0.0012872356,0.0005571036],"category_scores_gemma":[0.0021988691,0.00070994324,0.0022516851,0.0021275815,0.0005228875,0.00011603258,0.00048100157,0.0050187088,0.0013945977],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008033597,0.0005679161,0.0007851647,0.12990062,0.0012706768,0.00012494877,0.000060430513,0.0000019716,1.4581349e-7,0.00023420442,0.4600988,0.40615174],"study_design_scores_gemma":[0.0014143969,0.0014077742,0.0005837699,0.03150473,0.0022443975,0.00002704765,0.0000148069585,0.000026148371,6.9714645e-7,0.00023667046,0.9618824,0.0006571381],"about_ca_topic_score_codex":0.00057631504,"about_ca_topic_score_gemma":0.00049814396,"teacher_disagreement_score":0.5017836,"about_ca_system_score_codex":0.0015057317,"about_ca_system_score_gemma":0.0067655668,"threshold_uncertainty_score":0.99953514},"labels":[],"label_agreement":null},{"id":"W4402840630","doi":"10.1158/1078-0432.ccr-24-2100","title":"Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith–Wiedemann Syndrome and Other Predisposition Syndromes","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Deutsche Kinderkrebsstiftung; Hospital Research Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Foundation; Rally Foundation; Damon Runyon Cancer Research Foundation","keywords":"Hepatoblastoma; Medicine; Wilms' tumor; Context (archaeology); Beckwith–Wiedemann syndrome; Genetic predisposition; Cancer; Pediatrics; Intensive care medicine; Pathology; Internal medicine; Disease; Genetics; Biology","score_opus":0.15836542130704495,"score_gpt":0.5139456760334001,"score_spread":0.3555802547263552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402840630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030852843,0.96686727,0.000002487241,0.00020237014,0.0003303119,0.0011930118,0.0004281589,0.000012215749,0.00011130507],"genre_scores_gemma":[0.008724359,0.9889431,0.000015900636,0.00013709605,0.00034139413,0.0008077896,0.00010127959,0.0000849436,0.0008441469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971094,0.00043561152,0.0006549626,0.0010562254,0.00026468982,0.00047910903],"domain_scores_gemma":[0.9990258,0.00025154755,0.000120715675,0.00033278318,0.00007687378,0.00019226123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017115409,0.00032146779,0.0009824182,0.00018722545,0.00008430414,0.000074195734,0.00024201052,0.00058427005,0.000011661149],"category_scores_gemma":[0.00017072893,0.0002239766,0.0002652448,0.00027791387,0.00044535744,0.0000042317506,0.00022948139,0.0009002084,0.000021088264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015111114,0.00028844798,0.0021045634,0.048421435,0.001709436,0.00044513986,0.000036140565,0.000010727673,0.000044388362,0.00033699657,0.024987143,0.92010444],"study_design_scores_gemma":[0.00056978443,0.0014562437,0.00019894046,0.010891958,0.0001253404,0.00019344954,0.000008284385,0.000031317104,0.000010704669,0.00016356581,0.98600465,0.00034573444],"about_ca_topic_score_codex":0.000077513854,"about_ca_topic_score_gemma":0.0002093967,"teacher_disagreement_score":0.96101755,"about_ca_system_score_codex":0.00007707763,"about_ca_system_score_gemma":0.00041608303,"threshold_uncertainty_score":0.91335005},"labels":[],"label_agreement":null},{"id":"W4402859830","doi":"10.1158/1078-0432.ccr-23-3523","title":"The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric Adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research; Edmonton Civic Employees Charitable Assistance Fund","keywords":"Immunotherapy; Oncology; Internal medicine; Tumor microenvironment; Medicine; Microsatellite instability; Adjuvant; Chemotherapy; Subgroup analysis; Cancer; Survival analysis; Immune system; Immunology; Biology; Meta-analysis; Allele; Gene","score_opus":0.1226612006777825,"score_gpt":0.47501022213912314,"score_spread":0.3523490214613406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402859830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95607555,0.038425352,0.000025755502,0.0049209865,0.000101137404,0.0003962015,0.000022875705,0.000014479296,0.00001764412],"genre_scores_gemma":[0.99503696,0.0043904507,0.00004889447,0.00013401822,0.000029467325,0.00015535891,0.000007286372,0.00002514525,0.00017244737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961284,0.001626862,0.0007169786,0.00050223724,0.00062584144,0.00039969516],"domain_scores_gemma":[0.9971019,0.0020233542,0.00005483831,0.00052615895,0.0001232215,0.00017050152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054364633,0.00014388698,0.000632434,0.00049152545,0.00008132447,0.00007185103,0.00024464983,0.000082269165,0.00015950228],"category_scores_gemma":[0.00037865722,0.00008582429,0.0002700013,0.0018294258,0.0007918131,0.00003659455,0.00013927794,0.00080264185,0.000004522293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004691869,0.00027373814,0.9408998,0.000060944985,0.0012177577,0.00008302256,0.00025722102,0.000027285845,0.014166594,0.000082843224,0.000023854152,0.038215086],"study_design_scores_gemma":[0.0007292952,0.0013241936,0.99212533,0.00012351152,0.00047388425,0.0000016816002,0.0008039959,0.0018874522,0.0012285009,0.000032683038,0.0011886088,0.00008088118],"about_ca_topic_score_codex":0.000520539,"about_ca_topic_score_gemma":0.00027188,"teacher_disagreement_score":0.051225528,"about_ca_system_score_codex":0.00019269751,"about_ca_system_score_gemma":0.00038639238,"threshold_uncertainty_score":0.34998134},"labels":[],"label_agreement":null},{"id":"W4403486661","doi":"10.1158/1078-0432.ccr-24-2105","title":"Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"KRAS; PTEN; Medicine; Oncology; Internal medicine; Mutation; Cancer; ARID1A; Endometrial cancer; Cohort; Germline mutation; Retrospective cohort study; Cancer research; Gene; Colorectal cancer; Genetics; Biology","score_opus":0.10559196244007478,"score_gpt":0.5011542992905622,"score_spread":0.3955623368504874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403486661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97435504,0.022380495,0.0000068438717,0.0007378186,0.00075807,0.0003169628,0.00019532631,0.0000071223544,0.0012423383],"genre_scores_gemma":[0.92865485,0.069111444,0.000084004394,0.000088664594,0.00068826927,0.00013902885,0.000019280058,0.000028824761,0.0011856057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821335,0.00014322167,0.0005190076,0.00053488347,0.00022941886,0.0003600928],"domain_scores_gemma":[0.9985592,0.00082505157,0.000049755035,0.00030826536,0.000119624296,0.00013812883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013465628,0.00012412314,0.0003502676,0.00027287344,0.000037486712,0.00004228894,0.00022195686,0.00014030159,0.00012862668],"category_scores_gemma":[0.0006941044,0.000109061395,0.00011818773,0.00045539785,0.0002553565,0.0000045195957,0.00030407717,0.00036048325,0.0000055957503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009416572,0.00011359495,0.8815955,0.00014915154,0.0001382895,0.00001897838,0.000051425046,0.0001235163,0.04066578,0.00052531733,0.004876618,0.0708002],"study_design_scores_gemma":[0.0050626886,0.0011330934,0.77487147,0.00027586348,0.000049428934,0.0000016470163,0.00010783359,0.00033608382,0.017150132,0.0009274186,0.1996348,0.0004495318],"about_ca_topic_score_codex":0.0025198655,"about_ca_topic_score_gemma":0.011265698,"teacher_disagreement_score":0.19475819,"about_ca_system_score_codex":0.00006839039,"about_ca_system_score_gemma":0.0006637157,"threshold_uncertainty_score":0.6286524},"labels":[],"label_agreement":null},{"id":"W4403539151","doi":"10.1158/1078-0432.ccr-24-1562","title":"Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Foundation Medicine; European Society for Medical Oncology; PharmaMar; Les Laboratories Pierre Fabre; AstraZeneca; Amgen; Pfizer; Astellas Pharma; F. Hoffmann-La Roche","keywords":"Cetuximab; Medicine; Pharmacodynamics; Internal medicine; Head and neck squamous-cell carcinoma; Tolerability; Oncology; Pharmacokinetics; Phases of clinical research; Adverse effect; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Head and neck cancer; Clinical trial; Colorectal cancer; Cancer","score_opus":0.08702096082543363,"score_gpt":0.454809325563476,"score_spread":0.36778836473804233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403539151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972202,0.00034787206,0.0000016418435,0.001042689,0.000022755392,0.001019513,0.000021156675,0.000010692054,0.00031344],"genre_scores_gemma":[0.99941164,0.000024257275,0.0000077182785,0.00009370124,0.000036359175,0.00008650633,0.000018955756,0.000020851456,0.0002999997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757487,0.0003805146,0.0005334054,0.00041183265,0.0008196041,0.0002797812],"domain_scores_gemma":[0.99877274,0.00039882082,0.00006188936,0.00035774507,0.0002988149,0.00011001135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011578236,0.000120843,0.00039995776,0.0003289069,0.000058948677,0.000031567863,0.00011969566,0.00007534041,0.000094635005],"category_scores_gemma":[0.00016910827,0.000070352675,0.000053483058,0.001403726,0.00029502547,0.000078758254,0.000102688704,0.0009458335,0.000003965512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041338825,0.012113242,0.97693837,0.00022751118,0.00003084661,0.000102666636,0.0007076141,0.0000134364855,0.00012825377,0.000010376401,0.00019540651,0.0053984025],"study_design_scores_gemma":[0.049698338,0.012854064,0.934142,0.0007913374,0.00005440847,0.0000012027571,0.0007464171,0.0010050297,0.00045190105,0.000022759845,0.00013427669,0.000098267585],"about_ca_topic_score_codex":0.0020874059,"about_ca_topic_score_gemma":0.0034212563,"teacher_disagreement_score":0.045564454,"about_ca_system_score_codex":0.00017529605,"about_ca_system_score_gemma":0.000343427,"threshold_uncertainty_score":0.41092286},"labels":[],"label_agreement":null},{"id":"W4403831332","doi":"10.1158/1078-0432.ccr-24-2488","title":"Update on Surveillance Guidelines in Emerging Wilms Tumor Predisposition Syndromes","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Servier; Alexion Pharmaceuticals","keywords":"Wilms' tumor; Medicine; Wilms tumour; Genetic predisposition; Cancer; Pathology; Internal medicine; Disease","score_opus":0.1281392065172287,"score_gpt":0.5224941601153741,"score_spread":0.3943549535981454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403831332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745528,0.016706327,0.000037210593,0.006064792,0.0009887163,0.00022076246,0.000038847,0.00002588199,0.0013646559],"genre_scores_gemma":[0.9789737,0.017459251,0.00004148986,0.00048585885,0.00096792873,0.000093224975,0.000047352158,0.000027187561,0.0019040353],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798894,0.0002749514,0.00045178502,0.0005679259,0.0003383224,0.0003780943],"domain_scores_gemma":[0.9993231,0.000101061596,0.000028650193,0.0002622764,0.00017438811,0.00011050817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018948092,0.000114706025,0.00017348478,0.00011397408,0.000065011176,0.000052496292,0.00023026223,0.00016183923,0.000079574595],"category_scores_gemma":[0.00034205505,0.00008799085,0.00011765898,0.0003901539,0.0001843779,0.0000054399006,0.0001121162,0.0005978043,0.00008146271],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003576891,0.00037866947,0.07223449,0.0008206586,0.000633415,0.0010070774,0.0000988194,0.009493664,0.09180471,0.0010555105,0.48696664,0.33192945],"study_design_scores_gemma":[0.0017536947,0.0018944035,0.026450632,0.0020351992,0.000019084064,0.00005196318,0.000096794756,0.005643948,0.026997786,0.0010203356,0.93334174,0.00069442595],"about_ca_topic_score_codex":0.00019931555,"about_ca_topic_score_gemma":0.00020996942,"teacher_disagreement_score":0.4463751,"about_ca_system_score_codex":0.000060337155,"about_ca_system_score_gemma":0.00030203088,"threshold_uncertainty_score":0.35881627},"labels":[],"label_agreement":null},{"id":"W4403890847","doi":"10.1158/1078-0432.ccr-23-3518","title":"Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Chemotherapy; Proportional hazards model; Progression-free survival; Cancer; Immunotherapy","score_opus":0.08274151803402123,"score_gpt":0.46282926744188796,"score_spread":0.3800877494078667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403890847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864055,0.001076122,0.000012649532,0.008278505,0.000097052565,0.0011991729,0.000043874825,0.00001924267,0.00063282234],"genre_scores_gemma":[0.99675363,0.0006008706,0.00018912842,0.00017029734,0.00044633582,0.00019355741,0.0000072382472,0.000049850965,0.0015890637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976721,0.0002110033,0.00042024543,0.0004245556,0.0009465653,0.00032555743],"domain_scores_gemma":[0.99739176,0.0017462166,0.000118062315,0.00026695593,0.0003654484,0.00011154763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009792036,0.00016536858,0.00051387306,0.00013731235,0.00005481454,0.000025087389,0.00014061882,0.00009570697,0.00031190764],"category_scores_gemma":[0.00019284655,0.00008724743,0.000078076264,0.000619809,0.0004611459,0.000073482806,0.000026300371,0.00056027225,0.0000034245832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3668826,0.0007444616,0.5246577,0.0007684314,0.0015802166,0.00015711153,0.0038941693,0.000072786745,0.0017304863,0.00012677704,0.0011705533,0.098214716],"study_design_scores_gemma":[0.090421595,0.014128581,0.877113,0.0010901927,0.0002857869,0.000031383992,0.0009263069,0.000833358,0.0060976404,0.00007867747,0.008732642,0.00026084823],"about_ca_topic_score_codex":0.00080876134,"about_ca_topic_score_gemma":0.0006152942,"teacher_disagreement_score":0.3524553,"about_ca_system_score_codex":0.00029571864,"about_ca_system_score_gemma":0.001748455,"threshold_uncertainty_score":0.35578468},"labels":[],"label_agreement":null},{"id":"W4404165259","doi":"10.1158/1078-0432.ccr-24-1240","title":"Genomic, Epigenomic, and Transcriptomic Inter- and Intratumor Heterogeneity in Desmoid Tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; University of Toronto; Princess Margaret Cancer Centre; Artificial Intelligence in Medicine (Canada); McGill University; McGill University Health Centre","funders":"National Cancer Institute; Desmoid Tumor Research Foundation","keywords":"Epigenomics; Transcriptome; Biology; Cancer research; Computational biology; Genetics; Medicine; DNA methylation; Gene; Gene expression","score_opus":0.22377268011993665,"score_gpt":0.5242642067212291,"score_spread":0.3004915266012924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404165259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9437103,0.051406436,0.000010290375,0.003595459,0.00031470263,0.000642331,0.000025885685,0.00006390166,0.00023064944],"genre_scores_gemma":[0.99149394,0.007112161,0.00009448802,0.00024787823,0.00046723627,0.00014452157,0.0000036683855,0.000048572376,0.00038754742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974166,0.00032146196,0.0006393725,0.0007753483,0.00027458736,0.0005726033],"domain_scores_gemma":[0.9982994,0.0009571007,0.000023530549,0.0002820239,0.000090102934,0.00034781126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027270925,0.00018727622,0.0006010071,0.00030320245,0.00009649498,0.000079840516,0.0001202839,0.000112668844,0.00013283649],"category_scores_gemma":[0.00049714814,0.00016010429,0.00009682032,0.00032975108,0.0010695278,0.00007407182,0.00022708985,0.001359215,0.000057367986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026164402,0.00030385432,0.8123426,0.0016750272,0.0004090547,0.0036291287,0.0030092644,0.0000019062272,0.017430643,0.00033328304,0.0047433125,0.15350552],"study_design_scores_gemma":[0.003115337,0.0012474089,0.9747582,0.0012790681,0.00010177719,0.0004026653,0.0008583964,0.0007132364,0.0022575997,0.0010076459,0.013892722,0.00036591265],"about_ca_topic_score_codex":0.0005349823,"about_ca_topic_score_gemma":0.0017387636,"teacher_disagreement_score":0.16241567,"about_ca_system_score_codex":0.00026960296,"about_ca_system_score_gemma":0.00038960364,"threshold_uncertainty_score":0.65288633},"labels":[],"label_agreement":null},{"id":"W4404165262","doi":"10.1158/1078-0432.ccr-24-1612","title":"Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; University of Toronto; Sunnybrook Hospital; Kingston Health Sciences Centre; Canadian Cancer Society; CancerCare Manitoba; University of Manitoba; Juravinski Cancer Centre; Hamilton Health Sciences; Baker Hughes (Canada); Canadian Centre for Applied Research in Cancer Control; University Health Network; Saskatchewan Cancer Agency; Occupational Cancer Research Centre; Ottawa Hospital; Sunnybrook Health Science Centre; Kelowna General Hospital; London Health Sciences Centre; Interior Health; Princess Margaret Cancer Centre; BC Cancer Agency; Queen's University; Spinal Cord Injury BC","funders":"Canadian Cancer Society","keywords":"Durvalumab; Tremelimumab; Prostate cancer; Medicine; Oncology; Castration; Internal medicine; Prostate; Flutamide; Cancer; Randomized controlled trial; Immunotherapy; Hormone; Androgen receptor; Nivolumab","score_opus":0.2214674561537067,"score_gpt":0.5506320744122234,"score_spread":0.32916461825851673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404165262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864623,0.0027332457,0.000003827657,0.0011098227,0.00012056543,0.009172242,0.00014158507,0.000045893634,0.00021052158],"genre_scores_gemma":[0.9905972,0.0013842378,0.00010728153,0.00003025028,0.000107708,0.0033708038,0.000053176253,0.00007957639,0.0042697503],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935813,0.0012561544,0.0012131138,0.0009134299,0.002259022,0.0007769963],"domain_scores_gemma":[0.99642175,0.0013209772,0.00014775996,0.0005462261,0.0011985061,0.0003648054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040916246,0.00031740355,0.0015692608,0.00057806243,0.000189935,0.00008495752,0.0002154784,0.00008353249,0.00067533035],"category_scores_gemma":[0.00041774777,0.00015617037,0.00013509476,0.0018475666,0.0010504908,0.00020852497,0.00011647788,0.0011518489,0.000008306093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8489047,0.009737201,0.11299577,0.00083928695,0.0017004709,0.00056981196,0.0032955557,0.00003585391,0.00006899284,0.000014041915,0.00031943255,0.021518877],"study_design_scores_gemma":[0.90168506,0.0610268,0.029090557,0.0028330737,0.000856546,0.0000035406752,0.002273198,0.0010919143,0.0002973759,0.00004068545,0.00048921426,0.00031203026],"about_ca_topic_score_codex":0.0043088463,"about_ca_topic_score_gemma":0.0090253325,"teacher_disagreement_score":0.08390521,"about_ca_system_score_codex":0.00052704866,"about_ca_system_score_gemma":0.004297327,"threshold_uncertainty_score":0.7623273},"labels":[],"label_agreement":null},{"id":"W4404305717","doi":"10.1158/1557-3265.liqbiop24-pr004","title":"Abstract PR004: Biological insights into tissue-agnostic plasma cfDNA methylation signature for surveillance of head and neck tumor recurrence","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Head and neck cancer; Medicine; Methylation; DNA methylation; Pathology; Oncology; Cancer; Internal medicine; Biology; Surgery; DNA; Genetics; Gene","score_opus":0.10978618114041143,"score_gpt":0.4808599707084507,"score_spread":0.37107378956803927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94945735,0.04508786,0.0025244707,0.00084238563,0.0005385103,0.0011945331,0.00012686475,0.000025321748,0.00020268442],"genre_scores_gemma":[0.9893782,0.008758721,0.00055948854,0.000055380955,0.0005279765,0.00030082898,0.00015679367,0.000040165152,0.00022244887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699175,0.00042453085,0.0005809087,0.0009913262,0.00050703593,0.00050442055],"domain_scores_gemma":[0.9974189,0.0012387391,0.00008156389,0.00042098082,0.000599543,0.00024029893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022823485,0.00019915114,0.00035657114,0.000158256,0.0001331091,0.00007155505,0.00035823302,0.0004995213,0.00009035957],"category_scores_gemma":[0.003720901,0.00016567361,0.00014467577,0.00046768627,0.0005927691,0.000011381908,0.00031561058,0.00093095854,0.000013923903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013610993,0.0001465368,0.00045319437,0.0006299681,0.00014526956,0.000031781394,0.000069211615,0.00013635222,0.86729425,0.00044181218,0.0052394797,0.12405103],"study_design_scores_gemma":[0.001891621,0.0047777984,0.009352419,0.0006691826,0.000021581838,0.000009938568,0.000050504703,0.001933264,0.7721919,0.0044883867,0.20410694,0.0005064547],"about_ca_topic_score_codex":0.00017184776,"about_ca_topic_score_gemma":0.00053198094,"teacher_disagreement_score":0.19886746,"about_ca_system_score_codex":0.00007022826,"about_ca_system_score_gemma":0.0007094453,"threshold_uncertainty_score":0.67559737},"labels":[],"label_agreement":null},{"id":"W4404305723","doi":"10.1158/1557-3265.liqbiop24-pr003","title":"Abstract PR003: ctDNA release kinetics and fragmentation to monitor treatment response and resistance in esophageal adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre","funders":"","keywords":"Esophageal adenocarcinoma; Kinetics; Fragmentation (computing); Adenocarcinoma; Cancer research; Medicine; Esophageal cancer; Oncology; Chemistry; Internal medicine; Biology; Cancer","score_opus":0.0753115833577441,"score_gpt":0.45641381450280005,"score_spread":0.3811022311450559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96392107,0.032768525,0.000013965576,0.002456986,0.00019352509,0.00041074268,0.00010430271,0.000006826731,0.00012407744],"genre_scores_gemma":[0.98580956,0.012113689,0.00041348775,0.00016534652,0.0004999254,0.00016352418,0.000018828,0.000025798518,0.0007898365],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984226,0.00018290416,0.00032661017,0.0005837074,0.00018636686,0.00029778463],"domain_scores_gemma":[0.9988087,0.00057583454,0.000022687567,0.0002567351,0.00008304257,0.00025301406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009357342,0.0001228173,0.00015958103,0.00011040079,0.000059426697,0.00010850357,0.000096613,0.0001441139,0.000019107727],"category_scores_gemma":[0.0005940946,0.00011539652,0.000040445262,0.00017892323,0.00017508092,0.0000048576107,0.00012992423,0.00021523776,0.000009592688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0404398,0.0012482413,0.2511353,0.00082725886,0.00034408944,0.0014117286,0.0022047285,0.00022617847,0.3601053,0.0010484837,0.038659528,0.30234936],"study_design_scores_gemma":[0.0013353348,0.0019634399,0.9277315,0.00016868365,0.000018311543,0.000003323904,0.0001297224,0.00005720711,0.015316892,0.00041995072,0.052637465,0.00021815335],"about_ca_topic_score_codex":0.00027330607,"about_ca_topic_score_gemma":0.0014529614,"teacher_disagreement_score":0.6765962,"about_ca_system_score_codex":0.00014671817,"about_ca_system_score_gemma":0.00025122034,"threshold_uncertainty_score":0.47057334},"labels":[],"label_agreement":null},{"id":"W4404305779","doi":"10.1158/1557-3265.liqbiop24-b021","title":"Abstract B021: tRNA fragments extracted from patient plasma extra cellular vesicles display potential as biomarkers for high-grade glioma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Atlantic Cancer Research Institute; Dalhousie University","funders":"","keywords":"Glioma; Vesicle; Cancer research; Chemistry; Medicine; Pathology; Biology; Biochemistry","score_opus":0.0830709705604627,"score_gpt":0.43061400200269606,"score_spread":0.34754303144223336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874175,0.007991408,0.00063609116,0.0010719828,0.001282351,0.00065816345,0.0007518877,0.000030099134,0.00016046825],"genre_scores_gemma":[0.9946617,0.0018360735,0.00034281542,0.00007620017,0.0013564711,0.0005445636,0.00064253365,0.00006349315,0.0004761576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970626,0.00019550193,0.00064784184,0.00097320013,0.0005524204,0.00056843995],"domain_scores_gemma":[0.9985188,0.00028563384,0.00008911349,0.0005862292,0.00023290681,0.00028728833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081882323,0.0002138138,0.00024058536,0.00011032538,0.0002330796,0.00020458194,0.0004379676,0.00038091387,0.00049700565],"category_scores_gemma":[0.00022618756,0.00018722727,0.00028240943,0.00025991525,0.00033998527,0.000016422506,0.00014699044,0.00044237878,0.00008544727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092819805,0.00031784934,0.0002736715,0.00005681181,0.00039151794,0.000052672276,0.000030106845,0.000035518344,0.8846989,0.00013813918,0.018744418,0.09433217],"study_design_scores_gemma":[0.0023775003,0.0011532351,0.022884673,0.00021837775,0.00010491165,0.0000038884596,0.00021847877,0.0012564833,0.78248954,0.0017254225,0.18701094,0.00055657886],"about_ca_topic_score_codex":0.00093740976,"about_ca_topic_score_gemma":0.00008674735,"teacher_disagreement_score":0.16826652,"about_ca_system_score_codex":0.00008495836,"about_ca_system_score_gemma":0.0005057643,"threshold_uncertainty_score":0.7634907},"labels":[],"label_agreement":null},{"id":"W4404305804","doi":"10.1158/1557-3265.liqbiop24-b001","title":"Abstract B001: ctDNA release kinetics and fragmentation to monitor treatment response and resistance in esophageal adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre","funders":"","keywords":"Esophageal adenocarcinoma; Fragmentation (computing); Medicine; Esophageal cancer; Kinetics; Adenocarcinoma; Cancer research; Oncology; Internal medicine; Cancer; Biology","score_opus":0.07626756224814428,"score_gpt":0.4565329583700693,"score_spread":0.380265396121925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96342236,0.03328781,0.000013849927,0.0024594287,0.00019784858,0.0003745216,0.000107002204,0.0000067966625,0.00013038819],"genre_scores_gemma":[0.984943,0.013016742,0.00038325973,0.00017348875,0.0005172014,0.00014804244,0.000019290736,0.000025710433,0.0007732788],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984263,0.0001797581,0.00032621768,0.0005824752,0.00018535844,0.00029985423],"domain_scores_gemma":[0.9987812,0.0006011376,0.000022189239,0.0002583283,0.00008041005,0.0002567463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000932608,0.00012297474,0.00016060447,0.00011219363,0.00006008757,0.00010835673,0.00009790796,0.00014484202,0.000020838224],"category_scores_gemma":[0.00056369195,0.000115950614,0.000041668976,0.00017631277,0.00017633582,0.0000047804706,0.00013038598,0.00021682677,0.000010412431],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039739147,0.0011883875,0.23357987,0.0007496919,0.00033577214,0.0014804407,0.0020457527,0.00023403736,0.36817995,0.0009905719,0.037719958,0.3137564],"study_design_scores_gemma":[0.0013585543,0.0018875751,0.9286798,0.00016182476,0.000018271307,0.000003332143,0.00013315625,0.000059387938,0.014565348,0.0004451246,0.052468523,0.00021909745],"about_ca_topic_score_codex":0.0003079994,"about_ca_topic_score_gemma":0.0015188213,"teacher_disagreement_score":0.69509995,"about_ca_system_score_codex":0.00014714008,"about_ca_system_score_gemma":0.00023536672,"threshold_uncertainty_score":0.4728329},"labels":[],"label_agreement":null},{"id":"W4404305885","doi":"10.1158/1557-3265.liqbiop24-b064","title":"Abstract B064: Prevalence and clinical relevance of clonal hematopoiesis in metastatic urologic malignancies","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Clinical significance; Oncology; Cancer; Haematopoiesis; Intensive care medicine; Internal medicine; Stem cell; Biology","score_opus":0.14223305191781999,"score_gpt":0.49106979060416095,"score_spread":0.34883673868634096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519833,0.046128776,0.000035574983,0.0007868561,0.00035161586,0.00026871174,0.00011854969,0.000007389377,0.00031923692],"genre_scores_gemma":[0.9190961,0.07969863,0.00036369782,0.0001594579,0.00032044444,0.00006366681,0.000009473861,0.00002014473,0.00026838234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975145,0.00027433506,0.0008622935,0.0006665891,0.00030657017,0.0003757099],"domain_scores_gemma":[0.9970903,0.002131758,0.00007941796,0.00036918643,0.00018104262,0.00014831297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040051085,0.00013048838,0.0003422421,0.00008610363,0.00004216215,0.000044294833,0.00029154174,0.0001900575,0.00009759822],"category_scores_gemma":[0.0032541612,0.000114168106,0.00015740783,0.00023856854,0.0008818927,0.000007194588,0.00031628672,0.0005668058,0.00001337952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002186354,0.001094773,0.8409738,0.0038806053,0.00048015665,0.00033592962,0.00014709892,0.00017995971,0.026897432,0.0041656243,0.02655649,0.093101785],"study_design_scores_gemma":[0.0019216312,0.0026403482,0.8688885,0.0010067007,0.00010368665,0.000023994076,0.00012521086,0.0006139715,0.010605065,0.0071281195,0.1063648,0.0005779672],"about_ca_topic_score_codex":0.00015365834,"about_ca_topic_score_gemma":0.00041505147,"teacher_disagreement_score":0.09252382,"about_ca_system_score_codex":0.000028157492,"about_ca_system_score_gemma":0.0006367242,"threshold_uncertainty_score":0.465564},"labels":[],"label_agreement":null},{"id":"W4404305890","doi":"10.1158/1557-3265.liqbiop24-b011","title":"Abstract B011: Circulating tumor DNA profiling in colorectal cancer to detect guideline-based targeted mutations at a Quebec health care center","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Colorectal cancer; Guideline; Medicine; Circulating tumor DNA; Profiling (computer programming); Oncology; Cancer; DNA profiling; Internal medicine; DNA; Pathology; Biology; Genetics","score_opus":0.08300783161549298,"score_gpt":0.4843207700583968,"score_spread":0.40131293844290383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452026,0.0103542395,0.00013613066,0.0025368074,0.00065023627,0.00093796256,0.0006793256,0.00002619056,0.00015885886],"genre_scores_gemma":[0.99526995,0.00036859635,0.0008119996,0.0013821857,0.00096123636,0.0006415258,0.00042808813,0.000061631705,0.00007476515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702823,0.0002032253,0.0008584569,0.00083701045,0.00036701266,0.0007060793],"domain_scores_gemma":[0.9985303,0.00034960493,0.00007778572,0.0002876715,0.0004083822,0.00034620918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013562633,0.00018719007,0.0002917042,0.00017923694,0.00018417869,0.000106476175,0.0002666329,0.00015781481,0.00014989794],"category_scores_gemma":[0.00096224627,0.00018603302,0.00017160563,0.0004634854,0.00014682372,0.0000057103057,0.0002468974,0.0005372671,0.000029608318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034847893,0.00039281335,0.117433995,0.0015952355,0.0003074163,0.0003969737,0.0015082796,0.03259604,0.58615917,0.00007474469,0.080865376,0.17518519],"study_design_scores_gemma":[0.0069538904,0.002781549,0.16391982,0.0021510548,0.00005780664,0.000015225555,0.0014605103,0.0094630895,0.495426,0.00014576242,0.3157385,0.0018867672],"about_ca_topic_score_codex":0.015986469,"about_ca_topic_score_gemma":0.1840954,"teacher_disagreement_score":0.23487313,"about_ca_system_score_codex":0.0011851175,"about_ca_system_score_gemma":0.0052284147,"threshold_uncertainty_score":0.99056613},"labels":[],"label_agreement":null},{"id":"W4404305892","doi":"10.1158/1557-3265.liqbiop24-b050","title":"Abstract B050: Frequent monitoring of NSCLC immunotherapy using an mDETECT liquid biopsy reveals unexpected complexity and opportunities","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Immunotherapy; Liquid biopsy; Medicine; Biopsy; Oncology; Internal medicine; Cancer","score_opus":0.6264189750004209,"score_gpt":0.5694848793649353,"score_spread":0.05693409563548557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753769,0.02228221,0.0000049381088,0.0010429817,0.00033032108,0.00044038467,0.00006230513,0.00005851895,0.0004014598],"genre_scores_gemma":[0.9858611,0.012895582,0.00041899015,0.00004314869,0.0005703783,0.00007680581,0.000011470357,0.00003520748,0.00008727019],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976281,0.0002782566,0.0006696929,0.0004512758,0.0005900165,0.0003826607],"domain_scores_gemma":[0.99804497,0.00082748407,0.00007153821,0.00042293925,0.00032216098,0.00031091116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018322258,0.00015894568,0.0005048349,0.00020250326,0.00013177107,0.000077291,0.0001237238,0.00014691526,0.00033546038],"category_scores_gemma":[0.00014307178,0.000121271325,0.00015239243,0.0002501811,0.00068430277,0.000120016426,0.000078229634,0.00042874494,0.000005749487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072053196,0.0038111904,0.34501,0.0021152243,0.0022331188,0.0029338072,0.001801699,0.000008900184,0.27869397,0.0022897231,0.0006114725,0.35328555],"study_design_scores_gemma":[0.0039469227,0.0044477517,0.9434574,0.004298371,0.00015228214,0.00009465515,0.0012356559,0.0003314412,0.038643878,0.00086349907,0.0021968498,0.00033128873],"about_ca_topic_score_codex":0.0034250868,"about_ca_topic_score_gemma":0.00002442485,"teacher_disagreement_score":0.5984474,"about_ca_system_score_codex":0.00033825487,"about_ca_system_score_gemma":0.00065421493,"threshold_uncertainty_score":0.517773},"labels":[],"label_agreement":null},{"id":"W4404305902","doi":"10.1158/1557-3265.liqbiop24-b071","title":"Abstract B071: Identifying the clinical utility of CSF as a source of liquid biopsy in pediatric brain tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Alberta","funders":"","keywords":"Medicine; Liquid biopsy; Pathology; Biopsy; Brain biopsy; Intensive care medicine; Cancer; Internal medicine","score_opus":0.3158458056615881,"score_gpt":0.5751759539285666,"score_spread":0.2593301482669785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813826,0.008877431,0.0000032514793,0.007648084,0.00033536524,0.000696023,0.00001755116,0.000023649654,0.001016033],"genre_scores_gemma":[0.9950895,0.0038130276,0.000031717555,0.00013333188,0.0006082382,0.00011314484,0.0000054865814,0.000027026384,0.00017854902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995446,0.0007144208,0.001738048,0.00060745375,0.0010324996,0.0004615507],"domain_scores_gemma":[0.9886643,0.009909229,0.00015519827,0.0006703603,0.00033959793,0.0002612693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012516811,0.00014453259,0.00068439153,0.0003183201,0.000057723963,0.00003428955,0.00032784315,0.00022416117,0.00079312606],"category_scores_gemma":[0.0063772695,0.00009107889,0.0005021925,0.0012976002,0.00078677,0.00006275691,0.0002492331,0.0015273009,0.00010950143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018825823,0.0021146827,0.946867,0.0011266917,0.00018110288,0.0005533869,0.0003749088,0.0000036969107,0.00030840453,0.00016277321,0.008666394,0.037758384],"study_design_scores_gemma":[0.001620917,0.0011282902,0.99201936,0.00075221155,0.00009345369,0.000012189934,0.00030813282,0.00017265308,0.0008881462,0.0003700967,0.0025531193,0.00008143766],"about_ca_topic_score_codex":0.0027534948,"about_ca_topic_score_gemma":0.00026081738,"teacher_disagreement_score":0.04515236,"about_ca_system_score_codex":0.000077409306,"about_ca_system_score_gemma":0.0012538645,"threshold_uncertainty_score":0.86841744},"labels":[],"label_agreement":null},{"id":"W4404305937","doi":"10.1158/1557-3265.liqbiop24-b070","title":"Abstract B070: Dissecting EV dynamics in the sequestration of doxorubicin from breast cancer cells","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Breast cancer; Doxorubicin; Medicine; Cancer; Cancer research; Internal medicine; Chemotherapy","score_opus":0.13826979921980034,"score_gpt":0.5184922660968538,"score_spread":0.3802224668770535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96563196,0.0009069546,0.00003800384,0.0044781873,0.00013499458,0.00018537538,0.0009956061,0.00008040826,0.02754852],"genre_scores_gemma":[0.9968366,0.0015940682,0.000094059615,0.00003150241,0.0007154274,0.00029821144,0.000055548662,0.000019994599,0.00035461163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806386,0.000092884955,0.00059198,0.00042113662,0.00051595666,0.00031420312],"domain_scores_gemma":[0.9975333,0.0016945329,0.000075900854,0.00045425788,0.00017348211,0.00006852374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017707157,0.000108582986,0.00020333788,0.0000839656,0.00008154332,0.0001065508,0.0005036703,0.00018671123,0.0055015814],"category_scores_gemma":[0.00011610157,0.00007948742,0.00011077599,0.00067901274,0.00019811216,0.00007694575,0.000061722545,0.0014550834,0.000013961829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029333684,0.00097180484,0.13082917,0.0013137452,0.00017231818,0.00007829187,0.00071540935,0.000102897364,0.6014948,0.040948357,0.011860457,0.21121942],"study_design_scores_gemma":[0.0017017092,0.00028313848,0.3236153,0.005757199,0.0001816516,0.000013218239,0.007182991,0.054775465,0.49183965,0.081063695,0.03213585,0.0014501413],"about_ca_topic_score_codex":0.016917748,"about_ca_topic_score_gemma":0.005111646,"teacher_disagreement_score":0.20976926,"about_ca_system_score_codex":0.00043160334,"about_ca_system_score_gemma":0.000324101,"threshold_uncertainty_score":0.9954075},"labels":[],"label_agreement":null},{"id":"W4404305938","doi":"10.1158/1557-3265.liqbiop24-b013","title":"Abstract B013: An mDETECT assay for monitoring treatment response in metastatic breast cancer patients","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.19326708635712458,"score_gpt":0.5655350008236277,"score_spread":0.37226791446650315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963146,0.0010337107,0.00035169182,0.0009118495,0.00019564707,0.00072689605,0.00040830905,0.00003393968,0.000023390709],"genre_scores_gemma":[0.9947038,0.0019361081,0.0014032195,0.000030264906,0.00051283435,0.0010490561,0.000050974948,0.000038010345,0.000275701],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982805,0.00024408242,0.0003429954,0.0005766968,0.00018692696,0.0003687946],"domain_scores_gemma":[0.99887544,0.00039318597,0.000035951187,0.00034542213,0.00021418631,0.00013582186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016671271,0.0001290518,0.00016946535,0.00008539072,0.00010085699,0.00005623688,0.00017709644,0.00012392244,0.000016924807],"category_scores_gemma":[0.00022587777,0.00010489861,0.00011436507,0.00021477806,0.00013260246,0.00000904024,0.00006770548,0.00024078652,0.000004722941],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00634037,0.0012405749,0.0255568,0.00012760516,0.00016452088,0.000018984883,0.000080114514,0.00014875481,0.3092885,0.00005709839,0.0021218585,0.65485483],"study_design_scores_gemma":[0.0037107794,0.0068869763,0.44524002,0.0007226861,0.00008369053,0.0000066934313,0.00017736907,0.0014425477,0.33932704,0.0019193925,0.19957916,0.0009036204],"about_ca_topic_score_codex":0.00030465276,"about_ca_topic_score_gemma":0.00023747634,"teacher_disagreement_score":0.65395117,"about_ca_system_score_codex":0.00020654051,"about_ca_system_score_gemma":0.00036762372,"threshold_uncertainty_score":0.42776412},"labels":[],"label_agreement":null},{"id":"W4404305959","doi":"10.1158/1557-3265.liqbiop24-b069","title":"Abstract B069: Spatial and single-cell proteomic landscaping of the hypoxic microenvironment in glioblastoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Tumor microenvironment; Cancer research; Hypoxia (environmental); Medicine; Biology; Pathology; Computational biology; Tumor cells; Chemistry","score_opus":0.05809141532808029,"score_gpt":0.37986134425617,"score_spread":0.32176992892808975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810103,0.01715156,0.000012113747,0.00045031804,0.0006790091,0.0003894746,0.00002802259,0.000004088508,0.00027508018],"genre_scores_gemma":[0.99205434,0.006169566,0.000026352953,0.000058093785,0.0011958098,0.000068660214,0.0000022127076,0.000021093017,0.0004038602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851334,0.0001659678,0.00035419487,0.00041638833,0.0002503614,0.00029977493],"domain_scores_gemma":[0.9994501,0.000085110114,0.00004547213,0.0003018776,0.000034181554,0.000083262574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010737326,0.000100230645,0.00017588118,0.00006023409,0.00004813762,0.000032142125,0.00022088269,0.00015404372,0.00006728354],"category_scores_gemma":[0.00012936656,0.000074242525,0.00010695352,0.00013692338,0.00036060673,0.000003940242,0.00027820483,0.00044186323,0.000006997821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029679944,0.00012872636,0.006188508,0.00017033497,0.000022473821,0.0000025617744,0.00005298406,0.000016904449,0.95676845,0.000004032048,0.002267347,0.034080904],"study_design_scores_gemma":[0.001425459,0.0005482722,0.12603363,0.0003233731,0.000019253996,0.000004910106,0.000060932867,0.0000989353,0.73084795,0.00008473159,0.14035393,0.00019862597],"about_ca_topic_score_codex":0.00030686441,"about_ca_topic_score_gemma":0.0006624641,"teacher_disagreement_score":0.2259205,"about_ca_system_score_codex":0.0000366477,"about_ca_system_score_gemma":0.00025072173,"threshold_uncertainty_score":0.30275223},"labels":[],"label_agreement":null},{"id":"W4404305976","doi":"10.1158/1557-3265.liqbiop24-a008","title":"Abstract A008: Adaptive immune receptor repertoire characterization highlights the importance of interplay between B and T cells in disease progression","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Immune system; Disease; Repertoire; Biology; Immunology; Receptor; Medicine; Pathology; Genetics","score_opus":0.0642727596746989,"score_gpt":0.43419069465497795,"score_spread":0.36991793498027903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9300186,0.06613171,0.000008969592,0.0023803955,0.0007081454,0.0004965199,0.00011825692,0.000028320725,0.00010908219],"genre_scores_gemma":[0.9936436,0.005396269,0.0000029352261,0.000031187912,0.00002854051,0.00010903402,0.00012425982,0.000018120092,0.0006460828],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99768764,0.0005694432,0.00078231475,0.00045723421,0.00012190186,0.0003814679],"domain_scores_gemma":[0.99835896,0.0010262537,0.00012082046,0.0003581264,0.00011634687,0.000019473247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00237809,0.00013915283,0.00032224754,0.0001340164,0.00020225906,0.000035134337,0.00034900912,0.00021155251,0.0003724798],"category_scores_gemma":[0.00025086064,0.00008807007,0.00010925987,0.0004000475,0.0011305487,0.00015447612,0.00020656652,0.0010780393,0.00007505868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002385283,0.00043087357,0.0687956,0.00036570773,0.00022751861,0.00002712916,0.0027467564,0.0000026590344,0.5290895,0.0012729142,0.0004840254,0.39417204],"study_design_scores_gemma":[0.00088291656,0.00032783113,0.9045373,0.0017136264,0.000028635464,9.244717e-7,0.00045226465,0.00004530932,0.027099574,0.0003065025,0.06438838,0.0002167073],"about_ca_topic_score_codex":0.00014488421,"about_ca_topic_score_gemma":0.000011920919,"teacher_disagreement_score":0.83574176,"about_ca_system_score_codex":0.000051934894,"about_ca_system_score_gemma":0.00029269498,"threshold_uncertainty_score":0.4683604},"labels":[],"label_agreement":null},{"id":"W4404306006","doi":"10.1158/1557-3265.liqbiop24-ia018","title":"Abstract IA018: Liquid biopsy in head and neck cancers: A model for tissue-agnostic MRD detection","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Head and neck; Medicine; Head and neck cancer; Biopsy; Liquid biopsy; Pathology; Radiology; Cancer; Surgery; Internal medicine","score_opus":0.38384814825591657,"score_gpt":0.5960689238606206,"score_spread":0.21222077560470404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404306006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96790695,0.017258262,0.00093332416,0.011917709,0.0005680677,0.00071060896,0.000033331897,0.00006983373,0.0006018962],"genre_scores_gemma":[0.99120975,0.00537898,0.00041522493,0.00042762607,0.0007268235,0.00048740636,0.0000057817583,0.000026532052,0.0013218692],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99806106,0.000100383375,0.0004542847,0.0005553337,0.00033717972,0.00049173745],"domain_scores_gemma":[0.9971781,0.002157417,0.0000231647,0.00019928048,0.00017505906,0.00026700366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002558431,0.00011953246,0.00038303251,0.00019986455,0.000107818574,0.000030450248,0.000080830236,0.00020053869,0.00006356948],"category_scores_gemma":[0.0034019838,0.000093812174,0.00007289065,0.00033818625,0.00067533704,0.000055022094,0.000078712226,0.0011715224,0.000029789322],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011555688,0.00068238174,0.033872113,0.0063816593,0.00043581316,0.0021447486,0.0031213642,0.00028538937,0.01473079,0.00021036193,0.03974415,0.8868355],"study_design_scores_gemma":[0.019220125,0.016201964,0.2426679,0.017775726,0.0005846971,0.00043570576,0.0010601185,0.5534505,0.0060727517,0.008497027,0.13261268,0.0014207734],"about_ca_topic_score_codex":0.0010843624,"about_ca_topic_score_gemma":0.0013903958,"teacher_disagreement_score":0.8854148,"about_ca_system_score_codex":0.00019407469,"about_ca_system_score_gemma":0.00062884967,"threshold_uncertainty_score":0.50897473},"labels":[],"label_agreement":null},{"id":"W4404306062","doi":"10.1158/1557-3265.liqbiop24-b004","title":"Abstract B004: Biological insights into tissue-agnostic plasma cfDNA methylation signature for surveillance of head and neck tumor recurrence","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Head and neck cancer; Medicine; Methylation; DNA methylation; Pathology; Computational biology; Cancer; Internal medicine; Biology; Surgery; DNA; Genetics; Gene; Gene expression","score_opus":0.11003506870615119,"score_gpt":0.4808216580985556,"score_spread":0.3707865893924044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404306062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474749,0.047195647,0.0025415684,0.0007748055,0.0005547883,0.0010863948,0.00012816026,0.000024751153,0.00021898982],"genre_scores_gemma":[0.9885609,0.009595042,0.00053723453,0.000058642465,0.0005352475,0.00027521106,0.00015658682,0.00004015531,0.00024094254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969956,0.00042201384,0.0005799853,0.0009905735,0.0005055594,0.0005062157],"domain_scores_gemma":[0.99737674,0.001284598,0.00007989911,0.00042389904,0.0005919741,0.00024290034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022808493,0.0001996591,0.0003590343,0.00016035953,0.00013345189,0.0000714252,0.00036174708,0.00050229643,0.00009584384],"category_scores_gemma":[0.0036628658,0.00016662301,0.00014811823,0.00047050408,0.00059734867,0.000011219327,0.00031789814,0.00093717437,0.00001501142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013550642,0.0001398329,0.00042827416,0.0005857861,0.00014446802,0.000032977638,0.000063781365,0.0001465086,0.85803807,0.00039730198,0.006353481,0.13231444],"study_design_scores_gemma":[0.0019911635,0.0048186793,0.009587088,0.0006759703,0.000022587685,0.000010406221,0.0000533147,0.0021217354,0.7853773,0.005488696,0.18931837,0.00053467636],"about_ca_topic_score_codex":0.00015866425,"about_ca_topic_score_gemma":0.00045586104,"teacher_disagreement_score":0.1829649,"about_ca_system_score_codex":0.000069407404,"about_ca_system_score_gemma":0.00068009115,"threshold_uncertainty_score":0.67946887},"labels":[],"label_agreement":null},{"id":"W4404374818","doi":"10.1158/1078-0432.ccr-24-1947","title":"Update on Pediatric Surveillance Recommendations for <i>PTEN</i> Hamartoma Tumor Syndrome, <i>DICER1-</i> Related Tumor Predisposition, and Tuberous Sclerosis Complex","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Manchester Biomedical Research Centre; National Cancer Institute; National Institutes of Health; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"PTEN; Tuberous sclerosis; Medicine; Multidisciplinary approach; Hamartoma; Genetic predisposition; Pediatrics; Oncology; Pathology; PI3K/AKT/mTOR pathway; Disease; Genetics; Biology","score_opus":0.4323668482449535,"score_gpt":0.539893201562797,"score_spread":0.10752635331784344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404374818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026808004,0.9718756,0.0000089249015,0.009880034,0.0012741179,0.00882392,0.004585505,0.00041129554,0.0004597812],"genre_scores_gemma":[0.002451683,0.98496115,0.00042211724,0.0009812373,0.0016118094,0.0055335383,0.001797512,0.0004906053,0.001750365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9863763,0.0028635904,0.003549343,0.0029529778,0.0021698864,0.002087938],"domain_scores_gemma":[0.9862772,0.00835534,0.0005841034,0.0018552303,0.0015049175,0.0014231753],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009685979,0.0010488374,0.004342194,0.0014733911,0.00088152435,0.0005105066,0.0010921935,0.00062034896,0.00088041334],"category_scores_gemma":[0.00296635,0.00085337705,0.0013918711,0.0037272044,0.001220851,0.00017303853,0.0010911563,0.005937072,0.0013529266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072968873,0.0010629649,0.0011499341,0.042750474,0.0010737536,0.0004647589,0.000026677028,8.4708734e-7,0.0000035721578,0.0004091112,0.5926109,0.3597173],"study_design_scores_gemma":[0.00282047,0.0025738024,0.0039156084,0.02180135,0.0017264471,0.0009899252,0.000017598484,0.00019905296,0.0000010635636,0.00029758274,0.96479005,0.0008670409],"about_ca_topic_score_codex":0.00019363649,"about_ca_topic_score_gemma":0.00013788084,"teacher_disagreement_score":0.37217915,"about_ca_system_score_codex":0.0010999367,"about_ca_system_score_gemma":0.0028670942,"threshold_uncertainty_score":0.99942464},"labels":[],"label_agreement":null},{"id":"W4404395566","doi":"10.1158/1078-0432.ccr-24-2983","title":"Divergent Clinical and Immunologic Outcomes Based on <i>STK11</i> Co-mutation Status in Resectable <i>KRAS-</i> Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; McGill University Health Centre","funders":"Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; Swim Across America; American Lung Association; Mark Foundation For Cancer Research; Bristol-Myers Squibb; LUNGevity Foundation; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation","keywords":"KRAS; Immune checkpoint; Medicine; Lung cancer; Cancer research; Oncology; Context (archaeology); Cancer; Immunotherapy; Neoadjuvant therapy; Internal medicine; STK11; Biology; Colorectal cancer; Breast cancer","score_opus":0.1293539012176479,"score_gpt":0.506675577321772,"score_spread":0.37732167610412415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404395566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564636,0.030989809,0.00001774466,0.0071651973,0.0022206176,0.0015587558,0.00009833435,0.00013685212,0.001349095],"genre_scores_gemma":[0.9788418,0.018361032,0.00009535482,0.0010521169,0.0003448111,0.00037159864,0.00005247802,0.000075733304,0.00080508547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99291486,0.0011180275,0.002063549,0.0012681655,0.0013508053,0.0012846155],"domain_scores_gemma":[0.99520576,0.0032725302,0.00014922878,0.0007444982,0.00019301672,0.00043493757],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009678103,0.0003840039,0.0011562051,0.0005214691,0.00027394577,0.0001721305,0.00030889525,0.00046357192,0.00065542076],"category_scores_gemma":[0.0015312704,0.0002914808,0.0007559352,0.0012170303,0.0009279653,0.00016477962,0.00018703041,0.0027055198,0.00004413663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02269432,0.0010271728,0.83778983,0.00070824183,0.0013385508,0.0023043435,0.00050491444,0.00021091384,0.01839528,0.000048458776,0.0034145922,0.11156336],"study_design_scores_gemma":[0.029384289,0.0064433427,0.8550793,0.0051300307,0.00034501223,0.000027160137,0.0011023121,0.021920577,0.014102508,0.00024688893,0.06521,0.0010085987],"about_ca_topic_score_codex":0.00741546,"about_ca_topic_score_gemma":0.0007747945,"teacher_disagreement_score":0.11055476,"about_ca_system_score_codex":0.0015585567,"about_ca_system_score_gemma":0.002762086,"threshold_uncertainty_score":0.99995375},"labels":[],"label_agreement":null},{"id":"W4404636870","doi":"10.1158/1078-0432.ccr-24-2582","title":"Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Medicine; Internal medicine; Hepatocellular carcinoma; Decompensation; Sorafenib; Bevacizumab; Hazard ratio; Gastroenterology; Cumulative incidence; Cirrhosis; Atezolizumab; Lenvatinib; Incidence (geometry); Hepatic encephalopathy; Proportional hazards model; Oncology; Cancer; Chemotherapy; Confidence interval; Cohort; Immunotherapy","score_opus":0.18040252179863495,"score_gpt":0.39883108197148526,"score_spread":0.2184285601728503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404636870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941326,0.0024596439,0.000032348406,0.00029914372,0.00013504924,0.0023616895,0.00016948822,0.00012773802,0.00028231862],"genre_scores_gemma":[0.99485564,0.0008776856,0.00017956992,0.000018030352,0.0001925819,0.00045807054,0.00029267246,0.00011993239,0.003005827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99485743,0.0007887443,0.00095587294,0.0010235211,0.0016165505,0.00075790036],"domain_scores_gemma":[0.99608046,0.0013548214,0.00020084588,0.00080158294,0.0010785162,0.00048380037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013027927,0.00040005994,0.0009624665,0.0004410171,0.00029695756,0.00012248094,0.00025172016,0.00027883993,0.000762373],"category_scores_gemma":[0.00027721206,0.00023778582,0.00027885704,0.001179301,0.00059095817,0.00018219915,0.00016376958,0.0008467238,0.00018791264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014706999,0.00042147798,0.976119,0.00067254103,0.0008381207,0.0010697609,0.00035682583,0.0000026220705,0.000052231033,0.000028001996,0.00041792635,0.0053144875],"study_design_scores_gemma":[0.00923476,0.007252687,0.9697585,0.0011252753,0.0011817615,0.000017348306,0.000047269146,0.0047301543,0.005602894,0.00005845481,0.0006711815,0.00031967467],"about_ca_topic_score_codex":0.0053675813,"about_ca_topic_score_gemma":0.00082820526,"teacher_disagreement_score":0.006831209,"about_ca_system_score_codex":0.00094717776,"about_ca_system_score_gemma":0.0012266316,"threshold_uncertainty_score":0.9696624},"labels":[],"label_agreement":null},{"id":"W4404637171","doi":"10.1158/1078-0432.ccr-24-0841","title":"Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; University of British Columbia Hospital; University of Alberta; Ontario Institute for Cancer Research; BC Cancer Agency; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Stand Up To Cancer Canada","keywords":"Paclitaxel; Medicine; Breast cancer; Metastatic breast cancer; Pharmacodynamics; Cancer; Pharmacokinetics; Pharmacology; Clinical trial; Refractory (planetary science); Oncology; Internal medicine; Cancer research; Biology","score_opus":0.0711306112331,"score_gpt":0.4781960152094174,"score_spread":0.4070654039763174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404637171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995664,0.0015416857,0.000008601324,0.00043111257,0.0005099863,0.0014225425,0.00035167165,0.000015841597,0.000054534816],"genre_scores_gemma":[0.9983358,0.0002457785,0.00001907931,0.00012863801,0.00030290903,0.0005264227,0.000026968093,0.000073552575,0.00034089596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607784,0.00087849033,0.0006770383,0.00083047344,0.0009904164,0.00054575555],"domain_scores_gemma":[0.9981397,0.00027000642,0.00014412674,0.000708181,0.00056030985,0.00017767285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015292087,0.00025597916,0.0004206547,0.0001294848,0.00010332152,0.000051548006,0.00059847475,0.0001225715,0.00015467944],"category_scores_gemma":[0.00013203626,0.00015444594,0.0001076971,0.0007997284,0.00057763257,0.000019250536,0.00028258658,0.0009822627,0.0000046269583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040976334,0.017624233,0.84445304,0.0006944024,0.0019869164,0.00007978288,0.0008312127,0.0007099304,0.04174787,0.000016571195,0.007081167,0.04379856],"study_design_scores_gemma":[0.12167607,0.07947878,0.7334847,0.004067314,0.00097441796,0.000011318726,0.0018350548,0.0023077761,0.03820466,0.00012626639,0.015685933,0.0021477414],"about_ca_topic_score_codex":0.00094463344,"about_ca_topic_score_gemma":0.0026490723,"teacher_disagreement_score":0.11096835,"about_ca_system_score_codex":0.00024036299,"about_ca_system_score_gemma":0.001298245,"threshold_uncertainty_score":0.62981224},"labels":[],"label_agreement":null},{"id":"W4404749160","doi":"10.1158/1078-0432.ccr-24-2061","title":"Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; Genentech; National Institutes of Health; Astellas Pharma; Institute for Prostate Cancer Research; Celgene; U.S. Department of Defense; Sanofi; Prostate Cancer Foundation; Eli Lilly and Company; Bristol-Myers Squibb; Pfizer; V Foundation for Cancer Research; Intuitive Surgical; Doris Duke Charitable Foundation; Amgen","keywords":"Prostate cancer; Neuroendocrine differentiation; Medicine; Adenocarcinoma; Pathology; Context (archaeology); Enzalutamide; Prostate; Androgen deprivation therapy; Androgen receptor; Chromogranin A; Lineage markers; Neuroendocrine tumors; Synaptophysin; Cancer; Immunohistochemistry; Cancer research; Phenotype; Internal medicine; Biology","score_opus":0.6165722208737369,"score_gpt":0.6663704275781906,"score_spread":0.049798206704453785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404749160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010866042,0.98448825,0.000029928035,0.004871738,0.0012562991,0.0073160185,0.0017845583,0.000041680203,0.00010285704],"genre_scores_gemma":[0.00015766766,0.9768903,0.0006441614,0.000073345356,0.0013753591,0.012209913,0.00015353454,0.00015577827,0.008339934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935956,0.001008424,0.001922681,0.0011083945,0.0012432557,0.0011216383],"domain_scores_gemma":[0.9862815,0.010746918,0.0003845531,0.0010833608,0.001155849,0.0003478142],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005703399,0.0005094217,0.0027926005,0.00046785595,0.00030482316,0.00012075053,0.00066109106,0.00057314895,0.00047726763],"category_scores_gemma":[0.0022944226,0.000252072,0.0013708927,0.0017958111,0.0021432396,0.000052256404,0.00034805707,0.0034822107,0.000083429266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001593065,0.00027592148,0.000092933915,0.059600484,0.0029280826,0.00027793637,0.00020094312,0.0000013844676,0.0000045192673,0.0013881767,0.014671684,0.91896486],"study_design_scores_gemma":[0.0010546345,0.0012836521,0.00006935836,0.037691414,0.004806771,0.000018886629,0.00023336931,0.000020773947,0.000014391429,0.0025916551,0.95196044,0.00025464525],"about_ca_topic_score_codex":0.00036843505,"about_ca_topic_score_gemma":0.00023329827,"teacher_disagreement_score":0.93728876,"about_ca_system_score_codex":0.00056662486,"about_ca_system_score_gemma":0.008394221,"threshold_uncertainty_score":0.99999315},"labels":[],"label_agreement":null},{"id":"W4404756545","doi":"10.1158/1078-0432.ccr-24-2171","title":"Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; National Institute for Health and Care Research; Canadian Imperial Bank of Commerce; Manchester Biomedical Research Centre; American Association for Cancer Research","keywords":"Medicine; Cancer; Pathology; Renal cell carcinoma; Leiomyoma; Internal medicine","score_opus":0.24163367179375494,"score_gpt":0.4943200126923375,"score_spread":0.25268634089858255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404756545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28860947,0.7086074,2.2363702e-7,0.00035507078,0.00009396969,0.001656215,0.00055237586,0.00003781404,0.0000875031],"genre_scores_gemma":[0.06968567,0.92805946,0.00014520698,0.000074504234,0.0002840736,0.0007718641,0.00005015422,0.00020693883,0.00072215026],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99420476,0.0007315254,0.0015412054,0.0014859437,0.0012094609,0.0008270893],"domain_scores_gemma":[0.9969098,0.0013651415,0.0003165788,0.00075679645,0.00019354958,0.00045811746],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021203125,0.0006878921,0.0040674056,0.0011438652,0.00015028466,0.000050567247,0.0002694223,0.00047385012,0.00022483346],"category_scores_gemma":[0.00031201346,0.00046176158,0.000351912,0.001377516,0.0014009615,0.00007408165,0.0006843039,0.0028002502,0.000029811374],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075067015,0.00047374415,0.39793354,0.06451212,0.002805422,0.010890858,0.00017486795,0.0000010221636,8.1586734e-7,0.00003416321,0.012770463,0.5096523],"study_design_scores_gemma":[0.0074100173,0.0067386217,0.31166556,0.32390115,0.00825866,0.01827132,0.00052984466,0.000014977437,0.000016120837,0.000059387778,0.32116783,0.0019665156],"about_ca_topic_score_codex":0.0026333274,"about_ca_topic_score_gemma":0.0003487999,"teacher_disagreement_score":0.5076858,"about_ca_system_score_codex":0.00020359668,"about_ca_system_score_gemma":0.0011292039,"threshold_uncertainty_score":0.9997834},"labels":[],"label_agreement":null},{"id":"W4404958353","doi":"10.1158/1078-0432.ccr-24-0581","title":"Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; BC Children's Hospital; Nova Scotia Health Authority; Montreal Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Trk receptor; Medicine; Central nervous system; Glioma; Internal medicine; Retrospective cohort study; Oncology; Cohort; Histology; Pathology; Cancer research; Neurotrophin; Receptor","score_opus":0.20912988148926817,"score_gpt":0.5262566743083362,"score_spread":0.3171267928190681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404958353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921665,0.0033300086,0.0000077223685,0.0024180226,0.0010952282,0.00053599844,0.00011144456,0.00006601961,0.00026902073],"genre_scores_gemma":[0.9948623,0.0035813253,0.00019000076,0.00008455887,0.0009022202,0.00010226209,0.000014833832,0.000033720637,0.00022876904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968826,0.000320791,0.0011282272,0.0005364698,0.0006127281,0.0005191887],"domain_scores_gemma":[0.9963638,0.0023144686,0.000078077064,0.0004213254,0.00024710933,0.000575206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022605485,0.00015009551,0.000826496,0.00015358433,0.00010217206,0.00005683871,0.0001291641,0.00017081939,0.00011794982],"category_scores_gemma":[0.0010187293,0.00010374946,0.00029582466,0.00031953023,0.0004345239,0.00003937613,0.00021574677,0.00080533733,0.000044252716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015203787,0.00044677692,0.9368001,0.00051610376,0.00031513444,0.0009809108,0.000050379647,4.7525165e-7,0.00020201986,0.0008018273,0.0010158869,0.058718298],"study_design_scores_gemma":[0.0011119653,0.00055960275,0.9926422,0.0010152991,0.000182651,0.00002328303,0.00008614033,0.0006309333,0.00026668038,0.000017174363,0.0033765228,0.00008754341],"about_ca_topic_score_codex":0.0003203447,"about_ca_topic_score_gemma":0.000027047698,"teacher_disagreement_score":0.058630753,"about_ca_system_score_codex":0.00015529183,"about_ca_system_score_gemma":0.0005198616,"threshold_uncertainty_score":0.42307803},"labels":[],"label_agreement":null},{"id":"W4404959524","doi":"10.1158/1078-0432.ccr-24-2469","title":"The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada); McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Immunotherapy; Cancer; Medicine; Biomarker; Cancer immunotherapy; Precision oncology; Oncology; Biomarker discovery; Clinical Oncology; Perspective (graphical); Cancer research; Internal medicine; Biology; Computer science; Proteomics","score_opus":0.29019097892027956,"score_gpt":0.6372890486359728,"score_spread":0.34709806971569324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404959524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000068859714,0.97843486,0.00022809728,0.009207519,0.000352441,0.010829658,0.00060873094,0.000068668036,0.00020114788],"genre_scores_gemma":[0.000120586905,0.9764979,0.00017251381,0.00007881963,0.0005144391,0.017026681,0.00006246153,0.00014783004,0.005378794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959933,0.0004101048,0.0010786352,0.0010627054,0.0007179057,0.0007373258],"domain_scores_gemma":[0.9839814,0.013409761,0.00031014782,0.0010685088,0.0011427039,0.00008748148],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.006459357,0.0003720801,0.0018869645,0.00027573894,0.0003445312,0.00010792151,0.00068148883,0.0009823064,0.00007110038],"category_scores_gemma":[0.0012068942,0.00021254503,0.0018294889,0.0008725918,0.0028596837,0.0000387884,0.00023697413,0.0018078671,0.000006024038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036265769,0.00021901316,0.0000090576095,0.010357578,0.0022685393,0.0000014200964,0.000056688503,2.3046739e-7,0.00068321294,0.0010280446,0.010990461,0.97075915],"study_design_scores_gemma":[0.0019611032,0.0027252908,0.000012129203,0.0044865427,0.0006817988,0.0000020571308,0.00051205186,0.00010842748,0.0002784263,0.0012932216,0.98774546,0.0001935072],"about_ca_topic_score_codex":0.0006482619,"about_ca_topic_score_gemma":0.00022519685,"teacher_disagreement_score":0.97675496,"about_ca_system_score_codex":0.0021784862,"about_ca_system_score_gemma":0.0049307537,"threshold_uncertainty_score":0.99985397},"labels":[],"label_agreement":null},{"id":"W4405234144","doi":"10.1158/1078-0432.ccr-24-2334","title":"Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Medicine; Randomized controlled trial; Cancer; Oncology; Internal medicine","score_opus":0.1768726517848916,"score_gpt":0.5444452930986137,"score_spread":0.3675726413137221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405234144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94982725,0.0075228107,0.000056899775,0.03886822,0.00062352186,0.002374834,0.00007746104,0.00003391469,0.0006150933],"genre_scores_gemma":[0.9840022,0.012494429,0.00005626029,0.0001456851,0.0012970477,0.0013317071,0.00006459079,0.000022367942,0.00058571884],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960342,0.0009837527,0.0011304219,0.0004709924,0.0010194903,0.00036115057],"domain_scores_gemma":[0.9918083,0.007350826,0.00016269243,0.00013966669,0.00040707135,0.00013146357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069022696,0.00013828423,0.000938987,0.0005409199,0.00007307433,0.00004024356,0.00007557603,0.00028891777,0.00016121984],"category_scores_gemma":[0.004434773,0.00011816124,0.00017999862,0.001010531,0.00029287004,0.00019518936,0.00005103552,0.0010989447,0.000011157447],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26371548,0.00070760556,0.5497931,0.000961055,0.0010802015,0.000044024615,0.0022528013,0.0001050813,0.00021242746,0.0008264688,0.021512851,0.15878887],"study_design_scores_gemma":[0.6998902,0.00082214735,0.2668791,0.0019013123,0.00038001206,0.0000017953323,0.00035028576,0.0033602633,0.0002553423,0.003171402,0.022729803,0.00025830843],"about_ca_topic_score_codex":0.0031016557,"about_ca_topic_score_gemma":0.0052916347,"teacher_disagreement_score":0.43617475,"about_ca_system_score_codex":0.0010964648,"about_ca_system_score_gemma":0.0014018443,"threshold_uncertainty_score":0.5309158},"labels":[],"label_agreement":null},{"id":"W4405319343","doi":"10.1158/1078-0432.ccr-24-2523","title":"Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Gilead Sciences","keywords":"Medicine; Internal medicine; Neutropenia; Mucositis; Adverse effect; Nausea; Phases of clinical research; Head and neck squamous-cell carcinoma; Febrile neutropenia; Surgery; Clinical endpoint; Oncology; Chemotherapy; Gastroenterology; Head and neck cancer; Cancer; Clinical trial","score_opus":0.1086492114854232,"score_gpt":0.4598629325768382,"score_spread":0.351213721091415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405319343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847617,0.0076797004,8.86864e-7,0.003612926,0.00044577668,0.0018932004,0.00036541565,0.000052794996,0.0011875576],"genre_scores_gemma":[0.99705195,0.0006081366,0.000037394282,0.00032965757,0.000533879,0.000264961,0.00004713405,0.00005585673,0.0010710054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565417,0.00061028986,0.00087464147,0.0010971088,0.0010710232,0.0006927584],"domain_scores_gemma":[0.995765,0.002716174,0.00007477473,0.0007829191,0.00031652715,0.000344608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016819406,0.00027095687,0.00073312805,0.00015049448,0.0003566147,0.00006404074,0.00025341028,0.00015252826,0.00008663999],"category_scores_gemma":[0.0010483298,0.00016233078,0.000093146795,0.00074949005,0.00055062043,0.00013404367,0.0003313006,0.0021642768,0.000023857468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037044764,0.006383855,0.83645576,0.00018447587,0.00011462898,0.00040687076,0.006054276,0.0000034737075,0.000050795246,0.0000088357865,0.014977343,0.09831494],"study_design_scores_gemma":[0.056019012,0.031147202,0.87563545,0.00046430816,0.00008636825,6.242409e-7,0.0013463523,0.00008084875,0.000043539956,0.000035251152,0.03492627,0.00021480373],"about_ca_topic_score_codex":0.0041150656,"about_ca_topic_score_gemma":0.0064781285,"teacher_disagreement_score":0.09810014,"about_ca_system_score_codex":0.00047210304,"about_ca_system_score_gemma":0.0009542772,"threshold_uncertainty_score":0.9402826},"labels":[],"label_agreement":null},{"id":"W4405368058","doi":"10.1158/1078-0432.ccr-24-0439","title":"Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Pharmacodynamics; Adverse effect; Mesylate; Internal medicine; Pharmacology; Oncology; Pharmacokinetics; Melanoma; Cancer; Immunotherapy; Cancer research; Chemistry","score_opus":0.16615465021824888,"score_gpt":0.47784201619372335,"score_spread":0.3116873659754745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405368058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995708,0.00072104076,0.0000023421326,0.00093186134,0.00029224422,0.0021338689,0.000056599976,0.000086206375,0.00006784301],"genre_scores_gemma":[0.9969902,0.000596264,0.000024916446,0.00020195672,0.00007293095,0.00033514216,0.000001275786,0.000054174914,0.0017231152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99479395,0.0012318816,0.001016026,0.0011462593,0.0010346522,0.0007772332],"domain_scores_gemma":[0.9952317,0.0035468258,0.0001511641,0.00068803213,0.0001696306,0.00021263336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015622985,0.0002968954,0.00075477734,0.00030102566,0.00025841294,0.00013288716,0.00073626154,0.00013677753,0.00016081841],"category_scores_gemma":[0.003967602,0.00015652183,0.00009561919,0.0024560662,0.0014947176,0.00024250936,0.00057365594,0.0012569712,0.000014229167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30343416,0.060850214,0.02860822,0.0063421475,0.00046844935,0.01246068,0.022505416,0.00054649357,0.38373587,0.001489849,0.0142039545,0.16535456],"study_design_scores_gemma":[0.13519062,0.0961205,0.029576737,0.005358937,0.00006239421,0.0002121231,0.024084998,0.005743403,0.6973561,0.0015749527,0.002957208,0.0017620414],"about_ca_topic_score_codex":0.00019111033,"about_ca_topic_score_gemma":0.0037376331,"teacher_disagreement_score":0.31362024,"about_ca_system_score_codex":0.00011319,"about_ca_system_score_gemma":0.0010052109,"threshold_uncertainty_score":0.6382775},"labels":[],"label_agreement":null},{"id":"W4405368113","doi":"10.1158/1078-0432.ccr-24-1779","title":"Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Canadian Nuclear Laboratories; University of Saskatchewan; Saskatoon Medical Imaging; Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research","keywords":"Trastuzumab; Biodistribution; Medicine; Pharmacology; Cancer; Internal medicine; Breast cancer; Chemistry; In vitro","score_opus":0.32613720757807146,"score_gpt":0.588059894922568,"score_spread":0.2619226873444966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405368113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96334475,0.017461969,0.0002462545,0.010706226,0.0012433823,0.0028745583,0.0008122826,0.00019501688,0.0031155648],"genre_scores_gemma":[0.98622465,0.0074180216,0.0010902772,0.00030127433,0.0017333021,0.0001614018,0.00010228272,0.00020155813,0.0027672532],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9888843,0.0021316477,0.002034094,0.0016411906,0.003437111,0.0018716146],"domain_scores_gemma":[0.99197,0.0033024803,0.0001882167,0.0013337508,0.0017884679,0.0014170718],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009310997,0.00047762724,0.0016303811,0.0008598966,0.00047631827,0.0002084059,0.00084781396,0.00039986073,0.0016764634],"category_scores_gemma":[0.0019604089,0.00038988463,0.000738139,0.0028867344,0.002428602,0.00018471864,0.00062827306,0.00398588,0.00017394194],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007949171,0.0030352466,0.034787558,0.006688416,0.002605835,0.005501908,0.0020804233,0.00016444594,0.8153382,0.0009959093,0.06292464,0.057928246],"study_design_scores_gemma":[0.022035783,0.0140060065,0.19685291,0.063918926,0.0019243709,0.00064515346,0.003568763,0.062606856,0.11679101,0.002212512,0.5119876,0.003450079],"about_ca_topic_score_codex":0.005510885,"about_ca_topic_score_gemma":0.00024456283,"teacher_disagreement_score":0.6985472,"about_ca_system_score_codex":0.0013836225,"about_ca_system_score_gemma":0.005754994,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W4405424757","doi":"10.1158/1078-0432.ccr-24-2200","title":"HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Swim Across America","keywords":"Gemcitabine; HMGA2; Pancreatic cancer; Oncology; Internal medicine; Medicine; Immunohistochemistry; Mesothelin; Cohort; Pathology; Cancer research; Chemotherapy; Biology; Cancer","score_opus":0.22268691232988727,"score_gpt":0.465861301035083,"score_spread":0.24317438870519573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405424757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98267883,0.015482262,0.00003117926,0.0004389406,0.00051968696,0.00028405397,0.000031974356,0.000016062548,0.00051702943],"genre_scores_gemma":[0.98936003,0.008184597,0.00005392559,0.00003510979,0.0006746741,0.00008823408,0.000034862056,0.000028463499,0.0015400759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998128,0.0003183295,0.0003799293,0.00057557493,0.00024005085,0.0003581478],"domain_scores_gemma":[0.9992549,0.00021498343,0.000018741617,0.00028092577,0.000060876173,0.000169571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094486,0.00013528837,0.00024237821,0.000078543926,0.000066649394,0.000064153166,0.00015091183,0.0002192801,0.00005740061],"category_scores_gemma":[0.00021159276,0.000104008315,0.00009108806,0.0001638226,0.00024932515,0.0000058608025,0.00010653088,0.00033448008,0.000014418561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046009163,0.0001582501,0.92739314,0.00007299037,0.000046664747,0.00007425459,0.00006967165,0.0000038002793,0.06514717,0.00003489757,0.00075569795,0.0057833986],"study_design_scores_gemma":[0.0033628787,0.002959171,0.9204127,0.00034960607,0.00005514863,0.000014717086,0.00020344612,0.00070399104,0.042355902,0.0002320602,0.028923972,0.00042640846],"about_ca_topic_score_codex":0.0006280472,"about_ca_topic_score_gemma":0.0006835592,"teacher_disagreement_score":0.028168274,"about_ca_system_score_codex":0.00006131462,"about_ca_system_score_gemma":0.00024930906,"threshold_uncertainty_score":0.4241336},"labels":[],"label_agreement":null},{"id":"W4405803075","doi":"10.1158/1078-0432.ccr-24-2729","title":"Challenges to Innovation Arising from Current Companion Diagnostic Regulations and Suggestions for Improvements","year":2024,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Astellas Pharma; Regeneron Pharmaceuticals; International Association for the Study of Lung Cancer; Eisai; Daiichi Sankyo Europe; Sanofi; Genentech; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Flexibility (engineering); Companion diagnostic; Risk analysis (engineering); Diagnostic test; Quality (philosophy); Consistency (knowledge bases); Medicine; Clinical trial; Diagnostic accuracy; Unintended consequences; Medical physics; Precision medicine; New product development; Business; Computer science; Marketing; Pathology; Cancer","score_opus":0.16174615951432111,"score_gpt":0.5629987054769863,"score_spread":0.40125254596266513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405803075","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059017666,0.08180154,0.014424274,0.0028473332,0.8367985,0.002292787,0.0026812898,0.00004793338,0.00008869331],"genre_scores_gemma":[0.07935294,0.043010958,0.0008167832,0.000029239109,0.8711003,0.00131707,0.003772455,0.00010898785,0.0004912504],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802226,0.00009131111,0.0004652007,0.00074593304,0.00038046364,0.00029485134],"domain_scores_gemma":[0.99706286,0.001667924,0.000052103616,0.00034803603,0.00074891426,0.000120186916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012654118,0.00016278135,0.00023319059,0.00015917665,0.00011385217,0.00008394229,0.0001832687,0.00046119254,0.000006591552],"category_scores_gemma":[0.007163021,0.00016436861,0.00006865031,0.00020130898,0.00007902918,0.0000026020018,0.00031544958,0.0007075822,0.00000674224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051638453,0.000054998174,0.00009190793,0.00025842068,0.00008063596,4.275537e-7,0.000040964926,0.00007677646,0.003183891,0.00007512724,0.84570104,0.15038419],"study_design_scores_gemma":[0.00040292798,0.00031130324,0.0022599355,0.00049475767,0.000048074773,6.8843825e-8,0.000024648902,0.00016137052,0.0010383769,0.0008962682,0.994168,0.00019427437],"about_ca_topic_score_codex":0.000103127386,"about_ca_topic_score_gemma":0.00035631756,"teacher_disagreement_score":0.1501899,"about_ca_system_score_codex":0.00005679873,"about_ca_system_score_gemma":0.00033341325,"threshold_uncertainty_score":0.85753226},"labels":[],"label_agreement":null},{"id":"W4406229659","doi":"10.1158/1078-0432.ccr-24-3472","title":"Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Association of Medical Oncologists; Canadian Cancer Society Research Institute; EMD Serono; Genentech; Astellas Pharma; Break Through Cancer; Celgene; Symphogen; Bristol-Myers Squibb; AstraZeneca; Princess Margaret Cancer Foundation; Amgen; Pfizer; Agios Pharmaceuticals; GlaxoSmithKline","keywords":"Circulating tumor DNA; Breast cancer; Medicine; Internal medicine; Oncology; Cancer; Stage (stratigraphy); Carcinogenesis; Biology","score_opus":0.08430180109231573,"score_gpt":0.4622361139770893,"score_spread":0.3779343128847736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406229659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981625,0.0009412429,0.000078452125,0.000062539104,0.0003769753,0.00020179602,0.00011448812,0.0000026484372,0.000059343532],"genre_scores_gemma":[0.99853826,0.00086581515,0.00009651617,0.000031558666,0.00039714208,0.00002113012,0.0000024042347,0.000012884028,0.000034278666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986684,0.00016073164,0.0003586277,0.00037672513,0.00015227532,0.0002832467],"domain_scores_gemma":[0.9991872,0.00021397983,0.00007908859,0.00018432242,0.00025977977,0.000075676166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068840134,0.00009391793,0.00020047966,0.00009718918,0.00009431832,0.000029347926,0.00009927673,0.000117501455,0.000008470267],"category_scores_gemma":[0.0004241541,0.000096739124,0.000051301213,0.00025672987,0.00021400477,0.000005926029,0.00016692099,0.0003051017,1.8421909e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003147729,0.000018696688,0.615673,0.000057068482,0.000040291085,0.000008666755,0.000045849014,0.0005108599,0.37263638,0.000019571293,0.0000044395056,0.010670401],"study_design_scores_gemma":[0.00076480233,0.00007632036,0.88704437,0.00018036166,0.000012446137,0.0000037492007,0.00017681395,0.0014661874,0.11005133,0.00008343687,0.000040646333,0.000099561825],"about_ca_topic_score_codex":0.006722829,"about_ca_topic_score_gemma":0.0012430581,"teacher_disagreement_score":0.27137133,"about_ca_system_score_codex":0.00010673274,"about_ca_system_score_gemma":0.0004123687,"threshold_uncertainty_score":0.99989146},"labels":[],"label_agreement":null},{"id":"W4406529540","doi":"10.1158/1078-0432.ccr-24-3460","title":"Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Oncology; Internal medicine; Medical physics","score_opus":0.9229359243482055,"score_gpt":0.7965946298669643,"score_spread":0.1263412944812412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406529540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71181613,0.029076427,0.00016780007,0.21733187,0.0005133071,0.004713543,0.0000269091,0.000085223044,0.03626881],"genre_scores_gemma":[0.67630666,0.26319456,0.008549728,0.031267684,0.0006186922,0.0011025142,0.00006293964,0.00006574511,0.018831465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99058354,0.0044424958,0.0025498995,0.00064577814,0.001306573,0.00047174143],"domain_scores_gemma":[0.7830834,0.20517462,0.00084089383,0.0015944863,0.007814236,0.0014923777],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09993673,0.00013004485,0.0014650138,0.00034851776,0.00014727373,0.000018002247,0.00033061707,0.0007482169,0.00055431615],"category_scores_gemma":[0.43955478,0.00010037309,0.00015167707,0.0013557934,0.0019312009,0.000063878695,0.0005166989,0.004412693,0.000028158005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059889667,0.0014975658,0.099125706,0.029093329,0.0011923224,0.000040719548,0.00024700354,4.1102675e-7,0.008525897,0.014663006,0.11539553,0.7242295],"study_design_scores_gemma":[0.0064883106,0.0026539043,0.14259854,0.040160555,0.00070341304,0.0000054606535,0.0003754458,0.00005266137,0.07815907,0.055407204,0.6729765,0.00041890753],"about_ca_topic_score_codex":0.00011245097,"about_ca_topic_score_gemma":0.00012566813,"teacher_disagreement_score":0.7238106,"about_ca_system_score_codex":0.00029655223,"about_ca_system_score_gemma":0.014803799,"threshold_uncertainty_score":0.99788415},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4406665586","doi":"10.1158/1078-0432.ccr-24-2753","title":"Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Multiple myeloma; Cmax; Population; Medicine; Pharmacokinetics; Oncology; Immunology; Pharmacology; Internal medicine","score_opus":0.08116083786380267,"score_gpt":0.4550818260549206,"score_spread":0.3739209881911179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406665586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943435,0.00092678773,0.00000608753,0.0005061712,0.00036062414,0.0023979978,0.00004457384,0.00011655035,0.0012976908],"genre_scores_gemma":[0.9922681,0.0012124815,0.00081101194,0.000108546476,0.00023791874,0.00016980055,0.0002433317,0.000074394484,0.00487444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941761,0.0014238276,0.0011319496,0.0010100863,0.0014232548,0.0008347917],"domain_scores_gemma":[0.99627477,0.0008836671,0.00020980755,0.0010027225,0.001279236,0.00034981317],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028018905,0.00026581564,0.0008658932,0.0007675205,0.00012935248,0.000027948694,0.00045774723,0.00027190088,0.00175716],"category_scores_gemma":[0.0013637076,0.00022254058,0.00012378064,0.0024194254,0.0005672349,0.00014479662,0.0002710957,0.0018682088,0.00002686842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010968919,0.0027481022,0.7949818,0.00027842514,0.000115967254,0.000013987664,0.000098702374,0.00004381788,0.04597851,0.000002660211,0.0019626713,0.14280649],"study_design_scores_gemma":[0.010416441,0.0025622963,0.95414233,0.0002905435,0.000037592046,5.266839e-7,0.000034210803,0.00096786587,0.020572677,0.000015956983,0.010758208,0.00020135644],"about_ca_topic_score_codex":0.0018901193,"about_ca_topic_score_gemma":0.00034337817,"teacher_disagreement_score":0.15916057,"about_ca_system_score_codex":0.00049905106,"about_ca_system_score_gemma":0.0011857415,"threshold_uncertainty_score":0.99915534},"labels":[],"label_agreement":null},{"id":"W4406665590","doi":"10.1158/1078-0432.ccr-24-3128","title":"Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Medicine; Internal medicine; Bevacizumab; Neutropenia; Ovarian cancer; Clinical endpoint; Paclitaxel; Oncology; Refractory (planetary science); Progression-free survival; Phases of clinical research; Mesothelin; Gastroenterology; Urology; Cancer; Randomized controlled trial; Chemotherapy","score_opus":0.18897456220348152,"score_gpt":0.5220860365257134,"score_spread":0.33311147432223187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406665590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686331,0.0038361687,0.000016331915,0.015580615,0.00062222197,0.0099796625,0.0002142127,0.000056174707,0.0010615193],"genre_scores_gemma":[0.98512423,0.0034983899,0.00023458617,0.00033206082,0.0005855256,0.0047151763,0.000042792955,0.00007549408,0.005391718],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.990809,0.0024406624,0.0026027462,0.0013911005,0.001762224,0.0009942681],"domain_scores_gemma":[0.9911183,0.0057710693,0.000496217,0.0013158186,0.00083765516,0.00046090205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0063351225,0.0005106815,0.0032994922,0.0007865762,0.0003020207,0.000063436884,0.00046520395,0.00036913864,0.0017638778],"category_scores_gemma":[0.0017922815,0.00032748436,0.00031976134,0.0020910704,0.0009390449,0.00014442299,0.00026386237,0.0016955513,0.000008560126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9214471,0.029825335,0.007055563,0.00032517614,0.0022394191,0.00063196797,0.0007264138,0.000024842157,0.000102998674,0.0003319067,0.006295257,0.03099403],"study_design_scores_gemma":[0.9303441,0.03971202,0.019664649,0.0016788921,0.0010536298,0.0000024371275,0.0011023583,0.00009179823,0.00024467177,0.00026888083,0.0055285506,0.00030801483],"about_ca_topic_score_codex":0.02695289,"about_ca_topic_score_gemma":0.024310894,"teacher_disagreement_score":0.030686013,"about_ca_system_score_codex":0.0012598075,"about_ca_system_score_gemma":0.0055416287,"threshold_uncertainty_score":0.99991775},"labels":[],"label_agreement":null},{"id":"W4406833871","doi":"10.1158/1557-3265.targetedtherap-b027","title":"Abstract B027: Investigating NRF2-mediated radioresistance in HPV-negative head and neck squamous cell carcinoma preclinical models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radioresistance; Head and neck squamous-cell carcinoma; Head and neck; Medicine; Basal cell; Head and neck cancer; Cancer research; Oncology; Pathology; Radiation therapy; Internal medicine; Surgery","score_opus":0.1644090731531915,"score_gpt":0.4689146897931072,"score_spread":0.3045056166399157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406833871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817511,0.010091799,0.00006722494,0.0010601685,0.00017360377,0.00048534726,0.000054330852,0.000010726512,0.00630573],"genre_scores_gemma":[0.99487215,0.0024037387,0.0004282037,0.00047653276,0.00027953406,0.0002894302,0.0000344501,0.00002403422,0.0011919278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709815,0.0004605977,0.0007769427,0.00077207293,0.0003116504,0.0005805676],"domain_scores_gemma":[0.9978809,0.00089178316,0.00011420956,0.0005374063,0.00029863566,0.00027711462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022631472,0.00017650076,0.0003282557,0.00011616863,0.00016497186,0.000056311572,0.00036332733,0.00037191462,0.00003714381],"category_scores_gemma":[0.0021539119,0.00016898673,0.00009874007,0.00047501887,0.00074271794,0.000017488008,0.00024378524,0.0009000788,0.0000067517053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020993182,0.0013196167,0.88821006,0.0005891006,0.00008459075,0.000020333668,0.00045676628,0.0011161218,0.046135355,0.0010782805,0.032617413,0.026273068],"study_design_scores_gemma":[0.0043377243,0.00045275365,0.9655287,0.00015398294,0.000016143711,7.826708e-7,0.000299512,0.002642521,0.015720997,0.0024261286,0.008043386,0.00037734178],"about_ca_topic_score_codex":0.00088170765,"about_ca_topic_score_gemma":0.0011067833,"teacher_disagreement_score":0.07731869,"about_ca_system_score_codex":0.000101976664,"about_ca_system_score_gemma":0.0009856004,"threshold_uncertainty_score":0.68910795},"labels":[],"label_agreement":null},{"id":"W4406833883","doi":"10.1158/1557-3265.targetedtherap-b016","title":"Abstract B016: Targeting the angiotensin receptor in cancer-associated fibroblasts improves tumour perfusion, oxygenation, and radiotherapy response","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Oxygenation; Cancer; Perfusion; Radiation therapy; Receptor; Cancer research; Angiotensin II; Oncology; Internal medicine","score_opus":0.04477540321370125,"score_gpt":0.4245369218310078,"score_spread":0.3797615186173065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406833883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94554514,0.04113724,0.000010420739,0.011741473,0.00096943195,0.00046924088,0.000044510958,0.000012049996,0.00007047298],"genre_scores_gemma":[0.9485683,0.04520493,0.00010653688,0.00096190354,0.001652108,0.00016983239,0.000026340338,0.000031062656,0.0032790278],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709177,0.0009095607,0.0005482191,0.00061510876,0.00031703504,0.000518304],"domain_scores_gemma":[0.9983406,0.0005961333,0.00011528847,0.00032931063,0.0004950296,0.00012361738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055082366,0.00016581907,0.00029260144,0.00013284563,0.00027721637,0.00007149929,0.00033385438,0.00030262108,0.000081655315],"category_scores_gemma":[0.0032170892,0.00012757389,0.00012145093,0.0005149519,0.00041798194,0.000009360309,0.00019917387,0.0006448395,0.0000023996233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002388554,0.00010376037,0.004906517,0.000020075018,0.00006267352,9.830869e-7,0.00014798492,0.000031465344,0.8381816,0.000012584512,0.11185867,0.04228511],"study_design_scores_gemma":[0.0022592128,0.00026549553,0.4507922,0.00017451709,0.00001256873,6.197212e-7,0.00021749585,0.00016143051,0.045224387,0.00009425513,0.50057167,0.00022615773],"about_ca_topic_score_codex":0.0018498822,"about_ca_topic_score_gemma":0.002241944,"teacher_disagreement_score":0.79295725,"about_ca_system_score_codex":0.0001334846,"about_ca_system_score_gemma":0.0011304107,"threshold_uncertainty_score":0.52023125},"labels":[],"label_agreement":null},{"id":"W4406833916","doi":"10.1158/1557-3265.targetedtherap-ia08","title":"Abstract IA08: Theragnostics &amp; external beam radiation dose absorbed - Similarities, differences and thoughts for the future","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"External beam radiation; Medicine; Radiation; Medical physics; Nuclear medicine; Radiation therapy; Internal medicine; Physics; Optics","score_opus":0.10603975608696287,"score_gpt":0.5036678228059782,"score_spread":0.39762806671901535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406833916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6833907,0.047864377,0.24673864,0.013194969,0.002312424,0.0039875135,0.000541065,0.00017630894,0.0017939926],"genre_scores_gemma":[0.97454333,0.012177208,0.0039577247,0.00043618653,0.005685848,0.00081730494,0.000017196937,0.00003221685,0.0023329596],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862516,0.000119641765,0.0003462105,0.00032666608,0.00025382283,0.0003285198],"domain_scores_gemma":[0.9951223,0.0042156368,0.00008200953,0.0003283127,0.00017824107,0.000073502386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010869417,0.00013255708,0.00022954684,0.00005554639,0.0004100728,0.00013489879,0.00035695644,0.000104189596,0.00020770359],"category_scores_gemma":[0.00009773861,0.00008578745,0.00010553935,0.00016611756,0.00037096167,0.00009363524,0.00007368598,0.00070922286,0.0000010646972],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048864,0.00021664193,0.20788227,0.000065084394,0.0002218343,6.8656084e-7,0.00023782295,0.000029908782,0.0005065943,0.010147151,0.024483798,0.75571954],"study_design_scores_gemma":[0.001695574,0.000174691,0.45755616,0.00018214459,0.00004013645,1.7762599e-7,0.00028236082,0.0005701697,0.0013003575,0.086131,0.45181152,0.00025569086],"about_ca_topic_score_codex":0.000192816,"about_ca_topic_score_gemma":0.00007447563,"teacher_disagreement_score":0.7554639,"about_ca_system_score_codex":0.000047676098,"about_ca_system_score_gemma":0.00021106799,"threshold_uncertainty_score":0.34983104},"labels":[],"label_agreement":null},{"id":"W4406834038","doi":"10.1158/1557-3265.targetedtherap-p011","title":"Abstract P011: STN1 (OBFC1) promotes DNA double-strand break repair in a potentially CTC1-STN1-TEN1 (CST) complex-independent role in pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"DNA; Pancreatic cancer; DNA repair; Cancer; Homologous recombination; Cancer research; Biology; Genetics","score_opus":0.09368675203698996,"score_gpt":0.45092708273639587,"score_spread":0.3572403306994059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406834038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860142,0.0072297906,0.000024434621,0.0019969782,0.00040428503,0.0012023977,0.00024727822,0.000023910816,0.002856765],"genre_scores_gemma":[0.9872664,0.0096563,0.00016420089,0.00050648727,0.00046052647,0.00058761006,0.000104273706,0.000047066245,0.0012071317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958857,0.000285041,0.0011447656,0.0011598928,0.00054854184,0.0009760391],"domain_scores_gemma":[0.99801517,0.0003924472,0.00013970163,0.00080385373,0.0003783515,0.0002704887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025824336,0.00030459862,0.0006163876,0.0002749034,0.00013788832,0.00009672888,0.0006604902,0.0004846056,0.00036829954],"category_scores_gemma":[0.0005390766,0.00030138728,0.00029140693,0.000571358,0.00040155515,0.000012603292,0.00052154536,0.0010211401,0.000021395439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010813456,0.0026536407,0.7443134,0.00081229815,0.00067090674,0.00031596984,0.00026562402,0.0024142999,0.1658054,0.0005012306,0.028522575,0.042911194],"study_design_scores_gemma":[0.01116965,0.00071005314,0.89699554,0.0007103148,0.000074010204,0.0000047252975,0.00029143572,0.0008322525,0.020238329,0.0012301974,0.06704748,0.00069600693],"about_ca_topic_score_codex":0.016439555,"about_ca_topic_score_gemma":0.0760718,"teacher_disagreement_score":0.15268214,"about_ca_system_score_codex":0.00033430834,"about_ca_system_score_gemma":0.0022531964,"threshold_uncertainty_score":0.99994385},"labels":[],"label_agreement":null},{"id":"W4406834106","doi":"10.1158/1557-3265.targetedtherap-p008","title":"Abstract P008: Evaluating associations between genomic classifier and digital pathology based mutli-modal AI biomarkers in oligometastatic castration-sensitive prostate cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Prostate cancer; Medicine; Classifier (UML); Pathology; Digital pathology; Cancer; Oncology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.15360829387418082,"score_gpt":0.5487248457129404,"score_spread":0.3951165518387596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406834106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731603,0.0005238098,0.0001780207,0.024099704,0.00020723749,0.0008091876,0.00017247185,0.000026583735,0.0008226401],"genre_scores_gemma":[0.99728537,0.00029354042,0.00048638566,0.0011304534,0.0002364346,0.00014481357,0.00010626309,0.000027036074,0.0002897308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679047,0.0005613902,0.0008795068,0.0006148385,0.0005649621,0.00058885064],"domain_scores_gemma":[0.9952781,0.0036424412,0.00014908522,0.00023020475,0.0004372474,0.0002628882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054959077,0.00016328909,0.0005880051,0.00044554405,0.00020785844,0.00013424817,0.00011987387,0.00018519316,0.00006946722],"category_scores_gemma":[0.005914469,0.00014716153,0.00010458073,0.0006756458,0.00069049816,0.00012456944,0.000107353146,0.0019257804,0.000009935403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028788694,0.00012493473,0.7987823,0.00011639627,0.00023881203,0.00011373382,0.00020431276,0.00015615538,0.0016869261,0.000036449997,0.0007179529,0.19753416],"study_design_scores_gemma":[0.0033230162,0.00021327927,0.97600824,0.00044889475,0.000090109585,0.0000024360147,0.00020668127,0.018611334,0.00008078441,0.00050296454,0.00038418584,0.00012806203],"about_ca_topic_score_codex":0.0012139685,"about_ca_topic_score_gemma":0.0002883266,"teacher_disagreement_score":0.1974061,"about_ca_system_score_codex":0.0005040494,"about_ca_system_score_gemma":0.002235838,"threshold_uncertainty_score":0.83666646},"labels":[],"label_agreement":null},{"id":"W4407392464","doi":"10.1158/1078-0432.ccr-24-3278","title":"Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric <i>NF2</i> -, <i>SMARCB1</i> -, and <i>LZTR1</i> -Related Schwannomatosis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Manchester Biomedical Research Centre; National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; American Lebanese Syrian Associated Charities; National Institute for Health and Care Research; Department of Health and Social Care; Servier; Hospital Research Foundation; Alexion Pharmaceuticals","keywords":"Neurofibromatosis type 2; SMARCB1; Medicine; Schwannoma; Neurofibromatoses; Meningioma; Acoustic neuroma; Oncology; Pathology; Internal medicine; Neurofibromatosis; Surgery; Biology; Gene","score_opus":0.058320933855205655,"score_gpt":0.4134866590835648,"score_spread":0.35516572522835915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407392464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973744,0.014004186,9.949322e-7,0.007876463,0.00065926317,0.0009832698,0.00011264097,0.000106369465,0.0025128373],"genre_scores_gemma":[0.98384297,0.013449494,0.000030664418,0.0014717272,0.0003346139,0.00026050198,0.000011841671,0.000049558254,0.00054861116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951519,0.00076402235,0.0011810479,0.0011392839,0.0007220223,0.0010417571],"domain_scores_gemma":[0.99689394,0.0015312451,0.00015027876,0.00058532454,0.00028254237,0.0005566631],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020767462,0.0003209656,0.0009969105,0.00047758868,0.00024732246,0.00012695376,0.0002464302,0.00024382875,0.000044195036],"category_scores_gemma":[0.0006060194,0.00027036277,0.00014292436,0.0015552609,0.00051770394,0.00010982548,0.0003397005,0.0015484907,0.000022387087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016297468,0.00027756565,0.96771884,0.0014583162,0.000069976566,0.0008233962,0.000030745807,0.000009805287,0.00029052695,0.0010803238,0.017757889,0.008852861],"study_design_scores_gemma":[0.005286833,0.0006056294,0.9798034,0.0012798007,0.00008219776,0.000082657345,0.00010487122,0.00046055764,0.00063920976,0.00009142141,0.011239145,0.00032431824],"about_ca_topic_score_codex":0.0010068634,"about_ca_topic_score_gemma":0.0003959257,"teacher_disagreement_score":0.012084513,"about_ca_system_score_codex":0.00024789516,"about_ca_system_score_gemma":0.00084539544,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W4407392510","doi":"10.1158/1078-0432.ccr-24-1818","title":"AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"AstraZeneca","keywords":"Durvalumab; Medicine; Tolerability; Combination therapy; Adverse effect; Internal medicine; Toxicity; Pharmacology; Cancer; Urology; Oncology; Gastroenterology; Immunotherapy","score_opus":0.06226559789994827,"score_gpt":0.4923652683580123,"score_spread":0.430099670458064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407392510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952103,0.00062596524,0.00001026456,0.001335805,0.00013579662,0.0024183008,0.00000975956,0.000026562553,0.00022725771],"genre_scores_gemma":[0.99755275,0.0011318851,0.00021385324,0.0005460755,0.0000801552,0.00022998771,0.000029210807,0.00003579434,0.00018028918],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99688643,0.0005740284,0.0007707508,0.00063292845,0.000618106,0.0005177391],"domain_scores_gemma":[0.9985761,0.0004522218,0.00013383098,0.0003359436,0.00033163372,0.0001702755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002612173,0.00019014637,0.0006029956,0.00044953957,0.0001182894,0.000052874668,0.0001435298,0.00013295093,0.0000736006],"category_scores_gemma":[0.0004057465,0.00014396927,0.00005587591,0.0010611389,0.00051134074,0.00020930609,0.000044026016,0.0008007901,0.0000019094648],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6068077,0.0034121135,0.28174362,0.00007791559,0.00008817635,0.00007009446,0.00025470878,0.000012338508,0.00072244834,0.000020822858,0.00014511775,0.10664493],"study_design_scores_gemma":[0.47409567,0.019849926,0.50130725,0.0012360933,0.0000224799,0.0000015742412,0.0003612527,0.00047999964,0.0012118662,0.00013994533,0.0010598715,0.00023404564],"about_ca_topic_score_codex":0.0013231034,"about_ca_topic_score_gemma":0.0013049728,"teacher_disagreement_score":0.21956366,"about_ca_system_score_codex":0.00031175115,"about_ca_system_score_gemma":0.00085588824,"threshold_uncertainty_score":0.58708966},"labels":[],"label_agreement":null},{"id":"W4407564894","doi":"10.1158/1078-0432.ccr-24-1210","title":"Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Eisai; Daiichi-Sankyo; Irish Cancer Society; Wellcome Trust; Harvard T.H. Chan School of Public Health; Harvard University; National Cancer Institute; Brigham and Women's Hospital; Prostate Cancer Foundation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Pfizer; Revolution Medicines","keywords":"MSH2; Medicine; Microsatellite instability; MSH6; PMS2; Prostate cancer; Lynch syndrome; Prostate; Prospective cohort study; MLH1; Prostatectomy; Tissue microarray; Oncology; Internal medicine; Cancer; Pathology; DNA mismatch repair; Colorectal cancer; Biology","score_opus":0.06988423598424741,"score_gpt":0.48806543569206384,"score_spread":0.4181811997078164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407564894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97637564,0.011683664,0.0000040333252,0.00093461986,0.0003983565,0.0033248859,0.00008147814,0.000039241622,0.007158086],"genre_scores_gemma":[0.9844009,0.007513353,0.00019600292,0.00027731134,0.00007447667,0.0019919772,0.0000028080888,0.00002511795,0.005518029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955007,0.00051789824,0.0011870635,0.0009385742,0.0010309968,0.00082480395],"domain_scores_gemma":[0.99745435,0.0008935335,0.00011699187,0.0006477762,0.0007363244,0.00015102183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055791526,0.00018376618,0.0007250044,0.00046957907,0.000053375523,0.000011659562,0.00034719333,0.00026040646,0.0005743329],"category_scores_gemma":[0.0019973044,0.00016161561,0.00016665457,0.0021872632,0.0005765155,0.000063445696,0.00037709755,0.0016146869,0.000009421733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025235966,0.0008859597,0.9858059,0.002543585,0.00004568642,0.0000389956,0.00059657684,0.00003421654,0.0006336674,0.00006702981,0.0015347311,0.005290056],"study_design_scores_gemma":[0.003160306,0.00061241776,0.9913059,0.001929289,0.00003589229,0.0000011085186,0.00018165653,0.00022918885,0.0014369728,0.00047787977,0.0005002991,0.00012909093],"about_ca_topic_score_codex":0.0013517365,"about_ca_topic_score_gemma":0.003929262,"teacher_disagreement_score":0.0080252895,"about_ca_system_score_codex":0.0015948291,"about_ca_system_score_gemma":0.004145365,"threshold_uncertainty_score":0.73537},"labels":[],"label_agreement":null},{"id":"W4407909785","doi":"10.1158/1078-0432.ccr-24-3271","title":"Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Hospital Research Foundation; St. Baldrick's Foundation","keywords":"Retinoblastoma; Medicine; Penetrance; Disease; Genetic predisposition; Cancer; Genetic counseling; Germline mutation; Germline; Pediatrics; Pathology; Internal medicine; Mutation; Genetics; Biology","score_opus":0.24508427939212235,"score_gpt":0.6048086880280561,"score_spread":0.35972440863593375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407909785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017754729,0.9898849,0.00001031892,0.0045938627,0.00037270965,0.00342714,0.0008628379,0.000032194977,0.0006384974],"genre_scores_gemma":[0.000082781815,0.99342716,0.00021137537,0.0002595024,0.00054461544,0.0014143838,0.0015811389,0.000029152852,0.0024498778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972575,0.0008899582,0.00061682606,0.0006689993,0.00022771211,0.00033906262],"domain_scores_gemma":[0.9957183,0.0032987543,0.00013605978,0.00042823056,0.00024162963,0.00017704653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002050843,0.000202384,0.00123759,0.00022262325,0.0002248619,0.000022114891,0.00013766828,0.00053246156,0.00012257577],"category_scores_gemma":[0.0011940014,0.00015196386,0.00034869538,0.00032744242,0.00025800432,0.000023101376,0.00011776045,0.0010939109,0.000059174294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003696317,0.00028844428,0.002460194,0.0042059678,0.00050866924,0.000007934671,0.0000024683306,1.7272335e-8,8.355962e-9,0.00015482692,0.039901007,0.9521008],"study_design_scores_gemma":[0.0016527602,0.0014144813,0.004924615,0.011777793,0.00045735025,0.000010958202,0.000001389796,0.0000018481566,4.3389588e-7,0.00014800277,0.9794964,0.0001139591],"about_ca_topic_score_codex":0.000016718928,"about_ca_topic_score_gemma":0.00003535138,"teacher_disagreement_score":0.95198685,"about_ca_system_score_codex":0.00022309228,"about_ca_system_score_gemma":0.001010882,"threshold_uncertainty_score":0.6196906},"labels":[],"label_agreement":null},{"id":"W4408028458","doi":"10.1158/1078-0432.ccr-24-1724","title":"Health-Related Quality of Life in Patients with HR+/HER2− Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Aromatase inhibitor; Breast cancer; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Internal medicine; Oncology; Cancer; Clinical trial; Anxiety; Tamoxifen; Psychiatry","score_opus":0.11877911940044678,"score_gpt":0.47198029307840106,"score_spread":0.3532011736779543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408028458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97782195,0.0017716669,0.000008198162,0.012357678,0.00025346427,0.0031713853,0.004459212,0.000059491915,0.00009692985],"genre_scores_gemma":[0.9974611,0.00020017389,0.00008052467,0.00073536794,0.00036221455,0.0004711635,0.00033920328,0.000056659563,0.00029362613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99232477,0.0018652246,0.0023432795,0.0010399764,0.0015868428,0.0008399232],"domain_scores_gemma":[0.9937427,0.0030145242,0.0006827438,0.0012143259,0.0009054736,0.00044020853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035497549,0.0003464304,0.0015551362,0.00022976955,0.0002008537,0.00004306764,0.0004918992,0.00028911678,0.000115321396],"category_scores_gemma":[0.0010380044,0.00020688325,0.00015881406,0.0016926943,0.0016497703,0.00019559271,0.00021088263,0.0019656743,0.000010481474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4674968,0.0008300962,0.51529956,0.00009110942,0.0004292468,0.000011332225,0.00043244596,0.000037540703,0.00000989125,0.00001258451,0.0008103351,0.014539063],"study_design_scores_gemma":[0.19122727,0.0021981162,0.8036841,0.0019109849,0.000048843554,8.1271946e-7,0.00025728828,0.00002197571,0.000035981313,0.000051100917,0.0003878143,0.00017571115],"about_ca_topic_score_codex":0.10922929,"about_ca_topic_score_gemma":0.019960009,"teacher_disagreement_score":0.28838456,"about_ca_system_score_codex":0.0009235072,"about_ca_system_score_gemma":0.004840992,"threshold_uncertainty_score":0.9979232},"labels":[],"label_agreement":null},{"id":"W4408363509","doi":"10.1158/1078-0432.ccr-24-3301","title":"Update on Cancer Screening Recommendations for Individuals with Li–Fraumeni Syndrome","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Li–Fraumeni syndrome; Medicine; Cancer; Germline; Genetic predisposition; Population; Intervention (counseling); Modalities; Oncology; Germline mutation; Internal medicine; Gene; Genetics; Mutation; Environmental health; Psychiatry; Biology; Disease","score_opus":0.2692035386000909,"score_gpt":0.5625922580384279,"score_spread":0.29338871943833705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408363509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64978284,0.005307163,0.013514959,0.31045267,0.0014061176,0.008777033,0.0011158312,0.00035695737,0.009286442],"genre_scores_gemma":[0.948795,0.004699938,0.013600399,0.011324532,0.0007566203,0.007066373,0.0003368618,0.00020082212,0.013219448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99676645,0.00028304273,0.0005946239,0.0008146652,0.00079147023,0.0007497667],"domain_scores_gemma":[0.99684083,0.0012813243,0.00011585066,0.0007088275,0.00071960245,0.00033353473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022539576,0.00021554426,0.0005647989,0.00044619222,0.00034745387,0.000071027476,0.00030462397,0.00025621837,0.0007707521],"category_scores_gemma":[0.000603766,0.00016386737,0.00015718135,0.0012815344,0.00041135435,0.00007854734,0.00014517165,0.0016194403,0.000041135747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013838655,0.0013679352,0.09032033,0.00073347293,0.0036258895,0.00027134529,0.00022370384,0.0007899095,0.00036282884,0.00395574,0.3939182,0.490592],"study_design_scores_gemma":[0.0120848,0.0043019755,0.024488403,0.004484824,0.00038299317,0.000023922785,0.00017240393,0.0003946219,0.0022463803,0.00044406313,0.95062774,0.0003478584],"about_ca_topic_score_codex":0.00047682523,"about_ca_topic_score_gemma":0.00060548837,"teacher_disagreement_score":0.5567096,"about_ca_system_score_codex":0.00042768038,"about_ca_system_score_gemma":0.001975705,"threshold_uncertainty_score":0.8439195},"labels":[],"label_agreement":null},{"id":"W4408388714","doi":"10.1158/1078-0432.ccr-24-2198","title":"Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"AstraZeneca","keywords":"Durvalumab; Head and neck squamous-cell carcinoma; Tremelimumab; Medicine; Oncology; Internal medicine; Head and neck cancer; Immunotherapy; Eagle; Cancer; Cancer research; Biology; Pembrolizumab; Ipilimumab","score_opus":0.10291388378504208,"score_gpt":0.4685357877704034,"score_spread":0.3656219039853613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408388714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982118,0.009166157,0.0000039999027,0.0063821534,0.00015680889,0.00043671942,0.00003211545,0.000010668947,0.0016933917],"genre_scores_gemma":[0.99684477,0.0008769218,0.00019647917,0.00014839423,0.00008581572,0.000084883315,0.000010090183,0.000010622311,0.001742005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981052,0.00019726982,0.0005504962,0.00031627226,0.00054591027,0.00028479763],"domain_scores_gemma":[0.9974447,0.0016446104,0.00011479301,0.00015603878,0.00051428523,0.000125574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016047204,0.00011153295,0.00058827066,0.00014766936,0.000114306604,0.00001833888,0.000052824358,0.00008037088,0.000053453015],"category_scores_gemma":[0.0011920537,0.00007924386,0.00006691494,0.00034407628,0.0002462219,0.000044503926,0.00010823394,0.00053111435,0.0000026787209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011601093,0.00026547417,0.9885623,0.0006664801,0.00008503264,0.000012371374,0.00027892928,5.3609915e-7,0.0001948192,0.000040785355,0.0018780332,0.0068551553],"study_design_scores_gemma":[0.0066855014,0.0016548529,0.9882982,0.00028651507,0.00008917475,0.0000017904426,0.00036807213,0.00009556622,0.0013129686,0.000108897824,0.0010235222,0.0000749741],"about_ca_topic_score_codex":0.00039449774,"about_ca_topic_score_gemma":0.00033128908,"teacher_disagreement_score":0.014726803,"about_ca_system_score_codex":0.0001281506,"about_ca_system_score_gemma":0.0006068607,"threshold_uncertainty_score":0.3231471},"labels":[],"label_agreement":null},{"id":"W4408505231","doi":"10.1158/1078-0432.ccr-24-2971","title":"The Dynamically Evolving Cell States and Ecosystem from Benign Nevi to Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Science-Health Joint Medical Scientific Research Project of Chongqing; Natural Science Foundation of Chongqing; National Natural Science Foundation of China","keywords":"Melanoma; Malignant transformation; Cancer research; Biology; Melanocyte; Nevus; Transcriptome; Immune checkpoint; Immune system; Medicine; Immunology; Immunotherapy; Gene expression; Gene; Genetics","score_opus":0.060556040875511544,"score_gpt":0.44841885688119926,"score_spread":0.3878628160056877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408505231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644421,0.002391079,0.0002916078,0.019299403,0.00066101225,0.0009968875,0.000026189078,0.000053573694,0.011838176],"genre_scores_gemma":[0.9781409,0.0022682557,0.00015672285,0.000994284,0.00026052792,0.00013455737,0.0000054816005,0.00001538514,0.018023869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979564,0.0003376823,0.0004593015,0.00044193878,0.0004239661,0.0003807306],"domain_scores_gemma":[0.99629533,0.0026485408,0.000036633835,0.0004586944,0.00028023924,0.00028053983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019309174,0.00009960744,0.00027234346,0.000114220216,0.00031662837,0.00014055487,0.00021105024,0.000091076,0.00024030049],"category_scores_gemma":[0.00085601164,0.000067050125,0.000077697965,0.00033385053,0.00012369509,0.00002245688,0.0003594277,0.00057821546,0.00010156286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052525476,0.00052725873,0.10609808,0.000644878,0.00071137183,0.00037778544,0.0005379551,0.000050447154,0.004082545,0.0014880728,0.26537895,0.6148501],"study_design_scores_gemma":[0.002707403,0.0014603959,0.10080579,0.0005995455,0.0001257035,0.0000067400865,0.0019547702,0.011483652,0.0010360489,0.0020109392,0.8775732,0.0002358178],"about_ca_topic_score_codex":0.0010343095,"about_ca_topic_score_gemma":0.004282324,"teacher_disagreement_score":0.6146143,"about_ca_system_score_codex":0.00023744433,"about_ca_system_score_gemma":0.0002433839,"threshold_uncertainty_score":0.27342248},"labels":[],"label_agreement":null},{"id":"W4408592042","doi":"10.1158/1078-0432.ccr-24-0254","title":"Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with <i>BRAF</i> V600-Mutant Metastatic Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"Memorial Sloan-Kettering Cancer Center; Pfizer; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Metastatic melanoma; Melanoma; Adverse effect; MEK inhibitor; Clinical endpoint; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Cancer research; MAPK/ERK pathway; Kinase","score_opus":0.10792660299837883,"score_gpt":0.4474522176663169,"score_spread":0.33952561466793807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408592042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658126,0.00048171706,0.000076237724,0.00092284323,0.00020634131,0.0011728774,0.00028336613,0.0000040875584,0.00027126024],"genre_scores_gemma":[0.99859464,0.00012662844,0.00010989776,0.0002803521,0.0001134419,0.0001528938,0.000113889764,0.000012771801,0.0004955015],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99697477,0.0007344635,0.0007944626,0.00064699724,0.00043476332,0.00041454483],"domain_scores_gemma":[0.99836713,0.0002030752,0.0001550258,0.0007938901,0.0003575865,0.00012328551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020159665,0.00016422468,0.00048850756,0.0002203794,0.00013128045,0.000018919349,0.00057954073,0.00012777772,0.000049063317],"category_scores_gemma":[0.0008228408,0.00010075028,0.00024120983,0.001448224,0.0002520519,0.0000037783648,0.00039926587,0.00035166703,0.0000029412759],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53196144,0.008884479,0.3131259,0.00007563589,0.0042969,0.00003127053,0.00023587968,0.00084741745,0.09551558,0.00021285216,0.00826382,0.036548816],"study_design_scores_gemma":[0.2637554,0.03553871,0.5654288,0.00011651476,0.00052800844,5.268182e-7,0.00007810251,0.00013016282,0.10248558,0.00033731427,0.031013435,0.00058742653],"about_ca_topic_score_codex":0.00033430776,"about_ca_topic_score_gemma":0.0014231688,"teacher_disagreement_score":0.26820603,"about_ca_system_score_codex":0.000048450966,"about_ca_system_score_gemma":0.00060515833,"threshold_uncertainty_score":0.4108477},"labels":[],"label_agreement":null},{"id":"W4408695657","doi":"10.1158/1078-0432.ccr-24-3905","title":"Precision Endocrine Therapy in Endometrial Cancer: Has Its Time Finally Come?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Endometrial cancer; Endocrine system; Medicine; Cancer; Cancer therapy; Oncology; Gynecology; Internal medicine; Hormone","score_opus":0.34561102202869826,"score_gpt":0.5738653788999695,"score_spread":0.2282543568712712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408695657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88171,0.03773068,0.0000064300216,0.067144126,0.0013749052,0.0029725027,0.00010520711,0.000062810526,0.008893357],"genre_scores_gemma":[0.9187543,0.066558294,0.0000855648,0.0011354438,0.0010384344,0.001457748,0.00002118625,0.000032754542,0.010916307],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960029,0.0006027937,0.00091924064,0.00081014057,0.00094328565,0.00072161347],"domain_scores_gemma":[0.994818,0.003637301,0.00008597081,0.0006099823,0.0005644585,0.00028432687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027954208,0.00021476044,0.00087832054,0.0006827613,0.00015927879,0.00008778135,0.0003461166,0.00019273952,0.0047525642],"category_scores_gemma":[0.0018270018,0.00016444357,0.00026391257,0.0020272408,0.0003075385,0.00007995454,0.00021745876,0.0011437502,0.0002467051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009127783,0.0021490436,0.36694193,0.00009443149,0.00037068033,0.00023876908,0.000053404437,0.000019311723,0.00047253893,0.00023347464,0.06634783,0.55395085],"study_design_scores_gemma":[0.031037774,0.0031049675,0.52299064,0.001251512,0.00007033074,0.0000032041703,0.000015895543,0.00025207168,0.005168168,0.0005476739,0.43535498,0.00020279366],"about_ca_topic_score_codex":0.0019280093,"about_ca_topic_score_gemma":0.00063955534,"teacher_disagreement_score":0.553748,"about_ca_system_score_codex":0.00086190645,"about_ca_system_score_gemma":0.0026196989,"threshold_uncertainty_score":0.9961572},"labels":[],"label_agreement":null},{"id":"W4408889678","doi":"10.1158/1078-0432.ccr-24-3475","title":"Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Janssen Research and Development; National Cancer Institute","keywords":"Minimal residual disease; Clinical trial; Medicine; Oncology; Residual; Disease; Multiple myeloma; Selection (genetic algorithm); Internal medicine; Computer science; Machine learning; Algorithm; Leukemia","score_opus":0.23244624773717434,"score_gpt":0.53304227182326,"score_spread":0.30059602408608566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408889678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97219163,0.0018719719,0.00025656354,0.022368005,0.00016416526,0.002450449,0.00003816508,0.00003647483,0.00062260317],"genre_scores_gemma":[0.99256456,0.0034479967,0.00032860957,0.0006054629,0.00012211903,0.0005370104,0.000019903093,0.000022830596,0.0023515094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677086,0.00061492337,0.0004386987,0.00072471803,0.0006751076,0.0007756796],"domain_scores_gemma":[0.997543,0.0010707108,0.00002456586,0.00039455283,0.00023256455,0.00073463476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012565373,0.00022307219,0.000660926,0.000553908,0.00017699486,0.000063606094,0.00014195888,0.00017560343,0.000048003003],"category_scores_gemma":[0.0015817853,0.00015807376,0.000097144926,0.00068346807,0.0003606326,0.00006276767,0.00025416512,0.00063325616,0.000022313232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006643204,0.0012345568,0.7803825,0.0005230555,0.0010179711,0.00105327,0.0008539659,0.0002961912,0.00083541434,0.000407364,0.0013582151,0.20539427],"study_design_scores_gemma":[0.031038156,0.008101167,0.8878427,0.0020596774,0.00019032984,0.0000080668915,0.00119781,0.062151577,0.0027229474,0.0027425236,0.0015672882,0.0003777636],"about_ca_topic_score_codex":0.0028498715,"about_ca_topic_score_gemma":0.0056648003,"teacher_disagreement_score":0.20501651,"about_ca_system_score_codex":0.000841248,"about_ca_system_score_gemma":0.0009078353,"threshold_uncertainty_score":0.64460605},"labels":[],"label_agreement":null},{"id":"W4408890340","doi":"10.1158/1078-0432.ccr-24-1763","title":"A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden; National Cancer Institute; Ovarian Cancer Research Alliance","keywords":"Endometrial cancer; Proteogenomics; Ovarian cancer; Proteome; Stromal cell; Proteomics; Biology; Oncology; Cancer research; Metastasis; Cancer; Medicine; Internal medicine; Computational biology; Bioinformatics; Gene; Genomics; Genome; Genetics","score_opus":0.18350262832182185,"score_gpt":0.5261286637757375,"score_spread":0.3426260354539157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408890340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8900983,0.08905505,0.00008276999,0.0057930807,0.0012850921,0.0040311427,0.00016460627,0.000058177895,0.009431784],"genre_scores_gemma":[0.96125364,0.033924326,0.0003487606,0.0004485913,0.00084702665,0.0010303328,0.0000088048655,0.000029266379,0.0021092324],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99612904,0.0005452134,0.0011023469,0.00074539543,0.00082543585,0.0006525456],"domain_scores_gemma":[0.9948591,0.0033838872,0.00015499932,0.00054155325,0.0006393956,0.0004210841],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031582762,0.00022340757,0.001199001,0.0011010355,0.00015544266,0.000037796723,0.00028603416,0.0002672205,0.0016309556],"category_scores_gemma":[0.0046606315,0.00017052503,0.00030544636,0.00396278,0.0007508636,0.000064612,0.0003387932,0.000947833,0.000025249374],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010232905,0.0010184123,0.17619509,0.0012232692,0.0011139037,0.000051067327,0.000053380827,0.0000016706208,0.0031610122,0.0008422159,0.0012567184,0.80485034],"study_design_scores_gemma":[0.11375268,0.010548659,0.5429281,0.004176619,0.0015760874,0.000026941083,0.00021825421,0.00010042144,0.034455825,0.004359821,0.28704733,0.000809277],"about_ca_topic_score_codex":0.0039675105,"about_ca_topic_score_gemma":0.00019892483,"teacher_disagreement_score":0.8040411,"about_ca_system_score_codex":0.00049439544,"about_ca_system_score_gemma":0.0019286089,"threshold_uncertainty_score":0.9992817},"labels":[],"label_agreement":null},{"id":"W4409264686","doi":"10.1158/1078-0432.ccr-24-3791","title":"The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy– and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada); McGill University; Ontario Institute for Cancer Research; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Biomarker; Biomarker discovery; Medicine; Medical physics; Radiomics; Emerging technologies; Biobank; Computer science; Data science; Bioinformatics; Artificial intelligence; Proteomics; Biology","score_opus":0.0982077720343121,"score_gpt":0.5355280600723976,"score_spread":0.43732028803808554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409264686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006175945,0.99196863,0.0011777044,0.001654641,0.0002513298,0.0029093924,0.0013804225,0.000007767378,0.00003254115],"genre_scores_gemma":[0.0005183242,0.9923374,0.00029233893,0.000101568934,0.00023893181,0.0061978274,0.00010801432,0.000039837454,0.00016572807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980879,0.00014033483,0.0005874071,0.0007183292,0.00011889332,0.00034716682],"domain_scores_gemma":[0.99435586,0.0042483066,0.00030469627,0.0005737699,0.00047836505,0.00003899002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017047998,0.0002366475,0.00078910554,0.000078707766,0.00029398612,0.000058445326,0.00043909682,0.00070567767,9.023739e-7],"category_scores_gemma":[0.0010346031,0.00016547537,0.0007047968,0.00019619506,0.0014055981,0.0000028953975,0.0002462451,0.00032680502,1.0235303e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023566158,0.00009412019,0.000013580861,0.0024092756,0.00079612015,1.12389486e-7,0.000012328781,0.0000019858808,0.0011455343,0.0014024415,0.0033229187,0.988445],"study_design_scores_gemma":[0.0012428482,0.0015531933,0.000011773316,0.00090507156,0.00020414896,5.8697765e-7,0.00017453279,0.00004362576,0.0008960498,0.0005112573,0.9942641,0.00019279296],"about_ca_topic_score_codex":0.00023678948,"about_ca_topic_score_gemma":0.00022077188,"teacher_disagreement_score":0.9909412,"about_ca_system_score_codex":0.0003013669,"about_ca_system_score_gemma":0.0025332095,"threshold_uncertainty_score":0.674789},"labels":[],"label_agreement":null},{"id":"W4409412811","doi":"10.1158/1078-0432.ccr-24-1845","title":"A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer – Baseline Findings for CA125","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; School of Public Health, Imperial College London; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; Centers for Disease Control and Prevention; Institut Gustave-Roussy; Deutsche Krebshilfe; Vetenskapsrådet; Ministero della Salute; Cancerfonden; Congressionally Directed Medical Research Programs; ZonMw; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Mutuelle Générale de l'Education Nationale; U.S. Department of Defense; Associazione Italiana per la Ricerca sul Cancro; Imperial College London; Deutsches Krebsforschungszentrum; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; European Commission; Compagnia di San Paolo; Cancer Research UK; World Health Organization; Universitetet i Tromsø; NIHR Imperial Biomedical Research Centre; Centre International de Recherche sur le Cancer; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Biomarker; Prospective cohort study; Medicine; Ovarian cancer; Oncology; Cancer; Stage (stratigraphy); Internal medicine; Malignancy; Biomarker discovery; Disease; Biology; Proteomics","score_opus":0.14954379900309872,"score_gpt":0.5181273117367589,"score_spread":0.36858351273366013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409412811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96374345,0.0011609488,0.009135074,0.009278109,0.0006630618,0.015398057,0.00055232213,0.000015418176,0.00005355137],"genre_scores_gemma":[0.9788737,0.0005918222,0.00023163583,0.00014883035,0.00037209628,0.018475784,0.00001238278,0.000021780304,0.0012719173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821436,0.00015223629,0.00052744074,0.0005251452,0.00027484368,0.000305952],"domain_scores_gemma":[0.99243486,0.006201122,0.00010317985,0.00028784023,0.0008936695,0.00007934604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037359106,0.00012430434,0.00041220413,0.00012496416,0.00029195577,0.00006330167,0.00009803275,0.00010145877,0.000023608452],"category_scores_gemma":[0.0019628478,0.00008334102,0.00018432288,0.00032937378,0.0002502852,0.00008792494,0.000055281842,0.00021534582,2.369196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027310591,0.0013302177,0.8809884,0.0006884661,0.0017359112,0.0000014216769,0.00035925733,0.000017905159,0.00035778512,0.0007409332,0.0048091775,0.081659906],"study_design_scores_gemma":[0.020779539,0.0077733854,0.9484029,0.00041861102,0.0012825753,5.687211e-7,0.00090003724,0.0011226251,0.012564018,0.0012806681,0.005336832,0.0001382414],"about_ca_topic_score_codex":0.0020195434,"about_ca_topic_score_gemma":0.00143595,"teacher_disagreement_score":0.08152166,"about_ca_system_score_codex":0.00032503236,"about_ca_system_score_gemma":0.0008226552,"threshold_uncertainty_score":0.33985484},"labels":[],"label_agreement":null},{"id":"W4409478525","doi":"10.1158/1078-0432.ccr-24-3525","title":"Update on Surveillance in Von Hippel–Lindau Disease","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"St. Baldrick's Foundation","keywords":"Medicine; Von Hippel–Lindau disease; Disease; Cancer; Genetic predisposition; Childhood cancer; Intervention (counseling); Intensive care medicine; Bioinformatics; Pathology; Internal medicine; Psychiatry","score_opus":0.1871020730340491,"score_gpt":0.5520508886084972,"score_spread":0.364948815574448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409478525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003000908,0.99328935,0.0000046949835,0.00032409935,0.0031988947,0.0011473314,0.00060435286,0.0000138426085,0.0011173454],"genre_scores_gemma":[0.00014924136,0.9845232,0.000010180129,0.0003764779,0.00614098,0.0007504373,0.0005658509,0.00006964175,0.007414013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99397635,0.001912538,0.0011179138,0.0014966866,0.0006075258,0.00088897586],"domain_scores_gemma":[0.99705714,0.00060419797,0.00019647852,0.0014063348,0.00026785696,0.0004679862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037090513,0.00043587352,0.0015949255,0.00032001952,0.0001072148,0.00006349304,0.0010242924,0.0007694394,0.0001475314],"category_scores_gemma":[0.002586717,0.00037117954,0.0008036422,0.0007520056,0.00040206377,0.000003335375,0.00062828383,0.0018078609,0.0001414673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004281259,0.00019460576,0.00027856644,0.0047325296,0.00009415873,0.000013548969,0.00000224919,0.0000029455298,0.0000019159436,0.00010576349,0.053534165,0.9406114],"study_design_scores_gemma":[0.00065615086,0.00013380298,0.000475742,0.0044248784,0.00005998568,6.507719e-7,0.0000024979538,0.0000017727841,0.0000045173415,0.00007488578,0.9938045,0.00036058648],"about_ca_topic_score_codex":0.00013542516,"about_ca_topic_score_gemma":0.0007879631,"teacher_disagreement_score":0.94027036,"about_ca_system_score_codex":0.0001468928,"about_ca_system_score_gemma":0.0045937123,"threshold_uncertainty_score":0.999874},"labels":[],"label_agreement":null},{"id":"W4409907961","doi":"10.1158/1078-0432.ccr-25-0073","title":"INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research","funders":"EMD Serono; Genentech; Qbiotics; Ipsen; Daiichi Sankyo Europe; LEO Pharma; Gilead Sciences; Servier; Eisai; Astellas Pharma; Eli Lilly and Company; Ono Pharmaceutical; Coherus Biosciences; Rakuten Medical; BeiGene; Relay Therapeutics; Seagen; Agios Pharmaceuticals; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Pfizer; Incyte; F. Hoffmann-La Roche; Sanofi; Exelixis; Directorate for Biological Sciences; GlaxoSmithKline; Amgen; AstraZeneca; Bristol-Myers Squibb","keywords":"Cetuximab; Medicine; Head and neck; Head and neck squamous-cell carcinoma; Basal cell; Head and neck cancer; Oncology; Placebo; Phases of clinical research; Internal medicine; Cancer; Pathology; Chemotherapy; Surgery; Colorectal cancer","score_opus":0.148584438661407,"score_gpt":0.5159044063151957,"score_spread":0.3673199676537887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409907961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96329606,0.025585106,0.00001690157,0.0012070014,0.00035794664,0.006742421,0.000017390765,0.000020318737,0.0027568368],"genre_scores_gemma":[0.99406916,0.0018223333,0.00006180675,0.00020010691,0.000125304,0.002011541,0.000004320579,0.000024569832,0.001680836],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935833,0.002085197,0.0020778738,0.000779031,0.00081225333,0.0006623237],"domain_scores_gemma":[0.9918301,0.006625325,0.0002037377,0.0005230371,0.0005457253,0.00027203842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066099213,0.0002791257,0.003531524,0.00059671036,0.00013003274,0.000029371364,0.00024942224,0.00012759208,0.00014276433],"category_scores_gemma":[0.0035225814,0.00020629523,0.00032128423,0.0008727546,0.0007536593,0.000058033216,0.00034232088,0.0013975411,0.0000052065952],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93851006,0.007410258,0.015589863,0.00081002765,0.0002735657,0.00021030351,0.003162375,0.0000058955848,0.000043804164,0.000038385308,0.0017956869,0.032149803],"study_design_scores_gemma":[0.9778445,0.008659937,0.005489964,0.0007173247,0.0003780798,0.000002710082,0.0031232375,0.003057945,0.00008715903,0.00020662941,0.00027347196,0.0001590524],"about_ca_topic_score_codex":0.0032438072,"about_ca_topic_score_gemma":0.002957981,"teacher_disagreement_score":0.039334457,"about_ca_system_score_codex":0.00035142963,"about_ca_system_score_gemma":0.0014517021,"threshold_uncertainty_score":0.8412475},"labels":[],"label_agreement":null},{"id":"W4409916105","doi":"10.1158/1078-0432.ccr-24-2701","title":"A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech; Pfizer","keywords":"Paclitaxel; Avelumab; Metastatic breast cancer; Breast cancer; Oncology; Hormone receptor; Medicine; Internal medicine; Mammary gland; Cancer; Hormone; Randomized controlled trial; Immunotherapy","score_opus":0.08095628293231082,"score_gpt":0.487306013923848,"score_spread":0.40634973099153715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409916105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98648065,0.001626768,0.00004298584,0.0020373056,0.000060163922,0.0094428,0.00019427792,0.0000152343155,0.00009979894],"genre_scores_gemma":[0.9914715,0.0017470882,0.0000703698,0.00020236328,0.00011245783,0.003650934,0.000035021538,0.00007076098,0.0026395037],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98821414,0.00703905,0.0012733483,0.0011973758,0.0014069042,0.00086918176],"domain_scores_gemma":[0.99505955,0.0018276237,0.00030811233,0.0013359982,0.0012272029,0.00024151622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010602726,0.00041474213,0.0016164995,0.00028388886,0.00041582494,0.00007698832,0.0010393155,0.00015042987,0.00028894303],"category_scores_gemma":[0.001001144,0.0002091531,0.00015887158,0.0017961722,0.0017276211,0.000017767305,0.00063131534,0.0012608554,0.0000036596005],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9470654,0.018664673,0.013304304,0.00006179727,0.0028489884,0.00007490112,0.0017061807,0.00006591565,0.0043237577,0.0000043013315,0.0009820109,0.01089774],"study_design_scores_gemma":[0.7077624,0.26165387,0.0052342257,0.0003607682,0.00046318935,0.000010747487,0.014689567,0.0004023199,0.008631597,0.000028989876,0.00023919666,0.0005231398],"about_ca_topic_score_codex":0.0049608503,"about_ca_topic_score_gemma":0.07342018,"teacher_disagreement_score":0.24298918,"about_ca_system_score_codex":0.00017230076,"about_ca_system_score_gemma":0.0032191484,"threshold_uncertainty_score":0.94348747},"labels":[],"label_agreement":null},{"id":"W4410119734","doi":"10.1158/1078-0432.ccr-25-0423","title":"Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; St. Baldrick's Foundation","keywords":"Perspective (graphical); Cancer; Medicine; Environmental health; Intensive care medicine; Computer science; Internal medicine; Artificial intelligence","score_opus":0.1265205553772792,"score_gpt":0.5565805325251523,"score_spread":0.4300599771478731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410119734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005061439,0.9921993,4.1380852e-7,0.0023323891,0.000546474,0.0021736955,0.00080428226,0.00005655734,0.0013807702],"genre_scores_gemma":[0.0000667484,0.9913031,0.000020337424,0.000074190604,0.003674363,0.0013595651,0.00010844608,0.000053329633,0.0033399272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954526,0.0012905309,0.0006265455,0.001200188,0.00075391005,0.0006762161],"domain_scores_gemma":[0.99589986,0.0020974125,0.00012977571,0.00048610414,0.0007489804,0.0006378868],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012440594,0.00036616286,0.0015988032,0.0006188072,0.0003531907,0.0000929096,0.00017861337,0.0004879077,0.00022037177],"category_scores_gemma":[0.0006935176,0.00027121147,0.00031595156,0.0014406262,0.0005028124,0.00008792985,0.00039754994,0.0025086363,0.000023300488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003783727,0.00029743946,0.005755349,0.01706532,0.0004933704,0.00017942175,0.000019120842,1.3218488e-8,9.8962275e-8,0.00009427724,0.01713727,0.95857996],"study_design_scores_gemma":[0.0011915006,0.0005478113,0.012152067,0.0044806823,0.00059970794,0.000036029232,0.000034624747,0.0000022077793,2.7483233e-7,0.000077759374,0.9806701,0.00020725784],"about_ca_topic_score_codex":0.0005789921,"about_ca_topic_score_gemma":0.00043355394,"teacher_disagreement_score":0.9635328,"about_ca_system_score_codex":0.0006141841,"about_ca_system_score_gemma":0.0030908913,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W4410491589","doi":"10.1158/1078-0432.ccr-25-0369","title":"A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Servier; Astellas Pharma; Daiichi-Sankyo; Generalitat de Catalunya; Agencia Estatal de Investigación; Incyte; Centres de Recerca de Catalunya; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; BeiGene; Merck KGaA; Daiichi Sankyo Europe; Fundación Cellex; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Gastroesophageal Junction; Medicine; Avelumab; Cancer; Perioperative; Chemotherapy; Internal medicine; Oncology; Adenocarcinoma; Gastroenterology; Surgery; Immunotherapy","score_opus":0.142831375325894,"score_gpt":0.5226747736308411,"score_spread":0.3798433983049472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410491589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541117,0.0006003523,0.00010809113,0.0022221692,0.00055272697,0.010791549,0.000064497515,0.000033418597,0.00021601538],"genre_scores_gemma":[0.97056127,0.0006258907,0.00006182056,0.000413343,0.00048194907,0.0065686563,0.000012015599,0.000046053516,0.021229016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581474,0.00044696167,0.0008807439,0.00083225226,0.001296099,0.0007291969],"domain_scores_gemma":[0.99659777,0.000691238,0.00022172878,0.00071122724,0.0016064186,0.00017161347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019023119,0.00029502308,0.0009158839,0.00036575363,0.00068390684,0.000066514986,0.00044347762,0.00008978436,0.0007728947],"category_scores_gemma":[0.00037989757,0.00016353396,0.00015452651,0.0020299195,0.00035594884,0.00012675158,0.0002817043,0.0008423831,0.0000015793191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.080969736,0.01833646,0.7788615,0.00020885511,0.0018927191,0.000017226914,0.0038966853,0.00021240301,0.000017262662,0.000011067512,0.014515091,0.10106098],"study_design_scores_gemma":[0.17017372,0.09687491,0.7067956,0.00037756766,0.00094837445,4.8546343e-7,0.014609828,0.0011360825,0.000060663348,0.000008260646,0.008775438,0.00023908229],"about_ca_topic_score_codex":0.008299072,"about_ca_topic_score_gemma":0.011184501,"teacher_disagreement_score":0.1008219,"about_ca_system_score_codex":0.00090391,"about_ca_system_score_gemma":0.0021189174,"threshold_uncertainty_score":0.9983047},"labels":[],"label_agreement":null},{"id":"W4410580854","doi":"10.1158/1078-0432.ccr-24-3192","title":"Mechanism of Initial Favorable Response to Decitabine in <i>TP53</i> -Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada","funders":"Innovation and Technology Commission; Croucher Foundation; University Grants Committee; Li Shu Fan Medical Foundation","keywords":"Decitabine; Mechanism (biology); Azacitidine; Cancer research; Leukemia; Medicine; Myelodysplastic syndromes; Biology; Internal medicine; Genetics; DNA methylation; Gene; Bone marrow","score_opus":0.09173280905897802,"score_gpt":0.4895852973011111,"score_spread":0.3978524882421331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410580854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842457,0.00043001818,0.0023194584,0.010065219,0.00026794794,0.001741002,0.00008451554,0.000027588689,0.0008185361],"genre_scores_gemma":[0.99437493,0.00084618054,0.0017067096,0.00055945915,0.00008730919,0.00020761904,0.000013886509,0.000042964057,0.0021609266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934315,0.0019014631,0.0015165543,0.0008089417,0.0014499732,0.00089154154],"domain_scores_gemma":[0.99463814,0.0025193188,0.00013048382,0.00080755865,0.0013718492,0.000532638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013801481,0.00021943012,0.001040275,0.0013207215,0.00009453227,0.000024893876,0.0004913395,0.00042421377,0.0003262682],"category_scores_gemma":[0.007997965,0.00019804978,0.00017003629,0.002503544,0.00070025015,0.00009376643,0.0008712097,0.0017794353,0.000022384185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12463519,0.001540597,0.0044948286,0.0010356876,0.0003802383,0.0011774367,0.0005496515,0.000083302206,0.8245651,0.01822281,0.0067735184,0.016541641],"study_design_scores_gemma":[0.03655084,0.012127407,0.049634296,0.003474471,0.00022860285,0.00006130832,0.0019400247,0.0033050475,0.8332343,0.05586377,0.0029475226,0.00063238567],"about_ca_topic_score_codex":0.0020216473,"about_ca_topic_score_gemma":0.00026411968,"teacher_disagreement_score":0.08808435,"about_ca_system_score_codex":0.0006724828,"about_ca_system_score_gemma":0.004122072,"threshold_uncertainty_score":0.9574889},"labels":[],"label_agreement":null},{"id":"W4411255039","doi":"10.1158/1557-3265.sabcs24-p2-08-26","title":"Abstract P2-08-26: FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients with Early-Stage Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FLEX; Cancer; Medicine; Transcriptome; Breast cancer; Stage (stratigraphy); Oncology; Internal medicine; Biology; Gene; Genetics; Computer science; Gene expression; Telecommunications","score_opus":0.16654400283689585,"score_gpt":0.5251134407569966,"score_spread":0.35856943792010076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411255039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98816925,0.0016997986,0.000015130168,0.0040318402,0.0004887283,0.00349162,0.00022413173,0.00015683062,0.0017226656],"genre_scores_gemma":[0.99004406,0.0015710121,0.000069131645,0.0005963673,0.00048806242,0.0016395287,0.000007807997,0.00011901949,0.005464996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99313164,0.00061979465,0.0014188361,0.0014459589,0.0020016092,0.0013821849],"domain_scores_gemma":[0.99542326,0.0013364392,0.00020206273,0.0012065585,0.0012831715,0.0005484835],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029789568,0.0004607887,0.0012118142,0.00092550565,0.00022909968,0.00009750487,0.0007048785,0.0002301368,0.0038332408],"category_scores_gemma":[0.0002903738,0.00035978062,0.00019901978,0.0030087582,0.0009354896,0.00045754723,0.00019723746,0.002751371,0.00010210982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021987302,0.0023538356,0.91777277,0.00039064913,0.00035927727,0.00014557707,0.000582917,0.00006311731,0.00016080975,0.000038679955,0.0005805668,0.055564497],"study_design_scores_gemma":[0.011617472,0.0014872742,0.97681844,0.003142289,0.00010142793,0.0000010697273,0.0004956095,0.000018731533,0.000042681007,0.00009118056,0.005850163,0.00033365694],"about_ca_topic_score_codex":0.024919841,"about_ca_topic_score_gemma":0.031951707,"teacher_disagreement_score":0.059045672,"about_ca_system_score_codex":0.0015456639,"about_ca_system_score_gemma":0.0022482472,"threshold_uncertainty_score":0.99988544},"labels":[],"label_agreement":null},{"id":"W4411284824","doi":"10.1158/1557-3265.sabcs24-ps19-04","title":"Abstract PS19-04: Exploring the broad societal value of pembrolizumab in triple-negative breast cancer in Canada","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Pembrolizumab; Breast cancer; Medicine; Cancer; Value (mathematics); Oncology; Gynecology; Internal medicine; Immunotherapy; Statistics","score_opus":0.17892154257603307,"score_gpt":0.4915326437501494,"score_spread":0.3126111011741163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411284824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747601,0.003685902,7.072761e-7,0.01803067,0.00078464916,0.00082840247,0.00013039832,0.000007575328,0.0017715987],"genre_scores_gemma":[0.9895044,0.008256932,0.000007168076,0.0007522892,0.00021275786,0.00047900723,0.000002789153,0.000018379727,0.0007662879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670386,0.00039317517,0.0009992352,0.0004528348,0.0008267317,0.0006241843],"domain_scores_gemma":[0.99725956,0.0017887398,0.00011483208,0.000434876,0.00028543844,0.00011654979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027859414,0.00016299379,0.0005752475,0.00020570416,0.00009588178,0.000017860826,0.00039721566,0.00011569061,0.000724375],"category_scores_gemma":[0.00045533988,0.00011607258,0.00019852731,0.0015220657,0.0005875453,0.0000952825,0.00013179812,0.0015898821,0.0000022531328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023369065,0.00047426787,0.5738235,0.0005617485,0.00050199707,0.00009740206,0.00085590064,0.00020316603,0.0017521108,0.0001408556,0.018460419,0.37975955],"study_design_scores_gemma":[0.0069979713,0.0000912433,0.98632175,0.0011324013,0.000018905885,0.0000024077167,0.0015550065,0.00023515084,0.0011512942,0.0001298039,0.0022565126,0.000107528685],"about_ca_topic_score_codex":0.95693946,"about_ca_topic_score_gemma":0.94289416,"teacher_disagreement_score":0.41249827,"about_ca_system_score_codex":0.0027059263,"about_ca_system_score_gemma":0.013500922,"threshold_uncertainty_score":0.9920916},"labels":[],"label_agreement":null},{"id":"W4411285140","doi":"10.1158/1557-3265.sabcs24-ps5-07","title":"Abstract PS5-07: Financial difficulty over time in young adults with breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.07618288971698177,"score_gpt":0.40306856796497054,"score_spread":0.32688567824798875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411285140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95109785,0.003508373,0.000024560182,0.0038801634,0.00092237175,0.00064469734,0.00095052924,0.00004012553,0.03893133],"genre_scores_gemma":[0.9873597,0.003976802,0.000032927514,0.00070073403,0.0008469838,0.00029286215,0.000014839419,0.000043771928,0.0067313956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962182,0.00006089802,0.0014233647,0.0010830183,0.00015055633,0.0010639714],"domain_scores_gemma":[0.9982091,0.00037931057,0.00031425926,0.00059192884,0.0002429733,0.0002624199],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023278964,0.0002893455,0.00094645185,0.00046890008,0.00020042446,0.00015203413,0.00067119446,0.0004181504,0.004762522],"category_scores_gemma":[0.0005581256,0.00027948566,0.00020714183,0.0009022772,0.00054988975,0.0004586621,0.00020655259,0.0014450938,0.0009957021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022309714,0.00044003426,0.92632055,0.00012870796,0.000079506746,0.000023231683,0.00021107402,0.0001236104,0.000010083382,0.010982498,0.03589519,0.023554523],"study_design_scores_gemma":[0.0032225477,0.00011017632,0.97047424,0.0004436421,0.000005662787,0.0000012522657,0.00002865811,0.00038059894,0.000011612349,0.0038007253,0.021170694,0.0003501936],"about_ca_topic_score_codex":0.017777696,"about_ca_topic_score_gemma":0.014700003,"teacher_disagreement_score":0.044153668,"about_ca_system_score_codex":0.00086726225,"about_ca_system_score_gemma":0.00090814324,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W4411285509","doi":"10.1158/1557-3265.sabcs24-p3-08-22","title":"Abstract P3-08-22: Tucatinib, Trastuzumab and Capecitabine with brain and/or spinal radiotherapy (XRT) in patients with HER2+ metastatic breast cancer and leptomeningeal disease: A multi-centre phase II, single arm feasibility study (\"CLIMB LMD\"; NCT06016387)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Capecitabine; Trastuzumab; Medicine; Radiation therapy; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine; Colorectal cancer","score_opus":0.13026874419272086,"score_gpt":0.5033111665503891,"score_spread":0.37304242235766827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411285509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858648,0.004024723,0.000019477744,0.0055906447,0.00005946531,0.0039173784,0.0004833413,0.000027166565,0.0000129562595],"genre_scores_gemma":[0.99736786,0.00047391996,0.0007504919,0.00035009676,0.00009157355,0.00041973934,0.00004330366,0.000046798494,0.00045621488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995938,0.0005134987,0.0007624763,0.0012254333,0.0008267106,0.0007339033],"domain_scores_gemma":[0.9973568,0.00085590675,0.00014856474,0.00051070616,0.00036178058,0.00076625147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016445782,0.0004056909,0.0009947042,0.00025901038,0.00028299924,0.000098114986,0.00013299892,0.00007711884,0.0005059632],"category_scores_gemma":[0.00029110123,0.0002500894,0.000070401686,0.00068733195,0.0008788796,0.00014926157,0.00013215828,0.0008028556,7.078659e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05922768,0.041164197,0.7481479,0.00039329787,0.0006323624,0.00024022836,0.00049170636,0.0000042366723,0.000014225891,0.000002931282,0.00026875362,0.1494125],"study_design_scores_gemma":[0.07819217,0.023161378,0.8955335,0.0009334106,0.0003130478,0.000008472493,0.00109341,0.00019392364,0.0000069786847,0.000008923972,0.0003197862,0.00023500371],"about_ca_topic_score_codex":0.0016358407,"about_ca_topic_score_gemma":0.0043805568,"teacher_disagreement_score":0.1491775,"about_ca_system_score_codex":0.00058879226,"about_ca_system_score_gemma":0.0012021272,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W4411286445","doi":"10.1158/1557-3265.sabcs24-p5-03-01","title":"Abstract P5-03-01: Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Phases of clinical research; Cancer; Internal medicine; Open label; Randomized controlled trial; Clinical trial","score_opus":0.1548699941123187,"score_gpt":0.5548477553664776,"score_spread":0.39997776125415885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411286445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98260784,0.0017294541,0.0011211854,0.0016987909,0.00017470251,0.0122158695,0.00034450856,0.000029439272,0.000078187906],"genre_scores_gemma":[0.9923824,0.0008459184,0.0035434135,0.0002067593,0.00012242395,0.002279179,0.000023271929,0.000068634065,0.00052797707],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99503946,0.0009979182,0.0016992298,0.0008416774,0.00085456925,0.00056714047],"domain_scores_gemma":[0.9903127,0.00652063,0.00067480246,0.00080348615,0.0014343932,0.00025396657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00422214,0.00033765452,0.0018372993,0.0001883888,0.00029177286,0.00004922323,0.00058239186,0.000103818544,0.0001732644],"category_scores_gemma":[0.0020807544,0.00019330489,0.00011886498,0.00093690684,0.0013157545,0.00031427888,0.00027634483,0.0007022426,6.1588355e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.671713,0.005849095,0.0013975534,0.00077628094,0.001123715,0.000017420198,0.0007834056,0.0007627976,0.0013527836,0.000041120304,0.000017494853,0.31616533],"study_design_scores_gemma":[0.9468942,0.010079405,0.025384098,0.00384673,0.0010873245,0.000015925438,0.004240267,0.0056862715,0.0021054626,0.00013620865,0.00024159566,0.00028247043],"about_ca_topic_score_codex":0.002111387,"about_ca_topic_score_gemma":0.003974465,"teacher_disagreement_score":0.31588283,"about_ca_system_score_codex":0.00034546375,"about_ca_system_score_gemma":0.0017959576,"threshold_uncertainty_score":0.78827447},"labels":[],"label_agreement":null},{"id":"W4411287331","doi":"10.1158/1557-3265.sabcs24-p3-06-01","title":"Abstract P3-06-01: Occupational exposure to ionizing radiation in female physicians and risk of breast cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ionizing radiation; Medicine; Breast cancer; Meta-analysis; Cancer; Occupational exposure; Oncology; Non-ionizing radiation; Gynecology; Environmental health; Internal medicine; Irradiation","score_opus":0.3120725502798826,"score_gpt":0.5688611876200128,"score_spread":0.2567886373401302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023911566,0.9942623,0.000011223058,0.0012191394,0.000033617016,0.003353094,0.00082119,0.000009110992,0.000051245708],"genre_scores_gemma":[0.0019388272,0.99547946,0.000043370874,0.00034998602,0.00014454935,0.001523926,0.00009477265,0.000023088762,0.00040200405],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99468905,0.0014139578,0.0021247128,0.00070308754,0.0007594445,0.0003097689],"domain_scores_gemma":[0.9950513,0.002977043,0.00077991374,0.0005776413,0.00041216917,0.00020193229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005792964,0.00028074172,0.0064586992,0.00089675107,0.00009171235,0.000051000814,0.00020334066,0.00019747949,0.0002557232],"category_scores_gemma":[0.0023111422,0.00020107748,0.0011375367,0.0026281876,0.00014379407,0.00010917129,0.00011092849,0.0010169658,0.000009159421],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036945108,0.00011143847,0.0064310036,0.8072007,0.035144884,0.0000068977156,0.00006634177,0.000014401055,1.2284228e-7,0.000008065906,0.0009323126,0.15004694],"study_design_scores_gemma":[0.00063341693,0.00012647215,0.039557718,0.22209406,0.7279779,0.000006664918,0.000061817795,0.00006499045,4.585903e-7,0.000009780994,0.009122582,0.00034415405],"about_ca_topic_score_codex":0.001179412,"about_ca_topic_score_gemma":0.00039285637,"teacher_disagreement_score":0.692833,"about_ca_system_score_codex":0.00025202983,"about_ca_system_score_gemma":0.0012549447,"threshold_uncertainty_score":0.8199702},"labels":[],"label_agreement":null},{"id":"W4411287483","doi":"10.1158/1557-3265.sabcs24-p4-01-08","title":"Abstract P4-01-08: PYNK at 20: From SABCS Inspiration to Multisite Clinical, Research, and Educational Program for Young Women with Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Gynecology; Family medicine; Gerontology","score_opus":0.24732005577582888,"score_gpt":0.5148930023642165,"score_spread":0.26757294658838765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96732754,0.0035597293,0.00009054687,0.017435564,0.0010111795,0.0023164588,0.0026974129,0.000037556903,0.0055240435],"genre_scores_gemma":[0.97769165,0.005492696,0.0009511785,0.0012989485,0.002120908,0.004662915,0.000082668055,0.000064337335,0.007634693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955393,0.0001166335,0.0016195264,0.0013760853,0.0002104712,0.0011379898],"domain_scores_gemma":[0.9952077,0.0023290573,0.00032752324,0.00064477633,0.0008492484,0.00064163824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0067360112,0.00024399445,0.0008319045,0.0004421694,0.000635627,0.0003711634,0.00056921993,0.0003882167,0.0015409027],"category_scores_gemma":[0.0014550291,0.00024436176,0.0001233678,0.00072640815,0.001022629,0.00042468408,0.00036846317,0.0010901713,0.00030613565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035264522,0.00069273694,0.7997514,0.000110956484,0.00022994961,0.00000175706,0.00027830162,0.000034535653,0.000020805435,0.006247466,0.06185557,0.12725008],"study_design_scores_gemma":[0.002002765,0.00068135123,0.76321584,0.00016757309,0.0000063377865,4.2220316e-7,0.00007722609,0.00017250952,0.000015131386,0.013624595,0.21979077,0.00024548933],"about_ca_topic_score_codex":0.009821772,"about_ca_topic_score_gemma":0.015613874,"teacher_disagreement_score":0.1579352,"about_ca_system_score_codex":0.0014413709,"about_ca_system_score_gemma":0.0010918332,"threshold_uncertainty_score":0.9993718},"labels":[],"label_agreement":null},{"id":"W4411287522","doi":"10.1158/1557-3265.sabcs24-p1-03-28","title":"Abstract P1-03-28: Agreement between the DESTINY-Breast04/06 VENTANA 4B5 HER2 IHC clinical trial assay and other comparator assays for HER2-low breast cancer: Overall results of a large-scale, multicenter global ring study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Pathology; Cancer; Oncology; Internal medicine","score_opus":0.20641135838187216,"score_gpt":0.5548789198231137,"score_spread":0.34846756144124147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789103,0.0018414845,0.00026532996,0.0070142476,0.0009425103,0.0068205427,0.0032632484,0.00006656275,0.0008757326],"genre_scores_gemma":[0.99417454,0.0003002925,0.000433246,0.00075891986,0.0025971064,0.0010515428,0.000035800775,0.00006564462,0.00058288145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99144876,0.0014394373,0.002895816,0.0014432215,0.0015260924,0.0012466706],"domain_scores_gemma":[0.9908588,0.0056520915,0.00066148525,0.0012586783,0.000993929,0.00057500217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013848772,0.00048559872,0.0017111339,0.00014361972,0.00040252894,0.00009872869,0.0007953978,0.00038127482,0.00018007276],"category_scores_gemma":[0.001395684,0.00035030686,0.00055724557,0.00064171816,0.0012139961,0.00014365722,0.00056954124,0.0017449317,0.000018600902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13562179,0.00402657,0.80333364,0.0003486061,0.0015693534,0.00001928314,0.0002779994,0.000042862262,0.000024242414,0.000067940695,0.003595871,0.051071856],"study_design_scores_gemma":[0.12734465,0.0019365328,0.8465815,0.0012841963,0.00045225094,0.0000047023973,0.0011197991,0.00054314313,0.00005271282,0.00025735865,0.020121641,0.00030151397],"about_ca_topic_score_codex":0.003494681,"about_ca_topic_score_gemma":0.0037025986,"teacher_disagreement_score":0.050770342,"about_ca_system_score_codex":0.00075425213,"about_ca_system_score_gemma":0.0012161974,"threshold_uncertainty_score":0.9998949},"labels":[],"label_agreement":null},{"id":"W4411287533","doi":"10.1158/1557-3265.sabcs24-ps16-09","title":"Abstract PS16-09: A decision support intervention to promote the use of preventive therapy among women at high risk for invasive breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Intervention (counseling); Cancer; Intensive care medicine; Oncology; Internal medicine; Nursing","score_opus":0.10643425305857977,"score_gpt":0.4764172836697689,"score_spread":0.3699830306111891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534637,0.00085778144,0.00030303045,0.0005990329,0.0002698815,0.0014858497,0.0011143959,0.0000048481143,0.000018833494],"genre_scores_gemma":[0.987573,0.008454588,0.00019103725,0.00022927056,0.00031582423,0.0014483059,0.000084877785,0.000020409554,0.0016826721],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979886,0.00028365292,0.00053386105,0.0005270567,0.00029451752,0.0003723085],"domain_scores_gemma":[0.9978715,0.0003982285,0.00015276042,0.0005048322,0.0008801732,0.0001925034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016471909,0.00012793926,0.00022189526,0.00007933977,0.00018291471,0.00004546022,0.00036184123,0.00016674856,0.00031425798],"category_scores_gemma":[0.0010266204,0.000095130206,0.0002593517,0.00020340728,0.0003334923,0.000009268808,0.00030662838,0.0001971634,0.0000044198855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024971444,0.0015942851,0.32608986,0.00030602745,0.00068272505,0.0000032793546,0.00032850498,0.00018416265,0.023870356,0.000020625263,0.09365758,0.52829117],"study_design_scores_gemma":[0.0035982882,0.0012046801,0.9085936,0.00029773382,0.000034386503,3.4426395e-7,0.00012723666,0.000017062679,0.0406523,0.0014223347,0.043900475,0.0001515891],"about_ca_topic_score_codex":0.0011045221,"about_ca_topic_score_gemma":0.0029721882,"teacher_disagreement_score":0.58250374,"about_ca_system_score_codex":0.0001244071,"about_ca_system_score_gemma":0.0004946221,"threshold_uncertainty_score":0.38792974},"labels":[],"label_agreement":null},{"id":"W4411287646","doi":"10.1158/1557-3265.sabcs24-p2-03-01","title":"Abstract P2-03-01: Sexual health in unpartnered women after breast cancer: Report from a joint analysis of two international multi-site prospective cohorts of young breast cancer survivors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Prospective cohort study; Oncology; Gerontology; Internal medicine","score_opus":0.10374469337103288,"score_gpt":0.5014941183113505,"score_spread":0.3977494249403176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827784,0.002520892,0.000024339608,0.005805145,0.0013292284,0.0009949151,0.006067087,0.000029108991,0.0004509331],"genre_scores_gemma":[0.9938274,0.0028414452,0.000031045955,0.0003603436,0.0005018793,0.0011885986,0.00020220078,0.00003882215,0.0010082402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938304,0.00048669375,0.0022120918,0.0012104404,0.0014415978,0.00081879203],"domain_scores_gemma":[0.9958238,0.000508589,0.0006193657,0.00088248827,0.0017142993,0.00045144642],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004357768,0.00031120403,0.0018870598,0.0011113589,0.00007114455,0.000038435963,0.0003563699,0.0002324817,0.003397761],"category_scores_gemma":[0.0002649308,0.00027433547,0.00040395238,0.002983776,0.0006572532,0.00014126507,0.0003314379,0.0013210801,0.000004022869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059651136,0.0009182725,0.9704129,0.0002977854,0.0030735661,0.00012323556,0.0028641878,0.00015977526,0.0003278412,0.000011621279,0.00066406693,0.015181619],"study_design_scores_gemma":[0.0032728964,0.00011008986,0.9926103,0.00094866136,0.00024546875,0.000007448419,0.0014377579,0.00060292974,0.00010900941,0.00005834402,0.00039641908,0.00020069118],"about_ca_topic_score_codex":0.65528405,"about_ca_topic_score_gemma":0.7560206,"teacher_disagreement_score":0.10073656,"about_ca_system_score_codex":0.002902556,"about_ca_system_score_gemma":0.0041509136,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W4411287723","doi":"10.1158/1557-3265.sabcs24-p1-06-02","title":"Abstract P1-06-02: Remote functional cognitive rehabilitation in Breast Cancer Patients, a single center retrospective study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Center (category theory); Breast cancer; Retrospective cohort study; Cognition; Cancer; Rehabilitation; Single Center; Oncology; Physical medicine and rehabilitation; Physical therapy; Internal medicine; Psychiatry","score_opus":0.10918668829412125,"score_gpt":0.49107608830392374,"score_spread":0.3818894000098025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805493,0.0004444097,0.000010769023,0.009936038,0.0008676508,0.0034213138,0.0003149154,0.000058443704,0.0043971967],"genre_scores_gemma":[0.9961832,0.0004904908,0.000014680557,0.0005921284,0.00051480107,0.0006255975,0.00006344432,0.00003714485,0.0014784704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99524134,0.00062835147,0.0010447197,0.0010821132,0.0012897447,0.0007136996],"domain_scores_gemma":[0.99393505,0.0022728546,0.00015928892,0.0003011321,0.0031272462,0.0002044068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024435453,0.00026640258,0.0006951641,0.00059571816,0.00026413225,0.00004510288,0.00013516737,0.00021680923,0.0009691656],"category_scores_gemma":[0.0041604806,0.0002405136,0.00021635184,0.0016132463,0.00072050793,0.00017716731,0.00026964495,0.001953726,0.00007647961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008150458,0.0070574703,0.93873894,0.00013086679,0.00049686834,0.00002164897,0.0005376801,0.000004162175,0.00004442874,0.000011392818,0.013033957,0.03177213],"study_design_scores_gemma":[0.014098378,0.0022995684,0.97765315,0.0021236667,0.00012347374,0.0000012240785,0.0023127475,0.000036235877,0.000022920885,0.00029670168,0.0008460217,0.00018589322],"about_ca_topic_score_codex":0.0023180258,"about_ca_topic_score_gemma":0.0041527115,"teacher_disagreement_score":0.038914233,"about_ca_system_score_codex":0.0029316966,"about_ca_system_score_gemma":0.00094514916,"threshold_uncertainty_score":0.9999441},"labels":[],"label_agreement":null},{"id":"W4411288229","doi":"10.1158/1557-3265.sabcs24-ps9-05","title":"Abstract PS9-05: Somatic Structural Variation in Breast Cancer and its Application in Longitudinal Analysis of Circulating Tumor DNA in Early Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Somatic cell; Medicine; Circulating tumor DNA; Cancer; Oncology; Internal medicine; Cancer research; Pathology; Biology; Genetics; Gene","score_opus":0.05107939086591847,"score_gpt":0.436898555841891,"score_spread":0.3858191649759726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963029,0.0018546482,0.000018352064,0.00092416466,0.00009822689,0.00040772645,0.00035116804,0.0000026029127,0.000040178333],"genre_scores_gemma":[0.99762374,0.0018100472,0.000016361944,0.00007327163,0.00014223237,0.00027546543,0.000031913398,0.000012727138,0.000014217397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979336,0.0001284856,0.0007679047,0.00057413295,0.00024160642,0.00035421475],"domain_scores_gemma":[0.998964,0.00025313342,0.00016904951,0.00026651702,0.00026680727,0.000080466125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011185582,0.00013460529,0.00040472424,0.0004379029,0.00004595531,0.000033393924,0.00021200915,0.00016849372,0.000044410965],"category_scores_gemma":[0.0002011231,0.00013765556,0.00008580251,0.0013285911,0.00011674678,0.00001393398,0.00016602148,0.00037540327,5.389353e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032534456,0.00008217669,0.95654804,0.00012931248,0.00013630581,0.000004691103,0.00008463477,0.0048135417,0.027891515,0.00010352692,0.000018506606,0.009862424],"study_design_scores_gemma":[0.0010353713,0.000027100215,0.98554385,0.0001701548,0.000058581893,0.0000011122659,0.000037651724,0.012161164,0.0006251321,0.00020287899,0.000012419337,0.00012460208],"about_ca_topic_score_codex":0.029016268,"about_ca_topic_score_gemma":0.058627915,"teacher_disagreement_score":0.029611647,"about_ca_system_score_codex":0.00026561934,"about_ca_system_score_gemma":0.00067257136,"threshold_uncertainty_score":0.9774496},"labels":[],"label_agreement":null},{"id":"W4411288788","doi":"10.1158/1557-3265.sabcs24-p3-11-18","title":"Abstract P3-11-18: Prognostic significance of lobular versus ductal histology in HER2-positive breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Histology; Breast cancer; Cancer; Pathology; Oncology; Internal medicine","score_opus":0.10078710803102031,"score_gpt":0.47843219884641064,"score_spread":0.3776450908153903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98267466,0.00897312,0.000020093807,0.0044038314,0.00090556213,0.0007010995,0.0003950823,0.0000123588,0.0019141638],"genre_scores_gemma":[0.9952004,0.0031114868,0.00006666179,0.00013577117,0.0003783344,0.00064367603,0.000044992586,0.000025854344,0.00039282028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971274,0.00037766522,0.00064588245,0.0008516446,0.00035527084,0.00064210163],"domain_scores_gemma":[0.99810237,0.0005605603,0.00013699352,0.0004792281,0.0006000403,0.00012082113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087229104,0.00022900318,0.00050489453,0.00014957502,0.00011040139,0.000014268338,0.00043602125,0.0003098235,0.00023312155],"category_scores_gemma":[0.00058425195,0.00021607362,0.00016582529,0.0005336189,0.0012513304,0.000007788599,0.00034541867,0.00051696546,0.00000991138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009883107,0.0011902503,0.9360918,0.0002502787,0.00070126547,0.000091183836,0.000091392125,0.00012354672,0.013378909,0.00022619998,0.013620352,0.024351731],"study_design_scores_gemma":[0.003640333,0.00039300177,0.98146874,0.00027800092,0.0000621489,0.0000036841227,0.00017320258,0.000010362637,0.008290994,0.00012678759,0.0053273,0.00022541973],"about_ca_topic_score_codex":0.006655336,"about_ca_topic_score_gemma":0.008940635,"teacher_disagreement_score":0.04537698,"about_ca_system_score_codex":0.00032897113,"about_ca_system_score_gemma":0.0013436632,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W4411288900","doi":"10.1158/1557-3265.sabcs24-p3-12-26","title":"Abstract P3-12-26: Partial breast re-irradiation using ultra hypofractionation: A Phase 2 multi- institutional study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Phase (matter); Irradiation; Oncology; Chemistry; Physics","score_opus":0.4941946214710811,"score_gpt":0.6313563039220824,"score_spread":0.1371616824510013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190193,0.0004166961,0.0005347848,0.0028037538,0.0014091458,0.001362134,0.00009697197,0.00008437437,0.0013902138],"genre_scores_gemma":[0.9970664,0.0002467332,0.0001449726,0.00028593765,0.0014876096,0.000173695,0.000044186374,0.000022546035,0.0005279362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969042,0.00025823797,0.0008193583,0.00060720416,0.0009883987,0.00042262604],"domain_scores_gemma":[0.99783796,0.000693335,0.00012319055,0.00039142874,0.0006637683,0.00029031458],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024576923,0.00017038891,0.00041294674,0.00032833667,0.00047740273,0.00008305313,0.00016199304,0.00019667952,0.0011429811],"category_scores_gemma":[0.00084292825,0.00014362353,0.00019425708,0.00071043754,0.00039780358,0.00023485042,0.000059089238,0.0012502829,0.00006518456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008294457,0.01221691,0.70555276,0.00021364869,0.0006200428,0.00016063188,0.0004338346,0.00075447425,0.0032800057,0.0001773548,0.006605294,0.26169056],"study_design_scores_gemma":[0.014225273,0.00063859345,0.9551417,0.00026428406,0.0001278653,0.000013115066,0.00052308326,0.0047610393,0.00025819545,0.00004449406,0.023823112,0.00017921632],"about_ca_topic_score_codex":0.0047577852,"about_ca_topic_score_gemma":0.0012333806,"teacher_disagreement_score":0.26151136,"about_ca_system_score_codex":0.00086929783,"about_ca_system_score_gemma":0.0027299921,"threshold_uncertainty_score":0.9997701},"labels":[],"label_agreement":null},{"id":"W4411288963","doi":"10.1158/1557-3265.sabcs24-gs1-08","title":"Abstract GS1-08: Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: results from an international cohort study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Breast cancer; Cohort; Cancer; Internal medicine; Cohort study","score_opus":0.0560054673001109,"score_gpt":0.4601311686947561,"score_spread":0.4041257013946452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415094,0.0002730149,0.000013836965,0.0013543408,0.0007307757,0.0005190358,0.002052812,0.000011950219,0.0008932928],"genre_scores_gemma":[0.99608505,0.002013051,0.00004319438,0.000033910626,0.000818665,0.00022856932,0.00032328215,0.000022155944,0.00043214604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968186,0.0006838711,0.00062933925,0.0008839724,0.00062017277,0.00036406887],"domain_scores_gemma":[0.9979074,0.00066557684,0.00021535245,0.0004388383,0.00064320426,0.00012962871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004928745,0.00015175335,0.000317582,0.00013548619,0.00018863074,0.00012468094,0.00034655584,0.00023806348,0.000054916636],"category_scores_gemma":[0.0012829418,0.00014413174,0.000047600017,0.00034295773,0.00025178283,0.000027003523,0.00020760391,0.0006964362,0.0000018155538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012067774,0.00012338358,0.98639286,0.000006629443,0.0005977641,0.0000036774713,0.00025300047,0.00028691613,0.0003016702,0.0000023962891,0.00094822363,0.009876732],"study_design_scores_gemma":[0.0021547822,0.00013878211,0.9948605,0.00006223125,0.000054135617,2.5237793e-7,0.0007830657,0.000047453585,0.0005523858,0.00003822143,0.0011556671,0.00015252888],"about_ca_topic_score_codex":0.045619372,"about_ca_topic_score_gemma":0.074407175,"teacher_disagreement_score":0.028787803,"about_ca_system_score_codex":0.0007286178,"about_ca_system_score_gemma":0.0014402892,"threshold_uncertainty_score":0.9607359},"labels":[],"label_agreement":null},{"id":"W4411289080","doi":"10.1158/1557-3265.sabcs24-p4-04-14","title":"Abstract P4-04-14: Economic analysis of germline genetic testing to assess for hereditary breast cancer: a systematic review","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic testing; Germline; Breast cancer; Medicine; Cancer; Germline mutation; Oncology; Internal medicine; Genetics; Biology; Mutation; Gene","score_opus":0.315159796038709,"score_gpt":0.579580750645394,"score_spread":0.2644209546066851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117198804,0.98819345,0.00010586484,0.00027790852,0.00062590296,0.0049745636,0.005560719,0.00001258228,0.00013181947],"genre_scores_gemma":[0.00014804455,0.9870282,0.0008595098,0.00026697523,0.0012314185,0.009299171,0.0005108898,0.00008745554,0.0005683411],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933619,0.0009010635,0.0031497017,0.0014348333,0.0004854101,0.00066709606],"domain_scores_gemma":[0.9926444,0.0029435083,0.00097649626,0.0017005398,0.0014453769,0.00028962462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004927094,0.00048386457,0.004368847,0.00059639773,0.00013223702,0.000053559346,0.0014479196,0.00060994603,0.00026940132],"category_scores_gemma":[0.0038039885,0.00041869073,0.0015194272,0.0018278031,0.00023866321,0.000005586545,0.0005554916,0.00068057835,0.000019469038],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041824052,0.0000798673,0.000087896864,0.74529845,0.00502138,0.000005124724,0.0000031363388,0.00031713682,0.000008956445,0.0000031829902,0.011499491,0.23763356],"study_design_scores_gemma":[0.00063303014,0.0004386602,0.0005765754,0.7293553,0.032007568,0.000023209303,0.000016398355,0.00024036407,0.000025840518,0.000023595927,0.23557198,0.0010875177],"about_ca_topic_score_codex":0.00071471796,"about_ca_topic_score_gemma":0.0012338993,"teacher_disagreement_score":0.23654604,"about_ca_system_score_codex":0.00084857905,"about_ca_system_score_gemma":0.009121035,"threshold_uncertainty_score":0.9998265},"labels":[],"label_agreement":null},{"id":"W4411289211","doi":"10.1158/1557-3265.sabcs24-p4-02-02","title":"Abstract P4-02-02: Hospitalizations and emergency visits for Ontario breast cancer patients undergoing neoadjuvant chemotherapy with pembrolizumab: A population-based analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Breast cancer; Chemotherapy; Oncology; Cancer; Population; Neoadjuvant therapy; Internal medicine; Immunotherapy","score_opus":0.053933127609821885,"score_gpt":0.4515621291709281,"score_spread":0.3976290015611062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114734,0.0011545483,0.00041163867,0.0052366434,0.00025117304,0.001318129,0.0001762861,0.0000355672,0.00026870446],"genre_scores_gemma":[0.99513215,0.0016814197,0.00013504128,0.000611129,0.00014747422,0.00042389578,0.00017945275,0.0000345816,0.001654858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746716,0.00008763857,0.0007375186,0.00065009727,0.0005765385,0.00048104158],"domain_scores_gemma":[0.99787915,0.0004726166,0.00016824166,0.00039287872,0.0008838503,0.00020325894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073332794,0.00021240974,0.0005551826,0.00043604677,0.00036447585,0.000061390645,0.00016073702,0.00017830604,0.0016500038],"category_scores_gemma":[0.00011458287,0.00016690514,0.0002990689,0.0014794598,0.0001557366,0.000102578044,0.000033806038,0.00040175483,0.0000014460948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008484713,0.00047610386,0.96094346,0.0002111864,0.0016004007,0.0000018694923,0.00011637503,0.00013527928,0.000041651336,0.000029777393,0.001600754,0.026358414],"study_design_scores_gemma":[0.009410996,0.0006229345,0.98654276,0.0004147427,0.00045622824,3.258893e-7,0.000036449186,0.00066729455,0.000048985945,0.00007878494,0.0015346103,0.0001859023],"about_ca_topic_score_codex":0.07285593,"about_ca_topic_score_gemma":0.26765242,"teacher_disagreement_score":0.1947965,"about_ca_system_score_codex":0.00087166287,"about_ca_system_score_gemma":0.0021048216,"threshold_uncertainty_score":0.99926263},"labels":[],"label_agreement":null},{"id":"W4411289215","doi":"10.1158/1557-3265.sabcs24-p4-04-11","title":"Abstract P4-04-11: Managing Wait Time Between Surgery and Treatment Initiation Plan in Patients with Breast Cancer: a Mixed-method Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Surgery; Internal medicine","score_opus":0.15213721061533678,"score_gpt":0.3996779161633874,"score_spread":0.2475407055480506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562,0.0013684965,0.00015528811,0.0019570002,0.00022938359,0.000611873,0.0009308293,0.000023514895,0.009103592],"genre_scores_gemma":[0.99614316,0.0022236058,0.00019271685,0.00018632461,0.000323473,0.00024153032,0.00007843495,0.000033417222,0.00057730894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972596,0.0001118746,0.0010793727,0.00080331275,0.00009985262,0.0006459464],"domain_scores_gemma":[0.9979613,0.0010854318,0.00029519675,0.0003477192,0.00011567712,0.00019469149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028735667,0.00022218659,0.0009260183,0.00061575003,0.00015994192,0.00013525717,0.00022489241,0.00022993657,0.00023799],"category_scores_gemma":[0.00017409046,0.00021319381,0.000114283415,0.0005402615,0.00021787712,0.00036525325,0.00010811846,0.000478727,0.000051150142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003417054,0.00020784189,0.8905681,0.000065096516,0.00009744305,0.000002107304,0.00006418324,0.000056108365,1.683647e-7,0.0011673616,0.0010458613,0.10638402],"study_design_scores_gemma":[0.0019727296,0.00009275082,0.9897625,0.00015260164,0.000012178339,2.0032081e-7,0.00002325625,0.00033026494,0.0000041185385,0.0021013592,0.005317727,0.00023032712],"about_ca_topic_score_codex":0.008546946,"about_ca_topic_score_gemma":0.0009862429,"teacher_disagreement_score":0.10615369,"about_ca_system_score_codex":0.00082625495,"about_ca_system_score_gemma":0.00038684937,"threshold_uncertainty_score":0.9980552},"labels":[],"label_agreement":null},{"id":"W4411289429","doi":"10.1158/1557-3265.sabcs24-p3-07-07","title":"Abstract P3-07-07: 10-Year Local Recurrence Rates Following Selective Omission of Re-excision for Patients with Ductal Carcinoma in Situ and Margins","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ductal carcinoma; In situ; Carcinoma; Carcinoma in situ; Oncology; Internal medicine; Cancer; Chemistry; Breast cancer","score_opus":0.10258889666480478,"score_gpt":0.49554457372993577,"score_spread":0.392955677065131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518216,0.0014167583,0.00001861823,0.0010460232,0.00013825289,0.001279439,0.00003182459,0.000006426475,0.0008805254],"genre_scores_gemma":[0.99850154,0.0006923877,0.00017630076,0.000039899453,0.000071079245,0.00025079027,0.000026935648,0.00001544151,0.00022562564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980659,0.00011179803,0.00047885746,0.00053309446,0.00046347434,0.00034688067],"domain_scores_gemma":[0.99744076,0.0016214794,0.00007591829,0.00023471043,0.00046087592,0.00016626953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010195359,0.0001328841,0.00048029696,0.0001774358,0.00009058066,0.000018238497,0.000092992566,0.00012869822,0.00011900858],"category_scores_gemma":[0.0006665301,0.000095895244,0.000113844115,0.00041155625,0.00023938189,0.00007152908,0.000098803044,0.00042459817,0.00000605549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008503662,0.000970953,0.9394575,0.00023591581,0.00009200049,0.000022778106,0.00010762953,0.0000038612884,0.000060807626,0.000018413688,0.004579298,0.04594718],"study_design_scores_gemma":[0.008843886,0.002857771,0.98352283,0.0014921451,0.000054371598,2.404099e-7,0.00020588742,0.000088030254,0.0017015134,0.00015467772,0.0009913979,0.00008726247],"about_ca_topic_score_codex":0.0008589739,"about_ca_topic_score_gemma":0.00072812906,"teacher_disagreement_score":0.045859918,"about_ca_system_score_codex":0.0003986444,"about_ca_system_score_gemma":0.00077757647,"threshold_uncertainty_score":0.39104947},"labels":[],"label_agreement":null},{"id":"W4411289704","doi":"10.1158/1557-3265.sabcs24-p4-04-09","title":"Abstract P4-04-09: Supporting the Knowledge Translation of Exercise Recommendations for People with Bone Metastases using Experience-based Co-Design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Educational Games and Gamification","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Knowledge translation; Medicine; Translation (biology); Knowledge management; Computer science","score_opus":0.554718448280733,"score_gpt":0.6273219973605612,"score_spread":0.07260354907982813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85126144,0.006256738,0.09972491,0.031959362,0.0012403274,0.0053212177,0.0003332276,0.0000617621,0.0038410092],"genre_scores_gemma":[0.9934654,0.000116614574,0.004031692,0.00007566243,0.0001219176,0.0013560404,0.000081729464,0.000017312203,0.00073359977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978447,0.00050131796,0.00073601556,0.00036687648,0.00023877317,0.0003123212],"domain_scores_gemma":[0.99214804,0.0065195393,0.0002236305,0.00039236757,0.0006471978,0.00006921531],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045265052,0.00009810811,0.00026399113,0.00016672023,0.00029510193,0.000039762315,0.00025023153,0.00009379389,0.0011427333],"category_scores_gemma":[0.00041051148,0.00007094161,0.000110175475,0.0006613133,0.00033725638,0.000074841184,0.000013719362,0.00031610677,0.000010597156],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059333905,0.0038915644,0.041602414,0.0006972648,0.0003567832,0.000001552944,0.024842784,0.0010808134,0.002942838,0.0077242143,0.045131125,0.86579525],"study_design_scores_gemma":[0.014407281,0.0022046182,0.5756013,0.0032924323,0.0008529619,0.000004410944,0.0787797,0.021292508,0.021393728,0.007136381,0.27379003,0.001244636],"about_ca_topic_score_codex":0.0006000235,"about_ca_topic_score_gemma":0.00021525145,"teacher_disagreement_score":0.86455065,"about_ca_system_score_codex":0.000071514936,"about_ca_system_score_gemma":0.00096172735,"threshold_uncertainty_score":0.99977034},"labels":[],"label_agreement":null},{"id":"W4411289779","doi":"10.1158/1557-3265.sabcs24-p4-06-09","title":"Abstract P4-06-09: Does Age Impact Patient Involvement in Treatment Decision Making: Results from the Canadian Breast Cancer Network (CBCN) Assessment Project","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Gynecology; Oncology; Family medicine; Internal medicine","score_opus":0.21166987938525822,"score_gpt":0.48540969345232327,"score_spread":0.27373981406706505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953878,0.005802134,0.000025258081,0.010032927,0.0021063858,0.0020491695,0.007158867,0.00002653795,0.01892073],"genre_scores_gemma":[0.9881273,0.007933569,0.00016879273,0.0012709661,0.0010617563,0.0006852085,0.00008654919,0.000040812465,0.0006250732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948858,0.00018975615,0.002136116,0.0012040485,0.00021163502,0.0013726148],"domain_scores_gemma":[0.9959608,0.0019982108,0.0004820037,0.0010297816,0.00018997666,0.00033926495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044168644,0.00036380108,0.0009246814,0.000429951,0.0005607038,0.0004629854,0.00079864374,0.00037128897,0.00084500044],"category_scores_gemma":[0.0005525076,0.00025179295,0.0003692715,0.0009138737,0.00036230267,0.0002606848,0.0002532328,0.0011475419,0.00011971113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082573155,0.00031621894,0.7939694,0.000014049969,0.00026600817,0.000045594985,0.0004972166,0.0019496267,7.925375e-7,0.002727715,0.04616317,0.1532245],"study_design_scores_gemma":[0.0019264264,0.00019399515,0.83751225,0.00042725113,0.000010434162,2.128157e-7,0.000099780395,0.00054281065,0.0000020267128,0.016167488,0.142856,0.00026133383],"about_ca_topic_score_codex":0.8792621,"about_ca_topic_score_gemma":0.93274146,"teacher_disagreement_score":0.15296316,"about_ca_system_score_codex":0.008453018,"about_ca_system_score_gemma":0.0044300617,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W4411289812","doi":"10.1158/1557-3265.sabcs24-p3-12-05","title":"Abstract P3-12-05: Real-world use of sacituzumab govitecan (SG) in the management of metastatic triple-negative breast cancer (mTNBC) through a Canadian Patient Support Program (PSP)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Medicine; Metastatic breast cancer; Cancer; Oncology; Breast cancer; Internal medicine","score_opus":0.24053259445637507,"score_gpt":0.5369587132434502,"score_spread":0.29642611878707514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9392878,0.0019230564,0.000067615845,0.026219558,0.0010190808,0.01440798,0.0023461224,0.00013085362,0.014597931],"genre_scores_gemma":[0.990748,0.0025448846,0.0019198548,0.0010494086,0.000099197976,0.0022736492,0.000028772045,0.0000604348,0.0012758275],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99453354,0.0005884449,0.0016603458,0.0007688807,0.0013822084,0.0010665661],"domain_scores_gemma":[0.99602216,0.0013780617,0.00037753885,0.0010625613,0.00083459937,0.00032507197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021800355,0.00032874531,0.0010448466,0.000607973,0.000140678,0.00004391289,0.00058955513,0.0001299127,0.00082497456],"category_scores_gemma":[0.00022407877,0.00023887857,0.0002990438,0.0025276083,0.001351389,0.00024828114,0.00017743585,0.0013391414,0.000008001432],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009113545,0.002250945,0.07997325,0.00223486,0.0019558507,0.0004940005,0.0028813542,0.00020031277,0.000060725783,0.002823852,0.005834996,0.89217633],"study_design_scores_gemma":[0.007246279,0.0015117236,0.9202806,0.0031232198,0.00035822822,0.000012172062,0.004208406,0.0000942249,0.0004897611,0.0021645234,0.060183797,0.0003271171],"about_ca_topic_score_codex":0.5288675,"about_ca_topic_score_gemma":0.60551095,"teacher_disagreement_score":0.89184916,"about_ca_system_score_codex":0.001677496,"about_ca_system_score_gemma":0.003705343,"threshold_uncertainty_score":0.97411853},"labels":[],"label_agreement":null},{"id":"W4411289858","doi":"10.1158/1557-3265.sabcs24-p3-07-03","title":"Abstract P3-07-03: Real-world comparison of safety and effectiveness of dose dense (2-weekly) versus weekly paclitaxel given with trastuzumab as neoadjuvant treatment in HER2-positive early stage breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Paclitaxel; Oncology; Breast cancer; Stage (stratigraphy); Internal medicine; Cancer","score_opus":0.14634287494718778,"score_gpt":0.5437414468488628,"score_spread":0.39739857190167505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847365,0.0024493074,0.000009644059,0.002631693,0.00022621619,0.003206314,0.00078347075,0.000028365714,0.005928468],"genre_scores_gemma":[0.99016494,0.006969022,0.000066511835,0.000025251575,0.0001443661,0.00060964527,0.000030233386,0.00006763817,0.0019224074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99261326,0.001942155,0.0015285707,0.0011807706,0.001657198,0.0010780221],"domain_scores_gemma":[0.9897203,0.00723479,0.00029567815,0.0008984399,0.0012773928,0.0005734246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004996568,0.0004254795,0.0019771676,0.00074080867,0.00015733563,0.000046821926,0.0003978833,0.00032944034,0.00060173136],"category_scores_gemma":[0.00057479314,0.00033182206,0.0002403561,0.0017282732,0.0019851723,0.00014188551,0.00026872766,0.0018307312,0.000021640888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17121254,0.0027575807,0.7495544,0.0018706896,0.000936685,0.00029753867,0.00088974735,0.00015179446,0.0012781194,0.00025952168,0.00029047905,0.07050089],"study_design_scores_gemma":[0.01992925,0.010568537,0.95682454,0.0054548015,0.00015949042,0.0000033659612,0.0011501345,0.00013184041,0.004357753,0.000058649908,0.0011116831,0.0002499352],"about_ca_topic_score_codex":0.18163635,"about_ca_topic_score_gemma":0.04271994,"teacher_disagreement_score":0.20727013,"about_ca_system_score_codex":0.003217291,"about_ca_system_score_gemma":0.0055133644,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4411290570","doi":"10.1158/1557-3265.sabcs24-p2-11-15","title":"Abstract P2-11-15: Axillary Pathologic Complete Response in Triple-Negative Breast Cancer Patients with Mammary Pathologic Complete Response: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Complete response; Triple-negative breast cancer; Cancer; Triple negative; Pathology; Oncology; Internal medicine; Chemotherapy","score_opus":0.3170601579605599,"score_gpt":0.5545073676760174,"score_spread":0.23744720971545746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411290570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012771143,0.9579853,0.000005074354,0.0048147817,0.00060211244,0.028264858,0.0065374905,0.00018376688,0.0003295343],"genre_scores_gemma":[0.0006484368,0.97551155,0.00018026574,0.002001061,0.00035850273,0.017977519,0.00045100096,0.0002884307,0.0025832169],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9431835,0.038065184,0.006748795,0.0037029928,0.0052325996,0.0030669367],"domain_scores_gemma":[0.95011425,0.038398158,0.0019223995,0.004446389,0.003724291,0.0013945147],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity"],"category_scores_codex":[0.050272465,0.0017894016,0.013168821,0.0024543947,0.00050186506,0.0002458037,0.0033501028,0.0018115409,0.001853368],"category_scores_gemma":[0.03871538,0.0011986239,0.0018034693,0.007267994,0.0024655655,0.0002753484,0.0020244394,0.010299982,0.00044965686],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.021577612,0.0013064083,0.0021078861,0.89148897,0.0006779591,0.008204978,0.000087324006,9.677013e-7,0.0000016281015,0.000015776875,0.012484287,0.062046222],"study_design_scores_gemma":[0.0053608376,0.0028611706,0.03271747,0.85515815,0.0014903571,0.00033289703,0.000061449646,0.0000076084366,2.5885726e-7,0.000049736165,0.10079272,0.0011673216],"about_ca_topic_score_codex":0.00085136713,"about_ca_topic_score_gemma":0.0004980372,"teacher_disagreement_score":0.08830844,"about_ca_system_score_codex":0.005646314,"about_ca_system_score_gemma":0.021218894,"threshold_uncertainty_score":0.99948514},"labels":[],"label_agreement":null},{"id":"W4411290823","doi":"10.1158/1557-3265.sabcs24-p5-10-06","title":"Abstract P5-10-06: Retrospective, population-based cohort study on associations between tumor size, receptor status, &amp; regional nodal positivity rates for early-stage breast cancer: implications for decision between upfront surgery vs neoadjuvant systemic therapy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Retrospective cohort study; Oncology; Cancer; Cohort; Internal medicine; Gynecology; Biology","score_opus":0.12867735206575742,"score_gpt":0.4946366017761994,"score_spread":0.36595924971044197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411290823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679987,0.0005897874,0.00046578015,0.0041166977,0.00023901739,0.0040020854,0.022529015,0.00004005627,0.00001887782],"genre_scores_gemma":[0.9895725,0.0005769563,0.00018718952,0.00016375183,0.0010957159,0.0051531503,0.0028436228,0.00006283658,0.00034428047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99584574,0.00049581705,0.0010461914,0.0012534279,0.00057596585,0.0007828658],"domain_scores_gemma":[0.9877675,0.009116286,0.0004174385,0.0007440318,0.0017297852,0.00022494307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029593986,0.0003489661,0.0009346234,0.00017419577,0.00089752424,0.000104503764,0.00035715755,0.00027655516,0.000034873985],"category_scores_gemma":[0.0022349674,0.000314092,0.00046162415,0.0004484607,0.0001983377,0.000019704416,0.000117297444,0.00034877856,0.00001143928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025509337,0.00061568967,0.9739685,0.000035538087,0.00096810807,2.597127e-7,0.000018707009,0.000036643003,0.00033587145,0.00001522603,0.017031137,0.0044233636],"study_design_scores_gemma":[0.002645237,0.00042478545,0.99311864,0.00020782037,0.00011392373,1.3692544e-7,0.00003077996,0.0000028927416,0.00020579388,0.00015264691,0.00281703,0.00028031043],"about_ca_topic_score_codex":0.009374965,"about_ca_topic_score_gemma":0.0032903187,"teacher_disagreement_score":0.021573814,"about_ca_system_score_codex":0.0012993803,"about_ca_system_score_gemma":0.0015350119,"threshold_uncertainty_score":0.9999311},"labels":[],"label_agreement":null},{"id":"W4411290861","doi":"10.1158/1557-3265.sabcs24-p4-08-02","title":"Abstract P4-08-02: Identifying unique transcriptomes associated with HER2+ breast cancer recurrence at the single-cell level","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Transcriptome; Cancer; Oncology; Internal medicine; Computational biology; Biology; Genetics; Gene; Gene expression","score_opus":0.45902800883359274,"score_gpt":0.5609312424808137,"score_spread":0.10190323364722098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411290861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.919725,0.010624519,0.00008274561,0.047764454,0.0011197155,0.0026221785,0.0007632469,0.00016564883,0.017132478],"genre_scores_gemma":[0.9561416,0.006721347,0.000048809812,0.0013278852,0.0005354892,0.00093975774,0.00004241946,0.00010020277,0.034142513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99160755,0.0013627977,0.0011894912,0.0013232353,0.0027767408,0.0017401865],"domain_scores_gemma":[0.9915387,0.0041816267,0.00021190799,0.0012844219,0.0021438617,0.0006394534],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008930758,0.00040772452,0.0008991834,0.00038509752,0.00079729187,0.00024398202,0.0011674847,0.00051799865,0.0048699887],"category_scores_gemma":[0.0018137457,0.00027389728,0.00034369875,0.0027280173,0.0022832842,0.00019335753,0.00045630662,0.0046230527,0.000188626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007181105,0.0027474891,0.5244775,0.0022162392,0.0011747953,0.00045821452,0.0008913161,0.000058720296,0.02092348,0.00015694048,0.22669712,0.21301712],"study_design_scores_gemma":[0.0060585667,0.0008666828,0.92535734,0.0071591325,0.00021308877,0.000027432636,0.00051892863,0.00013103607,0.015202005,0.00031261047,0.043607403,0.0005457948],"about_ca_topic_score_codex":0.007876212,"about_ca_topic_score_gemma":0.019512897,"teacher_disagreement_score":0.40087986,"about_ca_system_score_codex":0.0030620773,"about_ca_system_score_gemma":0.005720969,"threshold_uncertainty_score":0.99997133},"labels":[],"label_agreement":null},{"id":"W4411291066","doi":"10.1158/1557-3265.sabcs24-p2-06-16","title":"Abstract P2-06-16: Addressing Thermal and Battery Efficiency in AI Enhanced Portable Ultrasound Screening Protocols for Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Breast cancer; Battery (electricity); Ultrasound; Internal medicine; Radiology","score_opus":0.18739584994741895,"score_gpt":0.5563357357897002,"score_spread":0.3689398858422812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677101,0.001871427,0.0009797785,0.007119066,0.00026572106,0.017683506,0.00015479063,0.000068734,0.0041468875],"genre_scores_gemma":[0.9801859,0.00030769932,0.00029487096,0.002097043,0.00082153024,0.015326194,0.000020496782,0.00004809206,0.00089811935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609125,0.0002481475,0.0010468942,0.0008005867,0.00077961804,0.0010334922],"domain_scores_gemma":[0.9957718,0.002568606,0.00014841925,0.0005321447,0.0006889977,0.00029002977],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005301996,0.00024764988,0.0007518889,0.0005133701,0.00028408723,0.00008948984,0.00032123958,0.0003190601,0.0009853459],"category_scores_gemma":[0.0014410807,0.00020147215,0.00016982449,0.0010823361,0.00095032045,0.00016632573,0.00011871898,0.0018940136,0.0000041537896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064535425,0.000767715,0.6718055,0.0021581796,0.0002476022,0.00005786391,0.00035111673,0.00008934073,0.050716586,0.00009289858,0.009184027,0.25807562],"study_design_scores_gemma":[0.007976498,0.00041304648,0.9733624,0.008018984,0.0000601438,0.000009199004,0.00034215953,0.00019596485,0.006243266,0.00033787263,0.0027956348,0.00024481918],"about_ca_topic_score_codex":0.00086608157,"about_ca_topic_score_gemma":0.00022428003,"teacher_disagreement_score":0.30155692,"about_ca_system_score_codex":0.00023447072,"about_ca_system_score_gemma":0.0012715951,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W4411291227","doi":"10.1158/1557-3265.sabcs24-p1-10-07","title":"Abstract P1-10-07: PROgress Tracker Breast Cancer Registry: Feasibility of a Longitudinal Peer-Led, National Patient-Reported Outcomes (PRO) Registry","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer registry; Medicine; Breast cancer; Patient registry; Cancer; Medical physics; Oncology; Family medicine; Internal medicine","score_opus":0.3995001306552787,"score_gpt":0.58418274641182,"score_spread":0.18468261575654132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635071,0.0023833415,0.0000076434335,0.02375126,0.0005776435,0.0013040584,0.00045696815,0.00007173533,0.007940262],"genre_scores_gemma":[0.99190843,0.00025468259,0.00018093734,0.0004750145,0.0004656885,0.00044139268,0.00006175504,0.000029078496,0.006182995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921493,0.00028357244,0.0018416157,0.00117741,0.0036874579,0.0008606718],"domain_scores_gemma":[0.99100727,0.0008696278,0.00059285096,0.0010896904,0.0059819417,0.00045863708],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052060434,0.00032111036,0.0010310921,0.00023628131,0.00024796548,0.00008436693,0.00057216384,0.0004424037,0.0028025284],"category_scores_gemma":[0.005456766,0.00026147848,0.00047680055,0.0011392917,0.0016972661,0.00021925913,0.0002976407,0.0017441751,0.000031400577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050196615,0.00079153094,0.89246655,0.00048864505,0.00041601644,0.00015208984,0.000047216865,0.000012654669,0.000059645885,0.00014376339,0.072848246,0.027554002],"study_design_scores_gemma":[0.0031003102,0.00031795877,0.98654026,0.0012528937,0.00012721842,0.000035270612,0.0002643689,0.00005229633,0.00019006708,0.00041230393,0.007495122,0.00021194504],"about_ca_topic_score_codex":0.0045811133,"about_ca_topic_score_gemma":0.001278761,"teacher_disagreement_score":0.09407371,"about_ca_system_score_codex":0.0010821627,"about_ca_system_score_gemma":0.006210348,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W4411291454","doi":"10.1158/1557-3265.sabcs24-p1-01-05","title":"Abstract P1-01-05: Conducting Ancillary Studies during an Active NCTN/NCORP Screening Trial – The TMIST (ECOG-ACRIN EA1151) Experience","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.5735997401750292,"score_gpt":0.6294568798058396,"score_spread":0.055857139630810404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98400444,0.0051894677,0.000022007323,0.00432282,0.0020359396,0.0010139028,0.00002656262,0.000094897994,0.0032899692],"genre_scores_gemma":[0.9931955,0.0018031237,0.00013876623,0.00070316263,0.0028341063,0.00034603293,0.000009492118,0.00003349278,0.00093631935],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99600935,0.00059209694,0.00085038744,0.0007920432,0.0009592076,0.0007969182],"domain_scores_gemma":[0.9905102,0.0073741563,0.00014735997,0.00085459376,0.0007982059,0.00031544862],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0044366214,0.00023018236,0.00072456914,0.00016277202,0.00087060046,0.00012918223,0.0003739749,0.00016481263,0.00012945151],"category_scores_gemma":[0.020160923,0.00016692148,0.0002972635,0.0006617895,0.0015620651,0.00020717397,0.000473704,0.0020649633,0.00001929394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17388564,0.002556875,0.30628955,0.001702413,0.0030596086,0.0026635868,0.016891843,0.00034217225,0.009545947,0.0003407918,0.06332147,0.4194001],"study_design_scores_gemma":[0.0820893,0.0022665146,0.7482972,0.0039284765,0.0004884312,0.00007631985,0.097872436,0.0003152933,0.02744674,0.0005142108,0.03572511,0.0009799483],"about_ca_topic_score_codex":0.00072539935,"about_ca_topic_score_gemma":0.00017625549,"teacher_disagreement_score":0.44200766,"about_ca_system_score_codex":0.00029296085,"about_ca_system_score_gemma":0.00092346466,"threshold_uncertainty_score":0.98809266},"labels":[],"label_agreement":null},{"id":"W4411291466","doi":"10.1158/1557-3265.sabcs24-p1-04-09","title":"Abstract P1-04-09: Evaluating the Necessity and Impact of Cardiac Imaging on Breast Cancer Care in Northwestern Ontario","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Breast cancer; Intensive care medicine; Oncology; Internal medicine","score_opus":0.137985187996293,"score_gpt":0.5609468726863178,"score_spread":0.4229616846900248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98558736,0.007716979,6.163106e-7,0.0022676678,0.00038404227,0.00054825004,0.00014851865,0.000013013172,0.0033335837],"genre_scores_gemma":[0.9981237,0.0009283354,0.00001023072,0.00024136488,0.0003129168,0.00008857329,0.000011769867,0.000016545002,0.00026658087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753267,0.00036583003,0.00052339095,0.0004430054,0.00068193645,0.00045315883],"domain_scores_gemma":[0.99546134,0.0031561116,0.00008726938,0.0005054508,0.00062036584,0.00016947115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031161464,0.00015374222,0.0005531177,0.00017861079,0.00014193836,0.000056477387,0.00016147562,0.00009073681,0.00012194926],"category_scores_gemma":[0.0007901299,0.000103063445,0.0002890152,0.0004207107,0.00046428683,0.00005756912,0.00019556136,0.0015342745,0.000004854758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089758117,0.00008252738,0.8138314,0.00013515812,0.000090429,0.0000131464785,0.0007986086,0.00010263934,0.00007827409,0.0000035742146,0.0009447818,0.18302187],"study_design_scores_gemma":[0.0013351158,0.00019734756,0.9957982,0.0013016985,0.00009398733,0.0000019285017,0.000641339,0.00010016566,0.00006638877,0.00003368137,0.00034373626,0.000086449574],"about_ca_topic_score_codex":0.4060174,"about_ca_topic_score_gemma":0.09523831,"teacher_disagreement_score":0.31077906,"about_ca_system_score_codex":0.0010238151,"about_ca_system_score_gemma":0.0036771612,"threshold_uncertainty_score":0.9212712},"labels":[],"label_agreement":null},{"id":"W4411291480","doi":"10.1158/1557-3265.sabcs24-p2-11-18","title":"Abstract P2-11-18: Patterns of Treatment in Older Patients with Early-Stage Triple Negative Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Stage (stratigraphy); Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Biology","score_opus":0.1123254802411527,"score_gpt":0.49916572405282017,"score_spread":0.3868402438116675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444777,0.00048665292,0.000028144874,0.0017394077,0.00022746151,0.0017986762,0.0007114078,0.000027369106,0.0005331269],"genre_scores_gemma":[0.9936278,0.00077510154,0.00007207261,0.00023489766,0.0001866476,0.000807213,0.000022612756,0.000045176388,0.0042284643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968449,0.00023878425,0.0008101788,0.0006921019,0.0007331447,0.00068088225],"domain_scores_gemma":[0.9973109,0.00080083066,0.00018584296,0.0005980869,0.00086105725,0.00024328951],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006485529,0.00026386563,0.00080899446,0.00035121813,0.000079562735,0.000019992545,0.00024143205,0.00017852742,0.0022529901],"category_scores_gemma":[0.00015146061,0.00018711988,0.00015165222,0.00086590473,0.00051251985,0.00014969906,0.00010447987,0.00074617687,0.0000095426085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006494456,0.0013086441,0.90151817,0.00023098147,0.00025811547,0.000023707926,0.00040336256,0.000047160378,0.000046789886,0.000029565326,0.00014953541,0.0894895],"study_design_scores_gemma":[0.016286625,0.00086615613,0.97741073,0.0014137186,0.00004707636,5.080814e-7,0.00035733762,0.000014363583,0.000824286,0.000061636754,0.0025623362,0.00015519926],"about_ca_topic_score_codex":0.030981526,"about_ca_topic_score_gemma":0.011678985,"teacher_disagreement_score":0.0893343,"about_ca_system_score_codex":0.0013859438,"about_ca_system_score_gemma":0.001762115,"threshold_uncertainty_score":0.9986591},"labels":[],"label_agreement":null},{"id":"W4411291698","doi":"10.1158/1557-3265.sabcs24-p2-09-01","title":"Abstract P2-09-01: Preliminary Findings from the Breast Cancer Combined Visualization And Characterization Tools (bCOMBAT): Low-Dose PEM and Liquid Biopsy Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Biopsy; Visualization; Liquid biopsy; Radiology; Pathology; Internal medicine; Computer science; Data mining","score_opus":0.13836652519548148,"score_gpt":0.5183740489704546,"score_spread":0.3800075237749731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613078,0.00036725824,0.00019085343,0.035852216,0.00012189713,0.001830314,0.00015774208,0.00008400645,0.00008787302],"genre_scores_gemma":[0.99385715,0.0031773238,0.000054239354,0.0011882178,0.00029300043,0.0007696698,0.00015728915,0.000023517754,0.00047960426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978144,0.00024804077,0.0005911906,0.00055993506,0.00048758803,0.00029881654],"domain_scores_gemma":[0.9975914,0.0013068613,0.0000910667,0.00045625103,0.0003296035,0.00022486591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018046077,0.00015066646,0.00035117092,0.00009800868,0.0003235838,0.00013578964,0.00022512778,0.00015926287,0.000343437],"category_scores_gemma":[0.0006293019,0.00010592212,0.000050030776,0.0005342254,0.00054555625,0.00012636128,0.0003240502,0.0007702263,0.0000065405306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008199732,0.0033664617,0.79573494,0.0004899384,0.00034357343,0.000042393454,0.0011334805,4.0386138e-7,0.038121518,0.0016249082,0.026105413,0.124837264],"study_design_scores_gemma":[0.0019303319,0.000551345,0.9922585,0.0007094054,0.00009441047,0.000003568268,0.00024304143,0.0009056767,0.00050140655,0.00015609394,0.0025399649,0.000106285945],"about_ca_topic_score_codex":0.0011814252,"about_ca_topic_score_gemma":0.000043065727,"teacher_disagreement_score":0.19652356,"about_ca_system_score_codex":0.0000869757,"about_ca_system_score_gemma":0.0003405917,"threshold_uncertainty_score":0.43193784},"labels":[],"label_agreement":null},{"id":"W4411489613","doi":"10.1158/1078-0432.ccr-24-3912","title":"<i>ERBB2</i> /HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Abbotsford Veterinary Clinic; Spinal Cord Injury BC; BC Cancer Agency; Kelowna General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Bladder Cancer Advocacy Network","keywords":"Genotype; Immunohistochemistry; Biology; Cancer; DNA sequencing; Tumour heterogeneity; Cancer research; Biomarker; Fluorescence in situ hybridization; Pathology; DNA; Medicine; Gene; Genetics; Immunology","score_opus":0.1118459611401712,"score_gpt":0.5057213308847733,"score_spread":0.39387536974460213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411489613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871096,0.00589232,0.000052291845,0.0024196976,0.00020000324,0.0015107127,0.00021567677,0.000017392942,0.0025823007],"genre_scores_gemma":[0.99404377,0.002267465,0.00035477255,0.00049714244,0.00010966005,0.00053707795,0.000024611727,0.000023744753,0.0021417795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781644,0.00030721276,0.00055632374,0.00044041872,0.00051983347,0.00035974692],"domain_scores_gemma":[0.9985478,0.00047005017,0.00006785665,0.00031908558,0.00043729637,0.00015793237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066826586,0.00015055026,0.0005817807,0.00023079144,0.00008573469,0.000024468467,0.00012143923,0.00007377341,0.0003692718],"category_scores_gemma":[0.00020626653,0.0001073672,0.00006815272,0.0006238072,0.00048042418,0.000086955326,0.00008182664,0.00047592536,0.0000053992467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038068593,0.0013795439,0.92923623,0.00037423612,0.00054304174,0.000021382722,0.0003209959,0.000016269316,0.00009058417,0.00024895268,0.0017532187,0.062208667],"study_design_scores_gemma":[0.017235087,0.0025508208,0.9561388,0.000984975,0.0004915182,9.2867356e-7,0.00015577185,0.00010084462,0.0026802765,0.00066977774,0.018785253,0.00020597204],"about_ca_topic_score_codex":0.0056641377,"about_ca_topic_score_gemma":0.0034503036,"teacher_disagreement_score":0.062002696,"about_ca_system_score_codex":0.00017353444,"about_ca_system_score_gemma":0.0012397808,"threshold_uncertainty_score":0.85625196},"labels":[],"label_agreement":null},{"id":"W4411541911","doi":"10.1158/1078-0432.ccr-24-4354","title":"Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma Syndromes","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"St. Baldrick's Foundation","keywords":"Pheochromocytoma; Paraganglioma; Medicine; Pathology; Pediatrics","score_opus":0.2285366944589447,"score_gpt":0.5441405957109416,"score_spread":0.31560390125199694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411541911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019797077,0.9892725,0.00001169593,0.00070325885,0.0006212031,0.0050513204,0.0011163295,0.00012920753,0.001114814],"genre_scores_gemma":[0.00074848416,0.986343,0.00014271503,0.00048108006,0.0029515338,0.0021600933,0.00096065697,0.00016275364,0.0060496856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99352056,0.0009813606,0.0014319804,0.0016028399,0.001252213,0.0012110549],"domain_scores_gemma":[0.99223614,0.0048294263,0.0003637483,0.001312736,0.00064526533,0.00061266514],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033208407,0.0006984341,0.0039289733,0.0006427708,0.00029176995,0.000063021915,0.0008276108,0.0005219223,0.00056489493],"category_scores_gemma":[0.0015582014,0.00044420833,0.0011238467,0.0018184658,0.00080023,0.00005482708,0.00027605984,0.0027764663,0.00037441988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026279867,0.000731718,0.0005427914,0.031264875,0.001962794,0.014480064,0.000008308051,0.0000019029101,9.177931e-9,0.0002714289,0.11660774,0.8315004],"study_design_scores_gemma":[0.00432629,0.0046537295,0.0030562861,0.062495645,0.0010894384,0.009051101,0.0000102295235,0.000007158173,0.0000042618694,0.00017021461,0.91427535,0.00086030713],"about_ca_topic_score_codex":0.000094870964,"about_ca_topic_score_gemma":0.00008936204,"teacher_disagreement_score":0.8306401,"about_ca_system_score_codex":0.00036471916,"about_ca_system_score_gemma":0.00523119,"threshold_uncertainty_score":0.999801},"labels":[],"label_agreement":null},{"id":"W4411604374","doi":"10.1158/1078-0432.ccr-24-3720","title":"Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; York University","keywords":"Immune system; Computer science; Immune checkpoint; Artificial intelligence; Computational biology; Immunology; Medicine; Biology; Immunotherapy","score_opus":0.19196513426731834,"score_gpt":0.5307325766693138,"score_spread":0.3387674424019955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411604374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90734273,0.005288927,0.003096231,0.07640884,0.0029898616,0.0022582852,0.000053936375,0.00020912154,0.002352041],"genre_scores_gemma":[0.9851229,0.0018456235,0.0014888112,0.0021465356,0.0013018985,0.00046592153,0.0000103505745,0.00004203393,0.0075759017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560004,0.00075907324,0.0013603056,0.0006939405,0.00088423083,0.00070241606],"domain_scores_gemma":[0.9966085,0.0015506687,0.00007414479,0.0007702468,0.0006197323,0.00037670947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011220572,0.00018207933,0.00049986405,0.0005077609,0.00023065142,0.00006932039,0.00038612486,0.00027505672,0.0006111479],"category_scores_gemma":[0.0035324583,0.00015426443,0.00034735654,0.0020229106,0.0007351615,0.000058474707,0.00032070975,0.0012335668,0.0002137657],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047865875,0.0004744127,0.0018221724,0.00007511549,0.00020256145,0.000064815125,0.00021605084,0.000003892863,0.041382533,0.000067369576,0.012810156,0.89501506],"study_design_scores_gemma":[0.0029258872,0.006590549,0.18243128,0.0029759281,0.00012176969,0.000016190743,0.0013972522,0.001581647,0.35754758,0.0028572986,0.4409474,0.00060721004],"about_ca_topic_score_codex":0.0007927431,"about_ca_topic_score_gemma":0.00009535506,"teacher_disagreement_score":0.8944078,"about_ca_system_score_codex":0.0005621387,"about_ca_system_score_gemma":0.0020420197,"threshold_uncertainty_score":0.6691641},"labels":[],"label_agreement":null},{"id":"W4411643060","doi":"10.1158/1078-0432.ccr-24-3860","title":"Updated Recommendations for Pediatric Surveillance in Hereditary Endocrine Neoplasia Syndromes: Multiple Endocrine Neoplasias, Hyperparathyroidism–Jaw Tumor Syndrome, and Carney Complex","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Ipsen; Deutsche Kinderkrebsstiftung; Bundesministerium für Bildung und Forschung; St. Baldrick's Foundation","keywords":"Penetrance; Endocrine system; Multiple endocrine neoplasia; Medicine; Pheochromocytoma; Hyperparathyroidism; Genetic testing; Carney complex; Bioinformatics; Pathology; Internal medicine; Phenotype; Biology; Genetics; Hormone","score_opus":0.16728557429756463,"score_gpt":0.4984775767315684,"score_spread":0.33119200243400376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411643060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650029,0.004208542,0.000026322143,0.024591465,0.0006846685,0.003855636,0.0006440823,0.00015573754,0.0008306599],"genre_scores_gemma":[0.98260635,0.009744503,0.0014239625,0.0008043474,0.0003463974,0.0017113377,0.00047903418,0.00009065974,0.0027934087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930663,0.001044595,0.001630386,0.0015264989,0.0009234336,0.0018087841],"domain_scores_gemma":[0.9902681,0.0070225657,0.00017132761,0.00093835685,0.0008529013,0.0007467218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019499288,0.00045250417,0.0013811943,0.0013150912,0.0003825191,0.00010436982,0.0006072303,0.00005609881,0.00039321723],"category_scores_gemma":[0.0067406623,0.0004256268,0.00023872711,0.0027844068,0.0006904461,0.0002799469,0.0006699113,0.0021679427,0.00005004403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030925837,0.0010777863,0.8251295,0.00092424476,0.000159837,0.0067501394,0.000025671536,0.000030853786,0.0003036768,0.000195468,0.1570938,0.0052164216],"study_design_scores_gemma":[0.020213006,0.0029276756,0.70596457,0.00032131988,0.000088215515,0.0034321465,0.0005439743,0.002261175,0.000320463,0.0005649067,0.2627719,0.0005906657],"about_ca_topic_score_codex":0.0018696409,"about_ca_topic_score_gemma":0.004324771,"teacher_disagreement_score":0.11916497,"about_ca_system_score_codex":0.00037473984,"about_ca_system_score_gemma":0.001438217,"threshold_uncertainty_score":0.9998196},"labels":[],"label_agreement":null},{"id":"W4411643375","doi":"10.1158/1078-0432.ccr-25-0597","title":"Radiation Concepts and Considerations for Pediatric Cancer Predisposition Syndrome Surveillance: A Report from the 2023 AACR Childhood Cancer Predisposition Workshop","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Terry Fox Foundation; Physicians' Services Incorporated Foundation; Radiological Society of North America","keywords":"Medicine; Cancer; Genetic predisposition; Childhood cancer; Ionizing radiation; Pediatric cancer; Radiation exposure; Medical physics; Pathology; Nuclear medicine; Internal medicine; Disease","score_opus":0.1335779421386495,"score_gpt":0.5210780326276089,"score_spread":0.3875000904889594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411643375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86891824,0.031332277,0.0004453593,0.09062475,0.0023375347,0.0040866085,0.0019404925,0.00011832983,0.00019641743],"genre_scores_gemma":[0.96825945,0.017974861,0.0001835077,0.0035777504,0.004417645,0.0038170358,0.0004926998,0.00005573548,0.0012213036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421865,0.0011291663,0.0015380376,0.0012498278,0.0011350218,0.00072931225],"domain_scores_gemma":[0.98654735,0.010486572,0.00040750531,0.0008743929,0.0013106369,0.0003735346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049771788,0.00032362784,0.00087556324,0.00021513646,0.00083548937,0.00020427085,0.00025586813,0.0004524443,0.00056678813],"category_scores_gemma":[0.006886681,0.00027008142,0.00028941355,0.0010590161,0.00061902544,0.00024510364,0.00020182565,0.0013371152,0.000008683279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014973943,0.00059276936,0.7342553,0.00051108014,0.00087693793,0.000074965705,0.0013580678,0.00013604734,0.00011131605,0.00042919454,0.24717101,0.012985892],"study_design_scores_gemma":[0.0047920146,0.00029269536,0.984489,0.0008799244,0.00044064244,0.000032414642,0.00048876076,0.00040888097,0.00009077512,0.0028701718,0.0049211127,0.00029356027],"about_ca_topic_score_codex":0.01079366,"about_ca_topic_score_gemma":0.011473899,"teacher_disagreement_score":0.25023374,"about_ca_system_score_codex":0.0006324807,"about_ca_system_score_gemma":0.003671609,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W4412110964","doi":"10.1158/1078-0432.ccr-25-0111","title":"Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Sinai Health System","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Sarcoma; Soft tissue; Soft tissue sarcoma; Medicine; Cell culture; Cancer research; Pathology; Biology; Genetics","score_opus":0.1386466768010725,"score_gpt":0.49468875857627753,"score_spread":0.356042081775205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412110964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838375,0.007257212,0.000007044799,0.005186023,0.0001905753,0.0009675076,0.000028884522,0.00002835832,0.002496931],"genre_scores_gemma":[0.99546874,0.0019318273,0.00011397303,0.0005430865,0.00013015178,0.00026585863,0.000023843313,0.000020324365,0.0015021856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693954,0.00038472374,0.00069606025,0.0005141398,0.0009547959,0.00051074475],"domain_scores_gemma":[0.9952077,0.0031086104,0.00012703217,0.0008167794,0.000535873,0.0002039951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016563586,0.00018983148,0.00058693707,0.00018173081,0.0002653012,0.0000642398,0.00052902574,0.00016688005,0.00033942008],"category_scores_gemma":[0.0005256655,0.000112609676,0.00021231269,0.0006035096,0.00086353096,0.00009259575,0.0004501192,0.0008212585,0.000017083321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033436404,0.001438668,0.9746785,0.00027492933,0.00012893656,0.00004277886,0.00013060398,0.000020460164,0.00091046205,0.00012205153,0.004892623,0.017025588],"study_design_scores_gemma":[0.0018770385,0.0007639589,0.9374477,0.00034755736,0.00010948552,9.838122e-7,0.0003478195,0.000010786309,0.038507853,0.00012341852,0.02036846,0.00009491101],"about_ca_topic_score_codex":0.0034527977,"about_ca_topic_score_gemma":0.00024754778,"teacher_disagreement_score":0.03759739,"about_ca_system_score_codex":0.00023680787,"about_ca_system_score_gemma":0.00071250484,"threshold_uncertainty_score":0.52196205},"labels":[],"label_agreement":null},{"id":"W4412163643","doi":"10.1158/1557-3265.aimachine-a023","title":"Abstract A023: Spatially resolved drug response predictions reveal fibroblast-associated resistances in <i>in situ</i> lung cancer samples","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; In situ; Drug response; Drug; Cancer; Medicine; Fibroblast; Carcinoma in situ; Cancer research; Pathology; Internal medicine; Oncology; Biology; Chemistry; Pharmacology; Cell culture; Genetics","score_opus":0.06551512070625558,"score_gpt":0.42111601519396274,"score_spread":0.35560089448770715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985296,0.0073551624,0.000101213016,0.0016483235,0.0012019061,0.0010278457,0.00047089075,0.00024887559,0.0026497755],"genre_scores_gemma":[0.99167144,0.00508842,0.0001490475,0.00012755375,0.00026279315,0.0006568048,0.000030100155,0.00007665399,0.0019371801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953805,0.00045349498,0.0014940107,0.0006815406,0.0008265347,0.0011639141],"domain_scores_gemma":[0.9930631,0.005686327,0.0001017162,0.00062126486,0.00031071712,0.00021689488],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0061385226,0.00030662902,0.00067383575,0.00071944675,0.00019664294,0.00010348511,0.0007204388,0.00040530018,0.00020101742],"category_scores_gemma":[0.0025945965,0.00031737887,0.00018008117,0.0023379659,0.00036665326,0.0002695086,0.00016782519,0.0023052767,0.000013898021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022651115,0.00096209755,0.48531306,0.001996541,0.0008774104,0.000300259,0.0019202076,0.10489692,0.1441079,0.000345622,0.21520895,0.021419939],"study_design_scores_gemma":[0.0054977587,0.00015049805,0.9483409,0.0057820147,0.00004544234,3.3502124e-7,0.00025430947,0.0068877703,0.0068913074,0.0021689017,0.023319447,0.00066132756],"about_ca_topic_score_codex":0.0050051683,"about_ca_topic_score_gemma":0.15992251,"teacher_disagreement_score":0.46302783,"about_ca_system_score_codex":0.0023927635,"about_ca_system_score_gemma":0.0015353578,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W4412163645","doi":"10.1158/1557-3265.aimachine-a062","title":"Abstract A062: Uncovering Social and Clinical Determinants of Baseline Distress Prior to Radiation Therapy: An Explainable Machine Learning Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Baseline (sea); Distress; Medicine; Radiation therapy; Psychology; Intensive care medicine; Psychotherapist; Clinical psychology; Surgery; Political science","score_opus":0.13878671856935565,"score_gpt":0.5319197666372175,"score_spread":0.39313304806786187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416417,0.0012509485,0.0006649926,0.0022926875,0.00024355683,0.00060256955,0.0000144886635,0.000039725008,0.0007268377],"genre_scores_gemma":[0.99379927,0.003190008,0.0009707099,0.0005128239,0.00075204985,0.00005612702,0.00003709189,0.00003423303,0.0006476733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99628824,0.0008652461,0.0010770393,0.000657436,0.0006182302,0.0004938316],"domain_scores_gemma":[0.99718267,0.001622462,0.00016526566,0.00031030306,0.00030036073,0.00041896492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010682283,0.0001669395,0.00073463825,0.0002325997,0.0003318416,0.000062702406,0.00025686403,0.0002311158,0.00008663306],"category_scores_gemma":[0.006000739,0.0001385091,0.0001615923,0.00048377778,0.00047623122,0.00010770629,0.00021542894,0.0020713652,0.0000031586637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010597495,0.00040997245,0.46616283,0.0002034672,0.000053932385,0.000015915937,0.00013555508,0.000066655855,0.00018279633,0.0000245138,0.00039055626,0.53129405],"study_design_scores_gemma":[0.0046956656,0.00095435034,0.91533715,0.00034815696,0.000054236065,0.0000039747993,0.0002296802,0.056402825,0.00022108154,0.00009275086,0.02147811,0.00018202419],"about_ca_topic_score_codex":0.001234916,"about_ca_topic_score_gemma":0.000061976956,"teacher_disagreement_score":0.531112,"about_ca_system_score_codex":0.0001049315,"about_ca_system_score_gemma":0.00045418701,"threshold_uncertainty_score":0.89991665},"labels":[],"label_agreement":null},{"id":"W4412163652","doi":"10.1158/1557-3265.aimachine-b007","title":"Abstract B007: TheBlueScrubs-v1: A Large-Scale Curated Dataset with ∼11 Billion Oncology Tokens for AI-Driven Cancer Research","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Scale (ratio); Oncology; Precision oncology; Medicine; Internal medicine; Clinical Oncology; Computer science; Computational biology; Biology; Cartography; Geography","score_opus":0.23548338623858694,"score_gpt":0.6182858435125832,"score_spread":0.38280245727399625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7867119,0.0028441497,0.0016033784,0.19617261,0.0013801103,0.0044203736,0.00222285,0.00015681896,0.004487844],"genre_scores_gemma":[0.96734643,0.007027549,0.0021647604,0.0094839865,0.0029318647,0.0023497683,0.001807118,0.00014995586,0.006738544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99407923,0.0010322586,0.00093912135,0.0011443928,0.0012241098,0.0015809132],"domain_scores_gemma":[0.9917692,0.004651272,0.00013193885,0.0009620882,0.0017954566,0.00069003715],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.013053169,0.00025181827,0.0008919205,0.000622899,0.0006734647,0.00012209403,0.00069925666,0.000449604,0.0009333196],"category_scores_gemma":[0.004106336,0.0001762909,0.0001818299,0.0016102811,0.0015315908,0.00013934178,0.000434032,0.004876556,0.000063180065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006527693,0.0013729373,0.10537006,0.00069752935,0.00047921925,0.00022561093,0.00036070216,0.00019780833,0.0018131752,0.000545465,0.83538735,0.047022436],"study_design_scores_gemma":[0.0075981095,0.0014563008,0.034215823,0.001197415,0.00011836569,0.0000085100455,0.0005383395,0.013870382,0.00041100176,0.0005023923,0.93986636,0.00021697668],"about_ca_topic_score_codex":0.00387385,"about_ca_topic_score_gemma":0.004698262,"teacher_disagreement_score":0.18668863,"about_ca_system_score_codex":0.0007109229,"about_ca_system_score_gemma":0.0039919573,"threshold_uncertainty_score":0.99998},"labels":[],"label_agreement":null},{"id":"W4412163656","doi":"10.1158/1557-3265.aimachine-pr-04","title":"Abstract PR-04: A practical framework for operationalizing responsible and equitable AI in healthcare: Tackling bias, inequity, and implementation challenges","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; Toronto Metropolitan University; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Operationalization; Health care; Health equity; Business; Political science; Medicine; Public economics; Economics; Economic growth","score_opus":0.7817136551151166,"score_gpt":0.7334528669107033,"score_spread":0.04826078820441326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57918364,0.0093263835,0.00050168234,0.40921775,0.0002989534,0.0013382175,0.000008095388,0.000015028478,0.000110256864],"genre_scores_gemma":[0.9715596,0.020004816,0.003989941,0.0031889237,0.000535332,0.00056480494,0.000017747945,0.000013795007,0.00012507041],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975375,0.00034734234,0.00079318276,0.00047247135,0.0003332069,0.0005162948],"domain_scores_gemma":[0.9914794,0.0073625115,0.00006966836,0.00019936124,0.0006818077,0.00020728291],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009530776,0.00009154527,0.0002885328,0.00026790716,0.0002978773,0.000090891765,0.000059340327,0.00024607574,0.000056252375],"category_scores_gemma":[0.009098267,0.000085772575,0.000033562002,0.0003803602,0.00018051358,0.00019849982,0.00012386938,0.001007777,0.0000036181852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002704902,0.00035432182,0.21759138,0.0021917997,0.000049107333,0.00001031224,0.0013597024,0.0000050252597,0.00045803905,0.1962168,0.0046734554,0.57438517],"study_design_scores_gemma":[0.0011510681,0.002211327,0.5417987,0.0031886522,0.00005617871,0.000010851679,0.012778903,0.0017394309,0.0035788277,0.4036501,0.029519882,0.00031608928],"about_ca_topic_score_codex":0.0040290267,"about_ca_topic_score_gemma":0.004942005,"teacher_disagreement_score":0.5740691,"about_ca_system_score_codex":0.0002365574,"about_ca_system_score_gemma":0.003120205,"threshold_uncertainty_score":0.9992485},"labels":[],"label_agreement":null},{"id":"W4412163664","doi":"10.1158/1557-3265.aimachine-a042","title":"Abstract A042: Real-world clinical multi-omics and AI/ML analyses reveal bifurcation of drug resistance mechanisms to CDK4/6 inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Drug resistance; Omics; Computational biology; Medicine; Biology; Pharmacology; Bioinformatics; Genetics","score_opus":0.2503190552700628,"score_gpt":0.5727243588979769,"score_spread":0.3224053036279141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98122936,0.00023498618,0.0014090398,0.010203244,0.00039151008,0.0012834948,0.00005221336,0.000038443566,0.0051577087],"genre_scores_gemma":[0.9844208,0.0026954664,0.005064892,0.0017892842,0.0001584455,0.00013683028,0.000009215711,0.000033231652,0.0056918385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938905,0.0012945059,0.0017432962,0.0013633526,0.0009899344,0.0007183675],"domain_scores_gemma":[0.9951475,0.0030959852,0.00028428165,0.00081700156,0.00010704369,0.0005481524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013385973,0.000221051,0.00060590485,0.00027625554,0.00031137973,0.000052468822,0.0005401274,0.0002168607,0.00043606924],"category_scores_gemma":[0.0030287972,0.0002115351,0.00016730743,0.0013478184,0.0012193449,0.00021544281,0.0008052463,0.0014293827,0.00017665715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010287176,0.0010312055,0.83272827,0.0002902751,0.00011751786,0.000024848003,0.00043296418,0.00026562624,0.016317658,0.0006066509,0.03554398,0.111612305],"study_design_scores_gemma":[0.001012069,0.00010132604,0.9776997,0.00032456027,0.000034267545,1.3185293e-7,0.00021114378,0.00027213315,0.0068985173,0.0022489503,0.010968205,0.00022898588],"about_ca_topic_score_codex":0.0052510807,"about_ca_topic_score_gemma":0.016052086,"teacher_disagreement_score":0.14497146,"about_ca_system_score_codex":0.00063246756,"about_ca_system_score_gemma":0.00029431784,"threshold_uncertainty_score":0.895744},"labels":[],"label_agreement":null},{"id":"W4412163674","doi":"10.1158/1557-3265.aimachine-a026","title":"Abstract A026: GenAI and Physics Assisted Methods for the Design and Development of USP1 Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug development; Medicine; Medical physics; Physics; Pharmacology; Drug","score_opus":0.5759676318210664,"score_gpt":0.6597587551175987,"score_spread":0.08379112329653238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163674","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28955004,0.03222675,0.6516203,0.017796168,0.0012176645,0.0061502256,0.00003476583,0.00007431176,0.0013297546],"genre_scores_gemma":[0.5832639,0.008318341,0.4025923,0.0016380815,0.0009542094,0.0019306525,0.000010048894,0.00006214111,0.0012303744],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99810284,0.000381571,0.0006017808,0.00033998446,0.00030061844,0.00027320147],"domain_scores_gemma":[0.9910905,0.007936045,0.00009628009,0.00027758558,0.00047582807,0.00012380164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007476146,0.00010591549,0.00035875264,0.00006402283,0.00022798564,0.000025666903,0.00011992818,0.0001312474,0.000050407456],"category_scores_gemma":[0.00094255165,0.00007128562,0.00007092002,0.00031325442,0.000720842,0.000036839647,0.00010391735,0.00051080895,0.0000013521045],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014698606,0.0001427281,0.0044575725,0.000458625,0.00027110518,9.842702e-7,0.00024432683,0.0000057369775,0.011617345,0.00022383338,0.0077170264,0.9733909],"study_design_scores_gemma":[0.011842327,0.0008529299,0.3751402,0.0018014273,0.0001826052,0.0000044576655,0.00063204794,0.0019362886,0.31284243,0.0065142997,0.28792027,0.0003307272],"about_ca_topic_score_codex":0.00003558542,"about_ca_topic_score_gemma":0.000008764858,"teacher_disagreement_score":0.97306013,"about_ca_system_score_codex":0.00012558978,"about_ca_system_score_gemma":0.0013142711,"threshold_uncertainty_score":0.29069433},"labels":[],"label_agreement":null},{"id":"W4412163675","doi":"10.1158/1557-3265.aimachine-b008","title":"Abstract B008: Fine-tuned large language model accurately estimates progression-free survival from radiology reports in immune checkpoint inhibitor–treated cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immune checkpoint; Cancer; Oncology; Internal medicine; Radiology; Cancer research; Immunotherapy","score_opus":0.10724996230744933,"score_gpt":0.5259392477263349,"score_spread":0.4186892854188856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781006,0.007601496,0.00013559908,0.009340124,0.0008828817,0.0008076166,0.000051864892,0.0001193536,0.0029604528],"genre_scores_gemma":[0.99528193,0.0011987288,0.0012404602,0.00038445208,0.0005246216,0.00023982117,0.00019737626,0.00005168133,0.0008808971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99519634,0.00040470535,0.0015988597,0.00097079325,0.0008347646,0.000994563],"domain_scores_gemma":[0.99580854,0.0021365841,0.0002515597,0.0010888159,0.00032916787,0.00038531952],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006678934,0.00028068214,0.0010615776,0.00035309035,0.00018175018,0.0000651708,0.00046164164,0.00041984956,0.0004655083],"category_scores_gemma":[0.014720811,0.00022195997,0.00023863495,0.00076849136,0.0006259933,0.00009892602,0.0005172863,0.0032739341,0.000014898424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004175953,0.0011472619,0.8601295,0.0005523904,0.0005038772,0.005252142,0.0008538221,0.001449033,0.041608784,0.00012629457,0.021210605,0.06299035],"study_design_scores_gemma":[0.01559867,0.00051298755,0.8052765,0.0051947436,0.00016420301,0.000037828806,0.0007395948,0.14993097,0.01413338,0.0044260747,0.003328211,0.00065684476],"about_ca_topic_score_codex":0.011273097,"about_ca_topic_score_gemma":0.0014106773,"teacher_disagreement_score":0.14848194,"about_ca_system_score_codex":0.00057463825,"about_ca_system_score_gemma":0.0020405694,"threshold_uncertainty_score":0.9990255},"labels":[],"label_agreement":null},{"id":"W4412163678","doi":"10.1158/1557-3265.aimachine-a063","title":"Abstract A063: Artificial Intelligence in Cytopathology and Histopathology of Cancer: The Evolution to Precision Pathology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytopathology; Histopathology; Pathology; Cancer; Anatomical pathology; Medicine; Premalignant lesion; Cytology; Internal medicine; Immunohistochemistry","score_opus":0.12663274599736044,"score_gpt":0.5545919012089935,"score_spread":0.4279591552116331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95286584,0.004463993,0.0023545742,0.038287725,0.000633341,0.0004076176,0.000004535631,0.000012436967,0.00096992595],"genre_scores_gemma":[0.99578965,0.0021417302,0.00045985478,0.00095546735,0.00021481159,0.00013078276,0.0000016679938,0.000010355494,0.0002956539],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974113,0.00062510493,0.00079090695,0.00048385008,0.00029422258,0.0003945925],"domain_scores_gemma":[0.99733275,0.0018324521,0.00008357237,0.0003606479,0.00025762874,0.00013296476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006710542,0.00009694214,0.00045384592,0.00037986177,0.00010007396,0.000010512712,0.0002556311,0.00020451764,0.00009911536],"category_scores_gemma":[0.0063933735,0.00006857322,0.00006805836,0.0006719917,0.0011587684,0.000024013772,0.00026677374,0.0016106551,0.000008678221],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010342279,0.00019272637,0.24341922,0.00010544467,0.000009973684,0.00013511821,0.00030129685,0.00012465457,0.011814849,0.0055755926,0.00079446996,0.73649246],"study_design_scores_gemma":[0.0003966561,0.0004471293,0.98099864,0.0004001535,0.00002551811,0.000020949085,0.00026892265,0.0021803277,0.0004660621,0.010278665,0.0044430215,0.0000739327],"about_ca_topic_score_codex":0.001922846,"about_ca_topic_score_gemma":0.0009691966,"teacher_disagreement_score":0.73757946,"about_ca_system_score_codex":0.00025659,"about_ca_system_score_gemma":0.00061855075,"threshold_uncertainty_score":0.7653927},"labels":[],"label_agreement":null},{"id":"W4412163685","doi":"10.1158/1557-3265.aimachine-a035","title":"Abstract A035: Denoising Models Enhance Detection of Tumor-Derived cfDNA fragments and Cancer Tissue signal in Liquid Biopsy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Cancer; Biopsy; Cancer detection; Medicine; Pathology; Internal medicine","score_opus":0.10298027075811987,"score_gpt":0.48492029384417645,"score_spread":0.38194002308605657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846938,0.012193088,0.0018734579,0.00042861846,0.00025319427,0.0002877617,0.000009915594,0.0000057303096,0.00025440165],"genre_scores_gemma":[0.9874566,0.011678524,0.00006637881,0.00013531298,0.00015449955,0.00019797964,0.0000068821955,0.000013527895,0.0002902801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981987,0.00021686194,0.000491624,0.00054184,0.00026498517,0.00028599106],"domain_scores_gemma":[0.99915975,0.00007354861,0.00011333892,0.00029170167,0.00026678576,0.00009485792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009765497,0.000113395734,0.00021208248,0.00014943433,0.000086872235,0.000037594964,0.00021413619,0.00019849036,0.000058834892],"category_scores_gemma":[0.00011950462,0.00010982109,0.000049829378,0.0003426267,0.0002611594,0.000019209725,0.00016911385,0.0003590672,0.0000016837421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009303246,0.00008069564,0.0010128266,0.00007503553,0.000021689262,0.0000012665148,0.000032192853,0.0001551622,0.9023862,0.000009904243,0.00015438123,0.09514034],"study_design_scores_gemma":[0.00061423675,0.00023894747,0.015291412,0.0003451022,0.0000063750113,4.5724357e-7,0.00016279038,0.00021524775,0.9796956,0.0002956188,0.0030254382,0.00010874643],"about_ca_topic_score_codex":0.0005719315,"about_ca_topic_score_gemma":0.0003834264,"teacher_disagreement_score":0.09503159,"about_ca_system_score_codex":0.000069156886,"about_ca_system_score_gemma":0.00041236074,"threshold_uncertainty_score":0.4478374},"labels":[],"label_agreement":null},{"id":"W4412163698","doi":"10.1158/1557-3265.aimachine-a034","title":"Abstract A034: A robust ensemble-feature selection and machine learning approach to identify true somatic variants","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatic cell; Feature selection; Artificial intelligence; Selection (genetic algorithm); Feature (linguistics); Machine learning; Computer science; Ensemble learning; Computational biology; Biology; Genetics; Gene","score_opus":0.14004128679786548,"score_gpt":0.5022422850503581,"score_spread":0.3622009982524926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94324327,0.00432633,0.0100223925,0.023761813,0.0005283366,0.0011856919,0.000004977459,0.00015444073,0.01677278],"genre_scores_gemma":[0.9838137,0.0015354855,0.004317214,0.0012004912,0.00059273944,0.00011846127,0.000020207042,0.000041649528,0.008360067],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969966,0.00049316284,0.0005276495,0.00070729625,0.000681077,0.0005942425],"domain_scores_gemma":[0.9978118,0.0010442937,0.00007567669,0.0002905035,0.00028895572,0.00048878056],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0052950983,0.00017966243,0.0005401683,0.00040447817,0.0003808257,0.00015530932,0.0002126327,0.00026117289,0.00012146871],"category_scores_gemma":[0.006239559,0.0001482803,0.000116909,0.0009781994,0.0002020551,0.00008215098,0.00021581005,0.003920815,0.00003014088],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016036715,0.0009962331,0.28244615,0.0019556666,0.00055216986,0.000110540095,0.00052837335,0.0032811377,0.011247889,0.0008407471,0.043489724,0.6529477],"study_design_scores_gemma":[0.0039276932,0.00046512688,0.75841534,0.001287927,0.0001520709,0.00006591218,0.00018428628,0.18801694,0.0001819525,0.0007021515,0.046317216,0.00028340542],"about_ca_topic_score_codex":0.0005377909,"about_ca_topic_score_gemma":0.00005525395,"teacher_disagreement_score":0.6526643,"about_ca_system_score_codex":0.0001677757,"about_ca_system_score_gemma":0.00045623365,"threshold_uncertainty_score":0.9983772},"labels":[],"label_agreement":null},{"id":"W4412163702","doi":"10.1158/1557-3265.aimachine-pr-05","title":"Abstract PR-05: Learning the Language of Somatic Mutations: A Large Language Model Approach to Precision Oncology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Somatic cell; Oncology; Medicine; Computational biology; Language model; Natural language processing; Internal medicine; Computer science; Artificial intelligence; Biology; Genetics; Cancer; Gene","score_opus":0.13813087850948066,"score_gpt":0.5422115612473367,"score_spread":0.404080682737856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804657,0.0034804065,0.006192497,0.0017563043,0.00011921138,0.00043341343,0.00002715075,0.000020137571,0.007505154],"genre_scores_gemma":[0.9931019,0.00028086972,0.002408474,0.00035754696,0.000133537,0.00017029005,0.00003572503,0.000010636707,0.0035010285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981484,0.00046097382,0.00041389745,0.00035149587,0.0002894549,0.00033577316],"domain_scores_gemma":[0.9985757,0.0007248069,0.000072871204,0.00038879333,0.00014816967,0.00008969491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034795287,0.00008771374,0.00022791531,0.00008187655,0.00014555057,0.00001856344,0.00046538928,0.00027323895,0.000028899236],"category_scores_gemma":[0.0043820404,0.000058003956,0.00010506606,0.00027209215,0.00035156545,0.0000022555823,0.00037868874,0.0006185575,0.000012294829],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011604823,0.0015760345,0.005081579,0.0004586439,0.00030741826,0.000014994868,0.006545336,0.0035523397,0.11294919,0.00062207546,0.045472898,0.822259],"study_design_scores_gemma":[0.01569827,0.009147179,0.11535533,0.0017978543,0.0003283793,0.000023534763,0.13105036,0.121540084,0.121841386,0.005181178,0.4762166,0.0018198477],"about_ca_topic_score_codex":0.00012072061,"about_ca_topic_score_gemma":0.00012854495,"teacher_disagreement_score":0.82043916,"about_ca_system_score_codex":0.000032816846,"about_ca_system_score_gemma":0.0004993444,"threshold_uncertainty_score":0.52460283},"labels":[],"label_agreement":null},{"id":"W4412163704","doi":"10.1158/1557-3265.aimachine-b028","title":"Abstract B028: Assessing variability in training deep models in delineating Prostate gland anatomy between clinical experts","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate gland; Prostate cancer; Prostate; Medicine; Anatomy; Pathology; Biology; Medical physics; Cancer; Internal medicine","score_opus":0.31012676839339437,"score_gpt":0.5719112199459427,"score_spread":0.26178445155254837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98136806,0.0007903022,0.011586354,0.0010804728,0.0002844438,0.00029639414,0.0000074930767,0.00010678642,0.0044796662],"genre_scores_gemma":[0.99717987,0.00067529234,0.0014246205,0.00011496564,0.00040665152,0.00010634989,0.000013975995,0.000029454204,0.000048839975],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99449146,0.0012232676,0.0021001361,0.0007119238,0.00060289085,0.0008703073],"domain_scores_gemma":[0.9910685,0.007911726,0.00006660355,0.00044523698,0.00018782736,0.00032010718],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.024611231,0.0001982073,0.0008516459,0.00041599196,0.00010153051,0.0001511453,0.00042566672,0.00033747972,0.000085754575],"category_scores_gemma":[0.00639613,0.00018243048,0.0001851844,0.0014265054,0.00035757295,0.000294817,0.00015910932,0.0026881138,0.0000053306953],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000142952185,0.00008092738,0.56075424,0.00013135074,0.00004705671,0.00003265193,0.0002748422,0.010259009,0.000014577752,0.00002001664,0.00019814372,0.4281729],"study_design_scores_gemma":[0.0014508811,0.000016533279,0.24196708,0.0008612195,0.00001903424,2.1288947e-7,0.00062645704,0.75012356,0.000025707526,0.0038883064,0.0007945768,0.00022640915],"about_ca_topic_score_codex":0.00079001434,"about_ca_topic_score_gemma":0.0005223993,"teacher_disagreement_score":0.7398646,"about_ca_system_score_codex":0.00028022123,"about_ca_system_score_gemma":0.0005195618,"threshold_uncertainty_score":0.99961275},"labels":[],"label_agreement":null},{"id":"W4412163706","doi":"10.1158/1557-3265.aimachine-a051","title":"Abstract A051: Multi-omic explainable machine learning improves cancer treatment outcome prediction","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Outcome (game theory); Medicine; Artificial intelligence; Bioinformatics; Computer science; Internal medicine; Biology; Mathematics","score_opus":0.20157133297784077,"score_gpt":0.5564497345569215,"score_spread":0.3548784015790807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96176386,0.008253227,0.00049678003,0.023086319,0.0016134994,0.0012100857,0.00003857313,0.00023234634,0.0033053046],"genre_scores_gemma":[0.94941115,0.011225126,0.00048826268,0.0010478591,0.0009305035,0.0005266502,0.00004673226,0.00005531599,0.036268417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646384,0.00034910924,0.0009660016,0.00077388383,0.00063032063,0.00081683934],"domain_scores_gemma":[0.9975863,0.0010541087,0.00012406324,0.00046300626,0.0003329711,0.00043956126],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003352069,0.00025008968,0.0007019416,0.00034490137,0.00040565338,0.000089646266,0.00025304136,0.00025554132,0.0007364931],"category_scores_gemma":[0.0028475292,0.0001893036,0.00029404822,0.00052402454,0.00045736422,0.00010399636,0.00016853462,0.0027801264,0.000060129812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000666656,0.0006102401,0.7493759,0.00030218047,0.00029884712,0.00007608418,0.00013393507,0.00032333398,0.0039223884,0.00006271269,0.0036594672,0.24056828],"study_design_scores_gemma":[0.00789076,0.00081831345,0.6414169,0.00059878075,0.0001735562,0.000005608535,0.00018435065,0.066958465,0.0006847908,0.00008747092,0.28096977,0.0002112225],"about_ca_topic_score_codex":0.00871497,"about_ca_topic_score_gemma":0.0002644495,"teacher_disagreement_score":0.2773103,"about_ca_system_score_codex":0.0009829126,"about_ca_system_score_gemma":0.0009848286,"threshold_uncertainty_score":0.9995205},"labels":[],"label_agreement":null},{"id":"W4412163707","doi":"10.1158/1557-3265.aimachine-pr-07","title":"Abstract PR-07: Automated segmentation pipeline for radiological imaging using UniverSeg and similarity-guided support set retrieval","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pipeline (software); Radiological weapon; Segmentation; Similarity (geometry); Artificial intelligence; Medicine; Computer science; Set (abstract data type); Pattern recognition (psychology); Computer vision; Radiology; Image (mathematics)","score_opus":0.23329529516041245,"score_gpt":0.5787951067437557,"score_spread":0.3454998115833432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690406,0.0006461188,0.0063370313,0.02044108,0.0006067937,0.001333043,0.00004223512,0.0002455134,0.0013076183],"genre_scores_gemma":[0.9885906,0.00092514075,0.005770401,0.002706141,0.00062675815,0.000025218906,0.00014458949,0.000034239325,0.0011768895],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973826,0.0003024923,0.0007148681,0.0005881671,0.0004651602,0.0005467509],"domain_scores_gemma":[0.9971777,0.0017384099,0.00010828542,0.0002558854,0.00039810376,0.00032160318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005989264,0.00015539801,0.0004941498,0.00024030349,0.00030888864,0.00007644715,0.00016513944,0.00018894918,0.00023216102],"category_scores_gemma":[0.005369827,0.0001309873,0.00013549223,0.0004167423,0.000695002,0.00009897211,0.00015098629,0.0013369401,0.0000057694824],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007267406,0.00076379906,0.4197241,0.0017303715,0.0005112105,0.0006767703,0.00045740695,0.0005190613,0.04197807,0.0006146288,0.35927796,0.16647923],"study_design_scores_gemma":[0.010548386,0.00036505025,0.09690753,0.000629336,0.0002479558,0.00006645864,0.0005807943,0.8458922,0.00088800373,0.0008736399,0.042705763,0.00029491057],"about_ca_topic_score_codex":0.00018791,"about_ca_topic_score_gemma":0.000004207962,"teacher_disagreement_score":0.8453731,"about_ca_system_score_codex":0.0002913389,"about_ca_system_score_gemma":0.0009063535,"threshold_uncertainty_score":0.64285725},"labels":[],"label_agreement":null},{"id":"W4412163708","doi":"10.1158/1557-3265.aimachine-a043","title":"Abstract A043: Mutational profiling and machine learning for risk stratification and biomarker identification in intraductal papillary mucinous neoplasms progressing to pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk stratification; Biomarker; Medicine; Pancreatic cancer; Pathology; Profiling (computer programming); Pancreas; Oncology; Internal medicine; Cancer research; Cancer; Biology; Computer science","score_opus":0.18592273104664248,"score_gpt":0.5364256847718474,"score_spread":0.3505029537252049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579097,0.005383017,0.0005208119,0.0054679266,0.000109003784,0.0024434067,0.000037606256,0.000026931008,0.00022034318],"genre_scores_gemma":[0.9906982,0.0048012664,0.0020421923,0.000100863435,0.00016543888,0.0014886147,0.0000797,0.00002119769,0.0006025061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971189,0.00046148966,0.00082067755,0.0006722526,0.00045148504,0.000475217],"domain_scores_gemma":[0.9959965,0.0028890874,0.00014051881,0.00021258043,0.0005187481,0.00024256387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054622567,0.00014749261,0.00049328513,0.00042905327,0.00037201823,0.00010331631,0.00010431997,0.00021107544,0.000056388522],"category_scores_gemma":[0.0046707853,0.00012768402,0.00005088252,0.0006167029,0.00047778152,0.00011201553,0.00008749421,0.0009512986,0.0000042027746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015686111,0.00017715324,0.80315816,0.0005809313,0.00012068759,0.000012866319,0.00022906381,0.000022305503,0.005254378,0.0001770796,0.00016306879,0.18853566],"study_design_scores_gemma":[0.002157057,0.0003490067,0.9699298,0.00058549404,0.00010781483,0.0000068910977,0.00030989578,0.024203528,0.00084960554,0.0010473505,0.00034099896,0.00011253497],"about_ca_topic_score_codex":0.0015655257,"about_ca_topic_score_gemma":0.00084152486,"teacher_disagreement_score":0.18842313,"about_ca_system_score_codex":0.00025431276,"about_ca_system_score_gemma":0.0011854905,"threshold_uncertainty_score":0.55917037},"labels":[],"label_agreement":null},{"id":"W4412163710","doi":"10.1158/1557-3265.aimachine-b029","title":"Abstract B029: Confident Filtering in the context of primary Gleason pattern classification","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gait Recognition and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Medicine; Primary (astronomy); Cancer; Prostate cancer; Pathology; Internal medicine; Biology","score_opus":0.25802725184872427,"score_gpt":0.48350119102772054,"score_spread":0.22547393917899627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787807,0.0010237962,0.00042927195,0.0018070041,0.0001971318,0.0002502076,0.000019128172,0.000029546347,0.017463231],"genre_scores_gemma":[0.9979692,0.0014793817,0.0000072926036,0.000268286,0.00006561922,0.00008244961,0.0000123721475,0.0000066605744,0.0001087078],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998746,0.00016605607,0.0004617793,0.0001515226,0.00029337202,0.00018130906],"domain_scores_gemma":[0.9987223,0.0008633608,0.000030126235,0.00022550151,0.00012361437,0.000035109308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018457992,0.000059963648,0.00019153662,0.00014352176,0.00003310717,0.000035746372,0.000262828,0.000076712495,0.0003136531],"category_scores_gemma":[0.00018415572,0.000046483077,0.00009175969,0.0003908309,0.000112510366,0.00004292445,0.000033638407,0.0005552544,0.000035176963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044661454,0.00015432129,0.05783479,0.00042119177,0.00008603462,0.000006844279,0.00029322677,0.00017307901,0.0058941566,0.00018333546,0.0107263075,0.92418206],"study_design_scores_gemma":[0.00057919516,0.000024419223,0.97906727,0.0003063007,0.00001294259,1.8767506e-7,0.0012118777,0.005054675,0.0013126971,0.00017570285,0.012177018,0.00007770974],"about_ca_topic_score_codex":0.00050340564,"about_ca_topic_score_gemma":0.0007414604,"teacher_disagreement_score":0.92410433,"about_ca_system_score_codex":0.00009308357,"about_ca_system_score_gemma":0.00007162241,"threshold_uncertainty_score":0.34342813},"labels":[],"label_agreement":null},{"id":"W4412163711","doi":"10.1158/1557-3265.aimachine-pr-06","title":"Abstract PR-06: Analysis of pathologists’ intraobserver, interobserver and AI agreement in breast cancer HER2 scoring: AI-assessed intra-sample tumor heterogeneity relates to lower agreement among pathologists and with AI","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Pathology; Radiology; Internal medicine","score_opus":0.07702883829687934,"score_gpt":0.47380851972291194,"score_spread":0.3967796814260326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97879964,0.0008915123,0.00047922507,0.018695489,0.00018503623,0.0007955273,0.00007358823,0.000022477892,0.000057484976],"genre_scores_gemma":[0.99378526,0.0016384319,0.0005353381,0.0035848226,0.00009692979,0.00022180729,0.000024489013,0.000024083769,0.00008884235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959766,0.00044993262,0.0011123783,0.0010396965,0.0007293834,0.0006919911],"domain_scores_gemma":[0.9972909,0.0008946108,0.00018701007,0.0006157337,0.0005439208,0.00046782664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045975465,0.00028722786,0.0010983447,0.0006085709,0.00011701626,0.000103145896,0.0003092959,0.0001873823,0.00024716096],"category_scores_gemma":[0.0014550862,0.00021507802,0.00015998866,0.0014855934,0.0011565465,0.00014169881,0.00047673963,0.0020310285,0.0000017727588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012451692,0.00053483155,0.9798153,0.00044935726,0.0006724278,0.00031097655,0.00017507254,0.0007544223,0.00062565156,0.00003815152,0.00083442405,0.014544185],"study_design_scores_gemma":[0.002235761,0.00056170765,0.990136,0.0014386104,0.00035004487,0.0000049913842,0.000117512216,0.0041646822,0.00021021652,0.00008751451,0.00049019814,0.00020272056],"about_ca_topic_score_codex":0.013405065,"about_ca_topic_score_gemma":0.008794697,"teacher_disagreement_score":0.015110667,"about_ca_system_score_codex":0.0003372024,"about_ca_system_score_gemma":0.00044757294,"threshold_uncertainty_score":0.9931648},"labels":[],"label_agreement":null},{"id":"W4412163712","doi":"10.1158/1557-3265.aimachine-a017","title":"Abstract A017: Personalizing treatment selection for prostate cancer using causal machine learning","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Cancer; Selection (genetic algorithm); Prostate; Medicine; Artificial intelligence; Oncology; Computer science; Internal medicine","score_opus":0.22192562760509268,"score_gpt":0.5782361287465765,"score_spread":0.35631050114148377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761647,0.006677079,0.0009306917,0.012668369,0.000748467,0.0013989257,0.00002495974,0.00010672351,0.0012800952],"genre_scores_gemma":[0.9803445,0.005210629,0.0013355416,0.0006611675,0.0013095256,0.00044488785,0.00003734932,0.000059903465,0.010596508],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99736995,0.00025730237,0.00056853314,0.0006157096,0.00048539948,0.00070312264],"domain_scores_gemma":[0.99781513,0.0011326342,0.000109837514,0.00017947801,0.00047584367,0.00028705996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028974179,0.00019095912,0.0005149356,0.00025682632,0.00059200625,0.00008555281,0.00012301687,0.00016592666,0.00032165676],"category_scores_gemma":[0.001852635,0.0001526123,0.00024076352,0.0005257159,0.0002963421,0.00006952821,0.00006748475,0.0016144488,0.0000063554025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020201977,0.00038638015,0.649823,0.00056300004,0.0005011432,0.000028377337,0.00033258455,0.0017918812,0.01056151,0.00017278598,0.0028224448,0.33099672],"study_design_scores_gemma":[0.010164569,0.0016928649,0.08029993,0.0018997204,0.00042971937,0.000018987057,0.0003407216,0.5178853,0.002012512,0.0003417269,0.3845263,0.00038761046],"about_ca_topic_score_codex":0.010417116,"about_ca_topic_score_gemma":0.0004865388,"teacher_disagreement_score":0.56952304,"about_ca_system_score_codex":0.0009841142,"about_ca_system_score_gemma":0.0016389262,"threshold_uncertainty_score":0.9961726},"labels":[],"label_agreement":null},{"id":"W4412163719","doi":"10.1158/1557-3265.aimachine-b015","title":"Abstract B015: Large language models to predict cancer risk from free-text clinical notes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto; North Pacific Marine Science Organization; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Medicine; Linguistics; Computer science; Internal medicine; Philosophy","score_opus":0.17617279812456935,"score_gpt":0.5355322737544392,"score_spread":0.3593594756298699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734087,0.014330934,0.002291895,0.0046713967,0.0012501266,0.00041826582,0.0016299322,0.00006288343,0.0019358792],"genre_scores_gemma":[0.9819019,0.010382027,0.0011764502,0.0019363101,0.0022414098,0.00025234403,0.0000991648,0.000033924993,0.0019765121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958195,0.0007214645,0.0009314791,0.001131338,0.0005645256,0.0008316552],"domain_scores_gemma":[0.99601746,0.0018378929,0.00012135749,0.0012180043,0.0003308762,0.00047443146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004410397,0.00022589145,0.0005241805,0.00010332137,0.00022468646,0.00006676074,0.0012001969,0.0008331539,0.00048093844],"category_scores_gemma":[0.0076261293,0.0001853138,0.0003193749,0.00037606846,0.0006780619,0.0000066158514,0.0012228618,0.0014609632,0.00007851076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016050761,0.00065468263,0.19960326,0.000055490484,0.0005319233,0.00003027772,0.00017641904,0.000098698336,0.0033166665,0.00008197542,0.31012762,0.4837179],"study_design_scores_gemma":[0.005799161,0.0012988815,0.44056982,0.0005260345,0.00013368046,5.443068e-7,0.0007821575,0.0014473004,0.008300478,0.0041911155,0.5362479,0.0007029361],"about_ca_topic_score_codex":0.0062951664,"about_ca_topic_score_gemma":0.006652082,"teacher_disagreement_score":0.48301497,"about_ca_system_score_codex":0.000053518736,"about_ca_system_score_gemma":0.00085588306,"threshold_uncertainty_score":0.951645},"labels":[],"label_agreement":null},{"id":"W4412163721","doi":"10.1158/1557-3265.aimachine-a028","title":"Abstract A028: Automated Rule Synthesis from Literature for Agent-Based Modeling of the Tumor Microenvironment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Cancer research; Computer science; Medicine; Computational biology; Tumor cells; Biology","score_opus":0.10806087661033964,"score_gpt":0.4620204237970602,"score_spread":0.35395954718672057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886968,0.0063741957,0.00073782256,0.0031280967,0.0002925263,0.00030677766,0.00032721303,0.000021856225,0.0001147264],"genre_scores_gemma":[0.99721414,0.0003462434,0.0013287665,0.00043587267,0.00015918745,0.00017538914,0.00003830911,0.000011628867,0.00029046496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853957,0.00019689229,0.00038177992,0.00038657428,0.00021782538,0.00027735138],"domain_scores_gemma":[0.99871844,0.00056477176,0.00006573334,0.00046258364,0.00012353585,0.00006490796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087538926,0.00009872718,0.00020666947,0.000035904697,0.00011170928,0.000021418427,0.0004726269,0.00024268207,0.000034982717],"category_scores_gemma":[0.0017923152,0.00006560033,0.0002148597,0.0001465884,0.00041246158,0.0000012425928,0.00019374967,0.00030688007,0.0000024593062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032433488,0.0011597308,0.019878954,0.00076863007,0.00069868914,0.000010561205,0.00008461127,0.0030927006,0.66016394,0.00003977257,0.111552015,0.19930707],"study_design_scores_gemma":[0.0030837697,0.00044632974,0.10442806,0.0020196845,0.000121546414,4.8243356e-7,0.00023590581,0.06556711,0.7277213,0.0010265696,0.09493484,0.00041441328],"about_ca_topic_score_codex":0.00011988682,"about_ca_topic_score_gemma":0.000037406597,"teacher_disagreement_score":0.19889265,"about_ca_system_score_codex":0.00003116666,"about_ca_system_score_gemma":0.00031047006,"threshold_uncertainty_score":0.26751038},"labels":[],"label_agreement":null},{"id":"W4412163722","doi":"10.1158/1557-3265.aimachine-a015","title":"Abstract A015: Precision medicine approach to melanoma immunotherapy: Predicting response, adverse events, and hospital admissions using machine learning and explainable artificial intelligence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Adverse effect; Precision medicine; Melanoma; Artificial intelligence; Machine learning; Intensive care medicine; Medical physics; Computer science; Internal medicine; Cancer; Pathology; Cancer research","score_opus":0.12511467088594824,"score_gpt":0.5043422509448524,"score_spread":0.37922758005890417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737706,0.0046559647,0.005769053,0.0134198805,0.00036586414,0.0009690337,0.000005576025,0.000065105545,0.0009789026],"genre_scores_gemma":[0.9894615,0.00268772,0.0055277892,0.00044902912,0.00043429976,0.00006684249,0.0000108796185,0.000043702796,0.0013182848],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99616843,0.0007582894,0.00090750185,0.00080316036,0.00075375696,0.00060886686],"domain_scores_gemma":[0.99551487,0.0029658838,0.00012665037,0.00032873245,0.00030432484,0.00075954443],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010240211,0.00022316852,0.000598993,0.00049868703,0.000662339,0.000037237685,0.00022445606,0.00020973015,0.00019222134],"category_scores_gemma":[0.019887295,0.00017459325,0.00008422043,0.0007786152,0.00050805224,0.00010815887,0.00040273764,0.0024214704,0.0000040154196],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013985435,0.00091056566,0.4024162,0.00065834326,0.00033851253,0.00012525567,0.0025366652,0.0006856428,0.01598248,0.00068894785,0.0009258894,0.5607461],"study_design_scores_gemma":[0.0062559377,0.0065567396,0.45768607,0.01106941,0.00031248797,0.00011383124,0.010070953,0.4308785,0.001278792,0.0051588467,0.0695942,0.001024257],"about_ca_topic_score_codex":0.00096935924,"about_ca_topic_score_gemma":0.000010722277,"teacher_disagreement_score":0.5597218,"about_ca_system_score_codex":0.000189437,"about_ca_system_score_gemma":0.0005985247,"threshold_uncertainty_score":0.99987996},"labels":[],"label_agreement":null},{"id":"W4412163723","doi":"10.1158/1557-3265.aimachine-b003","title":"Abstract B003: Towards machine learning fairness in glioblastoma: An evaluation of protected attributes in publicly available clinical datasets","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Computer science; Medicine; Artificial intelligence; Cancer research","score_opus":0.27140211578424217,"score_gpt":0.564677647575961,"score_spread":0.2932755317917188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98960483,0.0015065473,0.00006070392,0.0056770965,0.00030877328,0.0014125238,0.000050947154,0.000045499597,0.0013330936],"genre_scores_gemma":[0.99759996,0.0007942676,0.00031707145,0.00022008964,0.00024403093,0.00024248162,0.00023423602,0.000029623918,0.00031822582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.991537,0.0031748593,0.0019421013,0.0009395325,0.001703165,0.0007033687],"domain_scores_gemma":[0.9957476,0.0019003716,0.0002347454,0.00071511086,0.001055307,0.00034686583],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.053980373,0.00018942569,0.00090386573,0.0008061164,0.00010313486,0.00006679898,0.0005000671,0.00036945456,0.0011776133],"category_scores_gemma":[0.04267713,0.00016384717,0.00013997772,0.0020555018,0.0006511271,0.00024834118,0.00032942405,0.0050715916,0.000030594656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014678792,0.0012774651,0.75724006,0.00029413437,0.000056535377,0.000051445793,0.00004497294,0.00037435748,0.0003270476,0.000055701497,0.0034127475,0.23539768],"study_design_scores_gemma":[0.009171192,0.0009149524,0.81872874,0.0011461916,0.00005824943,0.0000034552545,0.00011877302,0.15715003,0.0003308672,0.00037314658,0.011838769,0.00016560055],"about_ca_topic_score_codex":0.009816432,"about_ca_topic_score_gemma":0.003884475,"teacher_disagreement_score":0.23523208,"about_ca_system_score_codex":0.00037902358,"about_ca_system_score_gemma":0.0029551042,"threshold_uncertainty_score":0.9997355},"labels":[],"label_agreement":null},{"id":"W4412163724","doi":"10.1158/1557-3265.aimachine-a009","title":"Abstract A009: AI-driven metabolomics and synthetic drug design for targeting CNS metastases","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metabolomics; Medicine; Drug; Computational biology; Pharmacology; Bioinformatics; Biology","score_opus":0.11176606254873372,"score_gpt":0.4711870729761719,"score_spread":0.3594210104274382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8251293,0.1453913,0.014555783,0.00619088,0.0042680316,0.0028290225,0.00058803236,0.000054447275,0.0009932086],"genre_scores_gemma":[0.94215995,0.043189503,0.005692539,0.0013299319,0.0033028596,0.00075863296,0.00008941436,0.00006359646,0.003413565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974995,0.00041777905,0.00052679784,0.00073282694,0.00023981952,0.0005832653],"domain_scores_gemma":[0.99804854,0.00080996647,0.0000848817,0.00042210668,0.00043341247,0.00020111831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003857058,0.00018278327,0.00041797516,0.00010969178,0.00026716146,0.00008315083,0.00035679134,0.0002058973,0.000050451756],"category_scores_gemma":[0.00230382,0.00016348495,0.00022078755,0.00020041382,0.00047715314,0.000008851145,0.00027553516,0.00045688613,0.0000052666933],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031900075,0.00046745336,0.002427642,0.0004690992,0.0009101676,0.0000039659753,0.00010360089,0.0006583532,0.31282407,0.0016145961,0.49142158,0.18590945],"study_design_scores_gemma":[0.0016182843,0.00016451761,0.0020815935,0.00006547743,0.00012889219,0.0000010798841,0.00013316146,0.00028420935,0.07558532,0.0011015587,0.91859025,0.00024563362],"about_ca_topic_score_codex":0.00016463466,"about_ca_topic_score_gemma":0.00013276705,"teacher_disagreement_score":0.42716867,"about_ca_system_score_codex":0.000026430005,"about_ca_system_score_gemma":0.000768774,"threshold_uncertainty_score":0.6666722},"labels":[],"label_agreement":null},{"id":"W4412163726","doi":"10.1158/1557-3265.aimachine-b043","title":"Abstract B043: Cellular localization as a prognostic indicator in invasive breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Cancer; Breast cancer; Medicine; Oncology; Pathology; Internal medicine","score_opus":0.1948853610627769,"score_gpt":0.5672121022401246,"score_spread":0.37232674117734776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552633,0.0056579513,0.000057310663,0.02556239,0.00069206546,0.0033204006,0.00011282198,0.00009507019,0.009238678],"genre_scores_gemma":[0.98498386,0.00801023,0.00003137359,0.001756976,0.0007627908,0.0017699114,0.000036698286,0.00006585824,0.0025823014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99369454,0.00076229067,0.0012100557,0.0011298533,0.0019318266,0.0012714172],"domain_scores_gemma":[0.9949484,0.0023153352,0.00012764681,0.00085393456,0.0010734963,0.0006811816],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053837495,0.00026521896,0.0007385875,0.0009813525,0.00021003748,0.00010665928,0.00065232493,0.00053387415,0.005666531],"category_scores_gemma":[0.005187661,0.00023695226,0.0001936748,0.0028880548,0.0011098667,0.00013276341,0.0004369172,0.003141856,0.00060267514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016452469,0.0008339074,0.91596395,0.0013002165,0.00013898226,0.00045192792,0.00017498076,0.000048580347,0.0011463452,0.0003160206,0.028720157,0.04925966],"study_design_scores_gemma":[0.00411351,0.00045693247,0.95841396,0.0041563185,0.000059882852,0.000009506636,0.00029783905,0.00043166528,0.004211527,0.0012058897,0.026357213,0.00028578076],"about_ca_topic_score_codex":0.0095848525,"about_ca_topic_score_gemma":0.0029228362,"teacher_disagreement_score":0.04897388,"about_ca_system_score_codex":0.0016333679,"about_ca_system_score_gemma":0.012293924,"threshold_uncertainty_score":0.99915797},"labels":[],"label_agreement":null},{"id":"W4412163728","doi":"10.1158/1557-3265.aimachine-b048","title":"Abstract B048: Large Scale, AI-Enabled, Spatial Signal Processing of Breast Cancer Pathology Identifies Consensus Tissue Structures Related to Biology and Outcomes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Scale (ratio); Pathology; Medicine; Biology; Computational biology; Internal medicine; Cartography","score_opus":0.06175049177618674,"score_gpt":0.4973120765686493,"score_spread":0.43556158479246254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602091,0.0026235431,0.017619286,0.016438544,0.0016909838,0.00076807814,0.00017187312,0.00011624655,0.00036237572],"genre_scores_gemma":[0.9977189,0.00023663974,0.00080894417,0.0005398951,0.00014666276,0.00012831712,0.000002307168,0.000015903328,0.0004024666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963413,0.0005965296,0.00093689066,0.0009734888,0.0004499743,0.00070180534],"domain_scores_gemma":[0.9970775,0.0011005239,0.00020129576,0.0005155221,0.00091131165,0.0001938006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026824053,0.00020185621,0.0005962315,0.00042139518,0.00032355174,0.00013360658,0.0008260754,0.00037863248,0.00022301692],"category_scores_gemma":[0.00035280292,0.00017135574,0.00008180149,0.0010217952,0.0008758902,0.00016303992,0.00087293616,0.0010826667,0.000009594184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005130066,0.00013909643,0.2933252,0.00035291334,0.00012918073,0.000044324403,0.00056070444,0.00019208268,0.011292993,0.0021480946,0.0036355173,0.6876669],"study_design_scores_gemma":[0.0013830883,0.00022875867,0.96660817,0.00023774692,0.000022463653,0.000018170073,0.00012010067,0.0024729485,0.005859796,0.020834893,0.0019638368,0.00025000644],"about_ca_topic_score_codex":0.0031074684,"about_ca_topic_score_gemma":0.0034127466,"teacher_disagreement_score":0.6874169,"about_ca_system_score_codex":0.00017594488,"about_ca_system_score_gemma":0.0010440783,"threshold_uncertainty_score":0.69876844},"labels":[],"label_agreement":null},{"id":"W4412163730","doi":"10.1158/1557-3265.aimachine-b041","title":"Abstract B041: A Cellular Network-Aware Foundation Model Improves Single-Cell Level Predictions","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wireless Body Area Networks","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Foundation (evidence); Computer science; Medicine; Computational biology; Biology; History","score_opus":0.20307209482385777,"score_gpt":0.42202974138715865,"score_spread":0.21895764656330088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54450184,0.0055524046,0.36470357,0.0016739625,0.005712803,0.0020988896,0.00015721853,0.0014463334,0.07415296],"genre_scores_gemma":[0.99351686,0.00087608903,0.00057393545,0.00007548628,0.0013121841,0.00021983543,0.00005308912,0.00006470386,0.0033078315],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99729306,0.00013294608,0.00073806796,0.0004976799,0.00050374557,0.00083450513],"domain_scores_gemma":[0.9978464,0.0009483488,0.000049053913,0.00059803243,0.0003431698,0.00021498115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017415007,0.00020361553,0.00032285386,0.00016569866,0.00028996755,0.0001509964,0.00047799648,0.0003808236,0.0001702143],"category_scores_gemma":[0.00016442672,0.00021344081,0.00016018639,0.0007777464,0.00027341643,0.00021429561,0.00020022452,0.0017077895,0.00010270949],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008386805,0.00019067044,0.001278009,0.00025326904,0.00009969549,0.0000075975163,0.000047803795,0.8539346,0.0038024154,0.0003160661,0.08754748,0.052438512],"study_design_scores_gemma":[0.0006793947,0.00006519506,0.0052882726,0.0002426914,0.000027035809,1.8884303e-7,0.000034869907,0.9817362,0.0009395705,0.0019986327,0.0087700505,0.00021791234],"about_ca_topic_score_codex":0.00012329982,"about_ca_topic_score_gemma":0.0003715787,"teacher_disagreement_score":0.449015,"about_ca_system_score_codex":0.0004266568,"about_ca_system_score_gemma":0.0004240082,"threshold_uncertainty_score":0.87038636},"labels":[],"label_agreement":null},{"id":"W4412163731","doi":"10.1158/1557-3265.aimachine-a020","title":"Abstract A020: Machine learning models of RNA expression landscapes help predict overall tumor response to chemotherapy in cholangiocarcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Oncology; Medicine; Expression (computer science); RNA; Cancer research; Computational biology; Biology; Internal medicine; Computer science; Genetics; Gene","score_opus":0.1292653265625747,"score_gpt":0.45105965007869037,"score_spread":0.3217943235161157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798698,0.0073924325,0.00003135863,0.008452706,0.00017562529,0.00085343636,0.00003228848,0.00004842465,0.0031439357],"genre_scores_gemma":[0.99528617,0.0015009413,0.0001520147,0.0008398803,0.00027150472,0.00020369796,0.0000119700835,0.000036898735,0.0016969049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651176,0.000498412,0.00087628525,0.0006801003,0.00081189803,0.0006215733],"domain_scores_gemma":[0.99724025,0.0014634366,0.00010446198,0.00053054374,0.00038602244,0.0002752996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038327011,0.00022328601,0.0007976485,0.00060859876,0.0001241332,0.000030864798,0.00033650777,0.0001672143,0.00028830377],"category_scores_gemma":[0.0013800935,0.00018221627,0.00025104123,0.0008093643,0.00017768097,0.0001062241,0.0003075653,0.0014344864,0.000014201028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04733615,0.0007173328,0.8793905,0.00051235995,0.00019867324,0.00018096011,0.0012998773,0.0005383923,0.039523404,0.000050346756,0.014009981,0.016242059],"study_design_scores_gemma":[0.0066395225,0.0010025522,0.9731139,0.0015119449,0.000025292304,0.0000026709529,0.00028559973,0.0012704601,0.00956265,0.0002862681,0.006128976,0.00017018613],"about_ca_topic_score_codex":0.0011658282,"about_ca_topic_score_gemma":0.0003168445,"teacher_disagreement_score":0.09372341,"about_ca_system_score_codex":0.00025961734,"about_ca_system_score_gemma":0.00067070394,"threshold_uncertainty_score":0.74305636},"labels":[],"label_agreement":null},{"id":"W4412163732","doi":"10.1158/1557-3265.aimachine-b020","title":"Abstract B020: Automated classification of thymic epithelial tumors. A novel deep learning approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deep learning; Pathology; Medicine; Cancer; Cancer research; Artificial intelligence; Computer science; Internal medicine","score_opus":0.1413354508483994,"score_gpt":0.5147644851405606,"score_spread":0.37342903429216123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965637,0.0009425736,0.004618609,0.00650064,0.00033519726,0.00065822963,0.000006974446,0.00026031,0.021040464],"genre_scores_gemma":[0.99529994,0.0005087267,0.0020526361,0.00032594058,0.00036755748,0.00007930196,0.000035973957,0.000030371346,0.0012995854],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99695635,0.00031735646,0.0009248099,0.00053889584,0.0007741155,0.00048846507],"domain_scores_gemma":[0.99708813,0.0015535114,0.00018504362,0.0004121129,0.0005118802,0.0002493352],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0055811773,0.00014122525,0.0005652235,0.0003327808,0.00018014558,0.00003793596,0.0003287604,0.00022179971,0.00017413464],"category_scores_gemma":[0.008015063,0.00011630562,0.00019453284,0.0008513029,0.000782115,0.0000535666,0.00014623387,0.0028327426,0.000028510622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026191967,0.003116818,0.31062508,0.0024722703,0.00062271464,0.000052014137,0.00058217003,0.0022397153,0.15718162,0.0057028057,0.011547942,0.50323766],"study_design_scores_gemma":[0.0026655253,0.00020874712,0.62916297,0.0005861538,0.000051892574,0.000006236616,0.00021986294,0.35629675,0.0004451896,0.0001450377,0.01010007,0.00011160173],"about_ca_topic_score_codex":0.00045965132,"about_ca_topic_score_gemma":0.0000074753243,"teacher_disagreement_score":0.5031261,"about_ca_system_score_codex":0.00016779426,"about_ca_system_score_gemma":0.0008416647,"threshold_uncertainty_score":0.9994678},"labels":[],"label_agreement":null},{"id":"W4412163733","doi":"10.1158/1557-3265.aimachine-a052","title":"Abstract A052: The S-RACE Platform: Empowering Healthcare Real-World Data with Artificial Intelligence (AI) Using a Cloud-Based Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Race (biology); Cloud computing; Computer science; Health care; Artificial intelligence; Data science; Medicine; Biology; Operating system; Political science","score_opus":0.8049209988426096,"score_gpt":0.707454911255144,"score_spread":0.09746608758746556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86218476,0.001738557,0.019828059,0.09386602,0.0053332364,0.008904579,0.0005938343,0.00044528098,0.0071056513],"genre_scores_gemma":[0.99010015,0.0006207064,0.0013760842,0.004014678,0.0025418603,0.0006261558,0.00009444996,0.00009093833,0.00053497445],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98872674,0.00293517,0.00280082,0.0017156553,0.0015988264,0.002222801],"domain_scores_gemma":[0.9804352,0.012947172,0.0005600638,0.0035254473,0.0019398666,0.00059225125],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019906037,0.0003943142,0.0008784857,0.00048817546,0.0040006847,0.00014046842,0.0029820174,0.00048606575,0.0004137926],"category_scores_gemma":[0.0037727805,0.00027292068,0.00014131289,0.003561243,0.00207709,0.00035386987,0.0015092588,0.008735795,0.000201867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009291624,0.00095434923,0.70615894,0.0042354856,0.00025050234,0.000099181765,0.0033046242,0.0070576873,0.0000747605,0.05061377,0.019041235,0.19891785],"study_design_scores_gemma":[0.001013655,0.0014265943,0.067078374,0.012679453,0.00022329034,0.0000039387505,0.092114374,0.6958448,0.001197615,0.03771436,0.08859965,0.002103853],"about_ca_topic_score_codex":0.13323878,"about_ca_topic_score_gemma":0.21458851,"teacher_disagreement_score":0.68878716,"about_ca_system_score_codex":0.0012676597,"about_ca_system_score_gemma":0.011809948,"threshold_uncertainty_score":0.9999723},"labels":[],"label_agreement":null},{"id":"W4412163734","doi":"10.1158/1557-3265.aimachine-a031","title":"Abstract A031: Unsupervised graph-based visualization of variational autoencoder latent spaces reveals hidden multiple myeloma subtypes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoencoder; Visualization; Multiple myeloma; Artificial intelligence; Graph; Pattern recognition (psychology); Computer science; Computational biology; Medicine; Biology; Theoretical computer science; Artificial neural network; Internal medicine","score_opus":0.1465657502516099,"score_gpt":0.46955915706531387,"score_spread":0.322993406813704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163734","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30409005,0.0014984467,0.6764293,0.011092744,0.0029472206,0.0015566908,0.000053545762,0.0003720475,0.0019599542],"genre_scores_gemma":[0.9896218,0.0002415676,0.009018279,0.00035409213,0.00020991518,0.00017062061,0.000011861427,0.000016679336,0.0003551824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598527,0.0007740408,0.0008925524,0.00074051105,0.0011599157,0.00044769832],"domain_scores_gemma":[0.9945739,0.0031098202,0.00022448739,0.00073553174,0.0012159629,0.00014028931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004772923,0.00015927614,0.0003514724,0.0004929678,0.00023883935,0.00015320569,0.0010709666,0.0002408524,0.00019739266],"category_scores_gemma":[0.0015267059,0.00014928206,0.00017859232,0.002020993,0.00033537683,0.00034538997,0.0002902362,0.00051907677,0.000028664297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010547754,0.0011448998,0.7670034,0.00082239276,0.00035078195,0.000013905596,0.0004367408,0.013538443,0.0068632937,0.049288772,0.02285629,0.13662627],"study_design_scores_gemma":[0.0015154172,0.00023973951,0.7378676,0.00030276246,0.000014950857,3.1575007e-7,0.000019061446,0.23781145,0.0047414,0.014995469,0.0022850586,0.00020676055],"about_ca_topic_score_codex":0.00078232517,"about_ca_topic_score_gemma":0.00036300984,"teacher_disagreement_score":0.68553174,"about_ca_system_score_codex":0.0002714486,"about_ca_system_score_gemma":0.0013492707,"threshold_uncertainty_score":0.6087546},"labels":[],"label_agreement":null},{"id":"W4412163735","doi":"10.1158/1557-3265.aimachine-a003","title":"Abstract A003: An active learning platform for predictive oncology in rare cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Precision oncology; Internal medicine; Clinical Oncology; Cancer; Cancer research","score_opus":0.1482777133428529,"score_gpt":0.5362465280913922,"score_spread":0.3879688147485393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868977,0.0013916208,0.00023883647,0.0006245277,0.0007227111,0.0008265201,0.00018550741,0.000010402888,0.00910217],"genre_scores_gemma":[0.99211156,0.0046742507,0.00011738031,0.00033970719,0.0007919424,0.0006990512,0.00015051346,0.00002467901,0.0010909342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807113,0.00014371662,0.00045616154,0.0006317577,0.0001679445,0.0005292665],"domain_scores_gemma":[0.99814665,0.00087345653,0.00008976976,0.000299701,0.00042584518,0.00016458619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00160855,0.0001310149,0.00028294697,0.00013002063,0.00016501475,0.000027842838,0.0003436818,0.00039601707,0.00006821934],"category_scores_gemma":[0.0020899416,0.00013346245,0.00011932688,0.0002443832,0.00031745114,0.000009134758,0.00021638432,0.00079660397,0.0000034386333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029888842,0.0012306381,0.13159904,0.00034469555,0.000633437,0.000033390188,0.00083937444,0.017481638,0.039356366,0.0011650425,0.06727118,0.7101564],"study_design_scores_gemma":[0.0066858577,0.0056889337,0.1341531,0.00018999698,0.000037561906,9.3794307e-7,0.0025164576,0.0019116662,0.029244483,0.002388445,0.81674796,0.000434586],"about_ca_topic_score_codex":0.001192031,"about_ca_topic_score_gemma":0.010150533,"teacher_disagreement_score":0.7494768,"about_ca_system_score_codex":0.0005828211,"about_ca_system_score_gemma":0.0032319685,"threshold_uncertainty_score":0.5733373},"labels":[],"label_agreement":null},{"id":"W4412163736","doi":"10.1158/1557-3265.aimachine-a048","title":"Abstract A048: Weakly supervised prediction of <i>EGFR</i> mutation status and early metastasis of lung adenocarcinoma whole slide histopathology images using artificial intelligence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histopathology; Adenocarcinoma; Metastasis; Medicine; Lung; Lung cancer; Pathology; Oncology; Cancer; Internal medicine","score_opus":0.147712398576796,"score_gpt":0.49030721034938923,"score_spread":0.3425948117725932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985597,0.005256778,0.0052977125,0.002825547,0.00031161302,0.000384387,0.0000471684,0.000018468303,0.00026133953],"genre_scores_gemma":[0.9959277,0.001082217,0.0025760974,0.00014657895,0.00015392626,0.000019042987,0.000013170604,0.000017932674,0.00006332688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725395,0.00039250168,0.0010405317,0.00041672154,0.00052198354,0.00037433574],"domain_scores_gemma":[0.997758,0.0010254451,0.00018167564,0.00028623245,0.0005566587,0.00019202285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034575197,0.000117693664,0.00054943236,0.0003830997,0.000106404514,0.000023263929,0.0001388835,0.00014692906,0.00007599015],"category_scores_gemma":[0.0029699046,0.0001068626,0.00012473947,0.00051495293,0.0010497419,0.00010199638,0.00012259626,0.0010495194,0.0000016872714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013648241,0.0003995322,0.6691496,0.0011919833,0.00015683232,0.00008191986,0.0004656519,0.00015980746,0.09577027,0.0013018729,0.0006317019,0.22932601],"study_design_scores_gemma":[0.0008233695,0.0005788735,0.9611673,0.0006752836,0.0002685107,0.000009066394,0.0004988254,0.01755315,0.014076782,0.003864036,0.0003828008,0.00010200454],"about_ca_topic_score_codex":0.0020031403,"about_ca_topic_score_gemma":0.000019558398,"teacher_disagreement_score":0.2920177,"about_ca_system_score_codex":0.00017282572,"about_ca_system_score_gemma":0.0006321703,"threshold_uncertainty_score":0.4559698},"labels":[],"label_agreement":null},{"id":"W4412163737","doi":"10.1158/1557-3265.aimachine-a021","title":"Abstract A021: Improving cardiotoxicity prediction for oncology drugs via domain-specific adaptation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; McMaster University","funders":"","keywords":"Cardiotoxicity; Medicine; Oncology; Internal medicine; Cancer; Pharmacology; Chemotherapy","score_opus":0.24175000458675547,"score_gpt":0.5435452181652249,"score_spread":0.3017952135784695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163737","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07337954,0.00070223457,0.9161405,0.0035432896,0.0023338024,0.0009898659,0.000030655283,0.000103998456,0.002776095],"genre_scores_gemma":[0.8540689,0.00040383489,0.1426454,0.0004280066,0.0012345299,0.0008635933,0.000020108411,0.000021959948,0.00031366228],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9958234,0.0011500018,0.0008116896,0.00090543507,0.00076664536,0.0005428403],"domain_scores_gemma":[0.989795,0.008398369,0.00014502749,0.00061145663,0.0008857678,0.00016434318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0116060255,0.00014100866,0.00035995943,0.00025138576,0.00040460328,0.00019968061,0.0009924261,0.00023179082,0.000022436901],"category_scores_gemma":[0.00064110704,0.00013982653,0.00025120654,0.0009600194,0.00028802291,0.00043611226,0.00050352677,0.0008581589,0.00002062055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030517115,0.00017489688,0.0003838281,0.000082649305,0.000060203965,0.0000047702797,0.00035191816,0.0080483835,0.0010680906,0.032012362,0.0055858963,0.9519218],"study_design_scores_gemma":[0.0031865512,0.0007344944,0.090418085,0.0001463711,0.000017641838,0.0000027169808,0.00036235983,0.4133482,0.0017674564,0.17443015,0.31523255,0.00035345435],"about_ca_topic_score_codex":0.00022079908,"about_ca_topic_score_gemma":0.00006462253,"teacher_disagreement_score":0.95156837,"about_ca_system_score_codex":0.00085710257,"about_ca_system_score_gemma":0.0018895192,"threshold_uncertainty_score":0.57019603},"labels":[],"label_agreement":null},{"id":"W4412163738","doi":"10.1158/1557-3265.aimachine-a064","title":"Abstract A064: Dynamics in automatic CT based body composition and blood biomarkers in predicting mortality on immune therapy treated solid malignancy patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Malignancy; Medicine; Solid tumor; Immune system; Internal medicine; Oncology; Cancer; Immunology","score_opus":0.06093815350943812,"score_gpt":0.4830402115322952,"score_spread":0.4221020580228571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951057,0.00044588718,0.0000105292365,0.00237743,0.00014495518,0.00085131766,0.000014401111,0.00004080698,0.0010090182],"genre_scores_gemma":[0.9985595,0.00070412207,0.00007081712,0.00038653234,0.000045947327,0.00009422727,0.00009253168,0.000021010082,0.00002533102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971655,0.00052740943,0.00088691805,0.00046882636,0.0005164191,0.00043491452],"domain_scores_gemma":[0.9980178,0.0012840936,0.00010759634,0.00031114952,0.00012358648,0.0001557629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003671224,0.00015143576,0.0004920079,0.0004391502,0.00010102879,0.000042153704,0.00014438397,0.00011638876,0.000057877365],"category_scores_gemma":[0.0012448783,0.00012751903,0.00008692752,0.00065139856,0.00031720588,0.000051179068,0.000057638295,0.0014137218,0.0000021200076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054793264,0.001417952,0.9422764,0.00023027913,0.00013196073,0.00012506952,0.000024167159,0.00004008668,0.00068250025,0.000024121282,0.000043135493,0.05445635],"study_design_scores_gemma":[0.0071408586,0.00036298274,0.8078074,0.0019820018,0.000024445537,7.9258336e-7,0.000030221352,0.18219152,0.00030243897,0.00006680008,0.000012576649,0.000078008045],"about_ca_topic_score_codex":0.0031445846,"about_ca_topic_score_gemma":0.00019124412,"teacher_disagreement_score":0.18215142,"about_ca_system_score_codex":0.00036827434,"about_ca_system_score_gemma":0.00030946106,"threshold_uncertainty_score":0.61419964},"labels":[],"label_agreement":null},{"id":"W4412163743","doi":"10.1158/1557-3265.aimachine-a027","title":"Abstract A027: Multiscale systems approach to target tumor ecosystem responses for therapeutic benefit","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Computational biology; Biology","score_opus":0.29748111601541166,"score_gpt":0.5397355488544545,"score_spread":0.24225443283904285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8767857,0.04228988,0.005869399,0.012398838,0.0048538707,0.014807606,0.001725665,0.00026110696,0.041007917],"genre_scores_gemma":[0.96832967,0.00067413726,0.0017228604,0.0010785444,0.0010876718,0.003032322,0.000028794626,0.00005937633,0.023986604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963013,0.00028775434,0.00097232056,0.0008792068,0.00072650914,0.0008329356],"domain_scores_gemma":[0.99549013,0.0022720615,0.00009703416,0.0008064697,0.00082310836,0.0005112032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057333466,0.00021709684,0.0008644903,0.00035965152,0.00024102646,0.00010785513,0.00038789687,0.00018330634,0.00013825287],"category_scores_gemma":[0.00087276736,0.00017117939,0.00036318376,0.00074522704,0.00015000365,0.000052095824,0.0001519946,0.00075054716,0.00007501742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08073603,0.008487889,0.10498513,0.025640108,0.00431712,0.00028755315,0.00091096974,0.0022976014,0.019307477,0.020427011,0.36883596,0.36376715],"study_design_scores_gemma":[0.004390758,0.0008131383,0.035168238,0.0009666022,0.0001497582,0.000013207158,0.0006279769,0.0011184528,0.002213714,0.00023768275,0.95403266,0.00026779447],"about_ca_topic_score_codex":0.0009900383,"about_ca_topic_score_gemma":0.00026782777,"teacher_disagreement_score":0.58519673,"about_ca_system_score_codex":0.00043626217,"about_ca_system_score_gemma":0.0011974557,"threshold_uncertainty_score":0.6980493},"labels":[],"label_agreement":null},{"id":"W4412163744","doi":"10.1158/1557-3265.aimachine-b054","title":"Abstract B054: Identification of spatial motifs linked to tumor genotype using graph attention networks","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Computing and Algorithms","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Identification (biology); Genotype; Computational biology; Biology; Genetics; Gene; Ecology","score_opus":0.2135867134938683,"score_gpt":0.5661440929592809,"score_spread":0.35255737946541266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91388494,0.00034736894,0.08153915,0.0011911335,0.0017000744,0.0004978049,0.0000066129996,0.000048180358,0.0007847381],"genre_scores_gemma":[0.9974414,0.00018452237,0.0006374613,0.0000769397,0.0009703765,0.00002051361,0.0000031544948,0.000009249494,0.00065635855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99739,0.00050643616,0.0006710004,0.00039536465,0.0006028592,0.00043438244],"domain_scores_gemma":[0.9978692,0.0008068062,0.0001548673,0.0002700768,0.00074501394,0.00015405793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005578941,0.000074337084,0.00021301497,0.00018422041,0.0005599599,0.00007651843,0.0004214684,0.0001237771,0.00005920361],"category_scores_gemma":[0.0015850109,0.000076066426,0.00011818424,0.0011078664,0.00046544318,0.00008060941,0.00013747526,0.00054580276,0.000016377238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043854755,0.0004706219,0.07192757,0.000113478076,0.000109311426,0.000010743845,0.00089696835,0.046281476,0.0066968617,0.004490826,0.0014205677,0.86714303],"study_design_scores_gemma":[0.0007963694,0.00015147592,0.93388706,0.00050494826,0.000035885907,1.4962582e-7,0.000996182,0.044523828,0.00026397945,0.010917181,0.0076417676,0.00028114783],"about_ca_topic_score_codex":0.009436371,"about_ca_topic_score_gemma":0.0014163689,"teacher_disagreement_score":0.8668619,"about_ca_system_score_codex":0.00017296533,"about_ca_system_score_gemma":0.000528723,"threshold_uncertainty_score":0.9971599},"labels":[],"label_agreement":null},{"id":"W4412163745","doi":"10.1158/1557-3265.aimachine-b016","title":"Abstract B016: Multi-Agent Framework for Deep Research in Cancer Immunogenomics via TCR Datasets and Scientific Literature Search","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Inro Consultants (Canada)","funders":"","keywords":"Cancer; T-cell receptor; Medicine; Computer science; Internal medicine; Immunology; T cell","score_opus":0.2479773072360743,"score_gpt":0.5931168608633651,"score_spread":0.3451395536272908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91442853,0.04268227,0.031052869,0.006409878,0.0005461722,0.0031201206,0.0016387563,0.000035677436,0.00008570157],"genre_scores_gemma":[0.95585936,0.014976849,0.026047999,0.00021956436,0.00042951698,0.0009324734,0.00068533333,0.000039554037,0.0008093267],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971234,0.00028580564,0.00046931082,0.0010382748,0.00034035963,0.00074285077],"domain_scores_gemma":[0.99755394,0.0005799632,0.000046644087,0.00093825377,0.00071815634,0.00016302198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005067537,0.0001491255,0.00022385595,0.00025989037,0.000577233,0.00022927458,0.00058638817,0.00046043907,0.00001319959],"category_scores_gemma":[0.0006591375,0.00013769451,0.00008704908,0.00096887327,0.0011239809,0.000010223173,0.00076293043,0.001368239,0.0000046368546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019515812,0.0012796688,0.01155654,0.00071347563,0.00016477294,0.000021971413,0.00021798139,0.00015454787,0.53379726,0.005666563,0.025972456,0.4185032],"study_design_scores_gemma":[0.0030109435,0.00067253585,0.040607408,0.0017608645,0.000025418858,0.0000047211506,0.00034541634,0.0031168896,0.16571733,0.03374438,0.75021434,0.0007797329],"about_ca_topic_score_codex":0.00025131908,"about_ca_topic_score_gemma":0.00084452087,"teacher_disagreement_score":0.7242419,"about_ca_system_score_codex":0.00014191636,"about_ca_system_score_gemma":0.00055433594,"threshold_uncertainty_score":0.5944394},"labels":[],"label_agreement":null},{"id":"W4412163746","doi":"10.1158/1557-3265.aimachine-a002","title":"Abstract A002: A Bayesian Machine Learning Approach for Estimating Treatment Effects in Decentralized Clinical Trials","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bayesian probability; Clinical trial; Machine learning; Artificial intelligence; Medicine; Computer science; Intensive care medicine; Internal medicine","score_opus":0.882817471872725,"score_gpt":0.7654210037911113,"score_spread":0.11739646808161364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163746","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027578637,0.0017691003,0.9488736,0.0024443802,0.003540399,0.012086065,0.00018954588,0.0002704516,0.0032478373],"genre_scores_gemma":[0.05157616,0.0012413657,0.9413411,0.00022479464,0.0014417833,0.0032298868,0.000017658649,0.00009598385,0.00083127903],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9556712,0.03197445,0.007968022,0.0017902736,0.0010206974,0.0015753951],"domain_scores_gemma":[0.45802543,0.5395575,0.0007419681,0.000785562,0.0003934039,0.00049609336],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.16887465,0.0004590536,0.0040396336,0.00036709598,0.0003302974,0.00017451888,0.00080537895,0.0009135966,0.00033825997],"category_scores_gemma":[0.78076416,0.00034464314,0.0013120242,0.0010031423,0.0007982345,0.00007810784,0.0003107585,0.0029441298,0.000016477752],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071919076,0.004218631,0.041758288,0.0019419567,0.0007977205,0.000045992834,0.00008887357,0.00024703215,0.00004667021,0.024057187,0.0037631863,0.91584253],"study_design_scores_gemma":[0.030579725,0.0022660815,0.009949397,0.0015420204,0.0004899496,0.000001015329,0.00007512625,0.18502975,0.00022661532,0.76468766,0.0045746635,0.0005780221],"about_ca_topic_score_codex":0.00031710198,"about_ca_topic_score_gemma":0.00015000867,"teacher_disagreement_score":0.91526455,"about_ca_system_score_codex":0.00053241185,"about_ca_system_score_gemma":0.001069316,"threshold_uncertainty_score":0.9999006},"labels":[],"label_agreement":null},{"id":"W4412163748","doi":"10.1158/1557-3265.aimachine-b024","title":"Abstract B024: Artificial intelligence enables the ethical reconstruction and social value realization of global cancer research: From technological innovation to humanistic care","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Realization (probability); Humanism; Value (mathematics); Artificial intelligence; Computer science; Engineering ethics; Knowledge management; Management science; Psychology; Machine learning; Engineering; Political science; Mathematics","score_opus":0.47269931309277596,"score_gpt":0.6113395670003337,"score_spread":0.1386402539075577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82292205,0.0011508006,0.0040182956,0.16931039,0.0005320801,0.0010634917,0.00011950857,0.000047552614,0.0008358288],"genre_scores_gemma":[0.9975965,0.0007750664,0.00019818752,0.0006192718,0.0006055989,0.00011624943,0.00004178186,0.0000086468,0.00003867292],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9962843,0.00071093015,0.00090329256,0.00052404543,0.0012192581,0.0003581619],"domain_scores_gemma":[0.99547046,0.0015883335,0.00010978803,0.00027355732,0.0024645391,0.0000933104],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006915269,0.000107310385,0.00032569325,0.00024839753,0.00056984107,0.00006352568,0.00023995899,0.0011406299,0.00016121086],"category_scores_gemma":[0.0044768294,0.000073135794,0.00006139409,0.0026684676,0.005644178,0.000035500612,0.0002743007,0.0028624926,0.0000054590437],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007349255,0.00008755211,0.0040522814,0.00021699951,0.000049946044,0.0000031210645,0.00034933825,0.000012153783,0.002699441,0.45616192,0.0009972517,0.53463507],"study_design_scores_gemma":[0.00052638544,0.00053564005,0.32508555,0.0013586973,0.00007918385,0.000002129427,0.004804066,0.0008674709,0.0038033612,0.65516067,0.0076013133,0.00017555243],"about_ca_topic_score_codex":0.0037577422,"about_ca_topic_score_gemma":0.0019595919,"teacher_disagreement_score":0.53445953,"about_ca_system_score_codex":0.00046624473,"about_ca_system_score_gemma":0.0014166977,"threshold_uncertainty_score":0.9994379},"labels":[],"label_agreement":null},{"id":"W4412163749","doi":"10.1158/1557-3265.aimachine-a037","title":"Abstract A037: Survival-based subtyping of lung cancer through integrated genomic and methylation signatures","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Subtyping; Lung cancer; Methylation; DNA methylation; Cancer; Biology; Computational biology; Medicine; Cancer research; Oncology; Genetics; Gene; Gene expression; Computer science","score_opus":0.2018856130309438,"score_gpt":0.5448642608443551,"score_spread":0.34297864781341136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96091056,0.028566143,0.0001943863,0.006791506,0.00047196422,0.00076609215,0.000057460893,0.000035957903,0.0022059174],"genre_scores_gemma":[0.98833454,0.010089707,0.00021398354,0.0005759931,0.00022111548,0.00021854768,0.000022012151,0.000024482522,0.00029960618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975245,0.0003463134,0.0007058959,0.00051908667,0.00051526,0.00038893532],"domain_scores_gemma":[0.9971756,0.001422461,0.00013099355,0.00034087794,0.00080042495,0.0001296781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026122555,0.00015647613,0.0005883911,0.00020151467,0.00012878727,0.00003390399,0.0001791634,0.00027976744,0.0007448152],"category_scores_gemma":[0.00078144006,0.00012400132,0.00016210231,0.0008036056,0.000498117,0.00007445595,0.00009647489,0.0010871179,0.0000020745601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004162805,0.0004818444,0.82131296,0.0023012618,0.0006961146,0.000009953135,0.00020911309,0.00027704306,0.038608987,0.0011761219,0.011706672,0.11905709],"study_design_scores_gemma":[0.0029604773,0.00027700813,0.9518576,0.001871604,0.00019083793,1.3694797e-7,0.00018013178,0.0027683044,0.024854457,0.0002977929,0.01456831,0.00017332834],"about_ca_topic_score_codex":0.006018506,"about_ca_topic_score_gemma":0.0008717275,"teacher_disagreement_score":0.13054462,"about_ca_system_score_codex":0.00029039563,"about_ca_system_score_gemma":0.001714349,"threshold_uncertainty_score":0.9098221},"labels":[],"label_agreement":null},{"id":"W4412163750","doi":"10.1158/1557-3265.aimachine-b019","title":"Abstract B019: Clinician-AI evaluation of prognostic information extraction in head and neck cancer using an on-premises LLM","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; University of Calgary; McGill University Health Centre; McGill University","funders":"","keywords":"Premises; Head and neck cancer; Medicine; Head and neck; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.2956370655473759,"score_gpt":0.6309681627015147,"score_spread":0.3353310971541388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924239,0.00081510085,0.000099348494,0.0039900374,0.0003884322,0.00082133,0.0000062266,0.0000157118,0.0014398983],"genre_scores_gemma":[0.99735016,0.0011554343,0.00022035827,0.0008677369,0.00025023217,0.000089262925,0.000016971702,0.000010636559,0.00003920623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717927,0.00043910052,0.0008744242,0.00029012386,0.0009319276,0.00028517842],"domain_scores_gemma":[0.99752593,0.0011208976,0.00016098924,0.00025097182,0.0007755382,0.00016569925],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008523128,0.00010187274,0.00034566817,0.00039119396,0.00009304064,0.000046514597,0.00010523168,0.00017508233,0.00016428655],"category_scores_gemma":[0.008569902,0.0000886621,0.00005827753,0.00048761375,0.0002746922,0.0003294026,0.000049497146,0.0014694983,0.0000033432214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007640718,0.00046923096,0.51805186,0.0003246973,0.000036863774,0.0000035495152,0.00013820369,0.0029093975,0.0005947427,0.00007459097,0.00041457228,0.4762182],"study_design_scores_gemma":[0.0029189116,0.00037107695,0.8061264,0.0019234032,0.00007291653,0.0000014251651,0.00012963737,0.1861798,0.00020217913,0.0004978258,0.0015057463,0.00007065115],"about_ca_topic_score_codex":0.0028937098,"about_ca_topic_score_gemma":0.00033823296,"teacher_disagreement_score":0.47614753,"about_ca_system_score_codex":0.00030938914,"about_ca_system_score_gemma":0.0016033493,"threshold_uncertainty_score":0.9997813},"labels":[],"label_agreement":null},{"id":"W4412163754","doi":"10.1158/1557-3265.aimachine-b010","title":"Abstract B010: From RECIST to reality: A foundation model pipeline for scalable therapy response evaluation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vector Institute; Structural Genomics Consortium; University Health Network","funders":"","keywords":"Pipeline (software); Medicine; Foundation (evidence); Response Evaluation Criteria in Solid Tumors; Medical physics; Computer science; Oncology; Intensive care medicine; Internal medicine; Chemotherapy; Progressive disease; Programming language; Political science","score_opus":0.5985100643909758,"score_gpt":0.6717496096403198,"score_spread":0.07323954524934406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4337766,0.00044865074,0.17206201,0.3831268,0.00024289888,0.0063059344,0.00015717155,0.00018781966,0.0036921408],"genre_scores_gemma":[0.93547493,0.0015498555,0.03320809,0.008541133,0.0010061935,0.0066393404,0.00037938327,0.000044434775,0.013156665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971605,0.00035776565,0.00070353417,0.0005962347,0.00084314955,0.000338808],"domain_scores_gemma":[0.99425864,0.0029573177,0.0000691857,0.0007813562,0.0016370246,0.0002964684],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015078806,0.00010663945,0.00032035465,0.00018400693,0.00020497886,0.00006161701,0.0002518337,0.00018078077,0.00055912085],"category_scores_gemma":[0.009406711,0.00008919108,0.00012576197,0.0005843836,0.00021304098,0.00005539027,0.00008892487,0.0006077752,0.00004955663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009257093,0.00042984076,0.00046502982,0.000035281155,0.000038083752,8.1656975e-7,0.00004393464,0.000055832308,0.01314871,0.0005051226,0.4051168,0.5709034],"study_design_scores_gemma":[0.0047511985,0.0003737082,0.016831465,0.0006011447,0.0000805546,3.0308627e-7,0.00004752015,0.41865116,0.005555523,0.045947615,0.5069936,0.00016624284],"about_ca_topic_score_codex":0.0014641924,"about_ca_topic_score_gemma":0.00012821458,"teacher_disagreement_score":0.5707372,"about_ca_system_score_codex":0.00037001134,"about_ca_system_score_gemma":0.0019207234,"threshold_uncertainty_score":0.9989375},"labels":[],"label_agreement":null},{"id":"W4412163755","doi":"10.1158/1557-3265.aimachine-b056","title":"Abstract B056: Deep Antigen Sets, a new deep-learning framework, enables in vivo modeling of patient neoantigens for effective targeted immunotherapy design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Antigen; In vivo; Cancer; Cancer immunotherapy; Immunology; Immune system; Biology; Internal medicine","score_opus":0.08061014837542442,"score_gpt":0.43722896135294687,"score_spread":0.35661881297752246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7974392,0.1401963,0.05803286,0.00042381365,0.0009349279,0.0026935418,0.000021903425,0.00007672385,0.00018072207],"genre_scores_gemma":[0.9790157,0.017818103,0.0017406747,0.00018614184,0.000047998798,0.00045073495,0.000017773977,0.00005226495,0.00067061704],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99450666,0.002456328,0.001243267,0.00064754527,0.00014490995,0.0010013079],"domain_scores_gemma":[0.98963594,0.009113551,0.00022778055,0.000508291,0.00046947296,0.00004498427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004390362,0.00029101956,0.0008551312,0.00053921127,0.00039175665,0.000040732564,0.0005868766,0.0007939745,0.0006834402],"category_scores_gemma":[0.0029787733,0.00026168823,0.00035861795,0.00075369334,0.00047323207,0.000121742996,0.0001488263,0.0019714811,0.000026324786],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036937248,0.00089458714,0.00817785,0.00020981698,0.0015300865,0.000009477949,0.0038570398,0.01623787,0.34671685,0.00044717075,0.0016151944,0.5833668],"study_design_scores_gemma":[0.024637854,0.008567666,0.040379863,0.0047357203,0.0001172189,0.0000088800325,0.0058062873,0.022738947,0.7545323,0.016562903,0.12021176,0.001700625],"about_ca_topic_score_codex":0.0018380835,"about_ca_topic_score_gemma":0.000116802126,"teacher_disagreement_score":0.5816662,"about_ca_system_score_codex":0.00018433522,"about_ca_system_score_gemma":0.00091431,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W4412163759","doi":"10.1158/1557-3265.aimachine-b001","title":"Abstract B001: Jarvais: A modular framework to standardize machine learning workflows and accelerate reproducible AI in oncology – benchmarking against a human-developed model for predicting emergency department visits during cancer treatment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Benchmarking; Workflow; Modular design; Medicine; Cancer; Emergency department; Cancer treatment; Oncology; Medical physics; Computer science; Internal medicine; Business; Nursing; Operating system; Database","score_opus":0.16115820120713506,"score_gpt":0.549015948345654,"score_spread":0.38785774713851895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97713363,0.0039577456,0.00265924,0.012907366,0.00046685166,0.0022077048,0.000025200354,0.00006696243,0.00057527836],"genre_scores_gemma":[0.97811425,0.01167364,0.005025423,0.0008687725,0.00078367855,0.0018400508,0.00003691358,0.000067911686,0.0015893868],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99527967,0.00035778165,0.0012921238,0.0014423743,0.00057995017,0.0010481244],"domain_scores_gemma":[0.99744177,0.0009443793,0.00017119708,0.0005179834,0.00043046463,0.0004942181],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005598012,0.00031648457,0.00096703,0.00048345613,0.00067451515,0.00008704194,0.00024139024,0.00030722225,0.00011945043],"category_scores_gemma":[0.004560553,0.0002767396,0.00017690478,0.00084095617,0.0001306072,0.00010494962,0.00034294892,0.0024265286,0.0000022392899],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033802192,0.00067532645,0.6162219,0.00068258314,0.0005946496,0.00013806966,0.0017649472,0.07660859,0.0064108763,0.000084729814,0.0009836961,0.2924544],"study_design_scores_gemma":[0.009485062,0.0014891305,0.27692243,0.004640055,0.00017996707,0.000004067024,0.00020649603,0.6713353,0.00083120633,0.0011126971,0.033230882,0.0005627009],"about_ca_topic_score_codex":0.0018322263,"about_ca_topic_score_gemma":0.0027431285,"teacher_disagreement_score":0.5947267,"about_ca_system_score_codex":0.0014933002,"about_ca_system_score_gemma":0.00137942,"threshold_uncertainty_score":0.99996847},"labels":[],"label_agreement":null},{"id":"W4412163760","doi":"10.1158/1557-3265.aimachine-b042","title":"Abstract B042: Identifying single-cell transcriptomic signatures and changes underlying the evolution of fusion-negative rhabdomyosarcoma in Li-Fraumeni Syndrome mice","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Transcriptome; Rhabdomyosarcoma; Cancer research; Biology; Fusion gene; Medicine; Computational biology; Genetics; Pathology; Gene; Sarcoma; Mutation; Gene expression","score_opus":0.11104567529600426,"score_gpt":0.4398445259677684,"score_spread":0.3287988506717642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97537893,0.01937246,0.0014446537,0.0018067656,0.00027754795,0.0008915611,0.00002547351,0.000009606897,0.00079301273],"genre_scores_gemma":[0.99582916,0.0031603535,0.000109881556,0.00012286921,0.00006168255,0.00014992569,0.000010593871,0.000028237746,0.0005273028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969422,0.00071632036,0.0005260794,0.00068776443,0.0005596408,0.0005679669],"domain_scores_gemma":[0.99833363,0.0006529229,0.000109629545,0.00045960455,0.0003326249,0.00011156909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002879667,0.00018053607,0.00031443223,0.0003339419,0.00021810191,0.00006561049,0.00056345057,0.00043085488,0.000047744146],"category_scores_gemma":[0.0007319606,0.0001531613,0.00012885712,0.00074512704,0.0006617313,0.00001125146,0.00041297867,0.0012367415,0.0000029452674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062879676,0.00018753432,0.00042102378,0.00022773856,0.00008555287,0.000017616676,0.00013793066,0.0001068144,0.9888609,0.0001545084,0.00044862155,0.008722964],"study_design_scores_gemma":[0.005968452,0.001890402,0.08118067,0.0015479202,0.00008075148,0.000015766796,0.0040413467,0.00096706353,0.89391094,0.0062742825,0.003527543,0.00059486425],"about_ca_topic_score_codex":0.0018912229,"about_ca_topic_score_gemma":0.00585761,"teacher_disagreement_score":0.09494996,"about_ca_system_score_codex":0.00026577333,"about_ca_system_score_gemma":0.00073770003,"threshold_uncertainty_score":0.62457365},"labels":[],"label_agreement":null},{"id":"W4412163761","doi":"10.1158/1557-3265.aimachine-b018","title":"Abstract B018: Practical benchmarking of large language models for structuring synthetic prostate cancer histopathology statements in English and Finnish","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Histopathology; Benchmarking; Medicine; Cancer; Structuring; Pathology; Medical physics; Internal medicine","score_opus":0.09570608012282598,"score_gpt":0.5610822752971152,"score_spread":0.4653761951742892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912595,0.0024257738,0.00046349686,0.0037001872,0.00044435717,0.0008093777,0.000051844967,0.000019155557,0.0008262817],"genre_scores_gemma":[0.99503523,0.0021578907,0.0015702402,0.00039001947,0.00022593114,0.00020858421,0.000012920907,0.000021739537,0.00037745642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976867,0.00022092563,0.00071207056,0.00047847358,0.00035927055,0.00054259173],"domain_scores_gemma":[0.9975102,0.0016648774,0.000119419434,0.00024176385,0.00030616886,0.00015759634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047439155,0.00011496064,0.00048555707,0.000240538,0.000089371,0.000024775438,0.00012065945,0.00013994343,0.00010908362],"category_scores_gemma":[0.0044010356,0.00010024835,0.00007329399,0.00023349111,0.00038390825,0.00011212644,0.00017551349,0.0013153601,3.2567394e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004108869,0.001040702,0.58377165,0.0050689057,0.00022791255,0.00040595725,0.006000121,0.0008112667,0.0042535053,0.0038846526,0.0063311025,0.38409534],"study_design_scores_gemma":[0.023090461,0.001315944,0.7531732,0.007105369,0.00029493542,0.000016955815,0.003526548,0.16358268,0.0016900783,0.010670423,0.03489996,0.00063347333],"about_ca_topic_score_codex":0.00067980925,"about_ca_topic_score_gemma":0.00019275927,"teacher_disagreement_score":0.3834619,"about_ca_system_score_codex":0.00017854833,"about_ca_system_score_gemma":0.00063875737,"threshold_uncertainty_score":0.57146585},"labels":[],"label_agreement":null},{"id":"W4412163764","doi":"10.1158/1557-3265.aimachine-b023","title":"Abstract B023: Deep learning-based prediction of immune checkpoint inhibitor efficacy in brain metastases using brain MRI","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brain metastasis; Immune system; Immune checkpoint; Oncology; Immunotherapy; Cancer; Internal medicine; Metastasis; Immunology","score_opus":0.19127722830192934,"score_gpt":0.5427043204363934,"score_spread":0.35142709213446405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9400134,0.0011970587,0.0051278537,0.051428013,0.00014116186,0.0013558982,0.000032629756,0.00012615115,0.0005778268],"genre_scores_gemma":[0.99524486,0.00030606045,0.0030171752,0.00057633786,0.00022003001,0.00017952925,0.000054616514,0.00002413955,0.00037724987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99673146,0.00047814395,0.0012655301,0.00047052972,0.00063939905,0.0004149441],"domain_scores_gemma":[0.9955475,0.0032064514,0.00016086875,0.00050053705,0.00037596357,0.00020871498],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0074212323,0.0001328037,0.00052768213,0.00040903175,0.00010933847,0.000021345933,0.00022894097,0.00020385023,0.00040738445],"category_scores_gemma":[0.009093306,0.00011589362,0.0002311059,0.0011622498,0.0006926061,0.000048661062,0.00014730697,0.0018367559,0.000008451968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004500794,0.011119747,0.14670435,0.002994973,0.00046445217,0.0001504202,0.00030541472,0.0026924708,0.47928044,0.0011847339,0.07475022,0.27585196],"study_design_scores_gemma":[0.014443099,0.0016224075,0.61756784,0.00816868,0.00018178351,0.0000053659883,0.0003199545,0.11219123,0.1375305,0.000863412,0.106713735,0.00039197915],"about_ca_topic_score_codex":0.0011146616,"about_ca_topic_score_gemma":0.00006010163,"teacher_disagreement_score":0.4708635,"about_ca_system_score_codex":0.00022925211,"about_ca_system_score_gemma":0.0008862232,"threshold_uncertainty_score":0.9992535},"labels":[],"label_agreement":null},{"id":"W4412163772","doi":"10.1158/1557-3265.aimachine-a018","title":"Abstract A018: Accelerating drug discovery at an HBCU with AI/ML: Text mining, computational modeling, and drug repurposing approaches","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug repositioning; Drug; Repurposing; Drug discovery; Computer science; Medicine; Pharmacology; Bioinformatics; Engineering; Biology","score_opus":0.22641333346967343,"score_gpt":0.4743242718112853,"score_spread":0.24791093834161185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913257,0.0034723503,0.0014874726,0.0021186967,0.000111413916,0.00020733349,0.000018552666,0.000026343901,0.0012321657],"genre_scores_gemma":[0.99228203,0.00036804393,0.00403117,0.0004575472,0.00033828843,0.0000672116,0.00008827182,0.000022235952,0.0023451713],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976023,0.00028583495,0.0004597991,0.00082595646,0.00038957864,0.00043655655],"domain_scores_gemma":[0.99881727,0.00038064684,0.00007880788,0.00035582585,0.0001896322,0.00017784734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020216955,0.00017078198,0.00026949347,0.00007961585,0.00041684724,0.00019628504,0.00031572333,0.000212713,0.000019960225],"category_scores_gemma":[0.00052127714,0.00013259125,0.000070070375,0.00018381832,0.00087521854,0.000019555566,0.0004557515,0.0005629513,0.000001974036],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004532791,0.0011865296,0.29990703,0.0006801258,0.00075013994,0.0000638294,0.001635371,0.019937994,0.0058644232,0.0008547847,0.06306399,0.601523],"study_design_scores_gemma":[0.018354991,0.0050085243,0.213672,0.0037146285,0.00033636804,0.00008557515,0.017394274,0.5625439,0.022560174,0.007324614,0.14489138,0.0041135415],"about_ca_topic_score_codex":0.0002394863,"about_ca_topic_score_gemma":0.00073335314,"teacher_disagreement_score":0.5974094,"about_ca_system_score_codex":0.00004589441,"about_ca_system_score_gemma":0.0005166073,"threshold_uncertainty_score":0.5406914},"labels":[],"label_agreement":null},{"id":"W4412163773","doi":"10.1158/1557-3265.aimachine-b053","title":"Abstract B053: Empowering AI-driven prediction of the tumor microenvironment from histopathology images via molecular annotation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histopathology; Annotation; Medicine; Pathology; Computer science; Artificial intelligence","score_opus":0.04307666403992606,"score_gpt":0.46314826344673304,"score_spread":0.420071599406807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940105,0.001285308,0.0028494068,0.014690811,0.00063270895,0.00037638427,0.000026722299,0.000019428475,0.0007181794],"genre_scores_gemma":[0.9971312,0.00034604323,0.00052754726,0.0014091639,0.00018521941,0.0000442981,0.000016284974,0.000015891066,0.0003243096],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99807143,0.00030160177,0.00054216245,0.0003604072,0.00045868923,0.00026573087],"domain_scores_gemma":[0.99883646,0.00041050924,0.00010581111,0.00041586705,0.0001290488,0.000102276754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014266913,0.00009122183,0.00028811945,0.000101361176,0.000106617605,0.000013387966,0.00022891739,0.000092820024,0.00018390316],"category_scores_gemma":[0.0011209146,0.0000676798,0.00014735291,0.00021299285,0.00068326725,0.00003525103,0.00018410842,0.001371107,0.000009543377],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027104214,0.00026487344,0.39402387,0.0001437743,0.00007720852,0.00008422357,0.000119152915,0.000339226,0.5600487,0.00004553154,0.006428372,0.03815406],"study_design_scores_gemma":[0.0011759348,0.00012840984,0.9687297,0.00040465943,0.0000614526,0.000004185818,0.000041813113,0.003646198,0.01484629,0.0005739524,0.010336496,0.00005091092],"about_ca_topic_score_codex":0.0005770254,"about_ca_topic_score_gemma":0.0000082965535,"teacher_disagreement_score":0.57470584,"about_ca_system_score_codex":0.00020151715,"about_ca_system_score_gemma":0.00024749208,"threshold_uncertainty_score":0.59568536},"labels":[],"label_agreement":null},{"id":"W4412163776","doi":"10.1158/1557-3265.aimachine-a030","title":"Abstract A030: Advancing Pharmacogenomic Modeling: Robust Dose-Response Curve Fitting and Drug Combination Analytics in the Next-Generation PharmacoGx Framework","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Drug response; Drug; Analytics; Computational biology; Pharmacology; Computer science; Bioinformatics; Data science; Biology","score_opus":0.4284215070863578,"score_gpt":0.5580699025537492,"score_spread":0.12964839546739143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74130005,0.0011944335,0.24596487,0.010368829,0.00057471707,0.00045101062,0.000004469134,0.000031740372,0.00010985832],"genre_scores_gemma":[0.9837202,0.0007409808,0.013952578,0.0011168648,0.00030651235,0.00009357703,0.000005370243,0.0000127626745,0.000051141345],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9933989,0.0036672319,0.0008627041,0.00074585166,0.0008095194,0.0005158059],"domain_scores_gemma":[0.9845756,0.014303021,0.0001253879,0.00045044452,0.0004245022,0.000121041165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025874251,0.0001679215,0.00026648986,0.0004148725,0.00041610247,0.00060994027,0.0011431464,0.00010783508,0.000020226516],"category_scores_gemma":[0.0038076022,0.00014582058,0.00009941498,0.0016014668,0.00017061991,0.0007256976,0.00053126033,0.0016196383,0.000007821614],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004553252,0.00032166849,0.0038225455,0.00007558987,0.000048955462,0.000024942214,0.0012042486,0.86275274,0.0025489356,0.0068506366,0.0014152246,0.12047919],"study_design_scores_gemma":[0.00085777225,0.000033998956,0.008659176,0.000107557906,0.00001118186,0.0000010886222,0.00018320333,0.97606677,0.00028074585,0.013362636,0.00029825896,0.00013761986],"about_ca_topic_score_codex":0.00020362526,"about_ca_topic_score_gemma":0.000069830545,"teacher_disagreement_score":0.24242014,"about_ca_system_score_codex":0.0003137908,"about_ca_system_score_gemma":0.00096671033,"threshold_uncertainty_score":0.89675504},"labels":[],"label_agreement":null},{"id":"W4412163777","doi":"10.1158/1557-3265.aimachine-b009","title":"Abstract B009: missense-kinase-toolkit: A toolkit to facilitate kinase sequence and structure-based modeling for property predictions","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Missense mutation; Computational biology; Kinase; Computer science; Sequence (biology); Property (philosophy); Bioinformatics; Biology; Genetics; Mutation; Gene","score_opus":0.23733933988297573,"score_gpt":0.4575650997632885,"score_spread":0.2202257598803128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96299076,0.001572366,0.026966263,0.0045067514,0.00040828818,0.0017495924,0.0008912178,0.0000255004,0.00088927784],"genre_scores_gemma":[0.99407667,0.00031043615,0.0022257327,0.0010532223,0.0002903392,0.00024585737,0.000103777544,0.000017904893,0.0016760468],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981489,0.00008522062,0.00052830257,0.0005410585,0.00020016701,0.0004963055],"domain_scores_gemma":[0.99860424,0.00018132133,0.00004527933,0.0004662596,0.0004479327,0.0002549765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001267836,0.00016048377,0.00022666238,0.00008488938,0.0002861704,0.0000960457,0.00024376811,0.0002704167,0.00002751462],"category_scores_gemma":[0.0006506206,0.00012105539,0.00011317028,0.00019182601,0.00023225987,0.0000072535713,0.00019238086,0.00043464196,0.000003293492],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007389471,0.00047518132,0.0020050714,0.0019335948,0.00058625033,0.000030261936,0.00038030586,0.10060988,0.22726026,0.00078848685,0.1323799,0.5261613],"study_design_scores_gemma":[0.0050524,0.0018973509,0.0029406482,0.0006200272,0.0000858231,0.0000064812784,0.00033185247,0.60146374,0.009842186,0.004920266,0.3719986,0.00084061344],"about_ca_topic_score_codex":0.00022272824,"about_ca_topic_score_gemma":0.00041771098,"teacher_disagreement_score":0.5253207,"about_ca_system_score_codex":0.00005486991,"about_ca_system_score_gemma":0.00073606643,"threshold_uncertainty_score":0.49364954},"labels":[],"label_agreement":null},{"id":"W4412163778","doi":"10.1158/1557-3265.aimachine-a045","title":"Abstract A045: Unlocking deep learning for cell-free DNA-based early colorectal cancer detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cell-free fetal DNA; Deep learning; Computational biology; Cancer; Medicine; Artificial intelligence; Biology; Oncology; Cancer research; Computer science; Internal medicine; Genetics","score_opus":0.06499498445537204,"score_gpt":0.4453659088239044,"score_spread":0.38037092436853237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022114,0.0035965822,0.0028011443,0.00066600833,0.00089886156,0.0006330737,0.00006103453,0.000020263446,0.001101892],"genre_scores_gemma":[0.9950968,0.0019820505,0.000151938,0.00031086412,0.001063351,0.00069211866,0.00003661729,0.000038969563,0.000627309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979248,0.0001464658,0.0004494629,0.0006450203,0.00026213066,0.00057213416],"domain_scores_gemma":[0.9979523,0.0008392997,0.00010865886,0.00038531562,0.000556281,0.00015816861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014173314,0.0001629048,0.00024309041,0.000115784875,0.00036555508,0.00009822741,0.00045346323,0.00035145498,0.00006291834],"category_scores_gemma":[0.0019127176,0.00016944794,0.00023062687,0.0002790419,0.00023568141,0.0000045561474,0.00026175394,0.000637056,0.0000067609767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005075846,0.0004516971,0.084523834,0.0003978263,0.00023732848,0.000008158561,0.00005535843,0.0072188554,0.66602874,0.00008403617,0.011399651,0.22451867],"study_design_scores_gemma":[0.004158459,0.0013672346,0.09579726,0.000115147035,0.00005512098,2.7180428e-7,0.00007675904,0.0026110203,0.7587884,0.00040843873,0.13626389,0.0003579731],"about_ca_topic_score_codex":0.00091718585,"about_ca_topic_score_gemma":0.004633244,"teacher_disagreement_score":0.2241607,"about_ca_system_score_codex":0.00017645153,"about_ca_system_score_gemma":0.000935299,"threshold_uncertainty_score":0.69098866},"labels":[],"label_agreement":null},{"id":"W4412163782","doi":"10.1158/1557-3265.aimachine-a016","title":"Abstract A016: A computational chemistry and AI-driven framework for structure-based drug design informed by underlying factors of mutation-induced drug resistance: A study of KRAS","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Drug resistance; KRAS; Mutation; Pharmacology; Computational biology; Medicine; Chemistry; Cancer research; Genetics; Biology; Gene","score_opus":0.2333151667370733,"score_gpt":0.5473814584485645,"score_spread":0.31406629171149114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6347802,0.00011463244,0.36332023,0.00071979454,0.00011407308,0.00084614684,0.000063053085,0.000020176762,0.000021660044],"genre_scores_gemma":[0.9212695,0.000005932116,0.07842426,0.000088557266,0.000025467427,0.0001133127,0.00001992992,0.000012848688,0.00004021217],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99626166,0.0006306879,0.0010721218,0.0006355938,0.001055088,0.0003448528],"domain_scores_gemma":[0.97031146,0.027710287,0.0003551053,0.00042729423,0.0010572044,0.00013865667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025539806,0.0001893816,0.00049622863,0.00012039988,0.00022875449,0.00013213832,0.00088591326,0.00013695977,0.000020356354],"category_scores_gemma":[0.003195262,0.0001789953,0.00011707964,0.0010225554,0.00030808855,0.00025895875,0.00024574614,0.00070906256,2.5628816e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054016113,0.005054407,0.07428395,0.0058392026,0.001751712,0.000022139007,0.018600892,0.7656864,0.006017858,0.021574877,0.014032848,0.08173409],"study_design_scores_gemma":[0.009328499,0.0006174859,0.23460118,0.0014856718,0.00008648076,5.448868e-7,0.0030348788,0.3541434,0.026690245,0.3690096,0.00023250803,0.00076946936],"about_ca_topic_score_codex":0.00018477398,"about_ca_topic_score_gemma":0.0001293127,"teacher_disagreement_score":0.411543,"about_ca_system_score_codex":0.00018785926,"about_ca_system_score_gemma":0.0025333958,"threshold_uncertainty_score":0.72992164},"labels":[],"label_agreement":null},{"id":"W4412163785","doi":"10.1158/1557-3265.aimachine-b050","title":"Abstract B050: Spatially aware transcriptomic topic modeling reveals novel signals of spatial organization in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Computing and Algorithms","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Transcriptome; Computational biology; Computer science; Neuroscience; Biology; Cancer research; Medicine; Gene; Gene expression; Genetics","score_opus":0.16588334508549793,"score_gpt":0.5168066541332751,"score_spread":0.35092330904777713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93621606,0.00023543011,0.05903658,0.0021874406,0.0005809378,0.00042083565,0.0000139464855,0.00004709694,0.001261648],"genre_scores_gemma":[0.99830604,0.0003539215,0.0003510779,0.00009037231,0.00045832485,0.000015609483,0.000002351903,0.000012962564,0.00040935833],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973486,0.00039752165,0.00077253184,0.00039553683,0.0006299692,0.00045584614],"domain_scores_gemma":[0.99769133,0.0009849694,0.000096112286,0.0002072783,0.00091153046,0.000108758635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037279967,0.00009551998,0.00033002766,0.0002174293,0.0002778901,0.000046327004,0.0004737955,0.00020429392,0.00017959737],"category_scores_gemma":[0.002412918,0.000097495475,0.000070486305,0.0014207569,0.00031825376,0.00010807268,0.000083060215,0.00064690685,0.0000069776524],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009305384,0.0017115127,0.15686753,0.0005826923,0.00014774919,0.00003197828,0.008587265,0.15839854,0.020079445,0.01069392,0.00074010843,0.64122874],"study_design_scores_gemma":[0.019187296,0.0019871946,0.29646757,0.010054367,0.00013713216,0.0000013655621,0.014588189,0.5374855,0.020848477,0.0853573,0.011293295,0.002592335],"about_ca_topic_score_codex":0.014547898,"about_ca_topic_score_gemma":0.011268565,"teacher_disagreement_score":0.6386364,"about_ca_system_score_codex":0.00021568332,"about_ca_system_score_gemma":0.0014002838,"threshold_uncertainty_score":0.9920143},"labels":[],"label_agreement":null},{"id":"W4412163786","doi":"10.1158/1557-3265.aimachine-b051","title":"Abstract B051: Elastic net discovery of DNA methylation biomarkers for non-invasive diagnosis and recurrence detection in head and neck cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck cancer; Medicine; Cancer; DNA methylation; Head and neck; Oncology; Pathology; Computational biology; Internal medicine; Surgery; Biology; Gene; Genetics; Gene expression","score_opus":0.11094399157241973,"score_gpt":0.4773775593495343,"score_spread":0.36643356777711455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929241,0.0047786976,0.00069392327,0.0006952162,0.00025975888,0.00051826704,0.000048446054,0.0000023554592,0.000079222875],"genre_scores_gemma":[0.97820485,0.020646857,0.000064385786,0.000057649977,0.00010127413,0.0007935614,0.000017378341,0.0000080743475,0.00010595501],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99872625,0.0001298482,0.0003633534,0.00044991833,0.00013587576,0.00019476734],"domain_scores_gemma":[0.99898756,0.0004729515,0.00009736649,0.00018617939,0.00019355533,0.00006237907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008606416,0.0000888692,0.00017326049,0.00013312831,0.00007247282,0.000029824982,0.00010303784,0.000177711,0.0000067436417],"category_scores_gemma":[0.0009835471,0.000081635415,0.000050051418,0.00027813733,0.00024066947,0.000013985728,0.00009080838,0.0001721435,2.2487599e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014470652,0.00011961312,0.18157959,0.00037300342,0.00006804111,3.4270164e-7,0.00004091828,0.00003216963,0.5457729,0.000024569345,0.0021026635,0.26843908],"study_design_scores_gemma":[0.0011814809,0.00030812295,0.6453827,0.00037528056,0.000014151407,1.0707372e-7,0.00009581811,0.00019636312,0.3484274,0.00030304788,0.003623109,0.00009239194],"about_ca_topic_score_codex":0.00042232606,"about_ca_topic_score_gemma":0.0026461612,"teacher_disagreement_score":0.4638031,"about_ca_system_score_codex":0.00004612819,"about_ca_system_score_gemma":0.00036106806,"threshold_uncertainty_score":0.33289954},"labels":[],"label_agreement":null},{"id":"W4412163788","doi":"10.1158/1557-3265.aimachine-a036","title":"Abstract A036: Genomic alterations associate with distinct tumor dynamics in NSCLC: A genomics-informed Bayesian hierarchical modeling approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genomics; Computational biology; Bayesian probability; Biology; Dynamics (music); Bioinformatics; Computer science; Genome; Genetics; Psychology; Gene; Artificial intelligence","score_opus":0.06061821309429859,"score_gpt":0.4179376750218751,"score_spread":0.3573194619275765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97756857,0.0007670756,0.010347534,0.0010361305,0.00019680317,0.0007308973,0.00021228379,0.000014090519,0.009126607],"genre_scores_gemma":[0.9958777,0.0009309026,0.0012859241,0.00041907115,0.00043418,0.00030480186,0.00031636131,0.000042276104,0.00038877697],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972348,0.00017347357,0.0007878386,0.0007675129,0.0002985236,0.00073780224],"domain_scores_gemma":[0.998401,0.00041381252,0.00010106868,0.0005842346,0.00026882076,0.00023110257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016694443,0.00022286325,0.00038341875,0.0001944278,0.0002488267,0.00015557627,0.00053842546,0.00025266566,0.000025416366],"category_scores_gemma":[0.00088798866,0.00020843062,0.00015377911,0.0003811542,0.00033745114,0.000008852591,0.00039759735,0.0010058644,0.000008446063],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015145718,0.0051211566,0.6212687,0.001277206,0.001881766,0.00023441126,0.0009018055,0.17013602,0.01521637,0.02045402,0.018047577,0.13031527],"study_design_scores_gemma":[0.011635769,0.0014316642,0.14000987,0.0005463242,0.00013007956,0.000015197433,0.0012184881,0.816929,0.0012760365,0.005709472,0.019371742,0.0017263581],"about_ca_topic_score_codex":0.0009791772,"about_ca_topic_score_gemma":0.014938151,"teacher_disagreement_score":0.646793,"about_ca_system_score_codex":0.001059577,"about_ca_system_score_gemma":0.0037218025,"threshold_uncertainty_score":0.8499554},"labels":[],"label_agreement":null},{"id":"W4412163789","doi":"10.1158/1557-3265.aimachine-b049","title":"Abstract B049: Deep Learning Enables Identification of Cell Types and Clusters (iCTC) in Immune Tumor Ecosystems for Prognostic Assessment in Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Identification (biology); Immune system; Biology; Immunology; Medicine; Computational biology; Genetics; Ecology","score_opus":0.06900483981934394,"score_gpt":0.4937628554574379,"score_spread":0.424758015638094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942766,0.0025348652,0.0016580168,0.00045603683,0.00005805136,0.0008388626,0.000017283457,0.000006548842,0.00015375104],"genre_scores_gemma":[0.99559164,0.0026839206,0.0008054416,0.000022160124,0.000047072408,0.0005698589,0.000030163043,0.000010132598,0.00023963125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987694,0.00010679589,0.00050901686,0.0003213851,0.00009496858,0.00019845861],"domain_scores_gemma":[0.9992468,0.00024332687,0.00011870029,0.00018140406,0.00017955565,0.000030253168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014465421,0.0000687833,0.00016900507,0.00009086212,0.000059040976,0.000018291026,0.00013242435,0.00009993102,0.0000032958117],"category_scores_gemma":[0.00030256214,0.00006539639,0.0000407457,0.00020051117,0.00012264327,0.0000044075846,0.00010244868,0.0002764664,2.5752965e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002445508,0.0002902197,0.099881686,0.00060520787,0.000024154904,0.000001229488,0.000031686643,0.0008064,0.86976004,0.00023363075,0.00021222641,0.02790896],"study_design_scores_gemma":[0.0024980123,0.00057347276,0.42641085,0.00090480136,0.000030066016,7.433622e-7,0.0006489889,0.013847615,0.53255516,0.0017885567,0.020395909,0.0003458146],"about_ca_topic_score_codex":0.000435949,"about_ca_topic_score_gemma":0.0015985506,"teacher_disagreement_score":0.33720487,"about_ca_system_score_codex":0.000060050952,"about_ca_system_score_gemma":0.00021736359,"threshold_uncertainty_score":0.26667872},"labels":[],"label_agreement":null},{"id":"W4412163791","doi":"10.1158/1557-3265.aimachine-b005","title":"Abstract B005: Designing ethically aligned AI to support palliative care in hematologic malignancies: Ethical considerations for equity and patient-centered care","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palliative care; Medicine; Hematologic Neoplasms; Intensive care medicine; Ethical issues; Equity (law); Nursing; Family medicine; Cancer; Engineering ethics; Internal medicine; Political science","score_opus":0.7046387215741549,"score_gpt":0.6796605728077869,"score_spread":0.024978148766367947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89161134,0.0014972104,0.0006349273,0.10117888,0.0006503571,0.0034304443,0.00007502519,0.00004278846,0.00087902095],"genre_scores_gemma":[0.97923267,0.00032583319,0.0016449951,0.017622428,0.00013137469,0.0009558353,0.000032347485,0.000014368744,0.00004015603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967574,0.0004383662,0.0010717027,0.0006301926,0.0004933796,0.0006089791],"domain_scores_gemma":[0.98988295,0.0068715042,0.0000767865,0.0003024321,0.0024970847,0.00036921777],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023824372,0.0001427548,0.00047228456,0.00023582327,0.00035720906,0.00007800167,0.00013029156,0.00068717793,0.00016653407],"category_scores_gemma":[0.01621652,0.0001278088,0.00010223925,0.0004164474,0.0004589934,0.000051299754,0.00023628012,0.0015268035,0.00001728732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071373866,0.0008731176,0.5353021,0.006873437,0.00015475218,0.00020433843,0.09517962,0.000084508465,0.003935383,0.012262364,0.052941445,0.28505155],"study_design_scores_gemma":[0.0049247933,0.022478236,0.3671837,0.015328143,0.00028565052,0.00001890286,0.32009983,0.00049077324,0.1148473,0.116458096,0.036225144,0.0016594407],"about_ca_topic_score_codex":0.0012533164,"about_ca_topic_score_gemma":0.0063860286,"teacher_disagreement_score":0.2833921,"about_ca_system_score_codex":0.0005550425,"about_ca_system_score_gemma":0.0045882114,"threshold_uncertainty_score":0.9920703},"labels":[],"label_agreement":null},{"id":"W4412163792","doi":"10.1158/1557-3265.aimachine-a049","title":"Abstract A049: Development of a tri-modal contrast learning model integrating pathology-text and CT-text for clinical oncology tasks","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Medicine; Contrast (vision); Clinical Oncology; Pathology; Modal; Medical physics; Anatomical pathology; Radiology; Computer science; Internal medicine; Artificial intelligence; Cancer; Precision medicine; Immunohistochemistry","score_opus":0.23504182417906772,"score_gpt":0.590668948559425,"score_spread":0.35562712438035726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713109,0.0020024655,0.011659325,0.009791032,0.00041205928,0.00093031174,0.000008219305,0.000042494925,0.0038432013],"genre_scores_gemma":[0.9746229,0.0018369791,0.020325277,0.0012024359,0.00037097497,0.00020812462,0.000021211335,0.00003419488,0.0013779185],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955261,0.00062784064,0.0019723403,0.00074170885,0.0004653632,0.0006666816],"domain_scores_gemma":[0.990289,0.008072065,0.00031230258,0.000283787,0.0006237387,0.00041912455],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.016914103,0.00019596529,0.0011966481,0.0002583189,0.000318547,0.00003324458,0.00026767835,0.00033861268,0.00008038927],"category_scores_gemma":[0.020864569,0.00015689105,0.0002530852,0.0002874178,0.0013297469,0.000052544525,0.00027402578,0.0040288903,0.0000064438273],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001679589,0.0005305949,0.069215946,0.00038105078,0.00021776951,0.00005589439,0.00033924714,0.00009042208,0.0014912938,0.00060572964,0.004688662,0.9207038],"study_design_scores_gemma":[0.03394751,0.0043703658,0.30298188,0.00343322,0.00042540667,0.00008378753,0.0023304129,0.4223976,0.00081490836,0.0050319913,0.22344872,0.0007341796],"about_ca_topic_score_codex":0.0001050749,"about_ca_topic_score_gemma":0.00007000783,"teacher_disagreement_score":0.9199696,"about_ca_system_score_codex":0.00020733103,"about_ca_system_score_gemma":0.003736067,"threshold_uncertainty_score":0.99826884},"labels":[],"label_agreement":null},{"id":"W4412163793","doi":"10.1158/1557-3265.aimachine-b031","title":"Abstract B031: Artificial Intelligence-Enhanced Image Analysis of Peripheral Blood Smears Supports the Diagnosis and Monitoring of Acute Promyelocytic Leukemia","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Peripheral blood; Leukemia; Pathology; Immunology; Biology; Cell culture; Retinoic acid","score_opus":0.1302920745080761,"score_gpt":0.4843128852277128,"score_spread":0.35402081071963676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954178,0.00076535373,0.0015904446,0.00080225663,0.000253191,0.00035885497,0.000044403758,0.00003512741,0.0007325813],"genre_scores_gemma":[0.9974837,0.00088494096,0.0012640109,0.00002935167,0.00006744278,0.00015308452,0.0000026476416,0.00000924727,0.00010563103],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970066,0.00020190576,0.0009370593,0.0006187218,0.0007756028,0.00046011785],"domain_scores_gemma":[0.9965867,0.0015791826,0.00019277698,0.00086315547,0.0006106059,0.00016758467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018153732,0.00015061529,0.00051411195,0.00039536037,0.00013883534,0.00029848889,0.0012776179,0.000078344405,0.000048672802],"category_scores_gemma":[0.00087407895,0.00011571445,0.0003134807,0.002713568,0.0011903876,0.00045161988,0.00075544143,0.00046753566,0.0000027537942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028701042,0.001243847,0.29532075,0.00036253125,0.005223178,0.00009095857,0.0010868892,0.0005742804,0.0039721276,0.0042580734,0.0005617505,0.68701863],"study_design_scores_gemma":[0.0004815555,0.00053352845,0.7776777,0.0005476077,0.0019305014,0.0000012975746,0.00059023494,0.009701475,0.19466871,0.0133753875,0.00011139786,0.00038060357],"about_ca_topic_score_codex":0.00048701713,"about_ca_topic_score_gemma":0.00004893512,"teacher_disagreement_score":0.686638,"about_ca_system_score_codex":0.00010620969,"about_ca_system_score_gemma":0.0010103207,"threshold_uncertainty_score":0.47186983},"labels":[],"label_agreement":null},{"id":"W4412163796","doi":"10.1158/1557-3265.aimachine-a006","title":"Abstract A006: Data Curation and Knowledge Integration Pipeline for Biomarker Discovery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Data curation; Pipeline (software); Data science; Biomarker; Medicine; Data integration; Biomarker discovery; Computational biology; Computer science; Biology; Data mining; Proteomics","score_opus":0.41854907872434727,"score_gpt":0.6062314006747581,"score_spread":0.18768232195041085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7884813,0.038706753,0.14478268,0.017738072,0.0023605016,0.0015253687,0.0008042289,0.00006200044,0.0055390787],"genre_scores_gemma":[0.99025464,0.0032120475,0.0006793083,0.00018389006,0.00053876697,0.00009394103,0.0005936466,0.000009246642,0.0044345134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987142,0.00013958203,0.00031901684,0.00050056074,0.000111312496,0.00021533718],"domain_scores_gemma":[0.99871063,0.0005063737,0.000039138507,0.00046507758,0.00021482153,0.00006397697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025057367,0.00007978971,0.00014197764,0.00005773912,0.00012059014,0.000069247304,0.00033136405,0.00024304444,0.000011031989],"category_scores_gemma":[0.0036787412,0.000060902097,0.00004396932,0.0001454854,0.00047055172,0.000012464604,0.00042209096,0.00022555835,0.000003224558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049683894,0.000116903604,0.001852092,0.00007202735,0.000039079117,4.275564e-7,0.000010409749,2.2466904e-7,0.0193487,0.000222959,0.18019554,0.7976448],"study_design_scores_gemma":[0.0018186409,0.00034555534,0.049596634,0.00021067039,0.000031015945,7.5887874e-7,0.00022925128,0.004170729,0.009542514,0.0016277602,0.9322269,0.00019958966],"about_ca_topic_score_codex":0.00007545567,"about_ca_topic_score_gemma":0.00063434686,"teacher_disagreement_score":0.79744524,"about_ca_system_score_codex":0.000014918797,"about_ca_system_score_gemma":0.00039425574,"threshold_uncertainty_score":0.44040626},"labels":[],"label_agreement":null},{"id":"W4412163797","doi":"10.1158/1557-3265.aimachine-b017","title":"Abstract B017: Check: A hybrid continuous-learning framework for enhancing factual reliability in clinical language models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Topic Modeling","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reliability (semiconductor); Computer science; Medicine; Natural language processing; Psychology; Reliability engineering; Engineering","score_opus":0.18614910490314512,"score_gpt":0.5355942354535079,"score_spread":0.3494451305503628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163797","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4574024,0.00047864203,0.537251,0.002469292,0.0007627915,0.0006518724,0.0000058400237,0.00010934578,0.0008687888],"genre_scores_gemma":[0.95601666,0.00027007418,0.04169728,0.00054226536,0.0005373609,0.0002598712,0.0000031053426,0.00002107193,0.00065232796],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9937744,0.0010336341,0.0019306517,0.0014870513,0.0007285906,0.0010456427],"domain_scores_gemma":[0.98325217,0.014469316,0.0001946184,0.0013182688,0.0004931336,0.00027246654],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.021547187,0.00021009934,0.00074710016,0.00023784181,0.00024653776,0.00026878828,0.0018337813,0.00040662935,0.00005793827],"category_scores_gemma":[0.018696917,0.00019923288,0.00035837444,0.0006444108,0.00032233715,0.00042831193,0.0010098385,0.003972859,0.000027019147],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007795101,0.0010592415,0.06677095,0.00055153464,0.000116364135,0.0001039095,0.0022913022,0.015362276,0.0002178787,0.06211684,0.0031050318,0.8475252],"study_design_scores_gemma":[0.0032912556,0.00053872296,0.03998058,0.0014156747,0.000016901686,0.0000017916941,0.001063244,0.73234284,0.0010566092,0.21292523,0.0067040515,0.0006630835],"about_ca_topic_score_codex":0.0007467841,"about_ca_topic_score_gemma":0.00046003904,"teacher_disagreement_score":0.8468621,"about_ca_system_score_codex":0.00027527654,"about_ca_system_score_gemma":0.0013584996,"threshold_uncertainty_score":0.998325},"labels":[],"label_agreement":null},{"id":"W4412163798","doi":"10.1158/1557-3265.aimachine-b040","title":"Abstract B040: Literature-scaled immunological gene set annotation using AI-powered immune cell knowledge graph (ICKG)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Annotation; Gene; Computational biology; Graph; Biology; Immunology; Computer science; Genetics; Theoretical computer science","score_opus":0.13461211621388794,"score_gpt":0.47618732162706473,"score_spread":0.34157520541317676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483516,0.04655809,0.00045272906,0.00038719535,0.00054344535,0.00048567404,0.00006287842,0.000020487452,0.0031378868],"genre_scores_gemma":[0.9870695,0.010405094,0.0005946515,0.00018339008,0.00030843346,0.00006727931,0.0003470652,0.000024790357,0.0009998187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973746,0.0003242021,0.00092544843,0.0005336521,0.0002458502,0.00059623085],"domain_scores_gemma":[0.9981612,0.00015452757,0.00014132548,0.0007173335,0.00071234157,0.00011327947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021275517,0.00023448493,0.00037815454,0.00018661302,0.00030680595,0.00017537526,0.0005888079,0.000569971,0.000073743235],"category_scores_gemma":[0.00040268124,0.00019528855,0.0003176457,0.00070426165,0.00027982512,0.00002012708,0.0005215475,0.0010243003,0.000027300079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020384763,0.0009359631,0.0063906563,0.00046172852,0.0003868828,0.000011775489,0.00029551264,0.00016899657,0.952658,0.000310431,0.010996907,0.025344653],"study_design_scores_gemma":[0.011512528,0.0022983653,0.21201833,0.0009465524,0.00016183085,0.000022362552,0.0012398605,0.005063961,0.6330214,0.0028335333,0.1292278,0.0016534572],"about_ca_topic_score_codex":0.00006848376,"about_ca_topic_score_gemma":0.000014723354,"teacher_disagreement_score":0.31963658,"about_ca_system_score_codex":0.000060857834,"about_ca_system_score_gemma":0.00050815893,"threshold_uncertainty_score":0.7963636},"labels":[],"label_agreement":null},{"id":"W4412163800","doi":"10.1158/1557-3265.aimachine-b058","title":"Abstract B058: An informed machine learning-based blood test for risk assessment of lethal and common cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 diagnosis using AI","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Test (biology); Risk assessment; Oncology; Cancer; Blood test; Internal medicine; Intensive care medicine; Computer science; Biology; Computer security","score_opus":0.20412498499858905,"score_gpt":0.5990526704937809,"score_spread":0.3949276854951918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97938603,0.00077853655,0.000072372466,0.017607305,0.00016953124,0.0012806371,0.00019819364,0.00005365673,0.0004537319],"genre_scores_gemma":[0.9948992,0.0012716711,0.0006173101,0.0023671119,0.00017415092,0.00033910453,0.000058937923,0.000028169548,0.00024434208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731797,0.00029554262,0.0007875338,0.0005005898,0.0006289295,0.00046945616],"domain_scores_gemma":[0.9818526,0.016474519,0.00020444221,0.0004940367,0.00066315715,0.00031123665],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0048409887,0.0001592571,0.000622819,0.00030144653,0.00022851312,0.000046438156,0.00023425001,0.0002153307,0.0001651008],"category_scores_gemma":[0.010667174,0.000139272,0.00015342537,0.00047752867,0.00068650447,0.00007599653,0.00012780524,0.0016363492,0.0000013794647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008799041,0.0009594033,0.9587243,0.0011613034,0.00014975508,0.000012747024,0.00004532054,0.0007226967,0.00037963557,0.000030618525,0.003332398,0.033601914],"study_design_scores_gemma":[0.00860409,0.003768073,0.9207454,0.00091342675,0.0002467656,6.8402426e-7,0.00006729699,0.025666289,0.0016507849,0.00012921357,0.038062867,0.00014516198],"about_ca_topic_score_codex":0.0148808975,"about_ca_topic_score_gemma":0.008221746,"teacher_disagreement_score":0.037978955,"about_ca_system_score_codex":0.00046712047,"about_ca_system_score_gemma":0.005465783,"threshold_uncertainty_score":0.9976664},"labels":[],"label_agreement":null},{"id":"W4412163802","doi":"10.1158/1557-3265.aimachine-a014","title":"Abstract A014: Machine Learning-Guided Discovery of Drug Combinations Targeting PI3K and mTOR Pathways Using Cell Line and PDX Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PI3K/AKT/mTOR pathway; Drug discovery; Computational biology; Medicine; Bioinformatics; Biology; Signal transduction; Cell biology","score_opus":0.26484641605504405,"score_gpt":0.5520178040006288,"score_spread":0.2871713879455848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854707,0.009429027,0.00011674083,0.0024811227,0.0001642107,0.00051527517,0.00028377664,0.000020083464,0.001519056],"genre_scores_gemma":[0.99266785,0.0034712253,0.0006735073,0.000107277425,0.00013060677,0.000022978547,0.00024520876,0.000017910703,0.002663405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821407,0.00017701805,0.0005579341,0.00046024186,0.0003322145,0.00025851058],"domain_scores_gemma":[0.9977965,0.0012400721,0.000116021,0.0003934911,0.00031385777,0.00014008208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017795123,0.000112235924,0.00035667434,0.00015559263,0.00026120208,0.000057341855,0.00015363628,0.000080347614,0.00006241229],"category_scores_gemma":[0.001182424,0.00008973488,0.000047187554,0.00030577148,0.00037636652,0.0001855299,0.0004119818,0.0006691735,0.0000018203586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011246175,0.003607699,0.89792705,0.0031625137,0.0009476626,0.000101650985,0.001290557,0.00022357656,0.01855058,0.0015672602,0.019087194,0.052409664],"study_design_scores_gemma":[0.04912856,0.0026747459,0.76630974,0.0048779277,0.0025485682,0.000023641684,0.0046170494,0.08119461,0.018803291,0.0047379932,0.063981034,0.0011028544],"about_ca_topic_score_codex":0.0023079328,"about_ca_topic_score_gemma":0.00018547934,"teacher_disagreement_score":0.13161731,"about_ca_system_score_codex":0.0001041874,"about_ca_system_score_gemma":0.00084021385,"threshold_uncertainty_score":0.36592823},"labels":[],"label_agreement":null},{"id":"W4412163803","doi":"10.1158/1557-3265.aimachine-b006","title":"Abstract B006: Using large language models for scalable extraction of real-world progression events across multiple cancer types","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Computer science; Scalability; Extraction (chemistry); Medicine; Internal medicine; Chemistry; Database","score_opus":0.2221175994035013,"score_gpt":0.6034192008268803,"score_spread":0.381301601423379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216783,0.0046084416,0.0014647344,0.0003117362,0.00041111402,0.0004081782,0.00021504074,0.00001603267,0.00039690878],"genre_scores_gemma":[0.99422246,0.0018232517,0.0012384073,0.000057620666,0.0003225534,0.0001720443,0.000045462733,0.000015892121,0.0021023222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832124,0.00012878145,0.0004127951,0.00041347125,0.0002576149,0.00046611828],"domain_scores_gemma":[0.9988532,0.0003306277,0.000113230715,0.0002929081,0.00032180108,0.00008819718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019464683,0.00010195225,0.00024189668,0.0000613419,0.00017651734,0.000016227827,0.00024855373,0.00029013655,0.000037524027],"category_scores_gemma":[0.00076665,0.00008293342,0.00012732961,0.00024821382,0.0002574523,0.0000073582555,0.00017175481,0.00031171544,0.0000013204398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003908169,0.0011203471,0.19282275,0.0009103237,0.00033662192,0.0000057561583,0.00021286975,0.0007199817,0.41283432,0.000087191926,0.0146605475,0.37238112],"study_design_scores_gemma":[0.009316707,0.0011158235,0.17969188,0.002429333,0.00011031845,0.0000013278178,0.0015381399,0.02599563,0.6537295,0.0017352729,0.1236057,0.0007303884],"about_ca_topic_score_codex":0.0015656552,"about_ca_topic_score_gemma":0.003101403,"teacher_disagreement_score":0.37165073,"about_ca_system_score_codex":0.00005685819,"about_ca_system_score_gemma":0.0004043573,"threshold_uncertainty_score":0.33819264},"labels":[],"label_agreement":null},{"id":"W4412163804","doi":"10.1158/1557-3265.aimachine-b057","title":"Abstract B057: DrBioRight: an AI chat assistant enabling scalable and flexible multi-omics analysis in cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Scalability; Computer science; Computational biology; Medicine; World Wide Web; Biology; Internal medicine; Database","score_opus":0.21692395987851304,"score_gpt":0.5446135379684263,"score_spread":0.3276895780899132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917883,0.0010483012,0.00036040874,0.00406494,0.00015935679,0.0006315896,0.00004276553,0.000033244116,0.0018710617],"genre_scores_gemma":[0.9901257,0.0057707517,0.00045920577,0.0015793394,0.00009950318,0.00023115538,0.000010903394,0.00002569047,0.0016977576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99535483,0.0006415803,0.00082472933,0.0013964857,0.0007494378,0.0010329351],"domain_scores_gemma":[0.99789464,0.0008355181,0.000109134075,0.0006422383,0.000050929717,0.00046755676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0075171953,0.00021221455,0.0005180656,0.00041080455,0.00041017894,0.00014207179,0.0004675234,0.00026252764,0.0029058298],"category_scores_gemma":[0.00054560794,0.00019588332,0.00011450546,0.002297128,0.0009579697,0.00044575936,0.00055247144,0.0015732106,0.000107384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013233365,0.00041682212,0.91751695,0.00005085983,0.00008804438,0.000023638255,0.00019447284,0.0024706256,0.0023635526,0.00002876827,0.00027372368,0.0764402],"study_design_scores_gemma":[0.0010331168,0.00006661258,0.9704473,0.00010529193,0.00006005936,1.3028821e-7,0.00021321567,0.012739188,0.0015899489,0.00025873628,0.013258158,0.00022824509],"about_ca_topic_score_codex":0.032515403,"about_ca_topic_score_gemma":0.036546696,"teacher_disagreement_score":0.07621196,"about_ca_system_score_codex":0.0014894743,"about_ca_system_score_gemma":0.00033426358,"threshold_uncertainty_score":0.9980056},"labels":[],"label_agreement":null},{"id":"W4412163805","doi":"10.1158/1557-3265.aimachine-b030","title":"Abstract B030: Multiple instance learning of large-scale DNA organization to characterize prostate cancer aggressiveness","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Cancer; Prostate; Scale (ratio); Medicine; Oncology; Computational biology; Biology; Internal medicine; Geography; Cartography","score_opus":0.06962003020005936,"score_gpt":0.4523497106650309,"score_spread":0.3827296804649715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484223,0.0014501731,0.00072226004,0.0016368002,0.00044318853,0.00047233698,0.00007810364,0.00001682327,0.00033807044],"genre_scores_gemma":[0.9914764,0.0043247393,0.00007169593,0.0004160745,0.00025829833,0.0002744602,0.00010972735,0.000027708193,0.0030409046],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979044,0.00026547298,0.00051688455,0.0005957176,0.00033919295,0.00037828338],"domain_scores_gemma":[0.9980768,0.00009343154,0.00018340524,0.00042250956,0.001074969,0.00014888187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011228911,0.00012947417,0.00024110591,0.00012571865,0.00019957512,0.000037810478,0.00037233188,0.00021277685,0.00018075852],"category_scores_gemma":[0.001225553,0.00012133077,0.00007160732,0.0008164852,0.00014921936,0.000010095005,0.00028350152,0.00039440568,0.000012723584],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055890635,0.00015542326,0.21365683,0.000115399474,0.000034699013,8.505412e-7,0.00013692382,0.00019912382,0.7534665,0.000023551635,0.0055412906,0.026110496],"study_design_scores_gemma":[0.00094014726,0.00010834086,0.41654783,0.00031915557,0.0000069164057,1.2448072e-7,0.0002314302,0.00006587127,0.41447833,0.000014820113,0.1671585,0.00012850642],"about_ca_topic_score_codex":0.00010373675,"about_ca_topic_score_gemma":0.0002467899,"teacher_disagreement_score":0.33898816,"about_ca_system_score_codex":0.000068726964,"about_ca_system_score_gemma":0.0007320912,"threshold_uncertainty_score":0.4947725},"labels":[],"label_agreement":null},{"id":"W4412163806","doi":"10.1158/1557-3265.aimachine-a025","title":"Abstract A025: PicoGen: A structure-grounded generative AI model for drugging undruggable targets, including the TEAD–YAP axis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Medicine; Computational biology; Cancer research; Biology","score_opus":0.1359265961266201,"score_gpt":0.5229733592768661,"score_spread":0.387046763150246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7056032,0.016431028,0.23821662,0.019999042,0.00046573914,0.0047790282,0.00030375723,0.00018313572,0.014018438],"genre_scores_gemma":[0.98584,0.0011708356,0.0028062642,0.0023433107,0.0005542408,0.00044690137,0.000107508225,0.00003523267,0.0066956966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973632,0.00029368012,0.0005939621,0.0007904754,0.00035878635,0.0005998898],"domain_scores_gemma":[0.9978332,0.00041974348,0.00010808293,0.0008147318,0.00071788614,0.000106364285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028686004,0.00020159793,0.0003402302,0.00012390444,0.0006077536,0.00016164905,0.0007559011,0.0002876045,0.000077081066],"category_scores_gemma":[0.001159694,0.00015169523,0.00031515514,0.00036517036,0.00046828896,0.000013431765,0.0006436354,0.0007679054,0.000003278986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072383985,0.00023183394,0.0018403133,0.00015753222,0.0007771403,0.000004837222,0.0002084447,0.0025565808,0.59062153,0.0010760659,0.36767274,0.03412914],"study_design_scores_gemma":[0.0014126917,0.00026563575,0.00056975626,0.000096424286,0.00013065575,0.0000011416373,0.00033198477,0.07626347,0.7314962,0.023535667,0.16540541,0.0004909375],"about_ca_topic_score_codex":0.0002924086,"about_ca_topic_score_gemma":0.0016796658,"teacher_disagreement_score":0.2802368,"about_ca_system_score_codex":0.00014786446,"about_ca_system_score_gemma":0.0008307205,"threshold_uncertainty_score":0.6185952},"labels":[],"label_agreement":null},{"id":"W4412163807","doi":"10.1158/1557-3265.aimachine-a008","title":"Abstract A008: AI-Predict: Artificial intelligence-mediated drug synergy prediction and validation in cancer models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Drug; Cancer drugs; Artificial intelligence; Medicine; Computer science; Pharmacology; Internal medicine","score_opus":0.280417761268561,"score_gpt":0.543195176155506,"score_spread":0.26277741488694506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58519864,0.0017163217,0.38836065,0.01973539,0.0023094388,0.0007943632,0.00008680756,0.00016216275,0.0016362531],"genre_scores_gemma":[0.9955016,0.0018501658,0.0014911925,0.00036325824,0.00031418062,0.00029316638,0.000017388149,0.000012166421,0.00015689075],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99575627,0.0009783184,0.0009946387,0.0008842292,0.00089362124,0.00049294776],"domain_scores_gemma":[0.99482125,0.0039406917,0.000099061785,0.0004484074,0.000509684,0.0001809318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063625583,0.00015786974,0.00030900387,0.000571776,0.00018281312,0.00028038476,0.000795185,0.00017568289,0.00006199191],"category_scores_gemma":[0.001217647,0.00015450803,0.00007831571,0.0018735374,0.0003433346,0.00087463006,0.0006161027,0.0011158353,0.000014072047],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024940865,0.00038567776,0.008686843,0.00011195882,0.000058270485,0.000017157543,0.0005114188,0.30849397,0.00015072782,0.08682538,0.0032696652,0.5912395],"study_design_scores_gemma":[0.00019749666,0.00004313707,0.040250264,0.00019275302,0.000004938071,3.6477599e-7,0.000056259465,0.75617146,0.00070858473,0.2017577,0.0005027879,0.00011425101],"about_ca_topic_score_codex":0.0022288535,"about_ca_topic_score_gemma":0.00088861724,"teacher_disagreement_score":0.59112525,"about_ca_system_score_codex":0.0003522446,"about_ca_system_score_gemma":0.0014652918,"threshold_uncertainty_score":0.6300655},"labels":[],"label_agreement":null},{"id":"W4412163808","doi":"10.1158/1557-3265.aimachine-a005","title":"Abstract A005: Monotherapy cancer drug-blind response prediction is limited to intraclass generalization","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Drug; Medicine; Generalization; Cancer drugs; Oncology; Pharmacology; Internal medicine; Mathematics","score_opus":0.23828161650978824,"score_gpt":0.5728428275790751,"score_spread":0.3345612110692869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7674493,0.0008969524,0.17048761,0.05763668,0.0019366147,0.0008873745,0.000069443624,0.0001530138,0.00048296116],"genre_scores_gemma":[0.95556325,0.0027638446,0.020518964,0.012023527,0.0014156835,0.0012378221,0.000019314797,0.000057507154,0.006400114],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942885,0.0020746482,0.0008720237,0.0010689104,0.0011184259,0.0005774857],"domain_scores_gemma":[0.9933627,0.004271657,0.000114740076,0.0008678395,0.0010870056,0.0002960062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009023128,0.00019191895,0.00032824252,0.0007066072,0.00031543223,0.0003910573,0.0013439797,0.00018722628,0.00023334014],"category_scores_gemma":[0.0015930643,0.00018709843,0.00015016565,0.0030840444,0.0001815412,0.00048169747,0.0005271719,0.00082137814,0.000076638884],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076358495,0.0005777728,0.01903006,0.00008614586,0.00024211688,0.000017834369,0.0015283016,0.08970616,0.00415115,0.00766795,0.20299852,0.6663581],"study_design_scores_gemma":[0.0026763882,0.00028491518,0.55115396,0.00032063248,0.000014444919,8.0183827e-7,0.000047875325,0.27304435,0.006099043,0.011186675,0.15479964,0.0003713136],"about_ca_topic_score_codex":0.0007425719,"about_ca_topic_score_gemma":0.00023830419,"teacher_disagreement_score":0.66598684,"about_ca_system_score_codex":0.00060967717,"about_ca_system_score_gemma":0.0021605387,"threshold_uncertainty_score":0.76296526},"labels":[],"label_agreement":null},{"id":"W4412163810","doi":"10.1158/1557-3265.aimachine-b059","title":"Abstract B059: Cancer Recurrence and Anxiety/Depression: High Accuracy Artificial Intelligence Predictive Modeling","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depression (economics); Anxiety; Cancer; Medicine; Psychiatry; Clinical psychology; Psychology; Oncology; Internal medicine","score_opus":0.19788921596295983,"score_gpt":0.5589213086711612,"score_spread":0.36103209270820136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94060767,0.012021156,0.013723942,0.028023822,0.0016601479,0.00093215937,0.000031058884,0.00010543868,0.0028946367],"genre_scores_gemma":[0.96922565,0.027583186,0.00061297236,0.0009008997,0.0010946806,0.00020193424,0.000009494152,0.00002398177,0.0003471972],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966651,0.00026272624,0.00082318083,0.0008604558,0.0007765412,0.000611952],"domain_scores_gemma":[0.9965565,0.0018559367,0.000099419005,0.0004518198,0.0005915515,0.00044476945],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037019784,0.0001870662,0.00049565424,0.00021492084,0.00034537693,0.00010612892,0.00033154257,0.00024182403,0.000469271],"category_scores_gemma":[0.0071691684,0.00015052126,0.000116070856,0.0006357314,0.0007581715,0.00014333765,0.00036258384,0.0031889237,0.000016646492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011007658,0.00020674056,0.05103853,0.0002664219,0.000104121646,0.000033142336,0.00014715278,0.0019945411,0.00042605487,0.0008266294,0.003975431,0.9398805],"study_design_scores_gemma":[0.0013087144,0.00038232285,0.098329306,0.0054643718,0.00017952561,0.00001585886,0.00055107573,0.854478,0.0014651469,0.024116974,0.013266783,0.00044193087],"about_ca_topic_score_codex":0.0026089149,"about_ca_topic_score_gemma":0.00007297834,"teacher_disagreement_score":0.9394385,"about_ca_system_score_codex":0.00018549645,"about_ca_system_score_gemma":0.0011397928,"threshold_uncertainty_score":0.99911076},"labels":[],"label_agreement":null},{"id":"W4412163813","doi":"10.1158/1557-3265.aimachine-b002","title":"Abstract B002: Fairness by Design: End-to-End Bias Evaluation for LLM-Generated Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics and Social Impacts of AI","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"End-to-end principle; Computer science; End user; Medicine; Computer network; World Wide Web","score_opus":0.87220080924877,"score_gpt":0.7180107518801088,"score_spread":0.1541900573686612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163813","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37756157,0.0064678076,0.007205048,0.5006294,0.006948413,0.012370009,0.0019829734,0.00028239787,0.08655235],"genre_scores_gemma":[0.9881497,0.0018249695,0.00044560875,0.0019053527,0.0012408675,0.00035416483,0.00016033999,0.00002139742,0.0058975676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993468,0.0025290379,0.00060424674,0.0007264717,0.0018767881,0.0007954753],"domain_scores_gemma":[0.98548114,0.010232797,0.00009952666,0.0006738724,0.0030851283,0.00042756042],"candidate_categories":["metaresearch","sts","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.066265665,0.0001195736,0.0003073149,0.00013905302,0.0014282038,0.000586376,0.0014959982,0.00045549113,0.0011127791],"category_scores_gemma":[0.052635454,0.00011269411,0.00009045938,0.0011064078,0.00090194214,0.00042268404,0.00033883785,0.00094108336,0.000061873594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034804054,0.00034264714,0.0012129708,0.000043328764,0.00011068496,0.0000016294252,0.0016530005,0.000068223766,0.00053126516,0.007471635,0.7256442,0.2625724],"study_design_scores_gemma":[0.0022109025,0.0005056138,0.009586748,0.00024708884,0.00009998839,3.010147e-8,0.0035383243,0.0037692147,0.0011735178,0.06259486,0.91581184,0.00046189825],"about_ca_topic_score_codex":0.021365102,"about_ca_topic_score_gemma":0.02018334,"teacher_disagreement_score":0.61058813,"about_ca_system_score_codex":0.00042241477,"about_ca_system_score_gemma":0.0072592623,"threshold_uncertainty_score":0.9998718},"labels":[],"label_agreement":null},{"id":"W4412163814","doi":"10.1158/1557-3265.aimachine-a010","title":"Abstract A010: Benchmarking 3D against 2D deep learning-driven image-based profiling for predicting biological relationships amongst genes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Benchmarking; Profiling (computer programming); Computational biology; Deep learning; Gene; Biology; Artificial intelligence; Computer science; Medicine; Genetics; Business","score_opus":0.1869479642711576,"score_gpt":0.4713965524421148,"score_spread":0.2844485881709572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783119,0.0023665582,0.013758178,0.0010402353,0.00054461946,0.000981849,0.0000261693,0.000054643395,0.002915851],"genre_scores_gemma":[0.9915098,0.0014253648,0.004239872,0.00019094543,0.0009363509,0.0007702198,0.0003506523,0.000022832803,0.0005539789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716675,0.0006130453,0.00063030474,0.0008125123,0.00028272602,0.0004946814],"domain_scores_gemma":[0.9978749,0.00076632586,0.00017374454,0.00040475122,0.0006249512,0.00015532652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031178985,0.0001651613,0.00022980696,0.00014349526,0.00067489943,0.00008984046,0.000387651,0.00046223652,0.000047461697],"category_scores_gemma":[0.003212247,0.00014607489,0.0001990794,0.00034908453,0.00037092832,0.000008952109,0.00018519314,0.0009510031,0.0000075466264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072797155,0.00017232155,0.50025123,0.00014870359,0.00007540679,0.0000018229431,0.000019908219,0.0028959352,0.35391867,0.00012274913,0.002591222,0.13907406],"study_design_scores_gemma":[0.0050894064,0.0013742291,0.4389249,0.00071396213,0.00006883206,8.2825085e-7,0.0011406301,0.075198375,0.23913747,0.00037783582,0.23708503,0.00088848994],"about_ca_topic_score_codex":0.000017947728,"about_ca_topic_score_gemma":0.000054632383,"teacher_disagreement_score":0.2344938,"about_ca_system_score_codex":0.00007962175,"about_ca_system_score_gemma":0.0005507357,"threshold_uncertainty_score":0.5956761},"labels":[],"label_agreement":null},{"id":"W4412163815","doi":"10.1158/1557-3265.aimachine-a019","title":"Abstract A019: A fully transparent and automatable form of AI for biomarker and new target discovery using diverse multi-omics data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; Biomarker discovery; Computational biology; Omics; Computer science; Bioinformatics; Medicine; Biology; Proteomics; Genetics; Gene","score_opus":0.36954026111179117,"score_gpt":0.5258084279340924,"score_spread":0.15626816682230127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90284425,0.007864998,0.0853042,0.0010497775,0.0003573677,0.0009230753,0.001535053,0.0000067169667,0.000114555056],"genre_scores_gemma":[0.9844945,0.0039579207,0.01008797,0.00030199907,0.00019608231,0.000018584973,0.00033643626,0.000016850596,0.0005896613],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988125,0.000032482603,0.00041923125,0.00034380757,0.00010724756,0.00028473922],"domain_scores_gemma":[0.9991443,0.00013043456,0.0000685576,0.00043575114,0.00010134264,0.000119574805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012712925,0.00009799125,0.0002196089,0.000045956007,0.00010434157,0.00006216575,0.00029496607,0.00018349384,0.000007968363],"category_scores_gemma":[0.0001626254,0.00008480584,0.00005488381,0.00008274397,0.00027709416,0.000022371063,0.0005341739,0.0001994789,2.299852e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009287886,0.0010776555,0.117772505,0.0041689426,0.002105453,0.000008103988,0.000505494,0.00081789185,0.13092802,0.0013393464,0.17137788,0.56061083],"study_design_scores_gemma":[0.019729143,0.0013015493,0.12844999,0.00095302693,0.00035793928,0.000007957018,0.0009801387,0.53001076,0.020184703,0.008023062,0.2888223,0.0011794296],"about_ca_topic_score_codex":0.00039572048,"about_ca_topic_score_gemma":0.00035285685,"teacher_disagreement_score":0.5594314,"about_ca_system_score_codex":0.000016866697,"about_ca_system_score_gemma":0.0005976928,"threshold_uncertainty_score":0.34582818},"labels":[],"label_agreement":null},{"id":"W4412163816","doi":"10.1158/1557-3265.aimachine-a050","title":"Abstract A050: Multimodal integration of H&amp;E slides and matched targeted DNA sequencing data for enhanced cancer subtype identification","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Identification (biology); Computational biology; DNA sequencing; DNA; Medicine; Biology; Cancer research; Genetics","score_opus":0.22026097765459376,"score_gpt":0.5179459816815548,"score_spread":0.2976850040269611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889195,0.0035535456,0.0051725106,0.0006088152,0.00041461183,0.0005981817,0.0006228558,0.000006320531,0.00010364265],"genre_scores_gemma":[0.9900161,0.007257179,0.0008900496,0.00010274492,0.00032730104,0.00021637589,0.0007188368,0.000016723894,0.00045466513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837625,0.00007224553,0.00055533735,0.00058128545,0.00016696099,0.00024790276],"domain_scores_gemma":[0.99801403,0.00040993755,0.00015085556,0.00069707213,0.00065140706,0.00007669826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017167581,0.00010682323,0.00023333769,0.000075439806,0.00010651493,0.00005097971,0.0003949461,0.00019898797,0.000032483487],"category_scores_gemma":[0.0019979489,0.00010311168,0.000060566646,0.00017335986,0.0002478678,0.00001139551,0.00029229277,0.00021021401,0.0000015284625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008115239,0.00005323158,0.0017031351,0.00013700439,0.00007922076,1.9734051e-7,0.000039942068,0.000064844564,0.96362466,0.00010868609,0.0038485301,0.029529031],"study_design_scores_gemma":[0.0015806085,0.00013334288,0.035302132,0.00015418524,0.000047084966,1.9430205e-7,0.00019014925,0.0008674961,0.9480543,0.0007496322,0.012750655,0.0001702121],"about_ca_topic_score_codex":0.002058439,"about_ca_topic_score_gemma":0.0065764873,"teacher_disagreement_score":0.033598997,"about_ca_system_score_codex":0.0000810004,"about_ca_system_score_gemma":0.00090927776,"threshold_uncertainty_score":0.42047724},"labels":[],"label_agreement":null},{"id":"W4412163818","doi":"10.1158/1557-3265.aimachine-a044","title":"Abstract A044: Developing a digital twin framework for colorectal cancer outcome prediction and robust clinical trial simulation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Outcome (game theory); Medicine; Clinical trial; Cancer; Oncology; Internal medicine; Mathematics","score_opus":0.35160112972281476,"score_gpt":0.6146728912783317,"score_spread":0.2630717615555169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94424456,0.0005947431,0.036584806,0.0131788235,0.0026405698,0.001983954,0.000042713284,0.000081570375,0.00064825907],"genre_scores_gemma":[0.9886767,0.0009264771,0.0044749253,0.0011986801,0.0033337036,0.0003940749,0.000036816265,0.00003582245,0.0009227646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964667,0.00021962203,0.0014763791,0.00070967525,0.0005922393,0.00053538306],"domain_scores_gemma":[0.98898256,0.009767294,0.0001634242,0.00024404102,0.0004981631,0.0003444955],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00604051,0.00017319081,0.00068583543,0.00020162573,0.0002872173,0.00017704126,0.00018099205,0.00048400392,0.00016360088],"category_scores_gemma":[0.028117426,0.00014478296,0.00026496602,0.00043345607,0.0006184496,0.00014632846,0.00016362409,0.0024798086,0.000012782063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02769055,0.00032048402,0.67314255,0.00035042342,0.00025936082,0.000012432018,0.000048468766,0.001159484,0.000012877604,0.0007897479,0.0035689748,0.29264465],"study_design_scores_gemma":[0.04719123,0.0015501616,0.7638582,0.0015942868,0.00018325922,0.000002442534,0.00010576046,0.12641844,0.00001748282,0.0053491364,0.05344779,0.00028181213],"about_ca_topic_score_codex":0.000105682266,"about_ca_topic_score_gemma":0.000021942973,"teacher_disagreement_score":0.29236284,"about_ca_system_score_codex":0.00028124137,"about_ca_system_score_gemma":0.0012427951,"threshold_uncertainty_score":0.9998215},"labels":[],"label_agreement":null},{"id":"W4412163819","doi":"10.1158/1557-3265.aimachine-b052","title":"Abstract B052: Utilizing Dimensionality Reduction for Classification of Cell Senescence and Immune Synapse Formation via Imaging Flow Cytometry","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Senescence; Flow cytometry; Cellular senescence; Immune system; Immunological synapse; Cell biology; Cell; Biology; Chemistry; Neuroscience; Immunology; T cell; Biochemistry; Phenotype","score_opus":0.10899985483038212,"score_gpt":0.4973195803481481,"score_spread":0.388319725517766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8391497,0.0015868499,0.15648155,0.0015383795,0.00011248171,0.000725967,0.00004307519,0.000023223525,0.00033874926],"genre_scores_gemma":[0.9901538,0.0010306978,0.008444645,0.000029519706,0.00008430812,0.000084770916,0.00008442376,0.000007933097,0.00007988602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891907,0.00007177085,0.00040229873,0.00031613358,0.00012444012,0.00016628091],"domain_scores_gemma":[0.99894804,0.00012762289,0.00012093945,0.00030330097,0.00045826082,0.00004182826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012947974,0.000070599206,0.00012531565,0.00007073557,0.0001784541,0.000014193944,0.000108445165,0.00011285271,0.000002239991],"category_scores_gemma":[0.00024495219,0.000068142326,0.00006571665,0.00021287025,0.0002712943,0.00001116279,0.00010951554,0.0001755853,4.6033097e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015320646,0.00006923617,0.0005314949,0.000109034336,0.0000069305665,7.5158475e-8,0.0000043561035,0.000004965729,0.95924175,0.00024294616,0.0005033897,0.039132632],"study_design_scores_gemma":[0.00035200763,0.00006784735,0.02680708,0.00008961614,0.000011166246,0.0000016459976,0.0001115172,0.0040752767,0.9640631,0.002159329,0.002176208,0.000085192114],"about_ca_topic_score_codex":0.00003002231,"about_ca_topic_score_gemma":0.0000056882755,"teacher_disagreement_score":0.15100409,"about_ca_system_score_codex":0.000035323264,"about_ca_system_score_gemma":0.0000989655,"threshold_uncertainty_score":0.27787635},"labels":[],"label_agreement":null},{"id":"W4412163820","doi":"10.1158/1557-3265.aimachine-b060","title":"Abstract B060: DIGIONE: From Fragmentation to Federation: Enabling Scalable Oncology RWE (Real World Evidence) through an international hospital based Cancer OMOP (Observational Medical Outcomes Partnership) Network","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Medicine; General partnership; Cancer; Medical physics; Oncology; Internal medicine; Intensive care medicine; Business","score_opus":0.43704388804110184,"score_gpt":0.5485966909366976,"score_spread":0.11155280289559577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8518881,0.0024462123,0.002277667,0.106786914,0.006293825,0.0011433824,0.0002911593,0.000082628125,0.028790087],"genre_scores_gemma":[0.9728867,0.005771895,0.0012585473,0.012184966,0.0040468546,0.0008959086,0.00017142993,0.00004035528,0.0027433601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564093,0.00016835317,0.0018652298,0.0011064571,0.00043299884,0.0007860195],"domain_scores_gemma":[0.99537057,0.0027553872,0.00044673702,0.00050264946,0.00047765035,0.00044700125],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004613599,0.0002587784,0.0008250998,0.00029295334,0.00047139637,0.0004332872,0.0009407701,0.00041566908,0.008527879],"category_scores_gemma":[0.0029595273,0.00028046936,0.00023137678,0.0007620096,0.00032218883,0.0016848325,0.00024356562,0.0010234585,0.0003023118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000524542,0.00036380973,0.8988416,0.000024623168,0.00018047256,0.000009384038,0.0001912102,0.0036954517,0.000002072718,0.04890261,0.0312779,0.015986327],"study_design_scores_gemma":[0.001461497,0.00020740644,0.79514265,0.00033743802,0.000011466764,6.047573e-8,0.00007375266,0.0028766987,0.000024081806,0.023609217,0.17594005,0.00031568337],"about_ca_topic_score_codex":0.018645862,"about_ca_topic_score_gemma":0.019424718,"teacher_disagreement_score":0.14466216,"about_ca_system_score_codex":0.0016577829,"about_ca_system_score_gemma":0.0023432574,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W4412163824","doi":"10.1158/1557-3265.aimachine-a029","title":"Abstract A029: Validation of a Deep Learning Serial Computed Tomography Response Biomarker for Predicting Overall Survival in Metastatic Kidney Cancer Treated with Immune Checkpoint Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Medicine; Biomarker; Cancer; Oncology; Immune system; Internal medicine; Immunology; Biology","score_opus":0.07322595110256533,"score_gpt":0.45973526590854913,"score_spread":0.38650931480598383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922366,0.0006962879,0.00084762485,0.004356242,0.0004110438,0.0011963549,0.00002425747,0.00005285381,0.00017874749],"genre_scores_gemma":[0.9977605,0.00024439665,0.0010558153,0.00012704195,0.00021588914,0.00027507063,0.000081984566,0.00004308557,0.00019626455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956499,0.0012375226,0.0012814517,0.0005648735,0.0006961141,0.00057019136],"domain_scores_gemma":[0.9949048,0.0035771555,0.00029212574,0.00028639182,0.00064253603,0.00029698986],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0117663015,0.00020237538,0.0007951207,0.0007042288,0.00015692068,0.000051061877,0.00019611446,0.00015628821,0.00011892937],"category_scores_gemma":[0.009035375,0.00016105117,0.0002513482,0.0013382311,0.0004781132,0.000095151285,0.00010761839,0.001523881,8.9369684e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041944124,0.000583996,0.8748896,0.0011538937,0.0007394715,0.000050914856,0.0003270184,0.0022371274,0.041079983,0.000025155414,0.00038418255,0.036584496],"study_design_scores_gemma":[0.015344902,0.0011389703,0.910471,0.0035821619,0.0001984731,0.0000029097137,0.00026717782,0.056703527,0.010209285,0.00008969573,0.0017816334,0.00021026532],"about_ca_topic_score_codex":0.0040163635,"about_ca_topic_score_gemma":0.00012683237,"teacher_disagreement_score":0.0544664,"about_ca_system_score_codex":0.000246338,"about_ca_system_score_gemma":0.0011360365,"threshold_uncertainty_score":0.9993119},"labels":[],"label_agreement":null},{"id":"W4412163825","doi":"10.1158/1557-3265.aimachine-b011","title":"Abstract B011: Pan-cancer immunotherapy response prediction using the CURE AI large clinicogenomic foundation model","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Cancer; Foundation (evidence); Cancer immunotherapy; Oncology; Immunology; Internal medicine; History","score_opus":0.18830264592713986,"score_gpt":0.5809798997474049,"score_spread":0.3926772538202651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9216242,0.003461448,0.011814427,0.06037641,0.0012141877,0.00093881355,0.00003231337,0.000115344024,0.00042289365],"genre_scores_gemma":[0.9773473,0.011489306,0.00048570518,0.006841542,0.0011592759,0.00017801026,0.000018810639,0.00007126989,0.0024087715],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9960813,0.00090878014,0.0009770211,0.0006085238,0.00077552965,0.0006488482],"domain_scores_gemma":[0.99644125,0.0019774567,0.00016049879,0.0007095575,0.0005309806,0.00018025332],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014171153,0.00018202445,0.00044487495,0.0002445407,0.00054329576,0.00012876118,0.00039662063,0.0002821593,0.00039679854],"category_scores_gemma":[0.0021430051,0.0001286488,0.00027253682,0.00060884916,0.00061199383,0.0001375836,0.00016367731,0.0033217086,0.000024398869],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02953136,0.0014454501,0.33207226,0.00041560206,0.0010890381,0.00004833196,0.0009022952,0.0101675885,0.05124833,0.0012348262,0.07385585,0.4979891],"study_design_scores_gemma":[0.0048875907,0.0002298023,0.1919199,0.0007173084,0.000117721174,0.000004670923,0.00015642183,0.56593084,0.0002101808,0.0017598434,0.23390053,0.00016521256],"about_ca_topic_score_codex":0.00046490956,"about_ca_topic_score_gemma":0.000041617015,"teacher_disagreement_score":0.55576324,"about_ca_system_score_codex":0.00052808016,"about_ca_system_score_gemma":0.002686337,"threshold_uncertainty_score":0.99897766},"labels":[],"label_agreement":null},{"id":"W4412163826","doi":"10.1158/1557-3265.aimachine-b045","title":"Abstract B045: Deep learning–guided spatial dissection of melanoma uncovers compartmentalized tumor states associated with response and resistance to immunotherapy and its combination with MAPK inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Melanoma; Immunotherapy; Medicine; Cancer research; Dissection (medical); Cancer; Resistance (ecology); Biology; Internal medicine; Surgery; Ecology","score_opus":0.03419208873550194,"score_gpt":0.37361467248780256,"score_spread":0.3394225837523006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973938,0.001158199,0.00020089203,0.00018870438,0.0001381221,0.0006678031,0.00003527285,0.000067432346,0.00014976897],"genre_scores_gemma":[0.998912,0.00059376366,0.00006878844,0.000028201363,0.00002000043,0.0000912394,0.000019308476,0.0000371858,0.00022954764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830616,0.00020004495,0.00046099495,0.00028499466,0.0004422666,0.0003055506],"domain_scores_gemma":[0.9978945,0.0014324639,0.00009393988,0.00014808733,0.0003200194,0.00011094309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015236198,0.00016254986,0.00036059617,0.00020817592,0.00014489691,0.00005698538,0.00010816086,0.000086723616,0.000027196225],"category_scores_gemma":[0.00039298073,0.0001351754,0.000029713436,0.0005628501,0.00020673934,0.00012855529,0.000036154845,0.00047330197,0.000001267103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15289639,0.000861891,0.6190061,0.0014005968,0.0025199277,0.00011623909,0.003719812,0.016205296,0.18116839,0.00048692853,0.002626654,0.018991798],"study_design_scores_gemma":[0.012335328,0.0027480784,0.8872448,0.001460778,0.000054066128,0.000001928881,0.00059185346,0.0030935395,0.08900452,0.0005211006,0.0025126603,0.0004313304],"about_ca_topic_score_codex":0.00021372258,"about_ca_topic_score_gemma":0.0025866593,"teacher_disagreement_score":0.26823872,"about_ca_system_score_codex":0.0003940305,"about_ca_system_score_gemma":0.0001444172,"threshold_uncertainty_score":0.5512293},"labels":[],"label_agreement":null},{"id":"W4412163828","doi":"10.1158/1557-3265.aimachine-b013","title":"Abstract B013: Emotional tone classification as a tool for psychosocial risk detection in oncology: An AI-powered chatbot","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Polytechnique Montréal; McGill University","funders":"","keywords":"Psychosocial; Tone (literature); Chatbot; Medicine; Oncology; Psychology; Internal medicine; Natural language processing; Computer science; Psychiatry; Linguistics","score_opus":0.22254297164388626,"score_gpt":0.6170841533903375,"score_spread":0.39454118174645125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832366,0.00073531974,0.00056329474,0.010638771,0.0013576812,0.001988159,0.000048360787,0.000043260083,0.0013885408],"genre_scores_gemma":[0.99247354,0.0040807608,0.00012448948,0.00075904344,0.0014648938,0.0006396272,0.00005783574,0.000019296,0.00038052344],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99689424,0.0006347626,0.00077820703,0.00059415004,0.0005906606,0.000507994],"domain_scores_gemma":[0.99744165,0.001143532,0.00010593083,0.0004157525,0.0006162537,0.00027688613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007257125,0.000116746334,0.0004800148,0.00033774576,0.00026401662,0.000028036073,0.00013801576,0.00054358423,0.0002028766],"category_scores_gemma":[0.0034254363,0.000103925275,0.0003470204,0.00062971417,0.00026406054,0.00009427205,0.00003346158,0.0016734067,0.000046504832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008103877,0.001004405,0.106290124,0.00022555853,0.0001625466,0.000010483129,0.00013808245,0.0000064053406,0.00073956477,0.00032071272,0.003558312,0.87943995],"study_design_scores_gemma":[0.0050749104,0.0009930326,0.9107484,0.00012790211,0.000046642395,0.0000022324307,0.00018449227,0.00039423606,0.00021048306,0.0016659088,0.08046276,0.000088957146],"about_ca_topic_score_codex":0.0022029455,"about_ca_topic_score_gemma":0.0035211055,"teacher_disagreement_score":0.87935096,"about_ca_system_score_codex":0.0009102407,"about_ca_system_score_gemma":0.0028076195,"threshold_uncertainty_score":0.7270213},"labels":[],"label_agreement":null},{"id":"W4412163829","doi":"10.1158/1557-3265.aimachine-b027","title":"Abstract B027: Multimodal prediction of pathological complete response in esophageal cancer using automated machine learning and variational autoencoder-based synthetic data augmentation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoencoder; Pathological; Artificial intelligence; Esophageal cancer; Medicine; Machine learning; Cancer; Computer science; Pattern recognition (psychology); Deep learning; Pathology; Internal medicine","score_opus":0.23480719697752436,"score_gpt":0.5437777774325331,"score_spread":0.3089705804550087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884624,0.0009547634,0.004993088,0.0044379625,0.00024510597,0.00051351794,0.00022946276,0.00009606685,0.000067630725],"genre_scores_gemma":[0.9922758,0.00034499425,0.0067271944,0.00022462488,0.00011032806,0.000042501822,0.00019499277,0.00001825317,0.00006133548],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9962172,0.0013148024,0.000848703,0.0006233346,0.00065009005,0.00034590194],"domain_scores_gemma":[0.9958926,0.003209807,0.00016034232,0.00032015343,0.00025823427,0.00015890226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0085895285,0.00013513,0.00045110274,0.00039263567,0.00017619268,0.000037939062,0.00021818581,0.0001862867,0.00028553145],"category_scores_gemma":[0.007532533,0.000117267846,0.000055585817,0.0005289859,0.0005801787,0.00010382729,0.00022839555,0.0016490626,0.0000015654674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008573144,0.0006751323,0.9118443,0.0004787057,0.0001168119,0.00014781242,0.00012462905,0.029530983,0.022391556,0.000058847516,0.0003441908,0.025713854],"study_design_scores_gemma":[0.002116759,0.00014175277,0.45812365,0.00039965354,0.000031086824,0.0000029539622,0.000018748793,0.5388676,0.000029361476,0.00003261926,0.0001965621,0.000039238825],"about_ca_topic_score_codex":0.0022646002,"about_ca_topic_score_gemma":0.00005547884,"teacher_disagreement_score":0.50933665,"about_ca_system_score_codex":0.000270055,"about_ca_system_score_gemma":0.0011164728,"threshold_uncertainty_score":0.9017689},"labels":[],"label_agreement":null},{"id":"W4412163831","doi":"10.1158/1557-3265.aimachine-b046","title":"Abstract B046: Enhancing the Diagnosis and Monitoring of Chronic Lymphocytic Leukemia with Artificial Intelligence-Driven Peripheral Blood Smear Image Analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Peripheral blood; Leukemia; Blood smear; Pathology; Internal medicine","score_opus":0.11511020060978346,"score_gpt":0.4568416712885259,"score_spread":0.34173147067874243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989015,0.0027748037,0.0064505506,0.0005990387,0.00019480738,0.00031324997,0.00001161087,0.00006381173,0.0005771502],"genre_scores_gemma":[0.9970378,0.00091803144,0.0015584683,0.00003656408,0.00019839469,0.00015361972,0.0000011021867,0.000012114769,0.0000838869],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971441,0.00021384278,0.0006846202,0.00067794195,0.00073740934,0.00054206984],"domain_scores_gemma":[0.9964242,0.0019957605,0.00012874702,0.0008287946,0.00043612494,0.00018639796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014348492,0.00016656556,0.00040712667,0.0002975346,0.00026121447,0.00059420697,0.0012696412,0.00006899449,0.00003516599],"category_scores_gemma":[0.0006918162,0.00011775118,0.00020269108,0.0023424167,0.0010705042,0.0004945716,0.0006798882,0.00048717458,0.000007652856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029652452,0.0006704342,0.3946897,0.0005456958,0.0029348014,0.00015852968,0.0007560894,0.01425641,0.0016944781,0.005487078,0.00031662948,0.5781936],"study_design_scores_gemma":[0.0020770992,0.0020120793,0.5986483,0.0026728753,0.0022245094,0.000008635203,0.0019008775,0.18201439,0.19357303,0.012945584,0.00066804787,0.001254548],"about_ca_topic_score_codex":0.0014464868,"about_ca_topic_score_gemma":0.00047352063,"teacher_disagreement_score":0.57693905,"about_ca_system_score_codex":0.0008494367,"about_ca_system_score_gemma":0.0035388884,"threshold_uncertainty_score":0.6277836},"labels":[],"label_agreement":null},{"id":"W4412163832","doi":"10.1158/1557-3265.aimachine-a001","title":"Abstract A001: Harnessing machine learning for the virtual screening of natural compounds as both EGFR and HER2 inhibitors in colorectal Cancer: A novel therapeutic approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Medicine; Cancer; Virtual screening; EGFR inhibitors; Cancer research; Bioinformatics; Internal medicine; Epidermal growth factor receptor; Biology; Drug discovery","score_opus":0.1491537711549479,"score_gpt":0.4877908820314224,"score_spread":0.3386371108764745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95468676,0.038650054,0.00009691906,0.003483458,0.00033966984,0.0013185982,0.000026770376,0.000023688805,0.0013741035],"genre_scores_gemma":[0.9948186,0.0033047816,0.00013344498,0.00022062528,0.00024406388,0.0005606263,0.000011840931,0.000024817711,0.0006811466],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99780864,0.00015097385,0.0005970041,0.0004913535,0.00047629094,0.00047571483],"domain_scores_gemma":[0.9962811,0.0030842307,0.00012250846,0.0001500086,0.0002717275,0.00009043432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020247772,0.00019421078,0.00063557475,0.00018866349,0.0004368389,0.00005748748,0.0001711609,0.00013565875,0.00002404401],"category_scores_gemma":[0.0006019512,0.00012452785,0.00016981257,0.0006119517,0.0008447231,0.00006906962,0.00021310154,0.001357133,3.394418e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011191354,0.00069124385,0.46503383,0.00038660012,0.0008866506,0.000008287758,0.0009862361,0.00023265916,0.004183295,0.00033295547,0.00034227385,0.5157246],"study_design_scores_gemma":[0.008982807,0.00152399,0.9599406,0.0009374829,0.00017910295,0.000005275776,0.0026710338,0.017473238,0.0011272891,0.000091784,0.0068756365,0.0001917311],"about_ca_topic_score_codex":0.011248052,"about_ca_topic_score_gemma":0.0034587602,"teacher_disagreement_score":0.51553285,"about_ca_system_score_codex":0.00028917482,"about_ca_system_score_gemma":0.00064620713,"threshold_uncertainty_score":0.9953361},"labels":[],"label_agreement":null},{"id":"W4412163836","doi":"10.1158/1557-3265.aimachine-b044","title":"Abstract B044: Distributed Transcriptomic Modeling for Biomarker Discovery in Immuno-Oncology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biomarker discovery; Transcriptome; Precision oncology; Medicine; Biomarker; Computational biology; Oncology; Cancer; Biology; Internal medicine; Proteomics; Gene; Genetics; Gene expression","score_opus":0.24217793872567472,"score_gpt":0.550050595073161,"score_spread":0.3078726563474863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608181,0.0043370877,0.028175361,0.0038329952,0.0007847397,0.0007352601,0.00014103552,0.000011681926,0.0011637348],"genre_scores_gemma":[0.99485207,0.0027872585,0.0000799081,0.00026837774,0.0001834695,0.0006412318,0.00021775738,0.000016108268,0.0009537986],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799937,0.000246957,0.00058648677,0.0005818679,0.00016833232,0.0004169913],"domain_scores_gemma":[0.99908614,0.00017501597,0.00005427032,0.00037034857,0.00023484239,0.00007938284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020489066,0.00011595893,0.00023396683,0.00014358615,0.00011294691,0.000048199014,0.00034997036,0.00035414865,0.000031351607],"category_scores_gemma":[0.00047626017,0.000105763036,0.0001715467,0.0003324921,0.00018840507,0.000009378401,0.00010579773,0.00034101226,0.0000030894887],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041656466,0.00044833284,0.006233178,0.00011754585,0.00009894799,0.0000020830796,0.000025778949,0.0006235429,0.878308,0.0002863167,0.034023903,0.0756667],"study_design_scores_gemma":[0.0117580565,0.0008065644,0.08688455,0.000457867,0.0000474032,0.0000012631875,0.0010278969,0.02380663,0.10576472,0.0037484616,0.7650158,0.0006807963],"about_ca_topic_score_codex":0.00014391118,"about_ca_topic_score_gemma":0.00047815833,"teacher_disagreement_score":0.7725433,"about_ca_system_score_codex":0.00014639103,"about_ca_system_score_gemma":0.001010514,"threshold_uncertainty_score":0.43128914},"labels":[],"label_agreement":null},{"id":"W4412163844","doi":"10.1158/1557-3265.aimachine-a032","title":"Abstract A032: Using machine learning to tackle tumor heterogeneity","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor heterogeneity; Cancer; Medicine; Computer science; Internal medicine","score_opus":0.1972787579798199,"score_gpt":0.5708786982592107,"score_spread":0.3735999402793908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821145,0.0017260594,0.00057890697,0.01074194,0.0005791089,0.00051447365,0.0000064412643,0.00008713036,0.003651441],"genre_scores_gemma":[0.9888666,0.00032523257,0.002505498,0.005116722,0.00074709114,0.000048045786,0.000009967078,0.000043437038,0.0023373617],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674195,0.00040687405,0.00069343933,0.00065999356,0.0007594406,0.00073827687],"domain_scores_gemma":[0.9974249,0.0010301536,0.00007371636,0.0004641666,0.0003750899,0.00063196296],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0054677906,0.00016938882,0.00054847106,0.00034472108,0.00036878677,0.00008585553,0.00032380497,0.00012869858,0.0005753107],"category_scores_gemma":[0.007188677,0.00014369817,0.00021628785,0.000856572,0.00035276046,0.000054381675,0.00037611576,0.003229726,0.00011361404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011162625,0.00046697338,0.8588197,0.0004444008,0.00023847002,0.00035264267,0.00009557679,0.0014250859,0.017757662,0.00014979648,0.011584876,0.10754852],"study_design_scores_gemma":[0.0045557693,0.00076576864,0.41098338,0.0018572488,0.00013540899,0.000039512153,0.00014947147,0.08653891,0.004709296,0.00033974013,0.48947617,0.00044930115],"about_ca_topic_score_codex":0.0020345005,"about_ca_topic_score_gemma":0.00011179138,"teacher_disagreement_score":0.4778913,"about_ca_system_score_codex":0.0002830655,"about_ca_system_score_gemma":0.00078576215,"threshold_uncertainty_score":0.99906987},"labels":[],"label_agreement":null},{"id":"W4412163847","doi":"10.1158/1557-3265.aimachine-b039","title":"Abstract B039: Detecting obesity-associated histopathology characteristics in breast cancer using an AI foundation model","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histopathology; Breast cancer; Medicine; Obesity; Cancer; Oncology; Pathology; Internal medicine","score_opus":0.18916254516848993,"score_gpt":0.5256313007403636,"score_spread":0.3364687555718736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645036,0.0005897886,0.00033930322,0.0016263829,0.0003082937,0.0003983308,0.0000528963,0.000039058028,0.00019556707],"genre_scores_gemma":[0.9979554,0.0005729806,0.000047431742,0.0007415242,0.0003539545,0.000056479315,0.000037346606,0.000021912721,0.00021296994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744827,0.0004885437,0.00060149597,0.00052818627,0.0004450036,0.00048849464],"domain_scores_gemma":[0.9985273,0.00024292477,0.00008921608,0.0004163739,0.00049288216,0.000231304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031843279,0.00012988679,0.0005571973,0.00026694563,0.00021553626,0.00004761207,0.00015343232,0.00028974423,0.0001060668],"category_scores_gemma":[0.00066236494,0.0001312315,0.0002312203,0.000574364,0.0002236271,0.00013909354,0.00012831016,0.0014506577,0.000007522684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090203405,0.00091260736,0.93357176,0.00019746086,0.00014161906,0.00015041431,0.00006779359,0.00046856282,0.0059538195,0.0000394537,0.00008094911,0.057513554],"study_design_scores_gemma":[0.0015298404,0.000040981493,0.9536181,0.00047093345,0.00016798062,0.0000062014547,0.00002746801,0.0435722,0.00011376225,0.00024642312,0.00009381848,0.00011227872],"about_ca_topic_score_codex":0.0021879794,"about_ca_topic_score_gemma":0.00082108314,"teacher_disagreement_score":0.057401273,"about_ca_system_score_codex":0.0008407679,"about_ca_system_score_gemma":0.001737387,"threshold_uncertainty_score":0.63024664},"labels":[],"label_agreement":null},{"id":"W4412163849","doi":"10.1158/1557-3265.aimachine-b038","title":"Abstract B038: Machine learning used to validate neutrophil classification in Triple Negative Breast Cancer patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Triple-negative breast cancer; Breast cancer; Triple negative; Oncology; Internal medicine","score_opus":0.19228561539028818,"score_gpt":0.5138475830742069,"score_spread":0.32156196768391865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841073,0.0003247179,0.0000045036572,0.011670621,0.0004924433,0.0017064839,0.00015080847,0.000062114836,0.0014809758],"genre_scores_gemma":[0.99643135,0.0005547731,0.00006397562,0.00061250175,0.00025559435,0.0010208896,0.000053607313,0.00003804088,0.0009692689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99601537,0.00072384416,0.0009527227,0.0007753155,0.00087195187,0.0006607933],"domain_scores_gemma":[0.9970902,0.0009421787,0.0001381011,0.00045671433,0.0009494464,0.00042333646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002726249,0.00020227715,0.0005006804,0.0005746814,0.0001999285,0.00006451988,0.00034182201,0.00023572448,0.0008602277],"category_scores_gemma":[0.0023447329,0.00018177358,0.0001683058,0.0015925227,0.00032047197,0.00012151536,0.00025322492,0.0015697209,0.000115416864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051633436,0.00069545914,0.9387091,0.00021835403,0.00012267624,0.000024085437,0.0001402724,0.000024624745,0.00096793636,0.00003558755,0.0047952705,0.04910334],"study_design_scores_gemma":[0.0047336062,0.00018522626,0.98862725,0.0007173013,0.0000450395,2.7460956e-7,0.000089440866,0.0006651454,0.0006876656,0.000088423294,0.004006676,0.0001539413],"about_ca_topic_score_codex":0.0019184268,"about_ca_topic_score_gemma":0.0009496911,"teacher_disagreement_score":0.04991821,"about_ca_system_score_codex":0.0009245515,"about_ca_system_score_gemma":0.0011474068,"threshold_uncertainty_score":0.941889},"labels":[],"label_agreement":null},{"id":"W4412163851","doi":"10.1158/1557-3265.aimachine-a011","title":"Abstract A011: Interpretable machine learning for discovery, evaluation and clinical translation of context-specific dependencies","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada); Roche (Canada)","funders":"","keywords":"Context (archaeology); Translation (biology); Artificial intelligence; Computer science; Natural language processing; Machine learning; Medicine; Biology","score_opus":0.33467449982982905,"score_gpt":0.5760950646150794,"score_spread":0.24142056478525037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6471069,0.039347626,0.28624287,0.018089846,0.002429152,0.0036525736,0.000039964372,0.00015483939,0.0029362654],"genre_scores_gemma":[0.99417555,0.0024016325,0.0025244593,0.00012304506,0.00015275185,0.00014302963,0.000011999252,0.000012427917,0.00045509948],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995125,0.0017003733,0.0012209838,0.0007488192,0.00080747803,0.0003973393],"domain_scores_gemma":[0.9884041,0.009685998,0.00022197037,0.00049787684,0.0010651355,0.00012489947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01901722,0.00012971982,0.0004413079,0.00022094812,0.00028573393,0.00019577563,0.0007284879,0.00021450658,0.000059124948],"category_scores_gemma":[0.005140445,0.00011556056,0.00018025958,0.00047650305,0.00038110084,0.0004564238,0.00028884335,0.001499831,0.000004171611],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032001478,0.00008817175,0.19130306,0.0002006331,0.000041014646,7.3488263e-7,0.00020355971,0.0003023199,0.000051397346,0.0050741592,0.00045460224,0.80196035],"study_design_scores_gemma":[0.0024107427,0.00078187644,0.3498401,0.00045426967,0.000024793695,8.0231706e-7,0.00013829402,0.610658,0.000113886825,0.0064524673,0.028949251,0.00017552891],"about_ca_topic_score_codex":0.0011215556,"about_ca_topic_score_gemma":0.0010188795,"teacher_disagreement_score":0.8017848,"about_ca_system_score_codex":0.00010440255,"about_ca_system_score_gemma":0.0009632042,"threshold_uncertainty_score":0.6591027},"labels":[],"label_agreement":null},{"id":"W4412163852","doi":"10.1158/1557-3265.aimachine-a054","title":"Abstract A054: Multimodal LLM-Driven Intervention for Precision Risk Prediction in Lung Cancer Surgery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Intervention (counseling); Cancer; Surgery; Oncology; Internal medicine; Nursing","score_opus":0.11368957863770339,"score_gpt":0.5594096166642134,"score_spread":0.44572003802651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98355854,0.0028543344,0.003673457,0.0060708467,0.0018176931,0.0013424718,0.000066296445,0.000056303743,0.00056006084],"genre_scores_gemma":[0.99059844,0.005190891,0.0005072254,0.00023648715,0.00090576295,0.0007219144,0.00005536645,0.000030130677,0.001753804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968341,0.00044028895,0.0010486143,0.0005954282,0.0005650039,0.0005165611],"domain_scores_gemma":[0.99447405,0.0044289613,0.00015468399,0.0003216936,0.0004041241,0.00021645949],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008475108,0.00013485563,0.0005154054,0.0005012485,0.00016691785,0.00004986509,0.00018564983,0.0002516264,0.00045197995],"category_scores_gemma":[0.010284939,0.00011519792,0.00036230413,0.0005557556,0.00025126155,0.00010916116,0.0001236592,0.0020719713,0.000008388912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012750677,0.0003915709,0.62288207,0.0004570275,0.00007008952,0.000009309587,0.000037256228,0.00041255186,0.00014757061,0.0000160363,0.03259785,0.34170356],"study_design_scores_gemma":[0.0032935322,0.000135178,0.8018683,0.002576826,0.00006372221,6.624489e-7,0.0000369376,0.17859453,0.00008138866,0.00028384005,0.012982941,0.00008214562],"about_ca_topic_score_codex":0.0044705314,"about_ca_topic_score_gemma":0.00049093895,"teacher_disagreement_score":0.34162143,"about_ca_system_score_codex":0.0005000173,"about_ca_system_score_gemma":0.0006742492,"threshold_uncertainty_score":0.9980518},"labels":[],"label_agreement":null},{"id":"W4412163853","doi":"10.1158/1557-3265.aimachine-b034","title":"Abstract B034: Decoding the Leukocyte Effect: How Cell Retention Shapes ML Outcomes in Platelet RNA-based Cancer Detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Platelet; Medicine; Cell; RNA; Decoding methods; Cancer detection; Cancer research; Immunology; Biology; Internal medicine; Biochemistry; Computer science; Gene; Algorithm","score_opus":0.08066441607132022,"score_gpt":0.4593110553046897,"score_spread":0.3786466392333695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903843,0.0057667033,0.00026174897,0.0019366561,0.00044300838,0.00064828957,0.000020901485,0.000017623383,0.0005207864],"genre_scores_gemma":[0.9961038,0.0015262845,0.00003244513,0.00031304234,0.00027260784,0.00042055352,0.000017809674,0.000027183078,0.0012862436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973465,0.0006882595,0.00042835428,0.00063928583,0.00038935064,0.000508223],"domain_scores_gemma":[0.99838865,0.00071362715,0.00010812305,0.00048801632,0.00018061741,0.00012095101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032074964,0.00018038573,0.00026065152,0.00012822647,0.00022395956,0.000105694715,0.0005122421,0.00032099776,0.00007505157],"category_scores_gemma":[0.0012390227,0.00013598763,0.00024645662,0.00035208272,0.0003280186,0.000010190148,0.00020941962,0.00085564796,0.000012659504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017455593,0.0002612575,0.146753,0.00037458935,0.00010936743,0.000033192835,0.000015387663,0.00076995493,0.70652676,0.000011273276,0.0027318827,0.1406678],"study_design_scores_gemma":[0.0023276685,0.00026717526,0.17209175,0.00016628957,0.00002984938,2.7447157e-7,0.000040838815,0.0017583783,0.8142018,0.00010571985,0.00880307,0.0002072026],"about_ca_topic_score_codex":0.0003299401,"about_ca_topic_score_gemma":0.0020459415,"teacher_disagreement_score":0.1404606,"about_ca_system_score_codex":0.00017417435,"about_ca_system_score_gemma":0.00047253817,"threshold_uncertainty_score":0.55454147},"labels":[],"label_agreement":null},{"id":"W4412163854","doi":"10.1158/1557-3265.aimachine-a013","title":"Abstract A013: Facilitating AI-Based Hit Discovery through the Development of the AIRCHECK Platform","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Structural Genomics Consortium","funders":"","keywords":"Medicine; Computer science","score_opus":0.22016094514071274,"score_gpt":0.506431172155065,"score_spread":0.28627022701435223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650515,0.0014295457,0.013332687,0.007868233,0.00062446174,0.00033276516,0.00002520305,0.00007317729,0.011262458],"genre_scores_gemma":[0.9976872,0.000065497465,0.00057727884,0.0003596915,0.00008734421,0.00006664745,0.0000031324826,0.000010652313,0.0011425524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979426,0.00011873894,0.0006835773,0.00021093982,0.00068081927,0.00036329494],"domain_scores_gemma":[0.9967518,0.0025758178,0.000039161376,0.00043780264,0.00013595089,0.000059454076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027822868,0.00010166849,0.00023921295,0.000048931244,0.00024752278,0.000057510184,0.00060746697,0.0000873134,0.00013426087],"category_scores_gemma":[0.0015264228,0.000054535016,0.0001869643,0.0006656461,0.00050340017,0.00009300232,0.00014911192,0.0010924177,0.000015985926],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097162876,0.0003375656,0.068672106,0.0019432651,0.0010049788,0.0000060822117,0.0035223153,0.0349556,0.0022086587,0.0010465843,0.07380342,0.81240225],"study_design_scores_gemma":[0.0045930017,0.000098843404,0.33460423,0.0054103318,0.00024845594,5.233947e-7,0.009200248,0.17839749,0.060691208,0.012506682,0.3930992,0.0011498019],"about_ca_topic_score_codex":0.00021355052,"about_ca_topic_score_gemma":0.00028365495,"teacher_disagreement_score":0.8112525,"about_ca_system_score_codex":0.00013242611,"about_ca_system_score_gemma":0.0006750021,"threshold_uncertainty_score":0.4746072},"labels":[],"label_agreement":null},{"id":"W4412163855","doi":"10.1158/1557-3265.aimachine-a004","title":"Abstract A004: Integrating high-throughput screening with ligand-based pharmacophore modeling and virtual screening strategies to optimize exonuclease 1 inhibitor design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacophore; Virtual screening; Ligand (biochemistry); High-throughput screening; Computational biology; Throughput; Combinatorial chemistry; Computer science; Exonuclease; Pharmacology; Medicine; Chemistry; Biology; Bioinformatics; Biochemistry; DNA; Receptor; Polymerase","score_opus":0.12163549211423999,"score_gpt":0.471039321416599,"score_spread":0.349403829302359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58308816,0.00041892726,0.41526458,0.00070855836,0.00004319821,0.0003409008,0.000017347755,0.00004925589,0.00006908289],"genre_scores_gemma":[0.87034696,0.00038050875,0.1281688,0.00056706974,0.00032307318,0.00006255162,0.000026976033,0.000032589985,0.000091455884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736047,0.00029597507,0.0005388358,0.00089344836,0.00038818177,0.000523076],"domain_scores_gemma":[0.9984304,0.00030988673,0.00008994165,0.0003816879,0.0005507346,0.00023739456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020761564,0.00026173575,0.000373728,0.00018807335,0.00037947128,0.00021965848,0.00028149772,0.00024839738,0.0000047334934],"category_scores_gemma":[0.0005102419,0.00020577355,0.00010876147,0.00049305137,0.00038773136,0.000021748234,0.0002737503,0.0007459385,8.8885446e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007294609,0.00021317825,0.0010558417,0.00009120237,0.00038155227,0.00005093307,0.000055933586,0.112938695,0.68987805,0.000084643994,0.0032740624,0.18468131],"study_design_scores_gemma":[0.0035078938,0.002451913,0.00067725725,0.0016375505,0.0001405149,0.0000035924297,0.0019259776,0.10718102,0.87979877,0.00017241597,0.0016718104,0.0008312838],"about_ca_topic_score_codex":0.00034012127,"about_ca_topic_score_gemma":0.00013574466,"teacher_disagreement_score":0.28725883,"about_ca_system_score_codex":0.00003694012,"about_ca_system_score_gemma":0.0005126712,"threshold_uncertainty_score":0.8391202},"labels":[],"label_agreement":null},{"id":"W4412163856","doi":"10.1158/1557-3265.aimachine-b014","title":"Abstract B014: Are histopathology foundation models clinically ready for survival prediction?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Histopathology; Medicine; Foundation (evidence); Pathology; History","score_opus":0.3062119964964399,"score_gpt":0.5841844480305458,"score_spread":0.27797245153410594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74943143,0.0018977227,0.06440794,0.1102397,0.009421122,0.003767867,0.00012197514,0.00041821424,0.060294017],"genre_scores_gemma":[0.98199815,0.0019947274,0.00235768,0.0026535199,0.0020274932,0.0004382911,0.00013477856,0.000047415986,0.00834796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965122,0.00040574427,0.0012010989,0.0007164334,0.00060773623,0.00055682746],"domain_scores_gemma":[0.9941421,0.0037820379,0.0001823699,0.0005536443,0.0010253625,0.00031448985],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010640938,0.000145019,0.0006194582,0.00023610199,0.00029468175,0.00005238694,0.00029105565,0.00033224473,0.00021177532],"category_scores_gemma":[0.0098670395,0.00012558246,0.00023900937,0.00032723357,0.0007288342,0.0000940835,0.00013250289,0.002066499,0.000041701758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055061616,0.0013793836,0.48279315,0.00090975314,0.00026498924,0.000096403615,0.00012909841,0.00057735614,0.00082724355,0.013230117,0.12632337,0.36796296],"study_design_scores_gemma":[0.0075113047,0.0011261252,0.6581335,0.0007545476,0.000182962,0.000008593207,0.00020577839,0.06326248,0.0000230752,0.028078618,0.24048398,0.00022903942],"about_ca_topic_score_codex":0.00024205928,"about_ca_topic_score_gemma":0.000041193303,"teacher_disagreement_score":0.36773393,"about_ca_system_score_codex":0.00027804472,"about_ca_system_score_gemma":0.0012265147,"threshold_uncertainty_score":0.9984733},"labels":[],"label_agreement":null},{"id":"W4412163857","doi":"10.1158/1557-3265.aimachine-b012","title":"Abstract B012: Prompting Large Language Models to Predict Adverse Events during Cancer Treatment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Adverse effect; Cancer; Medicine; Intensive care medicine; Oncology; Internal medicine","score_opus":0.5986622321742983,"score_gpt":0.6997175649584702,"score_spread":0.10105533278417189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822837,0.0011589356,0.000053221214,0.0062326356,0.00168262,0.0036398692,0.00030278254,0.00015270681,0.0044935346],"genre_scores_gemma":[0.9777099,0.0014370702,0.000088382134,0.0008232069,0.0014487929,0.004248379,0.000012918593,0.000049407638,0.014181979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993626,0.001363671,0.001533859,0.00089361606,0.00079514756,0.0017877192],"domain_scores_gemma":[0.99508333,0.0025370151,0.00017621537,0.00078584795,0.000796385,0.0006211945],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045527727,0.00023264631,0.0005361202,0.0003021729,0.0016177265,0.000010442691,0.0005596457,0.00043454202,0.0024321335],"category_scores_gemma":[0.0014637123,0.00019596666,0.00017632564,0.0008284379,0.00011899033,0.0001788997,0.0005745416,0.0021995485,0.00075381156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015753409,0.00059111026,0.9341441,0.0013152356,0.0001637813,0.00006502875,0.011960665,0.0017459177,0.00046658944,0.000581019,0.005169684,0.04222152],"study_design_scores_gemma":[0.004486903,0.00091481826,0.8632729,0.012642835,0.00010240046,5.348613e-7,0.052009523,0.016566273,0.0031107087,0.0041023646,0.041820917,0.0009698238],"about_ca_topic_score_codex":0.043061707,"about_ca_topic_score_gemma":0.05639987,"teacher_disagreement_score":0.070871204,"about_ca_system_score_codex":0.002399217,"about_ca_system_score_gemma":0.003227333,"threshold_uncertainty_score":0.999682},"labels":[],"label_agreement":null},{"id":"W4412163859","doi":"10.1158/1557-3265.aimachine-ia01","title":"Abstract IA01: The impact of bringing complex data to the point of care","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Point of care; Intensive care medicine; Data science; Computer science; Nursing","score_opus":0.9087592362411606,"score_gpt":0.7781554849029165,"score_spread":0.1306037513382441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8542916,0.0016530438,0.00034711472,0.088359974,0.0011241288,0.0031829465,0.00059396646,0.000037845944,0.050409384],"genre_scores_gemma":[0.99738854,0.0004089759,0.00004865045,0.001377442,0.00035368084,0.00007260347,0.000033759618,0.000006264833,0.0003100894],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.996424,0.0010331688,0.0012380783,0.00019842687,0.0006142002,0.00049212837],"domain_scores_gemma":[0.9896516,0.007913561,0.00022080653,0.0012263405,0.00080976955,0.00017788314],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015794158,0.0000674794,0.00030317542,0.00010388697,0.0007225194,0.000008594145,0.0012457125,0.00012765737,0.0011201868],"category_scores_gemma":[0.008108666,0.00003259267,0.000088015106,0.00058307906,0.00028176297,0.000059276244,0.00094733713,0.0019067765,0.000080928505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074005703,0.000066536406,0.09617458,0.0024645492,0.00007749708,6.149347e-7,0.0069392202,0.00019256966,0.000049926024,0.0012162888,0.7835146,0.108563565],"study_design_scores_gemma":[0.00055985554,0.0001940371,0.9065356,0.0013492275,0.0000094107,6.2707656e-8,0.0059433044,0.0026332608,0.00000953328,0.00020471764,0.08251732,0.000043660948],"about_ca_topic_score_codex":0.011654725,"about_ca_topic_score_gemma":0.0015463219,"teacher_disagreement_score":0.810361,"about_ca_system_score_codex":0.00020185638,"about_ca_system_score_gemma":0.00282471,"threshold_uncertainty_score":0.99979293},"labels":[],"label_agreement":null},{"id":"W4412163863","doi":"10.1158/1557-3265.aimachine-ia03","title":"Abstract IA03: Accelerating oncology drug discovery with the power of microscopy &amp; AI","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug discovery; Drug; Internal medicine; Oncology; Pharmacology; Bioinformatics; Biology","score_opus":0.0785102391528594,"score_gpt":0.5303171162217778,"score_spread":0.4518068770689184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984455,0.0016029485,0.00066257466,0.0046072407,0.000040692215,0.0002841126,0.000007721271,0.000008986775,0.008330719],"genre_scores_gemma":[0.99158853,0.0008575014,0.0004216612,0.0012183471,0.00013773807,0.000084770436,0.000020362468,0.000014837106,0.00565624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823594,0.00035009102,0.0004192667,0.0004357624,0.00025263932,0.0003063215],"domain_scores_gemma":[0.9982298,0.00041107772,0.00011054545,0.00072744297,0.0004690842,0.00005203809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002562988,0.0001079831,0.00026305762,0.00006866599,0.00013278118,0.00007006182,0.0005571552,0.00016375043,0.000108283944],"category_scores_gemma":[0.00047517815,0.0000683969,0.00015285531,0.00031610476,0.00082506664,0.000008724342,0.00040733416,0.00069016864,0.00000509703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086365297,0.00033617558,0.02503712,0.00005570594,0.00029011362,0.00000591086,0.00008143694,0.000023605779,0.6843356,0.0000680213,0.2777177,0.011184964],"study_design_scores_gemma":[0.00070140033,0.0004441719,0.013813717,0.00009085775,0.000045290715,0.0000010801889,0.00029616934,0.0000134348,0.6346524,0.00014418429,0.349632,0.00016532578],"about_ca_topic_score_codex":0.00048464394,"about_ca_topic_score_gemma":0.0023268885,"teacher_disagreement_score":0.07191426,"about_ca_system_score_codex":0.000044699733,"about_ca_system_score_gemma":0.0007325625,"threshold_uncertainty_score":0.30399925},"labels":[],"label_agreement":null},{"id":"W4412163864","doi":"10.1158/1557-3265.aimachine-b026","title":"Abstract B026: Artificial Intelligence Apps for Medical Image Analysis using pyCERR and Cancer Genomics Cloud","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cloud computing; Genomics; Cancer; Computer science; Data science; Medicine; Computational biology; World Wide Web; Biology; Genome; Genetics; Internal medicine; Operating system; Gene","score_opus":0.21203693097384477,"score_gpt":0.588695933687648,"score_spread":0.37665900271380326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91426766,0.005030917,0.05126335,0.02662453,0.0010254628,0.0008727891,0.000041864274,0.00005425591,0.0008191947],"genre_scores_gemma":[0.97960323,0.009807134,0.0052749254,0.0022924729,0.0022655365,0.00016609616,0.000026816397,0.000049320406,0.00051446736],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99645156,0.0002178761,0.0010469801,0.00075173826,0.00085014116,0.0006816797],"domain_scores_gemma":[0.99581736,0.0025183416,0.00011754648,0.00041049713,0.00051342224,0.00062280893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073151807,0.00017972423,0.00076474977,0.00046042376,0.00032547236,0.00011646584,0.00034835775,0.00031300265,0.0008537364],"category_scores_gemma":[0.0066470983,0.00015231105,0.00033002574,0.0011610778,0.001293044,0.00006004296,0.0002702599,0.0020403618,0.000007589089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014947437,0.00039664432,0.03815754,0.0006149744,0.0016314009,0.000091444956,0.00019132116,0.00044441962,0.0023132195,0.0026722807,0.005220617,0.9467714],"study_design_scores_gemma":[0.0021930197,0.00037482762,0.043308027,0.0012765087,0.0019587064,0.000012512958,0.0007173858,0.8728165,0.0018761243,0.013855131,0.061053507,0.000557757],"about_ca_topic_score_codex":0.0017945509,"about_ca_topic_score_gemma":0.00029287013,"teacher_disagreement_score":0.94621366,"about_ca_system_score_codex":0.0003055679,"about_ca_system_score_gemma":0.0019165486,"threshold_uncertainty_score":0.9347815},"labels":[],"label_agreement":null},{"id":"W4412163866","doi":"10.1158/1557-3265.aimachine-b032","title":"Abstract B032: Generative modeling (AI) for the analysis of Single-Cell RNA-seq data of radioresistant malignant pediatric brain tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; RNA-Seq; Medicine; Computational biology; Pathology; Cancer research; Biology; Internal medicine; Gene expression; Transcriptome; Radiation therapy; Genetics; Gene","score_opus":0.2566648837387934,"score_gpt":0.47246699489415556,"score_spread":0.21580211115536213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643578,0.008378956,0.024085067,0.0013641067,0.0002209401,0.0005313196,0.0008233451,0.0000047000153,0.0002337448],"genre_scores_gemma":[0.99574906,0.002562869,0.00046225655,0.00021769197,0.00033149112,0.000044537923,0.00021389779,0.00001842576,0.0003998025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755746,0.00024232923,0.0008901504,0.0006132059,0.00034929378,0.00034757593],"domain_scores_gemma":[0.99709815,0.0009979872,0.00016248463,0.0010322914,0.0006261279,0.000082976534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032959855,0.00013923564,0.00045731902,0.00019718314,0.00013951267,0.000030371555,0.0010249082,0.00018799606,0.000026869078],"category_scores_gemma":[0.0010728819,0.00010112939,0.00033456628,0.00079546496,0.00031808545,0.00000646694,0.00028427807,0.0003106284,3.7122075e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002482543,0.000950209,0.017079901,0.00047039514,0.0017271416,0.0000034585132,0.000098385004,0.02287467,0.93449,0.00018964963,0.010850748,0.008782848],"study_design_scores_gemma":[0.0057907184,0.0017028283,0.013455372,0.00020932005,0.0032453213,4.8218766e-7,0.0006765059,0.41217858,0.550938,0.0007173052,0.010291319,0.0007942524],"about_ca_topic_score_codex":0.0006821818,"about_ca_topic_score_gemma":0.0008215875,"teacher_disagreement_score":0.3893039,"about_ca_system_score_codex":0.000030048084,"about_ca_system_score_gemma":0.00078059395,"threshold_uncertainty_score":0.41239372},"labels":[],"label_agreement":null},{"id":"W4412163867","doi":"10.1158/1557-3265.aimachine-a024","title":"Abstract A024: AI-Integrated Framework for Predicting ADME and Toxicological Profiles: A Hybrid Data- and Physics-Driven Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ADME; Computer science; Computational biology; Medicine; Pharmacology; Biology; Pharmacokinetics","score_opus":0.26691127914115126,"score_gpt":0.5244278441977622,"score_spread":0.25751656505661097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95993847,0.00035350717,0.031726297,0.002909965,0.0001704986,0.0023968362,0.00040063146,0.000060988194,0.002042813],"genre_scores_gemma":[0.9859871,0.00087787095,0.01060804,0.0013322452,0.0002694923,0.0005657679,0.000070394424,0.000025014146,0.0002640566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626976,0.00047492003,0.0005402474,0.001468665,0.0005080239,0.00073836173],"domain_scores_gemma":[0.9952198,0.003672559,0.00009521672,0.0006427569,0.00003798025,0.00033164016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049805366,0.00018697754,0.00036796505,0.000035790625,0.00048621607,0.00011254377,0.0005669928,0.00022596326,0.00032527617],"category_scores_gemma":[0.0038708355,0.00015503354,0.000049257673,0.0003233418,0.0015322351,0.00026530327,0.0014405886,0.001819873,0.000031473068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048139796,0.0006900813,0.64482313,0.00032505946,0.00009282853,0.000017161863,0.00022236953,0.0001412613,0.00056877447,0.0005703795,0.013630897,0.3384367],"study_design_scores_gemma":[0.0021817961,0.0007005412,0.8105785,0.0005760125,0.00007122358,0.000004259456,0.0010484281,0.13481057,0.00061783753,0.017002199,0.031894654,0.0005139585],"about_ca_topic_score_codex":0.0003104253,"about_ca_topic_score_gemma":0.000049373706,"teacher_disagreement_score":0.33792272,"about_ca_system_score_codex":0.00024690587,"about_ca_system_score_gemma":0.00018014891,"threshold_uncertainty_score":0.79065436},"labels":[],"label_agreement":null},{"id":"W4412163869","doi":"10.1158/1557-3265.aimachine-b037","title":"Abstract B037: AI-powered virtual tissues from spatial proteomics for clinical diagnostics and biomedical discovery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Proteomics; Computational biology; Medicine; Data science; Computer science; Biology","score_opus":0.5421546771818586,"score_gpt":0.6767384420996166,"score_spread":0.13458376491775803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94727653,0.0037681353,0.003901655,0.039311636,0.0034248247,0.0019278825,0.00019088195,0.00003893096,0.00015952467],"genre_scores_gemma":[0.9587473,0.031840794,0.00065600395,0.0020534317,0.0052647744,0.00044913375,0.00016065004,0.000027421873,0.00080046785],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963809,0.00030901772,0.001489754,0.00072456273,0.00055031566,0.0005454239],"domain_scores_gemma":[0.9850144,0.013192593,0.00011676202,0.0004635634,0.00071243977,0.00050025596],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004119174,0.00015467918,0.00058773626,0.0001569333,0.00023905456,0.00011143649,0.00022023192,0.0005878276,0.00022363248],"category_scores_gemma":[0.020709537,0.00012931594,0.00017569163,0.00029011065,0.0013301991,0.0001242552,0.00016813895,0.0015685746,0.00004756591],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035190927,0.0010906907,0.3182196,0.00023143955,0.00013488549,0.000019177596,0.00022139309,3.3037324e-7,0.00011968235,0.0006239069,0.08490057,0.59091926],"study_design_scores_gemma":[0.0018805551,0.0054466347,0.69698834,0.002085094,0.00022699776,0.0000021263936,0.0018191781,0.0012231552,0.004206858,0.027613714,0.25807354,0.0004338003],"about_ca_topic_score_codex":0.006092183,"about_ca_topic_score_gemma":0.001018394,"teacher_disagreement_score":0.59048545,"about_ca_system_score_codex":0.0001522407,"about_ca_system_score_gemma":0.002622214,"threshold_uncertainty_score":0.98753947},"labels":[],"label_agreement":null},{"id":"W4412163871","doi":"10.1158/1557-3265.aimachine-b033","title":"Abstract B033: Identifying triple-negative breast cancer patients at high risk of worse prognosis using molecular features derived from histology images","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histology; Medicine; Breast cancer; Triple-negative breast cancer; Cancer; Triple negative; Pathology; Oncology; Internal medicine","score_opus":0.06299291689022113,"score_gpt":0.4667548794082291,"score_spread":0.40376196251800794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373406,0.0026435917,0.000760475,0.0006505248,0.00020664843,0.0007549339,0.0011044397,0.000015024328,0.00013028223],"genre_scores_gemma":[0.9933831,0.0035724135,0.0018445981,0.00020168857,0.00012088513,0.00046361375,0.00017763552,0.000028132987,0.00020792052],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972942,0.0005691162,0.0006187113,0.0008205799,0.0002631326,0.00043428392],"domain_scores_gemma":[0.9980666,0.00021656277,0.00030876164,0.00055313256,0.00073254004,0.00012237177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006702498,0.0002061917,0.0003977966,0.0001228652,0.00025464888,0.000022417866,0.00050957943,0.0004813468,0.00015720991],"category_scores_gemma":[0.00053969934,0.00018874052,0.00024788314,0.00033199455,0.00085809897,0.0000049995892,0.0006214507,0.0005862132,0.000003210474],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007475748,0.00035900305,0.29902786,0.000048344064,0.0004624757,0.0000050464946,0.000018005041,0.00002891487,0.6822901,0.00005209812,0.0048915185,0.012069088],"study_design_scores_gemma":[0.0009189201,0.000099185505,0.5357222,0.00009534168,0.000088347544,5.3761613e-7,0.00001746639,0.000012457928,0.46153808,0.0006907278,0.0006646167,0.00015214364],"about_ca_topic_score_codex":0.009137852,"about_ca_topic_score_gemma":0.001073708,"teacher_disagreement_score":0.23669429,"about_ca_system_score_codex":0.0001415654,"about_ca_system_score_gemma":0.00033745047,"threshold_uncertainty_score":0.99746037},"labels":[],"label_agreement":null},{"id":"W4412163872","doi":"10.1158/1557-3265.aimachine-a022","title":"Abstract A022: Deep Learning Meets Transcriptomics: CNN-1D Powered Interpretation of probe based transcriptome array in Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Prostate cancer; Artificial intelligence; Interpretation (philosophy); Computational biology; Deep learning; Computer science; Cancer; Biology; Medicine; Bioinformatics; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.046700899971770134,"score_gpt":0.45865300075473747,"score_spread":0.41195210078296735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97092247,0.0061963648,0.014844527,0.0042602643,0.00018667366,0.0015418318,0.000072685354,0.000035012792,0.001940153],"genre_scores_gemma":[0.9940747,0.0032516713,0.0008649849,0.00033404023,0.000049840106,0.00096472935,0.00010017436,0.000023171031,0.00033667064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772906,0.00038709413,0.0006936138,0.00060051656,0.00019858181,0.00039115766],"domain_scores_gemma":[0.99901634,0.00009902981,0.000113135444,0.00036500435,0.00032118912,0.00008527306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016198112,0.00015420785,0.0003039325,0.00017907663,0.0000846704,0.000020174608,0.00038736753,0.0002992456,0.00009444497],"category_scores_gemma":[0.00024321952,0.00014721869,0.00018525097,0.00041488605,0.00040157288,0.000006043966,0.000045600085,0.0007150052,0.0000021718092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010454009,0.00024242305,0.018510679,0.00015838242,0.00006739124,0.0000021785243,0.00010307175,0.00031114364,0.9469052,0.00017980796,0.00030211202,0.032172207],"study_design_scores_gemma":[0.0036205284,0.0010079257,0.06338802,0.00072042894,0.000052312145,7.982015e-7,0.0002489393,0.0022718913,0.85038394,0.0013762398,0.07643199,0.0004969952],"about_ca_topic_score_codex":0.0004199607,"about_ca_topic_score_gemma":0.00097020617,"teacher_disagreement_score":0.09652127,"about_ca_system_score_codex":0.00006263219,"about_ca_system_score_gemma":0.0004920608,"threshold_uncertainty_score":0.60034037},"labels":[],"label_agreement":null},{"id":"W4412163873","doi":"10.1158/1557-3265.aimachine-b036","title":"Abstract B036: Machine learning-based and marker-based combined strategy for circulating tumor cells candidates' detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Circulating tumor cell; Tumor cells; Cancer; Medicine; Computer science; Cancer research; Artificial intelligence; Computational biology; Internal medicine; Biology; Metastasis","score_opus":0.0928434296276607,"score_gpt":0.4815294511441824,"score_spread":0.38868602151652165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98258024,0.0010202135,0.0063411896,0.006937343,0.000490542,0.0013777018,0.00003213247,0.00012762134,0.0010929822],"genre_scores_gemma":[0.9970287,0.000093964925,0.00048745782,0.0011266056,0.00025523655,0.00018227434,0.000057044028,0.00004341472,0.0007252912],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972181,0.0003827265,0.00068638235,0.00062101544,0.00049368147,0.00059814565],"domain_scores_gemma":[0.995246,0.00357289,0.00013777499,0.00029638538,0.00038087854,0.00036607494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005144349,0.00018994212,0.000517345,0.00029407383,0.00042124244,0.00011013948,0.00016193159,0.00016841854,0.00019763605],"category_scores_gemma":[0.00419143,0.00016532309,0.00017680085,0.00045190894,0.0004692733,0.000043496773,0.000061265266,0.0022383963,0.000006252801],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011463205,0.0011263859,0.43622082,0.0042411555,0.00039894137,0.00024347207,0.000050835293,0.013051365,0.04597639,0.00014548888,0.005652633,0.4814293],"study_design_scores_gemma":[0.009332643,0.0012835988,0.11151087,0.0007099208,0.000100771525,0.0000030987999,0.000045700053,0.8539315,0.0052314415,0.00029278945,0.017342445,0.00021520762],"about_ca_topic_score_codex":0.0012929024,"about_ca_topic_score_gemma":0.00018140714,"teacher_disagreement_score":0.84088016,"about_ca_system_score_codex":0.00018258777,"about_ca_system_score_gemma":0.0009979034,"threshold_uncertainty_score":0.97248423},"labels":[],"label_agreement":null},{"id":"W4412163875","doi":"10.1158/1557-3265.aimachine-a058","title":"Abstract A058: Multimodal generative AI jointly learns pathology and clinical data to synthesize a multinational lung cancer cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Cohort; Cancer; Medicine; Multinational corporation; Pathology; Generative grammar; Computer science; Artificial intelligence; Internal medicine; Business","score_opus":0.2597887378410895,"score_gpt":0.5770479330291616,"score_spread":0.31725919518807205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75377035,0.003605172,0.14693709,0.08285351,0.0072313407,0.0034716479,0.0004559689,0.00035672553,0.0013182171],"genre_scores_gemma":[0.9681366,0.003282736,0.01890047,0.0056677647,0.0017396584,0.0008781418,0.0000193791,0.000040177543,0.0013350876],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99317616,0.0015241049,0.001272606,0.0022141393,0.0010149487,0.00079805875],"domain_scores_gemma":[0.99072754,0.005749094,0.00017943676,0.0018117616,0.0010857595,0.0004464052],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011069645,0.0002552581,0.00062897505,0.00033398232,0.00048434275,0.0003391234,0.0024490561,0.00041352585,0.00024563583],"category_scores_gemma":[0.005834694,0.00023819764,0.00013381925,0.0010371353,0.0007268926,0.00059270527,0.0034152672,0.0023224142,0.000056666915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047733798,0.00045012755,0.35456195,0.00009784075,0.00039479666,0.000106685904,0.00022902235,0.00044275567,0.00039106605,0.00143681,0.06652631,0.5748853],"study_design_scores_gemma":[0.00123071,0.00021703576,0.8049307,0.00019352045,0.000037805443,0.0000053529748,0.00004197336,0.17702423,0.00026296524,0.0006794537,0.015076725,0.00029953584],"about_ca_topic_score_codex":0.0013833569,"about_ca_topic_score_gemma":0.0028605033,"teacher_disagreement_score":0.57458574,"about_ca_system_score_codex":0.0004964137,"about_ca_system_score_gemma":0.002323196,"threshold_uncertainty_score":0.99997926},"labels":[],"label_agreement":null},{"id":"W4412163877","doi":"10.1158/1557-3265.aimachine-pr-03","title":"Abstract PR-03 Inferring genomic properties and histologic subtypes of solid tumors from H&amp;E whole-slide images","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pathology; Medicine; Cancer research; Computational biology; Biology","score_opus":0.19351091864998232,"score_gpt":0.4968909905268948,"score_spread":0.30338007187691246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773588,0.0109293405,0.00006652436,0.009149783,0.0002278111,0.0003278979,0.000018033423,0.000037479902,0.0018843218],"genre_scores_gemma":[0.99378794,0.002431004,0.00065270235,0.0005350182,0.00029789,0.00004023675,0.00001067861,0.000021424465,0.002223109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977774,0.0002214412,0.0007297742,0.00046704366,0.00039945514,0.00040489447],"domain_scores_gemma":[0.997982,0.0010564951,0.000116909796,0.0003737973,0.0002551543,0.0002156218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002401563,0.00013735644,0.00062596315,0.00020512786,0.00013731573,0.000035855854,0.00024276716,0.00013823574,0.00018407707],"category_scores_gemma":[0.0048573692,0.000101770616,0.00010840852,0.00020961819,0.0012206575,0.000059780323,0.00028127473,0.0015766271,0.000029781651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009355428,0.00026633908,0.7651858,0.0007841308,0.00022695147,0.00007428414,0.00029796085,0.00006297737,0.12535594,0.00007990663,0.012550678,0.09417951],"study_design_scores_gemma":[0.0017461854,0.00021605904,0.9497845,0.0015784426,0.000075880685,0.0000059975705,0.00017489972,0.0008608708,0.004062245,0.001246674,0.04008932,0.00015892918],"about_ca_topic_score_codex":0.0026648238,"about_ca_topic_score_gemma":0.00010220577,"teacher_disagreement_score":0.18459873,"about_ca_system_score_codex":0.00012686857,"about_ca_system_score_gemma":0.00065672974,"threshold_uncertainty_score":0.6849748},"labels":[],"label_agreement":null},{"id":"W4412163879","doi":"10.1158/1557-3265.aimachine-a060","title":"Abstract A060: OncoMindPro: An AI-augmented assistant to oncologists","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.22834382197644307,"score_gpt":0.6400331546755982,"score_spread":0.4116893326991551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8595587,0.0005526993,0.000746407,0.10178588,0.0011175877,0.0010015834,0.000012286277,0.00011960286,0.03510527],"genre_scores_gemma":[0.9772778,0.000303882,0.0011176256,0.013589452,0.00079930975,0.00016749847,0.00001819467,0.00003005215,0.006696164],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996524,0.00042459505,0.00076640636,0.0007110836,0.0008660677,0.00070788444],"domain_scores_gemma":[0.99664915,0.0012409989,0.000064202366,0.0006745408,0.000511661,0.0008594236],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006887766,0.00015645224,0.0005552606,0.00031572353,0.00023204698,0.00009731348,0.00044143279,0.00023037851,0.0010761678],"category_scores_gemma":[0.0061305976,0.0001236932,0.00016031571,0.0007979614,0.00052821415,0.000069457325,0.00025523413,0.0029100978,0.0001432407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024499658,0.0014368377,0.15267973,0.00024943126,0.0001945102,0.0004167019,0.00014050253,0.00005237729,0.0040568,0.0008324951,0.20977728,0.6277134],"study_design_scores_gemma":[0.0032560695,0.0013129051,0.56485623,0.00076291617,0.00005379761,0.0000053855674,0.00020276656,0.0023997314,0.0004642566,0.00066433515,0.42583472,0.0001868577],"about_ca_topic_score_codex":0.0010061737,"about_ca_topic_score_gemma":0.00023137213,"teacher_disagreement_score":0.6275265,"about_ca_system_score_codex":0.00042741987,"about_ca_system_score_gemma":0.0017070535,"threshold_uncertainty_score":0.999837},"labels":[],"label_agreement":null},{"id":"W4412163881","doi":"10.1158/1557-3265.aimachine-a046","title":"Abstract A046: Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Esophageal adenocarcinoma; Adenocarcinoma; Medicine; Primary (astronomy); Oncology; Esophageal cancer; Cancer research; Internal medicine; Cancer","score_opus":0.14439424247349258,"score_gpt":0.5110673304092923,"score_spread":0.3666730879357997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9195766,0.075345434,0.000009140643,0.0019591264,0.00009878065,0.0010332025,0.000107109554,0.000017474076,0.0018531338],"genre_scores_gemma":[0.9742842,0.023698231,0.00028517283,0.00024436478,0.000121190154,0.00014361629,0.000032875756,0.000025568112,0.0011647805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955987,0.00076600275,0.001318797,0.0008077125,0.000806264,0.0007025558],"domain_scores_gemma":[0.9933614,0.0051176045,0.00013124813,0.00048985536,0.00032448236,0.00057537435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053422297,0.00022317542,0.0010689752,0.00037371097,0.00009984892,0.000048736216,0.00020943483,0.00016603325,0.00023206971],"category_scores_gemma":[0.0011820769,0.00017294854,0.00015622756,0.0006149743,0.0015000107,0.00010517363,0.00040985187,0.0015879924,0.000008300226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025928067,0.0010774237,0.93067694,0.001668143,0.00017979722,0.0005808601,0.000071069415,9.964656e-7,0.00003310596,0.00014530336,0.0012303075,0.06174325],"study_design_scores_gemma":[0.007085534,0.0020983852,0.9882344,0.00038276328,0.00009056159,0.0000035949797,0.00013770962,0.00007669176,0.00040643805,0.0011243381,0.00025695545,0.00010262521],"about_ca_topic_score_codex":0.0018066956,"about_ca_topic_score_gemma":0.0005168889,"teacher_disagreement_score":0.061640624,"about_ca_system_score_codex":0.00022871191,"about_ca_system_score_gemma":0.0016508341,"threshold_uncertainty_score":0.7052637},"labels":[],"label_agreement":null},{"id":"W4412163882","doi":"10.1158/1557-3265.aimachine-a056","title":"Abstract A056: Integrative Machine Learning Approaches for Predicting Prostate Cancer Risk Using Multi-Omics Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Omics; Cancer; Prostate; Medicine; Computational biology; Artificial intelligence; Machine learning; Computer science; Bioinformatics; Internal medicine; Biology","score_opus":0.3757576763179307,"score_gpt":0.5336097729368587,"score_spread":0.15785209661892802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96062213,0.02757724,0.0070438115,0.0007863703,0.00061572576,0.0012419091,0.0017197903,0.000022247597,0.0003707542],"genre_scores_gemma":[0.9542604,0.03638161,0.005813369,0.00008114059,0.0007242165,0.0003226308,0.00039501043,0.000041967305,0.001979654],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974233,0.00033056154,0.0005465306,0.0009396154,0.0002118641,0.0005481199],"domain_scores_gemma":[0.9982431,0.0004663867,0.0002004751,0.00060442055,0.00038254337,0.00010305958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041753273,0.00019749945,0.00038786873,0.000111848,0.0005294589,0.00007607122,0.0006297113,0.00020439626,0.000017887363],"category_scores_gemma":[0.0047547864,0.00015848166,0.00013212833,0.00030189185,0.00037231957,0.000011166774,0.0011258136,0.0010374548,0.0000010422966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002203424,0.0004703201,0.81647474,0.00036158937,0.0017739488,0.000002730151,0.00024286959,0.0023535527,0.032244034,0.00025943792,0.0037252824,0.1398881],"study_design_scores_gemma":[0.01062463,0.0013937685,0.13339111,0.00060504006,0.0005932217,0.0000019371637,0.0039062258,0.45072347,0.048413243,0.0011847419,0.34781665,0.0013459636],"about_ca_topic_score_codex":0.0018070545,"about_ca_topic_score_gemma":0.0024548692,"teacher_disagreement_score":0.6830836,"about_ca_system_score_codex":0.00007481455,"about_ca_system_score_gemma":0.0006035195,"threshold_uncertainty_score":0.64626944},"labels":[],"label_agreement":null},{"id":"W4412163883","doi":"10.1158/1557-3265.aimachine-a038","title":"Abstract A038: Unmasking hidden mutational footprints of therapy in pediatric tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.2380721496292062,"score_gpt":0.5708286162095034,"score_spread":0.3327564665802972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891865,0.00079546,0.0000016785473,0.0018482996,0.00010197325,0.0006519895,0.00000889456,0.000014185351,0.007390971],"genre_scores_gemma":[0.99600935,0.002504437,0.00007116989,0.00012002758,0.00018529025,0.00013618429,0.0000067835795,0.000014831965,0.000951931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736154,0.000262305,0.00062325125,0.00039670075,0.0008916682,0.00046455086],"domain_scores_gemma":[0.9971021,0.0018240609,0.00006475718,0.00030063535,0.00051015924,0.00019830764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018193533,0.000101197584,0.00034841354,0.0005783962,0.000058503287,0.000016144175,0.00021803357,0.00010049938,0.00046914266],"category_scores_gemma":[0.0016559355,0.00008186353,0.000119166376,0.0013526016,0.00026629056,0.00004729518,0.00012310204,0.00096708204,0.000051581173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002170809,0.0010646944,0.8913672,0.00020092515,0.000078151264,0.00035897508,0.000035556204,0.000004955242,0.00048085526,0.00021679733,0.0010258572,0.1029952],"study_design_scores_gemma":[0.0041980534,0.0005735529,0.99096286,0.00019061827,0.0000074672876,0.0000018684896,0.00002881513,0.000022676686,0.0024771024,0.0011474023,0.00034088327,0.00004868284],"about_ca_topic_score_codex":0.0004883723,"about_ca_topic_score_gemma":0.00012743339,"teacher_disagreement_score":0.10294652,"about_ca_system_score_codex":0.00017063017,"about_ca_system_score_gemma":0.0020295833,"threshold_uncertainty_score":0.5136783},"labels":[],"label_agreement":null},{"id":"W4412163884","doi":"10.1158/1557-3265.aimachine-a007","title":"Abstract A007: Bayesian Counterfactual Machine Learning Individualizes Radiation Modality Selection to Mitigate Immunosuppression","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunosuppression; Modality (human–computer interaction); Counterfactual thinking; Medicine; Bayesian probability; Selection (genetic algorithm); Machine learning; Artificial intelligence; Computer science; Psychology; Internal medicine","score_opus":0.08295983461883612,"score_gpt":0.5184355499048301,"score_spread":0.435475715285994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96436614,0.0015463365,0.0027783914,0.02629056,0.00075492077,0.0007983885,0.000016060385,0.00014346387,0.003305725],"genre_scores_gemma":[0.9940448,0.0009767974,0.000400573,0.0013800112,0.00058860524,0.00009646715,0.00006425055,0.000033786473,0.0024147287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962745,0.0007345209,0.00079874194,0.00063747476,0.000938909,0.0006158896],"domain_scores_gemma":[0.997447,0.0013157612,0.00011551693,0.00031182804,0.00037759703,0.00043226843],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0063561844,0.00018444753,0.0004916948,0.00041236082,0.0004719034,0.00013255383,0.00026867003,0.000248143,0.00081427937],"category_scores_gemma":[0.006260235,0.00015691633,0.00016245103,0.0008169047,0.000271247,0.000117347496,0.00020309421,0.0032769185,0.000062849576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014991541,0.00031383033,0.51891243,0.00025876128,0.0002101162,0.000021692334,0.00032440032,0.0010860263,0.0075299493,0.00018109694,0.014390474,0.45527208],"study_design_scores_gemma":[0.0037077512,0.0006459594,0.79323196,0.0010733404,0.000086084314,0.0000071138156,0.0001290299,0.049754053,0.0032715034,0.000628016,0.14720945,0.00025573096],"about_ca_topic_score_codex":0.00191312,"about_ca_topic_score_gemma":0.000076663,"teacher_disagreement_score":0.45501634,"about_ca_system_score_codex":0.00035297047,"about_ca_system_score_gemma":0.0006643637,"threshold_uncertainty_score":0.99902254},"labels":[],"label_agreement":null},{"id":"W4412163886","doi":"10.1158/1557-3265.aimachine-a040","title":"Abstract A040: Digital Controls: An Efficient, Robust, and Privacy-Preserving Bayesian Tool for Adaptive Information Borrowing from External Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Distributed Sensor Networks and Detection Algorithms","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Bayesian probability; Internet privacy; Medicine; Data mining; Artificial intelligence","score_opus":0.16592162432776952,"score_gpt":0.44112254087147434,"score_spread":0.2752009165437048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163886","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041905545,0.0003864073,0.9545298,0.0008959036,0.00059913663,0.0005747442,0.00055872806,0.00008937093,0.00046032533],"genre_scores_gemma":[0.98197865,0.00008771244,0.016887818,0.00028674345,0.00047371408,0.000072647235,0.00013116615,0.000009257688,0.00007229853],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99755144,0.00015348468,0.00065647095,0.0006413674,0.00052264525,0.00047461136],"domain_scores_gemma":[0.99584377,0.0021650617,0.00012407995,0.001212594,0.0004453046,0.00020919499],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0024034814,0.00013400696,0.00026076616,0.0001355716,0.00035922116,0.0016731189,0.0019625823,0.0001450386,0.000024067773],"category_scores_gemma":[0.0018422019,0.00012215196,0.00006957413,0.00043515526,0.00015058169,0.002585987,0.0017224803,0.00060689374,0.00000747055],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006513322,0.00019156138,0.0025695255,0.000040148876,0.0000943077,0.000008258701,0.00013900766,0.011031532,0.0000282328,0.0019820693,0.007820287,0.9754437],"study_design_scores_gemma":[0.0013285273,0.00014384216,0.016915523,0.00013224667,0.000007675196,6.031134e-7,0.00009283662,0.966646,0.000023045739,0.00261311,0.011958047,0.00013854008],"about_ca_topic_score_codex":0.00035566505,"about_ca_topic_score_gemma":0.000048045702,"teacher_disagreement_score":0.9753052,"about_ca_system_score_codex":0.000083029314,"about_ca_system_score_gemma":0.0003059286,"threshold_uncertainty_score":0.99936324},"labels":[],"label_agreement":null},{"id":"W4412163888","doi":"10.1158/1557-3265.aimachine-a061","title":"Abstract A061: Machine Learning and Causal Inference-Based Predictive Risk Modeling of Unplanned Radiation Treatment Interruption","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Causal inference; Inference; Machine learning; Artificial intelligence; Computer science; Medicine; Pathology","score_opus":0.22478854432152584,"score_gpt":0.5553079831702357,"score_spread":0.3305194388487098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897045,0.002227548,0.0048041283,0.0013944528,0.00012037866,0.00044097492,0.000032951182,0.000031740008,0.0012433564],"genre_scores_gemma":[0.9938181,0.005539895,0.00007073692,0.00005527794,0.00014272053,0.000056344874,0.000057009558,0.00000964626,0.00025026995],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984273,0.00029831493,0.000485535,0.00029106103,0.00029380337,0.00020404081],"domain_scores_gemma":[0.99832475,0.0010646258,0.00010773601,0.00014345559,0.00024267982,0.00011673457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014340193,0.00009368626,0.00029207818,0.00029348873,0.00012385413,0.000025124664,0.000051423678,0.000102366816,0.00010333822],"category_scores_gemma":[0.0017627664,0.000076244345,0.000074453244,0.0002787511,0.0001423298,0.000083949264,0.00003164941,0.0006595812,0.0000045814886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015472653,0.00018661442,0.6892394,0.000079958096,0.00013794318,0.000003590703,0.00018597874,0.009215896,0.00037916057,0.000020949394,0.000054657638,0.2989486],"study_design_scores_gemma":[0.00315329,0.0009267978,0.22648102,0.00033160934,0.00007940398,2.8055885e-7,0.00013953462,0.7666686,0.0011108341,0.00012942195,0.00092463486,0.00005452981],"about_ca_topic_score_codex":0.001994062,"about_ca_topic_score_gemma":0.00010233612,"teacher_disagreement_score":0.7574527,"about_ca_system_score_codex":0.00025236013,"about_ca_system_score_gemma":0.00062156597,"threshold_uncertainty_score":0.3109154},"labels":[],"label_agreement":null},{"id":"W4412163890","doi":"10.1158/1557-3265.aimachine-ia02","title":"Abstract IA02: Cancer-specific foundation models: Friend or foe in healthcare AI?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Foundation (evidence); Cancer; Medicine; Health care; Intensive care medicine; Internal medicine; Political science","score_opus":0.38100412618073143,"score_gpt":0.569603953917716,"score_spread":0.18859982773698458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92210674,0.0016701147,0.00088589586,0.05585846,0.0007691516,0.0019736975,0.000054133845,0.00006264717,0.01661915],"genre_scores_gemma":[0.9815687,0.012999737,0.00017104311,0.0027956618,0.00020649008,0.00065900054,0.000012382151,0.00003138677,0.0015556337],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99476355,0.0008436936,0.00096610916,0.0012865288,0.0010563917,0.0010837214],"domain_scores_gemma":[0.9974128,0.0013896301,0.00011264957,0.0006564094,0.000060217124,0.00036829477],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060714856,0.00019906895,0.00037343946,0.00018616872,0.00038609828,0.00008721278,0.0005839408,0.00026517065,0.0071070013],"category_scores_gemma":[0.0005308013,0.0001799872,0.00008567282,0.0012303779,0.000825632,0.00049762835,0.0005157893,0.0020697033,0.0007194853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070197636,0.00038001128,0.25577742,0.00014628658,0.000018409453,0.000051416613,0.00038017862,0.0024367513,0.00023737388,0.0008497251,0.010813199,0.7282073],"study_design_scores_gemma":[0.0017574471,0.00019771891,0.8042322,0.00045478562,0.000006306149,6.494233e-7,0.0004233676,0.0050752815,0.0002394519,0.013589528,0.17368747,0.00033581225],"about_ca_topic_score_codex":0.028147023,"about_ca_topic_score_gemma":0.036860622,"teacher_disagreement_score":0.7278715,"about_ca_system_score_codex":0.0026628966,"about_ca_system_score_gemma":0.00068066537,"threshold_uncertainty_score":0.99380064},"labels":[],"label_agreement":null},{"id":"W4412163894","doi":"10.1158/1557-3265.aimachine-a047","title":"Abstract A047: Building clinically relevant and interpretable multi-modal machine learning algorithms to predict glioblastoma disease progression","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Modal; Algorithm; Disease; Medicine; Artificial intelligence; Computer science; Machine learning; Pathology; Cancer research","score_opus":0.06239027585795424,"score_gpt":0.5170713691029938,"score_spread":0.4546810932450395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959562,0.0040058233,0.0078031216,0.025041658,0.00090892764,0.0016346055,0.000023960572,0.00024234477,0.000777534],"genre_scores_gemma":[0.97971773,0.0020059142,0.012866579,0.0016180958,0.0006821675,0.00022330726,0.000014442621,0.00006615958,0.0028055792],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99509704,0.0005911449,0.0012634243,0.0011229549,0.0010198973,0.00090554735],"domain_scores_gemma":[0.99475986,0.0025678151,0.00014969776,0.000542867,0.00044611786,0.0015336149],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008022594,0.0002743098,0.0007461438,0.0004321991,0.00052232883,0.00021445086,0.0004011182,0.00023977847,0.00018043083],"category_scores_gemma":[0.021934567,0.00021507943,0.00022702457,0.000710887,0.0008438971,0.00011913898,0.00084396993,0.0044063893,0.000032128817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048887976,0.000622051,0.4302121,0.0005090846,0.00015133737,0.0003085255,0.000117637435,0.00016787813,0.0014903992,0.00007111881,0.0027630453,0.55869806],"study_design_scores_gemma":[0.006922283,0.002452824,0.48164532,0.0067019323,0.00018524897,0.000016175947,0.00010948914,0.4000973,0.00020548816,0.00037089337,0.100870684,0.00042237315],"about_ca_topic_score_codex":0.00034274306,"about_ca_topic_score_gemma":0.000026770776,"teacher_disagreement_score":0.55827564,"about_ca_system_score_codex":0.00019776807,"about_ca_system_score_gemma":0.0010803872,"threshold_uncertainty_score":0.9978905},"labels":[],"label_agreement":null},{"id":"W4412163898","doi":"10.1158/1557-3265.aimachine-a053","title":"Abstract A053: A pre-operative Artificial Intelligence-based model to estimate the risk of cancer specific mortality in patients with non-metastatic kidney cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Kidney cancer; Medicine; Oncology; Internal medicine","score_opus":0.14283247737582186,"score_gpt":0.565024378943111,"score_spread":0.42219190156728914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98176974,0.0003546661,0.006563743,0.008910077,0.00027046577,0.0016387703,0.00015039311,0.000014870941,0.00032726742],"genre_scores_gemma":[0.99594444,0.0006005647,0.0012622756,0.0012358115,0.00013978181,0.0006008628,0.000015710952,0.00003011316,0.00017042841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634326,0.0003957941,0.001011255,0.00063277665,0.0010415852,0.00057533896],"domain_scores_gemma":[0.9970295,0.0010798444,0.00017612096,0.0005800675,0.00072741206,0.00040707414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003880211,0.00020855905,0.00065823493,0.00026014665,0.0001750412,0.00005431482,0.00040005535,0.00009296354,0.0003495404],"category_scores_gemma":[0.0026033388,0.00012616535,0.00013105762,0.0011072136,0.00084250886,0.000059438542,0.00012728716,0.0021352589,0.0000072411426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026319406,0.0006590131,0.77016217,0.00024359571,0.00021339019,0.000009879508,0.00036844928,0.14488328,0.00006979398,0.000110497785,0.0016285328,0.07901944],"study_design_scores_gemma":[0.00123303,0.00030351104,0.7350753,0.0015378334,0.000109669134,4.4729042e-8,0.00006287784,0.2602105,0.0004232675,0.00059836585,0.0003230977,0.00012249385],"about_ca_topic_score_codex":0.011513234,"about_ca_topic_score_gemma":0.0043826727,"teacher_disagreement_score":0.11532724,"about_ca_system_score_codex":0.00035523705,"about_ca_system_score_gemma":0.0030937253,"threshold_uncertainty_score":0.9950692},"labels":[],"label_agreement":null},{"id":"W4412163899","doi":"10.1158/1557-3265.aimachine-b022","title":"Abstract B022: Prediction of radiotherapy-Induced esophagitis in non-small cell lung cancer using a 3D vision foundation model","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Lung cancer; Esophagitis; Cancer; Foundation (evidence); Internal medicine; Oncology; Disease; Reflux","score_opus":0.1599760508482635,"score_gpt":0.5298609495884697,"score_spread":0.36988489874020625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902202,0.0047415304,0.00051712507,0.0014323541,0.00046039035,0.0014398596,0.000041009003,0.00002004766,0.0011275042],"genre_scores_gemma":[0.9881024,0.009833854,0.0007418613,0.0002010745,0.00029753556,0.00043768127,0.000018753248,0.000029994233,0.00033685748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974534,0.00014851066,0.00083383557,0.0005825329,0.0005698367,0.0004119005],"domain_scores_gemma":[0.99836403,0.0004686572,0.00014336659,0.00042398166,0.00045053684,0.00014944664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015614885,0.00016147947,0.0005235905,0.00037465434,0.000100360114,0.00003400234,0.00014696512,0.00024227463,0.00027708936],"category_scores_gemma":[0.00011112862,0.00014085033,0.00015979286,0.00069870084,0.00013341769,0.00011994812,0.00007305416,0.000697248,0.0000026278224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018583057,0.002096233,0.84903085,0.0015902215,0.000312332,0.00003502629,0.00039000303,0.007192783,0.01864703,0.000034863315,0.0025053923,0.116306975],"study_design_scores_gemma":[0.008606176,0.00061321707,0.6363617,0.0033184788,0.00016734746,6.982469e-7,0.000049758986,0.34175205,0.008640317,0.00010540278,0.0002588013,0.0001259922],"about_ca_topic_score_codex":0.007659121,"about_ca_topic_score_gemma":0.0011025877,"teacher_disagreement_score":0.3345593,"about_ca_system_score_codex":0.0021179446,"about_ca_system_score_gemma":0.002081436,"threshold_uncertainty_score":0.998949},"labels":[],"label_agreement":null},{"id":"W4412163900","doi":"10.1158/1557-3265.aimachine-a033","title":"Abstract A033: Utilizing machine learning algorithms to identify methylation regions predictive of outcome in ICI-treated patients: Insights from the longitudinal RADIOHEAD study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Outcome (game theory); Algorithm; Methylation; Computer science; Machine learning; Medicine; Artificial intelligence; Oncology; Biology; Mathematics; Genetics","score_opus":0.19383250777942687,"score_gpt":0.5438099278505826,"score_spread":0.34997742007115573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010414,0.0011195594,0.00064742356,0.0053228256,0.00036960116,0.0015229578,0.000015619704,0.000039596598,0.00085830496],"genre_scores_gemma":[0.99856514,0.00026541314,0.00013958724,0.00034818304,0.00022513795,0.00012754415,0.000051765903,0.00002698396,0.0002502561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954486,0.0011908885,0.0012644161,0.000661235,0.0010237633,0.00041111303],"domain_scores_gemma":[0.9942407,0.0042546424,0.00018334914,0.0005003074,0.0005918286,0.00022918826],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040580304,0.00018282152,0.0006958163,0.00044372058,0.0002568487,0.000050100527,0.00038715688,0.00014872497,0.00007592671],"category_scores_gemma":[0.011010068,0.00012555048,0.00015994467,0.0014420912,0.00035157969,0.00009998927,0.0002906643,0.0030973284,0.00001151998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008057277,0.0008830065,0.96449184,0.000038899434,0.00021929256,0.000039076385,0.0008513307,0.0003134034,0.00018067744,0.000039956994,0.00058411004,0.031552657],"study_design_scores_gemma":[0.0035457336,0.0006780965,0.9839522,0.0005980695,0.00010587213,3.030767e-7,0.00088213786,0.008471815,0.00007927671,0.0002357466,0.001356934,0.00009379826],"about_ca_topic_score_codex":0.01374831,"about_ca_topic_score_gemma":0.0011679109,"teacher_disagreement_score":0.03145886,"about_ca_system_score_codex":0.00031233337,"about_ca_system_score_gemma":0.00023583205,"threshold_uncertainty_score":0.99920255},"labels":[],"label_agreement":null},{"id":"W4412163902","doi":"10.1158/1557-3265.aimachine-a057","title":"Abstract A057: Multimodal AI Modeling of Clinical Panel-Based Sequencing for HRD Detection in Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Medicine; Computational biology; DNA sequencing; Cancer; Oncology; Artificial intelligence; Bioinformatics; Computer science; Biology; Internal medicine; Genetics; Gene","score_opus":0.8227929207050889,"score_gpt":0.7389504298564317,"score_spread":0.08384249084865725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713337,0.0005680334,0.010855456,0.008625088,0.004032823,0.0036867463,0.00011580192,0.000064081876,0.0007183134],"genre_scores_gemma":[0.99322975,0.0005529781,0.0005587384,0.001572035,0.0014043201,0.0023395198,0.000009615035,0.000046444402,0.00028662267],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98992085,0.0027819453,0.004395822,0.00095093047,0.00067431835,0.0012761253],"domain_scores_gemma":[0.97918653,0.016765077,0.0004292845,0.0006889202,0.0025932102,0.00033696904],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.022787314,0.00020730114,0.0009507424,0.00046551955,0.00075408386,0.000016534714,0.0005816493,0.0011336,0.00043775962],"category_scores_gemma":[0.016057026,0.0001956571,0.00033523436,0.0010326862,0.00045920387,0.00014363216,0.00020300514,0.0052940035,0.00003980601],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050886585,0.00032116464,0.68377656,0.0025886686,0.00006650944,0.000008994976,0.0007146007,0.036058664,0.0009830979,0.00041611426,0.00057013764,0.26940683],"study_design_scores_gemma":[0.0019236511,0.0003075368,0.053680338,0.0030564836,0.000024237244,4.9387392e-8,0.0027159895,0.9296697,0.0016879289,0.005019842,0.0016841767,0.00023008343],"about_ca_topic_score_codex":0.08267331,"about_ca_topic_score_gemma":0.12074105,"teacher_disagreement_score":0.893611,"about_ca_system_score_codex":0.0013314231,"about_ca_system_score_gemma":0.011774606,"threshold_uncertainty_score":0.9970008},"labels":[],"label_agreement":null},{"id":"W4412163903","doi":"10.1158/1557-3265.aimachine-b021","title":"Abstract B021: Current oncological large language model research lacks reproducibility, transparency, and long term support","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Transparency (behavior); Current (fluid); Reproducibility; Medicine; Medical physics; Computer science; Intensive care medicine; Engineering; Computer security; Physics; Statistics; Mathematics","score_opus":0.32363014499013987,"score_gpt":0.6342184687243343,"score_spread":0.3105883237341944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96332675,0.0059586004,0.00044857597,0.01952666,0.0004183912,0.0010004109,0.000030015042,0.00008097636,0.00920963],"genre_scores_gemma":[0.98851573,0.00602894,0.00023047246,0.00062841957,0.000704245,0.00015340622,0.00004113916,0.000029309263,0.0036683264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937121,0.00088784425,0.0009747993,0.0018248324,0.0014332779,0.0011671471],"domain_scores_gemma":[0.9950653,0.0021405036,0.000063573425,0.001456465,0.0006146875,0.000659476],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.036391594,0.0001915523,0.00067989674,0.0003564801,0.00039573587,0.00010244959,0.00047809663,0.00029976867,0.00082201627],"category_scores_gemma":[0.012008223,0.00014713683,0.00019172509,0.00073268014,0.0015188279,0.00008502289,0.00056163745,0.006372513,0.00004342965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087884703,0.0014661558,0.6020816,0.0010245469,0.000081519094,0.00033150287,0.00053200434,0.000014282582,0.0008759151,0.0006410839,0.029064557,0.36300796],"study_design_scores_gemma":[0.0040654815,0.0006713966,0.9637918,0.0010349018,0.00006998303,0.000013469951,0.0002376131,0.008478228,0.00022838227,0.0020516792,0.019125419,0.00023163554],"about_ca_topic_score_codex":0.00021876582,"about_ca_topic_score_gemma":0.00017108505,"teacher_disagreement_score":0.36277634,"about_ca_system_score_codex":0.000287071,"about_ca_system_score_gemma":0.0018129417,"threshold_uncertainty_score":0.99631405},"labels":[],"label_agreement":null},{"id":"W4412163904","doi":"10.1158/1557-3265.aimachine-a059","title":"Abstract A059: CP-Fuse: A Comprehensive Assessment of Clinico-Pathological Fusion in TCGA Survival Prediction","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Jewish General Hospital; Q & T Research; McGill University","funders":"","keywords":"Pathological; Medicine; Oncology; Fuse (electrical); Internal medicine; Engineering","score_opus":0.40194063977625666,"score_gpt":0.6448293611972163,"score_spread":0.24288872142095969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725949,0.00026162626,0.00090294174,0.016260449,0.00031536745,0.0011690827,0.00004430401,0.000091381546,0.008359905],"genre_scores_gemma":[0.99184424,0.0035276052,0.0029585967,0.00057825533,0.00024017779,0.00035439382,0.000039687347,0.000012850332,0.00044416825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657655,0.0004492044,0.0012175159,0.0005539341,0.0008166303,0.00038616452],"domain_scores_gemma":[0.9960907,0.0023265746,0.00012455668,0.0005943744,0.0006371706,0.00022661893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004627888,0.00012303091,0.00061530794,0.0002574695,0.000085409985,0.000015437005,0.00027655903,0.00031946893,0.00054917036],"category_scores_gemma":[0.0015812558,0.00009677757,0.00015292791,0.0008398491,0.0008092451,0.00003910454,0.0002979978,0.002050941,0.000011193744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070579455,0.002851537,0.8664684,0.0005013212,0.00006081316,0.00007702088,0.000031705877,0.000008668023,0.021533404,0.0040526823,0.03748315,0.06622549],"study_design_scores_gemma":[0.001821495,0.0004986718,0.9722048,0.00074739376,0.00002689736,0.0000014371125,0.000083494655,0.0014657286,0.00043703945,0.0014076752,0.02123655,0.000068840294],"about_ca_topic_score_codex":0.00037265953,"about_ca_topic_score_gemma":0.000036703794,"teacher_disagreement_score":0.10573636,"about_ca_system_score_codex":0.0001846671,"about_ca_system_score_gemma":0.00089235115,"threshold_uncertainty_score":0.8910433},"labels":[],"label_agreement":null},{"id":"W4412163905","doi":"10.1158/1557-3265.aimachine-a012","title":"Abstract A012: AI-assisted Design of Novel NRF2Mut Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Computational biology; Pharmacology; Biology","score_opus":0.5758945951923626,"score_gpt":0.5891812392391099,"score_spread":0.013286644046747287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708375,0.0012050401,0.0007462048,0.0042471476,0.00035059574,0.00033667334,0.000046254776,0.000062563515,0.022168053],"genre_scores_gemma":[0.9974465,0.0004123995,0.00029988945,0.00018529671,0.00032121158,0.00010003801,0.0000075626467,0.00000961981,0.001217502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757266,0.00021166303,0.00081681565,0.0004334645,0.0006161664,0.00034925176],"domain_scores_gemma":[0.9945508,0.004266256,0.00012035855,0.00037891953,0.0005733911,0.00011023346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005062402,0.000111170746,0.0003407675,0.00008423047,0.000103745246,0.00003312763,0.00039442,0.00037925935,0.0030254992],"category_scores_gemma":[0.005819605,0.00008096756,0.00017283151,0.0004120297,0.0004650093,0.00004354776,0.00016059783,0.00077086315,0.000031373693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010354463,0.0014478377,0.03610616,0.00033396797,0.00014852209,0.0000039882298,0.000020176083,0.00011976719,0.6163366,0.00039386793,0.021445023,0.32260862],"study_design_scores_gemma":[0.004057577,0.00032379752,0.39354274,0.0016565174,0.00007805675,8.229902e-7,0.00023289051,0.0035558385,0.563603,0.0026169003,0.029888572,0.0004433211],"about_ca_topic_score_codex":0.00025162398,"about_ca_topic_score_gemma":0.000027472432,"teacher_disagreement_score":0.35743657,"about_ca_system_score_codex":0.00013610919,"about_ca_system_score_gemma":0.00061441446,"threshold_uncertainty_score":0.9978859},"labels":[],"label_agreement":null},{"id":"W4412163909","doi":"10.1158/1557-3265.aimachine-a041","title":"Abstract A041: A Hybrid Active Learning (AL) Random Forest Model with KNN Imputation to Predict Recurrence in Ductal Carcinoma In Situ (DCIS) of the Breast","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ductal carcinoma; In situ; Random forest; Medicine; Carcinoma in situ; Oncology; Breast cancer; Carcinoma; Internal medicine; Artificial intelligence; Cancer; Computer science; Chemistry","score_opus":0.07290023780787054,"score_gpt":0.4324860707928705,"score_spread":0.35958583298499996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97019655,0.00008377329,0.024573509,0.0032032845,0.0002818932,0.0009061018,0.00001193873,0.000025350993,0.000717594],"genre_scores_gemma":[0.9989345,0.00007638297,0.00046916216,0.000098998775,0.000059766677,0.00028130118,0.000001298529,0.000011099336,0.000067501875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677724,0.0005761381,0.00063233334,0.00071957207,0.00081978814,0.00047492207],"domain_scores_gemma":[0.9974852,0.0012959889,0.0001520994,0.00052854064,0.00043158807,0.00010658243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031364427,0.00013924837,0.00032338887,0.0003722018,0.0001288304,0.000069403126,0.0010543946,0.0000869447,0.000005003231],"category_scores_gemma":[0.0008391233,0.00010556809,0.00008469812,0.002049868,0.00028946815,0.00040871475,0.00056913367,0.0016026127,0.000003820169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052578896,0.00028404815,0.44918314,0.00012470786,0.000035228506,0.00003305126,0.0014196474,0.29537818,0.00080550025,0.00047562586,0.0006960539,0.24630694],"study_design_scores_gemma":[0.0024718344,0.00027364757,0.70149827,0.0004982045,0.0000039749716,0.000006582507,0.00010559052,0.29176947,0.0013703838,0.001832836,0.00005329516,0.00011586893],"about_ca_topic_score_codex":0.0018303175,"about_ca_topic_score_gemma":0.0059831277,"teacher_disagreement_score":0.25231516,"about_ca_system_score_codex":0.0006436812,"about_ca_system_score_gemma":0.0017418239,"threshold_uncertainty_score":0.6962644},"labels":[],"label_agreement":null},{"id":"W4412163913","doi":"10.1158/1557-3265.aimachine-a039","title":"Abstract A039: Pediatric pan-cancer characterization of transposable elements and their modulation by germline <i>TP53</i> variants","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Germline; Transposable element; Cancer; Biology; Genetics; Cancer research; Medicine; Computational biology; Genome; Gene","score_opus":0.04704075578717955,"score_gpt":0.3958971033129096,"score_spread":0.3488563475257301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968435,0.0011803195,0.00030710615,0.000489798,0.00016715852,0.0002528658,0.00049146335,0.0000047837248,0.0002629839],"genre_scores_gemma":[0.98730487,0.010702372,0.000033658656,0.00011209228,0.0002908886,0.000083318184,0.0003027091,0.000011106073,0.0011589801],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998693,0.00012263705,0.00050127564,0.0003164179,0.00013893853,0.00022774364],"domain_scores_gemma":[0.9993209,0.000058991245,0.000109145105,0.00020502308,0.00024946334,0.00005647957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008092951,0.00009885351,0.00017679748,0.00005898054,0.00010477016,0.000024906569,0.00015199083,0.00015972619,0.00012133864],"category_scores_gemma":[0.00006115384,0.000086371234,0.00005825181,0.00019219037,0.00009669753,0.000011031272,0.00007574405,0.00016629431,0.0000017223354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027678677,0.00023518087,0.30850455,0.00019758652,0.00009952442,2.9068804e-7,0.00005936864,0.000022602468,0.66951275,0.00010507243,0.0012810959,0.019705174],"study_design_scores_gemma":[0.0018379752,0.00027920248,0.8645667,0.00006853134,0.00004244444,3.7361434e-7,0.000070749826,0.0006621809,0.112344645,0.000391059,0.019513039,0.00022313763],"about_ca_topic_score_codex":0.00010316583,"about_ca_topic_score_gemma":0.000049433565,"teacher_disagreement_score":0.5571681,"about_ca_system_score_codex":0.000020401198,"about_ca_system_score_gemma":0.000249336,"threshold_uncertainty_score":0.35221168},"labels":[],"label_agreement":null},{"id":"W4412163914","doi":"10.1158/1557-3265.aimachine-b035","title":"Abstract B035: Deep learning-based spatially resolved immune clustering in the tumor microenvironment predicts distant metastasis risk in high-grade prostate cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Tumor microenvironment; Metastasis; Cancer; Immune system; Medicine; Distant metastasis; Oncology; Internal medicine; Immunology","score_opus":0.048547004041495964,"score_gpt":0.4292443246157977,"score_spread":0.3806973205743017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657522,0.0071288333,0.0006189694,0.024379892,0.00038872502,0.0014723615,0.00002601343,0.000036983834,0.00019602236],"genre_scores_gemma":[0.9905752,0.006636111,0.00045063984,0.0011257436,0.00022188261,0.0006382367,0.00003555968,0.00004610398,0.00027055413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942633,0.0016317336,0.001293785,0.0007887211,0.0010804932,0.00094199274],"domain_scores_gemma":[0.9965251,0.0022901753,0.00022968034,0.00062895246,0.00009861481,0.00022744334],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01079747,0.0002572051,0.0007319405,0.00038993236,0.00025537665,0.00009981289,0.00055806775,0.00013683237,0.0002515143],"category_scores_gemma":[0.0036641178,0.00018154678,0.0001962024,0.0008833032,0.0007376101,0.000063174455,0.00025795566,0.00523828,0.000011697373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026984042,0.0010253323,0.8072123,0.0005897453,0.0001634858,0.00065265363,0.0006721096,0.046957795,0.0016285286,0.000017334658,0.0005533287,0.13782899],"study_design_scores_gemma":[0.0067832316,0.0003305714,0.91299677,0.0014725183,0.000089356065,0.0000021199855,0.0003241201,0.06267952,0.0002836332,0.0001317038,0.014728632,0.00017782736],"about_ca_topic_score_codex":0.01653649,"about_ca_topic_score_gemma":0.0051720906,"teacher_disagreement_score":0.13765118,"about_ca_system_score_codex":0.0006630915,"about_ca_system_score_gemma":0.0007491802,"threshold_uncertainty_score":0.99705666},"labels":[],"label_agreement":null},{"id":"W4412163915","doi":"10.1158/1557-3265.aimachine-b047","title":"Abstract B047: Path2Space: An AI approach for cancer biomarker discovery via histopathology inferred spatial transcriptomics","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Histopathology; Transcriptome; Biomarker; Biomarker discovery; Medicine; Computational biology; Pathology; Biology; Internal medicine; Gene; Proteomics; Genetics; Gene expression","score_opus":0.15510649728027157,"score_gpt":0.481690051543773,"score_spread":0.3265835542635014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85250807,0.0038371067,0.13642798,0.0020940988,0.0022068294,0.0013243268,0.00046653382,0.000039929473,0.0010951099],"genre_scores_gemma":[0.9917647,0.0019839124,0.0007184203,0.0013475815,0.0010341053,0.00073730835,0.00043746247,0.00006439729,0.0019121175],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965814,0.00040515754,0.00075092487,0.001132046,0.00032281858,0.0008076618],"domain_scores_gemma":[0.99826086,0.00016936485,0.00009700607,0.0007299684,0.00049849437,0.00024430393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020419068,0.00029536255,0.00050470146,0.00015881508,0.0002942207,0.00011669426,0.0006686549,0.00072004844,0.000050884468],"category_scores_gemma":[0.00031192935,0.0002754729,0.00037539142,0.00026811572,0.00076407916,0.000027020862,0.00012481786,0.00078099506,0.000002440829],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006662031,0.0015479611,0.054282263,0.00039540374,0.0002296278,0.000009308009,0.00011691676,0.00023781158,0.7817091,0.00022998828,0.0113422405,0.14323735],"study_design_scores_gemma":[0.01833038,0.00411971,0.33988464,0.000302845,0.00039641655,0.000010943473,0.0003847645,0.020802643,0.14469355,0.0026746853,0.4659781,0.0024213288],"about_ca_topic_score_codex":0.002265776,"about_ca_topic_score_gemma":0.0032346253,"teacher_disagreement_score":0.6370155,"about_ca_system_score_codex":0.00013654902,"about_ca_system_score_gemma":0.0012877458,"threshold_uncertainty_score":0.9999697},"labels":[],"label_agreement":null},{"id":"W4412203029","doi":"10.1158/1078-0432.ccr-25-0100","title":"Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; EMD Serono; MacroGenics; Regeneron Pharmaceuticals; Belfer Center for Science and International Affairs, Harvard University; Seagen; Gilead Sciences; AstraZeneca; Pfizer; Coherus Biosciences; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Tolerability; Combination therapy; Rash; Internal medicine; Adverse effect; Pharmacodynamics; Cetuximab; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Phases of clinical research; Oncology; Gastroenterology; Pharmacology; Cancer; Clinical trial; Immunotherapy","score_opus":0.16525816706271146,"score_gpt":0.5464717634505963,"score_spread":0.3812135963878849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412203029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98436165,0.0008838586,0.000034480392,0.00862966,0.00039308993,0.004925351,0.000036973237,0.000013024122,0.0007219206],"genre_scores_gemma":[0.9947946,0.0007696279,0.000121884936,0.00018153373,0.0002305065,0.0017724369,0.000015520554,0.000015252964,0.0020986132],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99718857,0.00040839546,0.00095247565,0.0005249653,0.00059086306,0.00033470843],"domain_scores_gemma":[0.9971527,0.0016194889,0.0001753278,0.00031209877,0.0006318677,0.00010850677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002445466,0.00014862142,0.00071224436,0.00015740386,0.00022365195,0.00001707373,0.00013440449,0.00014169967,0.00004631164],"category_scores_gemma":[0.0021631299,0.000089099936,0.00017680501,0.0006041204,0.00076244655,0.00005935908,0.00017605111,0.00067667913,8.836713e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72366923,0.007612883,0.034796193,0.0003536288,0.00030088885,0.000012675501,0.00010145365,0.000008997707,0.00046900398,0.00045289233,0.001832404,0.23038976],"study_design_scores_gemma":[0.6852571,0.050823636,0.24316123,0.001863689,0.00021721079,0.0000037272084,0.00037136974,0.0009461134,0.0019256946,0.0020746111,0.013132197,0.00022345566],"about_ca_topic_score_codex":0.0002314964,"about_ca_topic_score_gemma":0.0010987398,"teacher_disagreement_score":0.2301663,"about_ca_system_score_codex":0.00023880789,"about_ca_system_score_gemma":0.0012169569,"threshold_uncertainty_score":0.36333898},"labels":[],"label_agreement":null},{"id":"W4412430993","doi":"10.1158/1078-0432.ccr-24-3726","title":"Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"René Vogels Stichting; Deutsche Forschungsgemeinschaft","keywords":"Bladder cancer; Cystectomy; Medicine; Neoadjuvant therapy; Oncology; Gene expression profiling; Pathology; Internal medicine; Cancer; Gene expression; Biology; Gene; Breast cancer","score_opus":0.08110261616488323,"score_gpt":0.4377643613611631,"score_spread":0.35666174519627986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412430993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867806,0.005271935,0.00005156117,0.003923527,0.000370346,0.0025923157,0.00027861143,0.00005109154,0.0006800219],"genre_scores_gemma":[0.98198354,0.008652049,0.000072537325,0.0010593559,0.00023508274,0.0036465318,0.00007118049,0.00006149957,0.0042182403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652016,0.00041924143,0.0007219726,0.0007799617,0.00094742,0.0006112719],"domain_scores_gemma":[0.9978386,0.00017541517,0.00012953918,0.00055382494,0.001093743,0.00020885783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007673188,0.00027128353,0.00070282124,0.0002983117,0.00013424204,0.0000642134,0.00024956104,0.00023118794,0.0012592154],"category_scores_gemma":[0.00008473275,0.00019797066,0.00021553553,0.0009363357,0.0006532813,0.00016516529,0.00007107061,0.00065639295,0.000015474661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022779653,0.0025909252,0.45510858,0.0014431629,0.0031556927,0.0002680368,0.0015991133,0.000012154372,0.41521072,0.000055515513,0.0048146346,0.092961825],"study_design_scores_gemma":[0.00913011,0.002221597,0.61395395,0.002203074,0.00044293297,0.000002949517,0.00028627933,0.000039206174,0.36607087,0.00009670078,0.005254238,0.0002980869],"about_ca_topic_score_codex":0.0016206013,"about_ca_topic_score_gemma":0.0007832855,"teacher_disagreement_score":0.1588454,"about_ca_system_score_codex":0.00021041239,"about_ca_system_score_gemma":0.0028539216,"threshold_uncertainty_score":0.99965376},"labels":[],"label_agreement":null},{"id":"W4412629665","doi":"10.1158/1078-0432.ccr-25-1248","title":"Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response–Deficient Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; Astellas Pharma; Seagen; Eisai; MacroGenics; AstraZeneca; National Cancer Institute; Novocure; Revolution Medicines; Pfizer; Amgen","keywords":"Liquid biopsy; Population; Cancer research; DNA repair; Context (archaeology); Epigenomics; Medicine; Biology; Cancer; Internal medicine; Gene; DNA methylation; Genetics","score_opus":0.09597505638137298,"score_gpt":0.4711381872705757,"score_spread":0.3751631308892027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412629665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932286,0.0019063296,0.00001091929,0.0023688797,0.0001800149,0.0015907341,0.000180093,0.000053333602,0.0004810797],"genre_scores_gemma":[0.9974789,0.0005834338,0.0002867341,0.0005727093,0.000121055906,0.00033846646,0.00006168532,0.000042626874,0.0005143937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960893,0.00097387127,0.0008428198,0.0008718139,0.00059012504,0.0006320827],"domain_scores_gemma":[0.9969214,0.0016620876,0.00010895601,0.0006321448,0.00041848057,0.00025689145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002815992,0.0002187022,0.0006126329,0.00053702644,0.00016951692,0.000052725463,0.00022804666,0.00019644076,0.00018243652],"category_scores_gemma":[0.0007711578,0.00017905259,0.00007370725,0.0009504997,0.0008893161,0.00007453385,0.00020187478,0.0010913577,0.000027054033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06336034,0.00046394402,0.9097244,0.00009554736,0.000098604956,0.00005265391,0.0003680201,0.00002412436,0.023601333,0.000036697926,0.0003614587,0.0018128356],"study_design_scores_gemma":[0.008669337,0.0020586825,0.96966916,0.0011465268,0.00002762146,6.943924e-7,0.0002801873,0.00012732498,0.016406212,0.00013795696,0.0012997409,0.00017656153],"about_ca_topic_score_codex":0.0013519771,"about_ca_topic_score_gemma":0.0003665736,"teacher_disagreement_score":0.059944715,"about_ca_system_score_codex":0.0009086639,"about_ca_system_score_gemma":0.0016477744,"threshold_uncertainty_score":0.7301552},"labels":[],"label_agreement":null},{"id":"W4412789893","doi":"10.1158/1078-0432.ccr-25-0112","title":"Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; American Cancer Society; U.S. Department of Veterans Affairs; National Institute of Dental and Craniofacial Research; Cancer Prevention and Research Institute of Texas","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Radioresistance; Haploinsufficiency; Carcinogenesis; Gene knockdown; Cancer; Biology; Tumor progression; Radiation therapy; Head and neck cancer; Medicine; Pathology; Cell culture; Internal medicine; Phenotype","score_opus":0.05149188685661864,"score_gpt":0.428044041155628,"score_spread":0.37655215429900935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412789893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990075,0.008000485,0.000020729909,0.00045916653,0.000057708203,0.00029630217,0.00002789424,0.0000022802649,0.001060469],"genre_scores_gemma":[0.99536407,0.0032871065,0.00023924549,0.00013600502,0.00007906213,0.00003540912,0.000019057941,0.000010817317,0.00082922535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99857336,0.00032762304,0.00033367213,0.00040028204,0.00013116973,0.00023388375],"domain_scores_gemma":[0.9990566,0.00027764155,0.00006743236,0.00032080724,0.00020453676,0.00007301684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064614107,0.00010170242,0.00024715933,0.00007946956,0.000071379814,0.000019409938,0.00018219353,0.00015458696,0.000017579907],"category_scores_gemma":[0.0004888182,0.00010017804,0.000043517543,0.00015925999,0.00050117343,0.0000068903596,0.00016490468,0.00034732456,4.5378394e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014765168,0.00017787742,0.31105384,0.00015058923,0.000013694245,0.0000025847135,0.00008689827,0.0000030062565,0.68517643,0.00005824727,0.000935337,0.0008649453],"study_design_scores_gemma":[0.0025267508,0.0002792989,0.506112,0.00005075816,0.0000048577344,4.0236947e-7,0.00010990856,0.000021901566,0.48501563,0.00036402652,0.005414015,0.000100449186],"about_ca_topic_score_codex":0.00068102917,"about_ca_topic_score_gemma":0.0005049025,"teacher_disagreement_score":0.2001608,"about_ca_system_score_codex":0.00003228107,"about_ca_system_score_gemma":0.000256873,"threshold_uncertainty_score":0.40851417},"labels":[],"label_agreement":null},{"id":"W4413111570","doi":"10.1158/1078-0432.ccr-22-3683","title":"Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Foundation Medicine; Puma Biotechnology; Bristol-Myers Squibb; Prostate Cancer Foundation","keywords":"Prostate cancer; Castration; Androgen; Cancer; Medicine; Prostate; Internal medicine; Oncology; Endocrinology; Biology; Hormone","score_opus":0.20686718664398343,"score_gpt":0.5004136707466903,"score_spread":0.2935464841027069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98757285,0.003138082,0.000014662669,0.007024566,0.000086978216,0.0017968476,0.00009640504,0.0000330946,0.00023652027],"genre_scores_gemma":[0.99527824,0.0014356839,0.00026067373,0.0006285721,0.00020337821,0.00076744513,0.000057916575,0.0000283853,0.0013396906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656117,0.0005191895,0.0006672225,0.00079403183,0.00080408616,0.0006542707],"domain_scores_gemma":[0.9978777,0.00046971458,0.00006499089,0.00028885066,0.0007952842,0.00050341536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025842325,0.00018949588,0.00042705607,0.000588519,0.00028189726,0.00015038949,0.00011161019,0.00018776061,0.00021203276],"category_scores_gemma":[0.00036052478,0.0001651253,0.00008438547,0.0012644322,0.00029199934,0.00023802891,0.00010260705,0.0007884813,0.000011898113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023180455,0.0009638253,0.6835279,0.00091598165,0.00035062656,0.0003993392,0.009273487,0.0003310755,0.20154865,0.00017144415,0.0014427619,0.07789447],"study_design_scores_gemma":[0.027078858,0.0072774794,0.7550913,0.0075077503,0.0003279105,0.000007057903,0.0105317095,0.0053918744,0.18050411,0.0019840128,0.0033328936,0.0009650067],"about_ca_topic_score_codex":0.012527831,"about_ca_topic_score_gemma":0.0036052938,"teacher_disagreement_score":0.076929465,"about_ca_system_score_codex":0.0006493621,"about_ca_system_score_gemma":0.0019130326,"threshold_uncertainty_score":0.9940478},"labels":[],"label_agreement":null},{"id":"W4413114152","doi":"10.1158/1078-0432.ccr-25-0570","title":"Adapting Laser Interstitial Thermal Therapy for the Treatment of Naturally Occurring Intracranial Tumors in Dogs","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Veterinary Orthopedics and Neurology","field":"Veterinary","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational and Environmental Medical Association of Canada","funders":"National Institute of General Medical Sciences; Cancer Research Institute","keywords":"Medicine; Laser therapy; Pathology; Laser; Optics","score_opus":0.3488139768996327,"score_gpt":0.5629243383002953,"score_spread":0.21411036140066259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412,0.0013519237,0.00003467909,0.002342001,0.0008349682,0.0009081767,0.000033500266,0.000015814836,0.000358955],"genre_scores_gemma":[0.99677527,0.0016411688,0.00005077932,0.0004182444,0.0005471227,0.00040475914,0.0000025193067,0.000018309453,0.00014183456],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99775374,0.0005530532,0.0006165283,0.00039869963,0.00022115141,0.00045685488],"domain_scores_gemma":[0.99561393,0.0037784956,0.00007721308,0.00032942442,0.00014653405,0.00005437295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017832731,0.00013646508,0.00034877585,0.0001422874,0.00015482736,0.000026850532,0.00041376686,0.00013506497,0.0001588617],"category_scores_gemma":[0.00028518666,0.00008711961,0.00021540919,0.00026961582,0.00040029248,0.000052737334,0.00014027326,0.000564089,0.0000042658567],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06877108,0.0017929855,0.12669392,0.00011507532,0.00034076272,0.0006673118,0.0011518319,0.00017743869,0.0072620087,0.00067478936,0.00074554916,0.79160726],"study_design_scores_gemma":[0.029223086,0.08922008,0.6169805,0.00066408503,0.00008354242,0.000071837254,0.00084528234,0.024317477,0.001856141,0.0012696465,0.23473215,0.0007361677],"about_ca_topic_score_codex":0.0010199909,"about_ca_topic_score_gemma":0.0005315418,"teacher_disagreement_score":0.7908711,"about_ca_system_score_codex":0.000087464316,"about_ca_system_score_gemma":0.0002618036,"threshold_uncertainty_score":0.35526344},"labels":[],"label_agreement":null},{"id":"W4413787387","doi":"10.1158/1078-0432.ccr-25-1648","title":"A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"BeiGene; Merck KGaA; American Association for Cancer Research; AstraZeneca; GlaxoSmithKline; Amgen","keywords":"Medicine; Adverse effect; Pharmacokinetics; Rash; Tolerability; Maculopapular rash; Toxicity; Pharmacodynamics; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pharmacology; Anemia; Mucositis; Gastroenterology; Phases of clinical research","score_opus":0.03361998146685217,"score_gpt":0.4489923089937287,"score_spread":0.41537232752687653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413787387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983923,0.00029369156,0.000005802146,0.00010957025,0.00005731541,0.0009171374,0.000007691571,0.0000032538937,0.00021323659],"genre_scores_gemma":[0.99888736,0.0002861709,0.000025152754,0.00010808746,0.000047151847,0.00019353288,0.000014771148,0.000017465392,0.00042031982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981921,0.00023632275,0.0005299661,0.0004696617,0.00024333422,0.00032861897],"domain_scores_gemma":[0.9991359,0.000072452254,0.0000683116,0.0004281609,0.00023254275,0.00006264662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006931979,0.000114683186,0.00030099208,0.00013438311,0.00005609482,0.000011738627,0.0002944176,0.00013272466,0.000020045552],"category_scores_gemma":[0.0001744494,0.000097697724,0.000050668805,0.00037609952,0.00014963953,0.000004764688,0.00017105395,0.00036820417,0.0000020864004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027231635,0.0026728723,0.9821802,0.000043005624,0.00005453696,0.000005021185,0.00012997189,0.00024252494,0.008473535,0.000017265205,0.00028641018,0.00317151],"study_design_scores_gemma":[0.015818397,0.008869922,0.95289326,0.00034336725,0.00000877635,9.288077e-8,0.00041824175,0.00006346687,0.018383916,0.00013345382,0.0028429513,0.00022417061],"about_ca_topic_score_codex":0.00059186306,"about_ca_topic_score_gemma":0.01080148,"teacher_disagreement_score":0.029286938,"about_ca_system_score_codex":0.000054303146,"about_ca_system_score_gemma":0.0002556289,"threshold_uncertainty_score":0.602748},"labels":[],"label_agreement":null},{"id":"W4413836422","doi":"10.1158/1078-0432.ccr-24-4342","title":"Phase I Dose-Escalation Trial Combining Olaparib and Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca; AstraZeneca United States","keywords":"Medicine; Olaparib; Pneumonitis; Esophagitis; Internal medicine; PARP inhibitor; Radiation therapy; Adverse effect; Oncology; Gastroenterology; Urology; Surgery; Lung","score_opus":0.24740009084507647,"score_gpt":0.6157291510270154,"score_spread":0.36832906018193895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413836422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9470594,0.037042014,0.00011511983,0.009017634,0.00069785095,0.003530904,0.00003631414,0.000057750072,0.002443046],"genre_scores_gemma":[0.94575197,0.040737648,0.00024623467,0.00097411365,0.0009505015,0.001510409,0.000015498692,0.00005463661,0.009758992],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99504185,0.0011105543,0.0009754031,0.00096732494,0.0009291913,0.0009757019],"domain_scores_gemma":[0.99549794,0.002680317,0.00012351248,0.00057813706,0.0007490226,0.00037105536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056139217,0.00025733048,0.000953775,0.00059307157,0.00029545152,0.00010631296,0.0002865195,0.0002875585,0.0003332634],"category_scores_gemma":[0.0019069647,0.00021900069,0.00016462317,0.0013673801,0.00083765766,0.00012893512,0.00032646727,0.0022545182,0.000005391243],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24912624,0.0044181803,0.42327768,0.003051891,0.00078690157,0.00033824318,0.0017217795,0.00007726102,0.0059198933,0.00035840322,0.028132603,0.28279093],"study_design_scores_gemma":[0.6421677,0.011136361,0.22182874,0.0054834257,0.00041970256,0.0000040896134,0.0017393931,0.03153638,0.004648794,0.00055454747,0.07943371,0.0010471819],"about_ca_topic_score_codex":0.0026438008,"about_ca_topic_score_gemma":0.001248759,"teacher_disagreement_score":0.39304143,"about_ca_system_score_codex":0.0010538263,"about_ca_system_score_gemma":0.0022825722,"threshold_uncertainty_score":0.9794885},"labels":[],"label_agreement":null},{"id":"W4413984867","doi":"10.1158/1078-0432.ccr-25-1796","title":"Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Università degli Studi di Padova; Ministero della Salute; Gilead Sciences","keywords":"Medicine; Breast cancer; Internal medicine; Retrospective cohort study; Cohort; Metastatic breast cancer; Oncology; Metastasis; Prospective cohort study; Cohort study; Gastroenterology; Cancer","score_opus":0.10126012981366476,"score_gpt":0.463870641970623,"score_spread":0.3626105121569582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413984867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552513,0.0053840885,0.0000066854545,0.00610777,0.00026623323,0.0010785119,0.0015414677,0.0000061277274,0.00008398224],"genre_scores_gemma":[0.9686922,0.029750966,0.000054659682,0.00026328122,0.0003380044,0.00072583125,0.000071955685,0.000010074939,0.00009305713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974782,0.00072813855,0.00063711085,0.0006224229,0.00022651577,0.00030763095],"domain_scores_gemma":[0.9978196,0.0013029212,0.00014661861,0.0003452695,0.00029643334,0.00008916173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001709769,0.0001596691,0.00051580864,0.0000388366,0.00015350153,0.00003566807,0.00022156078,0.00013724854,0.000024002584],"category_scores_gemma":[0.001141137,0.00009546012,0.00011378104,0.00014352711,0.0018511215,0.000003965235,0.00051058,0.0003041675,0.0000010534159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1980503,0.0006467611,0.70116955,0.00008321511,0.0019330586,0.0000053033023,0.00013158431,5.829803e-7,0.000852381,0.00011041095,0.0015444431,0.09547242],"study_design_scores_gemma":[0.05728486,0.0003698945,0.93803185,0.00017928595,0.00023088412,0.0000012041004,0.00011243657,0.000055107867,0.0009062539,0.00018910001,0.0025074205,0.00013170984],"about_ca_topic_score_codex":0.0025343471,"about_ca_topic_score_gemma":0.00045248636,"teacher_disagreement_score":0.2368623,"about_ca_system_score_codex":0.000036565838,"about_ca_system_score_gemma":0.0002692496,"threshold_uncertainty_score":0.68205345},"labels":[],"label_agreement":null},{"id":"W4414162081","doi":"10.1158/1078-0432.ccr-25-1513","title":"Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Immunocore; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Adverse effect; Incidence (geometry); Pooled analysis; Clinical trial; Cancer; MEDLINE","score_opus":0.08419773544247613,"score_gpt":0.49156527494688634,"score_spread":0.4073675395044102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414162081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975968,0.00032265257,0.000008084193,0.0002274352,0.000033650387,0.00097277004,0.00007488518,0.000004482243,0.0007592503],"genre_scores_gemma":[0.9974427,0.0011979535,0.00017246962,0.000034665332,0.0000030480862,0.00011590648,0.00008862602,0.000006308103,0.00093829964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977376,0.00055062963,0.0006465066,0.00034944544,0.00046587107,0.00024998296],"domain_scores_gemma":[0.99849594,0.0007099885,0.00015356377,0.00027850975,0.0002637939,0.00009818773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001198702,0.000115297866,0.0007921354,0.0004680552,0.00004581159,0.0000010306272,0.00009048118,0.00008554992,0.00009272986],"category_scores_gemma":[0.0002145775,0.000080694685,0.0001395401,0.001569915,0.00028428508,0.000035780322,0.0001078386,0.00020017957,0.000001718099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031278566,0.003275004,0.97317195,0.000115462484,0.01066606,0.00010873178,0.000077608565,0.00003211281,0.000003063207,0.00006052152,0.0000122862475,0.009349365],"study_design_scores_gemma":[0.012085612,0.0021085148,0.9803224,0.00045628546,0.0044547645,1.3127838e-7,0.00014751217,0.00020245707,0.00006903367,0.000057243782,0.00004830524,0.000047729416],"about_ca_topic_score_codex":0.0010699055,"about_ca_topic_score_gemma":0.003797422,"teacher_disagreement_score":0.009301635,"about_ca_system_score_codex":0.0005182752,"about_ca_system_score_gemma":0.00031605174,"threshold_uncertainty_score":0.32906336},"labels":[],"label_agreement":null},{"id":"W4414754886","doi":"10.1158/1078-0432.ccr-25-2186","title":"Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; London Health Sciences Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Veracyte; NRG Oncology; BeiGene; Congressionally Directed Medical Research Programs; Center for Cancer Research; Elekta; National Comprehensive Cancer Network; Academic Medical Organization of Southwestern Ontario; London Health Sciences Centre; National Center for Advancing Translational Sciences; Seagen; Association of Canadian Universities for Research in Astronomy; Nvidia; Moonshot Research and Development Program; AstraZeneca; Dartmouth College; Prostate Cancer Foundation; Cancer Moonshot; U.S. Department of Defense","keywords":"Prostate cancer; Transcriptome; Prostate; External beam radiotherapy; Radiation therapy; Biomarker; External beam radiation; Imaging biomarker","score_opus":0.08590075633874196,"score_gpt":0.4708184571642968,"score_spread":0.3849177008255549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414754886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840815,0.005892012,0.00009825277,0.0022197114,0.00041800877,0.0027108267,0.00012496716,0.000023103064,0.00010497153],"genre_scores_gemma":[0.993576,0.0043433155,0.0006968714,0.0003473398,0.00015640954,0.0005643089,0.0000047940725,0.000032203483,0.0002787873],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99689996,0.0003425965,0.00081779814,0.0007248305,0.000663939,0.00055087707],"domain_scores_gemma":[0.99741054,0.0010744935,0.0002004553,0.0005428702,0.00047403557,0.00029763696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019485039,0.00022930735,0.00094578735,0.00035477112,0.0000956735,0.000018674808,0.00031087318,0.00012076981,0.00010824341],"category_scores_gemma":[0.0004681277,0.00018458697,0.00028974592,0.00070423435,0.00052880857,0.00006412291,0.00007238345,0.00095214625,0.0000040298087],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014406543,0.0020524198,0.5384115,0.0013869952,0.00049663853,0.00008105674,0.00082358223,0.00012328266,0.33691236,0.00020046858,0.0014210502,0.10368409],"study_design_scores_gemma":[0.0046981755,0.0039519127,0.29998636,0.004699417,0.000075712385,0.0000027717633,0.00011234844,0.00021563396,0.68520826,0.00011243633,0.0007747173,0.00016225132],"about_ca_topic_score_codex":0.0002920245,"about_ca_topic_score_gemma":0.00003598914,"teacher_disagreement_score":0.3482959,"about_ca_system_score_codex":0.00065145903,"about_ca_system_score_gemma":0.0018252678,"threshold_uncertainty_score":0.7527238},"labels":[],"label_agreement":null},{"id":"W4415226237","doi":"10.1158/1078-0432.ccr-24-4010","title":"Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment Resistance","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Population Health Research Institute; McMaster University Medical Centre; Hospital for Sick Children; Hamilton Health Sciences; University of Toronto; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medulloblastoma; Dynamics (music); Cancer; Acquired resistance; Drug resistance; Chemotherapy","score_opus":0.19611104703557689,"score_gpt":0.5517871050590704,"score_spread":0.35567605802349345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415226237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367876,0.0020671,0.000052883403,0.048489906,0.0004557672,0.0009822228,0.00004477248,0.00005483343,0.011064896],"genre_scores_gemma":[0.97841233,0.0010971217,0.0005686053,0.0014161892,0.00029245846,0.0006752192,0.000020631798,0.000024129266,0.017493296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725056,0.00023265836,0.0005343884,0.00067520305,0.0006842933,0.0006228972],"domain_scores_gemma":[0.99728185,0.001201025,0.000038107573,0.00063217484,0.00038995343,0.00045687007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001051031,0.00018161569,0.0005221673,0.0003153112,0.00021597644,0.0000536252,0.00018966425,0.0001353612,0.00033125447],"category_scores_gemma":[0.0005975944,0.00013975667,0.0002408254,0.0009132304,0.00020217408,0.000034524328,0.00016776039,0.0004334538,0.00018175997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003630604,0.002982976,0.7835845,0.00016423134,0.0007604267,0.0007021766,0.00021084215,0.000033711152,0.00026127358,0.006144275,0.065023415,0.13650158],"study_design_scores_gemma":[0.0069625475,0.0016445073,0.7263337,0.0010015888,0.00015987302,0.0000058093756,0.00021038359,0.00039759977,0.0020232257,0.0014264479,0.25961223,0.000222112],"about_ca_topic_score_codex":0.00074998685,"about_ca_topic_score_gemma":0.002567054,"teacher_disagreement_score":0.19458881,"about_ca_system_score_codex":0.00210388,"about_ca_system_score_gemma":0.0009125692,"threshold_uncertainty_score":0.5699111},"labels":[],"label_agreement":null},{"id":"W4415355988","doi":"10.1158/1078-0432.ccr-24-3785","title":"Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Melanoma; Stage (stratigraphy); microRNA; Adjuvant; Cancer; Selection (genetic algorithm)","score_opus":0.03678259806618832,"score_gpt":0.42436566030159667,"score_spread":0.38758306223540834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415355988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978121,0.00057417626,0.000036616315,0.00026753618,0.00006705281,0.00043321258,0.000120101555,0.000006769098,0.0006824575],"genre_scores_gemma":[0.99598897,0.000042324464,0.00011869315,0.0001658085,0.000053724143,0.00006073636,0.000082650826,0.000016726452,0.0034703466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832124,0.00022849691,0.00032910187,0.00038925128,0.00043863914,0.000293292],"domain_scores_gemma":[0.9985872,0.0001329388,0.00013436475,0.0004085879,0.00064169423,0.000095252864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069280976,0.00011775494,0.00026052864,0.00007072028,0.000111962654,0.000016010023,0.00027897823,0.000137323,0.0000811371],"category_scores_gemma":[0.00035201677,0.00008061244,0.000083798564,0.00023410353,0.00034251236,0.0000042959146,0.0002342,0.00027749472,0.0000016659616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023479043,0.00041288717,0.9849213,0.000061696235,0.00040174936,0.0000034192544,0.000014049512,0.00005079278,0.0048189615,0.00006459033,0.005405916,0.0014967733],"study_design_scores_gemma":[0.0026619444,0.0008151451,0.96443665,0.00006842663,0.000031007545,3.5243964e-8,0.0000211991,0.000009908723,0.021321133,0.0000415489,0.010477868,0.00011510349],"about_ca_topic_score_codex":0.00010560771,"about_ca_topic_score_gemma":0.00031857306,"teacher_disagreement_score":0.020484582,"about_ca_system_score_codex":0.000050462295,"about_ca_system_score_gemma":0.00053844956,"threshold_uncertainty_score":0.32872796},"labels":[],"label_agreement":null},{"id":"W4415586443","doi":"10.1158/1078-0432.ccr-25-1459","title":"PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with <i>PIK3CA</i> -Mutated Solid Tumors and in Preclinical Models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; University Health Network; Discovery Centre","funders":"","keywords":"Precision oncology; Solid tumor; Cancer; Precision medicine; Cooperativity","score_opus":0.07439259426989839,"score_gpt":0.4929038867641238,"score_spread":0.41851129249422536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415586443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996587,0.0005871079,0.000024593257,0.0013484162,0.000053346357,0.0011142859,0.000088484114,0.00000952654,0.0001872714],"genre_scores_gemma":[0.9979569,0.00047084072,0.00015680271,0.00036197787,0.00007894948,0.00026434736,0.00003484204,0.000035412457,0.00063993316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99558145,0.0011290641,0.0007677025,0.0011272253,0.0005686202,0.000825947],"domain_scores_gemma":[0.9978626,0.00081070774,0.000060158094,0.00050234457,0.00037754173,0.00038667483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002627334,0.00022830593,0.00047806898,0.0003816781,0.00010000795,0.00007939046,0.0003655757,0.00033528754,0.000010857086],"category_scores_gemma":[0.002125453,0.0001977617,0.000044791544,0.0007624173,0.000785305,0.000018759576,0.0006732319,0.0011344552,0.0000028222266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017720094,0.0005983227,0.9630081,0.0001556993,0.00005166769,0.000023609282,0.00015858503,0.00013984655,0.008234028,0.000018003344,0.002650648,0.007241365],"study_design_scores_gemma":[0.0059410925,0.0034291896,0.93478847,0.00082124374,0.000007949548,0.0000015933084,0.00014064269,0.00037665997,0.052640352,0.0002751445,0.0011289446,0.00044869154],"about_ca_topic_score_codex":0.00057228125,"about_ca_topic_score_gemma":0.003484952,"teacher_disagreement_score":0.044406325,"about_ca_system_score_codex":0.000113807895,"about_ca_system_score_gemma":0.0009982331,"threshold_uncertainty_score":0.8064488},"labels":[],"label_agreement":null},{"id":"W4415586548","doi":"10.1158/1078-0432.ccr-24-4369","title":"Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Stage (stratigraphy); Identification (biology); Clinical Oncology; Group (periodic table); Cancer; Neoplasm staging","score_opus":0.11198657946332789,"score_gpt":0.5161100474194166,"score_spread":0.40412346795608867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415586548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841165,0.0012407883,0.00009911641,0.010121834,0.0011142505,0.001572149,0.0003718256,0.000062152016,0.0013013633],"genre_scores_gemma":[0.99037236,0.0030948904,0.0001934712,0.0007282054,0.0003084202,0.0002760562,0.00031453167,0.000039190356,0.0046728933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909927,0.0042747534,0.0017873349,0.0010879864,0.0010926622,0.0007645213],"domain_scores_gemma":[0.98879516,0.008405729,0.00047423373,0.0011843491,0.0007488119,0.00039174026],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00621499,0.0002446255,0.0010671553,0.0002118981,0.00034917766,0.000035832592,0.00059635704,0.0004539809,0.0004132199],"category_scores_gemma":[0.0078108734,0.00017166536,0.0004496357,0.000839844,0.0021502343,0.00008700495,0.0005825001,0.0026843562,0.000058379388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006277499,0.0040505705,0.7717433,0.000044502074,0.00088839035,0.0006960939,0.0000173978,0.0000018781031,0.0011714775,0.0005339668,0.19442971,0.020145236],"study_design_scores_gemma":[0.016599,0.006930795,0.92247295,0.00016136053,0.00038871303,0.000031700252,0.000043013923,0.00009941514,0.0018730789,0.0012353755,0.050004285,0.00016028121],"about_ca_topic_score_codex":0.017653095,"about_ca_topic_score_gemma":0.0027250668,"teacher_disagreement_score":0.1507297,"about_ca_system_score_codex":0.00039977708,"about_ca_system_score_gemma":0.0021117385,"threshold_uncertainty_score":0.9996165},"labels":[],"label_agreement":null},{"id":"W4415621606","doi":"10.1158/1078-0432.ccr-25-3143","title":"On the Road to ROME: Defining Tissue–Liquid Concordance in Precision Oncology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Concordance; Profiling (computer programming); Precision oncology; Precision medicine; Biopsy; Cancer; Liquid biopsy","score_opus":0.1089342623394439,"score_gpt":0.5243590187521124,"score_spread":0.4154247564126685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415621606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97083825,0.002720793,0.00016585822,0.011620758,0.0006633353,0.0005696007,0.000030604173,0.0000052298305,0.013385543],"genre_scores_gemma":[0.986895,0.0034416306,0.00013793164,0.0062261154,0.00030005423,0.00037384193,0.000012313084,0.000017008206,0.00259611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997813,0.0004927426,0.0004727538,0.00055333506,0.00024151806,0.00042667458],"domain_scores_gemma":[0.997098,0.0019350351,0.000049395014,0.0005801248,0.00021192367,0.0001255133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032254518,0.000110246445,0.00023718989,0.00010214263,0.0001240185,0.000035780125,0.0005422731,0.00022184654,0.00009900591],"category_scores_gemma":[0.006296289,0.0000859872,0.00006682037,0.00043705423,0.00022441227,0.0000017181877,0.0005557238,0.0005799481,0.000090953756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010054523,0.00069193414,0.009640959,0.00004743325,0.00009985704,0.000045309956,0.00018060817,0.0014144835,0.049500484,0.022723485,0.44447848,0.46112245],"study_design_scores_gemma":[0.0012503065,0.004154346,0.014669721,0.0002009246,0.000006732021,8.6101005e-7,0.00010835558,0.000069296686,0.031229235,0.0021496245,0.94597745,0.00018314281],"about_ca_topic_score_codex":0.0005001599,"about_ca_topic_score_gemma":0.002401867,"teacher_disagreement_score":0.501499,"about_ca_system_score_codex":0.00015462957,"about_ca_system_score_gemma":0.0009976621,"threshold_uncertainty_score":0.75377005},"labels":[],"label_agreement":null},{"id":"W4415764619","doi":"10.1158/1078-0432.ccr-25-2851","title":"Biomarkers in High-Grade Serous Ovarian Cancer: Context Is Everything","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Context (archaeology); Serous fluid; Serous ovarian cancer; Biomarker; Serous carcinoma; Ovarian carcinoma; Carcinoma","score_opus":0.19691061443441976,"score_gpt":0.531483358529785,"score_spread":0.33457274409536525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415764619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8200042,0.01660373,0.000016284455,0.15637514,0.0015629608,0.0015542773,0.00010163124,0.000065126325,0.003716619],"genre_scores_gemma":[0.9762792,0.012831429,0.00015675617,0.0065762103,0.00047250805,0.000927185,0.000012793198,0.000034576646,0.002709329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620724,0.0004651216,0.0008612361,0.00092609285,0.00072849443,0.000811843],"domain_scores_gemma":[0.99717015,0.0013378519,0.000086014734,0.00071339903,0.00034485786,0.00034775367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024005317,0.00022407368,0.0007576574,0.0004363754,0.00017431246,0.00007415004,0.00029807255,0.00031271635,0.0015049932],"category_scores_gemma":[0.00049416744,0.00018959268,0.00023376467,0.0014668225,0.00040342833,0.00009317578,0.00021185176,0.0012254931,0.00008170796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012376822,0.00087278447,0.71241,0.0002044241,0.00087469316,0.0002497795,0.000216398,0.0000053703097,0.000049394035,0.001125768,0.0761524,0.20660134],"study_design_scores_gemma":[0.013211847,0.0005444736,0.8594415,0.0022082624,0.00017803113,0.0000036381573,0.00036072294,0.00016061979,0.0014556554,0.0014471574,0.12074991,0.000238142],"about_ca_topic_score_codex":0.038921468,"about_ca_topic_score_gemma":0.007672528,"teacher_disagreement_score":0.2063632,"about_ca_system_score_codex":0.0014327383,"about_ca_system_score_gemma":0.0023812358,"threshold_uncertainty_score":0.99940777},"labels":[],"label_agreement":null},{"id":"W4416084768","doi":"10.1158/1078-0432.ccr-25-1946","title":"Machine Learning–Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2− Early Breast Cancer Using Real-World and NATALEE Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Astellas Pharma; Astex Pharmaceuticals; Seagen; Invitae; Gilead Sciences; BeiGene; Daiichi Sankyo Europe; Sanofi; Veracyte; Novartis Institutes for BioMedical Research; Amgen; Pfizer; Novartis Pharmaceuticals Corporation; AstraZeneca; Eli Lilly and Company","keywords":"Breast cancer; Cancer; MEDLINE; Risk assessment; Patient data","score_opus":0.1877959057952461,"score_gpt":0.5374822287604847,"score_spread":0.3496863229652386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352385,0.012085273,0.00015728825,0.0009980759,0.00021440508,0.0010573047,0.0018283867,0.000037799033,0.00009763706],"genre_scores_gemma":[0.98116165,0.017784925,0.00024258671,0.000038261504,0.00018430926,0.00015982939,0.00008162204,0.000032205407,0.0003146288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964767,0.0009569068,0.000688013,0.0009073028,0.00050655025,0.00046452356],"domain_scores_gemma":[0.99677587,0.0018448447,0.00018872991,0.00073261093,0.00023987518,0.00021809354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026747587,0.0002386507,0.00075845624,0.00036991274,0.00017136935,0.00003155093,0.00022300488,0.00013643959,0.00007791091],"category_scores_gemma":[0.0006071862,0.00018186422,0.000065290995,0.0009950801,0.00096974545,0.00018059883,0.00029562984,0.0011194973,7.460969e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005523681,0.00018088109,0.7397805,0.00027165608,0.00012484733,0.000016686665,0.00007938586,0.000078049976,0.00030676965,0.000013503214,0.000021125388,0.25360295],"study_design_scores_gemma":[0.007928707,0.0012609344,0.96265316,0.0020470966,0.00019406198,0.00000413701,0.000046381727,0.022184674,0.00047394854,0.00015711877,0.0029151768,0.00013458572],"about_ca_topic_score_codex":0.046362158,"about_ca_topic_score_gemma":0.0094217025,"teacher_disagreement_score":0.25346836,"about_ca_system_score_codex":0.0006862406,"about_ca_system_score_gemma":0.00080357597,"threshold_uncertainty_score":0.9599882},"labels":[],"label_agreement":null},{"id":"W4416202622","doi":"10.1158/1078-0432.ccr-25-3334","title":"Novel High-Dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have We Made Progress?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Chemotherapy; Germ cell; Germ cell tumors; Cell; Stem cell; Cancer","score_opus":0.13242648239890045,"score_gpt":0.5134600046485386,"score_spread":0.38103352224963816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416202622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93347013,0.03750164,0.000008900478,0.025389533,0.00044376057,0.0015786068,0.00009155488,0.0000709359,0.0014449095],"genre_scores_gemma":[0.9657772,0.015351848,0.0004226634,0.0010789816,0.00040974,0.0008375951,0.00002611525,0.0000545469,0.016041309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967914,0.00024041724,0.00065889745,0.0008040782,0.00075115333,0.0007540543],"domain_scores_gemma":[0.99762195,0.00073803746,0.00012726433,0.0007605158,0.0003216652,0.00043057947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095008384,0.00023428249,0.0006024462,0.000274534,0.00011689612,0.000042412423,0.00027593612,0.0002906518,0.00061518373],"category_scores_gemma":[0.00038859432,0.0001881161,0.00022989775,0.0006492091,0.0005674998,0.000049988234,0.00015810668,0.0012436041,0.000058237012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003069176,0.005484942,0.82708544,0.0004437714,0.00029246387,0.00041951908,0.0001078958,0.000008226111,0.0007859539,0.00015343324,0.014858056,0.14729114],"study_design_scores_gemma":[0.019450236,0.00089497026,0.927249,0.0012639518,0.00014542611,0.000003595144,0.000104524675,0.00017627652,0.0010974836,0.0004400951,0.04896122,0.00021321971],"about_ca_topic_score_codex":0.0028631717,"about_ca_topic_score_gemma":0.00048341736,"teacher_disagreement_score":0.14707793,"about_ca_system_score_codex":0.0007290732,"about_ca_system_score_gemma":0.0022425135,"threshold_uncertainty_score":0.7671152},"labels":[],"label_agreement":null},{"id":"W4416239499","doi":"10.1158/1078-0432.ccr-25-3040","title":"Real-World Outcomes of Elacestrant in ER+, HER2−, <i>ESR1</i> -Mutant Metastatic Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Research Group (Canada)","funders":"Menarini Group","keywords":"Metastatic breast cancer; Breast cancer; PI3K/AKT/mTOR pathway; Cancer; MEDLINE","score_opus":0.16887152885739296,"score_gpt":0.562525891090164,"score_spread":0.39365436223277106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416239499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592206,0.0041377842,0.00006358597,0.03018938,0.0007248095,0.001505904,0.0003162346,0.000076799886,0.0037649148],"genre_scores_gemma":[0.9852497,0.0061862646,0.00053087284,0.0011294653,0.00021534043,0.00058618403,0.000008077089,0.000058357775,0.0060357293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950363,0.00060129055,0.0015282959,0.0007960628,0.0011058451,0.00093217357],"domain_scores_gemma":[0.9959619,0.0019242273,0.00020601379,0.00086434715,0.00073196215,0.00031154134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030297458,0.000297262,0.0014393714,0.00070011953,0.00009163261,0.000022769855,0.00047499087,0.00013974319,0.0010852246],"category_scores_gemma":[0.00044544326,0.00023192025,0.0003101821,0.0024234685,0.0011122269,0.00014268537,0.00021880979,0.0015916007,0.000021668684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004630374,0.0009752816,0.83880466,0.00071089226,0.00062475476,0.00013055075,0.00017463403,0.000119107935,0.0021351862,0.0012712444,0.0008254746,0.14959785],"study_design_scores_gemma":[0.0067141317,0.00024376069,0.97582984,0.0016449075,0.00014903146,0.000008527478,0.00036218608,0.00013303536,0.0023999969,0.002247077,0.01004077,0.00022671871],"about_ca_topic_score_codex":0.01683873,"about_ca_topic_score_gemma":0.018472172,"teacher_disagreement_score":0.14937113,"about_ca_system_score_codex":0.00083883386,"about_ca_system_score_gemma":0.0026955435,"threshold_uncertainty_score":0.9998279},"labels":[],"label_agreement":null},{"id":"W4416328850","doi":"10.1158/1078-0432.ccr-25-1834","title":"Clinicogenomic Characterization of Primary Sclerosing Cholangitis–Associated Biliary Tract Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Foundation; University Health Network; University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Terry Fox Research Institute; Cholangiocarcinoma Foundation; Princess Margaret Cancer Foundation","keywords":"Biliary tract cancer; Biliary tract; Immunotherapy; Primary sclerosing cholangitis; Retrospective cohort study; Clinical trial; Prospective cohort study","score_opus":0.24221617536378215,"score_gpt":0.5035686205855475,"score_spread":0.2613524452217654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416328850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375,0.0011283085,0.000012839715,0.0010755941,0.0004968714,0.000610412,0.00015754534,0.000035992478,0.0027324774],"genre_scores_gemma":[0.99065095,0.0062292535,0.000019583527,0.0008822925,0.00023325093,0.000049560334,0.00020165431,0.00002102005,0.0017124063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743164,0.00056972826,0.00080463645,0.00035973603,0.00045171852,0.00038251557],"domain_scores_gemma":[0.9977735,0.0007992306,0.00016397388,0.00046016884,0.0006117464,0.00019136457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002614229,0.000112254456,0.00053983316,0.00020992759,0.00015624065,0.000027659386,0.00022857716,0.00020741604,0.00037700668],"category_scores_gemma":[0.001228218,0.00010222912,0.00025481926,0.0007507523,0.00045628552,0.00012270267,0.00016554109,0.00092259096,0.000018844758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001332213,0.000991308,0.86074525,0.00037846717,0.00025897275,0.000009818081,0.00006968434,0.0000019092827,0.057578217,0.00003166567,0.0016254772,0.076977044],"study_design_scores_gemma":[0.002313919,0.0003556794,0.9918033,0.00090046774,0.000120243174,4.4898192e-7,0.00004763856,0.00011176883,0.0015586178,0.000060007398,0.0026456476,0.00008228913],"about_ca_topic_score_codex":0.0012932656,"about_ca_topic_score_gemma":0.000027165366,"teacher_disagreement_score":0.13105805,"about_ca_system_score_codex":0.0007913129,"about_ca_system_score_gemma":0.0030489448,"threshold_uncertainty_score":0.5408697},"labels":[],"label_agreement":null},{"id":"W4416331414","doi":"10.1158/1078-0432.ccr-25-2440","title":"Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen–Positive Advanced/Metastatic Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Carcinoembryonic antigen; Pharmacodynamics; Solid tumor; Cancer; Pharmacokinetics","score_opus":0.07898439884002029,"score_gpt":0.5006161356055636,"score_spread":0.42163173676554333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416331414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932975,0.00038283443,0.000043596454,0.001973277,0.000030343464,0.0013845521,0.000021984559,0.000021472877,0.0028443928],"genre_scores_gemma":[0.9979368,0.00030092304,0.00017331143,0.00024631823,0.0000309964,0.00044365565,0.00006276899,0.00002241422,0.0007828405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731565,0.00025488637,0.0006343923,0.0005959897,0.00062980887,0.00056927203],"domain_scores_gemma":[0.99817526,0.0006510001,0.00007992365,0.00039622,0.00048534595,0.00021225787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083972595,0.00017298613,0.0005210897,0.00026249932,0.00010533914,0.000023973533,0.00021245341,0.00009236698,0.00008678294],"category_scores_gemma":[0.0002945796,0.00013366029,0.000054295713,0.0017699203,0.00054778485,0.00008577263,0.000075805714,0.0013866102,0.000014045929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007906812,0.0018867779,0.97030365,0.000321352,0.00008443159,0.00010331528,0.00008344175,0.00026515624,0.00022178164,0.00054592727,0.00025545264,0.018021889],"study_design_scores_gemma":[0.014268973,0.00097181485,0.9783097,0.0012798674,0.000032296164,0.0000020530908,0.00011572055,0.0006568102,0.003449466,0.00047754264,0.00028762387,0.00014811965],"about_ca_topic_score_codex":0.00015602369,"about_ca_topic_score_gemma":0.00014104176,"teacher_disagreement_score":0.01787377,"about_ca_system_score_codex":0.00074764487,"about_ca_system_score_gemma":0.0011642178,"threshold_uncertainty_score":0.60242087},"labels":[],"label_agreement":null},{"id":"W4416866070","doi":"10.1158/1078-0432.ccr-25-3327","title":"A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; National Cancer Institute; U.S. Department of Defense; National Heart, Lung, and Blood Institute; U.S. Department of Veterans Affairs","keywords":"Docetaxel; Prostate cancer; Androgen receptor; Prostate; Clinical trial; Cancer; Androgen","score_opus":0.15096268327338347,"score_gpt":0.5233388552715308,"score_spread":0.3723761719981473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416866070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700078,0.008763438,0.00067648967,0.017280776,0.00016896128,0.002346341,0.00039397264,0.000040097082,0.00032212734],"genre_scores_gemma":[0.96862113,0.018343389,0.002403725,0.0011956337,0.00011116858,0.0021636384,0.00006043841,0.000035176537,0.007065671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961857,0.00049822754,0.0007745677,0.0008883779,0.00081107003,0.00084204157],"domain_scores_gemma":[0.99721026,0.001187393,0.00006691829,0.00036512353,0.0006936102,0.0004766774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029927082,0.00021197497,0.00074564986,0.0006531039,0.00018836316,0.00005131945,0.0002112931,0.00015524212,0.00016546028],"category_scores_gemma":[0.00082047493,0.00016298235,0.00010035285,0.0012744518,0.0007038922,0.00008307411,0.00036475062,0.0012923881,0.000022888895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012782926,0.0009660212,0.77801603,0.00076937885,0.00045998915,0.00039403848,0.0006607816,0.028772343,0.000108898574,0.001395274,0.0078399265,0.16783439],"study_design_scores_gemma":[0.042068664,0.0029357306,0.66444486,0.0019102577,0.00037547597,0.000014413728,0.00039138796,0.21724743,0.00038402842,0.06299043,0.0067175785,0.00051974616],"about_ca_topic_score_codex":0.0037931046,"about_ca_topic_score_gemma":0.0015099102,"teacher_disagreement_score":0.18847509,"about_ca_system_score_codex":0.00049590116,"about_ca_system_score_gemma":0.0021857705,"threshold_uncertainty_score":0.6646228},"labels":[],"label_agreement":null},{"id":"W4416998054","doi":"10.1158/1078-0432.ccr-25-2426","title":"FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from <i>PLAG1</i> -Rearranged Adnexal and Salivary Gland Myoepithelial Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Cycle for Survival; U.S. Department of Defense","keywords":"Salivary gland; Myoepithelial cell; Myoepithelioma; Mammary gland; Cancer","score_opus":0.09446466903178602,"score_gpt":0.44692566264135386,"score_spread":0.35246099360956784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416998054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97998273,0.0075882804,0.000020428854,0.0078993635,0.0005706047,0.0015193989,0.0007049482,0.00012208757,0.0015921779],"genre_scores_gemma":[0.98898906,0.005960198,0.00040857587,0.0018422117,0.0015378164,0.00038393153,0.00013647262,0.00008958346,0.000652162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99281263,0.0013204841,0.001795979,0.0017743914,0.0011515034,0.0011450297],"domain_scores_gemma":[0.99118227,0.0058610006,0.0002573393,0.0009860863,0.0004948416,0.0012184719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002950667,0.0005754821,0.0017184959,0.0002761596,0.00052128854,0.00020251912,0.00039968468,0.0004976489,0.00050966186],"category_scores_gemma":[0.0029377334,0.00044424573,0.0003990286,0.00051827857,0.0017407729,0.00008325469,0.00059095206,0.001725204,0.0000772473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007554496,0.0012846435,0.9591705,0.00018812208,0.0005479184,0.0013278776,0.00011749183,0.0000018996348,0.00019800005,0.00006348082,0.0027752824,0.026770294],"study_design_scores_gemma":[0.011529467,0.0023875323,0.9771041,0.0015307157,0.00043131062,0.000059416223,0.000120755285,0.00013778888,0.00073282566,0.0018034272,0.0037296775,0.000432973],"about_ca_topic_score_codex":0.0026034436,"about_ca_topic_score_gemma":0.001112267,"teacher_disagreement_score":0.02633732,"about_ca_system_score_codex":0.00016110313,"about_ca_system_score_gemma":0.0007958969,"threshold_uncertainty_score":0.9998009},"labels":[],"label_agreement":null},{"id":"W4417201089","doi":"10.1158/1557-3265.earlyonsetca25-b002","title":"Abstract B002: Addressing knowledge gaps in early-onset cancers: Radiological insights into oncogenic-immune dynamics of anaplastic Wilms tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiological weapon; Wilms' tumor; Immune system; Personalized medicine; Radiological imaging; Immunophenotyping","score_opus":0.0754728213299657,"score_gpt":0.4553193133154719,"score_spread":0.3798464919855062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667463,0.029417338,0.000036256344,0.00026895493,0.00051041855,0.00031296958,0.000021960206,0.000010543302,0.0026752586],"genre_scores_gemma":[0.9863946,0.012480797,0.00004700314,0.00006492621,0.00022828425,0.00009428884,0.00006462723,0.000021594198,0.0006038698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996924,0.00051303353,0.0009885123,0.00070275966,0.00030219197,0.00056952547],"domain_scores_gemma":[0.99837565,0.00047478877,0.00015629249,0.00048004574,0.00032915833,0.00018406095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013521223,0.00021522283,0.0005487999,0.00025130264,0.00014506023,0.000029903305,0.00062659505,0.00060980587,0.000048615708],"category_scores_gemma":[0.0008694162,0.00017201382,0.00024431708,0.0008245146,0.0011803262,0.0000094979,0.0003712946,0.0012789274,0.0000114550085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02307684,0.0028179968,0.41035977,0.0028640674,0.0023098325,0.0004546772,0.0019564668,0.00930012,0.24316546,0.0013727315,0.022142714,0.28017932],"study_design_scores_gemma":[0.011648135,0.0056345384,0.8135898,0.0070639295,0.00014806825,0.000016228007,0.0014521595,0.0052415156,0.11766567,0.0051828506,0.030733649,0.001623432],"about_ca_topic_score_codex":0.0020117247,"about_ca_topic_score_gemma":0.004677954,"teacher_disagreement_score":0.40323007,"about_ca_system_score_codex":0.00044004494,"about_ca_system_score_gemma":0.002063901,"threshold_uncertainty_score":0.701452},"labels":[],"label_agreement":null},{"id":"W4417201092","doi":"10.1158/1557-3265.earlyonsetca25-a004","title":"Abstract A004: Paid Family Leave as a Cancer Prevention Strategy? The association of state paid family leave implementation with early-onset breast and endometrial cancer incidence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Quartile; Breast cancer; Breastfeeding; Socioeconomic status; Endometrial cancer; Cancer prevention; Cancer","score_opus":0.12455884813667735,"score_gpt":0.5340931242522976,"score_spread":0.40953427611562027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98761606,0.0067821043,0.000042900174,0.0023015994,0.00039262313,0.0021122221,0.00041836465,0.000025068131,0.0003090837],"genre_scores_gemma":[0.96662754,0.030928856,0.000015851745,0.0003474583,0.0004799131,0.0005464541,0.000039520884,0.000026214755,0.0009881989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949764,0.0010199327,0.0010198241,0.00060455693,0.0016920781,0.00068720785],"domain_scores_gemma":[0.9956962,0.0019438902,0.00040878667,0.00042110018,0.0012400782,0.0002899298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076015443,0.00021383307,0.00070487754,0.00030377507,0.00028558128,0.00008392433,0.00019167115,0.00022909291,0.00016923476],"category_scores_gemma":[0.0007845632,0.00014287552,0.00028288073,0.001165901,0.00037338506,0.00018660855,0.00010951318,0.001315027,0.00000825129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004580408,0.00012270454,0.7627357,0.00032077899,0.00077143457,0.000013080677,0.00029843315,0.000043772332,0.00052468793,0.000012035937,0.003115442,0.22746153],"study_design_scores_gemma":[0.0063296324,0.0008544444,0.9878041,0.00063695334,0.0002781262,0.0000034810525,0.0012446762,0.00002094658,0.0007178671,0.0002153028,0.0017594835,0.00013497865],"about_ca_topic_score_codex":0.092464924,"about_ca_topic_score_gemma":0.02085934,"teacher_disagreement_score":0.22732654,"about_ca_system_score_codex":0.00092159567,"about_ca_system_score_gemma":0.005262396,"threshold_uncertainty_score":0.9970074},"labels":[],"label_agreement":null},{"id":"W4417201093","doi":"10.1158/1557-3265.earlyonsetca25-b001","title":"Abstract B001: Implementation Science-Informed Development of a Comprehensive Early Onset Cancer Program: Provider Perspectives","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychosocial; Thematic analysis; Descriptive statistics; Clinical Oncology; MEDLINE; Radiation oncology; Needs assessment; Cancer","score_opus":0.33060855438891495,"score_gpt":0.5652553798403559,"score_spread":0.23464682545144094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784172,0.0058104354,0.000050695875,0.0015952641,0.00059992634,0.00119919,0.00017206687,0.00003338821,0.012121827],"genre_scores_gemma":[0.9945992,0.0024130861,0.0011282739,0.00017962094,0.00015994505,0.00075119094,0.000007654017,0.00001830305,0.0007426818],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966846,0.000030340632,0.0015875676,0.00072180235,0.00019556981,0.000780107],"domain_scores_gemma":[0.99761003,0.00035599913,0.00047937784,0.00038928905,0.00097568275,0.00018964839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002532291,0.00017711401,0.0006061173,0.00064508565,0.00040358366,0.00017286059,0.0006268344,0.00014255532,0.000858024],"category_scores_gemma":[0.00053573493,0.00018565202,0.00013741298,0.0011716583,0.0014161399,0.00056649646,0.00025535998,0.00054627564,0.00009951255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005581695,0.0005701792,0.4542853,0.00041071835,0.00030822845,0.0000022694094,0.0049084546,0.000015248073,0.0001039644,0.033122633,0.008471161,0.4972437],"study_design_scores_gemma":[0.001321979,0.00017554977,0.88001627,0.00012352176,0.0000056550025,1.2662007e-7,0.0025147982,0.000036937854,0.00093979604,0.0030488793,0.11160986,0.00020663634],"about_ca_topic_score_codex":0.0049391747,"about_ca_topic_score_gemma":0.0015301086,"teacher_disagreement_score":0.49703705,"about_ca_system_score_codex":0.001209729,"about_ca_system_score_gemma":0.0052593364,"threshold_uncertainty_score":0.9394761},"labels":[],"label_agreement":null},{"id":"W4417201094","doi":"10.1158/1557-3265.earlyonsetca25-a017","title":"Abstract A017: Equity and the age cutoff problem: Rethinking early detection and screening in Nigeria","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidemiology; Referral; Cancer registry; Cancer screening; Health equity; Cancer prevention; Cancer; Equity (law); Public health","score_opus":0.21507151025959742,"score_gpt":0.5369919488974084,"score_spread":0.321920438637811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98527116,0.0062873703,0.000093015595,0.004660182,0.0001754022,0.0009743499,0.000002032158,0.000022769804,0.0025136971],"genre_scores_gemma":[0.99196726,0.006902676,0.00009693522,0.00046496812,0.00023572541,0.00008409555,0.0000012779307,0.000010472121,0.00023655915],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976458,0.0005620609,0.00047750198,0.00037505588,0.00052656484,0.00041304927],"domain_scores_gemma":[0.99787223,0.0014898729,0.000043928652,0.00029490184,0.00013606937,0.00016301464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013211334,0.00008896412,0.00041251542,0.00015371853,0.0002721108,0.00008363237,0.000103584796,0.00021150347,0.000016372023],"category_scores_gemma":[0.0017028598,0.000057004014,0.000121720215,0.00041801675,0.00071142835,0.000057897156,0.00036471724,0.0018973583,0.0000021856624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004031046,0.000047195193,0.37668988,0.00060891296,0.00013054044,0.00008240305,0.00088175,0.0000031838686,0.0002409379,0.00015105864,0.0002622929,0.61687076],"study_design_scores_gemma":[0.0044850623,0.00011230843,0.9866353,0.0005487809,0.000027890612,0.0000048696334,0.00015011216,0.00009423415,0.000092032285,0.0030987167,0.0046910294,0.000059650833],"about_ca_topic_score_codex":0.00899383,"about_ca_topic_score_gemma":0.006472051,"teacher_disagreement_score":0.61681116,"about_ca_system_score_codex":0.00008139201,"about_ca_system_score_gemma":0.00036104527,"threshold_uncertainty_score":0.9976054},"labels":[],"label_agreement":null},{"id":"W4417201097","doi":"10.1158/1557-3265.earlyonsetca25-b005","title":"Abstract B005: Comparative genomic analysis between early-onset and average-onset colorectal cancer patients at the Cleveland Clinic","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer; Disease; Stage (stratigraphy); Exome sequencing; Etiology; Exome","score_opus":0.10612365787113569,"score_gpt":0.47475380503733106,"score_spread":0.36863014716619535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927044,0.0034462244,0.000014244703,0.00068347633,0.0002932443,0.00056004565,0.0016344145,0.000006293666,0.0006576751],"genre_scores_gemma":[0.9900075,0.0071194926,0.000014696104,0.00038843614,0.00037566054,0.00018954216,0.00031287732,0.000018382656,0.0015733751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973073,0.00040173167,0.0006775548,0.000774427,0.00031607927,0.0005229286],"domain_scores_gemma":[0.99718755,0.0015736583,0.00016059907,0.00046999194,0.00038761814,0.00022058752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016142802,0.00020888177,0.0005038123,0.00013107776,0.0004494745,0.000105914485,0.00044824995,0.00028681481,0.0003457009],"category_scores_gemma":[0.00043747816,0.00016391317,0.00025872065,0.00050168036,0.0008697428,0.00000528361,0.000812156,0.00063265086,0.000044010383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079542794,0.000096442425,0.9685701,0.000016621916,0.0010656952,0.0000016115349,0.00008006339,0.000055897803,0.00029389033,0.0000022505003,0.025835095,0.0031868888],"study_design_scores_gemma":[0.0012559069,0.00033611569,0.9744068,0.000021867394,0.00023443173,1.7828454e-7,0.00003684,0.000030122852,0.0020573167,0.00009463909,0.021341702,0.00018409737],"about_ca_topic_score_codex":0.0017675937,"about_ca_topic_score_gemma":0.009055592,"teacher_disagreement_score":0.007287998,"about_ca_system_score_codex":0.00017256108,"about_ca_system_score_gemma":0.00065516937,"threshold_uncertainty_score":0.66841847},"labels":[],"label_agreement":null},{"id":"W4417201098","doi":"10.1158/1557-3265.earlyonsetca25-a022","title":"Abstract A022: Exploring the association of quantitative fecal immunochemical test (qFIT) with red-flag symptoms of early onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Colorectal cancer; Abdominal pain; Odds ratio; Logistic regression; Triage; Test (biology)","score_opus":0.15479361769203548,"score_gpt":0.47992181848812215,"score_spread":0.3251282007960867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443763,0.0009958239,0.000017284048,0.0019288894,0.00035498408,0.00061505986,0.00006272133,0.000036123136,0.001551462],"genre_scores_gemma":[0.99811804,0.000558963,0.00007006497,0.000048485792,0.00019354047,0.00049558125,0.000007362893,0.000021395641,0.0004865359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969962,0.00029818178,0.00077483937,0.00042085824,0.0010513093,0.00045860017],"domain_scores_gemma":[0.9916162,0.0062647257,0.000292792,0.0003276657,0.001373842,0.00012477612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032830203,0.00015306381,0.0005821287,0.0001908846,0.00018549584,0.000032762666,0.0002503193,0.00020476535,0.00010243491],"category_scores_gemma":[0.00425278,0.00010499382,0.00020383317,0.0012542919,0.0007562584,0.000101406506,0.00013351456,0.001503735,0.0000049047885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029226435,0.00039633387,0.92683434,0.0002438956,0.0005586847,0.0000076248384,0.00051444944,0.000028140314,0.01416875,0.00008048921,0.0017046239,0.026236253],"study_design_scores_gemma":[0.0020644753,0.005677528,0.9401315,0.0010351465,0.00012208863,0.0000017135529,0.00033534697,0.00013647244,0.049638275,0.000074075746,0.00068008597,0.00010332167],"about_ca_topic_score_codex":0.004900049,"about_ca_topic_score_gemma":0.0016136506,"teacher_disagreement_score":0.035469525,"about_ca_system_score_codex":0.0007126052,"about_ca_system_score_gemma":0.0017063938,"threshold_uncertainty_score":0.7407441},"labels":[],"label_agreement":null},{"id":"W4417201100","doi":"10.1158/1557-3265.earlyonsetca25-a003","title":"Abstract A003: Unfinished Stories: Consequences of Melanoma Clinical Trial Discontinuation and Non-Publication","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Clinical trial; Psychological intervention; Melanoma; Logistic regression; MEDLINE; Clinical research; Cancer","score_opus":0.24084318701766835,"score_gpt":0.550600989740054,"score_spread":0.3097578027223856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96845436,0.00033061946,0.00011941759,0.011757332,0.0012985439,0.0014562869,0.0000118068465,0.000033012115,0.01653861],"genre_scores_gemma":[0.9914319,0.0014207289,0.000120731136,0.00036206655,0.00052846316,0.00016149796,0.000016934731,0.000009511653,0.005948192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971413,0.00036410516,0.0012500304,0.0004794565,0.0005196111,0.00024551753],"domain_scores_gemma":[0.9964588,0.0019218787,0.00022034487,0.0004248928,0.00079368125,0.00018035242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060285996,0.00010301262,0.0005017405,0.00024278517,0.00011386716,0.000058079317,0.0001540925,0.00021150353,0.00042085006],"category_scores_gemma":[0.0059047923,0.00008446418,0.00015034013,0.0005107633,0.0010115051,0.000075076554,0.00012356494,0.0006669212,0.000020096888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09297482,0.0023600222,0.17766131,0.0006283546,0.0007233566,0.000051590854,0.00027476772,0.000001434419,0.0017283194,0.004437342,0.07049355,0.64866513],"study_design_scores_gemma":[0.06622762,0.007046911,0.7232692,0.0006802836,0.0002584619,0.000007072726,0.0013381564,0.00020451866,0.0026281595,0.0015262326,0.19653673,0.00027662358],"about_ca_topic_score_codex":0.00054579595,"about_ca_topic_score_gemma":0.000265696,"teacher_disagreement_score":0.6483885,"about_ca_system_score_codex":0.00008712436,"about_ca_system_score_gemma":0.0008467759,"threshold_uncertainty_score":0.70690143},"labels":[],"label_agreement":null},{"id":"W4417201101","doi":"10.1158/1557-3265.earlyonsetca25-a030","title":"Abstract A030: The role of liquid biopsies in optimizing early-onset non-small cell lung cancer (NSCLC) cancer screening and detection in underserved populations globally","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Cancer; Lung cancer screening; Liquid biopsy; Medical diagnosis; Cancer screening; Health equity; Health care","score_opus":0.083402006360489,"score_gpt":0.4294044453057617,"score_spread":0.3460024389452727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803553,0.017512921,0.00017012372,0.00077214505,0.00020466605,0.00047876994,0.00009047672,0.0000038907356,0.00041170602],"genre_scores_gemma":[0.9863477,0.012806171,0.00019514088,0.00015267434,0.00015499428,0.00024137231,0.000011358484,0.000017389764,0.00007320737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982733,0.00015474587,0.0005457039,0.0004444783,0.00018548076,0.0003962841],"domain_scores_gemma":[0.9989903,0.00029817733,0.00011021892,0.00030947514,0.00021108617,0.000080726975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012252588,0.00013638174,0.00024081004,0.00014422117,0.00013438506,0.000057411846,0.0003055687,0.00023387112,0.000019026778],"category_scores_gemma":[0.00027743584,0.00012321923,0.00008883367,0.00046075493,0.00025917072,0.000008416251,0.0003296483,0.0005023476,3.630241e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014876078,0.00014098824,0.9057714,0.00013758859,0.00007659179,0.0000035156554,0.00019813722,0.01158612,0.058890503,0.000039072067,0.00028990922,0.021378595],"study_design_scores_gemma":[0.0018187221,0.00024290248,0.9309692,0.0004986646,0.000036146615,3.8047037e-7,0.00073830504,0.0039876346,0.05977741,0.0002043585,0.0015011802,0.00022514557],"about_ca_topic_score_codex":0.040047515,"about_ca_topic_score_gemma":0.117056124,"teacher_disagreement_score":0.077008605,"about_ca_system_score_codex":0.00013413494,"about_ca_system_score_gemma":0.00074194133,"threshold_uncertainty_score":0.9663449},"labels":[],"label_agreement":null},{"id":"W4417201103","doi":"10.1158/1557-3265.earlyonsetca25-b011","title":"Abstract B011: Associations between county-level air pollutants and early-onset breast cancer incidence rates in the U.S","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Incidence (geometry); Air pollutants; Cancer; Epidemiology; Cancer registry","score_opus":0.22805712930865624,"score_gpt":0.5491948911517422,"score_spread":0.321137761843086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691804,0.004880554,0.0000034761729,0.023156425,0.0002262255,0.000763295,0.001381911,0.00001701632,0.0003906614],"genre_scores_gemma":[0.9882788,0.009480786,0.000009569984,0.0012400439,0.00052181707,0.00012714669,0.000012104514,0.000013600955,0.00031613122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967175,0.000629062,0.0006738127,0.00043068468,0.00093915866,0.0006097879],"domain_scores_gemma":[0.9955116,0.003312163,0.00008169845,0.0004308542,0.00040234142,0.0002613394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077112443,0.00013206775,0.0005627083,0.00021840227,0.00030698485,0.00004904091,0.00026035286,0.0002615872,0.000089175046],"category_scores_gemma":[0.0017842053,0.00008779702,0.00017750428,0.0009893368,0.00045403338,0.00008653746,0.00011701913,0.0017893757,0.0000156455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019460199,0.00006934354,0.9539323,0.00008631651,0.00012781555,0.00002434481,0.00016339429,0.0000015946993,0.0000066007947,0.0000148980325,0.003968179,0.041410603],"study_design_scores_gemma":[0.001380625,0.000053727825,0.99480957,0.0003701903,0.00006495343,0.0000039569945,0.00018089359,0.000007227107,0.000017090071,0.00023399311,0.0027955833,0.00008219907],"about_ca_topic_score_codex":0.029731398,"about_ca_topic_score_gemma":0.006299384,"teacher_disagreement_score":0.041328404,"about_ca_system_score_codex":0.00040266398,"about_ca_system_score_gemma":0.0025176133,"threshold_uncertainty_score":0.9767297},"labels":[],"label_agreement":null},{"id":"W4417201104","doi":"10.1158/1557-3265.earlyonsetca25-a015","title":"Abstract A015: Retinoblastoma points to solutions for Early-Onset Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Public Health Ontario; Princess Margaret Cancer Centre","funders":"","keywords":"Retinoblastoma; Cancer; Childhood cancer; Clinical trial; Disease; Incidence (geometry); Childhood blindness","score_opus":0.29143358387595214,"score_gpt":0.5680200163333963,"score_spread":0.27658643245744413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8987361,0.001555997,0.000117715084,0.08653159,0.0009568936,0.002485684,0.00015840233,0.00010265111,0.009354959],"genre_scores_gemma":[0.9873199,0.00069512136,0.0011050099,0.002049475,0.0006732465,0.0010645293,0.000008951153,0.000031636086,0.0070521533],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99645364,0.00021292426,0.0007519979,0.0007351947,0.0007360901,0.001110173],"domain_scores_gemma":[0.9948265,0.0027844568,0.000069469876,0.0006741132,0.0011888387,0.00045663764],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005385911,0.0001784104,0.00060658314,0.00032766335,0.0005325586,0.000053900265,0.00036558422,0.00023660346,0.00022617663],"category_scores_gemma":[0.009880641,0.00016004767,0.0002967078,0.0007420592,0.0006475155,0.00005766415,0.000435687,0.0011687757,0.00020929954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004925678,0.00031160298,0.14350578,0.00066431996,0.0003698437,0.00003477172,0.00043085893,0.000007881603,0.00044093022,0.00047948267,0.82038915,0.028439686],"study_design_scores_gemma":[0.0022549853,0.0010082062,0.89481467,0.001097437,0.00007623347,0.0000023852697,0.0003575019,0.00005150056,0.0007602822,0.0018131821,0.09758609,0.0001775082],"about_ca_topic_score_codex":0.0012775917,"about_ca_topic_score_gemma":0.0014260252,"teacher_disagreement_score":0.7513089,"about_ca_system_score_codex":0.0007204461,"about_ca_system_score_gemma":0.0016936258,"threshold_uncertainty_score":0.9984596},"labels":[],"label_agreement":null},{"id":"W4417201105","doi":"10.1158/1557-3265.earlyonsetca25-a014","title":"Abstract A014: Prognostic value of tumor asphericity on initial staging 18F- FDG PET/CT in patients with breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Univariate; Proportional hazards model; Multivariate analysis; Univariate analysis; Breast carcinoma; Breast tumor; Multivariate statistics; Statistical software","score_opus":0.11281469332313845,"score_gpt":0.528996056236658,"score_spread":0.4161813629135196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835033,0.000054896886,0.000040469582,0.0076049045,0.00008067457,0.0012376241,0.00009065665,0.000048868093,0.0024915885],"genre_scores_gemma":[0.99754286,0.00010542798,0.00060386094,0.00092153286,0.00012665393,0.00051094533,0.000016563237,0.000019581323,0.00015257784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973846,0.00016868756,0.000659146,0.00047689272,0.0008653619,0.00044532336],"domain_scores_gemma":[0.99768794,0.0009708803,0.00011294521,0.00044444873,0.0005506703,0.00023310841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014886997,0.00013773589,0.0004495358,0.0001542788,0.00007830751,0.000019049001,0.0002629675,0.000021989634,0.00057398435],"category_scores_gemma":[0.00091883587,0.00010076293,0.00007839448,0.00079948915,0.00061522104,0.000048800805,0.00013124917,0.0014046493,0.000010038832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012782755,0.0015976793,0.9696879,0.00034508714,0.000049844828,0.000117757205,0.000010416947,0.00001337599,0.000042536103,0.00049555337,0.0054172105,0.020944377],"study_design_scores_gemma":[0.0023819003,0.00039283576,0.9922418,0.002267032,0.000034661676,0.0000030106294,0.000024804707,0.00038660193,0.0003746612,0.000243133,0.0015515789,0.00009799274],"about_ca_topic_score_codex":0.0028546238,"about_ca_topic_score_gemma":0.000100721154,"teacher_disagreement_score":0.022553902,"about_ca_system_score_codex":0.00024341072,"about_ca_system_score_gemma":0.0012718936,"threshold_uncertainty_score":0.6284726},"labels":[],"label_agreement":null},{"id":"W4417201106","doi":"10.1158/1557-3265.earlyonsetca25-a019","title":"Abstract A019: Clinical characteristics and outcomes of primary cardiac leiomyosarcoma cases from 2015-2025: A literature review","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leiomyosarcoma; Radiation therapy; Cardiac Tumors; Biopsy; Chemotherapy; Metastasis; Multimodal therapy; Distant metastasis; Cancer","score_opus":0.15570059842303902,"score_gpt":0.545287501120192,"score_spread":0.38958690269715296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7356259,0.24871168,0.0000013402738,0.009613818,0.001281917,0.0010188733,0.0008531433,0.00002990429,0.00286341],"genre_scores_gemma":[0.56739366,0.426395,0.00013615337,0.00295786,0.0009295774,0.000087759174,0.00020992944,0.000028962406,0.0018610903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956947,0.00070931547,0.0016973763,0.00071706274,0.0007410494,0.00044049506],"domain_scores_gemma":[0.9913663,0.0062579717,0.0002165181,0.00093881576,0.0008179532,0.00040239262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052238093,0.00023093392,0.0023469592,0.00015842864,0.00009047816,0.00005160252,0.00022854825,0.0003498706,0.00033084868],"category_scores_gemma":[0.0058707884,0.00017401115,0.0007946492,0.0005837158,0.00083094405,0.000078392106,0.00041504082,0.0019761885,0.000027826067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005901296,0.00038711925,0.8131736,0.003020461,0.00052140275,0.00035893513,0.000018935714,6.008954e-9,0.000073367366,0.000109156805,0.09004728,0.091699615],"study_design_scores_gemma":[0.0012622733,0.00026766828,0.9062186,0.00914828,0.00033592884,0.0000058294604,0.000016228216,0.0000012281449,0.00002543196,0.0001743358,0.08241765,0.00012653202],"about_ca_topic_score_codex":0.00047881872,"about_ca_topic_score_gemma":0.000024467341,"teacher_disagreement_score":0.17768334,"about_ca_system_score_codex":0.00010070712,"about_ca_system_score_gemma":0.0011700089,"threshold_uncertainty_score":0.8585666},"labels":[],"label_agreement":null},{"id":"W4417201107","doi":"10.1158/1557-3265.earlyonsetca25-b008","title":"Abstract B008: Neighborhood fast food, alcohol, and fruit/vegetable expenditure and early-onset colorectal cancer: A statewide spatio-ecological analysis in Alabama","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer registry; Incidence (geometry); Cancer; Cancer incidence; Covariate; Weighting; Consumption (sociology)","score_opus":0.09087566074048499,"score_gpt":0.46995773348455994,"score_spread":0.37908207274407496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97762376,0.01768184,0.000010566293,0.0025553042,0.0002546214,0.0010936996,0.00015738656,0.000033002965,0.0005897977],"genre_scores_gemma":[0.97435665,0.02433963,0.000048106263,0.00035488006,0.00023026441,0.000351908,0.000039227612,0.0000196758,0.0002596477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960223,0.0005399175,0.0008822731,0.00090602995,0.0007388223,0.0009106842],"domain_scores_gemma":[0.9969232,0.0016127646,0.000101248064,0.00040295476,0.00027937902,0.0006804707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032658377,0.00023902903,0.0012182562,0.00066363654,0.0002417746,0.00008998436,0.00016944123,0.000483668,0.0004049808],"category_scores_gemma":[0.0011145618,0.00018437348,0.00034864485,0.0015314484,0.00059867505,0.000114480164,0.00025827636,0.0019339591,0.000007752932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012475017,0.0002555046,0.96832544,0.00023268613,0.0011121371,0.000106787425,0.0001972234,0.000028894223,0.000034054054,0.000015669606,0.00121776,0.027226368],"study_design_scores_gemma":[0.003987773,0.00059562165,0.99016744,0.00018723609,0.0003702111,0.0000049272467,0.00028864524,0.00029882873,0.00012165622,0.00015523653,0.0036573447,0.00016509755],"about_ca_topic_score_codex":0.009087411,"about_ca_topic_score_gemma":0.020040108,"teacher_disagreement_score":0.02706127,"about_ca_system_score_codex":0.00033287102,"about_ca_system_score_gemma":0.0013021666,"threshold_uncertainty_score":0.9978416},"labels":[],"label_agreement":null},{"id":"W4417201109","doi":"10.1158/1557-3265.earlyonsetca25-a011","title":"Abstract A011: Early Onset Cancer Incidence: A Model for the Role of Diagnostic Advances","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Disease; Cancer; Natural history; Breast cancer; Age of onset; Epidemiology","score_opus":0.20411485168681887,"score_gpt":0.5843376517744753,"score_spread":0.3802228000876564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92434734,0.065719806,0.00037968828,0.0058500376,0.0005161317,0.001762971,0.00034787954,0.000027693972,0.0010484426],"genre_scores_gemma":[0.9579477,0.038208876,0.00007183745,0.0004309946,0.00036879312,0.0013423569,0.0000050066146,0.00002177049,0.0016026876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761724,0.000081930906,0.0006880617,0.00044273687,0.000660029,0.000509986],"domain_scores_gemma":[0.9877822,0.010613291,0.00012433901,0.00054608716,0.0007543549,0.00017972593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020508147,0.00014214255,0.0004864942,0.00013216144,0.00020443066,0.000030481095,0.0004096505,0.00017027573,0.0002905925],"category_scores_gemma":[0.0046911514,0.000092105845,0.00027967212,0.0005047027,0.0007570362,0.00009737475,0.00014865483,0.00093000004,0.000008116106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002686767,0.0002776694,0.6202158,0.0003675412,0.00021756729,0.0000044461153,0.00032771868,0.0008464236,0.00023299221,0.00042533578,0.012388797,0.362009],"study_design_scores_gemma":[0.0026407922,0.0005583462,0.88011956,0.001262622,0.00022549529,7.205765e-7,0.00045781027,0.01829917,0.001604177,0.009094674,0.08554676,0.00018989397],"about_ca_topic_score_codex":0.008449022,"about_ca_topic_score_gemma":0.0042618276,"teacher_disagreement_score":0.3618191,"about_ca_system_score_codex":0.00020275396,"about_ca_system_score_gemma":0.0022929262,"threshold_uncertainty_score":0.9981538},"labels":[],"label_agreement":null},{"id":"W4417201110","doi":"10.1158/1557-3265.earlyonsetca25-a027","title":"Abstract A027: Mode of presentation and symptoms at diagnosis of early- and late-onset colorectal cancer: a large retrospective AI-powered analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Presentation (obstetrics); Retrospective cohort study; Colorectal cancer; Odds ratio; Cohort; Stage (stratigraphy); Cancer","score_opus":0.05923124217897015,"score_gpt":0.4890505128601146,"score_spread":0.42981927068114445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481803,0.002841032,0.000026677375,0.00076437776,0.0001257932,0.0005878861,0.00029582926,0.000023356877,0.00051703316],"genre_scores_gemma":[0.99500763,0.0041974937,0.00002326579,0.000051168106,0.00007178555,0.00030362903,0.000018322115,0.000013055864,0.00031366682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770683,0.00022600652,0.00062540494,0.0005387667,0.00057933043,0.00032367575],"domain_scores_gemma":[0.997625,0.0010634582,0.00017784056,0.00024990004,0.0007028426,0.00018097035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011837884,0.00013327999,0.00072532234,0.00048590297,0.00013480817,0.00002172923,0.000093034374,0.0002198079,0.00022426186],"category_scores_gemma":[0.0008014901,0.000119875716,0.00019518074,0.0015621064,0.0005433346,0.00008355209,0.00021107822,0.00060537603,9.156455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011988402,0.00018344051,0.97509784,0.00021292194,0.001031475,0.000004868059,0.0003296775,0.000023480558,0.0007157305,0.000025532912,0.00037552605,0.010011093],"study_design_scores_gemma":[0.00219931,0.0022720606,0.98359174,0.00025504857,0.00052057503,7.905321e-7,0.00007024298,0.00200034,0.0086614555,0.00022424453,0.000115990944,0.000088183],"about_ca_topic_score_codex":0.013119164,"about_ca_topic_score_gemma":0.0113295745,"teacher_disagreement_score":0.0099229105,"about_ca_system_score_codex":0.0003100218,"about_ca_system_score_gemma":0.00035795255,"threshold_uncertainty_score":0.99345255},"labels":[],"label_agreement":null},{"id":"W4417201112","doi":"10.1158/1557-3265.earlyonsetca25-a021","title":"Abstract A021: A human-induced pluripotent stem cell (hiPSC)-derived cardiac spheroids (hiPSC-CSs) platform for individualized cancer drug cardiotoxicity assessment.","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiotoxicity; Induced pluripotent stem cell; Drug; Clinical trial; Cancer; Drug development; Cancer cell; Spheroid; Adverse effect","score_opus":0.14955042343294137,"score_gpt":0.49417189537815787,"score_spread":0.34462147194521653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810816,0.0049283006,0.00017318757,0.0010040981,0.0011915182,0.0035122393,0.0006770921,0.00005819161,0.0073737744],"genre_scores_gemma":[0.98004377,0.0046665906,0.00030318197,0.0002961246,0.0013074703,0.0030593206,0.0002769329,0.00011956243,0.0099270325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9918863,0.0011088408,0.0014484734,0.0019432604,0.0017108617,0.0019022563],"domain_scores_gemma":[0.9952729,0.00090859726,0.0002936121,0.0015589916,0.001312539,0.0006533804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007081853,0.00055990135,0.0011642794,0.00029286972,0.00088054576,0.0002810907,0.0016315704,0.0008641036,0.00026188642],"category_scores_gemma":[0.0003039913,0.00053178205,0.0010354969,0.0007050879,0.00063379016,0.000031056185,0.0013614246,0.0020420535,0.000033320786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013686267,0.00059489027,0.028700614,0.0008539442,0.0011273356,0.000019916686,0.000082018996,0.00010067935,0.8948524,0.000086433116,0.046806004,0.025407126],"study_design_scores_gemma":[0.008637143,0.0009162938,0.06559396,0.00040968918,0.00019930876,9.559999e-7,0.0010341353,0.00016753495,0.77640045,0.0003398529,0.1452359,0.0010647761],"about_ca_topic_score_codex":0.0020543272,"about_ca_topic_score_gemma":0.001197642,"teacher_disagreement_score":0.11845196,"about_ca_system_score_codex":0.00067333365,"about_ca_system_score_gemma":0.003468371,"threshold_uncertainty_score":0.99971336},"labels":[],"label_agreement":null},{"id":"W4417201213","doi":"10.1158/1557-3265.earlyonsetca25-pr001","title":"Abstract PR001: Risk prediction modeling for colorectal adenomas in persons under age 50: a risk-stratified approach to early onset colorectal cancer prevention","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Colonoscopy; Cohort; Area under the curve; Incidence (geometry); Cohort study; Disease; Predictive value","score_opus":0.19948045139744863,"score_gpt":0.48391518517979376,"score_spread":0.28443473378234513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825294,0.0008337982,0.008571277,0.00063328224,0.0006881234,0.004046634,0.00042676646,0.00014464241,0.002126069],"genre_scores_gemma":[0.99152964,0.0005970098,0.001079481,0.00008412837,0.00056138163,0.0049126116,0.00007530839,0.00005065844,0.0011097774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955256,0.0006265048,0.0010427142,0.0011713945,0.0007899333,0.0008438784],"domain_scores_gemma":[0.99748915,0.0010687124,0.00018812601,0.0003546073,0.0005124913,0.000386902],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0046335915,0.00028387865,0.00067899877,0.0006585374,0.00047713815,0.0001243708,0.00025431064,0.000540622,0.00006322819],"category_scores_gemma":[0.0017126905,0.00027282056,0.00037637074,0.0013867032,0.0002396095,0.00016025655,0.00012413686,0.0023587744,0.000009768674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16664907,0.0035061468,0.6517591,0.001012683,0.0012693851,0.000029794119,0.0029907518,0.04586794,0.0033058594,0.00019262958,0.009273111,0.11414355],"study_design_scores_gemma":[0.0059783817,0.0057152607,0.875682,0.00073098193,0.0002589129,0.000004726418,0.0011361949,0.10760613,0.00080367754,0.0012507456,0.00052476395,0.0003082452],"about_ca_topic_score_codex":0.015811889,"about_ca_topic_score_gemma":0.016297413,"teacher_disagreement_score":0.22392291,"about_ca_system_score_codex":0.0012744066,"about_ca_system_score_gemma":0.0017783806,"threshold_uncertainty_score":0.9999724},"labels":[],"label_agreement":null},{"id":"W4417201219","doi":"10.1158/1557-3265.earlyonsetca25-pr002","title":"Abstract PR002: Clinical, pathological, and molecular differences in early- and late-onset colorectal cancer: Results from a multicenter study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Colorectal adenoma; Odds ratio; Adenoma; Stage (stratigraphy); Cohort; Cohort study","score_opus":0.18655809943819782,"score_gpt":0.5056002351971923,"score_spread":0.31904213575899454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929373,0.002675221,0.000004767424,0.0020300134,0.00040162585,0.0014229314,0.00011345443,0.000057396974,0.00035727827],"genre_scores_gemma":[0.994355,0.004498551,0.00007122119,0.00032224535,0.00018759997,0.00037684795,0.000008819039,0.00001673053,0.0001629457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955754,0.001018089,0.0011999772,0.0011699018,0.0005386937,0.00049789844],"domain_scores_gemma":[0.9951579,0.0037447049,0.00013813603,0.00035965812,0.00027279614,0.00032681358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004060749,0.00021649506,0.00082288537,0.00023578158,0.0001654436,0.000115250295,0.00018612751,0.00036844442,0.00006211351],"category_scores_gemma":[0.0037050347,0.00016820358,0.00011619031,0.0005870106,0.00085322885,0.00007342657,0.00037574623,0.0019947318,0.0000063804314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0279517,0.00087240245,0.92371976,0.000037428945,0.00012986992,0.00022677965,0.000379196,0.0000010782617,0.00023122932,0.0000014836269,0.00025254764,0.046196498],"study_design_scores_gemma":[0.009065702,0.004726913,0.98401403,0.00046889953,0.00007321177,9.762367e-7,0.00042194218,0.00043532575,0.00018783886,0.00018287452,0.00026927126,0.00015303057],"about_ca_topic_score_codex":0.015203525,"about_ca_topic_score_gemma":0.007518547,"teacher_disagreement_score":0.06029423,"about_ca_system_score_codex":0.00012696124,"about_ca_system_score_gemma":0.0004007801,"threshold_uncertainty_score":0.99135435},"labels":[],"label_agreement":null},{"id":"W4417201242","doi":"10.1158/1557-3265.earlyonsetca25-b021","title":"Abstract B021: Survival differences between early onset (&amp;lt; 50 years) and average onset (≥ 50 years) colorectal cancer among African Americans in metropolitan Detroit","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Epidemiology; Proportional hazards model; Cancer; Metropolitan area; Survival analysis; Surveillance, Epidemiology, and End Results","score_opus":0.15099019781181341,"score_gpt":0.4858320395385569,"score_spread":0.33484184172674347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925892,0.0032570949,0.000015749169,0.0011132421,0.00047578008,0.000907486,0.00048514,0.00004948595,0.0011068371],"genre_scores_gemma":[0.9917909,0.006382175,0.00006468014,0.00012777255,0.0005709875,0.00019603522,0.00004154603,0.00004291261,0.0007829752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947145,0.0009748793,0.0009447815,0.0009116714,0.0012621544,0.0011919851],"domain_scores_gemma":[0.99544233,0.0027388732,0.00013077115,0.00058196974,0.0002258472,0.0008802054],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035716197,0.00027553743,0.0013245468,0.0006630754,0.0001726317,0.000089869456,0.00036458424,0.00037670552,0.000417213],"category_scores_gemma":[0.0014370339,0.00024279655,0.00038176333,0.0013366361,0.0015947551,0.00009154452,0.0002638902,0.002432922,0.000037244157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092466886,0.0001368553,0.9734425,0.00013238995,0.00037101487,0.00008317699,0.0002892324,0.000001362026,0.000033683038,0.000013798662,0.0014352427,0.023136059],"study_design_scores_gemma":[0.0020955182,0.0003692034,0.9855906,0.00029583785,0.000112727146,0.000001782343,0.00044424608,0.0000073302467,0.000027097745,0.00011151342,0.010722872,0.00022127063],"about_ca_topic_score_codex":0.14875573,"about_ca_topic_score_gemma":0.046810545,"teacher_disagreement_score":0.101945184,"about_ca_system_score_codex":0.0010483218,"about_ca_system_score_gemma":0.001873467,"threshold_uncertainty_score":0.9998685},"labels":[],"label_agreement":null},{"id":"W4417201252","doi":"10.1158/1557-3265.earlyonsetca25-c005","title":"Abstract C005: APC Mutation-induced Retardation of Tissue Renewal is Fundamental to Colon Tumorigenesis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Carcinogenesis; Crypt; Cancer; Phenotype; Cell; Stem cell","score_opus":0.27730323294716963,"score_gpt":0.590147371553084,"score_spread":0.3128441386059144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808766,0.00064661383,0.000032555334,0.009339883,0.00068179064,0.0010196392,0.00008931744,0.000021340305,0.0072922106],"genre_scores_gemma":[0.9918922,0.0006348769,0.0003870173,0.0009818613,0.00040863804,0.0001667019,0.000029804653,0.000019680643,0.0054791896],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973619,0.00015804055,0.00079081865,0.0005123014,0.0007961503,0.00038079306],"domain_scores_gemma":[0.9978799,0.00057544914,0.00010577848,0.0004639899,0.0006784535,0.00029639996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002176698,0.00012409368,0.0004903313,0.00029872012,0.000111972586,0.0000274649,0.00018759075,0.00014799742,0.002620347],"category_scores_gemma":[0.0007683561,0.00011399907,0.00015599256,0.00096221204,0.0001635226,0.000052457122,0.000119911994,0.0004573772,0.00010723233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006415706,0.0010937041,0.041471314,0.0010955167,0.00047529605,0.00009706456,0.0006961548,0.000020456468,0.26885182,0.00025729145,0.09551409,0.5840116],"study_design_scores_gemma":[0.003975828,0.002098798,0.24956213,0.0007363641,0.00020153621,0.0000036636914,0.0006332251,0.000028106972,0.5563383,0.00047674013,0.18570909,0.00023623665],"about_ca_topic_score_codex":0.004575587,"about_ca_topic_score_gemma":0.0009830877,"teacher_disagreement_score":0.58377534,"about_ca_system_score_codex":0.00037536802,"about_ca_system_score_gemma":0.0013483351,"threshold_uncertainty_score":0.9982914},"labels":[],"label_agreement":null},{"id":"W4417201254","doi":"10.1158/1557-3265.earlyonsetca25-b037","title":"Abstract B037: Early-Onset Cancer: A Focus on Pregnancy-Associated Cases","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnancy; Cancer; Incidence (geometry); Breast cancer; Thyroid cancer; Young adult; Ectopic pregnancy","score_opus":0.3092114205533619,"score_gpt":0.5821282712034643,"score_spread":0.2729168506501024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679856,0.008098481,0.0000017556416,0.009825357,0.0009818717,0.0010596442,0.000328112,0.000113362825,0.011605834],"genre_scores_gemma":[0.9778618,0.01132188,0.00000666778,0.00075039966,0.00046195913,0.000549015,0.000018456687,0.000043232514,0.00898657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961675,0.0002900173,0.0008065524,0.0008094389,0.001009227,0.00091730873],"domain_scores_gemma":[0.9955351,0.0025474387,0.00013153571,0.0007280305,0.00060694147,0.00045096845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014863773,0.00024631876,0.0007401919,0.00032621773,0.0002824193,0.000075786375,0.0003356798,0.0003937701,0.0018676253],"category_scores_gemma":[0.0025859566,0.00020025834,0.00035813136,0.0010892069,0.00053651,0.00007030074,0.00016955023,0.002147345,0.0001421075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002678384,0.00094566593,0.6939893,0.00018355656,0.00039833118,0.0004001544,0.00010016477,0.000005198302,0.00007796757,0.00015415576,0.09313743,0.20792972],"study_design_scores_gemma":[0.0036722654,0.0012339241,0.9619316,0.0039039676,0.00010025881,0.0000023983152,0.00006902452,0.000023826755,0.0009495992,0.0007224337,0.027177067,0.0002136411],"about_ca_topic_score_codex":0.03165771,"about_ca_topic_score_gemma":0.008921069,"teacher_disagreement_score":0.2679423,"about_ca_system_score_codex":0.0009217784,"about_ca_system_score_gemma":0.0024320062,"threshold_uncertainty_score":0.9990448},"labels":[],"label_agreement":null},{"id":"W4417201256","doi":"10.1158/1557-3265.earlyonsetca25-pr008","title":"Abstract PR008: Incidence of early onset colorectal, kidney, uterine and pancreatic cancer by county-level obesity prevalence in the U.S., 2010-2022","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Obesity; Pancreatic cancer; Kidney cancer; Incidence (geometry); Cancer; Cancer registry; Diabetes mellitus; Confidence interval","score_opus":0.1467561604789134,"score_gpt":0.5068258905119367,"score_spread":0.36006973003302334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840337,0.007565905,0.0000061107667,0.0057780235,0.00029150405,0.0011101888,0.00088445883,0.000013334315,0.00031678905],"genre_scores_gemma":[0.9610558,0.03563495,0.000021947082,0.0008367131,0.00011657556,0.0003934345,0.000012607554,0.000014963203,0.001912969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968814,0.00038746392,0.00076206925,0.0005655846,0.0009045556,0.0004988907],"domain_scores_gemma":[0.99677384,0.0019306437,0.00014172708,0.0005350431,0.00036706947,0.00025166688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038783131,0.00017746173,0.00058934756,0.00016080323,0.00013519078,0.000046047135,0.00045634314,0.00019646989,0.0007013906],"category_scores_gemma":[0.001439269,0.00012517479,0.00010172486,0.0008127578,0.0010991873,0.00011258808,0.00024239151,0.0014273574,0.000005586496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014871556,0.00042553418,0.9235746,0.0009930563,0.00006346537,0.00002444284,0.0002203185,6.1102605e-7,0.0009431639,0.00002235421,0.06549747,0.0067477864],"study_design_scores_gemma":[0.0014410982,0.0006390497,0.9866646,0.0011982197,0.000055317512,0.0000034261463,0.00010274196,0.000050252598,0.0005901375,0.00013320381,0.009010126,0.000111825764],"about_ca_topic_score_codex":0.03262402,"about_ca_topic_score_gemma":0.0039362335,"teacher_disagreement_score":0.06308997,"about_ca_system_score_codex":0.00028054652,"about_ca_system_score_gemma":0.0020147206,"threshold_uncertainty_score":0.9738178},"labels":[],"label_agreement":null},{"id":"W4417201259","doi":"10.1158/1557-3265.earlyonsetca25-ia003","title":"Abstract IA003: Trends in cancer mortality in young adults in selected upper-middle and high-income countries with focus on colorectal cancer: an update to 2026.","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Latin Americans; Poisson regression; Young adult; Colorectal cancer; Cancer; Mortality rate; Population","score_opus":0.06920934810645309,"score_gpt":0.47676286655675515,"score_spread":0.4075535184503021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989771,0.0032198858,5.622e-7,0.005047413,0.0003449258,0.0011052508,0.00018077012,0.00003089893,0.0002992797],"genre_scores_gemma":[0.98760486,0.010848061,0.00001470516,0.00030358305,0.00024704094,0.0007657041,0.000034623226,0.000031688764,0.00014971202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957893,0.00050129835,0.000874361,0.0009545873,0.0008983236,0.0009821212],"domain_scores_gemma":[0.99810314,0.00044262115,0.00007001704,0.00044993745,0.00039252176,0.0005417755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028939869,0.00024966788,0.0010008847,0.0009819254,0.00010145537,0.000044293014,0.00020172345,0.00032428137,0.00027165207],"category_scores_gemma":[0.00040403398,0.00019460851,0.000090105714,0.0030650003,0.00032780407,0.00011629168,0.00009870923,0.0019199194,0.0000063677476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011876172,0.0003159179,0.94478256,0.00031157944,0.00009928327,0.00017430368,0.00032165737,0.00013647585,0.000015075835,0.000035283738,0.0002776442,0.04165408],"study_design_scores_gemma":[0.0069523235,0.00093082257,0.98854357,0.0019012714,0.000031705888,0.0000020955106,0.0001540286,0.00015850391,0.0002977709,0.000029914,0.0008005212,0.00019744615],"about_ca_topic_score_codex":0.3435255,"about_ca_topic_score_gemma":0.80634487,"teacher_disagreement_score":0.46281937,"about_ca_system_score_codex":0.0014010916,"about_ca_system_score_gemma":0.0025075371,"threshold_uncertainty_score":0.8341201},"labels":[],"label_agreement":null},{"id":"W4417201262","doi":"10.1158/1557-3265.earlyonsetca25-c004","title":"Abstract C004: Colonic Tissue Renewal, Retinoic Acid Signaling, Early-onset CRC","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Retinoic acid; Calcitriol receptor; Retinoid X receptor gamma; Retinoid; Retinoic acid receptor; Germline mutation; Somatic cell; Retinoid X receptor; Vitamin","score_opus":0.08375311066845019,"score_gpt":0.4879194193459572,"score_spread":0.40416630867750697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748619,0.010160764,0.00007464456,0.0009709265,0.0005314709,0.00036944452,0.000029798564,0.00002957333,0.012971446],"genre_scores_gemma":[0.98216707,0.004879601,0.00014966937,0.0004419468,0.00081416336,0.00018025843,0.00006575695,0.00003438648,0.0112671545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996794,0.0004499867,0.00067295216,0.00087881583,0.0004952436,0.00070901297],"domain_scores_gemma":[0.9980164,0.0002897695,0.000112214344,0.0008013125,0.00056113425,0.00021917404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002818158,0.00021049177,0.000328788,0.0001069213,0.00028973178,0.000109303604,0.0008521496,0.00059165584,0.00050250534],"category_scores_gemma":[0.0017368906,0.00019662749,0.0001788407,0.00045276113,0.00076273666,0.0000062834038,0.00044243276,0.0010055365,0.00016168921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014461863,0.0003783486,0.06629894,0.0004370955,0.0002652938,0.00007271878,0.00006233848,0.000030795243,0.74616414,0.00020121853,0.16345954,0.021183372],"study_design_scores_gemma":[0.0008539444,0.00054681004,0.008450425,0.00014642425,0.00002282901,0.0000026737027,0.000045117093,0.0000046834216,0.7535544,0.0010639637,0.23507139,0.00023732611],"about_ca_topic_score_codex":0.0002736495,"about_ca_topic_score_gemma":0.00013712418,"teacher_disagreement_score":0.07161185,"about_ca_system_score_codex":0.00008460042,"about_ca_system_score_gemma":0.0016078048,"threshold_uncertainty_score":0.8018236},"labels":[],"label_agreement":null},{"id":"W4417201266","doi":"10.1158/1557-3265.earlyonsetca25-b038","title":"Abstract B038: Differences in metabolomic profiles predictive of fatigue in early-onset vs. later-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Logistic regression; Quality of life (healthcare); Prospective cohort study; Cancer; Cohort; Metabolomics; Stage (stratigraphy)","score_opus":0.1543884835307184,"score_gpt":0.5044586403563902,"score_spread":0.3500701568256718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989815,0.005986687,0.0000026865714,0.0015197187,0.0004805855,0.001513583,0.00030224968,0.000020235755,0.00035925547],"genre_scores_gemma":[0.98843896,0.010414091,0.000021143062,0.000099414305,0.00014981191,0.00064326497,0.000023018858,0.000017620756,0.00019269832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960479,0.00078877463,0.0010968286,0.00059845735,0.00076763565,0.0007003903],"domain_scores_gemma":[0.9971574,0.0017630985,0.00011337502,0.00036379058,0.0003332606,0.00026908942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036862998,0.00018439026,0.0011451212,0.000609176,0.000066006905,0.00001686131,0.00026538456,0.00037283427,0.00023804289],"category_scores_gemma":[0.0015974971,0.0001385822,0.00029589195,0.0011179217,0.00075034815,0.000071414004,0.0001483998,0.0018649361,0.0000084915555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055718287,0.00034063836,0.9832625,0.0004653494,0.00021054309,0.00004432307,0.000375838,0.000011986192,0.00012713361,0.00000728728,0.0010748944,0.008507695],"study_design_scores_gemma":[0.0031342108,0.00043581292,0.99213624,0.0010537854,0.000050704795,0.000001222232,0.00022403375,0.000114332746,0.0022313357,0.00010133337,0.0004108983,0.00010609889],"about_ca_topic_score_codex":0.03085935,"about_ca_topic_score_gemma":0.01084831,"teacher_disagreement_score":0.02001104,"about_ca_system_score_codex":0.0003666347,"about_ca_system_score_gemma":0.0030591758,"threshold_uncertainty_score":0.9755942},"labels":[],"label_agreement":null},{"id":"W4417201280","doi":"10.1158/1557-3265.earlyonsetca25-pr005","title":"Abstract PR005: Uncovering the Etiology of Early-Onset Gastric Cancer in Latinos Through Germline and Tumor Genomic Profiling","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline; Germline mutation; Cancer; Etiology; Disease; Epigenetics; Microbiome; Somatic cell; MLH1","score_opus":0.08547236932481178,"score_gpt":0.4635764095743373,"score_spread":0.37810404024952554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011576,0.0077075344,0.000030948253,0.0008330147,0.00026514335,0.0004524472,0.000144835,0.0000033674203,0.0004469492],"genre_scores_gemma":[0.9847616,0.014104878,0.00015971542,0.0003294964,0.00031453537,0.00016741994,0.000014496944,0.000015815807,0.00013206317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982516,0.00018291421,0.0005793951,0.00045121217,0.00014489227,0.00038997814],"domain_scores_gemma":[0.9986052,0.0006713552,0.00011595612,0.00036305204,0.00018582189,0.00005860661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014200885,0.00012173158,0.00027353244,0.000071836,0.000090960006,0.0000254383,0.00030599948,0.00015444696,0.00003812951],"category_scores_gemma":[0.0008154292,0.00009758598,0.00007860892,0.0002797358,0.0004946745,0.0000043478017,0.00042435306,0.0005406628,0.0000018654815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010225916,0.00012656253,0.9189438,0.0001686614,0.000103640356,0.000008678935,0.00008434938,0.0013484443,0.062702514,0.0002097298,0.001666527,0.013614463],"study_design_scores_gemma":[0.0013442695,0.00034352957,0.97289425,0.00014624094,0.000019826468,0.0000021690732,0.00010384377,0.00013467834,0.015447286,0.0010039272,0.008409079,0.00015090853],"about_ca_topic_score_codex":0.002811227,"about_ca_topic_score_gemma":0.0024155062,"teacher_disagreement_score":0.053950403,"about_ca_system_score_codex":0.00006921473,"about_ca_system_score_gemma":0.000790922,"threshold_uncertainty_score":0.4249753},"labels":[],"label_agreement":null},{"id":"W4417201282","doi":"10.1158/1557-3265.earlyonsetca25-c014","title":"Abstract C014: Unexplained familial early-onset colorectal cancer: Determining a shared etiology by tumor mutational signature profiling","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"MUTYH; Colorectal cancer; KRAS; Lynch syndrome; Correlation; Cancer","score_opus":0.10496106752459723,"score_gpt":0.4926459510388146,"score_spread":0.38768488351421737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888719,0.0022231343,0.000027457458,0.003321383,0.0017472813,0.0016212721,0.00063480507,0.00011203018,0.00144077],"genre_scores_gemma":[0.9939404,0.00040034964,0.0006633389,0.0012717468,0.0008147805,0.001650235,0.00019338807,0.00005963611,0.0010061413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949334,0.0005412568,0.0011328767,0.0011785718,0.0011178416,0.0010960249],"domain_scores_gemma":[0.9944448,0.0034472588,0.00019278609,0.00041602997,0.001061777,0.00043736427],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023153666,0.00034518485,0.0008395649,0.00032890023,0.00034854363,0.00007937368,0.0005306803,0.00061716087,0.0017648798],"category_scores_gemma":[0.0038323628,0.00031280902,0.00028629196,0.00096376246,0.0010333968,0.00009387317,0.00031633186,0.0030120432,0.000058748916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011559094,0.0005349747,0.7996491,0.00054943416,0.0005428065,0.00030383255,0.00040376384,0.00012543419,0.084900804,0.00004458724,0.074523605,0.026862564],"study_design_scores_gemma":[0.007352902,0.0022531822,0.92981094,0.00100187,0.0001505295,0.000027400101,0.00041578824,0.0016966737,0.049005684,0.00064181973,0.0070813666,0.0005618196],"about_ca_topic_score_codex":0.00094133976,"about_ca_topic_score_gemma":0.0005236701,"teacher_disagreement_score":0.13016187,"about_ca_system_score_codex":0.00084462325,"about_ca_system_score_gemma":0.0043989057,"threshold_uncertainty_score":0.9999324},"labels":[],"label_agreement":null},{"id":"W4417201283","doi":"10.1158/1557-3265.earlyonsetca25-pr004","title":"Abstract PR004: Mutational signature profiling identifies a distinct subgroup of early-onset colorectal cancer associated with younger age at diagnosis, recent birth year and specific genomic features","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Colorectal cancer; Exome sequencing; Microsatellite instability; Genomics; Exome; DNA sequencing; Cancer; Cluster analysis","score_opus":0.049182731363140914,"score_gpt":0.3934973011669421,"score_spread":0.34431456980380115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98269606,0.01465364,0.000003481071,0.00046301066,0.00031877318,0.0005749402,0.0010518428,0.000008710113,0.00022956658],"genre_scores_gemma":[0.9788495,0.019295443,0.00005330647,0.000093497605,0.00028716357,0.0003288003,0.0003548183,0.000030515463,0.0007069678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979989,0.00017037726,0.0004370819,0.00062326196,0.00037231532,0.00039808304],"domain_scores_gemma":[0.9982387,0.0007176723,0.00016148861,0.00024836053,0.00049964647,0.0001341375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090404926,0.00018244008,0.00032120268,0.00009536559,0.000189202,0.00008404767,0.00024894075,0.00029610406,0.00014015309],"category_scores_gemma":[0.00077868334,0.00015849528,0.000096731106,0.0002873749,0.0006736701,0.000007925453,0.000318332,0.0005291667,0.00000254485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032551812,0.00028652517,0.9172099,0.00013017043,0.00042837564,0.00004020678,0.00011073653,0.000084433166,0.05485895,0.00008459588,0.02062663,0.002884292],"study_design_scores_gemma":[0.0012209554,0.0003530697,0.94798446,0.00016476371,0.00003457465,0.0000012443577,0.000055838602,0.000003928268,0.040867597,0.00016363888,0.008965963,0.00018395191],"about_ca_topic_score_codex":0.0004536159,"about_ca_topic_score_gemma":0.005110911,"teacher_disagreement_score":0.030774571,"about_ca_system_score_codex":0.00020572805,"about_ca_system_score_gemma":0.0007247122,"threshold_uncertainty_score":0.64632505},"labels":[],"label_agreement":null},{"id":"W4417201294","doi":"10.1158/1557-3265.earlyonsetca25-b026","title":"Abstract B026: Pre-diagnostic disease and medication history in early-onset pancreatic cancer from large-scale registry and EHR data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pancreatic cancer; Danish; Disease; Cancer registry; Cancer; Logistic regression; Medical prescription; Gastrointestinal cancer","score_opus":0.19141287182337618,"score_gpt":0.5272541118584195,"score_spread":0.33584124003504334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93520284,0.052508295,0.000022471837,0.009593712,0.00022060481,0.0010053593,0.00043676,0.000026320711,0.0009836268],"genre_scores_gemma":[0.9433703,0.051118635,0.00016538105,0.00081813126,0.00039657688,0.00055606914,0.00021918437,0.000022827018,0.0033329236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631286,0.0006028625,0.00073466584,0.0009942206,0.00073350605,0.00062188064],"domain_scores_gemma":[0.98912364,0.008548269,0.000101732294,0.0012878034,0.00021873505,0.0007198279],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042637624,0.00017093238,0.0007213532,0.00023922746,0.00013553524,0.000030701653,0.00044893345,0.00029922553,0.0009911028],"category_scores_gemma":[0.01179132,0.00014789274,0.000044567867,0.00029460483,0.0014379867,0.00014033975,0.0006536832,0.0015452349,0.000020710737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016184986,0.0004002088,0.93417567,0.00043709463,0.0001411797,0.00013258411,0.00025081504,3.0290724e-7,0.000022909986,0.000019803707,0.054913417,0.007887501],"study_design_scores_gemma":[0.0032173514,0.00013126833,0.97151136,0.0014095602,0.00026488525,0.000001365971,0.00015582453,0.00144849,0.0000035009252,0.0008515737,0.02088901,0.00011583495],"about_ca_topic_score_codex":0.016472794,"about_ca_topic_score_gemma":0.0053574312,"teacher_disagreement_score":0.03733565,"about_ca_system_score_codex":0.00058059744,"about_ca_system_score_gemma":0.0039827116,"threshold_uncertainty_score":0.99992216},"labels":[],"label_agreement":null},{"id":"W4417201295","doi":"10.1158/1557-3265.earlyonsetca25-c030","title":"Abstract C030: Effect of palmitic acid exposure in normal colon organoids derived from young versus older individuals","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Organoid; Colorectal cancer; Matrigel; Palmitic acid; Crypt; Rectum","score_opus":0.10488224099725385,"score_gpt":0.4974944077884912,"score_spread":0.39261216679123734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890353,0.0054529877,0.0000064257465,0.0008639198,0.0010090021,0.0008826969,0.00011160662,0.000020020248,0.002618039],"genre_scores_gemma":[0.9970544,0.001812681,0.00007245388,0.00012241349,0.00034686664,0.00018862057,0.00004698062,0.000025412124,0.00033016197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966318,0.0005549092,0.0008677643,0.0005486491,0.00080779777,0.00058907084],"domain_scores_gemma":[0.9957375,0.0030846177,0.00010666082,0.00054080784,0.00029061848,0.0002398205],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033490246,0.00018657102,0.00085589645,0.00028783173,0.000073803734,0.000029089051,0.00029119686,0.00032273977,0.0020121203],"category_scores_gemma":[0.001992887,0.00015321525,0.00022932547,0.0008726851,0.0003845916,0.00006898382,0.00022038842,0.0013605517,0.000041720446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092279585,0.000435993,0.8638031,0.0006596306,0.00042670025,0.00012291607,0.00028270614,0.0000063694497,0.052307528,0.000013445663,0.0028477872,0.06986588],"study_design_scores_gemma":[0.014884073,0.0014852663,0.8038503,0.0007355216,0.0001711653,6.434984e-7,0.00014852619,0.0000061559535,0.17687796,0.000025761103,0.001693659,0.00012097384],"about_ca_topic_score_codex":0.0034424562,"about_ca_topic_score_gemma":0.0024463034,"teacher_disagreement_score":0.12457044,"about_ca_system_score_codex":0.00027349417,"about_ca_system_score_gemma":0.0010848581,"threshold_uncertainty_score":0.9989002},"labels":[],"label_agreement":null},{"id":"W4417201296","doi":"10.1158/1557-3265.earlyonsetca25-b019","title":"Abstract B019: Lifestyle and reproductive factors and early-onset invasive epithelial ovarian cancer risk","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Mary's Hospital Centre; Université de Montréal; McGill University","funders":"","keywords":"Ovarian cancer; Odds ratio; Logistic regression; Body mass index; Risk factor; Population; Epithelial ovarian cancer; Serous fluid","score_opus":0.12782186633567866,"score_gpt":0.48470631159900196,"score_spread":0.3568844452633233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753756,0.007900985,0.000002014481,0.01356954,0.0005597231,0.0010662074,0.00031557368,0.00003500111,0.0011753339],"genre_scores_gemma":[0.96020466,0.037161186,0.00007882337,0.0003264415,0.0007717751,0.000404367,0.000008938435,0.000029155548,0.0010146459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684966,0.00036739075,0.00058592344,0.0011605463,0.0004906112,0.00054590125],"domain_scores_gemma":[0.99564224,0.0026764765,0.00013445328,0.00064189767,0.00044793598,0.00045701335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020691284,0.00024119265,0.00066791027,0.00022212631,0.00033095456,0.000095204734,0.00013530636,0.00024769036,0.0004336284],"category_scores_gemma":[0.0029805226,0.00017837304,0.00013592243,0.00046460892,0.00086171814,0.00010906407,0.00024741606,0.0012477635,0.00001684245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094008207,0.00034204,0.9569706,0.00014548615,0.0005884803,0.000058721762,0.0003787293,0.0000010465884,0.000059520888,0.00012172983,0.006583724,0.033809856],"study_design_scores_gemma":[0.0033412739,0.00056282966,0.9813069,0.00053181825,0.00023289352,0.0000026283424,0.00021545656,0.0000033529402,0.002160873,0.00095275824,0.010539958,0.000149273],"about_ca_topic_score_codex":0.022945937,"about_ca_topic_score_gemma":0.0024538247,"teacher_disagreement_score":0.033660583,"about_ca_system_score_codex":0.00029814185,"about_ca_system_score_gemma":0.0014988171,"threshold_uncertainty_score":0.9835603},"labels":[],"label_agreement":null},{"id":"W4417201302","doi":"10.1158/1557-3265.earlyonsetca25-pr003","title":"Abstract PR003: Exploring the exposome impact in early-onset colon and rectal cancer using methylation scores","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exposome; Colorectal cancer; DNA methylation; Biomarker; Cancer; Methylation; Population; Cohort","score_opus":0.30324142490203715,"score_gpt":0.5534668886680574,"score_spread":0.25022546376602023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879635,0.0099950805,0.0000408701,0.0003707187,0.0002731335,0.0003631775,0.000020019348,0.0000043890677,0.00013624947],"genre_scores_gemma":[0.98980933,0.009541747,0.000056275272,0.00003672961,0.00027593254,0.00016219549,0.0000099767185,0.000014198126,0.00009361009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982625,0.00041042498,0.00037793285,0.00039275194,0.00022953254,0.0003268433],"domain_scores_gemma":[0.99901086,0.00038999974,0.000065576074,0.00027012164,0.0001837907,0.000079641606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002527578,0.00010787634,0.00016762092,0.000117935204,0.00016611208,0.000070856884,0.00017451982,0.00015414286,0.000021069678],"category_scores_gemma":[0.00076332496,0.00008083443,0.00007436989,0.00035591988,0.00024205256,0.000011990023,0.0001876808,0.00044666478,0.0000011821792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048980146,0.000053149695,0.78233117,0.000031029922,0.0000646449,0.0000023824864,0.0001116646,0.0007098135,0.17454748,0.000013485024,0.0001286726,0.041516732],"study_design_scores_gemma":[0.0004824101,0.00018550272,0.9194649,0.00009074725,0.000010001949,1.8736816e-7,0.00004942409,0.00033950558,0.07793655,0.00046006328,0.00088400254,0.0000967415],"about_ca_topic_score_codex":0.0034073724,"about_ca_topic_score_gemma":0.001963444,"teacher_disagreement_score":0.1371337,"about_ca_system_score_codex":0.000091318485,"about_ca_system_score_gemma":0.0004393116,"threshold_uncertainty_score":0.51509506},"labels":[],"label_agreement":null},{"id":"W4417201305","doi":"10.1158/1557-3265.earlyonsetca25-c011","title":"Abstract C011: Distinct peripheral immune signatures in early-onset colorectal cancer reveal candidate biomarkers for risk stratification","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Chemokine; Human leukocyte antigen; Peripheral blood mononuclear cell; Cytokine; Biomarker; Immunity; Colorectal cancer","score_opus":0.05961776792758723,"score_gpt":0.4325553703664647,"score_spread":0.37293760243887747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933285,0.0037388217,0.00011348219,0.00056217297,0.0005869112,0.00076262397,0.0004894102,0.000011153492,0.00040693657],"genre_scores_gemma":[0.9959668,0.002120383,0.00010983419,0.00007203201,0.00032293296,0.0005171312,0.00017451298,0.000024046343,0.00069232105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774235,0.00031879666,0.00060276577,0.00062369264,0.00021921528,0.00049315515],"domain_scores_gemma":[0.9988804,0.00031582368,0.000105306775,0.00030687344,0.00027972262,0.00011190413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018766093,0.00016680667,0.0002754572,0.00008955211,0.00021640274,0.00007319556,0.0003765977,0.00037422992,0.000069101065],"category_scores_gemma":[0.0006363272,0.00015330443,0.00018709633,0.00028177607,0.00040515166,0.0000076168253,0.00007216158,0.00064042804,0.0000016192323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007126644,0.00035564168,0.6527024,0.00016001184,0.0002715067,0.000004474237,0.00008545412,0.00015589663,0.28624293,0.00002406229,0.011042608,0.041828394],"study_design_scores_gemma":[0.002126424,0.00043683476,0.9374565,0.0001213083,0.00002677776,1.8494131e-7,0.00005692597,0.00039194507,0.05364167,0.0003618434,0.0051527666,0.00022681021],"about_ca_topic_score_codex":0.008822169,"about_ca_topic_score_gemma":0.018326806,"teacher_disagreement_score":0.28475416,"about_ca_system_score_codex":0.00012566414,"about_ca_system_score_gemma":0.0008121006,"threshold_uncertainty_score":0.99958616},"labels":[],"label_agreement":null},{"id":"W4417201306","doi":"10.1158/1557-3265.earlyonsetca25-c036","title":"Abstract C036: The Neurological and Immunological Interplay in Cancer Progression and Treatment Response","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer; Tumor progression; Immunotherapy; Psychoneuroimmunology; Mechanism (biology); Neurotransmitter Agents; Neuroimmunology; Cytokine; Phenotype","score_opus":0.17554515572638496,"score_gpt":0.5608560426691778,"score_spread":0.3853108869427928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9209646,0.041255336,5.9068935e-7,0.036309276,0.00019800302,0.0009325203,0.0000082003,0.000028486675,0.0003029798],"genre_scores_gemma":[0.93219155,0.06471159,0.00001617284,0.00073477573,0.00023203666,0.0006316582,0.0000018636235,0.000013810717,0.0014665351],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964255,0.0014444775,0.0005894777,0.00064234604,0.00035309265,0.0005450674],"domain_scores_gemma":[0.9934964,0.0056884754,0.00006685937,0.0004509763,0.0001342259,0.00016306575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035767916,0.00020182184,0.00055634644,0.00021167507,0.00022934338,0.0000729244,0.00020503368,0.0003027606,0.00022212941],"category_scores_gemma":[0.0023088155,0.000108111606,0.00011742593,0.00043386815,0.0017167041,0.00005286884,0.00025752597,0.0013020476,0.000006938057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072914176,0.0006292338,0.2730991,0.000056140394,0.0000769912,0.0002363789,0.00021104461,0.0000015136388,0.0014667233,0.000051567746,0.0013104791,0.6499467],"study_design_scores_gemma":[0.0026895832,0.002604706,0.89161545,0.000542556,0.00002969099,0.000024602728,0.00016793262,0.00011296093,0.00027386742,0.000072556264,0.101773925,0.00009218042],"about_ca_topic_score_codex":0.0008712738,"about_ca_topic_score_gemma":0.0004511856,"teacher_disagreement_score":0.6498545,"about_ca_system_score_codex":0.0002268861,"about_ca_system_score_gemma":0.00080496765,"threshold_uncertainty_score":0.6325268},"labels":[],"label_agreement":null},{"id":"W4417201309","doi":"10.1158/1557-3265.earlyonsetca25-b035","title":"Abstract B035: Multilevel Insights into Obesity, Race/Ethnicity, and Survival in Early-Onset Colorectal Cancer in Georgia","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Obesity; Proportional hazards model; Cancer; Cohort; Marital status; Body mass index; Cohort study; Retrospective cohort study","score_opus":0.11693370066834648,"score_gpt":0.5077404522054478,"score_spread":0.39080675153710137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983319,0.012002436,0.000004152418,0.0021015613,0.0007543107,0.0011682702,0.000027973092,0.00002738085,0.0005949054],"genre_scores_gemma":[0.97545063,0.02334076,0.000025003419,0.00021863094,0.0002925288,0.00021462991,0.000010490456,0.000025472584,0.00042186503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957946,0.00081347,0.00093195436,0.00078623835,0.00087222847,0.00080149027],"domain_scores_gemma":[0.9966081,0.0020544913,0.00006502552,0.0004108085,0.00036416965,0.00049744284],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004906376,0.00021234466,0.0009643675,0.0006286305,0.00014989916,0.000039598002,0.00023938292,0.0005057758,0.00014598247],"category_scores_gemma":[0.0019223286,0.00017630907,0.0001962503,0.0011476127,0.00069107226,0.00009945777,0.00041387603,0.002799526,0.000023283555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017996795,0.00038060427,0.94841254,0.0004476074,0.00009387301,0.00018978477,0.00075553695,0.000015151988,0.00012397997,0.000024677607,0.00055417087,0.047202405],"study_design_scores_gemma":[0.0049009956,0.00017518831,0.98959684,0.00074377394,0.000025841584,0.0000021183234,0.00016785297,0.00024500446,0.00032112063,0.00036256766,0.0033004985,0.00015820649],"about_ca_topic_score_codex":0.09125259,"about_ca_topic_score_gemma":0.11852885,"teacher_disagreement_score":0.0470442,"about_ca_system_score_codex":0.00084591523,"about_ca_system_score_gemma":0.0035749227,"threshold_uncertainty_score":0.99950105},"labels":[],"label_agreement":null},{"id":"W4417201312","doi":"10.1158/1557-3265.earlyonsetca25-pr006","title":"Abstract PR006: Temporal Trends in the Incidence of Obesity-Associated Cancers in Puerto Rico, 2000–2022: Disproportionate Increases Among Younger Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Cancer; Thyroid cancer; Cancer incidence; Standardized rate; Public health; Behavioral Risk Factor Surveillance System; Young adult","score_opus":0.09723857094561612,"score_gpt":0.49679555465873215,"score_spread":0.39955698371311604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924022,0.0021022866,7.380605e-7,0.0027515849,0.00021179371,0.000713456,0.000100881334,0.000018358447,0.001698717],"genre_scores_gemma":[0.9966126,0.0019016999,0.000005749895,0.00035950178,0.00013093589,0.00020336256,0.00007662775,0.000015848458,0.0006936357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958653,0.00054916006,0.0012274025,0.000584688,0.0011502504,0.00062320125],"domain_scores_gemma":[0.99750054,0.0012647714,0.00024110648,0.0005202461,0.00030159432,0.0001717535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048564803,0.0001919269,0.0006765472,0.0006806619,0.00009614432,0.00003090059,0.00044551966,0.00027481714,0.00080208865],"category_scores_gemma":[0.0020542268,0.00013684944,0.00021678071,0.0030586873,0.00076799945,0.00018239382,0.00012463299,0.0017957919,0.0000047124345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018016142,0.00074759417,0.9618812,0.000117415424,0.000057660895,0.00014834022,0.0002626493,0.00003144747,0.000021274469,0.000026526382,0.0053698225,0.02953446],"study_design_scores_gemma":[0.0028660842,0.00027436027,0.99372923,0.0011992785,0.000029117095,7.5422656e-7,0.0005797097,0.00026779875,0.00004776111,0.00014221476,0.00074067595,0.00012302479],"about_ca_topic_score_codex":0.37373814,"about_ca_topic_score_gemma":0.29408163,"teacher_disagreement_score":0.0796565,"about_ca_system_score_codex":0.0011971963,"about_ca_system_score_gemma":0.002257091,"threshold_uncertainty_score":0.8782308},"labels":[],"label_agreement":null},{"id":"W4417201316","doi":"10.1158/1557-3265.earlyonsetca25-a025","title":"Abstract A025: Accelerated aging as a predictor for early onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Colorectal cancer; Informed consent; Prospective cohort study; Cancer; Disease; Demographics; Young adult","score_opus":0.23635967442976202,"score_gpt":0.5543422393817735,"score_spread":0.3179825649520115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843067,0.001971593,0.00008581585,0.0053370385,0.0013435214,0.0016787171,0.000118557065,0.0001902392,0.004967813],"genre_scores_gemma":[0.9891547,0.0008375213,0.00009436532,0.00070047023,0.0012001412,0.0020081694,0.000024880397,0.000040285544,0.005939495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686986,0.00019484771,0.00069695804,0.0007790154,0.00069231185,0.00076700473],"domain_scores_gemma":[0.99618834,0.0018223657,0.00010141339,0.00034467317,0.0011704927,0.00037269862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024249118,0.00020297116,0.0005508916,0.00035095986,0.0003763244,0.00011842134,0.00026611137,0.00034867827,0.0008060115],"category_scores_gemma":[0.0022368743,0.00018039857,0.00029525303,0.0011516197,0.00038290583,0.0001135379,0.00015034487,0.0014938029,0.000047089587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08052383,0.0006623092,0.57032484,0.0008175612,0.0008898609,0.00007115263,0.00035053812,0.000034392597,0.004341186,0.00010569447,0.0889041,0.2529745],"study_design_scores_gemma":[0.0056817685,0.0040948293,0.93940204,0.0009975606,0.00012844648,0.0000058929036,0.00012489824,0.0009019213,0.01330122,0.00061040267,0.03452088,0.00023011526],"about_ca_topic_score_codex":0.006591003,"about_ca_topic_score_gemma":0.0018520567,"teacher_disagreement_score":0.3690772,"about_ca_system_score_codex":0.00061314617,"about_ca_system_score_gemma":0.0028667902,"threshold_uncertainty_score":0.99636686},"labels":[],"label_agreement":null},{"id":"W4417201375","doi":"10.1158/1557-3265.earlyonsetca25-c025","title":"Abstract C025: Endometrial cancer mutation patterns by age with possible increased TP53 and decreased PTEN mutations in patients 50+ years old","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PTEN; Endometrial cancer; KRAS; Stage (stratigraphy); Cancer; Histology; Medical record","score_opus":0.09224893516064057,"score_gpt":0.4686459342393317,"score_spread":0.3763969990786911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512565,0.0011273844,0.000012220195,0.0007619081,0.00022296462,0.0013799341,0.00036707512,0.00003340723,0.0009694569],"genre_scores_gemma":[0.9961504,0.0013030428,0.00007904216,0.00059022236,0.00020295885,0.0006182635,0.00031469803,0.000029927769,0.0007114455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685156,0.00031301533,0.0007122403,0.00066250237,0.0009102708,0.000550382],"domain_scores_gemma":[0.99674416,0.002069244,0.00011515257,0.0003076946,0.00032591418,0.00043782833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011320955,0.00020172623,0.0005969708,0.0007123022,0.00012003479,0.00008050442,0.00016835034,0.00021094043,0.0007257901],"category_scores_gemma":[0.001387782,0.00016007143,0.00010677187,0.0018611252,0.00030540998,0.00013101335,0.00009083104,0.00079984963,0.000013710332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007090137,0.0011144003,0.9106297,0.00014955632,0.0002307057,0.00008279065,0.00007170449,0.0000046178466,0.00008782793,0.000015326275,0.00091336144,0.0796099],"study_design_scores_gemma":[0.03126281,0.0009936257,0.9650289,0.000589583,0.00013278032,4.896723e-7,0.000090678834,0.000021434646,0.00030153367,0.00014655503,0.0012851382,0.00014650231],"about_ca_topic_score_codex":0.03980212,"about_ca_topic_score_gemma":0.004123355,"teacher_disagreement_score":0.0794634,"about_ca_system_score_codex":0.0005408998,"about_ca_system_score_gemma":0.0007693022,"threshold_uncertainty_score":0.9665919},"labels":[],"label_agreement":null},{"id":"W4417201441","doi":"10.1158/1557-3265.earlyonsetca25-pr015","title":"Abstract PR015: Multidimensional assessment of toxicities and survivorship among people with early-onset colorectal cancer – Results from the ColoCare Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Survivorship curve; Colorectal cancer; Incidence (geometry); Socioeconomic status; Quality of life (healthcare); Cohort; Cancer; Prospective cohort study","score_opus":0.12370613819137811,"score_gpt":0.49693509335273034,"score_spread":0.37322895516135224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118096,0.0018033291,8.567032e-7,0.0028381369,0.00025231275,0.002011234,0.0006772729,0.0000224245,0.0012135057],"genre_scores_gemma":[0.99709994,0.0010726217,0.000043650394,0.00010345094,0.00014984164,0.0008710118,0.000028217699,0.000018205666,0.00061303825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968148,0.00050223584,0.0006704576,0.0006472573,0.00096228265,0.00040296235],"domain_scores_gemma":[0.99235964,0.00614837,0.00014623371,0.00036734616,0.00082528783,0.00015314222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021089062,0.00020918611,0.0007151607,0.00009092572,0.00037576552,0.000039794635,0.00017215085,0.00011935325,0.00012352952],"category_scores_gemma":[0.00068475096,0.0001183806,0.000097443146,0.00053265644,0.0010840311,0.000056235032,0.00031294936,0.0008576707,0.0000010560605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009347852,0.00084748626,0.98228556,0.000055417135,0.0010050446,0.00003411769,0.0020474566,0.000011498203,0.00003407922,0.000023043032,0.0017131765,0.0025952694],"study_design_scores_gemma":[0.0061673583,0.0028566967,0.9832815,0.00050366484,0.00020003437,5.0894175e-7,0.0064313095,0.00007566248,0.00016584936,0.00003778129,0.00016984642,0.0001097827],"about_ca_topic_score_codex":0.110239655,"about_ca_topic_score_gemma":0.25992104,"teacher_disagreement_score":0.14968139,"about_ca_system_score_codex":0.00029003483,"about_ca_system_score_gemma":0.0013718838,"threshold_uncertainty_score":0.8956853},"labels":[],"label_agreement":null},{"id":"W4417201463","doi":"10.1158/1557-3265.earlyonsetca25-pr014","title":"Abstract PR014: FIT for red flag signs and symptoms of early onset colorectal cancer: low value or viable diagnostic tool?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Hazard ratio; Population; Proportional hazards model; Confidence interval; Cumulative incidence; Cohort; Anemia","score_opus":0.1358743743193789,"score_gpt":0.4912567668193131,"score_spread":0.3553823924999342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930966,0.0018263098,0.00009734221,0.0016214494,0.000695567,0.0018509487,0.00017225242,0.0000631945,0.00057633186],"genre_scores_gemma":[0.9943468,0.0012911396,0.00015548767,0.00018850554,0.00050648965,0.0013344481,0.000012460306,0.00003145341,0.0021332377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971802,0.00019496564,0.0007684482,0.00065175,0.0005725185,0.00063209626],"domain_scores_gemma":[0.9899901,0.008543515,0.00013341963,0.0003369942,0.00073049724,0.0002654668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024656588,0.00018584769,0.0006778983,0.00024546322,0.00021710258,0.000052532476,0.00019756376,0.0003152176,0.00031715241],"category_scores_gemma":[0.0073812995,0.00015014096,0.00019550638,0.0007710155,0.00053215603,0.000089547015,0.00014917862,0.0008532382,0.000005921239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14251472,0.0009980245,0.46914208,0.0032099055,0.00085778406,0.00006972239,0.00031377882,0.00021348649,0.0050188857,0.00013891542,0.032869942,0.34465277],"study_design_scores_gemma":[0.008596139,0.028252114,0.92728174,0.0029170932,0.00027745822,0.000009319408,0.00012011462,0.0022561585,0.018165683,0.00072341674,0.011044563,0.00035622437],"about_ca_topic_score_codex":0.003637995,"about_ca_topic_score_gemma":0.0014787248,"teacher_disagreement_score":0.45813966,"about_ca_system_score_codex":0.00033274535,"about_ca_system_score_gemma":0.0021512017,"threshold_uncertainty_score":0.88366383},"labels":[],"label_agreement":null},{"id":"W4417201520","doi":"10.1158/1557-3265.earlyonsetca25-a009","title":"Abstract A009: Mutation Matters: ATM and BRCA1/2 Shape Divergent Coagulopathy Programs in Pancreatic Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline mutation; Germline; Coagulation; Mutation; Factor V; Coagulopathy; Fibrinogen; Pancreatic cancer","score_opus":0.27396842602099336,"score_gpt":0.54578884735587,"score_spread":0.2718204213348766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97166526,0.0053796344,0.0000105980425,0.018669184,0.00023383816,0.0016781745,0.00001523284,0.00003690191,0.002311195],"genre_scores_gemma":[0.9822726,0.011494505,0.00018714057,0.0013740304,0.00027092765,0.0012159591,0.000024599864,0.000023312412,0.0031369277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963916,0.0004852898,0.00084643235,0.0006860924,0.00078511104,0.00080545753],"domain_scores_gemma":[0.9970534,0.0016463043,0.00008336446,0.00038846658,0.00045742205,0.00037104357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039427187,0.00018302177,0.0008119692,0.00035127604,0.00017584619,0.000060925257,0.00022201687,0.00029905076,0.0014684247],"category_scores_gemma":[0.0011248668,0.0001492408,0.00010029369,0.0008661677,0.0009411437,0.00009448785,0.00024967533,0.0013671744,0.0000808798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011889817,0.0005384786,0.85092425,0.00058770063,0.00016520878,0.00021289462,0.00025037874,0.0000015789263,0.00017637276,0.00008273628,0.005029654,0.14084177],"study_design_scores_gemma":[0.003883742,0.0005793096,0.9866682,0.0013427584,0.00011238574,0.0000060757898,0.000521662,0.001274264,0.000054039716,0.0006688299,0.0047605997,0.00012812825],"about_ca_topic_score_codex":0.005727828,"about_ca_topic_score_gemma":0.001963284,"teacher_disagreement_score":0.14071365,"about_ca_system_score_codex":0.0005161995,"about_ca_system_score_gemma":0.0016793067,"threshold_uncertainty_score":0.99944437},"labels":[],"label_agreement":null},{"id":"W4417201521","doi":"10.1158/1557-3265.earlyonsetca25-a001","title":"Abstract A001: Unravelling the molecular structural and functional roles of the homologous Mouse double minute RINGs interface for targeted anticancer design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer therapy; Cancer; Downregulation and upregulation; Cancer cell; Flexibility (engineering); Mechanism (biology); Folding (DSP implementation); Homologous chromosome; Apoptosis","score_opus":0.10592126432558735,"score_gpt":0.43500387880241587,"score_spread":0.3290826144768285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859249,0.0044856993,0.0064929607,0.002008446,0.00026439087,0.0006924679,0.00002557447,0.000005042242,0.00010053728],"genre_scores_gemma":[0.9974882,0.0003871396,0.0003209341,0.00021924409,0.00013255153,0.00011718257,0.000007789427,0.000010874822,0.0013160767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877423,0.00016920752,0.0003116071,0.00031039107,0.0002057855,0.0002287914],"domain_scores_gemma":[0.9990302,0.0002235412,0.00008047289,0.0003090346,0.00031110694,0.000045645123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012207587,0.00009382471,0.00013567175,0.000033592398,0.0001985215,0.000035086538,0.00029282685,0.00013949482,0.000027740274],"category_scores_gemma":[0.00044052678,0.000056930032,0.00010632163,0.00014669957,0.0006050492,0.000004840083,0.00021485888,0.0003110439,6.342397e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019972294,0.00004637988,0.0023593798,0.000079056386,0.00018402857,5.1726516e-7,0.0000392847,0.0011784697,0.97517353,0.0010808896,0.008644586,0.009216667],"study_design_scores_gemma":[0.00095126755,0.0001302402,0.007879483,0.000038941776,0.000014159997,6.9332435e-7,0.000061324165,0.00041059416,0.9819827,0.00071854354,0.0077383867,0.00007365857],"about_ca_topic_score_codex":0.000109866916,"about_ca_topic_score_gemma":0.00006515878,"teacher_disagreement_score":0.011563325,"about_ca_system_score_codex":0.00002206246,"about_ca_system_score_gemma":0.00031498226,"threshold_uncertainty_score":0.23215392},"labels":[],"label_agreement":null},{"id":"W4417201523","doi":"10.1158/1557-3265.earlyonsetca25-c010","title":"Abstract C010: Association of a germline KDM3C polymorphism with early cancer diagnosis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Loss of heterozygosity; Cohort; Cancer; Biobank; Prospective cohort study; Germline; Uniparental disomy","score_opus":0.08950192909358919,"score_gpt":0.4964822151284823,"score_spread":0.4069802860348931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98592955,0.009936344,0.000094311064,0.002120384,0.00021616455,0.00025551175,0.00006968562,0.0000058792243,0.0013721726],"genre_scores_gemma":[0.98072964,0.015320909,0.000107277294,0.00012093587,0.00039403516,0.00034307322,0.000020250285,0.000016358508,0.0029475202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982127,0.00020649144,0.0004589391,0.00038595384,0.00042033716,0.00031557036],"domain_scores_gemma":[0.99836445,0.00034469838,0.00017150979,0.00033021407,0.0006952776,0.000093840026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018836496,0.00010176458,0.00022970386,0.00009038037,0.00008468862,0.000026210284,0.00022067603,0.00028405318,0.00016988126],"category_scores_gemma":[0.00076150266,0.0000864126,0.000110864676,0.00033479696,0.00015978159,0.000004272078,0.00011560546,0.00035707996,0.000004966702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040635702,0.00019496497,0.9018493,0.00005119896,0.00022021918,0.0000015608381,0.000020379208,0.00005589461,0.053278763,0.0000420737,0.004543203,0.03933608],"study_design_scores_gemma":[0.0010580048,0.0003822496,0.78853095,0.00012378785,0.00003319029,3.189194e-8,0.000011371542,0.000014638217,0.17902704,0.00024448236,0.03046068,0.00011355245],"about_ca_topic_score_codex":0.002069826,"about_ca_topic_score_gemma":0.0015540418,"teacher_disagreement_score":0.12574828,"about_ca_system_score_codex":0.00008407831,"about_ca_system_score_gemma":0.000566589,"threshold_uncertainty_score":0.35238037},"labels":[],"label_agreement":null},{"id":"W4417201604","doi":"10.1158/1557-3265.earlyonsetca25-c008","title":"Abstract C008: Characterizing factors associated with early onset breast cancer to inform tailored strategies for cancer risk assessment, screening, and treatment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Family history; Retrospective cohort study; Cancer; Medical record; Cohort; Natural history; Categorical variable; Continuous variable","score_opus":0.15403152309469603,"score_gpt":0.5014860557292843,"score_spread":0.34745453263458825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918166,0.0006735409,0.0003615776,0.0027526491,0.00026682977,0.0011480676,0.002705255,0.000024088411,0.00025143544],"genre_scores_gemma":[0.9932411,0.002372353,0.00023507647,0.00032136583,0.0003110206,0.0022370573,0.00020761922,0.000044350167,0.0010300592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757785,0.00016234751,0.0004982235,0.0007561965,0.00035558682,0.00064982293],"domain_scores_gemma":[0.997949,0.0003869073,0.00019955433,0.00040782196,0.0008140715,0.00024262749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009411829,0.00027864115,0.00039223643,0.0001583013,0.0004860945,0.0002541559,0.00029974515,0.00028764835,0.00011721821],"category_scores_gemma":[0.00022971252,0.00022133486,0.00012966924,0.00046525343,0.00036101547,0.000033294556,0.00016825137,0.0004304213,0.0000011050482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014893006,0.00018697494,0.9078921,0.000051071205,0.0013162098,0.0000018287692,0.00028201487,0.0003552465,0.005361442,0.00003115854,0.004692091,0.07834056],"study_design_scores_gemma":[0.002073618,0.0007984648,0.97080356,0.00021182052,0.0000961832,3.1442218e-7,0.0005383956,0.00008328809,0.003515405,0.000055044533,0.021555876,0.0002680582],"about_ca_topic_score_codex":0.006063483,"about_ca_topic_score_gemma":0.018774692,"teacher_disagreement_score":0.0780725,"about_ca_system_score_codex":0.00063647295,"about_ca_system_score_gemma":0.003437937,"threshold_uncertainty_score":0.99913013},"labels":[],"label_agreement":null},{"id":"W4417201605","doi":"10.1158/1557-3265.earlyonsetca25-ia001","title":"Abstract IA001: Integrative cancer population sciences to decipher the etiology of early-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer; Incidence (geometry); Pancreatic cancer; Population; Obesity; Prostate cancer; Etiology; Kidney cancer; Epidemiology","score_opus":0.12233761220798132,"score_gpt":0.5356147811761156,"score_spread":0.41327716896813427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932546,0.0034133522,0.000052252475,0.0040485444,0.00084619864,0.00052303064,0.00023782565,0.000004539586,0.0015488105],"genre_scores_gemma":[0.9916093,0.005780625,0.00006996678,0.0008690638,0.00047933124,0.000506834,0.000018559527,0.000012385441,0.0006539591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795294,0.0002796145,0.0005011898,0.00055018225,0.00029389918,0.00042216628],"domain_scores_gemma":[0.9981199,0.0007964379,0.00011530504,0.0003018984,0.0005532133,0.00011322638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017914698,0.00014096216,0.0002775466,0.000102641636,0.0002569858,0.00004589779,0.00059027766,0.00022006937,0.00025938105],"category_scores_gemma":[0.0014078857,0.000097466655,0.00013377066,0.0005731988,0.0009426006,0.0000051552447,0.00036311388,0.00041876305,0.000009092828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016321868,0.00015663428,0.86131656,0.000038033195,0.00020357099,0.0000016183893,0.00020287397,0.0014591411,0.023367552,0.0009177346,0.06427686,0.046427216],"study_design_scores_gemma":[0.0005539528,0.00070740184,0.94988203,0.0001488051,0.000026739719,3.625197e-7,0.00024040186,0.000058445527,0.024529984,0.0009476804,0.022736728,0.00016747323],"about_ca_topic_score_codex":0.011050779,"about_ca_topic_score_gemma":0.02556987,"teacher_disagreement_score":0.08856545,"about_ca_system_score_codex":0.00012210288,"about_ca_system_score_gemma":0.0012245242,"threshold_uncertainty_score":0.9955347},"labels":[],"label_agreement":null},{"id":"W4417201607","doi":"10.1158/1557-3265.earlyonsetca25-a018","title":"Abstract A018: Colorectal Cancer Screening Remains Low Despite High Burden And Rising Early-Onset Cases In Puerto Rico, 2016–2021","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer screening; Colorectal cancer; Odds ratio; Public health; Cancer screening; Odds; Cancer; Young adult; Health insurance","score_opus":0.12217843182286921,"score_gpt":0.48584548695658264,"score_spread":0.36366705513371345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862942,0.0059618996,0.00008696565,0.004578405,0.000555376,0.0008486119,0.00005472261,0.00006947791,0.0015503266],"genre_scores_gemma":[0.99246025,0.0038454316,0.00027906348,0.00026520796,0.0012302113,0.00034785894,0.000012225012,0.000040815314,0.0015189598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996043,0.000484353,0.0008628625,0.00096514187,0.0007717069,0.0008728847],"domain_scores_gemma":[0.99567854,0.0028754324,0.00012862256,0.00040122058,0.0005111807,0.00040502136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033152062,0.00026284216,0.0007289554,0.0006450344,0.00034585517,0.00014776042,0.00021416499,0.0003977562,0.00044135307],"category_scores_gemma":[0.002871974,0.00024238734,0.00017191331,0.001585473,0.0006021867,0.00017696287,0.00031225965,0.0021198608,0.000021404567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022615736,0.00018437921,0.571461,0.00034142743,0.00022515813,0.00080835604,0.0003170304,0.00014391576,0.0016593143,0.000015814705,0.005284701,0.39694312],"study_design_scores_gemma":[0.0037353993,0.0016844886,0.9837208,0.0027790063,0.000069722046,0.000027492719,0.00027569997,0.0010872297,0.002371471,0.0001488354,0.0038310713,0.00026880926],"about_ca_topic_score_codex":0.05781536,"about_ca_topic_score_gemma":0.01747692,"teacher_disagreement_score":0.41225976,"about_ca_system_score_codex":0.0006026661,"about_ca_system_score_gemma":0.0012869798,"threshold_uncertainty_score":0.9884269},"labels":[],"label_agreement":null},{"id":"W4417201691","doi":"10.1158/1557-3265.earlyonsetca25-c034","title":"Abstract C034: Obesity-Linked Leptin Signaling Promotes Immune Checkpoint Expression and Tumor Cell Survival","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leptin; Gene knockdown; Adipokine; Immune system; Immune checkpoint; Leptin receptor; Tumor progression; Downregulation and upregulation; Gene silencing; Apoptosis","score_opus":0.1718553186604019,"score_gpt":0.4593158004566219,"score_spread":0.28746048179621997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163485,0.00047793676,0.000042681786,0.0015053577,0.00036691705,0.0005291442,0.000009540425,0.00006583597,0.0053677536],"genre_scores_gemma":[0.9957748,0.00053780864,0.00015785213,0.00016090515,0.00025467802,0.0000445596,0.000002273847,0.000018279661,0.0030488572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99634504,0.00076113374,0.0007714322,0.0008249675,0.00075380947,0.00054363767],"domain_scores_gemma":[0.99597603,0.0029438143,0.00018512315,0.00046639983,0.00021592669,0.0002126838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004431447,0.00016610889,0.00037433257,0.00016881681,0.0005301965,0.00018592145,0.0005007745,0.00016019001,0.00049808406],"category_scores_gemma":[0.0029905324,0.00014081119,0.0001439207,0.00052010827,0.0006325124,0.00018131426,0.0005232853,0.0011454746,0.00009491418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029241806,0.00035108687,0.020024234,0.00018260579,0.000003936488,0.000026244874,0.000072129726,0.000021067468,0.9756358,0.00021687546,0.0003479511,0.0028256015],"study_design_scores_gemma":[0.00086555775,0.0001039782,0.19759175,0.00027992122,0.000004577178,5.1278903e-7,0.0000629403,0.00024118919,0.7963306,0.0013996642,0.0029848225,0.00013448809],"about_ca_topic_score_codex":0.0001965844,"about_ca_topic_score_gemma":0.000025752703,"teacher_disagreement_score":0.17930526,"about_ca_system_score_codex":0.00007028611,"about_ca_system_score_gemma":0.00035238604,"threshold_uncertainty_score":0.5742113},"labels":[],"label_agreement":null},{"id":"W4417201693","doi":"10.1158/1557-3265.earlyonsetca25-b003","title":"Abstract B003: Risk Factors, Clinical and Molecular Characteristics of de novo Metastatic Early Onset Colorectal Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; KRAS; Cancer; Disease; Exome sequencing; Stage (stratigraphy); Clinical significance","score_opus":0.08045071176639222,"score_gpt":0.4749801635350249,"score_spread":0.3945294517686327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939824,0.0033678692,0.00017286532,0.00033534836,0.0004856541,0.00037488274,0.0010804294,0.000006979196,0.00019359397],"genre_scores_gemma":[0.9739774,0.024984816,0.00022888297,0.00025868145,0.000256969,0.00008688011,0.00005650117,0.000029026747,0.00012083356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971741,0.00047915222,0.0009341694,0.00062087714,0.00028514696,0.0005065794],"domain_scores_gemma":[0.9973928,0.0011995005,0.00022270945,0.00043041015,0.00046623245,0.00028838794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026074497,0.00019289277,0.0005239988,0.00009597671,0.00012121133,0.000056652847,0.00036934024,0.0003082433,0.00007285984],"category_scores_gemma":[0.00378088,0.0001807582,0.00023103463,0.00023158685,0.0010098801,0.0000047682865,0.00038851125,0.0008020481,0.0000034043017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008618986,0.00027723814,0.9679116,0.00009342953,0.00038443264,0.000018986935,0.000033294014,0.000013004687,0.011830566,0.000106623265,0.0026687875,0.015800135],"study_design_scores_gemma":[0.0012903026,0.0006261561,0.9650735,0.000087966335,0.00011756726,0.0000012496573,0.000046172216,0.000049687755,0.022745788,0.00046862627,0.009298188,0.00019476101],"about_ca_topic_score_codex":0.0022574298,"about_ca_topic_score_gemma":0.0007195421,"teacher_disagreement_score":0.021616947,"about_ca_system_score_codex":0.00005588853,"about_ca_system_score_gemma":0.0015799118,"threshold_uncertainty_score":0.73711056},"labels":[],"label_agreement":null},{"id":"W4417201745","doi":"10.1158/1557-3265.earlyonsetca25-b034","title":"Abstract B034: Sex and Racial Disparities in Time to Treatment for Early-Onset Colorectal Cancer Across a Four-Level Rurality Classification in the United States","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rurality; Colorectal cancer; Incidence (geometry); Proportional hazards model; Cohort; Disadvantaged; Census; Health equity; Retrospective cohort study; Cohort study","score_opus":0.33904326321870853,"score_gpt":0.5681588964899411,"score_spread":0.22911563327123258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367363,0.00068237825,0.000006879181,0.012659938,0.00009386479,0.0022072408,0.0006222605,0.000010531504,0.00004330475],"genre_scores_gemma":[0.99334407,0.0032931908,0.000015247634,0.0006341215,0.00016961938,0.0016412715,0.00013009144,0.000010899407,0.00076147536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976402,0.00049679854,0.0005149741,0.00037569524,0.00042297543,0.00054936577],"domain_scores_gemma":[0.99676585,0.0025429276,0.00003830906,0.00025245204,0.00020646518,0.00019397368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004546579,0.000120858094,0.00043831413,0.00018525477,0.00017791538,0.00006489514,0.0001392724,0.0001723778,0.00004944792],"category_scores_gemma":[0.00096914725,0.000078282625,0.00013642105,0.0006686058,0.00031026866,0.000038071517,0.000058710473,0.0005561416,0.000010275958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047750673,0.0002472995,0.93798965,0.00018633864,0.00009394547,0.000013923009,0.0016954063,0.000026745265,0.000026159418,0.0000075353732,0.002786046,0.052151896],"study_design_scores_gemma":[0.003284624,0.0003704427,0.9758285,0.00016966648,0.000023353316,9.5250687e-7,0.0006315394,0.0004925357,0.000064921755,0.00009712032,0.01896376,0.00007258074],"about_ca_topic_score_codex":0.06278952,"about_ca_topic_score_gemma":0.027249157,"teacher_disagreement_score":0.052079316,"about_ca_system_score_codex":0.00072097697,"about_ca_system_score_gemma":0.0009499578,"threshold_uncertainty_score":0.990501},"labels":[],"label_agreement":null},{"id":"W4417201812","doi":"10.1158/1557-3265.earlyonsetca25-c006","title":"Abstract C006: Association of high birth weight with risk of early-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Birth, Development, and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Birth weight; Gestational age; Confounding; Colorectal cancer; Logistic regression; Percentile; Incidence (geometry); Population; Record linkage; Fetal macrosomia","score_opus":0.09046669444400228,"score_gpt":0.48687465152503173,"score_spread":0.39640795708102944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909128,0.00085584144,0.00000783301,0.003733797,0.00033667442,0.00061892485,0.00022043289,0.000020698792,0.0032930134],"genre_scores_gemma":[0.91581905,0.08260404,0.00018792709,0.00018773288,0.00021968612,0.00011201043,0.000012403038,0.00001731775,0.00083984854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692744,0.0003504282,0.00084484305,0.00038063197,0.0010090203,0.00048760668],"domain_scores_gemma":[0.99631286,0.0015710037,0.00039320183,0.0002748955,0.0012332633,0.00021480786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041500404,0.00012151818,0.00066504645,0.00023954024,0.000117450145,0.0000102435415,0.00018100296,0.000290057,0.00072672055],"category_scores_gemma":[0.0010975383,0.00008984956,0.000108431304,0.0008421753,0.00036134323,0.000048148795,0.00007636943,0.0013096319,0.000016485536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037183145,0.00034335355,0.97230864,0.00055049785,0.00040493844,0.000006228705,0.00015524346,0.000002343049,0.00013576404,0.00079712947,0.013096333,0.008481207],"study_design_scores_gemma":[0.0031166624,0.00082092365,0.98784155,0.0006323549,0.00007381331,3.2925462e-7,0.000053539363,0.000011448967,0.0035281496,0.0017064656,0.0021361588,0.00007862496],"about_ca_topic_score_codex":0.015129936,"about_ca_topic_score_gemma":0.007660239,"teacher_disagreement_score":0.0817482,"about_ca_system_score_codex":0.0005635816,"about_ca_system_score_gemma":0.005125986,"threshold_uncertainty_score":0.9914284},"labels":[],"label_agreement":null},{"id":"W4417201848","doi":"10.1158/1557-3265.earlyonsetca25-pr011","title":"Abstract PR011: Early-onset colorectal cancer is characterized by transcriptional changes indicating increased epithelial-mesenchymal transition and metastatic potential","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Microsatellite instability; Cancer; Incidence (geometry); Rectum; Metastasis; Gene; Primary tumor; Overall survival; Survival rate","score_opus":0.09945902048054259,"score_gpt":0.45815969730083167,"score_spread":0.35870067682028905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742405,0.005004614,0.00012381123,0.016369235,0.00036434492,0.0013948565,0.002263619,0.000043466604,0.00019556284],"genre_scores_gemma":[0.9838664,0.011323304,0.00017812205,0.0020013044,0.0005824775,0.0010548836,0.00018874278,0.000035986868,0.0007687872],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965075,0.00044896212,0.0007188447,0.0007569086,0.00090126944,0.0006664901],"domain_scores_gemma":[0.9982362,0.0005512459,0.00014158168,0.00023767418,0.00038366462,0.00044962708],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024950553,0.00024954864,0.0007357707,0.00031025248,0.00030436844,0.00009318649,0.0001754632,0.0002123945,0.0024979706],"category_scores_gemma":[0.00017630843,0.00020084924,0.00023381885,0.0005864094,0.00070730044,0.00012319493,0.00005909826,0.0011872621,0.000017311935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014033171,0.0013351638,0.025149653,0.0019088963,0.0014545869,0.00012030921,0.0012164703,0.0000013903423,0.58834344,0.000026950765,0.012209932,0.3542],"study_design_scores_gemma":[0.017601714,0.0015657683,0.828886,0.0014477825,0.0011433914,0.000031563675,0.0005661236,0.0002396624,0.07813145,0.00030138044,0.06945234,0.00063283014],"about_ca_topic_score_codex":0.0050831866,"about_ca_topic_score_gemma":0.00046365982,"teacher_disagreement_score":0.8037363,"about_ca_system_score_codex":0.00020758895,"about_ca_system_score_gemma":0.001207487,"threshold_uncertainty_score":0.99841386},"labels":[],"label_agreement":null},{"id":"W4417201849","doi":"10.1158/1557-3265.earlyonsetca25-b036","title":"Abstract B036: Non-steroidal anti-inflammatory drugs use and risk of colorectal cancer molecular subtypes: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Microsatellite instability; Cancer; CpG site; MEDLINE; Meta-analysis; Drug; Relative risk","score_opus":0.0893934564786214,"score_gpt":0.4590180619095947,"score_spread":0.3696246054309733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8662135,0.13072172,0.000008933667,0.0005784368,0.00006985342,0.0022328575,0.000079156634,0.000016200242,0.00007937139],"genre_scores_gemma":[0.93659264,0.06183922,0.00004060053,0.0004488137,0.000042160445,0.00068454933,0.000006018716,0.000024662475,0.00032135376],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99571234,0.0011178706,0.0013382763,0.00062338094,0.00077314756,0.00043497185],"domain_scores_gemma":[0.9952335,0.0026484672,0.00037165344,0.0006276003,0.00077241665,0.0003464133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007683349,0.00025659066,0.0032657096,0.00039460184,0.00011634256,0.00004947752,0.00018581611,0.0002350022,0.00023725891],"category_scores_gemma":[0.0028056991,0.00017495075,0.00081787806,0.00093729846,0.00060987973,0.00010929517,0.00018349638,0.00094711874,0.0000081954995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070121913,0.00025079763,0.42768478,0.40696988,0.16050287,0.000207892,0.00029717386,0.000015911946,0.0015348006,0.00006841068,0.0015240203,0.0002422562],"study_design_scores_gemma":[0.002204205,0.00037318634,0.41157964,0.010638324,0.5702727,0.0000044981107,0.00011735761,0.00041882042,0.0038678462,0.000036093614,0.00013198181,0.00035533274],"about_ca_topic_score_codex":0.0010505074,"about_ca_topic_score_gemma":0.00035356288,"teacher_disagreement_score":0.40976983,"about_ca_system_score_codex":0.000091660186,"about_ca_system_score_gemma":0.0005951186,"threshold_uncertainty_score":0.71342844},"labels":[],"label_agreement":null},{"id":"W4417201852","doi":"10.1158/1557-3265.earlyonsetca25-a012","title":"Abstract A012: A Deep Learning Framework for Predicting Survival in Gastric Cancer: A Comparative Analysis with Traditional Cox Regression","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Proportional hazards model; Deep learning; Concordance; Cancer; Regression; Dropout (neural networks); Survival analysis; Cohort","score_opus":0.3125153198919803,"score_gpt":0.5669539830587064,"score_spread":0.2544386631667261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6262995,0.0027742942,0.35613358,0.010932602,0.0007593838,0.0014099807,0.00004247653,0.00019382703,0.0014543373],"genre_scores_gemma":[0.98063415,0.0003414377,0.01770499,0.00014212292,0.00033327716,0.0006460022,0.00001882502,0.000012055884,0.00016714305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99473464,0.0015432085,0.00082329643,0.0010319714,0.001065779,0.0008010964],"domain_scores_gemma":[0.98415273,0.014128175,0.00025629,0.0005043358,0.00071353244,0.00024492297],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0058836336,0.00019938874,0.00069433474,0.00081229804,0.00055905624,0.00019185896,0.0010598005,0.00024174617,0.000120364835],"category_scores_gemma":[0.0026010727,0.00016155951,0.00019482512,0.0051990156,0.0002753485,0.00021915307,0.00026324287,0.0036465954,0.0000040831346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057113485,0.00015717183,0.9034907,0.00017596186,0.000245134,0.00001633688,0.00096221804,0.040141307,0.000003617233,0.0075017884,0.00019405132,0.046540562],"study_design_scores_gemma":[0.00076942926,0.00034960007,0.6968138,0.0007751187,0.000032006737,5.2603633e-7,0.0002856231,0.29723316,0.000007801312,0.0029532674,0.00064325746,0.00013642717],"about_ca_topic_score_codex":0.0032296563,"about_ca_topic_score_gemma":0.0064598643,"teacher_disagreement_score":0.35433465,"about_ca_system_score_codex":0.00048173664,"about_ca_system_score_gemma":0.0013153434,"threshold_uncertainty_score":0.99865204},"labels":[],"label_agreement":null},{"id":"W4417201919","doi":"10.1158/1557-3265.earlyonsetca25-c027","title":"Abstract C027: Association of Binge Drinking with Early-Onset Colorectal Cancer: A Comparison to Late-Onset Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Binge drinking; Colorectal cancer; Alcohol consumption; Logistic regression; Family history; Confidence interval; Cancer","score_opus":0.28035565824938213,"score_gpt":0.5823786918049523,"score_spread":0.30202303355557014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98463005,0.00142606,0.000015030808,0.010635975,0.00049601274,0.0014136072,0.000063309286,0.00005692243,0.0012630117],"genre_scores_gemma":[0.9939139,0.0013942905,0.00008681847,0.0020460591,0.00020155468,0.0004710945,0.00001533362,0.000025411096,0.0018455761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964459,0.00042526537,0.0008410267,0.0005194509,0.0010500887,0.0007182673],"domain_scores_gemma":[0.9954491,0.0025695164,0.00025648213,0.0003093476,0.00097275793,0.00044276638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040088072,0.0001653465,0.0007703002,0.00038081125,0.00022880804,0.000038951934,0.00021538226,0.0002928432,0.00061817537],"category_scores_gemma":[0.0015321635,0.00014086072,0.00012217317,0.0011449531,0.00025311968,0.00006027424,0.00011530532,0.0015556208,0.00006510323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00443126,0.00016695748,0.9370334,0.00041969036,0.00021631084,0.000012633861,0.00035164822,0.00007641681,0.0002126117,0.00001088492,0.047210224,0.009857968],"study_design_scores_gemma":[0.0027631451,0.00094887655,0.9772803,0.0016298587,0.00007856392,6.4939974e-7,0.000086634456,0.00026255002,0.0011657948,0.000017100265,0.015641697,0.00012482038],"about_ca_topic_score_codex":0.0115184095,"about_ca_topic_score_gemma":0.01730878,"teacher_disagreement_score":0.040246915,"about_ca_system_score_codex":0.0021360724,"about_ca_system_score_gemma":0.0040787035,"threshold_uncertainty_score":0.99506396},"labels":[],"label_agreement":null},{"id":"W4417201952","doi":"10.1158/1557-3265.earlyonsetca25-b033","title":"Abstract B033: A Comparative Study of Cervical Cancer Treatment Outcomes Between Reproductive-Aged and Post-Menopausal Women in a Tertiary Hospital in Bangladesh.","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cervical cancer; Stage (stratigraphy); Chemotherapy; Cancer; Breast cancer; Hysterectomy; Cancer treatment","score_opus":0.18311796990997045,"score_gpt":0.5427053126358621,"score_spread":0.35958734272589166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868186,0.0018420393,2.1490817e-7,0.006902877,0.00012059828,0.003014044,0.000085615604,0.000019562769,0.0011964482],"genre_scores_gemma":[0.9964758,0.0007085005,0.000010060584,0.00012774121,0.00024771644,0.0017051619,0.000013153285,0.000023775048,0.00068806217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946505,0.0008565885,0.0012762747,0.001183622,0.000998323,0.0010347194],"domain_scores_gemma":[0.99586886,0.0023752565,0.00009771398,0.0006769855,0.0005315001,0.00044966265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038176118,0.00028152415,0.0015565567,0.00072381215,0.00009562624,0.00003868722,0.0003088192,0.0002253142,0.0011549883],"category_scores_gemma":[0.0008603964,0.00021200246,0.00008654071,0.001291811,0.00069410243,0.000116503485,0.0004116523,0.0017492652,0.0000071524264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004060085,0.0053079943,0.9459558,0.00028313795,0.00045965798,0.00011076125,0.006351036,0.0000043279847,0.00023606009,0.0000107227725,0.00016239728,0.037058022],"study_design_scores_gemma":[0.0118886875,0.007387212,0.9734854,0.00016882399,0.000052867425,3.606539e-7,0.0062526665,0.000013956968,0.00020058845,0.0002175931,0.00016699966,0.00016486298],"about_ca_topic_score_codex":0.027454868,"about_ca_topic_score_gemma":0.018083325,"teacher_disagreement_score":0.03689316,"about_ca_system_score_codex":0.0017404207,"about_ca_system_score_gemma":0.0015257066,"threshold_uncertainty_score":0.9998341},"labels":[],"label_agreement":null},{"id":"W4417202165","doi":"10.1158/1557-3265.earlyonsetca25-c001","title":"Abstract C001: Novel Sex-Specific Metabolic Phenotypes in Early Onset Colorectal Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Proportional hazards model; Hazard ratio; Cohort; Metabolomics; Metabolite; Cancer; Incidence (geometry); Multivariate analysis","score_opus":0.17629729535422098,"score_gpt":0.5174849194151687,"score_spread":0.3411876240609477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96081835,0.03127085,0.000012915696,0.0030043728,0.0010775296,0.0009938474,0.00009418205,0.00004554648,0.0026824083],"genre_scores_gemma":[0.9644792,0.03217277,0.0000594365,0.00051146845,0.00088256714,0.00034273468,0.000015354164,0.00003207918,0.0015043819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962349,0.00031454366,0.0008538618,0.0007282688,0.0009406745,0.0009277709],"domain_scores_gemma":[0.9972937,0.0012171073,0.000061296414,0.0005503253,0.00040344978,0.0004741231],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0042729354,0.00019382268,0.0008999814,0.000454879,0.00016405276,0.000045706103,0.00027712752,0.00036313693,0.0006094343],"category_scores_gemma":[0.000758892,0.00015563909,0.00041740015,0.0013333384,0.0005000065,0.00006896646,0.00014536724,0.0023475417,0.000110149325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022949209,0.00051538524,0.8396571,0.00021299886,0.0003026356,0.000069964444,0.00021856333,0.000018127499,0.0005403036,0.00017593103,0.009049986,0.14694406],"study_design_scores_gemma":[0.0030623875,0.000107812564,0.81693506,0.00024281786,0.00003618332,0.0000021562241,0.00009114355,0.000021991515,0.0007675235,0.00006320544,0.17855492,0.000114780494],"about_ca_topic_score_codex":0.016708057,"about_ca_topic_score_gemma":0.0046034134,"teacher_disagreement_score":0.16950494,"about_ca_system_score_codex":0.0003881113,"about_ca_system_score_gemma":0.0027537043,"threshold_uncertainty_score":0.9999541},"labels":[],"label_agreement":null},{"id":"W4417202207","doi":"10.1158/1557-3265.earlyonsetca25-pr013","title":"Abstract PR013: Distinct Oral Bacterial Signatures in Rectal Cancer Tumors Associated with Age of Onset and Treatment Response","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusobacterium nucleatum; Colorectal cancer; Bacteroides fragilis; Prevotella; Fusobacterium; Microbiome; Bacteroides; Cancer","score_opus":0.0914458160654076,"score_gpt":0.4862841877622393,"score_spread":0.3948383716968317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965855,0.0016437622,0.0000027867245,0.00044192225,0.00008214894,0.0006547536,0.0003640469,0.000006284237,0.000218836],"genre_scores_gemma":[0.9964655,0.0015390953,0.000030156041,0.000028455783,0.00008309662,0.000396999,0.00011791025,0.000018638315,0.0013201516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973618,0.0008877228,0.0003849991,0.00054930046,0.0003266902,0.00048952736],"domain_scores_gemma":[0.9985932,0.0006801923,0.00007789096,0.0002953352,0.00019102544,0.00016234662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016696454,0.00017278294,0.00037594483,0.00014696794,0.0000877581,0.00003977628,0.00019086107,0.00020319084,0.00012242724],"category_scores_gemma":[0.0012180887,0.00012729081,0.00008159814,0.00035261796,0.00066360435,0.0000063173384,0.00015519084,0.0003573817,9.1691777e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12991199,0.0021119348,0.74385345,0.0000887535,0.0011665096,0.000495223,0.00012899774,0.000099510136,0.06719677,0.000009066553,0.0058209766,0.049116828],"study_design_scores_gemma":[0.0057216813,0.0032375527,0.96233916,0.00031440824,0.000023866745,7.3039473e-7,0.000033338416,0.000012418141,0.022909096,0.00004487926,0.0052144593,0.00014843406],"about_ca_topic_score_codex":0.006883218,"about_ca_topic_score_gemma":0.048593957,"teacher_disagreement_score":0.2184857,"about_ca_system_score_codex":0.0002811892,"about_ca_system_score_gemma":0.00173695,"threshold_uncertainty_score":0.99973005},"labels":[],"label_agreement":null},{"id":"W4417202221","doi":"10.1158/1557-3265.earlyonsetca25-c018","title":"Abstract C018: Urinary Arsenic and Other Heavy Metals in Gallbladder Cancer Patients: A Pilot Study Correlating Exposure with Drinking Water and Assessing Carcinogenic Risk in Northeast India","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Arsenic contamination and mitigation","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Arsenic; Urine; Cadmium; Urinary system; Carcinogen; Inductively coupled plasma mass spectrometry; Incidence (geometry); Risk assessment","score_opus":0.07444173828058152,"score_gpt":0.40642744509406675,"score_spread":0.3319857068134852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770415,0.0003233339,0.0000070631663,0.00016087426,0.00007314883,0.0008688357,0.000005198489,0.000011044512,0.00084634],"genre_scores_gemma":[0.99923116,0.00016055384,0.000036704976,0.000129206,0.000025701826,0.00021564319,0.000002995351,0.000017438062,0.00018060936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973433,0.00061068515,0.0005632803,0.00059212296,0.00047139963,0.0004192209],"domain_scores_gemma":[0.9990823,0.00048456594,0.00009599915,0.00019228003,0.000041533676,0.00010329958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002735761,0.00014726188,0.0002700614,0.00016488848,0.00021741206,0.00008313699,0.00013529113,0.00007373322,0.0004061903],"category_scores_gemma":[0.00016571715,0.000109058645,0.000023402401,0.00041685466,0.0003502046,0.0002870951,0.00032525454,0.0008640734,0.000006039643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022162717,0.0006270192,0.96384126,0.000016987711,0.00002588677,0.000013309983,0.0018684942,0.00008562738,0.00013011957,0.0000026514658,0.000011911909,0.033155084],"study_design_scores_gemma":[0.0024969396,0.0006766658,0.9940588,0.00018950523,0.00001915902,6.60368e-7,0.0017431175,0.00046636313,0.0000439575,0.00006278542,0.000109538,0.00013249864],"about_ca_topic_score_codex":0.010307832,"about_ca_topic_score_gemma":0.056894433,"teacher_disagreement_score":0.046586603,"about_ca_system_score_codex":0.0003282687,"about_ca_system_score_gemma":0.000100642916,"threshold_uncertainty_score":0.99628264},"labels":[],"label_agreement":null},{"id":"W4417202225","doi":"10.1158/1557-3265.earlyonsetca25-b027","title":"Abstract B027: Early-Onset Head and Neck Cancer: Implications for Risk Stratification and Survival","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quartile; Odds; Logistic regression; Odds ratio; Proportional hazards model; Comorbidity; Hazard ratio; Incidence (geometry); Cancer registry","score_opus":0.3188056550330601,"score_gpt":0.5935237472237115,"score_spread":0.2747180921906514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570829,0.009073331,0.00004449435,0.030216057,0.0002489303,0.001084444,0.000346449,0.000033921628,0.0018694402],"genre_scores_gemma":[0.9611345,0.035922196,0.00017916749,0.0002766507,0.00033682134,0.001022558,0.000016977103,0.000015901871,0.0010952551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817806,0.00013519311,0.0005038092,0.000560941,0.00022051079,0.00040148382],"domain_scores_gemma":[0.9967704,0.0020009433,0.00007404672,0.00036199077,0.00054901355,0.00024359678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018986723,0.00012455483,0.0004455178,0.00011416665,0.0004657204,0.000057806512,0.00010620155,0.00015237457,0.00004258485],"category_scores_gemma":[0.0011620213,0.00010527877,0.00007641948,0.0003453824,0.0005476487,0.000063419655,0.000091976355,0.00064406695,0.000003889959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067270885,0.00011731206,0.80439276,0.00023879559,0.00012304088,6.269194e-7,0.000096244294,4.14605e-7,0.00021801252,0.0006648172,0.012830684,0.18064457],"study_design_scores_gemma":[0.002038598,0.00041849853,0.9702692,0.00026807727,0.00006973048,5.64854e-7,0.000101149606,0.00004030139,0.00012021421,0.0022609902,0.024323562,0.0000890921],"about_ca_topic_score_codex":0.0034275576,"about_ca_topic_score_gemma":0.004379166,"teacher_disagreement_score":0.18055548,"about_ca_system_score_codex":0.00011548079,"about_ca_system_score_gemma":0.0008380182,"threshold_uncertainty_score":0.5181465},"labels":[],"label_agreement":null},{"id":"W4417202229","doi":"10.1158/1557-3265.earlyonsetca25-c009","title":"Abstract C009: Distinct metabolic and genetic alterations in tumors from early-onset versus late-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metabolome; Metabolomics; Metabolite; Colorectal cancer; Cancer; Metabolism; Metabolic pathway; Sphingolipid; Homovanillic acid","score_opus":0.07868139299405447,"score_gpt":0.45288099462004316,"score_spread":0.3741996016259887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799905,0.017131453,0.0000105516665,0.0009332784,0.0005304421,0.00033536472,0.0004348832,0.000008119204,0.00062544877],"genre_scores_gemma":[0.98275465,0.015826596,0.00012758897,0.0001124866,0.00034025134,0.0003096666,0.00006655051,0.00001765747,0.00044457708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978083,0.0002856612,0.0005117,0.00068077556,0.0002314868,0.00048210582],"domain_scores_gemma":[0.99881166,0.0004863329,0.00006912717,0.0003165135,0.0001690286,0.0001473603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007282387,0.0001763395,0.00039597374,0.00015173109,0.00019551876,0.000076668046,0.00027471434,0.00018396066,0.00016395423],"category_scores_gemma":[0.00093284127,0.00016084636,0.00010064794,0.00040400232,0.00045871138,0.00000600204,0.0003856844,0.0005408607,0.000009006796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021042745,0.00018431635,0.9659657,0.00002617938,0.0003731991,0.000021957314,0.000059957445,0.000026732341,0.016315505,0.00007826598,0.0043534795,0.01049047],"study_design_scores_gemma":[0.001621117,0.00018311586,0.98105305,0.00003645008,0.000033716246,3.6212862e-7,0.00004261804,0.000053051932,0.007518425,0.00041521736,0.0088826455,0.00016025019],"about_ca_topic_score_codex":0.0056829387,"about_ca_topic_score_gemma":0.016297195,"teacher_disagreement_score":0.015087368,"about_ca_system_score_codex":0.00004323104,"about_ca_system_score_gemma":0.00047217094,"threshold_uncertainty_score":0.90942174},"labels":[],"label_agreement":null},{"id":"W4417202239","doi":"10.1158/1557-3265.earlyonsetca25-b007","title":"Abstract B007: Genetic and clinical profiles of early-onset prostate cancer in Puerto Rican men: A preliminary characterization","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Puerto rican; Germline; Incidence (geometry); Prostatectomy; Family history; Survivorship curve; Cancer; Centenarian","score_opus":0.11818066842839774,"score_gpt":0.5097840422258235,"score_spread":0.39160337379742577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854156,0.0047612297,0.0000026936134,0.006519598,0.00024287727,0.0023543844,0.00032554567,0.000021220356,0.00035688278],"genre_scores_gemma":[0.95005614,0.047335614,0.00008424452,0.0002363961,0.00018553018,0.001378312,0.000054834396,0.000026766373,0.0006421797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646324,0.00042792087,0.0013549518,0.0007431235,0.0004952055,0.0005155452],"domain_scores_gemma":[0.9974261,0.0011973192,0.00021109055,0.00044505924,0.00043625766,0.00028415295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002074919,0.00019254959,0.0007604708,0.00028373505,0.000077277145,0.000033806948,0.00016314733,0.00022594379,0.00015921336],"category_scores_gemma":[0.00062734704,0.00015488242,0.00014447467,0.0006877802,0.000743122,0.00008664168,0.00020885919,0.0008471042,0.00000561839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042430717,0.000986438,0.8393547,0.00044466354,0.0001738486,0.00008583659,0.00010655664,0.0000024672545,0.00023719753,0.000012752703,0.0014367481,0.15291573],"study_design_scores_gemma":[0.0041704103,0.0021572183,0.98923063,0.0015836464,0.00009592672,0.0000015637517,0.00006477787,0.00015433265,0.0009044255,0.0001356398,0.0013820606,0.000119367134],"about_ca_topic_score_codex":0.0017705073,"about_ca_topic_score_gemma":0.0004180316,"teacher_disagreement_score":0.15279636,"about_ca_system_score_codex":0.0002773837,"about_ca_system_score_gemma":0.0015941738,"threshold_uncertainty_score":0.63159215},"labels":[],"label_agreement":null},{"id":"W4417202273","doi":"10.1158/1557-3265.earlyonsetca25-c026","title":"Abstract C026: Disparate response to chemoradiation in early onset vs late onset rectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Logistic regression; Confounding; Colorectal cancer; Stage (stratigraphy); Cancer; Complete response; Comorbidity","score_opus":0.17096961343915115,"score_gpt":0.5512412144512254,"score_spread":0.38027160101207425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716583,0.00092943077,0.0000018682233,0.02240225,0.000676313,0.00158425,0.0001713757,0.0000679361,0.0025082775],"genre_scores_gemma":[0.98532826,0.001192803,0.00005260719,0.0013999334,0.00023704395,0.0013579765,0.000023781631,0.000041322615,0.010366253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952314,0.00091102096,0.0009610445,0.0009953461,0.0009430694,0.0009581401],"domain_scores_gemma":[0.9949757,0.003185391,0.00009485502,0.00067029387,0.00044986862,0.00062392536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047320114,0.00026791415,0.00080388266,0.00062377035,0.00014741815,0.000081395265,0.00033478,0.000335686,0.0011110915],"category_scores_gemma":[0.003590874,0.00023629455,0.00022544425,0.002427966,0.000317685,0.00012420886,0.00026353294,0.001598709,0.0004249626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090304606,0.00063570926,0.8634289,0.000104171275,0.0001518286,0.0004144982,0.00024013795,0.000061825536,0.0004660006,0.000006065772,0.012003337,0.032182924],"study_design_scores_gemma":[0.0047940854,0.001159349,0.97343916,0.00076106313,0.000036664285,0.000002275717,0.000024077406,0.00011426653,0.0015986956,0.00017400425,0.01770036,0.00019602019],"about_ca_topic_score_codex":0.0074908803,"about_ca_topic_score_gemma":0.0048884936,"teacher_disagreement_score":0.110010244,"about_ca_system_score_codex":0.0020135453,"about_ca_system_score_gemma":0.0024677136,"threshold_uncertainty_score":0.99980205},"labels":[],"label_agreement":null},{"id":"W4417202796","doi":"10.1158/1557-3265.earlyonsetca25-ia004","title":"Abstract IA004: Cancer: A tango of miscommunication between oncogenic stem cells and their microenvironment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Cancer stem cell; Tumor microenvironment; Immune system; Crosstalk; Niche; Epigenetics","score_opus":0.24224315779095065,"score_gpt":0.5115488506098214,"score_spread":0.26930569281887073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559565,0.034696627,0.00002697168,0.0069962963,0.0001571749,0.0007439475,0.00020431109,0.000013765619,0.0012043739],"genre_scores_gemma":[0.93906015,0.05755667,0.0001388733,0.00026871843,0.00021234335,0.00014150208,0.000009707379,0.000020255042,0.0025918067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783266,0.00025644567,0.00074355607,0.00043672285,0.00035674733,0.00037385782],"domain_scores_gemma":[0.9976277,0.001052823,0.00014230693,0.0007777403,0.00016535944,0.00023411331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021646975,0.00014719482,0.0006234337,0.00015130678,0.000107939486,0.000018823328,0.00029311035,0.00015954413,0.00031961632],"category_scores_gemma":[0.00004779461,0.00011484087,0.00019969886,0.00036003077,0.0006514308,0.000036226393,0.000317146,0.00083329104,0.000011702906],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006301524,0.0003493333,0.09509751,0.0007385778,0.00047280116,0.0000038176313,0.00021169594,0.0000045192946,0.07392773,0.000026174564,0.010010288,0.8185274],"study_design_scores_gemma":[0.0037002622,0.00050484866,0.24192162,0.0013171743,0.0002661234,0.0000010951065,0.0006733697,0.000021890934,0.29672363,0.00017670346,0.45449415,0.00019913938],"about_ca_topic_score_codex":0.0026618491,"about_ca_topic_score_gemma":0.00040739746,"teacher_disagreement_score":0.81832826,"about_ca_system_score_codex":0.0003115158,"about_ca_system_score_gemma":0.0007323718,"threshold_uncertainty_score":0.46830747},"labels":[],"label_agreement":null},{"id":"W4417202810","doi":"10.1158/1557-3265.earlyonsetca25-c013","title":"Abstract C013: Spatial immune profiling of early- and late-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Colorectal cancer; Cytotoxic T cell; T cell; Biomarker; Immunotherapy; Cell; Intestinal mucosa","score_opus":0.08931991019248108,"score_gpt":0.45182928892275503,"score_spread":0.36250937873027395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994217,0.003928307,0.000053940246,0.00030743924,0.00043092415,0.000306275,0.000078987934,0.0000073010397,0.0006698227],"genre_scores_gemma":[0.99505055,0.0039629084,0.00008963921,0.00006685855,0.0002551982,0.00007308306,0.000025781113,0.000016250046,0.00045972643],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99841666,0.00015368672,0.00047542984,0.00040940603,0.0002149889,0.00032979762],"domain_scores_gemma":[0.9991459,0.00017010226,0.00006819405,0.00022521608,0.00029364965,0.000096917334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010944057,0.000114947106,0.00026784622,0.00006179013,0.00010807737,0.000028181792,0.00024179186,0.00027082814,0.0000663557],"category_scores_gemma":[0.0002936032,0.000104365856,0.00011427633,0.00016509011,0.0005426464,0.0000039211036,0.00017011933,0.00047838342,0.000002349429],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014611243,0.00013008984,0.40672523,0.00011779517,0.00010602883,0.0000024980945,0.000026781365,0.000015105988,0.56901026,0.00001781474,0.00025317085,0.022134108],"study_design_scores_gemma":[0.0010350225,0.0003966012,0.5382909,0.000106911386,0.0000168849,3.3680533e-7,0.000020201995,0.00009756988,0.4580536,0.000103401566,0.0017630317,0.00011551626],"about_ca_topic_score_codex":0.0047264625,"about_ca_topic_score_gemma":0.001312893,"teacher_disagreement_score":0.13156569,"about_ca_system_score_codex":0.000024712075,"about_ca_system_score_gemma":0.0005778297,"threshold_uncertainty_score":0.71450293},"labels":[],"label_agreement":null},{"id":"W4417202875","doi":"10.1158/1557-3265.earlyonsetca25-pr010","title":"Abstract PR010: Early-life penicillin blooms colibactin-positive Escherichia coli and drives DNA damage and tumorigenesis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Penicillin; Antibiotics; Escherichia coli; DNA damage; Carcinogenesis; Immune system; Cancer; Enterobacteriaceae; Colorectal cancer","score_opus":0.0664400352800343,"score_gpt":0.45798192169637,"score_spread":0.3915418864163357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925055,0.0035717185,0.000012820395,0.0021898486,0.0001715719,0.000502309,0.00006355744,0.000010600083,0.0009720719],"genre_scores_gemma":[0.9885923,0.007979314,0.00013909927,0.0010455801,0.0003131851,0.000062615036,0.000024019651,0.000021853357,0.001822],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978826,0.0003314415,0.00043048046,0.00067479466,0.00018063634,0.0005000717],"domain_scores_gemma":[0.99865717,0.00032663404,0.000078531986,0.00033276805,0.0002641395,0.0003407579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013748568,0.00016275143,0.00031252584,0.00007411981,0.0003074101,0.00009116867,0.0002229546,0.00029080457,0.00006249751],"category_scores_gemma":[0.000508414,0.00015058643,0.000073387724,0.00020960286,0.00071599544,0.0000073935444,0.0003776293,0.0005841295,0.000010046489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001142452,0.00028214173,0.11092373,0.00025280603,0.0002041514,0.000017208338,0.0001416668,0.0000016553558,0.87014306,0.00032218138,0.011847235,0.0047217133],"study_design_scores_gemma":[0.0011488012,0.0004711297,0.9422567,0.00009171721,0.00002466809,9.55796e-7,0.00015972028,0.000011810991,0.035795692,0.00008900576,0.019775677,0.00017411438],"about_ca_topic_score_codex":0.0007427981,"about_ca_topic_score_gemma":0.00055383437,"teacher_disagreement_score":0.83434737,"about_ca_system_score_codex":0.00003122472,"about_ca_system_score_gemma":0.00088394433,"threshold_uncertainty_score":0.61407363},"labels":[],"label_agreement":null},{"id":"W4417202878","doi":"10.1158/1557-3265.earlyonsetca25-b013","title":"Abstract B013: Epidemiology of early-onset gastrointestinal cancers in Nepal: A scoping review","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Epidemiology; Cancer; Gastrointestinal cancer; Observational study; Colorectal cancer; Disease; Gallbladder cancer; Hepatocellular carcinoma","score_opus":0.403006158684619,"score_gpt":0.6358457422332121,"score_spread":0.23283958354859313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5968242,0.3801984,0.000022590793,0.014502659,0.00019916831,0.0037761547,0.000052413186,0.00004099233,0.004383378],"genre_scores_gemma":[0.9125183,0.084070675,0.0005760012,0.0014101476,0.00014896718,0.0007302403,0.000015131581,0.00002099525,0.00050950475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995041,0.0010603234,0.0015570916,0.0006900797,0.00062359544,0.0010278802],"domain_scores_gemma":[0.9927177,0.0054114135,0.00017614428,0.0006560927,0.000588752,0.00044991728],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009092255,0.00018801555,0.0012965294,0.00038799044,0.00007549334,0.0000061387045,0.00033464908,0.00012200835,0.0008988395],"category_scores_gemma":[0.010680111,0.00015218253,0.00028799433,0.0012050259,0.0009407548,0.000060651917,0.00021868061,0.0017408888,0.000047465262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019103661,0.00026705026,0.961636,0.009704387,0.00007536318,0.00028034797,0.000010689695,0.0000058657256,0.000007871433,0.0001047717,0.0053245504,0.020672744],"study_design_scores_gemma":[0.0025386075,0.0014907304,0.85731274,0.1376592,0.000035755067,0.000014589607,0.000020041181,0.000025835348,0.000084945,0.0006071446,0.00012765374,0.00008271705],"about_ca_topic_score_codex":0.010614267,"about_ca_topic_score_gemma":0.0034421466,"teacher_disagreement_score":0.3156941,"about_ca_system_score_codex":0.00087483553,"about_ca_system_score_gemma":0.0065707923,"threshold_uncertainty_score":0.99906105},"labels":[],"label_agreement":null},{"id":"W4417202888","doi":"10.1158/1557-3265.earlyonsetca25-pr016","title":"Abstract PR016: Supplement And Medication Use in Early-Onset Colorectal Cancer: An Analysis of the Ohio Colorectal Cancer Prevention Initiative","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Odds ratio; Cancer; Cancer prevention; Marital status; MEDLINE; Psychological intervention","score_opus":0.1728360929633381,"score_gpt":0.5399743512214655,"score_spread":0.3671382582581274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904402,0.0009548242,0.0000031269115,0.0057924287,0.0006671391,0.0013341651,0.000667891,0.0000150225615,0.00012523463],"genre_scores_gemma":[0.9975444,0.0006174547,0.00001935786,0.00036418522,0.00014321716,0.0011641387,0.000070629285,0.000012298611,0.00006431941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572706,0.001497402,0.00095267536,0.00057468406,0.0007418023,0.00050637225],"domain_scores_gemma":[0.99665856,0.001996914,0.0002592828,0.00031580837,0.00047740506,0.00029203738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003116207,0.00014307731,0.00044377102,0.0004610531,0.00023768138,0.000059913535,0.00033317198,0.00019454425,0.0008932895],"category_scores_gemma":[0.0016543668,0.00011394033,0.00015031318,0.0018394238,0.0006313399,0.00023231226,0.00015732959,0.0007412574,0.0000013360936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036706338,0.00044356458,0.97891635,0.00026894867,0.00011603157,0.0000018793498,0.0006388181,0.00010175543,0.000152302,0.000049567905,0.0012911422,0.014349005],"study_design_scores_gemma":[0.001365999,0.00034643302,0.9933515,0.0001549684,0.00032825008,6.739546e-8,0.0002518087,0.0021490508,0.0013096189,0.00033311624,0.0003079718,0.0001012244],"about_ca_topic_score_codex":0.047870964,"about_ca_topic_score_gemma":0.18892512,"teacher_disagreement_score":0.14105415,"about_ca_system_score_codex":0.00058103586,"about_ca_system_score_gemma":0.0016912821,"threshold_uncertainty_score":0.9780894},"labels":[],"label_agreement":null},{"id":"W4417202891","doi":"10.1158/1557-3265.earlyonsetca25-c037","title":"Abstract C037: Fructose-induced Akkermansia muciniphila promotes colorectal cancer progression through N-acetylneuraminic acid-mediated macrophage reprogramming","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Diet, Metabolism, and Disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Akkermansia muciniphila; Immune system; Macrophage polarization; Tumor progression; Mucin; Colorectal cancer; Macrophage; Tumor microenvironment","score_opus":0.17724204208167457,"score_gpt":0.5575806879932992,"score_spread":0.3803386459116246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704068,0.014947303,0.0000042943457,0.005165274,0.0016582586,0.0027161126,0.00008753108,0.00032331803,0.0046911095],"genre_scores_gemma":[0.9905825,0.003984607,0.0002560553,0.0009827577,0.0014607664,0.0014149523,0.000108112916,0.00009589882,0.0011143159],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9932377,0.00057048985,0.0014591881,0.0016205888,0.0016168838,0.0014951829],"domain_scores_gemma":[0.9955954,0.0010495866,0.00027501886,0.0010827004,0.0011095533,0.00088775234],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033721314,0.00046175983,0.0011527367,0.00030297448,0.0004654839,0.000176073,0.0005962817,0.0006647408,0.0011876184],"category_scores_gemma":[0.0048795654,0.00036716816,0.00049906084,0.0018373491,0.0010121473,0.0002888326,0.00045256337,0.0027229334,0.00020997078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012206938,0.0048850346,0.22998257,0.0025574123,0.0008812948,0.0016490656,0.0009997933,0.0000023280768,0.14379425,0.00027228278,0.022060465,0.58070856],"study_design_scores_gemma":[0.012268336,0.0020638364,0.85571307,0.0028234718,0.0004806291,0.000014280426,0.00085389323,0.00030586356,0.06801889,0.00065810635,0.056001827,0.0007977825],"about_ca_topic_score_codex":0.00071876,"about_ca_topic_score_gemma":0.00027375517,"teacher_disagreement_score":0.6257305,"about_ca_system_score_codex":0.00031259525,"about_ca_system_score_gemma":0.0031564313,"threshold_uncertainty_score":0.99987805},"labels":[],"label_agreement":null},{"id":"W4417202897","doi":"10.1158/1557-3265.earlyonsetca25-c003","title":"Abstract C003: Neonatal Dried Blood Spot Metabolomics Reveals Signatures of Early-Onset Myeloproliferative Neoplasms","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dried blood spot; Metabolomics; Confounding; Metabolome; Pathogenesis; Population; Etiology; Case-control study; Cancer","score_opus":0.0636110965128289,"score_gpt":0.4400740854778404,"score_spread":0.3764629889650115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97783935,0.018394219,0.000047556645,0.00090433954,0.00045234148,0.00046419434,0.00024325089,0.000010555895,0.0016442194],"genre_scores_gemma":[0.98213327,0.014012037,0.0005873961,0.00027681238,0.00037453353,0.000113550246,0.00005123372,0.000023711962,0.002427468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970738,0.00037708657,0.0008028172,0.0007339793,0.00043626846,0.0005760319],"domain_scores_gemma":[0.99779046,0.00053731824,0.00017918592,0.0006205963,0.0007171882,0.00015523339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025910093,0.00022470795,0.00063762127,0.00019785538,0.00019682605,0.0000436381,0.000579345,0.00039692273,0.00010332265],"category_scores_gemma":[0.0022267255,0.00019581759,0.00027818323,0.0005572344,0.00073259335,0.0000070358888,0.00056117325,0.00085910683,0.000007939864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053987657,0.0010370014,0.21031418,0.00032623048,0.0035685592,0.00003900956,0.00018887412,0.000053239874,0.7098285,0.0121678915,0.041776124,0.015301625],"study_design_scores_gemma":[0.003104752,0.0011146091,0.35912392,0.000103445505,0.00017327549,0.0000023391217,0.00021926289,0.000012609307,0.576565,0.004759345,0.05438934,0.00043208624],"about_ca_topic_score_codex":0.00015738861,"about_ca_topic_score_gemma":0.00020571155,"teacher_disagreement_score":0.14880973,"about_ca_system_score_codex":0.000021028649,"about_ca_system_score_gemma":0.00062207005,"threshold_uncertainty_score":0.798521},"labels":[],"label_agreement":null},{"id":"W4417202902","doi":"10.1158/1557-3265.earlyonsetca25-c020","title":"Abstract C020: Novel insights from the investigation of experimental mutational signatures in early-onset colorectal cancer and colonic polyps","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Colorectal cancer; COSMIC cancer database; Exome sequencing; Cancer; Exome; Mutation; Germline mutation","score_opus":0.06869939336294499,"score_gpt":0.43638423401340753,"score_spread":0.36768484065046253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98208636,0.016040055,0.0000043324176,0.0009677275,0.00022003945,0.00029337604,0.00025660227,0.0000020876557,0.00012942277],"genre_scores_gemma":[0.997291,0.0017147469,0.00004310756,0.0004512609,0.00022600868,0.00015635704,0.000059838378,0.000009019259,0.000048647384],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99885416,0.00009988769,0.00033680093,0.00033262395,0.00020086284,0.00017563652],"domain_scores_gemma":[0.9986961,0.0008576221,0.000070408205,0.00015646717,0.00015113979,0.00006825709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040145824,0.000088814086,0.00015258761,0.00005112015,0.00008642215,0.000030810832,0.00020591146,0.00018539233,0.00003462013],"category_scores_gemma":[0.00040870614,0.00007234577,0.0000498262,0.00018378954,0.00060700177,0.000004631316,0.00019574774,0.00034530883,7.9953475e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013832584,0.00019374637,0.4609467,0.000021081922,0.00012514705,0.0000037539803,0.0004291769,0.000283824,0.5278391,0.00060965127,0.006652207,0.0015123333],"study_design_scores_gemma":[0.0010610875,0.00016440159,0.8327735,0.00006296315,0.0000070589754,1.3417471e-7,0.00012825483,0.000100668534,0.16385652,0.00054523064,0.0012270436,0.00007312352],"about_ca_topic_score_codex":0.0062686894,"about_ca_topic_score_gemma":0.007337758,"teacher_disagreement_score":0.3718268,"about_ca_system_score_codex":0.000065267646,"about_ca_system_score_gemma":0.00094608025,"threshold_uncertainty_score":0.9476425},"labels":[],"label_agreement":null},{"id":"W4417202966","doi":"10.1158/1557-3265.earlyonsetca25-b028","title":"Abstract B028: Co-occurring social determinants of endometrial cancer disparities in All of Us","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Logistic regression; Social determinants of health; Socioeconomic status; Cluster (spacecraft); Health equity; Incidence (geometry); Odds ratio; Odds","score_opus":0.3903586450962635,"score_gpt":0.6332562303121234,"score_spread":0.2428975852158599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214125,0.005109271,0.0000014878533,0.0004068281,0.0006473059,0.00058463356,0.00011850599,0.000008134687,0.000982605],"genre_scores_gemma":[0.99174416,0.0073199803,0.000011651563,0.00014640354,0.00053575274,0.000088764005,0.0000050390913,0.0000129327545,0.00013530558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968968,0.00031476718,0.0011062132,0.00032081318,0.0008268882,0.00053451606],"domain_scores_gemma":[0.9973982,0.0016677676,0.00013465405,0.00028324034,0.00033648362,0.00017967199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042221756,0.00010862773,0.0009890248,0.00049990043,0.000063854786,0.000008198297,0.00019272704,0.00026152184,0.00020863023],"category_scores_gemma":[0.0024930055,0.00009023848,0.0004303158,0.0007133749,0.00058368576,0.000041251493,0.000107094726,0.0010321885,0.0000029693647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023678048,0.00021449922,0.9161496,0.0012703025,0.0001445316,0.000026196121,0.00008254173,0.0000041908465,0.00016491351,0.000022225648,0.0014513445,0.078101836],"study_design_scores_gemma":[0.0048115565,0.0001569641,0.9791083,0.00065585354,0.000055874665,5.451181e-7,0.00007678744,0.000021020434,0.0028662279,0.000049467326,0.012129466,0.0000679669],"about_ca_topic_score_codex":0.032288205,"about_ca_topic_score_gemma":0.0048512826,"teacher_disagreement_score":0.078033864,"about_ca_system_score_codex":0.00024591337,"about_ca_system_score_gemma":0.002003217,"threshold_uncertainty_score":0.97415584},"labels":[],"label_agreement":null},{"id":"W4417203745","doi":"10.1158/1557-3265.earlyonsetca25-b020","title":"Abstract B020: Early-onset colorectal cancer mortality trends and birth cohort effect in Mexico, 1998-2023","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Birth, Development, and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Cohort; Population; Mortality rate; Cohort effect; Cancer; Cohort study","score_opus":0.1454621290408858,"score_gpt":0.5421429742686512,"score_spread":0.3966808452277654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97984016,0.002471406,9.517968e-7,0.0051850495,0.00055565697,0.0009211791,0.00010913354,0.0000495282,0.010866914],"genre_scores_gemma":[0.9393029,0.05760307,0.000019590228,0.001085506,0.0002764166,0.0005925511,0.000028561717,0.000025780184,0.0010655994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594337,0.0005638361,0.0009170489,0.0008434695,0.0008332442,0.0008990122],"domain_scores_gemma":[0.9969324,0.0018822575,0.000092279806,0.00038711555,0.00017531785,0.0005306521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00731038,0.00022630555,0.00088131294,0.00051427964,0.00019704616,0.000048169215,0.00021651776,0.00039243797,0.0007615803],"category_scores_gemma":[0.0009571234,0.00018363545,0.00013444171,0.0013862347,0.00070905895,0.00007061782,0.00019770282,0.0021560015,0.00005323885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018149485,0.00021788034,0.9494258,0.0005544138,0.00019470703,0.000097110096,0.000095904885,7.740079e-7,0.0000738124,0.00019398783,0.014812105,0.032518532],"study_design_scores_gemma":[0.003231382,0.00057343754,0.99104786,0.0005347961,0.000043115604,0.0000018238311,0.000026626209,0.00006395747,0.0003695323,0.0009098251,0.0030431284,0.00015452768],"about_ca_topic_score_codex":0.019788433,"about_ca_topic_score_gemma":0.024681523,"teacher_disagreement_score":0.055131663,"about_ca_system_score_codex":0.0005689834,"about_ca_system_score_gemma":0.0025081113,"threshold_uncertainty_score":0.9931155},"labels":[],"label_agreement":null},{"id":"W4417203801","doi":"10.1158/1557-3265.earlyonsetca25-a016","title":"Abstract A016: Cascade Failure in Lynch Syndrome Diagnosis: A Single-Institution Analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lynch syndrome; MLH1; Germline; DNA mismatch repair; Genetic testing; Germline mutation; Microsatellite instability","score_opus":0.18497773573790396,"score_gpt":0.5196342647450558,"score_spread":0.3346565290071518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98419803,0.0025537035,0.00003990533,0.0075538973,0.00052038353,0.0008735856,0.000024947101,0.000051865078,0.0041836896],"genre_scores_gemma":[0.99610746,0.0012924878,0.00019993215,0.00050907466,0.00019502072,0.00080301386,0.000016118769,0.000019907027,0.00085695897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961089,0.00034921154,0.00096690556,0.00085347623,0.0009846331,0.000736893],"domain_scores_gemma":[0.9968932,0.001566731,0.000085011176,0.0007057773,0.00044828138,0.00030095872],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028597338,0.00020097187,0.0008083593,0.0011524113,0.00012403216,0.000060234746,0.00036395725,0.00046194976,0.0016175488],"category_scores_gemma":[0.0030492202,0.00017681549,0.00038375214,0.004583615,0.0006341166,0.000082039376,0.00022125377,0.0018456156,0.00009431909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006678066,0.0008461588,0.96488947,0.00029207676,0.0007251756,0.00041334835,0.00008300693,0.00029596075,0.0005926819,0.00008365855,0.008572066,0.022538615],"study_design_scores_gemma":[0.0018072978,0.0005172594,0.9780427,0.0007171735,0.00034311548,0.0000074579098,0.00014071772,0.00019105893,0.001953393,0.00027575556,0.015830945,0.00017309177],"about_ca_topic_score_codex":0.0024155588,"about_ca_topic_score_gemma":0.013474106,"teacher_disagreement_score":0.022365524,"about_ca_system_score_codex":0.0012340393,"about_ca_system_score_gemma":0.0014542277,"threshold_uncertainty_score":0.9992951},"labels":[],"label_agreement":null},{"id":"W4417203867","doi":"10.1158/1557-3265.earlyonsetca25-pr007","title":"Abstract PR007: Tumor-adjacent visceral adipose tissue displays an altered transcriptomic landscape in early-onset colorectal cancer patients: Results from the ColoCare Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Transcriptome; Adipose tissue; Paracrine signalling; Cancer; Body mass index; Endocrine system","score_opus":0.08424587665218894,"score_gpt":0.46683842374703766,"score_spread":0.3825925470948487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868382,0.002917019,5.3745265e-7,0.0028920877,0.001596016,0.003511122,0.0014555681,0.00004439444,0.0007450368],"genre_scores_gemma":[0.99590385,0.0009388308,0.00000834947,0.00093860005,0.00083397824,0.0007672896,0.00027352283,0.000039018345,0.00029654498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99483335,0.0011053088,0.0012323632,0.0010196659,0.0009964862,0.00081282406],"domain_scores_gemma":[0.996669,0.0015930781,0.00012800813,0.00074032356,0.0004745351,0.00039505606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026877446,0.00028068005,0.0007645022,0.00019461648,0.00024047852,0.000108621185,0.00061788486,0.00020208355,0.0004234864],"category_scores_gemma":[0.0015274651,0.00019160456,0.00015032326,0.0008254531,0.00042923001,0.00016204246,0.00017474695,0.0017639708,0.000037996357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02111274,0.0035317955,0.9404048,0.000057130466,0.00020478078,0.000041392443,0.0033791775,0.00001904082,0.00016517752,0.0000075027333,0.020325538,0.010750935],"study_design_scores_gemma":[0.020046217,0.0016661391,0.96738076,0.00033715097,0.000151771,2.4826778e-7,0.002037073,0.00012016402,0.00025039213,0.000047635614,0.007773883,0.00018855502],"about_ca_topic_score_codex":0.032702535,"about_ca_topic_score_gemma":0.059009187,"teacher_disagreement_score":0.026975982,"about_ca_system_score_codex":0.00024736224,"about_ca_system_score_gemma":0.0014563724,"threshold_uncertainty_score":0.9737388},"labels":[],"label_agreement":null},{"id":"W4417203945","doi":"10.1158/1557-3265.earlyonsetca25-pr009","title":"Abstract PR009: Bugs in Space: Spatial Analysis of the Immune-Microbial Axis in Rectal Cancer Reveals a Unique Interface in Young Onset Rectal Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Immune system; Transcriptome; Microbiome; Digital polymerase chain reaction; Tumor microenvironment; Cancer; Gene expression profiling","score_opus":0.05037476670770128,"score_gpt":0.48062560915743435,"score_spread":0.43025084244973305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244314,0.0038705126,0.000006947127,0.0012638257,0.00029418085,0.00090094144,0.00033109146,0.0000041391327,0.0008851981],"genre_scores_gemma":[0.9929176,0.0055349516,0.000013709783,0.000053077074,0.00008488571,0.00046497182,0.000044493587,0.000020469992,0.0008658478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600875,0.0010039158,0.00097107264,0.0007997583,0.0004504986,0.00076599256],"domain_scores_gemma":[0.99850297,0.00029416473,0.0001554501,0.0006879954,0.00024398869,0.00011541743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027587754,0.00021303332,0.00063374196,0.0006373107,0.00007073761,0.00003647305,0.00070989545,0.00034441348,0.0001848458],"category_scores_gemma":[0.001122929,0.00017742558,0.0003259326,0.0027950257,0.0005670991,0.000011920719,0.0005723851,0.0012335676,0.000002148519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004004172,0.00034593255,0.9259165,0.00008402502,0.00057429465,0.00002223605,0.00018663942,0.0010590586,0.059727125,0.000009335789,0.0012066008,0.006864081],"study_design_scores_gemma":[0.002469535,0.00023997389,0.92900956,0.0005114432,0.000046721674,7.33117e-7,0.00013898658,0.00017431554,0.06647081,0.00006993715,0.0006956198,0.00017235533],"about_ca_topic_score_codex":0.34443113,"about_ca_topic_score_gemma":0.7828182,"teacher_disagreement_score":0.4383871,"about_ca_system_score_codex":0.0012263034,"about_ca_system_score_gemma":0.0030244433,"threshold_uncertainty_score":0.7235205},"labels":[],"label_agreement":null},{"id":"W4417207033","doi":"10.1158/1557-3265.earlyonsetca25-a034","title":"Abstract A034: Model-free scoring system for risk prediction and early detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Receiver operating characteristic; Oracle; Risk assessment; Limiting; Cancer; Disease; Function (biology)","score_opus":0.4999134991118311,"score_gpt":0.6033027314913065,"score_spread":0.10338923237947545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417207033","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43543693,0.00018924587,0.56075853,0.00013495787,0.00043842426,0.00064349023,0.00014209021,0.00007178033,0.0021845382],"genre_scores_gemma":[0.95136285,0.0002479262,0.047439616,0.000010226024,0.00027395535,0.00040594186,4.329348e-7,0.000016243055,0.00024280652],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99814683,0.00025696878,0.0005828925,0.0003839176,0.0003170054,0.00031238835],"domain_scores_gemma":[0.99005055,0.008942863,0.000091003974,0.00038199182,0.00040978973,0.0001238218],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0063209706,0.00008982397,0.0002739905,0.00010600092,0.00028078788,0.00007905131,0.000199778,0.00017024478,0.000011367949],"category_scores_gemma":[0.016953425,0.0000761348,0.00007317975,0.00020529106,0.00018203202,0.00006526699,0.00014998546,0.00068680214,0.0000025499833],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011653085,0.0001708031,0.023987679,0.002776244,0.00015103954,0.0000027576084,0.00012244009,0.00007568908,0.0010955787,0.22776648,0.0032580942,0.73942786],"study_design_scores_gemma":[0.0015810515,0.0004261541,0.091402166,0.00078574923,0.00008218329,5.125613e-7,0.00012781234,0.10881191,0.0016225231,0.794601,0.00042315546,0.00013575506],"about_ca_topic_score_codex":0.00033786322,"about_ca_topic_score_gemma":0.00009706719,"teacher_disagreement_score":0.73929214,"about_ca_system_score_codex":0.00013514819,"about_ca_system_score_gemma":0.0001497512,"threshold_uncertainty_score":0.99132717},"labels":[],"label_agreement":null},{"id":"W4417207512","doi":"10.1158/1557-3265.earlyonsetca25-c028","title":"Abstract C028: GSK3β: a therapeutic target in KRAS mutant pancreatic cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Pancreatic cancer; Signal transduction; Kinase; Cell growth; Cancer; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.11709746190286066,"score_gpt":0.4884099852648104,"score_spread":0.37131252336194975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417207512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97887427,0.011176458,0.000075966,0.0014585316,0.00065167045,0.0004675967,0.000016608983,0.000017872087,0.0072610117],"genre_scores_gemma":[0.988553,0.005315298,0.00013198498,0.0009873983,0.0003863215,0.00039106177,0.000029975587,0.000027610262,0.004177348],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972763,0.00029789988,0.0006325867,0.0006989177,0.00040976435,0.00068452436],"domain_scores_gemma":[0.9988254,0.000254876,0.00007272794,0.00045929675,0.00025314756,0.0001345708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002572359,0.00018910659,0.00033642785,0.00016030385,0.00013211626,0.000052449366,0.00055269676,0.0003118484,0.0005732589],"category_scores_gemma":[0.00039938506,0.00016787813,0.00014083392,0.000518292,0.00041896224,0.0000061166556,0.00021519324,0.000710015,0.000039059178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003272158,0.0005085175,0.57092047,0.00037354784,0.00080187427,0.000079337595,0.00024436958,0.00074347685,0.288069,0.0006740618,0.056158695,0.078154474],"study_design_scores_gemma":[0.005214464,0.0006278433,0.36994493,0.0008087381,0.000055683042,0.0000025220215,0.00043110873,0.00024035606,0.20473985,0.0067942417,0.41021746,0.0009227939],"about_ca_topic_score_codex":0.00088787236,"about_ca_topic_score_gemma":0.000717706,"teacher_disagreement_score":0.35405877,"about_ca_system_score_codex":0.00025974275,"about_ca_system_score_gemma":0.0022398809,"threshold_uncertainty_score":0.6845871},"labels":[],"label_agreement":null},{"id":"W4417207561","doi":"10.1158/1557-3265.earlyonsetca25-c012","title":"Abstract C012: Transcriptional profiling of circulating immune cells from patients with early- and late-onset colorectal cancer reveals sex-specific differences","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Colorectal cancer; Cytotoxic T cell; Peripheral blood mononuclear cell; Cytolysis; Transcriptome; Gene; Effector; Gene expression profiling","score_opus":0.07289251582875907,"score_gpt":0.3730629924072911,"score_spread":0.3001704765785321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417207561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554914,0.0031073587,0.00006003701,0.00007492006,0.00027509002,0.00039581416,0.0004002004,0.0000070925607,0.00013036683],"genre_scores_gemma":[0.99755687,0.001716429,0.00022205035,0.00003396,0.00015413066,0.0000681722,0.00010109199,0.000018511617,0.00012877067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806285,0.00019154827,0.0005493003,0.00052805955,0.00034468118,0.00032353622],"domain_scores_gemma":[0.99899876,0.00026837748,0.000100511934,0.00020456639,0.000329818,0.000097957425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006069041,0.00015269064,0.00033779396,0.00005654659,0.0001478805,0.000043774417,0.00023121448,0.00022892264,0.00007550322],"category_scores_gemma":[0.0000585653,0.00012543715,0.00009719406,0.00016560385,0.0004997717,0.000008405928,0.00006701568,0.00044888686,0.0000010035143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071710296,0.00012921366,0.5512983,0.00004913695,0.0000913434,8.265437e-7,0.00004995808,0.000012471704,0.44300476,0.0000063091798,0.00002956599,0.0046109846],"study_design_scores_gemma":[0.0013220726,0.00027896435,0.8587236,0.00018739559,0.00001668435,6.3439636e-8,0.00003787887,0.000034689885,0.13896672,0.00010996079,0.00019368109,0.00012830281],"about_ca_topic_score_codex":0.0012030347,"about_ca_topic_score_gemma":0.00026802576,"teacher_disagreement_score":0.30742523,"about_ca_system_score_codex":0.000029851335,"about_ca_system_score_gemma":0.00025663388,"threshold_uncertainty_score":0.5115178},"labels":[],"label_agreement":null},{"id":"W4417208722","doi":"10.1158/1557-3265.earlyonsetca25-c021","title":"Abstract C021: Characterizing the clinicopathological, genomic and spatial transcriptomic features of colibactin-induced colorectal cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Loss of heterozygosity; Transcriptome; Colorectal cancer; Context (archaeology); Genomics; Exon; Adenocarcinoma; Gene","score_opus":0.08805616936942935,"score_gpt":0.44045234014387113,"score_spread":0.3523961707744418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196976,0.003461355,0.000013479881,0.0018643746,0.00084892433,0.0005196753,0.00011778028,0.000007089371,0.0011975722],"genre_scores_gemma":[0.9869063,0.011438272,0.000023341188,0.00076616986,0.00053918344,0.00012106584,0.000021958907,0.000019719904,0.00016398261],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979545,0.0002693677,0.0005952641,0.0005582155,0.00020848279,0.00041415571],"domain_scores_gemma":[0.9983702,0.0007270103,0.00014552749,0.0003999688,0.0002340847,0.0001232387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001902662,0.00016150824,0.00035153594,0.000065804896,0.00022009628,0.00006396152,0.0004435667,0.0003075667,0.000074366886],"category_scores_gemma":[0.00090569723,0.00012383748,0.00017187026,0.00016811451,0.0007463428,0.0000038860803,0.00028561166,0.000717799,0.0000031167287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00200451,0.00010960208,0.03710345,0.00007095129,0.00010077503,0.0000062621684,0.00006601412,0.000008472043,0.9028148,0.00012419172,0.006023399,0.05156756],"study_design_scores_gemma":[0.0011820483,0.0006583317,0.8860843,0.000062254396,0.000034977267,0.0000027360381,0.00014803516,0.000017867686,0.08765363,0.00011590904,0.02388502,0.00015485751],"about_ca_topic_score_codex":0.0025410342,"about_ca_topic_score_gemma":0.0043448852,"teacher_disagreement_score":0.8489809,"about_ca_system_score_codex":0.00011121443,"about_ca_system_score_gemma":0.0011943238,"threshold_uncertainty_score":0.50499463},"labels":[],"label_agreement":null},{"id":"W4417208861","doi":"10.1158/1557-3265.earlyonsetca25-ia002","title":"Abstract IA002: Early-Onset Colorectal Cancer as a Model for Precision Cancer Prevention","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer prevention; Colorectal cancer; Cancer; Disease; Precision medicine; Microbiome; Aspirin; Disease prevention; Breast cancer","score_opus":0.3123093736101132,"score_gpt":0.6194755135353421,"score_spread":0.30716613992522895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98349917,0.0046948786,0.00045966526,0.005467647,0.00112948,0.0027434404,0.00041307937,0.00007258397,0.0015200299],"genre_scores_gemma":[0.9640097,0.010622196,0.00015704724,0.00055652246,0.0008157866,0.0037157058,0.000035661724,0.00005402965,0.020033324],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99622405,0.00015882868,0.00092599395,0.000927522,0.00092347665,0.0008401272],"domain_scores_gemma":[0.99671906,0.001197778,0.00015536901,0.00048539456,0.0010266975,0.0004157249],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024172594,0.00025013826,0.00070715294,0.00029965767,0.00030971566,0.00008537486,0.00034337555,0.00044307247,0.0015520802],"category_scores_gemma":[0.0011105064,0.00020955336,0.0004947753,0.0006955323,0.00041066206,0.00014811916,0.00019678532,0.001330907,0.00004156544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021190476,0.0011208808,0.35833308,0.00078535586,0.0006713665,0.000017264274,0.00048161455,0.0007760058,0.0024459194,0.00023092536,0.1425566,0.47139052],"study_design_scores_gemma":[0.010257599,0.0018814185,0.88347507,0.0031127837,0.0003990643,0.0000024702356,0.00016754572,0.033091184,0.0054038367,0.007702739,0.053973906,0.00053236535],"about_ca_topic_score_codex":0.011970737,"about_ca_topic_score_gemma":0.007896415,"teacher_disagreement_score":0.525142,"about_ca_system_score_codex":0.00092883327,"about_ca_system_score_gemma":0.0049374825,"threshold_uncertainty_score":0.9993606},"labels":[],"label_agreement":null},{"id":"W4417208863","doi":"10.1158/1557-3265.earlyonsetca25-b031","title":"Abstract B031: Clinicopathologic features associated with metastatic early-onset gastric cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Odds ratio; Incidence (geometry); Conditional logistic regression; Disease; Logistic regression; Stage (stratigraphy); Retrospective cohort study; Primary tumor","score_opus":0.2260910781392836,"score_gpt":0.5354485241844146,"score_spread":0.30935744604513093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97520727,0.0042960923,0.000031121857,0.010319008,0.00071493036,0.0013409778,0.000080190504,0.00014457789,0.00786582],"genre_scores_gemma":[0.9685508,0.0037887637,0.00017658505,0.002252118,0.0003175009,0.0005013445,0.00003761861,0.000039426126,0.024335824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954937,0.0005159159,0.00091631623,0.00087626535,0.0011766045,0.0010211845],"domain_scores_gemma":[0.99538773,0.0026320803,0.0002242066,0.00069348066,0.00072460144,0.0003379102],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044761077,0.0002960019,0.0009631969,0.0005687125,0.00026095484,0.0001160542,0.00046140284,0.00021706185,0.0013137439],"category_scores_gemma":[0.003003868,0.00020808756,0.0003120831,0.002359214,0.0007289735,0.000109108805,0.00026659702,0.0021758862,0.00007146602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018247438,0.0004870084,0.8589288,0.00018732759,0.0006297208,0.00032559314,0.000041680498,0.000016317728,0.000015355645,0.000060443763,0.086928055,0.05055498],"study_design_scores_gemma":[0.00486783,0.001018836,0.98518187,0.00074071164,0.00042375427,0.0000042988822,0.00014158378,0.000019530773,0.000038631602,0.0003393547,0.007043041,0.00018057233],"about_ca_topic_score_codex":0.0013962116,"about_ca_topic_score_gemma":0.0014354124,"teacher_disagreement_score":0.12625308,"about_ca_system_score_codex":0.00050887995,"about_ca_system_score_gemma":0.0014894588,"threshold_uncertainty_score":0.9995992},"labels":[],"label_agreement":null},{"id":"W4417208876","doi":"10.1158/1557-3265.earlyonsetca25-b025","title":"Abstract B025: Universal Germline Testing in Young-Onset GI Malignancies: Expanding Access for Underserved Patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline; Psychosocial; Genetic testing; Cancer; Hereditary Cancer; Lynch syndrome; Colorectal cancer; Germline mutation; Incidence (geometry)","score_opus":0.4066752796112222,"score_gpt":0.5663796199608093,"score_spread":0.15970434034958714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914085,0.00029151083,0.000083982304,0.0013983857,0.0010949153,0.0017038594,0.00007540866,0.000047752324,0.003895684],"genre_scores_gemma":[0.9970634,0.00019297872,0.00044245156,0.00036273815,0.0002539278,0.0003440491,0.00003605147,0.00003618797,0.0012682447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672097,0.0001949362,0.000864586,0.00072350854,0.0006746593,0.0008213308],"domain_scores_gemma":[0.9938864,0.004216921,0.00012238507,0.00045524875,0.0010801564,0.00023885345],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025989022,0.00019610598,0.00053440046,0.00043678447,0.00018214117,0.0000798141,0.0005128711,0.00029075478,0.00030226255],"category_scores_gemma":[0.00838152,0.0001818971,0.00016096966,0.0013529449,0.00041948727,0.00013017001,0.00038884883,0.0010390555,0.000011344556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020948327,0.00037178042,0.97905576,0.00047673692,0.00006130236,0.000016585866,0.00008093555,0.000051372524,0.00059380097,0.000025847783,0.0075205755,0.00965044],"study_design_scores_gemma":[0.005918241,0.0006928187,0.98754495,0.0012125575,0.00003598353,7.189584e-7,0.00031798694,0.00047301932,0.0014569081,0.00077638816,0.0013913923,0.00017904272],"about_ca_topic_score_codex":0.0016804492,"about_ca_topic_score_gemma":0.0026171799,"teacher_disagreement_score":0.009471398,"about_ca_system_score_codex":0.0010799151,"about_ca_system_score_gemma":0.001966916,"threshold_uncertainty_score":0.99997133},"labels":[],"label_agreement":null},{"id":"W4417209005","doi":"10.1158/1557-3265.earlyonsetca25-c024","title":"Abstract C024: Somatic mutations in early-onset colorectal cancer: insights from a U.S. Hispanic cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatic cell; Colorectal cancer; Germline mutation; Lynch syndrome; Exome sequencing; Exome; MLH1","score_opus":0.055268379389918104,"score_gpt":0.4404204596819934,"score_spread":0.38515208029207526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897421,0.0071584214,0.00002205708,0.00064893573,0.000669283,0.0005897918,0.00028796782,0.0000113219885,0.0008701319],"genre_scores_gemma":[0.9904901,0.0075750835,0.000059147944,0.00035297644,0.00042707348,0.000643956,0.0001682076,0.000024698042,0.00025876006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775493,0.00021070242,0.0006320602,0.00066385523,0.0002984701,0.0004399865],"domain_scores_gemma":[0.9982857,0.0007853245,0.000083950574,0.00044023257,0.00023350224,0.00017129132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006365646,0.0001614242,0.0003292059,0.0001556227,0.00013998343,0.000083926585,0.00043470148,0.00031533669,0.0001917414],"category_scores_gemma":[0.00096193486,0.00016182594,0.00013617669,0.0003882289,0.0003112167,0.000006277615,0.0003005192,0.00063838885,0.0000451732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005673217,0.0003654569,0.95554876,0.000050512204,0.00024471965,0.000029986526,0.000167023,0.00023124264,0.016759017,0.00010808035,0.013167562,0.012760321],"study_design_scores_gemma":[0.0012230042,0.00019720357,0.9787331,0.00013191276,0.000030441368,3.2362982e-7,0.000105809304,0.00020030516,0.008298718,0.0017869519,0.0091032265,0.00018897762],"about_ca_topic_score_codex":0.008511895,"about_ca_topic_score_gemma":0.040941477,"teacher_disagreement_score":0.03242958,"about_ca_system_score_codex":0.00022047674,"about_ca_system_score_gemma":0.0017553751,"threshold_uncertainty_score":0.9980905},"labels":[],"label_agreement":null},{"id":"W4417209023","doi":"10.1158/1557-3265.earlyonsetca25-b022","title":"Abstract B022: Trends in the Cumulative Incidence of Second Primary Cancers Among Survivors of Early-Onset Cancer in the United States, 1975-2022","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cumulative incidence; Incidence (geometry); Cumulative risk; Cancer; Context (archaeology); Cancer incidence; Age groups","score_opus":0.1499192146807878,"score_gpt":0.4972420291156923,"score_spread":0.34732281443490454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868879,0.002549411,0.000001360898,0.002543648,0.00025281977,0.0008956057,0.00045502596,0.000008667599,0.0064055985],"genre_scores_gemma":[0.99154574,0.004585095,0.000009869086,0.0020371436,0.00009488201,0.00036475316,0.00013877517,0.000020604393,0.0012031187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943777,0.0016344329,0.0014627983,0.00058175734,0.0012859865,0.0006573717],"domain_scores_gemma":[0.9925922,0.0056662904,0.00030650562,0.00086076336,0.00045543385,0.000118788135],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008787597,0.00022991282,0.0008276129,0.0010210135,0.00010895577,0.000026233878,0.000974017,0.00022889658,0.0022322019],"category_scores_gemma":[0.00057712337,0.00014882543,0.00022066463,0.0044367146,0.0016436332,0.00016602076,0.00019031104,0.002589404,0.0000017545995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032194005,0.00029330773,0.94928735,0.0004889116,0.00015823869,0.00007341268,0.0051801642,0.0009998569,0.0001310945,0.00004658939,0.010767492,0.029354192],"study_design_scores_gemma":[0.0025843345,0.0004057244,0.9851065,0.0006046927,0.00003675033,9.3148276e-7,0.0025653457,0.0005451773,0.00017482531,0.00014728818,0.0076988977,0.00012950513],"about_ca_topic_score_codex":0.2084673,"about_ca_topic_score_gemma":0.22620612,"teacher_disagreement_score":0.035819188,"about_ca_system_score_codex":0.00085361215,"about_ca_system_score_gemma":0.0032645457,"threshold_uncertainty_score":0.9997117},"labels":[],"label_agreement":null},{"id":"W4417209033","doi":"10.1158/1557-3265.earlyonsetca25-c007","title":"Abstract C007: Age-stratified insight into genomic alterations in colon adenocarcinoma via AACR GENIE v18.0","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cohort; Cancer; Adenocarcinoma; Incidence (geometry); Colon adenocarcinoma","score_opus":0.09505588414339707,"score_gpt":0.46133266919523813,"score_spread":0.3662767850518411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825437,0.007196485,0.00021455593,0.0015357202,0.0006723735,0.00062085834,0.00004628917,0.00000990179,0.0071601155],"genre_scores_gemma":[0.99255645,0.003911124,0.00024510326,0.0008759982,0.0007569312,0.00026324604,0.00012718493,0.000026386691,0.0012375647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975297,0.00022698854,0.00074963894,0.00073288544,0.00024343678,0.0005173657],"domain_scores_gemma":[0.9984209,0.00041046797,0.000077580866,0.0006502417,0.0002505555,0.00019023947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013136872,0.00017776678,0.00030469053,0.00018321675,0.00019865931,0.000114439725,0.000500848,0.00036593692,0.00015745386],"category_scores_gemma":[0.00058205554,0.00018487094,0.0001497456,0.00037805224,0.00038705097,0.000006592098,0.0003868449,0.0007122617,0.000046391477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031420179,0.0011637473,0.19369493,0.00026817748,0.00034859974,0.0002414769,0.0006582936,0.0012693326,0.68702286,0.0020292348,0.056120716,0.05404057],"study_design_scores_gemma":[0.0042226855,0.00094571116,0.6900625,0.00014568349,0.00004232197,0.0000031390846,0.00017534746,0.00048812668,0.050941903,0.0053224745,0.24703188,0.0006181758],"about_ca_topic_score_codex":0.0022034966,"about_ca_topic_score_gemma":0.017041467,"teacher_disagreement_score":0.636081,"about_ca_system_score_codex":0.00021635833,"about_ca_system_score_gemma":0.0014328209,"threshold_uncertainty_score":0.95095384},"labels":[],"label_agreement":null},{"id":"W4417209066","doi":"10.1158/1557-3265.earlyonsetca25-c023","title":"Abstract C023: Studying early onset cancer: benefits and limitations of studies within the Military Health System","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Etiology; Cohort; Cancer; Military service; Cohort study; Epidemiology; Genetic predisposition","score_opus":0.4457567302058681,"score_gpt":0.5272275364900226,"score_spread":0.08147080628415454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607305,0.025648165,0.000007282478,0.011536278,0.00023773477,0.001061017,0.000055558638,0.000020367072,0.00070312415],"genre_scores_gemma":[0.963246,0.035301484,0.000105964915,0.000762934,0.000058786205,0.00035470573,0.0000013080963,0.000014081511,0.00015475364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606115,0.0011253869,0.00087992765,0.0006646494,0.0007532699,0.0005156141],"domain_scores_gemma":[0.99268454,0.0064215767,0.0001641831,0.00046085514,0.00007149277,0.00019735971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009876454,0.0001393025,0.00039482946,0.00007773683,0.00076905906,0.000018840448,0.0003673505,0.00007774826,0.0000374796],"category_scores_gemma":[0.0019020302,0.00010224934,0.00006261678,0.00056522945,0.0015783808,0.00013111981,0.0005898971,0.00090661173,0.000034278073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012410115,0.00016630394,0.7386686,0.00048138137,0.00016298695,0.0000049446644,0.0042292117,0.0013985323,0.000043768974,0.00024307167,0.0025837421,0.25189334],"study_design_scores_gemma":[0.00044003827,0.00019036082,0.98827344,0.00087823754,0.000018386909,4.485817e-7,0.008611757,0.00022878541,0.00005419787,0.00018268077,0.0010328295,0.00008882729],"about_ca_topic_score_codex":0.019650806,"about_ca_topic_score_gemma":0.020601723,"teacher_disagreement_score":0.2518045,"about_ca_system_score_codex":0.00079104083,"about_ca_system_score_gemma":0.00035335275,"threshold_uncertainty_score":0.99726975},"labels":[],"label_agreement":null},{"id":"W4417209333","doi":"10.1158/1557-3265.earlyonsetca25-c017","title":"Abstract C017: Exogenous carcinogenic exposures in early-onset pancreatic carcinogenesis: Insights from alcohol and tobacco-driven models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogenesis; Pancreas; Carcinogen; Pancreatitis; Immune system; Pancreatic Intraepithelial Neoplasia; Pancreatic cancer; Metaplasia; Stromal cell","score_opus":0.1380299526074797,"score_gpt":0.4090477430528915,"score_spread":0.2710177904454118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801105,0.01828826,0.000044896544,0.0001454834,0.00023582412,0.0004691993,0.00008794121,0.000013372865,0.00060448435],"genre_scores_gemma":[0.9922878,0.006611681,0.000099928766,0.00025925276,0.0002946379,0.0001532506,0.00007596654,0.000031718486,0.00018576163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997272,0.0004070579,0.000637514,0.0008392435,0.00032436417,0.0005197972],"domain_scores_gemma":[0.9985994,0.00032062628,0.00005942132,0.00060944736,0.00020753485,0.00020353131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059927267,0.00022022412,0.00042744586,0.00015446125,0.0001637984,0.00007557217,0.00045360308,0.00042685875,0.000019961457],"category_scores_gemma":[0.00016789237,0.00020395196,0.00015645534,0.00027060707,0.00036965995,0.000012046922,0.00023628674,0.00055875443,0.000007100452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089142774,0.00022889815,0.8736555,0.000059594724,0.00016831073,0.000034410474,0.0002720053,0.00020048933,0.11840358,0.000032382577,0.00037413364,0.005679278],"study_design_scores_gemma":[0.0023158195,0.0003447777,0.9505123,0.00018543721,0.000049157185,0.0000012268209,0.00016314963,0.0003642455,0.043394182,0.0015318341,0.00084005104,0.00029785014],"about_ca_topic_score_codex":0.011848669,"about_ca_topic_score_gemma":0.010081223,"teacher_disagreement_score":0.07685678,"about_ca_system_score_codex":0.00007607572,"about_ca_system_score_gemma":0.00056798157,"threshold_uncertainty_score":0.99473155},"labels":[],"label_agreement":null},{"id":"W4417209341","doi":"10.1158/1557-3265.earlyonsetca25-c032","title":"Abstract C032: Visceral fat area and age-related differences in visceral adipose tissue gene expression: implications for early-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adipokine; Colorectal cancer; Adipose tissue; Intra-Abdominal Fat; Visceral fat; Adiponectin; Cancer; Gene","score_opus":0.13521589041959542,"score_gpt":0.48530372521913806,"score_spread":0.35008783479954264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822041,0.010313597,0.000030201327,0.004797326,0.00023726559,0.0015741584,0.00028361627,0.000041619776,0.000518148],"genre_scores_gemma":[0.99371403,0.0029423235,0.00008290079,0.00020816627,0.00030464353,0.0011940873,0.00007538163,0.000022754002,0.0014556879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974934,0.0002595837,0.00061436417,0.0007190039,0.00035134377,0.000562294],"domain_scores_gemma":[0.9979532,0.00091570965,0.00006262733,0.00042011973,0.0002370901,0.0004112709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094278774,0.00018970662,0.00067443086,0.00021970639,0.00025775604,0.00008168879,0.00022013843,0.0003075288,0.00022750499],"category_scores_gemma":[0.00041122726,0.00015666473,0.00028918733,0.0004995465,0.00055744505,0.00008276022,0.00019911678,0.00092366734,0.000005992923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023174412,0.00046999336,0.93999887,0.00022442936,0.0005367236,0.0000695001,0.0001454711,0.0000060947673,0.017211197,0.00006808178,0.0055328943,0.033419292],"study_design_scores_gemma":[0.0034766777,0.00024411536,0.9885763,0.00053313765,0.00018450669,0.000004676161,0.00002901989,0.000059136444,0.0048180595,0.00082311657,0.0010939083,0.00015732434],"about_ca_topic_score_codex":0.001150201,"about_ca_topic_score_gemma":0.00053253956,"teacher_disagreement_score":0.04857744,"about_ca_system_score_codex":0.00014280269,"about_ca_system_score_gemma":0.0005527497,"threshold_uncertainty_score":0.63886017},"labels":[],"label_agreement":null},{"id":"W4417209366","doi":"10.1158/1557-3265.earlyonsetca25-b029","title":"Abstract B029: Clinical and Sociodemographic Associations Between Early-Onset and Late-Onset Colorectal Cancer in a U.S.–Mexico Border Population","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Comorbidity; Population; Cancer; Young adult; Population based study; Family history","score_opus":0.1296083776500052,"score_gpt":0.5514340146083316,"score_spread":0.4218256369583264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856706,0.0054547596,0.0000030660187,0.0069588837,0.00036538002,0.0010071667,0.00034973153,0.000039114726,0.00015127593],"genre_scores_gemma":[0.97832406,0.02042132,0.000029579041,0.00039871744,0.00038847007,0.00013751493,0.000095492025,0.000023776964,0.00018110011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958517,0.0009397673,0.0012104247,0.00069321226,0.0006476305,0.00065725256],"domain_scores_gemma":[0.9955562,0.0031957508,0.00012710482,0.00029046802,0.00031782564,0.0005126872],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0077284155,0.00017768923,0.0009444506,0.00042518112,0.00030140328,0.00005812255,0.00011286479,0.00068297936,0.00009765023],"category_scores_gemma":[0.0025312179,0.00015508269,0.00030999747,0.0009575931,0.00074235065,0.00009430947,0.0001483453,0.002413865,0.0000068600034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044482734,0.000124156,0.9450395,0.00011030924,0.00028107464,0.00001311421,0.00008891461,0.000002076052,0.0000013906954,0.0000062872336,0.0011669876,0.052721348],"study_design_scores_gemma":[0.0032800774,0.0001944375,0.99397236,0.00028557357,0.00013333441,0.0000010775634,0.0000491967,0.000061020513,0.0000050667254,0.0005406741,0.0013421761,0.0001349984],"about_ca_topic_score_codex":0.014882282,"about_ca_topic_score_gemma":0.009385509,"teacher_disagreement_score":0.05258635,"about_ca_system_score_codex":0.00022265282,"about_ca_system_score_gemma":0.0012098762,"threshold_uncertainty_score":0.9998876},"labels":[],"label_agreement":null},{"id":"W4417209579","doi":"10.1158/1557-3265.earlyonsetca25-a006","title":"Abstract A006: Natural interception of drug resistance in breast cancer: Nanoencapsulation of Terfezia extracts enhances doxorubicin sensitivity in early-onset models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Doxorubicin; Breast cancer; Anthracycline; Drug; Tolerability; Drug resistance; Cancer","score_opus":0.0552809482355644,"score_gpt":0.40696628480609215,"score_spread":0.35168533657052775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949997,0.0027868557,0.00016193122,0.00027661424,0.0006573686,0.00047359875,0.00013872636,0.00003522875,0.00046995195],"genre_scores_gemma":[0.99613714,0.0033699523,0.00013214906,0.000017473052,0.0000782917,0.00007356289,0.000009800623,0.000028636052,0.00015298044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970951,0.00018942672,0.0012429788,0.00039669094,0.0005636863,0.0005121225],"domain_scores_gemma":[0.998044,0.0010117763,0.00014722513,0.00038127849,0.00034177516,0.00007392934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027464794,0.00019844032,0.00059471425,0.00054515316,0.000035335757,0.000023419409,0.00028845578,0.00021552463,0.00004513014],"category_scores_gemma":[0.00015038619,0.00019709449,0.00011774635,0.0011866656,0.00033610724,0.00046150025,0.00008584392,0.0012013831,0.0000031198058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056617283,0.00059959816,0.3556466,0.0031625174,0.00020129872,0.000050083734,0.0033366345,0.054103635,0.5187257,0.0003751856,0.0018003962,0.0563366],"study_design_scores_gemma":[0.0014454321,0.000025976215,0.9097925,0.0028975923,0.000011834892,5.223491e-7,0.00014476101,0.013648247,0.068249986,0.0035129744,0.00004972074,0.00022045254],"about_ca_topic_score_codex":0.0050047953,"about_ca_topic_score_gemma":0.04604199,"teacher_disagreement_score":0.5541459,"about_ca_system_score_codex":0.0006659171,"about_ca_system_score_gemma":0.00034461002,"threshold_uncertainty_score":0.9713653},"labels":[],"label_agreement":null},{"id":"W4417210744","doi":"10.1158/1557-3265.earlyonsetca25-c031","title":"Abstract C031: Evexomostat (SDX-7320), a methionine aminopeptidase type 2 (METAP2) inhibitor, inhibits obesity-accelerated tumor growth and stimulates weight loss in obese mice","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weight loss; Ovariectomized rat; Obesity; Adipose tissue; Diet-induced obese; Methionine; Mammary tumor; Weight gain; White adipose tissue","score_opus":0.12070829159836349,"score_gpt":0.47980575682367776,"score_spread":0.35909746522531427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417210744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870039,0.0025381646,0.000007983802,0.0073886295,0.0001382598,0.00072537165,0.00004244528,0.00008449312,0.0020707152],"genre_scores_gemma":[0.9920588,0.0026334422,0.00020445818,0.0018751505,0.0003651489,0.00008899822,0.00009254084,0.000043137195,0.0026383072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99498826,0.00072880764,0.001392003,0.0010904244,0.0009220693,0.0008784231],"domain_scores_gemma":[0.99561733,0.0018333785,0.00015629415,0.000511837,0.0012583027,0.000622874],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034666727,0.00036160627,0.0010613973,0.0010174129,0.00025825272,0.00013294978,0.00026000576,0.00035005095,0.0010862325],"category_scores_gemma":[0.0039004907,0.0003035921,0.00023206027,0.0035060316,0.000827679,0.00026030117,0.00037359376,0.0024344234,0.00015388089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007759915,0.0050180703,0.8050644,0.002291178,0.00082522,0.0030997852,0.00045505975,0.000036000092,0.14090991,0.0009805581,0.021775035,0.01178486],"study_design_scores_gemma":[0.020937925,0.0015946568,0.743875,0.011162244,0.00037042677,0.00004815854,0.0005359208,0.0019414487,0.20867856,0.0022910542,0.0074588046,0.0011057771],"about_ca_topic_score_codex":0.0015402674,"about_ca_topic_score_gemma":0.0009775611,"teacher_disagreement_score":0.06776865,"about_ca_system_score_codex":0.00027812133,"about_ca_system_score_gemma":0.0011450166,"threshold_uncertainty_score":0.99994165},"labels":[],"label_agreement":null},{"id":"W4417210855","doi":"10.1158/1557-3265.earlyonsetca25-pr012","title":"Abstract PR012: Transcriptomic and pathway analyses patterns in early-onset and late-onset microsatellite stable colorectal cancer: Results from the ORIEN Network","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Microsatellite instability; Colorectal cancer; Transcriptome; Microsatellite; Cancer; Germline; Exome; Genomics","score_opus":0.0922474449862485,"score_gpt":0.4380795870415172,"score_spread":0.34583214205526874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417210855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97646666,0.018867644,0.00000910846,0.0012712113,0.0003260997,0.0004317037,0.0024989052,0.0000058994497,0.00012276627],"genre_scores_gemma":[0.94425535,0.054333318,0.000028102726,0.0004890482,0.0003917063,0.00011406271,0.0001744529,0.00001908658,0.00019489085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976425,0.00030918946,0.0005927678,0.00072614936,0.00018394641,0.0005454236],"domain_scores_gemma":[0.99790066,0.0013402774,0.00008483831,0.00038281488,0.00014087015,0.00015052044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016845112,0.00017809025,0.0003208951,0.000050046074,0.00020016714,0.0001524129,0.00031195558,0.00022717968,0.000023159238],"category_scores_gemma":[0.00047437893,0.00014175766,0.00008123935,0.00027744967,0.00046206143,0.000007415083,0.00028036901,0.0006077422,0.00000171619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026255671,0.000070410904,0.9745892,0.00002794968,0.00013916155,0.000014466519,0.000189033,0.00016558953,0.0074817534,0.00000592368,0.0052595977,0.009431301],"study_design_scores_gemma":[0.0019075992,0.0001800562,0.96446794,0.00016098039,0.000027911037,6.5341357e-7,0.00010009398,0.00007024509,0.011569083,0.00041697867,0.02092577,0.00017270712],"about_ca_topic_score_codex":0.02437172,"about_ca_topic_score_gemma":0.051270723,"teacher_disagreement_score":0.035465676,"about_ca_system_score_codex":0.00006342742,"about_ca_system_score_gemma":0.00068104663,"threshold_uncertainty_score":0.98212504},"labels":[],"label_agreement":null},{"id":"W4417212708","doi":"10.1158/1557-3265.earlyonsetca25-c035","title":"Abstract C035: Altered developmental programming of intestinal stem cells in a maternal obesogenic environment as a risk factor for EO-CRC","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Offspring; Immune system; Carcinogenesis; Pathological; Cancer; Cytokine; Cancer stem cell","score_opus":0.20409664627662627,"score_gpt":0.500907901552438,"score_spread":0.29681125527581176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417212708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664927,0.0006792555,0.00009524409,0.00025548477,0.00028008662,0.001653163,0.00018552945,0.00001675023,0.00018522555],"genre_scores_gemma":[0.99595577,0.0012288752,0.0011572402,0.00006340707,0.00018122926,0.00042173112,0.000005616495,0.000026397744,0.00095974753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970914,0.00013000795,0.0010267404,0.0005480542,0.0006039791,0.0005997879],"domain_scores_gemma":[0.9982727,0.0009148858,0.00016996442,0.0002653309,0.0001389742,0.00023810242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016440188,0.00017595255,0.0005460128,0.00025455438,0.000081150116,0.0000319919,0.0002529358,0.00016047897,0.0007501432],"category_scores_gemma":[0.00026138866,0.00014797384,0.00023083466,0.0002858615,0.00033514248,0.00004887851,0.00019436279,0.0009412181,0.000036518464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030261893,0.00045903263,0.53856385,0.00042226238,0.0001327938,0.00002237347,0.00024247455,0.0000070172864,0.004578449,0.000010706709,0.00030888914,0.45222598],"study_design_scores_gemma":[0.004946636,0.0011195249,0.9322679,0.001043622,0.00005265173,0.0000045549277,0.00056400057,0.00012404835,0.03298844,0.00012120294,0.026585536,0.00018189376],"about_ca_topic_score_codex":0.0032257915,"about_ca_topic_score_gemma":0.000609091,"teacher_disagreement_score":0.4520441,"about_ca_system_score_codex":0.0007473016,"about_ca_system_score_gemma":0.0012345841,"threshold_uncertainty_score":0.8213542},"labels":[],"label_agreement":null},{"id":"W4417213901","doi":"10.1158/1557-3265.earlyonsetca25-b024","title":"Abstract B024: Feasibility of survey-based data collection in a diverse colorectal cancer cohort: Early-onset vs. average-onset","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer; Cohort; Data collection; Quality of life (healthcare); Incidence (geometry); Psychological intervention; Clinical endpoint; Baseline (sea)","score_opus":0.3434410378495047,"score_gpt":0.5548343551026851,"score_spread":0.2113933172531804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417213901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932096,0.0013287447,0.000016002445,0.0009759828,0.00077446544,0.0020665163,0.0013776106,0.0000274439,0.00022366061],"genre_scores_gemma":[0.995104,0.0036655692,0.000031062813,0.00020231807,0.00012228654,0.00017351327,0.00038226496,0.000019724856,0.0002992159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99442303,0.001813677,0.0010581643,0.00094481214,0.001104611,0.00065571634],"domain_scores_gemma":[0.99396944,0.0033948822,0.00013218788,0.0012856253,0.00081941776,0.0003984484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016272578,0.00017881581,0.00097052864,0.00043399955,0.00017746029,0.000025615327,0.00044636228,0.00038136306,0.00059196603],"category_scores_gemma":[0.007161783,0.00015396874,0.00028506416,0.0019119974,0.00073233387,0.00008597265,0.00033032655,0.0017924636,0.000019006342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012419413,0.00057248125,0.9596911,0.0004738302,0.00021591704,0.000046681565,0.000041999087,0.000033060795,0.000017532107,4.427347e-7,0.021130247,0.0053573134],"study_design_scores_gemma":[0.004887214,0.00034713343,0.99164796,0.00039644586,0.000076120275,0.0000013342205,0.00003291851,0.0007025527,0.00022462368,0.000015123245,0.0015509629,0.00011760886],"about_ca_topic_score_codex":0.17896865,"about_ca_topic_score_gemma":0.096466504,"teacher_disagreement_score":0.08250215,"about_ca_system_score_codex":0.0009177641,"about_ca_system_score_gemma":0.008290407,"threshold_uncertainty_score":0.9973317},"labels":[],"label_agreement":null},{"id":"W4417458323","doi":"10.1158/1078-0432.ccr-25-1818","title":"KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Olaparib; Chemotherapy; Breast cancer; Clinical endpoint; Immunotherapy","score_opus":0.18903189963681183,"score_gpt":0.5269343380585764,"score_spread":0.33790243842176454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417458323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92207295,0.01496405,0.00047373105,0.048633315,0.0036498434,0.0057383943,0.0019116944,0.00021621371,0.0023397906],"genre_scores_gemma":[0.9123474,0.055613622,0.00066021143,0.009192764,0.0025016046,0.0053402027,0.000127045,0.00019065333,0.014026533],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9879617,0.0017535742,0.0038775092,0.0024394726,0.0020711464,0.0018965817],"domain_scores_gemma":[0.98893416,0.005924986,0.00047147155,0.001738395,0.0018893866,0.0010416281],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0050902017,0.00081951113,0.0029288016,0.00079992984,0.00035335682,0.00019000094,0.0010433772,0.0008062124,0.018114911],"category_scores_gemma":[0.0019666601,0.00065588474,0.00078793115,0.0028470356,0.0017917359,0.00035973405,0.0004797196,0.005029121,0.0002483436],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.48688537,0.0053912825,0.12275611,0.0011875731,0.0028875633,0.00091893354,0.0017291455,0.0011845314,0.00007464894,0.00030645862,0.07388713,0.30279124],"study_design_scores_gemma":[0.26977447,0.0059861685,0.562625,0.01229666,0.00074965396,0.000067443296,0.0007488681,0.020498486,0.0010184136,0.0053768163,0.11887406,0.0019839704],"about_ca_topic_score_codex":0.013792678,"about_ca_topic_score_gemma":0.027891828,"teacher_disagreement_score":0.4398689,"about_ca_system_score_codex":0.004793116,"about_ca_system_score_gemma":0.010626177,"threshold_uncertainty_score":0.99958926},"labels":[],"label_agreement":null},{"id":"W4417506867","doi":"10.1158/1078-0432.ccr-25-3541","title":"Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Eisai; Genentech; AstraZeneca; Canada Research Chairs; Genomic Health; Natera; Menarini Silicon Biosystems","keywords":"Repertoire; Head and neck; Head and neck squamous-cell carcinoma; T-cell receptor; Peripheral; Head and neck cancer; Receptor","score_opus":0.0896926933238834,"score_gpt":0.4311432024017427,"score_spread":0.3414505090778593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417506867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840954,0.00213686,8.513271e-7,0.011022825,0.00028602642,0.0015526494,0.000025573803,0.000021211748,0.0008586148],"genre_scores_gemma":[0.99350834,0.00049613114,0.0004927229,0.0012012081,0.0001588359,0.00032709813,0.0000056264385,0.000030112851,0.0037799173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970691,0.00032209558,0.00084342813,0.00074828346,0.00041585695,0.00060123316],"domain_scores_gemma":[0.99822515,0.0007736009,0.000051316485,0.00037286535,0.000114245624,0.0004628127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010727514,0.00023464438,0.0006094365,0.00038829035,0.0000965607,0.00006702105,0.00013949514,0.00022870259,0.000059854414],"category_scores_gemma":[0.00063306524,0.00019089789,0.00008952567,0.0008299881,0.00033753167,0.000051926716,0.0001915245,0.0006171527,0.0000048246015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028767493,0.000437764,0.9401551,0.00017556851,0.000016798655,0.000032978478,0.0016392061,0.000009444396,0.011172028,0.0000019955373,0.0019462749,0.041536123],"study_design_scores_gemma":[0.011294292,0.0057093543,0.96299446,0.0005108062,0.00001664362,0.0000015272383,0.0005832541,0.0001408939,0.007789566,0.000013588499,0.010754653,0.0001909917],"about_ca_topic_score_codex":0.011012365,"about_ca_topic_score_gemma":0.006690133,"teacher_disagreement_score":0.04134513,"about_ca_system_score_codex":0.0008546787,"about_ca_system_score_gemma":0.0006120396,"threshold_uncertainty_score":0.9955734},"labels":[],"label_agreement":null},{"id":"W7113895490","doi":"10.1158/1557-3265.earlyonsetca25-b014","title":"Abstract B014: Early-onset breast cancer and reproductive timing: results from the Mexican Teachers’ Cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Breast cancer; Hazard ratio; Proportional hazards model; Menarche; Incidence (geometry); Prospective cohort study; Cohort; Confidence interval; Cancer","score_opus":0.224946705773405,"score_gpt":0.5321430502352696,"score_spread":0.3071963444618646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113895490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94377583,0.0032139616,0.00000178829,0.04792443,0.0005779699,0.000903452,0.0010864501,0.000045370336,0.0024707494],"genre_scores_gemma":[0.9864531,0.0060332553,0.000023087016,0.0010391909,0.0016530976,0.00021229738,0.000040321327,0.00002961019,0.0045160027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964194,0.00030317734,0.00075512205,0.0011778298,0.0007708216,0.0005736382],"domain_scores_gemma":[0.9955356,0.0023681968,0.00013089497,0.001131676,0.000503177,0.0003304693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004349878,0.00020445183,0.00055607455,0.00010418336,0.00033283417,0.00010580852,0.00033535843,0.0002411833,0.00053811265],"category_scores_gemma":[0.0019777315,0.0001337725,0.00016677208,0.00056537613,0.0011398302,0.00008320288,0.00028292838,0.0021787954,0.00002854291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035271244,0.00013823099,0.7923168,0.000019681669,0.00038783287,0.000020789332,0.0012020966,0.0000018233976,0.00007547087,0.000014036447,0.10147191,0.100824215],"study_design_scores_gemma":[0.002191487,0.00011908735,0.95950574,0.00038216106,0.00013623474,0.0000030188378,0.00077128946,0.000017166081,0.00017033878,0.00028154624,0.036289647,0.0001322956],"about_ca_topic_score_codex":0.09037001,"about_ca_topic_score_gemma":0.005739971,"teacher_disagreement_score":0.16718894,"about_ca_system_score_codex":0.00036093252,"about_ca_system_score_gemma":0.0012845084,"threshold_uncertainty_score":0.9465903},"labels":[],"label_agreement":null},{"id":"W7113896951","doi":"10.1158/1557-3265.earlyonsetca25-b017","title":"Abstract B017: Trends in early-onset colorectal, appendiceal, and anal tumour incidence by histological subtype in Australia from 1990 to 2020: A population-based time-series analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Adenocarcinoma; Cancer; Colorectal cancer; Cohort; Anal cancer; Risk factor; Cohort study","score_opus":0.08128183789650542,"score_gpt":0.4658545856806381,"score_spread":0.38457274778413264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113896951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267787,0.00053179916,0.0000028936975,0.005881922,0.000082650964,0.00034307627,0.00023075166,0.000024879002,0.00022413791],"genre_scores_gemma":[0.9975764,0.00009549211,0.00015487139,0.00039692898,0.0000876754,0.00011286442,0.0003019945,0.000011085818,0.0012626502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672705,0.00039885507,0.0008909438,0.0007709421,0.0005943404,0.0006178639],"domain_scores_gemma":[0.9981059,0.0010675656,0.00009600653,0.00026518616,0.0001306265,0.00033470552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017694086,0.00020343327,0.0008503929,0.00080454873,0.00011726906,0.000073496725,0.00025994924,0.00029932015,0.0024254029],"category_scores_gemma":[0.0007808207,0.00017455466,0.00015289943,0.003165732,0.00042760433,0.0001056111,0.00012942559,0.0010972602,0.000069700225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033955185,0.0002938105,0.98354894,0.000037084043,0.00009801651,0.00029672333,0.00006992828,0.000037214133,0.0015206602,0.00001853662,0.008974037,0.0017095468],"study_design_scores_gemma":[0.0010382321,0.00057543843,0.9961995,0.00021922372,0.00009442287,0.000001422839,0.00005665639,0.00031537426,0.0003797015,0.00016037776,0.0007990125,0.00016064094],"about_ca_topic_score_codex":0.1034082,"about_ca_topic_score_gemma":0.03926612,"teacher_disagreement_score":0.064142086,"about_ca_system_score_codex":0.00036179164,"about_ca_system_score_gemma":0.00034790917,"threshold_uncertainty_score":0.9984865},"labels":[],"label_agreement":null},{"id":"W7113898291","doi":"10.1158/1557-3265.earlyonsetca25-a010","title":"Abstract A010: Are We Delaying Ovarian Cancer Diagnosis in Young Women?: Sensitivity of CA-125 Thresholds for Early-Onset Ovarian cancer in Large Cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cohort; Gynecologic oncology; Referral; Cancer; Serous fluid; Cohort study","score_opus":0.13548399230222435,"score_gpt":0.4943773748922086,"score_spread":0.35889338258998427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97181696,0.0056187413,0.00003264926,0.015275313,0.0009621303,0.0032484308,0.0023613889,0.000033387532,0.00065098674],"genre_scores_gemma":[0.95800734,0.02446203,0.00008797887,0.0006004522,0.00045620062,0.015806152,0.000037338134,0.00006894946,0.0004735517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938404,0.0006301279,0.0016015358,0.0013388952,0.00097231136,0.0016167435],"domain_scores_gemma":[0.99420035,0.0034028783,0.00030487464,0.0008900383,0.00074966246,0.00045222393],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008093723,0.00041536946,0.0016268983,0.00075773435,0.00021175593,0.0000791942,0.00030645748,0.00056702795,0.0016890767],"category_scores_gemma":[0.0012054943,0.0003805568,0.00036065903,0.0019127424,0.00035345022,0.00018147918,0.00027642655,0.0016749857,0.000009486632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026985768,0.0020978916,0.96293473,0.00091744785,0.00066577905,0.00028432006,0.00074098824,0.00012740814,0.00003853728,0.00012776595,0.006661244,0.022705304],"study_design_scores_gemma":[0.010264806,0.00030826684,0.9798968,0.004208969,0.00015188409,0.0000022691588,0.00063564355,0.000466193,0.00048774268,0.0004147785,0.0028632022,0.00029947632],"about_ca_topic_score_codex":0.06966707,"about_ca_topic_score_gemma":0.23339225,"teacher_disagreement_score":0.16372518,"about_ca_system_score_codex":0.0032519717,"about_ca_system_score_gemma":0.0030258666,"threshold_uncertainty_score":0.99986464},"labels":[],"label_agreement":null},{"id":"W7113898421","doi":"10.1158/1557-3265.earlyonsetca25-a028","title":"Abstract A028: Exploring exposure to and metabolism of polycyclic aromatic hydrocarbons (PAHs) in patients with cancer predisposition syndromes (CPS): research in progress","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Toxic Organic Pollutants Impact","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogen; Cancer; Population; Urine; Aryl hydrocarbon receptor; Genetic predisposition; Polycyclic aromatic hydrocarbon","score_opus":0.13005391682710082,"score_gpt":0.4433132777851479,"score_spread":0.3132593609580471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562067,0.00088670646,0.0000014735762,0.0016289431,0.00014110895,0.0011977496,0.00004406307,0.000015661259,0.00046360848],"genre_scores_gemma":[0.9987846,0.00045203938,0.0000921368,0.0000441877,0.000039484672,0.00047486476,0.0000012116743,0.000026667798,0.00008482137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954913,0.0007302681,0.0007448768,0.0006971256,0.0014200794,0.0009163188],"domain_scores_gemma":[0.99822915,0.0008712732,0.00008099817,0.0005043455,0.000008010316,0.0003062501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004570787,0.00017327271,0.0004584064,0.00055228616,0.000109767185,0.000052200085,0.00052407495,0.00014791383,0.00014509527],"category_scores_gemma":[0.0005943904,0.00014206047,0.0000380853,0.0025573326,0.0009416392,0.0003705301,0.0004957292,0.0010963362,0.000019275401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059369736,0.00045641602,0.830522,0.000036140467,0.00002785085,0.000013978794,0.0005054765,0.000018920398,0.00055834855,0.000004350608,0.00010943683,0.16715339],"study_design_scores_gemma":[0.0016829363,0.00036733964,0.99524057,0.00082653674,0.000008458461,3.3022638e-7,0.000179041,0.00003835468,0.0009845677,0.00042374252,0.00011359645,0.0001345059],"about_ca_topic_score_codex":0.003866589,"about_ca_topic_score_gemma":0.00475753,"teacher_disagreement_score":0.16701888,"about_ca_system_score_codex":0.0006525804,"about_ca_system_score_gemma":0.00026276486,"threshold_uncertainty_score":0.58451515},"labels":[],"label_agreement":null},{"id":"W7113898951","doi":"10.1158/1557-3265.earlyonsetca25-a007","title":"Abstract A007: Calcitonin gene-related peptide (CGRP) and receptor activity-modifying protein 1 (RAMP1) drive tumor cell growth in early-onset human gastric cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Calcitonin gene-related peptide; Immunohistochemistry; Stromal cell; Cancer; Cell growth; Receptor; Calcitonin; Orphan receptor","score_opus":0.08978429515848892,"score_gpt":0.4540710682988611,"score_spread":0.3642867731403722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875227,0.005619604,0.000005391619,0.0030955921,0.00030750278,0.0021204175,0.000056618137,0.00007402911,0.0011981103],"genre_scores_gemma":[0.98798865,0.004170425,0.00009350923,0.00025246837,0.0005604642,0.0010325806,0.000016790762,0.000074850985,0.0058102333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945451,0.0010358839,0.0011647542,0.0011721031,0.0008586466,0.0012235107],"domain_scores_gemma":[0.99637496,0.0017425716,0.00024963063,0.00065075065,0.000498572,0.0004835288],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034364148,0.0003975698,0.0010695533,0.0008484608,0.00040745465,0.00012485978,0.00042081455,0.00043371145,0.0005286744],"category_scores_gemma":[0.0015499651,0.00036965447,0.00028521844,0.0015670515,0.00091163215,0.00019415762,0.0002815869,0.0032966803,0.000053504053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016197754,0.0016608711,0.8206952,0.0015726631,0.0003143435,0.00048306162,0.0007365948,0.000016157415,0.10992575,0.000044391538,0.012321832,0.036031343],"study_design_scores_gemma":[0.007783853,0.0012928547,0.91953385,0.0026943998,0.000083468396,0.000016123453,0.00026961637,0.00010239033,0.0624757,0.00015877474,0.0051457663,0.00044320239],"about_ca_topic_score_codex":0.02339473,"about_ca_topic_score_gemma":0.0013871583,"teacher_disagreement_score":0.09883861,"about_ca_system_score_codex":0.00095606456,"about_ca_system_score_gemma":0.0025260772,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W7113898967","doi":"10.1158/1557-3265.earlyonsetca25-a026","title":"Abstract A026: Use of recommended diagnostic breast imaging among women under 40 in a community-based registry","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mammography; Breast cancer; Breast imaging; Medical diagnosis; Breast ultrasound; Cancer registry; Medical imaging; Cancer","score_opus":0.23807074185850866,"score_gpt":0.5038479017184526,"score_spread":0.265777159859944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866396,0.00023319219,0.00003284284,0.011058647,0.00012658583,0.00045025474,0.00005076403,0.000025691115,0.0013824201],"genre_scores_gemma":[0.99736726,0.00017590774,0.000087407425,0.001446187,0.00008184125,0.00019211246,0.000027198874,0.000023619648,0.0005984382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967414,0.0010715644,0.00080289715,0.00033066593,0.00045990627,0.00059355295],"domain_scores_gemma":[0.98902524,0.009153552,0.000108361324,0.0009999359,0.00042353044,0.0002893999],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0049307286,0.00014288531,0.00053144037,0.00039374115,0.00015600793,0.000044363976,0.0003384468,0.00017655182,0.00047281268],"category_scores_gemma":[0.0026806735,0.00012634769,0.00014869953,0.0009010406,0.0007590114,0.00009594255,0.00025943562,0.0028177602,0.0000101209425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015653172,0.0013016084,0.96129745,0.0005239403,0.000054697924,0.000088880166,0.00010481288,0.000038568152,0.00023779461,0.00007305451,0.007195387,0.027518513],"study_design_scores_gemma":[0.0029729283,0.00011519994,0.991299,0.0018241914,0.000020286525,0.000004919234,0.000893409,0.00027356416,0.00008822213,0.00045831566,0.0019527114,0.00009726105],"about_ca_topic_score_codex":0.009215982,"about_ca_topic_score_gemma":0.0010654466,"teacher_disagreement_score":0.030001566,"about_ca_system_score_codex":0.00052411016,"about_ca_system_score_gemma":0.0013297227,"threshold_uncertainty_score":0.99948275},"labels":[],"label_agreement":null},{"id":"W7113898984","doi":"10.1158/1557-3265.earlyonsetca25-a002","title":"Abstract A002: Real-world clinicogenomic comparison of early- and average-onset gastric cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cohort; Disease; Carcinogenesis; Signet ring cell; Immune system; CDH1; Microsatellite instability; Prospective cohort study","score_opus":0.2608322181748289,"score_gpt":0.5651584282480993,"score_spread":0.3043262100732704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787828,0.0040276656,0.000014838254,0.004192162,0.0006392776,0.0008425817,0.00004615639,0.000040841333,0.011413678],"genre_scores_gemma":[0.9725731,0.013025251,0.00011166065,0.00040120995,0.0004028513,0.00012501824,0.000011085782,0.00002541506,0.0133243855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965317,0.00021705401,0.001300291,0.00064274826,0.0006866823,0.000621511],"domain_scores_gemma":[0.9967224,0.0017809409,0.0002294094,0.000589586,0.00038557922,0.00029206125],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026013951,0.0001997735,0.0009766949,0.00067607913,0.00014602057,0.00004860958,0.0003197661,0.00016234876,0.0011669751],"category_scores_gemma":[0.00049992104,0.00017426947,0.0002389658,0.0013458173,0.00065426744,0.000070968934,0.00037203627,0.001271647,0.000033489272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014603343,0.00025334678,0.8574729,0.0004025776,0.0002513719,0.000014574214,0.000063902895,0.000013091701,0.000090438756,0.00015859061,0.032280937,0.10753793],"study_design_scores_gemma":[0.002928567,0.0004005882,0.96761686,0.00044263035,0.00015635538,4.8349904e-7,0.00008775945,0.0001253089,0.00017028574,0.00020435195,0.027749766,0.000117044205],"about_ca_topic_score_codex":0.008183239,"about_ca_topic_score_gemma":0.0032087758,"teacher_disagreement_score":0.11014396,"about_ca_system_score_codex":0.00028104938,"about_ca_system_score_gemma":0.00095565437,"threshold_uncertainty_score":0.9997461},"labels":[],"label_agreement":null},{"id":"W7113899212","doi":"10.1158/1557-3265.earlyonsetca25-a023","title":"Abstract A023: Cell-Free DNA: A Paradigm Shift in Cancer Diagnostics and Precision Medicine","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision medicine; Precision oncology; Digital polymerase chain reaction; Circulating tumor DNA; Cell-free fetal DNA; Personalized medicine; Cancer; Liquid biopsy; Minimal residual disease","score_opus":0.0977671510184656,"score_gpt":0.48487710132954936,"score_spread":0.38710995031108375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113899212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9355171,0.047511823,0.00008121407,0.012824025,0.00078371743,0.00054503395,0.00012125045,0.000007941532,0.002607932],"genre_scores_gemma":[0.85906786,0.13863124,0.000033751556,0.00085707876,0.000778541,0.0002218133,0.000026051444,0.000021670348,0.000361988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976873,0.00016314955,0.0006233336,0.00069848873,0.00032416117,0.0005035908],"domain_scores_gemma":[0.9971928,0.0016812425,0.00007799522,0.00069999864,0.000130131,0.00021785844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018816389,0.0001741817,0.00034604434,0.00015584662,0.00011210398,0.000043144784,0.00052437634,0.00032196386,0.00012983735],"category_scores_gemma":[0.0033345507,0.00015450644,0.00007148623,0.00035250332,0.0005822587,0.000004813952,0.0006637454,0.00061728194,0.0000060765915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00215427,0.0009068634,0.4673586,0.0004884882,0.0001527654,0.00008651106,0.00022418762,0.00025433445,0.011118338,0.0029938475,0.40558484,0.108676955],"study_design_scores_gemma":[0.00509186,0.000789103,0.6734651,0.0005915318,0.000039572937,7.820654e-7,0.00007870169,0.000072794996,0.005862356,0.016682753,0.2969865,0.0003389624],"about_ca_topic_score_codex":0.0028482287,"about_ca_topic_score_gemma":0.009369177,"teacher_disagreement_score":0.2061065,"about_ca_system_score_codex":0.00009777908,"about_ca_system_score_gemma":0.00077432557,"threshold_uncertainty_score":0.630059},"labels":[],"label_agreement":null},{"id":"W7113899263","doi":"10.1158/1557-3265.earlyonsetca25-b006","title":"Abstract B006: Early-onset colorectal cancer: 10 year review of histopathological trends in a tertiary hospital in Accra, Ghana","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Histopathology; Stage (stratigraphy); Pathological; Cancer; Medical diagnosis; Retrospective cohort study; Metastasis","score_opus":0.103804417180166,"score_gpt":0.49542439453428366,"score_spread":0.3916199773541177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113899263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656127,0.023077184,0.0000015089346,0.004877333,0.00039670806,0.00059467694,0.000038588238,0.000035756337,0.0053655175],"genre_scores_gemma":[0.98259115,0.014838746,0.000039749822,0.00035973956,0.00018621105,0.00048989226,0.000016214832,0.000017408001,0.001460894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664,0.00044935057,0.0010698995,0.0006666129,0.0006367073,0.00053737813],"domain_scores_gemma":[0.99832076,0.00068572024,0.00013046041,0.0003687738,0.00031590313,0.00017840856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034999533,0.00017473854,0.0008146148,0.000664587,0.00004906578,0.000013931463,0.0002763803,0.00031597086,0.0019224439],"category_scores_gemma":[0.0018496019,0.00015044953,0.0002659787,0.0020209856,0.00046161807,0.00007302083,0.00019628946,0.0017091254,0.00002312287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007185809,0.0007173779,0.77146137,0.0013557526,0.00003367051,0.00017204619,0.000087880355,0.0000016118961,0.00011645866,0.00000862349,0.018931897,0.1999275],"study_design_scores_gemma":[0.0020861567,0.0025402647,0.98435944,0.007032212,0.000029484547,0.0000028208035,0.000050297655,0.00003468582,0.00041760766,0.00005225085,0.0032611561,0.00013361567],"about_ca_topic_score_codex":0.005213884,"about_ca_topic_score_gemma":0.0031404786,"teacher_disagreement_score":0.21289806,"about_ca_system_score_codex":0.0007365804,"about_ca_system_score_gemma":0.00088578335,"threshold_uncertainty_score":0.99898994},"labels":[],"label_agreement":null},{"id":"W7113900680","doi":"10.1158/1557-3265.earlyonsetca25-a033","title":"Abstract A033: Community-Based Pilot Study of Colorectal Cancer Susceptibility and Cardiometabolic Risk in Young Hispanic Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Family history; Young adult; Cancer; Body mass index; Diabetes mellitus; Demographics; Aspirin; Cancer prevention; Descriptive statistics","score_opus":0.16541786361236877,"score_gpt":0.512983973973709,"score_spread":0.3475661103613402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113900680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188983,0.004719411,0.0000018436774,0.00029251227,0.00042597618,0.00224379,0.000093057715,0.000025751953,0.00030784786],"genre_scores_gemma":[0.9921633,0.00723444,0.000012195664,0.00007297671,0.00013431706,0.0003166672,0.0000118217495,0.000020908974,0.00003336063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99385875,0.0031274047,0.0010272282,0.00053378823,0.0008646713,0.00058815145],"domain_scores_gemma":[0.9955393,0.0024575067,0.00012768744,0.00087807636,0.0006416561,0.00035574293],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01231322,0.00018158216,0.0011748287,0.0005193707,0.0002651903,0.000017243852,0.00025435287,0.0001693636,0.00007637201],"category_scores_gemma":[0.0025031888,0.00014838474,0.00023040542,0.0014092928,0.00065103965,0.000043883985,0.0002188278,0.0034409487,0.0000032702349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008557843,0.0028489158,0.96221423,0.0009252798,0.0003004102,0.000014076839,0.00049050845,0.000046382935,0.00016789485,0.0000019890085,0.00018948848,0.024242956],"study_design_scores_gemma":[0.011120946,0.0036819861,0.9822579,0.00041716773,0.00015947172,7.0088925e-7,0.0016918618,0.0000936429,0.00012024779,0.00001725156,0.00033307643,0.0001057667],"about_ca_topic_score_codex":0.31626767,"about_ca_topic_score_gemma":0.24492954,"teacher_disagreement_score":0.07133812,"about_ca_system_score_codex":0.0004263493,"about_ca_system_score_gemma":0.0019903064,"threshold_uncertainty_score":0.99885815},"labels":[],"label_agreement":null},{"id":"W7113901088","doi":"10.1158/1557-3265.earlyonsetca25-b010","title":"Abstract B010: Building a global research nextwork focusing on etiology for early-onset colorectal cancer (EOCRC): findings from the Fight Colorectal Cancer 2025 Barcelona Think Tank","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Psychosocial; Epidemiology; Etiology; Global health; Stakeholder; Cancer","score_opus":0.19721506888130985,"score_gpt":0.5374125838781845,"score_spread":0.3401975149968746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113901088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95783246,0.0064019603,0.00011783342,0.025293907,0.0031911905,0.0036621173,0.0008745052,0.00017114458,0.002454893],"genre_scores_gemma":[0.98566115,0.002648383,0.00029309967,0.0017939243,0.0037875227,0.004663701,0.00006091522,0.00007642253,0.001014899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916426,0.001474887,0.0012530943,0.0018777838,0.001686652,0.0020650087],"domain_scores_gemma":[0.9814853,0.015108344,0.00020464131,0.00074924977,0.0019154195,0.00053700845],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00836448,0.0005011246,0.0011245734,0.00042613724,0.0020027717,0.00032977923,0.0010186651,0.0009950349,0.0011388401],"category_scores_gemma":[0.0059789727,0.00038337853,0.00060341135,0.003090645,0.0016603149,0.00016587609,0.00066287216,0.0048895245,0.000057776244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101428576,0.00056379905,0.5103884,0.00025854664,0.0011812508,0.00008957294,0.00064346415,0.00021548443,0.004028304,0.0007485443,0.24551415,0.13493992],"study_design_scores_gemma":[0.005294126,0.0044675525,0.9301394,0.0025755856,0.00021611126,0.000007746838,0.00034256512,0.001358935,0.008726225,0.0068969717,0.03948479,0.00048995594],"about_ca_topic_score_codex":0.042833794,"about_ca_topic_score_gemma":0.024441844,"teacher_disagreement_score":0.41975105,"about_ca_system_score_codex":0.0032040318,"about_ca_system_score_gemma":0.0046760156,"threshold_uncertainty_score":0.99986184},"labels":[],"label_agreement":null},{"id":"W7113902448","doi":"10.1158/1557-3265.earlyonsetca25-a029","title":"Abstract A029: Breast Cancer Screening During Reproductive Years in Women with Germline Pathogenic Variants: Gaps in Counseling and Practice","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer screening; Mammography; Breast cancer; Incidence (geometry); Cancer; Family history; Genetic counseling; Logistic regression","score_opus":0.08901040215752168,"score_gpt":0.4935613728343315,"score_spread":0.4045509706768098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113902448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853663,0.00528086,0.000008762459,0.008061886,0.0001393234,0.00068560237,0.000059004065,0.000023633276,0.0003746312],"genre_scores_gemma":[0.98195165,0.016287733,0.00018284837,0.00045965932,0.00046070735,0.00030177855,0.0000032036849,0.000034169607,0.00031826054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966266,0.0003551537,0.000714568,0.00095623545,0.00061189255,0.00073551567],"domain_scores_gemma":[0.9976186,0.0011090651,0.00012764198,0.0004780562,0.00043068512,0.00023592389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061718742,0.0001721371,0.00055782445,0.00043196173,0.00009489715,0.00005834806,0.00014925058,0.00017637227,0.0003260986],"category_scores_gemma":[0.001349459,0.00014941074,0.000044692766,0.0013209983,0.00044197385,0.00024047958,0.0001418245,0.0019152401,0.000004376367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055842303,0.000878879,0.70796937,0.00066469074,0.00040629556,0.0013835506,0.0034610077,0.0004179335,0.004762727,0.000035423425,0.0005324496,0.22364537],"study_design_scores_gemma":[0.00472839,0.00017334058,0.988371,0.0018525645,0.000031681924,0.00003856218,0.002228254,0.00006612305,0.00004088813,0.000056307887,0.0022573923,0.00015548532],"about_ca_topic_score_codex":0.013388631,"about_ca_topic_score_gemma":0.0032928872,"teacher_disagreement_score":0.28040165,"about_ca_system_score_codex":0.00080884533,"about_ca_system_score_gemma":0.0012929367,"threshold_uncertainty_score":0.9931813},"labels":[],"label_agreement":null},{"id":"W7113902549","doi":"10.1158/1557-3265.earlyonsetca25-a035","title":"Abstract A035: A complex clinical evolution: Mediastinal unicentric Castleman disease preceding paraneoplastic pemphigus and bronchiolitis obliterans","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paraneoplastic pemphigus; Bronchiolitis obliterans; Malignancy; Biopsy; Asymptomatic; Air trapping; Lymph node; Pulmonary function testing","score_opus":0.21921134650627383,"score_gpt":0.5316543470920033,"score_spread":0.3124430005857295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113902549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527002,0.024561767,0.00013543309,0.01499029,0.0015197347,0.0011904874,0.00011415887,0.000105604115,0.004682347],"genre_scores_gemma":[0.98026,0.016207408,0.00005984927,0.0009999337,0.0009884931,0.00013257306,0.000058216126,0.00003112477,0.0012623987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951598,0.00063032843,0.0013076533,0.0009648623,0.00094159937,0.0009957474],"domain_scores_gemma":[0.9938577,0.003671006,0.00016075239,0.0005016478,0.00062937086,0.0011795512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031738514,0.00026049005,0.0008038111,0.00029491508,0.0006094033,0.00028932444,0.00028147345,0.000307529,0.00069141685],"category_scores_gemma":[0.004848288,0.00023407913,0.0003300522,0.0010739854,0.0011732482,0.000211354,0.00023090746,0.0018354275,0.00005200678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005326683,0.00091982854,0.84290624,0.00090538996,0.0003794613,0.0003397338,0.0001306249,0.000030459034,0.000027423135,0.0010091112,0.035822224,0.11220283],"study_design_scores_gemma":[0.007906837,0.0005343456,0.9670228,0.0014166374,0.00023871088,0.000007682692,0.0004883583,0.0014274422,0.000001332165,0.0012989847,0.019439355,0.000217542],"about_ca_topic_score_codex":0.00085956184,"about_ca_topic_score_gemma":0.00075849245,"teacher_disagreement_score":0.12411654,"about_ca_system_score_codex":0.000520995,"about_ca_system_score_gemma":0.0026016985,"threshold_uncertainty_score":0.9545469},"labels":[],"label_agreement":null},{"id":"W7113902760","doi":"10.1158/1557-3265.earlyonsetca25-b004","title":"Abstract B004: The Cleveland Clinic’s Young-Onset Colorectal Cancer Center and Registry: Integrating multidisciplinary clinical care and research infrastructure","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Colorectal cancer; Cancer; Family history; Medical history; Multidisciplinary approach; Medical record; Cancer registry","score_opus":0.14098774666185201,"score_gpt":0.5401648914266247,"score_spread":0.39917714476477273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113902760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764089,0.008748603,0.000013733059,0.006551782,0.0013356773,0.001363569,0.0001502271,0.000070887276,0.0053566466],"genre_scores_gemma":[0.9851002,0.011066944,0.00024603723,0.0002790953,0.0013577403,0.00042134812,0.000029631536,0.00004172192,0.0014572843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99379086,0.001626198,0.0012755368,0.0012807997,0.0011108934,0.0009157011],"domain_scores_gemma":[0.9911612,0.005962318,0.0001843898,0.000694008,0.0014964689,0.0005016169],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009901187,0.00029981378,0.00077710074,0.00031177377,0.0011872088,0.00024193407,0.00041866084,0.0007103096,0.00022607314],"category_scores_gemma":[0.005820653,0.00020079715,0.000247053,0.0010765033,0.0032187398,0.00012357361,0.0010493296,0.006678617,0.000012942044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011171092,0.00011084645,0.7863168,0.00029988034,0.0001633644,0.000039314287,0.00078513153,0.0000013151845,0.000059980743,0.000021232465,0.024181148,0.17684986],"study_design_scores_gemma":[0.0036826162,0.0027231055,0.9685405,0.001182001,0.0000715638,0.000039354894,0.0050715343,0.00036185063,0.00013738404,0.00044631053,0.0175491,0.00019469317],"about_ca_topic_score_codex":0.0035711005,"about_ca_topic_score_gemma":0.008053585,"teacher_disagreement_score":0.18222365,"about_ca_system_score_codex":0.00043002967,"about_ca_system_score_gemma":0.002096588,"threshold_uncertainty_score":0.99949396},"labels":[],"label_agreement":null},{"id":"W7113904464","doi":"10.1158/1557-3265.earlyonsetca25-b018","title":"Abstract B018: Early-onset ovarian cancer in U.S. veterans: A National Cancer Database study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Logistic regression; Cancer; Cohort; Retrospective cohort study; Cohort study; Fallopian tube","score_opus":0.30878318328812354,"score_gpt":0.5968792021292982,"score_spread":0.2880960188411747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113904464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96594363,0.006425502,0.0000036055021,0.019454397,0.0011299565,0.0023984546,0.00090182526,0.000045392964,0.0036972149],"genre_scores_gemma":[0.9837543,0.007444333,0.000057007004,0.0014565929,0.0008527871,0.004822231,0.000041285253,0.000039693794,0.001531807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505067,0.00047681958,0.0010588621,0.0011395415,0.0014720424,0.000802075],"domain_scores_gemma":[0.99650085,0.0014976623,0.00010533511,0.00070990645,0.00082208414,0.00036416177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037686648,0.00027741192,0.0007419385,0.00056021847,0.00020247816,0.00010123709,0.00037844037,0.00021169479,0.0043967003],"category_scores_gemma":[0.0007502257,0.00023425372,0.00019865949,0.0014766625,0.0003242349,0.00016935274,0.00023688645,0.0016062631,0.000086651926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021436196,0.0038646185,0.914067,0.00017996444,0.0006062477,0.0003103758,0.00029687854,0.000034066627,0.00004135628,0.000119716125,0.02401365,0.054322563],"study_design_scores_gemma":[0.010304693,0.00051944883,0.9691618,0.0013513337,0.00012251697,0.0000012284283,0.00019931718,0.00007468573,0.00010949612,0.00021815124,0.017748168,0.00018912842],"about_ca_topic_score_codex":0.054622274,"about_ca_topic_score_gemma":0.03349156,"teacher_disagreement_score":0.055094887,"about_ca_system_score_codex":0.0016534677,"about_ca_system_score_gemma":0.005152362,"threshold_uncertainty_score":0.9965134},"labels":[],"label_agreement":null},{"id":"W7113904748","doi":"10.1158/1557-3265.earlyonsetca25-a013","title":"Abstract A013: 225Actinium and tandem 177Lutetium/225Actinium - FAPi therapy in medullary thyroid carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Calcitonin; Thyroid carcinoma; Progressive disease; Adverse effect; Thyroid cancer; Medullary thyroid cancer; Carcinoma","score_opus":0.19918230943351187,"score_gpt":0.5324398239048612,"score_spread":0.3332575144713493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113904748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95530957,0.0037989975,0.0000064419073,0.020093111,0.00014370246,0.0004838867,0.00001666833,0.00004711595,0.020100536],"genre_scores_gemma":[0.98595893,0.0072423196,0.000043740587,0.002611057,0.00050669967,0.000112132795,0.000021269656,0.000024993658,0.003478844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966102,0.00042461642,0.0008655003,0.00072463835,0.0007296291,0.0006454138],"domain_scores_gemma":[0.99705166,0.0015833011,0.00009338893,0.000498625,0.0003890975,0.00038394803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035165234,0.00020348598,0.00065884064,0.0005594829,0.00017915647,0.00007249775,0.00020614867,0.00034157478,0.0013409328],"category_scores_gemma":[0.0010397861,0.00016694337,0.00024145178,0.0011483061,0.00058741966,0.000111192065,0.00015760296,0.002027147,0.00006009862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025647623,0.0012348356,0.85851026,0.00024273094,0.00027417258,0.00042517972,0.00024191863,0.0000031296868,0.014561512,0.00029546377,0.054839693,0.06680634],"study_design_scores_gemma":[0.0058572516,0.00053292926,0.9592439,0.00073728425,0.000030890897,0.000008370674,0.0006762375,0.00015307883,0.0060670753,0.00046600946,0.026018282,0.00020871528],"about_ca_topic_score_codex":0.0011760105,"about_ca_topic_score_gemma":0.0005440878,"teacher_disagreement_score":0.10073361,"about_ca_system_score_codex":0.00019494594,"about_ca_system_score_gemma":0.00097441755,"threshold_uncertainty_score":0.999572},"labels":[],"label_agreement":null},{"id":"W7113904863","doi":"10.1158/1557-3265.earlyonsetca25-b016","title":"Abstract B016: Survival differences after diagnosis of early-onset colorectal cancer by race/ethnicity and neighborhood-level socioeconomic status","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Hazard ratio; Socioeconomic status; Incidence (geometry); Proportional hazards model; Cancer; Comorbidity; Confidence interval; Household income","score_opus":0.13515458615929568,"score_gpt":0.4877126637308485,"score_spread":0.3525580775715528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113904863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97261506,0.02222409,0.000005027171,0.002383327,0.0006747295,0.0007730219,0.0009783012,0.000020922113,0.00032551613],"genre_scores_gemma":[0.92533505,0.07327567,0.000010848002,0.00023227198,0.00025514956,0.00051454554,0.000016113532,0.000022080761,0.0003382821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659806,0.0005122499,0.00083388196,0.00064221787,0.0006114082,0.00080214767],"domain_scores_gemma":[0.9956425,0.0029270155,0.00009427234,0.0003658874,0.00036769555,0.0006026593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024649086,0.00020584106,0.0010271276,0.00016623683,0.00015047188,0.00003497795,0.00017597833,0.00036866826,0.0011279751],"category_scores_gemma":[0.0008155646,0.00016084984,0.0003699741,0.00026844506,0.0010923608,0.00007382952,0.00020143994,0.0013733245,0.000018506353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024835835,0.00020091324,0.9425423,0.00039076913,0.00042296675,0.000010168333,0.0001439648,4.4263894e-7,0.000044587057,0.000007713638,0.006517975,0.04723461],"study_design_scores_gemma":[0.002394436,0.00035655856,0.9930277,0.0002670877,0.00011312997,5.4221636e-7,0.00014012726,0.00001495126,0.00059270643,0.00011163569,0.0028391583,0.0001419735],"about_ca_topic_score_codex":0.024598742,"about_ca_topic_score_gemma":0.0045226407,"teacher_disagreement_score":0.051051583,"about_ca_system_score_codex":0.0003259144,"about_ca_system_score_gemma":0.0021061988,"threshold_uncertainty_score":0.9997851},"labels":[],"label_agreement":null},{"id":"W7113905652","doi":"10.1158/1557-3265.earlyonsetca25-a008","title":"Abstract A008: Psychosocial Survivorship Gaps in Early-Onset Cancers: Opportunities for Digital Health Research","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychosocial; Survivorship curve; Intervention (counseling); Pace; Cancer survivorship; Focus group; Scope (computer science); Health care; Participatory action research","score_opus":0.5751743848689548,"score_gpt":0.6007769247431088,"score_spread":0.025602539874154062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113905652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9212073,0.0056198672,0.000017401808,0.04973256,0.0019745452,0.0023595938,0.0006167732,0.00007676621,0.018395204],"genre_scores_gemma":[0.97897935,0.005694627,0.000017559494,0.0016268664,0.001434537,0.001392428,0.000110594265,0.00006211926,0.010681905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99309134,0.001085554,0.0013360407,0.0010570685,0.0015601035,0.0018699026],"domain_scores_gemma":[0.99062455,0.0060271793,0.00011986102,0.00083079323,0.0016349145,0.00076269906],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.017038176,0.00026177426,0.0009393186,0.0009967757,0.00047633616,0.0002744984,0.0006228369,0.00044793836,0.0003244907],"category_scores_gemma":[0.0031480489,0.000251425,0.00037309225,0.001948843,0.0013790468,0.0002298278,0.0002537,0.003188114,0.000037127644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01001768,0.0008057916,0.4684967,0.002241557,0.0002190649,0.000110900095,0.0030455654,0.0000025108702,0.000010313353,0.0016915802,0.28180635,0.23155196],"study_design_scores_gemma":[0.0065131485,0.0022529673,0.5276819,0.0034799692,0.000022219936,0.0000029727246,0.015098149,0.000030107056,0.000073041294,0.009604506,0.4348034,0.00043762816],"about_ca_topic_score_codex":0.045288906,"about_ca_topic_score_gemma":0.11197293,"teacher_disagreement_score":0.23111433,"about_ca_system_score_codex":0.0019617297,"about_ca_system_score_gemma":0.010181794,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W7113906019","doi":"10.1158/1557-3265.earlyonsetca25-a036","title":"Abstract A036: Afferent loop syndrome in a young patient with extrahepatic cholangiocarcinoma: A challenging postoperative anatomy after complex hepatobiliary surgery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Endoscopic retrograde cholangiopancreatography; Hepatectomy; Biliary tract; Abdomen; Biliary Tract Surgical Procedures; Intrahepatic bile ducts; Common bile duct; Bile duct; Hepatology","score_opus":0.11462528487903748,"score_gpt":0.43952180375927075,"score_spread":0.3248965188802333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113906019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98696125,0.003493017,0.0000068054674,0.0056459517,0.00018289432,0.0014325479,0.000021676808,0.000042572043,0.0022132727],"genre_scores_gemma":[0.99717706,0.00096865796,0.000028139066,0.00068214047,0.000047547383,0.0008150361,0.000037286143,0.000036216043,0.00020791596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629724,0.00040782618,0.00084891496,0.0007861446,0.0008277574,0.00083210855],"domain_scores_gemma":[0.99752265,0.0010937601,0.00006738267,0.000549251,0.0004143709,0.00035258906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016219933,0.00026798213,0.0008186998,0.0006386165,0.00011884355,0.00005523111,0.00018265004,0.00018866954,0.0009098263],"category_scores_gemma":[0.0004907045,0.00019978487,0.00023493696,0.0010030571,0.00043327545,0.000117288844,0.00015810187,0.001443627,0.000031841555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002014708,0.0011736603,0.9800283,0.00047860233,0.00015917739,0.0019439514,0.0004615813,0.0000060731986,0.000062935076,0.000026088632,0.0014581982,0.012186764],"study_design_scores_gemma":[0.0018851972,0.00056250935,0.99409735,0.0013203997,0.00004047114,0.00004963508,0.0011188796,0.00029030736,0.000038646274,0.000054699576,0.00033245084,0.00020945854],"about_ca_topic_score_codex":0.0021257065,"about_ca_topic_score_gemma":0.004164924,"teacher_disagreement_score":0.014069085,"about_ca_system_score_codex":0.00039401778,"about_ca_system_score_gemma":0.0013165392,"threshold_uncertainty_score":0.996196},"labels":[],"label_agreement":null},{"id":"W7113906340","doi":"10.1158/1557-3265.earlyonsetca25-b015","title":"Abstract B015: Impact of sun sensitivity and ultraviolet radiation on the association between blistering sunburns and keratinocyte carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sunburn; Confidence interval; Skin cancer; Basal cell; Basal cell carcinoma; Cancer; Cohort; Lifetime risk","score_opus":0.18959147791465997,"score_gpt":0.5269067756470491,"score_spread":0.33731529773238916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113906340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920641,0.0009889241,0.0000048076217,0.0045975423,0.000091824324,0.0004784941,0.00008235069,0.000009062477,0.0016828908],"genre_scores_gemma":[0.9978058,0.0014137328,0.000013026831,0.00011636089,0.00037886217,0.000031147956,0.000007734615,0.000010812742,0.00022254857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998047,0.00044676237,0.00042025498,0.00032207766,0.00046326398,0.00030063713],"domain_scores_gemma":[0.9927087,0.0064847786,0.00013866578,0.00025515578,0.00030603356,0.00010670333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004526914,0.00011679409,0.00043972253,0.00012508921,0.00017929576,0.00004498475,0.00005867947,0.00014300662,0.000026994385],"category_scores_gemma":[0.0025200981,0.00007944923,0.000101644066,0.00027829484,0.00028887083,0.00005400703,0.00011148064,0.00079576287,0.0000021104815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003653655,0.000040267958,0.9722961,0.000093963215,0.00024433466,0.0000076555425,0.00013576601,0.0000026862213,0.0008156572,0.000045088975,0.0017461589,0.024206953],"study_design_scores_gemma":[0.0011113845,0.00038564534,0.99612164,0.00022474794,0.00006364466,9.630204e-7,0.000074216674,0.000060553455,0.0015202173,0.00007910466,0.0002974066,0.000060445775],"about_ca_topic_score_codex":0.002294267,"about_ca_topic_score_gemma":0.00033263987,"teacher_disagreement_score":0.024146508,"about_ca_system_score_codex":0.00052569207,"about_ca_system_score_gemma":0.00037411883,"threshold_uncertainty_score":0.34682608},"labels":[],"label_agreement":null},{"id":"W7113906601","doi":"10.1158/1557-3265.earlyonsetca25-b012","title":"Abstract B012: Sociodemographic and clinical determinants associated with early-onset breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Logistic regression; Odds ratio; Cohort; Prospective cohort study; Odds; Univariate analysis; Cohort study","score_opus":0.1835118544814505,"score_gpt":0.5601915092745251,"score_spread":0.37667965479307464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113906601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898037,0.002287373,0.0000027238364,0.0055024554,0.0005161401,0.00073776953,0.0003156098,0.00007052331,0.00076373323],"genre_scores_gemma":[0.9840265,0.012398826,0.000014104702,0.0012203475,0.0004810971,0.00016033248,0.000011924413,0.000044150987,0.0016427089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99585474,0.00043625032,0.0010616693,0.0009178016,0.0008566165,0.0008729277],"domain_scores_gemma":[0.99549276,0.0023873688,0.0001915268,0.00055068266,0.0007537304,0.00062392384],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0041219075,0.00026154818,0.00096118177,0.00028061264,0.00032158,0.000093078226,0.00027166205,0.00055353483,0.00048098492],"category_scores_gemma":[0.00082160375,0.00019128037,0.00031146518,0.0010015888,0.002029384,0.000113218426,0.0002048689,0.0025964899,0.00001809586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021225712,0.0004391021,0.8831098,0.00009047537,0.00044576527,0.00007796972,0.000035233938,3.053477e-7,0.000007946627,0.0000074503223,0.009472158,0.10419122],"study_design_scores_gemma":[0.0044572037,0.00060060166,0.989751,0.001318793,0.00022133533,0.000006378547,0.000073552255,0.00006518715,0.00001723652,0.00013663311,0.003147011,0.00020508392],"about_ca_topic_score_codex":0.0049426793,"about_ca_topic_score_gemma":0.0065716975,"teacher_disagreement_score":0.10664119,"about_ca_system_score_codex":0.00027599224,"about_ca_system_score_gemma":0.0020249465,"threshold_uncertainty_score":0.99970454},"labels":[],"label_agreement":null},{"id":"W7116681136","doi":"10.1158/1078-0432.ccr-25-1197","title":"INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Princess Margaret Cancer Centre","funders":"EMD Serono; Genentech; Foundation Medicine; MacroGenics; BeiGene; Astellas Pharma; Mylan; Regeneron Pharmaceuticals; Gilead Sciences; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Head and neck squamous-cell carcinoma; Head and neck; Placebo; Basal cell; Phases of clinical research; Head and neck cancer; Carcinoma","score_opus":0.10950279646438475,"score_gpt":0.4662303413668743,"score_spread":0.35672754490248954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116681136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988897,0.003845174,0.00000760254,0.00064490584,0.00020802679,0.004920195,0.000031985826,0.00001445656,0.00043871487],"genre_scores_gemma":[0.99812204,0.00053412764,0.00003136442,0.00012380038,0.00005917257,0.0005233062,0.000022594817,0.000025897176,0.0005576931],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957428,0.0009039599,0.0013377585,0.00066394004,0.0008303004,0.00052122696],"domain_scores_gemma":[0.9968175,0.0016866892,0.00020689695,0.000566067,0.0005285285,0.00019428115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030282831,0.00024288641,0.0014686545,0.00050843647,0.00017090437,0.00002441974,0.00022384916,0.00012634425,0.00017412746],"category_scores_gemma":[0.00073437457,0.00017236618,0.00016352595,0.0012085716,0.0007204784,0.00007072143,0.00020586795,0.001007184,0.0000011375863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7546133,0.01231772,0.20578848,0.00043085616,0.00020317592,0.000034225523,0.001308894,0.0000040630885,0.000017386821,0.0000033707033,0.00047076444,0.024807768],"study_design_scores_gemma":[0.81729,0.024989963,0.15530498,0.00048424187,0.00022087527,9.0695556e-7,0.00055679464,0.000562849,0.0000838289,0.000027154374,0.00032549098,0.00015289088],"about_ca_topic_score_codex":0.005210857,"about_ca_topic_score_gemma":0.0032539684,"teacher_disagreement_score":0.06267673,"about_ca_system_score_codex":0.00037109712,"about_ca_system_score_gemma":0.0010681234,"threshold_uncertainty_score":0.78772914},"labels":[],"label_agreement":null},{"id":"W7116801625","doi":"10.1158/1078-0432.ccr-25-2239","title":"Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non–Hodgkin Lymphoma (CAPITAL)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Kite Pharma; Astex Pharmaceuticals; BeiGene; Gilead Sciences; AstraZeneca; Eli Lilly and Company","keywords":"Refractory (planetary science); Lymphoma; Limiting; Cancer; Clinical trial; Chemotherapy","score_opus":0.0427337186662007,"score_gpt":0.4066724772703794,"score_spread":0.36393875860417874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116801625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963918,0.001700409,0.00003487025,0.00020717463,0.00028192264,0.00079627824,0.00006986062,0.000010101166,0.0005075918],"genre_scores_gemma":[0.9966742,0.0012136358,0.00021577495,0.0002287746,0.00016696798,0.00010184686,0.00006228107,0.000042781332,0.0012937831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660635,0.00054122874,0.00083200715,0.00087434077,0.0005538041,0.0005922735],"domain_scores_gemma":[0.9979685,0.00044184848,0.00017233932,0.0007173479,0.0005058077,0.00019418063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016204187,0.00024319481,0.0004939796,0.00018191827,0.00010546425,0.000030098523,0.00044907455,0.00043207212,0.00005460495],"category_scores_gemma":[0.0008727116,0.00019113724,0.000099830635,0.0005399257,0.0007148102,0.000012779749,0.0004420913,0.0005484193,0.0000058766886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07702436,0.004699774,0.7092064,0.00058504974,0.0004027442,0.000050276496,0.00026478432,0.00008558381,0.058792904,0.00002874369,0.013976071,0.13488328],"study_design_scores_gemma":[0.04468764,0.010862465,0.82595533,0.0010056803,0.00007534779,0.0000011625808,0.0001912882,0.000053879146,0.087178804,0.00008360579,0.02925837,0.00064645504],"about_ca_topic_score_codex":0.0007185012,"about_ca_topic_score_gemma":0.0007216665,"teacher_disagreement_score":0.13423683,"about_ca_system_score_codex":0.0001877309,"about_ca_system_score_gemma":0.0016107763,"threshold_uncertainty_score":0.77943504},"labels":[],"label_agreement":null}]}